,Word,T,P
0,Fertility,0,1
1,outcome,0,1
2,after,0,0
3,systemic,0,1
4,methotrexate,0,0
5,and,0,1
6,laparoscopic,0,0
7,salpingostomy,0,0
8,for,0,0
9,tubal,0,1
10,pregnancy,0,0
11,.,0,0
12,Behavioral,1,1
13,and,1,1
14,physiological,1,1
15,effects,1,1
16,of,0,1
17,remifentanil,0,0
18,and,0,1
19,alfentanil,0,0
20,in,0,0
21,healthy,0,0
22,volunteers,0,0
23,.,0,0
24,BACKGROUND,0,0
25,The,1,0
26,subjective,1,1
27,and,1,0
28,psychomotor,1,1
29,effects,1,1
30,of,0,0
31,remifentanil,0,0
32,have,0,0
33,not,0,0
34,been,0,0
35,evaluated,0,0
36,.,0,0
37,Accordingly,0,0
38,",",0,0
39,the,0,0
40,authors,0,0
41,used,0,0
42,mood,0,1
43,inventories,0,1
44,and,0,1
45,psychomotor,0,1
46,tests,0,1
47,to,0,0
48,characterize,0,0
49,the,0,0
50,effects,0,0
51,of,0,0
52,remifentanil,0,0
53,in,0,0
54,healthy,0,0
55,",",0,0
56,non-drug-abusing,0,0
57,volunteers,0,0
58,.,0,1
59,Alfentanil,0,0
60,was,0,0
61,used,0,0
62,as,0,0
63,a,0,0
64,comparator,0,0
65,drug,0,0
66,.,0,1
67,METHODS,0,0
68,Ten,0,0
69,healthy,0,0
70,volunteers,0,0
71,were,0,0
72,enrolled,0,0
73,in,0,0
74,a,0,0
75,randomized,0,0
76,",",0,0
77,double-blinded,0,0
78,",",0,1
79,placebo-controlled,0,0
80,",",0,1
81,crossover,0,0
82,trial,0,0
83,in,0,0
84,which,0,0
85,they,0,0
86,received,0,0
87,an,0,0
88,infusion,0,0
89,of,0,1
90,saline,0,0
91,",",0,1
92,remifentanil,0,0
93,",",0,1
94,or,0,1
95,alfentanil,0,0
96,for,0,0
97,120,0,0
98,min,0,0
99,.,0,0
100,The,0,0
101,age-,0,0
102,and,0,0
103,weight-adjusted,0,0
104,infusions,0,1
105,(,0,0
106,determined,0,0
107,with,0,0
108,STANPUMP,0,0
109,",",0,0
110,a,0,0
111,computer,0,0
112,modeling,0,0
113,software,0,0
114,package,0,0
115,),0,1
116,were,0,0
117,given,0,0
118,to,0,0
119,achieve,0,0
120,three,0,0
121,predicted,0,0
122,constant,0,0
123,plasma,0,1
124,levels,0,1
125,for,0,0
126,40,0,0
127,min,0,0
128,each,0,0
129,of,0,0
130,remifentanil,0,0
131,(,0,0
132,0.75,0,0
133,",",0,0
134,1.5,0,0
135,",",0,0
136,and,0,0
137,3,0,1
138,ng/ml,0,0
139,),0,0
140,and,0,1
141,alfentanil,0,0
142,(,0,0
143,16,0,0
144,",",0,0
145,32,0,0
146,",",0,0
147,and,0,0
148,64,0,0
149,ng/ml,0,0
150,),0,0
151,.,0,0
152,Mood,0,1
153,forms,0,0
154,and,0,1
155,psychomotor,0,1
156,tests,0,1
157,were,0,0
158,completed,0,0
159,",",0,0
160,and,0,1
161,miosis,0,1
162,was,0,0
163,assessed,0,0
164,",",0,0
165,during,0,0
166,and,0,0
167,after,0,0
168,the,0,0
169,infusions,0,0
170,.,0,0
171,In,0,0
172,addition,0,0
173,",",0,1
174,analgesia,0,1
175,was,0,0
176,tested,0,0
177,at,0,0
178,each,0,0
179,dose,0,0
180,level,0,1
181,using,0,0
182,a,0,0
183,cold-pressor,0,0
184,test,0,0
185,.,0,0
186,RESULTS,0,0
187,Remifentanil,0,0
188,had,0,0
189,prototypic,1,0
190,micro-like,1,1
191,opioid,1,0
192,subjective,1,1
193,effects,1,1
194,",",1,1
195,impaired,1,1
196,psychomotor,1,1
197,performance,1,1
198,",",1,1
199,and,1,1
200,produced,1,0
201,analgesia,1,1
202,.,1,1
203,Alfentanil,0,0
204,at,0,0
205,the,0,0
206,dose,0,0
207,range,0,0
208,tested,0,0
209,had,0,0
210,more,0,0
211,mild,0,1
212,effects,0,0
213,on,0,0
214,these,0,0
215,measures,0,1
216,",",0,0
217,and,0,0
218,the,0,0
219,analgesia,1,1
220,data,0,0
221,indicated,0,0
222,that,0,0
223,a,0,0
224,40:1,0,0
225,potency,0,1
226,ratio,0,1
227,",",0,0
228,rather,0,0
229,than,0,0
230,the,0,0
231,20:1,0,0
232,ratio,0,0
233,we,0,0
234,used,0,0
235,",",0,0
236,may,0,0
237,exist,0,0
238,between,0,0
239,remifentanil,0,0
240,and,0,1
241,alfentanil,0,0
242,.,0,0
243,A,0,0
244,psychomotor,0,1
245,test,0,1
246,administered,0,0
247,60,0,0
248,min,0,0
249,after,0,0
250,the,0,0
251,remifentanil,0,0
252,infusion,0,0
253,was,0,0
254,discontinued,0,0
255,showed,0,0
256,that,0,0
257,the,0,0
258,volunteers,0,0
259,were,0,0
260,still,0,0
261,impaired,0,0
262,",",0,0
263,although,0,0
264,they,0,0
265,reported,0,0
266,feeling,0,1
267,no,0,0
268,drug,0,0
269,effects,0,0
270,.,0,0
271,CONCLUSIONS,0,0
272,The,0,0
273,notion,0,0
274,that,0,0
275,the,0,0
276,pharmacodynamic,1,1
277,effects,1,1
278,of,0,0
279,remifentanil,0,0
280,are,0,0
281,extremely,0,0
282,short-lived,0,0
283,after,0,0
284,the,0,0
285,drug,0,0
286,is,0,0
287,no,0,0
288,longer,0,0
289,administered,0,0
290,must,0,0
291,be,0,0
292,questioned,0,0
293,given,0,0
294,our,0,0
295,findings,0,0
296,that,0,0
297,psychomotor,1,1
298,effects,1,1
299,were,0,0
300,still,0,0
301,apparent,0,0
302,1,0,0
303,h,0,0
304,after,0,0
305,the,0,0
306,infusion,0,0
307,was,0,0
308,discontinued,0,0
309,.,0,0
310,Genotyping,0,0
311,of,0,1
312,CYP21,0,1
313,",",0,1
314,linked,0,0
315,chromosome,0,1
316,6p,0,1
317,markers,0,0
318,",",0,0
319,and,0,0
320,a,0,0
321,sex-specific,0,1
322,gene,0,1
323,in,0,0
324,neonatal,0,1
325,screening,0,0
326,for,0,0
327,congenital,0,0
328,adrenal,0,1
329,hyperplasia,0,0
330,.,0,0
331,We,0,0
332,investigated,0,0
333,the,0,0
334,feasibility,1,1
335,and,1,1
336,diagnostic,1,1
337,utility,1,1
338,of,0,0
339,genotyping,0,0
340,9,0,0
341,CYP21,0,0
342,mutations,0,1
343,",",0,1
344,linked,0,0
345,chromosome,0,1
346,6p,0,1
347,markers,0,0
348,",",0,0
349,and,0,0
350,a,0,0
351,dimorphic,0,0
352,X-Y,0,0
353,marker,0,1
354,from,0,0
355,neonatal,0,1
356,screening,0,0
357,samples,0,0
358,.,0,1
359,Blood-impregnated,0,0
360,filter,0,1
361,papers,0,0
362,(,0,0
363,Guthrie,0,0
364,cards,0,1
365,),0,0
366,from,0,0
367,603,0,0
368,randomly,0,0
369,chosen,0,0
370,New,0,0
371,Zealand,0,0
372,neonates,0,0
373,were,0,0
374,genotyped,0,0
375,blind,0,0
376,to,0,0
377,17-hydroxyprogesterone,0,0
378,(,0,0
379,17-OHP,0,0
380,),0,0
381,levels,0,1
382,.,0,0
383,Another,0,0
384,50,0,0
385,samples,0,0
386,from,0,0
387,Swiss,0,0
388,and,0,1
389,North,0,1
390,American,0,0
391,infants,0,0
392,with,0,0
393,correlative,0,0
394,hormonal,0,1
395,data,0,0
396,were,0,0
397,also,0,0
398,genotyped,0,0
399,.,0,0
400,DNA,0,1
401,was,0,0
402,extracted,0,0
403,",",0,0
404,and,0,1
405,gene-specific,0,1
406,PCR,0,1
407,was,0,0
408,performed,0,0
409,.,0,0
410,CYP21,0,0
411,PCR,0,1
412,products,0,1
413,were,0,0
414,subjected,0,0
415,to,0,0
416,ligase,0,1
417,detection,0,1
418,reaction,0,1
419,",",0,0
420,simultaneously,0,0
421,analyzing,0,0
422,9,0,0
423,CYP21,0,0
424,mutations,0,0
425,;,0,0
426,PCR,0,1
427,products,0,1
428,of,0,0
429,other,0,0
430,genes,0,1
431,were,0,0
432,subjected,0,0
433,to,0,0
434,direct,0,0
435,gel,0,0
436,analysis,0,0
437,.,0,0
438,CYP21,0,1
439,genotyping,0,0
440,indicated,0,0
441,a,0,0
442,heterozygote,1,0
443,rate,1,1
444,of,0,0
445,2.8,0,0
446,%,0,0
447,for,0,0
448,classic,0,0
449,mutations,0,1
450,(,0,0
451,excluding,0,0
452,CYP21,0,1
453,deletions,0,1
454,),0,1
455,",",0,0
456,and,0,0
457,2.0,0,0
458,%,0,0
459,for,0,0
460,nonclassic,0,0
461,mutations,0,1
462,in,0,0
463,New,0,0
464,Zealanders,0,0
465,.,0,0
466,Ten,0,0
467,full-term,0,0
468,affected,0,0
469,neonates,0,0
470,showed,0,0
471,a,0,0
472,wide,1,0
473,range,1,0
474,of,1,1
475,17-OHP,1,0
476,levels,1,1
477,(,0,0
478,15-1400,0,0
479,nmol/L,0,1
480,),0,0
481,.,0,1
482,Sick,0,0
483,or,0,0
484,preterm,0,1
485,infants,0,0
486,or,0,0
487,infants,0,0
488,screened,0,1
489,on,0,0
490,the,0,0
491,first,0,0
492,day,0,0
493,of,0,1
494,life,0,1
495,with,0,0
496,high,0,0
497,17-OHP,1,0
498,proved,0,0
499,genetically,0,0
500,unaffected,0,0
501,.,0,0
502,Genetic,1,1
503,linkage,1,1
504,disequilibrium,1,0
505,was,0,0
506,found,0,0
507,between,0,0
508,two,0,0
509,CYP21,0,0
510,mutations,0,1
511,and,0,0
512,chromosome,0,1
513,6p,0,0
514,markers,0,0
515,.,0,0
516,Guthrie,0,0
517,cards,0,0
518,can,0,0
519,be,0,0
520,used,0,0
521,to,0,0
522,accurately,0,0
523,genotype,0,0
524,CYP21,1,1
525,and,1,1
526,other,1,0
527,relevant,1,1
528,markers,1,1
529,",",0,0
530,potentially,0,0
531,enhancing,0,0
532,the,0,0
533,specificity,1,1
534,and,1,1
535,sensitivity,1,1
536,of,0,1
537,congenital,0,0
538,adrenal,0,1
539,hyperplasia,0,1
540,screening,0,0
541,.,0,1
542,CYP21,1,1
543,heterozygote,1,1
544,frequency,1,1
545,for,1,0
546,classic,1,0
547,mutations,1,1
548,is,0,0
549,higher,0,0
550,than,0,0
551,expected,0,0
552,based,0,0
553,on,0,0
554,genotype,0,0
555,compared,0,0
556,with,0,0
557,that,0,0
558,predicted,0,0
559,by,0,0
560,hormonal,0,0
561,newborn,0,0
562,screening,0,0
563,.,0,0
564,The,0,0
565,TOM,0,0
566,test,0,0
567,:,0,0
568,a,0,0
569,new,0,0
570,instrument,0,0
571,for,0,0
572,assessing,0,0
573,theory,0,0
574,of,0,1
575,mind,0,0
576,in,0,0
577,normal,0,0
578,children,0,0
579,and,0,1
580,children,0,0
581,with,0,0
582,pervasive,0,0
583,developmental,0,0
584,disorders,0,0
585,.,0,0
586,This,0,0
587,article,0,0
588,describes,0,0
589,a,0,0
590,first,0,0
591,attempt,0,0
592,to,0,0
593,investigate,0,0
594,the,0,0
595,reliability,0,1
596,and,0,1
597,validity,0,0
598,of,0,0
599,the,0,0
600,TOM,1,0
601,test,1,1
602,",",0,0
603,a,0,0
604,new,0,1
605,instrument,0,0
606,for,0,0
607,assessing,0,0
608,theory,0,0
609,of,0,1
610,mind,0,0
611,ability,0,1
612,in,0,0
613,normal,0,0
614,children,0,0
615,and,0,1
616,children,0,0
617,with,0,0
618,pervasive,0,0
619,developmental,0,1
620,disorders,0,0
621,(,0,1
622,PDDs,0,1
623,),0,0
624,.,0,0
625,In,0,0
626,Study,0,0
627,1,0,0
628,",",0,0
629,TOM,0,0
630,test,0,1
631,scores,0,1
632,of,0,0
633,normal,0,0
634,children,0,0
635,(,0,0
636,n,0,0
637,=,0,0
638,70,0,0
639,),0,0
640,correlated,0,0
641,positively,0,0
642,with,0,0
643,their,0,0
644,performance,0,1
645,on,0,0
646,other,0,0
647,theory,0,0
648,of,0,1
649,mind,0,0
650,tasks,0,1
651,.,0,1
652,Furthermore,0,0
653,",",0,0
654,young,0,0
655,children,0,0
656,only,0,0
657,succeeded,0,0
658,on,0,0
659,TOM,0,0
660,items,0,1
661,that,0,0
662,tap,0,0
663,the,0,0
664,basic,0,0
665,domains,0,1
666,of,0,0
667,theory,0,0
668,of,0,1
669,mind,0,0
670,(,0,1
671,e.g.,0,1
672,",",0,1
673,emotion,0,1
674,recognition,0,1
675,),0,1
676,",",0,0
677,whereas,0,0
678,older,0,0
679,children,0,0
680,also,0,0
681,passed,0,0
682,items,0,1
683,that,0,0
684,measure,0,0
685,the,0,0
686,more,0,0
687,mature,0,0
688,areas,0,1
689,of,0,0
690,theory,0,0
691,of,0,1
692,mind,0,0
693,(,0,1
694,e.g.,0,1
695,",",0,1
696,understanding,0,1
697,of,0,1
698,humor,0,1
699,",",0,0
700,understanding,0,1
701,of,0,1
702,second-order,0,1
703,beliefs,0,1
704,),0,0
705,.,0,0
706,Taken,0,0
707,together,0,0
708,",",0,0
709,the,0,0
710,findings,0,0
711,of,0,0
712,Study,0,0
713,1,0,0
714,suggest,0,0
715,that,0,0
716,the,0,0
717,TOM,1,0
718,test,1,0
719,is,0,0
720,a,0,0
721,valid,0,0
722,measure,0,0
723,.,0,0
724,Study,0,0
725,2,0,0
726,showed,0,0
727,for,0,0
728,a,0,0
729,separate,0,0
730,sample,0,0
731,of,0,1
732,normal,0,0
733,children,0,0
734,(,0,0
735,n,0,0
736,=,0,0
737,12,0,0
738,),0,0
739,that,0,0
740,the,0,0
741,TOM,1,0
742,test,1,0
743,possesses,0,0
744,sufficient,0,0
745,test-retest,0,1
746,stability,0,1
747,.,0,0
748,Study,0,0
749,3,0,0
750,demonstrated,0,0
751,for,0,0
752,a,0,0
753,sample,0,0
754,of,0,0
755,children,0,0
756,with,0,0
757,PDDs,0,1
758,(,0,0
759,n,0,0
760,=,0,0
761,10,0,0
762,),0,0
763,that,0,0
764,the,0,0
765,interrater,1,1
766,reliability,1,1
767,of,0,0
768,the,0,0
769,TOM,1,0
770,test,1,0
771,is,0,0
772,good,0,0
773,.,0,0
774,Study,0,0
775,4,0,0
776,found,0,0
777,that,0,0
778,children,0,0
779,with,0,0
780,PDDs,0,1
781,(,0,0
782,n,0,0
783,=,0,0
784,20,0,0
785,),0,0
786,had,0,0
787,significantly,0,0
788,lower,0,0
789,TOM,1,0
790,test,1,1
791,scores,1,1
792,than,0,0
793,children,0,0
794,with,0,0
795,other,0,0
796,psychiatric,0,1
797,disorders,0,0
798,(,0,1
799,e.g.,0,1
800,",",0,1
801,children,0,0
802,with,0,0
803,Attention-deficit,0,0
804,Hyperactivity,0,1
805,Disorder,0,0
806,;,0,0
807,n,0,0
808,=,0,0
809,32,0,0
810,),0,0
811,",",0,0
812,a,0,0
813,finding,0,0
814,that,0,0
815,underlines,0,0
816,the,0,0
817,discriminant,0,1
818,validity,0,0
819,of,0,0
820,the,0,0
821,TOM,0,0
822,test,0,1
823,.,0,0
824,Furthermore,0,0
825,",",0,0
826,Study,0,0
827,4,0,0
828,showed,0,0
829,that,0,0
830,intelligence,1,1
831,as,0,0
832,indexed,0,0
833,by,0,0
834,the,0,0
835,Wechsler,1,0
836,Intelligence,1,1
837,Scale,1,1
838,for,1,0
839,Children,1,0
840,was,0,0
841,positively,0,0
842,associated,0,0
843,with,0,0
844,TOM,1,0
845,test,1,0
846,scores,1,1
847,.,1,0
848,Finally,0,0
849,",",0,0
850,in,0,0
851,all,0,0
852,studies,0,0
853,",",0,0
854,the,0,0
855,TOM,1,0
856,test,1,1
857,was,0,0
858,found,0,0
859,to,0,0
860,be,0,0
861,reliable,0,1
862,in,0,0
863,terms,0,1
864,of,0,0
865,internal,0,0
866,consistency,0,1
867,.,0,0
868,Altogether,0,0
869,",",0,0
870,results,0,0
871,indicate,0,0
872,that,0,0
873,the,0,0
874,TOM,0,0
875,test,0,0
876,is,0,0
877,a,0,0
878,reliable,0,1
879,and,0,1
880,valid,0,0
881,instrument,0,0
882,that,0,0
883,can,0,0
884,be,0,0
885,employed,0,0
886,to,0,0
887,measure,0,0
888,various,0,0
889,aspects,0,1
890,of,0,0
891,theory,0,0
892,of,0,0
893,mind,0,0
894,.,0,0
895,Effects,1,0
896,of,0,0
897,oral,0,0
898,brovincamine,0,0
899,on,0,0
900,visual,0,1
901,field,0,0
902,damage,0,1
903,in,0,0
904,patients,0,0
905,with,0,0
906,normal-tension,0,0
907,glaucoma,0,1
908,with,0,0
909,low-normal,0,1
910,intraocular,0,1
911,pressure,0,1
912,.,0,0
913,PURPOSE,0,0
914,To,0,0
915,prospectively,0,0
916,study,0,0
917,the,0,0
918,effect,1,0
919,of,0,0
920,oral,0,0
921,brovincamine,0,0
922,",",0,0
923,a,0,0
924,relatively,0,0
925,selective,0,0
926,cerebral,0,1
927,vasodilator,0,0
928,",",0,0
929,on,0,0
930,further,0,0
931,deterioration,0,1
932,of,0,1
933,visual,0,1
934,field,0,0
935,in,0,0
936,patients,0,0
937,with,0,0
938,normal-tension,0,0
939,glaucoma,0,1
940,(,0,1
941,NTG,0,1
942,),0,0
943,with,0,0
944,low-normal,0,1
945,intraocular,0,1
946,pressure,0,1
947,(,0,1
948,IOP,0,1
949,),0,0
950,.,0,0
951,METHODS,0,0
952,Fifty-two,0,0
953,patients,0,0
954,with,0,0
955,NTG,0,1
956,(,0,0
957,average,0,1
958,age,0,0
959,57.7,0,0
960,years,0,0
961,),0,0
962,with,0,0
963,an,0,0
964,IOP,0,1
965,that,0,0
966,was,0,0
967,consistently,0,0
968,less,0,0
969,than,0,0
970,15,0,0
971,mmHg,0,0
972,were,0,0
973,randomly,0,0
974,assigned,0,0
975,to,0,0
976,receive,0,0
977,oral,0,0
978,brovincamine,0,0
979,(,0,0
980,20,0,0
981,mg,0,0
982,three,0,0
983,times,0,0
984,daily,0,0
985,),0,0
986,or,0,0
987,to,0,0
988,an,0,0
989,untreated,0,0
990,control,0,0
991,group,0,0
992,.,0,0
993,The,0,0
994,groups,0,0
995,were,0,0
996,prospectively,0,0
997,followed,0,0
998,for,0,0
999,2,0,0
1000,years,0,0
1001,with,0,0
1002,visual,0,1
1003,field,0,0
1004,examinations,0,0
1005,every,0,0
1006,4,0,0
1007,months,0,0
1008,",",0,0
1009,using,0,0
1010,the,0,0
1011,30-2,0,0
1012,Humphrey,0,1
1013,perimeter,0,1
1014,program,0,0
1015,.,0,0
1016,Changes,1,1
1017,in,1,0
1018,mean,1,1
1019,deviation,1,0
1020,(,1,1
1021,MD,1,1
1022,),1,1
1023,",",1,0
1024,corrected,1,1
1025,pattern,1,1
1026,standard,1,0
1027,deviation,1,0
1028,(,1,1
1029,CPSD,1,1
1030,),1,1
1031,",",0,0
1032,and,0,1
1033,total,1,1
1034,deviation,1,1
1035,(,1,1
1036,TD,1,1
1037,),1,0
1038,at,0,0
1039,74,0,0
1040,test,0,0
1041,points,0,0
1042,were,0,0
1043,analyzed,0,0
1044,using,0,0
1045,regression,0,0
1046,analysis,0,0
1047,with,0,0
1048,linear,0,0
1049,mixed,0,0
1050,model,0,0
1051,.,0,0
1052,Data,0,0
1053,from,0,0
1054,one,0,0
1055,eye,0,0
1056,without,0,0
1057,media,0,0
1058,opacity,0,0
1059,of,0,0
1060,each,0,0
1061,subject,0,0
1062,were,0,0
1063,analyzed,0,0
1064,.,0,0
1065,RESULTS,0,0
1066,There,0,0
1067,were,0,0
1068,no,1,0
1069,differences,1,0
1070,between,0,0
1071,groups,0,0
1072,in,0,0
1073,age,1,0
1074,;,1,0
1075,sex,1,0
1076,distribution,1,1
1077,;,1,0
1078,refraction,1,1
1079,;,1,0
1080,blood,1,1
1081,pressure,1,1
1082,;,1,0
1083,baseline,1,0
1084,IOP,1,1
1085,;,1,0
1086,MD,1,1
1087,",",1,1
1088,CPSD,1,1
1089,",",1,1
1090,or,1,1
1091,TD,1,1
1092,at,0,0
1093,each,0,0
1094,point,0,0
1095,.,0,0
1096,Changes,1,1
1097,in,1,0
1098,MD,1,1
1099,(,0,0
1100,standard,0,0
1101,error,0,1
1102,[,0,0
1103,SE,0,1
1104,],0,0
1105,),0,0
1106,during,0,0
1107,the,0,0
1108,study,0,0
1109,period,0,0
1110,were,0,0
1111,-0.778,0,0
1112,(,0,0
1113,0.178,0,0
1114,),0,0
1115,and,0,0
1116,-0.071,0,0
1117,(,0,0
1118,0.195,0,0
1119,),0,0
1120,dB/year,0,0
1121,in,0,0
1122,the,0,0
1123,control,0,0
1124,and,0,1
1125,brovincamine,0,0
1126,groups,0,0
1127,",",0,0
1128,respectively,0,0
1129,;,0,0
1130,change,0,0
1131,in,0,0
1132,the,0,0
1133,control,0,0
1134,group,0,0
1135,was,0,0
1136,significantly,0,0
1137,more,0,0
1138,negative,0,1
1139,than,0,0
1140,in,0,0
1141,the,0,0
1142,brovincamine,0,0
1143,group,0,0
1144,.,0,1
1145,Change,1,0
1146,in,1,0
1147,CPSD,1,0
1148,(,1,0
1149,SE,1,1
1150,),1,0
1151,was,0,0
1152,0.032,0,0
1153,(,0,0
1154,0.015,0,0
1155,),0,0
1156,and,0,0
1157,0.004,0,0
1158,(,0,0
1159,0.016,0,0
1160,),0,0
1161,dB/year,0,0
1162,in,0,0
1163,the,0,0
1164,control,0,0
1165,and,0,1
1166,brovincamine,0,0
1167,groups,0,0
1168,",",0,0
1169,respectively,0,0
1170,.,0,0
1171,Change,1,0
1172,in,0,0
1173,the,0,0
1174,control,0,0
1175,group,0,0
1176,was,0,0
1177,significantly,0,0
1178,positive,0,1
1179,",",0,0
1180,but,0,0
1181,the,0,0
1182,intergroup,0,0
1183,difference,0,0
1184,was,0,0
1185,not,0,0
1186,significant,0,0
1187,.,0,0
1188,Change,1,0
1189,in,1,0
1190,TD,1,1
1191,was,0,0
1192,significantly,0,0
1193,negative,0,0
1194,at,0,0
1195,six,0,0
1196,test,0,0
1197,points,0,0
1198,in,0,0
1199,the,0,0
1200,control,0,0
1201,group,0,0
1202,",",0,0
1203,whereas,0,0
1204,no,0,0
1205,points,0,0
1206,showed,0,0
1207,a,0,0
1208,significant,1,0
1209,trend,0,0
1210,in,0,0
1211,the,0,0
1212,brovincamine,0,0
1213,group,0,0
1214,;,0,0
1215,the,0,0
1216,intergroup,0,0
1217,difference,0,0
1218,was,0,0
1219,significant,0,0
1220,.,0,0
1221,The,0,0
1222,average,1,1
1223,IOP,1,1
1224,was,0,0
1225,13.2,0,0
1226,mmHg,0,0
1227,and,0,0
1228,13.1,0,0
1229,mmHg,0,0
1230,in,0,0
1231,the,0,0
1232,control,0,0
1233,and,0,1
1234,brovincamine,0,0
1235,groups,0,0
1236,",",0,0
1237,respectively,0,0
1238,",",0,0
1239,and,0,1
1240,there,0,0
1241,was,0,0
1242,no,1,0
1243,significant,1,0
1244,intergroup,0,0
1245,difference,0,0
1246,.,0,1
1247,CONCLUSION,0,0
1248,Oral,0,0
1249,brovincamine,0,0
1250,may,0,0
1251,retard,0,0
1252,further,0,0
1253,visual,0,1
1254,field,0,0
1255,deterioration,0,1
1256,in,0,0
1257,patients,0,0
1258,with,0,0
1259,NTG,0,0
1260,who,0,0
1261,have,0,0
1262,low-normal,0,0
1263,IOP,0,0
1264,.,0,0
1265,Microbiologic,0,1
1266,yields,0,1
1267,and,0,1
1268,complication,0,1
1269,rates,0,1
1270,of,0,0
1271,vitreous,0,1
1272,needle,0,0
1273,aspiration,0,1
1274,versus,0,0
1275,mechanized,0,0
1276,vitreous,0,1
1277,biopsy,0,0
1278,in,0,0
1279,the,0,0
1280,Endophthalmitis,0,0
1281,Vitrectomy,0,0
1282,Study,0,0
1283,.,0,0
1284,PURPOSE,0,0
1285,To,0,0
1286,compare,0,0
1287,the,0,0
1288,microbiologic,0,1
1289,yields,0,1
1290,and,0,1
1291,complication,0,1
1292,rates,0,1
1293,associated,0,0
1294,with,0,0
1295,vitreous,0,1
1296,needle,0,0
1297,tap,0,0
1298,and,0,1
1299,vitreous,0,1
1300,biopsy,0,0
1301,in,0,0
1302,the,0,0
1303,Endophthalmitis,0,0
1304,Vitrectomy,0,1
1305,Study,0,0
1306,(,0,1
1307,EVS,0,1
1308,),0,0
1309,.,0,0
1310,METHODS,0,0
1311,Of,0,0
1312,420,0,0
1313,EVS,0,0
1314,patients,0,0
1315,with,0,0
1316,postoperative,0,1
1317,endophthalmitis,0,0
1318,",",0,0
1319,201,0,0
1320,received,0,0
1321,immediate,0,0
1322,vitreous,0,1
1323,tap,0,0
1324,or,0,1
1325,biopsy,0,1
1326,(,0,1
1327,without,0,0
1328,pars,0,0
1329,plana,0,0
1330,vitrectomy,0,0
1331,),0,0
1332,by,0,0
1333,random,0,0
1334,assignment,0,0
1335,and,0,0
1336,193,0,0
1337,completed,0,0
1338,9-12,0,0
1339,months,0,0
1340,of,0,0
1341,follow-up,0,0
1342,.,0,0
1343,Vitreous,0,1
1344,specimens,0,0
1345,were,0,0
1346,obtained,0,0
1347,by,0,0
1348,biopsy,0,0
1349,with,0,0
1350,a,0,0
1351,20-gauge,0,0
1352,vitrectomy,0,0
1353,cutting,0,1
1354,instrument,0,1
1355,or,0,0
1356,by,0,0
1357,needle,0,0
1358,tap,0,0
1359,with,0,0
1360,a,0,0
1361,22-27-gauge,0,0
1362,needle,0,0
1363,.,0,0
1364,If,0,0
1365,resistance,0,1
1366,to,0,0
1367,aspiration,0,1
1368,by,0,0
1369,needle,0,0
1370,tap,0,0
1371,was,0,0
1372,noted,0,0
1373,",",0,0
1374,a,0,0
1375,vitreous,0,1
1376,biopsy,0,0
1377,was,0,0
1378,performed,0,0
1379,.,0,0
1380,RESULTS,0,0
1381,Of,0,0
1382,201,0,0
1383,patients,0,0
1384,undergoing,0,0
1385,tap,0,0
1386,or,0,1
1387,biopsy,0,1
1388,",",0,0
1389,70,0,0
1390,(,0,0
1391,35,0,0
1392,%,0,0
1393,),0,0
1394,had,0,0
1395,needle,0,0
1396,tap,0,0
1397,",",0,0
1398,127,0,0
1399,(,0,0
1400,63,0,0
1401,%,0,0
1402,),0,0
1403,had,0,0
1404,mechanized,0,0
1405,biopsy,0,0
1406,",",0,0
1407,and,0,0
1408,4,0,0
1409,(,0,0
1410,2,0,0
1411,%,0,0
1412,),0,0
1413,had,0,0
1414,initial,0,0
1415,needle,0,0
1416,tap,0,0
1417,that,0,0
1418,was,0,0
1419,aborted,0,0
1420,to,0,0
1421,mechanized,0,0
1422,biopsy,0,0
1423,(,0,0
1424,abort,0,1
1425,eyes,0,0
1426,),0,0
1427,.,0,0
1428,Intraoperative,1,1
1429,hyphema,1,1
1430,occurred,0,0
1431,in,0,0
1432,2,0,0
1433,tap,0,0
1434,eyes,0,0
1435,(,0,0
1436,3,0,0
1437,%,0,0
1438,),0,0
1439,",",0,0
1440,3,0,0
1441,biopsy,0,0
1442,eyes,0,0
1443,(,0,0
1444,2,0,0
1445,%,0,0
1446,),0,0
1447,",",0,0
1448,and,0,0
1449,0,0,0
1450,(,0,0
1451,0,0,0
1452,%,0,0
1453,),0,0
1454,abort,0,0
1455,eyes,0,0
1456,.,0,0
1457,Postoperative,1,1
1458,retinal,1,1
1459,detachment,1,1
1460,developed,0,0
1461,in,0,0
1462,8,0,0
1463,(,0,0
1464,11,0,0
1465,%,0,0
1466,),0,0
1467,tap,0,0
1468,eyes,0,0
1469,",",0,0
1470,10,0,0
1471,(,0,0
1472,8,0,0
1473,%,0,0
1474,),0,0
1475,biopsy,0,1
1476,eyes,0,1
1477,",",0,0
1478,and,0,0
1479,0,0,0
1480,(,0,0
1481,0,0,0
1482,%,0,0
1483,),0,0
1484,abort,0,1
1485,eyes,0,1
1486,(,0,0
1487,not,0,0
1488,significant,0,0
1489,),0,0
1490,.,0,0
1491,Respective,1,0
1492,rates,1,1
1493,of,1,1
1494,culture,1,1
1495,and,1,0
1496,gram,1,0
1497,stain,1,1
1498,positivity,1,1
1499,were,0,0
1500,69,0,0
1501,%,0,0
1502,and,0,0
1503,42,0,0
1504,%,0,0
1505,in,0,0
1506,tap,0,0
1507,eyes,0,0
1508,and,0,0
1509,66,0,0
1510,%,0,0
1511,and,0,0
1512,41,0,0
1513,%,0,0
1514,in,0,0
1515,biopsy,0,1
1516,eyes,0,0
1517,(,0,0
1518,not,0,0
1519,significant,0,0
1520,),0,0
1521,.,0,0
1522,The,0,0
1523,rate,1,1
1524,of,1,0
1525,severe,1,1
1526,visual,1,1
1527,loss,1,1
1528,(,0,0
1529,final,0,1
1530,acuity,0,1
1531,<,0,0
1532,5/200,0,0
1533,),0,0
1534,was,0,0
1535,significantly,0,0
1536,higher,0,0
1537,in,0,0
1538,tap,0,0
1539,eyes,0,0
1540,(,0,0
1541,16,0,0
1542,eyes,0,0
1543,",",0,0
1544,24,0,0
1545,%,0,0
1546,),0,0
1547,compared,0,0
1548,with,0,0
1549,biopsy,0,0
1550,eyes,0,0
1551,(,0,0
1552,13,0,0
1553,eyes,0,0
1554,",",0,0
1555,11,0,0
1556,%,0,0
1557,),0,0
1558,and,0,1
1559,abort,0,1
1560,eyes,0,0
1561,(,0,0
1562,0,0,0
1563,eyes,0,0
1564,",",0,0
1565,0,0,0
1566,%,0,0
1567,;,0,0
1568,P,0,0
1569,=,0,0
1570,0.043,0,0
1571,),0,0
1572,.,0,0
1573,The,0,0
1574,difference,0,0
1575,was,0,0
1576,largely,0,0
1577,explained,0,0
1578,by,0,0
1579,the,0,0
1580,greater,0,0
1581,proportion,1,1
1582,of,1,1
1583,virulent,1,1
1584,organisms,1,0
1585,in,1,0
1586,the,1,0
1587,tap,1,0
1588,eyes,1,0
1589,compared,0,0
1590,with,0,0
1591,biopsy,0,0
1592,eyes,0,0
1593,.,0,0
1594,When,0,0
1595,visual,1,1
1596,acuity,1,1
1597,outcome,1,1
1598,was,0,0
1599,defined,0,1
1600,by,0,0
1601,other,0,0
1602,thresholds,0,1
1603,(,0,0
1604,20/40,0,0
1605,and,0,0
1606,20/100,0,0
1607,),0,0
1608,",",0,0
1609,the,0,0
1610,difference,0,0
1611,was,0,0
1612,not,0,0
1613,significant,0,0
1614,.,0,0
1615,CONCLUSIONS,0,0
1616,This,0,0
1617,study,0,0
1618,showed,0,0
1619,no,0,0
1620,significant,0,0
1621,differences,0,0
1622,between,0,0
1623,mechanized,0,0
1624,vitreous,0,1
1625,biopsy,0,0
1626,and,0,1
1627,needle,0,1
1628,tap,0,0
1629,with,0,0
1630,respect,0,0
1631,to,0,0
1632,microbiologic,0,1
1633,yield,0,1
1634,",",0,1
1635,operative,0,1
1636,complications,0,1
1637,",",0,1
1638,short-term,0,1
1639,(,0,0
1640,9-12,0,0
1641,months,0,0
1642,),0,0
1643,retinal,0,1
1644,detachment,0,1
1645,risk,0,1
1646,",",0,1
1647,or,0,1
1648,visual,0,1
1649,outcome,0,1
1650,.,0,0
1651,Choice,0,1
1652,of,0,0
1653,vitreous,0,1
1654,sampling,0,0
1655,procedure,0,0
1656,must,0,0
1657,depend,0,0
1658,on,0,0
1659,the,0,0
1660,clinical,0,0
1661,judgment,0,0
1662,of,0,0
1663,the,0,0
1664,surgeon,0,0
1665,.,0,0
1666,Long,0,0
1667,term,0,1
1668,response,0,1
1669,to,0,0
1670,therapy,0,0
1671,of,0,0
1672,chronic,0,0
1673,anti-HBe-positive,0,1
1674,hepatitis,0,0
1675,B,0,0
1676,is,0,0
1677,poor,0,1
1678,independent,0,0
1679,of,0,1
1680,type,0,0
1681,and,0,1
1682,schedule,0,0
1683,of,0,1
1684,interferon,0,1
1685,.,0,0
1686,OBJECTIVE,0,0
1687,The,0,0
1688,response,1,1
1689,rate,1,1
1690,to,1,0
1691,alpha,1,1
1692,interferon,1,1
1693,(,1,1
1694,IFN,1,1
1695,),1,0
1696,of,0,0
1697,chronic,0,0
1698,anti-HBe-positive,0,1
1699,hepatitis,0,0
1700,B,0,0
1701,is,0,0
1702,variable,0,0
1703,.,0,0
1704,We,0,0
1705,studied,0,0
1706,whether,0,0
1707,type,0,0
1708,",",0,1
1709,dose,0,1
1710,",",0,1
1711,and,0,1
1712,schedule,0,0
1713,of,0,1
1714,IFN,0,1
1715,",",0,1
1716,and,0,1
1717,type,0,1
1718,and,0,1
1719,frequency,0,1
1720,of,0,1
1721,posttreatment,0,1
1722,monitoring,0,0
1723,",",0,0
1724,influence,0,0
1725,the,0,0
1726,response,0,1
1727,rate,0,1
1728,.,0,1
1729,METHODS,0,0
1730,Seventy-two,0,0
1731,consecutive,0,0
1732,anti-HBe-positive,0,1
1733,chronic,0,0
1734,hepatitis,0,0
1735,B,0,1
1736,patients,0,0
1737,(,0,0
1738,59,0,0
1739,male,0,0
1740,and,0,0
1741,13,0,0
1742,female,0,0
1743,",",0,0
1744,median,0,1
1745,age,0,0
1746,41,0,0
1747,yr,0,0
1748,),0,0
1749,stratified,0,0
1750,by,0,0
1751,sex,0,0
1752,and,0,1
1753,histology,0,1
1754,were,0,0
1755,randomly,0,0
1756,allocated,0,0
1757,to,0,0
1758,three,0,0
1759,treatment,0,0
1760,arms,0,0
1761,.,0,0
1762,Twenty-seven,0,0
1763,patients,0,0
1764,(,0,0
1765,A,0,0
1766,),0,0
1767,received,0,0
1768,10,0,0
1769,million,0,0
1770,units,0,0
1771,alpha-N1,0,0
1772,IFN,0,1
1773,i.m,0,0
1774,.,0,0
1775,t.w,0,0
1776,.,0,0
1777,for,0,0
1778,24,0,0
1779,wk,0,0
1780,(,0,0
1781,total,0,1
1782,dose,0,0
1783,:,0,0
1784,720,0,0
1785,million,0,0
1786,units,0,0
1787,),0,0
1788,;,0,0
1789,21,0,0
1790,(,0,0
1791,B,0,0
1792,),0,0
1793,received,0,0
1794,9,0,0
1795,million,0,0
1796,units,0,0
1797,alpha-2a,0,0
1798,IFN,0,1
1799,i.m,0,0
1800,.,0,0
1801,t.w,0,0
1802,.,0,0
1803,for,0,0
1804,4,0,0
1805,wk,0,0
1806,",",0,0
1807,followed,0,0
1808,by,0,0
1809,18,0,0
1810,million,0,0
1811,units,0,0
1812,for,0,0
1813,12,0,0
1814,wk,0,0
1815,and,0,0
1816,9,0,0
1817,million,0,0
1818,units,0,0
1819,for,0,0
1820,8,0,0
1821,wk,0,0
1822,(,0,0
1823,972,0,0
1824,million,0,0
1825,units,0,0
1826,),0,0
1827,;,0,0
1828,24,0,0
1829,(,0,0
1830,C,0,0
1831,),0,0
1832,received,0,0
1833,2,0,0
1834,alpha-2a,0,0
1835,IFN,0,1
1836,courses,0,0
1837,(,0,0
1838,9,0,0
1839,million,0,0
1840,units,0,0
1841,i.m,0,0
1842,.,0,0
1843,t.w,0,0
1844,.,0,0
1845,for,0,0
1846,16,0,0
1847,and,0,0
1848,12,0,0
1849,wk,0,0
1850,separated,0,0
1851,by,0,0
1852,a,0,0
1853,6-month,0,0
1854,interval,0,0
1855,[,0,0
1856,756,0,0
1857,million,0,0
1858,units,0,0
1859,],0,0
1860,),0,0
1861,.,0,0
1862,Primary,0,1
1863,response,0,1
1864,was,0,0
1865,defined,0,1
1866,by,0,0
1867,normal,1,0
1868,ALT,1,0
1869,and,1,1
1870,serum,1,1
1871,HBV-DNA,1,1
1872,levels,1,1
1873,below,0,0
1874,10,0,0
1875,pg/ml,0,0
1876,at,0,0
1877,the,0,0
1878,end,0,0
1879,of,0,1
1880,therapy,0,0
1881,and,0,1
1882,sustained,0,1
1883,response,0,1
1884,by,0,0
1885,normal,1,1
1886,ALT,1,1
1887,(,0,0
1888,tested,0,0
1889,monthly,0,1
1890,),0,0
1891,",",0,0
1892,undetectable,1,1
1893,HBV-DNA,1,1
1894,and,0,1
1895,IgM,0,1
1896,anti-HBc,0,1
1897,(,0,0
1898,<,0,0
1899,7,0,0
1900,I.U,0,0
1901,.,0,0
1902,Paul,0,0
1903,Ehrlich,0,0
1904,Institute,0,0
1905,),0,1
1906,(,0,0
1907,tested,0,0
1908,every,0,0
1909,3,0,0
1910,months,0,0
1911,),0,0
1912,during,0,0
1913,the,0,0
1914,posttreatment,0,0
1915,follow-up,0,0
1916,.,0,0
1917,RESULTS,0,0
1918,At,0,0
1919,the,0,0
1920,end,0,0
1921,of,0,1
1922,treatment,0,0
1923,",",0,0
1924,12,0,0
1925,",",0,0
1926,8,0,0
1927,",",0,0
1928,and,0,0
1929,13,0,0
1930,patients,0,0
1931,from,0,0
1932,groups,0,0
1933,A,0,0
1934,",",0,1
1935,B,0,1
1936,",",0,1
1937,and,0,1
1938,C,0,1
1939,",",0,1
1940,respectively,0,0
1941,",",0,0
1942,were,0,0
1943,responders,0,0
1944,.,0,0
1945,At,0,0
1946,the,0,0
1947,18-month,0,0
1948,follow-up,0,0
1949,",",0,0
1950,two,0,0
1951,patients,0,0
1952,in,0,0
1953,group,0,0
1954,A,0,0
1955,and,0,0
1956,only,0,0
1957,one,0,0
1958,in,0,0
1959,groups,0,0
1960,B,0,0
1961,and,0,1
1962,C,0,0
1963,maintained,0,0
1964,the,0,0
1965,response,1,1
1966,.,1,1
1967,Overall,0,1
1968,",",0,0
1969,after,0,0
1970,34,0,0
1971,months,0,0
1972,(,0,0
1973,median,0,1
1974,posttreatment,0,1
1975,follow-up,0,0
1976,),0,0
1977,",",0,0
1978,three,0,0
1979,patients,0,0
1980,were,0,0
1981,long,0,0
1982,term,0,1
1983,responders,0,1
1984,",",0,0
1985,whereas,0,0
1986,three,0,0
1987,showed,0,0
1988,a,0,0
1989,sustained,0,1
1990,remission,1,1
1991,after,0,0
1992,relapse,0,1
1993,.,0,0
1994,CONCLUSIONS,0,0
1995,The,0,0
1996,rate,1,1
1997,of,1,0
1998,long,1,0
1999,term,1,1
2000,response,1,1
2001,to,0,0
2002,interferon,0,0
2003,of,0,0
2004,anti-HBe-positive,0,1
2005,chronic,0,0
2006,hepatitis,0,0
2007,B,0,0
2008,is,0,0
2009,poor,0,1
2010,",",0,0
2011,independent,0,0
2012,of,0,1
2013,IFN,0,1
2014,type,0,0
2015,",",0,1
2016,dose,0,1
2017,",",0,1
2018,or,0,0
2019,schedule,0,0
2020,;,0,0
2021,the,0,0
2022,more,0,0
2023,stringent,0,0
2024,the,0,0
2025,monitoring,0,0
2026,",",0,0
2027,the,0,0
2028,higher,0,0
2029,the,0,0
2030,relapse,0,1
2031,rate,0,1
2032,.,0,0
2033,Effects,0,0
2034,of,0,1
2035,pyridostigmine,0,0
2036,and,0,1
2037,naloxone,0,0
2038,on,0,0
2039,the,0,0
2040,abnormal,1,1
2041,TSH,1,1
2042,response,1,1
2043,to,1,0
2044,TRH,1,0
2045,during,1,0
2046,starvation,1,0
2047,in,0,0
2048,humans,0,0
2049,.,0,0
2050,BACKGROUND,0,0
2051,Starvation,0,1
2052,is,0,0
2053,associated,0,0
2054,with,0,0
2055,a,0,0
2056,blunted,1,1
2057,TSH,1,1
2058,response,1,1
2059,to,0,0
2060,thyrotropin-releasing,1,1
2061,hormone,1,1
2062,(,1,1
2063,TRH,1,1
2064,),1,1
2065,(,0,0
2066,peak,0,1
2067,minus,0,0
2068,baseline,0,0
2069,<,0,0
2070,5,0,0
2071,mIU/L,0,0
2072,),0,0
2073,",",0,0
2074,despite,0,0
2075,basal,0,1
2076,TSH,0,1
2077,and,0,1
2078,thyroid,0,1
2079,hormone,0,1
2080,levels,0,1
2081,within,0,0
2082,the,0,0
2083,normal,0,0
2084,range,0,0
2085,.,0,0
2086,In,0,0
2087,light,0,0
2088,of,0,0
2089,the,0,0
2090,inhibitory,0,1
2091,effect,0,1
2092,of,0,1
2093,somatostatin,0,1
2094,on,0,0
2095,TSH,0,1
2096,secretion,0,1
2097,",",0,0
2098,we,0,0
2099,examined,0,0
2100,whether,0,0
2101,this,0,0
2102,condition,0,0
2103,is,0,0
2104,caused,0,0
2105,by,0,0
2106,an,0,0
2107,increased,0,0
2108,hypothalamic,1,1
2109,somatostatinergic,1,1
2110,tone,1,1
2111,in,0,0
2112,starving,0,0
2113,subjects,0,0
2114,.,0,0
2115,The,0,0
2116,possible,0,0
2117,involvement,1,1
2118,of,1,1
2119,endogenous,1,1
2120,opioids,1,0
2121,in,1,0
2122,the,1,0
2123,mechanism,1,0
2124,underlying,1,0
2125,the,1,0
2126,abnormal,1,1
2127,TSH,1,1
2128,response,1,1
2129,to,1,0
2130,TRH,1,0
2131,was,0,0
2132,also,0,0
2133,evaluated,0,0
2134,.,0,0
2135,METHODS,0,0
2136,The,0,0
2137,TSH,1,1
2138,response,1,1
2139,to,1,0
2140,TRH,1,0
2141,(,1,0
2142,25,1,0
2143,micrograms,1,0
2144,in,1,0
2145,an,1,0
2146,intravenous,1,0
2147,bolus,1,0
2148,),1,1
2149,",",1,0
2150,serum,1,1
2151,total,1,1
2152,and,1,1
2153,free,1,1
2154,T4,1,0
2155,and,1,1
2156,T3,1,0
2157,levels,1,1
2158,",",1,1
2159,and,1,1
2160,24-hour,1,1
2161,urinary-free,1,1
2162,cortisol,1,1
2163,levels,1,1
2164,were,0,0
2165,measured,0,0
2166,in,0,0
2167,28,0,0
2168,normal,0,0
2169,men,0,0
2170,(,0,0
2171,age,0,0
2172,27-35,0,0
2173,years,0,0
2174,),0,0
2175,within,0,0
2176,10,0,0
2177,%,0,0
2178,of,0,0
2179,their,0,0
2180,ideal,0,1
2181,body,0,1
2182,weight,0,1
2183,.,0,0
2184,They,0,0
2185,were,0,0
2186,randomly,0,0
2187,divided,0,0
2188,into,0,0
2189,4,0,0
2190,groups,0,0
2191,of,0,0
2192,7,0,0
2193,.,0,0
2194,In,0,0
2195,21,0,0
2196,subjects,0,0
2197,(,0,0
2198,groups,0,0
2199,1,0,0
2200,",",0,0
2201,2,0,0
2202,",",0,0
2203,and,0,0
2204,3,0,0
2205,),0,0
2206,",",0,0
2207,TRH,0,0
2208,tests,0,1
2209,were,0,0
2210,performed,0,0
2211,after,0,0
2212,an,0,0
2213,overnight,0,0
2214,(,0,0
2215,8,0,0
2216,hours,0,0
2217,),0,0
2218,fast,0,0
2219,",",0,0
2220,placebo,0,0
2221,administrations,0,0
2222,(,0,0
2223,control,0,0
2224,test,0,1
2225,),0,1
2226,",",0,1
2227,and,0,1
2228,after,0,0
2229,prolonged,0,1
2230,(,0,0
2231,56,0,0
2232,hours,0,0
2233,),0,0
2234,starvation,0,0
2235,.,0,0
2236,TRH,1,0
2237,tests,1,1
2238,after,1,0
2239,prolonged,1,1
2240,starvation,1,1
2241,were,0,0
2242,performed,0,0
2243,either,0,0
2244,after,0,0
2245,placebos,0,0
2246,(,0,0
2247,in,0,0
2248,all,0,0
2249,subjects,0,0
2250,),0,0
2251,or,0,0
2252,the,0,0
2253,administration,0,0
2254,of,0,1
2255,pyridostigmine,0,0
2256,(,0,0
2257,180,0,0
2258,mg,0,0
2259,orally,0,0
2260,),0,0
2261,(,0,0
2262,in,0,0
2263,7,0,0
2264,subjects,0,0
2265,",",0,0
2266,group,0,0
2267,1,0,0
2268,),0,0
2269,;,0,0
2270,naloxone,0,0
2271,(,0,0
2272,0.8,0,0
2273,mg,0,0
2274,in,0,0
2275,an,0,0
2276,i.v,0,0
2277,.,0,1
2278,bolus,0,0
2279,injection,0,0
2280,),0,1
2281,(,0,0
2282,in,0,0
2283,7,0,0
2284,subjects,0,0
2285,",",0,0
2286,group,0,0
2287,2,0,0
2288,),0,0
2289,;,0,0
2290,or,0,0
2291,the,0,0
2292,combination,0,0
2293,of,0,1
2294,pyridostigmine,0,0
2295,and,0,1
2296,naloxone,0,1
2297,(,0,0
2298,in,0,0
2299,7,0,0
2300,subjects,0,0
2301,",",0,0
2302,group,0,0
2303,3,0,0
2304,),0,0
2305,.,0,0
2306,The,0,0
2307,remaining,0,0
2308,7,0,0
2309,subjects,0,0
2310,(,0,0
2311,group,0,0
2312,4,0,0
2313,),0,0
2314,were,0,0
2315,tested,0,0
2316,at,0,0
2317,weekly,0,0
2318,intervals,0,0
2319,with,0,0
2320,TRH,0,0
2321,plus,0,0
2322,placebo,0,0
2323,",",0,1
2324,TRH,0,1
2325,plus,0,0
2326,naloxone,0,1
2327,",",0,1
2328,TRH,0,1
2329,plus,0,0
2330,pyridostigmine,0,0
2331,",",0,1
2332,and,0,1
2333,TRH,0,1
2334,plus,0,0
2335,naloxone,0,1
2336,plus,0,0
2337,pyridostigmine,0,0
2338,after,0,0
2339,a,0,0
2340,fasting,0,1
2341,period,0,0
2342,of,0,0
2343,8,0,0
2344,hours,0,0
2345,.,0,0
2346,RESULTS,0,0
2347,In,0,0
2348,all,0,0
2349,subjects,0,0
2350,of,0,0
2351,groups,0,0
2352,1,0,0
2353,",",0,0
2354,2,0,0
2355,",",0,0
2356,and,0,0
2357,3,0,0
2358,",",0,0
2359,TRH-induced,1,0
2360,TSH,1,1
2361,rise,1,0
2362,was,0,0
2363,significantly,0,0
2364,lower,0,0
2365,after,0,0
2366,prolonged,0,1
2367,starvation,0,0
2368,than,0,0
2369,after,0,0
2370,overnight,0,0
2371,fast,0,1
2372,.,0,1
2373,Neither,0,0
2374,pyridostigmine,0,0
2375,nor,0,0
2376,naloxone,0,0
2377,",",0,1
2378,given,0,0
2379,alone,0,0
2380,",",0,0
2381,changed,0,0
2382,the,0,0
2383,basal,1,1
2384,levels,1,1
2385,of,1,1
2386,TSH,1,1
2387,and,0,0
2388,the,0,0
2389,TSH,1,1
2390,response,1,1
2391,to,1,0
2392,TRH,1,0
2393,after,1,0
2394,prolonged,1,1
2395,starvation,1,0
2396,.,1,0
2397,In,0,0
2398,contrast,0,0
2399,",",0,0
2400,the,0,0
2401,concomitant,0,0
2402,administration,0,0
2403,of,0,1
2404,naloxone,0,0
2405,and,0,1
2406,pyridostigmine,0,0
2407,significantly,0,0
2408,enhanced,0,0
2409,the,0,0
2410,TRH-induced,0,0
2411,TSH,0,1
2412,rise,0,0
2413,.,0,0
2414,After,0,0
2415,overnight,0,1
2416,fasting,0,1
2417,",",0,1
2418,naloxone,0,0
2419,administration,0,0
2420,in,0,0
2421,group,0,0
2422,4,0,0
2423,subjects,0,0
2424,did,0,0
2425,not,0,0
2426,change,0,0
2427,the,0,0
2428,TSH,0,0
2429,response,0,1
2430,to,0,0
2431,TRH,0,0
2432,",",0,0
2433,whereas,0,0
2434,pyridostigmine,0,0
2435,significantly,0,0
2436,enhanced,0,0
2437,the,0,0
2438,TSH,0,0
2439,response,0,1
2440,to,0,0
2441,TRH,0,0
2442,.,0,0
2443,When,0,0
2444,naloxone,0,0
2445,was,0,0
2446,given,0,0
2447,together,0,0
2448,with,0,0
2449,pyridostigmine,0,0
2450,and,0,0
2451,TRH,0,0
2452,the,0,0
2453,TSH,0,1
2454,response,0,1
2455,was,0,0
2456,similar,0,0
2457,to,0,0
2458,that,0,0
2459,observed,0,0
2460,in,0,0
2461,the,0,0
2462,TRH,0,0
2463,plus,0,0
2464,pyridostigmine,0,0
2465,test,0,1
2466,.,0,0
2467,CONCLUSIONS,0,0
2468,These,0,0
2469,data,0,0
2470,indicate,0,0
2471,that,0,0
2472,naloxone-sensitive,0,1
2473,endogenous,0,0
2474,opioids,0,0
2475,exert,0,0
2476,an,0,0
2477,inhibitory,0,1
2478,effect,0,0
2479,on,0,0
2480,the,0,0
2481,cholinergic,1,1
2482,stimulatory,1,1
2483,control,1,0
2484,of,1,1
2485,TSH,1,1
2486,secretion,1,1
2487,during,0,0
2488,prolonged,0,1
2489,starvation,0,0
2490,.,0,0
2491,This,0,0
2492,suggests,0,0
2493,that,0,0
2494,an,0,0
2495,enhanced,0,0
2496,hypothalamic,0,1
2497,somatostatinergic,0,0
2498,activity,0,1
2499,is,0,0
2500,involved,0,0
2501,in,0,0
2502,the,0,0
2503,mechanism,0,0
2504,underlying,0,0
2505,the,0,0
2506,reduced,0,0
2507,TSH,0,0
2508,response,0,1
2509,to,0,0
2510,TRH,0,0
2511,.,0,0
2512,Effects,0,0
2513,of,0,0
2514,a,0,0
2515,videotape,0,0
2516,information,0,1
2517,intervention,0,0
2518,at,0,0
2519,discharge,0,1
2520,on,0,0
2521,diet,0,0
2522,and,0,1
2523,exercise,0,0
2524,compliance,0,1
2525,after,0,0
2526,coronary,0,1
2527,bypass,0,0
2528,surgery,0,0
2529,.,0,0
2530,BACKGROUND,0,0
2531,This,0,0
2532,study,0,0
2533,evaluated,0,0
2534,the,0,0
2535,relative,0,1
2536,effects,0,1
2537,on,0,0
2538,compliance,0,1
2539,with,0,0
2540,recommended,0,0
2541,lifestyle,0,0
2542,changes,0,1
2543,of,0,0
2544,two,0,0
2545,experimental,0,0
2546,videotapes,0,0
2547,that,0,0
2548,involved,0,0
2549,different,0,0
2550,approaches,0,0
2551,for,0,0
2552,preparing,0,0
2553,coronary,0,1
2554,artery,0,1
2555,bypass,0,1
2556,graft,0,1
2557,(,0,1
2558,CABG,0,1
2559,),0,0
2560,patients,0,0
2561,for,0,0
2562,the,0,0
2563,posthospital,0,1
2564,recovery,0,1
2565,period,0,0
2566,.,0,0
2567,The,0,0
2568,tapes,0,0
2569,differed,0,0
2570,in,0,0
2571,the,0,0
2572,extent,0,0
2573,to,0,0
2574,which,0,0
2575,they,0,0
2576,portrayed,0,0
2577,the,0,0
2578,recovery,0,1
2579,period,0,0
2580,as,0,0
2581,a,0,0
2582,steady,0,1
2583,",",0,0
2584,forward,0,0
2585,progression,0,1
2586,versus,0,0
2587,a,0,0
2588,series,0,0
2589,of,0,0
2590,ups,0,1
2591,and,0,0
2592,downs,0,1
2593,.,0,0
2594,METHODS,0,0
2595,Two,0,0
2596,hundred,0,0
2597,sixteen,0,0
2598,male,0,0
2599,and,0,1
2600,female,0,0
2601,CABG,0,1
2602,patients,0,0
2603,were,0,0
2604,assigned,0,0
2605,randomly,0,0
2606,either,0,0
2607,to,0,0
2608,view,0,0
2609,one,0,0
2610,of,0,0
2611,the,0,0
2612,two,0,0
2613,videotapes,0,0
2614,before,0,0
2615,discharge,0,0
2616,from,0,0
2617,the,0,0
2618,hospital,0,1
2619,or,0,0
2620,to,0,0
2621,receive,0,0
2622,only,0,0
2623,the,0,0
2624,standard,0,0
2625,discharge,0,1
2626,preparation,0,0
2627,provided,0,0
2628,by,0,0
2629,the,0,0
2630,hospital,0,0
2631,.,0,0
2632,All,0,0
2633,patients,0,0
2634,completed,0,0
2635,measures,1,0
2636,of,1,0
2637,anxiety,1,1
2638,and,1,1
2639,self-efficacy,1,1
2640,at,0,1
2641,discharge,0,0
2642,",",0,0
2643,1,0,0
2644,month,0,0
2645,and,0,0
2646,3,0,0
2647,months,0,0
2648,after,0,0
2649,discharge,0,0
2650,from,0,0
2651,the,0,0
2652,hospital,0,0
2653,.,0,0
2654,Patients,0,0
2655,also,0,0
2656,completed,0,0
2657,measures,0,0
2658,of,0,1
2659,dietary,1,0
2660,fat,1,1
2661,consumption,1,1
2662,and,0,1
2663,activity,1,1
2664,level,1,1
2665,1,1,0
2666,and,1,0
2667,3,1,0
2668,months,0,0
2669,after,0,0
2670,discharge,0,0
2671,.,0,0
2672,RESULTS,0,0
2673,Relative,0,0
2674,to,0,0
2675,controls,0,0
2676,",",0,0
2677,patients,0,0
2678,who,0,0
2679,viewed,0,0
2680,either,0,0
2681,of,0,0
2682,the,0,0
2683,videotapes,0,0
2684,before,0,0
2685,hospital,0,1
2686,release,0,1
2687,reported,0,0
2688,higher,0,0
2689,self-efficacy,1,1
2690,for,1,0
2691,adhering,1,0
2692,to,1,0
2693,the,1,0
2694,recommended,1,0
2695,low-fat,1,0
2696,diet,1,0
2697,both,0,0
2698,at,0,0
2699,discharge,0,0
2700,and,0,0
2701,1,0,0
2702,month,0,0
2703,after,0,0
2704,surgery,0,0
2705,.,0,0
2706,Viewing,0,0
2707,either,0,0
2708,of,0,0
2709,the,0,0
2710,videotapes,0,0
2711,also,0,0
2712,resulted,0,0
2713,in,0,0
2714,significantly,1,0
2715,less,1,0
2716,dietary,1,1
2717,fat,1,1
2718,intake,1,1
2719,1,1,0
2720,month,1,0
2721,after,1,0
2722,hospital,1,1
2723,release,1,1
2724,compared,0,0
2725,with,0,0
2726,controls,0,0
2727,.,0,0
2728,Patients,0,0
2729,who,0,0
2730,viewed,0,0
2731,the,0,0
2732,tape,0,1
2733,that,0,0
2734,portrayed,0,0
2735,the,0,0
2736,recovery,0,1
2737,period,0,0
2738,as,0,0
2739,consisting,0,0
2740,of,0,1
2741,ups,0,1
2742,and,0,1
2743,downs,0,1
2744,also,0,0
2745,reported,0,0
2746,significantly,0,0
2747,more,0,0
2748,frequent,0,1
2749,moderate,1,0
2750,exercise,1,0
2751,at,1,0
2752,1,1,0
2753,month,1,0
2754,and,0,0
2755,more,0,0
2756,frequent,0,1
2757,strenuous,1,0
2758,exercise,1,0
2759,3,0,0
2760,months,0,0
2761,after,0,0
2762,discharge,0,0
2763,.,0,0
2764,CONCLUSIONS,0,0
2765,The,0,0
2766,experimental,0,0
2767,videotapes,0,0
2768,proved,0,0
2769,to,0,0
2770,be,0,0
2771,an,0,0
2772,effective,0,1
2773,method,0,0
2774,for,0,0
2775,increasing,0,0
2776,dietary,1,1
2777,and,1,1
2778,exercise,1,0
2779,compliance,1,1
2780,during,0,0
2781,the,0,0
2782,first,0,0
2783,3,0,0
2784,months,0,0
2785,after,0,0
2786,CABG,0,1
2787,.,0,0
2788,Sleep,1,1
2789,patterns,1,1
2790,in,0,0
2791,autistic,0,0
2792,children,0,0
2793,.,0,0
2794,Sleep,1,0
2795,disturbances,1,1
2796,are,0,0
2797,regarded,0,0
2798,as,0,0
2799,a,0,0
2800,common,0,0
2801,clinical,0,0
2802,feature,0,0
2803,in,0,0
2804,autistic,0,0
2805,children,0,0
2806,.,0,0
2807,This,0,0
2808,concept,0,0
2809,is,0,0
2810,based,0,0
2811,primarily,0,0
2812,on,0,0
2813,informal,0,0
2814,observations,0,0
2815,or,0,0
2816,studies,0,0
2817,conducted,0,0
2818,with,0,0
2819,questionnaires,0,0
2820,.,0,0
2821,In,0,0
2822,this,0,0
2823,study,0,0
2824,we,0,0
2825,compared,0,0
2826,data,0,0
2827,obtained,0,0
2828,by,0,0
2829,questionnaires,0,0
2830,to,0,0
2831,that,0,0
2832,obtained,0,0
2833,with,0,0
2834,actigraphy,0,0
2835,.,0,0
2836,Among,0,0
2837,22,0,0
2838,autistic,0,0
2839,children,0,0
2840,",",0,0
2841,12,0,0
2842,were,0,0
2843,reported,0,0
2844,as,0,0
2845,having,0,0
2846,sleep,0,1
2847,problems,0,1
2848,and,0,0
2849,8,0,0
2850,patients,0,0
2851,completed,0,0
2852,72,0,0
2853,hours,0,0
2854,actigraphy,0,0
2855,.,0,0
2856,While,0,0
2857,the,0,0
2858,employment,0,1
2859,of,0,0
2860,questionnaires,0,1
2861,disclosed,0,0
2862,that,0,0
2863,autistic,0,0
2864,children,0,0
2865,had,0,0
2866,an,0,0
2867,earlier,1,0
2868,morning,1,1
2869,awakening,1,1
2870,time,1,1
2871,and,1,1
2872,multiple,1,1
2873,and,1,1
2874,early,1,1
2875,night,1,1
2876,arousals,1,1
2877,",",0,1
2878,actigraphic,0,1
2879,monitoring,0,0
2880,showed,0,0
2881,that,0,0
2882,with,0,0
2883,the,0,0
2884,exception,0,0
2885,of,0,0
2886,an,0,0
2887,earlier,1,0
2888,morning,1,1
2889,arousal,1,1
2890,time,1,1
2891,(,0,0
2892,p,0,0
2893,=,0,0
2894,.045,0,0
2895,),0,1
2896,",",0,0
2897,sleep,1,1
2898,patterns,1,1
2899,of,0,0
2900,autistic,0,0
2901,children,0,0
2902,were,0,0
2903,similar,0,0
2904,to,0,0
2905,that,0,0
2906,of,0,0
2907,normal,0,0
2908,children,0,0
2909,.,0,0
2910,Parental,0,1
2911,oversensitivity,0,0
2912,to,0,0
2913,sleep,1,1
2914,disturbances,1,1
2915,of,0,0
2916,the,0,0
2917,autistic,0,0
2918,children,0,0
2919,may,0,0
2920,explain,0,0
2921,this,0,0
2922,phenomenon,0,0
2923,.,0,0
2924,Comparison,0,0
2925,of,0,0
2926,the,0,0
2927,relative,0,1
2928,efficacy,1,1
2929,of,0,1
2930,formoterol,0,0
2931,and,0,1
2932,salmeterol,0,0
2933,in,0,0
2934,asthmatic,0,0
2935,patients,0,0
2936,.,0,0
2937,Studies,0,0
2938,performed,0,0
2939,on,0,0
2940,airway,0,1
2941,smooth,0,1
2942,muscle,0,1
2943,in,0,0
2944,vitro,0,0
2945,have,0,0
2946,indicated,0,0
2947,that,0,0
2948,salmeterol,0,0
2949,is,0,0
2950,a,0,0
2951,partial,0,1
2952,agonist,0,0
2953,on,0,0
2954,the,0,0
2955,beta2-receptor,0,0
2956,in,0,0
2957,comparison,0,0
2958,to,0,0
2959,formoterol,0,0
2960,.,0,0
2961,In,0,0
2962,the,0,0
2963,present,0,0
2964,study,0,0
2965,we,0,0
2966,evaluated,0,0
2967,whether,0,0
2968,these,0,0
2969,pharmacological,0,0
2970,differences,0,0
2971,between,0,0
2972,salmeterol,0,0
2973,and,0,1
2974,formoterol,0,0
2975,also,0,0
2976,are,0,0
2977,applicable,0,0
2978,to,0,0
2979,asthmatic,0,0
2980,patients,0,0
2981,.,0,0
2982,The,0,0
2983,protective,0,0
2984,effects,0,1
2985,by,0,0
2986,increasing,0,0
2987,cumulative,0,1
2988,doses,0,0
2989,of,0,1
2990,formoterol,0,0
2991,(,0,0
2992,12,0,0
2993,",",0,0
2994,60,0,0
2995,",",0,0
2996,120,0,0
2997,micrograms,0,0
2998,),0,0
2999,and,0,1
3000,salmeterol,0,0
3001,(,0,0
3002,50,0,0
3003,",",0,0
3004,250,0,0
3005,",",0,0
3006,500,0,0
3007,micrograms,0,0
3008,),0,0
3009,on,0,0
3010,methacholine-induced,0,1
3011,bronchoconstriction,0,1
3012,were,0,0
3013,evaluated,0,0
3014,in,0,0
3015,a,0,0
3016,double-blind,0,0
3017,",",0,1
3018,crossover,0,0
3019,",",0,1
3020,placebo-controlled,0,0
3021,design,0,0
3022,.,0,1
3023,Patients,0,0
3024,were,0,0
3025,regularly,0,0
3026,treated,0,0
3027,with,0,0
3028,salbutamol,0,0
3029,200,0,0
3030,micrograms,0,0
3031,twice,0,0
3032,daily,0,0
3033,during,0,0
3034,the,0,0
3035,study,0,0
3036,period,0,0
3037,",",0,0
3038,to,0,0
3039,avoid,0,0
3040,variability,0,1
3041,in,0,0
3042,beta2-adrenoceptor,1,0
3043,tolerance,1,1
3044,.,1,1
3045,S-potassium,1,0
3046,",",1,1
3047,heart,1,1
3048,rate,1,1
3049,corrected,1,1
3050,Q-T,1,1
3051,interval,1,0
3052,(,1,1
3053,Q-Tc,1,1
3054,),1,1
3055,",",1,1
3056,and,1,1
3057,tremor,1,1
3058,score,1,1
3059,were,0,0
3060,followed,0,0
3061,as,0,0
3062,measures,0,0
3063,of,0,0
3064,systemic,0,1
3065,effects,0,1
3066,.,0,0
3067,Formoterol,0,0
3068,dose-dependently,0,0
3069,protected,0,0
3070,against,0,0
3071,methacholine,0,1
3072,responsiveness,0,1
3073,(,0,0
3074,4.6,0,0
3075,doubling,0,0
3076,doses,0,0
3077,after,0,0
3078,120,0,0
3079,micrograms,0,0
3080,),0,0
3081,.,0,0
3082,Salmeterol,0,0
3083,",",0,0
3084,however,0,0
3085,",",0,0
3086,showed,0,0
3087,a,0,0
3088,flatter,0,1
3089,dose-response,0,1
3090,curve,0,1
3091,",",0,0
3092,and,0,0
3093,a,0,0
3094,significantly,0,0
3095,weaker,0,0
3096,maximal,0,1
3097,protective,0,1
3098,effect,0,1
3099,(,0,0
3100,2.8,0,0
3101,doubling,0,0
3102,doses,0,0
3103,after,0,0
3104,250,0,0
3105,micrograms,0,0
3106,),0,0
3107,.,0,0
3108,Formoterol,0,0
3109,caused,0,0
3110,a,0,0
3111,significantly,0,0
3112,higher,0,0
3113,tremor,1,1
3114,score,1,1
3115,and,0,0
3116,a,0,0
3117,larger,0,0
3118,drop,0,1
3119,in,0,0
3120,S-potassium,1,0
3121,than,0,0
3122,salmeterol,0,0
3123,at,0,0
3124,the,0,0
3125,highest,0,0
3126,doses,0,0
3127,.,0,0
3128,These,0,0
3129,data,0,0
3130,show,0,0
3131,that,0,0
3132,salmeterol,0,0
3133,is,0,0
3134,a,0,0
3135,partial,0,1
3136,agonist,0,0
3137,on,0,0
3138,the,0,0
3139,beta2-receptor,0,0
3140,in,0,0
3141,relation,0,0
3142,to,0,0
3143,formoterol,0,0
3144,in,0,0
3145,human,0,0
3146,airways,0,1
3147,in,0,0
3148,vivo,0,0
3149,.,0,0
3150,Further,0,0
3151,studies,0,0
3152,are,0,0
3153,required,0,0
3154,to,0,0
3155,document,0,0
3156,the,0,0
3157,clinical,0,0
3158,consequences,0,0
3159,of,0,0
3160,this,0,0
3161,finding,0,0
3162,",",0,0
3163,for,0,0
3164,example,0,0
3165,in,0,0
3166,severe,0,1
3167,asthmatic,0,0
3168,patients,0,0
3169,.,0,0
3170,[,0,0
3171,Efficacy,0,1
3172,of,0,1
3173,combination,0,0
3174,with,0,0
3175,granisetron,0,0
3176,and,0,1
3177,methylprednisolone,0,0
3178,for,0,0
3179,nausea,1,1
3180,",",1,1
3181,vomiting,1,1
3182,and,1,1
3183,appetite,1,1
3184,loss,1,1
3185,in,0,0
3186,remission,0,1
3187,induction,0,1
3188,chemotherapy,0,0
3189,of,0,1
3190,acute,0,0
3191,myeloid,0,0
3192,leukemia,0,0
3193,--,0,0
3194,a,0,0
3195,randomized,0,0
3196,comparative,0,0
3197,trial,0,0
3198,between,0,0
3199,granisetron,0,0
3200,alone,0,0
3201,and,0,0
3202,granisetron,0,0
3203,plus,0,0
3204,methylprednisolone,0,0
3205,],0,0
3206,.,0,0
3207,The,0,0
3208,prevention,0,0
3209,of,0,1
3210,nausea,1,1
3211,",",1,1
3212,vomiting,1,1
3213,and,1,1
3214,appetite,1,1
3215,loss,1,1
3216,induced,0,0
3217,by,0,0
3218,remission,0,1
3219,induction,0,1
3220,chemotherapy,0,0
3221,for,0,0
3222,acute,0,0
3223,myeloid,0,1
3224,leukemia,0,0
3225,was,0,0
3226,compared,0,0
3227,by,0,0
3228,randomization,0,0
3229,between,0,0
3230,granisetron,0,0
3231,alone,0,0
3232,and,0,0
3233,combination,0,0
3234,with,0,0
3235,granisetron,0,0
3236,plus,0,0
3237,methylprednisolone,0,0
3238,.,0,1
3239,Granisetron,0,0
3240,was,0,0
3241,administered,0,0
3242,at,0,0
3243,40,0,0
3244,micrograms/kg,0,0
3245,during,0,0
3246,chemotherapy,0,0
3247,",",0,1
3248,and,0,1
3249,methylprednisolone,0,0
3250,was,0,0
3251,administered,0,0
3252,concomitantly,0,0
3253,at,0,0
3254,125,0,0
3255,mg/body,0,0
3256,for,0,0
3257,3,0,0
3258,days,0,0
3259,or,0,0
3260,more,0,0
3261,in,0,0
3262,the,0,0
3263,combination,0,0
3264,group,0,0
3265,.,0,0
3266,The,0,0
3267,single,0,0
3268,and,0,1
3269,combination,0,0
3270,groups,0,0
3271,comprised,0,0
3272,14,0,0
3273,and,0,0
3274,13,0,0
3275,patients,0,0
3276,",",0,0
3277,respectively,0,0
3278,",",0,0
3279,and,0,1
3280,there,0,0
3281,was,0,0
3282,no,0,0
3283,significant,0,0
3284,difference,0,0
3285,between,0,0
3286,the,0,0
3287,background,0,0
3288,of,0,0
3289,both,0,0
3290,groups,0,0
3291,.,0,0
3292,To,0,0
3293,evaluate,0,0
3294,the,0,0
3295,effect,0,0
3296,they,0,0
3297,were,0,0
3298,scored,0,0
3299,according,0,0
3300,to,0,0
3301,4,0,0
3302,grades,0,1
3303,",",0,0
3304,and,0,1
3305,evaluated,0,0
3306,every,0,0
3307,24,0,0
3308,hours,0,0
3309,from,0,0
3310,the,0,0
3311,start,0,0
3312,of,0,0
3313,chemotherapy,0,0
3314,to,0,0
3315,5,0,0
3316,days,0,0
3317,after,0,0
3318,its,0,0
3319,completion,0,0
3320,.,0,0
3321,The,0,0
3322,complete,1,1
3323,inhibition,1,1
3324,rate,1,1
3325,of,1,1
3326,vomiting,1,1
3327,was,0,0
3328,as,0,0
3329,high,0,0
3330,as,0,0
3331,71.4,0,0
3332,%,0,0
3333,and,0,0
3334,92.3,0,0
3335,%,0,0
3336,in,0,0
3337,the,0,0
3338,single,0,0
3339,and,0,1
3340,combination,0,0
3341,groups,0,0
3342,",",0,0
3343,respectively,0,0
3344,",",0,0
3345,showing,0,0
3346,no,0,0
3347,significant,0,0
3348,difference,0,0
3349,.,0,0
3350,The,0,0
3351,grade,1,1
3352,of,1,0
3353,vomiting,1,1
3354,was,0,0
3355,mild,0,0
3356,in,0,0
3357,both,0,0
3358,groups,0,0
3359,.,0,0
3360,Nausea,1,1
3361,was,0,0
3362,noted,0,0
3363,in,0,0
3364,71.4,0,0
3365,%,0,0
3366,and,0,0
3367,46.2,0,0
3368,%,0,0
3369,",",0,0
3370,respectively,0,0
3371,",",0,0
3372,and,0,0
3373,the,0,0
3374,inhibitory,0,1
3375,effect,0,1
3376,tended,0,0
3377,to,0,0
3378,be,0,0
3379,higher,0,0
3380,in,0,0
3381,the,0,0
3382,combination,0,0
3383,group,0,0
3384,.,0,1
3385,Appetite,1,1
3386,loss,1,1
3387,developed,0,0
3388,in,0,0
3389,92.9,0,0
3390,%,0,0
3391,and,0,0
3392,41.7,0,0
3393,%,0,0
3394,",",0,0
3395,respectively,0,0
3396,",",0,0
3397,and,0,0
3398,the,0,0
3399,prevention,0,0
3400,effect,0,1
3401,was,0,0
3402,clearly,0,0
3403,higher,0,0
3404,in,0,0
3405,the,0,0
3406,combination,0,0
3407,group,0,0
3408,.,0,0
3409,The,0,0
3410,prevention,0,0
3411,effects,0,1
3412,on,0,0
3413,nausea,1,1
3414,7,0,0
3415,",",0,0
3416,8,0,0
3417,and,0,0
3418,10,0,0
3419,days,0,0
3420,after,0,0
3421,the,0,0
3422,start,0,0
3423,of,0,1
3424,chemotherapy,0,0
3425,",",0,0
3426,on,1,0
3427,appetite,1,1
3428,loss,1,1
3429,2-10,0,0
3430,days,0,0
3431,after,0,0
3432,it,0,0
3433,",",0,0
3434,and,0,1
3435,2-5,0,0
3436,days,0,0
3437,after,0,0
3438,its,0,0
3439,completion,0,1
3440,",",0,1
3441,were,0,0
3442,higher,0,0
3443,in,0,0
3444,the,0,0
3445,combination,0,0
3446,group,0,0
3447,.,0,1
3448,Granisetron,0,0
3449,revealed,0,0
3450,an,0,0
3451,excellent,0,1
3452,inhibitory,1,1
3453,effect,1,1
3454,on,1,0
3455,vomiting,1,1
3456,induced,0,0
3457,by,0,0
3458,remission,0,1
3459,induction,0,1
3460,chemotherapy,0,0
3461,for,0,0
3462,acute,0,0
3463,myeloid,0,1
3464,leukemia,0,0
3465,",",0,1
3466,but,0,0
3467,combination,0,0
3468,with,0,0
3469,granisetron,0,0
3470,and,0,1
3471,methylprednisolone,0,0
3472,was,0,0
3473,considered,0,0
3474,useful,0,0
3475,for,0,0
3476,nausea,1,1
3477,in,0,0
3478,the,0,0
3479,latter,0,0
3480,half,0,0
3481,of,0,0
3482,the,0,0
3483,treatment,0,0
3484,period,0,0
3485,and,0,1
3486,for,0,0
3487,appetite,1,1
3488,loss,1,1
3489,during,0,0
3490,the,0,0
3491,whole,0,0
3492,period,0,0
3493,.,0,0
3494,Preoperative,0,1
3495,small-dose,0,0
3496,ketamine,0,0
3497,has,0,0
3498,no,0,0
3499,preemptive,0,0
3500,analgesic,0,1
3501,effect,0,1
3502,in,0,0
3503,patients,0,0
3504,undergoing,0,0
3505,total,0,1
3506,mastectomy,0,0
3507,.,0,0
3508,UNLABELLED,0,0
3509,We,0,0
3510,evaluated,0,0
3511,the,0,0
3512,preemptive,0,0
3513,analgesic,0,1
3514,effect,0,0
3515,of,0,0
3516,a,0,0
3517,small,0,0
3518,dose,0,0
3519,of,0,1
3520,ketamine,0,0
3521,given,0,0
3522,before,0,0
3523,or,0,0
3524,immediately,0,0
3525,after,0,0
3526,surgery,0,0
3527,in,0,0
3528,a,0,0
3529,randomized,0,0
3530,",",0,0
3531,double-blinded,0,0
3532,study,0,0
3533,performed,0,0
3534,in,0,0
3535,128,0,0
3536,women,0,0
3537,undergoing,0,0
3538,total,0,1
3539,mastectomy,0,0
3540,.,0,0
3541,Group,0,0
3542,1,0,0
3543,patients,0,0
3544,received,0,0
3545,ketamine,0,0
3546,0.15,0,0
3547,mg/kg,0,0
3548,as,0,0
3549,a,0,0
3550,5-mL,0,0
3551,i.v,0,0
3552,.,0,0
3553,injection,0,0
3554,5,0,0
3555,min,0,0
3556,before,0,0
3557,surgery,0,0
3558,and,0,1
3559,isotonic,0,0
3560,saline,0,0
3561,5,0,0
3562,mL,0,0
3563,i.v,0,0
3564,.,0,0
3565,at,0,0
3566,the,0,0
3567,time,0,1
3568,of,0,0
3569,skin,0,1
3570,closure,0,1
3571,.,0,0
3572,Group,0,0
3573,2,0,0
3574,received,0,0
3575,5,0,0
3576,mL,0,0
3577,i.v,0,0
3578,.,0,0
3579,of,0,0
3580,isotonic,0,0
3581,saline,0,0
3582,",",0,0
3583,then,0,0
3584,0.15,0,0
3585,mg/kg,0,0
3586,i.v,0,0
3587,.,0,0
3588,ketamine,0,0
3589,.,0,0
3590,A,0,0
3591,standard,0,0
3592,general,0,0
3593,anesthesia,0,0
3594,procedure,0,0
3595,including,0,0
3596,sufentanil,0,0
3597,was,0,0
3598,used,0,0
3599,.,0,0
3600,In,0,0
3601,the,0,0
3602,recovery,0,1
3603,room,0,0
3604,",",0,1
3605,patient-controlled,0,0
3606,analgesia,0,1
3607,i.v,0,0
3608,.,0,1
3609,morphine,0,1
3610,was,0,0
3611,used,0,0
3612,for,0,0
3613,postoperative,0,1
3614,analgesia,0,1
3615,.,0,1
3616,Postoperative,0,1
3617,pain,0,1
3618,was,0,0
3619,assessed,0,0
3620,by,0,0
3621,measuring,0,0
3622,morphine,1,1
3623,consumption,1,1
3624,and,1,1
3625,visual,1,1
3626,analog,1,1
3627,scale,1,1
3628,pain,1,1
3629,scores,1,1
3630,.,1,0
3631,No,0,0
3632,significant,0,0
3633,intergroup,0,0
3634,differences,0,0
3635,were,0,0
3636,seen,0,0
3637,in,0,0
3638,the,0,0
3639,pain,1,1
3640,scores,1,1
3641,.,1,0
3642,Patient-controlled,1,0
3643,analgesia,1,1
3644,morphine,1,1
3645,consumption,1,1
3646,was,0,0
3647,lower,0,0
3648,during,0,0
3649,the,0,0
3650,first,0,0
3651,2,0,0
3652,h,0,0
3653,after,0,0
3654,surgery,0,0
3655,in,0,0
3656,patients,0,0
3657,given,0,0
3658,ketamine,0,0
3659,at,0,0
3660,the,0,0
3661,time,0,1
3662,of,0,0
3663,skin,0,1
3664,closure,0,1
3665,.,0,0
3666,No,0,0
3667,patient,0,1
3668,complained,0,0
3669,of,0,0
3670,hallucinations,1,1
3671,or,0,0
3672,nightmares,1,1
3673,.,1,0
3674,The,0,0
3675,incidence,1,1
3676,of,1,0
3677,adverse,1,1
3678,effects,1,1
3679,was,0,0
3680,not,0,0
3681,different,0,0
3682,between,0,0
3683,the,0,0
3684,two,0,0
3685,groups,0,0
3686,.,0,0
3687,In,0,0
3688,conclusion,0,0
3689,",",0,0
3690,administering,0,0
3691,ketamine,0,0
3692,at,0,0
3693,the,0,0
3694,end,0,0
3695,of,0,0
3696,surgery,0,0
3697,is,0,0
3698,more,0,0
3699,effective,0,1
3700,in,0,0
3701,reducing,0,0
3702,morphine,1,0
3703,consumption,1,0
3704,than,0,0
3705,it,0,0
3706,is,0,0
3707,when,0,0
3708,given,0,0
3709,before,0,0
3710,surgery,0,0
3711,.,0,0
3712,IMPLICATIONS,0,0
3713,We,0,0
3714,administered,0,0
3715,the,0,0
3716,same,0,0
3717,small,0,0
3718,dose,0,0
3719,of,0,1
3720,ketamine,0,0
3721,before,0,0
3722,or,0,0
3723,after,0,0
3724,surgery,0,0
3725,.,0,0
3726,The,0,0
3727,preoperative,0,1
3728,administration,0,0
3729,of,0,0
3730,0.15,0,0
3731,mg/kg,0,0
3732,ketamine,0,0
3733,in,0,0
3734,patients,0,0
3735,undergoing,0,0
3736,total,0,1
3737,mastectomy,0,0
3738,did,0,0
3739,not,0,0
3740,elicit,0,0
3741,a,0,0
3742,preemptive,0,0
3743,analgesic,0,1
3744,effect,0,0
3745,.,0,0
3746,Ketamine,0,0
3747,given,0,0
3748,at,0,0
3749,closure,0,1
3750,reduced,0,0
3751,the,0,0
3752,patient-controlled,1,0
3753,analgesia,1,1
3754,morphine,1,1
3755,requirement,1,1
3756,in,0,0
3757,the,0,0
3758,first,0,0
3759,2,0,0
3760,h,0,0
3761,after,0,0
3762,surgery,0,0
3763,.,0,0
3764,Continued,0,0
3765,improvement,0,1
3766,in,0,0
3767,pressure-flow,1,1
3768,parameters,1,1
3769,in,0,0
3770,men,0,0
3771,receiving,0,0
3772,finasteride,0,0
3773,for,0,0
3774,2,0,0
3775,years,0,0
3776,.,0,0
3777,Finasteride,0,0
3778,Urodynamics,0,1
3779,Study,0,0
3780,Group,0,0
3781,.,0,0
3782,OBJECTIVES,0,0
3783,To,0,0
3784,assess,0,0
3785,the,0,0
3786,long-term,0,0
3787,effects,0,1
3788,of,0,0
3789,finasteride,0,0
3790,on,0,0
3791,pressure-flow,1,1
3792,parameters,1,1
3793,in,0,0
3794,men,0,0
3795,with,0,0
3796,urodynamically,0,0
3797,documented,0,0
3798,bladder,0,1
3799,outflow,0,1
3800,obstruction,0,1
3801,(,0,1
3802,BOO,0,0
3803,),0,0
3804,.,0,0
3805,METHODS,0,0
3806,One,0,0
3807,hundred,0,0
3808,twenty-one,0,0
3809,men,0,0
3810,with,0,0
3811,benign,0,0
3812,prostatic,0,1
3813,enlargement,0,1
3814,(,0,1
3815,BPE,0,1
3816,),0,1
3817,and,0,1
3818,lower,0,1
3819,urinary,0,1
3820,tract,0,1
3821,symptoms,0,1
3822,(,0,1
3823,LUTS,0,1
3824,),0,0
3825,underwent,0,0
3826,a,0,0
3827,pressure-flow,0,1
3828,study,0,0
3829,(,0,1
3830,PFS,0,1
3831,),0,0
3832,at,0,0
3833,1,0,0
3834,of,0,0
3835,11,0,0
3836,clinical,0,0
3837,centers,0,0
3838,.,0,0
3839,The,0,0
3840,PFS,0,1
3841,technique,0,0
3842,was,0,0
3843,standardized,0,0
3844,",",0,0
3845,and,0,0
3846,all,0,1
3847,tracings,0,0
3848,were,0,0
3849,read,0,0
3850,by,0,0
3851,a,0,0
3852,single,0,0
3853,reader,0,1
3854,unaware,0,0
3855,of,0,0
3856,the,0,0
3857,treatment,0,0
3858,group,0,0
3859,.,0,0
3860,Patients,0,0
3861,who,0,0
3862,were,0,0
3863,obstructed,0,0
3864,according,0,0
3865,to,0,0
3866,a,0,0
3867,modified,1,0
3868,Abrams-Griffiths,1,0
3869,nomogram,1,1
3870,were,0,0
3871,randomized,0,0
3872,to,0,0
3873,5,0,0
3874,mg,0,0
3875,finasteride,0,0
3876,(,0,0
3877,n,0,0
3878,=,0,0
3879,81,0,0
3880,),0,0
3881,or,0,0
3882,placebo,0,0
3883,(,0,1
3884,n,0,0
3885,=,0,0
3886,40,0,0
3887,),0,0
3888,for,0,0
3889,12,0,0
3890,months,0,0
3891,;,0,0
3892,all,0,0
3893,patients,0,0
3894,continuing,0,0
3895,into,0,0
3896,an,0,0
3897,open,0,0
3898,extension,0,0
3899,received,0,0
3900,finasteride,0,0
3901,during,0,0
3902,the,0,0
3903,second,0,0
3904,12,0,0
3905,months,0,0
3906,of,0,0
3907,therapy,0,0
3908,.,0,0
3909,Results,0,0
3910,of,0,0
3911,the,0,0
3912,initial,0,0
3913,12-month,0,1
3914,study,0,0
3915,demonstrated,0,0
3916,the,0,0
3917,benefit,0,0
3918,of,0,0
3919,finasteride,0,0
3920,treatment,0,0
3921,on,0,0
3922,PFS,1,1
3923,parameters,1,1
3924,.,1,0
3925,To,0,0
3926,examine,0,0
3927,the,0,0
3928,continuing,0,0
3929,effects,0,1
3930,over,0,0
3931,time,0,1
3932,",",0,0
3933,an,0,0
3934,analysis,0,0
3935,of,0,0
3936,the,0,0
3937,data,0,0
3938,from,0,0
3939,54,0,0
3940,patients,0,0
3941,who,0,0
3942,completed,0,0
3943,24,0,0
3944,months,0,0
3945,of,0,0
3946,treatment,0,0
3947,with,0,0
3948,finasteride,0,0
3949,is,0,0
3950,provided,0,0
3951,.,0,0
3952,RESULTS,0,0
3953,Detrusor,1,1
3954,pressure,1,1
3955,at,0,0
3956,maximum,0,1
3957,flow,0,1
3958,(,1,1
3959,PdetQmax,1,1
3960,),1,0
3961,continued,0,0
3962,to,0,0
3963,decrease,0,0
3964,during,0,0
3965,the,0,0
3966,second,0,0
3967,12,0,0
3968,months,0,0
3969,of,0,0
3970,therapy,0,0
3971,(,0,0
3972,decreases,0,0
3973,of,0,0
3974,5.3,0,0
3975,and,0,0
3976,11.7,0,0
3977,cm,0,0
3978,H2O,0,0
3979,at,0,0
3980,months,0,0
3981,12,0,0
3982,and,0,0
3983,24,0,0
3984,",",0,0
3985,respectively,0,0
3986,),0,0
3987,.,0,0
3988,The,0,0
3989,percentage,0,1
3990,of,0,0
3991,patients,0,0
3992,obstructed,0,0
3993,by,0,0
3994,Abrams-Griffiths,1,0
3995,classification,1,1
3996,decreased,0,0
3997,from,0,0
3998,76.2,0,0
3999,%,0,0
4000,at,0,0
4001,baseline,0,0
4002,to,0,0
4003,66.7,0,0
4004,%,0,0
4005,at,0,0
4006,month,0,0
4007,12,0,0
4008,and,0,0
4009,59.6,0,0
4010,%,0,0
4011,at,0,0
4012,month,0,0
4013,24,0,0
4014,.,0,0
4015,An,0,0
4016,intention-to-treat,0,0
4017,analysis,0,0
4018,yielded,0,1
4019,similar,0,0
4020,results,0,0
4021,.,0,0
4022,CONCLUSIONS,0,0
4023,Finasteride,0,0
4024,improves,0,1
4025,urodynamic,0,0
4026,measures,0,1
4027,of,0,0
4028,obstruction,0,1
4029,in,0,0
4030,men,0,0
4031,with,0,0
4032,BPE,0,1
4033,and,0,1
4034,LUTS,0,1
4035,",",0,1
4036,with,0,0
4037,continued,0,0
4038,improvement,0,1
4039,during,0,0
4040,the,0,0
4041,second,0,0
4042,12,0,0
4043,months,0,0
4044,of,0,0
4045,therapy,0,0
4046,.,0,0
4047,Double-blind,0,0
4048,",",0,1
4049,randomized,0,0
4050,",",0,0
4051,placebo-controlled,0,0
4052,clinical,0,1
4053,trial,0,0
4054,on,0,0
4055,the,0,0
4056,efficacy,1,1
4057,and,1,1
4058,tolerability,1,1
4059,of,1,0
4060,a,1,0
4061,physostigmine,1,0
4062,patch,1,0
4063,in,0,0
4064,patients,0,0
4065,with,0,0
4066,senile,0,0
4067,dementia,0,0
4068,of,0,0
4069,the,0,0
4070,Alzheimer,0,1
4071,type,0,0
4072,.,0,0
4073,Owing,0,0
4074,to,0,0
4075,the,0,0
4076,pharmacokinetic,0,1
4077,properties,0,1
4078,of,0,0
4079,physostigmine,0,0
4080,when,0,0
4081,administered,0,0
4082,by,0,0
4083,conventional,0,0
4084,routes,0,0
4085,",",0,0
4086,long-term,0,1
4087,cholinergic,0,1
4088,treatment,0,0
4089,of,0,1
4090,Alzheimer,0,1
4091,'s,0,0
4092,disease,0,0
4093,is,0,0
4094,difficult,0,0
4095,to,0,0
4096,manage,0,0
4097,.,0,0
4098,In,0,0
4099,order,0,0
4100,to,0,0
4101,overcome,0,0
4102,the,0,0
4103,problems,0,1
4104,associated,0,0
4105,with,0,0
4106,the,0,0
4107,oral,0,0
4108,and,0,1
4109,intravenous,0,0
4110,application,0,0
4111,of,0,1
4112,physostigmine,0,0
4113,",",0,0
4114,and,0,0
4115,to,0,0
4116,improve,0,0
4117,patients,1,0
4118,',1,1
4119,compliance,1,1
4120,",",0,0
4121,a,0,0
4122,transdermal,0,0
4123,therapeutic,0,1
4124,system,0,0
4125,was,0,0
4126,developed,0,0
4127,.,0,0
4128,The,0,0
4129,efficacy,1,1
4130,and,1,1
4131,tolerability,1,1
4132,of,0,0
4133,this,0,0
4134,system,0,0
4135,were,0,0
4136,evaluated,0,0
4137,in,0,0
4138,a,0,0
4139,double-blind,0,0
4140,",",0,0
4141,randomized,0,0
4142,",",0,0
4143,multicenter,0,0
4144,study,0,0
4145,comparing,0,0
4146,patches,0,0
4147,containing,0,0
4148,30,0,0
4149,mg,0,0
4150,and,0,0
4151,60,0,0
4152,mg,0,0
4153,physostigmine,0,0
4154,with,0,0
4155,a,0,0
4156,placebo,0,0
4157,patch,0,0
4158,.,0,0
4159,The,0,0
4160,clinical,0,0
4161,trial,0,0
4162,followed,0,0
4163,the,0,0
4164,basic,0,0
4165,principles,0,0
4166,of,0,0
4167,the,0,0
4168,various,0,0
4169,guidelines,0,0
4170,on,0,0
4171,the,0,0
4172,evaluation,0,0
4173,of,0,0
4174,anti-dementia,0,1
4175,drugs,0,0
4176,",",0,1
4177,and,0,1
4178,included,0,0
4179,patients,0,0
4180,with,0,0
4181,mild,0,0
4182,to,0,0
4183,moderate,0,0
4184,probable,0,1
4185,Alzheimer,0,1
4186,'s,0,0
4187,disease,0,0
4188,.,0,0
4189,A,0,0
4190,total,0,0
4191,of,0,0
4192,204,0,0
4193,patients,0,0
4194,with,0,0
4195,probable,0,1
4196,Alzheimer,0,1
4197,'s,0,1
4198,disease,0,1
4199,were,0,0
4200,included,0,0
4201,in,0,0
4202,the,0,0
4203,study,0,0
4204,.,0,0
4205,Of,0,0
4206,these,0,0
4207,",",0,0
4208,136,0,0
4209,patients,0,0
4210,were,0,0
4211,eligible,0,0
4212,for,0,0
4213,the,0,0
4214,according-to-protocol,0,0
4215,analysis,0,0
4216,of,0,1
4217,efficacy,0,1
4218,",",0,0
4219,167,0,0
4220,subjects,0,0
4221,for,0,0
4222,the,0,0
4223,intention-to-treat,0,0
4224,analysis,0,0
4225,of,0,1
4226,efficacy,0,1
4227,",",0,0
4228,and,0,0
4229,181,0,0
4230,patients,0,0
4231,were,0,0
4232,included,0,0
4233,in,0,0
4234,the,0,0
4235,safety,0,1
4236,analysis,0,0
4237,.,0,0
4238,In,0,0
4239,contrast,0,0
4240,to,0,0
4241,the,0,0
4242,hypothesis,0,0
4243,to,0,0
4244,be,0,0
4245,tested,0,0
4246,",",0,0
4247,the,0,0
4248,efficacy,1,1
4249,of,0,1
4250,physostigmine,0,0
4251,was,0,0
4252,not,0,0
4253,superior,0,0
4254,to,0,0
4255,that,0,0
4256,of,0,0
4257,placebo,0,0
4258,after,0,0
4259,a,0,0
4260,treatment,0,0
4261,period,0,0
4262,of,0,0
4263,24,0,0
4264,weeks,0,0
4265,.,0,0
4266,On,0,0
4267,the,0,0
4268,contrary,0,0
4269,",",0,0
4270,there,0,0
4271,was,0,0
4272,even,0,0
4273,a,0,0
4274,slight,0,1
4275,",",0,1
4276,but,0,0
4277,not,0,0
4278,statistically,0,0
4279,significant,0,0
4280,",",0,0
4281,trend,0,0
4282,toward,0,0
4283,a,0,0
4284,better,0,0
4285,outcome,0,1
4286,in,0,0
4287,the,0,0
4288,placebo,0,0
4289,group,0,0
4290,.,0,1
4291,Median,1,1
4292,physostigmine,1,0
4293,plasma,1,1
4294,concentrations,1,1
4295,of,0,0
4296,approximately,0,0
4297,100,0,0
4298,pg/ml,0,0
4299,were,0,0
4300,measured,0,0
4301,",",0,0
4302,showing,0,0
4303,a,0,0
4304,high,0,0
4305,degree,0,1
4306,of,0,1
4307,interindividual,0,1
4308,variability,0,1
4309,and,0,0
4310,no,0,0
4311,linear,0,0
4312,dose,0,0
4313,relationship,0,1
4314,between,0,0
4315,the,0,0
4316,30,0,0
4317,mg,0,0
4318,and,0,0
4319,60,0,0
4320,mg,0,0
4321,dosages,0,0
4322,.,0,1
4323,Plasma,1,1
4324,cholinesterase,1,1
4325,activity,1,1
4326,was,0,0
4327,not,0,0
4328,significantly,0,0
4329,affected,0,0
4330,by,0,0
4331,physostigmine,0,0
4332,.,0,0
4333,The,0,0
4334,physostigmine,0,0
4335,patch,0,0
4336,application,0,0
4337,in,0,0
4338,doses,0,0
4339,of,0,0
4340,30,0,0
4341,mg,0,0
4342,and,0,0
4343,60,0,0
4344,mg,0,0
4345,apparently,0,0
4346,did,0,0
4347,not,0,0
4348,lead,0,0
4349,to,0,0
4350,physostigmine,1,0
4351,plasma,1,1
4352,concentrations,1,1
4353,that,0,0
4354,were,0,0
4355,sufficient,0,0
4356,to,0,0
4357,compensate,0,0
4358,for,0,0
4359,cholinergic,0,1
4360,deficiencies,0,0
4361,in,0,0
4362,affected,0,0
4363,brain,0,1
4364,areas,0,1
4365,and,0,1
4366,produce,0,0
4367,clinical,0,0
4368,benefits,0,0
4369,.,0,0
4370,Both,0,0
4371,the,0,0
4372,drug,0,0
4373,and,0,0
4374,the,0,0
4375,transdermal,0,0
4376,system,0,0
4377,were,0,0
4378,generally,0,0
4379,well,1,0
4380,tolerated,1,1
4381,under,0,0
4382,the,0,0
4383,study,0,0
4384,conditions,0,0
4385,.,0,0
4386,Modifications,0,0
4387,of,0,0
4388,the,0,0
4389,patch,0,0
4390,system,0,0
4391,may,0,0
4392,perhaps,0,0
4393,make,0,0
4394,it,0,0
4395,possible,0,0
4396,to,0,0
4397,achieve,0,0
4398,higher,0,0
4399,physostigmine,1,0
4400,plasma,1,1
4401,concentrations,1,1
4402,",",0,0
4403,which,0,0
4404,seem,0,0
4405,to,0,0
4406,be,0,0
4407,required,0,0
4408,to,0,0
4409,induce,0,0
4410,the,0,0
4411,expected,0,0
4412,beneficial,1,0
4413,effects,1,1
4414,during,0,0
4415,long-term,0,1
4416,treatment,0,0
4417,of,0,1
4418,Alzheimer,0,1
4419,'s,0,0
4420,disease,0,0
4421,.,0,0
4422,Assessment,0,1
4423,of,0,0
4424,the,0,0
4425,pain,0,1
4426,of,0,0
4427,blood-sugar,0,1
4428,testing,0,0
4429,:,0,0
4430,a,0,0
4431,randomised,0,0
4432,controlled,0,0
4433,trial,0,0
4434,.,0,0
4435,Lancet,0,0
4436,puncture,0,0
4437,to,0,0
4438,the,0,0
4439,side,0,1
4440,of,0,0
4441,the,0,0
4442,thumb,0,1
4443,resulted,0,0
4444,in,0,0
4445,less,1,0
4446,pain,1,1
4447,than,0,0
4448,lancet,0,0
4449,puncture,0,0
4450,to,0,0
4451,the,0,0
4452,finger,0,1
4453,or,0,0
4454,venepuncture,0,0
4455,at,0,0
4456,the,0,0
4457,elbow,0,0
4458,.,0,0
4459,Success,0,0
4460,rates,0,1
4461,were,0,0
4462,the,0,0
4463,same,0,0
4464,.,0,0
4465,Use,0,0
4466,of,0,0
4467,the,0,0
4468,oral,0,0
4469,neuraminidase,0,1
4470,inhibitor,0,0
4471,oseltamivir,0,0
4472,in,0,0
4473,experimental,0,0
4474,human,0,0
4475,influenza,0,0
4476,:,0,0
4477,randomized,0,0
4478,controlled,0,0
4479,trials,0,0
4480,for,0,0
4481,prevention,0,0
4482,and,0,1
4483,treatment,0,0
4484,.,0,1
4485,CONTEXT,0,1
4486,Influenza,0,1
4487,virus,0,0
4488,neuraminidase,0,0
4489,is,0,0
4490,thought,0,0
4491,to,0,0
4492,be,0,0
4493,essential,0,0
4494,for,0,0
4495,virus,0,1
4496,replication,0,0
4497,in,0,0
4498,humans,0,0
4499,;,0,0
4500,however,0,0
4501,",",0,0
4502,to,0,0
4503,date,0,1
4504,",",0,1
4505,available,0,0
4506,neuraminidase,0,0
4507,inhibitors,0,0
4508,are,0,0
4509,limited,0,0
4510,to,0,0
4511,zanamivir,0,0
4512,",",0,0
4513,which,0,0
4514,is,0,0
4515,topically,0,0
4516,administered,0,0
4517,.,0,0
4518,OBJECTIVE,0,0
4519,To,0,0
4520,determine,0,0
4521,the,0,0
4522,safety,1,1
4523,",",1,1
4524,tolerability,1,1
4525,",",1,1
4526,and,1,1
4527,antiviral,1,1
4528,activity,1,1
4529,of,0,1
4530,oral,0,0
4531,neuraminidase,0,1
4532,inhibitor,0,0
4533,oseltamivir,0,0
4534,(,0,1
4535,GS4104/Ro64-0796,0,0
4536,),0,1
4537,for,0,0
4538,prevention,0,0
4539,and,0,0
4540,the,0,0
4541,early,0,0
4542,treatment,0,0
4543,of,0,1
4544,influenza,0,0
4545,in,0,0
4546,experimentally,0,0
4547,infected,0,0
4548,humans,0,0
4549,.,0,0
4550,DESIGN,0,0
4551,Two,0,0
4552,randomized,0,0
4553,",",0,0
4554,double-blind,0,0
4555,",",0,1
4556,placebo-controlled,0,0
4557,trials,0,0
4558,conducted,0,0
4559,between,0,0
4560,June,0,0
4561,and,0,0
4562,July,0,0
4563,1997,0,0
4564,.,0,0
4565,SETTING,0,0
4566,Individual,0,0
4567,hotel,0,0
4568,rooms,0,0
4569,;,0,0
4570,2,0,0
4571,large,0,0
4572,US,0,0
4573,university,0,0
4574,medical,0,0
4575,schools,0,0
4576,.,0,0
4577,PARTICIPANTS,0,0
4578,A,0,0
4579,total,0,0
4580,of,0,0
4581,117,0,0
4582,healthy,0,0
4583,adult,0,0
4584,volunteers,0,0
4585,(,0,0
4586,aged,0,0
4587,18-40,0,0
4588,years,0,0
4589,;,0,0
4590,median,0,1
4591,age,0,0
4592,",",0,0
4593,21,0,0
4594,years,0,0
4595,),0,0
4596,who,0,0
4597,were,0,0
4598,susceptible,0,1
4599,(,0,0
4600,hemagglutination-inhibition,0,1
4601,antibody,0,1
4602,titer,0,1
4603,<,0,0
4604,or,0,1
4605,=1:8,0,1
4606,),0,1
4607,.,0,0
4608,INTERVENTIONS,0,0
4609,All,0,0
4610,subjects,0,0
4611,were,0,0
4612,inoculated,0,0
4613,intranasally,0,0
4614,with,0,0
4615,influenza,0,1
4616,A/Texas/36/91,0,1
4617,(,0,1
4618,H1N1,0,1
4619,),0,0
4620,virus,0,1
4621,.,0,0
4622,For,0,0
4623,the,0,0
4624,prophylaxis,0,0
4625,study,0,0
4626,",",0,1
4627,oral,0,0
4628,oseltamivir,0,0
4629,(,0,0
4630,100,0,0
4631,mg,0,0
4632,once,0,0
4633,daily,0,0
4634,[,0,0
4635,n,0,0
4636,=,0,0
4637,12,0,0
4638,],0,0
4639,",",0,0
4640,100,0,0
4641,mg,0,0
4642,twice,0,0
4643,daily,0,0
4644,[,0,0
4645,n,0,0
4646,=,0,0
4647,12,0,0
4648,],0,0
4649,",",0,0
4650,or,0,1
4651,matching,0,0
4652,placebo,0,0
4653,[,0,0
4654,n,0,0
4655,=,0,0
4656,13,0,0
4657,],0,0
4658,",",0,0
4659,starting,0,0
4660,26,0,0
4661,hours,0,0
4662,before,0,0
4663,virus,0,1
4664,inoculation,0,0
4665,),0,1
4666,was,0,0
4667,administered,0,0
4668,.,0,0
4669,For,0,0
4670,the,0,0
4671,treatment,0,0
4672,study,0,0
4673,",",0,0
4674,the,0,0
4675,same,0,0
4676,drug,0,0
4677,was,0,0
4678,given,0,0
4679,(,0,0
4680,20,0,0
4681,mg,0,0
4682,",",0,0
4683,100,0,0
4684,mg,0,0
4685,",",0,0
4686,or,0,0
4687,200,0,0
4688,mg,0,0
4689,twice,0,0
4690,daily,0,0
4691,",",0,0
4692,200,0,0
4693,mg,0,0
4694,once,0,0
4695,daily,0,0
4696,",",0,0
4697,or,0,1
4698,matching,0,0
4699,placebo,0,0
4700,[,0,0
4701,n,0,0
4702,=,0,0
4703,16,0,0
4704,],0,0
4705,",",0,0
4706,in,0,0
4707,each,0,0
4708,group,0,0
4709,starting,0,0
4710,28,0,0
4711,hours,0,0
4712,after,0,0
4713,inoculation,0,0
4714,),0,0
4715,.,0,0
4716,All,0,0
4717,regimens,0,0
4718,were,0,0
4719,continued,0,0
4720,for,0,0
4721,5,0,0
4722,days,0,0
4723,.,0,0
4724,MAIN,0,0
4725,OUTCOME,0,1
4726,MEASURES,0,1
4727,Comparing,0,0
4728,placebo,0,0
4729,groups,0,0
4730,with,0,0
4731,pooled,0,0
4732,treatment,0,0
4733,groups,0,0
4734,",",0,0
4735,for,0,0
4736,prophylaxis,0,0
4737,",",0,0
4738,outcomes,0,1
4739,included,0,0
4740,frequency,1,1
4741,of,1,1
4742,infection,1,1
4743,and,1,1
4744,viral,1,0
4745,shedding,1,1
4746,;,1,0
4747,for,0,0
4748,treatment,0,0
4749,",",0,0
4750,viral,0,1
4751,shedding,0,1
4752,in,0,0
4753,titers,0,1
4754,.,0,0
4755,RESULTS,0,0
4756,In,0,0
4757,the,0,0
4758,prophylaxis,0,0
4759,study,0,0
4760,",",0,0
4761,8,0,0
4762,(,0,0
4763,67,0,0
4764,%,0,0
4765,),0,0
4766,of,0,0
4767,12,0,0
4768,placebo,0,0
4769,and,0,0
4770,8,0,0
4771,(,0,0
4772,38,0,0
4773,%,0,0
4774,),0,0
4775,of,0,0
4776,21,0,0
4777,oseltamivir,0,0
4778,recipients,0,0
4779,became,0,0
4780,infected,1,0
4781,(,0,0
4782,P,0,0
4783,=,0,0
4784,.16,0,0
4785,;,0,1
4786,efficacy,0,1
4787,",",0,0
4788,61,0,0
4789,%,0,0
4790,),0,0
4791,;,0,0
4792,6,0,0
4793,(,0,0
4794,50,0,0
4795,%,0,0
4796,),0,0
4797,placebo,0,0
4798,compared,0,0
4799,with,0,0
4800,0,0,0
4801,oseltamivir,0,0
4802,recipients,0,0
4803,shed,0,0
4804,virus,0,1
4805,(,0,0
4806,P,0,0
4807,<,0,0
4808,.001,0,0
4809,;,0,1
4810,efficacy,0,1
4811,",",0,0
4812,100,0,0
4813,%,0,0
4814,),0,0
4815,",",0,0
4816,and,0,0
4817,33,0,0
4818,%,0,0
4819,of,0,0
4820,placebo,0,0
4821,but,0,0
4822,no,0,0
4823,oseltamivir,0,0
4824,recipient,0,0
4825,had,0,0
4826,infection-related,0,1
4827,respiratory,0,1
4828,illness,0,1
4829,(,0,1
4830,P,0,0
4831,<,0,0
4832,.01,0,0
4833,),0,0
4834,.,0,0
4835,Among,0,0
4836,infected,0,0
4837,subjects,0,0
4838,in,0,0
4839,the,0,0
4840,treatment,0,0
4841,study,0,0
4842,(,0,0
4843,n,0,0
4844,=,0,0
4845,69,0,0
4846,),0,0
4847,",",0,0
4848,the,0,0
4849,viral,1,1
4850,titer,1,1
4851,area,1,1
4852,under,1,0
4853,the,1,0
4854,curve,1,1
4855,of,0,0
4856,the,0,0
4857,combined,0,0
4858,oseltamivir,0,0
4859,groups,0,0
4860,(,0,0
4861,n,0,0
4862,=,0,0
4863,56,0,0
4864,),0,0
4865,was,0,0
4866,lower,0,1
4867,(,0,1
4868,median,0,1
4869,[,0,0
4870,interquartile,0,1
4871,range,0,0
4872,[,0,0
4873,IQR,0,1
4874,],0,0
4875,],0,0
4876,",",0,0
4877,80,0,0
4878,[,0,0
4879,23-151,0,0
4880,],0,0
4881,vs,0,0
4882,273,0,0
4883,[,0,0
4884,79-306,0,0
4885,],0,0
4886,log10,0,1
4887,tissue,0,1
4888,culture-infective,0,1
4889,doses50,0,1
4890,per,0,0
4891,milliliter,0,1
4892,x,0,0
4893,hour,0,0
4894,;,0,0
4895,P,0,0
4896,=,0,0
4897,.02,0,0
4898,),0,0
4899,than,0,0
4900,the,0,0
4901,placebo,0,0
4902,group,0,0
4903,(,0,0
4904,n,0,0
4905,=,0,0
4906,13,0,0
4907,),0,0
4908,",",0,0
4909,and,0,0
4910,the,0,0
4911,median,1,1
4912,(,1,0
4913,IQR,1,1
4914,),1,1
4915,duration,1,1
4916,of,1,0
4917,viral,1,0
4918,shedding,1,1
4919,with,0,0
4920,therapy,0,0
4921,was,0,0
4922,reduced,0,0
4923,from,0,0
4924,107,0,0
4925,(,0,0
4926,83-131,0,0
4927,),0,0
4928,to,0,0
4929,58,0,0
4930,(,0,0
4931,35-59,0,0
4932,),0,0
4933,hours,0,0
4934,(,0,0
4935,P,0,0
4936,=,0,0
4937,.003,0,0
4938,),0,0
4939,.,0,0
4940,Oseltamivir,0,0
4941,treatment,0,0
4942,also,0,0
4943,reduced,0,0
4944,symptom,1,1
4945,scores,1,1
4946,(,0,0
4947,median,0,1
4948,[,0,0
4949,IQR,0,1
4950,],0,0
4951,score-hours,0,1
4952,",",0,0
4953,225,0,0
4954,[,0,0
4955,97-349,0,0
4956,],0,0
4957,vs,0,0
4958,400,0,0
4959,[,0,0
4960,189-645,0,0
4961,],0,0
4962,;,0,0
4963,P,0,0
4964,=,0,0
4965,.05,0,0
4966,),0,1
4967,",",0,0
4968,and,0,1
4969,nasal,1,1
4970,proinflammatory,1,1
4971,cytokine,1,1
4972,levels,1,1
4973,.,1,1
4974,Transient,0,1
4975,mild,1,0
4976,to,1,0
4977,moderate,1,0
4978,nausea,1,1
4979,after,0,0
4980,dosing,0,0
4981,was,0,0
4982,observed,0,0
4983,in,0,0
4984,15,0,0
4985,(,0,0
4986,17,0,0
4987,%,0,0
4988,),0,0
4989,of,0,0
4990,88,0,0
4991,oseltamivir,0,0
4992,and,0,0
4993,2,0,0
4994,(,0,0
4995,7,0,0
4996,%,0,0
4997,),0,0
4998,of,0,0
4999,29,0,0
5000,placebo,0,0
5001,recipients,0,0
5002,(,0,0
5003,95,0,0
5004,%,0,0
5005,confidence,0,0
5006,interval,0,0
5007,for,0,0
5008,difference,0,0
5009,",",0,0
5010,-11,0,0
5011,%,0,0
5012,to,0,0
5013,68,0,0
5014,%,0,0
5015,),0,0
5016,",",0,0
5017,which,0,0
5018,was,0,0
5019,largely,0,0
5020,prevented,0,0
5021,by,0,0
5022,ingestion,0,0
5023,with,0,0
5024,food,0,0
5025,.,0,0
5026,CONCLUSIONS,0,0
5027,In,0,0
5028,these,0,0
5029,trials,0,0
5030,",",0,1
5031,prophylaxis,0,0
5032,and,0,1
5033,early,0,1
5034,treatment,0,0
5035,with,0,0
5036,oral,0,0
5037,oseltamivir,0,0
5038,were,0,0
5039,both,0,0
5040,associated,0,0
5041,with,0,0
5042,significant,0,0
5043,antiviral,0,0
5044,and,0,1
5045,clinical,0,1
5046,effects,0,1
5047,in,0,0
5048,experimental,0,0
5049,human,0,0
5050,influenza,0,0
5051,.,0,0
5052,An,0,0
5053,empirical,0,0
5054,comparison,0,0
5055,of,0,0
5056,the,0,0
5057,St,0,1
5058,George,0,1
5059,'s,0,1
5060,Respiratory,0,1
5061,Questionnaire,0,1
5062,(,0,1
5063,SGRQ,0,1
5064,),0,0
5065,and,0,0
5066,the,0,0
5067,Chronic,0,0
5068,Respiratory,0,1
5069,Disease,0,1
5070,Questionnaire,0,1
5071,(,0,1
5072,CRQ,0,1
5073,),0,0
5074,in,0,0
5075,a,0,0
5076,clinical,0,0
5077,trial,0,0
5078,setting,0,0
5079,.,0,0
5080,BACKGROUND,0,0
5081,The,0,0
5082,Chronic,0,0
5083,Respiratory,0,1
5084,Questionnaire,0,1
5085,(,0,1
5086,CRQ,0,1
5087,),0,0
5088,and,0,0
5089,the,0,0
5090,St,0,1
5091,George,0,1
5092,'s,0,1
5093,Respiratory,0,1
5094,Questionnaire,0,1
5095,(,0,1
5096,SGRQ,0,1
5097,),0,0
5098,are,0,0
5099,the,0,0
5100,two,0,0
5101,most,0,0
5102,widely,0,0
5103,used,0,0
5104,quality,0,1
5105,of,0,0
5106,life,0,1
5107,questionnaires,0,1
5108,in,0,0
5109,chronic,0,0
5110,obstructive,0,0
5111,pulmonary,0,1
5112,disease,0,1
5113,(,0,1
5114,COPD,0,0
5115,),0,0
5116,.,0,0
5117,A,0,0
5118,study,0,0
5119,was,0,0
5120,undertaken,0,0
5121,to,0,0
5122,compare,0,0
5123,directly,0,0
5124,the,0,0
5125,self-administered,0,0
5126,version,0,0
5127,of,0,0
5128,the,0,0
5129,CRQ,0,1
5130,and,0,0
5131,the,0,0
5132,SGRQ,0,1
5133,with,0,0
5134,respect,0,0
5135,to,0,0
5136,feasibility,0,1
5137,",",0,1
5138,internal,0,1
5139,consistency,0,1
5140,",",0,1
5141,validity,0,1
5142,",",0,1
5143,and,0,1
5144,sensitivity,0,1
5145,to,0,0
5146,changes,0,1
5147,resulting,0,0
5148,from,0,0
5149,bronchodilator,0,0
5150,therapy,0,0
5151,.,0,0
5152,METHODS,0,0
5153,One,0,0
5154,hundred,0,0
5155,and,0,0
5156,forty,0,0
5157,four,0,0
5158,patients,0,0
5159,with,0,0
5160,moderate,0,0
5161,or,0,0
5162,severe,0,1
5163,COPD,0,1
5164,were,0,0
5165,randomly,0,0
5166,assigned,0,0
5167,to,0,0
5168,receive,0,0
5169,three,0,0
5170,months,0,0
5171,of,0,0
5172,treatment,0,0
5173,with,0,0
5174,either,0,0
5175,salmeterol,0,0
5176,",",0,0
5177,salmeterol,0,0
5178,+,0,1
5179,ipratropium,0,0
5180,bromide,0,0
5181,",",0,1
5182,or,0,1
5183,placebo,0,0
5184,.,0,1
5185,Quality,1,1
5186,of,1,1
5187,life,1,1
5188,was,0,0
5189,measured,0,0
5190,at,0,0
5191,baseline,0,0
5192,and,0,0
5193,after,0,0
5194,12,0,0
5195,weeks,0,0
5196,of,0,0
5197,treatment,0,0
5198,.,0,0
5199,RESULTS,0,0
5200,The,0,0
5201,proportions,1,0
5202,of,1,0
5203,missing,1,0
5204,values,1,1
5205,per,0,0
5206,patient,0,1
5207,were,0,0
5208,low,0,0
5209,for,0,0
5210,both,0,0
5211,questionnaires,0,0
5212,(,0,0
5213,0.54,0,0
5214,%,0,0
5215,for,0,0
5216,the,0,0
5217,CRQ,0,1
5218,and,0,0
5219,2,0,0
5220,%,0,0
5221,for,0,0
5222,the,0,0
5223,SGRQ,0,0
5224,),0,0
5225,.,0,0
5226,The,0,0
5227,internal,1,0
5228,consistency,1,1
5229,was,0,0
5230,good,0,0
5231,for,0,0
5232,both,0,0
5233,questionnaires,0,0
5234,(,0,0
5235,Cronbach,0,1
5236,'s,0,1
5237,alpha,0,0
5238,coefficients,0,1
5239,>,0,0
5240,/=,0,0
5241,0.84,0,0
5242,for,0,0
5243,the,0,0
5244,CRQ,0,1
5245,and,0,1
5246,>,0,1
5247,/=,0,0
5248,0.76,0,0
5249,for,0,0
5250,the,0,0
5251,SGRQ,0,0
5252,),0,0
5253,.,0,0
5254,Factor,0,0
5255,analysis,0,0
5256,confirmed,0,0
5257,the,0,0
5258,original,0,0
5259,domain,0,0
5260,structure,0,0
5261,of,0,0
5262,the,0,0
5263,CRQ,0,1
5264,but,0,0
5265,not,0,0
5266,of,0,0
5267,the,0,0
5268,SGRQ,0,0
5269,.,0,0
5270,Correlations,0,0
5271,with,0,0
5272,forced,0,1
5273,expiratory,0,1
5274,volume,0,1
5275,in,0,0
5276,one,0,0
5277,second,0,0
5278,(,1,0
5279,FEV,1,1
5280,(,1,0
5281,1,1,0
5282,),1,0
5283,),1,0
5284,%,1,0
5285,predicted,0,1
5286,and,0,0
5287,peak,1,1
5288,expiratory,1,1
5289,flow,1,1
5290,rate,1,1
5291,(,1,1
5292,PEFR,1,1
5293,),1,1
5294,were,0,0
5295,low,0,0
5296,for,0,0
5297,both,0,0
5298,questionnaires,0,0
5299,but,0,0
5300,better,0,0
5301,for,0,0
5302,the,0,0
5303,SGRQ,0,0
5304,than,0,0
5305,for,0,0
5306,the,0,0
5307,CRQ,0,0
5308,.,0,0
5309,The,0,0
5310,ability,0,1
5311,to,0,0
5312,discriminate,0,0
5313,between,0,0
5314,subjects,0,0
5315,with,0,0
5316,different,0,0
5317,levels,0,1
5318,of,0,1
5319,FEV,1,0
5320,(,1,0
5321,1,1,0
5322,),1,0
5323,was,0,0
5324,somewhat,0,0
5325,better,0,0
5326,for,0,0
5327,the,0,0
5328,SGRQ,0,0
5329,.,0,0
5330,The,0,0
5331,correlations,0,1
5332,with,0,0
5333,symptom,0,1
5334,scores,0,1
5335,were,0,0
5336,comparable,0,0
5337,for,0,0
5338,both,0,0
5339,questionnaires,0,0
5340,.,0,0
5341,Cross,0,0
5342,sectionally,0,0
5343,",",0,0
5344,the,0,0
5345,scores,0,1
5346,of,0,0
5347,the,0,0
5348,two,0,0
5349,questionnaires,0,0
5350,were,0,0
5351,moderately,0,0
5352,to,0,0
5353,highly,0,0
5354,correlated,0,0
5355,(,0,0
5356,coefficients,0,1
5357,ranged,0,0
5358,from,0,0
5359,0.35,0,0
5360,to,0,0
5361,0.72,0,0
5362,),0,0
5363,.,0,0
5364,Longitudinally,0,0
5365,",",0,0
5366,these,0,0
5367,correlations,0,1
5368,were,0,0
5369,lower,0,1
5370,(,0,1
5371,coefficients,0,1
5372,ranged,0,0
5373,from,0,0
5374,0.17,0,0
5375,to,0,0
5376,0.54,0,0
5377,),0,0
5378,but,0,0
5379,were,0,0
5380,still,0,0
5381,significant,0,0
5382,.,0,0
5383,The,0,0
5384,CRQ,1,1
5385,total,1,1
5386,and,1,1
5387,emotions,1,1
5388,score,1,1
5389,and,1,0
5390,the,1,0
5391,SGRQ,1,1
5392,symptoms,1,1
5393,score,1,1
5394,were,0,0
5395,the,0,0
5396,most,0,0
5397,responsive,0,0
5398,to,0,0
5399,change,0,0
5400,.,0,0
5401,The,0,0
5402,SGRQ,1,1
5403,symptoms,1,1
5404,domain,1,0
5405,was,0,0
5406,the,0,0
5407,only,0,0
5408,domain,0,0
5409,where,0,0
5410,the,0,0
5411,improvement,0,1
5412,in,0,0
5413,patients,0,0
5414,receiving,0,0
5415,combination,0,0
5416,treatment,0,0
5417,crossed,0,0
5418,the,0,0
5419,threshold,0,1
5420,for,0,0
5421,clinical,0,0
5422,relevance,0,0
5423,.,0,0
5424,CONCLUSIONS,0,0
5425,Since,0,0
5426,this,0,0
5427,analysis,0,0
5428,of,0,1
5429,reliability,0,1
5430,",",0,1
5431,validity,0,1
5432,",",0,1
5433,and,0,1
5434,responsiveness,0,1
5435,to,0,0
5436,change,0,1
5437,did,0,0
5438,not,0,0
5439,clearly,0,0
5440,favour,0,0
5441,one,0,0
5442,instrument,0,0
5443,above,0,0
5444,the,0,0
5445,other,0,0
5446,",",0,0
5447,the,0,0
5448,choice,0,0
5449,between,0,0
5450,the,0,0
5451,CRQ,0,1
5452,and,0,0
5453,the,0,0
5454,SGRQ,0,0
5455,can,0,0
5456,be,0,0
5457,based,0,0
5458,on,0,0
5459,other,0,0
5460,considerations,0,0
5461,such,0,0
5462,as,0,0
5463,the,0,0
5464,required,0,1
5465,sample,0,0
5466,size,0,1
5467,or,0,0
5468,the,0,0
5469,availability,0,1
5470,of,0,0
5471,reference,0,0
5472,values,0,1
5473,.,0,0
5474,Granulocyte-macrophage,0,1
5475,colony-stimulating,0,1
5476,factor,0,1
5477,treatment,0,0
5478,before,0,0
5479,doxorubicin,0,0
5480,and,0,1
5481,cyclophosphamide,0,0
5482,chemotherapy,0,0
5483,priming,0,0
5484,in,0,0
5485,women,0,0
5486,with,0,0
5487,early-stage,0,0
5488,breast,0,0
5489,cancer,0,0
5490,.,0,0
5491,PURPOSE,0,0
5492,To,0,0
5493,determine,0,0
5494,if,0,0
5495,inhibition,0,1
5496,of,0,1
5497,stem-cell,0,0
5498,activity,0,1
5499,induced,0,0
5500,by,0,0
5501,granulocyte-macrophage,0,1
5502,colony-stimulating,0,1
5503,factor,0,1
5504,(,0,0
5505,[,0,0
5506,GM-CSF,0,0
5507,],0,0
5508,;,0,0
5509,Sargramostim,0,0
5510,;,0,0
5511,Immunex,0,0
5512,Corporation,0,1
5513,",",0,1
5514,Seattle,0,1
5515,",",0,1
5516,WA,0,1
5517,),0,1
5518,withdrawal,0,1
5519,or,0,0
5520,priming,0,0
5521,protects,0,0
5522,hematopoietic,0,1
5523,stem,0,1
5524,cells,0,1
5525,from,0,0
5526,the,0,0
5527,cytotoxic,0,1
5528,effects,0,1
5529,of,0,1
5530,adjuvant,0,0
5531,chemotherapy,0,0
5532,for,0,0
5533,early-stage,0,0
5534,breast,0,0
5535,cancer,0,0
5536,.,0,1
5537,PATIENTS,0,0
5538,AND,0,0
5539,METHODS,0,0
5540,Serial,0,1
5541,blood,0,1
5542,counts,0,1
5543,were,0,0
5544,performed,0,0
5545,in,0,0
5546,20,0,0
5547,women,0,0
5548,with,0,0
5549,early-stage,0,0
5550,breast,0,0
5551,cancer,0,0
5552,receiving,0,0
5553,four,0,0
5554,courses,0,0
5555,of,0,0
5556,cyclophosphamide,0,0
5557,and,0,1
5558,doxorubicin,0,0
5559,chemotherapy,0,0
5560,.,0,0
5561,By,0,0
5562,a,0,0
5563,double-blind,0,0
5564,",",0,0
5565,placebo-controlled,0,0
5566,",",0,1
5567,balanced,0,0
5568,randomization,0,0
5569,",",0,0
5570,subjects,0,0
5571,received,0,0
5572,GM-CSF,0,0
5573,priming,0,0
5574,on,0,0
5575,days,0,0
5576,5,0,0
5577,to,0,0
5578,1,0,0
5579,for,0,0
5580,courses,0,0
5581,1,0,0
5582,and,0,0
5583,3,0,0
5584,or,0,0
5585,courses,0,0
5586,2,0,0
5587,and,0,0
5588,4,0,0
5589,.,0,0
5590,RESULTS,0,0
5591,Compared,0,0
5592,with,0,0
5593,before,0,0
5594,priming,0,0
5595,",",0,0
5596,after,0,0
5597,priming,0,0
5598,the,0,0
5599,times,1,0
5600,to,1,0
5601,neutrophil,1,1
5602,nadir,1,1
5603,(,0,0
5604,12.8,0,0
5605,+/-,0,0
5606,2.5,0,0
5607,days,0,0
5608,v,0,0
5609,14.8,0,0
5610,+/-,0,0
5611,1.5,0,0
5612,days,0,0
5613,",",0,0
5614,respectively,0,0
5615,;,0,0
5616,P,0,0
5617,=.0001,0,0
5618,),0,1
5619,and,0,1
5620,platelet,1,1
5621,nadir,1,1
5622,(,0,0
5623,mean,0,1
5624,+/-,0,0
5625,SD,0,0
5626,",",0,0
5627,10.1,0,0
5628,+/-,0,0
5629,1.9,0,0
5630,days,0,0
5631,v,0,0
5632,11.1,0,0
5633,+/-,0,0
5634,2.2,0,0
5635,days,0,0
5636,",",0,0
5637,P,0,0
5638,<,0,0
5639,.05,0,0
5640,),0,1
5641,were,0,0
5642,shorter,0,1
5643,",",0,0
5644,indicating,0,0
5645,a,0,0
5646,shift,0,0
5647,of,0,0
5648,cytotoxicity,0,1
5649,to,0,0
5650,later,0,0
5651,progenitors,0,0
5652,.,0,0
5653,The,0,0
5654,neutrophil,1,1
5655,nadir,1,1
5656,was,0,0
5657,similar,0,0
5658,with,0,0
5659,and,0,0
5660,without,0,0
5661,priming,0,0
5662,(,0,0
5663,mean,0,1
5664,+/-,0,0
5665,SD,0,0
5666,",",0,0
5667,490,0,0
5668,+/-,0,0
5669,310/microL,0,0
5670,v,0,0
5671,550,0,0
5672,+/-,0,0
5673,350/microL,0,0
5674,",",0,0
5675,respectively,0,0
5676,;,0,0
5677,P,0,0
5678,=.2,0,0
5679,),0,0
5680,;,0,0
5681,however,0,0
5682,",",0,0
5683,on,0,0
5684,day,0,0
5685,16,0,0
5686,the,0,0
5687,mean,0,0
5688,neutrophil,1,1
5689,count,1,1
5690,was,0,0
5691,higher,0,1
5692,(,0,1
5693,mean,0,1
5694,+/-,0,0
5695,SD,0,0
5696,",",0,0
5697,1030,0,0
5698,+/-,0,0
5699,580/microL,0,0
5700,v,0,0
5701,690,0,0
5702,+/-,0,0
5703,370/microL,0,0
5704,",",0,0
5705,P,0,0
5706,=.004,0,0
5707,),0,1
5708,",",0,0
5709,and,0,0
5710,the,0,0
5711,proportion,0,1
5712,of,0,0
5713,patients,0,0
5714,with,0,0
5715,a,0,0
5716,neutrophil,1,1
5717,count,1,1
5718,less,0,0
5719,than,0,0
5720,500/microL,0,1
5721,was,0,0
5722,lower,0,0
5723,after,0,0
5724,priming,0,0
5725,than,0,0
5726,before,0,0
5727,(,0,0
5728,six,0,0
5729,of,0,0
5730,35,0,0
5731,or,0,0
5732,17,0,0
5733,.,0,0
5734,1,0,0
5735,%,0,0
5736,v,0,0
5737,12,0,0
5738,of,0,0
5739,34,0,0
5740,or,0,0
5741,35.3,0,0
5742,%,0,0
5743,",",0,0
5744,respectively,0,0
5745,;,0,0
5746,P,0,0
5747,=.04,0,0
5748,),0,0
5749,.,0,0
5750,The,0,0
5751,platelet,1,1
5752,nadir,1,1
5753,was,0,0
5754,higher,0,1
5755,(,0,1
5756,mean,0,1
5757,+/-,0,0
5758,SD,0,0
5759,",",0,0
5760,"166,000",0,0
5761,+/-,0,0
5762,"51,000/microL",0,0
5763,after,0,0
5764,priming,0,0
5765,v,0,0
5766,"151,000",0,0
5767,+/-,0,0
5768,"45,000/microL",0,1
5769,before,0,0
5770,priming,0,0
5771,",",0,1
5772,P,0,0
5773,=.007,0,0
5774,),0,1
5775,",",0,0
5776,and,0,0
5777,the,0,0
5778,duration,1,1
5779,of,1,1
5780,thrombocytopenia,1,1
5781,",",0,1
5782,ie,0,0
5783,",",0,0
5784,a,0,0
5785,platelet,0,1
5786,count,0,1
5787,less,0,0
5788,than,0,0
5789,"150,000/microL",0,1
5790,",",0,0
5791,was,0,0
5792,shorter,0,1
5793,(,0,0
5794,1.5,0,0
5795,+/-,0,0
5796,2.1,0,0
5797,days,0,0
5798,v,0,0
5799,2.8,0,0
5800,+/-,0,0
5801,2.9,0,0
5802,days,0,0
5803,",",0,0
5804,P,0,0
5805,=.0025,0,0
5806,),0,0
5807,after,0,0
5808,priming,0,0
5809,.,0,0
5810,Episodes,0,0
5811,of,0,1
5812,fever,1,1
5813,and,1,1
5814,neutropenia,1,1
5815,were,0,0
5816,not,0,0
5817,observed,0,0
5818,.,0,0
5819,CONCLUSIONS,0,0
5820,GM-CSF,0,0
5821,priming,0,0
5822,from,0,0
5823,days,0,0
5824,5,0,0
5825,to,0,0
5826,1,0,0
5827,before,0,0
5828,doxorubicin,0,0
5829,and,0,1
5830,cyclophosphamide,0,0
5831,chemotherapy,0,0
5832,was,0,0
5833,associated,0,0
5834,with,0,0
5835,an,0,0
5836,earlier,0,0
5837,neutrophil,1,1
5838,and,1,1
5839,platelet,1,1
5840,nadir,1,1
5841,.,1,0
5842,On,0,0
5843,day,0,0
5844,16,0,0
5845,",",0,0
5846,a,0,0
5847,higher,0,0
5848,mean,0,1
5849,neutrophil,1,1
5850,count,1,1
5851,and,0,0
5852,a,0,0
5853,lower,0,1
5854,proportion,0,1
5855,of,0,1
5856,patients,0,0
5857,with,0,0
5858,severe,0,1
5859,(,0,0
5860,<,0,0
5861,500/microL,0,0
5862,),0,0
5863,neutropenia,1,1
5864,were,0,0
5865,observed,0,0
5866,.,0,0
5867,Beneficial,0,0
5868,effects,0,0
5869,on,0,0
5870,the,0,0
5871,severity,0,1
5872,and,0,1
5873,duration,0,1
5874,of,0,1
5875,thrombocytopenia,1,1
5876,were,0,0
5877,also,0,0
5878,noted,0,0
5879,.,0,0
5880,These,0,0
5881,observations,0,0
5882,support,0,0
5883,the,0,0
5884,hypothesis,0,0
5885,that,0,0
5886,GM-CSF,0,0
5887,priming,0,0
5888,protects,0,0
5889,hematopoietic,0,1
5890,progenitors,0,1
5891,from,0,0
5892,the,0,0
5893,cytotoxic,0,1
5894,effects,0,1
5895,of,0,0
5896,chemotherapy,0,0
5897,.,0,0
5898,Lack,0,0
5899,of,0,1
5900,benefit,0,0
5901,of,0,0
5902,a,0,0
5903,single,0,0
5904,dose,0,0
5905,of,0,1
5906,synthetic,0,1
5907,human,0,0
5908,secretin,0,1
5909,in,0,0
5910,the,0,0
5911,treatment,0,0
5912,of,0,1
5913,autism,0,0
5914,and,0,1
5915,pervasive,0,0
5916,developmental,0,1
5917,disorder,0,0
5918,.,0,0
5919,BACKGROUND,0,0
5920,Secretin,0,1
5921,is,0,0
5922,a,0,0
5923,peptide,0,1
5924,hormone,0,0
5925,that,0,0
5926,stimulates,0,0
5927,pancreatic,0,0
5928,secretion,0,1
5929,.,0,0
5930,After,0,0
5931,recent,0,0
5932,publicity,0,0
5933,about,0,0
5934,a,0,0
5935,child,0,0
5936,with,0,0
5937,autism,0,0
5938,whose,0,0
5939,condition,0,0
5940,markedly,0,0
5941,improved,0,0
5942,after,0,0
5943,a,0,0
5944,single,0,0
5945,dose,0,0
5946,of,0,1
5947,secretin,0,1
5948,",",0,0
5949,thousands,0,0
5950,of,0,1
5951,children,0,0
5952,with,0,0
5953,autistic,0,0
5954,disorders,0,0
5955,may,0,0
5956,have,0,0
5957,received,0,0
5958,secretin,0,0
5959,injections,0,0
5960,.,0,0
5961,METHODS,0,0
5962,We,0,0
5963,conducted,0,0
5964,a,0,0
5965,double-blind,0,0
5966,",",0,0
5967,placebo-controlled,0,0
5968,trial,0,0
5969,of,0,0
5970,a,0,0
5971,single,0,0
5972,intravenous,0,0
5973,dose,0,0
5974,of,0,1
5975,synthetic,0,1
5976,human,0,0
5977,secretin,0,1
5978,in,0,0
5979,60,0,0
5980,children,0,0
5981,(,0,0
5982,age,0,0
5983,",",0,0
5984,3,0,0
5985,to,0,0
5986,14,0,0
5987,years,0,0
5988,),0,0
5989,with,0,0
5990,autism,0,0
5991,or,0,0
5992,pervasive,0,0
5993,developmental,0,1
5994,disorder,0,0
5995,.,0,0
5996,The,0,0
5997,children,0,0
5998,were,0,0
5999,randomly,0,0
6000,assigned,0,0
6001,to,0,0
6002,treatment,0,0
6003,with,0,0
6004,an,0,0
6005,intravenous,0,0
6006,infusion,0,0
6007,of,0,1
6008,synthetic,0,1
6009,human,0,0
6010,secretin,0,1
6011,(,0,0
6012,0.4,0,0
6013,microg,0,0
6014,per,0,0
6015,kilogram,0,0
6016,of,0,1
6017,body,0,1
6018,weight,0,1
6019,),0,1
6020,or,0,0
6021,saline,0,0
6022,placebo,0,0
6023,.,0,0
6024,We,0,0
6025,used,0,0
6026,standardized,0,0
6027,behavioral,0,1
6028,measures,0,0
6029,of,0,0
6030,the,0,0
6031,primary,0,0
6032,and,0,0
6033,secondary,0,1
6034,features,0,0
6035,of,0,1
6036,autism,0,0
6037,",",0,0
6038,including,0,0
6039,the,0,0
6040,Autism,0,1
6041,Behavior,0,1
6042,Checklist,0,1
6043,",",0,0
6044,to,0,0
6045,assess,0,0
6046,the,0,0
6047,degree,0,0
6048,of,0,0
6049,impairment,0,1
6050,at,0,0
6051,base,0,1
6052,line,0,0
6053,and,0,0
6054,over,0,0
6055,the,0,0
6056,course,0,0
6057,of,0,0
6058,a,0,0
6059,four-week,0,0
6060,period,0,0
6061,after,0,0
6062,treatment,0,0
6063,.,0,0
6064,RESULTS,0,0
6065,Of,0,0
6066,the,0,0
6067,60,0,0
6068,children,0,0
6069,",",0,0
6070,4,0,0
6071,could,0,0
6072,not,0,0
6073,be,0,0
6074,evaluated,0,0
6075,-,0,0
6076,2,0,0
6077,received,0,0
6078,secretin,0,0
6079,outside,0,0
6080,the,0,0
6081,study,0,0
6082,",",0,0
6083,and,0,0
6084,2,0,0
6085,did,0,0
6086,not,0,0
6087,return,0,1
6088,for,0,0
6089,follow-up,0,0
6090,.,0,0
6091,Thus,0,1
6092,",",0,0
6093,56,0,0
6094,children,0,0
6095,(,0,0
6096,28,0,0
6097,in,0,0
6098,each,0,0
6099,group,0,0
6100,),0,0
6101,completed,0,0
6102,the,0,0
6103,study,0,0
6104,.,0,0
6105,As,0,0
6106,compared,0,0
6107,with,0,0
6108,placebo,0,0
6109,",",0,0
6110,secretin,0,1
6111,treatment,0,0
6112,was,0,0
6113,not,0,0
6114,associated,0,0
6115,with,0,0
6116,significant,1,0
6117,improvements,1,0
6118,in,1,0
6119,any,1,0
6120,of,1,0
6121,the,1,0
6122,outcome,1,0
6123,measures,1,1
6124,.,1,0
6125,Among,0,0
6126,the,0,0
6127,children,0,0
6128,in,0,0
6129,the,0,0
6130,secretin,0,1
6131,group,0,0
6132,",",0,0
6133,the,0,0
6134,mean,1,1
6135,total,1,1
6136,score,1,1
6137,on,1,0
6138,the,1,0
6139,Autism,1,1
6140,Behavior,1,1
6141,Checklist,1,1
6142,at,0,0
6143,base,0,1
6144,line,0,0
6145,was,0,0
6146,59.0,0,0
6147,(,0,0
6148,range,0,0
6149,of,0,1
6150,possible,0,0
6151,values,0,1
6152,",",0,0
6153,0,0,0
6154,to,0,0
6155,158,0,0
6156,",",0,0
6157,with,0,0
6158,a,0,0
6159,larger,0,0
6160,value,0,1
6161,corresponding,0,1
6162,to,0,0
6163,greater,0,1
6164,impairment,0,1
6165,),0,1
6166,",",0,1
6167,and,0,0
6168,among,0,0
6169,those,0,0
6170,in,0,0
6171,the,0,0
6172,placebo,0,0
6173,group,0,0
6174,it,0,0
6175,was,0,0
6176,63.2,0,0
6177,.,0,0
6178,The,0,0
6179,mean,1,1
6180,decreases,1,0
6181,in,1,0
6182,scores,1,1
6183,over,0,0
6184,the,0,0
6185,four-week,0,0
6186,period,0,0
6187,were,0,0
6188,8.9,0,0
6189,in,0,0
6190,the,0,0
6191,secretin,0,1
6192,group,0,0
6193,and,0,0
6194,17.8,0,0
6195,in,0,0
6196,the,0,0
6197,placebo,0,0
6198,group,0,0
6199,(,0,1
6200,mean,0,1
6201,difference,0,1
6202,",",0,0
6203,-8.9,0,0
6204,;,0,0
6205,95,0,0
6206,percent,0,0
6207,confidence,0,0
6208,interval,0,0
6209,",",0,0
6210,-19.4,0,0
6211,to,0,0
6212,1.6,0,0
6213,;,0,0
6214,P=0.11,0,0
6215,),0,0
6216,.,0,0
6217,None,0,0
6218,of,0,0
6219,the,0,0
6220,children,0,0
6221,had,0,0
6222,treatment-limiting,1,0
6223,adverse,1,1
6224,effects,1,1
6225,.,1,0
6226,After,0,0
6227,they,0,0
6228,were,0,0
6229,told,0,0
6230,the,0,0
6231,results,0,0
6232,",",0,0
6233,69,0,0
6234,percent,0,0
6235,of,0,0
6236,the,0,0
6237,parents,0,0
6238,of,0,0
6239,the,0,0
6240,children,0,0
6241,in,0,0
6242,this,0,0
6243,study,0,0
6244,said,0,0
6245,they,0,0
6246,remained,0,0
6247,interested,0,0
6248,in,0,0
6249,secretin,0,1
6250,as,0,0
6251,a,0,0
6252,treatment,0,0
6253,for,0,0
6254,their,0,0
6255,children,0,0
6256,.,0,0
6257,CONCLUSIONS,0,0
6258,A,0,0
6259,single,0,0
6260,dose,0,0
6261,of,0,1
6262,synthetic,0,1
6263,human,0,0
6264,secretin,0,0
6265,is,0,0
6266,not,1,0
6267,an,1,0
6268,effective,1,1
6269,treatment,1,0
6270,for,0,0
6271,autism,0,0
6272,or,0,0
6273,pervasive,0,0
6274,developmental,0,1
6275,disorder,0,0
6276,.,0,0
6277,Clinical,1,1
6278,effects,1,1
6279,of,0,1
6280,root,0,1
6281,instrumentation,0,0
6282,using,0,0
6283,conventional,0,0
6284,steel,0,1
6285,or,0,1
6286,non-tooth,0,1
6287,substance,0,1
6288,removing,0,0
6289,plastic,0,0
6290,curettes,0,0
6291,during,0,0
6292,supportive,0,0
6293,periodontal,0,1
6294,therapy,0,0
6295,(,0,1
6296,SPT,0,1
6297,),0,0
6298,.,0,0
6299,Although,0,0
6300,root,0,0
6301,instrumentation,0,0
6302,has,0,0
6303,been,0,0
6304,accepted,0,0
6305,as,0,0
6306,the,0,0
6307,most,0,0
6308,important,0,0
6309,cause-related,0,1
6310,treatment,0,0
6311,of,0,1
6312,periodontal,0,1
6313,diseases,0,1
6314,",",0,1
6315,repeated,0,0
6316,scaling,0,1
6317,and,0,1
6318,root,0,1
6319,planing,0,0
6320,may,0,0
6321,over,0,0
6322,time,0,1
6323,result,0,0
6324,in,0,0
6325,substantive,0,1
6326,loss,0,1
6327,of,0,1
6328,tooth,0,1
6329,substance,0,1
6330,and,0,1
6331,increased,0,1
6332,sensitivity,0,1
6333,of,0,0
6334,the,0,0
6335,teeth,0,0
6336,.,0,0
6337,In,0,0
6338,an,0,0
6339,effort,0,0
6340,to,0,0
6341,minimize,0,0
6342,these,0,0
6343,side,0,1
6344,effects,0,1
6345,of,0,1
6346,therapy,0,0
6347,",",0,1
6348,non-root,0,1
6349,substance,0,1
6350,removing,0,0
6351,curettes,0,0
6352,have,0,0
6353,been,0,0
6354,developed,0,0
6355,.,0,0
6356,However,0,0
6357,",",0,0
6358,the,0,0
6359,clinical,1,0
6360,effects,1,1
6361,of,0,1
6362,such,0,0
6363,plastic,0,0
6364,curettes,0,0
6365,with,0,0
6366,regard,0,0
6367,to,0,0
6368,the,0,0
6369,control,0,0
6370,of,0,0
6371,the,0,0
6372,periodontal,0,0
6373,infection,0,0
6374,has,0,0
6375,not,0,0
6376,yet,0,0
6377,been,0,0
6378,established,0,0
6379,.,0,0
6380,The,0,0
6381,aims,0,0
6382,of,0,0
6383,this,0,0
6384,study,0,0
6385,were,0,0
6386,",",0,0
6387,therefore,0,0
6388,",",0,0
6389,to,0,0
6390,compare,0,0
6391,the,0,0
6392,effects,0,0
6393,of,0,0
6394,root,0,1
6395,instrumentation,0,0
6396,using,0,0
6397,plastic,0,0
6398,curettes,0,0
6399,(,0,0
6400,Universal,0,0
6401,Perio,0,1
6402,Soft,0,1
6403,Scaler,0,1
6404,",",0,1
6405,Hawe-Neos,0,1
6406,Dental,0,1
6407,",",0,1
6408,Bioggio,0,1
6409,",",0,1
6410,TI,0,1
6411,",",0,1
6412,Switzerland,0,0
6413,),0,0
6414,versus,0,0
6415,conventional,0,0
6416,steel,0,1
6417,curettes,0,0
6418,on,0,0
6419,the,0,0
6420,periodontal,0,1
6421,conditions,0,0
6422,during,0,0
6423,supportive,0,0
6424,periodontal,0,1
6425,therapy,0,0
6426,.,0,0
6427,40,0,0
6428,subjects,0,0
6429,participated,0,0
6430,in,0,0
6431,this,0,0
6432,parallel,0,0
6433,",",0,0
6434,randomized,0,0
6435,",",0,0
6436,double,0,0
6437,blind,0,0
6438,",",0,1
6439,prospective,0,0
6440,longitudinal,0,0
6441,clinical,0,1
6442,study,0,0
6443,following,0,0
6444,active,0,0
6445,peridontal,0,0
6446,therapy,0,0
6447,.,0,0
6448,20,0,0
6449,subjects,0,0
6450,served,0,0
6451,as,0,0
6452,a,0,0
6453,control,0,0
6454,group,0,0
6455,and,0,1
6456,were,0,0
6457,treated,0,0
6458,with,0,0
6459,conventional,0,0
6460,steel,0,1
6461,curettes,0,0
6462,during,0,0
6463,a,0,0
6464,supportive,0,0
6465,periodontal,0,1
6466,care,0,1
6467,visit,0,1
6468,(,0,1
6469,SPT,0,1
6470,),0,0
6471,.,0,0
6472,The,0,0
6473,other,0,0
6474,20,0,0
6475,subjects,0,0
6476,",",0,0
6477,the,0,0
6478,experimental,0,0
6479,group,0,0
6480,",",0,1
6481,were,0,0
6482,treated,0,0
6483,using,0,0
6484,plastic,0,0
6485,curettes,0,0
6486,during,0,0
6487,a,0,0
6488,similar,0,0
6489,SPT,0,1
6490,visit,0,1
6491,.,0,0
6492,Clinical,0,1
6493,parameters,0,1
6494,",",0,0
6495,such,0,0
6496,as,0,0
6497,bleeding,1,1
6498,on,1,0
6499,probing,1,1
6500,(,1,0
6501,BOP,1,1
6502,),1,1
6503,and,1,1
6504,probing,1,1
6505,pocket,1,1
6506,depth,1,1
6507,(,1,1
6508,PPD,1,1
6509,),1,1
6510,",",0,0
6511,were,0,0
6512,assessed,0,0
6513,at,0,0
6514,baseline,0,0
6515,and,0,1
6516,3-6,0,0
6517,months,0,0
6518,later,0,0
6519,at,0,0
6520,the,0,0
6521,next,0,0
6522,regular,0,0
6523,SPT,0,1
6524,visit,0,1
6525,.,0,0
6526,In,0,0
6527,addition,0,0
6528,",",0,0
6529,the,0,0
6530,BOP,1,1
6531,percentage,1,1
6532,was,0,0
6533,determined,0,0
6534,10,0,0
6535,days,0,0
6536,following,0,0
6537,baseline,0,0
6538,.,0,0
6539,The,0,0
6540,results,0,0
6541,showed,0,0
6542,that,0,0
6543,there,0,0
6544,were,0,0
6545,no,0,0
6546,statistically,0,0
6547,significant,0,0
6548,differences,0,0
6549,between,0,0
6550,the,0,0
6551,2,0,0
6552,treatment,0,0
6553,modalities,0,0
6554,regarding,0,0
6555,BOP,1,0
6556,and,1,1
6557,PPD,1,0
6558,at,0,0
6559,any,0,0
6560,observation,0,0
6561,time,0,1
6562,.,0,0
6563,Both,0,0
6564,treatments,0,0
6565,were,0,0
6566,effective,0,1
6567,in,0,0
6568,reducing,0,0
6569,the,0,0
6570,BOP,1,0
6571,percentage,1,1
6572,which,0,0
6573,ranged,0,0
6574,from,0,0
6575,17-42,0,0
6576,%,0,0
6577,at,0,0
6578,baseline,0,0
6579,by,0,0
6580,about,0,0
6581,40,0,0
6582,%,0,0
6583,after,0,0
6584,10,0,0
6585,days,0,0
6586,(,1,0
6587,mean,1,1
6588,BOP,1,0
6589,baseline,0,0
6590,:,0,0
6591,26,0,0
6592,%,0,0
6593,",",0,0
6594,mean,1,1
6595,BOP,1,0
6596,after,0,0
6597,10,0,0
6598,days,0,0
6599,:,0,0
6600,16,0,0
6601,%,0,0
6602,),0,0
6603,.,0,0
6604,This,0,0
6605,clinical,0,0
6606,study,0,0
6607,suggests,0,0
6608,that,0,0
6609,non-root,0,0
6610,substance,0,0
6611,removing,0,0
6612,curettes,0,0
6613,may,0,0
6614,be,0,0
6615,valuable,0,0
6616,instruments,0,0
6617,for,0,0
6618,periodontally,0,0
6619,treated,0,0
6620,patients,0,0
6621,during,0,0
6622,maintenance,0,0
6623,care,0,0
6624,",",0,0
6625,thus,0,0
6626,minimizing,0,1
6627,trauma,0,0
6628,on,0,0
6629,the,0,0
6630,hard,0,0
6631,structures,0,0
6632,of,0,0
6633,the,0,0
6634,teeth,0,0
6635,.,0,0
6636,Standard-dose,0,0
6637,lansoprazole,0,0
6638,is,0,0
6639,more,0,0
6640,effective,0,1
6641,than,0,0
6642,high-dose,0,0
6643,ranitidine,0,0
6644,in,0,0
6645,achieving,0,1
6646,endoscopic,0,1
6647,healing,0,1
6648,and,0,1
6649,symptom,0,1
6650,relief,0,1
6651,in,0,0
6652,patients,0,0
6653,with,0,0
6654,moderately,0,0
6655,severe,0,1
6656,reflux,0,1
6657,oesophagitis,0,1
6658,.,0,0
6659,The,0,0
6660,Dutch,0,0
6661,Lansoprazole,0,0
6662,Study,0,0
6663,Group,0,0
6664,.,0,0
6665,BACKGROUND,0,0
6666,In,0,0
6667,the,0,0
6668,treatment,0,0
6669,of,0,1
6670,reflux,0,1
6671,oesophagitis,0,1
6672,",",0,1
6673,H2-receptor,0,0
6674,antagonists,0,0
6675,are,0,0
6676,still,0,0
6677,widely,0,0
6678,used,0,0
6679,in,0,0
6680,spite,0,0
6681,of,0,0
6682,the,0,0
6683,apparent,0,0
6684,higher,0,0
6685,efficacy,0,1
6686,of,0,1
6687,proton,0,0
6688,pump,0,0
6689,inhibitors,0,1
6690,.,0,0
6691,In,0,0
6692,an,0,0
6693,attempt,0,0
6694,to,0,0
6695,compensate,0,0
6696,for,0,0
6697,the,0,0
6698,lower,0,0
6699,efficacy,0,1
6700,",",0,1
6701,H2-receptor,0,0
6702,antagonists,0,0
6703,are,0,0
6704,now,0,0
6705,increasingly,0,0
6706,being,0,0
6707,used,0,0
6708,at,0,0
6709,a,0,0
6710,higher,0,0
6711,dose,0,0
6712,.,0,1
6713,OBJECTIVE,0,0
6714,To,0,0
6715,assess,0,0
6716,whether,0,0
6717,or,0,0
6718,not,0,0
6719,standard-dose,0,0
6720,lansoprazole,0,0
6721,(,0,0
6722,30,0,0
6723,mg,0,0
6724,o.d,0,0
6725,.,0,0
6726,),0,0
6727,is,0,0
6728,more,0,0
6729,effective,0,1
6730,than,0,0
6731,high-dose,0,0
6732,ranitidine,0,0
6733,(,0,0
6734,300,0,0
6735,mg,0,0
6736,b.d,0,0
6737,.,0,0
6738,),0,0
6739,in,0,0
6740,moderately,0,0
6741,severe,0,1
6742,reflux,0,1
6743,oesophagitis,0,1
6744,(,0,0
6745,grades,0,1
6746,II-III,0,0
6747,),0,0
6748,.,0,0
6749,METHODS,0,0
6750,Lansoprazole,0,0
6751,or,0,1
6752,ranitidine,0,0
6753,was,0,0
6754,given,0,0
6755,to,0,0
6756,133,0,0
6757,patients,0,0
6758,for,0,0
6759,4-8,0,0
6760,weeks,0,0
6761,in,0,0
6762,a,0,0
6763,double-blind,0,0
6764,",",0,0
6765,randomized,0,0
6766,",",0,0
6767,parallel,0,0
6768,group,0,0
6769,",",0,0
6770,multicentre,0,0
6771,trial,0,0
6772,.,0,0
6773,RESULTS,0,0
6774,The,0,0
6775,percentage,1,1
6776,of,1,0
6777,patients,1,0
6778,with,1,0
6779,endoscopically-verified,1,0
6780,healing,1,1
6781,was,0,0
6782,significantly,0,0
6783,higher,0,0
6784,on,0,0
6785,lansoprazole,0,0
6786,than,0,0
6787,on,0,0
6788,ranitidine,0,0
6789,both,0,0
6790,after,0,0
6791,4,0,0
6792,weeks,0,0
6793,(,0,0
6794,79,0,0
6795,%,0,0
6796,vs.,0,0
6797,42,0,0
6798,%,0,0
6799,),0,0
6800,and,0,0
6801,8,0,0
6802,weeks,0,0
6803,(,0,0
6804,91,0,0
6805,%,0,0
6806,vs.,0,0
6807,66,0,0
6808,%,0,0
6809,),0,0
6810,",",0,0
6811,though,0,0
6812,smoking,0,1
6813,had,0,0
6814,a,0,0
6815,negative,0,1
6816,impact,0,0
6817,on,0,0
6818,oesophagitis,0,1
6819,healing,0,1
6820,with,0,0
6821,lansoprazole,0,0
6822,.,0,0
6823,Heartburn,1,1
6824,",",1,1
6825,retrosternal,1,1
6826,pain,1,1
6827,and,1,1
6828,belching,1,1
6829,improved,0,1
6830,significantly,0,0
6831,better,0,0
6832,with,0,0
6833,lansoprazole,0,0
6834,than,0,0
6835,with,0,0
6836,ranitidine,0,0
6837,",",0,1
6838,as,0,0
6839,did,0,0
6840,the,0,0
6841,patient-rated,0,1
6842,overall,0,1
6843,symptom,0,1
6844,severity,0,1
6845,.,0,1
6846,Relief,1,1
6847,of,1,1
6848,heartburn,1,1
6849,appeared,0,0
6850,somewhat,0,0
6851,faster,0,0
6852,with,0,0
6853,ranitidine,0,0
6854,",",0,1
6855,but,0,0
6856,was,0,0
6857,more,0,0
6858,pronounced,0,0
6859,with,0,0
6860,lansoprazole,0,0
6861,.,0,0
6862,The,0,0
6863,number,1,1
6864,of,1,0
6865,patients,1,0
6866,with,1,0
6867,adverse,1,1
6868,events,1,1
6869,was,0,0
6870,similar,0,0
6871,in,0,0
6872,both,0,0
6873,treatment,0,0
6874,groups,0,0
6875,.,0,0
6876,CONCLUSION,0,0
6877,Standard-dose,0,0
6878,lansoprazole,0,0
6879,is,0,0
6880,better,0,0
6881,than,0,0
6882,high-dose,0,0
6883,ranitidine,0,0
6884,in,0,0
6885,moderately,0,0
6886,severe,0,1
6887,reflux,0,1
6888,oesophagitis,0,1
6889,.,0,0
6890,Randomised,0,0
6891,controlled,0,0
6892,study,0,0
6893,of,0,1
6894,clinical,0,1
6895,outcome,0,1
6896,following,0,0
6897,trophic,0,0
6898,feeding,0,1
6899,.,0,0
6900,AIMS,0,0
6901,To,0,0
6902,determine,0,0
6903,the,0,0
6904,effect,0,0
6905,of,0,0
6906,trophic,0,0
6907,feeding,0,1
6908,on,0,0
6909,clinical,0,0
6910,outcome,0,1
6911,in,0,0
6912,ill,0,1
6913,preterm,0,0
6914,infants,0,0
6915,.,0,0
6916,METHODS,0,0
6917,A,0,0
6918,randomised,0,0
6919,",",0,0
6920,controlled,0,0
6921,",",0,0
6922,prospective,0,0
6923,study,0,0
6924,of,0,0
6925,100,0,0
6926,preterm,0,0
6927,infants,0,0
6928,",",0,0
6929,weighing,0,0
6930,less,0,0
6931,than,0,0
6932,1750,0,0
6933,g,0,0
6934,at,0,0
6935,birth,0,1
6936,and,0,1
6937,requiring,0,1
6938,ventilatory,0,1
6939,support,0,0
6940,and,0,1
6941,parenteral,0,1
6942,nutrition,0,1
6943,",",0,1
6944,was,0,0
6945,performed,0,0
6946,.,0,0
6947,Group,0,0
6948,TF,0,1
6949,(,0,0
6950,48,0,0
6951,infants,0,0
6952,),0,0
6953,received,0,0
6954,trophic,0,0
6955,feeding,0,1
6956,from,0,0
6957,day,0,0
6958,3,0,0
6959,(,0,0
6960,0.5-1,0,0
6961,ml/h,0,0
6962,),0,0
6963,along,0,0
6964,with,0,0
6965,parenteral,0,0
6966,nutrition,0,1
6967,until,0,0
6968,ventilatory,0,1
6969,support,0,0
6970,finished,0,0
6971,.,0,0
6972,Group,0,0
6973,C,0,0
6974,(,0,0
6975,52,0,0
6976,infants,0,0
6977,),0,0
6978,received,0,0
6979,parenteral,0,0
6980,nutrition,0,0
6981,alone,0,0
6982,.,0,0
6983,Nutritive,0,1
6984,milk,0,1
6985,feeding,0,1
6986,was,0,0
6987,then,0,0
6988,introduced,0,0
6989,to,0,0
6990,both,0,0
6991,groups,0,0
6992,.,0,0
6993,Clinical,0,1
6994,outcomes,0,1
6995,measured,0,1
6996,included,0,0
6997,total,1,1
6998,energy,1,1
6999,intake,1,1
7000,and,1,1
7001,growth,1,1
7002,over,1,0
7003,the,1,0
7004,first,1,0
7005,six,1,0
7006,postnatal,1,0
7007,weeks,1,0
7008,",",1,1
7009,sepsis,1,1
7010,incidence,1,1
7011,",",1,1
7012,liver,1,1
7013,function,1,1
7014,",",1,1
7015,milk,1,1
7016,tolerance,1,1
7017,",",1,1
7018,duration,1,1
7019,of,1,1
7020,respiratory,1,1
7021,support,1,0
7022,",",1,1
7023,duration,1,1
7024,of,1,1
7025,hospital,1,1
7026,stay,1,1
7027,and,1,1
7028,complication,1,1
7029,incidence,1,1
7030,.,1,1
7031,RESULTS,0,0
7032,Groups,0,1
7033,were,0,0
7034,well,0,0
7035,matched,0,0
7036,for,0,0
7037,birthweight,0,1
7038,",",0,1
7039,gestation,0,1
7040,and,0,1
7041,CRIB,0,0
7042,scores,0,1
7043,.,0,0
7044,Infants,0,0
7045,in,0,0
7046,group,0,0
7047,TF,0,1
7048,had,0,0
7049,significantly,0,0
7050,greater,0,0
7051,energy,1,1
7052,intake,1,1
7053,",",0,1
7054,mean,0,1
7055,difference,0,0
7056,41.4,0,0
7057,(,0,0
7058,95,0,0
7059,%,0,0
7060,confidence,0,0
7061,interval,0,0
7062,9,0,0
7063,",",0,0
7064,73.7,0,0
7065,),0,0
7066,kcal/kg,0,0
7067,p=0.02,0,0
7068,;,0,0
7069,weight,1,1
7070,gain,1,1
7071,",",0,0
7072,130,0,0
7073,(,0,0
7074,CI,0,0
7075,1,0,0
7076,",",0,0
7077,250,0,0
7078,),0,0
7079,g,0,0
7080,p,0,0
7081,=,0,0
7082,0.02,0,0
7083,;,0,0
7084,head,1,0
7085,circumference,1,1
7086,gain,1,1
7087,",",0,1
7088,mean,0,1
7089,difference,0,0
7090,0.7,0,0
7091,(,0,0
7092,CI,0,0
7093,0.1,0,0
7094,",",0,0
7095,1.3,0,0
7096,),0,0
7097,cm,0,0
7098,",",0,1
7099,p,0,0
7100,=,0,0
7101,0.04,0,0
7102,;,0,0
7103,fewer,0,0
7104,episodes,1,1
7105,of,1,1
7106,culture,1,1
7107,confirmed,1,0
7108,sepsis,1,0
7109,",",0,0
7110,mean,0,1
7111,difference,0,1
7112,-0.7,0,0
7113,(,0,1
7114,-1.3,0,0
7115,",",0,1
7116,-0.2,0,0
7117,),0,0
7118,episodes,0,1
7119,",",0,0
7120,p,0,0
7121,=,0,0
7122,0.04,0,0
7123,;,0,0
7124,less,0,0
7125,parenteral,1,0
7126,nutrition,1,1
7127,",",0,1
7128,mean,0,1
7129,difference,0,1
7130,-11.5,0,0
7131,(,0,0
7132,CI,0,0
7133,-20,0,1
7134,",",0,1
7135,-3,0,0
7136,),0,1
7137,days,0,0
7138,",",0,0
7139,p,0,0
7140,=,0,0
7141,0,0,0
7142,.,0,0
7143,03,0,0
7144,;,0,0
7145,tolerated,1,1
7146,full,1,0
7147,milk,1,1
7148,feeds,1,0
7149,(,0,0
7150,165,0,0
7151,ml/kg/day,0,0
7152,),0,0
7153,earlier,0,0
7154,",",0,1
7155,mean,0,1
7156,difference,0,1
7157,-11.2,0,0
7158,(,0,0
7159,CI,0,0
7160,-19,0,0
7161,",",0,1
7162,-3,0,0
7163,),0,1
7164,days,0,0
7165,",",0,0
7166,p,0,0
7167,=,0,0
7168,0.03,0,0
7169,;,0,0
7170,reduced,0,0
7171,requirement,1,1
7172,for,1,0
7173,supplemental,1,0
7174,oxygen,1,1
7175,",",0,1
7176,mean,0,1
7177,difference,0,1
7178,-22.4,0,0
7179,(,0,1
7180,CI-41.5,0,1
7181,",",0,1
7182,-3.3,0,0
7183,),0,1
7184,days,0,0
7185,",",0,0
7186,p,0,0
7187,=,0,0
7188,0.02,0,0
7189,;,0,0
7190,and,0,0
7191,were,0,0
7192,discharged,1,0
7193,home,1,0
7194,earlier,0,0
7195,",",0,1
7196,mean,0,1
7197,difference,0,1
7198,-22.1,0,0
7199,(,0,0
7200,CI,0,0
7201,-42.1,0,0
7202,",",0,1
7203,-2.2,0,0
7204,),0,1
7205,days,0,0
7206,",",0,0
7207,p,0,0
7208,=,0,0
7209,0.04,0,0
7210,.,0,0
7211,There,0,0
7212,was,0,0
7213,no,0,0
7214,significant,0,0
7215,difference,0,0
7216,in,0,0
7217,the,0,0
7218,relative,0,1
7219,risk,1,1
7220,of,1,0
7221,any,1,0
7222,complication,1,1
7223,.,1,0
7224,CONCLUSIONS,0,0
7225,Trophic,0,0
7226,feeding,0,1
7227,improves,0,1
7228,clinical,0,1
7229,outcome,0,1
7230,in,0,0
7231,ill,0,1
7232,preterm,0,0
7233,infants,0,0
7234,requiring,0,1
7235,parenteral,0,0
7236,nutrition,0,0
7237,.,0,0
7238,Treatment,0,0
7239,of,0,1
7240,hypertension,0,1
7241,with,0,0
7242,ascorbic,0,0
7243,acid,0,0
7244,.,0,0
7245,In,0,0
7246,a,0,0
7247,randomised,0,0
7248,",",0,0
7249,double-blind,0,0
7250,",",0,1
7251,placebo-controlled,0,0
7252,study,0,0
7253,we,0,0
7254,showed,0,0
7255,that,0,0
7256,treatment,0,0
7257,of,0,0
7258,hypertensive,0,0
7259,patients,0,0
7260,with,0,0
7261,ascorbic,0,0
7262,acid,0,1
7263,lowers,0,0
7264,blood,1,1
7265,pressure,1,1
7266,.,1,1
7267,Further,0,0
7268,studies,0,0
7269,of,0,1
7270,ascorbic,0,0
7271,acid,0,0
7272,to,0,0
7273,treat,0,0
7274,hypertension,1,1
7275,",",0,0
7276,with,0,0
7277,clinical,1,1
7278,endpoints,1,1
7279,",",0,0
7280,are,0,0
7281,warranted,0,0
7282,.,0,0
7283,Comparison,0,0
7284,of,0,1
7285,chemotherapy,0,0
7286,with,0,0
7287,chemohormonal,0,0
7288,therapy,0,0
7289,as,0,0
7290,first-line,0,0
7291,therapy,0,0
7292,for,0,0
7293,metastatic,0,0
7294,",",0,0
7295,hormone-sensitive,0,1
7296,breast,0,0
7297,cancer,0,0
7298,:,0,0
7299,An,0,0
7300,Eastern,0,0
7301,Cooperative,0,0
7302,Oncology,0,1
7303,Group,0,0
7304,study,0,0
7305,.,0,1
7306,PURPOSE,0,0
7307,Although,0,0
7308,hormonal,0,0
7309,therapy,0,0
7310,represents,0,0
7311,standard,0,0
7312,therapy,0,0
7313,for,0,0
7314,metastatic,0,0
7315,hormone-sensitive,0,1
7316,disease,0,1
7317,",",0,1
7318,many,0,0
7319,patients,0,0
7320,receive,0,0
7321,initial,0,0
7322,chemotherapy,0,0
7323,because,0,0
7324,of,0,0
7325,the,0,0
7326,location,0,0
7327,",",0,1
7328,bulk,0,1
7329,",",0,1
7330,or,0,1
7331,aggressiveness,0,1
7332,of,0,0
7333,their,0,0
7334,disease,0,0
7335,.,0,0
7336,It,0,0
7337,is,0,0
7338,uncertain,0,0
7339,whether,0,0
7340,simultaneous,0,0
7341,hormonal,0,0
7342,therapy,0,0
7343,provides,0,0
7344,additional,0,0
7345,benefit,0,0
7346,compared,0,0
7347,with,0,0
7348,chemotherapy,0,0
7349,alone,0,0
7350,.,0,0
7351,Eastern,0,0
7352,Cooperative,0,0
7353,Oncology,0,1
7354,Group,0,0
7355,trial,0,0
7356,E3186,0,0
7357,was,0,0
7358,initiated,0,0
7359,to,0,0
7360,explore,0,0
7361,this,0,0
7362,question,0,0
7363,.,0,1
7364,PATIENTS,0,0
7365,AND,0,0
7366,METHODS,0,0
7367,Between,0,0
7368,January,0,0
7369,1988,0,0
7370,and,0,0
7371,December,0,0
7372,1992,0,0
7373,",",0,0
7374,231,0,0
7375,patients,0,0
7376,with,0,0
7377,estrogen,0,1
7378,receptor,0,1
7379,(,0,1
7380,ER,0,1
7381,),0,0
7382,-positive,0,0
7383,or,0,0
7384,ER-unknown,0,0
7385,metastatic,0,0
7386,breast,0,0
7387,cancer,0,0
7388,were,0,0
7389,randomized,0,0
7390,to,0,0
7391,receive,0,0
7392,either,0,0
7393,chemotherapy,0,0
7394,(,0,1
7395,cyclophosphamide,0,0
7396,",",0,1
7397,doxorubicin,0,0
7398,",",0,1
7399,and,0,1
7400,fluorouracil,0,0
7401,?CAF,0,0
7402,),0,1
7403,or,0,0
7404,chemohormonal,0,1
7405,therapy,0,0
7406,(,0,1
7407,CAF,0,1
7408,plus,0,0
7409,tamoxifen,0,0
7410,and,0,1
7411,Halotestin,0,1
7412,?fluoxymesterone,0,0
7413,;,0,1
7414,Pharmacia-Upjohn,0,0
7415,",",0,1
7416,Kalamazoo,0,0
7417,",",0,1
7418,MI,0,1
7419,?CAFTH,0,0
7420,),0,0
7421,as,0,0
7422,front-line,0,0
7423,therapy,0,0
7424,for,0,0
7425,metastatic,0,0
7426,breast,0,0
7427,cancer,0,0
7428,.,0,0
7429,Patients,0,0
7430,who,0,0
7431,experienced,0,0
7432,a,0,0
7433,complete,0,1
7434,response,0,1
7435,to,0,0
7436,induction,0,1
7437,therapy,0,0
7438,either,0,0
7439,received,0,0
7440,or,0,1
7441,did,0,0
7442,not,0,0
7443,receive,0,0
7444,maintenance,0,0
7445,cyclophosphamide,0,0
7446,",",0,1
7447,methotrexate,0,0
7448,",",0,1
7449,fluorouracil,0,0
7450,",",0,1
7451,prednisone,0,0
7452,",",0,1
7453,and,0,1
7454,TH,0,1
7455,as,0,0
7456,a,0,0
7457,secondary,0,0
7458,randomization,0,0
7459,.,0,0
7460,RESULTS,0,0
7461,The,0,0
7462,response,1,1
7463,rates,1,1
7464,(,1,0
7465,complete,1,1
7466,response,1,1
7467,and,1,1
7468,partial,1,1
7469,response,1,1
7470,),1,0
7471,of,1,0
7472,patients,0,0
7473,who,0,0
7474,received,0,0
7475,CAF,0,1
7476,and,0,1
7477,CAFTH,0,0
7478,were,0,0
7479,similar,0,0
7480,(,0,0
7481,69.2,0,0
7482,%,0,0
7483,v,0,0
7484,68.9,0,0
7485,%,0,0
7486,",",0,0
7487,respectively,0,0
7488,;,0,0
7489,P,0,0
7490,=.99,1,0
7491,),1,0
7492,.,1,0
7493,Time,1,0
7494,to,1,0
7495,treatment,1,0
7496,failure,1,1
7497,(,1,1
7498,TTF,1,1
7499,),1,1
7500,was,1,0
7501,slightly,0,0
7502,longer,0,0
7503,for,0,0
7504,patients,0,0
7505,who,0,0
7506,received,0,0
7507,chemohormonal,0,0
7508,therapy,0,0
7509,compared,0,0
7510,with,0,0
7511,chemotherapy,0,0
7512,alone,0,0
7513,patients,0,0
7514,(,0,0
7515,13.4,0,0
7516,months,0,0
7517,v,0,0
7518,10.3,0,0
7519,months,0,0
7520,",",0,0
7521,respectively,0,0
7522,;,0,0
7523,P,0,0
7524,=.087,0,0
7525,),0,1
7526,",",0,0
7527,and,0,1
7528,TTF,1,1
7529,was,1,0
7530,significantly,0,0
7531,longer,0,0
7532,in,0,0
7533,ER-positive,0,1
7534,compared,0,0
7535,with,0,0
7536,ER-negative,0,0
7537,patients,0,0
7538,(,0,0
7539,17.4,0,0
7540,months,0,0
7541,v,0,0
7542,10.3,0,0
7543,months,0,0
7544,",",0,0
7545,respectively,0,0
7546,;,0,0
7547,P,0,0
7548,=.048,0,0
7549,),0,0
7550,.,0,0
7551,However,0,0
7552,",",0,0
7553,ER,0,1
7554,status,0,1
7555,had,0,0
7556,no,0,0
7557,effect,0,1
7558,on,0,0
7559,overall,1,1
7560,survival,1,1
7561,(,1,0
7562,30.0,1,0
7563,months,0,0
7564,for,0,0
7565,CAF,0,0
7566,v,0,0
7567,29.3,0,0
7568,months,0,0
7569,for,0,0
7570,CAFTH,0,0
7571,),0,0
7572,.,0,0
7573,CONCLUSION,0,0
7574,In,0,0
7575,patients,0,0
7576,with,0,0
7577,potentially,0,0
7578,hormone-sensitive,0,1
7579,metastatic,0,0
7580,breast,0,0
7581,cancer,0,0
7582,",",0,1
7583,chemohormonal,0,0
7584,therapy,0,0
7585,prolongs,0,1
7586,TTF,0,1
7587,for,0,0
7588,ER-positive,0,1
7589,patients,0,0
7590,without,0,0
7591,improving,0,1
7592,overall,0,1
7593,survival,0,1
7594,.,0,0
7595,Effectiveness,0,1
7596,of,0,1
7597,manual,0,1
7598,physical,0,1
7599,therapy,0,0
7600,and,0,1
7601,exercise,0,0
7602,in,0,0
7603,osteoarthritis,0,0
7604,of,0,0
7605,the,0,0
7606,knee,0,0
7607,.,0,0
7608,A,0,0
7609,randomized,0,0
7610,",",0,0
7611,controlled,0,0
7612,trial,0,0
7613,.,0,0
7614,BACKGROUND,0,0
7615,Few,0,0
7616,investigations,0,0
7617,include,0,0
7618,both,0,0
7619,subjective,0,1
7620,and,0,0
7621,objective,0,0
7622,measurements,0,1
7623,of,0,0
7624,the,0,0
7625,effectiveness,0,0
7626,of,0,0
7627,treatments,0,0
7628,for,0,0
7629,osteoarthritis,0,0
7630,of,0,0
7631,the,0,0
7632,knee,0,1
7633,.,0,0
7634,Beneficial,0,0
7635,interventions,0,0
7636,may,0,0
7637,decrease,0,0
7638,the,0,0
7639,disability,1,1
7640,associated,0,0
7641,with,0,0
7642,osteoarthritis,0,0
7643,and,0,0
7644,the,0,0
7645,need,0,0
7646,for,0,0
7647,more,0,0
7648,invasive,0,1
7649,treatments,0,0
7650,.,0,0
7651,OBJECTIVE,0,0
7652,To,0,0
7653,evaluate,0,0
7654,the,0,0
7655,effectiveness,0,0
7656,of,0,0
7657,physical,0,1
7658,therapy,0,0
7659,for,0,0
7660,osteoarthritis,0,0
7661,of,0,0
7662,the,0,0
7663,knee,0,1
7664,",",0,0
7665,applied,0,0
7666,by,0,0
7667,experienced,0,0
7668,physical,0,1
7669,therapists,0,0
7670,with,0,0
7671,formal,0,0
7672,training,0,0
7673,in,0,0
7674,manual,0,0
7675,therapy,0,0
7676,.,0,0
7677,DESIGN,0,0
7678,Randomized,0,0
7679,",",0,1
7680,controlled,0,0
7681,clinical,0,0
7682,trial,0,0
7683,.,0,1
7684,SETTING,0,0
7685,Outpatient,0,0
7686,physical,0,1
7687,therapy,0,0
7688,department,0,0
7689,of,0,0
7690,a,0,0
7691,large,0,0
7692,military,0,0
7693,medical,0,0
7694,center,0,0
7695,.,0,0
7696,PATIENTS,0,0
7697,83,0,0
7698,patients,0,0
7699,with,0,0
7700,osteoarthritis,0,0
7701,of,0,0
7702,the,0,0
7703,knee,0,0
7704,who,0,0
7705,were,0,0
7706,randomly,0,0
7707,assigned,0,0
7708,to,0,0
7709,receive,0,0
7710,treatment,0,0
7711,(,0,0
7712,n,0,0
7713,=,0,0
7714,42,0,0
7715,;,0,0
7716,15,0,0
7717,men,0,0
7718,and,0,0
7719,27,0,0
7720,women,0,0
7721,[,0,0
7722,mean,0,1
7723,age,0,0
7724,",",0,0
7725,60,0,0
7726,+/-,0,0
7727,11,0,0
7728,years,0,0
7729,],0,0
7730,),0,0
7731,or,0,1
7732,placebo,0,0
7733,(,0,0
7734,n,0,0
7735,=,0,0
7736,41,0,0
7737,;,0,0
7738,19,0,0
7739,men,0,0
7740,and,0,0
7741,22,0,0
7742,women,0,0
7743,[,0,0
7744,mean,0,1
7745,age,0,0
7746,",",0,0
7747,62,0,0
7748,+/-,0,0
7749,10,0,0
7750,years,0,0
7751,],0,0
7752,),0,0
7753,.,0,0
7754,INTERVENTION,0,0
7755,The,0,0
7756,treatment,0,0
7757,group,0,0
7758,received,0,0
7759,manual,0,1
7760,therapy,0,0
7761,",",0,0
7762,applied,0,0
7763,to,0,0
7764,the,0,0
7765,knee,0,1
7766,as,0,0
7767,well,0,0
7768,as,0,0
7769,to,0,0
7770,the,0,0
7771,lumbar,0,1
7772,spine,0,1
7773,",",0,1
7774,hip,0,1
7775,",",0,1
7776,and,0,1
7777,ankle,0,1
7778,as,0,0
7779,required,0,1
7780,",",0,0
7781,and,0,0
7782,performed,0,0
7783,a,0,0
7784,standardized,0,0
7785,knee,0,1
7786,exercise,0,0
7787,program,0,0
7788,in,0,0
7789,the,0,0
7790,clinic,0,0
7791,and,0,1
7792,at,0,0
7793,home,0,0
7794,.,0,0
7795,The,0,0
7796,placebo,0,0
7797,group,0,0
7798,had,0,0
7799,subtherapeutic,0,0
7800,ultrasound,0,0
7801,to,0,0
7802,the,0,0
7803,knee,0,0
7804,at,0,0
7805,an,0,0
7806,intensity,0,0
7807,of,0,0
7808,0.1,0,0
7809,W/cm2,0,0
7810,with,0,0
7811,a,0,0
7812,10,0,0
7813,%,0,0
7814,pulsed,0,0
7815,mode,0,0
7816,.,0,0
7817,Both,0,0
7818,groups,0,0
7819,were,0,0
7820,treated,0,0
7821,at,0,0
7822,the,0,0
7823,clinic,0,0
7824,twice,0,0
7825,weekly,0,0
7826,for,0,0
7827,4,0,0
7828,weeks,0,0
7829,.,0,0
7830,MEASUREMENTS,0,0
7831,Distance,1,1
7832,walked,1,0
7833,in,1,0
7834,6,1,0
7835,minutes,1,0
7836,and,1,0
7837,sum,1,1
7838,of,1,0
7839,the,1,0
7840,function,1,1
7841,",",1,1
7842,pain,1,1
7843,",",1,1
7844,and,1,1
7845,stiffness,1,1
7846,subscores,1,1
7847,of,1,0
7848,the,1,0
7849,Western,1,0
7850,Ontario,1,0
7851,and,1,1
7852,McMaster,1,0
7853,Universities,1,1
7854,Osteoarthritis,1,1
7855,Index,1,1
7856,(,1,1
7857,WOMAC,1,1
7858,),1,0
7859,.,1,0
7860,A,0,0
7861,tester,0,0
7862,who,0,0
7863,was,0,0
7864,blinded,0,0
7865,to,0,0
7866,group,0,0
7867,assignment,0,0
7868,made,0,0
7869,group,0,0
7870,comparisons,0,0
7871,at,0,0
7872,the,0,0
7873,initial,0,0
7874,visit,0,1
7875,(,0,0
7876,before,0,0
7877,initiation,0,0
7878,of,0,1
7879,treatment,0,0
7880,),0,0
7881,",",0,0
7882,4,0,0
7883,weeks,0,0
7884,",",0,0
7885,8,0,0
7886,weeks,0,0
7887,",",0,0
7888,and,0,0
7889,1,0,0
7890,year,0,0
7891,.,0,0
7892,RESULTS,0,0
7893,Clinically,0,0
7894,and,0,0
7895,statistically,0,0
7896,significant,0,0
7897,improvements,0,1
7898,in,0,0
7899,6-minute,1,0
7900,walk,1,0
7901,distance,1,1
7902,and,1,1
7903,WOMAC,1,1
7904,score,1,1
7905,at,0,0
7906,4,0,0
7907,weeks,0,0
7908,and,0,0
7909,8,0,0
7910,weeks,0,0
7911,were,0,0
7912,seen,0,0
7913,in,0,0
7914,the,0,0
7915,treatment,0,0
7916,group,0,0
7917,but,0,0
7918,not,0,0
7919,the,0,0
7920,placebo,0,0
7921,group,0,0
7922,.,0,0
7923,By,0,0
7924,8,0,0
7925,weeks,0,0
7926,",",0,0
7927,average,0,1
7928,6-minute,1,1
7929,walk,1,0
7930,distances,1,1
7931,had,0,0
7932,improved,0,0
7933,by,0,0
7934,13.1,0,0
7935,%,0,0
7936,and,0,0
7937,WOMAC,1,1
7938,scores,1,1
7939,had,0,0
7940,improved,0,0
7941,by,0,0
7942,55.8,0,0
7943,%,0,0
7944,over,0,0
7945,baseline,0,0
7946,values,0,1
7947,in,0,0
7948,the,0,0
7949,treatment,0,0
7950,group,0,0
7951,(,0,1
7952,P,0,0
7953,<,0,0
7954,0.05,0,0
7955,),0,0
7956,.,0,0
7957,After,0,0
7958,controlling,0,0
7959,for,0,0
7960,potential,0,0
7961,confounding,0,0
7962,variables,0,1
7963,",",0,0
7964,the,0,0
7965,average,0,1
7966,distance,1,1
7967,walked,1,0
7968,in,1,0
7969,6,1,0
7970,minutes,1,0
7971,at,0,0
7972,8,0,0
7973,weeks,0,0
7974,among,0,0
7975,patients,0,0
7976,in,0,0
7977,the,0,0
7978,treatment,0,0
7979,group,0,0
7980,was,0,0
7981,170,0,0
7982,m,0,0
7983,(,0,0
7984,95,0,0
7985,%,0,0
7986,CI,0,0
7987,",",0,0
7988,71,0,0
7989,to,0,0
7990,270,0,0
7991,m,0,0
7992,),0,0
7993,more,0,0
7994,than,0,0
7995,that,0,0
7996,in,0,0
7997,the,0,0
7998,placebo,0,0
7999,group,0,0
8000,and,0,0
8001,the,0,0
8002,average,0,1
8003,WOMAC,1,1
8004,scores,1,1
8005,were,0,0
8006,599,0,0
8007,mm,0,0
8008,higher,0,0
8009,(,0,0
8010,95,0,0
8011,%,0,0
8012,CI,0,0
8013,",",0,0
8014,197,0,0
8015,to,0,0
8016,1002,0,0
8017,mm,0,0
8018,),0,0
8019,.,0,0
8020,At,0,0
8021,1,0,0
8022,year,0,0
8023,",",0,0
8024,patients,0,0
8025,in,0,0
8026,the,0,0
8027,treatment,0,0
8028,group,0,0
8029,had,0,0
8030,clinically,0,0
8031,and,0,0
8032,statistically,0,0
8033,significant,0,0
8034,gains,0,1
8035,over,0,0
8036,baseline,1,0
8037,WOMAC,1,1
8038,scores,1,1
8039,and,1,1
8040,walking,1,1
8041,distance,1,1
8042,;,1,0
8043,20,0,0
8044,%,0,0
8045,of,0,0
8046,patients,0,0
8047,in,0,0
8048,the,0,0
8049,placebo,0,0
8050,group,0,0
8051,and,0,0
8052,5,0,0
8053,%,0,0
8054,of,0,0
8055,patients,0,0
8056,in,0,0
8057,the,0,0
8058,treatment,0,0
8059,group,0,0
8060,had,0,0
8061,undergone,0,0
8062,knee,1,1
8063,arthroplasty,1,0
8064,.,1,0
8065,CONCLUSIONS,0,0
8066,A,0,0
8067,combination,0,0
8068,of,0,0
8069,manual,0,1
8070,physical,0,1
8071,therapy,0,0
8072,and,0,1
8073,supervised,0,0
8074,exercise,0,0
8075,yields,0,1
8076,functional,1,1
8077,benefits,1,0
8078,for,0,0
8079,patients,0,0
8080,with,0,0
8081,osteoarthritis,0,0
8082,of,0,0
8083,the,0,0
8084,knee,0,0
8085,and,0,0
8086,may,0,0
8087,delay,0,1
8088,or,0,0
8089,prevent,0,0
8090,the,0,0
8091,need,0,0
8092,for,0,0
8093,surgical,1,0
8094,intervention,1,0
8095,.,1,0
8096,Bronchodilatory,1,0
8097,responses,1,1
8098,to,0,0
8099,formoterol,0,0
8100,",",0,1
8101,ipratropium,0,0
8102,",",0,1
8103,and,0,1
8104,their,0,1
8105,combination,0,0
8106,in,0,0
8107,patients,0,0
8108,with,0,0
8109,stable,0,1
8110,COPD,0,0
8111,.,0,0
8112,We,0,0
8113,studied,0,0
8114,27,0,0
8115,patients,0,0
8116,with,0,0
8117,stable,0,1
8118,chronic,0,0
8119,obstuctive,0,1
8120,pulmonary,0,1
8121,disease,0,1
8122,(,0,1
8123,COPD,0,0
8124,),0,0
8125,in,0,0
8126,a,0,0
8127,randomised,0,0
8128,",",0,0
8129,single-blind,0,0
8130,",",0,1
8131,within-patient,0,1
8132,",",0,1
8133,placebo-controlled,0,0
8134,clinical,0,0
8135,study,0,0
8136,.,0,0
8137,Each,0,0
8138,patient,0,1
8139,was,0,0
8140,assigned,0,0
8141,on,0,0
8142,six,0,0
8143,separate,0,0
8144,days,0,0
8145,to,0,0
8146,receive,0,0
8147,one,0,0
8148,of,0,0
8149,the,0,0
8150,following,0,0
8151,drug,0,0
8152,regimens,0,0
8153,in,0,0
8154,random,0,0
8155,order,0,0
8156,:,0,0
8157,A,0,0
8158,.,0,0
8159,40,0,0
8160,micrograms,0,0
8161,ipratropium,0,0
8162,bromide,0,0
8163,(,0,1
8164,Atrovent,0,0
8165,MDI,0,1
8166,",",0,0
8167,20,0,0
8168,micrograms/puff,0,0
8169,),0,0
8170,plus,0,0
8171,2,0,0
8172,puffs,0,0
8173,placebo,0,0
8174,;,0,0
8175,B,0,0
8176,.,0,0
8177,12,0,0
8178,micrograms,0,0
8179,formoterol,0,0
8180,fumarate,0,0
8181,(,0,0
8182,Foradil,0,0
8183,MDI,0,1
8184,",",0,0
8185,12,0,0
8186,micrograms/puff,0,0
8187,),0,0
8188,plus,0,0
8189,3,0,0
8190,puffs,0,0
8191,placebo,0,0
8192,;,0,0
8193,C.,0,1
8194,80,0,0
8195,micrograms,0,0
8196,ipratropium,0,0
8197,;,0,0
8198,D.,0,0
8199,24,0,0
8200,micrograms,0,0
8201,formoterol,0,0
8202,plus,0,0
8203,2,0,0
8204,puffs,0,0
8205,placebo,0,0
8206,;,0,0
8207,E.,0,0
8208,12,0,0
8209,micrograms,0,0
8210,formoterol,0,0
8211,plus,0,0
8212,40,0,0
8213,micrograms,0,0
8214,ipratropium,0,0
8215,plus,0,0
8216,1,0,0
8217,puff,0,0
8218,placebo,0,0
8219,;,0,0
8220,F.,0,0
8221,4,0,0
8222,puffs,0,0
8223,placebo,0,0
8224,.,0,0
8225,On,0,0
8226,each,0,0
8227,study,0,0
8228,day,0,1
8229,",",0,1
8230,spirometric,1,1
8231,indices,1,1
8232,and,1,1
8233,vital,1,1
8234,signs,1,1
8235,were,0,0
8236,measured,0,0
8237,at,0,0
8238,5,0,0
8239,",",0,0
8240,10,0,0
8241,",",0,0
8242,15,0,0
8243,and,0,0
8244,60,0,0
8245,minutes,0,0
8246,",",0,0
8247,and,0,1
8248,hourly,0,1
8249,thereafter,0,0
8250,up,0,0
8251,to,0,0
8252,and,0,0
8253,including,0,0
8254,12,0,0
8255,hours,0,0
8256,after,0,0
8257,study,0,0
8258,drug,0,0
8259,administration,0,0
8260,.,0,1
8261,Mean,1,1
8262,peak,1,1
8263,FEV1,1,1
8264,change,1,1
8265,(,0,1
8266,primary,0,1
8267,endpoint,0,1
8268,),0,1
8269,was,0,0
8270,maximum,0,1
8271,with,0,0
8272,the,0,0
8273,administration,0,0
8274,of,0,0
8275,the,0,0
8276,combination,0,0
8277,of,0,1
8278,ipratropium,0,0
8279,and,0,1
8280,formoterol,0,0
8281,(,0,0
8282,335.2,0,0
8283,ml,0,0
8284,",",0,0
8285,SE,0,0
8286,24.6,0,0
8287,),0,0
8288,",",0,0
8289,and,0,1
8290,it,0,0
8291,differed,0,0
8292,significantly,0,0
8293,from,0,0
8294,the,0,0
8295,observed,0,0
8296,peak,0,1
8297,changes,0,1
8298,following,0,0
8299,single,0,0
8300,administration,0,0
8301,of,0,0
8302,the,0,0
8303,two,0,0
8304,tested,0,0
8305,doses,0,0
8306,of,0,1
8307,ipratropium,0,0
8308,(,0,0
8309,p,0,0
8310,<,0,0
8311,0.05,0,0
8312,and,0,0
8313,p,0,0
8314,<,0,0
8315,0.05,0,0
8316,respectively,0,0
8317,),0,0
8318,.,0,0
8319,Safety,1,1
8320,and,1,1
8321,tolerability,1,1
8322,were,0,0
8323,satisfactory,0,1
8324,throughout,0,0
8325,the,0,0
8326,study,0,0
8327,.,0,0
8328,Safety,1,1
8329,of,0,0
8330,the,0,0
8331,combination,0,0
8332,of,0,1
8333,valsartan,0,0
8334,and,0,1
8335,benazepril,0,0
8336,in,0,0
8337,patients,0,0
8338,with,0,0
8339,chronic,0,0
8340,renal,0,1
8341,disease,0,1
8342,.,0,0
8343,European,0,0
8344,Group,0,0
8345,for,0,0
8346,the,0,0
8347,Investigation,0,0
8348,of,0,0
8349,Valsartan,0,0
8350,in,0,0
8351,Chronic,0,0
8352,Renal,0,1
8353,Disease,0,1
8354,.,0,0
8355,OBJECTIVE,0,0
8356,Several,0,0
8357,experimental,0,0
8358,and,0,1
8359,clinical,0,0
8360,studies,0,0
8361,indicate,0,0
8362,that,0,0
8363,the,0,0
8364,renin,0,0
8365,system,0,0
8366,may,0,0
8367,play,0,0
8368,a,0,0
8369,pivotal,0,0
8370,role,0,0
8371,in,0,0
8372,progressing,0,1
8373,renal,0,1
8374,disease,0,0
8375,.,0,0
8376,The,0,0
8377,combination,0,0
8378,of,0,0
8379,an,0,0
8380,angiotensin-converting,0,0
8381,enzyme,0,0
8382,inhibitor,0,0
8383,and,0,0
8384,an,0,0
8385,angiotensin,0,0
8386,receptor,0,0
8387,blocker,0,0
8388,could,0,0
8389,provide,0,0
8390,a,0,0
8391,higher,0,0
8392,degree,0,1
8393,of,0,1
8394,blockade,0,0
8395,of,0,0
8396,the,0,0
8397,renin-angiotensin,0,0
8398,system,0,0
8399,than,0,0
8400,either,0,0
8401,agent,0,0
8402,alone,0,0
8403,.,0,0
8404,Such,0,0
8405,enhanced,0,0
8406,suppression,0,0
8407,might,0,0
8408,be,0,0
8409,of,0,0
8410,benefit,0,0
8411,for,0,0
8412,patients,0,0
8413,exhibiting,0,0
8414,a,0,0
8415,progressive,0,0
8416,decline,0,1
8417,in,0,0
8418,renal,0,1
8419,function,0,1
8420,because,0,0
8421,of,0,0
8422,chronic,0,0
8423,renal,0,1
8424,disease,0,1
8425,.,0,0
8426,METHODS,0,0
8427,A,0,0
8428,pilot,0,0
8429,multinational,0,0
8430,",",0,1
8431,multicentre,0,0
8432,",",0,1
8433,randomized,0,0
8434,",",0,0
8435,active-controlled,0,0
8436,",",0,1
8437,parallel,0,0
8438,group,0,0
8439,open-label,0,0
8440,study,0,0
8441,has,0,0
8442,been,0,0
8443,conducted,0,0
8444,in,0,0
8445,a,0,0
8446,group,0,0
8447,of,0,0
8448,patients,0,0
8449,with,0,0
8450,progressive,0,0
8451,chronic,0,0
8452,renal,0,1
8453,failure,0,1
8454,(,0,0
8455,creatinine,0,1
8456,clearance,0,1
8457,20-45,0,0
8458,ml/min,0,0
8459,),0,1
8460,either,0,0
8461,with,0,0
8462,or,0,0
8463,without,0,0
8464,proteinuria,0,1
8465,and,0,0
8466,hypertension,0,1
8467,.,0,0
8468,The,0,0
8469,primary,0,0
8470,aim,0,0
8471,of,0,0
8472,the,0,0
8473,study,0,0
8474,was,0,0
8475,to,0,0
8476,investigate,0,0
8477,the,0,0
8478,safety,1,1
8479,and,1,1
8480,tolerability,1,1
8481,of,0,0
8482,the,0,0
8483,combination,0,0
8484,of,0,1
8485,valsartan,0,0
8486,and,0,1
8487,benazepril,0,0
8488,.,0,1
8489,Patients,0,0
8490,were,0,0
8491,randomly,0,0
8492,assigned,0,0
8493,to,0,0
8494,one,0,0
8495,of,0,0
8496,three,0,0
8497,groups,0,0
8498,:,0,0
8499,group,0,0
8500,1,0,0
8501,received,0,0
8502,valsartan,0,0
8503,160,0,0
8504,mg,0,0
8505,once,0,0
8506,daily,0,0
8507,(,0,0
8508,n,0,0
8509,=,0,0
8510,22,0,0
8511,),0,0
8512,;,0,0
8513,group,0,0
8514,2,0,0
8515,received,0,0
8516,valsartan,0,0
8517,80,0,0
8518,mg,0,0
8519,once,0,0
8520,daily,0,0
8521,plus,0,0
8522,benazepril,0,0
8523,5,0,0
8524,or,0,0
8525,10,0,0
8526,mg,0,0
8527,once,0,0
8528,daily,0,0
8529,(,0,0
8530,n,0,0
8531,=,0,0
8532,42,0,0
8533,),0,0
8534,;,0,0
8535,group,0,0
8536,3,0,0
8537,received,0,0
8538,valsartan,0,0
8539,160,0,0
8540,mg,0,0
8541,once,0,0
8542,daily,0,0
8543,plus,0,0
8544,benazepril,0,0
8545,5,0,0
8546,or,0,0
8547,10,0,0
8548,mg,0,0
8549,once,0,0
8550,daily,0,0
8551,(,0,0
8552,n,0,0
8553,=,0,0
8554,44,0,0
8555,),0,0
8556,.,0,0
8557,The,0,0
8558,study,0,0
8559,lasted,0,0
8560,for,0,0
8561,5,0,0
8562,weeks,0,0
8563,",",0,0
8564,and,0,1
8565,in,0,0
8566,groups,0,0
8567,2,0,0
8568,and,0,0
8569,3,0,0
8570,benazepril,0,0
8571,was,0,0
8572,added,0,0
8573,on,0,0
8574,top,0,0
8575,of,0,1
8576,valsartan,0,0
8577,after,0,0
8578,the,0,0
8579,first,0,0
8580,week,0,0
8581,of,0,1
8582,therapy,0,0
8583,with,0,0
8584,the,0,0
8585,angiotensin,0,0
8586,receptor,0,1
8587,blocker,0,0
8588,.,0,1
8589,RESULTS,0,0
8590,Serum,1,1
8591,creatinine,1,1
8592,increased,0,0
8593,in,0,0
8594,all,0,0
8595,three,0,0
8596,groups,0,0
8597,(,0,0
8598,mean,0,1
8599,change,0,1
8600,within,0,0
8601,a,0,0
8602,group,0,0
8603,:,0,0
8604,11,0,0
8605,micromol/l,0,0
8606,in,0,0
8607,group,0,0
8608,1,0,0
8609,",",0,0
8610,P=,0,0
8611,0.045,0,0
8612,;,0,0
8613,9,0,0
8614,micromol/l,0,0
8615,in,0,0
8616,group,0,0
8617,2,0,0
8618,",",0,0
8619,P=,0,0
8620,0.030,0,0
8621,;,0,0
8622,15,0,0
8623,micromol/l,0,0
8624,in,0,0
8625,group,0,0
8626,3,0,0
8627,",",0,0
8628,P=,0,0
8629,0.0006,0,0
8630,),0,0
8631,.,0,0
8632,Serum,1,1
8633,potassium,1,1
8634,also,0,0
8635,increased,0,0
8636,in,0,0
8637,all,0,0
8638,three,0,0
8639,groups,0,0
8640,of,0,0
8641,patients,0,0
8642,(,0,0
8643,mean,0,1
8644,change,0,1
8645,within,0,0
8646,a,0,0
8647,group,0,0
8648,:,0,0
8649,0.28,0,0
8650,mmol/l,0,0
8651,in,0,0
8652,group,0,0
8653,1,0,0
8654,",",0,0
8655,P=,0,0
8656,0.28,0,0
8657,;,0,0
8658,0.48,0,0
8659,mmol/l,0,0
8660,in,0,0
8661,group,0,0
8662,2,0,0
8663,",",0,0
8664,P=,0,0
8665,0.0008,0,0
8666,;,0,0
8667,0.36,0,0
8668,mmol/l,0,0
8669,in,0,0
8670,group,0,0
8671,3,0,0
8672,",",0,0
8673,P=,0,0
8674,0.02,0,0
8675,),0,0
8676,.,0,0
8677,After,0,0
8678,5,0,0
8679,weeks,0,0
8680,of,0,0
8681,treatment,0,0
8682,",",0,0
8683,the,0,0
8684,largest,0,0
8685,decrease,0,1
8686,in,0,0
8687,blood,1,1
8688,pressure,1,1
8689,was,0,0
8690,observed,0,0
8691,in,0,0
8692,group,0,0
8693,3,0,0
8694,(,0,0
8695,the,0,0
8696,mean,0,1
8697,change,0,1
8698,from,0,0
8699,baseline,0,0
8700,in,0,0
8701,seated,1,0
8702,diastolic,1,1
8703,blood,1,1
8704,pressure,1,1
8705,(,1,1
8706,SDBP,1,1
8707,),1,1
8708,and,0,1
8709,seated,1,0
8710,systolic,1,1
8711,blood,1,1
8712,pressure,1,1
8713,(,1,1
8714,SSBP,1,1
8715,),1,1
8716,",",0,0
8717,respectively,0,0
8718,",",0,0
8719,were,0,0
8720,:,0,0
8721,-2.0,0,0
8722,and,0,1
8723,-11.5,0,0
8724,mmHg,0,0
8725,in,0,0
8726,group,0,0
8727,1,0,0
8728,;,0,0
8729,-7.6,0,0
8730,and,0,1
8731,-15.4,0,0
8732,mmHg,0,0
8733,in,0,0
8734,group,0,0
8735,2,0,0
8736,;,0,0
8737,-12.6,0,0
8738,and,0,1
8739,-21.6,0,0
8740,mmHg,0,0
8741,in,0,0
8742,group,0,0
8743,3,0,0
8744,),0,0
8745,.,0,0
8746,In,0,0
8747,addition,0,0
8748,",",0,0
8749,both,0,0
8750,combination,0,0
8751,treatments,0,0
8752,resulted,0,0
8753,in,0,0
8754,the,0,0
8755,reduction,0,1
8756,of,0,0
8757,proteinuria,1,1
8758,.,1,0
8759,The,0,0
8760,total,1,1
8761,number,1,1
8762,of,1,0
8763,patients,1,0
8764,with,0,0
8765,adverse,1,1
8766,experiences,1,1
8767,were,0,0
8768,10,0,0
8769,(,0,0
8770,45.5,0,0
8771,%,0,0
8772,),0,0
8773,",",0,0
8774,14,0,0
8775,(,0,0
8776,33.3,0,0
8777,%,0,0
8778,),0,0
8779,and,0,0
8780,11,0,0
8781,(,0,0
8782,25,0,0
8783,%,0,0
8784,),0,0
8785,in,0,0
8786,groups,0,0
8787,"1,2",0,0
8788,and,0,0
8789,3,0,0
8790,",",0,0
8791,respectively,0,0
8792,.,0,0
8793,In,0,0
8794,six,0,0
8795,patients,0,0
8796,(,0,0
8797,5.6,0,0
8798,%,0,0
8799,),0,0
8800,therapy,0,0
8801,was,0,0
8802,discontinued,0,0
8803,as,0,0
8804,a,0,0
8805,result,0,0
8806,of,0,0
8807,adverse,1,1
8808,experiences,1,1
8809,.,1,0
8810,Only,0,0
8811,one,0,0
8812,patient,0,0
8813,in,0,0
8814,each,0,0
8815,of,0,0
8816,the,0,0
8817,combined,0,0
8818,therapy,0,0
8819,groups,0,0
8820,withdrew,0,0
8821,from,0,0
8822,the,0,0
8823,study,0,0
8824,because,0,0
8825,of,0,1
8826,hyperkalaemia,1,1
8827,and,0,0
8828,no,0,0
8829,patients,0,0
8830,were,0,0
8831,forced,0,0
8832,to,0,0
8833,withdraw,0,0
8834,because,0,0
8835,of,0,0
8836,an,0,0
8837,increase,0,0
8838,in,0,0
8839,serum,1,1
8840,creatinine,1,1
8841,",",1,1
8842,acute,1,1
8843,renal,1,1
8844,failure,1,1
8845,or,1,0
8846,hospitalization,1,1
8847,.,1,0
8848,CONCLUSIONS,0,0
8849,These,0,0
8850,results,0,0
8851,indicate,0,0
8852,that,0,0
8853,short-term,0,1
8854,combination,0,0
8855,of,0,0
8856,an,0,0
8857,angiotensin-converting,0,0
8858,enzyme,0,0
8859,inhibitor,0,0
8860,and,0,0
8861,an,0,0
8862,angiotensin,0,0
8863,receptor,0,0
8864,blocker,0,0
8865,is,0,0
8866,safe,1,1
8867,and,0,0
8868,well,1,1
8869,tolerated,1,1
8870,in,0,0
8871,patients,0,0
8872,with,0,0
8873,moderate,0,0
8874,chronic,0,0
8875,renal,0,1
8876,failure,0,0
8877,.,0,0
8878,Effect,0,1
8879,of,0,1
8880,topical,0,0
8881,rh-TGF-beta,0,0
8882,1,0,0
8883,on,0,0
8884,second,1,0
8885,intention,1,1
8886,wound,1,1
8887,healing,1,1
8888,in,0,0
8889,horses,0,0
8890,.,0,0
8891,OBJECTIVE,0,0
8892,To,0,0
8893,investigate,0,0
8894,the,0,0
8895,effects,0,0
8896,on,0,0
8897,wound,0,0
8898,healing,0,1
8899,of,0,0
8900,transforming,0,1
8901,growth,0,1
8902,factor-beta,0,0
8903,1,0,0
8904,as,0,0
8905,a,0,0
8906,topical,0,0
8907,treatment,0,0
8908,to,0,0
8909,full-thickness,0,1
8910,",",0,0
8911,excisional,0,1
8912,wounds,0,0
8913,of,0,0
8914,the,0,0
8915,distal,0,1
8916,limb,0,1
8917,of,0,0
8918,horses,0,0
8919,.,0,0
8920,DESIGN,0,0
8921,A,0,0
8922,randomised,0,0
8923,block,0,0
8924,study,0,0
8925,using,0,0
8926,four,0,0
8927,horses,0,0
8928,",",0,0
8929,each,0,0
8930,with,0,0
8931,wounds,0,0
8932,assigned,0,0
8933,to,0,0
8934,four,0,0
8935,treatment,0,0
8936,groups,0,0
8937,.,0,0
8938,ANIMALS,0,0
8939,Four,0,1
8940,adult,0,0
8941,Standardbred,0,0
8942,geldings,0,0
8943,.,0,0
8944,PROCEDURE,0,1
8945,Four,0,1
8946,",",0,0
8947,4,0,0
8948,cm2,0,0
8949,",",0,0
8950,full-thickness,0,1
8951,wounds,0,1
8952,were,0,0
8953,created,0,0
8954,on,0,0
8955,the,0,0
8956,dorsomedial,0,0
8957,and,0,1
8958,dorsolateral,0,1
8959,aspect,0,1
8960,of,0,0
8961,the,0,0
8962,metacarpus,0,1
8963,or,0,0
8964,metatarsus,0,1
8965,of,0,0
8966,each,0,0
8967,limb,0,1
8968,of,0,0
8969,four,0,0
8970,horses,0,0
8971,",",0,0
8972,giving,0,0
8973,a,0,0
8974,total,0,0
8975,of,0,0
8976,64,0,0
8977,wounds,0,0
8978,.,0,0
8979,For,0,0
8980,each,0,0
8981,limb,0,1
8982,",",0,0
8983,wounds,0,1
8984,were,0,0
8985,randomly,0,0
8986,assigned,0,0
8987,to,0,0
8988,four,0,0
8989,treatment,0,0
8990,groups,0,0
8991,:,0,0
8992,no,0,0
8993,treatment,0,0
8994,(,0,0
8995,control,0,0
8996,),0,1
8997,",",0,1
8998,carrier,0,1
8999,(,0,1
9000,Methyl,0,0
9001,Cellulose,0,1
9002,gel,0,0
9003,),0,0
9004,",",0,0
9005,50,0,0
9006,ng/wound,0,0
9007,rhTGF-beta,0,0
9008,1,0,0
9009,in,0,0
9010,carrier,0,0
9011,",",0,0
9012,and,0,0
9013,500,0,0
9014,ng/wound,0,0
9015,rhTGF-beta,0,0
9016,1,0,0
9017,in,0,0
9018,carrier,0,0
9019,.,0,1
9020,Wounds,0,0
9021,were,0,0
9022,treated,0,0
9023,on,0,0
9024,day,0,0
9025,0,0,0
9026,and,0,0
9027,day,0,0
9028,8,0,0
9029,.,0,0
9030,Effects,0,0
9031,of,0,1
9032,treatment,0,0
9033,were,0,0
9034,evaluated,0,0
9035,on,0,0
9036,the,0,0
9037,basis,0,0
9038,of,0,0
9039,the,0,0
9040,presence,1,0
9041,of,1,0
9042,exuberant,1,1
9043,granulation,1,1
9044,tissue,1,1
9045,requiring,1,1
9046,excision,1,0
9047,",",1,1
9048,number,1,1
9049,of,1,1
9050,times,1,1
9051,excision,1,0
9052,was,1,0
9053,required,1,1
9054,",",1,0
9055,total,1,1
9056,wound,1,1
9057,area,1,1
9058,",",1,1
9059,area,1,1
9060,of,1,1
9061,epithelialisation,1,1
9062,",",1,1
9063,area,1,1
9064,of,1,1
9065,granulation,1,1
9066,",",1,1
9067,and,1,1
9068,histological,1,1
9069,evaluation,1,0
9070,of,1,1
9071,biopsy,1,0
9072,samples,1,0
9073,of,1,0
9074,wounds,1,0
9075,on,0,0
9076,day,0,0
9077,8,0,0
9078,and,0,0
9079,excised,0,0
9080,wounds,0,1
9081,on,0,0
9082,day,0,0
9083,21,0,0
9084,.,0,0
9085,RESULTS,0,0
9086,Topical,0,1
9087,application,0,0
9088,of,0,0
9089,TGF-beta,0,0
9090,1,0,0
9091,at,0,0
9092,the,0,0
9093,two,0,0
9094,concentrations,0,1
9095,studied,0,0
9096,had,0,0
9097,no,0,0
9098,significant,0,0
9099,effect,0,0
9100,on,0,0
9101,the,0,0
9102,total,1,1
9103,area,1,1
9104,of,1,1
9105,wounds,1,1
9106,(,0,0
9107,P,0,0
9108,=,0,0
9109,0.7,0,0
9110,),0,0
9111,",",0,0
9112,the,1,0
9113,area,1,1
9114,of,1,1
9115,granulation,1,1
9116,tissue,1,1
9117,(,0,1
9118,P,0,0
9119,=,0,0
9120,0.78,0,0
9121,),0,0
9122,",",0,0
9123,the,1,0
9124,area,1,1
9125,of,1,1
9126,epithelialisation,1,1
9127,(,0,0
9128,P,0,0
9129,=,0,0
9130,0.92,0,0
9131,),0,0
9132,",",0,0
9133,histological,0,1
9134,assessment,0,1
9135,or,0,1
9136,subjective,1,1
9137,clinical,1,1
9138,assessment,1,0
9139,of,1,0
9140,wounds,1,0
9141,.,1,0
9142,CONCLUSION,0,0
9143,TGF-beta,0,0
9144,1,0,0
9145,had,0,0
9146,no,0,0
9147,beneficial,0,0
9148,effects,0,1
9149,on,0,0
9150,wound,1,0
9151,healing,1,1
9152,.,1,1
9153,Additional,0,0
9154,trials,0,0
9155,are,0,0
9156,needed,0,0
9157,to,0,0
9158,test,0,0
9159,if,0,0
9160,it,0,0
9161,has,0,0
9162,value,0,1
9163,for,0,0
9164,wound,0,1
9165,treatment,0,0
9166,in,0,0
9167,horses,0,0
9168,.,0,0
9169,A,0,0
9170,comparison,0,0
9171,of,0,0
9172,local,0,0
9173,anaesthetics,0,0
9174,for,0,0
9175,venepuncture,0,0
9176,.,0,0
9177,AIM,0,0
9178,To,0,0
9179,compare,0,0
9180,the,0,0
9181,effectiveness,0,0
9182,of,0,0
9183,EMLA,0,1
9184,cream,0,0
9185,and,0,1
9186,Ametop,0,0
9187,gel,0,0
9188,in,0,0
9189,providing,0,0
9190,analgesia,0,1
9191,for,0,0
9192,venous,0,1
9193,cannulation,0,0
9194,.,0,0
9195,METHODS,0,0
9196,Single,0,1
9197,blind,0,0
9198,study,0,0
9199,in,0,0
9200,120,0,0
9201,children,0,0
9202,.,0,0
9203,RESULTS,0,0
9204,Both,0,0
9205,anaesthetic,0,0
9206,agents,0,0
9207,produced,0,0
9208,adequate,1,0
9209,analgesia,1,1
9210,.,1,0
9211,However,0,0
9212,",",0,0
9213,Ametop,0,0
9214,gel,0,0
9215,was,0,0
9216,more,0,0
9217,effective,0,1
9218,",",0,0
9219,with,0,0
9220,a,0,0
9221,statistically,0,0
9222,significant,0,0
9223,difference,0,0
9224,in,0,0
9225,the,0,0
9226,pain,1,1
9227,scores,1,1
9228,of,0,0
9229,the,0,0
9230,two,0,0
9231,groups,0,0
9232,(,0,0
9233,p,0,0
9234,<,0,0
9235,0.05,0,0
9236,),0,0
9237,.,0,0
9238,Prediction,0,1
9239,of,0,1
9240,creatinine,1,1
9241,clearance,1,1
9242,from,1,0
9243,serum,1,1
9244,creatinine,1,1
9245,in,0,0
9246,patients,0,0
9247,with,0,0
9248,rheumatoid,0,0
9249,arthritis,0,0
9250,:,0,0
9251,comparison,0,0
9252,of,0,0
9253,six,0,0
9254,formulae,0,0
9255,and,0,0
9256,one,0,0
9257,nomogram,0,0
9258,.,0,0
9259,The,0,0
9260,estimation,0,0
9261,of,0,0
9262,glomerular,1,1
9263,filtration,1,1
9264,rate,1,1
9265,is,0,0
9266,important,0,0
9267,for,0,0
9268,the,0,0
9269,medical,0,0
9270,treatment,0,0
9271,of,0,0
9272,patients,0,0
9273,with,0,0
9274,rheumatoid,0,1
9275,arthritis,0,1
9276,(,0,1
9277,RA,0,0
9278,),0,0
9279,.,0,0
9280,However,0,0
9281,",",0,0
9282,the,0,0
9283,determination,0,0
9284,of,0,0
9285,endogenous,1,1
9286,creatinine,1,1
9287,clearance,1,1
9288,(,1,1
9289,Clcr,1,0
9290,),1,0
9291,from,0,0
9292,a,0,0
9293,24-h,0,1
9294,urine,0,1
9295,collection,0,0
9296,is,0,0
9297,an,0,0
9298,unreliable,0,0
9299,and,0,1
9300,time-consuming,0,1
9301,procedure,0,0
9302,.,0,0
9303,We,0,0
9304,therefore,0,0
9305,tested,0,0
9306,the,0,0
9307,accuracy,0,1
9308,of,0,0
9309,six,0,0
9310,equations,0,0
9311,and,0,0
9312,one,0,0
9313,nomogram,0,0
9314,for,0,0
9315,the,0,0
9316,prediction,1,1
9317,of,1,0
9318,Clcr,1,0
9319,from,1,0
9320,serum,1,1
9321,creatinine,1,1
9322,(,1,1
9323,Scr,1,1
9324,),1,0
9325,in,0,0
9326,38,0,0
9327,patients,0,0
9328,with,0,0
9329,RA,0,0
9330,and,0,0
9331,20,0,0
9332,controls,0,0
9333,.,0,0
9334,A,0,0
9335,positive,0,1
9336,correlation,1,0
9337,was,0,0
9338,found,0,0
9339,for,0,0
9340,all,0,0
9341,methods,0,0
9342,in,0,0
9343,the,0,0
9344,controls,0,0
9345,(,0,0
9346,r,0,1
9347,=,0,0
9348,0.83-0.94,0,0
9349,),0,1
9350,and,0,1
9351,RA,0,0
9352,patients,0,0
9353,(,0,0
9354,r,0,1
9355,=,0,0
9356,0.51-0.69,0,0
9357,),0,0
9358,.,0,0
9359,The,0,0
9360,methods,0,0
9361,did,0,0
9362,not,0,0
9363,overestimate,0,0
9364,Clcr,1,0
9365,in,0,0
9366,RA,0,0
9367,.,0,0
9368,In,0,0
9369,the,0,0
9370,RA,0,0
9371,group,0,0
9372,the,0,0
9373,simple,0,0
9374,formula,0,0
9375,published,0,0
9376,by,0,0
9377,Cockcroft,0,0
9378,[,0,0
9379,Clcr,0,1
9380,=,0,0
9381,(,0,0
9382,(,0,0
9383,140,0,0
9384,-,0,0
9385,age,0,0
9386,),0,0
9387,x,0,0
9388,body,0,1
9389,weight,0,1
9390,),0,1
9391,/,0,0
9392,(,0,0
9393,72,0,0
9394,x,0,0
9395,Scr,0,0
9396,),0,1
9397,",",0,0
9398,x,0,0
9399,0.85,0,0
9400,for,0,0
9401,females,0,0
9402,],0,0
9403,showed,0,0
9404,the,0,0
9405,best,0,0
9406,correlation,0,0
9407,with,0,0
9408,the,0,0
9409,measured,1,0
9410,Clcr,1,0
9411,.,1,0
9412,In,0,0
9413,RA,0,0
9414,the,0,0
9415,Cockroft,0,0
9416,formula,0,0
9417,can,0,0
9418,reliably,1,0
9419,be,0,0
9420,used,0,0
9421,to,1,0
9422,predict,1,0
9423,Clcr,1,0
9424,from,1,0
9425,Scr,1,0
9426,.,1,0
9427,Auditory,0,1
9428,integration,0,1
9429,training,0,0
9430,for,0,0
9431,children,0,0
9432,with,0,0
9433,autism,1,0
9434,:,1,0
9435,no,0,0
9436,behavioral,0,1
9437,benefits,0,0
9438,detected,0,0
9439,.,0,0
9440,Auditory,0,1
9441,integration,0,1
9442,training,0,0
9443,and,0,0
9444,a,0,0
9445,control,0,0
9446,treatment,0,0
9447,were,0,0
9448,provided,0,0
9449,for,0,0
9450,16,0,0
9451,children,0,0
9452,with,0,0
9453,autism,1,0
9454,in,0,0
9455,a,0,0
9456,crossover,0,0
9457,experimental,0,0
9458,design,0,0
9459,.,0,1
9460,Measures,0,1
9461,",",0,0
9462,blind,0,0
9463,to,0,0
9464,treatment,0,0
9465,order,0,0
9466,",",0,1
9467,included,0,0
9468,parent,1,1
9469,and,1,1
9470,teacher,1,1
9471,ratings,1,1
9472,of,1,1
9473,behavior,1,1
9474,",",1,0
9475,direct,1,1
9476,observational,1,0
9477,recordings,1,1
9478,",",1,1
9479,IQ,1,1
9480,",",1,1
9481,language,1,1
9482,",",1,1
9483,and,1,1
9484,social/adaptive,1,1
9485,tests,1,1
9486,.,1,0
9487,Significant,1,1
9488,differences,1,0
9489,tended,0,0
9490,to,0,0
9491,show,0,0
9492,that,0,0
9493,the,0,0
9494,control,0,0
9495,condition,0,0
9496,was,0,0
9497,superior,1,1
9498,on,1,0
9499,parent-rated,1,1
9500,measures,1,1
9501,of,1,1
9502,hyperactivity,1,1
9503,and,1,1
9504,on,1,0
9505,direct,1,1
9506,observational,1,0
9507,measures,1,1
9508,of,1,0
9509,ear-occlusion,1,1
9510,.,1,0
9511,No,1,0
9512,differences,1,0
9513,were,0,0
9514,detected,0,0
9515,on,0,0
9516,teacher-rated,1,1
9517,measures,1,0
9518,.,1,0
9519,Children,1,0
9520,'s,1,1
9521,IQs,1,1
9522,and,1,1
9523,language,1,1
9524,comprehension,1,1
9525,did,1,0
9526,not,1,0
9527,increase,1,1
9528,",",0,0
9529,but,0,0
9530,adaptive/social,1,1
9531,behavior,1,1
9532,scores,1,1
9533,and,1,1
9534,expressive,1,1
9535,language,1,1
9536,quotients,1,1
9537,decreased,1,0
9538,.,1,0
9539,The,0,0
9540,majority,0,0
9541,of,0,1
9542,parents,0,0
9543,(,0,0
9544,56,0,0
9545,%,0,0
9546,),0,0
9547,were,0,0
9548,unable,1,0
9549,to,1,0
9550,report,1,0
9551,in,1,0
9552,retrospect,1,0
9553,when,0,0
9554,their,0,0
9555,child,0,1
9556,had,0,0
9557,received,0,0
9558,auditory,0,1
9559,integration,0,1
9560,training,0,0
9561,.,0,0
9562,No,1,0
9563,individual,0,0
9564,child,0,1
9565,was,0,0
9566,identified,0,0
9567,as,0,0
9568,benefiting,1,0
9569,clinically,1,0
9570,or,1,0
9571,educationally,1,0
9572,from,0,0
9573,the,0,0
9574,treatment,0,0
9575,.,0,0
9576,Low,0,0
9577,molecular-weight,0,0
9578,heparin,0,0
9579,versus,0,0
9580,aspirin,0,0
9581,in,0,0
9582,patients,0,0
9583,with,0,0
9584,acute,0,0
9585,ischaemic,0,1
9586,stroke,0,1
9587,and,0,1
9588,atrial,0,1
9589,fibrillation,0,0
9590,:,0,0
9591,a,0,0
9592,double-blind,0,0
9593,randomised,0,0
9594,study,0,0
9595,.,0,0
9596,HAEST,0,0
9597,Study,0,0
9598,Group,0,0
9599,.,0,0
9600,Heparin,0,0
9601,in,0,0
9602,Acute,0,1
9603,Embolic,0,1
9604,Stroke,0,1
9605,Trial,0,0
9606,.,0,0
9607,BACKGROUND,0,0
9608,Patients,0,0
9609,with,0,0
9610,acute,0,0
9611,ischaemic,0,1
9612,stroke,0,1
9613,and,0,1
9614,atrial,0,1
9615,fibrillation,0,0
9616,have,0,0
9617,an,0,0
9618,increased,0,0
9619,risk,0,0
9620,of,0,0
9621,early,1,0
9622,stroke,1,1
9623,recurrence,1,1
9624,",",0,1
9625,and,0,1
9626,anticoagulant,0,1
9627,treatment,0,0
9628,with,0,0
9629,heparins,0,0
9630,has,0,0
9631,been,0,0
9632,widely,0,0
9633,advocated,0,0
9634,",",0,0
9635,despite,0,0
9636,missing,0,0
9637,data,0,0
9638,on,0,0
9639,the,0,0
9640,balance,0,1
9641,of,0,1
9642,risk,0,1
9643,and,0,1
9644,benefit,0,0
9645,.,0,1
9646,METHODS,0,0
9647,Heparin,0,0
9648,in,0,0
9649,Acute,0,1
9650,Embolic,0,1
9651,Stroke,0,1
9652,Trial,0,0
9653,(,0,1
9654,HAEST,0,1
9655,),0,0
9656,was,0,0
9657,a,0,0
9658,multicentre,0,0
9659,",",0,0
9660,randomised,0,0
9661,",",0,0
9662,double-blind,0,0
9663,",",0,1
9664,and,0,1
9665,double-dummy,0,0
9666,trial,0,0
9667,on,0,0
9668,the,0,0
9669,effect,0,0
9670,of,0,0
9671,low-molecular-weight,0,0
9672,heparin,0,0
9673,(,0,1
9674,LMWH,0,0
9675,",",0,0
9676,dalteparin,0,0
9677,100,0,0
9678,IU/kg,0,0
9679,subcutaneously,0,0
9680,twice,0,0
9681,a,0,0
9682,day,0,0
9683,),0,1
9684,or,0,1
9685,aspirin,0,0
9686,(,0,0
9687,160,0,0
9688,mg,0,0
9689,every,0,0
9690,day,0,0
9691,),0,0
9692,for,0,0
9693,the,0,0
9694,treatment,0,0
9695,of,0,0
9696,449,0,0
9697,patients,0,0
9698,with,0,0
9699,acute,0,0
9700,ischaemic,0,1
9701,stroke,0,1
9702,and,0,1
9703,atrial,0,1
9704,fibrillation,0,0
9705,.,0,0
9706,The,0,0
9707,primary,0,0
9708,aim,0,0
9709,was,0,0
9710,to,0,0
9711,test,0,1
9712,whether,0,0
9713,treatment,0,0
9714,with,0,0
9715,LMWH,0,1
9716,",",0,1
9717,started,0,0
9718,within,0,0
9719,30,0,0
9720,h,0,0
9721,of,0,0
9722,stroke,0,1
9723,onset,0,1
9724,",",0,0
9725,is,0,0
9726,superior,0,0
9727,to,0,0
9728,aspirin,0,0
9729,for,0,0
9730,the,0,0
9731,prevention,0,0
9732,of,0,0
9733,recurrent,1,1
9734,stroke,1,1
9735,during,0,0
9736,the,0,0
9737,first,0,0
9738,14,0,0
9739,days,0,0
9740,.,0,0
9741,FINDINGS,0,0
9742,The,0,0
9743,frequency,1,1
9744,of,1,0
9745,recurrent,1,1
9746,ischaemic,1,1
9747,stroke,1,1
9748,during,0,0
9749,the,0,0
9750,first,0,0
9751,14,0,0
9752,days,0,0
9753,was,0,0
9754,19/244,0,0
9755,(,0,0
9756,8.5,0,0
9757,%,0,0
9758,),0,0
9759,in,0,0
9760,dalteparin-allocated,0,0
9761,patients,0,0
9762,versus,0,0
9763,17/225,0,0
9764,(,0,0
9765,7.5,0,0
9766,%,0,0
9767,),0,0
9768,in,0,0
9769,aspirin-allocated,0,0
9770,patients,0,0
9771,(,0,0
9772,odds,0,1
9773,ratio=1.13,0,0
9774,",",0,0
9775,95,0,0
9776,%,0,0
9777,CI,0,0
9778,0.57-2.24,0,0
9779,),0,0
9780,.,0,0
9781,The,0,0
9782,secondary,0,0
9783,events,0,1
9784,during,0,0
9785,the,0,0
9786,first,0,0
9787,14,0,0
9788,days,0,0
9789,also,0,0
9790,revealed,0,0
9791,no,0,0
9792,benefit,0,0
9793,of,0,0
9794,dalteparin,0,0
9795,compared,0,0
9796,with,0,0
9797,aspirin,0,0
9798,:,0,0
9799,symptomatic,1,1
9800,cerebral,1,1
9801,haemorrhage,1,0
9802,6/224,0,0
9803,versus,0,0
9804,4/225,0,0
9805,;,0,0
9806,symptomatic,1,0
9807,and,1,1
9808,asymptomatic,1,1
9809,cerebral,1,1
9810,haemorrhage,1,0
9811,26/224,0,0
9812,versus,0,0
9813,32/225,0,0
9814,;,0,0
9815,progression,1,1
9816,of,1,0
9817,symptoms,1,1
9818,within,1,0
9819,the,1,0
9820,first,1,0
9821,48,1,0
9822,hours,1,0
9823,24/224,0,0
9824,versus,0,0
9825,17/225,0,0
9826,;,0,0
9827,and,0,0
9828,death,0,1
9829,21/224,0,0
9830,versus,0,0
9831,16/225,0,0
9832,.,0,0
9833,There,0,0
9834,were,0,0
9835,no,0,0
9836,significant,0,0
9837,differences,0,0
9838,in,0,0
9839,functional,1,1
9840,outcome,1,1
9841,or,1,1
9842,death,1,1
9843,at,0,0
9844,14,0,0
9845,days,0,0
9846,or,0,0
9847,3,0,0
9848,months,0,0
9849,.,0,0
9850,INTERPRETATION,0,0
9851,The,0,0
9852,present,0,0
9853,data,0,0
9854,do,0,0
9855,not,0,0
9856,provide,0,0
9857,any,0,0
9858,evidence,0,0
9859,that,0,0
9860,LMWH,0,0
9861,is,0,0
9862,superior,0,0
9863,to,0,0
9864,aspirin,0,0
9865,for,0,0
9866,the,0,0
9867,treatment,0,0
9868,of,0,0
9869,acute,0,0
9870,ischaemic,0,1
9871,stroke,0,1
9872,in,0,0
9873,patients,0,0
9874,with,0,0
9875,atrial,0,0
9876,fibrillation,0,0
9877,.,0,0
9878,However,0,0
9879,",",0,0
9880,the,0,0
9881,study,0,0
9882,could,0,0
9883,not,0,0
9884,exclude,0,0
9885,the,0,0
9886,possibility,0,0
9887,of,0,0
9888,smaller,0,0
9889,",",0,1
9890,but,0,0
9891,still,0,0
9892,worthwhile,0,0
9893,",",0,0
9894,effects,0,1
9895,of,0,0
9896,either,0,0
9897,of,0,0
9898,the,0,0
9899,trial,0,0
9900,drugs,0,0
9901,.,0,0
9902,Randomised,0,0
9903,",",0,0
9904,double,0,0
9905,blind,0,0
9906,",",0,1
9907,placebo,0,0
9908,controlled,0,0
9909,study,0,0
9910,of,0,1
9911,fluticasone,0,0
9912,propionate,0,0
9913,in,0,0
9914,patients,0,0
9915,with,0,0
9916,moderate,0,0
9917,to,0,0
9918,severe,0,1
9919,chronic,0,0
9920,obstructive,0,0
9921,pulmonary,0,1
9922,disease,0,0
9923,:,0,0
9924,the,0,0
9925,ISOLDE,0,0
9926,trial,0,0
9927,.,0,0
9928,OBJECTIVES,0,0
9929,To,0,0
9930,determine,0,0
9931,the,0,0
9932,effect,0,0
9933,of,0,0
9934,long,0,0
9935,term,0,1
9936,inhaled,0,0
9937,corticosteroids,0,0
9938,on,0,0
9939,lung,1,1
9940,function,1,1
9941,",",1,1
9942,exacerbations,1,1
9943,",",1,1
9944,and,1,1
9945,health,1,1
9946,status,1,1
9947,in,0,0
9948,patients,0,0
9949,with,0,0
9950,moderate,0,0
9951,to,0,0
9952,severe,0,1
9953,chronic,0,0
9954,obstructive,0,0
9955,pulmonary,0,1
9956,disease,0,1
9957,.,0,0
9958,DESIGN,0,0
9959,Double,0,1
9960,blind,0,0
9961,",",0,1
9962,placebo,0,0
9963,controlled,0,0
9964,study,0,0
9965,.,0,1
9966,SETTING,0,0
9967,Eighteen,0,1
9968,UK,0,1
9969,hospitals,0,0
9970,.,0,0
9971,PARTICIPANTS,0,0
9972,751,0,0
9973,men,0,0
9974,and,0,0
9975,women,0,0
9976,aged,0,0
9977,between,0,0
9978,40,0,0
9979,and,0,0
9980,75,0,0
9981,years,0,0
9982,with,0,0
9983,mean,0,1
9984,forced,0,1
9985,expiratory,0,1
9986,volume,0,1
9987,in,0,0
9988,one,0,0
9989,second,0,0
9990,(,0,0
9991,FEV,0,1
9992,(,0,0
9993,1,0,0
9994,),0,0
9995,),0,0
9996,50,0,0
9997,%,0,0
9998,of,0,0
9999,predicted,0,0
10000,normal,0,0
10001,.,0,0
10002,INTERVENTIONS,0,1
10003,Inhaled,0,0
10004,fluticasone,0,0
10005,propionate,0,0
10006,500,0,0
10007,microgram,0,0
10008,twice,0,0
10009,daily,0,0
10010,from,0,0
10011,a,0,0
10012,metered,0,0
10013,dose,0,0
10014,inhaler,0,0
10015,or,0,1
10016,identical,0,0
10017,placebo,0,0
10018,.,0,0
10019,MAIN,0,0
10020,OUTCOME,0,1
10021,MEASURES,0,0
10022,Efficacy,1,1
10023,measures,0,1
10024,:,0,0
10025,rate,1,1
10026,of,1,1
10027,decline,1,1
10028,in,1,0
10029,FEV,1,0
10030,(,1,0
10031,1,1,0
10032,),1,0
10033,after,1,0
10034,the,1,0
10035,bronchodilator,1,0
10036,and,1,1
10037,in,1,0
10038,health,1,1
10039,status,1,1
10040,",",1,1
10041,frequency,1,1
10042,of,1,1
10043,exacerbations,1,1
10044,",",1,0
10045,respiratory,1,1
10046,withdrawals,1,1
10047,.,1,0
10048,Safety,0,1
10049,measures,0,1
10050,:,0,0
10051,morning,1,1
10052,serum,1,1
10053,cortisol,1,1
10054,concentration,1,1
10055,",",1,1
10056,incidence,1,1
10057,of,1,1
10058,adverse,1,1
10059,events,1,1
10060,.,1,0
10061,RESULTS,0,0
10062,There,0,0
10063,was,0,0
10064,no,1,0
10065,significant,1,0
10066,difference,1,0
10067,in,0,0
10068,the,0,0
10069,annual,1,0
10070,rate,1,1
10071,of,1,1
10072,decline,1,1
10073,in,1,0
10074,FEV,1,0
10075,(,1,0
10076,1,1,0
10077,),1,0
10078,(,1,0
10079,P=0.16,1,0
10080,),1,0
10081,.,0,0
10082,Mean,1,1
10083,FEV,1,0
10084,(,1,0
10085,1,1,0
10086,),1,0
10087,after,0,0
10088,bronchodilator,0,0
10089,remained,0,0
10090,significantly,1,0
10091,higher,1,0
10092,throughout,0,0
10093,the,0,0
10094,study,0,0
10095,with,0,0
10096,fluticasone,0,0
10097,propionate,0,0
10098,compared,0,0
10099,with,0,0
10100,placebo,0,0
10101,(,0,0
10102,P,0,0
10103,<,0,0
10104,0.001,0,0
10105,),0,0
10106,.,0,0
10107,Median,1,1
10108,exacerbation,1,1
10109,rate,1,1
10110,was,0,0
10111,reduced,1,0
10112,by,0,0
10113,25,0,0
10114,%,0,0
10115,from,0,0
10116,1.32,0,0
10117,a,0,0
10118,year,0,0
10119,on,0,0
10120,placebo,0,0
10121,to,0,0
10122,0.99,0,0
10123,a,0,0
10124,year,0,0
10125,on,0,0
10126,with,0,0
10127,fluticasone,0,0
10128,propionate,0,0
10129,(,0,1
10130,P=0.026,0,0
10131,),0,0
10132,.,0,0
10133,Health,1,1
10134,status,1,1
10135,deteriorated,1,0
10136,by,0,0
10137,3.2,0,0
10138,units,0,0
10139,a,0,0
10140,year,0,0
10141,on,0,0
10142,placebo,0,0
10143,and,0,0
10144,2.0,0,0
10145,units,0,0
10146,a,0,0
10147,year,0,0
10148,on,0,0
10149,fluticasone,0,0
10150,propionate,0,0
10151,(,0,1
10152,P=0.0043,0,0
10153,),0,0
10154,.,0,0
10155,Withdrawals,1,1
10156,because,0,0
10157,of,0,0
10158,respiratory,0,1
10159,disease,0,1
10160,not,0,0
10161,related,0,0
10162,to,0,0
10163,malignancy,0,1
10164,were,0,0
10165,higher,0,0
10166,in,0,0
10167,the,0,0
10168,placebo,0,0
10169,group,0,0
10170,(,0,0
10171,25,0,0
10172,%,0,0
10173,v,0,0
10174,19,0,0
10175,%,0,0
10176,",",0,0
10177,P=0.034,0,0
10178,),0,0
10179,.,0,0
10180,CONCLUSIONS,0,0
10181,Fluticasone,0,0
10182,propionate,0,0
10183,500,0,0
10184,microgram,0,0
10185,twice,0,0
10186,daily,0,0
10187,did,0,0
10188,not,0,0
10189,affect,0,0
10190,the,0,0
10191,rate,1,1
10192,of,1,0
10193,decline,1,1
10194,in,1,0
10195,FEV,1,0
10196,(,1,0
10197,1,1,0
10198,),1,0
10199,but,0,0
10200,did,0,0
10201,produce,1,0
10202,a,1,0
10203,small,1,0
10204,increase,1,0
10205,in,1,0
10206,FEV,1,0
10207,(,1,0
10208,1,1,0
10209,),1,0
10210,.,1,0
10211,Patients,0,0
10212,on,0,0
10213,fluticasone,0,0
10214,propionate,0,0
10215,had,0,0
10216,fewer,0,1
10217,exacerbations,1,1
10218,and,0,1
10219,a,0,0
10220,slower,1,0
10221,decline,1,1
10222,in,1,1
10223,health,1,1
10224,status,1,1
10225,.,1,0
10226,These,0,0
10227,improvements,0,0
10228,in,0,0
10229,clinical,0,0
10230,outcomes,0,0
10231,support,0,0
10232,the,0,0
10233,use,0,0
10234,of,0,0
10235,this,0,0
10236,treatment,0,0
10237,in,0,0
10238,patients,0,0
10239,with,0,0
10240,moderate,0,0
10241,to,0,0
10242,severe,0,1
10243,chronic,0,0
10244,obstructive,0,0
10245,pulmonary,0,1
10246,disease,0,0
10247,.,0,0
10248,[,0,0
10249,Comparative,0,0
10250,study,0,0
10251,between,0,0
10252,5,0,0
10253,%,0,0
10254,prilocaine,0,0
10255,and,0,0
10256,2,0,0
10257,%,0,0
10258,mepivacaine,0,0
10259,by,0,0
10260,the,0,0
10261,subarachnoid,0,0
10262,route,0,0
10263,in,0,0
10264,transurethral,0,0
10265,resections,0,0
10266,],0,0
10267,.,0,0
10268,OBJECTIVE,0,0
10269,To,0,0
10270,compare,0,0
10271,the,0,0
10272,duration,1,1
10273,of,0,0
10274,spinal,0,1
10275,block,0,0
10276,with,0,0
10277,5,0,0
10278,%,0,0
10279,prilocaine,0,0
10280,and,0,0
10281,2,0,0
10282,%,0,0
10283,mepivacaine,0,0
10284,in,0,0
10285,short,0,1
10286,procedures,0,0
10287,for,0,0
10288,transurethral,0,0
10289,resection,0,0
10290,and,0,0
10291,to,0,0
10292,assess,1,0
10293,possible,1,0
10294,complications,1,1
10295,in,0,0
10296,the,0,0
10297,immediate,0,1
10298,postoperative,0,1
10299,period,0,0
10300,.,0,0
10301,MATERIAL,0,0
10302,AND,0,0
10303,METHODS,0,0
10304,Fifty-seven,0,0
10305,patients,0,0
10306,scheduled,0,0
10307,for,0,0
10308,transurethral,0,0
10309,resection,0,0
10310,of,0,0
10311,the,0,0
10312,prostate,0,0
10313,or,0,0
10314,a,0,0
10315,vesical,0,1
10316,tumor,0,1
10317,.,0,1
10318,Patients,0,0
10319,were,0,0
10320,ASA,0,1
10321,I-III,0,1
10322,",",0,0
10323,over,0,0
10324,55,0,0
10325,years,0,0
10326,of,0,0
10327,age,0,0
10328,and,0,0
10329,randomly,0,0
10330,assigned,0,0
10331,to,0,0
10332,two,0,0
10333,groups,0,0
10334,to,0,0
10335,receive,0,0
10336,5,0,0
10337,%,0,0
10338,prilocaine,0,0
10339,(,0,0
10340,1,0,0
10341,mg/kg,0,0
10342,",",0,0
10343,n,0,0
10344,=,0,0
10345,27,0,0
10346,),0,0
10347,or,0,0
10348,2,0,0
10349,%,0,0
10350,mepivacaine,0,0
10351,(,0,0
10352,0.8,0,0
10353,mg/kg,0,0
10354,",",0,0
10355,n,0,0
10356,=,0,0
10357,30,0,0
10358,),0,0
10359,.,0,0
10360,We,0,0
10361,collected,0,0
10362,data,0,0
10363,on,0,0
10364,anesthetic,1,1
10365,technique,1,0
10366,",",1,0
10367,levels,1,1
10368,of,1,1
10369,extension,1,0
10370,of,1,1
10371,motor,1,1
10372,and,1,1
10373,sensory,1,1
10374,blockades,1,1
10375,",",1,1
10376,duration,1,1
10377,of,1,1
10378,blockades,1,1
10379,and,1,1
10380,complications,1,1
10381,within,1,0
10382,the,1,0
10383,first,1,0
10384,24,1,0
10385,hours,1,0
10386,after,0,0
10387,surgery,0,0
10388,.,0,0
10389,RESULTS,0,0
10390,Demographic,0,1
10391,data,0,0
10392,",",0,1
10393,ASA,0,1
10394,classification,0,1
10395,and,0,1
10396,duration,0,1
10397,of,0,1
10398,surgery,0,0
10399,were,0,0
10400,similar,0,0
10401,in,0,0
10402,both,0,0
10403,groups,0,0
10404,.,0,0
10405,We,0,0
10406,found,0,0
10407,statistically,0,0
10408,significant,0,0
10409,differences,0,0
10410,(,0,0
10411,p,0,0
10412,<,0,0
10413,0.05,0,0
10414,),0,0
10415,in,0,0
10416,duration,1,1
10417,of,1,1
10418,sensory,1,1
10419,blockade,1,0
10420,(,0,0
10421,120.92,0,0
10422,+/-,0,0
10423,36.21,0,0
10424,min,0,0
10425,with,0,0
10426,prilocaine,0,0
10427,and,0,0
10428,145.83,0,0
10429,+/-,0,0
10430,35.81,0,0
10431,min,0,0
10432,with,0,0
10433,mepivacaine,0,0
10434,),0,1
10435,and,0,1
10436,in,0,0
10437,motor,1,1
10438,blockade,1,1
10439,(,0,0
10440,106.29,0,0
10441,+/-,0,0
10442,38.16,0,0
10443,min,0,0
10444,with,0,0
10445,prilocaine,0,0
10446,and,0,0
10447,133.16,0,0
10448,+/-,0,0
10449,42.21,0,0
10450,min,0,0
10451,with,0,0
10452,mepivacaine,0,0
10453,),0,0
10454,.,0,0
10455,Five,0,1
10456,cases,0,0
10457,of,0,1
10458,hypotension,1,1
10459,and,0,0
10460,4,0,0
10461,of,0,0
10462,bradycardia,1,1
10463,occurred,0,0
10464,in,0,0
10465,each,0,0
10466,group,0,0
10467,and,0,0
10468,one,0,0
10469,patient,0,0
10470,in,0,0
10471,the,0,0
10472,mepivacaine,0,0
10473,group,0,0
10474,suffered,0,1
10475,slight,0,1
10476,postoperative,0,1
10477,cephalea,0,1
10478,.,0,0
10479,CONCLUSIONS,0,0
10480,Both,0,0
10481,local,0,0
10482,anesthetics,0,0
10483,offer,0,0
10484,good,0,0
10485,surgical,1,0
10486,conditions,1,0
10487,with,0,0
10488,hemodynamic,0,1
10489,stability,0,1
10490,and,0,1
10491,few,0,0
10492,complications,1,1
10493,.,1,0
10494,The,0,0
10495,duration,0,1
10496,of,0,1
10497,sensory,1,1
10498,and,1,1
10499,motor,1,1
10500,blockade,1,0
10501,is,0,0
10502,shorter,0,1
10503,with,0,0
10504,prilocaine,0,0
10505,than,0,0
10506,with,0,0
10507,mepivacaine,0,0
10508,",",0,0
10509,making,0,1
10510,prilocaine,0,0
10511,more,0,0
10512,appropriate,0,0
10513,for,0,0
10514,short,0,0
10515,interventions,0,0
10516,.,0,0
10517,Effects,0,0
10518,of,0,0
10519,low-dose,0,0
10520,aspirin,0,0
10521,on,0,0
10522,clinic,1,1
10523,and,1,1
10524,ambulatory,1,1
10525,blood,1,1
10526,pressure,1,1
10527,in,0,0
10528,treated,0,0
10529,hypertensive,0,0
10530,patients,0,0
10531,.,0,0
10532,Collaborative,0,0
10533,Group,0,0
10534,of,0,0
10535,the,0,0
10536,Primary,0,0
10537,Prevention,0,0
10538,Project,0,1
10539,(,0,1
10540,PPP,0,0
10541,),0,0
10542,--,0,1
10543,Hypertension,0,1
10544,study,0,0
10545,.,0,1
10546,Nonsteroidal,0,0
10547,antiinflammatory,0,0
10548,drugs,0,0
10549,may,0,0
10550,affect,0,1
10551,blood,1,1
10552,pressure,1,1
10553,(,1,1
10554,BP,1,1
10555,),1,1
10556,control,1,0
10557,in,0,0
10558,hypertensive,0,0
10559,patients,0,0
10560,receiving,0,0
10561,drug,0,0
10562,treatment,0,0
10563,",",0,1
10564,but,0,0
10565,data,0,0
10566,on,0,0
10567,the,0,0
10568,effects,0,0
10569,of,0,0
10570,low-dose,0,0
10571,aspirin,0,0
10572,are,0,0
10573,scanty,0,0
10574,.,0,0
10575,This,0,0
10576,study,0,0
10577,assessed,0,0
10578,the,0,0
10579,effects,0,1
10580,of,0,0
10581,chronic,0,0
10582,treatment,0,0
10583,with,0,0
10584,low,0,0
10585,doses,0,0
10586,of,0,1
10587,aspirin,0,0
10588,(,0,0
10589,100,0,0
10590,mg/day,0,0
10591,),0,0
10592,on,0,0
10593,clinic,1,1
10594,and,1,1
10595,ambulatory,1,1
10596,systolic,1,1
10597,(,1,1
10598,SBP,1,1
10599,),1,1
10600,and,1,1
10601,diastolic,1,1
10602,(,1,1
10603,DBP,1,1
10604,),1,1
10605,BP,1,1
10606,in,0,0
10607,hypertensives,0,0
10608,on,0,0
10609,chronic,0,0
10610,",",0,0
10611,stable,0,1
10612,antihypertensive,0,0
10613,therapy,0,0
10614,.,0,0
10615,The,0,0
10616,study,0,0
10617,was,0,0
10618,conducted,0,0
10619,in,0,0
10620,the,0,0
10621,framework,0,0
10622,of,0,0
10623,the,0,0
10624,Primary,0,0
10625,Prevention,0,0
10626,Project,0,1
10627,(,0,1
10628,PPP,0,1
10629,),0,0
10630,",",0,0
10631,a,0,0
10632,randomized,0,0
10633,",",0,0
10634,controlled,0,0
10635,factorial,0,0
10636,trial,0,0
10637,on,0,0
10638,the,0,0
10639,preventive,0,0
10640,effect,0,1
10641,of,0,1
10642,aspirin,0,0
10643,or,0,1
10644,vitamin,0,1
10645,E,0,1
10646,in,0,0
10647,people,0,0
10648,with,0,0
10649,one,0,0
10650,or,0,0
10651,more,0,0
10652,cardiovascular,0,1
10653,risk,0,1
10654,factors,0,1
10655,.,0,0
10656,Fifteen,0,0
10657,Italian,0,0
10658,hypertension,0,1
10659,units,0,0
10660,studied,0,0
10661,142,0,0
10662,hypertensive,0,0
10663,patients,0,0
10664,(,0,0
10665,76,0,0
10666,men,0,0
10667,",",0,0
10668,66,0,0
10669,women,0,0
10670,;,0,0
10671,mean,0,1
10672,age,0,0
10673,59,0,0
10674,+/-,0,0
10675,5.9,0,0
10676,years,0,0
10677,),0,0
10678,treated,0,0
10679,with,0,0
10680,different,0,0
10681,antihypertensive,0,0
10682,drugs,0,0
10683,:,0,0
10684,71,0,0
10685,patients,0,0
10686,were,0,0
10687,randomized,0,0
10688,to,0,0
10689,aspirin,0,0
10690,and,0,0
10691,71,0,0
10692,served,0,0
10693,as,0,0
10694,controls,0,0
10695,.,0,0
10696,All,0,0
10697,patients,0,0
10698,underwent,0,0
10699,a,0,0
10700,clinic,1,0
10701,BP,1,1
10702,evaluation,1,0
10703,with,1,0
10704,an,1,0
10705,automatic,1,0
10706,sphygmomanometer,1,0
10707,and,0,0
10708,a,0,0
10709,24-h,1,1
10710,ambulatory,1,0
10711,BP,1,1
10712,monitoring,1,0
10713,",",0,1
10714,at,0,1
10715,baseline,0,1
10716,and,0,0
10717,after,0,0
10718,3,0,0
10719,months,0,0
10720,of,0,0
10721,aspirin,0,0
10722,treatment,0,0
10723,.,0,0
10724,At,0,0
10725,the,0,0
10726,end,0,0
10727,of,0,0
10728,the,0,0
10729,study,0,0
10730,the,0,0
10731,changes,0,1
10732,in,0,0
10733,clinic,1,1
10734,SBP,1,1
10735,and,1,1
10736,DBP,1,1
10737,were,0,0
10738,not,0,0
10739,statistically,0,0
10740,different,0,0
10741,in,0,0
10742,treated,0,0
10743,and,0,1
10744,untreated,0,0
10745,subjects,0,0
10746,.,0,0
10747,Ambulatory,1,1
10748,SBP,1,1
10749,and,1,1
10750,DBP,1,1
10751,after,0,0
10752,3,0,0
10753,months,0,0
10754,of,0,0
10755,aspirin,0,0
10756,treatment,0,0
10757,were,0,0
10758,similar,0,0
10759,to,0,0
10760,baseline,0,0
10761,:,0,0
10762,deltaSBP,0,1
10763,-0.5,0,0
10764,mmHg,0,0
10765,(,0,0
10766,95,0,0
10767,%,0,0
10768,confidence,0,0
10769,intervals,0,0
10770,[,0,0
10771,CI,0,0
10772,],0,0
10773,from,0,0
10774,-1.9,0,0
10775,to,0,0
10776,+2.9,0,0
10777,mm,0,0
10778,Hg,0,0
10779,),0,1
10780,and,0,1
10781,deltaDBP,0,1
10782,-1.1,0,0
10783,mm,0,1
10784,Hg,0,0
10785,(,0,0
10786,95,0,0
10787,%,0,0
10788,CI,0,0
10789,from,0,0
10790,-2.5,0,0
10791,to,0,0
10792,+0.3,0,0
10793,mm,0,0
10794,Hg,0,0
10795,),0,0
10796,.,0,0
10797,The,0,0
10798,pattern,0,0
10799,was,0,0
10800,similar,0,0
10801,in,0,0
10802,the,0,0
10803,control,0,0
10804,group,0,0
10805,.,0,0
10806,No,0,0
10807,interaction,0,1
10808,was,0,0
10809,found,0,0
10810,between,0,0
10811,aspirin,0,0
10812,and,0,0
10813,the,0,0
10814,most,0,0
10815,used,0,0
10816,antihypertensive,0,0
10817,drug,0,0
10818,classes,0,1
10819,(,0,0
10820,angiotensin,0,0
10821,converting,0,0
10822,enzyme,0,0
10823,inhibitors,0,1
10824,and,0,1
10825,calcium,0,1
10826,antagonists,0,0
10827,),0,0
10828,.,0,0
10829,Despite,0,0
10830,the,0,0
10831,relatively,0,0
10832,small,0,0
10833,sample,0,0
10834,size,0,1
10835,our,0,0
10836,results,0,0
10837,seem,0,0
10838,to,0,0
10839,exclude,0,0
10840,any,0,0
10841,significant,0,0
10842,influence,0,0
10843,of,0,1
10844,low-dose,0,0
10845,aspirin,0,0
10846,on,0,0
10847,BP,1,1
10848,control,1,0
10849,in,0,0
10850,hypertensives,0,0
10851,under,0,0
10852,treatment,0,0
10853,.,0,0
10854,Is,0,0
10855,a,0,0
10856,calculated,0,0
10857,total,0,1
10858,hip,0,1
10859,BMD,0,1
10860,of,0,1
10861,clinical,1,0
10862,use,1,0
10863,?,0,0
10864,The,0,0
10865,diagnosis,0,0
10866,of,0,0
10867,osteoporosis,0,0
10868,is,0,0
10869,based,0,0
10870,on,0,0
10871,bone,0,1
10872,mass,0,1
10873,measurement,0,1
10874,.,0,0
10875,To,0,0
10876,avoid,0,0
10877,the,0,0
10878,errors,0,1
10879,associated,0,0
10880,with,0,0
10881,the,0,0
10882,measurement,0,0
10883,of,0,0
10884,spinal,0,1
10885,bone,0,1
10886,density,0,1
10887,the,0,0
10888,total,0,1
10889,hip,0,0
10890,has,0,0
10891,been,0,0
10892,accepted,0,0
10893,as,0,0
10894,the,0,0
10895,standard,0,0
10896,measurement,0,0
10897,site,0,0
10898,.,0,0
10899,This,0,0
10900,information,0,0
10901,is,0,0
10902,not,0,0
10903,available,0,0
10904,for,0,0
10905,many,0,0
10906,early,0,0
10907,measurements,0,0
10908,.,0,0
10909,We,0,0
10910,have,0,0
10911,assessed,0,0
10912,whether,0,0
10913,it,0,0
10914,is,0,0
10915,possible,0,0
10916,to,0,0
10917,derive,0,0
10918,clinically,0,0
10919,useful,0,0
10920,information,0,1
10921,about,0,0
10922,total,0,1
10923,hip,0,1
10924,bone,0,1
10925,mineral,0,1
10926,density,0,1
10927,(,0,1
10928,BMD,0,1
10929,),0,0
10930,from,0,0
10931,measurements,0,0
10932,at,0,0
10933,other,0,0
10934,hip,0,1
10935,sites,0,0
10936,.,0,0
10937,The,0,0
10938,bone,0,1
10939,mass,0,1
10940,measurements,0,1
10941,of,0,0
10942,46,0,0
10943,patients,0,0
10944,participating,0,0
10945,in,0,0
10946,a,0,0
10947,current,0,0
10948,trial,0,0
10949,of,0,1
10950,therapy,0,0
10951,for,0,0
10952,osteoporosis,0,1
10953,were,0,0
10954,reviewed,0,0
10955,.,0,0
10956,The,0,0
10957,total,1,1
10958,hip,1,1
10959,BMD,1,1
10960,as,0,0
10961,directly,0,0
10962,measured,0,0
10963,was,0,0
10964,compared,0,0
10965,with,0,0
10966,that,0,0
10967,obtained,0,0
10968,from,0,0
10969,the,0,0
10970,formula,0,0
10971,:,0,0
10972,Total,1,1
10973,hip,1,0
10974,BMD,1,1
10975,=,0,0
10976,0.48,0,0
10977,x,0,0
10978,Neck,1,0
10979,BMD,1,1
10980,+,0,0
10981,0.62,0,0
10982,x,0,0
10983,Trochanteric,1,0
10984,BMD,1,1
10985,+,0,0
10986,0.03,0,0
10987,.,0,0
10988,In,0,0
10989,30,0,0
10990,patients,0,0
10991,with,0,0
10992,follow-up,0,0
10993,data,0,0
10994,the,0,0
10995,rate,1,1
10996,of,1,0
10997,change,1,1
10998,in,1,0
10999,hip,1,1
11000,BMD,1,1
11001,over,0,0
11002,a,0,0
11003,year,0,0
11004,was,0,0
11005,also,0,0
11006,determined,0,0
11007,by,0,0
11008,both,0,0
11009,methods,0,0
11010,.,0,0
11011,In,0,0
11012,the,0,0
11013,pretreatment,0,0
11014,state,0,1
11015,there,0,0
11016,was,0,0
11017,good,0,0
11018,agreement,1,0
11019,between,0,0
11020,the,0,0
11021,two,0,0
11022,measures,0,0
11023,(,0,0
11024,r2,0,0
11025,=,0,0
11026,0.96,0,0
11027,",",0,0
11028,SEE,0,0
11029,0.012,0,0
11030,g/cm2,0,0
11031,),0,0
11032,.,0,0
11033,If,0,0
11034,the,0,0
11035,formula,0,0
11036,was,0,0
11037,used,0,0
11038,to,0,0
11039,compute,0,0
11040,a,0,0
11041,change,1,1
11042,in,1,0
11043,total,1,1
11044,hip,1,1
11045,BMD,1,1
11046,",",0,0
11047,the,0,0
11048,agreement,1,0
11049,between,0,0
11050,both,0,0
11051,methods,0,0
11052,remained,0,0
11053,good,0,0
11054,.,0,0
11055,However,0,0
11056,",",0,0
11057,the,0,0
11058,standard,1,0
11059,error,1,0
11060,of,1,0
11061,the,1,0
11062,estimate,1,0
11063,of,1,0
11064,the,1,0
11065,change,1,0
11066,represented,0,0
11067,59,0,0
11068,%,0,0
11069,of,0,0
11070,the,0,0
11071,observed,0,0
11072,change,0,0
11073,.,0,0
11074,This,0,0
11075,indicates,0,0
11076,that,0,0
11077,the,0,0
11078,error,1,1
11079,associated,1,0
11080,with,1,0
11081,this,1,0
11082,estimate,1,0
11083,is,0,0
11084,too,0,0
11085,great,0,0
11086,to,0,0
11087,allow,0,0
11088,clinically,0,0
11089,meaningful,0,0
11090,conclusions,0,0
11091,to,0,0
11092,be,0,0
11093,drawn,0,0
11094,from,0,0
11095,calculated,1,0
11096,total,1,1
11097,hip,1,0
11098,BMD,1,1
11099,.,1,0
11100,We,0,0
11101,conclude,0,0
11102,that,0,0
11103,",",0,0
11104,whilst,0,0
11105,it,0,0
11106,may,0,0
11107,be,0,0
11108,possible,0,0
11109,to,0,0
11110,obtain,0,0
11111,reasonable,0,0
11112,point,0,0
11113,estimates,0,0
11114,of,0,1
11115,total,1,1
11116,hip,1,1
11117,BMD,1,1
11118,from,0,0
11119,other,0,0
11120,measures,0,0
11121,in,0,0
11122,the,0,0
11123,hip,0,0
11124,",",0,0
11125,these,0,0
11126,estimates,0,0
11127,are,0,0
11128,too,0,0
11129,imprecise,0,0
11130,to,0,0
11131,allow,0,0
11132,conclusions,0,0
11133,about,0,0
11134,change,1,1
11135,in,1,0
11136,BMD,1,1
11137,to,0,0
11138,be,0,0
11139,made,0,0
11140,.,0,0
11141,Randomized,0,0
11142,trial,0,0
11143,of,0,1
11144,intensive,0,0
11145,early,0,0
11146,intervention,0,0
11147,for,0,0
11148,children,0,0
11149,with,0,0
11150,pervasive,0,0
11151,developmental,0,1
11152,disorder,0,0
11153,.,0,0
11154,Young,0,0
11155,children,0,0
11156,with,0,0
11157,pervasive,0,0
11158,developmental,0,1
11159,disorder,0,0
11160,were,0,0
11161,randomly,0,0
11162,assigned,0,0
11163,to,0,0
11164,intensive,0,0
11165,treatment,0,0
11166,or,0,1
11167,parent,0,1
11168,training,0,0
11169,.,0,0
11170,The,0,0
11171,intensive,0,0
11172,treatment,0,0
11173,group,0,0
11174,(,0,0
11175,7,0,0
11176,with,0,0
11177,autism,0,0
11178,",",0,0
11179,8,0,0
11180,with,0,0
11181,pervasive,0,0
11182,developmental,0,1
11183,disorder,0,0
11184,not,0,0
11185,otherwise,0,0
11186,specified,0,0
11187,--,0,0
11188,NOS,0,0
11189,),0,0
11190,averaged,0,0
11191,24.52,0,0
11192,hours,0,0
11193,per,0,0
11194,week,0,0
11195,of,0,1
11196,individual,0,0
11197,treatment,0,0
11198,for,0,0
11199,one,0,0
11200,year,0,0
11201,",",0,0
11202,gradually,0,0
11203,reducing,0,0
11204,hours,0,0
11205,over,0,0
11206,the,0,0
11207,next,0,0
11208,1,0,0
11209,to,0,0
11210,2,0,0
11211,years,0,0
11212,.,0,0
11213,The,0,0
11214,parent,0,1
11215,training,0,0
11216,group,0,0
11217,(,0,0
11218,7,0,0
11219,with,0,0
11220,autism,0,0
11221,",",0,0
11222,6,0,0
11223,with,0,0
11224,pervasive,0,0
11225,developmental,0,1
11226,disorder,0,0
11227,NOS,0,1
11228,),0,0
11229,received,0,0
11230,3,0,0
11231,to,0,0
11232,9,0,0
11233,months,0,0
11234,of,0,0
11235,parent,0,1
11236,training,0,0
11237,.,0,0
11238,The,0,0
11239,groups,0,0
11240,appeared,0,0
11241,similar,0,0
11242,at,0,0
11243,intake,0,1
11244,on,0,0
11245,all,0,0
11246,measures,0,0
11247,;,0,0
11248,however,0,0
11249,",",0,0
11250,at,0,0
11251,follow-up,0,0
11252,the,0,0
11253,intensive,0,0
11254,treatment,0,0
11255,group,0,0
11256,outperformed,0,0
11257,the,0,0
11258,parent,0,1
11259,training,0,0
11260,group,0,0
11261,on,0,0
11262,measures,0,1
11263,of,0,1
11264,intelligence,1,1
11265,",",1,0
11266,visual-spatial,1,1
11267,skills,1,1
11268,",",1,1
11269,language,1,1
11270,",",1,1
11271,and,1,1
11272,academics,1,0
11273,",",0,1
11274,though,0,0
11275,not,0,0
11276,adaptive,1,1
11277,functioning,1,1
11278,or,1,1
11279,behavior,1,1
11280,problems,1,1
11281,.,1,0
11282,Children,0,0
11283,with,0,0
11284,pervasive,0,0
11285,developmental,0,1
11286,disorder,0,0
11287,NOS,0,0
11288,may,0,0
11289,have,0,0
11290,gained,0,0
11291,more,0,0
11292,than,0,0
11293,those,0,0
11294,with,0,0
11295,autism,0,0
11296,.,0,0
11297,VLDL,1,0
11298,",",1,0
11299,apolipoproteins,1,1
11300,B,1,1
11301,",",1,1
11302,CIII,1,1
11303,",",1,1
11304,and,1,1
11305,E,1,1
11306,",",0,1
11307,and,0,1
11308,risk,0,1
11309,of,0,1
11310,recurrent,1,1
11311,coronary,1,0
11312,events,1,1
11313,in,0,0
11314,the,0,0
11315,Cholesterol,0,1
11316,and,0,1
11317,Recurrent,0,1
11318,Events,0,1
11319,(,0,1
11320,CARE,0,0
11321,),0,0
11322,trial,0,0
11323,.,0,0
11324,BACKGROUND,0,0
11325,Plasma,0,1
11326,triglyceride,0,1
11327,concentration,0,1
11328,has,0,0
11329,been,0,0
11330,an,0,0
11331,inconsistent,0,0
11332,independent,0,0
11333,risk,0,1
11334,factor,0,1
11335,for,0,0
11336,coronary,0,1
11337,heart,0,1
11338,disease,0,1
11339,",",0,0
11340,perhaps,0,0
11341,because,0,0
11342,of,0,0
11343,the,0,0
11344,metabolic,0,1
11345,heterogeneity,0,1
11346,among,0,0
11347,VLDL,0,0
11348,particles,0,0
11349,",",0,0
11350,the,0,0
11351,main,0,1
11352,carriers,0,0
11353,of,0,0
11354,triglycerides,0,1
11355,in,0,0
11356,plasma,0,1
11357,.,0,1
11358,METHODS,0,0
11359,AND,0,0
11360,RESULTS,0,0
11361,We,0,0
11362,conducted,0,0
11363,a,0,0
11364,prospective,0,0
11365,",",0,0
11366,nested,0,0
11367,case-control,0,0
11368,study,0,0
11369,in,0,0
11370,the,0,0
11371,Cholesterol,0,1
11372,and,0,1
11373,Recurrent,0,1
11374,Events,0,1
11375,(,0,1
11376,CARE,0,0
11377,),0,1
11378,trial,0,0
11379,",",0,0
11380,a,0,0
11381,randomized,0,0
11382,placebo-controlled,0,0
11383,trial,0,0
11384,of,0,1
11385,pravastatin,0,0
11386,in,0,0
11387,4159,0,0
11388,patients,0,0
11389,with,0,0
11390,myocardial,0,1
11391,infarction,0,1
11392,and,0,1
11393,average,0,1
11394,LDL,0,1
11395,concentrations,0,1
11396,at,0,0
11397,baseline,0,0
11398,(,0,0
11399,115,0,0
11400,to,0,0
11401,174,0,0
11402,mg/dL,0,0
11403,",",0,0
11404,mean,0,0
11405,139,0,0
11406,mg/dL,0,0
11407,),0,0
11408,.,0,0
11409,Baseline,0,0
11410,concentrations,0,1
11411,of,0,1
11412,VLDL-apolipoprotein,1,1
11413,(,0,1
11414,apo,0,1
11415,),0,1
11416,B,1,0
11417,(,1,0
11418,the,1,0
11419,VLDL,1,0
11420,particle,1,1
11421,concentration,1,1
11422,),1,1
11423,",",1,0
11424,VLDL,1,1
11425,lipids,1,1
11426,",",0,1
11427,and,0,1
11428,apoCIII,1,1
11429,and,1,1
11430,apoE,1,1
11431,in,1,0
11432,VLDL+LDL,1,0
11433,and,1,1
11434,in,1,0
11435,HDL,1,1
11436,were,0,0
11437,compared,0,0
11438,in,0,0
11439,patients,0,0
11440,who,0,0
11441,had,0,0
11442,either,0,0
11443,a,0,0
11444,myocardial,0,1
11445,infarction,0,1
11446,or,0,1
11447,coronary,0,1
11448,death,0,1
11449,(,0,1
11450,cases,0,0
11451,",",0,1
11452,n=418,0,0
11453,),0,0
11454,with,0,0
11455,those,0,0
11456,in,0,0
11457,patients,0,0
11458,who,0,0
11459,did,0,0
11460,not,0,0
11461,have,0,0
11462,a,0,0
11463,cardiovascular,0,1
11464,event,0,1
11465,(,0,0
11466,control,0,0
11467,subjects,0,0
11468,",",0,1
11469,n=370,0,0
11470,),0,0
11471,in,0,0
11472,5,0,0
11473,years,0,0
11474,of,0,0
11475,follow-up,0,0
11476,.,0,1
11477,VLDL-cholesterol,1,1
11478,",",1,1
11479,VLDL-triglyceride,1,1
11480,",",1,1
11481,VLDL-apoB,1,1
11482,",",1,1
11483,apoCIII,1,1
11484,and,1,1
11485,apoE,1,1
11486,in,1,0
11487,VLDL+LDL,1,0
11488,and,1,1
11489,apoE,1,1
11490,in,1,0
11491,HDL,1,1
11492,were,0,0
11493,all,0,0
11494,interrelated,0,0
11495,",",0,0
11496,and,0,0
11497,each,0,0
11498,was,0,0
11499,a,0,0
11500,univariate,0,0
11501,predictor,0,0
11502,of,0,1
11503,subsequent,0,0
11504,coronary,0,0
11505,events,0,1
11506,.,0,0
11507,The,0,0
11508,significant,0,0
11509,independent,0,0
11510,predictors,0,0
11511,were,0,0
11512,VLDL-apoB,1,1
11513,(,0,1
11514,relative,0,1
11515,risk,0,1
11516,[,0,0
11517,RR,0,0
11518,],0,0
11519,3.2,0,0
11520,for,0,0
11521,highest,0,0
11522,to,0,0
11523,lowest,0,0
11524,quintiles,0,1
11525,",",0,0
11526,P,0,0
11527,:,0,1
11528,=0.04,0,0
11529,),0,1
11530,",",0,0
11531,apoCIII,1,0
11532,in,1,0
11533,VLDL+LDL,1,0
11534,(,0,0
11535,RR,0,1
11536,2.3,0,0
11537,",",0,0
11538,P,0,0
11539,:,0,1
11540,=0.04,0,0
11541,),0,1
11542,",",0,1
11543,and,0,1
11544,apoE,1,1
11545,in,1,1
11546,HDL,1,1
11547,(,0,0
11548,RR,0,1
11549,1.8,0,0
11550,",",0,0
11551,P,0,0
11552,:,0,1
11553,=0.02,0,0
11554,),0,0
11555,.,0,0
11556,Plasma,1,1
11557,triglycerides,1,1
11558,",",0,0
11559,a,0,0
11560,univariate,0,0
11561,predictor,0,0
11562,of,0,1
11563,coronary,1,1
11564,events,1,1
11565,(,0,0
11566,RR,0,0
11567,1.6,0,0
11568,",",0,0
11569,P,0,0
11570,:,0,1
11571,=0.03,0,0
11572,),0,1
11573,",",0,0
11574,was,0,0
11575,not,0,0
11576,related,0,0
11577,to,0,0
11578,coronary,1,0
11579,events,1,1
11580,(,0,0
11581,RR,0,0
11582,1.3,0,0
11583,",",0,0
11584,P,0,0
11585,:,0,1
11586,=0.6,0,0
11587,),0,0
11588,when,0,0
11589,apoCIII,1,0
11590,in,1,0
11591,VLDL+LDL,1,0
11592,was,0,0
11593,included,0,0
11594,in,0,0
11595,the,0,0
11596,model,0,0
11597,",",0,0
11598,whereas,0,0
11599,apoCIII,1,1
11600,remained,0,0
11601,significant,0,0
11602,.,0,0
11603,Adjustment,0,1
11604,for,0,0
11605,LDL-,1,0
11606,and,1,1
11607,HDL-cholesterol,1,1
11608,did,0,0
11609,not,0,0
11610,affect,0,0
11611,these,0,0
11612,results,0,0
11613,.,0,0
11614,CONCLUSIONS,0,0
11615,The,0,0
11616,plasma,0,1
11617,concentrations,0,1
11618,of,0,0
11619,VLDL,1,0
11620,particles,1,1
11621,and,1,1
11622,apoCIII,1,0
11623,in,1,0
11624,VLDL,1,0
11625,and,1,0
11626,LDL,1,1
11627,are,0,0
11628,more,0,0
11629,specific,0,0
11630,measures,0,0
11631,of,0,1
11632,coronary,0,1
11633,heart,0,1
11634,disease,0,1
11635,risk,0,1
11636,than,0,0
11637,plasma,0,1
11638,triglycerides,0,1
11639,perhaps,0,0
11640,because,0,0
11641,their,0,0
11642,known,0,0
11643,metabolic,0,1
11644,properties,0,0
11645,link,0,0
11646,them,0,0
11647,more,0,0
11648,closely,0,1
11649,to,0,0
11650,atherosclerosis,0,1
11651,.,0,0
11652,Efficacy,1,1
11653,and,1,1
11654,safety,1,1
11655,of,0,1
11656,recombinant,0,0
11657,human,0,0
11658,nerve,0,1
11659,growth,0,1
11660,factor,0,1
11661,in,0,0
11662,patients,0,0
11663,with,0,0
11664,diabetic,0,0
11665,polyneuropathy,0,0
11666,:,0,0
11667,A,0,0
11668,randomized,0,0
11669,controlled,0,0
11670,trial,0,0
11671,.,0,0
11672,rhNGF,0,0
11673,Clinical,0,1
11674,Investigator,0,0
11675,Group,0,0
11676,.,0,0
11677,CONTEXT,0,1
11678,Nerve,0,1
11679,growth,0,1
11680,factor,0,0
11681,is,0,0
11682,a,0,0
11683,neurotrophic,0,0
11684,factor,0,0
11685,that,0,0
11686,promotes,0,0
11687,the,0,0
11688,survival,0,1
11689,of,0,0
11690,small,0,0
11691,fiber,0,0
11692,sensory,0,1
11693,neurons,0,1
11694,and,0,1
11695,sympathetic,0,1
11696,neurons,0,1
11697,in,0,0
11698,the,0,0
11699,peripheral,0,1
11700,nervous,0,0
11701,system,0,0
11702,.,0,0
11703,Recombinant,0,0
11704,human,0,0
11705,nerve,0,1
11706,growth,0,1
11707,factor,0,1
11708,(,0,1
11709,rhNGF,0,0
11710,),0,0
11711,has,0,0
11712,demonstrated,0,0
11713,efficacy,0,1
11714,as,0,0
11715,treatment,0,0
11716,for,0,0
11717,peripheral,0,1
11718,neuropathy,0,1
11719,in,0,0
11720,experimental,0,0
11721,models,0,0
11722,and,0,0
11723,phase,0,0
11724,2,0,0
11725,clinical,0,0
11726,trials,0,0
11727,.,0,0
11728,OBJECTIVE,0,0
11729,To,0,0
11730,evaluate,0,0
11731,the,0,0
11732,efficacy,1,1
11733,and,1,1
11734,safety,1,1
11735,of,0,0
11736,a,0,0
11737,12-month,0,0
11738,regimen,0,0
11739,of,0,1
11740,rhNGF,0,0
11741,in,0,0
11742,patients,0,0
11743,with,0,0
11744,diabetic,0,0
11745,polyneuropathy,0,1
11746,.,0,0
11747,DESIGN,0,0
11748,Randomized,0,0
11749,",",0,1
11750,double-blind,0,0
11751,",",0,1
11752,placebo-controlled,0,0
11753,phase,0,0
11754,3,0,0
11755,trial,0,0
11756,conducted,0,0
11757,from,0,0
11758,July,0,0
11759,1997,0,0
11760,through,0,0
11761,May,0,0
11762,1999,0,0
11763,.,0,0
11764,SETTING,0,0
11765,Eighty-four,0,0
11766,outpatient,0,0
11767,centers,0,0
11768,throughout,0,0
11769,the,0,0
11770,United,0,0
11771,States,0,0
11772,.,0,0
11773,PATIENTS,0,0
11774,A,0,0
11775,total,0,0
11776,of,0,0
11777,1019,0,0
11778,men,0,0
11779,and,0,0
11780,women,0,0
11781,aged,0,0
11782,18,0,0
11783,to,0,0
11784,74,0,0
11785,years,0,0
11786,with,0,0
11787,either,0,0
11788,type,0,0
11789,1,0,0
11790,or,0,0
11791,type,0,0
11792,2,0,0
11793,diabetes,0,0
11794,and,0,0
11795,a,0,0
11796,sensory,0,1
11797,polyneuropathy,0,1
11798,attributable,0,0
11799,to,0,0
11800,diabetes,0,0
11801,.,0,0
11802,INTERVENTIONS,0,1
11803,Patients,0,0
11804,were,0,0
11805,randomly,0,0
11806,assigned,0,0
11807,to,0,0
11808,receive,0,0
11809,either,0,0
11810,rhNGF,0,0
11811,",",0,0
11812,0.1,0,0
11813,microg/kg,0,0
11814,(,0,0
11815,n,0,0
11816,=,0,0
11817,504,0,0
11818,),0,0
11819,",",0,0
11820,or,0,1
11821,placebo,0,0
11822,(,0,1
11823,n,0,0
11824,=,0,0
11825,515,0,0
11826,),0,0
11827,by,0,0
11828,subcutaneous,0,0
11829,injection,0,0
11830,3,0,0
11831,times,0,0
11832,per,0,0
11833,week,0,0
11834,for,0,0
11835,48,0,0
11836,weeks,0,0
11837,.,0,0
11838,Patients,0,0
11839,were,0,0
11840,assessed,0,0
11841,at,0,0
11842,baseline,0,0
11843,",",0,0
11844,12,0,0
11845,weeks,0,0
11846,",",0,0
11847,24,0,0
11848,weeks,0,0
11849,",",0,0
11850,and,0,0
11851,48,0,0
11852,weeks,0,0
11853,.,0,0
11854,MAIN,0,0
11855,OUTCOME,0,0
11856,MEASURES,0,0
11857,The,0,0
11858,primary,0,0
11859,outcome,0,1
11860,measure,0,1
11861,was,0,0
11862,a,0,0
11863,change,1,1
11864,in,1,0
11865,neuropathy,1,1
11866,between,1,0
11867,baseline,1,1
11868,and,1,1
11869,week,1,0
11870,48,1,0
11871,",",1,0
11872,demonstrated,1,0
11873,by,1,0
11874,the,1,0
11875,Neuropathy,1,1
11876,Impairment,1,1
11877,Score,1,0
11878,for,0,0
11879,the,0,0
11880,Lower,0,0
11881,Limbs,0,1
11882,",",0,0
11883,compared,0,0
11884,between,0,0
11885,the,0,0
11886,2,0,0
11887,groups,0,0
11888,.,0,0
11889,Secondary,0,0
11890,outcome,0,1
11891,measures,0,1
11892,included,0,0
11893,quantitative,1,0
11894,sensory,1,1
11895,tests,1,1
11896,using,1,0
11897,the,1,0
11898,CASE,1,0
11899,IV,1,1
11900,System,1,1
11901,",",1,0
11902,the,1,0
11903,Neuropathy,1,1
11904,Symptom,1,1
11905,and,1,1
11906,Change,1,1
11907,questionnaire,1,1
11908,",",1,0
11909,the,1,0
11910,Patient,1,1
11911,Benefit,1,1
11912,Questionnaire,1,1
11913,(,1,1
11914,PBQ,1,1
11915,),1,1
11916,",",1,0
11917,and,1,0
11918,a,1,0
11919,global,1,1
11920,symptom,1,1
11921,assessment,1,1
11922,",",1,0
11923,as,1,0
11924,well,1,0
11925,as,1,0
11926,nerve,1,1
11927,conduction,1,1
11928,studies,1,0
11929,and,1,1
11930,occurrence,1,1
11931,of,1,1
11932,new,1,1
11933,plantar,1,1
11934,foot,1,0
11935,ulcers,1,1
11936,.,1,0
11937,Patients,0,0
11938,also,0,0
11939,were,0,0
11940,evaluated,0,0
11941,for,0,0
11942,presence,0,0
11943,of,0,0
11944,adverse,1,1
11945,events,1,1
11946,.,1,0
11947,RESULTS,0,0
11948,Among,0,0
11949,patients,0,0
11950,who,0,0
11951,received,0,0
11952,rhNGF,0,0
11953,",",0,0
11954,418,0,0
11955,(,0,0
11956,83,0,0
11957,%,0,0
11958,),0,0
11959,completed,0,0
11960,the,0,0
11961,regimen,0,0
11962,compared,0,0
11963,with,0,0
11964,461,0,0
11965,(,0,0
11966,90,0,0
11967,%,0,0
11968,),0,0
11969,who,0,0
11970,received,0,0
11971,placebo,0,0
11972,.,0,1
11973,Administration,0,0
11974,of,0,1
11975,rhNGF,0,0
11976,was,0,0
11977,safe,0,1
11978,",",0,0
11979,with,0,0
11980,few,0,0
11981,adverse,1,1
11982,events,1,1
11983,attributed,0,0
11984,to,0,0
11985,treatment,0,0
11986,apart,0,0
11987,from,0,0
11988,injection,0,0
11989,site,1,1
11990,pain/hyperalgesia,1,1
11991,and,1,1
11992,other,1,1
11993,pain,1,1
11994,syndromes,1,0
11995,.,1,0
11996,However,0,0
11997,",",0,0
11998,neither,0,0
11999,the,0,0
12000,primary,0,0
12001,end,0,0
12002,point,0,0
12003,(,0,1
12004,P,0,0
12005,=.25,0,0
12006,),0,1
12007,nor,0,0
12008,most,0,0
12009,of,0,0
12010,the,0,0
12011,secondary,0,0
12012,end,0,0
12013,points,0,0
12014,demonstrated,0,0
12015,a,0,0
12016,significant,0,0
12017,benefit,0,0
12018,of,0,0
12019,rhNGF,0,0
12020,.,0,1
12021,Exceptions,0,0
12022,were,0,0
12023,the,0,0
12024,global,1,1
12025,symptom,1,1
12026,assessment,1,1
12027,(,0,1
12028,P,0,0
12029,=.03,0,0
12030,),0,0
12031,and,0,0
12032,2,0,0
12033,of,0,0
12034,32,0,0
12035,comparisons,0,0
12036,within,0,0
12037,the,0,0
12038,PBQ,0,0
12039,",",0,0
12040,which,0,0
12041,showed,0,0
12042,a,0,0
12043,modest,0,0
12044,but,0,0
12045,significant,0,0
12046,benefit,0,0
12047,of,0,1
12048,rhNGF,0,0
12049,(,0,0
12050,P,0,0
12051,=.05,0,0
12052,for,0,0
12053,severity,0,1
12054,of,0,1
12055,pain,0,1
12056,in,0,0
12057,the,0,0
12058,legs,0,1
12059,and,0,1
12060,P,0,0
12061,=.003,0,0
12062,for,0,0
12063,6-month,0,0
12064,symptoms,0,1
12065,in,0,0
12066,the,0,0
12067,feet,0,1
12068,and,0,1
12069,legs,0,1
12070,),0,0
12071,.,0,0
12072,CONCLUSION,0,0
12073,Unlike,0,1
12074,previous,0,0
12075,phase,0,0
12076,2,0,0
12077,trials,0,0
12078,",",0,0
12079,this,0,0
12080,phase,0,0
12081,3,0,0
12082,clinical,0,0
12083,trial,0,0
12084,failed,0,0
12085,to,0,0
12086,demonstrate,0,0
12087,a,0,0
12088,significant,0,0
12089,beneficial,0,0
12090,effect,0,1
12091,of,0,1
12092,rhNGF,0,0
12093,on,0,0
12094,diabetic,0,0
12095,polyneuropathy,0,1
12096,.,0,0
12097,JAMA,0,1
12098,.,0,0
12099,2000,0,0
12100,;,0,0
12101,284:2215-2221,0,0
12102,.,0,0
12103,Effects,0,0
12104,of,0,0
12105,nicotine,1,0
12106,on,0,0
12107,regional,1,0
12108,cerebral,1,1
12109,glucose,1,1
12110,metabolism,1,1
12111,in,0,0
12112,awake,0,1
12113,resting,0,1
12114,tobacco,0,0
12115,smokers,0,0
12116,.,0,0
12117,Eleven,0,0
12118,healthy,0,0
12119,tobacco,0,0
12120,smoking,0,1
12121,adult,0,0
12122,male,0,0
12123,volunteers,0,0
12124,of,0,1
12125,mixed,0,0
12126,race,0,0
12127,were,0,0
12128,tobacco,0,0
12129,abstinent,0,0
12130,overnight,0,0
12131,for,0,0
12132,this,0,0
12133,study,0,0
12134,.,0,0
12135,In,0,0
12136,each,0,0
12137,subject,0,0
12138,",",0,1
12139,positron,1,0
12140,emission,1,1
12141,tomographic,1,0
12142,images,1,0
12143,of,0,0
12144,regional,0,0
12145,cerebral,1,1
12146,metabolism,1,1
12147,of,1,1
12148,glucose,1,1
12149,with,0,0
12150,[,1,0
12151,18F,1,0
12152,],1,0
12153,fluorodeoxyglucose,1,0
12154,were,0,0
12155,obtained,0,0
12156,in,0,0
12157,two,0,0
12158,conditions,0,0
12159,in,0,0
12160,the,0,0
12161,morning,0,0
12162,on,0,0
12163,different,0,0
12164,days,0,0
12165,:,0,0
12166,about,0,0
12167,3min,0,0
12168,after,0,0
12169,approximately,0,0
12170,1-2mg,0,0
12171,of,0,0
12172,nasal,0,1
12173,nicotine,0,0
12174,spray,0,1
12175,and,0,0
12176,after,0,0
12177,an,0,0
12178,equivalent,0,0
12179,volume,0,1
12180,of,0,0
12181,an,0,0
12182,active,0,0
12183,placebo,0,0
12184,spray,0,0
12185,of,0,1
12186,oleoresin,0,0
12187,of,0,1
12188,pepper,0,0
12189,in,0,0
12190,a,0,0
12191,random,0,0
12192,counterbalanced,0,0
12193,design,0,0
12194,.,0,0
12195,A,0,0
12196,Siemens/CTI,0,1
12197,931/08-12,0,0
12198,scanner,0,0
12199,with,0,0
12200,the,0,0
12201,capability,0,0
12202,of,0,0
12203,15,0,0
12204,horizontal,0,1
12205,brain,0,0
12206,slices,0,1
12207,was,0,0
12208,used,0,0
12209,.,0,0
12210,The,0,0
12211,images,0,0
12212,were,0,0
12213,further,0,0
12214,converted,0,0
12215,into,0,0
12216,a,0,0
12217,standard,0,0
12218,uniform,0,0
12219,brain,0,1
12220,format,0,0
12221,in,0,0
12222,which,0,0
12223,the,0,0
12224,mean,0,1
12225,data,0,0
12226,of,0,0
12227,all,0,0
12228,11,0,0
12229,subjects,0,0
12230,were,0,0
12231,obtained,0,0
12232,.,0,0
12233,Images,0,0
12234,were,0,0
12235,analysed,0,0
12236,in,0,0
12237,stereotactic,0,0
12238,coordinates,0,0
12239,using,0,0
12240,pixel-wise,0,1
12241,t,0,0
12242,statistics,0,1
12243,and,0,0
12244,a,0,0
12245,smoothed,0,1
12246,Gaussian,0,0
12247,model,0,0
12248,.,0,0
12249,Peak,1,1
12250,plasma,1,1
12251,nicotine,1,0
12252,levels,1,1
12253,varied,0,0
12254,three-fold,0,0
12255,and,0,0
12256,the,0,0
12257,areas,0,1
12258,under,0,0
12259,the,0,0
12260,curve,0,1
12261,(,0,0
12262,0-30min,0,1
12263,),0,1
12264,varied,0,0
12265,seven-fold,0,1
12266,among,0,0
12267,the,0,0
12268,individual,0,0
12269,subjects,0,0
12270,.,0,1
12271,Nicotine,0,0
12272,caused,0,0
12273,a,0,0
12274,small,0,0
12275,overall,0,1
12276,reduction,0,1
12277,in,0,0
12278,global,1,1
12279,cerebral,1,1
12280,metabolism,1,1
12281,of,1,1
12282,glucose,1,1
12283,but,0,0
12284,",",0,0
12285,when,0,0
12286,the,0,0
12287,data,0,0
12288,were,0,0
12289,normalized,0,0
12290,",",0,0
12291,several,0,0
12292,brain,0,1
12293,regions,0,1
12294,showed,0,0
12295,relative,0,1
12296,increases,1,1
12297,in,1,0
12298,activity,1,1
12299,.,1,0
12300,Cerebral,0,1
12301,structures,0,0
12302,specifically,0,0
12303,activated,0,0
12304,by,0,0
12305,nicotine,0,0
12306,(,0,0
12307,nicotine,0,0
12308,minus,0,0
12309,pepper,0,1
12310,",",0,1
12311,Z,0,1
12312,score,0,1
12313,>,0,0
12314,4.0,0,0
12315,),0,0
12316,included,0,0
12317,:,0,0
12318,left,0,1
12319,inferior,0,0
12320,frontal,0,1
12321,gyrus,0,1
12322,",",0,1
12323,left,0,1
12324,posterior,0,0
12325,cingulate,0,1
12326,gyrus,0,1
12327,and,0,1
12328,right,0,1
12329,thalamus,0,1
12330,.,0,0
12331,The,0,0
12332,visual,0,1
12333,cortex,0,1
12334,",",0,0
12335,including,0,0
12336,the,0,0
12337,right,0,1
12338,and,0,1
12339,left,0,1
12340,cuneus,0,1
12341,and,0,1
12342,left,0,1
12343,lateral,0,0
12344,occipito-temporal,0,1
12345,gyrus,0,1
12346,fusiformis,0,1
12347,",",0,0
12348,also,0,0
12349,showed,0,0
12350,an,0,0
12351,increase,0,0
12352,in,0,0
12353,regional,1,0
12354,cerebral,1,1
12355,metabolism,1,1
12356,of,1,1
12357,glucose,1,1
12358,with,0,0
12359,Z,0,0
12360,scores,0,1
12361,>,0,0
12362,3,0,0
12363,.,0,0
12364,6,0,0
12365,.,0,0
12366,Structures,0,0
12367,with,0,0
12368,a,0,0
12369,decrease,1,1
12370,in,1,0
12371,regional,1,0
12372,cerebral,1,1
12373,metabolism,1,1
12374,of,1,1
12375,glucose,1,1
12376,(,1,0
12377,pepper,1,1
12378,minus,0,0
12379,nicotine,1,0
12380,),1,0
12381,were,0,0
12382,the,0,0
12383,left,0,1
12384,insula,0,1
12385,and,0,1
12386,right,0,1
12387,inferior,0,1
12388,occipital,0,1
12389,gyrus,0,1
12390,",",0,0
12391,with,0,0
12392,Z,0,1
12393,scores,0,1
12394,>,0,0
12395,3.5,0,0
12396,.,0,0
12397,Especially,0,0
12398,important,0,0
12399,is,0,0
12400,the,0,0
12401,fact,0,0
12402,that,0,0
12403,the,0,0
12404,thalamus,0,1
12405,is,0,0
12406,activated,0,1
12407,by,0,0
12408,nicotine,0,0
12409,.,0,0
12410,This,0,0
12411,is,0,0
12412,consistent,0,0
12413,with,0,0
12414,the,0,0
12415,high,0,0
12416,density,0,1
12417,of,0,1
12418,nicotinic,0,0
12419,cholinoceptors,0,0
12420,in,0,0
12421,that,0,0
12422,brain,0,1
12423,region,0,0
12424,.,0,0
12425,However,0,0
12426,",",0,0
12427,not,0,0
12428,all,0,0
12429,brain,0,1
12430,regions,0,1
12431,affected,0,0
12432,by,0,0
12433,nicotine,0,0
12434,are,0,0
12435,known,0,0
12436,to,0,0
12437,have,0,0
12438,many,0,0
12439,nicotinic,0,0
12440,cholinoceptors,0,0
12441,.,0,0
12442,The,0,0
12443,results,0,0
12444,are,0,0
12445,discussed,0,0
12446,in,0,0
12447,relation,0,0
12448,to,0,0
12449,the,0,0
12450,cognitive,1,1
12451,effects,1,1
12452,of,1,0
12453,nicotine,1,0
12454,.,1,0
12455,Use,0,0
12456,of,0,1
12457,World,0,0
12458,Wide,0,0
12459,Web-based,0,0
12460,directories,0,0
12461,for,0,0
12462,tracing,0,0
12463,subjects,0,0
12464,in,0,0
12465,epidemiologic,0,0
12466,studies,0,0
12467,.,0,0
12468,The,0,0
12469,recent,0,0
12470,availability,0,0
12471,of,0,1
12472,World,0,0
12473,Wide,0,0
12474,Web-based,0,0
12475,directories,0,0
12476,has,0,0
12477,opened,0,0
12478,up,0,0
12479,a,0,0
12480,new,0,0
12481,approach,0,0
12482,for,0,0
12483,tracing,0,0
12484,subjects,0,0
12485,in,0,0
12486,epidemiologic,0,0
12487,studies,0,0
12488,.,0,0
12489,The,0,0
12490,completeness,0,1
12491,of,0,0
12492,two,0,0
12493,World,0,0
12494,Wide,0,0
12495,Web-based,0,0
12496,directories,0,0
12497,(,0,1
12498,Canada411,0,0
12499,and,0,1
12500,InfoSpace,0,1
12501,Canada,0,1
12502,),0,0
12503,for,0,0
12504,subject,0,0
12505,tracing,0,1
12506,was,0,0
12507,evaluated,0,0
12508,by,0,0
12509,using,0,0
12510,a,0,0
12511,randomized,0,0
12512,crossover,0,0
12513,design,0,0
12514,for,0,0
12515,346,0,0
12516,adults,0,0
12517,randomly,0,0
12518,selected,0,0
12519,from,0,0
12520,respondents,0,0
12521,in,0,0
12522,an,0,0
12523,ongoing,0,0
12524,cohort,0,0
12525,study,0,0
12526,.,0,0
12527,About,0,1
12528,half,0,0
12529,(,0,0
12530,56.4,0,0
12531,%,0,0
12532,),0,0
12533,of,0,0
12534,the,0,0
12535,subjects,0,0
12536,were,0,0
12537,successfully,0,0
12538,located,0,0
12539,by,0,0
12540,using,0,0
12541,either,0,0
12542,Canada411,0,0
12543,or,0,1
12544,InfoSpace,0,1
12545,.,0,0
12546,Of,0,0
12547,the,0,0
12548,43.6,0,0
12549,%,0,0
12550,of,0,0
12551,the,0,0
12552,subjects,0,0
12553,who,0,0
12554,could,0,0
12555,not,0,0
12556,be,0,0
12557,located,0,0
12558,using,0,0
12559,either,0,0
12560,directory,0,0
12561,",",0,0
12562,the,0,0
12563,majority,0,0
12564,(,0,0
12565,73.5,0,0
12566,%,0,0
12567,),0,0
12568,were,0,0
12569,female,0,0
12570,.,0,1
12571,Overall,0,1
12572,",",0,0
12573,there,0,0
12574,was,0,0
12575,no,0,0
12576,clear,0,0
12577,advantage,1,0
12578,of,0,0
12579,one,0,0
12580,directory,0,0
12581,over,0,0
12582,the,0,0
12583,other,0,0
12584,.,0,0
12585,Although,0,0
12586,Canada411,0,0
12587,could,0,0
12588,find,1,0
12589,significantly,1,0
12590,more,1,0
12591,subjects,1,0
12592,than,0,0
12593,InfoSpace,0,0
12594,",",0,0
12595,the,0,0
12596,number,1,1
12597,of,1,0
12598,potential,1,0
12599,matches,1,1
12600,returned,0,0
12601,by,0,0
12602,Canada411,0,0
12603,was,0,0
12604,also,0,0
12605,higher,0,0
12606,",",0,1
12607,which,0,0
12608,meant,0,0
12609,that,0,0
12610,a,0,0
12611,longer,0,0
12612,list,0,0
12613,of,0,0
12614,potential,0,0
12615,matches,0,1
12616,had,0,0
12617,to,0,0
12618,be,0,0
12619,examined,0,0
12620,before,0,0
12621,a,0,0
12622,true,0,0
12623,match,0,0
12624,could,0,0
12625,be,0,0
12626,found,0,0
12627,.,0,0
12628,One,0,0
12629,strategy,0,0
12630,to,0,0
12631,minimize,0,0
12632,the,0,0
12633,number,0,1
12634,of,0,0
12635,potential,0,0
12636,matches,0,1
12637,per,0,0
12638,true,0,0
12639,match,0,0
12640,is,0,0
12641,to,0,0
12642,first,0,1
12643,search,0,0
12644,by,0,0
12645,InfoSpace,0,0
12646,with,0,0
12647,the,0,0
12648,last,0,1
12649,name,0,1
12650,and,0,1
12651,first,0,1
12652,name,0,1
12653,",",0,0
12654,then,0,0
12655,by,0,0
12656,Canada411,0,0
12657,with,0,0
12658,the,0,0
12659,last,0,1
12660,name,0,1
12661,and,0,1
12662,first,0,1
12663,name,0,1
12664,",",0,1
12665,and,0,1
12666,finally,0,0
12667,by,0,0
12668,InfoSpace,0,0
12669,with,0,0
12670,the,0,0
12671,last,0,1
12672,name,0,1
12673,and,0,1
12674,first,0,1
12675,initial,0,0
12676,.,0,0
12677,Internet-based,0,0
12678,searches,0,0
12679,represent,0,0
12680,a,0,0
12681,potentially,0,0
12682,useful,0,0
12683,approach,0,0
12684,to,0,0
12685,tracing,0,0
12686,subjects,0,0
12687,in,0,0
12688,epidemiologic,0,0
12689,studies,0,0
12690,.,0,0
12691,Percutaneous,0,0
12692,tracheostomy,0,1
12693,in,0,0
12694,critically,0,0
12695,ill,0,0
12696,patients,0,0
12697,:,0,0
12698,a,0,0
12699,prospective,0,0
12700,",",0,0
12701,randomized,0,0
12702,comparison,0,0
12703,of,0,0
12704,two,0,0
12705,techniques,0,0
12706,.,0,0
12707,OBJECTIVE,0,0
12708,To,0,0
12709,prospectively,0,0
12710,compare,0,0
12711,two,0,0
12712,commonly,0,0
12713,used,0,0
12714,methods,0,0
12715,for,0,0
12716,percutaneous,0,0
12717,dilational,0,1
12718,tracheostomy,0,1
12719,(,0,1
12720,PDT,0,0
12721,),0,0
12722,in,0,0
12723,critically,0,0
12724,ill,0,0
12725,patients,0,0
12726,.,0,0
12727,DESIGN,0,0
12728,Prospective,0,0
12729,",",0,1
12730,randomized,0,0
12731,",",0,1
12732,clinical,0,1
12733,trial,0,0
12734,.,0,1
12735,SETTING,0,0
12736,Trauma,0,1
12737,and,0,1
12738,general,0,1
12739,intensive,0,0
12740,care,0,0
12741,units,0,0
12742,of,0,0
12743,a,0,0
12744,university,0,0
12745,tertiary,0,0
12746,teaching,0,0
12747,hospital,0,1
12748,",",0,0
12749,which,0,0
12750,is,0,0
12751,also,0,0
12752,a,0,0
12753,level,0,0
12754,1,0,0
12755,trauma,0,0
12756,center,0,0
12757,.,0,0
12758,PATIENTS,0,0
12759,One,0,0
12760,hundred,0,0
12761,critically,0,0
12762,ill,0,0
12763,patients,0,0
12764,with,0,0
12765,an,0,0
12766,indication,0,0
12767,for,0,0
12768,PDT,0,0
12769,.,0,0
12770,INTERVENTIONS,0,1
12771,PDT,0,0
12772,with,0,0
12773,the,0,0
12774,Ciaglia,0,0
12775,technique,0,0
12776,using,0,0
12777,the,0,0
12778,Ciaglia,0,0
12779,PDT,0,0
12780,introducer,0,1
12781,set,0,0
12782,and,0,0
12783,the,0,0
12784,Griggs,0,0
12785,technique,0,0
12786,using,0,0
12787,a,0,0
12788,Griggs,0,0
12789,PDT,0,0
12790,kit,0,1
12791,and,0,1
12792,guidewire,0,1
12793,dilating,0,1
12794,forceps,0,0
12795,.,0,1
12796,MEASUREMENTS,0,0
12797,AND,0,0
12798,MAIN,0,1
12799,RESULTS,0,1
12800,Surgical,1,1
12801,time,1,1
12802,",",1,1
12803,difficulties,1,1
12804,",",1,1
12805,and,1,1
12806,surgical,1,1
12807,and,1,1
12808,anesthesia,1,1
12809,complications,1,1
12810,were,0,0
12811,measured,0,0
12812,at,0,0
12813,0-2,0,0
12814,hrs,0,1
12815,",",0,0
12816,24,0,0
12817,hrs,0,1
12818,",",0,0
12819,and,0,0
12820,7,0,0
12821,days,0,0
12822,postprocedure,0,0
12823,.,0,1
12824,Groups,0,1
12825,were,0,0
12826,well,0,1
12827,matched,0,0
12828,",",0,0
12829,and,0,0
12830,there,0,0
12831,were,0,0
12832,no,0,0
12833,differences,0,0
12834,between,0,0
12835,the,0,0
12836,two,0,0
12837,methods,0,0
12838,in,0,0
12839,surgical,1,1
12840,time,1,1
12841,or,0,0
12842,in,0,0
12843,anesthesia,1,0
12844,complications,1,1
12845,.,1,0
12846,Major,1,1
12847,bleeding,1,1
12848,complications,1,1
12849,were,0,0
12850,4.4,0,0
12851,times,0,0
12852,more,0,0
12853,frequent,0,1
12854,with,0,0
12855,the,0,0
12856,Griggs,0,0
12857,PDT,0,0
12858,kit,0,1
12859,.,0,0
12860,With,0,0
12861,the,0,0
12862,Ciaglia,0,0
12863,PDT,0,0
12864,kit,0,1
12865,",",0,0
12866,both,0,0
12867,intraoperative,0,1
12868,and,0,0
12869,at,0,0
12870,2,0,0
12871,and,0,0
12872,24,0,0
12873,hrs,0,1
12874,",",0,0
12875,surgical,1,1
12876,complications,1,1
12877,were,0,0
12878,less,0,0
12879,common,0,1
12880,(,0,1
12881,p,0,0
12882,=,0,0
12883,.023,0,0
12884,),0,0
12885,and,0,0
12886,the,0,0
12887,procedure,0,0
12888,was,0,0
12889,more,0,0
12890,often,0,0
12891,completed,0,0
12892,without,0,0
12893,expert,0,0
12894,assistance,0,1
12895,(,0,0
12896,p,0,0
12897,=,0,0
12898,.013,0,0
12899,),0,0
12900,.,0,0
12901,Tracheostomy,1,1
12902,bleeding,1,1
12903,was,0,0
12904,not,0,0
12905,associated,0,0
12906,with,0,0
12907,either,0,0
12908,anticoagulant,0,1
12909,therapy,0,0
12910,or,0,0
12911,an,0,0
12912,abnormal,0,1
12913,clotting,0,1
12914,profile,0,1
12915,.,0,1
12916,Multivariate,1,1
12917,analysis,1,0
12918,identified,0,0
12919,the,0,0
12920,predictors,0,0
12921,of,0,0
12922,PDT,0,0
12923,complications,0,1
12924,as,0,0
12925,the,0,0
12926,Griggs,0,0
12927,PDT,0,0
12928,kit,0,1
12929,(,0,0
12930,p,0,0
12931,=,0,0
12932,.027,0,0
12933,),0,0
12934,and,0,0
12935,the,0,0
12936,Acute,1,1
12937,Physiology,1,0
12938,and,1,1
12939,Chronic,1,1
12940,Health,1,1
12941,Evaluation,1,1
12942,(,1,1
12943,APACHE,1,1
12944,),1,1
12945,II,1,0
12946,score,1,1
12947,(,0,0
12948,p,0,0
12949,=,0,0
12950,.041,0,0
12951,),0,0
12952,.,0,0
12953,The,0,0
12954,significant,0,0
12955,predictors,0,0
12956,of,0,0
12957,time,0,1
12958,required,0,0
12959,to,0,0
12960,complete,0,1
12961,PDT,0,0
12962,were,0,0
12963,the,0,0
12964,APACHE,1,1
12965,II,1,0
12966,score,1,1
12967,(,0,0
12968,p,0,0
12969,=,0,0
12970,.041,0,0
12971,),0,0
12972,",",0,0
12973,a,0,0
12974,less,0,0
12975,experienced,0,1
12976,operator,0,1
12977,(,0,0
12978,p,0,0
12979,=,0,0
12980,.0001,0,0
12981,),0,1
12982,",",0,0
12983,and,0,0
12984,a,0,0
12985,female,0,0
12986,patient,0,1
12987,(,0,0
12988,p,0,0
12989,=,0,0
12990,.013,0,0
12991,),0,0
12992,.,0,0
12993,CONCLUSIONS,0,0
12994,Patients,0,0
12995,experiencing,0,1
12996,PDT,0,0
12997,with,0,0
12998,the,0,0
12999,Ciaglia,0,0
13000,PDT,0,0
13001,kit,0,1
13002,had,0,0
13003,a,0,0
13004,lower,1,0
13005,surgical,1,1
13006,complication,1,1
13007,rate,1,1
13008,(,0,0
13009,2,0,0
13010,%,0,0
13011,vs.,0,0
13012,25,0,0
13013,%,0,0
13014,),0,0
13015,",",0,0
13016,less,1,0
13017,operative,1,1
13018,and,1,1
13019,postoperative,1,1
13020,bleeding,1,1
13021,",",0,1
13022,and,0,1
13023,less,0,0
13024,overall,1,1
13025,technical,1,1
13026,difficulties,1,1
13027,than,0,0
13028,did,0,0
13029,patients,0,0
13030,undergoing,0,0
13031,PDT,0,0
13032,with,0,0
13033,the,0,0
13034,Griggs,0,0
13035,PDT,0,0
13036,kit,0,1
13037,.,0,1
13038,Ciaglia,0,0
13039,PDT,0,0
13040,is,0,0
13041,",",0,0
13042,therefore,0,0
13043,",",0,0
13044,the,0,0
13045,preferred,0,0
13046,technique,0,0
13047,for,0,0
13048,percutaneous,0,0
13049,tracheostomy,0,1
13050,in,0,0
13051,critically,0,0
13052,ill,0,0
13053,patients,0,0
13054,.,0,0
13055,Oral,0,1
13056,ciprofloxacin,0,0
13057,vs.,0,0
13058,intramuscular,0,0
13059,ceftriaxone,0,0
13060,as,0,0
13061,empiric,0,0
13062,treatment,0,0
13063,of,0,1
13064,acute,0,0
13065,invasive,0,1
13066,diarrhea,0,1
13067,in,0,0
13068,children,0,0
13069,.,0,0
13070,BACKGROUND,0,0
13071,Acute,0,1
13072,invasive,0,1
13073,diarrhea,0,1
13074,is,0,0
13075,a,0,0
13076,potentially,0,0
13077,serious,0,0
13078,condition,0,0
13079,in,0,0
13080,children,0,0
13081,.,0,0
13082,Because,0,0
13083,of,0,0
13084,the,0,0
13085,increasing,0,0
13086,resistance,0,1
13087,of,0,0
13088,enteric,0,1
13089,pathogens,0,1
13090,to,0,0
13091,commonly,0,0
13092,used,0,0
13093,oral,0,0
13094,antibiotics,0,1
13095,",",0,1
13096,intramuscular,0,0
13097,ceftriaxone,0,0
13098,has,0,0
13099,become,0,0
13100,the,0,0
13101,routine,0,0
13102,drug,0,0
13103,in,0,0
13104,the,0,0
13105,treatment,0,0
13106,of,0,0
13107,acute,0,0
13108,invasive,0,1
13109,diarrhea,0,1
13110,requiring,0,0
13111,an,0,0
13112,emergency,0,1
13113,visit,0,1
13114,in,0,0
13115,southern,0,0
13116,Israel,0,0
13117,.,0,0
13118,The,0,0
13119,inconvenience,0,1
13120,of,0,0
13121,this,0,0
13122,parenteral,0,0
13123,regimen,0,0
13124,created,0,0
13125,an,0,0
13126,increased,0,0
13127,need,0,0
13128,for,0,0
13129,oral,0,0
13130,pediatric,0,0
13131,formulations,0,0
13132,for,0,0
13133,the,0,0
13134,treatment,0,0
13135,of,0,0
13136,invasive,0,1
13137,diarrhea,0,1
13138,.,0,0
13139,OBJECTIVES,0,0
13140,To,0,0
13141,evaluate,0,0
13142,the,0,0
13143,efficacy,1,1
13144,and,1,1
13145,safety,1,1
13146,of,0,0
13147,a,0,0
13148,suspension,0,0
13149,formulation,0,0
13150,of,0,1
13151,ciprofloxacin,0,0
13152,in,0,0
13153,the,0,0
13154,treatment,0,0
13155,of,0,0
13156,acute,0,0
13157,invasive,0,1
13158,diarrhea,0,1
13159,in,0,0
13160,infants,0,0
13161,and,0,0
13162,children,0,0
13163,.,0,1
13164,PATIENTS,0,0
13165,AND,0,0
13166,METHODS,0,0
13167,From,0,1
13168,July,0,0
13169,1996,0,0
13170,through,0,0
13171,December,0,0
13172,1997,0,0
13173,",",0,0
13174,201,0,0
13175,evaluable,0,0
13176,children,0,0
13177,ages,0,0
13178,6,0,0
13179,months,0,0
13180,to,0,0
13181,10,0,0
13182,years,0,0
13183,(,0,0
13184,35,0,0
13185,%,0,0
13186,<,0,0
13187,1,0,0
13188,year,0,0
13189,;,0,0
13190,70,0,0
13191,%,0,0
13192,<,0,0
13193,3,0,0
13194,years,0,0
13195,),0,0
13196,presenting,0,1
13197,with,0,0
13198,acute,0,0
13199,invasive,0,1
13200,diarrhea,0,1
13201,at,0,0
13202,the,0,0
13203,Pediatric,0,0
13204,Emergency,0,1
13205,Room,0,1
13206,were,0,0
13207,randomized,0,0
13208,to,0,0
13209,receive,0,0
13210,either,0,0
13211,ciprofloxacin,0,0
13212,suspension,0,0
13213,(,0,0
13214,10,0,0
13215,mg/kg,0,0
13216,twice,0,0
13217,a,0,0
13218,day,0,0
13219,+,0,0
13220,im,0,0
13221,placebo,0,0
13222,;,0,0
13223,n,0,0
13224,=,0,0
13225,95,0,0
13226,),0,0
13227,or,0,0
13228,im,0,0
13229,ceftriaxone,0,0
13230,(,0,0
13231,50,0,0
13232,mg/kg/day,0,0
13233,+,0,0
13234,placebo,0,0
13235,suspension,0,0
13236,;,0,0
13237,n,0,0
13238,=,0,0
13239,106,0,0
13240,),0,0
13241,for,0,0
13242,3,0,0
13243,days,0,0
13244,in,0,0
13245,a,0,0
13246,double,0,0
13247,blind,0,0
13248,manner,0,0
13249,.,0,1
13250,Stool,1,0
13251,cultures,1,1
13252,for,1,0
13253,Shigella,1,1
13254,",",1,1
13255,Salmonella,1,1
13256,",",1,1
13257,Campylobacter,1,1
13258,spp,1,1
13259,.,1,1
13260,and,1,1
13261,diarrheagenic,1,1
13262,Escherichia,1,1
13263,coli,1,0
13264,were,0,0
13265,obtained,0,0
13266,on,0,0
13267,Days,0,0
13268,1,0,0
13269,",",0,0
13270,3,0,0
13271,",",0,0
13272,4,0,0
13273,to,0,0
13274,5,0,0
13275,and,0,0
13276,21,0,0
13277,+/-,0,0
13278,5,0,0
13279,.,0,0
13280,Clinical,1,0
13281,response,1,1
13282,and,1,1
13283,safety,1,1
13284,were,0,0
13285,assessed,0,0
13286,on,0,0
13287,Days,0,0
13288,1,0,0
13289,",",0,0
13290,2,0,0
13291,",",0,0
13292,3,0,0
13293,",",0,0
13294,4,0,0
13295,to,0,0
13296,5,0,0
13297,and,0,0
13298,21,0,0
13299,+/-,0,0
13300,5,0,0
13301,.,0,0
13302,RESULTS,0,0
13303,We,0,0
13304,isolated,0,0
13305,127,0,0
13306,pathogens,0,0
13307,from,0,0
13308,121,0,0
13309,(,0,0
13310,60,0,0
13311,%,0,0
13312,),0,0
13313,patients,0,0
13314,:,0,0
13315,73,0,0
13316,(,0,0
13317,57,0,0
13318,%,0,0
13319,),0,0
13320,Shigella,1,0
13321,;,1,0
13322,23,0,0
13323,(,0,0
13324,18,0,0
13325,%,0,0
13326,),0,0
13327,Salmonella,1,0
13328,;,1,0
13329,18,0,0
13330,(,0,0
13331,14,0,0
13332,%,0,0
13333,),0,0
13334,E.,1,0
13335,coli,1,0
13336,;,1,0
13337,and,0,0
13338,13,0,0
13339,(,0,0
13340,10,0,0
13341,%,0,0
13342,),0,0
13343,Campylobacter,1,1
13344,.,0,0
13345,Overall,1,1
13346,bacteriologic,1,1
13347,eradication,1,1
13348,on,0,0
13349,Day,0,0
13350,4,0,0
13351,to,0,0
13352,5,0,0
13353,was,0,0
13354,99,0,0
13355,%,0,0
13356,for,0,0
13357,Shigella,0,0
13358,",",0,0
13359,77,0,0
13360,%,0,0
13361,for,0,0
13362,Salmonella,0,0
13363,and,0,0
13364,77,0,0
13365,%,0,0
13366,for,0,0
13367,Campylobacter,0,1
13368,",",0,0
13369,with,0,0
13370,no,0,0
13371,difference,0,0
13372,between,0,0
13373,the,0,0
13374,2,0,0
13375,groups,0,0
13376,.,0,0
13377,Clinical,1,1
13378,cure,1,1
13379,or,1,1
13380,improvement,1,1
13381,was,0,0
13382,observed,0,0
13383,in,0,0
13384,100,0,0
13385,and,0,0
13386,99,0,0
13387,%,0,0
13388,of,0,0
13389,the,0,0
13390,ciprofloxacin,0,0
13391,and,0,1
13392,ceftriaxone,0,0
13393,groups,0,0
13394,",",0,0
13395,respectively,0,0
13396,.,0,0
13397,Serum,1,1
13398,ciprofloxacin,1,0
13399,values,1,1
13400,determined,0,0
13401,on,0,0
13402,Day,0,0
13403,3,0,0
13404,of,0,0
13405,the,0,0
13406,treatment,0,0
13407,were,0,0
13408,higher,0,0
13409,in,0,0
13410,the,0,0
13411,majority,0,0
13412,of,0,0
13413,patients,0,0
13414,than,0,0
13415,were,0,0
13416,the,0,0
13417,MIC50,1,0
13418,and,1,1
13419,MIC90,1,1
13420,values,1,1
13421,for,1,0
13422,the,1,0
13423,Shigella,1,0
13424,and,1,1
13425,Salmonella,1,1
13426,spp,1,1
13427,.,1,0
13428,isolated,1,0
13429,.,1,0
13430,Possible,1,0
13431,drug-related,1,1
13432,adverse,1,1
13433,events,1,1
13434,occurred,0,0
13435,in,0,0
13436,13,0,0
13437,patients,0,0
13438,[,0,0
13439,ciprofloxacin,0,0
13440,",",0,0
13441,8,0,0
13442,(,0,0
13443,8,0,0
13444,%,0,0
13445,),0,0
13446,;,0,0
13447,ceftriaxone,0,0
13448,",",0,0
13449,5,0,0
13450,(,0,0
13451,4.7,0,0
13452,%,0,0
13453,),0,0
13454,],0,0
13455,and,0,1
13456,were,0,0
13457,mild,0,1
13458,and,0,1
13459,transient,0,1
13460,.,0,1
13461,Joint,1,1
13462,examination,1,0
13463,was,0,0
13464,normal,0,0
13465,during,0,0
13466,and,0,1
13467,after,0,0
13468,completion,0,1
13469,of,0,1
13470,therapy,0,0
13471,in,0,0
13472,all,0,0
13473,patients,0,0
13474,.,0,0
13475,CONCLUSION,0,0
13476,Oral,0,1
13477,ciprofloxacin,0,1
13478,was,0,0
13479,as,0,0
13480,safe,1,1
13481,and,0,1
13482,effective,1,1
13483,as,0,0
13484,intramuscular,0,0
13485,ceftriaxone,0,0
13486,for,0,0
13487,the,0,0
13488,empiric,0,0
13489,treatment,0,0
13490,of,0,1
13491,acute,0,0
13492,invasive,0,1
13493,diarrhea,0,1
13494,in,0,0
13495,ambulatory,0,0
13496,pediatric,0,0
13497,patients,0,0
13498,requiring,0,0
13499,an,0,0
13500,emergency,0,1
13501,room,0,0
13502,visit,0,1
13503,.,0,0
13504,Cardiovascular,0,1
13505,effects,0,1
13506,of,0,0
13507,tamoxifen,0,0
13508,in,0,0
13509,women,0,0
13510,with,0,0
13511,and,0,0
13512,without,0,0
13513,heart,0,1
13514,disease,0,1
13515,:,0,0
13516,breast,0,0
13517,cancer,0,0
13518,prevention,0,0
13519,trial,0,0
13520,.,0,1
13521,National,0,1
13522,Surgical,0,1
13523,Adjuvant,0,0
13524,Breast,0,1
13525,and,0,1
13526,Bowel,0,1
13527,Project,0,1
13528,Breast,0,1
13529,Cancer,0,0
13530,Prevention,0,0
13531,Trial,0,0
13532,Investigators,0,0
13533,.,0,0
13534,BACKGROUND,0,0
13535,The,0,0
13536,overall,0,1
13537,effect,0,0
13538,of,0,1
13539,prophylactic,0,0
13540,tamoxifen,0,0
13541,in,0,0
13542,women,0,0
13543,depends,0,0
13544,on,0,0
13545,the,0,0
13546,balance,0,1
13547,between,0,0
13548,the,0,0
13549,effects,0,0
13550,of,0,0
13551,the,0,0
13552,drug,0,0
13553,",",0,0
13554,which,0,0
13555,include,0,0
13556,preventing,1,0
13557,breast,1,0
13558,cancer,1,0
13559,and,0,1
13560,altering,0,0
13561,cardiovascular,1,1
13562,risk,1,1
13563,.,1,0
13564,In,0,0
13565,a,0,0
13566,recent,0,0
13567,clinical,0,1
13568,trial,0,0
13569,",",0,1
13570,postmenopausal,0,0
13571,estrogen-progestin,0,0
13572,therapy,0,0
13573,was,0,0
13574,shown,0,0
13575,to,0,0
13576,increase,0,0
13577,the,0,0
13578,risk,0,1
13579,of,0,0
13580,early,1,0
13581,cardiovascular,1,1
13582,events,1,1
13583,among,0,0
13584,women,0,0
13585,with,0,0
13586,a,0,0
13587,history,0,1
13588,of,0,0
13589,coronary,0,1
13590,heart,0,1
13591,disease,0,1
13592,(,0,1
13593,CHD,0,0
13594,),0,0
13595,.,0,0
13596,The,0,0
13597,cardiovascular,1,1
13598,effects,1,1
13599,of,0,0
13600,tamoxifen,0,0
13601,in,0,0
13602,women,0,0
13603,with,0,0
13604,and,0,0
13605,without,0,0
13606,CHD,0,0
13607,are,0,0
13608,not,0,0
13609,known,0,0
13610,.,0,0
13611,The,0,0
13612,National,0,0
13613,Surgical,0,1
13614,Adjuvant,0,0
13615,Breast,0,1
13616,and,0,1
13617,Bowel,0,1
13618,Project,0,1
13619,Breast,0,1
13620,Cancer,0,0
13621,Prevention,0,0
13622,Trial,0,0
13623,(,0,1
13624,BCPT,0,0
13625,),0,0
13626,is,0,0
13627,the,0,0
13628,only,0,0
13629,clinical,0,0
13630,trial,0,0
13631,that,0,0
13632,provides,0,0
13633,data,0,0
13634,to,0,0
13635,assess,0,0
13636,the,0,0
13637,cardiovascular,1,1
13638,effects,1,1
13639,of,0,0
13640,tamoxifen,0,0
13641,in,0,0
13642,women,0,0
13643,with,0,0
13644,and,0,0
13645,without,0,0
13646,CHD,0,0
13647,.,0,0
13648,METHODS,0,0
13649,A,0,0
13650,total,0,1
13651,of,0,0
13652,13,0,0
13653,388,0,0
13654,women,0,0
13655,at,0,0
13656,increased,0,0
13657,risk,0,1
13658,for,0,0
13659,breast,0,0
13660,cancer,0,0
13661,were,0,0
13662,randomly,0,0
13663,assigned,0,0
13664,in,0,0
13665,the,0,0
13666,BCPT,0,0
13667,to,0,0
13668,receive,0,0
13669,either,0,0
13670,tamoxifen,0,0
13671,(,0,0
13672,20,0,0
13673,mg/day,0,0
13674,),0,0
13675,or,0,0
13676,placebo,0,0
13677,.,0,1
13678,Cardiovascular,0,1
13679,follow-up,0,0
13680,was,0,0
13681,available,0,0
13682,for,0,0
13683,13,0,0
13684,194,0,0
13685,women,0,0
13686,",",0,0
13687,1048,0,0
13688,of,0,0
13689,whom,0,0
13690,had,0,0
13691,prior,0,0
13692,clinical,0,0
13693,CHD,0,0
13694,.,0,1
13695,Fatal,1,1
13696,and,1,1
13697,nonfatal,1,1
13698,myocardial,1,1
13699,infarction,1,1
13700,",",1,1
13701,unstable,1,1
13702,angina,1,1
13703,",",1,1
13704,and,1,1
13705,severe,1,1
13706,angina,1,1
13707,were,0,0
13708,tabulated,0,0
13709,(,0,0
13710,mean,0,1
13711,follow-up,0,0
13712,:,0,0
13713,49,0,0
13714,months,0,0
13715,),0,0
13716,.,0,0
13717,All,0,0
13718,statistical,0,0
13719,tests,0,1
13720,were,0,0
13721,two-sided,0,0
13722,.,0,0
13723,RESULTS,0,0
13724,Cardiovascular,1,1
13725,event,1,1
13726,rates,1,1
13727,were,0,0
13728,not,0,0
13729,statistically,0,0
13730,significantly,0,0
13731,different,0,0
13732,between,0,0
13733,women,0,0
13734,assigned,0,0
13735,to,0,0
13736,receive,0,0
13737,tamoxifen,0,0
13738,and,0,0
13739,those,0,0
13740,assigned,0,0
13741,to,0,0
13742,receive,0,0
13743,placebo,0,0
13744,",",0,0
13745,independent,0,1
13746,of,0,1
13747,pre-existing,0,0
13748,CHD,0,0
13749,.,0,0
13750,Among,0,0
13751,women,0,0
13752,without,0,0
13753,CHD,0,0
13754,(,0,0
13755,6074,0,0
13756,on,0,0
13757,tamoxifen,0,0
13758,versus,0,0
13759,6072,0,0
13760,on,0,0
13761,placebo,0,0
13762,),0,1
13763,",",0,0
13764,risk,0,1
13765,ratios,0,1
13766,(,0,0
13767,95,0,0
13768,%,0,0
13769,confidence,0,0
13770,intervals,0,0
13771,[,0,0
13772,CIs,0,1
13773,],0,0
13774,),0,0
13775,for,0,0
13776,tamoxifen,0,0
13777,users,0,0
13778,were,0,0
13779,1.75,0,0
13780,(,0,0
13781,0.44,0,0
13782,to,0,0
13783,8.13,0,0
13784,),0,0
13785,for,0,0
13786,fatal,1,1
13787,myocardial,1,1
13788,infarction,1,1
13789,",",0,0
13790,1.11,0,0
13791,(,0,0
13792,0.55,0,0
13793,to,0,0
13794,2.28,0,0
13795,),0,0
13796,for,0,0
13797,nonfatal,1,1
13798,myocardial,1,1
13799,infarction,1,1
13800,",",0,0
13801,0.69,0,0
13802,(,0,0
13803,0.29,0,0
13804,to,0,0
13805,1.57,0,0
13806,),0,0
13807,for,0,0
13808,unstable,1,1
13809,angina,1,1
13810,",",0,0
13811,and,0,0
13812,0.83,0,0
13813,(,0,0
13814,0.32,0,0
13815,to,0,0
13816,2.10,0,0
13817,),0,0
13818,for,0,0
13819,severe,1,1
13820,angina,1,0
13821,.,1,0
13822,In,0,0
13823,women,0,0
13824,with,0,0
13825,CHD,0,0
13826,(,0,0
13827,516,0,0
13828,on,0,0
13829,tamoxifen,0,0
13830,versus,0,0
13831,532,0,0
13832,on,0,0
13833,placebo,0,0
13834,),0,1
13835,",",0,0
13836,risk,1,1
13837,ratios,1,1
13838,(,0,0
13839,95,0,0
13840,%,0,0
13841,CIs,0,0
13842,),0,0
13843,for,0,0
13844,tamoxifen,0,0
13845,users,0,0
13846,were,0,0
13847,0.00,0,0
13848,(,0,0
13849,0,0,0
13850,to,0,0
13851,1.58,0,0
13852,),0,0
13853,for,0,0
13854,fatal,1,1
13855,myocardial,1,1
13856,infarction,1,1
13857,",",0,0
13858,1.25,0,0
13859,(,0,0
13860,0.32,0,0
13861,to,0,0
13862,5.18,0,0
13863,),0,0
13864,for,0,0
13865,nonfatal,1,1
13866,myocardial,1,1
13867,infarction,1,1
13868,",",0,0
13869,2.26,0,0
13870,(,0,0
13871,0.87,0,0
13872,to,0,0
13873,6.55,0,0
13874,),0,0
13875,for,0,0
13876,unstable,1,1
13877,angina,1,1
13878,",",0,0
13879,and,0,0
13880,1.39,0,0
13881,(,0,0
13882,0.23,0,0
13883,to,0,0
13884,9.47,0,0
13885,),0,0
13886,for,0,0
13887,severe,1,1
13888,angina,1,0
13889,.,1,0
13890,There,0,0
13891,was,0,0
13892,no,0,0
13893,evidence,0,0
13894,that,0,0
13895,the,0,0
13896,lack,0,0
13897,of,0,0
13898,association,0,0
13899,between,0,0
13900,tamoxifen,0,0
13901,and,0,1
13902,cardiovascular,1,1
13903,events,1,1
13904,was,0,0
13905,related,0,0
13906,to,0,0
13907,an,0,0
13908,early,0,0
13909,increase,1,1
13910,in,1,0
13911,risk,1,0
13912,that,0,0
13913,may,0,0
13914,have,0,0
13915,been,0,0
13916,offset,0,0
13917,by,0,0
13918,a,0,0
13919,late,0,1
13920,decrease,0,1
13921,in,0,0
13922,risk,0,1
13923,.,0,0
13924,CONCLUSION,0,0
13925,When,0,0
13926,used,0,0
13927,for,0,0
13928,breast,0,0
13929,cancer,0,0
13930,prevention,0,0
13931,in,0,0
13932,women,0,0
13933,with,0,0
13934,or,0,0
13935,without,0,0
13936,heart,0,1
13937,disease,0,1
13938,",",0,0
13939,tamoxifen,0,0
13940,is,0,0
13941,not,0,0
13942,associated,0,0
13943,with,0,0
13944,beneficial,0,0
13945,or,0,0
13946,adverse,0,1
13947,cardiovascular,1,1
13948,effects,1,0
13949,.,1,0
13950,Sertraline,0,0
13951,treatment,0,0
13952,of,0,0
13953,generalized,1,0
13954,social,1,0
13955,phobia,1,1
13956,:,1,0
13957,a,0,0
13958,20-week,0,0
13959,",",0,0
13960,double-blind,0,0
13961,",",0,1
13962,placebo-controlled,0,0
13963,study,0,0
13964,.,0,0
13965,OBJECTIVE,0,0
13966,The,0,0
13967,authors,0,0
13968,evaluated,0,0
13969,the,0,0
13970,efficacy,1,1
13971,",",1,1
13972,safety,1,1
13973,",",1,1
13974,and,1,1
13975,tolerability,1,1
13976,of,1,1
13977,sertraline,1,0
13978,",",0,0
13979,a,0,0
13980,selective,0,1
13981,serotonin,0,1
13982,reuptake,0,0
13983,inhibitor,0,0
13984,",",0,0
13985,in,0,0
13986,the,0,0
13987,treatment,0,0
13988,of,0,0
13989,generalized,1,0
13990,social,1,1
13991,phobia,1,1
13992,.,1,0
13993,METHOD,0,0
13994,Adult,0,0
13995,outpatients,0,0
13996,with,0,0
13997,generalized,0,0
13998,social,0,1
13999,phobia,0,1
14000,(,0,1
14001,N=204,0,0
14002,),0,0
14003,from,0,0
14004,10,0,0
14005,Canadian,0,0
14006,centers,0,0
14007,were,0,0
14008,randomly,0,0
14009,assigned,0,0
14010,to,0,0
14011,receive,0,0
14012,sertraline,0,0
14013,or,0,1
14014,placebo,0,0
14015,in,0,0
14016,a,0,0
14017,2:1,0,0
14018,ratio,0,0
14019,for,0,0
14020,a,0,0
14021,20-week,0,0
14022,double-blind,0,0
14023,study,0,0
14024,following,0,0
14025,a,0,0
14026,1-week,0,0
14027,",",0,0
14028,single-blind,0,0
14029,",",0,1
14030,placebo,0,0
14031,run-in,0,0
14032,.,0,0
14033,The,0,0
14034,initial,0,0
14035,dose,0,0
14036,of,0,1
14037,sertraline,0,0
14038,was,0,0
14039,50,0,0
14040,mg/day,0,0
14041,with,0,0
14042,increases,0,0
14043,of,0,0
14044,50,0,0
14045,mg/day,0,0
14046,every,0,0
14047,3,0,0
14048,weeks,0,0
14049,permitted,0,0
14050,after,0,0
14051,the,0,0
14052,fourth,0,0
14053,week,0,0
14054,of,0,1
14055,treatment,0,0
14056,(,0,0
14057,dosing,0,0
14058,was,0,0
14059,flexible,0,0
14060,up,0,0
14061,to,0,0
14062,a,0,0
14063,maximum,0,0
14064,of,0,0
14065,200,0,0
14066,mg/day,0,0
14067,),0,0
14068,.,0,0
14069,Primary,0,1
14070,efficacy,1,1
14071,assessments,1,0
14072,were,0,0
14073,the,0,0
14074,percentage,0,1
14075,of,0,0
14076,patients,0,0
14077,rated,0,1
14078,much,0,0
14079,or,0,0
14080,very,0,0
14081,much,0,0
14082,improved,0,0
14083,on,0,0
14084,the,0,0
14085,Clinical,1,1
14086,Global,1,1
14087,Impression,1,1
14088,(,1,1
14089,CGI,1,1
14090,),1,1
14091,improvement,1,1
14092,item,1,1
14093,and,1,0
14094,the,1,0
14095,mean,1,1
14096,changes,1,1
14097,from,1,0
14098,baseline,1,0
14099,to,1,0
14100,study,1,0
14101,endpoint,1,1
14102,in,1,0
14103,total,1,1
14104,score,1,1
14105,on,1,0
14106,the,1,0
14107,social,1,1
14108,phobia,1,1
14109,subscale,1,1
14110,of,1,0
14111,the,1,0
14112,Marks,1,0
14113,Fear,1,1
14114,Questionnaire,1,1
14115,and,1,1
14116,total,1,1
14117,score,1,1
14118,on,1,0
14119,the,1,0
14120,Brief,1,1
14121,Social,1,1
14122,Phobia,1,1
14123,Scale,1,1
14124,.,1,0
14125,RESULTS,0,0
14126,In,0,0
14127,intent-to-treat,0,0
14128,endpoint,0,1
14129,analyses,0,0
14130,of,0,0
14131,203,0,0
14132,of,0,0
14133,the,0,0
14134,patients,0,0
14135,",",0,0
14136,significantly,0,0
14137,more,0,0
14138,of,0,0
14139,the,0,0
14140,134,0,0
14141,patients,0,0
14142,given,0,0
14143,sertraline,0,0
14144,(,0,0
14145,N=71,0,0
14146,[,0,0
14147,53,0,0
14148,%,0,0
14149,],0,0
14150,),0,0
14151,than,0,0
14152,of,0,0
14153,the,0,0
14154,69,0,0
14155,patients,0,0
14156,receiving,0,0
14157,placebo,0,0
14158,(,0,0
14159,N=20,0,0
14160,[,0,0
14161,29,0,0
14162,%,0,0
14163,],0,0
14164,),0,1
14165,were,0,0
14166,considered,0,0
14167,responders,0,0
14168,according,0,0
14169,to,0,0
14170,their,0,0
14171,CGI,1,1
14172,improvement,1,1
14173,scores,1,1
14174,at,0,0
14175,the,0,0
14176,end,0,0
14177,of,0,0
14178,treatment,0,0
14179,.,0,0
14180,The,0,0
14181,mean,0,1
14182,reductions,0,0
14183,in,0,0
14184,the,0,0
14185,social,1,1
14186,phobia,1,1
14187,subscale,1,1
14188,of,1,0
14189,the,1,0
14190,Marks,1,0
14191,Fear,1,1
14192,Questionnaire,1,1
14193,and,0,0
14194,in,0,0
14195,the,0,0
14196,total,1,1
14197,score,1,1
14198,on,1,0
14199,the,1,0
14200,Brief,1,1
14201,Social,1,1
14202,Phobia,1,1
14203,Scale,1,1
14204,were,0,0
14205,32.6,0,0
14206,%,0,0
14207,and,0,0
14208,34.3,0,0
14209,%,0,0
14210,in,0,0
14211,the,0,0
14212,sertraline,0,0
14213,group,0,0
14214,and,0,0
14215,10.8,0,0
14216,%,0,0
14217,and,0,0
14218,18.6,0,0
14219,%,0,0
14220,in,0,0
14221,the,0,0
14222,placebo,0,0
14223,group,0,0
14224,",",0,0
14225,respectively,0,0
14226,.,0,0
14227,Analysis,0,0
14228,of,0,1
14229,covariance,0,1
14230,showed,0,0
14231,superiority,0,0
14232,of,0,1
14233,sertraline,0,0
14234,over,0,0
14235,placebo,0,0
14236,on,0,0
14237,all,0,0
14238,primary,0,0
14239,and,0,1
14240,secondary,0,1
14241,efficacy,1,1
14242,measures,1,1
14243,.,1,1
14244,Sertraline,0,0
14245,was,0,0
14246,well,0,0
14247,tolerated,0,1
14248,:,0,0
14249,103,0,0
14250,(,0,0
14251,76,0,0
14252,%,0,0
14253,),0,0
14254,of,0,0
14255,the,0,0
14256,135,0,0
14257,sertraline-treated,0,0
14258,patients,0,0
14259,and,0,0
14260,54,0,0
14261,(,0,0
14262,78,0,0
14263,%,0,0
14264,),0,0
14265,of,0,0
14266,the,0,0
14267,69,0,0
14268,placebo-treated,0,0
14269,patients,0,0
14270,completed,0,0
14271,the,0,0
14272,study,0,0
14273,.,0,0
14274,CONCLUSIONS,0,0
14275,Sertraline,0,0
14276,is,0,0
14277,an,0,0
14278,effective,0,1
14279,treatment,0,0
14280,for,0,0
14281,patients,0,0
14282,with,0,0
14283,generalized,1,0
14284,social,1,1
14285,phobia,1,1
14286,.,1,0
14287,Counselor,0,0
14288,and,0,1
14289,stimulus,0,1
14290,control,0,0
14291,enhancements,0,1
14292,of,0,0
14293,a,0,0
14294,stage-matched,1,0
14295,expert,1,0
14296,system,1,0
14297,intervention,1,0
14298,for,1,0
14299,smokers,1,0
14300,in,0,0
14301,a,0,0
14302,managed,0,0
14303,care,0,0
14304,setting,0,0
14305,.,0,0
14306,BACKGROUND,0,0
14307,Previous,0,0
14308,research,0,0
14309,has,0,0
14310,demonstrated,0,0
14311,the,0,0
14312,efficacy,1,1
14313,of,0,0
14314,an,0,0
14315,interactive,0,0
14316,expert,0,0
14317,system,0,0
14318,intervention,0,0
14319,for,0,0
14320,smoking,0,1
14321,cessation,0,0
14322,for,0,0
14323,a,0,0
14324,general,0,0
14325,population,0,0
14326,.,0,0
14327,The,0,0
14328,intervention,0,0
14329,provides,0,0
14330,individualized,0,0
14331,feedback,0,0
14332,that,0,0
14333,guides,0,0
14334,participants,0,0
14335,through,0,0
14336,the,0,0
14337,stages,0,0
14338,of,0,0
14339,change,0,1
14340,for,0,0
14341,cessation,0,0
14342,.,0,0
14343,Enhancing,0,0
14344,the,0,0
14345,expert,0,0
14346,system,0,0
14347,by,0,0
14348,adding,0,0
14349,proactive,0,1
14350,telephone,0,0
14351,counseling,0,0
14352,or,0,0
14353,a,0,0
14354,stimulus,0,1
14355,control,0,0
14356,computer,0,0
14357,designed,0,0
14358,to,0,0
14359,produce,0,0
14360,nicotine,0,0
14361,fading,0,1
14362,could,0,0
14363,produce,0,0
14364,preventive,0,0
14365,programs,0,0
14366,with,0,0
14367,greater,0,0
14368,population,0,0
14369,impacts,0,1
14370,.,0,0
14371,METHODS,0,0
14372,Four,0,1
14373,interventions,0,0
14374,were,0,0
14375,compared,0,0
14376,:,0,0
14377,(,0,0
14378,a,0,0
14379,),0,0
14380,the,0,0
14381,interactive,0,0
14382,expert,0,0
14383,system,0,0
14384,intervention,0,0
14385,;,0,1
14386,(,0,0
14387,b,0,1
14388,),0,0
14389,the,0,0
14390,expert,0,0
14391,system,0,0
14392,intervention,0,0
14393,plus,0,0
14394,counselor,0,0
14395,calls,0,1
14396,;,0,0
14397,(,0,0
14398,c,0,0
14399,),0,0
14400,the,0,0
14401,expert,0,0
14402,system,0,0
14403,intervention,0,0
14404,plus,0,0
14405,the,0,0
14406,stimulus,0,1
14407,control,0,0
14408,computer,0,0
14409,;,0,1
14410,and,0,1
14411,(,0,1
14412,d,0,1
14413,),0,0
14414,an,0,0
14415,assessment,0,0
14416,only,0,0
14417,condition,0,0
14418,.,0,0
14419,A,0,0
14420,4,0,0
14421,(,0,0
14422,intervention,0,0
14423,),0,0
14424,x,0,0
14425,4,0,0
14426,(,0,0
14427,occasions,0,0
14428,),0,0
14429,(,0,0
14430,"0,6,12",0,1
14431,",",0,0
14432,and,0,0
14433,18,0,0
14434,months,0,0
14435,),0,0
14436,design,0,0
14437,was,0,0
14438,used,0,0
14439,.,0,0
14440,Smokers,0,0
14441,were,0,0
14442,contacted,0,0
14443,at,0,0
14444,home,0,0
14445,via,0,0
14446,telephone,0,0
14447,or,0,0
14448,mail,0,0
14449,.,0,0
14450,The,0,0
14451,initial,0,0
14452,subject,0,0
14453,pool,0,0
14454,was,0,0
14455,the,0,0
14456,"24,178",0,0
14457,members,0,0
14458,of,0,0
14459,a,0,0
14460,managed,0,0
14461,care,0,0
14462,company,0,0
14463,.,0,1
14464,Screening,0,0
14465,was,0,0
14466,completed,0,0
14467,for,0,0
14468,"19,236",0,0
14469,members,0,0
14470,(,0,0
14471,79.6,0,0
14472,%,0,0
14473,),0,0
14474,",",0,0
14475,of,0,0
14476,whom,0,0
14477,"4,653",0,0
14478,were,0,0
14479,smokers,0,0
14480,;,0,0
14481,85.3,0,0
14482,%,0,0
14483,of,0,0
14484,the,0,0
14485,smokers,0,0
14486,were,0,0
14487,enrolled,0,0
14488,.,0,0
14489,RESULTS,0,0
14490,Thirty-eight,0,0
14491,percent,0,1
14492,were,0,0
14493,in,0,0
14494,the,0,0
14495,precontemplation,0,1
14496,stage,0,0
14497,",",0,0
14498,45,0,0
14499,%,0,0
14500,in,0,0
14501,the,0,0
14502,contemplation,0,1
14503,stage,0,1
14504,",",0,1
14505,and,0,0
14506,only,0,0
14507,17,0,0
14508,%,0,0
14509,in,0,0
14510,the,0,0
14511,preparation,0,0
14512,stage,0,0
14513,.,0,0
14514,At,0,0
14515,18,0,0
14516,months,0,0
14517,",",0,0
14518,the,0,0
14519,expert,0,0
14520,system,0,0
14521,resulted,0,0
14522,in,0,0
14523,23.2,0,0
14524,%,0,0
14525,point,0,0
14526,prevalence,1,1
14527,abstinence,1,1
14528,",",0,1
14529,which,0,0
14530,was,0,0
14531,33,0,0
14532,%,0,0
14533,greater,0,0
14534,than,0,0
14535,that,0,0
14536,of,0,0
14537,assessment,0,0
14538,only,0,0
14539,.,0,0
14540,The,0,0
14541,counselor,0,0
14542,enhancement,0,1
14543,produced,0,0
14544,increased,0,1
14545,cessation,1,0
14546,at,0,0
14547,12,0,0
14548,months,0,0
14549,but,0,0
14550,not,0,0
14551,at,0,0
14552,18,0,0
14553,months,0,0
14554,.,0,0
14555,The,0,0
14556,stimulus,0,1
14557,control,0,0
14558,computer,0,0
14559,produced,0,0
14560,no,0,0
14561,improvement,1,1
14562,",",0,0
14563,resulting,0,0
14564,in,0,0
14565,20,0,0
14566,%,0,0
14567,worse,0,0
14568,cessation,1,1
14569,rates,1,1
14570,than,0,0
14571,the,0,0
14572,assessment,0,0
14573,only,0,0
14574,condition,0,0
14575,.,0,0
14576,CONCLUSIONS,0,0
14577,The,0,0
14578,enhanced,0,0
14579,conditions,0,0
14580,failed,0,0
14581,to,0,0
14582,outperform,1,0
14583,the,0,0
14584,expert,1,0
14585,system,1,0
14586,alone,0,0
14587,.,0,0
14588,The,0,0
14589,study,0,0
14590,also,0,0
14591,demonstrated,0,0
14592,the,0,0
14593,ability,0,1
14594,of,0,0
14595,the,0,0
14596,interactive,0,0
14597,expert,0,0
14598,system,0,0
14599,to,0,0
14600,produce,0,0
14601,significantly,0,0
14602,greater,0,0
14603,cessation,1,0
14604,in,0,0
14605,a,0,0
14606,population,0,0
14607,of,0,0
14608,smokers,0,0
14609,than,0,0
14610,assessment,0,0
14611,alone,0,0
14612,.,0,0
14613,Perioperative,0,0
14614,blood,0,1
14615,transfusions,0,1
14616,",",0,1
14617,with,0,0
14618,or,0,0
14619,without,0,0
14620,allogeneic,0,0
14621,leucocytes,0,1
14622,",",0,0
14623,relate,0,0
14624,to,0,0
14625,survival,1,1
14626,",",0,0
14627,not,0,0
14628,to,0,0
14629,cancer,1,0
14630,recurrence,1,1
14631,.,1,1
14632,BACKGROUND,0,0
14633,Perioperative,0,1
14634,blood,0,1
14635,transfusions,0,1
14636,are,0,0
14637,reported,0,0
14638,to,0,0
14639,be,0,0
14640,related,0,0
14641,to,0,0
14642,cancer,1,0
14643,recurrence,1,1
14644,and,0,1
14645,reduced,1,1
14646,survival,1,1
14647,.,1,0
14648,Different,0,0
14649,underlying,0,0
14650,mechanisms,0,0
14651,have,0,0
14652,been,0,0
14653,proposed,0,0
14654,",",0,0
14655,and,0,1
14656,allogeneic,0,1
14657,leucocytes,0,1
14658,in,0,0
14659,transfused,0,1
14660,blood,0,1
14661,have,0,0
14662,been,0,0
14663,suggested,0,0
14664,to,0,0
14665,contribute,0,0
14666,to,0,0
14667,this,0,0
14668,phenomenon,0,0
14669,.,0,1
14670,METHODS,0,0
14671,Packed,0,0
14672,red,0,1
14673,cells,0,1
14674,without,0,0
14675,buffy,0,0
14676,coat,0,0
14677,(,0,1
14678,PC,0,1
14679,group,0,0
14680,),0,1
14681,were,0,0
14682,compared,0,0
14683,with,0,0
14684,filtered,0,0
14685,",",0,1
14686,leucoreduced,0,1
14687,",",0,1
14688,red,0,1
14689,cells,0,1
14690,(,0,0
14691,LD,0,1
14692,group,0,0
14693,),0,0
14694,in,0,0
14695,a,0,0
14696,randomized,0,0
14697,trial,0,0
14698,of,0,0
14699,697,0,0
14700,patients,0,0
14701,with,0,0
14702,colorectal,0,0
14703,carcinoma,0,0
14704,.,0,1
14705,Five-year,1,0
14706,survival,1,1
14707,and,1,1
14708,cancer,1,1
14709,recurrence,1,1
14710,rates,1,1
14711,were,0,0
14712,determined,0,0
14713,",",0,0
14714,with,0,0
14715,special,0,0
14716,emphasis,0,0
14717,on,0,0
14718,the,0,0
14719,location,1,0
14720,of,1,0
14721,recurrence,1,1
14722,.,1,0
14723,RESULTS,0,0
14724,The,0,0
14725,intention-to-treat,0,0
14726,analysis,0,0
14727,showed,0,0
14728,a,0,0
14729,survival,1,1
14730,rate,1,1
14731,of,0,0
14732,63.6,0,0
14733,per,0,0
14734,cent,0,0
14735,in,0,0
14736,the,0,0
14737,PC,0,1
14738,group,0,0
14739,and,0,0
14740,65.3,0,0
14741,per,0,0
14742,cent,0,0
14743,in,0,0
14744,the,0,0
14745,LD,0,0
14746,group,0,0
14747,(,0,0
14748,P,0,0
14749,=,0,0
14750,0.69,0,0
14751,),0,0
14752,",",0,0
14753,with,0,0
14754,recurrence,1,1
14755,rates,1,1
14756,of,0,0
14757,27.8,0,0
14758,and,0,0
14759,27.9,0,0
14760,per,0,0
14761,cent,0,0
14762,respectively,0,0
14763,.,0,0
14764,The,0,0
14765,observational,0,0
14766,analysis,0,0
14767,showed,0,0
14768,a,0,0
14769,significant,0,0
14770,difference,1,0
14771,in,1,0
14772,survival,1,1
14773,between,0,0
14774,transfused,0,1
14775,and,0,0
14776,non-transfused,0,0
14777,patients,0,0
14778,(,0,0
14779,59.6,0,0
14780,versus,0,0
14781,72.9,0,0
14782,per,0,0
14783,cent,0,0
14784,;,0,0
14785,P,0,0
14786,<,0,0
14787,0.001,0,0
14788,),0,0
14789,.,0,0
14790,The,0,0
14791,difference,1,0
14792,in,1,0
14793,cancer,1,0
14794,recurrence,1,1
14795,rate,1,1
14796,between,0,0
14797,transfused,0,1
14798,and,0,0
14799,non-transfused,0,0
14800,patients,0,0
14801,was,0,0
14802,not,0,0
14803,statistically,0,0
14804,significant,0,0
14805,(,0,0
14806,29.8,0,0
14807,versus,0,0
14808,24.3,0,0
14809,per,0,0
14810,cent,0,0
14811,;,0,0
14812,P,0,0
14813,=,0,0
14814,0.13,0,0
14815,),0,0
14816,.,0,0
14817,Local,1,1
14818,recurrences,1,1
14819,were,0,0
14820,more,0,0
14821,frequent,0,1
14822,in,0,0
14823,transfused,0,1
14824,than,0,0
14825,non-transfused,0,0
14826,patients,0,0
14827,(,0,0
14828,11.9,0,0
14829,versus,0,0
14830,7.6,0,0
14831,per,0,0
14832,cent,0,0
14833,;,0,0
14834,P,0,0
14835,=,0,0
14836,0.09,0,0
14837,),0,0
14838,.,0,0
14839,CONCLUSION,0,0
14840,Leucocyte,0,1
14841,depletion,0,1
14842,of,0,1
14843,perioperative,0,1
14844,transfused,0,1
14845,blood,0,1
14846,has,0,0
14847,no,0,0
14848,effect,0,0
14849,on,0,0
14850,long-term,1,1
14851,survival,1,1
14852,and/or,1,0
14853,cancer,1,0
14854,recurrence,1,1
14855,.,1,1
14856,Perioperative,0,0
14857,blood,0,1
14858,transfusions,0,1
14859,are,0,0
14860,associated,0,0
14861,with,0,0
14862,impaired,0,1
14863,survival,0,1
14864,",",0,1
14865,but,0,0
14866,not,0,0
14867,with,0,0
14868,cancer,0,0
14869,recurrence,0,1
14870,.,0,0
14871,The,0,0
14872,slight,0,1
14873,increase,0,0
14874,in,0,0
14875,local,0,0
14876,recurrence,1,1
14877,rate,1,1
14878,in,0,0
14879,transfused,0,1
14880,patients,0,0
14881,appears,0,0
14882,to,0,0
14883,be,0,0
14884,related,0,0
14885,to,0,0
14886,complicated,0,0
14887,",",0,0
14888,in,0,0
14889,particular,0,0
14890,rectal,0,1
14891,",",0,0
14892,surgery,0,0
14893,.,0,0
14894,Spatial,0,1
14895,orientation,0,1
14896,adjustments,0,0
14897,in,0,0
14898,children,0,0
14899,with,0,0
14900,autism,0,0
14901,in,0,0
14902,Hong,0,0
14903,Kong,0,0
14904,.,0,0
14905,Abnormal,0,1
14906,spatial,1,1
14907,orientation,1,1
14908,and,1,1
14909,body,1,1
14910,postures,1,1
14911,in,0,0
14912,children,0,0
14913,with,0,0
14914,autism,0,0
14915,often,0,0
14916,interfere,0,0
14917,with,0,0
14918,visual,0,1
14919,abilities,0,1
14920,to,0,0
14921,attend,0,0
14922,tasks,0,1
14923,and,0,1
14924,social,0,1
14925,interactions,0,1
14926,.,0,0
14927,Twenty-four,0,0
14928,children,0,0
14929,diagnosed,0,0
14930,with,0,0
14931,autism,0,0
14932,from,0,0
14933,Kowloon,0,1
14934,",",0,0
14935,Hong,0,0
14936,Kong,0,0
14937,were,0,0
14938,assessed,0,0
14939,for,0,0
14940,spatial,1,1
14941,orientation,1,1
14942,and,0,1
14943,spatial,1,1
14944,management,1,0
14945,abilities,0,1
14946,.,0,0
14947,Positive,1,1
14948,changes,1,1
14949,in,0,0
14950,spatial,1,1
14951,orientation,1,1
14952,were,0,0
14953,evident,0,0
14954,when,0,0
14955,the,0,0
14956,children,0,0
14957,wore,0,0
14958,ambient,0,0
14959,prism,0,1
14960,lenses,0,1
14961,and,0,1
14962,included,0,0
14963,changes,1,1
14964,in,1,0
14965,posture,1,1
14966,from,0,0
14967,slanted,0,0
14968,to,0,0
14969,erect,0,0
14970,.,0,0
14971,Adjustments,0,1
14972,in,0,0
14973,spatial,1,1
14974,management,1,0
14975,were,0,0
14976,evident,0,0
14977,in,0,0
14978,improved,0,1
14979,ball,0,1
14980,catching,1,1
14981,ability,1,1
14982,",",0,0
14983,a,0,0
14984,task,0,1
14985,requiring,0,0
14986,visual,0,1
14987,tracking,0,1
14988,and,0,1
14989,eye-hand,0,1
14990,coordination,0,1
14991,.,0,0
14992,The,0,0
14993,findings,0,0
14994,suggest,0,0
14995,that,0,0
14996,alterations,0,0
14997,to,0,0
14998,the,0,0
14999,sensory,0,0
15000,systems,0,0
15001,may,0,0
15002,lead,0,0
15003,to,0,0
15004,behavioral,0,1
15005,change,0,1
15006,in,0,0
15007,some,0,0
15008,children,0,0
15009,.,0,0
15010,Comparison,0,0
15011,of,0,0
15012,the,0,0
15013,efficacy,0,1
15014,of,0,0
15015,fluoxetine,0,0
15016,alone,0,0
15017,vs.,0,0
15018,fluoxetine,0,0
15019,plus,0,0
15020,local,0,1
15021,lidocaine,0,0
15022,ointment,0,0
15023,in,0,0
15024,the,0,0
15025,treatment,0,0
15026,of,0,0
15027,premature,0,0
15028,ejaculation,0,1
15029,.,0,0
15030,OBJECTIVE,0,0
15031,The,0,0
15032,present,0,0
15033,study,0,0
15034,compares,0,0
15035,the,0,0
15036,efficacy,0,1
15037,and,0,1
15038,side,0,1
15039,effects,0,1
15040,of,0,0
15041,fluoxetine,0,0
15042,alone,0,0
15043,vs.,0,0
15044,fluoxetine,0,0
15045,plus,0,0
15046,local,0,1
15047,lidocaine,0,0
15048,ointment,0,0
15049,in,0,0
15050,the,0,0
15051,treatment,0,0
15052,of,0,0
15053,premature,0,0
15054,ejaculation,0,1
15055,.,0,0
15056,METHODS,0,0
15057,Forty-three,0,0
15058,patients,0,0
15059,suffering,0,0
15060,from,0,0
15061,premature,0,0
15062,ejaculation,0,1
15063,were,0,0
15064,studied,0,0
15065,.,0,0
15066,The,0,0
15067,exclusion,0,0
15068,criteria,0,0
15069,were,0,0
15070,erectile,0,1
15071,dysfunction,0,1
15072,",",0,1
15073,loss,0,1
15074,of,0,1
15075,libido,0,1
15076,",",0,1
15077,alcohol,0,1
15078,and,0,1
15079,substance,0,1
15080,abuse,0,1
15081,",",0,1
15082,mental,0,1
15083,retardation,0,0
15084,",",0,0
15085,diabetes,0,1
15086,mellitus,0,0
15087,",",0,1
15088,thyroid,0,1
15089,disease,0,1
15090,",",0,1
15091,hypotension,0,1
15092,",",0,1
15093,previous,0,0
15094,use,0,0
15095,of,0,0
15096,these,0,0
15097,drugs,0,0
15098,and,0,1
15099,urogenital,0,1
15100,infections,0,1
15101,.,0,0
15102,The,0,0
15103,patients,0,0
15104,',0,1
15105,ages,0,0
15106,ranged,0,0
15107,from,0,0
15108,19,0,0
15109,to,0,0
15110,48,0,0
15111,years,0,0
15112,(,0,0
15113,mean,0,1
15114,age,0,0
15115,28,0,0
15116,+/-,0,0
15117,1.6,0,0
15118,),0,0
15119,.,0,0
15120,They,0,0
15121,had,0,0
15122,regular,0,0
15123,sexual,0,1
15124,lives,0,1
15125,.,0,0
15126,They,0,0
15127,had,0,0
15128,normal,0,0
15129,psychiatric,0,1
15130,consultation,0,1
15131,and,0,0
15132,the,0,0
15133,Glombock,1,1
15134,Rast,1,0
15135,Sexual,1,1
15136,Satisfactory,1,1
15137,Test,1,1
15138,(,1,1
15139,GRISS,1,1
15140,),1,1
15141,psychiatric,1,1
15142,test,1,1
15143,were,0,0
15144,in,0,0
15145,accordance,0,0
15146,with,0,0
15147,premature,0,0
15148,ejaculation,0,1
15149,.,0,0
15150,RESULTS,0,0
15151,The,0,0
15152,patients,0,0
15153,were,0,0
15154,assigned,0,0
15155,to,0,0
15156,two,0,0
15157,groups,0,0
15158,.,0,0
15159,Twenty-six,0,0
15160,patients,0,0
15161,",",0,0
15162,aged,0,0
15163,21,0,0
15164,to,0,0
15165,36,0,0
15166,years,0,0
15167,(,0,0
15168,mean,0,1
15169,age,0,0
15170,27,0,0
15171,),0,0
15172,",",0,0
15173,received,0,0
15174,only,0,0
15175,fluoxetine,0,0
15176,20,0,0
15177,mg/day,0,0
15178,(,0,0
15179,1,0,0
15180,capsule,0,0
15181,),0,0
15182,for,0,0
15183,a,0,0
15184,week,0,0
15185,which,0,0
15186,was,0,0
15187,later,0,0
15188,increased,0,0
15189,to,0,0
15190,40,0,0
15191,mg/day,0,0
15192,(,0,0
15193,2,0,0
15194,capsules,0,0
15195,),0,0
15196,.,0,0
15197,Seventeen,0,1
15198,patients,0,0
15199,",",0,0
15200,aged,0,0
15201,19,0,0
15202,to,0,0
15203,48,0,0
15204,years,0,0
15205,(,0,0
15206,mean,0,1
15207,age,0,0
15208,31,0,0
15209,),0,0
15210,",",0,0
15211,were,0,0
15212,given,0,0
15213,fluoxetine,0,0
15214,20,0,0
15215,mg/day,0,0
15216,plus,0,0
15217,local,0,1
15218,application,0,0
15219,of,0,1
15220,lidocaine,0,0
15221,ointment,0,0
15222,.,0,0
15223,The,0,0
15224,patients,0,0
15225,and,0,1
15226,partners,0,1
15227,were,0,0
15228,re-evaluated,0,0
15229,8,0,0
15230,weeks,0,0
15231,after,0,0
15232,the,0,0
15233,treatment,0,0
15234,.,0,0
15235,The,0,0
15236,results,0,0
15237,were,0,0
15238,classified,0,0
15239,as,0,0
15240,unsuccessful,1,0
15241,",",1,1
15242,improvement,1,1
15243,and,1,1
15244,cure,1,1
15245,.,1,0
15246,The,0,0
15247,chi-square,1,0
15248,test,1,1
15249,was,0,0
15250,used,0,0
15251,for,0,0
15252,statistical,0,0
15253,analysis,0,0
15254,.,0,0
15255,In,0,0
15256,the,0,0
15257,fluoxetine,0,0
15258,group,0,0
15259,",",0,0
15260,8,0,0
15261,(,0,0
15262,30.8,0,0
15263,%,0,0
15264,),0,0
15265,patients,0,0
15266,cured,1,0
15267,",",0,0
15268,11,0,0
15269,(,0,0
15270,42.2,0,0
15271,%,0,0
15272,),0,0
15273,showed,0,0
15274,improvement,1,1
15275,and,0,1
15276,there,0,0
15277,were,0,0
15278,7,0,0
15279,failures,1,1
15280,(,0,0
15281,26.9,0,0
15282,%,0,0
15283,),0,0
15284,.,0,0
15285,In,0,0
15286,the,0,0
15287,combination,0,0
15288,treatment,0,0
15289,group,0,0
15290,",",0,0
15291,9,0,0
15292,(,0,0
15293,52.9,0,0
15294,%,0,0
15295,),0,0
15296,patients,0,0
15297,cured,0,0
15298,",",0,0
15299,improvement,1,1
15300,was,0,0
15301,observed,0,0
15302,in,0,0
15303,5,0,0
15304,(,0,0
15305,29.4,0,0
15306,%,0,0
15307,),0,0
15308,and,0,1
15309,failure,0,1
15310,in,0,0
15311,3,0,0
15312,(,0,0
15313,17.6,0,0
15314,%,0,0
15315,),0,0
15316,.,0,0
15317,Side,0,0
15318,effects,0,1
15319,in,0,0
15320,group,0,0
15321,I,0,0
15322,were,0,0
15323,observed,0,0
15324,in,0,0
15325,6,0,0
15326,patients,0,0
15327,(,0,0
15328,23,0,0
15329,%,0,0
15330,),0,0
15331,and,0,0
15332,in,0,0
15333,5,0,0
15334,(,0,0
15335,29.4,0,0
15336,%,0,0
15337,),0,0
15338,in,0,0
15339,group,0,0
15340,II,0,0
15341,.,0,0
15342,There,0,0
15343,were,0,0
15344,no,0,0
15345,statistical,0,0
15346,differences,0,0
15347,between,0,0
15348,the,0,0
15349,two,0,0
15350,groups,0,0
15351,according,0,0
15352,to,0,0
15353,the,0,0
15354,side,0,1
15355,effects,0,1
15356,(,0,0
15357,p,0,0
15358,>,0,0
15359,0.01,0,0
15360,),0,0
15361,.,0,0
15362,No,0,0
15363,patients,0,0
15364,were,0,0
15365,excluded,0,0
15366,from,0,0
15367,the,0,0
15368,study,0,0
15369,due,0,0
15370,to,0,0
15371,side,0,1
15372,effects,0,0
15373,.,0,0
15374,CONCLUSION,0,0
15375,The,0,0
15376,combination,0,0
15377,of,0,1
15378,fluoxetine,0,0
15379,plus,0,0
15380,local,0,1
15381,application,0,0
15382,of,0,1
15383,lidocaine,0,0
15384,ointment,0,0
15385,was,0,0
15386,found,0,0
15387,to,0,0
15388,be,0,0
15389,more,0,0
15390,effective,0,1
15391,than,0,0
15392,fluoxetine,0,0
15393,alone,0,0
15394,in,0,0
15395,the,0,0
15396,treatment,0,0
15397,of,0,0
15398,premature,0,0
15399,ejaculation,0,1
15400,.,0,0
15401,However,0,0
15402,",",0,0
15403,the,0,0
15404,results,0,0
15405,should,0,0
15406,be,0,0
15407,confirmed,0,0
15408,in,0,0
15409,further,0,0
15410,studies,0,0
15411,with,0,0
15412,a,0,0
15413,placebo,0,0
15414,group,0,0
15415,to,0,0
15416,rule,0,0
15417,out,0,0
15418,the,0,0
15419,placebo,0,0
15420,effect,0,0
15421,.,0,0
15422,Alternative,0,0
15423,voice,0,1
15424,after,0,0
15425,laryngectomy,0,0
15426,using,0,0
15427,a,0,0
15428,sound-producing,0,1
15429,voice,0,0
15430,prosthesis,0,1
15431,.,0,0
15432,OBJECTIVE,0,0
15433,To,0,0
15434,improve,1,0
15435,the,1,0
15436,voice,1,0
15437,quality,1,1
15438,of,0,1
15439,female,0,0
15440,laryngectomees,0,0
15441,and/or,0,0
15442,laryngectomees,0,0
15443,with,0,0
15444,a,0,0
15445,hypotonic,0,0
15446,pharyngoesophageal,0,1
15447,(,0,1
15448,PE,0,1
15449,),0,1
15450,segment,0,0
15451,by,0,0
15452,means,0,0
15453,of,0,0
15454,a,0,0
15455,pneumatic,1,0
15456,artificial,1,0
15457,source,1,1
15458,of,1,1
15459,voice,1,1
15460,incorporated,1,0
15461,in,1,0
15462,a,1,0
15463,regular,1,0
15464,tracheoesophageal,1,1
15465,(,1,1
15466,TE,1,1
15467,),1,1
15468,shunt,1,1
15469,valve,1,1
15470,.,1,1
15471,STUDY,0,0
15472,DESIGN,0,0
15473,Experimental,0,1
15474,",",0,1
15475,randomized,0,0
15476,",",0,1
15477,crossover,0,0
15478,trial,0,0
15479,.,0,0
15480,METHODS,0,0
15481,The,0,0
15482,new,0,0
15483,sound,0,0
15484,source,0,0
15485,consists,0,0
15486,of,0,0
15487,a,0,0
15488,single,0,0
15489,silicone,0,0
15490,lip,0,1
15491,",",0,0
15492,which,0,0
15493,performs,0,0
15494,an,0,0
15495,oscillatory,0,1
15496,movement,0,1
15497,driven,0,0
15498,by,0,0
15499,expired,0,1
15500,pulmonary,0,1
15501,air,0,0
15502,flowing,0,0
15503,along,0,0
15504,the,0,0
15505,outward-striking,0,0
15506,lip,0,0
15507,through,0,0
15508,the,0,0
15509,TE,0,1
15510,shunt,0,1
15511,valve,0,1
15512,.,0,0
15513,A,0,0
15514,prototype,0,0
15515,of,0,0
15516,this,0,0
15517,pneumatic,0,0
15518,sound,0,0
15519,source,0,0
15520,is,0,0
15521,evaluated,0,0
15522,in,0,0
15523,vitro,0,0
15524,and,0,0
15525,in,0,0
15526,six,0,0
15527,laryngectomees,0,0
15528,.,0,0
15529,In,0,0
15530,vivo,0,0
15531,evaluation,0,0
15532,includes,0,0
15533,speech,1,1
15534,rate,1,1
15535,",",1,1
15536,maximal,1,1
15537,phonation,1,1
15538,time,1,1
15539,",",1,1
15540,perceptual,1,1
15541,voice,1,1
15542,evaluation,1,0
15543,of,1,1
15544,read-aloud,1,0
15545,prose,1,0
15546,by,1,0
15547,an,1,0
15548,expert,1,0
15549,listener,1,1
15550,",",1,1
15551,speech,1,1
15552,intelligibility,1,1
15553,measurements,1,0
15554,with,1,0
15555,12,1,0
15556,listeners,1,1
15557,",",1,0
15558,and,1,1
15559,self-assessment,1,1
15560,by,1,0
15561,the,1,0
15562,patients,1,0
15563,.,1,0
15564,Moreover,0,0
15565,",",0,0
15566,extensive,1,1
15567,acoustical,1,1
15568,and,1,1
15569,aerodynamic,1,1
15570,in,1,0
15571,vivo,1,0
15572,registrations,1,0
15573,are,0,0
15574,performed,0,0
15575,using,0,0
15576,a,0,0
15577,newly,1,0
15578,developed,1,0
15579,data,1,0
15580,acquisition,1,0
15581,system,1,0
15582,.,1,0
15583,RESULTS,0,0
15584,The,0,0
15585,current,0,0
15586,prototype,0,0
15587,seems,0,0
15588,beneficial,0,0
15589,in,0,0
15590,female,0,0
15591,laryngectomees,0,0
15592,with,0,0
15593,a,0,0
15594,hypotonic,0,0
15595,PE,0,1
15596,segment,0,0
15597,only,0,0
15598,.,0,0
15599,For,0,0
15600,them,0,0
15601,the,0,0
15602,sound-producing,0,1
15603,voice,0,0
15604,prosthesis,0,0
15605,improves,1,1
15606,voice,1,1
15607,quality,1,1
15608,and,1,0
15609,increases,1,1
15610,the,1,0
15611,average,1,1
15612,pitch,1,0
15613,of,1,1
15614,voice,1,1
15615,",",1,0
15616,without,1,0
15617,decreasing,1,1
15618,intelligibility,1,1
15619,or,1,0
15620,necessitating,1,1
15621,other,1,1
15622,pressure,1,1
15623,and,1,1
15624,airflow,1,1
15625,rates,1,1
15626,than,1,0
15627,regular,1,0
15628,TE,1,1
15629,shunt,1,1
15630,speech,1,1
15631,.,1,1
15632,Pitch,1,0
15633,regulation,1,0
15634,of,0,0
15635,this,0,0
15636,prosthetic,0,0
15637,voice,0,0
15638,is,0,0
15639,possible,0,0
15640,",",0,0
15641,yet,0,0
15642,limited,0,0
15643,.,0,0
15644,CONCLUSIONS,0,0
15645,The,0,0
15646,mechanism,0,0
15647,is,0,0
15648,feasible,1,0
15649,and,0,0
15650,does,0,0
15651,not,0,0
15652,result,0,0
15653,in,0,0
15654,unacceptable,0,1
15655,airflow,0,1
15656,resistance,0,1
15657,.,0,0
15658,For,0,0
15659,this,0,0
15660,new,0,0
15661,mechanism,0,0
15662,of,0,1
15663,alaryngeal,0,1
15664,voice,0,0
15665,to,0,0
15666,become,0,0
15667,an,0,0
15668,established,0,0
15669,technique,0,0
15670,for,0,0
15671,postlaryngectomy,0,1
15672,voice,0,1
15673,restoration,0,1
15674,",",0,0
15675,a,0,0
15676,voice,0,0
15677,suitably,0,0
15678,pitched,0,0
15679,for,0,0
15680,male,0,0
15681,laryngectomees,0,0
15682,has,0,0
15683,to,0,0
15684,be,0,0
15685,generated,0,0
15686,and,0,0
15687,a,0,0
15688,large,0,0
15689,part,0,0
15690,of,0,0
15691,the,0,0
15692,melodic,0,1
15693,and,0,1
15694,dynamic,0,1
15695,range,0,0
15696,of,0,0
15697,the,0,0
15698,sound,0,0
15699,source,0,0
15700,has,0,0
15701,to,0,0
15702,be,0,0
15703,attainable,0,1
15704,within,0,0
15705,physiological,0,0
15706,airflow,0,1
15707,rates,0,1
15708,.,0,0
15709,Beneficial,0,0
15710,effects,0,0
15711,of,0,0
15712,a,0,0
15713,soy-based,0,0
15714,dietary,0,0
15715,supplement,0,0
15716,on,0,0
15717,lipid,1,1
15718,levels,1,1
15719,and,1,1
15720,cardiovascular,1,1
15721,risk,1,1
15722,markers,1,1
15723,in,0,0
15724,type,0,0
15725,2,0,0
15726,diabetic,0,0
15727,subjects,0,0
15728,.,0,0
15729,OBJECTIVE,0,0
15730,Consumption,0,1
15731,of,0,1
15732,soy,0,0
15733,protein,0,0
15734,has,0,0
15735,recently,0,0
15736,been,0,0
15737,shown,0,0
15738,to,0,0
15739,improve,0,0
15740,the,0,0
15741,blood,1,1
15742,lipid,1,1
15743,levels,1,1
15744,in,0,0
15745,nondiabetic,0,0
15746,subjects,0,0
15747,.,0,0
15748,The,0,0
15749,purpose,0,0
15750,of,0,0
15751,this,0,0
15752,study,0,0
15753,was,0,0
15754,to,0,0
15755,evaluate,0,0
15756,if,0,0
15757,a,0,0
15758,dietary,0,0
15759,supplement,0,0
15760,of,0,1
15761,soy,0,1
15762,protein,0,1
15763,",",0,1
15764,isoflavones,0,0
15765,",",0,0
15766,and,0,1
15767,cotyledon,0,1
15768,fiber,0,0
15769,(,0,1
15770,Abalon,0,0
15771,),0,0
15772,affects,0,0
15773,cardiovascular,1,1
15774,risk,1,1
15775,markers,1,1
15776,",",1,1
15777,blood,1,1
15778,glucose,1,1
15779,",",1,1
15780,and,1,1
15781,insulin,1,1
15782,levels,1,1
15783,in,0,0
15784,type,0,0
15785,2,0,0
15786,diabetic,0,0
15787,subjects,0,0
15788,.,0,0
15789,RESEARCH,0,0
15790,DESIGN,0,0
15791,AND,0,0
15792,METHODS,0,0
15793,Twenty,0,0
15794,type,0,0
15795,2,0,0
15796,diabetic,0,0
15797,subjects,0,0
15798,participated,0,0
15799,in,0,0
15800,a,0,0
15801,crossover,0,0
15802,trial,0,0
15803,.,0,0
15804,They,0,0
15805,were,0,0
15806,randomized,0,0
15807,to,0,0
15808,double-blind,0,0
15809,supplementation,0,0
15810,for,0,0
15811,6,0,0
15812,weeks,0,0
15813,with,0,0
15814,Abalon,0,0
15815,(,0,0
15816,soy,0,1
15817,protein,0,1
15818,[,0,0
15819,50,0,0
15820,g/day,0,0
15821,],0,0
15822,with,0,0
15823,high,0,0
15824,levels,0,1
15825,of,0,0
15826,isoflavones,0,0
15827,[,0,0
15828,minimum,0,0
15829,165,0,0
15830,mg/day,0,0
15831,],0,0
15832,and,0,1
15833,cotyledon,0,1
15834,fiber,0,0
15835,[,0,0
15836,20,0,0
15837,g/day,0,0
15838,],0,0
15839,),0,0
15840,or,0,1
15841,placebo,0,0
15842,(,0,0
15843,casein,0,0
15844,[,0,0
15845,50,0,0
15846,g/day,0,0
15847,],0,0
15848,and,0,1
15849,cellulose,0,0
15850,[,0,0
15851,20,0,0
15852,g/day,0,0
15853,],0,0
15854,),0,1
15855,",",0,0
15856,separated,0,0
15857,by,0,0
15858,a,0,0
15859,3-week,0,0
15860,wash-out,0,0
15861,period,0,0
15862,.,0,0
15863,RESULTS,0,0
15864,The,0,0
15865,results,0,0
15866,are,0,0
15867,expressed,0,0
15868,as,0,0
15869,means,0,0
15870,+/-,0,0
15871,SD,0,0
15872,.,0,0
15873,The,0,0
15874,percentage,0,1
15875,mean,0,1
15876,treatment,0,0
15877,difference,0,0
15878,between,0,0
15879,Abalon,0,0
15880,and,0,1
15881,placebo,0,0
15882,demonstrated,0,0
15883,significantly,0,0
15884,lower,0,0
15885,mean,0,1
15886,values,0,1
15887,after,0,0
15888,Abalon,0,0
15889,for,0,0
15890,LDL,1,1
15891,cholesterol,1,1
15892,(,0,0
15893,10,0,0
15894,+/-,0,0
15895,15,0,0
15896,%,0,0
15897,",",0,0
15898,P,0,0
15899,<,0,0
15900,0.05,0,0
15901,),0,0
15902,",",0,0
15903,LDL/UHDL,1,1
15904,ratio,1,1
15905,(,0,0
15906,12,0,0
15907,+/-,0,0
15908,18,0,0
15909,%,0,0
15910,",",0,0
15911,P,0,0
15912,<,0,0
15913,0.05,0,0
15914,),0,0
15915,",",0,0
15916,apolipoprotein,1,1
15917,(,0,0
15918,apo,0,1
15919,),0,1
15920,B100,0,0
15921,(,0,0
15922,30,0,0
15923,+/-,0,0
15924,38,0,0
15925,%,0,0
15926,",",0,0
15927,P,0,0
15928,<,0,0
15929,0.01,0,0
15930,),0,0
15931,",",0,0
15932,triglycerides,1,1
15933,(,0,0
15934,22,0,0
15935,+/-,0,0
15936,10,0,0
15937,%,0,0
15938,",",0,0
15939,P,0,0
15940,<,0,0
15941,0.05,0,0
15942,),0,0
15943,",",0,0
15944,and,0,1
15945,homocysteine,1,1
15946,(,0,0
15947,14,0,0
15948,+/-,0,0
15949,21,0,0
15950,%,0,0
15951,",",0,0
15952,P,0,0
15953,<,0,0
15954,0.01,0,0
15955,),0,0
15956,",",0,0
15957,whereas,0,0
15958,the,0,0
15959,total,1,1
15960,cholesterol,1,1
15961,value,1,1
15962,tended,0,0
15963,to,0,0
15964,be,0,0
15965,less,0,0
15966,significant,0,0
15967,but,0,0
15968,still,0,0
15969,lower,0,0
15970,(,0,0
15971,8,0,0
15972,+/-,0,0
15973,15,0,0
15974,%,0,0
15975,",",0,0
15976,P,0,0
15977,<,0,0
15978,0.08,0,0
15979,),0,0
15980,.,0,0
15981,No,0,0
15982,change,0,1
15983,occurred,0,0
15984,in,0,0
15985,HDL,1,1
15986,cholesterol,1,1
15987,",",1,1
15988,apo,1,1
15989,B100/apo,1,1
15990,A1,1,1
15991,ratio,1,1
15992,",",1,1
15993,plasminogen,1,1
15994,activator,1,0
15995,inhibitor,1,0
15996,1,1,0
15997,",",1,0
15998,factor,1,0
15999,VIIc,1,0
16000,",",1,1
16001,von,1,1
16002,Willebrand,1,1
16003,factor,1,1
16004,",",1,1
16005,fibrinogen,1,1
16006,",",1,1
16007,lipoprotein,1,1
16008,(,1,0
16009,a,1,0
16010,),1,0
16011,",",1,0
16012,glucose,1,1
16013,",",1,1
16014,HbA1c,1,0
16015,",",1,1
16016,or,1,1
16017,24-h,1,1
16018,blood,1,1
16019,pressure,1,1
16020,.,1,0
16021,CONCLUSIONS,0,0
16022,These,0,0
16023,results,0,0
16024,indicate,0,0
16025,beneficial,0,0
16026,effects,0,1
16027,of,0,1
16028,dietary,0,0
16029,supplementation,0,0
16030,with,0,0
16031,Abalon,0,0
16032,on,0,0
16033,cardiovascular,1,1
16034,risk,1,1
16035,markers,1,1
16036,in,0,0
16037,type,0,0
16038,2,0,0
16039,diabetic,0,0
16040,subjects,0,0
16041,.,0,0
16042,This,0,0
16043,improvement,0,0
16044,is,0,0
16045,seen,0,0
16046,even,0,0
16047,in,0,0
16048,individuals,0,0
16049,with,0,0
16050,near-normal,0,1
16051,lipid,0,1
16052,values,0,1
16053,.,0,0
16054,Effect,0,1
16055,of,0,1
16056,allopurinol,0,0
16057,on,0,0
16058,myocardial,0,1
16059,oxygen,1,1
16060,free,1,1
16061,radical,1,1
16062,production,1,1
16063,in,0,0
16064,coronary,0,1
16065,bypass,0,0
16066,surgery,0,0
16067,.,0,1
16068,OBJECTIVES,0,0
16069,Allopurinol,0,0
16070,protects,0,0
16071,the,0,0
16072,heart,0,1
16073,from,0,0
16074,reperfusion,0,1
16075,injury,0,1
16076,.,0,0
16077,The,0,0
16078,aim,0,0
16079,of,0,0
16080,this,0,0
16081,study,0,0
16082,was,0,0
16083,to,0,0
16084,investigate,0,0
16085,myocardial,1,1
16086,free,1,1
16087,radical,1,0
16088,production,1,1
16089,during,0,0
16090,reperfusion,0,1
16091,with,0,0
16092,and,0,1
16093,without,0,0
16094,allopurinol,0,0
16095,treatment,0,0
16096,in,0,0
16097,coronary,0,1
16098,artery,0,1
16099,bypass,0,0
16100,grafting,0,0
16101,patients,0,0
16102,randomized,0,0
16103,into,0,0
16104,allopurinol,0,0
16105,(,0,0
16106,n,0,0
16107,=,0,0
16108,14,0,0
16109,),0,0
16110,or,0,0
16111,placebo,0,0
16112,(,0,1
16113,n,0,0
16114,=,0,0
16115,13,0,0
16116,),0,0
16117,groups,0,0
16118,.,0,0
16119,DESIGN,0,0
16120,Allopurinol,0,0
16121,(,0,0
16122,1,0,0
16123,g,0,0
16124,),0,0
16125,was,0,0
16126,given,0,0
16127,blind,0,0
16128,prior,0,0
16129,to,0,0
16130,cardiopulmonary,0,1
16131,bypass,0,0
16132,and,0,1
16133,prior,0,0
16134,to,0,0
16135,opening,0,0
16136,the,0,0
16137,aorta,0,0
16138,.,0,0
16139,Oxygen,1,1
16140,free,1,1
16141,radicals,1,1
16142,were,0,0
16143,measured,0,0
16144,before,0,0
16145,anesthesia,0,0
16146,in,0,0
16147,arterial,0,1
16148,blood,0,1
16149,",",0,0
16150,before,0,0
16151,cross-clamping,0,1
16152,and,0,0
16153,1,0,0
16154,and,0,0
16155,10,0,0
16156,min,0,0
16157,after,0,0
16158,reperfusion,0,1
16159,in,0,0
16160,arterial,0,1
16161,and,0,1
16162,coronary,0,1
16163,sinus,0,0
16164,blood,0,1
16165,.,0,1
16166,Levels,0,1
16167,were,0,0
16168,measured,0,0
16169,as,0,0
16170,relative,0,0
16171,concentrations,0,1
16172,by,0,0
16173,the,0,0
16174,electron,0,0
16175,spin,0,1
16176,resonance,0,0
16177,method,0,0
16178,.,0,0
16179,RESULTS,0,0
16180,One,0,0
16181,minute,0,1
16182,after,0,0
16183,reperfusion,0,0
16184,the,0,0
16185,level,0,1
16186,of,0,0
16187,spin-trapped,1,0
16188,radicals,1,1
16189,in,1,0
16190,arterial,1,1
16191,blood,1,1
16192,was,0,0
16193,elevated,0,1
16194,significantly,0,0
16195,(,0,0
16196,p,0,0
16197,=,0,0
16198,0.016,0,0
16199,),0,0
16200,in,0,0
16201,the,0,0
16202,allopurinol,0,0
16203,group,0,0
16204,",",0,0
16205,from,0,0
16206,7.7,0,0
16207,(,0,0
16208,SE,0,0
16209,:,0,0
16210,0.8,0,0
16211,),0,0
16212,to,0,0
16213,8.6,0,0
16214,(,0,0
16215,1.4,0,0
16216,),0,0
16217,and,0,0
16218,non-significantly,0,0
16219,(,0,0
16220,p,0,0
16221,=,0,0
16222,0.074,0,0
16223,),0,0
16224,in,0,0
16225,the,0,0
16226,placebo,0,0
16227,group,0,0
16228,",",0,0
16229,from,0,0
16230,7.3,0,0
16231,(,0,0
16232,0.7,0,0
16233,),0,0
16234,to,0,0
16235,8.3,0,0
16236,(,0,0
16237,0.8,0,0
16238,),0,0
16239,.,0,0
16240,Ten,0,0
16241,minutes,0,0
16242,after,0,0
16243,reperfusion,0,0
16244,the,0,0
16245,arterial,1,1
16246,values,1,1
16247,were,1,0
16248,8.6,0,0
16249,(,0,0
16250,1.5,0,0
16251,),0,0
16252,in,0,0
16253,the,0,0
16254,allopurinol,0,0
16255,and,0,0
16256,7.6,0,0
16257,(,0,0
16258,0.7,0,0
16259,),0,0
16260,in,0,0
16261,the,0,0
16262,placebo,0,0
16263,group,0,0
16264,",",0,0
16265,the,1,0
16266,sinus,1,0
16267,values,1,1
16268,being,0,0
16269,7.6,0,0
16270,(,0,0
16271,1.3,0,0
16272,),0,0
16273,and,0,0
16274,8.3,0,0
16275,(,0,0
16276,0.8,0,0
16277,),0,0
16278,",",0,0
16279,respectively,0,0
16280,.,0,0
16281,Myocardial,1,1
16282,free,1,1
16283,radical,1,1
16284,production,1,1
16285,was,0,0
16286,-0.94,0,0
16287,(,0,0
16288,1.21,0,0
16289,),0,0
16290,in,0,0
16291,the,0,0
16292,allopurinol,0,0
16293,and,0,1
16294,+0.79,0,0
16295,(,0,0
16296,0.96,0,0
16297,),0,0
16298,in,0,0
16299,the,0,0
16300,placebo,0,0
16301,group,0,0
16302,after,0,0
16303,10,0,0
16304,min,0,0
16305,reperfusion,0,0
16306,",",0,0
16307,the,0,0
16308,difference,0,0
16309,being,0,0
16310,significant,0,0
16311,(,0,0
16312,p,0,0
16313,=,0,0
16314,0.043,0,0
16315,),0,0
16316,.,0,0
16317,CONCLUSIONS,0,0
16318,All,0,0
16319,patients,0,0
16320,in,0,0
16321,both,0,0
16322,groups,0,0
16323,had,0,0
16324,an,0,0
16325,increasing,0,0
16326,tendency,0,0
16327,to,0,0
16328,free,0,1
16329,radical,0,0
16330,production,0,1
16331,during,0,0
16332,early,0,0
16333,reperfusion,0,1
16334,.,0,1
16335,Patients,0,0
16336,treated,0,0
16337,with,0,0
16338,allopurinol,0,0
16339,showed,0,0
16340,less,0,0
16341,myocardial,1,1
16342,production,1,1
16343,of,1,1
16344,free,1,1
16345,radicals,1,1
16346,",",0,0
16347,indicating,0,0
16348,that,0,0
16349,its,0,0
16350,protective,0,0
16351,effect,0,0
16352,may,0,0
16353,be,0,0
16354,due,0,0
16355,to,0,0
16356,its,0,0
16357,antioxidative,0,0
16358,properties,0,1
16359,.,0,0
16360,Simplified,0,1
16361,subjective,0,1
16362,workload,0,1
16363,assessment,0,0
16364,technique,0,0
16365,.,0,0
16366,Although,0,0
16367,the,0,0
16368,subjective,1,1
16369,workload,1,1
16370,assessment,1,1
16371,technique,1,0
16372,(,0,1
16373,SWAT,0,1
16374,),0,0
16375,has,0,0
16376,been,0,0
16377,widely,0,0
16378,used,0,0
16379,",",0,0
16380,it,0,0
16381,has,0,0
16382,two,0,0
16383,main,0,0
16384,problems,0,0
16385,:,0,0
16386,it,0,0
16387,is,0,0
16388,not,0,0
16389,very,0,0
16390,sensitive,0,0
16391,for,0,0
16392,low,0,0
16393,mental,0,1
16394,workloads,0,1
16395,and,0,0
16396,it,0,0
16397,requires,0,0
16398,a,0,0
16399,time-consuming,0,0
16400,card,0,1
16401,sorting,0,1
16402,pretask,0,0
16403,procedure,0,0
16404,.,0,0
16405,In,0,0
16406,this,0,0
16407,study,0,0
16408,are,0,0
16409,presented,0,0
16410,five,0,0
16411,variations,0,0
16412,of,0,0
16413,SWAT,0,0
16414,in,0,0
16415,an,0,0
16416,effort,0,0
16417,to,0,0
16418,overcome,0,0
16419,the,0,0
16420,limitations,0,0
16421,.,0,0
16422,Four,0,0
16423,of,0,0
16424,the,0,0
16425,variants,0,1
16426,used,0,0
16427,the,0,0
16428,continuous,0,0
16429,SWAT,0,1
16430,subscales,0,1
16431,while,0,0
16432,one,0,0
16433,used,0,0
16434,the,0,0
16435,discrete,0,1
16436,SWAT,0,1
16437,subscale,0,1
16438,.,0,0
16439,Fifteen,0,0
16440,subjects,0,0
16441,participated,0,0
16442,in,0,0
16443,the,0,0
16444,experiment,0,0
16445,.,0,0
16446,The,0,0
16447,scales,0,1
16448,were,0,0
16449,compared,0,0
16450,with,0,0
16451,the,0,0
16452,original,0,0
16453,SWAT,0,1
16454,scale,0,1
16455,in,0,0
16456,terms,0,1
16457,of,0,1
16458,sensitivity,1,1
16459,and,0,1
16460,pretask,0,1
16461,procedure,0,0
16462,completion,0,1
16463,time,0,1
16464,when,0,0
16465,performing,0,0
16466,arithmetic,0,0
16467,tasks,0,0
16468,.,0,0
16469,The,0,0
16470,results,0,0
16471,show,0,0
16472,that,0,0
16473,all,0,0
16474,four,0,0
16475,variants,0,0
16476,are,0,0
16477,more,0,0
16478,sensitive,1,0
16479,than,0,0
16480,the,0,0
16481,conventional,1,0
16482,SWAT,1,1
16483,scale,1,1
16484,and,0,0
16485,that,0,0
16486,the,0,0
16487,pairwise,0,0
16488,comparison,0,0
16489,procedure,0,0
16490,takes,0,0
16491,significantly,0,0
16492,less,0,0
16493,pretask,1,1
16494,completion,1,1
16495,time,1,1
16496,compared,0,0
16497,with,0,0
16498,the,0,0
16499,original,0,0
16500,SWAT,0,1
16501,scale,0,1
16502,.,0,0
16503,Thus,0,1
16504,",",0,0
16505,the,0,0
16506,conventional,0,0
16507,pretask,0,0
16508,procedure,0,0
16509,can,0,0
16510,be,0,0
16511,replaced,0,0
16512,by,0,0
16513,a,0,0
16514,simple,0,0
16515,unweighted,0,0
16516,averaging,0,0
16517,to,0,0
16518,yield,0,0
16519,a,0,0
16520,scale,0,1
16521,of,0,0
16522,high,0,0
16523,sensitivity,0,1
16524,.,0,0
16525,Effect,0,1
16526,of,0,1
16527,acarbose,0,0
16528,on,0,0
16529,additional,0,0
16530,insulin,0,1
16531,therapy,0,0
16532,in,0,0
16533,type,0,0
16534,2,0,0
16535,diabetic,0,0
16536,patients,0,0
16537,with,0,0
16538,late,0,1
16539,failure,0,1
16540,of,0,1
16541,sulphonylurea,0,0
16542,therapy,0,0
16543,.,0,0
16544,AIM,0,0
16545,The,0,0
16546,present,0,0
16547,study,0,0
16548,investigated,0,0
16549,the,0,0
16550,effect,0,1
16551,of,0,0
16552,acarbose,0,0
16553,on,0,0
16554,insulin,1,1
16555,requirements,1,1
16556,and,0,1
16557,glycaemic,1,1
16558,control,1,0
16559,in,0,0
16560,patients,0,0
16561,with,0,0
16562,type,0,0
16563,2,0,0
16564,diabetes,0,0
16565,receiving,0,0
16566,exogenous,0,0
16567,insulin,0,1
16568,due,0,0
16569,to,0,0
16570,secondary,0,1
16571,failure,0,1
16572,of,0,1
16573,maximum,0,1
16574,dose,0,0
16575,sulphonylurea,0,0
16576,therapy,0,0
16577,.,0,0
16578,METHODS,0,0
16579,A,0,0
16580,single-centre,0,0
16581,",",0,0
16582,double-blind,0,0
16583,",",0,1
16584,randomized,0,0
16585,",",0,0
16586,placebo-controlled,0,0
16587,study,0,0
16588,was,0,0
16589,performed,0,0
16590,in,0,0
16591,48,0,0
16592,type,0,0
16593,2,0,0
16594,diabetic,0,0
16595,patients,0,0
16596,with,0,0
16597,late-term,0,0
16598,failure,0,1
16599,following,0,0
16600,at,0,0
16601,least,0,0
16602,3,0,0
16603,years,0,0
16604,of,0,0
16605,sulphonylurea,0,0
16606,therapy,0,0
16607,requiring,0,1
16608,additional,0,0
16609,insulin,0,1
16610,therapy,0,0
16611,to,0,0
16612,determine,0,0
16613,the,0,0
16614,impact,0,0
16615,of,0,0
16616,acarbose,0,0
16617,on,0,0
16618,glycaemic,0,1
16619,control,0,0
16620,and,0,1
16621,insulin,0,1
16622,requirements,0,1
16623,.,0,0
16624,The,0,0
16625,primary,0,0
16626,end,0,0
16627,points,0,0
16628,were,0,0
16629,glycaemic,1,1
16630,response,1,1
16631,rate,1,1
16632,(,0,0
16633,responders,0,0
16634,being,0,0
16635,predefined,0,0
16636,as,0,0
16637,patients,0,0
16638,who,0,0
16639,achieve,0,0
16640,a,0,0
16641,decrease,0,1
16642,in,0,0
16643,HbA1c,0,0
16644,to,0,0
16645,less,0,0
16646,than,0,0
16647,8,0,0
16648,%,0,0
16649,or,0,0
16650,a,0,0
16651,reduction,0,1
16652,by,0,0
16653,at,0,0
16654,least,0,0
16655,15,0,0
16656,%,0,0
16657,as,0,0
16658,compared,0,0
16659,to,0,0
16660,the,0,0
16661,baseline,0,0
16662,values,0,1
16663,),0,0
16664,and,0,0
16665,the,0,0
16666,daily,1,1
16667,insulin,1,1
16668,dose,1,0
16669,at,0,0
16670,6,0,0
16671,months,0,0
16672,.,0,0
16673,Secondary,0,0
16674,parameters,0,1
16675,assessed,0,0
16676,included,0,0
16677,postprandial,1,1
16678,changes,1,1
16679,in,1,0
16680,blood,1,1
16681,glucose,1,1
16682,",",1,1
16683,serum,1,1
16684,insulin,1,1
16685,and,1,1
16686,C-peptide,1,1
16687,during,0,0
16688,the,0,0
16689,treatment,0,0
16690,period,0,0
16691,.,0,1
16692,RESULTS,0,0
16693,There,0,0
16694,were,0,0
16695,significantly,0,0
16696,more,0,0
16697,responders,0,0
16698,in,0,0
16699,the,0,0
16700,acarbose-treated,0,0
16701,group,0,0
16702,compared,0,0
16703,with,0,0
16704,the,0,0
16705,placebo,0,0
16706,group,0,0
16707,(,0,0
16708,20/24,0,0
16709,patients,0,0
16710,vs.,0,0
16711,10/19,0,0
16712,patients,0,0
16713,;,0,0
16714,p,0,0
16715,<,0,0
16716,0.05,0,0
16717,),0,0
16718,.,0,0
16719,The,0,0
16720,mean,1,1
16721,daily,1,0
16722,insulin,1,1
16723,dose,1,0
16724,after,0,0
16725,24,0,0
16726,weeks,0,0
16727,of,0,0
16728,treatment,0,0
16729,was,0,0
16730,16.4,0,0
16731,+/-,0,0
16732,10.1,0,0
16733,IU,0,0
16734,in,0,0
16735,the,0,0
16736,acarbose,0,0
16737,group,0,0
16738,and,0,0
16739,22.4,0,0
16740,+/-,0,0
16741,12.2,0,0
16742,IU,0,0
16743,in,0,0
16744,the,0,0
16745,placebo,0,0
16746,group,0,0
16747,(,0,0
16748,mean,0,1
16749,+/-,0,0
16750,s.d,0,0
16751,.,0,0
16752,;,0,0
16753,p,0,0
16754,<,0,0
16755,0.07,0,0
16756,),0,0
16757,.,0,0
16758,Postprandial,1,1
16759,increases,1,1
16760,in,1,0
16761,blood,1,1
16762,glucose,1,1
16763,",",1,1
16764,insulin,1,1
16765,and,1,1
16766,C-peptide,1,1
16767,were,0,0
16768,consistently,0,0
16769,lower,0,0
16770,in,0,0
16771,the,0,0
16772,acarbose-treated,0,0
16773,group,0,0
16774,than,0,0
16775,in,0,0
16776,the,0,0
16777,placebo,0,0
16778,group,0,0
16779,.,0,0
16780,For,0,0
16781,example,0,0
16782,",",0,0
16783,the,0,0
16784,mean,1,1
16785,increase,1,0
16786,in,1,0
16787,2-h,1,1
16788,postprandial,1,1
16789,serum,1,1
16790,insulin,1,1
16791,remained,0,0
16792,almost,0,0
16793,unchanged,0,0
16794,in,0,0
16795,the,0,0
16796,acarbose,0,0
16797,group,0,0
16798,at,0,0
16799,the,0,0
16800,end,0,0
16801,of,0,0
16802,24,0,0
16803,weeks,0,0
16804,of,0,0
16805,treatment,0,0
16806,compared,0,0
16807,to,0,0
16808,an,0,0
16809,increase,0,0
16810,to,0,0
16811,43,0,0
16812,+/-,0,0
16813,29,0,0
16814,microU/ml,0,0
16815,(,0,0
16816,mean,0,1
16817,+/-,0,0
16818,s.d,0,0
16819,.,0,0
16820,),0,0
16821,at,0,0
16822,the,0,0
16823,end,0,0
16824,of,0,0
16825,the,0,0
16826,study,0,0
16827,period,0,0
16828,for,0,0
16829,the,0,0
16830,placebo,0,0
16831,group,0,0
16832,.,0,0
16833,CONCLUSIONS,0,0
16834,The,0,0
16835,findings,0,0
16836,of,0,0
16837,this,0,0
16838,study,0,0
16839,suggest,0,0
16840,that,0,0
16841,the,0,0
16842,addition,0,0
16843,of,0,0
16844,acarbose,0,0
16845,to,0,0
16846,sulphonylurea/insulin,0,0
16847,combination,0,0
16848,therapy,0,0
16849,can,0,0
16850,improve,0,0
16851,glycaemic,1,1
16852,control,1,0
16853,in,0,0
16854,type,0,0
16855,2,0,0
16856,diabetic,0,0
16857,patients,0,0
16858,.,0,0
16859,Acarbose,0,0
16860,may,0,0
16861,also,0,0
16862,reduce,0,0
16863,insulin,1,1
16864,resistance,1,1
16865,and,1,1
16866,hyperinsulinaemia,1,1
16867,.,1,0
16868,Central,0,1
16869,nervous,0,1
16870,system,0,0
16871,serotonin,0,1
16872,function,0,1
16873,and,0,1
16874,cardiovascular,1,1
16875,responses,1,1
16876,to,0,0
16877,stress,0,1
16878,.,0,0
16879,OBJECTIVE,0,0
16880,The,0,0
16881,objective,0,0
16882,of,0,0
16883,this,0,0
16884,study,0,0
16885,was,0,0
16886,to,0,0
16887,evaluate,0,0
16888,the,0,0
16889,impact,0,0
16890,of,0,0
16891,indices,0,1
16892,of,0,0
16893,central,0,1
16894,nervous,0,1
16895,system,0,0
16896,(,0,1
16897,CNS,0,0
16898,),0,1
16899,serotonin,0,1
16900,function,0,1
16901,on,0,0
16902,cardiovascular,1,1
16903,reactivity,1,1
16904,to,0,0
16905,mental,0,1
16906,stress,0,1
16907,.,0,0
16908,METHODS,0,0
16909,Lumbar,0,1
16910,puncture,0,1
16911,was,0,0
16912,performed,0,0
16913,on,0,0
16914,54,0,0
16915,healthy,0,0
16916,volunteers,0,0
16917,to,0,0
16918,obtain,0,0
16919,cerebrospinal,0,1
16920,fluid,0,1
16921,(,0,1
16922,CSF,0,0
16923,),0,1
16924,for,0,0
16925,determination,0,0
16926,of,0,1
16927,5-hydroxyindoleacetic,0,1
16928,acid,0,0
16929,(,0,0
16930,5HIAA,0,0
16931,),0,0
16932,levels,0,1
16933,.,0,0
16934,Genotypes,0,1
16935,were,0,0
16936,determined,0,0
16937,with,0,0
16938,respect,0,0
16939,to,0,0
16940,a,0,0
16941,functional,0,1
16942,polymorphism,0,0
16943,of,0,0
16944,the,0,0
16945,serotonin,0,1
16946,transporter,0,1
16947,gene,0,1
16948,promoter,0,1
16949,region,0,0
16950,(,0,0
16951,5HTTLPR,0,0
16952,),0,0
16953,.,0,0
16954,Subjects,0,0
16955,then,0,0
16956,underwent,0,0
16957,mental,0,1
16958,stress,0,1
16959,testing,0,0
16960,.,0,0
16961,RESULTS,0,0
16962,Persons,0,1
16963,with,0,0
16964,one,0,0
16965,or,0,0
16966,two,0,0
16967,long,0,0
16968,(,0,0
16969,l,0,1
16970,),0,0
16971,5HTTLPR,0,0
16972,alleles,0,1
16973,had,0,0
16974,CSF,1,0
16975,levels,1,1
16976,of,0,0
16977,the,0,0
16978,major,0,1
16979,serotonin,0,1
16980,metabolite,0,1
16981,",",0,0
16982,5HIAA,0,0
16983,",",0,0
16984,that,0,0
16985,were,0,0
16986,50,0,0
16987,%,0,0
16988,higher,0,0
16989,than,0,0
16990,those,0,0
16991,of,0,0
16992,persons,0,0
16993,with,0,0
16994,the,0,0
16995,s/s,0,0
16996,5HTTLPR,0,0
16997,genotype,0,0
16998,.,0,0
16999,Persons,0,1
17000,with,0,0
17001,one,0,0
17002,or,0,0
17003,two,0,0
17004,l,0,1
17005,alleles,0,1
17006,or,0,0
17007,higher,0,0
17008,CSF,1,0
17009,5HIAA,1,0
17010,levels,1,1
17011,also,0,0
17012,exhibited,0,0
17013,greater,0,0
17014,blood,1,1
17015,pressure,1,1
17016,and,1,1
17017,heart,1,1
17018,rate,1,1
17019,responses,1,1
17020,to,0,0
17021,a,0,0
17022,mental,0,1
17023,stress,0,1
17024,protocol,0,0
17025,.,0,0
17026,CONCLUSIONS,0,0
17027,These,0,0
17028,findings,0,0
17029,suggest,0,0
17030,the,0,0
17031,5HTTLPR,0,0
17032,polymorphism,0,0
17033,affects,0,0
17034,CNS,0,1
17035,serotonin,0,1
17036,function,0,1
17037,",",0,0
17038,and,0,0
17039,they,0,0
17040,are,0,0
17041,consistent,0,0
17042,with,0,0
17043,the,0,0
17044,general,0,0
17045,hypothesis,0,0
17046,that,0,0
17047,CNS,0,0
17048,serotonin,0,1
17049,function,0,1
17050,is,0,0
17051,involved,0,0
17052,in,0,0
17053,the,0,0
17054,regulation,0,0
17055,of,0,0
17056,potentially,0,0
17057,health-damaging,0,1
17058,biobehavioral,0,0
17059,characteristics,0,1
17060,.,0,0
17061,In,0,0
17062,particular,0,0
17063,",",0,0
17064,the,0,0
17065,l,0,1
17066,allele,0,0
17067,could,0,0
17068,contribute,0,0
17069,",",0,0
17070,through,0,0
17071,its,0,0
17072,association,0,0
17073,with,0,0
17074,increased,0,1
17075,cardiovascular,1,1
17076,reactivity,1,1
17077,to,0,0
17078,stress,0,1
17079,",",0,0
17080,to,0,0
17081,increased,0,1
17082,risk,0,1
17083,of,0,0
17084,cardiovascular,0,1
17085,disease,0,0
17086,.,0,0
17087,Interferential,0,1
17088,therapy,0,0
17089,electrode,0,1
17090,placement,0,1
17091,technique,0,0
17092,in,0,0
17093,acute,0,0
17094,low,0,0
17095,back,0,0
17096,pain,0,1
17097,:,0,0
17098,a,0,0
17099,preliminary,0,0
17100,investigation,0,0
17101,.,0,0
17102,OBJECTIVE,0,0
17103,To,0,0
17104,determine,0,0
17105,the,0,0
17106,efficacy,0,1
17107,of,0,0
17108,interferential,0,1
17109,therapy,0,0
17110,(,0,1
17111,IFT,0,1
17112,),0,0
17113,electrode,0,1
17114,placement,0,0
17115,technique,0,0
17116,compared,0,0
17117,with,0,0
17118,a,0,0
17119,control,0,0
17120,treatment,0,0
17121,in,0,0
17122,subjects,0,0
17123,with,0,0
17124,acute,0,0
17125,low,0,0
17126,back,0,1
17127,pain,0,1
17128,(,0,1
17129,LBP,0,1
17130,),0,0
17131,.,0,0
17132,DESIGN,0,0
17133,Single-blind,0,0
17134,",",0,1
17135,randomized,0,0
17136,",",0,1
17137,controlled,0,0
17138,trial,0,0
17139,with,0,0
17140,a,0,0
17141,3-month,0,0
17142,follow-up,0,0
17143,.,0,1
17144,SETTING,0,0
17145,Outpatient,0,0
17146,physiotherapy,0,0
17147,departments,0,0
17148,in,0,0
17149,hospital,0,1
17150,and,0,1
17151,university,0,0
17152,settings,0,0
17153,.,0,0
17154,PATIENTS,0,0
17155,A,0,0
17156,random,0,0
17157,sample,0,0
17158,of,0,0
17159,60,0,0
17160,eligible,0,0
17161,patients,0,0
17162,with,0,0
17163,back,0,1
17164,pain,0,1
17165,(,0,0
17166,28,0,0
17167,men,0,0
17168,",",0,0
17169,32,0,0
17170,women,0,0
17171,),0,0
17172,were,0,0
17173,recruited,0,0
17174,by,0,0
17175,general,0,0
17176,practitioners,0,0
17177,and,0,1
17178,self-referral,0,1
17179,for,0,0
17180,physiotherapy,0,0
17181,treatment,0,0
17182,and,0,1
17183,randomly,0,0
17184,assigned,0,0
17185,to,0,0
17186,1,0,0
17187,of,0,0
17188,3,0,0
17189,groups,0,0
17190,.,0,0
17191,INTERVENTIONS,0,0
17192,(,0,0
17193,1,0,0
17194,),0,0
17195,IFT,0,1
17196,painful,0,1
17197,area,0,1
17198,and,0,0
17199,The,0,0
17200,Back,0,0
17201,Book,0,0
17202,",",0,0
17203,(,0,0
17204,2,0,0
17205,),0,0
17206,IFT,0,1
17207,spinal,0,1
17208,nerve,0,1
17209,and,0,0
17210,The,0,0
17211,Back,0,0
17212,Book,0,0
17213,",",0,1
17214,and,0,1
17215,(,0,0
17216,3,0,0
17217,),0,0
17218,Control,0,0
17219,",",0,0
17220,The,0,0
17221,Back,0,0
17222,Book,0,0
17223,only,0,0
17224,.,0,0
17225,Standardized,0,0
17226,IFT,0,1
17227,stimulation,0,1
17228,parameters,0,1
17229,were,0,0
17230,used,0,0
17231,:,0,0
17232,carrier,0,0
17233,frequency,0,1
17234,3.85,0,0
17235,kHz,0,0
17236,;,0,0
17237,140,0,0
17238,Hz,0,0
17239,constant,0,0
17240,;,0,0
17241,pulse,0,1
17242,duration,0,1
17243,130,0,0
17244,micros,0,0
17245,;,0,0
17246,30,0,0
17247,minutes,0,1
17248,',0,0
17249,duration,0,1
17250,.,0,0
17251,MAIN,0,0
17252,OUTCOME,0,1
17253,MEASURES,0,0
17254,Pain,1,1
17255,Rating,1,1
17256,Index,1,1
17257,",",1,1
17258,Roland-Morris,1,1
17259,Disability,1,1
17260,Questionnaire,1,1
17261,(,1,1
17262,RMDQ,1,1
17263,),1,1
17264,",",1,0
17265,and,1,1
17266,EuroQol,1,1
17267,were,0,0
17268,completed,0,0
17269,by,0,0
17270,subjects,0,0
17271,pretreatment,0,0
17272,",",0,0
17273,at,0,1
17274,discharge,0,1
17275,",",0,1
17276,and,0,1
17277,3-month,0,1
17278,follow-up,0,0
17279,.,0,0
17280,RESULTS,0,0
17281,All,0,0
17282,groups,0,0
17283,had,0,0
17284,significant,0,0
17285,improvements,0,0
17286,in,0,0
17287,all,0,0
17288,outcomes,0,1
17289,at,0,0
17290,follow-up,0,0
17291,.,0,0
17292,Subjects,0,0
17293,managed,0,0
17294,by,0,0
17295,IFT,0,1
17296,spinal,0,1
17297,nerve,0,1
17298,and,0,0
17299,The,0,0
17300,Back,0,0
17301,Book,0,0
17302,displayed,0,0
17303,both,0,0
17304,a,0,0
17305,statistically,0,0
17306,significant,0,0
17307,(,0,0
17308,p,0,0
17309,=,0,0
17310,.030,0,0
17311,),0,1
17312,and,0,0
17313,clinically,0,1
17314,meaningful,0,1
17315,reduction,1,1
17316,in,1,0
17317,functional,1,1
17318,disability,1,1
17319,(,1,1
17320,RMDQ,1,1
17321,),1,1
17322,",",0,0
17323,compared,0,0
17324,with,0,0
17325,management,0,0
17326,via,0,0
17327,IFT,0,1
17328,painful,0,1
17329,area,0,1
17330,and,0,0
17331,The,0,0
17332,Back,0,0
17333,Book,0,0
17334,combined,0,0
17335,or,0,0
17336,The,0,0
17337,Back,0,0
17338,Book,0,0
17339,alone,0,0
17340,.,0,0
17341,CONCLUSIONS,0,0
17342,The,0,0
17343,findings,0,0
17344,showed,0,0
17345,that,0,0
17346,IFT,0,1
17347,electrode,0,1
17348,placement,0,0
17349,technique,0,0
17350,affects,0,0
17351,LBP-specific,0,1
17352,functional,0,1
17353,disability,0,1
17354,",",0,0
17355,providing,0,0
17356,preliminary,0,0
17357,implications,0,0
17358,for,0,0
17359,future,0,0
17360,clinical,0,0
17361,studies,0,0
17362,.,0,0
17363,Effect,0,0
17364,of,0,0
17365,the,0,0
17366,essential,0,0
17367,oils,0,0
17368,of,0,1
17369,garlic,0,0
17370,and,0,1
17371,onion,0,0
17372,on,0,0
17373,alimentary,0,1
17374,hyperlipemia,0,0
17375,.,0,0
17376,SUMMARY,0,0
17377,The,0,0
17378,effect,0,0
17379,of,0,1
17380,garlic,0,0
17381,and,0,1
17382,onion,0,0
17383,on,0,0
17384,alimentary,0,1
17385,hyperlipemia,0,1
17386,",",0,0
17387,induced,0,0
17388,by,0,0
17389,feeding,0,0
17390,100,0,0
17391,g,0,0
17392,butter,0,0
17393,",",0,0
17394,has,0,0
17395,been,0,0
17396,studied,0,0
17397,in,0,0
17398,10,0,0
17399,healthy,0,0
17400,subjects,0,0
17401,.,0,0
17402,The,0,0
17403,freshly,0,0
17404,extracted,0,0
17405,juice,0,0
17406,of,0,0
17407,50,0,0
17408,g,0,0
17409,of,0,0
17410,garlic,0,0
17411,or,0,1
17412,onion,0,0
17413,",",0,1
17414,as,0,0
17415,well,0,0
17416,as,0,0
17417,an,0,0
17418,equivalent,0,0
17419,amount,0,1
17420,of,0,0
17421,their,0,0
17422,ether-extracted,0,0
17423,essential,0,0
17424,oils,0,0
17425,",",0,1
17426,was,0,0
17427,administered,0,0
17428,randomly,0,0
17429,on,0,0
17430,four,0,0
17431,different,0,0
17432,days,0,0
17433,during,0,0
17434,a,0,0
17435,one-week,0,0
17436,period,0,0
17437,.,0,1
17438,Garlic,0,0
17439,and,0,0
17440,onion,0,0
17441,have,0,0
17442,a,0,0
17443,significant,0,0
17444,protective,0,0
17445,action,0,1
17446,against,0,0
17447,fat-induced,1,1
17448,increases,1,1
17449,in,1,0
17450,serum,1,1
17451,cholesterol,1,1
17452,and,1,1
17453,plasma,1,1
17454,fibrinogen,1,1
17455,and,1,1
17456,decreases,1,1
17457,in,1,0
17458,coagulation,1,1
17459,time,1,1
17460,and,1,1
17461,fibrinolytic,1,1
17462,activity,1,1
17463,.,1,0
17464,The,0,0
17465,essential,0,0
17466,oil,0,0
17467,fraction,0,1
17468,",",0,0
17469,which,0,0
17470,contains,0,0
17471,all,0,0
17472,the,0,0
17473,taste,0,1
17474,and,0,1
17475,odour,0,1
17476,",",0,1
17477,exactly,0,0
17478,duplicated,0,0
17479,the,0,0
17480,beneficial,1,0
17481,effects,1,1
17482,of,0,1
17483,whole,0,1
17484,garlic,0,0
17485,and,0,1
17486,onion,0,0
17487,.,0,0
17488,It,0,0
17489,is,0,0
17490,",",0,0
17491,therefore,0,0
17492,",",0,0
17493,concluded,0,0
17494,that,0,0
17495,the,0,0
17496,active,0,0
17497,principle,0,0
17498,of,0,1
17499,garlic,0,0
17500,and,0,0
17501,onion,0,0
17502,is,0,0
17503,the,0,0
17504,essential,0,0
17505,oil,0,0
17506,",",0,0
17507,which,0,0
17508,chemically,0,0
17509,is,0,0
17510,a,0,0
17511,combination,0,0
17512,of,0,0
17513,sulphur-containing,0,1
17514,compounds,0,0
17515,",",0,0
17516,mainly,0,0
17517,allyl,0,0
17518,propyl,0,0
17519,disulphide,0,1
17520,and,0,1
17521,diallyl,0,1
17522,disulphide,0,1
17523,.,0,0
17524,Children,0,0
17525,with,0,0
17526,persistent,0,1
17527,conduct,0,0
17528,problems,0,0
17529,who,0,0
17530,dropout,0,1
17531,of,0,0
17532,treatment,0,0
17533,.,0,0
17534,Dropout,1,1
17535,of,0,0
17536,treatment,0,0
17537,is,0,0
17538,one,0,0
17539,of,0,0
17540,the,0,0
17541,key,0,1
17542,issues,0,0
17543,in,0,0
17544,outcome,0,1
17545,in,0,0
17546,a,0,0
17547,child,0,0
17548,and,0,1
17549,adolescent,0,0
17550,mental,0,1
17551,health,0,1
17552,service,0,0
17553,.,0,0
17554,We,0,0
17555,report,0,0
17556,two,0,0
17557,studies,0,0
17558,focusing,0,0
17559,on,0,0
17560,the,0,0
17561,treatment,0,0
17562,process,0,0
17563,and,0,0
17564,the,0,0
17565,dropout,1,1
17566,rate,1,1
17567,of,1,1
17568,children,1,0
17569,with,0,0
17570,persistent,0,1
17571,conduct,0,0
17572,problems,0,1
17573,presenting,0,1
17574,to,0,0
17575,a,0,0
17576,community,0,0
17577,mental,0,1
17578,health,0,1
17579,service,0,1
17580,",",0,0
17581,using,0,0
17582,a,0,0
17583,prospective,0,0
17584,design,0,0
17585,.,0,0
17586,The,0,0
17587,first,0,1
17588,study,0,0
17589,included,0,0
17590,32,0,0
17591,children,0,0
17592,and,0,0
17593,used,0,0
17594,a,0,0
17595,randomised,0,0
17596,controlled,0,0
17597,treatment,0,0
17598,design,0,0
17599,comparing,0,0
17600,a,0,0
17601,CBT,0,0
17602,approach,0,0
17603,with,0,0
17604,conjoint,0,0
17605,family,0,1
17606,therapy,0,0
17607,and,0,0
17608,an,0,0
17609,eclectic,0,0
17610,approach,0,0
17611,.,0,0
17612,The,0,0
17613,overall,1,1
17614,dropout,1,1
17615,rate,1,1
17616,was,0,0
17617,36,0,0
17618,%,0,0
17619,.,0,0
17620,Dropout,1,1
17621,occurred,0,0
17622,significantly,0,0
17623,less,0,0
17624,frequently,0,0
17625,in,0,0
17626,the,0,0
17627,CBT,0,0
17628,group,0,0
17629,.,0,0
17630,The,0,0
17631,dropout,0,1
17632,group,0,0
17633,was,0,0
17634,associated,0,0
17635,with,0,0
17636,mothers,0,0
17637,who,0,0
17638,were,0,0
17639,younger,1,0
17640,and,1,1
17641,less,1,0
17642,educated,1,0
17643,",",0,0
17644,a,0,0
17645,poorer,1,0
17646,rating,1,1
17647,by,1,0
17648,the,1,0
17649,clinicians,1,0
17650,at,0,0
17651,the,0,0
17652,last,0,1
17653,meeting,0,0
17654,",",0,1
17655,parental,1,1
17656,dissatisfaction,1,1
17657,with,1,0
17658,the,1,0
17659,treatment,1,0
17660,service,1,1
17661,and,0,1
17662,perception,1,1
17663,that,1,0
17664,the,1,0
17665,treatment,1,0
17666,was,0,0
17667,less,0,0
17668,organised,0,0
17669,and,0,1
17670,having,0,0
17671,less,0,0
17672,behavioural,0,1
17673,tasks,0,1
17674,.,0,0
17675,In,0,0
17676,the,0,0
17677,second,0,0
17678,study,0,0
17679,we,0,0
17680,used,0,0
17681,a,0,0
17682,naturalistic,0,0
17683,follow-up,0,0
17684,design,0,0
17685,.,0,0
17686,Forty-six,0,0
17687,children,0,0
17688,were,0,0
17689,included,0,0
17690,.,0,0
17691,The,0,0
17692,overall,1,1
17693,dropout,1,1
17694,rate,1,1
17695,was,0,0
17696,48,0,0
17697,%,0,0
17698,.,0,0
17699,Again,0,1
17700,",",0,0
17701,the,0,0
17702,children,0,0
17703,who,0,0
17704,defaulted,0,0
17705,were,0,0
17706,rated,0,1
17707,by,0,0
17708,clinicians,0,0
17709,as,0,0
17710,less,0,0
17711,likely,0,0
17712,to,0,0
17713,have,0,0
17714,improved,0,1
17715,and,0,0
17716,dropout,0,1
17717,was,0,0
17718,also,0,0
17719,significantly,0,0
17720,associated,0,0
17721,with,0,0
17722,parental,1,1
17723,perception,1,1
17724,of,1,0
17725,a,1,0
17726,less,1,0
17727,organised,1,0
17728,treatment,1,0
17729,.,1,0
17730,In,0,0
17731,both,0,0
17732,studies,0,0
17733,dropout,1,1
17734,usually,0,0
17735,occurred,0,0
17736,after,0,0
17737,assessment,0,0
17738,and,0,0
17739,at,0,0
17740,the,0,0
17741,early,0,0
17742,phase,0,0
17743,of,0,0
17744,treatment,0,0
17745,.,0,0
17746,Peptide,1,1
17747,T,1,0
17748,:,1,0
17749,negative,1,1
17750,trial,1,0
17751,result,1,0
17752,.,1,0
17753,Dose,0,1
17754,response,0,1
17755,effect,0,1
17756,of,0,1
17757,cyclical,0,1
17758,medroxyprogesterone,0,0
17759,on,0,0
17760,blood,1,1
17761,pressure,1,1
17762,in,0,0
17763,postmenopausal,0,0
17764,women,0,0
17765,.,0,0
17766,OBJECTIVE,0,0
17767,This,0,0
17768,study,0,0
17769,was,0,0
17770,designed,0,0
17771,to,0,0
17772,compare,0,0
17773,with,0,0
17774,placebo,0,0
17775,the,0,0
17776,dose-response,0,1
17777,effect,0,0
17778,of,0,1
17779,cyclical,0,1
17780,doses,0,0
17781,of,0,0
17782,the,0,0
17783,C21,0,1
17784,progestogen,0,0
17785,",",0,1
17786,medroxyprogesterone,0,0
17787,acetate,0,1
17788,(,0,1
17789,MPA,0,1
17790,),0,1
17791,on,0,0
17792,blood,0,1
17793,pressure,0,1
17794,(,0,1
17795,BP,0,1
17796,),0,0
17797,when,0,0
17798,administered,0,0
17799,to,0,0
17800,normotensive,0,0
17801,postmenopausal,0,0
17802,women,0,0
17803,receiving,0,0
17804,a,0,0
17805,fixed,0,0
17806,mid-range,0,1
17807,daily,0,0
17808,dose,0,0
17809,of,0,1
17810,conjugated,0,1
17811,equine,0,0
17812,oestrogen,0,1
17813,(,0,1
17814,CEE,0,0
17815,),0,0
17816,.,0,0
17817,MATERIALS,0,0
17818,AND,0,0
17819,METHODS,0,0
17820,Twenty,0,0
17821,normotensive,0,0
17822,postmenopausal,0,0
17823,women,0,0
17824,(,0,0
17825,median,0,1
17826,age,0,0
17827,53,0,0
17828,years,0,0
17829,),0,0
17830,participated,0,0
17831,in,0,0
17832,the,0,0
17833,study,0,0
17834,which,0,0
17835,used,0,0
17836,a,0,0
17837,double-blind,0,0
17838,crossover,0,0
17839,design,0,0
17840,.,0,0
17841,There,0,0
17842,were,0,0
17843,four,0,0
17844,randomised,0,0
17845,treatment,0,0
17846,phases,0,0
17847,",",0,0
17848,each,0,0
17849,of,0,0
17850,4,0,0
17851,weeks,0,0
17852,duration,0,0
17853,.,0,0
17854,The,0,0
17855,four,0,0
17856,blinded,0,0
17857,treatments,0,0
17858,were,0,0
17859,MPA,0,0
17860,2.5,0,0
17861,mg,0,0
17862,",",0,0
17863,MPA,0,1
17864,5,0,0
17865,mg,0,0
17866,",",0,0
17867,MPA,0,1
17868,10,0,0
17869,mg,0,0
17870,and,0,0
17871,matching,0,0
17872,placebo,0,0
17873,",",0,0
17874,taken,0,0
17875,for,0,0
17876,the,0,0
17877,last,0,0
17878,14,0,0
17879,days,0,0
17880,of,0,0
17881,each,0,0
17882,28,0,0
17883,day,0,0
17884,treatment,0,0
17885,cycle,0,1
17886,.,0,0
17887,CEE,0,0
17888,0.625,0,0
17889,mg,0,0
17890,was,0,0
17891,also,0,0
17892,administered,0,0
17893,once,0,0
17894,daily,0,0
17895,as,0,0
17896,open,0,0
17897,labelled,0,0
17898,tablets,0,0
17899,to,0,0
17900,all,0,0
17901,subjects,0,0
17902,throughout,0,0
17903,the,0,0
17904,study,0,0
17905,.,0,0
17906,Clinic,1,0
17907,BP,1,1
17908,was,0,0
17909,measured,0,0
17910,weekly,0,0
17911,with,0,0
17912,the,0,0
17913,mean,0,1
17914,values,0,1
17915,of,0,0
17916,weeks,0,0
17917,3,0,0
17918,and,0,0
17919,4,0,0
17920,of,0,0
17921,each,0,0
17922,phase,0,0
17923,used,0,0
17924,for,0,0
17925,analysis,0,0
17926,.,0,0
17927,Ambulatory,1,1
17928,BP,1,1
17929,was,0,0
17930,performed,0,0
17931,in,0,0
17932,the,0,0
17933,final,0,1
17934,week,0,0
17935,of,0,0
17936,each,0,0
17937,phase,0,0
17938,.,0,1
17939,RESULTS,0,0
17940,Compared,0,0
17941,with,0,0
17942,the,0,0
17943,placebo,0,0
17944,phase,0,0
17945,",",0,1
17946,end,0,1
17947,of,0,1
17948,phase,0,0
17949,clinic,1,1
17950,BP,1,1
17951,was,0,0
17952,unchanged,0,0
17953,by,0,0
17954,any,0,0
17955,of,0,0
17956,the,0,0
17957,progestogen,0,0
17958,treatments,0,0
17959,.,0,0
17960,There,0,0
17961,was,0,0
17962,a,0,0
17963,dose-dependent,0,0
17964,decrease,1,1
17965,in,1,0
17966,ambulatory,1,0
17967,daytime,1,1
17968,diastolic,1,1
17969,and,1,1
17970,mean,1,1
17971,arterial,1,1
17972,BP,1,1
17973,with,0,0
17974,the,0,0
17975,progestogen,0,0
17976,treatments,0,0
17977,compared,0,0
17978,with,0,0
17979,placebo,0,0
17980,(,0,0
17981,P,0,0
17982,<,0,0
17983,0.05,0,0
17984,),0,0
17985,.,0,0
17986,CONCLUSION,0,0
17987,In,0,0
17988,a,0,0
17989,regimen,0,0
17990,of,0,1
17991,postmenopausal,0,0
17992,hormone,0,1
17993,replacement,0,0
17994,therapy,0,0
17995,with,0,0
17996,a,0,0
17997,fixed,0,0
17998,mid-range,0,1
17999,daily,0,0
18000,dose,0,0
18001,of,0,1
18002,CEE,0,0
18003,combined,0,0
18004,with,0,0
18005,a,0,0
18006,cyclical,0,1
18007,regimen,0,0
18008,of,0,0
18009,a,0,0
18010,C21,0,0
18011,progestogen,0,0
18012,spanning,0,0
18013,the,0,0
18014,current,0,0
18015,clinical,0,0
18016,dose,0,0
18017,range,0,0
18018,",",0,0
18019,the,0,0
18020,progestogen,0,0
18021,has,0,0
18022,either,0,0
18023,no,0,0
18024,effect,0,1
18025,or,0,0
18026,a,0,0
18027,small,0,0
18028,dose-dependent,0,0
18029,reduction,0,1
18030,in,0,0
18031,clinic,1,1
18032,and,1,1
18033,ambulatory,1,1
18034,BPs,1,1
18035,over,0,0
18036,one,0,0
18037,treatment,0,0
18038,cycle,0,0
18039,.,0,0
18040,Why,0,0
18041,were,0,0
18042,the,0,0
18043,results,0,0
18044,of,0,0
18045,the,0,0
18046,Heart,0,0
18047,Outcomes,0,1
18048,Prevention,0,0
18049,Evaluation,0,1
18050,(,0,1
18051,HOPE,0,1
18052,),0,1
18053,trial,0,0
18054,so,0,0
18055,astounding,0,0
18056,?,0,0
18057,The,0,0
18058,Heart,0,0
18059,Outcomes,0,1
18060,Prevention,0,0
18061,Evaluation,0,1
18062,(,0,1
18063,HOPE,0,1
18064,),0,1
18065,study,0,0
18066,was,0,0
18067,important,0,0
18068,because,0,0
18069,it,0,0
18070,showed,0,0
18071,the,0,0
18072,benefits,0,0
18073,of,0,0
18074,ramipril,0,0
18075,-,0,0
18076,an,0,0
18077,angiotensin-converting,0,0
18078,enzyme,0,0
18079,(,0,1
18080,ACE,0,1
18081,),0,0
18082,inhibitor,0,0
18083,-,0,0
18084,in,0,0
18085,patients,0,0
18086,at,0,0
18087,high,0,0
18088,risk,0,1
18089,for,0,0
18090,cardiovascular,0,1
18091,events,0,1
18092,.,0,0
18093,Treatment,0,0
18094,with,0,0
18095,ramipril,0,0
18096,significantly,0,0
18097,reduced,1,0
18098,the,1,0
18099,rates,1,1
18100,of,1,1
18101,death,1,1
18102,",",1,1
18103,myocardial,1,1
18104,infarction,1,1
18105,",",1,1
18106,stroke,1,1
18107,",",1,1
18108,coronary,1,1
18109,revascularization,1,1
18110,",",1,1
18111,cardiac,1,1
18112,arrest,1,1
18113,and,1,1
18114,heart,1,1
18115,failure,1,1
18116,",",1,0
18117,as,1,0
18118,well,1,0
18119,as,1,0
18120,the,1,0
18121,risk,1,1
18122,of,1,0
18123,diabetes-related,1,1
18124,complications,1,1
18125,and,1,1
18126,of,1,0
18127,diabetes,1,0
18128,itself,1,0
18129,.,1,0
18130,The,0,0
18131,effects,0,0
18132,of,0,0
18133,therapy,0,0
18134,with,0,0
18135,vitamin,0,1
18136,E,0,1
18137,were,0,0
18138,also,0,0
18139,evaluated,0,0
18140,",",0,0
18141,but,0,0
18142,no,1,0
18143,statistical,1,1
18144,benefits,1,0
18145,were,0,0
18146,shown,0,0
18147,.,0,0
18148,The,0,0
18149,benefits,0,0
18150,of,0,0
18151,ACE,0,1
18152,inhibitor,0,0
18153,therapy,0,0
18154,that,0,0
18155,were,0,0
18156,observed,0,0
18157,were,0,0
18158,likely,0,0
18159,due,0,0
18160,to,0,0
18161,a,0,0
18162,variety,0,0
18163,of,0,0
18164,mechanisms,0,0
18165,",",0,0
18166,not,0,0
18167,just,0,0
18168,a,0,0
18169,reduction,1,1
18170,in,1,0
18171,blood,1,1
18172,pressure,1,1
18173,.,1,0
18174,In,0,0
18175,vivo,0,0
18176,effect,0,1
18177,of,0,1
18178,clarithromycin,0,0
18179,on,0,0
18180,multiple,0,0
18181,cytochrome,0,0
18182,P450s,0,0
18183,.,0,0
18184,The,0,0
18185,in,0,0
18186,vivo,0,0
18187,effects,0,1
18188,of,0,0
18189,oral,0,0
18190,clarithromycin,0,0
18191,administration,0,0
18192,on,0,0
18193,the,0,0
18194,in,0,0
18195,vivo,0,0
18196,activity,0,1
18197,of,0,1
18198,cytochrome,0,0
18199,P450,0,0
18200,1A2,0,0
18201,",",0,0
18202,2C9,0,0
18203,",",0,0
18204,and,0,0
18205,2D6,0,0
18206,were,0,0
18207,determined,0,0
18208,.,0,0
18209,The,0,0
18210,cytochrome,0,0
18211,P450,0,0
18212,probes,0,0
18213,caffeine,0,0
18214,(,0,1
18215,CYP1A2,0,1
18216,),0,1
18217,",",0,0
18218,tolbutamide,0,0
18219,(,0,0
18220,CYP2C9,0,1
18221,),0,1
18222,",",0,1
18223,and,0,1
18224,dextromethorphan,0,0
18225,(,0,1
18226,CYP2D6,0,1
18227,),0,1
18228,were,0,0
18229,administered,0,0
18230,as,0,0
18231,an,0,0
18232,oral,0,0
18233,cocktail,0,0
18234,prior,0,0
18235,to,0,0
18236,and,0,0
18237,7,0,0
18238,days,0,0
18239,after,0,0
18240,oral,0,0
18241,clarithromycin,0,0
18242,(,0,0
18243,500,0,0
18244,mg,0,0
18245,twice,0,0
18246,daily,0,0
18247,),0,0
18248,administration,0,0
18249,to,0,0
18250,12,0,0
18251,healthy,0,0
18252,male,0,0
18253,subjects,0,0
18254,.,0,1
18255,Blood,1,1
18256,and,1,1
18257,urine,1,1
18258,samples,1,1
18259,were,0,0
18260,collected,0,0
18261,and,0,0
18262,assayed,0,0
18263,for,0,0
18264,each,0,0
18265,of,0,0
18266,the,0,0
18267,compounds,0,0
18268,and,0,0
18269,their,0,0
18270,metabolites,0,1
18271,using,0,0
18272,high-performance,0,0
18273,liquid,0,0
18274,chromatography,0,0
18275,.,0,0
18276,The,0,0
18277,CYP1A2,1,0
18278,indices,1,1
18279,",",1,1
18280,oral,1,0
18281,caffeine,1,0
18282,clearance,1,1
18283,(,0,0
18284,6.2,0,0
18285,+/-,0,0
18286,3.3,0,0
18287,l/h,0,0
18288,before,0,0
18289,and,0,0
18290,5.7,0,0
18291,+/-,0,0
18292,4.2,0,0
18293,l/h,0,0
18294,after,0,0
18295,",",0,0
18296,p,0,0
18297,>,0,0
18298,0.05,0,0
18299,),0,0
18300,and,0,0
18301,the,0,0
18302,6-h,1,0
18303,paraxanthine,1,0
18304,to,1,0
18305,caffeine,1,0
18306,serum,1,1
18307,concentration,1,1
18308,ratio,1,1
18309,(,0,0
18310,0.49,0,0
18311,+/-,0,0
18312,0.3,0,0
18313,before,0,0
18314,and,0,0
18315,0.44,0,0
18316,+/-,0,0
18317,0.3,0,0
18318,after,0,0
18319,",",0,0
18320,p,0,0
18321,>,0,0
18322,0.05,0,0
18323,),0,0
18324,",",0,0
18325,were,0,0
18326,unchanged,1,0
18327,following,0,0
18328,clarithromycin,0,0
18329,dosing,0,0
18330,.,0,0
18331,Neither,0,0
18332,the,0,0
18333,tolbutamide,1,0
18334,oral,1,0
18335,clearance,1,1
18336,(,0,0
18337,0.77,0,0
18338,+/-,0,0
18339,0.28,0,0
18340,l/h,0,0
18341,before,0,0
18342,and,0,0
18343,0.72,0,0
18344,+/-0.24,0,0
18345,l/h,0,0
18346,after,0,0
18347,",",0,0
18348,p,0,0
18349,>,0,0
18350,0.05,0,0
18351,),0,0
18352,nor,0,0
18353,the,0,0
18354,tolbutamide,1,0
18355,urinary,1,1
18356,metabolic,1,1
18357,ratio,1,1
18358,(,0,0
18359,779,0,0
18360,+/-,0,0
18361,294,0,0
18362,before,0,0
18363,and,0,0
18364,681,0,0
18365,+/-,0,0
18366,416,0,0
18367,after,0,0
18368,",",0,0
18369,p,0,0
18370,>,0,0
18371,0.05,0,0
18372,),0,0
18373,indices,0,1
18374,of,0,1
18375,CYP2C9,0,1
18376,were,0,0
18377,altered,0,0
18378,by,0,0
18379,clarithromycin,0,0
18380,administration,0,0
18381,.,0,0
18382,In,0,0
18383,the,0,0
18384,case,0,0
18385,of,0,1
18386,CYP2D6,0,0
18387,",",0,0
18388,the,0,0
18389,dextromethorphan,1,0
18390,to,1,0
18391,dextrorphan,1,0
18392,urinary,1,1
18393,ratio,1,1
18394,was,0,0
18395,not,0,0
18396,significantly,1,0
18397,different,1,0
18398,before,0,0
18399,(,0,0
18400,0.021,0,0
18401,+/-,0,0
18402,0.04,0,0
18403,),0,0
18404,and,0,0
18405,after,0,0
18406,(,0,0
18407,0.024,0,0
18408,+/-,0,0
18409,0.06,0,0
18410,),0,0
18411,clarithromycin,0,0
18412,dosing,0,0
18413,.,0,0
18414,In,0,0
18415,conclusion,0,0
18416,",",0,0
18417,clarithromycin,0,0
18418,does,0,0
18419,not,0,0
18420,appear,0,0
18421,to,0,0
18422,alter,0,0
18423,the,0,0
18424,in,0,0
18425,vivo,1,0
18426,catalytic,1,1
18427,activity,1,1
18428,of,0,1
18429,CYP1A2,0,1
18430,",",0,1
18431,CYP2C9,0,1
18432,",",0,1
18433,and,0,1
18434,CYP2D6,0,1
18435,in,0,0
18436,healthy,0,0
18437,individuals,0,0
18438,as,0,0
18439,assessed,0,0
18440,by,0,0
18441,caffeine,0,0
18442,",",0,1
18443,tolbutamide,0,0
18444,",",0,1
18445,and,0,1
18446,dextromethorphan,0,0
18447,",",0,0
18448,respectively,0,0
18449,.,0,0
18450,Gabapentin,0,0
18451,but,0,0
18452,not,0,0
18453,vigabatrin,0,0
18454,is,0,0
18455,effective,0,0
18456,in,0,0
18457,the,0,0
18458,treatment,0,0
18459,of,0,0
18460,acquired,0,0
18461,nystagmus,0,1
18462,in,0,0
18463,multiple,0,0
18464,sclerosis,0,0
18465,:,0,0
18466,How,0,0
18467,valid,0,0
18468,is,0,0
18469,the,0,0
18470,GABAergic,0,0
18471,hypothesis,0,0
18472,?,0,0
18473,Acquired,0,0
18474,nystagmus,0,1
18475,occurs,0,0
18476,frequently,0,0
18477,in,0,0
18478,patients,0,0
18479,with,0,0
18480,multiple,0,0
18481,sclerosis,0,0
18482,and,0,0
18483,is,0,0
18484,often,0,0
18485,the,0,0
18486,cause,0,0
18487,of,0,0
18488,illusory,0,1
18489,motion,0,1
18490,of,0,0
18491,the,0,0
18492,environment,0,0
18493,(,0,0
18494,oscillopsia,0,1
18495,),0,1
18496,",",0,1
18497,and,0,1
18498,blurring,0,1
18499,of,0,1
18500,vision,0,1
18501,.,0,0
18502,Based,0,0
18503,primarily,0,0
18504,on,0,0
18505,the,0,0
18506,beneficial,0,0
18507,effect,0,1
18508,of,0,1
18509,gabapentin,0,0
18510,on,0,0
18511,acquired,0,0
18512,pendular,0,0
18513,nystagmus,0,1
18514,(,0,1
18515,APN,0,0
18516,),0,0
18517,",",0,0
18518,a,0,0
18519,GABAergic,0,1
18520,mechanism,0,0
18521,in,0,0
18522,controlling,0,0
18523,nystagmus,0,1
18524,has,0,0
18525,been,0,0
18526,hypothesised,0,0
18527,.,0,0
18528,If,0,0
18529,increasing,0,0
18530,GABA,0,1
18531,concentrations,0,1
18532,in,0,0
18533,the,0,0
18534,CNS,0,0
18535,are,0,0
18536,critical,0,0
18537,for,0,0
18538,the,0,0
18539,treatment,0,0
18540,of,0,1
18541,nystagmus,0,1
18542,",",0,0
18543,then,0,0
18544,a,0,0
18545,selective,0,0
18546,GABAergic,0,0
18547,drug,0,0
18548,should,0,0
18549,be,0,0
18550,highly,0,0
18551,successful,0,0
18552,.,0,0
18553,However,0,0
18554,",",0,0
18555,as,0,0
18556,gabapentin,0,0
18557,is,0,0
18558,not,0,0
18559,a,0,0
18560,selective,0,0
18561,GABAergic,0,1
18562,agent,0,0
18563,",",0,1
18564,vigabatrin,0,0
18565,",",0,0
18566,a,0,0
18567,pure,0,0
18568,GABAergic,0,1
18569,medication,0,1
18570,",",0,1
18571,and,0,1
18572,gabapentin,0,0
18573,",",0,1
18574,were,0,0
18575,compared,0,0
18576,in,0,0
18577,a,0,0
18578,single,0,0
18579,blind,0,0
18580,cross,0,1
18581,over,0,0
18582,trial,0,0
18583,in,0,0
18584,eight,0,0
18585,patients,0,0
18586,with,0,0
18587,definite,0,0
18588,multiple,0,0
18589,sclerosis,0,0
18590,.,0,1
18591,Patients,0,0
18592,were,0,0
18593,randomly,0,0
18594,assigned,0,0
18595,to,0,0
18596,begin,0,0
18597,with,0,0
18598,gabapentin,0,0
18599,(,0,0
18600,1200,0,0
18601,mg,0,0
18602,daily,0,0
18603,),0,0
18604,or,0,1
18605,vigabatrin,0,0
18606,(,0,0
18607,2000,0,0
18608,mg,0,0
18609,daily,0,0
18610,),0,0
18611,.,0,0
18612,Neuro-ophthalmological,0,1
18613,and,0,1
18614,electro-oculographic,0,1
18615,(,0,1
18616,EOG,0,1
18617,),0,1
18618,evaluations,0,0
18619,were,0,0
18620,performed,0,0
18621,four,0,0
18622,and,0,0
18623,three,0,0
18624,times,0,1
18625,",",0,0
18626,respectively,0,0
18627,.,0,0
18628,Treatment,0,0
18629,efficacy,1,1
18630,was,0,0
18631,based,0,0
18632,on,0,0
18633,improving,0,0
18634,visual,1,1
18635,acuity,1,1
18636,and,0,1
18637,EOG,1,1
18638,indices,1,1
18639,(,1,1
18640,amplitude,1,1
18641,or,1,1
18642,frequency,1,1
18643,of,1,1
18644,nystagmus,1,1
18645,",",1,0
18646,or,1,0
18647,both,1,0
18648,),1,0
18649,by,0,0
18650,at,0,0
18651,least,0,0
18652,50,0,0
18653,%,0,0
18654,of,0,0
18655,pretreatment,0,0
18656,values,0,1
18657,.,0,0
18658,Three,0,0
18659,out,0,0
18660,of,0,0
18661,eight,0,0
18662,patients,0,0
18663,dropped,0,0
18664,out,0,0
18665,due,0,0
18666,to,0,0
18667,adverse,1,1
18668,effects,1,1
18669,.,1,0
18670,In,0,0
18671,the,0,0
18672,remaining,0,0
18673,five,0,0
18674,patients,0,0
18675,gabapentin,0,0
18676,improved,0,1
18677,symptomatic,1,1
18678,pendular,1,0
18679,or,1,1
18680,gaze,1,1
18681,evoked,1,1
18682,jerk,1,1
18683,nystagmus,1,1
18684,in,0,0
18685,four,0,0
18686,.,0,0
18687,Three,0,0
18688,patients,0,0
18689,decided,0,0
18690,to,0,0
18691,continue,0,0
18692,gabapentin,0,0
18693,therapy,0,0
18694,.,0,0
18695,Importantly,0,0
18696,",",0,0
18697,vigabatrin,0,0
18698,proved,0,0
18699,useful,0,0
18700,in,0,0
18701,only,0,0
18702,one,0,0
18703,out,0,0
18704,of,0,0
18705,five,0,0
18706,patients,0,0
18707,",",0,0
18708,suggesting,0,0
18709,that,0,0
18710,gabapentin,0,0
18711,effectiveness,0,0
18712,may,0,0
18713,be,0,0
18714,related,0,0
18715,to,0,0
18716,additional,0,0
18717,non-GABAergic,0,0
18718,mechanisms,0,0
18719,of,0,0
18720,action,0,1
18721,.,0,0
18722,Interaction,0,0
18723,with,0,0
18724,cerebral,0,1
18725,glutamate,0,1
18726,transmission,0,1
18727,by,0,0
18728,inhibition,0,1
18729,of,0,1
18730,NMDA,0,0
18731,receptor,0,0
18732,might,0,0
18733,be,0,0
18734,an,0,0
18735,alternative,0,0
18736,hypothesis,0,0
18737,for,0,0
18738,the,0,0
18739,therapeutic,0,0
18740,action,0,1
18741,of,0,0
18742,gabapentin,0,0
18743,.,0,0
18744,Four-year,0,1
18745,outcomes,0,1
18746,from,0,0
18747,adolescent,0,0
18748,alcohol,0,1
18749,and,0,1
18750,drug,0,0
18751,treatment,0,0
18752,.,0,1
18753,OBJECTIVE,0,1
18754,Knowledge,0,1
18755,of,0,1
18756,treatment,0,0
18757,response,0,1
18758,for,0,0
18759,alcohol,0,1
18760,and,0,1
18761,drug,0,0
18762,problems,0,1
18763,among,0,0
18764,adults,0,0
18765,is,0,0
18766,mounting,0,0
18767,;,0,0
18768,less,0,0
18769,is,0,0
18770,known,0,0
18771,about,0,0
18772,long-term,0,0
18773,outcome,0,1
18774,for,0,0
18775,adolescents,0,0
18776,who,0,0
18777,receive,0,0
18778,treatment,0,0
18779,for,0,0
18780,alcohol,0,1
18781,and,0,1
18782,drug,0,0
18783,problems,0,1
18784,.,0,0
18785,The,0,0
18786,current,0,0
18787,study,0,0
18788,examined,0,0
18789,youth,0,0
18790,substance,0,1
18791,involvement,0,1
18792,over,0,0
18793,4,0,0
18794,years,0,0
18795,(,0,0
18796,using,0,0
18797,five,0,0
18798,waves,0,0
18799,of,0,0
18800,data,0,0
18801,collection,0,0
18802,),0,0
18803,following,0,0
18804,treatment,0,0
18805,for,0,0
18806,alcohol,0,1
18807,and,0,1
18808,drug,0,0
18809,abuse,0,1
18810,.,0,1
18811,METHOD,0,0
18812,A,0,0
18813,cohort,0,0
18814,of,0,1
18815,youth,0,1
18816,(,0,0
18817,N,0,0
18818,=,0,0
18819,162,0,0
18820,",",0,0
18821,60,0,0
18822,%,0,0
18823,male,0,0
18824,),0,1
18825,treated,0,0
18826,during,0,0
18827,adolescence,0,1
18828,(,0,0
18829,mean,0,1
18830,age,0,0
18831,=,0,0
18832,16,0,0
18833,years,0,0
18834,),0,0
18835,was,0,0
18836,followed,0,0
18837,into,0,0
18838,young,0,0
18839,adulthood,0,0
18840,",",0,0
18841,a,0,0
18842,period,0,0
18843,associated,0,0
18844,with,0,0
18845,stabilization,0,0
18846,of,0,1
18847,alcohol,0,1
18848,use,0,1
18849,patterns,0,1
18850,and,0,1
18851,elevated,0,1
18852,risk,0,1
18853,for,0,0
18854,life,0,1
18855,problems,0,1
18856,secondary,0,0
18857,to,0,0
18858,both,0,0
18859,alcohol,0,1
18860,and,0,1
18861,drug,0,0
18862,use,0,1
18863,.,0,1
18864,Participants,0,0
18865,(,0,0
18866,14-18,0,0
18867,years,0,0
18868,old,0,0
18869,),0,0
18870,were,0,0
18871,consecutive,0,0
18872,admissions,0,1
18873,to,0,0
18874,inpatient,0,0
18875,adolescent,0,0
18876,alcohol,0,1
18877,and,0,1
18878,drug,0,1
18879,treatment,0,0
18880,centers,0,0
18881,in,0,0
18882,San,0,0
18883,Diego,0,0
18884,that,0,0
18885,were,0,0
18886,abstinence,0,1
18887,focused,0,0
18888,and,0,0
18889,based,0,0
18890,on,0,0
18891,the,0,0
18892,12-step,0,0
18893,approach,0,0
18894,.,0,0
18895,RESULTS,0,0
18896,Alcohol,1,1
18897,and,1,1
18898,other,1,1
18899,drug,1,1
18900,use,1,1
18901,were,0,0
18902,reduced,0,0
18903,during,0,0
18904,the,0,0
18905,4,0,0
18906,years,0,0
18907,posttreatment,0,0
18908,",",0,0
18909,with,0,0
18910,the,0,0
18911,exception,0,0
18912,of,0,0
18913,nicotine,0,0
18914,.,0,0
18915,The,0,0
18916,greatest,0,0
18917,prevalence,1,1
18918,reduction,1,1
18919,occurred,0,0
18920,for,0,0
18921,stimulants,0,0
18922,;,0,0
18923,modest,0,0
18924,changes,0,1
18925,were,0,0
18926,evident,0,0
18927,in,0,0
18928,alcohol,0,1
18929,and,0,1
18930,marijuana,0,1
18931,use,0,1
18932,.,0,1
18933,Nicotine,0,0
18934,was,0,0
18935,the,0,0
18936,most,0,0
18937,commonly,0,0
18938,used,0,0
18939,substance,0,0
18940,throughout,0,0
18941,the,0,0
18942,4,0,0
18943,years,0,0
18944,after,0,0
18945,treatment,0,0
18946,.,0,0
18947,Several,0,0
18948,distinct,0,0
18949,substance,0,1
18950,involvement,0,1
18951,trajectories,0,1
18952,were,0,0
18953,evident,0,0
18954,during,0,0
18955,the,0,0
18956,4,0,0
18957,years,0,0
18958,following,0,0
18959,treatment,0,0
18960,.,0,0
18961,CONCLUSIONS,0,0
18962,Alcohol,0,1
18963,and,0,1
18964,drug,0,1
18965,use,0,1
18966,patterns,0,0
18967,during,0,0
18968,the,0,0
18969,4,0,0
18970,years,0,0
18971,following,0,0
18972,treatment,0,0
18973,highlight,0,0
18974,both,0,0
18975,changes,0,1
18976,and,0,1
18977,diversity,0,1
18978,in,0,0
18979,substance,0,1
18980,involvement,0,1
18981,as,0,0
18982,youth,0,0
18983,make,0,0
18984,the,0,0
18985,transitions,0,0
18986,from,0,0
18987,middle,0,0
18988,to,0,0
18989,late,0,1
18990,adolescence,0,1
18991,and,0,1
18992,into,0,0
18993,young,0,0
18994,adulthood,0,0
18995,.,0,0
18996,Findings,0,0
18997,demonstrate,0,0
18998,the,0,0
18999,importance,0,0
19000,of,0,0
19001,identifying,0,0
19002,transitional,0,0
19003,periods,0,0
19004,and,0,0
19005,the,0,0
19006,need,0,0
19007,for,0,0
19008,alternative,0,0
19009,intervention,0,0
19010,strategies,0,0
19011,that,0,0
19012,may,0,0
19013,help,0,0
19014,the,0,0
19015,progression,0,1
19016,of,0,0
19017,this,0,0
19018,population,0,0
19019,into,0,0
19020,young,0,0
19021,adulthood,0,0
19022,.,0,0
19023,Effect,0,1
19024,of,0,1
19025,ischaemic,0,1
19026,preconditioning,0,0
19027,",",0,1
19028,cardiopulmonary,0,1
19029,bypass,0,1
19030,and,0,1
19031,myocardial,0,1
19032,ischaemic/reperfusion,0,1
19033,on,0,0
19034,free,1,1
19035,radical,1,0
19036,generation,1,1
19037,in,0,0
19038,CABG,0,1
19039,patients,0,0
19040,.,0,0
19041,OBJECTIVE,0,0
19042,To,0,0
19043,investigate,0,0
19044,the,0,0
19045,free,0,1
19046,radicals,0,1
19047,(,0,0
19048,FR,0,1
19049,),0,1
19050,generation,0,1
19051,after,0,0
19052,ischaemic,0,1
19053,preconditioning,0,0
19054,and,0,1
19055,cardiopulmonary,0,1
19056,bypass,0,1
19057,and,0,1
19058,during,0,0
19059,reperfusion,0,1
19060,in,0,0
19061,CABG,0,1
19062,patients,0,0
19063,",",0,0
19064,and,0,0
19065,the,0,0
19066,role,0,0
19067,of,0,0
19068,ischaemic,0,0
19069,preconditioning,0,0
19070,.,0,0
19071,METHODS,0,0
19072,Forty-three,0,0
19073,CABG,0,1
19074,patients,0,0
19075,were,0,0
19076,randomised,0,0
19077,into,0,0
19078,an,0,0
19079,ischaemic,0,1
19080,preconditioning,0,0
19081,and,0,0
19082,a,0,0
19083,control,0,0
19084,group,0,0
19085,.,0,0
19086,The,0,0
19087,protocol,0,0
19088,for,0,0
19089,ischaemic,0,1
19090,preconditioning,0,0
19091,was,0,0
19092,two,0,0
19093,cycles,0,0
19094,of,0,0
19095,2-min,0,0
19096,ischaemia,0,1
19097,followed,0,0
19098,by,0,0
19099,3-min,0,0
19100,reperfusion,0,1
19101,.,0,0
19102,Free,1,1
19103,radicals,1,1
19104,were,0,0
19105,measured,0,0
19106,using,0,0
19107,electron,0,0
19108,spin,0,1
19109,resonance,0,0
19110,spectroscopy,0,0
19111,.,0,1
19112,Global,1,1
19113,and,1,1
19114,right,1,1
19115,heart,1,1
19116,functions,1,1
19117,were,0,0
19118,collected,0,0
19119,.,0,0
19120,RESULTS,0,0
19121,The,0,0
19122,free,1,1
19123,radicals,1,1
19124,generation,1,1
19125,in,1,0
19126,coronary,1,1
19127,sinus,1,0
19128,blood,1,1
19129,in,0,0
19130,the,0,0
19131,ischaemic,0,0
19132,preconditioning,0,0
19133,group,0,0
19134,was,0,0
19135,9.7,0,0
19136,and,0,0
19137,16.6,0,0
19138,%,0,0
19139,after,0,0
19140,the,0,0
19141,ischaemic,0,0
19142,preconditioning,0,0
19143,protocol,0,0
19144,and,0,0
19145,10,0,0
19146,min,0,0
19147,after,0,0
19148,declamping,0,0
19149,",",0,0
19150,6.8,0,0
19151,and,0,0
19152,13.3,0,0
19153,%,0,0
19154,in,0,0
19155,the,0,0
19156,controls,0,0
19157,.,0,0
19158,The,0,0
19159,free,1,1
19160,radicals,1,1
19161,in,1,0
19162,arterial,1,1
19163,samples,1,0
19164,were,0,0
19165,",",0,0
19166,respectively,0,0
19167,",",0,0
19168,21,0,0
19169,",",0,0
19170,14,0,0
19171,",",0,0
19172,10,0,0
19173,and,0,0
19174,9,0,0
19175,%,0,0
19176,at,0,0
19177,10,0,0
19178,min,0,0
19179,",",0,0
19180,1,0,0
19181,",",0,0
19182,2,0,0
19183,and,0,0
19184,24,0,0
19185,h,0,0
19186,after,0,0
19187,reperfusion,0,1
19188,.,0,1
19189,Cardiac,1,1
19190,index,1,1
19191,(,1,1
19192,CI,1,0
19193,),1,1
19194,and,1,1
19195,right,1,1
19196,ventricular,1,1
19197,ejection,1,1
19198,fraction,1,1
19199,(,1,1
19200,RVEF,1,1
19201,),1,1
19202,were,0,0
19203,improved,0,0
19204,by,0,0
19205,ischaemic,0,0
19206,preconditioning,0,0
19207,.,0,0
19208,CONCLUSION,0,0
19209,Both,0,0
19210,ischaemic,0,1
19211,preconditioning,0,0
19212,and,0,1
19213,cardiopulmonary,0,1
19214,bypass,0,1
19215,induced,0,0
19216,free,1,1
19217,radicals,1,1
19218,generation,1,1
19219,.,1,0
19220,Although,0,0
19221,ischaemic,0,1
19222,preconditioning,0,0
19223,had,0,0
19224,no,0,0
19225,effect,0,1
19226,on,0,0
19227,free,1,1
19228,radicals,1,1
19229,generation,1,1
19230,after,0,0
19231,the,0,0
19232,operation,0,0
19233,",",0,0
19234,it,0,0
19235,protected,0,0
19236,against,0,0
19237,postoperative,0,1
19238,stunning,0,1
19239,.,0,0
19240,Nicotine,0,1
19241,infusion,0,0
19242,acutely,0,0
19243,impairs,0,0
19244,insulin,0,1
19245,sensitivity,0,1
19246,in,0,0
19247,type,0,0
19248,2,0,0
19249,diabetic,0,0
19250,patients,0,0
19251,but,0,0
19252,not,0,0
19253,in,0,0
19254,healthy,0,0
19255,subjects,0,0
19256,.,0,0
19257,OBJECTIVES,0,0
19258,The,0,0
19259,aim,0,0
19260,of,0,0
19261,this,0,0
19262,study,0,0
19263,was,0,0
19264,to,0,0
19265,examine,0,0
19266,if,0,0
19267,an,0,0
19268,acute,0,0
19269,nicotine,0,0
19270,infusion,0,0
19271,alters,0,0
19272,insulin,0,1
19273,sensitivity,0,1
19274,to,0,0
19275,a,0,0
19276,similar,0,0
19277,degree,0,1
19278,in,0,0
19279,type,0,0
19280,2,0,0
19281,diabetic,0,0
19282,patients,0,0
19283,as,0,0
19284,in,0,0
19285,healthy,0,0
19286,control,0,0
19287,subjects,0,0
19288,.,0,0
19289,DESIGN,0,0
19290,.,0,1
19291,Double-blind,0,0
19292,",",0,1
19293,cross-over,0,0
19294,",",0,1
19295,placebo-controlled,0,0
19296,",",0,1
19297,randomized,0,0
19298,experimental,0,0
19299,study,0,0
19300,.,0,0
19301,Nicotine,0,0
19302,0.3,0,0
19303,microg,0,0
19304,kg-1,0,0
19305,min,0,0
19306,(,0,1
19307,-1,0,0
19308,),0,1
19309,or,0,1
19310,NaCl,0,1
19311,was,0,0
19312,infused,0,0
19313,(,0,0
19314,2,0,0
19315,h,0,0
19316,),0,0
19317,during,0,0
19318,a,0,0
19319,euglycaemic,0,0
19320,hyperinsulinaemic,0,1
19321,clamp,0,0
19322,(,0,0
19323,4,0,0
19324,h,0,0
19325,),0,0
19326,to,0,0
19327,assess,0,0
19328,insulin,0,1
19329,sensitivity,0,1
19330,.,0,0
19331,SETTING,0,0
19332,University,0,0
19333,research,0,0
19334,laboratory,0,1
19335,.,0,1
19336,SUBJECTS,0,1
19337,Six,0,0
19338,male,0,0
19339,and,0,1
19340,female,0,0
19341,type,0,0
19342,2,0,0
19343,diabetic,0,0
19344,patients,0,0
19345,[,0,0
19346,DM2,0,1
19347,;,0,0
19348,age,0,0
19349,54,0,0
19350,+/-,0,0
19351,10,0,0
19352,(,0,0
19353,mean,0,1
19354,+/-,0,0
19355,SD,0,0
19356,),0,0
19357,years,0,0
19358,;,0,0
19359,body,0,1
19360,mass,0,1
19361,index,0,1
19362,(,0,1
19363,BMI,0,1
19364,),0,0
19365,25.6,0,0
19366,+/-,0,0
19367,2.9,0,0
19368,kg,0,0
19369,m,0,0
19370,(,0,1
19371,-2,0,0
19372,),0,1
19373,],0,0
19374,treated,0,0
19375,with,0,0
19376,diet,0,0
19377,or,0,0
19378,one,0,0
19379,oral,0,0
19380,hypoglycaemic,0,1
19381,agent,0,0
19382,and,0,0
19383,six,0,0
19384,age-,0,0
19385,and,0,0
19386,BMI-matched,0,0
19387,control,0,0
19388,subjects,0,0
19389,(,0,1
19390,Ctr,0,0
19391,),0,0
19392,.,0,0
19393,MAIN,0,0
19394,OUTCOME,0,1
19395,MEASURE,0,1
19396,Insulin,1,1
19397,sensitivity,1,1
19398,(,1,1
19399,rate,1,1
19400,of,1,1
19401,glucose,1,1
19402,infusion,1,0
19403,per,1,0
19404,kg,1,0
19405,fat,1,1
19406,free,1,1
19407,body,1,1
19408,mass,1,1
19409,and,1,1
19410,minute,1,1
19411,),1,1
19412,",",1,1
19413,nicotine,1,0
19414,and,1,1
19415,free,1,1
19416,fatty,1,1
19417,acid,1,1
19418,(,1,1
19419,FFA,1,0
19420,),1,1
19421,levels,1,1
19422,",",1,1
19423,pulse,1,1
19424,rate,1,1
19425,and,1,1
19426,blood,1,1
19427,pressure,1,1
19428,.,1,0
19429,RESULTS,0,0
19430,The,0,0
19431,infusions,0,0
19432,produced,0,0
19433,similar,0,0
19434,nicotine,0,0
19435,levels,0,1
19436,in,0,0
19437,both,0,0
19438,groups,0,0
19439,.,0,0
19440,In,0,0
19441,the,0,0
19442,absence,0,0
19443,of,0,1
19444,nicotine,0,0
19445,",",0,1
19446,DM2,0,1
19447,were,0,0
19448,more,0,0
19449,insulin,1,1
19450,resistant,1,1
19451,than,0,0
19452,Ctr,0,0
19453,(,0,0
19454,6.7,0,0
19455,+/-,0,0
19456,0.4,0,0
19457,vs.,0,0
19458,10.9,0,0
19459,+/-,0,0
19460,0.3,0,0
19461,mg,0,0
19462,kg-1,0,0
19463,LBM,0,1
19464,min,0,0
19465,(,0,1
19466,-1,0,0
19467,),0,1
19468,",",0,0
19469,respectively,0,0
19470,;,0,0
19471,P,0,0
19472,<,0,0
19473,0.0001,0,0
19474,),0,0
19475,.,0,0
19476,This,0,0
19477,insulin,1,1
19478,resistance,1,1
19479,was,0,0
19480,further,0,0
19481,aggravated,0,0
19482,by,0,0
19483,the,0,0
19484,nicotine,0,0
19485,infusion,0,0
19486,in,0,0
19487,DM2,0,1
19488,but,0,0
19489,not,0,0
19490,in,0,0
19491,Ctr,0,0
19492,(,0,0
19493,4.6,0,0
19494,+/-,0,0
19495,0.3,0,0
19496,vs.,0,0
19497,10.9,0,0
19498,+/-,0,0
19499,0.3,0,0
19500,mg,0,0
19501,kg,0,0
19502,(,0,1
19503,-1,0,0
19504,),0,1
19505,LBM,0,1
19506,min,0,0
19507,(,0,1
19508,-1,0,0
19509,),0,0
19510,;,0,0
19511,P,0,0
19512,<,0,0
19513,0.0001,0,0
19514,),0,0
19515,.,0,0
19516,Only,0,0
19517,minor,0,0
19518,differences,0,0
19519,were,0,0
19520,seen,0,0
19521,in,0,0
19522,FFA,1,0
19523,levels,1,1
19524,",",1,1
19525,pulse,1,1
19526,rates,1,1
19527,and,1,1
19528,blood,1,1
19529,pressure,1,1
19530,.,1,1
19531,CONCLUSIONS,0,0
19532,At,0,0
19533,this,0,0
19534,low,0,0
19535,infusion,0,0
19536,rate,0,1
19537,",",0,1
19538,nicotine,0,0
19539,aggravated,0,0
19540,the,0,0
19541,insulin,1,1
19542,resistance,1,1
19543,in,0,0
19544,DM2,0,1
19545,but,0,0
19546,not,0,0
19547,in,0,0
19548,Ctr,0,0
19549,.,0,0
19550,This,0,0
19551,finding,0,0
19552,may,0,0
19553,be,0,0
19554,because,0,0
19555,of,0,0
19556,the,0,0
19557,(,0,0
19558,dysmetabolic,0,1
19559,),0,1
19560,diabetic,0,0
19561,state,0,1
19562,per,0,1
19563,se,0,1
19564,or,0,0
19565,to,0,0
19566,an,0,0
19567,increased,0,0
19568,sensitivity,0,1
19569,to,0,0
19570,environmental,0,0
19571,factors,0,0
19572,associated,0,0
19573,with,0,0
19574,a,0,0
19575,genetic,0,0
19576,predisposition,0,0
19577,for,0,0
19578,type,0,0
19579,2,0,0
19580,diabetes,0,0
19581,.,0,0
19582,These,0,0
19583,results,0,0
19584,show,0,0
19585,that,0,0
19586,diabetic,0,0
19587,subjects,0,0
19588,are,0,0
19589,particularly,0,0
19590,susceptible,0,0
19591,to,0,0
19592,the,0,0
19593,detrimental,0,0
19594,effects,0,1
19595,of,0,0
19596,nicotine,0,0
19597,.,0,0
19598,The,0,0
19599,clinical,0,0
19600,and,0,0
19601,biochemical,0,1
19602,effects,0,1
19603,of,0,1
19604,propofol,0,0
19605,infusion,0,0
19606,with,0,0
19607,and,0,1
19608,without,0,0
19609,EDTA,0,0
19610,for,0,0
19611,maintenance,0,0
19612,anesthesia,0,0
19613,in,0,0
19614,healthy,0,0
19615,children,0,0
19616,undergoing,0,0
19617,ambulatory,0,0
19618,surgery,0,0
19619,.,0,0
19620,UNLABELLED,0,0
19621,We,0,0
19622,conducted,0,0
19623,this,0,0
19624,randomized,0,0
19625,",",0,0
19626,double-blinded,0,0
19627,",",0,1
19628,comparative,0,0
19629,",",0,1
19630,parallel-group,0,0
19631,study,0,0
19632,to,0,0
19633,determine,0,0
19634,whether,0,0
19635,adding,0,0
19636,EDTA,0,0
19637,to,0,0
19638,propofol,0,0
19639,would,0,0
19640,affect,0,0
19641,the,0,0
19642,clinical,0,0
19643,profile,0,1
19644,",",0,1
19645,calcium,0,1
19646,and,0,1
19647,magnesium,0,0
19648,homeostasis,0,1
19649,",",0,1
19650,or,0,1
19651,renal,0,1
19652,function,0,1
19653,in,0,0
19654,healthy,0,0
19655,children,0,0
19656,.,0,0
19657,After,0,0
19658,the,0,0
19659,induction,0,0
19660,of,0,0
19661,anesthesia,0,0
19662,with,0,0
19663,halothane,0,0
19664,",",0,0
19665,69,0,0
19666,ambulatory,0,0
19667,surgical,0,0
19668,patients,0,0
19669,(,0,0
19670,1,0,0
19671,mo,0,0
19672,to,0,0
19673,<,0,0
19674,17,0,0
19675,yr,0,0
19676,old,0,0
19677,),0,1
19678,",",0,1
19679,received,0,0
19680,propofol,0,0
19681,without,0,0
19682,EDTA,0,0
19683,(,0,0
19684,n,0,0
19685,=,0,0
19686,33,0,0
19687,),0,0
19688,or,0,0
19689,propofol,0,0
19690,with,0,0
19691,EDTA,0,0
19692,(,0,0
19693,n,0,0
19694,=,0,0
19695,36,0,0
19696,),0,0
19697,.,0,0
19698,Blood,1,1
19699,samples,1,0
19700,were,0,0
19701,obtained,0,0
19702,for,0,0
19703,the,0,0
19704,measurement,1,0
19705,of,1,0
19706,ionized,1,1
19707,calcium,1,1
19708,",",1,1
19709,ionized,1,1
19710,magnesium,1,0
19711,",",1,1
19712,and,1,1
19713,laboratory,1,1
19714,indicators,1,1
19715,of,1,1
19716,renal,1,1
19717,function,1,1
19718,.,1,0
19719,Hemodynamic,1,1
19720,measurements,1,1
19721,",",1,1
19722,recovery,1,1
19723,",",0,1
19724,and,0,1
19725,adverse,1,1
19726,events,1,1
19727,were,0,0
19728,recorded,0,0
19729,.,0,0
19730,Propofol,0,0
19731,with,0,0
19732,EDTA,0,0
19733,produced,0,0
19734,no,0,0
19735,significant,0,0
19736,effects,0,1
19737,on,0,0
19738,clinical,1,1
19739,efficacy,1,1
19740,or,1,1
19741,renal,1,1
19742,function,1,1
19743,.,1,1
19744,Propofol,0,0
19745,and,0,1
19746,propofol,0,0
19747,EDTA,0,0
19748,produced,0,0
19749,a,0,0
19750,statistically,0,0
19751,significant,0,0
19752,decrease,1,1
19753,from,1,0
19754,baseline,1,0
19755,in,1,0
19756,serum,1,1
19757,concentrations,1,1
19758,of,1,1
19759,ionized,1,1
19760,calcium,1,1
19761,and,1,1
19762,magnesium,1,0
19763,during,1,0
19764,infusion,1,0
19765,(,0,0
19766,P,0,0
19767,<,0,0
19768,0.05,0,0
19769,),0,0
19770,",",0,0
19771,but,0,0
19772,with,0,0
19773,no,0,0
19774,apparent,0,0
19775,clinical,0,0
19776,effect,0,1
19777,.,0,0
19778,Hemodynamic,1,1
19779,measurements,1,1
19780,generally,0,0
19781,remained,0,0
19782,stable,0,1
19783,and,0,1
19784,were,0,0
19785,similar,0,0
19786,for,0,0
19787,both,0,0
19788,groups,0,0
19789,.,0,0
19790,Statistically,0,0
19791,significant,0,0
19792,changes,0,1
19793,in,0,0
19794,systolic,1,1
19795,blood,1,1
19796,pressure,1,1
19797,",",1,1
19798,mean,1,1
19799,arterial,1,1
19800,pressure,1,1
19801,",",1,1
19802,and,1,1
19803,heart,1,1
19804,rate,1,1
19805,were,0,0
19806,not,0,0
19807,considered,0,0
19808,clinically,0,0
19809,significant,0,0
19810,.,0,0
19811,Adverse,0,1
19812,events,0,1
19813,were,0,0
19814,mild,0,0
19815,or,0,0
19816,moderate,0,0
19817,.,0,0
19818,The,0,0
19819,addition,0,0
19820,of,0,0
19821,EDTA,0,0
19822,does,0,0
19823,not,0,0
19824,alter,0,0
19825,the,0,0
19826,clinical,0,0
19827,profile,0,1
19828,of,0,1
19829,propofol,0,0
19830,in,0,0
19831,pediatric,0,0
19832,ambulatory,0,0
19833,surgical,0,0
19834,patients,0,0
19835,.,0,0
19836,With,0,0
19837,or,0,0
19838,without,0,0
19839,EDTA,0,1
19840,",",0,0
19841,propofol,0,0
19842,is,0,0
19843,associated,0,0
19844,with,0,0
19845,a,0,0
19846,decrease,0,1
19847,in,0,0
19848,ionized,1,1
19849,calcium,1,0
19850,with,0,0
19851,no,0,0
19852,apparent,0,0
19853,clinical,0,0
19854,effect,0,0
19855,.,0,0
19856,IMPLICATIONS,0,0
19857,The,0,0
19858,addition,0,0
19859,of,0,0
19860,EDTA,0,0
19861,does,0,0
19862,not,0,0
19863,alter,0,0
19864,the,0,0
19865,clinical,0,0
19866,profile,0,1
19867,of,0,1
19868,propofol,0,0
19869,in,0,0
19870,pediatric,0,0
19871,ambulatory,0,0
19872,surgical,0,0
19873,patients,0,0
19874,.,0,0
19875,With,0,0
19876,or,0,0
19877,without,0,0
19878,EDTA,0,1
19879,",",0,0
19880,propofol,0,0
19881,is,0,0
19882,associated,0,0
19883,with,0,0
19884,a,0,0
19885,decrease,0,1
19886,in,0,0
19887,ionized,1,1
19888,calcium,1,0
19889,with,0,0
19890,no,0,0
19891,apparent,0,0
19892,clinical,0,0
19893,effect,0,0
19894,.,0,0
19895,Lamotrigine,0,0
19896,therapy,0,0
19897,for,0,0
19898,autistic,0,0
19899,disorder,0,0
19900,:,0,0
19901,a,0,0
19902,randomized,0,0
19903,",",0,0
19904,double-blind,0,0
19905,",",0,1
19906,placebo-controlled,0,0
19907,trial,0,0
19908,.,0,0
19909,In,0,0
19910,autism,0,0
19911,",",0,0
19912,glutamate,0,0
19913,may,0,0
19914,be,0,0
19915,increased,0,0
19916,or,0,0
19917,its,0,0
19918,receptors,0,1
19919,up-regulated,0,0
19920,as,0,0
19921,part,0,0
19922,of,0,0
19923,an,0,0
19924,excitotoxic,0,1
19925,process,0,0
19926,that,0,0
19927,damages,0,1
19928,neural,0,0
19929,networks,0,0
19930,and,0,0
19931,subsequently,0,0
19932,contributes,0,0
19933,to,0,0
19934,behavioral,0,1
19935,and,0,0
19936,cognitive,0,1
19937,deficits,0,1
19938,seen,0,0
19939,in,0,0
19940,the,0,0
19941,disorder,0,0
19942,.,0,0
19943,This,0,0
19944,was,0,0
19945,a,0,0
19946,double-blind,0,0
19947,",",0,0
19948,placebo-controlled,0,0
19949,",",0,1
19950,parallel,0,0
19951,group,0,0
19952,study,0,0
19953,of,0,1
19954,lamotrigine,0,0
19955,",",0,0
19956,an,0,0
19957,agent,0,0
19958,that,0,0
19959,modulates,0,1
19960,glutamate,0,0
19961,release,0,1
19962,.,0,0
19963,Twenty-eight,0,0
19964,children,0,0
19965,(,0,0
19966,27,0,0
19967,boys,0,0
19968,),0,0
19969,ages,0,0
19970,3,0,0
19971,to,0,0
19972,11,0,0
19973,years,0,0
19974,(,0,0
19975,M,0,0
19976,=,0,0
19977,5.8,0,0
19978,),0,0
19979,with,0,0
19980,a,0,0
19981,primary,0,0
19982,diagnosis,0,0
19983,of,0,1
19984,autistic,0,1
19985,disorder,0,0
19986,received,0,0
19987,either,0,0
19988,placebo,0,0
19989,or,0,1
19990,lamotrigine,0,0
19991,twice,0,0
19992,daily,0,0
19993,.,0,0
19994,In,0,0
19995,children,0,0
19996,on,0,0
19997,lamotrigine,0,0
19998,",",0,0
19999,the,0,0
20000,drug,0,0
20001,was,0,0
20002,titrated,0,0
20003,upward,0,0
20004,over,0,0
20005,8,0,0
20006,weeks,0,0
20007,to,0,0
20008,reach,0,0
20009,a,0,0
20010,mean,0,1
20011,maintenance,0,0
20012,dose,0,0
20013,of,0,0
20014,5.0,0,0
20015,mg/kg,0,0
20016,per,0,0
20017,day,0,0
20018,.,0,0
20019,This,0,0
20020,dose,0,0
20021,was,0,0
20022,then,0,0
20023,maintained,0,0
20024,for,0,0
20025,4,0,0
20026,weeks,0,0
20027,.,0,0
20028,Following,0,1
20029,maintenance,0,0
20030,evaluations,0,0
20031,",",0,0
20032,the,0,0
20033,drug,0,0
20034,was,0,0
20035,tapered,0,0
20036,down,0,1
20037,over,0,0
20038,2,0,0
20039,weeks,0,0
20040,.,0,0
20041,The,0,0
20042,trial,0,0
20043,ended,0,0
20044,with,0,0
20045,a,0,0
20046,4-week,0,0
20047,drug-free,0,0
20048,period,0,0
20049,.,0,0
20050,Outcome,0,1
20051,measures,0,1
20052,included,0,0
20053,improvements,1,1
20054,in,1,0
20055,severity,1,1
20056,and,1,1
20057,behavioral,1,1
20058,features,1,0
20059,of,1,1
20060,autistic,1,1
20061,disorder,1,0
20062,(,1,1
20063,stereotypies,1,1
20064,",",1,1
20065,lethargy,1,1
20066,",",1,1
20067,irritability,1,1
20068,",",1,1
20069,hyperactivity,1,1
20070,",",1,1
20071,emotional,1,1
20072,reciprocity,1,1
20073,",",1,0
20074,sharing,1,1
20075,pleasures,1,1
20076,),1,0
20077,and,1,0
20078,improvements,1,1
20079,in,1,0
20080,language,1,1
20081,and,1,1
20082,communication,1,1
20083,",",1,1
20084,socialization,1,1
20085,",",1,1
20086,and,1,1
20087,daily,1,1
20088,living,1,1
20089,skills,1,1
20090,noted,0,0
20091,after,0,0
20092,12,0,0
20093,weeks,0,0
20094,(,0,0
20095,the,0,0
20096,end,0,0
20097,of,0,0
20098,a,0,0
20099,4-week,0,0
20100,maintenance,0,0
20101,phase,0,0
20102,),0,0
20103,.,0,0
20104,We,0,0
20105,did,0,0
20106,not,0,0
20107,find,0,0
20108,any,0,0
20109,significant,0,0
20110,differences,0,0
20111,in,0,0
20112,improvements,0,1
20113,between,0,0
20114,lamotrigine,0,0
20115,or,0,1
20116,placebo,0,0
20117,groups,0,0
20118,on,0,0
20119,the,0,0
20120,Autism,1,1
20121,Behavior,1,1
20122,Checklist,1,1
20123,",",1,0
20124,the,1,0
20125,Aberrant,1,1
20126,Behavior,1,1
20127,Checklist,1,1
20128,",",1,0
20129,the,1,0
20130,Vineland,1,1
20131,Adaptive,1,1
20132,Behavior,1,1
20133,scales,1,1
20134,",",1,0
20135,the,1,0
20136,PL-ADOS,1,1
20137,",",1,0
20138,or,1,0
20139,the,1,0
20140,CARS,1,0
20141,.,1,0
20142,Parent,1,1
20143,rating,1,1
20144,scales,1,1
20145,showed,0,0
20146,marked,0,0
20147,improvements,0,1
20148,",",0,0
20149,presumably,0,0
20150,due,0,0
20151,to,0,0
20152,expectations,0,1
20153,of,0,0
20154,benefits,0,0
20155,.,0,0
20156,Recurrent,0,1
20157,epithelial,0,1
20158,ovarian,0,1
20159,carcinoma,0,0
20160,:,0,0
20161,a,0,0
20162,randomized,0,0
20163,phase,0,0
20164,III,0,1
20165,study,0,0
20166,of,0,0
20167,pegylated,0,0
20168,liposomal,0,0
20169,doxorubicin,0,0
20170,versus,0,0
20171,topotecan,0,0
20172,.,0,0
20173,PURPOSE,0,0
20174,To,0,0
20175,compare,0,0
20176,the,0,0
20177,efficacy,1,1
20178,and,0,1
20179,safety,1,1
20180,of,0,1
20181,pegylated,0,0
20182,liposomal,0,0
20183,doxorubicin,0,0
20184,(,0,1
20185,PLD,0,0
20186,),0,1
20187,and,0,1
20188,topotecan,0,0
20189,in,0,0
20190,patients,0,0
20191,with,0,0
20192,epithelial,0,1
20193,ovarian,0,1
20194,carcinoma,0,0
20195,that,0,0
20196,recurred,0,0
20197,after,0,0
20198,or,0,1
20199,did,0,0
20200,n't,0,0
20201,respond,0,0
20202,to,0,0
20203,first-line,0,0
20204,",",0,0
20205,platinum-based,0,0
20206,chemotherapy,0,0
20207,.,0,1
20208,PATIENTS,0,0
20209,AND,0,0
20210,METHODS,0,0
20211,Patients,0,0
20212,with,0,0
20213,measurable,0,1
20214,and,0,1
20215,assessable,0,0
20216,disease,0,1
20217,were,0,0
20218,randomized,0,0
20219,to,0,0
20220,receive,0,0
20221,either,0,0
20222,PLD,0,0
20223,50,0,0
20224,mg/m,0,0
20225,(,0,0
20226,2,0,0
20227,),0,0
20228,as,0,0
20229,a,0,0
20230,1-hour,0,0
20231,infusion,0,0
20232,every,0,0
20233,4,0,0
20234,weeks,0,0
20235,or,0,0
20236,topotecan,0,0
20237,1.5,0,0
20238,mg/m,0,0
20239,(,0,0
20240,2,0,0
20241,),0,0
20242,/d,0,0
20243,for,0,0
20244,5,0,0
20245,consecutive,0,0
20246,days,0,0
20247,every,0,0
20248,3,0,0
20249,weeks,0,0
20250,.,0,0
20251,Patients,0,0
20252,were,0,0
20253,stratified,0,0
20254,prospectively,0,0
20255,for,0,0
20256,platinum,0,0
20257,sensitivity,0,1
20258,and,0,0
20259,for,0,0
20260,the,0,0
20261,presence,0,0
20262,or,0,0
20263,absence,0,0
20264,of,0,1
20265,bulky,0,0
20266,disease,0,0
20267,.,0,0
20268,RESULTS,0,0
20269,A,0,0
20270,total,0,0
20271,of,0,0
20272,474,0,0
20273,patients,0,0
20274,were,0,0
20275,treated,0,0
20276,(,0,0
20277,239,0,0
20278,PLD,0,0
20279,and,0,0
20280,235,0,0
20281,topotecan,0,0
20282,),0,0
20283,.,0,0
20284,They,0,0
20285,comprised,0,0
20286,the,0,0
20287,intent-to-treat,0,0
20288,population,0,0
20289,.,0,0
20290,The,0,0
20291,overall,1,1
20292,progression-free,1,1
20293,survival,1,1
20294,rates,1,1
20295,were,0,0
20296,similar,0,0
20297,between,0,0
20298,the,0,0
20299,two,0,0
20300,arms,0,0
20301,(,0,0
20302,P,0,0
20303,=.095,0,0
20304,),0,0
20305,.,0,0
20306,The,0,0
20307,overall,1,1
20308,response,1,1
20309,rates,1,1
20310,for,0,0
20311,PLD,0,0
20312,and,0,1
20313,topotecan,0,0
20314,were,0,0
20315,19.7,0,0
20316,%,0,0
20317,and,0,0
20318,17.0,0,0
20319,%,0,0
20320,",",0,0
20321,respectively,0,0
20322,(,0,0
20323,P,0,0
20324,=.390,0,0
20325,),0,0
20326,.,0,0
20327,Median,1,1
20328,overall,1,1
20329,survival,1,1
20330,times,1,1
20331,were,0,0
20332,60,0,0
20333,weeks,0,0
20334,for,0,0
20335,PLD,0,0
20336,and,0,0
20337,56.7,0,0
20338,weeks,0,0
20339,for,0,0
20340,topotecan,0,0
20341,.,0,0
20342,Data,0,1
20343,analyzed,0,0
20344,in,0,0
20345,platinum-sensitive,0,0
20346,patients,0,0
20347,demonstrated,0,0
20348,a,0,0
20349,statistically,0,0
20350,significant,0,0
20351,benefit,0,0
20352,from,0,0
20353,PLD,0,0
20354,for,0,0
20355,progression-free,1,1
20356,survival,1,1
20357,(,0,0
20358,P,0,0
20359,=.037,0,0
20360,),0,1
20361,",",0,0
20362,with,0,0
20363,medians,0,1
20364,of,0,0
20365,28.9,0,0
20366,for,0,0
20367,PLD,0,0
20368,versus,0,0
20369,23.3,0,0
20370,weeks,0,0
20371,for,0,0
20372,topotecan,0,0
20373,.,0,0
20374,For,0,0
20375,overall,1,1
20376,survival,1,1
20377,",",0,1
20378,PLD,0,0
20379,was,0,0
20380,significantly,0,0
20381,superior,0,0
20382,to,0,0
20383,topotecan,0,0
20384,(,0,0
20385,P,0,0
20386,=.008,0,0
20387,),0,1
20388,",",0,0
20389,with,0,0
20390,a,0,0
20391,median,0,0
20392,of,0,0
20393,108,0,0
20394,weeks,0,0
20395,versus,0,0
20396,71.1,0,0
20397,weeks,0,0
20398,.,0,0
20399,The,0,0
20400,platinum-refractory,0,0
20401,subgroup,0,0
20402,demonstrated,0,0
20403,a,0,0
20404,nonstatistically,0,0
20405,significant,0,0
20406,survival,0,1
20407,trend,0,0
20408,in,0,0
20409,favor,0,0
20410,of,0,1
20411,topotecan,0,0
20412,(,0,0
20413,P,0,0
20414,=.455,0,0
20415,),0,0
20416,.,0,0
20417,Severe,1,0
20418,hematologic,1,1
20419,toxicity,1,1
20420,was,0,0
20421,more,0,0
20422,common,0,1
20423,with,0,0
20424,topotecan,0,0
20425,and,0,1
20426,was,0,0
20427,more,0,0
20428,likely,0,0
20429,to,0,0
20430,be,0,0
20431,associated,0,0
20432,with,0,0
20433,dosage,0,0
20434,modification,0,1
20435,",",0,1
20436,or,0,1
20437,growth,1,1
20438,factor,1,1
20439,or,1,1
20440,blood,1,1
20441,product,1,1
20442,utilization,1,0
20443,.,1,0
20444,CONCLUSION,0,0
20445,The,0,0
20446,comparable,0,0
20447,efficacy,1,1
20448,",",0,1
20449,favorable,0,1
20450,safety,1,1
20451,profile,0,1
20452,",",0,1
20453,and,0,1
20454,convenient,0,0
20455,dosing,0,0
20456,support,0,0
20457,the,0,0
20458,role,0,0
20459,of,0,0
20460,PLD,0,0
20461,as,0,0
20462,a,0,0
20463,valuable,0,0
20464,treatment,0,0
20465,option,0,0
20466,in,0,0
20467,this,0,0
20468,patient,0,0
20469,population,0,0
20470,.,0,0
20471,Famotidine,0,0
20472,treatment,0,0
20473,of,0,0
20474,children,0,0
20475,with,0,0
20476,autistic,0,0
20477,spectrum,0,0
20478,disorders,0,0
20479,:,0,0
20480,pilot,0,0
20481,research,0,0
20482,using,0,0
20483,single,0,0
20484,subject,0,0
20485,research,0,0
20486,design,0,0
20487,.,0,0
20488,Using,0,0
20489,single,0,0
20490,subject,0,0
20491,research,0,0
20492,design,0,0
20493,",",0,0
20494,we,0,0
20495,performed,0,0
20496,pilot,0,0
20497,research,0,0
20498,to,0,0
20499,evaluate,0,0
20500,the,0,0
20501,safety,0,1
20502,and,0,1
20503,efficacy,0,1
20504,of,0,1
20505,famotidine,0,0
20506,for,0,0
20507,the,0,0
20508,treatment,0,0
20509,of,0,0
20510,children,0,0
20511,with,0,0
20512,autistic,0,0
20513,spectrum,0,0
20514,disorders,0,0
20515,.,0,0
20516,We,0,0
20517,studied,0,0
20518,9,0,0
20519,Caucasian,0,0
20520,boys,0,0
20521,",",0,0
20522,3.8-8.1,0,0
20523,years,0,0
20524,old,0,0
20525,",",0,0
20526,with,0,0
20527,a,0,0
20528,DSM-IV,0,1
20529,diagnosis,0,0
20530,of,0,0
20531,a,0,0
20532,pervasive,0,0
20533,developmental,0,1
20534,disorder,0,0
20535,",",0,1
20536,living,0,1
20537,with,0,0
20538,their,0,0
20539,families,0,0
20540,",",0,0
20541,receiving,0,0
20542,no,0,0
20543,chronic,0,0
20544,medications,0,0
20545,",",0,1
20546,and,0,1
20547,without,0,0
20548,significant,0,0
20549,gastrointestinal,0,1
20550,symptoms,0,1
20551,.,0,0
20552,The,0,0
20553,dose,0,0
20554,of,0,0
20555,oral,0,0
20556,famotidine,0,0
20557,was,0,0
20558,2,0,0
20559,mg/kg/day,0,0
20560,(,0,0
20561,given,0,0
20562,in,0,0
20563,two,0,0
20564,divided,0,0
20565,doses,0,0
20566,),0,0
20567,;,0,0
20568,the,0,0
20569,maximum,0,1
20570,total,0,1
20571,daily,0,1
20572,dose,0,0
20573,was,0,0
20574,100,0,0
20575,mg,0,0
20576,.,0,0
20577,Using,0,0
20578,single-subject,0,0
20579,research,0,0
20580,analysis,0,0
20581,and,0,1
20582,medication,0,1
20583,given,0,0
20584,in,0,0
20585,a,0,0
20586,randomized,0,0
20587,",",0,0
20588,double-blind,0,0
20589,",",0,1
20590,placebo-controlled,0,0
20591,",",0,1
20592,cross-over,0,0
20593,design,0,0
20594,",",0,0
20595,4,0,0
20596,of,0,0
20597,9,0,0
20598,children,0,0
20599,randomized,0,0
20600,(,0,0
20601,44,0,0
20602,%,0,0
20603,),0,0
20604,had,0,0
20605,evidence,0,0
20606,of,0,1
20607,behavioral,1,1
20608,improvement,1,1
20609,.,1,1
20610,Primary,0,1
20611,efficacy,0,1
20612,was,0,0
20613,based,0,0
20614,on,0,0
20615,data,0,0
20616,kept,0,0
20617,by,0,0
20618,primary,0,0
20619,caregivers,0,1
20620,",",0,0
20621,including,0,0
20622,a,0,0
20623,daily,1,0
20624,diary,1,0
20625,;,1,0
20626,daily,1,0
20627,visual,1,1
20628,analogue,1,1
20629,scales,1,1
20630,of,1,1
20631,affection,1,1
20632,",",1,1
20633,reciting,1,1
20634,",",1,1
20635,or,1,1
20636,aspects,1,1
20637,of,1,1
20638,social,1,1
20639,interaction,1,1
20640,;,1,0
20641,Aberrant,1,1
20642,Behavior,1,1
20643,Checklists,1,1
20644,(,1,1
20645,ABC,1,1
20646,",",1,1
20647,Aman,1,1
20648,),1,0
20649,;,1,0
20650,and,1,1
20651,Clinical,1,1
20652,Global,1,1
20653,Improvement,1,1
20654,scales,1,1
20655,.,1,0
20656,Children,0,0
20657,with,0,0
20658,marked,0,0
20659,stereotypy,0,1
20660,(,0,0
20661,meaningless,0,1
20662,",",0,1
20663,repetitive,0,1
20664,behaviors,0,1
20665,),0,0
20666,did,0,0
20667,not,0,0
20668,respond,0,0
20669,.,0,0
20670,Our,0,0
20671,subjects,0,0
20672,did,0,0
20673,not,0,0
20674,have,0,0
20675,prominent,0,0
20676,gastrointestinal,1,1
20677,symptoms,1,1
20678,and,0,1
20679,endoscopy,0,1
20680,was,0,0
20681,not,0,0
20682,part,0,0
20683,of,0,0
20684,our,0,0
20685,protocol,0,0
20686,;,0,0
20687,thus,0,0
20688,",",0,0
20689,we,0,0
20690,can,0,0
20691,not,0,0
20692,exclude,0,0
20693,the,0,0
20694,possibility,0,0
20695,that,0,0
20696,our,0,0
20697,subjects,0,0
20698,improved,0,0
20699,due,0,0
20700,to,0,0
20701,the,0,0
20702,effective,0,1
20703,treatment,0,0
20704,of,0,1
20705,asymptomatic,0,0
20706,esophagitis,0,1
20707,.,0,0
20708,The,0,0
20709,use,0,0
20710,of,0,0
20711,famotidine,0,0
20712,for,0,0
20713,the,0,0
20714,treatment,0,0
20715,of,0,0
20716,children,0,0
20717,with,0,0
20718,autistic,0,0
20719,spectrum,0,0
20720,disorders,0,0
20721,warrants,0,0
20722,further,0,0
20723,investigation,0,0
20724,.,0,0
20725,Relationships,0,1
20726,between,0,0
20727,age,0,0
20728,at,0,0
20729,diagnosis,0,0
20730,",",0,0
20731,clinical,0,1
20732,features,0,1
20733,",",0,1
20734,and,0,1
20735,outcome,0,1
20736,of,0,1
20737,therapy,0,0
20738,in,0,0
20739,children,0,0
20740,treated,0,0
20741,in,0,0
20742,the,0,0
20743,Medical,0,0
20744,Research,0,0
20745,Council,0,1
20746,AML,0,0
20747,10,0,0
20748,and,0,0
20749,12,0,0
20750,trials,0,0
20751,for,0,0
20752,acute,0,0
20753,myeloid,0,0
20754,leukemia,0,0
20755,.,0,1
20756,Between,0,0
20757,May,0,0
20758,1988,0,0
20759,and,0,0
20760,June,0,0
20761,2000,0,0
20762,",",0,0
20763,698,0,0
20764,children,0,0
20765,were,0,0
20766,treated,0,0
20767,in,0,0
20768,the,0,0
20769,Medical,0,0
20770,Research,0,0
20771,Council,0,0
20772,acute,0,0
20773,myeloid,0,0
20774,leukemia,0,0
20775,10,0,0
20776,and,0,0
20777,12,0,0
20778,trials,0,0
20779,.,0,0
20780,The,0,0
20781,presenting,0,1
20782,features,0,0
20783,and,0,1
20784,outcomes,0,1
20785,of,0,1
20786,therapy,0,0
20787,in,0,0
20788,these,0,0
20789,children,0,0
20790,were,0,0
20791,compared,0,0
20792,by,0,0
20793,age,0,0
20794,.,0,0
20795,Although,0,0
20796,there,0,0
20797,was,0,0
20798,no,0,0
20799,single,0,0
20800,cutoff,0,0
20801,in,0,0
20802,age,0,0
20803,",",0,0
20804,younger,0,0
20805,children,0,0
20806,were,0,0
20807,more,0,0
20808,likely,0,0
20809,to,0,0
20810,have,0,0
20811,intermediate,0,1
20812,risk,0,1
20813,and,0,1
20814,less,0,0
20815,likely,0,0
20816,to,0,0
20817,have,0,0
20818,favorable,1,0
20819,cytogenetics,1,0
20820,(,0,0
20821,P,0,0
20822,<,0,0
20823,.001,0,0
20824,),0,1
20825,",",0,0
20826,and,0,1
20827,they,0,0
20828,had,0,0
20829,a,0,0
20830,higher,0,0
20831,incidence,1,1
20832,of,1,1
20833,translocations,1,1
20834,involving,1,0
20835,chromosome,1,1
20836,11q23,1,1
20837,(,0,0
20838,P,0,0
20839,<,0,0
20840,.001,0,0
20841,),0,0
20842,.,0,0
20843,The,0,0
20844,distribution,0,0
20845,of,0,1
20846,French-American-British,0,0
20847,(,0,0
20848,FAB,0,1
20849,),0,0
20850,types,0,0
20851,also,0,0
20852,varied,0,0
20853,with,0,0
20854,age,0,0
20855,;,0,0
20856,FAB,1,0
20857,types,1,0
20858,M5,1,1
20859,(,0,0
20860,P,0,0
20861,<,0,0
20862,.001,0,0
20863,),0,1
20864,and,0,1
20865,M7,1,1
20866,(,0,1
20867,P,0,0
20868,<,0,0
20869,.001,0,0
20870,),0,1
20871,were,0,0
20872,more,0,0
20873,common,0,1
20874,in,0,0
20875,early,0,0
20876,childhood,0,0
20877,",",0,0
20878,whereas,0,0
20879,older,0,0
20880,children,0,0
20881,were,0,0
20882,more,0,0
20883,likely,0,0
20884,to,0,0
20885,have,0,0
20886,FAB,1,1
20887,types,1,0
20888,M0,1,1
20889,(,0,0
20890,P,0,0
20891,=.03,0,0
20892,),0,1
20893,",",0,1
20894,M1,0,1
20895,(,0,1
20896,P,0,0
20897,=.04,0,0
20898,),0,1
20899,",",0,1
20900,M2,1,1
20901,(,0,1
20902,P,0,0
20903,=.005,0,0
20904,),0,1
20905,",",0,0
20906,and,0,1
20907,M3,1,1
20908,(,0,1
20909,P,0,0
20910,<,0,0
20911,.001,0,0
20912,),0,0
20913,.,0,0
20914,Involvement,1,1
20915,of,1,0
20916,the,1,0
20917,central,1,1
20918,nervous,1,1
20919,system,1,0
20920,at,0,0
20921,diagnosis,0,0
20922,was,0,0
20923,also,0,0
20924,more,0,0
20925,common,0,0
20926,in,0,0
20927,the,0,0
20928,youngest,0,0
20929,children,0,0
20930,(,0,0
20931,P,0,0
20932,=.01,0,0
20933,),0,0
20934,.,0,0
20935,Younger,0,0
20936,children,0,0
20937,had,0,0
20938,more,0,0
20939,severe,1,1
20940,diarrhea,1,1
20941,(,0,0
20942,P,0,0
20943,=.002,0,0
20944,),0,1
20945,",",0,0
20946,whereas,0,0
20947,older,0,0
20948,children,0,0
20949,had,0,0
20950,worse,0,1
20951,nausea,1,1
20952,and,1,1
20953,vomiting,1,1
20954,(,0,1
20955,P,0,0
20956,=.01,0,0
20957,),0,0
20958,after,0,0
20959,chemotherapy,0,0
20960,.,0,0
20961,When,0,0
20962,adjusted,0,0
20963,for,0,0
20964,other,0,0
20965,important,0,1
20966,factors,0,1
20967,",",0,1
20968,complete,1,1
20969,remission,1,1
20970,rates,1,1
20971,were,0,0
20972,similar,0,0
20973,(,0,0
20974,P,0,0
20975,=.5,0,0
20976,),0,1
20977,and,0,0
20978,although,0,0
20979,there,0,0
20980,was,0,0
20981,less,0,0
20982,resistant,0,1
20983,disease,0,1
20984,in,0,0
20985,younger,0,0
20986,children,0,0
20987,(,0,1
20988,P,0,0
20989,=.003,0,0
20990,),0,0
20991,",",0,0
20992,this,0,0
20993,was,0,0
20994,partially,0,0
20995,balanced,0,0
20996,by,0,0
20997,a,0,0
20998,slight,0,1
20999,increase,0,0
21000,in,0,0
21001,deaths,1,1
21002,during,0,0
21003,induction,0,0
21004,therapy,0,0
21005,in,0,0
21006,younger,0,0
21007,patients,0,0
21008,(,0,1
21009,P,0,0
21010,=.06,0,0
21011,),0,0
21012,.,0,0
21013,On,0,0
21014,multivariate,0,0
21015,analysis,0,0
21016,overall,1,1
21017,survival,1,1
21018,(,0,0
21019,P,0,0
21020,=.02,0,0
21021,),0,1
21022,",",0,0
21023,event-free,1,1
21024,survival,1,1
21025,(,0,0
21026,P,0,0
21027,=.02,0,0
21028,),0,1
21029,",",0,0
21030,and,0,1
21031,disease-free,1,1
21032,survival,1,1
21033,were,0,0
21034,better,0,0
21035,(,0,1
21036,P,0,0
21037,=.06,0,0
21038,),0,0
21039,in,0,0
21040,younger,0,0
21041,children,0,0
21042,due,0,0
21043,to,0,0
21044,a,0,0
21045,lower,0,0
21046,relapse,1,1
21047,rate,1,1
21048,(,0,1
21049,P,0,0
21050,=.02,0,0
21051,),0,0
21052,especially,0,0
21053,in,0,0
21054,the,0,0
21055,bone,0,1
21056,marrow,0,0
21057,(,0,1
21058,P,0,0
21059,=.02,0,0
21060,),0,0
21061,.,0,0
21062,A,0,0
21063,randomized,0,0
21064,effectiveness,1,1
21065,trial,0,0
21066,of,0,1
21067,collaborative,0,0
21068,care,0,0
21069,for,0,0
21070,patients,0,0
21071,with,0,0
21072,panic,0,1
21073,disorder,0,0
21074,in,0,0
21075,primary,0,0
21076,care,0,0
21077,.,0,0
21078,BACKGROUND,0,0
21079,Effectiveness,1,1
21080,studies,0,0
21081,have,0,0
21082,tested,0,0
21083,interventions,0,0
21084,to,0,0
21085,improve,0,0
21086,quality,1,1
21087,of,1,1
21088,care,1,0
21089,for,0,0
21090,depression,0,1
21091,in,0,0
21092,primary,0,1
21093,care,0,0
21094,",",0,1
21095,but,0,0
21096,none,0,0
21097,",",0,1
21098,to,0,0
21099,our,0,0
21100,knowledge,0,0
21101,",",0,0
21102,have,0,0
21103,been,0,0
21104,completed,0,0
21105,for,0,0
21106,panic,0,1
21107,disorder,0,0
21108,(,0,1
21109,PD,0,1
21110,),0,0
21111,in,0,0
21112,this,0,0
21113,setting,0,0
21114,.,0,0
21115,This,0,0
21116,study,0,0
21117,sought,0,0
21118,to,0,0
21119,test,0,0
21120,the,0,0
21121,clinical,1,0
21122,effectiveness,1,1
21123,of,0,1
21124,PD,0,1
21125,pharmacotherapy,0,0
21126,embedded,0,0
21127,in,0,0
21128,a,0,0
21129,disease,0,1
21130,management,0,0
21131,framework,0,0
21132,of,0,1
21133,collaborative,0,0
21134,care,0,0
21135,(,0,1
21136,CC,0,0
21137,),0,0
21138,.,0,0
21139,METHODS,0,0
21140,One,0,0
21141,hundred,0,0
21142,fifteen,0,0
21143,patients,0,0
21144,with,0,0
21145,PD,0,0
21146,from,0,0
21147,3,0,0
21148,primary,0,0
21149,care,0,0
21150,clinics,0,0
21151,were,0,0
21152,randomized,0,0
21153,to,0,0
21154,CC,0,0
21155,or,0,1
21156,usual,0,0
21157,care,0,0
21158,(,0,1
21159,UC,0,1
21160,),0,0
21161,.,0,0
21162,Patients,0,0
21163,in,0,0
21164,CC,0,0
21165,(,0,0
21166,n,0,0
21167,=,0,0
21168,57,0,0
21169,),0,0
21170,received,0,0
21171,educational,0,0
21172,videotapes,0,0
21173,and,0,0
21174,pamphlets,0,0
21175,;,0,1
21176,pharmacotherapy,0,0
21177,with,0,0
21178,the,0,0
21179,selective,0,0
21180,serotonin,0,1
21181,reuptake,0,0
21182,inhibitor,0,0
21183,paroxetine,0,0
21184,;,0,0
21185,2,0,0
21186,psychiatrist,0,0
21187,visits,0,0
21188,and,0,0
21189,2,0,0
21190,telephone,0,0
21191,calls,0,0
21192,in,0,0
21193,the,0,0
21194,first,0,0
21195,8,0,0
21196,weeks,0,0
21197,;,0,0
21198,and,0,0
21199,up,0,0
21200,to,0,0
21201,5,0,0
21202,telephone,0,0
21203,calls,0,0
21204,between,0,0
21205,3,0,0
21206,and,0,0
21207,12,0,0
21208,months,0,0
21209,',0,0
21210,follow-up,0,0
21211,.,0,1
21212,Usual,0,1
21213,care,0,0
21214,patients,0,0
21215,(,0,0
21216,n,0,0
21217,=,0,0
21218,58,0,0
21219,),0,0
21220,were,0,0
21221,treated,0,0
21222,by,0,0
21223,their,0,0
21224,primary,0,0
21225,care,0,0
21226,physician,0,0
21227,.,0,0
21228,Telephone,0,0
21229,assessments,0,0
21230,of,0,0
21231,panic,1,1
21232,",",1,1
21233,anxiety,1,1
21234,sensitivity,1,1
21235,",",1,1
21236,depression,1,1
21237,",",1,1
21238,and,1,1
21239,disability,1,1
21240,variables,1,1
21241,were,0,0
21242,performed,0,0
21243,at,0,0
21244,3,0,0
21245,",",0,0
21246,6,0,0
21247,",",0,0
21248,9,0,0
21249,",",0,0
21250,and,0,0
21251,12,0,0
21252,months,0,0
21253,',0,0
21254,follow-up,0,0
21255,.,0,0
21256,Adequacy,1,1
21257,of,1,1
21258,pharmacotherapy,1,0
21259,was,0,0
21260,assessed,0,0
21261,with,0,0
21262,an,0,0
21263,algorithm,1,0
21264,based,0,0
21265,on,0,0
21266,a,0,0
21267,review,0,0
21268,of,0,0
21269,efficacy,0,1
21270,studies,0,0
21271,.,0,0
21272,RESULTS,0,0
21273,Patients,0,0
21274,in,0,0
21275,CC,0,0
21276,were,0,0
21277,more,0,0
21278,likely,0,0
21279,to,0,0
21280,receive,0,0
21281,adequate,1,0
21282,(,1,1
21283,type,1,1
21284,",",1,1
21285,dose,1,1
21286,",",1,1
21287,duration,1,1
21288,),1,1
21289,medication,1,1
21290,and,0,1
21291,more,0,0
21292,likely,0,0
21293,to,0,0
21294,adhere,1,0
21295,to,1,0
21296,this,1,0
21297,medication,1,0
21298,at,0,0
21299,3,0,0
21300,and,0,0
21301,6,0,0
21302,months,0,0
21303,.,0,0
21304,Random,0,0
21305,regression,0,1
21306,analyses,0,0
21307,showed,0,0
21308,that,0,0
21309,CC,0,0
21310,patients,0,0
21311,improved,1,0
21312,significantly,0,0
21313,more,0,0
21314,over,0,0
21315,time,0,1
21316,compared,0,0
21317,with,0,0
21318,UC,0,1
21319,patients,0,0
21320,on,0,0
21321,anxiety,1,1
21322,",",1,1
21323,depression,1,1
21324,",",1,1
21325,and,1,1
21326,disability,1,1
21327,measures,1,1
21328,",",0,0
21329,with,0,0
21330,the,0,0
21331,greatest,0,0
21332,effects,1,0
21333,at,0,0
21334,3,0,0
21335,and,0,0
21336,6,0,0
21337,months,0,0
21338,.,0,0
21339,CONCLUSIONS,0,0
21340,Compared,0,0
21341,with,0,0
21342,UC,0,1
21343,",",0,0
21344,CC,0,0
21345,interventions,0,0
21346,significantly,0,0
21347,improved,0,0
21348,both,0,0
21349,quality,1,1
21350,of,1,1
21351,care,1,0
21352,and,1,1
21353,clinical,1,1
21354,and,1,1
21355,functional,1,1
21356,outcomes,1,1
21357,in,0,0
21358,primary,0,0
21359,care,0,0
21360,PD,0,1
21361,patients,0,0
21362,.,0,0
21363,Clinical,0,1
21364,differences,0,0
21365,were,0,0
21366,greatest,0,0
21367,in,0,0
21368,the,0,0
21369,first,0,0
21370,6,0,0
21371,months,0,0
21372,",",0,0
21373,corresponding,0,1
21374,to,0,0
21375,the,0,0
21376,greater,0,0
21377,quality,1,1
21378,of,1,1
21379,care,1,0
21380,and,0,0
21381,the,0,0
21382,greater,0,1
21383,intensity,1,1
21384,of,0,1
21385,intervention,0,0
21386,.,0,0
21387,A,0,0
21388,randomized,0,0
21389,intervention,0,0
21390,to,0,0
21391,improve,0,0
21392,ongoing,1,0
21393,participation,1,0
21394,in,1,0
21395,mammography,1,0
21396,.,1,0
21397,OBJECTIVE,0,0
21398,To,0,0
21399,test,0,0
21400,the,0,0
21401,effectiveness,0,0
21402,of,0,0
21403,interventions,0,0
21404,intended,0,0
21405,to,0,0
21406,increase,0,0
21407,rates,1,1
21408,of,1,0
21409,regular,1,0
21410,breast,1,0
21411,cancer,1,1
21412,screening,1,0
21413,",",0,0
21414,according,0,0
21415,to,0,0
21416,recommended,0,0
21417,guidelines,0,0
21418,.,0,0
21419,STUDY,0,0
21420,DESIGN,0,0
21421,A,0,0
21422,randomized,0,0
21423,controlled,0,0
21424,trial,0,0
21425,of,0,0
21426,2,0,0
21427,outreach,0,0
21428,interventions,0,0
21429,(,0,0
21430,a,0,0
21431,mail,0,0
21432,reminder,0,0
21433,and,0,0
21434,a,0,0
21435,telephone,0,0
21436,reminder,0,0
21437,plus,0,0
21438,appointment,0,1
21439,scheduling,0,1
21440,),0,0
21441,compared,0,0
21442,with,0,0
21443,a,0,0
21444,routine,0,0
21445,publicity,0,0
21446,campaign,0,0
21447,to,0,0
21448,encourage,0,0
21449,continued,1,0
21450,participation,1,0
21451,in,1,0
21452,mammography,1,0
21453,screening,1,0
21454,.,1,1
21455,PARTICIPANTS,0,1
21456,AND,0,0
21457,METHODS,0,0
21458,Participants,0,0
21459,were,0,0
21460,1908,0,0
21461,women,0,0
21462,aged,0,0
21463,50,0,0
21464,to,0,0
21465,75,0,0
21466,years,0,0
21467,continuously,0,0
21468,enrolled,0,0
21469,in,0,0
21470,a,0,0
21471,large,0,0
21472,group-model,0,0
21473,HMO,0,0
21474,during,0,0
21475,the,0,0
21476,study,0,0
21477,who,0,0
21478,underwent,0,0
21479,a,0,0
21480,bilateral,0,0
21481,mammogram,0,0
21482,during,0,0
21483,the,0,0
21484,first,0,0
21485,quarter,0,0
21486,of,0,0
21487,1994,0,0
21488,and,0,0
21489,no,0,0
21490,subsequent,0,0
21491,mammogram,0,0
21492,during,0,0
21493,the,0,0
21494,next,0,0
21495,18,0,0
21496,to,0,0
21497,21,0,0
21498,months,0,0
21499,.,0,0
21500,Data,0,0
21501,were,0,0
21502,obtained,0,0
21503,from,0,0
21504,health,0,1
21505,plan,0,0
21506,administrative,0,1
21507,data,0,0
21508,files,0,0
21509,supplemented,0,0
21510,by,0,0
21511,medical,0,0
21512,chart,0,1
21513,review,0,0
21514,.,0,1
21515,Women,0,0
21516,were,0,0
21517,randomly,0,0
21518,assigned,0,0
21519,to,0,0
21520,receive,0,0
21521,(,0,0
21522,1,0,0
21523,),0,0
21524,a,0,0
21525,mail,0,0
21526,reminder,0,0
21527,",",0,0
21528,(,0,0
21529,2,0,0
21530,),0,0
21531,a,0,0
21532,telephone,0,0
21533,reminder,0,0
21534,",",0,1
21535,or,0,1
21536,(,0,0
21537,3,0,0
21538,),0,0
21539,routine,0,0
21540,publicity,0,0
21541,on,0,0
21542,mammography,0,0
21543,for,0,0
21544,all,0,0
21545,women,0,0
21546,.,0,0
21547,The,0,0
21548,outcome,0,1
21549,measure,0,0
21550,was,0,0
21551,a,0,0
21552,mammogram,1,1
21553,received,1,0
21554,after,1,0
21555,the,1,0
21556,intervention,1,0
21557,period,1,0
21558,and,1,0
21559,within,1,0
21560,2,1,0
21561,years,1,0
21562,of,1,0
21563,the,1,0
21564,initial,1,0
21565,mammogram,1,0
21566,date,1,1
21567,.,1,1
21568,RESULTS,0,0
21569,Bivariate,0,1
21570,and,0,1
21571,multivariate,0,0
21572,statistical,0,1
21573,analyses,0,0
21574,showed,0,0
21575,that,0,0
21576,participation,0,0
21577,was,0,0
21578,significantly,0,0
21579,higher,0,0
21580,for,0,0
21581,women,0,0
21582,contacted,0,0
21583,by,0,0
21584,telephone,0,0
21585,than,0,0
21586,through,0,0
21587,routine,0,0
21588,publicity,0,0
21589,.,0,1
21590,Mail,0,0
21591,reminders,0,0
21592,were,0,0
21593,no,0,0
21594,more,0,0
21595,effective,0,1
21596,than,0,0
21597,a,0,0
21598,routine,0,0
21599,publicity,0,0
21600,campaign,0,1
21601,.,0,1
21602,Primary,0,1
21603,care,0,0
21604,physician,0,1
21605,and,0,1
21606,gynecologist,0,0
21607,visits,0,1
21608,increased,0,0
21609,the,0,0
21610,likelihood,0,1
21611,of,0,0
21612,a,0,0
21613,subsequent,1,0
21614,mammogram,1,1
21615,for,0,0
21616,women,0,0
21617,in,0,0
21618,all,0,0
21619,intervention,0,0
21620,groups,0,0
21621,.,0,0
21622,CONCLUSIONS,0,0
21623,Telephone,0,0
21624,contact,0,1
21625,by,0,0
21626,regular,0,1
21627,health,0,1
21628,plan,0,0
21629,staff,0,1
21630,was,0,0
21631,more,0,0
21632,successful,0,1
21633,than,0,0
21634,publicity,0,0
21635,in,0,0
21636,encouraging,0,1
21637,continued,0,0
21638,participation,1,0
21639,in,0,0
21640,mammography,1,0
21641,screening,1,0
21642,in,0,0
21643,women,0,0
21644,enrolled,0,0
21645,in,0,0
21646,a,0,0
21647,group-model,0,0
21648,managed,0,0
21649,health,0,1
21650,care,0,0
21651,plan,0,0
21652,.,0,0
21653,Because,0,0
21654,mailings,0,0
21655,did,0,0
21656,not,0,0
21657,influence,0,0
21658,participation,0,0
21659,in,0,0
21660,mammography,1,1
21661,screening,1,0
21662,",",0,1
21663,health,0,1
21664,plans,0,0
21665,should,0,0
21666,be,0,0
21667,cautious,0,0
21668,about,0,0
21669,investing,0,0
21670,in,0,0
21671,member,0,1
21672,mailings,0,0
21673,without,0,0
21674,first,0,0
21675,evaluating,0,0
21676,their,0,0
21677,effectiveness,0,0
21678,in,0,0
21679,the,0,0
21680,context,0,0
21681,of,0,0
21682,existing,0,0
21683,outreach,0,0
21684,efforts,0,0
21685,.,0,0
21686,Benefit,0,1
21687,of,0,1
21688,FSH,0,1
21689,priming,0,0
21690,of,0,0
21691,women,0,0
21692,with,0,0
21693,PCOS,0,0
21694,to,0,0
21695,the,0,0
21696,in,0,0
21697,vitro,0,1
21698,maturation,0,1
21699,procedure,0,0
21700,and,0,0
21701,the,0,0
21702,outcome,0,0
21703,:,0,0
21704,a,0,0
21705,randomized,0,0
21706,prospective,0,0
21707,study,0,0
21708,.,0,0
21709,The,0,0
21710,aim,0,0
21711,of,0,0
21712,this,0,0
21713,study,0,0
21714,was,0,0
21715,to,0,0
21716,determine,0,0
21717,whether,0,0
21718,the,0,0
21719,rates,1,1
21720,of,1,0
21721,in,1,0
21722,vitro,1,1
21723,oocyte,1,1
21724,maturation,1,1
21725,",",1,1
21726,fertilization,1,1
21727,and,1,1
21728,cleavage,1,1
21729,",",0,1
21730,as,0,0
21731,well,0,0
21732,as,0,0
21733,implantation,1,0
21734,rate,1,1
21735,and,1,1
21736,pregnancy,1,1
21737,rate,1,1
21738,",",0,0
21739,could,0,0
21740,be,0,0
21741,improved,0,0
21742,by,0,0
21743,low-dose,0,0
21744,priming,0,0
21745,with,0,0
21746,FSH,0,1
21747,in,0,0
21748,vivo,0,0
21749,before,0,0
21750,retrieval,0,1
21751,of,0,1
21752,immature,0,1
21753,oocytes,0,0
21754,in,0,0
21755,patients,0,0
21756,with,0,0
21757,polycystic,0,0
21758,ovary,0,1
21759,syndrome,0,0
21760,(,0,1
21761,PCOS,0,0
21762,),0,0
21763,.,0,0
21764,From,0,0
21765,March,0,0
21766,1998,0,0
21767,to,0,0
21768,June,0,0
21769,2000,0,0
21770,",",0,0
21771,a,0,0
21772,total,0,1
21773,of,0,0
21774,28,0,0
21775,women,0,0
21776,underwent,0,0
21777,36,0,0
21778,completed,0,0
21779,treatment,0,0
21780,cycles,0,0
21781,",",0,0
21782,randomized,0,0
21783,sequentially,0,0
21784,in,0,0
21785,one,0,0
21786,of,0,0
21787,two,0,0
21788,groups,0,0
21789,.,0,0
21790,Women,0,0
21791,in,0,0
21792,group,0,0
21793,1,0,0
21794,(,0,0
21795,n,0,0
21796,=,0,0
21797,12,0,0
21798,cycles,0,0
21799,),0,0
21800,received,0,0
21801,no,0,0
21802,stimulation,0,1
21803,and,0,1
21804,women,0,0
21805,in,0,0
21806,group,0,0
21807,2,0,0
21808,(,0,0
21809,n,0,0
21810,=,0,0
21811,24,0,0
21812,cycles,0,0
21813,),0,0
21814,received,0,0
21815,150,0,0
21816,iu,0,0
21817,recombinant,0,0
21818,FSH,0,1
21819,day,0,1
21820,(,0,1
21821,-1,0,0
21822,),0,0
21823,for,0,0
21824,3,0,0
21825,days,0,0
21826,",",0,0
21827,initiated,0,0
21828,on,0,0
21829,day,0,0
21830,3,0,0
21831,after,0,0
21832,menstruation,0,0
21833,.,0,1
21834,Aspiration,0,1
21835,was,0,0
21836,performed,0,0
21837,transvaginally,0,0
21838,between,0,0
21839,day,0,0
21840,9,0,0
21841,and,0,0
21842,day,0,0
21843,17,0,0
21844,in,0,0
21845,the,0,0
21846,unstimulated,0,1
21847,group,0,0
21848,and,0,1
21849,on,0,0
21850,day,0,0
21851,8,0,0
21852,or,0,0
21853,day,0,0
21854,9,0,0
21855,in,0,0
21856,the,0,0
21857,FSH-primed,0,0
21858,group,0,0
21859,after,0,0
21860,FSH,0,1
21861,deprivation,0,0
21862,for,0,0
21863,2,0,0
21864,or,0,0
21865,3,0,0
21866,days,0,0
21867,.,0,0
21868,All,0,0
21869,cumulus-enclosed,0,0
21870,oocytes,0,0
21871,of,0,1
21872,healthy,0,0
21873,appearance,0,1
21874,were,0,0
21875,matured,0,0
21876,in,0,0
21877,culture,0,1
21878,medium,0,1
21879,(,0,1
21880,TCM-199,0,1
21881,),0,1
21882,in,0,0
21883,vitro,0,0
21884,for,0,0
21885,28-36,0,0
21886,h,0,0
21887,before,0,0
21888,intracytoplasmic,0,1
21889,sperm,0,1
21890,injection,0,0
21891,(,0,1
21892,ICSI,0,0
21893,),0,0
21894,.,0,0
21895,After,0,0
21896,oocyte,0,1
21897,retrieval,0,1
21898,the,0,0
21899,women,0,0
21900,were,0,0
21901,given,0,0
21902,oestradiol,0,0
21903,(,0,0
21904,6,0,0
21905,mg,0,0
21906,day,0,0
21907,(,0,1
21908,-1,0,0
21909,),0,1
21910,),0,0
21911,and,0,1
21912,progesterone,0,1
21913,administration,0,0
21914,(,0,0
21915,300,0,0
21916,mg,0,0
21917,day,0,0
21918,(,0,1
21919,-1,0,0
21920,),0,1
21921,),0,0
21922,was,0,0
21923,initiated,0,0
21924,2,0,0
21925,days,0,0
21926,later,0,0
21927,.,0,0
21928,Suitable,0,1
21929,embryos,0,1
21930,(,0,0
21931,maximum,0,1
21932,two,0,0
21933,embryos,0,0
21934,),0,0
21935,were,0,0
21936,transferred,0,0
21937,on,0,0
21938,day,0,0
21939,3,0,0
21940,after,0,0
21941,ICSI,0,0
21942,.,0,0
21943,The,0,0
21944,percentage,1,1
21945,of,1,0
21946,oocytes,1,0
21947,reaching,1,1
21948,metaphase,1,0
21949,II,1,0
21950,was,0,0
21951,significantly,0,0
21952,higher,0,0
21953,(,0,0
21954,P,0,0
21955,<,0,0
21956,0.05,0,0
21957,),0,0
21958,in,0,0
21959,the,0,0
21960,FSH-primed,0,1
21961,group,0,0
21962,(,0,0
21963,59,0,0
21964,%,0,0
21965,",",0,0
21966,92/156,0,0
21967,),0,0
21968,compared,0,0
21969,with,0,0
21970,the,0,0
21971,non-primed,0,0
21972,group,0,0
21973,(,0,0
21974,44,0,0
21975,%,0,0
21976,",",0,0
21977,36/81,0,0
21978,),0,0
21979,.,0,0
21980,There,0,0
21981,were,0,0
21982,no,0,0
21983,significant,0,0
21984,differences,0,0
21985,in,0,0
21986,the,0,0
21987,rates,1,1
21988,of,1,0
21989,oocyte,1,1
21990,fertilization,1,1
21991,and,1,1
21992,cleavage,1,1
21993,between,0,0
21994,these,0,0
21995,groups,0,0
21996,.,0,0
21997,No,0,0
21998,pregnancies,1,1
21999,were,0,0
22000,obtained,0,0
22001,in,0,0
22002,group,0,0
22003,1,0,0
22004,(,0,0
22005,0,0,0
22006,%,0,0
22007,",",0,0
22008,0/12,0,0
22009,),0,0
22010,",",0,0
22011,whereas,0,0
22012,seven,0,0
22013,clinical,1,0
22014,pregnancies,1,0
22015,were,0,0
22016,obtained,0,0
22017,in,0,0
22018,group,0,0
22019,2,0,0
22020,(,0,0
22021,29,0,0
22022,%,0,0
22023,",",0,0
22024,7/24,0,0
22025,),0,0
22026,(,0,0
22027,P,0,0
22028,<,0,0
22029,0.05,0,0
22030,),0,0
22031,.,0,0
22032,In,0,0
22033,group,0,0
22034,2,0,0
22035,",",0,0
22036,37,0,0
22037,embryo,0,0
22038,transfers,0,1
22039,resulted,0,0
22040,in,0,0
22041,eight,0,0
22042,implantations,1,0
22043,(,0,0
22044,21.6,0,0
22045,%,0,0
22046,),0,0
22047,.,0,0
22048,Three,0,0
22049,healthy,1,0
22050,singleton,1,0
22051,children,1,0
22052,have,0,0
22053,been,0,0
22054,born,1,0
22055,at,0,0
22056,term,0,0
22057,;,0,0
22058,the,0,0
22059,remaining,0,0
22060,pregnancies,0,1
22061,ended,0,0
22062,with,0,0
22063,spontaneous,1,1
22064,abortions,1,0
22065,in,0,0
22066,the,0,0
22067,first,0,0
22068,trimester,0,0
22069,.,0,0
22070,These,0,0
22071,results,0,0
22072,indicate,0,0
22073,that,0,0
22074,priming,0,0
22075,with,0,0
22076,recombinant,0,0
22077,FSH,0,1
22078,before,0,0
22079,harvesting,0,1
22080,of,0,1
22081,immature,0,1
22082,oocytes,0,0
22083,from,0,0
22084,patients,0,0
22085,with,0,0
22086,PCOS,0,0
22087,may,0,0
22088,improve,0,0
22089,the,0,0
22090,maturational,1,1
22091,potential,1,0
22092,of,1,0
22093,the,1,0
22094,oocytes,1,0
22095,and,1,0
22096,the,1,0
22097,implantation,1,0
22098,rate,1,1
22099,of,1,0
22100,the,1,0
22101,cleaved,1,0
22102,embryos,1,0
22103,.,1,0
22104,Safety,0,1
22105,and,0,1
22106,efficacy,0,1
22107,of,0,1
22108,PNU-142633,0,0
22109,",",0,0
22110,a,0,0
22111,selective,0,1
22112,5-HT1D,0,1
22113,agonist,0,0
22114,",",0,0
22115,in,0,0
22116,patients,0,0
22117,with,0,0
22118,acute,0,0
22119,migraine,0,1
22120,.,0,0
22121,In,0,0
22122,this,0,0
22123,randomized,0,0
22124,",",0,0
22125,double-blind,0,0
22126,",",0,1
22127,placebo-controlled,0,0
22128,",",0,1
22129,parallel-group,0,0
22130,study,0,0
22131,",",0,1
22132,patients,0,0
22133,received,0,0
22134,a,0,0
22135,single,0,0
22136,50-mg,0,0
22137,oral,0,0
22138,dose,0,0
22139,of,0,0
22140,a,0,0
22141,5-HT,0,0
22142,(,0,0
22143,1D,0,0
22144,),0,0
22145,agonist,0,0
22146,",",0,1
22147,PNU-142633,0,1
22148,(,0,1
22149,n,0,0
22150,=,0,0
22151,34,0,0
22152,),0,0
22153,",",0,0
22154,or,0,1
22155,matching,0,0
22156,placebo,0,0
22157,(,0,0
22158,n,0,0
22159,=,0,0
22160,35,0,0
22161,),0,0
22162,during,0,0
22163,an,0,0
22164,acute,0,0
22165,migraine,0,1
22166,attack,0,1
22167,.,0,0
22168,No,0,0
22169,statistically,0,0
22170,significant,0,0
22171,treatment,0,0
22172,effects,0,1
22173,were,0,0
22174,observed,0,0
22175,at,0,0
22176,1,0,0
22177,and,0,0
22178,2,0,0
22179,h,0,0
22180,after,0,0
22181,dosing,0,0
22182,",",0,0
22183,even,0,0
22184,after,0,0
22185,stratifying,0,0
22186,by,0,0
22187,baseline,0,0
22188,headache,0,1
22189,intensity,0,1
22190,.,0,0
22191,At,0,0
22192,1,0,0
22193,and,0,0
22194,2,0,0
22195,h,0,0
22196,post-dose,0,0
22197,",",0,0
22198,8.8,0,0
22199,%,0,0
22200,and,0,0
22201,29.4,0,0
22202,%,0,0
22203,of,0,0
22204,the,0,0
22205,PNU-142633,0,0
22206,group,0,0
22207,",",0,0
22208,respectively,0,0
22209,",",0,0
22210,and,0,0
22211,8.6,0,0
22212,%,0,0
22213,and,0,0
22214,40.0,0,0
22215,%,0,0
22216,of,0,0
22217,the,0,0
22218,placebo,0,0
22219,group,0,0
22220,",",0,1
22221,respectively,0,0
22222,",",0,0
22223,experienced,0,1
22224,headache,1,1
22225,relief,1,1
22226,;,1,0
22227,2.9,0,0
22228,%,0,0
22229,and,0,0
22230,8.8,0,0
22231,%,0,0
22232,of,0,0
22233,the,0,0
22234,PNU-142633,0,0
22235,group,0,0
22236,and,0,0
22237,0,0,0
22238,%,0,0
22239,and,0,0
22240,5.7,0,0
22241,%,0,0
22242,of,0,0
22243,the,0,0
22244,placebo,0,0
22245,group,0,0
22246,were,0,0
22247,free,1,1
22248,of,1,1
22249,headache,1,1
22250,pain,1,1
22251,.,1,1
22252,Adverse,1,1
22253,events,1,1
22254,associated,0,0
22255,with,0,0
22256,PNU-142633,0,0
22257,treatment,0,0
22258,included,0,0
22259,chest,1,1
22260,pain,1,1
22261,(,0,0
22262,two,0,0
22263,patients,0,0
22264,),0,0
22265,and,0,1
22266,QTc,1,1
22267,prolongation,1,1
22268,(,0,0
22269,three,0,0
22270,patients,0,0
22271,),0,0
22272,.,0,0
22273,Results,0,0
22274,from,0,0
22275,this,0,0
22276,study,0,0
22277,suggest,0,0
22278,that,0,0
22279,anti-migraine,0,0
22280,efficacy,0,1
22281,is,0,0
22282,not,0,0
22283,mediated,0,0
22284,solely,0,0
22285,through,0,0
22286,the,0,0
22287,5-HT,0,0
22288,(,0,0
22289,1D,0,0
22290,),0,0
22291,receptor,0,0
22292,subtype,0,1
22293,",",0,0
22294,although,0,0
22295,this,0,0
22296,receptor,0,0
22297,may,0,0
22298,contribute,0,0
22299,",",0,0
22300,at,0,0
22301,least,0,0
22302,in,0,0
22303,part,0,0
22304,",",0,0
22305,to,0,0
22306,the,0,0
22307,adverse,0,1
22308,cardiovascular,0,1
22309,effects,0,1
22310,observed,0,0
22311,with,0,0
22312,5-HT,0,0
22313,agonist,0,0
22314,medications,0,0
22315,.,0,0
22316,Controlled,0,0
22317,prospective,0,0
22318,trial,0,0
22319,of,0,1
22320,prednisolone,0,0
22321,and,0,1
22322,cytotoxics,0,1
22323,in,0,0
22324,progressive,0,0
22325,IgA,0,0
22326,nephropathy,0,1
22327,.,0,0
22328,In,0,0
22329,a,0,0
22330,single-center,0,0
22331,",",0,0
22332,multiple-referral,0,0
22333,source,0,1
22334,study,0,0
22335,",",0,0
22336,38,0,0
22337,patients,0,0
22338,with,0,0
22339,progressive,0,0
22340,IgA,0,1
22341,nephropathy,0,1
22342,and,0,1
22343,controlled,0,0
22344,hypertension,0,1
22345,were,0,0
22346,randomized,0,0
22347,to,0,0
22348,treatment,0,0
22349,with,0,0
22350,prednisolone,0,0
22351,and,0,1
22352,cytotoxic,0,1
22353,agents,0,0
22354,",",0,0
22355,to,0,0
22356,therapy,0,0
22357,with,0,0
22358,low-dose,0,0
22359,cyclophosphamide,0,0
22360,then,0,0
22361,azathioprine,0,0
22362,",",0,0
22363,and,0,0
22364,to,0,0
22365,control,0,0
22366,groups,0,0
22367,.,0,0
22368,The,0,0
22369,follow-up,0,0
22370,period,0,0
22371,lasted,0,0
22372,2,0,0
22373,to,0,0
22374,6,0,0
22375,yr.,0,0
22376,Renal,0,1
22377,survival,0,1
22378,",",0,0
22379,as,0,0
22380,assessed,0,0
22381,by,0,0
22382,Kaplan-Meier,0,1
22383,analysis,0,0
22384,annually,0,0
22385,to,0,0
22386,5,0,0
22387,yr,0,0
22388,",",0,0
22389,showed,0,0
22390,significant,0,0
22391,preservation,0,0
22392,of,0,1
22393,function,0,1
22394,from,0,0
22395,3,0,0
22396,yr,0,0
22397,in,0,0
22398,the,0,0
22399,treatment,0,0
22400,group,0,0
22401,and,0,0
22402,82,0,0
22403,",",0,0
22404,82,0,0
22405,",",0,0
22406,72,0,0
22407,",",0,0
22408,and,0,0
22409,72,0,0
22410,%,0,0
22411,for,0,0
22412,2,0,0
22413,",",0,0
22414,3,0,0
22415,",",0,0
22416,4,0,0
22417,",",0,0
22418,and,0,0
22419,5,0,0
22420,yr,0,0
22421,",",0,0
22422,respectively,0,0
22423,",",0,0
22424,compared,0,0
22425,with,0,0
22426,68,0,0
22427,",",0,0
22428,47,0,0
22429,",",0,0
22430,26,0,0
22431,",",0,0
22432,and,0,0
22433,6,0,0
22434,%,0,0
22435,in,0,0
22436,controls,0,0
22437,.,0,0
22438,Rate,0,0
22439,of,0,0
22440,loss,1,1
22441,of,1,1
22442,renal,1,1
22443,function,1,1
22444,",",0,0
22445,evaluated,0,0
22446,objectively,0,1
22447,by,0,0
22448,least-squares,1,0
22449,analyses,1,0
22450,of,1,1
22451,reciprocal,1,1
22452,serum,1,1
22453,creatinine,1,1
22454,",",0,1
22455,was,0,0
22456,reduced-and,0,0
22457,in,0,0
22458,one-third,0,0
22459,of,0,0
22460,the,0,0
22461,patients,0,0
22462,",",0,0
22463,arrested-during,0,1
22464,immunosuppressive,0,0
22465,treatment,0,0
22466,.,0,1
22467,Proteinuria,1,1
22468,",",0,0
22469,present,0,0
22470,in,0,0
22471,all,0,0
22472,patients,0,0
22473,at,0,0
22474,the,0,0
22475,time,0,1
22476,of,0,0
22477,entry,0,1
22478,into,0,0
22479,the,0,0
22480,trial,0,0
22481,",",0,0
22482,was,0,0
22483,reduced,0,1
22484,by,0,0
22485,treatment,0,0
22486,from,0,0
22487,12,0,0
22488,mo,0,0
22489,",",0,0
22490,compared,0,0
22491,with,0,0
22492,pretreatment,1,0
22493,levels,1,1
22494,or,1,0
22495,controls,1,0
22496,;,1,1
22497,erythrocyturia,1,1
22498,was,0,0
22499,reduced,0,0
22500,from,0,0
22501,6,0,0
22502,mo,0,0
22503,.,0,0
22504,Histologic,1,1
22505,activity,1,1
22506,and,1,1
22507,chronicity,1,1
22508,indexes,1,1
22509,were,0,0
22510,determined,0,0
22511,in,0,0
22512,renal,0,1
22513,biopsies,0,1
22514,performed,0,0
22515,at,0,0
22516,trial,0,0
22517,entry,0,1
22518,.,0,1
22519,Multivariate,1,1
22520,analysis,1,0
22521,demonstrated,0,0
22522,that,0,0
22523,mesangial,1,1
22524,cell,1,1
22525,proliferation,1,1
22526,and,1,1
22527,matrix,1,1
22528,scores,1,1
22529,were,0,0
22530,highest,0,0
22531,in,0,0
22532,those,0,0
22533,patients,0,0
22534,with,0,0
22535,more,0,0
22536,rapidly,0,0
22537,progressive,0,0
22538,disease,0,0
22539,.,0,0
22540,No,0,0
22541,morphologic,1,1
22542,variable,1,0
22543,or,1,1
22544,residual,1,1
22545,renal,1,1
22546,function,1,1
22547,predicted,0,1
22548,response,0,1
22549,to,0,0
22550,immunosuppressive,0,0
22551,therapy,0,0
22552,at,0,0
22553,entry,0,1
22554,.,0,0
22555,Mean,1,1
22556,arterial,1,1
22557,pressures,1,1
22558,did,0,0
22559,not,0,0
22560,differ,0,0
22561,significantly,0,0
22562,between,0,0
22563,treatment,0,0
22564,and,0,1
22565,control,0,0
22566,groups,0,0
22567,.,0,0
22568,There,0,0
22569,was,0,0
22570,thus,0,0
22571,no,0,0
22572,explanation,0,0
22573,other,0,0
22574,than,0,0
22575,treatment,0,0
22576,for,0,0
22577,the,0,0
22578,improved,0,1
22579,outcome,0,1
22580,in,0,0
22581,patients,0,0
22582,who,0,0
22583,received,0,0
22584,immunosuppressive,0,0
22585,therapy,0,0
22586,.,0,0
22587,Morbidity,1,1
22588,attributable,0,0
22589,to,0,0
22590,treatment,0,0
22591,or,0,0
22592,to,0,0
22593,renal,1,1
22594,failure,1,1
22595,occurred,0,0
22596,in,0,0
22597,both,0,0
22598,groups,0,0
22599,;,0,0
22600,an,0,0
22601,audit,0,1
22602,showed,0,0
22603,that,0,0
22604,benefits,1,0
22605,of,1,0
22606,therapy,1,0
22607,outweighed,0,0
22608,expected,0,0
22609,or,0,0
22610,minor,0,1
22611,side,0,1
22612,effects,0,1
22613,of,0,0
22614,drugs,0,0
22615,in,0,0
22616,this,0,0
22617,population,0,0
22618,at,0,0
22619,risk,0,1
22620,of,0,0
22621,end-stage,0,0
22622,renal,0,1
22623,failure,0,1
22624,.,0,0
22625,Patients,0,0
22626,selected,0,0
22627,for,0,0
22628,moderately,0,0
22629,progressive,1,0
22630,IgA,1,0
22631,nephropathy,1,1
22632,benefit,0,0
22633,from,0,0
22634,treatment,0,0
22635,with,0,0
22636,prednisolone,0,0
22637,and,0,1
22638,cytotoxic,0,1
22639,agents,0,0
22640,;,0,0
22641,results,0,0
22642,are,0,0
22643,consistent,0,0
22644,with,0,0
22645,modulation,1,1
22646,of,1,0
22647,systemic,1,1
22648,immune,1,1
22649,response,1,1
22650,or,1,1
22651,nephritic,1,1
22652,injury,1,1
22653,",",0,0
22654,thus,0,0
22655,explaining,0,0
22656,improved,0,1
22657,outcome,0,1
22658,",",0,0
22659,and,0,0
22660,indicate,0,0
22661,that,0,0
22662,this,0,0
22663,therapy,0,0
22664,has,0,0
22665,an,0,0
22666,acceptably,0,0
22667,low,0,0
22668,risk,0,1
22669,of,0,1
22670,side,1,1
22671,effects,1,0
22672,.,1,0
22673,Metformin,0,0
22674,therapy,0,0
22675,improves,0,1
22676,ovulatory,1,1
22677,rates,1,1
22678,",",1,0
22679,cervical,1,1
22680,scores,1,1
22681,",",1,1
22682,and,1,1
22683,pregnancy,1,1
22684,rates,1,1
22685,in,0,0
22686,clomiphene,0,0
22687,citrate-resistant,0,0
22688,women,0,0
22689,with,0,0
22690,polycystic,0,0
22691,ovary,0,0
22692,syndrome,0,0
22693,.,0,0
22694,OBJECTIVE,0,0
22695,To,0,0
22696,evaluate,0,0
22697,the,0,0
22698,effect,0,0
22699,of,0,1
22700,metformin,0,0
22701,therapy,0,0
22702,on,0,0
22703,hyperandrogenism,0,1
22704,",",0,1
22705,insulin,0,1
22706,resistance,0,1
22707,",",0,1
22708,cervical,0,1
22709,scores,0,1
22710,",",0,1
22711,ovulation,0,1
22712,",",0,1
22713,and,0,1
22714,pregnancy,0,1
22715,rates,0,1
22716,in,0,0
22717,clomiphene,0,0
22718,citrate-resistant,0,0
22719,women,0,0
22720,with,0,0
22721,polycystic,0,0
22722,ovary,0,1
22723,syndrome,0,0
22724,(,0,1
22725,PCOS,0,0
22726,),0,0
22727,.,0,0
22728,DESIGN,0,0
22729,Prospective,0,0
22730,",",0,1
22731,randomized,0,0
22732,",",0,1
22733,double-blind,0,0
22734,",",0,1
22735,placebo-controlled,0,0
22736,study,0,0
22737,.,0,0
22738,SETTING,0,0
22739,Infertility,0,1
22740,clinic,0,0
22741,of,0,0
22742,a,0,0
22743,tertiary,0,0
22744,referral,0,0
22745,center,0,0
22746,.,0,1
22747,PATIENT,0,0
22748,(,0,0
22749,S,0,0
22750,),0,1
22751,Fifty-six,0,0
22752,women,0,0
22753,with,0,0
22754,clomiphene,0,0
22755,citrate-resistant,0,0
22756,PCOS,0,0
22757,.,0,1
22758,INTERVENTION,0,1
22759,(,0,0
22760,S,0,0
22761,),0,0
22762,Two,0,0
22763,cycles,0,0
22764,of,0,0
22765,oral,0,0
22766,metformin,0,0
22767,therapy,0,0
22768,(,0,0
22769,850,0,0
22770,mg,0,0
22771,",",0,0
22772,twice,0,0
22773,daily,0,0
22774,),0,0
22775,in,0,0
22776,group,0,0
22777,I,0,0
22778,and,0,0
22779,placebo,0,0
22780,therapy,0,0
22781,(,0,0
22782,twice,0,0
22783,daily,0,0
22784,),0,0
22785,in,0,0
22786,group,0,0
22787,II,0,0
22788,.,0,1
22789,Clomiphene,0,0
22790,citrate,0,0
22791,(,0,0
22792,100,0,0
22793,mg/day,0,0
22794,),0,0
22795,on,0,0
22796,cycle,0,1
22797,days,0,0
22798,3-7,0,0
22799,of,0,0
22800,the,0,0
22801,second,0,0
22802,cycle,0,1
22803,in,0,0
22804,both,0,0
22805,groups,0,0
22806,.,0,0
22807,MAIN,0,0
22808,OUTCOME,0,1
22809,MEASURE,0,1
22810,(,0,1
22811,S,0,0
22812,),0,1
22813,Insulin,1,1
22814,",",1,1
22815,T,1,1
22816,",",1,1
22817,DHEAS,1,1
22818,",",1,1
22819,FSH,1,1
22820,",",1,1
22821,LH,1,1
22822,",",1,1
22823,body,1,1
22824,mass,1,1
22825,index,1,1
22826,(,1,1
22827,BMI,1,1
22828,),1,1
22829,",",1,0
22830,waist-to-hip,1,1
22831,ratio,1,1
22832,",",1,1
22833,endometrial,1,1
22834,thickness,1,1
22835,",",1,1
22836,cervical,1,1
22837,score,1,1
22838,",",1,1
22839,ovulation,1,1
22840,",",1,1
22841,and,1,1
22842,pregnancy,1,1
22843,rates,1,1
22844,in,0,0
22845,clomiphene-induced,0,0
22846,cycles,0,0
22847,after,0,0
22848,metformin,0,0
22849,therapy,0,0
22850,.,0,1
22851,RESULT,0,1
22852,(,0,0
22853,S,0,0
22854,),0,1
22855,Metformin,0,0
22856,therapy,0,0
22857,resulted,0,0
22858,in,0,0
22859,a,0,0
22860,significant,0,0
22861,decrease,0,1
22862,in,0,0
22863,total,1,1
22864,T,1,1
22865,",",1,1
22866,LH,1,1
22867,level,1,1
22868,",",1,1
22869,LH/FSH,1,1
22870,ratio,1,1
22871,",",1,1
22872,insulin,1,1
22873,resistance,1,1
22874,",",1,1
22875,and,1,1
22876,mean,1,1
22877,BMI,1,1
22878,.,1,0
22879,No,0,0
22880,difference,0,0
22881,in,0,0
22882,waist-to-hip,1,1
22883,ratio,1,1
22884,",",1,1
22885,DHEAS,1,1
22886,level,1,1
22887,",",1,1
22888,and,1,1
22889,fasting,1,1
22890,insulin,1,1
22891,level,1,1
22892,was,0,0
22893,observed,0,0
22894,.,0,0
22895,Clomiphene,0,0
22896,citrate,0,0
22897,induction,0,1
22898,resulted,0,0
22899,in,0,0
22900,higher,0,0
22901,ovulation,1,1
22902,rates,1,1
22903,and,1,1
22904,thicker,1,1
22905,endometrium,1,1
22906,in,0,0
22907,the,0,0
22908,metformin,0,0
22909,group,0,0
22910,than,0,0
22911,in,0,0
22912,the,0,0
22913,placebo,0,0
22914,group,0,0
22915,.,0,0
22916,There,0,0
22917,was,0,0
22918,higher,0,0
22919,cumulative,1,1
22920,pregnancy,1,1
22921,rate,1,1
22922,in,0,0
22923,the,0,0
22924,metformin,0,0
22925,group,0,0
22926,;,0,0
22927,however,0,0
22928,",",0,0
22929,there,0,0
22930,was,0,0
22931,no,0,0
22932,significant,0,0
22933,difference,0,0
22934,in,0,0
22935,the,0,0
22936,pregnancy,1,1
22937,rate,1,1
22938,between,0,0
22939,the,0,0
22940,two,0,0
22941,groups,0,0
22942,.,0,0
22943,CONCLUSION,0,0
22944,(,0,0
22945,S,0,0
22946,),0,1
22947,Metformin,0,0
22948,therapy,0,0
22949,not,0,0
22950,only,0,0
22951,decreases,0,0
22952,hyperandrogenism,1,1
22953,and,1,1
22954,insulin,1,1
22955,resistance,1,1
22956,but,0,0
22957,also,0,0
22958,improves,0,1
22959,ovulation,1,1
22960,rates,1,1
22961,",",1,0
22962,cervical,1,1
22963,scores,1,1
22964,",",1,1
22965,and,1,1
22966,pregnancy,1,1
22967,rates,1,1
22968,in,0,0
22969,clomiphene,0,0
22970,citrate-resistant,0,0
22971,women,0,0
22972,with,0,0
22973,PCOS,0,0
22974,.,0,0
22975,[,0,0
22976,Clinical,0,1
22977,study,0,0
22978,on,0,0
22979,retarding,1,0
22980,aging,1,0
22981,effect,1,1
22982,of,0,1
22983,tongbu,0,0
22984,recipe,0,0
22985,to,0,0
22986,traditional,0,0
22987,Chinese,0,0
22988,medicine,0,0
22989,],0,0
22990,.,0,0
22991,OBJECTIVE,0,0
22992,To,0,0
22993,study,0,0
22994,the,0,0
22995,mechanism,0,0
22996,of,0,0
22997,Tongbu,0,0
22998,No,0,0
22999,.,0,0
23000,1,0,0
23001,(,0,0
23002,TB1,0,0
23003,",",0,0
23004,a,0,0
23005,prescription,0,0
23006,for,0,0
23007,reinforcing,0,1
23008,Kidney,0,1
23009,and,0,1
23010,Spleen,0,1
23011,",",0,1
23012,clearing,0,1
23013,up,0,0
23014,the,0,0
23015,bowel,0,1
23016,viscera,0,1
23017,to,0,0
23018,send,0,0
23019,Turbid,0,1
23020,downward,0,1
23021,and,0,1
23022,regulating,0,1
23023,Qi,0,1
23024,and,0,1
23025,blood,0,1
23026,),0,1
23027,in,1,0
23028,retarding,1,0
23029,aging,1,0
23030,.,1,0
23031,METHODS,0,0
23032,A,0,0
23033,controlled,0,0
23034,",",0,0
23035,multiple,0,0
23036,indexes,0,1
23037,study,0,0
23038,was,0,0
23039,conducted,0,0
23040,in,0,0
23041,56,0,0
23042,old,0,0
23043,subjects,0,0
23044,randomized,0,0
23045,into,0,0
23046,3,0,0
23047,groups,0,0
23048,.,0,0
23049,RESULTS,0,0
23050,TB1,0,0
23051,(,0,0
23052,containing,0,0
23053,ginseng,0,0
23054,leaf,0,1
23055,",",0,1
23056,cistanche,0,1
23057,",",0,1
23058,fleeceflower,0,0
23059,root,0,1
23060,",",0,1
23061,immature,0,1
23062,bitter,0,1
23063,orange,0,1
23064,",",0,1
23065,rhubarb,0,1
23066,",",0,1
23067,etc,0,0
23068,),0,0
23069,could,0,0
23070,improve,0,0
23071,various,0,0
23072,symptoms,1,1
23073,of,1,1
23074,aging,1,1
23075,",",0,1
23076,and,0,1
23077,had,0,0
23078,the,0,0
23079,effect,0,1
23080,in,0,0
23081,regulating,1,1
23082,immune,1,1
23083,and,1,1
23084,endocrinal,1,1
23085,function,1,1
23086,",",1,0
23087,scavenging,1,1
23088,free,1,1
23089,radicals,1,1
23090,and,1,1
23091,adjusting,1,0
23092,coli,1,0
23093,flora,1,1
23094,.,1,0
23095,The,0,0
23096,effects,0,0
23097,of,0,0
23098,TB1,0,0
23099,and,0,1
23100,TB2,0,1
23101,(,0,1
23102,containing,0,0
23103,ginseng,0,0
23104,leaf,0,1
23105,",",0,1
23106,cistanche,0,1
23107,and,0,1
23108,fleeceflower,0,0
23109,root,0,1
23110,),0,1
23111,were,0,0
23112,different,0,0
23113,significantly,0,0
23114,(,0,0
23115,P,0,0
23116,<,0,0
23117,0.05,0,0
23118,",",0,0
23119,P,0,0
23120,<,0,0
23121,0.01,0,0
23122,),0,0
23123,.,0,0
23124,CONCLUSION,0,0
23125,TB1,0,0
23126,has,0,0
23127,a,0,0
23128,good,0,0
23129,comprehensive,0,0
23130,effect,0,1
23131,in,0,0
23132,retarding,1,0
23133,aging,1,0
23134,.,1,0
23135,Improved,1,1
23136,responsiveness,1,1
23137,of,0,1
23138,PCOS,0,0
23139,patients,0,0
23140,to,0,0
23141,clomiphene,0,0
23142,after,0,0
23143,CYP17a,0,0
23144,inhibitor,0,0
23145,.,0,0
23146,PURPOSE,0,0
23147,To,0,0
23148,study,0,0
23149,the,0,0
23150,effect,0,0
23151,of,0,0
23152,CYP17a,0,1
23153,inhibitor,0,0
23154,",",0,1
23155,ketoconazole,0,0
23156,",",0,1
23157,on,0,0
23158,clomiphene,0,0
23159,responsiveness,0,1
23160,in,0,0
23161,PCOS,0,0
23162,patients,0,0
23163,.,0,0
23164,METHODS,0,0
23165,Prospective,0,0
23166,analysis,0,0
23167,was,0,0
23168,employed,0,0
23169,with,0,0
23170,the,0,0
23171,setup,0,0
23172,at,0,0
23173,Alexandria,0,1
23174,IVF/ICSI,0,0
23175,center,0,0
23176,.,0,0
23177,Ninety-seven,0,0
23178,insulin-resistant,0,1
23179,PCOS,0,0
23180,patients,0,0
23181,undergoing,0,0
23182,ovulation,0,1
23183,induction,0,1
23184,using,0,0
23185,clomiphene,0,0
23186,citrate,0,0
23187,were,0,0
23188,randomly,0,0
23189,divided,0,0
23190,",",0,0
23191,by,0,0
23192,random,0,0
23193,number,0,1
23194,table,0,1
23195,",",0,0
23196,into,0,0
23197,two,0,0
23198,groups,0,0
23199,.,0,0
23200,The,0,0
23201,first,0,1
23202,group,0,0
23203,(,0,0
23204,n,0,0
23205,=,0,0
23206,49,0,0
23207,),0,0
23208,received,0,0
23209,ketoconazole,0,0
23210,(,0,0
23211,400,0,0
23212,mg,0,0
23213,daily,0,0
23214,),0,0
23215,till,0,1
23216,correction,0,1
23217,of,0,1
23218,metabolic,0,1
23219,syndrome,0,0
23220,followed,0,0
23221,by,0,0
23222,clomiphene,0,0
23223,(,0,0
23224,100,0,0
23225,mg/day,0,0
23226,),0,0
23227,;,0,0
23228,the,0,0
23229,second,0,0
23230,group,0,0
23231,(,0,0
23232,n,0,0
23233,=,0,0
23234,48,0,0
23235,),0,0
23236,receiving,0,0
23237,clomiphene,0,0
23238,without,0,0
23239,ketoconazole,0,0
23240,pretreatment,0,0
23241,.,0,0
23242,Main,0,0
23243,outcome,0,1
23244,measures,0,1
23245,were,0,0
23246,incidence,1,1
23247,of,1,1
23248,clomiphene,1,0
23249,resistance,1,1
23250,",",1,1
23251,monofollicular,1,1
23252,response,1,1
23253,",",1,0
23254,fasting,1,1
23255,insulin/glucose,1,1
23256,ratio,1,1
23257,",",1,1
23258,serum,1,1
23259,testosterone,1,1
23260,",",1,1
23261,and,1,1
23262,pregnancy,1,1
23263,rates,1,1
23264,.,1,0
23265,RESULTS,0,0
23266,The,0,0
23267,ketoconazole,0,0
23268,group,0,0
23269,showed,0,0
23270,significantly,0,0
23271,(,0,0
23272,p,0,0
23273,<,0,0
23274,0.05,0,0
23275,),0,0
23276,higher,0,0
23277,incidence,1,1
23278,of,1,1
23279,monofollicular,1,1
23280,response,1,1
23281,(,0,0
23282,38,0,0
23283,%,0,0
23284,),0,0
23285,",",0,0
23286,higher,1,1
23287,pregnancy,1,1
23288,rates,1,1
23289,",",0,1
23290,and,0,1
23291,significantly,1,1
23292,less,1,0
23293,marked,1,0
23294,antiestrogenic,1,1
23295,manifestations,1,1
23296,than,0,0
23297,did,0,0
23298,the,0,0
23299,control,0,0
23300,group,0,0
23301,.,0,0
23302,They,0,0
23303,also,0,0
23304,had,0,0
23305,significantly,0,0
23306,lower,0,0
23307,incidence,1,1
23308,of,1,1
23309,clomiphene,1,0
23310,resistance,1,1
23311,(,0,0
23312,11.6,0,0
23313,%,0,0
23314,),0,0
23315,",",0,0
23316,lower,1,1
23317,serum,1,1
23318,testosterone,1,1
23319,levels,1,1
23320,",",0,1
23321,less,0,0
23322,hyperinsulinaemia,1,1
23323,",",0,1
23324,than,0,0
23325,did,0,0
23326,the,0,0
23327,control,0,0
23328,group,0,0
23329,.,0,1
23330,CONCLUSION,0,0
23331,Ketoconazole,0,0
23332,improved,0,1
23333,clomiphene,1,0
23334,responsivenss,1,0
23335,in,1,0
23336,PCOS,1,0
23337,patients,1,0
23338,and,0,1
23339,attenuated,0,0
23340,its,0,0
23341,untoward,1,1
23342,biological,1,0
23343,effects,1,0
23344,.,1,0
23345,The,0,0
23346,Low,0,0
23347,Energy,0,1
23348,Safety,0,1
23349,Study,0,0
23350,(,0,1
23351,LESS,0,0
23352,),0,0
23353,:,0,0
23354,rationale,0,0
23355,",",0,1
23356,design,0,0
23357,",",0,1
23358,patient,0,1
23359,characteristics,0,1
23360,",",0,1
23361,and,0,1
23362,device,0,0
23363,utilization,0,1
23364,.,0,0
23365,BACKGROUND,0,0
23366,A,0,0
23367,10-J,0,0
23368,energy,0,1
23369,safety,0,1
23370,margin,0,1
23371,has,0,0
23372,traditionally,0,0
23373,been,0,0
23374,used,0,0
23375,in,0,0
23376,programming,0,0
23377,implantable,0,0
23378,cardioverter,0,0
23379,defibrillators,0,0
23380,(,0,1
23381,ICDs,0,0
23382,),0,0
23383,.,0,0
23384,The,0,0
23385,Low,0,0
23386,Energy,0,1
23387,Safety,0,1
23388,Study,0,0
23389,(,0,1
23390,LESS,0,0
23391,),0,0
23392,tests,0,1
23393,the,0,0
23394,hypothesis,0,0
23395,that,0,0
23396,programming,0,0
23397,shocks,0,0
23398,to,0,0
23399,lower,0,0
23400,energy,0,0
23401,margins,0,1
23402,is,0,0
23403,safe,0,1
23404,and,0,0
23405,effective,0,1
23406,.,0,1
23407,METHODS,0,0
23408,Patients,0,0
23409,with,0,0
23410,standard,0,0
23411,ICD,0,0
23412,indications,0,0
23413,undergo,0,0
23414,defibrillation,0,0
23415,threshold,0,1
23416,testing,0,1
23417,(,0,1
23418,DFT,0,1
23419,),0,0
23420,at,0,0
23421,the,0,0
23422,time,0,1
23423,of,0,0
23424,ICD,0,0
23425,implant,0,1
23426,",",0,1
23427,with,0,0
23428,reconfirmation,0,0
23429,of,0,0
23430,lowest,0,0
23431,successful,0,0
23432,energy,0,1
23433,twice,0,0
23434,(,0,0
23435,DFT++,0,0
23436,),0,0
23437,.,0,0
23438,Patients,0,0
23439,are,0,0
23440,randomized,0,0
23441,to,0,0
23442,2,0,0
23443,groups,0,0
23444,:,0,0
23445,the,0,0
23446,first,0,0
23447,has,0,0
23448,the,0,0
23449,initial,0,0
23450,2,0,0
23451,shocks,0,0
23452,for,0,0
23453,ventricular,0,1
23454,fibrillation,0,1
23455,conversion,0,1
23456,programmed,0,0
23457,at,0,0
23458,2,0,0
23459,energy,0,0
23460,steps,0,0
23461,above,0,1
23462,DFT++,0,0
23463,(,0,0
23464,typically,0,0
23465,4-6,0,0
23466,J,0,0
23467,",",0,0
23468,maximum,0,1
23469,10,0,0
23470,J,0,0
23471,),0,0
23472,with,0,0
23473,subsequent,0,0
23474,shocks,0,0
23475,at,0,0
23476,maximum,0,1
23477,energy,0,1
23478,",",0,0
23479,and,0,0
23480,the,0,0
23481,second,0,0
23482,has,0,0
23483,all,0,0
23484,shocks,0,0
23485,programmed,0,0
23486,at,0,0
23487,maximum,0,1
23488,energy,0,1
23489,.,0,0
23490,Patients,0,0
23491,are,0,0
23492,followed,0,0
23493,up,0,0
23494,every,0,0
23495,3,0,0
23496,months,0,0
23497,for,0,0
23498,2,0,0
23499,years,0,0
23500,to,0,0
23501,assess,0,0
23502,shock,1,0
23503,conversion,1,1
23504,efficacy,1,1
23505,of,1,1
23506,spontaneous,1,1
23507,arrhythmias,1,1
23508,.,1,0
23509,In,0,0
23510,a,0,0
23511,subgroup,0,0
23512,of,0,0
23513,patients,0,0
23514,",",0,0
23515,there,0,0
23516,is,0,0
23517,a,0,0
23518,second,0,0
23519,randomization,0,0
23520,to,0,0
23521,energy,0,1
23522,levels,0,1
23523,of,0,0
23524,0,0,0
23525,",",0,0
23526,1,0,0
23527,",",0,0
23528,2,0,0
23529,",",0,0
23530,3,0,0
23531,",",0,0
23532,or,0,0
23533,4,0,0
23534,steps,0,0
23535,above,0,0
23536,implant,0,0
23537,DFT++,0,0
23538,for,0,0
23539,conversion,0,1
23540,testing,0,0
23541,of,0,0
23542,3,0,0
23543,induced,0,0
23544,ventricular,0,1
23545,fibrillation,0,1
23546,episodes,0,1
23547,at,0,0
23548,prehospital,0,1
23549,discharge,0,0
23550,",",0,0
23551,3,0,0
23552,months,0,0
23553,",",0,0
23554,and,0,0
23555,12,0,0
23556,months,0,0
23557,after,0,0
23558,implant,0,0
23559,.,0,0
23560,RESULTS,0,0
23561,Enrollment,0,1
23562,is,0,0
23563,complete,0,1
23564,(,0,0
23565,702,0,0
23566,patients,0,0
23567,),0,0
23568,",",0,0
23569,but,0,0
23570,follow-up,0,0
23571,results,0,0
23572,are,0,0
23573,pending,0,0
23574,.,0,0
23575,There,0,0
23576,were,0,0
23577,no,0,0
23578,significant,0,0
23579,variations,0,0
23580,in,0,0
23581,implant,1,0
23582,indications,1,0
23583,and,1,1
23584,baseline,1,1
23585,antiarrhythmic,1,1
23586,drug,1,0
23587,use,1,0
23588,over,0,0
23589,the,0,0
23590,3-year,0,0
23591,enrollment,0,0
23592,period,0,0
23593,",",0,0
23594,although,0,0
23595,an,0,0
23596,increase,0,0
23597,in,0,0
23598,the,0,0
23599,percentage,1,1
23600,of,1,0
23601,dual-chamber,1,0
23602,ICDs,1,1
23603,implanted,1,0
23604,occurred,0,0
23605,",",0,0
23606,with,0,0
23607,the,0,0
23608,majority,0,0
23609,(,0,0
23610,65,0,0
23611,%,0,0
23612,),0,0
23613,of,0,0
23614,implanted,0,0
23615,ICDs,0,0
23616,being,0,0
23617,dual-chamber,0,0
23618,devices,0,0
23619,by,0,0
23620,the,0,0
23621,end,0,0
23622,of,0,0
23623,the,0,0
23624,enrollment,0,0
23625,period,0,0
23626,.,0,0
23627,CONCLUSION,0,0
23628,The,0,0
23629,results,0,0
23630,of,0,0
23631,LESS,0,0
23632,should,0,0
23633,facilitate,0,0
23634,the,0,0
23635,development,0,1
23636,of,0,0
23637,algorithms,0,0
23638,for,0,0
23639,programming,0,0
23640,ICD,0,0
23641,energy,1,1
23642,safety,1,1
23643,margins,1,1
23644,.,1,0
23645,Multicenter,0,0
23646,randomized,0,0
23647,controlled,0,0
23648,trial,0,0
23649,of,0,0
23650,the,0,0
23651,management,0,0
23652,of,0,0
23653,unresectable,0,0
23654,malignant,0,0
23655,mesothelioma,0,0
23656,proposed,0,0
23657,by,0,0
23658,the,0,0
23659,British,0,0
23660,Thoracic,0,1
23661,Society,0,1
23662,and,0,0
23663,the,0,0
23664,British,0,0
23665,Medical,0,0
23666,Research,0,0
23667,Council,0,1
23668,.,0,1
23669,Malignant,0,0
23670,mesothelioma,0,0
23671,is,0,0
23672,almost,0,0
23673,invariably,0,0
23674,fatal,0,0
23675,.,0,0
23676,The,0,0
23677,incidence,0,1
23678,of,0,0
23679,the,0,0
23680,disease,0,0
23681,is,0,0
23682,rising,0,0
23683,rapidly,0,0
23684,in,0,0
23685,many,0,0
23686,countries,0,0
23687,",",0,1
23688,and,0,0
23689,there,0,0
23690,is,0,0
23691,no,0,0
23692,generally,0,0
23693,accepted,0,0
23694,standard,0,0
23695,treatment,0,0
23696,for,0,0
23697,patients,0,0
23698,with,0,0
23699,unresectable,0,0
23700,disease,0,1
23701,.,0,0
23702,According,0,0
23703,to,0,0
23704,current,0,0
23705,British,0,0
23706,Thoracic,0,1
23707,Society,0,1
23708,(,0,1
23709,BTS,0,1
23710,),0,1
23711,guidelines,0,0
23712,",",0,0
23713,patients,0,0
23714,should,0,0
23715,be,0,0
23716,treated,0,0
23717,with,0,0
23718,active,0,0
23719,symptom,0,1
23720,control,0,0
23721,(,0,1
23722,ASC,0,1
23723,),0,1
23724,",",0,0
23725,involving,0,0
23726,(,0,0
23727,1,0,0
23728,),0,0
23729,regular,0,0
23730,follow-up,0,0
23731,in,0,0
23732,a,0,0
23733,specialist,0,0
23734,clinic,0,0
23735,;,0,0
23736,(,0,0
23737,2,0,0
23738,),0,0
23739,structured,0,0
23740,assessments,0,0
23741,of,0,1
23742,physical,0,1
23743,",",0,0
23744,psychological,0,1
23745,and,0,1
23746,social,0,1
23747,problems,0,1
23748,with,0,0
23749,appropriate,0,0
23750,action,0,1
23751,;,0,0
23752,(,0,0
23753,3,0,0
23754,),0,0
23755,rapid,0,0
23756,involvement,0,1
23757,of,0,1
23758,additional,0,0
23759,specialists,0,0
23760,;,0,1
23761,and,0,0
23762,(,0,0
23763,4,0,0
23764,),0,0
23765,parallel,0,0
23766,nursing,0,0
23767,support,0,0
23768,.,0,0
23769,Although,0,0
23770,many,0,0
23771,nonrandomized,0,0
23772,studies,0,0
23773,have,0,0
23774,reported,0,0
23775,tumor,0,0
23776,responses,0,1
23777,to,0,0
23778,anticancer,0,0
23779,chemotherapy,0,0
23780,",",0,0
23781,few,0,0
23782,have,0,0
23783,studied,0,0
23784,palliation,0,0
23785,and,0,0
23786,it,0,0
23787,is,0,0
23788,not,0,0
23789,known,0,0
23790,whether,0,0
23791,chemotherapy,0,0
23792,prolongs,0,1
23793,survival,0,1
23794,or,0,0
23795,provides,0,0
23796,clinically,0,1
23797,worthwhile,0,0
23798,palliation,0,1
23799,with,0,0
23800,acceptable,0,0
23801,toxicity,0,1
23802,when,0,0
23803,given,0,0
23804,in,0,0
23805,addition,0,0
23806,to,0,0
23807,ASC,0,0
23808,.,0,0
23809,We,0,0
23810,therefore,0,0
23811,plan,0,0
23812,to,0,0
23813,conduct,0,0
23814,a,0,0
23815,multicenter,0,0
23816,randomized,0,0
23817,controlled,0,0
23818,trial,0,0
23819,comparing,0,0
23820,(,0,0
23821,1,0,0
23822,),0,0
23823,ASC,0,0
23824,alone,0,0
23825,",",0,0
23826,(,0,0
23827,2,0,0
23828,),0,0
23829,ASC,0,0
23830,plus,0,0
23831,mitomycin,0,0
23832,vinblastine,0,0
23833,and,0,1
23834,cisplatin,0,0
23835,(,0,1
23836,MVP,0,1
23837,),0,1
23838,",",0,1
23839,and,0,1
23840,(,0,0
23841,3,0,0
23842,),0,0
23843,ASC,0,0
23844,plus,0,0
23845,vinorelbine,0,0
23846,(,0,0
23847,N,0,0
23848,;,0,1
23849,Navelbine,0,0
23850,",",0,0
23851,Pierre,0,0
23852,Fabre,0,1
23853,Oncology,0,1
23854,",",0,1
23855,Winchester,0,1
23856,",",0,1
23857,UK,0,1
23858,),0,0
23859,.,0,0
23860,We,0,0
23861,chose,0,0
23862,these,0,0
23863,chemotherapy,0,0
23864,regimens,0,0
23865,because,0,0
23866,they,0,0
23867,have,0,0
23868,been,0,0
23869,shown,0,0
23870,in,0,0
23871,nonrandomized,0,0
23872,studies,0,0
23873,to,0,0
23874,provide,0,0
23875,good,0,0
23876,symptom,0,1
23877,control,0,0
23878,as,0,0
23879,recorded,0,0
23880,by,0,0
23881,patients,0,0
23882,.,0,0
23883,The,0,0
23884,outcome,0,0
23885,measures,0,0
23886,are,0,0
23887,overall,1,1
23888,survival,1,1
23889,",",1,1
23890,palliation,1,1
23891,of,1,1
23892,symptoms,1,1
23893,",",1,1
23894,performance,1,1
23895,status,1,1
23896,",",1,1
23897,analgesic,1,1
23898,usage,1,1
23899,",",1,1
23900,toxicity,1,1
23901,",",1,1
23902,quality,1,1
23903,of,1,1
23904,life,1,1
23905,",",1,1
23906,tumor,1,1
23907,response,1,1
23908,",",1,1
23909,and,1,1
23910,recurrence/progression-free,1,1
23911,survival,1,1
23912,.,1,0
23913,In,0,0
23914,a,0,0
23915,preliminary,0,0
23916,feasibility,0,1
23917,study,0,0
23918,",",0,0
23919,we,0,0
23920,are,0,0
23921,assessing,0,0
23922,the,0,0
23923,acceptability,0,1
23924,of,0,0
23925,the,0,0
23926,trial,0,0
23927,design,0,0
23928,to,0,0
23929,patients,0,0
23930,and,0,0
23931,the,0,0
23932,suitability,0,0
23933,of,0,0
23934,two,0,0
23935,standard,0,0
23936,quality-of-life,1,1
23937,instruments,0,0
23938,in,0,0
23939,mesothelioma,0,0
23940,.,0,0
23941,Data,0,0
23942,will,0,0
23943,help,0,0
23944,us,0,0
23945,to,0,0
23946,decide,0,0
23947,the,0,0
23948,final,0,1
23949,details,0,0
23950,of,0,0
23951,the,0,0
23952,large,0,0
23953,multicenter,0,0
23954,trial,0,0
23955,.,0,0
23956,Effects,0,0
23957,of,0,0
23958,glucagon-like,0,1
23959,peptide-1,0,1
23960,(,0,0
23961,7-36,0,1
23962,),0,1
23963,amide,0,1
23964,on,0,0
23965,motility,1,1
23966,and,1,1
23967,sensation,1,1
23968,of,1,0
23969,the,1,0
23970,proximal,1,0
23971,stomach,1,1
23972,in,0,0
23973,humans,0,0
23974,.,0,0
23975,BACKGROUND,0,0
23976,Glucagon-like,0,1
23977,peptide-1,0,1
23978,(,0,1
23979,7-36,0,1
23980,),0,1
23981,amide,0,1
23982,(,0,1
23983,GLP-1,0,0
23984,),0,0
23985,retards,0,0
23986,gastric,1,1
23987,emptying,1,1
23988,",",1,1
23989,reduces,1,1
23990,food,1,1
23991,intake,1,1
23992,",",1,0
23993,and,1,0
23994,inhibits,1,1
23995,antroduodenal,1,1
23996,and,1,0
23997,stimulates,1,0
23998,pyloric,1,0
23999,motility,1,1
24000,.,1,0
24001,AIMS,0,0
24002,To,0,0
24003,assess,0,0
24004,the,0,0
24005,effects,0,0
24006,of,0,0
24007,synthetic,0,1
24008,GLP-1,0,0
24009,on,0,0
24010,fundus,1,1
24011,tone,1,1
24012,and,1,1
24013,volume,1,1
24014,waves,1,1
24015,",",1,1
24016,gastric,1,1
24017,compliance,1,1
24018,",",1,1
24019,and,1,1
24020,perception,1,1
24021,of,1,1
24022,gastric,1,1
24023,distension,1,1
24024,.,1,0
24025,SUBJECTS,0,1
24026,Eleven,0,0
24027,healthy,0,0
24028,male,0,0
24029,volunteers,0,0
24030,.,0,0
24031,METHODS,0,0
24032,Background,0,0
24033,infusions,0,1
24034,were,0,0
24035,saline,0,0
24036,",",0,1
24037,or,0,1
24038,GLP-1,0,0
24039,at,0,0
24040,0.3,0,0
24041,or,0,0
24042,0.9,0,0
24043,pmol/,0,0
24044,kg/min,0,1
24045,on,0,0
24046,separate,0,0
24047,days,0,0
24048,in,0,0
24049,random,0,0
24050,order,0,0
24051,.,0,1
24052,Interdigestive,1,1
24053,fundus,1,1
24054,motility,1,1
24055,was,0,0
24056,recorded,0,0
24057,by,0,0
24058,barostat,0,0
24059,(,0,0
24060,maximum,0,1
24061,capacity,0,1
24062,of,0,1
24063,intragastric,0,1
24064,bag,0,0
24065,1200,0,0
24066,ml,0,0
24067,),0,0
24068,during,0,0
24069,basal,0,1
24070,and,0,1
24071,peptide,0,1
24072,periods,0,0
24073,of,0,0
24074,60,0,0
24075,minutes,0,0
24076,each,0,0
24077,.,0,0
24078,Thereafter,0,0
24079,stepwise,0,0
24080,isobaric,0,0
24081,distensions,0,1
24082,were,0,0
24083,performed,0,0
24084,with,0,0
24085,ongoing,0,0
24086,peptide,0,1
24087,infusion,0,0
24088,",",0,1
24089,and,0,1
24090,gastric,1,1
24091,sensation,1,1
24092,was,0,0
24093,scored,0,0
24094,.,0,0
24095,RESULTS,0,0
24096,Low,0,0
24097,and,0,1
24098,high,0,0
24099,loads,0,1
24100,of,0,0
24101,GLP-1,0,0
24102,induced,0,0
24103,physiological,1,1
24104,and,1,1
24105,supraphysiological,1,0
24106,plasma,1,1
24107,immunoreactivities,1,1
24108,",",0,0
24109,respectively,0,0
24110,.,0,0
24111,GLP-1,0,0
24112,dose,0,0
24113,dependently,0,0
24114,diminished,0,1
24115,fundus,1,1
24116,tone,1,1
24117,(,0,0
24118,162.9,0,0
24119,(,0,0
24120,15.0,0,0
24121,),0,0
24122,and,0,0
24123,259.5,0,0
24124,(,0,0
24125,17.2,0,0
24126,),0,0
24127,v,0,0
24128,121.1,0,0
24129,(,0,0
24130,6.0,0,0
24131,),0,0
24132,ml,0,0
24133,with,0,0
24134,saline,0,0
24135,;,0,0
24136,p,0,0
24137,<,0,0
24138,0.0001,0,0
24139,),0,0
24140,.,0,0
24141,It,0,0
24142,greatly,0,0
24143,reduced,0,0
24144,volume,1,1
24145,waves,1,1
24146,and,1,1
24147,total,1,1
24148,volume,1,1
24149,displaced,1,0
24150,by,0,0
24151,these,0,0
24152,events,0,1
24153,(,0,0
24154,p,0,0
24155,<,0,0
24156,0.0001,0,0
24157,),0,0
24158,.,0,0
24159,Gastric,1,1
24160,compliance,1,1
24161,derived,0,0
24162,from,0,0
24163,isobaric,0,0
24164,distension,0,1
24165,rose,0,0
24166,in,0,0
24167,a,0,0
24168,dose,0,0
24169,related,0,1
24170,manner,0,0
24171,(,0,0
24172,42.6,0,0
24173,(,0,0
24174,5.5,0,0
24175,),0,0
24176,and,0,0
24177,63.6,0,0
24178,(,0,0
24179,7.7,0,0
24180,),0,0
24181,v,0,0
24182,27.0,0,0
24183,(,0,0
24184,3.5,0,0
24185,),0,0
24186,ml/mm,0,0
24187,Hg,0,0
24188,;,0,1
24189,p=0.0004,0,0
24190,),0,0
24191,with,0,0
24192,a,0,0
24193,concomitant,0,0
24194,reduction,0,1
24195,of,0,0
24196,the,0,0
24197,pressure,1,1
24198,at,0,0
24199,half,0,1
24200,maximum,0,1
24201,bag,0,0
24202,volume,0,1
24203,(,0,0
24204,6.4,0,0
24205,(,0,0
24206,0.4,0,0
24207,),0,0
24208,and,0,0
24209,5.5,0,0
24210,(,0,0
24211,0.4,0,0
24212,),0,0
24213,v,0,0
24214,7.2,0,0
24215,(,0,0
24216,0.1,0,0
24217,),0,0
24218,mm,0,0
24219,Hg,0,0
24220,;,0,0
24221,p,0,0
24222,<,0,0
24223,0.0001,0,0
24224,),0,0
24225,.,0,0
24226,GLP-1,0,0
24227,did,0,0
24228,not,0,0
24229,change,0,1
24230,perception,0,1
24231,of,0,1
24232,isobaric,1,0
24233,distension,1,1
24234,but,0,0
24235,reduced,0,1
24236,the,0,0
24237,perception,1,1
24238,score,1,1
24239,related,0,0
24240,to,0,0
24241,corresponding,0,1
24242,bag,0,0
24243,volume,0,1
24244,(,0,0
24245,p,0,0
24246,<,0,0
24247,0.0001,0,0
24248,),0,0
24249,.,0,0
24250,CONCLUSIONS,0,0
24251,GLP-1,0,0
24252,is,0,0
24253,a,0,0
24254,candidate,0,0
24255,physiological,0,1
24256,inhibitory,0,1
24257,regulator,0,1
24258,of,0,1
24259,fundus,1,1
24260,motility,1,1
24261,.,1,0
24262,It,0,0
24263,allows,0,0
24264,the,0,0
24265,stomach,0,1
24266,to,0,0
24267,afford,0,0
24268,a,0,0
24269,larger,0,0
24270,volume,0,1
24271,without,0,0
24272,increase,1,1
24273,in,1,0
24274,sensation,1,1
24275,.,1,0
24276,Immune,1,1
24277,status,1,1
24278,of,0,0
24279,infants,0,0
24280,fed,0,0
24281,soy-based,0,0
24282,formulas,0,0
24283,with,0,0
24284,or,0,0
24285,without,0,0
24286,added,0,0
24287,nucleotides,0,0
24288,for,0,0
24289,1,0,0
24290,year,0,0
24291,:,0,0
24292,part,0,0
24293,2,0,0
24294,:,0,0
24295,immune,0,0
24296,cell,0,1
24297,populations,0,0
24298,.,0,0
24299,BACKGROUND,0,0
24300,Infants,0,0
24301,fed,0,0
24302,a,0,0
24303,soy,0,0
24304,protein,0,1
24305,isolate-based,0,0
24306,formula,0,0
24307,have,0,0
24308,immunization,1,0
24309,responses,1,1
24310,similar,0,0
24311,to,0,0
24312,breast-fed,0,0
24313,infants,0,0
24314,.,0,0
24315,However,0,0
24316,",",0,0
24317,cellular,1,1
24318,aspects,1,1
24319,of,1,0
24320,the,1,0
24321,immunologic,1,1
24322,development,1,1
24323,of,0,1
24324,soy-fed,0,0
24325,infants,0,0
24326,have,0,0
24327,not,0,0
24328,been,0,0
24329,studied,0,0
24330,extensively,0,0
24331,.,0,0
24332,Nucleotides,0,1
24333,added,0,0
24334,to,0,0
24335,milk-based,0,0
24336,formula,0,0
24337,benefit,0,0
24338,infant,0,1
24339,immune,0,1
24340,status,0,1
24341,",",0,1
24342,but,0,0
24343,reports,0,0
24344,of,0,0
24345,the,0,0
24346,immunologic,1,1
24347,effects,1,1
24348,of,0,0
24349,adding,0,0
24350,nucleotides,0,1
24351,to,0,0
24352,soy-based,0,0
24353,formula,0,0
24354,are,0,0
24355,not,0,0
24356,available,0,0
24357,.,0,0
24358,This,0,0
24359,study,0,0
24360,examines,0,0
24361,immune,1,1
24362,cell,1,0
24363,populations,1,0
24364,of,0,0
24365,infants,0,0
24366,fed,0,0
24367,soy,0,0
24368,protein,0,1
24369,isolate,0,0
24370,formulas,0,0
24371,with,0,0
24372,and,0,0
24373,without,0,0
24374,added,0,0
24375,nucleotides,0,0
24376,for,0,0
24377,1,0,0
24378,year,0,0
24379,.,0,0
24380,METHODS,0,0
24381,Newborn,0,0
24382,",",0,1
24383,term,0,1
24384,infants,0,0
24385,studied,0,0
24386,in,0,0
24387,a,0,0
24388,masked,0,0
24389,12-month,0,0
24390,feeding,0,1
24391,trial,0,0
24392,were,0,0
24393,assigned,0,0
24394,randomly,0,0
24395,to,0,0
24396,soy,0,0
24397,formula,0,0
24398,groups,0,0
24399,with,0,0
24400,and,0,0
24401,without,0,0
24402,added,0,0
24403,nucleotides,0,0
24404,(,0,0
24405,n,0,0
24406,=,0,0
24407,94,0,0
24408,",",0,0
24409,n,0,0
24410,=,0,0
24411,92,0,0
24412,),0,0
24413,.,0,0
24414,A,0,0
24415,nonrandomized,0,0
24416,human,0,0
24417,milk/formula-fed,0,0
24418,cohort,0,0
24419,(,0,0
24420,n,0,0
24421,=,0,0
24422,81,0,0
24423,),0,0
24424,",",0,0
24425,was,0,0
24426,concurrently,0,0
24427,enrolled,0,0
24428,.,0,0
24429,Blood,0,1
24430,samples,0,0
24431,were,0,0
24432,collected,0,0
24433,at,0,0
24434,6,0,0
24435,",",0,0
24436,7,0,0
24437,",",0,0
24438,and,0,0
24439,12,0,0
24440,months,0,0
24441,.,0,0
24442,Thirty-two,1,0
24443,immune,1,1
24444,cell,1,1
24445,populations,1,1
24446,were,0,0
24447,characterized,0,0
24448,using,0,0
24449,three-color,0,0
24450,flow,0,1
24451,cytometry,0,0
24452,.,0,0
24453,Cellular,0,1
24454,markers,0,1
24455,were,0,0
24456,chosen,0,0
24457,to,0,0
24458,assess,0,0
24459,general,1,0
24460,pediatric,1,0
24461,immune,1,1
24462,status,1,1
24463,",",1,1
24464,emphasizing,1,0
24465,maturation,1,1
24466,and,1,1
24467,activation,1,1
24468,of,1,1
24469,B,1,0
24470,",",1,1
24471,T,1,1
24472,",",1,1
24473,and,1,1
24474,NK,1,1
24475,lymphocytes,1,1
24476,.,1,0
24477,RESULTS,0,0
24478,All,0,0
24479,cell,0,1
24480,populations,0,0
24481,",",0,1
24482,number,0,1
24483,and,0,1
24484,percentages,0,1
24485,",",0,1
24486,were,0,0
24487,within,0,0
24488,age-related,0,0
24489,normal,0,0
24490,ranges,0,1
24491,.,0,0
24492,The,0,0
24493,only,0,0
24494,significant,0,0
24495,difference,0,0
24496,found,0,0
24497,between,0,0
24498,soy,0,1
24499,formula,0,0
24500,and,0,1
24501,human,0,0
24502,milk/formula-fed,0,0
24503,infants,0,0
24504,was,0,0
24505,the,0,0
24506,percentage,1,1
24507,of,1,0
24508,CD57,1,0
24509,+,1,0
24510,NK,1,1
24511,T,1,1
24512,cells,1,1
24513,at,0,0
24514,12,0,0
24515,months,0,0
24516,(,0,0
24517,human,0,0
24518,milk/formula,0,0
24519,>,0,1
24520,soy,0,1
24521,formula,0,0
24522,",",0,1
24523,P,0,0
24524,=,0,0
24525,0.034,0,0
24526,),0,0
24527,.,0,0
24528,There,0,0
24529,were,0,0
24530,significant,0,0
24531,differences,0,0
24532,at,0,0
24533,some,0,0
24534,time,0,1
24535,points,0,0
24536,between,0,0
24537,human,0,0
24538,milk/formula-fed,0,0
24539,and,0,1
24540,nucleotide-supplemented,0,0
24541,soy,0,1
24542,formula-fed,0,0
24543,infants,0,0
24544,in,0,0
24545,populations,1,0
24546,of,1,0
24547,lymphocytes,1,1
24548,",",1,0
24549,eosinophils,1,1
24550,",",1,1
24551,total,1,1
24552,T,1,1
24553,",",1,1
24554,helper,1,1
24555,T,1,1
24556,",",1,1
24557,naive,1,1
24558,helper,1,1
24559,",",1,1
24560,memory/effector,1,1
24561,helper,1,1
24562,",",1,0
24563,CD57,1,0
24564,-,1,0
24565,T,1,1
24566,",",1,1
24567,and,1,1
24568,CD11b,1,1
24569,+,1,0
24570,CD8,1,0
24571,+,1,0
24572,NK,1,0
24573,cells,1,1
24574,.,1,0
24575,None,0,0
24576,of,0,0
24577,the,0,0
24578,cell,1,1
24579,populations,1,0
24580,differed,0,0
24581,between,0,0
24582,infants,0,0
24583,fed,0,0
24584,soy,0,0
24585,formula,0,0
24586,versus,0,0
24587,soy,0,1
24588,plus,0,0
24589,nucleotides,0,1
24590,.,0,1
24591,CONCLUSIONS,0,0
24592,Infants,0,0
24593,fed,0,0
24594,this,0,0
24595,commercial,0,0
24596,soy,0,0
24597,formula,0,0
24598,demonstrated,0,0
24599,immune,1,1
24600,cell,1,1
24601,status,1,1
24602,similar,0,0
24603,to,0,0
24604,human,0,0
24605,milk/formula-fed,0,0
24606,infants,0,0
24607,",",0,0
24608,consistent,0,0
24609,with,0,0
24610,normal,0,0
24611,immune,1,1
24612,system,1,0
24613,development,1,1
24614,.,1,0
24615,The,0,0
24616,addition,0,0
24617,of,0,0
24618,nucleotides,0,0
24619,to,0,0
24620,soy,0,0
24621,formula,0,0
24622,did,0,0
24623,not,0,0
24624,significantly,0,0
24625,change,0,0
24626,specific,0,0
24627,individual,0,0
24628,immune,1,1
24629,cell,1,1
24630,populations,1,1
24631,but,0,0
24632,tended,0,0
24633,to,0,0
24634,increase,0,1
24635,numbers,1,1
24636,and,1,1
24637,percentages,1,1
24638,of,1,1
24639,T,1,0
24640,cells,1,1
24641,and,0,1
24642,decreased,0,1
24643,numbers,1,1
24644,and,1,1
24645,percentages,1,1
24646,of,1,1
24647,NK,1,0
24648,cells,1,1
24649,.,1,0
24650,Prophylactic,0,0
24651,use,0,0
24652,of,0,0
24653,amifostine,0,0
24654,to,0,0
24655,prevent,0,0
24656,radiochemotherapy-induced,0,0
24657,mucositis,0,1
24658,and,0,1
24659,xerostomia,0,1
24660,in,0,0
24661,head-and-neck,0,0
24662,cancer,0,0
24663,.,0,0
24664,PURPOSE,0,0
24665,To,0,0
24666,determine,0,0
24667,the,0,0
24668,prophylactic,0,0
24669,properties,0,1
24670,of,0,0
24671,amifostine,0,0
24672,against,0,1
24673,acute,0,0
24674,and,0,1
24675,late,0,1
24676,toxicities,0,1
24677,from,0,0
24678,radiochemotherapy,0,0
24679,in,0,0
24680,patients,0,0
24681,with,0,0
24682,head-and-neck,0,0
24683,cancer,0,0
24684,.,0,1
24685,METHODS,0,0
24686,AND,0,0
24687,MATERIALS,0,1
24688,Fifty,0,1
24689,patients,0,0
24690,were,0,0
24691,randomized,0,0
24692,to,0,0
24693,receive,0,0
24694,conventional,0,0
24695,radiotherapy,0,0
24696,(,0,1
24697,RT,0,0
24698,),0,1
24699,(,0,0
24700,2-Gy,0,0
24701,fractions,0,1
24702,",",0,0
24703,5,0,0
24704,days,0,0
24705,weekly,0,0
24706,",",0,0
24707,to,0,0
24708,a,0,0
24709,total,0,1
24710,of,0,0
24711,60-74,0,0
24712,Gy,0,1
24713,",",0,0
24714,depending,0,0
24715,on,0,0
24716,the,0,0
24717,tumor,0,1
24718,localization,0,1
24719,and,0,1
24720,TNM,0,1
24721,classification,0,1
24722,),0,1
24723,and,0,1
24724,carboplatin,0,0
24725,(,0,0
24726,90,0,0
24727,mg/m,0,0
24728,(,0,0
24729,2,0,0
24730,),0,0
24731,infusion,0,0
24732,once,0,0
24733,per,0,0
24734,week,0,0
24735,before,0,0
24736,RT,0,0
24737,),0,0
24738,.,0,1
24739,Amifostine,0,0
24740,(,0,0
24741,300,0,0
24742,mg/m,0,0
24743,(,0,0
24744,2,0,0
24745,),0,0
24746,),0,0
24747,was,0,0
24748,administered,0,0
24749,in,0,0
24750,the,0,0
24751,study,0,0
24752,group,0,0
24753,only,0,0
24754,15-30,0,0
24755,min,0,0
24756,before,0,0
24757,RT,0,0
24758,for,0,0
24759,6-7.5,0,0
24760,weeks,0,0
24761,.,0,0
24762,The,0,0
24763,primary,0,0
24764,study,0,0
24765,end,0,1
24766,point,0,0
24767,was,0,0
24768,the,0,0
24769,grading,1,1
24770,of,1,1
24771,acute,1,0
24772,and,1,1
24773,late,1,1
24774,nonhematologic,1,1
24775,toxicities,1,1
24776,(,1,1
24777,mucositis,1,1
24778,",",1,1
24779,dysphagia,1,1
24780,",",1,1
24781,xerostomia,1,1
24782,),1,1
24783,induced,0,0
24784,by,0,0
24785,radiochemotherapy,0,0
24786,.,0,0
24787,Secondary,0,0
24788,end,0,0
24789,points,0,1
24790,included,0,0
24791,treatment,1,0
24792,duration,1,1
24793,",",1,1
24794,hematologic,1,1
24795,toxicity,1,1
24796,",",1,1
24797,and,1,1
24798,clinical,1,1
24799,outcome,1,1
24800,.,1,0
24801,RESULTS,0,0
24802,The,0,0
24803,treatment,1,0
24804,duration,1,1
24805,was,0,0
24806,significantly,0,0
24807,shorter,0,0
24808,in,0,0
24809,the,0,0
24810,amifostine-treated,0,0
24811,group,0,0
24812,(,0,0
24813,p,0,0
24814,=,0,0
24815,0.013,0,0
24816,),0,0
24817,",",0,0
24818,because,0,0
24819,treatment,0,0
24820,interruptions,0,1
24821,were,0,0
24822,more,0,0
24823,frequent,0,1
24824,in,0,0
24825,the,0,0
24826,control,0,0
24827,group,0,0
24828,.,0,1
24829,Acute,1,1
24830,toxicities,1,1
24831,(,1,1
24832,mucositis,1,1
24833,and,1,1
24834,dysphagia,1,1
24835,),1,1
24836,were,0,0
24837,less,0,0
24838,severe,0,1
24839,in,0,0
24840,the,0,0
24841,amifostine-treated,0,0
24842,group,0,0
24843,.,0,0
24844,By,0,0
24845,Week,0,0
24846,3,0,0
24847,",",0,0
24848,all,0,0
24849,in,0,0
24850,the,0,0
24851,control,0,0
24852,group,0,0
24853,experienced,0,0
24854,Grade,1,0
24855,2,1,0
24856,mucositis,1,0
24857,compared,0,0
24858,with,0,0
24859,only,0,0
24860,9,0,0
24861,%,0,0
24862,in,0,0
24863,the,0,0
24864,amifostine-treated,0,0
24865,group,0,0
24866,(,0,0
24867,p,0,0
24868,<,0,0
24869,0.0001,0,0
24870,),0,0
24871,.,0,0
24872,By,0,0
24873,Week,0,0
24874,5,0,0
24875,",",0,0
24876,52.2,0,0
24877,%,0,0
24878,of,0,0
24879,the,0,0
24880,patients,0,0
24881,in,0,0
24882,the,0,0
24883,control,0,0
24884,group,0,0
24885,experienced,0,0
24886,Grade,1,0
24887,4,1,0
24888,mucositis,1,0
24889,compared,0,0
24890,with,0,0
24891,4.5,0,0
24892,%,0,0
24893,in,0,0
24894,the,0,0
24895,amifostine-treated,0,0
24896,group,0,0
24897,(,0,0
24898,p,0,0
24899,=,0,0
24900,0.0006,0,0
24901,),0,0
24902,.,0,0
24903,Similar,0,0
24904,results,0,0
24905,were,0,0
24906,obtained,0,0
24907,for,0,0
24908,dysphagia,1,1
24909,.,1,0
24910,At,0,0
24911,3,0,0
24912,months,0,0
24913,of,0,0
24914,follow-up,0,0
24915,",",0,0
24916,only,0,0
24917,27,0,0
24918,%,0,0
24919,of,0,0
24920,patients,0,0
24921,in,0,0
24922,the,0,0
24923,study,0,0
24924,group,0,0
24925,experienced,0,0
24926,Grade,1,0
24927,2,1,0
24928,xerostomia,1,1
24929,compared,0,0
24930,with,0,0
24931,73.9,0,0
24932,%,0,0
24933,in,0,0
24934,the,0,0
24935,control,0,0
24936,group,0,0
24937,(,0,0
24938,p,0,0
24939,=,0,0
24940,0.0001,0,0
24941,),0,0
24942,.,0,0
24943,Eighteen,0,0
24944,months,0,0
24945,after,0,0
24946,cessation,0,0
24947,of,0,1
24948,therapy,0,0
24949,",",0,0
24950,the,0,0
24951,proportion,1,1
24952,of,1,0
24953,patients,1,0
24954,with,1,0
24955,Grade,1,0
24956,2,1,0
24957,xerostomia,1,1
24958,was,0,0
24959,4.5,0,0
24960,%,0,0
24961,vs.,0,0
24962,30.4,0,0
24963,%,0,0
24964,for,0,0
24965,each,0,0
24966,respective,0,1
24967,treatment,0,0
24968,group,0,0
24969,(,0,0
24970,p,0,0
24971,=,0,0
24972,0.047,0,0
24973,),0,0
24974,.,0,0
24975,Cytoprotection,0,1
24976,with,0,0
24977,amifostine,0,0
24978,did,0,0
24979,not,0,0
24980,affect,0,0
24981,treatment,0,0
24982,outcome,0,1
24983,",",0,0
24984,with,0,0
24985,90.9,0,0
24986,%,0,0
24987,complete,0,1
24988,responses,0,1
24989,in,0,0
24990,the,0,0
24991,amifostine-treated,0,0
24992,group,0,0
24993,compared,0,0
24994,with,0,0
24995,78.3,0,0
24996,%,0,0
24997,in,0,0
24998,the,0,0
24999,control,0,0
25000,group,0,0
25001,(,0,0
25002,p,0,0
25003,=,0,0
25004,0.414,0,0
25005,),0,0
25006,.,0,0
25007,CONCLUSION,0,0
25008,Amifostine,0,0
25009,was,0,0
25010,effective,0,1
25011,in,0,0
25012,reducing,0,0
25013,mucositis,0,1
25014,and,0,1
25015,dysphagia,0,1
25016,resulting,0,1
25017,from,0,0
25018,radiochemotherapy,0,0
25019,in,0,0
25020,patients,0,0
25021,with,0,0
25022,head-and-neck,0,0
25023,cancer,0,0
25024,.,0,1
25025,Furthermore,0,0
25026,",",0,1
25027,amifostine,0,0
25028,reduced,0,1
25029,the,0,0
25030,severity,0,1
25031,of,0,0
25032,late,0,1
25033,xerostomia,0,1
25034,",",0,0
25035,a,0,0
25036,side,0,1
25037,effect,0,1
25038,of,0,1
25039,RT,0,0
25040,with,0,0
25041,long-lasting,0,0
25042,consequences,0,0
25043,.,0,0
25044,Amifostine,0,0
25045,treatment,0,0
25046,did,0,0
25047,not,0,0
25048,affect,0,0
25049,the,0,0
25050,clinical,0,0
25051,outcome,0,0
25052,.,0,0
25053,Effect,0,1
25054,of,0,1
25055,delayed,0,1
25056,cord,0,1
25057,clamping,0,0
25058,on,0,0
25059,iron,1,0
25060,stores,1,0
25061,in,0,0
25062,infants,0,0
25063,born,0,0
25064,to,0,0
25065,anemic,0,0
25066,mothers,0,0
25067,:,0,0
25068,a,0,0
25069,randomized,0,0
25070,controlled,0,0
25071,trial,0,0
25072,.,0,0
25073,OBJECTIVE,0,0
25074,To,0,0
25075,study,0,0
25076,the,0,0
25077,effects,0,0
25078,of,0,0
25079,cord,0,1
25080,clamping,0,0
25081,on,0,0
25082,iron,0,0
25083,stores,0,0
25084,of,0,0
25085,infants,0,0
25086,born,0,0
25087,to,0,0
25088,anemic,0,0
25089,mothers,0,0
25090,at,0,0
25091,3,0,0
25092,months,0,0
25093,of,0,0
25094,age,0,0
25095,.,0,0
25096,DESIGN,0,0
25097,Randomized,0,0
25098,controlled,0,0
25099,trial,0,0
25100,.,0,1
25101,SETTING,0,0
25102,Teaching,0,0
25103,hospital,0,1
25104,.,0,1
25105,METHODS,0,0
25106,Infants,0,0
25107,born,0,0
25108,to,0,0
25109,mothers,0,0
25110,with,0,0
25111,hemoglobin,0,1
25112,(,0,1
25113,Hb,0,1
25114,),0,0
25115,<,0,0
25116,100,0,0
25117,g/L,0,0
25118,were,0,0
25119,randomized,0,0
25120,at,0,0
25121,delivery,0,0
25122,to,0,0
25123,either,0,0
25124,immediate,0,1
25125,cord,0,1
25126,clamping,0,1
25127,(,0,1
25128,early,0,1
25129,group,0,0
25130,),0,1
25131,or,0,0
25132,cord,0,1
25133,clamping,0,0
25134,delayed,0,1
25135,till,0,0
25136,descent,0,0
25137,of,0,1
25138,placenta,0,1
25139,into,0,0
25140,vagina,0,1
25141,(,0,0
25142,delayed,0,1
25143,group,0,0
25144,),0,0
25145,.,0,0
25146,The,0,0
25147,outcome,0,1
25148,measures,0,1
25149,were,0,0
25150,infant,1,1
25151,'s,1,1
25152,hemoglobin,1,1
25153,and,1,0
25154,serum,1,1
25155,ferritin,1,0
25156,3,1,0
25157,months,1,0
25158,after,1,0
25159,delivery,1,1
25160,.,1,1
25161,RESULTS,0,0
25162,There,0,0
25163,were,0,0
25164,102,0,0
25165,neonates,0,0
25166,randomized,0,0
25167,to,0,0
25168,early,0,0
25169,(,0,0
25170,n,0,0
25171,=,0,0
25172,43,0,0
25173,),0,0
25174,or,0,0
25175,delayed,0,1
25176,cord,0,1
25177,clamping,0,0
25178,(,0,0
25179,n,0,0
25180,=,0,0
25181,59,0,0
25182,),0,0
25183,.,0,0
25184,The,0,0
25185,groups,0,0
25186,were,0,0
25187,comparable,0,0
25188,for,0,0
25189,maternal,0,1
25190,age,0,0
25191,",",0,1
25192,parity,0,1
25193,",",0,1
25194,weight,0,1
25195,and,0,1
25196,supplemental,0,1
25197,iron,0,1
25198,intake,0,1
25199,",",0,1
25200,infant,0,1
25201,s,0,1
25202,birth,0,1
25203,weight,0,1
25204,",",0,1
25205,gestation,0,1
25206,and,0,1
25207,sex,0,0
25208,.,0,0
25209,The,0,0
25210,mean,1,1
25211,infant,1,1
25212,ferritin,1,1
25213,and,1,1
25214,Hb,1,1
25215,at,1,0
25216,3,1,0
25217,months,1,0
25218,were,0,0
25219,significantly,0,0
25220,higher,0,0
25221,in,0,0
25222,the,0,0
25223,delayed,0,1
25224,clamping,0,0
25225,group,0,0
25226,(,0,0
25227,118.4,0,0
25228,microg/L,0,0
25229,and,0,0
25230,99,0,0
25231,g/L,0,0
25232,),0,0
25233,than,0,0
25234,in,0,0
25235,the,0,0
25236,early,0,0
25237,clamping,0,0
25238,group,0,0
25239,(,0,0
25240,73,0,0
25241,microg/L,0,0
25242,and,0,0
25243,88,0,0
25244,g/L,0,0
25245,),0,0
25246,.,0,0
25247,The,0,0
25248,mean,0,1
25249,decrease,0,1
25250,in,0,0
25251,Hb,1,1
25252,(,0,1
25253,g/L,0,0
25254,),0,0
25255,at,0,0
25256,3,0,0
25257,months,0,0
25258,adjusted,0,0
25259,for,0,0
25260,co-variates,0,1
25261,was,0,0
25262,significantly,0,0
25263,less,0,0
25264,in,0,0
25265,the,0,0
25266,delayed,0,1
25267,clamping,0,0
25268,group,0,0
25269,compared,0,0
25270,to,0,0
25271,the,0,0
25272,early,0,0
25273,clamping,0,0
25274,group,0,0
25275,(,0,1
25276,-1.09,0,0
25277,",",0,0
25278,95,0,0
25279,%,0,0
25280,CI-1.58,0,0
25281,to,0,0
25282,-0.62,0,0
25283,",",0,0
25284,p,0,0
25285,>,0,0
25286,0.001,0,0
25287,),0,0
25288,.,0,0
25289,The,0,0
25290,odds,0,0
25291,for,0,0
25292,anemia,1,1
25293,(,0,0
25294,<,0,0
25295,100,0,0
25296,g/L,0,0
25297,),0,0
25298,at,0,0
25299,3,0,0
25300,months,0,0
25301,was,0,0
25302,7.7,0,0
25303,(,0,0
25304,95,0,0
25305,%,0,0
25306,CI,0,0
25307,1.84-34.9,0,0
25308,),0,0
25309,times,0,0
25310,higher,0,0
25311,in,0,0
25312,the,0,0
25313,early,0,0
25314,compared,0,0
25315,to,0,0
25316,the,0,0
25317,delayed,0,1
25318,clamping,0,0
25319,group,0,0
25320,.,0,1
25321,CONCLUSION,0,0
25322,Iron,1,0
25323,stores,1,1
25324,and,1,1
25325,Hb,1,1
25326,in,0,0
25327,infancy,0,0
25328,can,0,0
25329,be,0,0
25330,improved,0,0
25331,in,0,0
25332,neonates,0,0
25333,born,0,0
25334,to,0,0
25335,anemic,0,0
25336,mothers,0,0
25337,by,0,0
25338,delaying,0,1
25339,cord,0,1
25340,clamping,0,0
25341,at,0,0
25342,birth,0,0
25343,.,0,0
25344,Improved,0,0
25345,fibrinolysis,0,1
25346,after,0,0
25347,1-year,0,1
25348,treatment,0,0
25349,with,0,0
25350,HMG,0,0
25351,CoA,0,1
25352,reductase,0,1
25353,inhibitors,0,1
25354,in,0,0
25355,patients,0,0
25356,with,0,0
25357,coronary,0,1
25358,heart,0,1
25359,disease,0,1
25360,.,0,0
25361,The,0,0
25362,study,0,0
25363,was,0,0
25364,aimed,0,0
25365,to,0,0
25366,investigate,0,0
25367,the,0,0
25368,effect,0,0
25369,of,0,0
25370,two,0,0
25371,different,0,0
25372,statins,0,0
25373,on,0,0
25374,the,0,0
25375,levels,0,1
25376,of,0,0
25377,haemostatic,0,0
25378,variables,0,1
25379,reflecting,0,1
25380,procoagulant,0,1
25381,and,0,1
25382,fibrinolytic,0,1
25383,activity,0,1
25384,in,0,0
25385,patients,0,0
25386,with,0,0
25387,coronary,0,1
25388,heart,0,1
25389,disease,0,1
25390,(,0,1
25391,CHD,0,1
25392,),0,1
25393,",",0,0
25394,with,0,0
25395,the,0,0
25396,hypothesis,0,0
25397,that,0,0
25398,statins,0,0
25399,might,0,0
25400,beneficially,0,0
25401,modify,0,0
25402,these,0,0
25403,levels,0,1
25404,.,0,0
25405,Fifty-eight,0,0
25406,patients,0,0
25407,were,0,0
25408,randomized,0,0
25409,to,0,0
25410,treatment,0,0
25411,with,0,0
25412,atorvastatin,0,0
25413,(,0,0
25414,n=28,0,0
25415,),0,1
25416,or,0,1
25417,simvastatin,0,0
25418,(,0,1
25419,n=30,0,0
25420,),0,0
25421,for,0,0
25422,1,0,0
25423,year,0,0
25424,.,0,0
25425,The,0,0
25426,starting,0,0
25427,dose,0,0
25428,in,0,0
25429,both,0,0
25430,groups,0,0
25431,was,0,0
25432,20,0,0
25433,mg/day,0,0
25434,.,0,0
25435,Fasting,1,1
25436,blood,1,1
25437,samples,1,0
25438,were,0,0
25439,collected,0,0
25440,before,0,0
25441,and,0,0
25442,after,0,0
25443,12-month,0,1
25444,treatment,0,0
25445,for,0,0
25446,determinations,0,1
25447,of,0,1
25448,fibrinogen,1,1
25449,",",1,1
25450,prothrombin,1,1
25451,fragment,1,1
25452,1+2,1,1
25453,(,1,0
25454,F1+2,1,0
25455,),1,1
25456,",",1,0
25457,plasma,1,1
25458,D-dimer,1,1
25459,",",1,1
25460,soluble,1,1
25461,tissue,1,1
25462,factor,1,1
25463,",",1,1
25464,tissue,1,1
25465,plasminogen,1,1
25466,activator,1,0
25467,(,1,1
25468,tPA,1,1
25469,),1,1
25470,antigen,1,1
25471,",",1,1
25472,tPA,1,1
25473,activity,1,1
25474,",",1,1
25475,plasminogen,1,1
25476,activator,1,0
25477,inhibitor,1,0
25478,type-1,1,1
25479,activity,1,1
25480,(,1,1
25481,PAI-1,1,1
25482,activity,1,1
25483,),1,1
25484,and,1,1
25485,serum,1,1
25486,D-dimer,1,1
25487,as,1,0
25488,a,1,0
25489,global,1,1
25490,test,1,0
25491,of,1,1
25492,fibrinolytic,1,1
25493,activity,1,1
25494,.,1,0
25495,In,0,0
25496,the,0,0
25497,total,0,1
25498,population,0,0
25499,",",0,0
25500,improved,1,1
25501,fibrinolytic,1,1
25502,activity,1,1
25503,was,0,0
25504,observed,0,0
25505,after,0,0
25506,1,0,0
25507,year,0,0
25508,with,0,0
25509,increased,1,1
25510,levels,1,1
25511,of,0,0
25512,serum,1,1
25513,D-dimer,1,1
25514,(,0,1
25515,P=.001,0,1
25516,),0,1
25517,and,0,1
25518,tPA,1,1
25519,activity,1,1
25520,(,0,1
25521,P=.024,0,1
25522,),0,0
25523,and,0,0
25524,a,0,0
25525,reduction,1,1
25526,in,1,0
25527,tPA,1,1
25528,antigen,1,1
25529,(,0,1
25530,P=.048,0,0
25531,),0,0
25532,.,0,0
25533,No,0,0
25534,statistically,0,0
25535,significant,0,0
25536,changes,0,1
25537,were,0,0
25538,observed,0,0
25539,in,0,0
25540,any,0,0
25541,of,0,0
25542,the,0,0
25543,measured,0,1
25544,coagulation,0,0
25545,variables,0,1
25546,.,0,0
25547,Separately,0,0
25548,examined,0,0
25549,",",0,0
25550,an,0,0
25551,improved,0,1
25552,fibrinolytic,0,1
25553,profile,0,1
25554,was,0,0
25555,seen,0,0
25556,in,0,0
25557,the,0,0
25558,atorvastatin,0,0
25559,group,0,0
25560,with,0,0
25561,a,0,0
25562,significant,1,0
25563,increase,1,0
25564,in,1,0
25565,serum,1,1
25566,D-dimer,1,1
25567,(,0,1
25568,P=.005,0,0
25569,),0,0
25570,",",0,0
25571,a,0,0
25572,borderline,1,1
25573,increase,1,0
25574,in,1,0
25575,tPA,1,1
25576,activity,1,1
25577,(,0,1
25578,P=.083,0,0
25579,),0,0
25580,and,0,0
25581,a,0,0
25582,borderline,1,1
25583,reduction,1,1
25584,in,1,0
25585,tPA,1,1
25586,antigen,1,1
25587,(,0,1
25588,P=.069,0,0
25589,),0,0
25590,.,0,0
25591,Within,0,0
25592,the,0,0
25593,simvastatin,0,0
25594,group,0,0
25595,",",0,0
25596,a,0,0
25597,reduction,1,1
25598,in,1,0
25599,prothrombin,1,1
25600,F1+2,1,1
25601,was,0,0
25602,observed,0,0
25603,(,0,0
25604,P=.038,0,0
25605,),0,0
25606,.,0,0
25607,The,0,0
25608,differences,0,0
25609,in,0,0
25610,changes,0,1
25611,between,0,0
25612,the,0,0
25613,groups,0,0
25614,were,0,0
25615,statistically,0,0
25616,significant,0,0
25617,only,0,0
25618,for,0,0
25619,global,1,1
25620,fibrinolysis,1,1
25621,(,0,0
25622,serum,0,1
25623,D-dimer,0,1
25624,",",0,1
25625,P=.046,0,0
25626,),0,0
25627,.,0,0
25628,In,0,0
25629,conclusion,0,0
25630,",",0,0
25631,an,0,0
25632,improved,0,1
25633,fibrinolytic,1,1
25634,profile,1,1
25635,was,0,0
25636,observed,0,0
25637,after,0,0
25638,statin,0,0
25639,treatment,0,0
25640,",",0,1
25641,most,0,0
25642,pronounced,0,0
25643,with,0,0
25644,atorvastatin,0,0
25645,.,0,0
25646,The,0,0
25647,results,0,0
25648,indicate,0,0
25649,that,0,0
25650,the,0,0
25651,drugs,0,0
25652,promote,0,0
25653,a,0,0
25654,profibrinolytic,0,1
25655,profile,0,1
25656,",",0,0
25657,and,0,0
25658,may,0,0
25659,in,0,0
25660,part,0,0
25661,explain,0,0
25662,the,0,0
25663,benefit,0,0
25664,of,0,1
25665,statin,0,0
25666,treatment,0,0
25667,rendered,0,0
25668,in,0,0
25669,the,0,0
25670,prevention,0,0
25671,of,0,0
25672,CHD,0,0
25673,.,0,0
25674,Lack,0,0
25675,of,0,1
25676,benefit,0,0
25677,of,0,0
25678,an,0,0
25679,active,0,0
25680,pectoral,0,1
25681,pulse,0,1
25682,generator,0,1
25683,on,0,0
25684,atrial,0,1
25685,defibrillation,0,0
25686,thresholds,0,1
25687,.,0,0
25688,INTRODUCTION,0,1
25689,Atrial,0,0
25690,defibrillation,0,0
25691,can,0,0
25692,be,0,0
25693,achieved,0,0
25694,with,0,0
25695,standard,0,0
25696,implantable,0,0
25697,cardioverter,0,0
25698,defibrillator,0,0
25699,leads,0,1
25700,",",0,0
25701,which,0,0
25702,has,0,0
25703,led,0,0
25704,to,0,0
25705,the,0,0
25706,development,0,0
25707,of,0,0
25708,combined,0,0
25709,atrial,0,1
25710,and,0,1
25711,ventricular,0,1
25712,devices,0,0
25713,.,0,0
25714,For,0,0
25715,ventricular,0,1
25716,defibrillation,0,0
25717,",",0,1
25718,use,0,0
25719,of,0,0
25720,an,0,0
25721,active,0,0
25722,pectoral,0,1
25723,electrode,0,1
25724,(,0,0
25725,active,0,0
25726,can,0,0
25727,),0,0
25728,in,0,0
25729,the,0,0
25730,shocking,0,0
25731,pathway,0,0
25732,markedly,0,0
25733,reduces,0,0
25734,defibrillation,0,0
25735,thresholds,0,1
25736,(,0,1
25737,DFTs,0,0
25738,),0,0
25739,.,0,0
25740,However,0,0
25741,",",0,0
25742,the,0,0
25743,effect,0,0
25744,of,0,0
25745,an,0,0
25746,active,0,0
25747,pectoral,0,0
25748,can,0,0
25749,on,0,0
25750,atrial,0,0
25751,defibrillation,0,0
25752,is,0,0
25753,unknown,0,0
25754,.,0,0
25755,METHODS,0,0
25756,AND,0,0
25757,RESULTS,0,0
25758,This,0,0
25759,study,0,0
25760,was,0,0
25761,a,0,0
25762,prospective,0,0
25763,",",0,0
25764,randomized,0,0
25765,",",0,0
25766,paired,0,0
25767,comparison,0,0
25768,of,0,0
25769,two,0,0
25770,shock,0,0
25771,configurations,0,0
25772,on,0,0
25773,atrial,0,1
25774,DFTs,0,0
25775,in,0,0
25776,33,0,0
25777,patients,0,0
25778,.,0,0
25779,The,0,0
25780,lead,0,0
25781,system,0,0
25782,evaluated,0,0
25783,was,0,0
25784,a,0,0
25785,dual-coil,0,0
25786,transvenous,0,0
25787,defibrillation,0,0
25788,lead,0,0
25789,with,0,0
25790,a,0,0
25791,left,0,1
25792,pectoral,0,1
25793,pulse,0,1
25794,generator,0,1
25795,emulator,0,0
25796,.,0,1
25797,Shocks,0,0
25798,were,0,0
25799,delivered,0,0
25800,either,0,0
25801,between,0,0
25802,the,0,0
25803,right,0,1
25804,ventricular,0,1
25805,coil,0,1
25806,and,0,1
25807,proximal,0,1
25808,atrial,0,1
25809,coil,0,1
25810,(,0,1
25811,lead,0,1
25812,),0,1
25813,or,0,0
25814,between,0,0
25815,the,0,0
25816,right,0,1
25817,ventricular,0,1
25818,coil,0,0
25819,and,0,0
25820,an,0,0
25821,active,0,0
25822,can,0,0
25823,in,0,0
25824,common,0,0
25825,with,0,0
25826,the,0,0
25827,atrial,0,1
25828,coil,0,0
25829,(,0,0
25830,active,0,0
25831,can,0,0
25832,),0,0
25833,.,0,0
25834,Delivered,1,0
25835,energy,1,0
25836,at,1,0
25837,DFT,1,0
25838,was,0,0
25839,4.2,0,0
25840,+/-,0,0
25841,4.1,0,0
25842,J,0,0
25843,in,0,0
25844,the,0,0
25845,lead,0,0
25846,configuration,0,0
25847,and,0,0
25848,5.0,0,0
25849,+/-,0,0
25850,3.7,0,0
25851,J,0,0
25852,in,0,0
25853,the,0,0
25854,active,0,0
25855,can,0,0
25856,configuration,0,0
25857,(,0,0
25858,P,0,0
25859,=,0,0
25860,NS,0,1
25861,),0,0
25862,.,0,0
25863,Peak,1,1
25864,current,1,0
25865,was,0,0
25866,32,0,0
25867,%,0,0
25868,higher,0,0
25869,with,0,0
25870,an,0,0
25871,active,0,0
25872,can,0,0
25873,(,0,0
25874,P,0,0
25875,<,0,0
25876,0.01,0,0
25877,),0,0
25878,",",0,0
25879,whereas,0,0
25880,shock,1,1
25881,impedance,1,1
25882,was,0,0
25883,18,0,0
25884,%,0,0
25885,lower,0,0
25886,(,0,1
25887,P,0,0
25888,<,0,0
25889,0.001,0,0
25890,),0,0
25891,.,0,0
25892,Moreover,0,0
25893,",",0,0
25894,a,0,0
25895,low,1,1
25896,threshold,1,1
25897,(,0,0
25898,<,0,0
25899,or,0,0
25900,=,0,0
25901,3,0,0
25902,J,0,0
25903,),0,0
25904,was,0,0
25905,observed,0,0
25906,in,0,0
25907,61,0,0
25908,%,0,0
25909,of,0,0
25910,subjects,0,0
25911,in,0,0
25912,the,0,0
25913,lead,0,0
25914,configuration,0,0
25915,but,0,0
25916,in,0,0
25917,only,0,0
25918,36,0,0
25919,%,0,0
25920,in,0,0
25921,the,0,0
25922,active,0,0
25923,can,0,0
25924,configuration,0,0
25925,(,0,0
25926,P,0,0
25927,<,0,0
25928,0.05,0,0
25929,),0,0
25930,.,0,0
25931,There,0,0
25932,were,0,0
25933,no,1,0
25934,clinical,1,0
25935,predictors,1,0
25936,of,0,0
25937,the,0,0
25938,atrial,0,0
25939,DFT,0,0
25940,.,0,0
25941,CONCLUSION,0,0
25942,These,0,0
25943,results,0,0
25944,indicate,0,0
25945,that,0,0
25946,low,0,0
25947,atrial,0,0
25948,DFTs,0,0
25949,can,0,0
25950,be,0,0
25951,achieved,0,0
25952,using,0,0
25953,a,0,0
25954,transvenous,0,0
25955,ventricular,0,1
25956,defibrillation,0,0
25957,lead,0,0
25958,.,0,0
25959,Because,0,0
25960,no,0,0
25961,benefit,0,0
25962,was,0,0
25963,observed,0,0
25964,with,0,0
25965,the,0,0
25966,use,0,0
25967,of,0,0
25968,an,0,0
25969,active,0,0
25970,pectoral,0,1
25971,electrode,0,1
25972,for,0,0
25973,atrial,0,1
25974,defibrillation,0,0
25975,",",0,1
25976,programmable,0,0
25977,shock,0,0
25978,vectors,0,0
25979,may,0,0
25980,be,0,0
25981,useful,0,0
25982,for,0,0
25983,dual-chamber,0,0
25984,implantable,0,0
25985,cardioverter,0,0
25986,defibrillators,0,0
25987,.,0,0
25988,A,0,0
25989,single,0,0
25990,infusion,0,0
25991,of,0,1
25992,intravenous,0,0
25993,ketamine,0,0
25994,improves,0,0
25995,pain,0,1
25996,relief,0,1
25997,in,0,0
25998,patients,0,0
25999,with,0,0
26000,critical,0,1
26001,limb,0,1
26002,ischaemia,0,1
26003,:,0,0
26004,results,0,0
26005,of,0,0
26006,a,0,0
26007,double,0,0
26008,blind,0,0
26009,randomised,0,0
26010,controlled,0,0
26011,trial,0,0
26012,.,0,0
26013,We,0,0
26014,report,0,0
26015,the,0,0
26016,first,0,0
26017,double,0,0
26018,blind,0,0
26019,randomised,0,0
26020,controlled,0,0
26021,trial,0,0
26022,of,0,1
26023,regular,0,0
26024,opioids,0,0
26025,and,0,0
26026,an,0,0
26027,infusion,0,0
26028,of,0,0
26029,low,0,1
26030,dose,0,0
26031,(,0,0
26032,0.6,0,0
26033,mg/kg,0,0
26034,),0,0
26035,intravenous,0,0
26036,ketamine,0,0
26037,compared,0,0
26038,with,0,0
26039,opioids,0,0
26040,and,0,1
26041,placebo,0,0
26042,in,0,0
26043,patients,0,0
26044,with,0,0
26045,allodynia,0,1
26046,",",0,1
26047,hyperalgesia,0,1
26048,and,0,1
26049,hyperpathia,0,1
26050,secondary,0,1
26051,to,0,0
26052,critical,0,1
26053,limb,0,1
26054,ischaemia,0,1
26055,.,0,1
26056,Thirty-five,0,0
26057,patients,0,0
26058,completed,0,0
26059,the,0,0
26060,study,0,0
26061,",",0,0
26062,18,0,0
26063,received,0,0
26064,regular,0,0
26065,opioids,0,0
26066,plus,0,0
26067,ketamine,0,0
26068,",",0,0
26069,while,0,0
26070,17,0,0
26071,received,0,0
26072,regular,0,0
26073,opioids,0,0
26074,plus,0,0
26075,placebo,0,0
26076,.,0,0
26077,Using,0,0
26078,the,0,0
26079,Brief,1,1
26080,Pain,1,1
26081,Inventory,1,1
26082,",",1,0
26083,the,1,0
26084,%,1,0
26085,pain,1,1
26086,relief,1,1
26087,that,0,0
26088,the,0,0
26089,patients,0,0
26090,in,0,0
26091,the,0,0
26092,ketamine,0,0
26093,group,0,0
26094,attributed,0,0
26095,to,0,0
26096,their,0,0
26097,medication,0,0
26098,improved,0,0
26099,significantly,0,0
26100,from,0,0
26101,50,0,0
26102,%,0,0
26103,immediately,0,0
26104,pre-infusion,0,1
26105,to,0,0
26106,65,0,0
26107,%,0,0
26108,24,0,0
26109,h,0,0
26110,post-infusion,0,0
26111,and,0,0
26112,69,0,0
26113,%,0,0
26114,5,0,0
26115,days,0,0
26116,post,0,0
26117,infusion,0,0
26118,.,0,0
26119,Over,0,0
26120,the,0,0
26121,same,0,0
26122,period,0,0
26123,",",0,0
26124,the,0,0
26125,pain,1,1
26126,relief,1,1
26127,achieved,1,0
26128,by,0,0
26129,the,0,0
26130,placebo,0,0
26131,group,0,0
26132,rose,0,0
26133,from,0,0
26134,58,0,0
26135,%,0,0
26136,pre-infusion,0,0
26137,to,0,0
26138,56,0,0
26139,%,0,0
26140,24,0,0
26141,h,0,0
26142,post,0,0
26143,infusion,0,0
26144,and,0,0
26145,then,0,0
26146,50,0,0
26147,%,0,0
26148,relief,0,1
26149,5,0,0
26150,days,0,0
26151,later,0,0
26152,.,0,0
26153,This,0,0
26154,was,0,0
26155,statistically,1,0
26156,significant,1,0
26157,(,0,0
26158,P,0,0
26159,<,0,0
26160,0.05,0,0
26161,),0,0
26162,using,0,0
26163,both,0,0
26164,the,0,0
26165,t-test,1,0
26166,and,1,0
26167,the,1,0
26168,Wilcoxon,1,0
26169,Rank,1,1
26170,Sum,1,0
26171,test,1,0
26172,.,1,0
26173,The,0,0
26174,ketamine,0,0
26175,group,0,0
26176,also,0,0
26177,showed,0,0
26178,a,0,0
26179,statistically,0,0
26180,significant,0,0
26181,difference,0,0
26182,24,0,0
26183,h,0,0
26184,post,0,0
26185,infusion,0,0
26186,of,0,0
26187,the,0,0
26188,effect,0,0
26189,of,0,0
26190,pain,1,1
26191,on,0,0
26192,their,0,0
26193,general,0,0
26194,activity,0,1
26195,(,0,1
26196,P=0.03,0,0
26197,),0,1
26198,and,0,0
26199,on,0,0
26200,their,0,0
26201,enjoyment,0,1
26202,of,0,1
26203,life,0,1
26204,(,0,1
26205,P=0.004,0,0
26206,),0,0
26207,.,0,0
26208,This,0,0
26209,study,0,0
26210,shows,0,0
26211,that,0,0
26212,combining,0,0
26213,a,0,0
26214,single,0,0
26215,infusion,0,0
26216,of,0,1
26217,low,0,0
26218,dose,0,0
26219,ketamine,0,0
26220,with,0,0
26221,regular,0,0
26222,opioid,0,0
26223,analgesia,0,0
26224,can,0,0
26225,result,0,0
26226,in,0,0
26227,a,0,0
26228,significant,0,0
26229,improvement,0,1
26230,in,0,0
26231,pain,1,1
26232,relief,1,1
26233,for,0,0
26234,this,0,0
26235,patient,0,0
26236,group,0,0
26237,.,0,0
26238,Prospective,0,0
26239,study,0,0
26240,of,0,1
26241,C-reactive,1,1
26242,protein,1,1
26243,",",1,1
26244,homocysteine,1,1
26245,",",1,0
26246,and,1,1
26247,plasma,1,1
26248,lipid,1,1
26249,levels,1,1
26250,as,0,0
26251,predictors,0,0
26252,of,0,0
26253,sudden,0,1
26254,cardiac,0,1
26255,death,0,1
26256,.,0,0
26257,BACKGROUND,0,0
26258,Sudden,1,1
26259,cardiac,1,1
26260,death,1,1
26261,(,1,1
26262,SCD,1,1
26263,),1,0
26264,is,0,0
26265,an,0,0
26266,important,0,0
26267,cause,0,0
26268,of,0,1
26269,mortality,0,1
26270,even,0,0
26271,among,0,0
26272,apparently,0,0
26273,healthy,0,0
26274,populations,0,0
26275,.,0,0
26276,However,0,0
26277,",",0,0
26278,our,0,0
26279,ability,0,1
26280,to,0,0
26281,identify,0,0
26282,those,0,0
26283,at,0,0
26284,risk,0,1
26285,for,0,0
26286,SCD,0,1
26287,in,0,0
26288,the,0,0
26289,general,0,0
26290,population,0,0
26291,is,0,0
26292,poor,0,1
26293,",",0,0
26294,and,0,1
26295,more,0,1
26296,specific,0,0
26297,markers,0,0
26298,are,0,0
26299,needed,0,0
26300,.,0,0
26301,METHODS,0,0
26302,AND,0,0
26303,RESULTS,0,0
26304,To,0,0
26305,compare,0,0
26306,and,0,0
26307,contrast,0,0
26308,the,0,0
26309,relative,0,1
26310,importance,0,0
26311,of,0,1
26312,C-reactive,1,1
26313,protein,1,1
26314,(,1,1
26315,CRP,1,1
26316,),1,1
26317,",",1,1
26318,homocysteine,1,1
26319,",",1,1
26320,and,1,1
26321,lipids,1,1
26322,as,0,0
26323,long-term,0,0
26324,predictors,0,0
26325,of,0,1
26326,SCD,0,1
26327,",",0,0
26328,we,0,0
26329,performed,0,0
26330,a,0,0
26331,prospective,0,0
26332,",",0,0
26333,nested,0,0
26334,",",0,1
26335,case-control,0,0
26336,analysis,0,0
26337,involving,0,0
26338,97,0,0
26339,cases,0,0
26340,of,0,0
26341,SCD,0,1
26342,among,0,0
26343,apparently,0,0
26344,healthy,0,0
26345,men,0,0
26346,enrolled,0,0
26347,in,0,0
26348,the,0,0
26349,Physician,0,1
26350,'s,0,1
26351,Health,0,0
26352,Study,0,0
26353,.,0,0
26354,Of,0,0
26355,these,0,0
26356,plasma,0,1
26357,markers,0,1
26358,measured,0,1
26359,",",0,0
26360,only,0,0
26361,baseline,0,0
26362,CRP,1,1
26363,levels,1,1
26364,were,0,0
26365,significantly,0,0
26366,associated,0,0
26367,with,0,0
26368,the,0,0
26369,risk,0,1
26370,of,0,0
26371,SCD,0,1
26372,over,0,0
26373,the,0,0
26374,ensuing,0,0
26375,17,0,0
26376,years,0,0
26377,of,0,0
26378,follow-up,0,0
26379,(,0,0
26380,P,0,0
26381,for,0,0
26382,trend=0.001,0,0
26383,),0,0
26384,.,0,0
26385,The,0,0
26386,increase,0,0
26387,in,0,0
26388,risk,0,1
26389,associated,0,0
26390,with,0,0
26391,CRP,1,0
26392,levels,1,1
26393,was,0,0
26394,primarily,0,0
26395,seen,0,0
26396,among,0,0
26397,men,0,0
26398,in,0,0
26399,the,0,0
26400,highest,0,1
26401,quartile,0,1
26402,",",0,0
26403,who,0,0
26404,were,0,0
26405,at,0,0
26406,a,0,0
26407,2.78-fold,0,0
26408,increased,0,1
26409,risk,0,1
26410,of,0,1
26411,SCD,1,1
26412,(,0,0
26413,95,0,0
26414,%,0,0
26415,CI,0,0
26416,1.35,0,0
26417,to,0,0
26418,5.72,0,0
26419,),0,0
26420,compared,0,0
26421,with,0,0
26422,men,0,0
26423,in,0,0
26424,the,0,0
26425,lowest,0,0
26426,quartile,0,1
26427,.,0,0
26428,These,0,0
26429,results,0,0
26430,were,0,0
26431,not,0,0
26432,significantly,0,0
26433,altered,0,0
26434,in,0,0
26435,analyses,0,0
26436,that,0,0
26437,(,0,0
26438,in,0,0
26439,addition,0,0
26440,to,0,0
26441,the,0,0
26442,matching,0,0
26443,variables,0,1
26444,of,0,1
26445,age,0,0
26446,and,0,1
26447,smoking,0,1
26448,status,0,1
26449,),0,1
26450,controlled,0,0
26451,for,0,0
26452,lipid,1,1
26453,parameters,1,1
26454,",",1,1
26455,homocysteine,1,1
26456,",",1,1
26457,and,1,1
26458,multiple,1,1
26459,cardiac,1,1
26460,risk,1,1
26461,factors,1,1
26462,(,0,0
26463,relative,0,1
26464,risk,0,1
26465,for,0,0
26466,highest,0,1
26467,versus,0,0
26468,lowest,0,0
26469,quartile,0,1
26470,2.65,0,0
26471,",",0,0
26472,95,0,0
26473,%,0,0
26474,CI,0,0
26475,0.79,0,0
26476,to,0,0
26477,8.83,0,0
26478,;,0,0
26479,P,0,0
26480,for,0,0
26481,trend=0.03,0,0
26482,),0,0
26483,.,0,0
26484,In,0,0
26485,contrast,0,0
26486,to,0,0
26487,the,0,0
26488,positive,0,1
26489,relationship,0,1
26490,observed,0,0
26491,for,0,0
26492,CRP,0,0
26493,",",0,0
26494,neither,0,1
26495,homocysteine,0,0
26496,nor,0,0
26497,lipid,0,1
26498,levels,0,1
26499,were,0,0
26500,significantly,0,0
26501,associated,0,0
26502,with,0,0
26503,risk,0,1
26504,of,0,0
26505,SCD,1,1
26506,.,1,0
26507,CONCLUSIONS,0,0
26508,These,0,0
26509,prospective,0,0
26510,data,0,0
26511,suggest,0,0
26512,that,0,0
26513,CRP,0,0
26514,levels,0,1
26515,may,0,0
26516,be,0,0
26517,useful,0,0
26518,in,0,0
26519,identifying,0,0
26520,apparently,0,0
26521,healthy,0,0
26522,men,0,0
26523,who,0,0
26524,are,0,0
26525,at,0,0
26526,an,0,0
26527,increased,0,0
26528,long-term,1,0
26529,risk,1,1
26530,of,1,0
26531,SCD,1,1
26532,.,1,0
26533,Brief,0,1
26534,report,0,0
26535,:,0,0
26536,imitation,0,1
26537,effects,0,1
26538,on,0,0
26539,children,0,0
26540,with,0,0
26541,autism,0,0
26542,.,0,0
26543,Twenty,0,0
26544,children,0,0
26545,with,0,0
26546,autism,0,0
26547,(,0,0
26548,mean,0,1
26549,age,0,0
26550,",",0,0
26551,5,0,0
26552,years,0,0
26553,),0,0
26554,were,0,0
26555,recruited,0,0
26556,for,0,0
26557,the,0,0
26558,study,0,0
26559,from,0,0
26560,a,0,0
26561,school,0,0
26562,for,0,0
26563,children,0,0
26564,with,0,0
26565,autism,0,0
26566,.,0,0
26567,The,0,0
26568,children,0,0
26569,were,0,0
26570,randomly,0,0
26571,assigned,0,0
26572,to,0,0
26573,an,0,0
26574,imitation,0,1
26575,(,0,0
26576,n,0,0
26577,=,0,0
26578,10,0,0
26579,),0,0
26580,or,0,0
26581,contingently,0,0
26582,responsive,0,0
26583,(,0,0
26584,n,0,0
26585,=,0,0
26586,10,0,0
26587,),0,0
26588,interaction,0,0
26589,group,0,0
26590,based,0,0
26591,on,0,0
26592,a,0,0
26593,stratification,0,0
26594,table,0,0
26595,for,0,0
26596,gender,0,0
26597,and,0,1
26598,developmental,0,1
26599,and,0,1
26600,chronological,0,1
26601,age,0,0
26602,.,0,0
26603,The,0,0
26604,sessions,0,0
26605,consisted,0,0
26606,of,0,0
26607,four,0,0
26608,phases,0,0
26609,",",0,0
26610,with,0,0
26611,each,0,0
26612,phase,0,0
26613,lasting,0,0
26614,3,0,0
26615,minutes,0,0
26616,.,0,0
26617,In,0,0
26618,the,0,0
26619,first,0,1
26620,phase,0,0
26621,",",0,0
26622,the,0,0
26623,child,0,1
26624,walked,0,0
26625,into,0,0
26626,a,0,0
26627,room,0,0
26628,that,0,0
26629,was,0,0
26630,furnished,0,0
26631,with,0,0
26632,a,0,0
26633,sofa,0,1
26634,",",0,0
26635,a,0,0
26636,table,0,0
26637,",",0,0
26638,chairs,0,1
26639,",",0,1
26640,and,0,0
26641,two,0,0
26642,sets,0,0
26643,of,0,0
26644,identical,0,0
26645,toys,0,0
26646,.,0,0
26647,An,0,0
26648,adult,0,0
26649,was,0,0
26650,in,0,0
26651,the,0,0
26652,room,0,0
26653,sitting,0,1
26654,very,0,0
26655,still,0,0
26656,like,0,0
26657,a,0,0
26658,statue,0,1
26659,(,0,0
26660,first,0,1
26661,still-face,0,0
26662,condition,0,0
26663,),0,0
26664,.,0,0
26665,In,0,0
26666,the,0,0
26667,second,0,0
26668,phase,0,0
26669,",",0,0
26670,the,0,0
26671,adult,0,0
26672,either,0,0
26673,imitated,0,0
26674,the,0,0
26675,child,0,1
26676,or,0,1
26677,was,0,0
26678,contingently,0,0
26679,responsive,0,0
26680,to,0,0
26681,the,0,0
26682,child,0,0
26683,.,0,0
26684,In,0,0
26685,the,0,0
26686,third,0,0
26687,phase,0,0
26688,",",0,0
26689,the,0,0
26690,adult,0,0
26691,sat,0,1
26692,still,0,0
26693,again,0,0
26694,(,0,0
26695,second,0,0
26696,still-face,0,0
26697,condition,0,0
26698,),0,1
26699,",",0,1
26700,and,0,0
26701,in,0,0
26702,the,0,0
26703,fourth,0,0
26704,phase,0,0
26705,",",0,0
26706,the,0,0
26707,adult,0,0
26708,engaged,0,0
26709,in,0,0
26710,a,0,0
26711,spontaneous,0,1
26712,interaction,0,1
26713,.,0,0
26714,During,0,0
26715,the,0,0
26716,third,0,0
26717,phase,0,0
26718,(,0,0
26719,the,0,0
26720,second,0,0
26721,still-face,0,0
26722,condition,0,0
26723,),0,0
26724,",",0,0
26725,the,0,0
26726,children,0,0
26727,in,0,0
26728,the,0,0
26729,imitation,0,1
26730,group,0,0
26731,spent,1,1
26732,less,1,0
26733,time,1,1
26734,in,0,0
26735,gross,0,1
26736,motor,0,1
26737,activity,0,1
26738,and,0,1
26739,more,1,0
26740,time,1,1
26741,touching,1,1
26742,the,1,0
26743,adult,1,0
26744,",",0,0
26745,as,0,0
26746,if,0,0
26747,attempting,0,0
26748,to,0,0
26749,initiate,0,0
26750,an,0,0
26751,interaction,0,0
26752,.,0,0
26753,The,0,0
26754,contingency,0,1
26755,condition,0,0
26756,appeared,0,0
26757,to,0,0
26758,be,0,0
26759,a,0,0
26760,more,1,0
26761,effective,1,1
26762,way,0,0
26763,to,0,0
26764,facilitate,0,0
26765,a,0,0
26766,distal,1,1
26767,social,1,1
26768,behavior,1,1
26769,(,1,1
26770,attention,1,1
26771,),1,1
26772,",",0,0
26773,whereas,0,0
26774,the,0,0
26775,imitative,0,0
26776,condition,0,0
26777,was,0,0
26778,a,0,0
26779,more,1,0
26780,effective,1,1
26781,way,0,0
26782,to,0,0
26783,facilitate,0,0
26784,a,0,0
26785,proximal,1,0
26786,social,1,1
26787,behavior,1,1
26788,(,1,0
26789,touching,1,1
26790,),1,0
26791,.,1,0
26792,The,0,0
26793,effects,0,0
26794,of,0,0
26795,physical,0,1
26796,and,0,1
26797,emotional,0,1
26798,status,0,1
26799,on,0,0
26800,adherence,0,1
26801,to,0,0
26802,a,0,0
26803,low-fat,0,0
26804,dietary,0,0
26805,pattern,0,0
26806,in,0,0
26807,the,0,0
26808,Women,0,1
26809,'s,0,1
26810,Health,0,0
26811,Initiative,0,1
26812,.,0,0
26813,OBJECTIVE,0,0
26814,To,0,0
26815,examine,0,0
26816,whether,0,0
26817,the,0,0
26818,effects,0,0
26819,of,0,0
26820,physical,0,1
26821,and,0,1
26822,emotional,0,1
26823,status,0,1
26824,on,0,0
26825,adherance,0,1
26826,to,0,0
26827,a,0,0
26828,low-fat,0,0
26829,(,0,0
26830,20,0,0
26831,%,0,0
26832,energy,0,0
26833,),0,1
26834,dietary,0,0
26835,pattern,0,0
26836,are,0,0
26837,mediated,0,0
26838,by,0,0
26839,participation,0,0
26840,in,0,0
26841,an,0,0
26842,intervention,0,0
26843,program,0,0
26844,(,0,0
26845,attending,0,0
26846,sessions,0,0
26847,and,0,1
26848,self-monitoring,0,1
26849,),0,0
26850,.,0,0
26851,DESIGN,0,0
26852,The,0,0
26853,Baron,0,0
26854,and,0,1
26855,Kenny,0,1
26856,mediator,0,1
26857,model,0,0
26858,",",0,0
26859,a,0,0
26860,series,0,0
26861,of,0,0
26862,4,0,0
26863,regression,0,0
26864,analyses,0,0
26865,",",0,1
26866,was,0,0
26867,used,0,0
26868,to,0,0
26869,evaluate,0,0
26870,whether,0,0
26871,:,0,0
26872,a,0,0
26873,),0,0
26874,physical,0,1
26875,and,0,1
26876,emotional,0,1
26877,status,0,1
26878,predicted,0,1
26879,program,0,0
26880,participation,0,1
26881,",",0,1
26882,b,0,1
26883,),0,1
26884,program,0,0
26885,participation,0,1
26886,predicted,0,1
26887,dietary,0,1
26888,adherence,0,1
26889,",",0,1
26890,c,0,1
26891,),0,1
26892,physical,0,1
26893,and,0,1
26894,emotional,0,1
26895,status,0,1
26896,factors,0,1
26897,predicted,0,1
26898,dietary,0,1
26899,adherence,0,1
26900,",",0,1
26901,and,0,1
26902,",",0,1
26903,ultimately,0,1
26904,d,0,0
26905,),0,0
26906,the,0,0
26907,effects,0,0
26908,of,0,0
26909,physical,0,1
26910,and,0,1
26911,emotional,0,1
26912,status,0,1
26913,on,0,0
26914,dietary,0,1
26915,adherence,0,1
26916,were,0,0
26917,mediated,0,0
26918,by,0,0
26919,program,0,0
26920,participation,0,0
26921,.,0,1
26922,SUBJECTS/SETTING,0,1
26923,Data,0,0
26924,from,0,0
26925,"13,277",0,0
26926,postmenopausal,0,0
26927,women,0,0
26928,randomly,0,0
26929,assigned,0,0
26930,to,0,0
26931,the,0,0
26932,low-fat,0,0
26933,intervention,0,0
26934,arm,0,0
26935,of,0,0
26936,the,0,0
26937,Women,0,1
26938,'s,0,1
26939,Health,0,1
26940,Initiative,0,1
26941,Dietary,0,1
26942,Modification,0,0
26943,Trial,0,0
26944,.,0,0
26945,INTERVENTION,0,0
26946,The,0,0
26947,nutrition,0,1
26948,goals,0,1
26949,for,0,0
26950,women,0,0
26951,randomly,0,0
26952,assigned,0,0
26953,to,0,0
26954,the,0,0
26955,low-fat,0,0
26956,intervention,0,0
26957,were,0,0
26958,to,0,0
26959,reduce,0,0
26960,total,0,1
26961,fat,0,1
26962,intake,0,1
26963,to,0,0
26964,20,0,0
26965,%,0,0
26966,or,0,0
26967,less,0,0
26968,of,0,1
26969,energy,0,1
26970,from,0,0
26971,fat,0,1
26972,and,0,0
26973,to,0,0
26974,consume,0,0
26975,5,0,0
26976,or,0,0
26977,more,0,0
26978,fruit/vegetable,0,1
26979,servings,0,1
26980,daily,0,0
26981,and,0,0
26982,6,0,0
26983,or,0,0
26984,more,0,0
26985,grain,0,1
26986,servings,0,1
26987,daily,0,0
26988,.,0,0
26989,MAIN,0,0
26990,OUTCOME,0,1
26991,MEASURES,0,0
26992,Year,1,0
26993,1,1,0
26994,program,1,0
26995,participation,1,0
26996,(,1,1
26997,degree,1,1
26998,of,1,1
26999,attending,1,0
27000,group,1,0
27001,sessions,1,0
27002,and,1,1
27003,submitting,1,0
27004,fat,1,1
27005,scores,1,1
27006,),1,1
27007,and,0,0
27008,adherence,1,1
27009,to,1,0
27010,the,1,0
27011,low-fat,1,0
27012,dietary,1,1
27013,pattern,1,0
27014,(,1,0
27015,percent,1,1
27016,energy,1,1
27017,from,1,0
27018,fat,1,1
27019,),1,0
27020,as,0,0
27021,predicted,0,0
27022,by,0,0
27023,baseline,0,0
27024,physical,0,1
27025,and,0,1
27026,emotional,0,1
27027,status,0,1
27028,(,0,0
27029,eight,0,0
27030,SF-36,0,0
27031,Health,0,0
27032,Survey,0,0
27033,subscales,0,1
27034,),0,0
27035,.,0,0
27036,RESULTS,0,0
27037,Participating,0,0
27038,in,0,0
27039,the,0,0
27040,dietary,0,0
27041,intervention,0,0
27042,program,0,0
27043,reduced,0,1
27044,(,0,0
27045,mediated,0,0
27046,),0,0
27047,the,0,0
27048,negative,0,1
27049,effect,1,0
27050,of,1,0
27051,poorer,1,0
27052,mental,1,1
27053,health,1,1
27054,on,0,0
27055,dietary,1,0
27056,adherence,1,0
27057,by,0,0
27058,15,0,0
27059,%,0,0
27060,.,0,0
27061,Additional,0,0
27062,findings,0,0
27063,included,0,0
27064,that,0,0
27065,a,0,0
27066,10,0,0
27067,%,0,0
27068,increase,0,0
27069,in,0,0
27070,physical,1,1
27071,functioning,1,1
27072,increased,0,1
27073,session,1,0
27074,attendance,1,1
27075,by,0,0
27076,0.4,0,0
27077,%,0,0
27078,(,0,0
27079,P,0,0
27080,<,0,0
27081,.001,0,0
27082,),0,0
27083,and,0,0
27084,a,0,0
27085,10,0,0
27086,%,0,0
27087,increase,0,0
27088,in,0,0
27089,mental,1,1
27090,health,1,1
27091,predicted,0,1
27092,a,0,0
27093,decrease,0,1
27094,in,0,0
27095,percent,0,1
27096,energy,1,1
27097,from,1,0
27098,fat,1,1
27099,of,0,0
27100,0.3,0,0
27101,%,0,0
27102,(,0,0
27103,P,0,0
27104,<,0,0
27105,.001,0,0
27106,),0,0
27107,.,0,0
27108,Program,0,1
27109,participation,0,0
27110,had,0,0
27111,a,0,0
27112,marked,0,0
27113,effect,0,0
27114,on,0,0
27115,dietary,1,0
27116,adherence,1,0
27117,:,1,0
27118,a,0,0
27119,10,0,0
27120,%,0,0
27121,increase,0,0
27122,in,0,0
27123,session,1,0
27124,attendance,1,1
27125,predicted,0,0
27126,a,0,0
27127,1.2,0,0
27128,%,0,0
27129,decrease,0,0
27130,in,0,0
27131,percent,1,1
27132,energy,1,1
27133,from,1,0
27134,fat,1,1
27135,(,0,0
27136,P,0,0
27137,<,0,0
27138,.001,0,0
27139,),0,0
27140,.,0,0
27141,APPLICATIONS/CONCLUSIONS,0,0
27142,Understanding,0,1
27143,and,0,1
27144,using,0,0
27145,instruments,0,0
27146,to,0,0
27147,assess,0,0
27148,the,0,0
27149,physical,0,1
27150,and,0,1
27151,emotional,0,1
27152,status,0,1
27153,of,0,0
27154,a,0,0
27155,target,0,0
27156,population,0,0
27157,will,0,0
27158,help,0,0
27159,dietetic,0,0
27160,professionals,0,0
27161,promote,0,0
27162,healthful,0,1
27163,dietary,0,1
27164,change,0,1
27165,and,0,1
27166,maintenance,0,0
27167,.,0,0
27168,Double-blind,0,0
27169,placebo-controlled,0,0
27170,trial,0,0
27171,of,0,1
27172,aprindine,0,0
27173,and,0,1
27174,digoxin,0,1
27175,for,0,0
27176,the,0,0
27177,prevention,1,0
27178,of,1,0
27179,symptomatic,1,1
27180,atrial,1,0
27181,fibrillation,1,0
27182,.,1,0
27183,A,0,0
27184,multicenter,0,0
27185,",",0,1
27186,placebo-controlled,0,0
27187,",",0,1
27188,randomized,0,0
27189,",",0,0
27190,double-blind,0,0
27191,trial,0,0
27192,compared,0,0
27193,the,0,0
27194,preventive,1,0
27195,effect,1,1
27196,of,0,1
27197,aprindine,0,0
27198,and,0,1
27199,digoxin,0,1
27200,on,0,0
27201,the,0,0
27202,recurrence,1,1
27203,of,1,0
27204,atrial,1,1
27205,fibrillation,1,1
27206,(,1,1
27207,AF,1,1
27208,),1,1
27209,with,0,0
27210,placebo,0,0
27211,",",0,1
27212,and,0,0
27213,also,0,0
27214,compare,0,0
27215,the,0,0
27216,effectiveness,1,0
27217,of,0,0
27218,these,0,0
27219,2,0,0
27220,drugs,0,0
27221,in,0,0
27222,the,0,0
27223,prevention,1,0
27224,of,1,0
27225,AF,1,1
27226,.,1,0
27227,Patients,0,0
27228,with,0,0
27229,symptomatic,0,1
27230,paroxysmal,0,1
27231,or,0,1
27232,persistent,0,0
27233,AF,0,0
27234,who,0,0
27235,had,0,0
27236,converted,0,0
27237,to,0,0
27238,sinus,0,0
27239,rhythm,0,1
27240,(,0,1
27241,SR,0,1
27242,),0,1
27243,were,0,0
27244,randomly,0,0
27245,assigned,0,0
27246,aprindine,0,0
27247,(,0,0
27248,40,0,0
27249,mg/day,0,0
27250,),0,0
27251,",",0,1
27252,digoxin,0,1
27253,(,0,0
27254,0.25,0,0
27255,mg/day,0,0
27256,),0,0
27257,or,0,1
27258,placebo,0,0
27259,and,0,1
27260,followed,0,0
27261,up,0,0
27262,on,0,0
27263,an,0,0
27264,outpatient,0,0
27265,basis,0,0
27266,every,0,0
27267,2,0,0
27268,weeks,0,0
27269,for,0,0
27270,6,0,0
27271,months,0,0
27272,.,0,0
27273,Of,0,0
27274,the,0,0
27275,141,0,0
27276,patients,0,0
27277,from,0,0
27278,36,0,0
27279,participating,0,0
27280,centers,0,0
27281,",",0,0
27282,47,0,0
27283,were,0,0
27284,given,0,0
27285,aprindine,0,0
27286,",",0,0
27287,47,0,0
27288,digoxin,0,0
27289,",",0,0
27290,and,0,0
27291,47,0,0
27292,were,0,0
27293,on,0,0
27294,placebo,0,0
27295,.,0,0
27296,After,0,0
27297,the,0,0
27298,6-month,0,1
27299,follow-up,0,0
27300,",",0,0
27301,the,0,0
27302,Kaplan-Meier,1,1
27303,estimates,0,0
27304,of,0,0
27305,the,0,0
27306,percentage,0,1
27307,of,0,0
27308,patients,0,0
27309,remaining,0,0
27310,free,0,1
27311,of,0,0
27312,recurrent,1,1
27313,symptomatic,1,1
27314,AF,1,1
27315,on,0,0
27316,aprindine,0,0
27317,",",0,1
27318,digoxin,0,1
27319,and,0,1
27320,placebo,0,0
27321,were,0,0
27322,33.3,0,0
27323,%,0,0
27324,",",0,0
27325,29.2,0,0
27326,%,0,0
27327,and,0,0
27328,21.5,0,0
27329,%,0,0
27330,",",0,0
27331,respectively,0,0
27332,.,0,0
27333,In,0,0
27334,patients,0,0
27335,remaining,0,0
27336,in,0,0
27337,SR,0,0
27338,for,0,0
27339,15,0,0
27340,days,0,0
27341,after,0,0
27342,from,0,0
27343,the,0,0
27344,start,0,0
27345,of,0,1
27346,follow-up,0,0
27347,",",0,1
27348,freedom,1,1
27349,from,1,0
27350,recurrence,1,1
27351,was,0,0
27352,significantly,0,0
27353,more,0,0
27354,prevalent,1,0
27355,in,0,0
27356,the,0,0
27357,aprindine,0,0
27358,group,0,0
27359,than,0,0
27360,in,0,0
27361,the,0,0
27362,placebo,0,0
27363,group,0,0
27364,(,0,1
27365,p=0.0414,0,0
27366,),0,1
27367,",",0,1
27368,but,0,0
27369,there,0,0
27370,was,0,0
27371,no,0,0
27372,significant,1,0
27373,difference,1,0
27374,between,0,0
27375,the,0,0
27376,digoxin,0,1
27377,and,0,1
27378,placebo,0,0
27379,groups,0,0
27380,.,0,0
27381,The,0,0
27382,rate,1,1
27383,of,1,0
27384,adverse,1,1
27385,events,1,1
27386,was,0,0
27387,similar,0,0
27388,in,0,0
27389,the,0,0
27390,3,0,0
27391,groups,0,0
27392,.,0,0
27393,In,0,0
27394,conclusion,0,0
27395,",",0,1
27396,neither,0,1
27397,aprindine,0,1
27398,nor,0,0
27399,digoxin,0,1
27400,had,0,0
27401,a,0,0
27402,significant,1,0
27403,effect,1,0
27404,on,0,0
27405,preventing,1,0
27406,relapse,1,1
27407,of,1,0
27408,symptomatic,1,0
27409,AF,1,0
27410,;,1,0
27411,however,0,0
27412,",",0,0
27413,recurrence,1,1
27414,of,1,1
27415,AF,1,1
27416,occurred,0,0
27417,later,1,0
27418,with,0,0
27419,aprindine,0,0
27420,than,0,0
27421,with,0,0
27422,placebo,0,0
27423,or,0,0
27424,digoxin,0,1
27425,.,0,0
27426,A,0,0
27427,pilot,0,0
27428,study,0,0
27429,of,0,0
27430,the,0,0
27431,safety,0,1
27432,and,0,1
27433,efficacy,0,1
27434,of,0,1
27435,supplemental,0,0
27436,arginine,0,0
27437,to,0,0
27438,enhance,0,0
27439,immune,0,1
27440,function,0,1
27441,in,0,0
27442,persons,0,0
27443,with,0,0
27444,HIV/AIDS,0,0
27445,.,0,0
27446,OBJECTIVE,0,0
27447,We,0,0
27448,collected,0,0
27449,preliminary,0,0
27450,data,0,0
27451,on,0,0
27452,the,0,0
27453,safety,0,1
27454,and,0,1
27455,efficacy,0,1
27456,of,0,1
27457,supplemental,0,0
27458,arginine,0,0
27459,to,0,0
27460,improve,0,0
27461,natural,0,0
27462,killer,0,1
27463,cell,0,1
27464,cytotoxicity,0,1
27465,in,0,0
27466,a,0,0
27467,sample,0,0
27468,of,0,0
27469,persons,0,0
27470,with,0,0
27471,human,0,0
27472,immunodeficiency,0,0
27473,virus,0,1
27474,(,0,1
27475,HIV,0,1
27476,),0,1
27477,and,0,1
27478,acquired,0,0
27479,immunodeficiency,0,0
27480,syndrome,0,1
27481,(,0,1
27482,AIDS,0,0
27483,),0,0
27484,.,0,0
27485,METHODS,0,0
27486,In,0,0
27487,a,0,0
27488,randomized,0,0
27489,",",0,0
27490,double-blind,0,0
27491,",",0,1
27492,placebo-controlled,0,0
27493,pilot,0,0
27494,study,0,0
27495,in,0,0
27496,an,0,0
27497,academic,0,0
27498,medical,0,0
27499,center-based,0,0
27500,infectious,0,1
27501,disease,0,1
27502,clinic,0,0
27503,",",0,0
27504,11,0,0
27505,clinically,0,0
27506,stable,0,0
27507,",",0,0
27508,HIV-infected,0,1
27509,adults,0,0
27510,had,0,0
27511,been,0,0
27512,treated,0,0
27513,with,0,0
27514,highly,0,0
27515,active,0,0
27516,",",0,0
27517,antiretroviral,0,1
27518,therapy,0,0
27519,and,0,1
27520,had,0,0
27521,HIV,0,1
27522,plasma,0,1
27523,RNA,0,1
27524,levels,0,1
27525,of,0,0
27526,less,0,0
27527,than,0,0
27528,10,0,0
27529,000,0,0
27530,copies/mL,0,0
27531,.,0,0
27532,Participants,0,0
27533,were,0,0
27534,randomly,0,0
27535,assigned,0,0
27536,to,0,0
27537,receive,0,0
27538,19.6,0,0
27539,g,0,0
27540,of,0,0
27541,arginine/d,0,0
27542,(,0,0
27543,n,0,0
27544,=,0,0
27545,6,0,0
27546,),0,0
27547,or,0,0
27548,placebo,0,0
27549,(,0,1
27550,n,0,0
27551,=,0,0
27552,5,0,0
27553,),0,0
27554,for,0,0
27555,14,0,0
27556,d.,0,0
27557,Plasma,1,1
27558,HIV,1,1
27559,RNA,1,1
27560,levels,1,1
27561,",",1,0
27562,neuropsychologic,1,1
27563,functioning,1,1
27564,",",1,1
27565,and,1,1
27566,self-reported,1,1
27567,adverse,1,1
27568,events,1,1
27569,were,0,0
27570,analyzed,0,0
27571,for,0,0
27572,safety,0,1
27573,of,0,0
27574,treatment,0,0
27575,.,0,1
27576,Efficacy,1,1
27577,was,0,0
27578,measured,0,0
27579,by,0,0
27580,natural,0,0
27581,killer,0,1
27582,cell,0,1
27583,cytotoxicity,0,1
27584,.,0,1
27585,RESULTS,0,0
27586,None,0,0
27587,of,0,0
27588,the,0,0
27589,participants,0,0
27590,experienced,0,0
27591,any,0,0
27592,adverse,1,1
27593,clinical,1,0
27594,",",1,1
27595,virologic,1,1
27596,",",1,1
27597,or,1,1
27598,neuropsychologic,1,1
27599,events,1,1
27600,that,0,0
27601,necessitated,0,0
27602,withdrawal,0,0
27603,from,0,0
27604,the,0,0
27605,study,0,0
27606,.,0,0
27607,The,0,0
27608,arginine-supplemented,0,0
27609,group,0,0
27610,showed,0,0
27611,a,0,0
27612,mean,1,1
27613,natural,1,0
27614,killer,1,1
27615,cell,1,1
27616,cytotoxicity,1,1
27617,increase,0,1
27618,of,0,0
27619,18.9,0,0
27620,lytic,0,1
27621,units,0,0
27622,",",0,0
27623,whereas,0,0
27624,the,0,0
27625,placebo,0,0
27626,group,0,0
27627,showed,0,0
27628,an,0,0
27629,increase,0,0
27630,of,0,0
27631,0.3,0,0
27632,lytic,0,0
27633,units,0,0
27634,.,0,0
27635,This,0,0
27636,difference,0,0
27637,was,0,0
27638,not,0,0
27639,statistically,0,0
27640,significant,0,0
27641,(,0,0
27642,P,0,0
27643,=,0,0
27644,0.79,0,0
27645,),0,0
27646,.,0,0
27647,CONCLUSIONS,0,0
27648,Short-term,0,0
27649,arginine,0,0
27650,supplementation,0,0
27651,is,0,0
27652,safe,0,1
27653,for,0,0
27654,persons,0,0
27655,with,0,0
27656,HIV/AIDS,0,0
27657,.,0,0
27658,Additional,0,0
27659,studies,0,0
27660,with,0,0
27661,larger,0,0
27662,samples,0,0
27663,and,0,1
27664,longer,0,0
27665,periods,0,0
27666,are,0,0
27667,warranted,0,0
27668,to,0,0
27669,determine,0,0
27670,the,0,0
27671,effects,0,0
27672,of,0,0
27673,arginine,0,0
27674,supplementation,0,0
27675,on,0,0
27676,other,0,0
27677,indices,0,1
27678,of,0,1
27679,immune,0,1
27680,function,0,1
27681,and,0,1
27682,on,0,0
27683,clinical,0,1
27684,outcomes,0,1
27685,such,0,0
27686,as,0,0
27687,intercurrent,0,1
27688,illnesses,0,1
27689,.,0,0
27690,A,0,0
27691,scanning,0,0
27692,electron,0,0
27693,microscopic,0,1
27694,study,0,0
27695,of,0,1
27696,different,0,0
27697,caries,0,0
27698,removal,1,1
27699,techniques,1,0
27700,on,0,0
27701,human,0,0
27702,dentin,0,0
27703,.,0,0
27704,Scanning,0,0
27705,electron,0,1
27706,microscopy,0,1
27707,(,0,1
27708,SEM,0,0
27709,),0,0
27710,evaluated,0,0
27711,the,0,0
27712,effect,1,1
27713,of,1,0
27714,different,1,0
27715,caries,1,0
27716,removal,1,1
27717,techniques,1,0
27718,on,0,0
27719,human,0,0
27720,dentin,0,0
27721,topography,0,1
27722,.,0,1
27723,Thirty-six,0,0
27724,extracted,0,0
27725,human,0,0
27726,carious,0,1
27727,mandibular,0,1
27728,molars,0,1
27729,were,0,0
27730,randomly,0,0
27731,assigned,0,0
27732,to,0,0
27733,six,0,0
27734,groups,0,0
27735,according,0,0
27736,to,0,0
27737,caries,0,1
27738,removal,0,1
27739,technique,0,0
27740,.,0,1
27741,Carious,0,1
27742,tissue,0,1
27743,was,0,0
27744,removed,0,0
27745,by,0,0
27746,hand,1,1
27747,excavation,1,1
27748,",",1,1
27749,bur,1,0
27750,excavation,1,1
27751,",",1,1
27752,air-abrasion,1,0
27753,",",1,1
27754,laser,1,0
27755,ablation,1,1
27756,",",1,1
27757,chemomechanical,1,0
27758,methods,1,0
27759,and,1,1
27760,sono-abrasion,1,0
27761,.,1,0
27762,The,0,0
27763,remaining,0,0
27764,dentin,0,0
27765,surfaces,0,0
27766,were,0,0
27767,replicated,0,0
27768,and,0,0
27769,gold-coated,0,0
27770,.,0,0
27771,The,0,0
27772,surfaces,0,0
27773,were,0,0
27774,examined,0,0
27775,using,0,0
27776,SEM,0,0
27777,and,0,1
27778,distinct,0,0
27779,differences,0,0
27780,in,0,0
27781,appearance,0,1
27782,were,0,0
27783,observed,0,0
27784,among,0,0
27785,specimens,0,0
27786,treated,0,0
27787,with,0,0
27788,different,0,0
27789,caries,0,1
27790,removal,0,0
27791,techniques,0,0
27792,.,0,0
27793,While,0,0
27794,hand-excavated,0,0
27795,",",0,0
27796,bur-excavated,0,0
27797,and,0,1
27798,air-abraded,0,0
27799,carious,0,1
27800,dentin,0,0
27801,surfaces,0,0
27802,were,0,0
27803,covered,0,0
27804,with,0,0
27805,a,0,0
27806,residual,1,1
27807,smear,1,1
27808,layer,1,1
27809,",",0,1
27810,sono-abrasion,0,1
27811,with,0,0
27812,patent,0,0
27813,dentinal,0,0
27814,tubules,0,1
27815,completely,0,0
27816,removed,0,0
27817,the,0,0
27818,smear,0,0
27819,layer,0,1
27820,.,0,0
27821,A,0,0
27822,few,0,0
27823,patent,1,0
27824,orifices,1,1
27825,of,1,0
27826,dentinal,1,1
27827,tubules,1,1
27828,were,0,0
27829,observed,0,0
27830,in,0,0
27831,dentin,0,0
27832,subjected,0,0
27833,to,0,0
27834,laser,0,0
27835,ablation,0,0
27836,and,0,1
27837,chemo-mechanical,0,1
27838,caries,0,1
27839,removal,0,0
27840,.,0,0
27841,Is,0,0
27842,periprostatic,0,0
27843,local,0,0
27844,anesthesia,0,0
27845,for,0,0
27846,transrectal,0,1
27847,ultrasound,0,1
27848,guided,0,0
27849,prostate,0,0
27850,biopsy,0,1
27851,associated,0,0
27852,with,0,0
27853,increased,0,0
27854,infectious,1,1
27855,or,1,0
27856,hemorrhagic,1,1
27857,complications,1,1
27858,?,0,0
27859,A,0,0
27860,prospective,0,0
27861,randomized,0,0
27862,trial,0,0
27863,.,0,0
27864,PURPOSE,0,0
27865,Periprostatic,0,0
27866,local,0,0
27867,anesthesia,0,0
27868,for,0,0
27869,prostate,0,0
27870,biopsy,0,0
27871,requires,0,0
27872,2,0,0
27873,or,0,0
27874,more,0,0
27875,extra,0,1
27876,needle,0,1
27877,punctures,0,0
27878,and,0,1
27879,injection,0,0
27880,of,0,0
27881,the,0,0
27882,local,0,0
27883,anesthetic,0,0
27884,through,0,0
27885,the,0,0
27886,highly,0,0
27887,colonized,0,0
27888,rectum,0,1
27889,.,0,0
27890,To,0,0
27891,our,0,0
27892,knowledge,0,0
27893,we,0,0
27894,report,0,0
27895,the,0,0
27896,first,0,0
27897,prospective,0,0
27898,randomized,0,0
27899,trial,0,0
27900,to,0,0
27901,assess,0,0
27902,the,0,0
27903,infectious,1,1
27904,or,1,0
27905,hemorrhagic,1,1
27906,complications,1,1
27907,associated,0,0
27908,with,0,0
27909,this,0,0
27910,method,0,0
27911,.,0,0
27912,MATERIALS,0,0
27913,AND,0,0
27914,METHODS,0,0
27915,A,0,0
27916,total,0,1
27917,of,0,0
27918,100,0,0
27919,consecutive,0,0
27920,patients,0,0
27921,with,0,0
27922,sterile,0,0
27923,urine,0,1
27924,cultures,0,1
27925,underwent,0,0
27926,transrectal,0,1
27927,ultrasound,0,1
27928,guided,0,0
27929,prostate,0,0
27930,biopsy,0,0
27931,.,0,0
27932,They,0,0
27933,were,0,0
27934,randomized,0,0
27935,to,0,0
27936,receive,0,0
27937,a,0,0
27938,periprostatic,0,0
27939,nerve,0,1
27940,block,0,0
27941,or,0,0
27942,no,0,0
27943,anesthesia,0,0
27944,.,0,0
27945,Patients,0,0
27946,were,0,0
27947,evaluated,0,0
27948,for,0,0
27949,the,0,0
27950,amount,1,1
27951,of,1,1
27952,rectal,1,1
27953,and,1,1
27954,urethral,1,1
27955,bleeding,1,1
27956,",",0,1
27957,and,0,1
27958,symptoms,0,1
27959,and,0,1
27960,signs,0,1
27961,of,0,1
27962,infection,1,1
27963,after,1,0
27964,biopsy,1,0
27965,.,1,0
27966,RESULTS,0,0
27967,The,0,0
27968,amount,1,1
27969,of,1,0
27970,urethral,1,1
27971,bleeding,1,1
27972,was,0,0
27973,slight,0,1
27974,and,0,1
27975,similar,0,0
27976,in,0,0
27977,the,0,0
27978,2,0,0
27979,groups,0,0
27980,.,0,0
27981,Rectal,1,1
27982,bleeding,1,1
27983,was,0,0
27984,significantly,0,0
27985,less,0,0
27986,in,0,0
27987,the,0,0
27988,patients,0,0
27989,who,0,0
27990,received,0,0
27991,anesthesia,0,0
27992,.,0,1
27993,High,1,0
27994,fever,1,1
27995,(,0,0
27996,greater,0,0
27997,than,0,0
27998,37.8C,0,0
27999,),0,0
28000,was,0,0
28001,more,0,0
28002,frequent,0,1
28003,in,0,0
28004,the,0,0
28005,nerve,0,1
28006,block,0,1
28007,group,0,0
28008,and,0,0
28009,2,0,0
28010,patients,0,0
28011,in,0,0
28012,this,0,0
28013,group,0,0
28014,required,0,0
28015,rehospitalization,0,1
28016,.,0,1
28017,Bacteriuria,1,1
28018,in,1,0
28019,post-biopsy,1,1
28020,urine,1,1
28021,cultures,1,1
28022,was,0,0
28023,significantly,0,0
28024,more,0,0
28025,common,0,0
28026,in,0,0
28027,the,0,0
28028,anesthesia,0,0
28029,group,0,0
28030,.,0,1
28031,CONCLUSIONS,0,0
28032,Our,0,0
28033,results,0,0
28034,suggest,0,0
28035,that,0,0
28036,periprostatic,0,0
28037,local,0,0
28038,anesthesia,0,0
28039,for,0,0
28040,prostate,0,0
28041,biopsy,0,0
28042,does,0,0
28043,not,0,0
28044,increase,0,0
28045,the,0,0
28046,risk,0,1
28047,of,0,0
28048,urethral,1,1
28049,bleeding,1,1
28050,.,1,0
28051,It,0,0
28052,is,0,0
28053,associated,0,0
28054,with,0,0
28055,a,0,0
28056,decreased,0,1
28057,incidence,0,1
28058,of,0,1
28059,rectal,1,1
28060,bleeding,1,1
28061,",",0,0
28062,presumably,0,0
28063,due,0,0
28064,to,0,0
28065,decreased,0,1
28066,patient,0,1
28067,discomfort,0,1
28068,.,0,0
28069,The,0,0
28070,incidence,0,1
28071,of,0,1
28072,bacteriuria,1,1
28073,was,0,0
28074,significantly,0,0
28075,higher,0,0
28076,in,0,0
28077,the,0,0
28078,anesthesia,0,0
28079,group,0,0
28080,.,0,1
28081,High,1,0
28082,fever,1,1
28083,and,1,1
28084,hospitalization,1,1
28085,due,0,0
28086,to,0,0
28087,infectious,0,1
28088,complications,0,1
28089,were,0,0
28090,also,0,0
28091,more,0,0
28092,common,0,0
28093,in,0,0
28094,the,0,0
28095,local,0,0
28096,anesthesia,0,0
28097,group,0,0
28098,",",0,0
28099,although,0,0
28100,not,0,0
28101,statistically,0,0
28102,significant,0,0
28103,.,0,0
28104,Prospective,0,0
28105,randomized,0,0
28106,trials,0,0
28107,seem,0,0
28108,warranted,0,0
28109,to,0,0
28110,determine,0,0
28111,the,0,0
28112,optimum,0,1
28113,antibiotic,0,0
28114,prophylaxis,0,0
28115,regimen,0,0
28116,in,0,0
28117,patients,0,0
28118,undergoing,0,0
28119,biopsy,0,0
28120,with,0,0
28121,a,0,0
28122,periprostatic,0,0
28123,nerve,0,1
28124,block,0,0
28125,.,0,0
28126,Cyclosporine,0,0
28127,inhibition,0,1
28128,of,0,1
28129,P-glycoprotein,0,1
28130,in,0,0
28131,chronic,0,0
28132,myeloid,0,1
28133,leukemia,0,0
28134,blast,0,1
28135,phase,0,0
28136,.,0,1
28137,Chronic,0,1
28138,myeloid,0,1
28139,leukemia,0,0
28140,blast,0,1
28141,phase,0,0
28142,(,0,1
28143,CML-BP,0,1
28144,),0,0
28145,cells,0,1
28146,commonly,0,0
28147,express,0,0
28148,the,0,0
28149,multidrug,0,1
28150,transporter,0,1
28151,",",0,1
28152,P-glycoprotein,0,1
28153,(,0,1
28154,Pgp,0,0
28155,),0,0
28156,.,0,0
28157,To,0,0
28158,determine,0,0
28159,whether,0,0
28160,Pgp,0,0
28161,inhibition,0,1
28162,improves,0,1
28163,treatment,0,0
28164,outcome,0,1
28165,in,0,0
28166,CML-BP,0,0
28167,",",0,0
28168,the,0,0
28169,Southwest,0,0
28170,Oncology,0,1
28171,Group,0,0
28172,performed,0,0
28173,a,0,0
28174,randomized,0,0
28175,",",0,0
28176,controlled,0,0
28177,trial,0,0
28178,testing,0,0
28179,the,0,0
28180,benefit,0,0
28181,of,0,0
28182,the,0,0
28183,Pgp,0,0
28184,modulator,0,0
28185,",",0,0
28186,cyclosporin,0,0
28187,A,0,0
28188,(,0,0
28189,CsA,0,0
28190,),0,0
28191,.,0,0
28192,Seventy-three,0,0
28193,eligible,0,0
28194,patients,0,0
28195,were,0,0
28196,assigned,0,0
28197,to,0,0
28198,treatment,0,0
28199,with,0,0
28200,cytarabine,0,0
28201,and,0,1
28202,infusional,0,1
28203,daunorubicin,0,0
28204,with,0,0
28205,or,0,0
28206,without,0,0
28207,intravenous,0,0
28208,CsA,0,0
28209,.,0,0
28210,Treatment,0,0
28211,with,0,0
28212,CsA,0,0
28213,yielded,0,0
28214,no,1,0
28215,improvement,1,1
28216,in,0,0
28217,treatment,0,0
28218,outcome,0,1
28219,as,0,0
28220,measured,0,0
28221,by,0,0
28222,the,0,0
28223,frequency,1,1
28224,of,1,1
28225,induction,1,1
28226,resistance,1,1
28227,(,0,0
28228,68,0,0
28229,%,0,0
28230,vs,0,0
28231,53,0,0
28232,%,0,0
28233,),0,0
28234,",",0,0
28235,rate,1,1
28236,of,1,1
28237,complete,1,1
28238,remission,1,1
28239,or,1,0
28240,restored,1,0
28241,chronic,1,0
28242,phase,1,0
28243,(,0,1
28244,CR/CP,0,1
28245,",",0,0
28246,8,0,0
28247,%,0,0
28248,vs,0,0
28249,30,0,0
28250,%,0,0
28251,),0,0
28252,",",0,1
28253,and,0,1
28254,survival,1,1
28255,(,0,0
28256,3,0,0
28257,vs,0,0
28258,5,0,0
28259,months,0,0
28260,),0,0
28261,.,0,0
28262,Blast,1,0
28263,expression,1,1
28264,of,1,1
28265,Pgp,1,0
28266,(,0,0
28267,63,0,0
28268,%,0,0
28269,),0,0
28270,and,0,1
28271,LRP,1,0
28272,(,0,0
28273,71,0,0
28274,%,0,0
28275,),0,0
28276,was,0,0
28277,common,0,0
28278,",",0,0
28279,whereas,0,0
28280,only,0,0
28281,Pgp,0,0
28282,adversely,0,0
28283,impacted,0,0
28284,the,0,0
28285,rate,1,1
28286,of,1,1
28287,CR/CP,1,1
28288,(,0,0
28289,P,0,0
28290,=.025,0,0
28291,),0,0
28292,.,0,0
28293,We,0,0
28294,conclude,0,0
28295,that,0,0
28296,Pgp,0,0
28297,has,0,0
28298,prognostic,0,1
28299,relevance,0,0
28300,in,0,0
28301,CML-BP,0,1
28302,but,0,0
28303,that,0,0
28304,the,0,0
28305,modulation,0,1
28306,of,0,0
28307,Pgp,0,0
28308,function,0,1
28309,with,0,0
28310,CsA,0,0
28311,as,0,0
28312,applied,0,0
28313,in,0,0
28314,this,0,0
28315,trial,0,0
28316,is,0,0
28317,ineffective,0,0
28318,.,0,0
28319,Home,0,1
28320,based,0,0
28321,management,0,0
28322,in,0,0
28323,multiple,0,0
28324,sclerosis,0,0
28325,:,0,0
28326,results,0,0
28327,of,0,0
28328,a,0,0
28329,randomised,0,0
28330,controlled,0,0
28331,trial,0,0
28332,.,0,0
28333,BACKGROUND,0,0
28334,Home,0,1
28335,based,0,0
28336,medical,0,0
28337,care,0,0
28338,is,0,0
28339,a,0,0
28340,popular,0,0
28341,alternative,0,0
28342,to,0,0
28343,standard,0,0
28344,hospital,0,1
28345,care,0,0
28346,but,0,0
28347,there,0,0
28348,is,0,0
28349,uncertainty,0,1
28350,about,0,0
28351,its,0,0
28352,cost-effectiveness,1,0
28353,.,1,0
28354,OBJECTIVES,0,0
28355,To,0,0
28356,compare,0,0
28357,the,0,0
28358,effectiveness,1,0
28359,and,1,0
28360,the,1,0
28361,costs,1,1
28362,of,0,0
28363,multidisciplinary,0,0
28364,home,0,0
28365,based,0,0
28366,care,0,0
28367,in,0,0
28368,multiple,0,0
28369,sclerosis,0,0
28370,with,0,0
28371,hospital,0,1
28372,care,0,0
28373,in,0,0
28374,a,0,0
28375,prospective,0,0
28376,randomised,0,0
28377,controlled,0,0
28378,trial,0,0
28379,with,0,0
28380,a,0,0
28381,one,0,0
28382,year,0,0
28383,follow,0,0
28384,up,0,0
28385,.,0,0
28386,METHODS,0,0
28387,201,0,0
28388,patients,0,0
28389,with,0,0
28390,clinically,0,0
28391,definite,0,0
28392,multiple,0,0
28393,sclerosis,0,0
28394,were,0,0
28395,studied,0,0
28396,.,0,0
28397,They,0,0
28398,were,0,0
28399,randomised,0,0
28400,in,0,0
28401,a,0,0
28402,ratio,0,0
28403,2:1,0,0
28404,to,0,0
28405,an,0,0
28406,intervention,0,0
28407,group,0,0
28408,(,0,0
28409,133,0,0
28410,),0,0
28411,or,0,0
28412,a,0,0
28413,control,0,0
28414,group,0,0
28415,(,0,0
28416,68,0,0
28417,),0,0
28418,.,0,0
28419,They,0,0
28420,were,0,0
28421,assessed,0,0
28422,at,0,0
28423,baseline,0,0
28424,and,0,0
28425,one,0,0
28426,year,0,0
28427,after,0,0
28428,randomisation,0,0
28429,with,0,0
28430,validated,1,0
28431,measures,1,0
28432,of,1,1
28433,physical,1,1
28434,and,1,1
28435,psychological,1,1
28436,impairment,1,1
28437,and,1,1
28438,quality,1,1
28439,of,1,1
28440,life,1,1
28441,(,1,0
28442,SF-36,1,1
28443,health,1,1
28444,survey,1,0
28445,),1,0
28446,.,1,0
28447,The,0,0
28448,costs,1,1
28449,to,1,0
28450,the,1,0
28451,National,1,0
28452,Health,1,1
28453,Service,1,0
28454,over,1,0
28455,the,1,0
28456,one,1,0
28457,year,1,0
28458,follow,1,0
28459,up,1,0
28460,were,0,0
28461,calculated,0,0
28462,by,0,0
28463,a,0,0
28464,cost,0,1
28465,minimisation,0,0
28466,analysis,0,0
28467,.,0,1
28468,RESULTS,0,0
28469,There,0,0
28470,were,0,0
28471,no,0,0
28472,differences,0,0
28473,in,0,0
28474,functional,1,1
28475,status,1,1
28476,between,0,0
28477,the,0,0
28478,home,0,0
28479,based,0,0
28480,care,0,0
28481,group,0,0
28482,and,0,0
28483,the,0,0
28484,hospital,0,1
28485,group,0,0
28486,.,0,0
28487,There,0,0
28488,was,0,0
28489,a,0,0
28490,significant,0,0
28491,difference,0,0
28492,between,0,0
28493,the,0,0
28494,two,0,0
28495,groups,0,0
28496,favouring,0,0
28497,home,0,0
28498,based,0,0
28499,management,0,0
28500,in,0,0
28501,four,1,0
28502,SF-36,1,0
28503,health,1,0
28504,dimensions-general,1,1
28505,health,1,1
28506,",",1,0
28507,bodily,1,1
28508,pain,1,1
28509,",",1,1
28510,role-emotional,1,1
28511,",",1,1
28512,and,1,1
28513,social,1,1
28514,functioning,1,1
28515,(,0,0
28516,all,0,0
28517,p,0,0
28518,<,0,0
28519,or,0,0
28520,=,0,0
28521,0.001,0,0
28522,),0,0
28523,.,0,0
28524,The,0,0
28525,cost,1,1
28526,of,0,0
28527,home,0,0
28528,based,0,0
28529,care,0,0
28530,was,0,0
28531,slightly,0,0
28532,less,0,0
28533,(,0,0
28534,822,0,0
28535,euros/patient/year,0,0
28536,),0,0
28537,than,0,0
28538,hospital,0,1
28539,care,0,0
28540,",",0,0
28541,mainly,0,0
28542,as,0,0
28543,a,0,0
28544,result,0,0
28545,of,0,0
28546,a,0,0
28547,reduction,0,1
28548,in,0,0
28549,hospital,0,1
28550,admissions,0,1
28551,.,0,0
28552,CONCLUSIONS,0,0
28553,Comprehensive,0,0
28554,planning,0,1
28555,of,0,1
28556,home,0,0
28557,based,0,0
28558,intervention,0,0
28559,implemented,0,0
28560,by,0,0
28561,an,0,0
28562,interdisciplinary,0,0
28563,team,0,0
28564,and,0,1
28565,designed,0,0
28566,specifically,0,0
28567,for,0,0
28568,people,0,0
28569,with,0,0
28570,multiple,0,0
28571,sclerosis,0,0
28572,may,0,0
28573,provide,0,0
28574,a,0,0
28575,cost-effective,1,0
28576,approach,0,0
28577,to,0,0
28578,management,0,0
28579,and,0,0
28580,improve,0,0
28581,the,0,0
28582,quality,1,1
28583,of,1,0
28584,life,1,1
28585,.,1,0
28586,Endoscopic,0,1
28587,ligation,0,1
28588,compared,0,0
28589,with,0,0
28590,sclerotherapy,0,0
28591,for,0,0
28592,bleeding,1,1
28593,esophageal,1,0
28594,varices,1,0
28595,in,0,0
28596,children,0,0
28597,with,0,0
28598,extrahepatic,0,0
28599,portal,0,1
28600,venous,0,1
28601,obstruction,0,1
28602,.,0,1
28603,Endoscopic,0,0
28604,sclerotherapy,0,0
28605,is,0,0
28606,an,0,0
28607,effective,0,1
28608,treatment,0,0
28609,for,0,0
28610,bleeding,1,1
28611,esophageal,1,1
28612,varices,1,0
28613,",",0,0
28614,but,0,0
28615,it,0,0
28616,is,0,0
28617,associated,0,0
28618,with,0,0
28619,significant,1,0
28620,complications,1,1
28621,.,1,0
28622,Endoscopic,0,1
28623,ligation,0,0
28624,",",0,0
28625,a,0,0
28626,new,0,1
28627,form,0,0
28628,of,0,1
28629,endoscopic,0,1
28630,treatment,0,0
28631,for,0,0
28632,bleeding,1,1
28633,varices,1,0
28634,",",0,0
28635,has,0,0
28636,been,0,0
28637,shown,0,0
28638,to,0,0
28639,be,0,0
28640,superior,0,0
28641,to,0,0
28642,sclerotherapy,0,0
28643,in,0,0
28644,adult,0,0
28645,patients,0,0
28646,with,0,0
28647,cirrhosis,0,0
28648,.,0,0
28649,To,0,0
28650,determine,0,0
28651,the,0,0
28652,efficacy,1,1
28653,and,1,1
28654,safety,1,1
28655,of,0,1
28656,endoscopic,0,1
28657,sclerotherapy,0,0
28658,and,0,1
28659,ligation,0,1
28660,",",0,0
28661,the,0,0
28662,2,0,0
28663,methods,0,0
28664,were,0,0
28665,compared,0,0
28666,in,0,0
28667,a,0,0
28668,randomized,0,0
28669,control,0,0
28670,trial,0,0
28671,in,0,0
28672,49,0,0
28673,children,0,0
28674,with,0,0
28675,extrahepatic,0,0
28676,portal,0,1
28677,venous,0,1
28678,obstruction,0,1
28679,who,0,0
28680,had,0,0
28681,proven,0,0
28682,bleeding,0,1
28683,from,0,0
28684,esophageal,0,0
28685,varices,0,0
28686,.,0,0
28687,Twenty-four,0,0
28688,patients,0,0
28689,were,0,0
28690,treated,0,0
28691,with,0,0
28692,sclerotherapy,0,0
28693,and,0,0
28694,25,0,0
28695,with,0,0
28696,band,0,0
28697,ligation,0,0
28698,.,0,0
28699,No,0,0
28700,significant,0,0
28701,differences,0,0
28702,were,0,0
28703,found,0,0
28704,between,0,0
28705,the,0,0
28706,sclerotherapy,0,0
28707,and,0,1
28708,ligation,0,1
28709,groups,0,0
28710,in,0,0
28711,arresting,1,1
28712,active,1,0
28713,index,1,1
28714,bleeding,1,1
28715,(,0,0
28716,100,0,0
28717,%,0,0
28718,each,0,0
28719,),0,0
28720,and,0,0
28721,achieving,1,1
28722,variceal,1,1
28723,eradication,1,1
28724,(,0,0
28725,91.7,0,0
28726,%,0,0
28727,vs.,0,0
28728,96,0,0
28729,%,0,0
28730,",",0,0
28731,P,0,0
28732,=.61,0,0
28733,),0,0
28734,.,0,0
28735,Band,0,1
28736,ligation,0,1
28737,eradicated,0,0
28738,varices,1,0
28739,in,0,0
28740,fewer,0,1
28741,endoscopic,1,1
28742,sessions,1,0
28743,than,0,0
28744,did,0,0
28745,sclerotherapy,0,0
28746,(,0,0
28747,3.9,0,0
28748,+/-,0,0
28749,1.1,0,0
28750,vs.,0,0
28751,6.1,0,0
28752,+/-,0,0
28753,1.7,0,0
28754,",",0,0
28755,respectively,0,0
28756,",",0,0
28757,P,0,0
28758,<,0,0
28759,.0001,0,0
28760,),0,0
28761,.,0,0
28762,The,0,0
28763,rebleeding,1,1
28764,rate,1,1
28765,was,0,0
28766,significantly,0,0
28767,higher,0,0
28768,in,0,0
28769,the,0,0
28770,sclerotherapy,0,0
28771,group,0,0
28772,(,0,0
28773,25,0,0
28774,%,0,0
28775,vs.,0,0
28776,4,0,0
28777,%,0,0
28778,",",0,0
28779,P,0,0
28780,=.049,0,0
28781,),0,1
28782,",",0,0
28783,as,0,0
28784,was,0,0
28785,the,0,0
28786,rate,1,1
28787,of,1,0
28788,major,1,1
28789,complications,1,1
28790,(,0,0
28791,25,0,0
28792,%,0,0
28793,vs.,0,0
28794,4,0,0
28795,%,0,0
28796,",",0,0
28797,P,0,0
28798,=.049,0,0
28799,),0,0
28800,.,0,0
28801,After,0,0
28802,eradication,0,1
28803,",",0,1
28804,esophageal,1,1
28805,variceal,1,1
28806,recurrence,1,1
28807,was,0,0
28808,not,0,0
28809,significantly,0,0
28810,different,0,0
28811,in,0,0
28812,patients,0,0
28813,treated,0,0
28814,by,0,0
28815,ligation,0,0
28816,than,0,0
28817,by,0,0
28818,sclerotherapy,0,0
28819,(,0,0
28820,17.4,0,0
28821,%,0,0
28822,vs.,0,0
28823,10,0,0
28824,%,0,0
28825,",",0,0
28826,P,0,0
28827,=.67,0,0
28828,),0,0
28829,.,0,0
28830,In,0,0
28831,conclusion,0,0
28832,",",0,1
28833,variceal,0,1
28834,band,0,1
28835,ligation,0,1
28836,in,0,0
28837,children,0,0
28838,is,0,0
28839,a,0,0
28840,safe,1,1
28841,and,1,1
28842,effective,1,1
28843,technique,0,0
28844,that,0,0
28845,achieves,0,1
28846,variceal,1,1
28847,eradication,1,1
28848,more,0,0
28849,quickly,0,1
28850,",",0,0
28851,with,0,0
28852,a,0,0
28853,lower,0,0
28854,rebleeding,1,1
28855,rate,1,1
28856,and,0,1
28857,fewer,0,1
28858,complications,1,1
28859,compared,0,0
28860,with,0,0
28861,sclerotherapy,0,0
28862,.,0,0
28863,Effect,0,1
28864,of,0,1
28865,diuresis,0,1
28866,on,0,0
28867,extracorporeal,0,0
28868,shockwave,0,0
28869,lithotripsy,0,0
28870,treatment,0,0
28871,of,0,0
28872,ureteric,0,1
28873,calculi,0,1
28874,.,0,0
28875,OBJECTIVE,0,0
28876,To,0,0
28877,evaluate,0,0
28878,the,0,0
28879,effect,0,0
28880,of,0,0
28881,diuresis,0,1
28882,during,0,0
28883,extracorporeal,0,0
28884,shockwave,0,0
28885,lithotripsy,0,0
28886,(,0,1
28887,ESWL,0,0
28888,),0,1
28889,treatment,0,0
28890,of,0,1
28891,ureteric,0,1
28892,calculi,0,0
28893,.,0,0
28894,The,0,0
28895,purpose,0,0
28896,is,0,0
28897,to,0,0
28898,improve,0,0
28899,stone,0,1
28900,fragmentation,0,1
28901,and,0,1
28902,clearance,0,1
28903,rates,0,1
28904,.,0,1
28905,MATERIALS,0,0
28906,AND,0,0
28907,METHODS,0,0
28908,One,0,1
28909,hundred,0,0
28910,and,0,0
28911,six,0,0
28912,consecutive,0,0
28913,patients,0,0
28914,with,0,0
28915,ureteric,0,1
28916,calculi,0,0
28917,at,0,0
28918,different,0,0
28919,levels,0,1
28920,were,0,0
28921,treated,0,0
28922,by,0,0
28923,ESWL,0,0
28924,using,0,0
28925,Siemens,0,0
28926,Lithostar,0,0
28927,2,0,0
28928,machine,0,0
28929,.,0,0
28930,Patients,0,0
28931,have,0,0
28932,been,0,0
28933,randomized,0,0
28934,into,0,0
28935,two,0,0
28936,treatment,0,0
28937,groups,0,0
28938,.,0,0
28939,The,0,0
28940,first,0,1
28941,group,0,0
28942,was,0,0
28943,treated,0,0
28944,by,0,0
28945,standard,0,0
28946,ESWL,0,0
28947,and,0,1
28948,included,0,0
28949,54,0,0
28950,patients,0,0
28951,.,0,0
28952,The,0,0
28953,second,0,0
28954,group,0,0
28955,was,0,0
28956,treated,0,0
28957,by,0,0
28958,ESWL,0,0
28959,with,0,0
28960,diuresis,0,1
28961,during,0,0
28962,the,0,0
28963,ESWL,0,0
28964,session,0,0
28965,.,0,1
28966,Shock,0,1
28967,waves,0,1
28968,were,0,0
28969,given,0,0
28970,at,0,0
28971,a,0,0
28972,rate,0,1
28973,of,0,0
28974,90,0,0
28975,shocks/minute,0,0
28976,with,0,0
28977,energy,0,1
28978,starting,0,0
28979,from,0,0
28980,10,0,0
28981,up,0,0
28982,to,0,0
28983,18,0,0
28984,KV,0,0
28985,.,0,0
28986,During,0,0
28987,the,0,0
28988,ESWL,0,0
28989,session,0,0
28990,the,0,0
28991,patient,0,1
28992,belonging,0,0
28993,to,0,0
28994,the,0,0
28995,second,0,0
28996,group,0,0
28997,received,0,0
28998,i.v,0,0
28999,.,0,0
29000,infusion,0,0
29001,of,0,0
29002,500,0,0
29003,ml,0,0
29004,normal,0,0
29005,saline,0,0
29006,containing,0,0
29007,40,0,0
29008,mg,0,0
29009,furosemide,0,0
29010,as,0,0
29011,a,0,0
29012,diuretic,0,0
29013,.,0,0
29014,The,0,0
29015,stone,1,1
29016,fragmentation,1,1
29017,and,1,1
29018,clearance,1,1
29019,rates,1,1
29020,were,0,0
29021,the,0,0
29022,two,0,0
29023,end,0,0
29024,points,0,0
29025,for,0,0
29026,evaluation,0,0
29027,.,0,0
29028,RESULTS,0,0
29029,The,0,0
29030,average,1,1
29031,number,1,1
29032,of,1,0
29033,sessions,1,0
29034,per,1,0
29035,stone,1,1
29036,was,0,0
29037,1.92,0,0
29038,and,0,0
29039,1.5,0,0
29040,and,0,0
29041,the,0,0
29042,average,1,1
29043,number,1,1
29044,of,1,0
29045,shocks,1,0
29046,per,1,0
29047,stone,1,1
29048,was,0,0
29049,6295,0,0
29050,and,0,0
29051,5300,0,0
29052,for,0,0
29053,the,0,0
29054,first,0,0
29055,and,0,1
29056,second,0,1
29057,treatment,0,0
29058,groups,0,0
29059,respectively,0,0
29060,.,0,0
29061,Stone,1,0
29062,fragmentation,1,0
29063,rate,1,1
29064,was,0,0
29065,47/54,0,0
29066,(,0,0
29067,87,0,0
29068,%,0,0
29069,),0,0
29070,and,0,0
29071,50/52,0,0
29072,(,0,0
29073,96.2,0,0
29074,%,0,0
29075,),0,0
29076,and,0,0
29077,the,0,0
29078,stone,1,1
29079,clearance,1,1
29080,(,1,1
29081,success,1,1
29082,),1,1
29083,rate,1,1
29084,was,0,0
29085,47/54,0,0
29086,(,0,0
29087,87,0,0
29088,%,0,0
29089,),0,0
29090,and,0,0
29091,48/52,0,0
29092,(,0,0
29093,92.3,0,0
29094,%,0,0
29095,),0,0
29096,for,0,0
29097,the,0,0
29098,first,0,0
29099,and,0,0
29100,the,0,0
29101,second,0,0
29102,groups,0,0
29103,respectively,0,0
29104,.,0,0
29105,Analysis,0,0
29106,of,0,0
29107,the,0,0
29108,results,0,0
29109,in,0,0
29110,relation,0,0
29111,to,0,0
29112,stone,0,1
29113,location,0,1
29114,showed,0,0
29115,that,0,0
29116,the,0,0
29117,two,0,0
29118,treatment,0,0
29119,groups,0,0
29120,were,0,0
29121,comparable,0,0
29122,for,0,0
29123,upper,1,0
29124,and,1,1
29125,middle,1,1
29126,ureteric,1,1
29127,calculi,1,1
29128,.,1,0
29129,However,0,0
29130,for,0,0
29131,distal,0,1
29132,ureteric,0,1
29133,stones,0,0
29134,",",0,0
29135,the,0,0
29136,addition,0,0
29137,of,0,0
29138,diuresis,0,1
29139,during,0,0
29140,ESWL,0,0
29141,was,0,0
29142,associated,0,0
29143,with,0,0
29144,a,0,0
29145,lower,0,0
29146,mean,1,1
29147,number,1,1
29148,of,1,1
29149,ESWL,1,0
29150,sessions,1,0
29151,and,0,1
29152,shocks,1,1
29153,per,1,1
29154,stone,1,1
29155,compared,0,0
29156,with,0,0
29157,standard,0,0
29158,ESWL,0,0
29159,:,0,0
29160,1.38,0,0
29161,and,0,0
29162,4950,0,0
29163,for,0,0
29164,ESWL,0,0
29165,with,0,0
29166,diuresis,0,1
29167,compared,0,0
29168,with,0,0
29169,2.9,0,0
29170,and,0,0
29171,8544,0,0
29172,for,0,0
29173,standard,0,0
29174,ESWL,0,0
29175,respectively,0,0
29176,.,0,0
29177,The,0,0
29178,stone,1,1
29179,fragmentation,1,1
29180,and,1,1
29181,3-month,1,1
29182,clearance,1,1
29183,(,1,1
29184,success,1,1
29185,),1,1
29186,rates,1,1
29187,were,0,0
29188,clearly,0,0
29189,higher,0,0
29190,:,0,0
29191,93.8,0,0
29192,%,0,0
29193,and,0,0
29194,87.5,0,0
29195,%,0,0
29196,respectively,0,0
29197,for,0,0
29198,ESWL,0,0
29199,with,0,0
29200,diuresis,0,1
29201,compared,0,0
29202,with,0,0
29203,70.6,0,0
29204,%,0,0
29205,(,0,0
29206,for,0,0
29207,both,0,0
29208,fragmentation,0,1
29209,and,0,1
29210,clearance,0,1
29211,),0,1
29212,with,0,0
29213,standard,0,0
29214,ESWL,0,0
29215,.,0,0
29216,CONCLUSIONS,0,0
29217,Diuresis,0,1
29218,is,0,0
29219,a,0,0
29220,useful,0,0
29221,",",0,0
29222,inexpensive,0,0
29223,and,0,1
29224,safe,0,1
29225,adjunct,0,0
29226,to,0,0
29227,ESWL,0,0
29228,of,0,0
29229,ureteric,0,0
29230,stones,0,0
29231,.,0,0
29232,It,0,0
29233,markedly,0,0
29234,improves,0,0
29235,the,0,0
29236,results,0,0
29237,of,0,0
29238,ESWL,0,0
29239,treatment,0,0
29240,of,0,1
29241,distal,0,1
29242,ureteric,0,1
29243,stones,0,0
29244,compared,0,0
29245,with,0,0
29246,standard,0,0
29247,ESWL,0,0
29248,.,0,0
29249,Hysteroscopic,0,0
29250,transcervical,0,0
29251,endometrial,0,1
29252,resection,0,0
29253,versus,0,0
29254,thermal,0,1
29255,destruction,0,1
29256,for,0,0
29257,menorrhagia,0,0
29258,:,0,0
29259,a,0,0
29260,prospective,0,0
29261,randomized,0,0
29262,trial,0,0
29263,on,0,0
29264,satisfaction,0,1
29265,rate,0,1
29266,.,0,0
29267,OBJECTIVE,0,0
29268,The,0,0
29269,purpose,0,0
29270,of,0,0
29271,this,0,0
29272,study,0,0
29273,was,0,0
29274,to,0,0
29275,compare,0,0
29276,the,0,0
29277,satisfaction,1,1
29278,rate,1,1
29279,and,1,0
29280,the,1,0
29281,effectiveness,1,1
29282,of,0,0
29283,transcervical,0,0
29284,hysteroscopic,0,0
29285,endometrial,0,1
29286,resection,0,1
29287,and,0,1
29288,thermal,0,1
29289,destruction,0,1
29290,of,0,0
29291,the,0,0
29292,endometrium,0,1
29293,in,0,0
29294,the,0,0
29295,treatment,0,0
29296,of,0,0
29297,menorrhagia,0,1
29298,.,0,0
29299,STUDY,0,0
29300,DESIGN,0,0
29301,A,0,0
29302,prospective,0,0
29303,randomized,0,0
29304,trial,0,0
29305,with,0,0
29306,2,0,0
29307,years,0,0
29308,of,0,0
29309,follow-up,0,0
29310,was,0,0
29311,carried,0,0
29312,out,0,0
29313,in,0,0
29314,the,0,0
29315,Department,0,1
29316,of,0,0
29317,Gynecology,0,0
29318,of,0,0
29319,the,0,0
29320,University,0,0
29321,of,0,0
29322,Naples,0,0
29323,.,0,0
29324,Eighty-two,0,0
29325,patients,0,0
29326,who,0,0
29327,were,0,0
29328,affected,0,0
29329,by,0,0
29330,menorrhagia,0,0
29331,that,0,0
29332,was,0,0
29333,unresponsive,0,0
29334,to,0,0
29335,medical,0,1
29336,treatment,0,0
29337,were,0,0
29338,respectively,0,0
29339,randomized,0,0
29340,to,0,0
29341,transcervical,0,0
29342,hysteroscopic,0,0
29343,endometrial,0,1
29344,resection,0,0
29345,or,0,0
29346,to,0,0
29347,thermal,0,1
29348,destruction,0,1
29349,of,0,0
29350,the,0,0
29351,endometrium,0,1
29352,.,0,0
29353,Satisfaction,1,1
29354,rate,1,1
29355,",",1,1
29356,operative,1,1
29357,time,1,1
29358,",",1,1
29359,discharge,1,1
29360,time,1,1
29361,",",1,1
29362,complication,1,1
29363,rate,1,1
29364,",",1,1
29365,reintervention,1,1
29366,rate,1,1
29367,",",1,1
29368,and,1,1
29369,resumption,1,1
29370,of,1,1
29371,normal,1,1
29372,activity,1,1
29373,were,0,0
29374,evaluated,0,0
29375,in,0,0
29376,each,0,0
29377,group,0,0
29378,.,0,0
29379,RESULTS,0,0
29380,The,0,0
29381,satisfaction,1,1
29382,rate,1,1
29383,was,0,0
29384,significantly,0,0
29385,higher,0,0
29386,in,0,0
29387,the,0,0
29388,thermal,0,1
29389,destruction,0,1
29390,group,0,0
29391,.,0,1
29392,Operative,1,1
29393,time,1,1
29394,was,0,0
29395,significantly,0,0
29396,shorter,0,0
29397,in,0,0
29398,the,0,0
29399,thermal,0,1
29400,destruction,0,1
29401,group,0,0
29402,(,0,0
29403,24,0,0
29404,+/-,0,0
29405,4,0,0
29406,minutes,0,0
29407,vs,0,0
29408,37,0,0
29409,+/-,0,0
29410,6,0,0
29411,minutes,0,0
29412,),0,0
29413,.,0,0
29414,Intraoperative,1,1
29415,blood,1,1
29416,loss,1,1
29417,was,0,0
29418,significantly,0,0
29419,lower,0,0
29420,in,0,0
29421,the,0,0
29422,thermal,0,1
29423,destruction,0,1
29424,group,0,0
29425,(,0,0
29426,7.2,0,0
29427,+/-,0,0
29428,2.8,0,0
29429,mL,0,0
29430,vs,0,0
29431,89,0,0
29432,+/-,0,0
29433,38,0,0
29434,mL,0,0
29435,),0,0
29436,.,0,0
29437,Reintervention,1,1
29438,rates,1,1
29439,were,0,0
29440,higher,0,0
29441,in,0,0
29442,the,0,0
29443,transcervical,0,0
29444,hysteroscopic,0,0
29445,endometrial,0,1
29446,resection,0,1
29447,group,0,0
29448,",",0,0
29449,although,0,0
29450,postoperative,0,1
29451,pain,0,1
29452,was,0,0
29453,not,0,0
29454,significantly,0,0
29455,different,0,0
29456,between,0,0
29457,the,0,0
29458,two,0,0
29459,groups,0,0
29460,.,0,0
29461,Discharge,1,1
29462,time,1,1
29463,",",1,1
29464,complication,1,1
29465,rate,1,1
29466,",",1,1
29467,and,1,1
29468,resumption,1,1
29469,of,1,1
29470,normal,1,1
29471,activity,1,1
29472,were,0,0
29473,not,0,0
29474,significantly,0,0
29475,different,0,0
29476,between,0,0
29477,the,0,0
29478,two,0,0
29479,groups,0,0
29480,.,0,0
29481,CONCLUSION,0,0
29482,Thermal,0,1
29483,destruction,0,1
29484,of,0,0
29485,the,0,0
29486,endometrium,0,1
29487,for,0,0
29488,the,0,0
29489,treatment,0,0
29490,of,0,0
29491,menorrhagia,0,0
29492,should,0,0
29493,be,0,0
29494,considered,0,0
29495,an,0,0
29496,effective,0,0
29497,therapeutic,0,0
29498,option,0,0
29499,because,0,0
29500,of,0,0
29501,its,0,0
29502,acceptability,1,1
29503,among,0,0
29504,patients,0,0
29505,",",0,0
29506,shorter,1,1
29507,operative,1,1
29508,time,1,1
29509,",",1,1
29510,and,1,1
29511,lower,1,1
29512,blood,1,1
29513,loss,1,1
29514,.,1,0
29515,Combination,0,1
29516,of,0,1
29517,sotalol,0,0
29518,and,0,1
29519,magnesium,0,0
29520,prevents,0,1
29521,atrial,0,1
29522,fibrillation,0,1
29523,after,0,0
29524,coronary,0,1
29525,artery,0,1
29526,bypass,0,0
29527,grafting,0,0
29528,.,0,1
29529,BACKGROUND,0,0
29530,Atrial,0,1
29531,fibrillation,0,1
29532,(,0,1
29533,AF,0,0
29534,),0,0
29535,is,0,0
29536,a,0,0
29537,common,0,0
29538,complication,0,1
29539,reported,0,0
29540,in,0,0
29541,20,0,0
29542,%,0,0
29543,to,0,0
29544,40,0,0
29545,%,0,0
29546,of,0,0
29547,patients,0,0
29548,after,0,0
29549,coronary,0,0
29550,operations,0,0
29551,.,0,0
29552,Sotalol,0,0
29553,alone,0,0
29554,and,0,0
29555,magnesium,0,0
29556,alone,0,0
29557,have,0,0
29558,been,0,0
29559,shown,0,0
29560,to,0,0
29561,partially,0,0
29562,decrease,0,0
29563,the,0,0
29564,incidence,0,1
29565,of,0,0
29566,AF,0,0
29567,.,0,0
29568,The,0,0
29569,goal,0,0
29570,of,0,0
29571,this,0,0
29572,study,0,0
29573,was,0,0
29574,to,0,0
29575,evaluate,0,0
29576,the,0,0
29577,efficacy,0,1
29578,of,0,0
29579,these,0,0
29580,two,0,0
29581,pharmacological,0,0
29582,agents,0,0
29583,",",0,1
29584,used,0,0
29585,alone,0,0
29586,or,0,0
29587,in,0,0
29588,combination,0,0
29589,",",0,0
29590,to,0,0
29591,reduce,0,0
29592,postoperative,1,1
29593,AF,1,1
29594,.,1,0
29595,METHODS,0,0
29596,Two,0,0
29597,hundred,0,0
29598,seven,0,0
29599,consecutive,0,0
29600,coronary,0,0
29601,artery,0,1
29602,bypass,0,1
29603,patients,0,0
29604,(,0,0
29605,mean,0,1
29606,age,0,0
29607,62,0,0
29608,+/-,0,0
29609,11,0,0
29610,years,0,0
29611,),0,0
29612,were,0,0
29613,randomized,0,0
29614,to,0,0
29615,receive,0,0
29616,sotalol,0,0
29617,alone,0,0
29618,(,0,0
29619,80,0,0
29620,mg,0,0
29621,twice,0,0
29622,daily,0,0
29623,for,0,0
29624,5,0,0
29625,days,0,0
29626,starting,0,0
29627,from,0,0
29628,the,0,0
29629,morning,0,0
29630,of,0,0
29631,the,0,0
29632,first,0,0
29633,postoperative,0,1
29634,day,0,1
29635,),0,1
29636,(,0,0
29637,group,0,0
29638,S,0,1
29639,),0,1
29640,",",0,0
29641,magnesium,0,0
29642,alone,0,0
29643,(,0,0
29644,1.5,0,0
29645,g,0,0
29646,daily,0,0
29647,for,0,0
29648,6,0,0
29649,days,0,0
29650,starting,0,0
29651,in,0,0
29652,the,0,0
29653,operating,0,1
29654,room,0,0
29655,just,0,0
29656,before,0,0
29657,cardiopulmonary,0,1
29658,bypass,0,0
29659,),0,1
29660,(,0,0
29661,group,0,0
29662,M,0,0
29663,),0,0
29664,",",0,0
29665,both,0,0
29666,pharmacologic,0,0
29667,agents,0,0
29668,at,0,0
29669,the,0,0
29670,same,0,0
29671,dosages,0,0
29672,(,0,0
29673,group,0,0
29674,S+M,0,1
29675,),0,1
29676,",",0,0
29677,or,0,0
29678,no,0,0
29679,antiarrhythmic,0,1
29680,agents,0,0
29681,(,0,0
29682,group,0,0
29683,CTR,0,1
29684,),0,0
29685,.,0,0
29686,All,0,0
29687,patients,0,0
29688,with,0,0
29689,an,0,0
29690,ejection,0,1
29691,fraction,0,1
29692,less,0,0
29693,than,0,0
29694,0.40,0,0
29695,were,0,0
29696,excluded,0,0
29697,.,0,0
29698,RESULTS,0,0
29699,The,0,0
29700,incidence,1,1
29701,of,1,0
29702,postoperative,1,1
29703,AF,1,1
29704,was,0,0
29705,11.8,0,0
29706,%,0,0
29707,(,0,0
29708,6/51,0,0
29709,),0,0
29710,in,0,0
29711,the,0,0
29712,S,0,0
29713,group,0,0
29714,",",0,0
29715,14.8,0,0
29716,%,0,0
29717,(,0,0
29718,8/54,0,0
29719,),0,0
29720,in,0,0
29721,the,0,0
29722,M,0,0
29723,group,0,0
29724,",",0,0
29725,1.9,0,0
29726,%,0,0
29727,(,0,0
29728,1/52,0,0
29729,),0,0
29730,in,0,0
29731,the,0,0
29732,S+M,0,1
29733,group,0,0
29734,",",0,0
29735,and,0,0
29736,38,0,0
29737,%,0,0
29738,(,0,0
29739,19/50,0,0
29740,),0,0
29741,in,0,0
29742,the,0,0
29743,CTR,0,0
29744,group,0,0
29745,.,0,0
29746,The,0,0
29747,following,0,0
29748,differences,0,0
29749,were,0,0
29750,significant,0,0
29751,:,0,0
29752,group,0,0
29753,CTR,0,1
29754,versus,0,0
29755,groups,0,0
29756,S,0,1
29757,",",0,1
29758,M,0,0
29759,",",0,1
29760,and,0,1
29761,S+M,0,1
29762,with,0,0
29763,values,0,1
29764,of,0,1
29765,p,0,0
29766,=,0,0
29767,0.002,0,0
29768,",",0,0
29769,p,0,0
29770,=,0,0
29771,0.007,0,0
29772,and,0,0
29773,p,0,0
29774,<,0,0
29775,0.0001,0,0
29776,",",0,0
29777,respectively,0,0
29778,;,0,0
29779,and,0,1
29780,group,0,0
29781,S+M,0,1
29782,versus,0,0
29783,groups,0,0
29784,S,0,1
29785,and,0,1
29786,M,0,0
29787,with,0,0
29788,p,0,0
29789,=,0,0
29790,0.04,0,0
29791,and,0,0
29792,p,0,0
29793,=,0,0
29794,0.01,0,0
29795,",",0,0
29796,respectively,0,0
29797,.,0,0
29798,CONCLUSIONS,0,0
29799,Incidence,1,1
29800,of,1,1
29801,AF,1,1
29802,after,0,0
29803,coronary,0,1
29804,operation,0,0
29805,was,0,0
29806,significantly,0,0
29807,reduced,0,0
29808,by,0,0
29809,the,0,0
29810,administration,0,0
29811,of,0,0
29812,sotalol,0,0
29813,alone,0,0
29814,and,0,1
29815,magnesium,0,0
29816,alone,0,0
29817,;,0,0
29818,more,0,0
29819,importantly,0,0
29820,",",0,0
29821,the,0,0
29822,incidence,0,1
29823,was,0,0
29824,further,0,0
29825,reduced,0,1
29826,by,0,0
29827,combining,0,0
29828,these,0,0
29829,agents,0,0
29830,.,0,0
29831,Clinical,0,1
29832,evaluation,0,0
29833,of,0,0
29834,two,0,0
29835,adhesive,0,0
29836,composite,0,0
29837,cements,0,0
29838,for,0,0
29839,the,0,0
29840,suppression,1,1
29841,of,1,0
29842,dentinal,1,1
29843,cold,1,1
29844,sensitivity,1,1
29845,.,1,0
29846,STATEMENT,0,0
29847,OF,0,0
29848,PROBLEMS,0,1
29849,Postoperative,0,1
29850,cold,0,1
29851,sensitivity,0,1
29852,after,0,0
29853,the,0,0
29854,cementation,0,0
29855,of,0,0
29856,indirect,0,0
29857,restorations,0,0
29858,with,0,0
29859,composite,0,0
29860,cements,0,0
29861,has,0,0
29862,been,0,0
29863,reported,0,0
29864,frequently,0,0
29865,but,0,0
29866,not,0,0
29867,scientifically,0,0
29868,documented,0,0
29869,.,0,0
29870,PURPOSE,0,0
29871,This,0,0
29872,controlled,0,0
29873,clinical,0,1
29874,study,0,0
29875,was,0,0
29876,designed,0,0
29877,to,0,0
29878,simulate,0,0
29879,the,0,0
29880,dentin/composite,0,1
29881,cement,0,0
29882,interface,0,1
29883,immediately,0,0
29884,after,0,0
29885,cementation,0,0
29886,of,0,0
29887,a,0,0
29888,cast,0,0
29889,restoration,0,0
29890,.,0,0
29891,The,0,0
29892,desensitizing,0,0
29893,capabilities,0,0
29894,of,0,0
29895,a,0,0
29896,composite,0,1
29897,cement,0,0
29898,that,0,0
29899,contains,0,0
29900,a,0,0
29901,self-etching,0,0
29902,",",0,0
29903,dual-polymerizing,0,0
29904,resin,0,0
29905,adhesive,0,1
29906,system,0,0
29907,were,0,0
29908,compared,0,0
29909,with,0,0
29910,those,0,0
29911,of,0,0
29912,a,0,0
29913,composite,0,1
29914,cement,0,0
29915,that,0,0
29916,use,0,0
29917,phosphoric,0,0
29918,acid,0,0
29919,etching,0,0
29920,followed,0,0
29921,by,0,0
29922,a,0,0
29923,single-bottle,0,0
29924,",",0,0
29925,light-activated,0,1
29926,primer/resin-based,0,0
29927,adhesive,0,1
29928,.,0,1
29929,MATERIAL,0,0
29930,AND,0,0
29931,METHODS,0,0
29932,The,0,0
29933,hypersensitive,0,0
29934,root,0,0
29935,surfaces,0,0
29936,of,0,0
29937,selected,0,0
29938,teeth,0,0
29939,were,0,0
29940,randomized,0,0
29941,to,0,0
29942,receive,0,0
29943,1,0,0
29944,of,0,0
29945,3,0,0
29946,treatments,0,0
29947,:,0,0
29948,coating,0,0
29949,with,0,0
29950,a,0,0
29951,self-etching,0,0
29952,adhesive,0,1
29953,(,0,1
29954,Linkmax,0,0
29955,),0,1
29956,and,0,0
29957,its,0,0
29958,respective,0,1
29959,cement,0,1
29960,",",0,0
29961,coating,0,1
29962,with,0,0
29963,a,0,0
29964,conventionally,0,0
29965,etched,0,0
29966,adhesive,0,1
29967,(,0,0
29968,RelyX,0,1
29969,ARC,0,1
29970,),0,1
29971,and,0,0
29972,its,0,1
29973,cement,0,1
29974,",",0,0
29975,or,0,0
29976,no,0,1
29977,treatment,0,0
29978,(,0,0
29979,negative,0,1
29980,control,0,0
29981,),0,0
29982,.,0,0
29983,The,0,0
29984,sample,0,0
29985,size,0,1
29986,was,0,0
29987,22,0,0
29988,.,0,0
29989,Dentin,1,1
29990,sensitivity,1,1
29991,was,0,0
29992,ascertained,0,0
29993,with,0,0
29994,an,0,0
29995,accurate,0,1
29996,cold,0,1
29997,testing,0,0
29998,device,0,0
29999,that,0,0
30000,slowly,0,0
30001,decreased,0,0
30002,in,0,0
30003,temperature,0,0
30004,.,0,0
30005,Tooth,1,1
30006,sensitivity,1,1
30007,was,0,0
30008,measured,0,0
30009,both,0,0
30010,immediately,0,0
30011,and,0,0
30012,at,0,0
30013,7,0,0
30014,days,0,0
30015,after,0,0
30016,placement,0,0
30017,.,0,0
30018,Two-way,0,0
30019,analysis,0,0
30020,of,0,1
30021,variance,0,1
30022,and,0,1
30023,Fisher,0,1
30024,'s,0,1
30025,least,0,0
30026,significant,0,0
30027,difference,0,1
30028,test,0,1
30029,(,0,1
30030,P,0,0
30031,<,0,0
30032,.05,0,0
30033,),0,1
30034,were,0,0
30035,used,0,0
30036,to,0,0
30037,determine,0,0
30038,whether,0,0
30039,significant,0,0
30040,differences,0,0
30041,existed,0,0
30042,as,0,0
30043,a,0,0
30044,function,0,1
30045,of,0,1
30046,treatment,0,0
30047,type,0,1
30048,or,0,0
30049,time,0,1
30050,.,0,1
30051,RESULTS,0,0
30052,Immediately,0,0
30053,after,0,0
30054,placement,0,0
30055,",",0,0
30056,the,0,0
30057,self-etching,0,0
30058,adhesive,0,1
30059,and,0,0
30060,its,0,0
30061,respective,0,1
30062,cement,0,1
30063,resulted,0,0
30064,in,0,0
30065,more,0,0
30066,suppression,1,1
30067,of,1,1
30068,cold,1,1
30069,sensitivity,1,1
30070,than,0,0
30071,no,0,0
30072,treatment,0,0
30073,(,0,0
30074,control,0,0
30075,),0,0
30076,;,0,0
30077,with,0,0
30078,Linkmax,0,0
30079,treatment,0,0
30080,",",0,0
30081,the,0,0
30082,temperature,0,1
30083,at,0,0
30084,which,0,0
30085,teeth,0,0
30086,responded,0,0
30087,was,0,0
30088,reduced,0,0
30089,by,0,0
30090,8.4,0,0
30091,degrees,0,0
30092,C.,0,0
30093,The,0,0
30094,conventionally,0,0
30095,etched,0,0
30096,adhesive,0,1
30097,and,0,0
30098,its,0,1
30099,cement,0,1
30100,reduced,0,0
30101,the,0,0
30102,temperature,1,1
30103,at,1,0
30104,which,1,0
30105,teeth,1,0
30106,responded,1,0
30107,by,0,0
30108,9.4,0,0
30109,degrees,0,0
30110,C.,0,0
30111,After,0,0
30112,1,0,0
30113,week,0,0
30114,",",0,0
30115,these,0,0
30116,temperature,1,1
30117,reductions,1,1
30118,were,0,0
30119,7.0,0,0
30120,degrees,0,0
30121,C,0,0
30122,and,0,0
30123,4.3,0,0
30124,degrees,0,0
30125,C,0,0
30126,",",0,0
30127,respectively,0,0
30128,.,0,0
30129,Untreated,0,0
30130,controls,0,0
30131,at,0,0
30132,the,0,0
30133,2,0,0
30134,intervals,0,0
30135,showed,0,0
30136,a,0,0
30137,mean,0,1
30138,decrease,1,1
30139,in,1,0
30140,sensitivity,1,1
30141,to,1,0
30142,cold,1,0
30143,of,0,0
30144,3.6,0,0
30145,degrees,0,0
30146,C,0,0
30147,and,0,0
30148,4.1,0,0
30149,degrees,0,0
30150,C.,0,1
30151,Statistical,0,1
30152,analysis,0,0
30153,showed,0,0
30154,type,0,0
30155,of,0,1
30156,composite,0,1
30157,cement,0,0
30158,to,0,0
30159,be,0,0
30160,a,0,0
30161,significant,0,0
30162,factor,0,0
30163,.,0,0
30164,CONCLUSION,0,0
30165,Within,0,0
30166,the,0,0
30167,limitations,0,0
30168,of,0,0
30169,this,0,0
30170,study,0,0
30171,and,0,1
30172,in,0,0
30173,comparison,0,0
30174,to,0,0
30175,untreated,0,0
30176,control,0,0
30177,teeth,0,0
30178,",",0,1
30179,Linkmax,0,0
30180,treatment,0,0
30181,resulted,0,0
30182,in,0,0
30183,a,0,0
30184,significant,0,0
30185,reduction,0,1
30186,in,0,0
30187,tooth,1,1
30188,root,1,1
30189,sensitivity,1,1
30190,over,0,0
30191,1,0,0
30192,week,0,0
30193,(,0,0
30194,P=.02,0,1
30195,),0,1
30196,",",0,0
30197,whereas,0,0
30198,RelyX,0,1
30199,ARC,0,0
30200,did,0,0
30201,not,0,0
30202,(,0,0
30203,P=.066,0,0
30204,),0,0
30205,.,0,0
30206,Laser,0,0
30207,treatment,0,0
30208,of,0,1
30209,childhood,0,0
30210,haemangioma,0,0
30211,:,0,0
30212,progress,0,1
30213,or,0,0
30214,not,0,0
30215,?,0,0
30216,Efficacy,1,1
30217,of,0,0
30218,erbium,0,0
30219,:,0,0
30220,yttrium-aluminum-garnet,0,0
30221,laser-assisted,0,0
30222,delivery,0,1
30223,of,0,1
30224,topical,0,0
30225,anesthetic,0,0
30226,.,0,0
30227,BACKGROUND,0,0
30228,Penetration,0,1
30229,through,0,0
30230,the,0,0
30231,stratum,0,1
30232,corneum,0,1
30233,limits,0,0
30234,effectiveness,0,1
30235,of,0,0
30236,topical,0,0
30237,anesthetics,0,0
30238,.,0,0
30239,OBJECTIVE,0,0
30240,Our,0,0
30241,aim,0,0
30242,was,0,0
30243,to,0,0
30244,evaluate,0,0
30245,the,0,0
30246,effectiveness,0,0
30247,of,0,0
30248,5,0,0
30249,%,0,0
30250,lidocaine,0,0
30251,(,0,1
30252,ELA-Max,0,1
30253,),0,1
30254,cream,0,0
30255,applied,0,0
30256,after,0,0
30257,erbium,0,0
30258,:,0,0
30259,yttrium-aluminum-garnet,0,0
30260,(,0,0
30261,Er,0,0
30262,:,0,0
30263,YAG,0,0
30264,),0,0
30265,laser,0,0
30266,ablation,0,0
30267,of,0,0
30268,the,0,0
30269,stratum,0,0
30270,corneum,0,1
30271,.,0,1
30272,METHODS,0,0
30273,Randomized,0,0
30274,",",0,1
30275,controlled,0,0
30276,",",0,1
30277,split-face,0,0
30278,comparison,0,0
30279,of,0,1
30280,anesthesia,0,0
30281,was,0,0
30282,performed,0,0
30283,on,0,0
30284,12,0,0
30285,volunteers,0,0
30286,.,0,0
30287,The,0,0
30288,stratum,0,1
30289,corneum,0,1
30290,was,0,0
30291,painlessly,0,0
30292,ablated,0,0
30293,with,0,0
30294,a,0,0
30295,low-fluence,0,0
30296,Er,0,0
30297,:,0,0
30298,YAG,0,0
30299,laser,0,0
30300,on,0,0
30301,half,0,0
30302,of,0,0
30303,the,0,0
30304,face,0,0
30305,",",0,0
30306,then,0,0
30307,the,0,0
30308,whole,0,0
30309,face,0,0
30310,was,0,0
30311,covered,0,0
30312,with,0,0
30313,ELA-Max,0,0
30314,cream,0,0
30315,for,0,0
30316,60,0,0
30317,minutes,0,0
30318,.,0,0
30319,Full-face,0,0
30320,laser,0,0
30321,resurfacing,0,1
30322,was,0,0
30323,performed,0,0
30324,",",0,0
30325,and,0,1
30326,visual,1,1
30327,analog,1,1
30328,pain,1,1
30329,scores,1,1
30330,(,1,0
30331,0,1,0
30332,to,1,0
30333,10,1,0
30334,),1,0
30335,were,0,0
30336,recorded,0,0
30337,during,0,0
30338,each,0,0
30339,of,0,0
30340,2,0,0
30341,passes,0,0
30342,.,0,0
30343,RESULTS,0,0
30344,Laser-assisted,0,0
30345,topical,0,0
30346,anesthesia,0,0
30347,demonstrated,0,0
30348,significantly,0,0
30349,lower,0,0
30350,mean,1,1
30351,pain,1,1
30352,scores,1,1
30353,than,0,0
30354,topical,0,0
30355,anesthesia,0,0
30356,alone,0,0
30357,.,0,0
30358,This,0,0
30359,was,0,0
30360,more,0,0
30361,pronounced,0,0
30362,during,0,0
30363,the,0,0
30364,more,0,0
30365,painful,0,1
30366,second,0,0
30367,pass,0,1
30368,.,0,0
30369,Resurfacing,0,0
30370,after,0,0
30371,laser-assisted,0,0
30372,topical,0,0
30373,anesthesia,0,0
30374,was,0,0
30375,well,0,0
30376,tolerated,1,1
30377,by,0,0
30378,72,0,0
30379,%,0,0
30380,of,0,0
30381,subjects,0,0
30382,in,0,0
30383,pass,0,0
30384,1,0,0
30385,and,0,0
30386,58,0,0
30387,%,0,0
30388,in,0,0
30389,pass,0,0
30390,2,0,0
30391,.,0,0
30392,CONCLUSION,0,0
30393,Laser-assisted,0,0
30394,topical,0,0
30395,anesthesia,0,0
30396,is,0,0
30397,fast,0,1
30398,",",0,0
30399,painless,0,1
30400,",",0,1
30401,and,0,1
30402,substantially,0,0
30403,more,0,0
30404,effective,0,1
30405,than,0,0
30406,conventional,0,0
30407,topical,0,0
30408,anesthesia,0,0
30409,but,0,0
30410,does,0,0
30411,not,0,0
30412,provide,0,0
30413,adequate,0,0
30414,anesthesia,0,0
30415,for,0,0
30416,full-face,0,0
30417,resurfacing,0,0
30418,in,0,0
30419,all,0,0
30420,subjects,0,0
30421,.,0,0
30422,Tegaserod,0,1
30423,",",0,0
30424,a,0,0
30425,5-hydroxytryptamine,0,0
30426,type,0,0
30427,4,0,0
30428,receptor,0,0
30429,partial,0,0
30430,agonist,0,0
30431,",",0,0
30432,is,0,0
30433,devoid,0,0
30434,of,0,0
30435,electrocardiographic,1,1
30436,effects,1,1
30437,.,1,0
30438,OBJECTIVES,0,0
30439,Certain,0,0
30440,GI,0,1
30441,prokinetic,0,0
30442,agents,0,0
30443,have,0,0
30444,been,0,0
30445,shown,0,0
30446,to,0,0
30447,affect,0,0
30448,cardiac,0,1
30449,repolarization,0,1
30450,",",0,0
30451,which,0,0
30452,may,0,0
30453,be,0,0
30454,associated,0,0
30455,with,0,0
30456,life-threatening,0,0
30457,arrhythmias,0,1
30458,.,0,0
30459,The,0,0
30460,selective,0,0
30461,5-hydroxytryptamine,0,0
30462,type,0,0
30463,4,0,0
30464,receptor,0,0
30465,partial,0,0
30466,agonist,0,0
30467,tegaserod,0,0
30468,is,0,0
30469,a,0,0
30470,novel,0,0
30471,promotile,0,1
30472,agent,0,0
30473,developed,0,0
30474,for,0,0
30475,the,0,0
30476,treatment,0,0
30477,of,0,0
30478,functional,0,1
30479,motility,0,1
30480,disorders,0,0
30481,such,0,0
30482,as,0,0
30483,irritable,0,1
30484,bowel,0,1
30485,syndrome,0,1
30486,(,0,1
30487,IBS,0,0
30488,),0,0
30489,.,0,0
30490,The,0,0
30491,aim,0,0
30492,of,0,0
30493,the,0,0
30494,study,0,0
30495,was,0,0
30496,to,0,0
30497,investigate,0,0
30498,the,0,0
30499,cardiac,1,1
30500,safety,1,1
30501,profile,1,1
30502,of,0,1
30503,tegaserod,0,0
30504,through,0,0
30505,analysis,0,0
30506,of,0,0
30507,electrocardiographic,0,1
30508,data,0,0
30509,from,0,0
30510,clinical,0,0
30511,studies,0,0
30512,conducted,0,0
30513,in,0,0
30514,patients,0,0
30515,with,0,0
30516,IBS,0,0
30517,and,0,0
30518,a,0,0
30519,study,0,0
30520,conducted,0,0
30521,in,0,0
30522,healthy,0,0
30523,male,0,0
30524,subjects,0,0
30525,.,0,0
30526,METHODS,0,0
30527,In,0,0
30528,three,0,0
30529,randomized,0,0
30530,",",0,0
30531,double,0,0
30532,blind,0,0
30533,",",0,1
30534,placebo-controlled,0,0
30535,",",0,1
30536,parallel,0,0
30537,group,0,0
30538,clinical,0,1
30539,studies,0,0
30540,",",0,0
30541,2516,0,0
30542,IBS,0,0
30543,patients,0,0
30544,with,0,0
30545,symptoms,0,1
30546,of,0,0
30547,abdominal,0,1
30548,pain,0,1
30549,and,0,1
30550,constipation,0,1
30551,received,0,0
30552,tegaserod,0,0
30553,2,0,0
30554,or,0,0
30555,6,0,0
30556,mg,0,0
30557,b.i.d,0,0
30558,.,0,1
30559,(,0,0
30560,n,0,0
30561,=,0,0
30562,1679,0,0
30563,),0,0
30564,or,0,0
30565,placebo,0,0
30566,(,0,1
30567,n,0,0
30568,=,0,0
30569,837,0,0
30570,),0,0
30571,for,0,0
30572,12,0,0
30573,wk,0,0
30574,.,0,0
30575,In,0,0
30576,an,0,0
30577,additional,0,0
30578,study,0,0
30579,",",0,0
30580,36,0,0
30581,healthy,0,0
30582,male,0,0
30583,subjects,0,0
30584,received,0,0
30585,iv,0,0
30586,.,0,1
30587,single,0,0
30588,doses,0,0
30589,of,0,1
30590,tegaserod,0,0
30591,(,0,0
30592,0.8,0,0
30593,mg,0,0
30594,to,0,0
30595,20,0,0
30596,mg,0,0
30597,),0,0
30598,or,0,0
30599,placebo,0,0
30600,.,0,1
30601,Standard,0,0
30602,12-lead,0,1
30603,electrocardiograms,0,1
30604,were,0,0
30605,recorded,0,0
30606,at,0,0
30607,baseline,0,0
30608,and,0,1
30609,during,0,0
30610,treatment,0,0
30611,.,0,0
30612,Baseline,0,0
30613,values,0,1
30614,were,0,0
30615,compared,0,0
30616,with,0,0
30617,data,0,0
30618,collected,0,0
30619,during,0,0
30620,the,0,0
30621,treatment,0,0
30622,period,0,0
30623,.,0,0
30624,RESULTS,0,0
30625,The,0,0
30626,proportion,0,0
30627,of,0,0
30628,patients,0,0
30629,with,0,0
30630,prolongation,1,1
30631,of,1,0
30632,the,1,0
30633,QTc,1,1
30634,interval,1,0
30635,was,0,0
30636,the,0,0
30637,same,0,0
30638,for,0,0
30639,placebo,0,0
30640,and,0,1
30641,tegaserod,0,0
30642,",",0,1
30643,as,0,0
30644,was,0,0
30645,the,0,0
30646,frequency,1,1
30647,of,1,0
30648,overall,1,1
30649,electrocardiographic,1,1
30650,abnormalities,1,0
30651,.,1,0
30652,No,0,0
30653,ventricular,1,1
30654,or,1,0
30655,supraventricular,1,1
30656,tachycardia,1,1
30657,was,0,0
30658,observed,0,0
30659,.,0,0
30660,Comparable,0,0
30661,electrocardiographic,1,1
30662,results,1,0
30663,were,0,0
30664,obtained,0,0
30665,during,0,0
30666,placebo,0,0
30667,and,0,1
30668,tegaserod,0,0
30669,treatment,0,0
30670,.,0,0
30671,In,0,0
30672,healthy,0,0
30673,volunteers,0,0
30674,",",0,1
30675,tegaserod,0,0
30676,at,0,0
30677,i.v,0,0
30678,.,0,0
30679,doses,0,0
30680,resulting,0,0
30681,in,0,0
30682,plasma,1,1
30683,concentrations,1,1
30684,up,0,0
30685,to,0,0
30686,100,0,0
30687,times,0,0
30688,those,0,0
30689,measured,0,0
30690,after,0,0
30691,therapeutic,0,0
30692,doses,0,0
30693,(,0,0
30694,6,0,0
30695,mg,0,0
30696,b.i.d,0,0
30697,.,0,1
30698,),0,0
30699,did,0,0
30700,not,0,0
30701,influence,0,0
30702,electrocardiographic,0,1
30703,parameters,0,1
30704,.,0,0
30705,CONCLUSIONS,0,0
30706,Tegaserod,0,0
30707,is,0,0
30708,devoid,0,0
30709,of,0,0
30710,electrocardiographic,1,1
30711,effects,1,0
30712,and,0,0
30713,is,0,0
30714,not,0,0
30715,expected,0,0
30716,to,0,0
30717,adversely,0,0
30718,influence,0,0
30719,cardiac,1,1
30720,function,1,1
30721,.,1,0
30722,These,0,0
30723,data,0,0
30724,confirm,0,0
30725,preclinical,0,0
30726,findings,0,0
30727,.,0,0
30728,A,0,0
30729,randomized,0,0
30730,trial,0,0
30731,of,0,1
30732,continuous,0,0
30733,subcutaneous,0,0
30734,insulin,0,1
30735,infusion,0,0
30736,and,0,1
30737,intensive,0,0
30738,injection,0,0
30739,therapy,0,0
30740,in,0,0
30741,type,0,0
30742,1,0,0
30743,diabetes,0,0
30744,for,0,0
30745,patients,0,0
30746,with,0,0
30747,long-standing,0,0
30748,poor,0,1
30749,glycemic,0,1
30750,control,0,0
30751,.,0,0
30752,OBJECTIVE,0,0
30753,To,0,0
30754,assess,0,0
30755,in,0,0
30756,a,0,0
30757,randomized,0,0
30758,crossover,0,0
30759,trial,0,0
30760,the,0,0
30761,efficacy,0,1
30762,of,0,0
30763,continuous,0,0
30764,subcutaneous,0,0
30765,insulin,0,1
30766,infusion,0,0
30767,in,0,0
30768,improving,0,1
30769,glycemic,1,1
30770,control,1,0
30771,and,1,1
30772,health-related,1,1
30773,quality,1,1
30774,of,1,1
30775,life,1,1
30776,in,0,0
30777,type,0,0
30778,1,0,0
30779,diabetic,0,0
30780,patients,0,0
30781,with,0,0
30782,long-standing,0,0
30783,poor,0,1
30784,glycemic,0,1
30785,control,0,0
30786,.,0,0
30787,RESEARCH,0,0
30788,DESIGN,0,0
30789,AND,0,0
30790,METHODS,0,0
30791,A,0,0
30792,total,0,1
30793,of,0,0
30794,79,0,0
30795,patients,0,0
30796,in,0,0
30797,11,0,0
30798,Dutch,0,0
30799,centers,0,0
30800,were,0,0
30801,randomized,0,0
30802,to,0,0
30803,16,0,0
30804,weeks,0,0
30805,of,0,0
30806,continuous,0,0
30807,subcutaneous,0,0
30808,insulin,0,1
30809,infusion,0,0
30810,followed,0,0
30811,by,0,0
30812,16,0,0
30813,weeks,0,0
30814,intensive,0,0
30815,injection,0,0
30816,therapy,0,0
30817,or,0,0
30818,the,0,0
30819,reverse,0,0
30820,order,0,0
30821,.,0,1
30822,Glycemic,0,1
30823,control,0,0
30824,was,0,0
30825,assessed,0,0
30826,by,0,0
30827,HbA,0,0
30828,(,0,0
30829,1c,0,0
30830,),0,0
30831,",",0,0
30832,self-reported,0,1
30833,hypoglycemic,0,1
30834,events,0,1
30835,",",0,1
30836,and,0,1
30837,blood,0,1
30838,glucose,0,1
30839,memory,0,1
30840,meter,0,1
30841,read,0,0
30842,outs,0,1
30843,.,0,0
30844,Changes,0,1
30845,in,0,0
30846,quality,1,1
30847,of,1,1
30848,life,1,1
30849,were,0,0
30850,assessed,0,0
30851,by,0,0
30852,self-report,0,0
30853,questionnaires,0,0
30854,administered,0,0
30855,at,0,0
30856,baseline,0,0
30857,and,0,0
30858,16,0,0
30859,weeks,0,0
30860,.,0,0
30861,RESULTS,0,0
30862,As,0,0
30863,the,0,0
30864,drop-out,0,1
30865,rate,0,1
30866,after,0,0
30867,crossover,0,0
30868,was,0,0
30869,high,0,0
30870,(,0,0
30871,17,0,0
30872,of,0,0
30873,79,0,0
30874,patients,0,0
30875,[,0,0
30876,22,0,0
30877,%,0,0
30878,],0,0
30879,),0,0
30880,",",0,0
30881,we,0,0
30882,analyzed,0,0
30883,the,0,0
30884,trial,0,0
30885,as,0,0
30886,a,0,0
30887,parallel,0,0
30888,clinical,0,1
30889,trial,0,0
30890,",",0,0
30891,using,0,0
30892,data,0,0
30893,of,0,0
30894,the,0,0
30895,first,0,0
30896,half,0,0
30897,of,0,0
30898,the,0,0
30899,crossover,0,0
30900,phase,0,0
30901,only,0,0
30902,.,0,0
30903,At,0,0
30904,16,0,0
30905,weeks,0,0
30906,",",0,0
30907,mean,1,1
30908,HbA,1,1
30909,(,1,0
30910,1c,1,0
30911,),1,0
30912,was,0,0
30913,0.84,0,0
30914,%,0,0
30915,(,0,0
30916,95,0,0
30917,%,0,0
30918,CI,0,0
30919,-1.31,0,0
30920,to,0,0
30921,-0.36,0,0
30922,),0,0
30923,lower,0,0
30924,in,0,0
30925,the,0,0
30926,continuous,0,0
30927,subcutaneous,0,0
30928,insulin,0,1
30929,infusion,0,0
30930,group,0,0
30931,compared,0,0
30932,with,0,0
30933,the,0,0
30934,insulin,0,1
30935,injection,0,0
30936,group,0,0
30937,(,0,1
30938,P,0,0
30939,=,0,0
30940,0.002,0,0
30941,),0,0
30942,.,0,0
30943,Stability,1,1
30944,of,1,1
30945,blood,1,1
30946,glucose,1,1
30947,self-measurement,1,1
30948,values,1,1
30949,",",0,1
30950,expressed,0,1
30951,as,0,0
30952,SD,0,0
30953,of,0,0
30954,the,0,0
30955,nine-point,0,1
30956,blood,0,1
30957,glucose,0,1
30958,profiles,0,1
30959,",",0,0
30960,improved,0,0
30961,in,0,0
30962,the,0,0
30963,insulin,0,1
30964,pump,0,1
30965,group,0,0
30966,by,0,0
30967,29.3,0,0
30968,+/-,0,0
30969,41.1,0,0
30970,vs.,0,0
30971,8.2,0,0
30972,+/-,0,0
30973,36.5,0,0
30974,%,0,0
30975,in,0,0
30976,the,0,0
30977,injection,0,0
30978,group,0,0
30979,(,0,1
30980,P,0,0
30981,=,0,0
30982,0.039,0,0
30983,),0,0
30984,.,0,0
30985,The,0,0
30986,number,1,1
30987,of,1,0
30988,mild,1,0
30989,hypoglycemic,1,1
30990,episodes,1,1
30991,per,0,1
30992,patient-week,0,0
30993,was,0,0
30994,0.99,0,0
30995,(,0,0
30996,95,0,0
30997,%,0,0
30998,CI,0,0
30999,0.11-1.87,0,0
31000,),0,0
31001,higher,0,0
31002,in,0,0
31003,the,0,0
31004,insulin,0,1
31005,pump,0,1
31006,group,0,0
31007,(,0,1
31008,P,0,0
31009,=,0,0
31010,0.028,0,0
31011,),0,0
31012,.,0,0
31013,Weight,1,0
31014,gain,1,1
31015,was,0,0
31016,similar,0,0
31017,in,0,0
31018,both,0,0
31019,groups,0,0
31020,.,0,0
31021,Scores,1,0
31022,on,1,0
31023,the,1,0
31024,Short-Form,1,0
31025,36-Item,1,0
31026,subscales,1,1
31027,'general,1,1
31028,health,1,1
31029,',1,1
31030,and,1,1
31031,'mental,1,1
31032,health,1,1
31033,',1,1
31034,improved,0,0
31035,in,0,0
31036,the,0,0
31037,continuous,0,0
31038,subcutaneous,0,0
31039,insulin,0,1
31040,infusion,0,0
31041,group,0,0
31042,",",0,1
31043,compared,0,0
31044,with,0,0
31045,stable,0,0
31046,values,0,1
31047,in,0,0
31048,the,0,0
31049,injection,0,0
31050,group,0,0
31051,(,0,1
31052,P,0,0
31053,=,0,0
31054,0.048,0,0
31055,and,0,0
31056,0.050,0,0
31057,",",0,0
31058,respectively,0,0
31059,),0,0
31060,.,0,0
31061,CONCLUSIONS,0,0
31062,Continuous,0,0
31063,subcutaneous,0,0
31064,insulin,0,1
31065,infusion,0,0
31066,improves,0,1
31067,glycemic,0,1
31068,control,0,0
31069,and,0,0
31070,some,0,0
31071,aspects,0,1
31072,of,0,0
31073,health-related,0,1
31074,quality,0,1
31075,of,0,1
31076,life,0,1
31077,in,0,0
31078,patients,0,0
31079,with,0,0
31080,a,0,0
31081,history,0,1
31082,of,0,0
31083,long-term,0,1
31084,poor,0,1
31085,glycemic,0,1
31086,control,0,0
31087,.,0,0
31088,Hypnosis,0,1
31089,treatment,0,0
31090,for,0,0
31091,severe,1,1
31092,irritable,1,1
31093,bowel,1,1
31094,syndrome,1,0
31095,:,1,0
31096,investigation,0,0
31097,of,0,1
31098,mechanism,0,0
31099,and,0,1
31100,effects,0,1
31101,on,0,0
31102,symptoms,0,1
31103,.,0,0
31104,Hypnosis,0,0
31105,improves,0,1
31106,irritable,1,1
31107,bowel,1,1
31108,syndrome,1,1
31109,(,0,1
31110,IBS,0,1
31111,),0,1
31112,",",0,0
31113,but,0,0
31114,the,0,0
31115,mechanism,0,0
31116,is,0,0
31117,unknown,0,0
31118,.,0,0
31119,Possible,0,0
31120,physiological,0,1
31121,and,0,1
31122,psychological,0,1
31123,mechanisms,0,1
31124,were,0,0
31125,investigated,0,0
31126,in,0,0
31127,two,0,0
31128,studies,0,0
31129,.,0,0
31130,Patients,0,0
31131,with,0,0
31132,severe,0,1
31133,irritable,0,1
31134,bowel,0,1
31135,syndrome,0,0
31136,received,0,0
31137,seven,0,0
31138,biweekly,0,0
31139,hypnosis,0,0
31140,sessions,0,0
31141,and,0,1
31142,used,0,0
31143,hypnosis,0,1
31144,audiotapes,0,0
31145,at,0,0
31146,home,0,0
31147,.,0,0
31148,Rectal,0,1
31149,pain,0,1
31150,thresholds,0,1
31151,and,0,1
31152,smooth,0,1
31153,muscle,0,1
31154,tone,0,1
31155,were,0,0
31156,measured,0,0
31157,with,0,0
31158,a,0,0
31159,barostat,0,0
31160,before,0,0
31161,and,0,1
31162,after,0,0
31163,treatment,0,0
31164,in,0,0
31165,18,0,0
31166,patients,0,0
31167,(,0,0
31168,study,0,0
31169,I,0,0
31170,),0,0
31171,",",0,0
31172,and,0,1
31173,treatment,0,0
31174,changes,0,1
31175,in,0,0
31176,heart,0,1
31177,rate,0,1
31178,",",0,1
31179,blood,0,1
31180,pressure,0,1
31181,",",0,1
31182,skin,0,1
31183,conductance,0,1
31184,",",0,1
31185,finger,0,1
31186,temperature,0,1
31187,",",0,1
31188,and,0,1
31189,forehead,0,1
31190,electromyographic,0,1
31191,activity,0,1
31192,were,0,0
31193,assessed,0,0
31194,in,0,0
31195,24,0,0
31196,patients,0,0
31197,(,0,0
31198,study,0,0
31199,II,0,0
31200,),0,0
31201,.,0,1
31202,Somatization,0,1
31203,",",0,1
31204,anxiety,0,1
31205,",",0,1
31206,and,0,1
31207,depression,0,1
31208,were,0,0
31209,also,0,0
31210,measured,0,0
31211,.,0,0
31212,All,1,0
31213,central,1,0
31214,IBS,1,0
31215,symptoms,1,1
31216,improved,0,0
31217,substantially,0,0
31218,from,0,0
31219,treatment,0,0
31220,in,0,0
31221,both,0,0
31222,studies,0,0
31223,.,0,0
31224,Rectal,1,1
31225,pain,1,1
31226,thresholds,1,1
31227,",",1,0
31228,rectal,1,1
31229,smooth,1,1
31230,muscle,1,1
31231,tone,1,1
31232,",",1,1
31233,and,1,1
31234,autonomic,1,1
31235,functioning,1,1
31236,(,1,0
31237,except,1,0
31238,sweat,1,1
31239,gland,1,1
31240,reactivity,1,1
31241,),1,1
31242,were,0,0
31243,unaffected,0,0
31244,by,0,0
31245,hypnosis,0,0
31246,treatment,0,0
31247,.,0,0
31248,However,0,0
31249,",",0,0
31250,somatization,1,1
31251,and,1,1
31252,psychological,1,1
31253,distress,1,1
31254,showed,0,0
31255,large,0,0
31256,decreases,0,0
31257,.,0,0
31258,In,0,0
31259,conclusion,0,0
31260,",",0,1
31261,hypnosis,0,1
31262,improves,0,1
31263,IBS,1,0
31264,symptoms,1,1
31265,through,0,0
31266,reductions,0,1
31267,in,0,0
31268,psychological,1,1
31269,distress,1,1
31270,and,1,1
31271,somatization,1,1
31272,.,1,1
31273,Improvements,0,1
31274,were,0,0
31275,unrelated,0,0
31276,to,0,0
31277,changes,0,1
31278,in,0,0
31279,the,0,0
31280,physiological,0,0
31281,parameters,0,0
31282,measured,0,0
31283,.,0,0
31284,Is,0,0
31285,the,0,0
31286,orientation,0,0
31287,of,0,0
31288,the,0,0
31289,apical,0,1
31290,defibrillation,0,0
31291,paddle,0,1
31292,of,0,1
31293,importance,0,0
31294,during,0,0
31295,manual,0,1
31296,external,0,0
31297,defibrillation,0,0
31298,?,0,0
31299,OBJECTIVE,0,1
31300,Transthoracic,1,1
31301,impedance,1,1
31302,(,1,1
31303,TTI,1,1
31304,),1,0
31305,is,0,0
31306,a,0,0
31307,factor,0,0
31308,determining,0,0
31309,the,0,0
31310,magnitude,0,1
31311,of,0,0
31312,the,0,0
31313,transmyocardial,0,0
31314,current,0,0
31315,during,0,0
31316,external,0,0
31317,defibrillation,0,0
31318,.,0,0
31319,Minimising,0,0
31320,TTI,0,1
31321,increases,0,0
31322,the,0,0
31323,chances,0,0
31324,of,0,0
31325,successful,0,0
31326,defibrillation,0,0
31327,.,0,0
31328,Most,0,0
31329,external,0,0
31330,defibrillation,0,0
31331,paddles,0,0
31332,are,0,0
31333,rectangular,0,0
31334,in,0,0
31335,shape,0,0
31336,and,0,0
31337,can,0,0
31338,",",0,0
31339,therefore,0,0
31340,",",0,0
31341,be,0,0
31342,placed,0,0
31343,in,0,0
31344,a,0,0
31345,transverse,0,1
31346,or,0,0
31347,longitudinal,0,0
31348,orientation,0,1
31349,.,0,0
31350,The,0,0
31351,apical,0,0
31352,paddle,0,0
31353,is,0,0
31354,often,0,0
31355,placed,0,0
31356,in,0,0
31357,a,0,0
31358,transverse,0,1
31359,orientation,0,0
31360,.,0,0
31361,This,0,0
31362,may,0,0
31363,theoretically,0,0
31364,result,0,0
31365,in,0,0
31366,a,0,0
31367,higher,0,0
31368,TTI,0,1
31369,than,0,0
31370,a,0,0
31371,longitudinal,0,0
31372,orientation,0,1
31373,because,0,0
31374,of,0,1
31375,poorer,0,0
31376,contact,0,1
31377,at,0,0
31378,the,0,0
31379,lateral,0,0
31380,paddle,0,0
31381,edges,0,0
31382,.,0,0
31383,We,0,0
31384,compared,0,0
31385,TTI,0,1
31386,with,0,0
31387,the,0,0
31388,apical,0,1
31389,paddle,0,0
31390,in,0,0
31391,both,0,0
31392,a,0,0
31393,transverse,0,1
31394,and,0,1
31395,longitudinal,0,0
31396,orientation,0,1
31397,.,0,1
31398,MATERIALS,0,0
31399,AND,0,0
31400,METHODS,0,0
31401,Twenty,0,1
31402,sequential,0,0
31403,anaesthetised,0,0
31404,patients,0,0
31405,were,0,0
31406,studied,0,0
31407,.,0,0
31408,A,0,0
31409,pair,0,0
31410,of,0,0
31411,defibrillator,0,0
31412,paddles,0,0
31413,were,0,0
31414,instrumented,0,0
31415,to,0,0
31416,measure,0,0
31417,paddle,1,1
31418,force,1,1
31419,.,1,1
31420,TTI,1,1
31421,was,0,0
31422,recorded,0,0
31423,pre-operatively,0,0
31424,at,0,0
31425,end-expiration,0,1
31426,with,0,0
31427,the,0,0
31428,apical,0,1
31429,paddle,0,0
31430,in,0,0
31431,both,0,0
31432,longitudinal,0,0
31433,and,0,0
31434,transverse,0,1
31435,orientations,0,1
31436,.,0,0
31437,The,0,0
31438,sternal,0,1
31439,paddle,0,1
31440,was,0,0
31441,placed,0,0
31442,in,0,0
31443,a,0,0
31444,longitudinal,0,0
31445,orientation,0,0
31446,for,0,0
31447,all,0,0
31448,measurements,0,0
31449,.,0,0
31450,RESULTS,0,0
31451,TTI,1,1
31452,decreased,0,0
31453,in,0,0
31454,both,0,0
31455,transverse,0,1
31456,and,0,1
31457,longitudinal,0,0
31458,orientations,0,1
31459,as,0,0
31460,paddle,0,1
31461,force,0,1
31462,increased,0,0
31463,.,0,0
31464,Transverse,0,1
31465,paddle,0,1
31466,orientation,0,1
31467,resulted,0,0
31468,in,0,0
31469,a,0,0
31470,significantly,0,0
31471,(,0,0
31472,P,0,0
31473,<,0,0
31474,0.01,0,0
31475,),0,0
31476,higher,0,0
31477,TTI,1,1
31478,than,0,0
31479,longitudinal,0,0
31480,orientation,0,0
31481,at,0,0
31482,all,0,0
31483,paddle,0,1
31484,forces,0,0
31485,below,0,0
31486,12,0,0
31487,kg,0,0
31488,force,0,0
31489,.,0,0
31490,CONCLUSION,0,0
31491,The,0,0
31492,longitudinal,0,0
31493,orientation,0,0
31494,of,0,0
31495,a,0,0
31496,rectangular,0,0
31497,defibrillation,0,0
31498,paddle,0,0
31499,provides,0,0
31500,a,0,0
31501,lower,0,0
31502,TTI,1,1
31503,than,0,0
31504,orientation,0,0
31505,horizontally,0,0
31506,.,0,0
31507,Direct,0,1
31508,aortic,0,1
31509,cannulation,0,0
31510,in,0,0
31511,minimally,0,0
31512,invasive,0,0
31513,mitral-valve,0,0
31514,operations,0,0
31515,.,0,0
31516,The,0,0
31517,minimally,0,0
31518,invasive,0,1
31519,Port-Access,0,1
31520,(,0,1
31521,Heartport,0,0
31522,",",0,1
31523,Redwood,0,1
31524,City,0,1
31525,",",0,1
31526,CA,0,0
31527,),0,1
31528,approach,0,0
31529,in,0,0
31530,mitral-valve,0,0
31531,operations,0,0
31532,originally,0,0
31533,required,0,0
31534,femoral,0,1
31535,arterial,0,1
31536,cannulation,0,1
31537,",",0,0
31538,which,0,0
31539,is,0,0
31540,considered,0,0
31541,a,0,0
31542,disadvantage,0,0
31543,",",0,0
31544,especially,0,0
31545,in,0,0
31546,patients,0,0
31547,with,0,0
31548,peripheral,0,1
31549,vessel,0,1
31550,disease,0,1
31551,.,0,0
31552,In,0,0
31553,this,0,0
31554,study,0,0
31555,20,0,0
31556,patients,0,0
31557,were,0,0
31558,prospectively,0,0
31559,randomized,0,0
31560,into,0,0
31561,2,0,0
31562,groups,0,0
31563,",",0,0
31564,to,0,0
31565,undergo,0,0
31566,either,0,0
31567,standard,0,0
31568,femoral,0,1
31569,(,0,0
31570,group,0,0
31571,A,0,0
31572,),0,1
31573,or,0,0
31574,direct,0,1
31575,aortic,0,1
31576,cannulation,0,1
31577,(,0,0
31578,group,0,0
31579,B,0,0
31580,),0,0
31581,.,0,0
31582,Pre-,0,0
31583,and,0,1
31584,postoperative,0,1
31585,data,0,0
31586,as,0,0
31587,well,0,0
31588,as,0,0
31589,markers,0,0
31590,for,0,0
31591,myocardial,0,1
31592,damage,0,1
31593,were,0,0
31594,assessed,0,0
31595,.,0,0
31596,Postoperatively,0,0
31597,",",0,0
31598,patients,0,0
31599,of,0,1
31600,group,0,0
31601,B,0,0
31602,showed,0,0
31603,lower,0,0
31604,levels,1,1
31605,of,1,1
31606,damage,1,1
31607,",",0,0
31608,indicating,0,0
31609,that,0,0
31610,direct,0,1
31611,aortic,0,1
31612,cannulation,0,0
31613,might,0,0
31614,provide,0,0
31615,better,0,0
31616,myocardial,0,1
31617,protection,0,1
31618,.,0,1
31619,Furthermore,0,0
31620,",",0,0
31621,the,0,0
31622,direct,0,1
31623,aortic,0,1
31624,cannulation,0,0
31625,technique,0,0
31626,may,0,0
31627,eliminate,0,0
31628,complications,1,1
31629,associated,0,0
31630,with,0,0
31631,the,0,0
31632,standard,0,0
31633,femoral,0,1
31634,artery,0,0
31635,cannulation,0,0
31636,.,0,0
31637,Intravenous,0,0
31638,levosimendan,0,0
31639,treatment,0,0
31640,is,0,0
31641,cost-effective,0,0
31642,compared,0,0
31643,with,0,0
31644,dobutamine,0,0
31645,in,0,0
31646,severe,0,1
31647,low-output,0,0
31648,heart,0,1
31649,failure,0,0
31650,:,0,0
31651,an,0,0
31652,analysis,0,0
31653,based,0,0
31654,on,0,0
31655,the,0,0
31656,international,0,0
31657,LIDO,0,0
31658,trial,0,0
31659,.,0,1
31660,BACKGROUND,0,0
31661,Levosimendan,0,0
31662,",",0,0
31663,a,0,0
31664,novel,0,0
31665,calcium,0,1
31666,sensitiser,0,0
31667,",",0,0
31668,improves,0,1
31669,cardiac,0,1
31670,performance,0,1
31671,and,0,1
31672,symptoms,0,1
31673,without,0,0
31674,increasing,0,0
31675,oxygen,0,1
31676,consumption,0,1
31677,",",0,0
31678,and,0,0
31679,decreases,0,1
31680,the,0,0
31681,mortality,0,1
31682,of,0,0
31683,patients,0,0
31684,with,0,0
31685,low-output,0,0
31686,heart,0,1
31687,failure,0,1
31688,.,0,0
31689,AIMS,0,0
31690,To,0,0
31691,estimate,0,0
31692,the,0,0
31693,cost-effectiveness,0,0
31694,of,0,0
31695,intravenous,0,0
31696,treatment,0,0
31697,with,0,0
31698,levosimendan,0,0
31699,compared,0,0
31700,with,0,0
31701,dobutamine,0,0
31702,in,0,0
31703,patients,0,0
31704,with,0,0
31705,severe,0,1
31706,low-output,0,0
31707,heart,0,1
31708,failure,0,1
31709,.,0,0
31710,METHODS,0,0
31711,This,0,0
31712,economic,0,1
31713,evaluation,0,0
31714,was,0,0
31715,based,0,0
31716,on,0,0
31717,a,0,0
31718,European,0,0
31719,clinical,0,1
31720,trial,0,0
31721,(,0,1
31722,LIDO,0,0
31723,),0,1
31724,",",0,0
31725,in,0,0
31726,which,0,0
31727,203,0,0
31728,patients,0,0
31729,with,0,0
31730,severe,0,1
31731,heart,0,1
31732,failure,0,1
31733,randomly,0,0
31734,received,0,0
31735,a,0,0
31736,24,0,0
31737,h,0,0
31738,infusion,0,0
31739,with,0,0
31740,either,0,0
31741,levosimendan,0,0
31742,or,0,0
31743,dobutamine,0,0
31744,.,0,1
31745,Survival,0,1
31746,and,0,1
31747,resource,0,1
31748,utilisation,0,1
31749,data,0,0
31750,were,0,0
31751,collected,0,0
31752,for,0,0
31753,6,0,0
31754,months,0,0
31755,;,0,0
31756,survival,0,1
31757,was,0,0
31758,extrapolated,0,0
31759,assuming,0,0
31760,a,0,0
31761,mean,0,1
31762,additional,0,0
31763,lifetime,0,1
31764,of,0,0
31765,3,0,0
31766,years,0,0
31767,based,0,0
31768,on,0,0
31769,data,0,0
31770,from,0,0
31771,the,0,0
31772,Cooperative,0,0
31773,North,0,0
31774,Scandinavian,0,0
31775,Enalapril,0,0
31776,Survival,0,1
31777,Study,0,0
31778,trial,0,0
31779,.,0,1
31780,Costs,0,0
31781,were,0,0
31782,based,0,0
31783,on,0,0
31784,study,0,0
31785,drug,0,0
31786,usage,0,1
31787,and,0,1
31788,hospitalisation,0,1
31789,in,0,0
31790,the,0,0
31791,6-month,0,0
31792,follow-up,0,0
31793,.,0,0
31794,A,0,0
31795,sensitivity,0,1
31796,analysis,0,0
31797,on,0,0
31798,dosage,1,0
31799,of,1,1
31800,drug,1,0
31801,and,1,1
31802,duration,1,1
31803,of,1,1
31804,survival,1,1
31805,was,0,0
31806,performed,0,0
31807,.,0,0
31808,RESULTS,0,0
31809,The,0,0
31810,mean,1,1
31811,survival,1,1
31812,over,1,0
31813,6,1,0
31814,months,1,0
31815,was,0,0
31816,157+/-52,0,0
31817,days,0,0
31818,in,0,0
31819,the,0,0
31820,levosimendan,0,0
31821,group,0,0
31822,and,0,1
31823,139+/-64,0,0
31824,days,0,0
31825,in,0,0
31826,the,0,0
31827,dobutamine,0,0
31828,group,0,0
31829,(,0,1
31830,P,0,0
31831,<,0,0
31832,0.01,0,0
31833,),0,0
31834,.,0,0
31835,When,0,0
31836,extrapolated,0,0
31837,up,0,0
31838,to,0,0
31839,3,0,0
31840,years,0,0
31841,",",0,0
31842,the,0,0
31843,gain,1,1
31844,in,1,0
31845,life,1,1
31846,expectancy,1,1
31847,was,0,0
31848,estimated,0,0
31849,at,0,0
31850,0.35,0,0
31851,years,0,0
31852,(,0,0
31853,discounted,0,0
31854,at,0,0
31855,3,0,0
31856,%,0,0
31857,),0,0
31858,.,0,1
31859,Levosimendan,0,0
31860,increased,0,0
31861,the,0,0
31862,mean,1,1
31863,cost,1,1
31864,per,1,0
31865,patient,1,0
31866,by,0,0
31867,1108,0,0
31868,",",0,0
31869,which,0,0
31870,was,0,0
31871,entirely,0,0
31872,due,0,0
31873,to,0,0
31874,the,0,0
31875,cost,0,0
31876,of,0,0
31877,the,0,0
31878,study,0,0
31879,drug,0,0
31880,.,0,0
31881,The,0,0
31882,incremental,1,1
31883,cost,1,1
31884,per,1,0
31885,life-year,1,0
31886,saved,0,1
31887,(,0,1
31888,LYS,0,0
31889,),0,0
31890,was,0,0
31891,3205,0,0
31892,at,0,0
31893,the,0,0
31894,European,0,0
31895,level,0,1
31896,;,0,0
31897,in,0,0
31898,the,0,0
31899,individual,0,0
31900,countries,0,0
31901,the,0,0
31902,cost,0,1
31903,per,0,0
31904,LYS,0,0
31905,ranged,0,0
31906,between,0,0
31907,3091,0,0
31908,and,0,0
31909,3331,0,0
31910,.,0,0
31911,The,0,0
31912,result,0,0
31913,was,0,0
31914,robust,0,0
31915,in,0,0
31916,the,0,0
31917,sensitivity,0,1
31918,analysis,0,0
31919,.,0,1
31920,CONCLUSIONS,0,0
31921,Although,0,0
31922,the,0,0
31923,patients,0,0
31924,in,0,0
31925,the,0,0
31926,levosimendan,0,0
31927,group,0,0
31928,were,0,0
31929,alive,0,1
31930,for,0,0
31931,more,0,0
31932,days,0,0
31933,and,0,1
31934,thus,0,0
31935,at,0,0
31936,risk,1,1
31937,of,1,1
31938,hospitalisation,1,1
31939,for,0,0
31940,longer,0,0
31941,",",0,0
31942,there,0,0
31943,was,0,0
31944,no,0,0
31945,increase,0,1
31946,in,0,0
31947,hospitalisation,1,1
31948,or,1,1
31949,hospitalisation,1,1
31950,costs,1,1
31951,with,0,0
31952,levosimendan,0,0
31953,treatment,0,0
31954,.,0,0
31955,The,0,0
31956,cost,0,1
31957,per,0,0
31958,LYS,0,0
31959,using,0,0
31960,levosimendan,0,0
31961,compares,0,0
31962,favourably,0,0
31963,with,0,0
31964,other,0,0
31965,cost-effectiveness,1,1
31966,analyses,1,0
31967,in,0,0
31968,cardiology,0,0
31969,.,0,0
31970,S-phase,0,1
31971,kinase-associated,0,1
31972,protein,0,0
31973,2,0,0
31974,expression,0,1
31975,in,0,0
31976,laryngeal,0,1
31977,squamous,0,0
31978,cell,0,1
31979,carcinomas,0,1
31980,and,0,0
31981,its,0,0
31982,prognostic,0,1
31983,implications,0,0
31984,.,0,0
31985,The,0,0
31986,F-box,0,0
31987,protein,0,1
31988,S-phase,0,1
31989,kinase-associated,0,1
31990,protein,0,0
31991,2,0,0
31992,(,0,0
31993,Skp2,0,0
31994,),0,0
31995,positively,0,0
31996,regulates,0,0
31997,the,0,0
31998,G1-S,0,0
31999,transition,0,1
32000,by,0,0
32001,controlling,0,0
32002,the,0,0
32003,stability,0,1
32004,of,0,0
32005,several,0,0
32006,G1,0,0
32007,regulators,0,0
32008,",",0,0
32009,such,0,0
32010,as,0,0
32011,the,0,0
32012,cell,0,1
32013,cycle,0,1
32014,inhibitor,0,0
32015,p27kip1,0,1
32016,.,0,0
32017,However,0,0
32018,",",0,0
32019,the,0,0
32020,clinical,0,1
32021,significance,0,1
32022,of,0,1
32023,Skp2,0,0
32024,in,0,0
32025,patients,0,0
32026,with,0,0
32027,laryngeal,0,0
32028,squamous,0,0
32029,cell,0,1
32030,carcinoma,0,0
32031,(,0,1
32032,LSCC,0,0
32033,),0,0
32034,remains,0,0
32035,unknown,0,0
32036,.,0,0
32037,In,0,0
32038,this,0,0
32039,study,0,0
32040,",",0,0
32041,a,0,0
32042,potential,0,0
32043,distribution,0,0
32044,of,0,1
32045,Skp2,0,0
32046,in,0,0
32047,LSCC,0,0
32048,and,0,0
32049,its,0,0
32050,clinical,0,1
32051,implications,0,0
32052,was,0,0
32053,investigated,0,0
32054,by,0,0
32055,an,0,0
32056,immunohistochemical,0,0
32057,study,0,0
32058,.,0,1
32059,Overall,0,1
32060,",",0,1
32061,Skp2,1,1
32062,overexpression,1,1
32063,was,0,0
32064,observed,0,0
32065,in,0,0
32066,36.7,0,0
32067,%,0,0
32068,(,0,0
32069,37,0,0
32070,of,0,0
32071,102,0,0
32072,),0,0
32073,patients,0,0
32074,and,0,1
32075,was,0,0
32076,significantly,0,0
32077,associated,0,0
32078,with,0,0
32079,lymph,0,1
32080,node,0,1
32081,metastasis,0,1
32082,(,0,1
32083,p=0.002,0,1
32084,),0,1
32085,and,0,1
32086,was,0,0
32087,inversely,0,0
32088,associated,0,0
32089,with,0,0
32090,p27kip1,0,1
32091,expression,0,1
32092,(,0,1
32093,p=0.026,0,0
32094,),0,0
32095,.,0,0
32096,Survival,1,1
32097,analysis,1,0
32098,using,0,0
32099,the,0,0
32100,Kaplan-Meier,0,1
32101,method,0,0
32102,showed,0,0
32103,that,0,0
32104,Skp2,0,0
32105,overexpression,0,1
32106,was,0,0
32107,significantly,0,0
32108,associated,0,0
32109,with,0,0
32110,shorter,0,1
32111,disease-free,1,1
32112,and,1,1
32113,overall,1,1
32114,survival,1,1
32115,(,0,1
32116,p=0.0051,0,0
32117,and,0,1
32118,p=0.0002,0,0
32119,",",0,1
32120,respectively,0,0
32121,),0,0
32122,.,0,0
32123,When,0,0
32124,Skp2,1,0
32125,expression,1,1
32126,and,1,1
32127,p27kip1,1,1
32128,expression,1,1
32129,were,0,0
32130,combined,0,0
32131,",",0,0
32132,patients,0,0
32133,with,0,0
32134,both,0,0
32135,Skp2,0,0
32136,overexpression,0,1
32137,and,0,1
32138,reduced,0,1
32139,expression,1,1
32140,of,1,1
32141,p27kip1,1,1
32142,revealed,0,0
32143,poorest,1,0
32144,disease-free,1,1
32145,and,0,1
32146,overall,1,1
32147,survival,1,1
32148,as,0,0
32149,compared,0,0
32150,to,0,0
32151,the,0,0
32152,other,0,0
32153,cases,0,0
32154,(,0,1
32155,p=0.0017,0,0
32156,and,0,1
32157,p,0,0
32158,<,0,0
32159,0.0001,0,0
32160,",",0,0
32161,respectively,0,0
32162,),0,0
32163,.,0,0
32164,Additionally,0,0
32165,",",0,0
32166,in,0,0
32167,early,0,1
32168,stage,0,0
32169,(,0,0
32170,I,0,0
32171,",",0,0
32172,II,0,0
32173,),0,1
32174,cases,0,0
32175,",",0,1
32176,Skp2,0,1
32177,expression,0,1
32178,was,0,0
32179,also,0,0
32180,revealed,0,0
32181,to,0,0
32182,possess,0,0
32183,a,0,0
32184,significant,0,0
32185,prognostic,0,1
32186,factor,0,1
32187,in,0,0
32188,overall,1,1
32189,survival,1,1
32190,(,1,1
32191,p=0.0234,1,0
32192,),1,1
32193,",",0,1
32194,but,0,0
32195,not,0,0
32196,in,0,0
32197,disease-free,1,1
32198,survival,1,1
32199,(,0,1
32200,p=0.2055,0,0
32201,),0,0
32202,.,0,0
32203,By,0,0
32204,multivariate,0,0
32205,analysis,0,0
32206,using,0,0
32207,the,0,0
32208,Cox,1,0
32209,proportional,1,1
32210,hazards,1,1
32211,model,1,0
32212,",",1,1
32213,tumor,1,1
32214,grade,1,1
32215,",",1,1
32216,tumor,1,1
32217,size,1,1
32218,",",1,1
32219,clinical,1,1
32220,stage,1,1
32221,and,1,1
32222,Skp2,1,1
32223,expression,1,1
32224,were,0,0
32225,independent,0,0
32226,prognostic,0,1
32227,factors,0,0
32228,both,0,0
32229,in,0,0
32230,disease-free,1,1
32231,and,1,1
32232,overall,1,1
32233,survival,1,1
32234,.,1,0
32235,These,0,0
32236,findings,0,0
32237,indicated,0,0
32238,that,0,0
32239,Skp2,1,0
32240,expression,1,1
32241,was,0,0
32242,closely,0,1
32243,associated,0,0
32244,with,0,0
32245,tumor,0,1
32246,progression,0,1
32247,and,0,1
32248,represented,0,0
32249,an,0,0
32250,independent,0,0
32251,marker,0,1
32252,for,0,0
32253,prognosis,0,1
32254,of,0,0
32255,LSCC,0,0
32256,.,0,0
32257,Bioavailability,1,1
32258,of,0,0
32259,omega-3,0,0
32260,essential,0,0
32261,fatty,0,1
32262,acids,0,1
32263,from,0,0
32264,perilla,0,0
32265,seed,0,1
32266,oil,0,0
32267,.,0,1
32268,Increased,0,1
32269,dietary,0,0
32270,intake,0,1
32271,of,0,1
32272,fish,0,0
32273,oil,0,0
32274,omega-3,0,0
32275,fatty,0,1
32276,acids,0,1
32277,",",0,1
32278,eicosapentanoic,0,0
32279,acid,0,1
32280,and,0,1
32281,docosohexanoic,0,1
32282,acid,0,1
32283,",",0,1
32284,and,0,1
32285,their,0,1
32286,precursor,0,1
32287,",",0,1
32288,alpha-linolenic,0,1
32289,acid,0,1
32290,(,0,1
32291,ALA,0,1
32292,),0,0
32293,",",0,0
32294,is,0,0
32295,associated,0,0
32296,with,0,0
32297,various,0,0
32298,health,0,1
32299,benefits,0,0
32300,.,0,1
32301,Enteric-coating,0,0
32302,(,0,0
32303,Entrox,0,0
32304,),0,1
32305,",",0,0
32306,which,0,0
32307,improves,0,1
32308,stability,0,1
32309,of,0,0
32310,omega-3,0,0
32311,capsules,0,0
32312,",",0,0
32313,has,0,0
32314,been,0,0
32315,shown,0,0
32316,to,0,0
32317,facilitate,0,0
32318,fish,0,0
32319,oil,0,0
32320,absorption,0,1
32321,after,0,0
32322,chronic,0,0
32323,treatment,0,0
32324,.,0,0
32325,To,0,0
32326,assess,0,0
32327,the,0,0
32328,effect,0,0
32329,of,0,0
32330,Entrox,0,0
32331,coating,0,0
32332,on,0,0
32333,the,0,0
32334,short-term,0,0
32335,bioavailability,0,1
32336,of,0,1
32337,ALA,0,1
32338,administered,0,0
32339,in,0,0
32340,the,0,0
32341,form,0,0
32342,of,0,0
32343,ALA-rich,0,0
32344,Perilla,0,0
32345,seed,0,1
32346,oil,0,0
32347,",",0,0
32348,12,0,0
32349,healthy,0,0
32350,subjects,0,0
32351,(,0,0
32352,6,0,0
32353,males,0,0
32354,and,0,0
32355,6,0,0
32356,females,0,0
32357,),0,0
32358,received,0,0
32359,in,0,0
32360,a,0,0
32361,random,0,0
32362,order,0,0
32363,Entrox-coated,0,0
32364,and,0,1
32365,non-coated,0,0
32366,ALA,0,1
32367,formulations,0,0
32368,",",0,0
32369,each,0,0
32370,as,0,0
32371,a,0,0
32372,single,0,0
32373,6g,0,0
32374,dose,0,0
32375,separated,0,0
32376,by,0,0
32377,a,0,0
32378,3-week,0,0
32379,washout,0,0
32380,period,0,0
32381,.,0,0
32382,Measurements,0,0
32383,of,0,0
32384,plasma,1,1
32385,ALA,1,1
32386,concentrations,1,1
32387,from,0,0
32388,0,0,0
32389,to,0,0
32390,24h,0,0
32391,showed,0,0
32392,no,0,0
32393,difference,0,0
32394,in,0,0
32395,ALA,0,0
32396,pharmacokinetics,0,0
32397,between,0,0
32398,the,0,0
32399,two,0,0
32400,formulations,0,0
32401,.,0,0
32402,However,0,0
32403,",",0,0
32404,significantly,0,0
32405,greater,0,0
32406,increases,0,1
32407,in,0,0
32408,plasma,1,1
32409,ALA,1,0
32410,levels,1,1
32411,from,0,0
32412,baseline,0,0
32413,to,0,0
32414,24h,0,0
32415,were,0,0
32416,observed,0,0
32417,after,0,0
32418,ingestion,0,0
32419,of,0,0
32420,Entrox,0,0
32421,vs.,0,0
32422,non-coated,0,0
32423,product,0,1
32424,",",0,0
32425,suggesting,0,0
32426,a,0,0
32427,possible,0,0
32428,benefit,0,0
32429,of,0,1
32430,Entrox,0,0
32431,with,0,0
32432,long-term,0,0
32433,treatment,0,0
32434,.,0,0
32435,Optimal,0,1
32436,therapy,0,0
32437,for,0,0
32438,advanced,0,0
32439,chronic,0,0
32440,venous,0,1
32441,insufficiency,0,1
32442,.,0,0
32443,INTRODUCTION,0,0
32444,While,0,0
32445,definitive,0,0
32446,therapy,0,0
32447,awaits,0,0
32448,level,0,1
32449,I,0,0
32450,evidence,0,0
32451,",",0,1
32452,controversy,0,0
32453,persists,0,0
32454,regarding,0,0
32455,the,0,0
32456,optimal,0,0
32457,operation,0,0
32458,for,0,0
32459,treatment,0,0
32460,of,0,0
32461,advanced,0,0
32462,chronic,0,0
32463,venous,0,1
32464,insufficiency,0,1
32465,(,0,1
32466,CVI,0,0
32467,),0,0
32468,.,0,0
32469,We,0,0
32470,propose,0,0
32471,a,0,0
32472,pragmatic,0,0
32473,approach,0,0
32474,to,0,0
32475,the,0,0
32476,correction,0,0
32477,or,0,0
32478,amelioration,0,1
32479,of,0,1
32480,venous,0,1
32481,hypertension,0,1
32482,resulting,0,0
32483,from,0,0
32484,hydrodynamic,0,0
32485,and,0,1
32486,hydrostatic,0,1
32487,venous,0,1
32488,reflux,0,1
32489,.,0,0
32490,We,0,0
32491,evaluated,0,0
32492,a,0,0
32493,strategy,0,0
32494,of,0,1
32495,balloon,0,0
32496,dissection,0,0
32497,",",0,1
32498,subfascial,0,1
32499,endoscopic,0,1
32500,perforating,0,1
32501,vein,0,1
32502,surgery,0,0
32503,(,0,1
32504,SEPS,0,0
32505,),0,0
32506,with,0,0
32507,routine,0,0
32508,posterior,0,0
32509,deep,0,1
32510,compartment,0,1
32511,fasciotomy,0,0
32512,",",0,1
32513,including,0,0
32514,ligation,0,1
32515,and,0,1
32516,stripping,0,0
32517,of,0,0
32518,the,0,0
32519,superficial,0,1
32520,system,0,0
32521,",",0,0
32522,for,0,0
32523,use,0,1
32524,when,0,0
32525,reflux,0,1
32526,is,0,0
32527,documented,0,0
32528,at,0,0
32529,duplex,0,1
32530,ultrasound,0,1
32531,(,0,1
32532,US,0,1
32533,),0,0
32534,scanning,0,0
32535,.,0,0
32536,METHODS,0,0
32537,This,0,0
32538,is,0,0
32539,a,0,0
32540,cooperative,0,0
32541,",",0,0
32542,multicenter,0,0
32543,",",0,1
32544,retrospective,0,0
32545,review,0,0
32546,of,0,0
32547,832,0,0
32548,patients,0,0
32549,stratified,0,0
32550,by,0,0
32551,CEAP,0,0
32552,classification,0,1
32553,.,0,0
32554,The,0,0
32555,series,0,0
32556,consisted,0,0
32557,of,0,0
32558,300,0,0
32559,patients,0,0
32560,with,0,0
32561,C4,0,0
32562,CVI,0,0
32563,",",0,0
32564,119,0,0
32565,patients,0,0
32566,with,0,0
32567,C5,0,0
32568,CVI,0,1
32569,",",0,0
32570,and,0,0
32571,413,0,0
32572,patients,0,0
32573,with,0,0
32574,C6,0,1
32575,CVI,0,0
32576,.,0,1
32577,A,0,0
32578,subset,0,0
32579,of,0,0
32580,92,0,0
32581,patients,0,0
32582,with,0,0
32583,C4,0,0
32584,disease,0,1
32585,were,0,0
32586,prospectively,0,0
32587,randomized,0,0
32588,",",0,0
32589,and,0,0
32590,ambulatory,0,1
32591,venous,0,1
32592,pressure,0,1
32593,(,0,1
32594,AVP,0,1
32595,),0,1
32596,was,0,0
32597,determined,0,0
32598,preoperatively,0,0
32599,and,0,0
32600,postoperatively,0,1
32601,.,0,0
32602,All,0,0
32603,patients,0,0
32604,underwent,0,0
32605,duplex,0,1
32606,US,0,0
32607,scanning,0,0
32608,to,0,0
32609,document,0,1
32610,reflux,0,1
32611,in,0,0
32612,the,0,0
32613,deep,0,1
32614,",",0,0
32615,superficial,0,1
32616,",",0,1
32617,and,0,1
32618,perforating,0,1
32619,venous,0,1
32620,systems,0,0
32621,.,0,1
32622,Efficacy,1,1
32623,",",1,1
32624,safety,1,1
32625,",",1,1
32626,and,1,1
32627,durability,1,1
32628,were,0,0
32629,evaluated,0,0
32630,over,0,0
32631,follow-up,0,0
32632,of,0,0
32633,1,0,0
32634,to,0,0
32635,9,0,0
32636,years,0,0
32637,(,0,0
32638,mean,0,1
32639,",",0,0
32640,31/2,0,1
32641,years,0,0
32642,),0,0
32643,.,0,0
32644,Uniformity,0,1
32645,was,0,0
32646,attempted,0,0
32647,by,0,0
32648,adoption,0,0
32649,of,0,0
32650,the,0,0
32651,senior,0,0
32652,author,0,1
32653,'s,0,1
32654,protocol,0,0
32655,and,0,1
32656,technique,0,0
32657,through,0,0
32658,on-site,0,0
32659,preceptorship,0,0
32660,in,0,0
32661,each,0,0
32662,surgeon,0,1
32663,'s,0,1
32664,operative,0,1
32665,theater,0,0
32666,.,0,0
32667,RESULTS,0,0
32668,This,0,0
32669,technique,0,0
32670,interrupted,0,0
32671,3,0,0
32672,to,0,0
32673,14,0,0
32674,(,0,0
32675,mean,0,0
32676,",",0,0
32677,7,0,0
32678,),0,0
32679,incompetent,0,0
32680,perforating,0,1
32681,veins,0,1
32682,per,0,0
32683,patient,0,1
32684,.,0,0
32685,Of,0,0
32686,the,0,0
32687,832,0,0
32688,patients,0,0
32689,undergoing,0,0
32690,SEPS,0,0
32691,",",0,0
32692,460,0,0
32693,(,0,0
32694,55,0,0
32695,%,0,0
32696,),0,0
32697,underwent,0,0
32698,saphenous,0,1
32699,vein,0,1
32700,ligation,0,1
32701,and,0,1
32702,stripping,0,0
32703,at,0,0
32704,the,0,0
32705,same,0,0
32706,operation,0,0
32707,.,0,0
32708,In,0,0
32709,92,0,0
32710,%,0,0
32711,ulcers,1,1
32712,healed,1,1
32713,or,1,0
32714,were,1,0
32715,significantly,1,0
32716,improved,1,0
32717,within,0,0
32718,4,0,0
32719,to,0,0
32720,14,0,0
32721,weeks,0,0
32722,.,0,0
32723,In,0,0
32724,64,0,0
32725,(,0,0
32726,8,0,0
32727,%,0,0
32728,),0,0
32729,patients,0,0
32730,",",0,0
32731,ulcers,1,1
32732,failed,1,0
32733,to,1,0
32734,heal,1,1
32735,or,0,0
32736,there,0,0
32737,was,0,0
32738,no,0,0
32739,benefit,0,0
32740,from,0,0
32741,the,0,0
32742,operation,1,0
32743,.,1,0
32744,Thirty-two,0,0
32745,patients,0,0
32746,(,0,0
32747,4,0,0
32748,%,0,0
32749,),0,0
32750,experienced,0,1
32751,recurrent,1,1
32752,ulceration,1,1
32753,or,1,1
32754,skin,1,1
32755,deterioration,1,1
32756,at,0,0
32757,6,0,0
32758,months-2,0,0
32759,years,0,0
32760,(,0,1
32761,mean,0,1
32762,",",0,0
32763,15,0,0
32764,mo,0,0
32765,),0,0
32766,.,0,0
32767,Repeat,0,1
32768,SEPS,0,0
32769,was,0,0
32770,successful,0,0
32771,in,0,0
32772,25,0,0
32773,of,0,0
32774,these,0,0
32775,96,0,0
32776,patients,0,0
32777,",",0,0
32778,and,0,1
32779,deep,0,1
32780,valve,0,1
32781,repair,0,0
32782,was,0,0
32783,successful,0,0
32784,in,0,0
32785,4,0,0
32786,patients,0,0
32787,.,0,0
32788,In,0,0
32789,the,0,0
32790,92,0,0
32791,randomized,0,0
32792,patients,0,0
32793,with,0,0
32794,C4,0,0
32795,disease,0,1
32796,",",0,0
32797,41,0,0
32798,refused,0,0
32799,postoperative,0,1
32800,AVP,0,1
32801,",",0,0
32802,leaving,0,0
32803,51,0,0
32804,compliant,0,0
32805,patients,0,0
32806,.,0,0
32807,The,0,0
32808,SEPS,0,0
32809,group,0,0
32810,(,0,0
32811,n,0,0
32812,=,0,0
32813,25,0,0
32814,),0,0
32815,had,0,0
32816,significantly,0,0
32817,reduced,0,0
32818,AVP,1,0
32819,(,0,0
32820,P,0,0
32821,<,0,0
32822,.01,0,1
32823,),0,0
32824,compared,0,0
32825,with,0,0
32826,the,0,0
32827,control,0,0
32828,group,0,0
32829,(,0,0
32830,n,0,0
32831,=,0,0
32832,26,0,0
32833,),0,0
32834,.,0,0
32835,Complications,0,0
32836,in,0,0
32837,825,0,0
32838,patients,0,0
32839,were,0,0
32840,less,0,0
32841,than,0,0
32842,3,0,0
32843,%,0,0
32844,and,0,0
32845,consisted,0,0
32846,mostly,0,0
32847,of,0,0
32848,transient,1,1
32849,neurologic,1,1
32850,disorders,1,1
32851,(,0,1
32852,eg,0,1
32853,",",0,1
32854,paradysthesia,1,1
32855,),1,1
32856,",",1,1
32857,but,1,0
32858,deep,1,1
32859,venous,1,1
32860,thrombosis,1,1
32861,occurred,0,0
32862,in,0,0
32863,2,0,0
32864,patients,0,0
32865,",",0,0
32866,with,0,0
32867,pulmonary,0,1
32868,embolus,0,1
32869,in,0,0
32870,1,0,0
32871,.,0,0
32872,No,0,0
32873,operative,0,1
32874,deaths,1,1
32875,occurred,0,0
32876,.,0,0
32877,Follow-up,0,0
32878,for,0,0
32879,1,0,0
32880,to,0,0
32881,9,0,0
32882,years,0,0
32883,(,0,0
32884,mean,0,1
32885,",",0,0
32886,31/2,0,1
32887,years,0,0
32888,),0,0
32889,demonstrated,0,0
32890,durability,1,1
32891,.,1,0
32892,CONCLUSION,0,0
32893,The,0,0
32894,efficacy,0,1
32895,",",0,1
32896,safety,0,1
32897,",",0,1
32898,and,0,1
32899,durability,0,1
32900,of,0,0
32901,this,0,0
32902,operative,0,1
32903,protocol,0,0
32904,proved,0,0
32905,beneficial,0,0
32906,in,0,0
32907,our,0,0
32908,clinical,0,0
32909,experience,0,0
32910,with,0,0
32911,832,0,0
32912,patients,0,0
32913,during,0,0
32914,9,0,0
32915,years,0,0
32916,of,0,0
32917,follow-up,0,0
32918,.,0,0
32919,The,0,0
32920,SEPS,0,0
32921,subset,0,0
32922,of,0,1
32923,randomized,0,0
32924,patients,0,0
32925,with,0,0
32926,C4,0,0
32927,disease,0,1
32928,experienced,0,1
32929,significant,0,0
32930,decrease,0,1
32931,in,0,0
32932,AVP,0,1
32933,",",0,0
32934,objectively,0,1
32935,supporting,0,0
32936,the,0,0
32937,effectiveness,0,1
32938,of,0,1
32939,reflux,0,1
32940,surgery,0,0
32941,in,0,0
32942,advanced,0,0
32943,CVI,0,0
32944,.,0,0
32945,Until,0,0
32946,definitive,0,0
32947,level,0,1
32948,I,0,0
32949,evidence,0,0
32950,is,0,0
32951,available,0,0
32952,",",0,0
32953,this,0,0
32954,operative,0,0
32955,technique,0,0
32956,is,0,0
32957,advocated,0,0
32958,as,0,0
32959,optimal,0,0
32960,therapy,0,0
32961,for,0,0
32962,CVI,0,0
32963,.,0,0
32964,A,0,0
32965,preliminary,0,0
32966,study,0,0
32967,of,0,0
32968,the,0,0
32969,optimal,0,0
32970,anesthesia,0,0
32971,positioning,0,0
32972,for,0,0
32973,the,0,0
32974,morbidly,0,0
32975,obese,0,0
32976,patient,0,1
32977,.,0,0
32978,BACKGROUND,0,0
32979,Hypoxemia,0,1
32980,during,0,0
32981,the,0,0
32982,induction,0,0
32983,of,0,0
32984,general,0,0
32985,anesthesia,0,0
32986,for,0,0
32987,the,0,0
32988,morbidly,0,0
32989,obese,0,0
32990,patient,0,0
32991,is,0,0
32992,a,0,0
32993,major,0,1
32994,concern,0,0
32995,of,0,0
32996,anesthesiologists,0,0
32997,.,0,0
32998,The,0,0
32999,etiology,0,0
33000,of,0,0
33001,this,0,0
33002,pathophysiological,0,0
33003,problem,0,0
33004,is,0,0
33005,multifactorial,0,0
33006,",",0,0
33007,and,0,1
33008,patient,0,1
33009,positioning,0,0
33010,may,0,0
33011,be,0,0
33012,a,0,0
33013,contributing,0,0
33014,factor,0,0
33015,.,0,0
33016,The,0,0
33017,present,0,0
33018,study,0,0
33019,was,0,0
33020,designed,0,0
33021,to,0,0
33022,identify,0,0
33023,optimal,0,1
33024,patient,0,1
33025,positioning,0,0
33026,for,0,0
33027,the,0,0
33028,induction,0,0
33029,of,0,0
33030,general,0,0
33031,anesthesia,0,0
33032,that,0,0
33033,minimizes,0,0
33034,the,0,0
33035,risk,0,1
33036,of,0,0
33037,hypoxemia,0,1
33038,in,0,0
33039,these,0,0
33040,patients,0,0
33041,.,0,0
33042,METHODS,0,0
33043,26,0,0
33044,morbidly,0,0
33045,obese,0,0
33046,patients,0,0
33047,(,0,0
33048,body,0,1
33049,mass,0,1
33050,index-BMI,0,1
33051,56,0,0
33052,+/-,0,0
33053,3,0,0
33054,),0,0
33055,were,0,0
33056,randomly,0,0
33057,assigned,0,0
33058,to,0,0
33059,one,0,0
33060,of,0,0
33061,three,0,0
33062,positions,0,0
33063,for,0,0
33064,induction,0,0
33065,of,0,0
33066,anesthesia,0,0
33067,:,0,0
33068,1,0,0
33069,),0,0
33070,30,0,0
33071,degrees,0,0
33072,Reverse,0,0
33073,Trendelenburg,0,0
33074,;,0,0
33075,2,0,0
33076,),0,0
33077,Supine-Horizontal,0,0
33078,;,0,0
33079,3,0,0
33080,),0,0
33081,30,0,0
33082,degrees,0,0
33083,Back,0,0
33084,Up,0,0
33085,Fowler,0,0
33086,.,0,0
33087,Mask,0,0
33088,ventilation,0,1
33089,",",0,1
33090,full,0,1
33091,neuromuscular,0,1
33092,paralysis,0,1
33093,and,0,1
33094,direct,0,1
33095,laryngoscopy,0,1
33096,were,0,0
33097,performed,0,0
33098,.,0,0
33099,Any,0,0
33100,airway,1,1
33101,difficulties,1,1
33102,were,0,0
33103,noted,0,0
33104,.,0,0
33105,After,0,0
33106,endotracheal,0,1
33107,tube,0,1
33108,placement,0,0
33109,",",0,1
33110,subjects,0,0
33111,were,0,0
33112,ventilated,0,0
33113,for,0,0
33114,5,0,0
33115,minutes,0,0
33116,with,0,0
33117,1,0,0
33118,%,0,0
33119,isoflurane,0,0
33120,in,0,0
33121,a,0,0
33122,mixture,0,0
33123,of,0,0
33124,50,0,0
33125,%,0,0
33126,oxygen/50,0,0
33127,%,0,0
33128,air,0,0
33129,and,0,1
33130,then,0,0
33131,disconnected,0,0
33132,from,0,0
33133,the,0,0
33134,ventilation,0,0
33135,circuit,0,0
33136,.,0,0
33137,The,0,0
33138,time,1,1
33139,required,1,0
33140,for,1,0
33141,capillary,1,1
33142,oxygen,1,1
33143,saturation,1,1
33144,(,1,1
33145,SaO2,1,0
33146,),1,1
33147,",",0,0
33148,as,0,0
33149,measured,0,1
33150,by,0,0
33151,pulse,0,1
33152,oximeter,0,0
33153,",",0,0
33154,to,0,0
33155,decline,0,0
33156,from,0,0
33157,100,0,0
33158,%,0,0
33159,to,0,0
33160,92,0,0
33161,%,0,0
33162,was,0,0
33163,noted,0,1
33164,and,0,0
33165,identified,0,0
33166,as,0,0
33167,the,0,0
33168,safe,1,1
33169,apnea,1,1
33170,period,1,0
33171,(,1,1
33172,SAP,1,1
33173,),1,0
33174,.,1,0
33175,Ventilation,0,1
33176,was,0,0
33177,then,0,0
33178,immediately,0,0
33179,re-established,0,0
33180,.,0,0
33181,The,0,0
33182,lowest,0,0
33183,SaO2,1,0
33184,after,0,0
33185,resuming,0,1
33186,ventilation,0,1
33187,and,0,0
33188,the,0,0
33189,time,0,1
33190,from,0,0
33191,that,0,0
33192,nadir,0,1
33193,to,0,0
33194,an,0,0
33195,SaO2,0,0
33196,of,0,0
33197,97,0,0
33198,%,0,0
33199,were,0,0
33200,also,0,0
33201,recorded,0,0
33202,.,0,0
33203,RESULTS,0,0
33204,BMI,1,1
33205,and,1,1
33206,hip-waist,1,1
33207,ratios,1,1
33208,of,1,0
33209,patients,1,0
33210,in,0,0
33211,groups,0,0
33212,1,0,0
33213,",",0,0
33214,2,0,0
33215,and,0,0
33216,3,0,0
33217,did,0,0
33218,not,0,0
33219,significantly,0,0
33220,differ,0,0
33221,.,0,0
33222,There,0,0
33223,were,0,0
33224,no,0,0
33225,differences,0,0
33226,in,0,0
33227,airway,1,1
33228,difficulties,1,0
33229,between,0,0
33230,the,0,0
33231,different,0,0
33232,groups,0,0
33233,.,0,0
33234,The,0,0
33235,SAP,1,1
33236,in,0,0
33237,groups,0,0
33238,1,0,0
33239,",",0,0
33240,2,0,0
33241,and,0,0
33242,3,0,0
33243,was,0,0
33244,178,0,0
33245,+/-,0,0
33246,55,0,0
33247,",",0,0
33248,123,0,0
33249,+/-,0,0
33250,24,0,0
33251,and,0,0
33252,153,0,0
33253,+/-,0,0
33254,63,0,0
33255,seconds,0,0
33256,",",0,0
33257,respectively,0,0
33258,.,0,0
33259,The,0,0
33260,SaO2,1,0
33261,of,0,0
33262,patients,0,0
33263,in,0,0
33264,the,0,0
33265,reverse,0,0
33266,Trendelenburg,0,1
33267,position,1,1
33268,dropped,0,0
33269,the,0,0
33270,least,0,0
33271,and,0,0
33272,took,0,0
33273,the,0,0
33274,shortest,0,1
33275,time,1,1
33276,to,1,0
33277,recover,1,0
33278,to,0,0
33279,97,0,0
33280,%,0,0
33281,.,0,0
33282,CONCLUSIONS,0,0
33283,In,0,0
33284,morbidly,0,0
33285,obese,0,0
33286,patients,0,0
33287,",",0,0
33288,the,0,0
33289,30,0,0
33290,degrees,0,0
33291,Reverse,0,1
33292,Trendelenburg,0,1
33293,position,0,1
33294,provided,0,0
33295,the,0,0
33296,longest,0,1
33297,SAP,0,1
33298,when,0,0
33299,compared,0,0
33300,to,0,0
33301,the,0,0
33302,30,0,0
33303,degrees,0,0
33304,Back,0,0
33305,Up,0,1
33306,Fowler,0,0
33307,and,0,1
33308,Horizontal-Supine,0,1
33309,positions,0,0
33310,.,0,0
33311,Since,0,0
33312,on,0,0
33313,induction,0,0
33314,of,0,1
33315,general,0,0
33316,anesthesia,0,0
33317,morbidly,0,0
33318,obese,0,0
33319,patients,0,0
33320,may,0,0
33321,be,0,0
33322,difficult,0,0
33323,to,0,0
33324,mask,0,1
33325,ventilate,0,1
33326,and/or,0,0
33327,intubate,0,1
33328,",",0,0
33329,this,0,0
33330,extra,0,0
33331,time,0,1
33332,may,0,0
33333,preclude,0,0
33334,adverse,0,1
33335,sequelae,0,1
33336,resulting,0,0
33337,from,0,0
33338,hypoxemia,0,1
33339,.,0,0
33340,Therefore,0,0
33341,",",0,0
33342,Reverse,0,1
33343,Trendelenburg,0,1
33344,is,0,0
33345,recommended,0,0
33346,as,0,0
33347,the,0,0
33348,optimal,0,0
33349,position,0,1
33350,for,0,0
33351,induction,0,0
33352,.,0,0
33353,The,0,0
33354,effects,0,0
33355,of,0,0
33356,peer,0,0
33357,counseling,0,0
33358,on,0,0
33359,smoking,0,1
33360,cessation,1,0
33361,and,0,1
33362,reduction,0,1
33363,.,0,0
33364,OBJECTIVE,0,0
33365,To,0,0
33366,evaluate,0,0
33367,a,0,0
33368,peer,0,0
33369,counseling,0,0
33370,intervention,0,0
33371,for,0,0
33372,pregnant,0,0
33373,smokers,0,0
33374,.,0,0
33375,METHODS,0,0
33376,One,0,0
33377,hundred,0,0
33378,forty-two,0,0
33379,pregnant,0,0
33380,",",0,0
33381,predominantly,0,0
33382,Hispanic,0,0
33383,women,0,0
33384,were,0,0
33385,assigned,0,0
33386,to,0,0
33387,a,0,0
33388,peer-led,0,0
33389,smoking,0,1
33390,cessation,0,1
33391,program,0,0
33392,or,0,1
33393,to,0,0
33394,usual,0,0
33395,care,0,0
33396,.,0,1
33397,RESULTS,0,0
33398,Compared,0,0
33399,with,0,0
33400,usual,0,0
33401,care,0,0
33402,",",0,1
33403,peer,0,1
33404,counseling,0,0
33405,reduced,0,1
33406,smoking,0,1
33407,(,0,0
33408,-9.1,0,0
33409,versus,0,0
33410,-4.5,0,0
33411,cigarettes,0,0
33412,daily,0,0
33413,",",0,0
33414,P,0,0
33415,=.03,0,0
33416,),0,1
33417,",",0,1
33418,but,0,0
33419,did,0,0
33420,not,0,0
33421,affect,0,0
33422,absolute,0,1
33423,quit,1,1
33424,rates,1,1
33425,(,0,0
33426,24,0,0
33427,%,0,0
33428,versus,0,0
33429,21,0,0
33430,%,0,0
33431,),0,0
33432,at,0,0
33433,36,0,0
33434,weeks,0,0
33435,',0,0
33436,gestation,0,1
33437,.,0,1
33438,Infant,1,1
33439,birth,1,1
33440,weight,1,1
33441,negatively,0,0
33442,correlated,0,0
33443,with,0,0
33444,cigarettes,0,0
33445,smoked,0,0
33446,per,0,0
33447,day,0,0
33448,(,0,0
33449,r,0,1
33450,=,0,0
33451,-0.29,0,0
33452,",",0,1
33453,P,0,0
33454,<,0,0
33455,.01,0,1
33456,),0,1
33457,and,0,1
33458,expired,0,1
33459,carbon,0,1
33460,monoxide,0,1
33461,(,0,0
33462,r,0,1
33463,=,0,0
33464,-0.39,0,0
33465,",",0,1
33466,(,0,1
33467,P,0,0
33468,<,0,0
33469,.001,0,0
33470,),0,0
33471,at,0,0
33472,delivery,0,0
33473,.,0,1
33474,Birth,1,1
33475,weight,1,1
33476,for,1,0
33477,infants,1,0
33478,born,1,0
33479,to,1,0
33480,women,1,0
33481,who,1,0
33482,quit,1,0
33483,smoking,1,0
33484,averaged,0,0
33485,7.2,0,0
33486,lb,0,0
33487,versus,0,0
33488,6.8,0,0
33489,and,0,0
33490,6.3,0,0
33491,lb,0,0
33492,for,0,0
33493,mothers,0,0
33494,smoking,0,0
33495,one,0,0
33496,to,0,0
33497,six,0,0
33498,and,0,0
33499,more,0,0
33500,than,0,0
33501,six,0,0
33502,cigarettes,0,0
33503,per,0,0
33504,day,0,0
33505,at,0,0
33506,delivery,0,1
33507,(,0,0
33508,P,0,0
33509,<,0,0
33510,.01,0,0
33511,),0,0
33512,.,0,0
33513,CONCLUSION,0,0
33514,Peer,1,0
33515,counseling,1,0
33516,reduced,0,0
33517,the,0,0
33518,number,1,1
33519,of,1,0
33520,cigarettes,1,0
33521,smoked,1,0
33522,daily,1,0
33523,but,0,0
33524,did,0,0
33525,not,0,0
33526,increase,0,0
33527,cigarette,1,0
33528,abstinence,1,1
33529,rates,1,1
33530,.,1,1
33531,Infant,1,1
33532,birth,1,1
33533,weight,1,1
33534,increases,0,1
33535,with,0,0
33536,both,0,0
33537,smoking,0,1
33538,cessation,0,0
33539,and,0,1
33540,smoking,0,1
33541,reduction,0,1
33542,",",0,1
33543,suggesting,0,0
33544,that,0,0
33545,peer,0,0
33546,counseling,0,0
33547,intervention,0,0
33548,programs,0,0
33549,may,0,0
33550,improve,0,0
33551,newborn,1,0
33552,health,1,1
33553,despite,0,0
33554,their,0,0
33555,failure,0,0
33556,to,0,0
33557,affect,0,1
33558,smoking,0,0
33559,cessation,0,0
33560,.,0,0
33561,Single-dose,0,0
33562,tranexamic,0,0
33563,acid,0,0
33564,reduces,0,0
33565,postoperative,1,1
33566,bleeding,1,1
33567,after,0,0
33568,coronary,0,1
33569,surgery,0,0
33570,in,0,0
33571,patients,0,0
33572,treated,0,0
33573,with,0,0
33574,aspirin,0,0
33575,until,0,0
33576,surgery,0,0
33577,.,0,0
33578,UNLABELLED,0,1
33579,Tranexamic,0,0
33580,acid,0,0
33581,reduces,0,0
33582,postoperative,0,1
33583,bleeding,0,1
33584,after,0,0
33585,coronary,0,1
33586,artery,0,1
33587,bypass,0,0
33588,grafting,0,0
33589,.,0,0
33590,We,0,0
33591,evaluated,0,0
33592,the,0,0
33593,effects,1,0
33594,of,0,0
33595,a,0,0
33596,single,0,0
33597,dose,0,0
33598,of,0,1
33599,tranexamic,0,0
33600,acid,0,0
33601,given,0,0
33602,immediately,0,0
33603,before,0,0
33604,cardiopulmonary,0,1
33605,bypass,0,0
33606,(,0,1
33607,CPB,0,1
33608,),0,0
33609,in,0,0
33610,patients,0,0
33611,treated,0,0
33612,with,0,0
33613,aspirin,0,0
33614,until,0,0
33615,the,0,0
33616,day,0,0
33617,before,0,0
33618,surgery,0,0
33619,.,0,0
33620,The,0,0
33621,study,0,0
33622,was,0,0
33623,a,0,0
33624,prospective,0,0
33625,",",0,0
33626,randomized,0,0
33627,",",0,0
33628,double-blinded,0,0
33629,",",0,1
33630,placebo-controlled,0,0
33631,",",0,1
33632,parallel-group,0,0
33633,trial,0,0
33634,.,0,0
33635,Eighty,0,1
33636,patients,0,0
33637,were,0,0
33638,included,0,0
33639,and,0,0
33640,divided,0,0
33641,into,0,0
33642,two,0,0
33643,groups,0,0
33644,:,0,0
33645,one,0,0
33646,group,0,0
33647,received,0,0
33648,tranexamic,0,0
33649,acid,0,0
33650,30,0,0
33651,mg/kg,0,0
33652,",",0,0
33653,and,0,0
33654,one,0,0
33655,group,0,0
33656,received,0,0
33657,placebo,0,0
33658,(,0,0
33659,0.9,0,0
33660,%,0,0
33661,NaCl,0,0
33662,),0,0
33663,as,0,0
33664,a,0,0
33665,bolus,0,0
33666,injection,0,0
33667,before,0,0
33668,CPB,0,0
33669,.,0,0
33670,Postoperative,1,1
33671,blood,1,1
33672,loss,1,1
33673,was,0,0
33674,recorded,0,0
33675,for,0,0
33676,16,0,0
33677,h.,0,0
33678,Transfusions,1,1
33679,of,1,0
33680,blood,1,1
33681,products,1,1
33682,were,0,0
33683,recorded,0,0
33684,for,0,0
33685,the,0,0
33686,whole,0,0
33687,hospital,0,1
33688,stay,0,1
33689,.,0,0
33690,Transfusions,0,1
33691,of,0,0
33692,packed,0,0
33693,red,0,1
33694,cells,0,1
33695,were,0,0
33696,given,0,0
33697,when,0,0
33698,the,0,0
33699,hematocrit,1,1
33700,value,1,1
33701,was,0,0
33702,less,0,0
33703,than,0,0
33704,20,0,0
33705,%,0,0
33706,during,0,0
33707,CPB,0,1
33708,and,0,1
33709,less,0,0
33710,than,0,0
33711,25,0,0
33712,%,0,0
33713,after,0,0
33714,surgery,0,0
33715,.,0,0
33716,The,0,0
33717,patients,0,0
33718,in,0,0
33719,the,0,0
33720,tranexamic,0,0
33721,acid,0,1
33722,group,0,0
33723,had,0,0
33724,significantly,0,0
33725,less,0,0
33726,postoperative,1,1
33727,bleeding,1,1
33728,compared,0,0
33729,with,0,0
33730,the,0,0
33731,patients,0,0
33732,in,0,0
33733,the,0,0
33734,placebo,0,0
33735,group,0,0
33736,(,0,0
33737,mean,0,1
33738,[,0,0
33739,SD,0,1
33740,],0,0
33741,),0,0
33742,(,0,0
33743,475,0,0
33744,[,0,0
33745,274,0,0
33746,],0,0
33747,mL,0,0
33748,versus,0,0
33749,713,0,0
33750,[,0,0
33751,243,0,0
33752,],0,0
33753,mL,0,0
33754,;,0,0
33755,P,0,0
33756,<,0,0
33757,0.001,0,0
33758,),0,0
33759,.,0,0
33760,An,0,0
33761,effective,0,1
33762,inhibition,1,1
33763,of,1,1
33764,fibrinolysis,1,1
33765,was,0,0
33766,found,0,0
33767,in,0,0
33768,patients,0,0
33769,receiving,0,0
33770,tranexamic,0,0
33771,acid,0,0
33772,.,0,1
33773,Tranexamic,0,0
33774,acid,0,0
33775,reduces,0,0
33776,postoperative,1,1
33777,bleeding,1,1
33778,in,0,0
33779,coronary,0,1
33780,artery,0,1
33781,bypass,0,0
33782,grafting,0,0
33783,patients,0,0
33784,treated,0,0
33785,with,0,0
33786,aspirin,0,0
33787,until,0,0
33788,the,0,0
33789,day,0,0
33790,before,0,0
33791,surgery,0,0
33792,.,0,0
33793,IMPLICATIONS,0,0
33794,Continuation,0,1
33795,of,0,1
33796,aspirin,0,0
33797,medication,0,0
33798,until,0,0
33799,the,0,0
33800,day,0,0
33801,before,0,0
33802,coronary,0,1
33803,artery,0,1
33804,bypass,0,0
33805,grafting,0,0
33806,may,0,0
33807,increase,0,1
33808,postoperative,1,1
33809,bleeding,1,1
33810,.,1,0
33811,The,0,0
33812,administration,0,0
33813,of,0,0
33814,a,0,0
33815,single,0,0
33816,dose,0,0
33817,of,0,1
33818,tranexamic,0,0
33819,acid,0,0
33820,(,0,0
33821,30,0,0
33822,mg/kg,0,0
33823,),0,0
33824,immediately,0,0
33825,before,0,0
33826,cardiopulmonary,0,1
33827,bypass,0,0
33828,significantly,0,0
33829,reduced,0,0
33830,postoperative,1,1
33831,bleeding,1,1
33832,and,0,1
33833,inhibited,0,1
33834,fibrinolysis,1,1
33835,in,0,0
33836,these,0,0
33837,patients,0,0
33838,.,0,0
33839,Pharmacokinetics,1,1
33840,and,1,1
33841,tolerance,1,1
33842,of,0,1
33843,single-,0,0
33844,and,0,1
33845,multiple-dose,0,0
33846,oral,0,0
33847,or,0,0
33848,intravenous,0,0
33849,linezolid,0,0
33850,",",0,0
33851,an,0,0
33852,oxazolidinone,0,1
33853,antibiotic,0,0
33854,",",0,0
33855,in,0,0
33856,healthy,0,0
33857,volunteers,0,0
33858,.,0,0
33859,AIMS,0,0
33860,To,0,0
33861,determine,0,0
33862,the,0,0
33863,pharmacokinetics,0,1
33864,and,0,1
33865,tolerance,1,1
33866,of,0,1
33867,oral,0,0
33868,and,0,1
33869,intravenous,0,0
33870,linezolid,0,0
33871,",",0,0
33872,an,0,0
33873,oxazolidinone,0,1
33874,antibiotic,0,0
33875,",",0,0
33876,in,0,0
33877,healthy,0,0
33878,volunteers,0,0
33879,following,0,0
33880,single-,0,0
33881,and,0,1
33882,multiple-dose,0,0
33883,administration,0,0
33884,.,0,0
33885,METHODS,0,0
33886,In,0,0
33887,two,0,0
33888,randomized,0,0
33889,",",0,0
33890,double-blind,0,0
33891,",",0,1
33892,placebo-controlled,0,0
33893,",",0,1
33894,dose-escalating,0,0
33895,trials,0,0
33896,",",0,1
33897,subjects,0,0
33898,were,0,0
33899,exposed,0,0
33900,either,0,0
33901,to,0,0
33902,oral,0,0
33903,(,0,0
33904,375,0,0
33905,",",0,0
33906,500,0,0
33907,or,0,0
33908,625,0,0
33909,mg,0,0
33910,),0,0
33911,or,0,1
33912,intravenous,0,0
33913,(,0,0
33914,500,0,0
33915,or,0,0
33916,625,0,0
33917,mg,0,0
33918,),0,0
33919,linezolid,0,0
33920,or,0,0
33921,placebo,0,0
33922,twice,0,0
33923,daily,0,0
33924,.,0,0
33925,Serial,1,0
33926,blood,1,1
33927,and,1,1
33928,urine,1,1
33929,samples,1,1
33930,were,0,0
33931,obtained,0,0
33932,after,0,0
33933,the,0,0
33934,first-,0,0
33935,and,0,0
33936,multiple-dose,0,0
33937,administrations,0,0
33938,for,0,0
33939,up,0,0
33940,to,0,0
33941,18,0,0
33942,days,0,0
33943,.,0,0
33944,Non-compartmental,0,0
33945,pharmacokinetic,1,1
33946,analyses,1,0
33947,were,0,0
33948,used,0,0
33949,to,0,0
33950,describe,0,0
33951,the,0,0
33952,disposition,0,1
33953,of,0,0
33954,linezolid,0,0
33955,.,0,0
33956,RESULTS,0,0
33957,Plasma,1,1
33958,linezolid,1,0
33959,concentrations,1,1
33960,and,1,1
33961,area,1,1
33962,under,1,0
33963,the,1,0
33964,concentration-time,1,1
33965,curves,1,1
33966,increased,0,0
33967,proportionally,0,0
33968,with,0,0
33969,dose,0,0
33970,irrespective,0,0
33971,of,0,0
33972,the,0,0
33973,route,0,0
33974,of,0,0
33975,administration,0,0
33976,.,0,0
33977,Plasma,1,1
33978,linezolid,1,0
33979,concentrations,1,1
33980,remained,0,0
33981,above,0,0
33982,the,0,0
33983,MIC90,0,0
33984,for,0,0
33985,susceptible,0,1
33986,target,0,1
33987,pathogens,0,1
33988,(,0,0
33989,4.0,0,0
33990,mg/L,0,0
33991,),0,0
33992,for,0,0
33993,the,0,0
33994,majority,0,0
33995,of,0,0
33996,the,0,0
33997,12,0,0
33998,h,0,0
33999,dosing,0,0
34000,interval,0,0
34001,.,0,0
34002,Mean,1,1
34003,clearance,1,1
34004,",",1,1
34005,half-life,1,1
34006,and,1,1
34007,volume,1,1
34008,of,1,1
34009,distribution,1,1
34010,were,0,0
34011,similar,0,0
34012,irrespective,0,0
34013,of,0,1
34014,dose,0,0
34015,for,0,0
34016,both,0,0
34017,the,0,0
34018,oral,0,0
34019,and,0,0
34020,intravenous,0,0
34021,routes,0,0
34022,.,0,1
34023,Linezolid,0,0
34024,was,0,0
34025,well,0,1
34026,tolerated,1,1
34027,and,0,0
34028,the,0,0
34029,frequency,1,1
34030,of,1,0
34031,drug-related,1,1
34032,adverse,1,1
34033,events,1,1
34034,was,0,0
34035,similar,0,0
34036,between,0,0
34037,the,0,0
34038,linezolid,0,0
34039,and,0,0
34040,placebo,0,0
34041,groups,0,0
34042,.,0,0
34043,CONCLUSIONS,0,0
34044,Oral,0,1
34045,and,0,1
34046,intravenous,0,0
34047,linezolid,0,0
34048,exhibit,0,0
34049,linear,1,0
34050,pharmacokinetics,1,1
34051,",",0,0
34052,with,0,0
34053,concentrations,0,1
34054,remaining,0,0
34055,above,0,0
34056,the,0,0
34057,target,1,0
34058,MIC90,1,1
34059,for,0,0
34060,most,0,0
34061,of,0,0
34062,the,0,0
34063,dosing,0,0
34064,interval,0,0
34065,.,0,0
34066,These,0,0
34067,results,0,0
34068,support,0,0
34069,a,0,0
34070,twice-daily,0,0
34071,schedule,0,0
34072,for,0,0
34073,linezolid,0,0
34074,and,0,0
34075,demonstrate,0,0
34076,the,0,0
34077,feasibility,0,0
34078,of,0,0
34079,converting,0,0
34080,from,0,0
34081,intravenous,0,0
34082,to,0,0
34083,oral,0,0
34084,dosing,0,0
34085,without,0,0
34086,a,0,0
34087,dose,0,0
34088,adjustment,0,0
34089,.,0,0
34090,Effect,0,0
34091,of,0,0
34092,a,0,0
34093,high-protein,0,0
34094,",",0,0
34095,energy-restricted,0,0
34096,diet,0,0
34097,on,0,0
34098,weight,1,1
34099,loss,1,1
34100,and,1,1
34101,energy,1,1
34102,expenditure,1,1
34103,after,0,0
34104,weight,0,1
34105,stabilization,0,1
34106,in,0,0
34107,hyperinsulinemic,0,0
34108,subjects,0,0
34109,.,0,0
34110,OBJECTIVE,0,0
34111,To,0,0
34112,determine,0,0
34113,the,0,0
34114,effect,0,0
34115,of,0,0
34116,replacing,0,0
34117,some,0,0
34118,dietary,0,0
34119,carbohydrate,0,1
34120,with,0,0
34121,protein,0,1
34122,",",0,0
34123,during,0,0
34124,energy,0,1
34125,restriction,0,0
34126,",",0,0
34127,on,0,0
34128,weight,1,1
34129,loss,1,1
34130,",",1,1
34131,total,1,1
34132,energy,1,1
34133,expenditure,1,1
34134,(,1,1
34135,TEE,1,1
34136,),1,1
34137,",",1,0
34138,resting,1,1
34139,energy,1,1
34140,expenditure,1,1
34141,(,1,1
34142,REE,1,0
34143,),1,1
34144,",",1,0
34145,respiratory,1,1
34146,quotient,1,1
34147,(,1,1
34148,RQ,1,1
34149,),1,1
34150,",",1,0
34151,and,1,0
34152,the,1,0
34153,thermic,1,1
34154,effect,1,1
34155,of,1,1
34156,feeding,1,1
34157,(,1,1
34158,TEF,1,1
34159,),1,0
34160,in,0,0
34161,subjects,0,0
34162,with,0,0
34163,hyperinsulinemia,0,1
34164,.,0,0
34165,DESIGN,0,0
34166,Parallel,0,0
34167,",",0,1
34168,clinical,0,1
34169,intervention,0,0
34170,study,0,0
34171,of,0,0
34172,12,0,0
34173,weeks,0,0
34174,energy,0,0
34175,restriction,0,0
34176,(,0,0
34177,6.5,0,0
34178,MJ/day,0,0
34179,),0,0
34180,and,0,0
34181,4,0,0
34182,weeks,0,0
34183,energy,0,0
34184,balance,0,1
34185,(,0,0
34186,8.2,0,0
34187,MJ/day,0,0
34188,),0,0
34189,in,0,0
34190,two,0,0
34191,groups,0,0
34192,of,0,0
34193,subjects,0,0
34194,randomly,0,0
34195,assigned,0,0
34196,to,0,0
34197,either,0,0
34198,a,0,0
34199,high-protein,0,0
34200,(,0,0
34201,HP,0,1
34202,),0,1
34203,diet,0,0
34204,(,0,0
34205,27,0,0
34206,%,0,0
34207,of,0,0
34208,energy,0,1
34209,(,0,0
34210,%,0,0
34211,E,0,1
34212,),0,0
34213,as,0,0
34214,protein,0,1
34215,",",0,0
34216,45,0,0
34217,%,0,0
34218,E,0,0
34219,as,0,0
34220,carbohydrate,0,1
34221,),0,0
34222,or,0,0
34223,a,0,0
34224,lower-protein,0,0
34225,(,0,0
34226,LP,0,1
34227,),0,1
34228,diet,0,0
34229,(,0,0
34230,16,0,0
34231,%,0,0
34232,E,0,0
34233,as,0,0
34234,protein,0,1
34235,",",0,0
34236,57,0,0
34237,%,0,0
34238,E,0,0
34239,as,0,0
34240,carbohydrate,0,0
34241,),0,0
34242,.,0,0
34243,SUBJECTS,0,0
34244,A,0,0
34245,total,0,0
34246,of,0,0
34247,36,0,0
34248,obese,0,0
34249,nondiabetic,0,0
34250,volunteers,0,0
34251,with,0,0
34252,hyperinsulinemia,0,1
34253,(,0,0
34254,10,0,0
34255,males/26,0,0
34256,females,0,0
34257,",",0,1
34258,aged,0,0
34259,34-65,0,0
34260,y,0,0
34261,",",0,0
34262,BMI,0,1
34263,28-43,0,1
34264,kg/m,0,0
34265,(,0,0
34266,2,0,0
34267,),0,0
34268,",",0,0
34269,fasting,0,1
34270,insulin,0,1
34271,12-45,0,0
34272,mU/l,0,1
34273,),0,0
34274,.,0,0
34275,MEASUREMENTS,0,0
34276,Body,1,0
34277,weight,1,1
34278,and,1,1
34279,composition,1,1
34280,",",1,1
34281,TEE,1,1
34282,",",1,1
34283,REE,1,0
34284,",",1,1
34285,and,1,1
34286,RQ,1,1
34287,were,0,0
34288,measured,0,0
34289,at,0,0
34290,baseline,0,0
34291,and,0,1
34292,at,0,0
34293,week,0,0
34294,16,0,0
34295,.,0,0
34296,In,0,0
34297,addition,0,0
34298,",",0,0
34299,the,0,0
34300,TEF,1,0
34301,to,0,0
34302,an,0,0
34303,HP,0,1
34304,or,0,0
34305,LP,0,1
34306,meal,0,1
34307,was,0,0
34308,determined,0,0
34309,for,0,0
34310,3,0,0
34311,h,0,0
34312,",",0,0
34313,at,0,1
34314,baseline,0,1
34315,and,0,1
34316,at,0,0
34317,week,0,0
34318,16,0,0
34319,.,0,0
34320,RESULTS,0,0
34321,After,0,0
34322,16,0,0
34323,weeks,0,0
34324,",",0,0
34325,weight,1,1
34326,loss,1,1
34327,was,0,0
34328,similar,0,0
34329,in,0,0
34330,response,0,1
34331,to,0,0
34332,each,0,0
34333,diet,0,0
34334,;,0,0
34335,the,0,0
34336,overall,0,1
34337,decrease,0,1
34338,was,0,0
34339,7.9+/-0.6,0,0
34340,kg,0,0
34341,(,0,0
34342,P,0,0
34343,<,0,0
34344,0.001,0,0
34345,),0,0
34346,",",0,0
34347,of,0,0
34348,which,0,0
34349,6.8+/-0.5,0,0
34350,kg,0,0
34351,was,0,0
34352,fat,0,1
34353,(,0,0
34354,P,0,0
34355,<,0,0
34356,0.001,0,0
34357,),0,0
34358,.,0,0
34359,REE,1,0
34360,fell,0,1
34361,similarly,0,0
34362,with,0,0
34363,each,0,0
34364,diet,0,0
34365,;,0,0
34366,the,0,0
34367,overall,0,1
34368,decrease,0,1
34369,was,0,0
34370,719+/-106,0,0
34371,kJ/day,0,0
34372,(,0,0
34373,P,0,0
34374,<,0,0
34375,0.001,0,0
34376,),0,0
34377,.,0,0
34378,The,0,0
34379,TEF,1,0
34380,was,0,0
34381,2,0,0
34382,%,0,0
34383,greater,0,0
34384,after,0,0
34385,the,0,0
34386,HP,0,1
34387,than,0,0
34388,after,0,0
34389,the,0,0
34390,LP,0,0
34391,meal,0,0
34392,at,0,1
34393,baseline,0,1
34394,(,0,0
34395,P,0,0
34396,<,0,0
34397,0.01,0,0
34398,),0,0
34399,and,0,0
34400,0.8,0,0
34401,%,0,0
34402,greater,0,0
34403,at,0,0
34404,week,0,0
34405,16,0,0
34406,(,0,0
34407,P=0.35,0,0
34408,),0,0
34409,.,0,0
34410,After,0,0
34411,16,0,0
34412,weeks,0,0
34413,",",0,0
34414,the,0,0
34415,TEF,1,1
34416,was,0,0
34417,not,0,0
34418,reduced,0,0
34419,in,0,0
34420,either,0,0
34421,dietary,0,0
34422,group,0,0
34423,.,0,0
34424,There,0,0
34425,was,0,0
34426,no,0,0
34427,change,0,1
34428,in,0,0
34429,TEE,1,0
34430,after,0,0
34431,16,0,0
34432,weeks,0,0
34433,.,0,0
34434,CONCLUSION,0,0
34435,In,0,0
34436,subjects,0,0
34437,with,0,0
34438,hyperinsulinemia,0,0
34439,an,0,0
34440,energy-restrictive,0,0
34441,diet,0,0
34442,containing,0,0
34443,an,0,0
34444,increased,0,0
34445,protein-to-carbohydrate,1,0
34446,ratio,1,1
34447,does,0,0
34448,not,0,0
34449,enhance,0,0
34450,weight,1,1
34451,loss,1,1
34452,or,1,0
34453,significantly,1,1
34454,affect,1,1
34455,energy,1,1
34456,expenditure,1,1
34457,.,1,1
34458,Caloric,0,0
34459,restriction,0,0
34460,",",0,0
34461,rather,0,0
34462,than,0,0
34463,the,0,0
34464,macronutrient,0,0
34465,composition,0,0
34466,of,0,0
34467,the,0,0
34468,diet,0,0
34469,",",0,0
34470,is,0,0
34471,the,0,0
34472,most,0,0
34473,important,0,0
34474,determinant,0,1
34475,of,0,1
34476,weight,0,1
34477,loss,0,1
34478,.,0,0
34479,Comparison,0,0
34480,of,0,0
34481,the,0,0
34482,comet,0,1
34483,assay,0,0
34484,and,0,0
34485,the,0,0
34486,oxygen,0,1
34487,microelectrode,0,0
34488,for,0,0
34489,measuring,0,1
34490,tumor,1,1
34491,oxygenation,1,1
34492,in,0,0
34493,head-and-neck,0,0
34494,cancer,0,0
34495,patients,0,0
34496,.,0,0
34497,PURPOSE,0,0
34498,To,0,0
34499,compare,0,0
34500,the,0,0
34501,Eppendorf,0,0
34502,PO2,0,1
34503,histograph,0,0
34504,and,0,0
34505,the,0,0
34506,alkaline,0,1
34507,comet,0,1
34508,assay,0,1
34509,as,0,0
34510,methods,0,0
34511,of,0,0
34512,measuring,0,1
34513,tumor,1,1
34514,hypoxia,1,0
34515,in,0,0
34516,patients,0,0
34517,with,0,0
34518,head-and-neck,0,0
34519,squamous,0,0
34520,cell,0,1
34521,carcinomas,0,1
34522,.,0,1
34523,MATERIALS,0,0
34524,AND,0,0
34525,METHODS,0,0
34526,As,0,1
34527,part,0,0
34528,of,0,0
34529,a,0,0
34530,larger,0,0
34531,clinical,0,1
34532,trial,0,0
34533,",",0,0
34534,65,0,0
34535,patients,0,0
34536,with,0,0
34537,head-and-neck,0,0
34538,squamous,0,0
34539,cell,0,1
34540,carcinoma,0,0
34541,nodal,0,1
34542,metastasis,0,1
34543,underwent,0,0
34544,tumor,1,1
34545,oxygenation,1,1
34546,measurements,1,1
34547,with,1,0
34548,Eppendorf,1,0
34549,PO2,1,1
34550,histographs,1,1
34551,and,1,1
34552,comet,1,1
34553,assays,1,1
34554,",",0,0
34555,performed,0,0
34556,on,0,0
34557,fine-needle,0,0
34558,aspirates,0,1
34559,at,0,0
34560,1,0,0
34561,and,0,0
34562,2,0,0
34563,min,0,0
34564,after,0,0
34565,5,0,0
34566,Gy,0,0
34567,.,0,0
34568,Fifty-four,0,0
34569,patients,0,0
34570,had,0,0
34571,sufficient,0,0
34572,tumor,0,1
34573,cells,0,1
34574,for,0,0
34575,comet,0,1
34576,analysis,0,0
34577,at,0,0
34578,1,0,0
34579,min,0,0
34580,and,0,0
34581,26,0,0
34582,at,0,0
34583,both,0,0
34584,1,0,0
34585,and,0,0
34586,2,0,0
34587,min,0,0
34588,.,0,0
34589,Individual,0,0
34590,cells,0,1
34591,were,0,0
34592,examined,0,0
34593,for,0,0
34594,DNA,0,1
34595,single-strand,0,1
34596,breaks,0,1
34597,by,0,0
34598,alkaline,0,1
34599,gel,0,0
34600,electrophoresis,0,1
34601,",",0,0
34602,and,0,1
34603,the,0,0
34604,distribution,0,1
34605,of,0,0
34606,values,0,1
34607,was,0,0
34608,quantified,0,0
34609,using,0,0
34610,median,0,1
34611,tail,0,1
34612,moment,0,1
34613,(,0,1
34614,MTM,0,0
34615,),0,0
34616,.,0,0
34617,Nonirradiated,0,0
34618,tumor,0,0
34619,cells,0,1
34620,from,0,0
34621,pretreatment,0,0
34622,fine-needle,0,0
34623,aspirates,0,1
34624,received,0,0
34625,5,0,0
34626,Gy,0,0
34627,in,0,0
34628,vitro,0,0
34629,to,0,0
34630,establish,0,0
34631,the,0,0
34632,oxygenated,0,1
34633,response,0,1
34634,.,0,0
34635,RESULTS,0,0
34636,There,0,0
34637,was,0,0
34638,a,0,0
34639,significant,0,0
34640,correlation,0,0
34641,between,0,0
34642,the,0,0
34643,1-,0,0
34644,and,0,0
34645,2-min,0,1
34646,MTM,0,0
34647,(,0,0
34648,slope,0,1
34649,=,0,0
34650,0.77,0,0
34651,+/-,0,0
34652,0.03,0,0
34653,),0,0
34654,.,0,0
34655,There,0,0
34656,was,0,0
34657,no,0,0
34658,relationship,0,0
34659,between,0,0
34660,DNA,1,1
34661,damage,1,1
34662,in,1,0
34663,tumor,1,1
34664,cells,1,1
34665,irradiated,0,0
34666,in,0,0
34667,vitro,0,0
34668,and,0,1
34669,in,0,0
34670,vivo,0,0
34671,.,0,0
34672,No,0,0
34673,correlation,0,0
34674,was,0,0
34675,found,0,0
34676,between,0,0
34677,Eppendorf,1,0
34678,PO2,1,1
34679,measurements,1,1
34680,and,1,1
34681,comet,1,1
34682,MTM,1,0
34683,.,1,0
34684,There,0,0
34685,was,0,0
34686,a,0,0
34687,statistically,0,0
34688,significant,0,0
34689,correlation,0,0
34690,between,0,0
34691,the,0,0
34692,treatment,0,0
34693,response,0,1
34694,in,0,0
34695,the,0,0
34696,node,0,0
34697,studied,0,0
34698,and,0,1
34699,comet,0,1
34700,MTMs,0,0
34701,",",0,0
34702,whereas,0,0
34703,no,0,0
34704,correlation,0,0
34705,was,0,0
34706,observed,0,0
34707,between,0,0
34708,treatment,0,0
34709,response,0,1
34710,and,0,1
34711,Eppendorf,0,0
34712,measurements,0,1
34713,.,0,0
34714,CONCLUSIONS,0,0
34715,Comet,0,0
34716,assays,0,0
34717,are,0,0
34718,reproducible,0,0
34719,",",0,0
34720,as,0,0
34721,shown,0,0
34722,by,0,0
34723,biopsies,0,0
34724,at,0,0
34725,1,0,0
34726,and,0,0
34727,2,0,0
34728,min,0,0
34729,.,0,0
34730,Intertumor,0,1
34731,variation,0,1
34732,in,0,0
34733,the,0,0
34734,MTM,0,0
34735,is,0,0
34736,not,0,0
34737,a,0,0
34738,result,0,0
34739,of,0,0
34740,intrinsic,0,1
34741,radiosensitivity,0,1
34742,but,0,0
34743,of,0,1
34744,tumor,0,1
34745,hypoxia,0,0
34746,.,0,0
34747,There,0,0
34748,was,0,0
34749,no,0,0
34750,correlation,0,0
34751,between,0,0
34752,Eppendorf,0,0
34753,PO2,0,1
34754,measurements,0,1
34755,and,0,1
34756,comet,0,1
34757,MTM,0,0
34758,.,0,1
34759,Comet,0,0
34760,assays,0,1
34761,were,0,0
34762,better,0,0
34763,than,0,0
34764,Eppendorf,0,0
34765,in,0,0
34766,predicting,0,1
34767,treatment,0,0
34768,response,0,1
34769,as,0,0
34770,an,0,0
34771,end,0,0
34772,point,0,0
34773,for,0,0
34774,short-term,0,0
34775,outcome,0,1
34776,.,0,0
34777,Longer,0,0
34778,follow-up,0,0
34779,is,0,0
34780,needed,0,0
34781,to,0,0
34782,determine,0,0
34783,the,0,0
34784,role,0,0
34785,of,0,0
34786,the,0,0
34787,comet,0,1
34788,assay,0,0
34789,as,0,0
34790,a,0,0
34791,predictor,0,0
34792,for,0,0
34793,locoregional,0,0
34794,tumor,0,1
34795,control,0,0
34796,and,0,1
34797,survivals,0,1
34798,.,0,0
34799,The,0,0
34800,utility,0,0
34801,of,0,0
34802,laparoscopy,0,0
34803,in,0,0
34804,the,0,0
34805,diagnosis,0,0
34806,of,0,0
34807,acute,0,0
34808,appendicitis,0,0
34809,in,0,0
34810,women,0,0
34811,of,0,0
34812,reproductive,0,0
34813,age,0,0
34814,.,0,0
34815,AIM,0,0
34816,To,0,0
34817,see,0,0
34818,whether,0,0
34819,laparoscopy,0,0
34820,improves,0,0
34821,the,0,0
34822,accuracy,0,1
34823,of,0,0
34824,a,0,0
34825,clinical,0,0
34826,diagnosis,0,0
34827,of,0,1
34828,acute,0,0
34829,appendicitis,0,0
34830,in,0,0
34831,women,0,0
34832,of,0,0
34833,reproductive,0,1
34834,age,0,0
34835,",",0,0
34836,and,0,0
34837,to,0,0
34838,determine,0,0
34839,what,0,0
34840,the,0,0
34841,long-term,0,0
34842,sequelae,0,1
34843,are,0,0
34844,of,0,0
34845,not,0,0
34846,removing,0,0
34847,an,0,0
34848,appendix,0,0
34849,deemed,0,1
34850,at,0,0
34851,laparoscopy,0,0
34852,to,0,0
34853,be,0,0
34854,normal,0,0
34855,.,0,0
34856,METHOD,0,0
34857,The,0,0
34858,initial,0,0
34859,part,0,0
34860,of,0,0
34861,the,0,0
34862,study,0,0
34863,was,0,0
34864,undertaken,0,0
34865,during,0,0
34866,1991-1992,0,0
34867,.,0,0
34868,Female,0,0
34869,patients,0,0
34870,between,0,0
34871,16,0,0
34872,and,0,0
34873,45,0,0
34874,years,0,0
34875,were,0,0
34876,eligible,0,0
34877,for,0,0
34878,inclusion,0,0
34879,once,0,0
34880,a,0,0
34881,clinical,0,0
34882,decision,0,1
34883,had,0,0
34884,been,0,0
34885,made,0,0
34886,to,0,0
34887,perform,0,0
34888,an,0,0
34889,appendicectomy,0,0
34890,for,0,0
34891,suspected,0,0
34892,acute,0,0
34893,appendicitis,0,0
34894,.,0,0
34895,Following,0,1
34896,consent,0,1
34897,",",0,1
34898,patients,0,0
34899,were,0,0
34900,randomized,0,0
34901,into,0,0
34902,two,0,0
34903,groups,0,0
34904,.,0,0
34905,One,0,0
34906,group,0,0
34907,had,0,0
34908,open,0,0
34909,appendicectomy,0,0
34910,",",0,0
34911,as,0,0
34912,planned,0,0
34913,.,0,0
34914,The,0,0
34915,other,0,0
34916,group,0,0
34917,had,0,0
34918,laparoscopy,0,0
34919,",",0,0
34920,followed,0,0
34921,by,0,0
34922,open,0,0
34923,appendicectomy,0,0
34924,only,0,0
34925,if,0,0
34926,the,0,0
34927,appendix,0,0
34928,was,0,0
34929,seen,0,0
34930,to,0,0
34931,be,0,0
34932,inflamed,0,0
34933,or,0,0
34934,was,0,0
34935,not,0,0
34936,visualized,0,0
34937,.,0,0
34938,The,0,0
34939,end,0,0
34940,points,0,0
34941,for,0,0
34942,the,0,0
34943,study,0,0
34944,were,0,0
34945,the,0,0
34946,clinical,0,0
34947,outcomes,0,1
34948,of,0,0
34949,all,0,0
34950,patients,0,0
34951,",",0,0
34952,and,0,0
34953,the,0,0
34954,results,0,0
34955,of,0,1
34956,histology,1,1
34957,",",0,0
34958,where,0,0
34959,appropriate,0,0
34960,.,0,0
34961,An,0,0
34962,attempt,0,0
34963,was,0,0
34964,made,0,0
34965,to,0,0
34966,contact,0,0
34967,all,0,0
34968,patients,0,0
34969,at,0,0
34970,10,0,0
34971,years,0,0
34972,to,0,0
34973,determine,0,0
34974,whether,0,0
34975,they,0,0
34976,had,0,0
34977,had,0,0
34978,a,0,0
34979,subsequent,0,0
34980,appendicectomy,0,0
34981,",",0,1
34982,or,0,1
34983,had,0,0
34984,been,0,0
34985,diagnosed,0,0
34986,with,0,0
34987,another,0,0
34988,abdominal,0,1
34989,condition,0,0
34990,that,0,0
34991,might,0,0
34992,be,0,0
34993,relevant,0,0
34994,to,0,0
34995,the,0,0
34996,initial,0,0
34997,presentation,0,1
34998,in,0,0
34999,1991-1992,0,0
35000,.,0,0
35001,RESULTS,0,0
35002,Laparoscopic,0,0
35003,assessment,0,1
35004,was,0,0
35005,correct,0,0
35006,in,0,0
35007,all,0,0
35008,cases,0,0
35009,in,0,0
35010,which,0,0
35011,the,0,0
35012,appendix,0,0
35013,was,0,0
35014,visualized,0,0
35015,.,0,0
35016,Diagnostic,1,0
35017,accuracy,1,1
35018,was,0,0
35019,improved,0,0
35020,from,0,0
35021,75,0,0
35022,%,0,0
35023,to,0,0
35024,97,0,0
35025,%,0,0
35026,.,0,0
35027,Laparoscopy,0,0
35028,was,0,0
35029,associated,0,0
35030,with,0,0
35031,no,1,0
35032,added,1,0
35033,complications,1,1
35034,",",1,0
35035,no,1,0
35036,increase,1,1
35037,in,1,0
35038,hospital,1,1
35039,stay,1,1
35040,in,0,0
35041,patients,0,0
35042,who,0,0
35043,went,0,0
35044,on,0,0
35045,to,0,0
35046,appendicectomy,0,0
35047,",",0,0
35048,and,0,0
35049,a,0,0
35050,reduction,1,1
35051,in,1,0
35052,hospital,1,1
35053,stay,1,1
35054,for,0,0
35055,those,0,0
35056,who,0,0
35057,underwent,0,0
35058,laparoscopy,0,0
35059,alone,0,0
35060,.,0,0
35061,No,0,0
35062,patients,0,0
35063,developed,0,0
35064,a,0,0
35065,problem,0,0
35066,over,0,0
35067,the,0,0
35068,10-year,0,1
35069,follow-up,0,0
35070,period,0,0
35071,from,0,0
35072,having,0,0
35073,a,0,0
35074,normal-looking,0,0
35075,appendix,0,0
35076,not,0,0
35077,removed,0,0
35078,at,0,0
35079,laparoscopy,0,0
35080,.,0,0
35081,CONCLUSION,0,0
35082,Laparoscopic,0,0
35083,assessment,0,0
35084,of,0,0
35085,the,0,0
35086,appendix,0,0
35087,is,0,0
35088,reliable,0,1
35089,",",0,0
35090,and,0,0
35091,to,0,0
35092,leave,0,0
35093,a,0,0
35094,normal-looking,0,0
35095,appendix,0,0
35096,at,0,0
35097,laparoscopy,0,0
35098,does,0,0
35099,not,0,0
35100,appear,0,0
35101,to,0,0
35102,cause,0,0
35103,any,0,0
35104,long-term,0,0
35105,problems,0,0
35106,.,0,0
35107,Preservative-free,0,0
35108,ocular,0,1
35109,hydrating,0,0
35110,agents,0,0
35111,in,0,0
35112,symptomatic,0,0
35113,contact,0,0
35114,lens,0,0
35115,wearers,0,0
35116,:,0,0
35117,saline,0,0
35118,versus,0,0
35119,PVP,0,1
35120,solution,0,0
35121,.,0,0
35122,PURPOSE,0,0
35123,To,0,0
35124,compare,0,0
35125,two,0,0
35126,preservative-free,0,0
35127,hydrating,0,0
35128,agents,0,0
35129,",",0,0
35130,in,0,0
35131,multidose,0,0
35132,(,0,1
35133,ABAK,0,1
35134,),0,1
35135,bottles,0,0
35136,",",0,0
35137,in,0,0
35138,contact,0,1
35139,lens,0,0
35140,wearers,0,0
35141,experiencing,0,1
35142,symptoms,0,1
35143,of,0,0
35144,ocular,1,1
35145,dryness,1,1
35146,.,1,0
35147,METHODS,0,0
35148,The,0,0
35149,endpoint,0,0
35150,of,0,0
35151,this,0,0
35152,4-week,0,0
35153,multicenter,0,0
35154,",",0,1
35155,randomized,0,0
35156,",",0,0
35157,double-blind,0,0
35158,",",0,1
35159,parallel-group,0,0
35160,study,0,0
35161,comparing,0,0
35162,a,0,0
35163,2,0,0
35164,%,0,0
35165,polyvinylpyrrolidone,0,0
35166,(,0,1
35167,PVP,0,1
35168,),0,1
35169,solution,0,0
35170,with,0,0
35171,a,0,0
35172,0.9,0,0
35173,%,0,0
35174,NaCl,0,1
35175,solution,0,0
35176,was,0,0
35177,to,0,0
35178,assess,0,0
35179,ocular,0,1
35180,discomfort,0,1
35181,using,0,0
35182,a,0,0
35183,visual,0,1
35184,analog,0,1
35185,scale,0,1
35186,.,0,0
35187,A,0,0
35188,biomicroscopic,0,1
35189,examination,0,0
35190,and,0,0
35191,a,0,0
35192,test,0,1
35193,of,0,0
35194,tolerability,0,1
35195,on,0,0
35196,instillation,0,0
35197,were,0,0
35198,also,0,0
35199,performed,0,0
35200,",",0,0
35201,and,0,1
35202,adverse,0,1
35203,events,0,1
35204,were,0,0
35205,recorded,0,0
35206,.,0,0
35207,RESULTS,0,0
35208,Thirty-nine,0,0
35209,subjects,0,0
35210,were,0,0
35211,enrolled,0,0
35212,(,0,0
35213,23,0,0
35214,PVP,0,0
35215,;,0,0
35216,16,0,0
35217,NaCl,0,0
35218,),0,0
35219,.,0,0
35220,The,0,0
35221,average,0,1
35222,age,0,0
35223,was,0,0
35224,30,0,0
35225,;,0,0
35226,subjects,0,0
35227,were,0,0
35228,predominantly,0,0
35229,female,0,0
35230,",",0,0
35231,and,0,1
35232,mostly,0,0
35233,wore,0,0
35234,frequent-replacement,0,0
35235,contact,0,1
35236,lenses,0,0
35237,.,0,0
35238,They,0,0
35239,were,0,0
35240,all,0,0
35241,exposed,0,0
35242,to,0,0
35243,environmental,0,0
35244,factors,0,1
35245,such,0,0
35246,as,0,0
35247,routine,0,0
35248,use,0,0
35249,of,0,1
35250,video,0,0
35251,monitors,0,0
35252,or,0,1
35253,air,0,0
35254,conditioning,0,0
35255,.,0,0
35256,The,0,0
35257,two,0,0
35258,groups,0,0
35259,were,0,0
35260,similar,0,0
35261,at,0,0
35262,baseline,0,1
35263,(,0,1
35264,D0,0,1
35265,),0,0
35266,.,0,0
35267,Both,0,0
35268,PVP,0,1
35269,and,0,1
35270,NaCl,0,1
35271,improved,0,1
35272,the,0,0
35273,comfort,1,1
35274,of,1,0
35275,contact,1,0
35276,lens,1,0
35277,wear,1,1
35278,(,0,0
35279,P,0,0
35280,=,0,0
35281,0.0003,0,0
35282,),0,0
35283,",",0,0
35284,with,0,0
35285,no,0,0
35286,difference,0,0
35287,between,0,0
35288,them,0,0
35289,(,0,0
35290,P,0,0
35291,=,0,0
35292,0.25,0,0
35293,),0,0
35294,.,0,0
35295,The,0,0
35296,mean,1,1
35297,daily,1,0
35298,duration,1,1
35299,of,1,0
35300,lens,1,0
35301,wear,1,1
35302,and,1,0
35303,the,1,0
35304,daily,1,0
35305,number,1,1
35306,of,1,0
35307,instillations,1,0
35308,to,1,0
35309,relieve,1,0
35310,discomfort,1,1
35311,(,0,0
35312,4.2,0,0
35313,+/-,0,0
35314,2.0,0,0
35315,for,0,0
35316,PVP,0,0
35317,ABAK,0,1
35318,;,0,0
35319,4.6,0,0
35320,+/-,0,0
35321,1.9,0,0
35322,for,0,0
35323,NaCl,0,0
35324,ABAK,0,1
35325,),0,1
35326,were,0,0
35327,comparable,0,0
35328,.,0,0
35329,However,0,0
35330,",",0,0
35331,PVP,0,1
35332,use,0,1
35333,led,0,0
35334,to,0,0
35335,more,0,0
35336,favorable,0,1
35337,evolution,0,1
35338,of,0,1
35339,fluorescein-staining,1,0
35340,corneal,1,1
35341,punctuations,1,1
35342,(,0,0
35343,P,0,0
35344,=,0,0
35345,0.028,0,0
35346,),0,0
35347,.,0,0
35348,Safety,1,1
35349,was,0,0
35350,good,0,0
35351,",",0,0
35352,with,0,0
35353,minimal,0,1
35354,adverse,1,1
35355,events,1,1
35356,considered,0,0
35357,unrelated,0,0
35358,to,0,0
35359,the,0,0
35360,products,0,0
35361,.,0,0
35362,Lens,1,0
35363,wettability,1,1
35364,was,0,0
35365,excellent,0,1
35366,",",0,1
35367,and,0,1
35368,there,0,0
35369,were,0,0
35370,no,0,0
35371,clinically,0,0
35372,relevant,0,0
35373,deposits,0,1
35374,.,0,0
35375,Most,0,0
35376,subjects,0,0
35377,also,0,0
35378,found,0,0
35379,the,0,0
35380,ABAK,0,1
35381,bottles,0,0
35382,convenient,0,0
35383,.,0,0
35384,CONCLUSIONS,0,0
35385,Ocular,0,1
35386,hydration,0,0
35387,improves,0,1
35388,comfort,1,1
35389,in,0,0
35390,contact,0,1
35391,lens,0,0
35392,wearers,0,0
35393,.,0,0
35394,NaCl,0,0
35395,is,0,0
35396,an,0,0
35397,appropriate,0,0
35398,first-line,0,0
35399,treatment,0,0
35400,",",0,1
35401,but,0,0
35402,for,0,0
35403,subjects,0,0
35404,with,0,0
35405,fluorescein-staining,0,0
35406,punctuations,0,1
35407,",",0,1
35408,lubrication,0,1
35409,with,0,0
35410,PVP,0,1
35411,is,0,0
35412,preferable,0,0
35413,.,0,0
35414,Stapled,0,1
35415,mucosectomy,0,0
35416,for,0,0
35417,acute,0,0
35418,thrombosed,0,0
35419,circumferentially,0,0
35420,prolapsed,0,0
35421,piles,0,0
35422,:,0,0
35423,a,0,0
35424,prospective,0,0
35425,randomized,0,0
35426,comparison,0,0
35427,with,0,0
35428,conventional,0,0
35429,haemorrhoidectomy,0,0
35430,.,0,0
35431,OBJECTIVE,0,1
35432,Stapled,0,1
35433,mucosectomy,0,0
35434,has,0,0
35435,been,0,0
35436,developed,0,0
35437,as,0,0
35438,an,0,0
35439,alternative,0,0
35440,to,0,0
35441,conventional,0,0
35442,haemorrhoidectomy,0,0
35443,for,0,0
35444,the,0,0
35445,elective,0,0
35446,treatment,0,0
35447,of,0,1
35448,haemorrhoids,0,1
35449,",",0,0
35450,but,0,0
35451,has,0,0
35452,not,0,0
35453,been,0,0
35454,assessed,0,0
35455,in,0,0
35456,the,0,0
35457,emergency,0,1
35458,setting,0,0
35459,.,0,0
35460,The,0,0
35461,aim,0,0
35462,of,0,0
35463,this,0,0
35464,study,0,0
35465,was,0,0
35466,to,0,0
35467,compare,0,0
35468,this,0,0
35469,technique,0,0
35470,with,0,0
35471,a,0,0
35472,conventional,0,0
35473,procedure,0,0
35474,for,0,0
35475,acute,0,0
35476,thrombosed,0,0
35477,circumferential,0,1
35478,prolapsed,0,0
35479,haemorrhoids,0,0
35480,.,0,1
35481,PATIENTS,0,0
35482,AND,0,0
35483,METHODS,0,0
35484,A,0,0
35485,prospective,0,0
35486,randomized,0,0
35487,comparison,0,0
35488,of,0,0
35489,conventional,0,0
35490,Milligan-Morgan,0,1
35491,haemorrhoidectomy,0,0
35492,and,0,1
35493,stapled,0,1
35494,mucosectomy,0,0
35495,was,0,0
35496,carried,0,0
35497,out,0,0
35498,on,0,0
35499,35,0,0
35500,consecutive,0,0
35501,patients,0,0
35502,presenting,0,1
35503,with,0,0
35504,acute,0,0
35505,thrombosed,0,0
35506,circumferential,0,1
35507,prolapsed,0,0
35508,haemorrhoids,0,0
35509,.,0,0
35510,Operative,1,1
35511,data,1,0
35512,",",1,1
35513,postoperative,1,1
35514,stay,1,1
35515,",",1,1
35516,pain,1,1
35517,assessment,1,1
35518,and,1,1
35519,persistent,1,1
35520,symptoms,1,1
35521,were,0,0
35522,compared,0,0
35523,at,0,0
35524,discharge,0,0
35525,and,0,0
35526,at,0,0
35527,2,0,0
35528,week,0,0
35529,and,0,0
35530,6,0,0
35531,week,0,0
35532,review,0,0
35533,.,0,0
35534,Additionally,0,0
35535,at,0,0
35536,6,0,0
35537,week,0,0
35538,review,0,0
35539,the,0,0
35540,time,0,1
35541,to,0,0
35542,return,0,1
35543,to,0,0
35544,work,0,1
35545,was,0,0
35546,recorded,0,0
35547,and,0,0
35548,an,0,0
35549,endoanal,1,1
35550,ultrasound,1,1
35551,was,0,0
35552,carried,0,0
35553,out,0,0
35554,.,0,0
35555,RESULTS,0,0
35556,Thirty,0,0
35557,patients,0,0
35558,were,0,0
35559,randomized,0,0
35560,and,0,0
35561,followed,0,0
35562,up,0,0
35563,for,0,0
35564,six,0,0
35565,weeks,0,0
35566,.,0,0
35567,Although,0,0
35568,postoperative,1,1
35569,stay,1,1
35570,and,1,1
35571,in-hospital,1,1
35572,analgesia,1,1
35573,were,0,0
35574,the,0,0
35575,same,0,0
35576,",",0,0
35577,patients,0,0
35578,from,0,0
35579,the,0,0
35580,stapled,0,1
35581,group,0,0
35582,reported,0,0
35583,significantly,0,0
35584,more,0,0
35585,pain,0,1
35586,at,0,0
35587,discharge,0,0
35588,.,0,0
35589,However,0,0
35590,",",0,0
35591,by,0,0
35592,2,0,0
35593,weeks,0,0
35594,the,0,0
35595,conventional,0,0
35596,group,0,0
35597,reported,0,0
35598,significantly,0,0
35599,higher,1,0
35600,pain,1,1
35601,scores,1,1
35602,particularly,0,0
35603,on,0,0
35604,passing,0,1
35605,stool,0,1
35606,.,0,0
35607,By,0,0
35608,this,0,0
35609,stage,0,0
35610,over,0,0
35611,half,0,0
35612,the,0,0
35613,stapled,0,1
35614,group,0,0
35615,patients,0,0
35616,reported,0,0
35617,no,1,0
35618,pain,1,1
35619,at,0,0
35620,all,0,0
35621,.,0,0
35622,More,0,0
35623,patients,0,0
35624,in,0,0
35625,the,0,0
35626,conventional,0,0
35627,group,0,0
35628,complained,0,0
35629,of,0,0
35630,persistent,1,1
35631,symptoms,1,1
35632,of,1,1
35633,pain,1,1
35634,",",1,1
35635,bleeding,1,1
35636,and,1,1
35637,discharge,1,1
35638,at,0,0
35639,2,0,0
35640,week,0,0
35641,and,0,0
35642,6,0,0
35643,week,0,0
35644,review,0,0
35645,with,0,0
35646,20,0,0
35647,%,0,0
35648,requiring,0,0
35649,readmission,0,1
35650,compared,0,0
35651,with,0,0
35652,none,0,0
35653,in,0,0
35654,the,0,0
35655,stapled,0,0
35656,group,0,0
35657,.,0,0
35658,The,0,0
35659,median,1,1
35660,return,1,1
35661,to,1,0
35662,work,1,1
35663,was,1,0
35664,significantly,1,0
35665,shorter,1,0
35666,for,0,0
35667,the,0,0
35668,stapled,0,1
35669,group,0,0
35670,(,0,0
35671,14,0,0
35672,days,0,0
35673,vs,0,0
35674,28,0,0
35675,days,0,0
35676,",",0,0
35677,P,0,0
35678,<,0,0
35679,0.05,0,0
35680,),0,0
35681,.,0,0
35682,Although,0,0
35683,all,0,0
35684,patients,0,0
35685,claimed,0,0
35686,to,0,0
35687,be,0,0
35688,continent,0,0
35689,",",0,0
35690,two,0,0
35691,patients,0,0
35692,from,0,0
35693,each,0,0
35694,group,0,0
35695,had,0,0
35696,ultrasonic,0,1
35697,evidence,0,0
35698,of,0,1
35699,internal,1,0
35700,sphincter,1,1
35701,damage,1,1
35702,.,1,1
35703,CONCLUSION,0,0
35704,Stapled,0,1
35705,mucosectomy,0,0
35706,for,0,0
35707,acute,0,0
35708,thrombosed,0,0
35709,circumferential,0,1
35710,piles,0,0
35711,is,0,0
35712,feasible,0,0
35713,and,0,0
35714,may,0,0
35715,result,0,0
35716,in,0,0
35717,less,1,0
35718,pain,1,1
35719,",",0,0
35720,a,0,0
35721,more,0,0
35722,rapid,0,1
35723,resolution,0,1
35724,of,0,1
35725,symptoms,0,1
35726,and,0,0
35727,an,0,0
35728,earlier,0,0
35729,return,0,1
35730,to,0,0
35731,work,0,1
35732,compared,0,0
35733,with,0,0
35734,a,0,0
35735,conventional,0,0
35736,procedure,0,0
35737,.,0,0
35738,A,0,0
35739,randomized,0,0
35740,trial,0,0
35741,of,0,0
35742,the,0,0
35743,canalith,0,1
35744,repositioning,0,1
35745,procedure,0,0
35746,.,0,0
35747,OBJECTIVE,0,0
35748,To,0,0
35749,compare,0,0
35750,the,0,0
35751,effectiveness,1,1
35752,and,1,1
35753,complications,1,1
35754,of,1,0
35755,our,1,0
35756,adaptation,1,1
35757,of,1,0
35758,the,1,0
35759,canalith,1,1
35760,repositioning,1,1
35761,procedure,1,0
35762,(,1,1
35763,CRP,1,1
35764,),1,0
35765,with,0,0
35766,the,0,0
35767,expectation,0,1
35768,treatment,0,0
35769,for,0,0
35770,benign,0,0
35771,paroxysmal,0,1
35772,positional,0,1
35773,vertigo,0,1
35774,.,0,0
35775,STUDY,0,0
35776,DESIGN,0,0
35777,A,0,0
35778,randomized,0,0
35779,",",0,1
35780,controlled,0,0
35781,trial,0,0
35782,in,0,0
35783,the,0,0
35784,setting,0,0
35785,of,0,0
35786,a,0,0
35787,neurotological,0,0
35788,clinic,0,0
35789,in,0,0
35790,Thailand,0,0
35791,.,0,0
35792,METHODS,0,0
35793,Fifty-eight,0,0
35794,patients,0,0
35795,with,0,0
35796,posterior,0,0
35797,benign,0,0
35798,paroxysmal,0,1
35799,positional,0,1
35800,vertigo,0,1
35801,were,0,0
35802,randomly,0,0
35803,assigned,0,0
35804,to,0,0
35805,treatment,0,0
35806,and,0,1
35807,control,0,0
35808,groups,0,0
35809,using,0,0
35810,a,0,0
35811,block,0,0
35812,of,0,0
35813,four,0,0
35814,.,0,0
35815,The,0,0
35816,treatment,0,0
35817,group,0,0
35818,was,0,0
35819,treated,0,0
35820,with,0,0
35821,the,0,0
35822,modified,0,0
35823,CRP,0,1
35824,technique,0,0
35825,until,0,0
35826,the,0,0
35827,nystagmus,0,1
35828,disappeared,0,0
35829,.,0,0
35830,A,0,0
35831,mastoid,0,1
35832,oscillator,0,1
35833,was,0,0
35834,not,0,0
35835,used,0,0
35836,",",0,0
35837,nor,0,0
35838,were,0,0
35839,any,0,0
35840,instructions,0,1
35841,given,0,0
35842,for,0,0
35843,patients,0,0
35844,after,0,0
35845,the,0,0
35846,maneuver,0,0
35847,.,0,0
35848,Both,0,0
35849,groups,0,0
35850,recorded,0,0
35851,the,0,0
35852,daily,1,0
35853,grading,1,1
35854,of,1,1
35855,symptoms,1,1
35856,and,1,0
35857,the,1,0
35858,amount,1,1
35859,of,1,0
35860,anti-vertiginous,1,1
35861,drugs,1,0
35862,(,1,1
35863,cinnarizine,1,0
35864,),1,0
35865,taken,1,0
35866,.,1,0
35867,Objective,1,1
35868,and,1,1
35869,subjective,1,1
35870,assessments,1,0
35871,were,0,0
35872,made,0,0
35873,weekly,0,0
35874,until,0,0
35875,the,0,0
35876,nystagmus,1,1
35877,disappeared,0,0
35878,or,0,0
35879,until,0,0
35880,4,0,0
35881,weeks,0,0
35882,had,0,0
35883,passed,0,1
35884,since,0,0
35885,treatment,0,0
35886,began,0,0
35887,.,0,0
35888,RESULTS,0,0
35889,The,0,0
35890,rates,1,1
35891,of,1,0
35892,effectiveness,1,1
35893,of,1,1
35894,CRP,1,1
35895,treatment,1,0
35896,and,0,0
35897,the,0,0
35898,control,0,0
35899,treatment,0,0
35900,for,0,0
35901,benign,0,0
35902,paroxysmal,0,1
35903,positional,0,1
35904,vertigo,0,1
35905,were,0,0
35906,75.9,0,0
35907,%,0,0
35908,and,0,0
35909,48.2,0,0
35910,%,0,0
35911,",",0,0
35912,respectively,0,0
35913,.,0,0
35914,There,0,0
35915,was,0,0
35916,a,0,0
35917,significant,0,0
35918,difference,0,0
35919,in,0,0
35920,the,0,0
35921,treatment,0,0
35922,outcomes,0,1
35923,of,0,0
35924,the,0,0
35925,CRP,0,1
35926,and,0,1
35927,control,0,0
35928,groups,0,0
35929,(,0,0
35930,P,0,0
35931,=.03,0,0
35932,),0,0
35933,.,0,0
35934,The,0,0
35935,CRP,0,1
35936,group,0,0
35937,used,1,0
35938,significantly,1,0
35939,fewer,1,0
35940,drugs,1,0
35941,than,0,0
35942,the,0,0
35943,control,0,0
35944,group,0,0
35945,(,0,1
35946,P,0,0
35947,=.001,0,0
35948,),0,0
35949,.,0,0
35950,Complications,1,0
35951,in,0,0
35952,the,0,0
35953,CRP,0,1
35954,group,0,0
35955,",",0,1
35956,such,0,1
35957,as,0,0
35958,lateral,1,0
35959,canalithiasis,1,1
35960,and,1,1
35961,fainting,1,1
35962,",",0,1
35963,were,0,0
35964,observed,0,0
35965,in,0,0
35966,13.8,0,0
35967,%,0,0
35968,of,0,0
35969,the,0,0
35970,patients,0,0
35971,.,0,0
35972,CONCLUSIONS,0,0
35973,The,0,0
35974,CRP,0,0
35975,was,0,0
35976,more,0,0
35977,effective,0,1
35978,than,0,0
35979,the,0,0
35980,expectation,0,1
35981,treatment,0,0
35982,for,0,0
35983,benign,0,0
35984,paroxysmal,0,1
35985,positional,0,1
35986,vertigo,0,1
35987,insofar,0,0
35988,as,0,0
35989,it,0,0
35990,provided,0,0
35991,faster,0,1
35992,recovery,1,1
35993,and,0,1
35994,required,0,1
35995,less,0,0
35996,dependence,1,1
35997,on,1,0
35998,medication,1,0
35999,.,1,0
36000,Complications,1,1
36001,of,0,1
36002,CRP,0,1
36003,were,0,0
36004,limited,0,0
36005,to,0,0
36006,13.8,0,0
36007,%,0,0
36008,of,0,0
36009,patients,0,0
36010,.,0,0
36011,Prevention,0,0
36012,of,0,1
36013,coronary,0,1
36014,spasm,0,1
36015,by,0,0
36016,nicorandil,0,0
36017,:,0,0
36018,comparison,0,0
36019,with,0,0
36020,nifedipine,0,0
36021,.,0,0
36022,The,0,0
36023,efficacy,0,1
36024,of,0,1
36025,nicorandil,0,0
36026,was,0,0
36027,compared,0,0
36028,with,0,0
36029,that,0,0
36030,of,0,0
36031,nifedipine,0,0
36032,in,0,0
36033,13,0,0
36034,patients,0,0
36035,with,0,0
36036,vasospastic,0,1
36037,angina,0,0
36038,enrolled,0,0
36039,in,0,0
36040,a,0,0
36041,randomized,0,0
36042,",",0,0
36043,placebo-controlled,0,0
36044,",",0,1
36045,crossover,0,0
36046,study,0,0
36047,.,0,0
36048,All,0,0
36049,patients,0,0
36050,had,0,0
36051,a,0,0
36052,coronary,0,0
36053,spasm,0,1
36054,during,0,0
36055,coronary,0,1
36056,arteriography,0,1
36057,",",0,1
36058,either,0,0
36059,spontaneously,0,0
36060,or,0,0
36061,ergometrine-induced,0,1
36062,.,0,0
36063,During,0,0
36064,two,0,0
36065,consecutive,0,0
36066,periods,0,0
36067,of,0,0
36068,2,0,0
36069,days,0,0
36070,",",0,0
36071,patients,0,0
36072,received,0,0
36073,active,0,0
36074,drugs,0,0
36075,or,0,1
36076,placebo,0,0
36077,in,0,0
36078,a,0,0
36079,randomized,0,0
36080,order,0,0
36081,.,0,0
36082,Each,0,0
36083,patient,0,1
36084,received,0,0
36085,single,0,0
36086,oral,0,0
36087,doses,0,0
36088,of,0,0
36089,30,0,0
36090,mg,0,0
36091,nicorandil,0,0
36092,",",0,0
36093,10,0,0
36094,mg,0,0
36095,nifedipine,0,0
36096,",",0,1
36097,and,0,1
36098,",",0,0
36099,on,0,0
36100,2,0,0
36101,days,0,0
36102,",",0,0
36103,a,0,0
36104,placebo,0,0
36105,.,0,0
36106,One,0,0
36107,hour,0,0
36108,after,0,0
36109,drug,0,0
36110,intake,0,1
36111,",",0,1
36112,patients,0,0
36113,underwent,0,0
36114,an,0,0
36115,ergometrine,0,0
36116,test,0,0
36117,with,0,0
36118,increasing,0,0
36119,doses,0,0
36120,of,0,1
36121,Methergin,0,0
36122,(,0,1
36123,ergometrine,0,1
36124,),0,0
36125,(,0,0
36126,0.05,0,0
36127,",",0,0
36128,0.10,0,0
36129,",",0,0
36130,0.20,0,0
36131,",",0,0
36132,and,0,0
36133,0.40,0,0
36134,mg,0,0
36135,every,0,0
36136,5,0,0
36137,min,0,0
36138,),0,0
36139,.,0,0
36140,After,0,0
36141,placebo,0,0
36142,",",0,0
36143,the,0,0
36144,tests,0,1
36145,always,0,0
36146,were,0,0
36147,positive,0,1
36148,",",0,0
36149,and,0,0
36150,the,0,0
36151,ECG,1,1
36152,changes,1,1
36153,occurred,0,0
36154,at,0,0
36155,the,0,0
36156,same,0,0
36157,+/-,0,0
36158,1,0,0
36159,dose,0,0
36160,of,0,0
36161,ergometrine,0,0
36162,in,0,0
36163,10,0,0
36164,cases,0,0
36165,",",0,0
36166,showing,0,0
36167,good,1,0
36168,reproducibility,1,1
36169,.,1,0
36170,After,0,0
36171,nicorandil,0,0
36172,",",0,0
36173,the,0,0
36174,tests,0,1
36175,were,0,0
36176,negative,0,1
36177,in,0,0
36178,nine,0,0
36179,patients,0,0
36180,and,0,0
36181,positive,0,1
36182,for,0,0
36183,a,0,0
36184,higher,0,0
36185,or,0,0
36186,lower,0,1
36187,dose,0,1
36188,of,0,1
36189,ergometrine,0,0
36190,in,0,0
36191,three,0,0
36192,and,0,0
36193,one,0,0
36194,patient,0,0
36195,",",0,0
36196,respectively,0,0
36197,(,0,0
36198,p,0,0
36199,=,0,0
36200,0.0034,0,0
36201,vs.,0,0
36202,placebo,0,0
36203,),0,0
36204,.,0,0
36205,After,0,0
36206,nifedipine,0,0
36207,",",0,0
36208,the,0,0
36209,tests,0,1
36210,were,0,0
36211,negative,0,1
36212,in,0,0
36213,five,0,0
36214,patients,0,0
36215,and,0,0
36216,positive,0,1
36217,for,0,0
36218,a,0,0
36219,higher,0,0
36220,or,0,0
36221,the,0,0
36222,same,0,0
36223,dose,0,0
36224,of,0,1
36225,ergometrine,0,0
36226,in,0,0
36227,four,0,0
36228,and,0,0
36229,four,0,0
36230,patients,0,0
36231,",",0,0
36232,respectively,0,0
36233,(,0,0
36234,p,0,0
36235,=,0,0
36236,0.0039,0,0
36237,vs.,0,0
36238,placebo,0,0
36239,),0,0
36240,.,0,1
36241,Nifedipine,0,0
36242,(,0,0
36243,10,0,0
36244,mg,0,0
36245,),0,0
36246,and,0,1
36247,nicorandil,0,0
36248,(,0,0
36249,30,0,0
36250,mg,0,0
36251,),0,0
36252,were,0,0
36253,equally,0,0
36254,effective,0,0
36255,in,0,0
36256,eight,0,0
36257,patients,0,0
36258,;,0,0
36259,in,0,0
36260,the,0,0
36261,remaining,0,0
36262,five,0,0
36263,patients,0,0
36264,",",0,0
36265,nicorandil,0,0
36266,had,0,0
36267,better,0,0
36268,results,0,0
36269,(,0,1
36270,p,0,0
36271,=,0,0
36272,0.06,0,0
36273,),0,0
36274,.,0,0
36275,Nicorandil,0,0
36276,(,0,0
36277,30,0,0
36278,mg,0,0
36279,),0,0
36280,prevents,0,0
36281,ergometrine-induced,1,1
36282,coronary,1,0
36283,spasm,1,0
36284,.,1,0
36285,This,0,0
36286,compound,0,0
36287,may,0,0
36288,be,0,0
36289,beneficial,0,0
36290,in,0,0
36291,patients,0,0
36292,with,0,0
36293,vasospastic,1,1
36294,angina,1,0
36295,.,1,0
36296,Left,0,1
36297,ventricular,0,1
36298,mass,0,1
36299,regression,0,0
36300,in,0,0
36301,elderly,0,0
36302,hypertensives,0,0
36303,.,0,0
36304,It,0,0
36305,is,0,0
36306,now,0,0
36307,recognized,0,0
36308,that,0,0
36309,left,0,1
36310,ventricular,0,1
36311,hypertrophy,0,1
36312,(,0,1
36313,LVH,0,1
36314,),0,1
36315,",",0,0
36316,often,0,0
36317,associated,0,0
36318,with,0,0
36319,hypertension,0,0
36320,",",0,0
36321,is,0,0
36322,itself,0,0
36323,a,0,0
36324,risk,0,1
36325,factor,0,1
36326,for,0,0
36327,coronary,0,1
36328,disease,0,0
36329,in,0,0
36330,the,0,0
36331,elderly,0,0
36332,.,0,0
36333,Although,0,0
36334,many,0,0
36335,agents,0,0
36336,are,0,0
36337,capable,0,1
36338,of,0,0
36339,controlling,0,0
36340,blood,0,1
36341,pressure,0,1
36342,",",0,0
36343,the,0,0
36344,ability,0,1
36345,of,0,0
36346,these,0,0
36347,agents,0,0
36348,to,0,0
36349,induce,0,0
36350,regression,0,0
36351,of,0,1
36352,left,0,1
36353,ventricular,0,1
36354,(,0,1
36355,LV,0,1
36356,),0,1
36357,mass,0,1
36358,",",0,0
36359,and,0,1
36360,the,0,0
36361,effect,0,1
36362,of,0,0
36363,regression,0,0
36364,on,0,0
36365,diastolic,0,1
36366,relaxation,0,1
36367,and,0,1
36368,contractile,0,1
36369,indices,0,1
36370,in,0,0
36371,the,0,0
36372,elderly,0,0
36373,are,0,0
36374,less,0,0
36375,well,0,0
36376,known,0,0
36377,.,0,0
36378,Our,0,0
36379,study,0,0
36380,compared,0,0
36381,the,0,0
36382,ability,0,0
36383,of,0,0
36384,the,0,0
36385,calcium,0,1
36386,blocker,0,0
36387,",",0,1
36388,verapamil,0,0
36389,",",0,1
36390,and,0,1
36391,the,0,0
36392,beta-blocker,0,0
36393,",",0,1
36394,atenolol,0,0
36395,",",0,0
36396,to,0,0
36397,both,0,0
36398,control,0,0
36399,blood,1,1
36400,pressure,1,1
36401,(,1,1
36402,BP,1,1
36403,),1,0
36404,and,0,0
36405,to,0,0
36406,induce,0,0
36407,regression,1,0
36408,of,1,1
36409,LV,1,1
36410,mass,1,1
36411,in,0,0
36412,older,0,0
36413,hypertensives,0,0
36414,.,0,1
36415,In,0,0
36416,addition,0,0
36417,",",0,0
36418,the,0,0
36419,influence,0,1
36420,of,0,0
36421,regression,0,0
36422,on,0,0
36423,resting,0,1
36424,diastolic,0,1
36425,filling,0,1
36426,and,0,1
36427,on,0,0
36428,cardiac,0,1
36429,output,0,1
36430,and,0,1
36431,ejection,0,1
36432,fraction,0,1
36433,during,0,0
36434,rest,0,0
36435,and,0,1
36436,mild,0,1
36437,upright,0,0
36438,bicycle,0,0
36439,exercise,0,0
36440,were,0,0
36441,determined,0,0
36442,.,0,0
36443,Forty-two,0,0
36444,hypertensives,0,0
36445,60,0,0
36446,years,0,0
36447,of,0,0
36448,age,0,0
36449,or,0,1
36450,above,0,1
36451,",",0,1
36452,without,0,0
36453,evidence,0,0
36454,of,0,1
36455,ischemic,0,1
36456,disease,0,1
36457,underwent,0,0
36458,2-D,0,1
36459,echocardiographic,0,1
36460,evaluation,0,0
36461,of,0,1
36462,LV,0,1
36463,mass,0,1
36464,and,0,1
36465,gated,0,1
36466,blood,0,1
36467,pool,0,1
36468,scan,0,0
36469,determination,0,0
36470,of,0,1
36471,early,0,0
36472,diastolic,0,1
36473,filling,0,1
36474,",",0,1
36475,cardiac,0,1
36476,output,0,1
36477,and,0,1
36478,ejection,0,1
36479,fraction,0,1
36480,.,0,0
36481,They,0,0
36482,were,0,0
36483,then,0,0
36484,randomized,0,0
36485,to,0,0
36486,receive,0,0
36487,verapamil,0,0
36488,or,0,1
36489,atenolol,0,0
36490,during,0,0
36491,a,0,0
36492,four-week,0,0
36493,titration,0,0
36494,period,0,0
36495,so,0,0
36496,as,0,0
36497,to,0,0
36498,achieve,0,0
36499,a,0,0
36500,BP,1,1
36501,of,0,0
36502,less,0,0
36503,than,0,0
36504,160/90,0,0
36505,mm,0,0
36506,Hg,0,0
36507,.,0,0
36508,If,0,0
36509,BP,1,1
36510,was,0,0
36511,not,0,0
36512,controlled,0,0
36513,with,0,0
36514,either,0,0
36515,agent,0,0
36516,",",0,1
36517,chlorthalidone,0,0
36518,was,0,0
36519,added,0,0
36520,.,0,0
36521,Individuals,0,0
36522,whose,0,1
36523,BP,1,1
36524,was,0,0
36525,controlled,0,0
36526,continued,0,0
36527,on,0,0
36528,the,0,0
36529,protocol,0,0
36530,for,0,0
36531,six,0,0
36532,months,0,0
36533,.,0,0
36534,At,0,0
36535,that,0,0
36536,time,0,1
36537,",",0,0
36538,the,0,0
36539,echocardiographic,0,1
36540,and,0,1
36541,gated,0,1
36542,blood,0,1
36543,pool,0,1
36544,studies,0,0
36545,were,0,0
36546,repeated,0,0
36547,both,0,0
36548,on,0,0
36549,and,0,0
36550,after,0,0
36551,subsequent,0,1
36552,withdrawal,0,1
36553,of,0,0
36554,the,0,0
36555,study,0,0
36556,medications,0,0
36557,.,0,0
36558,Twenty-one,0,0
36559,patients,0,0
36560,were,0,0
36561,randomized,0,0
36562,to,0,0
36563,receive,0,0
36564,verapamil,0,0
36565,and,0,0
36566,21,0,0
36567,patients,0,0
36568,to,0,0
36569,receive,0,0
36570,atenolol,0,0
36571,.,0,1
36572,Blood,0,1
36573,pressure,0,1
36574,control,0,0
36575,was,0,0
36576,achieved,0,1
36577,with,0,0
36578,verapamil,0,0
36579,alone,0,0
36580,in,0,0
36581,18,0,0
36582,patients,0,0
36583,",",0,0
36584,but,0,0
36585,with,0,0
36586,atenolol,0,0
36587,alone,0,0
36588,in,0,0
36589,only,0,0
36590,8,0,0
36591,patients,0,0
36592,(,0,0
36593,p,0,0
36594,<,0,0
36595,0.01,0,0
36596,),0,0
36597,.,0,0
36598,(,0,0
36599,ABSTRACT,0,1
36600,TRUNCATED,0,0
36601,AT,0,0
36602,250,0,0
36603,WORDS,0,0
36604,),0,0
36605,Effects,0,0
36606,of,0,0
36607,pentoxifylline,0,0
36608,administration,0,0
36609,on,0,0
36610,urinary,0,1
36611,N-acetyl-beta-glucosaminidase,0,1
36612,excretion,0,1
36613,in,0,0
36614,type,0,0
36615,2,0,0
36616,diabetic,0,0
36617,patients,0,0
36618,:,0,0
36619,a,0,0
36620,short-term,0,0
36621,",",0,0
36622,prospective,0,0
36623,",",0,1
36624,randomized,0,0
36625,study,0,0
36626,.,0,0
36627,BACKGROUND,0,0
36628,Tubulointerstitial,0,1
36629,injury,0,0
36630,is,0,0
36631,a,0,0
36632,major,0,1
36633,feature,0,0
36634,of,0,1
36635,diabetic,0,0
36636,nephropathy,0,1
36637,and,0,0
36638,an,0,0
36639,important,0,1
36640,predictor,0,0
36641,of,0,1
36642,renal,0,1
36643,dysfunction,0,1
36644,.,0,0
36645,In,0,0
36646,45,0,0
36647,patients,0,0
36648,with,0,0
36649,type,0,0
36650,2,0,0
36651,diabetes,0,0
36652,mellitus,0,0
36653,(,0,0
36654,DM,0,1
36655,),0,0
36656,",",0,0
36657,we,0,0
36658,prospectively,0,0
36659,analyzed,0,0
36660,urinary,0,1
36661,excretion,0,1
36662,of,0,1
36663,N-acetyl-beta-glucosaminidase,0,1
36664,(,0,0
36665,NAG,0,1
36666,),0,0
36667,",",0,0
36668,a,0,0
36669,marker,0,1
36670,of,0,0
36671,tubular,0,0
36672,renal,0,1
36673,damage,0,1
36674,;,0,0
36675,the,0,0
36676,potential,0,0
36677,relationship,0,0
36678,with,0,0
36679,urinary,0,1
36680,protein,0,1
36681,excretion,0,1
36682,;,0,1
36683,and,0,1
36684,effects,0,1
36685,of,0,1
36686,pentoxifylline,0,0
36687,(,0,1
36688,PTF,0,0
36689,),0,0
36690,administration,0,0
36691,.,0,0
36692,METHODS,0,0
36693,Forty-five,0,0
36694,patients,0,0
36695,with,0,0
36696,type,0,0
36697,2,0,0
36698,DM,0,0
36699,initially,0,0
36700,were,0,0
36701,compared,0,0
36702,with,0,0
36703,15,0,0
36704,healthy,0,0
36705,controls,0,0
36706,matched,0,0
36707,for,0,0
36708,age,0,0
36709,and,0,1
36710,sex,0,0
36711,.,0,1
36712,After,0,0
36713,randomization,0,0
36714,",",0,1
36715,PTF,0,0
36716,(,0,0
36717,"1,200",0,0
36718,mg/d,0,0
36719,),0,0
36720,was,0,0
36721,administered,0,0
36722,for,0,0
36723,4,0,0
36724,months,0,0
36725,to,0,0
36726,30,0,0
36727,patients,0,0
36728,and,0,0
36729,results,0,0
36730,were,0,0
36731,compared,0,0
36732,with,0,0
36733,data,0,0
36734,from,0,0
36735,a,0,0
36736,control,0,0
36737,group,0,0
36738,(,0,0
36739,n,0,0
36740,=,0,0
36741,15,0,0
36742,),0,0
36743,.,0,0
36744,RESULTS,0,0
36745,Proteinuria,1,1
36746,and,1,1
36747,urinary,1,1
36748,NAG,1,1
36749,excretion,1,1
36750,were,0,0
36751,significantly,0,0
36752,greater,0,0
36753,in,0,0
36754,patients,0,0
36755,with,0,0
36756,DM,0,0
36757,with,0,0
36758,respect,0,0
36759,to,0,0
36760,healthy,0,0
36761,controls,0,0
36762,.,0,0
36763,Before,0,0
36764,PTF,0,0
36765,administration,0,0
36766,",",0,1
36767,baseline,0,1
36768,parameters,0,1
36769,were,0,0
36770,similar,0,0
36771,in,0,0
36772,both,0,0
36773,groups,0,0
36774,of,0,0
36775,patients,0,0
36776,with,0,0
36777,DM,0,0
36778,.,0,0
36779,At,0,0
36780,the,0,0
36781,end,0,0
36782,of,0,0
36783,the,0,0
36784,study,0,0
36785,",",0,0
36786,urinary,1,1
36787,protein,1,1
36788,excretion,1,1
36789,and,1,1
36790,NAG-creatinine,1,1
36791,ratios,1,1
36792,decreased,0,0
36793,in,0,0
36794,the,0,0
36795,active,0,0
36796,group,0,0
36797,from,0,0
36798,920,0,0
36799,+/-,0,0
36800,522,0,0
36801,mg/d,0,0
36802,and,0,0
36803,14.3,0,0
36804,+/-,0,0
36805,16.9,0,0
36806,U/g,0,0
36807,to,0,0
36808,803,0,0
36809,+/-,0,0
36810,523,0,0
36811,mg/d,0,0
36812,(,0,0
36813,P,0,0
36814,<,0,0
36815,0.001,0,0
36816,),0,0
36817,and,0,0
36818,10.5,0,0
36819,+/-,0,0
36820,9.3,0,0
36821,U/g,0,0
36822,(,0,0
36823,P,0,0
36824,<,0,0
36825,0.05,0,0
36826,),0,0
36827,",",0,0
36828,respectively,0,0
36829,.,0,0
36830,Conversely,0,0
36831,",",0,0
36832,proteinuria,1,1
36833,and,1,1
36834,urinary,1,1
36835,NAG,1,1
36836,excretion,1,1
36837,did,0,0
36838,not,0,0
36839,change,0,0
36840,in,0,0
36841,the,0,0
36842,control,0,0
36843,group,0,0
36844,.,0,1
36845,Regression,0,1
36846,analysis,0,0
36847,showed,0,0
36848,that,0,0
36849,urinary,1,1
36850,NAG,1,1
36851,excretion,1,1
36852,was,0,0
36853,significantly,0,0
36854,associated,0,0
36855,with,0,0
36856,duration,1,1
36857,of,1,1
36858,DM,1,0
36859,(,0,0
36860,r,0,0
36861,=,0,0
36862,0.61,0,0
36863,;,0,0
36864,P,0,0
36865,<,0,0
36866,0.001,0,0
36867,),0,0
36868,and,0,0
36869,proteinuria,1,1
36870,(,0,0
36871,r,0,0
36872,=,0,0
36873,0.51,0,0
36874,;,0,0
36875,P,0,0
36876,<,0,0
36877,0.001,0,0
36878,),0,0
36879,.,0,0
36880,CONCLUSION,0,0
36881,Urinary,1,1
36882,NAG,1,0
36883,excretion,1,1
36884,is,0,0
36885,elevated,0,1
36886,in,0,0
36887,patients,0,0
36888,with,0,0
36889,type,0,0
36890,2,0,0
36891,DM,0,0
36892,compared,0,0
36893,with,0,0
36894,healthy,0,0
36895,individuals,0,0
36896,and,0,1
36897,increases,0,1
36898,as,0,0
36899,nephropathy,0,0
36900,progresses,0,0
36901,.,0,0
36902,PTF,0,0
36903,administration,0,0
36904,is,0,0
36905,effective,0,1
36906,in,0,0
36907,reducing,0,0
36908,proteinuria,1,1
36909,and,1,1
36910,urinary,1,1
36911,NAG,1,1
36912,excretion,1,1
36913,in,0,0
36914,these,0,0
36915,patients,0,0
36916,.,0,0
36917,These,0,0
36918,findings,0,0
36919,suggest,0,0
36920,that,0,0
36921,PTF,0,0
36922,may,0,0
36923,have,0,0
36924,beneficial,0,0
36925,effects,0,1
36926,on,0,0
36927,tubulointerstitial,0,1
36928,damage,0,1
36929,in,0,0
36930,diabetic,0,0
36931,kidney,0,0
36932,disease,0,1
36933,.,0,0
36934,A,0,0
36935,comparison,0,0
36936,of,0,1
36937,magnesium,0,0
36938,sulfate,0,1
36939,and,0,1
36940,nimodipine,0,0
36941,for,0,0
36942,the,0,0
36943,prevention,1,0
36944,of,1,0
36945,eclampsia,1,0
36946,.,1,0
36947,Outcome,1,1
36948,of,0,1
36949,children,0,0
36950,with,0,0
36951,centrally,0,0
36952,reviewed,0,0
36953,low-grade,0,0
36954,gliomas,0,0
36955,treated,0,0
36956,with,0,0
36957,chemotherapy,0,0
36958,with,0,0
36959,or,0,0
36960,without,0,0
36961,radiotherapy,0,0
36962,on,0,0
36963,Children,0,1
36964,'s,0,1
36965,Cancer,0,0
36966,Group,0,0
36967,high-grade,0,0
36968,glioma,0,0
36969,study,0,0
36970,CCG-945,0,0
36971,.,0,0
36972,BACKGROUND,0,0
36973,The,0,0
36974,objectives,0,0
36975,of,0,0
36976,the,0,0
36977,current,0,0
36978,study,0,0
36979,were,0,0
36980,to,0,0
36981,determine,0,0
36982,the,0,0
36983,outcome,1,1
36984,of,0,0
36985,children,0,0
36986,who,0,0
36987,were,0,0
36988,treated,0,0
36989,with,0,0
36990,chemotherapy,0,0
36991,and,0,1
36992,radiotherapy,0,0
36993,on,0,0
36994,the,0,0
36995,Children,0,0
36996,'s,0,1
36997,Cancer,0,1
36998,Group,0,0
36999,(,0,1
37000,CCG,0,1
37001,),0,1
37002,high-grade,0,0
37003,glioma,0,1
37004,protocol,0,0
37005,(,0,1
37006,CCG-945,0,0
37007,),0,0
37008,who,0,0
37009,were,0,0
37010,diagnosed,0,0
37011,with,0,0
37012,low-grade,0,0
37013,gliomas,0,0
37014,on,0,0
37015,post,0,0
37016,hoc,0,0
37017,central,0,1
37018,pathologic,0,1
37019,review,0,0
37020,and,0,0
37021,to,0,0
37022,identify,0,0
37023,clinical,1,0
37024,and,1,1
37025,biologic,1,1
37026,features,1,0
37027,associated,0,0
37028,with,0,0
37029,prognosis,0,1
37030,.,0,0
37031,METHODS,0,0
37032,Between,0,0
37033,1985,0,0
37034,and,0,0
37035,1991,0,0
37036,",",0,0
37037,250,0,0
37038,children,0,0
37039,with,0,0
37040,institutionally,0,0
37041,classified,0,0
37042,high-grade,0,0
37043,gliomas,0,0
37044,were,0,0
37045,enrolled,0,0
37046,on,0,0
37047,CCG-945,0,0
37048,.,0,0
37049,Patients,0,0
37050,older,0,0
37051,than,0,0
37052,24,0,0
37053,months,0,0
37054,with,0,0
37055,intracranial,0,1
37056,lesions,0,1
37057,were,0,0
37058,assigned,0,0
37059,randomly,0,0
37060,to,0,0
37061,receive,0,0
37062,either,0,0
37063,lomustine,0,0
37064,",",0,1
37065,vincristine,0,0
37066,",",0,1
37067,and,0,1
37068,prednisone,0,0
37069,(,0,1
37070,control,0,0
37071,regimen,0,0
37072,),0,0
37073,or,0,0
37074,the,0,0
37075,8-drugs-in-1-day,0,1
37076,regimen,0,0
37077,(,0,0
37078,experimental,0,0
37079,regimen,0,0
37080,),0,0
37081,;,0,0
37082,younger,0,0
37083,patients,0,0
37084,and,0,1
37085,those,0,0
37086,with,0,0
37087,primary,0,0
37088,spinal,0,1
37089,cord,0,1
37090,tumors,0,1
37091,were,0,0
37092,assigned,0,0
37093,nonrandomly,0,0
37094,to,0,0
37095,the,0,0
37096,experimental,0,0
37097,regimen,0,0
37098,.,0,0
37099,Central,0,1
37100,independent,0,0
37101,review,0,0
37102,by,0,0
37103,5,0,0
37104,neuropathologists,0,0
37105,led,0,0
37106,to,0,0
37107,a,0,0
37108,reclassification,0,1
37109,of,0,0
37110,low-grade,0,0
37111,glioma,0,0
37112,in,0,0
37113,70,0,0
37114,patients,0,0
37115,",",0,0
37116,who,0,0
37117,were,0,0
37118,the,0,0
37119,focus,0,0
37120,of,0,0
37121,the,0,0
37122,current,0,0
37123,study,0,0
37124,.,0,0
37125,RESULTS,0,0
37126,The,0,0
37127,study,0,0
37128,involved,0,0
37129,42,0,0
37130,males,0,0
37131,and,0,0
37132,28,0,0
37133,females,0,0
37134,(,0,0
37135,median,0,1
37136,age,0,0
37137,",",0,0
37138,7.7,0,0
37139,years,0,0
37140,),0,0
37141,with,0,0
37142,a,0,0
37143,median,0,1
37144,follow-up,0,0
37145,of,0,0
37146,10.4,0,0
37147,years,0,0
37148,.,0,0
37149,At,0,0
37150,5,0,0
37151,years,0,0
37152,",",0,0
37153,the,0,0
37154,progression-free,1,1
37155,survival,1,1
37156,(,1,1
37157,PFS,1,1
37158,),1,1
37159,rate,1,1
37160,was,0,0
37161,63,0,0
37162,%,0,0
37163,+/-,0,0
37164,6,0,0
37165,%,0,0
37166,",",0,0
37167,and,0,0
37168,the,0,0
37169,overall,1,1
37170,survival,1,1
37171,(,1,1
37172,OS,1,1
37173,),1,1
37174,rate,1,1
37175,was,0,0
37176,79,0,0
37177,%,0,0
37178,+/-,0,0
37179,5,0,0
37180,%,0,0
37181,",",0,0
37182,compared,0,0
37183,with,0,0
37184,a,0,0
37185,PFS,1,1
37186,rate,1,1
37187,of,0,0
37188,19,0,0
37189,%,0,0
37190,+/-,0,0
37191,3,0,0
37192,%,0,0
37193,(,0,0
37194,P,0,0
37195,<,0,0
37196,0.0001,0,0
37197,),0,0
37198,and,0,0
37199,an,0,0
37200,OS,1,1
37201,rate,1,1
37202,of,0,0
37203,22,0,0
37204,%,0,0
37205,+/-,0,0
37206,3,0,0
37207,%,0,0
37208,(,0,0
37209,P,0,0
37210,<,0,0
37211,0.0001,0,0
37212,),0,0
37213,in,0,0
37214,the,0,0
37215,remainder,0,0
37216,of,0,0
37217,the,0,0
37218,cohort,0,0
37219,.,0,0
37220,Significantly,0,0
37221,poorer,0,0
37222,5-year,1,1
37223,PFS,1,1
37224,was,0,0
37225,seen,0,0
37226,in,0,0
37227,children,0,0
37228,younger,0,0
37229,than,0,0
37230,24,0,0
37231,months,0,0
37232,",",0,0
37233,those,0,0
37234,with,0,0
37235,fibrillary,0,1
37236,astrocytoma,0,0
37237,",",0,0
37238,and,0,0
37239,those,0,0
37240,with,0,0
37241,posterior,0,0
37242,fossa,0,0
37243,tumors,0,0
37244,.,0,1
37245,Patients,0,0
37246,demonstrated,0,0
37247,a,0,0
37248,modest,0,0
37249,improvement,0,1
37250,in,0,0
37251,PFS,1,1
37252,but,0,0
37253,no,0,0
37254,improvement,0,1
37255,in,0,0
37256,OS,1,1
37257,compared,0,0
37258,with,0,0
37259,children,0,0
37260,with,0,0
37261,low-grade,0,0
37262,gliomas,0,0
37263,who,0,0
37264,were,0,0
37265,treated,0,0
37266,with,0,0
37267,contemporary,0,0
37268,chemotherapy-alone,0,0
37269,approaches,0,0
37270,.,0,0
37271,CONCLUSIONS,0,0
37272,The,0,0
37273,current,0,0
37274,report,0,0
37275,calls,0,0
37276,attention,0,1
37277,to,0,0
37278,the,0,0
37279,importance,0,0
37280,of,0,0
37281,central,0,1
37282,pathologic,0,1
37283,review,0,0
37284,in,0,0
37285,large,0,0
37286,multiinstitutional,0,0
37287,trials,0,0
37288,of,0,0
37289,children,0,0
37290,with,0,0
37291,gliomas,0,0
37292,and,0,0
37293,suggests,0,0
37294,that,0,0
37295,aggressive,0,1
37296,front-line,0,0
37297,combined,0,0
37298,chemoradiotherapy,0,0
37299,does,0,0
37300,not,0,0
37301,confer,0,0
37302,a,0,0
37303,survival,1,1
37304,advantage,1,0
37305,in,0,0
37306,this,0,0
37307,highly,0,0
37308,selected,0,0
37309,population,0,0
37310,of,0,0
37311,patients,0,0
37312,.,0,0
37313,T,0,1
37314,lymphocyte,0,1
37315,subsets,0,1
37316,and,0,0
37317,NK,0,0
37318,cell,0,1
37319,cytotoxicity,0,1
37320,in,0,0
37321,chronic,0,0
37322,hemodialysis,0,0
37323,patients,0,0
37324,.,0,0
37325,The,0,0
37326,effect,0,0
37327,of,0,0
37328,recombinant,0,0
37329,human,0,0
37330,erythropoietin,0,0
37331,(,0,1
37332,rHu-EPO,0,1
37333,),0,0
37334,treatment,0,0
37335,.,0,0
37336,We,0,0
37337,investigated,0,0
37338,subpopulations,0,0
37339,of,0,1
37340,T,1,0
37341,lymphocytes,1,1
37342,",",1,1
37343,NK,1,1
37344,cell,1,1
37345,number,1,1
37346,and,1,1
37347,cytotoxic,1,1
37348,activity,1,1
37349,in,0,0
37350,14,0,0
37351,chronic,0,0
37352,uremic,0,0
37353,patients,0,0
37354,on,0,0
37355,regular,0,0
37356,hemodialysis,0,0
37357,treatment,0,0
37358,.,0,0
37359,We,0,0
37360,observed,0,0
37361,a,0,0
37362,significantly,0,0
37363,decreased,0,0
37364,absolute,1,1
37365,lymphocyte,1,1
37366,number,1,1
37367,and,1,1
37368,percentage,1,1
37369,of,1,1
37370,CD3,1,0
37371,cells,1,1
37372,.,1,0
37373,Relative,0,0
37374,numbers,0,1
37375,of,0,0
37376,CD16,1,0
37377,cells,1,1
37378,were,0,0
37379,significantly,0,0
37380,elevated,0,1
37381,",",0,0
37382,but,0,0
37383,NK,1,1
37384,cell,1,1
37385,cytotoxic,1,1
37386,activity,1,1
37387,was,0,0
37388,within,0,0
37389,a,0,0
37390,normal,0,0
37391,range,0,0
37392,.,0,0
37393,Nine,0,0
37394,patients,0,0
37395,with,0,0
37396,chronic,0,0
37397,renal,0,1
37398,anemia,0,1
37399,on,0,0
37400,maintenance,0,0
37401,hemodialysis,0,1
37402,were,0,0
37403,enrolled,0,0
37404,in,0,0
37405,rHu-EPO,0,0
37406,treatment,0,0
37407,trial,0,0
37408,.,0,0
37409,The,0,0
37410,treatment,0,0
37411,was,0,0
37412,continued,0,0
37413,till,0,0
37414,the,0,0
37415,hematocrit,1,1
37416,level,1,1
37417,reached,0,0
37418,30,0,0
37419,%,0,0
37420,.,0,0
37421,Each,0,0
37422,of,0,0
37423,the,0,0
37424,patients,0,0
37425,had,0,0
37426,corrected,0,0
37427,anemia,1,1
37428,and,0,0
37429,well-being,0,1
37430,.,0,0
37431,After,0,0
37432,12,0,0
37433,weeks,0,0
37434,of,0,0
37435,the,0,0
37436,treatment,0,0
37437,we,0,0
37438,observed,0,0
37439,in,0,0
37440,these,0,0
37441,patients,0,0
37442,decreases,0,0
37443,in,0,0
37444,CD3,1,0
37445,",",1,1
37446,CD4,1,1
37447,",",1,1
37448,CD8,1,0
37449,and,1,1
37450,CD16,1,1
37451,cell,1,1
37452,numbers,1,1
37453,and,0,1
37454,elevation,0,1
37455,of,0,1
37456,CD4/CD8,1,1
37457,ratio,1,1
37458,.,1,1
37459,Cytotoxic,1,1
37460,activity,1,1
37461,of,1,1
37462,NK,1,1
37463,cells,1,1
37464,did,0,0
37465,not,0,0
37466,change,0,0
37467,significantly,0,0
37468,.,0,0
37469,Presented,0,0
37470,results,0,0
37471,indicate,0,0
37472,that,0,0
37473,chronic,0,0
37474,hemodialysis,0,0
37475,patients,0,0
37476,have,0,0
37477,significantly,0,0
37478,diminished,0,1
37479,lymphocyte,1,1
37480,number,1,1
37481,.,1,0
37482,rHu,0,0
37483,EPO,0,0
37484,treatment,0,0
37485,affects,0,0
37486,the,0,0
37487,T,0,0
37488,lymphocyte,0,1
37489,subsets,0,1
37490,inducing,0,0
37491,a,0,0
37492,deep,0,0
37493,decrease,0,1
37494,of,0,1
37495,CD8,1,0
37496,and,1,1
37497,CD16,1,1
37498,cell,1,1
37499,percentage,1,1
37500,leading,0,0
37501,to,0,0
37502,normalisation,0,1
37503,of,0,0
37504,the,0,0
37505,CD4/CD8,1,0
37506,ratio,1,1
37507,.,1,0
37508,Changes,0,1
37509,in,0,0
37510,calcanean,0,1
37511,bone,0,1
37512,mineral,0,1
37513,occurring,0,0
37514,spontaneously,0,0
37515,and,0,0
37516,during,0,0
37517,hormone,0,1
37518,replacement,0,0
37519,therapy,0,0
37520,in,0,0
37521,early,0,0
37522,post-menopausal,0,0
37523,women,0,0
37524,.,0,0
37525,The,0,0
37526,spontaneous,0,1
37527,calcanean,0,1
37528,bone,0,1
37529,loss,0,1
37530,occurring,0,0
37531,in,0,0
37532,healthy,0,0
37533,early,0,0
37534,post-menopausal,0,0
37535,women,0,0
37536,and,0,0
37537,the,0,0
37538,effect,0,0
37539,of,0,0
37540,two,0,0
37541,hormone,0,0
37542,replacement,0,0
37543,therapies,0,0
37544,(,0,0
37545,HRT,0,1
37546,'s,0,1
37547,),0,0
37548,were,0,0
37549,investigated,0,0
37550,in,0,0
37551,a,0,0
37552,longitudinal,0,0
37553,study,0,0
37554,.,0,0
37555,There,0,0
37556,was,0,0
37557,no,0,0
37558,difference,0,0
37559,between,0,0
37560,the,0,0
37561,right,0,1
37562,and,0,1
37563,left,0,1
37564,calcanean,0,1
37565,BMC,0,1
37566,or,0,1
37567,BMD,0,1
37568,(,0,1
37569,p,0,0
37570,>,0,0
37571,0.15,0,0
37572,),0,0
37573,.,0,0
37574,The,0,0
37575,spontaneous,0,1
37576,bone,0,1
37577,loss,0,1
37578,was,0,0
37579,similar,0,0
37580,at,0,0
37581,all,0,0
37582,the,0,0
37583,skeletal,0,0
37584,sites,0,0
37585,measured,0,1
37586,",",0,0
37587,with,0,0
37588,a,0,0
37589,mean,0,1
37590,spontaneous,0,1
37591,loss,0,1
37592,in,0,0
37593,calcanean,0,1
37594,BMD,0,1
37595,of,0,0
37596,1.6,0,0
37597,%,0,0
37598,over,0,0
37599,one,0,0
37600,year,0,0
37601,.,0,0
37602,Both,0,0
37603,HRT,0,1
37604,'s,0,0
37605,significantly,0,0
37606,(,0,0
37607,p,0,0
37608,<,0,0
37609,0.01,0,0
37610,),0,0
37611,prevented,0,0
37612,the,0,0
37613,bone,1,1
37614,loss,1,1
37615,from,0,0
37616,all,0,0
37617,skeletal,0,0
37618,sites,0,0
37619,irrespective,0,0
37620,of,0,0
37621,the,0,0
37622,weight-bearing,0,1
37623,or,0,0
37624,content,0,1
37625,of,0,1
37626,trabecular,0,1
37627,bone,0,1
37628,",",0,1
37629,and,0,1
37630,(,0,0
37631,for,0,0
37632,the,0,0
37633,weight-bearing,0,1
37634,bones,0,1
37635,),0,0
37636,there,0,0
37637,was,0,0
37638,even,0,0
37639,a,0,0
37640,gain,0,1
37641,in,0,0
37642,calcanean,1,1
37643,BMC,1,1
37644,and,1,1
37645,BMD,1,1
37646,and,1,1
37647,spinal,1,1
37648,BMD,1,1
37649,(,0,0
37650,p,0,0
37651,<,0,0
37652,0.01,0,0
37653,),0,0
37654,.,0,0
37655,Bone,0,1
37656,mineral,0,1
37657,of,0,0
37658,the,0,0
37659,calcaneus,0,1
37660,and,0,0
37661,the,0,0
37662,spine,0,0
37663,correlated,0,0
37664,equally,0,0
37665,to,0,0
37666,body,0,1
37667,weight,0,1
37668,(,0,0
37669,r,0,0
37670,approximately,0,0
37671,0.4,0,0
37672,",",0,0
37673,p,0,0
37674,<,0,0
37675,0.001,0,0
37676,),0,0
37677,",",0,0
37678,whereas,0,0
37679,bone,0,1
37680,mineral,0,1
37681,in,0,0
37682,the,0,0
37683,forearm,0,1
37684,was,0,0
37685,not,0,0
37686,correlated,0,0
37687,to,0,0
37688,body,0,0
37689,weight,0,1
37690,.,0,0
37691,The,0,0
37692,correlations,0,1
37693,between,0,0
37694,the,0,0
37695,changes,0,1
37696,in,0,0
37697,bone,0,1
37698,mineral,0,1
37699,at,0,0
37700,the,0,0
37701,sites,0,0
37702,measured,0,0
37703,were,0,0
37704,all,0,0
37705,significant,0,0
37706,(,0,0
37707,r,0,1
37708,approximately,0,0
37709,0.2-0.4,0,0
37710,),0,0
37711,.,0,0
37712,Amisulpride,0,0
37713,versus,0,0
37714,bromocriptine,0,0
37715,in,0,0
37716,infantile,0,0
37717,autism,0,0
37718,:,0,0
37719,a,0,0
37720,controlled,0,0
37721,crossover,0,0
37722,comparative,0,0
37723,study,0,0
37724,of,0,0
37725,two,0,0
37726,drugs,0,0
37727,with,0,0
37728,opposite,0,0
37729,effects,0,1
37730,on,0,0
37731,dopaminergic,0,0
37732,function,0,1
37733,.,0,0
37734,An,0,0
37735,alteration,0,1
37736,of,0,1
37737,dopaminergic,1,0
37738,(,1,1
37739,DA,1,1
37740,),1,1
37741,function,1,1
37742,much,0,0
37743,more,0,0
37744,complex,0,0
37745,than,0,0
37746,simple,0,0
37747,hyperactivity,0,0
37748,has,0,0
37749,been,0,0
37750,evoked,0,0
37751,in,0,0
37752,infantile,0,0
37753,autism,0,0
37754,.,0,0
37755,We,0,0
37756,therefore,0,0
37757,compared,0,0
37758,the,0,0
37759,clinical,1,0
37760,efficacy,1,1
37761,of,0,0
37762,a,0,0
37763,DA,0,1
37764,antagonist,0,0
37765,(,0,0
37766,amisulpride,0,0
37767,),0,0
37768,and,0,0
37769,a,0,0
37770,DA,0,1
37771,agonist,0,0
37772,(,0,1
37773,bromocriptine,0,0
37774,),0,0
37775,in,0,0
37776,a,0,0
37777,randomized,0,0
37778,",",0,0
37779,double-blind,0,0
37780,",",0,1
37781,crossover,0,0
37782,trial,0,0
37783,in,0,0
37784,9,0,0
37785,children,0,0
37786,with,0,0
37787,autism,0,0
37788,",",0,0
37789,likely,0,0
37790,severely,0,0
37791,mentally,0,0
37792,retarded,0,0
37793,.,0,0
37794,Amisulpride,0,0
37795,acts,0,0
37796,preferentially,0,0
37797,on,0,0
37798,specific,0,0
37799,autistic,0,0
37800,symptoms,0,1
37801,whereas,0,0
37802,bromocriptine,0,0
37803,acts,0,0
37804,more,0,0
37805,on,0,0
37806,motor,1,1
37807,hyperactivity,1,1
37808,and,1,1
37809,attention,1,1
37810,symptoms,1,1
37811,.,1,0
37812,These,0,0
37813,findings,0,0
37814,raise,0,0
37815,the,0,0
37816,specificity,0,0
37817,of,0,0
37818,these,0,0
37819,two,0,0
37820,drugs,0,0
37821,which,0,0
37822,appear,0,0
37823,to,0,0
37824,act,0,0
37825,preferentially,0,0
37826,on,0,0
37827,some,0,0
37828,target,0,0
37829,symptoms,0,1
37830,and,0,0
37831,are,0,0
37832,consistent,0,0
37833,with,0,0
37834,some,0,0
37835,clinical,0,0
37836,and,0,0
37837,pharmacological,0,0
37838,observations,0,0
37839,showing,0,0
37840,a,0,0
37841,sedative,1,1
37842,effect,1,0
37843,with,0,0
37844,low,0,0
37845,doses,0,0
37846,of,0,0
37847,DA,0,1
37848,agonists,0,0
37849,and,0,0
37850,a,0,0
37851,stimulant,1,0
37852,effect,1,0
37853,with,0,0
37854,low,0,0
37855,doses,0,0
37856,of,0,0
37857,DA,0,0
37858,antagonists,0,0
37859,such,0,0
37860,as,0,0
37861,the,0,0
37862,benzamides,0,0
37863,.,0,0
37864,Oral,0,1
37865,ondansetron,0,0
37866,in,0,0
37867,the,0,0
37868,prevention,1,0
37869,of,1,0
37870,postoperative,1,1
37871,nausea,1,1
37872,and,1,1
37873,vomiting,1,1
37874,.,1,0
37875,The,0,0
37876,effect,0,0
37877,of,0,0
37878,three,0,0
37879,times,0,0
37880,daily,0,0
37881,oral,0,0
37882,ondansetron,0,0
37883,in,0,0
37884,preventing,0,0
37885,postoperative,1,1
37886,nausea,1,1
37887,and,1,1
37888,vomiting,1,1
37889,was,0,0
37890,investigated,0,0
37891,in,0,0
37892,two,0,0
37893,randomized,0,0
37894,",",0,0
37895,double-blind,0,0
37896,",",0,1
37897,placebo-controlled,0,0
37898,",",0,1
37899,multi-centre,0,0
37900,studies,0,0
37901,.,0,0
37902,The,0,0
37903,first,0,0
37904,study,0,0
37905,compared,0,0
37906,ondansetron,0,0
37907,1,0,0
37908,",",0,0
37909,8,0,0
37910,and,0,0
37911,16,0,0
37912,mg,0,0
37913,to,0,0
37914,placebo,0,0
37915,",",0,0
37916,and,0,0
37917,the,0,0
37918,second,0,0
37919,study,0,0
37920,compared,0,0
37921,8,0,0
37922,mg,0,0
37923,ondansetron,0,0
37924,to,0,0
37925,placebo,0,0
37926,.,0,0
37927,Both,0,0
37928,studies,0,0
37929,included,0,0
37930,ASA,0,1
37931,Class,0,1
37932,I-III,0,1
37933,female,0,0
37934,patients,0,0
37935,about,0,0
37936,to,0,0
37937,undergo,0,0
37938,major,0,1
37939,abdominal,0,1
37940,gynaecological,0,0
37941,surgery,0,0
37942,or,0,1
37943,vaginal,0,0
37944,hysterectomy,0,0
37945,.,0,0
37946,In,0,0
37947,the,0,0
37948,first,0,1
37949,study,0,0
37950,",",0,0
37951,the,0,0
37952,8,0,0
37953,and,0,0
37954,16,0,0
37955,mg,0,0
37956,ondansetron,0,0
37957,groups,0,0
37958,had,0,0
37959,a,0,0
37960,significantly,0,0
37961,lower,0,0
37962,incidence,1,1
37963,of,1,1
37964,nausea,1,1
37965,and,1,1
37966,vomiting,1,1
37967,in,0,0
37968,the,0,0
37969,0-24,0,0
37970,h,0,0
37971,period,0,0
37972,following,0,0
37973,recovery,0,1
37974,from,0,0
37975,anaesthesia,0,0
37976,than,0,0
37977,the,0,0
37978,placebo,0,0
37979,group,0,0
37980,.,0,0
37981,Ondansetron,0,0
37982,8,0,0
37983,mg,0,0
37984,three,0,0
37985,times,0,0
37986,daily,0,0
37987,was,0,0
37988,also,0,0
37989,significantly,0,0
37990,better,0,0
37991,than,0,0
37992,placebo,0,0
37993,in,0,0
37994,the,0,0
37995,second,0,0
37996,study,0,0
37997,.,0,0
37998,Side-effects,1,0
37999,mainly,0,0
38000,consisted,0,0
38001,of,0,0
38002,constipation,1,1
38003,",",1,1
38004,headache,1,1
38005,",",1,1
38006,and,1,1
38007,asymptomatic,1,1
38008,elevation,1,1
38009,of,1,1
38010,liver,1,1
38011,enzymes,1,1
38012,.,1,0
38013,The,0,0
38014,incidence,0,1
38015,of,0,0
38016,side-effects,1,1
38017,was,0,0
38018,similar,0,0
38019,in,0,0
38020,ondansetron-,0,1
38021,and,0,1
38022,placebo-treated,0,0
38023,patients,0,0
38024,.,0,0
38025,There,0,0
38026,appeared,0,0
38027,to,0,0
38028,be,0,0
38029,no,0,0
38030,clinically,1,0
38031,important,1,0
38032,benefit,1,0
38033,of,0,0
38034,the,0,0
38035,16,0,0
38036,mg,0,0
38037,three,0,0
38038,times,0,0
38039,daily,0,0
38040,ondansetron,0,0
38041,regimen,0,0
38042,over,0,0
38043,the,0,0
38044,8,0,0
38045,mg,0,0
38046,three,0,0
38047,times,0,0
38048,daily,0,0
38049,dose,0,0
38050,",",0,0
38051,therefore,0,0
38052,8,0,0
38053,mg,0,0
38054,three,0,0
38055,times,0,0
38056,daily,0,0
38057,is,0,0
38058,recommended,0,0
38059,as,0,0
38060,the,0,0
38061,optimal,1,0
38062,oral,1,0
38063,dose,1,0
38064,in,0,0
38065,the,0,0
38066,prevention,0,0
38067,of,0,0
38068,postoperative,1,1
38069,nausea,1,1
38070,and,1,1
38071,vomiting,1,1
38072,.,1,0
38073,Amphotericin,0,0
38074,versus,0,0
38075,pentamidine,0,0
38076,in,0,0
38077,antimony-unresponsive,0,1
38078,kala-azar,0,0
38079,.,0,0
38080,We,0,0
38081,compared,0,0
38082,the,0,0
38083,efficacy,0,1
38084,of,0,0
38085,amphotericin,0,0
38086,B,0,0
38087,and,0,1
38088,pentamidine,0,0
38089,isethionate,0,0
38090,in,0,0
38091,a,0,0
38092,prospective,0,0
38093,randomised,0,0
38094,trial,0,0
38095,in,0,0
38096,120,0,0
38097,uncomplicated,0,0
38098,and,0,0
38099,parasitologically,0,0
38100,confirmed,0,0
38101,cases,0,0
38102,of,0,0
38103,antimony-unresponsive,0,1
38104,kala-azar,0,1
38105,.,0,1
38106,Doses,0,1
38107,were,0,0
38108,twenty,0,0
38109,intramuscular,0,0
38110,injections,0,0
38111,of,0,0
38112,pentamidine,0,0
38113,4,0,0
38114,mg/kg,0,0
38115,on,0,0
38116,alternate,0,0
38117,days,0,0
38118,or,0,0
38119,fourteen,0,0
38120,definitive,0,0
38121,doses,0,0
38122,of,0,0
38123,amphotericin,0,0
38124,0.5,0,0
38125,mg/kg,0,0
38126,infused,0,0
38127,in,0,0
38128,5,0,0
38129,%,0,0
38130,dextrose,0,0
38131,on,0,0
38132,alternate,0,0
38133,days,0,0
38134,.,0,0
38135,48,0,0
38136,(,0,0
38137,80,0,0
38138,%,0,0
38139,),0,0
38140,patients,0,0
38141,given,0,0
38142,pentamidine,0,0
38143,showed,0,0
38144,initial,1,0
38145,cure,1,1
38146,and,0,0
38147,46,0,0
38148,(,0,0
38149,77,0,0
38150,%,0,0
38151,),0,0
38152,showed,0,0
38153,definitive,1,0
38154,cure,1,1
38155,compared,0,0
38156,with,0,0
38157,60,0,0
38158,(,0,0
38159,100,0,0
38160,%,0,0
38161,),0,0
38162,and,0,0
38163,59,0,0
38164,(,0,0
38165,98,0,0
38166,%,0,0
38167,),0,0
38168,cases,0,0
38169,",",0,0
38170,respectively,0,0
38171,",",0,0
38172,on,0,0
38173,amphotericin,0,0
38174,(,0,0
38175,p,0,0
38176,<,0,0
38177,0.001,0,0
38178,),0,0
38179,.,0,0
38180,Amphotericin,0,0
38181,also,0,0
38182,brought,0,0
38183,about,0,0
38184,quicker,0,0
38185,abatement,1,1
38186,of,1,1
38187,fever,1,1
38188,and,0,1
38189,more,0,0
38190,complete,1,1
38191,spleen,1,1
38192,regression,1,0
38193,.,1,0
38194,A,0,0
38195,randomized,0,0
38196,trial,0,0
38197,of,0,0
38198,a,0,0
38199,health,0,1
38200,care,0,0
38201,program,0,0
38202,for,0,0
38203,first-time,0,0
38204,adolescent,0,0
38205,mothers,0,0
38206,and,0,0
38207,their,0,0
38208,infants,0,0
38209,.,0,0
38210,To,0,0
38211,test,0,0
38212,the,0,0
38213,effectiveness,0,0
38214,of,0,0
38215,a,0,0
38216,special,0,0
38217,health,0,1
38218,care,0,0
38219,program,0,0
38220,for,0,0
38221,adolescent,0,0
38222,mothers,0,0
38223,(,0,0
38224,17,0,0
38225,years,0,0
38226,old,0,0
38227,or,0,0
38228,younger,0,0
38229,),0,1
38230,and,0,0
38231,their,0,0
38232,infants,0,0
38233,",",0,0
38234,243,0,0
38235,mother-infant,0,0
38236,pairs,0,0
38237,were,0,0
38238,randomly,0,0
38239,assigned,0,0
38240,to,0,0
38241,one,0,0
38242,of,0,0
38243,two,0,0
38244,groups,0,0
38245,.,0,0
38246,All,0,0
38247,of,0,0
38248,the,0,0
38249,mothers,0,0
38250,were,0,0
38251,unwed,0,0
38252,",",0,0
38253,on,0,0
38254,Medicaid,0,0
38255,",",0,1
38256,and,0,1
38257,black,0,0
38258,.,0,0
38259,The,0,0
38260,control,0,0
38261,group,0,0
38262,received,0,0
38263,routine,0,0
38264,well-baby,0,0
38265,care,0,0
38266,.,0,0
38267,The,0,0
38268,experimental,0,0
38269,group,0,0
38270,received,0,0
38271,routine,0,0
38272,care,0,0
38273,and,0,1
38274,services,0,1
38275,that,0,0
38276,included,0,0
38277,rigorous,0,0
38278,follow-up,0,0
38279,",",0,0
38280,discussions,0,0
38281,with,0,0
38282,the,0,0
38283,mother,0,1
38284,about,0,0
38285,her,0,1
38286,plans,0,0
38287,for,0,0
38288,return,0,1
38289,to,0,0
38290,school,0,1
38291,and,0,1
38292,use,0,1
38293,of,0,1
38294,family,0,1
38295,planning,0,1
38296,methods,0,0
38297,",",0,1
38298,and,0,1
38299,extra,0,1
38300,health,0,1
38301,teaching,0,0
38302,.,0,0
38303,The,0,0
38304,dropout,0,1
38305,rate,0,1
38306,in,0,0
38307,the,0,0
38308,experimental,0,0
38309,group,0,0
38310,(,0,0
38311,60,0,0
38312,%,0,0
38313,),0,0
38314,was,0,0
38315,significantly,0,0
38316,less,0,0
38317,after,0,0
38318,18,0,0
38319,months,0,0
38320,than,0,0
38321,the,0,0
38322,control,0,0
38323,group,0,0
38324,(,0,0
38325,82,0,0
38326,%,0,0
38327,),0,0
38328,.,0,0
38329,In,0,0
38330,spite,0,0
38331,of,0,0
38332,the,0,0
38333,high,0,0
38334,dropout,0,1
38335,rate,0,1
38336,",",0,0
38337,91,0,0
38338,%,0,0
38339,of,0,0
38340,the,0,0
38341,mothers,0,0
38342,were,0,0
38343,located,0,0
38344,for,0,0
38345,the,0,0
38346,18,0,0
38347,month,0,0
38348,follow-up,0,0
38349,interview,0,0
38350,.,0,0
38351,The,0,0
38352,repeat,1,1
38353,pregnancy,1,1
38354,rate,1,1
38355,in,0,0
38356,the,0,0
38357,experimental,0,0
38358,group,0,0
38359,was,0,0
38360,12,0,0
38361,%,0,0
38362,after,0,0
38363,18,0,0
38364,months,0,0
38365,",",0,0
38366,and,0,0
38367,28,0,0
38368,%,0,0
38369,in,0,0
38370,the,0,0
38371,control,0,0
38372,group,0,0
38373,.,0,0
38374,There,0,0
38375,was,0,0
38376,no,0,0
38377,significant,0,0
38378,difference,0,0
38379,in,0,0
38380,the,0,0
38381,percentage,1,1
38382,returning,1,1
38383,to,1,0
38384,school,1,0
38385,.,1,0
38386,After,0,0
38387,12,0,0
38388,months,0,0
38389,",",0,0
38390,the,0,0
38391,infants,0,0
38392,in,0,0
38393,the,0,0
38394,experimental,0,0
38395,group,0,0
38396,were,0,0
38397,more,0,0
38398,likely,0,0
38399,to,0,0
38400,be,0,0
38401,fully,1,0
38402,immunized,1,0
38403,(,0,0
38404,33,0,0
38405,%,0,0
38406,),0,0
38407,than,0,0
38408,the,0,0
38409,infants,0,0
38410,in,0,0
38411,the,0,0
38412,control,0,0
38413,group,0,0
38414,(,0,0
38415,18,0,0
38416,%,0,0
38417,),0,0
38418,.,0,0
38419,Mothers,0,0
38420,in,0,0
38421,the,0,0
38422,special,0,0
38423,care,0,0
38424,program,0,0
38425,who,0,0
38426,continued,0,0
38427,to,0,0
38428,attend,0,0
38429,clinic,0,0
38430,used,1,0
38431,the,1,0
38432,emergency,1,1
38433,room,1,0
38434,less,1,0
38435,than,0,0
38436,the,0,0
38437,mothers,0,0
38438,who,0,0
38439,continued,0,0
38440,to,0,0
38441,attend,0,0
38442,in,0,0
38443,the,0,0
38444,control,0,0
38445,group,0,0
38446,.,0,0
38447,These,0,0
38448,results,0,0
38449,suggest,0,0
38450,that,0,0
38451,a,0,0
38452,comprehensive,0,0
38453,health,0,1
38454,care,0,0
38455,program,0,0
38456,is,0,0
38457,one,0,0
38458,way,0,0
38459,to,0,0
38460,bring,0,0
38461,about,0,0
38462,better,0,0
38463,outcomes,0,1
38464,for,0,0
38465,both,0,0
38466,adolescent,0,0
38467,mothers,0,0
38468,and,0,0
38469,their,0,0
38470,infants,0,0
38471,.,0,0
38472,Improved,0,0
38473,acidosis,0,1
38474,correction,0,1
38475,and,0,1
38476,recovery,0,1
38477,of,0,1
38478,mesothelial,0,1
38479,cell,0,1
38480,mass,0,1
38481,with,0,0
38482,neutral-pH,0,0
38483,bicarbonate,0,1
38484,dialysis,0,0
38485,solution,0,0
38486,among,0,0
38487,children,0,0
38488,undergoing,0,0
38489,automated,0,0
38490,peritoneal,0,1
38491,dialysis,0,0
38492,.,0,1
38493,Acid-base,0,1
38494,balance,0,1
38495,and,0,1
38496,peritoneal,0,1
38497,membrane,0,1
38498,longevity,0,1
38499,are,0,0
38500,of,0,0
38501,utmost,0,1
38502,relevance,0,0
38503,for,0,0
38504,pediatric,0,0
38505,patients,0,0
38506,undergoing,0,0
38507,peritoneal,0,1
38508,dialysis,0,0
38509,(,0,1
38510,PD,0,1
38511,),0,0
38512,.,0,0
38513,PD,0,1
38514,fluids,0,0
38515,with,0,0
38516,neutral,0,0
38517,pH,0,1
38518,and,0,1
38519,reduced,0,1
38520,glucose,0,1
38521,degradation,0,1
38522,product,0,1
38523,contents,0,0
38524,are,0,0
38525,considered,0,0
38526,more,0,0
38527,biocompatible,0,0
38528,",",0,0
38529,because,0,0
38530,they,0,0
38531,preserve,0,0
38532,peritoneal,0,1
38533,cell,0,1
38534,functions,0,1
38535,in,0,0
38536,vitro,0,0
38537,.,0,0
38538,To,0,0
38539,investigate,0,0
38540,the,0,0
38541,clinical,0,0
38542,effects,1,0
38543,of,0,0
38544,a,0,0
38545,novel,0,0
38546,PD,0,1
38547,fluid,0,1
38548,buffered,0,0
38549,with,0,0
38550,34,0,0
38551,mM,0,0
38552,pure,0,0
38553,bicarbonate,0,0
38554,at,0,0
38555,neutral,0,1
38556,pH,0,0
38557,",",0,0
38558,a,0,0
38559,randomized,0,0
38560,",",0,0
38561,prospective,0,0
38562,",",0,1
38563,crossover,0,0
38564,comparison,0,0
38565,with,0,0
38566,conventional,0,0
38567,",",0,0
38568,acidic,0,0
38569,",",0,0
38570,35,0,0
38571,mM,0,0
38572,lactate,0,1
38573,PD,0,1
38574,fluid,0,1
38575,was,0,0
38576,performed,0,0
38577,for,0,0
38578,two,0,0
38579,consecutive,0,0
38580,12-wk,0,0
38581,periods,0,0
38582,with,0,0
38583,28,0,0
38584,children,0,0
38585,(,0,0
38586,age,0,0
38587,",",0,0
38588,6,0,0
38589,mo,0,0
38590,to,0,0
38591,15,0,0
38592,yr,0,0
38593,),0,0
38594,undergoing,0,0
38595,automated,0,0
38596,PD,0,1
38597,(,0,0
38598,APD,0,0
38599,),0,0
38600,.,0,0
38601,Blood,1,1
38602,bicarbonate,1,1
38603,levels,1,1
38604,and,1,1
38605,arterial,1,1
38606,pH,1,1
38607,were,0,0
38608,significantly,0,0
38609,higher,1,0
38610,after,0,0
38611,3,0,0
38612,mo,0,0
38613,of,0,0
38614,bicarbonate,1,1
38615,PD,1,1
38616,(,0,0
38617,24.6,0,0
38618,+/-,0,0
38619,2.3,0,0
38620,mM,0,0
38621,and,0,0
38622,7.43,0,0
38623,+/-,0,0
38624,0.06,0,0
38625,",",0,0
38626,respectively,0,0
38627,),0,0
38628,",",0,0
38629,compared,0,0
38630,with,0,0
38631,lactate,1,1
38632,PD,1,1
38633,(,0,0
38634,22.8,0,0
38635,+/-,0,0
38636,3.9,0,0
38637,mM,0,0
38638,and,0,0
38639,7.38,0,0
38640,+/-,0,0
38641,0.05,0,0
38642,",",0,0
38643,respectively,0,0
38644,;,0,0
38645,P,0,0
38646,<,0,0
38647,0.05,0,0
38648,),0,0
38649,.,0,0
38650,This,0,0
38651,effect,0,1
38652,was,0,0
38653,reversible,0,0
38654,among,0,0
38655,patients,0,0
38656,who,0,0
38657,returned,0,0
38658,from,0,0
38659,bicarbonate,0,0
38660,to,0,0
38661,lactate,0,1
38662,fluid,0,1
38663,.,0,0
38664,Low,0,0
38665,initial,1,0
38666,pH,1,1
38667,and,0,1
38668,young,0,0
38669,patient,0,1
38670,age,0,0
38671,independently,0,1
38672,predicted,0,1
38673,increased,0,0
38674,blood,1,1
38675,pH,1,0
38676,during,0,0
38677,bicarbonate,1,0
38678,APD,1,0
38679,.,1,1
38680,Peritoneal,0,0
38681,equilibration,0,1
38682,tests,0,1
38683,revealed,0,0
38684,subtle,1,1
38685,changes,1,1
38686,in,1,0
38687,solute,1,1
38688,transport,1,1
38689,",",0,0
38690,with,0,0
38691,a,0,0
38692,less,1,0
38693,steep,1,1
38694,creatinine,1,1
38695,equilibration,1,1
38696,curve,1,1
38697,during,0,0
38698,bicarbonate,0,1
38699,dialysis,0,0
38700,",",0,0
38701,suggesting,0,0
38702,reduced,0,1
38703,peritoneal,0,1
38704,vasodilation,0,1
38705,.,0,0
38706,The,0,0
38707,peritoneal,1,1
38708,release,1,1
38709,of,1,1
38710,carcinogen,1,0
38711,antigen-125,1,1
38712,increased,1,1
38713,twofold,0,1
38714,during,0,0
38715,bicarbonate,0,1
38716,APD,0,0
38717,(,0,0
38718,29,0,0
38719,+/-,0,0
38720,15,0,0
38721,versus,0,0
38722,15,0,0
38723,+/-,0,0
38724,8,0,0
38725,U/ml,0,0
38726,per,0,0
38727,4,0,0
38728,h,0,0
38729,",",0,0
38730,P,0,0
38731,<,0,0
38732,0.01,0,0
38733,),0,0
38734,",",0,0
38735,which,0,0
38736,is,0,0
38737,consistent,0,0
38738,with,0,0
38739,recovery,0,1
38740,of,0,0
38741,the,0,0
38742,mesothelial,0,0
38743,cell,0,1
38744,layer,0,1
38745,.,0,0
38746,This,0,0
38747,effect,0,1
38748,was,0,0
38749,fully,0,0
38750,reversed,0,0
38751,when,0,0
38752,the,0,0
38753,patients,0,0
38754,returned,0,0
38755,to,0,0
38756,lactate,0,1
38757,fluid,0,1
38758,.,0,0
38759,Effluent,1,0
38760,carcinogen,1,0
38761,antigen-125,1,1
38762,levels,1,1
38763,were,0,0
38764,inversely,0,0
38765,correlated,0,0
38766,with,0,0
38767,peritoneal,0,1
38768,glucose,0,1
38769,exposure,0,0
38770,during,0,0
38771,lactate,0,1
38772,but,0,0
38773,not,0,0
38774,bicarbonate,0,0
38775,APD,0,0
38776,",",0,0
38777,indicating,0,0
38778,improved,0,1
38779,in,0,0
38780,vivo,0,0
38781,mesothelial,0,1
38782,cell,0,1
38783,tolerance,0,1
38784,of,0,1
38785,high-dose,0,0
38786,glucose,0,1
38787,with,0,0
38788,the,0,0
38789,neutral-pH,0,0
38790,PD,0,1
38791,fluid,0,1
38792,with,0,0
38793,reduced,0,1
38794,glucose,0,1
38795,degradation,0,1
38796,product,0,1
38797,content,0,1
38798,.,0,0
38799,Among,0,0
38800,children,0,0
38801,undergoing,0,0
38802,APD,0,0
38803,",",0,1
38804,neutral-pH,0,0
38805,",",0,1
38806,bicarbonate-buffered,0,0
38807,PD,0,1
38808,fluid,0,1
38809,provides,0,0
38810,more,0,0
38811,effective,0,1
38812,correction,0,0
38813,of,0,1
38814,metabolic,0,1
38815,acidosis,0,1
38816,and,0,1
38817,better,0,0
38818,preservation,0,1
38819,of,0,1
38820,peritoneal,0,1
38821,cell,0,1
38822,mass,0,1
38823,than,0,0
38824,do,0,0
38825,conventional,0,0
38826,",",0,0
38827,acidic,0,1
38828,",",0,1
38829,lactate-based,0,0
38830,fluids,0,0
38831,.,0,0
38832,Prospective,0,0
38833,study,0,0
38834,of,0,1
38835,short,0,1
38836,and,0,1
38837,ultrashort,0,0
38838,regimens,0,0
38839,of,0,1
38840,gonadotropin-releasing,0,1
38841,hormone,0,1
38842,agonist,0,0
38843,in,0,0
38844,an,0,0
38845,in,0,0
38846,vitro,0,1
38847,fertilization,0,0
38848,program,0,0
38849,.,0,0
38850,OBJECTIVE,0,0
38851,To,0,0
38852,assess,0,0
38853,the,0,0
38854,usefulness,1,0
38855,of,0,0
38856,the,0,0
38857,ultrashort,0,0
38858,regimen,0,0
38859,of,0,1
38860,gonadotropin-releasing,0,1
38861,hormone,0,1
38862,agonist,0,0
38863,(,0,1
38864,GnRH-a,0,0
38865,),0,1
38866,in,0,0
38867,ovulation,0,1
38868,induction,0,0
38869,in,0,0
38870,an,0,0
38871,in,0,0
38872,vitro,0,1
38873,fertilization,0,1
38874,(,0,1
38875,IVF,0,1
38876,),0,0
38877,program,0,0
38878,.,0,0
38879,DESIGN,0,0
38880,A,0,0
38881,prospective,0,0
38882,randomized,0,0
38883,trial,0,0
38884,comparing,0,0
38885,short,0,1
38886,and,0,1
38887,ultrashort,0,0
38888,regimens,0,0
38889,of,0,0
38890,GnRH-a,0,0
38891,.,0,0
38892,SETTING,0,0
38893,Aberdeen,0,1
38894,Assisted,0,0
38895,Reproduction,0,1
38896,Unit,0,0
38897,.,0,0
38898,PATIENTS,0,0
38899,Forty-eight,0,0
38900,patients,0,0
38901,having,0,0
38902,IVF,0,0
38903,for,0,0
38904,the,0,0
38905,first,0,1
38906,time,0,1
38907,were,0,0
38908,randomized,0,0
38909,between,0,0
38910,the,0,0
38911,two,0,0
38912,protocols,0,0
38913,.,0,0
38914,MAIN,0,0
38915,OUTCOME,0,1
38916,MEASURES,0,0
38917,Response,1,1
38918,to,1,0
38919,ovarian,1,1
38920,stimulation,1,1
38921,and,1,1
38922,occurrence,1,1
38923,of,1,1
38924,spontaneous,1,1
38925,luteinizing,1,1
38926,hormone,1,1
38927,(,1,1
38928,LH,1,0
38929,),1,0
38930,surges,1,1
38931,.,1,0
38932,RESULTS,0,0
38933,In,0,0
38934,ovulation,1,1
38935,induction,1,1
38936,",",1,1
38937,fertilization,1,1
38938,",",1,1
38939,and,1,1
38940,pregnancy,1,1
38941,rates,1,1
38942,the,0,0
38943,ultrashort,0,0
38944,regimen,0,0
38945,produces,0,0
38946,results,0,0
38947,that,0,0
38948,were,0,0
38949,no,0,0
38950,different,0,0
38951,to,0,0
38952,the,0,0
38953,short,0,1
38954,regimen,0,0
38955,but,0,0
38956,it,0,0
38957,did,0,0
38958,not,0,0
38959,always,0,0
38960,prevent,0,0
38961,an,0,0
38962,LH,1,0
38963,surge,1,0
38964,.,1,0
38965,CONCLUSION,0,0
38966,The,0,0
38967,ultrashort,0,0
38968,regimen,0,0
38969,can,0,0
38970,be,0,0
38971,a,0,0
38972,useful,0,0
38973,alternative,0,0
38974,for,0,0
38975,ovarian,0,1
38976,stimulation,0,1
38977,of,0,0
38978,patients,0,0
38979,undergoing,0,0
38980,IVF,0,0
38981,.,0,0
38982,Presentation,0,1
38983,of,0,1
38984,allergen,0,0
38985,in,0,0
38986,different,0,0
38987,food,0,0
38988,preparations,0,0
38989,affects,0,0
38990,the,0,0
38991,nature,0,0
38992,of,0,0
38993,the,0,0
38994,allergic,0,1
38995,reaction,0,1
38996,--,0,0
38997,a,0,0
38998,case,0,0
38999,series,0,0
39000,.,0,1
39001,BACKGROUND,0,0
39002,Characterization,0,1
39003,of,0,1
39004,fatal,0,1
39005,and,0,1
39006,non-fatal,0,1
39007,reactions,0,1
39008,to,0,0
39009,food,0,0
39010,indicates,0,0
39011,that,0,0
39012,the,0,0
39013,majority,0,0
39014,of,0,0
39015,reactions,0,1
39016,are,0,0
39017,due,0,0
39018,to,0,0
39019,the,0,0
39020,ingestion,0,0
39021,of,0,0
39022,prepared,0,0
39023,foods,0,0
39024,rather,0,0
39025,than,0,0
39026,the,0,0
39027,non-processed,0,0
39028,allergen,0,0
39029,.,0,0
39030,In,0,0
39031,an,0,0
39032,ongoing,0,0
39033,study,0,0
39034,that,0,0
39035,used,0,0
39036,a,0,0
39037,double-blind,0,0
39038,placebo-controlled,0,0
39039,food,0,0
39040,challenge,0,0
39041,to,0,0
39042,investigate,0,0
39043,peanut,0,0
39044,allergy,0,1
39045,and,0,1
39046,clinical,0,1
39047,symptoms,0,1
39048,",",0,0
39049,the,0,0
39050,observed,0,0
39051,reaction,0,1
39052,severity,0,1
39053,in,0,0
39054,four,0,0
39055,of,0,0
39056,the,0,0
39057,first,0,0
39058,six,0,0
39059,subjects,0,0
39060,was,0,0
39061,greater,0,0
39062,than,0,0
39063,anticipated,0,0
39064,.,0,0
39065,We,0,0
39066,hypothesized,0,0
39067,that,0,0
39068,this,0,0
39069,was,0,0
39070,due,0,0
39071,to,0,0
39072,differences,0,0
39073,in,0,0
39074,the,0,0
39075,composition,0,0
39076,of,0,0
39077,the,0,0
39078,challenge,0,0
39079,vehicle,0,0
39080,.,0,0
39081,OBJECTIVE,0,0
39082,The,0,0
39083,aim,0,0
39084,was,0,0
39085,to,0,0
39086,investigate,0,0
39087,whether,0,0
39088,the,0,0
39089,severity,0,1
39090,of,0,0
39091,observed,0,0
39092,challenge,0,0
39093,reactions,0,1
39094,would,0,0
39095,be,0,0
39096,repeated,0,0
39097,on,0,0
39098,re-challenge,0,0
39099,with,0,0
39100,a,0,0
39101,lower,0,0
39102,fat,0,1
39103,challenge,0,0
39104,vehicle,0,0
39105,.,0,1
39106,METHODS,0,0
39107,Peanut-allergic,0,0
39108,subjects,0,0
39109,were,0,0
39110,re-challenged,0,0
39111,with,0,0
39112,a,0,0
39113,lower,0,0
39114,fat,0,1
39115,recipe,0,0
39116,after,0,0
39117,reacting,0,1
39118,more,0,0
39119,severely,0,0
39120,than,0,0
39121,was,0,0
39122,anticipated,0,0
39123,to,0,0
39124,an,0,0
39125,initial,0,0
39126,peanut,0,0
39127,challenge,0,0
39128,.,0,1
39129,Similar,0,0
39130,challenge,0,0
39131,vehicle,0,0
39132,recipes,0,0
39133,were,0,0
39134,used,0,0
39135,",",0,0
39136,the,0,0
39137,only,0,0
39138,difference,0,0
39139,being,0,0
39140,the,0,0
39141,lower,0,0
39142,fat,0,1
39143,content,0,1
39144,(,0,0
39145,22.9,0,0
39146,%,0,0
39147,compared,0,0
39148,with,0,0
39149,31.5,0,0
39150,%,0,0
39151,),0,0
39152,.,0,0
39153,The,0,0
39154,peanut,0,0
39155,content,0,1
39156,of,0,0
39157,the,0,0
39158,two,0,0
39159,recipes,0,0
39160,was,0,0
39161,analysed,0,0
39162,using,0,0
39163,RAST,0,0
39164,inhibition,0,1
39165,studies,0,0
39166,and,0,1
39167,ELISA,0,1
39168,tests,0,1
39169,.,0,0
39170,RESULTS,0,0
39171,Three,0,0
39172,of,0,0
39173,four,0,0
39174,subjects,0,0
39175,reacted,0,0
39176,to,0,0
39177,much,0,0
39178,smaller,0,0
39179,doses,1,0
39180,of,1,1
39181,peanut,1,0
39182,protein,1,1
39183,on,1,0
39184,re-challenge,1,0
39185,(,0,0
39186,mean,0,1
39187,dose,0,0
39188,equivalence,0,0
39189,-,0,0
39190,23,0,0
39191,times,0,0
39192,less,0,0
39193,peanut,0,0
39194,),0,0
39195,with,0,0
39196,the,0,0
39197,lower,0,0
39198,fat,0,1
39199,recipe,0,0
39200,.,0,1
39201,RAST,1,0
39202,inhibition,1,1
39203,showed,0,0
39204,that,0,0
39205,neither,0,0
39206,recipe,0,0
39207,altered,0,0
39208,epitope,1,1
39209,recognition,1,0
39210,.,1,0
39211,The,0,0
39212,higher,0,0
39213,fat,0,1
39214,recipe,0,0
39215,required,0,0
39216,twice,0,0
39217,as,0,0
39218,much,0,0
39219,peanut,0,0
39220,to,0,0
39221,cause,0,0
39222,50,1,0
39223,%,1,0
39224,inhibition,1,1
39225,.,1,1
39226,ELISA,0,1
39227,detected,0,0
39228,far,0,0
39229,lower,0,0
39230,levels,0,1
39231,of,0,1
39232,peanut,0,0
39233,in,0,0
39234,the,0,0
39235,higher,0,0
39236,fat,0,1
39237,recipe,0,0
39238,(,0,0
39239,220,0,0
39240,000,0,0
39241,parts,0,0
39242,per,0,0
39243,million,0,0
39244,(,0,0
39245,p.p.m,0,0
39246,.,0,1
39247,),0,0
39248,),0,0
39249,than,0,0
39250,in,0,0
39251,the,0,0
39252,lower,0,0
39253,fat,0,1
39254,recipe,0,0
39255,(,0,0
39256,990,0,0
39257,000,0,0
39258,p.p.m.,0,0
39259,),0,0
39260,.,0,0
39261,CONCLUSION,0,0
39262,The,0,0
39263,fat,0,1
39264,content,0,1
39265,of,0,0
39266,a,0,0
39267,challenge,0,0
39268,vehicle,0,0
39269,has,0,0
39270,a,0,0
39271,profound,0,0
39272,effect,0,0
39273,on,0,0
39274,the,0,0
39275,reaction,0,1
39276,experienced,0,0
39277,after,0,0
39278,allergen,0,0
39279,ingestion,0,0
39280,.,0,0
39281,This,0,0
39282,is,0,0
39283,another,0,0
39284,factor,0,0
39285,to,0,0
39286,be,0,0
39287,considered,0,0
39288,in,0,0
39289,assessing,0,0
39290,the,0,0
39291,risk,0,1
39292,of,0,0
39293,certain,0,0
39294,foods,0,0
39295,to,0,0
39296,food-allergic,0,1
39297,consumers,0,0
39298,and,0,0
39299,adds,0,0
39300,another,0,0
39301,dimension,0,1
39302,to,0,0
39303,clinical,0,1
39304,",",0,1
39305,research,0,0
39306,and,0,1
39307,regulatory,0,0
39308,practice,0,0
39309,.,0,0
39310,Effects,0,0
39311,of,0,0
39312,weight,0,1
39313,reduction,0,1
39314,interventions,0,0
39315,by,0,0
39316,community,0,0
39317,pharmacists,0,0
39318,.,0,0
39319,OBJECTIVE,0,0
39320,To,0,0
39321,compare,0,0
39322,a,0,0
39323,meal,0,0
39324,replacement,0,0
39325,(,0,1
39326,MR,0,1
39327,),0,1
39328,program,0,0
39329,with,0,0
39330,a,0,0
39331,conventional,0,0
39332,reduced-calorie,0,0
39333,diet,0,0
39334,(,0,1
39335,RCD,0,0
39336,),0,1
39337,for,0,0
39338,weight,1,1
39339,management,1,0
39340,using,0,0
39341,the,0,0
39342,pharmacy,0,0
39343,as,0,0
39344,the,0,0
39345,setting,0,0
39346,and,0,0
39347,the,0,0
39348,pharmacist,0,0
39349,as,0,0
39350,the,0,0
39351,point,0,0
39352,of,0,0
39353,contact,0,1
39354,for,0,0
39355,dietary,0,0
39356,advice,0,0
39357,.,0,0
39358,DESIGN,0,0
39359,Randomized,0,0
39360,",",0,1
39361,controlled,0,0
39362,",",0,1
39363,open-label,0,0
39364,trial,0,0
39365,.,0,1
39366,SETTING,0,0
39367,Travis,0,0
39368,Pharmacy,0,1
39369,in,0,0
39370,Shenandoah,0,0
39371,",",0,0
39372,Iowa,0,0
39373,.,0,1
39374,PATIENTS,0,0
39375,Ninety-five,0,0
39376,patients,0,0
39377,from,0,0
39378,southwestern,0,0
39379,iowa,0,0
39380,and,0,1
39381,southeastern,0,1
39382,Nebraska,0,1
39383,were,0,0
39384,enrolled,0,0
39385,",",0,0
39386,of,0,0
39387,whom,0,0
39388,88,0,0
39389,were,0,0
39390,considered,0,0
39391,eligible,0,0
39392,for,0,0
39393,comparison,0,0
39394,(,0,0
39395,by,0,0
39396,continuing,0,0
39397,through,0,0
39398,week,0,0
39399,2,0,0
39400,of,0,0
39401,the,0,0
39402,study,0,0
39403,),0,0
39404,.,0,0
39405,INTERVENTION,0,1
39406,Patients,0,0
39407,were,0,0
39408,randomized,0,0
39409,to,0,0
39410,an,0,0
39411,MR,0,1
39412,plan,0,0
39413,or,0,0
39414,a,0,0
39415,traditional,0,0
39416,RCD,0,0
39417,plan,0,0
39418,.,0,1
39419,Patients,0,0
39420,were,0,0
39421,followed,0,0
39422,for,0,0
39423,a,0,0
39424,3-month,0,0
39425,period,0,0
39426,of,0,1
39427,active,0,0
39428,weight,0,1
39429,loss,0,1
39430,and,0,0
39431,a,0,0
39432,10-week,0,0
39433,period,0,0
39434,of,0,1
39435,weight,0,1
39436,maintenance,0,0
39437,.,0,1
39438,Patients,0,0
39439,returned,0,0
39440,every,0,0
39441,3,0,0
39442,weeks,0,0
39443,for,0,0
39444,follow-up,0,0
39445,with,0,0
39446,the,0,0
39447,pharmacist,0,0
39448,",",0,0
39449,for,0,0
39450,a,0,0
39451,total,0,0
39452,of,0,0
39453,13,0,0
39454,visits,0,0
39455,.,0,0
39456,MAIN,0,0
39457,OUTCOME,0,1
39458,MEASURE,0,1
39459,Weight,1,0
39460,changes,1,1
39461,.,1,0
39462,RESULTS,0,0
39463,During,0,0
39464,the,0,0
39465,active,0,0
39466,weight,0,1
39467,loss,0,1
39468,phase,0,0
39469,",",0,0
39470,the,0,0
39471,MR,0,1
39472,(,0,0
39473,n,0,0
39474,=,0,0
39475,45,0,0
39476,),0,0
39477,and,0,0
39478,RCD,0,1
39479,(,0,1
39480,n,0,0
39481,=,0,0
39482,43,0,0
39483,),0,0
39484,groups,0,0
39485,lost,0,0
39486,a,0,0
39487,significant,1,0
39488,amount,1,1
39489,of,1,1
39490,weight,1,1
39491,",",0,0
39492,although,0,0
39493,no,0,0
39494,significant,0,0
39495,difference,0,0
39496,was,0,0
39497,found,0,0
39498,between,0,0
39499,the,0,0
39500,groups,0,0
39501,(,0,0
39502,mean,0,1
39503,+/-,0,0
39504,standard,0,0
39505,error,0,0
39506,=,0,0
39507,4.90,0,0
39508,+/-,0,0
39509,0.30,0,0
39510,kg,0,0
39511,MR,0,0
39512,versus,0,0
39513,4.30,0,0
39514,+/-,0,0
39515,0.30,0,0
39516,kg,0,0
39517,RCD,0,0
39518,;,0,0
39519,P,0,0
39520,=,0,0
39521,.16,0,0
39522,),0,0
39523,.,0,0
39524,In,0,0
39525,the,0,0
39526,weight,0,1
39527,maintenance,0,0
39528,phase,0,0
39529,",",0,0
39530,the,0,0
39531,MR,0,1
39532,group,0,0
39533,lost,0,0
39534,0.70,0,0
39535,+/-,0,0
39536,0.40,0,0
39537,kg,0,0
39538,and,0,0
39539,the,0,0
39540,RCD,0,0
39541,group,0,0
39542,lost,0,0
39543,0.90,0,0
39544,+/-,0,0
39545,0.40,0,0
39546,kg,0,0
39547,(,0,0
39548,P,0,0
39549,=,0,0
39550,.60,0,0
39551,),0,0
39552,.,0,0
39553,Significant,0,1
39554,improvements,0,1
39555,were,0,0
39556,observed,0,0
39557,in,0,0
39558,waist,1,1
39559,circumference,1,1
39560,",",1,1
39561,systolic,1,1
39562,and,1,1
39563,diastolic,1,1
39564,blood,1,1
39565,pressure,1,1
39566,",",1,1
39567,and,1,1
39568,triglyceride,1,1
39569,levels,1,1
39570,.,1,0
39571,No,0,0
39572,significant,0,0
39573,changes,0,1
39574,were,0,0
39575,seen,0,0
39576,in,0,0
39577,high-density,1,1
39578,lipoprotein,1,1
39579,cholesterol,1,1
39580,or,1,1
39581,low-density,1,1
39582,lipoprotein,1,1
39583,cholesterol,1,1
39584,levels,1,1
39585,in,0,0
39586,either,0,0
39587,group,0,0
39588,.,0,0
39589,CONCLUSION,0,0
39590,Successful,0,0
39591,weight,1,1
39592,management,1,0
39593,can,0,0
39594,be,0,0
39595,achieved,0,0
39596,in,0,0
39597,a,0,0
39598,pharmacy,0,0
39599,setting,0,0
39600,.,0,0
39601,Both,0,0
39602,MR,0,1
39603,and,0,1
39604,RCD,0,1
39605,programs,0,0
39606,were,0,0
39607,effective,0,0
39608,.,0,0
39609,Future,0,1
39610,therapeutic,0,0
39611,directions,0,0
39612,for,0,0
39613,factor,0,1
39614,Xa,0,0
39615,inhibition,0,1
39616,in,0,0
39617,the,0,0
39618,prophylaxis,0,0
39619,and,0,1
39620,treatment,0,0
39621,of,0,1
39622,thrombotic,0,1
39623,disorders,0,0
39624,.,0,0
39625,The,0,0
39626,targeted,0,0
39627,mechanism,0,0
39628,of,0,1
39629,factor,0,1
39630,Xa,0,0
39631,inhibition,0,1
39632,has,0,0
39633,been,0,0
39634,studied,0,0
39635,extensively,0,0
39636,",",0,0
39637,initially,0,0
39638,as,0,0
39639,prophylaxis,0,0
39640,for,0,0
39641,venous,0,1
39642,thromboembolism,0,1
39643,(,0,1
39644,VTE,0,0
39645,),0,0
39646,in,0,0
39647,the,0,0
39648,orthopedic,0,0
39649,surgical,0,0
39650,setting,0,0
39651,.,0,0
39652,Future,0,1
39653,therapeutic,0,0
39654,directions,0,0
39655,for,0,0
39656,selective,0,1
39657,factor,0,1
39658,Xa,0,0
39659,inhibition,0,1
39660,in,0,0
39661,the,0,0
39662,management,0,0
39663,of,0,0
39664,other,0,0
39665,thrombotic,0,1
39666,diseases,0,0
39667,are,0,0
39668,discussed,0,0
39669,.,0,0
39670,Thromboembolic,0,0
39671,diseases,0,0
39672,can,0,0
39673,occur,0,0
39674,in,0,0
39675,the,0,0
39676,venous,0,1
39677,or,0,0
39678,arterial,0,1
39679,sides,0,0
39680,of,0,0
39681,the,0,0
39682,circulatory,0,1
39683,system,0,0
39684,.,0,1
39685,Factor,0,0
39686,Xa,0,0
39687,inhibition,0,1
39688,is,0,0
39689,a,0,0
39690,targeted,0,0
39691,approach,0,0
39692,to,0,0
39693,anticoagulation,0,0
39694,that,0,0
39695,resulted,0,0
39696,from,0,0
39697,significant,0,0
39698,advances,0,0
39699,in,0,0
39700,our,0,0
39701,understanding,0,0
39702,of,0,0
39703,the,0,0
39704,coagulation,0,0
39705,cascade,0,1
39706,.,0,0
39707,The,0,0
39708,factor,0,1
39709,Xa,0,0
39710,inhibitor,0,0
39711,fondaparinux,0,0
39712,has,0,0
39713,been,0,0
39714,studied,0,0
39715,extensively,0,0
39716,in,0,0
39717,the,0,0
39718,orthopedic,0,0
39719,surgical,0,0
39720,setting,0,0
39721,for,0,0
39722,the,0,0
39723,prophylaxis,0,0
39724,of,0,0
39725,VTE,0,0
39726,.,0,0
39727,Current,0,1
39728,investigations,0,0
39729,that,0,0
39730,are,0,0
39731,under,0,0
39732,way,0,0
39733,or,0,0
39734,completed,0,0
39735,evaluate,0,0
39736,the,0,0
39737,efficacy,1,1
39738,and,1,1
39739,safety,1,1
39740,of,0,1
39741,fondaparinux,0,0
39742,for,0,0
39743,the,0,0
39744,management,0,0
39745,of,0,0
39746,various,0,0
39747,thrombotic,0,1
39748,diseases,0,0
39749,.,0,0
39750,The,0,0
39751,future,0,0
39752,development,0,1
39753,of,0,1
39754,fondaparinux,0,1
39755,resides,0,0
39756,primarily,0,0
39757,in,0,0
39758,three,0,0
39759,therapeutic,0,0
39760,areas,0,0
39761,:,0,0
39762,prevention,0,0
39763,of,0,1
39764,VTE,0,0
39765,",",0,0
39766,treatment,0,0
39767,of,0,1
39768,VTE,0,0
39769,",",0,1
39770,and,0,1
39771,treatment,0,0
39772,of,0,1
39773,acute,1,0
39774,coronary,1,0
39775,syndromes,1,0
39776,.,1,0
39777,For,0,0
39778,the,0,0
39779,prevention,0,0
39780,of,0,1
39781,VTE,0,0
39782,",",0,0
39783,fondaparinux,0,0
39784,has,0,0
39785,been,0,0
39786,studied,0,0
39787,as,0,0
39788,extended,0,0
39789,prophylaxis,0,0
39790,following,0,0
39791,hip,0,1
39792,fracture,0,1
39793,surgery,0,0
39794,(,0,1
39795,PENTHIFRA,0,1
39796,Plus,0,0
39797,),0,1
39798,",",0,0
39799,for,0,0
39800,use,0,0
39801,in,0,0
39802,high-risk,0,0
39803,abdominal,0,1
39804,surgical,0,1
39805,patients,0,0
39806,(,0,1
39807,PEGASUS,0,1
39808,and,0,1
39809,APOLLO,0,1
39810,),0,1
39811,",",0,0
39812,and,0,1
39813,for,0,0
39814,use,0,0
39815,in,0,0
39816,medical,0,1
39817,patients,0,0
39818,(,0,0
39819,ARTEMIS,0,0
39820,),0,0
39821,.,0,0
39822,Studies,0,0
39823,evaluating,0,0
39824,fondaparinux,0,0
39825,for,0,0
39826,the,0,0
39827,treatment,0,0
39828,of,0,0
39829,VTE,0,0
39830,are,0,0
39831,part,0,0
39832,of,0,0
39833,the,0,0
39834,large,0,0
39835,MATISSE,0,0
39836,clinical,0,1
39837,program,0,0
39838,(,0,0
39839,MATISSE,0,1
39840,DVT,0,1
39841,and,0,1
39842,MATISSE,0,1
39843,PE,0,1
39844,),0,0
39845,.,0,0
39846,Fondaparinux,0,1
39847,was,0,0
39848,investigated,0,0
39849,in,0,0
39850,phase,0,0
39851,2,0,0
39852,studies,0,0
39853,for,0,0
39854,the,0,0
39855,treatment,0,0
39856,of,0,0
39857,acute,0,0
39858,coronary,0,1
39859,syndromes,0,1
39860,",",0,0
39861,including,0,0
39862,acute,1,0
39863,ST-segment,1,1
39864,myocardial,1,1
39865,infarction,1,1
39866,(,1,1
39867,PENTALYSE,1,0
39868,),1,1
39869,and,1,1
39870,unstable,1,1
39871,angina,1,1
39872,(,1,1
39873,PENTUA,1,0
39874,),1,0
39875,.,1,0
39876,Encouraging,0,0
39877,data,0,0
39878,from,0,0
39879,these,0,0
39880,trials,0,0
39881,are,0,0
39882,the,0,0
39883,basis,0,0
39884,for,0,0
39885,phase,0,0
39886,3,0,0
39887,programs,0,0
39888,in,0,0
39889,this,0,0
39890,area,0,1
39891,(,0,0
39892,MICHELANGELO,0,1
39893,),0,0
39894,.,0,0
39895,The,0,0
39896,orthopedic,0,0
39897,prophylactic,0,0
39898,and,0,1
39899,nonorthopedic,0,0
39900,clinical,0,1
39901,programs,0,0
39902,for,0,0
39903,fondaparinux,0,0
39904,in,0,0
39905,the,0,0
39906,management,0,0
39907,of,0,1
39908,thrombosis,0,1
39909,support,0,0
39910,the,0,0
39911,concept,0,0
39912,that,0,0
39913,targeted,1,0
39914,inhibition,1,1
39915,of,1,0
39916,coagulation,1,0
39917,is,0,0
39918,an,0,0
39919,effective,1,1
39920,advance,1,0
39921,in,1,0
39922,antithrombotic,1,1
39923,therapy,1,0
39924,.,1,0
39925,Intraperitoneal,0,0
39926,cisplatin,0,0
39927,versus,0,0
39928,no,0,0
39929,further,0,0
39930,treatment,0,0
39931,:,0,0
39932,8-year,0,0
39933,results,0,0
39934,of,0,0
39935,EORTC,0,0
39936,55875,0,0
39937,",",0,0
39938,a,0,0
39939,randomized,0,0
39940,phase,0,0
39941,III,0,1
39942,study,0,0
39943,in,0,0
39944,ovarian,0,1
39945,cancer,0,0
39946,patients,0,0
39947,with,0,0
39948,a,0,0
39949,pathologically,0,0
39950,complete,0,1
39951,remission,0,1
39952,after,0,0
39953,platinum-based,0,0
39954,intravenous,0,0
39955,chemotherapy,0,0
39956,.,0,0
39957,First-line,0,0
39958,intravenous,0,0
39959,chemotherapy,0,0
39960,(,0,1
39961,CT,0,1
39962,),0,0
39963,following,0,0
39964,debulking,0,0
39965,surgery,0,0
39966,is,0,0
39967,associated,0,0
39968,with,0,0
39969,prolonged,1,1
39970,survival,1,1
39971,",",0,0
39972,in,0,0
39973,particular,0,0
39974,in,0,0
39975,patients,0,0
39976,who,0,0
39977,achieve,0,0
39978,a,0,0
39979,pathological,0,1
39980,complete,0,1
39981,remission,0,1
39982,(,0,1
39983,pCR,0,0
39984,),0,1
39985,at,0,0
39986,second-look,0,0
39987,surgery,0,0
39988,but,0,0
39989,in,0,0
39990,whom,0,0
39991,a,0,0
39992,high,0,0
39993,rate,0,1
39994,of,0,0
39995,relapses,0,0
39996,still,0,0
39997,occurs,0,0
39998,.,0,0
39999,Between,0,0
40000,1988,0,0
40001,and,0,0
40002,1997,0,0
40003,",",0,0
40004,153,0,0
40005,patients,0,0
40006,in,0,0
40007,pCR,0,0
40008,following,0,0
40009,platinum-based,0,0
40010,intravenous,0,0
40011,CT,0,1
40012,were,0,0
40013,randomized,0,0
40014,between,0,0
40015,four,0,0
40016,courses,0,0
40017,of,0,0
40018,intraperitoneal,0,0
40019,cisplatin,0,0
40020,(,0,1
40021,P,0,0
40022,),0,0
40023,(,0,0
40024,90,0,0
40025,mg/m2,0,0
40026,every,0,0
40027,3,0,0
40028,weeks,0,0
40029,),0,0
40030,or,0,0
40031,observation,0,0
40032,.,0,1
40033,Overall,1,1
40034,survival,1,1
40035,(,1,1
40036,OS,1,1
40037,),1,0
40038,was,0,0
40039,the,0,0
40040,primary,0,0
40041,endpoint,0,1
40042,",",0,0
40043,while,0,0
40044,progression-free,0,1
40045,survival,0,1
40046,(,0,1
40047,PFS,0,1
40048,),0,0
40049,was,0,0
40050,a,0,0
40051,secondary,0,0
40052,endpoint,0,0
40053,.,0,0
40054,This,0,0
40055,intent-to-treat,0,0
40056,analysis,0,0
40057,includes,0,0
40058,16,0,0
40059,patients,0,0
40060,who,0,0
40061,were,0,0
40062,not,0,0
40063,eligible,0,0
40064,and,0,0
40065,17,0,0
40066,patients,0,0
40067,who,0,0
40068,had,0,0
40069,protocol,0,0
40070,violations,0,1
40071,.,0,0
40072,The,0,0
40073,two,0,0
40074,groups,0,0
40075,were,0,0
40076,well,0,0
40077,balanced,0,0
40078,in,0,0
40079,terms,0,0
40080,of,0,1
40081,age,0,0
40082,(,0,0
40083,median,0,0
40084,=,0,0
40085,55,0,0
40086,years,0,0
40087,),0,0
40088,",",0,0
40089,performance,0,1
40090,status,0,1
40091,(,0,0
40092,78,0,0
40093,%,0,0
40094,P.S,0,0
40095,.,0,1
40096,O,0,1
40097,),0,0
40098,",",0,0
40099,FIGO,0,1
40100,stage,0,0
40101,(,0,0
40102,96,0,0
40103,%,0,0
40104,stage,0,0
40105,III,0,1
40106,),0,1
40107,",",0,1
40108,histology,0,1
40109,(,0,1
40110,serous,0,0
40111,in,0,0
40112,66,0,0
40113,%,0,0
40114,),0,0
40115,",",0,1
40116,grade,0,1
40117,(,0,0
40118,2,0,0
40119,or,0,0
40120,3,0,0
40121,in,0,0
40122,80,0,0
40123,%,0,0
40124,),0,0
40125,",",0,1
40126,and,0,1
40127,residuum,0,1
40128,before,0,0
40129,intravenous,0,0
40130,CT,0,1
40131,(,0,0
40132,>,0,0
40133,1,0,0
40134,cm,0,0
40135,in,0,0
40136,40,0,0
40137,%,0,0
40138,),0,0
40139,.,0,0
40140,Intraperitoneal,0,0
40141,CT,0,1
40142,was,0,0
40143,delivered,0,0
40144,mainly,0,0
40145,through,0,0
40146,intraperitoneal,0,0
40147,catheters,0,0
40148,(,0,0
40149,Port-a-Cath,0,0
40150,61,0,0
40151,%,0,0
40152,and,0,0
40153,Tenckhoff,0,0
40154,25,0,0
40155,%,0,0
40156,),0,0
40157,.,0,0
40158,Side,0,0
40159,effects,0,1
40160,of,0,1
40161,intraperitoneal,0,0
40162,cisplatin,0,0
40163,included,0,0
40164,vomiting,1,1
40165,[,0,0
40166,>,0,0
40167,or,0,0
40168,=grade,0,1
40169,2,0,0
40170,(,0,0
40171,82,0,0
40172,%,0,0
40173,),0,0
40174,],0,0
40175,",",0,1
40176,rise,1,0
40177,in,1,0
40178,serum,1,1
40179,creatinine,1,1
40180,[,0,0
40181,>,0,0
40182,or,0,0
40183,=grade,0,1
40184,2,0,0
40185,(,0,0
40186,14,0,0
40187,%,0,0
40188,),0,0
40189,],0,0
40190,",",0,1
40191,abdominal,1,1
40192,pain,1,1
40193,[,0,0
40194,grade,0,1
40195,1-2,0,0
40196,(,0,0
40197,38,0,0
40198,%,0,0
40199,),0,0
40200,],0,0
40201,",",0,1
40202,and,0,1
40203,neurotoxicity,1,1
40204,[,0,0
40205,grade,0,0
40206,2-3,0,0
40207,(,0,0
40208,15,0,0
40209,%,0,0
40210,),0,0
40211,],0,0
40212,.,0,0
40213,After,0,0
40214,a,0,0
40215,median,0,1
40216,follow-up,0,0
40217,of,0,0
40218,8,0,0
40219,years,0,0
40220,",",0,0
40221,80,0,0
40222,patients,0,0
40223,(,0,0
40224,52,0,0
40225,%,0,0
40226,),0,0
40227,have,0,0
40228,progressed,0,0
40229,with,0,0
40230,no,0,0
40231,difference,0,0
40232,in,0,0
40233,the,0,0
40234,pattern,1,0
40235,of,1,0
40236,relapse,1,1
40237,between,0,0
40238,the,0,0
40239,two,0,0
40240,groups,0,0
40241,and,0,0
40242,75,0,0
40243,patients,0,0
40244,(,0,0
40245,49,0,0
40246,%,0,0
40247,),0,0
40248,have,0,0
40249,died,1,0
40250,;,1,0
40251,the,0,0
40252,respective,0,0
40253,hazard,0,1
40254,ratios,0,1
40255,for,0,0
40256,PFS,0,1
40257,and,0,1
40258,OS,0,1
40259,with,0,0
40260,95,0,0
40261,%,0,0
40262,CI,0,0
40263,are,0,0
40264,0.89,0,0
40265,(,0,0
40266,0.59-1.33,0,0
40267,),0,0
40268,and,0,0
40269,0.82,0,0
40270,(,0,0
40271,0.52-1.29,0,0
40272,),0,0
40273,.,0,0
40274,These,0,0
40275,results,0,0
40276,are,0,0
40277,suggestive,0,0
40278,of,0,0
40279,a,0,0
40280,treatment,0,0
40281,benefit,0,0
40282,but,0,0
40283,do,0,0
40284,not,0,0
40285,support,0,0
40286,a,0,0
40287,change,0,1
40288,in,0,0
40289,clinical,0,0
40290,practice,0,0
40291,.,0,0
40292,Other,0,1
40293,randomized,0,0
40294,clinical,0,0
40295,trials,0,0
40296,of,0,0
40297,intraperitoneal,0,0
40298,CT,0,1
40299,are,0,0
40300,reviewed,0,0
40301,and,0,0
40302,briefly,0,0
40303,discussed,0,0
40304,.,0,0
40305,Early,0,1
40306,reperfusion,0,1
40307,and,0,1
40308,late,0,1
40309,clinical,0,1
40310,outcomes,0,1
40311,in,0,0
40312,patients,0,0
40313,presenting,0,1
40314,with,0,0
40315,acute,0,0
40316,myocardial,0,1
40317,infarction,0,1
40318,randomly,0,0
40319,assigned,0,0
40320,to,0,0
40321,primary,0,0
40322,percutaneous,0,0
40323,coronary,0,1
40324,intervention,0,0
40325,or,0,0
40326,streptokinase,0,0
40327,.,0,1
40328,BACKGROUND,0,0
40329,Primary,0,1
40330,percutaneous,0,0
40331,coronary,0,1
40332,intervention,0,0
40333,(,0,1
40334,PCI,0,1
40335,),0,0
40336,has,0,0
40337,become,0,0
40338,an,0,0
40339,alternative,0,0
40340,to,0,0
40341,thrombolytic,0,0
40342,therapy,0,0
40343,as,0,0
40344,a,0,0
40345,reperfusion,0,1
40346,strategy,0,0
40347,for,0,0
40348,ST-elevation,0,1
40349,acute,0,0
40350,myocardial,0,1
40351,infarction,0,1
40352,(,0,1
40353,AMI,0,1
40354,),0,0
40355,.,0,0
40356,METHODS,0,0
40357,The,0,0
40358,main,0,0
40359,goal,0,0
40360,of,0,0
40361,this,0,0
40362,study,0,0
40363,was,0,0
40364,to,0,0
40365,determine,0,0
40366,whether,0,0
40367,PCI,0,1
40368,and,0,1
40369,thrombolytic,0,0
40370,therapy,0,0
40371,achieve,0,0
40372,comparable,0,0
40373,reperfusion,0,1
40374,rates,0,1
40375,",",0,0
40376,as,0,0
40377,evidenced,0,0
40378,by,0,0
40379,ST-segment,0,0
40380,resolution,0,1
40381,.,0,1
40382,Secondary,0,0
40383,end,0,0
40384,points,0,0
40385,included,0,0
40386,infarct,1,1
40387,vessel,1,1
40388,patency,1,1
40389,rates,1,1
40390,before,0,0
40391,hospital,0,1
40392,discharge,0,1
40393,and,0,1
40394,short-,1,1
40395,and,1,1
40396,long-term,1,1
40397,outcomes,1,1
40398,.,1,0
40399,Patients,0,0
40400,with,0,0
40401,ischemic,0,1
40402,chest,0,1
40403,pain,0,1
40404,with,0,0
40405,duration,0,1
40406,<,0,0
40407,or,0,1
40408,=12,0,0
40409,hours,0,1
40410,and,0,0
40411,no,0,0
40412,contraindication,0,0
40413,for,0,0
40414,thrombolytic,0,1
40415,therapy,0,0
40416,were,0,0
40417,included,0,0
40418,.,0,0
40419,RESULTS,0,0
40420,Between,0,0
40421,October,0,0
40422,1993,0,0
40423,and,0,0
40424,August,0,0
40425,1995,0,0
40426,",",0,0
40427,58,0,0
40428,patients,0,0
40429,were,0,0
40430,randomly,0,0
40431,assigned,0,0
40432,to,0,0
40433,streptokinase,0,0
40434,(,0,0
40435,SK,0,1
40436,),0,0
40437,and,0,0
40438,54,0,0
40439,patients,0,0
40440,to,0,0
40441,primary,0,0
40442,PCI,0,1
40443,.,0,0
40444,Baseline,0,0
40445,clinical,0,1
40446,characteristics,0,1
40447,and,0,1
40448,infarct,0,1
40449,location,0,1
40450,were,0,0
40451,well,0,0
40452,balanced,0,0
40453,in,0,0
40454,both,0,0
40455,groups,0,0
40456,.,0,0
40457,Median,0,1
40458,age,0,0
40459,(,0,0
40460,interquartile,0,1
40461,range,0,0
40462,),0,0
40463,was,0,0
40464,68,0,0
40465,(,0,0
40466,58,0,0
40467,",",0,0
40468,75,0,0
40469,),0,0
40470,years,0,0
40471,",",0,0
40472,29,0,0
40473,%,0,0
40474,were,0,0
40475,women,0,0
40476,",",0,0
40477,and,0,0
40478,78,0,0
40479,%,0,0
40480,of,0,0
40481,the,0,0
40482,patients,0,0
40483,met,0,0
40484,at,0,0
40485,least,0,0
40486,one,0,0
40487,criterion,0,0
40488,for,0,0
40489,not,0,0
40490,low,0,0
40491,risk,0,1
40492,AMI,0,1
40493,(,0,1
40494,anterior,0,1
40495,location,0,1
40496,",",0,1
40497,age,0,0
40498,>,0,0
40499,70,0,0
40500,years,0,0
40501,old,0,0
40502,",",0,0
40503,previous,0,0
40504,MI,0,1
40505,",",0,1
40506,systolic,0,1
40507,blood,1,1
40508,pressure,1,1
40509,<,0,0
40510,100,0,0
40511,mm,0,0
40512,Hg,0,0
40513,",",0,1
40514,and/or,0,0
40515,heart,0,1
40516,rate,0,1
40517,>,0,0
40518,100,0,0
40519,bpm,0,0
40520,),0,0
40521,.,0,0
40522,The,0,0
40523,median,1,1
40524,time,1,1
40525,from,1,0
40526,symptom,1,1
40527,onset,1,0
40528,to,0,0
40529,random,0,0
40530,assignment,0,0
40531,was,0,0
40532,217,0,0
40533,(,0,0
40534,139,0,0
40535,",",0,0
40536,335,0,0
40537,),0,0
40538,minutes,0,0
40539,in,0,0
40540,the,0,0
40541,PCI,0,1
40542,group,0,0
40543,and,0,0
40544,210,0,0
40545,(,0,0
40546,145,0,0
40547,",",0,0
40548,334,0,0
40549,),0,0
40550,minutes,0,0
40551,in,0,0
40552,the,0,0
40553,SK,0,1
40554,group,0,0
40555,.,0,0
40556,Median,0,1
40557,random,0,0
40558,assignment,0,0
40559,to,0,0
40560,balloon,1,0
40561,time,1,1
40562,was,0,0
40563,82,0,0
40564,(,0,0
40565,55,0,0
40566,",",0,0
40567,100,0,0
40568,),0,0
40569,minutes,0,0
40570,",",0,1
40571,and,0,1
40572,median,0,1
40573,random,0,0
40574,assignment,0,0
40575,to,0,0
40576,needle,1,0
40577,time,1,1
40578,was,0,0
40579,15,0,0
40580,(,0,0
40581,10,0,0
40582,",",0,0
40583,26,0,0
40584,),0,0
40585,minutes,0,0
40586,(,0,0
40587,P,0,0
40588,<,0,0
40589,.0001,0,0
40590,),0,0
40591,.,0,0
40592,TIMI,1,0
40593,grade,1,0
40594,3,1,0
40595,flow,1,1
40596,after,0,0
40597,primary,0,0
40598,PCI,0,1
40599,was,0,0
40600,obtained,0,0
40601,in,0,0
40602,85,0,0
40603,%,0,0
40604,of,0,0
40605,patients,0,0
40606,.,0,0
40607,The,0,0
40608,proportion,0,0
40609,of,0,0
40610,patients,0,0
40611,with,0,0
40612,ST-segment,1,1
40613,resolution,1,1
40614,>,0,0
40615,or,0,1
40616,=50,0,0
40617,%,0,0
40618,at,0,0
40619,120,0,0
40620,minutes,0,0
40621,was,0,0
40622,80,0,0
40623,%,0,0
40624,in,0,0
40625,the,0,0
40626,PCI,0,1
40627,group,0,0
40628,and,0,0
40629,50,0,0
40630,%,0,0
40631,in,0,0
40632,the,0,0
40633,SK,0,1
40634,group,0,0
40635,(,0,0
40636,P,0,0
40637,=.001,0,0
40638,),0,0
40639,.,0,0
40640,The,0,0
40641,predischarge,0,1
40642,angiogram,0,1
40643,showed,0,0
40644,the,0,0
40645,presence,1,0
40646,of,1,0
40647,TIMI,1,0
40648,3,1,0
40649,flow,1,1
40650,in,0,0
40651,96,0,0
40652,%,0,0
40653,of,0,0
40654,patients,0,0
40655,who,0,0
40656,received,0,0
40657,PCI,0,1
40658,and,0,0
40659,65,0,0
40660,%,0,0
40661,of,0,0
40662,patients,0,0
40663,who,0,0
40664,received,0,0
40665,SK,0,1
40666,(,0,0
40667,P,0,0
40668,<,0,0
40669,.001,0,0
40670,),0,0
40671,.,0,0
40672,A,0,0
40673,composite,0,1
40674,of,0,0
40675,in-hospital,1,1
40676,death,1,1
40677,",",1,1
40678,reinfarction,1,1
40679,",",1,1
40680,severe,1,1
40681,heart,1,1
40682,failure,1,1
40683,",",1,1
40684,stroke,1,1
40685,",",1,1
40686,and,1,1
40687,major,1,1
40688,bleeding,1,1
40689,occurred,0,0
40690,in,0,0
40691,15,0,0
40692,%,0,0
40693,of,0,0
40694,patients,0,0
40695,who,0,0
40696,received,0,0
40697,PCI,0,1
40698,and,0,0
40699,21,0,0
40700,%,0,0
40701,of,0,0
40702,patients,0,0
40703,who,0,0
40704,received,0,0
40705,SK,0,1
40706,(,0,0
40707,P,0,0
40708,=.4,0,0
40709,),0,0
40710,.,0,0
40711,At,0,0
40712,3,0,0
40713,years,0,0
40714,",",0,0
40715,freedom,0,1
40716,from,0,0
40717,the,0,0
40718,composite,1,1
40719,end,1,0
40720,point,1,0
40721,of,1,1
40722,AMI,1,1
40723,",",1,1
40724,postdischarge,1,1
40725,revascularization,1,1
40726,",",1,1
40727,and,1,1
40728,death,1,1
40729,was,0,0
40730,61,0,0
40731,%,0,0
40732,in,0,0
40733,the,0,0
40734,PCI,0,1
40735,group,0,0
40736,and,0,0
40737,40,0,0
40738,%,0,0
40739,in,0,0
40740,the,0,0
40741,SK,0,1
40742,group,0,0
40743,(,0,0
40744,P,0,0
40745,=.025,0,0
40746,),0,0
40747,.,0,0
40748,CONCLUSIONS,0,0
40749,Our,0,0
40750,study,0,0
40751,shows,0,0
40752,that,0,0
40753,primary,0,0
40754,PCI,0,1
40755,",",0,0
40756,as,0,0
40757,compared,0,0
40758,with,0,0
40759,SK,0,0
40760,",",0,0
40761,is,0,0
40762,associated,0,0
40763,with,0,0
40764,more,0,0
40765,effective,0,1
40766,ST-segment,1,1
40767,resolution,1,1
40768,",",0,1
40769,higher,0,1
40770,patency,1,1
40771,rates,1,1
40772,in,0,0
40773,the,0,0
40774,infarct,0,1
40775,vessel,0,1
40776,at,0,0
40777,7,0,0
40778,days,0,0
40779,",",0,0
40780,and,0,1
40781,more,0,1
40782,favorable,0,1
40783,clinical,0,0
40784,outcomes,0,1
40785,at,0,0
40786,3,0,0
40787,years,0,0
40788,of,0,0
40789,follow-up,0,0
40790,.,0,0
40791,The,0,0
40792,effect,0,0
40793,of,0,0
40794,use,0,0
40795,of,0,1
40796,pyridostigmine,0,0
40797,and,0,1
40798,requirement,0,1
40799,of,0,1
40800,vecuronium,0,0
40801,in,0,0
40802,patients,0,0
40803,with,0,0
40804,myasthenia,0,0
40805,gravis,0,0
40806,.,0,0
40807,CONTEXT,0,0
40808,Patients,0,0
40809,with,0,0
40810,myasthenia,0,0
40811,gravis,0,0
40812,receive,0,0
40813,pyridostigmine,0,0
40814,",",0,0
40815,an,0,0
40816,anticholinesterase,0,1
40817,agent,0,0
40818,",",0,0
40819,as,0,0
40820,a,0,0
40821,part,0,0
40822,of,0,0
40823,therapy,0,0
40824,.,0,0
40825,These,0,0
40826,patients,0,0
40827,demonstrate,0,0
40828,a,0,0
40829,heightened,0,0
40830,sensitivity,0,1
40831,towards,0,0
40832,non-depolarising,0,0
40833,muscle,0,1
40834,relaxants,0,1
40835,.,0,0
40836,Continuing,0,0
40837,pyridostigmine,0,0
40838,till,0,0
40839,the,0,0
40840,day,0,0
40841,of,0,0
40842,the,0,0
40843,surgery,0,0
40844,or,0,0
40845,omitting,0,0
40846,it,0,0
40847,on,0,0
40848,the,0,0
40849,night,0,1
40850,before,0,0
40851,surgery,0,0
40852,could,0,0
40853,provide,0,0
40854,variable,0,0
40855,results,0,0
40856,with,0,0
40857,regards,0,0
40858,to,0,0
40859,the,0,0
40860,effect,0,0
40861,of,0,0
40862,vecuronium,0,0
40863,.,0,0
40864,AIMS,0,1
40865,Myographic,0,1
40866,evaluation,0,0
40867,of,0,0
40868,a,0,0
40869,dose,0,0
40870,of,0,0
40871,vecuronium,0,0
40872,in,0,0
40873,patients,0,0
40874,with,0,0
40875,myasthenia,0,0
40876,gravis,0,0
40877,on,0,0
40878,pyridostigmine,0,0
40879,therapy,0,0
40880,.,0,1
40881,SETTING,0,0
40882,AND,0,0
40883,DESIGN,0,1
40884,A,0,0
40885,randomised,0,0
40886,",",0,1
40887,double-blind,0,0
40888,",",0,1
40889,clinical,0,1
40890,study,0,0
40891,conducted,0,0
40892,in,0,0
40893,a,0,0
40894,teaching,0,0
40895,hospital,0,1
40896,.,0,0
40897,SUBJECTS,0,1
40898,AND,0,0
40899,METHODS,0,0
40900,Medically,0,0
40901,(,0,0
40902,oral,0,0
40903,pyridostigmine,0,0
40904,),0,1
40905,well-controlled,0,0
40906,adult,0,0
40907,patients,0,0
40908,with,0,0
40909,myasthenia,0,0
40910,gravis,0,0
40911,who,0,0
40912,were,0,0
40913,posted,0,0
40914,for,0,0
40915,thymectomy,0,0
40916,",",0,1
40917,were,0,0
40918,randomly,0,0
40919,divided,0,0
40920,into,0,0
40921,two,0,0
40922,groups,0,0
40923,.,0,0
40924,Patients,0,0
40925,in,0,0
40926,Group,0,0
40927,1,0,0
40928,received,0,0
40929,their,0,0
40930,last,0,1
40931,dose,0,0
40932,of,0,1
40933,pyridostigmine,0,0
40934,on,0,0
40935,the,0,0
40936,night,0,1
40937,before,0,0
40938,surgery,0,0
40939,while,0,0
40940,those,0,0
40941,in,0,0
40942,Group,0,0
40943,2,0,0
40944,received,0,0
40945,even,0,0
40946,the,0,0
40947,morning,0,1
40948,dose,0,0
40949,of,0,0
40950,the,0,0
40951,drug,0,0
40952,on,0,0
40953,the,0,0
40954,day,0,0
40955,of,0,0
40956,surgery,0,0
40957,.,0,1
40958,Neostigmine,0,0
40959,(,0,0
40960,1-2,0,1
40961,mg,0,0
40962,),0,0
40963,intravenously,0,0
40964,was,0,0
40965,used,0,0
40966,as,0,0
40967,rescue,0,1
40968,medication,0,0
40969,.,0,1
40970,Vecuronium,0,0
40971,(,0,0
40972,0.01,0,0
40973,mg/kg,0,0
40974,),0,0
40975,was,0,0
40976,used,0,0
40977,for,0,0
40978,intubation,0,0
40979,and,0,1
40980,muscle,0,1
40981,relaxation,0,1
40982,during,0,0
40983,trans-sternal,0,0
40984,thymectomy,0,0
40985,and,0,0
40986,its,0,1
40987,effect,0,1
40988,was,0,0
40989,reversed,0,1
40990,using,0,0
40991,neostigmine,0,0
40992,and,0,1
40993,atropine,0,0
40994,.,0,1
40995,RESULTS,0,0
40996,Fourteen,0,0
40997,patients,0,0
40998,(,0,0
40999,7,0,0
41000,in,0,0
41001,each,0,0
41002,group,0,0
41003,),0,0
41004,belonging,0,0
41005,to,0,0
41006,both,0,0
41007,sexes,0,0
41008,were,0,0
41009,enrolled,0,0
41010,in,0,0
41011,the,0,0
41012,study,0,0
41013,.,0,0
41014,The,0,0
41015,intubating,0,0
41016,dose,0,0
41017,of,0,1
41018,vecuronium,0,0
41019,showed,0,0
41020,quicker,0,1
41021,onset,1,1
41022,time,1,1
41023,(,0,0
41024,155,0,0
41025,sec,0,0
41026,or,0,0
41027,2.7,0,0
41028,min,0,0
41029,approx,0,0
41030,.,0,1
41031,),0,0
41032,and,0,1
41033,peak,1,1
41034,effect,1,1
41035,(,0,0
41036,99,0,0
41037,%,0,0
41038,T1,0,0
41039,suppression,0,1
41040,),0,0
41041,in,0,0
41042,patients,0,0
41043,belonging,0,0
41044,to,0,0
41045,Group,0,0
41046,1,0,0
41047,",",0,0
41048,and,0,0
41049,3/7,0,1
41050,(,0,0
41051,43,0,0
41052,%,0,0
41053,),0,0
41054,complained,0,0
41055,of,0,0
41056,respiratory,0,1
41057,discomfort,0,1
41058,while,0,0
41059,waiting,0,1
41060,for,0,0
41061,surgery,0,0
41062,.,0,0
41063,By,0,0
41064,giving,0,0
41065,the,0,0
41066,morning,0,1
41067,dose,0,0
41068,of,0,1
41069,pyridostigmine,0,0
41070,(,0,0
41071,Group,0,0
41072,2,0,0
41073,),0,0
41074,",",0,0
41075,an,0,0
41076,identical,0,0
41077,intubating,0,0
41078,dose,0,0
41079,of,0,1
41080,vecuronium,0,0
41081,showed,0,0
41082,relative,1,1
41083,resistance,1,1
41084,(,0,0
41085,peak,0,1
41086,effect-97,0,1
41087,%,0,0
41088,T1,0,1
41089,suppression,0,1
41090,),0,1
41091,and,0,1
41092,delayed,1,1
41093,onset,1,1
41094,time,1,1
41095,(,0,0
41096,198,0,0
41097,sec,0,1
41098,approx.,0,0
41099,),0,0
41100,.,0,0
41101,However,0,0
41102,",",0,0
41103,the,0,0
41104,reversal,0,1
41105,was,0,0
41106,complete,0,1
41107,at,0,0
41108,the,0,0
41109,end,0,0
41110,of,0,0
41111,surgery,0,0
41112,in,0,0
41113,both,0,0
41114,the,0,0
41115,regimens,0,0
41116,.,0,0
41117,CONCLUSIONS,0,0
41118,Omission,0,1
41119,of,0,0
41120,the,0,0
41121,pyridostigmine,0,0
41122,dose,0,0
41123,on,0,0
41124,the,0,0
41125,day,0,0
41126,of,0,0
41127,surgery,0,0
41128,predisposed,0,0
41129,patients,0,0
41130,with,0,0
41131,myasthenia,0,0
41132,gravis,0,0
41133,to,0,0
41134,the,0,0
41135,possibility,0,0
41136,of,0,0
41137,respiratory,0,1
41138,discomfort,0,1
41139,and,0,1
41140,sensitivity,0,1
41141,to,0,0
41142,vecuronium,0,0
41143,.,0,0
41144,Continued,0,0
41145,administration,0,0
41146,significantly,0,0
41147,prolonged,0,0
41148,the,0,0
41149,onset,0,1
41150,time,0,1
41151,of,0,1
41152,vecuronium,0,0
41153,and,0,0
41154,the,0,0
41155,patients,0,0
41156,required,0,0
41157,a,0,0
41158,higher,0,0
41159,dose,0,0
41160,of,0,1
41161,vecuronium,0,0
41162,.,0,0
41163,Randomized,0,0
41164,Phase,0,1
41165,II,0,0
41166,trial,0,0
41167,assessing,0,0
41168,estramustine,0,0
41169,and,0,1
41170,vinblastine,0,0
41171,combination,0,0
41172,chemotherapy,0,0
41173,vs,0,0
41174,estramustine,0,0
41175,alone,0,0
41176,in,0,0
41177,patients,0,0
41178,with,0,0
41179,progressive,0,0
41180,hormone-escaped,0,0
41181,metastatic,0,0
41182,prostate,0,0
41183,cancer,0,0
41184,.,0,0
41185,Based,0,0
41186,on,0,0
41187,the,0,0
41188,results,0,0
41189,of,0,0
41190,combined,0,0
41191,data,0,0
41192,from,0,0
41193,three,0,0
41194,North,0,0
41195,American,0,0
41196,Phase,0,1
41197,II,0,0
41198,studies,0,0
41199,",",0,0
41200,a,0,0
41201,randomised,0,0
41202,Phase,0,1
41203,II,0,0
41204,study,0,0
41205,in,0,0
41206,the,0,0
41207,same,0,0
41208,patient,0,1
41209,population,0,0
41210,was,0,0
41211,performed,0,0
41212,",",0,0
41213,using,0,0
41214,combination,0,0
41215,chemotherapy,0,0
41216,with,0,0
41217,estramustine,0,0
41218,phosphate,0,0
41219,(,0,1
41220,EMP,0,1
41221,),0,1
41222,and,0,1
41223,vinblastine,0,0
41224,(,0,1
41225,VBL,0,1
41226,),0,1
41227,in,0,0
41228,hormone,0,1
41229,refractory,0,0
41230,prostate,0,0
41231,cancer,0,0
41232,patients,0,0
41233,.,0,0
41234,In,0,0
41235,all,0,0
41236,",",0,0
41237,92,0,0
41238,patients,0,0
41239,were,0,0
41240,randomised,0,0
41241,into,0,0
41242,a,0,0
41243,Phase,0,1
41244,II,0,0
41245,study,0,0
41246,of,0,1
41247,oral,0,0
41248,EMP,0,1
41249,(,0,0
41250,10,0,0
41251,mg,0,0
41252,kg,0,0
41253,day,0,0
41254,continuously,0,0
41255,),0,0
41256,or,0,0
41257,oral,0,0
41258,EMP,0,1
41259,in,0,0
41260,combination,0,0
41261,with,0,0
41262,intravenous,0,0
41263,VBL,0,0
41264,(,0,0
41265,4,0,0
41266,mg,0,0
41267,m,0,0
41268,(,0,0
41269,2,0,0
41270,),0,0
41271,week,0,0
41272,for,0,0
41273,6,0,0
41274,weeks,0,0
41275,",",0,0
41276,followed,0,0
41277,by,0,0
41278,2,0,0
41279,weeks,0,0
41280,rest,0,0
41281,),0,0
41282,.,0,0
41283,The,0,0
41284,end,0,0
41285,points,0,0
41286,were,0,0
41287,toxicity,1,1
41288,and,1,1
41289,PSA,1,1
41290,response,1,1
41291,in,0,0
41292,both,0,0
41293,groups,0,0
41294,",",0,0
41295,with,0,0
41296,the,0,0
41297,option,0,0
41298,to,0,0
41299,continue,0,0
41300,the,0,0
41301,trial,0,0
41302,as,0,0
41303,a,0,0
41304,Phase,0,1
41305,III,0,0
41306,study,0,0
41307,with,0,0
41308,time,1,1
41309,to,1,0
41310,progression,1,1
41311,and,0,1
41312,survival,1,1
41313,as,0,0
41314,end,0,0
41315,points,0,0
41316,",",0,0
41317,if,0,0
41318,sufficient,0,0
41319,responses,0,1
41320,were,0,0
41321,observed,0,0
41322,.,0,0
41323,Toxicity,1,1
41324,was,0,0
41325,unexpectedly,0,0
41326,high,0,0
41327,in,0,0
41328,both,0,0
41329,treatment,0,0
41330,arms,0,1
41331,and,0,1
41332,led,0,0
41333,to,0,0
41334,treatment,0,0
41335,withdrawal,0,1
41336,or,0,1
41337,refusal,0,1
41338,in,0,0
41339,49,0,0
41340,%,0,0
41341,of,0,0
41342,all,0,0
41343,patients,0,0
41344,",",0,0
41345,predominantly,0,0
41346,already,0,0
41347,during,0,0
41348,the,0,0
41349,first,0,0
41350,treatment,0,0
41351,cycle,0,1
41352,.,0,0
41353,The,0,0
41354,mean,1,1
41355,treatment,1,0
41356,duration,1,1
41357,was,0,0
41358,10,0,0
41359,and,0,0
41360,14,0,0
41361,weeks,0,0
41362,",",0,0
41363,median,1,1
41364,time,1,1
41365,to,1,0
41366,PSA,1,1
41367,progression,1,1
41368,was,0,0
41369,27.2,0,0
41370,and,0,0
41371,30.8,0,0
41372,weeks,0,0
41373,",",0,0
41374,median,1,1
41375,survival,1,1
41376,time,1,1
41377,was,0,0
41378,44,0,0
41379,and,0,0
41380,50.9,0,0
41381,weeks,0,0
41382,",",0,0
41383,and,0,1
41384,PSA,1,1
41385,response,1,1
41386,rate,1,1
41387,was,0,0
41388,only,0,0
41389,24.6,0,0
41390,and,0,0
41391,28.9,0,0
41392,%,0,0
41393,in,0,0
41394,the,0,0
41395,EMP/VBL,0,0
41396,and,0,1
41397,EMP,0,1
41398,arms,0,1
41399,",",0,0
41400,respectively,0,0
41401,.,0,0
41402,There,0,0
41403,was,0,0
41404,no,0,0
41405,correlation,0,0
41406,between,0,0
41407,PSA,1,1
41408,response,1,1
41409,and,1,1
41410,survival,1,1
41411,.,1,0
41412,While,0,0
41413,the,0,0
41414,PSA,1,1
41415,response,1,1
41416,in,0,0
41417,the,0,0
41418,patients,0,0
41419,tested,0,0
41420,was,0,0
41421,less,0,0
41422,than,0,0
41423,half,0,1
41424,that,0,0
41425,recorded,0,0
41426,in,0,0
41427,the,0,0
41428,North,0,0
41429,American,0,0
41430,studies,0,0
41431,",",0,0
41432,the,0,0
41433,toxicity,1,1
41434,of,1,0
41435,EMP,1,1
41436,monotherapy,1,0
41437,or,0,1
41438,in,0,0
41439,combination,0,0
41440,with,0,0
41441,VBL,0,1
41442,was,0,0
41443,much,0,0
41444,higher,0,0
41445,than,0,0
41446,expected,0,0
41447,.,0,0
41448,Further,0,0
41449,research,0,0
41450,on,0,0
41451,more,0,0
41452,effective,1,1
41453,and,0,1
41454,less,0,0
41455,toxic,1,1
41456,treatment,0,0
41457,strategies,0,0
41458,for,0,0
41459,hormone,0,1
41460,refractory,0,0
41461,prostate,0,0
41462,cancer,0,0
41463,is,0,0
41464,mandatory,0,0
41465,.,0,0
41466,The,0,0
41467,long-term,0,0
41468,effect,0,1
41469,of,0,1
41470,oxandrolone,0,0
41471,on,0,0
41472,hepatic,0,1
41473,acute,0,0
41474,phase,0,0
41475,proteins,0,0
41476,in,0,0
41477,severely,0,0
41478,burned,0,0
41479,children,0,0
41480,.,0,0
41481,BACKGROUND,0,0
41482,Acute,0,1
41483,phase,0,0
41484,protein,0,1
41485,production,0,1
41486,is,0,0
41487,a,0,0
41488,hallmark,0,0
41489,of,0,0
41490,severe,0,1
41491,burns,0,1
41492,.,0,0
41493,We,0,0
41494,wondered,0,0
41495,whether,0,0
41496,anabolic,0,1
41497,treatment,0,0
41498,with,0,0
41499,oxandrolone,0,0
41500,would,0,0
41501,affect,0,0
41502,these,0,0
41503,proteins,0,0
41504,.,0,0
41505,METHODS,0,0
41506,Thirty-five,0,0
41507,children,0,0
41508,with,0,0
41509,>,0,0
41510,or,0,0
41511,=40,0,0
41512,%,0,0
41513,total,0,1
41514,body,0,1
41515,surface,0,1
41516,area,0,1
41517,burns,0,1
41518,were,0,0
41519,randomized,0,0
41520,to,0,0
41521,receive,0,0
41522,either,0,0
41523,placebo,0,0
41524,or,0,1
41525,oxandrolone,0,0
41526,(,0,0
41527,0.1,0,0
41528,mg/kg,0,0
41529,by,0,0
41530,mouth,0,1
41531,twice,0,0
41532,daily,0,0
41533,),0,0
41534,from,0,0
41535,postoperative,0,1
41536,day,0,0
41537,5,0,0
41538,to,0,0
41539,1,0,0
41540,year,0,0
41541,postburn,0,0
41542,.,0,1
41543,Levels,0,1
41544,of,0,0
41545,constitutive,0,1
41546,proteins,0,0
41547,and,0,1
41548,acute,0,1
41549,phase,0,0
41550,proteins,0,1
41551,were,0,0
41552,measured,0,0
41553,at,0,0
41554,admission,0,0
41555,;,0,0
41556,at,0,0
41557,discharge,0,0
41558,;,0,0
41559,and,0,0
41560,at,0,0
41561,6,0,0
41562,",",0,0
41563,9,0,0
41564,",",0,0
41565,and,0,0
41566,12,0,0
41567,months,0,0
41568,after,0,0
41569,burn,0,0
41570,.,0,0
41571,Total,1,1
41572,albumin,1,1
41573,supplementation,1,0
41574,and,1,1
41575,hepatic,1,1
41576,transaminases,1,1
41577,were,0,0
41578,also,0,0
41579,assessed,0,0
41580,.,0,0
41581,RESULTS,0,0
41582,Constitutive,1,1
41583,proteins,1,0
41584,such,1,0
41585,as,1,0
41586,albumin,1,1
41587,",",1,1
41588,prealbumin,1,1
41589,",",1,1
41590,and,1,1
41591,retinol-binding,1,1
41592,protein,1,1
41593,levels,1,1
41594,increased,0,1
41595,(,0,0
41596,p,0,0
41597,<,0,0
41598,0.05,0,0
41599,),0,0
41600,",",0,0
41601,and,0,1
41602,acute,1,1
41603,phase,1,0
41604,proteins,1,1
41605,such,1,0
41606,as,1,0
41607,alpha,1,1
41608,1-acid,1,1
41609,glycoprotein,1,1
41610,",",1,1
41611,C3,1,1
41612,complement,1,1
41613,",",1,1
41614,alpha,1,1
41615,2-macroglobulin,1,1
41616,",",1,1
41617,and,1,1
41618,fibrinogen,1,1
41619,levels,1,1
41620,significantly,0,0
41621,decreased,0,0
41622,in,0,0
41623,the,0,0
41624,oxandrolone,0,0
41625,group,0,0
41626,compared,0,0
41627,with,0,0
41628,placebo,0,0
41629,(,0,0
41630,p,0,0
41631,<,0,0
41632,0.05,0,0
41633,),0,0
41634,.,0,0
41635,Albumin,1,1
41636,supplementation,1,0
41637,during,1,0
41638,the,1,0
41639,acute,1,0
41640,hospitalization,1,1
41641,was,0,0
41642,reduced,0,0
41643,in,0,0
41644,the,0,0
41645,oxandrolone,0,0
41646,group,0,0
41647,.,0,1
41648,Hepatic,1,1
41649,transaminases,1,1
41650,remained,0,0
41651,within,0,0
41652,normal,1,0
41653,levels,1,1
41654,.,1,0
41655,CONCLUSION,0,0
41656,Treatment,0,0
41657,with,0,0
41658,oxandrolone,0,0
41659,in,0,0
41660,severe,0,1
41661,burns,0,1
41662,significantly,0,0
41663,increases,0,0
41664,constitutive,1,1
41665,protein,1,1
41666,and,0,1
41667,reduces,0,1
41668,acute,1,1
41669,phase,1,0
41670,protein,1,1
41671,levels,1,1
41672,.,1,0
41673,Body,0,0
41674,asymmetry,0,1
41675,affects,0,0
41676,conjugate,1,0
41677,lateral,1,0
41678,eye,1,0
41679,movement,1,1
41680,.,1,1
41681,A.,0,1
41682,H.,0,1
41683,Baker,0,0
41684,(,0,0
41685,1989,0,0
41686,),0,0
41687,and,0,0
41688,A.,0,1
41689,H.,0,1
41690,Baker,0,0
41691,and,0,1
41692,A.,0,1
41693,I.,0,1
41694,Ledner,0,1
41695,(,0,0
41696,1990,0,0
41697,),0,0
41698,reported,0,0
41699,that,0,0
41700,asymmetrical,0,0
41701,visual,0,1
41702,stimulation,0,1
41703,affects,0,0
41704,conjugate,1,0
41705,lateral,1,0
41706,eye,1,1
41707,movement,1,1
41708,(,1,1
41709,CLEM,1,1
41710,),1,0
41711,.,1,0
41712,In,0,0
41713,the,0,0
41714,present,0,0
41715,article,0,0
41716,",",0,0
41717,the,0,0
41718,authors,0,0
41719,explored,0,0
41720,whether,0,0
41721,asymmetrical,0,1
41722,body,0,1
41723,position,0,0
41724,similarly,0,0
41725,affects,0,0
41726,CLEM,0,0
41727,.,0,0
41728,The,0,0
41729,authors,0,0
41730,assessed,0,0
41731,CLEMs,0,0
41732,twice,0,0
41733,in,0,0
41734,a,0,0
41735,counterbalanced,0,0
41736,design,0,0
41737,.,0,0
41738,In,0,0
41739,the,0,0
41740,control,0,0
41741,(,0,0
41742,symmetric,0,0
41743,),0,1
41744,condition,0,0
41745,",",0,0
41746,each,0,0
41747,participant,0,0
41748,sat,0,1
41749,in,0,0
41750,a,0,0
41751,completely,0,0
41752,symmetrical,0,0
41753,position,0,1
41754,facing,0,0
41755,a,0,0
41756,wall,0,1
41757,devoid,0,0
41758,of,0,0
41759,any,0,0
41760,asymmetrical,0,0
41761,features,0,0
41762,.,0,0
41763,In,0,0
41764,the,0,0
41765,experimental,0,0
41766,(,0,0
41767,asymmetrical,0,1
41768,),0,1
41769,condition,0,0
41770,",",0,0
41771,half,0,0
41772,the,0,0
41773,participants,0,0
41774,rotated,0,0
41775,their,0,0
41776,heads,0,0
41777,68,0,0
41778,degrees,0,0
41779,clockwise,0,0
41780,relative,0,0
41781,to,0,0
41782,their,0,0
41783,bodies,0,0
41784,to,0,0
41785,face,0,0
41786,the,0,0
41787,experimenter,0,0
41788,",",0,0
41789,and,0,0
41790,the,0,0
41791,other,0,0
41792,half,0,1
41793,rotated,0,0
41794,their,0,0
41795,heads,0,0
41796,68,0,0
41797,degrees,0,0
41798,counterclockwise,0,0
41799,",",0,0
41800,also,0,0
41801,to,0,0
41802,face,0,0
41803,the,0,0
41804,experimenter,0,0
41805,.,0,1
41806,CLEM,0,1
41807,was,0,0
41808,predominantly,0,0
41809,toward,0,0
41810,the,0,0
41811,body,0,1
41812,'s,0,1
41813,position,0,1
41814,in,0,0
41815,the,0,0
41816,asymmetrical,0,0
41817,condition,0,0
41818,rather,0,0
41819,than,0,0
41820,toward,0,0
41821,the,0,0
41822,body,0,1
41823,'s,0,1
41824,position,0,1
41825,in,0,0
41826,the,0,0
41827,symmetrical,0,0
41828,condition,0,0
41829,.,0,0
41830,Pretreatment,0,0
41831,with,0,0
41832,thiopental,0,0
41833,for,0,0
41834,prevention,0,0
41835,of,0,1
41836,pain,1,1
41837,associated,1,0
41838,with,1,0
41839,propofol,1,0
41840,injection,1,0
41841,.,1,0
41842,UNLABELLED,0,0
41843,Propofol,0,0
41844,causes,0,0
41845,pain,1,1
41846,on,1,0
41847,IV,1,1
41848,injection,1,0
41849,in,0,0
41850,28,0,0
41851,%,0,0
41852,-90,0,0
41853,%,0,0
41854,of,0,0
41855,patients,0,0
41856,.,0,0
41857,A,0,0
41858,number,0,1
41859,of,0,0
41860,techniques,0,0
41861,have,0,0
41862,been,0,0
41863,tried,0,0
41864,to,0,0
41865,minimize,0,0
41866,propofol-induced,0,1
41867,pain,0,1
41868,",",0,0
41869,with,0,0
41870,variable,0,0
41871,results,0,0
41872,.,0,0
41873,We,0,0
41874,compared,0,0
41875,the,0,0
41876,efficacy,0,1
41877,of,0,0
41878,pretreatment,0,0
41879,with,0,0
41880,thiopental,0,0
41881,0.25,0,0
41882,mg/kg,0,0
41883,and,0,0
41884,0.5,0,0
41885,mg/kg,0,0
41886,and,0,0
41887,lidocaine,0,0
41888,40,0,0
41889,mg,0,0
41890,after,0,0
41891,venous,0,1
41892,occlusion,0,0
41893,for,0,0
41894,prevention,0,0
41895,of,0,1
41896,propofol-induced,1,1
41897,pain,1,1
41898,.,1,1
41899,One-hundred-twenty-four,0,0
41900,adult,0,0
41901,patients,0,0
41902,",",0,1
41903,ASA,0,1
41904,physical,0,1
41905,status,0,1
41906,I-II,0,0
41907,",",0,0
41908,undergoing,0,0
41909,elective,0,0
41910,surgery,0,0
41911,were,0,0
41912,randomly,0,0
41913,assigned,0,0
41914,into,0,0
41915,4,0,0
41916,groups,0,0
41917,of,0,0
41918,31,0,0
41919,each,0,0
41920,.,0,0
41921,Group,0,0
41922,I,0,0
41923,received,0,0
41924,normal,0,0
41925,saline,0,0
41926,",",0,1
41927,group,0,0
41928,II,0,0
41929,received,0,0
41930,lidocaine,0,0
41931,2,0,0
41932,%,0,0
41933,(,0,0
41934,40,0,0
41935,mg,0,0
41936,),0,0
41937,",",0,1
41938,and,0,1
41939,groups,0,0
41940,III,0,1
41941,and,0,1
41942,IV,0,1
41943,received,0,0
41944,thiopental,0,0
41945,0.25,0,0
41946,mg/kg,0,0
41947,and,0,0
41948,0.5,0,0
41949,mg/kg,0,0
41950,",",0,0
41951,respectively,0,0
41952,.,0,0
41953,All,0,0
41954,pretreatment,0,0
41955,drugs,0,0
41956,were,0,0
41957,made,0,0
41958,in,0,0
41959,2,0,0
41960,mL,0,0
41961,and,0,0
41962,were,0,0
41963,accompanied,0,0
41964,by,0,0
41965,manual,0,0
41966,venous,0,1
41967,occlusion,0,0
41968,for,0,0
41969,1,0,0
41970,min,0,0
41971,.,0,0
41972,Propofol,0,0
41973,was,0,0
41974,administered,0,0
41975,after,0,0
41976,release,0,1
41977,of,0,1
41978,venous,0,1
41979,occlusion,0,0
41980,.,0,1
41981,Pain,1,1
41982,was,0,0
41983,assessed,0,0
41984,with,0,0
41985,a,0,0
41986,four-point,0,1
41987,scale,0,1
41988,:,0,0
41989,0,0,0
41990,=,0,0
41991,no,0,0
41992,pain,0,1
41993,",",0,0
41994,1,0,0
41995,=,0,0
41996,mild,0,0
41997,pain,0,1
41998,",",0,0
41999,2,0,0
42000,=,0,0
42001,moderate,0,0
42002,pain,0,1
42003,",",0,0
42004,and,0,0
42005,3,0,0
42006,=,0,0
42007,severe,0,0
42008,pain,0,1
42009,at,0,0
42010,the,0,0
42011,time,0,1
42012,of,0,0
42013,propofol,0,0
42014,injection,0,0
42015,.,0,0
42016,Twenty-four,0,0
42017,patients,0,0
42018,(,0,0
42019,77,0,0
42020,%,0,0
42021,),0,0
42022,complained,0,0
42023,of,0,0
42024,pain,1,1
42025,in,0,0
42026,the,0,0
42027,group,0,0
42028,pretreated,0,0
42029,with,0,0
42030,normal,0,0
42031,saline,0,0
42032,as,0,0
42033,compared,0,0
42034,with,0,0
42035,12,0,0
42036,(,0,0
42037,39,0,0
42038,%,0,0
42039,),0,0
42040,",",0,0
42041,10,0,0
42042,(,0,0
42043,32,0,0
42044,%,0,0
42045,),0,0
42046,",",0,0
42047,and,0,0
42048,1,0,0
42049,(,0,0
42050,3,0,0
42051,%,0,0
42052,),0,0
42053,in,0,0
42054,the,0,0
42055,groups,0,0
42056,pretreated,0,0
42057,with,0,0
42058,lidocaine,0,0
42059,40,0,0
42060,mg,0,0
42061,",",0,0
42062,thiopental,0,0
42063,0.25,0,0
42064,mg/kg,0,0
42065,",",0,0
42066,and,0,1
42067,thiopental,0,0
42068,0.5,0,0
42069,mg/kg,0,0
42070,",",0,0
42071,respectively,0,0
42072,(,0,0
42073,P,0,0
42074,<,0,0
42075,0.05,0,0
42076,),0,0
42077,.,0,0
42078,Thiopental,0,0
42079,0.5,0,0
42080,mg/kg,0,0
42081,was,0,0
42082,the,0,0
42083,most,0,0
42084,effective,1,1
42085,treatment,0,0
42086,.,0,0
42087,We,0,0
42088,therefore,0,0
42089,suggest,0,0
42090,routine,0,0
42091,pretreatment,0,0
42092,with,0,0
42093,thiopental,0,0
42094,0.5,0,0
42095,mg/kg,0,0
42096,along,0,0
42097,with,0,0
42098,venous,0,1
42099,occlusion,0,0
42100,for,0,0
42101,1,0,0
42102,min,0,0
42103,for,0,0
42104,prevention,0,0
42105,of,0,1
42106,pain,1,1
42107,associated,0,0
42108,with,0,0
42109,propofol,0,0
42110,injection,0,0
42111,.,0,0
42112,IMPLICATIONS,0,1
42113,Pain,1,1
42114,associated,0,0
42115,with,0,0
42116,IV,0,1
42117,injection,0,0
42118,of,0,0
42119,propofol,0,0
42120,is,0,0
42121,seen,0,0
42122,in,0,0
42123,28,0,0
42124,%,0,0
42125,-90,0,0
42126,%,0,0
42127,patients,0,0
42128,.,0,1
42129,Pretreatment,0,0
42130,with,0,0
42131,thiopental,0,0
42132,0.25,0,0
42133,mg/kg,0,0
42134,and,0,0
42135,0.5,0,0
42136,mg/kg,0,0
42137,after,0,0
42138,manual,0,1
42139,venous,0,1
42140,occlusion,0,0
42141,for,0,0
42142,1,0,0
42143,min,0,0
42144,effectively,0,0
42145,attenuated,0,0
42146,pain,1,1
42147,associated,0,0
42148,with,0,0
42149,propofol,0,0
42150,injection,0,0
42151,.,0,0
42152,Thiopental,0,0
42153,0.5,0,0
42154,mg/kg,0,0
42155,was,0,0
42156,the,0,0
42157,most,0,0
42158,effective,0,1
42159,in,0,0
42160,prevention,0,0
42161,of,0,1
42162,propofol,1,0
42163,pain,1,1
42164,and,0,0
42165,can,0,0
42166,be,0,0
42167,used,0,0
42168,routinely,0,0
42169,.,0,0
42170,A,0,0
42171,randomised,0,0
42172,controlled,0,0
42173,trial,0,0
42174,comparing,0,0
42175,Drawtex,0,1
42176,with,0,0
42177,standard,0,0
42178,dressings,0,0
42179,for,0,0
42180,exuding,0,0
42181,wounds,0,0
42182,.,0,0
42183,OBJECTIVE,0,0
42184,This,0,0
42185,randomised,0,0
42186,controlled,0,0
42187,clinical,0,0
42188,trial,0,0
42189,compared,0,0
42190,a,0,0
42191,capillary,0,1
42192,dressing,0,0
42193,(,0,1
42194,Drawtex,0,1
42195,",",0,0
42196,now,0,0
42197,rebranded,0,0
42198,as,0,0
42199,Vibriant,0,0
42200,RCD,0,0
42201,[,0,0
42202,Vibriant,0,0
42203,Technology,0,0
42204,Services,0,1
42205,],0,0
42206,),0,0
42207,with,0,0
42208,routine,0,0
42209,practice,0,0
42210,for,0,0
42211,exuding,0,0
42212,wounds,0,0
42213,greater,0,0
42214,than,0,0
42215,2.5,0,0
42216,x,0,0
42217,2.5,0,0
42218,cm,0,0
42219,.,0,0
42220,METHOD,0,0
42221,The,0,0
42222,target,0,1
42223,population,0,0
42224,was,0,0
42225,300,0,0
42226,control,0,0
42227,and,0,0
42228,300,0,0
42229,test,0,0
42230,subjects,0,0
42231,across,0,0
42232,three,0,0
42233,sites,0,0
42234,in,0,0
42235,the,0,0
42236,UK,0,1
42237,",",0,0
42238,but,0,0
42239,recruitment,0,1
42240,difficulties,0,1
42241,resulted,0,0
42242,in,0,0
42243,only,0,0
42244,125,0,0
42245,patients,0,0
42246,being,0,0
42247,evaluable,0,0
42248,.,0,0
42249,Wound,1,0
42250,progress,1,1
42251,was,0,0
42252,recorded,0,0
42253,by,0,0
42254,nurses,0,1
42255,',0,1
42256,perception,0,1
42257,of,0,0
42258,the,0,0
42259,progress,0,1
42260,of,0,1
42261,wound,0,1
42262,healing,0,1
42263,and,0,1
42264,by,0,0
42265,objective,0,0
42266,digital,0,0
42267,imaging,0,0
42268,.,0,0
42269,In,0,0
42270,the,0,0
42271,final,0,1
42272,analysis,0,0
42273,digital,0,1
42274,images,0,1
42275,were,0,0
42276,randomised,0,0
42277,(,0,0
42278,in,0,0
42279,time,0,1
42280,order,0,0
42281,),0,0
42282,and,0,0
42283,a,0,0
42284,panel,0,0
42285,of,0,0
42286,nurses,0,0
42287,who,0,0
42288,were,0,0
42289,not,0,0
42290,otherwise,0,0
42291,involved,0,0
42292,in,0,0
42293,the,0,0
42294,research,0,0
42295,project,0,0
42296,graded,0,1
42297,the,0,0
42298,wound,0,1
42299,'s,0,0
42300,progress,0,1
42301,.,0,0
42302,RESULTS,0,0
42303,After,0,0
42304,deconvolution,0,0
42305,of,0,0
42306,the,0,0
42307,data,0,0
42308,",",0,0
42309,the,0,0
42310,subjective,0,1
42311,(,0,0
42312,nurse,0,1
42313,perception,0,1
42314,),0,1
42315,method,0,0
42316,of,0,1
42317,evaluation,0,0
42318,determined,0,0
42319,that,0,0
42320,the,0,0
42321,new,0,0
42322,dressing,0,0
42323,resulted,0,0
42324,in,0,0
42325,wound,1,1
42326,improvement,1,1
42327,in,0,0
42328,12.7,0,0
42329,%,0,0
42330,more,0,0
42331,patients,0,0
42332,than,0,0
42333,did,0,0
42334,routine,0,0
42335,practice,0,0
42336,",",0,0
42337,but,0,0
42338,the,0,0
42339,blinded,0,0
42340,assessment,0,0
42341,method,0,0
42342,(,0,0
42343,based,0,0
42344,on,0,0
42345,the,0,0
42346,digital,0,0
42347,images,0,0
42348,),0,0
42349,showed,0,0
42350,that,0,0
42351,routine,0,0
42352,practice,0,0
42353,was,0,0
42354,better,0,0
42355,by,0,0
42356,6.6,0,0
42357,%,0,0
42358,.,0,0
42359,CONCLUSION,0,0
42360,Evaluation,0,1
42361,of,0,1
42362,wound,1,0
42363,progress,1,0
42364,is,0,0
42365,clearly,0,0
42366,difficult,0,0
42367,.,0,0
42368,Human,0,0
42369,nature,0,0
42370,makes,0,0
42371,us,0,0
42372,favour,0,0
42373,novelty,0,0
42374,if,0,0
42375,we,0,0
42376,believe,0,0
42377,it,0,0
42378,is,0,0
42379,going,0,0
42380,to,0,0
42381,be,0,0
42382,better,0,0
42383,.,0,0
42384,Making,0,1
42385,interpretation,0,0
42386,more,0,0
42387,objective,0,0
42388,removed,0,0
42389,that,0,0
42390,bias,0,1
42391,and,0,1
42392,did,0,0
42393,not,0,0
42394,demonstrate,0,0
42395,a,0,0
42396,significant,0,0
42397,advantage,0,0
42398,for,0,0
42399,the,0,0
42400,test,0,0
42401,dressing,0,0
42402,.,0,0
42403,The,0,0
42404,findings,0,0
42405,suggest,0,0
42406,that,0,0
42407,unblinded,0,0
42408,assessment,0,0
42409,by,0,0
42410,trial,0,0
42411,nurses,0,0
42412,is,0,0
42413,unacceptable,0,1
42414,on,0,0
42415,its,0,0
42416,own,0,0
42417,.,0,0
42418,Blinded,0,0
42419,assessments,0,0
42420,may,0,0
42421,miss,0,1
42422,finer,0,0
42423,nuances,0,0
42424,of,0,1
42425,wound,1,1
42426,progression,1,1
42427,",",0,0
42428,but,0,0
42429,are,0,0
42430,likely,0,0
42431,to,0,0
42432,be,0,0
42433,more,0,0
42434,accurate,0,0
42435,.,0,0
42436,The,0,0
42437,authors,0,0
42438,suggest,0,0
42439,that,0,0
42440,the,0,0
42441,true,0,0
42442,result,0,0
42443,lies,0,0
42444,somewhere,0,0
42445,in,0,0
42446,the,0,0
42447,middle,0,0
42448,",",0,0
42449,with,0,0
42450,the,0,0
42451,trial,0,0
42452,dressing,0,0
42453,likely,0,0
42454,to,0,0
42455,be,0,0
42456,as,0,0
42457,effective,0,1
42458,as,0,0
42459,",",0,0
42460,but,0,0
42461,not,0,0
42462,more,0,0
42463,effective,0,1
42464,than,0,0
42465,",",0,0
42466,a,0,0
42467,standard,0,0
42468,dressing,0,0
42469,.,0,0
42470,Does,0,1
42471,aerobic,0,0
42472,training,0,0
42473,lead,0,0
42474,to,0,0
42475,a,0,0
42476,more,0,0
42477,active,1,1
42478,lifestyle,1,0
42479,and,1,1
42480,improved,1,1
42481,quality,1,1
42482,of,1,1
42483,life,1,1
42484,in,0,0
42485,patients,0,0
42486,with,0,0
42487,chronic,0,0
42488,heart,0,1
42489,failure,0,1
42490,?,0,0
42491,BACKGROUND,0,0
42492,Due,0,1
42493,to,0,0
42494,dyspnea,0,1
42495,and,0,1
42496,fatigue,0,1
42497,",",0,0
42498,patients,0,0
42499,with,0,0
42500,chronic,0,0
42501,heart,0,1
42502,failure,0,1
42503,(,0,1
42504,CHF,0,0
42505,),0,0
42506,are,0,0
42507,often,0,0
42508,restricted,0,0
42509,in,0,0
42510,the,0,0
42511,performance,0,1
42512,of,0,0
42513,everyday,0,0
42514,activities,0,1
42515,",",0,0
42516,which,0,0
42517,gradually,0,0
42518,may,0,0
42519,lead,0,0
42520,to,0,0
42521,hypoactivity,0,0
42522,.,0,0
42523,AIMS,0,0
42524,To,0,0
42525,assess,0,0
42526,whether,0,0
42527,aerobic,0,0
42528,training,0,0
42529,leads,0,0
42530,to,0,0
42531,a,0,0
42532,more,0,0
42533,active,1,1
42534,lifestyle,1,0
42535,and,1,1
42536,improved,1,1
42537,quality,1,1
42538,of,1,1
42539,life,1,1
42540,(,1,1
42541,QoL,1,1
42542,),1,0
42543,in,0,0
42544,patients,0,0
42545,with,0,0
42546,CHF,0,0
42547,.,0,0
42548,METHODS,0,0
42549,Patients,0,0
42550,with,0,0
42551,stable,0,1
42552,CHF,0,0
42553,(,0,0
42554,NYHA,0,0
42555,II/III,0,0
42556,;,0,0
42557,59,0,0
42558,(,0,0
42559,11,0,0
42560,),0,0
42561,years,0,0
42562,),0,0
42563,were,0,0
42564,randomly,0,0
42565,assigned,0,0
42566,to,0,0
42567,a,0,0
42568,training,0,0
42569,group,0,0
42570,(,0,0
42571,n=18,0,0
42572,;,0,0
42573,3-month,0,1
42574,aerobic,0,0
42575,program,0,0
42576,above,0,1
42577,standard,0,0
42578,treatment,0,0
42579,),0,0
42580,or,0,0
42581,control,0,0
42582,group,0,0
42583,(,0,0
42584,n=16,0,0
42585,;,0,0
42586,standard,0,0
42587,treatment,0,0
42588,without,0,0
42589,special,0,0
42590,advice,0,0
42591,for,0,0
42592,exercise,0,0
42593,),0,0
42594,.,0,0
42595,Measurements,0,0
42596,were,0,0
42597,performed,0,0
42598,on,0,0
42599,level,0,1
42600,of,0,0
42601,everyday,1,0
42602,physical,1,1
42603,activity,1,1
42604,(,1,1
42605,PA,1,1
42606,",",1,1
42607,novel,1,0
42608,accelerometry-based,1,1
42609,activity,1,1
42610,monitor,1,0
42611,),1,1
42612,and,1,1
42613,QoL,1,1
42614,",",0,1
42615,and,0,1
42616,on,0,0
42617,several,1,0
42618,related,1,0
42619,parameters,1,1
42620,.,1,0
42621,RESULTS,0,0
42622,Training,0,0
42623,did,0,0
42624,not,0,0
42625,result,0,0
42626,in,0,0
42627,a,0,0
42628,more,0,0
42629,active,1,1
42630,lifestyle,1,0
42631,or,1,0
42632,improved,1,1
42633,QoL,1,1
42634,",",0,0
42635,but,0,0
42636,improved,0,1
42637,(,0,0
42638,P,0,0
42639,<,0,0
42640,0.05,0,0
42641,),0,0
42642,peak,1,1
42643,power,1,1
42644,(,0,0
42645,17,0,0
42646,%,0,0
42647,),0,0
42648,",",0,0
42649,6-min,1,0
42650,walk,1,1
42651,distance,1,1
42652,(,0,0
42653,10,0,0
42654,%,0,0
42655,),0,0
42656,",",0,1
42657,muscle,1,1
42658,strength,1,1
42659,(,0,0
42660,13-15,0,0
42661,%,0,0
42662,),0,0
42663,and,0,1
42664,depression,1,1
42665,(,0,1
42666,-1.3,0,0
42667,unit,0,0
42668,),0,0
42669,.,0,0
42670,Changes,0,1
42671,in,0,0
42672,level,0,1
42673,of,0,0
42674,everyday,0,0
42675,PA,0,1
42676,were,0,0
42677,related,0,0
42678,to,0,0
42679,changes,0,1
42680,in,0,0
42681,peak,1,1
42682,Vo,1,0
42683,(,1,0
42684,2,1,0
42685,),1,0
42686,(,0,0
42687,r=0.58,0,0
42688,",",0,1
42689,P=0.01,0,0
42690,),0,1
42691,and,0,1
42692,knee,1,1
42693,extension,1,1
42694,strength,1,1
42695,(,0,1
42696,r=0.48,0,0
42697,",",0,1
42698,P=0.05,0,0
42699,),0,0
42700,.,0,0
42701,CONCLUSIONS,0,0
42702,At,0,0
42703,group,0,0
42704,level,0,1
42705,training,0,0
42706,did,0,0
42707,not,0,0
42708,result,0,0
42709,in,0,0
42710,a,0,0
42711,more,0,0
42712,active,1,1
42713,lifestyle,1,0
42714,or,1,0
42715,improved,1,1
42716,QoL,1,1
42717,.,1,0
42718,However,0,0
42719,",",0,0
42720,correlations,0,1
42721,between,0,0
42722,training-related,0,1
42723,changes,0,1
42724,in,0,0
42725,parameters,0,0
42726,suggest,0,0
42727,that,0,0
42728,aerobic,0,0
42729,training,0,0
42730,has,0,0
42731,the,0,0
42732,potential,0,0
42733,to,0,0
42734,increase,0,0
42735,levels,0,1
42736,of,0,0
42737,everyday,1,0
42738,PA,1,1
42739,in,0,0
42740,CHF,0,0
42741,.,0,0
42742,Metoprolol,0,0
42743,CR/XL,0,0
42744,improves,0,1
42745,systolic,1,1
42746,and,1,1
42747,diastolic,1,1
42748,left,1,1
42749,ventricular,1,1
42750,function,1,1
42751,in,0,0
42752,patients,0,0
42753,with,0,0
42754,chronic,0,0
42755,heart,0,1
42756,failure,0,1
42757,.,0,0
42758,AIMS,0,0
42759,To,0,0
42760,investigate,0,0
42761,whether,0,0
42762,metoprolol,0,0
42763,controlled,0,0
42764,release/extended,0,0
42765,release,0,1
42766,(,0,1
42767,CR/XL,0,0
42768,),0,0
42769,once,0,0
42770,daily,0,0
42771,would,0,0
42772,improve,0,0
42773,diastolic,1,1
42774,and,1,1
42775,systolic,1,1
42776,left,1,1
42777,ventricular,1,1
42778,function,1,1
42779,in,0,0
42780,patients,0,0
42781,with,0,0
42782,chronic,0,0
42783,heart,0,1
42784,failure,0,1
42785,and,0,1
42786,decreased,0,1
42787,ejection,0,1
42788,fraction,0,1
42789,.,0,1
42790,METHODS,0,0
42791,In,0,0
42792,an,0,0
42793,echocardiographic,0,0
42794,substudy,0,0
42795,to,0,0
42796,the,0,0
42797,Metoprolol,0,0
42798,CR/XL,0,0
42799,Randomized,0,0
42800,Intervention,0,0
42801,Trial,0,0
42802,in,0,0
42803,Heart,0,1
42804,Failure,0,1
42805,(,0,1
42806,MERIT-HF,0,1
42807,),0,0
42808,",",0,0
42809,66,0,0
42810,patients,0,0
42811,were,0,0
42812,examined,0,0
42813,three,0,0
42814,times,0,0
42815,during,0,0
42816,a,0,0
42817,12-month,0,0
42818,period,0,0
42819,blinded,0,0
42820,to,0,0
42821,treatment,0,0
42822,group,0,0
42823,",",0,1
42824,assessing,0,0
42825,left,1,1
42826,ventricular,1,1
42827,dimensions,1,1
42828,and,1,1
42829,ejection,1,1
42830,fraction,1,1
42831,",",1,1
42832,and,1,1
42833,Doppler,1,1
42834,mitral,1,1
42835,inflow,1,1
42836,parameters,1,1
42837,",",0,0
42838,all,0,0
42839,measured,0,0
42840,in,0,0
42841,a,0,0
42842,core,0,1
42843,laboratory,0,0
42844,.,0,1
42845,RESULTS,0,0
42846,In,0,0
42847,the,0,0
42848,metoprolol,0,0
42849,CR/XL,0,1
42850,group,0,0
42851,left,1,1
42852,ventricular,1,1
42853,ejection,1,1
42854,fraction,1,1
42855,increased,0,0
42856,from,0,0
42857,0.26,0,0
42858,to,0,0
42859,0.31,0,0
42860,(,0,0
42861,P,0,0
42862,=,0,0
42863,0.009,0,0
42864,),0,0
42865,after,0,0
42866,a,0,0
42867,mean,0,1
42868,observation,0,0
42869,period,0,0
42870,of,0,0
42871,10.6,0,0
42872,months,0,0
42873,",",0,0
42874,and,0,1
42875,deceleration,0,1
42876,time,1,1
42877,of,1,0
42878,the,1,0
42879,early,1,0
42880,mitral,1,1
42881,filling,1,1
42882,wave,1,1
42883,(,0,1
42884,E,0,1
42885,),0,1
42886,increased,0,0
42887,from,0,0
42888,189,0,0
42889,to,0,0
42890,246,0,0
42891,ms,0,0
42892,(,0,0
42893,P,0,0
42894,=,0,0
42895,0.0012,0,0
42896,),0,0
42897,",",0,0
42898,time,1,1
42899,velocity,1,1
42900,integral,1,0
42901,of,1,1
42902,E-wave,1,0
42903,increased,0,0
42904,from,0,0
42905,8.7,0,0
42906,to,0,0
42907,11.2,0,0
42908,cm,0,0
42909,(,0,0
42910,P,0,0
42911,=,0,0
42912,0.018,0,0
42913,),0,0
42914,",",0,0
42915,and,0,0
42916,the,0,0
42917,duration,1,1
42918,of,1,0
42919,the,1,0
42920,late,1,1
42921,mitral,1,1
42922,filling,1,1
42923,wave,1,1
42924,(,0,1
42925,A,0,0
42926,),0,1
42927,increased,0,0
42928,from,0,0
42929,122,0,0
42930,to,0,0
42931,145,0,0
42932,ms,0,0
42933,(,0,0
42934,P,0,0
42935,=,0,0
42936,0.014,0,0
42937,),0,0
42938,.,0,0
42939,No,0,0
42940,significant,0,0
42941,changes,0,1
42942,were,0,0
42943,seen,0,0
42944,in,0,0
42945,the,0,0
42946,placebo,0,0
42947,group,0,0
42948,regarding,0,0
42949,any,0,0
42950,of,0,0
42951,these,0,0
42952,variables,0,0
42953,.,0,0
42954,CONCLUSION,0,0
42955,Metoprolol,0,0
42956,CR/XL,0,0
42957,once,0,0
42958,daily,0,0
42959,in,0,0
42960,addition,0,0
42961,to,0,0
42962,standard,0,0
42963,therapy,0,0
42964,improved,0,0
42965,both,0,0
42966,diastolic,1,1
42967,and,1,1
42968,systolic,1,1
42969,function,1,1
42970,in,0,0
42971,patients,0,0
42972,with,0,0
42973,chronic,0,0
42974,heart,0,1
42975,failure,0,1
42976,and,0,1
42977,decreased,0,1
42978,ejection,0,1
42979,fraction,0,1
42980,.,0,0
42981,Phase,0,1
42982,III,0,1
42983,trial,0,0
42984,of,0,1
42985,gemcitabine,0,0
42986,plus,0,0
42987,tipifarnib,0,0
42988,compared,0,0
42989,with,0,0
42990,gemcitabine,0,0
42991,plus,0,0
42992,placebo,0,0
42993,in,0,0
42994,advanced,0,0
42995,pancreatic,0,0
42996,cancer,0,0
42997,.,0,0
42998,PURPOSE,0,0
42999,To,0,0
43000,determine,0,0
43001,whether,0,0
43002,addition,0,0
43003,of,0,0
43004,the,0,0
43005,farnesyltransferase,0,1
43006,inhibitor,0,0
43007,tipifarnib,0,0
43008,(,0,1
43009,Zarnestra,0,0
43010,",",0,0
43011,R115777,0,0
43012,;,0,1
43013,Johnson,0,1
43014,and,0,1
43015,Johnson,0,1
43016,Pharmaceutical,0,1
43017,Research,0,1
43018,and,0,1
43019,Development,0,1
43020,",",0,1
43021,Beerse,0,0
43022,",",0,1
43023,Belgium,0,0
43024,),0,0
43025,to,0,0
43026,standard,0,0
43027,gemcitabine,0,0
43028,therapy,0,0
43029,improves,0,1
43030,overall,1,1
43031,survival,1,1
43032,in,0,0
43033,advanced,0,0
43034,pancreatic,0,0
43035,cancer,0,0
43036,.,0,1
43037,PATIENTS,0,0
43038,AND,0,0
43039,METHODS,0,0
43040,This,0,0
43041,randomized,0,0
43042,",",0,0
43043,double-blind,0,0
43044,",",0,1
43045,placebo-controlled,0,0
43046,study,0,0
43047,compared,0,0
43048,gemcitabine,0,0
43049,+,0,0
43050,tipifarnib,0,0
43051,versus,0,0
43052,gemcitabine,0,0
43053,+,0,0
43054,placebo,0,0
43055,in,0,0
43056,patients,0,0
43057,with,0,0
43058,advanced,0,0
43059,pancreatic,0,0
43060,adenocarcinoma,0,0
43061,previously,0,0
43062,untreated,0,0
43063,with,0,0
43064,systemic,0,0
43065,therapy,0,0
43066,.,0,1
43067,Tipifarnib,0,0
43068,was,0,0
43069,given,0,0
43070,at,0,0
43071,200,0,0
43072,mg,0,0
43073,bid,0,0
43074,orally,0,0
43075,continuously,0,0
43076,;,0,0
43077,gemcitabine,0,0
43078,was,0,0
43079,given,0,0
43080,at,0,0
43081,"1,000",0,0
43082,mg/m,0,0
43083,(,0,0
43084,2,0,0
43085,),0,0
43086,intravenously,0,0
43087,weekly,0,0
43088,x,0,0
43089,7,0,0
43090,for,0,0
43091,8,0,0
43092,weeks,0,0
43093,",",0,0
43094,then,0,0
43095,weekly,0,0
43096,x,0,0
43097,3,0,0
43098,every,0,0
43099,4,0,0
43100,weeks,0,0
43101,.,0,0
43102,The,0,0
43103,primary,0,0
43104,end,0,0
43105,point,0,0
43106,was,0,0
43107,overall,1,1
43108,survival,1,1
43109,;,1,0
43110,secondary,0,1
43111,end,0,0
43112,points,0,0
43113,included,0,0
43114,6-month,1,1
43115,and,1,1
43116,1-year,1,1
43117,survival,1,1
43118,rates,1,1
43119,",",1,1
43120,progression-free,1,1
43121,survival,1,1
43122,",",1,1
43123,response,1,1
43124,rate,1,1
43125,",",1,1
43126,safety,1,1
43127,",",1,1
43128,and,1,1
43129,quality,1,1
43130,of,1,1
43131,life,1,1
43132,.,1,0
43133,RESULTS,0,0
43134,Six,0,0
43135,hundred,0,0
43136,eighty-eight,0,0
43137,patients,0,0
43138,were,0,0
43139,enrolled,0,0
43140,.,0,0
43141,Baseline,0,0
43142,characteristics,0,1
43143,were,0,0
43144,well,0,0
43145,balanced,0,0
43146,between,0,0
43147,the,0,0
43148,two,0,0
43149,treatment,0,0
43150,arms,0,0
43151,.,0,0
43152,No,0,0
43153,statistically,0,0
43154,significant,0,0
43155,differences,0,0
43156,in,0,0
43157,survival,1,1
43158,parameters,1,1
43159,were,0,0
43160,observed,0,0
43161,.,0,0
43162,The,0,0
43163,median,1,1
43164,overall,1,1
43165,survival,1,1
43166,for,0,0
43167,the,0,0
43168,experimental,0,0
43169,arm,0,0
43170,was,0,0
43171,193,0,0
43172,v,0,0
43173,182,0,0
43174,days,0,0
43175,for,0,0
43176,the,0,0
43177,control,0,0
43178,arm,0,0
43179,(,0,1
43180,P,0,0
43181,=.75,0,0
43182,),0,0
43183,;,0,0
43184,6-month,1,1
43185,and,1,1
43186,1-year,1,1
43187,survival,1,1
43188,rates,1,1
43189,were,0,0
43190,53,0,0
43191,%,0,0
43192,and,0,0
43193,27,0,0
43194,%,0,0
43195,v,0,0
43196,49,0,0
43197,%,0,0
43198,and,0,0
43199,24,0,0
43200,%,0,0
43201,for,0,0
43202,the,0,0
43203,control,0,0
43204,arm,0,0
43205,",",0,0
43206,respectively,0,0
43207,;,0,0
43208,median,1,1
43209,progression-free,1,1
43210,survival,1,1
43211,was,0,0
43212,112,0,0
43213,v,0,0
43214,109,0,0
43215,days,0,0
43216,for,0,0
43217,the,0,0
43218,control,0,0
43219,arm,0,0
43220,.,0,0
43221,Ten,0,0
43222,drug-related,1,0
43223,deaths,1,1
43224,were,0,0
43225,reported,0,0
43226,for,0,0
43227,the,0,0
43228,experimental,0,0
43229,arm,0,0
43230,and,0,0
43231,seven,0,0
43232,for,0,0
43233,the,0,0
43234,control,0,0
43235,arm,0,0
43236,.,0,1
43237,Neutropenia,1,1
43238,and,1,1
43239,thrombocytopenia,1,1
43240,grade,1,1
43241,>,1,1
43242,or,1,0
43243,=,1,0
43244,3,1,0
43245,were,0,0
43246,observed,0,0
43247,in,0,0
43248,40,0,0
43249,%,0,0
43250,and,0,0
43251,15,0,0
43252,%,0,0
43253,in,0,0
43254,the,0,0
43255,experimental,0,0
43256,arm,0,0
43257,versus,0,0
43258,30,0,0
43259,%,0,0
43260,and,0,0
43261,12,0,0
43262,%,0,0
43263,in,0,0
43264,the,0,0
43265,control,0,0
43266,arm,0,0
43267,.,0,0
43268,Incidences,0,1
43269,of,0,0
43270,nonhematologic,1,1
43271,adverse,1,1
43272,events,1,1
43273,were,0,0
43274,similar,0,0
43275,in,0,0
43276,two,0,0
43277,groups,0,0
43278,.,0,0
43279,CONCLUSION,0,0
43280,The,0,0
43281,combination,0,0
43282,of,0,1
43283,gemcitabine,0,0
43284,and,0,0
43285,tipifarnib,0,0
43286,has,0,0
43287,an,0,0
43288,acceptable,0,0
43289,toxicity,0,1
43290,profile,0,1
43291,but,0,0
43292,does,0,0
43293,not,0,0
43294,prolong,0,0
43295,overall,1,1
43296,survival,1,1
43297,in,0,0
43298,advanced,0,0
43299,pancreatic,0,0
43300,cancer,0,0
43301,compared,0,0
43302,with,0,0
43303,single-agent,0,0
43304,gemcitabine,0,0
43305,.,0,0
43306,Comparative,0,0
43307,effects,0,1
43308,of,0,1
43309,valsartan,0,0
43310,versus,0,0
43311,amlodipine,0,0
43312,on,0,0
43313,left,0,1
43314,ventricular,0,1
43315,mass,0,1
43316,and,0,1
43317,reactive,0,1
43318,oxygen,0,1
43319,species,0,1
43320,formation,0,1
43321,by,0,0
43322,monocytes,0,1
43323,in,0,0
43324,hypertensive,0,0
43325,patients,0,0
43326,with,0,0
43327,left,0,1
43328,ventricular,0,1
43329,hypertrophy,0,1
43330,.,0,0
43331,OBJECTIVES,0,0
43332,To,0,0
43333,compare,0,0
43334,the,0,0
43335,effects,0,0
43336,of,0,0
43337,the,0,0
43338,angiotensin,0,0
43339,receptor,0,1
43340,blocker,0,0
43341,(,0,1
43342,ARB,0,0
43343,),0,0
43344,valsartan,0,0
43345,versus,0,0
43346,the,0,0
43347,calcium,0,1
43348,channel,0,1
43349,blocker,0,0
43350,amlodipine,0,0
43351,",",0,1
43352,reactive,0,1
43353,oxygen,0,1
43354,species,0,1
43355,(,0,1
43356,ROS,0,0
43357,),0,1
43358,formation,0,1
43359,by,0,0
43360,monocytes,0,1
43361,",",0,0
43362,C-reactive,0,1
43363,protein,0,1
43364,(,0,1
43365,CRP,0,1
43366,),0,1
43367,",",0,1
43368,and,0,1
43369,left,0,1
43370,ventricular,0,1
43371,(,0,1
43372,LV,0,1
43373,),0,1
43374,mass,0,1
43375,were,0,0
43376,studied,0,0
43377,in,0,0
43378,104,0,0
43379,hypertensive,0,0
43380,patients,0,0
43381,with,0,0
43382,left,0,1
43383,ventricular,0,1
43384,hypertrophy,0,1
43385,(,0,1
43386,LVH,0,0
43387,),0,0
43388,.,0,0
43389,BACKGROUND,0,0
43390,There,0,0
43391,is,0,0
43392,evidence,0,0
43393,that,0,0
43394,ARBs,0,0
43395,have,0,0
43396,blood,0,1
43397,pressure,0,1
43398,(,0,0
43399,BP,0,1
43400,),0,1
43401,-independent,0,0
43402,effects,0,1
43403,on,0,0
43404,LV,0,1
43405,mass,0,1
43406,.,0,1
43407,Whether,0,0
43408,regression,0,0
43409,of,0,1
43410,LV,0,1
43411,mass,0,1
43412,by,0,0
43413,ARBs,0,0
43414,is,0,0
43415,correlated,0,0
43416,to,0,0
43417,ROS,0,0
43418,formation,0,1
43419,by,0,0
43420,monocytes,0,1
43421,and,0,0
43422,CRP,0,0
43423,is,0,0
43424,not,0,0
43425,fully,0,0
43426,understood,0,0
43427,yet,0,0
43428,.,0,0
43429,METHODS,0,0
43430,A,0,0
43431,cross-sectional,0,0
43432,and,0,1
43433,prospective,0,0
43434,study,0,0
43435,was,0,0
43436,performed,0,0
43437,.,0,0
43438,Participants,0,0
43439,were,0,0
43440,randomly,0,0
43441,assigned,0,0
43442,to,0,0
43443,either,0,0
43444,the,0,0
43445,80-mg,0,0
43446,valsartan,0,0
43447,(,0,0
43448,n,0,0
43449,=,0,0
43450,52,0,0
43451,),0,0
43452,or,0,0
43453,5-mg,0,0
43454,amlodipine,0,0
43455,(,0,0
43456,n,0,0
43457,=,0,0
43458,52,0,0
43459,),0,0
43460,group,0,0
43461,and,0,1
43462,were,0,0
43463,treated,0,0
43464,for,0,0
43465,eight,0,0
43466,months,0,0
43467,.,0,0
43468,The,0,0
43469,left,0,1
43470,ventricular,0,1
43471,mass,0,1
43472,index,0,1
43473,(,0,1
43474,LVMI,0,1
43475,),0,1
43476,was,0,0
43477,calculated,0,0
43478,from,0,0
43479,two-dimensional,0,0
43480,M-mode,0,0
43481,echocardiography,0,0
43482,.,0,1
43483,Formation,0,1
43484,of,0,0
43485,ROS,0,0
43486,by,0,0
43487,monocytes,0,1
43488,was,0,0
43489,measured,0,0
43490,by,0,0
43491,gated,0,0
43492,flow,0,1
43493,cytometry,0,0
43494,.,0,0
43495,In,0,0
43496,addition,0,0
43497,",",0,1
43498,CRP,0,1
43499,",",0,1
43500,plasma,0,1
43501,renin,0,1
43502,activity,0,1
43503,",",0,1
43504,plasma,0,1
43505,aldosterone,0,1
43506,",",0,1
43507,and,0,1
43508,traditional,0,0
43509,risk,0,1
43510,factors,0,1
43511,were,0,0
43512,assessed,0,0
43513,.,0,0
43514,RESULTS,0,0
43515,Multiple,0,1
43516,regression,0,1
43517,analysis,0,0
43518,showed,0,0
43519,a,0,0
43520,significant,0,0
43521,correlation,0,0
43522,between,0,0
43523,LVMI,0,1
43524,and,0,1
43525,ROS,0,0
43526,formation,0,1
43527,by,0,0
43528,monocytes,0,1
43529,and,0,1
43530,between,0,0
43531,LVMI,0,1
43532,and,0,0
43533,CRP,0,1
43534,.,0,1
43535,Treatment,1,0
43536,reduced,1,0
43537,BP,1,1
43538,to,0,0
43539,a,0,0
43540,similar,1,0
43541,extent,1,0
43542,in,0,0
43543,both,0,0
43544,groups,0,0
43545,.,0,0
43546,Valsartan,1,0
43547,significantly,1,0
43548,reduced,1,0
43549,LVMI,1,0
43550,after,0,0
43551,eight,0,0
43552,months,0,0
43553,",",0,0
43554,but,0,0
43555,amlodipine,0,0
43556,had,0,0
43557,less,1,0
43558,effect,1,1
43559,(,0,0
43560,16,0,0
43561,%,0,0
43562,vs.,0,0
43563,1.2,0,0
43564,%,0,0
43565,",",0,0
43566,n,0,0
43567,=,0,0
43568,50,0,0
43569,",",0,0
43570,p,0,0
43571,<,0,0
43572,0.01,0,0
43573,),0,0
43574,.,0,0
43575,Formation,1,1
43576,of,1,0
43577,ROS,1,0
43578,by,1,0
43579,monocytes,1,1
43580,was,0,0
43581,reduced,1,0
43582,to,1,0
43583,a,1,0
43584,greater,1,0
43585,extent,1,0
43586,with,0,0
43587,valsartan,0,0
43588,than,0,0
43589,with,0,0
43590,amlodipine,0,0
43591,(,0,0
43592,28,0,0
43593,%,0,0
43594,vs.,0,0
43595,2,0,0
43596,%,0,0
43597,",",0,0
43598,n,0,0
43599,=,0,0
43600,50,0,0
43601,",",0,0
43602,p,0,0
43603,<,0,0
43604,0.01,0,0
43605,),0,0
43606,.,0,0
43607,Valsartan,0,0
43608,but,0,0
43609,not,0,0
43610,amlodipine,0,0
43611,reduced,1,0
43612,CRP,1,0
43613,levels,1,1
43614,.,1,0
43615,A,0,0
43616,significant,1,0
43617,correlation,1,0
43618,between,0,0
43619,changes,1,1
43620,in,1,0
43621,ROS,1,0
43622,formation,1,1
43623,by,1,0
43624,monocytes,1,1
43625,and,1,1
43626,LVMI,1,1
43627,or,1,1
43628,between,1,0
43629,CRP,1,1
43630,and,1,1
43631,LVMI,1,1
43632,was,0,0
43633,observed,0,0
43634,.,0,0
43635,CONCLUSIONS,0,0
43636,The,0,0
43637,ARB,0,0
43638,valsartan,0,0
43639,has,0,0
43640,BP-independent,0,0
43641,effects,0,1
43642,on,0,0
43643,LVH,0,0
43644,",",0,1
43645,ROS,0,0
43646,formation,0,1
43647,by,0,0
43648,monocytes,0,1
43649,",",0,1
43650,and,0,1
43651,CRP,0,1
43652,in,0,0
43653,hypertensive,0,0
43654,patients,0,0
43655,with,0,0
43656,LVH,0,0
43657,.,0,0
43658,Bevacizumab,0,0
43659,plus,0,0
43660,irinotecan,0,0
43661,",",0,1
43662,fluorouracil,0,0
43663,",",0,1
43664,and,0,1
43665,leucovorin,0,0
43666,for,0,0
43667,metastatic,0,0
43668,colorectal,0,0
43669,cancer,0,0
43670,.,0,0
43671,BACKGROUND,0,0
43672,Bevacizumab,0,0
43673,",",0,0
43674,a,0,0
43675,monoclonal,0,1
43676,antibody,0,1
43677,against,0,0
43678,vascular,0,1
43679,endothelial,0,1
43680,growth,0,1
43681,factor,0,0
43682,",",0,0
43683,has,0,0
43684,shown,0,0
43685,promising,0,0
43686,preclinical,0,0
43687,and,0,1
43688,clinical,0,1
43689,activity,0,1
43690,against,0,0
43691,metastatic,0,0
43692,colorectal,0,0
43693,cancer,0,0
43694,",",0,0
43695,particularly,0,0
43696,in,0,0
43697,combination,0,0
43698,with,0,0
43699,chemotherapy,0,0
43700,.,0,0
43701,METHODS,0,0
43702,Of,0,0
43703,813,0,0
43704,patients,0,0
43705,with,0,0
43706,previously,0,0
43707,untreated,0,0
43708,metastatic,0,0
43709,colorectal,0,0
43710,cancer,0,0
43711,",",0,0
43712,we,0,0
43713,randomly,0,0
43714,assigned,0,0
43715,402,0,0
43716,to,0,0
43717,receive,0,0
43718,irinotecan,0,0
43719,",",0,0
43720,bolus,0,0
43721,fluorouracil,0,0
43722,",",0,1
43723,and,0,1
43724,leucovorin,0,0
43725,(,0,1
43726,IFL,0,1
43727,),0,1
43728,plus,0,0
43729,bevacizumab,0,0
43730,(,0,0
43731,5,0,0
43732,mg,0,0
43733,per,0,0
43734,kilogram,0,0
43735,of,0,1
43736,body,0,1
43737,weight,0,1
43738,every,0,0
43739,two,0,0
43740,weeks,0,0
43741,),0,0
43742,and,0,0
43743,411,0,0
43744,to,0,0
43745,receive,0,0
43746,IFL,0,1
43747,plus,0,0
43748,placebo,0,0
43749,.,0,0
43750,The,0,0
43751,primary,0,0
43752,end,0,0
43753,point,0,0
43754,was,0,0
43755,overall,1,1
43756,survival,1,1
43757,.,1,1
43758,Secondary,0,0
43759,end,0,0
43760,points,0,0
43761,were,0,0
43762,progression-free,1,1
43763,survival,1,1
43764,",",1,0
43765,the,1,0
43766,response,1,1
43767,rate,1,1
43768,",",1,0
43769,the,1,0
43770,duration,1,1
43771,of,1,0
43772,the,1,0
43773,response,1,1
43774,",",1,1
43775,safety,1,1
43776,",",1,1
43777,and,1,1
43778,the,1,0
43779,quality,1,1
43780,of,1,0
43781,life,1,1
43782,.,1,0
43783,RESULTS,0,0
43784,The,0,0
43785,median,1,1
43786,duration,1,1
43787,of,1,1
43788,survival,1,1
43789,was,0,0
43790,20.3,0,0
43791,months,0,0
43792,in,0,0
43793,the,0,0
43794,group,0,0
43795,given,0,0
43796,IFL,0,1
43797,plus,0,0
43798,bevacizumab,0,0
43799,",",0,1
43800,as,0,0
43801,compared,0,0
43802,with,0,0
43803,15.6,0,0
43804,months,0,0
43805,in,0,0
43806,the,0,0
43807,group,0,0
43808,given,0,0
43809,IFL,0,1
43810,plus,0,0
43811,placebo,0,0
43812,",",0,0
43813,corresponding,0,1
43814,to,0,0
43815,a,0,0
43816,hazard,0,1
43817,ratio,0,1
43818,for,0,0
43819,death,0,1
43820,of,0,0
43821,0.66,0,0
43822,(,0,0
43823,P,0,0
43824,<,0,0
43825,0.001,0,0
43826,),0,0
43827,.,0,0
43828,The,0,0
43829,median,1,1
43830,duration,1,1
43831,of,1,1
43832,progression-free,1,1
43833,survival,1,1
43834,was,0,0
43835,10.6,0,0
43836,months,0,0
43837,in,0,0
43838,the,0,0
43839,group,0,0
43840,given,0,0
43841,IFL,0,1
43842,plus,0,0
43843,bevacizumab,0,0
43844,",",0,1
43845,as,0,0
43846,compared,0,0
43847,with,0,0
43848,6.2,0,0
43849,months,0,0
43850,in,0,0
43851,the,0,0
43852,group,0,0
43853,given,0,0
43854,IFL,0,1
43855,plus,0,0
43856,placebo,0,0
43857,(,0,1
43858,hazard,0,1
43859,ratio,0,1
43860,for,0,0
43861,disease,0,1
43862,progression,0,1
43863,",",0,0
43864,0.54,0,0
43865,;,0,0
43866,P,0,0
43867,<,0,0
43868,0.001,0,0
43869,),0,0
43870,;,0,0
43871,the,0,0
43872,corresponding,0,1
43873,rates,0,1
43874,of,0,1
43875,response,0,1
43876,were,0,0
43877,44.8,0,0
43878,percent,0,0
43879,and,0,0
43880,34.8,0,0
43881,percent,0,1
43882,(,0,0
43883,P=0.004,0,0
43884,),0,0
43885,.,0,0
43886,The,0,0
43887,median,1,1
43888,duration,1,1
43889,of,1,0
43890,the,1,0
43891,response,1,1
43892,was,0,0
43893,10.4,0,0
43894,months,0,0
43895,in,0,0
43896,the,0,0
43897,group,0,0
43898,given,0,0
43899,IFL,0,1
43900,plus,0,0
43901,bevacizumab,0,0
43902,",",0,1
43903,as,0,0
43904,compared,0,0
43905,with,0,0
43906,7.1,0,0
43907,months,0,0
43908,in,0,0
43909,the,0,0
43910,group,0,0
43911,given,0,0
43912,IFL,0,1
43913,plus,0,0
43914,placebo,0,0
43915,(,0,1
43916,hazard,0,1
43917,ratio,0,1
43918,for,0,0
43919,progression,0,1
43920,",",0,0
43921,0.62,0,0
43922,;,0,0
43923,P=0.001,0,0
43924,),0,0
43925,.,0,0
43926,Grade,1,0
43927,3,1,0
43928,hypertension,1,0
43929,was,0,0
43930,more,0,0
43931,common,0,1
43932,during,0,0
43933,treatment,0,0
43934,with,0,0
43935,IFL,0,1
43936,plus,0,0
43937,bevacizumab,0,0
43938,than,0,0
43939,with,0,0
43940,IFL,0,1
43941,plus,0,0
43942,placebo,0,0
43943,(,0,0
43944,11.0,0,0
43945,percent,0,0
43946,vs.,0,0
43947,2.3,0,0
43948,percent,0,0
43949,),0,0
43950,but,0,0
43951,was,0,0
43952,easily,0,0
43953,managed,0,0
43954,.,0,0
43955,CONCLUSIONS,0,0
43956,The,0,0
43957,addition,0,0
43958,of,0,0
43959,bevacizumab,0,0
43960,to,0,0
43961,fluorouracil-based,0,0
43962,combination,0,0
43963,chemotherapy,0,0
43964,results,0,0
43965,in,0,0
43966,statistically,0,0
43967,significant,0,0
43968,and,0,0
43969,clinically,0,1
43970,meaningful,0,1
43971,improvement,0,1
43972,in,0,0
43973,survival,1,1
43974,among,0,0
43975,patients,0,0
43976,with,0,0
43977,metastatic,0,0
43978,colorectal,0,0
43979,cancer,0,0
43980,.,0,0
43981,Patterning,0,1
43982,of,0,1
43983,pain,1,1
43984,and,1,1
43985,power,1,1
43986,with,0,0
43987,guided,0,0
43988,imagery,0,0
43989,.,0,0
43990,Using,0,0
43991,Martha,0,0
43992,Rogers,0,1
43993,',0,1
43994,science,0,0
43995,of,0,0
43996,unitary,0,1
43997,human,0,0
43998,beings,0,0
43999,",",0,0
44000,changes,0,1
44001,in,0,0
44002,pain,1,1
44003,and,1,1
44004,power,1,1
44005,among,0,0
44006,42,0,0
44007,patients,0,0
44008,were,0,0
44009,examined,0,0
44010,in,0,0
44011,relation,0,0
44012,to,0,0
44013,the,0,0
44014,use,0,0
44015,of,0,0
44016,a,0,0
44017,guided,0,0
44018,imagery,0,0
44019,modality,0,0
44020,.,0,1
44021,Participants,0,0
44022,were,0,0
44023,randomly,0,0
44024,assigned,0,0
44025,to,0,0
44026,treatment,0,0
44027,and,0,1
44028,control,0,0
44029,groups,0,0
44030,and,0,1
44031,repeated,0,0
44032,measures,0,1
44033,MANCOVA,0,1
44034,was,0,0
44035,used,0,0
44036,to,0,0
44037,detect,0,0
44038,differences,0,0
44039,in,0,0
44040,pain,1,1
44041,and,1,1
44042,power,1,1
44043,over,0,0
44044,a,0,0
44045,4-day,0,0
44046,period,0,0
44047,of,0,0
44048,time,0,1
44049,.,0,0
44050,The,0,0
44051,treatment,0,0
44052,group,0,0
44053,'s,0,1
44054,pain,1,1
44055,decreased,0,0
44056,during,0,0
44057,the,0,0
44058,last,0,0
44059,2,0,0
44060,days,0,0
44061,of,0,0
44062,the,0,0
44063,study,0,0
44064,.,0,0
44065,No,0,0
44066,differences,0,0
44067,in,0,0
44068,power,1,1
44069,emerged,0,0
44070,.,0,0
44071,Guided,0,0
44072,imagery,0,0
44073,appeared,0,0
44074,to,0,0
44075,have,0,0
44076,potential,0,0
44077,as,0,0
44078,a,0,0
44079,useful,0,0
44080,nursing,0,1
44081,modality,0,0
44082,for,0,0
44083,chronic,0,0
44084,pain,0,1
44085,sufferers,0,0
44086,.,0,0
44087,Retroinfusion-supported,0,0
44088,stenting,0,0
44089,in,0,0
44090,high-risk,0,0
44091,patients,0,0
44092,for,0,0
44093,percutaneous,0,0
44094,intervention,0,0
44095,and,0,1
44096,bypass,0,0
44097,surgery,0,0
44098,:,0,0
44099,results,0,0
44100,of,0,0
44101,the,0,0
44102,prospective,0,0
44103,randomized,0,0
44104,myoprotect,0,0
44105,I,0,0
44106,study,0,0
44107,.,0,0
44108,The,0,0
44109,objective,0,0
44110,of,0,0
44111,this,0,0
44112,study,0,0
44113,was,0,0
44114,to,0,0
44115,assess,0,0
44116,event-free,1,0
44117,survival,1,1
44118,and,1,1
44119,total,1,1
44120,treatment,1,0
44121,costs,1,1
44122,of,0,1
44123,retroinfusion-supported,0,0
44124,stenting,0,0
44125,in,0,0
44126,high-risk,0,0
44127,patients,0,0
44128,compared,0,0
44129,to,0,0
44130,bypass,0,0
44131,surgery,0,0
44132,.,0,0
44133,An,0,0
44134,increasing,0,0
44135,number,0,1
44136,of,0,0
44137,patients,0,0
44138,with,0,0
44139,main-stem,0,1
44140,and,0,1
44141,main-stem-equivalent,0,0
44142,stenosis,0,1
44143,are,0,0
44144,treated,0,0
44145,by,0,0
44146,stent,0,1
44147,implantation,0,0
44148,",",0,0
44149,which,0,0
44150,appears,0,0
44151,to,0,0
44152,be,0,0
44153,safe,0,0
44154,in,0,0
44155,the,0,0
44156,short-term,0,0
44157,follow-up,0,0
44158,.,0,0
44159,However,0,0
44160,",",0,0
44161,there,0,0
44162,is,0,0
44163,a,0,0
44164,lack,0,0
44165,of,0,0
44166,randomized,0,0
44167,studies,0,0
44168,comparing,0,0
44169,conventional,0,0
44170,bypass,0,0
44171,surgery,0,0
44172,with,0,0
44173,stent,0,1
44174,implantation,0,0
44175,",",0,0
44176,particularly,0,0
44177,in,0,0
44178,patients,0,0
44179,with,0,0
44180,high,0,0
44181,risk,0,1
44182,for,0,0
44183,both,0,0
44184,treatments,0,0
44185,.,0,0
44186,We,0,0
44187,here,0,0
44188,report,0,0
44189,on,0,0
44190,the,0,0
44191,1-year,0,0
44192,results,0,0
44193,of,0,0
44194,a,0,0
44195,prospective,0,0
44196,randomized,0,0
44197,single-center,0,0
44198,study,0,0
44199,in,0,0
44200,patients,0,0
44201,with,0,0
44202,symptomatic,0,1
44203,main-stem,0,1
44204,and,0,1
44205,main-stem-equivalent,0,1
44206,lesions,0,1
44207,with,0,0
44208,substantially,0,0
44209,increased,0,0
44210,risk,0,1
44211,for,0,0
44212,bypass,0,0
44213,surgery,0,0
44214,.,0,0
44215,Patients,0,0
44216,where,0,0
44217,randomized,0,0
44218,to,0,0
44219,undergo,0,0
44220,either,0,0
44221,percutaneous,0,0
44222,transluminal,0,0
44223,coronary,0,1
44224,angioplasty/stent,0,0
44225,procedure,0,0
44226,(,0,0
44227,n,0,0
44228,=,0,0
44229,23,0,0
44230,),0,0
44231,or,0,0
44232,bypass,0,1
44233,surgery,0,0
44234,(,0,0
44235,n,0,0
44236,=,0,0
44237,21,0,0
44238,),0,0
44239,.,0,0
44240,Patients,0,0
44241,randomized,0,0
44242,to,0,0
44243,stent,0,1
44244,implantation,0,0
44245,were,0,0
44246,supported,0,0
44247,by,0,0
44248,selective,0,0
44249,pressure-regulated,0,0
44250,retroinfusion,0,0
44251,of,0,0
44252,the,0,0
44253,anterior,0,1
44254,cardiac,0,1
44255,vein,0,1
44256,during,0,0
44257,ischemia,0,1
44258,.,0,0
44259,Patients,0,0
44260,of,0,0
44261,the,0,0
44262,stent,0,1
44263,group,0,0
44264,and,0,0
44265,the,0,0
44266,bypass,0,1
44267,group,0,0
44268,did,0,0
44269,not,0,0
44270,differ,0,0
44271,in,0,0
44272,baseline,0,0
44273,characteristics,0,1
44274,",",0,0
44275,including,0,0
44276,Parsonnet,1,1
44277,score,1,1
44278,and,1,1
44279,quality-of-life,1,1
44280,score,1,1
44281,.,1,1
44282,Twenty-eight-day,1,1
44283,mortality,1,1
44284,and,1,1
44285,1-year,1,1
44286,mortality,1,1
44287,rate,1,1
44288,as,0,0
44289,well,0,0
44290,as,0,0
44291,quality-of-life,1,1
44292,scores,1,1
44293,were,0,0
44294,similar,0,0
44295,in,0,0
44296,both,0,0
44297,groups,0,0
44298,.,0,0
44299,Event-free,1,0
44300,survival,1,1
44301,after,0,0
44302,1,0,0
44303,year,0,0
44304,was,0,0
44305,higher,0,0
44306,in,0,0
44307,the,0,0
44308,bypass,0,0
44309,group,0,0
44310,(,0,0
44311,71.4,0,0
44312,%,0,0
44313,vs.,0,0
44314,52.3,0,0
44315,%,0,0
44316,;,0,0
44317,P,0,0
44318,=,0,0
44319,0.02,0,0
44320,),0,0
44321,due,0,0
44322,to,0,0
44323,a,0,0
44324,lower,0,0
44325,target,0,1
44326,lesion,0,1
44327,revascularization,0,1
44328,rate,0,1
44329,.,0,0
44330,With,0,0
44331,regard,0,0
44332,to,0,0
44333,total,1,1
44334,treatment,1,0
44335,costs,1,1
44336,",",0,0
44337,however,0,0
44338,",",0,0
44339,the,0,0
44340,stent,0,1
44341,group,0,0
44342,compared,0,0
44343,favorably,0,0
44344,to,0,0
44345,the,0,0
44346,bypass,0,0
44347,group,0,0
44348,(,0,0
44349,"9,346",0,0
44350,+/-,0,0
44351,807,0,0
44352,vs.,0,0
44353,"26,874",0,0
44354,+/-,0,0
44355,"3,985",0,0
44356,euro,0,0
44357,),0,0
44358,",",0,0
44359,predominantly,0,0
44360,as,0,0
44361,a,0,0
44362,result,0,0
44363,of,0,0
44364,a,0,0
44365,shorter,0,1
44366,intensive,0,0
44367,care,0,0
44368,and,0,1
44369,hospital,0,1
44370,stay,0,1
44371,.,0,0
44372,In,0,0
44373,this,0,0
44374,first,0,0
44375,randomized,0,0
44376,study,0,0
44377,in,0,0
44378,high-risk,0,0
44379,patients,0,0
44380,for,0,0
44381,stent,0,1
44382,implantation,0,1
44383,and,0,1
44384,bypass,0,1
44385,surgery,0,0
44386,",",0,1
44387,patients,0,0
44388,with,0,0
44389,retroinfusion-supported,0,0
44390,stent,0,1
44391,implantation,0,0
44392,had,0,0
44393,a,0,0
44394,similar,0,0
44395,1-year,1,1
44396,outcome,1,1
44397,and,1,1
44398,quality,1,1
44399,of,1,1
44400,life,1,1
44401,compared,0,0
44402,to,0,0
44403,patients,0,0
44404,with,0,0
44405,bypass,0,0
44406,surgery,0,0
44407,.,0,0
44408,Though,0,0
44409,in,0,0
44410,the,0,0
44411,stent,0,0
44412,group,0,0
44413,event-free,1,1
44414,survival,1,1
44415,was,0,0
44416,lower,0,0
44417,and,0,1
44418,target,0,1
44419,lesion,0,1
44420,revascularization,1,1
44421,rate,1,1
44422,was,0,0
44423,higher,0,0
44424,",",0,1
44425,retroinfusion-supported,0,1
44426,stent,0,1
44427,implantation,0,1
44428,was,0,0
44429,associated,0,0
44430,with,0,0
44431,substantially,0,0
44432,lower,1,0
44433,costs,1,1
44434,and,0,0
44435,might,0,0
44436,be,0,0
44437,considered,0,0
44438,as,0,0
44439,an,0,0
44440,alternative,0,0
44441,treatment,0,0
44442,option,0,0
44443,in,0,0
44444,this,0,0
44445,selected,0,0
44446,group,0,0
44447,of,0,0
44448,high-risk,0,0
44449,patients,0,0
44450,.,0,0
44451,Effect,0,0
44452,of,0,0
44453,the,0,0
44454,dietary,0,0
44455,approaches,0,0
44456,to,0,0
44457,stop,0,1
44458,hypertension,0,1
44459,diet,0,0
44460,and,0,1
44461,reduced,0,1
44462,sodium,0,1
44463,intake,0,1
44464,on,0,0
44465,blood,0,1
44466,pressure,0,1
44467,control,0,0
44468,.,0,0
44469,The,0,0
44470,authors,0,0
44471,hypothesized,0,0
44472,that,0,0
44473,the,0,0
44474,Dietary,0,0
44475,Approaches,0,0
44476,to,0,0
44477,Stop,0,1
44478,Hypertension,0,1
44479,(,0,0
44480,DASH,0,0
44481,),0,1
44482,diet,0,0
44483,and,0,1
44484,reduced,0,1
44485,sodium,0,0
44486,intake,0,0
44487,would,0,0
44488,control,0,0
44489,stage,0,0
44490,1,0,0
44491,hypertension,0,0
44492,and,0,0
44493,reduce,0,1
44494,high-normal,0,1
44495,blood,1,1
44496,pressure,1,1
44497,(,1,1
44498,BP,1,1
44499,),1,0
44500,to,0,0
44501,optimal,0,0
44502,levels,0,1
44503,.,0,0
44504,Adults,0,0
44505,with,0,0
44506,systolic,0,1
44507,BP,0,1
44508,120-159,0,1
44509,mm,0,1
44510,Hg,0,1
44511,and,0,1
44512,diastolic,0,1
44513,BP,0,1
44514,80-95,0,0
44515,mm,0,1
44516,Hg,0,1
44517,were,0,0
44518,randomly,0,0
44519,assigned,0,0
44520,to,0,0
44521,receive,0,0
44522,the,0,0
44523,DASH,0,0
44524,diet,0,0
44525,or,0,0
44526,a,0,0
44527,typical,0,0
44528,American,0,0
44529,(,0,1
44530,control,0,0
44531,),0,1
44532,diet,0,0
44533,",",0,0
44534,consuming,0,0
44535,three,0,0
44536,different,0,0
44537,sodium,0,0
44538,intakes,0,1
44539,(,0,0
44540,higher=142,0,1
44541,mmol/d,0,0
44542,",",0,1
44543,intermediate=107,0,1
44544,mmol/d,0,1
44545,",",0,1
44546,and,0,1
44547,lower=65,0,1
44548,mmol/d,0,0
44549,),0,0
44550,for,0,0
44551,30,0,0
44552,days,0,0
44553,each,0,0
44554,.,0,0
44555,BP,0,1
44556,control,0,0
44557,was,0,0
44558,defined,0,1
44559,as,0,0
44560,systolic,1,1
44561,BP,1,1
44562,<,0,0
44563,140,0,0
44564,mm,0,0
44565,Hg,0,0
44566,and,0,1
44567,diastolic,1,1
44568,BP,1,1
44569,<,0,0
44570,90,0,0
44571,mm,0,0
44572,Hg,0,0
44573,.,0,0
44574,Among,0,0
44575,subjects,0,0
44576,with,0,0
44577,hypertension,0,1
44578,at,0,0
44579,baseline,0,1
44580,",",0,0
44581,at,0,0
44582,higher,0,0
44583,sodium,0,0
44584,intake,0,1
44585,the,0,0
44586,DASH,0,0
44587,diet,0,0
44588,increased,1,1
44589,BP,1,1
44590,control,1,0
44591,two-fold,0,1
44592,over,0,0
44593,control,0,0
44594,(,0,0
44595,63,0,0
44596,%,0,0
44597,vs.,0,0
44598,32,0,0
44599,%,0,0
44600,;,0,0
44601,95,0,0
44602,%,0,0
44603,confidence,0,0
44604,interval,0,0
44605,",",0,1
44606,1.4-2.9,0,0
44607,),0,0
44608,.,0,0
44609,Reducing,0,0
44610,sodium,0,0
44611,intake,0,1
44612,in,0,0
44613,the,0,0
44614,control,0,0
44615,diet,0,0
44616,group,0,0
44617,increased,1,1
44618,BP,1,1
44619,control,1,0
44620,2.3-fold,0,1
44621,(,0,0
44622,74,0,0
44623,%,0,0
44624,vs.,0,0
44625,32,0,0
44626,%,0,0
44627,;,0,0
44628,95,0,0
44629,%,0,0
44630,confidence,0,0
44631,interval,0,0
44632,",",0,1
44633,1.7-3.2,0,0
44634,),0,0
44635,.,0,0
44636,The,0,0
44637,maximum,1,1
44638,BP,1,1
44639,control,1,0
44640,rate,1,1
44641,(,0,0
44642,84,0,0
44643,%,0,0
44644,),0,0
44645,was,0,0
44646,achieved,0,0
44647,with,0,0
44648,the,0,0
44649,DASH/lower,0,0
44650,sodium,0,0
44651,diet,0,0
44652,.,0,1
44653,BP,1,1
44654,became,1,0
44655,normal,1,0
44656,or,1,0
44657,optimal,1,1
44658,in,0,0
44659,71,0,0
44660,%,0,0
44661,of,0,0
44662,persons,0,0
44663,consuming,0,0
44664,the,0,0
44665,control/lower,0,0
44666,sodium,0,1
44667,diet,0,0
44668,and,0,0
44669,77,0,0
44670,%,0,0
44671,of,0,0
44672,persons,0,0
44673,consuming,0,0
44674,the,0,0
44675,DASH/lower,0,0
44676,sodium,0,0
44677,diet,0,0
44678,.,0,0
44679,Both,0,0
44680,the,0,0
44681,DASH,0,0
44682,diet,0,0
44683,and,0,1
44684,reduced,0,1
44685,sodium,0,1
44686,intake,0,1
44687,improved,0,1
44688,BP,1,1
44689,control,1,0
44690,.,1,0
44691,An,0,0
44692,evaluation,0,0
44693,of,0,0
44694,an,0,0
44695,adaptive,0,1
44696,automation,0,1
44697,system,0,0
44698,using,0,0
44699,a,0,0
44700,cognitive,0,1
44701,vigilance,0,1
44702,task,0,1
44703,.,0,0
44704,The,0,0
44705,performance,0,1
44706,of,0,0
44707,an,0,0
44708,adaptive,0,1
44709,automation,0,1
44710,system,0,0
44711,was,0,0
44712,evaluated,0,0
44713,using,0,0
44714,a,0,0
44715,cognitive,0,1
44716,vigilance,0,1
44717,task,0,1
44718,.,0,1
44719,Participants,0,0
44720,responded,0,0
44721,to,0,0
44722,the,0,0
44723,presence,0,0
44724,of,0,0
44725,a,0,0
44726,green,0,0
44727,K,0,0
44728,in,0,0
44729,an,0,0
44730,array,0,0
44731,of,0,0
44732,two,0,0
44733,",",0,0
44734,five,0,0
44735,",",0,0
44736,or,0,0
44737,nine,0,0
44738,distractor,0,0
44739,stimuli,0,0
44740,during,0,0
44741,a,0,0
44742,40-min,0,0
44743,vigil,0,1
44744,.,0,0
44745,The,0,0
44746,array,0,0
44747,with,0,0
44748,the,0,0
44749,target,0,0
44750,stimulus,0,1
44751,was,0,0
44752,presented,0,0
44753,once,0,0
44754,each,0,0
44755,minute,0,1
44756,.,0,0
44757,Participants,0,0
44758,EEG,0,0
44759,was,0,0
44760,recorded,0,0
44761,and,0,0
44762,an,0,0
44763,engagement,1,1
44764,index,1,1
44765,(,0,0
44766,EI,0,0
44767,=,0,0
44768,20,0,0
44769,x,0,0
44770,beta/,0,1
44771,(,0,0
44772,alpha,0,1
44773,+,0,0
44774,theta,0,1
44775,),0,1
44776,),0,0
44777,was,0,0
44778,derived,0,0
44779,.,0,0
44780,In,0,0
44781,the,0,0
44782,negative,0,1
44783,feedback,0,0
44784,condition,0,0
44785,",",0,0
44786,increases,0,1
44787,in,0,0
44788,the,0,0
44789,EI,1,0
44790,caused,1,0
44791,the,1,0
44792,number,1,1
44793,of,1,0
44794,stimuli,1,0
44795,in,1,0
44796,the,1,0
44797,array,1,0
44798,to,1,0
44799,decrease,1,1
44800,while,0,0
44801,decreases,1,0
44802,in,1,0
44803,the,1,0
44804,EI,1,0
44805,caused,1,0
44806,the,1,0
44807,number,1,1
44808,of,1,0
44809,stimuli,1,0
44810,to,1,0
44811,increase,1,0
44812,.,1,0
44813,For,0,0
44814,the,0,0
44815,positive,0,1
44816,feedback,0,0
44817,condition,0,0
44818,",",0,0
44819,increases,1,1
44820,in,1,0
44821,the,1,0
44822,index,1,1
44823,caused,1,0
44824,an,1,0
44825,increase,1,0
44826,in,1,0
44827,the,1,0
44828,array,1,0
44829,size,1,1
44830,(,1,1
44831,AS,1,1
44832,),1,0
44833,while,0,0
44834,decreases,1,0
44835,caused,1,0
44836,a,1,0
44837,decrease,1,0
44838,in,1,0
44839,the,1,0
44840,array,1,0
44841,size,1,1
44842,.,1,0
44843,Each,0,0
44844,experimental,0,0
44845,participant,0,0
44846,had,0,0
44847,a,0,0
44848,yoked,0,0
44849,control,0,0
44850,partner,0,0
44851,who,0,0
44852,received,0,0
44853,the,0,0
44854,same,0,0
44855,pattern,0,0
44856,of,0,0
44857,changes,0,1
44858,in,0,0
44859,array,0,0
44860,irrespective,0,0
44861,of,0,0
44862,their,0,0
44863,engagement,0,1
44864,index,0,1
44865,.,0,0
44866,A,0,0
44867,vigilance,0,1
44868,decrement,0,1
44869,was,0,0
44870,seen,0,0
44871,only,0,0
44872,for,0,0
44873,the,0,0
44874,positive,0,1
44875,feedback,0,0
44876,",",0,1
44877,experimental,0,0
44878,group,0,0
44879,.,0,0
44880,Once-daily,0,0
44881,versus,0,0
44882,twice-daily,0,0
44883,lamivudine,0,0
44884,",",0,0
44885,in,0,0
44886,combination,0,0
44887,with,0,0
44888,zidovudine,0,0
44889,and,0,1
44890,efavirenz,0,0
44891,",",0,0
44892,for,0,0
44893,the,0,0
44894,treatment,0,0
44895,of,0,0
44896,antiretroviral-naive,0,0
44897,adults,0,0
44898,with,0,0
44899,HIV,0,1
44900,infection,0,1
44901,:,0,0
44902,a,0,0
44903,randomized,0,0
44904,equivalence,1,0
44905,trial,0,0
44906,.,0,0
44907,A,0,0
44908,randomized,0,0
44909,",",0,0
44910,double-blind,0,0
44911,",",0,1
44912,double-dummy,0,0
44913,controlled,0,0
44914,",",0,0
44915,multicenter,0,0
44916,trial,0,0
44917,was,0,0
44918,conducted,0,0
44919,that,0,0
44920,involved,0,0
44921,554,0,0
44922,antiretroviral-naive,0,0
44923,human,0,0
44924,immunodeficiency,0,0
44925,virus-infected,0,0
44926,adults,0,0
44927,(,0,0
44928,plasma,0,1
44929,HIV,0,1
44930,type,0,0
44931,1,0,0
44932,[,0,0
44933,HIV-1,0,0
44934,],0,0
44935,RNA,0,1
44936,level,0,1
44937,",",0,0
44938,>,0,0
44939,or=400,0,0
44940,copies/mL,0,0
44941,;,0,1
44942,CD4,0,1
44943,(,0,0
44944,+,0,0
44945,),0,1
44946,cell,0,1
44947,count,0,1
44948,",",0,0
44949,>,0,0
44950,100,0,0
44951,cells/mm,0,0
44952,(,0,0
44953,3,0,0
44954,),0,0
44955,),0,0
44956,and,0,0
44957,compared,0,0
44958,a,0,0
44959,300-mg,0,0
44960,once-daily,0,0
44961,(,0,0
44962,q.d,0,0
44963,.,0,0
44964,),0,0
44965,regimen,0,0
44966,of,0,1
44967,lamivudine,0,0
44968,(,0,0
44969,3TC,0,0
44970,),0,0
44971,versus,0,0
44972,a,0,0
44973,150-mg,0,0
44974,twice-daily,0,0
44975,(,0,0
44976,b.i.d,0,0
44977,.,0,1
44978,),0,0
44979,regimen,0,0
44980,of,0,0
44981,3TC,0,0
44982,",",0,0
44983,combined,0,0
44984,with,0,0
44985,zidovudine,0,0
44986,(,0,0
44987,300,0,0
44988,mg,0,0
44989,b.i.d,0,0
44990,.,0,1
44991,),0,0
44992,and,0,1
44993,efavirenz,0,0
44994,(,0,0
44995,600,0,0
44996,mg,0,0
44997,q.d,0,0
44998,.,0,1
44999,),0,0
45000,",",0,0
45001,during,0,0
45002,a,0,0
45003,48-week,0,0
45004,period,0,0
45005,.,0,1
45006,Treatments,0,0
45007,were,0,0
45008,considered,0,0
45009,equivalent,1,0
45010,if,0,0
45011,the,0,0
45012,95,1,0
45013,%,1,0
45014,confidence,1,0
45015,interval,1,0
45016,(,1,1
45017,CI,1,0
45018,),1,0
45019,for,0,0
45020,the,0,0
45021,difference,0,0
45022,in,0,0
45023,proportions,1,1
45024,of,1,0
45025,patients,1,0
45026,achieving,1,0
45027,an,1,0
45028,HIV-1,1,0
45029,RNA,1,0
45030,level,1,1
45031,of,1,0
45032,<,1,0
45033,400,1,0
45034,copies/mL,1,0
45035,was,0,0
45036,within,0,0
45037,the,0,0
45038,bound,0,0
45039,of,0,1
45040,-12,0,0
45041,%,0,0
45042,to,0,0
45043,12,0,0
45044,%,0,0
45045,.,0,0
45046,At,0,0
45047,week,0,0
45048,48,0,0
45049,of,0,0
45050,the,0,0
45051,study,0,0
45052,",",0,0
45053,an,0,0
45054,intent-to-treat,0,0
45055,analysis,0,0
45056,in,0,0
45057,which,0,0
45058,patients,0,0
45059,with,0,0
45060,missing,0,0
45061,data,0,0
45062,were,0,0
45063,considered,0,0
45064,to,0,0
45065,have,0,0
45066,experienced,0,0
45067,treatment,0,0
45068,failure,1,1
45069,showed,0,0
45070,that,0,0
45071,the,0,0
45072,3TC,0,0
45073,q.d,0,0
45074,.,0,0
45075,and,0,0
45076,3TC,0,0
45077,b.i.d,0,0
45078,.,0,0
45079,regimens,0,0
45080,were,0,0
45081,equivalent,0,0
45082,(,0,0
45083,HIV-1,0,0
45084,RNA,0,1
45085,level,0,1
45086,<,0,0
45087,400,0,0
45088,copies/mL,0,0
45089,",",0,0
45090,178,0,0
45091,[,0,0
45092,64,0,0
45093,%,0,0
45094,],0,0
45095,of,0,0
45096,278,0,0
45097,vs.,0,0
45098,174,0,0
45099,[,0,0
45100,63,0,0
45101,%,0,0
45102,],0,0
45103,of,0,0
45104,276,0,0
45105,;,0,0
45106,treatment,0,0
45107,difference,0,0
45108,",",0,0
45109,1,0,0
45110,%,0,0
45111,[,0,0
45112,95,0,0
45113,%,0,0
45114,CI,0,0
45115,",",0,1
45116,-7.1,0,0
45117,%,0,0
45118,to,0,0
45119,8.9,0,0
45120,%,0,0
45121,],0,0
45122,;,0,0
45123,HIV-1,0,0
45124,RNA,0,1
45125,level,0,1
45126,<,0,0
45127,50,0,0
45128,copies/mL,0,0
45129,",",0,0
45130,165,0,0
45131,[,0,0
45132,59,0,0
45133,%,0,0
45134,],0,0
45135,of,0,0
45136,278,0,0
45137,vs.,0,0
45138,168,0,0
45139,[,0,0
45140,61,0,0
45141,%,0,0
45142,],0,0
45143,of,0,0
45144,276,0,0
45145,;,0,0
45146,treatment,0,0
45147,difference,0,0
45148,",",0,0
45149,1.7,0,0
45150,%,0,0
45151,[,0,0
45152,95,0,0
45153,%,0,0
45154,CI,0,0
45155,",",0,1
45156,-9.7,0,0
45157,%,0,0
45158,to,0,0
45159,6.6,0,0
45160,%,0,0
45161,],0,0
45162,),0,0
45163,.,0,0
45164,Median,1,1
45165,increase,1,1
45166,above,1,1
45167,baseline,1,0
45168,in,1,0
45169,CD4,1,1
45170,(,1,0
45171,+,1,0
45172,),1,1
45173,cell,1,1
45174,count,1,1
45175,was,0,0
45176,similar,0,0
45177,(,0,0
45178,q.d,0,0
45179,.,0,1
45180,group,0,0
45181,",",0,1
45182,+144,0,0
45183,cells/mm,0,0
45184,(,0,0
45185,3,0,0
45186,),0,0
45187,;,0,0
45188,b.i.d,0,0
45189,.,0,1
45190,group,0,0
45191,",",0,1
45192,+146,0,0
45193,cells/mm,0,0
45194,(,0,0
45195,3,0,0
45196,),0,0
45197,),0,0
45198,",",0,0
45199,and,0,0
45200,the,0,0
45201,incidences,1,1
45202,of,1,0
45203,adverse,1,1
45204,events,1,1
45205,",",1,1
45206,disease,1,1
45207,progression,1,1
45208,",",1,1
45209,and,1,1
45210,HIV-associated,1,1
45211,conditions,1,0
45212,were,0,0
45213,comparable,0,0
45214,.,0,0
45215,Rye,0,1
45216,bran,0,0
45217,bread,0,0
45218,intake,0,1
45219,elevates,0,0
45220,urinary,1,1
45221,excretion,1,1
45222,of,1,1
45223,ferulic,1,1
45224,acid,1,0
45225,in,0,0
45226,humans,0,0
45227,",",0,0
45228,but,0,0
45229,does,0,0
45230,not,0,0
45231,affect,0,0
45232,the,0,0
45233,susceptibility,1,1
45234,of,1,0
45235,LDL,1,1
45236,to,1,0
45237,oxidation,1,1
45238,ex,0,0
45239,vivo,0,0
45240,.,0,0
45241,BACKGROUND,0,0
45242,Rye,0,0
45243,bread,0,0
45244,contributes,0,0
45245,an,0,0
45246,important,0,0
45247,part,0,0
45248,of,0,0
45249,the,0,0
45250,whole,0,0
45251,grain,0,0
45252,intake,0,1
45253,in,0,0
45254,the,0,0
45255,Scandinavian,0,0
45256,diet,0,0
45257,.,0,1
45258,Ferulic,0,0
45259,acid,0,0
45260,is,0,0
45261,the,0,0
45262,major,0,1
45263,phenolic,0,1
45264,compound,0,0
45265,in,0,0
45266,rye,0,0
45267,bran,0,0
45268,and,0,0
45269,is,0,0
45270,an,0,0
45271,antioxidant,0,0
45272,in,0,0
45273,vitro,0,0
45274,and,0,0
45275,may,0,0
45276,",",0,0
45277,therefore,0,0
45278,",",0,0
45279,contribute,0,0
45280,to,0,0
45281,cardioprotective,0,0
45282,effects,0,1
45283,of,0,1
45284,whole,0,1
45285,grain,0,0
45286,consumption,0,1
45287,.,0,1
45288,AIM,0,0
45289,OF,0,0
45290,THE,0,0
45291,STUDY,0,1
45292,Firstly,0,0
45293,",",0,0
45294,to,0,0
45295,evaluate,0,0
45296,the,0,0
45297,bioavailability,1,1
45298,and,1,1
45299,potential,1,1
45300,antioxidative,1,1
45301,effects,1,1
45302,in,0,0
45303,humans,0,0
45304,of,0,0
45305,ferulic,0,1
45306,acid,0,0
45307,from,0,0
45308,rye,0,0
45309,.,0,0
45310,Secondly,0,0
45311,",",0,0
45312,to,0,0
45313,evaluate,0,0
45314,urine,1,1
45315,levels,1,1
45316,of,1,1
45317,ferulic,1,1
45318,acid,1,0
45319,as,0,0
45320,a,0,0
45321,possible,0,0
45322,biomarker,0,0
45323,of,0,0
45324,the,0,0
45325,ordinary,0,0
45326,dietary,0,0
45327,intake,0,1
45328,of,0,1
45329,ferulic,0,1
45330,acid,0,0
45331,.,0,0
45332,METHODS,0,0
45333,We,0,0
45334,determined,0,0
45335,the,0,0
45336,urinary,1,1
45337,excretion,1,1
45338,of,1,1
45339,ferulic,1,1
45340,acid,1,0
45341,in,0,0
45342,18,0,0
45343,postmenopausal,0,0
45344,women,0,0
45345,after,0,0
45346,a,0,0
45347,dietary,0,0
45348,intake,0,1
45349,of,0,1
45350,rye,0,0
45351,bran,0,0
45352,or,0,0
45353,an,0,0
45354,inert,0,0
45355,wheat,0,0
45356,bran,0,0
45357,(,0,1
45358,control,0,0
45359,),0,0
45360,in,0,0
45361,a,0,0
45362,crossover,0,0
45363,study,0,0
45364,(,0,0
45365,2,0,0
45366,x,0,0
45367,6,0,0
45368,weeks,0,0
45369,with,0,0
45370,4,0,0
45371,weeks,0,0
45372,washout,0,0
45373,),0,0
45374,.,0,0
45375,The,0,0
45376,potential,0,0
45377,antioxidative,0,1
45378,effect,0,0
45379,of,0,0
45380,the,0,0
45381,rye,0,0
45382,bran,0,0
45383,intervention,0,0
45384,was,0,0
45385,investigated,0,0
45386,by,0,0
45387,measuring,0,0
45388,low-density,1,1
45389,lipoprotein,1,1
45390,(,1,1
45391,LDL,1,1
45392,),1,0
45393,susceptibility,1,1
45394,to,1,0
45395,copper,1,1
45396,oxidation,1,1
45397,ex,1,0
45398,vivo,1,0
45399,.,1,0
45400,The,0,0
45401,subjects,0,0
45402,ingested,0,1
45403,rye,0,0
45404,bran,0,0
45405,enriched,0,0
45406,breads,0,0
45407,equivalent,0,0
45408,to,0,0
45409,approximately,0,0
45410,10.2,0,0
45411,mg,0,0
45412,ferulic,0,0
45413,acid,0,0
45414,per,0,0
45415,day,0,0
45416,.,0,0
45417,RESULTS,0,0
45418,The,0,0
45419,urinary,1,1
45420,excretion,1,1
45421,of,1,1
45422,ferulic,1,1
45423,acid,1,0
45424,averaged,0,0
45425,approximately,0,0
45426,4.8,0,0
45427,mg,0,0
45428,per,0,0
45429,day,0,0
45430,during,0,0
45431,intervention,0,0
45432,with,0,0
45433,rye,0,0
45434,bran,0,0
45435,breads,0,0
45436,and,0,0
45437,approximately,0,0
45438,1.9,0,0
45439,mg,0,0
45440,per,0,0
45441,day,0,0
45442,on,0,0
45443,the,0,0
45444,control,0,0
45445,breads,0,0
45446,(,0,0
45447,P,0,0
45448,=,0,0
45449,0.002,0,0
45450,),0,0
45451,.,0,0
45452,Rye,0,0
45453,bran,0,0
45454,intervention,0,0
45455,had,0,0
45456,no,0,0
45457,influence,0,0
45458,on,0,0
45459,lag,1,1
45460,time,1,1
45461,or,1,1
45462,propagation,1,1
45463,rate,1,1
45464,of,1,0
45465,the,1,0
45466,LDL,1,1
45467,oxidation,1,1
45468,ex,0,0
45469,vivo,0,0
45470,.,0,0
45471,CONCLUSIONS,0,0
45472,The,0,0
45473,present,0,0
45474,study,0,0
45475,demonstrated,0,0
45476,that,0,0
45477,ferulic,0,1
45478,acid,0,0
45479,from,0,0
45480,rye,0,0
45481,bran,0,0
45482,is,0,0
45483,bioavailable,0,1
45484,and,0,0
45485,that,0,0
45486,the,0,0
45487,urinary,0,1
45488,concentration,0,1
45489,of,0,1
45490,ferulic,0,0
45491,acid,0,0
45492,reflects,0,0
45493,the,0,0
45494,dietary,0,0
45495,intake,0,1
45496,of,0,0
45497,this,0,0
45498,hydroxycinnamic,0,0
45499,acid,0,0
45500,.,0,0
45501,Within,0,0
45502,the,0,0
45503,period,0,0
45504,of,0,1
45505,intervention,0,0
45506,",",0,0
45507,the,0,0
45508,elevated,0,1
45509,ferulic,0,1
45510,acid,0,1
45511,did,0,0
45512,not,0,0
45513,produce,0,0
45514,a,0,0
45515,measurable,0,1
45516,antioxidative,1,1
45517,effect,1,0
45518,on,0,0
45519,the,0,0
45520,subjects,0,0
45521,',0,1
45522,LDL,0,1
45523,.,0,0
45524,It,0,0
45525,is,0,0
45526,suggested,0,0
45527,that,0,0
45528,the,0,0
45529,determination,0,0
45530,of,0,0
45531,ferulic,0,1
45532,acid,0,0
45533,in,0,0
45534,urine,0,1
45535,is,0,0
45536,a,0,0
45537,useful,0,0
45538,biomarker,0,0
45539,to,0,0
45540,assess,0,0
45541,the,0,0
45542,intake,1,1
45543,of,1,0
45544,ferulic,1,1
45545,acid,1,0
45546,from,0,0
45547,a,0,0
45548,regular,0,0
45549,diet,0,0
45550,.,0,0
45551,Evaluation,0,1
45552,of,0,1
45553,additional,0,0
45554,amine,0,0
45555,fluoride/stannous,0,0
45556,fluoride-containing,0,0
45557,mouthrinse,0,0
45558,during,0,0
45559,supportive,0,0
45560,therapy,0,0
45561,in,0,0
45562,patients,0,0
45563,with,0,0
45564,generalized,0,0
45565,aggressive,0,0
45566,periodontitis,0,0
45567,.,0,0
45568,A,0,0
45569,randomized,0,0
45570,",",0,0
45571,crossover,0,0
45572,",",0,0
45573,double-blind,0,0
45574,",",0,1
45575,controlled,0,0
45576,trial,0,0
45577,.,0,0
45578,OBJECTIVES,0,0
45579,The,0,0
45580,objective,0,0
45581,of,0,0
45582,the,0,0
45583,present,0,0
45584,randomized,0,0
45585,controlled,0,0
45586,trial,0,0
45587,was,0,0
45588,to,0,0
45589,evaluate,0,0
45590,the,0,0
45591,efficacy,0,1
45592,of,0,0
45593,a,0,0
45594,mouthrinse,0,0
45595,containing,0,0
45596,a,0,0
45597,combination,0,0
45598,of,0,0
45599,AmF/SnF2,0,1
45600,in,0,0
45601,controlling,0,0
45602,supragingival,0,1
45603,plaque,0,1
45604,accumulation,0,1
45605,and,0,1
45606,gingival,0,1
45607,inflammation,0,1
45608,during,0,0
45609,a,0,0
45610,12-week,0,0
45611,period,0,0
45612,in,0,0
45613,patients,0,0
45614,affected,0,0
45615,by,0,0
45616,generalized,0,0
45617,aggressive,0,1
45618,periodontitis,0,0
45619,(,0,1
45620,GAP,0,0
45621,),0,0
45622,.,0,0
45623,METHODS,0,0
45624,Eighteen,0,1
45625,subjects,0,0
45626,",",0,0
45627,six,0,0
45628,males,0,0
45629,and,0,0
45630,12,0,0
45631,females,0,0
45632,",",0,0
45633,mean,0,1
45634,age,0,0
45635,:,0,0
45636,32.2,0,0
45637,years,0,0
45638,",",0,0
45639,were,0,0
45640,evaluated,0,0
45641,.,0,0
45642,One-half,0,0
45643,of,0,0
45644,the,0,0
45645,patients,0,0
45646,was,0,0
45647,either,0,0
45648,prescribed,0,0
45649,an,0,0
45650,AmF/SnF2-containing,0,0
45651,mouthrinse,0,0
45652,(,0,0
45653,test,0,1
45654,mouthrinse,0,0
45655,),0,0
45656,or,0,0
45657,a,0,0
45658,control,0,0
45659,mouthrinse,0,0
45660,in,0,0
45661,addition,0,0
45662,to,0,0
45663,mechanical,0,0
45664,plaque,0,1
45665,control,0,0
45666,for,0,0
45667,12,0,0
45668,weeks,0,0
45669,.,0,0
45670,After,0,0
45671,a,0,0
45672,2-week,0,0
45673,wash-out,0,0
45674,period,0,0
45675,",",0,0
45676,the,0,0
45677,patients,0,0
45678,received,0,0
45679,the,0,0
45680,alternative,0,0
45681,mouthrinse,0,0
45682,.,0,1
45683,Before,0,0
45684,and,0,0
45685,after,0,0
45686,treatment,0,0
45687,plaque,1,1
45688,index,1,1
45689,(,1,1
45690,PlI,1,1
45691,),1,1
45692,",",1,0
45693,gingival,1,1
45694,index,1,1
45695,(,1,1
45696,GI,1,1
45697,),1,1
45698,",",1,0
45699,angulated,1,1
45700,bleeding,1,1
45701,index,1,1
45702,(,1,1
45703,AngBI,1,0
45704,),1,1
45705,",",1,0
45706,tooth,1,0
45707,stain,1,1
45708,(,1,1
45709,GMSI,1,0
45710,),1,1
45711,",",1,1
45712,and,1,1
45713,tongue,1,1
45714,stain,1,1
45715,were,0,0
45716,recorded,0,0
45717,.,0,0
45718,RESULTS,0,0
45719,Test,0,1
45720,mouthrinse,0,0
45721,resulted,0,0
45722,in,0,0
45723,a,0,0
45724,statistically,0,0
45725,significant,0,0
45726,decrease,0,1
45727,in,0,0
45728,PlI,1,0
45729,(,0,0
45730,p,0,0
45731,=,0,0
45732,0.029,0,0
45733,),0,0
45734,and,0,0
45735,GI,0,1
45736,(,0,1
45737,p,0,0
45738,=,0,0
45739,0.017,0,0
45740,),0,0
45741,.,0,0
45742,After,0,0
45743,treatment,0,0
45744,",",0,1
45745,PlI,1,1
45746,was,0,0
45747,significantly,0,0
45748,lower,0,0
45749,in,0,0
45750,test,0,1
45751,compared,0,0
45752,to,0,0
45753,control,0,0
45754,mouthrinse,0,0
45755,(,0,0
45756,p,0,0
45757,=,0,0
45758,0.027,0,0
45759,),0,0
45760,.,0,0
45761,GMSI,1,0
45762,significantly,0,0
45763,increased,0,0
45764,post-treatment,0,0
45765,for,0,0
45766,both,0,0
45767,mouthrinse,0,0
45768,regimens,0,0
45769,(,0,0
45770,p,0,0
45771,<,0,0
45772,0.001,0,0
45773,),0,0
45774,",",0,0
45775,a,0,0
45776,significantly,0,0
45777,higher,0,0
45778,score,0,1
45779,being,0,0
45780,observed,0,0
45781,for,0,0
45782,the,0,0
45783,test,0,0
45784,compared,0,0
45785,to,0,0
45786,control,0,0
45787,mouthrinse,0,0
45788,(,0,0
45789,p,0,0
45790,=,0,0
45791,0.002,0,0
45792,),0,0
45793,.,0,0
45794,CONCLUSIONS,0,0
45795,The,0,0
45796,12-week,0,0
45797,use,0,0
45798,of,0,0
45799,a,0,0
45800,AmF/SnF2-containing,0,0
45801,mouthrinse,0,0
45802,as,0,0
45803,an,0,0
45804,adjunct,0,0
45805,to,0,0
45806,conventional,0,0
45807,mechanical,0,0
45808,oral,0,0
45809,hygiene,0,1
45810,procedures,0,0
45811,in,0,0
45812,GAP,0,0
45813,patients,0,0
45814,was,0,0
45815,effective,0,1
45816,in,0,0
45817,controlling,0,0
45818,the,0,0
45819,amount,0,1
45820,of,0,0
45821,supragingival,0,1
45822,plaque,0,1
45823,deposits,0,1
45824,.,0,0
45825,Comparison,0,0
45826,of,0,0
45827,an,0,0
45828,allograft,0,0
45829,in,0,0
45830,an,0,0
45831,experimental,0,0
45832,putty,0,1
45833,carrier,0,1
45834,and,0,0
45835,a,0,0
45836,bovine-derived,0,0
45837,xenograft,0,0
45838,used,0,0
45839,in,0,0
45840,ridge,0,0
45841,preservation,0,0
45842,:,0,0
45843,a,0,0
45844,clinical,0,0
45845,and,0,1
45846,histologic,0,1
45847,study,0,0
45848,in,0,0
45849,humans,0,0
45850,.,0,0
45851,PURPOSE,0,0
45852,The,0,0
45853,aim,0,0
45854,of,0,0
45855,this,0,0
45856,randomized,0,0
45857,",",0,0
45858,controlled,0,0
45859,",",0,0
45860,blinded,0,0
45861,clinical,0,1
45862,study,0,0
45863,was,0,0
45864,to,0,0
45865,compare,0,0
45866,ridge,1,1
45867,dimensions,1,1
45868,and,1,1
45869,histologic,1,1
45870,characteristics,1,1
45871,of,1,0
45872,ridges,1,1
45873,preserved,0,0
45874,with,0,0
45875,2,0,0
45876,different,0,0
45877,graft,0,0
45878,materials,0,0
45879,.,0,1
45880,MATERIALS,0,0
45881,AND,0,0
45882,METHODS,0,0
45883,Twenty-four,0,0
45884,subjects,0,0
45885,",",0,0
45886,each,0,0
45887,requiring,0,0
45888,a,0,0
45889,nonmolar,0,1
45890,extraction,0,1
45891,and,0,1
45892,delayed,0,1
45893,implant,0,1
45894,placement,0,1
45895,",",0,1
45896,were,0,0
45897,randomly,0,0
45898,selected,0,0
45899,to,0,0
45900,receive,0,0
45901,ridge,0,1
45902,preservation,0,1
45903,treatment,0,0
45904,with,0,0
45905,either,0,0
45906,an,0,0
45907,allograft,0,0
45908,in,0,0
45909,an,0,0
45910,experimental,0,0
45911,putty,0,1
45912,carrier,0,1
45913,plus,0,0
45914,a,0,0
45915,calcium,0,1
45916,sulfate,0,1
45917,barrier,0,1
45918,(,0,1
45919,PUT,0,1
45920,),0,0
45921,or,0,0
45922,a,0,0
45923,bovine-derived,0,1
45924,xenograft,0,0
45925,(,0,1
45926,BDX,0,1
45927,),0,0
45928,plus,0,0
45929,a,0,0
45930,collagen,0,0
45931,membrane,0,1
45932,.,0,1
45933,Horizontal,1,1
45934,and,1,1
45935,vertical,1,1
45936,ridge,1,1
45937,dimensions,1,1
45938,were,1,0
45939,determined,1,0
45940,using,1,0
45941,a,1,0
45942,digital,1,0
45943,caliper,1,0
45944,and,1,0
45945,a,1,0
45946,template,1,0
45947,.,1,0
45948,At,0,0
45949,4,0,0
45950,months,0,0
45951,postextraction,0,0
45952,",",0,0
45953,a,0,0
45954,trephine,0,1
45955,core,0,1
45956,was,0,0
45957,obtained,0,0
45958,for,0,0
45959,histologic,1,1
45960,analysis,1,0
45961,.,1,0
45962,RESULTS,0,0
45963,The,0,0
45964,average,0,1
45965,ridge,1,1
45966,width,1,1
45967,decreased,0,0
45968,by,0,0
45969,0.50,0,0
45970,mm,0,0
45971,for,0,0
45972,both,0,0
45973,groups,0,0
45974,(,0,0
45975,P,0,0
45976,<,0,0
45977,.05,0,0
45978,),0,0
45979,.,0,0
45980,The,0,0
45981,midbuccal,1,1
45982,vertical,1,1
45983,change,1,1
45984,for,0,0
45985,the,0,0
45986,PUT,0,1
45987,group,0,0
45988,was,0,0
45989,a,0,0
45990,loss,0,1
45991,of,0,0
45992,0.3+/-0.7,0,0
45993,mm,0,0
45994,versus,0,0
45995,a,0,0
45996,gain,0,1
45997,of,0,0
45998,0.7+/-1.2,0,0
45999,mm,0,0
46000,for,0,0
46001,the,0,0
46002,BDX,0,1
46003,group,0,0
46004,",",0,0
46005,a,0,0
46006,difference,0,0
46007,of,0,0
46008,1.0,0,0
46009,mm,0,0
46010,(,0,0
46011,P,0,0
46012,>,0,1
46013,.05,0,0
46014,),0,0
46015,.,0,0
46016,Histologic,0,1
46017,analysis,0,0
46018,revealed,0,0
46019,vital,1,1
46020,bone,1,1
46021,in,0,0
46022,the,0,0
46023,PUT,0,1
46024,group,0,0
46025,of,0,0
46026,about,0,0
46027,61,0,0
46028,%,0,0
46029,+/-9,0,0
46030,%,0,0
46031,versus,0,0
46032,26,0,0
46033,%,0,0
46034,+/-20,0,0
46035,%,0,0
46036,for,0,0
46037,the,0,0
46038,BDX,0,1
46039,group,0,0
46040,(,0,0
46041,P,0,0
46042,<,0,0
46043,.05,0,0
46044,),0,0
46045,.,0,0
46046,DISCUSSION,0,1
46047,Greater,0,1
46048,vital,1,1
46049,bone,1,1
46050,fill,1,0
46051,in,0,0
46052,the,0,0
46053,PUT,0,0
46054,group,0,0
46055,may,0,0
46056,be,0,0
46057,attributable,0,0
46058,to,0,0
46059,earlier,0,0
46060,and,0,1
46061,greater,0,1
46062,vascular,0,1
46063,invasion,0,1
46064,of,0,0
46065,the,0,0
46066,carrier,0,0
46067,material,0,0
46068,.,0,0
46069,The,0,0
46070,putty,0,1
46071,material,0,1
46072,was,0,0
46073,characterized,0,0
46074,by,0,0
46075,ease,0,1
46076,of,0,1
46077,handling,0,0
46078,",",0,0
46079,simple,0,0
46080,placement,0,1
46081,",",0,1
46082,and,0,1
46083,enhanced,0,1
46084,graft,0,1
46085,particle,0,1
46086,containment,0,1
46087,.,0,1
46088,CONCLUSIONS,0,0
46089,Allograft,0,1
46090,mixed,0,0
46091,with,0,0
46092,an,0,0
46093,experimental,0,0
46094,putty,0,1
46095,carrier,0,1
46096,produced,0,0
46097,significantly,0,0
46098,more,0,0
46099,vital,0,1
46100,bone,0,1
46101,fill,0,0
46102,than,0,0
46103,did,0,0
46104,the,0,0
46105,use,0,0
46106,of,0,0
46107,a,0,0
46108,xenograft,0,0
46109,with,0,0
46110,no,0,0
46111,carrier,0,0
46112,material,0,1
46113,.,0,1
46114,Ridge,1,0
46115,width,1,1
46116,and,1,1
46117,height,1,1
46118,dimensions,1,1
46119,were,0,0
46120,similarly,0,0
46121,preserved,0,0
46122,with,0,0
46123,both,0,0
46124,graft,0,1
46125,materials,0,0
46126,.,0,0
46127,Parent,0,1
46128,management,0,0
46129,training,0,0
46130,and,0,1
46131,Asperger,0,1
46132,syndrome,0,0
46133,:,0,0
46134,a,0,0
46135,randomized,0,0
46136,controlled,0,0
46137,trial,0,0
46138,to,0,0
46139,evaluate,0,0
46140,a,0,0
46141,parent,1,1
46142,based,1,0
46143,intervention,1,0
46144,.,1,0
46145,This,0,0
46146,controlled,0,0
46147,trial,0,0
46148,of,0,0
46149,a,0,0
46150,parent,0,1
46151,management,0,0
46152,intervention,0,0
46153,aimed,0,0
46154,to,0,0
46155,increase,0,0
46156,parental,0,1
46157,competence,0,1
46158,in,0,0
46159,management,0,0
46160,of,0,1
46161,problem,0,0
46162,behaviours,0,1
46163,associated,0,0
46164,with,0,0
46165,Asperger,0,0
46166,syndrome,0,0
46167,.,0,0
46168,The,0,0
46169,intervention,0,0
46170,compared,0,0
46171,two,0,0
46172,formats,0,0
46173,",",0,0
46174,a,0,0
46175,1,0,0
46176,day,0,0
46177,workshop,0,0
46178,and,0,0
46179,six,0,0
46180,individual,0,0
46181,sessions,0,0
46182,.,0,0
46183,Measures,0,1
46184,were,0,0
46185,taken,0,0
46186,on,0,0
46187,three,0,0
46188,occasions,0,0
46189,:,0,0
46190,pre-intervention,0,0
46191,",",0,0
46192,at,0,0
46193,4,0,0
46194,weeks,0,0
46195,",",0,0
46196,and,0,0
46197,at,0,0
46198,3,0,0
46199,month,0,0
46200,follow-up,0,0
46201,.,0,0
46202,Variables,0,1
46203,of,0,1
46204,interest,0,0
46205,were,0,0
46206,number,1,1
46207,and,1,1
46208,intensity,1,1
46209,of,1,1
46210,problem,1,1
46211,behaviours,1,1
46212,",",1,1
46213,and,1,1
46214,parent,1,1
46215,evaluation,1,0
46216,of,1,1
46217,social,1,1
46218,interaction,1,1
46219,skills,1,1
46220,.,1,1
46221,Results,0,0
46222,showed,0,0
46223,parents,0,0
46224,reporting,0,1
46225,fewer,0,1
46226,and,0,1
46227,lower,0,1
46228,intensity,1,1
46229,of,1,1
46230,problem,1,1
46231,behaviours,1,1
46232,and,0,1
46233,increased,1,1
46234,social,1,1
46235,interactions,1,0
46236,at,0,0
46237,4,0,0
46238,weeks,0,0
46239,and,0,0
46240,3,0,0
46241,months,0,0
46242,.,0,0
46243,Results,0,0
46244,held,0,0
46245,across,0,0
46246,formats,0,0
46247,and,0,0
46248,suggest,0,0
46249,that,0,0
46250,parent,0,1
46251,management,0,0
46252,training,0,0
46253,can,0,0
46254,provide,0,0
46255,an,0,0
46256,effective,1,1
46257,intervention,1,0
46258,for,1,0
46259,parents,1,0
46260,of,1,0
46261,a,1,0
46262,child,1,0
46263,with,1,0
46264,Asperger,1,0
46265,syndrome,1,0
46266,.,1,0
46267,Group,0,0
46268,differences,0,0
46269,on,0,0
46270,outcome,0,1
46271,measures,0,1
46272,and,0,0
46273,in,0,0
46274,the,0,0
46275,use,0,0
46276,of,0,0
46277,strategies,0,0
46278,are,0,0
46279,discussed,0,0
46280,along,0,0
46281,with,0,0
46282,limitations,0,0
46283,of,0,0
46284,the,0,0
46285,study,0,0
46286,.,0,0
46287,Transitions,0,0
46288,during,0,0
46289,effective,0,1
46290,treatment,0,0
46291,for,0,0
46292,cocaine-abusing,0,0
46293,homeless,0,0
46294,persons,0,0
46295,:,0,0
46296,establishing,0,0
46297,abstinence,0,1
46298,",",0,1
46299,lapse,0,1
46300,",",0,1
46301,and,0,1
46302,relapse,0,1
46303,",",0,1
46304,and,0,1
46305,reestablishing,0,0
46306,abstinence,0,1
46307,.,0,0
46308,Data,0,0
46309,are,0,0
46310,reported,0,0
46311,on,0,0
46312,drug,0,0
46313,use,0,0
46314,among,0,0
46315,cocaine-dependent,0,0
46316,homeless,0,0
46317,persons,0,0
46318,who,0,0
46319,participated,0,0
46320,in,0,0
46321,a,0,0
46322,clinical,0,0
46323,trial,0,0
46324,that,0,0
46325,compared,0,0
46326,day,0,0
46327,treatment,0,0
46328,only,0,0
46329,(,0,0
46330,DT,0,1
46331,",",0,1
46332,n,0,0
46333,=,0,0
46334,69,0,0
46335,),0,0
46336,with,0,0
46337,day,0,1
46338,treatment,0,0
46339,plus,0,0
46340,abstinent-contingent,0,1
46341,housing,0,1
46342,and,0,1
46343,work,0,1
46344,(,0,1
46345,DT+,0,1
46346,",",0,1
46347,n,0,0
46348,=,0,0
46349,72,0,0
46350,),0,0
46351,.,0,0
46352,Drug,1,0
46353,use,1,1
46354,was,1,0
46355,measured,1,0
46356,with,1,0
46357,multiple,1,0
46358,weekly,1,0
46359,urine,1,1
46360,toxicologies,1,0
46361,.,1,0
46362,Compared,0,0
46363,with,0,0
46364,DT,0,1
46365,participants,0,0
46366,",",0,0
46367,more,0,0
46368,DT+,0,1
46369,participants,0,0
46370,established,0,0
46371,abstinence,1,1
46372,",",1,0
46373,maintained,1,0
46374,abstinence,1,1
46375,for,1,0
46376,longer,1,0
46377,durations,1,1
46378,",",0,1
46379,were,0,0
46380,marginally,0,0
46381,significantly,0,0
46382,more,0,0
46383,likely,0,0
46384,to,0,0
46385,lapse,1,1
46386,",",0,0
46387,and,0,1
46388,significantly,0,1
46389,less,0,0
46390,likely,0,0
46391,to,0,0
46392,relapse,1,1
46393,.,1,0
46394,Of,0,0
46395,all,0,0
46396,participants,0,0
46397,who,0,0
46398,established,0,0
46399,abstinence,0,1
46400,and,0,1
46401,then,0,0
46402,relapsed,0,0
46403,",",0,0
46404,DT+,0,1
46405,participants,0,0
46406,relapsed,0,0
46407,later,0,0
46408,and,0,0
46409,were,0,0
46410,more,0,0
46411,likely,0,0
46412,to,0,0
46413,reestablish,1,0
46414,abstinence,1,1
46415,.,1,0
46416,These,0,0
46417,analyses,0,0
46418,yield,0,1
46419,information,0,0
46420,on,0,0
46421,the,0,0
46422,processes,0,0
46423,involved,0,0
46424,in,0,0
46425,the,0,0
46426,manner,0,0
46427,in,0,0
46428,which,0,0
46429,drug,0,0
46430,use,0,0
46431,changes,0,1
46432,as,0,0
46433,a,0,0
46434,result,0,0
46435,of,0,0
46436,abstinent-contingent,0,1
46437,housing,0,1
46438,and,0,1
46439,work,0,1
46440,.,0,0
46441,Effects,0,0
46442,of,0,0
46443,bifidobacterium,0,0
46444,breve,0,0
46445,supplementation,0,0
46446,on,0,0
46447,intestinal,0,1
46448,flora,0,1
46449,of,0,1
46450,low,0,0
46451,birth,0,1
46452,weight,0,1
46453,infants,0,0
46454,.,0,0
46455,BACKGROUND,0,0
46456,It,0,0
46457,is,0,0
46458,known,0,0
46459,that,0,0
46460,the,0,0
46461,bifidobacteria,0,1
46462,flora,0,1
46463,play,0,0
46464,important,0,1
46465,roles,0,0
46466,in,0,0
46467,mucosal,0,1
46468,host,0,1
46469,defense,0,1
46470,and,0,0
46471,can,0,0
46472,prevent,0,0
46473,infectious,0,1
46474,diseases,0,0
46475,.,0,0
46476,Because,0,0
46477,bacterial,0,0
46478,populations,0,0
46479,develop,0,0
46480,during,0,0
46481,the,0,0
46482,first,0,0
46483,day,0,0
46484,of,0,1
46485,life,0,1
46486,",",0,0
46487,the,0,0
46488,authors,0,0
46489,examined,0,0
46490,whether,0,0
46491,the,0,0
46492,early,0,0
46493,administration,0,0
46494,of,0,0
46495,bifidobacteria,0,1
46496,has,0,0
46497,a,0,0
46498,positive,0,1
46499,effect,1,0
46500,on,1,0
46501,the,1,0
46502,health,1,1
46503,of,0,0
46504,low,0,0
46505,birth,0,1
46506,weight,0,1
46507,infants,0,0
46508,.,0,0
46509,METHODS,0,0
46510,The,0,0
46511,effects,0,0
46512,of,0,0
46513,oral,0,0
46514,administration,0,0
46515,of,0,1
46516,Bifidobacterium,0,1
46517,breve,0,0
46518,(,0,0
46519,B.,0,1
46520,breve,0,0
46521,),0,0
46522,supplements,0,0
46523,were,0,0
46524,studied,0,0
46525,in,0,0
46526,a,0,0
46527,controlled,0,0
46528,trial,0,0
46529,with,0,0
46530,low,0,0
46531,birth,0,1
46532,weight,0,1
46533,infants,0,0
46534,(,0,0
46535,average,0,1
46536,birth,0,1
46537,weight,0,1
46538,1489,0,0
46539,g,0,0
46540,),0,0
46541,.,0,0
46542,The,0,0
46543,infants,0,0
46544,were,0,0
46545,divided,0,0
46546,into,0,0
46547,three,0,0
46548,groups,0,0
46549,:,0,0
46550,Group,0,0
46551,A,0,0
46552,and,0,1
46553,B,0,0
46554,received,0,0
46555,a,0,0
46556,dose,0,0
46557,of,0,0
46558,1.6,0,0
46559,x,0,0
46560,10,0,0
46561,(,0,0
46562,8,0,0
46563,),0,0
46564,cells,0,0
46565,of,0,0
46566,B.,0,0
46567,breve,0,0
46568,supplement,0,0
46569,twice,0,0
46570,a,0,0
46571,day,0,0
46572,",",0,0
46573,commencing,0,0
46574,either,0,0
46575,from,0,0
46576,several,0,0
46577,hours,0,0
46578,after,0,0
46579,birth,0,1
46580,(,0,0
46581,group,0,0
46582,A,0,0
46583,),0,0
46584,or,0,0
46585,24,0,0
46586,h,0,0
46587,after,0,0
46588,birth,0,1
46589,(,0,0
46590,group,0,0
46591,B,0,0
46592,),0,0
46593,.,0,0
46594,Group,0,0
46595,C,0,0
46596,",",0,0
46597,the,0,0
46598,control,0,0
46599,group,0,0
46600,",",0,0
46601,received,0,0
46602,no,0,0
46603,supplement,0,0
46604,.,0,0
46605,RESULTS,0,0
46606,There,0,0
46607,were,0,0
46608,no,0,0
46609,significant,0,0
46610,differences,0,0
46611,in,0,0
46612,birth,1,1
46613,weight,1,1
46614,",",1,1
46615,treatment,1,0
46616,with,1,0
46617,antibiotics,1,1
46618,",",1,0
46619,and,1,0
46620,the,1,0
46621,starting,1,0
46622,time,1,1
46623,of,1,1
46624,breast-feeding,1,0
46625,among,0,0
46626,the,0,0
46627,three,0,0
46628,groups,0,0
46629,.,0,0
46630,A,0,0
46631,Bifidobacterium-predominant,1,0
46632,flora,1,1
46633,was,0,0
46634,formed,0,0
46635,at,0,0
46636,an,0,0
46637,average,0,0
46638,of,0,0
46639,2,0,0
46640,weeks,0,0
46641,after,0,0
46642,birth,0,0
46643,in,0,0
46644,group,0,0
46645,A,0,0
46646,and,0,0
46647,at,0,0
46648,an,0,0
46649,average,0,0
46650,of,0,0
46651,4,0,0
46652,weeks,0,0
46653,after,0,0
46654,birth,0,0
46655,in,0,0
46656,group,0,0
46657,B,0,0
46658,",",0,0
46659,while,0,0
46660,no,0,0
46661,Bifidobacterium,1,1
46662,was,0,0
46663,isolated,0,0
46664,in,0,0
46665,eight,0,0
46666,out,0,0
46667,of,0,0
46668,10,0,0
46669,infants,0,0
46670,in,0,0
46671,group,0,0
46672,C,0,0
46673,during,0,0
46674,the,0,0
46675,observation,0,0
46676,period,0,0
46677,of,0,0
46678,7,0,0
46679,weeks,0,0
46680,.,0,0
46681,In,0,0
46682,comparison,0,0
46683,between,0,0
46684,group,0,0
46685,A,0,0
46686,and,0,1
46687,B,0,1
46688,",",0,1
46689,Bifidobacterium,1,1
46690,was,0,0
46691,detected,1,0
46692,significantly,0,0
46693,earlier,0,0
46694,in,0,0
46695,group,0,0
46696,A,0,0
46697,",",0,0
46698,and,0,0
46699,the,0,0
46700,number,0,1
46701,of,0,0
46702,Enterobacteriaceae,0,1
46703,present,0,0
46704,in,0,0
46705,the,0,0
46706,infants,0,0
46707,at,0,0
46708,2,0,0
46709,weeks,0,0
46710,after,0,0
46711,birth,0,1
46712,was,0,0
46713,significantly,0,0
46714,lower,0,0
46715,in,0,0
46716,group,0,0
46717,A,0,0
46718,.,0,0
46719,CONCLUSION,0,0
46720,The,0,0
46721,results,0,0
46722,of,0,0
46723,the,0,0
46724,present,0,0
46725,study,0,0
46726,suggest,0,0
46727,that,0,0
46728,very,0,0
46729,early,0,0
46730,administration,0,0
46731,of,0,0
46732,B.,0,0
46733,breve,0,0
46734,to,0,0
46735,low,0,0
46736,birth,0,1
46737,weight,0,1
46738,infants,0,0
46739,is,0,0
46740,useful,0,0
46741,in,0,0
46742,promoting,0,0
46743,the,0,0
46744,colonization,0,1
46745,of,0,0
46746,the,0,0
46747,Bifidobacterium,0,1
46748,and,0,0
46749,the,0,0
46750,formation,0,1
46751,of,0,0
46752,a,0,0
46753,normal,0,0
46754,intestinal,0,1
46755,flora,0,1
46756,.,0,0
46757,A,0,0
46758,randomized,0,0
46759,multicenter,0,0
46760,trial,0,0
46761,comparing,0,0
46762,resection,0,1
46763,and,0,1
46764,radiochemotherapy,0,0
46765,for,0,0
46766,resectable,0,0
46767,locally,0,0
46768,invasive,0,1
46769,pancreatic,0,0
46770,cancer,0,0
46771,.,0,0
46772,BACKGROUND,0,0
46773,Though,0,0
46774,the,0,0
46775,outcome,0,1
46776,of,0,0
46777,resection,0,0
46778,for,0,0
46779,locally,0,0
46780,invasive,0,1
46781,pancreatic,0,0
46782,cancer,0,0
46783,is,0,0
46784,still,0,0
46785,poor,0,0
46786,",",0,0
46787,it,0,0
46788,has,0,0
46789,gradually,0,0
46790,improved,0,0
46791,in,0,0
46792,Japan,0,0
46793,",",0,0
46794,and,0,0
46795,the,0,0
46796,5-year,1,0
46797,survival,1,1
46798,is,0,0
46799,now,0,0
46800,about,0,0
46801,10,0,0
46802,%,0,0
46803,.,0,0
46804,However,0,0
46805,",",0,0
46806,the,0,0
46807,advantage,0,0
46808,of,0,0
46809,resection,0,0
46810,over,0,0
46811,radiochemotherapy,0,0
46812,has,0,0
46813,not,0,0
46814,yet,0,0
46815,been,0,0
46816,confirmed,0,0
46817,by,0,0
46818,a,0,0
46819,randomized,0,0
46820,trial,0,0
46821,.,0,0
46822,We,0,0
46823,conducted,0,0
46824,this,0,0
46825,study,0,0
46826,to,0,0
46827,compare,0,0
46828,surgical,0,0
46829,resection,0,0
46830,alone,0,0
46831,versus,0,0
46832,radiochemotherapy,0,0
46833,without,0,0
46834,resection,0,0
46835,for,0,0
46836,locally,0,0
46837,invasive,0,1
46838,pancreatic,0,0
46839,cancer,0,0
46840,using,0,0
46841,a,0,0
46842,multicenter,0,0
46843,randomized,0,0
46844,design,0,0
46845,.,0,0
46846,METHODS,0,0
46847,Patients,0,0
46848,with,0,0
46849,pancreatic,0,0
46850,cancer,0,0
46851,who,0,0
46852,met,0,0
46853,our,0,0
46854,preoperative,0,1
46855,criteria,0,0
46856,for,0,0
46857,inclusion,0,0
46858,(,0,0
46859,pancreatic,0,1
46860,cancer,0,0
46861,invading,0,0
46862,the,0,0
46863,pancreatic,0,0
46864,capsule,0,0
46865,without,0,0
46866,involvement,0,0
46867,of,0,0
46868,the,0,0
46869,superior,0,0
46870,mesenteric,0,0
46871,artery,0,0
46872,or,0,0
46873,the,0,0
46874,common,0,0
46875,hepatic,0,1
46876,artery,0,1
46877,",",0,1
46878,or,0,1
46879,without,0,0
46880,distant,0,1
46881,metastasis,0,1
46882,),0,1
46883,underwent,0,0
46884,laparotomy,0,0
46885,.,0,0
46886,Patients,0,0
46887,with,0,0
46888,operative,0,1
46889,findings,0,0
46890,consistent,0,0
46891,with,0,0
46892,our,0,0
46893,criteria,0,0
46894,were,0,0
46895,randomized,0,0
46896,into,0,0
46897,a,0,0
46898,radical,0,0
46899,resection,0,0
46900,group,0,0
46901,and,0,0
46902,a,0,0
46903,radiochemotherapy,0,0
46904,group,0,0
46905,(,0,0
46906,200,0,0
46907,mg/m,0,0
46908,(,0,0
46909,2,0,0
46910,),0,0
46911,/day,0,0
46912,of,0,0
46913,intravenous,0,0
46914,5-fluorouracil,0,0
46915,and,0,0
46916,5040,0,0
46917,cGy,0,0
46918,of,0,0
46919,radiotherapy,0,0
46920,),0,0
46921,without,0,0
46922,resection,0,0
46923,.,0,0
46924,The,0,0
46925,2,0,0
46926,groups,0,0
46927,were,0,0
46928,compared,0,0
46929,for,0,0
46930,mean,1,1
46931,survival,1,1
46932,",",1,1
46933,hazard,1,1
46934,ratio,1,1
46935,",",1,1
46936,1-year,1,1
46937,survival,1,1
46938,",",1,1
46939,quality,1,1
46940,of,1,1
46941,life,1,1
46942,scores,1,1
46943,",",1,1
46944,and,1,1
46945,hematologic,1,1
46946,and,1,1
46947,blood,1,1
46948,chemical,1,0
46949,data,1,0
46950,.,1,0
46951,RESULTS,0,0
46952,Twenty,0,0
46953,patients,0,0
46954,were,0,0
46955,assigned,0,0
46956,to,0,0
46957,the,0,0
46958,resection,0,0
46959,group,0,0
46960,and,0,0
46961,22,0,0
46962,to,0,0
46963,the,0,0
46964,radiochemotherapy,0,0
46965,group,0,0
46966,.,0,0
46967,There,0,0
46968,was,0,0
46969,1,0,0
46970,operative,1,0
46971,death,1,1
46972,.,1,0
46973,The,0,0
46974,surgical,0,0
46975,resection,0,0
46976,group,0,0
46977,had,0,0
46978,better,0,0
46979,results,0,0
46980,than,0,0
46981,the,0,0
46982,radiochemotherapy,0,0
46983,group,0,0
46984,as,0,0
46985,measured,0,0
46986,by,0,0
46987,1-year,1,1
46988,survival,1,1
46989,(,0,0
46990,62,0,0
46991,%,0,0
46992,vs,0,0
46993,32,0,0
46994,%,0,0
46995,",",0,0
46996,P=.05,0,1
46997,),0,1
46998,",",0,0
46999,mean,1,1
47000,survival,1,1
47001,time,1,1
47002,(,0,0
47003,>,0,0
47004,17,0,0
47005,vs,0,0
47006,11,0,0
47007,months,0,0
47008,",",0,0
47009,P,0,0
47010,<,0,0
47011,.03,0,0
47012,),0,1
47013,",",0,0
47014,and,0,1
47015,hazard,1,1
47016,ratio,1,1
47017,(,0,0
47018,0.46,0,0
47019,",",0,0
47020,P=.04,0,0
47021,),0,0
47022,.,0,0
47023,There,0,0
47024,were,0,0
47025,no,0,0
47026,differences,0,0
47027,in,0,0
47028,the,0,0
47029,quality,1,1
47030,of,1,1
47031,life,1,1
47032,score,1,1
47033,or,0,1
47034,laboratory,1,1
47035,data,1,0
47036,apart,0,0
47037,from,0,0
47038,increased,0,0
47039,diarrhea,1,1
47040,after,0,0
47041,surgical,0,0
47042,resection,0,0
47043,.,0,0
47044,CONCLUSIONS,0,0
47045,Locally,0,0
47046,invasive,0,1
47047,pancreatic,0,1
47048,cancer,0,0
47049,without,0,0
47050,distant,0,1
47051,metastases,0,1
47052,and,0,1
47053,major,0,1
47054,arterial,0,1
47055,invasion,0,1
47056,appears,0,0
47057,to,0,0
47058,be,0,0
47059,best,0,0
47060,treated,0,0
47061,by,0,0
47062,surgical,0,0
47063,resection,0,0
47064,.,0,0
47065,Syncope,0,0
47066,Evaluation,0,1
47067,in,0,0
47068,the,0,0
47069,Emergency,0,1
47070,Department,0,1
47071,Study,0,0
47072,(,0,1
47073,SEEDS,0,0
47074,),0,0
47075,:,0,0
47076,a,0,0
47077,multidisciplinary,0,0
47078,approach,0,0
47079,to,0,0
47080,syncope,0,1
47081,management,0,0
47082,.,0,0
47083,BACKGROUND,0,0
47084,The,0,0
47085,primary,0,0
47086,aim,0,0
47087,and,0,1
47088,central,0,1
47089,hypothesis,0,0
47090,of,0,0
47091,the,0,0
47092,study,0,0
47093,are,0,0
47094,that,0,0
47095,a,0,0
47096,designated,0,0
47097,syncope,0,1
47098,unit,0,0
47099,in,0,0
47100,the,0,0
47101,emergency,0,1
47102,department,0,0
47103,improves,0,1
47104,diagnostic,0,1
47105,yield,0,1
47106,and,0,1
47107,reduces,0,1
47108,hospital,0,1
47109,admission,0,1
47110,for,0,0
47111,patients,0,0
47112,with,0,0
47113,syncope,0,0
47114,who,0,0
47115,are,0,0
47116,at,0,0
47117,intermediate,0,0
47118,risk,0,1
47119,for,0,0
47120,an,0,0
47121,adverse,0,1
47122,cardiovascular,0,1
47123,outcome,0,1
47124,.,0,1
47125,METHODS,0,0
47126,AND,0,0
47127,RESULTS,0,0
47128,In,0,0
47129,this,0,0
47130,prospective,0,0
47131,",",0,0
47132,randomized,0,0
47133,",",0,0
47134,single-center,0,0
47135,study,0,0
47136,",",0,1
47137,patients,0,0
47138,were,0,0
47139,randomly,0,0
47140,allocated,0,0
47141,to,0,0
47142,2,0,0
47143,treatment,0,0
47144,arms,0,0
47145,:,0,0
47146,syncope,0,1
47147,unit,0,1
47148,evaluation,0,1
47149,and,0,1
47150,standard,0,0
47151,care,0,0
47152,.,0,0
47153,The,0,0
47154,2,0,0
47155,groups,0,0
47156,were,0,0
47157,compared,0,0
47158,with,0,0
47159,chi2,0,0
47160,test,0,1
47161,for,0,0
47162,independence,0,1
47163,of,0,0
47164,categorical,0,1
47165,variables,0,0
47166,.,0,1
47167,Wilcoxon,0,0
47168,rank,0,1
47169,sum,0,1
47170,test,0,1
47171,was,0,0
47172,used,0,0
47173,for,0,0
47174,continuous,0,0
47175,variables,0,0
47176,.,0,1
47177,Survival,1,1
47178,was,0,0
47179,estimated,0,0
47180,with,0,0
47181,the,0,0
47182,Kaplan-Meier,0,1
47183,method,0,0
47184,.,0,0
47185,One,0,0
47186,hundred,0,0
47187,three,0,0
47188,consecutive,0,0
47189,patients,0,0
47190,(,0,0
47191,53,0,0
47192,women,0,0
47193,;,0,0
47194,mean,0,1
47195,age,0,0
47196,64+/-17,0,0
47197,years,0,0
47198,),0,0
47199,entered,0,0
47200,the,0,0
47201,study,0,0
47202,.,0,0
47203,Fifty-one,0,0
47204,patients,0,0
47205,were,0,0
47206,randomized,0,0
47207,to,0,0
47208,the,0,0
47209,syncope,0,1
47210,unit,0,0
47211,.,0,0
47212,For,0,0
47213,the,0,0
47214,syncope,0,1
47215,unit,0,0
47216,and,0,1
47217,standard,0,0
47218,care,0,0
47219,patients,0,0
47220,",",0,0
47221,the,0,0
47222,presumptive,1,1
47223,diagnosis,1,0
47224,was,0,0
47225,established,0,0
47226,in,0,0
47227,34,0,0
47228,(,0,0
47229,67,0,0
47230,%,0,0
47231,),0,0
47232,and,0,0
47233,5,0,0
47234,(,0,0
47235,10,0,0
47236,%,0,0
47237,),0,0
47238,patients,0,0
47239,(,0,0
47240,P,0,0
47241,<,0,0
47242,0.001,0,0
47243,),0,0
47244,",",0,0
47245,respectively,0,0
47246,",",0,0
47247,hospital,1,1
47248,admission,1,1
47249,was,0,0
47250,required,0,0
47251,for,0,0
47252,22,0,0
47253,(,0,0
47254,43,0,0
47255,%,0,0
47256,),0,0
47257,and,0,0
47258,51,0,0
47259,(,0,0
47260,98,0,0
47261,%,0,0
47262,),0,0
47263,patients,0,0
47264,(,0,0
47265,P,0,0
47266,<,0,0
47267,0.001,0,0
47268,),0,0
47269,",",0,0
47270,and,0,1
47271,total,1,1
47272,patient-hospital,1,1
47273,days,1,0
47274,were,0,0
47275,reduced,0,0
47276,from,0,0
47277,140,0,0
47278,to,0,0
47279,64,0,0
47280,.,0,0
47281,Actuarial,1,1
47282,survival,1,1
47283,was,0,0
47284,97,0,0
47285,%,0,0
47286,and,0,0
47287,90,0,0
47288,%,0,0
47289,(,0,0
47290,P=0.30,0,0
47291,),0,1
47292,",",0,0
47293,and,0,1
47294,survival,1,1
47295,free,1,1
47296,from,1,0
47297,recurrent,1,1
47298,syncope,1,1
47299,was,0,0
47300,88,0,0
47301,%,0,0
47302,and,0,0
47303,89,0,0
47304,%,0,0
47305,(,0,0
47306,P=0.72,0,0
47307,),0,0
47308,at,0,0
47309,2,0,0
47310,years,0,0
47311,for,0,0
47312,the,0,0
47313,syncope,0,1
47314,unit,0,0
47315,and,0,1
47316,standard,0,0
47317,care,0,0
47318,groups,0,0
47319,",",0,0
47320,respectively,0,0
47321,.,0,0
47322,CONCLUSIONS,0,0
47323,The,0,0
47324,novel,0,0
47325,syncope,0,1
47326,unit,0,0
47327,designed,0,0
47328,for,0,0
47329,this,0,0
47330,study,0,0
47331,significantly,0,0
47332,improved,0,0
47333,diagnostic,1,0
47334,yield,1,0
47335,in,0,0
47336,the,0,0
47337,emergency,0,1
47338,department,0,0
47339,and,0,1
47340,reduced,0,1
47341,hospital,1,1
47342,admission,1,1
47343,and,0,1
47344,total,1,1
47345,length,1,1
47346,of,1,1
47347,hospital,1,1
47348,stay,1,1
47349,without,0,0
47350,affecting,0,1
47351,recurrent,0,1
47352,syncope,0,1
47353,and,0,1
47354,all-cause,0,1
47355,mortality,1,1
47356,among,0,0
47357,intermediate-risk,0,0
47358,patients,0,0
47359,.,0,0
47360,Observations,0,0
47361,from,0,0
47362,the,0,0
47363,present,0,0
47364,study,0,0
47365,provide,0,0
47366,benchmark,0,1
47367,data,0,0
47368,for,0,0
47369,improving,0,1
47370,patient,0,1
47371,care,0,0
47372,and,0,1
47373,effectively,0,0
47374,utilizing,0,0
47375,healthcare,0,0
47376,resources,0,0
47377,.,0,0
47378,Buccal,0,0
47379,misoprostol,0,0
47380,to,0,0
47381,decrease,0,1
47382,blood,1,1
47383,loss,1,1
47384,after,0,0
47385,vaginal,0,0
47386,delivery,0,0
47387,:,0,0
47388,a,0,0
47389,randomized,0,0
47390,trial,0,0
47391,.,0,0
47392,OBJECTIVE,0,0
47393,To,0,0
47394,assess,0,0
47395,the,0,0
47396,efficacy,0,1
47397,of,0,0
47398,buccal,0,1
47399,misoprostol,0,0
47400,to,0,0
47401,decrease,0,1
47402,bleeding,1,1
47403,after,0,0
47404,vaginal,0,0
47405,delivery,0,1
47406,.,0,0
47407,METHODS,0,0
47408,This,0,0
47409,was,0,0
47410,a,0,0
47411,randomized,0,0
47412,study,0,0
47413,of,0,0
47414,patients,0,0
47415,between,0,0
47416,22,0,0
47417,weeks,0,0
47418,and,0,0
47419,42,0,0
47420,weeks,0,0
47421,of,0,0
47422,gestation,0,1
47423,with,0,0
47424,anticipated,0,0
47425,vaginal,0,0
47426,delivery,0,1
47427,.,0,1
47428,Patients,0,0
47429,were,0,0
47430,given,0,0
47431,either,0,0
47432,a,0,0
47433,200-mug,0,0
47434,misoprostol,0,0
47435,tablet,0,0
47436,or,0,1
47437,placebo,0,0
47438,in,0,0
47439,the,0,0
47440,buccal,0,1
47441,space,0,0
47442,at,0,0
47443,the,0,0
47444,time,0,1
47445,of,0,1
47446,cord,0,1
47447,clamping,0,0
47448,.,0,0
47449,A,0,0
47450,continuous,0,0
47451,dilute,0,0
47452,intravenous,0,0
47453,oxytocin,0,1
47454,infusion,0,0
47455,was,0,0
47456,given,0,0
47457,to,0,0
47458,all,0,0
47459,patients,0,0
47460,at,0,0
47461,delivery,0,0
47462,of,0,0
47463,the,0,0
47464,placenta,0,1
47465,.,0,0
47466,Postpartum,1,1
47467,hemorrhage,1,1
47468,was,0,0
47469,defined,0,1
47470,as,0,0
47471,blood,1,1
47472,loss,1,1
47473,exceeding,0,1
47474,500,0,0
47475,mL,0,0
47476,.,0,0
47477,Sample,0,1
47478,size,0,1
47479,calculations,0,0
47480,based,0,0
47481,on,0,0
47482,previous,0,0
47483,studies,0,0
47484,assumed,0,0
47485,a,0,0
47486,13,0,0
47487,%,0,0
47488,incidence,0,1
47489,of,0,1
47490,postpartum,0,1
47491,hemorrhage,0,1
47492,in,0,0
47493,the,0,0
47494,control,0,0
47495,group,0,0
47496,.,0,0
47497,To,0,0
47498,show,0,0
47499,a,0,0
47500,statistically,0,0
47501,significant,0,0
47502,reduction,0,1
47503,of,0,1
47504,postpartum,0,0
47505,hemorrhage,0,1
47506,a,0,0
47507,total,0,1
47508,of,0,0
47509,"1,604",0,0
47510,patients,0,0
47511,would,0,0
47512,be,0,0
47513,required,0,0
47514,in,0,0
47515,each,0,0
47516,group,0,0
47517,.,0,0
47518,RESULTS,0,0
47519,A,0,0
47520,total,0,0
47521,of,0,0
47522,848,0,0
47523,patients,0,0
47524,were,0,0
47525,enrolled,0,0
47526,and,0,0
47527,756,0,0
47528,randomly,0,0
47529,assigned,0,0
47530,",",0,0
47531,377,0,0
47532,in,0,0
47533,the,0,0
47534,misoprostol,0,0
47535,group,0,0
47536,and,0,0
47537,379,0,0
47538,in,0,0
47539,the,0,0
47540,placebo,0,0
47541,group,0,0
47542,.,0,1
47543,Demographic,0,1
47544,",",0,1
47545,antepartum,0,1
47546,",",0,1
47547,and,0,1
47548,intrapartum,0,1
47549,characteristics,0,1
47550,were,0,0
47551,similar,0,0
47552,between,0,0
47553,the,0,0
47554,groups,0,0
47555,.,0,0
47556,The,0,0
47557,incidence,1,1
47558,of,1,1
47559,postpartum,1,1
47560,hemorrhage,1,1
47561,",",0,0
47562,3,0,0
47563,%,0,0
47564,compared,0,0
47565,with,0,0
47566,5,0,0
47567,%,0,0
47568,",",0,0
47569,(,0,1
47570,relative,0,1
47571,risk,0,1
47572,0.65,0,0
47573,",",0,0
47574,95,0,0
47575,%,0,0
47576,confidence,0,0
47577,interval,0,0
47578,0.33-1.29,0,0
47579,",",0,0
47580,P,0,0
47581,=,0,0
47582,.22,0,0
47583,),0,1
47584,",",0,0
47585,mean,1,1
47586,estimated,1,0
47587,blood,1,1
47588,loss,1,1
47589,",",0,0
47590,322,0,0
47591,compared,0,0
47592,with,0,0
47593,329,0,0
47594,mL,0,0
47595,",",0,0
47596,(,0,0
47597,P,0,0
47598,=,0,0
47599,.45,0,0
47600,),0,1
47601,",",0,0
47602,and,0,1
47603,mean,1,1
47604,minutes,1,1
47605,of,1,0
47606,the,1,0
47607,third,1,0
47608,stage,1,0
47609,of,1,1
47610,labor,1,1
47611,",",0,0
47612,6.7,0,0
47613,compared,0,0
47614,with,0,0
47615,6.9,0,0
47616,(,0,0
47617,P,0,0
47618,=,0,0
47619,.52,0,1
47620,),0,1
47621,were,0,0
47622,similar,0,0
47623,between,0,0
47624,the,0,0
47625,groups,0,0
47626,",",0,1
47627,misoprostol,0,0
47628,and,0,1
47629,placebo,0,0
47630,",",0,0
47631,respectively,0,0
47632,.,0,0
47633,Hemoglobin,1,1
47634,difference,1,0
47635,before,1,0
47636,and,1,1
47637,after,1,0
47638,delivery,1,1
47639,",",1,1
47640,need,1,1
47641,for,1,0
47642,second,1,0
47643,or,1,0
47644,third,1,1
47645,uterotonic,1,1
47646,agent,1,0
47647,",",1,0
47648,and,1,0
47649,all,1,0
47650,measured,1,1
47651,neonatal,1,0
47652,variables,1,0
47653,including,1,0
47654,birth,1,1
47655,weights,1,1
47656,",",1,1
47657,and,1,1
47658,umbilical,1,1
47659,cord,1,1
47660,pH,1,1
47661,were,0,0
47662,similar,0,0
47663,between,0,0
47664,the,0,0
47665,groups,0,0
47666,.,0,0
47667,CONCLUSION,0,0
47668,Buccal,0,0
47669,misoprostol,0,0
47670,at,0,0
47671,cord,0,0
47672,clamping,0,0
47673,is,0,0
47674,no,0,0
47675,more,0,0
47676,effective,0,1
47677,than,0,0
47678,placebo,0,0
47679,in,0,0
47680,reducing,0,0
47681,postpartum,1,0
47682,hemorrhage,1,1
47683,.,1,0
47684,A,0,0
47685,placebo,0,0
47686,controlled,0,0
47687,crossover,0,0
47688,trial,0,0
47689,of,0,1
47690,liquid,0,0
47691,fluoxetine,0,0
47692,on,0,0
47693,repetitive,1,0
47694,behaviors,1,1
47695,in,0,0
47696,childhood,0,0
47697,and,0,1
47698,adolescent,0,0
47699,autism,0,0
47700,.,0,0
47701,Repetitive,1,0
47702,behaviors,1,1
47703,are,0,0
47704,a,0,0
47705,core,0,1
47706,symptom,0,1
47707,domain,0,0
47708,in,0,0
47709,autism,0,0
47710,that,0,0
47711,has,0,0
47712,been,0,0
47713,linked,0,0
47714,to,0,0
47715,alterations,0,0
47716,in,0,0
47717,the,0,0
47718,serotonin,0,1
47719,system,0,0
47720,.,0,0
47721,While,0,0
47722,the,0,0
47723,selective,0,0
47724,serotonin-receptive,0,1
47725,inhibitor,0,0
47726,fluvoxamine,0,0
47727,has,0,0
47728,been,0,0
47729,shown,0,0
47730,to,0,0
47731,be,0,0
47732,effective,0,1
47733,in,0,0
47734,adults,0,0
47735,with,0,0
47736,autism,0,0
47737,",",0,0
47738,as,0,0
47739,yet,0,0
47740,no,0,0
47741,published,0,0
47742,placebo,0,0
47743,controlled,0,0
47744,trials,0,0
47745,with,0,0
47746,these,0,0
47747,agents,0,0
47748,document,0,1
47749,safety,1,1
47750,and,0,1
47751,efficacy,1,1
47752,in,0,0
47753,children,0,0
47754,with,0,0
47755,autism,0,0
47756,.,0,0
47757,This,0,0
47758,study,0,0
47759,examines,0,0
47760,the,0,0
47761,selective,0,0
47762,serotonin,0,1
47763,reuptake,0,0
47764,inhibitor,0,0
47765,liquid,0,0
47766,fluoxetine,0,0
47767,in,0,0
47768,the,0,0
47769,treatment,0,0
47770,of,0,0
47771,repetitive,1,0
47772,behaviors,1,1
47773,in,0,0
47774,childhood,0,0
47775,and,0,1
47776,adolescent,0,0
47777,autism,0,1
47778,spectrum,0,0
47779,disorders,0,1
47780,(,0,1
47781,ASDs,0,0
47782,),0,0
47783,.,0,0
47784,In,0,0
47785,total,0,1
47786,",",0,0
47787,45,0,0
47788,child,0,0
47789,or,0,0
47790,adolescent,0,0
47791,patients,0,0
47792,with,0,0
47793,ASD,0,0
47794,were,0,0
47795,randomized,0,0
47796,into,0,0
47797,two,0,0
47798,acute,0,0
47799,8-week,0,0
47800,phases,0,0
47801,in,0,0
47802,a,0,0
47803,double-blind,0,0
47804,placebo-controlled,0,0
47805,crossover,0,0
47806,study,0,0
47807,of,0,1
47808,liquid,0,0
47809,fluoxetine,0,0
47810,.,0,1
47811,Study,0,0
47812,design,0,0
47813,included,0,0
47814,two,0,0
47815,randomized,0,0
47816,8-week,0,0
47817,fluoxetine,0,0
47818,and,0,1
47819,placebo,0,0
47820,phases,0,1
47821,separated,0,0
47822,by,0,0
47823,a,0,0
47824,4-week,0,0
47825,washout,0,0
47826,phase,0,0
47827,.,0,1
47828,Outcome,0,1
47829,measures,0,1
47830,included,0,0
47831,measures,1,0
47832,of,1,1
47833,repetitive,1,1
47834,behaviors,1,1
47835,and,1,1
47836,global,1,1
47837,improvement,1,1
47838,.,1,0
47839,Low-dose,0,0
47840,liquid,0,0
47841,fluoxetine,0,0
47842,(,0,0
47843,mean,0,1
47844,final,0,1
47845,dose,0,0
47846,:,0,0
47847,9.9+/-4.35,0,0
47848,mg/day,0,0
47849,),0,1
47850,was,0,0
47851,superior,0,0
47852,to,0,0
47853,placebo,0,0
47854,in,0,0
47855,the,0,0
47856,treatment,0,0
47857,of,0,0
47858,repetitive,1,0
47859,behaviors,1,1
47860,by,0,0
47861,CY-BOCS,1,1
47862,compulsion,1,1
47863,scale,1,1
47864,.,1,0
47865,The,0,0
47866,effect,1,1
47867,size,1,1
47868,was,0,0
47869,in,0,0
47870,the,0,0
47871,moderate,0,0
47872,to,0,0
47873,large,0,1
47874,range,0,0
47875,",",0,0
47876,and,0,0
47877,the,0,0
47878,doses,0,0
47879,used,0,0
47880,were,0,0
47881,low,0,0
47882,.,0,1
47883,Liquid,0,0
47884,fluoxetine,0,0
47885,was,0,0
47886,only,0,0
47887,slightly,0,0
47888,",",0,0
47889,and,0,1
47890,not,0,0
47891,significantly,0,0
47892,",",0,0
47893,superior,0,0
47894,to,0,0
47895,placebo,0,0
47896,on,0,0
47897,CGI,1,1
47898,autism,1,0
47899,score,1,1
47900,partially,0,0
47901,due,0,0
47902,to,0,0
47903,a,0,0
47904,phase,1,0
47905,order,1,0
47906,effect,1,1
47907,.,1,0
47908,However,0,0
47909,",",0,0
47910,fluoxetine,0,0
47911,was,0,0
47912,marginally,0,0
47913,superior,0,0
47914,to,0,0
47915,placebo,0,0
47916,on,0,0
47917,a,0,0
47918,composite,1,1
47919,measure,1,0
47920,of,1,1
47921,global,1,1
47922,effectiveness,1,1
47923,.,1,1
47924,Liquid,0,0
47925,fluoxetine,0,0
47926,did,0,0
47927,not,0,0
47928,significantly,0,0
47929,differ,0,0
47930,from,0,0
47931,placebo,0,0
47932,on,0,0
47933,treatment,1,0
47934,emergent,1,1
47935,side,1,1
47936,effects,1,1
47937,.,1,1
47938,Liquid,0,0
47939,fluoxetine,0,0
47940,in,0,0
47941,low,0,0
47942,doses,0,0
47943,is,0,0
47944,more,0,0
47945,effective,0,1
47946,than,0,0
47947,placebo,0,0
47948,in,0,0
47949,the,0,0
47950,treatment,0,0
47951,of,0,0
47952,repetitive,1,0
47953,behaviors,1,1
47954,in,0,0
47955,childhood,0,0
47956,autism,0,0
47957,.,0,0
47958,Limitations,0,0
47959,include,0,0
47960,small,0,0
47961,sample,0,0
47962,size,0,1
47963,and,0,0
47964,the,0,0
47965,crossover,0,0
47966,design,0,0
47967,of,0,0
47968,the,0,0
47969,study,0,0
47970,.,0,0
47971,Further,0,1
47972,replication,0,0
47973,and,0,1
47974,long-term,0,1
47975,maintenance,0,0
47976,trials,0,0
47977,are,0,0
47978,needed,0,0
47979,.,0,0
47980,Histamine,0,0
47981,intolerance-like,0,1
47982,symptoms,0,1
47983,in,0,0
47984,healthy,0,0
47985,volunteers,0,0
47986,after,0,0
47987,oral,0,0
47988,provocation,0,0
47989,with,0,0
47990,liquid,0,0
47991,histamine,0,1
47992,.,0,0
47993,Histamine,0,0
47994,in,0,0
47995,food,0,0
47996,at,0,0
47997,non-toxic,0,0
47998,doses,0,0
47999,has,0,0
48000,been,0,0
48001,proposed,0,0
48002,to,0,0
48003,be,0,0
48004,a,0,0
48005,major,0,1
48006,cause,0,0
48007,of,0,1
48008,food,0,0
48009,intolerance,0,1
48010,causing,0,1
48011,symptoms,0,1
48012,like,0,0
48013,diarrhea,0,1
48014,",",0,1
48015,hypotension,0,1
48016,",",0,1
48017,headache,0,1
48018,",",0,1
48019,pruritus,0,1
48020,and,0,1
48021,flush,0,1
48022,(,0,1
48023,histamine,0,1
48024,intolerance,0,1
48025,),0,0
48026,.,0,0
48027,Histamine-rich,0,0
48028,foods,0,0
48029,such,0,0
48030,as,0,0
48031,cheese,0,0
48032,",",0,1
48033,sausages,0,1
48034,",",0,1
48035,sauerkraut,0,1
48036,",",0,1
48037,tuna,0,0
48038,",",0,1
48039,tomatoes,0,1
48040,",",0,1
48041,and,0,1
48042,alcoholic,0,0
48043,beverages,0,0
48044,may,0,0
48045,contain,0,0
48046,histamine,0,0
48047,up,0,0
48048,to,0,0
48049,500,0,0
48050,mg/kg,0,0
48051,.,0,0
48052,We,0,0
48053,conducted,0,0
48054,a,0,0
48055,randomized,0,0
48056,",",0,0
48057,double-blind,0,0
48058,",",0,1
48059,placebo-controlled,0,0
48060,cross-over,0,0
48061,study,0,0
48062,in,0,0
48063,10,0,0
48064,healthy,0,0
48065,females,0,0
48066,(,0,0
48067,age,0,0
48068,range,0,0
48069,22-36,0,0
48070,years,0,0
48071,",",0,0
48072,mean,0,1
48073,29.1,0,0
48074,+/-,0,0
48075,5.4,0,0
48076,),0,0
48077,who,0,0
48078,were,0,0
48079,hospitalized,0,0
48080,and,0,0
48081,challenged,0,0
48082,on,0,0
48083,two,0,0
48084,consecutive,0,0
48085,days,0,0
48086,with,0,0
48087,placebo,0,0
48088,(,0,0
48089,peppermint,0,0
48090,tea,0,0
48091,),0,0
48092,or,0,0
48093,75,0,0
48094,mg,0,0
48095,of,0,0
48096,pure,0,0
48097,histamine,0,1
48098,(,0,0
48099,equaling,0,0
48100,124,0,0
48101,mg,0,0
48102,histamine,0,1
48103,dihydrochloride,0,0
48104,",",0,1
48105,dissolved,0,0
48106,in,0,0
48107,peppermint,0,0
48108,tea,0,0
48109,),0,0
48110,.,0,0
48111,Objective,0,1
48112,parameters,0,1
48113,(,0,0
48114,heart,0,1
48115,rate,0,1
48116,",",0,1
48117,blood,0,1
48118,pressure,0,1
48119,",",0,1
48120,skin,0,1
48121,temperature,0,1
48122,",",0,1
48123,peak,0,1
48124,flow,0,1
48125,),0,0
48126,as,0,0
48127,well,0,0
48128,as,0,0
48129,a,0,0
48130,total,0,1
48131,clinical,0,0
48132,symptom,0,1
48133,score,0,1
48134,using,0,0
48135,a,0,0
48136,standardized,0,0
48137,protocol,0,0
48138,were,0,0
48139,recorded,0,0
48140,at,0,0
48141,baseline,0,0
48142,",",0,0
48143,10,0,0
48144,",",0,0
48145,20,0,0
48146,",",0,0
48147,40,0,0
48148,",",0,0
48149,80,0,0
48150,minutes,0,0
48151,",",0,0
48152,and,0,0
48153,24,0,0
48154,hours,0,0
48155,.,0,0
48156,The,0,0
48157,subjects,0,0
48158,received,0,0
48159,a,0,0
48160,histamine-free,0,0
48161,diet,0,0
48162,also,0,0
48163,low,0,0
48164,in,0,0
48165,allergen,0,0
48166,24,0,0
48167,hours,0,0
48168,before,0,0
48169,hospitalization,0,1
48170,and,0,0
48171,over,0,0
48172,the,0,0
48173,whole,0,0
48174,observation,0,0
48175,period,0,0
48176,.,0,1
48177,Blood,0,1
48178,samples,0,0
48179,were,0,0
48180,drawn,0,0
48181,at,0,0
48182,baseline,0,0
48183,",",0,0
48184,10,0,0
48185,",",0,0
48186,20,0,0
48187,",",0,0
48188,40,0,0
48189,",",0,0
48190,and,0,0
48191,80,0,0
48192,minutes,0,0
48193,",",0,0
48194,and,0,1
48195,histamine,0,1
48196,and,0,1
48197,the,0,0
48198,histamine-degrading,0,1
48199,enzyme,0,0
48200,diamine,0,1
48201,oxidase,0,1
48202,(,0,1
48203,DAO,0,1
48204,),0,1
48205,were,0,0
48206,determined,0,0
48207,.,0,0
48208,After,0,0
48209,histamine,0,1
48210,challenge,0,0
48211,",",0,0
48212,5,0,0
48213,of,0,0
48214,10,0,0
48215,subjects,0,0
48216,showed,0,0
48217,no,1,0
48218,reaction,1,1
48219,.,1,0
48220,One,0,0
48221,individual,0,0
48222,experienced,0,0
48223,tachycardia,1,1
48224,",",1,1
48225,mild,1,1
48226,hypotension,1,1
48227,after,1,0
48228,20,1,0
48229,minutes,1,0
48230,",",1,0
48231,sneezing,1,1
48232,",",1,1
48233,itching,1,1
48234,of,1,0
48235,the,1,0
48236,nose,1,1
48237,",",1,1
48238,and,1,1
48239,rhinorrhea,1,1
48240,after,1,0
48241,60,1,0
48242,minutes,1,0
48243,.,1,0
48244,Four,0,1
48245,subjects,0,0
48246,experienced,0,0
48247,delayed,0,1
48248,symptoms,0,1
48249,like,0,0
48250,diarrhea,1,1
48251,(,1,0
48252,4x,1,0
48253,),1,0
48254,",",1,0
48255,flatulence,1,1
48256,(,1,0
48257,3x,1,0
48258,),1,0
48259,",",1,0
48260,headache,1,1
48261,(,1,0
48262,3x,1,0
48263,),1,0
48264,",",1,0
48265,pruritus,1,1
48266,(,1,0
48267,2x,1,0
48268,),1,0
48269,and,1,0
48270,ocular,1,1
48271,symptoms,1,1
48272,(,0,0
48273,1x,0,0
48274,),0,0
48275,starting,0,0
48276,3,0,0
48277,to,0,0
48278,24,0,0
48279,hours,0,0
48280,after,0,0
48281,provocation,0,0
48282,.,0,0
48283,No,0,0
48284,subject,0,0
48285,reacted,0,0
48286,to,0,0
48287,placebo,0,0
48288,.,0,0
48289,No,0,0
48290,changes,0,1
48291,were,0,0
48292,observed,0,0
48293,in,0,0
48294,histamine,1,1
48295,and,1,1
48296,DAO,1,1
48297,levels,1,1
48298,within,0,0
48299,the,0,0
48300,first,0,0
48301,80,0,0
48302,minutes,0,0
48303,in,0,0
48304,non-reactors,0,0
48305,as,0,0
48306,well,0,0
48307,as,0,0
48308,reactors,0,0
48309,.,0,0
48310,There,0,0
48311,was,0,0
48312,no,0,0
48313,difference,0,0
48314,in,0,0
48315,challenge,0,0
48316,with,0,0
48317,histamine,0,1
48318,versus,0,0
48319,challenge,0,0
48320,with,0,0
48321,placebo,0,0
48322,.,0,0
48323,We,0,0
48324,conclude,0,0
48325,that,0,0
48326,75,0,0
48327,mg,0,0
48328,of,0,0
48329,pure,0,0
48330,liquid,0,0
48331,oral,0,0
48332,histamine,0,0
48333,--,0,0
48334,a,0,0
48335,dose,0,0
48336,found,0,0
48337,in,0,0
48338,normal,0,0
48339,meals,0,0
48340,--,0,0
48341,can,0,0
48342,provoke,0,0
48343,immediate,0,1
48344,as,0,0
48345,well,0,0
48346,as,0,0
48347,delayed,0,1
48348,symptoms,0,1
48349,in,0,0
48350,50,0,0
48351,%,0,0
48352,of,0,0
48353,healthy,0,0
48354,females,0,0
48355,without,0,0
48356,a,0,0
48357,history,0,1
48358,of,0,1
48359,food,0,0
48360,intolerance,0,1
48361,.,0,0
48362,A,0,0
48363,randomized,0,0
48364,",",0,0
48365,evaluator-blind,0,0
48366,",",0,1
48367,multicenter,0,0
48368,comparison,0,0
48369,of,0,0
48370,the,0,0
48371,efficacy,0,1
48372,and,0,1
48373,tolerability,0,1
48374,of,0,1
48375,Perlane,0,0
48376,versus,0,0
48377,Zyplast,0,0
48378,in,0,0
48379,the,0,0
48380,correction,0,0
48381,of,0,0
48382,nasolabial,0,1
48383,folds,0,1
48384,.,0,0
48385,Bovine,0,0
48386,collagen,0,0
48387,is,0,0
48388,widely,0,0
48389,used,0,0
48390,as,0,0
48391,a,0,0
48392,dermal,0,1
48393,filler,0,1
48394,for,0,0
48395,facial,0,1
48396,soft-tissue,0,1
48397,augmentation,0,1
48398,",",0,0
48399,but,0,0
48400,it,0,0
48401,provides,0,0
48402,only,0,0
48403,temporary,0,1
48404,cosmetic,0,1
48405,improvement,0,1
48406,.,0,1
48407,Nonanimal,0,0
48408,stabilized,0,0
48409,hyaluronic,0,0
48410,acid,0,0
48411,has,0,0
48412,reduced,0,0
48413,potential,0,0
48414,for,0,0
48415,immunogenicity,0,1
48416,and,0,1
48417,hypersensitivity,0,1
48418,and,0,0
48419,may,0,0
48420,provide,0,0
48421,a,0,0
48422,more,0,0
48423,durable,0,1
48424,aesthetic,0,1
48425,result,0,0
48426,.,0,0
48427,Sixty-eight,0,0
48428,patients,0,0
48429,with,0,0
48430,prominent,0,0
48431,nasolabial,0,1
48432,folds,0,1
48433,were,0,0
48434,randomized,0,0
48435,to,0,0
48436,intradermal,0,0
48437,treatment,0,0
48438,with,0,0
48439,nonanimal,0,0
48440,stabilized,0,0
48441,hyaluronic,0,0
48442,acid,0,0
48443,gel,0,0
48444,(,0,1
48445,Perlane,0,1
48446,),0,1
48447,and,0,1
48448,bovine,0,0
48449,collagen,0,1
48450,(,0,1
48451,Zyplast,0,0
48452,),0,0
48453,on,0,0
48454,contralateral,0,1
48455,sides,0,0
48456,of,0,0
48457,the,0,0
48458,face,0,0
48459,.,0,0
48460,On,0,0
48461,achievement,0,1
48462,of,0,0
48463,optimal,1,1
48464,cosmetic,1,1
48465,result,1,1
48466,(,0,1
48467,baseline,0,1
48468,),0,1
48469,",",0,0
48470,patients,0,0
48471,were,0,0
48472,followed,0,0
48473,up,0,0
48474,for,0,0
48475,6,0,0
48476,months,0,0
48477,;,0,0
48478,bilateral,0,0
48479,retreatment,0,0
48480,with,0,0
48481,Perlane,0,0
48482,was,0,0
48483,offered,0,0
48484,at,0,0
48485,6,0,0
48486,or,0,0
48487,9,0,0
48488,months,0,0
48489,after,0,0
48490,baseline,0,0
48491,.,0,1
48492,Responses,0,1
48493,were,0,0
48494,evaluated,0,0
48495,at,0,0
48496,2,0,0
48497,",",0,0
48498,4,0,0
48499,",",0,0
48500,6,0,0
48501,",",0,0
48502,9,0,0
48503,",",0,0
48504,and,0,0
48505,12,0,0
48506,months,0,0
48507,after,0,0
48508,baseline,0,0
48509,.,0,1
48510,Investigator-based,1,0
48511,and,1,1
48512,patient-based,1,1
48513,ratings,1,1
48514,indicated,0,0
48515,that,0,0
48516,Perlane,0,0
48517,was,0,0
48518,more,0,0
48519,effective,0,1
48520,than,0,0
48521,Zyplast,0,0
48522,in,0,0
48523,maintaining,0,1
48524,cosmetic,1,0
48525,correction,0,0
48526,.,0,0
48527,According,0,0
48528,to,0,0
48529,investigator-based,1,0
48530,Wrinkle,1,0
48531,Severity,1,1
48532,Rating,1,1
48533,Scale,1,1
48534,assessments,1,0
48535,at,0,0
48536,6,0,0
48537,and,0,0
48538,9,0,0
48539,months,0,0
48540,after,0,0
48541,baseline,0,0
48542,",",0,1
48543,Perlane,0,1
48544,was,0,0
48545,superior,1,0
48546,in,0,0
48547,50.0,0,0
48548,percent,0,0
48549,and,0,0
48550,48.8,0,0
48551,percent,0,0
48552,of,0,0
48553,patients,0,0
48554,",",0,0
48555,respectively,0,0
48556,",",0,0
48557,whereas,0,0
48558,Zyplast,0,0
48559,was,0,0
48560,superior,1,0
48561,in,0,0
48562,10.3,0,0
48563,percent,0,0
48564,and,0,0
48565,14.0,0,0
48566,percent,0,0
48567,of,0,0
48568,patients,0,0
48569,",",0,0
48570,respectively,0,0
48571,(,0,0
48572,p,0,0
48573,<,0,0
48574,0.0004,0,0
48575,),0,0
48576,.,0,0
48577,Investigator-based,0,0
48578,Global,1,1
48579,Aesthetic,1,1
48580,Improvement,1,1
48581,Scale,1,1
48582,assessment,1,0
48583,at,0,0
48584,9,0,0
48585,months,0,0
48586,after,0,0
48587,baseline,0,0
48588,indicated,0,0
48589,that,0,0
48590,Perlane,0,0
48591,was,0,0
48592,superior,1,0
48593,in,0,0
48594,48.8,0,0
48595,percent,0,0
48596,of,0,0
48597,patients,0,0
48598,",",0,0
48599,whereas,0,0
48600,Zyplast,0,0
48601,was,0,0
48602,superior,1,0
48603,in,0,0
48604,14.0,0,0
48605,percent,0,0
48606,of,0,0
48607,patients,0,0
48608,(,0,0
48609,p,0,0
48610,=,0,0
48611,0.0025,0,0
48612,),0,0
48613,.,0,0
48614,Optimal,1,1
48615,cosmetic,1,1
48616,result,1,0
48617,was,0,0
48618,achieved,0,0
48619,with,0,0
48620,a,0,0
48621,smaller,1,0
48622,volume,1,1
48623,of,0,1
48624,Perlane,0,0
48625,than,0,0
48626,Zyplast,0,0
48627,(,0,1
48628,mean,0,1
48629,",",0,0
48630,1.2,0,0
48631,ml,0,0
48632,versus,0,0
48633,2.1,0,0
48634,ml,0,0
48635,),0,0
48636,.,0,0
48637,Local,0,0
48638,injection-site,0,1
48639,reactions,1,1
48640,(,1,1
48641,redness,1,1
48642,",",1,1
48643,swelling,1,1
48644,",",1,1
48645,pruritus,1,1
48646,",",1,1
48647,and,1,1
48648,induration,1,1
48649,),1,1
48650,were,0,0
48651,less,0,0
48652,frequent,0,1
48653,with,0,0
48654,Perlane,0,0
48655,than,0,0
48656,with,0,0
48657,Zyplast,0,0
48658,.,0,0
48659,Delayed-onset,0,0
48660,reactions,0,1
48661,were,0,0
48662,rare,0,0
48663,and,0,1
48664,did,0,0
48665,not,0,0
48666,reoccur,0,0
48667,after,0,0
48668,Perlane,0,0
48669,retreatment,0,0
48670,.,0,0
48671,Perlane,0,0
48672,has,0,0
48673,acceptable,0,0
48674,long-term,1,1
48675,safety,1,1
48676,and,0,0
48677,offers,0,0
48678,a,0,0
48679,longer-lasting,0,1
48680,aesthetic,1,1
48681,improvement,1,1
48682,than,0,0
48683,Zyplast,0,0
48684,.,0,0
48685,Pilot,0,1
48686,study,0,0
48687,of,0,0
48688,a,0,0
48689,moderate,0,0
48690,dose,0,0
48691,multivitamin/mineral,0,0
48692,supplement,0,0
48693,for,0,0
48694,children,0,0
48695,with,0,0
48696,autistic,0,1
48697,spectrum,0,0
48698,disorder,0,0
48699,.,0,1
48700,OBJECTIVE,0,0
48701,Determine,0,0
48702,the,0,0
48703,effect,0,0
48704,of,0,0
48705,a,0,0
48706,moderate,0,0
48707,dose,0,0
48708,multivitamin/mineral,0,0
48709,supplement,0,0
48710,on,0,0
48711,children,0,0
48712,with,0,0
48713,autistic,0,1
48714,spectrum,0,0
48715,disorder,0,0
48716,.,0,1
48717,DESIGN,0,0
48718,Randomized,0,0
48719,",",0,1
48720,double-blind,0,0
48721,",",0,1
48722,placebo-controlled,0,0
48723,3-month,0,1
48724,study,0,0
48725,.,0,0
48726,SUBJECTS,0,1
48727,Twenty,0,0
48728,(,0,0
48729,20,0,0
48730,),0,0
48731,children,0,0
48732,with,0,0
48733,autistic,0,1
48734,spectrum,0,0
48735,disorder,0,0
48736,",",0,0
48737,ages,0,0
48738,3-8,0,0
48739,years,0,0
48740,.,0,0
48741,RESULTS,0,0
48742,A,0,0
48743,Global,0,1
48744,Impressions,0,1
48745,parental,0,1
48746,questionnaire,0,1
48747,found,0,0
48748,that,0,0
48749,the,0,0
48750,supplement,0,0
48751,group,0,0
48752,reported,0,0
48753,statistically,1,0
48754,significant,1,0
48755,improvements,1,1
48756,in,0,0
48757,sleep,1,1
48758,and,1,1
48759,gastrointestinal,1,1
48760,problems,1,1
48761,compared,0,0
48762,to,0,0
48763,the,0,0
48764,placebo,0,0
48765,group,0,0
48766,.,0,0
48767,An,0,0
48768,evaluation,0,0
48769,of,0,0
48770,vitamin,1,1
48771,B,1,0
48772,(,1,0
48773,6,1,0
48774,),1,0
48775,levels,1,0
48776,prior,0,0
48777,to,0,0
48778,the,0,0
48779,study,0,0
48780,found,0,0
48781,that,0,0
48782,the,0,0
48783,autistic,0,0
48784,children,0,0
48785,had,0,0
48786,substantially,1,0
48787,elevated,1,0
48788,levels,1,1
48789,of,1,0
48790,B6,1,0
48791,compared,0,0
48792,to,0,0
48793,a,0,0
48794,control,0,0
48795,group,0,0
48796,of,0,1
48797,typical,0,0
48798,children,0,0
48799,(,0,0
48800,75,0,0
48801,%,0,0
48802,higher,0,0
48803,",",0,1
48804,p,0,0
48805,<,0,0
48806,0.0000001,0,0
48807,),0,0
48808,.,0,0
48809,Vitamin,1,0
48810,C,1,0
48811,levels,1,1
48812,were,0,0
48813,measured,0,0
48814,at,0,0
48815,the,0,0
48816,end,0,0
48817,of,0,0
48818,the,0,0
48819,study,0,0
48820,",",0,0
48821,and,0,1
48822,the,0,0
48823,placebo,0,0
48824,group,0,0
48825,had,0,0
48826,levels,0,1
48827,that,0,0
48828,were,0,0
48829,significantly,1,0
48830,below,1,0
48831,average,1,1
48832,for,0,0
48833,typical,0,0
48834,children,0,0
48835,",",0,0
48836,whereas,0,0
48837,the,0,0
48838,supplement,0,0
48839,group,0,0
48840,had,0,0
48841,near-average,0,1
48842,levels,0,1
48843,.,0,0
48844,DISCUSSION,0,0
48845,The,0,0
48846,finding,0,0
48847,of,0,0
48848,high,1,0
48849,vitamin,1,1
48850,B,1,0
48851,(,1,0
48852,6,1,0
48853,),1,0
48854,levels,1,0
48855,is,0,0
48856,consistent,0,0
48857,with,0,0
48858,recent,0,0
48859,reports,0,0
48860,of,0,0
48861,low,0,0
48862,levels,1,1
48863,of,1,1
48864,pyridoxal-5-phosphate,1,1
48865,and,0,1
48866,low,0,1
48867,activity,1,1
48868,of,1,1
48869,pyridoxal,1,1
48870,kinase,1,1
48871,(,0,1
48872,i.e.,0,1
48873,",",0,0
48874,pyridoxal,0,0
48875,is,0,0
48876,only,0,0
48877,poorly,0,0
48878,converted,0,0
48879,to,0,0
48880,pyridoxal-5-phosphate,0,0
48881,",",0,0
48882,the,0,0
48883,enzymatically,0,0
48884,active,0,0
48885,form,0,0
48886,),0,0
48887,.,0,0
48888,This,0,0
48889,may,0,0
48890,explain,0,0
48891,the,0,0
48892,functional,0,1
48893,need,0,0
48894,for,0,0
48895,high-dose,0,0
48896,vitamin,0,1
48897,B,0,0
48898,(,0,0
48899,6,0,0
48900,),0,0
48901,supplementation,0,0
48902,in,0,0
48903,many,0,0
48904,children,0,0
48905,and,0,1
48906,adults,0,0
48907,with,0,0
48908,autism,0,0
48909,.,0,0
48910,Effects,0,0
48911,of,0,0
48912,an,0,0
48913,antimicrobial,0,0
48914,additive,0,0
48915,to,0,0
48916,toothbrushes,0,0
48917,on,0,0
48918,residual,1,1
48919,periodontal,1,1
48920,pathogens,1,1
48921,.,1,0
48922,OBJECTIVE,0,0
48923,Previous,0,0
48924,studies,0,0
48925,have,0,0
48926,reported,0,0
48927,the,0,0
48928,link,0,0
48929,between,0,0
48930,residual,0,1
48931,microbial,0,1
48932,contamination,0,1
48933,of,0,1
48934,toothbrushes,0,0
48935,and,0,1
48936,periodontal,0,1
48937,diseases,0,0
48938,.,0,0
48939,The,0,0
48940,goal,0,0
48941,of,0,0
48942,this,0,0
48943,pilot,0,0
48944,study,0,0
48945,was,0,0
48946,to,0,0
48947,evaluate,0,0
48948,the,0,0
48949,effects,0,0
48950,of,0,0
48951,an,0,0
48952,antimicrobial,0,1
48953,additive,0,0
48954,(,0,1
48955,Microban,0,1
48956,),0,0
48957,to,0,0
48958,toothbrushes,0,0
48959,on,0,0
48960,residual,1,1
48961,retention,1,1
48962,of,1,1
48963,periodontal,1,1
48964,pathogens,1,1
48965,.,1,0
48966,METHODOLOGY,0,0
48967,Twenty,0,0
48968,patients,0,0
48969,had,0,0
48970,one,0,0
48971,side,0,1
48972,of,0,0
48973,their,0,0
48974,mouths,0,0
48975,brushed,0,0
48976,with,0,0
48977,a,0,0
48978,toothbrush,0,0
48979,containing,0,0
48980,the,0,0
48981,antimicrobial,0,1
48982,agent,0,0
48983,(,0,0
48984,experimental,0,0
48985,side,0,1
48986,),0,1
48987,",",0,0
48988,and,0,0
48989,the,0,0
48990,other,0,0
48991,side,0,1
48992,with,0,0
48993,a,0,0
48994,toothbrush,0,0
48995,containing,0,0
48996,no,0,0
48997,agent,0,0
48998,(,0,0
48999,control,0,0
49000,),0,0
49001,.,0,0
49002,Toothbrushes,0,0
49003,were,0,0
49004,air-dried,0,0
49005,(,0,0
49006,25,0,0
49007,degrees,0,0
49008,C,0,0
49009,),0,0
49010,for,0,0
49011,four,0,0
49012,or,0,0
49013,24,0,0
49014,hours,0,0
49015,.,0,0
49016,Toothbrush,0,0
49017,heads,0,0
49018,were,0,0
49019,vortexed,0,0
49020,and,0,1
49021,cultured,0,1
49022,for,0,0
49023,Prevotella,0,0
49024,species,0,1
49025,(,0,1
49026,Ps,0,1
49027,),0,1
49028,",",0,0
49029,Porphyromonas,0,1
49030,gingivalis,0,1
49031,(,0,1
49032,Pg,0,1
49033,),0,1
49034,",",0,0
49035,Actinobacillus,0,1
49036,actinomycetemcomitans,0,1
49037,(,0,1
49038,Aa,0,1
49039,),0,1
49040,",",0,0
49041,and,0,1
49042,non-specific,0,1
49043,colony-forming,0,1
49044,units,0,0
49045,(,0,0
49046,NS,0,1
49047,),0,0
49048,.,0,0
49049,The,0,0
49050,plates,0,0
49051,were,0,0
49052,incubated,0,0
49053,and,0,0
49054,counted,0,0
49055,.,0,0
49056,Means,0,0
49057,and,0,1
49058,standard,0,0
49059,deviations,0,1
49060,were,0,0
49061,calculated,0,0
49062,",",0,0
49063,and,0,1
49064,data,0,1
49065,were,0,0
49066,analyzed,0,0
49067,using,0,0
49068,a,0,0
49069,series,0,0
49070,of,0,1
49071,t-tests,0,0
49072,(,0,0
49073,paired,0,0
49074,and,0,0
49075,unpaired,0,0
49076,),0,0
49077,and,0,0
49078,Wilcoxon,0,1
49079,matched-pairs,0,0
49080,signed-rank,0,0
49081,test,0,1
49082,.,0,0
49083,RESULTS,0,0
49084,No,0,1
49085,significant,0,0
49086,inter-,0,1
49087,or,0,0
49088,intra-group,0,1
49089,differences,0,0
49090,in,0,0
49091,mean,1,1
49092,counts,1,1
49093,were,0,0
49094,found,0,0
49095,;,0,0
49096,however,0,0
49097,",",0,0
49098,when,0,0
49099,four-hour,0,1
49100,and,0,1
49101,24-hour,0,1
49102,data,0,0
49103,for,0,0
49104,Aa,1,1
49105,",",1,1
49106,Pg,1,1
49107,",",1,1
49108,or,1,1
49109,NS,1,1
49110,were,0,0
49111,combined,0,0
49112,",",0,0
49113,experimental,1,0
49114,counts,1,1
49115,were,0,0
49116,lower,0,0
49117,than,0,0
49118,controls,0,0
49119,in,0,0
49120,39/50,0,0
49121,(,0,0
49122,78,0,0
49123,%,0,0
49124,),0,0
49125,of,0,0
49126,the,0,0
49127,matched,0,0
49128,pairs,0,0
49129,(,0,0
49130,Wilcoxon,0,1
49131,signed-rank,0,1
49132,test,0,1
49133,p,0,0
49134,=,0,0
49135,0.01,0,0
49136,),0,0
49137,.,0,0
49138,CONCLUSION,0,0
49139,Toothbrushes,0,0
49140,containing,0,0
49141,the,0,0
49142,antimicrobial,0,1
49143,additive,0,0
49144,showed,0,0
49145,lower,0,1
49146,microbial,1,1
49147,counts,1,1
49148,than,0,0
49149,those,0,0
49150,without,0,0
49151,",",0,0
49152,but,0,0
49153,between-group,0,1
49154,means,0,0
49155,were,0,0
49156,not,0,0
49157,statistically,0,0
49158,significant,0,0
49159,.,0,0
49160,Efficacy,1,1
49161,screening,0,0
49162,trials,0,0
49163,of,0,1
49164,paroxetine,0,0
49165,",",0,1
49166,pentoxifylline,0,0
49167,",",0,1
49168,riluzole,0,0
49169,",",0,1
49170,pramipexole,0,0
49171,and,0,1
49172,venlafaxine,0,0
49173,in,0,0
49174,cocaine,0,0
49175,dependence,0,1
49176,.,0,0
49177,AIMS,0,0
49178,The,0,0
49179,two,0,0
49180,studies,0,0
49181,presented,0,0
49182,here,0,0
49183,were,0,0
49184,conducted,0,0
49185,to,0,0
49186,assess,0,0
49187,the,0,0
49188,efficacy,1,1
49189,of,0,1
49190,paroxetine,0,0
49191,",",0,1
49192,pentoxifylline,0,0
49193,",",0,1
49194,riluzole,0,0
49195,",",0,1
49196,venlafaxine,0,0
49197,and,0,1
49198,pramipexole,0,0
49199,as,0,0
49200,medications,0,0
49201,for,0,0
49202,the,0,0
49203,treatment,0,0
49204,of,0,1
49205,cocaine,0,0
49206,dependence,0,1
49207,.,0,0
49208,DESIGN,0,0
49209,A,0,0
49210,multi-arm,0,0
49211,",",0,0
49212,modified,0,1
49213,blinded,0,0
49214,",",0,0
49215,placebo-controlled,0,0
49216,design,0,0
49217,was,0,0
49218,used,0,0
49219,.,0,0
49220,SETTING,0,0
49221,The,0,0
49222,studies,0,0
49223,were,0,0
49224,conducted,0,0
49225,at,0,0
49226,the,0,0
49227,Boston,0,0
49228,VA,0,0
49229,Healthcare,0,1
49230,System,0,1
49231,and,0,0
49232,the,0,0
49233,Boston,0,0
49234,University,0,0
49235,School,0,1
49236,of,0,1
49237,Medicine,0,0
49238,Medication,0,0
49239,Development,0,1
49240,Research,0,1
49241,Unit,0,0
49242,(,0,1
49243,MDRU,0,1
49244,),0,0
49245,.,0,0
49246,PARTICIPANTS,0,1
49247,Participants,0,0
49248,met,0,0
49249,criteria,0,0
49250,for,0,0
49251,cocaine,0,0
49252,dependence,0,1
49253,during,0,0
49254,a,0,0
49255,2-week,0,0
49256,screening,0,0
49257,period,0,0
49258,.,0,1
49259,INTERVENTION,0,1
49260,Following,0,1
49261,random,0,0
49262,assignment,0,0
49263,to,0,0
49264,one,0,0
49265,of,0,0
49266,the,0,0
49267,treatment,0,0
49268,groups,0,0
49269,",",0,1
49270,subjects,0,0
49271,received,0,0
49272,active,0,0
49273,medication,0,1
49274,or,0,1
49275,placebo,0,0
49276,for,0,0
49277,8,0,0
49278,weeks,0,0
49279,in,0,0
49280,combination,0,0
49281,with,0,0
49282,cognitive,0,1
49283,behavioral,0,1
49284,counseling,0,0
49285,.,0,0
49286,In,0,0
49287,the,0,0
49288,first,0,0
49289,study,0,0
49290,the,0,0
49291,efficacy,1,1
49292,of,0,0
49293,the,0,0
49294,antidepressant,0,0
49295,paroxetine,0,0
49296,(,0,0
49297,20,0,0
49298,mg,0,0
49299,daily,0,0
49300,),0,0
49301,",",0,0
49302,the,0,0
49303,phosphodiesterase,0,1
49304,inhibitor,0,0
49305,pentoxifylline,0,0
49306,(,0,0
49307,1200,0,0
49308,mg,0,0
49309,daily,0,0
49310,),0,0
49311,and,0,0
49312,the,0,0
49313,glutamate,0,1
49314,release,0,1
49315,inhibitor,0,0
49316,riluzole,0,0
49317,(,0,0
49318,100,0,0
49319,mg,0,0
49320,daily,0,0
49321,),0,0
49322,was,0,0
49323,assessed,0,0
49324,.,0,0
49325,The,0,0
49326,antidepressant,0,0
49327,venlafaxine,0,0
49328,(,0,0
49329,150,0,0
49330,mg,0,0
49331,daily,0,0
49332,),0,0
49333,and,0,0
49334,the,0,0
49335,dopamine,0,1
49336,agonist,0,0
49337,pramipexole,0,0
49338,(,0,0
49339,1.5,0,0
49340,mg,0,0
49341,daily,0,0
49342,),0,0
49343,were,0,0
49344,evaluated,0,0
49345,in,0,0
49346,the,0,0
49347,second,0,0
49348,study,0,0
49349,.,0,0
49350,MEASUREMENTS,0,0
49351,Urine,1,1
49352,benzoylecgonine,1,1
49353,(,1,1
49354,BE,1,1
49355,),1,1
49356,concentrations,1,1
49357,",",1,0
49358,self-report,1,1
49359,of,1,1
49360,cocaine,1,1
49361,use,1,1
49362,and,1,1
49363,global,1,1
49364,impression,1,1
49365,scores,1,1
49366,served,0,0
49367,as,0,0
49368,primary,0,0
49369,outcome,0,1
49370,measures,0,1
49371,.,0,0
49372,Secondary,0,0
49373,measures,0,1
49374,included,0,0
49375,assessments,1,0
49376,of,1,1
49377,cocaine,1,1
49378,craving,1,1
49379,and,1,1
49380,psychiatric,1,1
49381,functioning,1,1
49382,.,1,0
49383,Adverse,1,1
49384,events,1,1
49385,were,0,0
49386,monitored,0,0
49387,during,0,0
49388,the,0,0
49389,treatment,0,0
49390,period,0,0
49391,.,0,1
49392,FINDINGS,0,0
49393,None,0,0
49394,of,0,0
49395,the,0,0
49396,active,0,0
49397,medications,0,0
49398,produced,0,0
49399,greater,0,0
49400,reductions,0,1
49401,in,0,0
49402,urine,1,1
49403,BE,1,0
49404,concentrations,1,1
49405,over,0,0
49406,the,0,0
49407,treatment,0,0
49408,period,0,0
49409,than,0,0
49410,did,0,0
49411,placebo,0,0
49412,.,0,0
49413,There,0,0
49414,were,0,0
49415,trends,0,0
49416,for,0,0
49417,BE,1,0
49418,levels,1,1
49419,to,0,0
49420,become,0,0
49421,reduced,0,0
49422,in,0,0
49423,the,0,0
49424,pentoxifylline,0,0
49425,group,0,0
49426,during,0,0
49427,the,0,0
49428,first,0,0
49429,4,0,0
49430,weeks,0,0
49431,of,0,0
49432,treatment,0,0
49433,and,0,1
49434,for,0,0
49435,Addiction,1,1
49436,Severity,1,1
49437,Index,1,1
49438,(,1,1
49439,ASI,1,0
49440,),1,1
49441,drug,0,0
49442,composite,0,1
49443,scores,0,1
49444,to,0,0
49445,be,0,0
49446,lower,0,0
49447,in,0,0
49448,the,0,0
49449,pentoxyfylline,0,0
49450,group,0,0
49451,at,0,0
49452,end-point,0,1
49453,compared,0,0
49454,to,0,0
49455,the,0,0
49456,placebo,0,0
49457,group,0,0
49458,.,0,1
49459,Significant,0,1
49460,within-group,0,1
49461,reductions,0,1
49462,in,0,0
49463,reported,0,0
49464,cocaine,1,1
49465,use,1,1
49466,and,1,1
49467,craving,1,1
49468,were,0,0
49469,found,0,0
49470,for,0,0
49471,all,0,0
49472,treatment,0,0
49473,groups,0,0
49474,",",0,1
49475,but,0,0
49476,none,0,0
49477,of,0,0
49478,the,0,0
49479,active,0,0
49480,medications,0,0
49481,were,0,0
49482,superior,0,0
49483,to,0,0
49484,placebo,0,0
49485,on,0,0
49486,these,0,0
49487,measures,0,0
49488,.,0,0
49489,The,0,0
49490,accuracy,0,1
49491,of,0,0
49492,self-reported,1,1
49493,cocaine,1,1
49494,use,1,1
49495,declined,0,0
49496,over,0,0
49497,the,0,0
49498,study,0,0
49499,period,0,0
49500,.,0,1
49501,Overall,0,0
49502,",",0,0
49503,the,0,0
49504,active,0,0
49505,medications,0,0
49506,were,0,0
49507,well,0,0
49508,tolerated,1,1
49509,.,1,0
49510,CONCLUSIONS,0,0
49511,This,0,0
49512,study,0,0
49513,does,0,0
49514,not,0,0
49515,support,0,0
49516,the,0,0
49517,use,0,0
49518,of,0,1
49519,paroxetine,0,0
49520,",",0,1
49521,pentoxifylline,0,0
49522,",",0,1
49523,riluzole,0,0
49524,",",0,1
49525,venlafaxine,0,0
49526,or,0,1
49527,pramipexole,0,0
49528,for,0,0
49529,the,0,0
49530,treatment,0,0
49531,of,0,1
49532,cocaine,0,0
49533,dependence,0,1
49534,.,0,0
49535,However,0,0
49536,",",0,0
49537,these,0,0
49538,results,0,0
49539,need,0,0
49540,to,0,0
49541,be,0,0
49542,interpreted,0,0
49543,with,0,0
49544,caution,0,0
49545,because,0,0
49546,of,0,0
49547,the,0,0
49548,small,0,0
49549,size,0,1
49550,and,0,1
49551,lack,0,0
49552,of,0,1
49553,homogeneity,0,1
49554,of,0,0
49555,the,0,0
49556,experimental,0,0
49557,groups,0,0
49558,.,0,0
49559,Low-dose,0,0
49560,angiotensin,0,0
49561,II,0,0
49562,receptor,0,1
49563,antagonists,0,0
49564,and,0,1
49565,angiotensin,0,1
49566,II-converting,0,1
49567,enzyme,0,0
49568,inhibitors,0,1
49569,alone,0,0
49570,or,0,0
49571,in,0,0
49572,combination,0,0
49573,for,0,0
49574,treatment,0,0
49575,of,0,1
49576,primary,0,0
49577,glomerulonephritis,0,0
49578,.,0,0
49579,OBJECTIVE,0,0
49580,The,0,0
49581,renin-angiotensin,0,0
49582,system,0,0
49583,is,0,0
49584,thought,0,0
49585,to,0,0
49586,be,0,0
49587,involved,0,0
49588,in,0,0
49589,the,0,0
49590,progression,0,1
49591,of,0,0
49592,chronic,0,0
49593,renal,0,1
49594,diseases,0,0
49595,of,0,0
49596,both,0,0
49597,diabetic,0,0
49598,and,0,1
49599,non-diabetic,0,0
49600,origin,0,0
49601,.,0,0
49602,It,0,0
49603,has,0,0
49604,been,0,0
49605,confirmed,0,0
49606,that,0,0
49607,angiotensin-converting,0,0
49608,enzyme,0,0
49609,inhibitors,0,1
49610,(,0,1
49611,ACEIs,0,1
49612,),0,1
49613,and,0,1
49614,angiotensin,0,1
49615,II,0,0
49616,receptor,0,1
49617,blockers,0,0
49618,(,0,1
49619,ARBs,0,1
49620,),0,0
49621,reduce,0,0
49622,urinary,0,1
49623,protein,0,1
49624,excretion,0,1
49625,and,0,1
49626,attenuate,0,1
49627,the,0,0
49628,development,0,0
49629,of,0,0
49630,renal,0,1
49631,injury,0,1
49632,.,0,0
49633,Clinical,0,1
49634,data,0,0
49635,comparing,0,0
49636,the,0,0
49637,renal,0,1
49638,effects,0,1
49639,of,0,1
49640,ACEIs,0,1
49641,and,0,1
49642,ARBs,0,1
49643,",",0,0
49644,either,0,0
49645,singly,0,0
49646,or,0,0
49647,in,0,0
49648,combination,0,0
49649,",",0,0
49650,are,0,0
49651,scarce,0,0
49652,and,0,0
49653,usually,0,0
49654,concern,0,0
49655,the,0,0
49656,use,0,0
49657,of,0,1
49658,standard,0,0
49659,or,0,0
49660,high,0,0
49661,doses,0,0
49662,.,0,1
49663,MATERIAL,0,0
49664,AND,0,0
49665,METHODS,0,0
49666,This,0,0
49667,was,0,0
49668,a,0,0
49669,prospective,0,0
49670,",",0,0
49671,randomized,0,0
49672,",",0,0
49673,9-month,0,0
49674,study,0,0
49675,of,0,0
49676,the,0,0
49677,effects,0,0
49678,of,0,0
49679,low,0,0
49680,doses,0,0
49681,of,0,1
49682,losartan,0,0
49683,(,0,0
49684,25,0,0
49685,mg,0,0
49686,;,0,0
49687,n,0,0
49688,=,0,0
49689,18,0,0
49690,),0,0
49691,versus,0,0
49692,enalapril,0,0
49693,(,0,0
49694,10,0,0
49695,mg,0,0
49696,;,0,0
49697,n,0,0
49698,=,0,0
49699,18,0,0
49700,),0,0
49701,versus,0,0
49702,the,0,0
49703,combination,0,0
49704,of,0,1
49705,losartan,0,0
49706,(,0,0
49707,25,0,0
49708,mg,0,0
49709,),0,0
49710,and,0,1
49711,enalapril,0,0
49712,(,0,0
49713,10,0,0
49714,mg,0,0
49715,),0,0
49716,(,0,0
49717,n,0,0
49718,=,0,0
49719,16,0,0
49720,),0,0
49721,on,0,0
49722,proteinuria,1,1
49723,",",1,1
49724,kidney,1,1
49725,function,1,1
49726,and,1,1
49727,metabolic,1,1
49728,profile,1,1
49729,in,0,0
49730,54,0,0
49731,patients,0,0
49732,with,0,0
49733,biopsy-proven,0,0
49734,chronic,0,0
49735,glomerulonephritis,0,1
49736,",",0,1
49737,hypertension,0,1
49738,and,0,1
49739,normal,0,1
49740,or,0,0
49741,slightly,0,1
49742,impaired,0,1
49743,kidney,0,0
49744,function,0,1
49745,.,0,0
49746,The,0,0
49747,clinical,1,0
49748,evaluation,1,0
49749,and,1,1
49750,laboratory,1,1
49751,tests,1,1
49752,were,0,0
49753,performed,0,0
49754,before,0,0
49755,treatment,0,0
49756,(,0,1
49757,baseline,0,1
49758,),0,1
49759,and,0,0
49760,after,0,0
49761,3,0,0
49762,and,0,0
49763,9,0,0
49764,months,0,0
49765,of,0,0
49766,therapy,0,0
49767,.,0,0
49768,RESULTS,0,0
49769,After,0,0
49770,3,0,0
49771,months,0,0
49772,",",0,0
49773,significant,0,0
49774,decreases,0,1
49775,in,0,0
49776,proteinuria,1,1
49777,were,0,0
49778,observed,0,0
49779,in,0,0
49780,all,0,0
49781,groups,0,0
49782,:,0,0
49783,losartan,0,0
49784,",",0,0
49785,22.6,0,0
49786,%,0,0
49787,(,0,0
49788,p,0,0
49789,=,0,0
49790,0.02,0,0
49791,),0,0
49792,;,0,0
49793,enalapril,0,0
49794,",",0,0
49795,43,0,0
49796,%,0,0
49797,(,0,0
49798,p,0,0
49799,=,0,0
49800,0.012,0,0
49801,),0,0
49802,;,0,0
49803,and,0,1
49804,combined,0,0
49805,therapy,0,0
49806,",",0,0
49807,63,0,0
49808,%,0,0
49809,(,0,0
49810,p,0,0
49811,=,0,0
49812,0.001,0,0
49813,),0,0
49814,.,0,0
49815,This,0,0
49816,anti-proteinuric,1,1
49817,effect,1,1
49818,was,0,0
49819,even,0,0
49820,greater,0,0
49821,after,0,0
49822,9,0,0
49823,months,0,0
49824,of,0,0
49825,therapy,0,0
49826,:,0,0
49827,losartan,0,0
49828,",",0,0
49829,44.2,0,0
49830,%,0,0
49831,(,0,0
49832,p,0,0
49833,=,0,0
49834,0.02,0,0
49835,),0,0
49836,;,0,0
49837,enalapril,0,0
49838,",",0,0
49839,49.6,0,0
49840,%,0,0
49841,(,0,0
49842,p,0,0
49843,=,0,0
49844,0.02,0,0
49845,),0,0
49846,;,0,0
49847,and,0,1
49848,combined,0,0
49849,therapy,0,0
49850,",",0,0
49851,51,0,0
49852,%,0,0
49853,(,0,0
49854,p,0,0
49855,=,0,0
49856,0.003,0,0
49857,),0,0
49858,.,0,0
49859,There,0,0
49860,was,0,0
49861,no,0,0
49862,significant,0,0
49863,difference,0,0
49864,between,0,0
49865,losartan,0,0
49866,and,0,1
49867,enalapril,0,0
49868,with,0,0
49869,respect,0,0
49870,to,0,0
49871,their,0,0
49872,impact,0,0
49873,on,0,0
49874,proteinuria,1,1
49875,level,1,1
49876,.,1,1
49877,Proteinuria,1,1
49878,reduction,1,1
49879,was,0,0
49880,significantly,0,0
49881,greater,0,0
49882,in,0,0
49883,patients,0,0
49884,receiving,0,0
49885,combined,0,0
49886,therapy,0,0
49887,in,0,0
49888,comparison,0,0
49889,with,0,0
49890,losartan,0,0
49891,treatment,0,0
49892,after,0,0
49893,3,0,0
49894,months,0,0
49895,of,0,0
49896,therapy,0,0
49897,(,0,0
49898,p,0,0
49899,=,0,0
49900,0.02,0,0
49901,),0,0
49902,.,0,0
49903,Creatinine,1,1
49904,clearance,1,1
49905,and,1,1
49906,serum,1,1
49907,creatinine,1,1
49908,were,0,0
49909,stable,0,0
49910,during,0,0
49911,the,0,0
49912,entire,0,0
49913,study,0,0
49914,period,0,0
49915,in,0,0
49916,all,0,0
49917,patients,0,0
49918,.,0,0
49919,No,0,0
49920,significant,0,0
49921,changes,1,1
49922,in,1,0
49923,lipids,1,1
49924,",",1,0
49925,serum,1,1
49926,uric,1,1
49927,acid,1,1
49928,or,1,1
49929,protein,1,1
49930,levels,1,1
49931,were,0,0
49932,observed,0,0
49933,.,0,0
49934,CONCLUSIONS,0,0
49935,These,0,0
49936,results,0,0
49937,indicate,0,0
49938,that,0,0
49939,proteinuria,0,1
49940,is,0,0
49941,reduced,0,0
49942,by,0,0
49943,low,0,0
49944,doses,0,0
49945,of,0,1
49946,losartan,0,0
49947,or,0,0
49948,enalapril,0,0
49949,.,0,0
49950,The,0,0
49951,combination,0,0
49952,of,0,0
49953,these,0,0
49954,drugs,0,0
49955,seems,0,0
49956,to,0,0
49957,be,0,0
49958,beneficial,0,0
49959,and,0,0
49960,may,0,0
49961,offer,0,0
49962,an,0,0
49963,additional,0,0
49964,renoprotective,0,0
49965,effect,0,0
49966,.,0,0
49967,This,0,0
49968,needs,0,0
49969,to,0,0
49970,be,0,0
49971,confirmed,0,0
49972,in,0,0
49973,a,0,0
49974,study,0,0
49975,with,0,0
49976,a,0,0
49977,larger,0,0
49978,sample,0,0
49979,size,0,1
49980,.,0,0
49981,Stapled,0,0
49982,hemorrhoidopexy,0,0
49983,vs.,0,0
49984,Harmonic,0,1
49985,Scalpel,0,0
49986,hemorrhoidectomy,0,0
49987,:,0,0
49988,a,0,0
49989,randomized,0,0
49990,trial,0,0
49991,.,0,0
49992,PURPOSE,0,0
49993,A,0,0
49994,randomized,0,0
49995,trial,0,0
49996,was,0,0
49997,undertaken,0,0
49998,to,0,0
49999,evaluate,0,0
50000,and,0,0
50001,compare,0,0
50002,stapled,0,1
50003,hemorrhoidopexy,0,0
50004,with,0,0
50005,excisional,0,0
50006,hemorrhoidectomy,0,0
50007,in,0,0
50008,which,0,0
50009,the,0,0
50010,Harmonic,0,1
50011,Scalpel,0,0
50012,was,0,0
50013,used,0,0
50014,.,0,0
50015,METHODS,0,0
50016,Patients,0,0
50017,with,0,0
50018,Grade,0,1
50019,III,0,0
50020,hemorrhoids,0,0
50021,who,0,0
50022,were,0,0
50023,employed,0,0
50024,during,0,0
50025,the,0,0
50026,trial,0,0
50027,period,0,0
50028,were,0,0
50029,recruited,0,0
50030,and,0,0
50031,randomized,0,0
50032,into,0,0
50033,two,0,0
50034,groups,0,0
50035,:,0,0
50036,(,0,0
50037,1,0,0
50038,),0,0
50039,Harmonic,0,0
50040,Scalpel,0,0
50041,hemorrhoidectomy,0,0
50042,",",0,1
50043,and,0,1
50044,(,0,0
50045,2,0,0
50046,),0,0
50047,stapled,0,0
50048,hemorrhoidopexy,0,0
50049,.,0,0
50050,All,0,0
50051,operations,0,0
50052,were,0,0
50053,performed,0,0
50054,by,0,0
50055,a,0,0
50056,single,0,0
50057,surgeon,0,0
50058,.,0,0
50059,In,0,0
50060,the,0,0
50061,stapled,0,1
50062,group,0,0
50063,",",0,0
50064,the,0,0
50065,doughnut,0,1
50066,obtained,0,0
50067,was,0,0
50068,sent,0,0
50069,for,0,0
50070,histopathologic,0,0
50071,examination,0,0
50072,to,0,0
50073,determine,0,0
50074,whether,0,0
50075,smooth,0,1
50076,muscles,0,1
50077,were,0,0
50078,included,0,0
50079,in,0,0
50080,the,0,0
50081,specimen,0,0
50082,.,0,0
50083,Operative,0,1
50084,data,0,0
50085,and,0,1
50086,complications,0,1
50087,were,0,0
50088,recorded,0,1
50089,",",0,0
50090,and,0,1
50091,patients,0,0
50092,were,0,0
50093,followed,0,0
50094,up,0,0
50095,through,0,0
50096,a,0,0
50097,structured,0,0
50098,pro,0,0
50099,forma,0,1
50100,protocol,0,0
50101,.,0,0
50102,An,0,0
50103,independent,0,0
50104,assessor,0,0
50105,was,0,0
50106,assigned,0,0
50107,to,0,0
50108,obtain,0,0
50109,postoperative,0,1
50110,pain,1,1
50111,scores,1,1
50112,and,1,1
50113,satisfaction,1,1
50114,scores,1,1
50115,at,0,0
50116,six-month,0,0
50117,follow-up,0,0
50118,.,0,0
50119,Patients,0,0
50120,were,0,0
50121,also,0,0
50122,administered,0,0
50123,a,0,0
50124,simple,1,0
50125,questionnaire,1,1
50126,at,0,0
50127,follow-up,0,0
50128,to,0,0
50129,assess,0,0
50130,continence,0,1
50131,functions,0,1
50132,.,0,0
50133,RESULTS,0,0
50134,Over,0,0
50135,a,0,0
50136,20-month,0,0
50137,period,0,0
50138,",",0,0
50139,88,0,0
50140,patients,0,0
50141,were,0,0
50142,recruited,0,0
50143,.,0,0
50144,The,0,0
50145,two,0,0
50146,groups,0,0
50147,were,0,0
50148,matched,0,0
50149,for,0,0
50150,age,0,0
50151,and,0,1
50152,gender,0,0
50153,distribution,0,1
50154,.,0,0
50155,No,0,0
50156,significant,0,0
50157,difference,0,0
50158,was,0,0
50159,identified,0,0
50160,between,0,0
50161,the,0,0
50162,two,0,0
50163,groups,0,0
50164,in,0,0
50165,terms,0,1
50166,of,0,1
50167,operation,1,0
50168,time,1,1
50169,",",1,1
50170,blood,1,1
50171,loss,1,1
50172,",",1,1
50173,day,1,1
50174,of,1,1
50175,first,1,1
50176,bowel,1,1
50177,movement,1,1
50178,after,1,0
50179,surgery,1,0
50180,",",1,1
50181,and,1,1
50182,complication,1,1
50183,rates,1,1
50184,.,1,0
50185,Despite,0,0
50186,a,0,0
50187,similar,0,0
50188,parenteral,0,0
50189,and,0,1
50190,oral,0,0
50191,analgesic,0,1
50192,requirement,0,1
50193,",",0,0
50194,the,0,0
50195,stapled,0,1
50196,group,0,0
50197,had,0,0
50198,a,0,0
50199,significantly,0,0
50200,better,0,0
50201,pain,1,1
50202,score,1,1
50203,(,0,1
50204,P,0,0
50205,=,0,0
50206,0.002,0,0
50207,),0,0
50208,;,0,0
50209,these,0,0
50210,patients,0,0
50211,also,0,0
50212,had,0,0
50213,a,0,0
50214,significantly,0,0
50215,shorter,0,1
50216,length,1,1
50217,of,1,1
50218,stay,1,1
50219,(,0,0
50220,P,0,0
50221,=,0,0
50222,0.02,0,0
50223,),0,0
50224,",",0,0
50225,and,0,1
50226,on,0,0
50227,average,0,1
50228,resumed,0,0
50229,work,0,0
50230,nine,0,0
50231,days,0,0
50232,earlier,0,0
50233,than,0,0
50234,the,0,0
50235,group,0,0
50236,treated,0,0
50237,with,0,0
50238,the,0,0
50239,Harmonic,0,1
50240,Scalpel,0,0
50241,(,0,0
50242,6.7,0,0
50243,vs.,0,0
50244,15.6,0,0
50245,",",0,0
50246,P,0,0
50247,=,0,0
50248,0.002,0,0
50249,),0,0
50250,.,0,0
50251,Although,0,0
50252,88,0,0
50253,percent,0,0
50254,of,0,0
50255,doughnuts,0,0
50256,obtained,0,0
50257,in,0,0
50258,the,0,0
50259,stapled,0,1
50260,group,0,0
50261,contained,0,0
50262,some,0,0
50263,smooth,1,1
50264,muscle,1,1
50265,fibers,1,0
50266,",",0,0
50267,no,0,0
50268,association,0,0
50269,was,0,0
50270,found,0,0
50271,between,0,0
50272,smooth,1,1
50273,muscle,1,1
50274,incorporation,1,1
50275,and,0,1
50276,postoperative,1,1
50277,continence,1,1
50278,function,1,1
50279,",",0,1
50280,and,0,1
50281,as,0,0
50282,a,0,0
50283,whole,0,0
50284,the,0,0
50285,continence,0,1
50286,outcomes,0,1
50287,of,0,0
50288,the,0,0
50289,stapled,0,1
50290,group,0,0
50291,were,0,0
50292,similar,0,0
50293,to,0,0
50294,those,0,0
50295,after,0,0
50296,Harmonic,0,1
50297,Scalpel,0,0
50298,hemorrhoidectomy,0,0
50299,.,0,0
50300,Finally,0,0
50301,",",0,0
50302,at,0,0
50303,six-month,0,1
50304,follow-up,0,0
50305,",",0,0
50306,patients,0,0
50307,who,0,0
50308,underwent,0,0
50309,the,0,0
50310,stapled,0,1
50311,procedure,0,0
50312,had,0,0
50313,significantly,0,0
50314,better,0,0
50315,satisfaction,1,1
50316,scores,1,1
50317,(,0,0
50318,P,0,0
50319,=,0,0
50320,0.001,0,0
50321,),0,0
50322,.,0,0
50323,CONCLUSION,0,0
50324,Stapled,0,1
50325,hemorrhoidopexy,0,0
50326,is,0,0
50327,a,0,0
50328,safe,1,1
50329,and,1,1
50330,effective,1,1
50331,procedure,0,0
50332,for,0,0
50333,Grade,0,1
50334,III,0,1
50335,hemorrhoidal,0,1
50336,disease,0,1
50337,.,0,0
50338,Patients,0,0
50339,derive,0,0
50340,greater,0,0
50341,short-term,0,1
50342,benefits,1,1
50343,of,0,1
50344,reduced,1,1
50345,pain,1,1
50346,",",1,1
50347,shorter,1,1
50348,length,1,1
50349,of,1,1
50350,stay,1,1
50351,",",1,1
50352,and,1,1
50353,earlier,1,0
50354,resumption,1,1
50355,to,1,0
50356,work,1,1
50357,.,1,0
50358,Long-term,0,0
50359,follow-up,0,0
50360,is,0,0
50361,necessary,0,0
50362,to,0,0
50363,determine,0,0
50364,whether,0,0
50365,these,0,0
50366,initial,0,0
50367,results,0,0
50368,are,0,0
50369,lasting,0,0
50370,.,0,0
50371,Comparison,0,0
50372,of,0,1
50373,warfarin,0,0
50374,and,0,1
50375,aspirin,0,0
50376,for,0,0
50377,symptomatic,0,1
50378,intracranial,0,1
50379,arterial,0,1
50380,stenosis,0,1
50381,.,0,0
50382,BACKGROUND,0,0
50383,Atherosclerotic,0,1
50384,intracranial,0,1
50385,arterial,0,1
50386,stenosis,0,1
50387,is,0,0
50388,an,0,0
50389,important,0,0
50390,cause,0,0
50391,of,0,0
50392,stroke,0,1
50393,.,0,0
50394,Warfarin,0,0
50395,is,0,0
50396,commonly,0,0
50397,used,0,0
50398,in,0,0
50399,preference,0,0
50400,to,0,0
50401,aspirin,0,0
50402,for,0,0
50403,this,0,0
50404,disorder,0,0
50405,",",0,0
50406,but,0,0
50407,these,0,0
50408,therapies,0,0
50409,have,0,0
50410,not,0,0
50411,been,0,0
50412,compared,0,0
50413,in,0,0
50414,a,0,0
50415,randomized,0,0
50416,trial,0,0
50417,.,0,0
50418,METHODS,0,0
50419,We,0,0
50420,randomly,0,0
50421,assigned,0,0
50422,patients,0,0
50423,with,0,0
50424,transient,0,1
50425,ischemic,0,1
50426,attack,0,1
50427,or,0,1
50428,stroke,0,1
50429,caused,0,0
50430,by,0,0
50431,angiographically,0,0
50432,verified,0,0
50433,50,0,0
50434,to,0,0
50435,99,0,0
50436,percent,0,0
50437,stenosis,0,0
50438,of,0,0
50439,a,0,0
50440,major,0,1
50441,intracranial,0,1
50442,artery,0,0
50443,to,0,0
50444,receive,0,0
50445,warfarin,0,0
50446,(,0,0
50447,target,0,1
50448,international,0,0
50449,normalized,0,1
50450,ratio,0,1
50451,",",0,0
50452,2.0,0,0
50453,to,0,0
50454,3.0,0,0
50455,),0,0
50456,or,0,0
50457,aspirin,0,0
50458,(,0,0
50459,1300,0,0
50460,mg,0,0
50461,per,0,0
50462,day,0,0
50463,),0,0
50464,in,0,0
50465,a,0,0
50466,double-blind,0,0
50467,",",0,0
50468,multicenter,0,0
50469,clinical,0,0
50470,trial,0,0
50471,.,0,0
50472,The,0,0
50473,primary,0,0
50474,end,0,0
50475,point,0,0
50476,was,0,0
50477,ischemic,1,1
50478,stroke,1,1
50479,",",1,1
50480,brain,1,1
50481,hemorrhage,1,1
50482,",",1,1
50483,or,1,1
50484,death,1,1
50485,from,0,0
50486,vascular,0,1
50487,causes,0,0
50488,other,0,0
50489,than,0,0
50490,stroke,1,1
50491,.,1,0
50492,RESULTS,0,0
50493,After,0,0
50494,569,0,0
50495,patients,0,0
50496,had,0,0
50497,undergone,0,0
50498,randomization,0,0
50499,",",0,1
50500,enrollment,0,0
50501,was,0,0
50502,stopped,0,0
50503,because,0,0
50504,of,0,0
50505,concerns,0,0
50506,about,0,0
50507,the,0,0
50508,safety,0,1
50509,of,0,0
50510,the,0,0
50511,patients,0,0
50512,who,0,0
50513,had,0,0
50514,been,0,0
50515,assigned,0,0
50516,to,0,0
50517,receive,0,0
50518,warfarin,0,0
50519,.,0,0
50520,During,0,0
50521,a,0,0
50522,mean,0,1
50523,follow-up,0,0
50524,period,0,0
50525,of,0,0
50526,1.8,0,0
50527,years,0,0
50528,",",0,0
50529,adverse,1,1
50530,events,1,1
50531,in,0,0
50532,the,0,0
50533,two,0,0
50534,groups,0,0
50535,included,0,0
50536,death,1,1
50537,(,0,0
50538,4.3,0,0
50539,percent,0,0
50540,in,0,0
50541,the,0,0
50542,aspirin,0,0
50543,group,0,0
50544,vs.,0,0
50545,9.7,0,0
50546,percent,0,0
50547,in,0,0
50548,the,0,0
50549,warfarin,0,0
50550,group,0,0
50551,;,0,1
50552,hazard,0,1
50553,ratio,0,1
50554,for,0,0
50555,aspirin,0,0
50556,relative,0,0
50557,to,0,0
50558,warfarin,0,0
50559,",",0,0
50560,0.46,0,0
50561,;,0,0
50562,95,0,0
50563,percent,0,0
50564,confidence,0,0
50565,interval,0,0
50566,",",0,0
50567,0.23,0,0
50568,to,0,0
50569,0.90,0,0
50570,;,0,0
50571,P=0.02,0,0
50572,),0,0
50573,",",0,0
50574,major,1,1
50575,hemorrhage,1,1
50576,(,0,0
50577,3.2,0,0
50578,percent,0,0
50579,vs.,0,0
50580,8.3,0,0
50581,percent,0,0
50582,",",0,0
50583,respectively,0,0
50584,;,0,0
50585,hazard,0,1
50586,ratio,0,1
50587,",",0,0
50588,0.39,0,0
50589,;,0,0
50590,95,0,0
50591,percent,0,0
50592,confidence,0,0
50593,interval,0,0
50594,",",0,0
50595,0.18,0,0
50596,to,0,0
50597,0.84,0,0
50598,;,0,0
50599,P=0.01,0,0
50600,),0,1
50601,",",0,0
50602,and,0,1
50603,myocardial,1,1
50604,infarction,1,1
50605,or,1,1
50606,sudden,1,1
50607,death,1,1
50608,(,0,0
50609,2.9,0,0
50610,percent,0,0
50611,vs.,0,0
50612,7.3,0,0
50613,percent,0,0
50614,",",0,0
50615,respectively,0,0
50616,;,0,0
50617,hazard,0,1
50618,ratio,0,1
50619,",",0,0
50620,0.40,0,0
50621,;,0,0
50622,95,0,0
50623,percent,0,0
50624,confidence,0,0
50625,interval,0,0
50626,",",0,0
50627,0.18,0,0
50628,to,0,0
50629,0.91,0,0
50630,;,0,0
50631,P=0.02,0,0
50632,),0,0
50633,.,0,0
50634,The,0,0
50635,rate,1,1
50636,of,1,0
50637,death,1,1
50638,from,0,0
50639,vascular,0,1
50640,causes,0,0
50641,was,0,0
50642,3.2,0,0
50643,percent,0,0
50644,in,0,0
50645,the,0,0
50646,aspirin,0,0
50647,group,0,0
50648,and,0,0
50649,5.9,0,0
50650,percent,0,0
50651,in,0,0
50652,the,0,0
50653,warfarin,0,0
50654,group,0,0
50655,(,0,1
50656,P=0.16,0,0
50657,),0,0
50658,;,0,0
50659,the,0,0
50660,rate,1,1
50661,of,1,0
50662,death,1,1
50663,from,0,0
50664,nonvascular,0,0
50665,causes,0,0
50666,was,0,0
50667,1.1,0,0
50668,percent,0,0
50669,and,0,0
50670,3.8,0,0
50671,percent,0,0
50672,",",0,0
50673,respectively,0,0
50674,(,0,0
50675,P=0.05,0,0
50676,),0,0
50677,.,0,0
50678,The,0,0
50679,primary,0,0
50680,end,0,0
50681,point,0,0
50682,occurred,0,0
50683,in,0,0
50684,22.1,0,0
50685,percent,0,0
50686,of,0,0
50687,the,0,0
50688,patients,0,0
50689,in,0,0
50690,the,0,0
50691,aspirin,0,0
50692,group,0,0
50693,and,0,0
50694,21.8,0,0
50695,percent,0,0
50696,of,0,0
50697,those,0,0
50698,in,0,0
50699,the,0,0
50700,warfarin,0,0
50701,group,0,0
50702,(,0,1
50703,hazard,0,1
50704,ratio,0,1
50705,",",0,0
50706,1.04,0,0
50707,;,0,0
50708,95,0,0
50709,percent,0,0
50710,confidence,0,0
50711,interval,0,0
50712,",",0,0
50713,0.73,0,0
50714,to,0,0
50715,1.48,0,0
50716,;,0,0
50717,P=0.83,0,0
50718,),0,0
50719,.,0,0
50720,CONCLUSIONS,0,0
50721,Warfarin,0,1
50722,was,0,0
50723,associated,0,0
50724,with,0,0
50725,significantly,0,0
50726,higher,0,0
50727,rates,0,1
50728,of,0,1
50729,adverse,0,1
50730,events,0,1
50731,and,0,1
50732,provided,0,0
50733,no,0,0
50734,benefit,0,0
50735,over,0,0
50736,aspirin,0,0
50737,in,0,0
50738,this,0,0
50739,trial,0,0
50740,.,0,0
50741,Aspirin,0,0
50742,should,0,0
50743,be,0,0
50744,used,0,0
50745,in,0,0
50746,preference,0,0
50747,to,0,0
50748,warfarin,0,0
50749,for,0,0
50750,patients,0,0
50751,with,0,0
50752,intracranial,0,1
50753,arterial,0,1
50754,stenosis,0,1
50755,.,0,0
50756,Development,0,1
50757,of,0,0
50758,the,0,0
50759,WAIS-III,0,0
50760,general,0,0
50761,ability,0,1
50762,index,0,1
50763,estimate,0,0
50764,(,0,1
50765,GAI-E,0,1
50766,),0,0
50767,.,0,0
50768,The,0,0
50769,WAIS-III,0,0
50770,General,0,1
50771,Ability,0,1
50772,Index,0,1
50773,(,0,0
50774,GAI,0,0
50775,;,0,1
50776,Tulsky,0,0
50777,",",0,1
50778,Saklofske,0,1
50779,",",0,1
50780,Wilkins,0,1
50781,",",0,1
50782,&,0,1
50783,Weiss,0,1
50784,",",0,0
50785,2001,0,0
50786,),0,0
50787,is,0,0
50788,a,0,0
50789,recently,0,0
50790,developed,0,0
50791,",",0,0
50792,6-subtest,0,1
50793,measure,0,1
50794,of,0,1
50795,global,0,1
50796,intellectual,0,0
50797,functioning,0,1
50798,.,0,0
50799,However,0,0
50800,",",0,0
50801,clinical,0,1
50802,use,0,0
50803,of,0,0
50804,the,0,0
50805,GAI,0,0
50806,is,0,0
50807,currently,0,0
50808,limited,0,0
50809,by,0,0
50810,the,0,0
50811,absence,0,0
50812,of,0,0
50813,a,0,0
50814,method,0,0
50815,to,0,0
50816,estimate,0,0
50817,premorbid,0,1
50818,functioning,0,1
50819,as,0,0
50820,measured,0,0
50821,by,0,0
50822,this,0,0
50823,index,0,1
50824,.,0,0
50825,The,0,0
50826,purpose,0,0
50827,of,0,0
50828,this,0,0
50829,study,0,0
50830,was,0,0
50831,to,0,0
50832,develop,0,0
50833,regression,0,0
50834,equations,0,0
50835,to,0,0
50836,estimate,0,0
50837,GAI,1,0
50838,scores,1,1
50839,from,0,0
50840,demographic,0,1
50841,variables,0,1
50842,and,0,1
50843,WAIS-III,1,1
50844,subtest,1,1
50845,performance,1,1
50846,.,1,1
50847,Participants,0,0
50848,consisted,0,0
50849,of,0,0
50850,those,0,0
50851,subjects,0,0
50852,in,0,0
50853,the,0,0
50854,WAIS-III,0,0
50855,standardization,0,0
50856,sample,0,0
50857,that,0,0
50858,has,0,0
50859,complete,0,1
50860,demographic,0,1
50861,data,0,0
50862,(,0,0
50863,"N=2,401",0,0
50864,),0,1
50865,and,0,1
50866,were,0,0
50867,randomly,0,0
50868,divided,0,0
50869,into,0,0
50870,two,0,0
50871,groups,0,0
50872,.,0,0
50873,The,0,0
50874,first,0,1
50875,group,0,0
50876,(,0,0
50877,"n=1,200",0,0
50878,),0,0
50879,was,0,0
50880,used,0,0
50881,to,0,0
50882,develop,0,0
50883,the,0,0
50884,formulas,0,0
50885,(,0,0
50886,i.e.,0,0
50887,",",0,1
50888,Development,0,1
50889,group,0,0
50890,),0,0
50891,and,0,0
50892,the,0,0
50893,second,0,0
50894,(,0,0
50895,"n=1,201",0,0
50896,),0,1
50897,group,0,0
50898,was,0,0
50899,used,0,0
50900,to,0,0
50901,validate,0,0
50902,the,0,0
50903,prediction,0,1
50904,algorithms,0,0
50905,(,0,1
50906,i.e.,0,0
50907,",",0,1
50908,Validation,0,1
50909,group,0,0
50910,),0,0
50911,.,0,0
50912,Demographic,1,1
50913,variables,1,1
50914,included,1,0
50915,age,1,0
50916,",",1,1
50917,education,1,0
50918,",",1,1
50919,ethnicity,1,0
50920,",",1,1
50921,gender,1,1
50922,and,1,1
50923,region,1,0
50924,of,1,1
50925,country,1,0
50926,.,1,0
50927,Subtest,0,1
50928,variables,0,1
50929,included,0,0
50930,vocabulary,1,1
50931,",",1,1
50932,information,1,1
50933,",",1,1
50934,picture,1,1
50935,completion,1,1
50936,",",1,1
50937,and,1,1
50938,matrix,1,1
50939,reasoning,1,1
50940,raw,1,0
50941,scores,1,1
50942,.,1,0
50943,Ten,0,0
50944,regression,0,0
50945,algorithms,0,0
50946,were,0,0
50947,generated,0,0
50948,designed,0,0
50949,to,0,0
50950,estimate,0,0
50951,GAI,1,0
50952,.,1,0
50953,The,0,0
50954,GAI-Estimate,1,0
50955,(,1,0
50956,GAI-E,1,1
50957,),1,1
50958,algorithms,1,0
50959,accounted,0,0
50960,for,0,0
50961,58,0,0
50962,%,0,0
50963,to,0,0
50964,82,0,0
50965,%,0,0
50966,of,0,0
50967,the,0,0
50968,variance,0,0
50969,.,0,0
50970,The,0,0
50971,standard,1,0
50972,error,1,1
50973,of,0,1
50974,estimate,0,0
50975,ranged,0,0
50976,from,0,0
50977,6.44,0,0
50978,to,0,0
50979,9.57,0,0
50980,.,0,0
50981,The,0,0
50982,correlations,0,1
50983,between,0,0
50984,actual,0,1
50985,and,0,1
50986,estimated,0,0
50987,GAI,0,1
50988,ranged,0,1
50989,from,0,0
50990,r=.76,0,1
50991,to,0,0
50992,r=.90,0,0
50993,.,0,0
50994,These,0,0
50995,algorithms,0,0
50996,provided,0,0
50997,accurate,0,1
50998,estimates,0,0
50999,of,0,0
51000,GAI,0,0
51001,in,0,0
51002,the,0,0
51003,WAIS-III,0,0
51004,standardization,0,0
51005,sample,0,0
51006,.,0,0
51007,Implications,0,0
51008,for,0,0
51009,estimating,0,0
51010,GAI,0,0
51011,in,0,0
51012,patients,0,0
51013,with,0,0
51014,known,0,0
51015,or,0,0
51016,suspected,0,0
51017,neurological,0,0
51018,dysfunction,0,0
51019,is,0,0
51020,discussed,0,0
51021,and,0,0
51022,future,0,0
51023,research,0,0
51024,is,0,0
51025,proposed,0,0
51026,.,0,0
51027,The,0,0
51028,influence,0,0
51029,of,0,0
51030,epidermal,0,1
51031,growth,0,1
51032,factor,0,1
51033,receptor,0,1
51034,and,0,1
51035,tumor,0,1
51036,differentiation,0,1
51037,on,0,0
51038,the,0,0
51039,response,0,1
51040,to,0,0
51041,accelerated,0,0
51042,radiotherapy,0,0
51043,of,0,0
51044,squamous,0,0
51045,cell,0,1
51046,carcinomas,0,1
51047,of,0,0
51048,the,0,0
51049,head,0,0
51050,and,0,1
51051,neck,0,1
51052,in,0,0
51053,the,0,0
51054,randomized,0,0
51055,DAHANCA,0,0
51056,6,0,0
51057,and,0,0
51058,7,0,0
51059,study,0,0
51060,.,0,0
51061,BACKGROUND,0,0
51062,AND,0,0
51063,PURPOSE,0,0
51064,Reduction,0,1
51065,of,0,0
51066,the,0,0
51067,overall,0,1
51068,treatment,0,0
51069,time,0,1
51070,of,0,0
51071,radiotherapy,0,0
51072,has,0,0
51073,increased,0,0
51074,locoregional,1,0
51075,control,1,0
51076,and,0,1
51077,disease,1,1
51078,specific,1,1
51079,survival,1,1
51080,in,0,0
51081,squamous,0,0
51082,cell,0,1
51083,carcinomas,0,1
51084,of,0,0
51085,the,0,0
51086,head,0,0
51087,and,0,1
51088,neck,0,1
51089,(,0,1
51090,HNSCC,0,1
51091,),0,1
51092,",",0,0
51093,but,0,0
51094,the,0,0
51095,response,0,1
51096,is,0,0
51097,heterogeneous,0,0
51098,.,0,0
51099,EGFr,0,0
51100,is,0,0
51101,often,0,0
51102,overexpressed,0,0
51103,in,0,0
51104,HNSCC,0,0
51105,and,0,0
51106,has,0,0
51107,been,0,0
51108,related,0,0
51109,to,0,0
51110,the,0,0
51111,repopulation,0,1
51112,taking,0,0
51113,place,0,0
51114,during,0,0
51115,radiotherapy,0,0
51116,.,0,0
51117,The,0,0
51118,aim,0,0
51119,of,0,0
51120,the,0,0
51121,current,0,0
51122,study,0,0
51123,was,0,0
51124,to,0,0
51125,address,0,0
51126,the,0,0
51127,influence,1,0
51128,of,1,1
51129,EGFr,1,0
51130,and,0,1
51131,histopathological,1,1
51132,differentiation,1,1
51133,when,0,0
51134,the,0,0
51135,overall,1,1
51136,treatment,1,0
51137,time,1,1
51138,of,1,1
51139,radiotherapy,1,0
51140,was,0,0
51141,moderately,0,0
51142,reduced,0,0
51143,.,0,0
51144,PATIENTS,0,0
51145,AND,0,0
51146,METHODS,0,0
51147,Eight,0,1
51148,hundred,0,0
51149,and,0,0
51150,three,0,0
51151,patients,0,0
51152,with,0,0
51153,representative,0,0
51154,pretreatment,0,0
51155,tissue,0,1
51156,samples,0,0
51157,from,0,0
51158,the,0,0
51159,randomized,0,0
51160,DAHANCA,0,0
51161,6,0,0
51162,and,0,0
51163,7,0,0
51164,study,0,0
51165,of,0,0
51166,5,0,0
51167,vs.,0,0
51168,6,0,0
51169,fx/wk,0,0
51170,of,0,0
51171,radiotherapy,0,0
51172,.,0,1
51173,EGFr,0,0
51174,was,0,0
51175,visualized,0,0
51176,using,0,0
51177,immunohistochemistry,0,0
51178,and,0,1
51179,separated,0,0
51180,into,0,0
51181,high,0,0
51182,and,0,1
51183,low,0,1
51184,expression,0,1
51185,before,0,0
51186,correlation,0,0
51187,with,0,0
51188,clinical,0,0
51189,data,0,0
51190,.,0,0
51191,RESULTS,0,0
51192,Tumors,0,0
51193,with,0,0
51194,high,0,0
51195,EGFr,0,0
51196,(,0,0
51197,84,0,0
51198,%,0,0
51199,),0,0
51200,responded,1,0
51201,better,0,0
51202,to,0,0
51203,moderately,0,0
51204,accelerated,0,0
51205,radiotherapy,0,0
51206,",",0,0
51207,than,0,0
51208,carcinomas,0,1
51209,with,0,0
51210,low,0,0
51211,EGFr,0,0
51212,",",0,0
51213,using,0,0
51214,locoregional,0,1
51215,control,0,0
51216,as,0,0
51217,endpoint,0,1
51218,and,0,0
51219,a,0,0
51220,similar,0,0
51221,pattern,0,0
51222,was,0,0
51223,seen,0,0
51224,",",0,0
51225,stratifying,0,0
51226,by,0,0
51227,well/moderate,0,1
51228,vs.,0,0
51229,poor,0,1
51230,tumor,1,1
51231,differentiation,1,1
51232,.,1,0
51233,Therefore,0,0
51234,",",0,0
51235,a,0,0
51236,combined,0,0
51237,parameter,0,1
51238,was,0,0
51239,constructed,0,0
51240,showing,0,0
51241,a,0,0
51242,more,0,0
51243,prominent,1,0
51244,separation,1,0
51245,of,1,0
51246,response,1,1
51247,:,1,0
51248,tumors,0,0
51249,with,0,0
51250,high,0,0
51251,EGFr,0,0
51252,and,0,1
51253,well/moderate,0,1
51254,differentiation,1,1
51255,did,0,0
51256,benefit,0,0
51257,from,0,0
51258,moderate,0,0
51259,acceleration,0,1
51260,of,0,1
51261,treatment,0,0
51262,regarding,0,0
51263,locoregional,0,1
51264,control,0,0
51265,",",0,0
51266,HR,0,1
51267,0.54,0,0
51268,(,0,0
51269,0.37-0.78,0,0
51270,),0,1
51271,",",0,0
51272,whereas,0,0
51273,such,0,0
51274,an,0,0
51275,effect,0,1
51276,was,0,0
51277,not,0,0
51278,seen,0,0
51279,in,0,0
51280,tumors,0,0
51281,with,0,0
51282,low,0,0
51283,EGFr,0,0
51284,and/or,0,0
51285,poor,0,1
51286,differentiation,0,1
51287,",",0,0
51288,HR,0,1
51289,0.8,0,0
51290,(,0,0
51291,0.51-1.25,0,0
51292,),0,0
51293,.,0,0
51294,These,0,0
51295,results,0,0
51296,reflected,0,0
51297,the,0,0
51298,disease,1,1
51299,specific,1,0
51300,survival,1,1
51301,as,0,0
51302,well,0,1
51303,and,0,0
51304,were,0,0
51305,confirmed,0,0
51306,in,0,0
51307,multivariable,0,0
51308,analyses,0,0
51309,.,0,0
51310,CONCLUSIONS,0,0
51311,Moderately,0,0
51312,accelerated,0,0
51313,fractionation,0,0
51314,is,0,0
51315,superior,1,1
51316,to,1,0
51317,conventional,1,0
51318,treatment,1,0
51319,in,0,0
51320,HNSCC,0,1
51321,but,0,0
51322,the,0,0
51323,response,1,1
51324,is,0,0
51325,heterogeneous,0,0
51326,and,0,0
51327,may,0,0
51328,be,0,0
51329,predicted,0,0
51330,by,0,0
51331,high,0,0
51332,expression,1,1
51333,of,1,1
51334,EGFr,1,0
51335,and,0,1
51336,well/moderate,0,1
51337,tumor,1,1
51338,differentiation,1,1
51339,.,1,0
51340,Disc,0,0
51341,coablation,0,0
51342,and,0,1
51343,epidural,0,0
51344,injection,0,0
51345,of,0,0
51346,steroids,0,0
51347,:,0,0
51348,a,0,0
51349,comparison,0,0
51350,of,0,0
51351,strategies,0,0
51352,in,0,0
51353,the,0,0
51354,treatment,0,0
51355,of,0,0
51356,mechanical,0,0
51357,spinal,0,1
51358,discogenic,0,1
51359,pain,0,1
51360,.,0,0
51361,In,0,0
51362,this,0,0
51363,study,0,0
51364,two,0,0
51365,strategies,0,0
51366,in,0,0
51367,the,0,0
51368,treatment,0,0
51369,of,0,0
51370,Mechanical,0,1
51371,Spinal,0,1
51372,Discogenic,0,1
51373,Pain,0,1
51374,have,0,0
51375,been,0,0
51376,compared,0,0
51377,:,0,0
51378,Disc,0,0
51379,Coablation,0,0
51380,and,0,1
51381,Epidural,0,1
51382,Injection,0,1
51383,of,0,0
51384,Steroids,0,0
51385,.,0,0
51386,In,0,0
51387,2003,0,0
51388,50,0,0
51389,patients,0,0
51390,treated,0,0
51391,with,0,0
51392,one,0,0
51393,or,0,0
51394,two,0,0
51395,epidural,0,0
51396,injections,0,0
51397,have,0,0
51398,been,0,0
51399,selected,0,0
51400,ad,0,0
51401,random,0,0
51402,and,0,0
51403,50,0,0
51404,patients,0,0
51405,treated,0,0
51406,with,0,0
51407,disc,0,0
51408,coablation,0,0
51409,.,0,0
51410,Comparison,0,0
51411,of,0,0
51412,the,0,0
51413,data,0,0
51414,indicated,0,0
51415,an,0,0
51416,improvement,0,1
51417,of,0,0
51418,average,1,1
51419,VAS,1,1
51420,when,0,0
51421,relaxed,0,0
51422,for,0,0
51423,both,0,0
51424,groups,0,0
51425,(,0,0
51426,p,0,0
51427,<,0,0
51428,0.01,0,0
51429,),0,0
51430,",",0,0
51431,while,0,0
51432,after,0,0
51433,slight-moderate,0,1
51434,strain,0,1
51435,",",0,0
51436,this,0,0
51437,value,0,1
51438,was,0,0
51439,significant,0,0
51440,only,0,0
51441,after,0,0
51442,coablation,0,0
51443,(,0,0
51444,p,0,0
51445,<,0,0
51446,0.001,0,0
51447,),0,0
51448,.,0,0
51449,Finally,0,0
51450,",",0,0
51451,average,1,1
51452,VAS,1,1
51453,was,0,0
51454,clearly,0,0
51455,lower,0,0
51456,(,0,0
51457,p,0,0
51458,<,0,0
51459,0.01,0,0
51460,),0,0
51461,after,0,0
51462,coablation,0,0
51463,as,0,0
51464,compared,0,0
51465,to,0,0
51466,epidural,0,0
51467,injections,0,0
51468,.,0,0
51469,Treatment,0,0
51470,outcome,0,1
51471,of,0,1
51472,appliance,0,0
51473,therapy,0,0
51474,in,0,0
51475,temporomandibular,0,1
51476,disorder,0,0
51477,patients,0,0
51478,with,0,0
51479,myofascial,1,1
51480,pain,1,1
51481,after,0,0
51482,6,0,0
51483,and,0,0
51484,12,0,0
51485,months,0,0
51486,.,0,0
51487,AIM,0,0
51488,To,0,0
51489,compare,0,0
51490,the,0,0
51491,long-term,0,0
51492,effect,0,1
51493,of,0,1
51494,treatment,0,0
51495,with,0,0
51496,a,0,0
51497,stabilization,0,1
51498,appliance,0,0
51499,(,0,1
51500,group,0,0
51501,T,0,1
51502,),0,1
51503,and,0,1
51504,treatment,0,0
51505,with,0,0
51506,a,0,0
51507,control,0,0
51508,appliance,0,0
51509,(,0,1
51510,group,0,0
51511,C,0,0
51512,),0,0
51513,in,0,0
51514,temporomandibular,0,1
51515,disorder,0,0
51516,(,0,1
51517,TMD,0,1
51518,),0,0
51519,patients,0,0
51520,with,0,0
51521,myofascial,0,1
51522,pain,0,1
51523,.,0,0
51524,METHODS,0,0
51525,In,0,0
51526,this,0,0
51527,controlled,0,0
51528,trial,0,0
51529,",",0,0
51530,60,0,0
51531,patients,0,0
51532,(,0,0
51533,mean,0,1
51534,age,0,0
51535,29,0,0
51536,years,0,0
51537,),0,0
51538,with,0,0
51539,myofascial,0,1
51540,pain,0,1
51541,were,0,0
51542,evaluated,0,0
51543,after,0,0
51544,10,0,0
51545,weeks,0,0
51546,of,0,0
51547,treatment,0,0
51548,with,0,0
51549,either,0,0
51550,a,0,0
51551,stabilization,0,1
51552,appliance,0,0
51553,or,0,0
51554,a,0,0
51555,control,0,0
51556,appliance,0,0
51557,.,0,0
51558,All,0,0
51559,60,0,0
51560,patients,0,0
51561,were,0,0
51562,then,0,0
51563,assigned,0,0
51564,to,0,0
51565,1,0,0
51566,of,0,0
51567,3,0,0
51568,groups,0,0
51569,according,0,0
51570,to,0,0
51571,demand,0,1
51572,for,0,0
51573,treatment,0,0
51574,.,0,0
51575,Seventeen,0,0
51576,patients,0,0
51577,from,0,0
51578,group,0,0
51579,C,0,0
51580,requested,0,0
51581,another,0,0
51582,appliance,0,0
51583,and,0,1
51584,were,0,0
51585,given,0,0
51586,a,0,0
51587,stabilization,0,0
51588,appliance,0,0
51589,",",0,0
51590,thus,0,0
51591,creating,0,0
51592,a,0,0
51593,mixed,0,0
51594,group,0,0
51595,(,0,0
51596,group,0,0
51597,M,0,0
51598,),0,0
51599,.,0,0
51600,RESULTS,0,0
51601,A,0,0
51602,significant,0,0
51603,difference,0,0
51604,in,0,0
51605,improvement,1,1
51606,of,1,0
51607,overall,1,1
51608,subjective,1,1
51609,symptoms,1,1
51610,in,0,0
51611,an,0,0
51612,intent-to-treat,0,0
51613,analysis,0,0
51614,between,0,0
51615,groups,0,0
51616,T,0,1
51617,and,0,1
51618,C,0,1
51619,was,0,0
51620,found,0,0
51621,at,0,0
51622,the,0,0
51623,follow-ups,0,0
51624,.,0,0
51625,In,0,0
51626,a,0,0
51627,survival,0,1
51628,analysis,0,0
51629,of,0,1
51630,treatment,0,0
51631,compliance,0,1
51632,",",0,0
51633,a,0,0
51634,significant,0,0
51635,difference,0,0
51636,was,0,0
51637,found,0,0
51638,between,0,0
51639,groups,0,0
51640,T,0,1
51641,and,0,1
51642,C.,0,1
51643,At,0,0
51644,the,0,0
51645,6-,0,0
51646,and,0,0
51647,12-month,0,1
51648,follow-ups,0,1
51649,",",0,0
51650,a,0,0
51651,significant,0,0
51652,reduction,0,1
51653,in,0,0
51654,myofascial,1,1
51655,pain,0,1
51656,",",0,0
51657,as,0,0
51658,measured,0,0
51659,on,0,0
51660,a,0,0
51661,visual,1,1
51662,analog,1,1
51663,scale,1,1
51664,",",0,1
51665,was,0,0
51666,found,0,0
51667,in,0,0
51668,all,0,0
51669,three,0,0
51670,groups,0,0
51671,.,0,0
51672,A,0,0
51673,significant,0,0
51674,decrease,0,1
51675,in,0,0
51676,frequency,1,1
51677,and,1,1
51678,intensity,1,1
51679,of,1,1
51680,myofascial,1,1
51681,pain,1,1
51682,was,0,0
51683,found,0,0
51684,in,0,0
51685,group,0,0
51686,T,0,0
51687,at,0,0
51688,the,0,0
51689,follow-ups,0,0
51690,.,0,0
51691,A,0,0
51692,significant,0,0
51693,decrease,0,1
51694,in,0,0
51695,number,1,1
51696,of,1,1
51697,tender,1,1
51698,sites,1,0
51699,on,1,0
51700,the,1,0
51701,masticatory,1,1
51702,muscles,1,1
51703,was,0,0
51704,found,0,0
51705,in,0,0
51706,group,0,0
51707,T,0,0
51708,at,0,0
51709,the,0,0
51710,follow-ups,0,0
51711,.,0,0
51712,CONCLUSION,0,0
51713,The,0,0
51714,results,0,0
51715,support,0,0
51716,the,0,0
51717,conclusion,0,0
51718,that,0,0
51719,the,0,0
51720,positive,0,1
51721,treatment,0,0
51722,outcome,0,1
51723,obtained,0,0
51724,by,0,0
51725,use,0,0
51726,of,0,0
51727,a,0,0
51728,stabilization,0,0
51729,appliance,0,0
51730,to,0,0
51731,alleviate,0,0
51732,the,0,0
51733,signs,0,1
51734,and,0,0
51735,symptoms,0,1
51736,in,0,0
51737,patients,0,0
51738,with,0,0
51739,myofascial,0,1
51740,pain,0,1
51741,persisted,0,1
51742,after,0,0
51743,6,0,0
51744,and,0,0
51745,12,0,0
51746,months,0,0
51747,.,0,0
51748,Most,0,0
51749,patients,0,0
51750,in,0,0
51751,groups,0,0
51752,T,0,1
51753,and,0,1
51754,M,0,0
51755,reported,0,0
51756,positive,0,1
51757,changes,0,1
51758,in,0,0
51759,overall,1,1
51760,subjective,1,1
51761,symptoms,1,1
51762,in,0,0
51763,this,0,0
51764,trial,0,0
51765,.,0,0
51766,We,0,0
51767,therefore,0,0
51768,recommend,0,0
51769,use,0,0
51770,of,0,0
51771,the,0,0
51772,stabilization,0,1
51773,appliance,0,0
51774,in,0,0
51775,the,0,0
51776,treatment,0,0
51777,of,0,0
51778,TMD,0,1
51779,patients,0,0
51780,with,0,0
51781,myofascial,1,1
51782,pain,1,1
51783,.,1,0
51784,Treatment,0,0
51785,of,0,1
51786,peri-implantitis,0,1
51787,by,0,0
51788,the,0,0
51789,Vector,0,0
51790,system,0,0
51791,.,0,0
51792,AIM,0,0
51793,To,0,0
51794,compare,0,0
51795,the,0,0
51796,effectiveness,1,1
51797,of,1,0
51798,treatment,1,0
51799,of,0,1
51800,peri-implantitis,0,1
51801,with,0,0
51802,a,0,0
51803,novel,0,0
51804,ultrasonic,0,1
51805,device,0,0
51806,",",0,0
51807,the,0,0
51808,Vector,0,0
51809,system,0,0
51810,",",0,0
51811,with,0,0
51812,that,0,0
51813,of,0,0
51814,subgingival,0,1
51815,debridement,0,0
51816,with,0,0
51817,carbon,0,0
51818,fiber,0,0
51819,curettes,0,0
51820,.,0,1
51821,MATERIAL,0,0
51822,AND,0,0
51823,METHODS,0,0
51824,The,0,0
51825,study,0,0
51826,",",0,0
51827,comprising,0,0
51828,11,0,0
51829,patients,0,0
51830,with,0,0
51831,at,0,0
51832,least,0,0
51833,two,0,0
51834,screw,0,0
51835,type,0,0
51836,implants,0,0
51837,with,0,0
51838,bleeding,1,1
51839,on,1,0
51840,probing,1,1
51841,(,1,0
51842,BOP,1,1
51843,),1,1
51844,",",1,0
51845,probing,1,1
51846,pocket,1,1
51847,depth,1,1
51848,(,1,1
51849,PPD,1,1
51850,),1,1
51851,>,0,0
51852,or,0,0
51853,=5,0,1
51854,mm,0,1
51855,",",0,1
51856,and,0,1
51857,at,0,0
51858,least,0,0
51859,1.5,0,0
51860,mm,0,0
51861,radiographic,0,1
51862,bone,1,1
51863,loss,1,1
51864,and,0,1
51865,exposed,0,0
51866,implant,0,0
51867,threads,0,1
51868,",",0,1
51869,was,0,0
51870,carried,0,0
51871,out,0,0
51872,as,0,0
51873,a,0,0
51874,single,0,0
51875,blind,0,0
51876,randomized,0,0
51877,clinical,0,0
51878,trial,0,0
51879,.,0,0
51880,At,0,0
51881,baseline,0,0
51882,one,0,0
51883,randomly,0,0
51884,chosen,0,0
51885,implant,0,0
51886,in,0,0
51887,each,0,0
51888,patient,0,1
51889,was,0,0
51890,treated,0,0
51891,by,0,0
51892,the,0,0
51893,Vector,0,0
51894,system,0,0
51895,(,0,1
51896,test,0,1
51897,),0,0
51898,while,0,0
51899,the,0,0
51900,other,0,0
51901,implant,0,0
51902,(,0,1
51903,control,0,0
51904,),0,1
51905,was,0,0
51906,treated,0,0
51907,by,0,0
51908,submucosal,0,0
51909,debridement,0,0
51910,with,0,0
51911,a,0,0
51912,carbon,0,0
51913,fiber,0,0
51914,curette,0,0
51915,.,0,0
51916,After,0,0
51917,3,0,0
51918,months,0,0
51919,",",0,0
51920,the,0,0
51921,same,0,0
51922,treatments,0,0
51923,were,0,0
51924,repeated,0,0
51925,.,0,0
51926,Plaque,1,1
51927,",",1,1
51928,BOP,1,1
51929,",",1,1
51930,and,1,1
51931,PPD,1,1
51932,were,0,0
51933,recorded,0,0
51934,on,0,0
51935,all,0,0
51936,implant,0,0
51937,surfaces,0,0
51938,at,0,0
51939,baseline,0,1
51940,",",0,1
51941,and,0,1
51942,after,0,0
51943,3,0,0
51944,and,0,0
51945,6,0,0
51946,months,0,0
51947,.,0,0
51948,Bone,1,1
51949,levels,1,1
51950,were,0,0
51951,recorded,0,0
51952,on,0,0
51953,radiographs,0,1
51954,taken,0,0
51955,prior,0,0
51956,to,0,0
51957,the,0,0
51958,start,0,0
51959,of,0,0
51960,the,0,0
51961,study,0,0
51962,",",0,1
51963,and,0,1
51964,after,0,0
51965,6,0,0
51966,months,0,0
51967,.,0,0
51968,RESULTS,0,0
51969,Oral,1,1
51970,hygiene,1,1
51971,around,0,0
51972,both,0,0
51973,test,0,1
51974,and,0,1
51975,control,0,0
51976,implants,0,1
51977,was,0,0
51978,improved,0,0
51979,at,0,0
51980,3,0,0
51981,and,0,0
51982,6,0,0
51983,months,0,0
51984,compared,0,0
51985,with,0,0
51986,baseline,0,0
51987,.,0,0
51988,At,0,0
51989,6,0,0
51990,months,0,0
51991,",",0,0
51992,four,0,0
51993,of,0,0
51994,the,0,0
51995,Vector-treated,0,1
51996,sites,0,0
51997,",",0,1
51998,and,0,0
51999,only,0,0
52000,one,0,0
52001,site,0,0
52002,treated,0,0
52003,with,0,0
52004,curettes,0,0
52005,",",0,0
52006,had,0,0
52007,stopped,0,0
52008,to,0,0
52009,bleed,1,0
52010,.,1,0
52011,In,0,0
52012,neither,0,0
52013,the,0,0
52014,test,0,1
52015,nor,0,0
52016,the,0,0
52017,control,0,0
52018,group,0,0
52019,",",0,1
52020,were,0,0
52021,there,0,0
52022,any,0,0
52023,differences,0,0
52024,between,0,0
52025,baseline,0,0
52026,and,0,0
52027,6,0,0
52028,months,0,0
52029,regarding,0,0
52030,PPD,1,0
52031,and,1,1
52032,bone,1,1
52033,levels,1,1
52034,.,1,0
52035,CONCLUSION,0,0
52036,Although,0,0
52037,there,0,0
52038,was,0,0
52039,a,0,0
52040,greater,0,0
52041,reduction,0,1
52042,in,0,0
52043,the,0,0
52044,number,1,1
52045,of,1,0
52046,sites,1,0
52047,with,1,0
52048,BOP,1,0
52049,following,0,0
52050,treatment,0,0
52051,with,0,0
52052,the,0,0
52053,Vector,0,0
52054,system,0,0
52055,than,0,0
52056,following,0,0
52057,instrumentation,0,0
52058,with,0,0
52059,carbon,0,0
52060,fiber,0,0
52061,curettes,0,0
52062,",",0,0
52063,there,0,0
52064,was,0,0
52065,no,0,0
52066,significant,0,0
52067,difference,0,0
52068,between,0,0
52069,the,0,0
52070,two,0,0
52071,methods,0,0
52072,.,0,0
52073,Automatic,0,0
52074,detection,0,1
52075,of,0,1
52076,red,0,1
52077,lesions,0,1
52078,in,0,0
52079,digital,0,1
52080,color,0,1
52081,fundus,0,1
52082,photographs,0,0
52083,.,0,0
52084,The,0,0
52085,robust,0,0
52086,detection,0,1
52087,of,0,1
52088,red,1,1
52089,lesions,1,1
52090,in,0,0
52091,digital,0,1
52092,color,0,1
52093,fundus,0,1
52094,photographs,0,0
52095,is,0,0
52096,a,0,0
52097,critical,0,1
52098,step,0,0
52099,in,0,0
52100,the,0,0
52101,development,0,0
52102,of,0,0
52103,automated,0,0
52104,screening,0,0
52105,systems,0,0
52106,for,0,0
52107,diabetic,0,0
52108,retinopathy,0,1
52109,.,0,0
52110,In,0,0
52111,this,0,0
52112,paper,0,0
52113,",",0,0
52114,a,0,0
52115,novel,0,0
52116,red,0,1
52117,lesion,0,1
52118,detection,0,1
52119,method,0,0
52120,is,0,0
52121,presented,0,0
52122,based,0,0
52123,on,0,0
52124,a,0,0
52125,hybrid,0,0
52126,approach,0,0
52127,",",0,0
52128,combining,0,0
52129,prior,0,0
52130,works,0,0
52131,by,0,0
52132,Spencer,0,1
52133,et,0,0
52134,al,0,1
52135,.,0,1
52136,(,0,0
52137,1996,0,0
52138,),0,0
52139,and,0,0
52140,Frame,0,1
52141,et,0,1
52142,al,0,1
52143,.,0,0
52144,(,0,0
52145,1998,0,0
52146,),0,0
52147,with,0,0
52148,two,0,0
52149,important,0,0
52150,new,0,0
52151,contributions,0,0
52152,.,0,0
52153,The,0,0
52154,first,0,0
52155,contribution,0,0
52156,is,0,0
52157,a,0,0
52158,new,0,0
52159,red,0,1
52160,lesion,0,1
52161,candidate,0,0
52162,detection,0,1
52163,system,0,0
52164,based,0,0
52165,on,0,0
52166,pixel,0,1
52167,classification,0,1
52168,.,0,0
52169,Using,0,0
52170,this,0,0
52171,technique,0,0
52172,",",0,1
52173,vasculature,1,1
52174,and,1,1
52175,red,1,1
52176,lesions,1,1
52177,are,0,0
52178,separated,0,0
52179,from,0,0
52180,the,0,0
52181,background,0,0
52182,of,0,0
52183,the,0,0
52184,image,0,0
52185,.,0,0
52186,After,0,0
52187,removal,0,0
52188,of,0,0
52189,the,0,0
52190,connected,0,0
52191,vasculature,0,1
52192,the,0,0
52193,remaining,0,0
52194,objects,0,0
52195,are,0,0
52196,considered,0,0
52197,possible,0,0
52198,red,0,1
52199,lesions,0,1
52200,.,0,1
52201,Second,0,0
52202,",",0,0
52203,an,0,0
52204,extensive,0,0
52205,number,0,1
52206,of,0,1
52207,new,0,0
52208,features,0,0
52209,are,0,0
52210,added,0,0
52211,to,0,0
52212,those,0,0
52213,proposed,0,0
52214,by,0,0
52215,Spencer-Frame,0,0
52216,.,0,0
52217,The,0,0
52218,detected,0,0
52219,candidate,0,0
52220,objects,0,1
52221,are,0,0
52222,classified,0,0
52223,using,0,0
52224,all,0,0
52225,features,0,0
52226,and,0,0
52227,a,0,0
52228,k-nearest,0,0
52229,neighbor,0,0
52230,classifier,0,0
52231,.,0,0
52232,An,0,0
52233,extensive,0,0
52234,evaluation,0,0
52235,was,0,0
52236,performed,0,0
52237,on,0,0
52238,a,0,0
52239,test,0,1
52240,set,0,0
52241,composed,0,0
52242,of,0,0
52243,images,0,0
52244,representative,0,0
52245,of,0,0
52246,those,0,0
52247,normally,0,0
52248,found,0,0
52249,in,0,0
52250,a,0,0
52251,screening,0,0
52252,set,0,0
52253,.,0,0
52254,When,0,0
52255,determining,0,0
52256,whether,0,0
52257,an,0,0
52258,image,0,0
52259,contains,0,0
52260,red,1,1
52261,lesions,1,1
52262,the,0,0
52263,system,0,0
52264,achieves,0,0
52265,a,0,0
52266,sensitivity,1,1
52267,of,0,0
52268,100,0,0
52269,%,0,0
52270,at,0,0
52271,a,0,0
52272,specificity,0,0
52273,of,0,0
52274,87,0,0
52275,%,0,0
52276,.,0,0
52277,The,0,0
52278,method,0,0
52279,is,0,0
52280,compared,0,0
52281,with,0,0
52282,several,0,0
52283,different,0,0
52284,automatic,0,0
52285,systems,0,0
52286,and,0,0
52287,is,0,0
52288,shown,0,0
52289,to,0,0
52290,outperform,0,0
52291,them,0,0
52292,all,0,0
52293,.,0,0
52294,Performance,1,1
52295,is,0,0
52296,close,0,0
52297,to,0,0
52298,that,0,0
52299,of,0,0
52300,a,0,0
52301,human,0,0
52302,expert,0,0
52303,examining,0,0
52304,the,0,0
52305,images,0,0
52306,for,0,0
52307,the,0,0
52308,presence,0,0
52309,of,0,0
52310,red,0,1
52311,lesions,0,1
52312,.,0,0
52313,Use,0,0
52314,of,0,0
52315,an,0,0
52316,inspiratory,0,1
52317,impedance,0,1
52318,threshold,0,1
52319,device,0,0
52320,on,0,0
52321,a,0,0
52322,facemask,0,0
52323,and,0,1
52324,endotracheal,0,1
52325,tube,0,0
52326,to,0,0
52327,reduce,0,0
52328,intrathoracic,1,1
52329,pressures,1,1
52330,during,0,0
52331,the,0,0
52332,decompression,0,0
52333,phase,0,0
52334,of,0,1
52335,active,0,0
52336,compression-decompression,1,1
52337,cardiopulmonary,1,1
52338,resuscitation,1,0
52339,.,1,0
52340,INTRODUCTION,0,1
52341,Use,0,0
52342,of,0,0
52343,an,0,0
52344,inspiratory,0,1
52345,impedance,0,1
52346,threshold,0,1
52347,device,0,0
52348,(,0,1
52349,ITD,0,1
52350,),0,0
52351,significantly,0,0
52352,increases,0,0
52353,coronary,0,0
52354,perfusion,0,1
52355,pressures,0,1
52356,and,0,1
52357,survival,0,1
52358,in,0,0
52359,patients,0,0
52360,ventilated,0,0
52361,with,0,0
52362,an,0,0
52363,endotracheal,0,1
52364,tube,0,0
52365,(,0,1
52366,ETT,0,1
52367,),0,0
52368,during,0,0
52369,active,0,0
52370,compression-decompression,0,1
52371,cardiopulmonary,0,1
52372,resuscitation,0,0
52373,.,0,0
52374,We,0,0
52375,tested,0,0
52376,the,0,0
52377,hypothesis,0,0
52378,that,0,0
52379,the,0,0
52380,ITD,0,0
52381,could,0,0
52382,lower,0,1
52383,intratracheal,0,0
52384,pressures,0,1
52385,when,0,0
52386,attached,0,0
52387,to,0,0
52388,either,0,0
52389,a,0,0
52390,facemask,0,0
52391,or,0,0
52392,ETT,0,1
52393,.,0,0
52394,METHODS,0,0
52395,An,0,0
52396,active,0,0
52397,and,0,0
52398,sham,0,0
52399,ITD,0,1
52400,were,0,0
52401,randomly,0,0
52402,applied,0,0
52403,first,0,0
52404,to,0,0
52405,a,0,0
52406,facemask,0,0
52407,and,0,0
52408,then,0,0
52409,to,0,0
52410,an,0,0
52411,ETT,0,1
52412,during,0,0
52413,active,0,0
52414,compression-decompression,0,1
52415,cardiopulmonary,0,1
52416,resuscitation,0,0
52417,in,0,0
52418,13,0,0
52419,out-of-hospital,0,0
52420,cardiac,0,1
52421,arrest,0,1
52422,patients,0,0
52423,in,0,0
52424,a,0,0
52425,randomized,0,0
52426,",",0,0
52427,double-blinded,0,0
52428,",",0,1
52429,prospective,0,0
52430,clinical,0,0
52431,trial,0,0
52432,.,0,0
52433,The,0,0
52434,compression-to-bag-valve,0,1
52435,ventilation,0,1
52436,ratio,0,1
52437,was,0,0
52438,15:2,0,0
52439,.,0,0
52440,Airway,0,0
52441,pressures,0,1
52442,(,0,0
52443,surrogate,0,0
52444,for,0,0
52445,intrathoracic,0,1
52446,pressure,0,1
52447,),0,1
52448,were,0,0
52449,measured,0,0
52450,with,0,0
52451,a,0,0
52452,pressure,0,1
52453,transducer,0,1
52454,.,0,0
52455,A,0,0
52456,sham,0,0
52457,and,0,0
52458,an,0,0
52459,active,0,0
52460,ITD,0,1
52461,were,0,0
52462,used,0,0
52463,for,0,0
52464,1,0,0
52465,min,0,0
52466,each,0,0
52467,in,0,0
52468,a,0,0
52469,randomized,0,0
52470,order,0,0
52471,",",0,0
52472,first,0,0
52473,on,0,0
52474,a,0,0
52475,facemask,0,0
52476,and,0,0
52477,then,0,0
52478,on,0,0
52479,an,0,0
52480,ETT,0,1
52481,.,0,0
52482,Statistical,0,0
52483,analyses,0,0
52484,were,0,0
52485,made,0,0
52486,using,0,0
52487,Friedman,0,1
52488,'s,0,1
52489,and,0,1
52490,Wilcoxon,0,1
52491,'s,0,1
52492,rank-sum,0,0
52493,tests,0,1
52494,.,0,0
52495,RESULTS,0,0
52496,For,0,0
52497,the,0,0
52498,primary,0,0
52499,end,0,0
52500,point,0,0
52501,",",0,1
52502,mean,1,1
52503,+/-,1,0
52504,sd,1,0
52505,maximum,1,1
52506,negative,1,1
52507,intrathoracic,1,1
52508,pressures,1,1
52509,(,0,0
52510,mm,0,0
52511,Hg,0,0
52512,),0,0
52513,during,0,0
52514,the,0,0
52515,decompression,1,0
52516,phase,1,0
52517,of,1,1
52518,cardiopulmonary,1,1
52519,resuscitation,1,0
52520,were,0,0
52521,-1.0,0,0
52522,+/-,0,0
52523,0.73,0,0
52524,mm,0,0
52525,Hg,0,0
52526,with,0,0
52527,a,0,0
52528,sham,0,0
52529,vs.,0,0
52530,-4.6,0,0
52531,+/-,0,0
52532,3.7,0,0
52533,mm,0,0
52534,Hg,0,0
52535,with,0,0
52536,an,0,0
52537,active,0,0
52538,ITD,0,1
52539,on,0,0
52540,the,0,0
52541,facemask,0,0
52542,(,0,0
52543,p,0,0
52544,=,0,0
52545,.003,0,0
52546,),0,1
52547,and,0,1
52548,-1.3,0,0
52549,+/-,0,0
52550,1.3,0,0
52551,mm,0,0
52552,Hg,0,0
52553,with,0,0
52554,a,0,0
52555,sham,0,0
52556,ITD,0,1
52557,vs.,0,0
52558,-7.3,0,0
52559,+/-,0,0
52560,4.5,0,0
52561,mm,0,0
52562,Hg,0,0
52563,with,0,0
52564,an,0,0
52565,active,0,0
52566,ITD,0,1
52567,on,0,0
52568,an,0,0
52569,ETT,0,1
52570,(,0,0
52571,p,0,0
52572,=,0,0
52573,.0009,0,0
52574,),0,0
52575,.,0,0
52576,Decompression,1,0
52577,phase,1,0
52578,airway,1,1
52579,pressures,1,1
52580,with,0,0
52581,the,0,0
52582,facemask,0,0
52583,and,0,1
52584,ETT,0,1
52585,were,0,0
52586,not,0,0
52587,statistically,0,0
52588,different,0,0
52589,.,0,0
52590,CONCLUSIONS,0,0
52591,Use,0,0
52592,of,0,0
52593,an,0,0
52594,active,0,0
52595,ITD,0,1
52596,attached,0,0
52597,to,0,0
52598,a,0,0
52599,facemask,0,0
52600,or,0,0
52601,an,0,0
52602,ETT,0,1
52603,resulted,0,0
52604,in,0,0
52605,a,0,0
52606,significantly,0,0
52607,lower,0,0
52608,negative,1,1
52609,intratracheal,1,1
52610,pressure,1,1
52611,during,0,0
52612,the,0,0
52613,decompression,0,0
52614,phase,0,0
52615,of,0,1
52616,active,0,0
52617,compression-decompression,0,1
52618,cardiopulmonary,0,1
52619,resuscitation,0,0
52620,when,0,0
52621,compared,0,0
52622,with,0,0
52623,controls,0,0
52624,.,0,0
52625,Airway,0,0
52626,pressures,0,1
52627,with,0,0
52628,an,0,0
52629,ITD,0,1
52630,on,0,0
52631,either,0,0
52632,a,0,0
52633,facemask,0,0
52634,or,0,1
52635,ETT,0,1
52636,were,0,0
52637,similar,0,0
52638,.,0,0
52639,The,0,0
52640,ITD-facemask,0,0
52641,combination,0,0
52642,was,0,0
52643,practical,0,0
52644,and,0,0
52645,enables,0,0
52646,rapid,0,1
52647,deployment,0,0
52648,of,0,0
52649,this,0,0
52650,life-saving,0,0
52651,technology,0,0
52652,.,0,0
52653,Uterine,0,1
52654,incision,0,0
52655,closure,0,1
52656,at,0,0
52657,caesarean,0,1
52658,section,0,0
52659,:,0,0
52660,a,0,0
52661,randomised,0,0
52662,comparative,0,0
52663,study,0,0
52664,of,0,1
52665,intraperitoneal,0,0
52666,closure,0,1
52667,and,0,1
52668,closure,0,1
52669,after,0,0
52670,temporary,0,1
52671,exteriorisation,0,0
52672,.,0,0
52673,BACKGROUND,0,0
52674,The,0,0
52675,safety,0,1
52676,of,0,0
52677,the,0,0
52678,technique,0,0
52679,of,0,0
52680,uterine,0,1
52681,exteriorization,0,1
52682,at,0,0
52683,caesarean,0,1
52684,section,0,1
52685,though,0,0
52686,popular,0,0
52687,among,0,0
52688,obstetricians,0,0
52689,",",0,0
52690,remains,0,0
52691,controversial,0,0
52692,.,0,0
52693,OBJECTIVE,0,0
52694,To,0,0
52695,evaluate,0,0
52696,the,0,0
52697,influence,0,0
52698,of,0,0
52699,exteriorization,0,1
52700,of,0,1
52701,uterus,0,1
52702,during,0,0
52703,uterine,0,1
52704,repair,0,0
52705,on,0,0
52706,caesarean,0,1
52707,morbidity,0,1
52708,.,0,0
52709,METHODS,0,0
52710,A,0,0
52711,randomized,0,0
52712,comparative,0,0
52713,study,0,0
52714,of,0,0
52715,136,0,0
52716,women,0,0
52717,undergoing,0,0
52718,primary,0,0
52719,caesarean,0,1
52720,delivery,0,1
52721,at,0,0
52722,Havana,0,0
52723,Specialist,0,0
52724,Hospital,0,1
52725,Lagos,0,0
52726,Nigeria,0,0
52727,.,0,0
52728,Data,0,0
52729,on,0,0
52730,operation,0,0
52731,time,0,1
52732,",",0,1
52733,estimated,0,0
52734,blood,0,1
52735,loss,0,1
52736,",",0,1
52737,postoperative,0,1
52738,morbidities,0,1
52739,were,0,0
52740,collected,0,0
52741,and,0,0
52742,analysed,0,0
52743,with,0,0
52744,comparison,0,0
52745,between,0,0
52746,the,0,0
52747,two,0,0
52748,groups,0,0
52749,using,0,0
52750,chi,0,0
52751,square,0,0
52752,",",0,1
52753,Fischer,0,1
52754,'s,0,1
52755,exact,0,1
52756,test,0,1
52757,and,0,1
52758,t-test,0,0
52759,as,0,0
52760,appropriate,0,0
52761,.,0,0
52762,RESULTS,0,0
52763,The,0,0
52764,mean,1,1
52765,operative,1,1
52766,time,1,1
52767,",",1,1
52768,estimated,1,0
52769,blood,1,1
52770,loss,1,1
52771,",",1,1
52772,transfusion,1,1
52773,rate,1,1
52774,and,1,1
52775,postoperative,1,1
52776,anemia,1,1
52777,rate,1,1
52778,were,0,0
52779,significantly,0,0
52780,less,0,0
52781,in,0,0
52782,the,0,0
52783,exteriorized,0,0
52784,group,0,0
52785,than,0,0
52786,the,0,0
52787,intraperitoneal,0,0
52788,group,0,0
52789,(,0,0
52790,p,0,0
52791,=,0,0
52792,0.000,0,0
52793,",",0,0
52794,"0.009,0.048",0,0
52795,0.038,0,0
52796,and,0,0
52797,0.028,0,0
52798,respectively,0,0
52799,),0,0
52800,",",0,0
52801,but,0,0
52802,not,0,0
52803,in,0,0
52804,other,0,0
52805,outcome,0,1
52806,measures,0,0
52807,.,0,0
52808,CONCLUSION,0,0
52809,With,0,0
52810,shorter,0,1
52811,operative,0,1
52812,time,0,1
52813,",",0,1
52814,less,0,0
52815,blood,0,1
52816,loss,0,1
52817,and,0,1
52818,similar,0,0
52819,morbidity,0,1
52820,profile,0,1
52821,exteriorization,0,1
52822,of,0,1
52823,uterus,0,1
52824,during,0,0
52825,caesarean,0,1
52826,section,0,0
52827,seems,0,0
52828,to,0,0
52829,be,0,0
52830,preferred,0,0
52831,except,0,0
52832,where,0,0
52833,it,0,0
52834,is,0,0
52835,not,0,0
52836,possible,0,0
52837,because,0,0
52838,of,0,0
52839,adhesions,0,1
52840,and,0,1
52841,surgeons,0,0
52842,inexperience,0,1
52843,.,0,0
52844,[,0,0
52845,Final,0,1
52846,evaluation,0,0
52847,of,0,0
52848,the,0,0
52849,randomized,0,0
52850,multicenter,0,0
52851,study,0,0
52852,SAKK,0,0
52853,40/81,0,0
52854,:,0,0
52855,adjuvant,0,0
52856,portal,0,1
52857,chemotherapy,0,0
52858,of,0,0
52859,curatively,0,0
52860,resected,0,0
52861,colorectal,0,0
52862,cancer,0,0
52863,],0,0
52864,.,0,0
52865,Between,0,0
52866,1981,0,0
52867,and,0,0
52868,1987,0,0
52869,",",0,0
52870,533,0,0
52871,patients,0,0
52872,from,0,0
52873,9,0,0
52874,institutions,0,0
52875,have,0,0
52876,been,0,0
52877,entered,0,0
52878,in,0,0
52879,a,0,0
52880,randomized,0,0
52881,trial,0,0
52882,to,0,0
52883,assess,0,0
52884,the,0,0
52885,value,0,1
52886,of,0,0
52887,adjuvant,0,0
52888,portal,0,1
52889,infusion,0,0
52890,(,0,1
52891,5-Fluorouracil,0,0
52892,",",0,1
52893,Mitomycin,0,0
52894,C,0,0
52895,),0,0
52896,compared,0,0
52897,to,0,0
52898,radical,0,0
52899,surgery,0,0
52900,alone,0,0
52901,.,0,0
52902,Analysis,0,0
52903,of,0,0
52904,469,0,0
52905,evaluable,0,0
52906,patients,0,0
52907,at,0,0
52908,a,0,0
52909,median,0,1
52910,follow-up,0,0
52911,of,0,0
52912,5.8,0,0
52913,years,0,0
52914,revealed,0,0
52915,110,0,0
52916,recurrences,0,0
52917,in,0,0
52918,the,0,0
52919,control,0,0
52920,and,0,0
52921,94,0,0
52922,recurrences,0,1
52923,in,0,0
52924,the,0,0
52925,infusion,0,0
52926,group,0,0
52927,.,0,0
52928,Estimated,0,0
52929,5-year,1,0
52930,disease-free,1,1
52931,survival,1,1
52932,was,0,0
52933,52,0,0
52934,%,0,0
52935,and,0,0
52936,61,0,0
52937,%,0,0
52938,respectively,0,0
52939,(,0,0
52940,hazard,0,1
52941,ratio,0,0
52942,1:0.75,0,0
52943,;,0,0
52944,95,0,0
52945,%,0,0
52946,confidence,0,0
52947,interval,0,0
52948,0.57-0.99,0,0
52949,;,0,0
52950,p,0,0
52951,=,0,0
52952,0.046,0,0
52953,),0,0
52954,.,0,0
52955,Overall,1,1
52956,survival,1,1
52957,was,0,0
52958,59,0,0
52959,%,0,0
52960,in,0,0
52961,the,0,0
52962,control,0,0
52963,and,0,0
52964,69,0,0
52965,in,0,0
52966,the,0,0
52967,infusion,0,0
52968,group,0,0
52969,(,0,0
52970,p,0,0
52971,=,0,0
52972,0.048,0,0
52973,),0,0
52974,.,0,0
52975,Adjuvant,0,0
52976,portal,0,1
52977,infusion,0,0
52978,did,0,0
52979,not,0,0
52980,influence,0,0
52981,the,0,0
52982,occurrence,1,1
52983,of,1,0
52984,liver,1,1
52985,metastases,1,1
52986,but,0,0
52987,reduced,0,0
52988,the,0,0
52989,overall,1,1
52990,recurrence,1,1
52991,rate,1,1
52992,.,1,0
52993,Anti-Xa,0,0
52994,effect,1,0
52995,of,0,0
52996,a,0,0
52997,low,0,0
52998,molecular,0,1
52999,weight,0,1
53000,heparin,0,0
53001,(,0,1
53002,dalteparin,0,0
53003,),0,0
53004,does,0,0
53005,not,0,0
53006,accumulate,0,0
53007,in,0,0
53008,extended,0,0
53009,duration,0,1
53010,therapy,0,0
53011,for,0,0
53012,venous,0,1
53013,thromboembolism,0,1
53014,in,0,0
53015,cancer,0,0
53016,patients,0,0
53017,.,0,0
53018,Many,0,0
53019,patients,0,0
53020,with,0,0
53021,venous,0,1
53022,thromboembolism,0,1
53023,are,0,0
53024,being,0,0
53025,treated,0,0
53026,with,0,0
53027,low,0,0
53028,molecular,0,1
53029,weight,0,1
53030,heparin,0,0
53031,for,0,0
53032,extended,0,0
53033,periods,0,0
53034,of,0,0
53035,time,0,1
53036,.,0,0
53037,It,0,0
53038,is,0,0
53039,not,0,0
53040,certain,0,0
53041,if,0,0
53042,it,0,0
53043,is,0,0
53044,necessary,0,0
53045,to,0,0
53046,assess,0,0
53047,anti-Xa,1,1
53048,levels,1,1
53049,for,0,0
53050,extended,0,0
53051,treatment,0,0
53052,periods,0,0
53053,.,0,0
53054,This,0,0
53055,study,0,0
53056,is,0,0
53057,a,0,0
53058,prospective,0,0
53059,assessment,0,0
53060,of,0,1
53061,anti-Xa,1,1
53062,levels,1,1
53063,in,0,0
53064,patients,0,0
53065,on,0,0
53066,long-term,0,1
53067,therapy,0,0
53068,for,0,0
53069,acute,0,0
53070,venous,0,1
53071,thromboembolism,0,0
53072,who,0,0
53073,have,0,0
53074,active,0,0
53075,cancer,0,0
53076,.,0,0
53077,Consecutive,0,0
53078,consenting,0,0
53079,patients,0,0
53080,from,0,0
53081,one,0,0
53082,center,0,0
53083,in,0,0
53084,a,0,0
53085,multicenter,0,0
53086,trial,0,0
53087,that,0,0
53088,compared,0,0
53089,6,0,0
53090,months,0,0
53091,of,0,0
53092,low,0,0
53093,molecular,0,1
53094,weight,0,1
53095,heparin,0,0
53096,with,0,0
53097,oral,0,0
53098,anticoagulant,0,1
53099,therapy,0,0
53100,were,0,0
53101,treated,0,0
53102,with,0,0
53103,therapeutic,0,0
53104,doses,0,0
53105,of,0,1
53106,dalteparin,0,0
53107,(,0,0
53108,200,0,0
53109,IU,0,0
53110,per,0,0
53111,kilogram,0,0
53112,),0,0
53113,subcutaneously,0,0
53114,daily,0,0
53115,.,0,0
53116,Anti-Xa,1,0
53117,levels,1,1
53118,were,0,0
53119,assessed,0,0
53120,at,0,0
53121,the,0,0
53122,end,0,0
53123,of,0,0
53124,weeks,0,0
53125,1,0,0
53126,and,0,0
53127,"4,4-6",0,0
53128,hours,0,1
53129,after,0,0
53130,injection,0,0
53131,of,0,0
53132,dalteparin,0,0
53133,.,0,1
53134,Patients,0,0
53135,were,0,0
53136,followed,0,0
53137,for,0,0
53138,bleeding,1,1
53139,and,1,1
53140,recurrent,1,1
53141,venous,1,1
53142,thromboembolism,1,1
53143,.,1,0
53144,There,0,0
53145,were,0,0
53146,24,0,0
53147,patients,0,0
53148,who,0,0
53149,had,0,0
53150,anti-Xa,1,1
53151,levels,1,1
53152,measured,0,0
53153,at,0,0
53154,weeks,0,0
53155,1,0,0
53156,and,0,0
53157,4,0,0
53158,.,0,0
53159,Two,0,0
53160,other,0,0
53161,patients,0,0
53162,had,0,0
53163,week,0,0
53164,1,0,0
53165,measurements,0,0
53166,performed,0,0
53167,but,0,0
53168,died,1,0
53169,before,0,0
53170,the,0,0
53171,week,0,0
53172,4,0,0
53173,sample,0,0
53174,was,0,0
53175,collected,0,0
53176,due,0,0
53177,to,0,0
53178,their,0,0
53179,underlying,0,0
53180,cancer,0,0
53181,.,0,0
53182,The,0,0
53183,mean,1,1
53184,anti-Xa,1,1
53185,levels,1,1
53186,at,0,0
53187,weeks,0,0
53188,1,0,0
53189,and,0,0
53190,4,0,0
53191,were,0,0
53192,1.11,0,0
53193,and,0,0
53194,1.03,0,0
53195,anti-Xa,0,1
53196,units/ml,0,0
53197,respectively,0,0
53198,(,0,0
53199,P=0.13,0,0
53200,),0,0
53201,.,0,0
53202,These,0,0
53203,results,0,0
53204,suggest,0,0
53205,that,0,0
53206,for,0,0
53207,patients,0,0
53208,with,0,0
53209,active,0,0
53210,cancer,0,0
53211,receiving,0,0
53212,extended,0,0
53213,duration,0,1
53214,therapy,0,0
53215,with,0,0
53216,low,0,0
53217,molecular,0,1
53218,weight,0,1
53219,heparin,0,0
53220,(,0,1
53221,dalteparin,0,0
53222,),0,0
53223,there,0,0
53224,is,0,0
53225,no,0,0
53226,accumulation,1,1
53227,of,1,0
53228,anti-Xa,1,1
53229,effect,1,0
53230,over,0,0
53231,the,0,0
53232,first,0,0
53233,month,0,0
53234,of,0,0
53235,therapy,0,0
53236,.,0,0
53237,Monitoring,0,0
53238,of,0,0
53239,anti-Xa,1,1
53240,levels,1,1
53241,in,0,0
53242,this,0,0
53243,situation,0,0
53244,is,0,0
53245,usually,0,0
53246,not,0,0
53247,required,0,0
53248,.,0,0
53249,D-dimer,0,0
53250,predicts,0,0
53251,outcome,0,1
53252,after,0,0
53253,aneurysmal,0,1
53254,subarachnoid,0,0
53255,hemorrhage,0,0
53256,:,0,0
53257,no,0,0
53258,effect,0,0
53259,of,0,0
53260,thromboprophylaxis,0,1
53261,on,0,0
53262,coagulation,1,1
53263,activity,1,1
53264,.,1,1
53265,OBJECTIVE,0,0
53266,Approximately,0,0
53267,one-third,0,0
53268,of,0,0
53269,all,0,0
53270,patients,0,0
53271,with,0,0
53272,acute,0,0
53273,nontraumatic,0,0
53274,subarachnoid,0,1
53275,hemorrhage,0,1
53276,(,0,1
53277,SAH,0,0
53278,),0,1
53279,experience,0,1
53280,complications,0,1
53281,owing,0,0
53282,to,0,0
53283,delayed,0,1
53284,ischemic,0,1
53285,deficit,0,0
53286,.,0,0
53287,We,0,0
53288,reported,0,0
53289,recently,0,0
53290,that,0,0
53291,enoxaparin,0,0
53292,40,0,0
53293,mg,0,0
53294,once,0,0
53295,daily,0,0
53296,for,0,0
53297,10,0,0
53298,days,0,0
53299,seems,0,0
53300,safe,0,0
53301,and,0,0
53302,demonstrates,0,0
53303,thromboprophylactic,1,0
53304,efficacy,1,1
53305,",",0,0
53306,but,0,0
53307,it,0,0
53308,failed,0,0
53309,to,0,0
53310,improve,0,0
53311,outcome,0,1
53312,in,0,0
53313,a,0,0
53314,randomized,0,0
53315,SAH,0,0
53316,trial,0,0
53317,.,0,0
53318,In,0,0
53319,the,0,0
53320,present,0,0
53321,study,0,0
53322,",",0,0
53323,we,0,0
53324,assessed,0,0
53325,hemostatic,1,0
53326,variables,1,1
53327,associated,0,0
53328,with,0,0
53329,clinical,0,0
53330,status,0,1
53331,and,0,1
53332,outcome,0,1
53333,of,0,1
53334,SAH,0,0
53335,.,0,0
53336,We,0,0
53337,also,0,0
53338,monitored,0,0
53339,the,0,0
53340,effect,0,1
53341,of,0,0
53342,enoxaparin,0,0
53343,on,0,0
53344,activation,1,1
53345,of,1,1
53346,coagulation,1,1
53347,and,1,1
53348,fibrinolysis,1,1
53349,after,0,0
53350,closure,0,1
53351,of,0,0
53352,the,0,0
53353,ruptured,0,0
53354,aneurysm,0,1
53355,.,0,0
53356,METHODS,0,0
53357,Blood,1,1
53358,samples,1,0
53359,to,0,0
53360,measure,0,0
53361,activation,1,1
53362,of,1,1
53363,coagulation,1,1
53364,and,1,1
53365,fibrinolysis,1,1
53366,were,0,0
53367,collected,0,0
53368,from,0,0
53369,42,0,0
53370,patients,0,0
53371,participating,0,0
53372,in,0,0
53373,the,0,0
53374,enoxaparin,0,0
53375,trial,0,0
53376,for,0,0
53377,acute,0,0
53378,aneurysmal,0,1
53379,SAH,0,0
53380,at,0,0
53381,four,0,0
53382,time,0,0
53383,points,0,0
53384,:,0,0
53385,1,0,0
53386,),0,0
53387,at,0,0
53388,hospital,0,1
53389,admission,0,0
53390,;,0,0
53391,2,0,0
53392,),0,0
53393,12,0,0
53394,to,0,0
53395,24,0,0
53396,hours,0,0
53397,after,0,0
53398,aneurysm,0,1
53399,surgery,0,0
53400,but,0,0
53401,before,0,0
53402,initiation,0,0
53403,of,0,1
53404,enoxaparin,0,0
53405,therapy,0,0
53406,;,0,0
53407,3,0,0
53408,),0,0
53409,3,0,0
53410,hours,0,0
53411,after,0,0
53412,the,0,0
53413,first,0,0
53414,dose,0,0
53415,;,0,0
53416,and,0,0
53417,4,0,0
53418,),0,0
53419,at,0,0
53420,the,0,0
53421,conclusion,0,0
53422,of,0,0
53423,treatment,0,0
53424,.,0,0
53425,RESULTS,0,0
53426,At,0,0
53427,admission,0,1
53428,",",0,0
53429,several,0,0
53430,variables,1,1
53431,of,1,1
53432,coagulation,1,1
53433,and,1,1
53434,fibrinolysis,1,1
53435,were,0,0
53436,elevated,0,1
53437,and,0,0
53438,correlated,0,0
53439,well,0,0
53440,with,0,0
53441,clinical,0,0
53442,status,0,1
53443,.,0,0
53444,Specifically,0,0
53445,",",0,0
53446,D-dimer,1,1
53447,levels,1,1
53448,at,0,0
53449,all,0,0
53450,four,0,0
53451,time,0,1
53452,points,0,0
53453,correlated,0,0
53454,with,0,0
53455,patients,0,0
53456,',0,1
53457,long-term,0,0
53458,outcomes,0,1
53459,.,0,0
53460,A,0,0
53461,single,0,0
53462,dose,0,0
53463,of,0,1
53464,enoxaparin,0,0
53465,suppressed,0,1
53466,early,1,0
53467,coagulation,1,1
53468,activity,1,1
53469,",",0,1
53470,but,0,0
53471,thrombin,1,1
53472,generation,1,1
53473,was,0,0
53474,not,1,0
53475,inhibited,1,0
53476,during,0,0
53477,thromboprophylaxis,0,0
53478,.,0,0
53479,However,0,0
53480,",",0,0
53481,PAI-1,1,1
53482,activity,1,1
53483,was,0,0
53484,suppressed,0,1
53485,.,0,0
53486,CONCLUSION,0,0
53487,D-dimer,0,0
53488,offers,0,0
53489,a,0,0
53490,useful,0,0
53491,laboratory,0,0
53492,tool,0,0
53493,for,0,0
53494,assessing,0,0
53495,early,0,0
53496,and,0,1
53497,late,0,1
53498,clinical,0,1
53499,severity,1,1
53500,of,1,0
53501,SAH,1,0
53502,.,1,0
53503,A,0,0
53504,thromboprophylactic,0,0
53505,dose,0,0
53506,of,0,1
53507,enoxaparin,0,0
53508,inhibited,0,0
53509,PAI-1,1,1
53510,activity,1,1
53511,but,0,0
53512,failed,0,0
53513,to,0,0
53514,down-regulate,0,1
53515,coagulation,1,1
53516,activity,1,1
53517,and,1,1
53518,D-dimer,1,1
53519,.,1,0
53520,These,0,0
53521,findings,0,0
53522,are,0,0
53523,compatible,0,0
53524,with,0,0
53525,the,0,0
53526,lack,0,0
53527,of,0,0
53528,efficacy,0,1
53529,of,0,1
53530,enoxaparin,0,0
53531,in,0,0
53532,reducing,0,0
53533,ischemic,0,1
53534,deficit,0,1
53535,after,0,0
53536,SAH,0,0
53537,.,0,0
53538,The,0,0
53539,assessment,0,0
53540,of,0,1
53541,erythema,1,1
53542,and,1,1
53543,thickness,1,1
53544,on,1,0
53545,burn,1,1
53546,related,1,0
53547,scars,1,1
53548,during,0,0
53549,pressure,0,1
53550,garment,0,0
53551,therapy,0,0
53552,as,0,0
53553,a,0,0
53554,preventive,0,0
53555,measure,0,0
53556,for,0,0
53557,hypertrophic,0,0
53558,scarring,0,1
53559,.,0,0
53560,The,0,0
53561,aim,0,0
53562,of,0,0
53563,this,0,0
53564,study,0,0
53565,was,0,0
53566,threefold,0,0
53567,:,0,0
53568,(,0,0
53569,1,0,0
53570,),0,0
53571,Assess,0,0
53572,the,0,0
53573,pressure,0,1
53574,loss,0,1
53575,of,0,0
53576,two,0,0
53577,types,0,0
53578,of,0,0
53579,pressure,0,1
53580,garments,0,0
53581,that,0,0
53582,are,0,0
53583,used,0,0
53584,in,0,0
53585,the,0,0
53586,treatment,0,0
53587,of,0,0
53588,hypertrophic,0,1
53589,scars,0,1
53590,after,0,0
53591,burn,0,1
53592,injury,0,1
53593,",",0,0
53594,(,0,0
53595,2,0,0
53596,),0,0
53597,investigate,0,0
53598,the,0,0
53599,influence,0,0
53600,of,0,0
53601,two,0,0
53602,different,0,0
53603,levels,0,1
53604,of,0,0
53605,compression,0,0
53606,on,0,0
53607,erythema,1,1
53608,and,1,1
53609,thickness,1,1
53610,of,1,1
53611,burn,1,1
53612,scars,1,1
53613,and,0,1
53614,(,0,0
53615,3,0,0
53616,),0,0
53617,examine,0,0
53618,the,0,0
53619,association,0,0
53620,between,0,0
53621,erythema,1,1
53622,and,1,1
53623,thickness,1,1
53624,.,1,0
53625,The,0,0
53626,study,0,0
53627,was,0,0
53628,a,0,0
53629,prospective,0,0
53630,trial,0,0
53631,in,0,0
53632,which,0,0
53633,76,0,0
53634,burn,0,0
53635,scars,0,1
53636,in,0,0
53637,60,0,0
53638,patients,0,0
53639,were,0,0
53640,objectively,0,1
53641,assessed,0,0
53642,with,0,0
53643,the,0,0
53644,Minolta,1,0
53645,Chromameter,1,1
53646,CR-300,1,1
53647,for,0,0
53648,erythema,0,1
53649,and,0,0
53650,with,0,0
53651,the,0,0
53652,Dermascan,1,0
53653,C,1,0
53654,for,1,0
53655,thickness,1,1
53656,of,1,0
53657,the,1,0
53658,scar,1,0
53659,over,0,0
53660,a,0,0
53661,period,0,0
53662,of,0,0
53663,3,0,0
53664,months,0,0
53665,.,0,0
53666,Each,0,0
53667,patient,0,1
53668,was,0,0
53669,randomly,0,0
53670,assigned,0,0
53671,to,0,0
53672,a,0,0
53673,normal,0,0
53674,or,0,0
53675,lower,0,1
53676,compression,0,1
53677,class,0,1
53678,treatment,0,0
53679,",",0,0
53680,with,0,0
53681,respectively,0,0
53682,mean,0,1
53683,values,0,1
53684,of,0,0
53685,15,0,0
53686,and,0,0
53687,10,0,0
53688,mmHg,0,0
53689,pressure,0,1
53690,after,0,0
53691,wearing,0,0
53692,the,0,0
53693,garment,0,0
53694,for,0,0
53695,1,0,0
53696,month,0,0
53697,.,0,0
53698,Measurements,0,0
53699,for,0,0
53700,both,0,0
53701,parameters,0,1
53702,were,0,0
53703,taken,0,0
53704,at,0,0
53705,0,0,0
53706,",",0,0
53707,1,0,0
53708,",",0,0
53709,2,0,0
53710,and,0,0
53711,3,0,0
53712,months,0,0
53713,of,0,0
53714,treatment,0,0
53715,.,0,0
53716,Pressure,0,1
53717,garments,0,0
53718,with,0,0
53719,normal,0,0
53720,compression,0,0
53721,did,0,0
53722,lose,0,0
53723,significantly,0,0
53724,more,0,0
53725,compression,1,0
53726,over,0,0
53727,1,0,0
53728,month,0,0
53729,(,0,0
53730,4.82,0,0
53731,mmHg,0,0
53732,),0,0
53733,than,0,0
53734,did,0,0
53735,the,0,0
53736,garments,0,0
53737,from,0,0
53738,the,0,0
53739,low,0,0
53740,compression,0,1
53741,class,0,0
53742,(,0,0
53743,2.57,0,0
53744,mmHg,0,0
53745,),0,0
53746,.,0,0
53747,Scars,1,1
53748,that,0,0
53749,were,0,0
53750,treated,0,0
53751,with,0,0
53752,garments,0,0
53753,from,0,0
53754,a,0,0
53755,normal,0,0
53756,compression,0,0
53757,class,0,0
53758,did,0,0
53759,score,0,1
53760,significantly,0,0
53761,better,0,0
53762,for,0,0
53763,thickness,1,1
53764,compared,0,0
53765,to,0,0
53766,the,0,0
53767,low,0,0
53768,compression,0,0
53769,class,0,0
53770,.,0,0
53771,The,0,0
53772,difference,0,0
53773,in,0,0
53774,thickness,1,1
53775,was,0,0
53776,most,0,0
53777,evident,0,0
53778,at,0,0
53779,1,0,0
53780,month,0,0
53781,.,0,0
53782,Thereafter,0,0
53783,no,0,0
53784,further,0,0
53785,significant,0,0
53786,improvement,0,1
53787,between,0,0
53788,the,0,0
53789,two,0,0
53790,different,0,0
53791,treatments,0,0
53792,over,0,0
53793,time,0,1
53794,could,0,0
53795,be,0,0
53796,obtained,0,0
53797,.,0,0
53798,This,0,0
53799,difference,0,0
53800,was,0,0
53801,not,0,0
53802,found,0,0
53803,for,0,0
53804,erythema,1,1
53805,.,1,0
53806,Positive,0,1
53807,correlations,0,0
53808,could,0,0
53809,be,0,0
53810,found,0,0
53811,between,0,0
53812,erythema,1,1
53813,and,1,1
53814,thickness,1,1
53815,values,1,1
53816,at,0,0
53817,all,0,0
53818,of,0,0
53819,the,0,0
53820,three,0,0
53821,test,0,0
53822,points,0,0
53823,while,0,0
53824,changes,0,1
53825,in,0,0
53826,erythema,1,1
53827,and,1,1
53828,thickness,1,1
53829,only,0,0
53830,correlated,0,0
53831,significantly,0,0
53832,after,0,0
53833,the,0,0
53834,first,0,0
53835,month,0,0
53836,.,0,0
53837,The,0,0
53838,pattern,0,0
53839,of,0,0
53840,change,0,1
53841,of,0,0
53842,both,0,0
53843,parameters,0,1
53844,correlated,0,0
53845,at,0,0
53846,a,0,0
53847,high,0,0
53848,level,0,1
53849,of,0,1
53850,significance,0,1
53851,after,0,0
53852,3,0,0
53853,months,0,0
53854,of,0,0
53855,treatment,0,0
53856,.,0,0
53857,These,0,0
53858,data,0,0
53859,suggest,0,0
53860,that,0,0
53861,pressure,0,1
53862,garments,0,0
53863,that,0,0
53864,deliver,0,0
53865,a,0,0
53866,pressure,0,1
53867,of,0,0
53868,at,0,0
53869,least,0,0
53870,15,0,0
53871,mmHg,0,0
53872,pressure,0,0
53873,tend,0,0
53874,to,0,0
53875,accelerate,0,0
53876,scar,1,1
53877,maturation,1,1
53878,and,0,1
53879,that,0,0
53880,measurements,0,1
53881,of,0,0
53882,the,0,0
53883,pattern,0,0
53884,of,0,0
53885,change,0,1
53886,of,0,0
53887,the,0,0
53888,erythema,0,1
53889,can,0,0
53890,be,0,0
53891,used,0,0
53892,to,0,0
53893,predict,0,0
53894,changes,0,1
53895,in,0,0
53896,scar,0,1
53897,thickness,0,1
53898,and,0,1
53899,vice,0,0
53900,versa,0,0
53901,.,0,0
53902,Prospective,0,0
53903,",",0,0
53904,randomized,0,0
53905,comparison,0,0
53906,of,0,1
53907,transperitoneal,0,0
53908,versus,0,0
53909,retroperitoneal,0,1
53910,laparoscopic,0,0
53911,adrenalectomy,0,0
53912,.,0,0
53913,PURPOSE,0,0
53914,We,0,0
53915,report,0,0
53916,a,0,0
53917,prospective,0,0
53918,",",0,0
53919,randomized,0,0
53920,comparison,0,0
53921,of,0,1
53922,transperitoneal,0,0
53923,laparoscopic,0,0
53924,adrenalectomy,0,0
53925,(,0,1
53926,TLA,0,0
53927,),0,0
53928,vs,0,0
53929,retroperitoneal,0,1
53930,laparoscopic,0,0
53931,adrenalectomy,0,0
53932,(,0,1
53933,RLA,0,0
53934,),0,0
53935,for,0,0
53936,adrenal,0,1
53937,lesions,0,1
53938,with,0,0
53939,long-term,0,0
53940,followup,0,1
53941,.,0,1
53942,MATERIALS,0,0
53943,AND,0,0
53944,METHODS,0,0
53945,Between,0,0
53946,December,0,0
53947,1997,0,0
53948,and,0,0
53949,November,0,0
53950,1999,0,0
53951,",",0,0
53952,57,0,0
53953,consecutive,0,0
53954,eligible,0,0
53955,patients,0,0
53956,with,0,0
53957,surgical,0,0
53958,adrenal,0,1
53959,disease,0,1
53960,were,0,0
53961,prospectively,0,0
53962,randomized,0,0
53963,to,0,0
53964,undergo,0,0
53965,TLA,0,0
53966,(,0,0
53967,25,0,0
53968,),0,0
53969,or,0,0
53970,RLA,0,0
53971,(,0,0
53972,32,0,0
53973,),0,0
53974,.,0,0
53975,Study,0,0
53976,exclusion,0,0
53977,criteria,0,0
53978,were,0,0
53979,patient,0,1
53980,age,0,0
53981,greater,0,0
53982,than,0,0
53983,80,0,0
53984,years,0,0
53985,",",0,0
53986,body,0,1
53987,mass,0,1
53988,index,0,1
53989,greater,0,0
53990,than,0,0
53991,40,0,0
53992,",",0,0
53993,bilateral,0,0
53994,adrenalectomy,0,0
53995,and,0,1
53996,significant,0,0
53997,prior,0,0
53998,abdominal,0,1
53999,surgery,0,0
54000,in,0,0
54001,the,0,0
54002,quadrant,0,0
54003,of,0,0
54004,interest,0,0
54005,.,0,1
54006,Mean,0,1
54007,followup,0,1
54008,was,0,0
54009,5.96,0,0
54010,years,0,0
54011,in,0,0
54012,the,0,0
54013,2,0,0
54014,groups,0,0
54015,.,0,0
54016,RESULTS,0,0
54017,The,0,0
54018,groups,0,0
54019,were,0,0
54020,matched,0,0
54021,in,0,0
54022,regard,0,0
54023,to,0,0
54024,patient,0,1
54025,age,0,0
54026,(,0,0
54027,p,0,0
54028,=,0,0
54029,0.84,0,0
54030,),0,0
54031,",",0,0
54032,body,0,1
54033,mass,0,1
54034,index,0,1
54035,(,0,0
54036,p,0,0
54037,=,0,0
54038,0.43,0,0
54039,),0,0
54040,",",0,0
54041,American,0,0
54042,Society,0,1
54043,of,0,1
54044,Anesthesiologists,0,1
54045,class,0,0
54046,(,0,0
54047,p,0,0
54048,=,0,0
54049,0.81,0,0
54050,),0,0
54051,and,0,0
54052,laterality,0,1
54053,(,0,1
54054,p,0,0
54055,=,0,0
54056,0.12,0,0
54057,),0,0
54058,.,0,0
54059,Median,0,1
54060,adrenal,1,1
54061,mass,1,1
54062,size,1,1
54063,was,0,0
54064,2.7,0,0
54065,cm,0,0
54066,(,0,0
54067,range,0,0
54068,1,0,0
54069,to,0,0
54070,9,0,0
54071,),0,0
54072,in,0,0
54073,the,0,0
54074,TLA,0,0
54075,group,0,0
54076,and,0,0
54077,2.6,0,0
54078,cm,0,0
54079,(,0,0
54080,range,0,0
54081,0.5,0,0
54082,to,0,0
54083,6,0,0
54084,),0,0
54085,in,0,0
54086,the,0,0
54087,RLA,0,0
54088,group,0,0
54089,(,0,0
54090,p,0,0
54091,=,0,0
54092,0.83,0,0
54093,),0,0
54094,.,0,0
54095,TLA,0,0
54096,was,0,0
54097,comparable,0,0
54098,to,0,0
54099,RLA,0,0
54100,in,0,0
54101,terms,0,1
54102,of,0,0
54103,operative,1,1
54104,time,1,1
54105,(,0,0
54106,130,0,0
54107,vs,0,0
54108,126.5,0,0
54109,minutes,0,0
54110,",",0,0
54111,p,0,0
54112,=,0,0
54113,0.64,0,0
54114,),0,0
54115,",",0,0
54116,estimated,1,0
54117,blood,1,1
54118,loss,1,1
54119,(,0,0
54120,p,0,0
54121,=,0,0
54122,0.92,0,0
54123,),0,0
54124,",",0,0
54125,specimen,1,1
54126,weight,1,1
54127,(,0,0
54128,p,0,0
54129,=,0,0
54130,0.81,0,0
54131,),0,0
54132,",",0,0
54133,analgesic,1,1
54134,requirements,1,1
54135,(,0,0
54136,p,0,0
54137,=,0,0
54138,0.25,0,0
54139,),0,0
54140,",",0,0
54141,hospital,1,1
54142,stay,1,1
54143,(,0,0
54144,p,0,0
54145,=,0,0
54146,0.56,0,0
54147,),0,0
54148,and,0,0
54149,the,0,0
54150,complication,1,1
54151,rate,1,1
54152,(,0,0
54153,p,0,0
54154,=,0,0
54155,0.58,0,0
54156,),0,0
54157,.,0,0
54158,One,0,0
54159,case,0,0
54160,per,0,0
54161,group,0,0
54162,was,0,0
54163,electively,0,0
54164,converted,0,0
54165,to,0,0
54166,open,1,0
54167,surgery,1,0
54168,.,1,0
54169,Pathology,0,1
54170,data,0,0
54171,on,0,0
54172,the,0,0
54173,intact,0,0
54174,extracted,0,0
54175,specimens,0,1
54176,were,0,0
54177,similar,0,0
54178,between,0,0
54179,the,0,0
54180,groups,0,0
54181,.,0,0
54182,Averaged,0,1
54183,convalescence,1,1
54184,was,0,0
54185,4.7,0,0
54186,weeks,0,0
54187,in,0,0
54188,the,0,0
54189,TLA,0,0
54190,group,0,0
54191,and,0,0
54192,2.3,0,0
54193,weeks,0,0
54194,in,0,0
54195,the,0,0
54196,RLA,0,0
54197,group,0,0
54198,(,0,0
54199,p,0,0
54200,=,0,0
54201,0.02,0,0
54202,),0,0
54203,.,0,0
54204,During,0,0
54205,a,0,0
54206,mean,0,1
54207,followup,0,0
54208,of,0,0
54209,6,0,0
54210,years,0,0
54211,2,0,0
54212,patients,0,0
54213,in,0,0
54214,the,0,0
54215,TLA,0,0
54216,group,0,0
54217,had,0,0
54218,a,0,0
54219,late,1,1
54220,complication,1,1
54221,(,1,0
54222,port,1,1
54223,site,1,1
54224,hernia,1,0
54225,),1,0
54226,.,1,1
54227,Mortality,1,1
54228,occurred,0,0
54229,in,0,0
54230,5,0,0
54231,patients,0,0
54232,",",0,0
54233,including,0,0
54234,1,0,0
54235,with,0,0
54236,TLA,0,0
54237,and,0,0
54238,4,0,0
54239,with,0,0
54240,RLA,0,0
54241,",",0,0
54242,during,0,0
54243,the,0,0
54244,6-year,0,0
54245,followup,0,1
54246,.,0,0
54247,CONCLUSIONS,0,0
54248,For,0,0
54249,most,0,0
54250,benign,0,0
54251,adrenal,0,1
54252,lesions,0,1
54253,requiring,0,1
54254,surgery,0,0
54255,laparoscopic,0,0
54256,adrenalectomy,0,0
54257,can,0,0
54258,be,0,0
54259,performed,0,0
54260,safely,1,0
54261,and,0,0
54262,effectively,1,0
54263,by,0,0
54264,the,0,0
54265,transperitoneal,0,0
54266,or,0,0
54267,the,0,0
54268,retroperitoneal,0,0
54269,approach,0,0
54270,.,0,0
54271,Interventions,0,0
54272,in,0,0
54273,the,0,0
54274,initial,0,0
54275,prodromal,0,1
54276,states,0,0
54277,of,0,0
54278,psychosis,0,0
54279,in,0,0
54280,Germany,0,0
54281,:,0,0
54282,concept,0,1
54283,and,0,1
54284,recruitment,0,0
54285,.,0,0
54286,BACKGROUND,0,0
54287,The,0,0
54288,Early,0,0
54289,Detection,0,1
54290,and,0,1
54291,Intervention,0,0
54292,Programme,0,0
54293,of,0,0
54294,the,0,0
54295,German,0,0
54296,Research,0,0
54297,Network,0,1
54298,on,0,0
54299,Schizophrenia,0,1
54300,(,0,0
54301,GRNS,0,0
54302,),0,0
54303,investigates,0,0
54304,the,0,0
54305,initial,0,0
54306,prodromal,0,1
54307,phase,0,0
54308,of,0,1
54309,psychosis,0,0
54310,in,0,0
54311,a,0,0
54312,multidimensional,0,0
54313,approach,0,0
54314,.,0,0
54315,Two,0,0
54316,intervention,0,0
54317,strategies,0,0
54318,are,0,0
54319,being,0,0
54320,studied,0,0
54321,by,0,0
54322,two,0,0
54323,large-scale,0,0
54324,multicentre,0,0
54325,projects,0,0
54326,.,0,0
54327,AIMS,0,0
54328,To,0,0
54329,present,0,0
54330,the,0,0
54331,concept,0,0
54332,of,0,0
54333,the,0,0
54334,intervention,0,0
54335,studies,0,0
54336,",",0,0
54337,and,0,0
54338,to,0,0
54339,provide,0,0
54340,an,0,0
54341,interim,0,0
54342,report,0,0
54343,of,0,0
54344,the,0,0
54345,recruitment,0,0
54346,procedure,0,0
54347,.,0,0
54348,METHOD,0,0
54349,Comprehensive,0,0
54350,cognitive-behavioural,0,0
54351,therapy,0,0
54352,has,0,0
54353,been,0,0
54354,developed,0,0
54355,for,0,0
54356,patients,0,0
54357,in,0,0
54358,the,0,0
54359,early,0,0
54360,initial,0,0
54361,prodromal,0,1
54362,state,0,1
54363,.,0,0
54364,For,0,0
54365,patients,0,0
54366,in,0,0
54367,the,0,0
54368,late,0,1
54369,initial,0,0
54370,prodromal,0,1
54371,state,0,0
54372,the,0,0
54373,atypical,0,0
54374,neuroleptic,0,0
54375,amisulpride,0,0
54376,is,0,0
54377,explored,0,0
54378,.,0,0
54379,Both,0,0
54380,interventions,0,0
54381,are,0,0
54382,evaluated,0,0
54383,in,0,0
54384,randomised,0,0
54385,controlled,0,0
54386,trials,0,0
54387,using,0,0
54388,clinical,0,0
54389,management,0,0
54390,as,0,0
54391,the,0,0
54392,control,0,0
54393,condition,0,0
54394,.,0,1
54395,RESULTS,0,0
54396,Between,0,0
54397,January,0,0
54398,2001,0,0
54399,and,0,0
54400,March,0,0
54401,2003,0,0
54402,",",0,0
54403,1212,0,0
54404,individuals,0,0
54405,seeking,0,0
54406,help,0,0
54407,for,0,0
54408,mental,0,1
54409,health,0,1
54410,problems,0,1
54411,were,0,0
54412,screened,0,1
54413,for,0,0
54414,putative,0,0
54415,prodromal,0,1
54416,symptoms,0,1
54417,at,0,0
54418,four,0,0
54419,university,0,0
54420,centres,0,0
54421,.,0,0
54422,More,0,0
54423,than,0,0
54424,388,0,0
54425,individuals,0,0
54426,fulfilled,0,0
54427,criteria,0,0
54428,for,0,0
54429,both,0,0
54430,interventions,0,0
54431,and,0,0
54432,188,0,0
54433,(,0,0
54434,48.5,0,0
54435,%,0,0
54436,),0,0
54437,gave,0,0
54438,informed,1,0
54439,consent,1,0
54440,to,0,0
54441,participate,0,0
54442,in,0,0
54443,the,0,0
54444,trials,0,0
54445,.,0,0
54446,CONCLUSIONS,0,0
54447,The,0,0
54448,screening,0,0
54449,procedure,0,0
54450,appears,0,0
54451,to,0,0
54452,be,0,0
54453,feasible,1,0
54454,and,0,1
54455,trial,1,0
54456,participation,1,0
54457,seems,0,0
54458,to,0,0
54459,be,0,0
54460,acceptable,0,0
54461,to,0,0
54462,a,0,0
54463,relevant,0,0
54464,proportion,0,0
54465,of,0,0
54466,people,0,0
54467,at,0,0
54468,increased,0,0
54469,risk,0,1
54470,of,0,0
54471,developing,0,0
54472,psychosis,0,0
54473,.,0,0
54474,Prospective,0,0
54475,randomized,0,0
54476,multicenter,0,0
54477,trial,0,0
54478,of,0,1
54479,sevelamer,0,0
54480,hydrochloride,0,0
54481,and,0,1
54482,calcium,0,1
54483,carbonate,0,0
54484,for,0,0
54485,the,0,0
54486,treatment,0,0
54487,of,0,0
54488,hyperphosphatemia,1,1
54489,in,0,0
54490,hemodialysis,0,0
54491,patients,0,0
54492,in,0,0
54493,Japan,0,0
54494,.,0,0
54495,A,0,0
54496,prospective,0,0
54497,",",0,0
54498,randomized,0,0
54499,open-label,0,0
54500,trial,0,0
54501,of,0,1
54502,sevelamer,0,0
54503,hydrochloride,0,0
54504,with,0,0
54505,or,0,0
54506,without,0,0
54507,calcium,0,1
54508,carbonate,0,0
54509,(,0,1
54510,CC,0,1
54511,),0,0
54512,involved,0,0
54513,86,0,0
54514,hemodialysis,0,0
54515,patients,0,0
54516,in,0,0
54517,Japan,0,0
54518,.,0,0
54519,The,0,0
54520,dosage,0,0
54521,of,0,1
54522,CC,0,0
54523,was,0,0
54524,fixed,0,0
54525,at,0,0
54526,3.0,0,0
54527,g/day,0,0
54528,for,0,0
54529,the,0,0
54530,12-week,0,0
54531,study,0,0
54532,.,0,0
54533,After,0,0
54534,the,0,0
54535,first,0,0
54536,4,0,0
54537,weeks,0,0
54538,all,0,0
54539,subjects,0,0
54540,were,0,0
54541,changed,0,0
54542,from,0,0
54543,CC,0,0
54544,to,0,0
54545,sevelamer,0,0
54546,3.0,0,0
54547,g/day,0,0
54548,for,0,0
54549,another,0,0
54550,4,0,0
54551,weeks,0,0
54552,",",0,0
54553,then,0,0
54554,allocated,0,0
54555,randomly,0,0
54556,to,0,0
54557,three,0,0
54558,groups,0,0
54559,for,0,0
54560,the,0,0
54561,final,0,0
54562,4,0,0
54563,weeks,0,0
54564,:,0,0
54565,group,0,0
54566,A,0,0
54567,",",0,0
54568,sevelamer,0,0
54569,6.0,0,0
54570,g/day,0,0
54571,;,0,0
54572,group,0,0
54573,B,0,1
54574,",",0,0
54575,sevelamer,0,0
54576,3.0,0,0
54577,g/day,0,0
54578,and,0,0
54579,CC,0,0
54580,3.0,0,0
54581,g/day,0,0
54582,;,0,0
54583,group,0,0
54584,C,0,0
54585,",",0,0
54586,CC,0,0
54587,3.0,0,0
54588,g/day,0,0
54589,.,0,0
54590,The,0,0
54591,target,1,0
54592,serum,1,1
54593,phosphorous,1,1
54594,concentration,1,1
54595,(,0,1
54596,P,0,0
54597,),0,0
54598,=5.5,0,1
54599,mg/dL,0,0
54600,and,0,0
54601,the,0,0
54602,corrected,1,1
54603,calcium,1,1
54604,concentration,1,1
54605,(,1,1
54606,Ca,1,1
54607,),1,1
54608,was,0,0
54609,9.0-10.0,0,0
54610,mg/dL,0,0
54611,.,0,0
54612,Of,0,0
54613,the,0,0
54614,86,0,0
54615,patients,0,0
54616,",",0,0
54617,62,0,0
54618,finished,0,0
54619,the,0,0
54620,study,0,0
54621,without,0,0
54622,a,0,0
54623,change,0,1
54624,of,0,1
54625,dosage,0,0
54626,and,0,0
54627,their,0,1
54628,data,0,0
54629,were,0,0
54630,analyzed,0,0
54631,(,0,0
54632,group,0,0
54633,A,0,0
54634,",",0,0
54635,N=16,0,0
54636,;,0,1
54637,group,0,0
54638,B,0,0
54639,",",0,0
54640,N=26,0,1
54641,;,0,1
54642,group,0,0
54643,C,0,0
54644,",",0,1
54645,N=20,0,0
54646,),0,0
54647,.,0,0
54648,At,0,0
54649,week,0,0
54650,8,0,0
54651,compared,0,0
54652,with,0,0
54653,week,0,0
54654,4,0,0
54655,",",0,0
54656,the,0,0
54657,concentration,1,1
54658,of,1,1
54659,P,1,0
54660,increased,0,0
54661,from,0,0
54662,5.7+/-1.4,0,0
54663,to,0,0
54664,6.4+/-1.7,0,0
54665,mg/dL,0,0
54666,in,0,0
54667,group,0,0
54668,A,0,0
54669,",",0,1
54670,and,0,1
54671,decreased,0,1
54672,significantly,0,0
54673,in,0,0
54674,groups,0,0
54675,B,0,0
54676,and,0,1
54677,C,0,1
54678,",",0,1
54679,and,0,1
54680,in,0,0
54681,group,0,0
54682,B,0,0
54683,compared,0,0
54684,with,0,0
54685,groups,0,0
54686,A,0,0
54687,and,0,0
54688,C,0,0
54689,;,0,0
54690,groups,0,0
54691,A,0,0
54692,and,0,1
54693,C,0,0
54694,had,0,0
54695,similar,0,0
54696,concentrations,0,1
54697,at,0,0
54698,week,0,0
54699,8,0,0
54700,.,0,0
54701,The,0,0
54702,Ca,1,1
54703,concentration,1,1
54704,decreased,0,1
54705,significantly,0,0
54706,from,0,0
54707,9.7+/-1.0,0,0
54708,to,0,0
54709,9.1+/-0.7,0,0
54710,mg/dL,0,0
54711,after,0,0
54712,the,0,0
54713,change,0,0
54714,to,0,0
54715,sevelamer,0,0
54716,.,0,0
54717,At,0,0
54718,week,0,0
54719,8,0,0
54720,Ca,1,0
54721,was,0,0
54722,not,0,0
54723,significantly,0,0
54724,changed,0,0
54725,in,0,0
54726,group,0,0
54727,A,0,0
54728,",",0,0
54729,whereas,0,0
54730,a,0,0
54731,significant,0,0
54732,increase,0,1
54733,occurred,0,0
54734,in,0,0
54735,groups,0,0
54736,B,0,0
54737,and,0,1
54738,C.,0,1
54739,Side-effects,1,1
54740,with,0,0
54741,sevelamer,0,0
54742,administration,0,0
54743,occurred,0,0
54744,in,0,0
54745,34,0,0
54746,of,0,0
54747,the,0,0
54748,86,0,0
54749,patients,0,0
54750,and,0,0
54751,24,0,0
54752,dropped,0,0
54753,out,0,0
54754,of,0,0
54755,the,0,0
54756,study,0,0
54757,",",0,0
54758,with,0,0
54759,a,0,0
54760,high,0,0
54761,frequency,0,1
54762,in,0,0
54763,group,0,0
54764,A,0,0
54765,(,0,0
54766,13/29,0,0
54767,;,0,0
54768,44.8,0,0
54769,%,0,0
54770,),0,0
54771,.,0,0
54772,In,0,0
54773,conclusion,0,0
54774,",",0,0
54775,there,0,0
54776,was,0,0
54777,an,0,0
54778,additive,1,0
54779,effect,1,1
54780,of,0,1
54781,sevelamer,0,0
54782,for,0,0
54783,the,0,0
54784,treatment,0,0
54785,of,0,0
54786,hyperphosphatemia,0,1
54787,with,0,0
54788,CC,0,0
54789,.,0,0
54790,The,0,0
54791,combination,0,0
54792,therapy,0,0
54793,was,0,0
54794,better,0,0
54795,tolerated,1,1
54796,and,0,0
54797,showed,0,0
54798,higher,0,1
54799,patient,1,1
54800,compliance,1,1
54801,than,0,0
54802,CC,0,0
54803,or,0,0
54804,sevelamer,0,0
54805,monotherapy,0,0
54806,.,0,0
54807,Analgesic,1,1
54808,efficacy,1,1
54809,of,0,1
54810,caudal,0,1
54811,block,0,0
54812,versus,0,0
54813,diclofenac,0,0
54814,suppository,0,0
54815,and,0,1
54816,local,0,1
54817,anesthetic,0,1
54818,infiltration,0,1
54819,following,0,0
54820,pediatric,0,0
54821,laparoscopy,0,0
54822,.,0,0
54823,AIM,0,0
54824,To,0,0
54825,compare,0,0
54826,the,0,0
54827,analgesic,1,1
54828,efficacy,0,1
54829,of,0,1
54830,caudal,0,0
54831,block,0,0
54832,with,0,0
54833,diclofenac,0,0
54834,suppository,0,0
54835,and,0,1
54836,local,0,1
54837,anesthetic,0,1
54838,infiltration,0,1
54839,in,0,0
54840,children,0,0
54841,undergoing,0,0
54842,laparoscopy,0,0
54843,.,0,0
54844,METHODS,0,0
54845,We,0,0
54846,studied,0,0
54847,50,0,0
54848,children,0,0
54849,undergoing,0,0
54850,laparoscopy,0,0
54851,for,0,0
54852,diagnostic,0,1
54853,and,0,1
54854,therapeutic,0,0
54855,purposes,0,0
54856,.,0,0
54857,Their,0,0
54858,ages,0,0
54859,ranged,0,0
54860,from,0,0
54861,3,0,0
54862,to,0,0
54863,13,0,0
54864,years,0,0
54865,",",0,0
54866,and,0,0
54867,all,0,0
54868,belonged,0,0
54869,to,0,0
54870,American,0,0
54871,Society,0,1
54872,of,0,1
54873,Anesthesiologists,0,0
54874,(,0,0
54875,ASA,0,1
54876,),0,0
54877,class,0,0
54878,I,0,0
54879,or,0,0
54880,II,0,0
54881,.,0,1
54882,Anesthesia,0,1
54883,was,0,0
54884,carried,0,0
54885,out,0,0
54886,using,0,0
54887,the,0,0
54888,standard,0,0
54889,procedure,0,0
54890,.,0,1
54891,Patients,0,0
54892,were,0,0
54893,randomly,0,0
54894,assigned,0,0
54895,to,0,0
54896,one,0,0
54897,of,0,0
54898,two,0,0
54899,groups,0,0
54900,.,0,0
54901,Group,0,0
54902,1,0,0
54903,received,0,0
54904,caudal,0,0
54905,block,0,0
54906,with,0,0
54907,bupivacaine,0,0
54908,1,0,0
54909,mL/kg,0,0
54910,after,0,0
54911,anesthetic,0,0
54912,induction,0,0
54913,.,0,0
54914,Group,0,0
54915,2,0,0
54916,received,0,0
54917,diclofenac,0,0
54918,suppository,0,0
54919,3,0,0
54920,mg/kg,0,0
54921,postinduction,0,0
54922,and,0,1
54923,local,0,1
54924,anesthetic,0,1
54925,infiltration,0,1
54926,at,0,0
54927,the,0,0
54928,port,0,0
54929,sites,0,0
54930,at,0,0
54931,the,0,0
54932,end,0,0
54933,of,0,0
54934,the,0,0
54935,procedure,0,0
54936,.,0,1
54937,Pain,1,1
54938,was,1,0
54939,assessed,1,0
54940,using,0,0
54941,the,0,0
54942,Hannallah,1,0
54943,objective,1,0
54944,pain,1,1
54945,scale,1,1
54946,at,0,0
54947,15,0,0
54948,",",0,0
54949,30,0,0
54950,",",0,0
54951,60,0,0
54952,",",0,0
54953,120,0,0
54954,",",0,0
54955,and,0,0
54956,360,0,0
54957,minutes,0,0
54958,postextubation,0,0
54959,.,0,0
54960,RESULTS,0,0
54961,The,0,0
54962,pain,1,1
54963,scores,1,1
54964,were,0,0
54965,comparable,0,0
54966,in,0,0
54967,both,0,0
54968,groups,0,0
54969,at,0,0
54970,all,0,0
54971,times,0,1
54972,.,0,0
54973,Twelve,0,0
54974,percent,0,1
54975,of,0,1
54976,caudal,0,0
54977,block,0,0
54978,patients,0,0
54979,and,0,0
54980,20,0,0
54981,%,0,0
54982,of,0,0
54983,diclofenac,0,0
54984,patients,0,0
54985,needed,0,1
54986,rescue,1,1
54987,analgesic,1,1
54988,",",0,0
54989,a,0,0
54990,statistically,0,0
54991,insignificant,0,0
54992,difference,0,0
54993,.,0,0
54994,In,0,0
54995,2,0,0
54996,patients,0,0
54997,",",0,0
54998,caudal,0,1
54999,block,0,1
55000,was,0,0
55001,technically,0,0
55002,difficult,0,0
55003,and,0,0
55004,they,0,0
55005,were,0,0
55006,excluded,0,0
55007,from,0,0
55008,the,0,0
55009,study,0,0
55010,.,0,0
55011,The,0,0
55012,incidence,0,1
55013,of,0,0
55014,side,0,1
55015,effects,0,1
55016,was,0,0
55017,low,0,0
55018,in,0,0
55019,our,0,0
55020,study,0,0
55021,.,0,0
55022,CONCLUSION,0,0
55023,We,0,0
55024,find,0,0
55025,the,0,0
55026,analgesic,1,1
55027,efficacy,0,1
55028,of,0,1
55029,diclofenac,0,0
55030,suppository,0,0
55031,combined,0,0
55032,with,0,0
55033,local,0,0
55034,anesthetic,0,1
55035,infiltration,0,1
55036,at,0,0
55037,port,0,0
55038,sites,0,0
55039,comparable,0,0
55040,to,0,0
55041,caudal,0,0
55042,block,0,0
55043,.,0,0
55044,Given,0,0
55045,the,0,0
55046,necessarily,0,0
55047,invasive,0,0
55048,nature,0,0
55049,of,0,1
55050,caudal,0,1
55051,block,0,0
55052,",",0,0
55053,we,0,0
55054,suggest,0,0
55055,the,0,0
55056,combined,0,0
55057,use,0,0
55058,of,0,1
55059,diclofenac,0,0
55060,suppository,0,0
55061,with,0,0
55062,local,0,0
55063,anesthetic,0,1
55064,infiltration,0,1
55065,at,0,0
55066,port,0,0
55067,sites,0,0
55068,as,0,0
55069,a,0,0
55070,useful,0,0
55071,and,0,0
55072,more,0,0
55073,economical,0,1
55074,alternative,0,0
55075,for,0,0
55076,analgesia,0,1
55077,following,0,0
55078,pediatric,0,0
55079,laparoscopy,0,0
55080,.,0,0
55081,Cervical,0,1
55082,spine,0,0
55083,motion,0,1
55084,:,0,0
55085,a,0,0
55086,fluoroscopic,0,0
55087,comparison,0,0
55088,during,0,0
55089,intubation,0,0
55090,with,0,0
55091,lighted,0,1
55092,stylet,0,0
55093,",",0,1
55094,GlideScope,0,1
55095,",",0,1
55096,and,0,1
55097,Macintosh,0,0
55098,laryngoscope,0,1
55099,.,0,0
55100,The,0,0
55101,question,0,0
55102,of,0,0
55103,which,0,0
55104,is,0,0
55105,the,0,0
55106,optimum,0,1
55107,technique,0,0
55108,to,0,0
55109,intubate,0,0
55110,the,0,0
55111,trachea,0,1
55112,in,0,0
55113,a,0,0
55114,patient,0,0
55115,who,0,0
55116,may,0,0
55117,have,0,0
55118,a,0,0
55119,cervical,0,0
55120,(,0,0
55121,C,0,0
55122,),0,0
55123,-spine,0,0
55124,injury,0,0
55125,remains,0,0
55126,unresolved,0,0
55127,.,0,0
55128,We,0,0
55129,compared,0,0
55130,",",0,0
55131,using,0,0
55132,fluoroscopic,0,0
55133,video,0,0
55134,",",0,1
55135,C-spine,1,1
55136,motion,1,1
55137,during,0,0
55138,intubation,0,0
55139,for,0,0
55140,Macintosh,0,0
55141,3,0,0
55142,blade,0,0
55143,",",0,0
55144,GlideScope,0,1
55145,",",0,1
55146,and,0,1
55147,Intubating,0,1
55148,Lighted,0,1
55149,Stylet,0,0
55150,",",0,0
55151,popularly,0,0
55152,known,0,0
55153,as,0,0
55154,the,0,0
55155,Lightwand,0,0
55156,or,0,0
55157,Trachlight,0,0
55158,.,0,1
55159,Thirty-six,0,0
55160,healthy,0,0
55161,patients,0,0
55162,were,0,0
55163,randomized,0,0
55164,to,0,0
55165,participate,0,0
55166,in,0,0
55167,a,0,0
55168,crossover,0,0
55169,trial,0,0
55170,of,0,0
55171,either,0,0
55172,Lightwand,0,0
55173,or,0,0
55174,GlideScope,0,1
55175,to,0,0
55176,Macintosh,0,0
55177,laryngoscopy,0,1
55178,",",0,0
55179,with,0,0
55180,in-line,0,1
55181,stabilization,0,1
55182,.,0,1
55183,C-spine,1,1
55184,motion,1,1
55185,was,0,0
55186,examined,0,0
55187,at,0,0
55188,the,0,0
55189,Occiput-C1,0,1
55190,junction,0,1
55191,",",0,1
55192,C1-2,0,1
55193,junction,0,1
55194,",",0,1
55195,C2-5,0,1
55196,motion,0,1
55197,segment,0,1
55198,",",0,1
55199,and,0,1
55200,C5-thoracic,0,1
55201,motion,0,1
55202,segment,0,1
55203,during,0,0
55204,manual,0,1
55205,ventilation,0,1
55206,via,0,0
55207,bag-mask,0,1
55208,",",0,1
55209,laryngoscopy,0,1
55210,",",0,1
55211,and,0,1
55212,intubation,0,1
55213,.,0,1
55214,Time,1,0
55215,to,0,0
55216,intubate,0,1
55217,was,0,0
55218,also,0,0
55219,measured,0,0
55220,.,0,0
55221,C-spine,1,1
55222,motion,1,1
55223,during,1,0
55224,bag-mask,1,1
55225,ventilation,1,1
55226,was,0,0
55227,82,0,0
55228,%,0,0
55229,less,0,0
55230,at,0,0
55231,the,0,0
55232,four,0,0
55233,motion,0,1
55234,segments,0,0
55235,studied,0,0
55236,than,0,0
55237,during,0,0
55238,Macintosh,0,0
55239,laryngoscopy,0,1
55240,(,0,0
55241,P,0,0
55242,<,0,0
55243,0.001,0,0
55244,),0,0
55245,.,0,0
55246,C-spine,1,1
55247,motion,1,1
55248,using,1,0
55249,the,1,0
55250,Lightwand,1,0
55251,was,0,0
55252,less,0,0
55253,than,0,0
55254,during,0,0
55255,Macintosh,0,0
55256,laryngoscopy,0,1
55257,",",0,0
55258,averaging,0,0
55259,57,0,0
55260,%,0,0
55261,less,0,0
55262,at,0,0
55263,the,0,0
55264,four,0,0
55265,motion,0,1
55266,segments,0,0
55267,studied,0,0
55268,(,0,0
55269,P,0,0
55270,<,0,0
55271,0.03,0,0
55272,),0,0
55273,.,0,0
55274,There,0,0
55275,was,0,0
55276,no,0,0
55277,significant,0,0
55278,difference,0,0
55279,in,0,0
55280,time,1,1
55281,to,1,0
55282,intubate,1,0
55283,between,0,0
55284,the,0,0
55285,Lightwand,0,0
55286,and,0,0
55287,the,0,0
55288,Macintosh,0,0
55289,blade,0,1
55290,.,0,1
55291,C-spine,1,1
55292,motion,1,1
55293,was,0,0
55294,reduced,0,0
55295,50,0,0
55296,%,0,0
55297,at,0,0
55298,the,0,0
55299,C2-5,0,0
55300,segment,0,0
55301,using,0,0
55302,the,0,0
55303,GlideScope,0,0
55304,(,0,0
55305,P,0,0
55306,<,0,0
55307,0.04,0,0
55308,),0,0
55309,but,0,0
55310,unchanged,0,0
55311,at,0,0
55312,the,0,0
55313,other,0,0
55314,segments,0,0
55315,.,0,0
55316,Laryngoscopy,0,1
55317,with,0,0
55318,GlideScope,0,0
55319,took,0,0
55320,62,0,0
55321,%,0,0
55322,longer,1,0
55323,than,0,0
55324,with,0,0
55325,the,0,0
55326,Macintosh,0,0
55327,blade,0,1
55328,(,0,0
55329,P,0,0
55330,<,0,0
55331,0.01,0,0
55332,),0,0
55333,.,0,0
55334,Thus,0,0
55335,",",0,0
55336,the,0,0
55337,Lightwand,0,0
55338,(,0,0
55339,Intubating,0,1
55340,Lighted,0,1
55341,Stylet,0,0
55342,),0,0
55343,is,0,0
55344,associated,0,0
55345,with,0,0
55346,reduced,0,1
55347,C-spine,1,1
55348,movement,1,1
55349,during,0,0
55350,endotracheal,0,1
55351,intubation,0,0
55352,compared,0,0
55353,with,0,0
55354,the,0,0
55355,Macintosh,0,0
55356,laryngoscope,0,0
55357,.,0,0
55358,Impact,0,0
55359,of,0,0
55360,a,0,0
55361,single,0,0
55362,intravenous,0,0
55363,administration,0,0
55364,of,0,1
55365,nicorandil,0,0
55366,before,0,0
55367,reperfusion,0,1
55368,in,0,0
55369,patients,0,0
55370,with,0,0
55371,ST-segment-elevation,0,0
55372,myocardial,0,1
55373,infarction,0,1
55374,.,0,0
55375,BACKGROUND,0,0
55376,Intravenous,0,0
55377,nicorandil,0,0
55378,",",0,0
55379,a,0,0
55380,hybrid,0,0
55381,compound,0,0
55382,of,0,1
55383,ATP-sensitive,0,1
55384,potassium,0,1
55385,channel,0,1
55386,opener,0,0
55387,and,0,1
55388,nitric,0,1
55389,oxide,0,1
55390,donor,0,0
55391,",",0,0
55392,has,0,0
55393,been,0,0
55394,reported,0,0
55395,to,0,0
55396,ameliorate,0,0
55397,early,0,0
55398,functional,0,1
55399,and,0,1
55400,clinical,0,1
55401,problems,0,1
55402,in,0,0
55403,patients,0,0
55404,with,0,0
55405,acute,0,0
55406,myocardial,0,1
55407,infarction,0,1
55408,.,0,0
55409,However,0,0
55410,",",0,0
55411,its,0,0
55412,effects,0,1
55413,on,0,0
55414,the,0,0
55415,late,0,0
55416,phase,0,0
55417,remain,0,0
55418,unclear,0,0
55419,.,0,0
55420,METHODS,0,0
55421,AND,0,0
55422,RESULTS,0,0
55423,This,0,0
55424,follow-up,0,0
55425,study,0,0
55426,to,0,0
55427,5,0,0
55428,years,0,0
55429,of,0,0
55430,a,0,0
55431,randomized,0,0
55432,",",0,0
55433,double-blinded,0,0
55434,trial,0,0
55435,was,0,0
55436,conducted,0,0
55437,among,0,0
55438,368,0,0
55439,patients,0,0
55440,with,0,0
55441,first,0,0
55442,ST-segment-elevation,0,0
55443,myocardial,0,1
55444,infarction,0,1
55445,undergoing,0,0
55446,percutaneous,0,0
55447,coronary,0,1
55448,intervention,0,0
55449,(,0,1
55450,PCI,0,1
55451,),0,0
55452,.,0,0
55453,They,0,0
55454,were,0,0
55455,randomly,0,0
55456,assigned,0,0
55457,to,0,0
55458,receive,0,0
55459,12,0,0
55460,mg,0,0
55461,of,0,0
55462,nicorandil,0,0
55463,or,0,0
55464,a,0,0
55465,placebo,0,0
55466,intravenously,0,0
55467,just,0,0
55468,before,0,0
55469,reperfusion,0,0
55470,.,0,0
55471,We,0,0
55472,analyzed,0,0
55473,incidence,0,1
55474,of,0,1
55475,cardiovascular,1,1
55476,death,1,1
55477,or,1,1
55478,rehospitalization,1,1
55479,for,0,0
55480,congestive,1,1
55481,heart,1,1
55482,failure,1,1
55483,after,0,0
55484,PCI,0,1
55485,as,0,0
55486,well,0,0
55487,as,0,0
55488,various,0,0
55489,aspects,0,1
55490,of,0,1
55491,epicardial,0,0
55492,flow,0,1
55493,and,0,1
55494,microvascular,0,1
55495,function,0,1
55496,.,0,1
55497,Mean,0,1
55498,follow-up,0,0
55499,was,0,0
55500,2.4,0,0
55501,years,0,0
55502,(,0,0
55503,SD,0,0
55504,",",0,0
55505,1.4,0,0
55506,),0,0
55507,.,0,0
55508,A,0,0
55509,total,0,0
55510,of,0,0
55511,12,0,0
55512,(,0,0
55513,6.5,0,0
55514,%,0,0
55515,),0,0
55516,patients,0,0
55517,receiving,0,0
55518,nicorandil,0,0
55519,and,0,0
55520,30,0,0
55521,(,0,0
55522,16.4,0,0
55523,%,0,0
55524,),0,0
55525,receiving,0,0
55526,placebo,0,0
55527,had,0,0
55528,cardiovascular,1,1
55529,death,1,1
55530,or,1,1
55531,hospital,1,1
55532,admission,1,1
55533,for,1,0
55534,congestive,1,1
55535,heart,1,1
55536,failure,1,1
55537,(,0,1
55538,hazard,0,1
55539,ratio,0,1
55540,",",0,0
55541,0.39,0,0
55542,;,0,0
55543,95,0,0
55544,%,0,0
55545,CI,0,0
55546,",",0,0
55547,0.20,0,0
55548,to,0,0
55549,0.76,0,0
55550,;,0,0
55551,P=0.0058,0,0
55552,),0,0
55553,.,0,0
55554,Postprocedural,1,1
55555,TIMI,1,0
55556,3,1,0
55557,flow,1,1
55558,was,0,0
55559,obtained,0,0
55560,in,0,0
55561,89.7,0,0
55562,%,0,0
55563,of,0,0
55564,the,0,0
55565,nicorandil,0,0
55566,group,0,0
55567,and,0,0
55568,in,0,0
55569,81.4,0,0
55570,%,0,0
55571,of,0,0
55572,the,0,0
55573,placebo,0,0
55574,(,0,0
55575,hazard,0,1
55576,ratio,0,1
55577,",",0,0
55578,1.99,0,0
55579,;,0,0
55580,95,0,0
55581,%,0,0
55582,CI,0,0
55583,",",0,0
55584,1.09,0,0
55585,to,0,0
55586,3.65,0,0
55587,;,0,0
55588,P=0.025,0,0
55589,),0,0
55590,.,0,0
55591,Corrected,1,0
55592,TIMI,1,1
55593,frame,1,0
55594,count,1,1
55595,was,0,0
55596,furthermore,0,0
55597,lower,0,0
55598,in,0,0
55599,the,0,0
55600,nicorandil,0,0
55601,group,0,0
55602,(,0,1
55603,21.0+/-9.1,0,0
55604,versus,0,0
55605,25.1+/-14.1,0,0
55606,;,0,0
55607,P=0.0009,0,0
55608,),0,0
55609,.,0,0
55610,ST-segment,1,1
55611,resolution,1,1
55612,>,1,0
55613,50,1,0
55614,%,1,0
55615,was,0,0
55616,observed,0,0
55617,in,0,0
55618,79.5,0,0
55619,%,0,0
55620,and,0,0
55621,61.2,0,0
55622,%,0,0
55623,of,0,0
55624,the,0,0
55625,nicorandil,0,0
55626,and,0,1
55627,placebo,0,0
55628,groups,0,0
55629,",",0,0
55630,respectively,0,0
55631,(,0,0
55632,hazard,0,1
55633,ratio,0,1
55634,",",0,0
55635,2.45,0,0
55636,;,0,0
55637,95,0,0
55638,%,0,0
55639,CI,0,0
55640,",",0,0
55641,1.54,0,0
55642,to,0,0
55643,3.90,0,0
55644,;,0,0
55645,P=0.0002,0,0
55646,),0,0
55647,.,0,0
55648,CONCLUSIONS,0,0
55649,The,0,0
55650,addition,0,0
55651,of,0,0
55652,intravenous,0,0
55653,nicorandil,0,0
55654,to,0,0
55655,PCI,0,0
55656,leads,0,0
55657,to,0,0
55658,beneficial,0,0
55659,clinical,1,1
55660,outcomes,1,1
55661,and,0,1
55662,prevents,0,0
55663,cardiovascular,1,1
55664,events,1,1
55665,of,1,1
55666,long,1,0
55667,duration,1,1
55668,and,1,1
55669,death,1,1
55670,in,0,0
55671,patients,0,0
55672,with,0,0
55673,ST-segment-elevation,0,0
55674,myocardial,0,1
55675,infarction,0,1
55676,.,0,0
55677,Clinical,0,1
55678,efficacy,0,1
55679,of,0,1
55680,fluvoxamine,0,0
55681,and,0,1
55682,functional,0,1
55683,polymorphism,0,1
55684,in,0,0
55685,a,0,0
55686,serotonin,0,1
55687,transporter,0,1
55688,gene,0,1
55689,on,0,0
55690,childhood,0,0
55691,autism,0,0
55692,.,0,0
55693,We,0,0
55694,studied,0,0
55695,the,0,0
55696,correlation,0,0
55697,between,0,0
55698,response,0,1
55699,to,0,0
55700,fluvoxamine,0,0
55701,and,0,1
55702,serotonin,0,1
55703,transporter,0,1
55704,gene,0,1
55705,promoter,0,1
55706,region,0,0
55707,polymorphism,0,1
55708,(,0,1
55709,5-HTTLPR,0,0
55710,),0,0
55711,.,0,0
55712,Eighteen,0,0
55713,children,0,0
55714,with,0,0
55715,autistic,0,1
55716,disorder,0,0
55717,completed,0,0
55718,a,0,0
55719,12-week,0,0
55720,double-blind,0,0
55721,",",0,1
55722,placebo-controlled,0,0
55723,",",0,1
55724,randomized,0,0
55725,crossover,0,0
55726,study,0,0
55727,of,0,0
55728,fluvoxamine,0,0
55729,.,0,0
55730,Behavioral,1,1
55731,assessments,1,0
55732,were,0,0
55733,obtained,0,0
55734,before,0,0
55735,and,0,0
55736,at,0,0
55737,12,0,0
55738,weeks,0,0
55739,of,0,0
55740,treatment,0,0
55741,.,0,1
55742,5-HTTLPR,0,0
55743,(,0,0
55744,long,0,1
55745,(,0,1
55746,l,0,1
55747,),0,1
55748,or,0,1
55749,short,0,1
55750,(,0,0
55751,s,0,1
55752,),0,0
55753,),0,0
55754,",",0,0
55755,was,0,0
55756,analyzed,0,0
55757,by,0,0
55758,the,0,0
55759,PCR,0,1
55760,method,0,0
55761,.,0,0
55762,Ten,0,0
55763,out,0,0
55764,of,0,0
55765,18,0,0
55766,patients,0,0
55767,responded,0,0
55768,to,0,0
55769,fluvoxamine,0,0
55770,treatment,0,0
55771,;,0,0
55772,allele,1,1
55773,type,1,1
55774,analysis,1,0
55775,revealed,0,0
55776,that,0,0
55777,clinical,0,1
55778,global,0,1
55779,effectiveness,0,1
55780,was,0,0
55781,noted,0,0
55782,significantly,0,0
55783,more,0,0
55784,in,0,0
55785,the,0,0
55786,l,0,1
55787,allele,0,1
55788,than,0,0
55789,in,0,0
55790,the,0,0
55791,s,0,0
55792,allele,0,0
55793,.,0,0
55794,However,0,0
55795,",",0,0
55796,with,0,0
55797,respect,0,1
55798,to,0,0
55799,language,1,1
55800,use,1,0
55801,",",0,0
55802,a,0,0
55803,significant,0,0
55804,effectiveness,0,1
55805,was,0,0
55806,noted,0,0
55807,in,0,0
55808,the,0,0
55809,s,0,0
55810,allele,0,0
55811,.,0,0
55812,5-HTTLPR,0,0
55813,may,0,0
55814,influence,0,0
55815,the,0,0
55816,individual,0,0
55817,responses,0,1
55818,to,0,0
55819,fluvoxamine,0,0
55820,administration,0,0
55821,.,0,0
55822,Safety,1,1
55823,and,0,1
55824,efficacy,1,1
55825,of,0,1
55826,irinotecan,0,0
55827,plus,0,0
55828,high-dose,0,0
55829,leucovorin,0,0
55830,and,0,1
55831,intravenous,0,0
55832,bolus,0,0
55833,5-fluorouracil,0,0
55834,for,0,0
55835,metastatic,0,0
55836,colorectal,0,0
55837,cancer,0,0
55838,:,0,0
55839,pooled,0,0
55840,analysis,0,0
55841,of,0,0
55842,two,0,0
55843,consecutive,0,0
55844,southern,0,0
55845,Italy,0,0
55846,cooperative,0,0
55847,oncology,0,0
55848,group,0,0
55849,trials,0,0
55850,.,0,0
55851,BACKGROUND,0,0
55852,A,0,0
55853,biweekly,0,0
55854,regimen,0,0
55855,of,0,0
55856,irinotecan,0,0
55857,200,0,0
55858,mg/m2,0,0
55859,on,0,0
55860,day,0,0
55861,1,0,0
55862,and,0,0
55863,levo-leucovorin,0,0
55864,(,0,1
55865,LV,0,1
55866,),0,0
55867,250,0,0
55868,mg/m2,0,0
55869,plus,0,0
55870,5-fluorouracil,0,0
55871,(,0,1
55872,5-FU,0,0
55873,),0,0
55874,850,0,0
55875,mg/m2,0,0
55876,via,0,0
55877,intravenous,0,0
55878,bolus,0,0
55879,on,0,0
55880,day,0,0
55881,2,0,0
55882,was,0,0
55883,assessed,0,0
55884,in,0,0
55885,2,0,0
55886,consecutive,0,0
55887,randomized,0,0
55888,trials,0,0
55889,in,0,0
55890,metastatic,0,0
55891,colorectal,0,0
55892,cancer,0,1
55893,(,0,1
55894,CRC,0,0
55895,),0,0
55896,.,0,0
55897,PATIENTS,0,0
55898,AND,0,0
55899,METHODS,0,0
55900,Individual,0,1
55901,data,0,0
55902,of,0,0
55903,254,0,0
55904,patients,0,0
55905,were,0,0
55906,merged,0,0
55907,",",0,0
55908,and,0,1
55909,baseline,0,1
55910,features,0,0
55911,potentially,0,0
55912,affecting,0,0
55913,overall,1,1
55914,response,1,1
55915,rate,1,1
55916,(,1,1
55917,ORR,1,1
55918,),1,1
55919,",",1,0
55920,progression-free,1,1
55921,survival,1,1
55922,(,1,1
55923,PFS,1,1
55924,),1,1
55925,",",1,0
55926,overall,1,1
55927,survival,1,1
55928,(,1,1
55929,OS,1,1
55930,),1,1
55931,",",1,1
55932,and,1,1
55933,occurrence,1,1
55934,of,1,1
55935,severe,1,1
55936,toxicity,1,1
55937,were,0,0
55938,analyzed,0,0
55939,by,0,0
55940,univariate,0,0
55941,and,0,1
55942,multivariate,0,0
55943,analyses,0,0
55944,.,0,0
55945,RESULTS,0,0
55946,In,0,0
55947,the,0,0
55948,pooled,0,0
55949,series,0,0
55950,",",0,1
55951,ORR,1,1
55952,was,0,0
55953,33,0,0
55954,%,0,0
55955,(,0,0
55956,95,0,0
55957,%,0,0
55958,confidence,0,0
55959,interval,0,0
55960,[,0,0
55961,CI,0,0
55962,],0,0
55963,",",0,0
55964,27,0,0
55965,%,0,0
55966,-39,0,0
55967,%,0,0
55968,),0,0
55969,.,0,0
55970,Liver-only,0,0
55971,disease,0,1
55972,(,0,0
55973,47,0,0
55974,%,0,0
55975,vs.,0,0
55976,25,0,0
55977,%,0,0
55978,;,0,0
55979,P=0.0012,0,0
55980,),0,1
55981,and,0,1
55982,absence,0,0
55983,of,0,1
55984,previous,0,0
55985,weight,0,1
55986,loss,0,1
55987,(,0,0
55988,38,0,0
55989,%,0,0
55990,vs.,0,0
55991,20,0,0
55992,%,0,0
55993,;,0,0
55994,P=0.0189,0,0
55995,),0,0
55996,were,0,0
55997,significantly,0,0
55998,associated,0,0
55999,with,0,0
56000,a,0,0
56001,higher,0,0
56002,ORR,0,1
56003,on,0,0
56004,the,0,0
56005,multivariate,0,0
56006,analysis,0,0
56007,.,0,1
56008,Absence,0,1
56009,of,0,1
56010,weight,1,1
56011,loss,1,1
56012,(,0,0
56013,hazard,0,1
56014,ratio,0,1
56015,",",0,0
56016,1.40,0,0
56017,;,0,0
56018,95,0,0
56019,%,0,0
56020,CI,0,0
56021,",",0,0
56022,1.02-1.93,0,0
56023,;,0,1
56024,P=0.0377,0,0
56025,),0,0
56026,was,0,0
56027,significantly,0,0
56028,associated,0,0
56029,with,0,0
56030,a,0,0
56031,longer,0,0
56032,PFS,0,1
56033,(,0,0
56034,7.5,0,0
56035,months,0,0
56036,vs.,0,0
56037,6,0,0
56038,months,0,0
56039,),0,0
56040,.,0,0
56041,Median,1,1
56042,OS,1,1
56043,was,0,0
56044,15.1,0,0
56045,months,0,0
56046,(,0,0
56047,95,0,0
56048,%,0,0
56049,CI,0,0
56050,",",0,1
56051,13.5-16.6,0,0
56052,months,0,0
56053,),0,0
56054,.,0,0
56055,Primary,0,1
56056,surgery,0,0
56057,",",0,1
56058,good,0,1
56059,performance,0,1
56060,status,0,1
56061,(,0,1
56062,PS,0,1
56063,),0,1
56064,",",0,0
56065,only,0,0
56066,one,0,0
56067,metastatic,0,0
56068,site,0,0
56069,",",0,1
56070,and,0,1
56071,oxaliplatin-based,0,0
56072,second-line,0,0
56073,treatment,0,0
56074,independently,0,0
56075,predicted,0,0
56076,a,0,0
56077,longer,1,0
56078,OS,1,1
56079,.,1,0
56080,Grade,1,0
56081,4,1,0
56082,neutropenia,1,1
56083,was,0,0
56084,significantly,0,0
56085,associated,0,0
56086,with,0,0
56087,a,0,0
56088,PS,0,1
56089,>,0,1
56090,or=1,0,1
56091,",",0,1
56092,whereas,0,0
56093,risk,0,1
56094,of,0,1
56095,grade,0,1
56096,>,0,1
56097,or=3,0,0
56098,diarrhea,1,1
56099,was,0,0
56100,directly,0,0
56101,related,0,0
56102,to,0,0
56103,age,0,0
56104,and,0,1
56105,previous,0,0
56106,weight,0,1
56107,loss,0,1
56108,.,0,1
56109,CONCLUSION,0,0
56110,Patients,0,0
56111,with,0,0
56112,no,0,0
56113,weight,0,1
56114,loss,0,1
56115,and/or,0,0
56116,preserved,0,0
56117,PS,0,1
56118,and,0,0
56119,with,0,0
56120,a,0,0
56121,limited,0,0
56122,disease,0,1
56123,extent,0,0
56124,appeared,0,0
56125,to,0,0
56126,obtain,0,0
56127,the,0,0
56128,greatest,0,0
56129,benefit,0,0
56130,from,0,0
56131,our,0,0
56132,irinotecan/5-FU/LV,0,0
56133,regimen,0,0
56134,",",0,0
56135,with,0,0
56136,acceptable,0,0
56137,toxicity,0,1
56138,.,0,0
56139,Notably,0,0
56140,",",0,0
56141,the,0,0
56142,regimen,0,0
56143,was,0,0
56144,effective,0,1
56145,and,0,0
56146,well,0,1
56147,tolerated,0,1
56148,by,0,0
56149,elderly,0,0
56150,patients,0,0
56151,.,0,0
56152,This,0,0
56153,regimen,0,0
56154,may,0,0
56155,represent,0,0
56156,the,0,0
56157,rationale,0,0
56158,for,0,0
56159,assessing,0,0
56160,the,0,0
56161,addition,0,0
56162,of,0,0
56163,novel,0,0
56164,antiangiogenic,0,0
56165,drugs,0,0
56166,to,0,0
56167,the,0,0
56168,treatment,0,0
56169,of,0,0
56170,metastatic,0,0
56171,CRC,0,0
56172,.,0,0
56173,Addition,0,0
56174,of,0,0
56175,fexofenadine,0,0
56176,to,0,0
56177,inhaled,0,0
56178,corticosteroid,0,0
56179,therapy,0,0
56180,to,0,0
56181,reduce,0,0
56182,inflammatory,1,1
56183,biomarkers,1,0
56184,in,0,0
56185,atopic,0,0
56186,asthma,0,0
56187,.,0,0
56188,BACKGROUND,0,0
56189,We,0,0
56190,previously,0,0
56191,showed,0,0
56192,that,0,0
56193,H1-antihistamines,0,0
56194,may,0,0
56195,shift,0,0
56196,the,0,0
56197,PC20,0,1
56198,(,0,0
56199,provocation,0,1
56200,concentration,0,1
56201,that,0,0
56202,caused,0,0
56203,a,0,0
56204,decrease,0,1
56205,in,0,0
56206,forced,0,1
56207,expiratory,0,1
56208,volume,0,1
56209,in,0,0
56210,1,0,0
56211,second,0,0
56212,of,0,0
56213,20,0,0
56214,%,0,0
56215,),0,0
56216,threshold,0,1
56217,to,0,0
56218,adenosine,0,1
56219,monophosphate,0,1
56220,(,0,1
56221,AMP,0,1
56222,),0,1
56223,challenge,0,0
56224,but,0,0
56225,may,0,0
56226,paradoxically,0,0
56227,prolong,0,0
56228,recovery,0,1
56229,.,0,0
56230,OBJECTIVES,0,0
56231,To,0,0
56232,measure,0,0
56233,AMP,0,1
56234,recovery,0,1
56235,using,0,0
56236,a,0,0
56237,constant,0,0
56238,predetermined,0,0
56239,AMP,0,1
56240,PC20,0,0
56241,and,0,0
56242,to,0,0
56243,evaluate,0,0
56244,whether,0,0
56245,fexofenadine,0,0
56246,use,0,0
56247,confers,0,0
56248,add-on,0,0
56249,effects,0,1
56250,to,0,0
56251,treatment,0,0
56252,with,0,0
56253,either,0,0
56254,fluticasone,0,0
56255,propionate,0,0
56256,alone,0,0
56257,or,0,0
56258,combined,0,0
56259,fluticasone,0,0
56260,propionate-salmeterol,0,0
56261,.,0,0
56262,METHODS,0,0
56263,Fourteen,0,0
56264,atopic,0,1
56265,patients,0,0
56266,with,0,0
56267,mild-to-moderate,0,0
56268,asthma,0,1
56269,(,0,0
56270,forced,0,1
56271,expiratory,0,1
56272,volume,0,1
56273,in,0,0
56274,1,0,0
56275,second,0,0
56276,of,0,0
56277,76,0,0
56278,%,0,0
56279,),0,0
56280,completed,0,0
56281,a,0,0
56282,double-blind,0,0
56283,",",0,0
56284,randomized,0,0
56285,",",0,0
56286,crossover,0,0
56287,study,0,0
56288,consisting,0,0
56289,of,0,0
56290,3-week,0,0
56291,treatment,0,0
56292,blocks,0,0
56293,of,0,0
56294,either,0,0
56295,fluticasone,0,0
56296,propionate-salmeterol,0,0
56297,",",0,0
56298,250,0,0
56299,microg,0,0
56300,twice,0,0
56301,daily,0,0
56302,",",0,0
56303,or,0,1
56304,fluticasone,0,0
56305,propionate,0,0
56306,alone,0,0
56307,",",0,0
56308,250,0,0
56309,microg,0,0
56310,twice,0,0
56311,daily,0,0
56312,",",0,0
56313,in,0,0
56314,conjunction,0,0
56315,with,0,0
56316,either,0,0
56317,fexofenadine,0,0
56318,",",0,0
56319,180,0,0
56320,mg,0,0
56321,once,0,0
56322,daily,0,0
56323,",",0,1
56324,or,0,1
56325,matched,0,0
56326,placebo,0,0
56327,.,0,1
56328,Recovery,1,1
56329,after,0,0
56330,a,0,0
56331,predetermined,1,0
56332,AMP,1,1
56333,PC20,1,1
56334,challenge,1,0
56335,was,0,0
56336,measured,0,1
56337,(,0,0
56338,primary,0,0
56339,outcome,0,1
56340,),0,1
56341,",",0,0
56342,along,0,0
56343,with,0,0
56344,exhaled,1,1
56345,nitric,1,1
56346,oxide,1,1
56347,levels,1,1
56348,",",1,1
56349,plasma,1,1
56350,eosinophil,1,1
56351,cationic,1,1
56352,protein,1,1
56353,levels,1,1
56354,",",1,1
56355,peripheral,1,1
56356,eosinophil,1,1
56357,counts,1,1
56358,",",1,1
56359,pulmonary,1,1
56360,function,1,1
56361,",",1,1
56362,diary,1,1
56363,card,1,1
56364,outcomes,1,1
56365,",",1,1
56366,and,1,1
56367,quality,1,1
56368,of,1,1
56369,life,1,1
56370,(,0,0
56371,all,0,0
56372,secondary,0,1
56373,outcomes,0,1
56374,),0,0
56375,.,0,0
56376,RESULTS,0,0
56377,There,0,0
56378,were,0,0
56379,no,0,0
56380,differences,0,0
56381,in,0,0
56382,any,0,0
56383,of,0,0
56384,the,0,0
56385,primary,0,0
56386,or,0,0
56387,secondary,0,1
56388,outcomes,0,1
56389,when,0,0
56390,fexofenadine,0,0
56391,was,0,0
56392,added,0,0
56393,to,0,0
56394,treatment,0,0
56395,with,0,0
56396,either,0,0
56397,fluticasone,0,0
56398,propionate-salmeterol,0,0
56399,or,0,1
56400,fluticasone,0,0
56401,propionate,0,0
56402,alone,0,0
56403,.,0,0
56404,The,0,0
56405,mean,0,1
56406,AMP,0,1
56407,recovery,0,1
56408,time,0,1
56409,was,0,0
56410,25.0,0,0
56411,vs,0,0
56412,23.4,0,0
56413,minutes,0,0
56414,for,0,0
56415,fexofenadine,0,0
56416,and,0,1
56417,placebo,0,0
56418,",",0,1
56419,respectively,0,0
56420,",",0,0
56421,as,0,0
56422,add-on,0,0
56423,to,0,0
56424,fluticasone-salmeterol,0,0
56425,and,0,0
56426,22.5,0,0
56427,vs,0,0
56428,23.9,0,0
56429,minutes,0,0
56430,",",0,0
56431,respectively,0,0
56432,",",0,0
56433,as,0,0
56434,add-on,0,0
56435,to,0,0
56436,fluticasone,0,0
56437,alone,0,0
56438,.,0,0
56439,CONCLUSION,0,0
56440,Fexofenadine,0,0
56441,did,0,0
56442,not,0,0
56443,affect,0,0
56444,recovery,0,1
56445,to,0,0
56446,a,0,0
56447,fixed,0,0
56448,dose,0,0
56449,of,0,0
56450,AMP,0,1
56451,challenge,0,0
56452,or,0,0
56453,any,0,1
56454,other,0,0
56455,surrogate,0,0
56456,inflammatory,0,1
56457,markers,0,1
56458,when,0,0
56459,given,0,0
56460,as,0,0
56461,add-on,0,0
56462,therapy,0,0
56463,to,0,0
56464,corticosteroid-treatedatopic,0,0
56465,asthmatic,0,0
56466,patients,0,0
56467,.,0,0
56468,[,0,0
56469,Study,0,0
56470,on,0,0
56471,classification,0,1
56472,and,0,1
56473,treatment,0,0
56474,of,0,1
56475,vulvovaginal,0,1
56476,candidiasis,0,0
56477,],0,0
56478,.,0,0
56479,OBJECTIVE,0,0
56480,To,0,0
56481,determine,0,0
56482,the,0,0
56483,clinical,0,0
56484,manifestations,0,1
56485,of,0,1
56486,vulvovaginal,0,1
56487,candidiasis,0,1
56488,(,0,1
56489,VVC,0,1
56490,),0,0
56491,and,0,0
56492,to,0,0
56493,study,0,0
56494,the,0,0
56495,mycologic,1,0
56496,eradication,1,1
56497,rate,1,1
56498,of,0,1
56499,different,0,0
56500,miconazole,0,0
56501,treatment,0,0
56502,courses,0,0
56503,for,0,0
56504,VVC,0,0
56505,.,0,0
56506,METHODS,0,0
56507,Three,0,0
56508,hundred,0,0
56509,cases,0,0
56510,of,0,1
56511,VVC,0,0
56512,were,0,0
56513,recruited,0,0
56514,.,0,0
56515,The,0,0
56516,Candidas,0,1
56517,were,0,0
56518,cultured,0,0
56519,.,0,0
56520,A,0,0
56521,prospective,0,0
56522,and,0,1
56523,randomized,0,0
56524,study,0,0
56525,was,0,0
56526,performed,0,0
56527,to,0,0
56528,compare,0,0
56529,the,0,0
56530,treatment,0,0
56531,effect,0,0
56532,of,0,0
56533,3,0,0
56534,day,0,0
56535,miconazole,0,0
56536,(,0,0
56537,400,0,0
56538,mg/d,0,0
56539,),0,0
56540,",",0,0
56541,6,0,0
56542,day,0,0
56543,miconazole,0,0
56544,(,0,0
56545,400,0,0
56546,mg/d,0,0
56547,),0,0
56548,",",0,0
56549,and,0,0
56550,7,0,0
56551,day,0,0
56552,miconazole,0,0
56553,(,0,0
56554,200,0,0
56555,mg/d,0,0
56556,),0,0
56557,for,0,0
56558,uncomplicated,0,0
56559,and,0,1
56560,complicated,0,1
56561,VVC,0,0
56562,.,0,1
56563,RESULTS,0,0
56564,Among,0,0
56565,300,0,0
56566,cases,0,0
56567,of,0,0
56568,VVC,0,0
56569,",",0,1
56570,uncomplicated,0,0
56571,",",0,1
56572,complicated,0,1
56573,and,0,1
56574,recurrent,0,1
56575,VVC,0,0
56576,were,0,0
56577,56.0,0,0
56578,%,0,0
56579,",",0,0
56580,44.0,0,0
56581,%,0,0
56582,and,0,0
56583,9.7,0,0
56584,%,0,0
56585,(,0,0
56586,29/300,0,0
56587,),0,0
56588,respectively,0,0
56589,.,0,0
56590,C.,0,1
56591,albicans,0,0
56592,was,0,0
56593,isolated,0,0
56594,most,0,0
56595,frequently,0,0
56596,90.3,0,0
56597,%,0,0
56598,(,0,0
56599,271/300,0,0
56600,),0,0
56601,",",0,0
56602,followed,0,0
56603,by,0,0
56604,C.,0,1
56605,glabrata,0,0
56606,(,0,0
56607,7.3,0,0
56608,%,0,0
56609,),0,0
56610,",",0,0
56611,C.,0,1
56612,tropicalis,0,1
56613,(,0,0
56614,1.3,0,0
56615,%,0,0
56616,),0,0
56617,",",0,0
56618,C.,0,1
56619,krusei,0,1
56620,(,0,0
56621,0.7,0,0
56622,%,0,0
56623,),0,0
56624,",",0,1
56625,and,0,1
56626,C.,0,1
56627,parapsilosis,0,1
56628,(,0,0
56629,0.3,0,0
56630,%,0,0
56631,),0,0
56632,.,0,0
56633,Mycologic,1,0
56634,eradication,1,1
56635,rate,1,1
56636,of,0,0
56637,3,0,0
56638,day,0,0
56639,",",0,0
56640,6,0,0
56641,day,0,0
56642,and,0,0
56643,7,0,0
56644,day,0,0
56645,miconazole,0,0
56646,courses,0,0
56647,for,0,0
56648,uncomplicated,0,0
56649,VVC,0,0
56650,at,0,0
56651,day,0,0
56652,14,0,0
56653,was,0,0
56654,96.0,0,0
56655,%,0,0
56656,",",0,0
56657,93.5,0,0
56658,%,0,0
56659,and,0,0
56660,98.0,0,0
56661,%,0,0
56662,",",0,0
56663,respectively,0,0
56664,(,0,0
56665,P,0,0
56666,>,0,0
56667,0.05,0,0
56668,),0,0
56669,.,0,0
56670,Eradication,1,1
56671,rate,1,1
56672,of,0,0
56673,3,0,0
56674,day,0,0
56675,",",0,0
56676,6,0,0
56677,day,0,0
56678,and,0,0
56679,7,0,0
56680,day,0,0
56681,miconazole,0,0
56682,courses,0,0
56683,for,0,0
56684,complicated,0,0
56685,VVC,0,0
56686,at,0,0
56687,day,0,0
56688,14,0,0
56689,was,0,0
56690,86.7,0,0
56691,%,0,0
56692,",",0,0
56693,92.5,0,0
56694,%,0,0
56695,",",0,0
56696,and,0,0
56697,86.4,0,0
56698,%,0,0
56699,",",0,0
56700,respectively,0,0
56701,(,0,0
56702,P,0,0
56703,>,0,0
56704,0.05,0,0
56705,),0,0
56706,.,0,0
56707,Eradication,1,1
56708,rate,1,1
56709,of,0,0
56710,3,0,0
56711,day,0,0
56712,",",0,0
56713,6,0,0
56714,day,0,0
56715,and,0,0
56716,7,0,0
56717,day,0,0
56718,miconazole,0,0
56719,courses,0,0
56720,for,0,0
56721,uncomplicated,0,0
56722,VVC,0,0
56723,at,0,0
56724,day,0,0
56725,35,0,0
56726,was,0,0
56727,93.8,0,0
56728,%,0,0
56729,",",0,0
56730,95.3,0,0
56731,%,0,0
56732,",",0,0
56733,and,0,0
56734,89.8,0,0
56735,%,0,0
56736,",",0,0
56737,respectively,0,0
56738,(,0,0
56739,P,0,0
56740,>,0,0
56741,0.05,0,0
56742,),0,0
56743,.,0,0
56744,Eradication,1,1
56745,rate,1,1
56746,of,0,0
56747,3,0,0
56748,day,0,0
56749,",",0,0
56750,6,0,0
56751,day,0,0
56752,and,0,0
56753,7,0,0
56754,day,0,0
56755,miconazole,0,0
56756,courses,0,0
56757,for,0,0
56758,complicated,0,0
56759,VVC,0,0
56760,at,0,0
56761,day,0,0
56762,35,0,0
56763,was,0,0
56764,89.7,0,0
56765,%,0,0
56766,",",0,0
56767,97.3,0,0
56768,%,0,0
56769,and,0,0
56770,86.8,0,0
56771,%,0,0
56772,",",0,0
56773,respectively,0,0
56774,(,0,0
56775,P,0,0
56776,>,0,0
56777,0.05,0,0
56778,),0,0
56779,.,0,0
56780,CONCLUSION,0,0
56781,Treatment,0,0
56782,of,0,0
56783,VVC,0,0
56784,should,0,0
56785,be,0,0
56786,individualized,0,0
56787,",",0,0
56788,and,0,1
56789,women,0,0
56790,with,0,0
56791,complicated,0,0
56792,VVC,0,0
56793,achieve,0,0
56794,superior,0,1
56795,mycologic,1,1
56796,eradication,1,1
56797,by,0,0
56798,a,0,0
56799,6,0,0
56800,day,0,0
56801,miconazole,0,0
56802,course,0,0
56803,.,0,0
56804,Treatment,0,0
56805,of,0,1
56806,anal,0,1
56807,fissures,0,1
56808,using,0,0
56809,a,0,0
56810,combination,0,0
56811,of,0,1
56812,minoxidil,0,0
56813,and,0,0
56814,lignocaine,0,0
56815,:,0,0
56816,a,0,0
56817,randomized,0,0
56818,",",0,0
56819,double-blind,0,0
56820,trial,0,0
56821,.,0,0
56822,AIM,0,1
56823,Anal,0,1
56824,fissures,0,1
56825,are,0,0
56826,associated,0,0
56827,with,0,0
56828,hypertonia,0,0
56829,of,0,0
56830,the,0,0
56831,internal,0,0
56832,anal,0,1
56833,sphincter,0,1
56834,and,0,1
56835,pain,0,1
56836,.,0,0
56837,We,0,0
56838,evaluated,0,0
56839,the,0,0
56840,efficacy,0,1
56841,of,0,0
56842,local,0,0
56843,application,0,0
56844,of,0,0
56845,a,0,0
56846,combination,0,0
56847,of,0,1
56848,minoxidil,0,0
56849,and,0,1
56850,lignocaine,0,0
56851,in,0,0
56852,healing,0,1
56853,anal,0,1
56854,fissures,0,1
56855,.,0,0
56856,METHODS,0,0
56857,In,0,0
56858,this,0,0
56859,prospective,0,0
56860,",",0,0
56861,randomized,0,0
56862,",",0,0
56863,double-blind,0,0
56864,study,0,0
56865,",",0,0
56866,90,0,0
56867,patients,0,0
56868,with,0,0
56869,anal,0,1
56870,fissure,0,1
56871,were,0,0
56872,recruited,0,0
56873,.,0,0
56874,Patients,0,0
56875,received,0,0
56876,local,0,0
56877,applications,0,0
56878,of,0,0
56879,ointments,0,0
56880,containing,0,0
56881,5,0,0
56882,%,0,0
56883,lignocaine,0,0
56884,(,0,1
56885,n=28,0,0
56886,),0,0
56887,",",0,0
56888,0.5,0,0
56889,%,0,0
56890,minoxidil,0,0
56891,(,0,1
56892,n=36,0,0
56893,),0,1
56894,",",0,0
56895,or,0,0
56896,both,0,0
56897,(,0,0
56898,n=26,0,0
56899,),0,0
56900,.,0,0
56901,Healing,1,0
56902,of,1,0
56903,anal,1,1
56904,fissure,1,0
56905,at,0,0
56906,6,0,0
56907,weeks,0,0
56908,was,0,0
56909,used,0,0
56910,as,0,0
56911,the,0,0
56912,primary,0,0
56913,end-point,0,1
56914,.,0,0
56915,RESULTS,0,0
56916,Rates,1,1
56917,of,1,0
56918,complete,1,1
56919,healing,1,1
56920,of,1,1
56921,fissure,1,1
56922,were,0,0
56923,similar,0,0
56924,in,0,0
56925,the,0,0
56926,three,0,0
56927,groups,0,0
56928,(,0,0
56929,lignocaine,0,0
56930,alone,0,0
56931,8/27,0,0
56932,",",0,0
56933,minoxidil,0,0
56934,alone,0,0
56935,10/34,0,0
56936,",",0,0
56937,combination,0,0
56938,7/22,0,0
56939,;,0,0
56940,p=ns,0,0
56941,),0,0
56942,.,0,1
56943,Mean,1,1
56944,(,1,0
56945,SD,1,1
56946,),1,1
56947,time,1,1
56948,taken,1,0
56949,for,1,0
56950,complete,1,1
56951,healing,1,1
56952,with,1,0
56953,combination,1,0
56954,treatment,1,0
56955,[,0,0
56956,1.9,0,0
56957,(,0,0
56958,0.6,0,0
56959,),0,0
56960,weeks,0,0
56961,],0,0
56962,was,0,0
56963,significantly,0,0
56964,shorter,0,0
56965,than,0,0
56966,that,0,0
56967,with,0,0
56968,minoxidil,0,0
56969,alone,0,0
56970,(,0,0
56971,3.1,0,0
56972,[,0,0
56973,1.7,0,0
56974,],0,0
56975,weeks,0,0
56976,;,0,0
56977,p=0.001,0,1
56978,),0,1
56979,or,0,0
56980,with,0,0
56981,lignocaine,0,0
56982,alone,0,0
56983,(,0,0
56984,3.3,0,0
56985,[,0,0
56986,0.8,0,0
56987,],0,0
56988,weeks,0,0
56989,;,0,0
56990,p=0.002,0,0
56991,),0,0
56992,.,0,0
56993,Rates,1,1
56994,of,1,1
56995,pain,1,1
56996,relief,1,1
56997,were,0,0
56998,similar,0,0
56999,in,0,0
57000,the,0,0
57001,three,0,0
57002,groups,0,0
57003,.,0,0
57004,Stoppage,1,0
57005,of,1,1
57006,bleeding,1,1
57007,occurred,0,0
57008,more,0,0
57009,often,0,0
57010,with,0,0
57011,combination,0,0
57012,treatment,0,0
57013,than,0,0
57014,with,0,0
57015,lignocaine,0,0
57016,alone,0,0
57017,.,0,0
57018,No,0,0
57019,patient,0,1
57020,had,0,0
57021,systemic,1,1
57022,or,1,1
57023,local,1,1
57024,side,1,1
57025,effects,1,1
57026,.,1,0
57027,CONCLUSION,0,0
57028,Combination,0,1
57029,treatment,0,0
57030,with,0,0
57031,minoxidil,0,0
57032,and,0,0
57033,lignocaine,0,0
57034,helps,0,0
57035,in,0,0
57036,faster,0,0
57037,healing,0,1
57038,of,0,0
57039,anal,0,1
57040,fissures,0,1
57041,and,0,0
57042,provides,0,0
57043,better,0,0
57044,symptomatic,0,1
57045,relief,0,1
57046,than,0,0
57047,either,0,0
57048,drug,0,0
57049,alone,0,0
57050,.,0,0
57051,Intensive,0,0
57052,behavioral,0,1
57053,treatment,0,0
57054,for,0,0
57055,children,0,0
57056,with,0,0
57057,autism,1,0
57058,:,1,0
57059,four-year,0,0
57060,outcome,0,1
57061,and,0,0
57062,predictors,0,1
57063,.,0,1
57064,Twenty-four,0,0
57065,children,0,0
57066,with,0,0
57067,autism,0,0
57068,were,0,0
57069,randomly,0,0
57070,assigned,0,0
57071,to,0,0
57072,a,0,0
57073,clinic-directed,0,0
57074,group,0,0
57075,",",0,0
57076,replicating,0,0
57077,the,0,0
57078,parameters,0,0
57079,of,0,0
57080,the,0,0
57081,early,0,0
57082,intensive,0,0
57083,behavioral,0,1
57084,treatment,0,0
57085,developed,0,0
57086,at,0,0
57087,UCLA,0,1
57088,",",0,0
57089,or,0,0
57090,to,0,0
57091,a,0,0
57092,parent-directed,0,0
57093,group,0,0
57094,that,0,0
57095,received,0,0
57096,intensive,0,0
57097,hours,0,1
57098,but,0,0
57099,less,0,0
57100,supervision,0,1
57101,by,0,0
57102,equally,0,0
57103,well-trained,0,0
57104,supervisors,0,0
57105,.,0,0
57106,Outcome,0,1
57107,after,0,0
57108,4,0,0
57109,years,0,0
57110,of,0,0
57111,treatment,0,0
57112,",",0,0
57113,including,0,0
57114,cognitive,1,1
57115,",",1,1
57116,language,1,1
57117,",",1,1
57118,adaptive,1,1
57119,",",1,1
57120,social,1,1
57121,",",1,1
57122,and,1,1
57123,academic,1,1
57124,measures,1,1
57125,",",0,1
57126,was,0,0
57127,similar,0,0
57128,for,0,0
57129,both,0,0
57130,groups,0,0
57131,.,0,0
57132,After,0,0
57133,combining,0,0
57134,groups,0,0
57135,",",0,0
57136,we,0,0
57137,found,0,0
57138,that,0,0
57139,48,0,0
57140,%,0,0
57141,of,0,0
57142,all,0,0
57143,children,0,0
57144,showed,0,0
57145,rapid,1,1
57146,learning,1,1
57147,",",0,0
57148,achieved,0,1
57149,average,1,1
57150,posttreatment,1,0
57151,scores,1,1
57152,",",0,1
57153,and,0,1
57154,at,0,0
57155,age,0,0
57156,7,0,0
57157,",",0,0
57158,were,0,0
57159,succeeding,0,0
57160,in,0,0
57161,regular,0,0
57162,education,0,0
57163,classrooms,0,0
57164,.,0,1
57165,Treatment,0,0
57166,outcome,0,1
57167,was,0,0
57168,best,0,0
57169,predicted,0,0
57170,by,0,0
57171,pretreatment,1,0
57172,imitation,1,1
57173,",",1,1
57174,language,1,1
57175,",",1,1
57176,and,1,1
57177,social,1,1
57178,responsiveness,1,1
57179,.,1,0
57180,These,0,0
57181,results,0,0
57182,are,0,0
57183,consistent,0,0
57184,with,0,0
57185,those,0,0
57186,reported,0,0
57187,by,0,0
57188,Lovaas,0,0
57189,and,0,1
57190,colleagues,0,1
57191,(,0,1
57192,Lovaas,0,0
57193,",",0,0
57194,1987,0,0
57195,;,0,0
57196,McEachin,0,0
57197,",",0,1
57198,Smith,0,1
57199,",",0,1
57200,&,0,1
57201,Lovaas,0,1
57202,",",0,0
57203,1993,0,0
57204,),0,0
57205,.,0,0
57206,Secondary,0,0
57207,prevention,0,0
57208,of,0,1
57209,macrovascular,1,1
57210,events,1,1
57211,in,0,0
57212,patients,0,0
57213,with,0,0
57214,type,0,0
57215,2,0,0
57216,diabetes,0,0
57217,in,0,0
57218,the,0,0
57219,PROactive,0,0
57220,Study,0,0
57221,(,0,0
57222,PROspective,0,0
57223,pioglitAzone,0,0
57224,Clinical,0,1
57225,Trial,0,0
57226,In,0,0
57227,macroVascular,0,1
57228,Events,0,0
57229,),0,0
57230,:,0,0
57231,a,0,0
57232,randomised,0,0
57233,controlled,0,0
57234,trial,0,0
57235,.,0,0
57236,BACKGROUND,0,0
57237,Patients,0,0
57238,with,0,0
57239,type,0,0
57240,2,0,0
57241,diabetes,0,0
57242,are,0,0
57243,at,0,0
57244,high,0,0
57245,risk,0,1
57246,of,0,1
57247,fatal,0,1
57248,and,0,1
57249,non-fatal,0,1
57250,myocardial,1,1
57251,infarction,1,1
57252,and,0,1
57253,stroke,1,1
57254,.,1,0
57255,There,0,0
57256,is,0,0
57257,indirect,0,0
57258,evidence,0,0
57259,that,0,0
57260,agonists,0,0
57261,of,0,0
57262,peroxisome,0,0
57263,proliferator-activated,0,0
57264,receptor,0,1
57265,gamma,0,1
57266,(,0,1
57267,PPAR,0,1
57268,gamma,0,0
57269,),0,0
57270,could,0,0
57271,reduce,0,0
57272,macrovascular,1,1
57273,complications,1,1
57274,.,1,0
57275,Our,0,0
57276,aim,0,0
57277,",",0,0
57278,therefore,0,0
57279,",",0,0
57280,was,0,0
57281,to,0,0
57282,ascertain,0,0
57283,whether,0,0
57284,pioglitazone,0,0
57285,reduces,0,1
57286,macrovascular,1,1
57287,morbidity,1,1
57288,and,0,1
57289,mortality,1,1
57290,in,0,0
57291,high-risk,0,0
57292,patients,0,0
57293,with,0,0
57294,type,0,0
57295,2,0,0
57296,diabetes,0,0
57297,.,0,0
57298,METHODS,0,0
57299,We,0,0
57300,did,0,0
57301,a,0,0
57302,prospective,0,0
57303,",",0,0
57304,randomised,0,0
57305,controlled,0,0
57306,trial,0,0
57307,in,0,0
57308,5238,0,0
57309,patients,0,0
57310,with,0,0
57311,type,0,0
57312,2,0,0
57313,diabetes,0,0
57314,who,0,0
57315,had,0,0
57316,evidence,0,0
57317,of,0,1
57318,macrovascular,1,1
57319,disease,1,0
57320,.,1,0
57321,We,0,0
57322,recruited,0,0
57323,patients,0,0
57324,from,0,0
57325,primary-care,0,0
57326,practices,0,1
57327,and,0,0
57328,hospitals,0,0
57329,.,0,0
57330,We,0,0
57331,assigned,0,0
57332,patients,0,0
57333,to,0,0
57334,oral,0,0
57335,pioglitazone,0,0
57336,titrated,0,0
57337,from,0,0
57338,15,0,0
57339,mg,0,0
57340,to,0,0
57341,45,0,0
57342,mg,0,0
57343,(,0,0
57344,n=2605,0,0
57345,),0,1
57346,or,0,0
57347,matching,0,0
57348,placebo,0,0
57349,(,0,0
57350,n=2633,0,0
57351,),0,0
57352,",",0,0
57353,to,0,0
57354,be,0,0
57355,taken,0,0
57356,in,0,0
57357,addition,0,0
57358,to,0,0
57359,their,0,0
57360,glucose-lowering,0,0
57361,drugs,0,0
57362,and,0,1
57363,other,0,0
57364,medications,0,0
57365,.,0,0
57366,Our,0,0
57367,primary,0,0
57368,endpoint,0,1
57369,was,0,0
57370,the,0,0
57371,composite,1,1
57372,of,1,0
57373,all-cause,1,1
57374,mortality,1,1
57375,",",1,1
57376,non,1,0
57377,fatal,1,1
57378,myocardial,1,1
57379,infarction,1,1
57380,(,1,0
57381,including,1,0
57382,silent,1,1
57383,myocardial,1,1
57384,infarction,1,1
57385,),1,1
57386,",",1,1
57387,stroke,1,1
57388,",",1,1
57389,acute,1,1
57390,coronary,1,1
57391,syndrome,1,0
57392,",",1,1
57393,endovascular,1,0
57394,or,1,1
57395,surgical,1,1
57396,intervention,1,0
57397,in,1,0
57398,the,1,0
57399,coronary,1,0
57400,or,1,0
57401,leg,1,1
57402,arteries,1,1
57403,",",1,1
57404,and,1,1
57405,amputation,1,1
57406,above,1,0
57407,the,1,0
57408,ankle,1,1
57409,.,1,1
57410,Analysis,0,0
57411,was,0,0
57412,by,0,0
57413,intention,0,1
57414,to,0,0
57415,treat,0,0
57416,.,0,0
57417,This,0,0
57418,study,0,0
57419,is,0,0
57420,registered,0,0
57421,as,0,0
57422,an,0,0
57423,International,0,1
57424,Standard,0,0
57425,Randomised,0,0
57426,Controlled,0,0
57427,Trial,0,0
57428,",",0,1
57429,number,0,1
57430,ISRCTN,0,0
57431,NCT00174993,0,0
57432,.,0,0
57433,FINDINGS,0,0
57434,Two,0,0
57435,patients,0,0
57436,were,0,0
57437,lost,0,0
57438,to,0,0
57439,follow-up,0,0
57440,",",0,1
57441,but,0,0
57442,were,0,0
57443,included,0,0
57444,in,0,0
57445,analyses,0,0
57446,.,0,0
57447,The,0,0
57448,average,0,1
57449,time,0,1
57450,of,0,1
57451,observation,0,0
57452,was,0,0
57453,34.5,0,0
57454,months,0,0
57455,.,0,0
57456,514,0,0
57457,of,0,0
57458,2605,0,0
57459,patients,0,0
57460,in,0,0
57461,the,0,0
57462,pioglitazone,0,0
57463,group,0,0
57464,and,0,0
57465,572,0,0
57466,of,0,0
57467,2633,0,0
57468,patients,0,0
57469,in,0,0
57470,the,0,0
57471,placebo,0,0
57472,group,0,0
57473,had,0,0
57474,at,0,0
57475,least,0,0
57476,one,0,0
57477,event,0,0
57478,in,0,0
57479,the,0,0
57480,primary,1,0
57481,composite,1,1
57482,endpoint,1,1
57483,(,0,0
57484,HR,0,0
57485,0.90,0,0
57486,",",0,0
57487,95,0,0
57488,%,0,0
57489,CI,0,0
57490,0.80-1.02,0,0
57491,",",0,0
57492,p=0.095,0,0
57493,),0,0
57494,.,0,0
57495,The,0,0
57496,main,0,0
57497,secondary,0,1
57498,endpoint,0,1
57499,was,0,0
57500,the,0,0
57501,composite,1,1
57502,of,1,0
57503,all-cause,1,1
57504,mortality,1,1
57505,",",1,1
57506,non-fatal,1,1
57507,myocardial,1,1
57508,infarction,1,1
57509,",",1,1
57510,and,1,1
57511,stroke,1,1
57512,.,1,0
57513,301,0,0
57514,patients,0,0
57515,in,0,0
57516,the,0,0
57517,pioglitazone,0,0
57518,group,0,0
57519,and,0,0
57520,358,0,0
57521,in,0,0
57522,the,0,0
57523,placebo,0,0
57524,group,0,0
57525,reached,0,0
57526,this,0,0
57527,endpoint,1,1
57528,(,0,0
57529,0.84,0,0
57530,",",0,0
57531,0.72-0.98,0,0
57532,",",0,0
57533,p=0.027,0,0
57534,),0,1
57535,.,0,0
57536,Overall,1,1
57537,safety,1,1
57538,and,1,1
57539,tolerability,1,1
57540,was,0,0
57541,good,0,0
57542,with,0,0
57543,no,0,0
57544,change,0,0
57545,in,0,0
57546,the,0,0
57547,safety,1,1
57548,profile,1,1
57549,of,0,1
57550,pioglitazone,0,0
57551,identified,0,0
57552,.,0,0
57553,6,0,0
57554,%,0,0
57555,(,0,0
57556,149,0,0
57557,of,0,0
57558,2065,0,0
57559,),0,0
57560,and,0,0
57561,4,0,0
57562,%,0,0
57563,(,0,0
57564,108,0,0
57565,of,0,0
57566,2633,0,0
57567,),0,0
57568,of,0,0
57569,those,0,0
57570,in,0,0
57571,the,0,0
57572,pioglitazone,0,0
57573,and,0,1
57574,placebo,0,0
57575,groups,0,0
57576,",",0,0
57577,respectively,0,0
57578,",",0,0
57579,were,0,0
57580,admitted,0,0
57581,to,0,0
57582,hospital,0,0
57583,with,0,0
57584,heart,1,1
57585,failure,1,1
57586,;,1,0
57587,mortality,1,1
57588,rates,1,1
57589,from,1,0
57590,heart,1,1
57591,failure,1,1
57592,did,0,0
57593,not,0,0
57594,differ,0,0
57595,between,0,0
57596,groups,0,0
57597,.,0,0
57598,INTERPRETATION,0,0
57599,Pioglitazone,0,0
57600,reduces,0,0
57601,the,0,0
57602,composite,0,1
57603,of,0,0
57604,all-cause,0,1
57605,mortality,1,1
57606,",",1,1
57607,non-fatal,1,1
57608,myocardial,1,1
57609,infarction,1,1
57610,",",0,1
57611,and,0,1
57612,stroke,1,1
57613,in,0,0
57614,patients,0,0
57615,with,0,0
57616,type,0,0
57617,2,0,0
57618,diabetes,0,0
57619,who,0,0
57620,have,0,0
57621,a,0,0
57622,high,0,0
57623,risk,0,1
57624,of,0,1
57625,macrovascular,0,1
57626,events,0,1
57627,.,0,0
57628,Efficacy,1,1
57629,",",1,1
57630,tolerability,1,1
57631,and,1,1
57632,pharmacokinetics,1,1
57633,of,0,0
57634,two,0,0
57635,nelfinavir-based,0,0
57636,regimens,0,0
57637,in,0,0
57638,human,0,0
57639,immunodeficiency,0,0
57640,virus-infected,0,0
57641,children,0,0
57642,and,0,0
57643,adolescents,0,0
57644,:,0,0
57645,pediatric,0,0
57646,AIDS,0,0
57647,clinical,0,1
57648,trials,0,0
57649,group,0,0
57650,protocol,0,0
57651,403,0,0
57652,.,0,0
57653,INTRODUCTION,0,0
57654,Few,0,0
57655,combinations,0,0
57656,of,0,0
57657,highly,0,0
57658,active,0,0
57659,antiretrovirals,0,0
57660,have,0,0
57661,been,0,0
57662,studied,0,0
57663,in,0,0
57664,nucleoside,0,1
57665,reverse,0,0
57666,transcription,0,1
57667,inhibitor,0,0
57668,(,0,1
57669,NRTI,0,1
57670,),0,1
57671,-experienced,0,0
57672,",",0,0
57673,human,0,0
57674,immunodeficiency,0,0
57675,virus,0,1
57676,(,0,1
57677,HIV,0,1
57678,),0,1
57679,-infected,0,0
57680,children,0,0
57681,.,0,0
57682,We,0,0
57683,tested,0,0
57684,the,0,0
57685,efficacy,0,1
57686,",",0,1
57687,tolerability,0,1
57688,and,0,1
57689,pharmacokinetics,0,1
57690,of,0,0
57691,2,0,0
57692,combination,0,0
57693,therapies,0,0
57694,containing,0,0
57695,an,0,0
57696,NRTI,0,0
57697,",",0,0
57698,protease,0,1
57699,inhibitors,0,0
57700,+/-,0,0
57701,a,0,0
57702,nonnucleoside,0,0
57703,reverse,0,0
57704,transcription,0,1
57705,inhibitor,0,0
57706,(,0,1
57707,NNRTI,0,0
57708,),0,0
57709,.,0,0
57710,METHODS,0,0
57711,This,0,0
57712,was,0,0
57713,a,0,0
57714,phase,0,0
57715,II,0,0
57716,",",0,1
57717,randomized,0,0
57718,",",0,1
57719,multicenter,0,0
57720,study,0,0
57721,.,0,0
57722,Forty-one,0,0
57723,children,0,0
57724,and,0,0
57725,youths,0,0
57726,between,0,0
57727,5,0,0
57728,months,0,0
57729,and,0,0
57730,21,0,0
57731,years,0,0
57732,with,0,0
57733,prior,0,0
57734,NRTI,0,0
57735,and,0,0
57736,no,0,0
57737,prior,0,0
57738,NNRTI,0,0
57739,or,0,1
57740,protease,0,1
57741,inhibitor,0,0
57742,experience,0,1
57743,received,0,0
57744,either,0,0
57745,nelfinavir,0,1
57746,(,0,1
57747,NFV,0,0
57748,),0,0
57749,30,0,0
57750,mg/kg,0,0
57751,twice,0,0
57752,daily,0,0
57753,(,0,0
57754,bid,0,1
57755,),0,1
57756,",",0,1
57757,ritonavir,0,0
57758,(,0,1
57759,RTV,0,1
57760,),0,0
57761,400,0,0
57762,mg/m,0,0
57763,bid,0,0
57764,and,0,1
57765,buffered,0,0
57766,didanosine,0,0
57767,(,0,0
57768,ddI,0,0
57769,),0,0
57770,240,0,0
57771,mg/m,0,0
57772,daily,0,0
57773,(,0,0
57774,arm,0,0
57775,A,0,0
57776,),0,1
57777,or,0,0
57778,NFV,0,0
57779,50-55,0,0
57780,mg/kg,0,0
57781,bid,0,1
57782,",",0,1
57783,nevirapine,0,0
57784,(,0,1
57785,NVP,0,0
57786,),0,0
57787,120,0,0
57788,mg/m,0,0
57789,bid,0,0
57790,and,0,1
57791,stavudine,0,0
57792,(,0,1
57793,d4T,0,1
57794,),0,0
57795,1,0,0
57796,mg/kg,0,0
57797,bid,0,0
57798,(,0,0
57799,arm,0,0
57800,B,0,0
57801,),0,0
57802,.,0,0
57803,Patients,0,0
57804,were,0,0
57805,evaluated,0,0
57806,clinically,0,0
57807,for,0,0
57808,48,0,0
57809,weeks,0,0
57810,after,0,0
57811,initiation,0,0
57812,of,0,0
57813,therapy,0,0
57814,.,0,0
57815,Intensive,0,0
57816,pharmacokinetic,0,1
57817,sampling,0,0
57818,occurred,0,0
57819,after,0,0
57820,4,0,0
57821,weeks,0,0
57822,of,0,0
57823,therapy,0,0
57824,.,0,0
57825,RESULTS,0,0
57826,:,0,0
57827,The,0,0
57828,proportion,0,0
57829,of,0,0
57830,children,0,0
57831,with,0,0
57832,HIV-1,0,0
57833,RNA,0,1
57834,<,0,0
57835,or,0,1
57836,=400,0,0
57837,copies/mL,0,0
57838,and,0,1
57839,on,0,0
57840,randomized,0,0
57841,treatment,0,0
57842,at,0,0
57843,48,0,0
57844,weeks,0,0
57845,was,0,0
57846,65,0,0
57847,%,0,0
57848,among,0,0
57849,children,0,0
57850,assigned,0,0
57851,NFV,0,0
57852,+,0,0
57853,RTV,0,1
57854,+,0,0
57855,ddI,0,0
57856,versus,0,0
57857,28,0,0
57858,%,0,0
57859,among,0,0
57860,those,0,0
57861,assigned,0,0
57862,NFV,0,0
57863,+,0,0
57864,NVP,0,1
57865,+,0,0
57866,d4T,0,1
57867,(,0,0
57868,P,0,0
57869,=,0,0
57870,0.039,0,0
57871,),0,0
57872,.,0,0
57873,No,0,0
57874,significant,0,0
57875,difference,0,0
57876,in,0,0
57877,median,1,1
57878,CD4,1,1
57879,%,1,0
57880,change,1,1
57881,from,0,0
57882,baseline,0,0
57883,to,0,0
57884,week,0,0
57885,48,0,0
57886,was,0,0
57887,found,0,0
57888,(,0,0
57889,3,0,0
57890,%,0,0
57891,versus,0,0
57892,1,0,0
57893,%,0,0
57894,),0,0
57895,.,0,0
57896,No,0,0
57897,significant,0,0
57898,differences,0,0
57899,in,0,0
57900,safety,1,1
57901,or,1,1
57902,tolerability,1,1
57903,between,0,0
57904,children,0,0
57905,randomized,0,0
57906,to,0,0
57907,NFV,0,0
57908,+,0,0
57909,RTV,0,1
57910,+,0,0
57911,ddI,0,1
57912,versus,0,0
57913,NFV,0,0
57914,+,0,0
57915,NVP,0,1
57916,+,0,0
57917,d4T,0,1
57918,were,0,0
57919,identified,0,0
57920,.,0,0
57921,However,0,0
57922,",",0,0
57923,a,0,0
57924,trend,0,0
57925,toward,0,0
57926,a,0,0
57927,higher,0,0
57928,rate,0,1
57929,of,0,1
57930,permanent,1,1
57931,discontinuation,1,0
57932,of,1,1
57933,study,1,0
57934,treatment,1,0
57935,was,0,0
57936,noted,0,0
57937,among,0,0
57938,children,0,0
57939,assigned,0,0
57940,to,0,0
57941,NFV,0,0
57942,+,0,0
57943,NVP,0,1
57944,+,0,0
57945,d4T,0,1
57946,compared,0,0
57947,with,0,0
57948,NFV,0,0
57949,+,0,0
57950,RTV,0,1
57951,+,0,0
57952,ddI,0,0
57953,[,0,0
57954,7,0,0
57955,of,0,0
57956,20,0,0
57957,(,0,0
57958,35,0,0
57959,%,0,0
57960,),0,0
57961,versus,0,0
57962,2,0,0
57963,of,0,0
57964,21,0,0
57965,(,0,0
57966,10,0,0
57967,%,0,0
57968,),0,0
57969,;,0,0
57970,P,0,0
57971,=,0,0
57972,0.12,0,0
57973,],0,0
57974,.,0,0
57975,NFV,1,0
57976,pharmacokinetic,1,1
57977,measurements,1,1
57978,were,0,0
57979,not,0,0
57980,statistically,0,0
57981,different,0,0
57982,between,0,0
57983,the,0,0
57984,treatment,0,0
57985,groups,0,0
57986,",",0,0
57987,yet,0,0
57988,exposure,0,0
57989,to,0,0
57990,the,0,0
57991,NFV,0,0
57992,metabolite,0,1
57993,",",0,1
57994,M8,0,0
57995,",",0,1
57996,was,0,0
57997,significantly,0,0
57998,higher,0,0
57999,in,0,0
58000,subjects,0,0
58001,receiving,0,0
58002,RTV,0,1
58003,.,0,0
58004,The,0,0
58005,pharmacokinetics,1,0
58006,for,1,0
58007,NVP,1,0
58008,",",1,1
58009,RTV,1,1
58010,and,1,1
58011,d4T,1,1
58012,were,0,0
58013,similar,0,0
58014,to,0,0
58015,those,0,0
58016,of,0,0
58017,previously,0,0
58018,reported,0,0
58019,data,0,0
58020,.,0,0
58021,CONCLUSION,0,0
58022,:,0,0
58023,Combination,0,1
58024,therapy,0,0
58025,containing,0,0
58026,NFV,0,0
58027,+,0,0
58028,RTV,0,1
58029,+,0,0
58030,ddI,0,0
58031,appears,0,0
58032,more,0,0
58033,efficacious,0,0
58034,in,0,0
58035,NRTI-experienced,0,0
58036,children,0,0
58037,than,0,0
58038,a,0,0
58039,regimen,0,0
58040,containing,0,0
58041,NFV,0,0
58042,+,0,0
58043,NVP,0,1
58044,+,0,0
58045,d4T,0,1
58046,.,0,0
58047,Differences,0,1
58048,in,0,0
58049,tolerability,1,1
58050,between,0,0
58051,the,0,0
58052,2,0,0
58053,treatment,0,0
58054,groups,0,0
58055,were,0,0
58056,not,0,0
58057,identified,0,0
58058,.,0,0
58059,Systemic,0,0
58060,exposure,0,0
58061,of,0,0
58062,these,0,0
58063,drugs,0,0
58064,was,0,0
58065,similar,0,0
58066,to,0,0
58067,that,0,0
58068,reported,0,0
58069,in,0,0
58070,other,0,0
58071,HIV-infected,0,0
58072,children,0,0
58073,and,0,0
58074,adults,0,0
58075,.,0,0
58076,Clinical,0,1
58077,trials,0,0
58078,of,0,0
58079,intrasplenic,0,1
58080,arterial,0,1
58081,infusion,0,0
58082,of,0,1
58083,interleukin-2,0,1
58084,(,0,1
58085,IS-IL-2,0,0
58086,),0,0
58087,to,0,0
58088,patients,0,0
58089,with,0,0
58090,advanced,0,0
58091,cancer,0,0
58092,.,0,0
58093,We,0,0
58094,tried,0,0
58095,a,0,0
58096,infusion,0,0
58097,of,0,1
58098,interleukin-2,0,1
58099,(,0,1
58100,IL-2,0,1
58101,),0,0
58102,of,0,0
58103,a,0,0
58104,relatively,0,0
58105,low,0,0
58106,dose,0,0
58107,via,0,0
58108,an,0,0
58109,intrasplenic,0,1
58110,arterial,0,1
58111,catheter,0,0
58112,connected,0,0
58113,to,0,0
58114,a,0,0
58115,chronometric,0,1
58116,infusion,0,0
58117,(,0,1
58118,IS-IL-2,0,0
58119,),0,0
58120,.,0,0
58121,Eighteen,0,0
58122,patients,0,0
58123,of,0,1
58124,colorectal,0,0
58125,cancer,0,0
58126,with,0,0
58127,metastases,0,0
58128,to,0,0
58129,the,0,0
58130,liver,0,1
58131,or,0,1
58132,lung,0,1
58133,or,0,1
58134,of,0,1
58135,unresectable,0,0
58136,hepatoma,0,0
58137,received,0,0
58138,a,0,0
58139,24,0,0
58140,hour,0,0
58141,continuous,0,0
58142,infusion,0,0
58143,with,0,0
58144,low,0,0
58145,dose,0,0
58146,recombinant,0,0
58147,of,0,1
58148,IL-2,0,1
58149,(,0,0
58150,mainly,0,0
58151,8,0,0
58152,x,0,0
58153,10,0,0
58154,(,0,0
58155,5,0,0
58156,),0,0
58157,JRU/day,0,0
58158,),0,0
58159,for,0,0
58160,25-40,0,0
58161,days,0,0
58162,.,0,0
58163,All,0,0
58164,patients,0,0
58165,tolerated,1,1
58166,this,0,0
58167,protocol,0,0
58168,of,0,0
58169,the,0,0
58170,therapy,0,0
58171,and,0,0
58172,the,0,0
58173,main,1,1
58174,toxic,1,1
58175,effects,1,1
58176,were,1,0
58177,fever,1,1
58178,and,1,0
58179,general,1,0
58180,fatigue,1,1
58181,.,1,0
58182,Such,0,0
58183,serious,0,1
58184,toxicity,1,1
58185,as,0,0
58186,previously,0,0
58187,reported,0,0
58188,by,0,0
58189,high,0,0
58190,dose,0,0
58191,IL-2,0,1
58192,therapy,0,0
58193,was,0,0
58194,not,0,0
58195,observed,0,0
58196,.,0,0
58197,Data,0,0
58198,of,0,1
58199,hepatic,1,1
58200,and,1,1
58201,renal,1,1
58202,functions,1,1
58203,were,0,0
58204,normal,0,0
58205,.,0,0
58206,IS-IL-2,0,0
58207,therapy,0,0
58208,induced,0,0
58209,a,0,0
58210,high,0,0
58211,incidence,0,1
58212,of,0,1
58213,eosinophilia,1,1
58214,(,1,0
58215,12/18,1,0
58216,),1,0
58217,and,1,0
58218,thrombocythemia,1,1
58219,(,0,0
58220,12/18,0,0
58221,),0,0
58222,.,0,0
58223,Peripheral,1,0
58224,natural,1,0
58225,killer,1,1
58226,(,1,1
58227,NK,1,1
58228,),1,1
58229,and,1,1
58230,LAK,1,1
58231,activities,1,1
58232,were,0,0
58233,augmented,0,0
58234,in,0,0
58235,all,0,0
58236,patients,0,0
58237,and,0,1
58238,total,1,1
58239,white,1,0
58240,blood,1,1
58241,cell,1,1
58242,counts,1,1
58243,were,0,0
58244,increased,0,0
58245,during,0,0
58246,IS-IL-2,0,0
58247,therapy,0,0
58248,.,0,0
58249,An,0,0
58250,increase,0,0
58251,in,0,0
58252,IL-2,1,1
58253,receptor,1,1
58254,expression,1,1
58255,of,1,1
58256,peripheral,1,1
58257,blood,1,1
58258,mononuclear,1,1
58259,cells,1,1
58260,and,1,1
58261,significant,1,0
58262,rises,1,1
58263,in,1,0
58264,numbers,1,1
58265,of,1,1
58266,Leu11,1,1
58267,(,1,0
58268,CD16,1,0
58269,),1,1
58270,+,1,0
58271,",",1,1
58272,OKM1,1,0
58273,(,1,1
58274,CD11,1,0
58275,),1,1
58276,+,1,0
58277,and,1,1
58278,OKIa1,1,1
58279,(,1,1
58280,HLA-DR,1,1
58281,),1,1
58282,+,1,0
58283,were,0,0
58284,observed,0,0
58285,.,0,0
58286,Of,0,0
58287,18,0,0
58288,patients,0,0
58289,12,0,0
58290,were,0,0
58291,evaluable,0,0
58292,for,0,0
58293,their,0,0
58294,response,0,1
58295,to,0,0
58296,therapy,0,0
58297,.,0,0
58298,Partial,0,1
58299,response,0,1
58300,(,0,1
58301,PR,0,1
58302,),0,1
58303,was,0,0
58304,observed,0,0
58305,in,0,0
58306,one,0,0
58307,unresectable,1,0
58308,hepatoma,1,0
58309,and,0,0
58310,11,0,0
58311,demonstrated,0,0
58312,no,1,0
58313,change,1,1
58314,(,1,0
58315,NC,1,1
58316,),1,1
58317,or,1,0
58318,progressive,1,1
58319,disease,1,1
58320,(,1,1
58321,PD,1,1
58322,),1,0
58323,.,1,0
58324,Six,0,0
58325,patients,0,0
58326,were,0,0
58327,not,0,0
58328,evaluable,0,0
58329,because,0,0
58330,of,0,0
58331,additional,0,0
58332,therapy,0,0
58333,(,0,0
58334,3,0,0
58335,cases,0,0
58336,),0,0
58337,or,0,0
58338,decreasing,0,1
58339,tumor,0,1
58340,cell,0,1
58341,markers,0,1
58342,having,0,0
58343,no,0,0
58344,measurable,0,1
58345,lesions,0,1
58346,(,0,0
58347,3,0,0
58348,cases,0,0
58349,),0,0
58350,.,0,0
58351,Three,0,0
58352,patients,0,0
58353,of,0,0
58354,colorectal,0,0
58355,cancer,0,0
58356,from,0,0
58357,an,0,0
58358,unresectable,0,0
58359,group,0,0
58360,were,0,0
58361,presumed,0,0
58362,to,0,0
58363,have,0,0
58364,micrometastases,0,0
58365,to,0,0
58366,the,0,0
58367,liver,0,1
58368,as,0,0
58369,suggested,0,0
58370,by,0,0
58371,an,0,0
58372,elevated,0,1
58373,serum,0,1
58374,CEA,0,1
58375,level,0,1
58376,.,0,0
58377,After,0,0
58378,receiving,0,0
58379,IS-IL-2,0,0
58380,therapy,0,0
58381,they,0,0
58382,demonstrated,0,0
58383,a,0,0
58384,decrease,0,0
58385,in,0,0
58386,the,0,0
58387,serum,0,1
58388,CEA,0,1
58389,level,0,1
58390,for,0,0
58391,more,0,0
58392,than,0,0
58393,3,0,0
58394,years,0,0
58395,after,0,0
58396,treatment,0,0
58397,.,0,1
58398,(,0,0
58399,ABSTRACT,0,1
58400,TRUNCATED,0,0
58401,AT,0,0
58402,250,0,0
58403,WORDS,0,0
58404,),0,0
58405,Mending,0,0
58406,the,0,0
58407,rhythm,0,1
58408,does,0,0
58409,not,0,0
58410,improve,0,0
58411,prognosis,0,1
58412,in,0,0
58413,patients,0,0
58414,with,0,0
58415,persistent,0,1
58416,atrial,0,0
58417,fibrillation,0,0
58418,:,0,0
58419,a,0,0
58420,subanalysis,0,0
58421,of,0,0
58422,the,0,0
58423,RACE,0,0
58424,study,0,0
58425,.,0,0
58426,AIMS,0,0
58427,To,0,0
58428,compare,0,0
58429,outcome,0,1
58430,of,0,0
58431,AF,0,1
58432,patients,0,0
58433,with,0,0
58434,effective,0,1
58435,rhythm,0,1
58436,control,0,0
58437,with,0,0
58438,patients,0,0
58439,treated,0,0
58440,with,0,0
58441,rate,0,1
58442,control,0,0
58443,.,0,1
58444,METHODS,0,0
58445,AND,0,0
58446,RESULTS,0,0
58447,Out,0,0
58448,of,0,0
58449,the,0,0
58450,266,0,0
58451,AF,0,0
58452,patients,0,0
58453,randomized,0,0
58454,to,0,0
58455,rhythm,0,1
58456,control,0,0
58457,in,0,0
58458,the,0,0
58459,RACE,0,1
58460,study,0,0
58461,",",0,0
58462,49,0,0
58463,patients,0,0
58464,turned,0,0
58465,to,0,0
58466,long-term,0,1
58467,sinus,0,1
58468,rhythm,0,1
58469,and,0,1
58470,were,0,0
58471,continuously,0,0
58472,treated,0,0
58473,with,0,0
58474,oral,0,0
58475,anticoagulation,0,0
58476,.,0,0
58477,The,0,0
58478,incidence,0,1
58479,of,0,0
58480,the,0,0
58481,primary,0,0
58482,endpoint,0,0
58483,in,0,0
58484,these,0,0
58485,patients,0,0
58486,was,0,0
58487,compared,0,0
58488,to,0,0
58489,that,0,0
58490,in,0,0
58491,178,0,0
58492,patients,0,0
58493,out,0,0
58494,of,0,0
58495,the,0,0
58496,initial,0,0
58497,256,0,0
58498,rate-control,0,0
58499,patients,0,0
58500,of,0,0
58501,RACE,0,0
58502,who,0,0
58503,were,0,0
58504,in,0,0
58505,AF,0,1
58506,and,0,1
58507,using,0,0
58508,oral,0,0
58509,anticoagulation,0,0
58510,continuously,0,0
58511,.,0,0
58512,Baseline,0,0
58513,characteristics,0,0
58514,of,0,0
58515,both,0,0
58516,groups,0,0
58517,were,0,0
58518,not,0,0
58519,different,0,0
58520,.,0,0
58521,After,0,0
58522,a,0,0
58523,mean,0,1
58524,follow-up,0,0
58525,of,0,0
58526,2.3+/-0.6,0,0
58527,years,0,0
58528,",",0,0
58529,the,0,0
58530,primary,0,1
58531,endpoint,0,1
58532,(,0,0
58533,a,0,0
58534,composite,1,1
58535,of,1,0
58536,cardiovascular,1,1
58537,mortality,1,1
58538,",",1,1
58539,heart,1,1
58540,failure,1,1
58541,",",1,1
58542,thrombo-embolic,1,1
58543,complications,1,1
58544,(,1,0
58545,TECs,1,0
58546,),1,1
58547,",",1,0
58548,bleeding,1,1
58549,",",1,1
58550,serious,1,1
58551,adverse,1,1
58552,effects,1,1
58553,of,1,0
58554,antiarrhythmic,1,1
58555,drugs,1,0
58556,and,1,1
58557,pacemaker,1,0
58558,implants,1,1
58559,),1,0
58560,was,0,0
58561,22.4,0,0
58562,%,0,0
58563,in,0,0
58564,the,0,0
58565,rhythm-control,0,0
58566,group,0,0
58567,vs.,0,0
58568,15.2,0,0
58569,%,0,0
58570,in,0,0
58571,the,0,0
58572,rate-control,0,0
58573,group,0,0
58574,.,0,1
58575,Multivariable,0,0
58576,regression,0,1
58577,analysis,0,0
58578,indicated,0,0
58579,coronary,1,1
58580,artery,1,1
58581,disease,1,1
58582,",",1,1
58583,heart,1,1
58584,failure,1,1
58585,",",1,1
58586,and,1,1
58587,digitalis,1,1
58588,as,0,0
58589,independent,0,0
58590,risk,0,1
58591,indicators,0,1
58592,of,0,1
58593,cardiovascular,0,1
58594,morbidity,0,1
58595,and,0,1
58596,mortality,0,1
58597,.,0,1
58598,Chronic,1,1
58599,sinus,1,1
58600,rhythm,1,1
58601,did,0,0
58602,not,0,0
58603,matter,0,0
58604,.,0,0
58605,CONCLUSION,0,0
58606,Among,0,0
58607,patients,0,0
58608,who,0,0
58609,remained,0,0
58610,on,0,0
58611,warfarin,0,0
58612,",",0,0
58613,those,0,0
58614,who,0,0
58615,mostly,0,0
58616,were,0,0
58617,maintained,0,0
58618,in,0,0
58619,sinus,0,0
58620,rhythm,0,1
58621,under,0,0
58622,a,0,0
58623,rhythm-control,0,0
58624,strategy,0,0
58625,did,0,0
58626,not,0,0
58627,have,0,0
58628,a,0,0
58629,superior,0,0
58630,prognosis,0,1
58631,compared,0,0
58632,to,0,0
58633,those,0,0
58634,who,0,0
58635,remained,0,0
58636,in,0,0
58637,AF,0,0
58638,under,0,0
58639,a,0,0
58640,rate-control,0,0
58641,strategy,0,0
58642,.,0,0
58643,Single-session,0,0
58644,behavioral,0,1
58645,treatment,0,0
58646,of,0,1
58647,earthquake-related,0,1
58648,posttraumatic,0,0
58649,stress,0,1
58650,disorder,0,0
58651,:,0,0
58652,a,0,0
58653,randomized,0,0
58654,waiting,0,1
58655,list,0,1
58656,controlled,0,0
58657,trial,0,0
58658,.,0,0
58659,In,0,0
58660,an,0,0
58661,attempt,0,0
58662,to,0,0
58663,develop,0,0
58664,a,0,0
58665,brief,0,0
58666,treatment,0,0
58667,for,0,0
58668,disaster,0,1
58669,survivors,0,0
58670,",",0,0
58671,the,0,0
58672,present,0,0
58673,study,0,0
58674,examined,0,0
58675,the,0,0
58676,effectiveness,0,0
58677,of,0,0
58678,a,0,0
58679,single,0,0
58680,session,0,0
58681,of,0,1
58682,modified,0,0
58683,behavioral,0,1
58684,treatment,0,0
58685,in,0,0
58686,earthquake-related,0,1
58687,posttraumatic,0,0
58688,stress,0,1
58689,disorder,0,0
58690,.,0,1
58691,Fifty-nine,0,0
58692,earthquake,0,1
58693,survivors,0,0
58694,in,0,0
58695,Turkey,0,0
58696,were,0,0
58697,randomized,0,0
58698,into,0,0
58699,either,0,0
58700,single-session,0,0
58701,modified,0,0
58702,behavioral,0,1
58703,treatment,0,0
58704,(,0,1
58705,SSBT,0,1
58706,),0,0
58707,designed,0,0
58708,to,0,0
58709,enhance,0,0
58710,sense,0,1
58711,of,0,1
58712,control,0,0
58713,over,0,0
58714,earthquake-related,1,1
58715,fears,1,1
58716,or,0,0
58717,waiting,0,1
58718,list,0,1
58719,control,0,0
58720,condition,0,1
58721,(,0,1
58722,WL,0,0
58723,),0,0
58724,.,0,0
58725,The,0,0
58726,WL,0,0
58727,group,0,0
58728,received,0,0
58729,SSBT,0,1
58730,after,0,0
58731,a,0,0
58732,second,0,0
58733,baseline,0,0
58734,assessment,0,0
58735,.,0,1
58736,Follow-ups,0,0
58737,were,0,0
58738,at,0,0
58739,weeks,0,0
58740,6,0,0
58741,",",0,0
58742,12,0,0
58743,",",0,0
58744,24,0,0
58745,",",0,0
58746,and,0,0
58747,at,0,1
58748,1-2,0,0
58749,years,0,0
58750,posttreatment,0,0
58751,.,0,0
58752,Significant,1,1
58753,treatment,1,0
58754,effects,1,1
58755,were,0,0
58756,found,0,0
58757,on,0,0
58758,all,0,0
58759,measures,0,0
58760,at,0,0
58761,posttreatment,0,0
58762,.,0,0
58763,The,0,0
58764,improvement,1,1
58765,rate,1,1
58766,was,0,0
58767,49,0,0
58768,%,0,0
58769,at,0,0
58770,week,0,0
58771,6,0,0
58772,;,0,0
58773,it,0,0
58774,rose,0,0
58775,to,0,0
58776,80,0,0
58777,%,0,0
58778,by,0,0
58779,week,0,0
58780,12,0,0
58781,",",0,0
58782,85,0,0
58783,%,0,0
58784,by,0,0
58785,week,0,0
58786,24,0,0
58787,",",0,0
58788,and,0,0
58789,83,0,0
58790,%,0,0
58791,by,0,0
58792,the,0,0
58793,1-2-year,0,0
58794,follow-up,0,0
58795,.,0,0
58796,Brief,0,1
58797,behavioral,0,1
58798,treatment,0,0
58799,has,0,0
58800,promise,0,0
58801,as,0,0
58802,a,0,0
58803,cost-effective,1,0
58804,intervention,0,0
58805,for,0,0
58806,disaster,0,0
58807,survivors,0,0
58808,.,0,0
58809,Divalproex,0,0
58810,sodium,0,0
58811,vs.,0,0
58812,placebo,0,0
58813,in,0,0
58814,the,0,0
58815,treatment,0,0
58816,of,0,0
58817,repetitive,1,0
58818,behaviours,1,1
58819,in,0,0
58820,autism,0,0
58821,spectrum,0,0
58822,disorder,0,0
58823,.,0,0
58824,Autism,0,0
58825,is,0,0
58826,a,0,0
58827,neurodevelopmental,0,0
58828,disorder,0,0
58829,characterized,0,0
58830,by,0,0
58831,impairment,0,0
58832,in,0,0
58833,three,0,0
58834,core,0,0
58835,symptom,0,0
58836,domains,0,1
58837,:,0,0
58838,socialization,0,1
58839,",",0,1
58840,communication,0,1
58841,",",0,1
58842,and,0,1
58843,repetitive/stereotyped,0,1
58844,behaviours,0,1
58845,.,0,0
58846,Other,0,1
58847,associated,0,0
58848,symptom,0,1
58849,domains,0,1
58850,are,0,0
58851,also,0,0
58852,affected,0,0
58853,including,0,0
58854,impulsivity/aggression,0,1
58855,",",0,1
58856,self-injury,0,1
58857,",",0,1
58858,anxiety,0,1
58859,",",0,1
58860,and,0,1
58861,mood,0,1
58862,lability,0,1
58863,.,0,0
58864,Divalproex,0,0
58865,has,0,0
58866,been,0,0
58867,shown,0,0
58868,to,0,0
58869,have,0,0
58870,efficacy,0,1
58871,in,0,0
58872,treating,0,0
58873,epilepsy,0,1
58874,",",0,1
58875,bipolar,0,1
58876,disorder,0,0
58877,",",0,1
58878,mood,0,1
58879,lability,0,1
58880,",",0,1
58881,and,0,1
58882,impulsive,0,1
58883,aggression,0,1
58884,.,0,0
58885,The,0,0
58886,present,0,0
58887,study,0,0
58888,evaluated,0,0
58889,the,0,0
58890,use,0,0
58891,of,0,0
58892,divalproex,0,0
58893,in,0,0
58894,the,0,0
58895,treatment,0,0
58896,of,0,1
58897,repetitive,1,1
58898,",",1,0
58899,compulsive-like,1,1
58900,symptoms,1,1
58901,of,1,1
58902,autism,1,0
58903,spectrum,1,1
58904,disorder,1,0
58905,(,1,1
58906,ASD,1,0
58907,),1,0
58908,.,1,0
58909,Thirteen,0,0
58910,individuals,0,0
58911,with,0,0
58912,ASD,0,0
58913,participated,0,0
58914,in,0,0
58915,an,0,0
58916,8-wk,0,0
58917,",",0,0
58918,double-blind,0,0
58919,",",0,1
58920,placebo-controlled,0,0
58921,trial,0,0
58922,of,0,1
58923,divalproex,0,0
58924,sodium,0,0
58925,vs.,0,0
58926,placebo,0,0
58927,.,0,0
58928,There,0,0
58929,was,0,0
58930,a,0,0
58931,significant,0,0
58932,group,0,0
58933,difference,0,0
58934,on,0,0
58935,improvement,0,1
58936,in,0,0
58937,repetitive,1,0
58938,behaviours,1,1
58939,as,0,0
58940,measured,0,0
58941,by,0,0
58942,the,0,0
58943,Children,1,0
58944,'s,1,0
58945,Yale-Brown,1,0
58946,Obsessive,1,0
58947,Compulsive,1,1
58948,Scale,1,1
58949,(,1,1
58950,C-YBOCS,1,1
58951,),1,1
58952,(,0,0
58953,p=0.037,0,0
58954,),0,0
58955,and,0,0
58956,a,0,0
58957,large,0,1
58958,effect,0,1
58959,size,0,1
58960,(,0,1
58961,d=1.616,0,0
58962,),0,0
58963,.,0,0
58964,This,0,0
58965,study,0,0
58966,provides,0,0
58967,preliminary,0,0
58968,support,0,0
58969,for,0,0
58970,the,0,0
58971,use,0,0
58972,of,0,0
58973,divalproex,0,0
58974,in,0,0
58975,treating,0,0
58976,repetitive,1,0
58977,behaviours,1,1
58978,in,0,0
58979,ASD,0,0
58980,.,0,0
58981,Further,0,0
58982,research,0,0
58983,is,0,0
58984,needed,0,0
58985,to,0,0
58986,evaluate,0,0
58987,the,0,0
58988,specificity,0,1
58989,and,0,1
58990,mechanism,0,0
58991,of,0,1
58992,action,0,0
58993,of,0,0
58994,these,0,0
58995,findings,0,0
58996,.,0,0
58997,Virtual,0,0
58998,reality,0,1
58999,colonoscopy,0,1
59000,simulation,0,0
59001,:,0,0
59002,a,0,0
59003,compulsory,0,0
59004,practice,0,0
59005,for,0,0
59006,the,0,0
59007,future,0,0
59008,colonoscopist,0,1
59009,?,0,0
59010,BACKGROUND,0,0
59011,AND,0,0
59012,STUDY,0,0
59013,AIM,0,1
59014,As,0,0
59015,for,0,0
59016,any,0,0
59017,manual,0,0
59018,procedure,0,0
59019,",",0,0
59020,the,0,0
59021,learning,0,1
59022,curves,0,1
59023,for,0,0
59024,medical,0,0
59025,interventions,0,0
59026,can,0,0
59027,have,0,0
59028,undesirable,0,1
59029,phases,0,0
59030,",",0,0
59031,occurring,0,0
59032,mostly,0,0
59033,in,0,0
59034,the,0,0
59035,early,0,0
59036,experience,0,1
59037,of,0,0
59038,applying,0,0
59039,a,0,0
59040,technique,0,0
59041,.,0,0
59042,There,0,0
59043,have,0,0
59044,been,0,0
59045,impressive,0,0
59046,advances,0,0
59047,in,0,0
59048,endoscopic,0,0
59049,procedures,0,0
59050,during,0,0
59051,recent,0,0
59052,years,0,0
59053,",",0,1
59054,and,0,0
59055,there,0,0
59056,is,0,0
59057,an,0,0
59058,emerging,0,0
59059,trend,0,0
59060,that,0,0
59061,the,0,0
59062,number,0,1
59063,of,0,0
59064,procedures,0,0
59065,is,0,0
59066,increasing,0,0
59067,in,0,0
59068,parallel,0,0
59069,with,0,0
59070,these,0,0
59071,.,0,0
59072,In,0,0
59073,addition,0,0
59074,",",0,0
59075,the,0,0
59076,introduction,0,0
59077,of,0,0
59078,screening,0,0
59079,programs,0,0
59080,for,0,0
59081,colorectal,0,0
59082,cancer,0,0
59083,will,0,0
59084,also,0,0
59085,increase,0,0
59086,the,0,0
59087,numbers,0,1
59088,of,0,0
59089,procedures,0,0
59090,needed,0,0
59091,.,0,0
59092,Recent,0,0
59093,developments,0,0
59094,in,0,0
59095,medical,0,0
59096,simulation,0,0
59097,seem,0,0
59098,promising,0,0
59099,with,0,0
59100,regard,0,0
59101,to,0,0
59102,the,0,0
59103,possibility,0,0
59104,of,0,0
59105,training,0,0
59106,out,0,0
59107,undesirable,0,1
59108,parts,0,0
59109,of,0,0
59110,the,0,0
59111,learning,0,1
59112,curve,0,1
59113,outside,0,0
59114,the,0,0
59115,operating,0,0
59116,room,0,0
59117,.,0,0
59118,The,0,0
59119,aim,0,0
59120,of,0,0
59121,this,0,0
59122,study,0,0
59123,was,0,0
59124,to,0,0
59125,investigate,0,0
59126,whether,0,0
59127,the,0,0
59128,use,0,0
59129,of,0,0
59130,the,0,0
59131,AccuTouch,0,0
59132,flexible,0,0
59133,endoscopy,0,0
59134,simulator,0,0
59135,improves,0,0
59136,the,0,0
59137,early,1,0
59138,part,1,0
59139,of,1,0
59140,the,1,0
59141,learning,1,1
59142,curve,1,1
59143,in,0,0
59144,colonoscopy,0,1
59145,training,0,0
59146,.,0,0
59147,METHOD,0,0
59148,12,0,0
59149,endoscopy,0,0
59150,trainees,0,0
59151,",",0,0
59152,10,0,0
59153,surgeons,0,0
59154,and,0,0
59155,two,0,0
59156,medical,0,0
59157,gastroenterologists,0,0
59158,",",0,0
59159,all,0,0
59160,with,0,0
59161,experience,0,1
59162,in,0,0
59163,gastroscopy,0,0
59164,but,0,0
59165,with,0,0
59166,no,0,0
59167,specific,0,0
59168,colonoscopy,0,1
59169,experience,0,1
59170,",",0,1
59171,were,0,0
59172,randomly,0,0
59173,assigned,0,0
59174,to,0,0
59175,either,0,0
59176,simulator,0,1
59177,training,0,0
59178,or,0,0
59179,to,0,0
59180,a,0,0
59181,control,0,0
59182,group,0,0
59183,.,0,0
59184,They,0,0
59185,all,0,0
59186,received,0,0
59187,the,0,0
59188,same,0,0
59189,theoretical,0,0
59190,study,0,0
59191,package,0,0
59192,and,0,0
59193,the,0,0
59194,training,0,0
59195,group,0,0
59196,practiced,0,0
59197,with,0,0
59198,the,0,0
59199,AccuTouch,0,1
59200,colonoscopy,0,1
59201,simulator,0,0
59202,until,0,0
59203,a,0,0
59204,predefined,0,1
59205,expert,0,0
59206,level,0,1
59207,of,0,1
59208,performance,0,1
59209,was,0,0
59210,reached,0,0
59211,.,0,0
59212,All,0,0
59213,trainees,0,0
59214,performed,0,0
59215,their,0,0
59216,first,0,1
59217,ten,0,0
59218,individual,0,0
59219,colonoscopies,0,1
59220,described,0,0
59221,in,0,0
59222,detail,0,0
59223,in,0,0
59224,a,0,0
59225,separate,0,0
59226,protocol,0,0
59227,.,0,0
59228,RESULTS,0,0
59229,Trainees,0,0
59230,in,0,0
59231,the,0,0
59232,simulator-trained,0,1
59233,group,0,0
59234,performed,1,0
59235,significantly,1,0
59236,better,1,0
59237,(,0,1
59238,P=0.0011,0,0
59239,),0,1
59240,and,0,0
59241,managed,1,0
59242,to,1,0
59243,reach,1,0
59244,the,1,0
59245,cecum,1,0
59246,in,0,0
59247,52,0,0
59248,%,0,0
59249,of,0,0
59250,their,0,0
59251,cases,0,0
59252,(,0,0
59253,vs.,0,0
59254,19,0,0
59255,%,0,0
59256,in,0,0
59257,the,0,0
59258,control,0,0
59259,group,0,0
59260,),0,1
59261,",",0,1
59262,and,0,1
59263,were,0,0
59264,4.53,0,0
59265,times,0,0
59266,more,0,0
59267,likely,0,0
59268,to,0,0
59269,succeed,0,0
59270,compared,0,0
59271,with,0,0
59272,the,0,0
59273,controls,0,0
59274,.,0,0
59275,Additionally,0,0
59276,",",0,0
59277,there,0,0
59278,was,0,0
59279,a,0,0
59280,significantly,0,0
59281,shorter,1,1
59282,procedure,1,0
59283,time,1,1
59284,and,1,1
59285,less,1,0
59286,patient,1,1
59287,discomfort,1,1
59288,in,0,0
59289,the,0,0
59290,hands,0,0
59291,of,0,0
59292,the,0,0
59293,simulator-trained,0,0
59294,group,0,0
59295,.,0,0
59296,CONCLUSION,0,0
59297,Skills,0,1
59298,acquired,0,0
59299,using,0,0
59300,the,0,0
59301,AccuTouch,0,1
59302,simulator,0,1
59303,transfer,0,1
59304,well,0,0
59305,into,0,0
59306,the,0,0
59307,clinical,0,0
59308,colonoscopy,0,1
59309,environment,0,0
59310,.,0,0
59311,The,0,0
59312,results,0,0
59313,of,0,0
59314,this,0,0
59315,trial,0,0
59316,clearly,0,0
59317,support,0,0
59318,the,0,0
59319,plan,0,0
59320,to,0,0
59321,integrate,0,0
59322,simulator,0,1
59323,training,0,0
59324,into,0,0
59325,endoscopic,0,1
59326,education,0,0
59327,curricula,0,0
59328,.,0,0
59329,Pre-treatment,0,0
59330,proliferation,0,1
59331,and,0,0
59332,the,0,0
59333,outcome,0,1
59334,of,0,1
59335,conventional,0,0
59336,and,0,1
59337,accelerated,0,0
59338,radiotherapy,0,0
59339,.,0,0
59340,This,0,0
59341,study,0,0
59342,investigated,0,0
59343,the,0,0
59344,influence,0,0
59345,of,0,0
59346,pre-treatment,0,0
59347,proliferation,0,1
59348,characteristics,0,1
59349,",",0,0
59350,assessed,0,0
59351,by,0,0
59352,Ki-67,0,1
59353,staining,0,1
59354,",",0,0
59355,in,0,0
59356,patients,0,0
59357,treated,0,0
59358,in,0,0
59359,the,0,0
59360,CHART,0,1
59361,trial,0,0
59362,of,0,1
59363,accelerated,0,0
59364,radiotherapy,0,0
59365,in,0,0
59366,head,0,0
59367,and,0,1
59368,neck,0,1
59369,cancer,0,0
59370,.,0,1
59371,Histological,0,1
59372,material,0,0
59373,from,0,0
59374,402,0,0
59375,patients,0,0
59376,was,0,0
59377,collected,0,0
59378,and,0,0
59379,stained,0,0
59380,for,0,0
59381,the,0,0
59382,presence,0,0
59383,and,0,1
59384,pattern,0,1
59385,of,0,1
59386,Ki-67,0,1
59387,staining,0,1
59388,.,0,1
59389,Locoregional,1,1
59390,control,1,0
59391,and,0,1
59392,overall,0,1
59393,survival,0,1
59394,were,0,0
59395,the,0,0
59396,main,0,0
59397,clinical,0,0
59398,endpoints,0,1
59399,.,0,0
59400,Increasing,0,1
59401,Ki-67,0,1
59402,positivity,0,1
59403,was,0,0
59404,associated,0,0
59405,with,0,0
59406,decreasing,0,1
59407,differentiation,0,1
59408,(,0,0
59409,P,0,0
59410,<,0,0
59411,0.001,0,0
59412,),0,0
59413,and,0,0
59414,increasing,0,1
59415,N-stage,0,1
59416,(,0,0
59417,P,0,0
59418,<,0,0
59419,0.004,0,0
59420,),0,0
59421,.,0,0
59422,Increasing,0,1
59423,N-stage,0,0
59424,was,0,0
59425,also,0,0
59426,associated,0,0
59427,with,0,0
59428,the,0,0
59429,progression,0,1
59430,of,0,1
59431,proliferation,0,1
59432,pattern,0,0
59433,from,0,0
59434,marginal,0,1
59435,to,0,0
59436,random,0,0
59437,(,0,0
59438,P,0,0
59439,<,0,0
59440,0.001,0,0
59441,),0,0
59442,.,0,0
59443,Using,0,0
59444,a,0,0
59445,multivariate,0,0
59446,model,0,0
59447,",",0,0
59448,a,0,0
59449,trend,0,0
59450,was,0,0
59451,seen,0,0
59452,towards,0,0
59453,a,0,0
59454,greater,0,0
59455,benefit,0,0
59456,from,0,0
59457,CHART,0,1
59458,in,0,0
59459,the,0,0
59460,lower,0,0
59461,Ki-67,0,1
59462,tumours,0,0
59463,(,0,0
59464,P,0,0
59465,=,0,0
59466,0.08,0,0
59467,),0,0
59468,;,0,0
59469,this,0,0
59470,became,0,0
59471,significant,0,0
59472,by,0,0
59473,pooling,0,0
59474,the,0,0
59475,low,0,0
59476,and,0,0
59477,intermediate,0,1
59478,Ki-67,0,1
59479,groups,0,0
59480,in,0,0
59481,comparison,0,0
59482,with,0,0
59483,the,0,0
59484,high,0,0
59485,Ki-67,0,1
59486,group,0,0
59487,(,0,0
59488,P,0,0
59489,=,0,0
59490,0.032,0,0
59491,),0,0
59492,.,0,0
59493,Tumours,0,0
59494,with,0,0
59495,marginal,0,1
59496,proliferation,0,1
59497,pattern,0,0
59498,showed,0,0
59499,a,0,0
59500,lower,0,1
59501,hazard,0,1
59502,ratio,0,1
59503,with,0,0
59504,CHART,0,1
59505,versus,0,0
59506,conventional,0,0
59507,for,0,0
59508,locoregional,0,1
59509,control,0,0
59510,(,0,0
59511,P,0,0
59512,=,0,0
59513,0.005,0,0
59514,),0,0
59515,.,0,0
59516,The,0,0
59517,data,0,0
59518,presented,0,0
59519,in,0,0
59520,this,0,0
59521,study,0,0
59522,do,0,0
59523,not,0,0
59524,support,0,0
59525,that,0,0
59526,a,0,0
59527,high,0,0
59528,pre-treatment,0,0
59529,Ki-67,0,0
59530,is,0,0
59531,associated,0,0
59532,with,0,0
59533,a,0,0
59534,therapeutic,1,0
59535,benefit,1,0
59536,from,0,0
59537,accelerated,0,0
59538,radiotherapy,0,0
59539,.,0,0
59540,Does,0,0
59541,an,0,0
59542,educational,0,0
59543,leaflet,0,1
59544,improve,0,0
59545,self-reported,0,1
59546,adherence,1,0
59547,to,0,0
59548,therapy,0,0
59549,in,0,0
59550,osteoporosis,0,0
59551,?,0,0
59552,The,0,0
59553,OPTIMA,0,0
59554,study,0,0
59555,.,0,1
59556,INTRODUCTION,0,0
59557,Adherence,1,1
59558,to,0,0
59559,treatment,0,0
59560,in,0,0
59561,osteoporosis,0,0
59562,remains,0,0
59563,poor,0,0
59564,.,0,0
59565,The,0,0
59566,aim,0,0
59567,of,0,0
59568,this,0,0
59569,study,0,0
59570,was,0,0
59571,to,0,0
59572,evaluate,0,0
59573,the,0,0
59574,effects,0,0
59575,of,0,0
59576,an,0,0
59577,educational,0,0
59578,leaflet,0,1
59579,on,0,0
59580,adherence,1,1
59581,to,0,0
59582,medication,0,1
59583,and,0,0
59584,to,0,0
59585,assess,0,0
59586,the,0,0
59587,association,0,0
59588,between,0,0
59589,adherence,1,1
59590,and,0,1
59591,health-related,1,1
59592,quality,1,1
59593,of,1,1
59594,life,1,1
59595,(,1,1
59596,HRQOL,1,1
59597,),1,1
59598,.,0,0
59599,METHODS,0,0
59600,A,0,0
59601,naturalistic,0,0
59602,",",0,1
59603,observational,0,0
59604,",",0,1
59605,multi-center,0,0
59606,",",0,1
59607,prospective,0,0
59608,study,0,0
59609,of,0,0
59610,12,0,0
59611,months,0,0
59612,',0,0
59613,follow-up,0,0
59614,was,0,0
59615,performed,0,0
59616,.,0,0
59617,Consecutive,0,0
59618,post-menopausal,0,0
59619,women,0,0
59620,aged,0,0
59621,50,0,0
59622,years,0,0
59623,to,0,0
59624,86,0,0
59625,years,0,0
59626,starting,0,0
59627,treatment,0,0
59628,with,0,0
59629,raloxifene,0,0
59630,according,0,0
59631,to,0,0
59632,daily,0,1
59633,practice,0,0
59634,were,0,0
59635,enrolled,0,0
59636,from,0,0
59637,126,0,0
59638,primary,0,0
59639,care,0,0
59640,offices,0,0
59641,in,0,0
59642,Spain,0,0
59643,.,0,0
59644,The,0,0
59645,women,0,0
59646,were,0,0
59647,assigned,0,0
59648,to,0,0
59649,two,0,0
59650,study,0,0
59651,groups,0,0
59652,.,0,0
59653,Group,0,0
59654,A,0,0
59655,received,0,0
59656,an,0,0
59657,educational,0,0
59658,leaflet,0,1
59659,with,0,0
59660,general,0,0
59661,information,0,1
59662,about,0,0
59663,osteoporosis,0,0
59664,;,0,0
59665,group,0,0
59666,B,0,0
59667,followed,0,0
59668,current,0,0
59669,practice,0,0
59670,.,0,0
59671,To,0,0
59672,assess,0,0
59673,adherence,1,1
59674,to,1,0
59675,medication,1,1
59676,and,1,1
59677,HRQOL,1,1
59678,",",1,0
59679,the,1,0
59680,Morisky,1,1
59681,test,1,1
59682,and,1,0
59683,the,1,0
59684,EuroQoL,1,1
59685,questionnaire,1,1
59686,were,0,0
59687,administered,0,0
59688,.,0,0
59689,A,0,0
59690,total,0,0
59691,of,0,0
59692,745,0,0
59693,post-menopausal,0,0
59694,women,0,0
59695,(,0,0
59696,group,0,0
59697,A,0,0
59698,",",0,0
59699,n=366,0,0
59700,;,0,0
59701,group,0,0
59702,B,0,1
59703,n=379,0,0
59704,),0,1
59705,",",0,0
59706,with,0,0
59707,a,0,0
59708,mean,0,1
59709,age,0,0
59710,of,0,0
59711,62,0,0
59712,years,0,0
59713,",",0,0
59714,were,0,0
59715,included,0,0
59716,.,0,0
59717,RESULTS,0,0
59718,Most,0,0
59719,patients,0,0
59720,in,0,0
59721,both,0,0
59722,study,0,0
59723,groups,0,0
59724,showed,0,0
59725,high,0,0
59726,adherence,1,0
59727,to,0,0
59728,raloxifene,0,0
59729,at,0,0
59730,the,0,0
59731,3-month,0,0
59732,visit,0,0
59733,:,0,0
59734,56.3,0,0
59735,%,0,0
59736,vs,0,0
59737,62.7,0,0
59738,%,0,0
59739,for,0,0
59740,groups,0,0
59741,A,0,0
59742,and,0,1
59743,B,0,1
59744,",",0,0
59745,respectively,0,0
59746,;,0,0
59747,this,0,0
59748,proportion,0,0
59749,at,0,0
59750,the,0,0
59751,12-month,0,0
59752,visit,0,1
59753,was,0,0
59754,47.4,0,0
59755,%,0,0
59756,(,0,0
59757,P=0.15,0,0
59758,),0,0
59759,and,0,0
59760,52.5,0,0
59761,%,0,0
59762,(,0,0
59763,P=0.02,0,0
59764,),0,1
59765,",",0,0
59766,respectively,0,0
59767,.,0,0
59768,At,0,0
59769,baseline,0,0
59770,",",0,1
59771,pain/discomfort,1,1
59772,was,0,0
59773,the,0,0
59774,dimension,0,1
59775,showing,0,0
59776,the,0,0
59777,highest,0,1
59778,percentage,0,1
59779,of,0,0
59780,women,0,0
59781,reporting,0,0
59782,problems,0,0
59783,:,0,0
59784,86.4,0,0
59785,%,0,0
59786,vs,0,0
59787,83.2,0,0
59788,%,0,0
59789,in,0,0
59790,groups,0,0
59791,A,0,0
59792,and,0,1
59793,B,0,1
59794,",",0,1
59795,respectively,0,0
59796,(,0,0
59797,P=0.22,0,0
59798,),0,0
59799,.,0,0
59800,HRQOL,1,1
59801,improved,0,0
59802,in,0,0
59803,both,0,0
59804,groups,0,0
59805,throughout,0,0
59806,the,0,0
59807,study,0,0
59808,",",0,0
59809,with,0,0
59810,an,0,0
59811,overall,0,1
59812,mean,0,1
59813,increment,0,1
59814,in,0,0
59815,the,0,0
59816,EuroQoL,1,0
59817,visual,1,1
59818,analog,1,1
59819,scale,1,1
59820,(,1,1
59821,EQ,1,1
59822,VAS,1,1
59823,),1,0
59824,of,0,0
59825,9.2,0,0
59826,at,0,0
59827,12,0,0
59828,months,0,0
59829,(,0,0
59830,P,0,0
59831,<,0,0
59832,0.01,0,0
59833,),0,0
59834,.,0,0
59835,Correlations,0,0
59836,between,0,0
59837,adherence,1,1
59838,and,1,1
59839,HRQOL,1,1
59840,were,0,0
59841,weak,0,0
59842,.,0,0
59843,After,0,0
59844,receiving,0,0
59845,an,0,0
59846,educational,0,0
59847,leaflet,0,1
59848,",",0,1
59849,young,0,0
59850,post-menopausal,0,0
59851,women,0,0
59852,suffering,0,1
59853,osteoporosis,0,1
59854,did,0,0
59855,not,0,0
59856,show,0,0
59857,improvement,0,1
59858,in,0,0
59859,adherence,1,0
59860,to,1,0
59861,therapy,1,0
59862,.,1,0
59863,HRQOL,1,1
59864,improved,0,1
59865,at,0,0
59866,12-month,0,1
59867,follow-up,0,0
59868,under,0,0
59869,treatment,0,0
59870,.,0,0
59871,CONCLUSION,0,0
59872,No,0,1
59873,consistent,0,0
59874,correlation,0,0
59875,between,0,0
59876,adherence,1,1
59877,and,1,1
59878,HRQOL,1,1
59879,was,0,0
59880,found,0,0
59881,.,0,0
59882,XS0601,0,0
59883,reduces,0,0
59884,the,0,0
59885,incidence,0,1
59886,of,0,0
59887,restenosis,0,1
59888,:,0,0
59889,a,0,0
59890,prospective,0,0
59891,study,0,0
59892,of,0,0
59893,335,0,0
59894,patients,0,0
59895,undergoing,0,0
59896,percutaneous,0,0
59897,coronary,0,1
59898,intervention,0,0
59899,in,0,0
59900,China,0,0
59901,.,0,0
59902,BACKGROUND,0,0
59903,XS0601,0,1
59904,",",0,0
59905,consisting,0,0
59906,of,0,1
59907,active,0,0
59908,ingredients,0,0
59909,(,0,1
59910,Chuangxiongol,0,0
59911,and,0,1
59912,paeoniflorin,0,0
59913,),0,0
59914,",",0,0
59915,has,0,0
59916,been,0,0
59917,shown,0,0
59918,to,0,0
59919,inhibit,0,0
59920,arterial,0,1
59921,neointimal,0,1
59922,hyperplasia,0,1
59923,in,0,0
59924,animal,0,0
59925,models,0,0
59926,and,0,1
59927,in,0,0
59928,preliminary,0,0
59929,human,0,0
59930,studies,0,0
59931,.,0,0
59932,The,0,0
59933,objective,0,0
59934,of,0,0
59935,this,0,0
59936,study,0,0
59937,was,0,0
59938,to,0,0
59939,evaluate,0,0
59940,the,0,0
59941,safety,0,1
59942,and,0,1
59943,efficacy,0,1
59944,of,0,1
59945,XS0601,0,0
59946,in,0,0
59947,preventing,0,0
59948,restenosis,0,1
59949,following,0,0
59950,percutaneous,0,0
59951,coronary,0,1
59952,intervention,0,0
59953,(,0,1
59954,PCI,0,1
59955,),0,0
59956,.,0,0
59957,METHODS,0,0
59958,A,0,0
59959,multi-center,0,0
59960,",",0,0
59961,randomized,0,0
59962,",",0,0
59963,double-blind,0,0
59964,",",0,1
59965,placebo-controlled,0,0
59966,trial,0,0
59967,was,0,0
59968,conducted,0,0
59969,.,0,0
59970,A,0,0
59971,total,0,0
59972,of,0,0
59973,335,0,0
59974,patients,0,0
59975,were,0,0
59976,randomized,0,0
59977,into,0,0
59978,treatment,0,0
59979,with,0,0
59980,the,0,0
59981,oral,0,0
59982,administration,0,0
59983,of,0,1
59984,XS0601,0,1
59985,",",0,0
59986,or,0,0
59987,a,0,0
59988,placebo,0,0
59989,for,0,0
59990,6,0,0
59991,months,0,0
59992,after,0,0
59993,successful,0,0
59994,PCI,0,1
59995,.,0,1
59996,Angiographic,0,1
59997,follow-up,0,0
59998,was,0,0
59999,scheduled,0,0
60000,at,0,0
60001,6,0,0
60002,months,0,0
60003,",",0,0
60004,and,0,1
60005,clinical,0,1
60006,follow-ups,0,1
60007,performed,0,0
60008,at,0,0
60009,1,0,0
60010,",",0,0
60011,3,0,0
60012,and,0,0
60013,6,0,0
60014,months,0,0
60015,after,0,0
60016,PCI,0,0
60017,.,0,0
60018,The,0,0
60019,primary,0,0
60020,end,0,0
60021,point,0,0
60022,was,0,0
60023,angiographic,1,1
60024,restenosis,1,1
60025,.,1,0
60026,The,0,0
60027,secondary,0,0
60028,end,0,0
60029,points,0,0
60030,were,0,0
60031,the,0,0
60032,combined,1,0
60033,incidence,1,1
60034,of,1,1
60035,death,1,1
60036,",",1,1
60037,target,1,1
60038,lesion,1,1
60039,nonfatal,1,1
60040,myocardial,1,1
60041,infarction,1,1
60042,",",1,1
60043,repeat,1,1
60044,angioplasty,1,1
60045,",",1,1
60046,and,1,1
60047,coronary,1,1
60048,artery,1,1
60049,bypass,1,1
60050,graft,1,1
60051,surgery,1,0
60052,.,1,0
60053,RESULTS,0,0
60054,A,0,0
60055,total,0,0
60056,of,0,0
60057,308,0,0
60058,patients,0,0
60059,(,0,0
60060,91.9,0,0
60061,%,0,0
60062,),0,0
60063,completed,0,0
60064,the,0,0
60065,study,0,0
60066,and,0,0
60067,145,0,0
60068,cases,0,0
60069,(,0,0
60070,47.1,0,0
60071,%,0,0
60072,),0,0
60073,received,0,0
60074,angiographic,0,1
60075,follow-up,0,0
60076,.,0,0
60077,The,0,0
60078,restenosis,1,1
60079,rates,1,1
60080,were,0,0
60081,significantly,0,0
60082,reduced,0,0
60083,in,0,0
60084,the,0,0
60085,XS0601,0,0
60086,group,0,0
60087,as,0,0
60088,compared,0,0
60089,with,0,0
60090,the,0,0
60091,placebo,0,0
60092,group,0,0
60093,(,0,0
60094,26.0,0,0
60095,%,0,0
60096,vs.,0,0
60097,47.2,0,0
60098,%,0,0
60099,",",0,0
60100,P,0,0
60101,<,0,0
60102,0.05,0,0
60103,),0,0
60104,",",0,0
60105,and,0,0
60106,the,0,0
60107,minimum,1,1
60108,lumen,1,1
60109,diameter,1,1
60110,(,1,1
60111,MLD,1,0
60112,),1,1
60113,was,0,0
60114,greater,0,1
60115,[,0,0
60116,(,0,0
60117,2.08,0,0
60118,+/-,0,0
60119,0.89,0,0
60120,),0,0
60121,mm,0,0
60122,for,0,0
60123,XS0601,0,1
60124,vs.,0,0
60125,(,0,0
60126,1.73,0,0
60127,+/-,0,0
60128,0.94,0,0
60129,),0,0
60130,mm,0,0
60131,for,0,0
60132,placebo,0,0
60133,",",0,0
60134,P,0,0
60135,<,0,0
60136,0.05,0,0
60137,],0,0
60138,.,0,0
60139,XS0601,0,0
60140,also,0,0
60141,significantly,0,0
60142,reduced,0,0
60143,the,0,0
60144,combined,1,0
60145,incidence,1,1
60146,of,1,1
60147,major,1,1
60148,adverse,1,1
60149,cardiac,1,1
60150,event,1,1
60151,(,0,0
60152,10.4,0,0
60153,%,0,0
60154,in,0,0
60155,the,0,0
60156,XS0601,0,0
60157,group,0,0
60158,vs.,0,0
60159,22.7,0,0
60160,%,0,0
60161,in,0,0
60162,the,0,0
60163,placebo,0,0
60164,group,0,0
60165,",",0,1
60166,P,0,0
60167,<,0,0
60168,0.05,0,0
60169,),0,0
60170,.,0,0
60171,The,0,0
60172,incidence,1,1
60173,of,1,0
60174,recurrent,1,1
60175,angina,1,0
60176,at,0,0
60177,3,0,0
60178,and,0,0
60179,6,0,0
60180,months,0,0
60181,after,0,0
60182,PCI,0,1
60183,was,0,0
60184,also,0,0
60185,significantly,0,0
60186,reduced,0,0
60187,in,0,0
60188,XS0601,0,0
60189,group,0,0
60190,(,0,0
60191,7.1,0,0
60192,%,0,0
60193,and,0,0
60194,11.0,0,0
60195,%,0,0
60196,),0,0
60197,as,0,0
60198,compared,0,0
60199,with,0,0
60200,those,0,0
60201,in,0,0
60202,placebo,0,0
60203,group,0,0
60204,(,0,0
60205,19.5,0,0
60206,%,0,0
60207,and,0,0
60208,42.9,0,0
60209,%,0,0
60210,),0,0
60211,(,0,0
60212,P,0,0
60213,<,0,0
60214,0.05,0,0
60215,),0,0
60216,.,0,0
60217,No,0,0
60218,significant,0,0
60219,side,0,1
60220,effects,0,1
60221,occurred,0,0
60222,within,0,0
60223,the,0,0
60224,6-month,0,0
60225,follow-up,0,0
60226,period,0,0
60227,in,0,0
60228,the,0,0
60229,XS0601,0,0
60230,group,0,0
60231,.,0,1
60232,CONCLUSION,0,0
60233,Administration,0,0
60234,of,0,1
60235,XS0601,0,0
60236,for,0,0
60237,6,0,0
60238,months,0,0
60239,is,0,0
60240,demonstrated,0,0
60241,to,0,0
60242,be,0,0
60243,safe,0,1
60244,and,0,1
60245,effective,0,1
60246,in,0,0
60247,reducing,0,0
60248,restenosis,0,1
60249,in,0,0
60250,post-PCI,0,0
60251,patients,0,0
60252,.,0,0
60253,Effects,0,0
60254,of,0,1
60255,cooking,0,1
60256,plant,0,0
60257,oils,0,0
60258,on,0,0
60259,recurrent,0,1
60260,aphthous,0,0
60261,stomatitis,0,0
60262,:,0,0
60263,a,0,0
60264,randomized,0,0
60265,",",0,0
60266,placebo-controlled,0,0
60267,",",0,1
60268,double-blind,0,0
60269,trial,0,0
60270,.,0,0
60271,OBJECTIVE,0,1
60272,One-third,0,1
60273,of,0,0
60274,the,0,0
60275,total,0,0
60276,population,0,0
60277,seems,0,0
60278,to,0,0
60279,develop,0,0
60280,minor,0,0
60281,recurrent,0,1
60282,aphthous,0,1
60283,stomatitis,0,1
60284,(,0,1
60285,RAS,0,0
60286,),0,0
60287,during,0,0
60288,their,0,0
60289,lifetime,0,1
60290,.,0,0
60291,However,0,0
60292,",",0,0
60293,well-controlled,0,1
60294,dietary,0,1
60295,intervention,0,0
60296,studies,0,0
60297,to,0,0
60298,prevent,0,0
60299,minor,0,0
60300,RAS,0,0
60301,are,0,0
60302,very,0,0
60303,rare,0,0
60304,.,0,0
60305,The,0,0
60306,objective,0,0
60307,of,0,0
60308,the,0,0
60309,present,0,0
60310,study,0,0
60311,was,0,0
60312,to,0,0
60313,investigate,0,0
60314,whether,0,0
60315,the,0,0
60316,prevalence,0,1
60317,of,0,1
60318,RAS,0,0
60319,decreased,0,1
60320,with,0,0
60321,perilla,0,1
60322,oil,0,0
60323,(,0,0
60324,rich,0,0
60325,in,0,0
60326,alpha-linolenic,0,0
60327,acid,0,0
60328,),0,0
60329,.,0,0
60330,METHODS,0,0
60331,Thirty,0,0
60332,subjects,0,0
60333,(,0,0
60334,8,0,0
60335,men,0,0
60336,and,0,0
60337,22,0,0
60338,women,0,0
60339,),0,0
60340,who,0,0
60341,had,0,0
60342,minor,0,0
60343,RAS,0,0
60344,at,0,0
60345,least,0,0
60346,once,0,0
60347,a,0,0
60348,month,0,0
60349,were,0,0
60350,randomly,0,0
60351,allocated,0,0
60352,to,0,0
60353,a,0,0
60354,soybean,0,0
60355,oil,0,0
60356,group,0,0
60357,or,0,0
60358,a,0,0
60359,perilla,0,0
60360,oil,0,0
60361,group,0,0
60362,in,0,0
60363,a,0,0
60364,double-blind,0,0
60365,manner,0,0
60366,(,0,0
60367,experimental,0,0
60368,phase,0,0
60369,),0,0
60370,after,0,0
60371,a,0,0
60372,run-in,0,0
60373,phase,0,0
60374,of,0,0
60375,4,0,0
60376,mo,0,0
60377,during,0,0
60378,which,0,0
60379,subjects,0,0
60380,used,0,0
60381,a,0,0
60382,reference,0,1
60383,oil,0,0
60384,",",0,0
60385,the,0,0
60386,most,0,0
60387,popular,0,0
60388,cooking,0,1
60389,oil,0,0
60390,in,0,0
60391,Japan,0,0
60392,",",0,0
60393,or,0,0
60394,a,0,0
60395,50/50,0,0
60396,mixture,0,0
60397,of,0,0
60398,soybean,0,0
60399,oil,0,0
60400,and,0,1
60401,rapeseed,0,0
60402,oil,0,0
60403,.,0,0
60404,During,0,0
60405,the,0,0
60406,experimental,0,0
60407,phase,0,0
60408,",",0,1
60409,subjects,0,0
60410,were,0,0
60411,asked,0,0
60412,to,0,0
60413,use,0,0
60414,soybean,0,0
60415,oil,0,0
60416,or,0,1
60417,perilla,0,1
60418,oil,0,0
60419,as,0,0
60420,the,0,0
60421,sole,0,0
60422,cooking,0,1
60423,oil,0,0
60424,for,0,0
60425,8,0,0
60426,mo,0,0
60427,.,0,0
60428,Blood,1,1
60429,samples,1,0
60430,were,0,0
60431,collected,0,0
60432,at,0,0
60433,the,0,0
60434,start,0,0
60435,and,0,1
60436,end,0,0
60437,of,0,0
60438,the,0,0
60439,experimental,0,0
60440,phase,0,0
60441,for,0,0
60442,fatty,0,1
60443,acid,0,1
60444,analysis,0,0
60445,of,0,1
60446,total,0,1
60447,plasma,0,1
60448,phospholipid,0,1
60449,fraction,0,1
60450,.,0,1
60451,Occurrence,1,1
60452,and,1,1
60453,needed,1,1
60454,days,1,0
60455,for,1,0
60456,healing,1,1
60457,of,1,0
60458,minor,1,1
60459,RAS,1,0
60460,were,0,0
60461,recorded,0,0
60462,during,0,0
60463,the,0,0
60464,two,0,0
60465,phases,0,0
60466,and,0,0
60467,compared,0,0
60468,.,0,0
60469,RESULTS,0,0
60470,alpha-Linolenic,1,0
60471,acid,1,0
60472,concentrations,1,1
60473,in,1,0
60474,the,1,0
60475,plasma,1,1
60476,phospholipid,1,1
60477,fraction,1,1
60478,increased,1,0
60479,significantly,0,0
60480,in,0,0
60481,both,0,0
60482,groups,0,0
60483,during,0,0
60484,the,0,0
60485,experimental,0,0
60486,phase,0,0
60487,to,0,0
60488,a,0,0
60489,similar,0,0
60490,extent,0,0
60491,.,0,0
60492,The,0,0
60493,prevalence,0,1
60494,of,0,0
60495,minor,1,1
60496,RAS,1,0
60497,in,1,0
60498,the,1,0
60499,experimental,1,0
60500,phase,1,0
60501,decreased,1,1
60502,significantly,1,0
60503,in,0,0
60504,both,0,0
60505,groups,0,0
60506,compared,0,0
60507,with,0,0
60508,the,0,0
60509,run-in,0,0
60510,phase,0,0
60511,to,0,0
60512,a,0,0
60513,similar,0,0
60514,extent,0,0
60515,",",0,0
60516,without,0,0
60517,intergroup,0,0
60518,differences,0,0
60519,.,0,0
60520,CONCLUSION,0,0
60521,Perilla,0,0
60522,oil,0,0
60523,",",0,0
60524,which,0,0
60525,is,0,0
60526,rich,0,0
60527,in,0,0
60528,alpha-linolenic,0,0
60529,acid,0,1
60530,",",0,1
60531,was,0,0
60532,not,0,0
60533,superior,0,0
60534,to,0,0
60535,soybean,0,0
60536,oil,0,0
60537,in,0,0
60538,preventing,0,0
60539,minor,0,0
60540,RAS,0,0
60541,.,0,0
60542,There,0,0
60543,was,0,0
60544,a,0,0
60545,possibility,0,0
60546,that,0,0
60547,avoiding,0,0
60548,rapeseed,0,0
60549,oil,0,0
60550,might,0,0
60551,be,0,0
60552,beneficial,0,0
60553,for,0,0
60554,prevention,0,0
60555,of,0,0
60556,minor,0,0
60557,RAS,0,0
60558,.,0,0
60559,Pharmacokinetic,0,1
60560,and,0,1
60561,safety,0,1
60562,evaluation,0,0
60563,of,0,1
60564,high-dose,0,0
60565,combinations,0,0
60566,of,0,1
60567,fosamprenavir,0,0
60568,and,0,1
60569,ritonavir,0,0
60570,.,0,1
60571,High-dose,0,0
60572,combinations,0,0
60573,of,0,1
60574,fosamprenavir,0,0
60575,(,0,1
60576,FPV,0,0
60577,),0,1
60578,and,0,1
60579,ritonavir,0,0
60580,(,0,1
60581,RTV,0,1
60582,),0,1
60583,were,0,0
60584,evaluated,0,0
60585,in,0,0
60586,healthy,0,0
60587,adult,0,0
60588,subjects,0,0
60589,in,0,0
60590,order,0,0
60591,to,0,0
60592,select,0,0
60593,doses,0,0
60594,for,0,0
60595,further,0,0
60596,study,0,0
60597,in,0,0
60598,multiple,0,0
60599,protease,0,1
60600,inhibitor,0,0
60601,(,0,1
60602,PI,0,0
60603,),0,1
60604,-experienced,0,0
60605,patients,0,0
60606,infected,0,0
60607,with,0,0
60608,human,0,0
60609,immunodeficiency,0,0
60610,virus,0,1
60611,type,0,0
60612,1,0,0
60613,.,0,0
60614,Two,0,0
60615,high-dose,0,0
60616,regimens,0,0
60617,",",0,0
60618,FPV,0,0
60619,"1,400",0,0
60620,mg,0,0
60621,twice,0,0
60622,a,0,0
60623,day,0,0
60624,(,0,0
60625,BID,0,1
60626,),0,1
60627,plus,0,0
60628,RTV,0,0
60629,100,0,0
60630,mg,0,0
60631,BID,0,0
60632,and,0,1
60633,FPV,0,0
60634,"1,400",0,0
60635,mg,0,0
60636,BID,0,0
60637,plus,0,0
60638,RTV,0,1
60639,200,0,0
60640,mg,0,0
60641,BID,0,0
60642,",",0,1
60643,were,0,0
60644,planned,0,0
60645,to,0,0
60646,be,0,0
60647,compared,0,0
60648,to,0,0
60649,the,0,0
60650,approved,0,0
60651,regimen,0,0
60652,",",0,0
60653,FPV,0,0
60654,700,0,0
60655,mg,0,0
60656,BID,0,0
60657,plus,0,0
60658,RTV,0,1
60659,100,0,0
60660,mg,0,0
60661,BID,0,0
60662,",",0,0
60663,in,0,0
60664,a,0,0
60665,randomized,0,0
60666,three-period,0,0
60667,crossover,0,0
60668,study,0,0
60669,.,0,1
60670,Forty-two,0,0
60671,healthy,0,0
60672,adult,0,0
60673,subjects,0,0
60674,were,0,0
60675,enrolled,0,0
60676,",",0,0
60677,and,0,0
60678,39,0,0
60679,subjects,0,0
60680,completed,0,0
60681,period,0,0
60682,1,0,0
60683,.,0,0
60684,Due,0,0
60685,to,0,0
60686,marked,0,0
60687,hepatic,0,1
60688,transaminase,0,1
60689,elevations,0,1
60690,",",0,0
60691,predominantly,0,0
60692,with,0,0
60693,FPV,0,0
60694,"1,400",0,0
60695,mg,0,0
60696,BID,0,0
60697,plus,0,0
60698,RTV,0,1
60699,200,0,0
60700,mg,0,0
60701,BID,0,0
60702,",",0,0
60703,the,0,0
60704,study,0,0
60705,was,0,0
60706,terminated,0,0
60707,prematurely,0,0
60708,.,0,0
60709,For,0,0
60710,FPV,0,0
60711,"1,400",0,0
60712,mg,0,0
60713,BID,0,0
60714,plus,0,0
60715,RTV,0,1
60716,100,0,0
60717,mg,0,0
60718,BID,0,0
60719,",",0,0
60720,the,0,0
60721,values,1,1
60722,for,1,0
60723,plasma,1,1
60724,amprenavir,1,1
60725,(,1,1
60726,APV,1,0
60727,),1,1
60728,area,1,1
60729,under,1,0
60730,the,1,0
60731,concentration-time,1,1
60732,profile,1,1
60733,over,1,0
60734,the,1,0
60735,dosing,1,0
60736,interval,1,0
60737,(,1,1
60738,tau,1,1
60739,),1,0
60740,at,1,0
60741,steady,1,1
60742,state,1,1
60743,[,0,0
60744,AUC,0,1
60745,(,0,0
60746,0-tau,0,1
60747,),0,1
60748,],0,0
60749,",",0,1
60750,maximum,1,1
60751,concentration,1,1
60752,of,1,1
60753,drug,1,0
60754,in,1,0
60755,plasma,1,1
60756,(,1,1
60757,C,1,1
60758,(,1,1
60759,max,1,1
60760,),1,1
60761,),1,1
60762,",",1,0
60763,and,1,1
60764,plasma,1,1
60765,concentration,1,1
60766,at,1,0
60767,the,1,0
60768,end,1,0
60769,of,1,0
60770,tau,1,1
60771,at,1,0
60772,steady,1,1
60773,state,1,1
60774,(,1,1
60775,C,1,1
60776,(,1,1
60777,tau,1,1
60778,),1,1
60779,),1,0
60780,were,0,0
60781,54,0,0
60782,",",0,0
60783,81,0,0
60784,",",0,0
60785,and,0,0
60786,26,0,0
60787,%,0,0
60788,higher,0,0
60789,",",0,1
60790,respectively,0,0
60791,",",0,0
60792,and,0,0
60793,the,0,0
60794,values,1,1
60795,for,1,0
60796,plasma,1,1
60797,RTV,1,1
60798,AUC,1,1
60799,(,1,1
60800,0-tau,1,1
60801,),1,1
60802,",",1,1
60803,C,1,1
60804,(,1,1
60805,max,1,1
60806,),1,1
60807,",",1,1
60808,and,1,1
60809,C,1,1
60810,(,1,1
60811,tau,1,1
60812,),1,0
60813,were,0,0
60814,49,0,0
60815,%,0,0
60816,higher,0,0
60817,",",0,0
60818,71,0,0
60819,%,0,0
60820,higher,0,0
60821,",",0,0
60822,and,0,0
60823,11,0,0
60824,%,0,0
60825,lower,0,0
60826,",",0,1
60827,respectively,0,0
60828,",",0,0
60829,than,0,0
60830,those,0,0
60831,for,0,0
60832,FPV,0,0
60833,700,0,0
60834,mg,0,0
60835,BID,0,0
60836,plus,0,0
60837,RTV,0,1
60838,100,0,0
60839,mg,0,0
60840,BID,0,0
60841,.,0,0
60842,For,0,0
60843,FPV,0,0
60844,"1,400",0,0
60845,mg,0,0
60846,BID,0,0
60847,plus,0,0
60848,RTV,0,1
60849,200,0,0
60850,mg,0,0
60851,BID,0,0
60852,",",0,0
60853,the,0,0
60854,values,1,1
60855,for,1,0
60856,plasma,1,1
60857,APV,1,1
60858,AUC,1,1
60859,(,1,1
60860,0-tau,1,1
60861,),1,1
60862,",",1,1
60863,C,1,1
60864,(,1,1
60865,max,1,1
60866,),1,1
60867,",",1,1
60868,and,1,1
60869,C,1,1
60870,(,1,1
60871,tau,1,1
60872,),1,0
60873,were,0,0
60874,26,0,0
60875,",",0,0
60876,48,0,0
60877,",",0,0
60878,and,0,0
60879,32,0,0
60880,%,0,0
60881,higher,0,0
60882,",",0,1
60883,respectively,0,0
60884,",",0,0
60885,and,0,0
60886,the,0,0
60887,values,0,1
60888,for,0,0
60889,plasma,1,1
60890,RTV,1,1
60891,AUC,1,1
60892,(,1,1
60893,0-tau,1,1
60894,),1,1
60895,",",1,1
60896,C,1,1
60897,(,1,1
60898,max,1,1
60899,),1,1
60900,",",1,1
60901,and,1,1
60902,C,1,1
60903,(,1,1
60904,tau,1,1
60905,),1,1
60906,increased,0,1
60907,4.15-fold,0,0
60908,",",0,1
60909,4.17-fold,0,1
60910,",",0,1
60911,and,0,1
60912,3.99-fold,0,1
60913,",",0,1
60914,respectively,0,0
60915,",",0,0
60916,compared,0,0
60917,to,0,0
60918,those,0,0
60919,for,0,0
60920,FPV,0,0
60921,700,0,0
60922,mg,0,0
60923,BID,0,0
60924,plus,0,0
60925,RTV,0,1
60926,100,0,0
60927,mg,0,0
60928,BID,0,0
60929,.,0,0
60930,FPV,0,0
60931,"1,400",0,0
60932,mg,0,0
60933,BID,0,0
60934,plus,0,0
60935,RTV,0,1
60936,200,0,0
60937,mg,0,0
60938,BID,0,0
60939,is,0,0
60940,not,0,0
60941,recommended,0,0
60942,due,0,0
60943,to,0,0
60944,an,0,0
60945,increased,0,0
60946,rate,1,1
60947,of,1,0
60948,marked,1,0
60949,hepatic,1,0
60950,transaminase,1,1
60951,elevations,1,1
60952,and,0,1
60953,lack,1,0
60954,of,1,1
60955,pharmacokinetic,1,1
60956,advantage,1,0
60957,.,1,0
60958,FPV,0,0
60959,"1,400",0,0
60960,mg,0,0
60961,BID,0,0
60962,plus,0,0
60963,RTV,0,1
60964,100,0,0
60965,mg,0,0
60966,BID,0,0
60967,is,0,0
60968,currently,0,0
60969,under,0,0
60970,clinical,0,0
60971,evaluation,0,0
60972,in,0,0
60973,multiple,0,0
60974,PI-experienced,0,0
60975,patients,0,0
60976,.,0,0
60977,Web-based,0,0
60978,weight,0,1
60979,management,0,0
60980,programs,0,0
60981,in,0,0
60982,an,0,0
60983,integrated,0,0
60984,health,0,1
60985,care,0,0
60986,setting,0,0
60987,:,0,0
60988,a,0,0
60989,randomized,0,0
60990,",",0,0
60991,controlled,0,0
60992,trial,0,0
60993,.,0,0
60994,OBJECTIVE,0,0
60995,To,0,0
60996,assess,0,0
60997,the,0,0
60998,efficacy,1,1
60999,of,0,0
61000,a,0,0
61001,Web-based,0,0
61002,tailored,0,0
61003,behavioral,0,1
61004,weight,0,1
61005,management,0,0
61006,program,0,0
61007,compared,0,0
61008,with,0,0
61009,Web-based,0,0
61010,information-only,0,0
61011,weight,0,1
61012,management,0,0
61013,materials,0,0
61014,.,0,0
61015,RESEARCH,0,0
61016,METHODS,0,0
61017,AND,0,0
61018,PROCEDURES,0,1
61019,Participants,0,0
61020,",",0,0
61021,2862,0,0
61022,eligible,0,0
61023,overweight,0,0
61024,and,0,1
61025,obese,0,0
61026,(,0,0
61027,BMI,0,0
61028,=,0,0
61029,27,0,0
61030,to,0,0
61031,40,0,0
61032,kg/m2,0,0
61033,),0,0
61034,members,0,0
61035,from,0,0
61036,four,0,0
61037,regions,0,0
61038,of,0,0
61039,Kaiser,0,0
61040,Permanente,0,0
61041,'s,0,1
61042,integrated,0,0
61043,health,0,1
61044,care,0,0
61045,delivery,0,1
61046,system,0,1
61047,",",0,1
61048,were,0,0
61049,randomized,0,0
61050,to,0,0
61051,receive,0,0
61052,either,0,0
61053,a,0,0
61054,tailored,0,0
61055,expert,0,0
61056,system,0,0
61057,or,0,1
61058,information-only,0,1
61059,Web-based,0,1
61060,weight,0,1
61061,management,0,0
61062,materials,0,0
61063,.,0,1
61064,Weight,1,0
61065,change,1,1
61066,and,1,1
61067,program,1,0
61068,satisfaction,1,1
61069,were,0,0
61070,assessed,0,0
61071,by,0,0
61072,self-report,0,0
61073,through,0,0
61074,an,0,0
61075,Internet-based,0,0
61076,survey,0,0
61077,at,0,0
61078,3-,0,0
61079,and,0,1
61080,6-month,0,1
61081,follow-up,0,0
61082,periods,0,0
61083,.,0,0
61084,RESULTS,0,0
61085,Significantly,0,0
61086,greater,0,1
61087,weight,1,1
61088,loss,1,1
61089,at,0,0
61090,follow-up,0,0
61091,was,0,0
61092,found,0,0
61093,among,0,0
61094,participants,0,0
61095,assigned,0,0
61096,to,0,0
61097,the,0,0
61098,tailored,0,0
61099,expert,0,0
61100,system,0,0
61101,than,0,0
61102,among,0,0
61103,those,0,0
61104,assigned,0,0
61105,to,0,0
61106,the,0,0
61107,information-only,0,0
61108,condition,0,0
61109,.,0,0
61110,Subjects,0,0
61111,in,0,0
61112,the,0,0
61113,tailored,0,0
61114,expert,0,0
61115,system,0,0
61116,lost,0,0
61117,a,0,0
61118,mean,0,1
61119,of,0,0
61120,3,0,0
61121,+/-,0,0
61122,0.3,0,0
61123,%,0,0
61124,of,0,0
61125,their,0,0
61126,baseline,1,1
61127,weight,1,1
61128,",",0,1
61129,whereas,0,0
61130,subjects,0,0
61131,in,0,0
61132,the,0,0
61133,information-only,0,0
61134,condition,0,0
61135,lost,0,0
61136,a,0,0
61137,mean,0,1
61138,of,0,0
61139,1.2,0,0
61140,+/-,0,0
61141,0.4,0,0
61142,%,0,0
61143,(,0,0
61144,p,0,0
61145,<,0,0
61146,0.0004,0,0
61147,),0,0
61148,.,0,0
61149,Participants,0,0
61150,were,0,0
61151,also,0,0
61152,more,0,0
61153,likely,0,0
61154,to,0,0
61155,report,0,0
61156,that,0,0
61157,the,0,0
61158,tailored,0,0
61159,expert,0,0
61160,system,0,0
61161,was,0,0
61162,personally,1,1
61163,relevant,1,0
61164,",",1,0
61165,helpful,1,1
61166,",",1,1
61167,and,1,1
61168,easy,1,1
61169,to,1,0
61170,understand,1,0
61171,.,1,0
61172,Notably,0,0
61173,",",0,0
61174,36,0,0
61175,%,0,0
61176,of,0,0
61177,enrollees,0,0
61178,were,0,0
61179,African-American,0,0
61180,",",0,0
61181,with,0,0
61182,enrollment,0,0
61183,rates,0,1
61184,higher,0,0
61185,than,0,0
61186,the,0,0
61187,general,0,0
61188,proportion,0,0
61189,of,0,1
61190,African,0,0
61191,Americans,0,0
61192,in,0,0
61193,any,0,0
61194,of,0,0
61195,the,0,0
61196,study,0,0
61197,regions,0,0
61198,.,0,0
61199,DISCUSSION,0,0
61200,The,0,0
61201,results,0,0
61202,of,0,0
61203,this,0,0
61204,large,0,0
61205,",",0,0
61206,randomized,0,0
61207,control,0,0
61208,trial,0,0
61209,show,0,0
61210,the,0,0
61211,potential,0,0
61212,benefit,0,0
61213,of,0,0
61214,the,0,0
61215,Web-based,0,0
61216,tailored,0,0
61217,expert,0,0
61218,system,0,0
61219,for,0,0
61220,weight,0,1
61221,management,0,0
61222,compared,0,0
61223,with,0,0
61224,a,0,0
61225,Web-based,0,0
61226,information-only,0,0
61227,weight,0,1
61228,management,0,0
61229,program,0,0
61230,.,0,0
61231,Nurse-led,0,0
61232,cardiac,0,1
61233,clinics,0,0
61234,for,0,0
61235,adults,0,0
61236,with,0,0
61237,coronary,0,1
61238,heart,0,1
61239,disease,0,1
61240,.,0,0
61241,This,0,0
61242,information,0,0
61243,on,0,0
61244,best,0,0
61245,practice,0,0
61246,is,0,0
61247,based,0,0
61248,on,0,0
61249,a,0,0
61250,systematic,0,0
61251,review,0,0
61252,of,0,1
61253,research,0,0
61254,",",0,0
61255,published,0,0
61256,by,0,0
61257,Blackwell,0,0
61258,Publishing,0,1
61259,Asia,0,1
61260,and,0,1
61261,conducted,0,0
61262,by,0,0
61263,the,0,0
61264,Centre,0,0
61265,for,0,0
61266,Evidence-based,0,0
61267,Nursing,0,1
61268,South,0,1
61269,Australia,0,0
61270,",",0,0
61271,a,0,0
61272,collaborating,0,0
61273,centre,0,0
61274,of,0,0
61275,the,0,0
61276,Joanna,0,0
61277,Briggs,0,1
61278,Institute,0,0
61279,(,0,1
61280,JBI,0,0
61281,),0,0
61282,.,0,0
61283,The,0,0
61284,primary,0,0
61285,references,0,0
61286,on,0,0
61287,which,0,0
61288,this,0,0
61289,information,0,0
61290,is,0,0
61291,based,0,0
61292,are,0,0
61293,provided,0,0
61294,in,0,0
61295,the,0,0
61296,systematic,0,0
61297,review,0,0
61298,report,0,1
61299,available,0,0
61300,online,0,0
61301,via,0,0
61302,Blackwell,0,0
61303,Synergy,0,1
61304,www.blackwell-synergy.com,0,0
61305,and,0,1
61306,to,0,0
61307,members,0,0
61308,of,0,0
61309,the,0,0
61310,institute,0,0
61311,via,0,0
61312,the,0,0
61313,web,0,0
61314,site,0,0
61315,:,0,0
61316,www.joannabriggs.edu.au,0,0
61317,.,0,0
61318,This,0,0
61319,information,0,0
61320,sheet,0,0
61321,covers,0,0
61322,the,0,0
61323,following,0,0
61324,:,0,0
61325,Nurse-led,0,0
61326,education,0,0
61327,and,0,1
61328,self-help,0,0
61329,.,0,1
61330,Education,0,1
61331,and,0,1
61332,motivational,0,0
61333,interview,0,0
61334,.,0,1
61335,Audit,0,1
61336,and,0,0
61337,recall,0,1
61338,.,0,1
61339,Secondary,0,0
61340,prevention,0,0
61341,.,0,0
61342,The,0,0
61343,double-blind,0,0
61344,sham-controlled,0,0
61345,study,0,0
61346,of,0,1
61347,high-frequency,0,1
61348,rTMS,0,0
61349,(,0,0
61350,20,0,0
61351,Hz,0,0
61352,),0,0
61353,for,0,0
61354,negative,0,1
61355,symptoms,0,1
61356,in,0,0
61357,schizophrenia,0,0
61358,:,0,0
61359,negative,0,1
61360,results,0,0
61361,.,0,0
61362,The,0,0
61363,high-frequency,0,0
61364,repetitive,0,1
61365,transcranial,0,1
61366,magnetic,0,0
61367,stimulation,0,1
61368,(,0,1
61369,HF-rTMS,0,1
61370,),0,0
61371,over,0,0
61372,the,0,0
61373,prefrontal,0,0
61374,cortex,0,0
61375,is,0,0
61376,a,0,0
61377,promising,0,0
61378,method,0,0
61379,for,0,0
61380,the,0,0
61381,treatment,0,0
61382,of,0,0
61383,negative,0,1
61384,symptoms,0,1
61385,of,0,0
61386,schizophrenia,0,0
61387,.,0,0
61388,Using,0,0
61389,double-blind,0,0
61390,sham-controlled,0,0
61391,parallel,0,0
61392,design,0,0
61393,",",0,0
61394,we,0,0
61395,evaluated,0,0
61396,the,0,0
61397,effect,0,1
61398,of,0,0
61399,HF-rTMS,0,0
61400,over,0,0
61401,the,0,0
61402,left,0,1
61403,dorsolateral,0,1
61404,prefrontal,0,1
61405,cortex,0,1
61406,(,0,1
61407,DLPFC,0,1
61408,),0,0
61409,on,0,0
61410,negative,0,1
61411,symptoms,0,1
61412,in,0,0
61413,patients,0,0
61414,with,0,0
61415,schizophrenia,0,0
61416,.,0,1
61417,Sixteen,0,0
61418,schizophrenia,0,1
61419,patients,0,0
61420,with,0,0
61421,predominantly,0,0
61422,negative,0,1
61423,symptoms,0,1
61424,on,0,0
61425,stable,0,1
61426,antipsychotic,0,0
61427,medication,0,1
61428,were,0,0
61429,treated,0,0
61430,with,0,0
61431,20,0,0
61432,Hz,0,0
61433,rTMS,0,0
61434,(,0,0
61435,90,0,0
61436,%,0,0
61437,of,0,0
61438,motor,0,1
61439,threshold,0,1
61440,",",0,0
61441,2000,0,0
61442,stimuli,0,0
61443,per,0,0
61444,session,0,0
61445,),0,0
61446,over,0,0
61447,ten,0,0
61448,days,0,0
61449,within,0,0
61450,2,0,0
61451,weeks,0,0
61452,with,0,0
61453,six,0,0
61454,weeks,0,0
61455,follow-up,0,0
61456,.,0,0
61457,The,0,0
61458,effect,0,1
61459,was,0,0
61460,assessed,0,0
61461,using,0,0
61462,PANSS,1,0
61463,",",1,1
61464,CGI,1,1
61465,",",1,1
61466,MADRS,1,1
61467,and,1,1
61468,neuropsychological,1,1
61469,tests,1,1
61470,.,1,0
61471,We,0,0
61472,failed,0,0
61473,to,0,0
61474,find,0,0
61475,any,0,0
61476,significant,0,0
61477,effect,0,0
61478,of,0,1
61479,active,1,0
61480,rTMS,1,0
61481,.,1,1
61482,Sham,1,0
61483,rTMS,1,0
61484,showed,0,0
61485,a,0,0
61486,trend,0,0
61487,for,0,0
61488,improvement,1,1
61489,over,1,0
61490,time,1,1
61491,on,0,0
61492,positive,1,1
61493,and,1,1
61494,negative,1,1
61495,subscales,1,1
61496,of,1,1
61497,PANSS,1,1
61498,and,1,0
61499,MADRS,1,0
61500,.,1,1
61501,Between-group,0,0
61502,comparisons,0,0
61503,failed,0,0
61504,to,0,0
61505,reveal,0,0
61506,any,0,0
61507,significant,0,0
61508,differences,0,0
61509,on,0,0
61510,any,0,0
61511,rating,1,1
61512,scales,1,1
61513,except,0,0
61514,a,0,0
61515,positive,1,1
61516,subscale,1,1
61517,of,1,1
61518,PANSS,1,0
61519,after,0,0
61520,8,0,0
61521,weeks,0,0
61522,.,0,0
61523,Results,0,0
61524,from,0,0
61525,our,0,0
61526,study,0,0
61527,did,0,0
61528,not,0,0
61529,confirm,0,0
61530,that,0,0
61531,HF-rTMS,1,0
61532,over,0,0
61533,the,0,0
61534,left,0,0
61535,DLPCF,1,1
61536,affects,1,0
61537,the,1,0
61538,negative,1,1
61539,symptoms,1,1
61540,of,1,1
61541,schizophrenia,1,1
61542,and,0,1
61543,alternative,0,0
61544,rTMS,0,0
61545,approaches,0,0
61546,are,0,0
61547,discussed,0,0
61548,.,0,0
61549,A,0,0
61550,randomised,0,0
61551,trial,0,0
61552,comparing,0,0
61553,holmium,0,0
61554,laser,0,0
61555,enucleation,0,0
61556,versus,0,0
61557,transurethral,0,0
61558,resection,0,0
61559,in,0,0
61560,the,0,0
61561,treatment,0,0
61562,of,0,0
61563,prostates,0,0
61564,larger,0,0
61565,than,0,0
61566,40,0,0
61567,grams,0,0
61568,:,0,0
61569,results,0,0
61570,at,0,0
61571,2,0,0
61572,years,0,0
61573,.,0,0
61574,OBJECTIVE,0,0
61575,To,0,0
61576,compare,0,0
61577,holmium,0,0
61578,laser,0,0
61579,enucleation,0,0
61580,of,0,0
61581,the,0,0
61582,prostate,0,0
61583,(,0,0
61584,HoLEP,0,1
61585,),0,0
61586,with,0,0
61587,transurethral,0,0
61588,resection,0,0
61589,of,0,0
61590,the,0,0
61591,prostate,0,0
61592,(,0,0
61593,TURP,0,1
61594,),0,1
61595,for,0,0
61596,treatment,0,0
61597,of,0,0
61598,men,0,0
61599,with,0,0
61600,bladder,0,1
61601,outflow,0,1
61602,obstruction,0,1
61603,(,0,1
61604,BOO,0,0
61605,),0,0
61606,secondary,0,0
61607,to,0,0
61608,benign,0,0
61609,prostatic,0,0
61610,hyperplasia,0,1
61611,with,0,0
61612,a,0,0
61613,minimum,0,1
61614,of,0,0
61615,24-month,0,0
61616,follow-up,0,0
61617,.,0,0
61618,PATIENTS,0,0
61619,AND,0,0
61620,METHODS,0,0
61621,Sixty-one,0,0
61622,patients,0,0
61623,were,0,0
61624,randomised,0,0
61625,to,0,0
61626,either,0,0
61627,HoLEP,0,1
61628,or,0,0
61629,TURP,0,0
61630,.,0,0
61631,All,0,0
61632,patients,0,0
61633,had,0,0
61634,BOO,0,0
61635,proven,0,0
61636,on,0,0
61637,urodynamic,0,0
61638,studies,0,0
61639,pre-operatively,0,1
61640,(,0,0
61641,prostate,0,0
61642,size,0,1
61643,40-200,0,0
61644,g,0,0
61645,),0,0
61646,.,0,0
61647,One,0,0
61648,patient,0,0
61649,died,0,0
61650,before,0,0
61651,treatment,0,0
61652,",",0,1
61653,which,0,0
61654,left,0,0
61655,30,0,0
61656,patients,0,0
61657,in,0,0
61658,each,0,0
61659,group,0,0
61660,.,0,0
61661,Perioperative,1,1
61662,data,1,0
61663,",",1,0
61664,as,1,0
61665,well,1,0
61666,as,1,0
61667,symptom,1,1
61668,scores,1,1
61669,",",1,1
61670,Quality,1,1
61671,of,1,1
61672,Life,1,0
61673,(,1,0
61674,QoL,1,0
61675,),1,0
61676,scores,1,1
61677,",",1,0
61678,and,1,1
61679,maximum,1,1
61680,urinary,1,1
61681,flow,1,1
61682,rates,1,1
61683,(,1,1
61684,Qmax,1,1
61685,),1,1
61686,were,0,0
61687,obtained,0,0
61688,at,0,0
61689,one,0,0
61690,",",0,0
61691,three,0,0
61692,",",0,0
61693,"six,12",0,0
61694,",",0,1
61695,and,0,0
61696,24,0,0
61697,months,0,0
61698,.,0,0
61699,Post-void,1,1
61700,residual,1,1
61701,volumes,1,1
61702,",",1,1
61703,transrectal,1,1
61704,ultrasound,1,1
61705,(,1,1
61706,TRUS,1,1
61707,),1,1
61708,volumes,1,1
61709,",",1,1
61710,and,1,1
61711,pressure,1,1
61712,flow,1,1
61713,studies,1,0
61714,were,0,0
61715,obtained,0,0
61716,six,0,0
61717,months,0,0
61718,post-operatively,0,0
61719,.,0,0
61720,Continence,1,1
61721,and,1,1
61722,potency,1,1
61723,data,1,0
61724,were,0,0
61725,also,0,0
61726,recorded,0,0
61727,.,0,0
61728,RESULTS,0,0
61729,There,0,0
61730,were,0,0
61731,no,0,0
61732,significant,0,0
61733,differences,0,0
61734,between,0,0
61735,the,0,0
61736,two,0,0
61737,surgical,0,0
61738,groups,0,0
61739,pre-operatively,0,0
61740,.,0,0
61741,Mean,1,1
61742,pre-operative,1,1
61743,TRUS,1,1
61744,volume,1,1
61745,was,0,0
61746,77.8+/-5.6,0,0
61747,g,0,0
61748,(,0,1
61749,42-152,0,0
61750,),0,0
61751,in,0,0
61752,the,0,0
61753,HoLEP,0,1
61754,group,0,0
61755,and,0,1
61756,70.0+/-5.0,0,0
61757,g,0,1
61758,(,0,1
61759,46-156,0,0
61760,),0,0
61761,in,0,0
61762,the,0,0
61763,TURP,0,0
61764,group,0,0
61765,.,0,0
61766,Patients,0,0
61767,in,0,0
61768,the,0,0
61769,HoLEP,0,1
61770,group,0,0
61771,had,0,0
61772,shorter,0,1
61773,catheter,1,1
61774,times,1,1
61775,and,0,1
61776,hospital,1,1
61777,stays,1,1
61778,.,1,0
61779,More,0,0
61780,prostate,1,0
61781,tissue,1,1
61782,was,0,0
61783,retrieved,0,0
61784,in,0,0
61785,the,0,0
61786,HoLEP,0,0
61787,group,0,0
61788,.,0,0
61789,At,0,0
61790,six,0,0
61791,months,0,0
61792,",",0,0
61793,HoLEP,0,1
61794,was,0,0
61795,urodynamically,1,0
61796,superior,0,0
61797,to,0,0
61798,TURP,0,0
61799,in,0,0
61800,relieving,0,0
61801,BOO,0,0
61802,.,0,0
61803,At,0,0
61804,24,0,0
61805,months,0,0
61806,",",0,0
61807,there,0,0
61808,was,0,0
61809,no,0,0
61810,significant,0,0
61811,difference,0,0
61812,between,0,0
61813,the,0,0
61814,two,0,0
61815,surgical,0,0
61816,groups,0,0
61817,with,0,0
61818,respect,0,0
61819,to,0,0
61820,American,1,0
61821,Urology,1,1
61822,Association,1,0
61823,scores,1,1
61824,",",1,0
61825,QoL,1,1
61826,scores,1,1
61827,",",1,0
61828,or,1,1
61829,Qmax,1,1
61830,values,1,1
61831,;,1,0
61832,however,0,0
61833,",",0,0
61834,two,0,0
61835,patients,0,0
61836,in,0,0
61837,the,0,0
61838,TURP,0,0
61839,group,0,0
61840,required,0,1
61841,re-operation,0,1
61842,.,0,1
61843,CONCLUSIONS,0,0
61844,HoLEP,0,0
61845,has,0,0
61846,less,0,0
61847,perioperative,1,1
61848,morbidity,1,1
61849,and,0,0
61850,produces,0,0
61851,superior,0,1
61852,urodynamic,1,0
61853,outcomes,1,1
61854,than,0,0
61855,TURP,0,0
61856,",",0,0
61857,when,0,0
61858,treating,0,0
61859,prostates,0,0
61860,>,0,0
61861,40,0,0
61862,g.,0,0
61863,At,0,0
61864,24,0,0
61865,months,0,0
61866,of,0,0
61867,follow-up,0,0
61868,",",0,0
61869,HoLEP,0,1
61870,is,0,0
61871,equivalent,0,0
61872,to,0,0
61873,TURP,0,0
61874,.,0,0
61875,[,0,0
61876,Profiles,0,1
61877,of,0,1
61878,irregular,1,1
61879,bleeding,1,1
61880,induced,0,0
61881,by,0,0
61882,low-dose,0,0
61883,hormone,0,1
61884,therapy,0,0
61885,and,0,1
61886,Chinese,0,0
61887,formulated,0,0
61888,herbs,0,0
61889,products,0,0
61890,],0,0
61891,.,0,0
61892,OBJECTIVE,0,0
61893,To,0,0
61894,compare,0,0
61895,profiles,0,1
61896,and,0,1
61897,related,0,1
61898,factors,0,1
61899,of,0,1
61900,irregular,1,1
61901,bleeding,1,1
61902,induced,0,0
61903,by,0,0
61904,different,0,0
61905,types,0,0
61906,of,0,1
61907,low-dose,0,0
61908,hormone,0,1
61909,therapy,0,0
61910,(,0,1
61911,HT,0,1
61912,),0,0
61913,and,0,0
61914,a,0,0
61915,Chinese,0,0
61916,formulated,0,0
61917,herbs,0,0
61918,products,0,0
61919,.,0,0
61920,METHODS,0,0
61921,Applied,0,1
61922,with,0,0
61923,open-labeled,0,0
61924,",",0,0
61925,randomized,0,0
61926,",",0,0
61927,and,0,1
61928,clinical,0,1
61929,trial,0,0
61930,design,0,0
61931,",",0,0
61932,136,0,0
61933,postmenopausal,0,0
61934,women,0,0
61935,were,0,0
61936,assigned,0,0
61937,into,0,0
61938,four,0,0
61939,groups,0,0
61940,:,0,0
61941,group,0,0
61942,A,0,0
61943,:,0,0
61944,estradiol,0,0
61945,valerate,0,0
61946,(,0,1
61947,E2,0,1
61948,V,0,0
61949,),0,0
61950,1,0,0
61951,mg/d,0,0
61952,+,0,0
61953,medroxyprogesterone,0,0
61954,acetate,0,0
61955,(,0,1
61956,MPA,0,1
61957,),0,0
61958,2,0,0
61959,mg/d,0,0
61960,;,0,0
61961,group,0,0
61962,B,0,0
61963,:,0,0
61964,conjugated,0,1
61965,equine,0,0
61966,estrogen,0,0
61967,0.45,0,0
61968,mg/d,0,0
61969,+,0,0
61970,MPA,0,1
61971,2,0,0
61972,mg/d,0,0
61973,;,0,0
61974,group,0,0
61975,C,0,0
61976,:,0,0
61977,tibolone,0,0
61978,1.25,0,0
61979,mg/d,0,0
61980,;,0,0
61981,group,0,0
61982,D,0,1
61983,:,0,0
61984,a,0,0
61985,Chinese,0,0
61986,formulated,0,0
61987,herbs,0,0
61988,product,0,1
61989,(,0,1
61990,Kuntai,0,0
61991,),0,0
61992,4,0,0
61993,#,0,0
61994,tid,0,0
61995,.,0,0
61996,Each,0,0
61997,subject,0,0
61998,took,0,0
61999,element,0,0
62000,calcium,0,0
62001,400,0,0
62002,mg/d,0,0
62003,and,0,0
62004,vitamin,0,1
62005,D,0,1
62006,200,0,0
62007,IU/d,0,0
62008,concomitantly,0,0
62009,.,0,0
62010,Modified,0,1
62011,Kupperman,1,1
62012,scores,1,1
62013,were,0,0
62014,assessed,0,0
62015,on,0,0
62016,baseline,0,0
62017,and,0,0
62018,every,0,0
62019,3,0,0
62020,months,0,0
62021,thereafter,0,0
62022,and,0,0
62023,irregular,1,1
62024,bleeding,1,1
62025,was,0,0
62026,recorded,0,0
62027,on,0,0
62028,menopausal,0,0
62029,diary,0,1
62030,every,0,0
62031,day,0,0
62032,.,0,0
62033,The,0,0
62034,duration,0,1
62035,of,0,0
62036,this,0,0
62037,study,0,0
62038,was,0,0
62039,1,0,0
62040,year,0,0
62041,.,0,0
62042,Results,0,0
62043,The,0,0
62044,efficacies,1,1
62045,were,0,0
62046,similar,0,0
62047,in,0,0
62048,three,0,0
62049,HT-managed,0,0
62050,groups,0,0
62051,",",0,1
62052,but,0,0
62053,was,0,0
62054,better,0,0
62055,than,0,0
62056,in,0,0
62057,group,0,0
62058,D,0,1
62059,",",0,0
62060,although,0,0
62061,the,0,0
62062,latter,0,0
62063,was,0,0
62064,also,0,0
62065,effective,1,0
62066,in,0,0
62067,alleviating,0,0
62068,menopausal,0,0
62069,symptoms,0,1
62070,.,0,1
62071,Hazard,1,1
62072,ratio,1,1
62073,(,1,1
62074,HR,1,1
62075,),1,0
62076,of,1,0
62077,irregular,1,1
62078,bleeding,1,1
62079,was,0,0
62080,1.00,0,0
62081,in,0,0
62082,group,0,0
62083,C,0,0
62084,",",0,0
62085,2.43,0,0
62086,in,0,0
62087,group,0,0
62088,A,0,0
62089,(,0,0
62090,95,0,0
62091,%,0,0
62092,CI,0,0
62093,:,0,0
62094,1.08-5.46,0,0
62095,),0,0
62096,",",0,0
62097,3.12,0,0
62098,in,0,0
62099,group,0,0
62100,B,0,0
62101,(,0,0
62102,95,0,0
62103,%,0,0
62104,CI,0,0
62105,:,0,0
62106,1.42-6.88,0,0
62107,),0,1
62108,",",0,0
62109,and,0,0
62110,0.73,0,0
62111,in,0,0
62112,group,0,0
62113,D,0,1
62114,(,0,0
62115,95,0,0
62116,%,0,0
62117,CI,0,0
62118,:,0,0
62119,0.26-2.04,0,0
62120,),0,0
62121,.,0,0
62122,Most,0,0
62123,cases,0,0
62124,initially,0,0
62125,experienced,0,0
62126,bleeding,1,1
62127,in,0,0
62128,the,0,0
62129,first,0,0
62130,3,0,0
62131,months,0,0
62132,but,0,0
62133,such,0,1
62134,initiation,1,0
62135,was,0,0
62136,a,0,0
62137,bit,0,0
62138,later,0,0
62139,in,0,0
62140,group,0,0
62141,C.,0,1
62142,Endometrium,1,1
62143,",",0,0
62144,as,0,0
62145,detected,0,0
62146,by,0,0
62147,B-mode,0,0
62148,ultrasound,0,1
62149,",",0,1
62150,increased,0,0
62151,approximately,0,0
62152,1,0,0
62153,mm,0,0
62154,in,0,0
62155,HT,0,1
62156,groups,0,0
62157,",",0,0
62158,while,0,0
62159,it,0,0
62160,was,0,0
62161,a,0,0
62162,bit,0,1
62163,thicker,0,1
62164,in,0,0
62165,group,0,0
62166,C.,0,1
62167,Long,0,0
62168,periods,0,0
62169,in,0,0
62170,reproductive,0,1
62171,age,0,0
62172,and,0,1
62173,short,0,1
62174,time,0,1
62175,since,0,0
62176,menopause,0,0
62177,were,0,0
62178,high,0,0
62179,risk,0,1
62180,factors,0,1
62181,for,0,0
62182,irregular,1,0
62183,bleeding,1,1
62184,.,1,0
62185,CONCLUSION,0,0
62186,Profiles,0,1
62187,of,0,1
62188,irregular,1,1
62189,bleeding,1,1
62190,in,0,0
62191,3,0,0
62192,commonly,0,0
62193,used,0,0
62194,types,0,0
62195,of,0,0
62196,low-dose,0,0
62197,HT,0,1
62198,are,0,0
62199,different,0,0
62200,and,0,0
62201,some,0,0
62202,factors,0,1
62203,such,0,0
62204,as,0,0
62205,long,0,0
62206,period,0,0
62207,in,0,0
62208,reproductive,0,1
62209,age,0,0
62210,and,0,1
62211,short,0,1
62212,time,0,1
62213,since,0,0
62214,menopause,0,0
62215,may,0,0
62216,contribute,0,0
62217,to,0,0
62218,bleeding,0,1
62219,initiation,0,0
62220,.,0,0
62221,Fifteen-year,0,0
62222,results,0,0
62223,of,0,0
62224,a,0,0
62225,randomized,0,0
62226,prospective,0,0
62227,trial,0,0
62228,of,0,0
62229,hyperfractionated,0,0
62230,chest,0,1
62231,wall,0,1
62232,irradiation,0,0
62233,versus,0,0
62234,once-daily,0,0
62235,chest,0,1
62236,wall,0,1
62237,irradiation,0,0
62238,after,0,0
62239,chemotherapy,0,0
62240,and,0,1
62241,mastectomy,0,0
62242,for,0,0
62243,patients,0,0
62244,with,0,0
62245,locally,0,0
62246,advanced,0,0
62247,noninflammatory,0,0
62248,breast,0,0
62249,cancer,0,0
62250,.,0,0
62251,PURPOSE,0,0
62252,To,0,0
62253,analyze,0,0
62254,the,0,0
62255,results,0,0
62256,of,0,0
62257,a,0,0
62258,Phase,0,1
62259,III,0,0
62260,clinical,0,1
62261,trial,0,0
62262,that,0,0
62263,investigated,0,0
62264,whether,0,0
62265,a,0,0
62266,hyperfractionated,0,0
62267,radiotherapy,0,0
62268,(,0,1
62269,RT,0,0
62270,),0,0
62271,schedule,0,0
62272,could,0,0
62273,reduce,0,0
62274,the,0,0
62275,risk,0,1
62276,of,0,0
62277,locoregional,0,0
62278,recurrence,0,1
62279,in,0,0
62280,patients,0,0
62281,with,0,0
62282,locally,0,0
62283,advanced,0,0
62284,breast,0,0
62285,cancer,0,0
62286,treated,0,0
62287,with,0,0
62288,chemotherapy,0,0
62289,and,0,1
62290,mastectomy,0,0
62291,.,0,1
62292,METHODS,0,0
62293,AND,0,0
62294,MATERIALS,0,0
62295,Between,0,0
62296,1985,0,0
62297,and,0,0
62298,1989,0,0
62299,",",0,0
62300,200,0,0
62301,patients,0,0
62302,with,0,0
62303,clinical,0,0
62304,Stage,0,1
62305,III,0,1
62306,noninflammatory,0,1
62307,breast,0,0
62308,cancer,0,0
62309,were,0,0
62310,enrolled,0,0
62311,in,0,0
62312,a,0,0
62313,prospective,0,0
62314,study,0,0
62315,investigating,0,0
62316,neoadjuvant,0,0
62317,and,0,1
62318,adjuvant,0,0
62319,chemotherapy,0,0
62320,.,0,0
62321,Of,0,0
62322,the,0,0
62323,179,0,0
62324,patients,0,0
62325,treated,0,0
62326,with,0,0
62327,mastectomy,0,0
62328,after,0,0
62329,neoadjuvant,0,0
62330,chemotherapy,0,0
62331,",",0,0
62332,108,0,0
62333,participated,0,0
62334,in,0,0
62335,a,0,0
62336,randomized,0,0
62337,component,0,0
62338,of,0,0
62339,the,0,0
62340,trial,0,0
62341,that,0,0
62342,compared,0,0
62343,a,0,0
62344,dose-escalated,0,0
62345,",",0,0
62346,hyperfractionated,0,0
62347,(,0,0
62348,twice-daily,0,0
62349,",",0,0
62350,b.i.d,0,0
62351,.,0,1
62352,),0,0
62353,chest,0,1
62354,wall,0,1
62355,RT,0,1
62356,schedule,0,0
62357,(,0,0
62358,72,0,0
62359,Gy,0,0
62360,in,0,0
62361,1.2-Gy,0,1
62362,b.i.d,0,0
62363,.,0,1
62364,fractions,0,1
62365,),0,0
62366,with,0,0
62367,a,0,0
62368,once-daily,0,0
62369,(,0,0
62370,q.d,0,0
62371,.,0,0
62372,),0,1
62373,schedule,0,0
62374,(,0,0
62375,60,0,0
62376,Gy,0,0
62377,in,0,0
62378,2-Gy,0,0
62379,q.d,0,0
62380,.,0,1
62381,fractions,0,1
62382,),0,0
62383,.,0,0
62384,In,0,0
62385,both,0,0
62386,arms,0,0
62387,of,0,0
62388,the,0,0
62389,study,0,0
62390,",",0,0
62391,the,0,0
62392,supraclavicular,0,1
62393,fossa,0,0
62394,and,0,1
62395,axillary,0,1
62396,apex,0,1
62397,were,0,0
62398,treated,0,0
62399,once,0,0
62400,daily,0,0
62401,to,0,0
62402,50,0,0
62403,Gy,0,0
62404,.,0,0
62405,The,0,0
62406,median,0,1
62407,follow-up,0,0
62408,period,0,0
62409,was,0,0
62410,15,0,0
62411,years,0,0
62412,.,0,0
62413,RESULTS,0,0
62414,The,0,0
62415,15-year,1,0
62416,actuarial,1,1
62417,locoregional,1,0
62418,recurrence,1,1
62419,rate,1,1
62420,was,0,0
62421,7,0,0
62422,%,0,0
62423,for,0,0
62424,the,0,0
62425,q.d,0,0
62426,.,0,1
62427,arm,0,0
62428,and,0,0
62429,12,0,0
62430,%,0,0
62431,for,0,0
62432,the,0,0
62433,b.i.d,0,0
62434,.,0,1
62435,arm,0,0
62436,(,0,1
62437,p=0.36,0,0
62438,),0,0
62439,.,0,0
62440,The,0,0
62441,rates,1,1
62442,of,1,0
62443,severe,1,1
62444,acute,1,0
62445,toxicity,1,1
62446,were,0,0
62447,similar,0,0
62448,(,0,0
62449,4,0,0
62450,%,0,0
62451,for,0,0
62452,q.d,0,0
62453,.,0,0
62454,vs.,0,0
62455,5,0,0
62456,%,0,0
62457,for,0,0
62458,b.i.d,0,0
62459,.,0,1
62460,),0,1
62461,",",0,0
62462,but,0,0
62463,moist,0,0
62464,desquamation,0,1
62465,developed,0,0
62466,in,0,0
62467,42,0,0
62468,%,0,0
62469,of,0,0
62470,patients,0,0
62471,in,0,0
62472,the,0,0
62473,b.i.d,0,0
62474,.,0,0
62475,arm,0,0
62476,compared,0,0
62477,with,0,0
62478,28,0,0
62479,%,0,0
62480,of,0,0
62481,the,0,0
62482,patients,0,0
62483,in,0,0
62484,the,0,0
62485,q.d,0,0
62486,.,0,1
62487,arm,0,0
62488,(,0,1
62489,p=0.16,0,0
62490,),0,0
62491,.,0,0
62492,The,0,0
62493,15-year,1,0
62494,actuarial,1,1
62495,rate,1,1
62496,of,1,1
62497,severe,1,1
62498,late,1,1
62499,RT,1,0
62500,complications,1,1
62501,did,0,0
62502,not,0,0
62503,differ,0,0
62504,between,0,0
62505,the,0,0
62506,two,0,0
62507,arms,0,0
62508,(,0,0
62509,6,0,0
62510,%,0,0
62511,for,0,0
62512,q.d,0,0
62513,.,0,0
62514,vs.,0,0
62515,11,0,0
62516,%,0,0
62517,for,0,0
62518,b.i.d.,0,0
62519,",",0,1
62520,p=0.54,0,0
62521,),0,1
62522,.,0,0
62523,CONCLUSION,0,0
62524,Although,0,0
62525,the,0,0
62526,sample,0,0
62527,size,0,1
62528,of,0,0
62529,this,0,0
62530,study,0,0
62531,was,0,0
62532,small,0,0
62533,",",0,0
62534,we,0,0
62535,found,0,0
62536,no,0,0
62537,evidence,0,0
62538,that,0,0
62539,this,0,0
62540,hyperfractionation,0,0
62541,schedule,0,0
62542,of,0,1
62543,postmastectomy,0,0
62544,RT,0,0
62545,offered,0,0
62546,a,0,0
62547,clinical,0,0
62548,advantage,0,0
62549,.,0,0
62550,Therefore,0,0
62551,",",0,0
62552,we,0,0
62553,have,0,0
62554,concluded,0,0
62555,that,0,0
62556,it,0,0
62557,should,0,0
62558,not,0,0
62559,be,0,0
62560,further,0,0
62561,studied,0,0
62562,in,0,0
62563,this,0,0
62564,cohort,0,0
62565,of,0,0
62566,patients,0,0
62567,.,0,0
62568,Dexamethasone,0,0
62569,effectively,0,0
62570,reduces,0,0
62571,postoperative,0,1
62572,nausea,0,1
62573,and,0,1
62574,vomiting,0,1
62575,in,0,0
62576,a,0,0
62577,general,0,0
62578,surgical,0,0
62579,adult,0,0
62580,patient,0,1
62581,population,0,0
62582,.,0,0
62583,BACKGROUND,0,0
62584,Postoperative,0,1
62585,nausea,0,1
62586,and,0,1
62587,vomiting,0,1
62588,(,0,1
62589,PONV,0,1
62590,),0,0
62591,is,0,0
62592,still,0,0
62593,a,0,0
62594,common,0,0
62595,and,0,1
62596,major,0,1
62597,complication,0,1
62598,for,0,0
62599,surgical,0,0
62600,patients,0,0
62601,",",0,0
62602,which,0,0
62603,may,0,0
62604,delay,0,1
62605,post-anesthetic,0,1
62606,care,0,0
62607,unit,0,1
62608,discharge,0,1
62609,",",0,1
62610,prolong,0,1
62611,hospital,0,1
62612,stay,0,1
62613,and,0,0
62614,thus,0,0
62615,increase,0,0
62616,the,0,0
62617,cost,0,1
62618,of,0,0
62619,hospitalization,0,1
62620,.,0,0
62621,It,0,0
62622,is,0,0
62623,understood,0,0
62624,that,0,0
62625,PONV,0,0
62626,is,0,0
62627,a,0,0
62628,multi-factorial,0,0
62629,outcome,0,1
62630,and,0,0
62631,occurs,0,0
62632,more,0,0
62633,often,0,0
62634,with,0,0
62635,general,0,0
62636,anesthesia,0,0
62637,than,0,0
62638,with,0,0
62639,other,0,0
62640,anesthetic,0,0
62641,methods,0,0
62642,.,0,0
62643,Prophylactic,0,0
62644,administration,0,0
62645,of,0,1
62646,antihistamines,0,0
62647,",",0,0
62648,antidopaminergics,0,1
62649,",",0,1
62650,anticholinergics,0,0
62651,",",0,1
62652,phenothiazines,0,1
62653,",",0,1
62654,serotonin,0,1
62655,antagonist,0,0
62656,",",0,1
62657,steroids,0,0
62658,and,0,1
62659,even,0,0
62660,acupuncture,0,0
62661,has,0,0
62662,been,0,0
62663,shown,0,0
62664,to,0,0
62665,be,0,0
62666,effective,0,1
62667,.,0,0
62668,However,0,0
62669,",",0,0
62670,expenses,0,1
62671,and,0,1
62672,side,0,1
62673,effects,0,1
62674,of,0,0
62675,these,0,0
62676,agents,0,0
62677,have,0,0
62678,also,0,0
62679,been,0,0
62680,a,0,0
62681,concern,0,0
62682,for,0,0
62683,clinical,0,0
62684,doctors,0,0
62685,.,0,0
62686,The,0,0
62687,aim,0,0
62688,for,0,0
62689,this,0,0
62690,prospective,0,0
62691,study,0,0
62692,was,0,0
62693,to,0,0
62694,find,0,0
62695,an,0,0
62696,agent,0,0
62697,that,0,0
62698,is,0,0
62699,cost,0,1
62700,effective,0,1
62701,and,0,1
62702,side,0,1
62703,effect,0,1
62704,free,0,1
62705,(,0,0
62706,or,0,0
62707,at,0,0
62708,least,0,0
62709,with,0,0
62710,a,0,0
62711,low,0,0
62712,incidence,0,1
62713,of,0,1
62714,side,0,1
62715,effects,0,1
62716,),0,0
62717,for,0,0
62718,the,0,0
62719,prevention,0,0
62720,of,0,0
62721,PONV,0,1
62722,.,0,0
62723,METHODS,0,0
62724,A,0,0
62725,total,0,1
62726,of,0,0
62727,700,0,0
62728,adult,0,0
62729,surgical,0,0
62730,patients,0,0
62731,who,0,0
62732,planned,0,0
62733,to,0,0
62734,have,0,0
62735,surgery,0,0
62736,under,0,0
62737,general,0,0
62738,anesthesia,0,0
62739,were,0,0
62740,enrolled,0,0
62741,in,0,0
62742,this,0,0
62743,double-blinded,0,0
62744,",",0,0
62745,randomized,0,0
62746,and,0,1
62747,placebo-controlled,0,0
62748,study,0,0
62749,.,0,0
62750,Group,0,0
62751,P,0,0
62752,received,0,0
62753,the,0,0
62754,placebo,0,0
62755,(,0,0
62756,0.9,0,0
62757,%,0,0
62758,normal,0,0
62759,saline,0,0
62760,2,0,0
62761,ml,0,0
62762,),0,0
62763,and,0,1
62764,Group,0,0
62765,D,0,1
62766,received,0,0
62767,10,0,0
62768,mg,0,0
62769,dexamethasone,0,0
62770,intravenously,0,0
62771,right,0,0
62772,before,0,0
62773,the,0,0
62774,induction,0,0
62775,of,0,0
62776,anesthesia,0,0
62777,.,0,0
62778,RESULTS,0,0
62779,We,0,0
62780,found,0,0
62781,that,0,0
62782,during,0,0
62783,the,0,0
62784,postoperative,0,1
62785,period,0,0
62786,of,0,1
62787,1-8,0,1
62788,h,0,0
62789,",",0,0
62790,patients,0,0
62791,in,0,0
62792,Group,0,0
62793,D,0,1
62794,reported,0,0
62795,a,0,0
62796,lower,0,0
62797,incidence,0,1
62798,of,0,1
62799,PONV,1,1
62800,(,0,0
62801,24,0,0
62802,%,0,0
62803,),0,0
62804,than,0,0
62805,those,0,0
62806,in,0,0
62807,Group,0,0
62808,P,0,0
62809,(,0,0
62810,39,0,0
62811,%,0,0
62812,",",0,0
62813,p,0,0
62814,<,0,0
62815,0.001,0,0
62816,),0,0
62817,.,0,0
62818,Patients,0,0
62819,in,0,0
62820,Group,0,0
62821,D,0,1
62822,also,0,0
62823,requested,0,0
62824,less,0,0
62825,rescue,0,1
62826,anti-emetic,0,1
62827,(,0,0
62828,17,0,0
62829,%,0,0
62830,),0,0
62831,than,0,0
62832,those,0,0
62833,in,0,0
62834,Group,0,0
62835,P,0,0
62836,(,0,0
62837,30,0,0
62838,%,0,0
62839,",",0,0
62840,p,0,0
62841,<,0,0
62842,0.05,0,0
62843,),0,0
62844,.,0,0
62845,The,0,0
62846,same,0,0
62847,phenomenon,0,0
62848,was,0,0
62849,also,0,0
62850,noted,0,0
62851,in,0,0
62852,the,0,0
62853,8-to-24-hour,0,1
62854,interval,0,0
62855,(,0,0
62856,PONV,0,1
62857,4,0,0
62858,%,0,0
62859,vs.,0,0
62860,12,0,0
62861,%,0,0
62862,",",0,0
62863,p,0,0
62864,<,0,0
62865,0.05,0,0
62866,and,0,0
62867,rescue,0,0
62868,anti-emetic,0,1
62869,3,0,0
62870,%,0,0
62871,vs.,0,0
62872,9,0,0
62873,%,0,0
62874,",",0,0
62875,p,0,0
62876,<,0,0
62877,0.05,0,0
62878,in,0,0
62879,Group,0,0
62880,D,0,1
62881,vs.,0,0
62882,Group,0,0
62883,P,0,0
62884,",",0,0
62885,respectively,0,0
62886,.,0,0
62887,),0,0
62888,CONCLUSIONS,0,0
62889,We,0,0
62890,conclude,0,0
62891,that,0,0
62892,the,0,0
62893,prophylactic,0,0
62894,intravenous,0,0
62895,administration,0,0
62896,of,0,0
62897,10,0,0
62898,mg,0,0
62899,dexamethasone,0,0
62900,immediately,0,0
62901,before,0,0
62902,the,0,0
62903,induction,0,0
62904,of,0,0
62905,anesthesia,0,0
62906,is,0,0
62907,effective,0,1
62908,in,0,0
62909,preventing,0,0
62910,PONV,0,1
62911,in,0,0
62912,the,0,0
62913,general,0,0
62914,surgical,0,0
62915,adult,0,0
62916,patient,0,1
62917,population,0,0
62918,.,0,0
62919,Effects,0,0
62920,of,0,0
62921,levosimendan,0,0
62922,versus,0,0
62923,dobutamine,0,0
62924,on,0,0
62925,inflammatory,0,1
62926,and,0,1
62927,apoptotic,0,1
62928,pathways,0,0
62929,in,0,0
62930,acutely,0,0
62931,decompensated,0,0
62932,chronic,0,0
62933,heart,0,1
62934,failure,0,0
62935,.,0,0
62936,A,0,0
62937,single,0,0
62938,levosimendan,0,0
62939,administration,0,0
62940,has,0,0
62941,recently,0,0
62942,been,0,0
62943,shown,0,0
62944,to,0,0
62945,result,0,0
62946,in,0,0
62947,clinical,0,0
62948,and,0,1
62949,hemodynamic,0,1
62950,improvement,0,1
62951,in,0,0
62952,patients,0,0
62953,with,0,0
62954,decompensated,0,1
62955,heart,0,1
62956,failure,0,1
62957,(,0,1
62958,HF,0,1
62959,),0,1
62960,",",0,0
62961,but,0,0
62962,without,0,0
62963,survival,0,1
62964,benefits,0,0
62965,.,0,0
62966,In,0,0
62967,this,0,0
62968,study,0,0
62969,",",0,0
62970,the,0,0
62971,effects,0,1
62972,of,0,1
62973,levosimendan,0,0
62974,and,0,1
62975,dobutamine,0,0
62976,on,0,0
62977,plasma,0,1
62978,levels,0,1
62979,of,0,1
62980,proinflammatory,0,1
62981,and,0,1
62982,proapoptotic,0,1
62983,mediators,0,1
62984,in,0,0
62985,decompensated,0,1
62986,HF,0,0
62987,were,0,0
62988,compared,0,0
62989,and,0,0
62990,correlated,0,0
62991,with,0,0
62992,the,0,0
62993,concomitant,0,0
62994,effects,0,1
62995,on,0,0
62996,cardiac,0,1
62997,function,0,1
62998,and,0,1
62999,prognosis,0,1
63000,.,0,1
63001,Sixty-nine,0,0
63002,patients,0,0
63003,were,0,0
63004,randomized,0,0
63005,to,0,0
63006,received,0,0
63007,24-hour,0,1
63008,intravenous,0,0
63009,infusions,0,0
63010,of,0,1
63011,levosimendan,0,0
63012,(,0,0
63013,n,0,0
63014,=,0,0
63015,23,0,0
63016,),0,0
63017,",",0,0
63018,dobutamine,0,1
63019,(,0,1
63020,n,0,0
63021,=,0,0
63022,23,0,0
63023,),0,0
63024,",",0,0
63025,or,0,1
63026,placebo,0,0
63027,(,0,1
63028,n,0,0
63029,=,0,0
63030,23,0,0
63031,),0,0
63032,.,0,0
63033,Echocardiographic,1,1
63034,",",1,1
63035,hemodynamic,1,1
63036,",",1,1
63037,and,1,1
63038,biochemical,1,1
63039,assessments,1,0
63040,were,0,0
63041,performed,0,0
63042,at,0,0
63043,baseline,0,0
63044,",",0,0
63045,immediately,0,0
63046,after,0,0
63047,treatment,0,0
63048,",",0,0
63049,and,0,0
63050,48,0,0
63051,hours,0,0
63052,later,0,0
63053,.,0,0
63054,Patients,0,0
63055,were,0,0
63056,subsequently,0,0
63057,followed,0,0
63058,for,0,0
63059,4,0,0
63060,months,0,0
63061,for,0,0
63062,disease,0,0
63063,progression,0,1
63064,.,0,1
63065,End-systolic,1,1
63066,wall,1,1
63067,stress,1,1
63068,",",1,0
63069,the,1,0
63070,left,1,1
63071,ventricular,1,1
63072,ejection,1,1
63073,fraction,1,1
63074,",",1,1
63075,pulmonary,1,1
63076,capillary,1,1
63077,wedge,1,1
63078,pressure,1,1
63079,",",1,1
63080,and,1,1
63081,cardiac,1,1
63082,index,1,1
63083,were,0,0
63084,significantly,0,0
63085,improved,0,0
63086,in,0,0
63087,the,0,0
63088,levosimendan,0,0
63089,group,0,0
63090,but,0,0
63091,remained,0,0
63092,practically,0,0
63093,unaffected,0,0
63094,in,0,0
63095,the,0,0
63096,other,0,0
63097,groups,0,0
63098,.,0,0
63099,Plasma,1,1
63100,N-terminal-pro-B-type,1,1
63101,natriuretic,1,1
63102,peptide,1,1
63103,",",1,1
63104,tumor,1,1
63105,necrosis,1,1
63106,factor-alpha,1,1
63107,",",1,1
63108,and,1,1
63109,soluble,1,1
63110,Fas,1,1
63111,ligand,1,0
63112,levels,1,1
63113,were,0,0
63114,significantly,0,0
63115,decreased,0,0
63116,only,0,0
63117,in,0,0
63118,the,0,0
63119,levosimendan,0,0
63120,group,0,0
63121,(,0,0
63122,from,0,0
63123,"1,900",0,0
63124,+/-,0,0
63125,223,0,0
63126,to,0,0
63127,"1,378",0,0
63128,+/-,0,0
63129,170,0,0
63130,pg/ml,0,0
63131,",",0,0
63132,13.4,0,0
63133,+/-,0,0
63134,1.0,0,0
63135,to,0,0
63136,12.3,0,0
63137,+/-,0,0
63138,1.2,0,0
63139,pg/ml,0,0
63140,",",0,0
63141,and,0,0
63142,68.2,0,0
63143,+/-,0,0
63144,3.7,0,0
63145,to,0,0
63146,59.8,0,0
63147,+/-,0,0
63148,3.6,0,0
63149,pg/ml,0,0
63150,",",0,0
63151,respectively,0,0
63152,;,0,0
63153,p,0,0
63154,<,0,0
63155,0.05,0,0
63156,for,0,0
63157,all,0,0
63158,),0,0
63159,;,0,0
63160,interleukin-6,1,1
63161,was,0,0
63162,also,0,0
63163,borderline,0,1
63164,reduced,0,1
63165,(,0,0
63166,p,0,0
63167,=,0,0
63168,0.051,0,0
63169,),0,0
63170,.,0,0
63171,Levosimendan-induced,1,0
63172,reduction,1,1
63173,in,1,0
63174,end-systolic,1,1
63175,wall,1,1
63176,stress,1,1
63177,was,0,0
63178,significantly,0,0
63179,correlated,0,0
63180,with,0,0
63181,respective,0,0
63182,decreases,0,0
63183,in,0,0
63184,N-terminal-pro-B-type,1,1
63185,natriuretic,1,1
63186,peptide,1,1
63187,(,0,0
63188,r,0,1
63189,=,0,0
63190,0.671,0,0
63191,",",0,0
63192,p,0,0
63193,<,0,0
63194,0.01,0,0
63195,),0,0
63196,",",0,0
63197,tumor,1,1
63198,necrosis,1,1
63199,factor-alpha,1,1
63200,(,0,1
63201,r,0,1
63202,=,0,0
63203,0.586,0,0
63204,",",0,0
63205,p,0,0
63206,<,0,0
63207,0.01,0,0
63208,),0,0
63209,",",0,0
63210,soluble,1,1
63211,Fas,1,1
63212,(,0,0
63213,r,0,0
63214,=,0,0
63215,0.441,0,0
63216,",",0,0
63217,p,0,0
63218,<,0,0
63219,0.05,0,0
63220,),0,0
63221,",",0,0
63222,and,0,1
63223,soluble,1,1
63224,Fas,1,1
63225,ligand,1,0
63226,(,0,1
63227,r,0,1
63228,=,0,0
63229,0.614,0,0
63230,",",0,0
63231,p,0,0
63232,<,0,0
63233,0.01,0,0
63234,),0,0
63235,.,0,0
63236,Event-free,1,1
63237,survival,1,1
63238,was,0,0
63239,significantly,0,0
63240,longer,0,0
63241,in,0,0
63242,the,0,0
63243,levosimendan,0,0
63244,group,0,0
63245,(,0,0
63246,p,0,0
63247,<,0,0
63248,0.05,0,0
63249,),0,0
63250,.,0,0
63251,In,0,0
63252,conclusion,0,0
63253,",",0,0
63254,the,0,0
63255,superiority,0,0
63256,of,0,0
63257,levosimendan,0,0
63258,over,0,0
63259,dobutamine,0,0
63260,in,0,0
63261,improving,0,1
63262,central,1,1
63263,hemodynamics,1,1
63264,and,0,1
63265,left,1,1
63266,ventricular,1,1
63267,performance,1,1
63268,in,0,0
63269,decompensated,0,0
63270,HF,0,0
63271,seems,0,0
63272,to,0,0
63273,be,0,0
63274,related,0,0
63275,to,0,0
63276,its,0,0
63277,anti-inflammatory,0,0
63278,and,0,1
63279,antiapoptotic,0,1
63280,effects,0,1
63281,.,0,0
63282,Specific,0,0
63283,immunoglobulin,0,1
63284,for,0,0
63285,treatment,0,0
63286,of,0,1
63287,whooping,0,1
63288,cough,0,1
63289,.,0,1
63290,Immunoglobulin,0,1
63291,treatment,0,0
63292,for,0,0
63293,whooping,0,1
63294,cough,0,1
63295,(,0,1
63296,pertussis,0,0
63297,),0,0
63298,is,0,0
63299,widely,0,0
63300,believed,0,0
63301,to,0,0
63302,be,0,0
63303,ineffective,1,1
63304,although,0,0
63305,there,0,0
63306,are,0,0
63307,sound,0,0
63308,reasons,0,0
63309,for,0,0
63310,regarding,0,0
63311,the,0,0
63312,condition,0,0
63313,as,0,0
63314,a,0,0
63315,toxin-induced,0,1
63316,disease,0,0
63317,.,0,0
63318,We,0,0
63319,wondered,0,0
63320,whether,0,0
63321,the,0,0
63322,lack,1,0
63323,of,1,0
63324,success,1,1
63325,with,0,0
63326,pertussis,0,0
63327,immunoglobulins,0,0
63328,might,0,0
63329,be,0,0
63330,attributable,0,0
63331,to,0,0
63332,inadequate,0,0
63333,dose,0,0
63334,",",0,0
63335,so,0,0
63336,we,0,0
63337,designed,0,0
63338,a,0,0
63339,randomised,0,0
63340,",",0,0
63341,double-blind,0,0
63342,",",0,1
63343,placebo-controlled,0,0
63344,trial,0,0
63345,of,0,0
63346,two,0,0
63347,immunoglobulin,0,0
63348,preparations,0,0
63349,.,0,0
63350,The,0,0
63351,study,0,0
63352,was,0,0
63353,conducted,0,0
63354,at,0,0
63355,three,0,0
63356,Swedish,0,0
63357,hospitals,0,0
63358,.,0,0
63359,We,0,0
63360,enrolled,0,0
63361,73,0,0
63362,children,0,0
63363,aged,0,0
63364,less,0,0
63365,than,0,0
63366,36,0,0
63367,months,0,0
63368,who,0,0
63369,were,0,0
63370,admitted,0,0
63371,with,0,0
63372,a,0,0
63373,clinical,0,0
63374,diagnosis,0,0
63375,of,0,1
63376,whooping,0,1
63377,cough,0,1
63378,.,0,0
63379,On,0,0
63380,admission,0,0
63381,they,0,0
63382,were,0,0
63383,assigned,0,0
63384,to,0,0
63385,one,0,0
63386,of,0,0
63387,three,0,0
63388,groups,0,0
63389,:,0,0
63390,(,0,0
63391,a,0,0
63392,),0,0
63393,monocomponent,0,0
63394,pertussis,0,0
63395,toxoid,0,1
63396,vaccine,0,0
63397,;,0,1
63398,(,0,0
63399,b,0,1
63400,),0,1
63401,two-component,0,0
63402,acellular,0,1
63403,vaccine,0,0
63404,also,0,0
63405,containing,0,0
63406,filamentous,0,0
63407,haemagglutinin,0,1
63408,;,0,1
63409,or,0,1
63410,(,0,1
63411,c,0,1
63412,),0,0
63413,20,0,0
63414,%,0,0
63415,albumin,0,1
63416,solution,0,1
63417,(,0,1
63418,placebo,0,0
63419,),0,0
63420,.,0,0
63421,The,0,0
63422,immunoglobulins,0,1
63423,had,0,0
63424,a,0,0
63425,high,0,0
63426,antitoxin,0,1
63427,content,0,1
63428,and,0,1
63429,had,0,0
63430,been,0,0
63431,raised,0,0
63432,with,0,0
63433,acellular,0,0
63434,pertussis,0,0
63435,vaccines,0,0
63436,.,0,1
63437,Diagnosis,0,0
63438,of,0,1
63439,pertussis,0,0
63440,was,0,0
63441,confirmed,0,0
63442,by,0,0
63443,laboratory,0,0
63444,tests,0,1
63445,and,0,0
63446,the,0,0
63447,follow-up,0,0
63448,was,0,0
63449,completed,0,0
63450,in,0,0
63451,67,0,0
63452,children,0,0
63453,.,0,0
63454,The,0,0
63455,main,0,0
63456,study,0,0
63457,group,0,0
63458,consisted,0,0
63459,of,0,0
63460,47,0,0
63461,children,0,0
63462,with,0,0
63463,less,0,0
63464,than,0,0
63465,or,0,0
63466,equal,0,0
63467,to,0,0
63468,14,0,0
63469,days,0,0
63470,of,0,0
63471,disease,0,1
63472,before,0,0
63473,therapy,0,0
63474,.,0,0
63475,Duration,1,1
63476,of,1,1
63477,whoops,1,1
63478,post-treatment,1,1
63479,was,0,0
63480,8.7,0,0
63481,days,0,0
63482,(,0,0
63483,95,0,0
63484,%,0,0
63485,Cl,0,0
63486,4.8,0,0
63487,",",0,0
63488,12.6,0,0
63489,),0,0
63490,in,0,0
63491,the,0,0
63492,33,0,0
63493,children,0,0
63494,receiving,0,0
63495,immunoglobulin,0,1
63496,vs,0,0
63497,20.6,0,0
63498,(,0,0
63499,95,0,0
63500,%,0,0
63501,Cl,0,0
63502,11.9,0,0
63503,",",0,0
63504,29.3,0,0
63505,),0,0
63506,in,0,0
63507,the,0,0
63508,14,0,0
63509,receiving,0,0
63510,placebo,0,0
63511,(,0,0
63512,p,0,0
63513,=,0,0
63514,0.0041,0,0
63515,),0,0
63516,.,0,0
63517,Mean,1,1
63518,number,1,1
63519,of,1,0
63520,whoops,1,0
63521,during,0,0
63522,the,0,0
63523,first,0,0
63524,week,0,0
63525,of,0,1
63526,follow-up,0,0
63527,was,0,0
63528,also,0,0
63529,significantly,0,0
63530,reduced,0,0
63531,(,0,0
63532,p,0,0
63533,=,0,0
63534,0.0196,0,0
63535,),0,0
63536,.,0,0
63537,We,0,0
63538,found,0,0
63539,that,0,0
63540,early,0,0
63541,treatment,0,0
63542,was,0,0
63543,important,0,1
63544,",",0,0
63545,since,0,0
63546,the,0,0
63547,effect,0,0
63548,on,0,0
63549,duration,1,1
63550,of,1,1
63551,whoops,1,0
63552,was,0,0
63553,most,0,0
63554,pronounced,0,0
63555,when,0,0
63556,disease,0,1
63557,duration,0,1
63558,before,0,0
63559,treatment,0,0
63560,was,0,0
63561,less,0,0
63562,than,0,0
63563,or,0,0
63564,equal,0,0
63565,to,0,0
63566,7,0,0
63567,days,0,0
63568,.,0,0
63569,There,0,0
63570,were,0,0
63571,no,0,0
63572,significant,0,0
63573,differences,1,0
63574,between,0,0
63575,the,0,0
63576,two,0,0
63577,immunoglobulin,0,0
63578,preparations,0,0
63579,.,0,0
63580,High-dose,0,0
63581,specific,0,0
63582,pertussis,0,0
63583,immunoglobulin,0,1
63584,with,0,0
63585,a,0,0
63586,high,0,0
63587,antitoxin,0,0
63588,concentration,0,1
63589,has,0,0
63590,a,0,0
63591,beneficial,1,0
63592,effect,1,0
63593,in,0,0
63594,the,0,0
63595,treatment,0,0
63596,of,0,0
63597,whooping,0,1
63598,cough,0,1
63599,.,0,0
63600,Resistance,0,1
63601,training,0,0
63602,increases,0,0
63603,basal,0,1
63604,limb,0,1
63605,blood,0,1
63606,flow,0,1
63607,and,0,1
63608,vascular,0,1
63609,conductance,0,1
63610,in,0,0
63611,aging,0,0
63612,humans,0,0
63613,.,0,0
63614,Age-related,0,1
63615,reductions,0,1
63616,in,0,0
63617,basal,0,1
63618,limb,0,1
63619,blood,0,1
63620,flow,0,1
63621,and,0,1
63622,vascular,0,1
63623,conductance,0,1
63624,are,0,0
63625,associated,0,0
63626,with,0,0
63627,the,0,0
63628,metabolic,0,1
63629,syndrome,0,0
63630,",",0,1
63631,functional,0,1
63632,impairments,0,1
63633,",",0,1
63634,and,0,1
63635,osteoporosis,0,1
63636,.,0,0
63637,We,0,0
63638,tested,0,0
63639,the,0,0
63640,hypothesis,0,0
63641,that,0,0
63642,a,0,0
63643,strength,0,1
63644,training,0,0
63645,program,0,0
63646,would,0,0
63647,increase,0,1
63648,basal,1,1
63649,femoral,1,1
63650,blood,1,1
63651,flow,1,1
63652,in,0,0
63653,aging,0,0
63654,adults,0,0
63655,.,0,0
63656,Twenty-six,0,0
63657,sedentary,0,0
63658,but,0,0
63659,healthy,0,0
63660,middle-aged,0,0
63661,and,0,1
63662,older,0,0
63663,subjects,0,0
63664,were,0,0
63665,randomly,0,0
63666,assigned,0,0
63667,to,0,0
63668,either,0,0
63669,a,0,0
63670,whole,0,1
63671,body,0,1
63672,strength,0,1
63673,training,0,0
63674,intervention,0,0
63675,group,0,0
63676,(,0,0
63677,52,0,0
63678,+/-,0,0
63679,2,0,0
63680,yr,0,0
63681,",",0,0
63682,3,0,0
63683,men,0,0
63684,",",0,0
63685,10,0,0
63686,women,0,0
63687,),0,0
63688,who,0,0
63689,underwent,0,0
63690,three,0,0
63691,supervised,0,0
63692,resistance,0,1
63693,training,0,0
63694,sessions,0,0
63695,per,0,0
63696,week,0,0
63697,for,0,0
63698,13,0,0
63699,wk,0,0
63700,or,0,0
63701,a,0,0
63702,control,0,0
63703,group,0,0
63704,(,0,0
63705,53,0,0
63706,+/-,0,0
63707,2,0,0
63708,yr,0,0
63709,",",0,0
63710,4,0,0
63711,men,0,0
63712,",",0,0
63713,9,0,0
63714,women,0,0
63715,),0,0
63716,who,0,0
63717,participated,0,0
63718,in,0,0
63719,a,0,0
63720,supervised,0,0
63721,stretching,0,0
63722,program,0,0
63723,.,0,0
63724,At,0,0
63725,baseline,0,0
63726,",",0,0
63727,there,0,0
63728,were,0,0
63729,no,0,0
63730,significant,0,0
63731,differences,0,0
63732,in,0,0
63733,blood,1,1
63734,pressure,1,1
63735,",",1,1
63736,cardiac,1,1
63737,output,1,1
63738,",",1,1
63739,basal,1,1
63740,femoral,1,1
63741,blood,1,1
63742,flow,1,1
63743,(,1,0
63744,via,1,0
63745,Doppler,1,1
63746,ultrasound,1,1
63747,),1,1
63748,",",1,0
63749,vascular,1,1
63750,conductance,1,1
63751,",",1,1
63752,and,1,1
63753,vascular,1,1
63754,resistance,1,1
63755,between,0,0
63756,the,0,0
63757,two,0,0
63758,groups,0,0
63759,.,0,0
63760,The,0,0
63761,strength,0,1
63762,training,0,0
63763,group,0,0
63764,increased,0,1
63765,maximal,1,1
63766,strength,1,1
63767,in,0,0
63768,all,0,0
63769,the,0,0
63770,major,0,1
63771,muscle,0,1
63772,groups,0,0
63773,tested,0,0
63774,(,0,0
63775,P,0,0
63776,<,0,0
63777,0.05,0,0
63778,),0,0
63779,.,0,0
63780,Whole,1,1
63781,body,1,1
63782,lean,1,1
63783,body,1,1
63784,mass,1,1
63785,increased,0,1
63786,(,0,0
63787,P,0,0
63788,<,0,0
63789,0.05,0,0
63790,),0,0
63791,with,0,0
63792,strength,0,1
63793,training,0,0
63794,",",0,0
63795,but,0,0
63796,leg,1,1
63797,fat-free,1,1
63798,mass,1,1
63799,did,0,0
63800,not,0,0
63801,.,0,0
63802,Basal,1,1
63803,femoral,1,1
63804,blood,1,1
63805,flow,1,1
63806,and,1,1
63807,vascular,1,1
63808,conductance,1,1
63809,increased,0,0
63810,by,0,0
63811,55-60,0,0
63812,%,0,0
63813,after,0,0
63814,strength,0,1
63815,training,0,0
63816,(,0,0
63817,both,0,0
63818,P,0,0
63819,<,0,0
63820,0.05,0,0
63821,),0,0
63822,.,0,0
63823,No,0,0
63824,such,0,0
63825,changes,0,1
63826,were,0,0
63827,observed,0,0
63828,in,0,0
63829,the,0,0
63830,control,0,0
63831,group,0,0
63832,.,0,0
63833,In,0,0
63834,both,0,0
63835,groups,0,0
63836,",",0,0
63837,there,0,0
63838,were,0,0
63839,no,0,0
63840,significant,0,0
63841,changes,0,1
63842,in,0,0
63843,brachial,1,1
63844,blood,1,1
63845,pressure,1,1
63846,",",1,1
63847,plasma,1,1
63848,endothelin-1,1,1
63849,and,1,1
63850,angiotensin,1,1
63851,II,1,0
63852,concentrations,1,1
63853,",",1,1
63854,femoral,1,1
63855,artery,1,1
63856,wall,1,1
63857,thickness,1,1
63858,",",1,1
63859,cardiac,1,1
63860,output,1,1
63861,",",1,1
63862,and,1,1
63863,systemic,1,1
63864,vascular,1,1
63865,resistance,1,1
63866,.,1,0
63867,Our,0,0
63868,results,0,0
63869,indicate,0,0
63870,that,0,0
63871,short-term,0,1
63872,strength,0,1
63873,training,0,0
63874,increases,0,0
63875,basal,0,1
63876,femoral,0,1
63877,blood,0,1
63878,flow,0,1
63879,and,0,1
63880,vascular,0,1
63881,conductance,0,1
63882,in,0,0
63883,healthy,0,0
63884,middle-aged,0,0
63885,and,0,1
63886,older,0,0
63887,adults,0,0
63888,.,0,0
63889,Divalproex,0,0
63890,versus,0,0
63891,placebo,0,0
63892,for,0,0
63893,the,0,0
63894,prevention,0,0
63895,of,0,0
63896,irritability,1,1
63897,associated,0,0
63898,with,0,0
63899,fluoxetine,0,0
63900,treatment,0,0
63901,in,0,0
63902,autism,0,0
63903,spectrum,0,0
63904,disorder,0,0
63905,.,0,0
63906,Effect,0,1
63907,of,0,1
63908,enamel,0,0
63909,preparation,0,0
63910,method,0,0
63911,on,0,0
63912,in,0,0
63913,vitro,0,1
63914,marginal,1,1
63915,microleakage,1,1
63916,of,0,0
63917,a,0,0
63918,flowable,0,0
63919,composite,0,1
63920,used,0,0
63921,as,0,0
63922,pit,0,0
63923,and,0,1
63924,fissure,0,1
63925,sealant,0,1
63926,.,0,0
63927,OBJECTIVES,0,0
63928,The,0,0
63929,aim,0,0
63930,of,0,0
63931,this,0,0
63932,in,0,0
63933,vitro,0,1
63934,study,0,0
63935,was,0,0
63936,to,0,0
63937,evaluate,0,0
63938,the,0,0
63939,microleakage,1,1
63940,in,1,0
63941,occlusal,1,1
63942,surfaces,1,0
63943,",",0,0
63944,after,0,0
63945,preparation,0,0
63946,with,0,0
63947,Er,0,0
63948,:,0,0
63949,YAG,0,1
63950,laser,0,0
63951,and,0,1
63952,compared,0,0
63953,to,0,0
63954,the,0,0
63955,diamond-bur,0,0
63956,conventional,0,0
63957,technique,0,0
63958,.,0,0
63959,METHODS,0,0
63960,Thirty,0,0
63961,premolars,0,0
63962,were,0,0
63963,divided,0,0
63964,into,0,0
63965,three,0,0
63966,groups,0,0
63967,:,0,0
63968,I,0,0
63969,-,0,0
63970,high-speed,0,0
63971,handpiece,0,0
63972,+,0,0
63973,37,0,0
63974,%,0,0
63975,phosphoric,0,0
63976,acid,0,0
63977,;,0,0
63978,II,0,0
63979,-,0,0
63980,Er,0,0
63981,:,0,0
63982,YAG,0,1
63983,laser,0,0
63984,(,0,0
63985,350,0,0
63986,mJ,0,0
63987,",",0,0
63988,4,0,0
63989,Hz,0,0
63990,and,0,0
63991,112,0,0
63992,J/cm,0,0
63993,(,0,0
63994,2,0,0
63995,),0,0
63996,),0,0
63997,+,0,0
63998,37,0,0
63999,%,0,0
64000,phosphoric,0,0
64001,acid,0,0
64002,;,0,0
64003,and,0,0
64004,III,0,0
64005,-,0,0
64006,Er,0,0
64007,:,0,0
64008,YAG,0,1
64009,laser,0,0
64010,(,0,0
64011,350,0,0
64012,mJ,0,0
64013,",",0,0
64014,4,0,0
64015,Hz,0,0
64016,and,0,0
64017,112,0,0
64018,J/cm,0,0
64019,(,0,0
64020,2,0,0
64021,),0,0
64022,),0,0
64023,+,0,0
64024,Er,0,0
64025,:,0,0
64026,YAG,0,1
64027,laser,0,0
64028,(,0,0
64029,80,0,0
64030,mJ,0,0
64031,",",0,0
64032,4,0,0
64033,Hz,0,0
64034,",",0,0
64035,and,0,0
64036,25,0,0
64037,mJ/cm,0,0
64038,(,0,0
64039,2,0,0
64040,),0,0
64041,),0,0
64042,.,0,0
64043,All,0,0
64044,cavities,0,0
64045,received,0,0
64046,the,0,0
64047,same,0,0
64048,adhesive,0,1
64049,system,0,0
64050,and,0,1
64051,were,0,0
64052,restored,0,0
64053,with,0,0
64054,flowable,0,0
64055,composite,0,1
64056,according,0,0
64057,to,0,0
64058,manufacturer,0,1
64059,'s,0,0
64060,instructions,0,1
64061,.,0,1
64062,Teeth,0,1
64063,were,0,0
64064,submitted,0,0
64065,to,0,0
64066,thermal,0,0
64067,cycling,0,1
64068,and,0,1
64069,immersed,0,0
64070,in,0,0
64071,50,0,0
64072,%,0,0
64073,silver,0,0
64074,nitrate,0,0
64075,solutions,0,0
64076,for,0,0
64077,8,0,0
64078,h,0,0
64079,in,0,0
64080,total,0,1
64081,darkness,0,1
64082,.,0,1
64083,Specimens,0,0
64084,were,0,0
64085,sectioned,0,0
64086,longitudinally,0,0
64087,in,0,0
64088,the,0,0
64089,bucco-lingual,0,0
64090,direction,0,1
64091,",",0,0
64092,in,0,0
64093,slices,0,0
64094,of,0,0
64095,1,0,0
64096,mm,0,0
64097,thick,0,0
64098,.,0,0
64099,Each,0,0
64100,slice,0,1
64101,was,0,0
64102,immersed,0,0
64103,into,0,0
64104,photo,0,1
64105,developing,0,1
64106,solution,0,1
64107,and,0,1
64108,was,0,0
64109,photographed,0,0
64110,",",0,0
64111,and,0,1
64112,microleakage,1,1
64113,was,1,0
64114,scored,1,0
64115,from,1,0
64116,0,1,0
64117,to,1,0
64118,7,1,0
64119,",",0,0
64120,by,0,0
64121,three,0,0
64122,calibrated,0,0
64123,examiners,0,0
64124,.,0,0
64125,RESULTS,0,0
64126,A,0,0
64127,statistically,0,0
64128,significant,0,0
64129,difference,0,0
64130,(,0,0
64131,P,0,0
64132,<,0,0
64133,0.0001,0,0
64134,),0,0
64135,was,0,0
64136,observed,0,0
64137,between,0,0
64138,Er,0,0
64139,:,0,0
64140,YAG,0,1
64141,laser,0,0
64142,prepared,0,0
64143,and,0,1
64144,etched,0,0
64145,specimens,0,0
64146,and,0,0
64147,those,0,0
64148,in,0,0
64149,the,0,0
64150,other,0,0
64151,groups,0,0
64152,.,0,0
64153,CONCLUSIONS,0,0
64154,It,0,0
64155,can,0,0
64156,be,0,0
64157,concluded,0,0
64158,that,0,0
64159,no,0,0
64160,significant,0,0
64161,difference,0,0
64162,was,0,0
64163,noted,0,0
64164,between,0,0
64165,the,0,0
64166,two,0,0
64167,types,0,0
64168,of,0,0
64169,enamel,0,0
64170,preparation,0,0
64171,when,0,0
64172,etching,0,0
64173,was,0,0
64174,performed,0,0
64175,.,0,0
64176,Preparing,0,0
64177,and,0,0
64178,treating,0,0
64179,the,0,0
64180,enamel,0,0
64181,surface,0,0
64182,exclusively,0,0
64183,by,0,0
64184,Er,0,0
64185,:,0,0
64186,YAG,0,1
64187,laser,0,0
64188,resulted,0,0
64189,in,0,0
64190,the,0,0
64191,highest,0,1
64192,degree,1,1
64193,of,1,0
64194,leakage,1,1
64195,.,1,0
64196,A,0,0
64197,randomized,0,0
64198,comparison,0,0
64199,of,0,0
64200,the,0,0
64201,effect,0,0
64202,of,0,0
64203,two,0,0
64204,prelinguistic,0,0
64205,communication,0,0
64206,interventions,0,0
64207,on,0,0
64208,the,0,0
64209,acquisition,0,0
64210,of,0,0
64211,spoken,0,1
64212,communication,0,1
64213,in,0,0
64214,preschoolers,0,0
64215,with,0,0
64216,ASD,0,0
64217,.,0,0
64218,PURPOSE,0,0
64219,This,0,0
64220,randomized,0,0
64221,group,0,0
64222,experiment,0,0
64223,compared,0,0
64224,the,0,0
64225,efficacy,0,1
64226,of,0,0
64227,2,0,0
64228,communication,0,0
64229,interventions,0,0
64230,(,0,0
64231,Responsive,0,1
64232,Education,0,1
64233,and,0,1
64234,Prelinguistic,0,1
64235,Milieu,0,1
64236,Teaching,0,1
64237,[,0,0
64238,RPMT,0,1
64239,],0,0
64240,and,0,0
64241,the,0,0
64242,Picture,0,1
64243,Exchange,0,0
64244,Communication,0,1
64245,System,0,1
64246,[,0,0
64247,PECS,0,1
64248,],0,0
64249,),0,0
64250,on,0,0
64251,spoken,0,1
64252,communication,0,0
64253,in,0,0
64254,36,0,0
64255,preschoolers,0,0
64256,with,0,0
64257,autism,0,0
64258,spectrum,0,0
64259,disorders,0,1
64260,(,0,1
64261,ASD,0,0
64262,),0,0
64263,.,0,0
64264,METHOD,0,0
64265,Each,0,0
64266,treatment,0,0
64267,was,0,0
64268,delivered,0,0
64269,to,0,0
64270,children,0,0
64271,for,0,0
64272,a,0,0
64273,maximum,0,1
64274,total,0,1
64275,of,0,0
64276,24,0,0
64277,hr,0,0
64278,over,0,0
64279,a,0,0
64280,6-month,0,0
64281,period,0,0
64282,.,0,1
64283,Spoken,0,1
64284,communication,0,1
64285,was,0,0
64286,assessed,0,0
64287,in,0,0
64288,a,0,0
64289,rigorous,0,0
64290,test,0,1
64291,of,0,1
64292,generalization,0,1
64293,at,0,0
64294,pretreatment,0,0
64295,",",0,1
64296,posttreatment,0,1
64297,",",0,1
64298,and,0,1
64299,6-month,0,1
64300,follow-up,0,0
64301,periods,0,0
64302,.,0,0
64303,RESULTS,0,0
64304,PECS,1,1
64305,was,1,0
64306,more,1,0
64307,successful,1,1
64308,than,1,0
64309,RPMT,1,1
64310,in,1,0
64311,increasing,1,0
64312,the,1,0
64313,number,1,1
64314,of,1,0
64315,nonimitative,1,0
64316,spoken,1,1
64317,communication,1,1
64318,acts,1,0
64319,and,1,0
64320,the,1,0
64321,number,1,1
64322,of,1,0
64323,different,1,0
64324,nonimitative,1,0
64325,words,1,1
64326,used,1,0
64327,at,1,0
64328,the,1,0
64329,posttreatment,1,0
64330,period,1,0
64331,.,1,0
64332,Considering,0,0
64333,growth,0,1
64334,over,0,0
64335,all,0,0
64336,3,0,0
64337,measurement,0,0
64338,periods,0,0
64339,",",0,0
64340,an,0,0
64341,exploratory,0,1
64342,analysis,0,0
64343,showed,0,0
64344,that,0,0
64345,growth,1,1
64346,rate,1,1
64347,of,1,0
64348,the,1,0
64349,number,1,1
64350,of,1,0
64351,different,1,0
64352,nonimitative,1,0
64353,words,1,1
64354,was,1,0
64355,faster,1,0
64356,in,1,0
64357,the,1,0
64358,PECS,1,0
64359,group,0,0
64360,than,0,0
64361,in,0,0
64362,the,0,0
64363,RPMT,0,1
64364,group,0,0
64365,for,0,0
64366,children,0,0
64367,who,0,0
64368,began,0,0
64369,treatment,0,0
64370,with,0,0
64371,relatively,0,0
64372,high,0,0
64373,object,0,1
64374,exploration,0,0
64375,.,0,0
64376,In,0,0
64377,contrast,0,0
64378,",",0,0
64379,analogous,1,0
64380,slopes,1,1
64381,were,0,0
64382,steeper,0,0
64383,in,0,0
64384,the,0,0
64385,RPMT,0,1
64386,group,0,0
64387,than,0,0
64388,in,0,0
64389,the,0,0
64390,PECS,0,0
64391,group,0,0
64392,for,0,0
64393,children,0,0
64394,who,0,0
64395,began,0,0
64396,treatment,0,0
64397,with,0,0
64398,relatively,0,0
64399,low,0,0
64400,object,0,1
64401,exploration,0,0
64402,.,0,0
64403,Heart,1,1
64404,rate,1,1
64405,variability,1,1
64406,and,0,1
64407,QT,1,1
64408,dispersion,1,1
64409,in,0,0
64410,patients,0,0
64411,with,0,0
64412,subclinical,0,1
64413,hypothyroidism,0,0
64414,.,0,0
64415,UNLABELLED,0,0
64416,The,0,0
64417,effect,0,0
64418,of,0,0
64419,subclinical,0,1
64420,hypothyroidism,0,1
64421,(,0,1
64422,SH,0,0
64423,),0,0
64424,on,0,0
64425,cardiovascular,0,1
64426,autonomic,0,1
64427,function,0,1
64428,and,0,1
64429,ventricular,0,1
64430,repolarization,0,1
64431,has,0,0
64432,not,0,0
64433,been,0,0
64434,yet,0,0
64435,elucidated,0,0
64436,.,0,0
64437,The,0,0
64438,aim,0,0
64439,of,0,0
64440,the,0,0
64441,present,0,0
64442,study,0,0
64443,was,0,0
64444,to,0,0
64445,evaluate,0,0
64446,the,0,0
64447,dispersion,0,1
64448,of,0,0
64449,QT,0,1
64450,interval,0,0
64451,",",0,0
64452,i.e,0,0
64453,.,0,0
64454,an,0,0
64455,index,0,1
64456,of,0,0
64457,inhomogeneity,0,1
64458,of,0,1
64459,repolarization,0,1
64460,",",0,1
64461,and,0,1
64462,heart,0,1
64463,rate,0,1
64464,variability,0,1
64465,(,0,1
64466,HRV,0,0
64467,),0,1
64468,",",0,0
64469,i.e,0,0
64470,.,0,0
64471,a,0,0
64472,measure,0,0
64473,of,0,0
64474,cardiac,0,1
64475,autonomic,0,1
64476,modulation,0,1
64477,",",0,0
64478,in,0,0
64479,SH,0,0
64480,patients,0,0
64481,.,0,0
64482,METHODS,0,0
64483,The,0,0
64484,study,0,0
64485,included,0,0
64486,42,0,0
64487,patients,0,0
64488,(,0,0
64489,29,0,0
64490,women,0,0
64491,and,0,0
64492,13,0,0
64493,men,0,0
64494,;,0,0
64495,mean,0,1
64496,age,0,0
64497,53.2+/-14.2,0,0
64498,years,0,0
64499,;,0,0
64500,body,0,1
64501,surface,0,1
64502,area,0,1
64503,1.76+/-0.14,0,0
64504,m2,0,0
64505,),0,0
64506,with,0,0
64507,SH,0,0
64508,",",0,0
64509,as,0,0
64510,judged,0,0
64511,by,0,0
64512,elevated,0,1
64513,serum,0,1
64514,TSH,0,1
64515,levels,0,1
64516,(,0,0
64517,>,0,0
64518,3.6,0,0
64519,mIU/l,0,0
64520,;,0,0
64521,range,0,0
64522,",",0,1
64523,3.8-12.0,0,1
64524,),0,1
64525,and,0,1
64526,normal,0,1
64527,free,0,1
64528,thyroid,0,1
64529,hormones,0,1
64530,(,0,1
64531,FT4,0,0
64532,and,0,1
64533,FT3,0,1
64534,),0,0
64535,and,0,0
64536,30,0,0
64537,euthyroid,0,0
64538,volunteer,0,0
64539,.,0,0
64540,Subjects,0,0
64541,with,0,0
64542,cardiac,0,1
64543,",",0,1
64544,metabolic,0,1
64545,",",0,1
64546,neurological,0,1
64547,disease,0,1
64548,or,0,0
64549,any,0,1
64550,other,0,0
64551,systemic,0,1
64552,disease,0,0
64553,that,0,0
64554,could,0,0
64555,affect,0,0
64556,autonomic,0,1
64557,activity,0,1
64558,were,0,0
64559,excluded,0,0
64560,from,0,0
64561,the,0,0
64562,study,0,0
64563,.,0,0
64564,Patients,0,0
64565,with,0,0
64566,SH,0,0
64567,and,0,1
64568,control,0,0
64569,subjects,0,0
64570,underwent,0,0
64571,a,0,0
64572,full,0,0
64573,history,0,1
64574,",",0,1
64575,physical,0,1
64576,examination,0,1
64577,",",0,1
64578,standard,0,0
64579,12-lead,0,1
64580,ECG,0,1
64581,",",0,1
64582,and,0,1
64583,24-h,0,1
64584,ambulatory,0,1
64585,ECG,0,1
64586,monitoring,0,0
64587,.,0,0
64588,To,0,0
64589,evaluate,0,0
64590,the,0,0
64591,effect,0,0
64592,of,0,0
64593,treatment,0,0
64594,with,0,0
64595,L-thyroxine,0,1
64596,on,0,0
64597,QT,0,1
64598,dispersion,0,1
64599,and,0,1
64600,HRV,0,0
64601,",",0,0
64602,15,0,0
64603,patients,0,0
64604,with,0,0
64605,SH,0,0
64606,were,0,0
64607,randomly,0,0
64608,assigned,0,0
64609,to,0,0
64610,receive,0,0
64611,therapy,0,0
64612,with,0,0
64613,L-thyroxine,0,1
64614,.,0,0
64615,All,0,0
64616,the,0,0
64617,subjects,0,0
64618,were,0,0
64619,evaluated,0,0
64620,at,0,0
64621,enrolment,0,0
64622,and,0,0
64623,after,0,0
64624,6,0,0
64625,months,0,0
64626,.,0,0
64627,RESULTS,0,0
64628,Patients,0,0
64629,with,0,0
64630,SH,0,0
64631,showed,0,0
64632,higher,0,0
64633,QT,1,1
64634,dispersion,1,1
64635,and,0,1
64636,lower,1,1
64637,HRV,1,0
64638,measures,1,1
64639,than,0,0
64640,healthy,0,0
64641,controls,0,0
64642,(,0,0
64643,P,0,0
64644,<,0,0
64645,0.01,0,0
64646,for,0,0
64647,all,0,0
64648,),0,0
64649,.,0,0
64650,In,0,0
64651,SH,0,0
64652,patients,0,0
64653,",",0,0
64654,the,0,0
64655,standard,1,0
64656,deviation,1,0
64657,of,1,1
64658,N-Ns,1,1
64659,(,1,0
64660,SDNN,1,0
64661,),1,1
64662,was,0,0
64663,negatively,0,0
64664,related,0,0
64665,to,0,0
64666,TSH,0,1
64667,(,0,0
64668,r=-0.42,0,1
64669,",",0,1
64670,P=0.006,0,0
64671,),0,1
64672,",",0,0
64673,while,0,0
64674,low,1,1
64675,frequency,1,1
64676,(,1,1
64677,LF,1,1
64678,),1,0
64679,/high,1,1
64680,frequency,1,1
64681,(,1,1
64682,HF,1,1
64683,),1,1
64684,ratio,1,1
64685,was,0,0
64686,positively,0,0
64687,related,0,0
64688,to,0,0
64689,TSH,0,1
64690,(,0,1
64691,r=0.42,0,0
64692,",",0,1
64693,P=0.006,0,0
64694,),0,0
64695,.,0,0
64696,Moreover,0,0
64697,",",0,0
64698,in,0,0
64699,SH,0,0
64700,patients,0,0
64701,both,0,0
64702,QT,1,1
64703,dispersion,1,1
64704,and,1,1
64705,QTc,1,1
64706,dispersion,1,1
64707,were,0,0
64708,positively,0,0
64709,related,0,0
64710,to,0,0
64711,TSH,0,1
64712,(,0,1
64713,r=0.64,0,0
64714,and,0,1
64715,r=0.63,0,1
64716,",",0,0
64717,P,0,0
64718,<,0,0
64719,0.001,0,0
64720,for,0,0
64721,both,0,0
64722,),0,0
64723,.,0,0
64724,After,0,0
64725,6,0,0
64726,months,0,0
64727,",",0,0
64728,the,0,0
64729,patients,0,0
64730,treated,0,0
64731,with,0,0
64732,L-tiroxine,0,0
64733,exhibited,0,0
64734,a,0,0
64735,reduction,0,1
64736,of,0,0
64737,QT,1,1
64738,dispersion,1,1
64739,and,0,0
64740,an,0,0
64741,increase,0,1
64742,of,0,0
64743,HRV,1,0
64744,parameters,1,0
64745,.,1,0
64746,CONCLUSION,0,0
64747,The,0,0
64748,results,0,0
64749,of,0,0
64750,the,0,0
64751,present,0,0
64752,study,0,0
64753,demonstrated,0,0
64754,that,0,0
64755,SH,0,0
64756,can,0,0
64757,alter,0,1
64758,autonomic,0,1
64759,modulation,0,1
64760,of,0,1
64761,heart,1,1
64762,rate,1,1
64763,and,0,1
64764,cause,0,1
64765,increased,0,1
64766,inhomogeneity,0,1
64767,of,0,1
64768,ventricular,0,1
64769,recovery,0,1
64770,times,0,1
64771,.,0,0
64772,Accordingly,0,0
64773,",",0,0
64774,early,0,0
64775,L-thyroxine,0,1
64776,treatment,0,0
64777,may,0,0
64778,be,0,0
64779,advised,0,0
64780,not,0,0
64781,only,0,0
64782,to,0,0
64783,prevent,0,0
64784,progression,0,1
64785,to,0,0
64786,overt,0,1
64787,hypothyroidism,0,0
64788,but,0,0
64789,also,0,0
64790,to,0,0
64791,improve,0,0
64792,abnormal,0,1
64793,cardiac,0,1
64794,autonomic,0,1
64795,function,0,1
64796,and,0,1
64797,ventricular,0,1
64798,repolarization,0,1
64799,inhomogeneity,0,1
64800,.,0,0
64801,Effectiveness,1,1
64802,of,0,1
64803,written,0,0
64804,guidelines,0,0
64805,on,0,0
64806,the,0,0
64807,appropriateness,0,0
64808,of,0,0
64809,thromboprophylaxis,0,1
64810,prescriptions,0,0
64811,for,0,0
64812,medical,0,0
64813,patients,0,0
64814,:,0,0
64815,a,0,0
64816,prospective,0,0
64817,randomized,0,0
64818,study,0,0
64819,.,0,0
64820,OBJECTIVE,0,0
64821,To,0,0
64822,assess,0,0
64823,the,0,0
64824,effectiveness,1,0
64825,of,0,0
64826,providing,0,0
64827,doctors,0,0
64828,with,0,0
64829,written,0,0
64830,thromboprophylaxis,0,0
64831,prescription,0,0
64832,aids,0,0
64833,based,0,0
64834,on,0,0
64835,current,0,0
64836,recommendations,0,0
64837,.,0,0
64838,DESIGN,0,0
64839,A,0,0
64840,prospective,0,0
64841,trial,0,0
64842,of,0,1
64843,specific,0,0
64844,anticoagulant,0,1
64845,prescription,0,0
64846,forms,0,0
64847,:,0,0
64848,a,0,0
64849,1-day,0,0
64850,survey,0,0
64851,before,0,0
64852,and,0,0
64853,after,0,0
64854,the,0,0
64855,intervention,0,0
64856,in,0,0
64857,each,0,0
64858,centre,0,0
64859,.,0,0
64860,SETTING,0,0
64861,30,0,0
64862,Internal,0,0
64863,Medicine,0,0
64864,departments,0,0
64865,of,0,0
64866,Assistance,0,0
64867,Publique-H?pitaux,0,1
64868,de,0,0
64869,Paris,0,0
64870,.,0,0
64871,SUBJECTS,0,0
64872,All,0,0
64873,inpatients,0,0
64874,were,0,0
64875,included,0,0
64876,",",0,0
64877,except,0,0
64878,those,0,0
64879,who,0,0
64880,were,0,0
64881,either,0,0
64882,admitted,0,0
64883,or,0,0
64884,discharged,0,0
64885,on,0,0
64886,the,0,0
64887,day,0,0
64888,of,0,0
64889,the,0,0
64890,survey,0,0
64891,",",0,0
64892,and,0,0
64893,those,0,0
64894,receiving,0,0
64895,curative,0,1
64896,anticoagulant,0,1
64897,treatment,0,0
64898,.,0,0
64899,INTERVENTIONS,0,0
64900,The,0,0
64901,study,0,0
64902,included,0,0
64903,three,0,0
64904,parts,0,0
64905,:,0,0
64906,(,0,0
64907,i,0,0
64908,),0,0
64909,a,0,0
64910,1-day,0,0
64911,baseline,0,0
64912,survey,0,0
64913,;,0,1
64914,(,0,0
64915,ii,0,0
64916,),0,0
64917,over,0,0
64918,the,0,0
64919,following,0,0
64920,3-month,0,1
64921,period,0,0
64922,",",0,1
64923,departments,0,0
64924,were,0,0
64925,randomized,0,0
64926,into,0,0
64927,two,0,0
64928,groups,0,0
64929,:,0,0
64930,all,0,0
64931,practitioners,0,0
64932,in,0,0
64933,wards,0,0
64934,allocated,0,0
64935,to,0,0
64936,the,0,0
64937,intervention,0,0
64938,group,0,0
64939,were,0,0
64940,required,0,0
64941,to,0,0
64942,systematically,0,0
64943,use,0,0
64944,specific,0,0
64945,anticoagulant,0,1
64946,prescription,0,0
64947,forms,0,0
64948,",",0,1
64949,whilst,0,0
64950,doctors,0,0
64951,in,0,0
64952,the,0,0
64953,control,0,0
64954,group,0,0
64955,continued,0,0
64956,prescribing,0,0
64957,according,0,0
64958,to,0,0
64959,their,0,0
64960,usual,0,0
64961,practices,0,1
64962,and,0,1
64963,(,0,1
64964,iii,0,0
64965,),0,0
64966,a,0,0
64967,1-day,0,0
64968,postintervention,0,1
64969,survey,0,0
64970,.,0,1
64971,MAIN,0,0
64972,OUTCOME,0,0
64973,MEASURE,1,0
64974,The,1,0
64975,proportion,1,0
64976,of,1,0
64977,prescriptions,1,0
64978,in,1,0
64979,accordance,1,0
64980,with,1,0
64981,the,1,0
64982,recommendations,1,0
64983,.,1,0
64984,RESULTS,0,0
64985,"1,469",0,0
64986,patients,0,0
64987,were,0,0
64988,included,0,0
64989,.,0,0
64990,The,0,0
64991,intervention,0,0
64992,produced,0,0
64993,a,0,0
64994,significant,1,0
64995,reduction,1,1
64996,in,0,0
64997,the,1,0
64998,frequency,1,1
64999,of,1,0
65000,over-prescriptions,1,1
65001,",",1,0
65002,from,0,0
65003,25,0,0
65004,%,0,0
65005,to,0,0
65006,14,0,0
65007,%,0,0
65008,of,0,0
65009,the,0,0
65010,patients,0,0
65011,who,0,0
65012,did,0,0
65013,not,0,0
65014,meet,0,0
65015,the,0,0
65016,guideline,0,0
65017,criteria,0,0
65018,(,0,0
65019,adjusted,0,0
65020,OR,0,0
65021,:,0,0
65022,0.3,0,0
65023,;,0,0
65024,95,0,0
65025,%,0,0
65026,CI,0,0
65027,:,0,0
65028,0.1-0.8,0,0
65029,),0,0
65030,.,0,0
65031,Using,1,0
65032,specific,1,0
65033,forms,1,0
65034,did,0,0
65035,not,1,0
65036,improve,1,0
65037,under-prescription,1,0
65038,of,1,0
65039,anticoagulants,1,0
65040,.,1,0
65041,A,0,0
65042,little,0,0
65043,over,0,0
65044,60,0,0
65045,%,0,0
65046,of,0,0
65047,the,0,0
65048,patients,0,0
65049,who,0,0
65050,met,0,0
65051,guideline,0,0
65052,criteria,0,0
65053,for,0,0
65054,thromboprophylaxis,0,1
65055,were,1,0
65056,prescribed,1,0
65057,anticoagulants,1,0
65058,in,0,0
65059,both,0,0
65060,intervention,0,0
65061,and,0,1
65062,control,0,0
65063,wards,0,1
65064,",",0,0
65065,either,0,0
65066,at,0,0
65067,baseline,0,0
65068,or,0,0
65069,after,0,0
65070,intervention,0,0
65071,.,0,1
65072,CONCLUSIONS,0,0
65073,Multitargeted,0,0
65074,interventions,0,0
65075,using,0,0
65076,a,0,0
65077,variety,0,0
65078,of,0,0
65079,means,0,0
65080,and,0,0
65081,strategies,0,0
65082,should,0,0
65083,still,0,0
65084,be,0,0
65085,considered,0,0
65086,to,1,0
65087,improve,1,0
65088,prescriptions,1,0
65089,that,0,0
65090,may,0,0
65091,have,0,0
65092,a,0,0
65093,significant,1,0
65094,impact,1,0
65095,on,1,0
65096,health,1,1
65097,expenses,1,1
65098,and,0,1
65099,",",0,1
65100,most,0,0
65101,importantly,0,1
65102,",",0,0
65103,on,1,0
65104,patients,1,0
65105,outcomes,1,1
65106,.,1,0
65107,Anecortave,0,0
65108,acetate,0,0
65109,treatment,0,0
65110,for,0,0
65111,retinal,0,1
65112,angiomatous,0,0
65113,proliferation,0,1
65114,:,0,0
65115,a,0,0
65116,pilot,0,0
65117,study,0,0
65118,.,0,0
65119,PURPOSE,0,0
65120,The,0,0
65121,purpose,0,0
65122,of,0,0
65123,this,0,0
65124,study,0,0
65125,was,0,0
65126,to,0,0
65127,evaluate,0,0
65128,anecortave,0,0
65129,acetate,0,0
65130,treatment,0,0
65131,of,0,1
65132,retinal,0,1
65133,angiomatous,0,1
65134,proliferation,0,1
65135,(,0,1
65136,RAP,0,1
65137,),0,0
65138,",",0,0
65139,a,0,0
65140,neovascular,0,0
65141,form,0,0
65142,of,0,1
65143,age-related,0,0
65144,macular,0,1
65145,degeneration,0,1
65146,",",0,0
65147,with,0,0
65148,specific,0,0
65149,regard,0,0
65150,to,0,0
65151,inhibition,1,1
65152,of,1,1
65153,neovascularization,1,1
65154,and,1,1
65155,maintenance,1,0
65156,of,1,1
65157,vision,1,1
65158,.,1,0
65159,METHODS,0,0
65160,Thirty-four,0,0
65161,patients,0,0
65162,with,0,0
65163,RAP,0,0
65164,with,0,0
65165,any,0,0
65166,stage,0,0
65167,of,0,1
65168,neovascularization,0,1
65169,were,0,0
65170,randomized,0,0
65171,1:1:1,0,0
65172,for,0,0
65173,treatment,0,0
65174,with,0,0
65175,three,0,0
65176,different,0,0
65177,quantities,0,0
65178,(,0,0
65179,30,0,0
65180,mg,0,0
65181,",",0,0
65182,15,0,0
65183,mg,0,0
65184,",",0,0
65185,3,0,0
65186,mg,0,0
65187,),0,0
65188,of,0,1
65189,anecortave,0,0
65190,acetate,0,0
65191,sterile,0,0
65192,suspension,0,0
65193,for,0,0
65194,juxtascleral,0,0
65195,administration,0,0
65196,.,0,0
65197,Best-corrected,1,1
65198,visual,1,1
65199,acuity,1,1
65200,(,1,0
65201,Early,1,1
65202,Treatment,1,0
65203,Diabetic,1,1
65204,Retinopathy,1,1
65205,Study,1,0
65206,chart,1,1
65207,),1,1
65208,",",1,0
65209,intraocular,1,1
65210,pressure,1,1
65211,measurement,1,1
65212,",",1,1
65213,biomicroscopy,1,1
65214,",",1,1
65215,funduscopy,1,1
65216,",",1,1
65217,digital,1,1
65218,fluorescein,1,1
65219,",",1,1
65220,and,1,1
65221,indocyanine,1,1
65222,green,1,1
65223,angiography,1,0
65224,were,0,0
65225,recorded,0,0
65226,at,0,0
65227,baseline,0,0
65228,and,0,0
65229,at,0,0
65230,3,0,0
65231,months,0,0
65232,.,0,0
65233,A,0,0
65234,6-month,0,0
65235,retreatment,0,0
65236,interval,0,0
65237,was,0,0
65238,established,0,0
65239,for,0,0
65240,this,0,0
65241,study,0,0
65242,with,0,0
65243,a,0,0
65244,follow-up,0,0
65245,of,0,0
65246,12,0,0
65247,months,0,0
65248,.,0,0
65249,In,0,0
65250,selected,0,0
65251,patients,0,0
65252,optical,0,1
65253,coherence,0,1
65254,tomography,0,1
65255,was,0,0
65256,performed,0,0
65257,.,0,0
65258,The,0,0
65259,outcomes,0,1
65260,were,0,0
65261,mean,1,1
65262,changes,1,1
65263,in,1,0
65264,visual,1,1
65265,acuity,1,1
65266,and,1,1
65267,lesion,1,1
65268,size,1,1
65269,at,1,0
65270,1,1,0
65271,year,1,0
65272,.,1,0
65273,RESULTS,0,0
65274,The,0,0
65275,detachment,1,0
65276,of,1,0
65277,the,1,0
65278,neurosensory,1,1
65279,retina,1,1
65280,and,1,1
65281,retinal,1,1
65282,pigment,1,1
65283,epithelium,1,1
65284,improved,0,0
65285,in,0,0
65286,all,0,0
65287,eyes,0,0
65288,",",0,0
65289,but,0,0
65290,all,0,0
65291,neovascular,1,1
65292,lesions,1,1
65293,increased,1,0
65294,in,1,0
65295,size,1,1
65296,.,1,1
65297,Vision,1,1
65298,loss,1,1
65299,occurred,0,0
65300,in,0,0
65301,the,0,0
65302,majority,0,0
65303,of,0,0
65304,study,0,0
65305,eyes,0,0
65306,(,0,0
65307,22,0,0
65308,out,0,0
65309,of,0,0
65310,34,0,0
65311,eyes,0,0
65312,",",0,0
65313,64.7,0,0
65314,%,0,0
65315,),0,0
65316,independent,0,0
65317,of,0,0
65318,the,0,0
65319,concentration,0,1
65320,administered,0,0
65321,.,0,0
65322,CONCLUSION,0,0
65323,The,0,0
65324,results,0,0
65325,suggest,0,0
65326,that,0,0
65327,a,0,0
65328,posterior,0,0
65329,juxtascleral,0,0
65330,injection,0,0
65331,of,0,1
65332,anecortave,0,0
65333,acetate,0,0
65334,reduces,0,1
65335,capillary,1,1
65336,permeability,1,1
65337,in,0,0
65338,patients,0,0
65339,with,0,0
65340,RAP,0,0
65341,.,0,0
65342,However,0,0
65343,",",0,0
65344,in,0,0
65345,spite,0,0
65346,of,0,1
65347,improvement,0,1
65348,of,0,0
65349,the,0,0
65350,exudation,0,0
65351,there,0,0
65352,is,0,0
65353,a,0,0
65354,progression,0,1
65355,of,0,1
65356,neovascularization,1,1
65357,and,0,0
65358,a,0,0
65359,significant,1,0
65360,loss,1,1
65361,of,1,1
65362,vision,1,1
65363,in,0,0
65364,all,0,0
65365,these,0,0
65366,patients,0,0
65367,.,0,0
65368,Like,0,0
65369,other,0,0
65370,monotherapeutic,0,0
65371,methods,0,0
65372,used,0,0
65373,to,0,0
65374,treat,0,0
65375,this,0,0
65376,variant,0,0
65377,of,0,0
65378,neovascular,0,0
65379,age-related,0,0
65380,macular,0,1
65381,degeneration,0,0
65382,",",0,0
65383,anecortave,0,0
65384,acetate,0,0
65385,alone,0,0
65386,does,0,0
65387,not,0,0
65388,appear,0,0
65389,to,0,0
65390,benefit,0,0
65391,these,0,0
65392,patients,0,0
65393,.,0,0
65394,Future,0,0
65395,studies,0,0
65396,should,0,0
65397,investigate,0,0
65398,a,0,0
65399,combination,0,0
65400,form,0,0
65401,of,0,0
65402,therapy,0,0
65403,.,0,0
65404,Trials,1,1
65405,and,0,1
65406,tribulations,1,0
65407,in,0,0
65408,speech,0,1
65409,therapy,0,0
65410,.,0,0
65411,Use,0,0
65412,of,0,0
65413,an,0,0
65414,alpha,0,1
65415,1-blocker,0,0
65416,",",0,1
65417,YM617,0,0
65418,",",0,0
65419,in,0,0
65420,the,0,0
65421,treatment,0,0
65422,of,0,0
65423,benign,0,0
65424,prostatic,0,0
65425,hypertrophy,0,1
65426,.,0,0
65427,YM617,0,0
65428,Clinical,0,1
65429,Study,0,0
65430,Group,0,0
65431,.,0,0
65432,A,0,0
65433,recently,0,0
65434,synthesized,0,0
65435,alpha,0,0
65436,1-blocker,0,0
65437,",",0,0
65438,(,0,0
65439,R,0,1
65440,),0,0
65441,(,0,0
65442,-,0,0
65443,),0,0
65444,-5-,0,0
65445,[,0,0
65446,2-,0,0
65447,[,0,0
65448,[,0,0
65449,2-,0,0
65450,(,0,0
65451,o-ethoxyphenoxy,0,0
65452,),0,0
65453,ethyl,0,0
65454,],0,0
65455,amino,0,0
65456,],0,0
65457,propyl,0,0
65458,],0,0
65459,-2-,0,0
65460,methoxybenzenesulfonamide,0,1
65461,hydrochloride,0,0
65462,(,0,1
65463,YM617,0,0
65464,),0,1
65465,",",0,0
65466,was,0,0
65467,evaluated,0,0
65468,in,0,0
65469,270,0,0
65470,patients,0,0
65471,with,0,0
65472,benign,0,0
65473,prostatic,0,1
65474,hypertrophy,0,1
65475,in,0,0
65476,a,0,0
65477,double-blind,0,0
65478,study,0,0
65479,.,0,0
65480,After,0,0
65481,2,0,0
65482,weeks,0,0
65483,on,0,0
65484,placebo,0,0
65485,the,0,0
65486,patients,0,0
65487,were,0,0
65488,assigned,0,0
65489,at,0,0
65490,random,0,0
65491,to,0,0
65492,4,0,0
65493,groups,0,0
65494,:,0,0
65495,group,0,0
65496,P,0,0
65497,--,0,1
65498,placebo,0,0
65499,",",0,1
65500,group,0,0
65501,L,0,0
65502,--,0,0
65503,0.1,0,0
65504,mg.,0,0
65505,",",0,0
65506,group,0,0
65507,M,0,0
65508,--,0,0
65509,0.2,0,0
65510,mg.,0,0
65511,and,0,0
65512,group,0,0
65513,H,0,1
65514,--,0,0
65515,0.4,0,0
65516,mg.,0,0
65517,of,0,0
65518,YM617,0,0
65519,.,0,0
65520,Comparing,0,0
65521,the,0,0
65522,placebo,0,0
65523,to,0,0
65524,the,0,0
65525,treatment,0,0
65526,period,0,0
65527,",",0,1
65528,subjective,0,1
65529,symptoms,0,1
65530,",",0,0
65531,such,0,0
65532,as,0,0
65533,nocturia,1,1
65534,and,1,1
65535,urgency,1,1
65536,",",0,1
65537,were,0,0
65538,significantly,0,0
65539,decreased,0,0
65540,in,0,0
65541,group,0,0
65542,H,0,1
65543,(,0,0
65544,p,0,0
65545,less,0,0
65546,than,0,0
65547,0.01,0,0
65548,),0,0
65549,.,0,0
65550,The,0,0
65551,sensation,1,1
65552,of,1,0
65553,incomplete,1,0
65554,voiding,1,1
65555,was,0,0
65556,significantly,0,0
65557,improved,0,0
65558,in,0,0
65559,groups,0,0
65560,M,0,0
65561,and,0,1
65562,H,0,1
65563,(,0,1
65564,p,0,0
65565,less,0,0
65566,than,0,0
65567,0.01,0,0
65568,),0,0
65569,.,0,0
65570,However,0,0
65571,",",0,0
65572,the,0,0
65573,differences,0,0
65574,among,0,0
65575,the,0,0
65576,groups,0,0
65577,were,0,0
65578,statistically,0,0
65579,insignificant,0,0
65580,.,0,0
65581,Residual,1,1
65582,urine,1,1
65583,volume,1,1
65584,was,0,0
65585,significantly,0,0
65586,decreased,0,0
65587,in,0,0
65588,groups,0,0
65589,L,0,0
65590,",",0,1
65591,M,0,0
65592,and,0,1
65593,H,0,1
65594,after,0,0
65595,instillation,0,0
65596,of,0,1
65597,saline,0,0
65598,into,0,0
65599,the,0,0
65600,bladder,0,1
65601,(,0,0
65602,p,0,0
65603,less,0,0
65604,than,0,0
65605,0.01,0,0
65606,),0,0
65607,but,0,0
65608,not,0,0
65609,in,0,0
65610,group,0,0
65611,P.,0,0
65612,The,0,0
65613,maximum,1,1
65614,and,1,1
65615,average,1,1
65616,flow,1,1
65617,rates,1,1
65618,were,0,0
65619,significantly,0,0
65620,increased,0,0
65621,in,0,0
65622,groups,0,0
65623,L,0,0
65624,",",0,1
65625,M,0,0
65626,and,0,1
65627,H,0,1
65628,(,0,1
65629,p,0,0
65630,less,0,0
65631,than,0,0
65632,0.01,0,0
65633,),0,0
65634,but,0,0
65635,not,0,0
65636,in,0,0
65637,group,0,0
65638,P.,0,1
65639,Average,1,1
65640,flow,1,1
65641,rate,1,1
65642,showed,0,0
65643,significant,0,0
65644,differences,0,0
65645,between,0,0
65646,groups,0,0
65647,M,0,0
65648,or,0,1
65649,H,0,1
65650,versus,0,0
65651,group,0,0
65652,P.,0,1
65653,Neither,0,0
65654,orthostatic,1,1
65655,hypotension,1,1
65656,nor,0,0
65657,a,0,0
65658,decrease,0,1
65659,in,0,0
65660,blood,1,1
65661,pressure,1,1
65662,was,0,0
65663,noted,0,0
65664,.,0,0
65665,Adverse,0,1
65666,side,0,1
65667,effects,0,1
65668,and,0,1
65669,changes,0,1
65670,in,0,0
65671,laboratory,0,1
65672,data,0,0
65673,were,0,0
65674,all,0,0
65675,slight,0,1
65676,and,0,1
65677,disappeared,0,0
65678,when,0,0
65679,the,0,0
65680,second,0,0
65681,tests,0,1
65682,were,0,0
65683,performed,0,0
65684,.,0,0
65685,In,0,0
65686,summary,0,0
65687,",",0,0
65688,the,0,0
65689,irritative,1,1
65690,and,1,0
65691,obstructive,1,1
65692,symptoms,1,1
65693,caused,0,0
65694,by,0,0
65695,benign,1,0
65696,prostatic,1,1
65697,hypertrophy,1,1
65698,were,0,0
65699,decreased,0,1
65700,and,0,0
65701,urodynamic,1,0
65702,studies,1,0
65703,were,0,0
65704,markedly,0,0
65705,improved,0,0
65706,by,0,0
65707,the,0,0
65708,alpha,0,1
65709,1-blocker,0,0
65710,",",0,0
65711,YM617,0,0
65712,.,0,0
65713,The,0,0
65714,drug,0,0
65715,seems,0,0
65716,to,0,0
65717,be,0,0
65718,useful,0,0
65719,in,0,0
65720,the,0,0
65721,treatment,0,0
65722,of,0,0
65723,patients,0,0
65724,with,0,0
65725,benign,0,0
65726,prostatic,0,0
65727,hypertrophy,0,1
65728,.,0,0
65729,Long-term,1,0
65730,results,1,0
65731,of,0,0
65732,the,0,0
65733,MRC,0,0
65734,AML10,0,0
65735,trial,0,0
65736,.,0,0
65737,A,0,0
65738,stable,0,1
65739,prostacyclin,0,1
65740,analogue,0,1
65741,(,0,1
65742,iloprost,0,0
65743,),0,0
65744,in,0,0
65745,the,0,0
65746,treatment,0,0
65747,of,0,0
65748,ischaemic,0,0
65749,ulcers,0,1
65750,of,0,0
65751,the,0,0
65752,lower,0,0
65753,limb,0,1
65754,.,0,0
65755,A,0,0
65756,Scandinavian-Polish,0,0
65757,placebo,0,0
65758,controlled,0,0
65759,",",0,0
65760,randomised,0,0
65761,multicenter,0,0
65762,study,0,0
65763,.,0,0
65764,The,0,0
65765,clinical,1,0
65766,efficacy,1,1
65767,of,0,0
65768,the,0,0
65769,prostacyclin,0,1
65770,analogue,0,1
65771,iloprost,0,0
65772,was,0,0
65773,studied,0,0
65774,during,0,0
65775,a,0,0
65776,2,0,0
65777,week,0,0
65778,treatment,0,0
65779,and,0,0
65780,6,0,0
65781,month,0,0
65782,follow-up,0,0
65783,period,0,0
65784,in,0,0
65785,103,0,0
65786,patients,0,0
65787,with,0,0
65788,ischaemic,0,0
65789,ulcers,0,1
65790,who,0,0
65791,were,0,0
65792,randomised,0,0
65793,to,0,0
65794,receive,0,0
65795,active,0,0
65796,treatment,0,0
65797,or,0,0
65798,placebo,0,0
65799,.,0,1
65800,Responders,0,0
65801,were,0,0
65802,defined,0,0
65803,as,0,0
65804,those,0,0
65805,patients,0,0
65806,who,0,0
65807,achieved,0,1
65808,healing,0,1
65809,of,0,0
65810,at,0,0
65811,least,0,0
65812,one,0,0
65813,third,0,0
65814,of,0,0
65815,the,0,0
65816,ulcer,0,1
65817,area,0,1
65818,during,0,0
65819,the,0,0
65820,study,0,0
65821,period,0,0
65822,.,0,0
65823,The,0,0
65824,overall,0,1
65825,responder,1,1
65826,rate,1,1
65827,was,0,0
65828,41.3,0,0
65829,%,0,0
65830,",",0,0
65831,compared,0,0
65832,with,0,0
65833,25,0,0
65834,%,0,0
65835,for,0,0
65836,the,0,0
65837,control,0,0
65838,group,0,0
65839,(,0,1
65840,P,0,0
65841,=,0,0
65842,0.086,0,0
65843,),0,0
65844,.,0,0
65845,Side,0,0
65846,effects,0,1
65847,including,0,0
65848,flushing,1,1
65849,and,1,1
65850,headache,1,1
65851,",",0,1
65852,were,0,0
65853,common,0,0
65854,.,0,0
65855,The,0,0
65856,study,0,0
65857,population,0,0
65858,had,0,0
65859,a,0,0
65860,mortality,1,1
65861,of,0,0
65862,23,0,0
65863,%,0,0
65864,during,0,0
65865,the,0,0
65866,6,0,0
65867,month,0,0
65868,period,0,0
65869,",",0,0
65870,the,0,0
65871,amputation,1,1
65872,rate,1,1
65873,was,0,0
65874,43.5,0,0
65875,%,0,0
65876,for,0,0
65877,iloprost,0,0
65878,and,0,0
65879,50,0,0
65880,%,0,0
65881,for,0,0
65882,placebo,0,0
65883,treated,0,0
65884,patients,0,0
65885,.,0,0
65886,In,0,0
65887,this,0,0
65888,severely,0,0
65889,diseased,0,1
65890,population,0,0
65891,of,0,0
65892,patients,0,0
65893,a,0,0
65894,treatment,0,0
65895,period,0,0
65896,limited,0,0
65897,to,0,0
65898,2,0,0
65899,weeks,0,0
65900,did,0,0
65901,not,0,0
65902,sufficiently,0,0
65903,improve,0,0
65904,ulcer,1,1
65905,healing,1,1
65906,.,1,0
65907,Comparison,0,0
65908,of,0,0
65909,the,0,0
65910,effectiveness,1,1
65911,of,1,1
65912,fennel,1,0
65913,and,1,1
65914,mefenamic,1,1
65915,acid,1,1
65916,on,0,0
65917,pain,0,1
65918,intensity,0,1
65919,in,0,0
65920,dysmenorrhoea,0,0
65921,.,0,0
65922,A,0,0
65923,study,0,0
65924,in,0,0
65925,Kerman,0,0
65926,",",0,0
65927,Islamic,0,1
65928,Republic,0,1
65929,of,0,1
65930,Iran,0,0
65931,in,0,0
65932,2002,0,0
65933,compared,0,0
65934,the,0,0
65935,effectiveness,1,0
65936,of,1,1
65937,fennel,1,0
65938,and,1,1
65939,mefenamic,1,1
65940,acid,1,1
65941,on,0,0
65942,pain,0,1
65943,relief,0,1
65944,in,0,0
65945,primary,0,0
65946,dysmenorrhoea,0,0
65947,.,0,0
65948,Two,0,0
65949,groups,0,0
65950,of,0,0
65951,high-school,0,0
65952,girls,0,0
65953,(,0,0
65954,mean,0,1
65955,age,0,0
65956,13,0,0
65957,years,0,0
65958,),0,0
65959,suffering,0,1
65960,dysmenorrhoea,0,0
65961,were,0,0
65962,randomized,0,0
65963,to,0,0
65964,receive,0,0
65965,fennel,0,0
65966,extract,0,0
65967,(,0,0
65968,n,0,0
65969,=,0,0
65970,55,0,0
65971,),0,0
65972,or,0,0
65973,mefenamic,0,1
65974,acid,0,1
65975,(,0,0
65976,n,0,0
65977,=,0,0
65978,55,0,0
65979,),0,0
65980,for,0,0
65981,2,0,0
65982,months,0,0
65983,.,0,0
65984,In,0,0
65985,the,0,0
65986,fennel,0,0
65987,group,0,0
65988,",",0,0
65989,80,0,0
65990,%,0,0
65991,of,0,0
65992,girls,0,0
65993,and,0,0
65994,in,0,0
65995,the,0,0
65996,mefenamic,0,0
65997,acid,0,1
65998,group,0,0
65999,",",0,0
66000,73,0,0
66001,%,0,0
66002,of,0,0
66003,girls,0,0
66004,showed,0,0
66005,complete,0,1
66006,pain,1,1
66007,relief,1,1
66008,or,1,1
66009,pain,1,1
66010,decrease,1,1
66011,",",0,0
66012,while,0,0
66013,80,0,0
66014,%,0,0
66015,in,0,0
66016,the,0,0
66017,fennel,0,0
66018,group,0,0
66019,and,0,0
66020,62,0,0
66021,%,0,0
66022,in,0,0
66023,the,0,0
66024,mefenamic,0,0
66025,acid,0,0
66026,group,0,0
66027,no,0,0
66028,longer,0,0
66029,needed,0,0
66030,to,0,0
66031,rest,0,0
66032,.,0,0
66033,There,0,0
66034,was,0,0
66035,no,0,0
66036,significant,0,0
66037,difference,0,0
66038,between,0,0
66039,the,0,0
66040,2,0,0
66041,groups,0,0
66042,in,0,0
66043,the,0,0
66044,level,1,1
66045,of,1,1
66046,pain,1,1
66047,relief,1,1
66048,.,1,0
66049,Effect,0,1
66050,of,0,1
66051,patient,0,1
66052,withdrawal,0,1
66053,on,0,0
66054,a,0,0
66055,study,0,0
66056,evaluating,0,0
66057,pharmacist,0,1
66058,management,0,0
66059,of,0,0
66060,hypertension,0,1
66061,.,0,0
66062,STUDY,0,0
66063,OBJECTIVES,0,0
66064,To,0,0
66065,examine,0,0
66066,potential,0,0
66067,threats,0,1
66068,to,0,0
66069,internal,0,0
66070,and,0,1
66071,external,0,1
66072,study,0,0
66073,validity,0,1
66074,caused,0,0
66075,by,0,0
66076,differential,0,1
66077,patient,0,1
66078,withdrawal,0,1
66079,from,0,0
66080,a,0,0
66081,randomized,0,0
66082,controlled,0,0
66083,trial,0,0
66084,evaluating,0,0
66085,pharmacist,0,1
66086,management,0,0
66087,of,0,1
66088,hypertension,0,1
66089,",",0,0
66090,to,0,0
66091,compare,0,0
66092,the,0,0
66093,characteristics,0,0
66094,of,0,0
66095,patients,0,0
66096,who,0,0
66097,withdrew,0,0
66098,with,0,0
66099,those,0,0
66100,of,0,0
66101,patients,0,0
66102,who,0,0
66103,completed,0,0
66104,the,0,0
66105,study,0,0
66106,",",0,0
66107,and,0,0
66108,to,0,0
66109,identify,0,0
66110,characteristics,0,0
66111,that,0,0
66112,predispose,0,0
66113,patients,0,0
66114,to,0,0
66115,withdraw,0,0
66116,from,0,0
66117,hypertension,0,1
66118,management,0,0
66119,.,0,1
66120,DESIGN,0,0
66121,Prospective,0,0
66122,",",0,1
66123,randomized,0,0
66124,",",0,1
66125,comparative,0,0
66126,study,0,0
66127,.,0,0
66128,SETTING,0,0
66129,Network,0,1
66130,of,0,1
66131,primary,0,0
66132,care,0,0
66133,clinics,0,0
66134,.,0,0
66135,PATIENTS,0,0
66136,Four,0,0
66137,hundred,0,0
66138,sixty-three,0,0
66139,patients,0,0
66140,with,0,0
66141,a,0,0
66142,diagnosis,0,0
66143,of,0,1
66144,hypertension,0,1
66145,and,0,0
66146,a,0,0
66147,last,0,1
66148,documented,0,0
66149,systolic,0,1
66150,blood,0,1
66151,pressure,0,1
66152,of,0,0
66153,160,0,0
66154,mm,0,0
66155,Hg,0,0
66156,or,0,0
66157,greater,0,1
66158,and/or,0,0
66159,diastolic,0,1
66160,blood,0,1
66161,pressure,0,1
66162,of,0,0
66163,100,0,0
66164,mm,0,0
66165,Hg,0,0
66166,or,0,0
66167,greater,0,1
66168,.,0,1
66169,INTERVENTION,0,1
66170,Patients,0,0
66171,were,0,0
66172,randomly,0,0
66173,allocated,0,0
66174,to,0,0
66175,the,0,0
66176,pharmacist,0,0
66177,intervention,0,0
66178,or,0,1
66179,usual-care,0,0
66180,(,0,1
66181,control,0,0
66182,),0,0
66183,group,0,0
66184,.,0,0
66185,Those,0,0
66186,in,0,0
66187,the,0,0
66188,pharmacist,0,0
66189,intervention,0,0
66190,group,0,0
66191,were,0,0
66192,collaboratively,0,0
66193,managed,0,0
66194,by,0,0
66195,a,0,0
66196,primary,0,0
66197,care,0,0
66198,clinical,0,1
66199,pharmacy,0,1
66200,specialist,0,1
66201,and,0,0
66202,their,0,1
66203,primary,0,1
66204,care,0,0
66205,provider,0,1
66206,.,0,0
66207,Patients,0,0
66208,in,0,0
66209,the,0,0
66210,control,0,0
66211,group,0,0
66212,received,0,0
66213,usual,0,0
66214,care,0,0
66215,from,0,0
66216,only,0,0
66217,their,0,0
66218,primary,0,0
66219,care,0,0
66220,provider,0,1
66221,.,0,1
66222,MEASUREMENTS,0,0
66223,AND,0,0
66224,MAIN,0,1
66225,RESULTS,0,0
66226,Of,0,0
66227,the,0,0
66228,463,0,0
66229,patients,0,0
66230,",",0,0
66231,191,0,0
66232,(,0,0
66233,41,0,0
66234,%,0,0
66235,),0,0
66236,withdrew,0,0
66237,from,0,0
66238,the,0,0
66239,study,0,0
66240,after,0,0
66241,randomization,0,0
66242,and,0,0
66243,272,0,0
66244,(,0,0
66245,59,0,0
66246,%,0,0
66247,),0,0
66248,completed,0,0
66249,the,0,0
66250,study,0,0
66251,.,0,0
66252,Patients,0,0
66253,who,0,0
66254,withdrew,0,0
66255,from,0,0
66256,the,0,0
66257,pharmacist,0,0
66258,intervention,0,0
66259,group,0,0
66260,were,0,0
66261,similar,0,0
66262,to,0,0
66263,patients,0,0
66264,who,0,0
66265,withdrew,0,0
66266,from,0,0
66267,the,0,0
66268,usual-care,0,0
66269,group,0,0
66270,with,0,0
66271,respect,0,0
66272,to,0,0
66273,age,0,0
66274,",",0,1
66275,sex,0,1
66276,",",0,1
66277,insurance,0,1
66278,status,0,1
66279,",",0,1
66280,and,0,1
66281,chronic,0,0
66282,conditions,0,0
66283,.,0,0
66284,Patients,0,0
66285,who,0,0
66286,smoked,0,1
66287,or,0,0
66288,had,0,0
66289,commercial,0,0
66290,insurance,0,1
66291,were,0,0
66292,more,0,0
66293,likely,0,0
66294,to,0,0
66295,withdraw,1,0
66296,from,0,0
66297,the,0,0
66298,study,0,0
66299,than,0,0
66300,the,0,0
66301,other,0,0
66302,participants,0,0
66303,.,0,0
66304,However,0,0
66305,",",0,0
66306,multivariate,0,0
66307,analysis,0,0
66308,of,0,0
66309,all,0,0
66310,variables,0,1
66311,",",0,0
66312,when,0,0
66313,adjusted,0,0
66314,for,0,0
66315,the,0,0
66316,effect,0,0
66317,of,0,0
66318,the,0,0
66319,intervention,0,0
66320,",",0,0
66321,revealed,0,0
66322,that,0,0
66323,insurance,1,1
66324,status,1,1
66325,was,0,0
66326,the,0,0
66327,only,0,0
66328,variable,0,0
66329,associated,0,0
66330,with,0,0
66331,a,0,0
66332,heightened,0,0
66333,probability,0,1
66334,of,0,1
66335,withdrawal,1,1
66336,(,0,1
66337,p=0.002,0,0
66338,),0,0
66339,.,0,0
66340,CONCLUSION,0,0
66341,Although,0,0
66342,this,0,0
66343,study,0,0
66344,had,0,0
66345,a,0,0
66346,high,0,0
66347,withdrawal,0,1
66348,rate,0,1
66349,",",0,1
66350,between-group,0,1
66351,patient,0,1
66352,characteristics,0,1
66353,remained,0,0
66354,balanced,0,0
66355,.,0,0
66356,Therefore,0,0
66357,",",0,0
66358,internal,0,1
66359,validity,0,1
66360,was,0,0
66361,preserved,0,0
66362,",",0,0
66363,and,0,0
66364,outcomes,0,1
66365,from,0,0
66366,the,0,0
66367,study,0,0
66368,groups,0,0
66369,could,0,0
66370,be,0,0
66371,reliably,0,0
66372,compared,0,0
66373,.,0,0
66374,A,0,0
66375,lack,0,0
66376,of,0,0
66377,significant,0,0
66378,differences,0,0
66379,between,0,0
66380,patients,0,0
66381,who,0,0
66382,withdrew,0,0
66383,versus,0,0
66384,those,0,0
66385,who,0,0
66386,completed,0,0
66387,",",0,0
66388,with,0,0
66389,the,0,0
66390,exception,0,0
66391,of,0,1
66392,insurance,0,1
66393,status,0,1
66394,",",0,0
66395,suggests,0,0
66396,that,0,0
66397,external,0,0
66398,validity,0,1
66399,was,0,0
66400,not,0,0
66401,jeopardized,0,0
66402,.,0,0
66403,A,0,0
66404,comparative,0,0
66405,analysis,0,0
66406,of,0,0
66407,the,0,0
66408,effects,0,0
66409,of,0,0
66410,the,0,0
66411,fixed,0,0
66412,combination,0,0
66413,of,0,1
66414,timolol,0,0
66415,and,0,1
66416,dorzolamide,0,0
66417,versus,0,0
66418,latanoprost,0,0
66419,plus,0,0
66420,timolol,0,0
66421,on,0,0
66422,ocular,1,1
66423,hemodynamics,1,1
66424,and,1,1
66425,visual,1,1
66426,function,1,1
66427,in,0,0
66428,patients,0,0
66429,with,0,0
66430,primary,0,0
66431,open-angle,0,0
66432,glaucoma,0,1
66433,.,0,0
66434,AIMS,0,0
66435,The,0,0
66436,aim,0,0
66437,of,0,0
66438,this,0,0
66439,study,0,0
66440,was,0,0
66441,to,0,0
66442,assess,0,0
66443,the,0,0
66444,effects,0,0
66445,of,0,0
66446,fixed,0,0
66447,combination,0,0
66448,of,0,1
66449,timolol,0,0
66450,and,0,1
66451,dorzolamide,0,0
66452,and,0,1
66453,latanoprost,0,0
66454,plus,0,0
66455,timolol,0,0
66456,on,0,0
66457,retinal,1,1
66458,",",1,0
66459,choroidal,1,1
66460,",",1,1
66461,and,1,1
66462,retrobulbar,1,0
66463,hemodynamics,1,1
66464,and,0,1
66465,visual,1,1
66466,function,1,1
66467,in,0,0
66468,primary,0,0
66469,open-angle,0,0
66470,glaucoma,0,1
66471,(,0,1
66472,OAG,0,0
66473,),0,0
66474,subjects,0,0
66475,.,0,0
66476,METHODS,0,0
66477,Sixteen,0,0
66478,(,0,0
66479,16,0,0
66480,),0,0
66481,OAG,0,0
66482,patients,0,0
66483,(,0,1
66484,age,0,0
66485,",",0,0
66486,63.5,0,0
66487,+/-,0,0
66488,10.8,0,0
66489,years,0,0
66490,;,0,0
66491,9,0,0
66492,male,0,0
66493,),0,0
66494,were,0,0
66495,evaluated,0,0
66496,in,0,0
66497,a,0,0
66498,randomized,0,0
66499,",",0,0
66500,crossover,0,0
66501,",",0,0
66502,double-blind,0,0
66503,study,0,0
66504,design,0,0
66505,after,0,0
66506,4,0,0
66507,weeks,0,0
66508,of,0,0
66509,treatment,0,0
66510,of,0,1
66511,latanoprost,0,0
66512,with,0,0
66513,timolol,0,0
66514,and,0,1
66515,fixed,0,1
66516,combination,0,0
66517,of,0,1
66518,timolol,0,0
66519,and,0,1
66520,dorzolamide,0,0
66521,.,0,1
66522,After,0,0
66523,randomization,0,0
66524,",",0,0
66525,9,0,0
66526,right,0,0
66527,eyes,0,0
66528,and,0,0
66529,7,0,0
66530,left,0,1
66531,eyes,0,0
66532,were,0,0
66533,included,0,0
66534,in,0,0
66535,the,0,0
66536,hemodynamic,0,1
66537,portion,0,0
66538,of,0,0
66539,the,0,0
66540,study,0,0
66541,.,0,0
66542,Measurements,0,0
66543,included,0,0
66544,:,0,0
66545,adverse,1,1
66546,events,1,1
66547,check,1,1
66548,",",1,1
66549,visual,1,1
66550,acuity,1,1
66551,",",1,1
66552,contrast,1,0
66553,sensitivity,1,1
66554,",",1,1
66555,blood,1,1
66556,pressure,1,1
66557,",",1,1
66558,heart,1,1
66559,rate,1,1
66560,",",1,1
66561,intraocular,1,1
66562,pressure,1,1
66563,(,1,1
66564,IOP,1,1
66565,),1,1
66566,",",1,0
66567,and,1,1
66568,fundus,1,1
66569,examination,1,0
66570,.,1,1
66571,Ocular,1,1
66572,blood,1,1
66573,flow,1,1
66574,was,0,0
66575,assessed,0,0
66576,using,0,0
66577,confocal,0,0
66578,scanning,0,0
66579,laser,0,0
66580,Doppler,0,1
66581,flowmetry,0,1
66582,",",0,1
66583,color,0,1
66584,Doppler,0,1
66585,imaging,0,1
66586,",",0,1
66587,and,0,1
66588,scanning,0,1
66589,laser,0,0
66590,ophthalmoscopy,0,1
66591,.,0,1
66592,RESULTS,0,0
66593,Both,0,0
66594,therapies,0,0
66595,were,0,0
66596,effective,0,1
66597,at,0,0
66598,lowering,0,1
66599,IOP,1,1
66600,",",0,0
66601,whereas,0,0
66602,there,0,0
66603,was,0,0
66604,no,0,0
66605,statistically,0,0
66606,significant,0,0
66607,difference,0,0
66608,between,0,0
66609,latanoprost,0,0
66610,plus,0,0
66611,timolol,0,0
66612,and,0,1
66613,the,0,0
66614,fixed,0,0
66615,combination,0,0
66616,of,0,1
66617,timolol,0,0
66618,and,0,1
66619,dorzolamide,0,0
66620,(,0,0
66621,13.9,0,0
66622,%,0,0
66623,and,0,0
66624,12.2,0,0
66625,%,0,0
66626,reduction,0,1
66627,",",0,0
66628,respectively,0,0
66629,;,0,0
66630,P,0,0
66631,=,0,0
66632,0.5533,0,0
66633,),0,0
66634,.,0,0
66635,Fixed,0,0
66636,combination,0,0
66637,of,0,0
66638,timolol,0,0
66639,and,0,1
66640,dorzolamide,0,0
66641,significantly,0,0
66642,increased,0,0
66643,central,1,1
66644,retinal,1,1
66645,artery,1,1
66646,end,1,1
66647,diastolic,1,1
66648,blood,1,1
66649,flow,1,1
66650,velocity,1,1
66651,(,0,1
66652,P,0,0
66653,=,0,0
66654,0.0168,0,0
66655,),0,0
66656,and,0,0
66657,lowered,0,0
66658,resistance,1,1
66659,to,1,0
66660,flow,1,1
66661,(,0,0
66662,P,0,0
66663,=,0,0
66664,0.0279,0,0
66665,),0,0
66666,.,0,0
66667,Temporal,1,0
66668,posterior,1,0
66669,ciliary,1,1
66670,artery,1,1
66671,peak,1,1
66672,systolic,1,1
66673,and,1,1
66674,end,1,0
66675,diastolic,1,1
66676,velocities,1,1
66677,were,0,0
66678,significantly,0,0
66679,increased,0,0
66680,with,0,0
66681,the,0,0
66682,fixed,0,0
66683,combination,0,0
66684,of,0,1
66685,timolol,0,0
66686,and,0,1
66687,dorzolamide,0,0
66688,(,0,1
66689,P,0,0
66690,=,0,0
66691,0.0125,0,0
66692,and,0,0
66693,0.0238,0,0
66694,",",0,0
66695,respectively,0,0
66696,),0,0
66697,.,0,0
66698,Latanoprost,0,0
66699,plus,0,0
66700,timolol,0,0
66701,had,0,0
66702,no,0,0
66703,significant,0,0
66704,effects,0,1
66705,on,0,0
66706,ocular,1,1
66707,blood,1,1
66708,flow,1,1
66709,during,0,0
66710,4,0,0
66711,weeks,0,0
66712,of,0,0
66713,treatment,0,0
66714,.,0,0
66715,There,0,0
66716,were,0,0
66717,no,0,0
66718,statistically,0,0
66719,significant,0,0
66720,differences,0,0
66721,in,0,0
66722,adverse,1,1
66723,events,1,1
66724,",",1,1
66725,blood,1,1
66726,pressure,1,1
66727,",",1,1
66728,heart,1,1
66729,rate,1,1
66730,",",1,1
66731,visual,1,1
66732,acuity,1,1
66733,",",1,1
66734,contrast,1,0
66735,sensitivity,1,1
66736,scanning,1,0
66737,laser,1,0
66738,ophthalmoscopy,1,1
66739,",",1,1
66740,or,1,1
66741,Heidelberg,1,1
66742,Retinal,1,1
66743,Flowmeter,1,1
66744,for,0,0
66745,any,0,0
66746,treatment,0,0
66747,period,0,0
66748,.,0,1
66749,CONCLUSIONS,0,0
66750,Fixed,0,0
66751,combination,0,0
66752,of,0,1
66753,timolol,0,0
66754,and,0,1
66755,dorzolamide,0,0
66756,therapy,0,0
66757,might,0,0
66758,increase,0,1
66759,blood,1,1
66760,flow,1,1
66761,in,0,0
66762,OAG,0,0
66763,patients,0,0
66764,while,0,0
66765,attaining,0,0
66766,a,0,0
66767,similar,0,0
66768,IOP,1,1
66769,reduction,0,1
66770,compared,0,0
66771,to,0,0
66772,latanoprost,0,0
66773,plus,0,0
66774,timolol,0,0
66775,.,0,1
66776,Visual,1,1
66777,function,1,1
66778,",",0,0
66779,however,0,0
66780,",",0,0
66781,was,0,0
66782,not,0,0
66783,different,0,0
66784,in,0,0
66785,this,0,0
66786,short-term,0,0
66787,comparison,0,0
66788,between,0,0
66789,the,0,0
66790,two,0,0
66791,treatments,0,0
66792,.,0,0
66793,Folate,0,0
66794,and,0,1
66795,arsenic,0,0
66796,metabolism,0,1
66797,:,0,0
66798,a,0,0
66799,double-blind,0,0
66800,",",0,0
66801,placebo-controlled,0,0
66802,folic,0,0
66803,acid-supplementation,0,0
66804,trial,0,0
66805,in,0,0
66806,Bangladesh,0,1
66807,.,0,0
66808,BACKGROUND,0,0
66809,Populations,0,0
66810,in,0,0
66811,South,0,0
66812,and,0,1
66813,East,0,1
66814,Asia,0,1
66815,and,0,1
66816,many,0,0
66817,other,0,0
66818,regions,0,0
66819,of,0,0
66820,the,0,0
66821,world,0,0
66822,are,0,0
66823,chronically,0,0
66824,exposed,0,0
66825,to,0,0
66826,arsenic-contaminated,0,0
66827,drinking,0,0
66828,water,0,0
66829,.,0,0
66830,To,0,0
66831,various,0,0
66832,degrees,0,0
66833,",",0,0
66834,ingested,0,1
66835,inorganic,0,1
66836,arsenic,0,0
66837,(,0,1
66838,InAs,0,1
66839,),0,0
66840,is,0,0
66841,methylated,0,0
66842,to,0,0
66843,monomethylarsonic,0,1
66844,acid,0,1
66845,(,0,1
66846,MMA,0,0
66847,),0,1
66848,and,0,1
66849,dimethylarsinic,0,1
66850,acid,0,1
66851,(,0,1
66852,DMA,0,0
66853,),0,0
66854,via,0,0
66855,folate-dependent,0,1
66856,one-carbon,0,0
66857,metabolism,0,1
66858,;,0,0
66859,impaired,0,0
66860,methylation,0,0
66861,is,0,0
66862,associated,0,0
66863,with,0,0
66864,adverse,0,1
66865,health,0,1
66866,outcomes,0,1
66867,.,0,0
66868,Consequently,0,0
66869,",",0,0
66870,folate,0,1
66871,nutritional,0,1
66872,status,0,0
66873,may,0,0
66874,influence,0,0
66875,arsenic,1,0
66876,methylation,1,1
66877,and,0,1
66878,toxicity,0,1
66879,.,0,1
66880,OBJECTIVE,0,0
66881,The,0,0
66882,objective,0,0
66883,of,0,0
66884,this,0,0
66885,study,0,0
66886,was,0,0
66887,to,0,0
66888,test,0,0
66889,the,0,0
66890,hypothesis,0,0
66891,that,0,0
66892,folic,0,0
66893,acid,0,0
66894,supplementation,0,0
66895,of,0,0
66896,arsenic-exposed,0,0
66897,adults,0,0
66898,would,0,0
66899,increase,0,1
66900,arsenic,0,0
66901,methylation,0,0
66902,.,0,0
66903,DESIGN,0,0
66904,Two,0,0
66905,hundred,0,0
66906,adults,0,0
66907,in,0,0
66908,a,0,0
66909,rural,0,0
66910,region,0,0
66911,of,0,1
66912,Bangladesh,0,1
66913,",",0,0
66914,previously,0,0
66915,found,0,0
66916,to,0,0
66917,have,0,0
66918,low,0,0
66919,plasma,0,1
66920,concentrations,0,1
66921,of,0,1
66922,folate,0,1
66923,(,0,0
66924,<,0,0
66925,/=9,0,1
66926,nmol/L,0,1
66927,),0,1
66928,were,0,0
66929,enrolled,0,0
66930,in,0,0
66931,a,0,0
66932,randomized,0,0
66933,",",0,0
66934,double-blind,0,0
66935,",",0,1
66936,placebo-controlled,0,0
66937,folic,0,0
66938,acid-supplementation,0,0
66939,trial,0,0
66940,.,0,1
66941,Plasma,1,1
66942,concentrations,1,1
66943,of,1,1
66944,folate,1,1
66945,and,1,1
66946,homocysteine,1,1
66947,and,1,1
66948,urinary,1,1
66949,concentrations,1,1
66950,of,1,0
66951,arsenic,1,0
66952,metabolites,1,1
66953,were,0,0
66954,analyzed,0,0
66955,at,0,0
66956,baseline,0,0
66957,and,0,0
66958,after,0,0
66959,12,0,0
66960,wk,0,0
66961,of,0,0
66962,supplementation,0,0
66963,with,0,0
66964,folic,0,0
66965,acid,0,0
66966,at,0,0
66967,a,0,0
66968,dose,0,0
66969,of,0,0
66970,400,0,0
66971,microg/d,0,0
66972,or,0,0
66973,placebo,0,0
66974,.,0,0
66975,RESULTS,0,0
66976,The,0,0
66977,increase,0,0
66978,in,0,0
66979,the,0,0
66980,proportion,1,0
66981,of,1,0
66982,total,1,1
66983,urinary,1,1
66984,arsenic,1,0
66985,excreted,0,1
66986,as,0,0
66987,DMA,0,0
66988,in,0,0
66989,the,0,0
66990,folic,0,0
66991,acid,0,1
66992,group,0,0
66993,(,0,0
66994,72,0,0
66995,%,0,0
66996,before,0,0
66997,and,0,0
66998,79,0,0
66999,%,0,0
67000,after,0,0
67001,supplementation,0,0
67002,),0,1
67003,was,0,0
67004,significantly,0,0
67005,(,0,0
67006,P,0,0
67007,<,0,0
67008,0.0001,0,0
67009,),0,0
67010,greater,0,0
67011,than,0,0
67012,that,0,0
67013,in,0,0
67014,the,0,0
67015,placebo,0,0
67016,group,0,0
67017,",",0,1
67018,as,0,0
67019,was,0,0
67020,the,0,0
67021,reduction,0,1
67022,in,0,0
67023,the,0,0
67024,proportions,0,0
67025,of,0,0
67026,total,1,1
67027,urinary,1,1
67028,arsenic,1,0
67029,excreted,1,1
67030,as,0,0
67031,MMA,0,0
67032,(,0,0
67033,13,0,0
67034,%,0,0
67035,and,0,0
67036,10,0,0
67037,%,0,0
67038,",",0,0
67039,respectively,0,0
67040,;,0,0
67041,P,0,0
67042,<,0,0
67043,0.0001,0,0
67044,),0,0
67045,and,0,0
67046,as,0,0
67047,InAs,0,1
67048,(,0,0
67049,15,0,0
67050,%,0,0
67051,and,0,0
67052,11,0,0
67053,%,0,0
67054,",",0,0
67055,respectively,0,0
67056,;,0,0
67057,P,0,0
67058,<,0,0
67059,0.001,0,0
67060,),0,0
67061,.,0,0
67062,CONCLUSIONS,0,0
67063,These,0,0
67064,data,0,0
67065,indicate,0,0
67066,that,0,0
67067,folic,0,0
67068,acid,0,0
67069,supplementation,0,0
67070,to,0,0
67071,participants,0,0
67072,with,0,0
67073,low,0,0
67074,plasma,0,1
67075,folate,0,1
67076,enhances,0,1
67077,arsenic,0,0
67078,methylation,0,0
67079,.,0,0
67080,Because,0,0
67081,persons,0,0
67082,whose,0,0
67083,urine,0,1
67084,contains,0,0
67085,low,0,0
67086,proportions,0,1
67087,of,0,1
67088,DMA,0,0
67089,and,0,1
67090,high,0,0
67091,proportions,0,1
67092,of,0,1
67093,MMA,0,0
67094,and,0,0
67095,InAs,0,1
67096,have,0,0
67097,been,0,0
67098,reported,0,0
67099,to,0,0
67100,be,0,0
67101,at,0,0
67102,greater,0,0
67103,risk,0,1
67104,of,0,1
67105,skin,0,1
67106,and,0,1
67107,bladder,0,1
67108,cancers,0,1
67109,and,0,1
67110,peripheral,0,1
67111,vascular,0,1
67112,disease,0,1
67113,",",0,0
67114,these,0,0
67115,results,0,0
67116,suggest,0,0
67117,that,0,0
67118,folic,0,0
67119,acid,0,0
67120,supplementation,0,0
67121,may,0,0
67122,reduce,0,0
67123,the,0,0
67124,risk,0,1
67125,of,0,0
67126,arsenic-related,0,1
67127,health,0,1
67128,outcomes,0,1
67129,.,0,0
67130,The,0,0
67131,effects,1,0
67132,of,0,0
67133,chewing,0,1
67134,versus,0,0
67135,caffeine,0,0
67136,on,0,0
67137,alertness,0,1
67138,",",0,1
67139,cognitive,0,1
67140,performance,0,1
67141,and,0,1
67142,cardiac,0,1
67143,autonomic,0,1
67144,activity,0,1
67145,during,0,0
67146,sleep,0,1
67147,deprivation,0,0
67148,.,0,0
67149,Chewing,0,0
67150,has,0,0
67151,been,0,0
67152,shown,0,0
67153,to,0,0
67154,alleviate,0,0
67155,feelings,0,1
67156,of,0,1
67157,sleepiness,0,1
67158,and,0,1
67159,improve,0,0
67160,cognitive,0,1
67161,performance,0,1
67162,during,0,0
67163,the,0,0
67164,day,0,0
67165,.,0,0
67166,This,0,0
67167,study,0,0
67168,investigated,0,0
67169,the,0,0
67170,effect,1,1
67171,of,0,0
67172,chewing,0,0
67173,on,0,0
67174,alertness,0,1
67175,and,0,1
67176,cognitive,0,1
67177,performance,0,1
67178,across,0,0
67179,one,0,0
67180,night,0,0
67181,without,0,0
67182,sleep,0,1
67183,as,0,0
67184,well,0,0
67185,as,0,0
67186,the,0,0
67187,possible,0,0
67188,mediating,0,1
67189,role,0,0
67190,of,0,1
67191,cardiac,0,1
67192,autonomic,0,1
67193,activity,0,1
67194,.,0,0
67195,Fourteen,0,0
67196,adults,0,0
67197,participated,0,0
67198,in,0,0
67199,a,0,0
67200,randomized,0,0
67201,",",0,0
67202,counterbalanced,0,0
67203,protocol,0,0
67204,employing,0,0
67205,a,0,0
67206,chewing,0,1
67207,",",0,1
67208,placebo,0,0
67209,and,0,1
67210,caffeine,0,0
67211,condition,0,0
67212,.,0,1
67213,Participants,0,0
67214,completed,0,0
67215,tasks,0,1
67216,assessing,0,0
67217,psychomotor,1,1
67218,vigilance,1,1
67219,",",1,1
67220,tracking,1,1
67221,",",1,1
67222,grammatical,1,1
67223,reasoning,1,1
67224,",",1,1
67225,alertness,1,1
67226,and,1,1
67227,sleepiness,1,1
67228,each,0,0
67229,hour,0,0
67230,across,0,0
67231,the,0,0
67232,night,0,1
67233,.,0,0
67234,All,0,0
67235,participants,0,0
67236,received,0,0
67237,either,0,0
67238,placebo,0,0
67239,or,0,1
67240,caffeine,0,0
67241,(,0,0
67242,200,0,0
67243,mg,0,0
67244,),0,0
67245,",",0,0
67246,while,0,0
67247,the,0,0
67248,chewing,0,0
67249,condition,0,0
67250,also,0,0
67251,chewed,0,0
67252,on,0,0
67253,a,0,0
67254,tasteless,0,0
67255,and,0,1
67256,odorless,0,1
67257,substance,0,0
67258,for,0,0
67259,15,0,0
67260,min,0,0
67261,each,0,0
67262,hour,0,0
67263,.,0,0
67264,Heart,1,1
67265,rate,1,1
67266,(,1,1
67267,HR,1,1
67268,),1,1
67269,",",1,0
67270,root,1,1
67271,mean,1,1
67272,square,1,0
67273,of,1,0
67274,the,1,0
67275,successive,1,0
67276,differences,1,0
67277,in,1,0
67278,R-R,1,0
67279,intervals,1,0
67280,on,1,0
67281,the,1,0
67282,ECG,1,1
67283,(,1,0
67284,RMSSD,1,1
67285,),1,1
67286,",",1,1
67287,and,1,1
67288,preejection,1,1
67289,period,1,0
67290,(,1,1
67291,PEP,1,1
67292,),1,1
67293,were,0,0
67294,simultaneously,0,0
67295,recorded,0,0
67296,.,0,0
67297,Alertness,1,1
67298,and,1,1
67299,cognitive,1,1
67300,performance,1,1
67301,amongst,0,0
67302,the,0,0
67303,chewing,0,1
67304,condition,0,0
67305,did,0,0
67306,not,1,0
67307,differ,1,0
67308,or,1,0
67309,were,1,0
67310,in,1,0
67311,fact,1,0
67312,worse,1,1
67313,when,0,0
67314,compared,0,0
67315,with,0,0
67316,placebo,0,0
67317,.,0,0
67318,Similarly,0,0
67319,",",0,0
67320,measures,0,1
67321,of,0,1
67322,HR,1,1
67323,and,1,1
67324,RMSSD,1,1
67325,remained,0,0
67326,the,0,0
67327,same,1,0
67328,between,0,0
67329,these,0,0
67330,two,0,0
67331,conditions,0,0
67332,;,0,0
67333,however,0,0
67334,",",0,0
67335,PEP,1,1
67336,was,0,0
67337,reduced,0,0
67338,in,0,0
67339,the,0,0
67340,later,0,0
67341,part,0,0
67342,of,0,0
67343,the,0,0
67344,night,0,1
67345,in,0,0
67346,the,0,0
67347,chewing,0,0
67348,condition,0,0
67349,compared,0,0
67350,with,0,0
67351,a,0,0
67352,relative,0,1
67353,increase,0,1
67354,for,0,0
67355,placebo,0,0
67356,.,0,1
67357,Caffeine,0,1
67358,led,0,0
67359,to,0,0
67360,improved,1,1
67361,speed,1,1
67362,and,1,1
67363,accuracy,1,1
67364,on,1,0
67365,cognitive,1,1
67366,tasks,1,1
67367,and,1,1
67368,increased,1,1
67369,alertness,1,1
67370,when,0,0
67371,compared,0,0
67372,with,0,0
67373,chewing,0,0
67374,.,0,0
67375,Relative,1,0
67376,increases,1,1
67377,in,1,0
67378,RMSSD,1,1
67379,and,0,1
67380,reductions,1,1
67381,in,1,0
67382,HR,1,1
67383,were,0,0
67384,demonstrated,0,0
67385,following,0,0
67386,caffeine,0,0
67387,;,0,0
67388,however,0,0
67389,",",0,0
67390,no,1,0
67391,change,1,1
67392,in,1,0
67393,PEP,1,0
67394,was,0,0
67395,seen,0,0
67396,.,0,0
67397,Strong,0,0
67398,associations,0,0
67399,between,0,0
67400,cardiac,0,1
67401,parasympathetic,0,1
67402,activity,0,1
67403,and,0,1
67404,complex,0,0
67405,cognitive,0,1
67406,tasks,0,1
67407,",",0,0
67408,as,0,0
67409,well,0,0
67410,as,0,0
67411,between,0,0
67412,subjective,0,1
67413,alertness,1,1
67414,and,0,1
67415,simpler,1,1
67416,cognitive,1,1
67417,tasks,1,1
67418,",",0,0
67419,suggest,0,0
67420,a,0,0
67421,differential,0,1
67422,process,0,0
67423,mediating,0,1
67424,complex,0,0
67425,versus,0,0
67426,simple,0,0
67427,cognitive,0,1
67428,performance,0,1
67429,during,0,0
67430,sleep,0,1
67431,deprivation,0,0
67432,.,0,0
67433,Parent,0,1
67434,satisfaction,0,1
67435,in,0,0
67436,a,0,0
67437,multi-site,0,0
67438,acute,0,0
67439,trial,0,0
67440,of,0,1
67441,risperidone,0,0
67442,in,0,0
67443,children,0,0
67444,with,0,0
67445,autism,0,0
67446,:,0,0
67447,a,0,0
67448,social,0,1
67449,validity,0,0
67450,study,0,0
67451,.,0,1
67452,RATIONALE,0,0
67453,Subjects,0,0
67454,who,0,0
67455,view,0,0
67456,experimental,0,0
67457,procedures,0,0
67458,as,0,0
67459,worthwhile,0,0
67460,are,0,0
67461,more,0,0
67462,likely,0,0
67463,to,0,0
67464,participate,0,0
67465,in,0,0
67466,clinical,0,0
67467,trials,0,0
67468,and,0,1
67469,comply,0,1
67470,with,0,0
67471,study,0,0
67472,procedures,0,0
67473,.,0,0
67474,Designing,0,0
67475,studies,0,0
67476,that,0,0
67477,consider,0,0
67478,the,0,0
67479,consumer,0,1
67480,'s,0,0
67481,perspective,0,0
67482,will,0,0
67483,help,0,0
67484,to,0,0
67485,forge,0,0
67486,a,0,0
67487,better,0,0
67488,alliance,0,0
67489,between,0,1
67490,participants,0,0
67491,and,0,0
67492,researchers,0,0
67493,.,0,1
67494,OBJECTIVE,0,1
67495,Participant,0,0
67496,satisfaction,0,1
67497,is,0,0
67498,seldom,0,0
67499,assessed,0,0
67500,in,0,0
67501,pharmacological,0,0
67502,research,0,0
67503,.,0,0
67504,In,0,0
67505,this,0,0
67506,paper,0,0
67507,",",0,0
67508,we,0,0
67509,report,0,0
67510,on,0,0
67511,parent,0,1
67512,satisfaction,0,1
67513,in,0,0
67514,a,0,0
67515,randomized,0,0
67516,clinical,0,0
67517,trial,0,0
67518,in,0,0
67519,children,0,0
67520,with,0,0
67521,autistic,0,1
67522,disorder,0,0
67523,and,0,1
67524,severely,0,0
67525,disruptive,0,0
67526,behavior,0,1
67527,.,0,0
67528,METHOD,0,0
67529,Parents,0,0
67530,of,0,0
67531,101,0,0
67532,children,0,0
67533,with,0,0
67534,autism,0,0
67535,who,0,0
67536,had,0,0
67537,participated,0,0
67538,in,0,0
67539,a,0,0
67540,multi-site,0,0
67541,8-week,0,0
67542,double-blind,0,0
67543,clinical,0,1
67544,trial,0,0
67545,of,0,1
67546,risperidone,0,0
67547,were,0,0
67548,given,0,0
67549,a,0,0
67550,questionnaire,0,0
67551,at,0,0
67552,the,0,0
67553,end,0,0
67554,to,0,0
67555,elicit,0,0
67556,their,0,0
67557,perceptions,0,0
67558,of,0,0
67559,the,0,0
67560,appropriateness,0,1
67561,and,0,1
67562,acceptability,0,1
67563,of,0,1
67564,clinical,0,1
67565,trial,0,0
67566,procedures,0,0
67567,.,0,0
67568,RESULTS,0,0
67569,Ninety-six,0,0
67570,(,0,0
67571,95.0,0,0
67572,%,0,0
67573,),0,0
67574,parents,0,0
67575,returned,0,0
67576,the,0,0
67577,questionnaire,0,1
67578,.,0,0
67579,Of,0,0
67580,these,0,0
67581,",",0,0
67582,80.0,0,0
67583,to,0,0
67584,96.8,0,0
67585,%,0,0
67586,",",0,0
67587,depending,0,0
67588,on,0,0
67589,the,0,0
67590,question,0,0
67591,",",0,0
67592,expressed,0,1
67593,satisfaction,0,1
67594,with,0,0
67595,their,0,0
67596,child,0,1
67597,'s,0,1
67598,research,0,0
67599,participation,0,1
67600,regardless,0,0
67601,of,0,1
67602,treatment,0,0
67603,outcome,0,1
67604,or,0,0
67605,assignment,0,0
67606,to,0,0
67607,active,0,0
67608,drug,0,0
67609,or,0,0
67610,placebo,0,0
67611,.,0,0
67612,In,0,0
67613,all,0,0
67614,",",0,0
67615,90.5,0,0
67616,%,0,0
67617,of,0,0
67618,parents,0,0
67619,indicated,0,0
67620,that,0,0
67621,they,0,0
67622,would,0,0
67623,definitely,0,0
67624,recommend,0,0
67625,the,0,0
67626,clinical,0,0
67627,trial,0,0
67628,to,0,0
67629,other,0,0
67630,families,0,0
67631,with,0,0
67632,similar,0,0
67633,children,0,0
67634,.,0,0
67635,A,0,0
67636,total,0,0
67637,of,0,0
67638,92.7,0,0
67639,%,0,0
67640,indicated,0,0
67641,that,0,0
67642,they,0,0
67643,would,0,0
67644,rejoin,0,0
67645,the,0,0
67646,clinical,0,0
67647,trial,0,0
67648,if,0,0
67649,they,0,0
67650,had,0,0
67651,to,0,0
67652,do,0,0
67653,it,0,0
67654,all,0,0
67655,over,0,0
67656,again,0,0
67657,.,0,0
67658,Ethnic,0,0
67659,minority,0,0
67660,subjects,0,0
67661,were,0,0
67662,more,0,0
67663,satisfied,0,1
67664,than,0,0
67665,white,0,0
67666,participants,0,0
67667,with,0,0
67668,the,0,0
67669,use,0,0
67670,of,0,0
67671,learning,0,1
67672,tests,0,1
67673,.,0,0
67674,CONCLUSIONS,0,0
67675,Parents,0,1
67676,of,0,0
67677,children,0,0
67678,participating,0,0
67679,in,0,0
67680,this,0,0
67681,trial,0,0
67682,were,0,0
67683,highly,1,0
67684,satisfied,1,1
67685,and,1,1
67686,supportive,1,0
67687,of,1,0
67688,the,1,0
67689,clinical,1,0
67690,trial,1,0
67691,procedures,1,0
67692,.,1,1
67693,Random,0,0
67694,assignment,0,0
67695,to,0,0
67696,drug,0,0
67697,or,0,1
67698,placebo,0,0
67699,and,0,1
67700,the,0,0
67701,clinical,0,1
67702,response,0,1
67703,of,0,0
67704,their,0,0
67705,children,0,0
67706,did,0,0
67707,not,0,0
67708,appear,0,0
67709,to,0,0
67710,influence,0,0
67711,their,0,0
67712,views,0,0
67713,.,0,0
67714,Further,0,0
67715,satisfaction,0,1
67716,studies,0,0
67717,of,0,0
67718,this,0,0
67719,sort,0,0
67720,are,0,0
67721,encouraged,0,0
67722,.,0,0
67723,Effect,0,1
67724,of,0,1
67725,age,0,0
67726,and,0,1
67727,radiation,0,1
67728,dose,0,1
67729,on,0,0
67730,local,1,0
67731,control,1,0
67732,after,0,0
67733,breast,0,0
67734,conserving,0,0
67735,treatment,0,0
67736,:,0,0
67737,EORTC,0,0
67738,trial,0,0
67739,22881-10882,0,0
67740,.,0,0
67741,PURPOSE,0,0
67742,To,0,0
67743,determine,0,0
67744,whether,0,0
67745,the,0,0
67746,effect,0,0
67747,of,0,0
67748,an,0,0
67749,additional,0,0
67750,boost,0,0
67751,radiation,0,0
67752,after,0,0
67753,breast,0,0
67754,conservative,0,0
67755,therapy,0,0
67756,(,0,1
67757,BCT,0,0
67758,),0,0
67759,on,0,0
67760,local,0,0
67761,control,0,0
67762,depends,0,0
67763,on,0,0
67764,age,0,0
67765,and,0,0
67766,evaluate,0,0
67767,the,0,0
67768,impact,0,0
67769,of,0,0
67770,a,0,0
67771,treatment,0,0
67772,policy,0,0
67773,with,0,0
67774,a,0,0
67775,threshold,0,1
67776,for,0,0
67777,age,0,0
67778,.,0,1
67779,PATIENTS,0,0
67780,AND,0,0
67781,METHODS,0,0
67782,We,0,0
67783,used,0,0
67784,data,0,0
67785,from,0,0
67786,EORTC,0,0
67787,22881-10882,0,0
67788,trial,0,0
67789,",",0,0
67790,with,0,0
67791,median,0,1
67792,follow-up,0,0
67793,of,0,0
67794,77.4,0,0
67795,months,0,0
67796,.,0,0
67797,Patients,0,0
67798,receiving,0,0
67799,BCT,0,0
67800,and,0,0
67801,50Gy,0,0
67802,whole,0,0
67803,breast,0,0
67804,irradiation,0,0
67805,were,0,0
67806,randomized,0,0
67807,to,0,0
67808,no,0,0
67809,boost,0,0
67810,and,0,0
67811,16Gy,0,0
67812,boost,0,0
67813,(,0,0
67814,N=5318,0,0
67815,),0,0
67816,.,0,0
67817,RESULTS,0,0
67818,In,0,0
67819,univariate,0,0
67820,analysis,0,0
67821,",",0,0
67822,a,0,0
67823,boost,0,0
67824,reduced,0,1
67825,local,1,0
67826,failure,1,0
67827,by,0,0
67828,a,0,0
67829,factor,0,0
67830,of,0,0
67831,2,0,0
67832,(,0,0
67833,P,0,0
67834,<,0,0
67835,0.0001,0,0
67836,),0,0
67837,.,0,0
67838,Multivariate,0,1
67839,analysis,0,0
67840,showed,0,0
67841,local,1,1
67842,control,1,0
67843,increased,0,1
67844,with,0,0
67845,age,0,0
67846,(,0,1
67847,P=0.0003,0,0
67848,),0,0
67849,.,0,0
67850,There,0,0
67851,was,0,0
67852,no,0,0
67853,evidence,0,0
67854,that,0,0
67855,the,0,0
67856,relative,0,1
67857,effect,0,0
67858,of,0,0
67859,a,0,0
67860,boost,0,0
67861,on,0,0
67862,local,1,0
67863,control,1,0
67864,depends,0,0
67865,on,0,0
67866,age,0,0
67867,(,0,1
67868,P=0.97,0,0
67869,),0,0
67870,However,0,0
67871,in,0,0
67872,younger,0,0
67873,patients,0,0
67874,the,0,0
67875,5-year,0,0
67876,local,1,0
67877,failure,1,1
67878,was,0,0
67879,higher,0,0
67880,",",0,0
67881,therefore,0,0
67882,the,0,0
67883,absolute,0,1
67884,reduction,0,1
67885,was,0,0
67886,greater,0,0
67887,.,0,0
67888,If,0,0
67889,the,0,0
67890,threshold-age,0,0
67891,for,0,0
67892,boost,0,0
67893,treatment,0,0
67894,were,0,0
67895,set,0,0
67896,at,0,0
67897,40,0,0
67898,years,0,0
67899,",",0,0
67900,8.4,0,0
67901,%,0,0
67902,of,0,0
67903,the,0,0
67904,study,0,0
67905,population,0,0
67906,would,0,0
67907,receive,0,0
67908,a,0,0
67909,boost,0,0
67910,",",0,0
67911,resulting,0,0
67912,in,0,0
67913,a,0,0
67914,5-year,0,0
67915,local,1,0
67916,failure,1,0
67917,of,0,0
67918,6.1,0,0
67919,%,0,0
67920,in,0,0
67921,the,0,0
67922,study,0,0
67923,population,0,0
67924,.,0,0
67925,Changing,0,0
67926,the,0,0
67927,threshold-age,0,0
67928,to,0,0
67929,60,0,0
67930,years,0,0
67931,",",0,0
67932,67,0,0
67933,%,0,0
67934,of,0,0
67935,the,0,0
67936,study,0,0
67937,population,0,0
67938,would,0,0
67939,receive,0,0
67940,a,0,0
67941,boost,0,0
67942,and,0,0
67943,the,0,0
67944,5-year,0,1
67945,local,1,0
67946,failure,1,0
67947,would,0,0
67948,be,0,0
67949,reduced,0,0
67950,to,0,0
67951,4.4,0,0
67952,%,0,0
67953,.,0,0
67954,CONCLUSIONS,0,0
67955,In,0,0
67956,younger,0,0
67957,patients,0,0
67958,a,0,0
67959,boost,0,0
67960,dose,0,0
67961,resulted,0,0
67962,in,0,0
67963,a,0,0
67964,greater,0,0
67965,absolute,0,1
67966,reduction,0,1
67967,of,0,1
67968,local,1,0
67969,failure,1,0
67970,.,1,0
67971,The,0,0
67972,relative,1,1
67973,risk,1,1
67974,reduction,1,1
67975,was,0,0
67976,however,0,0
67977,similar,0,0
67978,for,0,0
67979,all,0,0
67980,ages,0,0
67981,.,0,0
67982,Applying,0,0
67983,a,0,0
67984,treatment,0,0
67985,policy,0,0
67986,with,0,0
67987,a,0,0
67988,threshold-age,0,0
67989,of,0,0
67990,60,0,0
67991,would,0,0
67992,result,0,0
67993,in,0,0
67994,0.6,0,0
67995,%,0,0
67996,increase,0,0
67997,in,0,0
67998,local,1,0
67999,failure,1,0
68000,in,0,0
68001,the,0,0
68002,total,0,1
68003,study,0,0
68004,population,0,1
68005,",",0,0
68006,while,0,0
68007,sparing,0,0
68008,the,0,0
68009,boost,0,0
68010,to,0,0
68011,1/3,0,0
68012,of,0,0
68013,the,0,0
68014,patients,0,0
68015,.,0,0
68016,The,0,0
68017,use,0,0
68018,of,0,0
68019,the,0,0
68020,Antenatal,0,0
68021,Psychosocial,0,1
68022,Health,0,1
68023,Assessment,0,1
68024,(,0,1
68025,ALPHA,0,0
68026,),0,1
68027,tool,0,0
68028,in,0,0
68029,the,0,0
68030,detection,0,1
68031,of,0,0
68032,psychosocial,1,1
68033,risk,1,1
68034,factors,1,1
68035,for,0,0
68036,postpartum,0,0
68037,depression,0,1
68038,:,0,0
68039,a,0,0
68040,randomized,0,0
68041,controlled,0,0
68042,trial,0,0
68043,.,0,0
68044,OBJECTIVE,0,0
68045,Eliciting,0,1
68046,known,0,0
68047,risk,1,1
68048,factors,1,0
68049,for,1,0
68050,postpartum,1,1
68051,depression,1,1
68052,(,0,1
68053,PPD,0,0
68054,),0,1
68055,during,0,0
68056,pregnancy,0,0
68057,may,0,0
68058,enable,0,0
68059,primary,0,0
68060,health,0,1
68061,care,0,0
68062,providers,0,0
68063,to,0,0
68064,identify,0,0
68065,women,0,0
68066,at,0,0
68067,increased,0,1
68068,risk,0,1
68069,of,0,0
68070,becoming,0,0
68071,depressed,0,0
68072,.,0,0
68073,The,0,0
68074,purpose,0,0
68075,of,0,0
68076,this,0,0
68077,study,0,0
68078,was,0,0
68079,to,0,0
68080,examine,0,0
68081,how,0,0
68082,well,0,0
68083,the,0,0
68084,Antenatal,0,0
68085,Psychosocial,0,1
68086,Health,0,1
68087,Assessment,0,1
68088,(,0,1
68089,ALPHA,0,0
68090,),0,1
68091,form,0,0
68092,identified,0,0
68093,antenatal,0,0
68094,risk,0,1
68095,factors,0,1
68096,for,0,0
68097,PPD,0,0
68098,",",0,0
68099,compared,0,0
68100,with,0,0
68101,routine,0,0
68102,care,0,0
68103,",",0,0
68104,in,0,0
68105,a,0,0
68106,sample,0,0
68107,of,0,0
68108,pregnant,0,0
68109,women,0,0
68110,.,0,0
68111,METHODS,0,0
68112,A,0,0
68113,randomized,0,0
68114,controlled,0,0
68115,trial,0,0
68116,was,0,0
68117,conducted,0,0
68118,to,0,0
68119,assess,0,0
68120,the,0,0
68121,effectiveness,1,0
68122,of,1,0
68123,the,1,0
68124,ALPHA,1,0
68125,form,0,0
68126,in,0,0
68127,detecting,0,0
68128,antenatal,0,0
68129,risk,0,1
68130,factors,0,1
68131,associated,0,0
68132,with,0,0
68133,the,0,0
68134,adverse,0,1
68135,postpartum,0,0
68136,outcomes,0,1
68137,of,0,1
68138,postpartum,1,1
68139,depression,1,1
68140,",",1,1
68141,intimate,1,1
68142,partner,1,1
68143,violence,1,1
68144,",",1,1
68145,child,1,1
68146,abuse,1,1
68147,",",1,1
68148,and,1,1
68149,couple,1,0
68150,dysfunction,1,1
68151,.,1,0
68152,The,0,0
68153,participants,0,0
68154,were,0,0
68155,primary,0,0
68156,antenatal,0,0
68157,care,0,0
68158,providers,0,0
68159,--,0,1
68160,family,0,1
68161,physicians,0,1
68162,",",0,1
68163,obstetricians,0,1
68164,",",0,1
68165,and,0,0
68166,midwives,0,0
68167,--,0,0
68168,from,0,0
68169,four,0,0
68170,diverse,0,0
68171,communities,0,0
68172,in,0,0
68173,Ontario,0,0
68174,.,0,0
68175,These,0,0
68176,providers,0,0
68177,were,0,0
68178,matched,0,0
68179,and,0,0
68180,then,0,0
68181,randomly,0,0
68182,allocated,0,0
68183,into,0,0
68184,the,0,0
68185,intervention,0,0
68186,group,0,0
68187,",",0,0
68188,who,0,0
68189,used,0,0
68190,the,0,0
68191,ALPHA,0,0
68192,form,0,0
68193,",",0,1
68194,or,0,0
68195,into,0,0
68196,the,0,0
68197,control,0,0
68198,group,0,0
68199,",",0,0
68200,who,0,0
68201,administered,0,0
68202,usual,0,0
68203,care,0,0
68204,.,0,0
68205,In,0,0
68206,total,0,1
68207,",",0,0
68208,227,0,0
68209,pregnant,0,0
68210,women,0,0
68211,were,0,0
68212,recruited,0,0
68213,:,0,0
68214,98,0,0
68215,in,0,0
68216,the,0,0
68217,ALPHA,0,0
68218,group,0,0
68219,and,0,0
68220,129,0,0
68221,in,0,0
68222,the,0,0
68223,control,0,0
68224,group,0,0
68225,.,0,0
68226,The,0,0
68227,data,0,0
68228,presented,0,0
68229,in,0,0
68230,this,0,0
68231,paper,0,0
68232,are,0,0
68233,from,0,0
68234,a,0,0
68235,secondary,0,0
68236,analysis,0,0
68237,focusing,0,0
68238,on,0,0
68239,PPD,0,0
68240,as,0,0
68241,the,0,0
68242,outcome,0,1
68243,.,0,0
68244,RESULTS,0,0
68245,Providers,0,0
68246,randomized,0,0
68247,to,0,0
68248,the,0,0
68249,ALPHA,0,0
68250,group,0,0
68251,identified,0,0
68252,a,0,0
68253,statistically,0,0
68254,significantly,0,0
68255,higher,0,0
68256,proportion,0,1
68257,of,0,1
68258,women,0,0
68259,with,0,0
68260,antenatal,1,0
68261,psychosocial,1,1
68262,risk,1,1
68263,factors,1,1
68264,for,1,0
68265,PPD,1,0
68266,(,0,0
68267,36,0,0
68268,%,0,0
68269,vs.,0,0
68270,26,0,0
68271,%,0,0
68272,),0,0
68273,and,0,0
68274,a,0,0
68275,significantly,0,0
68276,higher,0,0
68277,number,0,1
68278,of,0,1
68279,risk,1,1
68280,factors,1,1
68281,per,0,0
68282,woman,0,0
68283,compared,0,0
68284,with,0,0
68285,the,0,0
68286,control,0,0
68287,group,0,0
68288,(,0,0
68289,mean,0,1
68290,2.1,0,0
68291,vs.1.8,0,0
68292,),0,0
68293,(,0,0
68294,z,0,1
68295,=,0,0
68296,-1.96,0,0
68297,",",0,1
68298,P,0,0
68299,=,0,0
68300,0.05,0,0
68301,),0,0
68302,.,0,0
68303,Providers,0,0
68304,in,0,0
68305,the,0,0
68306,ALPHA,0,0
68307,group,0,0
68308,also,0,0
68309,identified,0,0
68310,significantly,0,0
68311,more,0,0
68312,women,0,0
68313,having,0,0
68314,a,0,0
68315,previous,1,0
68316,history,1,1
68317,of,1,1
68318,depression,1,1
68319,(,0,0
68320,16,0,0
68321,%,0,0
68322,vs.,0,0
68323,6,0,0
68324,%,0,0
68325,),0,0
68326,(,0,0
68327,chi2,0,0
68328,=,0,0
68329,5.243,0,0
68330,",",0,0
68331,df,0,0
68332,=,0,0
68333,1,0,0
68334,",",0,0
68335,P,0,0
68336,=,0,0
68337,0.03,0,0
68338,),0,0
68339,and,0,0
68340,[,1,0
68341,having,1,0
68342,],1,0
68343,witnessed,1,1
68344,or,1,0
68345,experienced,1,1
68346,abuse,1,1
68347,as,1,0
68348,a,1,0
68349,child,1,0
68350,(,0,0
68351,17,0,0
68352,%,0,0
68353,vs.,0,0
68354,3,0,0
68355,%,0,0
68356,),0,0
68357,(,0,0
68358,chi2,0,0
68359,=,0,0
68360,12.488,0,0
68361,",",0,0
68362,df,0,0
68363,=,0,0
68364,1,0,0
68365,",",0,0
68366,P,0,0
68367,=,0,0
68368,0.0005,0,0
68369,),0,0
68370,",",0,0
68371,which,0,0
68372,are,0,0
68373,both,0,0
68374,established,0,0
68375,risk,0,1
68376,factors,0,0
68377,for,0,0
68378,PPD,1,0
68379,.,1,0
68380,CONCLUSION,0,0
68381,The,0,0
68382,ALPHA,0,0
68383,provides,0,0
68384,a,0,0
68385,systematic,0,0
68386,means,0,0
68387,of,0,0
68388,eliciting,0,0
68389,antenatal,0,0
68390,psychosocial,0,1
68391,risk,0,1
68392,factors,0,1
68393,for,0,0
68394,PPD,0,0
68395,for,0,0
68396,primary,0,0
68397,care,0,0
68398,providers,0,0
68399,",",0,0
68400,and,0,0
68401,it,0,0
68402,may,0,0
68403,be,0,0
68404,particularly,0,0
68405,useful,0,0
68406,for,0,0
68407,raising,0,0
68408,and,0,0
68409,discussing,0,0
68410,sensitive,0,0
68411,issues,0,0
68412,.,0,0
68413,The,0,0
68414,detection,0,1
68415,of,0,0
68416,depressive,1,1
68417,symptomatology,1,1
68418,during,0,0
68419,pregnancy,0,0
68420,remains,0,0
68421,problematic,0,0
68422,",",0,0
68423,however,0,0
68424,",",0,0
68425,and,0,0
68426,detection,0,1
68427,may,0,0
68428,be,0,0
68429,improved,0,0
68430,by,0,0
68431,administering,0,0
68432,a,0,0
68433,simple,0,0
68434,standardized,0,0
68435,measure,0,0
68436,of,0,1
68437,depressive,0,1
68438,symptomatology,0,1
68439,during,0,0
68440,routine,0,0
68441,antenatal,0,0
68442,care,0,0
68443,.,0,0
68444,Further,0,1
68445,validation,0,0
68446,of,0,0
68447,the,0,0
68448,alcohol,0,1
68449,dependence,0,1
68450,scale,0,1
68451,as,0,0
68452,an,0,0
68453,index,0,1
68454,of,0,0
68455,severity,0,1
68456,.,0,0
68457,OBJECTIVE,0,0
68458,The,0,0
68459,Alcohol,0,1
68460,Dependence,0,1
68461,Scale,0,1
68462,(,0,1
68463,ADS,0,1
68464,),0,0
68465,yields,0,1
68466,continuous,0,0
68467,scores,0,1
68468,purported,0,0
68469,to,0,0
68470,reflect,0,0
68471,the,0,0
68472,severity,0,1
68473,of,0,0
68474,the,0,0
68475,dependence,0,1
68476,syndrome,0,0
68477,.,0,0
68478,We,0,0
68479,evaluated,0,0
68480,the,0,0
68481,concurrent,1,0
68482,validity,1,0
68483,of,1,0
68484,the,1,0
68485,ADS,1,1
68486,as,1,0
68487,a,1,0
68488,general,1,0
68489,measure,1,0
68490,of,1,1
68491,severity,1,1
68492,and,1,0
68493,the,1,0
68494,screening,1,0
68495,accuracy,1,1
68496,of,0,0
68497,the,0,0
68498,total,0,1
68499,score,0,1
68500,and,0,1
68501,subscales,0,1
68502,to,0,0
68503,detect,0,0
68504,Diagnostic,0,1
68505,and,0,1
68506,Statistical,0,1
68507,Manual,0,1
68508,of,0,1
68509,Mental,0,1
68510,Disorders,0,1
68511,",",0,1
68512,Fourth,0,1
68513,Edition,0,1
68514,(,0,1
68515,DSM-IV,0,1
68516,),0,1
68517,",",0,0
68518,physiological,0,0
68519,dependence,0,1
68520,.,0,0
68521,METHOD,0,0
68522,Treatment-seeking,0,1
68523,",",0,0
68524,alcohol-dependent,0,0
68525,individuals,0,0
68526,entering,0,0
68527,the,0,0
68528,Combining,0,0
68529,Pharmacotherapies,0,0
68530,and,0,1
68531,Behavioral,0,1
68532,Interventions,0,0
68533,for,0,0
68534,Alcohol,0,1
68535,Dependence,0,1
68536,(,0,1
68537,COMBINE,0,1
68538,),0,1
68539,Study,0,0
68540,(,0,0
68541,N,0,0
68542,=,0,0
68543,"1,372",0,0
68544,;,0,0
68545,69,0,0
68546,%,0,0
68547,men,0,0
68548,),0,0
68549,completed,0,0
68550,the,0,0
68551,ADS,0,1
68552,",",0,0
68553,diagnostic,0,1
68554,interviews,0,0
68555,",",0,1
68556,and,0,1
68557,other,0,1
68558,measures,0,1
68559,before,0,0
68560,randomization,0,0
68561,.,0,0
68562,Analyses,1,0
68563,of,1,0
68564,variance,1,1
68565,tested,1,0
68566,differences,1,0
68567,between,1,0
68568,ADS,1,1
68569,quartiles,1,1
68570,on,1,0
68571,alcohol-,1,0
68572,related,1,0
68573,measures,1,0
68574,.,1,0
68575,Areas,0,1
68576,under,0,0
68577,the,0,0
68578,receiver,0,0
68579,operating,0,1
68580,characteristic,0,1
68581,(,0,0
68582,AUROC,0,0
68583,),0,1
68584,curve,0,1
68585,assessed,0,0
68586,screening,0,0
68587,accuracy,0,1
68588,for,0,0
68589,DSM-IV,0,1
68590,physiological,0,1
68591,dependence,0,1
68592,(,0,1
68593,tolerance,0,1
68594,or,0,1
68595,withdrawal,0,1
68596,),0,0
68597,or,0,0
68598,withdrawal,0,1
68599,alone,0,0
68600,.,0,0
68601,RESULTS,0,0
68602,ADS,0,1
68603,quartiles,0,1
68604,differed,0,0
68605,on,0,0
68606,age,0,0
68607,",",0,0
68608,other,0,1
68609,demographics,0,1
68610,",",0,1
68611,and,0,1
68612,prior,0,0
68613,treatment,0,0
68614,episodes,0,1
68615,.,0,1
68616,Linear,0,0
68617,correlation,0,0
68618,showed,0,0
68619,moderate,0,0
68620,to,0,0
68621,large,0,0
68622,magnitude,0,1
68623,associations,0,0
68624,with,0,0
68625,alcohol-related,0,1
68626,self-report,0,1
68627,measures,0,1
68628,and,0,1
68629,most,0,0
68630,indices,0,1
68631,of,0,0
68632,consumption,0,1
68633,.,0,0
68634,ADS,0,1
68635,quartiles,0,1
68636,differed,0,0
68637,significantly,0,0
68638,on,0,0
68639,proportion,1,0
68640,with,1,0
68641,DSM-IV,1,1
68642,physiological,1,1
68643,dependence,1,1
68644,",",0,1
68645,but,0,0
68646,AUROC,0,1
68647,curves,0,1
68648,indicated,0,0
68649,that,0,0
68650,the,0,0
68651,ADS,0,1
68652,had,0,0
68653,limited,0,0
68654,accuracy,1,1
68655,as,0,0
68656,a,0,0
68657,continuous,0,0
68658,measure,0,0
68659,to,0,0
68660,detect,0,0
68661,DSMIV,1,0
68662,physiological,1,1
68663,dependence,1,1
68664,(,0,0
68665,AUROC,0,0
68666,=,0,0
68667,.75,0,0
68668,[,0,0
68669,95,0,0
68670,%,0,0
68671,confidence,0,0
68672,interval,0,0
68673,{,0,0
68674,CI,0,0
68675,},0,0
68676,:,0,0
68677,.70-.79,0,1
68678,],0,0
68679,and,0,0
68680,.67,0,0
68681,[,0,0
68682,95,0,0
68683,%,0,0
68684,CI,0,0
68685,:,0,0
68686,.60-.74,0,1
68687,],0,0
68688,for,0,0
68689,men,0,0
68690,and,0,1
68691,women,0,0
68692,",",0,0
68693,respectively,0,0
68694,;,0,0
68695,p,0,0
68696,=,0,0
68697,.08,0,0
68698,),0,0
68699,or,0,0
68700,withdrawal,0,1
68701,alone,0,0
68702,(,0,0
68703,AUROC,0,0
68704,=,0,0
68705,.77,0,0
68706,[,0,0
68707,95,0,0
68708,%,0,0
68709,CI,0,0
68710,:,0,0
68711,.74-.80,0,1
68712,],0,0
68713,and,0,0
68714,.74,0,0
68715,[,0,0
68716,95,0,0
68717,%,0,0
68718,CI,0,0
68719,:,0,0
68720,.69-.79,0,1
68721,],0,0
68722,for,0,0
68723,men,0,0
68724,and,0,1
68725,women,0,0
68726,",",0,0
68727,respectively,0,0
68728,;,0,0
68729,p,0,0
68730,=,0,0
68731,.30,0,0
68732,),0,0
68733,.,0,0
68734,Screening,1,0
68735,accuracy,1,1
68736,was,0,0
68737,comparably,0,0
68738,limited,0,0
68739,based,0,0
68740,on,0,0
68741,ADS,0,1
68742,subscales,0,1
68743,reflecting,0,1
68744,psychoperceptual,0,1
68745,or,0,0
68746,psychophysical,0,1
68747,withdrawal,0,1
68748,.,0,0
68749,CONCLUSIONS,0,0
68750,The,0,0
68751,ADS,0,1
68752,reflected,0,1
68753,variation,0,1
68754,in,0,0
68755,symptom,0,1
68756,severity,0,1
68757,but,0,0
68758,did,0,0
68759,not,0,0
68760,adequately,0,0
68761,identify,0,0
68762,physiological,0,1
68763,dependence,0,1
68764,or,0,1
68765,withdrawal,0,1
68766,in,0,0
68767,treatment-seeking,0,0
68768,individuals,0,0
68769,with,0,0
68770,DSM-IV,0,1
68771,alcohol,0,1
68772,dependence,0,1
68773,.,0,0
68774,[,0,0
68775,A,0,0
68776,randomized,0,0
68777,trial,0,0
68778,of,0,1
68779,PVB,0,1
68780,",",0,1
68781,VAB-6,0,1
68782,",",0,0
68783,BVP,0,0
68784,regimen,0,0
68785,versus,0,0
68786,PEB,0,1
68787,chemotherapy,0,0
68788,in,0,0
68789,patients,0,0
68790,with,0,0
68791,disseminated,0,0
68792,testicular,0,0
68793,tumors,0,0
68794,],0,0
68795,.,0,0
68796,During,0,0
68797,2,0,0
68798,years,0,0
68799,and,0,0
68800,7,0,0
68801,months,0,0
68802,from,0,0
68803,June,0,0
68804,",",0,0
68805,1985,0,0
68806,to,0,0
68807,December,0,0
68808,",",0,0
68809,1987,0,0
68810,",",0,0
68811,a,0,0
68812,randomized,0,0
68813,multi-center,0,0
68814,trial,0,0
68815,of,0,1
68816,PVB,0,1
68817,",",0,1
68818,VAB-6,0,1
68819,",",0,1
68820,BVP,0,1
68821,regimen,0,0
68822,(,0,0
68823,group,0,0
68824,A,0,0
68825,),0,0
68826,without,0,0
68827,etoposide,0,0
68828,versus,0,0
68829,PEB,0,1
68830,chemotherapy,0,0
68831,(,0,1
68832,bleomycin,0,0
68833,",",0,1
68834,etoposide,0,0
68835,and,0,1
68836,cisplatinum,0,0
68837,),0,1
68838,(,0,0
68839,group,0,0
68840,B,0,1
68841,),0,1
68842,was,0,0
68843,given,0,0
68844,to,0,0
68845,patients,0,0
68846,with,0,0
68847,disseminated,0,0
68848,testicular,0,1
68849,tumors,0,0
68850,.,0,0
68851,Of,0,0
68852,34,0,0
68853,patients,0,0
68854,registered,0,0
68855,",",0,0
68856,10,0,0
68857,patients,0,0
68858,were,0,0
68859,with,0,0
68860,minimal,0,1
68861,disease,0,1
68862,in,0,0
68863,stages,0,1
68864,IIA,0,0
68865,",",0,1
68866,IIIO,0,1
68867,and,0,1
68868,IIIA,0,1
68869,and,0,0
68870,24,0,0
68871,with,0,0
68872,extensive,0,0
68873,disease,0,1
68874,in,0,0
68875,IIB,0,0
68876,",",0,1
68877,IIIB2,0,1
68878,and,0,1
68879,IIIC,0,1
68880,.,0,1
68881,Seminomas,0,1
68882,were,0,0
68883,found,0,0
68884,in,0,0
68885,10,0,0
68886,patients,0,0
68887,",",0,0
68888,while,0,0
68889,non-seminomatous,0,0
68890,tumors,0,0
68891,in,0,0
68892,24,0,0
68893,.,0,0
68894,Among,0,0
68895,groups,0,0
68896,A,0,0
68897,and,0,1
68898,B,0,1
68899,",",0,0
68900,there,0,0
68901,was,0,0
68902,no,0,0
68903,statistical,0,0
68904,difference,0,0
68905,in,0,0
68906,clinicopathological,0,0
68907,profiles,0,0
68908,.,0,0
68909,A,0,0
68910,group,0,0
68911,patients,0,0
68912,were,0,0
68913,given,0,0
68914,either,0,0
68915,PVB,0,0
68916,",",0,1
68917,VAB-6,0,1
68918,or,0,1
68919,BVP,0,0
68920,according,0,0
68921,to,0,0
68922,the,0,0
68923,physician,0,1
68924,'s,0,0
68925,discretion,0,0
68926,.,0,0
68927,In,0,0
68928,groups,0,0
68929,A,0,0
68930,and,0,1
68931,B,0,0
68932,",",0,0
68933,35,0,0
68934,%,0,0
68935,and,0,0
68936,43,0,0
68937,%,0,0
68938,of,0,0
68939,the,0,0
68940,patients,0,0
68941,achieved,0,1
68942,complete,1,1
68943,response,1,1
68944,",",0,0
68945,and,0,0
68946,45,0,0
68947,%,0,0
68948,and,0,0
68949,50,0,0
68950,%,0,0
68951,achieved,0,0
68952,partial,1,1
68953,response,1,1
68954,",",0,0
68955,respectively,0,0
68956,.,0,0
68957,The,0,0
68958,difference,0,0
68959,in,0,0
68960,CR,1,1
68961,rates,1,1
68962,among,0,0
68963,both,0,0
68964,groups,0,0
68965,was,0,0
68966,not,0,0
68967,statistically,0,0
68968,significant,0,0
68969,even,0,0
68970,when,0,0
68971,calculated,0,0
68972,according,0,0
68973,to,0,0
68974,the,0,0
68975,stage,0,0
68976,or,0,0
68977,histologic,0,1
68978,grouping,0,1
68979,.,0,1
68980,Salvage,0,0
68981,treatments,0,0
68982,mainly,0,0
68983,with,0,0
68984,surgical,0,0
68985,resection,0,0
68986,of,0,1
68987,residual,0,1
68988,tumors,0,0
68989,after,0,0
68990,the,0,0
68991,chemotherapy,0,0
68992,",",0,0
68993,however,0,0
68994,",",0,0
68995,were,0,0
68996,more,0,0
68997,successful,0,1
68998,in,0,0
68999,group,0,0
69000,B,0,0
69001,(,0,0
69002,88,0,0
69003,%,0,0
69004,),0,0
69005,than,0,0
69006,group,0,0
69007,A,0,0
69008,(,0,0
69009,61,0,0
69010,%,0,0
69011,),0,0
69012,.,0,0
69013,It,0,0
69014,appears,0,0
69015,likely,0,0
69016,that,0,0
69017,the,0,0
69018,higher,0,0
69019,response,0,1
69020,of,0,1
69021,induction,0,1
69022,chemotherapy,0,0
69023,in,0,0
69024,patients,0,0
69025,with,0,0
69026,extensive,0,0
69027,disease,0,1
69028,made,0,0
69029,the,0,0
69030,salvage,0,1
69031,surgery,0,0
69032,more,0,0
69033,successful,0,1
69034,in,0,0
69035,group,0,0
69036,B,0,0
69037,than,0,0
69038,in,0,0
69039,group,0,0
69040,A,0,0
69041,.,0,0
69042,The,0,0
69043,3,1,0
69044,year,1,0
69045,survival,1,1
69046,rate,1,1
69047,was,0,0
69048,100,0,0
69049,%,0,0
69050,in,0,0
69051,group,0,0
69052,B,0,0
69053,",",0,0
69054,whereas,0,0
69055,it,0,0
69056,was,0,0
69057,76,0,0
69058,%,0,0
69059,in,0,0
69060,group,0,0
69061,A,0,0
69062,.,0,0
69063,Although,0,0
69064,the,0,0
69065,incidence,1,1
69066,of,1,1
69067,myelosuppression,1,1
69068,and,1,1
69069,alopecia,1,1
69070,was,0,0
69071,significantly,0,0
69072,higher,0,0
69073,in,0,0
69074,group,0,0
69075,B,0,1
69076,",",0,1
69077,neuropathy,1,1
69078,was,0,0
69079,significantly,0,0
69080,more,0,0
69081,frequent,0,1
69082,in,0,0
69083,group,0,0
69084,A,0,0
69085,.,0,0
69086,From,0,0
69087,the,0,0
69088,above,0,0
69089,results,0,0
69090,",",0,0
69091,PEB,0,0
69092,seems,0,0
69093,to,0,0
69094,be,0,0
69095,a,0,0
69096,better,0,0
69097,induction,0,1
69098,chemotherapy,0,0
69099,than,0,0
69100,the,0,0
69101,conventional,0,0
69102,one,0,0
69103,for,0,0
69104,advanced,0,0
69105,testicular,0,1
69106,tumors,0,0
69107,.,0,0
69108,Do,0,1
69109,readers,0,0
69110,with,0,0
69111,autism,0,0
69112,make,0,0
69113,bridging,0,0
69114,inferences,0,0
69115,from,0,0
69116,world,0,0
69117,knowledge,0,1
69118,?,0,0
69119,Individuals,0,0
69120,with,0,0
69121,autism,0,0
69122,frequently,0,0
69123,show,0,0
69124,impairments,0,1
69125,in,0,0
69126,text,0,0
69127,reading,0,0
69128,comprehension,0,1
69129,.,0,0
69130,This,0,0
69131,often,0,0
69132,is,0,0
69133,attributed,0,0
69134,to,0,0
69135,poor,0,0
69136,ability,0,1
69137,to,0,0
69138,draw,0,0
69139,inferences,0,0
69140,during,0,0
69141,reading,0,0
69142,and,0,0
69143,to,0,0
69144,inadequate,0,0
69145,access,0,0
69146,to,0,0
69147,relevant,0,0
69148,knowledge,0,0
69149,.,0,0
69150,The,0,0
69151,current,0,0
69152,study,0,0
69153,tested,0,0
69154,this,0,0
69155,hypothesis,0,0
69156,by,0,0
69157,measuring,0,0
69158,the,0,0
69159,time,0,1
69160,taken,0,0
69161,to,0,0
69162,read,0,0
69163,the,0,0
69164,same,0,0
69165,question,0,0
69166,",",0,0
69167,relating,0,0
69168,to,0,0
69169,either,0,0
69170,physical,0,1
69171,or,0,0
69172,social,0,1
69173,world,0,1
69174,knowledge,0,1
69175,",",0,0
69176,when,0,0
69177,it,0,0
69178,was,0,0
69179,either,0,0
69180,relevant,0,1
69181,or,0,0
69182,irrelevant,0,1
69183,to,0,0
69184,the,0,0
69185,bridging,0,0
69186,inference,0,0
69187,evoked,0,0
69188,by,0,0
69189,a,0,0
69190,preceding,0,0
69191,two-sentence,0,0
69192,vignette,0,0
69193,.,0,0
69194,In,0,0
69195,the,0,0
69196,study,0,0
69197,",",0,0
69198,16,0,0
69199,normally,0,0
69200,developing,0,0
69201,adolescents,0,0
69202,and,0,0
69203,16,0,0
69204,adolescents,0,0
69205,with,0,0
69206,autism,0,0
69207,were,0,0
69208,matched,0,0
69209,on,0,0
69210,word,0,1
69211,reading,0,1
69212,accuracy,0,1
69213,",",0,1
69214,chronological,0,1
69215,age,0,1
69216,",",0,1
69217,and,0,1
69218,vocabulary,0,1
69219,but,0,0
69220,differed,0,0
69221,significantly,0,0
69222,in,0,0
69223,text,0,0
69224,comprehension,0,1
69225,.,0,0
69226,A,0,0
69227,strong,0,0
69228,priming,0,0
69229,effect,0,1
69230,was,0,0
69231,found,0,0
69232,",",0,0
69233,robust,0,0
69234,over,0,0
69235,participants,0,0
69236,and,0,1
69237,over,0,0
69238,items,0,1
69239,;,0,0
69240,participants,0,0
69241,read,0,0
69242,those,0,0
69243,questions,0,1
69244,that,0,0
69245,were,0,0
69246,relevant,0,0
69247,to,0,0
69248,the,0,0
69249,inference,0,0
69250,evoked,0,0
69251,by,0,0
69252,the,0,0
69253,vignette,0,0
69254,faster,0,0
69255,than,0,0
69256,they,0,0
69257,read,0,0
69258,those,0,0
69259,questions,0,1
69260,that,0,0
69261,were,0,0
69262,irrelevant,0,1
69263,",",0,0
69264,and,0,0
69265,no,0,0
69266,interaction,0,1
69267,with,0,0
69268,group,0,0
69269,membership,0,1
69270,or,0,1
69271,type,0,0
69272,of,0,1
69273,knowledge,0,1
69274,was,0,0
69275,found,0,0
69276,.,0,0
69277,This,0,0
69278,indicates,0,0
69279,that,0,0
69280,readers,0,0
69281,with,0,0
69282,autism,0,0
69283,",",0,0
69284,just,0,0
69285,like,0,0
69286,controls,0,0
69287,",",0,0
69288,were,0,0
69289,activating,0,1
69290,appropriate,0,0
69291,world,0,1
69292,knowledge,0,1
69293,primed,0,0
69294,by,0,0
69295,implicit,0,0
69296,inferences,0,0
69297,while,0,0
69298,reading,0,0
69299,the,0,0
69300,vignettes,0,0
69301,.,0,0
69302,Thus,0,0
69303,",",0,0
69304,the,0,0
69305,comprehension,0,1
69306,problems,0,1
69307,in,0,0
69308,these,0,0
69309,readers,0,0
69310,can,0,0
69311,not,0,0
69312,be,0,0
69313,attributed,0,0
69314,to,0,0
69315,an,0,0
69316,inability,0,0
69317,to,0,0
69318,make,0,0
69319,implicit,0,1
69320,inferences,0,0
69321,or,0,0
69322,to,0,0
69323,draw,0,0
69324,on,0,0
69325,relevant,0,0
69326,world,0,0
69327,knowledge,0,1
69328,.,0,0
69329,Instead,0,0
69330,",",0,0
69331,we,0,0
69332,suggest,0,0
69333,that,0,0
69334,these,0,0
69335,problems,0,0
69336,must,0,0
69337,be,0,0
69338,sought,0,0
69339,at,0,0
69340,a,0,0
69341,higher,0,0
69342,level,0,1
69343,of,0,1
69344,text,0,0
69345,processing,0,0
69346,.,0,0
69347,5,0,0
69348,alpha-metabolism,0,0
69349,in,0,0
69350,finasteride-treated,0,0
69351,subjects,0,0
69352,and,0,1
69353,male,0,0
69354,pseudohermaphrodites,0,0
69355,with,0,0
69356,inherited,0,0
69357,5,0,0
69358,alpha-reductase,0,0
69359,deficiency,0,0
69360,.,0,0
69361,A,0,0
69362,review,0,0
69363,.,0,0
69364,Male,0,0
69365,pseudohermaphrodites,0,0
69366,(,0,0
69367,MPHs,0,0
69368,),0,0
69369,with,0,0
69370,inherited,0,0
69371,5,0,0
69372,alpha-reductase,0,1
69373,deficiency,0,0
69374,and,0,1
69375,decreased,0,1
69376,dihydrotestosterone,0,1
69377,production,0,1
69378,have,0,0
69379,a,0,0
69380,global,0,1
69381,defect,0,1
69382,in,0,0
69383,5,0,0
69384,alpha-metabolism,0,1
69385,affecting,0,0
69386,both,0,0
69387,C19,0,0
69388,androgen,0,1
69389,metabolism,0,1
69390,and,0,0
69391,C21,0,0
69392,steroid,0,0
69393,metabolism,0,1
69394,.,0,0
69395,However,0,0
69396,",",0,0
69397,the,0,0
69398,decreased,0,0
69399,5,0,0
69400,alpha-reduction,0,0
69401,of,0,0
69402,testosterone,0,1
69403,to,0,0
69404,dihydrotestosterone,0,0
69405,is,0,0
69406,the,0,0
69407,only,0,0
69408,impaired,0,0
69409,steroid,0,0
69410,conversion,0,1
69411,to,0,0
69412,have,0,0
69413,clinical,0,0
69414,consequences,0,1
69415,",",0,1
69416,e.g.,0,1
69417,",",0,1
69418,ambiguous,1,1
69419,genitalia,1,1
69420,",",1,1
69421,impaired,1,1
69422,prostate,1,0
69423,differentiation,1,1
69424,and,1,1
69425,development,1,1
69426,",",0,1
69427,and,0,1
69428,decreased,1,1
69429,facial,1,1
69430,and,1,1
69431,body,1,1
69432,hair,1,1
69433,.,1,0
69434,The,0,0
69435,5,1,0
69436,alpha-steroid,1,0
69437,metabolite,1,0
69438,profile,1,1
69439,in,0,0
69440,the,0,0
69441,MPHs,0,0
69442,was,0,0
69443,compared,0,0
69444,with,0,0
69445,that,0,0
69446,of,0,0
69447,men,0,0
69448,with,0,0
69449,benign,0,0
69450,prostatic,0,0
69451,hyperplasia,0,0
69452,who,0,0
69453,were,0,0
69454,administered,0,0
69455,varying,0,0
69456,doses,0,0
69457,of,0,0
69458,the,0,0
69459,5,0,0
69460,alpha-reductase,0,1
69461,inhibitor,0,0
69462,finasteride,0,0
69463,.,0,1
69464,Finasteride,0,0
69465,was,0,0
69466,found,0,0
69467,to,0,0
69468,be,0,0
69469,a,0,0
69470,potent,0,0
69471,inhibitor,0,0
69472,of,0,0
69473,both,0,0
69474,C19,1,1
69475,androgen,1,1
69476,and,1,1
69477,C21,1,0
69478,5,1,0
69479,alpha-steroid,1,1
69480,metabolism,1,0
69481,affecting,0,0
69482,both,0,0
69483,hepatic,1,1
69484,and,1,0
69485,peripheral,1,1
69486,5,1,0
69487,alpha-metabolism,1,0
69488,.,1,0
69489,The,0,0
69490,5,0,0
69491,alpha-steroid,1,0
69492,metabolite,1,1
69493,profile,1,1
69494,was,0,0
69495,strikingly,0,0
69496,similar,0,0
69497,to,0,0
69498,that,0,0
69499,of,0,0
69500,MPHs,0,0
69501,with,0,0
69502,inherited,0,0
69503,5,0,0
69504,alpha-reductase,0,0
69505,deficiency,0,0
69506,.,0,0
69507,The,0,0
69508,data,0,0
69509,suggest,0,0
69510,that,0,0
69511,a,0,0
69512,5,0,0
69513,alpha-reductase,0,1
69514,gene,0,0
69515,codes,0,0
69516,for,0,0
69517,an,0,0
69518,enzyme,0,0
69519,with,0,0
69520,affinity,1,1
69521,for,1,0
69522,multiple,1,0
69523,steroid,1,0
69524,substrates,1,1
69525,.,1,0
69526,Can,0,0
69527,patient,0,0
69528,coaching,0,0
69529,reduce,0,0
69530,racial/ethnic,0,0
69531,disparities,0,0
69532,in,0,0
69533,cancer,0,0
69534,pain,0,1
69535,control,0,0
69536,?,0,0
69537,Secondary,0,0
69538,analysis,0,0
69539,of,0,0
69540,a,0,0
69541,randomized,0,0
69542,controlled,0,0
69543,trial,0,0
69544,.,0,0
69545,PURPOSE,0,0
69546,Minority,0,0
69547,patients,0,0
69548,with,0,0
69549,cancer,0,0
69550,experience,0,1
69551,worse,0,1
69552,control,0,0
69553,of,0,1
69554,their,0,0
69555,pain,0,1
69556,than,0,0
69557,do,0,0
69558,their,0,0
69559,white,0,0
69560,counterparts,0,0
69561,.,0,0
69562,This,0,0
69563,disparity,0,1
69564,may,0,0
69565,",",0,0
69566,in,0,0
69567,part,0,0
69568,",",0,0
69569,reflect,0,0
69570,more,0,0
69571,miscommunication,0,1
69572,between,0,1
69573,minority,0,0
69574,patients,0,0
69575,and,0,0
69576,their,0,0
69577,physicians,0,0
69578,.,0,0
69579,Therefore,0,0
69580,",",0,0
69581,we,0,0
69582,examined,0,0
69583,whether,0,0
69584,patient,0,0
69585,coaching,0,0
69586,could,0,0
69587,reduce,0,0
69588,disparities,1,0
69589,in,1,0
69590,pain,1,1
69591,control,1,0
69592,in,0,0
69593,a,0,0
69594,secondary,0,0
69595,analysis,0,0
69596,of,0,0
69597,a,0,0
69598,randomized,0,0
69599,controlled,0,0
69600,trial,0,0
69601,.,0,0
69602,METHODS,0,0
69603,Sixty-seven,0,0
69604,English-speaking,0,0
69605,adult,0,0
69606,cancer,0,0
69607,outpatients,0,0
69608,",",0,0
69609,including,0,0
69610,15,0,0
69611,minorities,0,0
69612,",",0,0
69613,with,0,0
69614,moderate,0,0
69615,pain,0,1
69616,over,0,0
69617,the,0,0
69618,prior,0,0
69619,2,0,0
69620,weeks,0,0
69621,were,0,0
69622,randomly,0,0
69623,assigned,0,0
69624,to,0,0
69625,the,0,0
69626,experimental,0,0
69627,(,0,0
69628,N,0,0
69629,=,0,0
69630,34,0,0
69631,),0,0
69632,or,0,0
69633,control,0,0
69634,group,0,0
69635,(,0,0
69636,N,0,0
69637,=,0,0
69638,33,0,0
69639,),0,0
69640,.,0,0
69641,Experimental,0,1
69642,patients,0,0
69643,received,0,0
69644,a,0,0
69645,20-minute,0,0
69646,individualized,0,0
69647,education,0,0
69648,and,0,1
69649,coaching,0,0
69650,session,0,0
69651,to,0,0
69652,increase,0,1
69653,knowledge,0,1
69654,of,0,1
69655,pain,0,1
69656,self-management,0,0
69657,",",0,0
69658,to,0,0
69659,redress,0,0
69660,personal,0,1
69661,misconceptions,0,1
69662,about,0,0
69663,pain,0,1
69664,treatment,0,0
69665,",",0,1
69666,and,0,0
69667,to,0,0
69668,rehearse,0,0
69669,an,0,0
69670,individually,0,0
69671,scripted,0,0
69672,patient-physician,0,0
69673,dialog,0,0
69674,about,0,0
69675,pain,1,1
69676,control,1,0
69677,.,1,0
69678,The,0,0
69679,control,0,0
69680,group,0,0
69681,received,0,0
69682,standardized,0,0
69683,information,0,1
69684,on,0,0
69685,controlling,0,0
69686,pain,0,1
69687,.,0,0
69688,Data,0,0
69689,on,0,0
69690,average,1,1
69691,pain,1,1
69692,(,0,1
69693,0-10,0,1
69694,scale,0,1
69695,),0,1
69696,were,0,0
69697,collected,0,0
69698,at,0,0
69699,enrollment,0,0
69700,and,0,1
69701,2-week,0,0
69702,follow-up,0,0
69703,.,0,0
69704,RESULTS,0,0
69705,At,0,0
69706,enrollment,0,0
69707,",",0,1
69708,minority,0,0
69709,patients,0,0
69710,had,0,0
69711,significantly,0,0
69712,more,0,0
69713,pain,1,1
69714,than,0,0
69715,their,0,0
69716,white,0,0
69717,counterparts,0,0
69718,(,0,0
69719,6.0,0,0
69720,vs,0,0
69721,5.0,0,0
69722,",",0,0
69723,P,0,0
69724,=,0,0
69725,0.05,0,0
69726,),0,0
69727,.,0,0
69728,At,0,0
69729,follow-up,0,0
69730,",",0,0
69731,minorities,0,0
69732,in,0,0
69733,the,0,0
69734,control,0,0
69735,group,0,0
69736,continued,0,0
69737,to,0,0
69738,have,0,0
69739,more,0,0
69740,pain,1,1
69741,(,0,0
69742,6.4,0,0
69743,vs,0,0
69744,4.7,0,0
69745,",",0,0
69746,P,0,0
69747,=,0,0
69748,0.01,0,0
69749,),0,0
69750,",",0,0
69751,whereas,0,0
69752,in,0,0
69753,the,0,0
69754,experimental,0,0
69755,group,0,0
69756,",",0,1
69757,disparities,0,1
69758,were,0,0
69759,eliminated,0,0
69760,(,0,0
69761,4.0,0,0
69762,vs,0,0
69763,4.3,0,0
69764,",",0,0
69765,P,0,0
69766,=,0,0
69767,0.71,0,0
69768,),0,0
69769,.,0,0
69770,The,0,0
69771,effect,0,0
69772,of,0,0
69773,the,0,0
69774,intervention,0,0
69775,on,0,0
69776,reducing,0,0
69777,disparities,0,1
69778,was,0,0
69779,significant,0,0
69780,(,0,0
69781,P,0,0
69782,=,0,0
69783,0.04,0,0
69784,),0,0
69785,.,0,0
69786,CONCLUSIONS,0,0
69787,Patient,0,1
69788,coaching,0,0
69789,offers,0,0
69790,promise,0,0
69791,as,0,0
69792,a,0,0
69793,means,0,0
69794,of,0,0
69795,reducing,0,0
69796,racial/ethnic,1,0
69797,disparities,1,0
69798,in,1,0
69799,pain,1,1
69800,control,1,0
69801,.,1,1
69802,Larger,0,0
69803,studies,0,0
69804,are,0,0
69805,needed,0,0
69806,to,0,0
69807,validate,0,0
69808,these,0,0
69809,findings,0,0
69810,and,0,0
69811,to,0,0
69812,explore,0,0
69813,possible,0,0
69814,mechanisms,0,0
69815,.,0,0
69816,How,0,0
69817,does,0,0
69818,Cash,0,1
69819,and,0,1
69820,Counseling,0,0
69821,affect,0,1
69822,costs,0,1
69823,?,0,0
69824,OBJECTIVE,0,0
69825,To,0,0
69826,test,0,0
69827,the,0,0
69828,effect,0,0
69829,of,0,0
69830,a,0,0
69831,consumer-directed,0,0
69832,model,0,0
69833,(,0,1
69834,Cash,0,1
69835,and,0,1
69836,Counseling,0,0
69837,),0,1
69838,of,0,0
69839,Medicaid,0,0
69840,personal,0,1
69841,care,0,0
69842,services,0,1
69843,(,0,0
69844,PCS,0,0
69845,),0,1
69846,or,0,0
69847,home-,0,0
69848,and,0,1
69849,community-based,0,0
69850,waiver,0,0
69851,services,0,1
69852,(,0,1
69853,HCBS,0,1
69854,),0,0
69855,on,0,0
69856,the,0,0
69857,cost,0,1
69858,of,0,0
69859,Medicaid,0,0
69860,services,0,1
69861,.,0,0
69862,DATA,0,1
69863,SOURCES/STUDY,0,0
69864,SETTING,0,0
69865,Medicaid,0,0
69866,claims,0,0
69867,data,0,0
69868,were,0,0
69869,collected,0,0
69870,for,0,0
69871,all,0,0
69872,enrollees,0,0
69873,in,0,0
69874,the,0,0
69875,Cash,0,1
69876,and,0,1
69877,Counseling,0,0
69878,demonstration,0,1
69879,.,0,1
69880,Demonstration,0,0
69881,enrollees,0,0
69882,included,0,0
69883,those,0,0
69884,eligible,0,0
69885,for,0,0
69886,PCS,0,0
69887,(,0,0
69888,in,0,0
69889,Arkansas,0,0
69890,),0,0
69891,",",0,0
69892,those,0,0
69893,assessed,0,0
69894,to,0,0
69895,receive,0,0
69896,such,0,0
69897,services,0,1
69898,(,0,0
69899,in,0,0
69900,New,0,1
69901,Jersey,0,1
69902,),0,1
69903,",",0,0
69904,and,0,1
69905,recipients,0,0
69906,of,0,1
69907,Medicaid,0,0
69908,HCBS,0,1
69909,(,0,0
69910,in,0,0
69911,Florida,0,0
69912,),0,0
69913,.,0,0
69914,Enrollment,0,1
69915,occurred,0,0
69916,from,0,0
69917,December,0,0
69918,1998,0,0
69919,through,0,0
69920,April,0,0
69921,2001,0,0
69922,.,0,0
69923,The,0,0
69924,follow-up,0,0
69925,period,0,0
69926,covered,0,0
69927,up,0,0
69928,to,0,0
69929,24,0,0
69930,months,0,0
69931,after,0,0
69932,enrollment,0,0
69933,.,0,0
69934,STUDY,0,0
69935,DESIGN,0,0
69936,Demonstration,0,0
69937,volunteers,0,0
69938,were,0,0
69939,randomly,0,0
69940,assigned,0,0
69941,to,0,0
69942,have,0,0
69943,the,0,0
69944,option,0,0
69945,to,0,0
69946,participate,0,0
69947,in,0,0
69948,Cash,0,1
69949,and,0,1
69950,Counseling,0,0
69951,(,0,0
69952,the,0,0
69953,treatment,0,0
69954,group,0,0
69955,),0,1
69956,",",0,0
69957,or,0,0
69958,to,0,0
69959,receive,0,0
69960,Medicaid,0,0
69961,services,0,0
69962,as,0,0
69963,usual,0,0
69964,from,0,0
69965,an,0,0
69966,agency,0,1
69967,(,0,0
69968,the,0,0
69969,control,0,0
69970,group,0,0
69971,),0,0
69972,.,0,0
69973,Ordinary,0,0
69974,least,0,0
69975,squares,0,0
69976,regressions,0,0
69977,were,0,0
69978,used,0,0
69979,to,0,0
69980,estimate,0,0
69981,the,0,0
69982,effect,0,0
69983,of,0,0
69984,the,0,0
69985,program,0,0
69986,on,0,0
69987,costs,1,1
69988,for,1,0
69989,Medicaid,1,0
69990,PCS/waiver,1,1
69991,services,1,1
69992,and,0,1
69993,other,0,0
69994,Medicaid,1,0
69995,services,1,1
69996,",",0,0
69997,while,0,0
69998,controlling,0,0
69999,for,0,0
70000,consumers,0,0
70001,',0,1
70002,preenrollment,0,0
70003,characteristics,0,1
70004,and,0,1
70005,preenrollment,0,0
70006,Medicaid,0,0
70007,spending,0,1
70008,.,0,1
70009,Models,0,0
70010,were,0,0
70011,estimated,0,0
70012,separately,0,0
70013,for,0,0
70014,nonelderly,0,0
70015,and,0,0
70016,elderly,0,0
70017,adults,0,0
70018,in,0,0
70019,each,0,0
70020,state,0,1
70021,and,0,1
70022,for,0,0
70023,children,0,0
70024,in,0,0
70025,Florida,0,0
70026,.,0,0
70027,DATA,0,1
70028,EXTRACTION,0,1
70029,METHODS,0,0
70030,Each,0,0
70031,state,0,1
70032,supplied,0,0
70033,claims,0,0
70034,data,0,0
70035,for,0,0
70036,demonstration,0,0
70037,enrollees,0,0
70038,.,0,0
70039,PRINCIPAL,0,1
70040,FINDINGS,0,0
70041,Largely,0,0
70042,because,0,0
70043,the,0,0
70044,program,0,0
70045,increased,0,0
70046,consumers,0,0
70047,',0,1
70048,ability,0,1
70049,to,0,0
70050,get,0,0
70051,the,0,0
70052,authorized,0,0
70053,amount,0,1
70054,of,0,1
70055,paid,0,0
70056,care,0,0
70057,",",0,0
70058,expenditures,1,1
70059,for,1,0
70060,personal,1,1
70061,care/waiver,1,1
70062,services,1,1
70063,were,0,0
70064,higher,0,0
70065,for,0,0
70066,the,0,0
70067,treatment,0,0
70068,group,0,0
70069,than,0,0
70070,for,0,0
70071,the,0,0
70072,control,0,0
70073,group,0,0
70074,in,0,0
70075,each,0,0
70076,state,0,1
70077,and,0,1
70078,age,0,1
70079,group,0,0
70080,",",0,0
70081,except,0,0
70082,among,0,0
70083,the,0,0
70084,elderly,0,0
70085,in,0,0
70086,Florida,0,0
70087,.,0,0
70088,Higher,0,0
70089,costs,1,1
70090,for,1,0
70091,personal,1,1
70092,care/waiver,1,1
70093,services,1,1
70094,were,0,0
70095,partially,0,0
70096,offset,0,0
70097,by,0,0
70098,savings,0,1
70099,in,0,0
70100,other,0,0
70101,Medicaid,0,0
70102,services,0,1
70103,",",0,0
70104,particularly,0,0
70105,those,0,0
70106,related,0,0
70107,to,0,0
70108,long-term,0,0
70109,care,0,0
70110,.,0,0
70111,During,0,0
70112,year,0,0
70113,1,0,0
70114,",",0,0
70115,total,1,1
70116,Medicaid,1,0
70117,costs,1,1
70118,were,0,0
70119,generally,0,0
70120,higher,0,0
70121,for,0,0
70122,the,0,0
70123,treatment,0,0
70124,group,0,0
70125,than,0,0
70126,for,0,0
70127,the,0,0
70128,control,0,0
70129,group,0,0
70130,",",0,0
70131,with,0,0
70132,treatment-control,0,1
70133,cost,0,1
70134,differences,0,0
70135,ranging,0,0
70136,from,0,0
70137,1,0,0
70138,percent,0,0
70139,(,0,0
70140,and,0,1
70141,statistically,0,1
70142,insignificant,0,0
70143,),0,0
70144,for,0,0
70145,the,0,0
70146,elderly,0,0
70147,in,0,0
70148,Florida,0,0
70149,to,0,0
70150,17,0,0
70151,percent,0,0
70152,for,0,0
70153,the,0,0
70154,elderly,0,0
70155,in,0,0
70156,Arkansas,0,0
70157,.,0,0
70158,In,0,0
70159,year,0,0
70160,2,0,0
70161,",",0,0
70162,these,0,0
70163,cost,1,1
70164,differences,1,0
70165,were,0,0
70166,generally,0,0
70167,greater,0,0
70168,than,0,0
70169,in,0,0
70170,year,0,0
70171,1,0,0
70172,.,0,0
70173,Only,0,0
70174,in,0,0
70175,Arkansas,0,0
70176,did,0,0
70177,the,0,0
70178,treatment-control,0,0
70179,difference,0,0
70180,in,0,0
70181,total,0,1
70182,cost,1,1
70183,shrink,1,1
70184,over,1,0
70185,time-to,1,1
70186,less,0,0
70187,than,0,0
70188,5,0,0
70189,percent,0,0
70190,(,0,0
70191,and,0,1
70192,statistically,0,1
70193,insignificant,0,0
70194,),0,0
70195,in,0,0
70196,year,0,0
70197,2,0,0
70198,.,0,0
70199,CONCLUSIONS,0,0
70200,Medicaid,1,0
70201,costs,1,1
70202,were,0,0
70203,generally,0,0
70204,higher,0,0
70205,under,0,0
70206,Cash,0,1
70207,and,0,1
70208,Counseling,0,0
70209,because,0,0
70210,those,0,0
70211,in,0,0
70212,the,0,0
70213,traditional,0,0
70214,system,0,0
70215,did,0,0
70216,not,0,0
70217,get,0,0
70218,the,0,0
70219,services,0,0
70220,they,0,0
70221,were,0,0
70222,entitled,0,0
70223,to,0,0
70224,.,0,0
70225,Compared,0,0
70226,with,0,0
70227,the,0,0
70228,treatment,0,0
70229,group,0,0
70230,",",0,0
70231,(,0,0
70232,1,0,0
70233,),0,0
70234,control,0,0
70235,group,0,0
70236,members,0,0
70237,were,0,0
70238,less,0,0
70239,likely,0,0
70240,to,0,0
70241,receive,1,0
70242,any,1,0
70243,services,1,0
70244,at,0,0
70245,all,0,0
70246,(,0,0
70247,despite,0,0
70248,being,0,0
70249,authorized,0,0
70250,for,0,0
70251,them,0,0
70252,),0,0
70253,",",0,1
70254,and,0,1
70255,(,0,0
70256,2,0,0
70257,),0,0
70258,service,0,0
70259,recipients,0,0
70260,received,0,0
70261,a,0,0
70262,lower,1,0
70263,proportion,1,0
70264,of,1,0
70265,the,1,0
70266,amount,1,1
70267,of,1,0
70268,care,1,0
70269,that,0,0
70270,was,0,0
70271,authorized,0,0
70272,.,0,0
70273,In,0,0
70274,addition,0,0
70275,",",0,0
70276,a,0,0
70277,flaw,0,0
70278,in,0,0
70279,Florida,0,0
70280,'s,0,1
70281,reassessment,0,0
70282,procedures,0,0
70283,led,0,0
70284,to,0,0
70285,treatment,0,0
70286,group,0,0
70287,members,0,0
70288,receiving,0,0
70289,more,0,0
70290,generous,0,1
70291,benefit,0,0
70292,amounts,0,1
70293,than,0,0
70294,control,0,0
70295,group,0,0
70296,members,0,0
70297,.,0,0
70298,To,0,0
70299,keep,0,0
70300,total,0,1
70301,Medicaid,0,0
70302,costs,0,1
70303,per,0,0
70304,recipient,0,0
70305,at,0,0
70306,the,0,0
70307,level,0,1
70308,incurred,0,0
70309,under,0,0
70310,the,0,0
70311,traditional,0,0
70312,system,0,0
70313,",",0,1
70314,consumer-directed,0,0
70315,programs,0,0
70316,need,0,0
70317,to,0,0
70318,be,0,0
70319,carefully,0,0
70320,designed,0,0
70321,and,0,0
70322,closely,0,0
70323,monitored,0,0
70324,.,0,0
70325,Effects,0,0
70326,of,0,0
70327,sibutramine,0,0
70328,on,0,0
70329,thermogenesis,0,1
70330,in,0,0
70331,obese,0,0
70332,patients,0,0
70333,assessed,0,0
70334,via,0,0
70335,immersion,0,0
70336,calorimetry,0,0
70337,.,0,1
70338,Glucose,0,1
70339,utilization,0,0
70340,studies,0,0
70341,show,0,0
70342,that,0,0
70343,sibutramine-induced,0,0
70344,thermogenesis,0,1
70345,is,0,0
70346,mediated,0,0
70347,via,0,0
70348,selective,0,0
70349,sympathetic,0,1
70350,activation,0,1
70351,of,0,1
70352,brown,0,1
70353,adipose,0,1
70354,tissue,0,0
70355,.,0,0
70356,The,0,0
70357,goal,0,0
70358,of,0,0
70359,the,0,0
70360,present,0,0
70361,study,0,0
70362,was,0,0
70363,to,0,0
70364,use,0,0
70365,a,0,0
70366,new,0,0
70367,calorimetry,0,0
70368,method,0,0
70369,in,0,0
70370,which,0,0
70371,resting,0,1
70372,metabolic,0,1
70373,rate,0,1
70374,is,0,0
70375,enhanced,0,0
70376,to,0,0
70377,evaluate,0,0
70378,the,0,0
70379,effects,0,0
70380,of,0,0
70381,sibutramine,0,0
70382,treatment,0,0
70383,on,0,0
70384,thermogenesis,0,1
70385,.,0,0
70386,Sixty,0,0
70387,obese,0,0
70388,women,0,0
70389,were,0,0
70390,included,0,0
70391,in,0,0
70392,the,0,0
70393,study,0,0
70394,.,0,0
70395,Subjects,0,0
70396,were,0,0
70397,divided,0,0
70398,into,0,0
70399,2,0,0
70400,equal,0,0
70401,groups-the,0,0
70402,placebo,0,0
70403,and,0,1
70404,sibutramine,0,0
70405,treatment,0,0
70406,groups,0,0
70407,.,0,0
70408,The,0,0
70409,sibutramine,0,0
70410,group,0,0
70411,was,0,0
70412,given,0,0
70413,sibutramine,0,0
70414,10,0,0
70415,mg,0,0
70416,daily,0,0
70417,for,0,0
70418,12,0,0
70419,wk,0,0
70420,.,0,0
70421,At,0,0
70422,baseline,0,0
70423,and,0,0
70424,at,0,0
70425,the,0,0
70426,end,0,0
70427,of,0,0
70428,the,0,0
70429,12-wk,0,0
70430,treatment,0,0
70431,period,0,0
70432,",",0,1
70433,thermogenic,0,1
70434,measurements,0,1
70435,were,0,0
70436,taken,0,0
70437,with,0,0
70438,the,0,0
70439,use,0,0
70440,of,0,1
70441,water,1,1
70442,immersion,1,0
70443,calorimetry,1,0
70444,.,1,1
70445,Subjects,0,0
70446,were,0,0
70447,examined,0,0
70448,at,0,0
70449,weeks,0,0
70450,4,0,0
70451,",",0,0
70452,8,0,0
70453,",",0,0
70454,and,0,0
70455,12,0,0
70456,of,0,0
70457,treatment,0,0
70458,to,0,0
70459,identify,0,0
70460,adverse,0,1
70461,effects,0,1
70462,.,0,0
70463,Body,1,0
70464,mass,1,1
70465,index,1,1
70466,",",0,1
70467,measured,0,1
70468,at,0,0
70469,31.5+/-2.05,0,0
70470,kg/m2,0,0
70471,in,0,0
70472,the,0,0
70473,placebo,0,0
70474,group,0,0
70475,",",0,0
70476,decreased,0,1
70477,to,0,0
70478,30.4+/-2.94,0,0
70479,kg/m,0,0
70480,(,0,0
70481,2,0,0
70482,),0,0
70483,after,0,0
70484,12,0,0
70485,wk,0,0
70486,(,0,0
70487,P=.07,0,0
70488,),0,0
70489,.,0,0
70490,In,0,0
70491,the,0,0
70492,sibutramine,0,0
70493,group,0,0
70494,",",0,0
70495,it,0,0
70496,decreased,0,0
70497,from,0,0
70498,33.5+/-4.1,0,0
70499,kg/m,0,0
70500,(,0,0
70501,2,0,0
70502,),0,0
70503,to,0,0
70504,30.9+/-4.8,0,0
70505,kg/m,0,0
70506,(,0,0
70507,2,0,0
70508,),0,0
70509,(,0,0
70510,P,0,0
70511,<,0,0
70512,.05,0,0
70513,),0,0
70514,.,0,0
70515,In,0,0
70516,the,0,0
70517,sibutramine,0,0
70518,group,0,0
70519,",",0,0
70520,mean,1,1
70521,thermogenic,1,1
70522,response,1,1
70523,changed,0,0
70524,from,0,0
70525,a,0,0
70526,baseline,0,0
70527,value,0,1
70528,of,0,1
70529,1.27+/-0.29,0,0
70530,kcal/kg/h,0,0
70531,to,0,0
70532,1.44+/-0.13,0,0
70533,kcal/kg/h,0,0
70534,after,0,0
70535,12,0,0
70536,wk,0,0
70537,of,0,0
70538,treatment,0,0
70539,.,0,0
70540,In,0,0
70541,the,0,0
70542,placebo,0,0
70543,group,0,0
70544,",",0,0
70545,the,0,0
70546,baseline,0,1
70547,value,0,1
70548,was,0,0
70549,1.56+/-0.27,0,0
70550,kcal/kg/h,0,0
70551,;,0,0
70552,it,0,0
70553,changed,0,0
70554,to,0,0
70555,1.33+/-0.36,0,0
70556,kcal/kg/h,0,0
70557,at,0,0
70558,the,0,0
70559,end,0,0
70560,of,0,0
70561,12,0,0
70562,wk,0,0
70563,.,0,0
70564,The,0,0
70565,findings,0,0
70566,of,0,0
70567,this,0,0
70568,study,0,0
70569,suggest,0,0
70570,that,0,0
70571,sibutramine,0,0
70572,treatment,0,0
70573,promotes,0,0
70574,thermogenesis,1,1
70575,",",0,0
70576,thus,0,0
70577,facilitating,0,0
70578,weight,1,1
70579,loss,1,1
70580,.,1,0
70581,Calorimetry,0,0
70582,enhances,0,0
70583,resting,1,1
70584,metabolism,1,1
70585,through,0,0
70586,more,0,0
70587,efficient,0,1
70588,heat,1,1
70589,transfer,1,1
70590,from,1,0
70591,the,1,0
70592,body,1,0
70593,.,1,0
70594,Effectiveness,1,1
70595,of,0,1
70596,aromatherapy,0,0
70597,massage,0,0
70598,in,0,0
70599,the,0,0
70600,management,0,0
70601,of,0,1
70602,anxiety,1,1
70603,and,1,1
70604,depression,1,1
70605,in,0,0
70606,patients,0,0
70607,with,0,0
70608,cancer,0,0
70609,:,0,0
70610,a,0,0
70611,multicenter,0,0
70612,randomized,0,0
70613,controlled,0,0
70614,trial,0,0
70615,.,0,0
70616,PURPOSE,0,0
70617,To,0,0
70618,test,0,0
70619,the,0,0
70620,effectiveness,1,0
70621,of,0,0
70622,supplementing,0,0
70623,usual,0,0
70624,supportive,0,0
70625,care,0,0
70626,with,0,0
70627,aromatherapy,0,0
70628,massage,0,0
70629,in,0,0
70630,the,0,0
70631,management,0,0
70632,of,0,1
70633,anxiety,0,1
70634,and,0,1
70635,depression,0,1
70636,in,0,0
70637,cancer,0,0
70638,patients,0,0
70639,through,0,0
70640,a,0,0
70641,pragmatic,0,0
70642,two-arm,0,0
70643,randomized,0,0
70644,controlled,0,0
70645,trial,0,0
70646,in,0,0
70647,four,0,0
70648,United,0,0
70649,Kingdom,0,0
70650,cancer,0,0
70651,centers,0,0
70652,and,0,0
70653,a,0,0
70654,hospice,0,0
70655,.,0,1
70656,PATIENTS,0,0
70657,AND,0,0
70658,METHODS,0,0
70659,Two,0,0
70660,hundred,0,0
70661,eighty-eight,0,0
70662,cancer,0,0
70663,patients,0,0
70664,",",0,0
70665,referred,0,0
70666,to,0,0
70667,complementary,0,0
70668,therapy,0,0
70669,services,0,1
70670,with,0,0
70671,clinical,0,0
70672,anxiety,0,1
70673,and/or,0,0
70674,depression,0,1
70675,",",0,1
70676,were,0,0
70677,allocated,0,0
70678,randomly,0,0
70679,to,0,0
70680,a,0,0
70681,course,0,0
70682,of,0,0
70683,aromatherapy,0,0
70684,massage,0,0
70685,or,0,1
70686,usual,0,0
70687,supportive,0,0
70688,care,0,0
70689,alone,0,0
70690,.,0,0
70691,RESULTS,0,0
70692,Patients,0,0
70693,who,0,0
70694,received,0,0
70695,aromatherapy,0,0
70696,massage,0,0
70697,had,0,0
70698,no,0,0
70699,significant,0,0
70700,improvement,0,1
70701,in,0,0
70702,clinical,1,1
70703,anxiety,1,1
70704,and/or,1,0
70705,depression,1,1
70706,compared,0,0
70707,with,0,0
70708,those,0,0
70709,receiving,0,0
70710,usual,0,0
70711,care,0,0
70712,at,0,0
70713,10,0,0
70714,weeks,0,0
70715,postrandomization,0,0
70716,(,0,0
70717,odds,0,0
70718,ratio,0,0
70719,[,0,0
70720,OR,0,0
70721,],0,0
70722,",",0,0
70723,1.3,0,0
70724,;,0,0
70725,95,0,0
70726,%,0,0
70727,CI,0,0
70728,",",0,0
70729,0.9,0,0
70730,to,0,0
70731,1.7,0,0
70732,;,0,0
70733,P,0,0
70734,=,0,0
70735,.1,0,0
70736,),0,1
70737,",",0,1
70738,but,0,0
70739,did,0,0
70740,at,0,0
70741,6,0,0
70742,weeks,0,0
70743,postrandomization,0,0
70744,(,0,1
70745,OR,0,1
70746,",",0,0
70747,1.4,0,0
70748,;,0,0
70749,95,0,0
70750,%,0,0
70751,CI,0,0
70752,",",0,0
70753,1.1,0,0
70754,to,0,0
70755,1.9,0,0
70756,;,0,0
70757,P,0,0
70758,=,0,0
70759,.01,0,0
70760,),0,0
70761,.,0,0
70762,Patients,0,0
70763,receiving,0,0
70764,aromatherapy,0,0
70765,massage,0,0
70766,also,0,0
70767,described,0,0
70768,greater,0,0
70769,improvement,0,1
70770,in,0,0
70771,self-reported,1,1
70772,anxiety,1,1
70773,at,0,0
70774,both,0,0
70775,6,0,0
70776,and,0,0
70777,10,0,0
70778,weeks,0,0
70779,postrandomization,0,0
70780,(,0,1
70781,OR,0,1
70782,",",0,0
70783,3.4,0,0
70784,;,0,0
70785,95,0,0
70786,%,0,0
70787,CI,0,0
70788,",",0,0
70789,0.2,0,0
70790,to,0,0
70791,6.7,0,0
70792,;,0,0
70793,P,0,0
70794,=,0,0
70795,.04,0,0
70796,and,0,1
70797,OR,0,1
70798,",",0,0
70799,3.4,0,0
70800,;,0,0
70801,95,0,0
70802,%,0,0
70803,CI,0,0
70804,",",0,0
70805,0.2,0,0
70806,to,0,0
70807,6.6,0,0
70808,;,0,0
70809,P,0,0
70810,=,0,0
70811,.04,0,0
70812,),0,1
70813,",",0,0
70814,respectively,0,0
70815,.,0,0
70816,CONCLUSION,0,0
70817,Aromatherapy,0,0
70818,massage,0,0
70819,does,0,0
70820,not,0,0
70821,appear,0,0
70822,to,0,0
70823,confer,0,0
70824,benefit,1,0
70825,on,0,0
70826,cancer,0,0
70827,patients,0,0
70828,',0,1
70829,anxiety,1,1
70830,and/or,1,0
70831,depression,1,1
70832,in,0,0
70833,the,0,0
70834,long-term,0,1
70835,",",0,0
70836,but,0,0
70837,is,0,0
70838,associated,0,0
70839,with,0,0
70840,clinically,0,0
70841,important,0,0
70842,benefit,1,0
70843,up,0,0
70844,to,0,0
70845,2,0,0
70846,weeks,0,0
70847,after,0,0
70848,the,0,0
70849,intervention,0,0
70850,.,0,0
70851,The,0,0
70852,safety,0,1
70853,of,0,0
70854,whey,0,0
70855,protein,0,1
70856,concentrate,0,0
70857,derived,0,0
70858,from,0,0
70859,the,0,0
70860,milk,0,0
70861,of,0,0
70862,cows,0,1
70863,immunized,0,0
70864,against,0,0
70865,Clostridium,0,1
70866,difficile,0,0
70867,.,0,0
70868,A,0,0
70869,whey,0,0
70870,protein,0,1
70871,concentrate,0,0
70872,prepared,0,0
70873,from,0,0
70874,the,0,0
70875,milk,0,0
70876,of,0,0
70877,cows,0,0
70878,that,0,0
70879,have,0,0
70880,been,0,0
70881,immunized,0,0
70882,against,0,0
70883,Clostridium,0,1
70884,difficile,0,1
70885,(,0,1
70886,C.,0,1
70887,difficile,0,1
70888,),0,1
70889,and,0,0
70890,its,0,0
70891,toxins,0,1
70892,",",0,0
70893,toxin,0,1
70894,A,0,0
70895,and,0,1
70896,toxin,0,1
70897,B,0,0
70898,",",0,0
70899,is,0,0
70900,produced,0,0
70901,for,0,0
70902,use,0,0
70903,as,0,0
70904,a,0,0
70905,medical,0,0
70906,food,0,0
70907,for,0,0
70908,the,0,0
70909,dietary,0,0
70910,management,0,0
70911,of,0,0
70912,patients,0,0
70913,with,0,0
70914,C.,0,1
70915,difficile-associated,0,1
70916,diarrhea,0,1
70917,(,0,1
70918,CDAD,0,0
70919,),0,0
70920,to,0,0
70921,prevent,0,0
70922,a,0,0
70923,relapse,0,1
70924,of,0,0
70925,the,0,0
70926,infection,0,0
70927,.,0,0
70928,The,0,0
70929,safety,0,1
70930,of,0,0
70931,anti-C.,0,1
70932,difficile,0,0
70933,whey,0,0
70934,protein,0,1
70935,concentrate,0,0
70936,(,0,0
70937,anti-CD,0,1
70938,WPC,0,1
70939,),0,0
70940,is,0,0
70941,supported,0,0
70942,by,0,0
70943,analytical,0,0
70944,data,0,0
70945,comparing,0,0
70946,the,0,0
70947,composition,0,0
70948,of,0,0
70949,raw,0,0
70950,milk,0,1
70951,from,0,0
70952,immunized,0,0
70953,cows,0,0
70954,versus,0,0
70955,that,0,0
70956,from,0,0
70957,non-immunized,0,0
70958,cows,0,1
70959,",",0,0
70960,and,0,0
70961,the,0,0
70962,composition,0,1
70963,of,0,0
70964,anti-CD,0,1
70965,WPC,0,1
70966,versus,0,0
70967,that,0,0
70968,of,0,0
70969,regular,0,0
70970,whey,0,0
70971,protein,0,1
70972,concentrate,0,0
70973,.,0,0
70974,Additionally,0,0
70975,",",0,0
70976,a,0,0
70977,prospective,0,0
70978,clinical,0,1
70979,study,0,0
70980,was,0,0
70981,conducted,0,0
70982,in,0,0
70983,77,0,0
70984,patients,0,0
70985,with,0,0
70986,CDAD,0,0
70987,to,0,0
70988,demonstrate,0,0
70989,the,0,0
70990,safety,0,1
70991,of,0,0
70992,consuming,0,0
70993,anti-CD,0,1
70994,WPC,0,1
70995,to,0,0
70996,prevent,0,0
70997,relapse,0,1
70998,of,0,0
70999,the,0,0
71000,infection,0,0
71001,.,0,0
71002,This,0,0
71003,study,0,0
71004,",",0,0
71005,which,0,0
71006,included,0,0
71007,adverse,0,1
71008,event,0,1
71009,monitoring,0,0
71010,",",0,1
71011,physical,0,1
71012,examinations,0,1
71013,",",0,1
71014,and,0,1
71015,extensive,0,1
71016,hematological,0,1
71017,and,0,1
71018,biochemical,0,1
71019,assessments,0,1
71020,",",0,1
71021,showed,0,0
71022,that,0,0
71023,anti-CD,0,0
71024,WPC,0,1
71025,is,0,0
71026,safe,1,0
71027,to,0,0
71028,consume,0,0
71029,by,0,0
71030,patients,0,0
71031,with,0,0
71032,CDAD,0,0
71033,.,0,0
71034,The,0,0
71035,available,0,0
71036,analytical,0,1
71037,and,0,1
71038,clinical,0,1
71039,evidence,0,0
71040,demonstrate,0,0
71041,that,0,0
71042,anti-CD,0,0
71043,WPC,0,1
71044,is,0,0
71045,safe,1,1
71046,for,0,0
71047,use,0,0
71048,by,0,0
71049,individuals,0,0
71050,with,0,0
71051,CDAD,0,0
71052,",",0,0
71053,under,0,0
71054,the,0,0
71055,described,0,0
71056,conditions,0,0
71057,of,0,0
71058,use,0,0
71059,.,0,0
71060,Safety,0,1
71061,trial,0,0
71062,of,0,0
71063,the,0,0
71064,vaginal,0,0
71065,microbicide,0,0
71066,cellulose,0,1
71067,sulfate,0,1
71068,gel,0,0
71069,in,0,0
71070,HIV-positive,0,0
71071,men,0,0
71072,.,0,0
71073,OBJECTIVE,0,1
71074,Cellulose,0,1
71075,sulfate,0,1
71076,(,0,1
71077,CS,0,1
71078,),0,0
71079,is,0,0
71080,a,0,0
71081,promising,0,0
71082,vaginal,0,0
71083,microbicide,0,0
71084,.,0,0
71085,Because,0,0
71086,men,0,0
71087,will,0,0
71088,be,0,0
71089,exposed,0,0
71090,to,0,0
71091,the,0,0
71092,microbicide,0,0
71093,when,0,0
71094,engaging,0,0
71095,in,0,0
71096,vaginal,0,0
71097,intercourse,0,1
71098,",",0,1
71099,safety,1,1
71100,and,1,1
71101,acceptability,1,1
71102,need,0,0
71103,to,0,0
71104,be,0,0
71105,assessed,0,0
71106,in,0,0
71107,men,0,0
71108,.,0,0
71109,DESIGN,0,0
71110,This,0,0
71111,randomized,0,0
71112,double-blind,0,0
71113,phase,0,0
71114,I,0,0
71115,study,0,0
71116,assessed,0,0
71117,the,0,0
71118,safety,1,1
71119,and,1,1
71120,acceptability,1,1
71121,of,0,0
71122,seven,0,0
71123,consecutive,0,0
71124,daily,0,0
71125,doses,0,0
71126,of,0,1
71127,CS,0,1
71128,versus,0,0
71129,KY,0,0
71130,Jelly,0,0
71131,in,0,0
71132,36,0,0
71133,HIV-positive,0,0
71134,men,0,0
71135,.,0,0
71136,RESULTS,0,0
71137,No,0,1
71138,new,1,1
71139,or,1,0
71140,worsening,1,1
71141,of,1,1
71142,existing,1,0
71143,genital,1,1
71144,findings,1,0
71145,were,0,0
71146,observed,0,0
71147,during,0,0
71148,the,0,0
71149,follow-up,0,0
71150,examination,0,0
71151,.,0,0
71152,Mild,1,1
71153,genital,1,1
71154,symptoms,1,1
71155,were,0,0
71156,reported,0,0
71157,in,0,0
71158,42,0,0
71159,%,0,0
71160,of,0,0
71161,CS,0,1
71162,users,0,0
71163,(,1,0
71164,itching,1,1
71165,",",1,1
71166,burning,1,1
71167,",",1,1
71168,tingling,1,1
71169,",",1,1
71170,testicular,1,1
71171,pain,1,1
71172,",",1,1
71173,dysuria,1,1
71174,",",1,1
71175,and,1,1
71176,warm,1,1
71177,or,1,1
71178,cold,1,1
71179,feeling,1,1
71180,),1,0
71181,and,0,0
71182,8,0,0
71183,%,0,0
71184,of,0,0
71185,KY,0,0
71186,Jelly,0,0
71187,users,0,0
71188,.,0,0
71189,CONCLUSION,0,0
71190,CS,0,1
71191,gel,0,0
71192,applied,0,0
71193,to,0,0
71194,the,0,0
71195,penis,0,1
71196,was,0,0
71197,well,0,0
71198,tolerated,1,1
71199,in,0,0
71200,this,0,0
71201,HIV-positive,0,1
71202,male,0,0
71203,population,0,0
71204,.,0,0
71205,The,0,0
71206,itching,1,1
71207,and,1,1
71208,burning,1,1
71209,symptoms,0,1
71210,were,0,0
71211,not,0,0
71212,severe,0,0
71213,and,0,0
71214,can,0,0
71215,be,0,0
71216,explained,0,0
71217,by,0,0
71218,the,0,0
71219,preservative,0,0
71220,benzyl,0,0
71221,alcohol,0,1
71222,present,0,0
71223,in,0,0
71224,the,0,0
71225,CS,0,1
71226,gel,0,0
71227,.,0,0
71228,Injection,0,1
71229,sclerotherapy,0,0
71230,versus,0,0
71231,electrocoagulation,0,0
71232,in,0,0
71233,the,0,0
71234,management,0,0
71235,outcome,0,1
71236,of,0,1
71237,early,0,0
71238,haemorrhoids,0,0
71239,.,0,0
71240,OBJECTIVE,0,0
71241,To,0,0
71242,study,0,0
71243,the,0,0
71244,symptomatology,0,1
71245,of,0,0
71246,early,0,0
71247,hemorrhoids,0,0
71248,and,0,0
71249,to,0,0
71250,compare,0,0
71251,injection,0,0
71252,sclerotherapy,0,0
71253,(,0,1
71254,IS,0,1
71255,),0,1
71256,with,0,0
71257,electrocoagulation,0,0
71258,(,0,1
71259,EC,0,1
71260,),0,0
71261,in,0,0
71262,the,0,0
71263,management,0,0
71264,outcome,0,1
71265,of,0,1
71266,early,0,0
71267,haemorrhoids,0,0
71268,with,0,0
71269,respect,0,0
71270,to,0,0
71271,pain,1,1
71272,during,1,0
71273,the,1,0
71274,procedure,1,0
71275,",",1,0
71276,reduction,1,1
71277,in,1,0
71278,bleeding,1,1
71279,per,1,0
71280,rectum,1,1
71281,",",0,1
71282,and,0,1
71283,overall,1,1
71284,patient,1,1
71285,satisfaction,1,1
71286,score,1,1
71287,.,1,1
71288,METHODS,0,0
71289,A,0,0
71290,total,0,1
71291,of,0,0
71292,102,0,0
71293,patients,0,0
71294,were,0,0
71295,included,0,0
71296,in,0,0
71297,this,0,0
71298,experimental,0,0
71299,study,0,0
71300,at,0,0
71301,the,0,0
71302,POF,0,0
71303,Hospital,0,1
71304,",",0,1
71305,Wah,0,1
71306,Cantt,0,1
71307,from,0,0
71308,October,0,0
71309,2004,0,0
71310,to,0,0
71311,June,0,0
71312,2005,0,0
71313,.,0,0
71314,A,0,0
71315,detailed,0,0
71316,history,0,1
71317,was,0,0
71318,taken,0,0
71319,and,0,0
71320,proctoscopic,0,1
71321,examination,0,1
71322,was,0,0
71323,performed,0,0
71324,.,0,0
71325,Patients,0,0
71326,were,0,0
71327,then,0,0
71328,randomly,0,0
71329,divided,0,0
71330,into,0,0
71331,two,0,0
71332,groups,0,0
71333,(,0,0
71334,Lottery,0,1
71335,method,0,0
71336,),0,0
71337,.,0,0
71338,One,0,0
71339,group,0,0
71340,was,0,0
71341,subjected,0,0
71342,to,0,0
71343,EC,0,1
71344,and,0,0
71345,the,0,0
71346,other,0,0
71347,to,0,0
71348,IS,0,1
71349,.,0,0
71350,In,0,0
71351,the,0,0
71352,EC,0,1
71353,",",0,0
71354,using,0,0
71355,the,0,0
71356,EC,0,1
71357,machine,0,0
71358,(,0,1
71359,Wieda,0,1
71360,",",0,1
71361,China,0,0
71362,),0,1
71363,",",0,0
71364,direct,0,1
71365,current,0,0
71366,of,0,0
71367,10-20,0,0
71368,mA,0,0
71369,was,0,0
71370,applied,0,0
71371,in,0,0
71372,the,0,0
71373,submucosal,0,0
71374,plane,0,1
71375,of,0,0
71376,each,0,0
71377,pile,0,0
71378,core,0,1
71379,for,0,0
71380,5-7,0,0
71381,minutes,0,1
71382,.,0,0
71383,In,0,0
71384,the,0,0
71385,IS,0,1
71386,1-2,0,0
71387,ml,0,0
71388,of,0,0
71389,5,0,0
71390,%,0,0
71391,phenol,0,0
71392,in,0,0
71393,almond,0,1
71394,oil,0,0
71395,was,0,0
71396,injected,0,0
71397,in,0,0
71398,the,0,0
71399,same,0,0
71400,plane,0,1
71401,in,0,0
71402,each,0,0
71403,pile,0,0
71404,core,0,1
71405,.,0,1
71406,Pain,1,1
71407,during,1,0
71408,the,1,0
71409,procedure,1,0
71410,",",1,0
71411,reduction,1,1
71412,in,1,0
71413,bleeding,1,1
71414,per,1,0
71415,rectum,1,1
71416,and,1,1
71417,overall,1,1
71418,patient,1,1
71419,satisfaction,1,1
71420,",",0,1
71421,were,0,0
71422,studied,0,0
71423,as,0,0
71424,outcome,0,0
71425,measures,0,0
71426,.,0,0
71427,RESULTS,0,0
71428,The,0,0
71429,mean,0,1
71430,age,0,0
71431,of,0,0
71432,the,0,0
71433,patients,0,0
71434,was,0,0
71435,44,0,0
71436,years,0,0
71437,",",0,0
71438,86,0,0
71439,were,0,0
71440,males,0,0
71441,and,0,0
71442,16,0,0
71443,were,0,0
71444,females,0,0
71445,.,0,0
71446,Two,0,0
71447,thirds,0,0
71448,of,0,0
71449,the,0,0
71450,patients,0,0
71451,were,0,0
71452,having,0,0
71453,symptoms,0,1
71454,for,0,0
71455,more,0,0
71456,than,0,0
71457,6,0,0
71458,months,0,0
71459,.,0,0
71460,A,0,0
71461,third,0,0
71462,of,0,0
71463,patients,0,0
71464,had,0,0
71465,associated,0,0
71466,local,1,0
71467,pain,1,1
71468,while,0,0
71469,another,0,0
71470,third,0,0
71471,had,0,0
71472,associated,0,0
71473,mucous,1,1
71474,discharge,1,0
71475,.,1,1
71476,Chronic,1,0
71477,constipation,1,1
71478,was,0,0
71479,present,0,0
71480,in,0,0
71481,81,0,0
71482,%,0,0
71483,patients,0,0
71484,.,0,0
71485,Only,0,0
71486,24.5,0,0
71487,%,0,0
71488,of,0,0
71489,the,0,0
71490,patients,0,0
71491,had,0,0
71492,a,0,0
71493,positive,0,1
71494,family,0,1
71495,history,0,1
71496,of,0,0
71497,haemorrhoids,0,0
71498,.,0,0
71499,Patients,0,0
71500,in,0,0
71501,the,0,0
71502,electrocoagulation,0,0
71503,(,0,0
71504,EC,0,1
71505,),0,1
71506,group,0,0
71507,experienced,0,1
71508,more,0,0
71509,pain,1,1
71510,during,1,0
71511,the,1,0
71512,procedure,1,0
71513,than,0,0
71514,the,0,0
71515,injection,0,0
71516,sclerotherapy,0,0
71517,(,0,1
71518,IS,0,1
71519,),0,1
71520,group,0,0
71521,(,0,0
71522,P,0,0
71523,<,0,0
71524,0.000,0,0
71525,),0,0
71526,",",0,0
71527,but,0,0
71528,EC,0,1
71529,was,0,0
71530,significantly,0,0
71531,more,0,0
71532,effective,0,1
71533,than,0,0
71534,IS,0,1
71535,in,0,0
71536,terms,0,1
71537,of,0,0
71538,reducing,0,0
71539,the,0,0
71540,bleeding,1,1
71541,per,1,0
71542,rectum,1,1
71543,(,0,0
71544,P,0,0
71545,=,0,0
71546,0.039,0,0
71547,),0,0
71548,",",0,0
71549,and,0,1
71550,also,0,0
71551,significantly,0,0
71552,higher,0,0
71553,number,0,1
71554,of,0,1
71555,patients,0,0
71556,were,0,0
71557,fully,1,0
71558,satisfied,1,0
71559,with,0,0
71560,EC,0,1
71561,than,0,0
71562,with,0,0
71563,IS,0,1
71564,(,0,0
71565,P,0,0
71566,<,0,0
71567,0.04,0,0
71568,),0,0
71569,.,0,0
71570,CONCLUSION,0,0
71571,EC,0,1
71572,",",0,0
71573,although,0,0
71574,more,0,0
71575,painful,1,1
71576,",",0,0
71577,is,0,0
71578,a,0,0
71579,safe,1,1
71580,",",0,0
71581,more,0,0
71582,effective,1,1
71583,and,0,0
71584,a,0,0
71585,highly,1,0
71586,satisfying,1,0
71587,procedure,0,0
71588,for,0,0
71589,treating,0,0
71590,early,0,0
71591,hemorrhoids,0,0
71592,.,0,0
71593,The,0,0
71594,study,0,0
71595,of,0,0
71596,inhibiting,0,1
71597,systematic,0,0
71598,inflammatory,0,1
71599,response,0,1
71600,syndrome,0,0
71601,by,0,0
71602,applying,0,0
71603,xenogenic,0,1
71604,(,0,0
71605,porcine,0,0
71606,),0,1
71607,acellular,0,1
71608,dermal,0,1
71609,matrix,0,1
71610,on,0,0
71611,second-degree,0,1
71612,burns,0,1
71613,.,0,0
71614,OBJECTIVE,0,0
71615,To,0,0
71616,investigate,0,0
71617,the,0,0
71618,influence,0,0
71619,of,0,1
71620,xenogenic,0,1
71621,(,0,1
71622,porcine,0,0
71623,),0,1
71624,acellular,0,1
71625,dermal,0,1
71626,matrix,0,0
71627,on,0,0
71628,the,0,0
71629,systematic,0,0
71630,inflammatory,0,1
71631,reaction,0,1
71632,syndrome,0,1
71633,(,0,1
71634,SIRS,0,1
71635,),0,1
71636,",",0,0
71637,and,0,0
71638,the,0,0
71639,reaction,0,1
71640,of,0,0
71641,burn,0,0
71642,patients,0,0
71643,to,0,0
71644,tissue,0,1
71645,damage,0,1
71646,upon,0,0
71647,application,0,0
71648,to,0,0
71649,second-degree,0,1
71650,burn,0,0
71651,wounds,0,0
71652,.,0,0
71653,METHOD,0,0
71654,Seventy-two,0,0
71655,cases,0,0
71656,of,0,0
71657,patients,0,0
71658,with,0,0
71659,acute,0,0
71660,second-degree,0,1
71661,burns,0,1
71662,were,0,0
71663,enrolled,0,0
71664,in,0,0
71665,the,0,0
71666,study,0,0
71667,.,0,0
71668,According,0,0
71669,to,0,0
71670,the,0,0
71671,total,0,1
71672,burn,0,1
71673,surface,0,1
71674,area,0,1
71675,(,0,1
71676,TBSA,0,0
71677,),0,0
71678,and,0,0
71679,the,0,0
71680,treatment,0,0
71681,methods,0,0
71682,",",0,0
71683,we,0,0
71684,randomly,0,0
71685,divided,0,0
71686,the,0,0
71687,patients,0,0
71688,into,0,0
71689,four,0,0
71690,groups,0,0
71691,.,0,0
71692,Group,0,0
71693,A,0,0
71694,(,0,1
71695,treatment,0,0
71696,group,0,0
71697,),0,0
71698,:,0,0
71699,patients,0,0
71700,with,0,0
71701,less,0,0
71702,than,0,0
71703,30,0,0
71704,%,0,0
71705,TBSA,0,0
71706,covered,0,0
71707,with,0,0
71708,xenogenic,0,1
71709,acellular,0,1
71710,dermal,0,1
71711,matrix,0,1
71712,.,0,1
71713,Group,0,0
71714,B,0,0
71715,(,0,0
71716,control,0,0
71717,group,0,0
71718,),0,0
71719,:,0,0
71720,patients,0,0
71721,with,0,0
71722,less,0,0
71723,than,0,0
71724,30,0,0
71725,%,0,0
71726,TBSA,0,0
71727,covered,0,0
71728,with,0,0
71729,betadine,0,0
71730,ointment,0,0
71731,gauzes,0,1
71732,.,0,0
71733,Group,0,0
71734,C,0,1
71735,(,0,1
71736,treatment,0,0
71737,group,0,0
71738,),0,0
71739,:,0,0
71740,patients,0,0
71741,with,0,0
71742,more,0,0
71743,than,0,0
71744,30,0,0
71745,%,0,0
71746,TBSA,0,0
71747,covered,0,0
71748,with,0,0
71749,porcine,0,0
71750,acellular,0,1
71751,dermal,0,1
71752,matrix,0,1
71753,.,0,1
71754,Group,0,0
71755,D,0,1
71756,(,0,0
71757,control,0,0
71758,group,0,0
71759,),0,0
71760,:,0,0
71761,patients,0,0
71762,with,0,0
71763,more,0,0
71764,than,0,0
71765,30,0,0
71766,%,0,0
71767,TBSA,0,0
71768,covered,0,0
71769,with,0,0
71770,betadine,0,0
71771,ointment,0,0
71772,gauzes,0,1
71773,.,0,1
71774,Serum,0,1
71775,level,0,1
71776,of,0,1
71777,C-reactive,0,1
71778,protein,0,1
71779,(,0,1
71780,CRP,0,1
71781,),0,1
71782,was,0,0
71783,measured,0,0
71784,by,0,0
71785,single,0,0
71786,radial,0,1
71787,immunodiffusion,0,1
71788,method,0,0
71789,on,0,0
71790,1,0,0
71791,",",0,0
71792,4,0,0
71793,",",0,0
71794,7,0,0
71795,and,0,0
71796,14,0,0
71797,days,0,0
71798,postburn,0,0
71799,.,0,0
71800,RESULTS,0,0
71801,The,0,0
71802,serum,1,1
71803,level,1,1
71804,of,1,1
71805,CRP,1,1
71806,in,0,0
71807,group,0,0
71808,A,0,0
71809,was,0,0
71810,significantly,0,0
71811,less,0,0
71812,than,0,0
71813,that,0,0
71814,of,0,0
71815,in,0,0
71816,group,0,0
71817,B,0,0
71818,(,0,0
71819,P,0,0
71820,<,0,0
71821,0.05,0,0
71822,),0,0
71823,on,0,0
71824,days,0,0
71825,4,0,0
71826,",",0,0
71827,7,0,0
71828,and,0,0
71829,14,0,0
71830,.,0,0
71831,The,0,0
71832,serum,1,1
71833,level,1,1
71834,of,1,1
71835,CRP,1,1
71836,in,0,0
71837,group,0,0
71838,C,0,0
71839,increased,0,1
71840,slowly,0,0
71841,",",0,0
71842,descended,0,0
71843,quickly,0,1
71844,and,0,0
71845,was,0,0
71846,significantly,0,0
71847,less,0,0
71848,than,0,0
71849,that,0,0
71850,of,0,0
71851,in,0,0
71852,group,0,0
71853,D,0,1
71854,on,0,0
71855,days,0,0
71856,4,0,0
71857,",",0,0
71858,7,0,0
71859,and,0,0
71860,14,0,0
71861,.,0,0
71862,CONCLUSION,0,0
71863,The,0,0
71864,application,0,0
71865,of,0,1
71866,xenogenic,0,1
71867,(,0,1
71868,porcine,0,0
71869,),0,1
71870,acellular,0,1
71871,dermal,0,1
71872,matrix,0,1
71873,on,0,0
71874,second-degree,0,1
71875,burn,0,0
71876,wound,0,0
71877,can,0,0
71878,decrease,0,1
71879,serum,1,1
71880,level,1,1
71881,of,1,1
71882,CRP,1,0
71883,of,0,0
71884,the,0,0
71885,patients,0,0
71886,",",0,0
71887,which,0,0
71888,may,0,0
71889,play,0,0
71890,an,0,0
71891,important,0,0
71892,role,0,0
71893,in,0,0
71894,reducing,0,0
71895,SIRS,0,1
71896,and,0,1
71897,sepsis,0,0
71898,incidence,0,1
71899,.,0,0
71900,Safety,1,1
71901,",",1,1
71902,pharmacokinetics,1,1
71903,and,1,1
71904,pharmocodynamics,1,1
71905,of,0,1
71906,recombinant,0,0
71907,human,0,0
71908,porphobilinogen,0,1
71909,deaminase,0,1
71910,in,0,0
71911,healthy,0,0
71912,subjects,0,0
71913,and,0,1
71914,asymptomatic,0,1
71915,carriers,0,0
71916,of,0,0
71917,the,0,0
71918,acute,0,0
71919,intermittent,0,0
71920,porphyria,0,0
71921,gene,0,0
71922,who,0,0
71923,have,0,0
71924,increased,0,0
71925,porphyrin,0,0
71926,precursor,0,0
71927,excretion,0,1
71928,.,0,1
71929,BACKGROUND,0,0
71930,AND,0,0
71931,OBJECTIVE,0,1
71932,Acute,0,1
71933,intermittent,0,0
71934,porphyria,0,0
71935,is,0,0
71936,an,0,0
71937,autosomal,0,0
71938,dominant,0,0
71939,disorder,0,0
71940,caused,0,0
71941,by,0,0
71942,deficient,0,0
71943,activity,0,1
71944,of,0,0
71945,the,0,0
71946,third,0,0
71947,enzyme,0,0
71948,in,0,0
71949,the,0,0
71950,haem,0,0
71951,biosynthetic,0,1
71952,pathway,0,1
71953,",",0,1
71954,porphobilinogen,0,1
71955,deaminase,0,0
71956,.,0,0
71957,It,0,0
71958,is,0,0
71959,characterised,0,0
71960,by,0,0
71961,acute,0,0
71962,",",0,0
71963,potentially,0,0
71964,life-threatening,0,0
71965,neurological,0,1
71966,attacks,0,1
71967,that,0,0
71968,are,0,0
71969,precipitated,0,0
71970,by,0,0
71971,various,0,0
71972,drugs,0,0
71973,",",0,0
71974,reproductive,0,1
71975,hormones,0,1
71976,and,0,1
71977,other,0,0
71978,factors,0,1
71979,.,0,0
71980,During,0,0
71981,acute,0,0
71982,attacks,0,1
71983,",",0,0
71984,the,0,0
71985,porphyrin,0,1
71986,precursors,0,0
71987,5-aminolevulinic,0,0
71988,acid,0,1
71989,and,0,1
71990,porphobilinogen,0,1
71991,accumulate,0,0
71992,and,0,0
71993,are,0,0
71994,excreted,0,1
71995,at,0,0
71996,high,0,0
71997,concentrations,0,1
71998,in,0,0
71999,the,0,0
72000,urine,0,1
72001,.,0,0
72002,Current,0,0
72003,treatment,0,0
72004,is,0,0
72005,based,0,0
72006,on,0,0
72007,glucose,0,1
72008,loading,0,1
72009,and,0,1
72010,parenteral,0,0
72011,haem,0,1
72012,replenishment,0,1
72013,",",0,0
72014,which,0,0
72015,reduce,0,0
72016,the,0,0
72017,accumulation,0,1
72018,of,0,0
72019,5-aminolevulinic,1,0
72020,acid,1,1
72021,and,1,1
72022,porphobilinogen,1,1
72023,.,1,1
72024,Recently,0,0
72025,",",0,0
72026,a,0,0
72027,new,0,1
72028,form,0,0
72029,of,0,1
72030,treatment,0,0
72031,based,0,0
72032,on,0,0
72033,porphobilinogen,0,1
72034,deaminase,0,1
72035,enzyme,0,1
72036,replacement,0,0
72037,therapy,0,0
72038,has,0,0
72039,been,0,0
72040,shown,0,0
72041,to,0,0
72042,be,0,0
72043,effective,0,0
72044,in,0,0
72045,an,0,0
72046,acute,0,0
72047,intermittent,0,0
72048,porphyria,0,1
72049,mouse,0,0
72050,model,0,0
72051,which,0,0
72052,",",0,0
72053,during,0,0
72054,phenobarbital,0,0
72055,(,0,0
72056,phenobarbitone,0,0
72057,),0,1
72058,induction,0,0
72059,of,0,1
72060,haem,0,1
72061,biosynthesis,0,1
72062,",",0,0
72063,mimics,0,0
72064,the,0,0
72065,biochemical,0,1
72066,pattern,0,0
72067,of,0,1
72068,acute,0,0
72069,porphyric,0,1
72070,attacks,0,1
72071,.,0,0
72072,The,0,0
72073,objective,0,0
72074,of,0,0
72075,the,0,0
72076,present,0,0
72077,study,0,0
72078,was,0,0
72079,to,0,0
72080,investigate,0,0
72081,the,0,0
72082,safety,0,1
72083,",",0,0
72084,pharmacokinetics,0,1
72085,and,0,1
72086,pharmacodynamics,0,0
72087,of,0,1
72088,recombinant,0,0
72089,human,0,0
72090,porphobilinogen,0,1
72091,deaminase,0,1
72092,(,0,0
72093,P,0,0
72094,9808,0,0
72095,),0,0
72096,",",0,0
72097,administered,0,0
72098,to,0,0
72099,healthy,0,0
72100,subjects,0,0
72101,and,0,1
72102,asymptomatic,0,1
72103,porphobilinogen,0,1
72104,deaminase-deficient,0,1
72105,subjects,0,0
72106,with,0,0
72107,high,0,0
72108,concentrations,0,1
72109,of,0,1
72110,porphobilinogen,0,1
72111,",",0,0
72112,the,0,0
72113,substrate,0,1
72114,of,0,1
72115,porphobilinogen,0,1
72116,deaminase,0,1
72117,.,0,1
72118,STUDY,0,0
72119,DESIGN,0,0
72120,Forty,0,0
72121,individuals,0,0
72122,participated,0,0
72123,in,0,0
72124,this,0,0
72125,two-part,0,0
72126,study,0,0
72127,:,0,0
72128,20,0,0
72129,asymptomatic,0,0
72130,porphobilinogen,0,1
72131,deaminase-deficient,0,1
72132,subjects,0,0
72133,(,0,0
72134,both,0,0
72135,male,0,0
72136,and,0,1
72137,female,0,0
72138,),0,1
72139,with,0,0
72140,>,0,0
72141,or,0,0
72142,=4,0,0
72143,times,0,1
72144,the,0,0
72145,upper,0,0
72146,reference,0,0
72147,urinary,0,1
72148,porphobilinogen,0,1
72149,level,0,1
72150,",",0,0
72151,and,0,0
72152,20,0,0
72153,healthy,0,0
72154,male,0,0
72155,subjects,0,0
72156,.,0,0
72157,Four,0,0
72158,different,0,0
72159,doses,0,0
72160,of,0,0
72161,recombinant,0,0
72162,human,0,0
72163,porphobilinogen,0,1
72164,deaminase,0,1
72165,were,0,0
72166,studied,0,0
72167,(,0,0
72168,0.5,0,0
72169,",",0,0
72170,1,0,0
72171,",",0,0
72172,2,0,0
72173,and,0,0
72174,4,0,0
72175,mg/kg,0,0
72176,bodyweight,0,0
72177,),0,0
72178,.,0,0
72179,Part,0,0
72180,A,0,0
72181,included,0,0
72182,12,0,0
72183,asymptomatic,0,0
72184,porphobilinogen,0,1
72185,deaminase-deficient,0,1
72186,subjects,0,0
72187,",",0,0
72188,and,0,0
72189,the,0,0
72190,enzyme,0,0
72191,was,0,0
72192,administered,0,0
72193,in,0,0
72194,an,0,0
72195,open-label,0,0
72196,",",0,0
72197,single-dose,0,0
72198,design,0,0
72199,.,0,1
72200,Part,0,0
72201,B,0,0
72202,included,0,0
72203,20,0,0
72204,asymptomatic,0,0
72205,porphobilinogen,0,1
72206,deaminase-deficient,0,1
72207,subjects,0,0
72208,and,0,0
72209,20,0,0
72210,healthy,0,0
72211,subjects,0,0
72212,.,0,0
72213,The,0,0
72214,same,0,0
72215,enzyme,0,0
72216,dosages,0,1
72217,were,0,0
72218,administered,0,0
72219,as,0,0
72220,divided,0,0
72221,doses,0,0
72222,every,0,0
72223,12,0,0
72224,hours,0,0
72225,for,0,0
72226,4,0,0
72227,consecutive,0,0
72228,days,0,0
72229,in,0,0
72230,a,0,0
72231,randomised,0,0
72232,",",0,0
72233,double-blinded,0,0
72234,",",0,1
72235,placebo-controlled,0,0
72236,design,0,0
72237,.,0,0
72238,The,0,0
72239,washout,0,0
72240,period,0,0
72241,between,0,0
72242,Parts,0,1
72243,A,0,0
72244,and,0,1
72245,B,0,0
72246,was,0,0
72247,2,0,0
72248,weeks,0,0
72249,.,0,0
72250,METHODS,0,0
72251,The,0,0
72252,concentrations,1,1
72253,of,1,0
72254,recombinant,1,0
72255,human,1,0
72256,porphobilinogen,1,1
72257,deaminase,1,1
72258,and,1,1
72259,titres,1,1
72260,of,1,1
72261,antibodies,1,1
72262,against,1,0
72263,recombinant,1,0
72264,human,1,0
72265,porphobilinogen,1,1
72266,deaminase,1,1
72267,were,0,0
72268,analysed,0,0
72269,by,0,0
72270,ELISA,0,0
72271,.,0,0
72272,Plasma,1,1
72273,porphobilinogen,1,1
72274,and,1,1
72275,5-aminolevulinic,1,0
72276,acid,1,1
72277,concentrations,1,1
72278,were,0,0
72279,analysed,0,0
72280,using,0,0
72281,a,0,0
72282,novel,0,0
72283,liquid,0,0
72284,chromatography-tandem,0,0
72285,mass,0,1
72286,spectrometry,0,0
72287,method,0,0
72288,.,0,1
72289,Urinary,1,1
72290,porphobilinogen,1,1
72291,",",1,1
72292,5-aminolevulinic,1,0
72293,acid,1,1
72294,and,1,1
72295,porphyrin,1,1
72296,concentrations,1,1
72297,",",0,0
72298,as,0,0
72299,well,0,0
72300,as,0,0
72301,plasma,1,1
72302,porphyrin,1,1
72303,concentrations,1,1
72304,",",0,1
72305,were,0,0
72306,analysed,0,0
72307,using,0,0
72308,standard,0,0
72309,methods,0,0
72310,.,0,0
72311,The,0,0
72312,pharmacodynamic,0,1
72313,effect,0,0
72314,of,0,0
72315,the,0,0
72316,enzyme,0,0
72317,was,0,0
72318,studied,0,0
72319,through,0,0
72320,changes,0,1
72321,in,0,0
72322,plasma,0,1
72323,porphobilinogen,0,1
72324,concentrations,0,1
72325,.,0,0
72326,RESULTS,0,0
72327,No,0,1
72328,serious,1,1
72329,adverse,1,1
72330,events,1,1
72331,were,0,0
72332,observed,0,0
72333,.,0,0
72334,Seven,0,1
72335,subjects,0,0
72336,(,0,0
72337,four,0,0
72338,healthy,0,0
72339,men,0,0
72340,and,0,0
72341,three,0,0
72342,asymptomatic,0,0
72343,porphobilinogen,0,1
72344,deaminase-deficient,0,1
72345,subjects,0,0
72346,),0,0
72347,developed,0,0
72348,antibodies,1,1
72349,against,1,0
72350,recombinant,1,0
72351,human,1,0
72352,porphobilinogen,1,1
72353,deaminase,1,1
72354,but,0,0
72355,did,0,0
72356,not,0,0
72357,experience,0,0
72358,allergic,1,1
72359,manifestations,1,0
72360,.,1,0
72361,The,0,0
72362,mean,1,1
72363,elimination,1,1
72364,half-lives,1,1
72365,of,1,0
72366,the,1,0
72367,highest,1,1
72368,doses,1,0
72369,of,1,0
72370,recombinant,1,0
72371,human,1,0
72372,porphobilinogen,1,1
72373,deaminase,1,1
72374,ranged,0,0
72375,between,0,0
72376,1.7,0,0
72377,and,0,0
72378,2.5,0,0
72379,hours,0,0
72380,for,0,0
72381,both,0,0
72382,healthy,0,0
72383,men,0,0
72384,and,0,1
72385,asymptomatic,0,1
72386,porphobilinogen,0,1
72387,deaminase-deficient,0,0
72388,subjects,0,0
72389,.,0,0
72390,The,0,0
72391,area,1,1
72392,under,1,0
72393,the,1,0
72394,plasma,1,1
72395,concentration-time,1,1
72396,curve,1,1
72397,was,0,0
72398,proportional,0,0
72399,to,0,0
72400,the,0,0
72401,respective,0,0
72402,dose,0,0
72403,.,0,0
72404,In,0,0
72405,asymptomatic,0,1
72406,porphobilinogen,0,1
72407,deaminase-deficient,0,1
72408,subjects,0,0
72409,",",0,1
72410,plasma,1,1
72411,porphobilinogen,1,1
72412,concentrations,1,1
72413,decreased,0,1
72414,below,0,0
72415,measurable,0,1
72416,levels,0,1
72417,almost,0,0
72418,instantaneously,0,0
72419,after,0,0
72420,administration,0,0
72421,of,0,0
72422,any,0,0
72423,dose,0,0
72424,of,0,0
72425,the,0,0
72426,enzyme,0,0
72427,.,0,0
72428,The,0,0
72429,effect,0,1
72430,lasted,0,1
72431,for,0,0
72432,approximately,0,0
72433,2,0,0
72434,hours,0,0
72435,",",0,0
72436,after,0,0
72437,which,0,0
72438,the,0,0
72439,plasma,1,1
72440,porphobilinogen,1,1
72441,concentration,1,1
72442,slowly,0,0
72443,increased,0,0
72444,",",0,0
72445,reaching,0,1
72446,about,0,0
72447,70,0,0
72448,%,0,0
72449,of,0,0
72450,the,0,0
72451,initial,0,0
72452,values,0,0
72453,12,0,0
72454,hours,0,0
72455,after,0,0
72456,administration,0,0
72457,.,0,0
72458,There,0,0
72459,was,0,0
72460,no,0,0
72461,effect,0,1
72462,on,0,0
72463,plasma,1,1
72464,5-aminolevulinic,1,0
72465,acid,1,1
72466,concentrations,1,1
72467,",",0,1
72468,and,0,1
72469,there,0,0
72470,was,0,0
72471,a,0,0
72472,transitory,0,1
72473,increment,0,1
72474,in,0,0
72475,porphyrin,1,0
72476,concentrations,1,1
72477,.,1,0
72478,The,0,0
72479,corresponding,1,1
72480,concentrations,1,1
72481,of,1,0
72482,metabolites,1,1
72483,in,1,0
72484,the,1,0
72485,urine,1,1
72486,reflected,0,0
72487,the,0,0
72488,pattern,0,0
72489,observed,0,0
72490,in,0,0
72491,the,0,0
72492,plasma,0,1
72493,.,0,0
72494,CONCLUSIONS,0,0
72495,The,0,0
72496,recombinant,0,0
72497,human,0,0
72498,porphobilinogen,0,1
72499,deaminase,0,1
72500,enzyme,0,1
72501,preparation,0,0
72502,was,0,0
72503,found,0,0
72504,to,0,0
72505,be,0,0
72506,safe,0,0
72507,to,0,0
72508,administer,0,0
72509,and,0,1
72510,effective,0,1
72511,for,0,0
72512,removal,0,0
72513,of,0,0
72514,the,0,0
72515,accumulated,0,1
72516,metabolite,0,1
72517,porphobilinogen,0,1
72518,from,0,0
72519,plasma,0,1
72520,and,0,1
72521,urine,0,1
72522,.,0,0
72523,The,0,0
72524,pharmacokinetic,0,1
72525,profile,0,1
72526,of,0,1
72527,recombinant,0,0
72528,human,0,0
72529,porphobilinogen,0,1
72530,deaminase,0,1
72531,showed,0,0
72532,dose,0,0
72533,proportionality,0,1
72534,",",0,0
72535,and,0,1
72536,the,0,0
72537,elimination,0,1
72538,half-life,0,1
72539,was,0,0
72540,about,0,0
72541,2.0,0,0
72542,hours,0,0
72543,for,0,0
72544,the,0,0
72545,two,0,0
72546,highest,0,0
72547,doses,0,0
72548,.,0,0
72549,Thus,0,1
72550,",",0,0
72551,clinical,0,1
72552,grounds,0,0
72553,were,0,0
72554,established,0,0
72555,for,0,0
72556,investigation,0,0
72557,of,0,0
72558,the,0,0
72559,therapeutic,1,0
72560,efficacy,1,1
72561,of,0,0
72562,the,0,0
72563,enzyme,0,0
72564,during,0,0
72565,periods,0,0
72566,of,0,0
72567,overt,0,1
72568,disease,0,1
72569,in,0,0
72570,patients,0,0
72571,with,0,0
72572,acute,0,0
72573,intermittent,0,0
72574,porphyria,0,0
72575,.,0,0
72576,A,0,0
72577,prospective,0,0
72578,study,0,0
72579,of,0,1
72580,plasma,0,1
72581,vitamin,0,0
72582,D,0,1
72583,metabolites,0,1
72584,",",0,0
72585,vitamin,0,1
72586,D,0,1
72587,receptor,0,1
72588,polymorphisms,0,1
72589,",",0,1
72590,and,0,1
72591,prostate,0,0
72592,cancer,0,0
72593,.,0,1
72594,BACKGROUND,0,0
72595,Vitamin,0,1
72596,D,0,1
72597,insufficiency,0,0
72598,is,0,0
72599,a,0,0
72600,common,0,0
72601,public,0,0
72602,health,0,1
72603,problem,0,0
72604,nationwide,0,0
72605,.,0,0
72606,Circulating,0,0
72607,25-hydroxyvitamin,0,1
72608,D3,0,0
72609,(,0,0
72610,25,0,0
72611,[,0,0
72612,OH,0,0
72613,],0,0
72614,D,0,1
72615,),0,0
72616,",",0,0
72617,the,0,0
72618,most,0,0
72619,commonly,0,0
72620,used,0,0
72621,index,0,1
72622,of,0,1
72623,vitamin,0,1
72624,D,0,1
72625,status,0,1
72626,",",0,0
72627,is,0,0
72628,converted,0,0
72629,to,0,0
72630,the,0,0
72631,active,0,0
72632,hormone,0,0
72633,"1,25",0,0
72634,dihydroxyvitamin,0,0
72635,D3,0,0
72636,(,0,0
72637,"1,25",0,0
72638,[,0,0
72639,OH,0,0
72640,],0,0
72641,2D,0,1
72642,),0,0
72643,",",0,0
72644,which,0,0
72645,",",0,0
72646,operating,0,1
72647,through,0,0
72648,the,0,0
72649,vitamin,0,0
72650,D,0,1
72651,receptor,0,1
72652,(,0,1
72653,VDR,0,1
72654,),0,0
72655,",",0,0
72656,inhibits,0,1
72657,in,0,0
72658,vitro,0,1
72659,cell,0,1
72660,proliferation,0,1
72661,",",0,1
72662,induces,0,1
72663,differentiation,0,1
72664,and,0,1
72665,apoptosis,0,1
72666,",",0,0
72667,and,0,0
72668,may,0,0
72669,protect,0,1
72670,against,0,0
72671,prostate,0,0
72672,cancer,0,0
72673,.,0,0
72674,Despite,0,0
72675,intriguing,0,0
72676,results,0,0
72677,from,0,0
72678,laboratory,0,1
72679,studies,0,0
72680,",",0,0
72681,previous,0,0
72682,epidemiological,0,1
72683,studies,0,0
72684,showed,0,0
72685,inconsistent,0,0
72686,associations,0,0
72687,of,0,0
72688,circulating,0,1
72689,levels,0,1
72690,of,0,0
72691,25,0,0
72692,(,0,0
72693,OH,0,0
72694,),0,1
72695,D,0,1
72696,",",0,0
72697,"1,25",0,0
72698,(,0,0
72699,OH,0,0
72700,),0,0
72701,2D,0,1
72702,",",0,0
72703,and,0,0
72704,several,0,0
72705,VDR,0,0
72706,polymorphisms,0,1
72707,with,0,0
72708,prostate,0,0
72709,cancer,0,0
72710,risk,0,1
72711,.,0,1
72712,Few,0,0
72713,studies,0,0
72714,have,0,0
72715,explored,0,0
72716,the,0,0
72717,joint,0,1
72718,association,0,0
72719,of,0,0
72720,circulating,0,1
72721,vitamin,0,0
72722,D,0,1
72723,levels,0,1
72724,with,0,0
72725,VDR,0,0
72726,polymorphisms,0,1
72727,.,0,1
72728,METHODS,0,0
72729,AND,0,0
72730,FINDINGS,0,0
72731,During,0,0
72732,18,0,0
72733,y,0,0
72734,of,0,0
72735,follow-up,0,0
72736,of,0,0
72737,"14,916",0,0
72738,men,0,0
72739,initially,0,0
72740,free,0,1
72741,of,0,0
72742,diagnosed,0,0
72743,cancer,0,0
72744,",",0,0
72745,we,0,0
72746,identified,0,0
72747,"1,066",0,0
72748,men,0,0
72749,with,0,0
72750,incident,0,1
72751,prostate,0,0
72752,cancer,0,1
72753,(,0,0
72754,including,0,0
72755,496,0,0
72756,with,0,0
72757,aggressive,0,0
72758,disease,0,1
72759,",",0,1
72760,defined,0,1
72761,as,0,0
72762,stage,0,0
72763,C,0,0
72764,or,0,1
72765,D,0,1
72766,",",0,0
72767,Gleason,0,1
72768,7-10,0,0
72769,",",0,0
72770,metastatic,0,0
72771,",",0,1
72772,and,0,1
72773,fatal,0,1
72774,prostate,0,0
72775,cancer,0,0
72776,),0,0
72777,and,0,0
72778,"1,618",0,0
72779,cancer-free,0,0
72780,",",0,0
72781,age-,0,0
72782,and,0,1
72783,smoking-matched,0,0
72784,control,0,0
72785,participants,0,0
72786,in,0,0
72787,the,0,0
72788,Physicians,0,0
72789,',0,1
72790,Health,0,0
72791,Study,0,0
72792,.,0,0
72793,We,0,0
72794,examined,0,0
72795,the,0,0
72796,associations,0,0
72797,of,0,0
72798,prediagnostic,0,1
72799,plasma,0,1
72800,levels,0,1
72801,of,0,0
72802,25,0,0
72803,(,0,0
72804,OH,0,0
72805,),0,1
72806,D,0,1
72807,and,0,0
72808,"1,25",0,0
72809,(,0,0
72810,OH,0,0
72811,),0,0
72812,2D,0,1
72813,",",0,0
72814,individually,0,0
72815,and,0,0
72816,jointly,0,0
72817,",",0,0
72818,with,0,0
72819,total,0,1
72820,and,0,1
72821,aggressive,0,1
72822,disease,0,1
72823,",",0,1
72824,and,0,1
72825,explored,0,0
72826,whether,0,0
72827,relations,0,1
72828,between,0,0
72829,vitamin,0,0
72830,D,0,1
72831,metabolites,0,1
72832,and,0,1
72833,prostate,0,0
72834,cancer,0,1
72835,were,0,0
72836,modified,0,0
72837,by,0,0
72838,the,0,0
72839,functional,0,1
72840,VDR,0,0
72841,FokI,0,0
72842,polymorphism,0,1
72843,",",0,0
72844,using,0,0
72845,conditional,0,1
72846,logistic,0,0
72847,regression,0,0
72848,.,0,0
72849,Among,0,0
72850,these,0,0
72851,US,0,1
72852,physicians,0,0
72853,",",0,0
72854,the,0,0
72855,median,1,1
72856,plasma,1,1
72857,25,1,0
72858,(,1,0
72859,OH,1,0
72860,),1,1
72861,D,1,1
72862,levels,1,1
72863,were,0,0
72864,25,0,0
72865,ng/ml,0,0
72866,in,0,0
72867,the,0,0
72868,blood,0,1
72869,samples,0,0
72870,collected,0,0
72871,during,0,0
72872,the,0,0
72873,winter,0,0
72874,or,0,1
72875,spring,0,1
72876,and,0,0
72877,32,0,0
72878,ng/ml,0,0
72879,in,0,0
72880,samples,0,0
72881,collected,0,0
72882,during,0,0
72883,the,0,0
72884,summer,0,0
72885,or,0,0
72886,fall,0,1
72887,.,0,0
72888,Nearly,0,0
72889,13,0,0
72890,%,0,0
72891,(,0,0
72892,summer/fall,0,1
72893,),0,0
72894,to,0,0
72895,36,0,0
72896,%,0,0
72897,(,0,0
72898,winter/spring,0,0
72899,),0,0
72900,of,0,0
72901,the,0,0
72902,control,0,0
72903,participants,0,0
72904,were,0,0
72905,deficient,0,0
72906,in,0,0
72907,25,1,0
72908,(,1,0
72909,OH,1,0
72910,),1,1
72911,D,1,1
72912,(,0,0
72913,<,0,0
72914,20,0,0
72915,ng/ml,0,0
72916,),0,0
72917,and,0,0
72918,51,0,0
72919,%,0,0
72920,(,0,0
72921,summer/fall,0,1
72922,),0,0
72923,and,0,0
72924,77,0,0
72925,%,0,0
72926,(,0,0
72927,winter/spring,0,0
72928,),0,1
72929,had,0,0
72930,insufficient,0,0
72931,plasma,1,1
72932,25,1,0
72933,(,1,0
72934,OH,1,0
72935,),1,1
72936,D,1,1
72937,levels,1,1
72938,(,0,0
72939,<,0,0
72940,32,0,0
72941,ng/ml,0,0
72942,),0,0
72943,.,0,0
72944,Plasma,1,1
72945,levels,1,1
72946,of,1,0
72947,"1,25",1,0
72948,(,1,0
72949,OH,1,0
72950,),1,0
72951,2D,1,1
72952,did,1,0
72953,not,0,0
72954,vary,0,0
72955,by,0,0
72956,season,0,0
72957,.,0,0
72958,Men,0,0
72959,whose,0,0
72960,levels,0,1
72961,for,0,0
72962,both,0,0
72963,25,0,0
72964,(,0,0
72965,OH,0,0
72966,),0,1
72967,D,0,1
72968,and,0,0
72969,"1,25",0,0
72970,(,0,0
72971,OH,0,0
72972,),0,0
72973,2D,0,1
72974,were,0,0
72975,below,0,0
72976,(,0,0
72977,versus,0,0
72978,above,0,0
72979,),0,0
72980,the,0,0
72981,median,0,1
72982,had,0,0
72983,a,0,0
72984,significantly,0,0
72985,increased,0,0
72986,risk,1,1
72987,of,1,0
72988,aggressive,1,1
72989,prostate,1,0
72990,cancer,1,1
72991,(,0,0
72992,odds,0,0
72993,ratio,0,0
72994,[,0,0
72995,OR,0,0
72996,],0,0
72997,=,0,0
72998,2.1,0,0
72999,",",0,0
73000,95,0,0
73001,%,0,0
73002,confidence,0,0
73003,interval,0,0
73004,[,0,0
73005,CI,0,0
73006,],0,0
73007,1.2-3.4,0,0
73008,),0,0
73009,",",0,0
73010,although,0,0
73011,the,0,0
73012,interaction,0,0
73013,between,0,0
73014,the,0,0
73015,two,0,0
73016,vitamin,0,0
73017,D,0,1
73018,metabolites,0,1
73019,was,0,0
73020,not,0,0
73021,statistically,0,0
73022,significant,0,0
73023,(,0,0
73024,pinteraction,0,0
73025,=,0,0
73026,0.23,0,0
73027,),0,0
73028,.,0,0
73029,We,0,0
73030,observed,0,0
73031,a,0,0
73032,significant,0,0
73033,interaction,0,1
73034,between,0,0
73035,circulating,0,0
73036,25,1,0
73037,(,1,0
73038,OH,1,0
73039,),1,1
73040,D,1,1
73041,levels,1,1
73042,and,1,0
73043,the,1,0
73044,VDR,1,0
73045,FokI,1,0
73046,genotype,1,1
73047,(,0,1
73048,pinteraction,0,0
73049,<,0,0
73050,0.05,0,0
73051,),0,0
73052,.,0,0
73053,Compared,0,0
73054,with,0,0
73055,those,0,0
73056,with,0,0
73057,plasma,1,1
73058,25,1,0
73059,(,1,0
73060,OH,1,0
73061,),1,1
73062,D,1,1
73063,levels,1,1
73064,above,0,0
73065,the,0,0
73066,median,0,1
73067,and,0,0
73068,with,0,0
73069,the,0,0
73070,FokI,0,0
73071,FF,0,0
73072,or,0,1
73073,Ff,0,1
73074,genotype,0,1
73075,",",0,0
73076,men,0,0
73077,who,0,0
73078,had,0,0
73079,low,0,0
73080,25,0,0
73081,(,0,0
73082,OH,0,0
73083,),0,1
73084,D,0,1
73085,levels,0,1
73086,and,0,0
73087,the,0,0
73088,less,0,0
73089,functional,0,1
73090,FokI,0,0
73091,ff,0,1
73092,genotype,0,0
73093,had,0,0
73094,increased,0,0
73095,risks,1,1
73096,of,1,0
73097,total,1,1
73098,(,0,0
73099,OR,0,0
73100,=,0,0
73101,1.9,0,0
73102,",",0,0
73103,95,0,0
73104,%,0,0
73105,CI,0,0
73106,1.1-3.3,0,0
73107,),0,0
73108,and,0,0
73109,aggressive,1,1
73110,prostate,1,1
73111,cancer,1,1
73112,(,0,0
73113,OR,0,0
73114,=,0,0
73115,2.5,0,0
73116,",",0,0
73117,95,0,0
73118,%,0,0
73119,CI,0,0
73120,1.1-5.8,0,0
73121,),0,0
73122,.,0,0
73123,Among,0,0
73124,men,0,0
73125,with,0,0
73126,plasma,1,1
73127,25,1,0
73128,(,1,0
73129,OH,1,0
73130,),1,1
73131,D,1,1
73132,levels,1,1
73133,above,0,0
73134,the,0,0
73135,median,0,1
73136,",",0,0
73137,the,0,0
73138,ff,0,1
73139,genotype,0,0
73140,was,0,0
73141,no,0,0
73142,longer,0,0
73143,associated,0,0
73144,with,0,0
73145,risk,0,1
73146,.,0,0
73147,Conversely,0,0
73148,",",0,0
73149,among,0,0
73150,men,0,0
73151,with,0,0
73152,the,0,0
73153,ff,0,0
73154,genotype,0,0
73155,",",0,1
73156,high,1,0
73157,plasma,1,1
73158,25,1,0
73159,(,1,0
73160,OH,1,0
73161,),1,1
73162,D,1,1
73163,level,1,1
73164,(,0,0
73165,above,0,1
73166,versus,0,0
73167,below,0,0
73168,the,0,0
73169,median,0,1
73170,),0,0
73171,was,0,0
73172,related,0,0
73173,to,0,0
73174,significant,0,0
73175,60,0,0
73176,%,0,0
73177,approximately,0,0
73178,70,0,0
73179,%,0,0
73180,lower,0,0
73181,risks,1,1
73182,of,1,1
73183,total,1,1
73184,and,1,1
73185,aggressive,1,1
73186,prostate,1,0
73187,cancer,1,0
73188,.,1,0
73189,CONCLUSIONS,0,0
73190,Our,0,0
73191,data,0,0
73192,suggest,0,0
73193,that,0,0
73194,a,0,0
73195,large,0,0
73196,proportion,0,0
73197,of,0,0
73198,the,0,0
73199,US,0,1
73200,men,0,0
73201,had,0,0
73202,suboptimal,0,0
73203,vitamin,0,1
73204,D,0,1
73205,status,0,1
73206,(,0,0
73207,especially,0,0
73208,during,0,0
73209,the,0,0
73210,winter/spring,0,0
73211,season,0,0
73212,),0,1
73213,",",0,0
73214,and,0,0
73215,both,0,0
73216,25,0,0
73217,(,0,0
73218,OH,0,0
73219,),0,1
73220,D,0,1
73221,and,0,0
73222,"1,25",0,0
73223,(,0,0
73224,OH,0,0
73225,),0,0
73226,2D,0,0
73227,may,0,0
73228,play,0,0
73229,an,0,0
73230,important,0,0
73231,role,0,0
73232,in,0,0
73233,preventing,0,0
73234,prostate,0,0
73235,cancer,0,0
73236,progression,0,1
73237,.,0,0
73238,Moreover,0,0
73239,",",0,0
73240,vitamin,0,1
73241,D,0,1
73242,status,0,1
73243,",",0,0
73244,measured,0,0
73245,by,0,0
73246,25,1,0
73247,(,1,0
73248,OH,1,0
73249,),1,1
73250,D,1,1
73251,in,1,0
73252,plasma,1,1
73253,",",0,0
73254,interacts,0,0
73255,with,0,0
73256,the,0,0
73257,VDR,0,0
73258,FokI,0,0
73259,polymorphism,0,1
73260,and,0,0
73261,modifies,0,0
73262,prostate,0,0
73263,cancer,0,0
73264,risk,0,1
73265,.,0,1
73266,Men,0,0
73267,with,0,0
73268,the,0,0
73269,less,0,0
73270,functional,0,1
73271,FokI,0,0
73272,ff,0,1
73273,genotype,0,0
73274,(,0,0
73275,14,0,0
73276,%,0,0
73277,in,0,0
73278,the,0,0
73279,European-descent,0,0
73280,population,0,0
73281,of,0,0
73282,this,0,0
73283,cohort,0,0
73284,),0,0
73285,are,0,0
73286,more,0,0
73287,susceptible,0,0
73288,to,0,0
73289,this,0,0
73290,cancer,0,0
73291,in,0,0
73292,the,0,0
73293,presence,0,0
73294,of,0,0
73295,low,0,0
73296,25,0,0
73297,(,0,0
73298,OH,0,0
73299,),0,1
73300,D,0,1
73301,status,0,1
73302,.,0,0
73303,Effects,0,0
73304,of,0,0
73305,electro-acupuncture,0,0
73306,on,0,0
73307,T,1,1
73308,cell,1,1
73309,subpopulations,1,1
73310,",",1,1
73311,NK,1,1
73312,activity,1,1
73313,",",1,1
73314,humoral,1,1
73315,immunity,1,1
73316,and,1,1
73317,leukocyte,1,1
73318,count,1,1
73319,in,0,0
73320,patients,0,0
73321,undergoing,0,0
73322,chemotherapy,0,0
73323,.,0,0
73324,OBJECTIVE,0,0
73325,To,0,0
73326,observe,0,0
73327,the,0,0
73328,effects,0,0
73329,of,0,0
73330,electro-acupuncture,0,0
73331,on,0,0
73332,T,1,1
73333,cell,1,1
73334,subpopulations,1,1
73335,",",1,1
73336,natural,1,0
73337,killer,1,1
73338,cell,1,1
73339,(,1,1
73340,NK,1,1
73341,),1,1
73342,activity,1,1
73343,",",1,1
73344,humoral,1,1
73345,immunity,1,1
73346,and,1,1
73347,leukocyte,1,1
73348,count,1,1
73349,in,0,0
73350,patients,0,0
73351,undergoing,0,0
73352,chemotherapy,0,0
73353,.,0,1
73354,METHODS,0,0
73355,Electro-acupuncture,0,0
73356,was,0,0
73357,added,0,0
73358,for,0,0
73359,patients,0,0
73360,undergoing,0,0
73361,chemotherapy,0,0
73362,.,0,1
73363,Tests,0,1
73364,were,0,0
73365,done,0,0
73366,on,0,0
73367,T,1,0
73368,cell,1,1
73369,subpopulations,1,1
73370,",",1,1
73371,NK,1,1
73372,activity,1,1
73373,",",1,1
73374,humoral,1,1
73375,immunity,1,1
73376,and,1,1
73377,leukocyte,1,1
73378,count,1,1
73379,before,0,0
73380,treatment,0,0
73381,and,0,0
73382,after,0,0
73383,4,0,0
73384,courses,0,0
73385,of,0,0
73386,treatment,0,0
73387,.,0,0
73388,RESULTS,0,0
73389,After,0,0
73390,4,0,0
73391,courses,0,0
73392,of,0,0
73393,treatment,0,0
73394,with,0,0
73395,chemotherapy,0,0
73396,and,0,1
73397,electro-acupuncture,0,0
73398,",",0,0
73399,no,0,0
73400,obvious,0,1
73401,changes,1,1
73402,were,0,0
73403,found,0,0
73404,in,0,0
73405,T,1,0
73406,cell,1,1
73407,subpopulations,1,1
73408,",",1,1
73409,NK,1,1
73410,activity,1,1
73411,",",1,1
73412,humoral,1,1
73413,immunity,1,1
73414,and,1,1
73415,leukocyte,1,1
73416,count,1,1
73417,(,0,1
73418,P,0,0
73419,>,0,0
73420,0.05,0,0
73421,),0,0
73422,as,0,0
73423,compared,0,0
73424,with,0,0
73425,those,0,0
73426,before,0,0
73427,treatment,0,0
73428,.,0,0
73429,Patients,0,0
73430,undergoing,0,0
73431,chemotherapy,0,0
73432,combined,0,0
73433,with,0,0
73434,electro-acupuncture,0,0
73435,showed,0,0
73436,obviously,0,0
73437,higher,0,0
73438,leukocyte,1,1
73439,count,1,1
73440,than,0,0
73441,that,0,0
73442,of,0,0
73443,the,0,0
73444,control,0,0
73445,group,0,0
73446,given,0,0
73447,no,0,0
73448,leukogenic,0,1
73449,drugs,0,0
73450,(,0,0
73451,P,0,0
73452,<,0,0
73453,0.01,0,0
73454,),0,0
73455,.,0,0
73456,CONCLUSION,0,0
73457,Electro-acupuncture,0,0
73458,may,0,0
73459,reduce,0,0
73460,immunologic,1,1
73461,damage,1,1
73462,caused,0,0
73463,by,0,0
73464,chemotherapy,0,0
73465,",",0,0
73466,thus,0,0
73467,it,0,0
73468,can,0,0
73469,be,0,0
73470,used,0,0
73471,as,0,0
73472,the,0,0
73473,auxiliary,0,0
73474,therapy,0,0
73475,for,0,0
73476,patients,0,0
73477,undergoing,0,0
73478,chemotherapy,0,0
73479,.,0,0
73480,[,0,0
73481,Evaluation,0,1
73482,on,0,0
73483,the,0,0
73484,effect,0,0
73485,of,0,0
73486,intervention,0,0
73487,regarding,0,0
73488,breast,0,0
73489,self-examination,0,1
73490,for,0,0
73491,decreasing,0,1
73492,breast,0,0
73493,cancer,0,0
73494,mortality,0,1
73495,],0,0
73496,.,0,0
73497,OBJECTIVE,0,0
73498,A,0,0
73499,randomized,0,0
73500,trial,0,0
73501,of,0,1
73502,breast,0,0
73503,self-examination,0,1
73504,(,0,1
73505,BSE,0,1
73506,),0,1
73507,Program,0,1
73508,was,0,0
73509,carried,0,0
73510,out,0,0
73511,to,0,0
73512,evaluate,0,0
73513,whether,0,0
73514,the,0,0
73515,intensive,0,0
73516,BSE,0,0
73517,could,0,0
73518,reduce,0,0
73519,the,0,0
73520,number,0,1
73521,of,0,0
73522,deaths,0,1
73523,among,0,0
73524,women,0,0
73525,from,0,0
73526,breast,0,0
73527,cancer,0,0
73528,.,0,0
73529,METHODS,0,0
73530,This,0,0
73531,study,0,0
73532,was,0,0
73533,a,0,0
73534,randomized,0,0
73535,controlled,0,0
73536,trial,0,0
73537,(,0,0
73538,RCT,0,0
73539,),0,0
73540,.,0,0
73541,A,0,0
73542,total,0,0
73543,of,0,0
73544,266,0,0
73545,064,0,0
73546,women,0,0
73547,(,0,0
73548,age,0,0
73549,of,0,0
73550,30,0,0
73551,to,0,0
73552,64,0,0
73553,years,0,0
73554,),0,0
73555,associated,0,0
73556,with,0,0
73557,519,0,0
73558,textile,0,0
73559,factories,0,0
73560,in,0,0
73561,Shanghai,0,0
73562,had,0,0
73563,been,0,0
73564,randomly,0,0
73565,assigned,0,0
73566,to,0,0
73567,a,0,0
73568,BSE,0,1
73569,group,0,0
73570,(,0,0
73571,132,0,0
73572,979,0,0
73573,women,0,0
73574,),0,0
73575,or,0,0
73576,a,0,0
73577,control,0,0
73578,group,0,0
73579,(,0,0
73580,133,0,0
73581,085,0,0
73582,women,0,0
73583,),0,0
73584,since,0,0
73585,1989,0,0
73586,.,0,0
73587,Initial,0,1
73588,instruction,0,0
73589,in,0,0
73590,BSE,0,0
73591,group,0,0
73592,would,0,0
73593,include,0,0
73594,demonstration,0,0
73595,of,0,1
73596,proper,0,0
73597,palpation,0,1
73598,techniques,0,0
73599,and,0,1
73600,was,0,0
73601,followed,0,0
73602,by,0,0
73603,2,0,0
73604,reinforcement,0,0
73605,sessions,0,0
73606,during,0,0
73607,the,0,0
73608,subsequent,0,0
73609,4,0,0
73610,years,0,0
73611,including,0,0
73612,video,0,0
73613,shows,0,0
73614,",",0,1
73615,BSE,0,1
73616,instruction,0,1
73617,sessions,0,0
73618,and,0,1
73619,BSE,0,1
73620,practice,0,0
73621,under,0,0
73622,medical,0,0
73623,supervision,0,0
73624,.,0,0
73625,These,0,0
73626,activities,0,1
73627,were,0,0
73628,continued,0,0
73629,for,0,0
73630,5,0,0
73631,years,0,0
73632,.,0,0
73633,Attendance,0,1
73634,at,0,0
73635,all,0,0
73636,events,0,1
73637,was,0,0
73638,recorded,0,0
73639,.,0,0
73640,The,0,0
73641,cohort,0,0
73642,was,0,0
73643,followed,0,0
73644,through,0,0
73645,July,0,0
73646,2000,0,0
73647,for,0,0
73648,development,0,0
73649,of,0,1
73650,breast,0,0
73651,diseases,0,1
73652,",",0,0
73653,and,0,0
73654,the,0,0
73655,breast,0,0
73656,cancer,0,0
73657,cases,0,0
73658,were,0,0
73659,followed,0,0
73660,through,0,0
73661,2001,0,0
73662,for,0,0
73663,vital,0,1
73664,status,0,1
73665,.,0,1
73666,Data,0,1
73667,analysis,0,0
73668,methods,0,0
73669,used,0,0
73670,would,0,0
73671,include,0,0
73672,Kaplan-Meier,0,1
73673,plots,0,0
73674,",",0,1
73675,log-rank,0,0
73676,test,0,1
73677,and,0,1
73678,Cox,0,0
73679,modeling,0,0
73680,.,0,1
73681,RESULTS,0,0
73682,Among,0,0
73683,women,0,0
73684,under,0,0
73685,instruction,0,0
73686,",",0,0
73687,864,0,0
73688,breast,0,0
73689,cancers,0,0
73690,detected,0,0
73691,and,0,0
73692,133,0,0
73693,breast,0,0
73694,cancer,0,0
73695,deaths,0,1
73696,occurred,0,0
73697,while,0,0
73698,896,0,0
73699,breast,0,0
73700,cancers,0,0
73701,were,0,0
73702,detected,0,0
73703,and,0,0
73704,130,0,0
73705,deaths,0,1
73706,recorded,0,0
73707,in,0,0
73708,the,0,0
73709,control,0,0
73710,group,0,0
73711,.,0,0
73712,The,0,0
73713,tumor,0,1
73714,size,0,1
73715,(,0,1
73716,P,0,0
73717,=,0,0
73718,0.07,0,0
73719,),0,0
73720,",",0,0
73721,TNM,0,1
73722,stage,0,1
73723,(,0,0
73724,P,0,0
73725,=,0,0
73726,0.39,0,0
73727,),0,0
73728,and,0,0
73729,cumulative,0,1
73730,breast,1,0
73731,cancer,1,1
73732,mortality,1,1
73733,rate,1,1
73734,(,0,1
73735,P,0,0
73736,=,0,0
73737,0.72,0,0
73738,),0,0
73739,were,0,0
73740,not,0,0
73741,significantly,0,0
73742,different,0,0
73743,between,0,0
73744,the,0,0
73745,2,0,0
73746,groups,0,0
73747,.,0,0
73748,However,0,0
73749,",",0,0
73750,more,0,0
73751,and,0,1
73752,smaller,0,1
73753,fibroadenomas,0,1
73754,were,0,0
73755,detected,0,0
73756,in,0,0
73757,the,0,0
73758,instruction,0,0
73759,group,0,0
73760,than,0,0
73761,in,0,0
73762,the,0,0
73763,control,0,0
73764,group,0,0
73765,(,0,1
73766,P,0,0
73767,<,0,0
73768,0.01,0,0
73769,),0,0
73770,.,0,0
73771,CONCLUSION,0,0
73772,Intensive,1,0
73773,instruction,1,0
73774,in,1,0
73775,BSE,1,1
73776,did,1,0
73777,not,1,0
73778,seem,1,0
73779,to,1,0
73780,have,1,0
73781,reduced,1,0
73782,the,1,0
73783,mortality,1,1
73784,rate,1,1
73785,of,1,1
73786,breast,1,0
73787,cancer,1,1
73788,",",1,1
73789,but,1,0
73790,more,1,1
73791,and,1,1
73792,smaller,1,1
73793,benign,1,0
73794,breast,1,0
73795,lumps,1,1
73796,could,1,0
73797,be,1,0
73798,detected,1,0
73799,.,1,0
73800,Neurophysiological,0,1
73801,double-blind,0,0
73802,trial,0,0
73803,of,0,0
73804,a,0,0
73805,botulinum,0,0
73806,neurotoxin,0,0
73807,type,0,0
73808,a,0,0
73809,free,0,1
73810,of,0,0
73811,complexing,0,0
73812,proteins,0,0
73813,.,0,0
73814,OBJECTIVE,0,1
73815,Safety,1,1
73816,and,1,1
73817,efficacy,1,1
73818,of,0,1
73819,botulinum,0,1
73820,neurotoxin,0,0
73821,type,0,0
73822,A,0,0
73823,preparation,0,0
73824,NT,0,0
73825,201,0,0
73826,(,0,0
73827,Xeomin,0,0
73828,",",0,1
73829,Merz,0,0
73830,Pharmaceuticals,0,1
73831,GmbH,0,1
73832,",",0,0
73833,Frankfurt,0,0
73834,am,0,1
73835,Main,0,0
73836,",",0,1
73837,Germany,0,0
73838,),0,1
73839,were,0,0
73840,investigated,0,0
73841,over,0,0
73842,52,0,0
73843,weeks,0,0
73844,in,0,0
73845,a,0,0
73846,double-blind,0,0
73847,",",0,0
73848,randomized,0,0
73849,trial,0,0
73850,with,0,0
73851,32,0,0
73852,male,0,0
73853,volunteers,0,0
73854,.,0,0
73855,METHODS,0,0
73856,Electroneurographic,1,1
73857,assessments,1,0
73858,with,1,0
73859,surface,1,1
73860,electrodes,1,1
73861,were,0,0
73862,performed,0,0
73863,after,0,0
73864,single,0,0
73865,injections,0,0
73866,of,0,0
73867,NT,0,0
73868,201,0,0
73869,(,0,0
73870,2,0,0
73871,",",0,0
73872,4,0,0
73873,",",0,0
73874,16,0,0
73875,",",0,0
73876,or,0,0
73877,32,0,0
73878,units,0,0
73879,),0,0
73880,into,0,0
73881,the,0,0
73882,extensor,0,1
73883,digitorum,0,1
73884,brevis,0,1
73885,(,0,1
73886,EDB,0,1
73887,),0,1
73888,muscle,0,1
73889,and,0,0
73890,the,0,0
73891,same,0,0
73892,dose,0,0
73893,(,0,0
73894,Botox,0,0
73895,;,0,0
73896,Allergan,0,0
73897,Pharmaceuticals,0,1
73898,(,0,1
73899,Ireland,0,0
73900,),0,1
73901,Ltd.,0,0
73902,Westport,0,1
73903,",",0,1
73904,Ireland,0,0
73905,),0,0
73906,into,0,0
73907,the,0,0
73908,contralateral,0,1
73909,EDB,0,1
73910,.,0,0
73911,RESULTS,0,0
73912,All,0,0
73913,NT,0,0
73914,201,0,0
73915,and,0,0
73916,BTXCo,0,0
73917,doses,0,0
73918,achieved,0,0
73919,a,0,0
73920,statistically,0,0
73921,significant,0,0
73922,reduction,1,1
73923,of,1,0
73924,the,1,0
73925,compound,1,0
73926,muscle,1,1
73927,action,1,1
73928,potential,1,1
73929,M-wave,1,1
73930,amplitude,1,1
73931,in,0,0
73932,the,1,0
73933,EDB,1,0
73934,muscle,1,1
73935,.,1,0
73936,At,0,0
73937,week,0,0
73938,4,0,0
73939,",",0,0
73940,the,0,0
73941,highest,0,1
73942,dose,0,0
73943,was,0,0
73944,statistically,0,0
73945,significantly,0,0
73946,more,0,0
73947,effective,1,1
73948,than,0,0
73949,the,0,0
73950,lowest,0,0
73951,dose,0,0
73952,(,0,0
73953,NT,0,0
73954,201,0,0
73955,",",0,0
73956,P,0,0
73957,=,0,0
73958,0.019,0,0
73959,;,0,0
73960,95,0,0
73961,%,0,0
73962,confidence,0,0
73963,interval,0,0
73964,",",0,0
73965,0.195-1.370,0,0
73966,;,0,1
73967,and,0,1
73968,BTXCo,0,1
73969,",",0,1
73970,P,0,0
73971,=,0,0
73972,0.002,0,0
73973,;,0,0
73974,95,0,0
73975,%,0,0
73976,confidence,0,0
73977,interval,0,0
73978,",",0,1
73979,0.309-1.167,0,0
73980,),0,0
73981,.,0,0
73982,Duration,1,1
73983,of,1,1
73984,effect,1,1
73985,was,0,0
73986,dose,0,0
73987,dependent,0,0
73988,.,0,0
73989,The,0,0
73990,mean,1,1
73991,values,1,1
73992,of,1,1
73993,compound,1,0
73994,muscle,1,1
73995,action,1,1
73996,potential,1,0
73997,M-wave,1,1
73998,amplitudes,1,1
73999,in,1,0
74000,the,1,0
74001,adjacent,1,0
74002,muscles,1,1
74003,(,0,0
74004,abductor,0,1
74005,digiti,0,1
74006,quinti,0,0
74007,and,0,1
74008,abductor,0,1
74009,hallucis,0,1
74010,),0,1
74011,were,0,0
74012,above,0,0
74013,the,0,0
74014,predefined,0,1
74015,threshold,0,1
74016,of,0,1
74017,effect,0,1
74018,",",0,0
74019,indicating,0,0
74020,that,0,0
74021,there,0,0
74022,was,0,0
74023,no,0,0
74024,relevant,0,0
74025,diffusion-induced,0,1
74026,reduction,0,1
74027,of,0,1
74028,muscle,1,1
74029,activity,1,1
74030,.,1,0
74031,NT,0,0
74032,201,0,0
74033,and,0,0
74034,BTXCo,0,0
74035,were,0,0
74036,well,0,0
74037,tolerated,1,1
74038,.,1,0
74039,CONCLUSIONS,0,0
74040,NT,0,0
74041,201,0,0
74042,is,0,0
74043,effective,0,0
74044,and,0,1
74045,safe,0,1
74046,in,0,0
74047,inducing,0,0
74048,the,0,0
74049,desired,0,1
74050,paretic,0,1
74051,effect,0,0
74052,.,0,0
74053,Recombinant,0,0
74054,human,0,0
74055,granulocyte-macrophage,0,1
74056,colony-stimulating,0,0
74057,factor,0,0
74058,ameliorates,0,1
74059,zidovudine-induced,0,1
74060,neutropenia,0,1
74061,in,0,0
74062,patients,0,0
74063,with,0,0
74064,acquired,0,0
74065,immunodeficiency,0,0
74066,syndrome,0,1
74067,(,0,1
74068,AIDS,0,1
74069,),0,1
74070,/AIDS-related,0,0
74071,complex,0,0
74072,.,0,0
74073,To,0,0
74074,evaluate,0,0
74075,the,0,0
74076,effect,1,0
74077,of,0,0
74078,recombinant,0,0
74079,granulocyte-macrophage,0,1
74080,colony-stimulating,0,1
74081,factor,0,1
74082,(,0,1
74083,GM-CSF,0,0
74084,),0,0
74085,on,0,0
74086,patients,0,0
74087,with,0,0
74088,acquired,0,0
74089,immunodeficiency,0,0
74090,syndrome,0,1
74091,(,0,1
74092,AIDS,0,1
74093,),0,1
74094,or,0,0
74095,AIDS-related,0,1
74096,complex,0,0
74097,(,0,1
74098,ARC,0,0
74099,),0,0
74100,who,0,0
74101,were,0,0
74102,intolerant,0,0
74103,to,0,0
74104,zidovudine,0,0
74105,because,0,0
74106,of,0,0
74107,neutropenia,0,1
74108,",",0,0
74109,we,0,0
74110,performed,0,0
74111,a,0,0
74112,randomized,0,0
74113,",",0,0
74114,open-label,0,0
74115,study,0,0
74116,in,0,0
74117,which,0,0
74118,patients,0,0
74119,were,0,0
74120,assigned,0,0
74121,to,0,0
74122,one,0,0
74123,of,0,0
74124,two,0,0
74125,groups,0,0
74126,.,0,0
74127,Zidovudine,0,0
74128,was,0,0
74129,discontinued,0,0
74130,in,0,0
74131,group,0,0
74132,A,0,0
74133,patients,0,0
74134,before,0,0
74135,instituting,0,0
74136,GM-CSF,0,0
74137,treatment,0,0
74138,and,0,1
74139,was,0,0
74140,restarted,0,0
74141,in,0,0
74142,a,0,0
74143,graduated,0,0
74144,fashion,0,0
74145,over,0,0
74146,4,0,0
74147,weeks,0,0
74148,.,0,0
74149,Group,0,0
74150,B,0,0
74151,patients,0,0
74152,continued,0,0
74153,on,0,0
74154,full-dose,0,0
74155,(,0,0
74156,"1,200",0,0
74157,mg/d,0,0
74158,),0,0
74159,zidovudine,0,0
74160,therapy,0,0
74161,while,0,0
74162,beginning,0,0
74163,GM-CSF,0,0
74164,therapy,0,0
74165,.,0,0
74166,A,0,0
74167,total,0,0
74168,of,0,0
74169,17,0,0
74170,patients,0,0
74171,were,0,0
74172,entered,0,0
74173,",",0,0
74174,eight,0,0
74175,in,0,0
74176,group,0,0
74177,A,0,0
74178,and,0,0
74179,nine,0,0
74180,in,0,0
74181,group,0,0
74182,B,0,0
74183,.,0,0
74184,Five,0,0
74185,of,0,0
74186,eight,0,0
74187,patients,0,0
74188,in,0,0
74189,group,0,0
74190,A,0,0
74191,and,0,0
74192,seven,0,0
74193,of,0,0
74194,nine,0,0
74195,in,0,0
74196,group,0,0
74197,B,0,0
74198,had,0,0
74199,a,0,0
74200,history,0,1
74201,of,0,0
74202,Pneumocystis,0,0
74203,carinii,0,0
74204,pneumonia,0,1
74205,(,0,1
74206,PCP,0,0
74207,),0,0
74208,.,0,0
74209,All,0,0
74210,were,0,0
74211,homosexual,0,0
74212,males,0,0
74213,",",0,0
74214,except,0,0
74215,one,0,0
74216,female,0,0
74217,in,0,0
74218,group,0,0
74219,A,0,0
74220,who,0,0
74221,was,0,0
74222,the,0,0
74223,sex,0,0
74224,partner,0,0
74225,of,0,0
74226,a,0,0
74227,bisexual,0,0
74228,male,0,0
74229,with,0,0
74230,AIDS,0,0
74231,.,0,0
74232,All,0,0
74233,patients,0,0
74234,had,0,0
74235,neutropenia,1,1
74236,(,0,0
74237,absolute,0,1
74238,neutrophil,0,1
74239,count,0,1
74240,[,0,0
74241,ANC,0,0
74242,],0,0
74243,less,0,0
74244,than,0,0
74245,"1,000/microL",0,1
74246,),0,0
74247,while,0,0
74248,taking,0,0
74249,full-dose,0,0
74250,zidovudine,0,0
74251,.,0,0
74252,The,0,0
74253,mean,0,1
74254,CD4,0,1
74255,(,0,0
74256,+/-,0,0
74257,SD,0,1
74258,),0,1
74259,lymphocyte,0,1
74260,level,0,1
74261,was,0,0
74262,37,0,0
74263,(,0,0
74264,+/-,0,0
74265,29,0,0
74266,),0,0
74267,/microL,0,0
74268,and,0,0
74269,39,0,0
74270,(,0,0
74271,+/-,0,0
74272,44,0,0
74273,),0,0
74274,/microL,0,0
74275,in,0,0
74276,groups,0,0
74277,A,0,0
74278,and,0,1
74279,B,0,1
74280,",",0,0
74281,respectively,0,0
74282,.,0,0
74283,After,0,0
74284,randomization,0,0
74285,",",0,1
74286,patients,0,0
74287,were,0,0
74288,begun,0,0
74289,on,0,0
74290,subcutaneous,0,0
74291,GM-CSF,0,0
74292,at,0,0
74293,a,0,0
74294,dose,0,0
74295,of,0,0
74296,1.0,0,0
74297,microgram/kg/d,0,0
74298,.,0,0
74299,Patients,0,0
74300,in,0,0
74301,group,0,0
74302,A,0,0
74303,received,0,0
74304,2,0,0
74305,weeks,0,0
74306,of,0,0
74307,daily,0,1
74308,GM-CSF,0,0
74309,",",0,0
74310,at,0,0
74311,which,0,0
74312,time,0,1
74313,zidovudine,0,0
74314,was,0,0
74315,restarted,0,0
74316,if,0,0
74317,the,0,0
74318,ANC,0,0
74319,was,0,0
74320,greater,0,0
74321,than,0,0
74322,"1,000/microL",0,0
74323,;,0,0
74324,if,0,0
74325,the,0,0
74326,ANC,0,0
74327,was,0,0
74328,less,0,0
74329,than,0,0
74330,"1,000/microL",0,0
74331,",",0,0
74332,the,0,0
74333,dose,0,0
74334,of,0,1
74335,GM-CSF,0,0
74336,was,0,0
74337,increased,0,0
74338,to,0,0
74339,3.0,0,0
74340,micrograms/kg,0,0
74341,",",0,0
74342,and,0,1
74343,at,0,1
74344,2-week,0,0
74345,intervals,0,1
74346,either,0,0
74347,zidovudine,0,0
74348,was,0,0
74349,restarted,0,0
74350,or,0,0
74351,the,0,0
74352,dose,0,0
74353,of,0,1
74354,GM-CSF,0,0
74355,was,0,0
74356,increased,0,0
74357,to,0,0
74358,5,0,0
74359,micrograms/kg,0,0
74360,and,0,0
74361,then,0,0
74362,10,0,0
74363,micrograms/kg,0,0
74364,",",0,0
74365,to,0,0
74366,maintain,0,0
74367,the,0,0
74368,ANC,0,0
74369,greater,0,0
74370,than,0,0
74371,"1,000/microL",0,0
74372,.,0,0
74373,Group,0,0
74374,B,0,0
74375,patients,0,0
74376,received,0,0
74377,full-dose,0,0
74378,zidovudine,0,0
74379,concurrently,0,0
74380,with,0,0
74381,GM-CSF,0,0
74382,administration,0,0
74383,.,0,0
74384,The,0,0
74385,dose,0,0
74386,of,0,1
74387,GM-CSF,0,0
74388,was,0,0
74389,increased,0,0
74390,every,0,0
74391,2,0,0
74392,weeks,0,0
74393,if,0,0
74394,necessary,0,0
74395,to,0,0
74396,keep,0,0
74397,the,0,0
74398,ANC,1,0
74399,greater,0,0
74400,than,0,0
74401,"1,000/microL",0,0
74402,while,0,0
74403,maintaining,0,0
74404,full-dose,0,0
74405,zidovudine,0,0
74406,therapy,0,0
74407,.,0,0
74408,Patients,0,0
74409,in,0,0
74410,each,0,0
74411,group,0,0
74412,showed,0,0
74413,an,0,0
74414,increase,0,0
74415,in,0,0
74416,total,1,1
74417,white,1,0
74418,blood,1,1
74419,cell,1,1
74420,(,1,1
74421,WBC,1,1
74422,),1,0
74423,count,1,1
74424,.,1,1
74425,Neutrophils,1,1
74426,and,1,1
74427,eosinophils,1,1
74428,were,0,0
74429,responsible,0,0
74430,for,0,0
74431,the,0,0
74432,majority,0,0
74433,of,0,0
74434,this,0,0
74435,increase,0,0
74436,.,0,0
74437,Patients,0,0
74438,in,0,0
74439,group,0,0
74440,A,0,0
74441,had,0,0
74442,a,0,0
74443,more,0,0
74444,rapid,0,1
74445,increase,1,1
74446,in,1,0
74447,WBC,1,0
74448,than,0,0
74449,those,0,0
74450,in,0,0
74451,group,0,0
74452,B,0,0
74453,;,0,0
74454,however,0,0
74455,",",0,0
74456,by,0,0
74457,week,0,0
74458,8,0,0
74459,",",0,0
74460,the,0,0
74461,WBC,1,0
74462,in,0,0
74463,each,0,0
74464,group,0,0
74465,was,0,0
74466,essentially,0,0
74467,equal,0,0
74468,.,0,0
74469,Viral,1,0
74470,replication,1,0
74471,as,0,0
74472,measured,0,0
74473,by,0,0
74474,human,1,0
74475,immunodeficiency,1,0
74476,virus,1,1
74477,(,1,1
74478,HIV,1,1
74479,),1,1
74480,p24,1,1
74481,antigen,1,1
74482,(,1,1
74483,Ag,1,1
74484,),1,1
74485,was,0,0
74486,decreased,0,0
74487,in,0,0
74488,four,0,0
74489,patients,0,0
74490,in,0,0
74491,each,0,0
74492,group,0,0
74493,",",0,0
74494,increased,0,0
74495,in,0,0
74496,one,0,0
74497,patient,0,0
74498,in,0,0
74499,each,0,0
74500,group,0,0
74501,",",0,1
74502,and,0,1
74503,remained,0,1
74504,unchanged,0,0
74505,in,0,0
74506,the,0,0
74507,remainder,0,0
74508,.,0,0
74509,The,0,0
74510,ability,1,1
74511,to,1,0
74512,culture,1,1
74513,virus,1,1
74514,from,0,0
74515,peripheral,0,1
74516,blood,0,1
74517,mononuclear,0,1
74518,cells,0,1
74519,was,0,0
74520,not,0,0
74521,changed,0,0
74522,by,0,0
74523,the,0,0
74524,regimen,0,0
74525,.,0,0
74526,The,0,0
74527,major,0,0
74528,toxicities,0,1
74529,of,0,0
74530,the,0,0
74531,regimen,0,0
74532,were,0,0
74533,fever,0,1
74534,and,0,0
74535,malaise,0,1
74536,.,0,1
74537,(,0,0
74538,ABSTRACT,0,1
74539,TRUNCATED,0,0
74540,AT,0,0
74541,400,0,0
74542,WORDS,0,0
74543,),0,0
74544,Similar,0,0
74545,effects,0,1
74546,of,0,1
74547,rofecoxib,0,0
74548,and,0,1
74549,indomethacin,0,0
74550,on,0,0
74551,the,0,0
74552,incidence,0,1
74553,of,0,1
74554,heterotopic,0,1
74555,ossification,0,1
74556,after,0,0
74557,hip,0,1
74558,arthroplasty,0,1
74559,.,0,1
74560,BACKGROUND,0,0
74561,Although,0,0
74562,indomethacin,0,0
74563,is,0,0
74564,effective,0,1
74565,in,0,0
74566,preventing,0,0
74567,heterotopic,1,1
74568,ossification,1,1
74569,(,1,1
74570,HO,1,0
74571,),1,0
74572,after,0,0
74573,primary,0,0
74574,total,0,1
74575,hip,0,1
74576,arthroplasty,0,1
74577,",",0,1
74578,side,1,1
74579,effects,1,1
74580,are,0,0
74581,frequently,0,0
74582,observed,0,0
74583,.,0,0
74584,In,0,0
74585,the,0,0
74586,last,0,0
74587,decade,0,0
74588,a,0,0
74589,new,0,0
74590,class,0,0
74591,of,0,0
74592,drugs,0,0
74593,--,0,0
74594,the,0,0
74595,COX-2,0,0
74596,selective,0,1
74597,nonsteroidal,0,0
74598,anti-inflammatory,0,0
74599,drugs,0,0
74600,--,0,0
74601,has,0,0
74602,been,0,0
74603,developed,0,0
74604,.,0,0
74605,To,0,0
74606,investigate,0,0
74607,the,0,0
74608,effect,0,0
74609,of,0,0
74610,these,0,0
74611,COX-2,0,0
74612,selective,0,1
74613,NSAIDs,1,1
74614,on,1,0
74615,heterotopic,1,1
74616,ossification,1,1
74617,(,1,1
74618,HO,1,0
74619,),1,0
74620,after,0,0
74621,primary,0,0
74622,total,0,1
74623,hip,0,1
74624,arthroplasty,0,1
74625,(,0,1
74626,THA,0,1
74627,),0,0
74628,",",0,0
74629,we,0,0
74630,conducted,0,0
74631,a,0,0
74632,randomized,0,0
74633,controlled,0,0
74634,trial,0,0
74635,using,0,0
74636,either,0,0
74637,indomethacin,0,0
74638,or,0,1
74639,rofecoxib,0,0
74640,for,0,0
74641,7,0,0
74642,days,0,0
74643,.,0,0
74644,METHODS,0,0
74645,186,0,0
74646,patients,0,0
74647,received,0,0
74648,either,0,0
74649,indomethacin,0,0
74650,3,0,0
74651,times,0,0
74652,daily,0,0
74653,",",0,0
74654,or,0,1
74655,rofecoxib,0,0
74656,twice,0,0
74657,",",0,0
74658,and,0,0
74659,1,0,0
74660,placebo,0,0
74661,",",0,0
74662,daily,0,0
74663,for,0,0
74664,7,0,0
74665,days,0,0
74666,.,0,0
74667,HO,1,0
74668,was,1,0
74669,graded,1,0
74670,according,0,0
74671,to,0,0
74672,the,0,0
74673,1-year,0,1
74674,postoperative,0,1
74675,radiographs,0,1
74676,according,0,0
74677,to,0,0
74678,the,0,0
74679,Brooker,0,0
74680,classification,0,1
74681,.,0,0
74682,RESULTS,0,0
74683,12,0,0
74684,of,0,0
74685,the,0,0
74686,186,0,0
74687,patients,0,0
74688,included,0,0
74689,discontinued,1,0
74690,their,0,0
74691,medication,0,0
74692,before,0,0
74693,the,0,0
74694,end,0,0
74695,of,0,0
74696,the,0,0
74697,trial,0,0
74698,due,0,0
74699,to,0,0
74700,side,1,1
74701,effects,1,0
74702,.,1,0
74703,The,0,0
74704,remaining,0,0
74705,174,0,0
74706,patients,0,0
74707,were,0,0
74708,included,0,0
74709,in,0,0
74710,the,0,0
74711,analysis,0,0
74712,.,0,0
74713,In,0,0
74714,the,0,0
74715,indomethacin,0,0
74716,group,0,0
74717,(,0,0
74718,n,0,0
74719,=,0,0
74720,89,0,0
74721,),0,0
74722,",",0,0
74723,77,0,0
74724,patients,0,0
74725,(,0,0
74726,87,0,0
74727,%,0,0
74728,),0,0
74729,showed,1,0
74730,no,1,0
74731,HO,1,0
74732,",",0,0
74733,9,0,0
74734,showed,1,0
74735,HO,1,0
74736,of,1,0
74737,grade,1,0
74738,1,1,0
74739,and,0,0
74740,3,0,0
74741,showed,1,0
74742,HO,1,0
74743,of,1,0
74744,grade,1,0
74745,2,1,0
74746,according,0,0
74747,to,0,0
74748,the,0,0
74749,Brooker,0,0
74750,classification,0,1
74751,.,0,0
74752,In,0,0
74753,the,0,0
74754,rofecoxib,0,0
74755,group,0,0
74756,(,0,0
74757,n,0,0
74758,=,0,0
74759,85,0,0
74760,),0,0
74761,73,0,0
74762,patients,0,0
74763,(,0,0
74764,86,0,0
74765,%,0,0
74766,),0,0
74767,showed,1,0
74768,no,1,0
74769,ossification,1,0
74770,",",0,0
74771,9,0,0
74772,showed,1,0
74773,grade,1,0
74774,1,1,0
74775,",",0,0
74776,and,0,0
74777,3,0,0
74778,showed,1,0
74779,grade,1,0
74780,2,1,0
74781,.,1,0
74782,INTERPRETATION,0,0
74783,The,0,0
74784,prophylactic,0,0
74785,effect,0,1
74786,of,0,1
74787,rofecoxib,0,0
74788,for,0,0
74789,7,0,0
74790,days,0,0
74791,in,0,0
74792,preventing,0,0
74793,heterotopic,0,1
74794,ossification,0,1
74795,after,0,0
74796,primary,0,0
74797,total,0,1
74798,hip,0,0
74799,arthroplasty,0,0
74800,is,0,0
74801,comparable,0,0
74802,to,0,0
74803,the,0,0
74804,effect,0,0
74805,of,0,0
74806,indomethacin,0,0
74807,given,0,0
74808,for,0,0
74809,7,0,0
74810,days,0,0
74811,.,0,0
74812,These,0,0
74813,results,0,0
74814,indicate,0,0
74815,that,0,0
74816,the,0,0
74817,development,0,0
74818,of,0,0
74819,HO,0,0
74820,follows,0,0
74821,a,0,0
74822,COX-2,0,0
74823,pathway,0,0
74824,.,0,0
74825,The,0,0
74826,effectiveness,0,0
74827,of,0,0
74828,Picture,0,1
74829,Exchange,0,0
74830,Communication,0,1
74831,System,0,1
74832,(,0,1
74833,PECS,0,1
74834,),0,1
74835,training,0,0
74836,for,0,0
74837,teachers,0,0
74838,of,0,0
74839,children,0,0
74840,with,0,0
74841,autism,0,0
74842,:,0,0
74843,a,0,0
74844,pragmatic,0,0
74845,",",0,0
74846,group,0,0
74847,randomised,0,0
74848,controlled,0,0
74849,trial,0,0
74850,.,0,0
74851,OBJECTIVE,0,0
74852,To,0,0
74853,assess,0,0
74854,the,0,0
74855,effectiveness,0,0
74856,of,0,0
74857,expert,0,0
74858,training,0,0
74859,and,0,1
74860,consultancy,0,1
74861,for,0,0
74862,teachers,0,0
74863,of,0,0
74864,children,0,0
74865,with,0,0
74866,autism,0,0
74867,spectrum,0,0
74868,disorder,0,0
74869,in,0,0
74870,the,0,0
74871,use,0,0
74872,of,0,0
74873,the,0,0
74874,Picture,0,1
74875,Exchange,0,0
74876,Communication,0,1
74877,System,0,1
74878,(,0,1
74879,PECS,0,0
74880,),0,0
74881,.,0,0
74882,METHOD,0,0
74883,DESIGN,0,0
74884,Group,0,0
74885,randomised,0,0
74886,",",0,0
74887,controlled,0,0
74888,trial,0,0
74889,(,0,0
74890,3,0,0
74891,groups,0,0
74892,:,0,0
74893,immediate,0,1
74894,treatment,0,0
74895,",",0,1
74896,delayed,0,1
74897,treatment,0,0
74898,",",0,0
74899,no,0,0
74900,treatment,0,0
74901,),0,0
74902,.,0,0
74903,PARTICIPANTS,0,0
74904,84,0,0
74905,elementary,0,0
74906,school,0,0
74907,children,0,0
74908,",",0,1
74909,mean,0,1
74910,age,0,0
74911,6.8,0,0
74912,years,0,0
74913,.,0,0
74914,TREATMENT,0,0
74915,A,0,0
74916,2-day,0,1
74917,PECS,0,0
74918,workshop,0,0
74919,for,0,0
74920,teachers,0,0
74921,plus,0,0
74922,6,0,0
74923,half-day,0,0
74924,",",0,0
74925,school-based,0,0
74926,training,0,0
74927,sessions,0,0
74928,with,0,0
74929,expert,0,0
74930,consultants,0,0
74931,over,0,0
74932,5,0,0
74933,months,0,0
74934,.,0,0
74935,OUTCOME,0,0
74936,MEASURES,0,0
74937,Rates,0,1
74938,of,0,0
74939,:,0,0
74940,communicative,1,1
74941,initiations,1,0
74942,",",1,1
74943,use,1,1
74944,of,1,1
74945,PECS,1,1
74946,",",1,1
74947,and,1,1
74948,speech,1,1
74949,in,1,0
74950,the,1,0
74951,classroom,1,0
74952,;,1,0
74953,Autism,1,1
74954,Diagnostic,1,1
74955,Observation,1,0
74956,Schedule-Generic,1,1
74957,(,1,1
74958,ADOS-G,1,0
74959,),1,1
74960,domain,1,0
74961,scores,1,1
74962,for,1,0
74963,Communication,1,1
74964,and,1,1
74965,Reciprocal,1,1
74966,Social,1,1
74967,Interaction,1,0
74968,;,1,0
74969,scores,1,1
74970,on,1,0
74971,formal,1,0
74972,language,1,0
74973,tests,1,1
74974,.,1,0
74975,RESULTS,0,0
74976,Controlling,0,1
74977,for,0,0
74978,baseline,0,1
74979,age,0,0
74980,",",0,1
74981,developmental,1,1
74982,quotient,1,1
74983,(,1,1
74984,DQ,1,1
74985,),1,1
74986,and,1,0
74987,language,1,1
74988,;,1,0
74989,rates,1,1
74990,of,1,0
74991,initiations,1,0
74992,and,1,1
74993,PECS,1,1
74994,usage,1,1
74995,increased,0,0
74996,significantly,0,0
74997,immediately,0,0
74998,post-treatment,0,1
74999,(,0,0
75000,Odds,0,1
75001,Ratio,0,1
75002,(,0,1
75003,OR,0,1
75004,),0,0
75005,of,0,0
75006,being,0,0
75007,in,0,0
75008,a,0,0
75009,higher,0,0
75010,ordinal,0,1
75011,rate,0,1
75012,category,0,0
75013,2.72,0,0
75014,",",0,0
75015,95,0,0
75016,%,0,0
75017,confidence,0,0
75018,interval,0,0
75019,1.22-6.09,0,0
75020,",",0,0
75021,p,0,0
75022,<,0,0
75023,.05,0,0
75024,and,0,0
75025,OR,0,0
75026,3.90,0,0
75027,(,0,0
75028,95,0,0
75029,%,0,0
75030,CI,0,0
75031,1.75-8.68,0,0
75032,),0,0
75033,",",0,0
75034,p,0,0
75035,<,0,0
75036,.001,0,0
75037,",",0,0
75038,respectively,0,0
75039,),0,0
75040,.,0,0
75041,There,0,0
75042,were,0,0
75043,no,0,0
75044,increases,0,1
75045,in,0,0
75046,frequency,1,1
75047,of,1,1
75048,speech,1,1
75049,",",1,1
75050,or,1,1
75051,improvements,1,1
75052,in,1,0
75053,ADOS-G,1,0
75054,ratings,1,1
75055,or,1,1
75056,language,1,1
75057,test,1,1
75058,scores,1,1
75059,.,1,0
75060,CONCLUSIONS,0,0
75061,The,0,0
75062,results,0,0
75063,indicate,0,0
75064,modest,0,0
75065,effectiveness,0,1
75066,of,0,1
75067,PECS,0,1
75068,teacher,0,1
75069,training/consultancy,0,1
75070,.,0,0
75071,Rates,0,1
75072,of,0,0
75073,pupils,0,1
75074,',0,1
75075,initiations,0,0
75076,and,0,1
75077,use,0,1
75078,of,0,1
75079,symbols,0,0
75080,in,0,0
75081,the,0,0
75082,classroom,0,0
75083,increased,0,1
75084,",",0,0
75085,although,0,0
75086,there,0,0
75087,was,0,0
75088,no,0,0
75089,evidence,0,0
75090,of,0,0
75091,improvement,0,1
75092,in,0,0
75093,other,0,0
75094,areas,0,1
75095,of,0,0
75096,communication,0,1
75097,.,0,0
75098,TREATMENT,0,0
75099,effects,0,1
75100,were,0,0
75101,not,0,0
75102,maintained,0,0
75103,once,0,0
75104,active,0,0
75105,intervention,0,0
75106,ceased,0,0
75107,.,0,0
75108,[,0,1
75109,Laparoscopic,0,0
75110,lymphadenectomy,0,0
75111,as,0,0
75112,treatment,0,0
75113,of,0,1
75114,endometrial,0,1
75115,cancer,0,0
75116,],0,0
75117,.,0,0
75118,AIM,0,0
75119,This,0,0
75120,study,0,0
75121,compares,0,0
75122,the,0,0
75123,effects,1,0
75124,of,0,0
75125,laparoscopic,0,0
75126,lymphadenectomy,0,0
75127,versus,0,0
75128,those,0,0
75129,of,0,0
75130,abdominal,0,1
75131,lymphadenectomy,0,0
75132,in,0,0
75133,patients,0,0
75134,with,0,0
75135,endometrial,0,1
75136,cancer,0,0
75137,.,0,0
75138,METHODS,0,0
75139,A,0,0
75140,prospective,0,0
75141,randomized,0,0
75142,study,0,0
75143,was,0,0
75144,performed,0,0
75145,among,0,0
75146,80,0,0
75147,patients,0,0
75148,randomly,0,0
75149,assigned,0,0
75150,to,0,0
75151,laparoscopic,0,0
75152,lymphadenectomy,0,0
75153,and,0,1
75154,to,0,0
75155,abdominal,0,1
75156,lymphadenectomy,0,0
75157,in,0,0
75158,the,0,0
75159,treatment,0,0
75160,of,0,0
75161,endometrial,0,1
75162,cancer,0,0
75163,.,0,0
75164,Clinical,0,1
75165,outcomes,1,1
75166,and,0,1
75167,complications,1,1
75168,were,0,0
75169,compared,0,0
75170,for,0,0
75171,1,0,0
75172,year,0,0
75173,of,0,0
75174,follow-up,0,0
75175,.,0,0
75176,RESULTS,0,0
75177,Forty,0,0
75178,patients,0,0
75179,were,0,0
75180,assigned,0,0
75181,to,0,0
75182,laparoscopic,0,0
75183,lymphadenectomy,0,0
75184,and,0,0
75185,40,0,0
75186,patients,0,0
75187,to,0,0
75188,abdominal,0,1
75189,lymphadenectomy,0,0
75190,.,0,0
75191,The,0,0
75192,laparoscopic,0,0
75193,approach,0,0
75194,was,0,0
75195,associated,0,0
75196,with,0,0
75197,a,0,0
75198,longer,1,0
75199,operative,1,1
75200,time,1,1
75201,(,0,0
75202,234.1,0,0
75203,min,0,0
75204,vs,0,0
75205,137.3,0,0
75206,min,0,0
75207,),0,0
75208,but,0,0
75209,was,0,0
75210,less,1,0
75211,painful,1,1
75212,(,0,0
75213,VAS,0,1
75214,5.3,0,0
75215,vs,0,0
75216,7.9,0,0
75217,;,0,0
75218,P,0,0
75219,<,0,0
75220,0.000,0,0
75221,),0,0
75222,and,0,0
75223,resulted,0,0
75224,in,0,0
75225,a,0,0
75226,shorter,1,1
75227,hospital,1,1
75228,stay,1,1
75229,(,0,1
75230,4.4+/-1,0,0
75231,vs,0,0
75232,7.9+/-1.2,0,0
75233,days,0,0
75234,;,0,0
75235,P,0,0
75236,<,0,0
75237,0.000,0,0
75238,),0,0
75239,.,0,0
75240,At,0,0
75241,6,0,0
75242,weeks,0,0
75243,the,0,0
75244,quality,1,1
75245,of,1,1
75246,life,1,1
75247,was,0,0
75248,better,0,0
75249,in,0,0
75250,patients,0,0
75251,who,0,0
75252,had,0,0
75253,laparoscopic,0,0
75254,lymphadenectomy,0,0
75255,(,0,0
75256,SF-12,0,0
75257,),0,0
75258,.,0,0
75259,CONCLUSION,0,0
75260,Laparoscopic,0,0
75261,lymphadenectomy,0,0
75262,was,0,0
75263,associated,0,0
75264,with,0,0
75265,a,0,0
75266,significantly,0,0
75267,lower,0,0
75268,rate,1,1
75269,of,1,1
75270,major,1,1
75271,and,1,1
75272,minor,1,1
75273,postoperative,1,1
75274,complications,1,1
75275,and,0,0
75276,a,0,0
75277,better,0,0
75278,short,0,1
75279,term,0,1
75280,quality,1,1
75281,of,1,0
75282,life,1,1
75283,.,1,0
75284,Tacrolimus,0,0
75285,monotherapy,0,0
75286,without,0,0
75287,steroids,0,0
75288,after,0,0
75289,liver,0,1
75290,transplantation,0,0
75291,--,0,0
75292,a,0,0
75293,prospective,0,0
75294,randomized,0,0
75295,double-blinded,0,0
75296,placebo-controlled,0,0
75297,trial,0,0
75298,.,0,1
75299,Early,0,1
75300,steroid,0,0
75301,withdrawal,0,1
75302,after,0,0
75303,liver,0,1
75304,transplantation,0,0
75305,(,0,1
75306,LT,0,1
75307,),0,0
75308,is,0,0
75309,desirable,0,1
75310,in,0,0
75311,order,0,0
75312,to,0,0
75313,reduce,0,0
75314,steroid,0,0
75315,side,0,1
75316,effects,0,1
75317,.,0,0
75318,Between,0,0
75319,February,0,0
75320,2000,0,0
75321,and,0,0
75322,August,0,0
75323,2004,0,0
75324,",",0,0
75325,110,0,0
75326,patients,0,0
75327,after,0,0
75328,LT,0,1
75329,were,0,0
75330,included,0,0
75331,in,0,0
75332,this,0,0
75333,prospective,0,0
75334,",",0,0
75335,randomized,0,0
75336,",",0,0
75337,double-blind,0,0
75338,",",0,1
75339,placebo-controlled,0,0
75340,trial,0,0
75341,.,0,1
75342,Randomization,0,0
75343,was,0,0
75344,performed,0,0
75345,before,0,0
75346,LT,0,1
75347,.,0,0
75348,In,0,0
75349,all,0,0
75350,patients,0,0
75351,",",0,1
75352,tacrolimus,0,0
75353,was,0,0
75354,used,0,0
75355,without,0,0
75356,induction,0,0
75357,therapy,0,0
75358,.,0,0
75359,All,0,0
75360,patients,0,0
75361,received,0,0
75362,methylprednisolon,0,0
75363,for,0,0
75364,14,0,0
75365,days,0,0
75366,",",0,0
75367,thereafter,0,0
75368,a,0,0
75369,double-blinded,0,0
75370,medication,0,1
75371,containing,0,0
75372,either,0,0
75373,placebo,0,0
75374,(,0,1
75375,n,0,0
75376,=,0,0
75377,56,0,0
75378,),0,0
75379,or,0,0
75380,methylprednisolon,0,0
75381,(,0,1
75382,n,0,0
75383,=,0,0
75384,54,0,0
75385,),0,0
75386,for,0,0
75387,6,0,0
75388,months,0,0
75389,",",0,0
75390,which,0,0
75391,was,0,0
75392,completely,0,0
75393,stopped,0,0
75394,thereafter,0,0
75395,.,0,0
75396,End,0,0
75397,points,0,0
75398,were,0,0
75399,patient,1,1
75400,and,1,1
75401,graft,1,1
75402,survival,1,1
75403,",",1,1
75404,acute,1,1
75405,and,1,1
75406,chronic,1,1
75407,rejection,1,1
75408,",",1,1
75409,and,1,1
75410,incidence,1,1
75411,of,1,1
75412,steroid,1,0
75413,side,1,1
75414,effects,1,1
75415,during,0,0
75416,the,0,0
75417,first,0,0
75418,year,0,0
75419,after,0,0
75420,LT,0,1
75421,.,0,0
75422,One-year,0,1
75423,patient,1,1
75424,survival,1,1
75425,was,0,0
75426,85.7,0,0
75427,%,0,0
75428,(,0,0
75429,placebo,0,0
75430,),0,0
75431,and,0,0
75432,88.8,0,0
75433,%,0,0
75434,(,0,0
75435,steroid,0,1
75436,),0,1
75437,(,0,0
75438,p,0,0
75439,=,0,0
75440,0.572,0,0
75441,),0,0
75442,.,0,0
75443,Twenty-seven,0,0
75444,(,0,0
75445,48.2,0,0
75446,%,0,0
75447,),0,0
75448,and,0,0
75449,19,0,0
75450,(,0,0
75451,35.2,0,0
75452,%,0,0
75453,),0,0
75454,patients,0,0
75455,experienced,0,1
75456,acute,1,0
75457,rejection,1,1
75458,(,0,0
75459,placebo,0,0
75460,versus,0,0
75461,steroid,0,1
75462,",",0,0
75463,respectively,0,0
75464,;,0,0
75465,p,0,0
75466,=,0,0
75467,0.116,0,0
75468,),0,0
75469,.,0,0
75470,Two,0,0
75471,patients,0,0
75472,in,0,0
75473,the,0,0
75474,placebo,0,0
75475,group,0,0
75476,but,0,0
75477,none,0,0
75478,in,0,0
75479,the,0,0
75480,steroid,0,0
75481,group,0,0
75482,experienced,0,1
75483,chronic,1,0
75484,rejection,1,1
75485,(,0,0
75486,p,0,0
75487,=,0,0
75488,0.257,0,0
75489,),0,0
75490,.,0,0
75491,The,0,0
75492,rates,1,1
75493,of,1,0
75494,side,1,1
75495,effects,1,1
75496,were,0,0
75497,(,0,0
75498,placebo,0,0
75499,versus,0,0
75500,steroid,0,1
75501,",",0,0
75502,respectively,0,0
75503,),0,0
75504,:,0,0
75505,CMV,1,0
75506,infection,1,0
75507,25,0,0
75508,%,0,0
75509,versus,0,0
75510,33,0,0
75511,%,0,0
75512,(,0,0
75513,p,0,0
75514,=,0,0
75515,0.336,0,0
75516,),0,0
75517,",",0,0
75518,post-transplant,1,1
75519,diabetes,1,0
75520,30,0,0
75521,%,0,0
75522,versus,0,0
75523,53,0,0
75524,%,0,0
75525,(,0,0
75526,p,0,0
75527,=,0,0
75528,0.024,0,0
75529,),0,0
75530,",",0,0
75531,hypertension,1,0
75532,39,0,0
75533,%,0,0
75534,versus,0,0
75535,52,0,0
75536,%,0,0
75537,(,0,0
75538,p,0,0
75539,=,0,0
75540,0.248,0,0
75541,),0,0
75542,",",0,0
75543,hypercholesterolemia,1,0
75544,10,0,0
75545,%,0,0
75546,versus,0,0
75547,41,0,0
75548,%,0,0
75549,(,0,0
75550,p,0,0
75551,=,0,0
75552,0.002,0,0
75553,),0,0
75554,and,0,0
75555,hypertriglyceridemia,1,0
75556,32,0,0
75557,%,0,0
75558,versus,0,0
75559,54,0,0
75560,%,0,0
75561,(,0,0
75562,p,0,0
75563,=,0,0
75564,0.046,0,0
75565,),0,0
75566,.,0,0
75567,In,0,0
75568,conclusion,0,0
75569,",",0,1
75570,early,0,1
75571,steroid,0,1
75572,withdrawal,0,1
75573,after,0,0
75574,LT,0,1
75575,is,0,0
75576,feasible,1,0
75577,under,0,0
75578,tacrolimus,0,0
75579,monotherapy,0,0
75580,without,0,0
75581,increased,0,1
75582,rejection,0,1
75583,rates,0,1
75584,and,0,0
75585,with,0,0
75586,a,0,0
75587,lower,1,0
75588,rate,1,1
75589,of,1,1
75590,side,1,1
75591,effects,1,0
75592,.,1,0
75593,Comparison,0,0
75594,of,0,0
75595,self-administered,0,0
75596,vaginal,0,0
75597,misoprostol,0,0
75598,versus,0,0
75599,placebo,0,0
75600,for,0,0
75601,cervical,0,0
75602,ripening,0,0
75603,prior,0,0
75604,to,0,0
75605,operative,0,1
75606,hysteroscopy,0,0
75607,using,0,0
75608,a,0,0
75609,sequential,0,0
75610,trial,0,0
75611,design,0,0
75612,.,0,0
75613,OBJECTIVE,0,0
75614,To,0,0
75615,compare,0,0
75616,the,0,0
75617,impact,0,0
75618,of,0,0
75619,1000-microgram,0,0
75620,self-administered,0,0
75621,vaginal,0,0
75622,misoprostol,0,0
75623,versus,0,0
75624,self-administered,0,0
75625,vaginal,0,0
75626,placebo,0,0
75627,at,0,0
75628,home,0,0
75629,on,0,0
75630,preoperative,0,1
75631,cervical,0,0
75632,ripening,0,0
75633,in,0,0
75634,both,0,0
75635,premenopausal,0,0
75636,and,0,1
75637,postmenopausal,0,0
75638,women,0,0
75639,prior,0,0
75640,to,0,0
75641,outpatient,0,0
75642,resectoscopy,0,0
75643,.,0,1
75644,DESIGN,0,1
75645,Randomised,0,0
75646,",",0,0
75647,double-blind,0,0
75648,",",0,1
75649,placebo-controlled,0,0
75650,sequential,0,0
75651,trial,0,0
75652,.,0,1
75653,SETTING,0,0
75654,Norwegian,0,0
75655,university,0,0
75656,teaching,0,0
75657,hospital,0,1
75658,.,0,0
75659,SAMPLE,0,1
75660,Premenopausal,0,1
75661,and,0,1
75662,postmenopausal,0,0
75663,women,0,0
75664,referred,0,0
75665,to,0,0
75666,outpatient,0,0
75667,resectoscopy,0,0
75668,.,0,0
75669,METHODS,0,0
75670,The,0,0
75671,women,0,0
75672,were,0,0
75673,randomised,0,0
75674,to,0,0
75675,either,0,0
75676,1000,0,0
75677,micrograms,0,0
75678,of,0,0
75679,self-administered,0,0
75680,vaginal,0,0
75681,misoprostol,0,0
75682,or,0,1
75683,self-administered,0,0
75684,vaginal,0,0
75685,placebo,0,0
75686,the,0,0
75687,evening,0,1
75688,before,0,0
75689,outpatient,0,0
75690,resectoscopy,0,0
75691,.,0,0
75692,MAIN,0,0
75693,OUTCOME,0,1
75694,MEASURES,0,0
75695,Preoperative,1,1
75696,cervical,1,1
75697,dilatation,1,1
75698,",",1,1
75699,acceptability,1,1
75700,and,1,1
75701,complications,1,1
75702,.,1,1
75703,RESULTS,0,0
75704,(,0,0
75705,a,0,0
75706,),0,0
75707,Intraoperative,0,0
75708,findings,0,0
75709,and,0,1
75710,distribution,0,1
75711,of,1,1
75712,cervical,1,0
75713,dilatation,1,1
75714,in,0,0
75715,the,0,0
75716,two,0,0
75717,treatment,0,0
75718,groups,0,0
75719,.,0,0
75720,Values,0,0
75721,are,0,0
75722,given,0,0
75723,as,0,0
75724,median,1,1
75725,(,1,0
75726,range,1,0
75727,),1,1
75728,or,1,1
75729,n,1,0
75730,(,1,1
75731,%,1,0
75732,),1,1
75733,.,1,1
75734,(,0,0
75735,b,0,1
75736,),0,1
75737,Acceptability,1,1
75738,in,0,0
75739,the,0,0
75740,two,0,0
75741,treatment,0,0
75742,groups,0,0
75743,.,0,0
75744,Values,0,0
75745,are,0,0
75746,given,0,0
75747,as,0,0
75748,completely,0,0
75749,acceptable,0,0
75750,",",0,1
75751,n,0,0
75752,(,0,1
75753,%,0,0
75754,),0,0
75755,;,0,0
75756,fairly,0,0
75757,acceptable,0,0
75758,",",0,1
75759,n,0,0
75760,(,0,1
75761,%,0,0
75762,),0,0
75763,;,0,0
75764,fairly,0,0
75765,unacceptable,0,1
75766,",",0,1
75767,n,0,0
75768,(,0,1
75769,%,0,0
75770,),0,1
75771,and,0,0
75772,completely,0,0
75773,unacceptable,0,1
75774,",",0,1
75775,n,0,0
75776,(,0,1
75777,%,0,0
75778,),0,1
75779,.,0,1
75780,(,0,0
75781,c,0,1
75782,),0,1
75783,Pain,1,1
75784,in,0,0
75785,the,0,0
75786,two,0,0
75787,treatment,0,0
75788,groups,0,0
75789,.,0,1
75790,Pain,1,1
75791,was,0,0
75792,measured,0,0
75793,with,0,0
75794,a,0,0
75795,visual,0,1
75796,analogue,0,1
75797,scale,0,1
75798,score,0,1
75799,",",0,1
75800,scale,0,1
75801,ranges,0,1
75802,from,0,0
75803,0,0,0
75804,(,0,0
75805,no,0,0
75806,pain,0,1
75807,),0,0
75808,to,0,0
75809,10,0,0
75810,(,0,0
75811,unbearable,0,1
75812,pain,0,1
75813,),0,0
75814,.,0,0
75815,Values,0,0
75816,are,0,0
75817,given,0,0
75818,as,0,0
75819,median,0,1
75820,(,0,0
75821,range,0,0
75822,),0,1
75823,.,0,1
75824,(,0,0
75825,d,0,1
75826,),0,1
75827,Occurrence,1,1
75828,of,1,0
75829,adverse,1,1
75830,effects,1,0
75831,in,0,0
75832,the,0,0
75833,two,0,0
75834,treatment,0,0
75835,groups,0,0
75836,.,0,0
75837,Values,0,0
75838,are,0,0
75839,given,0,0
75840,as,0,0
75841,n,0,0
75842,(,0,0
75843,%,0,0
75844,),0,1
75845,.,0,1
75846,(,0,0
75847,e,0,1
75848,),0,1
75849,Complications,1,1
75850,",",0,0
75851,given,0,0
75852,as,0,0
75853,n,0,0
75854,(,0,0
75855,%,0,0
75856,),0,0
75857,.,0,0
75858,Using,0,0
75859,the,0,0
75860,demand-control,0,0
75861,model,0,0
75862,of,0,1
75863,job,0,1
75864,strain,0,0
75865,to,0,0
75866,predict,0,1
75867,caregiver,1,1
75868,burden,1,1
75869,and,0,1
75870,caregiver,1,1
75871,satisfaction,1,1
75872,in,0,0
75873,the,0,0
75874,informal,0,0
75875,caregivers,0,0
75876,of,0,1
75877,heart,0,1
75878,failure,0,1
75879,patients,0,0
75880,.,0,0
75881,OBJECTIVES,0,0
75882,The,0,0
75883,demand-control,0,0
75884,(,0,0
75885,D-C,0,0
75886,),0,1
75887,model,0,0
75888,of,0,1
75889,job,0,1
75890,strain,0,0
75891,has,0,0
75892,generated,0,0
75893,a,0,0
75894,considerable,0,0
75895,body,0,1
75896,of,0,1
75897,empirical,0,0
75898,support,0,0
75899,in,0,0
75900,predicting,0,1
75901,psychological,0,1
75902,health,0,1
75903,outcomes,0,1
75904,in,0,0
75905,the,0,0
75906,context,0,0
75907,of,0,0
75908,work,0,0
75909,.,0,0
75910,This,0,0
75911,study,0,0
75912,aimed,0,0
75913,to,0,0
75914,extend,0,0
75915,previous,0,0
75916,work,0,0
75917,using,0,0
75918,the,0,0
75919,D-C,0,0
75920,model,0,0
75921,of,0,1
75922,job,0,1
75923,strain,0,0
75924,to,0,0
75925,predict,0,1
75926,caregiver,1,1
75927,burden,1,1
75928,and,0,1
75929,satisfaction,1,1
75930,in,0,0
75931,the,0,0
75932,informal,0,0
75933,caregivers,0,0
75934,of,0,0
75935,patients,0,0
75936,with,0,0
75937,heart,0,1
75938,failure,0,1
75939,.,0,1
75940,DESIGN,0,0
75941,AND,0,0
75942,METHOD,0,1
75943,Data,0,1
75944,were,0,0
75945,gathered,0,0
75946,from,0,0
75947,60,0,0
75948,caregiver/patient,0,0
75949,dyads,0,0
75950,in,0,0
75951,a,0,0
75952,cross-sectional,0,0
75953,design,0,0
75954,.,0,0
75955,Patients,0,0
75956,with,0,0
75957,chronic,0,0
75958,stable,0,1
75959,heart,0,1
75960,failure,0,1
75961,were,0,0
75962,recruited,0,0
75963,from,0,0
75964,out-patient,0,0
75965,clinics,0,0
75966,.,0,0
75967,The,0,0
75968,dependent,0,0
75969,variables,0,1
75970,were,0,0
75971,caregiver,1,1
75972,burden,1,1
75973,and,1,1
75974,satisfaction,1,1
75975,.,1,1
75976,Demand,1,0
75977,and,1,1
75978,control,1,0
75979,were,0,0
75980,measured,0,0
75981,using,0,0
75982,both,0,0
75983,patient-,1,1
75984,and,1,0
75985,caregiver-derived,1,1
75986,measures,1,0
75987,.,1,0
75988,RESULTS,0,0
75989,The,0,0
75990,D-C,0,0
75991,model,0,0
75992,accounted,0,0
75993,for,0,0
75994,15,0,0
75995,and,0,0
75996,19,0,0
75997,%,0,0
75998,of,0,0
75999,the,0,0
76000,variance,0,1
76001,in,0,0
76002,caregiver,1,1
76003,burden,1,1
76004,",",0,0
76005,after,0,0
76006,controlling,0,1
76007,for,0,0
76008,age,0,0
76009,",",0,1
76010,gender,0,1
76011,and,0,1
76012,relationship,0,1
76013,to,0,0
76014,the,0,0
76015,patient,0,0
76016,.,0,0
76017,Lower,0,0
76018,control,1,0
76019,was,0,0
76020,associated,0,0
76021,with,0,0
76022,higher,1,0
76023,burden,1,1
76024,.,1,0
76025,The,0,0
76026,D-C,0,0
76027,model,0,0
76028,did,0,0
76029,not,0,0
76030,predict,0,0
76031,caregiver,1,1
76032,satisfaction,1,1
76033,.,1,0
76034,CONCLUSION,0,0
76035,The,0,0
76036,D-C,0,0
76037,model,0,0
76038,was,0,0
76039,associated,0,0
76040,with,0,0
76041,caregiver,1,1
76042,burden,1,1
76043,",",0,1
76044,but,0,0
76045,not,0,0
76046,satisfaction,1,1
76047,in,0,0
76048,caregivers,0,1
76049,",",0,0
76050,with,0,0
76051,control,0,0
76052,being,0,0
76053,the,0,0
76054,dominant,0,0
76055,predictor,0,0
76056,.,0,0
76057,Research,0,0
76058,linking,0,0
76059,the,0,0
76060,theory,0,0
76061,and,0,1
76062,findings,0,0
76063,from,0,0
76064,job,0,1
76065,strain,0,1
76066,and,0,1
76067,informal,0,1
76068,caregiving,0,1
76069,studies,0,0
76070,may,0,0
76071,elucidate,0,0
76072,both,0,0
76073,fields,0,0
76074,of,0,0
76075,research,0,0
76076,.,0,0
76077,Using,0,0
76078,the,0,0
76079,demand-control,0,0
76080,model,0,0
76081,of,0,1
76082,job,0,1
76083,strain,0,0
76084,to,0,0
76085,predict,0,1
76086,caregiver,1,1
76087,burden,1,1
76088,and,0,1
76089,caregiver,1,1
76090,satisfaction,1,1
76091,in,0,0
76092,the,0,0
76093,informal,0,0
76094,caregivers,0,0
76095,of,0,1
76096,heart,0,1
76097,failure,0,1
76098,patients,0,0
76099,.,0,0
76100,The,0,0
76101,relationship,0,0
76102,between,0,0
76103,histology,1,1
76104,and,1,1
76105,outcome,1,1
76106,in,0,0
76107,advanced,0,0
76108,and,0,1
76109,recurrent,0,1
76110,endometrial,0,1
76111,cancer,0,0
76112,patients,0,0
76113,participating,0,0
76114,in,0,0
76115,first-line,0,0
76116,chemotherapy,0,0
76117,trials,0,0
76118,:,0,0
76119,a,0,0
76120,Gynecologic,0,0
76121,Oncology,0,1
76122,Group,0,0
76123,study,0,0
76124,.,0,0
76125,OBJECTIVES,0,0
76126,To,0,0
76127,explore,0,0
76128,associations,0,0
76129,between,0,0
76130,histology,1,1
76131,and,1,1
76132,outcome,1,1
76133,in,0,0
76134,advanced,0,0
76135,or,0,0
76136,recurrent,0,1
76137,endometrial,0,1
76138,cancer,0,0
76139,patients,0,0
76140,participating,0,0
76141,in,0,0
76142,Gynecologic,0,0
76143,Oncology,0,1
76144,Group,0,0
76145,chemotherapy,0,0
76146,trials,0,0
76147,.,0,0
76148,METHODS,0,0
76149,Age,1,1
76150,",",1,1
76151,race,1,0
76152,",",1,1
76153,performance,1,1
76154,status,1,1
76155,",",1,1
76156,histologic,1,1
76157,type,1,1
76158,(,1,0
76159,serous=S,1,1
76160,;,1,0
76161,clear,1,0
76162,cell=CC,1,0
76163,;,1,1
76164,endometrioid=E,1,1
76165,),1,1
76166,",",1,1
76167,disease,1,1
76168,stage,1,1
76169,",",1,1
76170,and,1,1
76171,prior,1,1
76172,radiation,1,1
76173,were,0,0
76174,evaluated,0,0
76175,using,0,0
76176,various,0,0
76177,analytic,0,0
76178,methods,0,0
76179,to,0,0
76180,evaluate,0,0
76181,the,0,0
76182,probability,0,1
76183,of,0,1
76184,response,0,1
76185,and,0,1
76186,identify,0,0
76187,independent,0,0
76188,predictors,0,0
76189,of,0,1
76190,progression-free,1,1
76191,survival,1,1
76192,(,1,1
76193,PFS,1,1
76194,),1,1
76195,and,1,1
76196,overall,1,1
76197,survival,1,1
76198,(,1,1
76199,OS,1,1
76200,),1,0
76201,.,1,0
76202,RESULTS,0,0
76203,Single,0,1
76204,agent,0,0
76205,or,0,1
76206,combination,0,0
76207,chemotherapy,0,0
76208,regimens,0,0
76209,including,0,0
76210,doxorubicin,0,0
76211,(,0,0
76212,A,0,0
76213,),0,0
76214,(,0,0
76215,12,0,0
76216,%,0,0
76217,),0,0
76218,",",0,1
76219,doxorubicin/cisplatin,0,0
76220,(,0,1
76221,AP,0,1
76222,),0,0
76223,(,0,0
76224,63,0,0
76225,%,0,0
76226,),0,0
76227,",",0,1
76228,doxorubicin/paclitaxel,0,0
76229,(,0,1
76230,AT,0,0
76231,),0,0
76232,(,0,0
76233,13,0,0
76234,%,0,0
76235,),0,0
76236,",",0,1
76237,and,0,1
76238,paclitaxel/doxorubicin/cisplatin,0,0
76239,(,0,1
76240,TAP,0,1
76241,),0,0
76242,(,0,0
76243,11,0,0
76244,%,0,0
76245,),0,0
76246,were,0,0
76247,used,0,0
76248,among,0,0
76249,1203,0,0
76250,patients,0,0
76251,treated,0,0
76252,on,0,0
76253,4,0,0
76254,randomized,0,0
76255,clinical,0,0
76256,trials,0,0
76257,.,0,0
76258,Breakdown,0,1
76259,of,0,1
76260,disease,1,1
76261,stage,1,0
76262,was,0,0
76263,7.8,0,0
76264,%,0,0
76265,stage,0,0
76266,III,0,0
76267,",",0,0
76268,22.8,0,0
76269,%,0,0
76270,stage,0,0
76271,IV,0,1
76272,",",0,0
76273,and,0,0
76274,69.4,0,0
76275,%,0,0
76276,recurrent,0,0
76277,disease,0,1
76278,.,0,1
76279,Histologic,1,1
76280,distribution,1,1
76281,was,0,0
76282,18,0,0
76283,%,0,0
76284,S,0,0
76285,",",0,0
76286,3.7,0,0
76287,%,0,0
76288,CC,0,0
76289,",",0,0
76290,8.5,0,0
76291,%,0,0
76292,mixed,0,0
76293,",",0,0
76294,51.7,0,0
76295,%,0,0
76296,E,0,0
76297,and,0,0
76298,18.1,0,0
76299,%,0,0
76300,other,0,0
76301,.,0,0
76302,More,0,0
76303,S/CC,0,0
76304,patients,0,0
76305,enrolled,0,0
76306,on,0,0
76307,trials,0,0
76308,with,0,0
76309,advanced,0,0
76310,stage,0,0
76311,(,0,1
76312,III-IV,0,1
76313,),0,1
76314,disease,0,1
76315,(,0,0
76316,as,0,0
76317,opposed,0,0
76318,to,0,0
76319,recurrent,0,0
76320,disease,0,1
76321,),0,0
76322,compared,0,0
76323,to,0,0
76324,E,0,0
76325,patients,0,0
76326,(,0,0
76327,45,0,0
76328,%,0,0
76329,vs.,0,0
76330,24,0,0
76331,%,0,0
76332,",",0,0
76333,p,0,0
76334,<,0,0
76335,0.05,0,0
76336,),0,0
76337,.,0,0
76338,Overall,1,1
76339,response,1,1
76340,rate,1,1
76341,was,0,0
76342,42,0,0
76343,%,0,0
76344,(,0,0
76345,E=44,0,0
76346,%,0,0
76347,",",0,1
76348,S=44,0,1
76349,%,0,0
76350,",",0,1
76351,CC=32,0,1
76352,%,0,0
76353,),0,0
76354,.,0,0
76355,Histologic,1,1
76356,type,1,0
76357,was,0,0
76358,not,0,0
76359,an,0,0
76360,independent,0,0
76361,predictor,0,0
76362,of,0,0
76363,response,0,1
76364,.,0,0
76365,Independent,0,0
76366,predictors,0,0
76367,of,0,1
76368,PFS,0,1
76369,included,0,0
76370,race,1,0
76371,",",1,1
76372,performance,1,1
76373,status,1,1
76374,",",1,1
76375,disease,1,1
76376,stage,1,1
76377,",",1,1
76378,and,1,1
76379,CC,1,1
76380,histology,1,1
76381,.,1,1
76382,Histology,1,1
76383,was,0,0
76384,also,0,0
76385,an,0,0
76386,independent,0,0
76387,predictor,0,0
76388,of,0,0
76389,OS,0,1
76390,;,0,0
76391,the,0,0
76392,relative,1,1
76393,hazard,1,1
76394,ratio,1,1
76395,for,0,0
76396,S,0,1
76397,histology,0,1
76398,was,0,0
76399,1.2,0,0
76400,(,0,0
76401,1.02-1.4,0,0
76402,;,0,0
76403,p=0.03,0,0
76404,),0,1
76405,",",0,1
76406,and,0,1
76407,for,0,0
76408,CC,0,0
76409,was,0,0
76410,1.51,0,0
76411,(,0,0
76412,1.1-2.07,0,0
76413,;,0,0
76414,p=0.01,0,0
76415,),0,0
76416,.,0,0
76417,CONCLUSION,0,0
76418,In,0,0
76419,patients,0,0
76420,with,0,0
76421,advanced/recurrent,0,0
76422,endometrial,0,1
76423,cancer,0,0
76424,treated,0,0
76425,with,0,0
76426,A,0,0
76427,",",0,0
76428,P,0,0
76429,and/or,0,0
76430,T,0,1
76431,",",0,1
76432,response,0,1
76433,was,0,0
76434,not,1,0
76435,associated,1,0
76436,with,1,0
76437,histology,1,0
76438,.,1,0
76439,This,0,0
76440,exploratory,0,0
76441,analysis,0,0
76442,does,0,0
76443,not,0,0
76444,support,0,0
76445,exclusion,0,0
76446,of,0,0
76447,S,0,0
76448,tumors,0,0
76449,in,0,0
76450,future,0,0
76451,trials,0,0
76452,.,0,0
76453,Poorer,1,0
76454,PFS,1,1
76455,and,1,1
76456,OS,1,1
76457,were,0,0
76458,observed,0,0
76459,in,0,0
76460,CC,0,0
76461,compared,0,0
76462,to,0,0
76463,other,0,0
76464,types,0,0
76465,",",0,0
76466,but,0,0
76467,a,0,0
76468,lack,0,0
76469,of,0,0
76470,benefit,0,0
76471,from,0,0
76472,chemotherapy,0,0
76473,was,0,0
76474,not,0,0
76475,shown,0,0
76476,",",0,0
76477,and,0,0
76478,as,0,0
76479,this,0,0
76480,histology,0,0
76481,represents,0,0
76482,such,0,0
76483,a,0,0
76484,small,0,0
76485,fraction,0,1
76486,",",0,0
76487,it,0,0
76488,does,0,0
76489,not,0,0
76490,seem,0,0
76491,feasible,0,0
76492,to,0,0
76493,have,0,0
76494,separate,0,0
76495,chemotherapy,0,0
76496,trials,0,0
76497,for,0,0
76498,CC,0,0
76499,.,0,0
76500,A,0,0
76501,comparison,0,0
76502,of,0,0
76503,the,0,0
76504,laryngeal,0,0
76505,tube-S,0,1
76506,and,0,1
76507,Proseal,0,0
76508,laryngeal,0,1
76509,mask,0,1
76510,during,0,0
76511,outpatient,0,0
76512,surgical,0,0
76513,procedures,0,0
76514,.,0,1
76515,BACKGROUND,0,0
76516,AND,0,0
76517,OBJECTIVE,0,0
76518,The,0,0
76519,Laryngeal,0,0
76520,Tube,0,1
76521,Sonda,0,0
76522,(,0,1
76523,LTS,0,0
76524,),0,0
76525,and,0,0
76526,the,0,0
76527,ProSeal,0,1
76528,Laryngeal,0,0
76529,Mask,0,0
76530,Airway,0,1
76531,(,0,1
76532,PLMA,0,0
76533,),0,0
76534,are,0,0
76535,two,0,0
76536,new,0,0
76537,devices,0,0
76538,introduced,0,0
76539,for,0,0
76540,maintaining,0,0
76541,the,0,0
76542,airway,0,1
76543,during,0,0
76544,controlled,0,0
76545,ventilation,0,0
76546,under,0,0
76547,general,0,0
76548,anaesthesia,0,0
76549,.,0,0
76550,The,0,0
76551,present,0,0
76552,investigation,0,0
76553,compared,0,0
76554,their,0,0
76555,performance,0,0
76556,in,0,0
76557,a,0,0
76558,randomized,0,0
76559,controlled,0,0
76560,study,0,0
76561,.,0,0
76562,METHODS,0,0
76563,One,0,0
76564,hundred,0,0
76565,ASA,0,0
76566,I-II,0,0
76567,patients,0,0
76568,",",0,0
76569,aged,0,0
76570,18-60,0,0
76571,yr,0,0
76572,undergoing,0,0
76573,elective,0,0
76574,minor,0,1
76575,surgery,0,0
76576,",",0,1
76577,were,0,0
76578,randomized,0,0
76579,to,0,0
76580,receive,0,0
76581,either,0,0
76582,an,0,0
76583,LTS,0,0
76584,(,0,0
76585,n,0,0
76586,=,0,0
76587,50,0,0
76588,),0,0
76589,or,0,0
76590,PLMA,0,0
76591,(,0,1
76592,n,0,0
76593,=,0,0
76594,50,0,0
76595,),0,0
76596,for,0,0
76597,airway,0,1
76598,management,0,0
76599,.,0,0
76600,After,0,0
76601,induction,0,0
76602,of,0,1
76603,general,0,0
76604,anaesthesia,0,0
76605,",",0,0
76606,the,0,0
76607,devices,0,0
76608,were,0,0
76609,inserted,0,0
76610,",",0,0
76611,its,0,0
76612,correct,0,1
76613,placement,0,0
76614,was,0,0
76615,verified,0,0
76616,and,0,0
76617,airway,0,1
76618,leak,0,1
76619,pressure,0,1
76620,was,0,0
76621,measured,0,0
76622,.,0,0
76623,Ease,1,1
76624,of,1,1
76625,insertion,1,1
76626,",",1,1
76627,quality,1,1
76628,of,1,1
76629,airway,1,1
76630,seal,1,1
76631,",",1,1
76632,fibre-optic,1,0
76633,view,1,1
76634,and,1,1
76635,postoperative,1,1
76636,pharyngeal,1,1
76637,morbidity,1,1
76638,were,0,0
76639,examined,0,0
76640,.,0,0
76641,RESULTS,0,0
76642,There,0,0
76643,were,0,0
76644,no,0,0
76645,differences,0,0
76646,in,0,0
76647,patient,0,1
76648,characteristics,0,0
76649,for,0,0
76650,both,0,0
76651,groups,0,0
76652,.,0,0
76653,First-time,1,1
76654,and,1,1
76655,second-time,1,1
76656,success,1,1
76657,rates,1,1
76658,were,0,0
76659,comparable,0,0
76660,for,0,0
76661,both,0,0
76662,groups,0,0
76663,(,0,0
76664,86,0,0
76665,vs.,0,0
76666,88,0,0
76667,%,0,0
76668,and,0,0
76669,96,0,0
76670,vs.,0,0
76671,98,0,0
76672,%,0,0
76673,in,0,0
76674,LTS,0,0
76675,and,0,1
76676,PLMA,0,0
76677,groups,0,0
76678,",",0,0
76679,respectively,0,0
76680,),0,0
76681,.,0,0
76682,The,0,0
76683,airway,1,1
76684,of,0,0
76685,one,0,0
76686,patient,0,0
76687,in,0,0
76688,each,0,0
76689,group,0,0
76690,could,0,0
76691,not,0,0
76692,be,0,0
76693,managed,0,0
76694,with,0,0
76695,these,0,0
76696,devices,0,0
76697,after,0,0
76698,three,0,0
76699,attempts,0,0
76700,.,0,0
76701,Time,1,0
76702,until,1,0
76703,delivery,1,1
76704,of,1,0
76705,first,1,1
76706,tidal,1,1
76707,volume,1,1
76708,for,0,0
76709,LTS,0,0
76710,and,0,1
76711,PLMA,0,0
76712,was,0,0
76713,24.5,0,0
76714,+/-,0,0
76715,6.9,0,0
76716,and,0,0
76717,28.8,0,0
76718,+/-,0,0
76719,10.3,0,0
76720,s.,0,0
76721,Fixation,1,0
76722,and,1,1
76723,manipulation,1,1
76724,time,1,1
76725,was,0,0
76726,54.9,0,0
76727,+/-,0,0
76728,15.2,0,0
76729,and,0,0
76730,73.2,0,0
76731,+/-,0,0
76732,25,0,0
76733,s,0,0
76734,",",0,0
76735,respectively,0,0
76736,(,0,0
76737,P,0,0
76738,<,0,0
76739,0.05,0,0
76740,),0,0
76741,.,0,0
76742,Airway,1,1
76743,seal,1,1
76744,pressure,1,1
76745,(,0,0
76746,cm,0,1
76747,H,0,1
76748,(,0,0
76749,2,0,0
76750,),0,0
76751,O,0,0
76752,),0,0
76753,for,0,0
76754,LTS,0,0
76755,and,0,1
76756,PLMA,0,0
76757,was,0,0
76758,20,0,0
76759,+/-,0,0
76760,8.6,0,0
76761,and,0,0
76762,24.1,0,0
76763,+/-,0,0
76764,10.8,0,0
76765,",",0,0
76766,respectively,0,0
76767,(,0,0
76768,P,0,0
76769,=,0,0
76770,0.04,0,0
76771,),0,0
76772,.,0,0
76773,Patients,0,0
76774,were,0,0
76775,questioned,0,0
76776,on,0,0
76777,a,0,0
76778,variety,0,0
76779,of,0,0
76780,postoperative,1,1
76781,pharyngeal,1,0
76782,morbidities,1,1
76783,.,1,0
76784,Only,0,0
76785,hoarseness,1,1
76786,was,0,0
76787,more,0,0
76788,frequent,0,1
76789,in,0,0
76790,the,0,0
76791,LTS,0,0
76792,group,0,0
76793,.,0,1
76794,CONCLUSIONS,0,0
76795,Both,0,0
76796,devices,0,0
76797,provide,0,0
76798,a,0,0
76799,secure,0,0
76800,airway,0,1
76801,",",0,0
76802,are,0,0
76803,similar,0,0
76804,in,0,0
76805,clinical,0,1
76806,utility,0,1
76807,and,0,0
76808,are,0,0
76809,easy,0,1
76810,to,0,0
76811,insert,0,0
76812,.,0,0
76813,Better,0,0
76814,airway,1,1
76815,seal,1,0
76816,was,0,0
76817,detected,0,0
76818,in,0,0
76819,the,0,0
76820,PLMA,0,0
76821,group,0,0
76822,.,0,0
76823,A,0,0
76824,prospective,0,0
76825,",",0,0
76826,randomized,0,0
76827,trial,0,0
76828,of,0,1
76829,clear,0,0
76830,liquids,0,0
76831,versus,0,0
76832,low-fat,0,0
76833,solid,0,0
76834,diet,0,0
76835,as,0,0
76836,the,0,0
76837,initial,0,0
76838,meal,0,0
76839,in,0,0
76840,mild,0,0
76841,acute,0,0
76842,pancreatitis,0,0
76843,.,0,1
76844,BACKGROUND,0,0
76845,&,0,0
76846,AIMS,0,1
76847,Patients,0,0
76848,recovering,0,0
76849,from,0,0
76850,mild,0,0
76851,acute,0,0
76852,pancreatitis,0,0
76853,typically,0,0
76854,receive,0,0
76855,a,0,0
76856,clear,0,0
76857,liquid,0,0
76858,diet,0,0
76859,(,0,1
76860,CLD,0,0
76861,),0,0
76862,when,0,0
76863,ready,0,0
76864,to,0,0
76865,initiate,0,0
76866,oral,0,0
76867,nutrition,0,1
76868,.,0,1
76869,Patient,0,1
76870,discharge,0,0
76871,then,0,0
76872,depends,0,0
76873,on,0,0
76874,their,0,0
76875,successful,0,0
76876,advancement,0,0
76877,to,0,0
76878,solid,0,0
76879,food,0,0
76880,.,0,0
76881,We,0,0
76882,hypothesized,0,0
76883,that,0,0
76884,initiating,0,0
76885,oral,0,0
76886,nutrition,0,0
76887,with,0,0
76888,a,0,0
76889,low-fat,0,0
76890,solid,0,1
76891,diet,0,0
76892,(,0,1
76893,LFSD,0,1
76894,),0,0
76895,after,0,0
76896,mild,0,0
76897,pancreatitis,0,0
76898,would,0,0
76899,be,0,0
76900,well,0,0
76901,tolerated,0,1
76902,and,0,0
76903,would,0,0
76904,result,0,0
76905,in,0,0
76906,a,0,0
76907,shorter,0,1
76908,length,1,1
76909,of,1,1
76910,hospitalization,1,1
76911,(,0,1
76912,LOH,0,1
76913,),0,0
76914,.,0,0
76915,METHODS,0,0
76916,Patients,0,0
76917,with,0,0
76918,mild,0,0
76919,pancreatitis,0,0
76920,were,0,0
76921,randomized,0,0
76922,to,0,0
76923,a,0,0
76924,CLD,0,0
76925,or,0,0
76926,LFSD,0,0
76927,when,0,0
76928,they,0,0
76929,were,0,0
76930,ready,0,0
76931,to,0,0
76932,resume,0,1
76933,oral,0,0
76934,nutrition,0,1
76935,.,0,0
76936,Decisions,0,1
76937,about,0,0
76938,diet,0,0
76939,advancement,0,0
76940,and,0,1
76941,hospital,0,1
76942,discharge,0,1
76943,were,0,0
76944,at,0,0
76945,the,0,0
76946,discretion,0,0
76947,of,0,0
76948,the,0,0
76949,medical,0,0
76950,team,0,0
76951,",",0,0
76952,without,0,0
76953,input,0,1
76954,from,0,0
76955,study,0,0
76956,team,0,0
76957,members,0,0
76958,.,0,1
76959,Patients,0,0
76960,were,0,0
76961,monitored,0,0
76962,daily,0,0
76963,for,0,0
76964,recurrence,0,1
76965,of,0,1
76966,pain,1,1
76967,",",1,0
76968,need,1,0
76969,to,1,0
76970,stop,1,1
76971,feeding,1,1
76972,",",1,0
76973,post-refeeding,1,1
76974,LOH,1,1
76975,(,0,0
76976,primary,0,1
76977,end,0,1
76978,point,0,0
76979,),0,1
76980,",",0,1
76981,and,0,0
76982,for,0,0
76983,28,0,0
76984,days,0,0
76985,post-refeeding,0,0
76986,to,0,0
76987,capture,0,1
76988,re-admission,1,1
76989,rates,1,1
76990,.,1,0
76991,RESULTS,0,0
76992,We,0,0
76993,randomized,0,0
76994,121,0,0
76995,patients,0,0
76996,:,0,0
76997,66,0,0
76998,to,0,0
76999,CLD,0,0
77000,and,0,0
77001,55,0,0
77002,to,0,0
77003,LFSD,0,0
77004,.,0,0
77005,The,0,0
77006,number,1,1
77007,of,1,0
77008,patients,1,0
77009,requiring,1,0
77010,cessation,1,0
77011,of,1,0
77012,feeding,1,1
77013,because,1,0
77014,of,1,0
77015,pain,1,1
77016,or,1,1
77017,nausea,1,1
77018,was,0,0
77019,similar,0,0
77020,in,0,0
77021,both,0,0
77022,groups,0,0
77023,(,0,0
77024,6,0,0
77025,%,0,0
77026,for,0,0
77027,CLD,0,0
77028,",",0,0
77029,11,0,0
77030,%,0,0
77031,for,0,0
77032,LFSD,0,0
77033,;,0,0
77034,P,0,0
77035,=,0,0
77036,.51,0,0
77037,),0,0
77038,.,0,0
77039,The,0,0
77040,median,1,1
77041,LOH,1,1
77042,after,1,0
77043,refeeding,1,1
77044,was,0,0
77045,identical,0,0
77046,in,0,0
77047,both,0,0
77048,groups,0,0
77049,(,0,0
77050,1-day,0,1
77051,interquartile,0,1
77052,range,0,0
77053,",",0,0
77054,1-2,0,0
77055,;,0,0
77056,P,0,0
77057,=,0,0
77058,.77,0,0
77059,),0,0
77060,.,0,0
77061,Patients,0,0
77062,in,0,0
77063,the,0,0
77064,LFSD,0,0
77065,arm,0,0
77066,consumed,0,0
77067,significantly,0,0
77068,more,0,0
77069,calories,1,1
77070,and,1,1
77071,grams,1,1
77072,of,1,1
77073,fat,1,1
77074,than,0,0
77075,those,0,0
77076,in,0,0
77077,the,0,0
77078,CLD,0,0
77079,arm,0,0
77080,during,0,0
77081,their,0,0
77082,first,0,1
77083,meal,0,0
77084,and,0,1
77085,on,0,0
77086,study,0,0
77087,day,0,0
77088,1,0,0
77089,.,0,0
77090,There,0,0
77091,was,0,0
77092,no,0,0
77093,difference,0,0
77094,in,0,0
77095,the,0,0
77096,28-day,1,1
77097,re-admission,1,1
77098,rates,1,1
77099,between,0,0
77100,the,0,0
77101,2,0,0
77102,arms,0,0
77103,.,0,0
77104,CONCLUSIONS,0,0
77105,Initiating,0,0
77106,oral,0,0
77107,nutrition,0,1
77108,after,0,0
77109,mild,1,0
77110,acute,1,0
77111,pancreatitis,1,0
77112,with,0,0
77113,an,0,0
77114,LFSD,1,0
77115,appeared,0,0
77116,safe,0,1
77117,and,0,1
77118,provided,0,0
77119,more,0,0
77120,calories,0,1
77121,than,0,0
77122,a,0,0
77123,CLD,0,0
77124,",",0,1
77125,but,0,0
77126,did,0,0
77127,not,0,0
77128,result,0,0
77129,in,0,0
77130,a,0,0
77131,shorter,0,1
77132,LOH,1,1
77133,.,1,0
77134,The,0,0
77135,peroxisome,0,0
77136,proliferator-activated,0,0
77137,receptor-gamma,0,1
77138,agonist,0,0
77139,pioglitazone,0,0
77140,increases,0,1
77141,number,1,1
77142,and,1,1
77143,function,1,1
77144,of,1,1
77145,endothelial,1,1
77146,progenitor,1,1
77147,cells,1,1
77148,in,0,0
77149,patients,0,0
77150,with,0,0
77151,coronary,0,1
77152,artery,0,1
77153,disease,0,1
77154,and,0,1
77155,normal,0,1
77156,glucose,0,1
77157,tolerance,0,1
77158,.,0,1
77159,OBJECTIVE,0,0
77160,Peroxisome,0,1
77161,proliferator-activated,0,1
77162,receptor-gamma,0,1
77163,(,0,1
77164,PPAR,0,1
77165,gamma,0,0
77166,),0,0
77167,agonists,0,0
77168,(,0,0
77169,thiazolidinediones,0,1
77170,[,0,0
77171,TZDs,0,0
77172,],0,0
77173,),0,0
77174,are,0,0
77175,used,0,0
77176,for,0,0
77177,the,0,0
77178,treatment,0,0
77179,of,0,0
77180,diabetes,0,0
77181,.,0,0
77182,Bone,0,0
77183,marrow-derived,0,0
77184,endothelial,0,0
77185,progenitor,0,1
77186,cells,0,1
77187,(,0,1
77188,EPCs,0,0
77189,),0,0
77190,improve,0,0
77191,vascular,1,1
77192,function,1,1
77193,and,0,1
77194,predict,0,1
77195,cardiovascular,1,1
77196,risk,1,1
77197,.,1,0
77198,The,0,0
77199,effect,0,0
77200,of,0,1
77201,pioglitazone,0,0
77202,therapy,0,0
77203,on,0,0
77204,EPCs,0,0
77205,was,0,0
77206,examined,0,0
77207,.,0,0
77208,RESEARCH,0,0
77209,DESIGN,0,0
77210,AND,0,0
77211,METHODS,0,0
77212,AND,0,0
77213,RESULTS,0,0
77214,We,0,0
77215,performed,0,0
77216,a,0,0
77217,prospective,0,0
77218,",",0,0
77219,randomized,0,0
77220,",",0,0
77221,double-blind,0,0
77222,study,0,0
77223,on,0,0
77224,patients,0,0
77225,with,0,0
77226,documented,0,0
77227,stable,0,1
77228,coronary,0,1
77229,artery,0,1
77230,disease,0,1
77231,and,0,1
77232,normal,0,1
77233,glucose,0,1
77234,tolerance,0,1
77235,.,0,0
77236,Of,0,0
77237,54,0,0
77238,patients,0,0
77239,with,0,0
77240,normal,0,0
77241,fasting,0,1
77242,glucose,0,1
77243,levels,0,1
77244,",",0,0
77245,18,0,0
77246,showed,0,0
77247,impaired,0,0
77248,glucose,0,1
77249,tolerance,0,1
77250,and,0,0
77251,36,0,0
77252,patients,0,0
77253,with,0,0
77254,normal,0,0
77255,glucose,0,1
77256,tolerance,0,1
77257,were,0,0
77258,randomized,0,0
77259,to,0,0
77260,30-day,0,1
77261,treatment,0,0
77262,with,0,0
77263,pioglitazone,0,0
77264,(,0,0
77265,45,0,0
77266,mg,0,0
77267,),0,0
77268,or,0,0
77269,placebo,0,0
77270,in,0,0
77271,addition,0,0
77272,to,0,0
77273,optimal,0,1
77274,medical,0,0
77275,therapy,0,0
77276,.,0,0
77277,All,0,0
77278,patients,0,0
77279,in,0,0
77280,the,0,0
77281,TZD,0,0
77282,group,0,0
77283,showed,0,0
77284,an,0,0
77285,increase,0,0
77286,of,0,0
77287,adiponectin,1,1
77288,levels,1,1
77289,as,0,0
77290,an,0,0
77291,indicator,0,0
77292,of,0,1
77293,compliance,0,1
77294,(,0,0
77295,11.4,0,0
77296,+/-,0,0
77297,1.1,0,0
77298,to,0,0
77299,36.8,0,0
77300,+/-,0,0
77301,2.1,0,0
77302,microg/ml,0,0
77303,;,0,0
77304,P,0,0
77305,<,0,0
77306,0.001,0,0
77307,),0,0
77308,.,0,0
77309,TZD,0,0
77310,",",0,1
77311,but,0,0
77312,not,0,0
77313,placebo,0,0
77314,",",0,0
77315,decreased,0,1
77316,mean,1,1
77317,high-sensitivity,1,0
77318,C-reactive,1,1
77319,protein,1,1
77320,to,0,0
77321,43,0,0
77322,+/-,0,0
77323,19,0,0
77324,%,0,0
77325,(,0,0
77326,P,0,0
77327,<,0,0
77328,0.05,0,0
77329,),0,0
77330,.,0,0
77331,Pioglitazone,0,0
77332,increased,0,1
77333,CD34,1,0
77334,(,1,1
77335,+,1,0
77336,),1,1
77337,/kinase,1,1
77338,insert,1,1
77339,domain,1,1
77340,receptor,1,1
77341,(,1,1
77342,+,1,0
77343,),1,0
77344,EPCs,1,0
77345,to,0,0
77346,142,0,0
77347,+/-,0,0
77348,9,0,0
77349,%,0,0
77350,and,0,0
77351,cultured,1,1
77352,"1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine-labeled",1,1
77353,acetylated,1,1
77354,LDL,1,1
77355,(,1,1
77356,+,1,0
77357,),1,1
77358,/lectin,1,0
77359,(,1,1
77360,+,1,0
77361,),1,0
77362,EPCs,1,0
77363,to,0,0
77364,180,0,0
77365,+/-,0,0
77366,3,0,0
77367,%,0,0
77368,(,0,0
77369,P,0,0
77370,<,0,0
77371,0.05,0,0
77372,),0,0
77373,.,0,0
77374,EPC,1,1
77375,numbers,1,1
77376,were,0,0
77377,not,0,0
77378,changed,0,0
77379,in,0,0
77380,the,0,0
77381,placebo,0,0
77382,group,0,0
77383,.,0,1
77384,TZD,0,0
77385,increased,0,0
77386,the,0,0
77387,SDF-1-induced,1,1
77388,migratory,1,1
77389,capacity,1,1
77390,to,0,0
77391,146,0,0
77392,+/-,0,0
77393,9,0,0
77394,%,0,0
77395,per,0,0
77396,EPC,0,1
77397,number,0,1
77398,(,0,0
77399,P,0,0
77400,<,0,0
77401,0.05,0,0
77402,),0,0
77403,and,0,0
77404,upregulated,0,0
77405,the,0,0
77406,clonogenic,1,1
77407,potential,1,0
77408,of,1,1
77409,EPCs,1,0
77410,",",0,0
77411,increasing,0,0
77412,the,1,0
77413,colony-forming,1,1
77414,units,1,0
77415,to,0,0
77416,172,0,0
77417,+/-,0,0
77418,12,0,0
77419,%,0,0
77420,(,0,0
77421,P,0,0
77422,<,0,0
77423,0.001,0,0
77424,),0,0
77425,.,0,0
77426,In,0,0
77427,cultured,0,1
77428,human,0,0
77429,EPCs,0,0
77430,",",0,1
77431,TZD,0,0
77432,increased,0,1
77433,EPC,1,1
77434,numbers,1,1
77435,and,1,1
77436,migration,1,1
77437,and,1,1
77438,reduced,1,1
77439,NADPH-oxidase,1,1
77440,activity,1,1
77441,.,1,0
77442,The,0,0
77443,TZD,0,0
77444,effect,0,1
77445,was,0,0
77446,reversed,0,0
77447,by,0,0
77448,the,0,0
77449,PPAR,0,1
77450,gamma,0,1
77451,antagonist,0,0
77452,GW9662,0,0
77453,and,0,1
77454,mimicked,0,0
77455,by,0,0
77456,treatment,0,0
77457,with,0,0
77458,adiponectin,0,1
77459,.,0,0
77460,CONCLUSIONS,0,0
77461,The,0,0
77462,PPAR,0,1
77463,gamma,0,1
77464,agonist,0,0
77465,pioglitazone,0,0
77466,increases,0,1
77467,the,0,0
77468,number,1,1
77469,and,1,1
77470,function,1,1
77471,of,1,1
77472,EPCs,1,0
77473,in,0,0
77474,patients,0,0
77475,with,0,0
77476,coronary,0,1
77477,artery,0,0
77478,disease,0,1
77479,.,0,0
77480,The,0,0
77481,effect,0,0
77482,represents,0,0
77483,a,0,0
77484,potential,0,0
77485,regenerative,0,1
77486,mechanism,0,0
77487,in,0,0
77488,atherosclerosis,0,1
77489,and,0,0
77490,is,0,0
77491,observed,0,0
77492,in,0,0
77493,normoglycemic,0,0
77494,individuals,0,0
77495,with,0,0
77496,stable,0,1
77497,coronary,0,1
77498,artery,0,0
77499,disease,0,1
77500,.,0,0
77501,Should,0,0
77502,snacks,0,0
77503,be,0,0
77504,recommended,0,0
77505,in,0,0
77506,obesity,0,0
77507,treatment,0,0
77508,?,0,0
77509,A,0,0
77510,1-year,0,0
77511,randomized,0,0
77512,clinical,0,0
77513,trial,0,0
77514,.,0,0
77515,OBJECTIVE,0,0
77516,To,0,0
77517,study,0,0
77518,the,0,0
77519,effect,0,0
77520,to,0,0
77521,recommend,0,0
77522,no,0,0
77523,snacks,0,0
77524,vs,0,0
77525,three,0,0
77526,snacks,0,0
77527,per,0,0
77528,day,0,0
77529,on,0,0
77530,1-year,0,1
77531,weight,0,1
77532,loss,0,1
77533,.,0,0
77534,The,0,0
77535,hypothesis,0,0
77536,was,0,0
77537,that,0,0
77538,it,0,0
77539,is,0,0
77540,easier,0,0
77541,to,0,0
77542,control,0,0
77543,energy,0,1
77544,intake,0,1
77545,and,0,1
77546,lose,0,0
77547,weight,0,1
77548,if,0,0
77549,snacks,0,0
77550,in,0,0
77551,between,0,0
77552,meals,0,0
77553,are,0,0
77554,omitted,0,0
77555,.,0,0
77556,SUBJECTS/METHOD,0,0
77557,In,0,0
77558,total,0,0
77559,140,0,0
77560,patients,0,0
77561,(,0,0
77562,36,0,0
77563,men,0,0
77564,",",0,0
77565,104,0,0
77566,women,0,0
77567,),0,0
77568,",",0,0
77569,aged,0,0
77570,18-60,0,0
77571,years,0,0
77572,and,0,0
77573,body,0,1
77574,mass,0,1
77575,index,0,1
77576,>,0,0
77577,30,0,0
77578,kg/m,0,0
77579,(,0,0
77580,2,0,0
77581,),0,0
77582,were,0,0
77583,randomized,0,0
77584,and,0,0
77585,93,0,0
77586,patients,0,0
77587,(,0,0
77588,27,0,0
77589,men,0,0
77590,",",0,0
77591,66,0,0
77592,women,0,0
77593,),0,0
77594,completed,0,0
77595,the,0,0
77596,study,0,0
77597,.,0,0
77598,A,0,0
77599,1-year,0,0
77600,randomized,0,0
77601,intervention,0,0
77602,trial,0,0
77603,was,0,0
77604,conducted,0,0
77605,with,0,0
77606,two,0,0
77607,treatment,0,0
77608,arms,0,0
77609,with,0,0
77610,different,0,0
77611,eating,0,1
77612,frequencies,0,1
77613,;,0,0
77614,3,0,0
77615,meals/day,0,0
77616,(,0,0
77617,3M,0,0
77618,),0,0
77619,or,0,0
77620,3,0,0
77621,meals,0,0
77622,and,0,0
77623,3,0,0
77624,snacks/day,0,0
77625,(,0,0
77626,3+3M,0,0
77627,),0,0
77628,.,0,0
77629,The,0,0
77630,patients,0,0
77631,received,0,0
77632,regular,0,0
77633,and,0,1
77634,individualized,0,0
77635,counseling,0,0
77636,by,0,0
77637,dieticians,0,0
77638,.,0,0
77639,Information,1,0
77640,on,1,0
77641,eating,1,1
77642,patterns,1,1
77643,",",1,1
77644,dietary,1,1
77645,intake,1,1
77646,",",1,1
77647,weight,1,1
77648,and,1,1
77649,metabolic,1,1
77650,variables,1,1
77651,was,0,0
77652,collected,0,0
77653,at,0,0
77654,baseline,0,0
77655,and,0,0
77656,after,0,0
77657,1,0,0
77658,year,0,0
77659,.,0,0
77660,RESULTS,0,0
77661,Over,0,0
77662,1,0,0
77663,year,0,0
77664,the,0,0
77665,3M,0,0
77666,group,0,0
77667,reported,0,0
77668,a,0,0
77669,decrease,0,0
77670,in,0,0
77671,the,0,0
77672,number,1,1
77673,of,1,0
77674,snacks,1,0
77675,whereas,0,0
77676,the,0,0
77677,3+3M,0,0
77678,group,0,0
77679,reported,0,0
77680,an,0,0
77681,increase,0,1
77682,(,0,0
77683,-1.1,0,0
77684,vs,0,0
77685,+0.4,0,0
77686,snacks/day,0,1
77687,",",0,1
77688,respectively,0,0
77689,",",0,0
77690,P,0,0
77691,<,0,0
77692,0.0001,0,0
77693,),0,0
77694,.,0,0
77695,Both,0,0
77696,groups,0,0
77697,decreased,0,1
77698,energy,1,1
77699,intake,1,1
77700,and,0,1
77701,E,1,1
77702,%,1,0
77703,(,1,1
77704,energy,1,1
77705,percent,1,1
77706,),1,1
77707,fat,1,1
77708,and,0,1
77709,increased,0,1
77710,E,1,1
77711,%,1,0
77712,protein,1,1
77713,and,1,1
77714,fiber,1,0
77715,intake,1,1
77716,but,0,0
77717,there,0,0
77718,was,0,0
77719,no,0,0
77720,differences,0,0
77721,between,0,0
77722,the,0,0
77723,groups,0,0
77724,.,0,0
77725,Both,0,0
77726,groups,0,0
77727,lost,1,1
77728,weight,1,1
77729,",",0,1
77730,but,0,0
77731,there,0,0
77732,was,0,0
77733,no,0,0
77734,significant,0,0
77735,difference,0,0
77736,in,0,0
77737,weight,1,1
77738,loss,1,1
77739,after,0,0
77740,1,0,0
77741,year,0,0
77742,of,0,0
77743,treatment,0,0
77744,(,0,0
77745,3M,0,0
77746,vs,0,0
77747,3+3M=-4.1+/-6.1,0,0
77748,vs,0,0
77749,-5.9+/-9.4,0,0
77750,kg,0,0
77751,;,0,1
77752,P=0.31,0,0
77753,),0,0
77754,.,0,0
77755,Changes,0,1
77756,in,0,0
77757,metabolic,1,1
77758,variables,1,1
77759,did,0,0
77760,not,0,0
77761,differ,0,0
77762,between,0,0
77763,the,0,0
77764,groups,0,0
77765,",",0,0
77766,except,0,0
77767,for,0,0
77768,high-density,1,1
77769,lipoprotein,1,1
77770,that,0,0
77771,increased,0,0
77772,in,0,0
77773,the,0,0
77774,3M,0,0
77775,group,0,0
77776,but,0,0
77777,not,0,0
77778,in,0,0
77779,3+3M,0,0
77780,group,0,0
77781,(,0,0
77782,P,0,0
77783,<,0,0
77784,0.033,0,0
77785,for,0,0
77786,group,0,0
77787,difference,0,0
77788,),0,0
77789,.,0,0
77790,CONCLUSION,0,0
77791,Recommending,0,0
77792,snacks,0,0
77793,or,0,0
77794,not,0,0
77795,between,0,0
77796,meals,0,0
77797,does,0,0
77798,not,0,0
77799,influence,0,0
77800,1-year,1,1
77801,weight,1,1
77802,loss,1,1
77803,.,1,0
77804,Comparison,0,0
77805,of,0,0
77806,the,0,0
77807,therapeutic,0,0
77808,efficacy,0,1
77809,of,0,1
77810,phonophoresis,0,0
77811,and,0,1
77812,iontophoresis,0,0
77813,using,0,0
77814,dexamethasone,0,0
77815,sodium,0,0
77816,phosphate,0,0
77817,in,0,0
77818,the,0,0
77819,management,0,0
77820,of,0,0
77821,patients,0,0
77822,with,0,0
77823,knee,0,1
77824,osteoarthritis,0,0
77825,.,0,0
77826,BACKGROUND,0,0
77827,AND,0,0
77828,OBJECTIVE,0,1
77829,Many,0,1
77830,treatment,0,0
77831,options,0,0
77832,",",0,0
77833,including,0,0
77834,non-pharmacological,0,0
77835,and,0,1
77836,pharmacological,0,0
77837,measures,0,1
77838,",",0,0
77839,have,0,0
77840,been,0,0
77841,recommended,0,0
77842,in,0,0
77843,the,0,0
77844,management,0,0
77845,of,0,1
77846,osteoarthritis,0,1
77847,(,0,1
77848,OA,0,1
77849,),0,0
77850,.,0,0
77851,Among,0,0
77852,the,0,0
77853,non-pharmacological,0,0
77854,approach,0,0
77855,is,0,0
77856,physiotherapy,0,0
77857,",",0,0
77858,which,0,0
77859,involves,0,0
77860,the,0,0
77861,use,0,0
77862,of,0,0
77863,physical,0,1
77864,modalities,0,0
77865,like,0,0
77866,",",0,0
77867,heat,0,1
77868,therapy,0,0
77869,",",0,1
77870,exercise,0,0
77871,therapy,0,0
77872,",",0,1
77873,electrical,0,1
77874,stimulation,0,1
77875,",",0,1
77876,therapeutic,0,1
77877,ultrasound,0,1
77878,",",0,1
77879,iontophoresis,0,0
77880,",",0,1
77881,and,0,1
77882,phonophoresis,0,0
77883,.,0,0
77884,This,0,0
77885,study,0,0
77886,was,0,0
77887,therefore,0,0
77888,designed,0,0
77889,to,0,0
77890,compare,0,0
77891,the,0,0
77892,effectiveness,0,0
77893,of,0,0
77894,0.4,0,0
77895,%,0,0
77896,Dexamethasone,0,0
77897,sodium,0,1
77898,phosphate,0,0
77899,(,0,1
77900,DEX-P,0,1
77901,),0,1
77902,phonophoresis,0,0
77903,(,0,1
77904,PH,0,0
77905,),0,0
77906,with,0,0
77907,0.4,0,0
77908,%,0,0
77909,DEX-P,0,0
77910,iontophoresis,0,0
77911,(,0,1
77912,ION,0,0
77913,),0,1
77914,therapy,0,0
77915,in,0,0
77916,the,0,0
77917,management,0,0
77918,of,0,0
77919,patients,0,0
77920,with,0,0
77921,knee,0,1
77922,joint,0,1
77923,OA,0,1
77924,.,0,0
77925,METHODS,0,0
77926,Fifty,0,1
77927,patients,0,0
77928,(,0,0
77929,19,0,0
77930,males,0,0
77931,and,0,0
77932,31,0,0
77933,females,0,0
77934,),0,0
77935,with,0,0
77936,a,0,0
77937,mean,0,1
77938,age,0,0
77939,of,0,0
77940,53.6,0,0
77941,+/-,0,0
77942,8.9,0,0
77943,years,0,0
77944,were,0,0
77945,randomly,0,0
77946,assigned,0,0
77947,to,0,0
77948,PH,0,0
77949,or,0,0
77950,ION,0,0
77951,groups,0,0
77952,with,0,0
77953,25,0,0
77954,patients,0,0
77955,in,0,0
77956,each,0,0
77957,group,0,0
77958,.,0,0
77959,Ultrasound,0,0
77960,waves,0,1
77961,of,0,0
77962,1,0,0
77963,MHz,0,0
77964,frequency,0,1
77965,was,0,0
77966,applied,0,0
77967,for,0,0
77968,5,0,0
77969,minutes,0,0
77970,to,0,0
77971,the,0,0
77972,target,0,0
77973,knee,0,1
77974,",",0,0
77975,so,0,0
77976,also,0,0
77977,was,0,0
77978,the,0,0
77979,direct,0,0
77980,current,0,0
77981,for,0,0
77982,10,0,0
77983,minutes,0,0
77984,for,0,0
77985,10,0,0
77986,sessions,0,0
77987,treatment,0,0
77988,period,0,0
77989,.,0,1
77990,Western,1,0
77991,Ontario,1,0
77992,and,1,1
77993,McMaster,1,0
77994,University,1,0
77995,Osteoarthritis,1,1
77996,Index,1,1
77997,(,1,1
77998,WOMAC,1,1
77999,),1,0
78000,scores,1,1
78001,",",1,0
78002,20,1,0
78003,meters,1,0
78004,ambulatory,1,0
78005,time,1,1
78006,",",0,0
78007,and,0,1
78008,knee,1,1
78009,range,1,0
78010,of,1,1
78011,motion,1,1
78012,(,1,1
78013,ROM,1,1
78014,),1,1
78015,were,0,0
78016,evaluated,0,0
78017,before,0,0
78018,and,0,0
78019,after,0,0
78020,therapy,0,0
78021,as,0,0
78022,the,0,0
78023,outcome,0,0
78024,measures,0,1
78025,.,0,0
78026,RESULTS,0,0
78027,At,0,0
78028,the,0,0
78029,end,0,0
78030,of,0,0
78031,two,0,0
78032,weeks,0,0
78033,",",0,0
78034,significant,0,0
78035,improvement,0,1
78036,in,0,0
78037,total,0,1
78038,WOMAC,1,1
78039,scores,1,1
78040,was,0,0
78041,observed,0,0
78042,in,0,0
78043,15,0,0
78044,(,0,0
78045,60,0,0
78046,%,0,0
78047,),0,0
78048,and,0,0
78049,16,0,0
78050,(,0,0
78051,64,0,0
78052,%,0,0
78053,),0,0
78054,patients,0,0
78055,in,0,0
78056,the,0,0
78057,PH,0,0
78058,and,0,1
78059,ION,0,0
78060,groups,0,0
78061,respectively,0,0
78062,",",0,0
78063,indicating,0,0
78064,no,0,0
78065,significant,0,0
78066,difference,0,0
78067,in,0,0
78068,the,0,0
78069,improvement,0,1
78070,rate,0,1
78071,.,0,1
78072,Twenty,0,0
78073,(,0,0
78074,20,0,0
78075,),0,0
78076,metres,0,0
78077,ambulatory,1,1
78078,time,1,1
78079,and,1,1
78080,knee,1,1
78081,range,1,1
78082,of,1,1
78083,motion,1,1
78084,also,0,0
78085,improved,0,0
78086,significantly,0,0
78087,in,0,0
78088,both,0,0
78089,groups,0,0
78090,",",0,0
78091,yet,0,0
78092,these,0,0
78093,variables,0,0
78094,showed,0,0
78095,no,0,0
78096,significant,0,0
78097,difference,0,0
78098,between,0,0
78099,the,0,0
78100,two,0,0
78101,groups,0,0
78102,.,0,0
78103,CONCLUSION,0,0
78104,Both,0,0
78105,therapeutic,0,1
78106,modalities,0,0
78107,were,0,0
78108,found,0,0
78109,to,0,0
78110,be,0,0
78111,effective,0,1
78112,and,0,0
78113,generally,0,0
78114,well,0,0
78115,tolerated,0,1
78116,after,0,0
78117,10,0,0
78118,treatment,0,0
78119,sessions,0,0
78120,.,0,1
78121,DEX-P,0,1
78122,phonophoresis,0,0
78123,was,0,0
78124,not,0,0
78125,superior,0,0
78126,to,0,0
78127,DEX-P,0,1
78128,iontophoresis,0,0
78129,in,0,0
78130,the,0,0
78131,treatment,0,0
78132,of,0,0
78133,patients,0,0
78134,with,0,0
78135,OA,0,0
78136,of,0,0
78137,the,0,0
78138,knee,0,0
78139,.,0,0
78140,New,0,1
78141,mini-extracorporeal,0,0
78142,circulation,0,1
78143,system,0,0
78144,(,0,1
78145,ECC.O,0,0
78146,),0,0
78147,is,0,0
78148,a,0,0
78149,safe,0,1
78150,technique,0,0
78151,in,0,0
78152,coronary,0,0
78153,surgery,0,0
78154,.,0,0
78155,OBJECTIVES,0,1
78156,Cardiopulmonary,0,1
78157,bypass,0,1
78158,(,0,1
78159,CPB,0,0
78160,),0,0
78161,is,0,0
78162,known,0,0
78163,to,0,0
78164,cause,0,0
78165,the,0,0
78166,systemic,0,1
78167,inflammatory,0,1
78168,reaction,0,1
78169,after,0,0
78170,cardiac,0,1
78171,surgery,0,0
78172,.,0,1
78173,New,0,1
78174,coated,0,0
78175,and,0,1
78176,closed,0,0
78177,loop,0,1
78178,circuit,0,0
78179,systems,0,0
78180,may,0,0
78181,reduce,0,0
78182,this,0,0
78183,inflammation,1,1
78184,response,1,1
78185,and,1,1
78186,improve,1,0
78187,the,1,0
78188,surgical,1,0
78189,outcome,1,0
78190,.,1,0
78191,This,0,0
78192,study,0,0
78193,was,0,0
78194,designed,0,0
78195,to,0,0
78196,evaluate,0,0
78197,the,0,0
78198,safety,0,1
78199,and,0,1
78200,efficacy,0,1
78201,of,0,0
78202,the,0,0
78203,mini-extracorporeal,0,0
78204,circulation,0,1
78205,system,0,0
78206,(,0,1
78207,ECC.O,0,0
78208,),0,0
78209,in,0,0
78210,CABG,0,1
78211,patients,0,0
78212,.,0,0
78213,DESIGN,0,0
78214,Forty,0,0
78215,patients,0,0
78216,undergoing,0,0
78217,elective,0,0
78218,coronary,0,1
78219,surgery,0,0
78220,were,0,0
78221,randomized,0,0
78222,into,0,0
78223,two,0,0
78224,groups,0,0
78225,",",0,0
78226,the,0,0
78227,ECC.O,0,0
78228,group,0,0
78229,and,0,0
78230,the,0,0
78231,standard,0,0
78232,CPB,0,0
78233,group,0,0
78234,.,0,1
78235,Routine,0,0
78236,hemodynamic,0,1
78237,monitoring,0,0
78238,and,0,1
78239,biochemical,0,1
78240,measurements,0,1
78241,were,0,0
78242,registered,0,0
78243,according,0,0
78244,to,0,0
78245,the,0,0
78246,hospital,0,0
78247,practice,0,0
78248,.,0,0
78249,RESULTS,0,0
78250,The,0,0
78251,clinical,0,0
78252,outcome,0,1
78253,of,0,0
78254,the,0,0
78255,patients,0,0
78256,was,0,0
78257,similar,0,0
78258,in,0,0
78259,both,0,0
78260,groups,0,0
78261,.,0,0
78262,There,0,0
78263,were,0,0
78264,no,0,0
78265,significant,0,0
78266,differences,0,0
78267,between,0,0
78268,the,0,0
78269,groups,0,0
78270,in,0,0
78271,the,0,0
78272,duration,1,1
78273,of,1,0
78274,intubation,1,0
78275,following,1,0
78276,surgery,1,0
78277,",",1,0
78278,the,1,0
78279,length,1,1
78280,of,1,0
78281,intensive,1,0
78282,care,1,0
78283,unit-stay,1,1
78284,or,1,0
78285,the,1,0
78286,total,1,1
78287,hospital,1,1
78288,stay,1,1
78289,.,1,0
78290,The,0,0
78291,haemoglobin,1,1
78292,level,1,1
78293,was,0,0
78294,significantly,0,0
78295,higher,0,0
78296,(,0,1
78297,p=0.0069,0,0
78298,),0,1
78299,during,0,0
78300,and,0,0
78301,after,0,0
78302,the,0,0
78303,perfusion,0,0
78304,in,0,0
78305,the,0,0
78306,ECC.O,0,0
78307,group,0,0
78308,.,0,0
78309,CONCLUSIONS,0,0
78310,The,0,0
78311,ECC.O,0,0
78312,system,0,0
78313,can,0,0
78314,be,0,0
78315,safely,0,0
78316,used,0,0
78317,in,0,0
78318,CABG,0,1
78319,patients,0,0
78320,and,0,0
78321,it,0,0
78322,maintains,0,0
78323,haemoglobin,0,1
78324,level,0,1
78325,better,0,0
78326,than,0,0
78327,conventional,0,0
78328,CPB,0,0
78329,.,0,0
78330,Injury,1,1
78331,and,1,1
78332,illness,1,1
78333,costs,1,1
78334,in,0,0
78335,the,0,0
78336,Certified,0,0
78337,Safe,0,1
78338,Farm,0,1
78339,study,0,0
78340,.,0,0
78341,CONTEXT,0,0
78342,The,0,0
78343,Certified,0,1
78344,Safe,0,1
78345,Farm,0,1
78346,(,0,1
78347,CSF,0,0
78348,),0,1
78349,intervention,0,0
78350,program,0,0
78351,aims,0,0
78352,to,0,0
78353,reduce,0,0
78354,occupational,0,1
78355,injuries,0,1
78356,and,0,1
78357,illnesses,0,1
78358,",",0,0
78359,and,0,1
78360,promote,0,0
78361,wellness,0,0
78362,to,0,0
78363,reduce,0,0
78364,health,0,1
78365,care,0,0
78366,and,0,1
78367,related,0,0
78368,costs,0,1
78369,to,0,0
78370,farmers,0,0
78371,",",0,0
78372,insurers,0,0
78373,",",0,1
78374,and,0,1
78375,other,0,0
78376,stakeholders,0,0
78377,.,0,0
78378,PURPOSE,0,0
78379,To,0,0
78380,evaluate,0,0
78381,the,0,0
78382,cost,1,1
78383,effectiveness,1,1
78384,of,1,0
78385,CSF,1,0
78386,.,1,0
78387,METHODS,0,0
78388,Farms,0,1
78389,(,0,0
78390,316,0,0
78391,),0,0
78392,located,0,0
78393,in,0,0
78394,a,0,0
78395,9-county,0,0
78396,area,0,1
78397,of,0,1
78398,northwestern,0,0
78399,Iowa,0,0
78400,were,0,0
78401,recruited,0,0
78402,and,0,0
78403,randomized,0,0
78404,into,0,0
78405,intervention,0,0
78406,and,0,1
78407,control,0,0
78408,cohorts,0,0
78409,.,0,1
78410,Intervention,0,0
78411,farms,0,0
78412,received,0,0
78413,occupational,0,1
78414,health,0,1
78415,screenings,0,1
78416,",",0,1
78417,health,0,1
78418,and,0,1
78419,wellness,0,1
78420,screening,0,1
78421,",",0,1
78422,education,0,0
78423,",",0,1
78424,on-farm,0,0
78425,safety,0,1
78426,reviews,0,1
78427,",",0,1
78428,and,0,1
78429,performance,0,1
78430,incentives,0,0
78431,.,0,0
78432,For,0,0
78433,both,0,0
78434,cohorts,0,0
78435,",",0,0
78436,quarterly,0,1
78437,calls,0,0
78438,over,0,0
78439,3,0,0
78440,years,0,0
78441,were,0,0
78442,used,0,0
78443,to,0,0
78444,collect,0,0
78445,self-reported,0,1
78446,occupational,0,1
78447,injury,0,1
78448,and,0,1
78449,illness,0,1
78450,information,0,1
78451,",",0,0
78452,including,0,0
78453,costs,0,1
78454,to,0,0
78455,the,0,0
78456,farmers,0,0
78457,and,0,0
78458,their,0,0
78459,insurers,0,0
78460,.,0,0
78461,FINDINGS,0,0
78462,Annual,1,1
78463,occupational,1,1
78464,injury,1,1
78465,and,1,1
78466,illness,1,1
78467,costs,1,1
78468,per,0,0
78469,farmer,0,0
78470,paid,0,0
78471,by,0,0
78472,insurers,0,0
78473,were,0,0
78474,45,0,0
78475,%,0,0
78476,lower,0,0
78477,in,0,0
78478,the,0,0
78479,intervention,0,0
78480,cohort,0,0
78481,(,0,0
78482,$,0,0
78483,183,0,0
78484,),0,0
78485,than,0,0
78486,in,0,0
78487,the,0,0
78488,control,0,0
78489,cohort,0,0
78490,(,0,0
78491,$,0,0
78492,332,0,0
78493,),0,0
78494,.,0,0
78495,Although,0,0
78496,out-of-pocket,1,1
78497,expenses,1,1
78498,were,0,0
78499,similar,0,0
78500,for,0,0
78501,both,0,0
78502,cohorts,0,0
78503,",",0,0
78504,combined,1,0
78505,costs,1,1
78506,of,1,0
78507,insurance,1,1
78508,and,1,1
78509,out-of-pocket,1,1
78510,expenses,1,1
78511,were,0,0
78512,27,0,0
78513,%,0,0
78514,lower,0,0
78515,in,0,0
78516,the,0,0
78517,intervention,0,0
78518,cohort,0,0
78519,(,0,0
78520,$,0,0
78521,374/year,0,0
78522,per,0,0
78523,farmer,0,0
78524,),0,0
78525,compared,0,0
78526,to,0,0
78527,the,0,0
78528,control,0,0
78529,cohort,0,0
78530,(,0,0
78531,$,0,0
78532,512/year,0,0
78533,per,0,0
78534,farmer,0,0
78535,),0,0
78536,.,0,0
78537,Within,0,0
78538,the,0,0
78539,cohort,0,0
78540,of,0,0
78541,intervention,0,0
78542,farmers,0,0
78543,",",0,0
78544,annual,1,1
78545,occupational,1,1
78546,injury,1,1
78547,and,1,1
78548,illness,1,1
78549,cost,1,1
78550,savings,1,1
78551,were,0,0
78552,directly,0,0
78553,associated,0,0
78554,with,0,0
78555,on-farm,0,0
78556,safety,0,1
78557,review,0,0
78558,scores,0,1
78559,.,0,1
78560,Reported,0,0
78561,health,1,1
78562,care,1,0
78563,costs,1,1
78564,were,0,0
78565,$,0,0
78566,237,0,0
78567,per,0,0
78568,farmer,0,0
78569,in,0,0
78570,the,0,0
78571,safest,0,0
78572,farms,0,0
78573,(,0,0
78574,those,0,0
78575,farms,0,0
78576,scoring,0,0
78577,in,0,0
78578,the,0,0
78579,highest,0,1
78580,tertile,0,1
78581,),0,1
78582,versus,0,0
78583,$,0,0
78584,485,0,0
78585,per,0,0
78586,farmer,0,0
78587,in,0,0
78588,the,0,0
78589,least,0,0
78590,safe,0,1
78591,farms,0,0
78592,(,0,0
78593,lowest,0,1
78594,tertile,0,1
78595,),0,0
78596,.,0,0
78597,CONCLUSIONS,0,0
78598,Results,0,0
78599,suggest,0,0
78600,that,0,0
78601,farmers,0,0
78602,receiving,0,0
78603,the,0,0
78604,intervention,0,0
78605,had,0,0
78606,lower,0,1
78607,health,1,1
78608,care,1,0
78609,costs,1,1
78610,for,0,0
78611,occupational,0,1
78612,injuries,0,1
78613,and,0,1
78614,illnesses,0,1
78615,than,0,0
78616,control,0,0
78617,farmers,0,0
78618,.,0,0
78619,These,0,0
78620,cost,1,1
78621,savings,1,1
78622,more,0,0
78623,than,0,0
78624,cover,0,1
78625,the,0,0
78626,cost,0,1
78627,of,0,0
78628,providing,0,0
78629,CSF,0,0
78630,services,0,1
78631,(,0,0
78632,about,0,0
78633,$,0,0
78634,100,0,0
78635,per,0,0
78636,farm,0,0
78637,per,0,1
78638,year,0,0
78639,),0,0
78640,.,0,0
78641,Continuous,0,0
78642,event,0,1
78643,recorders,0,1
78644,did,0,0
78645,not,0,0
78646,affect,0,0
78647,anxiety,1,1
78648,or,0,1
78649,quality,1,1
78650,of,1,1
78651,life,1,1
78652,in,0,0
78653,patients,0,0
78654,with,0,0
78655,palpitations,0,1
78656,.,0,0
78657,OBJECTIVES,0,0
78658,Palpitations,0,0
78659,can,0,0
78660,generate,0,0
78661,feelings,0,1
78662,of,0,1
78663,anxiety,1,1
78664,and,0,1
78665,decrease,0,1
78666,quality,1,1
78667,of,1,1
78668,life,1,1
78669,(,1,1
78670,QoL,1,1
78671,),1,0
78672,due,0,0
78673,to,0,0
78674,fear,0,1
78675,of,0,0
78676,a,0,0
78677,cardiac,0,1
78678,abnormality,0,0
78679,.,0,1
78680,Continuous,0,0
78681,event,0,1
78682,recorders,0,1
78683,(,0,1
78684,CERs,0,0
78685,),0,0
78686,have,0,0
78687,proven,0,0
78688,to,0,0
78689,be,0,0
78690,successful,0,0
78691,in,0,0
78692,diagnosing,0,0
78693,causes,0,0
78694,of,0,0
78695,palpitations,0,1
78696,but,0,0
78697,may,0,0
78698,affect,0,1
78699,patient,0,1
78700,QoL,1,1
78701,and,0,1
78702,anxiety,1,1
78703,.,1,0
78704,The,0,0
78705,aim,0,0
78706,is,0,0
78707,to,0,0
78708,determine,0,0
78709,anxiety,1,1
78710,and,0,1
78711,health-related,1,1
78712,(,1,1
78713,HR,1,1
78714,),1,1
78715,-QoL,1,1
78716,and,0,0
78717,evaluate,0,0
78718,the,0,0
78719,burden,0,1
78720,of,0,0
78721,carrying,0,0
78722,a,0,0
78723,CER,0,0
78724,in,0,0
78725,general,0,0
78726,practice,0,0
78727,populations,0,0
78728,.,0,0
78729,STUDY,0,0
78730,DESIGN,0,0
78731,AND,0,0
78732,SETTING,0,1
78733,Patients,0,0
78734,(,0,1
78735,n=244,0,0
78736,),0,1
78737,participated,0,0
78738,in,0,0
78739,a,0,0
78740,randomized,0,0
78741,trial,0,0
78742,.,0,0
78743,One,0,0
78744,group,0,0
78745,(,0,0
78746,n=127,0,0
78747,),0,0
78748,carried,0,0
78749,a,0,0
78750,CER,0,0
78751,during,0,0
78752,4,0,0
78753,weeks,0,0
78754,.,0,0
78755,One,0,0
78756,hundred,0,0
78757,and,0,0
78758,seventeen,0,0
78759,patients,0,0
78760,formed,0,0
78761,the,0,0
78762,usual,0,0
78763,care,0,0
78764,(,0,1
78765,UC,0,1
78766,),0,0
78767,group,0,0
78768,.,0,0
78769,State-Trait,1,1
78770,Anxiety,1,1
78771,Inventory,1,1
78772,(,1,1
78773,STAI,1,1
78774,),1,0
78775,and,1,0
78776,the,1,0
78777,Short,1,1
78778,Form-36,1,1
78779,(,1,1
78780,SF-36,1,1
78781,),1,1
78782,were,0,0
78783,administered,0,0
78784,at,0,0
78785,study,0,0
78786,inclusion,0,0
78787,",",0,0
78788,after,0,0
78789,1,0,0
78790,",",0,0
78791,6,0,0
78792,months,0,0
78793,.,0,0
78794,RESULTS,0,0
78795,At,0,0
78796,baseline,0,0
78797,",",0,1
78798,patients,0,0
78799,reported,0,0
78800,greater,0,1
78801,anxiety,1,1
78802,and,0,1
78803,lower,1,1
78804,QoL,1,1
78805,than,0,0
78806,healthy,0,0
78807,populations,0,0
78808,.,0,0
78809,The,0,0
78810,CER,0,1
78811,group,0,0
78812,had,0,0
78813,three,0,0
78814,times,0,0
78815,more,0,0
78816,cardiac,1,1
78817,diagnoses,1,0
78818,than,0,0
78819,the,0,0
78820,UC,0,1
78821,group,0,0
78822,.,0,0
78823,No,0,0
78824,differences,0,0
78825,were,0,0
78826,found,0,0
78827,between,0,0
78828,CER,0,1
78829,group,0,0
78830,and,0,1
78831,UC,0,1
78832,group,0,0
78833,at,0,0
78834,6,0,0
78835,weeks,0,0
78836,.,0,0
78837,At,0,0
78838,6,0,0
78839,months,0,0
78840,",",0,0
78841,the,0,0
78842,UC,0,1
78843,group,0,0
78844,showed,0,0
78845,QoL,1,1
78846,improvement,1,1
78847,and,0,1
78848,less,0,0
78849,anxiety,1,1
78850,compared,0,0
78851,to,0,0
78852,the,0,0
78853,CER,0,0
78854,group,0,0
78855,.,0,1
78856,Type,1,0
78857,of,1,1
78858,diagnosis,1,1
78859,had,0,0
78860,influence,0,1
78861,",",0,1
78862,but,0,0
78863,did,0,0
78864,not,0,0
78865,fully,0,0
78866,explain,0,0
78867,these,0,0
78868,differences,0,0
78869,.,0,0
78870,CONCLUSION,0,0
78871,A,0,0
78872,CER,0,0
78873,does,0,0
78874,not,0,0
78875,negatively,0,0
78876,influence,0,0
78877,anxiety,1,1
78878,or,0,0
78879,QoL,1,1
78880,.,1,0
78881,Better,0,0
78882,outcomes,0,1
78883,in,0,0
78884,the,0,0
78885,UC,0,0
78886,group,0,0
78887,might,0,0
78888,be,0,0
78889,attributed,0,0
78890,to,0,0
78891,less,0,0
78892,cardiac,1,1
78893,diagnosis,1,1
78894,and,0,1
78895,more,0,0
78896,emphasis,0,0
78897,on,0,0
78898,psychological,1,1
78899,well-being,1,1
78900,.,1,0
78901,A,0,0
78902,randomized,0,0
78903,parallel,0,0
78904,study,0,0
78905,to,0,0
78906,assess,0,0
78907,the,0,0
78908,safety,1,1
78909,and,1,1
78910,efficacy,1,1
78911,of,0,0
78912,two,0,0
78913,different,0,0
78914,dosing,0,0
78915,regimens,0,0
78916,of,0,0
78917,5,0,0
78918,%,0,0
78919,imiquimod,0,0
78920,in,0,0
78921,the,0,0
78922,treatment,0,0
78923,of,0,0
78924,superficial,0,1
78925,basal,0,1
78926,cell,0,1
78927,carcinoma,0,0
78928,.,0,0
78929,OBJECTIVES,0,0
78930,This,0,0
78931,study,0,0
78932,was,0,0
78933,designed,0,0
78934,to,0,0
78935,compare,0,0
78936,the,0,0
78937,safety,1,1
78938,and,1,1
78939,efficacy,1,1
78940,of,0,0
78941,two,0,0
78942,cycled,0,0
78943,dosing,0,0
78944,regimens,0,0
78945,of,0,0
78946,imiquimod,0,0
78947,5,0,0
78948,%,0,0
78949,cream,0,0
78950,for,0,0
78951,treatment,0,0
78952,of,0,1
78953,superficial,0,1
78954,basal,0,1
78955,cell,0,1
78956,carcinoma,0,0
78957,(,0,1
78958,sBCC,0,0
78959,),0,0
78960,.,0,0
78961,METHODS,0,0
78962,Patients,0,0
78963,(,0,0
78964,n,0,0
78965,=,0,0
78966,32,0,0
78967,),0,0
78968,were,0,0
78969,randomized,0,0
78970,to,0,0
78971,receive,0,0
78972,one,0,0
78973,of,0,0
78974,two,0,0
78975,treatment,0,0
78976,regimens,0,0
78977,:,0,0
78978,8,0,0
78979,weeks,0,0
78980,of,0,0
78981,treatment,0,0
78982,with,0,0
78983,once-daily,0,0
78984,dosing,0,0
78985,for,0,0
78986,alternate,0,0
78987,weeks,0,0
78988,(,0,0
78989,R1,0,1
78990,),0,0
78991,and,0,0
78992,5,0,0
78993,weeks,0,0
78994,of,0,0
78995,once-daily,0,0
78996,dosing,0,0
78997,with,0,0
78998,a,0,0
78999,1-week,0,0
79000,interval,0,0
79001,in,0,0
79002,the,0,0
79003,middle,0,0
79004,of,0,0
79005,the,0,0
79006,course,0,1
79007,(,0,0
79008,R2,0,1
79009,),0,0
79010,.,0,0
79011,Efficacy,0,1
79012,measures,0,1
79013,were,0,0
79014,tumour,1,1
79015,clearance,1,1
79016,at,0,0
79017,weeks,0,0
79018,19,0,0
79019,and,0,0
79020,52,0,0
79021,and,0,0
79022,measures,1,0
79023,of,1,1
79024,patients,1,0
79025,',1,1
79026,acceptability,1,1
79027,.,1,0
79028,RESULTS,0,0
79029,Data,0,0
79030,from,0,0
79031,30,0,0
79032,patients,0,0
79033,(,0,0
79034,13,0,0
79035,females,0,0
79036,),0,0
79037,",",0,0
79038,14,0,0
79039,on,0,0
79040,R1,0,0
79041,and,0,0
79042,16,0,0
79043,on,0,0
79044,R2,0,0
79045,",",0,1
79046,were,0,0
79047,analysed,0,0
79048,.,0,0
79049,The,0,0
79050,results,0,0
79051,revealed,0,0
79052,an,0,0
79053,initial,0,0
79054,clearance,1,1
79055,rate,1,1
79056,of,0,0
79057,64,0,0
79058,%,0,0
79059,at,0,0
79060,week,0,0
79061,19,0,0
79062,for,0,0
79063,R1,0,0
79064,and,0,0
79065,81,0,0
79066,%,0,0
79067,for,0,0
79068,R2,0,1
79069,(,0,0
79070,95,0,0
79071,%,0,0
79072,CI,0,0
79073,for,0,0
79074,difference,0,0
79075,:,0,0
79076,-14,0,0
79077,%,0,0
79078,to,0,0
79079,45,0,0
79080,%,0,0
79081,",",0,0
79082,p,0,0
79083,=,0,0
79084,0.21,0,0
79085,),0,0
79086,.,0,0
79087,However,0,0
79088,",",0,0
79089,clearance,1,1
79090,rates,1,1
79091,at,0,0
79092,week,0,0
79093,52,0,0
79094,were,0,0
79095,significantly,0,0
79096,different,0,0
79097,:,0,0
79098,43,0,0
79099,%,0,0
79100,for,0,0
79101,R1,0,1
79102,and,0,0
79103,88,0,0
79104,%,0,0
79105,for,0,0
79106,R2,0,1
79107,(,0,0
79108,95,0,0
79109,%,0,0
79110,CI,0,0
79111,for,0,0
79112,difference,0,0
79113,:,0,0
79114,11,0,0
79115,%,0,0
79116,to,0,0
79117,68,0,0
79118,%,0,0
79119,",",0,0
79120,p,0,0
79121,=,0,0
79122,0.02,0,0
79123,),0,0
79124,.,0,0
79125,There,0,0
79126,was,0,0
79127,no,0,0
79128,difference,0,0
79129,in,0,0
79130,acceptability,1,1
79131,of,1,1
79132,treatment,1,0
79133,as,0,0
79134,measured,0,0
79135,by,0,0
79136,composite,0,1
79137,median,0,1
79138,visual,0,1
79139,analogue,0,1
79140,scores,0,1
79141,at,0,0
79142,week,0,0
79143,8,0,0
79144,.,0,0
79145,CONCLUSION,0,0
79146,Five,0,1
79147,weeks,0,0
79148,of,0,0
79149,5,0,0
79150,%,0,0
79151,imiquimod,0,0
79152,cream,0,0
79153,once,0,0
79154,daily,0,0
79155,with,0,0
79156,a,0,0
79157,1-week,0,0
79158,interval,0,0
79159,was,0,0
79160,more,0,0
79161,effective,1,1
79162,but,0,0
79163,as,0,0
79164,well,1,0
79165,tolerated,1,1
79166,as,0,0
79167,the,0,0
79168,8-week,0,0
79169,alternate,0,0
79170,week,0,0
79171,regimen,0,0
79172,for,0,0
79173,sBCC,0,0
79174,.,0,0
79175,Rehabilitation,0,1
79176,of,0,1
79177,therapy-related,0,1
79178,cognitive,0,1
79179,deficits,0,1
79180,in,0,0
79181,patients,0,0
79182,after,0,0
79183,hematopoietic,0,1
79184,stem,0,1
79185,cell,0,1
79186,transplantation,0,0
79187,.,0,1
79188,Neuropsychological,0,0
79189,deficits,0,0
79190,are,0,0
79191,potential,0,0
79192,side,0,1
79193,effects,0,1
79194,of,0,1
79195,hematopoietic,0,1
79196,stem,0,1
79197,cell,0,1
79198,therapy,0,0
79199,(,0,1
79200,HSCT,0,1
79201,),0,0
79202,.,0,0
79203,Systematic,0,0
79204,data,0,0
79205,on,0,0
79206,the,0,0
79207,long-term,0,0
79208,course,0,1
79209,of,0,1
79210,and,0,1
79211,therapeutic,0,1
79212,options,0,0
79213,for,0,0
79214,these,0,0
79215,consequences,0,0
79216,are,0,0
79217,limited,0,0
79218,.,0,0
79219,One,0,0
79220,hundred,0,0
79221,fifty-seven,0,0
79222,patients,0,0
79223,were,0,0
79224,screened,0,1
79225,for,0,0
79226,cognitive,0,1
79227,deficits,0,1
79228,following,0,0
79229,HSCT,0,1
79230,for,0,0
79231,malignant,0,0
79232,diseases,0,0
79233,at,0,0
79234,an,0,0
79235,in-patient,0,1
79236,oncologic,0,0
79237,rehabilitation,0,0
79238,clinic,0,1
79239,.,0,0
79240,Patients,0,0
79241,showing,0,0
79242,evidence,0,0
79243,of,0,1
79244,impairment,0,1
79245,were,0,0
79246,randomly,0,0
79247,assigned,0,0
79248,to,0,0
79249,one,0,0
79250,of,0,0
79251,two,0,0
79252,training,0,0
79253,groups,0,0
79254,:,0,0
79255,individualized,0,0
79256,PC-supported,0,0
79257,training,0,0
79258,or,0,1
79259,neuropsychological,0,1
79260,group,0,0
79261,therapy,0,0
79262,.,0,0
79263,The,0,0
79264,control,0,0
79265,group,0,0
79266,consisted,0,0
79267,of,0,0
79268,patients,0,0
79269,who,0,0
79270,received,0,0
79271,no,0,0
79272,specific,0,0
79273,training,0,0
79274,.,0,0
79275,During,0,0
79276,in-patient,0,1
79277,rehabilitation,0,0
79278,",",0,0
79279,the,0,0
79280,results,1,0
79281,of,1,0
79282,a,1,0
79283,comprehensive,1,0
79284,neuropsychological,1,1
79285,test,1,1
79286,battery,1,1
79287,improved,0,1
79288,significantly,0,0
79289,in,0,0
79290,all,0,0
79291,three,0,0
79292,groups,0,0
79293,",",0,0
79294,and,0,0
79295,no,0,0
79296,specific,0,0
79297,intervention,0,0
79298,effects,0,1
79299,were,0,0
79300,identified,0,0
79301,.,0,0
79302,Neuropsychological,1,1
79303,deficits,1,1
79304,were,0,0
79305,still,0,0
79306,evident,0,0
79307,in,0,0
79308,a,0,0
79309,subgroup,0,0
79310,of,0,0
79311,patients,0,0
79312,6,0,0
79313,months,0,0
79314,later,0,0
79315,.,0,0
79316,Correlation,1,1
79317,between,1,0
79318,neuropsychological,1,1
79319,testing,1,0
79320,and,1,1
79321,patients,1,0
79322,',1,1
79323,self-evaluation,1,1
79324,of,1,1
79325,cognitive,1,1
79326,functioning,1,1
79327,in,1,0
79328,daily,1,1
79329,life,1,1
79330,was,0,0
79331,generally,0,0
79332,low,0,0
79333,.,0,0
79334,Sustained,1,1
79335,attention,1,1
79336,and,1,1
79337,verbal-semantic,1,1
79338,memory,1,1
79339,played,0,0
79340,the,0,0
79341,main,0,1
79342,role,0,0
79343,for,0,0
79344,self-appraisal,0,1
79345,and,0,0
79346,in,0,0
79347,the,0,0
79348,designation,0,0
79349,as,0,0
79350,'neuropsychologically,0,1
79351,impaired,0,0
79352,',0,0
79353,.,0,0
79354,In,0,0
79355,conclusion,0,0
79356,",",0,0
79357,a,0,0
79358,substantial,0,0
79359,number,0,1
79360,of,0,0
79361,patients,0,0
79362,revealed,0,0
79363,evidence,0,0
79364,of,0,1
79365,cognitive,0,1
79366,deficits,0,0
79367,a,0,0
79368,long,0,0
79369,time,0,1
79370,after,0,0
79371,HSCT,0,1
79372,.,0,0
79373,There,0,0
79374,is,0,0
79375,a,0,0
79376,need,0,0
79377,for,0,0
79378,more,0,0
79379,studies,0,0
79380,and,0,1
79381,for,0,0
79382,the,0,0
79383,development,0,0
79384,of,0,0
79385,differentiated,0,1
79386,rehabilitative,0,0
79387,measures,0,1
79388,for,0,0
79389,such,0,0
79390,therapeutic,0,0
79391,consequences,0,0
79392,.,0,0
79393,An,0,0
79394,exploratory,0,0
79395,",",0,1
79396,pragmatic,0,0
79397,",",0,1
79398,cluster,0,1
79399,randomised,0,0
79400,trial,0,0
79401,of,0,1
79402,practice,0,0
79403,nurse,0,1
79404,training,0,0
79405,in,0,0
79406,the,0,0
79407,use,0,0
79408,of,0,0
79409,asthma,0,1
79410,action,0,0
79411,plans,0,0
79412,.,0,0
79413,INTRODUCTION,0,0
79414,To,0,0
79415,investigate,0,0
79416,the,0,0
79417,feasibility,1,0
79418,of,0,0
79419,improving,0,1
79420,asthma,0,0
79421,management,0,0
79422,-,0,0
79423,in,0,0
79424,particular,0,0
79425,",",0,0
79426,the,0,0
79427,implementation,0,0
79428,of,0,0
79429,individualised,0,0
79430,asthma,0,1
79431,action,0,1
79432,plans,0,0
79433,(,0,1
79434,AAPs,0,1
79435,),0,0
79436,for,0,0
79437,poorly-controlled,0,0
79438,adult,0,0
79439,asthma,0,0
79440,patients,0,0
79441,-,0,0
79442,by,0,0
79443,providing,0,0
79444,training,0,0
79445,in,0,0
79446,asthma-focused,0,0
79447,clinical,0,1
79448,and,0,1
79449,communication,0,1
79450,skills,0,1
79451,for,0,0
79452,practice,0,0
79453,nurses,0,0
79454,who,0,0
79455,deliver,0,0
79456,asthma,0,0
79457,clinics,0,0
79458,.,0,0
79459,METHODS,0,0
79460,A,0,0
79461,pragmatic,0,0
79462,",",0,1
79463,cluster,0,1
79464,randomised,0,0
79465,trial,0,0
79466,with,0,0
79467,an,0,0
79468,intervention,0,0
79469,(,0,0
79470,an,0,0
79471,interactive,0,1
79472,seminar,0,0
79473,),0,1
79474,delivered,0,0
79475,at,0,0
79476,practice,0,0
79477,level,0,1
79478,(,0,0
79479,n=13,0,0
79480,practices,0,0
79481,;,0,0
79482,6=intervention,0,0
79483,",",0,0
79484,7=control,0,0
79485,),0,0
79486,.,0,0
79487,The,0,0
79488,impact,0,0
79489,of,0,0
79490,the,0,0
79491,intervention,0,0
79492,was,0,0
79493,assessed,0,0
79494,against,0,0
79495,patient,1,0
79496,outcomes,1,1
79497,:,1,0
79498,routinely,1,0
79499,available,1,0
79500,asthma,1,1
79501,outcome,1,1
79502,measures,1,1
79503,(,1,0
79504,beta2-agonist,1,0
79505,prescription,1,1
79506,rate,1,1
79507,and,1,1
79508,number,1,1
79509,of,1,1
79510,oral,1,0
79511,steroid,1,0
79512,courses,1,0
79513,),1,0
79514,for,0,0
79515,asthma,0,0
79516,patients,0,0
79517,identified,0,0
79518,as,0,0
79519,being,0,0
79520,poorly-controlled,0,0
79521,from,0,0
79522,practice,0,0
79523,records,0,0
79524,;,0,0
79525,and,0,0
79526,questionnaire,1,1
79527,data,1,0
79528,-,1,0
79529,Mini,1,0
79530,Asthma,1,1
79531,Quality,1,1
79532,of,1,1
79533,Life,1,0
79534,Questionnaire,1,1
79535,(,1,1
79536,AQLQ,1,1
79537,),1,0
79538,and,1,0
79539,the,1,0
79540,Asthma,1,1
79541,Control,1,1
79542,Questionnaire,1,1
79543,(,1,1
79544,ACQ,1,1
79545,),1,0
79546,-,0,0
79547,from,0,0
79548,a,0,0
79549,subset,0,0
79550,of,0,0
79551,consenting,0,0
79552,patients,0,0
79553,.,0,1
79554,Data,0,0
79555,was,0,0
79556,collected,0,0
79557,at,0,0
79558,baseline,0,0
79559,and,0,1
79560,at,0,1
79561,6-month,0,1
79562,follow-up,0,0
79563,.,0,0
79564,ANALYSISs,0,0
79565,:,0,0
79566,Routine,0,1
79567,data,0,0
79568,was,0,0
79569,analysed,0,0
79570,for,0,0
79571,629,0,0
79572,patients,0,0
79573,.,0,0
79574,236,0,0
79575,(,0,0
79576,37,0,0
79577,%,0,0
79578,),0,0
79579,of,0,0
79580,these,0,0
79581,patients,0,0
79582,consented,0,0
79583,to,0,0
79584,provide,0,0
79585,questionnaire,0,1
79586,data,0,0
79587,at,0,0
79588,baseline,0,0
79589,",",0,0
79590,with,0,0
79591,75,0,0
79592,%,0,0
79593,returning,0,0
79594,questionnaires,0,1
79595,at,0,0
79596,follow-up,0,0
79597,.,0,0
79598,After,0,0
79599,adjustment,0,0
79600,for,0,0
79601,baseline,0,1
79602,and,0,1
79603,practice,0,0
79604,",",0,0
79605,there,0,0
79606,was,0,0
79607,a,0,0
79608,significant,0,0
79609,difference,0,0
79610,at,0,0
79611,followup,0,1
79612,between,0,0
79613,intervention,0,0
79614,and,0,1
79615,control,0,0
79616,practices,0,1
79617,on,0,0
79618,the,0,0
79619,Mini,1,0
79620,AQLQ,1,1
79621,only,0,0
79622,(,0,0
79623,p=0.03,0,0
79624,),0,0
79625,.,0,0
79626,Estimates,0,0
79627,for,0,0
79628,subsequent,0,0
79629,sample,0,0
79630,sizes,0,1
79631,to,0,0
79632,inform,0,0
79633,future,0,0
79634,trials,0,0
79635,of,0,1
79636,asthma,0,1
79637,training,0,0
79638,were,0,0
79639,identified,0,0
79640,.,0,0
79641,CONCLUSION,0,0
79642,Training,0,0
79643,designed,0,0
79644,to,0,0
79645,support,0,0
79646,practice,0,0
79647,nurses,0,0
79648,in,0,0
79649,implementing,0,0
79650,individualised,0,0
79651,AAPs,0,1
79652,impacted,0,0
79653,on,0,0
79654,one,0,0
79655,patient,0,0
79656,outcome,0,0
79657,only,0,0
79658,.,0,0
79659,This,0,0
79660,disappointing,0,0
79661,outcome,0,0
79662,may,0,0
79663,have,0,0
79664,been,0,0
79665,due,0,0
79666,to,0,0
79667,many,0,0
79668,different,0,0
79669,factors,0,1
79670,such,0,0
79671,as,0,0
79672,outcome,0,1
79673,measure,0,1
79674,limitations,0,1
79675,",",0,1
79676,data,0,0
79677,collection,0,1
79678,problems,0,1
79679,",",0,1
79680,and,0,0
79681,underestimating,0,0
79682,the,0,0
79683,complexity,0,1
79684,of,0,0
79685,supporting,0,0
79686,practice,0,0
79687,nurses,0,0
79688,in,0,0
79689,behaviour,0,1
79690,change,0,0
79691,.,0,0
79692,Comparison,0,0
79693,of,0,1
79694,menopausal,0,0
79695,symptoms,0,1
79696,during,0,0
79697,the,0,0
79698,first,0,0
79699,year,0,0
79700,of,0,1
79701,adjuvant,0,0
79702,therapy,0,0
79703,with,0,0
79704,either,0,0
79705,exemestane,0,0
79706,or,0,0
79707,tamoxifen,0,0
79708,in,0,0
79709,early,0,0
79710,breast,0,0
79711,cancer,0,0
79712,:,0,0
79713,report,0,0
79714,of,0,0
79715,a,0,0
79716,Tamoxifen,0,0
79717,Exemestane,0,0
79718,Adjuvant,0,0
79719,Multicenter,0,0
79720,trial,0,0
79721,substudy,0,0
79722,.,0,1
79723,PURPOSE,0,0
79724,Hormonal,0,1
79725,breast,0,0
79726,cancer,0,0
79727,treatment,0,0
79728,increases,0,0
79729,menopausal,1,0
79730,symptoms,1,1
79731,in,0,0
79732,women,0,0
79733,.,0,0
79734,This,0,0
79735,study,0,0
79736,investigated,0,0
79737,differences,0,0
79738,between,0,0
79739,the,0,0
79740,symptoms,0,1
79741,associated,0,0
79742,with,0,0
79743,either,0,0
79744,adjuvant,0,0
79745,tamoxifen,0,0
79746,or,0,0
79747,exemestane,0,0
79748,.,0,1
79749,PATIENTS,0,0
79750,AND,0,0
79751,METHODS,0,0
79752,Ten,0,0
79753,common,0,1
79754,symptoms,0,1
79755,were,0,0
79756,assessed,0,0
79757,by,0,0
79758,self-report,0,1
79759,questionnaire,0,1
79760,administered,0,0
79761,to,0,0
79762,"1,614",0,0
79763,consecutive,0,0
79764,patients,0,0
79765,at,0,0
79766,baseline,0,0
79767,and,0,0
79768,every,0,0
79769,3,0,0
79770,months,0,0
79771,during,0,0
79772,the,0,0
79773,first,0,0
79774,year,0,0
79775,of,0,0
79776,a,0,0
79777,double-blind,0,0
79778,",",0,0
79779,randomized,0,0
79780,trial,0,0
79781,of,0,0
79782,postmenopausal,0,0
79783,women,0,0
79784,with,0,0
79785,early,0,0
79786,hormone,0,1
79787,receptor-positive,0,1
79788,breast,0,0
79789,cancer,0,0
79790,.,0,1
79791,Symptoms,0,1
79792,were,0,0
79793,categorized,0,0
79794,as,0,0
79795,none,0,0
79796,",",0,1
79797,mild,0,1
79798,",",0,1
79799,moderate,0,0
79800,",",0,1
79801,or,0,0
79802,severe,0,1
79803,.,0,0
79804,A,0,0
79805,hot,1,1
79806,flash,1,0
79807,score,1,1
79808,was,0,0
79809,calculated,0,0
79810,at,0,0
79811,each,0,0
79812,time,0,1
79813,point,0,0
79814,.,0,1
79815,Symptoms,0,1
79816,were,0,0
79817,analyzed,0,0
79818,by,0,0
79819,repeated-measures,0,0
79820,analysis,0,0
79821,of,0,0
79822,variance,0,1
79823,.,0,0
79824,Each,0,0
79825,time,0,1
79826,period,0,0
79827,was,0,0
79828,tested,0,0
79829,repeatedly,0,0
79830,against,0,0
79831,the,0,0
79832,baseline,0,0
79833,;,0,0
79834,an,0,0
79835,overall,0,1
79836,P,0,0
79837,value,0,1
79838,was,0,0
79839,assigned,0,0
79840,for,0,0
79841,each,0,0
79842,reported,0,0
79843,symptom,0,1
79844,.,0,0
79845,RESULTS,0,0
79846,Compliance,0,1
79847,was,0,0
79848,excellent,0,1
79849,",",0,0
79850,with,0,0
79851,"7,286",0,0
79852,questionnaires,0,0
79853,analyzed,0,0
79854,.,0,0
79855,Baseline,1,0
79856,symptom,1,1
79857,prevalence,0,1
79858,ranged,0,0
79859,from,0,0
79860,2,0,0
79861,%,0,0
79862,(,0,0
79863,vaginal,0,1
79864,bleeding,0,1
79865,),0,0
79866,to,0,0
79867,60,0,0
79868,%,0,0
79869,to,0,0
79870,70,0,0
79871,%,0,0
79872,(,1,0
79873,bone/muscle,1,1
79874,aches,1,1
79875,and,1,1
79876,low,1,1
79877,energy,1,1
79878,),1,0
79879,.,0,0
79880,There,0,0
79881,were,0,0
79882,no,0,0
79883,significant,0,0
79884,differences,0,0
79885,in,0,0
79886,vaginal,1,0
79887,bleeding,1,1
79888,",",1,1
79889,mood,1,1
79890,alteration,1,1
79891,",",1,1
79892,or,1,1
79893,low,1,1
79894,energy,1,1
79895,.,1,0
79896,Patients,0,0
79897,receiving,0,0
79898,tamoxifen,0,0
79899,had,0,0
79900,significantly,0,0
79901,more,0,0
79902,vaginal,1,1
79903,discharge,1,1
79904,(,0,0
79905,P,0,0
79906,<,0,0
79907,.0001,0,0
79908,),0,0
79909,.,0,0
79910,Exemestane,0,0
79911,patients,0,0
79912,reported,0,0
79913,more,0,0
79914,bone/muscle,1,1
79915,aches,1,1
79916,(,0,0
79917,P,0,0
79918,<,0,0
79919,.0001,0,0
79920,),0,1
79921,",",0,0
79922,vaginal,1,1
79923,dryness,1,1
79924,(,0,0
79925,P,0,0
79926,=,0,0
79927,.0004,0,0
79928,),0,1
79929,",",0,1
79930,and,0,1
79931,difficulty,1,1
79932,sleeping,1,1
79933,(,0,1
79934,P,0,0
79935,=,0,0
79936,.03,0,0
79937,),0,0
79938,.,0,0
79939,In,0,0
79940,both,0,0
79941,groups,0,0
79942,",",0,0
79943,the,0,0
79944,hot,1,1
79945,flash,1,0
79946,score,1,1
79947,peaked,0,0
79948,at,0,0
79949,3,0,0
79950,months,0,0
79951,and,0,0
79952,decreased,0,1
79953,thereafter,0,0
79954,.,0,0
79955,At,0,0
79956,12,0,0
79957,months,0,0
79958,",",0,0
79959,patients,0,0
79960,receiving,0,0
79961,tamoxifen,0,0
79962,had,0,0
79963,a,0,0
79964,significantly,0,0
79965,higher,0,0
79966,mean,1,1
79967,hot,1,1
79968,flash,1,1
79969,score,1,1
79970,(,0,1
79971,P,0,0
79972,=,0,0
79973,.03,0,0
79974,),0,1
79975,",",0,0
79976,with,0,0
79977,daily,0,1
79978,hot,1,1
79979,flashes,1,1
79980,increasing,0,0
79981,from,0,0
79982,baseline,0,0
79983,by,0,0
79984,33,0,0
79985,%,0,0
79986,compared,0,0
79987,with,0,0
79988,a,0,0
79989,7,0,0
79990,%,0,0
79991,increase,0,0
79992,from,0,0
79993,baseline,0,0
79994,with,0,0
79995,exemestane,0,0
79996,.,0,0
79997,CONCLUSION,0,0
79998,At,0,0
79999,12,0,0
80000,months,0,0
80001,",",0,0
80002,exemestane,0,0
80003,was,0,0
80004,associated,0,0
80005,with,0,0
80006,fewer,0,0
80007,hot,1,1
80008,flashes,1,1
80009,and,0,1
80010,less,0,0
80011,vaginal,1,1
80012,discharge,1,1
80013,than,0,0
80014,tamoxifen,0,0
80015,",",0,1
80016,but,0,0
80017,with,0,0
80018,more,0,0
80019,vaginal,1,1
80020,dryness,1,1
80021,",",1,1
80022,bone/muscle,1,1
80023,aches,1,1
80024,",",1,1
80025,and,1,1
80026,difficulty,1,1
80027,sleeping,1,1
80028,.,1,1
80029,Symptoms,0,1
80030,were,0,0
80031,common,0,0
80032,in,0,0
80033,both,0,0
80034,groups,0,0
80035,.,0,0
80036,Robotic,0,0
80037,therapy,0,0
80038,:,0,0
80039,a,0,0
80040,novel,0,0
80041,approach,0,0
80042,in,0,0
80043,upper-limb,1,1
80044,neurorehabilitation,1,0
80045,after,0,0
80046,stroke,0,1
80047,.,0,0
80048,Sivelestat,0,0
80049,sodium,0,0
80050,hydrate,0,0
80051,improves,0,1
80052,septic,0,1
80053,acute,0,0
80054,lung,0,1
80055,injury,0,1
80056,by,0,0
80057,reducing,0,0
80058,alveolar,0,1
80059,dysfunction,0,1
80060,.,0,1
80061,Sivelestat,0,0
80062,sodium,0,1
80063,hydrate,0,0
80064,(,0,1
80065,sivelestat,0,0
80066,),0,0
80067,is,0,0
80068,a,0,0
80069,selective,0,0
80070,inhibitor,0,0
80071,of,0,1
80072,polymorphonuclear,0,1
80073,leukocyte,0,1
80074,elastase,0,1
80075,(,0,1
80076,PMN-E,0,1
80077,),0,0
80078,.,0,0
80079,We,0,0
80080,administered,0,0
80081,sivelestat,0,0
80082,to,0,0
80083,patients,0,0
80084,with,0,0
80085,septic,0,1
80086,acute,0,0
80087,lung,0,1
80088,injury,0,1
80089,(,0,1
80090,ALI,0,1
80091,),0,0
80092,to,0,0
80093,examine,0,0
80094,its,0,0
80095,usefulness,0,0
80096,.,0,0
80097,The,0,0
80098,primary,0,0
80099,endpoints,0,1
80100,in,0,0
80101,the,0,0
80102,study,0,0
80103,were,0,0
80104,the,0,0
80105,duration,1,1
80106,of,1,0
80107,artificial,1,1
80108,ventilation,1,1
80109,and,1,1
80110,pulmonary,1,1
80111,oxygenation,1,1
80112,ability,1,1
80113,",",0,0
80114,and,0,0
80115,the,0,0
80116,secondary,0,1
80117,endpoints,0,1
80118,were,0,0
80119,mortality,1,1
80120,and,1,0
80121,the,1,0
80122,concentrations,1,1
80123,of,1,0
80124,PMN-E,1,1
80125,",",1,1
80126,SP-D,1,1
80127,",",1,1
80128,TNF-alpha,1,1
80129,and,1,1
80130,IL-8,1,1
80131,in,1,0
80132,blood,1,1
80133,.,1,0
80134,In,0,0
80135,the,0,0
80136,sivelestat,0,0
80137,group,0,0
80138,",",0,0
80139,the,0,0
80140,duration,1,1
80141,of,1,0
80142,artificial,1,1
80143,ventilation,1,1
80144,",",1,1
80145,pulmonary,1,1
80146,oxygenation,1,1
80147,ability,1,1
80148,",",1,0
80149,and,1,1
80150,the,1,0
80151,blood,1,1
80152,PMN-E,1,1
80153,",",1,1
80154,SP-D,1,1
80155,",",1,1
80156,TNF-alpha,1,1
80157,and,1,1
80158,IL-8,1,1
80159,concentrations,1,1
80160,decreased,0,0
80161,significantly,0,0
80162,.,0,0
80163,Administration,0,0
80164,of,0,1
80165,sivelestat,0,0
80166,was,0,0
80167,found,0,0
80168,to,0,0
80169,reduce,0,0
80170,alveolar,1,1
80171,dysfunction,1,1
80172,and,0,1
80173,improve,0,0
80174,respiratory,1,1
80175,function,1,1
80176,",",0,0
80177,and,0,1
80178,it,0,0
80179,was,0,0
80180,suggested,0,0
80181,that,0,0
80182,early,0,0
80183,administration,0,0
80184,might,0,0
80185,be,0,0
80186,useful,0,0
80187,.,0,0
80188,Home,0,1
80189,blood,1,1
80190,pressure,1,1
80191,monitoring,0,0
80192,:,0,0
80193,advantages,0,0
80194,and,0,0
80195,limitations,0,0
80196,.,0,1
80197,Home,0,1
80198,blood,0,1
80199,pressure,0,1
80200,monitoring,0,0
80201,is,0,0
80202,a,0,0
80203,useful,0,0
80204,tool,0,0
80205,for,0,0
80206,clinical,1,1
80207,management,1,0
80208,of,0,0
80209,patients,0,0
80210,with,0,0
80211,hypertension,0,1
80212,.,0,0
80213,Its,0,0
80214,major,0,0
80215,advantages,0,0
80216,are,0,0
80217,the,0,0
80218,ease,0,1
80219,with,0,0
80220,which,0,0
80221,the,0,0
80222,techniques,0,0
80223,can,0,0
80224,be,0,0
80225,learned,0,0
80226,",",0,0
80227,reproducibility,0,1
80228,of,0,1
80229,values,0,1
80230,",",0,0
80231,sensitivity,0,1
80232,of,0,1
80233,measurement,0,1
80234,and,0,1
80235,availability,0,1
80236,of,0,1
80237,normotensive,0,0
80238,data,0,0
80239,.,0,0
80240,In,0,0
80241,spite,0,0
80242,of,0,0
80243,the,0,0
80244,ability,0,1
80245,to,0,0
80246,tell,0,0
80247,whether,0,0
80248,a,0,0
80249,subject,0,0
80250,has,0,0
80251,normal,0,0
80252,or,0,0
80253,abnormal,0,1
80254,values,0,1
80255,",",0,0
80256,because,0,0
80257,of,0,0
80258,the,0,0
80259,lack,0,0
80260,of,0,0
80261,prospective,0,0
80262,mortality/morbidity,0,1
80263,data,0,0
80264,",",0,1
80265,home,0,1
80266,blood,0,1
80267,pressure,0,1
80268,monitoring,0,0
80269,can,0,0
80270,not,0,0
80271,be,0,0
80272,used,0,0
80273,to,0,0
80274,decide,0,0
80275,whether,0,0
80276,treatment,0,0
80277,is,0,0
80278,indicated,0,0
80279,.,0,0
80280,The,0,0
80281,treatment,0,0
80282,decision,0,0
80283,must,0,0
80284,be,0,0
80285,based,0,0
80286,on,0,0
80287,repeated,0,0
80288,clinic,1,0
80289,blood,1,1
80290,pressure,1,1
80291,readings,1,1
80292,.,1,0
80293,After,0,0
80294,that,0,0
80295,the,0,0
80296,home,0,0
80297,blood,1,1
80298,pressure,1,1
80299,monitoring,0,0
80300,can,0,0
80301,be,0,0
80302,used,0,0
80303,to,0,0
80304,exclude,0,0
80305,individuals,0,0
80306,who,0,0
80307,are,0,0
80308,at,0,0
80309,risk,0,1
80310,for,0,0
80311,side,0,1
80312,effects,0,1
80313,due,0,0
80314,to,0,0
80315,low,0,0
80316,out-of-office,0,1
80317,blood,1,1
80318,pressure,1,1
80319,readings,0,1
80320,and,0,1
80321,to,0,0
80322,precisely,0,0
80323,monitor,0,0
80324,the,0,0
80325,blood,1,1
80326,pressure,1,1
80327,response,1,1
80328,to,0,0
80329,therapy,0,0
80330,.,0,1
80331,Home,0,1
80332,blood,0,1
80333,pressure,0,1
80334,monitoring,0,0
80335,is,0,0
80336,frequently,0,0
80337,used,0,0
80338,to,0,0
80339,find,0,0
80340,subjects,0,0
80341,with,0,0
80342,'white-coat,1,1
80343,',1,1
80344,hypertension,1,1
80345,.,1,0
80346,In,0,0
80347,our,0,0
80348,study,0,0
80349,of,0,1
80350,borderline,0,1
80351,hypertension,0,1
80352,in,0,0
80353,Tecumseh,0,1
80354,",",0,1
80355,white-coat,0,0
80356,hypertension,0,0
80357,is,0,0
80358,present,0,0
80359,in,0,0
80360,7.1,0,0
80361,%,0,0
80362,of,0,0
80363,the,0,0
80364,whole,0,0
80365,population,0,0
80366,and,0,0
80367,in,0,0
80368,58,0,0
80369,%,0,0
80370,of,0,0
80371,all,0,0
80372,subjects,0,0
80373,with,0,0
80374,elevated,0,1
80375,blood,1,1
80376,pressures,1,1
80377,in,0,0
80378,the,0,0
80379,clinic,0,0
80380,.,0,0
80381,Subjects,0,0
80382,with,0,0
80383,white-coat,0,0
80384,hypertension,0,1
80385,in,0,0
80386,Tecumseh,0,0
80387,appear,0,0
80388,to,0,0
80389,be,0,0
80390,at,0,0
80391,an,0,0
80392,increased,0,0
80393,risk,0,0
80394,for,0,0
80395,coronary,1,1
80396,heart,1,1
80397,disease,1,0
80398,:,1,0
80399,they,0,0
80400,show,0,0
80401,repeated,0,0
80402,elevated,0,1
80403,clinic,1,0
80404,readings,1,1
80405,throughout,0,0
80406,their,0,0
80407,life,0,1
80408,time,0,1
80409,",",0,0
80410,their,0,0
80411,parents,0,0
80412,have,0,0
80413,higher,0,0
80414,blood,1,1
80415,pressure,1,1
80416,",",0,0
80417,their,0,1
80418,high-density,1,1
80419,lipoprotein,1,0
80420,is,0,0
80421,decreased,0,1
80422,and,0,0
80423,insulin,1,1
80424,",",1,1
80425,cholesterol,1,1
80426,and,1,1
80427,triglycerides,1,1
80428,are,0,0
80429,elevated,0,0
80430,.,0,0
80431,Whereas,0,0
80432,subjects,0,0
80433,with,0,0
80434,white-coat,0,0
80435,hypertension,0,0
80436,should,0,0
80437,not,0,0
80438,be,0,0
80439,treated,0,0
80440,with,0,0
80441,antihypertensive,0,0
80442,agents,0,0
80443,",",0,0
80444,they,0,0
80445,must,0,0
80446,be,0,0
80447,followed,0,0
80448,and,0,0
80449,managed,0,0
80450,through,0,0
80451,non-pharmacologic,0,0
80452,means,0,0
80453,.,0,0
80454,A,0,0
80455,prospective,0,0
80456,randomized,0,0
80457,treatment,0,0
80458,study,0,0
80459,comparing,0,0
80460,three,0,0
80461,treatment,0,0
80462,options,0,0
80463,for,0,0
80464,chalazia,0,0
80465,:,0,0
80466,triamcinolone,0,0
80467,acetonide,0,0
80468,injections,0,0
80469,",",0,1
80470,incision,0,1
80471,and,0,1
80472,curettage,0,0
80473,and,0,1
80474,treatment,0,0
80475,with,0,0
80476,hot,0,1
80477,compresses,0,0
80478,.,0,0
80479,BACKGROUND,0,0
80480,Three,0,0
80481,methods,0,0
80482,of,0,0
80483,treating,0,0
80484,chalazia,0,0
80485,were,0,0
80486,compared,0,0
80487,:,0,0
80488,intralesional,0,0
80489,triamcinolone,0,0
80490,acetonide,0,0
80491,injections,0,0
80492,(,0,0
80493,0.2,0,0
80494,mL,0,0
80495,of,0,0
80496,10,0,0
80497,mg/mL,0,0
80498,),0,0
80499,",",0,1
80500,incision,0,1
80501,and,0,1
80502,curettage,0,0
80503,and,0,1
80504,advice,0,0
80505,regarding,0,0
80506,the,0,0
80507,application,0,0
80508,of,0,0
80509,hot,0,1
80510,compresses,0,0
80511,to,0,0
80512,the,0,0
80513,affected,0,0
80514,eyelid,0,1
80515,.,0,0
80516,METHODS,0,0
80517,This,0,0
80518,was,0,0
80519,a,0,0
80520,single,0,0
80521,centre,0,0
80522,randomized,0,0
80523,treatment,0,0
80524,study,0,0
80525,.,0,0
80526,Patients,0,0
80527,with,0,0
80528,a,0,0
80529,chalazion,0,0
80530,underwent,0,0
80531,either,0,0
80532,of,0,0
80533,the,0,0
80534,three,0,0
80535,treatment,0,0
80536,options,0,0
80537,.,0,1
80538,Chalazion,1,1
80539,resolution,1,1
80540,",",1,1
80541,pain,1,1
80542,",",1,1
80543,satisfaction,1,1
80544,and,1,1
80545,inconvenience,1,1
80546,experienced,1,1
80547,because,1,0
80548,of,1,0
80549,treatments,1,0
80550,were,0,0
80551,the,0,0
80552,outcomes,0,1
80553,assessed,0,0
80554,via,0,0
80555,a,0,0
80556,telephone,0,0
80557,interview,0,0
80558,at,0,0
80559,3,0,0
80560,weeks,0,0
80561,.,0,0
80562,RESULTS,0,0
80563,136,0,0
80564,consecutive,0,0
80565,patients,0,0
80566,were,0,0
80567,enrolled,0,0
80568,into,0,0
80569,the,0,0
80570,study,0,0
80571,.,0,0
80572,At,0,0
80573,the,0,0
80574,3-week,0,0
80575,follow,0,0
80576,up,0,0
80577,",",0,0
80578,the,0,0
80579,resolution,1,1
80580,rates,1,1
80581,in,0,0
80582,the,0,0
80583,triamcinolone,0,0
80584,acetonide,0,0
80585,injection,0,0
80586,and,0,1
80587,surgical,0,1
80588,treatment,0,0
80589,groups,0,0
80590,were,0,0
80591,not,0,0
80592,significantly,0,0
80593,different,0,0
80594,from,0,0
80595,each,0,0
80596,other,0,0
80597,at,0,0
80598,84,0,0
80599,%,0,0
80600,(,0,0
80601,47/56,0,0
80602,),0,0
80603,and,0,0
80604,87,0,0
80605,%,0,0
80606,(,0,0
80607,39/45,0,0
80608,),0,0
80609,",",0,0
80610,respectively,0,0
80611,(,0,0
80612,P,0,0
80613,<,0,0
80614,0.001,0,0
80615,),0,0
80616,",",0,0
80617,but,0,0
80618,was,0,0
80619,significantly,0,0
80620,lower,0,0
80621,in,0,0
80622,the,0,0
80623,conservative,0,0
80624,treatment,0,0
80625,group,0,0
80626,at,0,0
80627,46,0,0
80628,%,0,0
80629,(,0,0
80630,16/35,0,0
80631,),0,0
80632,(,0,0
80633,P,0,0
80634,<,0,0
80635,0.001,0,0
80636,),0,0
80637,.,0,0
80638,Pain,1,1
80639,scores,1,1
80640,were,0,0
80641,higher,0,0
80642,in,0,0
80643,the,0,0
80644,surgical,0,0
80645,treatment,0,0
80646,group,0,0
80647,compared,0,0
80648,with,0,0
80649,the,0,0
80650,triamcinolone,0,0
80651,injection,0,0
80652,group,0,0
80653,(,0,1
80654,P,0,0
80655,<,0,0
80656,0.003,0,0
80657,),0,0
80658,.,0,0
80659,Inconvenience,1,0
80660,experienced,1,0
80661,by,1,0
80662,patients,1,0
80663,was,0,0
80664,reported,0,0
80665,as,0,0
80666,significantly,0,0
80667,less,0,0
80668,in,0,0
80669,the,0,0
80670,triamcinolone,0,0
80671,group,0,0
80672,compared,0,0
80673,with,0,0
80674,the,0,0
80675,conservative,0,0
80676,and,0,1
80677,surgical,0,1
80678,treatment,0,0
80679,groups,0,0
80680,(,0,0
80681,P,0,0
80682,<,0,0
80683,0.001,0,0
80684,),0,0
80685,.,0,0
80686,Patient,1,1
80687,satisfaction,1,1
80688,scores,1,1
80689,were,0,0
80690,lower,0,0
80691,in,0,0
80692,the,0,0
80693,conservative,0,0
80694,treatment,0,0
80695,group,0,0
80696,compared,0,0
80697,with,0,0
80698,each,0,0
80699,of,0,0
80700,the,0,0
80701,other,0,0
80702,two,0,0
80703,groups,0,0
80704,which,0,0
80705,in,0,0
80706,turn,0,1
80707,",",0,0
80708,were,0,0
80709,no,0,0
80710,different,0,0
80711,from,0,0
80712,each,0,0
80713,other,0,0
80714,regarding,0,0
80715,this,0,0
80716,outcome,0,1
80717,(,0,0
80718,P,0,0
80719,<,0,0
80720,0.001,0,0
80721,),0,0
80722,.,0,0
80723,CONCLUSIONS,0,0
80724,To,0,0
80725,our,0,0
80726,knowledge,0,1
80727,",",0,0
80728,this,0,0
80729,is,0,0
80730,the,0,0
80731,first,0,0
80732,prospective,0,0
80733,randomized,0,0
80734,study,0,0
80735,comparing,0,0
80736,the,0,0
80737,three,0,0
80738,methods,0,0
80739,of,0,0
80740,chalazia,0,0
80741,treatment,0,0
80742,.,0,0
80743,Results,0,0
80744,suggest,0,0
80745,that,0,0
80746,a,0,0
80747,single,0,0
80748,triamcinolone,0,0
80749,acetonide,0,0
80750,injection,0,0
80751,followed,0,0
80752,by,0,0
80753,lid,0,0
80754,massage,0,0
80755,is,0,0
80756,almost,0,0
80757,as,0,0
80758,effective,0,0
80759,as,0,0
80760,incision,0,0
80761,and,0,1
80762,curettage,0,0
80763,in,0,0
80764,the,0,0
80765,treatment,0,0
80766,of,0,1
80767,chalazia,0,0
80768,and,0,1
80769,with,0,0
80770,similar,0,0
80771,patient,1,1
80772,satisfaction,1,1
80773,and,0,1
80774,less,0,0
80775,pain,1,1
80776,and,0,1
80777,patient,1,1
80778,inconvenience,1,1
80779,.,1,0
80780,Results,0,0
80781,of,0,0
80782,a,0,0
80783,phase,0,0
80784,III,0,1
80785,",",0,1
80786,8-week,0,0
80787,",",0,1
80788,multicenter,0,0
80789,",",0,1
80790,prospective,0,0
80791,",",0,1
80792,randomized,0,0
80793,",",0,0
80794,double-blind,0,0
80795,",",0,1
80796,parallel-group,0,0
80797,clinical,0,1
80798,trial,0,0
80799,to,0,0
80800,assess,0,0
80801,the,0,0
80802,effects,0,0
80803,of,0,0
80804,amlodipine,0,0
80805,camsylate,0,0
80806,versus,0,0
80807,amlodipine,0,0
80808,besylate,0,0
80809,in,0,0
80810,Korean,0,0
80811,adults,0,0
80812,with,0,0
80813,mild,0,0
80814,to,0,0
80815,moderate,0,0
80816,hypertension,0,1
80817,.,0,0
80818,BACKGROUND,0,0
80819,Amlodipine,0,0
80820,besylate,0,0
80821,has,0,0
80822,been,0,0
80823,used,0,0
80824,in,0,0
80825,Korea,0,0
80826,for,0,0
80827,the,0,0
80828,treatment,0,0
80829,of,0,0
80830,hypertension,0,1
80831,for,0,0
80832,>,0,0
80833,17,0,0
80834,years,0,0
80835,",",0,0
80836,with,0,0
80837,well-established,0,0
80838,efficacy,0,1
80839,and,0,1
80840,tolerability,0,1
80841,.,0,1
80842,Amlodipine,0,0
80843,camsylate,0,0
80844,is,0,0
80845,a,0,0
80846,newer,0,0
80847,formulation,0,0
80848,developed,0,0
80849,for,0,0
80850,generic,0,0
80851,use,0,0
80852,.,0,0
80853,It,0,0
80854,has,0,0
80855,been,0,0
80856,assessed,0,0
80857,in,0,0
80858,terms,0,0
80859,of,0,0
80860,physical,0,1
80861,stability,0,1
80862,and,0,1
80863,pharmacokinetic,0,1
80864,and,0,1
80865,pharmacodynamic,0,1
80866,properties,0,1
80867,and,0,1
80868,been,0,0
80869,found,0,0
80870,to,0,0
80871,be,0,0
80872,effective,0,1
80873,in,0,0
80874,lowering,0,1
80875,blood,0,1
80876,pressure,0,1
80877,in,0,0
80878,preclinical,0,0
80879,and,0,0
80880,Phase,0,1
80881,I,0,1
80882,and,0,0
80883,II,0,0
80884,trials,0,0
80885,.,0,0
80886,However,0,0
80887,",",0,0
80888,to,0,0
80889,date,0,1
80890,",",0,0
80891,no,0,0
80892,studies,0,0
80893,have,0,0
80894,compared,0,0
80895,the,0,0
80896,clinical,0,0
80897,effectiveness,0,1
80898,of,0,1
80899,amlodipine,0,0
80900,camsylate,0,0
80901,and,0,1
80902,amlodipine,0,0
80903,besylate,0,0
80904,in,0,0
80905,treating,0,0
80906,hypertension,0,1
80907,.,0,0
80908,OBJECTIVE,0,0
80909,This,0,0
80910,study,0,0
80911,was,0,0
80912,designed,0,0
80913,to,0,0
80914,determine,0,0
80915,the,0,0
80916,effectiveness,1,1
80917,and,1,1
80918,tolerability,1,1
80919,of,0,1
80920,amlodipine,0,0
80921,camsylate,0,0
80922,compared,0,0
80923,with,0,0
80924,amlodipine,0,0
80925,besylate,0,0
80926,in,0,0
80927,Korean,0,0
80928,patients,0,0
80929,with,0,0
80930,mild,0,0
80931,to,0,0
80932,moderate,0,0
80933,hypertension,0,1
80934,.,0,0
80935,METHODS,0,0
80936,This,0,0
80937,Phase,0,1
80938,III,0,1
80939,",",0,1
80940,8-week,0,0
80941,",",0,1
80942,prospective,0,0
80943,",",0,1
80944,randomized,0,0
80945,",",0,0
80946,double-blind,0,0
80947,",",0,1
80948,parallel-group,0,0
80949,study,0,0
80950,was,0,0
80951,conducted,0,0
80952,in,0,0
80953,13,0,0
80954,cardiology,0,0
80955,centers,0,0
80956,across,0,0
80957,the,0,0
80958,Republic,0,0
80959,of,0,0
80960,Korea,0,0
80961,.,0,1
80962,Male,0,0
80963,and,0,1
80964,female,0,0
80965,Korean,0,1
80966,patients,0,0
80967,aged,0,0
80968,18,0,0
80969,to,0,0
80970,75,0,0
80971,years,0,0
80972,having,0,0
80973,uncomplicated,0,0
80974,",",0,0
80975,mild,0,0
80976,to,0,0
80977,moderate,0,0
80978,",",0,0
80979,essential,0,1
80980,hypertension,0,1
80981,(,0,0
80982,sitting,0,1
80983,diastolic,0,1
80984,blood,0,1
80985,pressure,0,1
80986,[,0,0
80987,SiDBP,0,1
80988,],0,0
80989,90-,0,0
80990,<,0,0
80991,110,0,0
80992,mm,0,0
80993,Hg,0,0
80994,),0,1
80995,and,0,0
80996,receiving,0,0
80997,no,0,0
80998,antihypertensives,0,0
80999,in,0,0
81000,the,0,0
81001,2,0,0
81002,weeks,0,0
81003,before,0,0
81004,randomization,0,0
81005,were,0,0
81006,eligible,0,0
81007,.,0,0
81008,Patients,0,0
81009,were,0,0
81010,randomly,0,0
81011,assigned,0,0
81012,to,0,0
81013,receive,0,0
81014,oral,0,0
81015,treatment,0,0
81016,with,0,0
81017,amlodipine,0,0
81018,camsylate,0,0
81019,or,0,1
81020,amlodipine,0,0
81021,besylate,0,0
81022,.,0,0
81023,For,0,0
81024,the,0,0
81025,first,0,0
81026,4,0,0
81027,weeks,0,0
81028,",",0,0
81029,patients,0,0
81030,received,0,0
81031,amlodipine,0,0
81032,5,0,0
81033,mg,0,0
81034,QD,0,1
81035,(,0,1
81036,morning,0,1
81037,),0,0
81038,.,0,0
81039,After,0,0
81040,4,0,0
81041,weeks,0,0
81042,",",0,0
81043,if,0,0
81044,either,0,0
81045,blood,1,1
81046,pressure,1,1
81047,was,0,0
81048,>,0,1
81049,or,0,1
81050,=140/,0,0
81051,>,0,0
81052,or,0,0
81053,=90,0,0
81054,mm,0,1
81055,Hg,0,1
81056,or,0,1
81057,SiDBP,0,1
81058,had,0,0
81059,not,0,0
81060,decreased,0,0
81061,by,0,0
81062,>,0,0
81063,or,0,0
81064,=10,0,0
81065,mm,0,1
81066,Hg,0,0
81067,from,0,0
81068,baseline,0,0
81069,",",0,0
81070,the,0,0
81071,dose,0,0
81072,of,0,1
81073,amlodipine,0,0
81074,was,0,0
81075,increased,0,0
81076,to,0,0
81077,10,0,0
81078,mg,0,0
81079,QD,0,0
81080,for,0,0
81081,4,0,0
81082,weeks,0,0
81083,.,0,0
81084,Trough,1,0
81085,blood,1,1
81086,pressure,1,1
81087,and,1,1
81088,heart,1,1
81089,rate,1,1
81090,were,0,0
81091,measured,0,0
81092,in,0,0
81093,duplicate,0,0
81094,with,0,0
81095,the,0,0
81096,patient,0,0
81097,in,0,0
81098,the,0,0
81099,sitting,0,1
81100,position,0,1
81101,at,0,0
81102,each,0,0
81103,clinic,0,0
81104,visit,0,1
81105,(,0,0
81106,baseline,0,1
81107,[,0,0
81108,week,0,0
81109,0,0,0
81110,],0,0
81111,and,0,0
81112,weeks,0,0
81113,4,0,0
81114,and,0,0
81115,8,0,0
81116,of,0,0
81117,treatment,0,0
81118,),0,0
81119,;,0,0
81120,mean,0,1
81121,values,0,1
81122,were,0,0
81123,calculated,0,0
81124,and,0,0
81125,recorded,0,0
81126,.,0,0
81127,At,0,0
81128,weeks,0,0
81129,4,0,0
81130,and,0,0
81131,8,0,0
81132,",",0,0
81133,tolerability,1,1
81134,was,0,0
81135,assessed,0,0
81136,using,0,0
81137,history,0,1
81138,taking,0,0
81139,and,0,1
81140,laboratory,0,1
81141,analysis,0,0
81142,",",0,1
81143,and,0,1
81144,compliance,0,1
81145,was,0,0
81146,assessed,0,0
81147,using,0,0
81148,pill,0,0
81149,counts,0,1
81150,.,0,0
81151,The,0,0
81152,primary,0,0
81153,end,0,0
81154,point,0,0
81155,was,0,0
81156,change,0,1
81157,from,0,0
81158,baseline,0,0
81159,in,0,0
81160,SiDBP,1,1
81161,at,0,0
81162,week,0,0
81163,8,0,0
81164,.,0,0
81165,Secondary,0,0
81166,end,0,0
81167,points,0,1
81168,were,0,0
81169,change,0,1
81170,from,0,0
81171,baseline,0,0
81172,in,0,0
81173,sitting,1,1
81174,systolic,1,1
81175,blood,1,1
81176,pressure,1,1
81177,(,0,1
81178,SiSBP,0,0
81179,),0,1
81180,at,0,0
81181,week,0,0
81182,8,0,0
81183,in,0,0
81184,the,0,0
81185,total,0,1
81186,population,0,0
81187,and,0,0
81188,in,0,0
81189,the,0,0
81190,subgroup,0,0
81191,of,0,0
81192,patients,0,0
81193,who,0,0
81194,had,0,0
81195,previously,0,0
81196,received,0,0
81197,antihypertensive,0,0
81198,treatment,0,0
81199,versus,0,0
81200,those,0,0
81201,who,0,0
81202,had,0,0
81203,not,0,0
81204,.,0,0
81205,RESULTS,0,0
81206,A,0,0
81207,total,0,0
81208,of,0,0
81209,189,0,0
81210,patients,0,0
81211,were,0,0
81212,enrolled,0,0
81213,(,0,0
81214,mean,0,1
81215,age,0,0
81216,",",0,0
81217,53,0,0
81218,years,0,0
81219,;,0,0
81220,105,0,0
81221,women,0,0
81222,",",0,0
81223,84,0,0
81224,men,0,0
81225,;,0,0
81226,mean,0,1
81227,body,0,1
81228,weight,0,1
81229,",",0,0
81230,65.8,0,0
81231,kg,0,0
81232,),0,0
81233,.,0,0
81234,One,0,0
81235,patient,0,0
81236,in,0,0
81237,the,0,0
81238,amlodipine,0,0
81239,camsylate,0,0
81240,group,0,0
81241,dropped,0,1
81242,out,0,0
81243,of,0,0
81244,the,0,0
81245,study,0,0
81246,at,0,0
81247,week,0,0
81248,0,0,0
81249,of,0,0
81250,treatment,0,0
81251,(,0,0
81252,this,0,0
81253,patient,0,1
81254,did,0,0
81255,not,0,0
81256,use,0,0
81257,any,0,0
81258,study,0,0
81259,medication,0,1
81260,),0,1
81261,and,0,1
81262,was,0,0
81263,excluded,0,0
81264,from,0,0
81265,the,0,0
81266,modified,0,0
81267,intent-to-treat,0,0
81268,(,0,0
81269,ITT,0,0
81270,),0,0
81271,analysis,0,0
81272,.,0,0
81273,Thus,0,1
81274,",",0,0
81275,188,0,0
81276,patients,0,0
81277,were,0,0
81278,treated,0,0
81279,and,0,0
81280,included,0,0
81281,in,0,0
81282,the,0,0
81283,ITT,0,0
81284,analysis,0,0
81285,(,0,0
81286,94,0,0
81287,patients,0,0
81288,per,0,0
81289,treatment,0,0
81290,group,0,0
81291,;,0,1
81292,ITT,0,0
81293,analysis,0,0
81294,),0,0
81295,;,0,0
81296,161,0,0
81297,patients,0,0
81298,were,0,0
81299,included,0,0
81300,in,0,0
81301,the,0,0
81302,perprotocol,0,0
81303,(,0,0
81304,PP,0,0
81305,),0,1
81306,analysis,0,0
81307,(,0,0
81308,n,0,0
81309,=,0,0
81310,80,0,0
81311,for,0,0
81312,amlodipine,0,0
81313,camsylate,0,0
81314,",",0,0
81315,n,0,0
81316,=,0,0
81317,81,0,0
81318,for,0,0
81319,amlodipine,0,0
81320,besylate,0,0
81321,),0,0
81322,(,0,0
81323,14,0,0
81324,patients,0,0
81325,in,0,0
81326,the,0,0
81327,amlodipine,0,0
81328,camsylate,0,0
81329,group,0,0
81330,and,0,0
81331,13,0,0
81332,patients,0,0
81333,in,0,0
81334,the,0,0
81335,amlodipine,0,0
81336,besylate,0,0
81337,group,0,0
81338,were,0,0
81339,excluded,0,0
81340,from,0,0
81341,the,0,0
81342,PP,0,0
81343,analysis,0,0
81344,due,0,0
81345,to,0,0
81346,consistent,0,0
81347,withdrawal,0,1
81348,or,0,1
81349,protocol,0,0
81350,violation,0,1
81351,),0,0
81352,.,0,1
81353,Mean,1,1
81354,(,1,0
81355,SD,1,0
81356,),1,1
81357,SiSBP,1,0
81358,and,1,1
81359,SiDBP,1,1
81360,were,0,0
81361,significantly,0,0
81362,decreased,0,0
81363,from,0,0
81364,baseline,0,0
81365,in,0,0
81366,both,0,0
81367,groups,0,0
81368,(,0,0
81369,amlodipine,0,0
81370,camsylate,0,0
81371,",",0,0
81372,from,0,0
81373,146.7,0,0
81374,[,0,0
81375,12.3,0,0
81376,],0,0
81377,/96.6,0,0
81378,[,0,0
81379,5.4,0,0
81380,],0,0
81381,to,0,0
81382,127.9,0,0
81383,[,0,0
81384,14.8,0,0
81385,],0,0
81386,/83.4,0,0
81387,[,0,0
81388,7.7,0,0
81389,],0,0
81390,mm,0,0
81391,Hg,0,0
81392,[,0,0
81393,both,0,0
81394,",",0,0
81395,P,0,0
81396,<,0,0
81397,0.001,0,0
81398,],0,0
81399,;,0,0
81400,amlodipine,0,0
81401,besylate,0,0
81402,",",0,0
81403,from,0,0
81404,146.8,0,0
81405,[,0,0
81406,12.8,0,0
81407,],0,0
81408,/96.7,0,0
81409,[,0,0
81410,5.1,0,0
81411,],0,0
81412,to,0,0
81413,128.0,0,0
81414,[,0,0
81415,10.1,0,0
81416,],0,0
81417,/83.8,0,0
81418,[,0,0
81419,7.5,0,0
81420,],0,0
81421,mm,0,0
81422,Hg,0,0
81423,[,0,0
81424,both,0,0
81425,",",0,0
81426,P,0,0
81427,<,0,0
81428,0.001,0,0
81429,],0,0
81430,),0,0
81431,.,0,0
81432,The,0,0
81433,differences,0,0
81434,in,0,0
81435,SiSBP/SiDBP,1,0
81436,between,0,0
81437,the,0,0
81438,2,0,0
81439,groups,0,0
81440,at,0,0
81441,week,0,0
81442,8,0,0
81443,were,0,0
81444,not,0,0
81445,significant,0,0
81446,.,0,0
81447,The,0,0
81448,SiDBP,1,1
81449,response,1,1
81450,rates,1,1
81451,in,0,0
81452,the,0,0
81453,subgroups,0,0
81454,that,0,0
81455,had,0,0
81456,and,0,1
81457,had,0,0
81458,not,0,0
81459,been,0,0
81460,previously,0,0
81461,treated,0,0
81462,with,0,0
81463,antihypertensives,0,0
81464,were,0,0
81465,statistically,0,0
81466,similar,0,0
81467,(,0,0
81468,56/69,0,0
81469,[,0,0
81470,81.2,0,0
81471,%,0,0
81472,],0,0
81473,and,0,0
81474,83/92,0,0
81475,[,0,0
81476,90.2,0,0
81477,%,0,0
81478,],0,0
81479,",",0,0
81480,respectively,0,0
81481,),0,0
81482,.,0,0
81483,The,0,0
81484,prevalences,0,0
81485,of,0,0
81486,clinical,1,0
81487,adverse,1,1
81488,events,1,1
81489,(,0,0
81490,AEs,0,1
81491,),0,1
81492,were,0,0
81493,not,0,0
81494,significantly,0,0
81495,different,0,0
81496,between,0,0
81497,the,0,0
81498,2,0,0
81499,treatment,0,0
81500,groups,0,0
81501,(,0,0
81502,amlodipine,0,0
81503,camsylate,0,0
81504,",",0,0
81505,27.3,0,0
81506,%,0,0
81507,;,0,0
81508,amlodipine,0,0
81509,besylate,0,0
81510,",",0,0
81511,28.7,0,0
81512,%,0,0
81513,),0,0
81514,.,0,0
81515,The,0,0
81516,most,0,0
81517,common,0,0
81518,AEs,0,1
81519,were,0,0
81520,dizziness,1,1
81521,and,1,1
81522,dyspnea,1,1
81523,(,0,0
81524,both,0,0
81525,in,0,0
81526,3/94,0,0
81527,[,0,0
81528,3.2,0,0
81529,%,0,0
81530,],0,0
81531,and,0,0
81532,1/94,0,0
81533,[,0,0
81534,1.1,0,0
81535,%,0,0
81536,],0,0
81537,patients,0,0
81538,who,0,0
81539,received,0,0
81540,amlodipine,0,0
81541,camsylate,0,0
81542,and,0,1
81543,amlodipine,0,0
81544,besylate,0,0
81545,",",0,0
81546,respectively,0,0
81547,),0,0
81548,.,0,0
81549,CONCLUSION,0,0
81550,The,0,0
81551,effectiveness,0,1
81552,and,0,1
81553,tolerability,0,1
81554,of,0,1
81555,amlodipine,0,0
81556,camsylate,0,0
81557,were,0,0
81558,not,0,0
81559,significantly,0,0
81560,different,0,0
81561,from,0,0
81562,those,0,0
81563,of,0,0
81564,amlodipine,0,0
81565,besylate,0,0
81566,in,0,0
81567,these,0,0
81568,Korean,0,0
81569,adults,0,0
81570,with,0,0
81571,mild,0,0
81572,to,0,0
81573,moderate,0,0
81574,hypertension,0,0
81575,.,0,0
81576,Intensive,0,0
81577,insulin,0,1
81578,therapy,0,0
81579,improves,0,1
81580,endothelial,1,1
81581,function,1,1
81582,and,0,1
81583,microvascular,0,1
81584,reactivity,0,1
81585,in,0,0
81586,young,0,0
81587,people,0,0
81588,with,0,0
81589,type,0,0
81590,1,0,0
81591,diabetes,0,0
81592,.,0,0
81593,AIMS/HYPOTHESIS,0,0
81594,Macrovascular,0,1
81595,disease,0,0
81596,is,0,0
81597,an,0,0
81598,important,0,0
81599,cause,0,0
81600,of,0,0
81601,the,0,0
81602,increased,0,0
81603,morbidity,0,1
81604,and,0,1
81605,mortality,0,1
81606,rates,0,1
81607,associated,0,0
81608,with,0,0
81609,type,0,0
81610,1,0,0
81611,diabetes,0,0
81612,",",0,0
81613,and,0,0
81614,this,0,0
81615,vascular,0,1
81616,impairment,0,0
81617,begins,0,0
81618,in,0,0
81619,childhood,0,0
81620,.,0,0
81621,The,0,0
81622,aim,0,0
81623,of,0,0
81624,this,0,0
81625,study,0,0
81626,was,0,0
81627,to,0,0
81628,determine,0,0
81629,whether,0,0
81630,introducing,0,0
81631,intensive,0,0
81632,diabetes,0,0
81633,management,0,0
81634,[,0,0
81635,intensive,0,0
81636,insulin,0,1
81637,therapy,0,0
81638,(,0,1
81639,IIT,0,1
81640,),0,1
81641,and,0,1
81642,'Sweet,0,0
81643,Talk,0,1
81644,',0,1
81645,text-messaging,0,0
81646,support,0,0
81647,],0,0
81648,produces,0,0
81649,measurable,0,1
81650,improvements,0,1
81651,in,0,0
81652,endothelial,1,1
81653,function,1,1
81654,.,1,0
81655,METHODS,0,0
81656,One,0,0
81657,hundred,0,0
81658,and,0,0
81659,twenty-six,0,0
81660,patients,0,0
81661,fulfilled,0,0
81662,the,0,0
81663,eligibility,0,0
81664,criteria,0,0
81665,(,0,0
81666,type,0,0
81667,1,0,0
81668,diabetes,0,0
81669,for,0,0
81670,>,0,0
81671,1,0,0
81672,year,0,0
81673,;,0,0
81674,on,0,0
81675,conventional,0,0
81676,insulin,0,1
81677,therapy,0,0
81678,(,0,1
81679,CIT,0,1
81680,),0,0
81681,;,0,0
81682,aged,0,0
81683,between,0,0
81684,8,0,0
81685,and,0,0
81686,18,0,0
81687,years,0,0
81688,),0,0
81689,",",0,0
81690,of,0,0
81691,whom,0,0
81692,92,0,0
81693,enrolled,0,0
81694,.,0,0
81695,Patients,0,0
81696,were,0,0
81697,randomised,0,0
81698,to,0,0
81699,group,0,0
81700,1,0,0
81701,",",0,0
81702,CIT,0,0
81703,only,0,0
81704,(,0,0
81705,n=28,0,0
81706,),0,0
81707,;,0,0
81708,group,0,0
81709,2,0,0
81710,",",0,0
81711,CIT,0,1
81712,and,0,1
81713,Sweet,0,1
81714,Talk,0,1
81715,(,0,1
81716,n=33,0,0
81717,),0,0
81718,;,0,0
81719,or,0,0
81720,group,0,0
81721,3,0,0
81722,",",0,0
81723,IIT,0,0
81724,and,0,1
81725,Sweet,0,1
81726,Talk,0,1
81727,(,0,1
81728,n=31,0,0
81729,),0,0
81730,.,0,0
81731,Vascular,1,1
81732,assessments,1,0
81733,(,1,0
81734,including,1,0
81735,measures,1,1
81736,of,1,0
81737,endothelial,1,1
81738,damage,1,1
81739,",",1,1
81740,activation,1,1
81741,",",1,1
81742,dysfunction,1,1
81743,and,1,1
81744,oxidative,1,1
81745,stress,1,1
81746,),1,1
81747,and,1,1
81748,HbA1c,1,0
81749,were,0,0
81750,performed,0,0
81751,at,0,0
81752,baseline,0,0
81753,and,0,1
81754,repeated,0,0
81755,after,0,0
81756,12,0,0
81757,months,0,0
81758,of,0,0
81759,the,0,0
81760,study,0,0
81761,.,0,0
81762,RESULTS,0,0
81763,Glycaemic,1,1
81764,control,1,0
81765,deteriorated,0,1
81766,in,0,0
81767,patients,0,0
81768,on,0,0
81769,CIT,0,1
81770,",",0,1
81771,but,0,0
81772,improved,0,1
81773,significantly,0,0
81774,in,0,0
81775,patients,0,0
81776,allocated,0,0
81777,to,0,0
81778,IIT,0,1
81779,(,0,1
81780,p=0.007,0,0
81781,),0,0
81782,.,0,1
81783,IIT,0,1
81784,was,0,0
81785,associated,0,0
81786,with,0,0
81787,significantly,0,0
81788,greater,0,0
81789,improvements,0,1
81790,in,0,1
81791,E-selectin,1,1
81792,(,0,0
81793,p,0,0
81794,<,0,0
81795,0.0001,0,0
81796,),0,0
81797,than,0,0
81798,CIT,0,1
81799,(,0,0
81800,group,0,0
81801,1,0,0
81802,",",0,0
81803,p=0.026,0,0
81804,and,0,1
81805,group,0,0
81806,2,0,0
81807,",",0,0
81808,p=0.053,0,0
81809,),0,1
81810,.,0,0
81811,Vascular,1,1
81812,responses,1,1
81813,to,0,0
81814,acetylcholine,0,0
81815,improved,0,0
81816,in,0,0
81817,patients,0,0
81818,on,0,0
81819,IIT,0,1
81820,(,0,1
81821,p=0.017,0,1
81822,),0,1
81823,",",0,1
81824,but,0,0
81825,not,0,0
81826,in,0,0
81827,patients,0,0
81828,receiving,0,0
81829,CIT,0,0
81830,.,0,0
81831,These,0,0
81832,changes,0,1
81833,were,0,0
81834,all,0,0
81835,independent,0,0
81836,of,0,0
81837,HbA1c,0,0
81838,level,0,1
81839,.,0,1
81840,CONCLUSIONS/INTERPRETATION,0,0
81841,IIT,0,0
81842,appears,0,0
81843,to,0,0
81844,be,0,0
81845,associated,0,0
81846,with,0,0
81847,improvements,0,0
81848,in,0,0
81849,vascular,1,1
81850,markers,1,1
81851,",",0,0
81852,independently,0,0
81853,of,0,0
81854,changes,0,1
81855,in,0,0
81856,HbA1c,0,0
81857,",",0,0
81858,suggesting,0,0
81859,that,0,0
81860,IIT,0,0
81861,may,0,0
81862,confer,0,0
81863,vascular,0,1
81864,protection,0,1
81865,in,0,0
81866,addition,0,0
81867,to,0,0
81868,improving,0,1
81869,glycaemic,1,1
81870,control,1,0
81871,.,1,0
81872,Effect,0,0
81873,of,0,0
81874,a,0,0
81875,ferrule,0,0
81876,and,0,1
81877,increased,0,1
81878,clinical,0,1
81879,crown,0,1
81880,length,0,1
81881,on,0,0
81882,the,0,0
81883,in,0,0
81884,vitro,0,1
81885,fracture,0,1
81886,resistance,0,1
81887,of,0,1
81888,premolars,0,0
81889,restored,0,0
81890,using,0,0
81891,two,0,0
81892,dowel-and-core,0,0
81893,systems,0,0
81894,.,0,0
81895,This,0,0
81896,study,0,0
81897,investigated,0,0
81898,the,0,0
81899,effect,0,0
81900,of,0,0
81901,a,0,0
81902,crown-lengthening,0,1
81903,ferrule,0,0
81904,on,0,0
81905,the,0,0
81906,fracture,0,1
81907,resistance,0,1
81908,of,0,1
81909,endodontically-treated,0,0
81910,teeth,0,0
81911,restored,0,0
81912,with,0,0
81913,two,0,0
81914,dowel-core,0,0
81915,systems,0,0
81916,.,0,1
81917,Thirty-two,0,0
81918,extracted,0,0
81919,mandibular,0,0
81920,first,0,1
81921,premolars,0,0
81922,were,0,0
81923,sectioned,0,0
81924,perpendicular,0,0
81925,to,0,0
81926,the,0,0
81927,long,0,0
81928,axis,0,0
81929,at,0,0
81930,a,0,0
81931,point,0,0
81932,1.0,0,0
81933,mm,0,0
81934,occlusal,0,0
81935,to,0,0
81936,the,0,0
81937,buccal,0,1
81938,cementoenamel,0,1
81939,junction,0,1
81940,.,0,0
81941,Following,0,1
81942,endodontic,0,0
81943,treatment,0,0
81944,",",0,0
81945,the,0,0
81946,teeth,0,0
81947,were,0,0
81948,randomly,0,0
81949,assigned,0,0
81950,to,0,0
81951,four,0,0
81952,groups,0,0
81953,:,0,0
81954,cast,0,0
81955,Ni-Cr,0,0
81956,alloy,0,1
81957,dowel-core,0,0
81958,with,0,0
81959,no,0,0
81960,ferrule,0,0
81961,(,0,0
81962,Group,0,0
81963,A1,0,1
81964,),0,1
81965,",",0,0
81966,cast,0,0
81967,Ni-Cr,0,1
81968,alloy,0,1
81969,dowel-core,0,0
81970,with,0,0
81971,2.0,0,0
81972,mm,0,0
81973,ferrule,0,0
81974,(,0,0
81975,Group,0,0
81976,A2,0,1
81977,),0,1
81978,",",0,0
81979,prefabricated,0,0
81980,carbon,0,0
81981,fiber-reinforced,0,0
81982,dowel-resin,0,0
81983,core,0,1
81984,with,0,0
81985,no,0,0
81986,ferrule,0,0
81987,(,0,0
81988,Group,0,0
81989,B1,0,1
81990,),0,1
81991,and,0,1
81992,carbon,0,1
81993,fiber-reinforced,0,1
81994,dowel-resin,0,0
81995,core,0,1
81996,with,0,0
81997,2.0,0,0
81998,mm,0,0
81999,ferrule,0,0
82000,(,0,0
82001,Group,0,0
82002,B2,0,1
82003,),0,0
82004,.,0,0
82005,Each,0,0
82006,specimen,0,1
82007,was,0,0
82008,embedded,0,0
82009,in,0,0
82010,a,0,0
82011,self-cured,0,0
82012,acrylic,0,0
82013,resin,0,0
82014,block,0,0
82015,from,0,0
82016,2.0,0,0
82017,mm,0,0
82018,apical,0,0
82019,to,0,0
82020,the,0,0
82021,margins,0,0
82022,of,0,0
82023,a,0,0
82024,cast,0,0
82025,Ni-Cr,0,1
82026,alloy,0,1
82027,crown,0,1
82028,",",0,0
82029,then,0,0
82030,loaded,0,0
82031,at,0,0
82032,150,0,0
82033,degrees,0,0
82034,from,0,0
82035,the,0,0
82036,long,0,0
82037,axis,0,0
82038,in,0,0
82039,a,0,0
82040,universal,0,0
82041,testing,0,0
82042,machine,0,0
82043,at,0,0
82044,a,0,0
82045,crosshead,0,0
82046,speed,0,1
82047,of,0,0
82048,1.0,0,0
82049,mm/minute,0,0
82050,until,0,0
82051,fracture,0,1
82052,.,0,0
82053,The,0,0
82054,data,0,0
82055,were,0,0
82056,recorded,0,0
82057,and,0,0
82058,analyzed,0,0
82059,using,0,0
82060,ANOVA,1,0
82061,and,1,1
82062,Fisher,1,1
82063,'s,1,1
82064,exact,1,1
82065,tests,1,1
82066,",",0,0
82067,with,0,0
82068,alpha,0,1
82069,=,0,0
82070,0.05,0,0
82071,.,0,0
82072,Mean,1,0
82073,failure,1,1
82074,loads,1,1
82075,(,1,1
82076,kN,1,1
82077,),1,0
82078,for,0,0
82079,the,0,0
82080,A1,0,1
82081,",",0,1
82082,A2,0,1
82083,",",0,1
82084,B1,0,1
82085,and,0,1
82086,B2,0,1
82087,Groups,0,1
82088,were,0,0
82089,:,0,0
82090,1.46,0,0
82091,(,0,0
82092,S.D,0,0
82093,.,0,0
82094,0.45,0,0
82095,),0,0
82096,",",0,0
82097,1.07,0,0
82098,(,0,0
82099,0.21,0,0
82100,),0,0
82101,",",0,0
82102,1.13,0,0
82103,(,0,0
82104,0.30,0,0
82105,),0,0
82106,and,0,0
82107,1.02,0,0
82108,(,0,0
82109,0.27,0,0
82110,),0,0
82111,.,0,0
82112,The,0,0
82113,teeth,0,0
82114,restored,0,0
82115,with,0,0
82116,cast,0,0
82117,Ni-Cr,0,1
82118,dowel-cores,0,1
82119,and,0,0
82120,2.0,0,0
82121,mm,0,0
82122,ferrules,0,0
82123,demonstrated,0,0
82124,significantly,0,0
82125,lower,0,0
82126,fracture,1,1
82127,strengths,1,1
82128,",",0,0
82129,p,0,0
82130,=,0,0
82131,0.04,0,0
82132,.,0,0
82133,There,0,0
82134,were,0,0
82135,significant,0,0
82136,differences,0,0
82137,in,0,0
82138,the,0,0
82139,root,1,0
82140,fracture,1,0
82141,patterns,1,0
82142,between,0,0
82143,the,0,0
82144,two,0,0
82145,dowel,0,0
82146,systems,0,0
82147,",",0,0
82148,with,0,0
82149,the,0,0
82150,carbon,0,0
82151,fiber-reinforced,0,0
82152,dowel-resin,0,0
82153,core,0,1
82154,system,0,0
82155,",",0,0
82156,being,0,0
82157,the,0,0
82158,less,0,0
82159,severe,0,1
82160,p,0,0
82161,<,0,0
82162,0.05,0,0
82163,.,0,0
82164,Crown,0,0
82165,lengthening,0,1
82166,with,0,0
82167,a,0,0
82168,2.0,0,0
82169,mm,0,0
82170,apical,0,1
82171,extended,0,0
82172,ferrule,0,0
82173,resulted,0,0
82174,in,0,0
82175,reduced,0,1
82176,fracture,1,1
82177,strengths,1,0
82178,for,0,0
82179,endodontically-treated,0,0
82180,teeth,0,0
82181,restored,0,0
82182,using,0,0
82183,two,0,0
82184,dowel-core,0,0
82185,systems,0,0
82186,and,0,1
82187,cast,0,0
82188,metal,0,1
82189,crowns,0,0
82190,.,0,0
82191,The,0,0
82192,carbon,0,0
82193,fiber-reinforced,0,0
82194,dowel-resin,0,0
82195,core,0,1
82196,system,0,0
82197,reduced,0,0
82198,the,0,0
82199,severity,0,1
82200,of,0,0
82201,the,0,0
82202,root,0,0
82203,fractures,0,0
82204,.,0,0
82205,Effectiveness,0,1
82206,of,0,1
82207,cetrorelix,0,0
82208,for,0,0
82209,the,0,0
82210,prevention,0,0
82211,of,0,0
82212,premature,1,0
82213,luteinizing,1,1
82214,hormone,1,1
82215,surge,1,1
82216,during,0,0
82217,controlled,0,0
82218,ovarian,0,1
82219,stimulation,0,1
82220,using,0,0
82221,letrozole,0,0
82222,and,0,0
82223,gonadotropins,0,1
82224,:,0,0
82225,a,0,0
82226,randomized,0,0
82227,trial,0,0
82228,.,0,0
82229,OBJECTIVE,0,0
82230,To,0,0
82231,evaluate,0,0
82232,the,0,0
82233,effectiveness,0,0
82234,of,0,0
82235,a,0,0
82236,GnRH,0,0
82237,antagonist,0,0
82238,in,0,0
82239,preventing,0,0
82240,premature,1,0
82241,LH,1,1
82242,surge,1,0
82243,under,0,0
82244,a,0,0
82245,letrozole,0,0
82246,and,0,1
82247,gonadotropin,0,1
82248,protocol,0,0
82249,.,0,1
82250,DESIGN,0,0
82251,Prospective,0,0
82252,",",0,1
82253,randomized,0,0
82254,clinical,0,0
82255,trial,0,0
82256,.,0,0
82257,SETTING,0,0
82258,A,0,0
82259,teaching,0,0
82260,hospital,0,1
82261,and,0,1
82262,tertiary,0,0
82263,medical,0,0
82264,center,0,0
82265,.,0,1
82266,PATIENT,0,0
82267,(,0,0
82268,S,0,0
82269,),0,0
82270,Sixty-one,0,0
82271,patients,0,0
82272,were,0,0
82273,randomly,0,0
82274,assigned,0,0
82275,into,0,0
82276,two,0,0
82277,letrozole,0,0
82278,and,0,0
82279,gonadotropin-treated,0,0
82280,groups,0,0
82281,.,0,0
82282,These,0,0
82283,were,0,0
82284,distinguished,0,0
82285,by,0,0
82286,the,0,0
82287,absence,0,0
82288,(,0,0
82289,group,0,0
82290,I,0,0
82291,),0,0
82292,or,0,1
82293,presence,0,0
82294,(,0,1
82295,group,0,0
82296,II,0,0
82297,),0,0
82298,of,0,0
82299,supplementation,0,0
82300,with,0,0
82301,0.25,0,0
82302,mg,0,0
82303,of,0,0
82304,cetrorelix,0,0
82305,.,0,1
82306,INTERVENTION,0,1
82307,(,0,0
82308,S,0,1
82309,),0,1
82310,Controlled,0,0
82311,ovarian,0,1
82312,stimulation,0,1
82313,with,0,0
82314,letrozole,0,0
82315,and,0,1
82316,gonadotropins,0,1
82317,",",0,1
82318,cetrorelix,0,0
82319,and,0,1
82320,intrauterine,0,0
82321,insemination,0,1
82322,.,0,0
82323,MAIN,0,0
82324,OUTCOME,0,1
82325,MEASURE,0,1
82326,(,0,1
82327,S,0,0
82328,),0,1
82329,Rate,1,0
82330,of,1,0
82331,premature,1,0
82332,LH,1,1
82333,surge,1,1
82334,.,1,1
82335,RESULT,0,1
82336,(,0,0
82337,S,0,0
82338,),0,1
82339,Compared,0,0
82340,with,0,0
82341,group,0,0
82342,I,0,0
82343,",",0,0
82344,the,0,0
82345,rate,1,1
82346,of,1,0
82347,premature,1,0
82348,LH,1,1
82349,surge,1,1
82350,was,0,0
82351,statistically,0,0
82352,significantly,0,0
82353,lower,0,0
82354,for,0,0
82355,group,0,0
82356,II,0,0
82357,(,0,0
82358,43.4,0,0
82359,%,0,0
82360,[,0,0
82361,13/30,0,1
82362,],0,0
82363,vs.,0,0
82364,19.4,0,0
82365,%,0,0
82366,[,0,0
82367,6/31,0,0
82368,],0,0
82369,),0,0
82370,",",0,0
82371,but,0,0
82372,the,0,0
82373,amount,1,1
82374,of,1,0
82375,gonadotropins,1,1
82376,used,0,0
82377,was,0,0
82378,statistically,0,0
82379,significantly,0,0
82380,higher,0,0
82381,(,0,0
82382,817.5,0,0
82383,+/-,0,0
82384,28.5,0,0
82385,vs.,0,0
82386,907.5,0,0
82387,+/-,0,0
82388,27.3,0,0
82389,IU,0,0
82390,),0,0
82391,.,0,0
82392,Patients,0,0
82393,with,0,0
82394,premature,1,0
82395,LH,1,1
82396,surge,1,1
82397,had,0,0
82398,a,0,0
82399,statistically,0,0
82400,significantly,0,0
82401,lower,0,0
82402,pregnancy,1,1
82403,rate,1,1
82404,(,0,0
82405,21.4,0,0
82406,%,0,0
82407,[,0,0
82408,9/42,0,1
82409,],0,0
82410,vs.,0,0
82411,0,0,0
82412,[,0,0
82413,0/18,0,0
82414,],0,0
82415,),0,0
82416,relative,0,0
82417,to,0,0
82418,their,0,0
82419,unaffected,0,0
82420,counterparts,0,0
82421,.,0,1
82422,CONCLUSION,0,0
82423,(,0,0
82424,S,0,0
82425,),0,1
82426,A,0,0
82427,flexible,0,0
82428,protocol,0,0
82429,of,0,0
82430,0.25,0,0
82431,mg,0,0
82432,of,0,0
82433,cetrorelix,0,0
82434,for,0,0
82435,IUI,0,1
82436,cycles,0,0
82437,appears,0,0
82438,to,0,0
82439,suppress,0,0
82440,the,0,0
82441,rate,0,1
82442,of,0,0
82443,premature,1,0
82444,LH,1,1
82445,surge,1,1
82446,during,0,0
82447,ovarian,0,1
82448,stimulation,0,1
82449,with,0,0
82450,letrozole,0,0
82451,and,0,0
82452,gonadotropins,0,1
82453,.,0,1
82454,However,0,0
82455,",",0,0
82456,the,0,0
82457,incidence,0,1
82458,of,0,0
82459,premature,1,0
82460,LH,1,0
82461,surge,1,0
82462,remains,0,0
82463,too,0,0
82464,high,0,0
82465,",",0,1
82466,and,0,0
82467,modification,0,0
82468,will,0,0
82469,be,0,0
82470,necessary,0,0
82471,before,0,0
82472,the,0,0
82473,application,0,0
82474,of,0,0
82475,cetrorelix,0,0
82476,to,0,0
82477,IVF,0,1
82478,treatment,0,0
82479,.,0,0
82480,Comparison,0,0
82481,of,0,0
82482,two,0,0
82483,sedation,0,1
82484,techniques,0,0
82485,in,0,0
82486,patients,0,0
82487,undergoing,0,0
82488,surgical,0,0
82489,procedures,0,0
82490,under,0,0
82491,regional,0,0
82492,anaesthesia,0,0
82493,.,0,0
82494,OBJECTIVE,0,1
82495,Intraoperative,0,1
82496,comfort,0,1
82497,and,0,1
82498,patient,1,1
82499,satisfaction,1,1
82500,during,0,0
82501,surgical,0,0
82502,procedures,0,0
82503,under,0,0
82504,regional,0,0
82505,anaesthesia,0,0
82506,can,0,0
82507,be,0,0
82508,improved,0,0
82509,with,0,0
82510,the,0,0
82511,use,0,0
82512,of,0,0
82513,supplemental,0,0
82514,intravenous,0,0
82515,sedation,0,1
82516,.,0,0
82517,The,0,0
82518,authors,0,0
82519,conducted,0,0
82520,a,0,0
82521,study,0,0
82522,to,0,0
82523,compare,0,0
82524,two,0,0
82525,sedation,0,1
82526,techniques,0,0
82527,for,0,0
82528,surgical,0,0
82529,procedures,0,0
82530,performed,0,0
82531,under,0,0
82532,regional,0,0
82533,anaesthesia,0,0
82534,",",0,1
82535,i.e.,0,1
82536,",",0,1
82537,midazolam,0,1
82538,and,0,1
82539,pethidine,0,0
82540,combination,0,0
82541,compared,0,0
82542,with,0,0
82543,midazolam,0,0
82544,and,0,1
82545,tramadol,0,0
82546,combination,0,0
82547,.,0,0
82548,METHODS,0,0
82549,Forty,0,0
82550,adult,0,0
82551,American,0,0
82552,Society,0,0
82553,of,0,1
82554,Anaesthesiologists,0,0
82555,(,0,0
82556,ASA,0,1
82557,),0,1
82558,grade,0,1
82559,1-111,0,0
82560,patients,0,0
82561,",",0,0
82562,aged,0,0
82563,between,0,0
82564,40-65,0,0
82565,years,0,0
82566,undergoing,0,0
82567,surgery,0,0
82568,under,0,0
82569,regional,0,0
82570,anaesthesia,0,0
82571,(,0,0
82572,sub-arachnoid,0,1
82573,block,0,1
82574,),0,1
82575,were,0,0
82576,included,0,0
82577,.,0,0
82578,The,0,0
82579,patients,0,0
82580,were,0,0
82581,randomly,0,0
82582,divided,0,0
82583,into,0,0
82584,two,0,0
82585,groups,0,0
82586,.,0,0
82587,All,0,0
82588,patients,0,0
82589,received,0,0
82590,standardized,0,0
82591,premedication,0,0
82592,",",0,1
82593,intraoperative,0,1
82594,monitoring,0,0
82595,and,0,1
82596,oxygen,0,1
82597,therapy,0,0
82598,.,0,1
82599,Group,0,0
82600,A,0,0
82601,patients,0,0
82602,received,0,0
82603,midazolam,0,0
82604,0.03,0,0
82605,mg/kg,0,0
82606,followed,0,0
82607,by,0,0
82608,pethidine,0,0
82609,20,0,0
82610,mg,0,0
82611,intravenously,0,0
82612,",",0,0
82613,and,0,1
82614,group,0,0
82615,B,0,1
82616,patients,0,0
82617,received,0,0
82618,midazolam,0,0
82619,0.03,0,0
82620,mg/kg,0,0
82621,followed,0,0
82622,by,0,0
82623,tramadol,0,0
82624,20,0,0
82625,mg,0,0
82626,intravenously,0,0
82627,after,0,0
82628,the,0,0
82629,institution,0,0
82630,of,0,0
82631,regional,0,0
82632,anaesthesia,0,0
82633,.,0,1
82634,Monitoring,0,1
82635,included,0,0
82636,ECG,1,1
82637,",",1,1
82638,blood,1,1
82639,pressure,1,1
82640,",",1,1
82641,respiratory,1,1
82642,rate,1,1
82643,",",1,1
82644,oxygen,1,1
82645,saturation,1,1
82646,and,1,1
82647,sedation,1,1
82648,score,1,1
82649,.,1,1
82650,Complications,0,1
82651,",",0,0
82652,if,0,0
82653,any,0,1
82654,",",0,0
82655,were,0,0
82656,recorded,0,0
82657,.,0,0
82658,Monitoring,0,0
82659,was,0,0
82660,continued,0,0
82661,during,0,0
82662,the,0,0
82663,recovery,0,1
82664,room,0,0
82665,stay,0,1
82666,.,0,0
82667,All,0,0
82668,patients,0,0
82669,were,0,0
82670,interviewed,0,0
82671,in,0,0
82672,the,0,0
82673,evening,0,1
82674,and,0,1
82675,time,0,1
82676,of,0,1
82677,ambulation,0,1
82678,and,0,1
82679,rating,0,1
82680,of,0,1
82681,OR,0,1
82682,experience,0,1
82683,was,0,0
82684,noted,0,0
82685,.,0,0
82686,RESULTS,0,0
82687,Data,0,1
82688,analysis,0,0
82689,showed,0,0
82690,no,0,0
82691,significant,0,0
82692,difference,0,0
82693,between,0,0
82694,pethidine,0,0
82695,and,0,1
82696,tramadol,0,0
82697,for,0,0
82698,all,0,0
82699,the,0,0
82700,haemodynamic,1,1
82701,variables,1,1
82702,(,0,0
82703,p,0,0
82704,=,0,0
82705,>,0,0
82706,0.05,0,0
82707,),0,0
82708,.,0,0
82709,There,0,0
82710,was,0,0
82711,also,0,0
82712,no,0,0
82713,significant,0,0
82714,difference,0,0
82715,in,0,0
82716,patient,0,1
82717,'s,0,1
82718,and,0,1
82719,surgeon,0,1
82720,'s,0,1
82721,assessment,0,0
82722,of,0,0
82723,their,0,0
82724,experience,0,1
82725,.,0,1
82726,Complications,1,1
82727,and,1,1
82728,recovery,1,1
82729,characteristics,1,1
82730,also,0,0
82731,did,0,0
82732,not,0,0
82733,show,0,0
82734,any,0,0
82735,significant,0,0
82736,difference,0,0
82737,.,0,0
82738,CONCLUSION,0,0
82739,Midazolam-tramadol,0,0
82740,combination,0,0
82741,may,0,0
82742,be,0,0
82743,used,0,0
82744,as,0,0
82745,an,0,0
82746,alternative,0,0
82747,to,0,0
82748,midazolam-pethidine,0,0
82749,combination,0,0
82750,for,0,0
82751,sedation,0,1
82752,during,0,0
82753,surgical,0,0
82754,procedures,0,0
82755,performed,0,0
82756,under,0,0
82757,regional,0,0
82758,anaesthesia,0,0
82759,.,0,0
82760,Short-term,0,0
82761,aerobic,0,0
82762,exercise,0,0
82763,training,0,0
82764,in,0,0
82765,obese,0,0
82766,humans,0,0
82767,with,0,0
82768,type,0,0
82769,2,0,0
82770,diabetes,0,0
82771,mellitus,0,0
82772,improves,0,1
82773,whole-body,0,1
82774,insulin,0,1
82775,sensitivity,0,1
82776,through,0,0
82777,gains,0,1
82778,in,0,0
82779,peripheral,0,1
82780,",",0,0
82781,not,0,0
82782,hepatic,0,1
82783,insulin,0,1
82784,sensitivity,0,1
82785,.,0,1
82786,CONTEXT,0,0
82787,Short-term,0,0
82788,aerobic,0,0
82789,exercise,0,0
82790,training,0,0
82791,can,0,0
82792,improve,0,0
82793,whole-body,1,1
82794,insulin,1,1
82795,sensitivity,1,1
82796,in,0,0
82797,humans,0,0
82798,with,0,0
82799,type,0,0
82800,2,0,0
82801,diabetes,0,0
82802,mellitus,0,0
82803,;,0,0
82804,however,0,0
82805,",",0,0
82806,the,0,0
82807,contributions,0,0
82808,of,0,0
82809,peripheral,0,1
82810,and,0,1
82811,hepatic,0,1
82812,tissues,0,1
82813,to,0,0
82814,these,0,0
82815,improvements,0,0
82816,are,0,0
82817,not,0,0
82818,known,0,0
82819,.,0,0
82820,OBJECTIVE,0,0
82821,Our,0,0
82822,objective,0,0
82823,was,0,0
82824,to,0,0
82825,determine,0,0
82826,the,0,0
82827,effect,0,0
82828,of,0,0
82829,7-d,0,0
82830,aerobic,0,0
82831,exercise,0,0
82832,training,0,0
82833,on,0,0
82834,peripheral,0,1
82835,and,0,1
82836,hepatic,0,1
82837,insulin,0,1
82838,sensitivity,0,1
82839,during,0,0
82840,isoglycemic/hyperinsulinemic,0,0
82841,clamp,0,0
82842,conditions,0,0
82843,.,0,0
82844,DESIGN,0,0
82845,Subjects,0,0
82846,were,0,0
82847,randomly,0,0
82848,assigned,0,0
82849,to,0,0
82850,one,0,0
82851,of,0,0
82852,two,0,0
82853,groups,0,0
82854,.,0,0
82855,The,0,0
82856,energy,0,1
82857,balance,0,1
82858,group,0,0
82859,consumed,0,0
82860,an,0,0
82861,isocaloric,0,0
82862,diet,0,0
82863,consisting,0,0
82864,of,0,0
82865,50,0,0
82866,%,0,0
82867,carbohydrate,0,0
82868,",",0,0
82869,30,0,0
82870,%,0,0
82871,fat,0,1
82872,",",0,0
82873,and,0,0
82874,20,0,0
82875,%,0,0
82876,protein,0,0
82877,for,0,0
82878,15,0,0
82879,d.,0,0
82880,The,0,0
82881,energy,0,1
82882,balance,0,1
82883,plus,0,0
82884,exercise,0,0
82885,group,0,0
82886,consumed,0,0
82887,a,0,0
82888,similar,0,0
82889,diet,0,0
82890,over,0,0
82891,the,0,0
82892,15,0,0
82893,d,0,0
82894,and,0,0
82895,performed,0,0
82896,50-min,0,0
82897,of,0,0
82898,treadmill,0,0
82899,walking,0,1
82900,at,0,0
82901,70,0,0
82902,%,0,0
82903,of,0,0
82904,maximum,0,1
82905,oxygen,0,1
82906,consumption,0,1
82907,maximum,0,1
82908,during,0,0
82909,the,0,0
82910,second,0,0
82911,7,0,0
82912,d,0,0
82913,of,0,0
82914,the,0,0
82915,15-d,0,0
82916,study,0,0
82917,period,0,0
82918,.,0,0
82919,Each,0,0
82920,subject,0,0
82921,underwent,0,0
82922,an,0,0
82923,initial,0,0
82924,isoglycemic/hyperinsulinemic,0,0
82925,clamp,0,0
82926,after,0,0
82927,1-wk,0,0
82928,dietary,0,1
82929,control,0,0
82930,and,0,0
82931,a,0,0
82932,second,0,0
82933,clamp,0,0
82934,after,0,0
82935,completing,0,0
82936,the,0,0
82937,study,0,0
82938,.,0,0
82939,SETTING,0,0
82940,The,0,0
82941,study,0,0
82942,was,0,0
82943,performed,0,0
82944,at,0,0
82945,Ohio,0,0
82946,State,0,1
82947,University,0,1
82948,'s,0,1
82949,General,0,1
82950,Clinical,0,1
82951,Research,0,0
82952,Center,0,0
82953,.,0,1
82954,PARTICIPANTS,0,0
82955,There,0,0
82956,were,0,0
82957,18,0,0
82958,obese,0,0
82959,",",0,0
82960,mildly,0,1
82961,diabetic,0,0
82962,humans,0,0
82963,included,0,0
82964,in,0,0
82965,the,0,0
82966,study,0,0
82967,.,0,0
82968,INTERVENTION,0,1
82969,Aerobic,0,1
82970,exercise,0,0
82971,training,0,0
82972,was,0,0
82973,performed,0,0
82974,for,0,0
82975,7,0,0
82976,d.,0,0
82977,MAIN,0,0
82978,OUTCOME,0,1
82979,MEASURES,0,1
82980,Whole-body,1,1
82981,",",1,1
82982,peripheral,1,1
82983,",",1,1
82984,and,1,1
82985,hepatic,1,1
82986,insulin,1,1
82987,sensitivity,1,1
82988,were,0,0
82989,measured,0,0
82990,.,0,0
82991,RESULTS,0,0
82992,Exercise,0,0
82993,training,0,0
82994,did,0,0
82995,not,0,0
82996,have,0,0
82997,an,0,0
82998,impact,0,0
82999,on,0,0
83000,peripheral,1,1
83001,glucose,1,1
83002,uptake,1,1
83003,or,1,1
83004,endogenous,1,1
83005,glucose,1,1
83006,production,1,1
83007,during,0,0
83008,the,0,0
83009,basal,0,1
83010,state,0,1
83011,or,0,1
83012,low-dose,0,0
83013,insulin,0,1
83014,.,0,1
83015,Likewise,0,0
83016,",",0,0
83017,it,0,0
83018,did,0,0
83019,not,0,0
83020,alter,0,0
83021,endogenous,1,1
83022,glucose,1,1
83023,production,1,1
83024,during,0,0
83025,high-dose,0,0
83026,insulin,0,1
83027,.,0,0
83028,However,0,0
83029,",",0,0
83030,1-wk,0,0
83031,of,0,0
83032,exercise,0,0
83033,training,0,0
83034,increased,0,0
83035,both,0,0
83036,whole-body,1,1
83037,(,1,0
83038,P,1,0
83039,<,1,0
83040,0.05,1,0
83041,),1,0
83042,and,1,0
83043,peripheral,1,1
83044,insulin,1,1
83045,sensitivity,1,1
83046,(,0,1
83047,P,0,0
83048,<,0,0
83049,0.0001,0,0
83050,),0,0
83051,during,0,0
83052,high-dose,0,0
83053,insulin,0,1
83054,.,0,0
83055,CONCLUSION,0,0
83056,Improvements,0,1
83057,to,0,0
83058,whole,0,0
83059,body,0,1
83060,insulin,0,1
83061,sensitivity,0,1
83062,after,0,0
83063,short-term,0,1
83064,aerobic,0,0
83065,exercise,0,0
83066,training,0,0
83067,are,0,0
83068,due,0,0
83069,to,0,0
83070,gains,0,1
83071,in,0,0
83072,peripheral,0,1
83073,",",0,0
83074,not,0,0
83075,heptic,0,1
83076,insulin,0,1
83077,sensitivity,0,1
83078,.,0,0
83079,A,0,0
83080,double-blind,0,0
83081,",",0,0
83082,randomized,0,0
83083,",",0,0
83084,controlled,0,0
83085,",",0,0
83086,multicenter,0,0
83087,safety,0,1
83088,and,0,1
83089,immunogenicity,0,1
83090,study,0,0
83091,of,0,0
83092,a,0,0
83093,refrigerator-stable,0,0
83094,formulation,0,0
83095,of,0,0
83096,Zostavax,0,0
83097,.,0,0
83098,The,0,0
83099,vaccine,0,0
83100,Zostavax,0,0
83101,has,0,0
83102,been,0,0
83103,shown,0,0
83104,to,0,0
83105,prevent,0,0
83106,herpes,0,1
83107,zoster,0,1
83108,(,0,0
83109,HZ,0,1
83110,),0,1
83111,and,0,1
83112,postherpetic,0,1
83113,neuralgia,0,0
83114,and,0,0
83115,is,0,0
83116,recommended,0,0
83117,for,0,0
83118,individuals,0,0
83119,>,0,0
83120,or,0,0
83121,=60,0,0
83122,years,0,0
83123,of,0,0
83124,age,0,0
83125,.,0,0
83126,This,0,0
83127,study,0,0
83128,compared,0,0
83129,the,0,0
83130,safety,1,1
83131,and,0,0
83132,the,0,0
83133,immunogenicity,1,1
83134,of,0,0
83135,a,0,0
83136,refrigerator-stable,0,1
83137,formulation,0,0
83138,(,0,1
83139,Zostavax,0,1
83140,refrigerated,0,1
83141,),0,0
83142,with,0,0
83143,those,0,0
83144,of,0,0
83145,the,0,0
83146,current,0,0
83147,formulation,0,0
83148,(,0,0
83149,Zostavax,0,0
83150,frozen,0,0
83151,),0,0
83152,in,0,0
83153,subjects,0,0
83154,>,0,0
83155,or,0,0
83156,=50,0,0
83157,years,0,0
83158,of,0,0
83159,age,0,0
83160,.,0,0
83161,Subjects,0,0
83162,with,0,0
83163,a,0,0
83164,negative,0,1
83165,history,0,1
83166,for,0,0
83167,HZ,0,1
83168,were,0,0
83169,randomized,0,0
83170,1:1,0,0
83171,to,0,0
83172,receive,0,0
83173,one,0,0
83174,dose,0,0
83175,of,0,0
83176,either,0,0
83177,formulation,0,0
83178,.,0,1
83179,Enrollment,0,1
83180,was,0,0
83181,stratified,0,0
83182,1:2,0,0
83183,by,0,0
83184,age,0,0
83185,(,0,0
83186,50,0,0
83187,to,0,0
83188,59,0,0
83189,years,0,0
83190,and,0,0
83191,>,0,1
83192,or,0,0
83193,=60,0,0
83194,years,0,0
83195,),0,0
83196,.,0,0
83197,Safety,1,1
83198,was,0,0
83199,evaluated,0,0
83200,for,0,0
83201,28,0,0
83202,days,0,0
83203,postvaccination,0,0
83204,.,0,0
83205,Varicella-zoster,1,1
83206,virus,1,1
83207,(,1,1
83208,VZV,1,1
83209,),1,1
83210,antibody,1,1
83211,responses,1,1
83212,were,0,0
83213,measured,0,0
83214,by,0,0
83215,a,0,0
83216,glycoprotein,0,0
83217,enzyme-linked,0,1
83218,immunosorbent,0,0
83219,assay,0,1
83220,(,0,1
83221,gpELISA,0,0
83222,),0,0
83223,.,0,0
83224,The,0,0
83225,primary,0,0
83226,endpoints,0,1
83227,were,0,0
83228,the,0,0
83229,VZV,1,1
83230,antibody,1,1
83231,geometric,1,1
83232,mean,1,1
83233,titer,1,1
83234,(,1,0
83235,GMT,1,1
83236,;,1,0
83237,day,1,0
83238,28,1,0
83239,),1,0
83240,",",0,0
83241,the,0,0
83242,VZV,1,1
83243,antibody,1,1
83244,geometric,1,1
83245,mean,1,1
83246,rise,1,1
83247,(,1,0
83248,GMR,1,1
83249,;,1,0
83250,days,1,0
83251,1,1,0
83252,to,1,0
83253,28,1,0
83254,),1,0
83255,",",0,0
83256,and,0,0
83257,the,0,0
83258,incidence,1,1
83259,of,1,0
83260,vaccine-related,1,1
83261,serious,1,1
83262,adverse,1,1
83263,experiences,1,1
83264,(,1,0
83265,AEs,1,1
83266,),1,0
83267,over,0,0
83268,28,0,0
83269,days,0,0
83270,.,0,0
83271,The,0,0
83272,refrigerated,0,1
83273,(,0,0
83274,n,0,0
83275,=,0,0
83276,182,0,0
83277,),0,0
83278,and,0,0
83279,frozen,0,1
83280,(,0,0
83281,n,0,0
83282,=,0,0
83283,185,0,0
83284,),0,0
83285,formulations,0,0
83286,induced,0,0
83287,similar,0,0
83288,GMTs,1,1
83289,(,0,0
83290,727.4,0,0
83291,and,0,0
83292,834.4,0,0
83293,gpELISA,0,0
83294,units/ml,0,0
83295,",",0,0
83296,respectively,0,0
83297,),0,0
83298,;,0,0
83299,the,0,0
83300,estimated,1,0
83301,GMT,1,1
83302,ratio,1,1
83303,(,1,0
83304,refrigerated,1,1
83305,formulation/frozen,1,0
83306,formulation,1,0
83307,),1,0
83308,was,0,0
83309,0.87,0,0
83310,(,0,0
83311,95,0,0
83312,%,0,0
83313,confidence,0,0
83314,interval,0,0
83315,",",0,0
83316,0.71,0,0
83317,to,0,0
83318,1.07,0,0
83319,),0,0
83320,.,0,0
83321,The,0,0
83322,GMRs,1,0
83323,were,0,0
83324,2.6-,0,1
83325,and,0,1
83326,2.9-fold,0,1
83327,",",0,0
83328,respectively,0,0
83329,.,0,0
83330,No,0,0
83331,vaccine-related,1,0
83332,serious,1,1
83333,AEs,1,1
83334,were,0,0
83335,reported,0,0
83336,in,0,0
83337,either,0,0
83338,group,0,0
83339,",",0,0
83340,and,0,1
83341,the,0,0
83342,safety,1,1
83343,profiles,1,0
83344,of,0,0
83345,the,0,0
83346,formulations,0,0
83347,were,0,0
83348,generally,0,0
83349,similar,0,0
83350,.,0,0
83351,The,0,0
83352,frequencies,1,1
83353,of,1,0
83354,injection-site,1,0
83355,AEs,1,1
83356,during,0,0
83357,follow-up,0,0
83358,were,0,0
83359,35.6,0,0
83360,%,0,0
83361,and,0,0
83362,46.4,0,0
83363,%,0,0
83364,in,0,0
83365,the,0,0
83366,refrigerated,0,1
83367,and,0,0
83368,the,0,0
83369,frozen,0,0
83370,formulation,0,0
83371,groups,0,0
83372,",",0,0
83373,respectively,0,0
83374,",",0,1
83375,and,0,1
83376,were,0,0
83377,generally,0,0
83378,mild,0,0
83379,.,0,0
83380,The,0,0
83381,frequencies,1,1
83382,of,1,0
83383,systemic,1,1
83384,AEs,1,1
83385,were,0,0
83386,similar,0,0
83387,in,0,0
83388,the,0,0
83389,two,0,0
83390,groups,0,0
83391,",",0,0
83392,and,0,0
83393,those,0,0
83394,of,0,0
83395,vaccine-related,1,1
83396,AEs,1,1
83397,were,0,0
83398,approximately,0,0
83399,6,0,0
83400,%,0,0
83401,in,0,0
83402,both,0,0
83403,groups,0,0
83404,.,0,0
83405,The,0,0
83406,refrigerator-stable,0,0
83407,formulation,0,0
83408,of,0,0
83409,Zostavax,0,0
83410,has,0,0
83411,an,0,0
83412,acceptable,0,0
83413,safety,1,1
83414,profile,1,1
83415,and,0,0
83416,is,0,0
83417,as,0,0
83418,immunogenic,1,0
83419,as,0,0
83420,the,0,0
83421,frozen,0,0
83422,formulation,0,0
83423,;,0,0
83424,thus,0,0
83425,",",0,0
83426,the,0,0
83427,vaccine,0,0
83428,may,0,0
83429,be,0,0
83430,used,0,0
83431,in,0,0
83432,clinical,0,0
83433,settings,0,0
83434,where,0,0
83435,freezer,0,0
83436,availability,0,0
83437,is,0,0
83438,limited,0,0
83439,.,0,0
83440,Risperidone,0,0
83441,versus,0,0
83442,haloperidol,0,0
83443,in,0,0
83444,children,0,0
83445,and,0,1
83446,adolescents,0,0
83447,with,0,0
83448,AD,0,0
83449,:,0,0
83450,a,0,0
83451,randomized,0,0
83452,",",0,0
83453,controlled,0,0
83454,",",0,0
83455,double-blind,0,0
83456,trial,0,0
83457,.,0,0
83458,OBJECTIVE,0,0
83459,The,0,0
83460,aim,0,0
83461,of,0,0
83462,the,0,0
83463,study,0,0
83464,was,0,0
83465,to,0,0
83466,compare,0,0
83467,safety,1,1
83468,",",1,1
83469,efficacy,1,1
83470,and,1,1
83471,tolerability,1,1
83472,of,0,1
83473,risperidone,0,0
83474,with,0,0
83475,haloperidol,0,0
83476,in,0,0
83477,the,0,0
83478,treatment,0,0
83479,of,0,0
83480,Autistic,0,1
83481,Disorder,0,0
83482,(,0,1
83483,AD,0,0
83484,),0,0
83485,.,0,0
83486,METHOD,0,0
83487,This,0,0
83488,study,0,0
83489,was,0,0
83490,designed,0,0
83491,as,0,0
83492,a,0,0
83493,double-blind,0,0
83494,",",0,1
83495,prospective,0,0
83496,",",0,0
83497,for,0,0
83498,a,0,0
83499,12-week,0,0
83500,period,0,0
83501,.,0,0
83502,A,0,0
83503,total,0,0
83504,of,0,0
83505,30,0,0
83506,subjects,0,0
83507,",",0,0
83508,between,0,0
83509,the,0,0
83510,ages,0,0
83511,of,0,0
83512,8,0,0
83513,and,0,0
83514,18,0,0
83515,with,0,0
83516,AD,0,0
83517,based,0,0
83518,on,0,0
83519,DSM,0,0
83520,IV,0,1
83521,criteria,0,1
83522,",",0,1
83523,were,0,0
83524,included,0,0
83525,in,0,0
83526,the,0,0
83527,study,0,0
83528,.,0,0
83529,Behavioral,1,1
83530,Rating,1,1
83531,Scales,1,1
83532,were,0,0
83533,performed,0,0
83534,by,0,0
83535,the,0,0
83536,investigators,0,0
83537,and,0,0
83538,the,0,0
83539,parents,0,0
83540,.,0,0
83541,Safety,1,1
83542,assessment,1,1
83543,included,0,0
83544,vital,1,1
83545,signs,1,1
83546,",",1,1
83547,electrocardiogram,1,1
83548,",",1,1
83549,electroencephalogram,1,1
83550,",",1,1
83551,adverse,1,1
83552,events,1,1
83553,",",1,1
83554,laboratory,1,1
83555,tests,1,1
83556,",",1,1
83557,extrapyramidal,1,1
83558,symptoms,1,1
83559,and,1,0
83560,the,1,0
83561,side,1,1
83562,effects,1,0
83563,.,1,0
83564,Both,0,0
83565,treatments,0,0
83566,were,0,0
83567,applied,0,0
83568,in,0,0
83569,a,0,0
83570,once,0,0
83571,daily,0,0
83572,dosage,0,0
83573,regimen,0,0
83574,of,0,1
83575,0.01-0.08,0,0
83576,mg/kg/day,0,0
83577,.,0,0
83578,RESULTS,0,0
83579,The,0,0
83580,reduction,0,1
83581,from,0,0
83582,baseline,0,0
83583,in,0,0
83584,Ritvo-Freeman,1,0
83585,Real,1,1
83586,Life,1,0
83587,Rating,1,1
83588,Scale,1,1
83589,(,1,1
83590,RF-RLRS,1,1
83591,),1,1
83592,",",1,0
83593,sensory,1,1
83594,motor,1,1
83595,(,1,0
83596,subscale,1,1
83597,I,1,0
83598,),1,0
83599,and,1,1
83600,language,1,1
83601,(,1,1
83602,subscale,1,1
83603,V,1,1
83604,),1,0
83605,scores,1,1
83606,were,0,0
83607,significant,0,0
83608,in,0,0
83609,risperidone,0,0
83610,group,0,0
83611,(,0,1
83612,P,0,0
83613,<,0,0
83614,0.05,0,0
83615,),0,0
83616,.,0,0
83617,Compared,0,0
83618,to,0,0
83619,haloperidol,0,0
83620,",",0,0
83621,risperidone,0,0
83622,led,0,0
83623,to,0,0
83624,a,0,0
83625,significantly,0,0
83626,greater,0,0
83627,reduction,0,1
83628,in,0,0
83629,the,0,0
83630,Aberrant,1,0
83631,Behavior,1,1
83632,Checklist,1,1
83633,(,1,1
83634,ABC,1,1
83635,),1,1
83636,and,1,1
83637,Turgay,1,0
83638,DSM-IV,1,1
83639,Pervasive,1,1
83640,Developmental,1,1
83641,Disorder,1,0
83642,(,1,1
83643,PDD,1,1
83644,),1,1
83645,scale,1,1
83646,scores,1,1
83647,(,0,0
83648,P,0,0
83649,<,0,0
83650,0.05,0,0
83651,and,0,0
83652,P,0,0
83653,<,0,0
83654,0.01,0,0
83655,),0,0
83656,.,0,0
83657,There,0,0
83658,was,0,0
83659,a,0,0
83660,greater,0,0
83661,increase,0,1
83662,of,0,1
83663,prolactin,1,1
83664,in,0,0
83665,the,0,0
83666,risperidone,0,0
83667,group,0,0
83668,",",0,0
83669,while,0,0
83670,alanine,1,1
83671,amino,1,0
83672,transferase,1,1
83673,(,1,1
83674,ALT,1,1
83675,),1,1
83676,had,0,0
83677,further,0,0
83678,increased,0,0
83679,in,0,0
83680,the,0,0
83681,haloperidol,0,0
83682,group,0,0
83683,.,0,1
83684,Sensory,1,0
83685,motor,1,1
83686,behaviors,1,1
83687,(,1,0
83688,subscale,1,1
83689,I,1,0
83690,),1,0
83691,and,0,1
83692,language,1,1
83693,at,0,0
83694,the,0,0
83695,end,0,0
83696,of,0,0
83697,the,0,0
83698,12th,0,0
83699,week,0,0
83700,",",0,0
83701,RF-RLRS,1,1
83702,sensory,1,1
83703,motor,1,1
83704,and,1,1
83705,language,1,1
83706,subscale,1,1
83707,scores,1,1
83708,decreased,0,0
83709,in,0,0
83710,the,0,0
83711,risperidone,0,0
83712,group,0,0
83713,further,0,0
83714,than,0,0
83715,the,0,0
83716,other,0,0
83717,group,0,0
83718,(,0,0
83719,P,0,0
83720,<,0,0
83721,0.05,0,0
83722,),0,0
83723,.,0,0
83724,CONCLUSIONS,0,0
83725,Risperidone,0,0
83726,was,0,0
83727,found,0,0
83728,to,0,0
83729,be,0,0
83730,more,0,0
83731,effective,0,1
83732,than,0,0
83733,haloperidol,0,0
83734,in,0,0
83735,the,0,0
83736,treatment,0,0
83737,of,0,0
83738,behavioral,1,1
83739,symptoms,1,1
83740,",",1,1
83741,impulsivity,1,1
83742,",",1,1
83743,language,1,1
83744,skills,1,1
83745,",",0,1
83746,and,0,1
83747,impaired,1,1
83748,social,1,1
83749,relations,1,1
83750,in,0,0
83751,children,0,0
83752,with,0,0
83753,AD,0,0
83754,.,0,0
83755,These,0,0
83756,results,0,0
83757,demonstrated,0,0
83758,that,0,0
83759,both,0,0
83760,drugs,0,0
83761,were,0,0
83762,safe,0,1
83763,and,0,0
83764,well,0,1
83765,tolerated,0,1
83766,in,0,0
83767,the,0,0
83768,treatment,0,0
83769,of,0,0
83770,AD,0,0
83771,.,0,0
83772,The,0,0
83773,cost-effectiveness,1,0
83774,of,0,0
83775,parasitologic,0,1
83776,diagnosis,0,0
83777,for,0,0
83778,malaria-suspected,0,0
83779,patients,0,0
83780,in,0,0
83781,an,0,0
83782,era,0,0
83783,of,0,1
83784,combination,0,0
83785,therapy,0,0
83786,.,0,0
83787,The,0,0
83788,introduction,0,0
83789,of,0,0
83790,artemisinin-based,0,0
83791,combination,0,0
83792,therapy,0,0
83793,in,0,0
83794,sub-Saharan,0,0
83795,Africa,0,0
83796,has,0,0
83797,prompted,0,0
83798,calls,0,0
83799,for,0,0
83800,increased,0,0
83801,use,0,0
83802,of,0,0
83803,parasitologic,0,1
83804,diagnosis,0,0
83805,for,0,0
83806,malaria,0,0
83807,.,0,0
83808,We,0,0
83809,evaluated,0,0
83810,the,0,0
83811,cost-effectiveness,1,0
83812,of,0,0
83813,rapid,0,0
83814,diagnostic,0,1
83815,tests,0,1
83816,(,0,0
83817,RDTs,0,1
83818,),0,1
83819,in,0,0
83820,comparison,0,0
83821,to,0,0
83822,microscopy,0,0
83823,in,0,0
83824,guiding,0,0
83825,treatment,0,0
83826,of,0,0
83827,non-severe,0,0
83828,febrile,0,1
83829,illness,0,1
83830,at,0,0
83831,varying,0,0
83832,levels,0,1
83833,of,0,1
83834,malaria,0,1
83835,endemicity,0,1
83836,using,0,0
83837,data,0,0
83838,on,0,0
83839,test,0,1
83840,accuracy,0,1
83841,and,0,1
83842,costs,1,1
83843,collected,0,0
83844,as,0,0
83845,part,0,0
83846,of,0,0
83847,a,0,0
83848,Tanzanian,0,0
83849,trial,0,0
83850,.,0,0
83851,If,0,0
83852,prescribers,0,0
83853,complied,0,0
83854,with,0,0
83855,current,0,0
83856,guidelines,0,0
83857,",",0,0
83858,microscopy,0,0
83859,would,0,0
83860,give,0,0
83861,rise,0,0
83862,to,0,0
83863,lower,0,1
83864,average,0,1
83865,costs,1,1
83866,per,0,0
83867,patient,0,1
83868,correctly,0,0
83869,treated,0,0
83870,than,0,0
83871,RDTs,0,1
83872,in,0,0
83873,areas,0,1
83874,of,0,0
83875,both,0,0
83876,high,0,0
83877,and,0,1
83878,low,0,0
83879,transmission,0,1
83880,.,0,1
83881,RDT,0,0
83882,introduction,0,0
83883,would,0,0
83884,result,0,0
83885,in,0,0
83886,an,0,0
83887,additional,0,0
83888,2.3,0,0
83889,%,0,0
83890,and,0,0
83891,9.4,1,0
83892,%,1,0
83893,of,1,0
83894,patients,1,0
83895,correctly,1,0
83896,treated,1,0
83897,",",0,0
83898,at,0,0
83899,an,0,0
83900,incremental,1,1
83901,cost,1,1
83902,of,0,0
83903,$,0,0
83904,25,0,0
83905,and,0,0
83906,$,0,0
83907,7,0,0
83908,in,0,0
83909,the,0,0
83910,low,0,0
83911,and,0,1
83912,high,0,1
83913,transmission,0,1
83914,settings,0,0
83915,",",0,0
83916,respectively,0,0
83917,.,0,0
83918,Cost-effectiveness,1,0
83919,would,0,0
83920,be,0,0
83921,worse,0,1
83922,if,0,0
83923,prescribers,0,0
83924,do,0,0
83925,not,0,0
83926,comply,0,0
83927,with,0,0
83928,test,0,0
83929,results,0,0
83930,.,0,0
83931,The,0,0
83932,cost,0,0
83933,of,0,0
83934,this,0,0
83935,additional,0,0
83936,benefit,0,0
83937,may,0,0
83938,be,0,0
83939,higher,0,0
83940,than,0,0
83941,many,0,0
83942,countries,0,0
83943,can,0,0
83944,afford,0,0
83945,without,0,0
83946,external,0,0
83947,assistance,0,1
83948,or,0,0
83949,lower,0,1
83950,RDT,0,0
83951,prices,0,1
83952,.,0,0
83953,Feasibility,0,1
83954,of,0,0
83955,two,0,0
83956,dose-dense,0,0
83957,FEC,0,0
83958,regimens,0,0
83959,with,0,0
83960,growth,0,1
83961,factor,0,1
83962,support,0,0
83963,for,0,0
83964,adjuvant,0,0
83965,therapy,0,0
83966,in,0,0
83967,patients,0,0
83968,with,0,0
83969,early,0,0
83970,breast,0,0
83971,cancer,0,0
83972,:,0,0
83973,results,0,0
83974,from,0,0
83975,a,0,0
83976,randomised,0,0
83977,study,0,0
83978,of,0,0
83979,the,0,0
83980,Central,0,1
83981,European,0,0
83982,Cooperative,0,0
83983,Oncology,0,1
83984,Group,0,0
83985,(,0,1
83986,CECOG,0,0
83987,),0,0
83988,.,0,0
83989,Addition,0,0
83990,of,0,0
83991,epirubicin,0,0
83992,to,0,0
83993,adjuvant,0,0
83994,chemotherapy,0,0
83995,can,0,0
83996,provide,0,0
83997,important,0,0
83998,benefits,0,0
83999,for,0,0
84000,patients,0,0
84001,with,0,0
84002,early,0,0
84003,breast,0,0
84004,cancer,0,1
84005,",",0,0
84006,but,0,0
84007,the,0,0
84008,optimal,0,0
84009,dose,0,0
84010,remains,0,0
84011,unclear,0,0
84012,.,0,0
84013,Further,0,0
84014,improvements,0,0
84015,can,0,0
84016,be,0,0
84017,achieved,0,0
84018,with,0,0
84019,dose-dense,0,0
84020,regimens,0,0
84021,",",0,1
84022,but,0,0
84023,densification,0,1
84024,of,0,1
84025,fluorouracil/epirubicin/cyclophosphamide,0,0
84026,(,0,1
84027,FEC,0,1
84028,),0,0
84029,has,0,0
84030,proved,0,0
84031,difficult,0,0
84032,",",0,0
84033,with,0,0
84034,FEC,0,1
84035,(,0,0
84036,60,0,0
84037,),0,0
84038,providing,0,0
84039,little,0,0
84040,benefit,0,0
84041,over,0,0
84042,standard,0,0
84043,chemotherapy,0,0
84044,and,0,1
84045,FEC,0,1
84046,(,0,0
84047,100,0,0
84048,),0,0
84049,associated,0,0
84050,with,0,0
84051,toxicity,0,1
84052,.,0,0
84053,We,0,0
84054,investigated,0,0
84055,the,0,0
84056,feasibility,0,0
84057,of,0,0
84058,two,0,0
84059,intermediate,0,0
84060,dose-dense,0,0
84061,FEC,0,1
84062,regimens,0,0
84063,.,0,0
84064,Patients,0,0
84065,were,0,0
84066,randomised,0,0
84067,to,0,0
84068,six,0,0
84069,cycles,0,0
84070,of,0,0
84071,FEC,0,1
84072,(,0,0
84073,75,0,0
84074,),0,0
84075,or,0,0
84076,FEC,0,1
84077,(,0,0
84078,90,0,0
84079,),0,0
84080,",",0,0
84081,with,0,0
84082,all,0,0
84083,three,0,0
84084,drugs,0,0
84085,given,0,0
84086,on,0,0
84087,day,0,0
84088,1,0,0
84089,of,0,0
84090,each,0,0
84091,14-day,0,0
84092,cycle,0,1
84093,.,0,0
84094,Patients,0,0
84095,also,0,0
84096,received,0,0
84097,pegfilgrastim,0,0
84098,6,0,0
84099,mg,0,0
84100,as,0,0
84101,a,0,0
84102,single,0,0
84103,subcutaneous,0,0
84104,injection,0,0
84105,on,0,0
84106,day,0,0
84107,2,0,0
84108,of,0,0
84109,each,0,0
84110,cycle,0,1
84111,.,0,0
84112,The,0,0
84113,primary,0,0
84114,efficacy,0,1
84115,endpoint,0,1
84116,was,0,0
84117,the,0,0
84118,proportion,1,0
84119,of,1,0
84120,subjects,1,0
84121,receiving,1,0
84122,>,1,0
84123,or,1,0
84124,=85,1,0
84125,%,1,0
84126,relative,1,0
84127,dose,1,1
84128,intensity,1,1
84129,and,0,1
84130,was,0,0
84131,achieved,0,0
84132,by,0,0
84133,96,0,0
84134,%,0,0
84135,and,0,0
84136,88,0,0
84137,%,0,0
84138,of,0,0
84139,patients,0,0
84140,in,0,0
84141,the,0,0
84142,FEC,0,1
84143,(,0,0
84144,75,0,0
84145,),0,0
84146,and,0,0
84147,FEC,0,1
84148,(,0,0
84149,90,0,0
84150,),0,0
84151,arms,0,0
84152,",",0,0
84153,respectively,0,0
84154,.,0,0
84155,Of,0,0
84156,147,0,0
84157,FEC,0,0
84158,(,0,0
84159,75,0,0
84160,),0,0
84161,infusions,0,0
84162,",",0,0
84163,4.1,0,0
84164,%,0,0
84165,were,0,0
84166,delayed,0,1
84167,",",0,0
84168,while,0,0
84169,9.8,0,0
84170,%,0,0
84171,of,0,0
84172,143,0,0
84173,FEC,0,0
84174,(,0,0
84175,90,0,0
84176,),0,0
84177,infusions,0,0
84178,were,0,0
84179,delayed,0,0
84180,.,0,0
84181,The,0,0
84182,most,0,0
84183,common,0,0
84184,reasons,0,0
84185,for,0,0
84186,delay,0,1
84187,were,0,0
84188,adverse,1,1
84189,events,1,1
84190,and,0,1
84191,personal/logistical,1,0
84192,reasons,1,0
84193,.,1,0
84194,One,0,0
84195,dose,0,0
84196,reduction,0,1
84197,occurred,0,0
84198,during,0,0
84199,the,0,0
84200,study,0,0
84201,(,0,1
84202,FEC,0,1
84203,(,0,0
84204,90,0,0
84205,),0,0
84206,),0,0
84207,",",0,0
84208,related,0,0
84209,to,0,0
84210,diarrhoea,1,1
84211,.,1,0
84212,Grade,1,0
84213,3-4,1,0
84214,haematological,1,1
84215,toxicities,1,1
84216,were,0,0
84217,reported,0,0
84218,in,0,0
84219,two,0,0
84220,patients,0,0
84221,in,0,0
84222,the,0,0
84223,FEC,0,1
84224,(,0,0
84225,90,0,0
84226,),0,0
84227,arm,0,0
84228,.,0,0
84229,There,0,0
84230,were,0,0
84231,no,0,0
84232,incidences,0,1
84233,of,0,0
84234,febrile,1,1
84235,neutropenia,1,1
84236,during,0,0
84237,the,0,0
84238,study,0,0
84239,.,0,0
84240,The,0,0
84241,most,0,0
84242,common,0,0
84243,adverse,0,1
84244,events,0,1
84245,were,0,0
84246,increases,0,1
84247,in,0,0
84248,liver,1,1
84249,enzymes,1,1
84250,and,1,1
84251,gastrointestinal,1,1
84252,events,1,1
84253,;,1,0
84254,no,0,0
84255,event,0,1
84256,resulted,0,0
84257,in,0,0
84258,discontinuation,0,0
84259,.,0,0
84260,Only,0,0
84261,one,0,0
84262,patient,0,0
84263,(,0,0
84264,FEC,0,1
84265,(,0,0
84266,90,0,0
84267,),0,0
84268,),0,0
84269,experienced,0,0
84270,serious,1,1
84271,adverse,1,1
84272,events,1,1
84273,(,1,0
84274,vomiting,1,1
84275,and,1,1
84276,throat,1,1
84277,oedema,1,1
84278,),1,0
84279,.,1,0
84280,In,0,0
84281,conclusion,0,0
84282,",",0,0
84283,dose-dense,0,0
84284,FEC,0,1
84285,(,0,0
84286,75,0,0
84287,),0,0
84288,and,0,0
84289,FEC,0,1
84290,(,0,0
84291,90,0,0
84292,),0,0
84293,are,0,0
84294,feasible,0,0
84295,with,0,0
84296,pegfilgrastim,0,0
84297,support,0,0
84298,.,0,0
84299,These,0,0
84300,regimens,0,0
84301,are,0,0
84302,associated,0,0
84303,with,0,0
84304,a,0,0
84305,very,0,0
84306,low,0,0
84307,risk,0,1
84308,of,0,1
84309,Grade,1,1
84310,3-4,1,0
84311,toxicity,1,1
84312,.,1,0
84313,[,0,0
84314,Effects,0,0
84315,of,0,1
84316,early,0,0
84317,acupuncture,0,0
84318,on,0,0
84319,motor,0,1
84320,function,0,1
84321,of,0,0
84322,the,0,0
84323,limb,0,1
84324,in,0,0
84325,the,0,0
84326,severe,0,1
84327,head,0,0
84328,injury,0,1
84329,patients,0,0
84330,],0,0
84331,.,0,0
84332,UNLABELLED,0,0
84333,OBJECTIVE,0,0
84334,;,0,0
84335,To,0,0
84336,observe,0,0
84337,the,0,0
84338,effects,0,0
84339,of,0,0
84340,early,0,0
84341,acupuncture,0,0
84342,on,0,0
84343,motor,0,1
84344,function,0,1
84345,of,0,0
84346,the,0,0
84347,limb,0,1
84348,in,0,0
84349,the,0,0
84350,severe,0,1
84351,head,0,0
84352,injury,0,1
84353,patients,0,0
84354,.,0,0
84355,METHODS,0,0
84356,Ninety-six,0,0
84357,patients,0,0
84358,were,0,0
84359,randomly,0,0
84360,divided,0,0
84361,into,0,0
84362,an,0,0
84363,observation,0,0
84364,group,0,0
84365,and,0,0
84366,a,0,0
84367,control,0,0
84368,group,0,0
84369,",",0,0
84370,48,0,0
84371,cases,0,0
84372,in,0,0
84373,each,0,0
84374,group,0,0
84375,.,0,0
84376,The,0,0
84377,patient,0,0
84378,in,0,0
84379,the,0,0
84380,control,0,0
84381,group,0,0
84382,were,0,0
84383,treated,0,0
84384,by,0,0
84385,routine,0,0
84386,treatment,0,0
84387,of,0,1
84388,neurosurgical,0,1
84389,operation,0,0
84390,and,0,1
84391,drug,0,1
84392,treatment,0,0
84393,(,0,1
84394,Mannitol,0,1
84395,",",0,1
84396,Citioline,0,1
84397,Sodium,0,1
84398,",",0,1
84399,Cefeazidime,0,1
84400,",",0,1
84401,etc.,0,1
84402,),0,1
84403,.,0,0
84404,While,0,0
84405,the,0,0
84406,patient,0,0
84407,in,0,0
84408,the,0,0
84409,observation,0,0
84410,group,0,0
84411,were,0,0
84412,treated,0,0
84413,by,0,0
84414,the,0,0
84415,routine,0,0
84416,treatment,0,0
84417,and,0,1
84418,acupuncture,0,0
84419,treatment,0,0
84420,48,0,0
84421,h,0,0
84422,(,0,0
84423,-1,0,0
84424,),0,1
84425,week,0,0
84426,after,0,0
84427,operation,0,0
84428,in,0,0
84429,different,0,0
84430,stages,0,0
84431,with,0,0
84432,different,0,0
84433,acupoints,0,0
84434,selected,0,0
84435,when,0,0
84436,the,0,0
84437,situation,0,0
84438,was,0,0
84439,stable,0,0
84440,.,0,0
84441,The,0,0
84442,selected,0,0
84443,main,0,0
84444,points,0,0
84445,were,0,0
84446,Neiguan,0,0
84447,(,0,0
84448,PC,0,1
84449,6,0,0
84450,),0,0
84451,",",0,0
84452,Qu-chi,0,1
84453,(,0,0
84454,LI,0,0
84455,11,0,0
84456,),0,0
84457,",",0,0
84458,Waiguan,0,1
84459,(,0,0
84460,TE,0,1
84461,5,0,0
84462,),0,0
84463,",",0,0
84464,Hegu,0,1
84465,(,0,0
84466,LI,0,0
84467,4,0,0
84468,),0,0
84469,",",0,0
84470,Binao,0,1
84471,(,0,0
84472,LI,0,0
84473,14,0,0
84474,),0,0
84475,",",0,0
84476,Jianyu,0,0
84477,(,0,0
84478,LI,0,0
84479,15,0,0
84480,),0,0
84481,",",0,0
84482,Fengshi,0,1
84483,(,0,0
84484,GB,0,1
84485,31,0,0
84486,),0,0
84487,",",0,0
84488,Xuehai,0,1
84489,(,0,0
84490,SP,0,0
84491,10,0,0
84492,),0,0
84493,",",0,0
84494,Yinlingquan,0,0
84495,(,0,0
84496,SP,0,0
84497,9,0,0
84498,),0,0
84499,",",0,0
84500,Sanyinjiao,0,0
84501,(,0,0
84502,SP,0,0
84503,6,0,0
84504,),0,0
84505,",",0,0
84506,Taichong,0,0
84507,(,0,0
84508,LR,0,1
84509,3,0,0
84510,),0,0
84511,",",0,0
84512,etc..,0,0
84513,The,0,0
84514,limb,1,1
84515,motor,1,1
84516,function,1,1
84517,was,0,0
84518,evaluated,0,0
84519,with,0,0
84520,Fugl-Meyer,1,1
84521,Assessment,1,1
84522,(,1,1
84523,FMA,1,1
84524,),1,1
84525,scale,1,1
84526,before,0,0
84527,treatment,0,0
84528,and,0,1
84529,after,0,0
84530,10-week,0,0
84531,treatment,0,0
84532,.,0,0
84533,RESULTS,0,0
84534,There,0,0
84535,was,0,0
84536,a,0,0
84537,significant,0,0
84538,improvement,0,1
84539,in,0,0
84540,the,0,0
84541,FMA,1,0
84542,score,1,1
84543,in,0,0
84544,the,0,0
84545,two,0,0
84546,groups,0,0
84547,after,0,0
84548,the,0,0
84549,treatment,0,0
84550,(,0,0
84551,P,0,0
84552,<,0,0
84553,0.01,0,0
84554,),0,0
84555,.,0,0
84556,The,0,0
84557,comparison,0,0
84558,between,0,0
84559,the,0,0
84560,two,0,0
84561,groups,0,0
84562,after,0,0
84563,the,0,0
84564,treatment,0,0
84565,showed,0,0
84566,that,0,0
84567,the,0,0
84568,improvement,1,1
84569,of,1,0
84570,FMA,1,0
84571,score,1,1
84572,in,0,0
84573,the,0,0
84574,observation,0,0
84575,group,0,0
84576,was,0,0
84577,significantly,0,0
84578,better,0,0
84579,than,0,0
84580,the,0,0
84581,control,0,0
84582,group,0,0
84583,(,0,0
84584,P,0,0
84585,<,0,0
84586,0.05,0,0
84587,or,0,0
84588,P,0,0
84589,<,0,0
84590,0.01,0,0
84591,),0,0
84592,.,0,0
84593,CONCLUSION,0,0
84594,Early,0,0
84595,acupuncture,0,0
84596,can,0,0
84597,improve,0,0
84598,the,0,0
84599,limb,0,1
84600,motor,0,1
84601,function,0,1
84602,in,0,0
84603,the,0,0
84604,severe,0,1
84605,head,0,0
84606,injury,0,1
84607,patients,0,0
84608,.,0,0
84609,[,0,0
84610,4,0,0
84611,years,0,0
84612,',0,0
84613,experience,0,0
84614,with,0,0
84615,a,0,0
84616,balloon-expandable,0,0
84617,endoprosthesis,0,0
84618,.,0,1
84619,Experimental,0,1
84620,and,0,1
84621,clinical,0,1
84622,application,0,0
84623,],0,0
84624,.,0,0
84625,During,0,0
84626,a,0,0
84627,4-year,0,0
84628,period,0,0
84629,of,0,1
84630,clinical,0,1
84631,application,0,0
84632,of,0,0
84633,the,0,0
84634,balloon-expandable,0,0
84635,Palmaz,0,0
84636,stent,0,1
84637,",",0,0
84638,a,0,0
84639,randomized,0,0
84640,trial,0,0
84641,comparing,0,0
84642,stent,0,1
84643,implantation,0,0
84644,and,0,1
84645,traditional,0,0
84646,balloon,0,0
84647,angioplasty,0,0
84648,of,0,1
84649,iliac,0,1
84650,arteries,0,1
84651,in,0,0
84652,arterial,0,1
84653,occlusive,0,1
84654,disease,0,1
84655,was,0,0
84656,started,0,0
84657,.,0,0
84658,The,0,0
84659,first,0,0
84660,long-term,0,1
84661,results,0,0
84662,",",0,1
84663,recorded,0,0
84664,after,0,0
84665,2,0,0
84666,years,0,0
84667,",",0,0
84668,indicate,0,0
84669,statistically,0,0
84670,significant,0,0
84671,differences,0,0
84672,in,0,0
84673,the,0,0
84674,complication,1,1
84675,rate,1,1
84676,(,0,0
84677,after,0,0
84678,stenting,0,0
84679,2/62,0,0
84680,and,0,0
84681,after,0,0
84682,angioplasty,0,0
84683,5/69,0,0
84684,),0,0
84685,and,0,0
84686,patency,1,1
84687,(,0,1
84688,greater,0,1
84689,than,0,0
84690,or,0,0
84691,equal,0,0
84692,to,0,0
84693,70,0,0
84694,%,0,0
84695,of,0,0
84696,original,0,0
84697,lumen,0,1
84698,size,0,1
84699,upon,0,0
84700,stent,0,1
84701,implantation,0,1
84702,or,0,1
84703,balloon,0,0
84704,inflation,0,1
84705,:,0,0
84706,95,0,0
84707,%,0,0
84708,after,0,0
84709,stenting,0,0
84710,and,0,0
84711,72,0,0
84712,%,0,0
84713,after,0,0
84714,angioplasty,0,0
84715,),0,0
84716,.,0,0
84717,Clinical,1,1
84718,improvement,1,1
84719,after,1,0
84720,2,1,0
84721,years,1,0
84722,was,0,0
84723,89,0,0
84724,%,0,0
84725,after,0,0
84726,stenting,0,0
84727,and,0,0
84728,70,0,0
84729,%,0,0
84730,after,0,0
84731,angioplasty,0,0
84732,.,0,0
84733,Parallel,0,0
84734,to,0,0
84735,the,0,0
84736,clinical,0,0
84737,trials,0,0
84738,",",0,1
84739,experimental,0,0
84740,canine,0,0
84741,artery,0,1
84742,stenting,0,1
84743,was,0,0
84744,performed,0,0
84745,to,0,0
84746,evaluate,0,0
84747,differences,0,0
84748,in,0,0
84749,the,0,0
84750,long-term,0,0
84751,patency,0,1
84752,of,0,0
84753,stents,0,0
84754,exposed,0,0
84755,to,0,0
84756,restricted,0,0
84757,flow,0,1
84758,.,0,0
84759,Significant,0,1
84760,differences,0,0
84761,in,0,0
84762,neointimal,1,1
84763,healing,1,1
84764,were,0,0
84765,found,0,0
84766,between,0,0
84767,normally,0,0
84768,perfused,0,0
84769,stents,0,0
84770,and,0,0
84771,stents,0,0
84772,with,0,0
84773,artificially,0,0
84774,reduced,0,0
84775,flow,0,1
84776,:,0,0
84777,during,0,0
84778,the,0,0
84779,total,0,1
84780,observation,0,0
84781,period,0,0
84782,of,0,0
84783,6,0,0
84784,months,0,0
84785,the,0,0
84786,neointimal,1,1
84787,height,1,1
84788,was,0,0
84789,up,0,0
84790,to,0,0
84791,200,0,0
84792,%,0,0
84793,higher,0,0
84794,in,0,0
84795,flow-restricted,0,1
84796,stents,0,0
84797,",",0,0
84798,while,0,0
84799,the,0,0
84800,histological,1,1
84801,composition,1,0
84802,of,1,0
84803,the,1,0
84804,neointima,1,1
84805,was,0,0
84806,the,0,0
84807,same,0,0
84808,as,0,0
84809,with,0,0
84810,normally,0,0
84811,perfused,0,0
84812,stents,0,0
84813,.,0,0
84814,[,1,0
84815,Specific,1,0
84816,T,1,1
84817,cell,1,1
84818,immune,1,1
84819,response,1,1
84820,in,0,0
84821,chronic,0,0
84822,hepatitis,0,0
84823,B,0,0
84824,patients,0,0
84825,treated,0,0
84826,with,0,0
84827,different,0,0
84828,doses,0,0
84829,of,0,1
84830,recombinant,0,0
84831,hepatitis,0,0
84832,B,0,1
84833,vaccine,0,0
84834,],0,0
84835,.,0,0
84836,OBJECTIVE,0,0
84837,To,0,0
84838,study,0,0
84839,the,0,0
84840,specific,1,0
84841,cellular,1,1
84842,immunoresponse,1,1
84843,of,0,1
84844,peripheral,0,1
84845,blood,0,1
84846,lymphocytes,0,1
84847,in,0,0
84848,the,0,0
84849,chronic,0,0
84850,hepatitis,0,0
84851,B,0,0
84852,patients,0,0
84853,treated,0,0
84854,with,0,0
84855,different,0,0
84856,doses,0,0
84857,of,0,1
84858,recombinant,0,0
84859,hepatitis,0,0
84860,B,0,0
84861,vaccine,0,0
84862,.,0,1
84863,METHODS,0,0
84864,Seventy-two,0,0
84865,chronic,0,0
84866,hepatitis,0,0
84867,B,0,0
84868,patients,0,0
84869,who,0,0
84870,did,0,0
84871,not,0,0
84872,use,0,0
84873,any,0,0
84874,anti-HBV,0,1
84875,drugs,0,0
84876,within,0,0
84877,6,0,0
84878,months,0,0
84879,were,0,0
84880,randomized,0,0
84881,into,0,0
84882,3,0,0
84883,groups,0,0
84884,(,0,0
84885,90,0,0
84886,micrograms,0,0
84887,",",0,0
84888,60,0,0
84889,micrograms,0,0
84890,",",0,0
84891,and,0,1
84892,placebo,0,0
84893,),0,0
84894,in,0,0
84895,a,0,0
84896,ratio,0,1
84897,of,0,0
84898,1:1:1,0,0
84899,.,0,0
84900,The,0,0
84901,patients,0,0
84902,in,0,0
84903,different,0,0
84904,groups,0,0
84905,were,0,0
84906,treated,0,0
84907,with,0,0
84908,different,0,0
84909,doses,0,0
84910,of,0,1
84911,recombinant,0,0
84912,hepatitis,0,0
84913,B,0,0
84914,vaccine,0,0
84915,in,0,0
84916,combination,0,0
84917,with,0,0
84918,IFN,0,1
84919,alpha,0,0
84920,1b,0,0
84921,50,0,0
84922,micrograms,0,0
84923,with,0,0
84924,3,0,0
84925,times,0,0
84926,a,0,0
84927,week,0,0
84928,for,0,0
84929,24,0,0
84930,weeks,0,0
84931,.,0,0
84932,All,0,0
84933,patients,0,0
84934,were,0,0
84935,followed,0,0
84936,up,0,0
84937,for,0,0
84938,24,0,0
84939,weeks,0,0
84940,(,0,0
84941,W24,0,0
84942,),0,0
84943,.,0,0
84944,HBV,1,1
84945,DNA,1,1
84946,",",1,1
84947,HBeAg,1,1
84948,and,1,1
84949,liver,1,1
84950,functions,1,1
84951,were,0,0
84952,detected,0,0
84953,at,0,0
84954,different,0,0
84955,time,0,1
84956,points,0,1
84957,",",0,0
84958,and,0,0
84959,the,0,0
84960,number,0,1
84961,of,0,0
84962,cells,0,1
84963,that,0,0
84964,secrete,1,1
84965,IFN-gamma,1,1
84966,were,0,0
84967,detected,0,0
84968,by,0,0
84969,ELISPOT,1,0
84970,.,1,0
84971,RESULTS,0,0
84972,There,0,0
84973,were,0,0
84974,no,0,0
84975,significant,0,0
84976,difference,0,0
84977,in,0,0
84978,ELISPOT,1,1
84979,positive,1,1
84980,ratio,1,1
84981,among,0,0
84982,the,0,0
84983,3,0,0
84984,groups,0,0
84985,on,0,0
84986,baseline,0,0
84987,detection,0,1
84988,.,0,0
84989,At,0,0
84990,W24,0,0
84991,",",0,0
84992,12,0,0
84993,cases,0,0
84994,",",0,0
84995,12,0,0
84996,cases,0,0
84997,",",0,0
84998,and,0,0
84999,7,0,0
85000,cases,0,0
85001,showed,0,0
85002,ELISPOT,1,1
85003,positive,1,1
85004,in,0,0
85005,the,0,0
85006,group,0,0
85007,of,0,0
85008,90,0,0
85009,micrograms,0,0
85010,",",0,0
85011,60,0,0
85012,micrograms,0,0
85013,",",0,0
85014,and,0,1
85015,placebo,0,0
85016,.,0,0
85017,The,0,0
85018,proportion,0,0
85019,of,0,0
85020,patients,0,0
85021,who,0,0
85022,were,0,0
85023,ELISPOT,1,1
85024,positive,1,1
85025,was,0,0
85026,higher,0,0
85027,in,0,0
85028,the,0,0
85029,groups,0,0
85030,treated,0,0
85031,with,0,0
85032,recombinant,0,0
85033,hepatitis,0,0
85034,B,0,1
85035,vaccine,0,0
85036,(,0,0
85037,including,0,0
85038,the,0,0
85039,dose,0,0
85040,of,0,0
85041,90,0,0
85042,micrograms,0,0
85043,and,0,0
85044,60,0,0
85045,micrograms,0,0
85046,),0,0
85047,than,0,0
85048,that,0,0
85049,in,0,0
85050,the,0,0
85051,placebo,0,0
85052,group,0,0
85053,(,0,1
85054,P=0.0446,0,0
85055,),0,0
85056,.,0,0
85057,HBV,1,1
85058,DNA,1,1
85059,turned,0,0
85060,negative,0,1
85061,in,0,0
85062,6/24,0,1
85063,of,0,0
85064,the,0,0
85065,patients,0,0
85066,treated,0,0
85067,with,0,0
85068,recombinant,0,0
85069,hepatitis,0,0
85070,B,0,1
85071,vaccine,0,0
85072,(,0,0
85073,at,0,0
85074,both,0,0
85075,the,0,0
85076,doses,0,0
85077,of,0,0
85078,90,0,0
85079,micrograms,0,0
85080,and,0,0
85081,60,0,0
85082,micrograms,0,0
85083,),0,0
85084,",",0,0
85085,and,0,1
85086,HBeAg/Anti-HBe,1,1
85087,seroconversion,1,1
85088,or,1,1
85089,HBeAg,1,1
85090,became,0,0
85091,negative,0,1
85092,in,0,0
85093,7/24,0,0
85094,of,0,0
85095,them,0,0
85096,.,0,0
85097,In,0,0
85098,the,0,0
85099,placebo,0,0
85100,group,0,0
85101,",",0,1
85102,none,0,0
85103,of,0,0
85104,the,0,0
85105,patients,0,0
85106,showed,0,0
85107,undetectable,1,1
85108,HBV,1,1
85109,DNA,1,1
85110,",",1,1
85111,HBeAg/Anti-HBe,1,1
85112,seroconversion,1,1
85113,or,1,1
85114,HBeAg,1,1
85115,disappearance,1,1
85116,.,1,0
85117,At,0,0
85118,the,0,0
85119,24W,0,0
85120,of,0,0
85121,follow,0,0
85122,up,0,0
85123,",",0,0
85124,in,0,0
85125,the,0,0
85126,patients,0,0
85127,who,0,0
85128,were,0,0
85129,ELISPOT,1,1
85130,positive,1,1
85131,",",1,0
85132,HBV,1,1
85133,DNA,1,1
85134,became,0,0
85135,undetectable,0,0
85136,in,0,0
85137,4,0,0
85138,of,0,0
85139,the,0,0
85140,patients,0,0
85141,treated,0,0
85142,with,0,0
85143,recombinant,0,0
85144,hepatitis,0,0
85145,B,0,1
85146,vaccine,0,0
85147,(,0,0
85148,at,0,0
85149,doses,0,0
85150,of,0,0
85151,90,0,0
85152,micrograms,0,0
85153,and,0,0
85154,60,0,0
85155,micrograms,0,0
85156,),0,0
85157,",",0,0
85158,and,0,1
85159,HBeAg/Anti-HBe,1,1
85160,seroconversion,1,1
85161,or,1,1
85162,HBeAg,1,1
85163,disappearance,1,1
85164,were,0,0
85165,found,0,0
85166,in,0,0
85167,9,0,0
85168,of,0,0
85169,the,0,0
85170,cases,0,0
85171,.,0,0
85172,In,0,0
85173,the,0,0
85174,placebo,0,0
85175,group,0,0
85176,",",0,1
85177,none,0,0
85178,of,0,0
85179,the,0,0
85180,cases,0,0
85181,showed,0,0
85182,undetectable,0,1
85183,HBV,1,1
85184,DNA,1,1
85185,",",0,1
85186,and,0,0
85187,only,0,0
85188,1,0,0
85189,case,0,0
85190,had,0,0
85191,HBeAg/Anti-HBe,1,0
85192,seroconversion,1,1
85193,.,1,0
85194,CONCLUSION,0,0
85195,The,0,0
85196,recombinant,0,0
85197,hepatitis,0,0
85198,B,0,0
85199,vaccine,0,0
85200,may,0,0
85201,increase,0,0
85202,the,0,0
85203,function,1,1
85204,of,1,0
85205,specific,1,0
85206,T,1,0
85207,lymphocytes,1,1
85208,in,0,0
85209,patients,0,0
85210,with,0,0
85211,chronic,0,0
85212,hepatitis,0,0
85213,B,0,0
85214,.,0,0
85215,There,0,0
85216,were,0,0
85217,no,0,0
85218,significant,0,0
85219,differences,0,0
85220,between,0,0
85221,the,0,0
85222,patients,0,0
85223,treated,0,0
85224,with,0,0
85225,the,0,0
85226,dose,0,0
85227,of,0,0
85228,90,0,0
85229,micrograms,0,0
85230,and,0,0
85231,60,0,0
85232,micrograms,0,0
85233,hepatitis,0,0
85234,B,0,0
85235,vaccine,0,0
85236,.,0,0
85237,Desogestrel,0,0
85238,and,0,1
85239,gestodene,0,0
85240,in,0,0
85241,oral,0,0
85242,contraceptives,0,0
85243,:,0,0
85244,12,0,0
85245,months,0,0
85246,',0,0
85247,assessment,0,0
85248,of,0,1
85249,carbohydrate,1,1
85250,and,1,1
85251,lipoprotein,1,1
85252,metabolism,1,1
85253,.,1,0
85254,We,0,0
85255,examined,0,0
85256,the,0,0
85257,influence,0,0
85258,on,0,0
85259,carbohydrate,0,1
85260,and,0,1
85261,lipoprotein,0,1
85262,metabolism,0,1
85263,of,0,1
85264,oral,0,0
85265,contraceptives,0,0
85266,(,0,0
85267,OCs,0,0
85268,),0,0
85269,containing,0,0
85270,two,0,0
85271,new,0,0
85272,third-generation,0,0
85273,progestogens,0,0
85274,",",0,1
85275,desogestrel,0,0
85276,and,0,1
85277,gestodene,0,0
85278,.,0,0
85279,This,0,0
85280,was,0,0
85281,a,0,0
85282,prospective,0,0
85283,randomized,0,0
85284,study,0,0
85285,in,0,0
85286,which,0,0
85287,monophasic,0,0
85288,combinations,0,0
85289,of,0,0
85290,20,0,0
85291,micrograms,0,0
85292,ethinyl,0,0
85293,estradiol,0,0
85294,(,0,1
85295,E2,0,1
85296,),0,0
85297,and,0,0
85298,150,0,0
85299,micrograms,0,0
85300,desogestrel,0,0
85301,or,0,0
85302,30,0,0
85303,micrograms,0,0
85304,ethinyl,0,0
85305,E2,0,1
85306,plus,0,0
85307,75,0,0
85308,micrograms,0,0
85309,gestodene,0,0
85310,were,0,0
85311,administered,0,0
85312,to,0,0
85313,15,0,0
85314,and,0,0
85315,19,0,0
85316,healthy,0,0
85317,women,0,0
85318,",",0,0
85319,respectively,0,0
85320,.,0,0
85321,An,0,0
85322,oral,1,0
85323,glucose,1,1
85324,tolerance,1,1
85325,test,1,1
85326,including,0,0
85327,measurement,0,1
85328,of,0,1
85329,insulin,0,1
85330,response,0,1
85331,was,0,0
85332,performed,0,0
85333,before,0,0
85334,treatment,0,0
85335,and,0,0
85336,after,0,0
85337,3,0,0
85338,",",0,0
85339,6,0,0
85340,",",0,0
85341,and,0,0
85342,12,0,0
85343,months,0,0
85344,of,0,0
85345,treatment,0,0
85346,.,0,0
85347,We,0,0
85348,also,0,0
85349,determined,0,0
85350,fasting,1,1
85351,plasma,1,1
85352,concentrations,1,1
85353,of,1,1
85354,total,1,1
85355,cholesterol,1,1
85356,;,1,0
85357,high-density,1,1
85358,lipoprotein,1,1
85359,cholesterol,1,1
85360,",",1,0
85361,including,1,0
85362,the,1,0
85363,subfractions,1,1
85364,high-density,1,1
85365,lipoprotein2,1,1
85366,cholesterol,1,1
85367,and,1,1
85368,high-density,1,1
85369,lipoprotein3,1,1
85370,cholesterol,1,1
85371,;,1,0
85372,low-density,1,1
85373,lipoprotein,1,1
85374,cholesterol,1,1
85375,;,1,0
85376,very,1,0
85377,low-density,1,1
85378,lipoprotein,1,1
85379,cholesterol,1,1
85380,;,1,1
85381,and,1,0
85382,triglycerides,1,1
85383,.,1,0
85384,A,0,0
85385,transient,1,1
85386,deterioration,1,1
85387,of,1,1
85388,glucose,1,1
85389,tolerance,1,1
85390,was,0,0
85391,observed,0,0
85392,despite,0,0
85393,unchanged,0,0
85394,levels,0,1
85395,of,0,0
85396,insulin,1,1
85397,after,0,0
85398,treatment,0,0
85399,with,0,0
85400,both,0,0
85401,compounds,0,0
85402,for,0,0
85403,3,0,0
85404,months,0,0
85405,.,0,0
85406,In,0,0
85407,both,0,0
85408,groups,0,0
85409,plasma,1,1
85410,levels,1,1
85411,of,1,0
85412,triglycerides,1,1
85413,",",1,0
85414,very,1,0
85415,low-density,1,1
85416,lipoprotein,1,1
85417,cholesterol,1,1
85418,",",1,1
85419,and,1,1
85420,high-density,1,1
85421,lipoprotein,1,1
85422,cholesterol,1,1
85423,increased,1,0
85424,significantly,0,0
85425,after,0,0
85426,3,0,0
85427,months,0,0
85428,.,0,0
85429,After,0,0
85430,12,0,0
85431,months,0,0
85432,",",0,0
85433,a,0,0
85434,significant,0,0
85435,increase,0,0
85436,in,0,0
85437,the,0,0
85438,high-density,1,1
85439,lipoprotein,1,1
85440,cholesterol/total,1,1
85441,cholesterol,1,1
85442,ratio,1,1
85443,was,0,0
85444,observed,0,0
85445,in,0,0
85446,the,0,0
85447,ethinyl,0,0
85448,E2-desogestrel,0,0
85449,group,0,0
85450,",",0,0
85451,and,0,0
85452,no,0,0
85453,persistent,0,0
85454,changes,0,1
85455,in,0,0
85456,low-density,1,1
85457,lipoprotein,1,1
85458,cholesterol,1,1
85459,could,0,0
85460,be,0,0
85461,demonstrated,0,0
85462,in,0,0
85463,any,0,0
85464,of,0,0
85465,the,0,0
85466,groups,0,0
85467,.,0,0
85468,Our,0,0
85469,results,0,0
85470,indicate,0,0
85471,that,0,0
85472,treatment,0,0
85473,with,0,0
85474,either,0,0
85475,compound,0,0
85476,for,0,0
85477,12,0,0
85478,months,0,0
85479,has,0,0
85480,no,0,0
85481,effect,0,0
85482,on,0,0
85483,carbohydrate,1,1
85484,or,1,1
85485,lipoprotein,1,1
85486,metabolism,1,1
85487,known,0,0
85488,to,0,0
85489,increase,0,0
85490,the,0,0
85491,risk,0,1
85492,of,0,0
85493,cardiovascular,0,1
85494,disease,0,0
85495,.,0,0
85496,A,0,0
85497,double-blind,0,0
85498,randomized,0,0
85499,clinical,0,1
85500,evaluation,0,0
85501,of,0,1
85502,enamel,0,0
85503,matrix,0,0
85504,derivative,0,0
85505,proteins,0,0
85506,for,0,0
85507,the,0,0
85508,treatment,0,0
85509,of,0,0
85510,proximal,0,0
85511,class-II,0,1
85512,furcation,0,1
85513,involvements,0,0
85514,.,0,0
85515,OBJECTIVE,0,0
85516,The,0,0
85517,aim,0,0
85518,of,0,0
85519,the,0,0
85520,present,0,0
85521,randomized,0,0
85522,",",0,0
85523,double-blind,0,0
85524,study,0,0
85525,was,0,0
85526,to,0,0
85527,evaluate,0,0
85528,the,0,0
85529,clinical,1,0
85530,response,1,1
85531,of,0,1
85532,proximal,0,0
85533,furcations,0,0
85534,treated,0,0
85535,with,0,0
85536,enamel,0,0
85537,matrix,0,0
85538,derivative,0,0
85539,proteins,0,0
85540,(,0,0
85541,EMD,0,1
85542,),0,0
85543,.,0,0
85544,MATERIAL,0,0
85545,AND,0,0
85546,METHODS,0,0
85547,Fifteen,0,1
85548,patients,0,0
85549,",",0,0
85550,each,0,0
85551,with,0,0
85552,a,0,0
85553,pair,0,0
85554,of,0,0
85555,contralateral,0,1
85556,class-II,0,1
85557,proximal,0,0
85558,furcation,0,1
85559,involvements,0,1
85560,",",0,0
85561,presenting,0,1
85562,probing,0,1
85563,depths,0,1
85564,(,0,0
85565,PDs,0,0
85566,),0,0
85567,>,0,0
85568,/=5,0,0
85569,mm,0,0
85570,and,0,1
85571,bleeding,0,1
85572,on,0,0
85573,probing,0,1
85574,(,0,0
85575,BOP,0,1
85576,),0,1
85577,were,0,0
85578,selected,0,0
85579,.,0,0
85580,The,0,0
85581,patients,0,0
85582,were,0,0
85583,randomly,0,0
85584,assigned,0,0
85585,to,0,0
85586,:,0,0
85587,control,0,0
85588,group,0,0
85589,(,0,1
85590,n=15,0,0
85591,),0,0
85592,-,0,0
85593,open,0,0
85594,flap,0,0
85595,debridement,0,1
85596,(,0,1
85597,OFD,0,0
85598,),0,0
85599,+24,0,0
85600,%,0,0
85601,ethylenediaminetetraacetic,0,0
85602,acid,0,1
85603,(,0,1
85604,EDTA,0,1
85605,),0,0
85606,conditioning,0,0
85607,;,0,1
85608,test,0,1
85609,group,0,0
85610,(,0,1
85611,n=15,0,0
85612,),0,0
85613,-,0,0
85614,OFD+24,0,0
85615,%,0,0
85616,EDTA,0,0
85617,conditioning+EMD,0,0
85618,application,0,0
85619,.,0,1
85620,Plaque,1,1
85621,index,1,1
85622,(,1,1
85623,PI,1,0
85624,),1,1
85625,",",1,1
85626,BOP,1,1
85627,",",1,1
85628,PD,1,1
85629,",",1,1
85630,gingival,1,1
85631,margin,1,1
85632,position,1,1
85633,(,1,1
85634,GMP,1,0
85635,),1,1
85636,",",1,0
85637,relative,1,1
85638,vertical,1,1
85639,and,1,1
85640,horizontal,1,1
85641,clinical,1,1
85642,attachment,1,1
85643,level,1,1
85644,(,1,1
85645,RVCAL,1,1
85646,and,1,1
85647,RHCAL,1,1
85648,),1,1
85649,",",1,0
85650,vertical,1,1
85651,and,1,1
85652,horizontal,1,1
85653,bone,1,1
85654,level,1,1
85655,(,1,1
85656,VBL,1,1
85657,and,1,1
85658,HBL,1,1
85659,),1,1
85660,and,1,1
85661,furcation,1,1
85662,closure,1,1
85663,were,0,0
85664,evaluated,0,0
85665,immediately,0,0
85666,before,0,0
85667,and,0,0
85668,2,0,0
85669,",",0,0
85670,4,0,0
85671,and,0,0
85672,6,0,0
85673,months,0,0
85674,after,0,0
85675,the,0,0
85676,surgeries,0,0
85677,.,0,0
85678,RESULTS,0,0
85679,At,0,0
85680,6,0,0
85681,months,0,0
85682,",",0,0
85683,the,0,0
85684,RVCAL,1,1
85685,gains,1,1
85686,of,0,0
85687,the,0,0
85688,control,0,0
85689,and,0,1
85690,test,0,1
85691,group,0,0
85692,were,0,0
85693,0.39,0,0
85694,+/-,0,0
85695,1.00,0,0
85696,and,0,0
85697,0.54,0,0
85698,+/-,0,0
85699,0.95,0,0
85700,mm,0,0
85701,",",0,0
85702,while,0,0
85703,the,0,0
85704,RHCAL,1,0
85705,gains,0,1
85706,were,0,0
85707,1.21,0,0
85708,+/-,0,0
85709,2.28,0,0
85710,and,0,0
85711,1.36,0,0
85712,+/-,0,0
85713,1.26,0,0
85714,mm,0,0
85715,(,0,0
85716,p,0,0
85717,>,0,0
85718,0.05,0,0
85719,),0,0
85720,.,0,0
85721,The,0,0
85722,VBL,1,0
85723,and,1,1
85724,HBL,1,1
85725,gains,1,1
85726,of,0,0
85727,the,0,0
85728,control,0,0
85729,group,0,0
85730,were,0,0
85731,1.04,0,0
85732,+/-,0,0
85733,1.12,0,0
85734,and,0,0
85735,1.00,0,0
85736,+/-,0,0
85737,1.79,0,0
85738,mm,0,0
85739,",",0,0
85740,and,0,0
85741,0.82,0,0
85742,+/-,0,0
85743,1.82,0,0
85744,and,0,0
85745,1.17,0,0
85746,+/-,0,0
85747,1.38,0,0
85748,mm,0,0
85749,for,0,0
85750,the,0,0
85751,test,0,1
85752,group,0,0
85753,(,0,0
85754,p,0,0
85755,>,0,0
85756,0.05,0,0
85757,),0,0
85758,.,0,0
85759,In,0,0
85760,addition,0,0
85761,",",0,0
85762,a,0,0
85763,statistical,0,1
85764,difference,0,0
85765,was,0,0
85766,observed,0,0
85767,in,0,0
85768,the,0,0
85769,number,1,1
85770,of,1,0
85771,the,1,0
85772,remaining,1,0
85773,class-II,1,0
85774,furcations,1,0
85775,between,0,0
85776,the,0,0
85777,test,0,1
85778,and,0,1
85779,control,0,0
85780,groups,0,0
85781,(,0,0
85782,p,0,0
85783,<,0,0
85784,0.05,0,0
85785,),0,0
85786,in,0,0
85787,this,0,0
85788,period,0,0
85789,.,0,0
85790,CONCLUSION,0,0
85791,It,0,0
85792,may,0,0
85793,be,0,0
85794,concluded,0,0
85795,that,0,0
85796,the,0,0
85797,use,0,0
85798,of,0,0
85799,EMD,0,1
85800,in,0,0
85801,proximal,0,0
85802,furcations,0,0
85803,did,0,0
85804,not,0,0
85805,promote,0,0
85806,a,0,0
85807,superior,0,0
85808,reduction,0,1
85809,in,0,0
85810,PD,1,1
85811,or,0,0
85812,a,0,0
85813,gain,0,1
85814,in,0,0
85815,clinical,1,1
85816,and,1,1
85817,osseous,1,1
85818,attachment,1,1
85819,levels,1,1
85820,",",0,1
85821,but,0,0
85822,resulted,0,0
85823,in,0,0
85824,a,0,0
85825,higher,0,0
85826,rate,0,1
85827,of,0,1
85828,class-II,1,1
85829,to,1,0
85830,class-I,1,1
85831,furcation,1,1
85832,conversion,1,1
85833,.,1,0
85834,Does,0,1
85835,surface,0,1
85836,preparation,0,0
85837,alter,0,1
85838,ALA,1,1
85839,uptake,1,1
85840,in,0,0
85841,superficial,0,1
85842,non-melanoma,0,1
85843,skin,0,1
85844,cancer,0,0
85845,in,0,0
85846,vivo,0,0
85847,?,0,0
85848,BACKGROUND/PURPOSE,0,0
85849,Photodynamic,0,0
85850,therapy,0,0
85851,(,0,1
85852,PDT,0,0
85853,),0,0
85854,using,0,0
85855,aminolaevulinic,0,0
85856,acid,0,1
85857,(,0,1
85858,ALA,0,0
85859,),0,0
85860,is,0,0
85861,widely,0,0
85862,used,0,0
85863,in,0,0
85864,the,0,0
85865,treatment,0,0
85866,of,0,0
85867,non-melanoma,0,1
85868,skin,0,1
85869,cancer,0,0
85870,.,0,1
85871,Surface,0,1
85872,preparation,0,0
85873,of,0,0
85874,the,0,0
85875,lesion,0,0
85876,is,0,0
85877,commonly,0,0
85878,performed,0,0
85879,before,0,0
85880,application,0,0
85881,of,0,1
85882,ALA,0,0
85883,but,0,0
85884,the,0,0
85885,extent,0,0
85886,of,0,0
85887,the,0,0
85888,preparation,0,0
85889,varies,0,1
85890,from,0,0
85891,centre,0,0
85892,to,0,0
85893,centre,0,0
85894,and,0,0
85895,there,0,0
85896,has,0,0
85897,been,0,0
85898,no,0,0
85899,study,0,0
85900,of,0,0
85901,its,0,0
85902,effects,0,0
85903,.,0,0
85904,The,0,0
85905,purpose,0,0
85906,of,0,0
85907,this,0,0
85908,study,0,0
85909,was,0,0
85910,to,0,0
85911,examine,0,0
85912,the,0,0
85913,effects,0,0
85914,of,0,0
85915,surface,0,1
85916,preparation,0,0
85917,on,0,0
85918,the,0,0
85919,local,0,0
85920,uptake,1,1
85921,of,1,1
85922,ALA,1,0
85923,by,0,0
85924,recording,0,0
85925,fluorescence,0,1
85926,from,0,0
85927,accumulated,0,1
85928,protoporphyrin,0,0
85929,IX,0,0
85930,(,0,1
85931,PPIX,0,1
85932,),0,0
85933,.,0,0
85934,METHODS,0,0
85935,The,0,0
85936,study,0,0
85937,was,0,0
85938,performed,0,0
85939,on,0,0
85940,16,0,0
85941,lesions,0,1
85942,",",0,0
85943,either,0,0
85944,superficial,0,1
85945,basal,0,1
85946,cell,0,1
85947,carcinoma,0,0
85948,(,0,1
85949,BCC,0,1
85950,),0,1
85951,or,0,0
85952,Bowen,0,1
85953,'s,0,1
85954,disease,0,1
85955,(,0,1
85956,BD,0,0
85957,),0,0
85958,.,0,0
85959,Each,0,0
85960,half,0,0
85961,of,0,0
85962,the,0,0
85963,lesion,0,1
85964,was,0,0
85965,randomly,0,0
85966,assigned,0,0
85967,to,0,0
85968,(,0,0
85969,a,0,0
85970,),0,0
85971,no,0,0
85972,surface,0,1
85973,preparation,0,0
85974,or,0,1
85975,(,0,1
85976,b,0,1
85977,),0,1
85978,surface,0,1
85979,preparation,0,0
85980,(,0,0
85981,randomly,0,0
85982,allocated,0,0
85983,to,0,0
85984,gentle,0,0
85985,curettage,0,0
85986,or,0,1
85987,abrasion,0,1
85988,with,0,0
85989,a,0,0
85990,spatula,0,0
85991,),0,0
85992,.,0,1
85993,ALA,0,0
85994,was,0,0
85995,left,0,0
85996,for,0,0
85997,4,0,0
85998,h,0,0
85999,(,0,0
86000,BCC,0,1
86001,),0,0
86002,or,0,0
86003,6,0,0
86004,h,0,0
86005,(,0,0
86006,BD,0,0
86007,),0,0
86008,.,0,0
86009,PPIX,1,1
86010,fluorescence,1,1
86011,was,0,0
86012,measured,0,0
86013,using,0,0
86014,an,0,0
86015,excitation,0,1
86016,wavelength,0,0
86017,of,0,1
86018,405+/-5,0,0
86019,nm,0,1
86020,and,0,1
86021,emission,0,1
86022,spectrum,0,1
86023,recorded,0,0
86024,using,0,0
86025,a,0,0
86026,photodiode,0,0
86027,array,0,0
86028,.,0,1
86029,Spectra,0,1
86030,were,0,0
86031,measured,0,0
86032,(,0,0
86033,a,0,0
86034,),0,0
86035,before,0,0
86036,and,0,1
86037,(,0,1
86038,b,0,1
86039,),0,1
86040,after,0,0
86041,surface,0,1
86042,preparation,0,1
86043,",",0,1
86044,(,0,1
86045,c,0,1
86046,),0,0
86047,immediately,0,0
86048,before,0,0
86049,and,0,1
86050,(,0,1
86051,d,0,1
86052,),0,1
86053,after,0,0
86054,laser,0,0
86055,irradiation,0,0
86056,at,0,0
86057,630,0,0
86058,nm,0,0
86059,.,0,0
86060,RESULTS,0,0
86061,The,0,0
86062,ratio,1,1
86063,of,1,0
86064,fluorescence,1,1
86065,after,1,0
86066,incubation,1,1
86067,to,0,0
86068,that,0,0
86069,before,0,0
86070,incubation,0,1
86071,was,0,0
86072,6.1+/-1.2,0,0
86073,in,0,0
86074,the,0,0
86075,non-prepared,0,0
86076,section,0,0
86077,.,0,0
86078,This,0,0
86079,increased,0,0
86080,slightly,0,0
86081,but,0,0
86082,not,0,0
86083,significantly,0,0
86084,to,0,0
86085,6.8,0,0
86086,+/-1.8,0,0
86087,in,0,0
86088,the,0,0
86089,prepared,0,0
86090,section,0,1
86091,(,0,0
86092,P,0,0
86093,<,0,0
86094,0.1,0,0
86095,),0,0
86096,.,0,0
86097,There,0,0
86098,was,0,0
86099,no,0,0
86100,significant,0,0
86101,difference,0,0
86102,between,0,0
86103,curettage,1,0
86104,and,1,1
86105,abrasion,1,1
86106,.,1,0
86107,There,0,0
86108,was,0,0
86109,also,0,0
86110,no,0,0
86111,significant,0,0
86112,difference,0,0
86113,in,0,0
86114,outcome,1,1
86115,after,0,0
86116,PDT,0,0
86117,.,0,0
86118,CONCLUSIONS,0,0
86119,The,0,0
86120,clinical,0,0
86121,assessment,0,0
86122,agrees,0,0
86123,with,0,0
86124,the,0,0
86125,fluorescence,0,1
86126,data,0,0
86127,as,0,0
86128,no,0,0
86129,significant,0,0
86130,difference,0,0
86131,was,0,0
86132,seen,0,0
86133,between,0,0
86134,prepared,0,0
86135,and,0,1
86136,unprepared,0,0
86137,halves,0,0
86138,of,0,0
86139,the,0,0
86140,lesion,0,0
86141,12,0,0
86142,months,0,0
86143,after,0,0
86144,PDT,0,0
86145,.,0,0
86146,Overall,0,0
86147,our,0,0
86148,data,0,0
86149,seem,0,0
86150,to,0,0
86151,suggest,0,0
86152,that,0,0
86153,for,0,0
86154,most,0,0
86155,BCC,0,1
86156,and,0,1
86157,BD,0,1
86158,lesions,0,1
86159,",",0,1
86160,surface,0,1
86161,preparation,0,1
86162,did,0,0
86163,not,0,0
86164,increase,0,0
86165,ALA,1,0
86166,uptake,1,1
86167,.,1,0
86168,Resource,1,1
86169,utilization,1,1
86170,and,0,1
86171,economic,1,1
86172,costs,1,1
86173,of,0,0
86174,care,0,0
86175,based,0,0
86176,on,0,0
86177,a,0,0
86178,randomized,0,0
86179,trial,0,0
86180,of,0,1
86181,vacuum-assisted,0,0
86182,closure,0,1
86183,therapy,0,0
86184,in,0,0
86185,the,0,0
86186,treatment,0,0
86187,of,0,0
86188,diabetic,0,0
86189,foot,0,0
86190,wounds,0,0
86191,.,0,0
86192,BACKGROUND,0,0
86193,To,0,0
86194,evaluate,0,0
86195,resource,1,1
86196,utilization,1,1
86197,and,0,1
86198,direct,1,1
86199,economic,1,1
86200,costs,1,1
86201,of,0,0
86202,care,0,0
86203,for,0,0
86204,patients,0,0
86205,treated,0,0
86206,with,0,0
86207,negative-pressure,0,0
86208,wound,0,1
86209,therapy,0,0
86210,(,0,1
86211,NPWT,0,1
86212,),0,1
86213,",",0,0
86214,using,0,0
86215,the,0,0
86216,Vacuum-Assisted,0,0
86217,Closure,0,0
86218,(,0,0
86219,V.A.C,0,0
86220,.,0,1
86221,),0,1
86222,system,0,0
86223,",",0,0
86224,compared,0,0
86225,to,0,0
86226,standard,0,0
86227,moist,0,0
86228,wound,0,1
86229,therapy,0,0
86230,(,0,1
86231,MWT,0,1
86232,),0,1
86233,.,0,0
86234,METHODS,0,0
86235,A,0,0
86236,total,0,1
86237,of,0,0
86238,162,0,0
86239,diabetic,0,0
86240,patients,0,0
86241,with,0,0
86242,post-amputation,0,1
86243,wounds,0,1
86244,(,0,0
86245,up,0,0
86246,to,0,0
86247,the,0,0
86248,trans-metatarsal,0,1
86249,level,0,1
86250,),0,0
86251,entered,0,0
86252,a,0,0
86253,16-week,0,0
86254,",",0,0
86255,randomized,0,0
86256,clinical,0,0
86257,trial,0,0
86258,.,0,1
86259,Patients,0,0
86260,randomized,0,0
86261,to,0,0
86262,V.A.C,0,0
86263,.,0,1
86264,(,0,0
86265,n,0,0
86266,=,0,0
86267,77,0,0
86268,),0,0
86269,received,0,0
86270,therapy,0,0
86271,with,0,0
86272,dressing,0,0
86273,changes,0,1
86274,every,0,0
86275,48,0,0
86276,hours,0,0
86277,.,0,0
86278,Control,0,0
86279,patients,0,0
86280,(,0,0
86281,n,0,0
86282,=,0,0
86283,85,0,0
86284,),0,0
86285,received,0,0
86286,standard,0,0
86287,MWT,0,0
86288,.,0,1
86289,Resource,1,1
86290,utilization,1,1
86291,",",1,1
86292,procedures,1,0
86293,",",1,1
86294,and,1,1
86295,direct,1,1
86296,costs,1,1
86297,were,0,0
86298,calculated,0,0
86299,and,0,0
86300,analyzed,0,0
86301,in,0,0
86302,this,0,0
86303,post,0,0
86304,hoc,0,0
86305,retrospective,0,0
86306,study,0,0
86307,.,0,1
86308,RESULTS,0,0
86309,There,0,0
86310,was,0,0
86311,no,0,0
86312,difference,0,0
86313,between,0,0
86314,groups,0,0
86315,for,0,0
86316,in-patient,1,1
86317,hospital,1,1
86318,stay,1,1
86319,(,1,1
86320,number,1,1
86321,of,1,1
86322,admissions,1,1
86323,or,1,0
86324,length,1,1
86325,of,1,1
86326,stay,1,1
86327,),1,0
86328,.,0,0
86329,More,0,0
86330,surgical,0,1
86331,procedures,0,0
86332,(,0,0
86333,including,0,0
86334,debridement,0,1
86335,),0,1
86336,were,0,0
86337,required,0,0
86338,in,0,0
86339,the,0,0
86340,MWT,0,1
86341,group,0,0
86342,(,0,0
86343,120,0,0
86344,vs,0,0
86345,43,0,0
86346,NPWT,0,0
86347,",",0,0
86348,P,0,0
86349,<,0,0
86350,.001,0,0
86351,),0,0
86352,.,0,0
86353,The,0,0
86354,average,1,1
86355,number,1,1
86356,of,1,0
86357,dressing,1,0
86358,changes,1,1
86359,performed,1,0
86360,per,1,0
86361,patient,1,0
86362,was,0,0
86363,118.0,0,0
86364,(,0,0
86365,range,0,0
86366,12-226,0,0
86367,),0,0
86368,for,0,0
86369,MWT,0,1
86370,versus,0,0
86371,41,0,0
86372,(,0,0
86373,6-140,0,0
86374,),0,0
86375,for,0,0
86376,NPWT,0,1
86377,(,0,0
86378,P,0,0
86379,=,0,0
86380,.0001,0,0
86381,),0,0
86382,.,0,0
86383,The,0,0
86384,MWT,0,1
86385,group,0,0
86386,had,0,0
86387,11,0,0
86388,(,0,0
86389,range,0,0
86390,0-106,0,0
86391,),0,1
86392,outpatient,1,0
86393,treatment,1,0
86394,visits,1,0
86395,during,0,0
86396,the,0,0
86397,study,0,0
86398,versus,0,0
86399,4,0,0
86400,(,0,0
86401,range,0,0
86402,0-47,0,0
86403,),0,0
86404,in,0,0
86405,the,0,0
86406,NPWT,0,1
86407,group,0,0
86408,(,0,0
86409,P,0,0
86410,<,0,0
86411,.05,0,0
86412,),0,0
86413,.,0,0
86414,The,0,0
86415,average,1,1
86416,direct,1,0
86417,cost,1,1
86418,per,1,0
86419,patient,1,1
86420,treated,0,0
86421,for,0,0
86422,8,0,0
86423,weeks,0,0
86424,or,0,0
86425,longer,0,1
86426,(,0,1
86427,independent,0,1
86428,of,0,1
86429,clinical,0,1
86430,outcome,0,1
86431,),0,1
86432,was,0,0
86433,$,0,0
86434,"27,270",0,0
86435,and,0,0
86436,$,0,0
86437,"36,096",0,0
86438,in,0,0
86439,the,0,0
86440,NPWT,0,0
86441,and,0,1
86442,MWT,0,1
86443,groups,0,0
86444,",",0,0
86445,respectively,0,0
86446,.,0,0
86447,The,0,0
86448,average,1,1
86449,total,1,1
86450,cost,1,0
86451,to,1,0
86452,achieve,1,0
86453,healing,1,1
86454,was,0,0
86455,$,0,0
86456,"25,954",0,0
86457,for,0,0
86458,patients,0,0
86459,treated,0,0
86460,with,0,0
86461,NPWT,0,0
86462,(,0,0
86463,n,0,0
86464,=,0,0
86465,43,0,0
86466,),0,0
86467,compared,0,0
86468,with,0,0
86469,$,0,0
86470,"38,806",0,0
86471,for,0,0
86472,the,0,0
86473,MWT,0,1
86474,group,0,0
86475,(,0,0
86476,n,0,0
86477,=,0,0
86478,33,0,0
86479,),0,0
86480,.,0,0
86481,CONCLUSION,0,0
86482,Treatment,0,0
86483,of,0,0
86484,diabetic,0,0
86485,patients,0,0
86486,with,0,0
86487,post,0,0
86488,amputation,0,1
86489,wounds,0,1
86490,using,0,0
86491,NPWT,0,1
86492,resulted,0,0
86493,in,0,0
86494,lower,0,1
86495,resource,1,1
86496,utilization,1,1
86497,and,0,0
86498,a,0,0
86499,greater,0,1
86500,proportion,1,1
86501,of,1,1
86502,patients,1,0
86503,obtaining,0,0
86504,wound,0,0
86505,healing,0,1
86506,at,0,0
86507,a,0,0
86508,lower,1,0
86509,overall,1,1
86510,cost,1,1
86511,of,1,1
86512,care,1,0
86513,when,0,0
86514,compared,0,0
86515,to,0,0
86516,MWT,0,0
86517,.,0,0
86518,Effect,0,1
86519,of,0,1
86520,finasteride,0,0
86521,treatment,0,0
86522,on,0,0
86523,suburethral,0,1
86524,prostatic,0,1
86525,microvessel,0,1
86526,density,0,1
86527,in,0,0
86528,patients,0,0
86529,with,0,0
86530,hematuria,0,1
86531,related,0,0
86532,to,0,0
86533,benign,0,0
86534,prostate,0,0
86535,hyperplasia,0,1
86536,.,0,0
86537,INTRODUCTION,0,0
86538,In,0,0
86539,the,0,0
86540,present,0,0
86541,study,0,0
86542,we,0,0
86543,evaluated,0,0
86544,the,0,0
86545,effect,0,1
86546,of,0,0
86547,short-term,0,1
86548,finasteride,0,0
86549,treatment,0,0
86550,on,0,0
86551,microvessel,0,1
86552,density,0,1
86553,(,0,1
86554,MVD,0,1
86555,),0,0
86556,which,0,0
86557,is,0,0
86558,an,0,0
86559,indicator,0,0
86560,of,0,0
86561,prostatic,0,1
86562,angiogenesis,0,1
86563,in,0,0
86564,patients,0,0
86565,with,0,0
86566,hematuria,0,1
86567,secondary,0,0
86568,to,0,0
86569,benign,0,0
86570,prostatic,0,1
86571,hyperplasia,0,1
86572,(,0,1
86573,BPH,0,1
86574,),0,0
86575,.,0,0
86576,MATERIALS,0,0
86577,AND,0,0
86578,METHODS,0,0
86579,30,0,0
86580,patients,0,0
86581,who,0,0
86582,were,0,0
86583,candidates,0,0
86584,for,0,0
86585,BPH,0,1
86586,surgery,0,0
86587,were,0,0
86588,prospectively,0,0
86589,included,0,0
86590,in,0,0
86591,the,0,0
86592,study,0,0
86593,.,0,0
86594,All,0,0
86595,patients,0,0
86596,had,0,0
86597,history,0,1
86598,of,0,1
86599,gross,0,1
86600,hematuria,0,1
86601,and,0,1
86602,evaluated,0,0
86603,by,0,0
86604,ultrasonography,0,1
86605,and,0,1
86606,cystoscopy,0,0
86607,.,0,0
86608,The,0,0
86609,patients,0,0
86610,were,0,0
86611,randomized,0,0
86612,two,0,0
86613,groups,0,0
86614,before,0,0
86615,surgery,0,0
86616,.,0,0
86617,The,0,0
86618,treatment,0,0
86619,group,0,0
86620,consisted,0,0
86621,of,0,0
86622,13,0,0
86623,patients,0,0
86624,who,0,0
86625,were,0,0
86626,given,0,0
86627,5,0,0
86628,mg,0,0
86629,finasteride,0,0
86630,daily,0,0
86631,for,0,0
86632,4,0,0
86633,weeks,0,0
86634,before,0,0
86635,surgery,0,0
86636,.,0,0
86637,The,0,0
86638,control,0,0
86639,group,0,0
86640,consisted,0,0
86641,of,0,0
86642,17,0,0
86643,patients,0,0
86644,who,0,0
86645,did,0,0
86646,not,0,0
86647,receive,0,0
86648,finasteride,0,0
86649,before,0,0
86650,surgery,0,0
86651,.,0,0
86652,During,0,0
86653,surgery,0,0
86654,",",0,0
86655,resected,0,1
86656,suburethral,0,1
86657,and,0,0
86658,hyperplastic,0,0
86659,prostate,0,0
86660,specimens,0,1
86661,were,0,0
86662,sent,0,0
86663,for,0,0
86664,histopathologic,0,1
86665,MVD,0,1
86666,determination,0,0
86667,separately,0,0
86668,.,0,0
86669,RESULTS,0,0
86670,Mean,1,1
86671,MVD,1,1
86672,in,1,0
86673,the,1,0
86674,suburethral,1,1
86675,portion,1,0
86676,of,1,1
86677,prostate,1,0
86678,was,1,0
86679,significantly,1,0
86680,lower,1,0
86681,in,0,0
86682,patients,0,0
86683,treated,0,0
86684,with,0,0
86685,finasteride,0,0
86686,when,0,0
86687,compared,0,0
86688,with,0,0
86689,controls,0,0
86690,(,0,0
86691,9.08,0,0
86692,+/-,0,0
86693,5.6,0,0
86694,and,0,0
86695,13.94,0,0
86696,+/-,0,0
86697,5.90,0,0
86698,",",0,0
86699,respectively,0,0
86700,",",0,0
86701,p,0,0
86702,<,0,0
86703,0.05,0,0
86704,),0,0
86705,.,0,0
86706,Mean,1,1
86707,MVD,1,1
86708,for,1,0
86709,the,1,0
86710,hyperplastic,1,0
86711,portion,1,0
86712,of,1,1
86713,prostate,1,0
86714,was,0,0
86715,similar,0,0
86716,for,0,0
86717,the,0,0
86718,finasteride,0,0
86719,and,0,1
86720,control,0,0
86721,groups,0,0
86722,(,0,0
86723,14.21,0,0
86724,+/-,0,0
86725,7.10,0,0
86726,and,0,0
86727,19.75,0,0
86728,+/-,0,0
86729,9.73,0,0
86730,",",0,0
86731,respectively,0,0
86732,",",0,0
86733,p,0,0
86734,>,0,0
86735,0.05,0,0
86736,),0,0
86737,.,0,0
86738,CONCLUSION,0,0
86739,The,0,0
86740,potential,0,0
86741,role,0,0
86742,of,0,1
86743,finasteride,0,0
86744,on,0,0
86745,hematuria,0,1
86746,related,0,0
86747,to,0,0
86748,BPH,0,0
86749,may,0,0
86750,be,0,0
86751,the,0,0
86752,suppressive,0,1
86753,effect,0,0
86754,on,0,0
86755,MVD,1,1
86756,in,0,0
86757,the,0,0
86758,suburethral,0,1
86759,tissue,0,1
86760,of,0,0
86761,prostate,0,0
86762,.,0,0
86763,Post-laparoscopic,0,1
86764,cholecystectomy,0,0
86765,pain,0,1
86766,:,0,0
86767,effects,1,1
86768,of,0,0
86769,intraperitoneal,0,0
86770,local,0,0
86771,anesthetics,0,0
86772,on,0,0
86773,pain,0,1
86774,control,0,0
86775,--,0,0
86776,a,0,0
86777,randomized,0,0
86778,prospective,0,0
86779,double-blinded,0,0
86780,placebo-controlled,0,0
86781,trial,0,0
86782,.,0,1
86783,Postoperative,0,1
86784,pain,0,1
86785,after,0,0
86786,laparoscopic,0,0
86787,cholecystectomy,0,0
86788,(,0,1
86789,LC,0,0
86790,),0,0
86791,is,0,0
86792,generally,0,0
86793,less,0,0
86794,than,0,0
86795,open,0,0
86796,cholecystectomy,0,0
86797,;,0,0
86798,however,0,0
86799,",",0,0
86800,the,0,0
86801,postoperative,0,1
86802,shoulder,0,1
86803,and,0,1
86804,abdominal,0,1
86805,pain,0,1
86806,experienced,0,0
86807,by,0,0
86808,patients,0,0
86809,still,0,0
86810,causes,0,0
86811,preventable,0,1
86812,distress,0,1
86813,.,0,1
86814,Intraperitoneal,0,0
86815,irrigation,0,0
86816,of,0,0
86817,the,0,0
86818,diaphragmatic,0,1
86819,surface,0,1
86820,and,0,1
86821,gallbladder,0,1
86822,fossa,0,1
86823,using,0,0
86824,normal,0,1
86825,saline,0,0
86826,",",0,1
86827,bupivacaine,0,0
86828,",",0,1
86829,or,0,0
86830,lignocaine,0,0
86831,may,0,0
86832,effectively,0,0
86833,control,0,0
86834,visceral,1,1
86835,abdominal,1,1
86836,pain,1,1
86837,after,0,0
86838,an,0,0
86839,LC,0,0
86840,.,0,0
86841,Two,0,0
86842,hundred,0,0
86843,patients,0,0
86844,with,0,0
86845,similar,0,0
86846,demographics,0,1
86847,undergoing,0,0
86848,elective,0,0
86849,LC,0,1
86850,were,0,0
86851,randomized,0,0
86852,to,0,0
86853,one,0,0
86854,of,0,0
86855,four,0,0
86856,groups,0,0
86857,of,0,0
86858,50,0,0
86859,patients,0,0
86860,each,0,0
86861,",",0,0
86862,including,0,0
86863,Group,0,0
86864,A,0,0
86865,placebo,0,0
86866,control,0,0
86867,",",0,1
86868,Group,0,0
86869,B,0,0
86870,with,0,0
86871,isotonic,0,0
86872,saline,0,0
86873,irrigation,0,1
86874,",",0,1
86875,Group,0,0
86876,C,0,0
86877,with,0,0
86878,bupivacaine,0,0
86879,irrigation,0,1
86880,",",0,1
86881,and,0,1
86882,Group,0,0
86883,D,0,1
86884,with,0,0
86885,lignocaine,0,0
86886,irrigation,0,0
86887,.,0,0
86888,All,0,0
86889,patients,0,0
86890,received,0,0
86891,preperitoneal,0,0
86892,abdominal,0,1
86893,wall,0,1
86894,infiltration,0,1
86895,with,0,0
86896,0.25,0,0
86897,per,0,0
86898,cent,0,0
86899,bupivacaine,0,0
86900,to,0,0
86901,control,0,0
86902,parietal,0,1
86903,(,0,0
86904,somatic,0,1
86905,),0,1
86906,abdominal,0,1
86907,pain,0,1
86908,.,0,0
86909,The,0,0
86910,visual,1,1
86911,analogue,1,1
86912,and,1,1
86913,verbal,1,1
86914,rating,1,1
86915,pain,1,1
86916,scores,1,1
86917,at,0,0
86918,0,0,0
86919,",",0,0
86920,4,0,0
86921,",",0,0
86922,8,0,0
86923,",",0,0
86924,12,0,0
86925,and,0,0
86926,24,0,0
86927,hours,0,0
86928,for,0,0
86929,both,0,0
86930,shoulder,0,0
86931,and,0,1
86932,abdominal,0,1
86933,pain,0,1
86934,were,0,0
86935,recorded,0,0
86936,in,0,0
86937,a,0,0
86938,prospective,0,0
86939,double-blind,0,0
86940,fashion,0,0
86941,at,0,0
86942,four,0,0
86943,points,0,0
86944,during,0,0
86945,the,0,0
86946,first,0,0
86947,24,0,0
86948,postoperative,0,0
86949,hours,0,0
86950,.,0,0
86951,Analgesia,1,1
86952,requirements,1,1
86953,",",1,0
86954,vital,1,1
86955,signs,1,1
86956,",",1,1
86957,blood,1,1
86958,glucose,1,1
86959,",",1,1
86960,and,1,1
86961,incidence,1,1
86962,of,1,1
86963,nausea,1,1
86964,and,1,1
86965,vomiting,1,1
86966,were,0,0
86967,also,0,0
86968,recorded,0,0
86969,.,0,0
86970,Patients,0,0
86971,in,0,0
86972,each,0,0
86973,group,0,0
86974,demonstrated,0,0
86975,a,0,0
86976,significant,0,0
86977,difference,0,0
86978,in,0,0
86979,visual,1,1
86980,analogue,1,1
86981,and,1,1
86982,verbal,1,1
86983,rating,1,1
86984,pain,1,1
86985,scores,1,1
86986,and,1,1
86987,analgesic,1,1
86988,consumption,1,1
86989,when,0,0
86990,compared,0,0
86991,with,0,0
86992,controls,0,0
86993,.,0,1
86994,Lignocaine,0,1
86995,controlled,1,0
86996,pain,1,1
86997,significantly,0,0
86998,better,0,0
86999,than,0,0
87000,saline,0,0
87001,or,0,0
87002,bupivacaine,0,0
87003,.,0,1
87004,Bowel,1,1
87005,function,1,1
87006,recovery,1,1
87007,was,0,0
87008,similar,1,0
87009,in,0,0
87010,all,0,0
87011,patients,0,0
87012,",",0,0
87013,and,0,1
87014,there,0,0
87015,were,0,0
87016,no,0,0
87017,significant,0,0
87018,complications,0,1
87019,.,0,0
87020,We,0,0
87021,conclude,0,0
87022,that,0,0
87023,intraperitoneal,0,0
87024,irrigation,0,0
87025,with,0,0
87026,either,0,0
87027,saline,0,0
87028,",",0,1
87029,bupivacaine,0,0
87030,",",0,1
87031,or,0,0
87032,lignocaine,0,0
87033,can,0,0
87034,significantly,0,0
87035,reduce,0,0
87036,visceral,1,1
87037,abdominal,1,1
87038,pain,1,1
87039,after,0,0
87040,LC,0,1
87041,.,0,1
87042,Lignocaine,0,0
87043,was,0,0
87044,the,0,0
87045,most,0,0
87046,efficacious,0,0
87047,local,0,0
87048,anesthetic,0,0
87049,in,0,0
87050,this,0,0
87051,trial,0,0
87052,and,0,0
87053,has,0,0
87054,a,0,0
87055,high,0,0
87056,safety,0,1
87057,profile,0,1
87058,when,0,0
87059,used,0,0
87060,at,0,0
87061,recommended,0,0
87062,doses,0,0
87063,.,0,0
87064,Does,0,1
87065,3-day,0,0
87066,course,0,0
87067,of,0,1
87068,oral,0,0
87069,amoxycillin,0,0
87070,benefit,0,0
87071,children,0,0
87072,of,0,1
87073,non-severe,0,0
87074,pneumonia,0,1
87075,with,0,0
87076,wheeze,0,0
87077,:,0,0
87078,a,0,0
87079,multicentric,0,0
87080,randomised,0,0
87081,controlled,0,0
87082,trial,0,0
87083,.,0,0
87084,BACKGROUND,0,0
87085,WHO-defined,0,1
87086,pneumonias,0,0
87087,",",0,0
87088,treated,0,0
87089,with,0,0
87090,antibiotics,0,0
87091,",",0,0
87092,are,0,0
87093,responsible,0,0
87094,for,0,0
87095,a,0,0
87096,significant,0,0
87097,proportion,0,1
87098,of,0,1
87099,childhood,0,1
87100,morbidity,0,1
87101,and,0,1
87102,mortality,0,1
87103,in,0,0
87104,the,0,0
87105,developing,0,0
87106,countries,0,0
87107,.,0,0
87108,Since,0,0
87109,substantial,0,0
87110,proportion,0,0
87111,pneumonias,0,0
87112,have,0,0
87113,a,0,0
87114,viral,0,0
87115,etiology,0,1
87116,",",0,0
87117,where,0,0
87118,children,0,0
87119,are,0,0
87120,more,0,0
87121,likely,0,0
87122,to,0,0
87123,present,0,0
87124,with,0,0
87125,wheeze,0,1
87126,",",0,0
87127,there,0,0
87128,is,0,0
87129,a,0,0
87130,concern,0,0
87131,that,0,0
87132,currently,0,0
87133,antibiotics,0,0
87134,are,0,0
87135,being,0,0
87136,over-prescribed,0,0
87137,for,0,0
87138,it,0,0
87139,.,0,0
87140,Hence,0,0
87141,the,0,0
87142,current,0,0
87143,trial,0,0
87144,was,0,0
87145,conducted,0,0
87146,with,0,0
87147,the,0,0
87148,objective,0,0
87149,to,0,0
87150,show,0,0
87151,the,0,0
87152,therapeutic,0,0
87153,equivalence,0,0
87154,of,0,0
87155,two,0,0
87156,treatments,0,0
87157,(,0,0
87158,placebo,0,0
87159,and,0,1
87160,amoxycillin,0,0
87161,),0,1
87162,for,0,0
87163,children,0,0
87164,presenting,0,1
87165,with,0,0
87166,non-severe,0,0
87167,pneumonia,0,1
87168,with,0,0
87169,wheeze,0,0
87170,",",0,0
87171,who,0,0
87172,have,0,0
87173,persistent,0,0
87174,fast,0,0
87175,breathing,0,0
87176,after,0,0
87177,nebulisation,0,1
87178,with,0,0
87179,salbutamol,0,0
87180,",",0,0
87181,and,0,0
87182,have,0,0
87183,normal,0,1
87184,chest,0,1
87185,radiograph,0,1
87186,.,0,0
87187,METHODOLOGY,0,0
87188,This,0,0
87189,multi-centric,0,0
87190,",",0,0
87191,randomised,0,0
87192,placebo,0,0
87193,controlled,0,0
87194,double,0,0
87195,blind,0,0
87196,clinical,0,1
87197,trial,0,0
87198,intended,0,0
87199,to,0,0
87200,investigate,0,0
87201,equivalent,0,0
87202,efficacy,0,1
87203,of,0,1
87204,placebo,0,0
87205,and,0,1
87206,amoxicillin,0,0
87207,and,0,1
87208,was,0,0
87209,conducted,0,0
87210,in,0,0
87211,ambulatory,0,0
87212,care,0,0
87213,settings,0,0
87214,in,0,0
87215,eight,0,0
87216,government,0,0
87217,hospitals,0,0
87218,in,0,0
87219,India,0,0
87220,.,0,0
87221,Participants,0,0
87222,were,0,0
87223,children,0,0
87224,aged,0,0
87225,2-59,0,0
87226,months,0,0
87227,of,0,1
87228,age,0,0
87229,",",0,0
87230,who,0,0
87231,received,0,0
87232,either,0,0
87233,oral,0,0
87234,amoxycillin,0,0
87235,(,0,0
87236,31-54,0,0
87237,mg/Kg/day,0,0
87238,",",0,0
87239,in,0,0
87240,three,0,0
87241,divided,0,0
87242,doses,0,0
87243,for,0,0
87244,three,0,0
87245,days,0,0
87246,),0,0
87247,or,0,1
87248,placebo,0,0
87249,",",0,1
87250,and,0,1
87251,standard,0,1
87252,bronchodilator,0,1
87253,therapy,0,0
87254,.,0,1
87255,Primary,0,1
87256,outcome,0,1
87257,was,0,0
87258,clinical,1,1
87259,failure,1,1
87260,on,1,0
87261,or,1,0
87262,before,1,0
87263,day-,1,1
87264,4,1,0
87265,.,1,0
87266,PRINCIPAL,0,0
87267,FINDINGS,0,0
87268,We,0,0
87269,randomized,0,0
87270,836,0,0
87271,cases,0,0
87272,in,0,0
87273,placebo,0,0
87274,and,0,0
87275,835,0,0
87276,in,0,0
87277,amoxycillin,0,0
87278,group,0,0
87279,.,0,1
87280,Clinical,1,1
87281,failures,1,1
87282,occurred,0,0
87283,in,0,0
87284,201,0,0
87285,(,0,0
87286,24.0,0,0
87287,%,0,0
87288,),0,0
87289,on,0,0
87290,placebo,0,0
87291,and,0,0
87292,166,0,0
87293,(,0,0
87294,19.9,0,0
87295,%,0,0
87296,),0,0
87297,on,0,0
87298,amoxycillin,0,0
87299,(,0,1
87300,risk,0,1
87301,difference,0,0
87302,4.2,0,0
87303,%,0,0
87304,in,0,0
87305,favour,0,0
87306,of,0,1
87307,antibiotic,0,0
87308,",",0,0
87309,95,0,0
87310,%,0,0
87311,CI,0,0
87312,:,0,0
87313,0.2,0,0
87314,to,0,0
87315,8.1,0,0
87316,),0,0
87317,.,0,0
87318,Adherence,1,1
87319,for,0,0
87320,both,0,0
87321,placebo,0,0
87322,and,0,1
87323,amoxycillin,0,0
87324,was,0,0
87325,>,0,0
87326,96,0,0
87327,%,0,0
87328,and,0,0
87329,98.9,0,0
87330,%,0,0
87331,subjects,0,0
87332,were,0,0
87333,followed,0,0
87334,up,0,0
87335,on,0,0
87336,day-,0,1
87337,4,0,0
87338,.,0,0
87339,Clinical,1,0
87340,failure,1,1
87341,was,0,0
87342,associated,0,0
87343,with,0,0
87344,(,0,0
87345,i,0,0
87346,),0,1
87347,placebo,1,0
87348,treatment,1,0
87349,(,0,0
87350,adjusted,0,0
87351,OR,0,0
87352,=,0,0
87353,1.28,0,0
87354,",",0,0
87355,95,0,0
87356,%,0,0
87357,CI,0,0
87358,:,0,0
87359,1.01,0,0
87360,to1.62,0,0
87361,),0,0
87362,",",0,1
87363,(,0,1
87364,ii,0,0
87365,),0,1
87366,excess,1,1
87367,respiratory,1,1
87368,rate,1,1
87369,of,1,0
87370,>,1,0
87371,10,1,0
87372,breaths,1,0
87373,per,1,0
87374,minute,1,1
87375,(,0,0
87376,adjusted,0,0
87377,OR,0,0
87378,=,0,0
87379,1.51,0,0
87380,",",0,0
87381,95,0,0
87382,%,0,0
87383,CI,0,0
87384,:,0,0
87385,1.19,0,0
87386,",",0,0
87387,1.92,0,0
87388,),0,0
87389,",",0,0
87390,(,0,1
87391,iii,0,1
87392,),0,1
87393,vomiting,1,1
87394,at,1,0
87395,enrolment,1,0
87396,(,0,0
87397,adjusted,0,0
87398,OR,0,0
87399,=,0,0
87400,1.49,0,0
87401,",",0,0
87402,95,0,0
87403,%,0,0
87404,CI,0,0
87405,:,0,0
87406,1.13,0,0
87407,",",0,0
87408,1.96,0,0
87409,),0,0
87410,",",0,0
87411,(,0,1
87412,iv,0,0
87413,),0,1
87414,history,1,1
87415,of,1,1
87416,use,1,0
87417,of,1,1
87418,broncho-dilators,1,1
87419,(,0,0
87420,adjusted,0,0
87421,OR,0,0
87422,=,0,0
87423,1.71,0,0
87424,",",0,0
87425,95,0,0
87426,%,0,0
87427,CI,0,0
87428,:,0,0
87429,1.30,0,0
87430,",",0,0
87431,2.24,0,0
87432,),0,0
87433,and,0,0
87434,(,0,1
87435,v,0,1
87436,),0,1
87437,non-adherence,1,1
87438,(,0,0
87439,adjusted,0,0
87440,OR,0,0
87441,=,0,0
87442,8.06,0,0
87443,",",0,0
87444,95,0,0
87445,%,0,0
87446,CI,0,0
87447,:,0,0
87448,4.36,0,0
87449,",",0,0
87450,14.92,0,0
87451,),0,0
87452,.,0,0
87453,CONCLUSIONS,0,0
87454,Treating,0,1
87455,children,0,0
87456,with,0,0
87457,non-severe,0,0
87458,pneumonia,0,1
87459,and,0,1
87460,wheeze,0,1
87461,with,0,0
87462,a,0,0
87463,placebo,0,0
87464,is,0,0
87465,not,0,0
87466,equivalent,0,0
87467,to,0,0
87468,treatment,0,0
87469,with,0,0
87470,oral,0,0
87471,amoxycillin,0,0
87472,.,0,0
87473,TRIAL,0,0
87474,REGISTRATION,0,0
87475,ClinicalTrials.gov,0,0
87476,NCT00407394,0,0
87477,.,0,0
87478,Immunoenhanced,0,0
87479,enteral,0,0
87480,nutrition,0,1
87481,formulas,0,0
87482,in,0,0
87483,head,0,0
87484,and,0,1
87485,neck,0,1
87486,cancer,0,0
87487,surgery,0,0
87488,:,0,0
87489,a,0,0
87490,prospective,0,0
87491,",",0,0
87492,randomized,0,0
87493,clinical,0,0
87494,trial,0,0
87495,.,0,0
87496,INTRODUCTION,0,1
87497,Significant,0,0
87498,malnutrition,0,0
87499,exists,0,0
87500,in,0,0
87501,a,0,0
87502,high,0,0
87503,percentage,0,1
87504,of,0,0
87505,patients,0,0
87506,with,0,0
87507,head,0,0
87508,and,0,1
87509,neck,0,1
87510,cancer,0,0
87511,.,0,0
87512,Malnutrition,0,0
87513,is,0,0
87514,associated,0,0
87515,with,0,0
87516,defects,0,0
87517,in,0,0
87518,immune,0,1
87519,function,0,1
87520,that,0,0
87521,may,0,0
87522,impair,0,0
87523,the,0,0
87524,host,0,0
87525,response,0,1
87526,to,0,0
87527,malignancy,0,1
87528,.,0,1
87529,Malnutrition,0,1
87530,and,0,0
87531,immunosupression,0,0
87532,make,0,0
87533,patients,0,0
87534,highly,0,0
87535,susceptible,0,0
87536,to,0,0
87537,postoperative,0,1
87538,infections,0,1
87539,and,0,0
87540,complications,0,1
87541,.,0,1
87542,OBJECTIVES,0,0
87543,Compare,0,0
87544,two,0,0
87545,immunoenhanced,0,0
87546,enteral,0,0
87547,nutritions,0,0
87548,with,0,0
87549,a,0,0
87550,control,0,0
87551,diet,0,0
87552,",",0,0
87553,and,0,1
87554,evaluate,0,0
87555,the,0,0
87556,effect,0,0
87557,in,0,0
87558,postoperative,1,1
87559,infections,1,1
87560,",",1,1
87561,length,1,1
87562,of,1,1
87563,stay,1,1
87564,and,1,1
87565,inflammatory,1,1
87566,markers,1,0
87567,.,1,0
87568,PATIENTS,0,0
87569,A,0,0
87570,population,0,0
87571,of,0,0
87572,44,0,0
87573,patients,0,0
87574,with,0,0
87575,oral,0,0
87576,and,0,1
87577,laryngeal,0,1
87578,cancer,0,1
87579,was,0,0
87580,enrolled,0,0
87581,in,0,0
87582,a,0,0
87583,randomized,0,0
87584,trial,0,0
87585,.,0,0
87586,At,0,0
87587,surgery,0,0
87588,",",0,1
87589,patients,0,0
87590,were,0,0
87591,randomly,0,0
87592,allocated,0,0
87593,to,0,0
87594,three,0,0
87595,groups,0,0
87596,:,0,0
87597,(,0,0
87598,group,0,0
87599,I,0,0
87600,),0,0
87601,;,0,0
87602,patients,0,0
87603,receiving,0,0
87604,an,0,0
87605,arginine-enhanced,0,0
87606,formula,0,0
87607,(,0,0
87608,group,0,0
87609,II,0,0
87610,),0,0
87611,;,0,0
87612,patients,0,0
87613,receiving,0,0
87614,a,0,0
87615,standard,0,0
87616,polymeric,0,0
87617,formula,0,0
87618,",",0,1
87619,and,0,1
87620,(,0,1
87621,group,0,0
87622,III,0,1
87623,),0,0
87624,patients,0,0
87625,receiving,0,0
87626,an,0,0
87627,arginine,0,0
87628,",",0,1
87629,RNA,0,1
87630,and,0,1
87631,omega-3,0,0
87632,fatty,0,1
87633,acids,0,1
87634,enhanced,0,1
87635,formula,0,0
87636,",",0,0
87637,in,0,0
87638,an,0,0
87639,isonitrogenous,0,0
87640,way,0,0
87641,.,0,0
87642,RESULTS,0,0
87643,The,0,0
87644,duration,1,1
87645,of,1,0
87646,enteral,1,0
87647,nutrition,1,0
87648,in,0,0
87649,the,0,0
87650,three,0,0
87651,groups,0,0
87652,was,0,0
87653,similar,0,0
87654,with,0,0
87655,an,0,0
87656,average,0,1
87657,duration,0,1
87658,of,0,0
87659,"14,5",0,0
87660,+/-,0,0
87661,8,0,0
87662,days,0,0
87663,.,0,0
87664,The,0,0
87665,length,1,1
87666,of,1,0
87667,postoperative,1,1
87668,stay,1,1
87669,was,0,0
87670,similar,0,0
87671,",",0,0
87672,with,0,0
87673,an,0,0
87674,average,0,0
87675,of,0,0
87676,"19,8",0,0
87677,+/-,0,0
87678,"8,5",0,0
87679,days,0,0
87680,.,0,0
87681,Wound,1,0
87682,infections,1,1
87683,and,1,1
87684,general,1,1
87685,infections,1,1
87686,were,0,0
87687,more,0,0
87688,frequent,0,1
87689,in,0,0
87690,the,0,0
87691,control,0,0
87692,group,0,0
87693,.,0,1
87694,Fistula,1,1
87695,rates,1,1
87696,were,0,0
87697,not,0,0
87698,improved,0,0
87699,in,0,0
87700,the,0,0
87701,enhanced,0,0
87702,diet,0,0
87703,groups,0,0
87704,.,0,0
87705,No,0,0
87706,significant,0,0
87707,intergroup,0,0
87708,differences,0,0
87709,in,0,0
87710,the,0,0
87711,trend,0,0
87712,of,0,0
87713,the,0,0
87714,two,1,0
87715,plasma,1,1
87716,proteins,1,0
87717,(,1,1
87718,albumin,1,1
87719,",",1,1
87720,transferrin,1,1
87721,),1,0
87722,",",1,0
87723,lymphocytes,1,1
87724,",",1,1
87725,weight,1,1
87726,",",1,1
87727,IL-6,1,1
87728,",",1,1
87729,CPR,1,1
87730,and,1,1
87731,TNFalpha,1,1
87732,were,0,0
87733,detected,0,0
87734,.,0,0
87735,The,0,0
87736,control,0,0
87737,group,0,0
87738,showed,0,0
87739,the,0,0
87740,highest,0,1
87741,levels,0,1
87742,of,0,0
87743,TNFalpha,1,0
87744,at,0,0
87745,the,0,0
87746,fourteenth,0,0
87747,postoperative,0,1
87748,day,0,0
87749,.,0,1
87750,Gastrointestinal,1,1
87751,tolerance,1,1
87752,and,1,1
87753,diarrhoea,1,1
87754,rate,1,1
87755,were,0,0
87756,similar,0,0
87757,in,0,0
87758,all,0,0
87759,the,0,0
87760,patients,0,0
87761,.,0,0
87762,CONCLUSIONS,0,0
87763,Immunoenhanced,0,0
87764,enteral,0,0
87765,nutrition,0,1
87766,formulas,0,0
87767,improved,0,0
87768,the,0,0
87769,infection,1,1
87770,rate,1,1
87771,in,0,0
87772,the,0,0
87773,postoperative,0,1
87774,of,0,1
87775,head,0,0
87776,and,0,1
87777,neck,0,1
87778,cancer,0,0
87779,patients,0,0
87780,.,0,0
87781,In,0,0
87782,the,0,0
87783,fistula,1,1
87784,rates,1,1
87785,",",0,0
87786,we,0,0
87787,observed,0,0
87788,that,0,0
87789,technical,0,1
87790,problems,0,1
87791,and,0,1
87792,nutritional,0,1
87793,status,0,1
87794,might,0,0
87795,have,0,0
87796,played,0,0
87797,an,0,0
87798,equally,0,0
87799,important,0,0
87800,role,0,0
87801,",",0,1
87802,and,0,0
87803,therefore,0,0
87804,the,0,0
87805,positive,0,1
87806,effect,0,1
87807,of,0,1
87808,immunonutrition,0,0
87809,in,0,0
87810,this,0,0
87811,parameter,0,0
87812,might,0,0
87813,have,0,0
87814,been,0,0
87815,overestimated,0,0
87816,.,0,0
87817,Randomized,0,0
87818,clinical,0,1
87819,study,0,0
87820,comparing,0,0
87821,Compeed,0,1
87822,cold,0,1
87823,sore,0,1
87824,patch,0,0
87825,to,0,0
87826,acyclovir,0,0
87827,cream,0,0
87828,5,0,0
87829,%,0,0
87830,in,0,0
87831,the,0,0
87832,treatment,0,0
87833,of,0,0
87834,herpes,0,1
87835,simplex,0,0
87836,labialis,0,0
87837,.,0,0
87838,BACKGROUND,0,0
87839,Hydrocolloid,0,0
87840,technology,0,0
87841,has,0,0
87842,been,0,0
87843,proven,0,0
87844,effective,0,0
87845,in,0,0
87846,treating,0,0
87847,dermal,0,1
87848,wounds,0,0
87849,.,0,0
87850,A,0,0
87851,previous,0,0
87852,study,0,0
87853,showed,0,0
87854,that,0,0
87855,a,0,0
87856,newly,0,0
87857,developed,0,0
87858,thin,0,0
87859,hydrocolloid,0,0
87860,patch,0,0
87861,[,0,1
87862,Compeed,0,1
87863,cold,0,1
87864,sore,0,1
87865,patch,0,0
87866,(,0,1
87867,CSP,0,1
87868,),0,1
87869,],0,0
87870,provided,0,0
87871,multiple,0,0
87872,wound-healing,0,1
87873,benefits,0,0
87874,across,0,0
87875,all,0,0
87876,stages,0,0
87877,of,0,0
87878,a,0,0
87879,herpes,0,1
87880,simplex,0,0
87881,labialis,0,0
87882,(,0,1
87883,HSL,0,1
87884,),0,0
87885,outbreak,0,1
87886,.,0,0
87887,METHODS,0,0
87888,An,0,0
87889,assessment,0,0
87890,of,0,0
87891,CSP,0,1
87892,efficacy,0,1
87893,and,0,1
87894,safety,0,1
87895,was,0,0
87896,conducted,0,0
87897,in,0,0
87898,an,0,0
87899,international,0,0
87900,",",0,0
87901,multicentre,0,0
87902,",",0,1
87903,assessor-blinded,0,0
87904,study,0,0
87905,",",0,1
87906,which,0,0
87907,enrolled,0,0
87908,728,0,0
87909,subjects,0,0
87910,with,0,0
87911,a,0,0
87912,history,0,1
87913,of,0,0
87914,recurrent,0,0
87915,HSL,0,0
87916,.,0,0
87917,Of,0,0
87918,these,0,0
87919,",",0,0
87920,351,0,0
87921,experienced,0,0
87922,an,0,0
87923,HSL,0,1
87924,outbreak,0,1
87925,and,0,1
87926,were,0,0
87927,randomized,0,0
87928,to,0,0
87929,use,0,0
87930,CSP,0,0
87931,(,0,0
87932,n,0,0
87933,=,0,0
87934,179,0,0
87935,),0,0
87936,or,0,0
87937,acyclovir,0,0
87938,cream,0,0
87939,5,0,0
87940,%,0,0
87941,(,0,0
87942,n,0,0
87943,=,0,0
87944,172,0,0
87945,),0,0
87946,at,0,0
87947,the,0,0
87948,onset,0,1
87949,of,0,0
87950,symptoms,0,1
87951,until,0,0
87952,the,0,0
87953,lesion,0,1
87954,healed,0,1
87955,",",0,0
87956,for,0,0
87957,a,0,0
87958,maximum,0,0
87959,of,0,0
87960,10,0,0
87961,days,0,0
87962,.,0,0
87963,The,0,0
87964,primary,0,0
87965,end,0,0
87966,point,0,0
87967,was,0,0
87968,the,0,0
87969,subject,1,0
87970,'s,1,1
87971,global,1,1
87972,assessment,1,0
87973,of,1,1
87974,therapy,1,0
87975,(,1,0
87976,SGAT,1,1
87977,;,1,1
87978,0-10,1,0
87979,scale,1,1
87980,;,1,0
87981,0,1,0
87982,=,1,0
87983,no,1,0
87984,response,1,1
87985,",",1,0
87986,10,1,0
87987,=,1,0
87988,excellent,1,0
87989,response,1,1
87990,),1,0
87991,.,1,0
87992,Multiple,0,1
87993,secondary,0,1
87994,end,0,0
87995,points,0,0
87996,included,0,0
87997,clinician-assessed,1,1
87998,healing,1,1
87999,time,1,1
88000,and,1,1
88001,subject,1,0
88002,assessment,1,1
88003,of,1,1
88004,lesion,1,1
88005,protection,1,1
88006,",",1,1
88007,noticeability,1,1
88008,and,1,1
88009,social,1,1
88010,embarrassment,1,1
88011,.,1,0
88012,RESULTS,0,0
88013,CSP,0,1
88014,and,0,1
88015,acyclovir,0,0
88016,were,0,0
88017,highly,0,0
88018,effective,0,1
88019,(,0,0
88020,mean,0,1
88021,SGAT,0,1
88022,=,0,0
88023,7.89,0,0
88024,and,0,0
88025,8.00,0,0
88026,",",0,0
88027,respectively,0,0
88028,),0,0
88029,",",0,0
88030,with,0,0
88031,no,0,0
88032,significant,0,0
88033,difference,0,1
88034,observed,0,0
88035,(,0,0
88036,P,0,0
88037,=,0,0
88038,0.65,0,0
88039,),0,0
88040,.,0,0
88041,The,0,0
88042,difference,0,0
88043,in,0,0
88044,healing,1,1
88045,times,1,1
88046,between,1,0
88047,products,1,1
88048,was,0,0
88049,not,0,0
88050,significant,0,0
88051,(,0,0
88052,median,0,1
88053,",",0,0
88054,7.57,0,0
88055,days,0,0
88056,with,0,0
88057,CSP,0,0
88058,vs.,0,0
88059,7.03,0,0
88060,days,0,0
88061,with,0,0
88062,acyclovir,0,0
88063,",",0,1
88064,P,0,0
88065,=,0,0
88066,0.37,0,0
88067,),0,0
88068,.,0,0
88069,Both,0,0
88070,treatments,0,0
88071,were,0,0
88072,well,0,0
88073,tolerated,1,1
88074,.,1,0
88075,CONCLUSION,0,0
88076,CSP,0,0
88077,using,0,0
88078,hydrocolloid,0,0
88079,technology,0,0
88080,provides,0,0
88081,an,0,0
88082,efficacious,1,0
88083,and,1,1
88084,safe,1,1
88085,alternative,0,0
88086,to,0,0
88087,topical,0,0
88088,antivirals,0,0
88089,in,0,0
88090,treating,0,0
88091,HSL,0,0
88092,as,0,0
88093,a,0,0
88094,wound,0,0
88095,while,0,0
88096,affording,0,0
88097,additional,0,0
88098,immediate,0,1
88099,benefits,0,0
88100,of,0,1
88101,wound,0,1
88102,protection,0,1
88103,",",0,1
88104,discretion,0,1
88105,and,0,1
88106,relief,0,1
88107,of,0,1
88108,social,0,1
88109,embarrassment,0,1
88110,.,0,0
88111,Effect,0,1
88112,of,0,0
88113,esomeprazole,0,0
88114,triple,0,0
88115,therapy,0,0
88116,on,0,0
88117,eradication,1,1
88118,rates,1,1
88119,of,1,1
88120,Helicobacter,1,1
88121,pylori,1,1
88122,",",1,1
88123,gastric,1,1
88124,ulcer,1,1
88125,healing,1,1
88126,and,1,1
88127,prevention,1,0
88128,of,1,1
88129,relapse,1,1
88130,in,0,0
88131,gastric,0,1
88132,ulcer,0,1
88133,patients,0,0
88134,.,0,0
88135,OBJECTIVES,0,0
88136,To,0,0
88137,compare,0,0
88138,esomeprazole-based,0,0
88139,triple,0,0
88140,therapy,0,0
88141,with,0,0
88142,esomeprazole,0,0
88143,alone,0,0
88144,for,0,0
88145,the,0,0
88146,eradication,1,1
88147,of,1,0
88148,Helicobacter,1,1
88149,pylori,1,1
88150,(,1,0
88151,H.,1,1
88152,pylori,1,1
88153,),1,1
88154,",",1,0
88155,healing,1,1
88156,of,1,1
88157,ulcer,1,1
88158,and,1,1
88159,prevention,1,0
88160,of,1,1
88161,relapse,1,1
88162,in,0,0
88163,H.,0,0
88164,pylori-related,0,0
88165,gastric,0,1
88166,ulcer,0,1
88167,(,0,1
88168,GU,0,1
88169,),0,0
88170,diseases,0,0
88171,.,0,0
88172,METHODS,0,0
88173,In,0,0
88174,this,0,0
88175,double-blind,0,0
88176,study,0,0
88177,",",0,0
88178,401,0,0
88179,H.,0,0
88180,pylori-positive,0,0
88181,patients,0,0
88182,with,0,0
88183,more,0,0
88184,than,0,0
88185,or,0,0
88186,equal,0,0
88187,to,0,0
88188,two,0,0
88189,GUs,0,1
88190,were,0,0
88191,randomized,0,0
88192,to,0,0
88193,:,0,0
88194,esomeprazole,0,0
88195,(,0,0
88196,20,0,0
88197,mg,0,0
88198,),0,0
88199,twice,0,0
88200,daily,0,0
88201,(,0,0
88202,bid,0,1
88203,),0,1
88204,and,0,1
88205,amoxicillin,0,0
88206,(,0,0
88207,1000,0,0
88208,mg,0,0
88209,),0,0
88210,bid,0,1
88211,and,0,1
88212,clarithromycin,0,0
88213,(,0,0
88214,500,0,0
88215,mg,0,0
88216,),0,0
88217,bid,0,1
88218,(,0,1
88219,EAC,0,1
88220,),0,0
88221,for,0,0
88222,1,0,0
88223,week,0,0
88224,",",0,0
88225,followed,0,0
88226,by,0,0
88227,placebo,0,0
88228,for,0,0
88229,3,0,0
88230,weeks,0,0
88231,(,0,0
88232,EAC,0,1
88233,and,0,1
88234,placebo,0,0
88235,),0,0
88236,;,0,0
88237,EAC,0,0
88238,for,0,0
88239,1,0,0
88240,week,0,0
88241,",",0,0
88242,followed,0,0
88243,by,0,0
88244,esomeprazole,0,0
88245,(,0,0
88246,20,0,0
88247,mg,0,0
88248,),0,0
88249,once,0,0
88250,daily,0,0
88251,(,0,0
88252,E20,0,0
88253,),0,0
88254,for,0,0
88255,3,0,0
88256,weeks,0,0
88257,(,0,0
88258,EAC,0,1
88259,and,0,1
88260,E20,0,0
88261,),0,0
88262,;,0,0
88263,or,0,0
88264,esomeprazole,0,0
88265,(,0,0
88266,20,0,0
88267,mg,0,0
88268,),0,0
88269,bid,0,1
88270,and,0,1
88271,placebo,0,0
88272,antimicrobials,0,1
88273,for,0,0
88274,1,0,0
88275,week,0,0
88276,",",0,0
88277,followed,0,0
88278,by,0,0
88279,E20,0,0
88280,for,0,0
88281,3,0,0
88282,weeks,0,0
88283,(,0,0
88284,E20,0,1
88285,bid,0,1
88286,and,0,1
88287,E20,0,0
88288,),0,0
88289,.,0,0
88290,Patients,0,0
88291,with,0,0
88292,unhealed,0,1
88293,GUs,0,1
88294,at,0,0
88295,4,0,0
88296,weeks,0,0
88297,received,0,0
88298,E20,0,0
88299,for,0,0
88300,an,0,0
88301,additional,0,0
88302,4,0,0
88303,weeks,0,0
88304,.,0,0
88305,Healed,0,0
88306,patients,0,0
88307,were,0,0
88308,followed,0,0
88309,up,0,0
88310,for,0,0
88311,12,0,0
88312,months,0,0
88313,.,0,0
88314,RESULTS,0,0
88315,Eradication,1,1
88316,rates,1,1
88317,at,0,0
88318,4,0,0
88319,weeks,0,0
88320,or,0,0
88321,8,0,0
88322,weeks,0,0
88323,were,0,0
88324,82,0,0
88325,%,0,0
88326,for,0,0
88327,EAC,0,1
88328,and,0,1
88329,E20,0,0
88330,",",0,0
88331,77,0,0
88332,%,0,0
88333,for,0,0
88334,EAC,0,1
88335,and,0,1
88336,placebo,0,0
88337,and,0,0
88338,9.5,0,0
88339,%,0,0
88340,for,0,0
88341,E20,0,1
88342,bid,0,1
88343,and,0,1
88344,E20,0,1
88345,(,0,1
88346,intention-to-treat,0,0
88347,analysis,0,0
88348,),0,0
88349,.,0,0
88350,Significantly,0,0
88351,more,0,0
88352,patients,0,0
88353,receiving,0,0
88354,EAC,0,0
88355,than,0,0
88356,those,0,0
88357,receiving,0,0
88358,esomeprazole,0,0
88359,alone,0,0
88360,remained,1,0
88361,free,1,1
88362,of,1,0
88363,GUs,1,1
88364,during,0,0
88365,follow-up,0,0
88366,[,0,0
88367,EAC,0,1
88368,and,0,1
88369,E20,0,0
88370,",",0,0
88371,90,0,0
88372,%,0,0
88373,;,0,0
88374,EAC,0,1
88375,and,0,1
88376,placebo,0,0
88377,",",0,0
88378,87,0,0
88379,%,0,0
88380,;,0,0
88381,P=0.0005,0,0
88382,for,0,0
88383,combined,0,0
88384,group,0,0
88385,vs.,0,0
88386,esomeprazole,0,0
88387,alone,0,0
88388,[,0,0
88389,E20,0,1
88390,bid,0,1
88391,and,0,1
88392,E20,0,1
88393,(,0,0
88394,74,0,0
88395,%,0,0
88396,),0,0
88397,],0,0
88398,.,0,0
88399,All,0,0
88400,treatments,0,0
88401,were,0,0
88402,well,0,0
88403,tolerated,1,1
88404,.,1,0
88405,CONCLUSION,0,0
88406,Esomeprazole-based,0,0
88407,triple,0,0
88408,therapy,0,0
88409,is,0,0
88410,effective,1,1
88411,for,0,0
88412,the,0,0
88413,eradication,1,1
88414,of,1,0
88415,H.,1,1
88416,pylori,1,1
88417,",",1,1
88418,healing,1,1
88419,of,1,1
88420,GU,1,1
88421,and,1,1
88422,prevention,1,0
88423,of,1,1
88424,relapse,1,1
88425,.,1,1
88426,Esomeprazole,0,0
88427,monotherapy,0,0
88428,for,0,0
88429,3,0,0
88430,weeks,0,0
88431,after,0,0
88432,triple,0,0
88433,therapy,0,0
88434,may,0,0
88435,be,0,0
88436,beneficial,1,0
88437,in,0,0
88438,terms,0,1
88439,of,0,0
88440,healing,0,1
88441,.,0,0
88442,Atypical,0,0
88443,recruitment,0,0
88444,of,0,1
88445,medial,0,1
88446,prefrontal,0,1
88447,cortex,0,1
88448,in,0,0
88449,autism,0,0
88450,spectrum,0,0
88451,disorders,0,0
88452,:,0,0
88453,an,0,0
88454,fMRI,0,1
88455,study,0,0
88456,of,0,0
88457,two,0,0
88458,executive,0,0
88459,function,0,1
88460,tasks,0,1
88461,.,0,0
88462,Recent,0,0
88463,studies,0,0
88464,have,0,0
88465,suggested,0,0
88466,an,0,0
88467,uneven,0,0
88468,profile,0,1
88469,of,0,1
88470,executive,0,1
88471,dysfunction,0,1
88472,in,0,0
88473,autism,0,0
88474,spectrum,0,0
88475,disorders,0,1
88476,(,0,1
88477,ASD,0,0
88478,),0,0
88479,.,0,0
88480,For,0,0
88481,example,0,0
88482,",",0,0
88483,some,0,0
88484,authors,0,0
88485,have,0,0
88486,reported,0,0
88487,deficits,0,0
88488,on,0,0
88489,newly,0,0
88490,developed,0,0
88491,tests,0,1
88492,of,0,0
88493,executive,0,1
88494,function,0,1
88495,sensitive,0,0
88496,to,0,0
88497,rostral,0,0
88498,prefrontal,0,1
88499,function,0,1
88500,",",0,0
88501,despite,0,0
88502,spared,0,0
88503,",",0,0
88504,or,0,0
88505,even,0,0
88506,superior,0,1
88507,",",0,0
88508,performance,0,1
88509,on,0,0
88510,other,0,0
88511,tests,0,0
88512,.,0,0
88513,We,0,0
88514,investigated,0,0
88515,the,0,0
88516,performance,0,1
88517,of,0,0
88518,a,0,0
88519,group,0,0
88520,of,0,0
88521,high-functioning,0,0
88522,participants,0,0
88523,with,0,0
88524,ASD,0,0
88525,(,0,0
88526,N=15,0,0
88527,),0,0
88528,and,0,0
88529,an,0,0
88530,age-,0,0
88531,and,0,1
88532,IQ-matched,0,0
88533,control,0,0
88534,group,0,0
88535,(,0,1
88536,N=18,0,0
88537,),0,0
88538,on,0,0
88539,two,0,0
88540,executive,0,0
88541,function,0,1
88542,tests,0,1
88543,",",0,0
88544,whilst,0,0
88545,undergoing,0,0
88546,functional,0,1
88547,magnetic,0,0
88548,resonance,0,0
88549,imaging,0,1
88550,(,0,1
88551,fMRI,0,1
88552,),0,0
88553,.,0,1
88554,Behaviourally,0,0
88555,",",0,0
88556,there,0,0
88557,were,0,0
88558,no,0,0
88559,significant,0,0
88560,differences,0,0
88561,between,0,0
88562,the,0,0
88563,two,0,0
88564,groups,0,0
88565,.,0,0
88566,In,0,0
88567,a,0,0
88568,classical,0,0
88569,test,0,1
88570,of,0,1
88571,executive,0,1
88572,function,0,1
88573,(,0,1
88574,random,0,0
88575,response,0,1
88576,generation,0,1
88577,),0,1
88578,",",0,0
88579,BOLD,1,0
88580,signal,1,1
88581,differed,0,0
88582,between,0,0
88583,the,0,0
88584,groups,0,0
88585,in,0,0
88586,the,0,0
88587,cerebellum,0,1
88588,but,0,0
88589,not,0,0
88590,in,0,0
88591,the,0,0
88592,frontal,0,1
88593,lobes,0,1
88594,.,0,0
88595,However,0,0
88596,",",0,0
88597,on,0,0
88598,a,0,0
88599,new,0,0
88600,test,0,1
88601,of,0,1
88602,executive,0,1
88603,function,0,1
88604,(,0,1
88605,selection,0,1
88606,between,0,0
88607,stimulus-oriented,0,1
88608,and,0,1
88609,stimulus-independent,0,1
88610,thought,0,0
88611,),0,0
88612,",",0,0
88613,the,0,0
88614,ASD,0,0
88615,group,0,0
88616,exhibited,0,0
88617,significantly,0,0
88618,greater,0,0
88619,signal-change,1,1
88620,in,1,0
88621,medial,1,1
88622,rostral,1,1
88623,prefrontal,1,1
88624,cortex,1,1
88625,(,1,0
88626,especially,1,0
88627,Brodmann,1,1
88628,Area,1,0
88629,10,1,0
88630,),1,0
88631,in,0,0
88632,the,0,0
88633,comparison,0,0
88634,of,0,0
88635,stimulus-oriented,0,1
88636,versus,0,0
88637,stimulus-independent,0,1
88638,attention,0,1
88639,.,0,0
88640,In,0,0
88641,addition,0,0
88642,",",0,0
88643,the,0,0
88644,new,0,1
88645,test,0,1
88646,(,0,1
88647,but,0,0
88648,not,0,0
88649,the,0,0
88650,classical,0,0
88651,test,0,1
88652,),0,1
88653,provided,0,0
88654,evidence,0,0
88655,for,0,0
88656,abnormal,1,1
88657,functional,1,1
88658,organisation,1,0
88659,of,1,1
88660,medial,1,1
88661,prefrontal,1,1
88662,cortex,1,1
88663,in,1,0
88664,ASD,1,0
88665,.,1,0
88666,These,0,0
88667,results,0,0
88668,underline,0,0
88669,the,0,0
88670,heterogeneity,0,0
88671,of,0,0
88672,different,0,0
88673,tests,0,1
88674,of,0,1
88675,executive,0,1
88676,function,0,1
88677,",",0,0
88678,and,0,0
88679,suggest,0,0
88680,that,0,0
88681,executive,0,1
88682,functioning,0,1
88683,in,0,0
88684,ASD,0,0
88685,is,0,0
88686,associated,0,0
88687,with,0,0
88688,task-specific,0,1
88689,functional,0,1
88690,change,0,1
88691,.,0,0
88692,Comparative,0,0
88693,bioavailability,0,1
88694,study,0,0
88695,with,0,0
88696,two,0,0
88697,pantoprazole,0,0
88698,delayed-released,0,0
88699,tablet,0,0
88700,formulations,0,0
88701,administered,0,0
88702,with,0,0
88703,and,0,0
88704,without,0,0
88705,food,0,0
88706,in,0,0
88707,healthy,0,0
88708,subjects,0,0
88709,.,0,0
88710,OBJECTIVE,0,0
88711,To,0,0
88712,assess,0,0
88713,the,0,0
88714,comparative,1,0
88715,bioavailability,1,1
88716,of,0,0
88717,two,0,0
88718,formulations,0,0
88719,(,0,0
88720,40,0,0
88721,mg,0,0
88722,delayed-released,0,0
88723,[,0,0
88724,DR,0,0
88725,],0,0
88726,tablet,0,0
88727,;,0,1
88728,test,0,1
88729,and,0,1
88730,reference,0,1
88731,),0,1
88732,of,0,1
88733,pantoprazole,0,0
88734,(,0,0
88735,CAS,0,0
88736,102625-70-7,0,0
88737,),0,0
88738,in,0,0
88739,healthy,0,0
88740,volunteers,0,0
88741,of,0,0
88742,both,0,0
88743,sexes,0,0
88744,",",0,0
88745,with,0,0
88746,and,0,1
88747,without,0,0
88748,food,0,0
88749,.,0,0
88750,METHODS,0,0
88751,The,0,0
88752,study,0,0
88753,was,0,0
88754,conducted,0,0
88755,using,0,0
88756,an,0,0
88757,open,0,0
88758,",",0,0
88759,randomized,0,0
88760,",",0,0
88761,two-period,0,0
88762,crossover,0,0
88763,design,0,0
88764,with,0,0
88765,a,0,0
88766,1-week,0,0
88767,washout,0,0
88768,interval,0,0
88769,",",0,0
88770,in,0,0
88771,two,0,0
88772,groups,0,0
88773,",",0,0
88774,with,0,0
88775,and,0,1
88776,without,0,0
88777,food,0,0
88778,.,0,0
88779,Plasma,0,1
88780,samples,0,0
88781,were,0,0
88782,obtained,0,0
88783,for,0,0
88784,up,0,0
88785,to,0,0
88786,24,0,0
88787,h,0,0
88788,post,0,0
88789,dose,0,0
88790,.,0,1
88791,Plasma,0,1
88792,pantoprazole,0,0
88793,concentrations,0,1
88794,were,0,0
88795,analyzed,0,0
88796,by,0,0
88797,liquid,0,0
88798,chromatography,0,0
88799,coupled,0,0
88800,to,0,0
88801,tandem,0,0
88802,mass,0,1
88803,spectrometry,0,0
88804,(,0,1
88805,LC-MS-MS,0,1
88806,),0,0
88807,with,0,0
88808,positive,0,1
88809,ion,0,1
88810,electrospray,0,0
88811,ionization,0,0
88812,using,0,0
88813,multiple,0,0
88814,reactions,0,1
88815,monitoring,0,0
88816,(,0,1
88817,MRM,0,1
88818,),0,0
88819,.,0,0
88820,From,0,0
88821,the,0,0
88822,pantoprazole,0,0
88823,plasma,0,1
88824,concentration,0,1
88825,vs.,0,0
88826,time,0,1
88827,curves,0,1
88828,",",0,0
88829,the,0,0
88830,pharmacokinetic,0,1
88831,parameters,0,1
88832,AUC,0,1
88833,(,0,0
88834,last,0,1
88835,),0,1
88836,and,0,1
88837,C,0,1
88838,(,0,1
88839,max,0,1
88840,),0,1
88841,were,0,0
88842,obtained,0,0
88843,",",0,0
88844,with,0,0
88845,and,0,1
88846,without,0,0
88847,food,0,0
88848,.,0,0
88849,RESULTS,0,0
88850,The,0,0
88851,limit,1,0
88852,of,1,1
88853,quantification,1,0
88854,was,0,0
88855,5,0,0
88856,ng/mL,0,0
88857,for,0,0
88858,plasma,0,1
88859,pantoprazole,0,0
88860,analysis,0,0
88861,.,0,0
88862,The,0,0
88863,geometric,1,1
88864,mean,1,1
88865,and,1,0
88866,90,1,0
88867,%,1,0
88868,confidence,1,0
88869,interval,1,0
88870,CI,1,0
88871,of,1,1
88872,test/reference,1,1
88873,percent,1,1
88874,ratios,1,1
88875,were,0,0
88876,",",0,0
88877,without,0,0
88878,and,0,1
88879,with,0,0
88880,food,0,0
88881,",",0,0
88882,respectively,0,0
88883,:,0,0
88884,104.6540,0,0
88885,%,0,0
88886,(,0,0
88887,90.8616,0,0
88888,%,0,0
88889,-120.5401,0,0
88890,%,0,0
88891,),0,0
88892,and,0,0
88893,99.9708,0,0
88894,%,0,0
88895,(,0,0
88896,90.9987,0,0
88897,%,0,0
88898,-109.8275,0,0
88899,%,0,0
88900,),0,0
88901,for,0,0
88902,C,1,0
88903,(,1,1
88904,max,1,1
88905,),1,0
88906,",",0,0
88907,95.6634,0,0
88908,%,0,0
88909,(,0,0
88910,85.2675,0,0
88911,%,0,0
88912,-107.3267,0,0
88913,%,0,0
88914,),0,0
88915,and,0,0
88916,89.3500,0,0
88917,%,0,0
88918,(,0,0
88919,83.6630,0,0
88920,%,0,0
88921,-95.4237,0,0
88922,%,0,0
88923,),0,0
88924,for,0,0
88925,AUC,0,0
88926,(,0,0
88927,last,0,0
88928,),0,0
88929,.,0,0
88930,CONCLUSION,0,0
88931,Since,0,0
88932,the,0,0
88933,90,0,0
88934,%,0,0
88935,CI,0,0
88936,for,0,0
88937,AUC,1,0
88938,(,1,0
88939,last,1,1
88940,),1,1
88941,and,0,1
88942,C,1,1
88943,(,1,1
88944,max,1,1
88945,),1,1
88946,ratios,1,1
88947,were,0,0
88948,within,0,0
88949,the,0,0
88950,80-125,0,0
88951,%,0,0
88952,interval,0,0
88953,proposed,0,0
88954,by,0,0
88955,the,0,0
88956,US,0,1
88957,FDA,0,0
88958,",",0,0
88959,it,0,0
88960,was,0,0
88961,concluded,0,0
88962,that,0,0
88963,pantoprazole,0,0
88964,40,0,0
88965,mg,0,0
88966,DR,0,0
88967,tablet,0,0
88968,(,0,0
88969,test,0,1
88970,formulation,0,0
88971,),0,0
88972,with,0,0
88973,and,0,0
88974,without,0,0
88975,food,0,1
88976,was,0,0
88977,bioequivalent,0,0
88978,to,0,0
88979,the,0,0
88980,reference,0,0
88981,40,0,0
88982,mg,0,0
88983,DR,0,0
88984,tablet,0,0
88985,for,0,0
88986,both,0,0
88987,the,0,0
88988,rate,0,1
88989,and,0,1
88990,extent,0,1
88991,of,0,1
88992,absorption,0,1
88993,.,0,0
88994,Gene,0,0
88995,expression,0,1
88996,is,0,0
88997,altered,0,0
88998,in,0,0
88999,piglet,0,0
89000,small,0,0
89001,intestine,0,0
89002,by,0,0
89003,weaning,0,0
89004,and,0,1
89005,dietary,0,1
89006,glutamine,0,0
89007,supplementation,0,0
89008,.,0,1
89009,Dietary,0,0
89010,supplementation,0,0
89011,of,0,1
89012,glutamine,0,0
89013,prevents,0,0
89014,intestinal,0,1
89015,dysfunction,0,1
89016,and,0,1
89017,atrophy,0,1
89018,in,0,0
89019,weanling,0,0
89020,piglets,0,0
89021,",",0,0
89022,but,0,0
89023,the,0,0
89024,underlying,0,0
89025,mechanism,0,0
89026,(,0,1
89027,s,0,0
89028,),0,0
89029,are,0,0
89030,largely,0,0
89031,unknown,0,0
89032,.,0,0
89033,This,0,0
89034,study,0,0
89035,was,0,0
89036,conducted,0,0
89037,to,0,0
89038,test,0,0
89039,the,0,0
89040,hypothesis,0,0
89041,that,0,0
89042,weaning,0,0
89043,or,0,0
89044,glutamine,0,0
89045,may,0,0
89046,modulate,0,0
89047,expression,0,1
89048,of,0,0
89049,genes,0,1
89050,that,0,0
89051,are,0,0
89052,crucial,0,0
89053,for,0,0
89054,intestinal,0,1
89055,metabolism,0,1
89056,and,0,1
89057,function,0,1
89058,.,0,1
89059,In,0,0
89060,Expt,0,0
89061,.,0,0
89062,1,0,0
89063,",",0,0
89064,we,0,0
89065,obtained,0,0
89066,small,0,0
89067,intestine,0,0
89068,from,0,0
89069,28-d-old,0,0
89070,pigs,0,0
89071,weaned,0,0
89072,at,0,0
89073,21,0,0
89074,d,0,0
89075,of,0,0
89076,age,0,0
89077,and,0,1
89078,from,0,0
89079,age-matched,0,0
89080,suckling,0,1
89081,piglets,0,0
89082,.,0,0
89083,In,0,0
89084,Expt,0,0
89085,.,0,0
89086,2,0,0
89087,",",0,0
89088,piglets,0,0
89089,were,0,0
89090,weaned,0,0
89091,at,0,0
89092,21,0,0
89093,d,0,0
89094,of,0,0
89095,age,0,0
89096,and,0,1
89097,then,0,0
89098,had,0,0
89099,free,0,1
89100,access,0,1
89101,to,0,0
89102,diets,0,0
89103,supplemented,0,0
89104,with,0,0
89105,1,0,0
89106,%,0,0
89107,L-glutamine,0,0
89108,(,0,0
89109,wt,0,0
89110,:,0,1
89111,wt,0,0
89112,),0,1
89113,or,0,0
89114,isonitrogenous,0,0
89115,L-alanine,0,1
89116,(,0,0
89117,control,0,0
89118,),0,0
89119,.,0,0
89120,At,0,0
89121,d,0,0
89122,28,0,0
89123,",",0,0
89124,we,0,0
89125,collected,0,0
89126,small,0,0
89127,intestine,0,0
89128,for,0,0
89129,biochemical,0,1
89130,and,0,1
89131,morphological,0,1
89132,measurements,0,1
89133,and,0,1
89134,microarray,0,0
89135,analysis,0,0
89136,of,0,1
89137,gene,1,1
89138,expression,1,1
89139,using,0,0
89140,the,0,0
89141,Operon,0,0
89142,Porcine,0,0
89143,Genome,0,1
89144,Oligo,0,0
89145,set,0,0
89146,.,0,1
89147,Early,0,1
89148,weaning,0,0
89149,resulted,0,0
89150,in,0,0
89151,increased,0,0
89152,(,0,0
89153,52-346,0,0
89154,%,0,0
89155,),0,0
89156,expression,1,1
89157,of,1,0
89158,genes,1,1
89159,related,1,0
89160,to,1,0
89161,oxidative,1,1
89162,stress,1,1
89163,and,1,1
89164,immune,1,1
89165,activation,1,1
89166,but,0,0
89167,decreased,0,1
89168,(,0,0
89169,35-77,0,0
89170,%,0,0
89171,),0,0
89172,expression,1,1
89173,of,1,0
89174,genes,1,1
89175,related,1,0
89176,to,1,0
89177,macronutrient,1,0
89178,metabolism,1,1
89179,and,0,1
89180,cell,1,1
89181,proliferation,1,1
89182,in,1,0
89183,the,1,0
89184,gut,1,0
89185,.,1,0
89186,Dietary,0,1
89187,glutamine,0,1
89188,supplementation,0,0
89189,increased,0,1
89190,intestinal,1,1
89191,expression,1,1
89192,(,1,0
89193,120-124,1,0
89194,%,1,0
89195,),1,0
89196,of,1,0
89197,genes,1,1
89198,that,0,0
89199,are,0,0
89200,necessary,0,0
89201,for,0,0
89202,cell,0,1
89203,growth,0,1
89204,and,0,1
89205,removal,1,1
89206,of,1,1
89207,oxidants,1,1
89208,",",0,0
89209,while,0,0
89210,reducing,0,0
89211,(,0,0
89212,34-75,0,0
89213,%,0,0
89214,),0,0
89215,expression,1,1
89216,of,1,0
89217,genes,1,1
89218,that,0,0
89219,promote,0,0
89220,oxidative,1,1
89221,stress,1,1
89222,and,1,1
89223,immune,1,1
89224,activation,1,1
89225,.,1,0
89226,Functionally,0,0
89227,",",0,0
89228,the,0,0
89229,glutamine,0,1
89230,treatment,0,0
89231,enhanced,0,1
89232,intestinal,1,1
89233,oxidative-defense,1,1
89234,capacity,1,1
89235,(,0,0
89236,indicated,0,0
89237,by,0,0
89238,a,0,0
89239,29,0,0
89240,%,0,0
89241,increase,0,0
89242,in,0,0
89243,glutathione,0,1
89244,concentration,0,1
89245,),0,1
89246,",",0,0
89247,prevented,0,0
89248,jejunal,1,1
89249,atrophy,1,1
89250,",",0,1
89251,and,0,1
89252,promoted,0,0
89253,small,1,0
89254,intestine,1,1
89255,growth,1,1
89256,(,0,0
89257,+12,0,0
89258,%,0,0
89259,),0,0
89260,and,0,1
89261,body,1,1
89262,weight,1,1
89263,gain,1,1
89264,(,0,0
89265,+19,0,0
89266,%,0,0
89267,),0,0
89268,in,0,0
89269,weaned,0,0
89270,piglets,0,0
89271,.,0,0
89272,These,0,0
89273,findings,0,0
89274,reveal,0,0
89275,coordinate,0,0
89276,alterations,0,1
89277,of,0,1
89278,gene,0,1
89279,expression,0,1
89280,in,0,0
89281,response,0,1
89282,to,0,0
89283,weaning,0,0
89284,and,0,1
89285,aid,0,0
89286,in,0,0
89287,providing,0,0
89288,molecular,0,0
89289,mechanisms,0,0
89290,for,0,0
89291,the,0,0
89292,beneficial,0,0
89293,effect,0,0
89294,of,0,1
89295,dietary,0,1
89296,glutamine,0,0
89297,supplementation,0,0
89298,to,0,0
89299,improve,0,0
89300,nutrition,0,1
89301,status,0,1
89302,in,0,0
89303,young,0,0
89304,mammals,0,0
89305,.,0,0
89306,A,0,0
89307,multi-component,0,0
89308,social,0,1
89309,skills,0,1
89310,intervention,0,0
89311,for,0,0
89312,children,0,0
89313,with,0,0
89314,Asperger,0,0
89315,syndrome,0,0
89316,:,0,0
89317,the,0,0
89318,Junior,0,0
89319,Detective,0,0
89320,Training,0,0
89321,Program,0,1
89322,.,0,0
89323,BACKGROUND,0,0
89324,The,0,0
89325,study,0,0
89326,aimed,0,0
89327,to,0,0
89328,investigate,0,0
89329,the,0,0
89330,effectiveness,1,0
89331,of,0,0
89332,a,0,0
89333,new,0,0
89334,multi-component,0,0
89335,social,0,1
89336,skills,0,1
89337,intervention,0,0
89338,for,0,0
89339,children,0,0
89340,with,0,0
89341,Asperger,0,1
89342,syndrome,0,0
89343,(,0,0
89344,AS,0,1
89345,),0,0
89346,:,0,0
89347,The,0,0
89348,Junior,0,0
89349,Detective,0,0
89350,Training,0,0
89351,Program,0,1
89352,.,0,0
89353,This,0,0
89354,7-week,0,0
89355,program,0,0
89356,included,0,0
89357,a,0,0
89358,computer,0,1
89359,game,0,0
89360,",",0,1
89361,small,0,1
89362,group,0,0
89363,sessions,0,0
89364,",",0,1
89365,parent,0,1
89366,training,0,0
89367,sessions,0,0
89368,and,0,1
89369,teacher,0,1
89370,handouts,0,0
89371,.,0,0
89372,METHOD,0,0
89373,Forty-nine,0,0
89374,children,0,0
89375,with,0,0
89376,AS,0,1
89377,were,0,0
89378,recruited,0,0
89379,to,0,0
89380,participate,0,0
89381,and,0,0
89382,randomly,0,0
89383,assigned,0,0
89384,to,0,0
89385,intervention,0,0
89386,(,0,0
89387,n,0,0
89388,=,0,0
89389,26,0,0
89390,),0,0
89391,or,0,0
89392,wait-list,0,0
89393,control,0,0
89394,(,0,0
89395,n,0,0
89396,=,0,0
89397,23,0,0
89398,),0,0
89399,conditions,0,0
89400,.,0,0
89401,RESULTS,0,0
89402,Relative,0,0
89403,to,0,0
89404,children,0,0
89405,in,0,0
89406,the,0,0
89407,wait-list,0,0
89408,group,0,0
89409,",",0,1
89410,program,0,0
89411,participants,0,0
89412,showed,0,0
89413,greater,0,0
89414,improvements,1,1
89415,in,1,0
89416,social,1,1
89417,skills,1,1
89418,over,0,0
89419,the,0,0
89420,course,0,0
89421,of,0,0
89422,the,0,0
89423,intervention,0,0
89424,",",0,0
89425,as,0,0
89426,indicated,0,0
89427,by,0,0
89428,parent-report,0,0
89429,measures,0,0
89430,.,0,0
89431,Teacher-report,0,1
89432,data,0,0
89433,also,0,0
89434,confirmed,0,0
89435,that,0,0
89436,children,0,0
89437,receiving,0,0
89438,the,0,0
89439,intervention,0,0
89440,made,0,0
89441,significant,0,0
89442,improvements,0,1
89443,in,0,0
89444,social,1,1
89445,functioning,1,1
89446,from,0,0
89447,pre-,0,1
89448,to,0,0
89449,post-treatment,0,1
89450,.,0,0
89451,Treatment,0,0
89452,group,0,0
89453,participants,0,0
89454,were,0,0
89455,better,0,0
89456,able,0,0
89457,to,0,0
89458,suggest,0,0
89459,appropriate,0,0
89460,emotion-management,1,1
89461,strategies,1,0
89462,for,0,0
89463,story,0,1
89464,characters,0,1
89465,at,0,0
89466,post-intervention,0,0
89467,than,0,0
89468,at,0,0
89469,pre-intervention,0,0
89470,",",0,0
89471,whereas,0,0
89472,control,0,0
89473,participants,0,0
89474,were,0,0
89475,not,0,0
89476,.,0,0
89477,However,0,0
89478,",",0,0
89479,there,0,0
89480,was,0,0
89481,no,0,0
89482,difference,0,0
89483,in,0,0
89484,the,0,0
89485,improvements,0,0
89486,made,0,0
89487,by,0,0
89488,children,0,0
89489,in,0,0
89490,the,0,0
89491,intervention,0,0
89492,and,0,1
89493,control,0,0
89494,conditions,0,0
89495,on,0,0
89496,facial,1,1
89497,expression,1,1
89498,and,1,1
89499,body-posture,1,1
89500,recognition,1,1
89501,measures,1,1
89502,.,1,1
89503,Follow-up,0,1
89504,data,0,0
89505,suggested,0,0
89506,that,0,0
89507,treatment,0,0
89508,gains,0,1
89509,were,0,0
89510,maintained,0,0
89511,by,0,0
89512,children,0,0
89513,at,0,0
89514,5-months,0,0
89515,post-intervention,0,0
89516,.,0,0
89517,CONCLUSIONS,0,0
89518,The,0,0
89519,Junior,0,0
89520,Detective,0,0
89521,Training,0,1
89522,Program,0,1
89523,appeared,0,0
89524,to,0,0
89525,be,0,0
89526,effective,0,1
89527,in,0,0
89528,enhancing,0,0
89529,the,0,0
89530,social,1,1
89531,skills,1,1
89532,and,1,1
89533,emotional,1,1
89534,understanding,1,1
89535,of,0,0
89536,children,0,0
89537,with,0,0
89538,AS,0,1
89539,.,0,0
89540,Limitations,0,0
89541,and,0,1
89542,suggestions,0,0
89543,for,0,0
89544,future,0,0
89545,research,0,0
89546,are,0,0
89547,discussed,0,0
89548,.,0,0
89549,LEGO,0,1
89550,therapy,0,0
89551,and,0,0
89552,the,0,0
89553,social,0,1
89554,use,0,0
89555,of,0,1
89556,language,0,1
89557,programme,0,0
89558,:,0,0
89559,an,0,0
89560,evaluation,0,0
89561,of,0,0
89562,two,0,0
89563,social,1,0
89564,skills,1,0
89565,interventions,0,0
89566,for,0,0
89567,children,0,0
89568,with,0,0
89569,high,0,0
89570,functioning,0,1
89571,autism,0,0
89572,and,0,1
89573,Asperger,0,1
89574,Syndrome,0,1
89575,.,0,1
89576,LEGO,0,1
89577,therapy,0,0
89578,and,0,0
89579,the,0,0
89580,Social,0,1
89581,Use,0,0
89582,of,0,1
89583,Language,0,1
89584,Programme,0,0
89585,(,0,1
89586,SULP,0,1
89587,),0,1
89588,were,0,0
89589,evaluated,0,0
89590,as,0,0
89591,social,0,1
89592,skills,0,1
89593,interventions,0,0
89594,for,0,0
89595,6-11,0,0
89596,year,0,0
89597,olds,0,0
89598,with,0,0
89599,high,0,0
89600,functioning,0,1
89601,autism,0,0
89602,and,0,1
89603,Asperger,0,1
89604,Syndrome,0,1
89605,.,0,1
89606,Children,0,0
89607,were,0,0
89608,matched,0,0
89609,on,0,0
89610,CA,0,0
89611,",",0,1
89612,IQ,0,1
89613,",",0,1
89614,and,0,1
89615,autistic,0,1
89616,symptoms,0,1
89617,before,0,0
89618,being,0,0
89619,randomly,0,0
89620,assigned,0,0
89621,to,0,0
89622,LEGO,0,1
89623,or,0,0
89624,SULP,0,1
89625,.,0,1
89626,Therapy,0,0
89627,occurred,0,0
89628,for,0,0
89629,1,0,0
89630,h/week,0,0
89631,over,0,0
89632,18,0,0
89633,weeks,0,0
89634,.,0,0
89635,A,0,0
89636,no-intervention,0,0
89637,control,0,0
89638,group,0,0
89639,was,0,0
89640,also,0,0
89641,assessed,0,0
89642,.,0,0
89643,Results,0,0
89644,showed,0,0
89645,that,0,0
89646,the,0,0
89647,LEGO,0,1
89648,therapy,0,0
89649,group,0,0
89650,improved,0,1
89651,more,0,0
89652,than,0,0
89653,the,0,0
89654,other,0,0
89655,groups,0,0
89656,on,0,0
89657,autism-specific,1,0
89658,social,1,1
89659,interaction,1,1
89660,scores,1,1
89661,(,1,0
89662,Gilliam,1,0
89663,Autism,1,1
89664,Rating,1,1
89665,Scale,1,1
89666,),1,0
89667,.,0,0
89668,Maladaptive,1,1
89669,behaviour,1,1
89670,decreased,0,1
89671,significantly,0,0
89672,more,0,0
89673,in,0,0
89674,the,0,0
89675,LEGO,0,1
89676,and,0,1
89677,SULP,0,1
89678,groups,0,0
89679,compared,0,0
89680,to,0,0
89681,the,0,0
89682,control,0,0
89683,group,0,0
89684,.,0,0
89685,There,0,0
89686,was,0,0
89687,a,0,0
89688,non-significant,0,1
89689,trend,0,0
89690,for,0,0
89691,SULP,0,1
89692,and,0,1
89693,LEGO,0,1
89694,groups,0,0
89695,to,0,0
89696,improve,0,0
89697,more,0,0
89698,than,0,0
89699,the,0,0
89700,no-intervention,0,0
89701,group,0,0
89702,in,0,0
89703,communication,1,1
89704,and,1,1
89705,socialisation,1,1
89706,skills,1,1
89707,.,1,0
89708,Cognitive,0,1
89709,effects,0,1
89710,of,0,0
89711,risperidone,0,0
89712,in,0,0
89713,children,0,0
89714,with,0,0
89715,autism,0,0
89716,and,0,1
89717,irritable,0,1
89718,behavior,0,1
89719,.,0,0
89720,OBJECTIVE,0,0
89721,The,0,0
89722,objective,0,0
89723,of,0,0
89724,this,0,0
89725,research,0,0
89726,was,0,0
89727,to,0,0
89728,explore,0,0
89729,the,0,0
89730,effects,0,0
89731,of,0,0
89732,risperidone,0,0
89733,on,0,0
89734,cognitive,1,1
89735,processes,1,1
89736,in,0,0
89737,children,0,0
89738,with,0,0
89739,autism,0,0
89740,and,0,1
89741,irritable,0,1
89742,behavior,0,1
89743,.,0,0
89744,METHOD,0,0
89745,Thirty-eight,0,0
89746,children,0,0
89747,",",0,0
89748,ages,0,0
89749,5-17,0,0
89750,years,0,0
89751,with,0,0
89752,autism,0,0
89753,and,0,1
89754,severe,0,1
89755,behavioral,0,1
89756,disturbance,0,1
89757,",",0,1
89758,were,0,0
89759,randomly,0,0
89760,assigned,0,0
89761,to,0,0
89762,risperidone,0,0
89763,(,0,0
89764,0.5,0,0
89765,to,0,0
89766,3.5,0,0
89767,mg/day,0,0
89768,),0,0
89769,or,0,0
89770,placebo,0,0
89771,for,0,0
89772,8,0,0
89773,weeks,0,0
89774,.,0,0
89775,This,0,0
89776,sample,0,0
89777,of,0,0
89778,38,0,0
89779,was,0,0
89780,a,0,0
89781,subset,0,0
89782,of,0,0
89783,101,0,0
89784,subjects,0,0
89785,who,0,0
89786,participated,0,0
89787,in,0,0
89788,the,0,0
89789,clinical,0,0
89790,trial,0,0
89791,;,0,0
89792,63,0,0
89793,were,0,0
89794,unable,0,0
89795,to,0,0
89796,perform,0,0
89797,the,0,0
89798,cognitive,0,1
89799,tasks,0,0
89800,.,0,0
89801,A,0,0
89802,double-blind,0,0
89803,placebo-controlled,0,0
89804,parallel,0,0
89805,groups,0,0
89806,design,0,0
89807,was,0,0
89808,used,0,0
89809,.,0,0
89810,Dependent,0,0
89811,measures,0,1
89812,included,0,0
89813,tests,1,1
89814,of,1,1
89815,sustained,1,1
89816,attention,1,1
89817,",",1,1
89818,verbal,1,1
89819,learning,1,1
89820,",",1,1
89821,hand-eye,1,1
89822,coordination,1,1
89823,",",1,1
89824,and,1,1
89825,spatial,1,1
89826,memory,1,1
89827,assessed,1,0
89828,before,1,0
89829,",",1,0
89830,during,1,0
89831,",",1,1
89832,and,1,0
89833,after,1,0
89834,the,1,0
89835,8-week,1,0
89836,treatment,1,0
89837,.,1,0
89838,Changes,0,1
89839,in,0,0
89840,performance,0,1
89841,were,0,0
89842,compared,0,0
89843,by,0,0
89844,repeated,0,0
89845,measures,0,0
89846,ANOVA,1,0
89847,.,1,0
89848,RESULTS,0,0
89849,Twenty-nine,0,0
89850,boys,0,0
89851,and,0,0
89852,9,0,0
89853,girls,0,0
89854,with,0,0
89855,autism,0,0
89856,and,0,1
89857,severe,0,1
89858,behavioral,0,1
89859,disturbance,0,1
89860,and,0,0
89861,a,0,0
89862,mental,0,1
89863,age,0,0
89864,>,0,1
89865,or=18,0,0
89866,months,0,0
89867,completed,0,0
89868,the,0,0
89869,cognitive,0,1
89870,part,0,0
89871,of,0,0
89872,the,0,0
89873,study,0,0
89874,.,0,0
89875,No,0,0
89876,decline,0,1
89877,in,0,0
89878,performance,0,1
89879,occurred,0,0
89880,with,0,0
89881,risperidone,0,0
89882,.,0,0
89883,Performance,0,1
89884,on,0,0
89885,a,0,0
89886,cancellation,1,1
89887,task,1,1
89888,(,1,1
89889,number,1,1
89890,of,1,1
89891,correct,1,0
89892,detections,1,1
89893,),1,0
89894,and,0,0
89895,a,0,0
89896,verbal,1,1
89897,learning,1,1
89898,task,1,1
89899,(,1,1
89900,word,1,1
89901,recognition,1,1
89902,),1,1
89903,was,0,0
89904,better,0,0
89905,on,0,0
89906,risperidone,0,0
89907,than,0,0
89908,on,0,0
89909,placebo,0,0
89910,(,0,0
89911,without,0,0
89912,correction,0,1
89913,for,0,0
89914,multiplicity,0,0
89915,),0,0
89916,.,0,0
89917,Equivocal,1,1
89918,improvement,1,1
89919,also,0,0
89920,occurred,0,0
89921,on,0,0
89922,a,0,0
89923,spatial,1,1
89924,memory,1,1
89925,task,1,1
89926,.,1,0
89927,There,0,0
89928,were,0,0
89929,no,0,0
89930,significant,0,0
89931,differences,0,0
89932,between,0,0
89933,treatment,0,0
89934,conditions,0,0
89935,on,0,0
89936,the,0,0
89937,Purdue,1,0
89938,Pegboard,1,1
89939,(,1,0
89940,hand-eye,1,1
89941,coordination,1,1
89942,),1,1
89943,task,0,1
89944,or,0,0
89945,the,0,0
89946,Analog,1,1
89947,Classroom,1,1
89948,Task,1,0
89949,(,1,0
89950,timed,1,1
89951,math,1,0
89952,test,1,0
89953,),1,0
89954,.,0,0
89955,CONCLUSION,0,0
89956,Risperidone,0,0
89957,given,0,0
89958,to,0,0
89959,children,0,0
89960,with,0,0
89961,autism,0,0
89962,at,0,0
89963,doses,0,0
89964,up,0,0
89965,to,0,0
89966,3.5,0,0
89967,mg,0,0
89968,for,0,0
89969,up,0,0
89970,to,0,0
89971,8,0,0
89972,weeks,0,0
89973,appears,0,0
89974,to,0,0
89975,have,0,0
89976,no,0,0
89977,detrimental,0,0
89978,effect,0,0
89979,on,0,0
89980,cognitive,1,1
89981,performance,1,1
89982,.,1,0
89983,Comparison,0,0
89984,of,0,1
89985,amantadine,0,0
89986,and,0,1
89987,desipramine,0,0
89988,combined,0,0
89989,with,0,0
89990,psychotherapy,0,0
89991,for,0,0
89992,treatment,0,0
89993,of,0,1
89994,cocaine,0,0
89995,dependence,0,1
89996,.,0,0
89997,We,0,0
89998,conducted,0,0
89999,a,0,0
90000,single-blind,0,0
90001,",",0,0
90002,random,0,0
90003,assignment,0,0
90004,",",0,1
90005,placebo-controlled,0,0
90006,",",0,1
90007,12-week,0,0
90008,comparison,0,0
90009,of,0,1
90010,desipramine,0,0
90011,hydrochloride,0,0
90012,and,0,1
90013,amantadine,0,0
90014,hydrochloride,0,0
90015,as,0,0
90016,adjunctive,0,0
90017,treatments,0,0
90018,to,0,0
90019,counseling,0,0
90020,for,0,0
90021,cocaine,0,0
90022,dependence,0,1
90023,.,0,1
90024,Subjects,0,0
90025,were,0,0
90026,54,0,0
90027,outpatients,0,0
90028,who,0,0
90029,met,0,0
90030,DSM,0,0
90031,III-R,0,1
90032,criteria,0,0
90033,for,0,0
90034,active,0,0
90035,cocaine,0,1
90036,dependence,0,1
90037,and,0,0
90038,who,0,0
90039,completed,0,0
90040,a,0,0
90041,minimum,0,1
90042,of,0,0
90043,2,0,0
90044,weeks,0,0
90045,of,0,0
90046,treatment,0,0
90047,.,0,1
90048,Subjects,0,0
90049,treated,0,0
90050,with,0,0
90051,fixed,0,0
90052,doses,0,0
90053,of,0,0
90054,200,0,0
90055,mg/day,0,0
90056,desipramine,0,0
90057,(,0,0
90058,N,0,0
90059,=,0,0
90060,17,0,0
90061,),0,0
90062,",",0,0
90063,400,0,0
90064,mg/day,0,0
90065,amantadine-placebo,0,0
90066,(,0,0
90067,N,0,0
90068,=,0,0
90069,16,0,0
90070,),0,0
90071,",",0,0
90072,and,0,1
90073,placebo,0,0
90074,(,0,1
90075,N,0,0
90076,=,0,0
90077,21,0,0
90078,),0,0
90079,did,0,0
90080,not,0,0
90081,differ,0,0
90082,for,0,0
90083,lifetime,0,1
90084,cocaine,0,1
90085,use,0,1
90086,",",0,1
90087,lifetime,0,1
90088,histories,0,0
90089,of,0,1
90090,psychopathology,0,1
90091,",",0,1
90092,admission,0,1
90093,scores,0,1
90094,on,0,0
90095,psychometric,0,1
90096,assessments,0,0
90097,",",0,1
90098,and,0,0
90099,sociodemographics,0,1
90100,.,0,0
90101,All,0,0
90102,treatment,0,0
90103,groups,0,0
90104,demonstrated,0,0
90105,dramatic,1,0
90106,and,1,1
90107,persistent,1,1
90108,decreases,1,1
90109,in,0,0
90110,cocaine,1,1
90111,use,1,1
90112,",",1,1
90113,craving,1,1
90114,for,1,0
90115,cocaine,1,1
90116,",",1,1
90117,and,1,1
90118,psychiatric,1,1
90119,symptoms,1,1
90120,consequent,0,0
90121,to,0,0
90122,treatment,0,0
90123,.,0,0
90124,Although,0,0
90125,there,0,0
90126,was,0,0
90127,a,0,0
90128,trend,0,0
90129,for,0,0
90130,more,0,0
90131,dropouts,1,0
90132,by,0,0
90133,subjects,0,0
90134,taking,0,0
90135,desipramine,0,0
90136,",",0,0
90137,there,0,0
90138,were,0,0
90139,no,0,0
90140,significant,0,0
90141,differences,0,0
90142,among,0,0
90143,treatment,0,0
90144,groups,0,0
90145,regarding,0,0
90146,retention,1,1
90147,in,1,0
90148,treatment,1,0
90149,",",1,0
90150,craving,1,1
90151,for,1,0
90152,cocaine,1,1
90153,",",1,1
90154,and,1,1
90155,decreased,1,1
90156,cocaine,1,1
90157,use,1,1
90158,confirmed,0,0
90159,by,0,0
90160,urine,1,1
90161,toxicology,1,0
90162,.,1,0
90163,There,0,0
90164,was,0,0
90165,a,0,0
90166,trend,0,0
90167,for,0,0
90168,subjects,0,0
90169,treated,0,0
90170,with,0,0
90171,desipramine,0,0
90172,to,0,0
90173,maintain,0,1
90174,longer,0,0
90175,periods,0,1
90176,of,0,1
90177,cocaine,1,0
90178,abstinence,1,1
90179,.,1,1
90180,Mean,1,1
90181,plasma,1,1
90182,concentration,1,1
90183,of,1,1
90184,desipramine,1,0
90185,in,0,0
90186,a,0,0
90187,subsample,0,0
90188,of,0,0
90189,our,0,0
90190,subjects,0,0
90191,was,0,0
90192,less,0,0
90193,than,0,0
90194,that,0,0
90195,recommended,0,0
90196,for,0,0
90197,treatment,0,0
90198,of,0,1
90199,depression,0,1
90200,",",0,0
90201,thus,0,0
90202,the,0,0
90203,dosage,0,0
90204,of,0,0
90205,desipramine,0,0
90206,may,0,0
90207,have,0,0
90208,been,0,0
90209,subtherapeutic,0,0
90210,.,0,0
90211,Which,0,0
90212,socio-demographic,0,0
90213,factors,0,0
90214,are,0,0
90215,associated,0,0
90216,with,0,0
90217,participation,0,0
90218,in,0,0
90219,oral,0,0
90220,cancer,0,0
90221,screening,0,0
90222,in,0,0
90223,the,0,0
90224,developing,0,0
90225,world,0,0
90226,?,0,0
90227,Results,0,0
90228,from,0,0
90229,a,0,0
90230,population-based,0,0
90231,screening,0,0
90232,project,0,0
90233,in,0,0
90234,India,0,0
90235,.,0,0
90236,BACKGROUND,0,0
90237,This,0,0
90238,study,0,0
90239,examines,0,0
90240,socio-demographic,0,0
90241,determinants,0,0
90242,of,0,0
90243,participation,0,0
90244,in,0,0
90245,a,0,0
90246,population-based,0,0
90247,randomized,0,0
90248,controlled,0,0
90249,trial,0,0
90250,that,0,0
90251,proved,0,0
90252,that,0,0
90253,oral,0,0
90254,visual,0,1
90255,inspection,0,0
90256,was,0,0
90257,effective,0,1
90258,in,0,0
90259,reducing,0,0
90260,oral,1,0
90261,cancer,1,0
90262,mortality,1,1
90263,in,0,0
90264,high-risk,0,0
90265,individuals,0,0
90266,in,0,0
90267,India,0,0
90268,.,0,0
90269,METHODS,0,0
90270,Multivariate,0,1
90271,logistic,0,1
90272,regression,0,1
90273,was,0,0
90274,used,0,0
90275,to,0,0
90276,establish,0,0
90277,socio-demographic,0,0
90278,characteristics,0,1
90279,of,0,0
90280,participants,0,0
90281,versus,0,0
90282,non-participants,0,0
90283,in,0,0
90284,the,0,0
90285,intervention,0,0
90286,arm,0,0
90287,.,0,1
90288,Compliance,1,1
90289,with,1,0
90290,referral,1,1
90291,was,0,0
90292,analysed,0,0
90293,according,0,0
90294,to,0,0
90295,the,0,0
90296,socio-demographic,0,0
90297,characteristics,0,0
90298,of,0,0
90299,screen-positives,0,1
90300,.,0,0
90301,RESULTS,0,0
90302,Of,0,0
90303,"96,517",0,0
90304,eligible,0,0
90305,subjects,0,0
90306,",",0,0
90307,"87,655",0,0
90308,were,0,0
90309,screened,0,0
90310,",",0,0
90311,8688,0,0
90312,individuals,0,0
90313,never,0,0
90314,received,0,0
90315,the,0,0
90316,invitation,0,0
90317,and,0,0
90318,174,0,0
90319,refused,0,0
90320,screening,0,0
90321,.,0,0
90322,Compared,0,0
90323,to,0,0
90324,the,0,0
90325,non-screened,0,0
90326,",",0,0
90327,a,0,0
90328,higher,0,0
90329,proportion,0,1
90330,of,0,1
90331,screened,1,1
90332,individuals,0,0
90333,were,0,0
90334,women,0,0
90335,(,0,0
90336,OR=4.51,0,0
90337,;,0,0
90338,CI,0,0
90339,:,0,0
90340,4.28-4.75,0,0
90341,),0,1
90342,",",0,0
90343,lived,0,0
90344,in,0,0
90345,better,0,0
90346,housing,0,1
90347,(,0,0
90348,OR=1.35,0,0
90349,;,0,0
90350,CI,0,0
90351,:,0,0
90352,1.25-1.41,0,0
90353,),0,1
90354,",",0,1
90355,had,0,0
90356,television/radio,0,1
90357,(,0,0
90358,OR=1.50,0,0
90359,;,0,0
90360,CI,0,0
90361,:,0,0
90362,1.43-1.58,0,0
90363,),0,1
90364,and,0,1
90365,were,0,0
90366,tobacco,0,0
90367,and,0,1
90368,alcohol,0,1
90369,users,0,0
90370,(,0,0
90371,OR=2.75,0,0
90372,;,0,0
90373,CI,0,0
90374,:,0,0
90375,2.57-2.95,0,0
90376,),0,0
90377,.,0,0
90378,Being,0,1
90379,65,0,0
90380,and,0,0
90381,older,0,0
90382,decreased,0,1
90383,the,0,0
90384,chances,1,1
90385,of,1,1
90386,screening,1,0
90387,(,0,0
90388,OR=0.39,0,0
90389,;,0,0
90390,CI,0,0
90391,:,0,0
90392,0.37-0.42,0,0
90393,),0,1
90394,",",0,0
90395,as,0,0
90396,well,0,0
90397,as,0,0
90398,living,1,1
90399,in,1,0
90400,high-size,1,0
90401,households,1,0
90402,(,0,0
90403,OR=0.73,0,0
90404,;,0,0
90405,CI,0,0
90406,:,0,0
90407,0.68-0.78,0,0
90408,),0,0
90409,.,0,0
90410,Sixty-three,0,0
90411,percent,0,0
90412,of,0,0
90413,5143,0,0
90414,screen-positives,0,0
90415,complied,0,0
90416,with,0,0
90417,referral,1,0
90418,.,1,0
90419,Controlling,0,0
90420,for,0,0
90421,all,0,0
90422,other,0,0
90423,factors,0,1
90424,",",0,0
90425,individuals,0,0
90426,older,0,0
90427,than,0,0
90428,44,0,0
90429,",",0,0
90430,and,0,0
90431,those,0,0
90432,with,0,0
90433,more,0,0
90434,advanced,0,0
90435,lesions,0,1
90436,were,0,0
90437,more,0,0
90438,likely,0,0
90439,to,0,0
90440,comply,0,0
90441,with,0,0
90442,referral,1,1
90443,(,0,0
90444,p,0,0
90445,<,0,0
90446,0.001,0,0
90447,),0,0
90448,.,0,0
90449,Individuals,0,0
90450,living,0,1
90451,in,0,0
90452,better,0,0
90453,housing,0,1
90454,were,0,0
90455,less,0,0
90456,likely,0,0
90457,to,0,0
90458,comply,1,0
90459,with,1,0
90460,referral,1,1
90461,(,0,0
90462,OR=0.79,0,0
90463,;,0,0
90464,CI,0,0
90465,:,0,0
90466,0.65-0.95,0,0
90467,),0,0
90468,.,0,0
90469,CONCLUSIONS,0,0
90470,In,0,0
90471,summary,0,0
90472,",",0,0
90473,adequate,0,0
90474,coverage,0,0
90475,can,0,0
90476,be,0,0
90477,obtained,0,0
90478,in,0,0
90479,population-based,0,0
90480,oral,0,0
90481,screening,0,0
90482,in,0,0
90483,developing,0,0
90484,countries,0,0
90485,.,0,0
90486,The,0,0
90487,study,0,0
90488,underscores,0,0
90489,the,0,0
90490,important,0,0
90491,role,0,0
90492,of,0,1
90493,patient-provider,0,1
90494,communication,0,1
90495,in,0,0
90496,assuring,0,1
90497,high,0,0
90498,compliance,0,1
90499,with,0,0
90500,referral,0,0
90501,.,0,0
90502,The,0,0
90503,effect,0,0
90504,of,0,0
90505,acupressure,0,0
90506,at,0,0
90507,the,0,0
90508,extra,0,0
90509,1,0,0
90510,point,0,0
90511,on,0,0
90512,subjective,0,1
90513,and,0,1
90514,autonomic,1,1
90515,responses,1,1
90516,to,0,0
90517,needle,0,0
90518,insertion,0,0
90519,.,0,0
90520,BACKGROUND,0,0
90521,Premedication,0,0
90522,with,0,0
90523,sedatives,0,0
90524,can,0,0
90525,decrease,0,0
90526,the,0,0
90527,discomfort,1,1
90528,associated,0,0
90529,with,0,0
90530,invasive,0,1
90531,anesthetic,0,0
90532,procedures,0,0
90533,.,0,0
90534,Some,0,0
90535,researchers,0,0
90536,have,0,0
90537,shown,0,0
90538,that,0,0
90539,acupressure,0,0
90540,on,0,0
90541,the,0,0
90542,acupuncture,0,0
90543,extra,0,0
90544,1,0,0
90545,point,0,0
90546,is,0,0
90547,effective,0,1
90548,for,0,0
90549,sedation,0,1
90550,.,0,0
90551,We,0,0
90552,investigated,0,0
90553,whether,0,0
90554,acupressure,0,0
90555,on,0,0
90556,the,0,0
90557,extra,0,0
90558,1,0,0
90559,point,0,0
90560,could,0,0
90561,alleviate,0,0
90562,the,0,0
90563,pain,1,1
90564,of,0,0
90565,needle,0,0
90566,insertion,0,0
90567,.,0,0
90568,METHODS,0,0
90569,We,0,0
90570,investigated,0,0
90571,the,0,0
90572,effect,0,1
90573,of,0,0
90574,acupressure,0,0
90575,at,0,0
90576,the,0,0
90577,extra,0,0
90578,1,0,0
90579,point,0,0
90580,or,0,0
90581,a,0,0
90582,sham,0,0
90583,point,0,0
90584,on,0,0
90585,needle,0,0
90586,insertion,0,0
90587,using,0,0
90588,verbal,1,1
90589,rating,1,1
90590,scale,1,1
90591,(,1,1
90592,VRS,1,1
90593,),1,1
90594,pain,1,1
90595,scores,1,1
90596,and,0,1
90597,heart,1,1
90598,rate,1,1
90599,variability,1,1
90600,(,1,1
90601,HRV,1,0
90602,),1,0
90603,.,1,0
90604,Twenty-two,0,0
90605,healthy,0,0
90606,female,0,0
90607,volunteers,0,0
90608,were,0,0
90609,randomly,0,0
90610,allocated,0,0
90611,to,0,0
90612,two,0,0
90613,groups,0,0
90614,:,0,0
90615,the,0,0
90616,extra,0,0
90617,1,0,0
90618,group,0,0
90619,received,0,0
90620,acupressure,0,0
90621,at,0,0
90622,the,0,0
90623,extra,0,0
90624,1,0,0
90625,point,0,0
90626,",",0,0
90627,and,0,1
90628,the,0,0
90629,sham,0,0
90630,group,0,0
90631,received,0,0
90632,acupressure,0,0
90633,at,0,0
90634,a,0,0
90635,sham,0,0
90636,point,0,0
90637,.,0,0
90638,After,0,0
90639,starting,0,0
90640,the,0,0
90641,electrocardiogram,0,1
90642,record,0,0
90643,",",0,0
90644,a,0,0
90645,27-gauge,0,1
90646,needle,0,0
90647,was,0,0
90648,inserted,0,0
90649,into,0,0
90650,the,0,0
90651,skin,0,1
90652,of,0,0
90653,a,0,0
90654,forearm,0,0
90655,.,0,1
90656,Thereafter,0,0
90657,",",0,0
90658,another,0,0
90659,needle,0,0
90660,was,0,0
90661,inserted,0,0
90662,into,0,0
90663,the,0,0
90664,skin,0,1
90665,of,0,0
90666,the,0,0
90667,other,0,0
90668,forearm,0,1
90669,during,0,0
90670,acupressure,0,0
90671,.,0,0
90672,RESULTS,0,0
90673,Acupressure,0,0
90674,at,0,0
90675,the,0,0
90676,extra,0,0
90677,1,0,0
90678,point,0,0
90679,significantly,0,0
90680,reduced,0,0
90681,the,0,0
90682,VRS,1,1
90683,",",0,1
90684,but,0,0
90685,acupressure,0,0
90686,at,0,0
90687,the,0,0
90688,sham,0,0
90689,increased,0,0
90690,the,0,0
90691,VRS,1,1
90692,.,1,0
90693,Acupressure,0,0
90694,at,0,0
90695,the,0,0
90696,extra,0,0
90697,1,0,0
90698,significantly,0,0
90699,reduced,0,0
90700,the,0,0
90701,low,1,0
90702,frequency/high,1,1
90703,frequency,1,1
90704,ratio,1,1
90705,of,1,1
90706,HRV,1,0
90707,responding,1,0
90708,to,1,0
90709,needle,1,0
90710,insertion,1,0
90711,.,1,0
90712,CONCLUSIONS,0,0
90713,Acupressure,0,0
90714,at,0,0
90715,the,0,0
90716,extra,0,0
90717,1,0,0
90718,point,0,0
90719,significantly,0,0
90720,reduced,0,0
90721,needle,1,0
90722,insertion,1,1
90723,pain,1,1
90724,compared,0,0
90725,with,0,0
90726,acupressure,0,0
90727,at,0,0
90728,the,0,0
90729,sham,0,0
90730,point,0,0
90731,.,0,0
90732,Also,0,0
90733,",",0,0
90734,acupressure,0,0
90735,at,0,0
90736,the,0,0
90737,extra,0,0
90738,1,0,0
90739,point,0,0
90740,significantly,0,0
90741,reduced,0,0
90742,the,0,0
90743,low,1,0
90744,frequency/high,1,1
90745,frequency,1,1
90746,ratio,1,1
90747,of,1,1
90748,HRV,1,0
90749,responding,0,0
90750,to,0,0
90751,needle,0,0
90752,insertion,0,1
90753,",",0,0
90754,which,0,0
90755,implies,0,0
90756,a,0,0
90757,reduction,1,1
90758,in,0,0
90759,sympathetic,1,1
90760,nervous,1,1
90761,system,1,0
90762,activity,1,1
90763,.,1,0
90764,Local,0,1
90765,delivery,0,0
90766,of,0,0
90767,a,0,0
90768,recombinant,0,0
90769,adenoassociated,0,0
90770,vector,0,0
90771,containing,0,0
90772,a,0,0
90773,tumour,0,1
90774,necrosis,0,1
90775,factor,0,1
90776,alpha,0,1
90777,antagonist,0,0
90778,gene,0,1
90779,in,0,0
90780,inflammatory,0,1
90781,arthritis,0,0
90782,:,0,0
90783,a,0,0
90784,phase,0,0
90785,1,0,0
90786,dose-escalation,0,0
90787,safety,1,1
90788,and,1,1
90789,tolerability,1,1
90790,study,0,0
90791,.,0,0
90792,OBJECTIVE,0,0
90793,To,0,0
90794,examine,0,0
90795,the,0,0
90796,safety,1,1
90797,and,1,1
90798,tolerability,1,1
90799,of,0,0
90800,a,0,0
90801,single,0,0
90802,intra-articular,0,1
90803,injection,0,0
90804,of,0,0
90805,rAAV2-TNFR,0,0
90806,:,0,0
90807,Fc,0,1
90808,",",0,0
90809,an,0,0
90810,adenoassociated,0,0
90811,virus,0,0
90812,serotype,0,0
90813,2,0,0
90814,vector,0,0
90815,containing,0,0
90816,the,0,0
90817,cDNA,0,0
90818,for,0,0
90819,the,0,0
90820,human,0,0
90821,tumour,0,1
90822,necrosis,0,1
90823,factor-immunoglobulin,0,1
90824,Fc,0,1
90825,fusion,0,1
90826,gene,0,1
90827,(,0,1
90828,tgAAC94,0,1
90829,),0,1
90830,",",0,0
90831,in,0,0
90832,subjects,0,0
90833,with,0,0
90834,inflammatory,0,1
90835,arthritis,0,0
90836,.,0,0
90837,METHODS,0,0
90838,In,0,0
90839,a,0,0
90840,double-blind,0,0
90841,",",0,0
90842,placebo-controlled,0,0
90843,",",0,0
90844,phase,0,0
90845,1,0,0
90846,",",0,0
90847,dose-escalation,0,0
90848,study,0,0
90849,",",0,0
90850,15,0,0
90851,subjects,0,0
90852,with,0,0
90853,inflammatory,0,1
90854,arthritis,0,0
90855,(,0,0
90856,14,0,0
90857,with,0,0
90858,rheumatoid,0,0
90859,arthritis,0,0
90860,and,0,0
90861,1,0,0
90862,with,0,0
90863,ankylosing,0,0
90864,spondylitis,0,0
90865,),0,0
90866,not,0,0
90867,receiving,0,0
90868,tumour,0,1
90869,necrosis,0,1
90870,factor,0,1
90871,alpha,0,1
90872,(,0,1
90873,TNFalpha,0,1
90874,),0,0
90875,inhibitors,0,1
90876,with,0,0
90877,persistent,0,1
90878,moderate,0,0
90879,(,0,0
90880,grade,0,1
90881,2,0,0
90882,),0,0
90883,or,0,0
90884,severe,0,1
90885,(,0,0
90886,grade,0,0
90887,3,0,0
90888,),0,0
90889,swelling,0,0
90890,in,0,0
90891,a,0,0
90892,target,0,0
90893,joint,0,1
90894,due,0,0
90895,to,0,0
90896,inflammatory,0,1
90897,arthritis,0,0
90898,received,0,0
90899,a,0,0
90900,single,0,0
90901,intra-articular,0,1
90902,injection,0,0
90903,of,0,0
90904,rAAV2-TNFR,0,0
90905,:,0,0
90906,Fc,0,0
90907,at,0,0
90908,1,0,0
90909,x,0,0
90910,10,0,0
90911,(,0,0
90912,10,0,0
90913,),0,0
90914,(,0,0
90915,n,0,0
90916,=,0,0
90917,5,0,0
90918,),0,0
90919,or,0,0
90920,1,0,0
90921,x,0,0
90922,10,0,0
90923,(,0,0
90924,11,0,0
90925,),0,0
90926,(,0,0
90927,n,0,0
90928,=,0,0
90929,6,0,0
90930,),0,0
90931,DNase,0,0
90932,resistant,0,1
90933,particles,0,1
90934,per,0,0
90935,ml,0,0
90936,joint,0,1
90937,volume,0,1
90938,or,0,1
90939,placebo,0,0
90940,(,0,1
90941,n,0,0
90942,=,0,0
90943,4,0,0
90944,),0,0
90945,into,0,0
90946,a,0,0
90947,knee,0,1
90948,(,0,0
90949,n,0,0
90950,=,0,0
90951,14,0,0
90952,),0,0
90953,or,0,0
90954,ankle,0,1
90955,(,0,1
90956,n,0,0
90957,=,0,0
90958,1,0,0
90959,),0,0
90960,.,0,0
90961,Safety,1,1
90962,was,0,0
90963,assessed,0,0
90964,through,0,0
90965,adverse,0,1
90966,event,0,1
90967,monitoring,0,0
90968,.,0,0
90969,As,0,0
90970,a,0,0
90971,secondary,0,1
90972,objective,0,0
90973,",",0,0
90974,changes,1,1
90975,in,1,0
90976,injected,1,0
90977,joint,1,1
90978,tenderness,1,1
90979,and,1,1
90980,swelling,1,1
90981,scores,1,1
90982,",",0,0
90983,each,0,0
90984,measured,0,0
90985,on,0,0
90986,a,0,0
90987,four-point,0,1
90988,scale,0,1
90989,",",0,1
90990,were,0,0
90991,evaluated,0,0
90992,.,0,0
90993,RESULTS,0,0
90994,Intra-articular,0,1
90995,injections,0,0
90996,of,0,0
90997,rAAV2-TNFR,0,0
90998,:,0,0
90999,Fc,0,1
91000,were,0,0
91001,well,0,0
91002,tolerated,0,1
91003,with,0,0
91004,no,0,0
91005,major,0,1
91006,safety,0,1
91007,issues,0,0
91008,.,0,0
91009,One,0,0
91010,event,0,0
91011,",",0,0
91012,mild,0,1
91013,knee,0,1
91014,pruritus,0,1
91015,",",0,1
91016,was,0,0
91017,considered,0,0
91018,probably,0,0
91019,related,0,0
91020,.,0,0
91021,Synovial,1,0
91022,fluid,1,1
91023,TNFR,1,0
91024,:,1,0
91025,Fc,1,1
91026,protein,1,1
91027,was,0,0
91028,not,0,0
91029,detected,0,0
91030,(,0,0
91031,nor,0,0
91032,expected,0,0
91033,),0,0
91034,at,0,0
91035,the,0,0
91036,doses,0,0
91037,used,0,0
91038,.,0,0
91039,At,0,0
91040,12,0,0
91041,weeks,0,0
91042,after,0,0
91043,injection,0,0
91044,",",0,0
91045,a,0,0
91046,two-point,0,1
91047,decrease,1,1
91048,in,1,0
91049,swelling,1,1
91050,was,0,0
91051,noted,0,0
91052,in,0,0
91053,2/11,0,0
91054,and,0,0
91055,2/4,0,0
91056,subjects,0,0
91057,injected,0,0
91058,with,0,0
91059,rAAV2-TNFR,0,0
91060,:,0,0
91061,Fc,0,1
91062,and,0,1
91063,placebo,0,0
91064,",",0,0
91065,respectively,0,0
91066,.,0,0
91067,CONCLUSION,0,0
91068,A,0,0
91069,single,0,0
91070,dose,0,0
91071,of,0,1
91072,intra-articular,0,1
91073,rAAV2-TNFR,0,0
91074,:,0,0
91075,Fc,0,0
91076,appears,0,0
91077,to,0,0
91078,be,0,0
91079,safe,0,1
91080,and,0,0
91081,well,0,1
91082,tolerated,0,1
91083,in,0,0
91084,subjects,0,0
91085,without,0,0
91086,concurrent,0,0
91087,systemic,0,1
91088,TNFalpha,0,1
91089,antagonist,0,0
91090,use,0,0
91091,.,0,0
91092,It,0,0
91093,is,0,0
91094,thus,0,0
91095,feasible,0,0
91096,to,0,0
91097,proceed,0,0
91098,with,0,0
91099,larger,0,0
91100,trials,0,0
91101,to,0,0
91102,further,0,0
91103,test,0,0
91104,the,0,0
91105,safety,1,1
91106,and,1,1
91107,efficacy,1,1
91108,of,0,1
91109,local,0,0
91110,TNFR,0,0
91111,:,0,0
91112,Fc,0,1
91113,gene,0,1
91114,transfer,0,1
91115,as,0,0
91116,a,0,0
91117,therapeutic,0,0
91118,modality,0,0
91119,for,0,0
91120,patients,0,0
91121,with,0,0
91122,inflammatory,0,1
91123,arthritis,0,0
91124,.,0,0
91125,Concurrent,0,0
91126,doxorubicin,0,0
91127,plus,0,0
91128,docetaxel,0,0
91129,is,0,0
91130,not,0,0
91131,more,0,0
91132,effective,0,1
91133,than,0,0
91134,concurrent,0,0
91135,doxorubicin,0,0
91136,plus,0,0
91137,cyclophosphamide,0,0
91138,in,0,0
91139,operable,0,0
91140,breast,1,0
91141,cancer,1,0
91142,with,0,0
91143,0,0,0
91144,to,0,0
91145,3,0,0
91146,positive,0,0
91147,axillary,0,0
91148,nodes,0,0
91149,:,0,0
91150,North,0,0
91151,American,0,0
91152,Breast,0,1
91153,Cancer,0,0
91154,Intergroup,0,1
91155,Trial,0,0
91156,E,0,0
91157,2197,0,0
91158,.,0,0
91159,PURPOSE,0,0
91160,The,0,0
91161,combination,0,0
91162,of,0,1
91163,doxorubicin,0,0
91164,and,0,1
91165,cyclophosphamide,0,0
91166,(,0,1
91167,AC,0,0
91168,),0,0
91169,is,0,0
91170,a,0,0
91171,standard,0,0
91172,adjuvant,0,0
91173,regimen,0,0
91174,.,0,1
91175,Doxorubicin,0,0
91176,and,0,1
91177,docetaxel,0,0
91178,(,0,1
91179,AT,0,0
91180,),0,0
91181,is,0,0
91182,one,0,0
91183,of,0,0
91184,the,0,0
91185,most,0,0
91186,active,0,0
91187,cytotoxic,0,1
91188,regimens,0,0
91189,for,0,0
91190,metastatic,1,0
91191,breast,1,0
91192,cancer,1,0
91193,.,1,0
91194,The,0,0
91195,purpose,0,0
91196,of,0,0
91197,this,0,0
91198,trial,0,0
91199,was,0,0
91200,to,0,0
91201,determine,0,0
91202,whether,0,0
91203,adjuvant,0,0
91204,AT,0,0
91205,improved,0,1
91206,disease-free,0,1
91207,survival,0,1
91208,compared,0,0
91209,with,0,0
91210,AC,0,0
91211,in,0,0
91212,operable,0,0
91213,breast,1,0
91214,cancer,1,0
91215,.,1,1
91216,PATIENTS,0,0
91217,AND,0,0
91218,METHODS,0,0
91219,Women,0,1
91220,with,0,0
91221,invasive,0,1
91222,breast,0,0
91223,cancer,0,0
91224,were,0,0
91225,eligible,0,0
91226,if,0,0
91227,there,0,0
91228,were,0,0
91229,one,0,0
91230,to,0,0
91231,three,0,0
91232,positive,0,0
91233,lymph,0,0
91234,nodes,0,1
91235,or,0,0
91236,if,0,0
91237,the,0,0
91238,node-negative,0,0
91239,tumor,0,1
91240,was,0,0
91241,greater,0,0
91242,than,0,0
91243,1,0,0
91244,cm,0,0
91245,.,0,0
91246,Patients,0,0
91247,were,0,0
91248,randomly,0,0
91249,assigned,0,0
91250,after,0,0
91251,surgery,0,0
91252,to,0,0
91253,receive,0,0
91254,doxorubicin,0,0
91255,(,0,0
91256,60,0,0
91257,mg/m,0,0
91258,(,0,0
91259,2,0,0
91260,),0,0
91261,),0,0
91262,plus,0,0
91263,either,0,0
91264,cyclophosphamide,0,0
91265,(,0,0
91266,600,0,0
91267,mg/m,0,0
91268,(,0,0
91269,2,0,0
91270,),0,0
91271,;,0,0
91272,AC,0,1
91273,),0,1
91274,or,0,1
91275,docetaxel,0,0
91276,(,0,0
91277,60,0,0
91278,mg/m,0,0
91279,(,0,0
91280,2,0,0
91281,),0,0
91282,;,0,0
91283,AT,0,0
91284,),0,0
91285,given,0,0
91286,every,0,0
91287,3,0,0
91288,weeks,0,0
91289,for,0,0
91290,four,0,0
91291,cycles,0,0
91292,",",0,0
91293,followed,0,0
91294,by,0,0
91295,hormone,0,1
91296,therapy,0,0
91297,for,0,0
91298,patients,0,0
91299,with,0,0
91300,estrogen,0,1
91301,receptor,0,1
91302,(,0,1
91303,ER,0,1
91304,),0,0
91305,and/or,0,0
91306,progesterone,0,1
91307,receptor,0,1
91308,(,0,1
91309,PR,0,1
91310,),0,1
91311,-positive,0,1
91312,tumors,0,0
91313,.,0,0
91314,RESULTS,0,0
91315,There,0,0
91316,were,0,0
91317,"2,882",0,0
91318,eligible,0,0
91319,patients,0,0
91320,enrolled,0,0
91321,.,0,0
91322,After,0,0
91323,a,0,0
91324,median,0,1
91325,follow-up,0,0
91326,of,0,0
91327,79.5,0,0
91328,months,0,0
91329,",",0,0
91330,there,0,0
91331,was,0,0
91332,no,0,0
91333,significant,0,0
91334,difference,0,0
91335,in,0,0
91336,disease-free,1,1
91337,survival,1,1
91338,(,0,0
91339,DFS,0,0
91340,;,0,0
91341,85,0,0
91342,%,0,0
91343,in,0,0
91344,both,0,0
91345,arms,0,0
91346,),0,0
91347,or,0,0
91348,overall,1,1
91349,survival,1,1
91350,(,0,0
91351,91,0,0
91352,%,0,0
91353,v,0,0
91354,92,0,0
91355,%,0,0
91356,),0,0
91357,at,0,0
91358,5,0,0
91359,years,0,0
91360,.,0,0
91361,The,0,0
91362,hazard,1,1
91363,ratio,1,1
91364,for,0,0
91365,AC,0,1
91366,versus,0,0
91367,AT,0,0
91368,was,0,0
91369,1.02,0,0
91370,(,0,0
91371,95,0,0
91372,%,0,0
91373,CI,0,0
91374,for,0,0
91375,DFS,0,0
91376,",",0,0
91377,0.86,0,0
91378,to,0,0
91379,1.22,0,0
91380,;,0,0
91381,P,0,0
91382,=,0,0
91383,.78,0,1
91384,),0,0
91385,.,0,0
91386,In,0,0
91387,an,0,0
91388,exploratory,0,0
91389,analysis,0,0
91390,of,0,1
91391,prespecified,0,1
91392,stratification,0,0
91393,factors,0,1
91394,by,0,0
91395,ER,0,1
91396,and,0,1
91397,PR,0,1
91398,expression,0,1
91399,there,0,0
91400,were,0,0
91401,trends,0,0
91402,toward,0,0
91403,improved,1,1
91404,DFS,1,0
91405,for,0,0
91406,AT,0,0
91407,in,0,0
91408,ER/PR-negative,0,0
91409,disease,0,0
91410,.,0,0
91411,Grade,1,0
91412,3,1,0
91413,neutropenia,1,1
91414,associated,1,0
91415,with,1,0
91416,fever,1,1
91417,or,1,1
91418,infection,1,1
91419,occurred,0,0
91420,more,0,0
91421,often,0,0
91422,with,0,0
91423,AT,0,0
91424,(,0,0
91425,26,0,0
91426,%,0,0
91427,v,0,0
91428,10,0,0
91429,%,0,0
91430,;,0,0
91431,P,0,0
91432,<,0,0
91433,.05,0,0
91434,),0,0
91435,.,0,0
91436,CONCLUSION,0,0
91437,AT,0,0
91438,did,0,0
91439,not,0,0
91440,improve,0,0
91441,DFS,1,1
91442,or,1,1
91443,overall,1,1
91444,survival,1,1
91445,in,0,0
91446,this,0,0
91447,population,0,0
91448,",",0,1
91449,and,0,1
91450,was,0,0
91451,associated,0,0
91452,with,0,0
91453,more,0,0
91454,toxicity,1,1
91455,.,1,0
91456,[,1,0
91457,Intra-uterine,1,0
91458,insemination,1,0
91459,with,0,0
91460,controlled,0,0
91461,ovarian,1,1
91462,hyperstimulation,1,0
91463,compared,0,0
91464,to,0,0
91465,an,0,0
91466,expectant,1,0
91467,management,1,0
91468,in,0,0
91469,couples,0,0
91470,with,0,0
91471,unexplained,0,1
91472,subfertility,1,1
91473,and,0,0
91474,an,0,0
91475,intermediate,0,0
91476,prognosis,0,0
91477,:,0,0
91478,a,0,0
91479,randomised,0,0
91480,study,0,0
91481,],0,0
91482,.,0,1
91483,OBJECTIVE,0,1
91484,Intrauterine,1,0
91485,insemination,1,1
91486,(,1,1
91487,IUI,1,1
91488,),1,0
91489,with,0,0
91490,controlled,1,0
91491,ovarian,1,1
91492,hyperstimulation,1,1
91493,(,1,1
91494,COH,1,0
91495,),1,0
91496,is,0,0
91497,commonly,0,0
91498,used,0,0
91499,as,0,0
91500,treatment,0,0
91501,of,0,1
91502,first,0,1
91503,choice,0,0
91504,in,0,0
91505,couples,0,0
91506,with,0,0
91507,unexplained,1,0
91508,subfertility,1,1
91509,.,1,0
91510,This,0,0
91511,treatment,0,0
91512,should,0,0
91513,only,0,0
91514,be,0,0
91515,applied,0,0
91516,when,0,0
91517,there,0,0
91518,is,0,0
91519,a,0,0
91520,realistic,0,1
91521,increase,1,1
91522,in,1,0
91523,chance,1,1
91524,of,1,1
91525,pregnancy,1,1
91526,",",0,0
91527,particularly,0,0
91528,because,0,0
91529,it,0,0
91530,carries,0,0
91531,the,0,0
91532,increased,0,0
91533,risk,0,0
91534,of,0,0
91535,multiple,0,0
91536,pregnancies,0,0
91537,.,0,0
91538,We,0,0
91539,evaluated,0,0
91540,the,0,0
91541,effectiveness,0,1
91542,of,0,0
91543,IUI,1,1
91544,with,0,0
91545,COH,1,0
91546,relative,0,0
91547,to,0,0
91548,expectant,1,0
91549,management,1,0
91550,in,0,0
91551,couples,0,0
91552,with,0,0
91553,unexplained,1,1
91554,subfertility,1,1
91555,and,0,0
91556,an,0,0
91557,intermediate,0,1
91558,prognosis,0,1
91559,of,0,0
91560,a,0,0
91561,spontaneous,1,1
91562,ongoing,1,0
91563,pregnancy,1,1
91564,.,1,0
91565,DESIGN,0,0
91566,Multicentre,0,0
91567,randomised,0,0
91568,clinical,0,0
91569,study,0,0
91570,.,0,0
91571,METHOD,0,0
91572,253,0,0
91573,couples,0,0
91574,with,0,0
91575,unexplained,1,1
91576,subfertility,1,1
91577,and,0,0
91578,a,0,0
91579,probability,0,1
91580,of,0,0
91581,a,0,0
91582,spontaneous,1,1
91583,ongoing,1,0
91584,pregnancy,1,0
91585,of,0,0
91586,30,0,0
91587,%,0,0
91588,to,0,0
91589,40,0,0
91590,%,0,0
91591,within,0,0
91592,12,0,0
91593,months,0,0
91594,",",0,0
91595,were,0,0
91596,randomly,0,0
91597,assigned,0,0
91598,to,0,0
91599,IUI,1,1
91600,with,0,0
91601,COH,1,0
91602,for,0,0
91603,6,0,0
91604,months,0,0
91605,or,0,0
91606,expectant,0,0
91607,management,0,0
91608,for,0,0
91609,6,0,0
91610,months,0,0
91611,.,0,0
91612,The,0,0
91613,primary,0,0
91614,endpoint,0,1
91615,of,0,0
91616,our,0,0
91617,study,0,0
91618,was,0,0
91619,ongoing,1,0
91620,pregnancy,1,0
91621,within,1,0
91622,6,1,0
91623,months,1,0
91624,.,1,0
91625,Analysis,0,0
91626,was,0,0
91627,carried,0,0
91628,out,0,0
91629,according,0,0
91630,to,0,0
91631,the,0,0
91632,intention,0,0
91633,to,0,0
91634,treat,0,0
91635,principle,0,0
91636,.,0,0
91637,This,0,0
91638,study,0,0
91639,was,0,0
91640,registered,0,0
91641,with,0,0
91642,the,0,0
91643,Dutch,0,0
91644,Trial,0,0
91645,Register,0,0
91646,and,0,0
91647,has,0,0
91648,the,0,0
91649,International,0,1
91650,Standard,0,0
91651,Randomised,0,0
91652,Clinical,0,1
91653,Trial,0,0
91654,number,0,1
91655,ISRCTN72675518,0,0
91656,.,0,1
91657,RESULTS,0,0
91658,Of,0,0
91659,the,0,0
91660,253,0,0
91661,couples,0,0
91662,included,0,0
91663,",",0,0
91664,127,0,0
91665,couples,0,0
91666,were,0,0
91667,allocated,0,0
91668,to,0,0
91669,IUI,1,1
91670,with,0,0
91671,COH,1,0
91672,and,0,0
91673,126,0,0
91674,to,0,0
91675,expectant,1,0
91676,management,1,0
91677,.,1,0
91678,In,0,0
91679,the,0,0
91680,intervention,0,0
91681,group,0,0
91682,",",0,0
91683,42,0,0
91684,women,0,0
91685,(,0,0
91686,33,0,0
91687,%,0,0
91688,),0,0
91689,conceived,0,0
91690,",",0,0
91691,of,0,0
91692,which,0,0
91693,29,0,0
91694,pregnancies,0,0
91695,were,0,0
91696,ongoing,0,0
91697,(,0,0
91698,23,0,0
91699,%,0,0
91700,),0,0
91701,.,0,0
91702,In,0,0
91703,the,0,0
91704,expectant,0,0
91705,management,0,0
91706,group,0,0
91707,",",0,0
91708,40,0,0
91709,women,0,0
91710,(,0,0
91711,32,0,0
91712,%,0,0
91713,),0,0
91714,conceived,1,0
91715,",",0,0
91716,of,0,0
91717,which,0,0
91718,34,0,0
91719,pregnancies,0,0
91720,were,0,0
91721,ongoing,1,0
91722,(,0,0
91723,27,0,0
91724,%,0,0
91725,),0,0
91726,(,0,0
91727,relative,0,1
91728,risk,0,1
91729,:,0,0
91730,0.85,0,0
91731,;,0,0
91732,95,0,0
91733,%,0,0
91734,CI,0,0
91735,:,0,0
91736,0.63-1.1,0,0
91737,),0,0
91738,.,0,0
91739,In,0,0
91740,the,0,0
91741,expectant,0,0
91742,management,0,0
91743,group,0,0
91744,one,0,0
91745,twin,1,0
91746,pregnancy,1,0
91747,occurred,0,0
91748,and,0,0
91749,in,0,0
91750,the,0,0
91751,intervention,0,0
91752,group,0,0
91753,one,0,0
91754,woman,0,0
91755,conceived,0,0
91756,twins,1,1
91757,and,1,0
91758,one,1,0
91759,a,1,0
91760,triplet,1,0
91761,.,1,0
91762,CONCLUSION,0,0
91763,A,0,0
91764,substantial,0,0
91765,beneficial,0,0
91766,effect,0,1
91767,of,0,1
91768,IUI,1,1
91769,with,1,0
91770,COH,1,0
91771,in,0,0
91772,couples,0,0
91773,with,0,0
91774,unexplained,1,1
91775,subfertility,1,1
91776,and,0,0
91777,an,0,0
91778,intermediate,0,0
91779,prognosis,0,0
91780,can,0,0
91781,be,0,0
91782,excluded,0,0
91783,.,0,0
91784,Expectant,1,1
91785,management,1,0
91786,for,0,0
91787,a,0,0
91788,period,0,0
91789,of,0,0
91790,6,0,0
91791,months,0,0
91792,therefore,0,0
91793,appears,0,0
91794,justified,0,0
91795,in,0,0
91796,these,0,0
91797,couples,0,0
91798,.,0,0
91799,Beneficial,1,0
91800,effects,1,0
91801,of,0,0
91802,a,0,0
91803,diabetes,0,0
91804,specific,0,0
91805,formula,0,0
91806,on,0,0
91807,insulin,1,1
91808,sensitivity,1,1
91809,and,1,1
91810,free,1,1
91811,fatty,1,1
91812,acid,1,1
91813,in,0,0
91814,patients,0,0
91815,with,0,0
91816,type,0,0
91817,2,0,0
91818,diabetes,0,0
91819,mellitus,0,0
91820,.,0,0
91821,BACKGROUND,0,0
91822,This,0,0
91823,prospective,0,0
91824,",",0,0
91825,randomized,0,0
91826,",",0,0
91827,controlled,0,0
91828,study,0,0
91829,was,0,0
91830,designed,0,0
91831,to,0,0
91832,investigate,0,0
91833,the,0,0
91834,effects,0,0
91835,of,0,0
91836,a,0,0
91837,diabetes,0,0
91838,specific,0,0
91839,formula,0,0
91840,(,0,0
91841,Diason,0,1
91842,low,0,0
91843,energy,0,0
91844,:,0,0
91845,313.8,0,0
91846,kJ/100,0,0
91847,ml,0,0
91848,),0,1
91849,",",0,0
91850,compared,0,0
91851,with,0,0
91852,a,0,0
91853,standard,0,0
91854,formula,0,0
91855,",",0,0
91856,on,0,0
91857,insulin,1,1
91858,sensitivity,1,1
91859,",",1,1
91860,serum,1,1
91861,C,1,1
91862,peptide,1,1
91863,",",1,1
91864,serum,1,1
91865,lipids,1,1
91866,and,1,1
91867,free,1,1
91868,fatty,1,1
91869,acid,1,1
91870,(,1,1
91871,FFA,1,0
91872,),1,1
91873,in,0,0
91874,type,0,0
91875,2,0,0
91876,diabetics,0,0
91877,.,0,0
91878,METHODS,0,0
91879,In,0,0
91880,total,0,1
91881,of,0,0
91882,71,0,0
91883,type,0,0
91884,2,0,0
91885,diabetics,0,0
91886,completed,0,0
91887,the,0,0
91888,study,0,0
91889,.,0,0
91890,Enteral,0,0
91891,formulas,0,0
91892,were,0,0
91893,given,0,0
91894,orally,0,0
91895,as,0,0
91896,the,0,0
91897,sole,0,0
91898,source,0,0
91899,of,0,0
91900,nutrition,0,1
91901,to,0,0
91902,the,0,0
91903,subjects,0,0
91904,for,0,0
91905,6,0,0
91906,days,0,0
91907,.,0,0
91908,Venous,0,1
91909,blood,0,1
91910,samples,0,0
91911,(,0,0
91912,0.5,0,0
91913,",",0,0
91914,1,0,0
91915,",",0,0
91916,2,0,0
91917,",",0,0
91918,3,0,0
91919,hours,0,0
91920,),0,0
91921,were,0,0
91922,collected,0,0
91923,at,0,0
91924,day-7,0,0
91925,after,0,0
91926,a,0,0
91927,75,0,0
91928,g,0,0
91929,oral,0,0
91930,glucose,0,1
91931,tolerance,0,1
91932,test,0,1
91933,(,0,1
91934,OGTT,0,1
91935,),0,1
91936,",",0,0
91937,day,0,0
91938,1,0,0
91939,after,0,0
91940,a,0,0
91941,standard,0,0
91942,test,0,1
91943,meal,0,0
91944,(,0,0
91945,1673.6,0,0
91946,kJ,0,0
91947,),0,0
91948,and,0,0
91949,after,0,0
91950,6,0,0
91951,days,0,0
91952,of,0,0
91953,either,0,0
91954,the,0,0
91955,test,0,0
91956,diabetes,0,0
91957,specific,0,0
91958,formula,0,0
91959,or,0,0
91960,a,0,0
91961,standard,0,0
91962,formula,0,0
91963,.,0,1
91964,Plasma,1,1
91965,glucose,1,1
91966,",",1,1
91967,serum,1,1
91968,insulin,1,1
91969,",",1,1
91970,C,1,1
91971,peptide,1,1
91972,and,1,1
91973,lipids,1,1
91974,were,0,0
91975,measured,0,0
91976,.,0,0
91977,RESULTS,0,0
91978,After,0,0
91979,the,0,0
91980,intervention,0,0
91981,period,0,0
91982,",",0,0
91983,the,0,0
91984,diabetes,0,0
91985,specific,0,0
91986,formula,0,0
91987,resulted,0,0
91988,in,0,0
91989,a,0,0
91990,significantly,0,0
91991,lower,0,0
91992,postprandial,1,1
91993,rise,1,1
91994,in,1,0
91995,blood,1,1
91996,glucose,1,1
91997,concentrations,1,1
91998,at,0,0
91999,0.5,0,0
92000,hour,0,0
92001,(,0,0
92002,P,0,0
92003,<,0,0
92004,0.05,0,0
92005,),0,0
92006,and,0,0
92007,1,0,0
92008,hour,0,0
92009,(,0,0
92010,P,0,0
92011,<,0,0
92012,0.01,0,0
92013,),0,0
92014,;,0,0
92015,significantly,0,0
92016,lower,0,0
92017,peak,1,1
92018,height,1,1
92019,of,1,1
92020,plasma,1,1
92021,glucose,1,1
92022,(,0,1
92023,P,0,0
92024,=,0,0
92025,0.05,0,0
92026,),0,0
92027,;,0,0
92028,significantly,0,0
92029,lower,0,0
92030,plasma,1,1
92031,insulin,1,1
92032,concentrations,1,1
92033,at,0,0
92034,0.5,0,0
92035,hour,0,0
92036,(,0,0
92037,P,0,0
92038,<,0,0
92039,0.01,0,0
92040,),0,0
92041,",",0,0
92042,1,0,0
92043,hour,0,0
92044,(,0,0
92045,P,0,0
92046,<,0,0
92047,0.01,0,0
92048,),0,0
92049,and,0,0
92050,2,0,0
92051,hours,0,0
92052,(,0,0
92053,P,0,0
92054,<,0,0
92055,0.01,0,0
92056,),0,0
92057,;,0,0
92058,and,0,0
92059,a,0,0
92060,significantly,0,0
92061,lower,0,0
92062,plasma,1,1
92063,insulin,1,1
92064,peak,1,1
92065,compared,0,0
92066,to,0,0
92067,controls,0,0
92068,;,0,0
92069,both,0,0
92070,OGTT,0,0
92071,and,0,0
92072,a,0,0
92073,standard,0,0
92074,test,0,1
92075,meal,0,1
92076,(,0,1
92077,P,0,0
92078,<,0,0
92079,0.05,0,0
92080,),0,0
92081,.,0,0
92082,The,0,0
92083,glucose,1,1
92084,and,1,1
92085,insulin,1,1
92086,area,0,1
92087,under,0,0
92088,the,0,0
92089,curve,0,1
92090,after,0,0
92091,the,0,0
92092,diabetes,0,0
92093,specific,0,0
92094,formula,0,0
92095,compared,0,0
92096,to,0,0
92097,the,0,0
92098,standard,0,0
92099,formula,0,0
92100,were,0,0
92101,significantly,0,0
92102,lower,0,0
92103,.,0,0
92104,The,0,0
92105,C,1,0
92106,peptide,1,1
92107,level,1,1
92108,was,0,0
92109,lower,0,0
92110,after,0,0
92111,6,0,0
92112,days,0,0
92113,of,0,0
92114,both,0,0
92115,nutrition,0,0
92116,formulas,0,0
92117,compare,0,0
92118,to,0,0
92119,75,0,0
92120,g,0,0
92121,OGTT,0,0
92122,",",0,1
92123,but,0,0
92124,not,0,0
92125,different,0,0
92126,from,0,0
92127,the,0,0
92128,standard,0,0
92129,mixed,0,0
92130,meal,0,0
92131,.,0,0
92132,Both,0,0
92133,formulas,0,0
92134,were,0,0
92135,well,0,0
92136,tolerated,0,1
92137,.,0,0
92138,CONCLUSIONS,0,0
92139,In,0,0
92140,summary,0,0
92141,the,0,0
92142,diabetes,0,0
92143,specific,0,0
92144,formula,0,0
92145,with,0,0
92146,a,0,0
92147,relatively,0,0
92148,high,0,0
92149,monounsaturated,0,1
92150,fatty,0,1
92151,acid,0,0
92152,and,0,1
92153,high,0,1
92154,multi,0,0
92155,fiber,0,0
92156,proportion,0,1
92157,significantly,0,0
92158,improved,0,0
92159,glycemic,1,1
92160,control,1,0
92161,.,1,0
92162,On,0,0
92163,top,0,0
92164,of,0,0
92165,this,0,0
92166,",",0,0
92167,the,0,0
92168,insulin,1,1
92169,sensitivity,1,1
92170,(,1,1
92171,HOMA-IS,1,1
92172,),1,1
92173,was,0,0
92174,significantly,0,0
92175,improved,0,0
92176,and,0,0
92177,may,0,0
92178,therefore,0,0
92179,directly,0,0
92180,improve,0,0
92181,the,0,0
92182,impact,0,0
92183,on,0,0
92184,long,0,0
92185,term,0,0
92186,complications,0,1
92187,.,0,0
92188,The,0,0
92189,disease,0,1
92190,specific,0,0
92191,formula,0,0
92192,should,0,0
92193,therefore,0,0
92194,be,0,0
92195,the,0,0
92196,preferred,0,0
92197,option,0,0
92198,to,0,0
92199,be,0,0
92200,used,0,0
92201,by,0,0
92202,diabetic,0,0
92203,and,0,1
92204,hyperglycemic,0,1
92205,patients,0,0
92206,in,0,0
92207,need,0,0
92208,of,0,1
92209,nutritional,0,1
92210,support,0,0
92211,.,0,0
92212,Association,0,0
92213,of,0,1
92214,chronic,0,0
92215,kidney,0,0
92216,disease,0,1
92217,with,0,0
92218,outcomes,0,1
92219,in,0,0
92220,chronic,1,0
92221,heart,1,1
92222,failure,1,0
92223,:,1,0
92224,a,0,0
92225,propensity-matched,0,0
92226,study,0,0
92227,.,0,0
92228,BACKGROUND,0,0
92229,Chronic,0,1
92230,kidney,0,0
92231,disease,0,1
92232,(,0,1
92233,CKD,0,0
92234,),0,0
92235,is,0,0
92236,associated,0,0
92237,with,0,0
92238,increased,0,0
92239,mortality,1,1
92240,in,0,0
92241,patients,0,0
92242,with,0,0
92243,heart,0,1
92244,failure,0,1
92245,(,0,1
92246,HF,0,0
92247,),0,0
92248,.,0,0
92249,However,0,0
92250,",",0,0
92251,its,0,0
92252,association,0,0
92253,with,0,0
92254,hospitalization,0,1
92255,in,0,0
92256,HF,0,0
92257,patients,0,0
92258,has,0,0
92259,not,0,0
92260,been,0,0
92261,well,0,0
92262,studied,0,0
92263,.,0,0
92264,METHODS,0,0
92265,Of,0,0
92266,7788,0,0
92267,patients,0,0
92268,in,0,0
92269,the,0,0
92270,Digitalis,0,0
92271,Investigation,0,0
92272,Group,0,0
92273,trial,0,0
92274,",",0,0
92275,3527,0,0
92276,had,0,0
92277,CKD,0,0
92278,",",0,0
92279,defined,0,1
92280,by,0,0
92281,an,0,0
92282,estimated,0,0
92283,glomerular,0,1
92284,filtration,0,1
92285,rate,0,1
92286,(,0,1
92287,GFR,0,1
92288,),0,0
92289,<,0,0
92290,60,0,0
92291,ml/min/1.73,0,0
92292,m,0,0
92293,(,0,0
92294,2,0,0
92295,),0,0
92296,body,0,0
92297,surface,0,1
92298,area,0,1
92299,(,0,1
92300,BSA,0,0
92301,),0,0
92302,.,0,0
92303,Propensity,0,0
92304,scores,0,1
92305,for,0,0
92306,CKD,0,0
92307,were,0,0
92308,calculated,0,0
92309,using,0,0
92310,a,0,0
92311,multivariable,0,0
92312,logistic,0,0
92313,regression,0,1
92314,model,0,0
92315,and,0,1
92316,used,0,0
92317,to,0,0
92318,match,0,0
92319,2399,0,0
92320,pairs,0,0
92321,of,0,0
92322,patients,0,0
92323,with,0,0
92324,and,0,0
92325,without,0,0
92326,CKD,0,0
92327,.,0,0
92328,Matched,0,0
92329,Cox,0,0
92330,regression,0,1
92331,analyses,0,0
92332,were,0,0
92333,used,0,0
92334,to,0,0
92335,estimate,0,0
92336,association,0,0
92337,of,0,0
92338,CKD,0,0
92339,with,0,0
92340,outcomes,0,1
92341,.,0,0
92342,RESULTS,0,0
92343,All-cause,1,1
92344,hospitalization,1,1
92345,occurred,0,0
92346,in,0,0
92347,1636,0,0
92348,(,0,0
92349,rate,0,1
92350,",",0,0
92351,"4233/10,000",0,0
92352,person-years,0,0
92353,),0,0
92354,and,0,0
92355,1587,0,0
92356,(,0,0
92357,rate,0,1
92358,",",0,0
92359,"3733/10,000",0,0
92360,person-years,0,0
92361,),0,0
92362,patients,0,0
92363,respectively,0,0
92364,",",0,0
92365,with,0,0
92366,and,0,1
92367,without,0,0
92368,CKD,0,0
92369,(,0,0
92370,matched,0,0
92371,hazard,0,0
92372,ratio,0,1
92373,[,0,0
92374,HR,0,1
92375,],0,0
92376,for,0,0
92377,CKD,0,0
92378,",",0,0
92379,1.18,0,0
92380,",",0,0
92381,95,0,0
92382,%,0,0
92383,confidence,0,0
92384,interval,0,0
92385,[,0,0
92386,CI,0,0
92387,],0,0
92388,",",0,0
92389,1.08-1.29,0,0
92390,;,0,0
92391,P,0,0
92392,<,0,0
92393,0.0001,0,0
92394,),0,0
92395,.,0,0
92396,Matched,1,0
92397,HR,1,0
92398,for,1,0
92399,cardiovascular,1,1
92400,and,1,1
92401,HF,1,1
92402,hospitalization,1,1
92403,were,0,0
92404,respectively,0,0
92405,1.17,0,0
92406,(,0,0
92407,95,0,0
92408,%,0,0
92409,CI,0,0
92410,",",0,1
92411,1.06-1.28,0,0
92412,",",0,1
92413,P,0,0
92414,=,0,0
92415,0.002,0,0
92416,),0,0
92417,and,0,0
92418,1.28,0,0
92419,(,0,0
92420,95,0,0
92421,%,0,0
92422,CI,0,0
92423,",",0,1
92424,1.13-1.45,0,0
92425,",",0,1
92426,P,0,0
92427,<,0,0
92428,0.0001,0,0
92429,),0,0
92430,.,0,0
92431,Compared,0,0
92432,to,0,0
92433,GFR,0,0
92434,>,0,0
92435,or=60,0,0
92436,ml/min/1.73,0,1
92437,m,0,0
92438,(,0,0
92439,2,0,0
92440,),0,0
92441,BSA,0,0
92442,",",0,0
92443,HR,1,1
92444,for,1,0
92445,all-cause,1,1
92446,hospitalization,1,1
92447,for,1,0
92448,GFR,1,0
92449,45-59,0,0
92450,and,0,0
92451,<,0,0
92452,45,0,0
92453,ml/min/1.73,0,0
92454,m,0,0
92455,(,0,0
92456,2,0,0
92457,),0,0
92458,BSA,0,0
92459,were,0,0
92460,respectively,0,0
92461,1.04,0,0
92462,(,0,0
92463,95,0,0
92464,%,0,0
92465,CI,0,0
92466,",",0,0
92467,0.94-1.16,0,0
92468,;,0,1
92469,P,0,0
92470,=,0,0
92471,0.422,0,0
92472,),0,0
92473,and,0,0
92474,1.58,0,0
92475,(,0,0
92476,95,0,0
92477,%,0,0
92478,CI,0,0
92479,",",0,0
92480,1.34-1.87,0,0
92481,;,0,0
92482,P,0,0
92483,<,0,0
92484,0.0001,0,0
92485,),0,0
92486,.,0,0
92487,Similarly,0,0
92488,",",0,0
92489,HR,1,1
92490,for,1,0
92491,all-cause,1,1
92492,death,1,1
92493,for,1,0
92494,GFR,1,0
92495,45-59,1,0
92496,and,1,0
92497,<,1,0
92498,45,1,0
92499,ml/min/1.73,1,0
92500,m,1,0
92501,(,1,0
92502,2,1,0
92503,),1,0
92504,BSA,1,0
92505,were,0,0
92506,respectively,0,0
92507,1.03,0,0
92508,(,0,0
92509,95,0,0
92510,%,0,0
92511,CI,0,0
92512,",",0,0
92513,0.90-1.18,0,0
92514,;,0,1
92515,P,0,0
92516,=,0,0
92517,0.651,0,0
92518,),0,0
92519,and,0,0
92520,1.70,0,0
92521,(,0,0
92522,95,0,0
92523,%,0,0
92524,CI,0,0
92525,",",0,0
92526,1.40-2.07,0,0
92527,;,0,0
92528,P,0,0
92529,<,0,0
92530,0.0001,0,0
92531,),0,0
92532,.,0,0
92533,Matched,1,0
92534,HR,1,0
92535,for,1,0
92536,death,1,1
92537,due,1,0
92538,to,1,0
92539,cardiovascular,1,1
92540,causes,1,0
92541,and,1,1
92542,progressive,1,1
92543,HF,1,1
92544,were,0,0
92545,respectively,0,0
92546,1.24,0,0
92547,(,0,0
92548,95,0,0
92549,%,0,0
92550,CI,0,0
92551,",",0,0
92552,1.09-1.40,0,0
92553,;,0,0
92554,P,0,0
92555,=,0,0
92556,0.001,0,0
92557,),0,0
92558,and,0,0
92559,1.42,0,0
92560,(,0,0
92561,95,0,0
92562,%,0,0
92563,CI,0,0
92564,",",0,0
92565,1.16-1.72,0,0
92566,;,0,0
92567,P,0,0
92568,=,0,0
92569,0.001,0,0
92570,),0,0
92571,.,0,0
92572,CONCLUSION,0,0
92573,CKD,0,0
92574,was,0,0
92575,associated,0,0
92576,with,0,0
92577,increased,0,0
92578,mortality,1,1
92579,and,1,1
92580,hospitalization,1,1
92581,in,0,0
92582,ambulatory,0,0
92583,patients,0,0
92584,with,0,0
92585,chronic,0,0
92586,HF,0,0
92587,",",0,1
92588,which,0,0
92589,increased,0,0
92590,progressively,0,0
92591,with,0,0
92592,worsening,0,1
92593,kidney,1,0
92594,function,1,1
92595,.,1,0
92596,A,0,0
92597,prospective,0,0
92598,study,0,0
92599,on,0,0
92600,the,0,0
92601,clinical,0,0
92602,performance,0,1
92603,of,0,1
92604,polysiloxane,0,0
92605,soft,0,0
92606,liners,0,0
92607,:,0,0
92608,one-year,0,1
92609,results,0,0
92610,.,0,0
92611,OBJECTIVE,0,0
92612,The,0,0
92613,aim,0,0
92614,of,0,0
92615,the,0,0
92616,present,0,0
92617,study,0,0
92618,was,0,0
92619,to,0,0
92620,evaluate,0,0
92621,the,0,0
92622,clinical,0,0
92623,performance,0,1
92624,of,0,0
92625,four,0,0
92626,denture,0,0
92627,soft,0,0
92628,liners,0,0
92629,up,0,0
92630,to,0,0
92631,12,0,0
92632,months,0,0
92633,.,0,0
92634,MATERIALS,0,0
92635,AND,0,0
92636,METHODS,0,0
92637,Thirty-three,0,0
92638,edentulous,0,0
92639,patients,0,0
92640,who,0,0
92641,experienced,0,0
92642,difficulties,0,0
92643,when,0,0
92644,using,0,0
92645,hard,0,1
92646,denture,0,1
92647,bases,0,1
92648,because,0,0
92649,of,0,0
92650,changes,0,1
92651,in,0,0
92652,denture-supporting,0,1
92653,tissues,0,1
92654,were,0,0
92655,accepted,0,0
92656,for,0,0
92657,the,0,0
92658,study,0,0
92659,and,0,1
92660,randomly,0,0
92661,received,0,0
92662,Molloplast,0,0
92663,B,0,1
92664,",",0,1
92665,GC,0,1
92666,Reline,0,1
92667,Soft,0,0
92668,",",0,1
92669,Silagum,0,1
92670,Comfort,0,1
92671,",",0,1
92672,or,0,1
92673,Mollosil,0,0
92674,Plus,0,0
92675,relines,0,0
92676,.,0,0
92677,Performance,0,1
92678,of,0,0
92679,the,0,0
92680,materials,0,0
92681,was,0,0
92682,evaluated,0,0
92683,using,0,0
92684,nine,0,0
92685,criteria,0,0
92686,at,0,0
92687,3,0,0
92688,",",0,0
92689,6,0,0
92690,",",0,0
92691,and,0,0
92692,12,0,0
92693,months,0,0
92694,:,0,0
92695,physical,1,1
92696,integrity,1,1
92697,",",1,1
92698,surface,1,1
92699,detail,1,1
92700,",",1,1
92701,adhesion,1,1
92702,",",1,1
92703,color,1,1
92704,",",1,1
92705,odor,1,1
92706,",",1,1
92707,plaque,1,1
92708,accumulation,1,1
92709,",",1,1
92710,resilience,1,1
92711,",",1,1
92712,hygiene,1,1
92713,",",1,1
92714,and,1,1
92715,mucosal,1,1
92716,condition,1,0
92717,.,1,0
92718,A,0,0
92719,four-point,0,1
92720,categorized,0,0
92721,scale,0,1
92722,(,0,0
92723,1=poor,0,1
92724,",",0,0
92725,2=fair,0,0
92726,",",0,0
92727,3=good,0,1
92728,",",0,0
92729,4=excellent,0,1
92730,),0,0
92731,was,0,0
92732,used,0,0
92733,.,0,0
92734,Unscheduled,1,0
92735,maintenance,1,0
92736,events,1,1
92737,and,1,0
92738,the,1,0
92739,presence,1,0
92740,of,1,0
92741,fungal,1,1
92742,colonization,1,1
92743,were,0,0
92744,also,0,0
92745,recorded,0,0
92746,.,0,0
92747,RESULTS,0,0
92748,The,0,0
92749,percentage,0,1
92750,of,0,0
92751,patients,0,0
92752,available,0,0
92753,at,0,0
92754,3,0,0
92755,",",0,0
92756,6,0,0
92757,",",0,0
92758,and,0,0
92759,12,0,0
92760,months,0,0
92761,were,0,0
92762,91,0,0
92763,%,0,0
92764,",",0,0
92765,91,0,0
92766,%,0,0
92767,",",0,0
92768,and,0,0
92769,66,0,0
92770,%,0,0
92771,.,0,0
92772,Main,0,0
92773,reasons,0,0
92774,for,0,0
92775,dropouts,0,0
92776,and,0,1
92777,discontinuation,0,1
92778,were,0,0
92779,fractured,1,1
92780,dentures,1,1
92781,and,1,0
92782,patient,1,1
92783,dissatisfaction,1,1
92784,.,1,0
92785,At,0,0
92786,6,0,0
92787,months,0,0
92788,",",0,0
92789,96,0,0
92790,%,0,0
92791,of,0,0
92792,the,0,0
92793,performance,1,1
92794,scores,1,1
92795,were,0,0
92796,good,0,0
92797,or,0,1
92798,excellent,0,1
92799,and,0,0
92800,the,0,0
92801,largest,0,0
92802,changes,0,1
92803,were,0,0
92804,observed,0,0
92805,for,0,0
92806,physical,1,1
92807,integrity,1,1
92808,",",1,1
92809,surface,1,1
92810,detail,1,1
92811,",",1,1
92812,color,1,1
92813,",",1,1
92814,and,1,1
92815,fungal,1,1
92816,colonization,1,1
92817,.,1,1
92818,Fungal,1,1
92819,colonization,1,1
92820,was,0,0
92821,the,0,0
92822,most,0,0
92823,commonly,0,0
92824,observed,0,0
92825,problem,0,0
92826,and,0,0
92827,was,0,0
92828,the,0,0
92829,only,0,0
92830,reason,0,0
92831,of,0,1
92832,failure,0,0
92833,at,0,0
92834,12,0,0
92835,months,0,0
92836,.,0,0
92837,CONCLUSIONS,0,0
92838,The,0,0
92839,clinical,0,0
92840,performance,0,1
92841,of,0,0
92842,all,0,0
92843,soft,0,0
92844,liners,0,0
92845,was,0,0
92846,slightly,0,0
92847,impaired,0,0
92848,over,0,0
92849,the,0,0
92850,12-month,0,0
92851,observation,0,0
92852,.,0,0
92853,Except,0,0
92854,for,0,0
92855,cases,0,0
92856,showing,0,0
92857,extensive,0,0
92858,fungal,1,1
92859,colonization,1,1
92860,",",0,0
92861,the,0,0
92862,observed,0,0
92863,changes,0,1
92864,in,0,0
92865,clinical,0,1
92866,performance,0,1
92867,did,0,0
92868,not,0,0
92869,necessitate,0,0
92870,remaking,0,0
92871,of,0,0
92872,the,0,0
92873,dentures,0,0
92874,.,0,0
92875,Mollosil,0,0
92876,Plus,0,0
92877,showed,0,0
92878,a,0,0
92879,performance,0,1
92880,comparable,0,0
92881,to,0,0
92882,that,0,0
92883,of,0,0
92884,Molloplast,0,0
92885,B,0,1
92886,",",0,0
92887,and,0,0
92888,the,0,0
92889,other,0,0
92890,materials,0,0
92891,had,0,0
92892,slightly,0,0
92893,lower,0,0
92894,performance,0,1
92895,especially,0,0
92896,in,0,0
92897,terms,0,1
92898,of,0,0
92899,fungal,1,0
92900,colonization,1,1
92901,.,1,0
92902,Treatment,0,0
92903,of,0,1
92904,posterior,0,0
92905,uveitis,0,1
92906,with,0,0
92907,a,0,0
92908,fluocinolone,0,0
92909,acetonide,0,0
92910,implant,0,0
92911,:,0,0
92912,three-year,0,0
92913,clinical,0,0
92914,trial,0,0
92915,results,0,0
92916,.,0,0
92917,OBJECTIVES,0,0
92918,To,0,0
92919,evaluate,0,0
92920,the,0,0
92921,safety,1,1
92922,and,1,1
92923,efficacy,1,1
92924,of,0,1
92925,0.59-mg,0,0
92926,and,0,1
92927,2.1-mg,0,0
92928,fluocinolone,0,0
92929,acetonide,0,0
92930,(,0,1
92931,FA,0,0
92932,),0,1
92933,intravitreous,0,0
92934,implants,0,0
92935,in,0,0
92936,noninfectious,0,0
92937,posterior,0,0
92938,uveitis,0,1
92939,.,0,0
92940,DESIGN,0,0
92941,A,0,0
92942,3-year,0,0
92943,",",0,0
92944,multicenter,0,0
92945,",",0,1
92946,randomized,0,0
92947,",",0,0
92948,historically,0,0
92949,controlled,0,0
92950,trial,0,0
92951,of,0,0
92952,the,0,0
92953,0.59-mg,0,0
92954,FA,0,0
92955,intravitreous,0,0
92956,implant,0,0
92957,in,0,0
92958,110,0,0
92959,patients,0,0
92960,and,0,0
92961,the,0,0
92962,2.1-mg,0,0
92963,FA,0,0
92964,intravitreous,0,0
92965,implant,0,0
92966,in,0,0
92967,168,0,0
92968,patients,0,0
92969,.,0,0
92970,MAIN,0,0
92971,OUTCOME,0,1
92972,MEASURES,0,1
92973,Recurrence,1,1
92974,rate,1,1
92975,",",1,1
92976,vision,1,1
92977,",",1,1
92978,and,1,1
92979,complications,1,1
92980,.,1,1
92981,RESULTS,0,0
92982,Uveitis,1,1
92983,recurrence,1,1
92984,was,1,0
92985,reduced,1,0
92986,in,0,0
92987,implanted,0,0
92988,eyes,0,0
92989,from,0,0
92990,62,0,0
92991,%,0,0
92992,(,0,0
92993,during,0,0
92994,the,0,0
92995,1-year,0,1
92996,preimplantation,0,0
92997,period,0,0
92998,),0,0
92999,to,0,0
93000,4,0,0
93001,%,0,0
93002,",",0,0
93003,10,0,0
93004,%,0,0
93005,",",0,0
93006,and,0,0
93007,20,0,0
93008,%,0,0
93009,during,0,0
93010,the,0,0
93011,1-,0,0
93012,",",0,0
93013,2-,0,0
93014,",",0,1
93015,and,0,1
93016,3-year,0,0
93017,postimplantation,0,1
93018,periods,0,1
93019,",",0,0
93020,respectively,0,0
93021,",",0,0
93022,for,0,0
93023,the,0,0
93024,0.59-mg,0,0
93025,dose,0,0
93026,group,0,0
93027,(,0,1
93028,P,0,0
93029,<,0,0
93030,.01,0,1
93031,),0,1
93032,and,0,0
93033,from,0,0
93034,58,0,0
93035,%,0,0
93036,to,0,0
93037,7,0,0
93038,%,0,0
93039,",",0,0
93040,17,0,0
93041,%,0,0
93042,",",0,0
93043,and,0,0
93044,41,0,0
93045,%,0,0
93046,",",0,0
93047,respectively,0,0
93048,",",0,0
93049,for,0,0
93050,the,0,0
93051,2.1-mg,0,0
93052,dose,0,0
93053,group,0,0
93054,(,0,1
93055,P,0,0
93056,<,0,0
93057,.01,0,0
93058,),0,0
93059,.,0,0
93060,More,0,0
93061,implanted,0,0
93062,eyes,0,0
93063,than,0,0
93064,nonimplanted,0,0
93065,eyes,0,0
93066,had,0,0
93067,improved,1,0
93068,visual,1,1
93069,acuity,1,1
93070,(,0,0
93071,P,0,0
93072,<,0,0
93073,.01,0,0
93074,),0,0
93075,.,0,0
93076,Implanted,1,0
93077,eyes,1,0
93078,had,1,0
93079,higher,1,0
93080,incidences,1,1
93081,of,1,1
93082,intraocular,1,1
93083,pressure,1,1
93084,elevation,1,1
93085,(,0,0
93086,>,0,0
93087,or,0,0
93088,=,0,0
93089,10,0,0
93090,mm,0,0
93091,Hg,0,0
93092,),0,0
93093,than,0,0
93094,nonimplanted,0,0
93095,eyes,0,0
93096,(,0,0
93097,P,0,0
93098,<,0,0
93099,.01,0,1
93100,),0,1
93101,",",0,1
93102,and,0,1
93103,glaucoma,1,1
93104,surgery,1,0
93105,was,0,0
93106,required,0,0
93107,in,0,0
93108,40,0,0
93109,%,0,0
93110,of,0,0
93111,implanted,0,0
93112,eyes,0,0
93113,vs,0,0
93114,2,0,0
93115,%,0,0
93116,of,0,0
93117,nonimplanted,0,0
93118,eyes,0,0
93119,(,0,0
93120,P,0,0
93121,<,0,0
93122,.01,0,0
93123,),0,0
93124,.,0,0
93125,Cataracts,1,0
93126,were,0,0
93127,extracted,0,0
93128,in,0,0
93129,93,0,0
93130,%,0,0
93131,of,0,0
93132,phakic,0,0
93133,implanted,0,0
93134,eyes,0,0
93135,vs,0,0
93136,20,0,0
93137,%,0,0
93138,of,0,0
93139,phakic,0,0
93140,nonimplanted,0,0
93141,eyes,0,0
93142,(,0,0
93143,P,0,0
93144,<,0,0
93145,.01,0,0
93146,),0,0
93147,.,0,0
93148,CONCLUSIONS,0,0
93149,The,0,0
93150,FA,0,0
93151,implant,0,0
93152,significantly,0,0
93153,reduced,1,0
93154,uveitis,1,1
93155,recurrence,1,1
93156,and,1,1
93157,improved,1,1
93158,or,1,0
93159,stabilized,1,0
93160,visual,1,1
93161,acuity,1,1
93162,in,0,0
93163,subjects,0,0
93164,with,0,0
93165,noninfectious,0,0
93166,posterior,0,0
93167,uveitis,0,1
93168,.,0,0
93169,Most,0,0
93170,subjects,0,0
93171,required,0,0
93172,cataract,1,0
93173,extraction,1,1
93174,",",0,0
93175,and,0,0
93176,a,0,0
93177,significant,0,0
93178,proportion,0,1
93179,required,0,1
93180,intraocular,1,1
93181,pressure-lowering,1,0
93182,surgery,1,0
93183,.,1,0
93184,APPLICATION,0,0
93185,TO,0,1
93186,CLINICAL,0,0
93187,PRACTICE,0,0
93188,The,0,0
93189,FA,0,0
93190,implant,0,0
93191,provides,0,0
93192,an,0,0
93193,alternative,0,0
93194,therapy,0,0
93195,for,0,0
93196,prolonged,0,1
93197,control,0,0
93198,of,0,1
93199,inflammation,0,1
93200,in,0,0
93201,noninfectious,0,1
93202,posterior,0,0
93203,uveitis,0,1
93204,.,0,0
93205,TRIAL,0,0
93206,REGISTRATION,0,0
93207,clinicaltrials.gov,0,0
93208,Identifier,0,0
93209,:,0,0
93210,NCT00407082,0,0
93211,.,0,0
93212,CASTLE,0,1
93213,data,0,0
93214,show,0,0
93215,no,0,0
93216,gender,0,0
93217,differences,0,0
93218,.,0,0
93219,Influence,0,1
93220,of,0,1
93221,phase-related,0,1
93222,variability,0,1
93223,in,0,0
93224,premenstrual,1,1
93225,symptomatology,1,1
93226,",",1,1
93227,mood,1,1
93228,",",1,1
93229,smoking,1,1
93230,withdrawal,1,1
93231,",",1,1
93232,and,1,1
93233,smoking,1,1
93234,behavior,1,1
93235,during,1,0
93236,ad,1,1
93237,libitum,1,0
93238,smoking,1,1
93239,",",1,0
93240,on,1,0
93241,smoking,1,1
93242,cessation,1,0
93243,outcome,1,1
93244,.,1,1
93245,Emerging,0,0
93246,evidence,0,0
93247,suggests,0,0
93248,that,0,0
93249,women,0,0
93250,have,0,0
93251,a,0,0
93252,more,0,0
93253,difficult,0,0
93254,time,0,1
93255,quitting,1,1
93256,smoking,1,1
93257,than,0,0
93258,men-possibly,0,1
93259,due,0,0
93260,",",0,0
93261,in,0,0
93262,part,0,0
93263,",",0,0
93264,to,0,0
93265,sex,0,0
93266,hormones,0,1
93267,.,0,0
93268,The,0,0
93269,present,0,0
93270,study,0,0
93271,characterized,0,1
93272,mood,1,1
93273,",",1,1
93274,premenstrual,1,1
93275,symptomatology,1,1
93276,",",1,1
93277,and,1,1
93278,smoking,1,1
93279,withdrawal,1,1
93280,",",1,0
93281,as,1,0
93282,well,1,0
93283,as,1,0
93284,smoking,1,1
93285,behavior,1,1
93286,",",0,0
93287,in,0,0
93288,the,0,0
93289,follicular,0,1
93290,and,0,1
93291,luteal,0,1
93292,phases,0,1
93293,during,0,0
93294,ad,0,1
93295,libitum,0,0
93296,smoking,0,1
93297,in,0,0
93298,25,0,0
93299,women,0,0
93300,intending,0,0
93301,to,0,0
93302,quit,0,0
93303,.,0,0
93304,We,0,0
93305,also,0,0
93306,investigated,0,0
93307,the,0,0
93308,possible,0,0
93309,influence,0,0
93310,of,0,1
93311,phase-related,0,1
93312,variability,0,1
93313,in,0,0
93314,these,0,0
93315,measures,0,0
93316,on,0,0
93317,likelihood,1,1
93318,of,1,1
93319,study,1,0
93320,adherence,1,1
93321,and,1,1
93322,smoking,1,1
93323,cessation,1,0
93324,.,1,0
93325,We,0,0
93326,found,0,0
93327,that,0,0
93328,premenstrual,1,1
93329,symptomatology,1,1
93330,",",0,0
93331,as,0,0
93332,well,0,0
93333,as,0,0
93334,some,0,0
93335,measures,1,0
93336,of,1,1
93337,mood,1,1
93338,and,1,1
93339,smoking,1,1
93340,withdrawal,1,1
93341,",",0,1
93342,were,0,0
93343,significantly,0,0
93344,higher,0,0
93345,during,0,0
93346,the,0,0
93347,luteal,0,1
93348,phase,0,0
93349,than,0,0
93350,in,0,0
93351,the,0,0
93352,follicular,0,1
93353,phase,0,0
93354,.,0,1
93355,Cigarettes/day,1,0
93356,did,0,0
93357,not,0,0
93358,vary,0,0
93359,by,0,0
93360,menstrual,0,1
93361,cycle,0,1
93362,phase,0,0
93363,.,0,1
93364,Phase-related,1,1
93365,variability,1,1
93366,in,0,0
93367,premenstrual,0,0
93368,symptomatology,0,1
93369,[,0,1
93370,F,0,0
93371,(,0,0
93372,3,0,0
93373,",",0,0
93374,20,0,0
93375,),0,0
93376,=2.82,0,0
93377,",",0,1
93378,p=0.0650,0,0
93379,),0,1
93380,],0,0
93381,and,0,1
93382,urge,1,1
93383,to,1,0
93384,smoke,1,0
93385,[,0,0
93386,F,0,0
93387,(,0,0
93388,2,0,0
93389,",",0,0
93390,21,0,0
93391,),0,0
93392,=4.85,0,0
93393,",",0,1
93394,p=0.0186,0,0
93395,),0,1
93396,],0,0
93397,were,0,0
93398,associated,0,0
93399,with,0,0
93400,relapse,0,1
93401,.,0,0
93402,These,0,0
93403,data,0,0
93404,support,0,0
93405,the,0,0
93406,inference,0,0
93407,that,0,0
93408,sex,0,0
93409,hormones,0,1
93410,influence,0,1
93411,smoking,1,1
93412,cessation,1,0
93413,outcome,1,1
93414,.,1,0
93415,This,0,0
93416,knowledge,0,0
93417,may,0,0
93418,contribute,0,0
93419,to,0,0
93420,the,0,0
93421,development,0,0
93422,of,0,0
93423,more,0,0
93424,rational,0,1
93425,and,0,1
93426,effective,0,1
93427,smoking,0,1
93428,cessation,0,0
93429,interventions,0,0
93430,for,0,0
93431,women,0,0
93432,.,0,0
93433,Need,0,0
93434,the,0,0
93435,thumb,0,1
93436,be,0,0
93437,immobilised,0,0
93438,in,0,0
93439,scaphoid,0,1
93440,fractures,0,0
93441,?,0,0
93442,A,0,0
93443,randomised,0,0
93444,prospective,0,0
93445,trial,0,0
93446,.,0,1
93447,Immobilisation,0,0
93448,of,0,0
93449,the,0,0
93450,thumb,0,0
93451,is,0,0
93452,widely,0,0
93453,believed,0,0
93454,to,0,0
93455,be,0,0
93456,important,0,0
93457,in,0,0
93458,the,0,0
93459,management,0,0
93460,of,0,0
93461,fractures,0,0
93462,of,0,0
93463,the,0,0
93464,carpal,0,1
93465,scaphoid,0,1
93466,.,0,0
93467,To,0,0
93468,assess,0,0
93469,the,0,0
93470,need,0,0
93471,for,0,0
93472,this,0,0
93473,",",0,0
93474,we,0,0
93475,randomly,0,0
93476,allocated,0,0
93477,392,0,0
93478,fresh,0,0
93479,fractures,0,0
93480,for,0,0
93481,treatment,0,0
93482,by,0,0
93483,either,0,0
93484,a,0,0
93485,forearm,0,1
93486,gauntlet,0,0
93487,(,0,0
93488,Colles,0,1
93489,',0,1
93490,),0,1
93491,cast,0,0
93492,",",0,0
93493,leaving,0,0
93494,the,0,0
93495,thumb,0,1
93496,free,0,1
93497,",",0,1
93498,or,0,0
93499,by,0,0
93500,a,0,0
93501,conventional,0,0
93502,'scaphoid,0,1
93503,',0,1
93504,plaster,0,0
93505,incorporating,0,0
93506,the,0,0
93507,thumb,0,1
93508,as,0,0
93509,far,0,0
93510,as,0,0
93511,its,0,0
93512,interphalangeal,0,0
93513,joint,0,1
93514,.,0,0
93515,In,0,0
93516,the,0,0
93517,292,0,0
93518,fractures,0,0
93519,which,0,0
93520,were,0,0
93521,followed,0,0
93522,for,0,0
93523,six,0,0
93524,months,0,0
93525,",",0,0
93526,the,0,0
93527,incidence,1,1
93528,of,1,1
93529,nonunion,1,1
93530,was,0,0
93531,independent,0,0
93532,of,0,0
93533,the,0,0
93534,type,0,0
93535,of,0,0
93536,cast,0,0
93537,used,0,0
93538,.,0,0
93539,Treatment,0,0
93540,with,0,0
93541,the,0,0
93542,dipeptidyl,0,0
93543,peptidase-4,0,0
93544,inhibitor,0,0
93545,vildagliptin,0,0
93546,improves,0,1
93547,fasting,0,1
93548,islet-cell,0,1
93549,function,0,1
93550,in,0,0
93551,subjects,0,0
93552,with,0,0
93553,type,0,0
93554,2,0,0
93555,diabetes,0,0
93556,.,0,0
93557,CONTEXT,0,0
93558,Dipeptidyl,0,0
93559,peptidase,0,0
93560,4,0,0
93561,(,0,0
93562,DPP-4,0,0
93563,),0,0
93564,inhibitors,0,0
93565,are,0,0
93566,proposed,0,0
93567,to,0,0
93568,lower,0,0
93569,blood,0,1
93570,glucose,0,1
93571,in,0,0
93572,type,0,0
93573,2,0,0
93574,diabetes,0,0
93575,mellitus,0,0
93576,(,0,0
93577,T2DM,0,0
93578,),0,0
93579,by,0,0
93580,prolonging,0,0
93581,the,0,0
93582,activity,0,1
93583,of,0,0
93584,the,0,0
93585,circulating,0,1
93586,incretins,0,1
93587,",",0,1
93588,glucose-dependent,0,1
93589,insulinotropic,0,1
93590,polypeptide,0,1
93591,(,0,1
93592,GIP,0,0
93593,),0,1
93594,and,0,1
93595,glucagon-like,0,1
93596,peptide,0,0
93597,1,0,0
93598,(,0,0
93599,GLP-1,0,0
93600,),0,0
93601,.,0,0
93602,Consistent,0,0
93603,with,0,0
93604,this,0,0
93605,mechanism,0,0
93606,of,0,1
93607,action,0,1
93608,",",0,1
93609,DPP-4,0,0
93610,inhibitors,0,1
93611,improve,0,0
93612,glucose,0,1
93613,tolerance,0,1
93614,after,0,0
93615,meals,0,1
93616,by,0,0
93617,increasing,0,0
93618,insulin,0,1
93619,and,0,1
93620,reducing,0,1
93621,glucagon,0,1
93622,levels,0,1
93623,in,0,0
93624,the,0,0
93625,plasma,0,1
93626,.,0,0
93627,However,0,0
93628,",",0,0
93629,DPP-4,0,0
93630,inhibitors,0,0
93631,also,0,0
93632,reduce,0,0
93633,fasting,0,1
93634,blood,0,1
93635,glucose,0,1
93636,",",0,0
93637,an,0,0
93638,unexpected,0,1
93639,effect,0,0
93640,because,0,0
93641,circulating,0,1
93642,levels,0,1
93643,of,0,0
93644,active,0,0
93645,GIP,0,0
93646,and,0,0
93647,GLP-1,0,0
93648,are,0,0
93649,low,0,0
93650,in,0,0
93651,the,0,0
93652,postabsorptive,0,1
93653,state,0,1
93654,.,0,0
93655,OBJECTIVE,0,0
93656,The,0,0
93657,objective,0,0
93658,of,0,0
93659,the,0,0
93660,study,0,0
93661,was,0,0
93662,to,0,0
93663,examine,0,0
93664,the,0,0
93665,effects,1,0
93666,of,1,0
93667,DPP-4,1,0
93668,inhibition,1,1
93669,on,1,0
93670,fasting,1,1
93671,islet,1,1
93672,function,1,1
93673,.,1,0
93674,DESIGN,0,0
93675,We,0,0
93676,conducted,0,0
93677,a,0,0
93678,randomized,0,0
93679,",",0,0
93680,double-blind,0,0
93681,",",0,1
93682,placebo-controlled,0,0
93683,trial,0,0
93684,.,0,0
93685,SETTING,0,0
93686,The,0,0
93687,study,0,0
93688,was,0,0
93689,performed,0,0
93690,in,0,0
93691,General,0,0
93692,Clinical,0,1
93693,Research,0,0
93694,Centers,0,0
93695,at,0,0
93696,two,0,0
93697,University,0,0
93698,Hospitals,0,0
93699,.,0,0
93700,SUBJECTS,0,1
93701,Forty-one,0,0
93702,subjects,0,0
93703,with,0,0
93704,T2DM,0,0
93705,were,0,0
93706,treated,0,0
93707,with,0,0
93708,metformin,0,0
93709,or,0,1
93710,diet,0,0
93711,",",0,1
93712,having,0,0
93713,good,0,0
93714,glycemic,0,1
93715,control,0,0
93716,with,0,0
93717,glycosylated,0,1
93718,hemoglobin,0,1
93719,values,0,1
93720,of,0,1
93721,6.2-7.5,0,0
93722,%,0,0
93723,.,0,0
93724,INTERVENTION,0,1
93725,Subjects,0,0
93726,were,0,0
93727,treated,0,0
93728,with,0,0
93729,vildagliptin,0,0
93730,(,0,0
93731,50,0,0
93732,mg,0,0
93733,twice,0,0
93734,daily,0,0
93735,),0,0
93736,or,0,0
93737,placebo,0,0
93738,for,0,0
93739,3,0,0
93740,months,0,0
93741,",",0,0
93742,followed,0,0
93743,by,0,0
93744,a,0,0
93745,2-wk,0,0
93746,washout,0,0
93747,.,0,0
93748,Major,0,1
93749,Outcome,0,1
93750,Measure,0,0
93751,:,0,0
93752,We,0,0
93753,measured,0,0
93754,insulin,1,1
93755,secretion,1,1
93756,in,1,0
93757,response,1,1
93758,to,1,0
93759,iv,1,0
93760,glucose,1,1
93761,and,1,1
93762,arginine,1,1
93763,before,0,0
93764,and,0,1
93765,after,0,0
93766,treatment,0,0
93767,and,0,1
93768,after,0,0
93769,drug,0,0
93770,washout,0,0
93771,.,0,1
93772,RESULTS,0,0
93773,There,0,0
93774,were,0,0
93775,small,0,0
93776,and,0,1
93777,comparable,0,0
93778,reductions,0,1
93779,in,0,0
93780,glycosylated,1,1
93781,hemoglobin,1,1
93782,in,0,0
93783,both,0,0
93784,groups,0,0
93785,over,0,0
93786,3,0,0
93787,months,0,0
93788,.,0,0
93789,Vildagliptin,0,0
93790,increased,0,0
93791,fasting,0,1
93792,GLP-1,1,0
93793,levels,0,1
93794,in,0,0
93795,subjects,0,0
93796,taking,0,0
93797,metformin,0,0
93798,",",0,1
93799,but,0,0
93800,not,0,0
93801,those,0,0
93802,managed,0,0
93803,with,0,0
93804,diet,0,0
93805,",",0,1
93806,and,0,1
93807,raised,0,1
93808,active,0,0
93809,GIP,0,0
93810,levels,0,1
93811,slightly,0,0
93812,.,0,0
93813,DPP-4,0,0
93814,inhibitor,0,0
93815,treatment,0,0
93816,improved,0,0
93817,the,0,0
93818,acute,1,0
93819,insulin,1,1
93820,and,1,1
93821,C-peptide,1,1
93822,responses,1,1
93823,to,0,0
93824,glucose,0,1
93825,(,0,0
93826,50,0,0
93827,and,0,0
93828,100,0,0
93829,%,0,0
93830,respectively,0,0
93831,;,0,0
93832,P,0,0
93833,<,0,0
93834,0.05,0,0
93835,),0,0
93836,and,0,0
93837,increased,0,0
93838,the,0,0
93839,slope,0,1
93840,of,0,0
93841,the,0,0
93842,C-peptide,1,0
93843,response,1,1
93844,to,0,0
93845,glucose,0,1
93846,(,0,0
93847,33,0,0
93848,%,0,0
93849,;,0,0
93850,P,0,0
93851,=,0,0
93852,0.023,0,0
93853,),0,0
93854,.,0,0
93855,CONCLUSION,0,0
93856,Vildagliptin,0,0
93857,improves,0,1
93858,islet,0,1
93859,function,0,1
93860,in,0,0
93861,T2DM,0,0
93862,under,0,0
93863,fasting,0,1
93864,conditions,0,0
93865,.,0,0
93866,This,0,0
93867,suggests,0,0
93868,that,0,0
93869,DPP-4,0,0
93870,inhibition,0,1
93871,has,0,0
93872,metabolic,0,1
93873,benefits,0,0
93874,in,0,0
93875,addition,0,0
93876,to,0,0
93877,enhancing,0,1
93878,meal-induced,0,1
93879,GLP-1,0,0
93880,and,0,1
93881,GIP,0,0
93882,activity,0,1
93883,.,0,0
93884,Consumer-directed,0,1
93885,care,0,0
93886,for,0,0
93887,beneficiaries,0,0
93888,with,0,0
93889,mental,0,1
93890,illness,0,1
93891,:,0,0
93892,lessons,0,0
93893,from,0,0
93894,New,0,1
93895,Jersey,0,1
93896,'s,0,1
93897,Cash,0,1
93898,and,0,1
93899,Counseling,0,0
93900,program,0,0
93901,.,0,1
93902,OBJECTIVE,0,1
93903,Previous,0,0
93904,research,0,0
93905,from,0,0
93906,the,0,0
93907,Cash,0,1
93908,and,0,1
93909,Counseling,0,1
93910,Demonstration,0,0
93911,and,0,1
93912,Evaluation,0,1
93913,(,0,1
93914,CCDE,0,1
93915,),0,0
93916,programs,0,0
93917,in,0,0
93918,New,0,1
93919,Jersey,0,1
93920,",",0,1
93921,Arkansas,0,0
93922,",",0,1
93923,and,0,0
93924,Florida,0,0
93925,suggests,0,0
93926,that,0,0
93927,consumers,0,0
93928,',0,1
93929,control,0,0
93930,over,0,0
93931,personal,0,1
93932,care,0,0
93933,greatly,0,0
93934,improves,0,0
93935,their,0,0
93936,satisfaction,0,1
93937,with,0,0
93938,care,1,0
93939,arrangements,1,0
93940,and,0,0
93941,their,0,0
93942,outlook,1,0
93943,on,1,0
93944,life,1,1
93945,.,1,0
93946,Still,0,0
93947,",",0,0
93948,some,0,0
93949,argue,0,0
93950,that,0,0
93951,consumer-directed,0,0
93952,care,0,0
93953,may,0,0
93954,not,0,0
93955,be,0,0
93956,appropriate,0,0
93957,for,0,0
93958,consumers,0,0
93959,with,0,0
93960,a,0,0
93961,diagnosis,0,0
93962,of,0,0
93963,mental,0,1
93964,illness,0,1
93965,.,0,0
93966,This,0,0
93967,study,0,0
93968,examined,0,0
93969,the,0,0
93970,effectiveness,1,0
93971,of,1,0
93972,the,1,0
93973,CCDE,1,1
93974,program,1,0
93975,for,0,0
93976,those,0,0
93977,with,0,0
93978,a,0,0
93979,diagnosis,0,0
93980,of,0,0
93981,mental,0,1
93982,illness,0,1
93983,.,0,0
93984,METHODS,0,0
93985,This,0,0
93986,study,0,0
93987,examined,0,0
93988,nonelderly,0,0
93989,Medicaid,0,0
93990,beneficiaries,0,0
93991,in,0,0
93992,New,0,1
93993,Jersey,0,0
93994,with,0,0
93995,a,0,0
93996,diagnosis,0,0
93997,of,0,0
93998,mental,0,1
93999,illness,0,1
94000,and,0,1
94001,compared,0,0
94002,and,0,0
94003,contrasted,0,0
94004,the,0,0
94005,experiences,0,0
94006,of,0,0
94007,those,0,0
94008,in,0,0
94009,New,0,1
94010,Jersey,0,1
94011,'s,0,1
94012,CCDE,0,1
94013,program,0,0
94014,(,0,1
94015,N=109,0,1
94016,),0,0
94017,and,0,0
94018,those,0,0
94019,who,0,0
94020,received,0,0
94021,services,0,0
94022,provided,0,0
94023,by,0,0
94024,an,0,0
94025,agency,0,1
94026,(,0,0
94027,N=119,0,1
94028,),0,0
94029,.,0,0
94030,Logistic,1,0
94031,regression,1,0
94032,analyses,1,0
94033,were,0,0
94034,performed,0,0
94035,on,0,0
94036,baseline,0,0
94037,and,0,1
94038,nine-month,0,0
94039,follow-up,0,0
94040,data,0,0
94041,.,0,0
94042,RESULTS,0,0
94043,By,0,0
94044,examining,0,0
94045,outcome,0,1
94046,measures,0,0
94047,--,0,1
94048,including,0,0
94049,satisfaction,1,1
94050,with,1,0
94051,care,1,0
94052,arrangements,1,0
94053,",",1,0
94054,consumers,1,0
94055,',1,1
94056,perceptions,1,0
94057,of,1,0
94058,paid,1,0
94059,caregivers,1,1
94060,',1,1
94061,attitudes,1,1
94062,",",1,0
94063,unmet,1,1
94064,needs,1,1
94065,",",1,0
94066,adverse,1,1
94067,events,1,1
94068,",",1,1
94069,and,1,1
94070,satisfaction,1,1
94071,with,1,0
94072,life,1,1
94073,--,1,0
94074,this,1,0
94075,study,0,0
94076,offers,0,0
94077,evidence,0,0
94078,that,0,0
94079,",",0,0
94080,from,0,0
94081,the,0,0
94082,perspective,0,0
94083,of,0,0
94084,consumers,0,0
94085,",",0,0
94086,the,0,0
94087,CCDE,0,1
94088,program,0,0
94089,is,0,0
94090,appropriate,0,0
94091,for,0,0
94092,participants,0,0
94093,with,0,0
94094,a,0,0
94095,mental,0,1
94096,illness,0,1
94097,diagnosis,0,0
94098,.,0,0
94099,For,0,0
94100,most,0,0
94101,outcome,0,1
94102,measures,0,0
94103,the,0,0
94104,CCDE,0,1
94105,program,0,0
94106,demonstrated,0,0
94107,a,0,0
94108,positive,1,1
94109,effect,1,1
94110,after,0,0
94111,baseline,0,1
94112,characteristics,0,1
94113,were,0,0
94114,controlled,0,0
94115,for,0,0
94116,.,0,0
94117,The,0,0
94118,analysis,0,0
94119,of,0,0
94120,measures,0,1
94121,of,0,0
94122,adverse,1,1
94123,events,1,1
94124,",",1,1
94125,health,1,1
94126,problems,1,1
94127,",",1,1
94128,and,1,1
94129,general,1,1
94130,health,1,1
94131,status,1,1
94132,did,0,0
94133,not,0,0
94134,yield,0,0
94135,statistically,0,0
94136,significant,0,0
94137,differences,0,0
94138,between,0,0
94139,the,0,0
94140,control,0,0
94141,group,0,0
94142,and,0,0
94143,the,0,0
94144,treatment,0,0
94145,group,0,0
94146,",",0,1
94147,indicating,0,0
94148,that,0,0
94149,CCDE,0,1
94150,care,0,0
94151,was,0,0
94152,at,0,0
94153,least,0,0
94154,as,0,0
94155,safe,0,0
94156,as,0,0
94157,agency-directed,0,0
94158,care,0,0
94159,.,0,0
94160,CONCLUSIONS,0,0
94161,Considering,0,0
94162,the,0,0
94163,growing,0,0
94164,need,0,0
94165,for,0,0
94166,long-term,0,1
94167,care,0,0
94168,services,0,1
94169,and,0,0
94170,the,0,0
94171,limited,0,0
94172,resources,0,0
94173,available,0,0
94174,",",0,0
94175,a,0,0
94176,consumer-directed,0,0
94177,option,0,0
94178,can,0,0
94179,be,0,0
94180,a,0,0
94181,valuable,0,0
94182,alternative,0,0
94183,for,0,0
94184,persons,0,0
94185,with,0,0
94186,a,0,0
94187,diagnosis,0,0
94188,of,0,0
94189,mental,0,1
94190,illness,0,1
94191,.,0,0
94192,Bolus,0,0
94193,injection,0,0
94194,of,0,1
94195,contrast,0,0
94196,agents,0,0
94197,with,0,0
94198,various,0,0
94199,iodine,0,0
94200,concentrations,0,1
94201,and,0,1
94202,delivery,0,1
94203,rates,0,1
94204,for,0,0
94205,intracranial,0,1
94206,three-dimensional,0,1
94207,CT,0,1
94208,angiography,0,0
94209,:,0,0
94210,evaluation,1,0
94211,of,1,0
94212,intracranial,1,1
94213,arteriovenous,1,1
94214,contrast,1,0
94215,using,0,0
94216,a,0,0
94217,multidetector-row,0,0
94218,CT,0,1
94219,scanner,0,0
94220,.,0,0
94221,PURPOSE,0,0
94222,We,0,0
94223,evaluated,0,0
94224,the,0,0
94225,difference,1,0
94226,in,1,0
94227,computed,1,1
94228,tomography,1,0
94229,(,1,1
94230,CT,1,1
94231,),1,1
94232,attenuation,1,1
94233,values,1,1
94234,of,1,0
94235,the,1,0
94236,intracranial,1,1
94237,arterial,1,1
94238,and,1,1
94239,venous,1,1
94240,systems,1,0
94241,among,0,0
94242,the,0,0
94243,various,0,0
94244,contrast,0,0
94245,injection,0,0
94246,protocols,0,0
94247,(,0,0
94248,higher,0,1
94249,iodine,0,1
94250,delivery,0,1
94251,rate,0,1
94252,or,0,1
94253,higher,0,1
94254,concentration,0,1
94255,of,0,0
94256,the,0,0
94257,agent,0,0
94258,),0,0
94259,on,0,0
94260,the,0,0
94261,source,0,0
94262,images,0,0
94263,of,0,0
94264,intracranial,0,1
94265,three-dimensional,0,1
94266,CT,0,1
94267,angiography,0,0
94268,(,0,1
94269,3D-CTA,0,1
94270,),0,0
94271,using,0,0
94272,a,0,0
94273,multidetector-row,0,0
94274,CT,0,1
94275,(,0,1
94276,MDCT,0,0
94277,),0,0
94278,scanner,0,0
94279,.,0,1
94280,MATERIALS,0,0
94281,AND,0,0
94282,METHODS,0,0
94283,We,0,0
94284,used,0,0
94285,100,0,0
94286,ml,0,0
94287,of,0,0
94288,iopamidol,0,0
94289,300,0,0
94290,at,0,0
94291,an,0,0
94292,injection,0,0
94293,rate,0,1
94294,of,0,0
94295,3.0,0,0
94296,ml/s,0,0
94297,",",0,0
94298,100,0,0
94299,ml,0,0
94300,of,0,0
94301,iopamidol,0,0
94302,300,0,0
94303,at,0,0
94304,an,0,0
94305,injection,0,0
94306,rate,0,1
94307,of,0,0
94308,3.7,0,0
94309,ml/s,0,0
94310,",",0,0
94311,and,0,0
94312,80,0,0
94313,ml,0,0
94314,of,0,0
94315,iopamidol,0,0
94316,370,0,0
94317,at,0,0
94318,an,0,0
94319,injection,0,0
94320,rate,0,1
94321,of,0,0
94322,3.0,0,0
94323,ml/s,0,0
94324,.,0,0
94325,There,0,0
94326,were,0,0
94327,10,0,0
94328,patients,0,0
94329,in,0,0
94330,each,0,0
94331,group,0,0
94332,.,0,0
94333,Attenuation,1,1
94334,values,1,1
94335,of,1,0
94336,the,1,0
94337,bilateral,1,0
94338,internal,1,0
94339,carotid,1,1
94340,arteries,1,1
94341,(,1,1
94342,ICAs,1,1
94343,),1,1
94344,",",1,0
94345,basilar,1,1
94346,artery,1,1
94347,trunk,1,1
94348,",",1,1
94349,bilateral,1,1
94350,cavernous,1,1
94351,sinuses,1,0
94352,(,1,0
94353,CSs,1,0
94354,),1,1
94355,",",1,0
94356,and,1,1
94357,Galenic,1,0
94358,vein,1,1
94359,were,0,0
94360,measured,0,0
94361,quantitatively,0,0
94362,on,0,0
94363,the,0,0
94364,axial,0,0
94365,CT,0,1
94366,angiographic,0,1
94367,source,0,1
94368,images,0,0
94369,obtained,0,0
94370,by,0,0
94371,four-channel,0,0
94372,MDCT,0,0
94373,.,0,0
94374,RESULTS,0,0
94375,Injection,0,0
94376,of,0,0
94377,the,0,0
94378,high-concentration,0,0
94379,contrast,0,0
94380,with,0,0
94381,a,0,0
94382,higher,0,0
94383,iodine-delivery,0,0
94384,rate,0,1
94385,achieved,0,1
94386,good,0,0
94387,arteriovenous,1,1
94388,contrast,1,0
94389,at,0,0
94390,the,0,0
94391,cavernous,0,0
94392,portion,0,0
94393,.,0,0
94394,With,0,0
94395,the,0,0
94396,same,0,0
94397,rate,0,1
94398,of,0,1
94399,iodine,0,1
94400,delivery,0,1
94401,",",0,1
94402,injection,0,0
94403,of,0,0
94404,the,0,0
94405,intermediate,0,0
94406,concentrate,0,0
94407,agent,0,0
94408,increased,0,0
94409,the,0,0
94410,CT,1,1
94411,value,1,1
94412,of,0,0
94413,not,0,0
94414,only,0,0
94415,the,0,0
94416,ICAs,0,0
94417,but,0,0
94418,also,0,0
94419,the,0,0
94420,CSs,0,0
94421,.,0,0
94422,CONCLUSION,0,0
94423,High-concentration,0,1
94424,contrast,0,0
94425,could,0,0
94426,increase,0,1
94427,ICA,1,0
94428,attenuation,1,1
94429,without,0,0
94430,intracavernous,1,1
94431,attenuation,1,1
94432,gain,0,1
94433,during,0,0
94434,the,0,0
94435,first-pass,0,0
94436,phase,0,0
94437,.,0,0
94438,Combined,0,0
94439,delivery,0,0
94440,approach,0,0
94441,of,0,1
94442,bone,0,1
94443,marrow,0,0
94444,mononuclear,0,1
94445,stem,0,1
94446,cells,0,1
94447,early,0,0
94448,and,0,0
94449,late,0,1
94450,after,0,0
94451,myocardial,0,1
94452,infarction,0,0
94453,:,0,0
94454,the,0,0
94455,MYSTAR,0,1
94456,prospective,0,0
94457,",",0,0
94458,randomized,0,0
94459,study,0,0
94460,.,0,0
94461,BACKGROUND,0,0
94462,Combined,0,0
94463,intracoronary,0,0
94464,and,0,1
94465,intramyocardial,0,1
94466,administration,0,0
94467,might,0,0
94468,improve,0,0
94469,outcomes,0,1
94470,for,0,0
94471,bone-marrow-derived,0,0
94472,stem,0,1
94473,cell,0,1
94474,therapy,0,0
94475,for,0,0
94476,acute,0,0
94477,myocardial,0,1
94478,infarction,0,1
94479,(,0,1
94480,AMI,0,1
94481,),0,0
94482,.,0,0
94483,We,0,0
94484,compared,0,0
94485,the,0,0
94486,safety,1,1
94487,and,1,1
94488,feasibility,1,1
94489,of,0,1
94490,early,0,0
94491,and,0,1
94492,late,0,1
94493,delivery,0,1
94494,of,0,1
94495,stem,0,1
94496,cells,0,1
94497,with,0,0
94498,combined,0,0
94499,therapy,0,0
94500,approaches,0,0
94501,.,0,0
94502,METHODS,0,0
94503,Patients,0,0
94504,with,0,0
94505,left,0,1
94506,ventricular,0,1
94507,ejection,0,1
94508,fraction,0,1
94509,less,0,0
94510,than,0,0
94511,45,0,0
94512,%,0,0
94513,after,0,0
94514,AMI,0,1
94515,were,0,0
94516,randomly,0,0
94517,assigned,0,0
94518,stem,0,1
94519,cell,0,1
94520,delivery,0,1
94521,via,0,0
94522,intramyocardial,0,1
94523,injection,0,0
94524,and,0,1
94525,intracoronary,0,0
94526,infusion,0,0
94527,3-6,0,0
94528,weeks,0,0
94529,or,0,0
94530,3-4,0,1
94531,months,0,0
94532,after,0,0
94533,AMI,0,1
94534,.,0,0
94535,Primary,0,1
94536,end,0,0
94537,points,0,0
94538,were,0,0
94539,changes,1,1
94540,in,1,0
94541,infarct,1,1
94542,size,1,1
94543,and,1,1
94544,left,1,1
94545,ventricular,1,1
94546,ejection,1,1
94547,fraction,1,1
94548,3,1,0
94549,months,1,0
94550,after,1,0
94551,therapy,1,0
94552,.,1,0
94553,RESULTS,0,0
94554,A,0,0
94555,total,0,0
94556,of,0,0
94557,60,0,0
94558,patients,0,0
94559,were,0,0
94560,treated,0,0
94561,.,0,0
94562,The,0,0
94563,mean,1,1
94564,changes,1,1
94565,in,1,0
94566,infarct,1,1
94567,size,1,1
94568,at,1,0
94569,3,1,0
94570,months,1,0
94571,were,0,0
94572,-3.5,0,0
94573,+/-,0,0
94574,5.1,0,0
94575,%,0,0
94576,(,0,0
94577,95,0,0
94578,%,0,0
94579,CI,0,0
94580,-5.5,0,0
94581,%,0,0
94582,to,0,0
94583,-1.5,0,0
94584,%,0,0
94585,",",0,0
94586,P,0,0
94587,=,0,0
94588,0.001,0,0
94589,),0,0
94590,in,0,0
94591,the,0,0
94592,early,0,0
94593,group,0,0
94594,and,0,0
94595,-3.9,0,0
94596,+/-,0,0
94597,5.6,0,0
94598,%,0,0
94599,(,0,0
94600,95,0,0
94601,%,0,0
94602,CI,0,0
94603,-6.1,0,0
94604,%,0,0
94605,to,0,0
94606,-1.6,0,0
94607,%,0,0
94608,",",0,0
94609,P,0,0
94610,=,0,0
94611,0.002,0,0
94612,),0,0
94613,in,0,0
94614,the,0,0
94615,late,0,1
94616,group,0,0
94617,",",0,1
94618,and,0,1
94619,changes,1,1
94620,in,1,0
94621,ejection,1,1
94622,fraction,1,1
94623,were,0,0
94624,3.5,0,0
94625,+/-,0,0
94626,5.6,0,0
94627,%,0,0
94628,(,0,0
94629,95,0,0
94630,%,0,0
94631,CI,0,0
94632,1.3-5.6,0,0
94633,%,0,0
94634,",",0,0
94635,P,0,0
94636,=,0,0
94637,0.003,0,0
94638,),0,0
94639,and,0,0
94640,3.4,0,0
94641,+/-,0,0
94642,7.0,0,0
94643,%,0,0
94644,(,0,0
94645,95,0,0
94646,%,0,0
94647,CI,0,0
94648,0.7-6.1,0,0
94649,%,0,0
94650,",",0,0
94651,P,0,0
94652,=,0,0
94653,0.017,0,0
94654,),0,0
94655,",",0,0
94656,respectively,0,0
94657,.,0,0
94658,At,0,0
94659,9-12,0,0
94660,months,0,0
94661,after,0,0
94662,AMI,0,1
94663,",",0,1
94664,ejection,1,1
94665,fraction,1,1
94666,remained,0,0
94667,significantly,0,0
94668,higher,0,0
94669,than,0,0
94670,at,0,0
94671,baseline,0,0
94672,in,0,0
94673,both,0,0
94674,groups,0,0
94675,.,0,0
94676,In,0,0
94677,the,0,0
94678,early,0,0
94679,and,0,0
94680,late,0,1
94681,groups,0,0
94682,",",0,0
94683,a,0,0
94684,mean,0,1
94685,of,0,0
94686,200.3,0,0
94687,+/-,0,0
94688,68.7,0,0
94689,x,0,0
94690,10,0,0
94691,(,0,0
94692,6,0,0
94693,),0,0
94694,and,0,0
94695,194.8,0,0
94696,+/-,0,0
94697,60.4,0,0
94698,x,0,0
94699,10,0,0
94700,(,0,0
94701,6,0,0
94702,),0,0
94703,stem,1,0
94704,cells,1,1
94705,",",0,0
94706,respectively,0,0
94707,",",0,0
94708,were,0,0
94709,delivered,0,0
94710,to,0,0
94711,the,0,0
94712,myocardium,0,1
94713,",",0,0
94714,and,0,0
94715,1.30,0,0
94716,+/-,0,0
94717,0.68,0,0
94718,x,0,0
94719,10,0,0
94720,(,0,0
94721,9,0,0
94722,),0,0
94723,and,0,0
94724,1.29,0,0
94725,+/-,0,0
94726,0.41,0,0
94727,x,0,0
94728,10,0,0
94729,(,0,0
94730,9,0,0
94731,),0,0
94732,cells,0,1
94733,",",0,0
94734,respectively,0,0
94735,",",0,0
94736,were,0,0
94737,delivered,0,0
94738,into,0,0
94739,the,0,0
94740,artery,0,0
94741,.,0,0
94742,A,0,0
94743,high,0,0
94744,number,1,1
94745,of,1,1
94746,cells,1,1
94747,was,0,0
94748,required,0,0
94749,for,0,0
94750,significant,0,0
94751,improvements,0,0
94752,in,0,0
94753,the,0,0
94754,primary,0,0
94755,end,0,0
94756,points,0,0
94757,.,0,1
94758,CONCLUSIONS,0,0
94759,Combined,0,0
94760,cardiac,0,1
94761,stem,0,1
94762,cell,0,1
94763,delivery,0,0
94764,induces,0,0
94765,a,0,0
94766,moderate,0,0
94767,but,0,0
94768,significant,0,0
94769,improvement,0,1
94770,in,0,0
94771,myocardial,1,1
94772,infarct,1,1
94773,size,1,1
94774,and,1,1
94775,left,1,1
94776,ventricular,1,1
94777,function,1,1
94778,.,1,0
94779,Comparison,0,0
94780,between,0,0
94781,lithium,0,0
94782,and,0,1
94783,valproate,0,0
94784,in,0,0
94785,the,0,0
94786,treatment,0,0
94787,of,0,1
94788,acute,0,0
94789,mania,0,1
94790,.,0,0
94791,Stepping,0,0
94792,Stones,0,1
94793,Triple,0,0
94794,P,0,0
94795,:,0,0
94796,an,0,0
94797,RCT,0,0
94798,of,0,0
94799,a,0,0
94800,parenting,0,1
94801,program,0,0
94802,with,0,0
94803,parents,0,0
94804,of,0,0
94805,a,0,0
94806,child,0,0
94807,diagnosed,0,0
94808,with,0,0
94809,an,0,0
94810,autism,0,0
94811,spectrum,0,0
94812,disorder,0,0
94813,.,0,0
94814,Whilst,0,0
94815,the,0,0
94816,Triple,0,0
94817,P,0,0
94818,Positive,0,1
94819,Parenting,0,1
94820,Program,0,0
94821,has,0,0
94822,a,0,0
94823,large,0,0
94824,evidence,0,0
94825,base,0,1
94826,(,0,1
94827,Sanders,0,0
94828,",",0,1
94829,Clinical,0,1
94830,Child,0,1
94831,and,0,1
94832,Family,0,1
94833,Psychology,0,1
94834,Review,0,0
94835,2:71-90,0,0
94836,",",0,0
94837,1999,0,0
94838,;,0,0
94839,Sanders,0,0
94840,",",0,0
94841,Journal,0,1
94842,of,0,1
94843,Consulting,0,1
94844,and,0,1
94845,Clinical,0,1
94846,Psychology,0,1
94847,68:624-640,0,0
94848,",",0,0
94849,2000,0,0
94850,),0,0
94851,and,0,0
94852,preliminary,0,0
94853,evidence,0,0
94854,indicates,0,0
94855,that,0,0
94856,Stepping,0,0
94857,Stones,0,1
94858,Triple,0,0
94859,P,0,0
94860,is,0,0
94861,also,0,0
94862,efficacious,0,0
94863,(,0,0
94864,Roberts,0,0
94865,",",0,1
94866,Journal,0,1
94867,of,0,1
94868,Clinical,0,1
94869,Child,0,1
94870,and,0,1
94871,Adolescent,0,1
94872,Psychology,0,1
94873,",",0,0
94874,35,0,0
94875,(,0,0
94876,2,0,0
94877,),0,0
94878,:180-193,0,0
94879,",",0,0
94880,2006,0,0
94881,),0,0
94882,",",0,0
94883,to,0,0
94884,date,0,1
94885,Stepping,0,0
94886,Stones,0,1
94887,has,0,0
94888,not,0,0
94889,been,0,0
94890,evaluated,0,0
94891,with,0,0
94892,the,0,0
94893,ASD,0,0
94894,population,0,0
94895,.,0,0
94896,Fifty-nine,0,0
94897,families,0,0
94898,with,0,0
94899,a,0,0
94900,child,0,0
94901,with,0,0
94902,ASD,0,0
94903,aged,0,0
94904,between,0,0
94905,2,0,0
94906,and,0,0
94907,9,0,0
94908,participated,0,0
94909,in,0,0
94910,this,0,0
94911,randomized,0,0
94912,controlled,0,0
94913,trial,0,0
94914,.,0,0
94915,The,0,0
94916,results,0,0
94917,demonstrate,0,0
94918,significant,0,0
94919,improvements,0,1
94920,in,0,0
94921,parental,1,1
94922,reports,1,0
94923,of,1,1
94924,child,1,1
94925,behaviour,1,1
94926,and,1,1
94927,parenting,1,1
94928,styles,1,1
94929,with,1,0
94930,the,1,0
94931,treatment,1,0
94932,effects,1,1
94933,for,1,0
94934,child,1,1
94935,behaviour,1,1
94936,",",1,1
94937,parental,1,1
94938,over,1,0
94939,reactivity,1,1
94940,and,1,1
94941,parental,1,1
94942,verbosity,1,1
94943,being,0,0
94944,maintained,0,0
94945,at,0,0
94946,follow-up,0,0
94947,6,0,0
94948,months,0,0
94949,later,0,0
94950,.,0,0
94951,Further,0,0
94952,",",0,0
94953,the,0,0
94954,results,0,0
94955,suggest,0,0
94956,significant,0,0
94957,improvements,0,1
94958,in,0,0
94959,parental,1,1
94960,satisfaction,1,1
94961,and,1,1
94962,conflict,1,1
94963,about,1,0
94964,parenting,1,0
94965,as,0,0
94966,well,0,0
94967,as,0,0
94968,a,0,0
94969,sleeper,1,1
94970,effect,1,0
94971,for,1,0
94972,parental,1,1
94973,efficacy,1,1
94974,.,1,0
94975,The,0,0
94976,results,0,0
94977,indicate,0,0
94978,that,0,0
94979,Stepping,0,0
94980,Stones,0,1
94981,Triple,0,0
94982,P,0,0
94983,is,0,0
94984,a,0,0
94985,promising,0,0
94986,intervention,0,0
94987,for,0,0
94988,parents,0,0
94989,of,0,0
94990,children,0,0
94991,with,0,0
94992,ASD,0,0
94993,.,0,0
94994,Limitations,0,0
94995,and,0,1
94996,future,0,0
94997,research,0,0
94998,are,0,0
94999,also,0,0
95000,addressed,0,0
95001,.,0,0
95002,Impacts,0,0
95003,of,0,0
95004,a,0,0
95005,disease,0,1
95006,management,0,0
95007,program,0,0
95008,for,0,0
95009,dually,0,0
95010,eligible,0,0
95011,beneficiaries,0,0
95012,.,0,0
95013,The,0,0
95014,LifeMasters,0,0
95015,Supported,0,0
95016,SelfCare,0,1
95017,demonstration,0,0
95018,program,0,0
95019,provides,0,0
95020,disease,0,1
95021,management,0,0
95022,(,0,1
95023,DM,0,1
95024,),0,0
95025,services,0,0
95026,to,0,0
95027,Florida,0,0
95028,Medicare,0,0
95029,beneficiaries,0,0
95030,who,0,0
95031,are,0,0
95032,also,0,0
95033,enrolled,0,0
95034,in,0,0
95035,Medicaid,0,0
95036,and,0,0
95037,have,0,0
95038,congestive,0,1
95039,heart,0,1
95040,failure,0,1
95041,(,0,1
95042,CHF,0,0
95043,),0,0
95044,",",0,0
95045,diabetes,0,1
95046,",",0,1
95047,or,0,1
95048,coronary,0,1
95049,artery,0,1
95050,disease,0,1
95051,(,0,1
95052,CAD,0,0
95053,),0,0
95054,.,0,0
95055,The,0,0
95056,population-based,0,0
95057,program,0,0
95058,provides,0,0
95059,primarily,0,0
95060,telephonic,0,0
95061,patient,0,1
95062,education,0,0
95063,and,0,1
95064,monitoring,0,0
95065,services,0,1
95066,.,0,0
95067,Findings,0,0
95068,from,0,0
95069,the,0,0
95070,randomized,0,0
95071,",",0,0
95072,intent-to-treat,0,0
95073,design,0,0
95074,over,0,0
95075,the,0,0
95076,first,0,0
95077,18,0,0
95078,months,0,0
95079,of,0,0
95080,operations,0,0
95081,show,0,0
95082,virtually,0,0
95083,no,0,0
95084,overall,0,1
95085,impacts,1,0
95086,on,1,0
95087,hospital,1,1
95088,or,1,1
95089,emergency,1,1
95090,room,1,1
95091,(,1,1
95092,ER,1,1
95093,),1,1
95094,use,1,0
95095,",",1,0
95096,Medicare,1,0
95097,expenditures,1,1
95098,",",1,0
95099,quality,1,1
95100,of,1,1
95101,care,1,0
95102,",",1,1
95103,or,1,1
95104,prescription,1,1
95105,drug,1,1
95106,use,1,0
95107,for,0,0
95108,the,0,0
95109,"33,000",0,0
95110,enrollees,0,0
95111,.,0,0
95112,However,0,0
95113,",",0,0
95114,for,0,0
95115,beneficiaries,0,0
95116,with,0,0
95117,CHF,0,0
95118,who,0,0
95119,resided,0,0
95120,in,0,0
95121,high-cost,0,0
95122,South,0,0
95123,Florida,0,0
95124,counties,0,0
95125,",",0,0
95126,the,0,0
95127,program,0,0
95128,reduced,0,1
95129,Medicare,1,0
95130,expenditures,1,1
95131,by,0,0
95132,9.6,0,0
95133,percent,0,0
95134,.,0,0
95135,Modified,0,0
95136,constraint-induced,0,0
95137,therapy,0,0
95138,combined,0,0
95139,with,0,0
95140,mental,0,0
95141,practice,0,0
95142,:,0,0
95143,thinking,0,1
95144,through,0,0
95145,better,0,0
95146,motor,0,1
95147,outcomes,0,1
95148,.,0,1
95149,BACKGROUND,0,0
95150,AND,0,0
95151,PURPOSE,0,0
95152,Modified,0,1
95153,constraint-induced,0,0
95154,therapy,0,0
95155,(,0,1
95156,mCIT,0,0
95157,),0,0
95158,is,0,0
95159,an,0,0
95160,outpatient,0,0
95161,therapy,0,0
95162,encouraging,0,1
95163,repetitive,0,1
95164,",",0,0
95165,task-specific,0,1
95166,practice,0,0
95167,with,0,0
95168,the,0,0
95169,affected,0,0
95170,arm,0,0
95171,.,0,0
95172,mCIT,0,0
95173,has,0,0
95174,shown,0,0
95175,efficacy,1,1
95176,in,0,0
95177,all,0,0
95178,stages,0,0
95179,poststroke,0,0
95180,.,0,0
95181,Given,0,0
95182,its,0,0
95183,efficacy,0,1
95184,when,0,0
95185,combined,0,0
95186,with,0,0
95187,other,0,0
95188,therapy,0,0
95189,regimens,0,0
95190,",",0,0
95191,the,0,0
95192,current,0,0
95193,study,0,0
95194,examined,0,0
95195,the,0,0
95196,efficacy,1,1
95197,of,0,0
95198,mental,0,1
95199,practice,0,0
95200,when,0,0
95201,combined,0,0
95202,with,0,0
95203,mCIT,0,0
95204,versus,0,0
95205,mCIT,0,0
95206,only,0,0
95207,using,0,0
95208,randomized,0,0
95209,",",0,0
95210,controlled,0,0
95211,methods,0,0
95212,.,0,0
95213,METHOD,0,0
95214,Ten,0,0
95215,patients,0,0
95216,with,0,0
95217,chronic,0,0
95218,stroke,0,1
95219,(,0,0
95220,7,0,0
95221,males,0,0
95222,;,0,0
95223,mean,0,1
95224,age,0,0
95225,",",0,1
95226,61.4+/-3.02,0,0
95227,years,0,0
95228,;,0,0
95229,age,0,0
95230,range,0,0
95231,",",0,0
95232,48,0,0
95233,to,0,0
95234,79,0,0
95235,years,0,0
95236,;,0,0
95237,mean,0,1
95238,time,0,1
95239,since,0,0
95240,stroke,0,1
95241,",",0,0
95242,28.5,0,0
95243,months,0,0
95244,;,0,0
95245,range,0,0
95246,",",0,0
95247,13,0,0
95248,to,0,0
95249,42,0,0
95250,months,0,0
95251,),0,0
95252,exhibiting,0,0
95253,stable,0,1
95254,",",0,0
95255,affected,0,1
95256,arm,0,0
95257,motor,0,1
95258,deficits,0,1
95259,were,0,0
95260,administered,0,0
95261,mCIT,0,0
95262,",",0,0
95263,consisting,0,0
95264,of,0,0
95265,:,0,0
95266,(,0,0
95267,1,0,0
95268,),0,0
95269,structured,0,0
95270,therapy,0,0
95271,emphasizing,0,0
95272,affected,0,1
95273,arm,0,0
95274,use,0,0
95275,in,0,0
95276,functional,0,1
95277,activities,0,0
95278,3,0,0
95279,days/week,0,0
95280,for,0,0
95281,10,0,0
95282,weeks,0,0
95283,;,0,0
95284,and,0,0
95285,(,0,0
95286,2,0,0
95287,),0,0
95288,less,0,0
95289,affected,0,1
95290,arm,0,0
95291,restraint,0,0
95292,5,0,0
95293,days/week,0,0
95294,for,0,0
95295,5,0,0
95296,hours,0,0
95297,.,0,0
95298,Both,0,0
95299,of,0,0
95300,these,0,0
95301,components,0,1
95302,were,0,0
95303,administered,0,0
95304,during,0,0
95305,a,0,0
95306,10-week,0,0
95307,period,0,0
95308,.,0,0
95309,Subjects,0,0
95310,randomly,0,0
95311,assigned,0,0
95312,to,0,0
95313,the,0,0
95314,mCIT+mental,0,0
95315,practice,0,0
95316,experimental,0,0
95317,condition,0,0
95318,also,0,0
95319,received,0,0
95320,30-minute,0,0
95321,mental,0,1
95322,practice,0,0
95323,sessions,0,0
95324,provided,0,0
95325,directly,0,0
95326,after,0,0
95327,therapy,0,0
95328,sessions,0,0
95329,.,0,0
95330,These,0,0
95331,mental,0,1
95332,practice,0,0
95333,sessions,0,0
95334,required,0,0
95335,daily,0,0
95336,cognitive,0,1
95337,rehearsal,0,1
95338,of,0,0
95339,the,0,0
95340,activities,0,1
95341,of,0,0
95342,daily,0,1
95343,living,0,1
95344,practiced,0,0
95345,during,0,0
95346,mCIT,0,0
95347,clinical,0,0
95348,sessions,0,0
95349,.,0,0
95350,RESULTS,0,0
95351,No,0,1
95352,pre-existing,0,1
95353,differences,0,0
95354,were,0,0
95355,found,0,0
95356,between,0,0
95357,groups,0,0
95358,on,0,0
95359,any,0,0
95360,demographic,0,1
95361,variable,0,1
95362,or,0,1
95363,movement,0,1
95364,scale,0,1
95365,.,0,0
95366,All,0,0
95367,subjects,0,0
95368,exhibited,0,0
95369,marked,0,0
95370,reductions,0,1
95371,in,0,0
95372,affected,1,0
95373,arm,1,0
95374,impairment,1,1
95375,and,1,1
95376,functional,1,1
95377,limitation,1,0
95378,.,1,0
95379,However,0,0
95380,",",0,0
95381,subjects,0,0
95382,in,0,0
95383,the,0,0
95384,mCIT+mental,0,0
95385,practice,0,0
95386,group,0,0
95387,exhibited,0,0
95388,significantly,0,0
95389,larger,0,0
95390,changes,0,1
95391,on,0,0
95392,both,0,0
95393,movement,1,1
95394,measures,1,1
95395,after,0,0
95396,intervention,0,0
95397,:,0,0
95398,Action,0,1
95399,Research,0,0
95400,Arm,0,1
95401,Test,0,1
95402,",",0,1
95403,+15.4-point,0,1
95404,change,0,1
95405,versus,0,0
95406,+8.4-point,0,1
95407,change,0,1
95408,for,0,0
95409,mCIT,0,0
95410,only,0,0
95411,subjects,0,0
95412,(,0,0
95413,P,0,0
95414,<,0,0
95415,0.001,0,0
95416,),0,0
95417,;,0,0
95418,Fugl-Meyer,0,1
95419,",",0,1
95420,+7.8-point,0,1
95421,change,0,1
95422,versus,0,0
95423,+4.1-point,0,1
95424,change,0,1
95425,for,0,0
95426,the,0,0
95427,mCIT,0,0
95428,only,0,0
95429,subjects,0,0
95430,(,0,0
95431,P=0.01,0,0
95432,),0,0
95433,.,0,0
95434,These,0,0
95435,changes,0,1
95436,were,0,0
95437,sustained,0,0
95438,3,0,0
95439,months,0,0
95440,after,0,0
95441,intervention,0,0
95442,.,0,1
95443,CONCLUSIONS,0,0
95444,mCIT,0,0
95445,remains,0,0
95446,a,0,0
95447,promising,0,0
95448,motor,0,1
95449,intervention,0,0
95450,.,0,0
95451,However,0,0
95452,",",0,0
95453,its,0,0
95454,efficacy,1,1
95455,appears,0,0
95456,to,0,0
95457,be,0,0
95458,enhanced,0,0
95459,by,0,0
95460,use,0,0
95461,of,0,1
95462,mental,0,1
95463,practice,0,0
95464,provided,0,0
95465,directly,0,0
95466,after,0,0
95467,mCIT,0,0
95468,clinical,0,0
95469,sessions,0,0
95470,.,0,0
95471,Prevention,0,0
95472,of,0,1
95473,postoperative,0,1
95474,hypocalcemia,0,1
95475,with,0,0
95476,routine,0,0
95477,oral,0,0
95478,calcium,0,1
95479,and,0,1
95480,vitamin,0,1
95481,D,0,1
95482,supplements,0,0
95483,in,0,0
95484,patients,0,0
95485,with,0,0
95486,differentiated,0,1
95487,papillary,0,0
95488,thyroid,0,1
95489,carcinoma,0,0
95490,undergoing,0,0
95491,total,0,1
95492,thyroidectomy,0,0
95493,plus,0,0
95494,central,0,1
95495,neck,0,1
95496,dissection,0,0
95497,.,0,1
95498,BACKGROUND,0,0
95499,Routine,0,0
95500,oral,0,0
95501,calcium,0,1
95502,and,0,1
95503,vitamin,0,1
95504,D,0,1
95505,supplementation,0,0
95506,may,0,0
95507,prevent,0,0
95508,hypocalcemic,0,1
95509,crisis,0,1
95510,",",0,1
95511,but,0,0
95512,its,0,0
95513,efficacy,0,1
95514,has,0,0
95515,not,0,0
95516,been,0,0
95517,studied,0,0
95518,in,0,0
95519,patients,0,0
95520,undergoing,0,0
95521,thyroidectomy,0,0
95522,plus,0,0
95523,central,0,1
95524,neck,0,1
95525,dissection,0,0
95526,(,0,1
95527,CND,0,0
95528,),0,0
95529,.,0,0
95530,The,0,0
95531,authors,0,0
95532,therefore,0,0
95533,prospectively,0,0
95534,evaluated,0,0
95535,the,0,0
95536,clinical,0,0
95537,usefulness,0,0
95538,of,0,1
95539,routine,0,0
95540,oral,0,0
95541,calcium,0,1
95542,and,0,1
95543,vitamin,0,1
95544,D,0,1
95545,supplementation,0,0
95546,for,0,0
95547,prevention,0,0
95548,of,0,1
95549,hypocalcemia,0,1
95550,after,0,0
95551,total,0,1
95552,thyroidectomy,0,0
95553,and,0,1
95554,CND,0,1
95555,.,0,1
95556,METHODS,0,0
95557,Of,0,0
95558,197,0,0
95559,patients,0,0
95560,with,0,0
95561,differentiated,0,1
95562,papillary,0,0
95563,thyroid,0,1
95564,carcinoma,0,0
95565,",",0,0
95566,49,0,0
95567,underwent,0,0
95568,total,0,0
95569,thyroidectomy,0,0
95570,alone,0,0
95571,",",0,0
95572,and,0,0
95573,148,0,0
95574,underwent,0,0
95575,total,0,1
95576,thyroidectomy,0,0
95577,plus,0,0
95578,CND,0,0
95579,.,0,0
95580,The,0,0
95581,latter,0,0
95582,were,0,0
95583,randomized,0,0
95584,to,0,0
95585,oral,0,0
95586,calcium,0,1
95587,(,0,0
95588,3,0,0
95589,g/day,0,0
95590,),0,0
95591,plus,0,0
95592,vitamin,0,1
95593,D,0,1
95594,(,0,0
95595,1,0,0
95596,mg/day,0,0
95597,),0,0
95598,(,0,0
95599,Group,0,0
95600,A,0,0
95601,",",0,1
95602,n=49,0,0
95603,),0,1
95604,",",0,0
95605,calcium,0,1
95606,alone,0,0
95607,(,0,0
95608,Group,0,0
95609,B,0,1
95610,",",0,1
95611,n=49,0,0
95612,),0,1
95613,",",0,0
95614,or,0,0
95615,no,0,0
95616,supplements,0,0
95617,(,0,0
95618,Group,0,0
95619,C,0,1
95620,",",0,0
95621,n=50,0,0
95622,),0,0
95623,.,0,0
95624,Hypocalcemic,1,1
95625,symptoms,1,1
95626,",",1,1
95627,serum,1,1
95628,calcium,1,1
95629,",",1,0
95630,and,1,1
95631,parathyroid,1,1
95632,hormone,1,1
95633,(,1,1
95634,PTH,1,1
95635,),1,1
95636,levels,1,1
95637,were,0,0
95638,compared,0,0
95639,among,0,0
95640,the,0,0
95641,groups,0,0
95642,.,0,0
95643,RESULTS,0,0
95644,Group,0,0
95645,C,0,0
95646,had,0,0
95647,significantly,0,0
95648,higher,0,0
95649,incidences,0,1
95650,of,0,1
95651,symptomatic,0,0
95652,(,0,0
95653,26.0,0,0
95654,%,0,0
95655,vs,0,0
95656,6.1,0,0
95657,%,0,0
95658,;,0,0
95659,P,0,0
95660,<,0,0
95661,.015,0,0
95662,),0,1
95663,and,0,1
95664,laboratory,0,1
95665,(,0,0
95666,44.0,0,0
95667,%,0,0
95668,vs,0,0
95669,14.3,0,0
95670,%,0,0
95671,;,0,0
95672,P,0,0
95673,<,0,0
95674,.015,0,0
95675,),0,0
95676,hypocalcemia,1,1
95677,than,0,0
95678,the,0,0
95679,group,0,0
95680,without,0,0
95681,CND,0,0
95682,.,0,0
95683,The,0,0
95684,incidences,0,1
95685,of,0,0
95686,symptomatic,1,1
95687,and,1,1
95688,laboratory,1,1
95689,hypocalcemia,1,1
95690,were,0,0
95691,significantly,0,0
95692,decreased,0,0
95693,in,0,0
95694,Groups,0,0
95695,A,0,0
95696,(,0,0
95697,2.0,0,0
95698,%,0,0
95699,and,0,0
95700,8.2,0,0
95701,%,0,0
95702,",",0,0
95703,respectively,0,0
95704,),0,0
95705,and,0,1
95706,B,0,0
95707,(,0,0
95708,12.2,0,0
95709,%,0,0
95710,and,0,0
95711,24.5,0,0
95712,%,0,0
95713,",",0,0
95714,respectively,0,0
95715,),0,0
95716,(,0,0
95717,P,0,0
95718,<,0,0
95719,.05,0,0
95720,),0,0
95721,.,0,0
95722,Serum,1,1
95723,calcium,1,1
95724,levels,1,1
95725,decreased,0,0
95726,in,0,0
95727,most,0,0
95728,patients,0,0
95729,after,0,0
95730,surgery,0,0
95731,",",0,1
95732,but,0,0
95733,recovered,0,1
95734,earliest,0,1
95735,in,0,0
95736,Group,0,0
95737,A.,0,1
95738,Hypercalcemia,0,1
95739,and,0,1
95740,PTH,0,1
95741,inhibition,0,1
95742,did,0,0
95743,not,0,0
95744,occur,0,0
95745,in,0,0
95746,gs,0,1
95747,A,0,0
95748,and,0,1
95749,B,0,0
95750,.,0,1
95751,CONCLUSIONS,0,0
95752,Compared,0,0
95753,with,0,0
95754,total,0,1
95755,thyroidectomy,0,0
95756,alone,0,0
95757,",",0,0
95758,CND,0,0
95759,significantly,0,0
95760,increases,0,0
95761,the,0,0
95762,rate,0,1
95763,of,0,0
95764,postoperative,1,1
95765,hypocalcemia,1,1
95766,",",0,0
95767,which,0,0
95768,can,0,0
95769,be,0,0
95770,prevented,0,0
95771,by,0,0
95772,routine,0,0
95773,postoperative,0,1
95774,supplementation,0,0
95775,with,0,0
95776,oral,0,0
95777,calcium,0,1
95778,and,0,1
95779,vitamin,0,1
95780,D,0,1
95781,.,0,0
95782,Effects,0,0
95783,of,0,0
95784,static,0,0
95785,stretching,0,0
95786,on,0,0
95787,repeated,1,0
95788,sprint,1,1
95789,and,1,1
95790,change,1,1
95791,of,1,1
95792,direction,1,1
95793,performance,1,1
95794,.,1,0
95795,PURPOSE,0,0
95796,To,0,0
95797,examine,0,0
95798,the,0,0
95799,effects,0,0
95800,of,0,0
95801,static,0,0
95802,stretching,0,0
95803,during,0,0
95804,the,0,0
95805,recovery,0,1
95806,periods,0,0
95807,of,0,1
95808,field-based,0,0
95809,team,0,0
95810,sports,0,0
95811,on,0,0
95812,subsequent,0,0
95813,repeated,1,0
95814,sprint,1,1
95815,ability,1,1
95816,(,1,1
95817,RSA,1,1
95818,),1,1
95819,and,1,1
95820,change,1,1
95821,of,1,1
95822,direction,1,1
95823,speed,1,1
95824,(,1,1
95825,CODS,1,1
95826,),1,0
95827,performance,1,1
95828,.,1,0
95829,METHODS,0,0
95830,On,0,0
95831,four,0,0
95832,separate,0,0
95833,occasions,0,0
95834,",",0,0
95835,12,0,0
95836,male,0,0
95837,team-sport,0,1
95838,players,0,0
95839,performed,0,0
95840,a,0,0
95841,standardized,0,0
95842,warm-up,0,0
95843,",",0,0
95844,followed,0,0
95845,by,0,0
95846,a,0,0
95847,test,0,0
95848,of,0,0
95849,either,0,0
95850,RSA,1,0
95851,or,0,1
95852,CODS,0,1
95853,(,0,0
95854,on,0,0
95855,two,0,0
95856,occasions,0,0
95857,each,0,0
95858,),0,0
95859,in,0,0
95860,a,0,0
95861,counterbalanced,0,0
95862,design,0,0
95863,.,0,0
95864,Both,0,0
95865,tests,0,1
95866,involved,0,0
95867,three,0,0
95868,sets,0,0
95869,of,0,0
95870,six,0,0
95871,maximal,0,1
95872,sprint,0,0
95873,repetitions,0,1
95874,",",0,0
95875,with,0,0
95876,a,0,0
95877,4-min,0,0
95878,recovery,0,1
95879,between,0,0
95880,sets,0,0
95881,.,0,0
95882,During,0,0
95883,the,0,0
95884,break,0,1
95885,between,0,0
95886,sets,0,0
95887,",",0,0
95888,the,0,0
95889,participants,0,0
95890,either,0,0
95891,rested,0,0
95892,(,0,0
95893,control,0,0
95894,[,0,0
95895,CON,0,0
95896,],0,0
95897,),0,1
95898,or,0,0
95899,completed,0,0
95900,a,0,0
95901,static,0,0
95902,stretching,0,0
95903,protocol,0,0
95904,(,0,1
95905,static,0,1
95906,stretch,0,0
95907,[,0,0
95908,SS,0,1
95909,],0,0
95910,),0,0
95911,.,0,0
95912,The,0,0
95913,RSA,0,0
95914,test,0,1
95915,involved,0,0
95916,straight-line,0,1
95917,sprints,0,1
95918,",",0,0
95919,whereas,0,0
95920,the,0,0
95921,CODS,0,1
95922,test,0,1
95923,required,0,0
95924,a,0,0
95925,change,0,1
95926,of,0,1
95927,direction,0,1
95928,(,0,0
95929,100,0,0
95930,degrees,0,0
95931,),0,0
95932,every,0,0
95933,4,0,0
95934,m,0,0
95935,(,0,0
95936,total,0,1
95937,of,0,0
95938,four,0,0
95939,),0,0
95940,.,0,0
95941,Mean,1,1
95942,",",1,1
95943,total,1,1
95944,(,1,1
95945,sum,1,1
95946,of,1,0
95947,six,1,0
95948,sprints,1,0
95949,),1,0
95950,",",1,0
95951,first,1,1
95952,",",1,0
95953,and,1,1
95954,best,1,0
95955,sprint,1,1
95956,times,1,1
95957,(,1,1
95958,MST,1,1
95959,",",1,1
95960,TST,1,1
95961,",",1,1
95962,FST,1,0
95963,",",1,1
95964,and,1,1
95965,BST,1,1
95966,",",1,1
95967,respectively,1,0
95968,),1,0
95969,were,0,0
95970,recorded,0,0
95971,for,0,0
95972,each,0,0
95973,set,0,0
95974,.,0,0
95975,RESULTS,0,0
95976,There,0,0
95977,was,0,0
95978,a,0,0
95979,consistent,0,0
95980,tendency,0,0
95981,for,0,0
95982,RSA,1,0
95983,times,1,1
95984,to,0,0
95985,be,0,0
95986,slower,0,0
95987,after,0,0
95988,the,0,0
95989,static,0,0
95990,stretching,0,0
95991,intervention,0,0
95992,",",0,1
95993,which,0,0
95994,was,0,0
95995,supported,0,0
95996,by,0,0
95997,statistical,0,0
95998,significance,0,1
95999,for,0,0
96000,three,0,0
96001,performance,0,0
96002,variables,0,0
96003,(,0,0
96004,MST,0,1
96005,0-5,0,1
96006,m,0,0
96007,set,0,0
96008,2,0,0
96009,",",0,0
96010,MST,0,0
96011,0-20,0,1
96012,m,0,0
96013,set,0,0
96014,2,0,0
96015,",",0,0
96016,and,0,0
96017,TST,0,1
96018,set,0,0
96019,2,0,0
96020,;,0,0
96021,P,0,0
96022,<,0,0
96023,0.05,0,0
96024,),0,0
96025,.,0,0
96026,This,0,0
96027,tendency,0,1
96028,was,0,0
96029,also,0,0
96030,supported,0,0
96031,by,0,0
96032,moderate,0,0
96033,effect,0,1
96034,sizes,0,1
96035,and,0,1
96036,qualitative,0,0
96037,indications,0,0
96038,of,0,1
96039,likely,0,0
96040,harmful,0,0
96041,or,0,1
96042,detrimental,0,1
96043,effects,0,1
96044,associated,0,0
96045,with,0,0
96046,RSA-SS,0,0
96047,.,0,1
96048,Further,0,1
96049,",",0,0
96050,sprint,1,1
96051,times,1,1
96052,again,0,0
96053,tended,0,0
96054,to,0,0
96055,be,0,0
96056,slower,0,0
96057,in,0,0
96058,the,0,0
96059,CODS-SS,0,0
96060,trial,0,0
96061,compared,0,0
96062,with,0,0
96063,the,0,0
96064,CODS-CON,0,0
96065,across,0,0
96066,all,0,0
96067,sprint,0,1
96068,variables,0,1
96069,",",0,0
96070,with,0,0
96071,a,0,0
96072,significantly,0,0
96073,slower,0,0
96074,(,0,0
96075,P,0,0
96076,<,0,0
96077,0.05,0,0
96078,),0,0
96079,BST,0,0
96080,recorded,0,1
96081,for,0,0
96082,set,0,0
96083,3,0,0
96084,after,0,0
96085,static,0,0
96086,stretching,0,0
96087,.,0,0
96088,CONCLUSION,0,0
96089,These,0,0
96090,results,0,0
96091,suggest,0,0
96092,that,0,0
96093,an,0,0
96094,acute,0,0
96095,bout,0,1
96096,(,0,0
96097,4,0,0
96098,min,0,0
96099,),0,0
96100,of,0,0
96101,static,0,0
96102,stretching,0,0
96103,of,0,0
96104,the,0,0
96105,lower,0,0
96106,limbs,0,0
96107,during,0,0
96108,recovery,0,1
96109,periods,0,0
96110,between,0,0
96111,efforts,0,0
96112,may,0,0
96113,compromise,0,1
96114,RSA,1,1
96115,performance,1,1
96116,but,0,0
96117,has,0,0
96118,less,0,0
96119,effect,0,1
96120,on,0,0
96121,CODS,1,0
96122,performance,1,1
96123,.,1,0
96124,An,0,0
96125,emergency,0,1
96126,clinical,0,1
96127,pathway,0,0
96128,for,0,0
96129,stroke,0,1
96130,patients,0,0
96131,--,0,0
96132,results,0,0
96133,of,0,0
96134,a,0,0
96135,cluster,0,0
96136,randomised,0,0
96137,trial,0,0
96138,(,0,0
96139,isrctn41456865,0,0
96140,),0,0
96141,.,0,0
96142,BACKGROUND,0,0
96143,Emergency,0,1
96144,Clinical,0,1
96145,Pathways,0,1
96146,(,0,1
96147,ECP,0,1
96148,),0,1
96149,for,0,0
96150,stroke,0,1
96151,have,0,0
96152,never,0,0
96153,been,0,0
96154,tested,0,0
96155,in,0,0
96156,randomized,0,0
96157,controlled,0,0
96158,trials,0,0
96159,(,0,0
96160,RCTs,0,0
96161,),0,0
96162,.,0,0
96163,OBJECTIVE,0,0
96164,To,0,0
96165,evaluate,0,0
96166,the,0,0
96167,effectiveness,1,0
96168,of,0,0
96169,an,0,0
96170,ECP,0,1
96171,for,0,0
96172,stroke,0,1
96173,patients,0,0
96174,in,0,0
96175,Latium,0,0
96176,(,0,0
96177,Italy,0,0
96178,),0,1
96179,emergency,0,1
96180,system,0,0
96181,.,0,1
96182,METHODS,0,0
96183,cluster-RCT,0,0
96184,designed,0,0
96185,to,0,0
96186,compare,0,0
96187,stroke,0,1
96188,patient,0,1
96189,referrals,0,0
96190,by,0,0
96191,Emergency,0,1
96192,Medical,0,0
96193,Service,0,1
96194,(,0,1
96195,EMS,0,0
96196,),0,1
96197,and,0,1
96198,Emergency,0,1
96199,Room,0,1
96200,(,0,1
96201,ER,0,1
96202,),0,1
96203,health,0,1
96204,professionals,0,0
96205,trained,0,0
96206,in,0,0
96207,the,0,0
96208,ECP,0,1
96209,",",0,0
96210,with,0,0
96211,those,0,0
96212,of,0,0
96213,non-trained,0,0
96214,EMS,0,0
96215,and,0,1
96216,ER,0,1
96217,controls,0,0
96218,.,0,0
96219,Primary,0,1
96220,outcome,0,1
96221,measure,0,0
96222,was,0,0
96223,the,0,0
96224,proportion,1,0
96225,of,1,1
96226,eligible,1,0
96227,(,1,0
96228,aged,1,0
96229,<,1,0
96230,/=,1,0
96231,80,1,0
96232,and,1,0
96233,symptom,1,1
96234,onset,1,1
96235,<,1,0
96236,/=,1,0
96237,6,1,0
96238,hours,1,0
96239,),1,0
96240,stroke,1,1
96241,patients,1,0
96242,referred,1,0
96243,to,1,0
96244,a,1,0
96245,stroke,1,1
96246,unit,1,0
96247,(,1,1
96248,SU,1,1
96249,),1,0
96250,.,1,0
96251,Intention,1,0
96252,to,1,0
96253,treat,1,0
96254,(,1,0
96255,ITT,1,0
96256,),1,1
96257,and,1,1
96258,per-protocol,1,0
96259,(,1,1
96260,PP,1,0
96261,),1,1
96262,analyses,1,0
96263,were,0,0
96264,performed,0,0
96265,",",0,0
96266,and,0,1
96267,risk,1,1
96268,ratios,1,1
96269,(,1,1
96270,RR,1,1
96271,),1,0
96272,adjusted,0,0
96273,by,0,0
96274,age,0,0
96275,",",0,1
96276,gender,0,1
96277,and,0,1
96278,area,0,1
96279,",",0,1
96280,were,0,0
96281,calculated,0,0
96282,.,0,0
96283,RESULTS,0,0
96284,2656,0,0
96285,patients,0,0
96286,in,0,0
96287,the,0,0
96288,intervention,0,0
96289,arm,0,0
96290,and,0,0
96291,2239,0,0
96292,in,0,0
96293,the,0,0
96294,control,0,0
96295,arm,0,0
96296,required,0,0
96297,assistance,1,0
96298,;,1,0
96299,78.3,0,0
96300,%,0,0
96301,of,0,0
96302,the,0,0
96303,former,0,0
96304,and,0,0
96305,80.6,0,0
96306,%,0,0
96307,of,0,0
96308,the,0,0
96309,latter,0,0
96310,were,0,0
96311,admitted,1,0
96312,to,1,0
96313,hospitals,1,0
96314,",",0,1
96315,and,0,0
96316,respectively,0,0
96317,74.8,0,0
96318,%,0,0
96319,and,0,0
96320,78.3,0,0
96321,%,0,0
96322,were,0,0
96323,confirmed,1,0
96324,strokes,1,1
96325,.,1,0
96326,Of,0,0
96327,the,0,0
96328,eligible,0,0
96329,confirmed,1,0
96330,strokes,1,1
96331,",",0,0
96332,106/434,0,0
96333,(,0,0
96334,24.4,0,0
96335,%,0,0
96336,),0,0
96337,in,0,0
96338,the,0,0
96339,intervention,0,0
96340,arm,0,0
96341,and,0,0
96342,43/328,0,0
96343,(,0,0
96344,13.1,0,0
96345,%,0,0
96346,),0,0
96347,in,0,0
96348,the,0,0
96349,control,0,0
96350,arm,0,0
96351,were,0,0
96352,referred,0,0
96353,to,0,0
96354,the,0,0
96355,SU,1,0
96356,in,0,0
96357,the,0,0
96358,ITT,0,0
96359,analysis,0,0
96360,(,0,0
96361,RR,0,1
96362,=,0,0
96363,2.01,0,0
96364,;,0,0
96365,95,0,0
96366,%,0,0
96367,CI,0,0
96368,:,0,0
96369,0.79-4.00,0,0
96370,),0,1
96371,",",0,1
96372,and,0,0
96373,respectively,0,0
96374,105/243,0,0
96375,(,0,0
96376,43.2,0,0
96377,%,0,0
96378,),0,0
96379,and,0,0
96380,43/311,0,0
96381,(,0,0
96382,13.8,0,0
96383,%,0,0
96384,),0,0
96385,in,0,0
96386,the,0,0
96387,PP,0,0
96388,analysis,0,0
96389,(,0,0
96390,RR,0,1
96391,=,0,0
96392,3.21,0,0
96393,;,0,0
96394,95,0,0
96395,%,0,0
96396,CI,0,0
96397,:,0,0
96398,1.62-4.98,0,0
96399,),0,0
96400,.,0,0
96401,Of,0,0
96402,patients,0,0
96403,suitable,0,0
96404,for,0,0
96405,i.v,0,0
96406,.,0,1
96407,thrombolysis,0,0
96408,",",0,0
96409,15/175,0,0
96410,(,0,0
96411,8.6,0,0
96412,%,0,0
96413,),0,0
96414,in,0,0
96415,the,0,0
96416,intervention,0,0
96417,arm,0,0
96418,and,0,0
96419,2/115,0,0
96420,(,0,0
96421,1.7,0,0
96422,%,0,0
96423,),0,0
96424,in,0,0
96425,the,0,0
96426,control,0,0
96427,arm,0,0
96428,received,0,0
96429,thrombolysis,0,0
96430,(,0,0
96431,p,0,0
96432,=,0,0
96433,0.02,0,0
96434,),0,0
96435,in,0,0
96436,the,0,0
96437,ITT,0,0
96438,analysis,0,0
96439,",",0,1
96440,and,0,0
96441,respectively,0,0
96442,15/99,0,0
96443,(,0,0
96444,15.1,0,0
96445,%,0,0
96446,),0,0
96447,and,0,0
96448,2/107,0,0
96449,(,0,0
96450,1.9,0,0
96451,%,0,0
96452,),0,0
96453,(,0,0
96454,p,0,0
96455,=,0,0
96456,0.001,0,0
96457,),0,0
96458,in,0,0
96459,the,0,0
96460,PP,0,0
96461,analysis,0,0
96462,.,0,1
96463,CONCLUSION,0,0
96464,Our,0,0
96465,data,0,0
96466,suggest,0,0
96467,potenti,0,0
96468,efficiency,1,1
96469,and,1,1
96470,feasibility,1,1
96471,of,0,0
96472,an,0,0
96473,ECP,0,1
96474,.,0,0
96475,The,0,0
96476,integration,0,1
96477,of,0,1
96478,EMS,0,0
96479,and,0,1
96480,ERs,0,0
96481,with,0,0
96482,SU,0,1
96483,networks,0,0
96484,for,0,0
96485,organised,0,0
96486,acute,0,0
96487,stroke,0,1
96488,care,0,0
96489,is,0,0
96490,feasible,0,0
96491,and,0,0
96492,may,0,0
96493,ameliorate,0,0
96494,the,0,0
96495,quality,1,1
96496,of,1,0
96497,care,1,0
96498,for,0,0
96499,stroke,0,1
96500,patients,0,0
96501,.,0,0
96502,TRIAL,0,0
96503,REGISTRATION,0,0
96504,Current,0,1
96505,Controlled,0,0
96506,Trials,0,1
96507,(,0,1
96508,ISRCTN41456865,0,0
96509,),0,0
96510,.,0,0
96511,A,0,0
96512,randomized,0,0
96513,",",0,0
96514,phase,0,0
96515,II,0,0
96516,trial,0,0
96517,of,0,0
96518,two,0,0
96519,dose,0,0
96520,schedules,0,0
96521,of,0,0
96522,carboplatin/paclitaxel/cetuximab,0,0
96523,in,0,0
96524,stage,0,0
96525,IIIB/IV,0,1
96526,non-small-cell,0,0
96527,lung,0,1
96528,cancer,0,1
96529,(,0,1
96530,NSCLC,0,1
96531,),0,0
96532,.,0,0
96533,BACKGROUND,0,0
96534,This,0,0
96535,trial,0,0
96536,investigated,0,0
96537,the,0,0
96538,efficacy,1,1
96539,and,1,1
96540,safety,1,1
96541,of,0,1
96542,weekly,0,0
96543,cetuximab,0,0
96544,combined,0,0
96545,with,0,0
96546,two,0,0
96547,different,0,0
96548,schedules,0,0
96549,of,0,0
96550,paclitaxel/carboplatin,0,0
96551,for,0,0
96552,stage,0,0
96553,IIIB/IV,0,1
96554,non-small-cell,0,0
96555,lung,0,1
96556,cancer,0,1
96557,(,0,1
96558,NSCLC,0,1
96559,),0,1
96560,.,0,0
96561,METHODS,0,0
96562,A,0,0
96563,total,0,1
96564,of,0,0
96565,168,0,0
96566,patients,0,0
96567,with,0,0
96568,previously,0,0
96569,untreated,0,0
96570,stage,0,0
96571,IIIB/IV,0,1
96572,NSCLC,0,1
96573,were,0,0
96574,randomized,0,0
96575,to,0,0
96576,arm,0,0
96577,A,0,0
96578,",",0,1
96579,cetuximab,0,0
96580,(,0,0
96581,400,0,0
96582,mg/m,0,0
96583,(,0,0
96584,2,0,0
96585,),0,0
96586,day,0,0
96587,1,0,0
96588,followed,0,0
96589,by,0,0
96590,weekly,0,0
96591,250,0,0
96592,mg/m,0,0
96593,(,0,0
96594,2,0,0
96595,),0,0
96596,),0,0
96597,+,0,0
96598,paclitaxel,0,0
96599,(,0,1
96600,Taxol,0,0
96601,),0,0
96602,(,0,0
96603,225,0,0
96604,mg/m,0,0
96605,(,0,0
96606,2,0,0
96607,),0,0
96608,),0,0
96609,/carboplatin,0,0
96610,(,0,1
96611,AUC6,0,1
96612,),0,0
96613,day,0,0
96614,1,0,0
96615,every,0,0
96616,3,0,0
96617,weeks,0,0
96618,or,0,0
96619,arm,0,0
96620,B,0,1
96621,",",0,1
96622,same,0,0
96623,cetuximab,0,0
96624,regimen,0,0
96625,plus,0,0
96626,paclitaxel,0,0
96627,(,0,0
96628,100,0,0
96629,mg/m,0,0
96630,(,0,0
96631,2,0,0
96632,),0,0
96633,),0,0
96634,days,0,0
96635,1,0,0
96636,",",0,0
96637,8,0,0
96638,",",0,0
96639,and,0,0
96640,15,0,0
96641,every,0,0
96642,3,0,0
96643,weeks,0,0
96644,and,0,0
96645,carboplatin,0,0
96646,(,0,1
96647,AUC6,0,1
96648,),0,0
96649,day,0,0
96650,1,0,0
96651,every,0,0
96652,4,0,0
96653,weeks,0,0
96654,.,0,0
96655,Treatment,0,0
96656,continued,0,0
96657,for,0,0
96658,a,0,0
96659,four-cycle,0,0
96660,maximum,0,1
96661,.,0,0
96662,Patients,0,0
96663,with,0,0
96664,a,0,0
96665,complete,0,1
96666,response,0,1
96667,",",0,1
96668,partial,0,1
96669,response,0,1
96670,",",0,1
96671,or,0,1
96672,stable,0,1
96673,disease,0,1
96674,after,0,0
96675,four,0,0
96676,cycles,0,0
96677,could,0,0
96678,receive,0,0
96679,cetuximab,0,0
96680,250,0,0
96681,mg/m,0,0
96682,(,0,0
96683,2,0,0
96684,),0,0
96685,/week,0,0
96686,until,0,0
96687,disease,1,1
96688,progression,1,1
96689,or,1,1
96690,unacceptable,1,1
96691,toxicity,1,1
96692,.,1,0
96693,The,0,0
96694,primary,0,0
96695,end,0,0
96696,point,0,0
96697,was,0,0
96698,to,0,0
96699,evaluate,0,0
96700,progression-free,1,1
96701,survival,1,1
96702,(,1,1
96703,PFS,1,1
96704,),1,0
96705,.,1,0
96706,RESULTS,0,0
96707,Median,0,1
96708,PFS,1,1
96709,was,0,0
96710,4.7,0,0
96711,and,0,0
96712,4.3,0,0
96713,months,0,0
96714,for,0,0
96715,arms,0,0
96716,A,0,0
96717,and,0,1
96718,B,0,1
96719,",",0,1
96720,respectively,0,0
96721,(,0,0
96722,6-month,0,1
96723,PFS,0,1
96724,",",0,0
96725,27.3,0,0
96726,%,0,0
96727,versus,0,0
96728,30.9,0,0
96729,%,0,0
96730,),0,0
96731,.,0,0
96732,Median,1,1
96733,overall,1,1
96734,survival,1,1
96735,was,0,0
96736,11.4,0,0
96737,versus,0,0
96738,9.8,0,0
96739,months,0,0
96740,for,0,0
96741,arms,0,0
96742,A,0,0
96743,and,0,1
96744,B,0,1
96745,",",0,0
96746,respectively,0,0
96747,;,0,0
96748,estimated,0,0
96749,1-year,0,1
96750,survival,0,1
96751,",",0,0
96752,47.7,0,0
96753,%,0,0
96754,versus,0,0
96755,39.3,0,0
96756,%,0,0
96757,;,0,0
96758,and,0,1
96759,objective,0,0
96760,response,0,1
96761,rate,0,1
96762,",",0,0
96763,29.6,0,0
96764,%,0,0
96765,versus,0,0
96766,25,0,0
96767,%,0,0
96768,.,0,0
96769,The,0,0
96770,regimen,0,0
96771,was,0,0
96772,well,0,0
96773,tolerated,1,1
96774,with,0,0
96775,rash,1,1
96776,and,1,1
96777,hematologic,1,1
96778,toxicity,1,1
96779,being,0,0
96780,most,0,0
96781,common,0,0
96782,.,0,0
96783,CONCLUSIONS,0,0
96784,This,0,0
96785,study,0,0
96786,did,0,0
96787,not,0,0
96788,meet,0,0
96789,the,0,0
96790,prespecified,0,0
96791,benchmark,0,0
96792,of,0,0
96793,35,0,0
96794,%,0,0
96795,6-month,0,0
96796,PFS,0,1
96797,rate,0,1
96798,;,0,0
96799,both,0,0
96800,combination,0,0
96801,schedules,0,0
96802,of,0,1
96803,cetuximab,0,0
96804,plus,0,0
96805,paclitaxel/carboplatin,0,0
96806,were,0,0
96807,feasible,0,0
96808,and,0,1
96809,equivalent,0,0
96810,for,0,0
96811,treating,0,0
96812,advanced,0,0
96813,NSCLC,0,1
96814,.,0,0
96815,Effect,0,1
96816,of,0,1
96817,light-cured,0,0
96818,filled,0,0
96819,sealant,0,0
96820,on,0,0
96821,shear,0,1
96822,bond,0,1
96823,strength,0,1
96824,of,0,1
96825,metal,0,1
96826,and,0,1
96827,ceramic,0,0
96828,brackets,0,0
96829,bonded,0,0
96830,with,0,0
96831,a,0,0
96832,resin-modified,0,0
96833,glass,0,1
96834,ionomer,0,0
96835,cement,0,1
96836,.,0,1
96837,INTRODUCTION,0,0
96838,Our,0,0
96839,objective,0,0
96840,was,0,0
96841,to,0,0
96842,evaluate,0,0
96843,the,0,0
96844,effects,0,0
96845,of,0,0
96846,a,0,0
96847,highly,0,0
96848,filled,0,0
96849,light-cured,0,0
96850,sealant,0,0
96851,(,0,1
96852,HFLCS,0,1
96853,),0,0
96854,on,0,0
96855,the,0,0
96856,shear,0,1
96857,bond,0,1
96858,strength,0,1
96859,and,0,1
96860,bond,0,1
96861,failure,0,1
96862,site,0,1
96863,of,0,1
96864,metal,0,1
96865,and,0,1
96866,ceramic,0,0
96867,brackets,0,0
96868,bonded,0,0
96869,with,0,0
96870,resin-modified,0,0
96871,glass,0,1
96872,ionomer,0,0
96873,cement,0,1
96874,(,0,1
96875,RMGIC,0,0
96876,),0,0
96877,.,0,0
96878,METHODS,0,0
96879,Eighty,0,1
96880,freshly,0,0
96881,extracted,0,0
96882,maxillary,0,0
96883,premolars,0,0
96884,were,0,0
96885,randomly,0,0
96886,divided,0,0
96887,into,0,0
96888,4,0,0
96889,groups,0,0
96890,(,0,0
96891,20,0,0
96892,in,0,0
96893,each,0,0
96894,group,0,0
96895,),0,0
96896,.,0,0
96897,In,0,0
96898,all,0,0
96899,groups,0,0
96900,",",0,0
96901,the,0,0
96902,teeth,0,0
96903,were,0,0
96904,etched,0,0
96905,with,0,0
96906,37,0,0
96907,%,0,0
96908,phosphoric,0,0
96909,acid,0,0
96910,for,0,0
96911,20,0,0
96912,seconds,0,0
96913,",",0,0
96914,and,0,1
96915,RMGIC,0,1
96916,(,0,1
96917,Fuji,0,1
96918,Ortho,0,1
96919,LC,0,1
96920,",",0,1
96921,GC,0,1
96922,Europe,0,1
96923,",",0,1
96924,Leuven,0,0
96925,",",0,1
96926,Belgium,0,1
96927,),0,1
96928,was,0,0
96929,used,0,0
96930,for,0,0
96931,bracket,0,0
96932,bonding,0,1
96933,.,0,0
96934,In,0,0
96935,groups,0,0
96936,1,0,0
96937,and,0,0
96938,3,0,0
96939,",",0,0
96940,the,0,0
96941,brackets,0,0
96942,were,0,0
96943,bonded,0,0
96944,directly,0,0
96945,to,0,0
96946,etched,0,0
96947,enamel,0,0
96948,surfaces,0,0
96949,;,0,0
96950,in,0,0
96951,groups,0,0
96952,2,0,0
96953,and,0,0
96954,4,0,0
96955,",",0,0
96956,the,0,0
96957,etched,0,0
96958,enamel,0,0
96959,was,0,0
96960,covered,0,0
96961,with,0,0
96962,HFLCS,0,1
96963,(,0,0
96964,Pro,0,1
96965,Seal,0,1
96966,",",0,1
96967,Reliance,0,1
96968,Orthodontic,0,1
96969,Products,0,1
96970,",",0,1
96971,Itasca,0,1
96972,",",0,1
96973,Ill,0,1
96974,),0,0
96975,.,0,0
96976,Groups,0,0
96977,1,0,0
96978,and,0,0
96979,2,0,0
96980,received,0,0
96981,metal,0,0
96982,brackets,0,0
96983,",",0,1
96984,and,0,0
96985,groups,0,0
96986,3,0,0
96987,and,0,0
96988,4,0,0
96989,had,0,0
96990,ceramic,0,0
96991,brackets,0,0
96992,.,0,0
96993,The,0,0
96994,specimens,0,0
96995,were,0,0
96996,stored,0,0
96997,in,0,0
96998,distilled,0,0
96999,water,0,0
97000,at,0,0
97001,room,0,0
97002,temperature,0,1
97003,for,0,0
97004,24,0,0
97005,hours,0,0
97006,and,0,0
97007,subsequently,0,0
97008,tested,0,0
97009,in,0,0
97010,shear,0,1
97011,mode,0,0
97012,with,0,0
97013,a,0,0
97014,universal,0,0
97015,testing,0,0
97016,machine,0,0
97017,.,0,0
97018,After,0,0
97019,debonding,0,1
97020,",",0,0
97021,the,0,0
97022,teeth,0,0
97023,and,0,0
97024,the,0,0
97025,brackets,0,0
97026,were,0,0
97027,examined,0,0
97028,under,0,0
97029,a,0,0
97030,stereomicroscope,0,1
97031,(,0,0
97032,model,0,0
97033,SMZ-1B,0,1
97034,",",0,1
97035,Nikon,0,0
97036,",",0,1
97037,Osaka,0,1
97038,",",0,1
97039,Japan,0,0
97040,),0,1
97041,at,0,0
97042,20-times,0,1
97043,magnification,0,0
97044,to,0,0
97045,assess,0,0
97046,the,0,0
97047,residual,0,1
97048,adhesive,0,0
97049,on,0,0
97050,the,0,0
97051,tooth,0,0
97052,surfaces,0,0
97053,.,0,0
97054,RESULTS,0,0
97055,Interaction,0,0
97056,between,0,0
97057,HFLCS,0,1
97058,and,0,1
97059,bracket,0,0
97060,type,0,1
97061,was,0,0
97062,not,0,0
97063,statistically,0,0
97064,significant,0,0
97065,(,0,0
97066,P,0,0
97067,=,0,0
97068,0.15,0,0
97069,),0,0
97070,.,0,0
97071,Pretreatment,0,0
97072,with,0,0
97073,HFLCS,1,1
97074,did,1,0
97075,not,1,0
97076,cause,1,0
97077,a,1,0
97078,statistically,1,0
97079,significant,1,0
97080,change,1,1
97081,in,1,0
97082,the,1,0
97083,shear,1,1
97084,bond,1,1
97085,values,1,1
97086,of,1,0
97087,either,1,0
97088,metal,1,1
97089,or,1,0
97090,ceramic,1,0
97091,brackets,1,0
97092,(,0,0
97093,P,0,0
97094,=,0,0
97095,0.38,0,0
97096,),0,0
97097,.,0,0
97098,Shear,1,1
97099,bond,1,1
97100,values,1,1
97101,of,1,0
97102,the,1,0
97103,ceramic,1,0
97104,brackets,1,0
97105,were,0,0
97106,higher,0,0
97107,than,0,0
97108,those,0,0
97109,of,0,0
97110,the,0,0
97111,metal,0,0
97112,brackets,0,0
97113,independent,0,0
97114,of,0,0
97115,HFLCS,0,1
97116,application,0,0
97117,(,0,0
97118,P,0,0
97119,<,0,0
97120,0.001,0,0
97121,),0,0
97122,.,0,0
97123,No,0,0
97124,significant,0,0
97125,differences,0,0
97126,were,0,0
97127,found,0,0
97128,in,0,0
97129,bond,1,0
97130,failure,1,0
97131,modes,1,0
97132,in,0,0
97133,the,0,0
97134,4,0,0
97135,groups,0,0
97136,.,0,0
97137,CONCLUSIONS,0,0
97138,HFLCS,0,1
97139,application,0,0
97140,on,0,0
97141,enamel,0,0
97142,etched,0,0
97143,with,0,0
97144,37,0,0
97145,%,0,0
97146,phosphoric,0,0
97147,acid,0,1
97148,did,0,0
97149,not,0,0
97150,affect,0,0
97151,the,0,0
97152,bond,1,1
97153,strength,1,1
97154,values,1,1
97155,and,0,0
97156,the,0,0
97157,bond,1,1
97158,failure,1,1
97159,modes,1,0
97160,of,0,1
97161,metal,0,1
97162,and,0,1
97163,ceramic,0,0
97164,brackets,0,0
97165,bonded,0,0
97166,with,0,0
97167,RMGIC,0,0
97168,.,0,0
97169,RESULTS,0,0
97170,Interaction,0,0
97171,between,0,0
97172,HFLCS,0,1
97173,and,0,1
97174,bracket,0,0
97175,type,0,1
97176,was,0,0
97177,not,0,0
97178,statistically,0,0
97179,significant,0,0
97180,(,0,0
97181,P,0,0
97182,=,0,0
97183,0.15,0,0
97184,),0,0
97185,.,0,0
97186,Pretreatment,0,0
97187,with,0,0
97188,HFLCS,0,1
97189,did,0,0
97190,not,0,0
97191,cause,0,0
97192,a,0,0
97193,statistically,0,0
97194,significant,0,0
97195,change,0,1
97196,in,0,0
97197,the,0,0
97198,shear,1,1
97199,bond,1,1
97200,values,1,1
97201,of,1,0
97202,either,1,0
97203,metal,1,1
97204,or,1,0
97205,ceramic,1,0
97206,brackets,1,0
97207,(,0,0
97208,P,0,0
97209,=,0,0
97210,0.38,0,0
97211,),0,0
97212,.,0,0
97213,Shear,1,1
97214,bond,1,1
97215,values,1,1
97216,of,1,0
97217,the,1,0
97218,ceramic,1,0
97219,brackets,1,0
97220,were,0,0
97221,higher,0,0
97222,than,0,0
97223,those,0,0
97224,of,0,0
97225,the,0,0
97226,metal,0,0
97227,brackets,0,0
97228,independent,0,0
97229,of,0,0
97230,HFLCS,0,1
97231,application,0,0
97232,(,0,0
97233,P,0,0
97234,<,0,0
97235,0.001,0,0
97236,),0,0
97237,.,0,0
97238,No,0,0
97239,significant,0,0
97240,differences,0,0
97241,were,0,0
97242,found,0,0
97243,in,0,0
97244,bond,0,0
97245,failure,0,0
97246,modes,0,0
97247,in,0,0
97248,the,0,0
97249,4,0,0
97250,groups,0,0
97251,.,0,0
97252,CONCLUSIONS,0,0
97253,HFLCS,0,1
97254,application,0,0
97255,on,0,0
97256,enamel,0,0
97257,etched,0,0
97258,with,0,0
97259,37,0,0
97260,%,0,0
97261,phosphoric,0,0
97262,acid,0,1
97263,did,0,0
97264,not,0,0
97265,affect,0,0
97266,the,0,0
97267,bond,0,1
97268,strength,0,1
97269,values,0,1
97270,and,0,0
97271,the,0,0
97272,bond,0,1
97273,failure,0,1
97274,modes,0,0
97275,of,0,1
97276,metal,0,1
97277,and,0,1
97278,ceramic,0,0
97279,brackets,0,0
97280,bonded,0,0
97281,with,0,0
97282,RMGIC,0,0
97283,.,0,0
97284,Cardiac,0,1
97285,failure,0,0
97286,:,0,0
97287,symptoms,0,1
97288,and,0,1
97289,functional,0,1
97290,status,0,1
97291,.,0,0
97292,The,0,0
97293,associations,0,0
97294,between,0,0
97295,exercise,0,0
97296,capacity,0,1
97297,",",0,1
97298,symptoms,0,1
97299,and,0,1
97300,specific,0,0
97301,aspects,0,1
97302,of,0,0
97303,quality,0,1
97304,of,0,1
97305,life,0,1
97306,were,0,0
97307,examined,0,0
97308,in,0,0
97309,subjects,0,0
97310,participating,0,0
97311,in,0,0
97312,a,0,0
97313,trial,0,0
97314,of,0,0
97315,the,0,0
97316,treatment,0,0
97317,of,0,1
97318,heart,0,1
97319,failure,0,1
97320,.,0,1
97321,Patients,0,0
97322,were,0,0
97323,assessed,0,0
97324,on,0,0
97325,entry,0,1
97326,and,0,0
97327,after,0,0
97328,three,0,0
97329,months,0,0
97330,treatment,0,0
97331,.,0,0
97332,The,0,0
97333,principle,0,0
97334,symptoms,0,1
97335,were,0,0
97336,fatigue,0,1
97337,",",0,1
97338,breathlessness,0,1
97339,and,0,1
97340,chest,0,1
97341,pain,0,1
97342,.,0,0
97343,These,0,0
97344,limited,0,0
97345,the,0,0
97346,extent,0,0
97347,and,0,1
97348,speed,0,1
97349,of,0,1
97350,physical,0,1
97351,activities,0,1
97352,",",0,0
97353,restricted,0,0
97354,social,0,1
97355,",",0,0
97356,leisure,0,1
97357,and,0,1
97358,family,0,1
97359,life,0,1
97360,and,0,1
97361,were,0,0
97362,associated,0,0
97363,with,0,0
97364,emotional,0,1
97365,distress,0,1
97366,.,0,0
97367,There,0,0
97368,were,0,0
97369,associations,0,0
97370,between,0,0
97371,baseline,1,0
97372,exercise,1,0
97373,capacity,1,1
97374,and,1,1
97375,measures,1,1
97376,of,1,1
97377,quality,1,1
97378,of,1,0
97379,life,1,1
97380,.,1,0
97381,Change,0,0
97382,in,0,0
97383,exercise,0,0
97384,capacity,0,1
97385,during,0,0
97386,three,0,0
97387,months,0,0
97388,treatment,0,0
97389,was,0,0
97390,correlated,0,0
97391,with,0,0
97392,changes,0,1
97393,in,0,0
97394,measures,1,0
97395,of,1,0
97396,symptoms,1,1
97397,",",1,0
97398,limitation,1,1
97399,of,1,1
97400,activity,1,1
97401,and,1,1
97402,quality,1,1
97403,of,1,1
97404,life,1,1
97405,.,1,0
97406,The,0,0
97407,findings,0,0
97408,confirm,0,0
97409,the,0,0
97410,value,0,1
97411,of,0,0
97412,change,0,1
97413,in,0,0
97414,exercise,1,0
97415,capacity,1,1
97416,as,0,0
97417,a,0,0
97418,measure,0,0
97419,of,0,0
97420,functional,0,1
97421,status,0,1
97422,and,0,0
97423,suggest,0,0
97424,that,0,0
97425,it,0,0
97426,should,0,0
97427,be,0,0
97428,supported,0,0
97429,by,0,0
97430,a,0,0
97431,limited,0,0
97432,number,0,1
97433,of,0,1
97434,specific,0,0
97435,measures,0,1
97436,of,0,0
97437,quality,1,1
97438,of,1,0
97439,life,1,1
97440,.,1,0
97441,Comparison,0,0
97442,of,0,1
97443,injection,1,0
97444,comfort,1,1
97445,of,0,0
97446,a,0,0
97447,new,0,0
97448,category,0,0
97449,of,0,1
97450,cohesive,0,0
97451,hyaluronic,0,0
97452,acid,0,1
97453,filler,0,1
97454,with,0,0
97455,preincorporated,0,0
97456,lidocaine,0,0
97457,and,0,0
97458,a,0,0
97459,hyaluronic,0,0
97460,acid,0,0
97461,filler,0,1
97462,alone,0,0
97463,.,0,0
97464,BACKGROUND,0,0
97465,A,0,0
97466,smooth,0,1
97467,",",0,0
97468,cohesive,0,1
97469,",",0,1
97470,24-mg/mL,0,1
97471,hyaluronic,0,1
97472,acid,0,1
97473,(,0,1
97474,HA,0,1
97475,),0,1
97476,gel,0,0
97477,with,0,0
97478,uniform,0,0
97479,consistency,0,1
97480,",",0,0
97481,even,0,0
97482,flow,0,1
97483,characteristics,0,1
97484,",",0,1
97485,and,0,1
97486,extended,0,1
97487,duration,0,1
97488,was,0,0
97489,designed,0,0
97490,for,0,0
97491,injection,0,0
97492,into,0,0
97493,the,0,0
97494,mid,0,0
97495,to,0,0
97496,deep,0,0
97497,dermis,0,1
97498,.,0,0
97499,OBJECTIVE,0,0
97500,To,0,0
97501,compare,0,0
97502,injection,0,0
97503,pain,0,1
97504,of,0,0
97505,a,0,0
97506,HA,0,0
97507,gel,0,0
97508,with,0,0
97509,preincorporated,0,0
97510,lidocaine,0,0
97511,with,0,0
97512,that,0,0
97513,with,0,0
97514,a,0,0
97515,non-lidocaine,0,0
97516,formulation,0,0
97517,.,0,1
97518,METHODS,0,0
97519,&,0,0
97520,MATERIALS,0,0
97521,This,0,0
97522,double-blind,0,0
97523,study,0,0
97524,at,0,0
97525,three,0,0
97526,centers,0,0
97527,enrolled,0,0
97528,60,0,0
97529,subjects,0,0
97530,",",0,0
97531,injected,0,0
97532,with,0,0
97533,both,0,0
97534,products,0,0
97535,",",0,0
97536,randomly,0,0
97537,assigned,0,0
97538,to,0,0
97539,left,0,1
97540,or,0,0
97541,right,0,1
97542,nasolabial,0,1
97543,fold,0,1
97544,.,0,0
97545,The,0,0
97546,injecting,0,0
97547,physician,0,1
97548,assessed,0,0
97549,severity,0,1
97550,of,0,1
97551,pain,1,1
97552,and,0,1
97553,ease,1,1
97554,of,1,1
97555,injection,1,0
97556,.,1,1
97557,Subjects,0,0
97558,used,0,0
97559,a,0,0
97560,visual,0,1
97561,analog,0,1
97562,scale,0,1
97563,(,0,1
97564,0-10,0,1
97565,),0,0
97566,for,0,0
97567,pain,0,1
97568,assessment,0,0
97569,.,0,1
97570,Adverse,0,1
97571,events,0,1
97572,were,0,0
97573,recorded,0,0
97574,.,0,0
97575,RESULTS,0,0
97576,Physician,0,1
97577,assessment,0,0
97578,of,0,1
97579,injection,1,0
97580,pain,1,1
97581,was,0,0
97582,none,0,0
97583,or,0,1
97584,mild,0,0
97585,in,0,0
97586,81,0,0
97587,%,0,0
97588,of,0,0
97589,HA,0,0
97590,gel,0,0
97591,injections,0,0
97592,with,0,0
97593,preincorporated,0,0
97594,lidocaine,0,0
97595,and,0,0
97596,36,0,0
97597,%,0,0
97598,of,0,0
97599,HA-alone,0,0
97600,injections,0,0
97601,(,0,0
97602,p,0,0
97603,<,0,0
97604,.001,0,0
97605,),0,0
97606,.,0,0
97607,Mean,1,1
97608,pain,1,1
97609,assessment,1,0
97610,by,0,0
97611,subjects,0,0
97612,was,0,0
97613,3.6,0,0
97614,for,0,0
97615,HA+lidocaine,0,0
97616,and,0,0
97617,5.8,0,0
97618,for,0,0
97619,HA,0,0
97620,alone,0,0
97621,(,0,0
97622,p,0,0
97623,<,0,0
97624,.001,0,0
97625,),0,0
97626,.,0,0
97627,Ninety-five,0,0
97628,percent,0,0
97629,of,0,0
97630,the,0,0
97631,injections,0,0
97632,were,0,0
97633,considered,0,0
97634,easy,0,1
97635,or,0,0
97636,very,0,0
97637,easy,0,0
97638,;,0,0
97639,a,0,0
97640,greater,0,0
97641,percentage,0,1
97642,of,0,1
97643,HA+lidocaine,0,0
97644,injections,0,0
97645,were,0,0
97646,rated,0,1
97647,very,0,0
97648,easy,0,0
97649,.,0,0
97650,Mild,0,0
97651,to,0,0
97652,moderate,0,0
97653,adverse,0,1
97654,events,0,1
97655,were,0,0
97656,reported,0,0
97657,for,0,0
97658,both,0,0
97659,products,0,0
97660,.,0,0
97661,CONCLUSION,0,0
97662,The,0,0
97663,smooth,0,1
97664,",",0,0
97665,cohesive,0,1
97666,HA,0,1
97667,gel,0,0
97668,with,0,0
97669,preincorporated,0,0
97670,lidocaine,0,0
97671,increased,0,1
97672,subject,1,0
97673,comfort,1,1
97674,during,0,0
97675,treatment,0,0
97676,and,0,1
97677,improved,0,1
97678,the,0,0
97679,injection,1,0
97680,experience,1,0
97681,.,1,0
97682,Effect,0,1
97683,of,0,0
97684,broccoli,0,0
97685,intake,0,1
97686,on,0,0
97687,markers,1,0
97688,related,1,0
97689,to,1,0
97690,oxidative,1,1
97691,stress,1,1
97692,and,1,1
97693,cancer,1,1
97694,risk,1,1
97695,in,0,0
97696,healthy,0,0
97697,smokers,0,0
97698,and,0,0
97699,nonsmokers,0,0
97700,.,0,1
97701,Cruciferous,0,1
97702,vegetables,0,0
97703,(,0,0
97704,CVs,0,0
97705,),0,0
97706,have,0,0
97707,been,0,0
97708,widely,0,0
97709,studied,0,0
97710,for,0,0
97711,their,0,0
97712,anticarcinogenic,0,0
97713,properties,0,1
97714,.,0,0
97715,The,0,0
97716,aim,0,0
97717,of,0,0
97718,the,0,0
97719,present,0,0
97720,study,0,0
97721,was,0,0
97722,to,0,0
97723,evaluate,0,0
97724,the,0,0
97725,protective,0,0
97726,effect,0,0
97727,of,0,0
97728,broccoli,0,0
97729,intake,0,1
97730,in,0,0
97731,smokers,0,0
97732,and,0,0
97733,nonsmokers,0,0
97734,.,0,1
97735,Twenty,0,0
97736,young,0,0
97737,healthy,0,0
97738,males,0,0
97739,(,0,0
97740,10,0,0
97741,smokers,0,0
97742,and,0,0
97743,10,0,0
97744,nonsmokers,0,0
97745,),0,0
97746,were,0,0
97747,randomized,0,0
97748,in,0,0
97749,a,0,0
97750,cross-over,0,0
97751,design,0,0
97752,and,0,1
97753,received,0,0
97754,a,0,0
97755,portion,0,0
97756,of,0,1
97757,broccoli,0,0
97758,(,0,0
97759,200,0,0
97760,g,0,0
97761,),0,0
97762,or,0,0
97763,maintained,0,0
97764,a,0,0
97765,controlled,0,0
97766,diet,0,0
97767,for,0,0
97768,10,0,0
97769,days,0,0
97770,each,0,0
97771,.,0,0
97772,The,0,0
97773,two,0,0
97774,periods,0,0
97775,were,0,0
97776,separated,0,0
97777,by,0,0
97778,a,0,0
97779,wash-out,0,0
97780,period,0,0
97781,(,0,0
97782,20,0,0
97783,days,0,0
97784,),0,0
97785,.,0,0
97786,Blood,0,1
97787,samples,0,0
97788,were,0,0
97789,collected,0,0
97790,at,0,0
97791,0,0,0
97792,",",0,0
97793,10,0,0
97794,",",0,0
97795,30,0,0
97796,",",0,0
97797,and,0,0
97798,40,0,0
97799,days,0,0
97800,and,0,0
97801,used,0,0
97802,for,0,0
97803,the,0,0
97804,evaluation,0,0
97805,of,0,0
97806,DNA,1,1
97807,damage,1,1
97808,",",1,1
97809,insulin-like,1,1
97810,growth,1,1
97811,factor-I,1,1
97812,(,1,0
97813,IGF-I,1,1
97814,),1,1
97815,and,1,1
97816,histone,1,1
97817,deacetylase,1,1
97818,(,1,1
97819,HDAC,1,0
97820,),1,0
97821,.,1,0
97822,Ex,1,0
97823,vivo,1,0
97824,protection,1,1
97825,from,1,0
97826,H,1,1
97827,(,1,0
97828,2,1,0
97829,),1,0
97830,O,1,0
97831,(,1,0
97832,2,1,0
97833,),1,0
97834,-induced,1,0
97835,DNA,1,1
97836,damage,1,1
97837,and,1,1
97838,endogenous,1,1
97839,DNA,1,1
97840,damage,1,1
97841,were,1,0
97842,evaluated,1,0
97843,in,0,0
97844,lymphocytes,0,1
97845,by,0,0
97846,means,0,0
97847,of,0,0
97848,the,0,0
97849,comet,1,1
97850,assay,1,0
97851,.,1,1
97852,Strand,1,1
97853,breaks,1,1
97854,decreased,0,0
97855,significantly,0,0
97856,after,0,0
97857,the,0,0
97858,broccoli,0,0
97859,diet,0,0
97860,in,0,0
97861,smokers,0,0
97862,as,0,0
97863,well,0,0
97864,as,0,0
97865,in,0,0
97866,nonsmokers,0,0
97867,(,0,0
97868,-22.2,0,0
97869,%,0,0
97870,;,0,0
97871,P,0,0
97872,<,0,0
97873,0.0001,0,0
97874,),0,0
97875,",",0,0
97876,whereas,0,0
97877,oxidized,1,1
97878,purines,1,1
97879,decreased,0,0
97880,significantly,0,0
97881,only,0,0
97882,in,0,0
97883,smokers,0,0
97884,(,0,0
97885,-51.0,0,0
97886,%,0,0
97887,;,0,0
97888,P,0,0
97889,<,0,0
97890,0.0001,0,0
97891,),0,0
97892,.,0,0
97893,Broccoli,0,0
97894,intake,0,1
97895,did,0,0
97896,not,0,0
97897,modify,0,0
97898,HDAC,1,1
97899,activity,1,1
97900,and,1,1
97901,IGF-I,1,1
97902,serum,1,1
97903,levels,1,1
97904,.,1,0
97905,Our,0,0
97906,results,0,0
97907,strengthen,0,0
97908,the,0,0
97909,importance,0,0
97910,of,0,0
97911,consuming,0,0
97912,CVs,0,0
97913,to,0,0
97914,increase,1,1
97915,cell,1,1
97916,protection,1,1
97917,against,1,1
97918,DNA,1,1
97919,damage,1,1
97920,.,1,1
97921,Future,0,1
97922,investigation,0,0
97923,",",0,0
97924,with,0,0
97925,different,0,0
97926,amount,0,1
97927,of,0,1
97928,broccoli,0,0
97929,and/or,0,0
97930,different,0,0
97931,time,0,1
97932,of,0,1
97933,exposure,0,0
97934,",",0,0
97935,is,0,0
97936,needed,0,0
97937,to,0,0
97938,understand,0,0
97939,the,0,0
97940,lack,0,0
97941,of,0,0
97942,effect,0,1
97943,on,0,0
97944,HDAC,1,1
97945,activity,1,1
97946,and,1,1
97947,IGF-I,1,1
97948,levels,1,1
97949,.,1,0
97950,A,0,0
97951,randomized,0,0
97952,",",0,0
97953,controlled,0,0
97954,study,0,0
97955,on,0,0
97956,the,0,0
97957,influence,0,0
97958,of,0,1
97959,acetaminophen,0,1
97960,",",0,1
97961,diclofenac,0,0
97962,",",0,1
97963,or,0,0
97964,naproxen,0,0
97965,on,0,0
97966,aspirin-induced,0,1
97967,inhibition,0,1
97968,of,0,1
97969,platelet,1,1
97970,aggregation,1,1
97971,.,1,1
97972,Nonsteroidal,0,0
97973,anti-inflammatory,0,0
97974,drugs,0,0
97975,(,0,0
97976,NSAID,0,0
97977,),0,0
97978,may,0,0
97979,interfere,0,1
97980,with,0,0
97981,aspirin,0,0
97982,(,0,0
97983,acetylsalicylic,0,0
97984,acid,0,1
97985,),0,0
97986,and,0,0
97987,increase,0,0
97988,the,0,0
97989,risk,0,1
97990,for,0,0
97991,cardiovascular,1,1
97992,events,1,1
97993,.,1,0
97994,The,0,0
97995,clinical,0,0
97996,relevance,0,0
97997,is,0,0
97998,uncertain,0,0
97999,.,0,0
98000,The,0,0
98001,aim,0,0
98002,of,0,0
98003,this,0,0
98004,study,0,0
98005,was,0,0
98006,to,0,0
98007,analyse,0,0
98008,the,0,0
98009,influence,0,0
98010,of,0,0
98011,a,0,0
98012,co-administration,0,0
98013,of,0,1
98014,aspirin,0,0
98015,and,0,1
98016,NSAID,0,1
98017,on,0,0
98018,platelet,1,1
98019,aggregation,1,1
98020,.,1,0
98021,In,0,0
98022,a,0,0
98023,randomized,0,0
98024,",",0,0
98025,placebo,0,0
98026,controlled,0,0
98027,trial,0,0
98028,",",0,0
98029,eleven,0,0
98030,healthy,0,0
98031,volunteers,0,0
98032,were,0,0
98033,studied,0,0
98034,during,0,0
98035,4,0,0
98036,separate,0,0
98037,study,0,0
98038,periods,0,0
98039,of,0,0
98040,4,0,0
98041,days,0,0
98042,each,0,0
98043,.,0,0
98044,Individuals,0,0
98045,were,0,0
98046,treated,0,0
98047,on,0,0
98048,each,0,0
98049,occasion,0,0
98050,with,0,0
98051,100,0,0
98052,mg,0,0
98053,aspirin,0,0
98054,daily,0,0
98055,in,0,0
98056,combination,0,0
98057,with,0,0
98058,either,0,0
98059,3,0,0
98060,x,0,0
98061,1,0,0
98062,g,0,0
98063,acetaminophen,0,0
98064,",",0,0
98065,3,0,0
98066,x,0,0
98067,50,0,0
98068,mg,0,0
98069,diclofenac,0,0
98070,",",0,0
98071,3,0,0
98072,x,0,0
98073,250,0,0
98074,mg,0,0
98075,naproxen,0,0
98076,",",0,0
98077,or,0,0
98078,3,0,0
98079,x,0,0
98080,1,0,0
98081,placebo,0,0
98082,.,0,0
98083,Primary,1,1
98084,hemostasis,1,1
98085,was,0,0
98086,assessed,0,0
98087,with,0,0
98088,a,0,0
98089,platelet,0,1
98090,function,0,1
98091,analyser,0,1
98092,(,0,1
98093,PFA-100,0,1
98094,),0,1
98095,",",0,0
98096,which,0,0
98097,measures,0,0
98098,the,1,0
98099,closure,1,1
98100,time,1,1
98101,(,1,1
98102,CT,1,1
98103,),1,0
98104,of,1,0
98105,a,1,0
98106,collagen-,1,1
98107,and,1,1
98108,epinephrine-coated,1,1
98109,pore,1,1
98110,by,1,0
98111,aggregating,1,1
98112,platelets,1,1
98113,in,1,0
98114,flowing,1,0
98115,blood,1,1
98116,.,1,1
98117,Naproxen,0,0
98118,enhanced,0,0
98119,the,0,0
98120,anti-aggregatory,1,1
98121,action,1,1
98122,of,0,1
98123,aspirin,0,0
98124,after,0,0
98125,24,0,0
98126,h,0,0
98127,(,1,0
98128,CT,1,1
98129,rising,0,1
98130,from,0,0
98131,104+/-16,0,0
98132,s,0,1
98133,at,0,0
98134,baseline,0,0
98135,to,0,0
98136,212+/-69,0,0
98137,s,0,0
98138,at,0,0
98139,24,0,0
98140,h,0,0
98141,",",0,0
98142,P,0,0
98143,<,0,0
98144,0.001,0,0
98145,),0,0
98146,",",0,0
98147,which,0,0
98148,was,0,0
98149,not,0,0
98150,seen,0,0
98151,with,0,0
98152,any,0,0
98153,other,0,0
98154,drug,0,0
98155,combination,0,0
98156,.,0,1
98157,Diclofenac,0,0
98158,reduced,0,0
98159,the,0,0
98160,anti-aggregatory,1,1
98161,action,1,1
98162,of,0,1
98163,aspirin,0,0
98164,in,0,0
98165,the,0,0
98166,first,0,0
98167,two,0,0
98168,days,0,0
98169,",",0,0
98170,since,0,0
98171,the,0,0
98172,CT,1,1
98173,did,0,0
98174,not,0,0
98175,rise,0,0
98176,significantly,0,0
98177,(,0,0
98178,109+/-19,0,0
98179,s,0,1
98180,",",0,1
98181,148+/-56,0,0
98182,s,0,1
98183,",",0,1
98184,and,0,1
98185,168+/-66,0,0
98186,s,0,0
98187,at,0,0
98188,0,0,0
98189,h,0,0
98190,",",0,0
98191,24,0,0
98192,h,0,0
98193,",",0,0
98194,48,0,0
98195,h,0,0
98196,",",0,0
98197,respectively,0,0
98198,",",0,0
98199,P,0,0
98200,>,0,0
98201,0.05,0,0
98202,),0,0
98203,.,0,0
98204,Acetaminophen,0,0
98205,had,0,0
98206,no,0,0
98207,effect,0,1
98208,compared,0,0
98209,with,0,0
98210,placebo,0,0
98211,.,0,0
98212,After,0,0
98213,4,0,0
98214,days,0,0
98215,of,0,0
98216,treatment,0,0
98217,platelet,1,1
98218,aggregation,1,1
98219,was,0,0
98220,similarly,0,0
98221,inhibited,0,0
98222,by,0,0
98223,all,0,0
98224,combinations,0,0
98225,.,0,0
98226,We,0,0
98227,conclude,0,0
98228,that,0,0
98229,a,0,0
98230,co-administration,0,0
98231,of,0,1
98232,NSAID,0,0
98233,and,0,0
98234,aspirin,0,0
98235,may,0,0
98236,interfere,0,1
98237,with,0,0
98238,platelet,1,1
98239,inhibition,1,1
98240,at,0,0
98241,the,0,0
98242,beginning,0,0
98243,of,0,0
98244,a,0,0
98245,treatment,0,0
98246,with,0,0
98247,an,0,0
98248,increase,0,0
98249,of,0,1
98250,naproxen,0,0
98251,and,0,0
98252,a,0,0
98253,decrease,0,1
98254,of,0,0
98255,diclofenac,0,0
98256,.,0,0
98257,This,0,0
98258,effect,0,0
98259,is,0,0
98260,lost,0,0
98261,after,0,0
98262,4,0,0
98263,days,0,0
98264,",",0,0
98265,suggesting,0,0
98266,that,0,0
98267,a,0,0
98268,regular,0,0
98269,daily,0,0
98270,co-administration,0,0
98271,of,0,0
98272,NSAID,0,0
98273,does,0,0
98274,not,0,0
98275,have,0,0
98276,an,0,0
98277,influence,0,0
98278,on,0,0
98279,platelet,1,1
98280,inhibition,1,1
98281,by,0,0
98282,aspirin,0,0
98283,.,0,0
98284,Ongoing,0,0
98285,Telmisartan,0,0
98286,Alone,0,1
98287,and,0,1
98288,in,0,0
98289,Combination,0,1
98290,With,0,0
98291,Ramipril,0,0
98292,Global,0,1
98293,Endpoint,0,1
98294,Trial,0,0
98295,(,0,1
98296,ONTARGET,0,0
98297,),0,0
98298,:,0,0
98299,implications,0,0
98300,for,0,0
98301,reduced,0,1
98302,cardiovascular,1,1
98303,risk,1,1
98304,.,1,0
98305,The,0,0
98306,recently,0,0
98307,published,0,0
98308,Ongoing,0,0
98309,Telmisartan,0,0
98310,Alone,0,1
98311,and,0,1
98312,in,0,0
98313,Combination,0,1
98314,With,0,0
98315,Ramipril,0,0
98316,Global,0,1
98317,Endpoint,0,1
98318,Trial,0,0
98319,(,0,1
98320,ONTARGET,0,0
98321,),0,0
98322,in,0,0
98323,patients,0,0
98324,with,0,0
98325,vascular,0,1
98326,disease,0,1
98327,or,0,1
98328,high-risk,0,0
98329,diabetes,0,1
98330,",",0,0
98331,as,0,0
98332,the,0,0
98333,largest,0,0
98334,published,0,0
98335,comparative,0,0
98336,trial,0,0
98337,of,0,0
98338,these,0,0
98339,agent,0,0
98340,classes,0,0
98341,",",0,0
98342,provides,0,0
98343,further,0,0
98344,evidence,0,0
98345,concerning,0,0
98346,the,0,0
98347,comparison,0,0
98348,between,0,0
98349,the,0,0
98350,angiotensin-receptor,0,0
98351,blockers,0,0
98352,(,0,1
98353,ARBs,0,1
98354,),0,0
98355,and,0,0
98356,the,0,0
98357,angiotensin-converting,0,0
98358,enzyme,0,0
98359,inhibitors,0,1
98360,(,0,1
98361,ACEIs,0,0
98362,),0,0
98363,.,0,0
98364,In,0,0
98365,this,0,0
98366,trial,0,0
98367,",",0,1
98368,telmisartan,0,0
98369,(,0,0
98370,an,0,0
98371,ARB,0,0
98372,),0,0
98373,was,0,0
98374,non-inferior,0,0
98375,to,0,0
98376,ramipril,0,0
98377,(,0,0
98378,an,0,0
98379,ACEI,0,0
98380,),0,0
98381,in,0,0
98382,reducing,0,0
98383,fatal,1,1
98384,and,1,1
98385,nonfatal,1,1
98386,cardiovascular,1,1
98387,events,1,1
98388,.,1,0
98389,Moreover,0,0
98390,",",0,0
98391,ONTARGET,0,0
98392,is,0,0
98393,an,0,0
98394,example,0,0
98395,of,0,0
98396,a,0,0
98397,high-quality,0,0
98398,noninferiority,0,0
98399,trial,0,0
98400,.,0,0
98401,However,0,0
98402,",",0,0
98403,the,0,0
98404,combination,0,0
98405,of,0,0
98406,the,0,0
98407,2,0,0
98408,agents,0,0
98409,was,0,0
98410,associated,0,0
98411,with,0,0
98412,more,0,0
98413,adverse,1,1
98414,effects,1,1
98415,without,0,0
98416,an,0,0
98417,increase,0,0
98418,in,0,0
98419,benefit,0,0
98420,.,0,0
98421,The,0,0
98422,study,0,0
98423,differed,0,0
98424,from,0,0
98425,several,0,0
98426,other,0,0
98427,comparative,0,0
98428,studies,0,0
98429,in,0,0
98430,which,0,0
98431,the,0,0
98432,dose,0,0
98433,and,0,1
98434,choice,0,1
98435,of,0,1
98436,ACEI,0,0
98437,was,0,0
98438,left,0,1
98439,to,0,0
98440,individual,0,0
98441,physicians,0,0
98442,.,0,1
98443,Further,0,1
98444,",",0,0
98445,in,0,0
98446,ONTARGET,0,0
98447,",",0,0
98448,the,0,0
98449,ACEI,0,1
98450,was,0,0
98451,not,0,0
98452,titrated,0,0
98453,to,0,0
98454,the,0,0
98455,maximum,0,1
98456,dose,0,0
98457,and,0,1
98458,patients,0,0
98459,with,0,0
98460,heart,0,1
98461,failure,0,1
98462,were,0,0
98463,excluded,0,0
98464,.,0,0
98465,The,0,0
98466,SNRI,0,0
98467,venlafaxine,0,0
98468,improves,0,1
98469,emotional,1,1
98470,unawareness,1,1
98471,in,0,0
98472,patients,0,0
98473,with,0,0
98474,post-stroke,0,0
98475,depression,0,1
98476,.,0,1
98477,OBJECTIVE,0,0
98478,Patients,0,0
98479,with,0,0
98480,stroke,0,0
98481,have,0,0
98482,a,0,0
98483,high,0,0
98484,prevalence,0,1
98485,of,0,1
98486,depression,0,1
98487,and,0,1
98488,unawareness,0,1
98489,of,0,1
98490,emotions,0,1
98491,or,0,0
98492,alexithymia,1,1
98493,.,1,0
98494,Here,0,0
98495,we,0,0
98496,investigated,0,0
98497,the,0,0
98498,effects,0,0
98499,of,0,0
98500,the,0,0
98501,serotoninergic,0,1
98502,and,0,1
98503,noradrenergic,0,1
98504,reuptake,0,0
98505,inhibitor,0,0
98506,(,0,1
98507,SNRI,0,1
98508,),0,1
98509,venlafaxine,0,0
98510,in,0,0
98511,comparison,0,0
98512,with,0,0
98513,the,0,0
98514,SSRI,0,1
98515,fluoxetine,0,0
98516,on,0,0
98517,alexithymia,1,1
98518,severity,0,1
98519,in,0,0
98520,patients,0,0
98521,with,0,0
98522,DSM-IV,0,1
98523,post-stroke,0,1
98524,major,0,1
98525,depressive-like,0,1
98526,episode,0,1
98527,(,0,1
98528,PSD,0,0
98529,),0,0
98530,.,0,0
98531,METHODS,0,0
98532,Fifty,0,0
98533,inpatients,0,0
98534,with,0,0
98535,first-ever,0,0
98536,stroke,0,1
98537,and,0,1
98538,PSD,0,1
98539,were,0,0
98540,consecutively,0,0
98541,enrolled,0,0
98542,in,0,0
98543,this,0,0
98544,randomized,0,0
98545,open-label,0,0
98546,study,0,0
98547,.,0,1
98548,Twenty-five,0,0
98549,were,0,0
98550,treated,0,0
98551,with,0,0
98552,the,0,0
98553,SNRI,0,0
98554,venlafaxine,0,0
98555,SR,0,1
98556,(,0,1
98557,75-150,0,0
98558,mg/die,0,0
98559,),0,1
98560,",",0,0
98561,and,0,0
98562,25,0,0
98563,with,0,0
98564,the,0,0
98565,SSRI,0,1
98566,fluoxetine,0,0
98567,(,0,1
98568,20-40,0,0
98569,mg/die,0,0
98570,),0,0
98571,.,0,0
98572,All,0,0
98573,patients,0,0
98574,were,0,0
98575,assessed,0,0
98576,at,0,0
98577,day,0,0
98578,0,0,0
98579,",",0,0
98580,and,0,0
98581,after,0,0
98582,1,0,0
98583,",",0,0
98584,2,0,0
98585,",",0,0
98586,4,0,0
98587,",",0,0
98588,6,0,0
98589,",",0,0
98590,and,0,0
98591,8,0,0
98592,weeks,0,0
98593,",",0,0
98594,using,0,0
98595,the,0,0
98596,Mini-Mental,1,0
98597,State,1,1
98598,Examination,1,0
98599,",",1,0
98600,the,1,0
98601,Hamilton,1,1
98602,Depression,1,1
98603,Rating,1,1
98604,Scale,1,1
98605,",",1,0
98606,and,1,0
98607,the,1,0
98608,Toronto,1,0
98609,Alexithymia,1,1
98610,Scale,1,1
98611,(,0,1
98612,TAS-20,0,1
98613,),0,0
98614,.,0,0
98615,RESULTS,0,0
98616,Patients,0,0
98617,treated,0,0
98618,with,0,0
98619,fluoxetine,0,0
98620,and,0,0
98621,those,0,0
98622,treated,0,0
98623,with,0,0
98624,venlafaxine,0,0
98625,showed,0,0
98626,similar,0,0
98627,improvement,0,1
98628,in,0,0
98629,depressive,1,1
98630,symptoms,1,1
98631,.,1,0
98632,However,0,0
98633,",",0,0
98634,patients,0,0
98635,treated,0,0
98636,with,0,0
98637,venlafaxine,0,0
98638,had,0,0
98639,a,0,0
98640,greater,0,0
98641,improvement,0,1
98642,on,0,0
98643,alexithymia,1,1
98644,severity,1,1
98645,than,0,0
98646,those,0,0
98647,treated,0,0
98648,with,0,0
98649,fluoxetine,0,0
98650,.,0,0
98651,The,0,0
98652,effect,0,0
98653,of,0,0
98654,venlafaxine,0,0
98655,on,0,0
98656,unawareness,1,1
98657,of,1,1
98658,emotions,1,1
98659,was,0,0
98660,evident,0,0
98661,in,0,0
98662,patients,0,0
98663,with,0,0
98664,alexithymia,0,1
98665,(,0,0
98666,TAS-20,0,1
98667,>,0,0
98668,or=,0,0
98669,61,0,0
98670,),0,0
98671,at,0,0
98672,the,0,0
98673,baseline,0,0
98674,and,0,0
98675,in,0,0
98676,those,0,0
98677,without,0,0
98678,alexithymia,0,1
98679,(,0,0
98680,TAS-20,0,1
98681,<,0,0
98682,61,0,0
98683,),0,0
98684,.,0,0
98685,CONCLUSIONS,0,0
98686,Antidepressants,0,0
98687,acting,0,0
98688,on,0,0
98689,both,0,0
98690,the,0,0
98691,serotoninergic,0,1
98692,and,0,1
98693,noradrenergic,0,1
98694,systems,0,0
98695,might,0,0
98696,represent,0,0
98697,a,0,0
98698,valid,0,0
98699,resource,0,0
98700,not,0,0
98701,only,0,0
98702,for,0,0
98703,the,0,0
98704,treatment,0,0
98705,of,0,1
98706,depression,0,1
98707,but,0,0
98708,also,0,0
98709,for,0,0
98710,improving,0,1
98711,emotional,1,1
98712,unawareness,1,1
98713,in,0,0
98714,stroke,0,1
98715,patients,0,0
98716,.,0,0
98717,What,0,0
98718,is,0,0
98719,the,0,0
98720,optimum,0,1
98721,maximal,0,1
98722,gonadotropin,0,1
98723,dosage,0,0
98724,used,0,0
98725,in,0,0
98726,microdose,0,0
98727,flare-up,0,0
98728,cycles,0,0
98729,in,0,0
98730,poor,0,0
98731,responders,0,0
98732,?,0,0
98733,OBJECTIVE,0,0
98734,To,0,0
98735,find,0,0
98736,out,0,0
98737,the,0,0
98738,optimum,0,1
98739,maximal,0,1
98740,dosage,0,0
98741,of,0,1
98742,recombinant,0,0
98743,follicle,0,1
98744,stimulating,0,1
98745,hormone,0,1
98746,(,0,1
98747,rFSH,0,0
98748,),0,0
98749,in,0,0
98750,microdose,0,0
98751,gonadotropin-releasing,0,1
98752,hormone,0,1
98753,analog,0,1
98754,(,0,1
98755,GnRH-a,0,0
98756,),0,1
98757,flare,0,1
98758,cycles,0,0
98759,in,0,0
98760,poor,0,0
98761,responders,0,0
98762,.,0,0
98763,DESIGN,0,0
98764,Prospective,0,0
98765,randomized,0,0
98766,study,0,0
98767,.,0,1
98768,SETTING,0,0
98769,Private,0,0
98770,infertility,0,1
98771,clinic,0,0
98772,.,0,1
98773,PATIENT,0,0
98774,(,0,0
98775,S,0,0
98776,),0,1
98777,A,0,0
98778,total,0,1
98779,of,0,0
98780,119,0,0
98781,women,0,0
98782,were,0,0
98783,taken,0,0
98784,into,0,0
98785,the,0,0
98786,study,0,0
98787,.,0,1
98788,INTERVENTION,0,1
98789,(,0,0
98790,S,0,0
98791,),0,0
98792,The,0,0
98793,study,0,0
98794,group,0,0
98795,underwent,0,0
98796,a,0,0
98797,microdose,0,0
98798,protocol,0,0
98799,with,0,0
98800,a,0,0
98801,GnRH-agonist,0,0
98802,followed,0,0
98803,by,0,0
98804,rFSH,0,0
98805,administration,0,0
98806,.,0,0
98807,On,0,0
98808,the,0,0
98809,third,0,0
98810,day,0,0
98811,of,0,1
98812,GnRH-a,0,0
98813,administration,0,0
98814,",",0,0
98815,119,0,0
98816,patients,0,0
98817,were,0,0
98818,randomized,0,0
98819,in,0,0
98820,three,0,0
98821,groups,0,0
98822,to,0,0
98823,receive,0,0
98824,daily,0,0
98825,fixed,0,0
98826,doses,0,0
98827,of,0,0
98828,300,0,0
98829,IU,0,0
98830,of,0,0
98831,rFSH,0,0
98832,(,0,0
98833,group,0,0
98834,A,0,0
98835,",",0,1
98836,n,0,0
98837,=,0,0
98838,38,0,0
98839,),0,0
98840,",",0,0
98841,or,0,0
98842,450,0,0
98843,IU,0,0
98844,of,0,0
98845,rFSH,0,0
98846,(,0,0
98847,group,0,0
98848,B,0,1
98849,",",0,1
98850,n,0,0
98851,=,0,0
98852,39,0,0
98853,),0,0
98854,",",0,0
98855,or,0,0
98856,600,0,0
98857,IU,0,0
98858,of,0,0
98859,rFSH,0,0
98860,(,0,0
98861,group,0,0
98862,C,0,1
98863,",",0,1
98864,n,0,0
98865,=,0,0
98866,42,0,0
98867,),0,0
98868,.,0,0
98869,MAIN,0,0
98870,OUTCOME,0,1
98871,MEASURE,0,1
98872,(,0,1
98873,S,0,0
98874,),0,1
98875,Peak,1,1
98876,E,1,1
98877,(,1,0
98878,2,1,0
98879,),1,0
98880,levels,1,1
98881,",",1,0
98882,days,1,0
98883,of,1,1
98884,stimulation,1,1
98885,with,1,0
98886,rFSH,1,0
98887,",",1,1
98888,total,1,1
98889,rFSH,1,1
98890,dosage,1,0
98891,",",1,1
98892,total,1,1
98893,number,1,1
98894,of,1,0
98895,oocytes,1,0
98896,retrieved,1,0
98897,",",1,0
98898,M2,1,0
98899,oocytes,1,1
98900,retrieved,1,0
98901,",",1,0
98902,total,1,1
98903,number,1,1
98904,of,1,1
98905,embryos,1,1
98906,",",1,1
98907,number,1,1
98908,of,1,1
98909,embryos,1,1
98910,transferred,1,0
98911,",",1,0
98912,number,1,1
98913,of,1,1
98914,Grade-1,1,0
98915,embryos,1,1
98916,transferred,1,0
98917,",",1,0
98918,clinical,1,1
98919,pregnancy,1,1
98920,rate,1,1
98921,(,1,0
98922,positive,1,1
98923,fetal,1,1
98924,cardiac,1,1
98925,activity,1,1
98926,),1,1
98927,",",1,1
98928,and,1,1
98929,cancellation,1,1
98930,rates,1,1
98931,of,1,1
98932,stimulation,1,1
98933,and,1,1
98934,embryo,1,1
98935,transfer,1,1
98936,.,1,1
98937,RESULT,0,1
98938,(,0,0
98939,S,0,0
98940,),0,1
98941,Clinical,1,1
98942,pregnancy,1,1
98943,rates,1,1
98944,were,0,0
98945,13.1,0,0
98946,%,0,0
98947,",",0,0
98948,15.3,0,0
98949,%,0,0
98950,",",0,0
98951,and,0,0
98952,16.1,0,0
98953,%,0,0
98954,for,0,0
98955,group,0,0
98956,A,0,0
98957,",",0,1
98958,group,0,0
98959,B,0,1
98960,",",0,1
98961,and,0,1
98962,group,0,0
98963,C,0,1
98964,",",0,0
98965,respectively,0,0
98966,.,0,0
98967,There,0,0
98968,were,0,0
98969,no,0,0
98970,significant,0,0
98971,differences,0,0
98972,in,0,0
98973,the,0,0
98974,age,0,0
98975,",",0,0
98976,peak,1,1
98977,serum,1,1
98978,E,1,1
98979,(,1,0
98980,2,1,0
98981,),1,0
98982,concentration,1,1
98983,",",1,0
98984,days,1,0
98985,of,1,1
98986,stimulation,1,1
98987,with,1,0
98988,rFSH,1,0
98989,",",1,1
98990,total,1,1
98991,number,1,1
98992,of,1,0
98993,M2,1,0
98994,oocytes,1,0
98995,retrieved,1,0
98996,",",1,0
98997,number,1,1
98998,of,1,1
98999,embryos,1,1
99000,transferred,1,0
99001,",",1,0
99002,clinical,1,0
99003,pregnancy,1,1
99004,rates,1,1
99005,",",1,1
99006,and,1,1
99007,cancellation,1,1
99008,rates,1,1
99009,of,0,1
99010,stimulation,0,1
99011,and,0,1
99012,embryo,0,1
99013,transfer,0,1
99014,between,0,0
99015,the,0,0
99016,three,0,0
99017,groups,0,0
99018,except,0,0
99019,for,0,0
99020,total,0,1
99021,rFSH,0,0
99022,dosage,0,0
99023,.,0,1
99024,CONCLUSION,0,0
99025,(,0,0
99026,S,0,0
99027,),0,0
99028,There,0,0
99029,is,0,0
99030,no,0,0
99031,need,0,0
99032,to,0,0
99033,use,0,0
99034,doses,0,0
99035,above,0,0
99036,300,0,0
99037,IU,0,0
99038,of,0,0
99039,rFSH,0,0
99040,to,0,0
99041,increase,0,0
99042,the,0,0
99043,pregnancy,0,1
99044,rate,0,1
99045,in,0,0
99046,microdose,0,0
99047,cycles,0,0
99048,.,0,0
99049,In,0,0
99050,addition,0,0
99051,",",0,0
99052,because,0,0
99053,the,0,0
99054,duration,0,1
99055,of,0,0
99056,stimulation,0,1
99057,does,0,0
99058,not,0,0
99059,differ,0,0
99060,between,0,0
99061,the,0,0
99062,groups,0,0
99063,",",0,0
99064,the,0,0
99065,usage,0,1
99066,of,0,0
99067,300,0,0
99068,IU,0,0
99069,rFSH,0,0
99070,in,0,0
99071,microdose,0,0
99072,cycles,0,0
99073,results,0,0
99074,in,0,0
99075,less,0,0
99076,total,0,1
99077,amount,0,1
99078,of,0,1
99079,rFSH,0,0
99080,consumed,0,0
99081,in,0,0
99082,a,0,0
99083,cycle,0,1
99084,compared,0,0
99085,with,0,0
99086,higher,0,0
99087,dosages,0,1
99088,",",0,1
99089,and,0,0
99090,this,0,0
99091,would,0,0
99092,obviously,0,0
99093,cost,0,0
99094,less,0,0
99095,money,0,1
99096,to,0,0
99097,the,0,0
99098,patients,0,0
99099,.,0,0
99100,Randomized,0,0
99101,evaluation,0,0
99102,of,0,0
99103,octreotide,0,0
99104,vs,0,0
99105,prochlorperazine,0,0
99106,for,0,0
99107,ED,0,0
99108,treatment,0,0
99109,of,0,1
99110,migraine,1,1
99111,headache,1,1
99112,.,1,1
99113,UNLABELLED,0,0
99114,Patients,0,0
99115,with,0,0
99116,headaches,0,0
99117,account,0,0
99118,for,0,0
99119,approximately,0,0
99120,2,0,0
99121,%,0,0
99122,of,0,0
99123,all,0,0
99124,ED,0,0
99125,visits,0,1
99126,",",0,0
99127,with,0,0
99128,migraines,0,1
99129,being,0,0
99130,the,0,0
99131,most,0,0
99132,common,0,0
99133,defined,0,1
99134,primary,0,0
99135,headache,0,1
99136,syndrome,0,0
99137,.,0,0
99138,Our,0,0
99139,goals,0,0
99140,were,0,0
99141,to,0,0
99142,evaluate,0,0
99143,the,0,0
99144,efficacy,0,1
99145,of,0,0
99146,intravenous,0,0
99147,octreotide,0,0
99148,(,0,1
99149,OC,0,0
99150,),0,0
99151,for,0,0
99152,the,0,0
99153,treatment,0,0
99154,of,0,0
99155,migraines,0,1
99156,",",0,0
99157,when,0,0
99158,compared,0,0
99159,to,0,0
99160,standard,0,0
99161,therapy,0,0
99162,with,0,0
99163,prochlorperazine,0,0
99164,.,0,0
99165,METHODS,0,0
99166,The,0,0
99167,study,0,0
99168,was,0,0
99169,conducted,0,0
99170,as,0,0
99171,a,0,0
99172,double-blinded,0,0
99173,",",0,0
99174,randomized,0,0
99175,controlled,0,0
99176,trial,0,0
99177,.,0,0
99178,Each,0,0
99179,subject,0,0
99180,received,0,0
99181,either,0,0
99182,100,0,0
99183,microg,0,0
99184,of,0,0
99185,octreotide,0,0
99186,or,0,0
99187,10,0,0
99188,mg,0,0
99189,of,0,0
99190,prochlorperazine,0,0
99191,intravenously,0,0
99192,for,0,0
99193,a,0,0
99194,2-minute,0,0
99195,period,0,0
99196,.,0,0
99197,RESULTS,0,0
99198,Comparison,0,0
99199,of,0,0
99200,the,0,0
99201,change,0,1
99202,in,0,0
99203,median,1,1
99204,visual,1,1
99205,analog,1,1
99206,scale,1,1
99207,scores,1,1
99208,for,0,0
99209,60,0,0
99210,minutes,0,0
99211,demonstrated,0,0
99212,that,0,0
99213,octreotide,0,0
99214,was,0,0
99215,less,0,0
99216,effective,0,1
99217,at,0,0
99218,reducing,0,0
99219,pain,1,1
99220,(,0,0
99221,P,0,0
99222,=,0,0
99223,.03,0,0
99224,),0,1
99225,and,0,1
99226,producing,0,1
99227,clinical,0,1
99228,success,0,1
99229,(,0,0
99230,P,0,0
99231,<,0,0
99232,.01,0,0
99233,),0,0
99234,.,0,0
99235,Restlessness,1,1
99236,consistent,1,0
99237,with,1,0
99238,akathisia,1,1
99239,was,0,0
99240,noted,0,0
99241,by,0,0
99242,35,0,0
99243,%,0,0
99244,of,0,0
99245,the,0,0
99246,PC,0,1
99247,group,0,0
99248,and,0,0
99249,8,0,0
99250,%,0,0
99251,of,0,0
99252,the,0,0
99253,OC,0,0
99254,group,0,0
99255,(,0,0
99256,P,0,0
99257,<,0,0
99258,.01,0,0
99259,),0,0
99260,.,0,0
99261,At,0,0
99262,60,0,0
99263,minutes,0,0
99264,",",0,0
99265,rescue,1,1
99266,medication,1,1
99267,was,0,0
99268,required,0,0
99269,by,0,0
99270,48,0,0
99271,%,0,0
99272,of,0,0
99273,the,0,0
99274,patients,0,0
99275,in,0,0
99276,the,0,0
99277,OC,0,0
99278,group,0,0
99279,",",0,0
99280,whereas,0,0
99281,10,0,0
99282,%,0,0
99283,of,0,0
99284,the,0,0
99285,PC,0,1
99286,group,0,0
99287,required,0,1
99288,such,0,1
99289,therapy,0,0
99290,(,0,0
99291,P,0,0
99292,<,0,0
99293,.01,0,0
99294,),0,0
99295,.,0,0
99296,All,0,0
99297,44,0,0
99298,patients,0,0
99299,were,0,0
99300,contacted,0,0
99301,for,0,0
99302,follow-up,0,0
99303,at,0,0
99304,48,0,0
99305,to,0,0
99306,72,0,0
99307,hours,0,0
99308,after,0,0
99309,enrollment,0,0
99310,.,0,0
99311,At,0,0
99312,that,0,0
99313,time,0,1
99314,",",0,0
99315,10,0,0
99316,%,0,0
99317,of,0,0
99318,the,0,0
99319,prochlorperazine,0,0
99320,and,0,0
99321,25,0,0
99322,%,0,0
99323,of,0,0
99324,the,0,0
99325,octreotide,0,0
99326,patients,0,0
99327,had,0,0
99328,experienced,0,0
99329,some,0,0
99330,headache,1,1
99331,recurrence,1,1
99332,(,0,1
99333,P,0,0
99334,=,0,0
99335,.1,0,0
99336,),0,0
99337,.,0,0
99338,CONCLUSION,0,0
99339,Prochlorperazine,0,0
99340,was,0,0
99341,statistically,0,0
99342,superior,0,0
99343,to,0,0
99344,octreotide,0,0
99345,in,0,0
99346,clinical,1,0
99347,success,1,1
99348,rate,1,1
99349,and,0,1
99350,decrease,0,1
99351,in,0,0
99352,pain,1,1
99353,in,0,0
99354,migraine,0,1
99355,patients,0,0
99356,but,0,0
99357,caused,0,0
99358,more,0,0
99359,restlessness,1,1
99360,and,0,1
99361,sedation,1,1
99362,.,1,0
99363,Rapid,0,1
99364,efficacy,0,1
99365,of,0,0
99366,the,0,0
99367,highly,0,0
99368,selective,0,0
99369,alpha1A-adrenoceptor,0,1
99370,antagonist,0,0
99371,silodosin,0,0
99372,in,0,0
99373,men,0,0
99374,with,0,0
99375,signs,0,1
99376,and,0,1
99377,symptoms,0,1
99378,of,0,1
99379,benign,0,0
99380,prostatic,0,0
99381,hyperplasia,0,1
99382,:,0,0
99383,pooled,0,0
99384,results,0,0
99385,of,0,0
99386,2,0,0
99387,phase,0,0
99388,3,0,0
99389,studies,0,0
99390,.,0,0
99391,PURPOSE,0,0
99392,We,0,0
99393,evaluated,0,0
99394,the,0,0
99395,efficacy,1,1
99396,and,1,1
99397,safety,1,1
99398,of,0,1
99399,silodosin,0,0
99400,for,0,0
99401,treatment,0,0
99402,of,0,0
99403,benign,0,0
99404,prostatic,0,1
99405,hyperplasia,0,1
99406,symptoms,0,1
99407,in,0,0
99408,2,0,0
99409,randomized,0,0
99410,",",0,0
99411,placebo,0,0
99412,controlled,0,0
99413,",",0,0
99414,phase,0,0
99415,3,0,0
99416,studies,0,0
99417,.,0,0
99418,MATERIALS,0,0
99419,AND,0,0
99420,METHODS,0,0
99421,Men,0,0
99422,50,0,0
99423,years,0,0
99424,or,0,0
99425,older,0,0
99426,with,0,0
99427,an,0,0
99428,International,0,1
99429,Prostate,0,0
99430,Symptom,0,1
99431,Score,0,0
99432,of,0,0
99433,13,0,0
99434,or,0,0
99435,greater,0,0
99436,and,0,1
99437,peak,0,1
99438,urinary,0,1
99439,flow,0,1
99440,rate,0,1
99441,of,0,0
99442,4,0,0
99443,to,0,0
99444,15,0,0
99445,ml,0,0
99446,per,0,0
99447,second,0,0
99448,received,0,0
99449,placebo,0,0
99450,or,0,0
99451,8,0,0
99452,mg,0,0
99453,silodosin,0,0
99454,daily,0,0
99455,with,0,0
99456,breakfast,0,0
99457,for,0,0
99458,12,0,0
99459,weeks,0,0
99460,.,0,0
99461,The,0,0
99462,primary,0,0
99463,end,0,0
99464,point,0,0
99465,was,0,0
99466,International,1,1
99467,Prostate,1,0
99468,Symptom,1,1
99469,Score,1,1
99470,change,0,1
99471,from,0,0
99472,baseline,0,0
99473,to,0,0
99474,last,0,0
99475,observation,0,0
99476,.,0,1
99477,Change,0,0
99478,in,0,0
99479,peak,1,1
99480,urinary,1,1
99481,flow,1,1
99482,rate,1,1
99483,was,0,0
99484,a,0,0
99485,secondary,0,1
99486,end,0,0
99487,point,0,0
99488,.,0,0
99489,Differences,1,1
99490,in,1,0
99491,treatment,1,0
99492,efficacy,1,1
99493,were,0,0
99494,assessed,0,0
99495,by,0,0
99496,ANCOVA,0,1
99497,.,0,0
99498,RESULTS,0,0
99499,Of,0,0
99500,923,0,0
99501,patients,0,0
99502,(,0,0
99503,mean,0,1
99504,age,0,0
99505,65,0,0
99506,years,0,0
99507,),0,0
99508,466,0,0
99509,received,0,0
99510,silodosin,0,0
99511,and,0,0
99512,457,0,0
99513,placebo,0,0
99514,.,0,0
99515,After,0,0
99516,0.5,0,0
99517,week,0,0
99518,(,0,0
99519,range,0,0
99520,3,0,0
99521,to,0,0
99522,4,0,0
99523,days,0,0
99524,),0,0
99525,of,0,0
99526,treatment,0,0
99527,patients,0,0
99528,receiving,0,0
99529,silodosin,0,0
99530,vs,0,0
99531,placebo,0,0
99532,achieved,0,1
99533,significant,0,0
99534,improvement,0,1
99535,in,0,0
99536,total,1,1
99537,International,1,1
99538,Prostate,1,0
99539,Symptom,1,1
99540,Score,1,1
99541,(,0,1
99542,difference,0,1
99543,-1.9,0,0
99544,",",0,1
99545,p,0,0
99546,<,0,0
99547,0.0001,0,0
99548,),0,0
99549,and,0,0
99550,irritative,1,1
99551,(,0,1
99552,-0.5,0,0
99553,",",0,1
99554,p,0,0
99555,=,0,0
99556,0.0002,0,0
99557,),0,0
99558,and,0,0
99559,obstructive,1,1
99560,(,0,1
99561,-1.4,0,0
99562,",",0,1
99563,p,0,0
99564,<,0,0
99565,0.0001,0,0
99566,),0,0
99567,subscores,0,0
99568,.,0,0
99569,The,0,0
99570,mean,0,1
99571,+/-,0,0
99572,SD,0,0
99573,change,0,1
99574,from,0,0
99575,baseline,0,0
99576,in,0,0
99577,total,0,1
99578,International,1,1
99579,Prostate,1,0
99580,Symptom,1,1
99581,Score,1,1
99582,was,0,0
99583,-4.2,0,0
99584,+/-,0,0
99585,5.3,0,0
99586,for,0,0
99587,silodosin,0,0
99588,vs,0,0
99589,-2.3,0,0
99590,+/-,0,0
99591,4.4,0,0
99592,for,0,0
99593,placebo,0,0
99594,.,0,1
99595,Differences,0,1
99596,(,0,0
99597,silodosin,0,0
99598,vs,0,0
99599,placebo,0,0
99600,),0,0
99601,in,0,0
99602,International,1,1
99603,Prostate,1,0
99604,Symptom,1,1
99605,Score,1,1
99606,and,0,1
99607,subscores,0,1
99608,increased,0,1
99609,by,0,0
99610,week,0,0
99611,12,0,0
99612,(,0,0
99613,p,0,0
99614,<,0,0
99615,0.0001,0,0
99616,),0,0
99617,.,0,0
99618,Mean,0,1
99619,change,0,1
99620,from,0,0
99621,baseline,0,0
99622,in,0,0
99623,peak,1,1
99624,urinary,1,1
99625,flow,1,1
99626,rate,1,1
99627,(,0,0
99628,ml,0,0
99629,per,0,1
99630,second,0,0
99631,),0,0
99632,2,0,0
99633,to,0,0
99634,6,0,0
99635,hours,0,0
99636,after,0,0
99637,initial,0,0
99638,dose,0,0
99639,was,0,0
99640,greater,0,1
99641,(,0,1
99642,p,0,0
99643,<,0,0
99644,0.0001,0,0
99645,),0,0
99646,with,0,0
99647,silodosin,0,0
99648,(,0,0
99649,2.8,0,0
99650,+/-,0,0
99651,3.4,0,0
99652,),0,0
99653,than,0,0
99654,placebo,0,0
99655,(,0,0
99656,1.5,0,0
99657,+/-,0,0
99658,3.8,0,0
99659,),0,0
99660,.,0,0
99661,Differences,0,1
99662,remained,0,0
99663,significant,0,0
99664,(,0,0
99665,p,0,0
99666,<,0,0
99667,0.001,0,0
99668,),0,0
99669,through,0,0
99670,week,0,0
99671,12,0,0
99672,.,0,0
99673,The,0,0
99674,most,0,0
99675,common,0,0
99676,treatment,0,0
99677,emergent,0,1
99678,adverse,1,1
99679,event,1,1
99680,was,0,0
99681,(,0,0
99682,mostly,0,0
99683,mild,0,0
99684,),0,0
99685,retrograde,1,1
99686,ejaculation,1,1
99687,(,0,0
99688,silodosin,0,0
99689,28.1,0,0
99690,%,0,0
99691,of,0,0
99692,patients,0,0
99693,",",0,0
99694,placebo,0,0
99695,0.9,0,0
99696,%,0,0
99697,),0,0
99698,.,0,0
99699,Few,0,0
99700,patients,0,0
99701,receiving,0,0
99702,silodosin,0,0
99703,(,0,0
99704,2.8,0,0
99705,%,0,0
99706,),0,0
99707,discontinued,0,0
99708,because,0,0
99709,of,0,0
99710,retrograde,1,1
99711,ejaculation,1,1
99712,.,1,0
99713,Proportions,0,1
99714,of,0,0
99715,patients,0,0
99716,with,0,0
99717,treatment,0,0
99718,emergent,0,1
99719,orthostatic,1,1
99720,hypotension,1,1
99721,were,0,0
99722,similar,0,0
99723,for,0,0
99724,silodosin,0,0
99725,(,0,0
99726,2.6,0,0
99727,%,0,0
99728,),0,0
99729,and,0,1
99730,placebo,0,0
99731,(,0,0
99732,1.5,0,0
99733,%,0,0
99734,),0,0
99735,.,0,0
99736,CONCLUSIONS,0,0
99737,Treatment,0,0
99738,with,0,0
99739,silodosin,0,0
99740,produced,0,0
99741,rapid,0,0
99742,improvement,0,1
99743,in,0,0
99744,urinary,1,1
99745,symptoms,1,1
99746,that,0,0
99747,was,0,0
99748,sustained,0,0
99749,for,0,0
99750,12,0,0
99751,weeks,0,0
99752,.,0,0
99753,Silodosin,0,0
99754,was,0,0
99755,well,0,0
99756,tolerated,0,1
99757,with,0,0
99758,a,0,0
99759,low,0,0
99760,incidence,0,1
99761,of,0,1
99762,orthostatic,1,1
99763,hypotension,1,1
99764,.,1,0
99765,The,0,0
99766,effect,0,0
99767,of,0,0
99768,nebivolol,0,0
99769,treatment,0,0
99770,on,0,0
99771,oxidative,1,1
99772,stress,1,1
99773,and,1,1
99774,antioxidant,1,1
99775,status,1,1
99776,in,0,0
99777,patients,0,0
99778,with,0,0
99779,cardiac,0,1
99780,syndrome-X,0,0
99781,.,0,0
99782,BACKGROUND,0,0
99783,Free,0,1
99784,radical-mediated,0,1
99785,oxidative,0,1
99786,stress,0,1
99787,has,0,0
99788,been,0,0
99789,implicated,0,0
99790,in,0,0
99791,the,0,0
99792,etiopathogenesis,0,0
99793,of,0,0
99794,several,0,0
99795,disorders,0,0
99796,.,0,0
99797,The,0,0
99798,aim,0,0
99799,of,0,0
99800,this,0,0
99801,study,0,0
99802,was,0,0
99803,to,0,0
99804,elucidate,0,0
99805,the,0,0
99806,effect,0,0
99807,of,0,0
99808,treatment,0,0
99809,with,0,0
99810,nebivolol,0,0
99811,on,0,0
99812,the,0,0
99813,metabolic,1,1
99814,state,1,1
99815,of,1,1
99816,oxidative,1,1
99817,stress,1,1
99818,",",0,1
99819,and,0,1
99820,antioxidant,0,1
99821,status,0,1
99822,markers,0,1
99823,in,0,0
99824,patients,0,0
99825,with,0,0
99826,cardiac,0,1
99827,syndrome-X,0,1
99828,(,0,1
99829,CSX,0,1
99830,),0,1
99831,",",0,0
99832,additionally,0,0
99833,",",0,0
99834,to,0,0
99835,compare,0,0
99836,with,0,0
99837,the,0,0
99838,effect,0,0
99839,of,0,1
99840,metoprolol,0,0
99841,treatment,0,0
99842,.,0,1
99843,METHODS,0,0
99844,Thirty,0,0
99845,patients,0,0
99846,",",0,0
99847,17,0,0
99848,female,0,0
99849,and,0,0
99850,13,0,0
99851,male,0,0
99852,",",0,0
99853,with,0,0
99854,CSX,0,1
99855,were,0,0
99856,enrolled,0,0
99857,in,0,0
99858,the,0,0
99859,study,0,0
99860,.,0,1
99861,Nebivolol,0,0
99862,(,0,0
99863,5,0,0
99864,mg/day,0,0
99865,),0,0
99866,or,0,1
99867,metoprolol,0,0
99868,(,0,0
99869,50,0,0
99870,mg/day,0,0
99871,),0,0
99872,was,0,0
99873,administrated,0,0
99874,for,0,0
99875,12,0,0
99876,weeks,0,0
99877,.,0,0
99878,Twelve,0,0
99879,hour,0,0
99880,fasting,0,1
99881,blood,1,1
99882,samples,1,0
99883,",",0,0
99884,taken,0,0
99885,at,0,0
99886,the,0,0
99887,initiation,0,0
99888,and,0,0
99889,on,0,0
99890,the,0,0
99891,third,0,0
99892,month,0,0
99893,of,0,1
99894,therapy,0,0
99895,",",0,1
99896,were,0,0
99897,analyzed,0,0
99898,for,0,0
99899,the,0,0
99900,levels,1,1
99901,of,1,1
99902,malondialdehyde,1,1
99903,(,1,1
99904,MDA,1,1
99905,),1,1
99906,",",1,1
99907,nitrite+nitrate,1,1
99908,(,1,1
99909,NOx,1,1
99910,),1,1
99911,",",1,0
99912,and,1,0
99913,the,1,0
99914,activity,1,1
99915,of,1,1
99916,myeloperoxidase,1,1
99917,(,1,1
99918,MPO,1,1
99919,),1,1
99920,",",1,0
99921,superoxide,1,1
99922,dismutase,1,1
99923,(,1,1
99924,SOD,1,1
99925,),1,0
99926,.,1,0
99927,No,0,0
99928,patient,0,1
99929,presented,0,0
99930,additional,0,0
99931,risk,0,1
99932,factors,0,1
99933,for,0,0
99934,increased,0,1
99935,reactive,0,1
99936,oxygen,0,1
99937,species,0,0
99938,levels,0,1
99939,.,0,1
99940,RESULTS,0,0
99941,Compared,0,0
99942,with,0,0
99943,sixteen,0,0
99944,control,0,0
99945,participants,0,0
99946,",",0,0
99947,patients,0,0
99948,with,0,0
99949,CSX,0,0
99950,had,0,0
99951,significantly,0,0
99952,higher,0,0
99953,activity,1,1
99954,of,1,1
99955,MPO,1,1
99956,and,1,1
99957,levels,1,1
99958,of,1,1
99959,MDA,1,1
99960,",",0,1
99961,but,0,0
99962,significantly,0,1
99963,lower,1,1
99964,SOD,1,1
99965,activity,1,1
99966,and,1,1
99967,levels,1,1
99968,of,1,1
99969,NOx,1,1
99970,before,0,0
99971,treatment,0,0
99972,.,0,0
99973,After,0,0
99974,treatment,0,0
99975,",",0,1
99976,MPO,1,1
99977,activity,1,1
99978,and,1,1
99979,MDA,1,1
99980,levels,1,1
99981,were,0,0
99982,significantly,0,0
99983,reduced,0,0
99984,;,0,0
99985,SOD,1,1
99986,activity,1,1
99987,and,1,1
99988,NOx,1,1
99989,levels,1,1
99990,were,0,0
99991,significantly,0,0
99992,increased,0,0
99993,with,0,0
99994,nebivolol,0,0
99995,but,0,0
99996,remained,0,1
99997,unchanged,0,0
99998,with,0,0
99999,metoprolol,0,0
100000,.,0,0
100001,CONCLUSION,0,0
100002,We,0,0
100003,have,0,0
100004,shown,0,0
100005,that,0,0
100006,patients,0,0
100007,with,0,0
100008,CSX,0,0
100009,who,0,0
100010,taken,0,0
100011,nebivolol,0,0
100012,have,0,0
100013,lower,0,0
100014,serum,1,1
100015,MPO,1,1
100016,activity,1,1
100017,",",1,0
100018,levels,1,1
100019,of,1,1
100020,MDA,1,1
100021,and,0,1
100022,higher,0,1
100023,serum,1,1
100024,SOD,1,1
100025,activity,1,1
100026,",",1,1
100027,NOx,1,1
100028,levels,1,1
100029,when,0,0
100030,compared,0,0
100031,with,0,0
100032,metoprolol,0,0
100033,treatment,0,0
100034,.,0,0
100035,Exercise,0,0
100036,stress,0,1
100037,test,0,1
100038,parameters,0,1
100039,were,0,0
100040,also,0,0
100041,ameliorated,0,0
100042,in,0,0
100043,patients,0,0
100044,who,0,0
100045,had,0,0
100046,taken,0,0
100047,nebivolol,0,0
100048,in,0,0
100049,contrast,0,0
100050,to,0,0
100051,metoprolol,0,0
100052,.,0,0
100053,Nebivolol,0,0
100054,treatment,0,0
100055,may,0,0
100056,be,0,0
100057,a,0,0
100058,novel,0,0
100059,treatment,0,0
100060,strategy,0,0
100061,in,0,0
100062,cases,0,0
100063,with,0,0
100064,CSX,0,0
100065,in,0,0
100066,the,0,0
100067,future,0,0
100068,.,0,0
100069,Pulse,0,1
100070,oximeter,0,1
100071,perfusion,0,1
100072,index,0,1
100073,as,0,0
100074,an,0,0
100075,early,0,0
100076,indicator,0,0
100077,of,0,1
100078,sympathectomy,0,0
100079,after,0,0
100080,epidural,0,0
100081,anesthesia,0,0
100082,.,0,0
100083,BACKGROUND,0,0
100084,The,0,0
100085,pulse,0,1
100086,oximeter,0,0
100087,perfusion,0,1
100088,index,0,1
100089,(,0,1
100090,PI,0,0
100091,),0,0
100092,has,0,0
100093,been,0,0
100094,used,0,0
100095,to,0,0
100096,indicate,0,0
100097,sympathectomy-induced,0,1
100098,vasodilatation,0,0
100099,.,0,0
100100,We,0,0
100101,hypothesized,0,0
100102,that,0,0
100103,pulse,0,1
100104,oximeter,0,0
100105,PI,0,0
100106,provides,0,0
100107,an,0,0
100108,earlier,0,0
100109,and,0,1
100110,clearer,0,0
100111,indication,0,0
100112,of,0,1
100113,sympathectomy,0,0
100114,following,0,0
100115,epidural,0,0
100116,anesthesia,0,0
100117,than,0,0
100118,skin,0,1
100119,temperature,0,1
100120,and,0,1
100121,arterial,0,1
100122,pressure,0,1
100123,.,0,0
100124,METHODS,0,0
100125,Forty,0,0
100126,patients,0,0
100127,received,0,0
100128,lumbar,0,1
100129,epidural,0,0
100130,catheters,0,0
100131,.,0,0
100132,Patients,0,0
100133,were,0,0
100134,randomized,0,0
100135,to,0,0
100136,receive,0,0
100137,either,0,0
100138,10,0,0
100139,ml,0,0
100140,0.5,0,0
100141,%,0,0
100142,bupivacaine,0,0
100143,or,0,0
100144,10,0,0
100145,ml,0,0
100146,0.25,0,0
100147,%,0,0
100148,bupivacaine,0,0
100149,.,0,1
100150,PI,1,0
100151,in,1,0
100152,the,1,0
100153,toe,1,1
100154,",",1,0
100155,mean,1,1
100156,arterial,1,1
100157,pressure,1,1
100158,(,1,1
100159,MAP,1,1
100160,),1,1
100161,and,1,1
100162,toe,1,1
100163,temperature,1,1
100164,were,0,0
100165,all,0,0
100166,assessed,0,0
100167,at,0,0
100168,baseline,0,0
100169,and,0,0
100170,at,0,0
100171,5,0,0
100172,",",0,0
100173,10,0,0
100174,and,0,0
100175,20,0,0
100176,min,0,0
100177,following,0,0
100178,epidural,0,0
100179,anesthesia,0,0
100180,.,0,0
100181,The,0,0
100182,effect,1,0
100183,of,0,0
100184,epidural,0,0
100185,anesthesia,0,0
100186,over,0,0
100187,time,0,1
100188,was,0,0
100189,assessed,0,0
100190,by,0,0
100191,repeated,0,0
100192,measures,1,1
100193,analysis,1,0
100194,of,1,0
100195,variance,1,1
100196,.,1,0
100197,Additionally,0,0
100198,",",0,0
100199,we,0,0
100200,defined,0,0
100201,clinically,1,0
100202,evident,1,0
100203,sympathectomy,1,0
100204,criteria,1,0
100205,(,1,0
100206,a,1,0
100207,100,1,0
100208,%,1,0
100209,increase,1,0
100210,in,1,0
100211,the,1,0
100212,PI,1,0
100213,",",1,0
100214,a,1,0
100215,15,1,0
100216,%,1,0
100217,decrease,1,0
100218,in,1,0
100219,MAP,1,1
100220,and,1,0
100221,a,1,0
100222,1,1,0
100223,degrees,1,0
100224,C,1,0
100225,increase,1,1
100226,in,1,0
100227,toe,1,1
100228,temperature,1,1
100229,),1,0
100230,.,1,0
100231,The,0,0
100232,numbers,0,1
100233,of,0,0
100234,patients,0,0
100235,demonstrating,0,0
100236,these,0,0
100237,changes,1,1
100238,for,0,0
100239,each,0,0
100240,test,0,1
100241,were,0,0
100242,compared,0,0
100243,using,0,0
100244,the,0,0
100245,McNemar,1,0
100246,test,1,0
100247,for,0,0
100248,each,0,0
100249,time,0,1
100250,point,0,0
100251,.,0,1
100252,RESULTS,0,0
100253,Twenty-nine,0,0
100254,subjects,0,0
100255,had,0,0
100256,photoplethysmography,1,1
100257,signals,1,1
100258,that,0,0
100259,met,0,0
100260,a,0,0
100261,priori,0,0
100262,signal,0,1
100263,quality,0,1
100264,criteria,0,0
100265,for,0,0
100266,analysis,0,0
100267,.,0,0
100268,By,0,0
100269,20,0,0
100270,min,0,0
100271,",",0,0
100272,PI,1,0
100273,increased,0,0
100274,by,0,0
100275,326,0,0
100276,%,0,0
100277,",",0,0
100278,compared,0,0
100279,with,0,0
100280,a,0,0
100281,10,0,0
100282,%,0,0
100283,decrease,0,0
100284,and,0,0
100285,a,0,0
100286,3,0,0
100287,%,0,0
100288,increase,0,0
100289,in,0,0
100290,MAP,1,1
100291,and,1,1
100292,toe,1,1
100293,temperature,1,1
100294,",",0,0
100295,respectively,0,0
100296,.,0,0
100297,For,0,0
100298,PI,0,0
100299,15/29,0,0
100300,",",0,0
100301,26/29,0,0
100302,and,0,0
100303,29/29,0,0
100304,of,0,0
100305,the,0,0
100306,subjects,0,0
100307,met,0,0
100308,the,0,0
100309,sympathectomy,1,0
100310,criteria,1,0
100311,at,0,0
100312,5,0,0
100313,",",0,0
100314,10,0,0
100315,and,0,0
100316,20,0,0
100317,min,0,0
100318,",",0,0
100319,respectively,0,0
100320,",",0,0
100321,compared,0,0
100322,with,0,0
100323,4/29,0,0
100324,",",0,0
100325,6/29,0,0
100326,and,0,0
100327,18/29,0,0
100328,for,0,0
100329,MAP,1,0
100330,changes,0,1
100331,and,0,0
100332,3/29,0,1
100333,",",0,0
100334,8/29,0,0
100335,and,0,0
100336,14/29,0,0
100337,for,0,0
100338,toe,0,0
100339,temperature,1,1
100340,changes,1,1
100341,.,1,0
100342,CONCLUSIONS,0,0
100343,PI,0,0
100344,was,0,0
100345,an,0,0
100346,earlier,0,0
100347,",",0,1
100348,clearer,0,0
100349,and,0,1
100350,more,0,1
100351,sensitive,0,0
100352,indicator,0,0
100353,of,0,0
100354,the,0,0
100355,development,0,0
100356,of,0,0
100357,epidural-induced,0,0
100358,sympathectomy,0,0
100359,than,0,0
100360,either,0,0
100361,skin,1,1
100362,temperature,1,1
100363,or,0,0
100364,MAP,1,1
100365,.,1,0
100366,Adjuvant,0,0
100367,therapy,0,0
100368,with,0,0
100369,pegylated,0,0
100370,interferon,0,1
100371,alfa-2b,0,0
100372,versus,0,0
100373,observation,0,0
100374,in,0,0
100375,resected,0,0
100376,stage,0,0
100377,III,0,0
100378,melanoma,0,0
100379,:,0,0
100380,a,0,0
100381,phase,0,0
100382,III,0,1
100383,randomized,0,0
100384,controlled,0,0
100385,trial,0,0
100386,of,0,0
100387,health-related,0,1
100388,quality,0,1
100389,of,0,1
100390,life,0,1
100391,and,0,1
100392,symptoms,0,1
100393,by,0,0
100394,the,0,0
100395,European,0,0
100396,Organisation,0,0
100397,for,0,0
100398,Research,0,0
100399,and,0,1
100400,Treatment,0,0
100401,of,0,1
100402,Cancer,0,0
100403,Melanoma,0,1
100404,Group,0,0
100405,.,0,0
100406,PURPOSE,0,0
100407,Interferon,0,0
100408,(,0,1
100409,IFN,0,1
100410,),0,1
100411,-based,0,0
100412,adjuvant,0,0
100413,therapy,0,0
100414,in,0,0
100415,melanoma,0,0
100416,is,0,0
100417,associated,0,0
100418,with,0,0
100419,significant,0,0
100420,side,0,1
100421,effects,0,1
100422,",",0,0
100423,which,0,0
100424,necessitates,0,0
100425,evaluation,0,0
100426,of,0,1
100427,health-related,1,1
100428,quality,1,1
100429,of,1,1
100430,life,1,1
100431,(,0,1
100432,HRQOL,0,1
100433,),0,0
100434,.,0,0
100435,Our,0,0
100436,trial,0,0
100437,examined,0,0
100438,the,0,0
100439,HRQOL,0,1
100440,effects,0,1
100441,of,0,0
100442,adjuvant,0,0
100443,pegylated,0,0
100444,IFN-alpha-2b,0,0
100445,(,0,0
100446,PEG-IFN-alpha-2b,0,0
100447,),0,1
100448,versus,0,0
100449,observation,0,0
100450,in,0,0
100451,patients,0,0
100452,with,0,0
100453,stage,0,0
100454,III,0,0
100455,melanoma,0,0
100456,.,0,1
100457,METHODS,0,0
100458,A,0,0
100459,total,0,1
100460,of,0,0
100461,"1,256",0,0
100462,patients,0,0
100463,with,0,0
100464,stage,0,0
100465,III,0,1
100466,melanoma,0,1
100467,were,0,0
100468,randomly,0,0
100469,assigned,0,0
100470,after,0,0
100471,full,0,0
100472,lymphadenectomy,0,0
100473,to,0,0
100474,receive,0,0
100475,either,0,0
100476,observation,0,0
100477,(,0,0
100478,n,0,0
100479,=,0,0
100480,629,0,0
100481,),0,0
100482,or,0,0
100483,PEG-IFN-alpha-2b,0,0
100484,(,0,1
100485,n,0,0
100486,=,0,0
100487,627,0,0
100488,),0,0
100489,:,0,0
100490,induction,0,0
100491,6,0,0
100492,micrograms/kg/wk,0,0
100493,[,0,0
100494,DOSAGE,0,0
100495,ERROR,0,0
100496,CORRECTED,0,0
100497,],0,0
100498,for,0,0
100499,8,0,0
100500,weeks,0,0
100501,then,0,0
100502,maintenance,0,0
100503,3,0,0
100504,micrograms/kg/wk,0,0
100505,[,0,0
100506,DOSAGE,0,0
100507,ERROR,0,0
100508,CORRECTED,0,0
100509,],0,0
100510,for,0,0
100511,an,0,0
100512,intended,0,0
100513,total,0,1
100514,duration,0,1
100515,of,0,0
100516,5,0,0
100517,years,0,0
100518,.,0,0
100519,The,0,0
100520,European,1,0
100521,Organisation,1,0
100522,for,1,0
100523,Research,1,0
100524,and,1,1
100525,Treatment,1,0
100526,of,1,1
100527,Cancer,1,0
100528,Quality,1,1
100529,of,1,1
100530,Life,1,0
100531,Questionnaire,1,1
100532,C30,1,0
100533,was,0,0
100534,used,0,0
100535,to,0,0
100536,assess,0,0
100537,HRQOL,0,1
100538,.,0,0
100539,RESULTS,0,0
100540,At,0,0
100541,3.8,0,0
100542,years,0,0
100543,of,0,0
100544,median,0,1
100545,follow-up,0,0
100546,",",0,0
100547,for,0,0
100548,the,0,0
100549,primary,0,0
100550,end,0,0
100551,point,0,0
100552,",",0,1
100553,recurrence-free,1,1
100554,survival,1,1
100555,(,1,1
100556,RFS,1,1
100557,),1,1
100558,",",0,1
100559,risk,0,1
100560,was,0,0
100561,reduced,0,0
100562,by,0,0
100563,18,0,0
100564,%,0,0
100565,(,0,0
100566,hazard,0,1
100567,rate,0,1
100568,=,0,0
100569,0.82,0,0
100570,;,0,0
100571,P,0,0
100572,=,0,0
100573,.01,0,1
100574,),0,0
100575,in,0,0
100576,the,0,0
100577,PEG-IFN-alpha-2b,0,0
100578,arm,0,0
100579,compared,0,0
100580,with,0,0
100581,observation,0,0
100582,.,0,1
100583,Significant,0,1
100584,and,0,0
100585,clinically,0,1
100586,meaningful,0,1
100587,differences,0,0
100588,occurred,0,0
100589,with,0,0
100590,the,0,0
100591,PEG-IFN-alpha-2b,0,0
100592,treatment,0,0
100593,arm,0,0
100594,compared,0,0
100595,with,0,0
100596,the,0,0
100597,observation,0,0
100598,group,0,0
100599,",",0,1
100600,showing,0,0
100601,decreased,0,1
100602,global,0,1
100603,HRQOL,1,1
100604,at,0,0
100605,month,0,0
100606,3,0,0
100607,(,0,0
100608,-11.6,0,0
100609,points,0,0
100610,;,0,0
100611,99,0,0
100612,%,0,0
100613,CI,0,0
100614,",",0,0
100615,-8.2,0,0
100616,to,0,0
100617,-15.0,0,0
100618,),0,0
100619,and,0,0
100620,year,0,0
100621,2,0,0
100622,(,0,0
100623,-10.5,0,0
100624,points,0,0
100625,;,0,0
100626,99,0,0
100627,%,0,0
100628,CI,0,0
100629,",",0,0
100630,-6.6,0,0
100631,to,0,0
100632,-14.4,0,0
100633,),0,0
100634,.,0,0
100635,Many,0,0
100636,of,0,0
100637,the,0,0
100638,other,0,0
100639,scales,0,1
100640,showed,0,0
100641,statistically,0,0
100642,significant,0,0
100643,differences,0,0
100644,between,0,0
100645,scores,0,1
100646,when,0,0
100647,comparing,0,0
100648,the,0,0
100649,two,0,0
100650,arms,0,0
100651,.,0,0
100652,From,0,0
100653,a,0,0
100654,clinical,0,0
100655,point,0,0
100656,of,0,1
100657,view,0,0
100658,",",0,0
100659,important,0,1
100660,differences,0,1
100661,were,0,0
100662,found,0,0
100663,for,0,0
100664,five,0,0
100665,scales,0,1
100666,:,0,0
100667,two,0,0
100668,functioning,0,1
100669,scales,0,1
100670,(,1,1
100671,social,1,1
100672,and,1,1
100673,role,1,1
100674,functioning,1,1
100675,),1,0
100676,and,0,0
100677,three,0,0
100678,symptom,0,1
100679,scales,0,1
100680,(,1,0
100681,appetite,1,1
100682,loss,1,1
100683,",",1,1
100684,fatigue,1,1
100685,",",1,1
100686,and,1,1
100687,dyspnea,1,1
100688,),1,1
100689,",",0,0
100690,with,0,0
100691,the,0,0
100692,PEG-IFN-alpha-2b,0,0
100693,arm,0,0
100694,being,0,0
100695,most,0,0
100696,impaired,0,0
100697,.,0,0
100698,CONCLUSION,0,0
100699,PEG-IFN-alpha-2b,0,0
100700,leads,0,0
100701,to,0,0
100702,a,0,0
100703,significant,0,0
100704,and,0,1
100705,sustained,0,1
100706,improvement,0,1
100707,in,0,0
100708,RFS,0,1
100709,.,0,0
100710,There,0,0
100711,is,0,0
100712,an,0,0
100713,expected,0,0
100714,negative,0,1
100715,effect,0,1
100716,on,0,0
100717,global,1,1
100718,HRQOL,1,1
100719,and,0,1
100720,selected,0,0
100721,symptoms,0,1
100722,when,0,0
100723,patients,0,0
100724,undergo,0,0
100725,PEG-IFN-alpha-2b,0,0
100726,treatment,0,0
100727,.,0,0
100728,One-year,0,1
100729,follow-up,0,0
100730,of,0,0
100731,the,0,0
100732,outcome,0,0
100733,of,0,0
100734,a,0,0
100735,randomized,0,0
100736,controlled,0,0
100737,trial,0,0
100738,of,0,0
100739,a,0,0
100740,home-based,0,0
100741,intervention,0,0
100742,programme,0,0
100743,for,0,0
100744,children,0,0
100745,with,0,0
100746,autism,0,0
100747,and,0,1
100748,developmental,0,1
100749,delay,0,1
100750,and,0,0
100751,their,0,0
100752,families,0,0
100753,.,0,0
100754,INTRODUCTION,0,0
100755,There,0,0
100756,is,0,0
100757,debate,0,0
100758,about,0,0
100759,the,0,0
100760,type,0,0
100761,and,0,1
100762,intensity,0,1
100763,of,0,1
100764,early,0,0
100765,childhood,0,0
100766,intervention,0,0
100767,that,0,0
100768,is,0,0
100769,most,0,0
100770,helpful,0,0
100771,for,0,0
100772,children,0,0
100773,with,0,0
100774,developmental,0,0
100775,problems,0,0
100776,.,0,0
100777,The,0,0
100778,aim,0,0
100779,of,0,0
100780,the,0,0
100781,study,0,0
100782,was,0,0
100783,to,0,0
100784,determine,0,0
100785,whether,0,0
100786,a,0,0
100787,home-based,0,0
100788,programme,0,0
100789,provided,0,0
100790,over,0,0
100791,12,0,0
100792,months,0,0
100793,resulted,0,0
100794,in,0,0
100795,sustained,1,1
100796,improvement,1,1
100797,in,1,0
100798,development,1,1
100799,and,1,0
100800,behaviour,1,1
100801,12,0,0
100802,months,0,0
100803,after,0,0
100804,the,0,0
100805,intervention,0,0
100806,ceased,0,0
100807,.,0,0
100808,The,0,0
100809,characteristics,0,0
100810,of,0,0
100811,the,0,0
100812,children,0,0
100813,and,0,0
100814,families,0,0
100815,who,0,0
100816,benefited,0,0
100817,most,0,0
100818,from,0,0
100819,the,0,0
100820,intervention,0,0
100821,were,0,0
100822,also,0,0
100823,studied,0,0
100824,.,0,0
100825,METHOD,0,0
100826,Randomized,0,0
100827,controlled,0,0
100828,trial,0,0
100829,.,0,0
100830,Participants,0,0
100831,A,0,0
100832,total,0,0
100833,of,0,0
100834,59,0,0
100835,children,0,0
100836,",",0,0
100837,aged,0,0
100838,3-5,0,0
100839,years,0,0
100840,",",0,0
100841,attending,0,0
100842,two,0,0
100843,early,0,0
100844,childhood,0,0
100845,intervention,0,0
100846,centres,0,0
100847,in,0,0
100848,Melbourne,0,0
100849,",",0,0
100850,Australia,0,0
100851,.,0,1
100852,Intervention,0,0
100853,Half,0,0
100854,of,0,0
100855,the,0,0
100856,subjects,0,0
100857,received,0,0
100858,an,0,0
100859,additional,0,0
100860,home-based,0,0
100861,programme,0,0
100862,consisting,0,0
100863,of,0,0
100864,40,0,0
100865,weekly,0,0
100866,visits,0,0
100867,.,0,0
100868,MAIN,0,0
100869,OUTCOME,0,1
100870,MEASURES,0,0
100871,Bayley,1,1
100872,Scales,1,1
100873,of,1,1
100874,Infant,1,1
100875,Development,1,1
100876,and,1,1
100877,Wechsler,1,1
100878,Preschool,1,1
100879,and,1,1
100880,Primary,1,1
100881,Scale,1,1
100882,of,1,1
100883,Intelligence,1,1
100884,Revised,1,1
100885,",",1,0
100886,Preschool,1,1
100887,Behaviour,1,1
100888,Checklist,1,1
100889,",",1,1
100890,Bayley,1,1
100891,Behaviour,1,1
100892,Rating,1,1
100893,Scale,1,1
100894,and,1,1
100895,Behaviour,1,1
100896,Screening,1,0
100897,Questionnaire,1,1
100898,.,1,0
100899,All,0,0
100900,tests,0,1
100901,administered,0,0
100902,pre-intervention,0,0
100903,",",0,0
100904,following,0,0
100905,the,0,0
100906,intervention,0,0
100907,and,0,0
100908,12,0,0
100909,months,0,0
100910,later,0,0
100911,.,0,0
100912,Secondary,0,0
100913,outcome,1,1
100914,measures,1,1
100915,Family,1,1
100916,stress,1,1
100917,",",1,1
100918,support,1,1
100919,and,1,1
100920,empowerment,1,1
100921,.,1,1
100922,RESULTS,0,0
100923,Fifty-four,0,0
100924,children,0,0
100925,completed,0,0
100926,the,0,0
100927,assessments,0,0
100928,12,0,0
100929,months,0,0
100930,after,0,0
100931,conclusion,0,0
100932,of,0,0
100933,the,0,0
100934,intervention,0,0
100935,.,0,0
100936,Compared,0,0
100937,with,0,0
100938,the,0,0
100939,control,0,0
100940,group,0,0
100941,",",0,1
100942,improvement,1,1
100943,in,1,0
100944,aspects,1,1
100945,of,1,0
100946,cognitive,1,1
100947,development,1,0
100948,in,0,0
100949,the,0,0
100950,children,0,0
100951,who,0,0
100952,received,0,0
100953,the,0,0
100954,extra,0,0
100955,intervention,0,0
100956,was,0,0
100957,sustained,0,0
100958,1,0,0
100959,year,0,0
100960,later,0,0
100961,(,0,0
100962,P=,0,1
100963,0.007,0,0
100964,),0,0
100965,while,0,0
100966,significant,0,0
100967,behavioural,1,1
100968,differences,1,0
100969,post,0,0
100970,intervention,0,0
100971,were,0,0
100972,not,0,0
100973,.,0,0
100974,Analyses,0,0
100975,of,0,0
100976,the,0,0
100977,data,0,0
100978,by,0,0
100979,the,0,0
100980,Reliable,1,0
100981,Change,1,1
100982,Index,1,1
100983,indicated,0,0
100984,improvement,0,1
100985,of,0,1
100986,clinical,0,1
100987,significance,0,1
100988,occurred,0,0
100989,in,0,0
100990,non-verbal,1,1
100991,areas,1,1
100992,.,1,0
100993,In,0,0
100994,contrast,0,0
100995,to,0,0
100996,the,0,0
100997,control,0,0
100998,group,0,0
100999,who,0,0
101000,deteriorated,0,1
101001,",",0,0
101002,language,1,1
101003,skills,1,1
101004,in,0,0
101005,the,0,0
101006,intervention,0,0
101007,group,0,0
101008,remained,0,0
101009,stable,0,1
101010,.,0,0
101011,Improvements,0,1
101012,were,0,0
101013,significantly,0,0
101014,associated,0,0
101015,with,0,0
101016,higher,0,0
101017,stress,1,1
101018,in,0,0
101019,the,0,0
101020,families,0,0
101021,.,0,0
101022,CONCLUSION,0,0
101023,Improvements,1,1
101024,following,0,0
101025,the,0,0
101026,provision,0,0
101027,of,0,0
101028,a,0,0
101029,home-based,0,0
101030,programme,0,0
101031,to,0,0
101032,preschool,0,0
101033,children,0,0
101034,with,0,0
101035,developmental,0,1
101036,disabilities,0,1
101037,were,0,0
101038,sustained,0,0
101039,1,0,0
101040,year,0,0
101041,later,0,0
101042,.,0,0
101043,Children,0,0
101044,from,0,0
101045,highly,0,0
101046,stressed,1,0
101047,families,0,0
101048,appeared,0,0
101049,to,0,0
101050,benefit,0,0
101051,most,0,0
101052,",",0,0
101053,reinforcing,0,0
101054,the,0,0
101055,importance,0,0
101056,of,0,0
101057,involving,0,0
101058,families,0,0
101059,in,0,0
101060,early,0,0
101061,childhood,0,0
101062,intervention,0,0
101063,programmes,0,0
101064,.,0,0
101065,[,0,0
101066,Clinical,0,1
101067,observation,0,0
101068,on,0,0
101069,acupuncture,0,0
101070,combined,0,0
101071,with,0,0
101072,Yizhi,0,0
101073,Jiannao,0,0
101074,granules,0,0
101075,for,0,0
101076,treatment,0,0
101077,of,0,0
101078,Alzheimer,0,1
101079,'s,0,1
101080,disease,0,1
101081,],0,0
101082,.,0,0
101083,OBJECTIVE,0,0
101084,To,0,0
101085,observe,0,0
101086,clinical,0,0
101087,therapeutic,1,0
101088,effect,1,1
101089,of,0,1
101090,acupuncture,0,0
101091,combined,0,0
101092,with,0,0
101093,Yizhi,0,0
101094,Jiannao,0,0
101095,Granules,0,1
101096,for,0,0
101097,treatment,0,0
101098,of,0,0
101099,Alzheimer,0,1
101100,'s,0,1
101101,disease,0,1
101102,and,0,0
101103,its,0,0
101104,effects,0,1
101105,on,0,0
101106,intelligence,1,1
101107,",",1,1
101108,daily,1,1
101109,life,1,1
101110,and,1,1
101111,social,1,1
101112,activity,1,1
101113,ability,1,1
101114,.,1,1
101115,METHODS,0,0
101116,Eighty-four,0,0
101117,cases,0,0
101118,were,0,0
101119,randomly,0,0
101120,divided,0,0
101121,into,0,0
101122,3,0,0
101123,groups,0,0
101124,",",0,0
101125,28,0,0
101126,cases,0,0
101127,in,0,0
101128,each,0,0
101129,group,0,0
101130,.,0,0
101131,The,0,0
101132,combined,0,0
101133,acupuncture,0,0
101134,and,0,1
101135,medication,0,1
101136,group,0,0
101137,was,0,0
101138,treated,0,0
101139,with,0,0
101140,acupuncture,0,0
101141,at,0,0
101142,Baihui,0,0
101143,(,0,0
101144,GV,0,0
101145,20,0,0
101146,),0,0
101147,",",0,0
101148,Sishencong,0,0
101149,(,0,0
101150,EX-HN,0,0
101151,1,0,0
101152,),0,0
101153,",",0,0
101154,Dazhui,0,0
101155,(,0,0
101156,GV,0,0
101157,14,0,0
101158,),0,0
101159,",",0,0
101160,Guanyuan,0,0
101161,(,0,0
101162,CV,0,1
101163,4,0,0
101164,),0,0
101165,",",0,0
101166,etc,0,1
101167,.,0,1
101168,and,0,1
101169,oral,0,0
101170,administration,0,0
101171,of,0,1
101172,Yizhi,0,0
101173,Jiannao,0,0
101174,Granules,0,1
101175,;,0,0
101176,the,0,0
101177,Chinese,0,0
101178,herb,0,0
101179,group,0,0
101180,was,0,0
101181,treated,0,0
101182,with,0,0
101183,Yizhi,0,0
101184,Jiannao,0,0
101185,Granules,0,1
101186,",",0,0
101187,and,0,0
101188,the,0,0
101189,western,0,0
101190,medicine,0,0
101191,group,0,0
101192,with,0,0
101193,oral,0,0
101194,administration,0,0
101195,of,0,0
101196,Aricept,0,0
101197,.,0,0
101198,The,0,0
101199,scores,1,1
101200,for,1,0
101201,the,1,0
101202,Mini-Mental,1,0
101203,State,1,1
101204,Examination,1,1
101205,(,1,1
101206,MMSE,1,1
101207,),1,1
101208,",",1,0
101209,Ability,1,1
101210,of,1,1
101211,Daily,1,0
101212,Life,1,0
101213,(,1,1
101214,ADL,1,1
101215,),1,0
101216,and,1,0
101217,the,1,0
101218,therapeutic,1,1
101219,effects,1,1
101220,were,0,0
101221,assessed,0,0
101222,and,0,0
101223,compared,0,0
101224,before,0,0
101225,treatment,0,0
101226,and,0,1
101227,after,0,0
101228,treatment,0,0
101229,for,0,0
101230,12,0,0
101231,weeks,0,0
101232,among,0,0
101233,the,0,0
101234,groups,0,0
101235,.,0,0
101236,RESULTS,0,0
101237,After,0,0
101238,treatment,0,0
101239,",",0,0
101240,the,0,0
101241,scores,0,1
101242,for,0,0
101243,MMSE,1,1
101244,and,1,1
101245,ADL,1,1
101246,were,0,0
101247,improved,0,0
101248,in,0,0
101249,the,0,0
101250,combined,0,0
101251,acupuncture,0,0
101252,and,0,1
101253,medication,0,1
101254,group,0,0
101255,",",0,0
101256,the,0,0
101257,Chinese,0,0
101258,herb,0,0
101259,group,0,0
101260,and,0,0
101261,the,0,0
101262,western,0,0
101263,medicine,0,0
101264,group,0,0
101265,",",0,1
101266,which,0,0
101267,were,0,0
101268,better,0,0
101269,in,0,0
101270,the,0,0
101271,combined,0,0
101272,acupuncture,0,0
101273,and,0,1
101274,medication,0,1
101275,group,0,0
101276,(,0,1
101277,P,0,0
101278,<,0,0
101279,0.05,0,0
101280,),0,0
101281,.,0,0
101282,The,0,0
101283,total,1,1
101284,effective,1,1
101285,rate,1,1
101286,of,0,0
101287,85.7,0,0
101288,%,0,0
101289,in,0,0
101290,the,0,0
101291,combined,0,0
101292,acupuncture,0,0
101293,and,0,1
101294,medication,0,1
101295,group,0,0
101296,was,0,0
101297,better,0,0
101298,than,0,0
101299,71.4,0,0
101300,%,0,0
101301,in,0,0
101302,the,0,0
101303,Chinese,0,0
101304,herb,0,0
101305,group,0,0
101306,and,0,0
101307,67.9,0,0
101308,%,0,0
101309,in,0,0
101310,the,0,0
101311,western,0,0
101312,medicine,0,0
101313,group,0,0
101314,.,0,1
101315,CONCLUSION,0,0
101316,Acupuncture,0,1
101317,combined,0,0
101318,with,0,0
101319,Yizhi,0,0
101320,Jiannao,0,0
101321,Granules,0,0
101322,has,0,0
101323,a,0,0
101324,significant,0,0
101325,therapeutic,1,0
101326,effect,1,1
101327,on,0,0
101328,Alzheimer,0,1
101329,'s,0,1
101330,disease,0,1
101331,",",0,0
101332,which,0,0
101333,is,0,0
101334,better,0,0
101335,than,0,0
101336,that,0,0
101337,of,0,0
101338,Yizhi,0,0
101339,Jiannao,0,0
101340,Granules,0,1
101341,or,0,0
101342,Aricept,0,0
101343,.,0,0
101344,Excimer,0,0
101345,laser,0,0
101346,trabeculotomy,0,1
101347,vs,0,0
101348,180,0,0
101349,degrees,0,0
101350,selective,0,0
101351,laser,0,0
101352,trabeculoplasty,0,0
101353,in,0,0
101354,primary,0,0
101355,open-angle,0,0
101356,glaucoma,0,0
101357,.,0,0
101358,A,0,0
101359,2-year,0,0
101360,randomized,0,0
101361,",",0,1
101362,controlled,0,0
101363,trial,0,0
101364,.,0,0
101365,PURPOSE,0,0
101366,To,0,0
101367,compare,0,0
101368,the,0,0
101369,effectiveness,1,1
101370,and,1,1
101371,safety,1,1
101372,of,0,1
101373,excimer,0,0
101374,laser,0,0
101375,trabeculotomy,0,1
101376,(,0,1
101377,ELT,0,0
101378,),0,0
101379,ab,0,1
101380,interno,0,0
101381,vs,0,0
101382,selective,0,1
101383,laser,0,0
101384,trabeculoplasty,0,1
101385,(,0,1
101386,SLT,0,0
101387,),0,0
101388,over,0,0
101389,24,0,0
101390,months,0,0
101391,of,0,0
101392,follow-up,0,0
101393,in,0,0
101394,patients,0,0
101395,with,0,0
101396,primary,0,0
101397,open-angle,0,0
101398,glaucoma,0,1
101399,(,0,1
101400,POAG,0,0
101401,),0,0
101402,refractory,0,0
101403,to,0,0
101404,medical,0,0
101405,therapy,0,0
101406,.,0,1
101407,PATIENTS,0,0
101408,AND,0,0
101409,METHODS,0,0
101410,This,0,0
101411,prospective,0,0
101412,",",0,0
101413,randomized,0,0
101414,study,0,0
101415,included,0,0
101416,30,0,0
101417,consecutive,0,0
101418,eyes,0,0
101419,assigned,0,0
101420,randomly,0,0
101421,to,0,0
101422,either,0,0
101423,ELT,0,0
101424,or,0,0
101425,SLT,0,0
101426,group,0,0
101427,.,0,1
101428,ELT,0,0
101429,was,0,0
101430,carried,0,0
101431,out,0,0
101432,using,0,0
101433,a,0,0
101434,XeCl,0,0
101435,Excimer,0,0
101436,Laser,0,0
101437,with,0,0
101438,an,0,0
101439,emission,0,0
101440,wavelength,0,0
101441,of,0,0
101442,308,0,0
101443,nm,0,0
101444,.,0,0
101445,Eight,0,1
101446,spots,0,1
101447,were,0,0
101448,equally,0,0
101449,distributed,0,0
101450,at,0,0
101451,a,0,0
101452,distance,0,0
101453,of,0,0
101454,500,0,0
101455,microm,0,0
101456,from,0,0
101457,one,0,0
101458,another,0,0
101459,over,0,0
101460,the,0,0
101461,anterior,0,0
101462,trabeculum,0,0
101463,.,0,0
101464,The,0,0
101465,SLT,0,0
101466,patients,0,0
101467,were,0,0
101468,treated,0,0
101469,with,0,0
101470,a,0,0
101471,frequency-doubled,0,0
101472,q-switched,0,0
101473,neodymium,0,0
101474,:,0,0
101475,yytrium-aluminum-garnet,0,0
101476,laser,0,0
101477,(,0,0
101478,wavelength,0,0
101479,532,0,0
101480,nm,0,0
101481,),0,0
101482,.,0,0
101483,Approximately,0,0
101484,50,0,0
101485,adjacent,0,0
101486,",",0,0
101487,but,0,0
101488,not,0,0
101489,overlapping,0,0
101490,",",0,0
101491,laser,0,0
101492,spots,0,1
101493,were,0,0
101494,distributed,0,0
101495,over,0,0
101496,180,0,0
101497,degrees,0,0
101498,of,0,0
101499,the,0,0
101500,trabecular,0,1
101501,meshwork,0,1
101502,",",0,0
101503,using,0,0
101504,an,0,0
101505,energy,0,1
101506,level,0,1
101507,ranging,0,0
101508,from,0,0
101509,0.7,0,0
101510,to,0,0
101511,1.0,0,0
101512,mJ,0,0
101513,per,0,0
101514,pulse,0,1
101515,.,0,0
101516,The,0,0
101517,main,0,0
101518,outcome,0,1
101519,measure,0,1
101520,was,0,0
101521,intraocular,1,1
101522,pressure,1,1
101523,(,1,1
101524,IOP,1,1
101525,),1,1
101526,lowering,1,1
101527,after,1,0
101528,ELT,1,0
101529,and,1,0
101530,SLT,1,0
101531,.,1,1
101532,Success,0,0
101533,was,0,0
101534,defined,0,1
101535,as,0,0
101536,>,0,0
101537,or=20,0,0
101538,%,0,0
101539,reduction,1,1
101540,in,1,0
101541,IOP,1,1
101542,without,0,0
101543,further,0,0
101544,glaucoma,0,1
101545,intervention,0,0
101546,.,0,1
101547,RESULTS,0,0
101548,At,0,0
101549,24,0,0
101550,months,0,0
101551,",",0,0
101552,complete,0,1
101553,success,1,1
101554,rates,1,1
101555,were,0,0
101556,53.3,0,0
101557,%,0,0
101558,for,0,0
101559,the,0,0
101560,ELT,0,0
101561,group,0,0
101562,and,0,0
101563,40,0,0
101564,%,0,0
101565,for,0,0
101566,the,0,0
101567,SLT,0,0
101568,group,0,0
101569,(,0,1
101570,P=0.35,0,0
101571,",",0,1
101572,Fisher,0,1
101573,'s,0,1
101574,exact,0,1
101575,test,0,0
101576,),0,0
101577,;,0,0
101578,qualified,1,0
101579,success,1,1
101580,rates,1,1
101581,were,0,0
101582,33.3,0,0
101583,%,0,0
101584,for,0,0
101585,the,0,0
101586,ELT,0,0
101587,and,0,0
101588,26.6,0,0
101589,%,0,0
101590,for,0,0
101591,the,0,0
101592,SLT,0,0
101593,group,0,0
101594,(,0,1
101595,P=0.5,0,0
101596,",",0,1
101597,Fisher,0,1
101598,'s,0,1
101599,exact,0,1
101600,test,1,0
101601,),1,0
101602,.Mean,1,0
101603,IOP,1,1
101604,decreased,1,1
101605,from,0,0
101606,25.0+/-1.9,0,0
101607,to,0,0
101608,17.6+/-2.2,0,0
101609,mmHg,0,0
101610,(,0,0
101611,-29.6,0,0
101612,%,0,0
101613,;,0,0
101614,P,0,0
101615,<,0,0
101616,0.0001,0,0
101617,),0,0
101618,in,0,0
101619,the,0,0
101620,ELT,0,0
101621,group,0,0
101622,and,0,1
101623,from,0,0
101624,23.9+/-0.9,0,0
101625,to,0,0
101626,19.1+/-1.8,0,0
101627,mmHg,0,0
101628,(,0,0
101629,-21,0,0
101630,%,0,0
101631,;,0,0
101632,P,0,0
101633,<,0,0
101634,0.0001,0,0
101635,),0,0
101636,in,0,0
101637,the,0,0
101638,SLT,0,0
101639,group,0,0
101640,.,0,1
101641,CONCLUSIONS,0,0
101642,Both,0,0
101643,ELT,0,0
101644,and,0,1
101645,SLT,0,0
101646,proved,0,0
101647,to,0,0
101648,be,0,0
101649,effective,0,1
101650,techniques,0,0
101651,in,0,0
101652,the,0,0
101653,treatment,0,0
101654,of,0,0
101655,POAG,0,0
101656,refractory,0,0
101657,to,0,0
101658,medical,0,0
101659,therapy,0,0
101660,.,0,0
101661,A,0,0
101662,double-blind,0,0
101663,placebo-controlled,0,0
101664,study,0,0
101665,to,0,0
101666,evaluate,0,0
101667,valacyclovir,0,0
101668,alone,0,0
101669,and,0,0
101670,with,0,0
101671,aspirin,0,0
101672,for,0,0
101673,asymptomatic,0,1
101674,HSV-1,0,1
101675,DNA,0,1
101676,shedding,0,1
101677,in,0,0
101678,human,0,0
101679,tears,0,1
101680,and,0,1
101681,saliva,0,0
101682,.,0,1
101683,PURPOSE,0,0
101684,To,0,0
101685,test,0,0
101686,the,0,0
101687,effect,0,0
101688,of,0,0
101689,valacyclovir,0,0
101690,alone,0,0
101691,and,0,0
101692,with,0,0
101693,aspirin,0,0
101694,on,0,0
101695,the,0,0
101696,asymptomatic,0,0
101697,shedding,0,1
101698,of,0,1
101699,HSV-1,0,1
101700,DNA,0,1
101701,in,0,0
101702,tears,0,1
101703,and,0,1
101704,saliva,0,1
101705,of,0,1
101706,healthy,0,0
101707,individuals,0,0
101708,.,0,0
101709,METHOD,0,0
101710,.,0,0
101711,The,0,0
101712,subjects,0,0
101713,(,0,0
101714,n,0,0
101715,=,0,0
101716,45,0,0
101717,),0,0
101718,were,0,0
101719,randomized,0,0
101720,into,0,0
101721,three,0,0
101722,groups,0,0
101723,without,0,0
101724,regard,0,0
101725,to,0,0
101726,age,0,0
101727,",",0,1
101728,sex,0,1
101729,",",0,1
101730,or,0,1
101731,race,0,0
101732,.,0,0
101733,Group,0,0
101734,1,0,0
101735,(,0,0
101736,n,0,0
101737,=,0,0
101738,14,0,0
101739,),0,0
101740,received,0,0
101741,the,0,0
101742,placebo,0,0
101743,",",0,0
101744,group,0,0
101745,2,0,0
101746,(,0,0
101747,n,0,0
101748,=,0,0
101749,15,0,0
101750,),0,0
101751,received,0,0
101752,a,0,0
101753,dose,0,0
101754,of,0,0
101755,500,0,0
101756,mg,0,0
101757,valacyclovir,0,0
101758,once,0,0
101759,daily,0,0
101760,",",0,1
101761,and,0,1
101762,group,0,0
101763,3,0,0
101764,(,0,0
101765,n,0,0
101766,=,0,0
101767,16,0,0
101768,),0,0
101769,received,0,0
101770,a,0,0
101771,dose,0,0
101772,of,0,0
101773,500,0,0
101774,mg,0,0
101775,valacyclovir,0,0
101776,once,0,0
101777,daily,0,0
101778,and,0,0
101779,350,0,0
101780,mg,0,0
101781,aspirin,0,0
101782,twice,0,0
101783,daily,0,0
101784,for,0,0
101785,30,0,0
101786,days,0,0
101787,.,0,0
101788,Ocular,0,1
101789,and,0,1
101790,oral,0,0
101791,swabs,0,1
101792,were,0,0
101793,collected,0,0
101794,twice,0,0
101795,daily,0,0
101796,for,0,0
101797,30,0,0
101798,days,0,0
101799,.,0,0
101800,DNA,0,1
101801,was,0,0
101802,extracted,0,0
101803,from,0,0
101804,all,0,0
101805,swabs,0,0
101806,and,0,1
101807,HSV-1,0,1
101808,DNA,0,1
101809,copy,0,1
101810,numbers,0,1
101811,were,0,0
101812,determined,0,0
101813,.,0,0
101814,Statistical,0,0
101815,analysis,0,0
101816,was,0,0
101817,performed,0,0
101818,to,0,0
101819,compare,0,0
101820,the,0,0
101821,DNA,0,1
101822,copy,0,1
101823,numbers,0,1
101824,of,0,0
101825,the,0,0
101826,three,0,0
101827,groups,0,0
101828,.,0,0
101829,RESULTS,0,0
101830,There,0,0
101831,was,0,0
101832,no,0,0
101833,significant,0,0
101834,difference,0,0
101835,in,0,0
101836,the,0,0
101837,HSV-1,1,1
101838,DNA,1,1
101839,copy,1,1
101840,numbers,1,1
101841,in,1,0
101842,the,1,0
101843,tears,1,1
101844,or,1,0
101845,saliva,1,0
101846,among,0,0
101847,any,0,0
101848,of,0,0
101849,the,0,0
101850,three,0,0
101851,treatment,0,0
101852,groups,0,0
101853,.,0,0
101854,The,0,0
101855,mean,1,1
101856,copy,1,1
101857,numbers,1,1
101858,+/-,1,0
101859,SE,1,0
101860,of,1,1
101861,mean,1,1
101862,(,1,1
101863,SEM,1,0
101864,),1,0
101865,of,1,0
101866,HSV-1,1,1
101867,DNA,1,1
101868,in,0,0
101869,tears,0,1
101870,were,0,0
101871,340,0,0
101872,+/-,0,0
101873,35,0,0
101874,",",0,0
101875,1074,0,0
101876,+/-,0,0
101877,320,0,0
101878,",",0,0
101879,and,0,0
101880,630,0,0
101881,+/-,0,0
101882,51,0,0
101883,for,0,0
101884,groups,0,0
101885,1,0,0
101886,",",0,0
101887,2,0,0
101888,",",0,0
101889,and,0,0
101890,3,0,1
101891,",",0,0
101892,and,0,0
101893,in,0,1
101894,saliva,0,0
101895,were,0,0
101896,238,0,0
101897,+/-,0,0
101898,35,0,0
101899,",",0,0
101900,963,0,0
101901,+/-,0,0
101902,462,0,0
101903,",",0,0
101904,and,0,0
101905,493,0,0
101906,+/-,0,0
101907,25,0,0
101908,",",0,0
101909,respectively,0,0
101910,",",0,0
101911,for,0,0
101912,groups,0,0
101913,1,0,0
101914,",",0,0
101915,2,0,0
101916,",",0,0
101917,and,0,0
101918,3,0,0
101919,.,0,0
101920,CONCLUSIONS,0,0
101921,No,0,1
101922,correlation,0,1
101923,was,0,0
101924,found,0,0
101925,between,0,0
101926,HSV-1,1,1
101927,shedding,1,1
101928,and,0,1
101929,valacyclovir,0,0
101930,and,0,1
101931,valacyclovir,0,0
101932,with,0,0
101933,aspirin,0,0
101934,treatment,0,0
101935,.,0,0
101936,The,0,0
101937,HSV-1,0,1
101938,DNA,0,1
101939,copy,0,1
101940,number,0,1
101941,was,0,0
101942,not,0,0
101943,reduced,0,0
101944,by,0,0
101945,treatment,0,0
101946,with,0,0
101947,500,0,0
101948,mg,0,0
101949,of,0,0
101950,valacyclovir,0,0
101951,daily,0,1
101952,or,0,0
101953,with,0,0
101954,a,0,0
101955,combination,0,0
101956,of,0,0
101957,daily,0,1
101958,valacyclovir,0,0
101959,(,0,0
101960,500,0,0
101961,mg,0,0
101962,),0,0
101963,plus,0,0
101964,twice-daily,0,0
101965,doses,0,0
101966,of,0,1
101967,aspirin,0,0
101968,(,0,0
101969,350,0,0
101970,mg,0,0
101971,),0,0
101972,over,0,0
101973,30,0,0
101974,days,0,0
101975,.,0,0
101976,Clinical,0,1
101977,effects,0,1
101978,of,0,0
101979,nanocrystalline,0,0
101980,hydroxyapatite,0,0
101981,paste,0,0
101982,in,0,0
101983,the,0,0
101984,treatment,0,0
101985,of,0,0
101986,intrabony,0,1
101987,periodontal,0,1
101988,defects,0,0
101989,:,0,0
101990,a,0,0
101991,randomized,0,0
101992,controlled,0,0
101993,clinical,0,0
101994,study,0,0
101995,.,0,0
101996,The,0,0
101997,purpose,0,0
101998,of,0,0
101999,the,0,0
102000,present,0,0
102001,randomized,0,0
102002,controlled,0,0
102003,clinical,0,1
102004,study,0,0
102005,was,0,0
102006,to,0,0
102007,compare,0,0
102008,the,0,0
102009,clinical,0,0
102010,outcomes,0,1
102011,of,0,1
102012,papilla,0,1
102013,preservation,0,1
102014,flap,0,1
102015,surgery,0,0
102016,with,0,0
102017,or,0,0
102018,without,0,0
102019,the,0,0
102020,application,0,0
102021,of,0,0
102022,a,0,0
102023,novel,0,0
102024,nanocrystalline,0,0
102025,hydroxyapatite,0,1
102026,(,0,1
102027,nano-HA,0,0
102028,),0,1
102029,bone,0,1
102030,graft,0,1
102031,substitute,0,0
102032,.,0,1
102033,Fourteen,0,0
102034,patients,0,0
102035,with,0,0
102036,paired,0,0
102037,intrabony,0,1
102038,periodontal,0,1
102039,defects,0,0
102040,of,0,0
102041,?,0,0
102042,4,0,0
102043,mm,0,0
102044,participated,0,0
102045,in,0,0
102046,this,0,0
102047,split-mouth,0,0
102048,design,0,0
102049,study,0,0
102050,.,0,0
102051,The,0,0
102052,defects,0,0
102053,in,0,0
102054,each,0,0
102055,subject,0,0
102056,were,0,0
102057,randomly,0,0
102058,selected,0,0
102059,to,0,0
102060,receive,0,0
102061,nano-HA,0,0
102062,paste,0,0
102063,in,0,0
102064,conjunction,0,0
102065,with,0,0
102066,papilla,0,1
102067,preservation,0,1
102068,flaps,0,0
102069,or,0,1
102070,papilla,0,1
102071,preservation,0,1
102072,flaps,0,0
102073,alone,1,0
102074,.,1,0
102075,Probing,1,1
102076,bone,1,1
102077,levels,1,1
102078,(,1,1
102079,PBL,1,0
102080,),1,0
102081,from,1,0
102082,a,0,0
102083,customized,0,0
102084,acrylic,0,0
102085,stent,0,1
102086,and,1,1
102087,probing,1,1
102088,pocket,1,1
102089,depths,1,1
102090,(,1,1
102091,PPD,1,1
102092,),1,1
102093,were,1,0
102094,measured,0,0
102095,at,0,0
102096,baseline,0,0
102097,and,0,0
102098,again,0,0
102099,6,0,0
102100,months,0,0
102101,following,0,0
102102,surgery,0,0
102103,.,0,0
102104,No,0,0
102105,differences,0,0
102106,in,0,0
102107,any,0,0
102108,of,0,0
102109,the,0,0
102110,investigated,0,0
102111,parameters,0,1
102112,were,0,0
102113,observed,0,0
102114,at,0,0
102115,baseline,0,0
102116,between,0,0
102117,the,0,0
102118,two,0,0
102119,groups,1,0
102120,.,1,0
102121,Healing,1,1
102122,was,1,0
102123,uneventful,0,1
102124,in,0,0
102125,all,0,0
102126,patients,0,0
102127,.,0,0
102128,Both,0,0
102129,treatments,0,0
102130,resulted,0,0
102131,in,0,0
102132,significant,0,0
102133,improvements,0,1
102134,between,0,0
102135,baseline,0,0
102136,and,0,0
102137,6,0,0
102138,months,0,0
102139,(,0,0
102140,p,0,0
102141,<,0,0
102142,0.05,0,0
102143,),0,0
102144,.,0,0
102145,At,0,0
102146,6,0,0
102147,months,0,0
102148,after,0,0
102149,therapy,0,0
102150,",",0,0
102151,the,0,0
102152,sites,0,0
102153,treated,0,0
102154,with,0,0
102155,nano-HA,0,0
102156,paste,0,0
102157,showed,0,0
102158,a,0,0
102159,reduction,0,1
102160,in,0,0
102161,mean,1,1
102162,PPD,1,0
102163,from,1,0
102164,8.3,0,0
102165,?,0,0
102166,1.2,0,0
102167,to,0,0
102168,4.0,0,0
102169,?,0,0
102170,1.1,0,0
102171,mm,0,0
102172,and,0,0
102173,a,0,0
102174,gain,0,1
102175,in,1,0
102176,PBL,1,0
102177,of,0,0
102178,4.3,0,0
102179,?,0,0
102180,1.4,0,0
102181,mm,0,0
102182,",",0,0
102183,whereas,0,0
102184,in,0,0
102185,the,0,0
102186,control,0,0
102187,group,0,0
102188,",",0,0
102189,the,0,0
102190,mean,0,1
102191,PPD,1,0
102192,changed,0,0
102193,from,0,0
102194,7.9,0,0
102195,?,0,0
102196,1.2,0,0
102197,mm,0,0
102198,to,0,0
102199,5.0,0,0
102200,?,0,0
102201,1.2,0,0
102202,mm,0,0
102203,and,0,0
102204,PBL,1,1
102205,gain,1,1
102206,was,0,0
102207,2.6,0,0
102208,?,0,0
102209,1.4,0,0
102210,mm,0,0
102211,.,0,0
102212,Results,0,0
102213,demonstrated,0,0
102214,statistically,0,0
102215,greater,0,0
102216,PPD,1,1
102217,reduction,1,1
102218,and,1,1
102219,PBL,1,1
102220,gain,1,1
102221,(,1,0
102222,p,1,0
102223,<,0,0
102224,0.05,0,0
102225,),0,0
102226,in,0,0
102227,the,0,0
102228,test,0,1
102229,group,0,0
102230,as,0,0
102231,compared,0,0
102232,with,0,0
102233,the,0,0
102234,control,0,0
102235,group,0,0
102236,.,0,0
102237,In,0,0
102238,conclusion,0,0
102239,",",0,0
102240,after,0,0
102241,6,0,0
102242,months,0,0
102243,",",0,0
102244,the,0,0
102245,treatment,0,0
102246,of,0,0
102247,intrabony,0,1
102248,periodontal,0,1
102249,defects,0,0
102250,with,0,0
102251,a,0,0
102252,nano-HA,0,0
102253,paste,0,0
102254,leads,0,0
102255,to,0,0
102256,significantly,0,0
102257,improved,0,0
102258,clinical,0,0
102259,outcomes,0,1
102260,when,0,0
102261,compared,0,0
102262,with,0,0
102263,papilla,0,1
102264,preservation,0,1
102265,flap,0,1
102266,surgery,0,0
102267,alone,0,0
102268,.,0,0
102269,Depiction,1,1
102270,of,1,1
102271,hypervascular,1,1
102272,hepatocellular,1,0
102273,carcinoma,1,0
102274,with,0,0
102275,64-MDCT,1,0
102276,:,1,0
102277,comparison,0,0
102278,of,0,1
102279,moderate-,0,0
102280,and,0,1
102281,high-concentration,0,1
102282,contrast,0,0
102283,material,0,1
102284,with,0,0
102285,and,0,1
102286,without,0,0
102287,saline,0,0
102288,flush,0,0
102289,.,0,0
102290,OBJECTIVE,0,0
102291,The,0,0
102292,purpose,0,0
102293,of,0,0
102294,this,0,0
102295,study,0,0
102296,was,0,0
102297,to,0,0
102298,evaluate,0,0
102299,prospectively,0,0
102300,the,0,0
102301,depiction,1,0
102302,of,1,0
102303,hypervascular,1,1
102304,hepatocellular,1,0
102305,carcinoma,1,0
102306,on,0,0
102307,64-MDCT,0,0
102308,scans,0,0
102309,obtained,0,0
102310,with,0,0
102311,contrast,0,0
102312,agents,0,0
102313,of,0,0
102314,varying,0,0
102315,iodine,0,0
102316,concentrations,0,1
102317,administered,0,0
102318,with,0,0
102319,and,0,0
102320,without,0,0
102321,saline,0,0
102322,flush,0,0
102323,.,0,1
102324,SUBJECTS,0,1
102325,AND,0,0
102326,METHODS,0,0
102327,The,0,0
102328,study,0,0
102329,included,0,0
102330,149,0,0
102331,patients,0,0
102332,",",0,0
102333,among,0,0
102334,whom,0,0
102335,36,0,0
102336,patients,0,0
102337,with,0,0
102338,hypervascular,0,1
102339,hepatocellular,0,0
102340,carcinoma,0,0
102341,were,0,0
102342,identified,0,0
102343,.,0,0
102344,Patients,0,0
102345,were,0,0
102346,randomly,0,0
102347,assigned,0,0
102348,to,0,0
102349,one,0,0
102350,of,0,0
102351,three,0,0
102352,protocols,0,0
102353,:,0,0
102354,A,0,0
102355,",",0,0
102356,contrast,0,0
102357,material,0,1
102358,of,0,0
102359,300,0,0
102360,mg,0,0
102361,I/mL,0,0
102362,;,0,0
102363,B,0,0
102364,",",0,0
102365,370,0,0
102366,mg,0,0
102367,I/mL,0,0
102368,;,0,1
102369,C,0,0
102370,",",0,0
102371,370,0,0
102372,mg,0,0
102373,I/mL,0,0
102374,plus,0,0
102375,saline,0,0
102376,flush,0,0
102377,.,0,0
102378,In,0,0
102379,all,0,0
102380,protocols,0,0
102381,",",0,0
102382,the,0,0
102383,same,0,0
102384,iodine,0,0
102385,load,0,1
102386,per,0,0
102387,kilogram,0,0
102388,of,0,1
102389,body,0,1
102390,weight,0,1
102391,(,0,0
102392,516,0,0
102393,mg/kg,0,0
102394,),0,0
102395,was,0,0
102396,administered,0,0
102397,for,0,0
102398,the,0,0
102399,same,0,0
102400,injection,0,0
102401,duration,0,1
102402,(,0,0
102403,30,0,0
102404,seconds,0,0
102405,),0,0
102406,.,0,0
102407,Enhancement,1,1
102408,values,1,1
102409,in,1,0
102410,the,1,0
102411,aorta,1,1
102412,",",1,1
102413,liver,1,1
102414,",",1,1
102415,and,1,1
102416,portal,1,1
102417,vein,1,1
102418,and,1,1
102419,tumor-liver,1,1
102420,contrast,1,0
102421,were,0,0
102422,measured,0,0
102423,at,0,0
102424,multiphase,0,0
102425,CT,0,1
102426,.,0,1
102427,RESULTS,0,0
102428,Aortic,1,0
102429,enhancement,1,1
102430,was,0,0
102431,significantly,0,0
102432,different,0,0
102433,between,0,0
102434,protocols,0,0
102435,A,0,0
102436,and,0,1
102437,B,0,1
102438,(,0,1
102439,p,0,0
102440,=,0,0
102441,0.04,0,0
102442,",",0,0
102443,p,0,0
102444,<,0,0
102445,0.0001,0,0
102446,),0,0
102447,and,0,0
102448,protocols,0,0
102449,B,0,1
102450,and,0,1
102451,C,0,1
102452,(,0,1
102453,p,0,0
102454,=,0,0
102455,0.02,0,0
102456,",",0,0
102457,p,0,0
102458,<,0,0
102459,0.001,0,0
102460,),0,0
102461,in,0,0
102462,the,0,0
102463,first,0,0
102464,and,0,0
102465,second,0,0
102466,phases,0,0
102467,.,0,0
102468,Portal,1,0
102469,venous,1,1
102470,enhancement,1,1
102471,was,0,0
102472,significantly,0,0
102473,different,0,0
102474,between,0,0
102475,protocols,0,0
102476,B,0,0
102477,and,0,1
102478,C,0,1
102479,(,0,1
102480,p,0,0
102481,=,0,0
102482,0.02,0,0
102483,),0,0
102484,in,0,0
102485,the,0,0
102486,first,0,1
102487,phase,0,0
102488,and,0,1
102489,between,0,0
102490,protocols,0,0
102491,B,0,0
102492,and,0,1
102493,C,0,0
102494,and,0,0
102495,protocols,0,0
102496,A,0,0
102497,and,0,1
102498,C,0,0
102499,(,0,1
102500,p,0,0
102501,<,0,0
102502,0.01,0,0
102503,",",0,0
102504,p,0,0
102505,=,0,0
102506,0.02,0,0
102507,),0,0
102508,in,0,0
102509,the,0,0
102510,second,0,0
102511,phase,0,0
102512,.,0,1
102513,Tumor-liver,1,1
102514,contrast,1,0
102515,was,0,0
102516,significantly,0,0
102517,different,0,0
102518,between,0,0
102519,protocols,0,0
102520,A,0,0
102521,and,0,1
102522,B,0,1
102523,(,0,1
102524,p,0,0
102525,=,0,0
102526,0.03,0,0
102527,",",0,0
102528,p,0,0
102529,=,0,0
102530,0.02,0,0
102531,),0,0
102532,and,0,0
102533,protocols,0,0
102534,B,0,1
102535,and,0,1
102536,C,0,1
102537,(,0,1
102538,p,0,0
102539,=,0,0
102540,0.03,0,0
102541,",",0,0
102542,p,0,0
102543,=,0,0
102544,0.04,0,0
102545,),0,0
102546,in,0,0
102547,the,0,0
102548,first,0,0
102549,and,0,0
102550,second,0,1
102551,phases,0,1
102552,but,0,0
102553,not,0,0
102554,between,0,0
102555,protocols,0,0
102556,A,0,0
102557,and,0,1
102558,C.,0,1
102559,There,0,0
102560,was,0,0
102561,no,0,0
102562,significant,0,0
102563,difference,0,0
102564,in,0,0
102565,hepatic,1,1
102566,enhancement,1,1
102567,among,0,0
102568,the,0,0
102569,three,0,0
102570,protocols,0,0
102571,.,0,0
102572,CONCLUSION,0,0
102573,Use,0,0
102574,of,0,1
102575,moderate,0,0
102576,concentration,0,1
102577,was,0,0
102578,more,0,0
102579,effective,0,1
102580,than,0,0
102581,use,0,0
102582,of,0,0
102583,a,0,0
102584,high,0,0
102585,concentration,0,1
102586,of,0,1
102587,contrast,0,0
102588,material,0,1
102589,for,0,0
102590,depiction,0,0
102591,of,0,1
102592,hepatocellular,0,0
102593,carcinoma,0,0
102594,.,0,0
102595,Adding,0,0
102596,a,0,0
102597,saline,0,0
102598,flush,0,0
102599,to,0,0
102600,the,0,0
102601,high-concentration,0,1
102602,protocol,0,0
102603,eliminated,0,0
102604,the,0,0
102605,difference,0,0
102606,in,0,0
102607,depiction,1,0
102608,of,1,1
102609,hepatocellular,1,0
102610,carcinoma,1,0
102611,between,0,0
102612,the,0,0
102613,moderate-,0,0
102614,and,0,1
102615,high-concentration,0,1
102616,protocols,0,0
102617,.,0,0
102618,Randomized,0,0
102619,",",0,0
102620,placebo-controlled,0,0
102621,",",0,1
102622,crossover,0,0
102623,study,0,0
102624,of,0,1
102625,methylphenidate,0,0
102626,for,0,0
102627,attention-deficit/hyperactivity,0,0
102628,disorder,0,0
102629,symptoms,0,1
102630,in,0,0
102631,preschoolers,0,0
102632,with,0,0
102633,developmental,0,0
102634,disorders,0,0
102635,.,0,0
102636,OBJECTIVE,0,0
102637,The,0,0
102638,aim,0,0
102639,of,0,0
102640,this,0,0
102641,study,0,0
102642,was,0,0
102643,to,0,0
102644,investigate,0,0
102645,the,0,0
102646,short-term,0,1
102647,efficacy,1,1
102648,and,0,1
102649,safety,0,1
102650,of,0,1
102651,methylphenidate,0,0
102652,(,0,1
102653,MPH,0,0
102654,),0,0
102655,to,0,0
102656,treat,0,0
102657,attention-deficit/hyperactivity,0,0
102658,disorder,0,0
102659,(,0,1
102660,ADHD,0,0
102661,),0,0
102662,symptoms,0,1
102663,in,0,0
102664,an,0,0
102665,understudied,0,0
102666,population,0,0
102667,of,0,0
102668,preschoolers,0,0
102669,with,0,0
102670,pervasive,0,0
102671,developmental,0,1
102672,disorder,0,0
102673,(,0,1
102674,PDD,0,1
102675,),0,1
102676,or,0,0
102677,intellectual,0,1
102678,disability,0,1
102679,(,0,1
102680,ID,0,0
102681,),0,0
102682,.,0,0
102683,METHODS,0,0
102684,Fourteen,0,0
102685,preschoolers,0,0
102686,with,0,0
102687,developmental,0,1
102688,disorders,0,0
102689,(,0,1
102690,DD,0,0
102691,",",0,0
102692,n,0,0
102693,=,0,0
102694,14,0,0
102695,;,0,0
102696,PDD,0,0
102697,",",0,0
102698,n,0,0
102699,=,0,0
102700,12,0,0
102701,;,0,0
102702,ID,0,0
102703,",",0,0
102704,n,0,0
102705,=,0,0
102706,2,0,0
102707,),0,0
102708,underwent,0,0
102709,MPH,0,0
102710,titration,0,0
102711,in,0,0
102712,a,0,0
102713,single-blind,0,0
102714,manner,0,0
102715,followed,0,0
102716,by,0,0
102717,a,0,0
102718,4-week,0,0
102719,double-blind,0,0
102720,crossover,0,0
102721,phase,0,0
102722,.,0,0
102723,Each,0,0
102724,child,0,0
102725,was,0,0
102726,administered,0,0
102727,placebo,0,0
102728,for,0,0
102729,2,0,0
102730,weeks,0,0
102731,and,0,0
102732,optimal,0,1
102733,dose,0,0
102734,for,0,0
102735,2,0,0
102736,weeks,0,0
102737,.,0,0
102738,The,0,0
102739,primary,0,0
102740,outcome,0,1
102741,measure,0,1
102742,was,0,0
102743,the,0,0
102744,Diagnostic,1,1
102745,and,1,1
102746,Statistical,1,1
102747,Manual,1,1
102748,of,1,1
102749,Mental,1,1
102750,Disorders,1,0
102751,",",1,0
102752,4,1,0
102753,(,1,0
102754,th,1,1
102755,),1,1
102756,edition,1,0
102757,(,1,1
102758,DSM-IV,1,1
102759,),1,1
102760,ADHD,1,0
102761,subscale,1,1
102762,of,1,0
102763,the,1,0
102764,Conners,1,1
102765,',1,1
102766,Parent,1,0
102767,Rating,1,1
102768,Scale-Revised,1,0
102769,(,0,0
102770,CPRS-R-DSM-IV-ADHD,0,0
102771,),0,0
102772,.,0,0
102773,RESULTS,0,0
102774,MPH,0,0
102775,improved,0,1
102776,parent-rated,1,1
102777,ADHD,1,0
102778,symptoms,1,1
102779,of,0,0
102780,the,0,0
102781,preschoolers,0,0
102782,;,0,0
102783,50,0,0
102784,%,0,0
102785,were,0,0
102786,rated,0,1
102787,as,0,0
102788,responders,0,0
102789,.,0,0
102790,The,0,0
102791,CPRS-R-DSM-IV-ADHD,1,0
102792,subscale,1,1
102793,was,0,0
102794,significant,0,0
102795,for,0,0
102796,the,0,0
102797,PDD,0,1
102798,subgroup,0,0
102799,(,0,1
102800,p,0,0
102801,=,0,0
102802,0.005,0,0
102803,",",0,0
102804,Cohen,0,0
102805,d,0,1
102806,=,0,0
102807,0.97,0,0
102808,),0,0
102809,and,0,0
102810,marginally,0,0
102811,significant,0,0
102812,for,0,0
102813,the,0,0
102814,entire,0,0
102815,DD,0,0
102816,sample,0,0
102817,(,0,1
102818,p,0,0
102819,=,0,0
102820,0.08,0,0
102821,",",0,0
102822,Cohen,0,0
102823,d,0,1
102824,=,0,0
102825,0.50,0,0
102826,),0,0
102827,.,0,0
102828,Half,0,0
102829,of,0,0
102830,the,0,0
102831,preschoolers,0,0
102832,experienced,0,0
102833,side,1,1
102834,effects,1,1
102835,with,0,0
102836,MPH,0,0
102837,",",0,0
102838,including,0,0
102839,reports,0,0
102840,of,0,0
102841,increased,0,0
102842,stereotypic,1,1
102843,behavior,1,1
102844,",",1,1
102845,upset,1,1
102846,stomach,1,1
102847,",",1,1
102848,sleep-related,1,1
102849,difficulties,1,1
102850,",",1,1
102851,and,1,1
102852,emotional,1,1
102853,lability,1,1
102854,.,1,0
102855,One,0,0
102856,child,0,0
102857,discontinued,0,0
102858,during,0,0
102859,titration,0,0
102860,due,0,0
102861,to,0,0
102862,side,0,1
102863,effects,0,0
102864,.,0,0
102865,CONCLUSION,0,0
102866,The,0,0
102867,predominant,0,0
102868,direction,0,1
102869,of,0,1
102870,response,0,1
102871,in,0,0
102872,these,0,0
102873,preschoolers,0,0
102874,with,0,0
102875,both,0,0
102876,ADHD,0,0
102877,and,0,1
102878,PDD/ID,0,1
102879,favored,0,0
102880,MPH,0,0
102881,",",0,0
102882,even,0,0
102883,though,0,0
102884,the,0,0
102885,response,0,1
102886,was,0,0
102887,more,0,0
102888,subtle,0,1
102889,and,0,1
102890,variable,0,1
102891,than,0,0
102892,in,0,0
102893,older,0,0
102894,and,0,0
102895,typically,0,0
102896,developing,0,0
102897,children,0,0
102898,.,0,0
102899,Due,0,1
102900,to,0,0
102901,high,0,0
102902,rates,0,1
102903,of,0,0
102904,adverse,0,1
102905,effects,0,1
102906,",",0,0
102907,preschoolers,0,0
102908,should,0,0
102909,be,0,0
102910,monitored,0,0
102911,closely,0,0
102912,.,0,0
102913,Pharmacokinetic-pharmacodynamic,1,1
102914,modelling,1,0
102915,of,0,0
102916,the,0,0
102917,antihistaminic,0,1
102918,(,0,0
102919,H1,0,1
102920,),0,1
102921,effect,0,1
102922,of,0,0
102923,bilastine,0,0
102924,.,0,0
102925,OBJECTIVE,0,0
102926,To,0,0
102927,model,0,0
102928,the,0,0
102929,pharmacokinetic,1,1
102930,and,1,1
102931,pharmacodynamic,1,1
102932,relationship,0,1
102933,of,0,1
102934,bilastine,0,0
102935,",",0,0
102936,a,0,0
102937,new,0,1
102938,histamine,0,1
102939,H,0,1
102940,(,0,0
102941,1,0,0
102942,),0,0
102943,receptor,0,0
102944,antagonist,0,0
102945,",",0,0
102946,from,0,0
102947,single-,0,0
102948,and,0,1
102949,multiple-dose,0,0
102950,studies,0,0
102951,in,0,0
102952,healthy,0,0
102953,adult,0,0
102954,subjects,0,0
102955,.,0,0
102956,METHODS,0,0
102957,The,0,0
102958,pharmacokinetic,0,1
102959,model,0,0
102960,was,0,0
102961,developed,0,0
102962,from,0,0
102963,different,0,0
102964,single-dose,0,0
102965,and,0,1
102966,multiple-dose,0,0
102967,studies,0,0
102968,.,0,0
102969,In,0,0
102970,the,0,0
102971,single-dose,0,0
102972,studies,0,0
102973,",",0,0
102974,a,0,0
102975,total,0,1
102976,of,0,0
102977,183,0,0
102978,subjects,0,0
102979,received,0,0
102980,oral,0,0
102981,doses,0,0
102982,of,0,0
102983,bilastine,0,0
102984,2.5,0,0
102985,",",0,0
102986,5,0,0
102987,",",0,0
102988,10,0,0
102989,",",0,0
102990,20,0,0
102991,",",0,0
102992,50,0,0
102993,",",0,0
102994,100,0,0
102995,",",0,0
102996,120,0,0
102997,",",0,0
102998,160,0,0
102999,",",0,0
103000,200,0,0
103001,and,0,0
103002,220,0,0
103003,mg,0,0
103004,.,0,0
103005,In,0,0
103006,the,0,0
103007,multiple-dose,0,0
103008,studies,0,0
103009,",",0,0
103010,127,0,0
103011,healthy,0,0
103012,subjects,0,0
103013,received,0,0
103014,bilastine,0,0
103015,10,0,0
103016,",",0,0
103017,20,0,0
103018,",",0,0
103019,40,0,0
103020,",",0,0
103021,50,0,0
103022,",",0,0
103023,80,0,0
103024,",",0,0
103025,100,0,0
103026,",",0,0
103027,140,0,0
103028,or,0,0
103029,200,0,0
103030,mg/day,0,0
103031,as,0,0
103032,multiple,0,0
103033,doses,0,0
103034,during,0,0
103035,a,0,0
103036,4-,0,0
103037,",",0,0
103038,7-,0,1
103039,or,0,1
103040,14-day,0,0
103041,period,0,0
103042,.,0,0
103043,The,0,0
103044,pharmacokinetic,1,1
103045,profile,1,1
103046,of,0,1
103047,bilastine,0,0
103048,was,0,0
103049,investigated,0,0
103050,using,0,0
103051,a,0,0
103052,simultaneous,0,0
103053,analysis,0,0
103054,of,0,0
103055,all,0,0
103056,concentration-time,1,1
103057,data,1,0
103058,by,0,0
103059,means,0,0
103060,of,0,0
103061,nonlinear,0,0
103062,mixed-effects,0,0
103063,modelling,0,0
103064,population,0,0
103065,pharmacokinetic,0,1
103066,software,0,0
103067,NONMEM,0,1
103068,version,0,0
103069,6.1,0,0
103070,.,0,0
103071,Plasma,1,0
103072,concentrations,1,1
103073,were,0,0
103074,modelled,0,0
103075,according,0,0
103076,to,0,0
103077,a,0,0
103078,two-compartment,0,1
103079,open,0,0
103080,model,0,0
103081,with,0,0
103082,first-order,0,1
103083,absorption,0,1
103084,and,0,1
103085,elimination,0,1
103086,.,0,0
103087,For,0,0
103088,the,0,0
103089,pharmacodynamic,0,1
103090,analysis,0,0
103091,",",0,0
103092,the,0,0
103093,inhibitory,0,1
103094,effect,0,1
103095,of,0,1
103096,bilastine,0,0
103097,(,0,0
103098,inhibition,0,1
103099,of,0,1
103100,histamine-induced,0,1
103101,wheal,0,1
103102,and,0,1
103103,flare,0,1
103104,),0,1
103105,was,0,0
103106,assessed,0,0
103107,on,0,0
103108,a,0,0
103109,preselected,0,0
103110,time,0,1
103111,schedule,0,0
103112,",",0,0
103113,and,0,0
103114,the,0,0
103115,predicted,0,1
103116,typical,1,0
103117,pharmacokinetic,1,1
103118,profile,1,1
103119,(,0,0
103120,based,0,0
103121,on,0,0
103122,the,0,0
103123,pharmacokinetic,0,1
103124,model,0,0
103125,previously,0,0
103126,developed,0,0
103127,),0,0
103128,was,0,0
103129,used,0,0
103130,.,0,0
103131,An,0,0
103132,indirect,0,0
103133,response,0,1
103134,model,0,0
103135,was,0,0
103136,developed,0,0
103137,to,0,0
103138,describe,0,0
103139,the,0,0
103140,pharmacodynamic,1,1
103141,relationships,1,1
103142,between,0,0
103143,flare,0,1
103144,or,0,0
103145,wheal,0,1
103146,areas,0,1
103147,and,0,1
103148,bilastine,1,0
103149,plasma,1,1
103150,concentrations,1,1
103151,.,1,0
103152,Finally,0,0
103153,",",0,0
103154,once,0,0
103155,values,0,1
103156,of,0,0
103157,the,0,0
103158,concentration,1,1
103159,that,1,0
103160,produced,1,0
103161,50,1,0
103162,%,1,0
103163,inhibition,1,1
103164,(,1,1
103165,IC,1,1
103166,(,1,0
103167,50,1,0
103168,),1,0
103169,),1,0
103170,had,0,0
103171,been,0,0
103172,estimated,0,0
103173,for,0,0
103174,wheal,0,1
103175,and,0,1
103176,flare,0,1
103177,effects,0,1
103178,",",0,1
103179,simulations,0,0
103180,were,0,0
103181,carried,0,0
103182,out,0,0
103183,to,0,0
103184,predict,0,0
103185,plasma,1,1
103186,concentrations,1,1
103187,for,0,0
103188,the,0,0
103189,doses,0,0
103190,of,0,0
103191,bilastine,0,0
103192,5,0,0
103193,",",0,0
103194,10,0,0
103195,and,0,0
103196,20,0,0
103197,mg,0,0
103198,at,0,0
103199,steady,0,1
103200,state,0,1
103201,(,0,0
103202,72-96,0,1
103203,hours,0,0
103204,),0,0
103205,.,0,0
103206,RESULTS,0,0
103207,A,0,0
103208,non-compartmental,0,0
103209,analysis,0,0
103210,resulted,0,0
103211,in,0,0
103212,linear,0,0
103213,kinetics,0,1
103214,of,0,0
103215,bilastine,0,0
103216,in,0,0
103217,the,0,0
103218,dose,0,0
103219,range,0,0
103220,studied,0,0
103221,.,0,0
103222,Bilastine,0,0
103223,was,0,0
103224,characterized,0,0
103225,by,0,0
103226,two-compartmental,0,0
103227,kinetics,0,1
103228,with,0,0
103229,a,0,0
103230,rapid-absorption,0,1
103231,phase,0,0
103232,(,0,1
103233,first-order,0,1
103234,absorption,0,1
103235,rate,0,1
103236,constant,0,1
103237,=,0,0
103238,1.50,0,0
103239,h,0,0
103240,(,0,0
103241,-1,0,0
103242,),0,1
103243,),0,0
103244,",",0,0
103245,plasma,1,1
103246,peak,1,1
103247,concentrations,1,1
103248,were,0,0
103249,observed,0,0
103250,at,0,0
103251,1,0,0
103252,hour,0,0
103253,following,0,0
103254,administration,0,0
103255,and,0,0
103256,the,0,0
103257,maximal,1,1
103258,response,1,1
103259,was,0,0
103260,observed,0,0
103261,at,0,0
103262,approximately,0,0
103263,4,0,0
103264,hours,0,0
103265,or,0,0
103266,later,0,0
103267,.,0,0
103268,Concerning,0,0
103269,the,0,0
103270,selected,0,0
103271,pharmacodynamic,0,1
103272,model,0,0
103273,to,0,0
103274,fit,0,1
103275,the,0,0
103276,data,0,0
103277,(,0,0
103278,type,0,0
103279,I,0,0
103280,indirect,0,0
103281,response,0,1
103282,model,0,0
103283,),0,0
103284,",",0,0
103285,this,0,0
103286,selection,0,0
103287,is,0,0
103288,attributable,0,0
103289,to,0,0
103290,the,0,0
103291,presence,0,0
103292,of,0,0
103293,inhibitory,1,1
103294,bilastine,1,0
103295,plasma,1,1
103296,concentrations,1,1
103297,that,0,0
103298,decrease,0,0
103299,the,0,0
103300,input,1,1
103301,response,1,1
103302,function,1,1
103303,",",0,0
103304,i.e,0,0
103305,.,0,0
103306,the,0,0
103307,production,0,1
103308,of,0,0
103309,the,0,0
103310,skin,0,1
103311,reaction,0,1
103312,.,0,0
103313,This,0,0
103314,model,0,0
103315,resulted,0,0
103316,in,0,0
103317,the,0,0
103318,best,0,0
103319,fit,0,1
103320,of,0,1
103321,wheal,0,1
103322,and,0,1
103323,flare,0,1
103324,data,0,0
103325,.,0,0
103326,The,0,0
103327,estimates,0,0
103328,(,0,0
103329,with,0,0
103330,relative,0,1
103331,standard,0,0
103332,errors,0,1
103333,expressed,0,0
103334,in,0,0
103335,percentages,0,1
103336,in,0,0
103337,parentheses,0,0
103338,),0,0
103339,of,0,0
103340,the,0,0
103341,apparent,1,0
103342,zero-order,1,1
103343,rate,1,1
103344,constant,1,1
103345,for,1,0
103346,flare,1,1
103347,or,1,1
103348,wheal,1,1
103349,spontaneous,1,1
103350,appearance,1,1
103351,(,0,1
103352,k,0,1
103353,(,0,1
103354,in,0,0
103355,),0,0
103356,),0,0
103357,",",0,0
103358,the,0,0
103359,first-order,1,1
103360,rate,1,1
103361,constant,1,1
103362,for,1,0
103363,flare,1,1
103364,or,1,1
103365,wheal,1,1
103366,disappearance,1,1
103367,(,0,1
103368,k,0,1
103369,(,0,1
103370,out,0,0
103371,),0,0
103372,),0,0
103373,and,0,1
103374,bilastine,1,0
103375,IC,1,1
103376,(,1,0
103377,50,1,0
103378,),1,0
103379,values,1,0
103380,were,0,0
103381,0.44,0,0
103382,ng/mL/h,0,0
103383,(,0,0
103384,14.60,0,0
103385,%,0,0
103386,),0,0
103387,",",0,0
103388,1.09,0,0
103389,h,0,0
103390,(,0,0
103391,-1,0,0
103392,),0,0
103393,(,0,0
103394,15.14,0,0
103395,%,0,0
103396,),0,0
103397,and,0,0
103398,5.15,0,0
103399,ng/mL,0,0
103400,(,0,0
103401,16.16,0,0
103402,%,0,0
103403,),0,0
103404,",",0,0
103405,respectively,0,0
103406,",",0,0
103407,for,0,0
103408,wheal,0,1
103409,inhibition,0,1
103410,",",0,0
103411,and,0,0
103412,11.10,0,0
103413,ng/mL/h,0,0
103414,(,0,0
103415,8.48,0,0
103416,%,0,0
103417,),0,0
103418,",",0,0
103419,1.03,0,0
103420,h,0,0
103421,(,0,0
103422,-1,0,0
103423,),0,0
103424,(,0,0
103425,8.35,0,0
103426,%,0,0
103427,),0,0
103428,and,0,0
103429,1.25,0,0
103430,ng/mL,0,0
103431,(,0,0
103432,14.56,0,0
103433,%,0,0
103434,),0,0
103435,",",0,0
103436,respectively,0,0
103437,",",0,0
103438,for,0,0
103439,flare,0,1
103440,inhibition,0,1
103441,.,0,0
103442,The,0,0
103443,simulation,0,0
103444,results,0,0
103445,revealed,0,0
103446,that,0,0
103447,bilastine,1,0
103448,plasma,1,1
103449,concentrations,1,1
103450,do,0,0
103451,not,0,0
103452,remain,0,0
103453,over,0,0
103454,the,0,0
103455,IC,0,1
103456,(,0,0
103457,50,0,0
103458,),0,0
103459,value,0,0
103460,throughout,0,0
103461,the,0,0
103462,inter-dose,0,1
103463,period,0,0
103464,for,0,0
103465,doses,0,0
103466,of,0,0
103467,5,0,0
103468,and,0,0
103469,10,0,0
103470,mg,0,0
103471,.,0,0
103472,However,0,0
103473,",",0,0
103474,with,0,0
103475,a,0,0
103476,dose,0,0
103477,of,0,0
103478,20,0,0
103479,mg,0,0
103480,of,0,0
103481,bilastine,0,0
103482,administered,0,0
103483,every,0,0
103484,24,0,0
103485,hours,0,0
103486,",",0,0
103487,plasma,1,1
103488,concentrations,1,1
103489,remained,0,0
103490,over,0,0
103491,the,0,0
103492,IC,0,1
103493,(,0,0
103494,50,0,0
103495,),0,0
103496,value,0,0
103497,during,0,0
103498,the,0,0
103499,considered,0,0
103500,period,0,0
103501,for,0,0
103502,the,0,0
103503,flare,0,1
103504,effect,0,1
103505,",",0,1
103506,and,0,0
103507,up,0,0
103508,to,0,0
103509,20,0,0
103510,hours,0,0
103511,for,0,0
103512,the,0,0
103513,wheal,0,1
103514,effect,0,0
103515,.,0,0
103516,CONCLUSION,0,0
103517,Pharmacokinetic,0,1
103518,and,0,1
103519,pharmacodynamic,0,1
103520,relationships,0,1
103521,of,0,1
103522,bilastine,0,0
103523,were,0,0
103524,reliably,0,0
103525,described,0,0
103526,with,0,0
103527,the,0,0
103528,use,0,0
103529,of,0,0
103530,an,0,0
103531,indirect,0,0
103532,response,0,1
103533,pharmacodynamic,0,1
103534,model,0,0
103535,;,0,0
103536,this,0,0
103537,led,0,0
103538,to,0,0
103539,an,0,0
103540,accurate,0,1
103541,prediction,0,0
103542,of,0,0
103543,the,0,0
103544,pharmacodynamic,0,1
103545,activity,0,1
103546,of,0,0
103547,bilastine,0,0
103548,.,0,0
103549,Qigong,0,0
103550,massage,0,0
103551,treatment,0,0
103552,for,0,0
103553,sensory,1,1
103554,and,1,1
103555,self-regulation,1,1
103556,problems,1,1
103557,in,0,0
103558,young,0,0
103559,children,0,0
103560,with,0,0
103561,autism,0,0
103562,:,0,0
103563,a,0,0
103564,randomized,0,0
103565,controlled,0,0
103566,trial,0,0
103567,.,0,0
103568,Autism,0,0
103569,is,0,0
103570,commonly,0,0
103571,associated,0,0
103572,with,0,0
103573,sensory,1,1
103574,and,1,1
103575,self-regulatory,1,0
103576,disturbances,1,1
103577,.,1,0
103578,This,0,0
103579,article,0,0
103580,presents,0,0
103581,a,0,0
103582,randomized,0,0
103583,controlled,0,0
103584,study,0,0
103585,evaluating,0,0
103586,the,0,0
103587,effect,0,0
103588,of,0,0
103589,a,0,0
103590,5-month,0,0
103591,intervention,0,0
103592,directed,0,0
103593,toward,0,0
103594,improving,0,1
103595,sensory,1,1
103596,impairment,1,1
103597,",",1,1
103598,digestion,1,1
103599,",",1,1
103600,and,1,1
103601,sleep,1,1
103602,in,0,0
103603,46,0,0
103604,children,0,0
103605,with,0,0
103606,autism,0,0
103607,<,0,0
103608,age,0,0
103609,6,0,0
103610,.,0,0
103611,The,0,0
103612,intervention,0,0
103613,",",0,0
103614,Qigong,0,0
103615,Sensory,0,1
103616,Training,0,1
103617,(,0,1
103618,QST,0,0
103619,),0,0
103620,",",0,0
103621,is,0,0
103622,a,0,0
103623,qigong,0,0
103624,massage,0,0
103625,intervention,0,0
103626,based,0,0
103627,in,0,0
103628,Chinese,0,0
103629,medicine,0,0
103630,.,0,0
103631,It,0,0
103632,is,0,0
103633,two-pronged,0,0
103634,:,0,0
103635,Trainers,0,0
103636,work,0,1
103637,with,0,0
103638,children,0,0
103639,directly,0,0
103640,20,0,0
103641,times,0,0
103642,over,0,0
103643,5,0,0
103644,months,0,0
103645,",",0,0
103646,and,0,0
103647,parents,0,0
103648,give,0,0
103649,the,0,0
103650,massage,0,0
103651,daily,0,0
103652,to,0,0
103653,their,0,0
103654,children,0,0
103655,.,0,1
103656,Improvement,0,1
103657,was,0,0
103658,evaluated,0,0
103659,in,0,0
103660,two,0,0
103661,settings,0,0
103662,--,0,0
103663,preschool,0,0
103664,and,0,0
103665,home,0,0
103666,--,0,1
103667,by,0,0
103668,teachers,0,0
103669,(,0,0
103670,blind,0,0
103671,to,0,0
103672,group,0,0
103673,),0,1
103674,and,0,0
103675,parents,0,1
103676,.,0,1
103677,Teacher,0,0
103678,evaluations,0,1
103679,showed,0,0
103680,that,0,0
103681,treated,0,0
103682,children,0,0
103683,had,0,0
103684,significant,0,0
103685,classroom,0,0
103686,improvement,0,1
103687,of,0,1
103688,social,1,1
103689,and,1,1
103690,language,1,1
103691,skills,1,1
103692,and,0,1
103693,reduction,1,1
103694,in,1,0
103695,autistic,1,1
103696,behavior,1,1
103697,compared,0,0
103698,with,0,0
103699,wait-list,0,0
103700,control,0,0
103701,participants,0,0
103702,.,0,0
103703,These,0,0
103704,findings,0,0
103705,were,0,0
103706,confirmed,0,0
103707,by,0,0
103708,parent,0,1
103709,data,0,0
103710,",",0,0
103711,indicating,0,0
103712,that,0,0
103713,the,0,0
103714,gains,1,1
103715,had,0,0
103716,generalized,0,0
103717,across,0,0
103718,contexts,0,0
103719,.,0,0
103720,A,0,0
103721,model,0,0
103722,and,0,1
103723,supporting,0,0
103724,data,0,0
103725,for,0,0
103726,understanding,0,1
103727,and,0,1
103728,treating,0,1
103729,sensory,1,1
103730,and,1,1
103731,self-regulation,1,1
103732,problems,1,1
103733,in,0,0
103734,autism,0,0
103735,is,0,0
103736,presented,0,0
103737,.,0,0
103738,[,0,0
103739,Effects,0,0
103740,of,0,0
103741,auditory,0,1
103742,integrative,0,0
103743,training,0,0
103744,on,0,0
103745,autistic,0,0
103746,children,0,0
103747,],0,0
103748,.,0,0
103749,OBJECTIVE,0,0
103750,To,0,0
103751,explore,0,0
103752,the,0,0
103753,short-term,0,0
103754,treatment,0,0
103755,effect,0,1
103756,of,0,0
103757,the,0,0
103758,auditory,0,1
103759,integrative,0,0
103760,training,0,0
103761,on,0,0
103762,autistic,0,1
103763,children,0,0
103764,and,0,0
103765,provide,0,0
103766,them,0,0
103767,with,0,0
103768,clinical,0,0
103769,support,0,0
103770,for,0,0
103771,rehabilitative,0,0
103772,treatment,0,0
103773,.,0,0
103774,METHODS,0,0
103775,A,0,0
103776,total,0,1
103777,of,0,0
103778,81,0,0
103779,cases,0,0
103780,of,0,0
103781,autistic,0,0
103782,children,0,0
103783,were,0,0
103784,selected,0,0
103785,through,0,0
103786,the,0,0
103787,standard,0,0
103788,of,0,1
103789,DSM-4,0,0
103790,and,0,1
103791,clinical,0,1
103792,case,0,0
103793,study,0,0
103794,was,0,0
103795,used,0,0
103796,.,0,0
103797,They,0,0
103798,were,0,0
103799,divided,0,0
103800,randomly,0,0
103801,into,0,0
103802,experimental,0,0
103803,group,0,0
103804,and,0,0
103805,control,0,0
103806,one,0,0
103807,",",0,0
103808,and,0,0
103809,respectively,0,0
103810,received,0,0
103811,auditory,0,1
103812,integrative,0,0
103813,training,0,0
103814,and,0,0
103815,no,0,0
103816,training,0,0
103817,based,0,0
103818,on,0,0
103819,the,0,0
103820,multiple,0,0
103821,therapies,0,0
103822,.,0,0
103823,The,0,0
103824,patients,0,0
103825,were,0,0
103826,investigated,0,0
103827,using,0,0
103828,clinical,1,0
103829,manifestation,1,1
103830,and,0,1
103831,Autism,1,1
103832,Behavior,1,1
103833,Checklist,1,1
103834,(,1,1
103835,ABC,1,1
103836,),1,1
103837,and,0,1
103838,intelligence,1,1
103839,quotient,1,1
103840,(,1,1
103841,IQ,1,1
103842,),1,1
103843,before,0,0
103844,and,0,0
103845,after,0,0
103846,six,0,0
103847,months,0,0
103848,of,0,0
103849,treatment,0,0
103850,.,0,0
103851,The,0,0
103852,effect,0,1
103853,was,0,0
103854,evaluated,0,0
103855,through,0,0
103856,the,0,0
103857,changes,1,1
103858,of,1,0
103859,clinical,1,0
103860,manifestations,1,1
103861,and,0,1
103862,scores,0,1
103863,of,0,1
103864,ABC,1,1
103865,and,0,0
103866,IQ,1,1
103867,.,1,0
103868,The,0,0
103869,changes,0,1
103870,of,0,0
103871,scores,0,1
103872,of,0,1
103873,IQ,1,1
103874,were,0,0
103875,determined,0,0
103876,with,0,0
103877,Gesell,0,0
103878,and,0,1
103879,WPPSI,0,1
103880,or,0,1
103881,WISC-R,0,0
103882,.,0,1
103883,RESULTS,0,0
103884,Compared,0,0
103885,with,0,0
103886,40,0,0
103887,patients,0,0
103888,of,0,0
103889,the,0,0
103890,control,0,0
103891,group,0,0
103892,after,0,0
103893,the,0,0
103894,six,0,0
103895,months,0,0
103896,of,0,0
103897,the,0,0
103898,auditory,0,1
103899,integrative,0,0
103900,training,0,0
103901,",",0,0
103902,41,0,0
103903,of,0,0
103904,the,0,0
103905,experimental,0,0
103906,group,0,0
103907,had,0,0
103908,greatly,1,0
103909,improved,1,0
103910,in,0,0
103911,many,0,0
103912,aspects,0,1
103913,",",0,0
103914,such,0,0
103915,as,0,0
103916,the,0,0
103917,disorders,1,0
103918,of,1,0
103919,their,1,0
103920,language,1,1
103921,",",1,0
103922,social,1,1
103923,interactions,1,1
103924,and,1,1
103925,typical,1,0
103926,behavior,1,1
103927,symptoms,1,1
103928,while,0,0
103929,they,0,0
103930,had,0,0
103931,not,0,0
103932,changed,0,0
103933,in,0,0
103934,their,0,0
103935,abnormal,1,1
103936,behaviors,1,1
103937,.,1,0
103938,The,0,0
103939,scores,1,1
103940,of,1,0
103941,IQ,1,1
103942,or,1,1
103943,DQ,1,1
103944,had,1,0
103945,increased,1,0
103946,and,0,0
103947,scores,0,1
103948,of,0,1
103949,ABC,1,1
103950,had,1,0
103951,dropped,1,0
103952,.,1,0
103953,The,0,0
103954,differences,0,0
103955,between,0,0
103956,the,0,0
103957,two,0,0
103958,groups,0,0
103959,were,0,0
103960,greatly,0,0
103961,significant,0,0
103962,in,0,0
103963,statistics,0,1
103964,(,0,0
103965,P,0,0
103966,<,0,0
103967,0.01,0,0
103968,),0,0
103969,.,0,0
103970,The,0,0
103971,decreasing,1,1
103972,level,1,1
103973,of,1,0
103974,both,1,0
103975,ABC,1,1
103976,scores,1,1
103977,and,1,0
103978,the,1,0
103979,increasing,1,0
103980,level,1,1
103981,of,1,0
103982,the,1,0
103983,IQ,1,1
103984,scores,1,1
103985,were,0,0
103986,negatively,0,0
103987,correlated,0,0
103988,with,0,0
103989,age,0,0
103990,",",0,0
103991,and,0,0
103992,the,0,0
103993,decreasing,1,1
103994,level,1,1
103995,of,1,0
103996,ABC,1,1
103997,scores,1,1
103998,was,0,0
103999,in,0,0
104000,line,0,0
104001,regression,0,1
104002,(,0,1
104003,positive,0,1
104004,correlation,0,0
104005,),0,0
104006,with,0,0
104007,base,0,0
104008,IQ,0,1
104009,.,0,0
104010,CONCLUSION,0,0
104011,The,0,0
104012,treatment,0,0
104013,of,0,0
104014,auditory,0,1
104015,integrative,0,0
104016,training,0,0
104017,(,0,1
104018,AIT,0,0
104019,),0,0
104020,could,0,0
104021,greatly,0,0
104022,improve,0,0
104023,on,0,0
104024,language,1,1
104025,disorders,1,0
104026,",",0,0
104027,the,0,0
104028,difficulties,1,0
104029,of,1,0
104030,social,1,1
104031,interactions,1,1
104032,",",1,1
104033,typical,1,0
104034,behavior,1,1
104035,symptoms,1,1
104036,and,0,1
104037,developmental,1,1
104038,levels,1,1
104039,",",0,0
104040,therefore,0,0
104041,it,0,0
104042,is,0,0
104043,positive,0,0
104044,to,0,0
104045,the,0,0
104046,autistic,0,0
104047,children,0,0
104048,in,0,0
104049,its,0,0
104050,short-term,0,1
104051,treatment,0,0
104052,effect,0,0
104053,.,0,0
104054,A,0,0
104055,good,0,0
104056,response,0,1
104057,to,0,0
104058,oil,0,0
104059,with,0,0
104060,medium-,0,0
104061,and,0,1
104062,long-chain,0,1
104063,fatty,0,1
104064,acids,0,1
104065,in,0,0
104066,body,1,1
104067,fat,1,1
104068,and,0,1
104069,blood,1,1
104070,lipid,1,1
104071,profiles,1,1
104072,of,0,0
104073,male,0,0
104074,hypertriglyceridemic,0,0
104075,subjects,0,0
104076,.,0,0
104077,A,0,0
104078,double,0,0
104079,blind,0,0
104080,clinical,0,1
104081,trial,0,0
104082,was,0,0
104083,carried,0,0
104084,out,0,0
104085,to,0,0
104086,clarify,0,0
104087,the,0,0
104088,effects,0,0
104089,of,0,0
104090,oil,0,0
104091,with,0,0
104092,medium-,0,0
104093,and,0,1
104094,long-chain,0,1
104095,triglyceride,0,1
104096,(,0,1
104097,MLCT,0,0
104098,),0,1
104099,on,0,0
104100,body,1,1
104101,fat,1,1
104102,and,0,1
104103,blood,1,1
104104,lipid,1,1
104105,profiles,1,1
104106,in,0,0
104107,hypertriglyceridemic,0,0
104108,subjects,0,0
104109,.,0,0
104110,One-hundred-and-twelve,0,0
104111,subjects,0,0
104112,were,0,0
104113,enrolled,0,0
104114,and,0,0
104115,divided,0,0
104116,into,0,0
104117,two,0,0
104118,groups,0,0
104119,;,0,0
104120,those,0,0
104121,that,0,0
104122,consumed,0,0
104123,MLCT,0,0
104124,oil,0,0
104125,and,0,0
104126,those,0,0
104127,that,0,0
104128,consumed,0,0
104129,long-chain,0,1
104130,triglyceride,0,1
104131,(,0,1
104132,LCT,0,0
104133,),0,1
104134,oil,0,0
104135,for,0,0
104136,8,0,0
104137,weeks,0,0
104138,.,0,0
104139,All,0,0
104140,subjects,0,0
104141,were,0,0
104142,requested,0,0
104143,to,0,0
104144,consume,0,0
104145,25-30,0,0
104146,g,0,0
104147,of,0,0
104148,the,0,0
104149,oils,0,0
104150,daily,0,0
104151,and,0,0
104152,maintain,0,0
104153,a,0,0
104154,fixed,0,0
104155,level,0,1
104156,of,0,1
104157,energy,0,1
104158,intake,0,1
104159,and,0,1
104160,exercise,0,0
104161,.,0,1
104162,Anthropometric,1,1
104163,and,1,1
104164,blood,1,1
104165,biochemical,1,1
104166,parameters,1,1
104167,were,0,0
104168,measured,0,0
104169,when,0,0
104170,the,0,0
104171,study,0,0
104172,was,0,0
104173,initiated,0,0
104174,and,0,0
104175,completed,0,0
104176,.,0,0
104177,The,0,0
104178,LCT,0,0
104179,group,0,0
104180,consisted,0,0
104181,of,0,0
104182,50,0,0
104183,subjects,0,0
104184,(,0,0
104185,34,0,0
104186,men,0,0
104187,and,0,0
104188,16,0,0
104189,women,0,0
104190,),0,0
104191,",",0,0
104192,while,0,0
104193,the,0,0
104194,MLCT,0,0
104195,group,0,0
104196,consisted,0,0
104197,of,0,0
104198,51,0,0
104199,subjects,0,0
104200,(,0,0
104201,33,0,0
104202,men,0,0
104203,and,0,0
104204,18,0,0
104205,women,0,0
104206,),0,0
104207,who,0,0
104208,completed,0,0
104209,the,0,0
104210,study,0,0
104211,.,0,0
104212,Larger,0,0
104213,decreases,0,1
104214,in,0,0
104215,body,1,1
104216,weight,1,1
104217,",",1,1
104218,body,1,1
104219,mass,1,1
104220,index,1,1
104221,",",1,1
104222,waist,1,1
104223,circumference,1,1
104224,",",1,1
104225,body,1,1
104226,fat,1,1
104227,",",1,1
104228,total,1,1
104229,fat,1,1
104230,area,1,1
104231,and,1,1
104232,subcutaneous,1,0
104233,fat,1,1
104234,area,1,1
104235,in,1,0
104236,the,1,0
104237,abdomen,1,1
104238,and,1,1
104239,serum,1,1
104240,triglycerides,1,1
104241,",",1,1
104242,low-density,1,1
104243,lipoprotein,1,1
104244,cholesterol,1,1
104245,",",1,1
104246,apolipoprotein,1,1
104247,B,1,1
104248,",",1,1
104249,C2,1,1
104250,",",1,1
104251,C3,1,1
104252,and,1,1
104253,E,1,1
104254,were,0,0
104255,observed,0,0
104256,in,0,0
104257,male,0,0
104258,subjects,0,0
104259,in,0,0
104260,the,0,0
104261,MLCT,0,0
104262,group,0,0
104263,than,0,0
104264,those,0,0
104265,in,0,0
104266,the,0,0
104267,LCT,0,0
104268,group,0,0
104269,.,0,0
104270,However,0,0
104271,",",0,0
104272,no,0,0
104273,significant,0,0
104274,differences,0,0
104275,in,0,0
104276,these,1,0
104277,parameters,1,0
104278,between,0,0
104279,the,0,0
104280,female,0,0
104281,subjects,0,0
104282,in,0,0
104283,the,0,0
104284,two,0,0
104285,groups,0,0
104286,were,0,0
104287,observed,0,0
104288,.,0,0
104289,Data,0,0
104290,from,0,0
104291,this,0,0
104292,study,0,0
104293,indicate,0,0
104294,that,0,0
104295,consumption,0,1
104296,of,0,0
104297,medium-and,0,0
104298,long-chain,0,0
104299,triglycerides,0,0
104300,can,0,0
104301,reduce,0,0
104302,body,1,1
104303,weight,1,1
104304,and,0,1
104305,body,1,1
104306,fat,1,1
104307,and,0,1
104308,improve,0,0
104309,blood,1,1
104310,lipid,1,1
104311,profiles,1,1
104312,in,0,0
104313,male,0,0
104314,hypertriglyceridemic,0,0
104315,subjects,0,0
104316,.,0,0
104317,The,0,0
104318,experience,0,0
104319,of,0,0
104320,pleasure,0,1
104321,before,0,0
104322,and,0,1
104323,after,0,0
104324,hearing,0,0
104325,rehabilitation,0,0
104326,.,0,1
104327,Hearing,0,0
104328,loss,0,1
104329,may,0,0
104330,lead,0,0
104331,to,0,0
104332,major,0,1
104333,changes,0,1
104334,in,0,0
104335,the,0,0
104336,social,0,1
104337,and,0,0
104338,emotional,0,1
104339,aspects,0,1
104340,of,0,1
104341,daily,0,0
104342,life,0,1
104343,.,0,0
104344,This,0,0
104345,follow-up,0,0
104346,study,0,0
104347,investigated,0,0
104348,the,0,0
104349,effect,0,1
104350,of,0,1
104351,hearing-aid,0,1
104352,use,0,0
104353,on,0,0
104354,emotional,0,1
104355,experience,0,1
104356,in,0,0
104357,adults,0,0
104358,with,0,0
104359,hearing,0,0
104360,impairment,0,1
104361,.,0,0
104362,Thirteen,0,0
104363,individuals,0,0
104364,with,0,0
104365,impaired,0,1
104366,hearing,0,1
104367,were,0,0
104368,tested,0,0
104369,before,0,0
104370,and,0,0
104371,after,0,0
104372,6,0,0
104373,months,0,0
104374,of,0,0
104375,hearing-aid,0,1
104376,use,0,1
104377,",",0,1
104378,and,0,1
104379,were,0,0
104380,compared,0,0
104381,with,0,0
104382,19,0,0
104383,individuals,0,0
104384,who,0,0
104385,had,0,0
104386,worn,0,0
104387,hearing,0,0
104388,aids,0,0
104389,for,0,0
104390,many,0,0
104391,years,0,0
104392,.,0,0
104393,The,0,0
104394,participants,0,0
104395,reported,0,0
104396,their,0,0
104397,daily,1,0
104398,emotional,1,1
104399,experiences,1,1
104400,",",0,0
104401,by,0,0
104402,completing,0,0
104403,questionnaires,1,0
104404,relating,1,0
104405,to,1,0
104406,sensory,1,1
104407,and,1,1
104408,social,1,1
104409,pleasure,1,1
104410,.,1,0
104411,After,0,0
104412,6,0,0
104413,months,0,0
104414,of,0,0
104415,hearing-aid,0,1
104416,use,0,0
104417,",",0,1
104418,individuals,0,0
104419,experienced,0,1
104420,more,0,0
104421,physical,1,1
104422,and,1,1
104423,social,1,1
104424,pleasure,1,1
104425,",",0,1
104426,whereas,0,0
104427,individuals,0,0
104428,using,0,0
104429,hearing,0,0
104430,aids,0,0
104431,for,0,0
104432,long,0,0
104433,periods,0,0
104434,of,0,1
104435,time,0,1
104436,reported,0,0
104437,similar,0,0
104438,levels,0,1
104439,of,0,0
104440,pleasure,0,1
104441,at,0,0
104442,the,0,0
104443,beginning,0,0
104444,and,0,0
104445,at,0,0
104446,the,0,0
104447,end,0,0
104448,of,0,0
104449,a,0,0
104450,6-month,0,0
104451,interval,0,0
104452,.,0,0
104453,The,0,0
104454,participants,0,0
104455,also,0,0
104456,performed,0,0
104457,a,0,0
104458,visual,0,1
104459,task,0,1
104460,",",0,0
104461,in,0,0
104462,which,0,0
104463,they,0,0
104464,rated,0,0
104465,the,0,0
104466,intensity,1,1
104467,of,1,0
104468,pleasure,1,1
104469,they,1,0
104470,experienced,1,0
104471,in,1,0
104472,response,1,1
104473,to,1,0
104474,emotionally,1,1
104475,positive,1,1
104476,and,1,1
104477,neutral,1,1
104478,pictures,1,1
104479,differing,1,0
104480,in,1,0
104481,luminance,1,1
104482,contrast,1,0
104483,.,1,0
104484,In,0,0
104485,this,0,0
104486,task,0,1
104487,",",0,0
104488,pleasure,0,1
104489,typically,0,0
104490,decreases,0,0
104491,with,0,0
104492,decreasing,0,1
104493,contrast,0,0
104494,of,0,0
104495,the,0,0
104496,positive,0,0
104497,images,0,0
104498,displayed,0,0
104499,.,0,0
104500,Once,0,0
104501,they,0,0
104502,had,0,0
104503,been,0,0
104504,fitted,0,0
104505,with,0,0
104506,hearing,0,0
104507,aids,0,0
104508,",",0,0
104509,the,0,0
104510,participants,0,0
104511,reported,0,0
104512,lower,0,0
104513,levels,1,1
104514,of,1,1
104515,pleasure,1,1
104516,",",0,0
104517,especially,0,0
104518,at,0,0
104519,low,0,0
104520,contrast,0,0
104521,.,0,0
104522,These,0,0
104523,findings,0,0
104524,highlight,0,0
104525,that,0,0
104526,the,0,0
104527,anhedonia,1,0
104528,scales,1,1
104529,provide,0,0
104530,a,0,0
104531,measure,0,0
104532,sensitive,0,0
104533,to,0,0
104534,emotional,0,1
104535,improvements,0,0
104536,that,0,0
104537,accompany,0,0
104538,the,0,0
104539,partial,0,1
104540,restoration,0,1
104541,of,0,1
104542,hearing,0,1
104543,function,0,1
104544,",",0,0
104545,although,0,0
104546,these,0,0
104547,scales,0,1
104548,were,0,0
104549,not,0,0
104550,specifically,0,0
104551,designed,0,0
104552,for,0,0
104553,hearing-impaired,0,0
104554,populations,0,0
104555,.,0,0
104556,In,0,0
104557,contrast,0,0
104558,",",0,0
104559,the,0,0
104560,surprising,0,0
104561,decrease,0,1
104562,in,0,0
104563,pleasure,0,1
104564,ratings,0,1
104565,for,0,0
104566,pictures,0,0
104567,after,0,0
104568,the,0,0
104569,introduction,0,0
104570,of,0,0
104571,hearing-aid,0,1
104572,use,0,0
104573,may,0,0
104574,be,0,0
104575,because,0,0
104576,of,0,0
104577,the,0,0
104578,compensation,0,0
104579,of,0,0
104580,hearing,0,1
104581,loss,0,1
104582,by,0,0
104583,changes,0,1
104584,in,0,0
104585,visual,0,1
104586,attention,0,1
104587,functions,0,1
104588,.,0,0
104589,Efficacy,0,1
104590,and,0,1
104591,long-term,0,1
104592,tolerability,0,1
104593,of,0,1
104594,sublingual,0,1
104595,fentanyl,0,0
104596,orally,0,0
104597,disintegrating,0,0
104598,tablet,0,0
104599,in,0,0
104600,the,0,0
104601,treatment,0,0
104602,of,0,1
104603,breakthrough,0,1
104604,cancer,0,0
104605,pain,0,1
104606,.,0,1
104607,BACKGROUND,0,0
104608,AND,0,0
104609,OBJECTIVES,0,1
104610,Breakthrough,0,1
104611,cancer,0,1
104612,pain,0,1
104613,(,0,1
104614,BTcP,0,1
104615,),0,0
104616,represents,0,0
104617,an,0,0
104618,important,0,0
104619,clinical,0,0
104620,challenge,0,0
104621,in,0,0
104622,the,0,0
104623,care,0,0
104624,of,0,0
104625,patients,0,0
104626,with,0,0
104627,cancer,0,0
104628,.,0,0
104629,This,0,0
104630,trial,0,0
104631,evaluated,0,0
104632,the,0,0
104633,efficacy,0,1
104634,and,0,1
104635,long-term,0,1
104636,tolerability,0,1
104637,of,0,0
104638,a,0,0
104639,sublingual,0,1
104640,formulation,0,0
104641,of,0,0
104642,the,0,0
104643,fast-acting,0,0
104644,opioid,0,0
104645,fentanyl,0,0
104646,",",0,0
104647,for,0,0
104648,the,0,0
104649,treatment,0,0
104650,of,0,0
104651,BTcP,0,1
104652,in,0,0
104653,opioid-tolerant,0,0
104654,patients,0,0
104655,with,0,0
104656,cancer,0,0
104657,.,0,0
104658,RESEARCH,0,0
104659,DESIGN,0,0
104660,AND,0,0
104661,METHODS,0,0
104662,This,0,0
104663,was,0,0
104664,a,0,0
104665,randomized,0,0
104666,",",0,0
104667,placebo-controlled,0,0
104668,",",0,1
104669,multi-center,0,0
104670,",",0,1
104671,phase,0,0
104672,III,0,1
104673,trial,0,0
104674,",",0,0
104675,conducted,0,0
104676,in,0,0
104677,opioid-tolerant,0,0
104678,male,0,0
104679,and,0,1
104680,female,0,0
104681,patients,0,0
104682,(,0,0
104683,aged,0,0
104684,>,0,0
104685,or,0,0
104686,=17,0,0
104687,years,0,0
104688,),0,0
104689,with,0,0
104690,BTcP,0,1
104691,.,0,0
104692,The,0,0
104693,study,0,0
104694,was,0,0
104695,conducted,0,0
104696,at,0,0
104697,36,0,0
104698,centers,0,0
104699,across,0,0
104700,the,0,0
104701,USA,0,0
104702,.,0,0
104703,The,0,0
104704,study,0,0
104705,comprised,0,0
104706,a,0,0
104707,2-week,0,0
104708,open-label,0,0
104709,titration,0,0
104710,phase,0,0
104711,",",0,1
104712,followed,0,0
104713,by,0,0
104714,a,0,0
104715,double-blind,0,0
104716,efficacy,0,1
104717,phase,0,0
104718,",",0,0
104719,during,0,0
104720,which,0,0
104721,patients,0,0
104722,received,0,0
104723,sublingual,0,1
104724,fentanyl,0,0
104725,citrate,0,0
104726,orally,0,0
104727,disintegrating,0,0
104728,tablet,0,0
104729,(,0,0
104730,sublingual,0,1
104731,fentanyl,0,0
104732,ODT,0,0
104733,),0,1
104734,or,0,1
104735,placebo,0,0
104736,",",0,0
104737,in,0,0
104738,a,0,0
104739,random,0,0
104740,order,0,0
104741,.,0,0
104742,The,0,0
104743,primary,0,0
104744,efficacy,0,1
104745,endpoint,0,1
104746,was,0,0
104747,the,0,0
104748,sum,1,1
104749,of,1,1
104750,pain,1,1
104751,intensity,1,1
104752,difference,1,1
104753,(,1,1
104754,SPID,1,1
104755,),1,0
104756,over,1,0
104757,30,1,0
104758,min,1,0
104759,post-administration,1,0
104760,.,1,1
104761,Secondary,0,0
104762,efficacy,0,1
104763,endpoints,0,1
104764,included,0,0
104765,pain,1,1
104766,intensity,1,1
104767,difference,1,1
104768,(,1,1
104769,PID,1,1
104770,),1,1
104771,and,1,1
104772,pain,1,1
104773,relief,1,1
104774,(,1,1
104775,PR,1,1
104776,),1,0
104777,throughout,0,0
104778,the,0,0
104779,60-min,0,0
104780,post-dose,0,1
104781,assessment,0,0
104782,period,0,0
104783,.,0,1
104784,Following,0,1
104785,efficacy,0,1
104786,evaluation,0,0
104787,",",0,1
104788,patients,0,0
104789,entered,0,0
104790,a,0,0
104791,long-term,1,1
104792,safety,1,1
104793,phase,1,0
104794,of,1,0
104795,up,1,0
104796,to,1,0
104797,12,1,0
104798,months,1,0
104799,.,1,0
104800,Adverse,1,1
104801,events,1,1
104802,were,0,0
104803,recorded,0,0
104804,throughout,0,0
104805,the,0,0
104806,study,0,0
104807,.,0,0
104808,[,0,0
104809,CLINICAL,0,0
104810,TRIAL,0,0
104811,REGISTRATION,0,0
104812,NCT00262678,0,0
104813,],0,0
104814,RESULTS,0,0
104815,A,0,0
104816,total,0,1
104817,of,0,0
104818,131,0,0
104819,patients,0,0
104820,entered,0,0
104821,the,0,0
104822,titration,0,0
104823,phase,0,0
104824,",",0,0
104825,of,0,0
104826,whom,0,0
104827,61,0,0
104828,were,0,0
104829,included,0,0
104830,in,0,0
104831,the,0,0
104832,primary,0,0
104833,efficacy,0,1
104834,analysis,0,0
104835,.,0,1
104836,Sublingual,0,0
104837,fentanyl,0,0
104838,ODT,0,0
104839,provided,0,0
104840,significant,0,0
104841,improvements,0,1
104842,in,0,0
104843,SPID,1,0
104844,relative,0,0
104845,to,0,0
104846,placebo,0,0
104847,at,0,0
104848,30,0,0
104849,min,0,0
104850,(,0,0
104851,49.5,0,0
104852,vs.,0,0
104853,36.6,0,0
104854,",",0,0
104855,p,0,0
104856,=,0,0
104857,0.0004,0,0
104858,),0,0
104859,and,0,0
104860,60,0,0
104861,min,0,0
104862,post-administration,0,0
104863,(,0,0
104864,143.0,0,0
104865,vs.,0,0
104866,104.5,0,0
104867,",",0,0
104868,p,0,0
104869,=,0,0
104870,0.0002,0,0
104871,),0,0
104872,.,0,0
104873,Furthermore,0,0
104874,",",0,0
104875,sublingual,0,1
104876,fentanyl,0,0
104877,ODT,0,0
104878,provided,0,0
104879,significant,0,0
104880,improvements,0,1
104881,in,0,0
104882,PID,1,0
104883,and,1,1
104884,PR,1,1
104885,compared,0,0
104886,to,0,0
104887,placebo,0,0
104888,",",0,0
104889,from,0,0
104890,10,0,0
104891,min,0,0
104892,post-dose,0,0
104893,(,0,0
104894,p,0,0
104895,=,0,0
104896,0.0055,0,0
104897,and,0,0
104898,p,0,0
104899,=,0,0
104900,0.049,0,0
104901,for,0,0
104902,PID,0,0
104903,and,0,1
104904,PR,0,1
104905,",",0,1
104906,respectively,0,0
104907,),0,0
104908,.,0,0
104909,Patient,0,1
104910,recruitment,0,1
104911,was,0,0
104912,stopped,0,0
104913,early,0,0
104914,",",0,0
104915,due,0,0
104916,to,0,0
104917,positive,0,1
104918,interim,0,0
104919,analysis,0,0
104920,results,0,0
104921,(,0,0
104922,significant,0,0
104923,at,0,0
104924,prespecified,0,1
104925,level,0,1
104926,",",0,1
104927,p,0,0
104928,<,0,0
104929,or,0,0
104930,=,0,0
104931,0.0414,0,0
104932,),0,0
104933,.,0,0
104934,Overall,0,0
104935,",",0,0
104936,sublingual,0,1
104937,fentanyl,0,0
104938,ODT,0,0
104939,was,0,0
104940,well-tolerated,1,0
104941,both,1,0
104942,systemically,1,0
104943,and,1,0
104944,sublingually,1,0
104945,",",0,0
104946,with,0,0
104947,41,0,0
104948,patients,0,0
104949,experiencing,0,0
104950,>,0,1
104951,or,0,1
104952,=1,0,0
104953,study,0,0
104954,drug-related,1,1
104955,adverse,1,1
104956,event,1,1
104957,(,0,1
104958,AE,0,1
104959,),0,0
104960,.,0,0
104961,The,0,0
104962,most,0,0
104963,common,0,0
104964,AEs,0,1
104965,included,0,0
104966,nausea,1,1
104967,(,0,0
104968,12.2,0,0
104969,%,0,0
104970,),0,0
104971,",",0,1
104972,vomiting,1,1
104973,(,0,0
104974,5.3,0,0
104975,%,0,0
104976,),0,0
104977,and,0,1
104978,somnolence,1,1
104979,(,0,0
104980,4.6,0,0
104981,%,0,0
104982,),0,0
104983,.,0,0
104984,One,0,0
104985,serious,1,0
104986,AE,1,0
104987,(,1,0
104988,mild,1,0
104989,affect,1,1
104990,lability,1,1
104991,),1,1
104992,was,0,0
104993,considered,0,0
104994,possibly,0,0
104995,related,0,0
104996,to,0,0
104997,study,0,0
104998,medication,0,0
104999,.,0,0
105000,The,0,0
105001,observed,0,0
105002,pattern,0,0
105003,of,0,1
105004,AEs,0,1
105005,was,0,0
105006,consistent,0,0
105007,with,0,0
105008,that,0,0
105009,previously,0,0
105010,observed,0,0
105011,with,0,0
105012,fentanyl,0,0
105013,.,0,0
105014,CONCLUSIONS,0,0
105015,Sublingual,0,0
105016,fentanyl,0,0
105017,ODT,0,0
105018,was,0,0
105019,efficacious,0,0
105020,and,0,1
105021,well-tolerated,0,0
105022,for,0,0
105023,the,0,0
105024,treatment,0,0
105025,of,0,0
105026,BTcP,0,1
105027,in,0,0
105028,opioid-tolerant,0,0
105029,patients,0,0
105030,with,0,0
105031,cancer,0,0
105032,.,0,0
105033,Sublingual,0,0
105034,fentanyl,0,0
105035,ODT,0,0
105036,provided,0,0
105037,significant,0,0
105038,improvements,0,1
105039,in,0,0
105040,pain,0,1
105041,intensity,0,1
105042,compared,0,0
105043,to,0,0
105044,placebo,0,0
105045,",",0,0
105046,from,0,0
105047,10,0,0
105048,min,0,0
105049,post-administration,0,0
105050,and,0,0
105051,throughout,0,0
105052,the,0,0
105053,60-min,0,0
105054,post-dose,0,1
105055,assessment,0,0
105056,period,0,0
105057,.,0,1
105058,Sublingual,0,0
105059,fentanyl,0,0
105060,ODT,0,0
105061,was,0,0
105062,well,0,0
105063,tolerated,0,1
105064,over,0,0
105065,12,0,0
105066,months,0,0
105067,of,0,0
105068,treatment,0,0
105069,.,0,0
105070,Comparison,0,0
105071,of,0,1
105072,fluid,0,1
105073,types,0,0
105074,for,0,0
105075,resuscitation,0,0
105076,after,0,0
105077,acute,1,0
105078,blood,1,1
105079,loss,1,1
105080,in,0,0
105081,mallard,0,0
105082,ducks,0,0
105083,(,0,1
105084,Anas,0,1
105085,platyrhynchos,0,0
105086,),0,0
105087,.,0,0
105088,OBJECTIVE,0,0
105089,The,0,0
105090,purpose,0,0
105091,of,0,0
105092,this,0,0
105093,study,0,0
105094,was,0,0
105095,to,0,0
105096,determine,0,0
105097,the,0,0
105098,LD,0,0
105099,(,0,0
105100,50,0,0
105101,),0,0
105102,for,0,0
105103,acute,0,0
105104,blood,0,1
105105,loss,0,1
105106,in,0,0
105107,mallard,0,0
105108,ducks,0,0
105109,(,0,1
105110,Anas,0,1
105111,platyrhynchos,0,0
105112,),0,0
105113,",",0,0
105114,compare,0,0
105115,the,0,0
105116,mortality,0,1
105117,rate,0,1
105118,among,0,0
105119,3,0,0
105120,fluid,0,1
105121,resuscitation,0,0
105122,groups,0,0
105123,",",0,0
105124,and,0,0
105125,determine,0,0
105126,the,0,0
105127,time,0,1
105128,required,0,0
105129,for,0,0
105130,a,0,0
105131,regenerative,0,0
105132,RBC,0,1
105133,response,0,1
105134,.,0,1
105135,DESIGN,0,0
105136,Prospective,0,0
105137,study,0,0
105138,.,0,1
105139,SETTING,0,0
105140,Medical,0,0
105141,College,0,0
105142,of,0,1
105143,Wisconsin,0,0
105144,Research,0,0
105145,facility,0,1
105146,.,0,1
105147,ANIMALS,0,1
105148,Eighteen,0,1
105149,mallard,0,0
105150,ducks,0,0
105151,were,0,0
105152,included,0,0
105153,for,0,0
105154,the,0,0
105155,LD,0,0
105156,(,0,0
105157,50,0,0
105158,),0,0
105159,study,0,0
105160,and,0,0
105161,28,0,0
105162,for,0,0
105163,the,0,0
105164,fluid,0,1
105165,resuscitation,0,0
105166,study,0,0
105167,.,0,1
105168,INTERVENTIONS,0,1
105169,Phlebotomy,0,0
105170,was,0,0
105171,performed,0,0
105172,during,0,0
105173,both,0,0
105174,the,0,0
105175,LD,0,0
105176,(,0,0
105177,50,0,0
105178,),0,0
105179,and,0,0
105180,fluid,0,1
105181,resuscitation,0,0
105182,studies,0,0
105183,.,0,0
105184,Ducks,0,0
105185,in,0,0
105186,the,0,0
105187,fluid,0,1
105188,resuscitation,0,1
105189,study,0,0
105190,received,0,0
105191,a,0,0
105192,5,0,0
105193,mL/kg,0,0
105194,intravenous,0,0
105195,bolus,0,0
105196,of,0,1
105197,crystalloids,0,0
105198,",",0,1
105199,hetastarch,0,0
105200,(,0,1
105201,HES,0,1
105202,),0,1
105203,",",0,0
105204,or,0,0
105205,a,0,0
105206,hemoglobin-based,0,1
105207,oxygen-carrying,0,1
105208,solution,0,1
105209,(,0,1
105210,HBOCS,0,1
105211,),0,0
105212,.,0,0
105213,MEASUREMENTS,0,0
105214,AND,0,0
105215,MAIN,0,0
105216,RESULTS,0,0
105217,The,0,0
105218,LD,0,0
105219,(,0,0
105220,50,0,0
105221,),0,0
105222,for,0,0
105223,acute,1,0
105224,blood,1,1
105225,loss,1,1
105226,was,0,0
105227,60,0,0
105228,%,0,0
105229,of,0,0
105230,total,1,1
105231,blood,1,1
105232,volume,1,1
105233,.,1,0
105234,This,0,0
105235,blood,0,1
105236,volume,0,1
105237,was,0,0
105238,removed,0,0
105239,in,0,0
105240,the,0,0
105241,fluid,0,1
105242,resuscitation,0,0
105243,study,0,0
105244,to,0,0
105245,create,0,0
105246,a,0,0
105247,model,0,0
105248,of,0,0
105249,acute,0,0
105250,blood,0,1
105251,loss,0,1
105252,.,0,0
105253,Following,0,1
105254,fluid,0,1
105255,administration,0,0
105256,",",0,0
105257,6,0,0
105258,birds,0,0
105259,in,0,0
105260,the,0,0
105261,crystalloid,0,0
105262,group,0,0
105263,(,0,0
105264,66,0,0
105265,%,0,0
105266,),0,0
105267,",",0,0
105268,4,0,0
105269,birds,0,0
105270,in,0,0
105271,the,0,0
105272,HES,0,1
105273,group,0,0
105274,(,0,0
105275,40,0,0
105276,%,0,0
105277,),0,0
105278,",",0,0
105279,and,0,0
105280,2,0,0
105281,birds,0,0
105282,in,0,0
105283,the,0,0
105284,HBOCS,0,1
105285,group,0,0
105286,(,0,0
105287,20,0,0
105288,%,0,0
105289,),0,0
105290,died,0,1
105291,.,0,0
105292,No,0,1
105293,statistical,0,1
105294,difference,0,0
105295,in,0,0
105296,mortality,1,1
105297,rate,1,1
105298,was,0,0
105299,seen,0,0
105300,among,0,0
105301,the,0,0
105302,3,0,0
105303,fluid,0,0
105304,resuscitation,0,0
105305,groups,0,0
105306,.,0,1
105307,Relative,0,0
105308,polychromasia,0,1
105309,evaluated,0,0
105310,post-phlebotomy,0,1
105311,demonstrated,0,0
105312,regeneration,0,1
105313,starting,0,0
105314,at,0,0
105315,24,0,0
105316,hours,0,0
105317,and,0,0
105318,continuing,0,0
105319,through,0,0
105320,48,0,0
105321,hours,0,0
105322,.,0,0
105323,CONCLUSIONS,0,0
105324,The,0,0
105325,LD,0,0
105326,(,0,0
105327,50,0,0
105328,),0,0
105329,for,0,0
105330,acute,1,0
105331,blood,1,1
105332,loss,1,1
105333,in,0,0
105334,mallard,0,0
105335,ducks,0,0
105336,was,0,0
105337,60,0,0
105338,%,0,0
105339,of,0,0
105340,their,0,0
105341,total,0,1
105342,blood,0,1
105343,volume,0,1
105344,.,0,0
105345,Although,0,0
105346,no,0,0
105347,statistical,0,0
105348,difference,0,0
105349,in,0,0
105350,mortality,1,1
105351,rate,1,1
105352,was,0,0
105353,appreciated,0,0
105354,among,0,0
105355,the,0,0
105356,3,0,0
105357,fluid,0,0
105358,resuscitation,0,0
105359,groups,0,0
105360,",",0,0
105361,a,0,0
105362,trend,0,0
105363,of,0,0
105364,decreased,0,1
105365,mortality,1,1
105366,rate,1,1
105367,was,0,0
105368,observed,0,0
105369,in,0,0
105370,the,0,0
105371,HBOCS,0,1
105372,group,0,0
105373,.,0,0
105374,An,0,0
105375,early,0,0
105376,regenerative,0,1
105377,response,0,1
105378,was,0,0
105379,apparent,0,0
105380,following,0,0
105381,acute,1,0
105382,blood,1,1
105383,loss,1,1
105384,.,1,0
105385,Treatment,0,0
105386,of,0,1
105387,beta-hemolytic,0,1
105388,streptococcal,0,0
105389,pharyngitis,0,0
105390,with,0,0
105391,cefaclor,0,0
105392,or,0,0
105393,penicillin,0,0
105394,.,0,1
105395,Efficacy,0,1
105396,and,0,1
105397,interaction,0,1
105398,with,0,0
105399,beta-lactamase-producing,0,1
105400,organisms,0,0
105401,in,0,0
105402,the,0,0
105403,pharynx,0,0
105404,.,0,0
105405,The,0,0
105406,recommended,0,0
105407,treatment,0,0
105408,for,0,0
105409,group,0,0
105410,A,0,0
105411,beta-hemolytic,0,1
105412,streptococcal,0,0
105413,pharyngitis,0,0
105414,has,0,0
105415,continued,0,0
105416,to,0,0
105417,be,0,0
105418,penicillin,0,0
105419,given,0,0
105420,in,0,0
105421,parenteral,0,0
105422,or,0,0
105423,oral,0,0
105424,form,0,0
105425,.,0,0
105426,Treatment,1,0
105427,failures,1,1
105428,",",0,0
105429,as,0,0
105430,determined,0,0
105431,by,0,0
105432,the,0,0
105433,continued,0,0
105434,presence,0,0
105435,of,0,0
105436,the,0,0
105437,streptococcal,0,0
105438,organism,0,0
105439,in,0,0
105440,the,0,0
105441,pharynx,0,1
105442,",",0,0
105443,however,0,0
105444,",",0,0
105445,do,0,0
105446,occur,0,0
105447,in,0,0
105448,6,0,0
105449,%,0,0
105450,to,0,0
105451,25,0,0
105452,%,0,0
105453,of,0,0
105454,patients,0,0
105455,treated,0,0
105456,with,0,0
105457,penicillin,0,0
105458,.,0,0
105459,Furthermore,0,0
105460,",",0,0
105461,beta-lactamase,0,1
105462,produced,0,0
105463,by,0,0
105464,other,0,0
105465,bacteria,0,1
105466,in,0,0
105467,the,0,0
105468,pharynx,0,0
105469,could,0,0
105470,potentially,0,0
105471,inactivate,0,0
105472,the,0,0
105473,penicillin,0,0
105474,",",0,0
105475,resulting,0,0
105476,in,0,0
105477,increased,0,0
105478,treatment,1,0
105479,failures,1,1
105480,or,1,1
105481,infection,1,1
105482,relapses,1,1
105483,.,1,0
105484,A,0,0
105485,study,0,0
105486,was,0,0
105487,undertaken,0,0
105488,to,0,0
105489,compare,0,0
105490,the,0,0
105491,efficacy,0,1
105492,of,0,1
105493,cefaclor,0,0
105494,",",0,0
105495,which,0,0
105496,is,0,0
105497,relatively,0,0
105498,resistant,0,0
105499,to,0,0
105500,inactivation,0,1
105501,by,0,0
105502,beta-lactamase,0,1
105503,",",0,0
105504,with,0,0
105505,penicillin,0,0
105506,for,0,0
105507,eradicating,0,0
105508,the,0,0
105509,group,0,0
105510,A,0,0
105511,beta-hemolytic,0,1
105512,streptococcal,0,0
105513,organism,0,0
105514,from,0,0
105515,the,0,0
105516,throats,0,0
105517,of,0,0
105518,93,0,0
105519,patients,0,0
105520,with,0,0
105521,pharyngitis,0,0
105522,.,0,0
105523,Additionally,0,0
105524,",",0,0
105525,extensive,0,0
105526,cultures,0,1
105527,for,0,0
105528,potential,0,0
105529,beta-lactamase-producing,0,1
105530,organisms,0,0
105531,were,0,0
105532,conducted,0,0
105533,on,0,0
105534,37,0,0
105535,patients,0,0
105536,;,0,0
105537,27,0,0
105538,%,0,0
105539,of,0,0
105540,these,0,0
105541,had,0,0
105542,one,0,0
105543,or,0,0
105544,more,0,0
105545,pharyngeal,0,1
105546,organisms,0,1
105547,that,0,0
105548,were,0,0
105549,producing,0,0
105550,beta-lactamase,0,1
105551,.,0,0
105552,No,0,0
105553,statistically,0,0
105554,significant,0,0
105555,difference,0,0
105556,was,0,0
105557,found,0,0
105558,between,0,0
105559,the,0,0
105560,clinical,1,0
105561,responses,1,1
105562,or,1,0
105563,the,1,0
105564,bacteriological,1,1
105565,cure,1,1
105566,rates,1,1
105567,of,0,0
105568,those,0,0
105569,treated,0,0
105570,with,0,0
105571,cefaclor,0,0
105572,and,0,0
105573,those,0,0
105574,treated,0,0
105575,with,0,0
105576,penicillin,0,0
105577,when,0,0
105578,stratified,0,0
105579,by,0,0
105580,the,0,0
105581,presence,0,0
105582,or,0,0
105583,absence,0,0
105584,of,0,1
105585,beta-lactamase-producing,0,1
105586,organisms,0,0
105587,.,0,0
105588,The,0,0
105589,prevalence,1,1
105590,of,1,0
105591,beta-lactamase-producing,1,1
105592,organisms,1,0
105593,in,1,0
105594,the,1,0
105595,pharynx,1,1
105596,",",0,0
105597,however,0,0
105598,",",0,0
105599,was,0,0
105600,increased,0,0
105601,after,0,0
105602,treatment,0,0
105603,with,0,0
105604,penicillin,0,0
105605,",",0,0
105606,whereas,0,0
105607,no,0,0
105608,change,0,1
105609,was,0,0
105610,noted,0,1
105611,following,0,0
105612,treatment,1,0
105613,with,1,0
105614,cefaclor,1,0
105615,.,1,0
105616,Conjugated,0,0
105617,equine,0,0
105618,estrogen,0,1
105619,influence,0,1
105620,on,0,0
105621,mammographic,1,1
105622,density,1,1
105623,in,0,0
105624,postmenopausal,0,0
105625,women,0,0
105626,in,0,0
105627,a,0,0
105628,substudy,0,0
105629,of,0,0
105630,the,0,0
105631,women,0,0
105632,'s,0,1
105633,health,0,1
105634,initiative,0,1
105635,randomized,0,0
105636,trial,0,0
105637,.,0,0
105638,PURPOSE,0,0
105639,Increased,0,1
105640,mammographic,1,1
105641,density,1,1
105642,is,0,0
105643,associated,0,0
105644,with,0,0
105645,increased,0,0
105646,breast,0,0
105647,cancer,0,1
105648,risk,0,1
105649,and,0,1
105650,reduced,0,1
105651,sensitivity,0,1
105652,of,0,1
105653,screening,0,0
105654,mammography,0,0
105655,and,0,0
105656,is,0,0
105657,related,0,0
105658,to,0,0
105659,hormone,0,0
105660,exposure,0,0
105661,.,0,0
105662,However,0,0
105663,",",0,0
105664,the,0,0
105665,effects,0,1
105666,of,0,0
105667,conjugated,0,1
105668,equine,0,0
105669,estrogens,0,1
105670,(,0,1
105671,CEEs,0,0
105672,),0,0
105673,alone,0,0
105674,on,0,0
105675,mammographic,1,1
105676,density,1,1
105677,in,0,0
105678,diverse,0,0
105679,racial/ethnic,0,0
105680,populations,0,0
105681,are,0,0
105682,not,0,0
105683,established,0,0
105684,.,0,0
105685,We,0,0
105686,examined,0,0
105687,the,0,0
105688,effect,0,1
105689,of,0,0
105690,CEE,0,0
105691,alone,0,0
105692,on,0,0
105693,mammographic,1,1
105694,density,1,1
105695,in,0,0
105696,a,0,0
105697,subsample,0,0
105698,of,0,0
105699,the,0,0
105700,Women,0,1
105701,'s,0,1
105702,Health,0,1
105703,Initiative,0,1
105704,(,0,1
105705,WHI,0,1
105706,),0,1
105707,clinical,0,0
105708,trial,0,0
105709,participants,0,0
105710,.,0,1
105711,PATIENTS,0,0
105712,AND,0,0
105713,METHODS,0,0
105714,In,0,0
105715,the,0,0
105716,WHI,0,1
105717,trial,0,0
105718,",",0,1
105719,women,0,0
105720,were,0,0
105721,randomly,0,0
105722,assigned,0,0
105723,to,0,0
105724,daily,0,0
105725,CEE,0,0
105726,0.625,0,0
105727,mg,0,0
105728,or,0,0
105729,placebo,0,0
105730,.,0,0
105731,The,0,0
105732,effect,0,0
105733,of,0,0
105734,CEE,0,0
105735,on,0,0
105736,mammographic,1,1
105737,percent,1,1
105738,density,1,1
105739,was,0,0
105740,determined,0,0
105741,over,0,0
105742,1,0,0
105743,and,0,0
105744,2,0,0
105745,years,0,0
105746,in,0,0
105747,a,0,0
105748,stratified,0,0
105749,random,0,0
105750,sample,0,0
105751,of,0,0
105752,435,0,0
105753,racially,0,0
105754,and,0,0
105755,ethnically,0,0
105756,diverse,0,0
105757,participants,0,0
105758,from,0,0
105759,15,0,0
105760,of,0,0
105761,40,0,0
105762,WHI,0,0
105763,clinics,0,0
105764,.,0,0
105765,RESULTS,0,0
105766,Use,0,0
105767,of,0,1
105768,CEE,0,0
105769,resulted,0,0
105770,in,0,0
105771,mean,0,1
105772,increase,0,1
105773,in,0,0
105774,mammographic,1,1
105775,percent,1,1
105776,density,1,1
105777,of,0,0
105778,1.6,0,0
105779,percentage,0,1
105780,points,0,0
105781,(,0,0
105782,95,0,0
105783,%,0,0
105784,CI,0,0
105785,",",0,0
105786,0.8,0,0
105787,to,0,0
105788,2.4,0,0
105789,),0,0
105790,at,0,0
105791,year,0,0
105792,1,0,0
105793,compared,0,0
105794,with,0,0
105795,a,0,0
105796,mean,0,1
105797,decrease,0,0
105798,of,0,0
105799,1.0,0,0
105800,percentage,0,1
105801,point,0,0
105802,(,0,0
105803,95,0,0
105804,%,0,0
105805,CI,0,0
105806,",",0,0
105807,-1.7,0,0
105808,to,0,0
105809,-0.4,0,0
105810,),0,0
105811,in,0,0
105812,the,0,0
105813,placebo,0,0
105814,group,0,0
105815,(,0,1
105816,P,0,0
105817,<,0,0
105818,.001,0,0
105819,),0,0
105820,.,0,0
105821,The,0,0
105822,effect,0,1
105823,persisted,0,0
105824,for,0,0
105825,2,0,0
105826,years,0,0
105827,",",0,0
105828,with,0,0
105829,a,0,0
105830,mean,0,1
105831,increase,0,0
105832,of,0,0
105833,1.7,0,0
105834,percentage,0,1
105835,points,0,0
105836,(,0,0
105837,95,0,0
105838,%,0,0
105839,CI,0,0
105840,",",0,0
105841,0.7,0,0
105842,to,0,0
105843,2.7,0,0
105844,),0,0
105845,versus,0,0
105846,a,0,0
105847,mean,0,1
105848,decrease,0,0
105849,of,0,0
105850,1.2,0,0
105851,percentage,0,1
105852,points,0,0
105853,(,0,0
105854,95,0,0
105855,%,0,0
105856,CI,0,0
105857,",",0,0
105858,-1.8,0,0
105859,to,0,0
105860,-0.5,0,0
105861,;,0,0
105862,P,0,0
105863,<,0,0
105864,.001,0,0
105865,),0,0
105866,in,0,0
105867,the,0,0
105868,hormone,0,1
105869,and,0,1
105870,placebo,0,0
105871,groups,0,0
105872,",",0,0
105873,respectively,0,0
105874,.,0,0
105875,These,0,0
105876,effects,0,1
105877,were,0,0
105878,greater,0,0
105879,in,0,0
105880,women,0,0
105881,age,0,0
105882,60,0,0
105883,to,0,0
105884,79,0,0
105885,years,0,0
105886,(,0,0
105887,P,0,0
105888,=,0,0
105889,.03,0,0
105890,for,0,0
105891,interaction,0,1
105892,across,0,0
105893,age,0,0
105894,),0,0
105895,.,0,0
105896,CONCLUSION,0,0
105897,Use,0,0
105898,of,0,1
105899,CEE,0,0
105900,results,0,0
105901,in,0,0
105902,a,0,0
105903,modest,0,0
105904,but,0,0
105905,statistically,0,0
105906,significant,0,0
105907,increase,0,1
105908,in,0,0
105909,mammographic,1,1
105910,density,1,1
105911,that,0,0
105912,is,0,0
105913,sustained,0,0
105914,over,0,0
105915,at,0,0
105916,least,0,0
105917,a,0,0
105918,2-year,0,0
105919,period,0,0
105920,.,0,0
105921,The,0,0
105922,clinical,0,0
105923,significance,0,0
105924,of,0,0
105925,the,0,0
105926,CEE,0,0
105927,effect,0,1
105928,on,0,0
105929,mammographic,1,1
105930,density,1,1
105931,remains,0,0
105932,to,0,0
105933,be,0,0
105934,determined,0,0
105935,.,0,0
105936,Conservative,0,0
105937,surgery,0,0
105938,with,0,0
105939,and,0,1
105940,without,0,0
105941,radiotherapy,0,0
105942,in,0,0
105943,elderly,0,0
105944,patients,0,0
105945,with,0,0
105946,early-stage,0,0
105947,breast,0,0
105948,cancer,0,0
105949,:,0,0
105950,a,0,0
105951,prospective,0,0
105952,randomised,0,0
105953,multicentre,0,0
105954,trial,0,0
105955,.,0,0
105956,Breast,0,1
105957,conserving,0,0
105958,therapy,0,0
105959,(,0,1
105960,BCT,0,0
105961,),0,0
105962,including,0,0
105963,postoperative,0,1
105964,irradiation,0,0
105965,of,0,0
105966,the,0,0
105967,remaining,0,0
105968,breast,0,0
105969,tissue,0,0
105970,is,0,0
105971,generally,0,0
105972,accepted,0,0
105973,as,0,0
105974,the,0,0
105975,best,0,0
105976,treatment,0,0
105977,for,0,0
105978,the,0,0
105979,majority,0,0
105980,of,0,0
105981,patients,0,0
105982,with,0,0
105983,early-stage,0,0
105984,breast,0,0
105985,cancer,0,0
105986,.,0,0
105987,The,0,0
105988,question,0,0
105989,is,0,0
105990,whether,0,0
105991,there,0,0
105992,is,0,0
105993,a,0,0
105994,necessity,0,0
105995,for,0,0
105996,irradiating,0,0
105997,all,0,0
105998,patients,0,0
105999,.,0,0
106000,Between,0,0
106001,2001,0,0
106002,and,0,0
106003,2005,0,0
106004,",",0,0
106005,749,0,0
106006,women,0,0
106007,aged,0,0
106008,55-75,0,0
106009,years,0,0
106010,with,0,0
106011,infiltrating,0,0
106012,breast,0,0
106013,carcinoma,0,0
106014,were,0,0
106015,randomly,0,0
106016,assigned,0,0
106017,to,0,0
106018,breast,0,0
106019,conservative,0,0
106020,surgery,0,0
106021,",",0,1
106022,with,0,0
106023,or,0,1
106024,without,0,0
106025,radiotherapy,0,0
106026,(,0,1
106027,RT,0,0
106028,),0,0
106029,",",0,0
106030,to,0,0
106031,evaluate,0,0
106032,the,0,0
106033,incidence,1,1
106034,of,1,0
106035,in-breast,1,1
106036,recurrence,1,1
106037,(,1,1
106038,IBR,1,1
106039,),1,0
106040,.,1,0
106041,After,0,0
106042,5,0,0
106043,years,0,0
106044,of,0,0
106045,median,0,1
106046,follow-up,0,0
106047,",",0,0
106048,the,0,0
106049,cumulative,1,1
106050,incidence,1,1
106051,of,1,1
106052,IBR,1,1
106053,was,0,0
106054,2.5,0,0
106055,%,0,0
106056,in,0,0
106057,the,0,0
106058,surgery-only,0,0
106059,arm,0,0
106060,and,0,0
106061,0.7,0,0
106062,%,0,0
106063,in,0,0
106064,the,0,0
106065,surgery,0,0
106066,plus,0,0
106067,RT,0,0
106068,arm,0,0
106069,.,0,0
106070,There,0,0
106071,are,0,0
106072,no,1,0
106073,differences,1,0
106074,in,0,0
106075,terms,0,1
106076,of,0,0
106077,overall,1,1
106078,survival,1,1
106079,and,1,1
106080,distant,1,1
106081,disease-free,1,1
106082,survival,1,1
106083,.,1,0
106084,The,0,0
106085,preliminary,0,0
106086,evaluation,0,0
106087,suggests,0,0
106088,that,0,0
106089,breast,0,0
106090,irradiation,0,0
106091,after,0,0
106092,conservative,0,0
106093,surgery,0,0
106094,can,0,0
106095,be,0,0
106096,avoided,0,0
106097,without,0,0
106098,exposing,0,0
106099,these,0,0
106100,patients,0,0
106101,to,0,0
106102,an,0,0
106103,increased,0,0
106104,risk,1,0
106105,of,1,0
106106,distant-disease,1,0
106107,recurrence,1,1
106108,.,1,0
106109,Prolonged,0,0
106110,follow-up,0,0
106111,will,0,0
106112,further,0,0
106113,clarify,0,0
106114,the,0,0
106115,possible,0,0
106116,risks,0,1
106117,and,0,1
106118,late,0,1
106119,sequelae,0,1
106120,potentially,0,0
106121,induced,0,0
106122,by,0,0
106123,breast,0,0
106124,RT,0,0
106125,.,0,0
106126,The,0,0
106127,role,0,0
106128,of,0,0
106129,ethnic,0,0
106130,matching,0,0
106131,between,0,0
106132,patient,0,1
106133,and,0,1
106134,provider,0,1
106135,on,0,0
106136,the,0,0
106137,effectiveness,1,1
106138,of,0,1
106139,brief,0,0
106140,alcohol,0,1
106141,interventions,0,0
106142,with,0,0
106143,Hispanics,0,0
106144,.,0,0
106145,BACKGROUND,0,0
106146,Evaluating,0,0
106147,the,0,0
106148,effectiveness,0,0
106149,of,0,0
106150,treatments,0,0
106151,such,0,0
106152,as,0,0
106153,brief,0,0
106154,alcohol,0,1
106155,interventions,0,0
106156,among,0,0
106157,Hispanics,0,0
106158,is,0,0
106159,essential,0,0
106160,to,0,0
106161,effectively,0,0
106162,addressing,0,0
106163,their,0,0
106164,treatment,0,0
106165,needs,0,0
106166,.,0,0
106167,Clinicians,0,0
106168,of,0,0
106169,the,0,0
106170,same,0,0
106171,ethnicity,0,0
106172,as,0,0
106173,the,0,0
106174,client,0,0
106175,may,0,0
106176,be,0,0
106177,more,0,0
106178,likely,0,0
106179,to,0,0
106180,understand,0,0
106181,the,0,0
106182,culture-specific,0,0
106183,values,0,1
106184,",",0,1
106185,norms,0,1
106186,",",0,1
106187,and,0,1
106188,attitudes,0,1
106189,and,0,1
106190,",",0,1
106191,therefore,0,0
106192,",",0,0
106193,the,0,0
106194,intervention,0,0
106195,may,0,0
106196,be,0,0
106197,more,0,0
106198,effective,0,1
106199,.,0,0
106200,Thus,0,1
106201,",",0,0
106202,in,0,0
106203,cases,0,0
106204,in,0,0
106205,which,0,0
106206,Hispanic,0,0
106207,patients,0,0
106208,were,0,0
106209,provided,0,0
106210,intervention,0,0
106211,by,0,0
106212,a,0,0
106213,Hispanic,0,0
106214,clinician,0,0
106215,improved,0,1
106216,drinking,0,1
106217,outcomes,0,1
106218,were,0,0
106219,expected,0,0
106220,.,0,0
106221,METHODS,0,0
106222,Patients,0,0
106223,were,0,0
106224,recruited,0,0
106225,from,0,0
106226,an,0,0
106227,urban,0,0
106228,Level,0,0
106229,I,0,0
106230,Trauma,0,0
106231,following,0,0
106232,screening,0,0
106233,for,0,0
106234,an,0,0
106235,alcohol-related,0,1
106236,injury,0,1
106237,or,0,1
106238,alcohol,0,1
106239,problems,0,1
106240,.,0,0
106241,Five,0,0
106242,hundred,0,0
106243,thirty-seven,0,0
106244,Hispanics,0,0
106245,were,0,0
106246,randomly,0,0
106247,assigned,0,0
106248,to,0,0
106249,brief,0,0
106250,intervention,0,0
106251,or,0,1
106252,treatment,0,0
106253,as,0,0
106254,usual,0,0
106255,.,0,0
106256,Hierarchical,0,1
106257,linear,0,0
106258,modeling,0,0
106259,was,0,0
106260,used,0,0
106261,to,0,0
106262,determine,0,0
106263,the,0,0
106264,effects,1,0
106265,of,1,0
106266,ethnic,1,0
106267,match,1,0
106268,on,1,0
106269,drinking,1,0
106270,outcomes,1,1
106271,including,0,0
106272,volume,1,1
106273,per,1,1
106274,week,1,0
106275,",",1,1
106276,maximum,1,1
106277,amount,1,1
106278,",",1,1
106279,and,1,1
106280,frequency,1,1
106281,of,1,0
106282,5,1,0
106283,or,1,0
106284,more,1,0
106285,drinks,1,1
106286,per,1,0
106287,occasion,1,0
106288,.,1,1
106289,Analyses,0,0
106290,controlled,0,0
106291,for,0,0
106292,level,0,1
106293,of,0,1
106294,acculturation,0,1
106295,and,0,1
106296,immigration,0,1
106297,status,0,1
106298,.,0,1
106299,RESULTS,0,0
106300,For,0,0
106301,Hispanics,0,0
106302,who,0,0
106303,received,0,0
106304,brief,0,0
106305,motivational,0,0
106306,intervention,0,0
106307,",",0,0
106308,an,0,0
106309,ethnic,0,0
106310,match,0,0
106311,between,0,0
106312,patient,0,1
106313,and,0,1
106314,provider,0,1
106315,resulted,0,0
106316,in,0,0
106317,a,0,0
106318,significant,1,0
106319,reduction,1,1
106320,in,1,0
106321,drinking,1,0
106322,outcomes,1,1
106323,at,0,0
106324,12-month,0,0
106325,follow-up,0,0
106326,.,0,0
106327,In,0,0
106328,addition,0,0
106329,",",0,0
106330,there,0,0
106331,was,0,0
106332,a,0,0
106333,tendency,0,0
106334,for,0,0
106335,ethnic,0,0
106336,match,0,0
106337,to,0,0
106338,be,0,0
106339,most,1,0
106340,beneficial,1,0
106341,to,0,0
106342,foreign-born,0,0
106343,Hispanics,0,0
106344,and,0,0
106345,less,1,0
106346,acculturated,0,1
106347,Hispanics,0,0
106348,.,0,0
106349,CONCLUSION,0,0
106350,As,0,0
106351,hypothesized,0,0
106352,",",0,0
106353,an,0,0
106354,ethnic,0,0
106355,match,0,0
106356,between,0,0
106357,patient,0,1
106358,and,0,1
106359,provider,0,1
106360,significantly,0,0
106361,enhanced,0,0
106362,the,0,0
106363,effectiveness,1,1
106364,of,1,0
106365,brief,1,0
106366,intervention,1,0
106367,among,0,0
106368,Hispanics,0,0
106369,.,0,0
106370,Ethnic,0,0
106371,concordance,0,1
106372,between,0,0
106373,patient,0,1
106374,and,0,0
106375,provider,0,0
106376,may,0,0
106377,have,0,0
106378,impacted,0,0
106379,the,0,0
106380,effectiveness,1,0
106381,of,0,0
106382,the,0,0
106383,intervention,0,0
106384,through,0,0
106385,several,0,0
106386,mechanisms,0,0
106387,including,0,0
106388,cultural,0,1
106389,scripts,0,0
106390,",",0,0
106391,ethnic-specific,0,0
106392,perceptions,0,0
106393,pertaining,0,0
106394,to,0,0
106395,substance,0,1
106396,abuse,0,1
106397,",",0,1
106398,and,0,1
106399,ethnic-specific,0,1
106400,preferred,0,0
106401,channels,0,1
106402,of,0,0
106403,communication,0,0
106404,.,0,0
106405,Different,0,1
106406,therapeutic,0,0
106407,modalities,0,0
106408,for,0,0
106409,treatment,0,0
106410,of,0,0
106411,melasma,1,0
106412,.,1,0
106413,BACKGROUND,0,0
106414,Chemical,0,1
106415,peels,0,0
106416,and,0,1
106417,topical,0,0
106418,depigmenting,0,1
106419,agents,0,0
106420,have,0,0
106421,become,0,0
106422,a,0,0
106423,popular,0,0
106424,modality,0,0
106425,in,0,0
106426,the,0,0
106427,treatment,0,0
106428,of,0,0
106429,melasma,1,0
106430,.,1,0
106431,AIMS,0,0
106432,To,0,0
106433,compare,0,0
106434,the,0,0
106435,clinical,1,0
106436,efficacy,1,1
106437,of,0,1
106438,trichloroacetic,0,0
106439,acid,0,0
106440,peel,0,0
106441,20,0,0
106442,%,0,0
106443,vs,0,0
106444,.,0,1
106445,Jessner,0,1
106446,'s,0,1
106447,solution,0,0
106448,peel,0,0
106449,vs.,0,0
106450,the,0,0
106451,topical,0,0
106452,mixture,0,0
106453,of,0,0
106454,hydroquinone,0,0
106455,2,0,0
106456,%,0,0
106457,and,0,0
106458,kojic,0,1
106459,acid,0,1
106460,.,0,1
106461,PATIENTS,0,0
106462,AND,0,0
106463,METHODS,0,0
106464,Forty,0,0
106465,five,0,0
106466,patients,0,0
106467,with,0,0
106468,melasma,0,0
106469,were,0,0
106470,randomly,0,0
106471,assigned,0,0
106472,into,0,0
106473,three,0,0
106474,groups,0,0
106475,of,0,0
106476,fifteen,0,0
106477,patients,0,0
106478,each,0,0
106479,.,0,0
106480,Group,0,0
106481,A,0,0
106482,received,0,0
106483,Jessner,0,1
106484,'s,0,1
106485,solution,0,1
106486,peel,0,1
106487,",",0,1
106488,group,0,0
106489,B,0,1
106490,received,0,0
106491,trichloroacetic,0,0
106492,acid,0,0
106493,peel,0,0
106494,20,0,0
106495,%,0,0
106496,",",0,0
106497,and,0,1
106498,group,0,0
106499,C,0,1
106500,received,0,0
106501,topical,0,0
106502,hydroquinone,0,0
106503,2,0,0
106504,%,0,0
106505,and,0,0
106506,kojic,0,1
106507,acid,0,0
106508,.,0,0
106509,All,0,0
106510,patients,0,0
106511,were,0,0
106512,seen,0,0
106513,in,0,0
106514,follow-up,0,0
106515,period,0,0
106516,after,0,0
106517,16,0,0
106518,weeks,0,0
106519,;,0,0
106520,clinical,0,0
106521,evaluation,0,0
106522,using,0,0
106523,Melasma,1,1
106524,Area,1,1
106525,and,1,1
106526,Severity,1,1
106527,Index,1,1
106528,(,1,1
106529,MASI,1,1
106530,),1,1
106531,score,1,1
106532,and,1,1
106533,photography,1,0
106534,were,0,0
106535,recorded,0,0
106536,before,0,0
106537,and,0,0
106538,after,0,0
106539,treatment,0,0
106540,and,0,0
106541,after,0,0
106542,16,0,0
106543,weeks,0,0
106544,.,0,0
106545,RESULTS,0,0
106546,There,0,0
106547,was,0,0
106548,a,0,0
106549,decrease,0,1
106550,in,0,0
106551,MASI,1,0
106552,score,1,1
106553,in,0,0
106554,all,0,0
106555,three,0,0
106556,groups,0,0
106557,after,0,0
106558,treatment,0,0
106559,and,0,1
106560,after,0,0
106561,follow-up,0,0
106562,period,0,0
106563,but,0,0
106564,after,0,0
106565,treatment,0,0
106566,MASI,1,1
106567,score,1,1
106568,was,0,0
106569,statistically,0,0
106570,significantly,0,0
106571,lower,0,0
106572,in,0,0
106573,group,0,0
106574,A,0,0
106575,than,0,0
106576,group,0,0
106577,C,0,0
106578,(,0,0
106579,P,0,0
106580,=,0,0
106581,0.01,0,0
106582,),0,0
106583,",",0,0
106584,and,0,1
106585,it,0,0
106586,was,0,0
106587,also,0,0
106588,statistically,0,0
106589,significantly,0,0
106590,lower,0,0
106591,in,0,0
106592,group,0,0
106593,B,0,0
106594,than,0,0
106595,group,0,0
106596,C,0,0
106597,(,0,0
106598,P,0,0
106599,<,0,0
106600,0.001,0,0
106601,),0,0
106602,but,0,0
106603,there,0,0
106604,was,0,0
106605,no,0,0
106606,statistically,0,0
106607,significant,0,0
106608,difference,0,0
106609,between,0,0
106610,groups,0,0
106611,A,0,0
106612,and,0,0
106613,B,0,0
106614,.,0,0
106615,After,0,0
106616,the,0,0
106617,follow-up,0,0
106618,period,0,0
106619,",",0,1
106620,MASI,1,1
106621,score,1,1
106622,was,0,0
106623,statistically,0,0
106624,significantly,0,0
106625,lower,0,0
106626,in,0,0
106627,group,0,0
106628,A,0,0
106629,than,0,0
106630,group,0,0
106631,C,0,0
106632,(,0,0
106633,P,0,0
106634,<,0,0
106635,0.001,0,0
106636,),0,0
106637,",",0,0
106638,statistically,0,0
106639,significantly,0,0
106640,lower,0,0
106641,in,0,0
106642,group,0,0
106643,B,0,0
106644,than,0,0
106645,group,0,0
106646,C,0,0
106647,(,0,0
106648,P,0,0
106649,<,0,0
106650,0.001,0,0
106651,),0,0
106652,",",0,0
106653,and,0,1
106654,statistically,0,0
106655,significantly,0,0
106656,lower,0,0
106657,in,0,0
106658,group,0,0
106659,B,0,0
106660,than,0,0
106661,group,0,0
106662,A,0,0
106663,(,0,0
106664,P,0,0
106665,=,0,0
106666,0.035,0,0
106667,),0,0
106668,.,0,0
106669,The,0,0
106670,statistical,0,0
106671,analysis,0,0
106672,was,0,0
106673,done,0,0
106674,through,0,0
106675,one-way,0,0
106676,anova,0,0
106677,followed,0,0
106678,by,0,0
106679,least,0,0
106680,significant,0,0
106681,difference,0,0
106682,(,0,1
106683,LSD,0,1
106684,),0,0
106685,.,0,0
106686,CONCLUSION,0,0
106687,Trichloroacetic,0,0
106688,acid,0,0
106689,20,0,0
106690,%,0,0
106691,showed,0,0
106692,better,0,0
106693,results,0,0
106694,than,0,0
106695,Jessner,0,1
106696,'s,0,1
106697,solution,0,0
106698,as,0,0
106699,peeling,0,1
106700,agent,0,0
106701,and,0,0
106702,hydroquinone,0,0
106703,2,0,0
106704,%,0,0
106705,with,0,0
106706,kojic,0,0
106707,acid,0,0
106708,as,0,0
106709,a,0,0
106710,topical,0,0
106711,agent,0,0
106712,in,0,0
106713,the,0,0
106714,treatment,1,0
106715,of,1,0
106716,melasma,1,0
106717,.,1,0
106718,A,0,0
106719,prospective,0,0
106720,",",0,0
106721,randomized,0,0
106722,trial,0,0
106723,of,0,1
106724,nerve,0,1
106725,monitoring,0,0
106726,of,0,0
106727,the,0,0
106728,external,0,0
106729,branch,0,0
106730,of,0,0
106731,the,0,0
106732,superior,0,1
106733,laryngeal,0,0
106734,nerve,0,1
106735,during,0,0
106736,thyroidectomy,0,0
106737,under,0,0
106738,local/regional,0,1
106739,anesthesia,0,0
106740,and,0,1
106741,IV,0,1
106742,sedation,0,1
106743,.,0,0
106744,BACKGROUND,0,0
106745,The,0,0
106746,aim,0,0
106747,of,0,0
106748,this,0,0
106749,study,0,0
106750,was,0,0
106751,to,0,0
106752,assess,0,0
106753,the,0,0
106754,impact,0,0
106755,of,0,0
106756,the,0,0
106757,neuromonitoring,0,0
106758,of,0,0
106759,the,0,0
106760,external,0,0
106761,branch,0,0
106762,of,0,0
106763,the,0,0
106764,superior,0,1
106765,laryngeal,0,1
106766,nerve,0,1
106767,(,0,1
106768,EBSLN,0,0
106769,),0,0
106770,on,0,0
106771,the,0,0
106772,voice,1,0
106773,quality,1,1
106774,after,0,0
106775,mini-incision,0,0
106776,thyroidectomy,0,0
106777,under,0,0
106778,local/regional,0,1
106779,anesthesia,0,0
106780,and,0,1
106781,intravenous,0,0
106782,sedation,0,1
106783,.,0,0
106784,METHODS,0,0
106785,Patients,0,0
106786,undergoing,0,0
106787,mini-incision,0,0
106788,thyroidectomy,0,0
106789,under,0,0
106790,local,0,1
106791,anesthesia,0,0
106792,were,0,0
106793,prospectively,0,0
106794,randomized,0,0
106795,for,0,0
106796,either,0,0
106797,nerve,0,1
106798,monitoring,0,0
106799,of,0,0
106800,the,0,0
106801,EBSLN,0,0
106802,(,0,0
106803,group,0,0
106804,1,0,0
106805,),0,0
106806,or,0,0
106807,no,0,0
106808,nerve,0,1
106809,monitoring,0,0
106810,(,0,0
106811,group,0,0
106812,2,0,0
106813,),0,0
106814,.,0,0
106815,Voice,1,0
106816,and,1,1
106817,swallowing,1,1
106818,assessment,0,1
106819,were,0,0
106820,obtained,0,0
106821,by,0,0
106822,using,0,0
106823,the,0,0
106824,Voice,1,0
106825,Handicap,1,1
106826,Index-10,1,1
106827,(,1,1
106828,VHI-10,1,1
106829,),1,0
106830,and,1,0
106831,the,1,0
106832,Reflux,1,0
106833,Symptom,1,1
106834,Index,1,1
106835,questionnaires,1,1
106836,(,1,1
106837,RSI,1,1
106838,),1,1
106839,before,0,0
106840,surgery,0,0
106841,and,0,0
106842,at,0,0
106843,3,0,0
106844,weeks,0,0
106845,and,0,0
106846,3,0,0
106847,months,0,0
106848,after,0,0
106849,surgery,0,0
106850,.,0,0
106851,RESULTS,0,0
106852,Recruitment,0,1
106853,led,0,0
106854,to,0,0
106855,22,0,0
106856,patients,0,0
106857,in,0,0
106858,group,0,0
106859,1,0,0
106860,and,0,0
106861,25,0,0
106862,patients,0,0
106863,in,0,0
106864,group,0,0
106865,2,0,0
106866,.,0,0
106867,The,0,0
106868,rate,1,1
106869,of,1,0
106870,visualized,1,1
106871,EBSLN,1,0
106872,was,0,0
106873,higher,0,0
106874,in,0,0
106875,group,0,0
106876,1,0,0
106877,(,0,0
106878,66,0,0
106879,%,0,0
106880,vs,0,0
106881,21,0,0
106882,%,0,0
106883,;,0,0
106884,P,0,0
106885,=,0,0
106886,.003,0,0
106887,),0,0
106888,.,0,0
106889,Contrary,0,0
106890,to,0,0
106891,group,0,0
106892,1,0,0
106893,",",0,0
106894,in,0,0
106895,group,0,0
106896,2,0,0
106897,",",0,0
106898,the,0,0
106899,median,1,1
106900,total,1,1
106901,VHI-10,1,0
106902,score,1,1
106903,was,0,0
106904,significantly,0,0
106905,higher,0,0
106906,3,0,0
106907,months,0,0
106908,after,0,0
106909,surgery,0,0
106910,(,0,0
106911,P,0,0
106912,=,0,0
106913,.034,0,0
106914,),0,0
106915,compared,0,0
106916,with,0,0
106917,preoperatively,0,0
106918,",",0,0
106919,indicating,0,0
106920,a,0,0
106921,subjective,0,1
106922,voice,0,0
106923,handicap,0,1
106924,.,0,0
106925,In,0,0
106926,both,0,0
106927,groups,0,0
106928,",",0,0
106929,there,0,0
106930,was,0,0
106931,no,0,0
106932,difference,0,0
106933,in,0,0
106934,median,1,1
106935,total,1,1
106936,RSI,1,1
106937,score,1,1
106938,before,0,0
106939,surgery,0,0
106940,or,0,0
106941,at,0,0
106942,3,0,0
106943,weeks,0,0
106944,and,0,0
106945,3,0,0
106946,months,0,0
106947,after,0,0
106948,surgery,0,0
106949,.,0,0
106950,CONCLUSION,0,0
106951,Nerve,0,1
106952,monitoring,0,0
106953,aids,0,0
106954,in,0,0
106955,the,0,0
106956,visualization,0,0
106957,of,0,0
106958,the,0,0
106959,EBSLN,1,0
106960,during,0,0
106961,mini-incision,0,0
106962,thyroidectomy,0,0
106963,under,0,0
106964,local/regional,0,1
106965,anesthesia,0,0
106966,and,0,0
106967,leads,0,0
106968,to,0,0
106969,an,0,0
106970,improvement,0,1
106971,in,0,0
106972,patient-assessed,0,1
106973,voice,1,1
106974,quality,1,1
106975,after,0,0
106976,surgery,0,0
106977,but,0,0
106978,does,0,0
106979,not,0,0
106980,impact,0,0
106981,swallowing,1,1
106982,.,1,0
106983,Rituximab,0,0
106984,plus,0,0
106985,concurrent,0,0
106986,infusional,0,1
106987,EPOCH,0,0
106988,chemotherapy,0,0
106989,is,0,0
106990,highly,0,0
106991,effective,0,0
106992,in,0,0
106993,HIV-associated,0,1
106994,B-cell,0,1
106995,non-Hodgkin,0,0
106996,lymphoma,0,0
106997,.,0,1
106998,Rituximab,0,0
106999,plus,0,0
107000,intravenous,0,0
107001,bolus,0,0
107002,chemotherapy,0,0
107003,is,0,0
107004,a,0,0
107005,standard,0,0
107006,treatment,0,0
107007,for,0,0
107008,immunocompetent,0,0
107009,patients,0,0
107010,with,0,0
107011,B-cell,0,1
107012,non-Hodgkin,0,0
107013,lymphoma,0,1
107014,(,0,1
107015,NHL,0,1
107016,),0,0
107017,.,0,0
107018,Some,0,0
107019,studies,0,0
107020,have,0,0
107021,suggested,0,0
107022,that,0,0
107023,rituximab,0,0
107024,is,0,0
107025,associated,0,0
107026,with,0,0
107027,excessive,1,0
107028,toxicity,1,1
107029,in,0,0
107030,HIV-associated,0,1
107031,NHL,0,1
107032,",",0,1
107033,and,0,1
107034,that,0,0
107035,infusional,0,0
107036,chemotherapy,0,0
107037,may,0,0
107038,be,0,0
107039,more,0,0
107040,effective,0,1
107041,.,0,0
107042,We,0,0
107043,performed,0,0
107044,a,0,0
107045,randomized,0,0
107046,phase,0,0
107047,2,0,0
107048,trial,0,0
107049,of,0,0
107050,rituximab,0,0
107051,(,0,0
107052,375,0,0
107053,mg/m,0,0
107054,(,0,0
107055,2,0,0
107056,),0,0
107057,),0,0
107058,given,0,0
107059,either,0,0
107060,concurrently,0,0
107061,before,0,0
107062,each,0,0
107063,infusional,0,0
107064,etoposide,0,0
107065,",",0,1
107066,vincristine,0,0
107067,",",0,1
107068,doxorubicin,0,0
107069,",",0,1
107070,cyclophosphamide,0,0
107071,",",0,1
107072,and,0,1
107073,prednisone,0,0
107074,(,0,1
107075,EPOCH,0,1
107076,),0,1
107077,chemotherapy,0,0
107078,cycle,0,1
107079,or,0,1
107080,sequentially,0,0
107081,(,0,0
107082,weekly,0,0
107083,for,0,0
107084,6,0,0
107085,weeks,0,0
107086,),0,0
107087,after,0,0
107088,completion,0,0
107089,of,0,0
107090,all,0,0
107091,chemotherapy,0,0
107092,in,0,0
107093,HIV-associated,0,1
107094,NHL,0,1
107095,.,0,1
107096,EPOCH,0,1
107097,consisted,0,0
107098,of,0,0
107099,a,0,0
107100,96-hour,0,1
107101,intravenous,0,0
107102,infusion,0,0
107103,of,0,1
107104,etoposide,0,0
107105,",",0,1
107106,doxorubicin,0,0
107107,",",0,1
107108,and,0,1
107109,vincristine,0,0
107110,plus,0,0
107111,oral,0,0
107112,prednisone,0,0
107113,followed,0,0
107114,by,0,0
107115,intravenous,0,0
107116,bolus,0,0
107117,cyclophosphamide,0,0
107118,given,0,0
107119,every,0,0
107120,21,0,0
107121,days,0,0
107122,for,0,0
107123,4,0,0
107124,to,0,0
107125,6,0,0
107126,cycles,0,0
107127,.,0,0
107128,In,0,0
107129,the,0,0
107130,concurrent,0,0
107131,arm,0,0
107132,",",0,0
107133,35,0,0
107134,of,0,0
107135,48,0,0
107136,evaluable,0,0
107137,patients,0,0
107138,(,0,0
107139,73,0,0
107140,%,0,0
107141,;,0,0
107142,95,0,0
107143,%,0,0
107144,confidence,0,0
107145,interval,0,0
107146,",",0,0
107147,58,0,0
107148,%,0,0
107149,-85,0,1
107150,%,0,0
107151,),0,0
107152,had,0,0
107153,a,0,0
107154,complete,1,1
107155,response,1,1
107156,.,1,0
107157,In,0,0
107158,the,0,0
107159,sequential,0,0
107160,arm,0,0
107161,",",0,0
107162,29,0,0
107163,of,0,0
107164,53,0,0
107165,evaluable,0,0
107166,patients,0,0
107167,(,0,0
107168,55,0,0
107169,%,0,0
107170,;,0,0
107171,95,0,0
107172,%,0,0
107173,confidence,0,0
107174,interval,0,0
107175,",",0,0
107176,41,0,0
107177,%,0,0
107178,-68,0,0
107179,%,0,0
107180,),0,0
107181,had,0,0
107182,a,0,0
107183,complete,0,1
107184,response,0,1
107185,.,0,0
107186,The,0,0
107187,primary,0,0
107188,efficacy,0,1
107189,endpoint,0,1
107190,was,0,0
107191,met,0,0
107192,for,0,0
107193,the,0,0
107194,concurrent,0,0
107195,arm,0,0
107196,only,0,0
107197,.,0,0
107198,Toxicity,1,1
107199,was,0,0
107200,comparable,0,0
107201,in,0,0
107202,the,0,0
107203,2,0,0
107204,arms,0,0
107205,",",0,0
107206,although,0,0
107207,patients,0,0
107208,with,0,0
107209,a,0,0
107210,baseline,0,0
107211,CD4,1,1
107212,count,0,1
107213,less,0,0
107214,than,0,0
107215,50/microL,0,1
107216,had,0,0
107217,a,0,0
107218,high,0,0
107219,infectious,1,1
107220,death,1,1
107221,rate,1,1
107222,in,0,0
107223,the,0,0
107224,concurrent,0,0
107225,arm,0,0
107226,.,0,0
107227,We,0,0
107228,conclude,0,0
107229,that,0,0
107230,concurrent,0,0
107231,rituximab,0,0
107232,plus,0,0
107233,infusional,0,0
107234,EPOCH,0,0
107235,is,0,0
107236,an,0,0
107237,effective,0,1
107238,regimen,0,0
107239,for,0,0
107240,HIV-associated,0,1
107241,lymphoma,0,0
107242,.,0,0
107243,Randomized,0,0
107244,clinical,0,1
107245,trial,0,0
107246,of,0,1
107247,radiofrequency,0,0
107248,ablation,0,0
107249,or,0,1
107250,conventional,0,0
107251,high,0,1
107252,ligation,0,1
107253,and,0,1
107254,stripping,0,0
107255,for,0,0
107256,great,0,0
107257,saphenous,0,1
107258,varicose,0,0
107259,veins,0,1
107260,.,0,0
107261,BACKGROUND,0,0
107262,This,0,0
107263,randomized,0,0
107264,clinical,0,0
107265,trial,0,0
107266,compared,0,0
107267,early,0,0
107268,outcomes,0,1
107269,after,0,0
107270,radiofrequency,0,0
107271,ablation,0,0
107272,(,0,1
107273,RFA,0,1
107274,),0,1
107275,and,0,1
107276,conventional,0,0
107277,surgery,0,0
107278,for,0,0
107279,varicose,0,0
107280,veins,0,1
107281,.,0,0
107282,METHODS,0,0
107283,Consecutive,0,0
107284,patients,0,0
107285,with,0,0
107286,symptomatic,0,1
107287,varicose,0,1
107288,veins,0,1
107289,due,0,0
107290,to,0,0
107291,isolated,0,0
107292,great,0,0
107293,saphenous,0,1
107294,vein,0,1
107295,(,0,1
107296,GSV,0,1
107297,),0,1
107298,incompetence,0,1
107299,and,0,1
107300,suitable,0,0
107301,for,0,0
107302,RFA,0,1
107303,were,0,0
107304,randomized,0,0
107305,to,0,0
107306,either,0,0
107307,RFA,0,1
107308,or,0,0
107309,conventional,0,0
107310,surgery,0,0
107311,(,0,0
107312,saphenofemoral,0,1
107313,disconnection,0,1
107314,and,0,1
107315,stripping,0,0
107316,),0,1
107317,.,0,0
107318,Clinical,1,1
107319,",",1,0
107320,radiological,1,1
107321,and,1,1
107322,patient-based,1,1
107323,outcomes,1,1
107324,were,0,0
107325,recorded,0,0
107326,at,0,0
107327,1,0,0
107328,and,0,0
107329,5,0,0
107330,weeks,0,0
107331,after,0,0
107332,intervention,0,0
107333,.,0,0
107334,RESULTS,0,0
107335,RFA,0,1
107336,resulted,0,0
107337,in,0,0
107338,successful,0,1
107339,obliteration,0,1
107340,of,0,0
107341,the,0,0
107342,GSV,0,0
107343,in,0,0
107344,all,0,0
107345,47,0,0
107346,patients,0,0
107347,.,0,0
107348,Complete,1,0
107349,above-knee,1,0
107350,stripping,1,0
107351,was,0,0
107352,unsuccessful,0,0
107353,in,0,0
107354,seven,0,0
107355,of,0,0
107356,41,0,0
107357,patients,0,0
107358,.,0,0
107359,RFA,0,1
107360,took,0,0
107361,longer,0,0
107362,than,0,0
107363,conventional,0,0
107364,surgery,0,0
107365,:,0,0
107366,median,0,1
107367,interquartile,0,0
107368,range,0,0
107369,76,0,0
107370,(,0,0
107371,67-84,0,0
107372,),0,0
107373,versus,0,0
107374,48,0,0
107375,(,0,0
107376,39-54,0,0
107377,),0,0
107378,min,0,0
107379,;,0,0
107380,P,0,0
107381,<,0,0
107382,0.001,0,0
107383,.,0,0
107384,Patients,0,0
107385,returned,1,0
107386,to,1,0
107387,their,1,0
107388,normal,1,0
107389,activities,1,1
107390,significantly,0,0
107391,earlier,0,0
107392,after,0,0
107393,RFA,0,1
107394,(,0,0
107395,median,0,1
107396,3,0,0
107397,(,0,0
107398,2-5,0,0
107399,),0,0
107400,versus,0,0
107401,12.5,0,0
107402,(,0,0
107403,4-21,0,0
107404,),0,0
107405,days,0,0
107406,;,0,0
107407,P,0,0
107408,<,0,0
107409,0.001,0,0
107410,),0,0
107411,.,0,0
107412,Postoperative,1,1
107413,pain,1,1
107414,was,0,0
107415,significantly,0,0
107416,less,0,0
107417,after,0,0
107418,RFA,0,1
107419,(,0,0
107420,median,0,1
107421,score,0,1
107422,on,0,0
107423,visual,0,1
107424,analogue,0,1
107425,scale,0,1
107426,1.70,0,0
107427,(,0,0
107428,0.50-4.30,0,0
107429,),0,0
107430,versus,0,0
107431,4.0,0,0
107432,(,0,0
107433,2.35-6.05,0,0
107434,),0,0
107435,;,0,0
107436,P,0,0
107437,=,0,0
107438,0.001,0,0
107439,),0,0
107440,.,0,0
107441,Patient,1,1
107442,satisfaction,1,1
107443,",",1,1
107444,quality,1,1
107445,of,1,1
107446,life,1,1
107447,improvement,1,1
107448,and,1,1
107449,analgesic,1,1
107450,requirements,1,1
107451,significantly,0,0
107452,favoured,0,0
107453,RFA,0,0
107454,.,0,1
107455,CONCLUSION,0,0
107456,RFA,0,1
107457,took,0,0
107458,longer,0,0
107459,to,0,0
107460,perform,0,0
107461,but,0,0
107462,resulted,0,0
107463,in,0,0
107464,a,0,0
107465,significantly,1,0
107466,better,1,0
107467,early,1,0
107468,outcome,1,1
107469,than,0,0
107470,conventional,0,0
107471,surgery,0,0
107472,in,0,0
107473,suitable,0,0
107474,patients,0,0
107475,with,0,0
107476,great,0,0
107477,saphenous,0,1
107478,varicose,0,0
107479,veins,0,1
107480,.,0,0
107481,A,0,0
107482,randomized,0,0
107483,controlled,0,0
107484,study,0,0
107485,of,0,0
107486,parent-assisted,0,0
107487,Children,0,1
107488,'s,0,1
107489,Friendship,0,1
107490,Training,0,0
107491,with,0,0
107492,children,0,0
107493,having,0,0
107494,autism,0,0
107495,spectrum,0,0
107496,disorders,0,0
107497,.,0,0
107498,This,0,0
107499,study,0,0
107500,evaluated,0,0
107501,Children,0,1
107502,'s,0,1
107503,Friendship,0,1
107504,Training,0,1
107505,(,0,1
107506,CFT,0,0
107507,),0,0
107508,",",0,0
107509,a,0,0
107510,manualized,0,0
107511,parent-assisted,0,0
107512,intervention,0,0
107513,to,0,0
107514,improve,0,0
107515,social,0,1
107516,skills,0,1
107517,among,0,0
107518,second,0,0
107519,to,0,0
107520,fifth,0,0
107521,grade,0,1
107522,children,0,0
107523,with,0,0
107524,autism,0,0
107525,spectrum,0,0
107526,disorders,0,0
107527,.,0,1
107528,Comparison,0,0
107529,was,0,0
107530,made,0,0
107531,with,0,0
107532,a,0,0
107533,delayed,0,1
107534,treatment,0,0
107535,control,0,0
107536,group,0,0
107537,(,0,1
107538,DTC,0,0
107539,),0,0
107540,.,0,0
107541,Targeted,0,0
107542,skills,0,1
107543,included,0,0
107544,conversational,1,1
107545,skills,1,1
107546,",",1,0
107547,peer,1,1
107548,entry,1,1
107549,skills,1,1
107550,",",1,0
107551,developing,1,0
107552,friendship,1,1
107553,networks,1,0
107554,",",1,1
107555,good,1,1
107556,sportsmanship,1,1
107557,",",1,1
107558,good,1,1
107559,host,1,1
107560,behavior,1,1
107561,during,1,0
107562,play,1,0
107563,dates,1,1
107564,",",1,1
107565,and,1,1
107566,handling,1,1
107567,teasing,1,1
107568,.,1,0
107569,At,0,0
107570,post-testing,0,0
107571,",",0,0
107572,the,0,0
107573,CFT,0,0
107574,group,0,0
107575,was,0,0
107576,superior,0,0
107577,to,0,0
107578,the,0,0
107579,DTC,0,0
107580,group,0,0
107581,on,0,0
107582,parent,0,1
107583,measures,0,1
107584,of,0,1
107585,social,1,1
107586,skill,1,1
107587,and,1,1
107588,play,1,0
107589,date,1,1
107590,behavior,1,1
107591,",",0,1
107592,and,0,1
107593,child,0,1
107594,measures,0,1
107595,of,0,1
107596,popularity,1,1
107597,and,1,1
107598,loneliness,1,1
107599,",",0,1
107600,At,0,0
107601,3-month,0,1
107602,follow-up,0,0
107603,",",0,1
107604,parent,0,1
107605,measures,0,1
107606,showed,0,0
107607,significant,0,0
107608,improvement,0,1
107609,from,0,0
107610,baseline,0,0
107611,.,0,0
107612,Post-hoc,0,0
107613,analysis,0,0
107614,indicated,0,0
107615,more,0,0
107616,than,0,0
107617,87,0,0
107618,%,0,0
107619,of,0,0
107620,children,0,0
107621,receiving,0,0
107622,CFT,0,0
107623,showed,0,0
107624,reliable,0,1
107625,change,0,1
107626,on,0,0
107627,at,0,0
107628,least,0,0
107629,one,0,0
107630,measure,0,0
107631,at,0,0
107632,post-test,0,0
107633,and,0,0
107634,66.7,0,0
107635,%,0,0
107636,after,0,0
107637,3,0,0
107638,months,0,0
107639,follow-up,0,0
107640,.,0,0
107641,Catheter,0,1
107642,ablation,0,0
107643,of,0,1
107644,stable,0,1
107645,ventricular,0,1
107646,tachycardia,0,1
107647,before,0,0
107648,defibrillator,0,0
107649,implantation,0,0
107650,in,0,0
107651,patients,0,0
107652,with,0,0
107653,coronary,0,1
107654,heart,0,1
107655,disease,0,1
107656,(,0,1
107657,VTACH,0,0
107658,),0,0
107659,:,0,0
107660,a,0,0
107661,multicentre,0,0
107662,randomised,0,0
107663,controlled,0,0
107664,trial,0,0
107665,.,0,0
107666,BACKGROUND,0,0
107667,In,0,0
107668,patients,0,0
107669,with,0,0
107670,ventricular,0,1
107671,tachycardia,0,1
107672,(,0,1
107673,VT,0,0
107674,),0,0
107675,and,0,0
107676,a,0,0
107677,history,0,1
107678,of,0,0
107679,myocardial,0,1
107680,infarction,0,1
107681,",",0,1
107682,intervention,0,0
107683,with,0,0
107684,an,0,0
107685,implantable,0,0
107686,cardioverter,0,0
107687,defibrillator,0,0
107688,(,0,1
107689,ICD,0,0
107690,),0,0
107691,can,0,0
107692,prevent,0,0
107693,sudden,0,1
107694,cardiac,0,1
107695,death,0,1
107696,and,0,0
107697,thereby,0,1
107698,reduce,0,0
107699,total,0,1
107700,mortality,0,1
107701,.,0,0
107702,However,0,0
107703,",",0,0
107704,ICD,0,0
107705,shocks,0,0
107706,are,0,0
107707,painful,0,1
107708,and,0,0
107709,do,0,0
107710,not,0,0
107711,provide,0,0
107712,complete,0,1
107713,protection,0,1
107714,against,0,0
107715,sudden,0,1
107716,cardiac,0,1
107717,death,0,1
107718,.,0,0
107719,We,0,0
107720,assessed,0,0
107721,the,0,0
107722,potential,0,0
107723,benefit,0,0
107724,of,0,1
107725,catheter,0,1
107726,ablation,0,0
107727,before,0,0
107728,implantation,0,0
107729,of,0,0
107730,a,0,0
107731,cardioverter,0,0
107732,defibrillator,0,0
107733,.,0,0
107734,METHODS,0,0
107735,The,0,0
107736,Ventricular,0,1
107737,Tachycardia,0,1
107738,Ablation,0,1
107739,in,0,0
107740,Coronary,0,0
107741,Heart,0,1
107742,Disease,0,1
107743,(,0,1
107744,VTACH,0,0
107745,),0,1
107746,study,0,0
107747,was,0,0
107748,a,0,0
107749,prospective,0,0
107750,",",0,0
107751,open,0,0
107752,",",0,1
107753,randomised,0,0
107754,controlled,0,0
107755,trial,0,0
107756,",",0,0
107757,undertaken,0,0
107758,in,0,0
107759,16,0,0
107760,centres,0,0
107761,in,0,0
107762,four,0,0
107763,European,0,0
107764,countries,0,0
107765,.,0,0
107766,Patients,0,0
107767,aged,0,0
107768,18-80,0,0
107769,years,0,0
107770,were,0,0
107771,eligible,0,0
107772,for,0,0
107773,enrolment,0,0
107774,if,0,0
107775,they,0,0
107776,had,0,0
107777,stable,0,1
107778,VT,0,0
107779,",",0,0
107780,previous,0,0
107781,myocardial,0,1
107782,infarction,0,1
107783,",",0,1
107784,and,0,1
107785,reduced,0,1
107786,left-ventricular,0,1
107787,ejection,0,1
107788,fraction,0,1
107789,(,0,0
107790,LVEF,0,1
107791,;,0,0
107792,<,0,0
107793,or=50,0,0
107794,%,0,0
107795,),0,0
107796,.,0,0
107797,110,0,0
107798,patients,0,0
107799,were,0,0
107800,randomly,0,0
107801,allocated,0,0
107802,in,0,0
107803,a,0,0
107804,1:1,0,0
107805,ratio,0,0
107806,to,0,0
107807,receive,0,0
107808,catheter,0,1
107809,ablation,0,0
107810,and,0,0
107811,an,0,0
107812,ICD,0,0
107813,(,0,0
107814,ablation,0,1
107815,group,0,0
107816,",",0,0
107817,n=54,0,0
107818,),0,0
107819,or,0,0
107820,ICD,0,0
107821,alone,0,0
107822,(,0,0
107823,control,0,0
107824,group,0,0
107825,",",0,0
107826,n=56,0,0
107827,),0,0
107828,.,0,0
107829,Randomisation,0,0
107830,was,0,0
107831,done,0,0
107832,by,0,0
107833,computer-generated,0,0
107834,randomly,0,0
107835,permuted,0,0
107836,blocks,0,0
107837,and,0,0
107838,stratified,0,0
107839,by,0,0
107840,centre,0,0
107841,and,0,1
107842,LVEF,0,1
107843,(,0,0
107844,<,0,0
107845,or=30,0,0
107846,%,0,0
107847,or,0,0
107848,>,0,0
107849,30,0,0
107850,%,0,0
107851,),0,0
107852,.,0,0
107853,Patients,0,0
107854,were,0,0
107855,followed,0,0
107856,up,0,0
107857,for,0,0
107858,at,0,0
107859,least,0,0
107860,1,0,0
107861,year,0,0
107862,.,0,0
107863,The,0,0
107864,primary,0,0
107865,endpoint,0,1
107866,was,0,0
107867,the,0,0
107868,time,1,1
107869,to,1,0
107870,first,1,1
107871,recurrence,1,1
107872,of,1,1
107873,VT,1,0
107874,or,1,1
107875,ventricular,1,1
107876,fibrillation,1,1
107877,(,1,1
107878,VF,1,0
107879,),1,0
107880,.,1,0
107881,Analysis,0,0
107882,was,0,0
107883,by,0,0
107884,intention,0,1
107885,to,0,0
107886,treat,0,0
107887,(,0,0
107888,ITT,0,0
107889,),0,0
107890,.,0,0
107891,This,0,0
107892,study,0,0
107893,is,0,0
107894,registered,0,0
107895,with,0,0
107896,ClinicalTrials.gov,0,0
107897,",",0,0
107898,number,0,1
107899,NCT00919373,0,0
107900,.,0,0
107901,FINDINGS,0,0
107902,107,0,0
107903,patients,0,0
107904,were,0,0
107905,included,0,0
107906,in,0,0
107907,the,0,0
107908,ITT,0,0
107909,population,0,0
107910,(,0,1
107911,ablation,0,1
107912,group,0,0
107913,",",0,0
107914,n=52,0,0
107915,;,0,0
107916,control,0,0
107917,group,0,0
107918,",",0,0
107919,n=55,0,0
107920,),0,0
107921,.,0,0
107922,Two,0,0
107923,patients,0,0
107924,(,0,0
107925,one,0,0
107926,in,0,0
107927,each,0,0
107928,group,0,0
107929,),0,1
107930,withdrew,0,0
107931,consent,0,0
107932,immediately,0,0
107933,after,0,0
107934,randomisation,0,0
107935,without,0,0
107936,any,0,0
107937,follow-up,0,0
107938,data,0,0
107939,and,0,0
107940,one,0,0
107941,patient,0,1
107942,(,0,0
107943,ablation,0,1
107944,group,0,0
107945,),0,1
107946,was,0,0
107947,excluded,0,0
107948,because,0,0
107949,of,0,0
107950,a,0,0
107951,protocol,0,0
107952,violaton,0,0
107953,.,0,1
107954,Mean,0,1
107955,follow-up,0,0
107956,was,0,0
107957,22.5,0,0
107958,months,0,0
107959,(,0,0
107960,SD,0,0
107961,9.0,0,0
107962,),0,0
107963,.,0,0
107964,Time,1,0
107965,to,1,0
107966,recurrence,1,1
107967,of,1,1
107968,VT,1,0
107969,or,1,1
107970,VF,1,0
107971,was,0,0
107972,longer,0,0
107973,in,0,0
107974,the,0,0
107975,ablation,0,0
107976,group,0,0
107977,(,0,0
107978,median,0,0
107979,18.6,0,0
107980,months,0,0
107981,[,0,0
107982,lower,0,0
107983,quartile,0,1
107984,2.4,0,0
107985,",",0,0
107986,upper,0,0
107987,quartile,0,1
107988,not,0,0
107989,determinable,0,1
107990,],0,0
107991,),0,0
107992,than,0,0
107993,in,0,0
107994,the,0,0
107995,control,0,0
107996,group,0,0
107997,(,0,0
107998,5.9,0,0
107999,months,0,0
108000,[,0,0
108001,IQR,0,1
108002,0.8-26.7,0,1
108003,],0,0
108004,),0,0
108005,.,0,0
108006,At,0,0
108007,2,0,0
108008,years,0,0
108009,",",0,0
108010,estimates,0,0
108011,for,0,0
108012,survival,1,1
108013,free,0,1
108014,from,0,0
108015,VT,1,0
108016,or,1,1
108017,VF,1,0
108018,were,0,0
108019,47,0,0
108020,%,0,0
108021,in,0,0
108022,the,0,0
108023,ablation,0,0
108024,group,0,0
108025,and,0,0
108026,29,0,0
108027,%,0,0
108028,in,0,0
108029,the,0,0
108030,control,0,0
108031,group,0,0
108032,(,0,1
108033,hazard,0,1
108034,ratio,0,0
108035,0.61,0,0
108036,;,0,0
108037,95,0,0
108038,%,0,0
108039,CI,0,0
108040,0.37-0.99,0,0
108041,;,0,0
108042,p=0.045,0,0
108043,),0,0
108044,.,0,0
108045,Complications,0,0
108046,related,0,0
108047,to,0,0
108048,the,0,0
108049,ablation,0,0
108050,procedure,0,0
108051,occurred,0,0
108052,in,0,0
108053,two,0,0
108054,patients,0,0
108055,;,0,0
108056,no,1,0
108057,deaths,1,1
108058,occurred,0,0
108059,within,0,0
108060,30,0,0
108061,days,0,0
108062,after,0,0
108063,ablation,0,0
108064,.,0,0
108065,15,0,0
108066,device-related,0,1
108067,complications,0,1
108068,requiring,0,1
108069,surgical,0,1
108070,intervention,0,0
108071,occurred,0,0
108072,in,0,0
108073,13,0,0
108074,patients,0,0
108075,(,0,0
108076,ablation,0,1
108077,group,0,0
108078,",",0,0
108079,four,0,0
108080,;,0,0
108081,control,0,0
108082,group,0,0
108083,",",0,0
108084,nine,0,0
108085,),0,0
108086,.,0,0
108087,Nine,0,0
108088,patients,0,0
108089,died,1,0
108090,during,0,0
108091,the,0,0
108092,study,0,0
108093,(,0,0
108094,ablation,0,1
108095,group,0,0
108096,",",0,0
108097,five,0,0
108098,;,0,0
108099,control,0,0
108100,group,0,0
108101,",",0,0
108102,four,0,0
108103,),0,0
108104,.,0,0
108105,INTERPRETATION,0,0
108106,Prophylactic,0,0
108107,VT,0,0
108108,ablation,0,0
108109,before,0,0
108110,defibrillator,0,0
108111,implantation,0,0
108112,seemed,0,0
108113,to,0,0
108114,prolong,0,1
108115,time,0,1
108116,to,0,0
108117,recurrence,0,1
108118,of,0,0
108119,VT,0,0
108120,in,0,0
108121,patients,0,0
108122,with,0,0
108123,stable,0,1
108124,VT,0,0
108125,",",0,0
108126,previous,0,0
108127,myocardial,0,1
108128,infarction,0,1
108129,",",0,1
108130,and,0,1
108131,reduced,0,1
108132,LVEF,0,1
108133,.,0,1
108134,Prophylactic,0,0
108135,catheter,0,0
108136,ablation,0,0
108137,should,0,0
108138,therefore,0,0
108139,be,0,0
108140,considered,0,0
108141,before,0,0
108142,implantation,0,0
108143,of,0,0
108144,a,0,0
108145,cardioverter,0,0
108146,defibrillator,0,0
108147,in,0,0
108148,such,0,0
108149,patients,0,0
108150,.,0,0
108151,FUNDING,0,0
108152,St,0,1
108153,Jude,0,0
108154,Medical,0,0
108155,.,0,0
108156,Randomized,0,0
108157,phase,0,0
108158,II,0,0
108159,study,0,0
108160,of,0,0
108161,two,0,0
108162,different,0,0
108163,schedules,0,0
108164,of,0,1
108165,gemcitabine,0,0
108166,and,0,1
108167,oral,0,0
108168,S-1,0,1
108169,in,0,0
108170,chemo-na?ve,0,0
108171,patients,0,0
108172,with,0,0
108173,advanced,0,0
108174,non-small,0,0
108175,cell,0,1
108176,lung,0,1
108177,cancer,0,0
108178,.,0,0
108179,INTRODUCTION,0,0
108180,This,0,0
108181,study,0,0
108182,was,0,0
108183,conducted,0,0
108184,to,0,0
108185,evaluate,0,0
108186,the,1,0
108187,efficacy,1,1
108188,and,1,1
108189,safety,1,1
108190,and,0,1
108191,to,0,0
108192,compare,0,0
108193,dosing,0,0
108194,schedules,0,0
108195,of,0,0
108196,gemcitabine,0,0
108197,combined,0,0
108198,with,0,0
108199,S-1,0,0
108200,in,0,0
108201,chemo-na?ve,0,0
108202,non-small,0,0
108203,cell,0,1
108204,lung,0,1
108205,cancer,0,0
108206,patients,0,0
108207,.,0,0
108208,METHODS,0,0
108209,Patients,0,0
108210,with,0,0
108211,chemo-na?ve,0,0
108212,stage,0,0
108213,IIIB/IV,0,1
108214,non-small,0,0
108215,cell,0,1
108216,lung,0,1
108217,cancer,0,1
108218,were,0,0
108219,randomized,0,0
108220,into,0,0
108221,two,0,0
108222,treatment,0,0
108223,arms,0,0
108224,.,0,1
108225,Patients,0,0
108226,were,0,0
108227,given,0,0
108228,oral,0,0
108229,S-1,0,0
108230,(,0,0
108231,60,0,0
108232,mg/m/d,0,0
108233,",",0,0
108234,twice,0,0
108235,a,0,0
108236,day,0,0
108237,),0,0
108238,from,0,0
108239,days,0,0
108240,1,0,0
108241,to,0,0
108242,14,0,0
108243,with,0,0
108244,gemcitabine,0,0
108245,(,0,0
108246,1000,0,0
108247,mg/m/d,0,0
108248,),0,0
108249,on,0,0
108250,days,0,0
108251,1,0,0
108252,and,0,0
108253,8,0,0
108254,(,0,0
108255,arm,0,0
108256,A,0,0
108257,),0,1
108258,or,0,0
108259,on,0,0
108260,days,0,0
108261,8,0,0
108262,and,0,0
108263,15,0,0
108264,(,0,0
108265,arm,0,0
108266,B,0,0
108267,),0,0
108268,.,0,0
108269,This,0,0
108270,cycle,0,1
108271,was,0,0
108272,repeated,0,0
108273,every,0,0
108274,21,0,0
108275,days,0,0
108276,.,0,0
108277,RESULTS,0,0
108278,A,0,0
108279,total,0,0
108280,of,0,0
108281,80,0,0
108282,patients,0,0
108283,were,0,0
108284,entered,0,0
108285,in,0,0
108286,this,0,0
108287,trial,0,0
108288,.,0,0
108289,The,0,0
108290,primary,0,0
108291,end,0,0
108292,point,0,0
108293,of,0,0
108294,this,0,0
108295,study,0,0
108296,was,0,0
108297,response,1,1
108298,rate,1,1
108299,.,1,0
108300,The,1,0
108301,response,1,1
108302,rates,1,1
108303,of,1,1
108304,arm,0,0
108305,A,0,0
108306,and,0,1
108307,arm,0,0
108308,B,0,0
108309,were,0,0
108310,22.0,0,0
108311,and,0,0
108312,28.9,0,0
108313,%,0,0
108314,",",0,0
108315,respectively,0,0
108316,(,0,0
108317,p,0,0
108318,=,0,0
108319,0.606,1,0
108320,),1,0
108321,.,1,0
108322,Median,1,1
108323,time,1,1
108324,to,1,0
108325,treatment,1,0
108326,failure,1,1
108327,in,1,0
108328,arm,0,0
108329,A,0,0
108330,was,0,0
108331,3.6,0,0
108332,months,0,0
108333,and,0,0
108334,4.8,0,0
108335,months,0,0
108336,in,0,0
108337,arm,0,0
108338,B,0,0
108339,.,0,1
108340,Median,1,1
108341,time,1,1
108342,to,1,0
108343,progression,1,1
108344,in,1,0
108345,arm,0,0
108346,A,0,0
108347,was,0,0
108348,4.1,0,0
108349,months,0,0
108350,and,0,0
108351,5.5,0,0
108352,months,0,0
108353,in,0,0
108354,arm,0,0
108355,B,0,0
108356,.,0,0
108357,Median,1,1
108358,survival,1,1
108359,time,1,1
108360,in,1,0
108361,arm,0,0
108362,A,0,0
108363,and,0,1
108364,arm,0,0
108365,B,0,0
108366,was,0,0
108367,15.5,0,0
108368,months,0,0
108369,and,0,0
108370,18.8,0,0
108371,months,0,0
108372,",",0,0
108373,respectively,0,0
108374,.,0,0
108375,The,0,0
108376,toxicity,1,1
108377,profile,1,1
108378,was,1,0
108379,relatively,0,0
108380,mild,0,0
108381,and,0,1
108382,did,0,0
108383,not,0,0
108384,differ,0,0
108385,very,0,0
108386,much,0,0
108387,between,0,0
108388,two,0,0
108389,arms,0,0
108390,.,0,0
108391,CONCLUSION,0,0
108392,The,0,0
108393,combination,0,0
108394,of,0,1
108395,gemcitabine,0,0
108396,and,0,1
108397,S-1,0,1
108398,was,0,0
108399,determined,0,0
108400,to,0,0
108401,be,0,0
108402,feasible,1,0
108403,and,1,1
108404,effective,1,1
108405,for,1,0
108406,advanced,0,0
108407,non-small,0,0
108408,cell,0,1
108409,lung,0,1
108410,cancer,0,0
108411,.,0,0
108412,We,0,0
108413,selected,0,0
108414,arm,0,0
108415,B,0,0
108416,for,0,0
108417,further,0,0
108418,studies,0,0
108419,because,0,0
108420,of,0,0
108421,its,0,0
108422,higher,1,0
108423,response,1,1
108424,rate,1,1
108425,and,1,1
108426,survival,1,1
108427,data,1,0
108428,.,1,0
108429,Pilot,0,1
108430,randomized,0,0
108431,controlled,0,0
108432,trial,0,0
108433,of,0,0
108434,Reciprocal,0,1
108435,Imitation,0,1
108436,Training,0,0
108437,for,0,0
108438,teaching,0,0
108439,elicited,0,0
108440,and,0,0
108441,spontaneous,1,1
108442,imitation,1,1
108443,to,0,0
108444,children,0,0
108445,with,0,0
108446,autism,0,0
108447,.,0,0
108448,Children,0,0
108449,with,0,0
108450,autism,0,0
108451,exhibit,0,0
108452,significant,0,0
108453,deficits,0,1
108454,in,0,0
108455,imitation,1,0
108456,skills,1,1
108457,.,1,0
108458,Reciprocal,0,1
108459,Imitation,0,1
108460,Training,0,1
108461,(,0,1
108462,RIT,0,1
108463,),0,0
108464,",",0,0
108465,a,0,0
108466,naturalistic,0,0
108467,imitation,0,1
108468,intervention,0,0
108469,",",0,1
108470,was,0,0
108471,developed,0,0
108472,to,0,0
108473,teach,0,0
108474,young,0,0
108475,children,0,0
108476,with,0,0
108477,autism,0,0
108478,to,0,0
108479,imitate,0,0
108480,during,0,0
108481,play,0,0
108482,.,0,0
108483,This,0,0
108484,study,0,0
108485,used,0,0
108486,a,0,0
108487,randomized,0,0
108488,controlled,0,0
108489,trial,0,0
108490,to,0,0
108491,evaluate,0,0
108492,the,0,0
108493,efficacy,1,1
108494,of,0,0
108495,RIT,0,0
108496,on,0,0
108497,elicited,0,1
108498,and,0,0
108499,spontaneous,0,1
108500,imitation,1,1
108501,skills,1,1
108502,in,0,0
108503,21,0,0
108504,young,0,0
108505,children,0,0
108506,with,0,0
108507,autism,0,0
108508,.,0,1
108509,Results,0,0
108510,found,0,0
108511,that,0,0
108512,children,0,0
108513,in,0,0
108514,the,0,0
108515,treatment,0,0
108516,group,0,0
108517,made,0,0
108518,significantly,1,0
108519,more,1,0
108520,gains,1,1
108521,in,0,0
108522,elicited,1,1
108523,and,1,1
108524,spontaneous,1,1
108525,imitation,1,1
108526,",",0,0
108527,replicating,0,0
108528,previous,0,0
108529,single-subject,0,0
108530,design,0,0
108531,studies,0,0
108532,.,0,0
108533,Number,1,0
108534,of,1,0
108535,spontaneous,1,1
108536,play,1,0
108537,acts,1,0
108538,at,0,0
108539,pre-treatment,0,0
108540,was,0,0
108541,related,0,0
108542,to,0,0
108543,improvements,0,0
108544,in,0,0
108545,imitation,1,0
108546,during,0,0
108547,the,0,0
108548,intervention,0,0
108549,",",0,0
108550,suggesting,0,0
108551,that,0,0
108552,children,0,0
108553,with,0,0
108554,a,0,0
108555,greater,0,0
108556,play,0,0
108557,repertoire,0,1
108558,make,0,0
108559,greater,0,0
108560,gains,0,1
108561,during,0,0
108562,RIT,0,0
108563,.,0,0
108564,Vancomycin,0,0
108565,added,0,0
108566,to,0,0
108567,empirical,0,0
108568,combination,0,0
108569,antibiotic,0,0
108570,therapy,0,0
108571,for,0,0
108572,fever,0,1
108573,in,0,0
108574,granulocytopenic,0,0
108575,cancer,0,0
108576,patients,0,0
108577,.,0,0
108578,European,0,0
108579,Organization,0,0
108580,for,0,0
108581,Research,0,0
108582,and,0,1
108583,Treatment,0,0
108584,of,0,1
108585,Cancer,0,0
108586,(,0,0
108587,EORTC,0,0
108588,),0,1
108589,International,0,1
108590,Antimicrobial,0,1
108591,Therapy,0,0
108592,Cooperative,0,1
108593,Group,0,0
108594,and,0,0
108595,the,0,0
108596,National,0,1
108597,Cancer,0,0
108598,Institute,0,0
108599,of,0,1
108600,Canada-Clinical,0,1
108601,Trials,0,1
108602,Group,0,0
108603,.,0,1
108604,A,0,0
108605,total,0,1
108606,of,0,0
108607,747,0,0
108608,febrile,0,0
108609,granulocytopenic,0,0
108610,patients,0,0
108611,with,0,0
108612,cancer,0,0
108613,were,0,0
108614,randomized,0,0
108615,to,0,0
108616,receive,0,0
108617,ceftazidime,0,0
108618,plus,0,0
108619,amikacin,0,1
108620,(,0,1
108621,CA,0,0
108622,),0,1
108623,with,0,0
108624,or,0,0
108625,without,0,0
108626,vancomycin,0,0
108627,(,0,1
108628,V,0,1
108629,),0,0
108630,as,0,0
108631,initial,0,0
108632,empirical,0,0
108633,therapy,0,0
108634,.,0,0
108635,Single,0,1
108636,gram-positive,0,1
108637,bacteremias,0,1
108638,responded,0,0
108639,in,0,0
108640,29,0,0
108641,(,0,0
108642,43,0,0
108643,%,0,0
108644,),0,0
108645,of,0,0
108646,68,0,0
108647,patients,0,0
108648,treated,0,0
108649,with,0,0
108650,CA,0,0
108651,and,0,0
108652,in,0,0
108653,48,0,0
108654,(,0,0
108655,72,0,0
108656,%,0,0
108657,),0,0
108658,of,0,0
108659,67,0,0
108660,treated,0,0
108661,with,0,0
108662,CAV,0,0
108663,(,0,0
108664,P,0,0
108665,=,0,0
108666,.001,0,0
108667,),0,0
108668,.,0,0
108669,For,0,0
108670,single,0,0
108671,gram-negative,0,1
108672,bacteremias,0,1
108673,and,0,1
108674,clinically,0,1
108675,documented,0,0
108676,and,0,0
108677,possible,0,0
108678,infections,0,1
108679,the,0,0
108680,response,1,1
108681,rates,1,1
108682,of,0,1
108683,CA,0,0
108684,and,0,1
108685,CAV,0,0
108686,were,0,0
108687,80,0,0
108688,%,0,0
108689,and,0,0
108690,63,0,0
108691,%,0,0
108692,(,0,0
108693,P,0,0
108694,=,0,0
108695,.17,0,0
108696,),0,0
108697,",",0,0
108698,55,0,0
108699,%,0,0
108700,and,0,0
108701,75,0,0
108702,%,0,0
108703,(,0,0
108704,P,0,0
108705,=,0,0
108706,.009,0,0
108707,),0,1
108708,",",0,0
108709,and,0,0
108710,74,0,0
108711,%,0,0
108712,and,0,0
108713,81,0,0
108714,%,0,0
108715,(,0,0
108716,P,0,0
108717,=,0,0
108718,.16,0,0
108719,),0,1
108720,",",0,0
108721,respectively,0,0
108722,.,0,0
108723,However,0,0
108724,",",0,0
108725,for,0,0
108726,patients,0,0
108727,with,0,0
108728,gram-positive,0,1
108729,bacteremia,0,1
108730,and,0,0
108731,for,0,0
108732,all,0,0
108733,other,0,0
108734,patients,0,0
108735,",",0,0
108736,there,0,0
108737,were,0,0
108738,no,0,0
108739,differences,0,0
108740,by,0,0
108741,treatment,0,0
108742,regimens,0,0
108743,in,0,0
108744,the,0,0
108745,proportion,1,0
108746,of,1,0
108747,febrile,1,1
108748,patients,1,0
108749,on,0,0
108750,each,0,0
108751,trial,0,0
108752,day,0,1
108753,(,0,1
108754,P,0,0
108755,=,0,0
108756,.85,0,1
108757,",",0,1
108758,P,0,0
108759,=,0,0
108760,.82,0,1
108761,",",0,0
108762,respectively,0,0
108763,),0,0
108764,or,0,0
108765,in,0,0
108766,the,0,0
108767,duration,1,1
108768,of,1,1
108769,fever,1,1
108770,(,0,0
108771,P,0,0
108772,=,0,0
108773,.22,0,0
108774,",",0,1
108775,P,0,0
108776,=,0,0
108777,.93,0,0
108778,",",0,0
108779,respectively,0,0
108780,),0,0
108781,.,0,0
108782,Moreover,0,0
108783,",",0,0
108784,no,0,0
108785,patient,0,1
108786,with,0,0
108787,gram-positive,0,1
108788,bacteremia,0,1
108789,died,1,1
108790,during,0,0
108791,the,0,0
108792,first,0,0
108793,3,0,0
108794,days,0,0
108795,of,0,0
108796,true,0,0
108797,empirical,0,0
108798,therapy,0,0
108799,.,0,1
108800,Antibiotic-associated,1,1
108801,nephrotoxicity,1,1
108802,was,0,0
108803,more,0,0
108804,frequent,0,1
108805,in,0,0
108806,patients,0,0
108807,treated,0,0
108808,with,0,0
108809,vancomycin,0,0
108810,(,0,0
108811,6,0,0
108812,%,0,0
108813,vs.,0,0
108814,2,0,0
108815,%,0,0
108816,",",0,0
108817,P,0,0
108818,=,0,0
108819,.02,0,0
108820,),0,0
108821,.,0,0
108822,These,0,0
108823,results,0,0
108824,do,0,0
108825,not,0,0
108826,support,0,0
108827,the,0,0
108828,empirical,0,0
108829,addition,0,0
108830,of,0,0
108831,vancomycin,0,0
108832,to,0,0
108833,initial,0,0
108834,antibiotic,0,0
108835,therapy,0,0
108836,in,0,0
108837,cancer,0,0
108838,patients,0,0
108839,with,0,0
108840,fever,0,1
108841,and,0,1
108842,granulocytopenia,0,1
108843,.,0,0
108844,The,0,0
108845,development,0,0
108846,of,0,0
108847,a,0,0
108848,web-,0,0
108849,and,0,0
108850,a,0,0
108851,print-based,0,0
108852,decision,0,1
108853,aid,0,0
108854,for,0,0
108855,prostate,1,0
108856,cancer,1,0
108857,screening,1,0
108858,.,1,0
108859,BACKGROUND,0,0
108860,Whether,0,0
108861,early,0,1
108862,detection,0,1
108863,and,0,1
108864,treatment,0,0
108865,of,0,1
108866,prostate,0,0
108867,cancer,0,0
108868,(,0,1
108869,PCa,0,1
108870,),0,0
108871,will,0,0
108872,reduce,0,0
108873,disease-related,1,1
108874,mortality,1,1
108875,remains,0,0
108876,uncertain,0,0
108877,.,0,0
108878,As,0,0
108879,a,0,0
108880,result,0,0
108881,",",0,0
108882,tools,0,1
108883,are,0,0
108884,needed,0,0
108885,to,0,0
108886,facilitate,0,0
108887,informed,0,0
108888,decision,1,1
108889,making,1,1
108890,.,1,0
108891,While,0,0
108892,there,0,0
108893,have,0,0
108894,been,0,0
108895,several,0,0
108896,decision,0,1
108897,aids,0,1
108898,(,0,1
108899,DAs,0,1
108900,),0,1
108901,developed,0,0
108902,and,0,1
108903,tested,0,0
108904,",",0,0
108905,very,0,0
108906,few,0,0
108907,have,0,0
108908,included,0,0
108909,an,0,0
108910,exercise,0,0
108911,to,0,0
108912,help,0,0
108913,men,0,0
108914,clarify,0,0
108915,their,0,0
108916,values,1,1
108917,and,1,1
108918,preferences,1,0
108919,about,0,1
108920,PCa,0,1
108921,screening,0,0
108922,.,0,1
108923,Further,0,1
108924,",",0,0
108925,only,0,0
108926,one,0,0
108927,DA,0,0
108928,has,0,0
108929,utilized,0,0
108930,an,0,0
108931,interactive,0,0
108932,web-based,0,0
108933,format,0,0
108934,",",0,0
108935,which,0,0
108936,allows,0,0
108937,for,0,0
108938,an,0,0
108939,expansion,0,1
108940,and,0,1
108941,customization,0,1
108942,of,0,0
108943,the,0,0
108944,material,0,0
108945,.,0,0
108946,We,0,0
108947,describe,0,0
108948,the,0,0
108949,development,0,0
108950,of,0,0
108951,two,0,0
108952,DAs,0,0
108953,",",0,0
108954,a,0,0
108955,booklet,0,0
108956,and,0,0
108957,an,0,0
108958,interactive,0,1
108959,website,0,0
108960,",",0,0
108961,each,0,0
108962,with,0,0
108963,a,0,0
108964,values,0,1
108965,clarification,0,1
108966,component,0,1
108967,and,0,1
108968,designed,0,0
108969,for,0,0
108970,use,0,0
108971,in,0,0
108972,diverse,0,0
108973,settings,0,0
108974,.,0,0
108975,METHODS,0,0
108976,We,0,0
108977,conducted,0,0
108978,two,0,0
108979,feasibility,0,0
108980,studies,0,0
108981,to,0,0
108982,assess,0,0
108983,men,0,0
108984,'s,0,0
108985,(,0,0
108986,45-70,0,0
108987,years,0,0
108988,),0,0
108989,Internet,0,0
108990,access,0,1
108991,and,0,0
108992,their,0,0
108993,willingness,0,0
108994,to,0,0
108995,use,0,0
108996,a,0,0
108997,web-,0,0
108998,vs.,0,0
108999,a,0,0
109000,print-based,0,0
109001,tool,0,0
109002,.,0,0
109003,The,0,0
109004,booklet,0,0
109005,was,0,0
109006,adapted,0,0
109007,from,0,0
109008,two,0,0
109009,previous,0,0
109010,versions,0,0
109011,evaluated,0,0
109012,in,0,0
109013,randomized,0,0
109014,controlled,0,0
109015,trials,0,0
109016,(,0,0
109017,RCTs,0,0
109018,),0,0
109019,and,0,0
109020,the,0,0
109021,website,0,0
109022,was,0,0
109023,created,0,0
109024,to,0,0
109025,closely,0,0
109026,match,0,0
109027,the,0,0
109028,content,0,1
109029,of,0,0
109030,the,0,0
109031,revised,0,1
109032,booklet,0,0
109033,.,0,1
109034,Usability,1,1
109035,testing,1,1
109036,was,0,0
109037,conducted,0,0
109038,to,0,0
109039,obtain,0,0
109040,feedback,0,0
109041,regarding,0,0
109042,draft,0,0
109043,versions,0,1
109044,of,0,0
109045,the,0,0
109046,materials,0,0
109047,.,0,0
109048,The,0,0
109049,tools,0,1
109050,were,0,0
109051,also,0,0
109052,reviewed,0,0
109053,by,0,0
109054,a,0,0
109055,plain,0,0
109056,language,0,1
109057,expert,0,0
109058,and,0,0
109059,the,0,0
109060,interdisciplinary,0,0
109061,research,0,0
109062,team,0,1
109063,.,0,1
109064,Feedback,0,0
109065,on,0,0
109066,the,0,0
109067,content,0,1
109068,and,0,1
109069,presentation,0,1
109070,led,0,0
109071,to,0,0
109072,iterative,0,0
109073,modifications,0,0
109074,of,0,0
109075,the,0,0
109076,tools,0,0
109077,.,0,0
109078,RESULTS,0,0
109079,The,0,0
109080,feasibility,0,1
109081,studies,0,0
109082,confirmed,0,0
109083,that,0,0
109084,the,0,0
109085,Internet,1,0
109086,was,0,0
109087,a,0,0
109088,viable,0,0
109089,medium,0,0
109090,",",0,0
109091,as,0,0
109092,the,0,0
109093,majority,0,0
109094,of,0,0
109095,men,0,0
109096,used,1,0
109097,a,1,0
109098,computer,1,0
109099,",",0,1
109100,had,0,0
109101,access,1,0
109102,to,1,0
109103,the,1,0
109104,Internet,1,0
109105,",",0,0
109106,and,0,1
109107,Internet,1,1
109108,use,1,1
109109,increased,0,1
109110,over,0,0
109111,time,0,1
109112,.,0,0
109113,Feedback,0,0
109114,from,0,0
109115,the,0,0
109116,usability,0,1
109117,testing,0,0
109118,on,0,0
109119,the,0,0
109120,length,1,1
109121,",",1,1
109122,presentation,1,1
109123,",",1,1
109124,and,1,1
109125,content,1,1
109126,of,1,0
109127,the,1,0
109128,materials,1,0
109129,was,0,0
109130,incorporated,0,0
109131,into,0,0
109132,the,0,0
109133,final,0,1
109134,versions,0,1
109135,of,0,0
109136,the,0,0
109137,booklet,0,0
109138,and,0,0
109139,website,0,1
109140,.,0,1
109141,Both,0,0
109142,the,0,0
109143,feasibility,1,1
109144,studies,1,0
109145,and,1,0
109146,the,1,0
109147,usability,1,1
109148,testing,1,0
109149,highlighted,0,0
109150,the,0,0
109151,need,0,0
109152,to,0,0
109153,address,0,0
109154,men,0,0
109155,'s,0,1
109156,informed,0,0
109157,decision,0,0
109158,making,0,0
109159,regarding,0,0
109160,screening,0,0
109161,.,0,0
109162,CONCLUSIONS,0,0
109163,Informed,0,0
109164,decision,0,1
109165,making,0,1
109166,for,0,0
109167,PCa,0,1
109168,screening,0,0
109169,is,0,0
109170,crucial,0,0
109171,at,0,0
109172,present,0,0
109173,and,0,0
109174,may,0,0
109175,be,0,0
109176,important,0,0
109177,for,0,0
109178,some,0,0
109179,time,0,1
109180,",",0,0
109181,particularly,0,0
109182,if,0,0
109183,a,0,0
109184,definitive,0,0
109185,recommendation,0,0
109186,either,0,0
109187,for,0,0
109188,or,0,0
109189,against,0,0
109190,screening,0,0
109191,does,0,0
109192,not,0,0
109193,emerge,0,0
109194,from,0,0
109195,ongoing,0,0
109196,prostate,0,0
109197,cancer,0,0
109198,screening,0,0
109199,trials,0,0
109200,.,0,0
109201,We,0,0
109202,have,0,0
109203,detailed,0,0
109204,our,0,0
109205,efforts,0,0
109206,at,0,0
109207,developing,0,0
109208,print-,0,0
109209,and,0,1
109210,web-based,0,0
109211,DAs,0,0
109212,to,0,0
109213,assist,0,0
109214,men,0,0
109215,in,0,0
109216,determining,0,0
109217,how,0,0
109218,to,0,0
109219,best,0,0
109220,meet,0,0
109221,their,0,0
109222,PCa,0,1
109223,screening,0,0
109224,preferences,0,0
109225,.,0,0
109226,Following,0,1
109227,completion,0,1
109228,of,0,0
109229,our,0,0
109230,ongoing,0,0
109231,RCT,0,0
109232,designed,0,0
109233,to,0,0
109234,test,0,0
109235,these,0,0
109236,materials,0,0
109237,",",0,0
109238,our,0,0
109239,goal,0,0
109240,will,0,0
109241,be,0,0
109242,to,0,0
109243,develop,0,0
109244,a,0,0
109245,dissemination,1,0
109246,project,1,0
109247,for,0,0
109248,the,0,0
109249,more,0,0
109250,effective,0,1
109251,tool,0,0
109252,.,0,0
109253,TRIAL,0,0
109254,REGISTRATION,0,0
109255,NCT00623090,0,0
109256,.,0,0
109257,Comparison,0,0
109258,of,0,1
109259,neodymium-doped,0,0
109260,yttrium,0,0
109261,aluminum,0,0
109262,garnet,0,0
109263,laser,0,0
109264,treatment,0,0
109265,with,0,0
109266,cold,0,1
109267,knife,0,1
109268,endoscopic,0,1
109269,incision,0,0
109270,of,0,1
109271,urethral,0,1
109272,strictures,0,1
109273,in,0,0
109274,male,0,0
109275,patients,0,0
109276,.,0,0
109277,OBJECTIVE,0,0
109278,To,0,0
109279,assess,0,0
109280,the,0,0
109281,effectiveness,1,0
109282,of,0,0
109283,visual,0,1
109284,laser,0,0
109285,ablation,0,0
109286,treatment,0,0
109287,with,0,0
109288,neodymium-doped,0,0
109289,yttrium,0,0
109290,aluminum,0,0
109291,garnet,0,0
109292,(,0,0
109293,Nd,0,0
109294,:,0,0
109295,YAG,0,0
109296,),0,0
109297,laser,0,0
109298,in,0,0
109299,male,0,0
109300,patients,0,0
109301,with,0,0
109302,urethral,0,1
109303,strictures,0,1
109304,and,0,0
109305,to,0,0
109306,compare,0,0
109307,the,0,0
109308,effects,0,0
109309,with,0,0
109310,those,0,0
109311,obtained,0,0
109312,in,0,0
109313,patients,0,0
109314,treated,0,0
109315,with,0,0
109316,Sachse,0,1
109317,'s,0,1
109318,optical,0,0
109319,urethrotomy,0,0
109320,.,0,1
109321,MATERIALS,0,0
109322,AND,0,0
109323,METHODS,0,0
109324,Fifty,0,1
109325,patients,0,0
109326,aged,0,0
109327,22,0,0
109328,to,0,0
109329,83,0,0
109330,(,0,0
109331,mean,0,0
109332,age,0,0
109333,61.8,0,0
109334,),0,0
109335,with,0,0
109336,primary,0,0
109337,(,0,0
109338,n,0,0
109339,=,0,0
109340,26,0,0
109341,",",0,0
109342,52,0,0
109343,%,0,0
109344,),0,0
109345,and,0,1
109346,recurrent,0,1
109347,(,0,1
109348,n,0,0
109349,=,0,0
109350,24,0,0
109351,",",0,0
109352,48,0,0
109353,%,0,0
109354,),0,0
109355,urethral,0,1
109356,strictures,0,0
109357,0.3,0,0
109358,to,0,0
109359,2.4,0,0
109360,cm,0,0
109361,long,0,0
109362,qualified,0,0
109363,for,0,0
109364,the,0,0
109365,study,0,0
109366,.,0,0
109367,The,0,0
109368,patients,0,0
109369,were,0,0
109370,randomized,0,0
109371,into,0,0
109372,two,0,0
109373,groups,0,0
109374,:,0,0
109375,30,0,0
109376,men,0,0
109377,treated,0,0
109378,using,0,0
109379,visual,0,1
109380,laser,0,0
109381,ablation,0,0
109382,of,0,1
109383,urethral,0,1
109384,strictures,0,1
109385,(,0,0
109386,VLASU,0,0
109387,),0,0
109388,with,0,0
109389,Nd,0,0
109390,:,0,0
109391,YAGlaser,0,0
109392,and,0,0
109393,20,0,0
109394,men,0,0
109395,treated,0,0
109396,by,0,0
109397,correction,0,0
109398,of,0,0
109399,urethral,0,1
109400,strictures,0,1
109401,using,0,0
109402,Sachse,0,1
109403,'s,0,1
109404,optical,0,0
109405,urethrotomy,0,0
109406,.,0,0
109407,RESULTS,0,0
109408,At,0,0
109409,12-month,0,1
109410,follow-up,0,0
109411,",",0,0
109412,seven,0,0
109413,(,0,0
109414,35,0,0
109415,%,0,0
109416,),0,0
109417,patients,0,0
109418,who,0,0
109419,underwent,0,0
109420,optical,0,1
109421,urethrotomy,0,0
109422,and,0,0
109423,21,0,0
109424,(,0,0
109425,70,0,0
109426,%,0,0
109427,),0,0
109428,in,0,0
109429,the,0,0
109430,VLASU,0,0
109431,group,0,0
109432,did,0,0
109433,not,0,0
109434,require,0,0
109435,repetition,1,1
109436,of,1,0
109437,the,1,0
109438,procedure,1,0
109439,.,1,0
109440,The,0,0
109441,choice,0,0
109442,of,0,0
109443,VLASU,0,0
109444,as,0,0
109445,a,0,0
109446,method,0,0
109447,of,0,0
109448,treatment,0,0
109449,significantly,0,0
109450,decreased,1,0
109451,the,1,0
109452,probability,1,1
109453,of,1,0
109454,therapeutic,1,1
109455,failure,1,1
109456,and,1,1
109457,recurrence,1,1
109458,of,1,1
109459,urethral,1,1
109460,strictures,1,1
109461,(,0,0
109462,p,0,0
109463,=,0,0
109464,0.02,0,0
109465,),0,0
109466,.,0,0
109467,CONCLUSION,0,0
109468,VLASU,0,0
109469,can,0,0
109470,be,0,0
109471,used,0,0
109472,as,0,0
109473,a,0,0
109474,method,0,0
109475,of,0,0
109476,treatment,0,0
109477,of,0,0
109478,this,0,0
109479,disorder,0,0
109480,.,0,0
109481,It,0,0
109482,is,0,0
109483,an,0,0
109484,effective,0,1
109485,",",0,0
109486,modern,0,0
109487,",",0,1
109488,low-invasive,0,0
109489,",",0,1
109490,and,0,1
109491,repeatable,0,1
109492,technique,0,0
109493,and,0,0
109494,is,0,0
109495,technically,0,0
109496,simple,0,0
109497,and,0,0
109498,easy,0,1
109499,to,0,0
109500,master,0,0
109501,.,0,0
109502,It,0,0
109503,can,0,0
109504,be,0,0
109505,used,0,0
109506,in,0,0
109507,cases,0,0
109508,in,0,0
109509,which,0,0
109510,introduction,0,0
109511,of,0,0
109512,a,0,0
109513,22,0,0
109514,Char,0,0
109515,optical,0,0
109516,urethrotome,0,0
109517,into,0,0
109518,the,0,0
109519,stricture,0,1
109520,site,0,0
109521,is,0,0
109522,impossible,0,0
109523,",",0,0
109524,as,0,0
109525,well,0,0
109526,as,0,0
109527,for,0,0
109528,treatment,0,0
109529,of,0,0
109530,multiple,0,0
109531,strictures,0,0
109532,during,0,0
109533,one,0,0
109534,procedure,0,0
109535,.,0,0
109536,Effect,1,1
109537,of,0,1
109538,membrane,0,1
109539,permeability,0,1
109540,on,0,0
109541,inflammation,0,1
109542,and,0,1
109543,arterial,0,1
109544,stiffness,0,1
109545,:,0,0
109546,a,0,0
109547,randomized,0,0
109548,trial,0,0
109549,.,0,1
109550,BACKGROUND,0,0
109551,AND,0,0
109552,OBJECTIVES,0,1
109553,Both,0,0
109554,larger,0,0
109555,molecule,0,1
109556,removal,0,1
109557,and,0,1
109558,dialyzer,0,0
109559,biocompatibility,0,1
109560,have,0,0
109561,been,0,0
109562,implicated,0,0
109563,in,0,0
109564,the,0,0
109565,high-flux,0,0
109566,hemodialysis,0,0
109567,(,0,1
109568,HD,0,1
109569,),0,1
109570,-associated,0,0
109571,favorable,0,0
109572,outcome,0,1
109573,.,0,0
109574,In,0,0
109575,an,0,0
109576,attempt,0,0
109577,to,0,0
109578,delineate,0,0
109579,the,0,0
109580,effect,0,0
109581,of,0,1
109582,membrane,0,1
109583,permeability,0,1
109584,",",0,0
109585,we,0,0
109586,performed,0,0
109587,a,0,0
109588,randomized,0,0
109589,",",0,0
109590,crossover,0,0
109591,study,0,0
109592,to,0,0
109593,compare,0,0
109594,the,0,0
109595,inflammatory,0,1
109596,biomarkers,0,0
109597,",",0,1
109598,lipid,0,1
109599,profile,0,1
109600,",",0,1
109601,and,0,1
109602,aortic,0,1
109603,pulse,0,1
109604,wave,0,1
109605,velocity,0,1
109606,(,0,1
109607,PWV,0,1
109608,),0,0
109609,of,0,0
109610,two,0,0
109611,dialyzers,0,0
109612,that,0,0
109613,are,0,0
109614,composed,0,0
109615,of,0,0
109616,identical,0,0
109617,membranes,0,1
109618,but,0,0
109619,with,0,0
109620,different,0,0
109621,flux,0,1
109622,characteristics,0,1
109623,.,0,1
109624,DESIGN,0,0
109625,",",0,1
109626,SETTING,0,1
109627,",",0,1
109628,PARTICIPANTS,0,1
109629,",",0,1
109630,&,0,1
109631,MEASUREMENTS,0,1
109632,Stable,0,0
109633,patients,0,0
109634,who,0,0
109635,had,0,0
109636,anuria,0,1
109637,and,0,1
109638,were,0,0
109639,on,0,0
109640,low-flux,0,0
109641,polysulfone,0,0
109642,membrane,0,1
109643,were,0,0
109644,randomly,0,0
109645,allocated,0,0
109646,either,0,0
109647,to,0,0
109648,HD,0,1
109649,with,0,0
109650,high-flux,0,0
109651,polyamide,0,1
109652,membrane,0,1
109653,(,0,1
109654,group,0,0
109655,A,0,0
109656,;,0,0
109657,22,0,0
109658,patients,0,0
109659,),0,0
109660,or,0,0
109661,to,0,0
109662,HD,0,1
109663,with,0,0
109664,low-flux,0,0
109665,polyamide,0,1
109666,membrane,0,1
109667,(,0,1
109668,group,0,0
109669,B,0,0
109670,;,0,0
109671,24,0,0
109672,patients,0,0
109673,),0,0
109674,for,0,0
109675,24,0,0
109676,weeks,0,0
109677,",",0,0
109678,then,0,0
109679,they,0,0
109680,were,0,0
109681,started,0,0
109682,on,0,0
109683,24,0,0
109684,weeks,0,0
109685,of,0,0
109686,the,0,0
109687,alternative,0,0
109688,HD,0,1
109689,treatment,0,0
109690,.,0,0
109691,Apart,0,0
109692,from,0,0
109693,the,0,0
109694,dialyzer,0,0
109695,",",0,0
109696,the,0,0
109697,dialysis,0,0
109698,prescription,0,1
109699,remained,0,0
109700,unchanged,0,0
109701,.,0,0
109702,RESULTS,0,0
109703,Nineteen,0,0
109704,patients,0,0
109705,from,0,0
109706,group,0,0
109707,A,0,0
109708,and,0,0
109709,23,0,0
109710,patients,0,0
109711,from,0,0
109712,group,0,0
109713,B,0,0
109714,completed,0,0
109715,the,0,0
109716,study,0,0
109717,.,0,0
109718,Predialysis,1,1
109719,beta,1,1
109720,(,1,0
109721,2,1,0
109722,),1,0
109723,-microglobulin,1,1
109724,levels,1,1
109725,decreased,0,0
109726,significantly,0,0
109727,when,0,0
109728,using,0,0
109729,the,0,0
109730,high-flux,0,0
109731,polyamide,0,0
109732,membrane,0,1
109733,.,0,0
109734,No,0,0
109735,difference,0,0
109736,between,0,0
109737,membranes,0,1
109738,was,0,0
109739,observed,0,0
109740,for,0,0
109741,serum,1,1
109742,albumin,1,1
109743,",",1,1
109744,high-sensitivity,1,1
109745,C-reactive,1,1
109746,protein,1,1
109747,",",1,1
109748,fibrinogen,1,1
109749,",",1,1
109750,IL-6,1,1
109751,",",1,1
109752,triglycerides,1,1
109753,",",1,1
109754,HDL,1,1
109755,cholesterol,1,1
109756,",",1,1
109757,LDL,1,1
109758,cholesterol,1,1
109759,",",1,1
109760,and,1,1
109761,lipoprotein,1,1
109762,(,1,0
109763,a,1,0
109764,),1,0
109765,during,0,0
109766,the,0,0
109767,study,0,0
109768,.,0,0
109769,A,0,0
109770,significant,0,0
109771,increase,0,0
109772,in,0,0
109773,aortic,1,1
109774,PWV,1,1
109775,",",1,0
109776,a,1,0
109777,marker,1,1
109778,of,1,0
109779,aortic,1,1
109780,stiffness,1,1
109781,",",0,1
109782,was,0,0
109783,noted,0,1
109784,after,0,0
109785,patients,0,0
109786,switched,0,0
109787,from,0,0
109788,high-flux,0,0
109789,to,0,0
109790,low-flux,0,0
109791,polyamide,0,0
109792,membranes,0,1
109793,.,0,0
109794,Similarly,0,0
109795,",",0,0
109796,the,0,0
109797,rate,1,1
109798,of,1,0
109799,change,1,1
109800,in,1,0
109801,aortic,1,1
109802,PWV,1,1
109803,was,0,0
109804,significantly,0,0
109805,decreased,0,0
109806,with,0,0
109807,the,0,0
109808,use,0,0
109809,of,0,0
109810,the,0,0
109811,high-flux,0,0
109812,polyamide,0,0
109813,membrane,0,1
109814,.,0,1
109815,CONCLUSIONS,0,0
109816,Our,0,0
109817,findings,0,0
109818,suggest,0,0
109819,that,0,0
109820,dialysis,0,0
109821,with,0,0
109822,polyamide,0,0
109823,membranes,0,1
109824,with,0,0
109825,different,0,0
109826,flux,0,1
109827,characteristics,0,1
109828,did,0,0
109829,not,0,0
109830,modify,0,0
109831,the,0,0
109832,inflammatory,0,1
109833,indices,0,1
109834,and,0,1
109835,lipid,0,1
109836,profile,0,1
109837,in,0,0
109838,stable,0,1
109839,HD,0,1
109840,patients,0,0
109841,;,0,0
109842,however,0,0
109843,",",0,0
109844,a,0,0
109845,seemingly,0,0
109846,beneficial,0,0
109847,effect,0,1
109848,on,0,0
109849,aortic,0,1
109850,stiffness,0,1
109851,was,0,0
109852,noted,0,0
109853,for,0,0
109854,patients,0,0
109855,who,0,0
109856,were,0,0
109857,maintained,0,0
109858,on,0,0
109859,high-flux,0,0
109860,polyamide,0,0
109861,membrane,0,1
109862,.,0,0
109863,Attenuation,0,1
109864,of,0,1
109865,hemodynamic,0,1
109866,responses,0,1
109867,to,0,0
109868,laryngoscopy,0,0
109869,and,0,1
109870,tracheal,0,1
109871,intubation,0,0
109872,during,0,0
109873,rapid,0,1
109874,sequence,0,0
109875,induction,0,0
109876,:,0,0
109877,remifentanil,0,0
109878,vs.,0,0
109879,lidocaine,0,0
109880,with,0,0
109881,esmolol,0,0
109882,.,0,0
109883,AIM,0,0
109884,This,0,0
109885,study,0,0
109886,was,0,0
109887,designed,0,0
109888,to,0,0
109889,compare,0,0
109890,the,0,0
109891,effectiveness,0,1
109892,of,0,0
109893,remifentanil,0,0
109894,vs.,0,0
109895,a,0,0
109896,lidocaine-esmolol,0,0
109897,combination,0,0
109898,in,0,0
109899,blunting,0,0
109900,the,0,0
109901,hemodynamic,1,1
109902,response,1,1
109903,to,0,0
109904,laryngoscopy,0,1
109905,and,0,1
109906,intubation,0,1
109907,during,0,0
109908,rapid,0,1
109909,sequence,0,0
109910,induction,0,1
109911,using,0,0
109912,thiopental,0,0
109913,and,0,1
109914,rocuronium,0,0
109915,in,0,0
109916,normotensive,0,0
109917,patients,0,0
109918,.,0,0
109919,METHODS,0,0
109920,Sixty-six,0,0
109921,patients,0,0
109922,with,0,0
109923,American,0,0
109924,Society,0,0
109925,of,0,1
109926,Anesthesiologists,0,0
109927,(,0,0
109928,ASA,0,1
109929,),0,1
109930,physical,0,1
109931,status,0,1
109932,class,0,0
109933,I,0,0
109934,who,0,0
109935,required,0,1
109936,tracheal,0,1
109937,intubation,0,0
109938,for,0,0
109939,elective,0,0
109940,surgery,0,0
109941,were,0,0
109942,randomly,0,0
109943,assigned,0,0
109944,to,0,0
109945,one,0,0
109946,of,0,0
109947,two,0,0
109948,groups,0,0
109949,.,0,0
109950,Group,0,0
109951,R,0,1
109952,received,0,0
109953,0.9,0,0
109954,%,0,0
109955,saline,0,0
109956,10,0,0
109957,ml,0,0
109958,and,0,0
109959,remifentanil,0,0
109960,1,0,0
109961,microg/kg,0,0
109962,.,0,0
109963,Group,0,0
109964,LE,0,1
109965,received,0,0
109966,lidocaine,0,0
109967,1.5,0,0
109968,mg/kg,0,0
109969,and,0,0
109970,esmolol,0,0
109971,1.0,0,0
109972,mg/kg,0,0
109973,.,0,0
109974,Anesthesia,0,1
109975,was,0,0
109976,induced,0,0
109977,with,0,0
109978,thiopental,0,0
109979,sodium,0,0
109980,5,0,0
109981,mg/kg,0,0
109982,",",0,0
109983,followed,0,0
109984,by,0,0
109985,rocuronium,0,0
109986,1.0,0,0
109987,mg/kg,0,0
109988,.,0,0
109989,Mean,1,1
109990,arterial,1,1
109991,pressure,1,1
109992,and,1,1
109993,heart,1,1
109994,rate,1,1
109995,were,0,0
109996,recorded,0,0
109997,at,0,0
109998,baseline,0,0
109999,",",0,0
110000,after,0,0
110001,induction,0,1
110002,",",0,0
110003,immediately,0,0
110004,after,0,0
110005,intubation,0,0
110006,and,0,0
110007,every,0,0
110008,minute,0,1
110009,for,0,0
110010,five,0,0
110011,minutes,0,0
110012,after,0,0
110013,intubation,0,0
110014,.,0,0
110015,RESULTS,0,0
110016,Changes,0,1
110017,in,0,0
110018,mean,1,1
110019,arterial,1,1
110020,pressure,1,1
110021,over,1,0
110022,time,1,1
110023,between,0,0
110024,the,0,0
110025,two,0,0
110026,groups,0,0
110027,were,0,0
110028,significantly,0,0
110029,different,0,0
110030,(,0,0
110031,P,0,0
110032,<,0,0
110033,0.0001,0,0
110034,),0,0
110035,.,0,0
110036,The,0,0
110037,maximum,1,1
110038,pressor,1,1
110039,response,1,1
110040,was,0,0
110041,observed,0,0
110042,immediately,0,0
110043,after,0,0
110044,intubation,0,0
110045,",",0,0
110046,at,0,0
110047,which,0,0
110048,time,0,1
110049,the,0,0
110050,mean,1,1
110051,arterial,1,1
110052,pressure,1,1
110053,change,1,1
110054,from,0,0
110055,baseline,0,0
110056,in,0,0
110057,group,0,0
110058,LE,0,1
110059,(,0,0
110060,29.7,0,0
110061,%,0,0
110062,),0,0
110063,(,0,0
110064,95,0,0
110065,%,0,0
110066,confidence,0,0
110067,interval,0,0
110068,[,0,0
110069,CI,0,0
110070,],0,0
110071,:,0,0
110072,116.1,0,0
110073,",",0,0
110074,121.9,0,0
110075,),0,0
110076,was,0,0
110077,higher,0,0
110078,than,0,0
110079,that,0,0
110080,in,0,0
110081,group,0,0
110082,R,0,1
110083,(,0,0
110084,4.4,0,0
110085,%,0,0
110086,),0,0
110087,(,0,0
110088,95,0,0
110089,%,0,0
110090,CI,0,0
110091,:,0,0
110092,92.9,0,0
110093,",",0,0
110094,98.5,0,0
110095,),0,0
110096,(,0,0
110097,P,0,0
110098,<,0,0
110099,0.0001,0,0
110100,),0,0
110101,.,0,0
110102,Two,0,0
110103,patients,0,0
110104,in,0,0
110105,group,0,0
110106,R,0,1
110107,and,0,0
110108,15,0,0
110109,patients,0,0
110110,in,0,0
110111,group,0,0
110112,LE,0,1
110113,developed,0,1
110114,hypertension,1,1
110115,(,0,0
110116,odds,0,0
110117,ratio,0,0
110118,[,0,0
110119,OR,0,0
110120,],0,0
110121,:,0,0
110122,0.064,0,0
110123,),0,0
110124,(,0,0
110125,P,0,0
110126,<,0,0
110127,0.001,0,0
110128,),0,0
110129,.,0,0
110130,Changes,0,1
110131,in,0,0
110132,heart,1,1
110133,rate,1,1
110134,over,1,0
110135,time,1,1
110136,between,0,0
110137,the,0,0
110138,two,0,0
110139,groups,0,0
110140,were,0,0
110141,not,0,0
110142,significantly,0,0
110143,different,0,0
110144,(,0,0
110145,P=0.465,0,0
110146,),0,0
110147,.,0,0
110148,CONCLUSION,0,0
110149,The,0,0
110150,results,0,0
110151,of,0,0
110152,this,0,0
110153,study,0,0
110154,show,0,0
110155,that,0,0
110156,remifentanil,0,0
110157,1,0,0
110158,mg/kg,0,0
110159,is,0,0
110160,more,0,0
110161,effective,0,1
110162,than,0,0
110163,the,0,0
110164,combination,0,0
110165,of,0,0
110166,lidocaine,0,0
110167,1.5,0,0
110168,mg/kg,0,0
110169,and,0,0
110170,esmolol,0,0
110171,1,0,0
110172,mg/kg,0,0
110173,for,0,0
110174,attenuating,0,0
110175,the,0,0
110176,hemodynamic,1,1
110177,responses,1,1
110178,to,0,0
110179,rapid,0,0
110180,sequence,0,0
110181,intubation,0,0
110182,.,0,0
110183,PSK,0,0
110184,may,0,0
110185,suppress,0,1
110186,CD57,0,0
110187,(,0,0
110188,+,0,0
110189,),0,1
110190,T,0,0
110191,cells,0,1
110192,to,0,0
110193,improve,0,0
110194,survival,0,1
110195,of,0,0
110196,advanced,0,0
110197,gastric,0,1
110198,cancer,0,0
110199,patients,0,0
110200,.,0,0
110201,BACKGROUND,0,0
110202,A,0,0
110203,recent,0,0
110204,report,0,1
110205,showed,0,0
110206,that,0,0
110207,oral,0,0
110208,adjuvant,0,0
110209,immunochemotherapy,0,0
110210,with,0,0
110211,protein-bound,0,1
110212,polysaccharide,0,1
110213,K,0,1
110214,(,0,1
110215,PSK,0,1
110216,),0,1
110217,and,0,1
110218,tegafur/uracil,0,0
110219,(,0,1
110220,UFT,0,1
110221,),0,1
110222,for,0,0
110223,stage,0,0
110224,II,0,0
110225,and,0,1
110226,III,0,1
110227,colorectal,0,0
110228,cancer,0,0
110229,improves,0,1
110230,overall,0,1
110231,survival,0,1
110232,compared,0,0
110233,with,0,0
110234,UFT,0,0
110235,alone,0,0
110236,.,0,0
110237,PSK,0,0
110238,has,0,0
110239,been,0,0
110240,supposed,0,0
110241,to,0,0
110242,improve,0,0
110243,survival,0,1
110244,through,0,0
110245,immunological,0,1
110246,mechanisms,0,0
110247,such,0,0
110248,as,0,0
110249,induction,0,0
110250,of,0,1
110251,cytokines,0,1
110252,",",0,0
110253,regulation,0,1
110254,of,0,1
110255,Th1/Th2,0,0
110256,balance,0,1
110257,",",0,1
110258,and,0,1
110259,inhibition,0,1
110260,of,0,1
110261,immunosuppressive,0,0
110262,molecules,0,0
110263,.,0,0
110264,METHODS,0,0
110265,We,0,0
110266,investigated,0,0
110267,the,0,0
110268,mechanisms,0,0
110269,by,0,0
110270,which,0,0
110271,PSK,0,0
110272,influences,0,0
110273,immunological,1,1
110274,parameters,1,1
110275,such,0,0
110276,as,0,0
110277,Th1,1,0
110278,cells,1,1
110279,(,1,0
110280,IFN-gamma-positive,1,1
110281,CD4,1,1
110282,(,1,1
110283,+,1,0
110284,),1,1
110285,T,1,0
110286,cells,1,1
110287,),1,0
110288,",",1,0
110289,Th2,1,0
110290,cells,1,1
110291,(,1,0
110292,IL-4-positive,1,1
110293,CD4,1,1
110294,(,1,1
110295,+,1,0
110296,),1,1
110297,T,1,0
110298,cells,1,1
110299,),1,0
110300,",",1,0
110301,Th1/Th2,1,1
110302,ratio,1,1
110303,",",1,1
110304,NKT,1,1
110305,cells,1,1
110306,(,1,1
110307,CD56,1,1
110308,(,1,1
110309,+,1,0
110310,),1,1
110311,T,1,1
110312,cells,1,1
110313,and,1,1
110314,CD57,1,1
110315,(,1,1
110316,+,1,0
110317,),1,1
110318,T,1,0
110319,cells,1,1
110320,),1,0
110321,",",1,0
110322,NK,1,1
110323,cells,1,1
110324,",",1,1
110325,and,1,1
110326,CD25,1,1
110327,(,1,1
110328,+,1,0
110329,),1,1
110330,CD4,1,1
110331,(,1,0
110332,+,1,0
110333,),1,1
110334,T,1,0
110335,cells,1,1
110336,in,0,0
110337,stage,0,0
110338,III,0,1
110339,gastric,0,1
110340,cancer,0,0
110341,patients,0,0
110342,.,0,1
110343,Patients,0,0
110344,were,0,0
110345,randomly,0,0
110346,assigned,0,0
110347,to,0,0
110348,receive,0,0
110349,either,0,0
110350,3,0,0
110351,g,0,0
110352,PSK,0,0
110353,plus,0,0
110354,300,0,0
110355,mg,0,0
110356,UFT,0,0
110357,(,0,1
110358,PSK,0,1
110359,group,0,0
110360,),0,0
110361,or,0,0
110362,300,0,0
110363,mg,0,0
110364,UFT,0,0
110365,alone,0,0
110366,(,0,0
110367,control,0,0
110368,),0,0
110369,orally,0,0
110370,each,0,0
110371,day,0,0
110372,for,0,0
110373,at,0,0
110374,least,0,0
110375,1,0,0
110376,year,0,0
110377,following,0,0
110378,their,0,0
110379,operation,0,0
110380,.,0,0
110381,RESULTS,0,0
110382,Twenty-one,0,0
110383,registered,0,0
110384,patients,0,0
110385,with,0,0
110386,stage,0,0
110387,III,0,1
110388,gastric,0,1
110389,cancer,0,0
110390,were,0,0
110391,analyzed,0,0
110392,.,0,0
110393,The,0,0
110394,3-year,1,0
110395,overall,1,1
110396,survival,1,1
110397,was,0,0
110398,62.2,0,0
110399,%,0,0
110400,in,0,0
110401,the,0,0
110402,PSK,0,0
110403,group,0,0
110404,(,0,0
110405,n,0,0
110406,=,0,0
110407,10,0,0
110408,),0,0
110409,and,0,0
110410,12.5,0,0
110411,%,0,0
110412,in,0,0
110413,the,0,0
110414,control,0,0
110415,group,0,0
110416,(,0,0
110417,n,0,0
110418,=,0,0
110419,11,0,0
110420,),0,0
110421,(,0,0
110422,P,0,0
110423,=,0,0
110424,0.038,0,0
110425,),0,0
110426,.,0,0
110427,Before,0,0
110428,operation,0,0
110429,",",0,0
110430,there,0,0
110431,were,0,0
110432,no,0,0
110433,significant,0,0
110434,differences,0,0
110435,in,0,0
110436,the,0,0
110437,proportions,0,0
110438,of,0,0
110439,Th1,1,0
110440,cells,1,1
110441,",",1,0
110442,Th2,1,0
110443,cells,1,1
110444,",",1,1
110445,Th1/Th2,1,1
110446,ratio,1,1
110447,",",1,1
110448,CD56,1,1
110449,(,1,1
110450,+,1,0
110451,),1,1
110452,T,1,1
110453,cells,1,1
110454,",",1,1
110455,CD57,1,1
110456,(,1,1
110457,+,1,0
110458,),1,1
110459,T,1,1
110460,cells,1,1
110461,",",1,0
110462,NK,1,1
110463,cells,1,1
110464,",",1,1
110465,and,1,1
110466,CD4,1,1
110467,(,1,1
110468,+,1,0
110469,),1,1
110470,CD25,1,0
110471,(,1,0
110472,+,1,0
110473,),1,1
110474,T,1,0
110475,cells,1,1
110476,between,0,0
110477,PSK,0,1
110478,and,0,1
110479,control,0,0
110480,groups,0,0
110481,.,0,0
110482,However,0,0
110483,",",0,0
110484,after,0,0
110485,operation,0,0
110486,",",0,1
110487,CD57,1,1
110488,(,1,1
110489,+,1,0
110490,),1,1
110491,T,1,0
110492,cells,1,1
110493,decreased,0,0
110494,significantly,0,0
110495,in,0,0
110496,the,0,0
110497,PSK,0,0
110498,group,0,0
110499,compared,0,0
110500,to,0,0
110501,the,0,0
110502,control,0,0
110503,(,0,0
110504,P,0,0
110505,=,0,0
110506,0.0486,0,0
110507,),0,0
110508,.,0,0
110509,When,0,0
110510,all,0,0
110511,patients,0,0
110512,were,0,0
110513,analyzed,0,0
110514,",",0,0
110515,patients,0,0
110516,with,0,0
110517,increased,0,1
110518,proportion,0,1
110519,(,0,0
110520,>,0,0
110521,18,0,0
110522,%,0,0
110523,),0,0
110524,of,0,1
110525,CD57,0,0
110526,(,0,0
110527,+,0,0
110528,),0,1
110529,T,0,0
110530,cells,0,1
110531,showed,0,0
110532,worse,0,1
110533,survival,0,1
110534,than,0,0
110535,those,0,0
110536,with,0,0
110537,lower,0,0
110538,(,0,0
110539,<,0,0
110540,or,0,0
110541,=,0,0
110542,18,0,0
110543,%,0,0
110544,),0,0
110545,CD57,0,0
110546,(,0,0
110547,+,0,0
110548,),0,1
110549,T,0,1
110550,cells,0,1
110551,(,0,0
110552,3-year,0,0
110553,survival,0,1
110554,",",0,0
110555,25.0,0,0
110556,and,0,0
110557,45.7,0,0
110558,%,0,0
110559,",",0,0
110560,respectively,0,0
110561,;,0,0
110562,P,0,0
110563,=,0,0
110564,0.046,0,0
110565,),0,0
110566,",",0,0
110567,consistent,0,0
110568,with,0,0
110569,our,0,0
110570,previous,0,0
110571,report,0,0
110572,that,0,0
110573,high,0,1
110574,CD57,0,0
110575,(,0,1
110576,+,0,0
110577,),0,0
110578,is,0,0
110579,an,0,0
110580,indicator,0,0
110581,of,0,0
110582,poor,0,1
110583,prognosis,0,1
110584,in,0,0
110585,patients,0,0
110586,with,0,0
110587,advanced,0,0
110588,gastric,0,1
110589,cancer,0,0
110590,.,0,0
110591,However,0,0
110592,",",0,0
110593,in,0,0
110594,the,0,0
110595,group,0,0
110596,treated,0,0
110597,with,0,0
110598,PSK,0,1
110599,+,0,0
110600,UFT,0,1
110601,",",0,1
110602,3-year,1,0
110603,survival,1,1
110604,of,0,1
110605,CD57-high,0,0
110606,patients,0,0
110607,was,0,0
110608,as,0,0
110609,great,0,0
110610,as,0,0
110611,that,0,0
110612,of,0,0
110613,CD57-low,0,1
110614,patients,0,0
110615,(,0,0
110616,66.7,0,0
110617,and,0,0
110618,51.4,0,0
110619,%,0,0
110620,",",0,0
110621,respectively,0,0
110622,;,0,0
110623,P,0,0
110624,=,0,0
110625,0.67,0,0
110626,),0,0
110627,.,0,0
110628,CONCLUSION,0,0
110629,The,0,0
110630,present,0,0
110631,findings,0,0
110632,suggest,0,0
110633,that,0,0
110634,PSK,0,0
110635,improves,0,1
110636,overall,0,1
110637,survival,0,1
110638,of,0,1
110639,stage,0,0
110640,III,0,1
110641,gastric,0,1
110642,cancer,0,0
110643,patients,0,0
110644,partly,0,0
110645,by,0,0
110646,inhibiting,0,1
110647,CD57,0,0
110648,(,0,0
110649,+,0,0
110650,),0,1
110651,T,0,1
110652,cells,0,1
110653,",",0,0
110654,a,0,0
110655,proven,0,0
110656,poor,0,1
110657,prognostic,0,1
110658,factor,0,1
110659,in,0,0
110660,advanced,0,0
110661,gastric,0,1
110662,cancer,0,0
110663,.,0,0
110664,Stroke,0,1
110665,team,0,1
110666,remote,0,0
110667,evaluation,0,0
110668,using,0,0
110669,a,0,0
110670,digital,0,0
110671,observation,0,0
110672,camera,0,1
110673,in,0,0
110674,Arizona,0,0
110675,:,0,0
110676,the,0,0
110677,initial,0,0
110678,mayo,0,1
110679,clinic,0,1
110680,experience,0,1
110681,trial,0,0
110682,.,0,1
110683,BACKGROUND,0,0
110684,AND,0,0
110685,PURPOSE,0,0
110686,Telemedicine,0,0
110687,techniques,0,0
110688,can,0,0
110689,be,0,0
110690,used,0,0
110691,to,0,0
110692,address,0,0
110693,the,0,0
110694,rural-metropolitan,0,0
110695,disparity,0,1
110696,in,0,0
110697,acute,0,0
110698,stroke,0,1
110699,care,0,0
110700,.,0,0
110701,The,0,0
110702,Stroke,0,1
110703,Team,0,1
110704,Remote,0,0
110705,Evaluation,0,1
110706,Using,0,0
110707,a,0,0
110708,Digital,0,1
110709,Observation,0,0
110710,Camera,0,0
110711,(,0,0
110712,STRokE,0,0
110713,DOC,0,1
110714,),0,1
110715,trial,0,0
110716,reported,0,0
110717,more,0,0
110718,accurate,0,1
110719,decision,0,1
110720,making,0,1
110721,for,0,0
110722,telemedicine,0,0
110723,consultations,0,1
110724,compared,0,0
110725,with,0,0
110726,telephone-only,0,0
110727,and,0,0
110728,that,0,0
110729,the,0,0
110730,California-based,0,0
110731,research,0,0
110732,network,0,0
110733,facilitated,0,0
110734,a,0,0
110735,high,0,0
110736,rate,0,1
110737,of,0,1
110738,thrombolysis,0,0
110739,use,0,1
110740,",",0,1
110741,improved,0,1
110742,data,0,0
110743,collection,0,0
110744,",",0,1
110745,low,0,1
110746,risk,0,1
110747,of,0,1
110748,complications,0,1
110749,",",0,0
110750,low,0,0
110751,technical,0,1
110752,complications,0,1
110753,",",0,1
110754,and,0,1
110755,favorable,0,1
110756,assessment,0,0
110757,times,0,1
110758,.,0,0
110759,The,0,0
110760,main,0,0
110761,objective,0,0
110762,of,0,0
110763,the,0,0
110764,STRokE,0,0
110765,DOC,0,0
110766,Arizona,0,1
110767,TIME,0,1
110768,(,0,0
110769,The,0,0
110770,Initial,0,1
110771,Mayo,0,1
110772,Clinic,0,0
110773,Experience,0,1
110774,),0,1
110775,trial,0,0
110776,was,0,0
110777,to,0,0
110778,determine,0,0
110779,the,0,0
110780,feasibility,0,0
110781,of,0,0
110782,establishing,0,0
110783,",",0,0
110784,de,0,0
110785,novo,0,1
110786,",",0,0
110787,a,0,0
110788,single-hub,0,0
110789,",",0,0
110790,multirural,0,0
110791,spoke,0,0
110792,hospital,0,1
110793,telestroke,0,0
110794,research,0,0
110795,network,0,0
110796,across,0,0
110797,a,0,0
110798,large,0,0
110799,geographical,0,1
110800,area,0,1
110801,in,0,0
110802,Arizona,0,0
110803,by,0,0
110804,replicating,0,0
110805,the,0,0
110806,STRokE,0,0
110807,DOC,0,0
110808,protocol,0,0
110809,.,0,1
110810,METHODS,0,0
110811,Methods,0,0
110812,included,0,0
110813,prospective,0,0
110814,",",0,1
110815,single-hub,0,0
110816,",",0,1
110817,2-spoke,0,0
110818,",",0,1
110819,randomized,0,0
110820,",",0,1
110821,blinded,0,0
110822,",",0,1
110823,controlled,0,0
110824,trial,0,0
110825,of,0,0
110826,a,0,0
110827,2-way,0,0
110828,",",0,0
110829,site-independent,0,0
110830,",",0,1
110831,audiovisual,0,1
110832,telemedicine,0,0
110833,system,0,0
110834,designed,0,0
110835,for,0,0
110836,remote,0,0
110837,examination,0,0
110838,of,0,1
110839,adult,0,0
110840,patients,0,0
110841,with,0,0
110842,acute,0,0
110843,stroke,0,1
110844,versus,0,0
110845,telephone,0,0
110846,consultation,0,0
110847,to,0,0
110848,assess,0,0
110849,eligibility,0,0
110850,for,0,0
110851,treatment,0,0
110852,with,0,0
110853,intravenous,0,0
110854,thrombolysis,0,0
110855,.,0,0
110856,The,0,0
110857,primary,0,0
110858,outcome,0,1
110859,measure,0,1
110860,was,0,0
110861,whether,0,0
110862,the,0,0
110863,decision,1,0
110864,to,1,0
110865,give,1,1
110866,thrombolysis,1,0
110867,was,1,0
110868,correct,1,0
110869,.,1,0
110870,Secondary,0,0
110871,outcomes,0,1
110872,were,0,0
110873,rate,1,1
110874,of,1,1
110875,thrombolytic,1,1
110876,use,1,0
110877,",",1,1
110878,90-day,1,1
110879,functional,1,1
110880,outcomes,1,1
110881,",",1,1
110882,incidence,1,1
110883,of,1,1
110884,intracerebral,1,1
110885,hemorrhages,1,1
110886,",",1,1
110887,and,1,1
110888,technical,1,1
110889,observations,1,0
110890,.,1,0
110891,RESULTS,0,0
110892,From,0,0
110893,December,0,0
110894,2007,0,0
110895,to,0,0
110896,October,0,0
110897,2008,0,0
110898,",",0,0
110899,54,0,0
110900,patients,0,0
110901,were,0,0
110902,assessed,0,0
110903,",",0,0
110904,27,0,0
110905,of,0,0
110906,whom,0,0
110907,were,0,0
110908,randomized,0,0
110909,to,0,0
110910,each,0,0
110911,arm,0,0
110912,.,0,0
110913,Mean,0,1
110914,National,0,1
110915,Institutes,0,0
110916,of,0,0
110917,Health,0,1
110918,Stroke,0,1
110919,Scale,0,1
110920,score,0,1
110921,at,0,1
110922,presentation,0,1
110923,was,0,0
110924,7.3,0,0
110925,(,0,0
110926,SD,0,0
110927,6.2,0,0
110928,),0,0
110929,points,0,0
110930,.,0,0
110931,No,0,0
110932,consultations,0,1
110933,were,0,0
110934,aborted,0,0
110935,;,0,0
110936,however,0,0
110937,",",0,0
110938,technical,1,1
110939,problems,1,1
110940,(,0,0
110941,74,0,0
110942,%,0,0
110943,),0,0
110944,were,0,0
110945,prevalent,0,0
110946,in,0,0
110947,the,0,0
110948,telemedicine,0,0
110949,arm,0,0
110950,.,0,1
110951,Overall,0,0
110952,",",0,0
110953,the,0,0
110954,correct,0,1
110955,treatment,1,0
110956,decision,1,1
110957,was,0,0
110958,established,0,0
110959,in,0,0
110960,87,0,0
110961,%,0,0
110962,of,0,0
110963,the,0,0
110964,consultations,0,0
110965,.,0,0
110966,Both,0,0
110967,modalities,0,0
110968,",",0,1
110969,telephone,0,0
110970,(,0,0
110971,89,0,0
110972,%,0,0
110973,correct,0,0
110974,),0,1
110975,and,0,1
110976,telemedicine,0,0
110977,(,0,0
110978,85,0,0
110979,%,0,0
110980,correct,0,0
110981,),0,1
110982,",",0,0
110983,performed,0,0
110984,well,0,0
110985,.,0,0
110986,Intravenous,0,0
110987,thrombolytic,0,1
110988,treatment,0,0
110989,was,0,0
110990,used,0,0
110991,in,0,0
110992,30,0,0
110993,%,0,0
110994,of,0,0
110995,the,0,0
110996,telemedicine,0,0
110997,and,0,1
110998,telephone,0,0
110999,consultations,0,1
111000,.,0,0
111001,Good,0,1
111002,functional,1,1
111003,outcomes,1,1
111004,at,0,0
111005,90,0,0
111006,days,0,0
111007,were,0,0
111008,not,0,0
111009,significantly,0,0
111010,different,0,0
111011,.,0,0
111012,There,0,0
111013,were,0,0
111014,no,0,0
111015,statistically,0,0
111016,significant,0,0
111017,differences,0,0
111018,in,0,0
111019,mortality,1,1
111020,(,0,0
111021,4,0,0
111022,%,0,0
111023,in,0,0
111024,telemedicine,0,0
111025,and,0,0
111026,11,0,0
111027,%,0,0
111028,in,0,0
111029,telephone,0,0
111030,),0,1
111031,or,0,0
111032,rates,1,1
111033,of,1,1
111034,intracerebral,1,1
111035,hemorrhage,1,1
111036,(,0,0
111037,4,0,0
111038,%,0,0
111039,in,0,0
111040,telemedicine,0,0
111041,and,0,0
111042,0,0,0
111043,%,0,0
111044,in,0,0
111045,telephone,0,0
111046,),0,0
111047,.,0,0
111048,CONCLUSIONS,0,0
111049,It,0,0
111050,is,0,0
111051,feasible,0,0
111052,to,0,0
111053,extend,0,0
111054,the,0,0
111055,original,0,0
111056,STRokE,0,0
111057,DOC,0,1
111058,trial,0,0
111059,protocol,0,0
111060,to,0,0
111061,a,0,0
111062,new,0,0
111063,state,0,0
111064,and,0,0
111065,establish,0,0
111066,an,0,0
111067,operational,0,1
111068,single-hub,0,0
111069,",",0,1
111070,multispoke,0,0
111071,rural,0,0
111072,hospital,0,1
111073,telestroke,0,0
111074,research,0,0
111075,network,0,0
111076,in,0,0
111077,Arizona,0,0
111078,.,0,0
111079,The,0,0
111080,trial,0,0
111081,was,0,0
111082,not,0,0
111083,designed,0,0
111084,to,0,0
111085,have,0,0
111086,sufficient,0,0
111087,power,0,1
111088,to,0,0
111089,detect,0,0
111090,a,0,0
111091,difference,0,0
111092,between,0,0
111093,the,0,0
111094,2,0,0
111095,consultative,0,0
111096,modes,0,0
111097,:,0,0
111098,telemedicine,0,0
111099,and,0,0
111100,telephone-only,0,0
111101,.,0,0
111102,Whether,0,0
111103,by,0,0
111104,telemedicine,0,0
111105,or,0,1
111106,telephone,0,0
111107,consultative,0,1
111108,modalities,0,0
111109,",",0,0
111110,there,0,0
111111,were,0,0
111112,appropriate,0,0
111113,treatment,1,0
111114,decisions,1,1
111115,",",0,0
111116,high,0,0
111117,rates,0,1
111118,of,0,1
111119,thrombolysis,1,0
111120,use,1,1
111121,",",0,1
111122,improved,0,1
111123,data,1,0
111124,collection,1,0
111125,",",0,0
111126,low,0,1
111127,rates,1,1
111128,of,1,1
111129,intracerebral,1,1
111130,hemorrhage,1,1
111131,",",0,1
111132,and,0,1
111133,equally,0,1
111134,favorable,0,0
111135,time,1,1
111136,requirements,1,1
111137,.,1,0
111138,The,0,0
111139,learning,0,1
111140,curve,0,1
111141,was,0,0
111142,steep,0,0
111143,for,0,0
111144,the,0,0
111145,hub,0,0
111146,and,0,1
111147,spoke,0,0
111148,personnel,0,1
111149,of,0,0
111150,the,0,0
111151,new,0,0
111152,telestroke,0,0
111153,network,0,0
111154,",",0,0
111155,as,0,0
111156,reflected,0,1
111157,by,0,0
111158,frequent,0,1
111159,technical,0,0
111160,problems,0,1
111161,.,0,1
111162,Overall,0,0
111163,",",0,0
111164,the,0,0
111165,results,0,0
111166,support,0,0
111167,the,0,0
111168,effectiveness,0,1
111169,of,0,0
111170,highly,0,0
111171,organized,0,0
111172,and,0,0
111173,structured,0,0
111174,stroke,0,1
111175,telemedicine,0,0
111176,networks,0,0
111177,for,0,0
111178,extending,0,0
111179,expert,0,0
111180,stroke,0,1
111181,care,0,0
111182,into,0,0
111183,rural,0,0
111184,remote,0,0
111185,communities,0,0
111186,lacking,0,0
111187,sufficient,0,0
111188,neurological,0,1
111189,expertise,0,0
111190,.,0,0
111191,Small,0,0
111192,but,0,0
111193,important,0,1
111194,errors,0,1
111195,in,0,0
111196,cardiovascular,0,1
111197,risk,0,1
111198,calculation,0,1
111199,by,0,0
111200,practice,0,0
111201,nurses,0,0
111202,:,0,0
111203,a,0,0
111204,cross-sectional,0,0
111205,study,0,0
111206,in,0,0
111207,randomised,0,0
111208,trial,0,0
111209,setting,0,0
111210,.,0,1
111211,BACKGROUND,0,0
111212,Practice,0,0
111213,nurses,0,0
111214,play,0,0
111215,an,0,0
111216,increasingly,0,0
111217,important,0,0
111218,role,0,0
111219,in,0,0
111220,the,0,0
111221,prevention,0,0
111222,of,0,0
111223,cardiovascular,0,1
111224,diseases,0,0
111225,but,0,0
111226,we,0,0
111227,do,0,0
111228,not,0,0
111229,have,0,0
111230,evidence,0,0
111231,about,0,0
111232,the,0,0
111233,accuracy,1,1
111234,of,0,0
111235,their,0,0
111236,cardiovascular,0,1
111237,risk,0,1
111238,assessments,0,0
111239,during,0,0
111240,real,0,1
111241,practice,0,0
111242,consultations,0,1
111243,.,0,0
111244,OBJECTIVES,0,0
111245,To,0,0
111246,examine,0,0
111247,how,0,0
111248,nurses,0,0
111249,perform,0,0
111250,with,0,0
111251,regard,0,0
111252,to,0,0
111253,absolute,0,1
111254,10-year,0,1
111255,cardiovascular,1,1
111256,risk,1,1
111257,assessment,1,0
111258,in,0,0
111259,actual,0,1
111260,practice,0,0
111261,.,0,0
111262,DESIGN,0,0
111263,Cross-sectional,0,1
111264,study,0,0
111265,.,0,0
111266,SETTING,0,0
111267,This,0,0
111268,study,0,0
111269,was,0,0
111270,nested,0,0
111271,in,0,0
111272,the,0,0
111273,IMPALA,0,0
111274,study,0,0
111275,",",0,0
111276,a,0,0
111277,clustered,0,1
111278,randomised,0,0
111279,controlled,0,0
111280,trial,0,0
111281,involving,0,0
111282,24,0,0
111283,general,0,0
111284,practices,0,0
111285,in,0,0
111286,The,0,0
111287,Netherlands,0,0
111288,.,0,0
111289,PARTICIPANTS,0,0
111290,24,0,0
111291,practice,0,0
111292,nurses,0,0
111293,",",0,0
111294,trained,0,0
111295,in,0,0
111296,10-year,0,1
111297,cardiovascular,0,1
111298,risk,0,1
111299,assessment,0,1
111300,",",0,0
111301,calculated,0,0
111302,the,0,0
111303,risk,0,1
111304,of,0,0
111305,a,0,0
111306,total,0,0
111307,of,0,0
111308,421,0,0
111309,patients,0,0
111310,without,0,0
111311,established,0,0
111312,cardiovascular,0,1
111313,diseases,0,0
111314,but,0,0
111315,eligible,0,0
111316,for,0,0
111317,cardiovascular,1,1
111318,risk,1,1
111319,assessment,1,0
111320,.,1,0
111321,METHODS,0,0
111322,The,0,0
111323,main,0,1
111324,outcome,0,1
111325,measure,0,1
111326,was,0,0
111327,the,0,0
111328,accuracy,1,1
111329,of,1,0
111330,risk,1,1
111331,assessments,1,0
111332,",",0,0
111333,defined,0,1
111334,as,0,0
111335,(,0,0
111336,1,0,0
111337,),0,0
111338,the,0,0
111339,difference,1,0
111340,between,1,0
111341,the,1,0
111342,10-year,1,1
111343,cardiovascular,1,1
111344,risk,1,1
111345,percentage,1,1
111346,calculated,1,0
111347,by,1,0
111348,nurses,1,0
111349,and,1,0
111350,an,1,0
111351,independent,1,1
111352,assessor,1,1
111353,",",0,1
111354,and,0,1
111355,(,0,0
111356,2,0,0
111357,),0,0
111358,the,1,0
111359,agreement,1,0
111360,between,1,0
111361,the,1,0
111362,treatment,1,0
111363,categories,1,0
111364,assigned,1,0
111365,by,1,0
111366,the,1,0
111367,nurses,1,0
111368,(,1,0
111369,low,1,0
111370,",",1,1
111371,moderate,1,0
111372,or,1,1
111373,high,1,1
111374,risk,1,1
111375,),1,0
111376,and,1,0
111377,those,1,0
111378,assigned,1,0
111379,by,1,0
111380,the,1,0
111381,independent,1,0
111382,assessor,1,0
111383,.,1,0
111384,RESULTS,0,0
111385,Thirty-one,0,0
111386,(,0,0
111387,7.4,0,0
111388,%,0,0
111389,),0,0
111390,of,0,0
111391,the,0,0
111392,calculated,0,0
111393,risk,0,1
111394,percentages,0,1
111395,differed,0,0
111396,by,0,0
111397,more,0,0
111398,than,0,0
111399,our,0,0
111400,preset,0,0
111401,limits,0,0
111402,",",0,0
111403,25,0,0
111404,(,0,0
111405,81,0,0
111406,%,0,0
111407,),0,0
111408,being,0,0
111409,underestimations,0,0
111410,.,0,0
111411,Elderly,0,0
111412,patients,0,0
111413,(,0,0
111414,OR,0,0
111415,1.1,0,0
111416,",",0,0
111417,95,0,0
111418,%,0,0
111419,CI,0,0
111420,1.0-1.1,0,0
111421,),0,0
111422,",",0,0
111423,male,0,0
111424,patients,0,0
111425,(,0,0
111426,vs.,0,0
111427,female,0,0
111428,OR,0,0
111429,3.1,0,0
111430,",",0,0
111431,95,0,0
111432,%,0,0
111433,CI,0,0
111434,1.2-7.3,0,0
111435,),0,0
111436,",",0,0
111437,and,0,1
111438,smoking,0,1
111439,patients,0,0
111440,(,0,0
111441,vs.,0,0
111442,non-smoking,0,0
111443,OR,0,0
111444,3.8,0,0
111445,",",0,0
111446,95,0,0
111447,%,0,0
111448,CI,0,0
111449,1.7-8.9,0,0
111450,),0,0
111451,were,0,0
111452,more,0,0
111453,likely,0,0
111454,to,0,0
111455,have,0,0
111456,their,0,0
111457,cardiovascular,1,1
111458,risk,1,1
111459,miscalculated,1,1
111460,.,1,1
111461,Ten,0,0
111462,(,0,0
111463,28,0,0
111464,%,0,0
111465,),0,0
111466,of,0,0
111467,the,0,0
111468,36,0,0
111469,patients,0,0
111470,who,0,0
111471,should,0,0
111472,be,0,0
111473,assigned,0,0
111474,to,0,0
111475,the,0,0
111476,high-risk,0,0
111477,treatment,0,0
111478,category,0,0
111479,according,0,0
111480,to,0,0
111481,the,0,0
111482,independent,0,0
111483,calculation,0,1
111484,",",0,1
111485,were,0,0
111486,missed,0,0
111487,as,0,0
111488,high-risk,0,0
111489,patients,0,0
111490,by,0,0
111491,the,0,0
111492,practice,0,0
111493,nurses,0,0
111494,.,0,0
111495,CONCLUSIONS,0,0
111496,The,0,0
111497,overall,0,1
111498,standard,0,0
111499,of,0,1
111500,accuracy,0,1
111501,of,0,1
111502,cardiovascular,0,1
111503,risk,0,1
111504,assessment,0,0
111505,by,0,0
111506,trained,0,0
111507,practice,0,0
111508,nurses,0,0
111509,in,0,0
111510,actual,0,0
111511,practice,0,0
111512,is,0,0
111513,high,0,0
111514,.,0,0
111515,However,0,0
111516,",",0,0
111517,a,0,0
111518,significant,0,0
111519,number,0,1
111520,of,0,1
111521,high-risk,0,0
111522,patients,0,0
111523,were,0,0
111524,misclassified,0,0
111525,",",0,0
111526,with,0,0
111527,the,0,0
111528,probability,0,0
111529,that,0,0
111530,it,0,0
111531,led,0,0
111532,to,0,0
111533,missed,0,0
111534,opportunities,0,0
111535,for,0,0
111536,risk-reducing,0,0
111537,interventions,0,0
111538,.,0,0
111539,As,0,0
111540,cardiovascular,0,1
111541,risk,0,1
111542,assessments,0,0
111543,are,0,0
111544,frequently,0,0
111545,done,0,0
111546,by,0,0
111547,nurses,0,0
111548,in,0,0
111549,general,0,0
111550,practice,0,0
111551,",",0,1
111552,further,0,0
111553,specific,0,0
111554,training,0,0
111555,should,0,0
111556,be,0,0
111557,considered,0,0
111558,to,0,0
111559,prevent,0,0
111560,undertreatment,0,0
111561,.,0,0
111562,Catheter-related,1,1
111563,infections,1,1
111564,via,0,0
111565,temporary,0,1
111566,vascular,0,1
111567,access,0,0
111568,catheters,0,0
111569,:,0,0
111570,a,0,0
111571,randomized,0,0
111572,prospective,0,0
111573,study,0,0
111574,.,0,0
111575,Temporary,0,0
111576,vascular,0,1
111577,access,0,1
111578,catheters,0,1
111579,(,0,1
111580,VACs,0,0
111581,),0,0
111582,are,0,0
111583,important,0,0
111584,devices,0,0
111585,used,0,0
111586,in,0,0
111587,acute,0,0
111588,blood,0,1
111589,purification,0,1
111590,therapies,0,0
111591,.,0,0
111592,The,0,0
111593,aim,0,0
111594,of,0,0
111595,this,0,0
111596,study,0,0
111597,was,0,0
111598,to,0,0
111599,determine,0,0
111600,whether,0,0
111601,a,0,0
111602,catheterization,0,0
111603,duration,0,1
111604,of,0,0
111605,2,0,0
111606,weeks,0,0
111607,increased,0,0
111608,the,0,0
111609,risk,1,1
111610,of,1,0
111611,nosocomial,1,1
111612,complications,1,1
111613,when,0,0
111614,compared,0,0
111615,with,0,0
111616,a,0,0
111617,1-week,0,0
111618,duration,0,1
111619,.,0,0
111620,Fifty-six,0,0
111621,patients,0,0
111622,with,0,0
111623,90,0,0
111624,double,0,0
111625,lumen,0,1
111626,VACs,0,0
111627,were,0,0
111628,randomly,0,0
111629,chosen,0,0
111630,",",0,0
111631,and,0,0
111632,received,0,0
111633,either,0,0
111634,1-,0,0
111635,or,0,0
111636,2-week,0,0
111637,catheterizations,0,1
111638,from,0,0
111639,operators,0,0
111640,experienced,0,0
111641,in,0,0
111642,the,0,0
111643,placement,0,0
111644,of,0,0
111645,such,0,0
111646,catheters,0,0
111647,at,0,0
111648,three,0,0
111649,sites,0,0
111650,such,0,0
111651,as,0,0
111652,the,0,0
111653,internal,0,0
111654,jugular,0,0
111655,",",0,1
111656,subclavian,0,1
111657,",",0,1
111658,or,0,1
111659,femoral,0,1
111660,vein,0,1
111661,.,0,0
111662,The,0,0
111663,characteristics,0,0
111664,of,0,0
111665,the,0,0
111666,VACs,0,0
111667,",",0,0
111668,including,0,0
111669,the,0,0
111670,sites,0,0
111671,",",0,0
111672,procedures,0,0
111673,",",0,1
111674,and,0,1
111675,lengths,0,1
111676,",",0,1
111677,were,0,0
111678,similar,0,0
111679,in,0,0
111680,both,0,0
111681,groups,0,0
111682,.,0,0
111683,No,0,0
111684,significant,0,0
111685,difference,0,0
111686,in,0,0
111687,the,0,0
111688,rate,1,1
111689,of,1,1
111690,catheter,1,1
111691,colonization,1,1
111692,was,0,0
111693,observed,0,0
111694,between,0,0
111695,the,0,0
111696,groups,0,0
111697,(,0,0
111698,14.6,0,0
111699,%,0,0
111700,vs,0,0
111701,26.2,0,0
111702,%,0,0
111703,",",0,0
111704,P,0,0
111705,=,0,0
111706,0.1371,0,0
111707,),0,0
111708,.,0,0
111709,No,0,0
111710,significant,0,0
111711,difference,0,0
111712,in,0,0
111713,the,0,0
111714,rate,1,1
111715,of,1,0
111716,catheter-related,1,1
111717,bloodstream,1,1
111718,infections,1,1
111719,was,0,0
111720,observed,0,0
111721,between,0,0
111722,the,0,0
111723,groups,0,0
111724,(,0,0
111725,2.1,0,0
111726,%,0,0
111727,vs,0,0
111728,4.8,0,0
111729,%,0,0
111730,",",0,0
111731,P,0,0
111732,=,0,0
111733,0.5967,0,0
111734,),0,0
111735,.,0,0
111736,Two-week,0,0
111737,indwelling,0,1
111738,did,0,0
111739,not,0,0
111740,increase,0,0
111741,the,0,0
111742,risk,1,1
111743,of,1,0
111744,infection,1,1
111745,compared,0,0
111746,with,0,0
111747,1-week,0,0
111748,indwelling,0,0
111749,at,0,0
111750,any,0,0
111751,of,0,0
111752,the,0,0
111753,sites,0,0
111754,in,0,0
111755,critically,0,0
111756,ill,0,0
111757,patients,0,0
111758,.,0,0
111759,Response,1,1
111760,to,1,0
111761,familiar,1,0
111762,faces,1,1
111763,",",0,0
111764,newly,0,0
111765,familiar,0,0
111766,faces,0,1
111767,",",0,0
111768,and,0,0
111769,novel,0,0
111770,faces,0,1
111771,as,0,0
111772,assessed,0,0
111773,by,0,0
111774,ERPs,0,0
111775,is,0,0
111776,intact,0,0
111777,in,0,0
111778,adults,0,0
111779,with,0,0
111780,autism,0,0
111781,spectrum,0,0
111782,disorders,0,0
111783,.,0,0
111784,Individuals,0,0
111785,with,0,0
111786,autism,0,0
111787,spectrum,0,0
111788,disorders,0,1
111789,(,0,1
111790,ASD,0,0
111791,),0,0
111792,have,0,0
111793,pervasive,0,0
111794,impairments,0,1
111795,in,0,0
111796,social,0,1
111797,functioning,0,1
111798,",",0,0
111799,which,0,0
111800,may,0,0
111801,include,0,0
111802,problems,0,1
111803,with,0,0
111804,processing,0,1
111805,and,0,0
111806,remembering,0,1
111807,faces,0,1
111808,.,0,0
111809,In,0,0
111810,this,0,0
111811,study,0,0
111812,",",0,0
111813,we,0,0
111814,examined,0,0
111815,whether,0,0
111816,posterior,0,0
111817,ERP,0,0
111818,components,0,1
111819,associated,0,0
111820,with,0,0
111821,identity,0,1
111822,processing,0,1
111823,(,0,1
111824,P2,0,0
111825,",",0,1
111826,N250,0,1
111827,and,0,1
111828,face-N400,0,1
111829,),0,1
111830,and,0,1
111831,components,0,1
111832,associated,0,0
111833,with,0,0
111834,early-stage,0,0
111835,face,0,1
111836,processing,0,1
111837,(,0,1
111838,P1,0,1
111839,and,0,1
111840,N170,0,0
111841,),0,0
111842,are,0,0
111843,atypical,0,0
111844,in,0,0
111845,ASD,0,0
111846,.,0,0
111847,We,0,0
111848,collected,0,0
111849,ERP,1,0
111850,responses,1,1
111851,to,1,0
111852,a,1,0
111853,familiar,1,0
111854,repeated,1,0
111855,face,1,0
111856,(,1,0
111857,Familiar,1,1
111858,),1,0
111859,",",0,0
111860,an,0,0
111861,unfamiliar,1,0
111862,repeated,1,0
111863,face,1,0
111864,(,1,1
111865,Other,1,1
111866,),1,1
111867,and,1,0
111868,novel,1,0
111869,faces,1,1
111870,(,1,0
111871,Novels,1,1
111872,),1,0
111873,in,0,0
111874,29,0,0
111875,high-functioning,0,0
111876,adults,0,0
111877,with,0,0
111878,ASD,0,0
111879,and,0,1
111880,matched,0,0
111881,controls,0,0
111882,.,0,0
111883,For,0,0
111884,both,0,0
111885,groups,0,0
111886,",",0,0
111887,the,0,0
111888,P2,0,0
111889,and,0,1
111890,N250,0,0
111891,were,0,0
111892,sensitive,0,0
111893,to,0,0
111894,repetition,0,1
111895,(,0,0
111896,Other,0,1
111897,vs.,0,0
111898,Novels,0,1
111899,),0,1
111900,and,0,1
111901,personal,0,1
111902,familiarity,0,1
111903,(,0,0
111904,Familiar,0,1
111905,vs.,0,0
111906,Other,0,1
111907,),0,1
111908,",",0,0
111909,and,0,0
111910,the,0,0
111911,face-N400,0,1
111912,was,0,0
111913,sensitive,0,0
111914,to,0,0
111915,repetition,0,1
111916,.,0,0
111917,Adults,0,0
111918,with,0,0
111919,ASD,0,0
111920,did,0,0
111921,not,0,0
111922,show,0,0
111923,significantly,0,0
111924,atypical,0,0
111925,processing,1,1
111926,of,1,1
111927,facial,1,1
111928,familiarity,1,1
111929,and,1,1
111930,repetition,1,1
111931,in,0,0
111932,an,0,0
111933,ERP,0,1
111934,paradigm,0,0
111935,",",0,0
111936,despite,0,0
111937,showing,0,0
111938,significantly,0,0
111939,poorer,0,0
111940,performance,0,1
111941,than,0,0
111942,controls,0,0
111943,on,0,0
111944,a,0,0
111945,behavioral,0,1
111946,test,0,1
111947,of,0,1
111948,face,1,0
111949,memory,1,1
111950,.,1,0
111951,This,0,0
111952,study,0,0
111953,found,0,0
111954,no,0,0
111955,evidence,0,0
111956,that,0,0
111957,early-stage,0,0
111958,facial,0,1
111959,identity,0,1
111960,processing,0,0
111961,is,0,0
111962,a,0,0
111963,primary,0,0
111964,contributor,0,0
111965,to,0,0
111966,the,0,0
111967,face,0,0
111968,recognition,0,1
111969,deficit,0,1
111970,in,0,0
111971,high-functioning,0,0
111972,ASD,0,0
111973,.,0,0
111974,Capsaicin,0,0
111975,jelly,0,0
111976,against,0,0
111977,migraine,1,1
111978,pain,1,1
111979,.,1,1
111980,OBJECTIVE,0,1
111981,Recent,0,0
111982,studies,0,0
111983,support,0,0
111984,the,0,0
111985,role,0,0
111986,of,0,0
111987,extracranial,0,1
111988,perivascular,0,1
111989,afferents,0,0
111990,in,0,0
111991,a,0,0
111992,substantial,0,0
111993,percentage,0,1
111994,of,0,0
111995,migraineurs,0,0
111996,.,0,0
111997,Perivascular,0,1
111998,afferent,0,1
111999,fibres,0,0
112000,of,0,0
112001,the,0,0
112002,superficial,0,1
112003,temporal,0,1
112004,artery,0,1
112005,contain,0,0
112006,peptides,0,1
112007,",",0,0
112008,like,0,0
112009,calcitonin,0,1
112010,gene-related,0,1
112011,peptide,0,1
112012,(,0,1
112013,CGRP,0,1
112014,),0,1
112015,and,0,1
112016,substance,0,1
112017,P,0,0
112018,(,0,1
112019,SP,0,0
112020,),0,0
112021,.,0,0
112022,CGRP,0,0
112023,and,0,0
112024,SP,0,0
112025,are,0,0
112026,considered,0,0
112027,relevant,0,0
112028,in,0,0
112029,the,0,0
112030,genesis,0,0
112031,of,0,1
112032,migraine,0,1
112033,pain,0,1
112034,.,0,0
112035,Capsaicin,0,0
112036,is,0,0
112037,an,0,0
112038,agonist,0,0
112039,of,0,0
112040,the,0,0
112041,transient,0,1
112042,receptor,0,1
112043,potential,0,1
112044,vanilloid,0,0
112045,type,0,0
112046,1,0,0
112047,.,0,0
112048,It,0,0
112049,causes,0,0
112050,membrane,0,1
112051,depolarisation,0,1
112052,of,0,1
112053,sensory,0,1
112054,neurons,0,1
112055,",",0,0
112056,which,0,0
112057,release,0,1
112058,CGRP,0,0
112059,",",0,1
112060,SP,0,0
112061,and,0,1
112062,other,0,1
112063,pain,0,1
112064,peptides,0,1
112065,;,0,0
112066,excitation,0,0
112067,is,0,0
112068,followed,0,0
112069,by,0,0
112070,a,0,0
112071,refractory,0,0
112072,state,0,1
112073,",",0,1
112074,causing,0,1
112075,inactivation,0,1
112076,.,0,0
112077,Topical,0,0
112078,capsaicin,0,0
112079,has,0,0
112080,been,0,0
112081,found,0,0
112082,to,0,0
112083,be,0,0
112084,efficacious,0,0
112085,in,0,0
112086,several,0,0
112087,types,0,0
112088,of,0,1
112089,neuropathic,1,1
112090,pain,1,1
112091,.,1,0
112092,We,0,0
112093,attempted,0,0
112094,to,0,0
112095,verify,0,0
112096,whether,0,0
112097,topical,0,0
112098,periarterial,0,1
112099,capsaicin,0,0
112100,could,0,0
112101,ameliorate,0,0
112102,pain,1,1
112103,in,1,0
112104,absence,1,0
112105,of,1,1
112106,and,1,0
112107,during,1,0
112108,a,1,0
112109,migraine,1,1
112110,attack,1,1
112111,.,1,0
112112,METHODS,0,0
112113,On,0,0
112114,23,0,0
112115,migraineurs,0,0
112116,showing,0,0
112117,pain,0,1
112118,at,0,0
112119,pressure,0,1
112120,on,0,0
112121,scalp,0,1
112122,arteries,0,1
112123,",",0,0
112124,we,0,0
112125,administered,0,0
112126,topical,0,0
112127,capsaicin,0,0
112128,0.1,0,0
112129,%,0,0
112130,or,0,0
112131,vaseline,0,0
112132,jelly,0,0
112133,on,0,0
112134,painful,0,1
112135,arteries,0,1
112136,in,0,0
112137,absence,0,0
112138,of,0,1
112139,migraine,0,1
112140,attack,0,1
112141,.,0,0
112142,In,0,0
112143,those,0,0
112144,having,0,0
112145,pain,0,1
112146,reduction,0,1
112147,>,0,0
112148,50,0,0
112149,%,0,0
112150,",",0,0
112151,we,0,0
112152,made,0,0
112153,the,0,0
112154,same,0,0
112155,comparison,0,0
112156,during,0,0
112157,a,0,0
112158,migraine,0,1
112159,attack,0,1
112160,.,0,0
112161,RESULTS,0,0
112162,Topical,0,1
112163,capsaicin,0,0
112164,caused,0,0
112165,>,0,0
112166,50,0,0
112167,%,0,0
112168,reduction,0,1
112169,of,0,1
112170,arterial,1,1
112171,pain,1,1
112172,in,0,0
112173,absence,0,0
112174,of,0,1
112175,attack,0,1
112176,in,0,0
112177,17/23,0,0
112178,patients,0,0
112179,",",0,0
112180,as,0,0
112181,opposed,0,0
112182,to,0,0
112183,two,0,0
112184,with,0,0
112185,vaseline,0,0
112186,.,0,0
112187,During,0,0
112188,attacks,0,1
112189,of,0,0
112190,mild-,0,0
112191,to,0,0
112192,moderate-intensity,0,0
112193,",",0,0
112194,>,0,0
112195,50,0,0
112196,%,0,0
112197,improvement,0,1
112198,was,0,0
112199,obtained,0,0
112200,in,0,0
112201,11/17,0,0
112202,with,0,0
112203,capsaicin,0,0
112204,and,0,0
112205,in,0,0
112206,one,0,0
112207,with,0,0
112208,vaseline,0,0
112209,.,0,0
112210,CONCLUSIONS,0,0
112211,Although,0,0
112212,referring,0,0
112213,to,0,0
112214,a,0,0
112215,small,0,0
112216,number,0,1
112217,of,0,1
112218,patients,0,0
112219,",",0,0
112220,our,0,0
112221,data,0,0
112222,show,0,0
112223,that,0,0
112224,topical,0,0
112225,capsaicin,0,0
112226,may,0,0
112227,relieve,0,0
112228,arterial,1,1
112229,pain,1,1
112230,in,0,0
112231,absence,0,0
112232,of,0,1
112233,and,0,0
112234,during,0,0
112235,a,0,0
112236,migraine,0,1
112237,attack,0,0
112238,in,0,0
112239,a,0,0
112240,substantial,0,0
112241,number,0,1
112242,of,0,0
112243,patients,0,0
112244,experiencing,0,1
112245,scalp,0,1
112246,arterial,0,1
112247,tenderness,0,1
112248,.,0,0
112249,More,0,0
112250,active,0,0
112251,capsacinoids,0,0
112252,might,0,0
112253,be,0,0
112254,tried,0,0
112255,in,0,0
112256,the,0,0
112257,future,0,0
112258,and,0,0
112259,could,0,0
112260,provide,0,0
112261,a,0,0
112262,new,0,0
112263,method,0,0
112264,for,0,0
112265,treating,0,0
112266,migraine,0,1
112267,attacks,0,1
112268,.,0,0
112269,Effects,0,0
112270,of,0,0
112271,fish,0,0
112272,oil,0,0
112273,supplementation,0,0
112274,on,0,0
112275,markers,0,0
112276,of,0,0
112277,the,0,0
112278,metabolic,0,1
112279,syndrome,0,0
112280,.,0,0
112281,OBJECTIVE,0,0
112282,To,0,0
112283,investigate,0,0
112284,whether,0,0
112285,fish,0,0
112286,oil,0,0
112287,affects,0,0
112288,cardiovascular,1,1
112289,risk,1,1
112290,factors,1,0
112291,during,0,0
112292,the,0,0
112293,adolescent,0,0
112294,growth,0,1
112295,spurt,0,1
112296,.,0,1
112297,STUDY,0,0
112298,DESIGN,0,0
112299,A,0,0
112300,total,0,1
112301,of,0,0
112302,78,0,0
112303,boys,0,0
112304,age,0,0
112305,13-15,0,0
112306,years,0,0
112307,with,0,0
112308,a,0,0
112309,mean,0,1
112310,body,0,1
112311,fat,0,1
112312,percentage,0,1
112313,of,0,0
112314,30,0,0
112315,%,0,0
112316,+/-9,0,0
112317,%,0,0
112318,were,0,0
112319,randomly,0,0
112320,assigned,0,0
112321,to,0,0
112322,consume,0,0
112323,fish,0,0
112324,oil,0,0
112325,(,0,0
112326,providing,0,0
112327,1.5,0,0
112328,g,0,0
112329,of,0,0
112330,n-3,0,1
112331,long-chain,0,1
112332,polyunsaturated,0,1
112333,fatty,0,1
112334,acid/day,0,0
112335,),0,1
112336,or,0,0
112337,vegetable,0,1
112338,oil,0,0
112339,(,0,1
112340,control,0,0
112341,),0,0
112342,for,0,0
112343,16,0,0
112344,weeks,0,0
112345,.,0,0
112346,The,0,0
112347,oils,0,0
112348,were,0,0
112349,included,0,0
112350,in,0,0
112351,bread,0,0
112352,.,0,0
112353,RESULTS,0,0
112354,After,0,0
112355,the,0,0
112356,intervention,0,0
112357,",",0,0
112358,the,0,0
112359,red,1,1
112360,blood,1,1
112361,cell,1,1
112362,(,1,1
112363,RBC,1,1
112364,),1,1
112365,content,0,1
112366,of,0,1
112367,eicosapentaenoic,1,1
112368,acid,1,1
112369,(,1,1
112370,EPA,1,1
112371,),1,1
112372,and,1,1
112373,docosahexaenoic,1,1
112374,acid,1,1
112375,(,1,1
112376,DHA,1,1
112377,),1,0
112378,were,0,0
112379,1.2,0,0
112380,%,0,0
112381,+/-0.5,0,0
112382,%,0,0
112383,and,0,0
112384,6.7,0,0
112385,%,0,0
112386,+/-1.6,0,0
112387,%,0,0
112388,",",0,0
112389,respectively,0,0
112390,",",0,0
112391,in,0,0
112392,the,0,0
112393,those,0,0
112394,receiving,0,0
112395,fish,0,0
112396,oil,0,0
112397,(,0,1
112398,FO,0,0
112399,group,0,0
112400,),0,1
112401,",",0,0
112402,compared,0,0
112403,with,0,0
112404,0.6,0,0
112405,%,0,0
112406,+/-0.3,0,0
112407,%,0,0
112408,and,0,0
112409,4.1,0,0
112410,%,0,0
112411,+/-0.9,0,0
112412,%,0,0
112413,in,0,0
112414,the,0,0
112415,control,0,0
112416,group,0,0
112417,.,0,1
112418,Systolic,1,1
112419,blood,1,1
112420,pressure,1,1
112421,(,1,1
112422,SBP,1,1
112423,),1,1
112424,was,0,0
112425,3.8+/-1.4,0,0
112426,mm,0,0
112427,Hg,0,1
112428,lower,0,1
112429,(,0,0
112430,P,0,0
112431,<,0,0
112432,.006,0,0
112433,),0,1
112434,and,0,1
112435,diastolic,0,1
112436,blood,0,1
112437,pressure,0,1
112438,(,0,1
112439,DBP,0,1
112440,),0,1
112441,was,0,0
112442,2.6+/-1.1,0,0
112443,mm,0,0
112444,Hg,0,1
112445,lower,0,1
112446,(,0,0
112447,P,0,0
112448,<,0,0
112449,.01,0,1
112450,),0,0
112451,in,0,0
112452,the,0,0
112453,FO,0,0
112454,group,0,0
112455,compared,0,0
112456,with,0,0
112457,the,0,0
112458,control,0,0
112459,group,0,0
112460,.,0,1
112461,Plasma,1,1
112462,triacylglycerol,1,1
112463,(,1,1
112464,TAG,1,1
112465,),1,1
112466,concentration,1,1
112467,and,0,1
112468,insulin,1,1
112469,sensitivity,1,1
112470,were,0,0
112471,unaffected,0,0
112472,by,0,0
112473,either,0,0
112474,of,0,0
112475,the,0,0
112476,treatments,0,0
112477,.,0,0
112478,Plasma,1,1
112479,high-density,1,1
112480,lipoprotein,1,1
112481,(,1,1
112482,HDL,1,1
112483,),1,1
112484,and,1,1
112485,non-HDL,1,0
112486,cholesterol,1,1
112487,were,0,0
112488,increased,0,0
112489,by,0,0
112490,5,0,0
112491,%,0,0
112492,and,0,0
112493,7,0,0
112494,%,0,0
112495,",",0,0
112496,respectively,0,0
112497,",",0,0
112498,in,0,0
112499,the,0,0
112500,FO,0,0
112501,group,0,0
112502,",",0,1
112503,and,0,1
112504,by,0,0
112505,2,0,0
112506,%,0,0
112507,and,0,0
112508,0,0,0
112509,%,0,0
112510,in,0,0
112511,the,0,0
112512,control,0,0
112513,group,0,0
112514,(,0,1
112515,P,0,0
112516,<,0,0
112517,.01-.02,0,0
112518,),0,0
112519,.,0,0
112520,The,0,0
112521,changes,1,1
112522,in,1,0
112523,RBC,1,1
112524,EPA,1,1
112525,content,1,1
112526,were,0,0
112527,inversely,0,0
112528,correlated,0,0
112529,with,0,0
112530,the,0,0
112531,changes,1,1
112532,in,1,0
112533,SBP,1,1
112534,and,1,1
112535,DBP,1,1
112536,and,0,1
112537,directly,0,0
112538,correlated,0,0
112539,with,0,0
112540,the,0,0
112541,increases,0,0
112542,in,0,0
112543,HDL,1,1
112544,cholesterol,1,1
112545,and,1,1
112546,non-HDL,1,0
112547,cholesterol,1,1
112548,concentrations,1,1
112549,.,1,0
112550,No,0,0
112551,association,0,0
112552,was,0,0
112553,seen,0,0
112554,between,0,0
112555,RBC,1,1
112556,EPA,1,1
112557,and,1,1
112558,plasma,1,1
112559,TAG,1,1
112560,concentration,1,1
112561,or,1,1
112562,insulin,1,1
112563,sensitivity,1,1
112564,.,1,0
112565,CONCLUSION,0,0
112566,Fish,0,0
112567,oil,0,0
112568,improves,0,1
112569,BP,1,1
112570,in,0,0
112571,normotensive,0,0
112572,and,0,1
112573,normolipidemic,0,0
112574,slightly,0,1
112575,overweight,0,0
112576,adolescent,0,0
112577,boys,0,0
112578,.,0,0
112579,Biomarkers,0,1
112580,of,0,0
112581,dietary,0,0
112582,exposure,0,0
112583,are,0,0
112584,associated,0,0
112585,with,0,0
112586,lower,0,0
112587,risk,0,1
112588,of,0,1
112589,breast,0,0
112590,fibroadenomas,0,1
112591,in,0,0
112592,Chinese,0,0
112593,women,0,0
112594,.,0,0
112595,Fibroadenomas,0,0
112596,are,0,0
112597,the,0,0
112598,most,0,0
112599,common,0,0
112600,benign,0,0
112601,breast,0,0
112602,condition,0,0
112603,among,0,0
112604,women,0,0
112605,and,0,1
112606,account,0,0
112607,for,0,0
112608,up,0,0
112609,to,0,0
112610,50,0,0
112611,%,0,0
112612,of,0,0
112613,all,0,0
112614,breast,0,0
112615,biopsies,0,1
112616,being,0,0
112617,performed,0,0
112618,.,0,0
112619,Although,0,0
112620,considered,0,0
112621,a,0,0
112622,benign,0,0
112623,condition,0,0
112624,",",0,0
112625,fibroadenomas,0,1
112626,utilize,0,0
112627,substantial,0,0
112628,resources,0,0
112629,for,0,0
112630,management,0,0
112631,and,0,1
112632,treatment,0,0
112633,to,0,0
112634,rule,0,0
112635,out,0,0
112636,potential,0,0
112637,malignancies,0,0
112638,.,0,0
112639,Dietary,0,0
112640,factors,0,0
112641,may,0,0
112642,influence,0,0
112643,benign,0,0
112644,fibrocystic,0,1
112645,breast,0,0
112646,conditions,0,0
112647,",",0,1
112648,but,0,0
112649,little,0,0
112650,is,0,0
112651,known,0,0
112652,of,0,0
112653,their,0,0
112654,association,0,0
112655,with,0,0
112656,fibroadenomas,0,0
112657,.,0,0
112658,We,0,0
112659,examined,0,0
112660,possible,0,0
112661,associations,0,0
112662,between,0,0
112663,a,0,0
112664,broad,0,0
112665,spectrum,0,0
112666,of,0,0
112667,circulating,0,1
112668,biomarkers,1,0
112669,of,1,0
112670,dietary,1,1
112671,intake,1,1
112672,and,0,1
112673,risk,0,1
112674,of,0,1
112675,fibroadenomas,0,1
112676,.,0,1
112677,Participants,0,0
112678,were,0,0
112679,women,0,0
112680,in,0,0
112681,a,0,0
112682,breast,0,0
112683,self-examination,0,1
112684,trial,0,0
112685,in,0,0
112686,Shanghai,0,0
112687,",",0,0
112688,China,0,0
112689,who,0,0
112690,were,0,0
112691,diagnosed,0,0
112692,with,0,0
112693,fibroadenomas,0,1
112694,(,0,0
112695,n,0,0
112696,=,0,0
112697,258,0,0
112698,),0,0
112699,and,0,0
112700,1035,0,0
112701,controls,0,0
112702,.,0,0
112703,Conditional,1,0
112704,logistic,1,1
112705,regression,1,1
112706,was,0,0
112707,used,0,0
112708,to,0,0
112709,estimate,1,0
112710,adjusted,1,0
112711,odds,1,0
112712,ratios,1,1
112713,(,1,0
112714,OR,1,1
112715,),1,0
112716,and,0,0
112717,95,1,0
112718,%,1,0
112719,CI,1,0
112720,.,1,1
112721,Isoflavone,1,0
112722,concentrations,1,1
112723,were,0,0
112724,inversely,0,0
112725,associated,0,0
112726,with,0,0
112727,risk,1,1
112728,of,1,0
112729,fibroadenomas,1,1
112730,.,1,0
112731,Adjusted,1,1
112732,OR,1,0
112733,(,1,0
112734,95,1,0
112735,%,1,0
112736,CI,1,0
112737,),1,0
112738,for,0,0
112739,the,0,0
112740,highest,0,0
112741,versus,0,0
112742,the,0,0
112743,lowest,0,0
112744,quartile,0,1
112745,of,0,1
112746,plasma,0,1
112747,concentration,0,1
112748,were,0,0
112749,0.36,0,0
112750,(,0,0
112751,0.16-0.79,0,0
112752,;,0,0
112753,P-trend,0,0
112754,<,0,0
112755,0.001,0,0
112756,),0,0
112757,for,0,0
112758,daidzein,0,0
112759,and,0,0
112760,0.39,0,0
112761,(,0,0
112762,0.19-0.84,0,0
112763,;,0,0
112764,P-trend,0,0
112765,=,0,0
112766,0.010,0,0
112767,),0,0
112768,for,0,0
112769,genistein,0,0
112770,.,0,0
112771,We,0,0
112772,also,0,0
112773,observed,0,0
112774,inverse,1,1
112775,associations,1,0
112776,between,0,0
112777,higher,0,0
112778,percentages,1,1
112779,of,1,0
112780,the,1,0
112781,RBC,1,1
112782,(,1,0
112783,n-3,1,1
112784,),1,0
112785,fatty,1,1
112786,acids,1,1
112787,",",1,1
112788,eicosapentaenoic,1,1
112789,acid,1,1
112790,(,1,1
112791,EPA,1,1
112792,),1,1
112793,(,0,0
112794,[,0,0
112795,0.38,0,0
112796,(,0,0
112797,0.19-0.77,0,0
112798,),0,0
112799,;,0,0
112800,P-trend,0,0
112801,=,0,0
112802,0.007,0,0
112803,],0,0
112804,and,0,0
112805,docosapentaenoic,1,1
112806,acid,1,1
112807,(,1,1
112808,DPA,1,0
112809,),1,0
112810,[,0,0
112811,0.32,0,0
112812,(,0,0
112813,0.15-0.70,0,0
112814,),0,0
112815,;,0,0
112816,P-trend,0,0
112817,=,0,0
112818,0.024,0,0
112819,],0,0
112820,",",0,0
112821,and,0,1
112822,fibroadenoma,0,1
112823,risk,0,1
112824,.,0,0
112825,Circulating,0,0
112826,concentrations,0,1
112827,of,0,0
112828,carotenoids,1,1
112829,",",1,0
112830,vitamin,1,1
112831,C,1,1
112832,",",1,1
112833,retinol,1,1
112834,",",1,1
112835,and,1,1
112836,ferritin,1,1
112837,were,0,0
112838,not,0,0
112839,associated,0,0
112840,with,0,0
112841,fibroadenoma,0,0
112842,risk,0,1
112843,.,0,0
112844,The,0,0
112845,inverse,1,1
112846,associations,1,0
112847,between,0,0
112848,plasma,1,1
112849,isoflavone,1,0
112850,concentrations,1,1
112851,and,0,1
112852,RBC,1,1
112853,EPA,1,1
112854,and,1,1
112855,DPA,1,1
112856,and,0,1
112857,fibroadenoma,1,1
112858,risk,1,1
112859,suggest,0,0
112860,that,0,0
112861,higher,0,0
112862,intakes,0,1
112863,of,0,1
112864,soy,0,0
112865,foods,0,0
112866,and,0,1
112867,fatty,0,1
112868,fish,0,0
112869,may,0,0
112870,lower,0,0
112871,the,0,0
112872,risk,1,1
112873,of,1,0
112874,fibroadenomas,1,0
112875,.,1,0
112876,Clonidine,1,0
112877,clearance,1,1
112878,matures,0,1
112879,rapidly,0,0
112880,during,0,0
112881,the,0,0
112882,early,0,0
112883,postnatal,0,1
112884,period,0,0
112885,:,0,0
112886,a,0,0
112887,population,0,0
112888,pharmacokinetic,0,1
112889,analysis,0,0
112890,in,0,0
112891,newborns,0,0
112892,with,0,0
112893,neonatal,0,1
112894,abstinence,0,1
112895,syndrome,0,0
112896,.,0,0
112897,The,0,0
112898,population,0,0
112899,pharmacokinetic,1,1
112900,(,1,1
112901,PK,1,0
112902,),1,1
112903,profile,1,1
112904,of,0,1
112905,oral,0,0
112906,clonidine,0,0
112907,was,0,0
112908,characterized,0,0
112909,in,0,0
112910,newborns,0,0
112911,with,0,0
112912,neonatal,0,1
112913,abstinence,0,1
112914,syndrome,0,1
112915,",",0,1
112916,and,0,1
112917,significant,0,1
112918,covariates,0,1
112919,affecting,0,0
112920,its,0,0
112921,PK,0,0
112922,parameters,0,1
112923,were,0,0
112924,identified,0,0
112925,.,0,0
112926,Plasma,1,1
112927,clonidine,1,0
112928,concentration,1,1
112929,data,1,0
112930,were,0,0
112931,obtained,0,0
112932,from,0,0
112933,a,0,0
112934,clinical,0,0
112935,trial,0,0
112936,in,0,0
112937,which,0,0
112938,36,0,0
112939,newborns,0,0
112940,",",0,0
112941,aged,0,0
112942,1,0,0
112943,to,0,0
112944,25,0,0
112945,days,0,0
112946,(,0,0
112947,postnatal,0,1
112948,age,0,0
112949,",",0,1
112950,PNA,0,1
112951,),0,1
112952,and,0,0
112953,weighing,0,0
112954,2.1,0,0
112955,to,0,0
112956,3.9,0,0
112957,kg,0,0
112958,",",0,0
112959,were,0,0
112960,enrolled,0,0
112961,to,0,0
112962,take,0,0
112963,multiple,0,0
112964,oral,0,0
112965,doses,0,0
112966,of,0,0
112967,clonidine,0,0
112968,.,0,0
112969,The,0,0
112970,population,0,0
112971,PK,1,0
112972,model,1,0
112973,of,1,1
112974,clonidine,1,0
112975,was,0,0
112976,developed,0,0
112977,by,0,0
112978,NONMEM,0,1
112979,",",0,1
112980,and,0,1
112981,significant,0,1
112982,covariates,0,1
112983,were,0,0
112984,identified,0,0
112985,",",0,0
112986,followed,0,0
112987,by,0,0
112988,nonparametric,0,0
112989,bootstraps,0,0
112990,(,0,0
112991,2000,0,0
112992,replicates,0,0
112993,),0,0
112994,and,0,1
112995,simulation,0,0
112996,experiments,0,0
112997,.,0,0
112998,A,0,0
112999,1-compartment,0,1
113000,open,0,0
113001,linear,0,0
113002,PK,0,0
113003,model,0,0
113004,was,0,0
113005,chosen,0,0
113006,to,0,0
113007,describe,0,0
113008,plasma,1,1
113009,concentrations,1,1
113010,of,1,1
113011,clonidine,1,0
113012,",",0,1
113013,and,0,1
113014,body,1,1
113015,weight,1,1
113016,and,1,1
113017,PNA,1,1
113018,were,0,0
113019,significant,0,0
113020,covariates,0,1
113021,for,0,0
113022,apparent,1,1
113023,clearance,1,1
113024,(,0,1
113025,CL/F,0,1
113026,),0,0
113027,as,0,0
113028,follows,0,0
113029,:,0,0
113030,CL/F,0,1
113031,(,0,0
113032,L/h,0,1
113033,),0,0
113034,=,0,0
113035,15.2,0,0
113036,?,0,0
113037,[,0,0
113038,body,0,1
113039,weight,0,1
113040,(,0,1
113041,kg,0,0
113042,),0,1
113043,/70,0,0
113044,],0,0
113045,(,0,0
113046,0.75,0,0
113047,),0,0
113048,?,0,0
113049,[,0,0
113050,PNA,0,1
113051,(,0,1
113052,day,0,1
113053,),0,0
113054,(,0,0
113055,0.441,0,0
113056,),0,0
113057,/,0,0
113058,(,0,0
113059,4.06,0,0
113060,(,0,0
113061,0.441,0,0
113062,),0,0
113063,+,0,0
113064,PNA,0,1
113065,(,0,1
113066,day,0,1
113067,),0,0
113068,(,0,0
113069,0.441,0,0
113070,),0,0
113071,),0,0
113072,],0,0
113073,.,0,1
113074,Furthermore,1,0
113075,",",1,0
113076,CL/F,1,1
113077,of,1,1
113078,clonidine,1,0
113079,increased,1,0
113080,rapidly,0,0
113081,with,0,0
113082,PNA,0,0
113083,during,0,0
113084,the,0,0
113085,first,0,0
113086,month,0,0
113087,of,0,1
113088,life,0,1
113089,after,0,0
113090,body,0,1
113091,weight,0,1
113092,was,0,0
113093,adjusted,0,0
113094,.,0,0
113095,Any,0,0
113096,optimal,0,0
113097,dosage,0,0
113098,regimen,0,0
113099,for,0,0
113100,clonidine,0,0
113101,in,0,0
113102,term,0,0
113103,neonates,0,0
113104,should,0,0
113105,be,0,0
113106,based,0,0
113107,on,0,0
113108,infant,0,1
113109,'s,0,1
113110,age,0,0
113111,and,0,1
113112,body,0,1
113113,weight,0,1
113114,",",0,0
113115,and,0,0
113116,1.5,0,0
113117,?g/kg,0,0
113118,every,0,0
113119,4,0,0
113120,hours,0,0
113121,is,0,0
113122,proposed,0,0
113123,starting,0,0
113124,the,0,0
113125,second,0,0
113126,week,0,0
113127,of,0,1
113128,life,0,1
113129,based,0,0
113130,on,0,0
113131,the,0,0
113132,simulation,0,0
113133,results,0,0
113134,.,0,0
113135,Influence,1,1
113136,of,0,1
113137,bony,0,1
113138,defects,0,1
113139,on,0,0
113140,implant,0,0
113141,stability,0,1
113142,.,0,0
113143,INTRODUCTION,0,0
113144,The,0,0
113145,purpose,0,0
113146,of,0,0
113147,this,0,0
113148,study,0,0
113149,was,0,0
113150,to,0,0
113151,analyze,0,0
113152,the,0,0
113153,evolution,0,1
113154,of,0,0
113155,implant,0,0
113156,mechanical,0,0
113157,stability,0,1
113158,in,0,0
113159,different,0,0
113160,types/sizes,0,0
113161,of,0,0
113162,bony,0,1
113163,defects,0,0
113164,using,0,0
113165,both,0,0
113166,Periotest,0,1
113167,and,0,1
113168,Osstell,0,0
113169,devices,0,0
113170,as,0,0
113171,objective,0,0
113172,tools,0,1
113173,.,0,1
113174,MATERIALS,0,0
113175,AND,0,0
113176,METHODS,0,0
113177,Thirty-two,0,0
113178,implants,0,1
113179,were,0,0
113180,randomly,0,0
113181,allocated,0,0
113182,to,0,0
113183,one,0,0
113184,of,0,0
113185,the,0,0
113186,four,0,0
113187,types,0,0
113188,of,0,0
113189,bone,0,1
113190,defects,0,0
113191,:,0,0
113192,marginal,0,1
113193,bone,0,1
113194,loss,0,1
113195,",",0,1
113196,peri-apical,0,1
113197,bone,0,1
113198,defect,0,1
113199,",",0,1
113200,constant,0,1
113201,width,0,1
113202,dehiscence,0,1
113203,and,0,1
113204,constant,0,1
113205,length,0,1
113206,dehiscences,0,1
113207,.,0,0
113208,Periotest/Osstell,1,1
113209,measurements,1,1
113210,were,0,0
113211,completed,0,0
113212,before,0,0
113213,and,0,0
113214,during,0,0
113215,staged,0,0
113216,bone,0,1
113217,removal,0,0
113218,(,0,0
113219,to,0,0
113220,enlarge,0,0
113221,defect,0,1
113222,size,0,1
113223,),0,0
113224,.,0,0
113225,RESULTS,0,0
113226,Significant,0,1
113227,differences,0,0
113228,(,0,0
113229,P,0,0
113230,<,0,0
113231,0.05,0,0
113232,),0,0
113233,with,0,0
113234,initial,0,0
113235,values,0,1
113236,were,0,0
113237,found,0,0
113238,after,0,0
113239,a,0,0
113240,2,0,0
113241,mm,0,0
113242,marginal,0,1
113243,bone,0,1
113244,removal,0,1
113245,(,0,1
113246,Osstell/Periotest,0,1
113247,),0,0
113248,;,0,0
113249,for,0,0
113250,a,0,0
113251,peri-apical,1,1
113252,bone,1,1
113253,lesion,1,1
113254,",",0,1
113255,after,0,0
113256,removal,0,0
113257,of,0,0
113258,5,0,0
113259,mm,0,0
113260,(,0,0
113261,Osstell,0,1
113262,),0,0
113263,or,0,0
113264,8,0,0
113265,mm,0,0
113266,(,0,0
113267,Periotest,0,1
113268,),0,0
113269,;,0,0
113270,for,0,0
113271,a,0,0
113272,6-mm-long,0,0
113273,dehiscence,0,1
113274,",",0,0
113275,after,0,0
113276,removal,0,0
113277,up,0,0
113278,to,0,0
113279,180,0,0
113280,degrees,0,0
113281,of,0,0
113282,the,0,0
113283,implant,0,0
113284,perimeter,0,1
113285,(,0,1
113286,Osstell/Periotest,0,1
113287,),0,0
113288,;,0,0
113289,for,0,0
113290,a,0,0
113291,3-mm-wide,0,1
113292,dehiscence,0,1
113293,",",0,0
113294,after,0,0
113295,removal,0,0
113296,of,0,0
113297,10,0,0
113298,mm,0,0
113299,(,0,0
113300,Osstell,0,1
113301,),0,0
113302,or,0,0
113303,6,0,0
113304,mm,0,0
113305,(,0,0
113306,Periotest,0,1
113307,),0,0
113308,.,0,0
113309,CONCLUSION,0,0
113310,Periotest,1,1
113311,and,0,0
113312,Osstell,1,0
113313,are,0,0
113314,in,0,0
113315,general,0,0
113316,not,0,0
113317,very,0,0
113318,sensitive,0,0
113319,in,0,0
113320,the,0,0
113321,identification,0,1
113322,of,0,0
113323,peri-implant,0,1
113324,bone,0,1
113325,destruction,0,1
113326,",",0,0
113327,except,0,0
113328,for,0,0
113329,marginal,0,1
113330,bone,0,1
113331,loss,0,1
113332,.,0,0
113333,Improving,0,0
113334,the,0,0
113335,immunogenicity,1,1
113336,of,0,0
113337,pneumococcal,0,1
113338,conjugate,0,0
113339,vaccine,0,0
113340,in,0,0
113341,HIV-infected,0,0
113342,adults,0,0
113343,with,0,0
113344,a,0,0
113345,toll-like,0,0
113346,receptor,0,0
113347,9,0,0
113348,agonist,0,0
113349,adjuvant,0,0
113350,:,0,0
113351,a,0,0
113352,randomized,0,0
113353,",",0,0
113354,controlled,0,0
113355,trial,0,0
113356,.,0,0
113357,BACKGROUND,0,0
113358,Persons,0,1
113359,infected,0,0
113360,with,0,0
113361,human,0,0
113362,immunodeficiency,0,0
113363,virus,0,1
113364,(,0,1
113365,HIV,0,1
113366,),0,0
113367,are,0,0
113368,often,0,0
113369,hyporesponsive,0,0
113370,to,0,0
113371,immunization,0,1
113372,",",0,0
113373,including,0,0
113374,pneumococcal,0,0
113375,vaccines,0,0
113376,.,0,0
113377,We,0,0
113378,hypothesized,0,0
113379,that,0,0
113380,adding,0,0
113381,CPG,0,0
113382,7909,0,0
113383,",",0,0
113384,a,0,0
113385,toll-like,0,1
113386,receptor,0,0
113387,9,0,0
113388,(,0,0
113389,TLR9,0,0
113390,),0,1
113391,agonist,0,0
113392,and,0,1
113393,vaccine,0,1
113394,adjuvant,0,0
113395,",",0,1
113396,to,0,0
113397,7-valent,0,0
113398,pneumococcal,0,1
113399,conjugate,0,0
113400,vaccine,0,0
113401,(,0,0
113402,7vPnC,0,0
113403,),0,0
113404,would,0,0
113405,increase,0,0
113406,its,0,0
113407,immunogenicity,0,1
113408,in,0,0
113409,HIV-infected,0,0
113410,adults,0,0
113411,.,0,0
113412,METHODS,0,0
113413,We,0,0
113414,performed,0,0
113415,a,0,0
113416,double-blind,0,0
113417,",",0,0
113418,placebo-controlled,0,0
113419,",",0,0
113420,phase,0,0
113421,1b/2a,0,0
113422,trial,0,0
113423,randomizing,0,0
113424,HIV-positive,0,0
113425,patients,0,0
113426,to,0,0
113427,receive,0,0
113428,double,0,0
113429,doses,0,0
113430,of,0,0
113431,7vPnC,0,0
113432,(,0,0
113433,Prevnar,0,0
113434,),0,0
113435,at,0,0
113436,0,0,0
113437,and,0,0
113438,3,0,0
113439,months,0,0
113440,and,0,0
113441,1,0,0
113442,dose,0,0
113443,of,0,0
113444,23-valent,0,0
113445,pneumococcal,0,1
113446,polysaccharide,0,1
113447,vaccine,0,0
113448,(,0,0
113449,PPV-23,0,0
113450,;,0,0
113451,Pneumo,0,0
113452,Novum,0,1
113453,),0,0
113454,at,0,0
113455,9,0,0
113456,months,0,0
113457,",",0,0
113458,with,0,0
113459,experimental,0,0
113460,patients,0,0
113461,receiving,0,0
113462,1,0,0
113463,mg,0,0
113464,of,0,0
113465,CPG,0,1
113466,7909,0,0
113467,added,0,0
113468,to,0,0
113469,each,0,0
113470,of,0,0
113471,their,0,0
113472,3,0,0
113473,vaccine,0,0
113474,doses,0,0
113475,;,0,0
113476,control,0,0
113477,patients,0,0
113478,had,0,0
113479,phosphate-buffered,0,0
113480,saline,0,0
113481,added,0,0
113482,instead,0,0
113483,.,0,0
113484,Immunogenicity,1,1
113485,and,1,1
113486,safety,1,1
113487,were,0,0
113488,evaluated,0,0
113489,for,0,0
113490,up,0,0
113491,to,0,0
113492,10,0,0
113493,months,0,0
113494,.,0,0
113495,The,0,0
113496,primary,0,0
113497,end,0,0
113498,point,0,0
113499,was,0,0
113500,the,0,0
113501,proportion,1,1
113502,of,1,0
113503,vaccine,1,0
113504,high,1,0
113505,responders,1,0
113506,at,1,0
113507,9,1,0
113508,months,1,0
113509,",",0,0
113510,defined,0,1
113511,as,0,0
113512,a,0,0
113513,2-fold,0,0
113514,increase,0,0
113515,in,0,0
113516,IgG,0,0
113517,levels,0,1
113518,to,0,0
113519,>,0,0
113520,or,0,0
113521,=,0,0
113522,1,0,0
113523,microg/mL,0,0
113524,for,0,0
113525,at,0,0
113526,least,0,0
113527,5,0,0
113528,of,0,0
113529,7,0,0
113530,of,0,0
113531,the,0,0
113532,7vPnC,0,0
113533,serotypes,0,0
113534,.,0,0
113535,RESULTS,0,0
113536,Ninety-seven,0,0
113537,participants,0,0
113538,were,0,0
113539,included,0,0
113540,in,0,0
113541,the,0,0
113542,study,0,0
113543,.,0,0
113544,The,0,0
113545,proportion,1,0
113546,of,1,0
113547,vaccine,1,0
113548,high,1,0
113549,responders,1,0
113550,was,0,0
113551,higher,0,0
113552,in,0,0
113553,the,0,0
113554,experimental,0,0
113555,group,0,0
113556,(,0,0
113557,n,0,0
113558,=,0,0
113559,48,0,0
113560,),0,0
113561,than,0,0
113562,among,0,0
113563,controls,0,0
113564,(,0,0
113565,n,0,0
113566,=,0,0
113567,49,0,0
113568,;,0,0
113569,48.8,0,0
113570,%,0,0
113571,vs,0,0
113572,25.0,0,0
113573,%,0,0
113574,;,0,0
113575,P,0,0
113576,=,0,0
113577,.02,0,0
113578,),0,0
113579,at,0,0
113580,9,0,0
113581,months,0,0
113582,.,0,0
113583,Greater,0,0
113584,proportions,1,1
113585,of,1,0
113586,high,1,0
113587,responders,1,0
113588,were,0,0
113589,also,0,0
113590,observed,0,0
113591,at,0,0
113592,3,0,0
113593,(,0,0
113594,51.1,0,0
113595,%,0,0
113596,vs,0,0
113597,39.6,0,0
113598,%,0,0
113599,;,0,0
113600,P,0,0
113601,=,0,0
113602,.26,0,0
113603,),0,0
113604,",",0,0
113605,4,0,0
113606,(,0,0
113607,77.3,0,0
113608,%,0,0
113609,vs,0,0
113610,56.3,0,0
113611,%,0,0
113612,;,0,0
113613,P,0,0
113614,=,0,0
113615,.03,0,0
113616,),0,1
113617,",",0,0
113618,and,0,0
113619,10,0,0
113620,months,0,0
113621,(,0,0
113622,87.8,0,0
113623,%,0,0
113624,vs,0,0
113625,51.1,0,0
113626,%,0,0
113627,;,0,0
113628,P,0,0
113629,<,0,0
113630,.001,0,0
113631,),0,0
113632,.,0,0
113633,Mild,1,1
113634,systemic,1,1
113635,and,1,1
113636,injection,1,0
113637,site,1,1
113638,reactions,1,1
113639,to,0,0
113640,7vPnC,0,0
113641,were,0,0
113642,more,0,0
113643,common,0,0
113644,in,0,0
113645,the,0,0
113646,experimental,0,0
113647,group,0,0
113648,than,0,0
113649,the,0,0
113650,control,0,0
113651,group,0,0
113652,(,0,0
113653,100,0,0
113654,%,0,0
113655,vs,0,0
113656,81.3,0,0
113657,%,0,0
113658,;,0,0
113659,P,0,0
113660,=,0,0
113661,.002,0,0
113662,),0,0
113663,.,0,0
113664,CPG,0,0
113665,7909,0,0
113666,did,0,0
113667,not,0,0
113668,increase,0,0
113669,non-7vPnC,1,0
113670,IgG,1,0
113671,levels,1,1
113672,after,0,0
113673,PPV-23,0,0
113674,immunization,0,0
113675,.,0,0
113676,No,0,0
113677,adverse,0,1
113678,effects,0,1
113679,on,0,0
113680,CD4,1,1
113681,(,1,0
113682,+,1,0
113683,),1,1
113684,cell,1,1
113685,count,1,1
113686,or,1,1
113687,organ,1,1
113688,functions,1,1
113689,occurred,0,0
113690,in,0,0
113691,either,0,0
113692,group,0,0
113693,.,0,0
113694,CONCLUSIONS,0,0
113695,The,0,0
113696,addition,0,0
113697,of,0,0
113698,a,0,0
113699,TLR9,0,0
113700,agonist,0,0
113701,to,0,0
113702,7vPnC,0,0
113703,significantly,0,0
113704,enhanced,0,0
113705,the,0,0
113706,proportion,0,1
113707,of,0,0
113708,vaccine,1,0
113709,high,1,0
113710,responders,1,0
113711,.,1,0
113712,TRIAL,0,0
113713,REGISTRATION,0,0
113714,ClinicalTrials.gov,0,0
113715,identifier,0,0
113716,:,0,0
113717,NCT00562939,0,0
113718,.,0,0
113719,[,0,0
113720,Pleural,0,1
113721,tent,0,0
113722,after,0,0
113723,upper,0,0
113724,lobectomy,0,0
113725,--,0,1
113726,randomized,0,0
113727,study,0,0
113728,of,0,0
113729,it,0,0
113730,'s,0,0
113731,efficacy,0,1
113732,and,0,1
113733,duration,0,1
113734,of,0,0
113735,the,0,0
113736,effect,0,0
113737,],0,0
113738,.,0,0
113739,UNLABELLED,0,0
113740,The,0,0
113741,aim,0,0
113742,of,0,0
113743,our,0,0
113744,study,0,0
113745,is,0,0
113746,to,0,0
113747,evaluate,0,0
113748,the,0,0
113749,safety,1,1
113750,",",1,1
113751,efficacy,1,1
113752,and,1,0
113753,also,1,0
113754,the,1,0
113755,maximum,1,1
113756,duration,1,1
113757,of,1,1
113758,effect,1,0
113759,of,1,0
113760,the,1,0
113761,pleural,1,1
113762,tent,1,0
113763,in,0,0
113764,reducing,0,0
113765,the,0,0
113766,incidence,0,1
113767,of,0,1
113768,air,0,0
113769,leak,0,1
113770,after,0,0
113771,upper,0,0
113772,lobectomy,0,0
113773,.,0,0
113774,METHODS,0,0
113775,Sixty,0,0
113776,patients,0,0
113777,who,0,0
113778,underwent,0,0
113779,upper,0,0
113780,lobectomy,0,0
113781,were,0,0
113782,prospectively,0,0
113783,randomized,0,0
113784,into,0,0
113785,two,0,0
113786,groups,0,0
113787,:,0,0
113788,30,0,0
113789,patients,0,0
113790,had,0,0
113791,creation,0,0
113792,of,0,1
113793,pleural,0,1
113794,tent,0,1
113795,(,0,0
113796,group,0,0
113797,1,0,0
113798,),0,0
113799,and,0,0
113800,30,0,0
113801,did,0,0
113802,not,0,0
113803,(,0,0
113804,group,0,0
113805,2,0,0
113806,),0,0
113807,.,0,0
113808,The,0,0
113809,preoperative,0,1
113810,",",0,0
113811,operative,0,1
113812,",",0,1
113813,and,0,1
113814,postoperative,0,1
113815,characteristics,0,1
113816,of,0,0
113817,both,0,0
113818,groups,0,0
113819,were,0,0
113820,compared,0,0
113821,.,0,0
113822,Then,0,0
113823,multivariate,0,0
113824,analyses,0,0
113825,were,0,0
113826,used,0,0
113827,to,0,0
113828,identify,0,0
113829,factors,0,0
113830,predictive,0,0
113831,of,0,0
113832,prolonged,0,0
113833,air,0,0
113834,leaks,0,1
113835,and,0,0
113836,their,0,0
113837,duration,0,1
113838,.,0,0
113839,The,0,0
113840,reduction,0,1
113841,of,0,0
113842,incidences,1,1
113843,of,1,1
113844,air,1,0
113845,leak,1,1
113846,in,0,0
113847,the,0,0
113848,two,0,0
113849,groups,0,0
113850,was,0,0
113851,subsequently,0,0
113852,compared,0,0
113853,during,0,0
113854,successive,0,0
113855,postoperative,0,1
113856,periods,0,0
113857,.,0,0
113858,RESULTS,0,0
113859,Demographic,0,1
113860,and,0,1
113861,clinical,0,1
113862,profiles,0,1
113863,of,0,0
113864,both,0,0
113865,groups,0,0
113866,were,0,0
113867,not,0,0
113868,statistically,0,0
113869,different,0,0
113870,.,0,0
113871,The,0,0
113872,tented,0,1
113873,patients,0,0
113874,had,0,0
113875,statistically,0,0
113876,significant,0,0
113877,reduction,0,1
113878,of,0,1
113879,mean,1,1
113880,duration,1,1
113881,of,1,1
113882,air,1,0
113883,leak,1,1
113884,in,0,0
113885,days,0,0
113886,(,0,0
113887,4.9,0,0
113888,+/-,0,0
113889,1.79,0,0
113890,vs,0,0
113891,8.2,0,0
113892,+/-,0,0
113893,4.2,0,0
113894,),0,0
113895,",",0,0
113896,the,0,0
113897,number,1,1
113898,of,1,0
113899,days,1,0
113900,of,1,0
113901,a,1,0
113902,chest,1,1
113903,tube,1,1
113904,duration,1,1
113905,(,0,0
113906,7.3,0,0
113907,+/-,0,0
113908,1.14,0,0
113909,vs,0,0
113910,12.46,0,0
113911,+/-,0,0
113912,3.6,0,0
113913,),0,0
113914,",",0,0
113915,the,0,0
113916,length,1,1
113917,of,1,0
113918,postoperative,1,1
113919,in-hospital,1,1
113920,stay,1,1
113921,in,1,0
113922,days,1,0
113923,(,0,0
113924,9.4,0,0
113925,+/-,0,0
113926,1.86,0,0
113927,vs,0,0
113928,13.6,0,0
113929,+/-,0,0
113930,2.49,0,0
113931,),0,0
113932,",",0,0
113933,and,0,0
113934,the,0,0
113935,hospital,1,1
113936,stay,1,1
113937,cost,1,1
113938,per,1,1
113939,patient,1,1
113940,(,0,1
113941,leva,0,0
113942,",",0,0
113943,3840,0,0
113944,+/-,0,0
113945,298,0,0
113946,vs,0,0
113947,5160,0,0
113948,+/-,0,0
113949,3890,0,0
113950,),0,0
113951,.,0,0
113952,Logistic,0,0
113953,regression,0,0
113954,analyses,0,0
113955,showed,0,0
113956,that,0,0
113957,no,0,0
113958,having,0,0
113959,creation,0,0
113960,a,0,0
113961,pleural,0,1
113962,tent,0,0
113963,procedure,0,0
113964,was,0,0
113965,the,0,0
113966,most,0,0
113967,significant,0,0
113968,predictive,0,1
113969,factor,0,0
113970,of,0,0
113971,the,0,0
113972,occurrence,1,1
113973,and,1,1
113974,duration,1,1
113975,of,1,1
113976,prolonged,1,1
113977,air,1,0
113978,leaks,1,1
113979,.,1,0
113980,A,0,0
113981,greater,0,0
113982,reduction,0,1
113983,in,0,0
113984,the,0,0
113985,duration,1,1
113986,of,1,0
113987,air,1,0
113988,leaks,1,1
113989,was,0,0
113990,observed,0,0
113991,before,0,0
113992,postoperative,0,1
113993,day,0,0
113994,4,0,0
113995,in,0,0
113996,group,0,0
113997,1,0,0
113998,",",0,0
113999,and,0,0
114000,logistic,0,1
114001,regression,0,1
114002,analysis,0,0
114003,showed,0,0
114004,that,0,0
114005,having,0,0
114006,a,0,0
114007,pleural,0,1
114008,tent,0,0
114009,procedure,0,0
114010,was,0,0
114011,the,0,0
114012,most,0,0
114013,significant,0,0
114014,predictive,0,1
114015,factor,0,1
114016,of,0,1
114017,air,1,0
114018,leaks,1,1
114019,that,0,0
114020,persisted,0,1
114021,for,0,0
114022,less,0,0
114023,than,0,0
114024,4,0,0
114025,days,0,0
114026,.,0,0
114027,CONCLUSIONS,0,0
114028,Pleural,0,1
114029,tent,0,1
114030,creation,0,1
114031,after,0,0
114032,upper,0,0
114033,lobectomy,0,0
114034,is,0,0
114035,a,0,0
114036,simple,1,0
114037,and,1,1
114038,safe,1,1
114039,procedure,1,0
114040,that,0,0
114041,reduces,0,0
114042,the,0,0
114043,duration,1,1
114044,of,1,0
114045,air,1,0
114046,leaks,1,1
114047,and,0,0
114048,the,0,0
114049,hospital,1,1
114050,stay,1,1
114051,costs,1,1
114052,.,1,0
114053,The,0,0
114054,benefit,0,0
114055,from,0,0
114056,that,0,0
114057,procedure,0,0
114058,is,0,0
114059,achieved,0,0
114060,before,0,0
114061,postoperative,0,1
114062,day,0,0
114063,4,0,0
114064,.,0,0
114065,Comparing,0,0
114066,the,0,0
114067,effectiveness,1,1
114068,of,0,1
114069,peer,0,1
114070,mentoring,0,1
114071,and,0,1
114072,student,0,1
114073,mentoring,0,0
114074,in,0,0
114075,a,0,0
114076,35-week,0,0
114077,fitness,0,1
114078,program,0,0
114079,for,0,0
114080,older,0,0
114081,adults,0,0
114082,.,0,0
114083,To,0,0
114084,investigate,0,0
114085,the,0,0
114086,applicability,1,1
114087,and,0,1
114088,effectiveness,1,1
114089,of,0,0
114090,a,0,0
114091,peer-mentored,0,0
114092,exercise,0,0
114093,program,0,0
114094,",",0,0
114095,this,0,0
114096,study,0,0
114097,compared,0,0
114098,the,0,0
114099,retention,1,1
114100,and,1,1
114101,participation,1,1
114102,rates,1,1
114103,",",0,1
114104,and,0,1
114105,physical,1,1
114106,improvements,1,1
114107,of,0,0
114108,older,0,0
114109,adults,0,0
114110,trained,0,0
114111,by,0,0
114112,peer,0,0
114113,mentors,0,0
114114,(,0,1
114115,PM,0,0
114116,),0,0
114117,to,0,0
114118,a,0,0
114119,group,0,0
114120,trained,0,0
114121,by,0,0
114122,young,0,0
114123,qualified,0,0
114124,student,0,1
114125,mentors,0,0
114126,(,0,1
114127,SM,0,1
114128,),0,0
114129,.,0,0
114130,A,0,0
114131,group,0,0
114132,of,0,0
114133,older,0,0
114134,adults,0,0
114135,were,0,0
114136,prepared,0,0
114137,as,0,0
114138,peer,0,0
114139,mentors,0,0
114140,through,0,0
114141,a,0,0
114142,30-week,0,0
114143,preparation,0,0
114144,program,0,0
114145,.,0,1
114146,Later,0,0
114147,",",0,0
114148,60,0,0
114149,older,0,0
114150,adults,0,0
114151,(,0,0
114152,mean,0,1
114153,?,0,0
114154,SD,0,0
114155,age,0,0
114156,:,0,0
114157,68.7,0,0
114158,?,0,0
114159,6.1,0,0
114160,years,0,0
114161,),0,0
114162,were,0,0
114163,recruited,0,0
114164,and,0,0
114165,randomly,0,0
114166,assigned,0,0
114167,to,0,0
114168,either,0,0
114169,the,0,0
114170,PM,0,0
114171,or,0,0
114172,SM,0,1
114173,group,0,0
114174,.,0,0
114175,Both,0,0
114176,groups,0,0
114177,completed,0,0
114178,an,0,0
114179,identical,0,0
114180,35-week,0,0
114181,fitness,0,1
114182,program,0,0
114183,.,0,1
114184,Pre-,0,0
114185,",",0,1
114186,midterm-,0,1
114187,and,0,1
114188,post-training,1,1
114189,assessments,1,0
114190,of,1,1
114191,fitness,1,1
114192,were,1,0
114193,completed,0,0
114194,and,1,0
114195,rates,1,1
114196,of,1,1
114197,participation,1,0
114198,and,1,1
114199,retention,1,1
114200,were,1,0
114201,documented,0,0
114202,.,0,0
114203,The,0,0
114204,same,0,0
114205,retention,0,1
114206,rates,0,1
114207,were,0,0
114208,observed,0,0
114209,in,0,0
114210,the,0,0
114211,two,0,0
114212,groups,0,0
114213,",",0,0
114214,but,0,0
114215,SM,0,1
114216,group,0,0
114217,had,1,0
114218,higher,1,0
114219,participation,1,0
114220,.,1,0
114221,Both,0,0
114222,groups,1,0
114223,improved,1,0
114224,significantly,1,0
114225,in,1,0
114226,all,1,0
114227,measures,1,0
114228,of,1,1
114229,fitness,1,1
114230,and,1,0
114231,there,0,0
114232,were,0,0
114233,no,0,0
114234,significant,0,0
114235,post-test,0,0
114236,differences,0,0
114237,between,0,0
114238,the,0,0
114239,groups,0,0
114240,in,0,0
114241,the,0,0
114242,fitness,0,1
114243,measures,0,1
114244,.,0,0
114245,Findings,0,0
114246,suggest,0,0
114247,that,0,0
114248,the,0,0
114249,peer,0,0
114250,mentor,0,0
114251,model,0,0
114252,is,0,0
114253,applicable,0,0
114254,in,0,0
114255,an,0,0
114256,older,0,0
114257,adult,0,0
114258,exercise,0,0
114259,program,0,0
114260,and,0,0
114261,may,0,0
114262,be,0,0
114263,as,0,0
114264,effective,0,0
114265,as,0,0
114266,a,0,0
114267,program,0,0
114268,mentored,0,0
114269,by,0,0
114270,young,0,0
114271,professionals,0,0
114272,.,0,0
114273,Hematologic,0,1
114274,patients,0,0
114275,',0,1
114276,clinical,0,0
114277,and,0,1
114278,psychosocial,0,1
114279,experiences,0,1
114280,with,0,0
114281,implanted,0,0
114282,long-term,0,1
114283,central,0,1
114284,venous,0,1
114285,catheter,0,0
114286,:,0,0
114287,self-management,0,0
114288,versus,0,0
114289,professionally,0,0
114290,controlled,0,0
114291,care,0,0
114292,.,0,0
114293,BACKGROUND,0,0
114294,A,0,0
114295,significant,0,0
114296,decrease,0,1
114297,in,0,0
114298,catheter-related,0,1
114299,infections,0,1
114300,was,0,0
114301,demonstrated,0,0
114302,in,0,0
114303,our,0,0
114304,earlier,0,0
114305,randomized,0,0
114306,controlled,0,0
114307,trial,0,0
114308,of,0,1
114309,central,0,1
114310,venous,0,1
114311,catheter,0,1
114312,(,0,1
114313,CVC,0,1
114314,),0,1
114315,care,0,0
114316,in,0,0
114317,hematologic,0,1
114318,patients,0,0
114319,.,0,0
114320,OBJECTIVE,0,0
114321,This,0,0
114322,article,0,0
114323,focuses,0,0
114324,on,0,0
114325,patients,0,0
114326,',0,1
114327,clinical,0,0
114328,and,0,1
114329,psychosocial,0,1
114330,experiences,0,1
114331,with,0,0
114332,CVC,0,1
114333,self-care,0,1
114334,compared,0,0
114335,with,0,0
114336,professionally,0,0
114337,controlled,0,0
114338,CVC,0,0
114339,care,0,0
114340,.,0,1
114341,METHODS,0,0
114342,Eighty-two,0,0
114343,patients,0,0
114344,with,0,0
114345,tunneled,0,0
114346,CVCs,0,0
114347,were,0,0
114348,enrolled,0,0
114349,in,0,0
114350,the,0,0
114351,randomized,0,0
114352,controlled,0,0
114353,trial,0,0
114354,.,0,0
114355,The,0,0
114356,intervention,0,0
114357,group,0,0
114358,(,0,0
114359,n,0,0
114360,=,0,0
114361,42,0,0
114362,),0,0
114363,was,0,0
114364,trained,0,0
114365,to,0,0
114366,perform,0,0
114367,CVC,0,0
114368,self-care,0,1
114369,.,0,0
114370,The,0,0
114371,control,0,0
114372,group,0,0
114373,(,0,0
114374,n,0,0
114375,=,0,0
114376,40,0,0
114377,),0,0
114378,followed,0,0
114379,standard,0,0
114380,CVC,0,1
114381,procedure,0,0
114382,provided,0,0
114383,by,0,0
114384,nurses,0,0
114385,.,0,0
114386,Eighteen,0,0
114387,patients,0,0
114388,were,0,0
114389,selected,0,0
114390,for,0,0
114391,semistructured,0,0
114392,interviews,0,0
114393,focusing,0,0
114394,on,0,0
114395,patients,0,0
114396,',0,1
114397,clinical,0,0
114398,and,0,1
114399,psychosocial,0,1
114400,experiences,0,1
114401,with,0,0
114402,CVCs,0,0
114403,.,0,0
114404,RESULTS,0,0
114405,Methods,0,0
114406,of,0,1
114407,CVC,0,0
114408,care,0,0
114409,have,0,0
114410,different,0,0
114411,influences,0,0
114412,on,0,0
114413,the,0,0
114414,patients,0,0
114415,',0,1
114416,clinical,1,0
114417,and,1,1
114418,psychosocial,1,1
114419,outcomes,1,1
114420,",",0,0
114421,depending,0,0
114422,on,0,0
114423,whether,0,0
114424,they,0,0
114425,were,0,0
114426,hospitalized,0,0
114427,or,0,0
114428,outpatients,0,0
114429,.,0,1
114430,Central,0,1
114431,venous,0,1
114432,catheter,0,1
114433,was,0,0
114434,viewed,0,0
114435,as,0,0
114436,important,0,0
114437,because,0,0
114438,it,0,0
114439,was,0,0
114440,the,0,0
114441,main,0,1
114442,port,0,0
114443,of,0,1
114444,treatment,0,0
114445,toward,0,0
114446,a,0,0
114447,cure,0,1
114448,",",0,0
114449,although,0,0
114450,patients,0,0
114451,constantly,0,0
114452,fear,0,1
114453,complications,0,1
114454,.,0,0
114455,Central,0,1
114456,venous,0,1
114457,catheter,0,1
114458,self-care,0,1
114459,increased,0,1
114460,patients,1,0
114461,',1,1
114462,independence,1,1
114463,from,0,0
114464,health,0,1
114465,professionals,0,0
114466,and,0,1
114467,supported,0,0
114468,perceived,0,1
114469,self-efficacy,1,1
114470,and,0,0
114471,control,0,0
114472,.,0,1
114473,Central,0,1
114474,venous,0,1
114475,catheters,0,0
114476,cause,0,1
114477,psychosocial,1,0
114478,problems,1,1
114479,including,0,0
114480,altered,1,0
114481,body,1,1
114482,perception,1,1
114483,",",1,1
114484,sexual,1,1
114485,activity,1,1
114486,avoidance,1,1
114487,",",1,1
114488,and,1,1
114489,feeling,1,1
114490,stigmatized,1,0
114491,.,1,0
114492,CONCLUSIONS,0,0
114493,Patients,0,0
114494,experience,0,1
114495,increased,0,1
114496,perceived,1,1
114497,self-control,1,1
114498,and,1,1
114499,independence,1,1
114500,when,0,0
114501,individually,0,0
114502,supervised,0,0
114503,and,0,0
114504,trained,0,0
114505,in,0,0
114506,CVC,0,0
114507,self-management,0,0
114508,.,0,1
114509,Assuming,0,0
114510,ownership,0,1
114511,of,0,1
114512,CVC,0,0
114513,care,0,0
114514,can,0,0
114515,encourage,0,0
114516,patients,0,0
114517,to,0,0
114518,feel,0,0
114519,less,0,0
114520,inhibited,0,0
114521,about,0,0
114522,sexual,1,1
114523,activity,1,1
114524,and,1,1
114525,socialization,1,1
114526,.,1,1
114527,IMPLICATIONS,0,0
114528,FOR,0,1
114529,PRACTICE,0,1
114530,Placement,0,0
114531,of,0,0
114532,a,0,0
114533,tunneled,0,0
114534,CVC,0,0
114535,should,0,0
114536,engage,0,0
114537,nurses,0,0
114538,to,0,0
114539,organize,0,0
114540,individualized,0,0
114541,structured,0,0
114542,and,0,0
114543,supervised,0,0
114544,patient,0,1
114545,education,0,0
114546,.,0,0
114547,Stigma,0,1
114548,originating,0,0
114549,from,0,0
114550,CVCs,0,0
114551,should,0,0
114552,be,0,0
114553,carefully,0,0
114554,considered,0,0
114555,by,0,0
114556,health,0,1
114557,professionals,0,0
114558,when,0,0
114559,maintaining,0,1
114560,CVC,0,1
114561,insertion,0,1
114562,for,0,0
114563,longer,0,0
114564,periods,0,0
114565,.,0,1
114566,Central,0,1
114567,venous,0,1
114568,catheters,0,0
114569,should,0,0
114570,be,0,0
114571,removed,0,0
114572,whenever,0,0
114573,the,0,0
114574,potential,0,0
114575,risks,0,0
114576,exceed,0,0
114577,the,0,0
114578,catheter,0,1
114579,'s,0,1
114580,functional,0,1
114581,necessity,0,0
114582,.,0,0
114583,Losartan,0,0
114584,vs.,0,0
114585,amlodipine,0,0
114586,treatment,0,0
114587,in,0,0
114588,elderly,0,0
114589,oncologic,0,0
114590,hypertensive,0,0
114591,patients,0,0
114592,:,0,0
114593,a,0,0
114594,randomized,0,0
114595,clinical,0,0
114596,trial,0,0
114597,.,0,0
114598,Elderly,0,0
114599,neoplastic,0,1
114600,patients,0,0
114601,frequently,0,0
114602,may,0,0
114603,show,0,0
114604,hypertension,0,1
114605,and,0,1
114606,hyperuricemia,0,1
114607,",",0,1
114608,before,0,0
114609,and,0,1
114610,after,0,0
114611,chemotherapeutic,0,0
114612,treatments,0,0
114613,.,0,0
114614,The,0,0
114615,purpose,0,0
114616,of,0,0
114617,this,0,0
114618,study,0,0
114619,was,0,0
114620,to,0,0
114621,evaluate,0,0
114622,the,0,0
114623,efficacy,0,1
114624,of,0,0
114625,losartan,0,0
114626,which,0,0
114627,is,0,0
114628,an,0,0
114629,antihypertensive,0,0
114630,drug,0,0
114631,with,0,0
114632,uricosuric,0,1
114633,properties,0,1
114634,vs.,0,0
114635,amlodipine,0,0
114636,in,0,0
114637,hypertensive,0,0
114638,neoplastic,0,1
114639,elderly,0,0
114640,patients,0,0
114641,.,0,0
114642,This,0,0
114643,was,0,0
114644,an,0,0
114645,open-labeled,0,0
114646,",",0,0
114647,randomized,0,0
114648,",",0,0
114649,comparative,0,0
114650,trial,0,0
114651,.,0,0
114652,The,0,0
114653,study,0,0
114654,was,0,0
114655,performed,0,0
114656,as,0,0
114657,a,0,0
114658,30-day,0,1
114659,study,0,0
114660,.,0,0
114661,Seventy,0,0
114662,patients,0,0
114663,with,0,0
114664,cancer,0,0
114665,were,0,0
114666,randomly,0,0
114667,assigned,0,0
114668,to,0,0
114669,receive,0,0
114670,losartan,0,0
114671,or,0,0
114672,amlodipine,0,0
114673,.,0,1
114674,Blood,1,1
114675,pressure,1,1
114676,(,1,1
114677,BP,1,1
114678,),1,1
114679,",",1,0
114680,blood,1,1
114681,urea,1,1
114682,nitrogen,1,0
114683,(,1,1
114684,BUN,1,0
114685,),1,1
114686,levels,1,1
114687,",",1,1
114688,creatinine,1,1
114689,",",1,1
114690,serum,1,1
114691,and,1,1
114692,urinary,1,1
114693,uric,1,1
114694,acid,1,1
114695,",",1,1
114696,creatinine,1,1
114697,and,1,1
114698,uric,1,1
114699,acid,1,1
114700,clearance,1,1
114701,were,0,0
114702,determined,0,0
114703,before,0,0
114704,and,0,0
114705,after,0,0
114706,chemotherapy,0,0
114707,.,0,0
114708,One,0,0
114709,day,0,0
114710,after,0,0
114711,chemotherapy,0,0
114712,in,0,0
114713,losartan,0,0
114714,group,0,0
114715,vs.,0,0
114716,amlodipine,0,0
114717,group,0,0
114718,we,0,0
114719,observed,0,0
114720,a,0,0
114721,significant,0,0
114722,difference,0,0
114723,in,0,0
114724,urinary,1,1
114725,uric,1,1
114726,acid,1,1
114727,(,0,0
114728,p,0,0
114729,<,0,0
114730,0.001,0,0
114731,),0,0
114732,of,0,0
114733,18,0,0
114734,mg/24,0,0
114735,h,0,0
114736,vs.,0,0
114737,40,0,0
114738,mg/24,0,0
114739,h.,0,0
114740,Thirty,0,0
114741,days,0,0
114742,after,0,0
114743,chemotherapy,0,0
114744,we,0,0
114745,observed,0,0
114746,a,0,0
114747,significant,0,0
114748,difference,0,0
114749,in,0,0
114750,azotemia,1,1
114751,of,0,0
114752,0.0,0,0
114753,mg/dl,0,0
114754,vs.,0,0
114755,3.8,0,0
114756,mg/dl,0,0
114757,(,0,0
114758,p,0,0
114759,<,0,0
114760,0.001,0,0
114761,),0,0
114762,",",0,0
114763,serum,1,1
114764,uric,1,1
114765,acid,1,0
114766,of,0,0
114767,0.05,0,0
114768,mg/dl,0,0
114769,vs.,0,0
114770,0.49,0,0
114771,mg/dl,0,0
114772,(,0,0
114773,p,0,0
114774,<,0,0
114775,0.001,0,0
114776,),0,0
114777,",",0,0
114778,urinary,1,1
114779,uric,1,1
114780,acid,1,1
114781,(,0,0
114782,p,0,0
114783,<,0,0
114784,0.001,0,0
114785,),0,0
114786,of,0,0
114787,23,0,0
114788,mg/24,0,0
114789,h,0,0
114790,vs.,0,0
114791,0.0,0,0
114792,mg/24,0,0
114793,h,0,0
114794,",",0,1
114795,GFR,0,0
114796,of,0,0
114797,2,0,0
114798,ml/min/1.73,0,0
114799,m,0,0
114800,(,0,0
114801,2,0,0
114802,),0,0
114803,vs.,0,0
114804,-8,0,0
114805,ml/min/1.73,0,0
114806,m,0,0
114807,(,0,0
114808,2,0,0
114809,),0,0
114810,(,0,0
114811,p,0,0
114812,<,0,0
114813,0.05,0,0
114814,),0,0
114815,and,0,0
114816,systolic,1,1
114817,BP,1,1
114818,(,0,1
114819,SBP,0,1
114820,),0,0
114821,of,0,0
114822,3.6,0,0
114823,mmHg,0,0
114824,vs.,0,0
114825,0.8,0,0
114826,mmHg,0,0
114827,(,0,0
114828,p,0,0
114829,<,0,0
114830,0.05,0,0
114831,),0,0
114832,.,0,0
114833,The,0,0
114834,findings,0,0
114835,of,0,0
114836,the,0,0
114837,present,0,0
114838,study,0,0
114839,support,0,0
114840,the,0,0
114841,effective,0,1
114842,role,0,0
114843,of,0,1
114844,losartan,0,0
114845,compared,0,0
114846,to,0,0
114847,amlodipine,0,0
114848,in,0,0
114849,treating,0,0
114850,hypertension,0,1
114851,and,0,1
114852,hyperuricemia,0,1
114853,in,0,0
114854,elderly,0,0
114855,patients,0,0
114856,under,0,0
114857,chemotherapeutic,0,0
114858,treatment,0,0
114859,.,0,0
114860,Human,0,0
114861,papillomavirus,0,1
114862,genotypes,0,0
114863,in,0,0
114864,cervical,0,0
114865,intraepithelial,0,1
114866,neoplasia,0,0
114867,grade,0,0
114868,3,0,0
114869,.,0,0
114870,BACKGROUND,0,0
114871,There,0,0
114872,are,0,0
114873,few,0,0
114874,large,0,1
114875,case,0,0
114876,series,0,0
114877,describing,0,0
114878,the,0,0
114879,human,1,0
114880,papillomavirus,1,1
114881,(,1,1
114882,HPV,1,1
114883,),1,0
114884,genotypes,0,0
114885,found,0,0
114886,in,0,0
114887,women,0,0
114888,diagnosed,0,0
114889,with,0,0
114890,rigorously,0,0
114891,reviewed,0,0
114892,cervical,0,0
114893,intraepithelial,0,1
114894,neoplasia,0,0
114895,grade,0,0
114896,3,0,0
114897,(,0,0
114898,CIN3,0,0
114899,),0,1
114900,",",0,0
114901,cervical,0,0
114902,precancer,0,1
114903,.,0,0
114904,METHODS,0,0
114905,The,0,0
114906,Atypical,0,0
114907,Squamous,0,0
114908,Cells,0,1
114909,of,0,0
114910,Undetermined,0,0
114911,Significance,0,0
114912,(,0,0
114913,ASCUS,0,1
114914,),0,1
114915,and,0,1
114916,Low-Grade,0,1
114917,Squamous,0,1
114918,Intraepithelial,0,1
114919,Lesion,0,1
114920,(,0,1
114921,LSIL,0,1
114922,),0,1
114923,Triage,0,1
114924,Study,0,0
114925,(,0,1
114926,ALTS,0,1
114927,),0,0
114928,was,0,0
114929,a,0,0
114930,clinical,0,0
114931,trial,0,0
114932,to,0,0
114933,evaluate,0,0
114934,the,0,0
114935,best,0,0
114936,management,0,0
114937,strategies,0,0
114938,for,0,0
114939,women,0,0
114940,with,0,0
114941,equivocal,0,0
114942,(,0,0
114943,ASCUS,0,1
114944,),0,1
114945,or,0,0
114946,mildly,0,1
114947,abnormal,0,1
114948,(,0,0
114949,LSIL,0,1
114950,),0,1
114951,Pap,0,1
114952,tests,0,1
114953,.,0,0
114954,During,0,0
114955,enrollment,0,0
114956,and,0,0
114957,the,0,0
114958,2-year,0,1
114959,follow-up,0,0
114960,",",0,0
114961,608,0,0
114962,women,0,0
114963,had,0,0
114964,a,0,0
114965,histopathologic,0,1
114966,diagnosis,0,0
114967,of,0,1
114968,CIN3,0,0
114969,and,0,1
114970,PCR-based,0,1
114971,HPV,0,1
114972,genotyping,0,0
114973,results,0,0
114974,on,0,0
114975,cervical,0,0
114976,specimens,0,0
114977,.,0,0
114978,The,0,0
114979,genotyping,0,0
114980,results,0,0
114981,were,0,0
114982,ranked,0,0
114983,hierarchically,0,0
114984,according,0,0
114985,to,0,0
114986,cancer,0,0
114987,risk,0,1
114988,:,0,0
114989,HPV16,0,0
114990,>,0,0
114991,other,0,0
114992,carcinogenic,0,1
114993,HPV,0,1
114994,>,0,1
114995,noncarcinogenic,0,1
114996,HPV,0,1
114997,>,0,1
114998,PCR,0,1
114999,negative,0,1
115000,.,0,0
115001,RESULTS,0,0
115002,Among,0,0
115003,the,0,0
115004,608,0,0
115005,women,0,0
115006,diagnosed,0,0
115007,with,0,0
115008,CIN3,0,0
115009,",",0,0
115010,601,0,0
115011,(,0,0
115012,98.8,0,0
115013,%,0,0
115014,),0,0
115015,cases,0,0
115016,were,0,0
115017,positive,0,0
115018,for,0,0
115019,any,0,0
115020,HPV,0,1
115021,genotype,0,0
115022,and,0,0
115023,95.4,0,0
115024,%,0,0
115025,for,0,0
115026,any,0,0
115027,carcinogenic,1,0
115028,HPV,1,1
115029,.,1,1
115030,HPV16,1,0
115031,(,0,0
115032,59.9,0,0
115033,%,0,0
115034,),0,0
115035,",",0,1
115036,HPV31,1,1
115037,(,0,0
115038,18.1,0,0
115039,%,0,0
115040,),0,0
115041,",",0,1
115042,HPV52,1,0
115043,(,0,0
115044,14.8,0,0
115045,%,0,0
115046,),0,0
115047,",",0,1
115048,HPV51,1,1
115049,(,0,0
115050,14.0,0,0
115051,%,0,0
115052,),0,0
115053,",",0,1
115054,and,0,1
115055,HPV18,1,1
115056,(,0,0
115057,13.2,0,0
115058,%,0,0
115059,),0,0
115060,were,0,0
115061,the,0,0
115062,five,0,0
115063,most,0,0
115064,common,0,0
115065,HPV,0,1
115066,genotypes,0,0
115067,detected,0,0
115068,.,0,0
115069,Younger,1,0
115070,age,1,0
115071,",",1,1
115072,consensus,1,0
115073,histologic,1,1
115074,confirmation,1,0
115075,",",1,1
115076,smoking,1,1
115077,",",1,1
115078,and,1,1
115079,multiparity,1,1
115080,increased,0,0
115081,the,0,0
115082,likelihood,0,1
115083,of,0,0
115084,testing,1,0
115085,HPV,1,0
115086,16,1,0
115087,positive,1,0
115088,.,1,0
115089,Specifically,0,0
115090,",",0,0
115091,HPV16-positive,1,0
115092,CIN3,1,1
115093,occurred,0,0
115094,at,0,0
115095,a,0,0
115096,younger,0,0
115097,age,0,0
115098,than,0,0
115099,CIN3,1,0
115100,positive,1,1
115101,for,0,0
115102,other,0,0
115103,carcinogenic,1,1
115104,HPV,1,1
115105,genotypes,1,1
115106,(,0,0
115107,median,0,1
115108,of,0,0
115109,23.5,0,0
115110,years,0,0
115111,versus,0,0
115112,25,0,0
115113,years,0,0
115114,",",0,0
115115,respectively,0,0
115116,;,0,0
115117,P,0,0
115118,=,0,0
115119,0.0003,0,0
115120,",",0,0
115121,Kruskal-Wallis,0,0
115122,),0,0
115123,.,0,0
115124,CONCLUSIONS,0,0
115125,HPV16-positive,1,0
115126,CIN3,1,0
115127,was,0,0
115128,more,0,0
115129,commonly,0,0
115130,diagnosed,0,0
115131,in,0,0
115132,younger,0,0
115133,women,0,0
115134,(,0,1
115135,versus,0,0
115136,older,0,0
115137,women,0,0
115138,),0,1
115139,",",0,0
115140,with,0,0
115141,consensus,0,0
115142,diagnosis,0,1
115143,(,0,0
115144,versus,0,0
115145,some,0,0
115146,disagreement,0,0
115147,between,0,0
115148,reviewers,0,0
115149,),0,1
115150,",",0,0
115151,and,0,1
115152,in,0,1
115153,smokers,0,0
115154,(,0,0
115155,versus,0,0
115156,nonsmokers,0,0
115157,),0,1
115158,",",0,1
115159,and,0,1
115160,was,0,0
115161,less,0,0
115162,commonly,0,0
115163,diagnosed,0,0
115164,in,0,0
115165,multiparous,0,0
115166,women,0,0
115167,compared,0,0
115168,CIN3,1,0
115169,positive,1,1
115170,for,0,0
115171,other,0,0
115172,carcinogenic,1,1
115173,HPV,1,1
115174,genotypes,1,0
115175,.,1,0
115176,IMPACT,0,0
115177,In,0,0
115178,populations,0,0
115179,vaccinated,0,0
115180,against,0,0
115181,HPV16,0,0
115182,(,0,0
115183,and,0,1
115184,HPV18,0,1
115185,),0,0
115186,",",0,0
115187,the,0,0
115188,median,0,1
115189,age,0,0
115190,of,0,1
115191,CIN3,0,0
115192,in,0,0
115193,women,0,0
115194,with,0,0
115195,ASCUS,0,1
115196,and,0,1
115197,LSIL,0,1
115198,cytology,0,1
115199,should,0,0
115200,shift,0,0
115201,to,0,0
115202,older,0,0
115203,ages,0,0
115204,",",0,0
115205,possibly,0,0
115206,permitting,0,0
115207,later,0,0
115208,age,0,0
115209,at,0,0
115210,first,0,0
115211,screening,0,0
115212,.,0,0
115213,Translucency,0,1
115214,of,0,1
115215,zirconia,0,0
115216,copings,0,1
115217,made,0,0
115218,with,0,0
115219,different,0,0
115220,CAD/CAM,0,0
115221,systems,0,0
115222,.,0,0
115223,STATEMENT,0,0
115224,OF,0,0
115225,PROBLEM,0,0
115226,Zirconia,0,0
115227,cores,0,0
115228,are,0,0
115229,reported,0,0
115230,to,0,0
115231,be,0,0
115232,less,0,0
115233,translucent,0,1
115234,than,0,0
115235,glass,0,1
115236,",",0,1
115237,lithium,0,1
115238,disilicate,0,1
115239,",",0,1
115240,or,0,1
115241,alumina,0,1
115242,cores,0,1
115243,.,0,0
115244,This,0,0
115245,could,0,0
115246,affect,0,0
115247,the,0,0
115248,esthetic,0,1
115249,appearance,0,1
115250,and,0,0
115251,the,0,0
115252,clinical,0,1
115253,choices,0,1
115254,made,0,0
115255,when,0,0
115256,using,0,0
115257,zirconia-based,0,0
115258,restorations,0,0
115259,.,0,0
115260,PURPOSE,0,0
115261,The,0,0
115262,purpose,0,0
115263,of,0,0
115264,this,0,0
115265,in,0,0
115266,vitro,0,1
115267,study,0,0
115268,was,0,0
115269,to,0,0
115270,evaluate,0,0
115271,the,0,0
115272,translucency,1,1
115273,of,0,0
115274,zirconia,0,0
115275,copings,0,1
115276,for,0,0
115277,single,0,0
115278,crowns,0,0
115279,fabricated,0,0
115280,using,0,0
115281,different,0,0
115282,CAD/CAM,0,1
115283,systems,0,0
115284,",",0,0
115285,using,0,0
115286,lithium,0,0
115287,disilicate,0,0
115288,glass,0,1
115289,ceramic,0,0
115290,as,0,0
115291,a,0,0
115292,control,0,0
115293,.,0,0
115294,MATERIAL,0,0
115295,AND,0,0
115296,METHODS,0,0
115297,Using,0,1
115298,impressions,0,0
115299,made,0,0
115300,from,0,0
115301,a,0,0
115302,stainless,0,0
115303,steel,0,1
115304,complete-crown,0,0
115305,master,0,1
115306,die,0,1
115307,",",0,0
115308,9,0,0
115309,stone,0,1
115310,cast,0,0
115311,replicas,0,0
115312,were,0,0
115313,fabricated,0,0
115314,",",0,0
115315,numbered,0,0
115316,",",0,1
115317,and,0,1
115318,distributed,0,0
115319,into,0,0
115320,8,0,0
115321,ceramic,0,0
115322,ZrO,0,0
115323,(,0,0
115324,2,0,0
115325,),0,0
115326,CAD/CAM,0,0
115327,system,0,0
115328,groups,0,0
115329,(,0,0
115330,Lava,0,1
115331,Frame,0,1
115332,0.3,0,0
115333,and,0,0
115334,0.5,0,0
115335,",",0,0
115336,IPS,0,0
115337,e.max,0,0
115338,ZirCAD,0,1
115339,",",0,0
115340,VITA,0,1
115341,YZ,0,0
115342,",",0,1
115343,Procera,0,0
115344,AllZircon,0,1
115345,",",0,1
115346,Digizon,0,1
115347,",",0,1
115348,DC,0,0
115349,Zircon,0,1
115350,",",0,1
115351,and,0,1
115352,Cercon,0,0
115353,Base,0,1
115354,),0,0
115355,and,0,0
115356,to,0,0
115357,a,0,0
115358,lithium,0,0
115359,disilicate,0,0
115360,glass-ceramic,0,0
115361,control,0,0
115362,group,0,0
115363,(,0,1
115364,IPS,0,0
115365,e.max,0,0
115366,Press,0,0
115367,),0,0
115368,using,0,0
115369,a,0,0
115370,simple,0,0
115371,computer-generated,0,0
115372,randomization,0,0
115373,method,0,0
115374,.,0,0
115375,From,0,0
115376,each,0,0
115377,die,0,0
115378,",",0,0
115379,the,0,0
115380,manufacturer,0,1
115381,'s,0,1
115382,authorized,0,0
115383,milling,0,0
115384,centers,0,0
115385,supplied,0,0
115386,5,0,0
115387,copings,0,1
115388,per,0,0
115389,group,0,0
115390,without,0,0
115391,applying,0,0
115392,any,0,0
115393,dying,0,1
115394,technique,0,0
115395,to,0,0
115396,the,0,0
115397,ceramic,0,0
115398,base,0,0
115399,material,0,0
115400,.,0,0
115401,The,0,0
115402,copings,0,1
115403,were,0,0
115404,prepared,0,0
115405,to,0,0
115406,allow,0,0
115407,for,0,0
115408,a,0,0
115409,40-mum,0,0
115410,cement,0,1
115411,layer,0,1
115412,and,0,1
115413,were,0,0
115414,of,0,1
115415,different,0,0
115416,thicknesses,0,1
115417,according,0,0
115418,to,0,0
115419,system,0,0
115420,specifications,0,1
115421,.,0,1
115422,Translucency,1,1
115423,was,0,0
115424,measured,0,0
115425,by,0,0
115426,the,0,0
115427,direct,0,0
115428,transmission,0,1
115429,method,0,0
115430,with,0,0
115431,a,0,0
115432,digital,0,0
115433,photoradiometer,0,0
115434,mounted,0,0
115435,in,0,0
115436,a,0,0
115437,dark,0,0
115438,chamber,0,0
115439,.,0,0
115440,The,0,0
115441,light,0,1
115442,source,0,0
115443,was,0,0
115444,a,0,0
115445,150-W,0,0
115446,halogen,0,0
115447,lamp,0,0
115448,beam,0,1
115449,.,0,1
115450,Measurements,0,1
115451,were,0,0
115452,repeated,0,0
115453,3,0,0
115454,times,0,0
115455,for,0,0
115456,each,0,0
115457,specimen,0,0
115458,.,0,0
115459,Data,0,0
115460,obtained,0,0
115461,were,0,0
115462,analyzed,0,0
115463,using,0,0
115464,1-way,0,0
115465,ANOVA,0,0
115466,and,0,0
115467,the,0,0
115468,Bonferroni,0,1
115469,multiple,0,0
115470,comparison,0,0
115471,test,0,1
115472,(,0,1
115473,alpha=.05,0,0
115474,),0,0
115475,.,0,0
115476,RESULTS,0,0
115477,Among,0,0
115478,ZrO,0,0
115479,(,0,0
115480,2,0,0
115481,),0,0
115482,copings,0,1
115483,",",0,1
115484,Lava,0,1
115485,(,0,0
115486,0.3,0,0
115487,mm,0,0
115488,and,0,0
115489,0.5,0,0
115490,mm,0,0
115491,thick,0,0
115492,),0,0
115493,showed,0,0
115494,the,0,0
115495,highest,0,1
115496,(,0,0
115497,P,0,0
115498,<,0,0
115499,.05,0,0
115500,),0,0
115501,values,1,1
115502,of,1,0
115503,translucency,1,1
115504,measured,0,0
115505,as,0,0
115506,light,0,0
115507,flow,0,1
115508,units,0,0
115509,(,0,0
115510,3.572,0,0
115511,+,0,0
115512,or,0,0
115513,-,0,0
115514,018,0,0
115515,x,0,0
115516,10,0,0
115517,(,0,0
115518,3,0,0
115519,),0,0
115520,lx,0,1
115521,and,0,0
115522,3.181,0,0
115523,+,0,0
115524,or,0,0
115525,-,0,0
115526,0.13,0,0
115527,x,0,0
115528,10,0,0
115529,(,0,0
115530,3,0,0
115531,),0,0
115532,lx,0,1
115533,",",0,0
115534,respectively,0,0
115535,),0,0
115536,.,0,0
115537,These,0,0
115538,values,0,0
115539,represent,0,0
115540,71.7,0,0
115541,%,0,0
115542,and,0,0
115543,63.9,0,0
115544,%,0,0
115545,",",0,0
115546,respectively,0,0
115547,",",0,0
115548,of,0,0
115549,the,0,0
115550,glass-ceramic,0,0
115551,control,0,0
115552,group,0,0
115553,(,0,0
115554,4.98,0,0
115555,x,0,0
115556,10,0,0
115557,(,0,0
115558,3,0,0
115559,),0,0
115560,lx,0,0
115561,),0,0
115562,.,0,0
115563,CONCLUSIONS,0,0
115564,All,0,0
115565,ZrO,0,0
115566,(,0,0
115567,2,0,0
115568,),0,0
115569,copings,0,1
115570,demonstrated,0,0
115571,different,0,0
115572,levels,0,1
115573,of,0,1
115574,light,0,1
115575,transmission,0,1
115576,",",0,0
115577,with,0,0
115578,the,0,0
115579,2,0,0
115580,Lava,0,0
115581,specimens,0,0
115582,showing,0,0
115583,the,0,0
115584,highest,0,0
115585,values,0,1
115586,.,0,0
115587,Translucency,1,1
115588,of,0,1
115589,zirconia,0,0
115590,copings,0,1
115591,was,0,0
115592,significantly,0,0
115593,lower,0,0
115594,(,0,1
115595,P=.001,0,1
115596,),0,0
115597,than,0,0
115598,that,0,0
115599,of,0,0
115600,the,0,0
115601,lithium,0,0
115602,disilicate,0,0
115603,glass-ceramic,0,0
115604,control,0,0
115605,.,0,0
115606,Effects,1,0
115607,of,0,0
115608,intravenous,0,0
115609,iron,0,0
115610,combined,0,0
115611,with,0,0
115612,low-dose,0,0
115613,recombinant,0,0
115614,human,0,0
115615,erythropoietin,0,0
115616,on,0,0
115617,transfusion,1,1
115618,requirements,1,1
115619,in,0,0
115620,iron-deficient,0,0
115621,patients,0,0
115622,undergoing,0,0
115623,bilateral,0,0
115624,total,0,1
115625,knee,0,1
115626,replacement,0,0
115627,arthroplasty,0,1
115628,.,0,0
115629,BACKGROUND,0,0
115630,The,0,0
115631,authors,0,0
115632,examined,0,0
115633,the,0,0
115634,impact,0,0
115635,of,0,0
115636,parenteral,0,0
115637,iron,0,0
115638,and,0,1
115639,recombinant,0,0
115640,human,0,0
115641,erythropoietin-?,0,0
115642,(,0,1
115643,rHuEPO-?,0,0
115644,),0,0
115645,administered,0,0
115646,in,0,0
115647,the,0,0
115648,bilateral,0,0
115649,total,0,1
115650,knee,0,1
115651,replacement,0,0
115652,arthroplasty,0,1
115653,(,0,1
115654,TKRA,0,1
115655,),0,1
115656,",",0,0
115657,on,0,0
115658,postoperative,1,1
115659,anemia,1,1
115660,and,1,1
115661,transfusion,1,1
115662,requirements,1,1
115663,in,1,0
115664,iron-deficient,0,0
115665,patients,0,0
115666,.,0,0
115667,STUDY,0,0
115668,DESIGN,0,0
115669,AND,0,0
115670,METHODS,0,0
115671,A,0,0
115672,total,0,1
115673,of,0,0
115674,108,0,0
115675,iron-deficient,0,0
115676,patients,0,0
115677,were,0,0
115678,randomly,0,0
115679,assigned,0,0
115680,to,0,0
115681,two,0,0
115682,groups,0,0
115683,:,0,0
115684,Group,0,0
115685,C,0,1
115686,(,0,1
115687,control,0,0
115688,),0,1
115689,or,0,0
115690,Group,0,0
115691,IE,0,0
115692,(,0,0
115693,200,0,0
115694,mg,0,0
115695,of,0,0
115696,iron,0,0
115697,sucrose,0,0
115698,intravenously,0,0
115699,over,0,0
115700,1,0,0
115701,hr,0,0
115702,and,0,0
115703,3000,0,0
115704,IU,0,0
115705,of,0,0
115706,rHuEPO-?,0,0
115707,subcutaneously,0,0
115708,during,0,0
115709,the,0,0
115710,operation,0,0
115711,and,0,0
115712,during,0,0
115713,the,0,0
115714,postoperative,0,1
115715,period,0,0
115716,if,0,0
115717,the,0,0
115718,hemoglobin,0,1
115719,[,0,0
115720,Hb,0,1
115721,],0,0
115722,level,0,1
115723,was,0,0
115724,70-80,0,1
115725,g/L,0,0
115726,),0,0
115727,.,0,0
115728,One,0,0
115729,or,0,0
115730,2,0,0
115731,units,0,0
115732,of,0,0
115733,blood,0,1
115734,were,0,0
115735,transfused,0,1
115736,to,0,0
115737,patients,0,0
115738,in,0,0
115739,both,0,0
115740,groups,0,0
115741,according,0,0
115742,to,0,0
115743,postoperative,0,1
115744,Hb,0,1
115745,level,0,1
115746,(,0,0
115747,between,0,0
115748,60,0,0
115749,and,0,0
115750,70,0,0
115751,g/L,0,0
115752,or,0,0
115753,betweeen,0,0
115754,50,0,0
115755,and,0,0
115756,60,0,0
115757,g/L,0,0
115758,",",0,0
115759,respectively,1,0
115760,),1,0
115761,.,1,0
115762,Perioperative,1,0
115763,laboratory,1,1
115764,and,1,1
115765,clinical,1,1
115766,outcomes,1,1
115767,(,1,1
115768,Hb,1,1
115769,",",1,1
115770,iron,1,1
115771,variables,1,1
115772,",",1,1
115773,postoperative,1,1
115774,bleeding,1,1
115775,amount,1,1
115776,",",1,1
115777,and,1,1
115778,number,1,1
115779,of,1,1
115780,units,1,0
115781,of,1,1
115782,RBCs,1,1
115783,transfused,1,1
115784,and,1,1
115785,incidences,1,1
115786,),1,1
115787,were,1,0
115788,documented,0,0
115789,.,0,0
115790,RESULTS,0,0
115791,Although,1,0
115792,preoperative,1,1
115793,Hb,1,1
115794,and,0,0
115795,the,0,0
115796,amount,1,1
115797,of,1,0
115798,postoperative,1,1
115799,bleeding,1,1
115800,were,1,0
115801,comparable,0,0
115802,in,0,0
115803,the,0,0
115804,two,0,0
115805,groups,1,0
115806,",",1,0
115807,Hb,1,1
115808,levels,1,1
115809,at,1,0
115810,1,0,0
115811,",",0,0
115812,2,0,0
115813,",",0,0
115814,and,0,0
115815,3,0,0
115816,days,0,0
115817,and,0,0
115818,at,0,0
115819,2,0,0
115820,and,0,0
115821,6,0,0
115822,weeks,0,0
115823,postoperation,0,1
115824,were,0,0
115825,significantly,0,0
115826,higher,0,0
115827,in,0,0
115828,Group,0,0
115829,IE,0,0
115830,.,0,1
115831,Furthermore,0,0
115832,",",0,0
115833,the,0,0
115834,transfusion,1,1
115835,rate,1,1
115836,was,1,0
115837,significantly,0,0
115838,lower,0,0
115839,in,0,0
115840,Group,0,0
115841,IE,0,0
115842,(,0,0
115843,20.4,0,0
115844,%,0,0
115845,vs.,0,0
115846,53.7,0,0
115847,%,0,0
115848,",",0,0
115849,p=0.011,0,0
115850,),0,1
115851,and,0,0
115852,the,0,0
115853,mean,1,1
115854,number,1,1
115855,of,1,1
115856,red,1,1
115857,blood,1,1
115858,cell,1,1
115859,units,1,1
115860,transfused,1,1
115861,was,1,0
115862,markedly,0,0
115863,lower,0,0
115864,in,0,0
115865,Group,0,0
115866,IE,0,0
115867,(,0,0
115868,0.2?0.5,0,0
115869,vs.,0,0
115870,0.8?0.8,0,0
115871,",",0,0
115872,p=0.005,1,0
115873,),1,1
115874,.,1,0
115875,Postoperative,1,1
115876,iron,1,1
115877,",",1,1
115878,ferritin,1,1
115879,",",1,1
115880,and,1,1
115881,transferrin,1,1
115882,saturation,1,1
115883,levels,1,1
115884,were,1,0
115885,significantly,0,0
115886,higher,0,0
115887,in,0,0
115888,Group,0,0
115889,IE,0,0
115890,.,0,0
115891,CONCLUSIONS,0,0
115892,Treatment,0,0
115893,with,0,0
115894,parenteral,0,0
115895,iron,0,0
115896,and,0,1
115897,low-dose,0,0
115898,rHuEPO-?,0,0
115899,in,0,0
115900,bilateral,0,0
115901,TKRA,0,0
115902,effectively,1,0
115903,attenuated,1,0
115904,anemia,1,1
115905,and,1,1
115906,decreased,1,1
115907,transfusion,1,1
115908,requirements,1,1
115909,in,1,0
115910,iron-deficient,1,0
115911,patients,0,0
115912,.,0,0
115913,Efficacy,1,1
115914,of,0,1
115915,patient,0,1
115916,education,0,0
115917,and,0,1
115918,supervised,0,0
115919,exercise,0,0
115920,vs,0,0
115921,patient,0,1
115922,education,0,0
115923,alone,0,0
115924,in,0,0
115925,patients,0,0
115926,with,0,0
115927,hip,0,1
115928,osteoarthritis,0,0
115929,:,0,0
115930,a,0,0
115931,single,0,0
115932,blind,0,0
115933,randomized,0,0
115934,clinical,0,0
115935,trial,0,0
115936,.,0,0
115937,OBJECTIVE,0,0
115938,To,0,0
115939,compare,0,0
115940,the,0,0
115941,efficacy,0,1
115942,of,0,0
115943,patient,0,1
115944,education,0,0
115945,and,0,1
115946,supervised,0,0
115947,exercise,0,0
115948,with,0,0
115949,that,0,0
115950,of,0,0
115951,patient,0,1
115952,education,0,0
115953,alone,0,0
115954,for,0,0
115955,the,0,0
115956,management,1,0
115957,of,1,0
115958,pain,1,1
115959,in,0,0
115960,patients,0,0
115961,with,0,0
115962,hip,0,1
115963,osteoarthritis,0,1
115964,(,0,1
115965,OA,0,1
115966,),0,0
115967,.,0,0
115968,DESIGN,0,0
115969,Single,0,0
115970,blind,0,0
115971,randomized,0,0
115972,clinical,0,0
115973,trial,0,0
115974,.,0,0
115975,SETTING,0,0
115976,Recruitment,0,1
115977,of,0,0
115978,patients,0,0
115979,from,0,0
115980,hospitals,0,0
115981,",",0,0
115982,primary,0,1
115983,health,0,1
115984,care,0,0
115985,and,0,1
115986,advertisement,0,1
115987,",",0,1
115988,Oslo,0,1
115989,",",0,0
115990,Norway,0,0
115991,.,0,0
115992,PARTICIPANTS,0,0
115993,109,0,0
115994,patients,0,0
115995,with,0,0
115996,radiographic,0,1
115997,and,0,1
115998,symptomatic,0,1
115999,hip,0,1
116000,OA,0,1
116001,with,0,0
116002,mild,0,0
116003,to,0,0
116004,moderate,0,0
116005,symptoms,0,1
116006,.,0,0
116007,INTERVENTIONS,0,1
116008,Patient,0,1
116009,education,0,0
116010,(,0,1
116011,PE,0,1
116012,),0,0
116013,.,0,0
116014,Patient,0,1
116015,education,0,0
116016,and,0,1
116017,supervised,0,0
116018,exercise,0,0
116019,(,0,0
116020,PE+SE,0,0
116021,),0,0
116022,.,0,0
116023,PRIMARY,0,0
116024,OUTCOME,0,0
116025,MEASURE,0,0
116026,The,0,0
116027,pain,1,1
116028,subscale,1,1
116029,of,1,0
116030,the,1,0
116031,Western,1,0
116032,Ontario,1,0
116033,and,1,1
116034,McMaster,1,0
116035,Universities,1,1
116036,Osteoarthritis,1,1
116037,Index,1,1
116038,(,1,0
116039,WOMAC,1,1
116040,pain,1,1
116041,),1,0
116042,.,1,0
116043,RESULTS,0,0
116044,No,0,1
116045,significant,0,0
116046,between,0,0
116047,group,0,0
116048,differences,0,0
116049,were,0,0
116050,found,0,0
116051,for,0,0
116052,WOMAC,1,1
116053,pain,1,1
116054,over,0,0
116055,the,0,0
116056,16-month,0,0
116057,follow-up,0,0
116058,.,0,0
116059,Significant,0,1
116060,improvements,0,1
116061,were,0,0
116062,found,0,0
116063,for,0,0
116064,the,0,0
116065,secondary,0,0
116066,outcome,0,1
116067,WOMAC,1,1
116068,physical,1,1
116069,function,1,1
116070,(,0,1
116071,P=0.011,0,0
116072,),0,0
116073,in,0,0
116074,the,0,0
116075,group,0,0
116076,receiving,0,0
116077,PE+SE,0,0
116078,compared,0,0
116079,to,0,0
116080,the,0,0
116081,group,0,0
116082,receiving,0,0
116083,PE,0,0
116084,only,0,0
116085,.,0,0
116086,No,0,0
116087,significant,0,0
116088,differences,0,0
116089,were,0,0
116090,found,0,0
116091,for,0,0
116092,WOMAC,1,1
116093,stiffness,1,1
116094,",",0,0
116095,the,0,0
116096,SF-36,0,0
116097,subscales,0,1
116098,or,0,0
116099,the,0,0
116100,activity,0,1
116101,scale,0,1
116102,.,0,0
116103,The,0,0
116104,effect,0,0
116105,sizes,0,1
116106,(,0,0
116107,95,0,0
116108,%,0,0
116109,confidence,0,0
116110,interval,0,0
116111,),0,0
116112,for,0,0
116113,WOMAC,1,1
116114,pain,1,1
116115,were,0,0
116116,-0.26,0,0
116117,(,0,0
116118,0.11,0,0
116119,",",0,0
116120,-0.64,0,0
116121,),0,1
116122,",",0,1
116123,-0.35,0,0
116124,(,0,0
116125,0.07,0,0
116126,",",0,0
116127,-0.77,0,0
116128,),0,1
116129,",",0,1
116130,and,0,1
116131,-0.30,0,0
116132,(,0,0
116133,0.15,0,0
116134,",",0,0
116135,-0.75,0,0
116136,),0,1
116137,",",0,1
116138,and,0,1
116139,for,0,0
116140,WOMAC,1,1
116141,physical,1,1
116142,function,1,1
116143,-0.29,0,0
116144,(,0,0
116145,0.09,0,0
116146,",",0,0
116147,-0.67,0,0
116148,),0,1
116149,",",0,1
116150,-0.48,0,0
116151,(,0,1
116152,-0.06,0,0
116153,",",0,1
116154,-0.91,0,0
116155,),0,1
116156,",",0,0
116157,and,0,1
116158,-0.47,0,0
116159,(,0,1
116160,-0.02,0,0
116161,",",0,1
116162,-0.93,0,0
116163,),0,0
116164,at,0,0
116165,4,0,0
116166,",",0,0
116167,10,0,0
116168,and,0,0
116169,16,0,0
116170,months,0,0
116171,",",0,0
116172,respectively,0,0
116173,",",0,0
116174,in,0,0
116175,favor,0,0
116176,of,0,0
116177,the,0,0
116178,group,0,0
116179,receiving,0,0
116180,both,0,0
116181,PE,0,1
116182,and,0,0
116183,SE,0,0
116184,.,0,0
116185,All,0,0
116186,patients,0,0
116187,attended,0,0
116188,the,0,0
116189,three-session,0,0
116190,PE,0,1
116191,program,0,0
116192,",",0,0
116193,and,0,0
116194,75,0,0
116195,%,0,0
116196,performed,0,0
116197,?16,0,1
116198,sessions,0,0
116199,of,0,0
116200,the,0,0
116201,12-week,0,0
116202,SE,0,0
116203,program,0,0
116204,.,0,0
116205,CONCLUSION,0,0
116206,The,0,0
116207,study,0,0
116208,could,0,0
116209,not,0,0
116210,demonstrate,0,0
116211,a,0,0
116212,significant,0,0
116213,difference,0,0
116214,in,0,0
116215,pain,1,1
116216,reduction,1,1
116217,over,1,0
116218,time,0,1
116219,between,0,0
116220,PE+SE,0,1
116221,vs,0,0
116222,PE,0,0
116223,alone,0,0
116224,.,0,0
116225,Adding,0,0
116226,SE,0,0
116227,to,0,0
116228,PE,0,0
116229,may,0,0
116230,improve,1,0
116231,physical,1,1
116232,function,1,1
116233,",",1,0
116234,but,0,0
116235,the,0,0
116236,magnitude,0,1
116237,of,0,0
116238,possible,0,0
116239,benefit,0,0
116240,is,0,0
116241,unknown,0,0
116242,as,0,0
116243,the,0,0
116244,95,0,0
116245,%,0,0
116246,confidence,0,0
116247,intervals,0,0
116248,around,0,0
116249,the,0,0
116250,mean,0,1
116251,difference,0,0
116252,were,0,0
116253,wide,0,0
116254,.,0,0
116255,TRIAL,0,0
116256,REGISTRATION,0,0
116257,Clinical,0,1
116258,Trials,0,1
116259,NCT00319423,0,0
116260,.,0,0
116261,Effects,0,0
116262,of,0,0
116263,two,0,0
116264,combined,0,0
116265,hormonal,0,0
116266,contraceptives,0,0
116267,with,0,0
116268,the,0,0
116269,same,0,0
116270,composition,0,1
116271,and,0,1
116272,different,0,0
116273,doses,0,0
116274,on,0,0
116275,female,0,0
116276,sexual,0,1
116277,function,0,1
116278,and,0,1
116279,plasma,0,1
116280,androgen,0,1
116281,levels,0,1
116282,.,0,0
116283,BACKGROUND,0,0
116284,This,0,0
116285,study,0,0
116286,was,0,0
116287,conducted,0,0
116288,to,0,0
116289,compare,0,0
116290,the,0,0
116291,effects,0,0
116292,of,0,0
116293,two,0,0
116294,contraceptive,0,0
116295,pills,0,0
116296,with,0,0
116297,different,0,0
116298,doses,0,0
116299,of,0,0
116300,the,0,0
116301,same,0,0
116302,components,0,1
116303,",",0,0
116304,on,0,0
116305,plasma,1,1
116306,androgen,1,1
116307,levels,1,1
116308,and,0,1
116309,female,1,0
116310,sexual,1,1
116311,function,1,1
116312,among,1,0
116313,women,1,0
116314,without,1,0
116315,previous,1,0
116316,sexual,1,1
116317,dysfunction,1,1
116318,.,1,0
116319,STUDY,0,0
116320,DESIGN,0,0
116321,The,0,0
116322,participants,0,0
116323,were,0,0
116324,randomized,0,0
116325,into,0,0
116326,two,0,0
116327,groups,0,0
116328,",",0,0
116329,to,0,0
116330,receive,0,0
116331,pills,0,0
116332,containing,0,0
116333,ethynylestradiol,0,0
116334,(,0,1
116335,EE,0,1
116336,),0,0
116337,30,0,0
116338,mcg,0,0
116339,and,0,0
116340,levonorgestrel,0,0
116341,(,0,1
116342,LNG,0,0
116343,),0,0
116344,150,0,0
116345,mcg,0,0
116346,or,0,0
116347,EE,0,1
116348,20,0,0
116349,mcg,0,0
116350,and,0,0
116351,LNG,0,0
116352,100,0,0
116353,mcg,0,0
116354,",",0,0
116355,for,0,0
116356,six,0,0
116357,cycles,0,0
116358,.,0,0
116359,Sexual,1,1
116360,function,1,1
116361,was,0,0
116362,assessed,0,0
116363,using,0,0
116364,a,0,0
116365,standardized,0,0
116366,questionnaire,0,1
116367,[,0,0
116368,Female,0,0
116369,Sexual,0,1
116370,Function,0,1
116371,Index,0,1
116372,(,0,1
116373,FSFI,0,1
116374,),0,0
116375,],0,0
116376,.,0,0
116377,Hormone,1,0
116378,assays,1,1
116379,were,0,0
116380,performed,0,0
116381,at,0,0
116382,baseline,0,0
116383,and,0,0
116384,after,0,0
116385,the,0,0
116386,sixth,0,0
116387,cycle,0,1
116388,.,0,0
116389,RESULTS,0,0
116390,Forty-nine,0,0
116391,women,0,0
116392,were,0,0
116393,included,0,0
116394,in,0,0
116395,the,0,0
116396,EE30/LNG150,0,0
116397,group,0,0
116398,and,0,0
116399,48,0,0
116400,in,0,0
116401,the,0,0
116402,EE20/LNG100,0,0
116403,group,0,0
116404,.,0,1
116405,EE30/LNG150,0,0
116406,group,0,0
116407,presented,0,0
116408,54,0,0
116409,%,0,0
116410,and,0,0
116411,67,0,0
116412,%,0,0
116413,decreases,0,0
116414,of,0,1
116415,total,1,1
116416,testosterone,1,1
116417,and,1,1
116418,free,1,1
116419,androgen,1,1
116420,index,1,1
116421,",",0,1
116422,respectively,0,0
116423,",",0,0
116424,with,0,0
116425,statistical,0,1
116426,significance,0,1
116427,.,0,1
116428,EE20/LNG100,0,0
116429,presented,0,0
116430,reductions,0,1
116431,of,0,0
116432,20,0,0
116433,%,0,0
116434,and,0,0
116435,42,0,0
116436,%,0,0
116437,",",0,0
116438,respectively,0,0
116439,",",0,0
116440,but,0,0
116441,without,0,0
116442,statistical,0,1
116443,significance,0,1
116444,.,0,0
116445,Both,0,0
116446,groups,0,0
116447,showed,0,0
116448,improvements,0,0
116449,in,0,0
116450,the,0,0
116451,FSFI,1,1
116452,desire,1,1
116453,score,1,1
116454,",",0,1
116455,but,0,0
116456,with,0,0
116457,statistical,0,1
116458,significance,0,1
116459,only,0,0
116460,for,0,0
116461,EE20/LNG100,0,0
116462,group,0,0
116463,.,0,1
116464,CONCLUSIONS,0,0
116465,EE30/LNG150,0,0
116466,decreased,0,1
116467,plasma,0,1
116468,androgen,0,1
116469,levels,0,1
116470,",",0,1
116471,but,0,0
116472,there,0,0
116473,was,0,0
116474,no,0,0
116475,impairment,0,1
116476,in,0,0
116477,sexual,0,1
116478,desire,0,1
116479,",",0,0
116480,on,0,0
116481,the,0,0
116482,other,0,0
116483,hand,0,1
116484,",",0,1
116485,sexual,0,1
116486,desire,0,1
116487,score,0,1
116488,increased,0,1
116489,with,0,0
116490,EE20/LNG100,0,0
116491,formulation,0,0
116492,.,0,0
116493,Tensile,1,1
116494,bond,1,1
116495,strength,1,1
116496,of,0,0
116497,a,0,0
116498,lithium-disilicate,0,0
116499,pressed,0,0
116500,glass,0,0
116501,ceramic,0,0
116502,to,0,0
116503,dentin,0,0
116504,of,0,0
116505,different,0,0
116506,surface,0,0
116507,treatments,0,0
116508,.,0,0
116509,The,0,0
116510,effects,0,0
116511,of,0,1
116512,desensitizer,0,0
116513,",",0,1
116514,disinfectant,0,1
116515,",",0,1
116516,saliva,0,1
116517,",",0,1
116518,blood,0,1
116519,",",0,1
116520,and,0,1
116521,hydrogen,0,1
116522,peroxide,0,1
116523,on,0,0
116524,the,0,0
116525,tensile,1,1
116526,bond,1,1
116527,strength,1,1
116528,between,0,0
116529,adhesive,0,1
116530,and,0,1
116531,ceramic,0,0
116532,as,0,0
116533,well,0,0
116534,as,0,0
116535,between,0,0
116536,adhesive,0,1
116537,and,0,1
116538,dentin,0,0
116539,were,0,0
116540,examined,0,0
116541,.,0,0
116542,Sixty,0,0
116543,7x3,0,0
116544,mm,0,0
116545,pressed,0,0
116546,ceramic,0,0
116547,discs,0,0
116548,of,0,1
116549,IPS,0,0
116550,e.max,0,0
116551,were,0,0
116552,fabricated,0,0
116553,and,0,0
116554,randomly,0,0
116555,assigned,0,0
116556,to,0,0
116557,six,0,0
116558,groups,0,0
116559,of,0,0
116560,different,0,0
116561,dentin,0,0
116562,surface,0,1
116563,treatments,0,0
116564,(,0,1
116565,control,0,0
116566,",",0,1
116567,desensitizer,0,0
116568,",",0,1
116569,disinfectant,0,1
116570,",",0,1
116571,saliva,0,1
116572,",",0,1
116573,blood,0,1
116574,",",0,0
116575,and,0,1
116576,hydrogen,0,1
116577,peroxide,0,1
116578,),0,0
116579,.,0,0
116580,Representative,0,0
116581,samples,0,0
116582,of,0,0
116583,fractured,0,1
116584,specimens,0,0
116585,were,0,0
116586,observed,0,0
116587,by,0,0
116588,SEM,0,0
116589,(,0,0
116590,scanning,0,0
116591,electron,0,1
116592,microscopy,0,0
116593,),0,0
116594,.,0,0
116595,There,0,0
116596,were,0,0
116597,significant,0,0
116598,differences,0,0
116599,between,0,0
116600,the,0,0
116601,control,0,0
116602,group,0,0
116603,and,0,1
116604,saliva,0,1
116605,",",0,1
116606,blood,0,1
116607,",",0,1
116608,and,0,1
116609,hydrogen,0,1
116610,peroxide,0,1
116611,groups,0,0
116612,(,0,0
116613,p,0,0
116614,<,0,0
116615,0.05,0,0
116616,),0,0
116617,.,0,0
116618,However,0,0
116619,",",0,0
116620,there,0,0
116621,were,0,0
116622,no,0,0
116623,significant,0,0
116624,differences,0,0
116625,between,0,0
116626,any,0,0
116627,other,0,0
116628,dentin,0,0
116629,surface,0,1
116630,treatment,0,0
116631,groups,0,0
116632,(,0,0
116633,p,0,0
116634,>,0,0
116635,0.05,0,0
116636,),0,0
116637,.,0,0
116638,Results,0,0
116639,of,0,0
116640,this,0,0
116641,study,0,0
116642,suggested,0,0
116643,that,0,0
116644,only,0,0
116645,saliva,0,0
116646,",",0,1
116647,blood,0,1
116648,",",0,1
116649,and,0,1
116650,hydrogen,0,1
116651,peroxide,0,1
116652,influenced,0,0
116653,the,0,0
116654,tensile,1,1
116655,bond,1,1
116656,strength,1,1
116657,between,0,0
116658,dentin,0,0
116659,and,0,0
116660,ceramic,0,0
116661,.,0,0
116662,Therapeutic,0,0
116663,effects,0,1
116664,of,0,1
116665,combined,0,0
116666,treatment,0,0
116667,using,0,0
116668,tetracycline-immobilized,0,0
116669,collagen,0,0
116670,film,0,1
116671,and,0,1
116672,root,0,1
116673,planing,0,0
116674,in,0,0
116675,periodontal,0,1
116676,furcation,0,1
116677,pockets,0,1
116678,.,0,0
116679,46,0,0
116680,upper,0,0
116681,and,0,0
116682,lower,0,1
116683,molars,0,1
116684,with,0,0
116685,furcation,0,1
116686,grade,0,1
116687,II,0,0
116688,involvement,0,1
116689,were,0,0
116690,selected,0,0
116691,from,0,0
116692,16,0,0
116693,patients,0,0
116694,with,0,0
116695,periodontal,0,1
116696,disease,0,0
116697,.,0,0
116698,The,0,0
116699,teeth,0,0
116700,were,0,0
116701,randomly,0,0
116702,allocated,0,0
116703,to,0,0
116704,the,0,0
116705,following,0,0
116706,groups,0,0
116707,according,0,0
116708,to,0,0
116709,treatment,0,0
116710,;,0,0
116711,(,0,0
116712,1,0,0
116713,),0,0
116714,4,0,0
116715,consecutive,0,0
116716,administrations,0,0
116717,of,0,0
116718,tetracycline-immobilized,0,0
116719,cross-linked,0,0
116720,collagen,0,0
116721,film,0,1
116722,(,0,1
116723,TC,0,1
116724,film,0,1
116725,),0,0
116726,at,0,0
116727,intervals,0,0
116728,of,0,0
116729,1,0,0
116730,week,0,0
116731,(,0,0
116732,TC,0,1
116733,group,0,0
116734,),0,0
116735,;,0,0
116736,(,0,0
116737,2,0,0
116738,),0,0
116739,1,0,0
116740,root,0,0
116741,planing,0,0
116742,treatment,0,0
116743,(,0,0
116744,RP,0,1
116745,group,0,0
116746,),0,0
116747,;,0,0
116748,(,0,0
116749,3,0,0
116750,),0,0
116751,combination,0,0
116752,treatment,0,0
116753,(,0,1
116754,TC,0,1
116755,+,0,0
116756,RP,0,1
116757,group,0,0
116758,),0,0
116759,;,0,0
116760,(,0,0
116761,4,0,0
116762,),0,0
116763,no,0,0
116764,treatment,0,0
116765,(,0,0
116766,control,0,0
116767,group,0,0
116768,),0,0
116769,.,0,0
116770,The,0,0
116771,therapeutic,0,0
116772,effects,0,0
116773,of,0,0
116774,each,0,0
116775,treatment,0,0
116776,were,0,0
116777,compared,0,0
116778,both,0,0
116779,clinically,0,0
116780,and,0,0
116781,microbiologically,0,0
116782,.,0,0
116783,Records,0,0
116784,of,0,1
116785,plaque,1,1
116786,index,1,1
116787,",",1,1
116788,gingival,1,1
116789,index,1,1
116790,",",1,1
116791,bleeding,1,1
116792,on,1,0
116793,probing,1,1
116794,",",1,0
116795,probing,1,1
116796,depth,1,1
116797,",",1,0
116798,probing,1,1
116799,attachment,1,1
116800,level,1,1
116801,and,1,1
116802,microscopic,1,1
116803,counts,1,1
116804,were,0,0
116805,obtained,0,0
116806,at,0,0
116807,0,0,0
116808,",",0,0
116809,4,0,0
116810,",",0,0
116811,6,0,0
116812,and,0,0
116813,8,0,0
116814,weeks,0,0
116815,.,0,0
116816,The,0,0
116817,results,0,0
116818,showed,0,0
116819,marked,0,0
116820,decreases,0,1
116821,in,0,0
116822,probing,1,1
116823,depth,1,1
116824,and,1,1
116825,density,1,1
116826,of,1,1
116827,micro-organisms,1,1
116828,in,0,0
116829,both,0,0
116830,the,0,0
116831,RP,0,1
116832,and,0,1
116833,TC,0,1
116834,+,0,0
116835,RP,0,0
116836,groups,0,0
116837,.,0,0
116838,In,0,0
116839,particular,0,0
116840,",",0,0
116841,the,0,0
116842,TC,0,1
116843,+,0,0
116844,RP,0,1
116845,group,0,0
116846,was,0,0
116847,characterized,0,0
116848,by,0,0
116849,a,0,0
116850,decreased,0,1
116851,rate,1,1
116852,of,1,0
116853,bleeding,1,1
116854,on,1,0
116855,pocket,1,1
116856,probing,1,1
116857,and,0,0
116858,an,0,0
116859,increased,0,1
116860,probing,1,1
116861,attachment,1,1
116862,gain,1,1
116863,.,1,0
116864,The,0,0
116865,above,0,0
116866,findings,0,0
116867,demonstrated,0,0
116868,that,0,0
116869,root,0,0
116870,planning,0,0
116871,is,0,0
116872,effective,0,1
116873,in,0,0
116874,the,0,0
116875,treatment,0,0
116876,of,0,1
116877,furcation,0,1
116878,involvement,0,1
116879,and,0,0
116880,that,0,0
116881,the,0,0
116882,effects,0,0
116883,are,0,0
116884,enhanced,0,0
116885,by,0,0
116886,the,0,0
116887,local,0,0
116888,administration,0,0
116889,of,0,1
116890,TC,0,1
116891,films,0,0
116892,.,0,0
116893,[,0,0
116894,A,0,0
116895,prospective,0,0
116896,randomized,0,0
116897,study,0,0
116898,of,0,0
116899,the,0,0
116900,radiotherapy,0,0
116901,volume,0,1
116902,for,0,0
116903,limited-stage,0,0
116904,small,0,0
116905,cell,0,1
116906,lung,0,0
116907,cancer,0,0
116908,:,0,0
116909,a,0,0
116910,preliminary,0,0
116911,report,0,0
116912,],0,0
116913,.,0,1
116914,BACKGROUND,0,0
116915,AND,0,0
116916,OBJECTIVE,0,0
116917,Controversies,0,0
116918,exists,0,0
116919,with,0,0
116920,regard,0,0
116921,to,0,0
116922,target,0,0
116923,volumes,0,1
116924,as,0,0
116925,far,0,0
116926,as,0,0
116927,thoracic,0,1
116928,radiotherapy,0,0
116929,(,0,1
116930,TRT,0,0
116931,),0,0
116932,is,0,0
116933,concerned,0,0
116934,in,0,0
116935,the,0,0
116936,multimodality,0,0
116937,treatment,0,0
116938,for,0,0
116939,limited-stage,0,0
116940,small,0,0
116941,cell,0,1
116942,lung,0,1
116943,cancer,0,1
116944,(,0,1
116945,LSCLC,0,0
116946,),0,0
116947,.,0,0
116948,The,0,0
116949,aim,0,0
116950,of,0,0
116951,this,0,0
116952,study,0,0
116953,is,0,0
116954,to,0,0
116955,prospectively,0,0
116956,compare,0,0
116957,the,0,0
116958,local,0,0
116959,control,0,0
116960,rate,0,1
116961,",",0,1
116962,toxicity,0,1
116963,profiles,0,1
116964,",",0,1
116965,and,0,1
116966,overall,0,1
116967,survival,0,1
116968,(,0,1
116969,OS,0,1
116970,),0,0
116971,between,0,0
116972,patients,0,0
116973,received,0,0
116974,different,0,0
116975,target,0,0
116976,volumes,0,1
116977,irradiation,0,0
116978,after,0,0
116979,induction,0,0
116980,chemotherapy,0,0
116981,.,0,1
116982,METHODS,0,0
116983,LSCLC,0,0
116984,patients,0,0
116985,received,0,0
116986,2,0,0
116987,cycles,0,0
116988,of,0,0
116989,etoposide,0,0
116990,and,0,1
116991,cisplatin,0,0
116992,(,0,1
116993,EP,0,1
116994,),0,1
116995,induction,0,1
116996,chemotherapy,0,0
116997,and,0,1
116998,were,0,0
116999,randomly,0,0
117000,assigned,0,0
117001,to,0,0
117002,receive,0,0
117003,TRT,0,0
117004,to,0,0
117005,either,0,0
117006,the,0,0
117007,post-,0,0
117008,or,0,0
117009,pre-chemotherapy,0,0
117010,tumor,0,1
117011,extent,0,1
117012,(,0,1
117013,GTV-T,0,0
117014,),0,1
117015,as,0,0
117016,study,0,0
117017,arm,0,0
117018,and,0,1
117019,control,0,0
117020,arm,0,0
117021,",",0,1
117022,CTV-N,0,1
117023,included,0,0
117024,the,0,0
117025,positive,0,1
117026,nodal,0,1
117027,drainage,0,1
117028,area,0,1
117029,for,0,0
117030,both,0,0
117031,arms,0,0
117032,.,0,0
117033,One,0,0
117034,to,0,0
117035,2,0,0
117036,weeks,0,0
117037,after,0,0
117038,induction,0,1
117039,chemotherapy,0,0
117040,",",0,0
117041,45,0,0
117042,Gy/30,0,0
117043,Fx/19,0,0
117044,d,0,1
117045,TRT,0,0
117046,was,0,0
117047,administered,0,0
117048,concurrently,0,0
117049,with,0,0
117050,the,0,0
117051,third,0,0
117052,cycle,0,1
117053,of,0,1
117054,EP,0,0
117055,regimen,0,0
117056,.,0,0
117057,After,0,0
117058,that,0,0
117059,",",0,0
117060,additional,0,0
117061,3,0,0
117062,cycles,0,0
117063,of,0,0
117064,EP,0,0
117065,consolidation,0,1
117066,were,0,0
117067,administered,0,0
117068,.,0,0
117069,Prophylactic,0,0
117070,cranial,0,1
117071,irradiation,0,0
117072,(,0,1
117073,PCI,0,1
117074,),0,1
117075,was,0,0
117076,administered,0,0
117077,to,0,0
117078,patients,0,0
117079,with,0,0
117080,a,0,0
117081,complete,0,1
117082,response,0,1
117083,.,0,0
117084,RESULTS,0,0
117085,Thirty-seven,0,0
117086,and,0,0
117087,40,0,0
117088,patients,0,0
117089,were,0,0
117090,randomly,0,0
117091,assigned,0,0
117092,to,0,0
117093,study,0,0
117094,arm,0,0
117095,and,0,1
117096,control,0,0
117097,arm,0,0
117098,.,0,0
117099,The,0,0
117100,local,1,0
117101,recurrence,1,1
117102,rates,1,1
117103,were,0,0
117104,32.4,0,0
117105,%,0,0
117106,and,0,0
117107,28.2,0,0
117108,%,0,0
117109,respectively,0,0
117110,(,0,0
117111,P,0,0
117112,=,0,0
117113,0.80,0,0
117114,),0,0
117115,;,0,0
117116,the,0,0
117117,isolated,0,0
117118,nodal,1,1
117119,failure,1,1
117120,(,1,1
117121,INF,1,1
117122,),1,1
117123,rates,0,1
117124,were,0,0
117125,3.0,0,0
117126,%,0,0
117127,and,0,0
117128,2.6,0,0
117129,%,0,0
117130,respectively,0,0
117131,(,0,0
117132,P,0,0
117133,=,0,0
117134,0.91,0,0
117135,),0,0
117136,;,0,0
117137,all,0,0
117138,INF,0,0
117139,sites,0,0
117140,were,0,0
117141,in,0,0
117142,the,0,0
117143,ipsilateral,0,0
117144,supraclavicular,0,0
117145,fossa,0,0
117146,.,0,0
117147,Medastinal,1,0
117148,N3,1,1
117149,disease,1,1
117150,was,0,0
117151,the,0,0
117152,risk,0,1
117153,factor,0,1
117154,for,0,0
117155,INF,0,1
117156,(,0,0
117157,P,0,0
117158,=,0,0
117159,0.02,0,0
117160,",",0,0
117161,OR,0,0
117162,=,0,0
117163,14.13,0,0
117164,",",0,0
117165,95,0,0
117166,%,0,0
117167,CI,0,0
117168,:,0,0
117169,1.47-136.13,0,0
117170,),0,0
117171,.,0,0
117172,During,0,0
117173,radiotherapy,0,0
117174,",",0,0
117175,grade,1,1
117176,I,1,1
117177,",",1,0
117178,II,1,0
117179,weight,1,1
117180,loss,1,1
117181,was,0,0
117182,observed,0,0
117183,in,0,0
117184,29.4,0,0
117185,%,0,0
117186,",",0,0
117187,5.9,0,0
117188,%,0,0
117189,and,0,0
117190,56.4,0,0
117191,%,0,0
117192,",",0,0
117193,7.7,0,0
117194,%,0,0
117195,patients,0,0
117196,respectively,0,0
117197,(,0,0
117198,P,0,0
117199,=,0,0
117200,0.04,0,0
117201,),0,0
117202,.,0,0
117203,Grade,1,0
117204,0-I,1,0
117205,and,1,0
117206,II-III,1,0
117207,late,1,1
117208,pulmonary,1,1
117209,injury,1,1
117210,was,0,0
117211,developed,0,0
117212,in,0,0
117213,97.1,0,0
117214,%,0,0
117215,",",0,0
117216,2.9,0,0
117217,%,0,0
117218,and,0,0
117219,86.4,0,0
117220,%,0,0
117221,",",0,0
117222,15.4,0,0
117223,%,0,0
117224,patients,0,0
117225,respectively,0,0
117226,(,0,0
117227,P,0,0
117228,=,0,0
117229,0.07,0,0
117230,),0,0
117231,.,0,0
117232,Median,1,1
117233,survival,1,1
117234,time,1,1
117235,was,0,0
117236,22.1,0,0
117237,months,0,0
117238,and,0,0
117239,26.9,0,0
117240,months,0,0
117241,respectively,0,0
117242,.,0,0
117243,The,0,0
117244,1,1,0
117245,to,1,0
117246,3-year,1,0
117247,OS,1,1
117248,were,0,0
117249,77.9,0,0
117250,%,0,0
117251,",",0,0
117252,44.4,0,0
117253,%,0,0
117254,",",0,0
117255,37.3,0,0
117256,%,0,0
117257,and,0,0
117258,75.8,0,0
117259,%,0,0
117260,",",0,0
117261,56.3,0,0
117262,%,0,0
117263,",",0,0
117264,41.7,0,0
117265,%,0,0
117266,respectively,0,0
117267,(,0,0
117268,P,0,0
117269,=,0,0
117270,0.79,0,0
117271,),0,0
117272,.,0,0
117273,CONCLUSIONS,0,0
117274,The,0,0
117275,preliminary,0,0
117276,results,0,0
117277,of,0,0
117278,this,0,0
117279,study,0,0
117280,indicate,0,0
117281,that,0,0
117282,irradiant,0,0
117283,the,0,0
117284,post-chemotherapy,0,0
117285,tumor,0,1
117286,extent,0,1
117287,(,0,1
117288,GTV-T,0,1
117289,),0,1
117290,and,0,1
117291,positive,0,1
117292,nodal,0,1
117293,drainage,0,1
117294,area,0,1
117295,did,0,0
117296,not,0,0
117297,decrease,0,1
117298,local,0,0
117299,control,0,0
117300,and,0,1
117301,overall,0,1
117302,survival,0,1
117303,while,0,0
117304,radiation,0,0
117305,toxicity,0,1
117306,was,0,0
117307,reduced,0,0
117308,.,0,0
117309,But,0,0
117310,the,0,0
117311,current,0,0
117312,sample,0,0
117313,size,0,1
117314,has,0,0
117315,not,0,0
117316,met,0,0
117317,designed,0,0
117318,requirements,0,1
117319,",",0,0
117320,and,0,1
117321,further,0,0
117322,investigation,0,0
117323,is,0,0
117324,warranted,0,0
117325,before,0,0
117326,final,0,0
117327,conclusions,0,0
117328,could,0,0
117329,be,0,0
117330,drawn,0,0
117331,.,0,0
117332,Tracheal,0,1
117333,soiling,0,1
117334,with,0,0
117335,blood,0,1
117336,during,0,0
117337,intranasal,0,0
117338,surgery,0,0
117339,--,0,1
117340,comparison,0,0
117341,of,0,0
117342,two,0,0
117343,endotracheal,0,0
117344,tubes,0,0
117345,.,0,0
117346,Sixty,0,0
117347,adult,0,0
117348,patients,0,0
117349,",",0,1
117350,ASA,0,1
117351,Classes,0,1
117352,I,0,0
117353,&,0,0
117354,II,0,0
117355,",",0,1
117356,were,0,0
117357,involved,0,0
117358,in,0,0
117359,a,0,0
117360,study,0,0
117361,to,0,0
117362,compare,0,0
117363,the,0,0
117364,effectiveness,0,0
117365,of,0,0
117366,Mallinckrodt,0,0
117367,Hi-Lo-Evac,0,0
117368,tube,0,1
117369,and,0,1
117370,Portex,0,1
117371,blue,0,1
117372,line,0,0
117373,tube,0,0
117374,in,0,0
117375,preventing,0,0
117376,soiling,0,1
117377,of,0,0
117378,the,0,0
117379,lower,0,0
117380,airways,0,1
117381,during,0,0
117382,intranasal,0,0
117383,surgery,0,0
117384,.,0,0
117385,The,0,0
117386,Hi-Lo-Evac,0,0
117387,tube,0,0
117388,with,0,0
117389,and,0,1
117390,without,0,0
117391,pack,0,0
117392,was,0,0
117393,significantly,0,0
117394,more,0,0
117395,effective,1,1
117396,than,0,0
117397,the,0,0
117398,Portex,0,0
117399,tube,0,0
117400,with,0,0
117401,pharyngeal,0,1
117402,pack,0,0
117403,(,0,0
117404,P,0,0
117405,less,0,0
117406,than,0,0
117407,0.002,0,0
117408,),0,0
117409,and,0,0
117410,(,0,1
117411,P,0,0
117412,less,0,0
117413,than,0,0
117414,0.01,0,0
117415,respectively,0,0
117416,),0,0
117417,.,0,0
117418,There,0,0
117419,was,0,0
117420,no,0,0
117421,significant,0,0
117422,difference,0,0
117423,when,0,0
117424,the,0,0
117425,Hi-Lo-Evac,0,0
117426,tube,0,0
117427,was,0,0
117428,used,0,0
117429,with,0,0
117430,or,0,0
117431,without,0,0
117432,a,0,0
117433,pack,0,0
117434,(,0,0
117435,P,0,0
117436,greater,0,0
117437,than,0,0
117438,0.2,0,0
117439,),0,0
117440,.,0,0
117441,The,0,0
117442,more,0,0
117443,effective,1,1
117444,protection,1,1
117445,of,1,0
117446,the,1,0
117447,lower,1,0
117448,airways,1,0
117449,by,0,0
117450,the,0,0
117451,Hi-Lo-Evac,0,0
117452,tube,0,0
117453,is,0,0
117454,attributed,0,0
117455,to,0,0
117456,the,0,0
117457,facility,0,0
117458,of,0,0
117459,subglottic,0,1
117460,aspiration,0,1
117461,during,0,0
117462,surgery,0,0
117463,.,0,0
117464,It,0,0
117465,is,0,0
117466,suggested,0,0
117467,that,0,0
117468,the,0,0
117469,Hi-Lo-Evac,0,0
117470,tube,0,0
117471,could,0,0
117472,be,0,0
117473,used,0,0
117474,with,0,0
117475,safety,1,1
117476,during,0,0
117477,intranasal,0,0
117478,surgery,0,0
117479,in,0,0
117480,order,0,0
117481,to,0,0
117482,reduce,0,0
117483,postoperative,1,1
117484,morbidity,1,1
117485,associated,0,0
117486,with,0,0
117487,the,0,0
117488,use,0,0
117489,of,0,0
117490,pharyngeal,0,1
117491,pack,0,0
117492,.,0,0
117493,Anti-angiogenic,0,1
117494,effect,0,1
117495,of,0,1
117496,tamoxifen,0,0
117497,combined,0,0
117498,with,0,0
117499,epirubicin,0,0
117500,in,0,0
117501,breast,0,0
117502,cancer,0,0
117503,patients,0,0
117504,.,0,0
117505,Vascular,0,1
117506,endothelial,0,1
117507,growth,0,1
117508,factor,0,1
117509,A,0,0
117510,(,0,1
117511,VEGF-A,0,0
117512,),0,1
117513,and,0,1
117514,vascular,0,1
117515,endothelial,0,1
117516,growth,0,1
117517,factor,0,1
117518,receptor,0,0
117519,2,0,0
117520,(,0,0
117521,VEGFR2,0,0
117522,),0,0
117523,are,0,0
117524,the,0,0
117525,key,0,1
117526,factors,0,0
117527,mediating,0,1
117528,neo-vascularization,0,0
117529,.,0,0
117530,They,0,0
117531,are,0,0
117532,often,0,0
117533,coexpressed,0,0
117534,in,0,0
117535,breast,0,0
117536,cancer,0,0
117537,.,0,1
117538,Sex,0,0
117539,steroids,0,0
117540,may,0,0
117541,stimulate,0,0
117542,angiogenesis,0,0
117543,via,0,0
117544,the,0,0
117545,estrogen,0,1
117546,receptor,0,1
117547,(,0,1
117548,ER,0,1
117549,),0,0
117550,pathway,0,0
117551,.,0,0
117552,We,0,0
117553,investigated,0,0
117554,to,0,0
117555,compare,0,0
117556,the,0,0
117557,effects,0,0
117558,of,0,0
117559,the,0,0
117560,addition,0,0
117561,of,0,0
117562,tamoxifen,0,0
117563,to,0,0
117564,epirubicin,0,0
117565,versus,0,0
117566,epirubicin,0,0
117567,alone,0,0
117568,on,0,0
117569,VEGF,0,1
117570,and,0,1
117571,VEGFR2,0,1
117572,expression,0,1
117573,in,0,0
117574,breast,0,0
117575,cancer,0,0
117576,patients,0,0
117577,.,0,0
117578,The,0,0
117579,expression,0,1
117580,of,0,1
117581,VEGF,1,1
117582,and,1,1
117583,VEGFR2,1,1
117584,was,0,0
117585,assessed,0,0
117586,on,0,0
117587,tissue,0,1
117588,microarray,0,0
117589,by,0,0
117590,immunohistochemistry,0,0
117591,at,0,0
117592,baseline,0,1
117593,conditions,0,0
117594,and,0,1
117595,after,0,0
117596,treatments,0,0
117597,in,0,0
117598,the,0,0
117599,case,0,0
117600,of,0,0
117601,191,0,0
117602,patients,0,0
117603,with,0,0
117604,T2-4,0,1
117605,N0-1,0,0
117606,breast,0,0
117607,cancer,0,0
117608,enrolled,0,0
117609,in,0,0
117610,a,0,0
117611,randomized,0,0
117612,trial,0,0
117613,comparing,0,0
117614,four,0,0
117615,cycles,0,0
117616,of,0,0
117617,single,0,0
117618,agent,0,0
117619,epirubicin,0,0
117620,versus,0,0
117621,epirubicin,0,0
117622,plus,0,0
117623,tamoxifen,0,0
117624,as,0,0
117625,primary,0,0
117626,systemic,0,1
117627,treatment,0,0
117628,.,0,0
117629,Epirubicin,0,0
117630,alone,0,0
117631,failed,0,0
117632,to,0,0
117633,induce,0,0
117634,changes,1,1
117635,in,1,0
117636,VEGF,1,1
117637,expression,1,1
117638,(,0,0
117639,P,0,0
117640,=,0,0
117641,0.54,0,0
117642,),0,0
117643,",",0,0
117644,while,0,0
117645,the,0,0
117646,addition,0,0
117647,of,0,0
117648,tamoxifen,0,0
117649,to,0,0
117650,epirubicin,0,0
117651,resulted,0,0
117652,in,0,0
117653,a,0,0
117654,significant,0,0
117655,reduction,0,1
117656,in,0,0
117657,VEGF,1,1
117658,expression,1,1
117659,(,0,0
117660,P,0,0
117661,<,0,0
117662,0.001,0,0
117663,),0,0
117664,.,0,0
117665,As,0,0
117666,a,0,0
117667,consequence,0,0
117668,",",0,0
117669,baseline,1,1
117670,VEGF,1,1
117671,had,0,0
117672,a,0,0
117673,negative,0,1
117674,prognostic,0,1
117675,role,0,0
117676,in,0,0
117677,patients,0,0
117678,who,0,0
117679,received,0,0
117680,epirubicin,0,0
117681,alone,0,0
117682,but,0,0
117683,not,0,0
117684,in,0,0
117685,patients,0,0
117686,receiving,0,0
117687,epirubicin,0,0
117688,plus,0,0
117689,tamoxifen,0,0
117690,(,0,1
117691,interaction,0,1
117692,test,0,1
117693,P,0,0
117694,<,0,0
117695,0.05,0,0
117696,),0,0
117697,.,0,0
117698,VEGFR2,1,1
117699,expression,1,1
117700,increased,0,0
117701,at,0,0
117702,residual,0,1
117703,tumor,0,1
117704,histology,0,1
117705,in,0,0
117706,both,0,0
117707,treatment,0,0
117708,arms,0,0
117709,",",0,0
117710,with,0,0
117711,a,0,0
117712,lesser,0,0
117713,extent,0,0
117714,in,0,0
117715,patients,0,0
117716,receiving,0,0
117717,tamoxifen,0,0
117718,plus,0,0
117719,epirubicin,0,0
117720,.,0,1
117721,Decrease,0,1
117722,in,0,0
117723,VEGFR2,1,1
117724,expression,1,1
117725,was,0,0
117726,significantly,0,0
117727,associated,0,0
117728,with,0,0
117729,response,1,1
117730,rate,1,1
117731,(,0,1
117732,P,0,0
117733,=,0,0
117734,0.02,0,0
117735,),0,0
117736,.,0,0
117737,The,0,0
117738,addition,0,0
117739,of,0,0
117740,tamoxifen,0,0
117741,to,0,0
117742,epirubicin,0,0
117743,resulted,0,0
117744,in,0,0
117745,a,0,0
117746,suppression,1,1
117747,of,1,0
117748,a,1,0
117749,key,1,1
117750,angiogenic,1,1
117751,pathway,1,0
117752,.,1,0
117753,These,0,0
117754,data,0,0
117755,suggest,0,0
117756,a,0,0
117757,potential,0,0
117758,synergism,0,0
117759,of,0,0
117760,these,0,0
117761,two,0,0
117762,drugs,0,0
117763,.,0,0
117764,Cost-effectiveness,1,1
117765,of,0,1
117766,cognitive-behavioral,0,0
117767,group,0,0
117768,therapy,0,0
117769,for,0,0
117770,dysfunctional,0,1
117771,fear,0,1
117772,of,0,1
117773,progression,0,1
117774,in,0,0
117775,cancer,0,0
117776,patients,0,0
117777,.,0,1
117778,Anxiety,1,1
117779,and,1,0
117780,fear,1,1
117781,are,0,0
117782,often,0,0
117783,associated,0,0
117784,with,0,0
117785,chronic,0,0
117786,conditions,0,0
117787,such,0,0
117788,as,0,0
117789,cancer,0,0
117790,.,0,0
117791,This,0,0
117792,paper,0,0
117793,targets,0,0
117794,the,0,0
117795,cost-effectiveness,1,0
117796,analysis,1,0
117797,of,0,0
117798,a,0,0
117799,cognitive-behavioral,0,0
117800,group,0,0
117801,therapy,0,0
117802,(,0,1
117803,CBT,0,0
117804,),0,1
117805,in,0,0
117806,comparison,0,0
117807,to,0,0
117808,a,0,0
117809,client-centered,0,1
117810,",",0,0
117811,supportive-experiential,0,1
117812,group,0,0
117813,therapy,0,0
117814,(,0,1
117815,SET,0,1
117816,),0,1
117817,in,0,0
117818,cancer,0,0
117819,patients,0,0
117820,with,0,0
117821,dysfunctional,0,0
117822,fear,0,1
117823,of,0,0
117824,progression,0,1
117825,.,0,0
117826,An,0,0
117827,incremental,0,1
117828,cost-effectiveness,1,1
117829,analysis,1,0
117830,was,0,0
117831,performed,0,0
117832,using,0,0
117833,data,0,0
117834,from,0,0
117835,a,0,0
117836,randomized,0,0
117837,controlled,0,0
117838,trial,0,0
117839,among,0,0
117840,cancer,0,0
117841,patients,0,0
117842,receiving,0,0
117843,inpatient,0,0
117844,rehabilitation,0,0
117845,.,0,0
117846,The,0,0
117847,means,1,0
117848,",",1,0
117849,95,1,0
117850,%,1,0
117851,confidence,1,0
117852,intervals,1,0
117853,[,1,0
117854,95,1,0
117855,%,1,0
117856,CI,1,0
117857,],1,0
117858,",",1,0
117859,incremental,1,1
117860,cost-effectiveness,1,1
117861,graphic,1,1
117862,and,1,1
117863,acceptability,1,1
117864,curve,1,1
117865,were,0,0
117866,obtained,0,0
117867,from,0,0
117868,"1,000",0,0
117869,bootstrap,0,0
117870,replications,0,0
117871,.,0,0
117872,A,0,0
117873,total,0,0
117874,of,0,0
117875,174,0,0
117876,patients,0,0
117877,were,0,0
117878,included,0,0
117879,in,0,0
117880,the,0,0
117881,economic,0,0
117882,evaluation,0,0
117883,.,0,0
117884,The,0,0
117885,estimated,1,0
117886,means,1,0
117887,[,0,0
117888,95,0,0
117889,%,0,0
117890,CI,0,0
117891,],0,0
117892,of,1,0
117893,direct,1,1
117894,costs,1,1
117895,and,1,1
117896,reduction,1,1
117897,of,1,1
117898,fear,1,1
117899,of,1,1
117900,progression,1,1
117901,were,0,0
117902,<,0,0
117903,euro,0,0
117904,>,0,0
117905,"9,045.03",0,0
117906,[,0,0
117907,"6,359.07",0,0
117908,;,0,0
117909,"12,091.87",0,0
117910,],0,0
117911,and,0,0
117912,1.41,0,0
117913,[,0,0
117914,0.93,0,0
117915,;,0,0
117916,1.92,0,0
117917,],0,0
117918,for,0,0
117919,patients,0,0
117920,in,0,0
117921,the,0,0
117922,SET,0,0
117923,and,0,0
117924,<,0,0
117925,euro,0,0
117926,>,0,0
117927,"6,682.78",0,0
117928,[,0,0
117929,"4,998.09",0,0
117930,;,0,0
117931,"8,440.95",0,0
117932,],0,0
117933,and,0,0
117934,1.44,0,0
117935,[,0,0
117936,1.02,0,0
117937,;,0,0
117938,1.09,0,0
117939,],0,0
117940,for,0,0
117941,patients,0,0
117942,in,0,0
117943,the,0,0
117944,CBT,0,0
117945,.,0,0
117946,The,0,0
117947,incremental,1,1
117948,cost-effectiveness,1,1
117949,ratio,1,1
117950,[,0,0
117951,95,0,0
117952,%,0,0
117953,CI,0,0
117954,],0,0
117955,amounts,0,1
117956,to,0,0
117957,minus,0,0
117958,<,0,0
117959,euro,0,0
117960,>,0,0
117961,"78,741.66",0,0
117962,[,0,0
117963,"-154,987.20",0,0
117964,;,0,0
117965,"110,486.32",0,0
117966,],0,0
117967,for,0,0
117968,an,0,0
117969,additional,0,0
117970,unit,0,0
117971,of,0,0
117972,effect,0,1
117973,.,0,0
117974,Given,0,0
117975,the,0,0
117976,acceptability,1,1
117977,curve,1,1
117978,",",0,0
117979,there,0,0
117980,is,0,0
117981,a,0,0
117982,92.4,0,0
117983,%,0,0
117984,chance,0,0
117985,that,0,0
117986,the,0,0
117987,CBT,0,0
117988,",",0,0
117989,compared,0,0
117990,with,0,0
117991,the,0,0
117992,SET,0,0
117993,",",0,0
117994,is,0,0
117995,cost-effective,1,0
117996,without,0,0
117997,the,0,0
117998,need,0,0
117999,of,0,0
118000,additional,0,0
118001,costs,0,1
118002,to,0,0
118003,payers,0,0
118004,.,0,0
118005,Our,0,0
118006,main,0,0
118007,result,0,0
118008,is,0,0
118009,the,0,0
118010,superior,0,0
118011,cost-effectiveness,1,0
118012,of,0,0
118013,the,0,0
118014,cognitive-behavioral,0,0
118015,intervention,0,0
118016,program,0,0
118017,in,0,0
118018,comparison,0,0
118019,to,0,0
118020,the,0,0
118021,non-directive,0,0
118022,encounter,0,0
118023,group,0,0
118024,for,0,0
118025,our,0,0
118026,sample,0,0
118027,of,0,1
118028,cancer,0,0
118029,patients,0,0
118030,with,0,0
118031,high,0,0
118032,levels,0,1
118033,of,0,0
118034,anxiety,1,1
118035,.,1,0
118036,Changes,0,1
118037,in,0,0
118038,sleep,0,1
118039,quality,0,1
118040,",",0,1
118041,but,0,0
118042,not,0,0
118043,hormones,0,1
118044,predict,0,0
118045,time,0,1
118046,to,0,0
118047,postpartum,0,1
118048,depression,0,1
118049,recurrence,0,1
118050,.,0,1
118051,BACKGROUND,0,0
118052,Poor,0,0
118053,sleep,0,1
118054,quality,0,1
118055,",",0,1
118056,dysregulation,0,1
118057,of,0,1
118058,hormones,0,1
118059,and,0,1
118060,increased,0,1
118061,inflammatory,0,1
118062,cytokines,0,1
118063,are,0,0
118064,all,0,0
118065,associated,0,0
118066,with,0,0
118067,the,0,0
118068,risk,0,1
118069,for,0,0
118070,postpartum,0,1
118071,major,0,1
118072,depression,0,1
118073,(,0,1
118074,PPMD,0,1
118075,),0,0
118076,.,0,0
118077,We,0,0
118078,evaluated,0,0
118079,change,0,1
118080,over,0,0
118081,time,0,1
118082,in,0,0
118083,sleep,1,1
118084,quality,1,1
118085,and,0,1
118086,hormones,1,1
118087,during,0,0
118088,the,0,0
118089,first,0,0
118090,17,0,0
118091,weeks,0,0
118092,postpartum,0,0
118093,",",0,0
118094,as,0,0
118095,well,0,0
118096,as,0,0
118097,a,0,0
118098,single,0,0
118099,cytokine,0,1
118100,measure,0,1
118101,",",0,1
118102,and,0,1
118103,their,0,1
118104,association,0,0
118105,with,0,0
118106,PPMD,0,1
118107,recurrence,0,1
118108,.,0,0
118109,METHODS,0,0
118110,Participants,0,0
118111,were,0,0
118112,pregnant,0,0
118113,women,0,0
118114,(,0,0
118115,N=56,0,0
118116,),0,1
118117,",",0,0
118118,with,0,0
118119,past,0,0
118120,histories,0,0
118121,of,0,1
118122,MDD/PPMD,0,0
118123,but,0,0
118124,not,0,0
118125,depressed,0,1
118126,in,0,0
118127,their,0,0
118128,current,0,0
118129,pregnancy,0,0
118130,.,0,0
118131,The,0,0
118132,Pittsburgh,1,0
118133,Sleep,1,1
118134,Quality,1,1
118135,Index,1,1
118136,(,0,1
118137,PSQI,0,1
118138,),0,1
118139,and,0,1
118140,blood,0,1
118141,samples,0,1
118142,were,0,0
118143,collected,0,0
118144,8,0,0
118145,times,0,0
118146,during,0,0
118147,the,0,0
118148,first,0,0
118149,17,0,0
118150,weeks,0,0
118151,postpartum,0,0
118152,.,0,1
118153,Estradiol,1,1
118154,",",1,1
118155,prolactin,1,1
118156,and,1,1
118157,cortisol,1,1
118158,",",1,1
118159,and,1,0
118160,a,1,0
118161,single,1,0
118162,measure,1,0
118163,of,1,1
118164,IL-6,1,0
118165,were,0,0
118166,assayed,0,0
118167,.,0,0
118168,Recurrence,0,1
118169,was,0,0
118170,determined,0,0
118171,by,0,0
118172,two,0,0
118173,consecutive,0,0
118174,21-item,1,0
118175,Hamilton,1,1
118176,Rating,1,1
118177,Scale,1,1
118178,for,1,0
118179,Depression,1,1
118180,(,1,0
118181,HRSD,1,1
118182,),1,1
118183,scores?15,1,1
118184,and,1,1
118185,clinician,1,1
118186,interview,1,0
118187,.,1,0
118188,RESULTS,0,0
118189,In,0,0
118190,the,0,0
118191,analyses,0,0
118192,of,0,0
118193,time,0,1
118194,to,0,0
118195,PPMD,1,1
118196,recurrence,1,1
118197,",",1,1
118198,poor,1,1
118199,sleep,1,1
118200,quality,1,1
118201,",",1,1
118202,but,0,0
118203,none,0,0
118204,of,0,0
118205,the,0,0
118206,hormones,0,1
118207,",",0,0
118208,was,0,0
118209,associated,0,0
118210,with,1,0
118211,PPMD,1,1
118212,recurrence,1,1
118213,(,1,0
118214,p,0,0
118215,<,0,0
118216,.05,0,0
118217,),0,0
118218,after,0,0
118219,controlling,0,0
118220,for,0,0
118221,medication,0,0
118222,assignment,0,0
118223,.,0,0
118224,With,0,0
118225,every,0,0
118226,one,0,0
118227,point,0,0
118228,increase,0,0
118229,in,0,0
118230,PSQI,0,1
118231,scores,0,1
118232,across,0,0
118233,time,0,1
118234,",",0,0
118235,a,0,0
118236,woman,0,0
118237,'s,0,1
118238,risk,0,1
118239,for,0,0
118240,recurrence,0,1
118241,increased,0,0
118242,by,0,0
118243,approximately,0,0
118244,25,0,0
118245,%,0,0
118246,There,0,0
118247,was,0,0
118248,no,0,0
118249,significant,0,0
118250,association,0,0
118251,between,1,0
118252,PSQI,1,1
118253,scores,1,1
118254,and,1,1
118255,IL-6,1,0
118256,concentrations,1,1
118257,in,0,0
118258,early,0,0
118259,postpartum,0,1
118260,(,0,0
118261,?,0,0
118262,(,0,0
118263,2,0,0
118264,),0,0
118265,=0.98,0,0
118266,",",0,1
118267,p=.32,0,0
118268,),0,1
118269,.,0,0
118270,CONCLUSIONS,0,0
118271,Poor,0,0
118272,sleep,0,1
118273,quality,0,1
118274,across,0,0
118275,the,0,0
118276,first,0,0
118277,17,0,0
118278,weeks,0,0
118279,post-delivery,0,0
118280,increases,0,0
118281,the,0,0
118282,risk,0,1
118283,for,0,0
118284,recurrent,0,1
118285,PPMD,0,1
118286,among,0,0
118287,women,0,0
118288,with,0,0
118289,a,0,0
118290,history,0,1
118291,of,0,0
118292,MDD,0,0
118293,.,0,0
118294,Changes,0,1
118295,in,0,0
118296,the,0,0
118297,hormonal,0,1
118298,milieu,0,0
118299,were,0,0
118300,not,0,0
118301,associated,0,0
118302,with,0,0
118303,recurrence,0,1
118304,.,0,0
118305,Further,0,1
118306,exploration,0,0
118307,of,0,0
118308,the,0,0
118309,degree,0,0
118310,to,0,0
118311,which,0,0
118312,poor,0,1
118313,sleep,0,1
118314,contributes,0,0
118315,to,0,0
118316,hormonal,0,1
118317,and,0,1
118318,cytokine,0,1
118319,dysregulation,0,1
118320,and,0,0
118321,how,0,0
118322,they,0,0
118323,are,0,0
118324,involved,0,0
118325,in,0,0
118326,the,0,0
118327,pathophysiology,0,0
118328,of,0,0
118329,PPMD,0,0
118330,is,0,0
118331,warranted,0,0
118332,.,0,0
118333,[,0,0
118334,Study,0,0
118335,on,0,0
118336,safety,0,1
118337,and,0,1
118338,immunogenicity,0,1
118339,of,0,1
118340,oral,0,0
118341,poliomyelitis,0,1
118342,attenuated,0,0
118343,live,0,1
118344,vaccine,0,0
118345,(,0,0
118346,human,0,0
118347,diploid,0,1
118348,cell,0,1
118349,),0,0
118350,],0,0
118351,.,0,0
118352,OBJECTIVE,0,0
118353,To,0,0
118354,evaluate,0,0
118355,the,0,0
118356,safety,1,1
118357,and,0,1
118358,Immunogenicity,1,1
118359,of,0,0
118360,the,0,0
118361,Poliomyelitis,0,1
118362,vaccine,0,0
118363,(,0,0
118364,Human,0,0
118365,Diploid,0,1
118366,Cell,0,0
118367,),0,0
118368,in,0,0
118369,>,0,0
118370,or,0,0
118371,=2,0,0
118372,month-old,0,0
118373,children,0,0
118374,.,0,0
118375,METHODS,0,0
118376,A,0,0
118377,random,0,0
118378,",",0,1
118379,blind,0,0
118380,and,0,1
118381,control,0,0
118382,trial,0,0
118383,",",0,0
118384,1200,0,0
118385,healthy,0,0
118386,children,0,0
118387,of,0,0
118388,2-5,0,0
118389,months,0,0
118390,old,0,0
118391,in,0,0
118392,Jiangsu,0,1
118393,province,0,0
118394,were,0,0
118395,administered,0,0
118396,OPV,0,1
118397,(,0,0
118398,HDC,0,0
118399,),0,1
118400,vaccine,0,0
118401,and,0,1
118402,control,0,0
118403,vaccines,0,0
118404,.,0,0
118405,The,0,0
118406,antibody,0,1
118407,was,0,0
118408,tested,0,0
118409,by,0,0
118410,neutralization,0,0
118411,test,0,1
118412,.,0,1
118413,RESULTS,0,0
118414,After,0,0
118415,3,0,0
118416,doses,0,0
118417,of,0,0
118418,the,0,0
118419,OPV,0,1
118420,(,0,0
118421,HDC,0,0
118422,),0,1
118423,vaccine,0,0
118424,",",0,0
118425,the,0,0
118426,systemic,1,1
118427,reactions,1,1
118428,were,0,0
118429,mild,0,0
118430,.,0,0
118431,After,0,0
118432,1,0,0
118433,month,0,0
118434,of,0,0
118435,vaccination,0,0
118436,with,0,0
118437,3,0,0
118438,doses,0,0
118439,of,0,0
118440,the,0,0
118441,OPV,0,1
118442,(,0,0
118443,HDC,0,0
118444,),0,1
118445,vaccine,0,0
118446,",",0,0
118447,the,0,0
118448,immune,1,1
118449,success,1,1
118450,rates,1,1
118451,of,1,0
118452,I,1,0
118453,",",1,0
118454,II,1,0
118455,",",1,1
118456,III,1,1
118457,type,1,0
118458,were,0,0
118459,98.28,0,0
118460,%,0,0
118461,",",0,0
118462,99.45,0,0
118463,%,0,0
118464,",",0,0
118465,and,0,0
118466,95.71,0,1
118467,%,0,0
118468,respectively,0,0
118469,",",0,0
118470,the,0,0
118471,GMTs,1,0
118472,of,1,0
118473,I,1,0
118474,",",1,0
118475,II,1,0
118476,",",1,1
118477,III,1,1
118478,type,1,0
118479,in,0,0
118480,susceptible,0,1
118481,children,0,0
118482,were,0,0
118483,1:1243.72,0,0
118484,",",0,0
118485,1:234.38,0,0
118486,and,0,0
118487,1:273.10,0,0
118488,respectively,0,0
118489,.,0,0
118490,CONCLUSIONS,0,0
118491,The,0,0
118492,OPV,0,1
118493,(,0,0
118494,HDC,0,0
118495,),0,1
118496,vaccine,0,0
118497,was,0,0
118498,safe,0,1
118499,and,0,1
118500,immunogenicity,0,1
118501,for,0,0
118502,the,0,0
118503,children,0,0
118504,>,0,0
118505,or,0,0
118506,=2,0,0
118507,months,0,0
118508,old,0,0
118509,.,0,0
118510,Effect,0,1
118511,of,0,1
118512,thermal,0,1
118513,stress,0,1
118514,",",0,1
118515,restricted,0,0
118516,feeding,0,1
118517,and,0,1
118518,combined,0,0
118519,stresses,0,1
118520,(,0,0
118521,thermal,0,1
118522,stress,0,1
118523,and,0,1
118524,restricted,0,0
118525,feeding,0,1
118526,),0,0
118527,on,0,0
118528,growth,0,1
118529,and,0,1
118530,plasma,0,1
118531,reproductive,0,1
118532,hormone,0,1
118533,levels,0,1
118534,of,0,1
118535,Malpura,0,0
118536,ewes,0,1
118537,under,0,0
118538,semi-arid,0,1
118539,tropical,0,0
118540,environment,0,0
118541,.,0,0
118542,A,0,0
118543,study,0,0
118544,was,0,0
118545,conducted,0,0
118546,to,0,0
118547,assess,0,0
118548,the,0,0
118549,effect,0,0
118550,of,0,1
118551,thermal,0,1
118552,",",0,1
118553,nutritional,0,1
118554,and,0,1
118555,combined,0,0
118556,stresses,0,1
118557,(,0,0
118558,thermal,0,1
118559,and,0,1
118560,nutritional,0,1
118561,),0,0
118562,on,0,0
118563,the,0,0
118564,growth,0,1
118565,",",0,1
118566,oestradiol,0,1
118567,and,0,1
118568,progesterone,0,1
118569,levels,0,1
118570,during,0,0
118571,oestrus,0,1
118572,cycles,0,0
118573,in,0,0
118574,Malpura,0,0
118575,ewes,0,1
118576,.,0,1
118577,Twenty-eight,0,0
118578,adult,0,0
118579,Malpura,0,1
118580,ewes,0,1
118581,were,0,0
118582,used,0,0
118583,in,0,0
118584,the,0,0
118585,present,0,0
118586,study,0,0
118587,.,0,0
118588,The,0,0
118589,ewes,0,1
118590,were,0,0
118591,randomly,0,0
118592,allocated,0,0
118593,into,0,0
118594,four,0,0
118595,groups,0,0
118596,",",0,0
118597,viz.,0,1
118598,",",0,1
118599,GI,0,1
118600,(,0,0
118601,n=7,0,0
118602,;,0,0
118603,control,0,0
118604,),0,1
118605,",",0,1
118606,GII,0,1
118607,(,0,0
118608,n=7,0,0
118609,;,0,0
118610,thermal,0,1
118611,stress,0,1
118612,),0,1
118613,",",0,1
118614,GIII,0,1
118615,(,0,0
118616,n=7,0,0
118617,;,0,0
118618,restricted,0,0
118619,feeding,0,1
118620,),0,0
118621,and,0,1
118622,GIV,0,1
118623,(,0,0
118624,n=7,0,0
118625,;,0,0
118626,combined,0,0
118627,stress,0,1
118628,),0,0
118629,.,0,0
118630,The,0,0
118631,animals,0,0
118632,were,0,0
118633,stall,0,0
118634,fed,0,0
118635,with,0,0
118636,a,0,0
118637,diet,0,0
118638,consisting,0,0
118639,of,0,0
118640,60,0,0
118641,%,0,0
118642,roughage,0,0
118643,and,0,0
118644,40,0,0
118645,%,0,0
118646,concentrate,0,0
118647,.,0,1
118648,GI,0,1
118649,and,0,1
118650,GII,0,1
118651,ewes,0,1
118652,were,0,0
118653,provided,0,0
118654,with,0,0
118655,ad,0,0
118656,libitum,0,0
118657,feeding,0,1
118658,while,0,0
118659,GIII,0,1
118660,and,0,1
118661,GIV,0,1
118662,ewes,0,1
118663,were,0,0
118664,provided,0,0
118665,with,0,0
118666,restricted,0,0
118667,feed,0,1
118668,(,0,0
118669,30,0,0
118670,%,0,0
118671,intake,0,0
118672,of,0,1
118673,GI,0,1
118674,and,0,1
118675,GII,0,1
118676,ewes,0,1
118677,),0,0
118678,to,0,0
118679,induce,0,0
118680,nutritional,0,1
118681,insufficiency,0,1
118682,.,0,1
118683,GII,0,0
118684,and,0,1
118685,GIV,0,1
118686,ewes,0,1
118687,were,0,0
118688,kept,0,0
118689,in,0,0
118690,climatic,0,1
118691,chamber,0,0
118692,at,0,0
118693,40?C,0,0
118694,and,0,0
118695,55,0,0
118696,%,0,0
118697,RH,0,0
118698,for,0,0
118699,6,0,0
118700,h,0,0
118701,a,0,0
118702,day,0,0
118703,between,0,0
118704,10:00,0,0
118705,and,0,0
118706,16:00,0,0
118707,hours,0,0
118708,to,0,0
118709,induce,0,0
118710,thermal,0,1
118711,stress,0,1
118712,for,0,0
118713,a,0,0
118714,period,0,0
118715,of,0,0
118716,two,0,0
118717,oestrous,0,0
118718,cycles,0,0
118719,.,0,0
118720,Parameters,0,1
118721,studied,0,0
118722,were,1,0
118723,body,1,1
118724,weight,1,1
118725,",",1,1
118726,oestrus,1,1
118727,incidences,1,1
118728,",",1,0
118729,plasma,1,1
118730,oestradiol,1,1
118731,17-?,1,0
118732,",",1,0
118733,plasma,1,1
118734,progesterone,1,1
118735,",",1,1
118736,conception,1,1
118737,rate,1,1
118738,",",1,1
118739,gestation,1,1
118740,period,1,0
118741,",",1,1
118742,lambing,1,1
118743,rate,1,1
118744,",",1,1
118745,and,1,1
118746,birth,1,1
118747,weight,1,1
118748,of,1,0
118749,lambs,1,0
118750,.,1,0
118751,The,0,0
118752,results,0,0
118753,indicate,0,0
118754,that,0,0
118755,combined,0,0
118756,stress,0,1
118757,significantly,0,1
118758,(,0,0
118759,p,0,0
118760,<,0,0
118761,0.05,0,0
118762,),0,0
118763,reduced,1,0
118764,body,1,1
118765,weight,1,1
118766,",",1,1
118767,oestrus,1,1
118768,duration,1,1
118769,",",1,1
118770,birth,1,1
118771,weight,1,1
118772,of,1,1
118773,lambs,1,0
118774,",",1,1
118775,and,1,1
118776,oestradiol,1,1
118777,17-?,1,0
118778,whereas,1,0
118779,significantly,1,0
118780,(,1,0
118781,p,1,0
118782,<,1,0
118783,0.05,1,0
118784,),1,0
118785,increased,1,0
118786,oestrus,1,1
118787,cycle,1,1
118788,length,1,1
118789,and,1,1
118790,progesterone,1,1
118791,.,1,1
118792,Furthermore,1,0
118793,",",0,0
118794,the,0,0
118795,results,0,0
118796,reveal,0,0
118797,that,0,0
118798,on,0,0
118799,comparative,0,0
118800,basis,0,0
118801,",",0,1
118802,ewes,0,1
118803,were,0,0
118804,able,0,0
118805,to,0,0
118806,better,0,0
118807,adapt,0,0
118808,in,0,0
118809,terms,1,1
118810,of,1,1
118811,growth,1,1
118812,and,1,1
118813,reproduction,1,1
118814,to,1,0
118815,restricted,0,0
118816,feeding,0,1
118817,than,0,0
118818,thermal,0,1
118819,stress,0,1
118820,.,0,0
118821,However,0,0
118822,",",0,0
118823,when,0,0
118824,restricted,0,0
118825,feeding,0,1
118826,was,0,0
118827,coupled,0,0
118828,with,0,0
118829,thermal,0,0
118830,stress,0,1
118831,it,0,0
118832,had,0,0
118833,significant,0,0
118834,(,0,0
118835,p,0,0
118836,<,0,0
118837,0.05,0,0
118838,),0,0
118839,influence,0,0
118840,on,0,0
118841,body,1,1
118842,weight,1,1
118843,",",1,1
118844,average,1,1
118845,daily,1,1
118846,gain,1,1
118847,",",1,1
118848,oestradiol,1,1
118849,17-?,1,0
118850,and,1,1
118851,progesterone,1,1
118852,concentrations,1,1
118853,.,1,0
118854,This,1,0
118855,showed,0,0
118856,that,0,0
118857,combined,0,0
118858,stress,0,1
118859,were,0,0
118860,more,0,0
118861,detrimental,0,1
118862,for,0,0
118863,these,0,0
118864,reproductive,0,0
118865,hormones,0,1
118866,in,0,0
118867,Malpura,0,0
118868,ewes,0,0
118869,under,0,0
118870,a,0,0
118871,hot,0,1
118872,semi-arid,0,0
118873,environment,0,0
118874,.,0,0
118875,Randomized,0,0
118876,controlled,0,0
118877,trial,0,0
118878,of,0,1
118879,electro-acupuncture,0,0
118880,for,0,0
118881,autism,0,0
118882,spectrum,0,0
118883,disorder,0,0
118884,.,0,0
118885,OBJECTIVE,0,0
118886,To,0,0
118887,study,0,0
118888,the,0,0
118889,efficacy,0,1
118890,",",0,1
118891,safety,0,1
118892,",",0,1
118893,and,0,1
118894,compliance,0,1
118895,of,0,1
118896,short-term,0,1
118897,electro-acupuncture,0,0
118898,for,0,0
118899,children,0,0
118900,with,0,0
118901,autism,0,0
118902,spectrum,0,1
118903,disorder,0,0
118904,(,0,1
118905,ASD,0,0
118906,),0,0
118907,.,0,0
118908,DESIGN,0,0
118909,Randomized,0,0
118910,",",0,1
118911,double-blind,0,0
118912,",",0,1
118913,sham-controlled,0,0
118914,",",0,1
118915,clinical,0,1
118916,trial,0,0
118917,.,0,0
118918,SUBJECTS,0,1
118919,AND,0,0
118920,METHODS,0,0
118921,Children,0,0
118922,with,0,0
118923,ASD,0,0
118924,were,0,0
118925,randomly,0,0
118926,assigned,0,0
118927,to,0,0
118928,an,0,0
118929,electro-acupuncture,0,0
118930,(,0,0
118931,EA,0,1
118932,),0,1
118933,group,0,0
118934,(,0,0
118935,n=30,0,0
118936,),0,0
118937,or,0,0
118938,a,0,0
118939,sham,0,0
118940,electro-acupuncture,0,0
118941,(,0,1
118942,SEA,0,0
118943,),0,1
118944,group,0,0
118945,(,0,0
118946,n=25,0,0
118947,),0,0
118948,matched,0,0
118949,by,0,0
118950,age,0,0
118951,and,0,1
118952,severity,0,1
118953,of,0,1
118954,autism,0,0
118955,.,0,0
118956,The,0,0
118957,EA,0,1
118958,group,0,0
118959,received,0,0
118960,electro-acupuncture,0,0
118961,for,0,0
118962,selected,0,0
118963,acupoints,0,0
118964,while,0,0
118965,the,0,0
118966,SEA,0,0
118967,group,0,0
118968,received,0,0
118969,sham,0,0
118970,electro-acupuncture,0,0
118971,to,0,0
118972,sham,0,0
118973,acupoints,0,0
118974,.,0,0
118975,A,0,0
118976,total,0,0
118977,of,0,0
118978,12,0,0
118979,EA,0,0
118980,and,0,0
118981,SEA,0,0
118982,sessions,0,0
118983,over,0,0
118984,four,0,0
118985,weeks,0,0
118986,were,0,0
118987,given,0,0
118988,.,0,0
118989,Primary,1,0
118990,outcome,1,1
118991,measures,1,1
118992,included,1,0
118993,Functional,1,0
118994,Independence,1,1
118995,Measure,1,1
118996,for,1,0
118997,Children,1,0
118998,(,1,0
118999,WeeFIM,1,1
119000,),1,1
119001,",",1,0
119002,Pediatric,1,0
119003,Evaluation,1,1
119004,of,1,1
119005,Disability,1,1
119006,Inventory,1,1
119007,(,1,1
119008,PEDI,1,1
119009,),1,1
119010,",",1,0
119011,Leiter,1,1
119012,International,1,1
119013,Performance,1,1
119014,Scale-Revised,1,0
119015,(,1,0
119016,Leiter-R,1,1
119017,),1,1
119018,",",0,0
119019,and,0,1
119020,Clinical,1,1
119021,Global,1,1
119022,Impression-Improvement,1,1
119023,(,1,1
119024,CGI-I,1,1
119025,),1,0
119026,scale,1,1
119027,.,1,0
119028,Secondary,0,0
119029,outcome,0,1
119030,measures,0,1
119031,consisted,0,0
119032,of,0,0
119033,Aberrant,1,0
119034,Behavior,1,1
119035,Checklist,1,1
119036,(,1,1
119037,ABC,1,1
119038,),1,1
119039,",",1,0
119040,Ritvo-Freeman,1,0
119041,Real,1,1
119042,Life,1,0
119043,Scale,1,1
119044,(,1,1
119045,RFRLS,1,0
119046,),1,1
119047,",",1,0
119048,Reynell,1,1
119049,Developmental,1,1
119050,Language,1,1
119051,Scale,1,1
119052,(,1,1
119053,RDLS,1,1
119054,),1,1
119055,",",1,0
119056,and,1,0
119057,a,1,0
119058,standardized,1,0
119059,parental,1,1
119060,report,1,0
119061,.,1,1
119062,Data,0,1
119063,were,0,0
119064,analyzed,0,0
119065,by,0,0
119066,the,0,0
119067,Mann-Whitney,0,0
119068,test,0,1
119069,.,0,1
119070,RESULTS,0,0
119071,There,0,0
119072,were,0,0
119073,significant,0,0
119074,improvements,1,0
119075,in,1,0
119076,the,1,0
119077,language,1,1
119078,comprehension,1,1
119079,domain,1,0
119080,of,1,1
119081,WeeFIM,1,1
119082,(,1,1
119083,p=0.02,1,0
119084,),1,1
119085,",",1,0
119086,self-care,1,1
119087,caregiver,1,1
119088,assistant,1,0
119089,domain,1,0
119090,of,1,1
119091,PEDI,1,1
119092,(,1,1
119093,p=0.028,1,0
119094,),1,1
119095,",",1,1
119096,and,1,1
119097,CGI-I,1,1
119098,(,0,1
119099,p=0.003,0,0
119100,),0,0
119101,in,0,0
119102,the,0,0
119103,EA,0,1
119104,group,0,0
119105,compared,0,0
119106,to,0,0
119107,the,0,0
119108,SEA,0,0
119109,group,0,0
119110,.,0,0
119111,As,0,0
119112,for,0,0
119113,the,0,0
119114,parental,0,1
119115,report,0,0
119116,",",0,0
119117,the,0,0
119118,EA,0,1
119119,group,0,0
119120,also,0,0
119121,showed,0,0
119122,significantly,0,0
119123,better,1,0
119124,social,1,1
119125,initiation,1,1
119126,(,1,1
119127,p=0.01,1,1
119128,),1,1
119129,",",1,0
119130,receptive,1,1
119131,language,1,1
119132,(,1,1
119133,p=0.006,1,0
119134,),1,1
119135,",",1,0
119136,motor,1,1
119137,skills,1,1
119138,(,1,1
119139,p=0.034,1,0
119140,),1,1
119141,",",1,1
119142,coordination,1,1
119143,(,1,1
119144,p=0.07,1,0
119145,),1,1
119146,",",1,1
119147,and,1,1
119148,attention,1,1
119149,span,1,1
119150,(,0,1
119151,p=0.003,0,0
119152,),0,0
119153,.,0,0
119154,More,0,0
119155,than,0,0
119156,70,0,0
119157,percent,0,0
119158,of,0,0
119159,children,0,0
119160,with,0,0
119161,ASD,0,0
119162,adapted,1,0
119163,to,1,0
119164,acupuncture,1,0
119165,easily,1,0
119166,",",0,0
119167,while,0,0
119168,eight,0,0
119169,percent,0,0
119170,had,0,0
119171,poor,1,1
119172,acupuncture,1,0
119173,compliance,1,1
119174,.,1,1
119175,Mild,1,1
119176,side,1,1
119177,effects,1,1
119178,of,1,0
119179,minor,1,0
119180,superficial,1,1
119181,bleeding,1,1
119182,or,1,1
119183,irritability,1,1
119184,during,1,0
119185,acupuncture,1,0
119186,were,0,0
119187,observed,0,0
119188,.,0,0
119189,CONCLUSION,0,0
119190,A,0,0
119191,short,0,1
119192,",",0,0
119193,four-week,0,0
119194,(,0,0
119195,12,0,0
119196,sessions,0,0
119197,),0,0
119198,course,0,1
119199,of,0,0
119200,electro-acupuncture,0,0
119201,is,0,0
119202,useful,0,0
119203,to,0,0
119204,improve,0,0
119205,specific,0,0
119206,functions,0,1
119207,in,0,0
119208,children,0,0
119209,with,0,0
119210,ASD,0,0
119211,",",0,0
119212,especially,0,0
119213,for,0,0
119214,language,0,1
119215,comprehension,0,1
119216,and,0,1
119217,self-care,0,1
119218,ability,0,1
119219,.,0,0
119220,Green,0,0
119221,banana-supplemented,0,0
119222,diet,0,0
119223,in,0,0
119224,the,0,0
119225,home,0,0
119226,management,0,0
119227,of,0,1
119228,acute,1,0
119229,and,1,1
119230,prolonged,1,1
119231,diarrhoea,1,1
119232,in,1,0
119233,children,1,0
119234,:,1,0
119235,a,0,0
119236,community-based,0,0
119237,trial,0,0
119238,in,0,0
119239,rural,0,0
119240,Bangladesh,0,0
119241,.,0,0
119242,SUMMARY,0,0
119243,OBJECTIVE,0,0
119244,To,0,0
119245,determine,0,0
119246,the,0,0
119247,effectiveness,0,0
119248,of,0,0
119249,green,0,1
119250,banana,0,0
119251,in,0,0
119252,the,0,0
119253,home,0,0
119254,management,0,0
119255,of,0,1
119256,acute,1,0
119257,(,0,0
119258,<,0,0
119259,7,0,0
119260,days,0,0
119261,),0,0
119262,or,0,0
119263,prolonged,1,1
119264,(,0,0
119265,?,0,0
119266,7,0,0
119267,days,1,0
119268,),1,0
119269,diarrhoea,1,1
119270,at,1,0
119271,the,0,0
119272,community,0,0
119273,level,0,1
119274,.,0,1
119275,METHODS,0,0
119276,A,0,0
119277,cluster,0,1
119278,randomized,0,0
119279,field,0,0
119280,trial,0,0
119281,was,0,0
119282,conducted,0,0
119283,among,0,0
119284,2968,0,0
119285,Bangladeshi,0,0
119286,rural,0,0
119287,children,0,0
119288,6-36,0,0
119289,months,0,0
119290,old,0,0
119291,.,0,0
119292,Wards,0,0
119293,(,0,0
119294,villages,0,0
119295,),0,1
119296,were,0,0
119297,randomly,0,0
119298,assigned,0,0
119299,to,0,0
119300,either,0,0
119301,a,0,0
119302,standard,0,0
119303,care,0,0
119304,group,0,0
119305,or,0,0
119306,a,0,0
119307,standard,0,0
119308,care,0,0
119309,plus,0,0
119310,green,0,1
119311,banana,0,1
119312,group,0,0
119313,where,0,0
119314,mothers,0,0
119315,were,0,0
119316,instructed,0,0
119317,to,0,0
119318,add,0,0
119319,cooked,0,0
119320,green,0,0
119321,banana,0,0
119322,to,0,0
119323,the,0,0
119324,diets,0,0
119325,of,0,0
119326,diarrhoeal,0,1
119327,children,0,0
119328,.,0,0
119329,Through,0,0
119330,a,0,0
119331,village-based,0,0
119332,surveillance,0,0
119333,system,1,0
119334,",",1,1
119335,diarrhoeal,1,1
119336,morbidity,1,1
119337,data,1,0
119338,(,1,1
119339,severity,1,1
119340,",",1,1
119341,duration,1,1
119342,",",1,1
119343,compliance,1,1
119344,),1,1
119345,were,1,0
119346,collected,0,0
119347,for,0,0
119348,14,0,0
119349,days,0,0
119350,.,0,0
119351,Treatment,0,0
119352,effects,0,1
119353,were,0,0
119354,determined,0,0
119355,by,0,0
119356,analysing,1,0
119357,cumulative,1,1
119358,probability,1,1
119359,of,1,1
119360,cure,1,1
119361,by,1,0
119362,testing,1,0
119363,Cox,1,0
119364,proportional,1,1
119365,hazards,1,1
119366,models,1,0
119367,and,1,1
119368,relative,1,1
119369,risk,1,1
119370,(,1,1
119371,RR,0,1
119372,),0,0
119373,.,0,0
119374,RESULTS,0,0
119375,The,1,0
119376,cumulative,1,1
119377,probability,1,1
119378,of,1,1
119379,cure,1,1
119380,was,1,0
119381,significantly,0,0
119382,(,0,0
119383,P,0,0
119384,<,0,0
119385,0.001,0,0
119386,),0,0
119387,different,0,0
119388,in,0,0
119389,children,0,0
119390,receiving,0,0
119391,GB,0,1
119392,for,0,0
119393,both,1,0
119394,acute,1,0
119395,[,1,0
119396,hazard,0,1
119397,ratio,0,1
119398,(,0,1
119399,HR,0,0
119400,),0,0
119401,=,0,0
119402,0.63,0,0
119403,(,0,0
119404,95,0,0
119405,%,0,0
119406,CI,0,0
119407,:,0,0
119408,0.56-0.67,0,0
119409,),0,1
119410,],0,0
119411,and,1,1
119412,prolonged,1,1
119413,diarrhoea,1,1
119414,[,1,0
119415,HR,0,0
119416,=,0,0
119417,0.38,0,0
119418,(,0,0
119419,95,0,0
119420,%,0,0
119421,CI,0,0
119422,:,0,0
119423,0.26-0.59,0,0
119424,),0,0
119425,],0,0
119426,.,0,0
119427,The,1,0
119428,recovery,1,1
119429,rates,1,1
119430,of,1,0
119431,children,1,0
119432,with,1,0
119433,acute,1,0
119434,diarrhoea,1,1
119435,receiving,1,0
119436,GB,0,1
119437,(,0,0
119438,vs.,0,0
119439,control,0,0
119440,),0,1
119441,were,0,0
119442,significantly,0,0
119443,more,0,0
119444,by,0,0
119445,day,0,0
119446,3,0,0
119447,:,0,0
119448,79.9,0,0
119449,%,0,0
119450,vs,0,0
119451,.,0,0
119452,53.3,0,0
119453,%,0,0
119454,[,0,0
119455,(,0,1
119456,RR,0,1
119457,),0,0
119458,=,0,0
119459,0.47,0,0
119460,",",0,0
119461,95,0,0
119462,%,0,0
119463,CI,0,0
119464,:,0,0
119465,0.41-0.55,0,0
119466,],0,0
119467,",",0,1
119468,(,0,1
119469,P,0,0
119470,<,0,0
119471,0.001,0,0
119472,),0,0
119473,and,0,0
119474,day,0,0
119475,7,0,0
119476,:,0,0
119477,96.6,0,0
119478,%,0,0
119479,vs,0,0
119480,.,0,0
119481,89.1,0,0
119482,%,0,0
119483,(,0,0
119484,RR,0,1
119485,=,0,0
119486,0.32,0,0
119487,;,0,0
119488,0.22-0.46,0,0
119489,),0,1
119490,",",0,0
119491,(,0,0
119492,P,0,0
119493,<,0,0
119494,0.001,0,0
119495,),0,0
119496,.,0,0
119497,Children,0,0
119498,with,0,0
119499,prolonged,0,1
119500,diarrhoea,0,1
119501,receiving,0,0
119502,green,0,1
119503,banana,0,0
119504,had,0,0
119505,significantly,0,0
119506,higher,1,0
119507,recovery,1,1
119508,rates,1,1
119509,by,1,0
119510,day,0,0
119511,10,0,0
119512,:,0,0
119513,79.8,0,0
119514,%,0,0
119515,vs,0,0
119516,.,0,0
119517,51.9,0,0
119518,%,0,0
119519,(,0,0
119520,RR,0,1
119521,=,0,0
119522,0.42,0,0
119523,;,0,0
119524,0.23-0.73,0,0
119525,),0,1
119526,",",0,0
119527,(,0,0
119528,P,0,0
119529,<,0,0
119530,0.001,0,0
119531,),0,0
119532,and,0,0
119533,day,0,0
119534,14,0,0
119535,:,0,0
119536,93.6,0,0
119537,%,0,0
119538,vs,0,0
119539,.,0,0
119540,67.2,0,0
119541,%,0,0
119542,(,0,0
119543,RR,0,1
119544,=,0,0
119545,0.22,0,0
119546,;,0,0
119547,0.08-0.54,0,0
119548,),0,1
119549,",",0,0
119550,(,0,0
119551,P,0,0
119552,<,0,0
119553,0.001,0,0
119554,),0,0
119555,.,0,0
119556,CONCLUSION,0,0
119557,A,0,0
119558,green,0,0
119559,banana-supplemented,0,0
119560,diet,1,0
119561,hastened,1,1
119562,recovery,1,1
119563,of,1,1
119564,acute,0,1
119565,and,0,1
119566,prolonged,0,1
119567,childhood,0,1
119568,diarrhoea,0,1
119569,managed,0,0
119570,at,0,0
119571,home,0,0
119572,in,0,0
119573,rural,0,0
119574,Bangladesh,0,0
119575,.,0,0
119576,Pharmacokinetics,0,1
119577,and,0,1
119578,follicular,0,1
119579,dynamics,0,1
119580,of,0,1
119581,corifollitropin,0,0
119582,alfa,0,0
119583,versus,0,0
119584,recombinant,0,0
119585,FSH,0,1
119586,during,0,0
119587,ovarian,0,1
119588,stimulation,0,1
119589,for,0,0
119590,IVF,0,1
119591,.,0,0
119592,A,0,0
119593,single,0,0
119594,injection,0,0
119595,of,0,1
119596,corifollitropin,0,0
119597,alfa,0,0
119598,can,0,0
119599,replace,0,0
119600,seven,0,0
119601,daily,0,0
119602,injections,0,0
119603,of,0,0
119604,recombinant,0,0
119605,FSH,0,1
119606,(,0,1
119607,rFSH,0,0
119608,),0,0
119609,using,0,0
119610,a,0,0
119611,gonadotrophin-releasing,0,1
119612,hormone,0,1
119613,antagonist,0,0
119614,protocol,0,0
119615,in,0,0
119616,ovarian,0,1
119617,stimulation,0,1
119618,prior,0,0
119619,to,0,0
119620,IVF,0,1
119621,or,0,0
119622,intracytoplasmic,0,1
119623,sperm,0,1
119624,injection,0,0
119625,.,0,0
119626,This,0,0
119627,double-blind,0,0
119628,randomized,0,0
119629,controlled,0,0
119630,trial,0,0
119631,assessed,0,0
119632,the,0,0
119633,pharmacokinetics,0,1
119634,and,0,0
119635,pharmacodynamics,0,0
119636,of,0,0
119637,150?g,0,0
119638,corifollitropin,0,0
119639,alfa,0,0
119640,versus,0,0
119641,daily,0,0
119642,200IU,0,0
119643,rFSH,0,0
119644,in,0,0
119645,1509,0,0
119646,patients,0,0
119647,.,0,0
119648,Comparative,0,0
119649,analyses,0,0
119650,were,0,0
119651,performed,0,0
119652,on,1,0
119653,serum,1,1
119654,concentrations,1,1
119655,of,1,1
119656,FSH,1,1
119657,immunoreactivity,1,1
119658,(,0,1
119659,pharmacokinetics,0,1
119660,),0,1
119661,",",0,0
119662,and,0,0
119663,the,1,0
119664,number,1,1
119665,and,1,1
119666,size,1,1
119667,of,1,1
119668,growing,1,0
119669,follicles,1,1
119670,",",1,1
119671,and,1,1
119672,inhibin,1,1
119673,B,1,1
119674,and,1,1
119675,oestradiol,1,1
119676,concentrations,1,1
119677,as,0,0
119678,biomarkers,0,0
119679,of,0,0
119680,ovarian,0,1
119681,response,0,1
119682,(,0,0
119683,pharmacodynamics,0,0
119684,),0,0
119685,.,0,0
119686,The,1,0
119687,rate,1,1
119688,of,1,0
119689,follicular,1,1
119690,development,1,1
119691,was,0,0
119692,similar,0,0
119693,in,0,0
119694,both,0,0
119695,treatment,0,0
119696,groups,0,0
119697,.,0,0
119698,By,0,0
119699,stimulation,0,1
119700,day,0,0
119701,8,0,0
119702,",",0,0
119703,33,0,0
119704,%,0,0
119705,of,0,0
119706,patients,0,0
119707,treated,0,0
119708,with,0,0
119709,corifollitropin,0,0
119710,alfa,0,0
119711,reached,0,0
119712,the,0,0
119713,criterion,0,0
119714,for,0,0
119715,human,0,0
119716,chorionic,0,1
119717,gonadotrophin,0,1
119718,(,0,1
119719,HCG,0,1
119720,),0,0
119721,injection,0,0
119722,.,0,0
119723,The,1,0
119724,number,1,1
119725,of,1,0
119726,follicles,1,1
119727,?11mm,1,1
119728,was,1,0
119729,slightly,0,0
119730,higher,0,0
119731,after,0,0
119732,corifollitropin,0,0
119733,alfa,0,0
119734,compared,0,0
119735,with,0,0
119736,daily,0,0
119737,rFSH,0,0
119738,at,0,0
119739,stimulation,0,1
119740,day,0,0
119741,8,0,0
119742,(,0,0
119743,difference,0,0
119744,",",0,0
119745,1.2,0,0
119746,;,0,0
119747,95,0,0
119748,%,0,0
119749,confidence,0,0
119750,interval,0,0
119751,(,0,1
119752,CI,0,0
119753,),0,0
119754,0.5-1.8,0,0
119755,;,0,0
119756,P,0,0
119757,<,0,0
119758,0.01,0,0
119759,),0,0
119760,and,0,0
119761,on,0,0
119762,the,0,0
119763,day,0,0
119764,of,0,0
119765,HCG,0,1
119766,injection,0,0
119767,(,0,1
119768,difference,0,0
119769,",",0,0
119770,2.1,0,0
119771,;,0,0
119772,95,0,0
119773,%,0,0
119774,CI,0,0
119775,1.4-2.8,0,0
119776,;,0,0
119777,P,0,0
119778,<,0,0
119779,0.01,0,0
119780,),0,0
119781,.,0,0
119782,The,0,0
119783,rise,1,0
119784,of,1,0
119785,inhibin,1,1
119786,B,1,0
119787,and,1,1
119788,oestradiol,1,1
119789,concentrations,1,1
119790,was,1,0
119791,similar,0,0
119792,in,0,0
119793,both,0,0
119794,treatment,0,0
119795,groups,0,0
119796,.,0,0
119797,Although,0,0
119798,the,0,0
119799,pharmacokinetics,0,0
119800,of,0,0
119801,corifollitropin,0,0
119802,alfa,0,0
119803,and,0,0
119804,rFSH,0,0
119805,are,0,0
119806,quite,0,0
119807,different,0,0
119808,their,0,0
119809,pharmacodynamic,0,1
119810,profiles,0,0
119811,at,0,0
119812,the,0,0
119813,dosages,0,0
119814,used,0,0
119815,are,0,0
119816,similar,0,0
119817,.,0,0
119818,A,0,0
119819,single,0,0
119820,injection,0,0
119821,of,0,1
119822,corifollitropin,0,0
119823,alfa,0,0
119824,can,0,0
119825,replace,0,0
119826,seven,0,0
119827,daily,0,0
119828,injections,0,0
119829,of,0,0
119830,recombinant,0,0
119831,FSH,0,1
119832,(,0,1
119833,rFSH,0,0
119834,),0,0
119835,using,0,0
119836,a,0,0
119837,gonadotrophin-releasing,0,1
119838,hormone,0,1
119839,antagonist,0,0
119840,protocol,0,0
119841,in,0,0
119842,ovarian,0,1
119843,stimulation,0,1
119844,prior,0,0
119845,to,0,0
119846,IVF,0,1
119847,or,0,0
119848,intracytoplasmic,0,1
119849,sperm,0,1
119850,injection,0,0
119851,.,0,0
119852,The,0,0
119853,objective,0,0
119854,of,0,0
119855,this,0,0
119856,study,0,0
119857,was,0,0
119858,to,0,0
119859,compare,0,0
119860,the,0,0
119861,pharmacokinetics,0,1
119862,and,0,0
119863,pharmacodynamics,0,0
119864,of,0,1
119865,corifollitropin,0,0
119866,alfa,0,0
119867,versus,0,0
119868,daily,0,0
119869,rFSH,0,0
119870,.,0,0
119871,A,0,0
119872,total,0,0
119873,of,0,0
119874,1509,0,0
119875,patients,0,0
119876,were,0,0
119877,randomized,0,0
119878,in,0,0
119879,a,0,0
119880,double-blind,0,0
119881,",",0,0
119882,controlled,0,0
119883,trial,0,0
119884,to,0,0
119885,either,0,0
119886,a,0,0
119887,single,0,0
119888,injection,0,0
119889,of,0,0
119890,150?g,0,0
119891,corifollitropin,0,0
119892,alfa,0,0
119893,or,0,1
119894,to,0,0
119895,daily,0,1
119896,injections,0,0
119897,of,0,0
119898,200IU,0,0
119899,rFSH,0,0
119900,for,0,0
119901,the,0,0
119902,first,0,0
119903,7,0,0
119904,days,0,0
119905,of,0,0
119906,ovarian,0,0
119907,stimulation,1,1
119908,.,1,0
119909,Serum,1,0
119910,levels,1,1
119911,of,1,1
119912,FSH,1,1
119913,immunoreactivity,1,1
119914,were,1,0
119915,analysed,0,0
119916,(,0,0
119917,pharmacokinetic,0,1
119918,analysis,0,0
119919,),0,1
119920,",",0,0
119921,together,0,0
119922,with,0,0
119923,the,0,0
119924,number,1,1
119925,and,1,1
119926,size,1,1
119927,of,1,1
119928,growing,1,0
119929,follicles,1,1
119930,and,1,1
119931,serum,1,1
119932,inhibin,1,1
119933,B,1,1
119934,and,1,1
119935,oestradiol,1,1
119936,concentrations,1,1
119937,as,1,0
119938,biomarkers,0,0
119939,of,0,0
119940,the,0,0
119941,ovarian,0,1
119942,response,0,1
119943,(,0,0
119944,pharmacodynamic,0,1
119945,analysis,1,0
119946,),1,0
119947,.,1,0
119948,Serum,1,1
119949,FSH,1,1
119950,immunoreactivity,1,1
119951,levels,1,1
119952,were,1,0
119953,higher,0,0
119954,up,0,0
119955,to,0,0
119956,stimulation,0,1
119957,day,0,0
119958,5,0,0
119959,for,0,0
119960,corifollitropin,0,0
119961,alfa,0,0
119962,compared,0,0
119963,with,0,0
119964,the,0,0
119965,daily,0,0
119966,rFSH,0,0
119967,regimen,0,0
119968,but,0,0
119969,were,0,0
119970,similar,0,0
119971,from,0,0
119972,day,0,0
119973,8,0,0
119974,onwards,0,0
119975,",",0,0
119976,when,0,0
119977,patients,0,0
119978,started,0,0
119979,rFSH,0,0
119980,if,0,0
119981,the,0,0
119982,criteria,0,0
119983,for,0,0
119984,human,0,0
119985,chorionic,0,1
119986,gonadotrophin,0,1
119987,were,0,0
119988,not,0,0
119989,yet,0,0
119990,reached,0,0
119991,.,0,0
119992,Corifollitropin,0,0
119993,alfa,0,0
119994,treatment,0,0
119995,resulted,0,0
119996,in,0,0
119997,a,0,0
119998,similar,1,0
119999,growth,1,1
120000,rate,1,1
120001,of,1,1
120002,follicles,1,1
120003,though,1,0
120004,a,0,0
120005,slightly,1,0
120006,higher,1,0
120007,number,1,1
120008,of,1,1
120009,follicles,1,1
120010,were,1,0
120011,recruited,0,0
120012,compared,0,0
120013,with,0,0
120014,daily,0,0
120015,rFSH,0,0
120016,.,0,0
120017,It,0,0
120018,is,0,0
120019,concluded,0,0
120020,that,0,0
120021,the,0,0
120022,pharmacokinetics,0,0
120023,of,0,0
120024,corifollitropin,0,0
120025,alfa,0,0
120026,and,0,0
120027,rFSH,0,0
120028,are,0,0
120029,quite,0,0
120030,different,0,0
120031,but,0,0
120032,their,0,0
120033,induced,1,0
120034,pharmacodynamic,1,1
120035,effects,1,0
120036,at,1,0
120037,the,0,0
120038,dosages,0,0
120039,used,0,0
120040,are,0,0
120041,similar,0,0
120042,.,0,0
120043,Acamprosate,0,0
120044,appears,0,0
120045,to,0,0
120046,decrease,1,1
120047,alcohol,1,1
120048,intake,1,1
120049,in,0,0
120050,weaned,0,0
120051,alcoholics,0,0
120052,.,0,0
120053,Five,0,0
120054,hundred,0,0
120055,and,0,0
120056,sixty-nine,0,0
120057,alcoholics,0,0
120058,were,0,0
120059,included,0,0
120060,in,0,0
120061,a,0,0
120062,double-blind,0,0
120063,placebo-controlled,0,0
120064,randomized,0,0
120065,multicenter,0,0
120066,study,0,0
120067,of,0,0
120068,the,0,0
120069,effects,0,0
120070,of,0,1
120071,Acamprosate,0,0
120072,(,0,0
120073,calcium,0,1
120074,acetylhomotaurinate,0,0
120075,(,0,1
120076,CA,0,0
120077,),0,0
120078,",",0,0
120079,1.3,0,0
120080,g/day,0,0
120081,),0,0
120082,on,0,0
120083,indicators,0,1
120084,of,0,0
120085,alcoholic,0,0
120086,relapse,0,1
120087,after,0,0
120088,withdrawal,0,1
120089,.,0,0
120090,One,0,0
120091,hundred,0,0
120092,and,0,0
120093,eighty-one,0,0
120094,patients,0,0
120095,in,0,0
120096,the,0,0
120097,CA,0,0
120098,group,0,0
120099,versus,0,0
120100,175,0,0
120101,in,0,0
120102,the,0,0
120103,placebo,0,0
120104,group,0,0
120105,completed,0,0
120106,the,0,0
120107,three-month,0,0
120108,study,0,0
120109,.,0,0
120110,The,0,0
120111,major,0,1
120112,efficacy,0,1
120113,criterion,0,1
120114,was,0,0
120115,plasma,0,1
120116,gamma-glutamyl,0,1
120117,transpeptidase,0,1
120118,(,0,1
120119,GGT,0,1
120120,),0,1
120121,",",0,0
120122,as,0,0
120123,an,0,0
120124,indicator,0,0
120125,of,0,0
120126,recent,0,0
120127,alcohol,0,1
120128,ingestion,0,0
120129,.,0,0
120130,This,0,0
120131,analysis,0,0
120132,was,0,0
120133,completed,0,0
120134,by,0,0
120135,criteria,0,0
120136,concordance,0,1
120137,analysis,0,0
120138,on,0,0
120139,a,0,0
120140,number,0,1
120141,of,0,0
120142,indicators,0,1
120143,of,0,1
120144,alcohol,0,0
120145,intake,0,1
120146,.,0,0
120147,Patients,0,0
120148,in,0,0
120149,both,0,0
120150,groups,0,0
120151,were,0,0
120152,similar,0,0
120153,initially,0,0
120154,.,0,0
120155,After,0,0
120156,3,0,0
120157,months,0,0
120158,of,0,0
120159,treatment,0,0
120160,",",0,0
120161,the,0,0
120162,patients,0,0
120163,in,0,0
120164,the,0,0
120165,CA,0,0
120166,group,0,0
120167,had,0,0
120168,significantly,0,0
120169,lower,1,0
120170,GGT,1,0
120171,(,0,0
120172,1.4,0,0
120173,+/-,0,0
120174,1.56,0,0
120175,versus,0,0
120176,2.0,0,0
120177,+/-,0,0
120178,3.19,0,0
120179,times,0,0
120180,normal,0,0
120181,",",0,0
120182,P,0,0
120183,=,0,0
120184,0.016,0,0
120185,),0,0
120186,.,0,0
120187,All,0,0
120188,significant,0,0
120189,differences,0,0
120190,(,0,0
120191,P,0,0
120192,less,0,0
120193,than,0,0
120194,0.05,0,0
120195,),0,0
120196,or,0,0
120197,trends,0,1
120198,(,0,0
120199,0.10,0,0
120200,greater,0,0
120201,than,0,0
120202,P,0,0
120203,greater,0,0
120204,than,0,0
120205,0.05,0,0
120206,),0,0
120207,were,0,0
120208,in,0,0
120209,favor,0,0
120210,of,0,0
120211,a,0,0
120212,superior,0,0
120213,effect,0,0
120214,of,0,1
120215,CA,0,0
120216,over,0,0
120217,placebo,0,0
120218,.,0,0
120219,The,0,0
120220,major,0,1
120221,side-effect,0,0
120222,of,0,1
120223,CA,0,0
120224,was,0,0
120225,diarrhea,1,1
120226,(,0,0
120227,present,0,0
120228,in,0,0
120229,13,0,0
120230,%,0,0
120231,of,0,0
120232,CA,0,0
120233,patients,0,0
120234,versus,0,0
120235,7,0,0
120236,%,0,0
120237,of,0,0
120238,placebo,0,0
120239,",",0,1
120240,P,0,0
120241,=,0,0
120242,0.04,0,0
120243,),0,0
120244,.,0,0
120245,CA,0,0
120246,proved,0,0
120247,superior,0,0
120248,to,0,0
120249,placebo,0,0
120250,on,0,0
120251,the,0,0
120252,evolution,0,1
120253,of,0,0
120254,markers,0,1
120255,of,0,1
120256,alcohol,0,1
120257,ingestion,0,0
120258,at,0,0
120259,three,0,0
120260,months,0,0
120261,",",0,0
120262,in,0,0
120263,this,0,0
120264,large-scale,0,0
120265,multicenter,0,0
120266,study,0,0
120267,.,0,0
120268,It,0,0
120269,could,0,0
120270,be,0,0
120271,a,0,0
120272,new,0,0
120273,modality,0,0
120274,in,0,0
120275,the,0,0
120276,drug,0,0
120277,therapy,0,0
120278,of,0,1
120279,alcoholism,0,1
120280,",",0,0
120281,not,0,0
120282,involving,0,0
120283,an,0,0
120284,antabuse,0,0
120285,effect,0,1
120286,",",0,0
120287,an,0,0
120288,antidepressant,0,0
120289,action,0,1
120290,",",0,1
120291,or,0,1
120292,conditioning,0,0
120293,.,0,0
120294,[,1,0
120295,Acute,1,1
120296,cardiovascular,1,1
120297,and,1,1
120298,metabolic,1,1
120299,changes,1,1
120300,in,0,0
120301,interval,0,0
120302,and,0,1
120303,endurance,0,1
120304,training,0,0
120305,in,0,0
120306,selected,0,0
120307,patients,0,0
120308,following,0,0
120309,aortocoronary,0,0
120310,bypass,0,0
120311,operation,0,0
120312,],0,0
120313,.,0,0
120314,UNLABELLED,0,0
120315,This,0,0
120316,study,0,0
120317,compared,0,0
120318,the,0,0
120319,acute,1,0
120320,changes,1,1
120321,of,1,1
120322,cardiovascular,1,1
120323,and,1,1
120324,metabolic,1,1
120325,reactions,1,1
120326,during,0,0
120327,interval,0,0
120328,and,0,1
120329,continuous,0,1
120330,training,0,0
120331,after,0,0
120332,coronary,0,1
120333,bypass,0,0
120334,surgery,0,0
120335,.,0,0
120336,Two,0,0
120337,groups,0,0
120338,of,0,0
120339,9,0,0
120340,male,0,0
120341,patients,0,0
120342,(,0,0
120343,age,0,0
120344,:,0,0
120345,59,0,0
120346,+/-,0,0
120347,4,0,0
120348,and,0,0
120349,56,0,0
120350,+/-,0,0
120351,6,0,0
120352,years,0,0
120353,",",0,0
120354,resp,0,1
120355,.,0,0
120356,),0,0
120357,each,0,0
120358,trained,0,0
120359,on,0,0
120360,bicycle,0,0
120361,ergometer,0,0
120362,start,0,0
120363,on,0,0
120364,post-operative,0,1
120365,days,0,0
120366,24,0,0
120367,and,0,0
120368,26,0,0
120369,",",0,0
120370,resp,0,1
120371,.,0,0
120372,In,0,0
120373,both,0,0
120374,training,0,0
120375,groups,0,0
120376,training,1,0
120377,heart,1,1
120378,rate,1,1
120379,was,0,0
120380,set,0,0
120381,at,0,0
120382,86,0,0
120383,%,0,0
120384,of,0,0
120385,individual,0,0
120386,maximum,0,1
120387,heart,0,1
120388,rate,0,1
120389,.,0,0
120390,In,0,0
120391,the,0,0
120392,last,0,0
120393,week,0,0
120394,of,0,0
120395,training,0,0
120396,the,0,0
120397,exercise,0,0
120398,intensity,0,1
120399,in,0,0
120400,the,0,0
120401,group,0,0
120402,of,0,0
120403,patients,0,0
120404,who,0,0
120405,were,0,0
120406,trained,0,0
120407,by,0,0
120408,the,0,0
120409,continuous,0,0
120410,method,0,0
120411,was,0,0
120412,at,0,0
120413,83,0,0
120414,watts,0,0
120415,",",0,0
120416,and,0,1
120417,at,0,0
120418,20:121,0,0
120419,watts,0,0
120420,in,0,0
120421,the,0,0
120422,group,0,0
120423,of,0,0
120424,patients,0,0
120425,who,0,0
120426,were,0,0
120427,trained,0,0
120428,by,0,0
120429,interval,0,0
120430,method,0,0
120431,(,0,0
120432,rest,0,1
120433,:,0,0
120434,work,0,0
120435,each,0,0
120436,1:1,0,0
120437,min,0,0
120438,),0,0
120439,.,0,0
120440,At,0,0
120441,this,0,0
120442,exercise,0,0
120443,training,0,0
120444,that,0,0
120445,lasted,0,0
120446,for,0,0
120447,20,0,0
120448,min,0,0
120449,the,0,0
120450,acute,1,0
120451,response,1,1
120452,of,1,1
120453,heart,1,1
120454,rate,1,1
120455,",",1,1
120456,blood,1,1
120457,pressure,1,1
120458,",",1,1
120459,rate-pressure,1,1
120460,product,1,1
120461,",",1,1
120462,glucose,1,1
120463,",",1,1
120464,lactate,1,1
120465,and,1,1
120466,catecholamines,1,1
120467,was,0,0
120468,measured,0,0
120469,.,0,0
120470,RESULTS,0,0
120471,In,0,0
120472,both,0,0
120473,methods,0,0
120474,there,0,0
120475,were,0,0
120476,no,1,0
120477,significant,1,0
120478,differences,1,0
120479,in,1,0
120480,systolic,1,1
120481,and,1,1
120482,diastolic,1,1
120483,pressure,1,1
120484,",",1,1
120485,rate-pressure,1,1
120486,product,1,1
120487,",",1,0
120488,in,1,0
120489,glucose,1,1
120490,or,1,1
120491,catecholamine,1,1
120492,levels,1,1
120493,.,1,0
120494,However,0,0
120495,",",0,0
120496,there,0,0
120497,was,0,0
120498,a,0,0
120499,significantly,0,0
120500,higher,0,0
120501,rate,1,1
120502,of,1,1
120503,lactate,1,1
120504,in,0,0
120505,the,0,0
120506,second,0,0
120507,10,0,0
120508,min,0,0
120509,of,0,0
120510,the,0,0
120511,interval,0,0
120512,training,0,0
120513,.,0,1
120514,And,0,0
120515,",",0,1
120516,in,0,0
120517,spite,0,0
120518,of,0,0
120519,higher,0,0
120520,peripheral,0,1
120521,exercise,0,0
120522,intensity,0,1
120523,by,0,0
120524,interval,0,0
120525,training,0,0
120526,",",0,0
120527,there,0,0
120528,was,0,0
120529,no,0,0
120530,higher,0,0
120531,cardiac,1,1
120532,work,1,1
120533,than,0,0
120534,by,0,0
120535,the,0,0
120536,continuous,0,0
120537,training,0,0
120538,.,0,0
120539,These,0,0
120540,findings,0,0
120541,suggest,0,0
120542,that,0,0
120543,interval,0,0
120544,training,0,0
120545,strains,0,0
120546,the,0,0
120547,oxidative,0,1
120548,capacity,0,1
120549,of,0,0
120550,the,0,0
120551,trained,0,0
120552,muscles,0,0
120553,in,0,0
120554,a,0,0
120555,more,0,0
120556,intensive,0,0
120557,and,0,1
120558,direct,0,1
120559,way,0,0
120560,than,0,0
120561,does,0,0
120562,continuous,0,0
120563,training,0,0
120564,.,0,0
120565,PDE5,0,1
120566,inhibition,0,1
120567,with,0,0
120568,sildenafil,0,0
120569,improves,0,1
120570,left,0,1
120571,ventricular,0,1
120572,diastolic,0,1
120573,function,0,1
120574,",",0,1
120575,cardiac,0,1
120576,geometry,0,0
120577,",",0,1
120578,and,0,1
120579,clinical,0,1
120580,status,0,1
120581,in,0,0
120582,patients,0,0
120583,with,0,0
120584,stable,0,1
120585,systolic,0,1
120586,heart,0,1
120587,failure,0,1
120588,:,0,0
120589,results,0,0
120590,of,0,0
120591,a,0,0
120592,1-year,0,0
120593,",",0,0
120594,prospective,0,0
120595,",",0,1
120596,randomized,0,0
120597,",",0,0
120598,placebo-controlled,0,0
120599,study,0,0
120600,.,0,0
120601,BACKGROUND,0,0
120602,In,0,0
120603,heart,0,1
120604,failure,0,1
120605,(,0,1
120606,HF,0,1
120607,),0,0
120608,",",0,0
120609,a,0,0
120610,defective,0,0
120611,nitric,0,1
120612,oxide,0,0
120613,signaling,0,1
120614,is,0,0
120615,involved,0,0
120616,in,0,0
120617,left,0,1
120618,ventricular,0,1
120619,(,0,1
120620,LV,0,1
120621,),0,1
120622,diastolic,0,1
120623,abnormalities,0,1
120624,and,0,0
120625,remodeling,0,0
120626,.,0,1
120627,PDE5,0,1
120628,inhibition,0,1
120629,",",0,0
120630,by,0,0
120631,blocking,0,0
120632,degradation,0,1
120633,of,0,0
120634,nitric,0,1
120635,oxide,0,0
120636,second-messenger,0,1
120637,cyclic,0,1
120638,guanosine,0,1
120639,monophosphate,0,0
120640,",",0,0
120641,might,0,0
120642,be,0,0
120643,beneficial,0,0
120644,.,0,0
120645,In,0,0
120646,a,0,0
120647,cohort,0,0
120648,of,0,0
120649,systolic,0,1
120650,HF,0,0
120651,patients,0,0
120652,",",0,0
120653,we,0,0
120654,tested,0,0
120655,the,0,0
120656,effects,0,1
120657,of,0,0
120658,PDE5,0,1
120659,inhibition,0,1
120660,(,0,1
120661,sildenafil,0,0
120662,),0,0
120663,on,0,0
120664,LV,0,1
120665,ejection,0,1
120666,fraction,0,1
120667,",",0,1
120668,diastolic,0,1
120669,function,0,1
120670,",",0,1
120671,cardiac,0,1
120672,geometry,0,0
120673,",",0,1
120674,and,0,1
120675,clinical,0,1
120676,status,0,1
120677,.,0,1
120678,METHODS,0,0
120679,AND,0,0
120680,RESULTS,0,0
120681,Forty-five,0,0
120682,HF,0,1
120683,patients,0,0
120684,(,0,0
120685,New,0,1
120686,York,0,0
120687,Heart,0,1
120688,Association,0,0
120689,class,0,0
120690,II-III,0,1
120691,),0,1
120692,were,0,0
120693,randomly,0,0
120694,assigned,0,0
120695,to,0,0
120696,placebo,0,0
120697,or,0,0
120698,sildenafil,0,0
120699,(,0,0
120700,50,0,0
120701,mg,0,0
120702,three,0,0
120703,times,0,0
120704,per,0,0
120705,day,0,0
120706,),0,0
120707,for,0,0
120708,1,0,0
120709,year,0,0
120710,",",0,0
120711,with,0,0
120712,assessment,0,0
120713,(,0,0
120714,6,0,0
120715,months,0,0
120716,and,0,0
120717,1,0,0
120718,year,0,0
120719,),0,0
120720,of,0,0
120721,LV,1,1
120722,ejection,1,1
120723,fraction,1,1
120724,",",1,1
120725,diastolic,1,1
120726,function,1,1
120727,",",1,1
120728,geometry,1,0
120729,",",1,1
120730,cardiopulmonary,1,1
120731,exercise,1,0
120732,performance,1,1
120733,",",1,1
120734,and,1,1
120735,quality,1,1
120736,of,1,1
120737,life,1,1
120738,.,1,0
120739,In,0,0
120740,the,0,0
120741,sildenafil,0,0
120742,group,0,0
120743,only,0,0
120744,",",0,0
120745,at,0,0
120746,6,0,0
120747,months,0,0
120748,and,0,0
120749,1,0,0
120750,year,0,0
120751,",",0,0
120752,LV,1,1
120753,ejection,1,1
120754,fraction,1,1
120755,",",1,1
120756,early,1,1
120757,diastolic,1,1
120758,tissue,1,1
120759,Doppler,1,1
120760,velocities,1,1
120761,(,1,0
120762,E,1,1
120763,',1,1
120764,),1,0
120765,at,1,0
120766,the,1,0
120767,mitral,1,1
120768,lateral,1,0
120769,(,0,0
120770,from,0,0
120771,4.62,0,0
120772,to,0,0
120773,5.20,0,0
120774,and,0,0
120775,5.19,0,0
120776,m/s,0,0
120777,),0,0
120778,and,0,1
120779,septal,1,1
120780,(,0,0
120781,from,0,0
120782,4.71,0,0
120783,to,0,0
120784,5.23,0,0
120785,and,0,0
120786,5.24,0,0
120787,m/s,0,0
120788,),0,0
120789,annuli,1,1
120790,significantly,1,0
120791,increased,0,0
120792,",",0,0
120793,whereas,0,0
120794,the,0,0
120795,ratio,0,1
120796,of,0,0
120797,early,0,1
120798,transmitral,0,1
120799,(,0,1
120800,E,0,1
120801,),0,0
120802,to,0,0
120803,E,0,1
120804,',0,1
120805,lateral,0,0
120806,decreased,0,1
120807,(,0,0
120808,from,0,0
120809,13.1,0,0
120810,to,0,0
120811,9.8,0,0
120812,to,0,0
120813,9.4,0,0
120814,),0,0
120815,(,0,0
120816,P,0,0
120817,<,0,0
120818,0.01,0,0
120819,),0,0
120820,.,0,0
120821,Changes,0,1
120822,were,0,0
120823,accompanied,0,0
120824,by,0,0
120825,a,0,0
120826,reverse,1,0
120827,remodeling,1,0
120828,of,1,1
120829,left,1,1
120830,atrial,1,1
120831,volume,1,1
120832,index,1,1
120833,(,0,0
120834,from,0,0
120835,32.0,0,0
120836,to,0,0
120837,29.0,0,0
120838,and,0,0
120839,29.1,0,0
120840,mL/m,0,0
120841,(,0,0
120842,2,0,0
120843,),0,0
120844,;,0,0
120845,P,0,0
120846,<,0,0
120847,0.01,0,0
120848,),0,0
120849,and,0,0
120850,LV,1,1
120851,mass,1,1
120852,index,1,1
120853,(,0,0
120854,from,0,0
120855,148.0,0,0
120856,to,0,0
120857,130.0,0,0
120858,and,0,0
120859,128.0,0,0
120860,g/m,0,0
120861,(,0,0
120862,2,0,0
120863,),0,0
120864,;,0,0
120865,P,0,0
120866,<,0,0
120867,0.01,0,0
120868,),0,0
120869,.,0,0
120870,Furthermore,0,0
120871,",",0,0
120872,sildenafil,0,0
120873,improved,0,1
120874,exercise,1,0
120875,performance,1,1
120876,(,1,0
120877,peak,1,1
120878,Vo,1,0
120879,(,1,0
120880,2,1,0
120881,),1,0
120882,),1,0
120883,",",1,0
120884,ventilation,1,1
120885,efficiency,1,1
120886,(,1,0
120887,ventilation,1,1
120888,to,1,0
120889,CO,1,0
120890,(,1,0
120891,2,1,0
120892,),1,0
120893,production,1,1
120894,slope,1,1
120895,),1,1
120896,",",1,1
120897,and,1,1
120898,quality,1,1
120899,of,1,1
120900,life,1,1
120901,(,0,0
120902,P,0,0
120903,<,0,0
120904,0.01,0,0
120905,),0,0
120906,.,0,0
120907,Minor,0,1
120908,adverse,0,1
120909,effects,0,1
120910,were,0,0
120911,noted,0,0
120912,:,0,0
120913,flushing,1,1
120914,in,0,0
120915,4,0,0
120916,and,0,0
120917,headache,1,0
120918,in,0,0
120919,2,0,0
120920,treated,0,0
120921,patients,0,0
120922,.,0,0
120923,CONCLUSIONS,0,0
120924,Findings,0,1
120925,confirm,0,0
120926,that,0,0
120927,in,0,0
120928,HF,0,0
120929,",",0,0
120930,sildenafil,0,0
120931,improves,0,1
120932,functional,1,1
120933,capacity,1,1
120934,and,1,1
120935,clinical,1,1
120936,status,1,1
120937,and,0,0
120938,provide,0,0
120939,the,0,0
120940,first,0,0
120941,human,0,0
120942,evidence,0,0
120943,that,0,0
120944,LV,1,1
120945,diastolic,1,1
120946,function,1,1
120947,and,0,1
120948,cardiac,1,1
120949,geometry,1,0
120950,are,0,0
120951,additional,0,0
120952,targets,0,0
120953,of,0,0
120954,benefits,0,0
120955,related,0,0
120956,to,0,0
120957,chronic,0,0
120958,PDE5,0,1
120959,inhibition,0,1
120960,.,0,0
120961,Pre-transplant,0,1
120962,pharmacokinetic,0,1
120963,profiling,0,0
120964,and,0,1
120965,tacrolimus,1,0
120966,requirements,1,1
120967,post-transplant,1,1
120968,.,1,0
120969,AIM,0,0
120970,To,0,0
120971,determine,0,0
120972,the,0,0
120973,proportion,0,0
120974,of,0,0
120975,patients,0,0
120976,achieving,0,1
120977,tacrolimus,1,0
120978,whole-blood,1,0
120979,concentrations,1,1
120980,of,0,1
120981,?10,0,1
120982,ng/mL,0,0
120983,within,0,0
120984,3,0,0
120985,days,0,0
120986,of,0,0
120987,kidney,0,0
120988,transplantation,0,0
120989,",",0,1
120990,after,0,0
120991,randomization,0,0
120992,either,0,0
120993,to,0,0
120994,standard,0,0
120995,dosing,0,0
120996,(,0,0
120997,control,0,0
120998,group,0,0
120999,),0,1
121000,or,0,1
121001,post-transplantation,0,1
121002,dosing,0,1
121003,guided,0,0
121004,by,0,0
121005,a,0,0
121006,2-hour,0,1
121007,(,0,0
121008,C,0,0
121009,(,0,0
121010,2,0,0
121011,),0,0
121012,),0,0
121013,level,0,1
121014,following,0,0
121015,a,0,0
121016,preoperative,0,1
121017,tacrolimus,0,0
121018,dose,0,1
121019,(,0,1
121020,T2,0,0
121021,group,0,0
121022,),0,0
121023,.,0,0
121024,METHODS,0,0
121025,The,0,0
121026,first,0,0
121027,postoperative,0,1
121028,tacrolimus,0,0
121029,dose,0,1
121030,was,0,0
121031,given,0,0
121032,either,0,0
121033,according,0,0
121034,to,0,0
121035,standard,0,0
121036,care,0,0
121037,(,0,0
121038,control,0,0
121039,group,0,0
121040,),0,0
121041,or,0,0
121042,0.15,0,0
121043,mg/kg,0,0
121044,b.d,0,0
121045,.,0,0
121046,if,0,0
121047,the,0,0
121048,pre-transplant,0,1
121049,C,0,0
121050,(,0,0
121051,2,0,0
121052,),0,0
121053,level,0,1
121054,was,0,0
121055,?20,0,0
121056,ng/mL,0,0
121057,",",0,0
121058,0.1,0,0
121059,mg/kg,0,0
121060,b.d,0,0
121061,.,0,0
121062,if,0,0
121063,the,0,0
121064,C,0,0
121065,(,0,0
121066,2,0,0
121067,),0,0
121068,level,0,1
121069,was,0,0
121070,21-59,0,0
121071,ng/mL,0,1
121072,or,0,0
121073,0.05,0,0
121074,mg/kg,0,0
121075,b.d,0,0
121076,.,0,0
121077,if,0,0
121078,the,0,0
121079,C,0,0
121080,(,0,0
121081,2,0,0
121082,),0,0
121083,level,0,1
121084,was,0,0
121085,?60,0,0
121086,ng/mL,0,1
121087,(,0,1
121088,T2,0,0
121089,group,0,0
121090,),0,0
121091,.,0,0
121092,Subsequent,0,0
121093,dosing,0,0
121094,in,0,0
121095,both,0,0
121096,groups,0,0
121097,was,0,0
121098,based,0,0
121099,upon,0,0
121100,tacrolimus,0,0
121101,trough,0,1
121102,level,0,1
121103,monitoring,0,0
121104,.,0,1
121105,Participants,0,0
121106,received,0,0
121107,concomitant,0,0
121108,mycophenolate,0,0
121109,mofetil,0,0
121110,and,0,1
121111,steroids,0,0
121112,.,0,1
121113,RESULTS,0,0
121114,Ninety,0,0
121115,patients,0,0
121116,were,0,0
121117,recruited,0,0
121118,",",0,0
121119,of,0,0
121120,which,0,0
121121,84,0,0
121122,were,0,0
121123,included,0,0
121124,in,0,0
121125,the,0,0
121126,analysis,0,0
121127,(,0,0
121128,control,0,0
121129,group,0,0
121130,n=43,0,0
121131,;,0,0
121132,T2,0,0
121133,group,0,0
121134,n=41,0,0
121135,),0,0
121136,.,0,0
121137,There,0,0
121138,was,0,0
121139,no,0,0
121140,difference,0,0
121141,in,0,0
121142,the,0,0
121143,proportion,1,0
121144,of,1,0
121145,subjects,1,0
121146,achieving,1,1
121147,tacrolimus,1,0
121148,trough,1,0
121149,levels,1,1
121150,?10,1,0
121151,ng/mL,1,0
121152,(,0,0
121153,82.9,0,0
121154,%,0,0
121155,Control,0,0
121156,vs,0,0
121157,93.0,0,0
121158,%,0,0
121159,T2,0,0
121160,;,0,1
121161,P=0.19,0,0
121162,),0,1
121163,or,0,0
121164,between,0,0
121165,10,0,0
121166,and,0,0
121167,15,0,0
121168,ng/mL,0,0
121169,(,0,0
121170,41.5,0,0
121171,%,0,0
121172,Control,0,0
121173,vs,0,0
121174,41.9,0,0
121175,%,0,0
121176,T2,0,0
121177,;,0,1
121178,P=0.97,0,0
121179,),0,0
121180,at,0,0
121181,day,0,0
121182,3,0,0
121183,post,0,0
121184,transplant,0,0
121185,.,0,0
121186,The,0,0
121187,T2,0,0
121188,group,0,0
121189,achieved,0,1
121190,tacrolimus,1,0
121191,trough,1,1
121192,levels,1,1
121193,of,1,0
121194,?10,1,0
121195,ng/mL,1,0
121196,significantly,1,0
121197,faster,0,0
121198,than,0,0
121199,the,0,0
121200,control,0,0
121201,group,0,0
121202,(,0,0
121203,100,0,0
121204,%,0,0
121205,achievement,0,1
121206,in,0,0
121207,14,0,0
121208,days,0,0
121209,(,0,0
121210,Control,0,0
121211,),0,0
121212,versus,0,0
121213,4,0,0
121214,days,0,0
121215,(,0,0
121216,T2,0,0
121217,),0,0
121218,;,0,0
121219,P=0.01,0,0
121220,),0,0
121221,.,0,0
121222,CONCLUSION,0,0
121223,Performing,0,0
121224,a,0,0
121225,pre-transplant,0,1
121226,tacrolimus,0,0
121227,C,0,0
121228,(,0,0
121229,2,0,0
121230,),0,0
121231,does,0,0
121232,not,0,0
121233,significantly,0,0
121234,increase,0,0
121235,the,1,0
121236,high,1,0
121237,proportion,1,0
121238,of,1,0
121239,subjects,1,0
121240,achieving,1,0
121241,10,1,0
121242,ng/mL,1,0
121243,tacrolimus,1,0
121244,concentrations,1,1
121245,by,1,0
121246,day,1,0
121247,3,1,0
121248,using,0,0
121249,routine,0,0
121250,protocols,0,0
121251,.,0,0
121252,However,0,0
121253,",",0,0
121254,compared,0,0
121255,with,0,0
121256,standard,0,0
121257,care,0,0
121258,",",0,0
121259,performing,0,0
121260,a,0,0
121261,pre-transplant,0,1
121262,tacrolimus,0,0
121263,C,0,0
121264,(,0,0
121265,2,0,0
121266,),0,0
121267,does,0,0
121268,lead,0,0
121269,to,0,0
121270,patients,0,0
121271,achieving,0,0
121272,a,1,0
121273,whole-blood,1,0
121274,concentration,1,1
121275,of,1,1
121276,?10,1,1
121277,ng/mL,1,1
121278,sooner,0,0
121279,.,0,0
121280,Antimigraine,1,1
121281,efficacy,1,1
121282,of,0,1
121283,telcagepant,0,0
121284,based,0,0
121285,on,0,0
121286,patient,0,1
121287,'s,0,1
121288,historical,0,0
121289,triptan,0,0
121290,response,0,1
121291,.,0,0
121292,OBJECTIVE,0,0
121293,To,0,0
121294,evaluate,0,0
121295,whether,0,0
121296,the,0,0
121297,same,0,0
121298,or,0,0
121299,different,0,0
121300,patients,0,0
121301,respond,1,0
121302,to,1,0
121303,triptans,1,0
121304,and,0,0
121305,telcagepant,0,0
121306,.,0,1
121307,BACKGROUND,0,0
121308,Telcagepant,0,0
121309,is,0,0
121310,an,0,0
121311,oral,0,0
121312,calcitonin,0,1
121313,gene-related,0,1
121314,peptide,0,1
121315,receptor,0,1
121316,antagonist,0,0
121317,with,0,0
121318,acute,0,0
121319,antimigraine,1,1
121320,efficacy,1,1
121321,comparable,0,0
121322,to,0,0
121323,oral,0,0
121324,triptans,0,0
121325,.,0,0
121326,It,0,0
121327,is,0,0
121328,currently,0,0
121329,unknown,0,0
121330,whether,0,0
121331,migraine,0,0
121332,patients,0,0
121333,who,0,0
121334,can,0,0
121335,not,0,0
121336,be,0,0
121337,adequately,0,0
121338,helped,0,0
121339,with,0,0
121340,triptans,0,0
121341,might,0,0
121342,benefit,0,0
121343,from,0,0
121344,treatment,0,0
121345,with,0,0
121346,telcagepant,0,0
121347,.,0,0
121348,METHODS,0,0
121349,Post-hoc,0,0
121350,analysis,0,0
121351,of,0,0
121352,data,0,0
121353,from,0,0
121354,a,0,0
121355,randomized,0,0
121356,",",0,0
121357,controlled,0,0
121358,trial,0,0
121359,of,0,1
121360,telcagepant,0,0
121361,(,0,0
121362,150,0,0
121363,mg,0,0
121364,",",0,0
121365,300,0,0
121366,mg,0,0
121367,),0,0
121368,zolmitriptan,0,0
121369,5,0,0
121370,mg,0,0
121371,",",0,0
121372,or,0,1
121373,placebo,0,0
121374,for,0,0
121375,a,0,0
121376,moderate/severe,0,1
121377,migraine,0,0
121378,.,0,0
121379,Responder,0,0
121380,rates,0,1
121381,were,0,0
121382,analyzed,0,0
121383,according,0,0
121384,to,0,0
121385,patients,0,0
121386,',0,1
121387,self-reported,1,1
121388,historical,1,0
121389,triptan,1,0
121390,response,1,1
121391,(,1,1
121392,HTR,1,0
121393,),1,0
121394,:,1,0
121395,(,0,0
121396,1,0,0
121397,),0,0
121398,good,0,0
121399,HTR,0,1
121400,(,0,0
121401,N,0,0
121402,=,0,0
121403,660,0,0
121404,),0,0
121405,:,0,0
121406,response,0,1
121407,in,0,0
121408,75-100,0,0
121409,%,0,0
121410,of,0,0
121411,attacks,0,1
121412,;,0,0
121413,(,0,0
121414,2,0,0
121415,),0,0
121416,intermediate,0,0
121417,HTR,0,1
121418,(,0,0
121419,N,0,0
121420,=,0,0
121421,248,0,0
121422,),0,0
121423,:,0,0
121424,response,0,1
121425,in,0,0
121426,25-74,0,0
121427,%,0,0
121428,of,0,0
121429,attacks,0,1
121430,;,0,0
121431,(,0,0
121432,3,0,0
121433,),0,0
121434,poor,0,0
121435,HTR/no,0,1
121436,use,0,1
121437,(,0,0
121438,N,0,0
121439,=,0,0
121440,407,0,0
121441,),0,0
121442,:,0,0
121443,response,0,1
121444,in,0,0
121445,<,0,0
121446,25,0,0
121447,%,0,0
121448,of,0,0
121449,attacks,0,1
121450,",",0,1
121451,or,0,1
121452,patient,0,1
121453,did,0,0
121454,not,0,0
121455,take,0,0
121456,triptans,0,0
121457,.,0,0
121458,A,0,0
121459,limitation,0,0
121460,of,0,0
121461,the,0,0
121462,analysis,0,0
121463,is,0,0
121464,that,0,0
121465,the,0,0
121466,last,0,1
121467,subgroup,0,0
121468,comprised,0,0
121469,mainly,0,0
121470,(,0,0
121471,91,0,0
121472,%,0,0
121473,),0,0
121474,patients,0,0
121475,who,0,0
121476,reported,0,0
121477,that,0,0
121478,they,0,0
121479,did,0,0
121480,not,0,0
121481,take,0,0
121482,triptans,0,0
121483,",",0,0
121484,but,0,0
121485,it,0,0
121486,was,0,0
121487,not,0,0
121488,known,0,0
121489,whether,0,0
121490,these,0,0
121491,patients,0,0
121492,were,0,0
121493,triptan-na?ve,0,0
121494,or,0,1
121495,had,0,0
121496,previously,0,0
121497,used,0,0
121498,triptans,0,0
121499,and,0,1
121500,stopped,0,0
121501,taking,0,0
121502,them,0,0
121503,.,0,0
121504,RESULTS,0,0
121505,For,0,0
121506,zolmitriptan,0,0
121507,",",0,0
121508,2-hour,1,1
121509,pain,1,1
121510,relief,1,1
121511,rates,1,1
121512,were,0,0
121513,higher,0,0
121514,in,0,0
121515,the,0,0
121516,good,0,0
121517,HTR,0,1
121518,subgroup,0,0
121519,(,0,0
121520,116/162,0,0
121521,",",0,0
121522,72,0,0
121523,%,0,0
121524,),0,0
121525,than,0,0
121526,in,0,0
121527,the,0,0
121528,intermediate,0,0
121529,(,0,0
121530,29/62,0,0
121531,",",0,0
121532,47,0,0
121533,%,0,0
121534,),0,0
121535,and,0,1
121536,poor/no,0,1
121537,use,0,1
121538,(,0,0
121539,44/111,0,0
121540,",",0,0
121541,40,0,0
121542,%,0,0
121543,),0,0
121544,HTR,0,0
121545,subgroups,0,0
121546,.,0,0
121547,The,1,0
121548,2-hour,1,1
121549,pain,1,1
121550,relief,1,1
121551,rates,1,1
121552,were,0,0
121553,similar,0,0
121554,across,0,0
121555,HTR,0,0
121556,subgroups,0,0
121557,for,0,0
121558,telcagepant,0,0
121559,150,0,0
121560,mg,0,0
121561,(,0,0
121562,48-58,0,0
121563,%,0,0
121564,),0,0
121565,",",0,0
121566,300,0,0
121567,mg,0,0
121568,(,0,0
121569,52-58,0,0
121570,%,0,0
121571,),0,0
121572,",",0,1
121573,and,0,1
121574,placebo,0,0
121575,(,0,0
121576,26-31,0,0
121577,%,0,0
121578,),0,0
121579,.,0,0
121580,In,0,0
121581,the,0,0
121582,poor/no,0,1
121583,use,0,1
121584,HTR,0,1
121585,subgroup,0,0
121586,",",0,0
121587,more,0,0
121588,patients,0,0
121589,receiving,0,0
121590,telcagepant,0,0
121591,300,0,0
121592,mg,0,0
121593,(,0,0
121594,56/98,0,0
121595,",",0,0
121596,57.1,0,0
121597,%,0,0
121598,),0,0
121599,had,1,0
121600,2-hour,1,1
121601,pain,1,1
121602,relief,1,1
121603,than,0,0
121604,those,0,0
121605,receiving,0,0
121606,zolmitriptan,0,0
121607,(,0,0
121608,44/111,0,0
121609,",",0,0
121610,39.6,0,0
121611,%,0,0
121612,;,0,0
121613,odds,0,0
121614,ratio,0,1
121615,=,0,0
121616,2.11,0,0
121617,[,0,0
121618,95,0,0
121619,%,0,0
121620,CI,0,0
121621,:,0,0
121622,"1.20,3.71",0,0
121623,],0,0
121624,",",0,0
121625,P,0,0
121626,=,0,0
121627,.009,0,0
121628,),0,0
121629,;,0,0
121630,the,0,0
121631,percentage,0,1
121632,for,0,0
121633,telcagepant,0,0
121634,150,0,0
121635,mg,0,0
121636,(,0,0
121637,57/119,0,0
121638,",",0,0
121639,47.9,0,0
121640,%,0,0
121641,),0,0
121642,was,0,0
121643,not,0,0
121644,significantly,0,0
121645,different,0,0
121646,from,0,0
121647,zolmitriptan,0,0
121648,(,0,0
121649,odds,0,0
121650,ratio,0,1
121651,=,0,0
121652,1.41,0,0
121653,[,0,0
121654,95,0,0
121655,%,0,0
121656,CI,0,0
121657,:,0,0
121658,0.82,0,0
121659,",",0,0
121660,2.40,0,0
121661,],0,0
121662,",",0,0
121663,P,0,0
121664,=,0,0
121665,.211,0,0
121666,),0,0
121667,.,0,0
121668,CONCLUSIONS,0,0
121669,This,0,0
121670,suggests,0,0
121671,that,0,0
121672,different,0,0
121673,patients,0,0
121674,may,0,0
121675,respond,0,0
121676,to,0,0
121677,triptans,0,0
121678,or,0,0
121679,telcagepant,0,0
121680,300,0,0
121681,mg,0,0
121682,.,0,0
121683,Caution,0,0
121684,should,0,0
121685,be,0,0
121686,exercised,0,0
121687,in,0,0
121688,interpreting,0,0
121689,the,0,0
121690,results,0,0
121691,because,0,0
121692,of,0,0
121693,the,0,0
121694,post-hoc,0,0
121695,nature,0,0
121696,of,0,0
121697,the,0,0
121698,analysis,0,0
121699,(,0,0
121700,clinical,0,1
121701,trial,0,0
121702,registry,0,0
121703,:,0,0
121704,NCT00442936,0,0
121705,),0,0
121706,.,0,0
121707,[,0,0
121708,Management,0,0
121709,of,0,0
121710,the,0,0
121711,perineal,0,1
121712,wounds,0,0
121713,after,0,0
121714,abdominoperineal,0,0
121715,resection,0,0
121716,:,0,0
121717,simple,0,0
121718,drainage,0,1
121719,only,0,0
121720,or,0,0
121721,with,0,0
121722,continuous,0,0
121723,irrigation,0,0
121724,?,0,0
121725,],0,0
121726,.,0,0
121727,OBJECTIVE,0,0
121728,To,0,0
121729,compare,0,0
121730,the,0,0
121731,effects,0,0
121732,of,0,0
121733,presacral,0,1
121734,irrigation,0,1
121735,and,0,1
121736,simple,0,0
121737,drainage,0,1
121738,on,0,0
121739,the,0,0
121740,perineal,0,1
121741,wound,0,1
121742,healing,0,1
121743,in,0,0
121744,patients,0,0
121745,after,0,0
121746,abdominoperineal,0,0
121747,resection,0,0
121748,(,0,1
121749,APR,0,0
121750,),0,0
121751,.,0,0
121752,METHODS,0,0
121753,From,0,0
121754,October,0,0
121755,2004,0,0
121756,to,0,0
121757,August,0,0
121758,2009,0,0
121759,",",0,0
121760,patients,0,0
121761,with,0,0
121762,rectal,0,1
121763,cancer,0,0
121764,",",0,1
121765,ulcerative,0,1
121766,colitis,0,1
121767,or,0,1
121768,rectal,0,1
121769,gastrointestinal,0,1
121770,stromal,0,1
121771,tumor,0,0
121772,",",0,0
121773,who,0,0
121774,underwent,0,0
121775,APR,0,1
121776,or,0,1
121777,proctocolectomy,0,0
121778,",",0,1
121779,were,0,0
121780,randomized,0,0
121781,into,0,0
121782,two,0,0
121783,arms,0,0
121784,:,0,0
121785,simple,0,0
121786,drainage,0,1
121787,group,0,0
121788,(,0,0
121789,n,0,0
121790,=,0,0
121791,37,0,0
121792,),0,0
121793,and,0,0
121794,continuous,0,1
121795,irrigation,0,1
121796,(,0,0
121797,n,0,0
121798,=,0,0
121799,37,0,0
121800,),0,0
121801,.,0,0
121802,Patients,0,0
121803,randomized,0,0
121804,to,0,0
121805,arm,0,0
121806,B,0,0
121807,received,0,0
121808,simple,0,0
121809,drainage,0,1
121810,only,0,0
121811,to,0,0
121812,presacral,0,0
121813,space,0,0
121814,;,0,0
121815,while,0,0
121816,those,0,0
121817,patients,0,0
121818,in,0,0
121819,arm,0,0
121820,A,0,0
121821,received,0,0
121822,continuous,0,0
121823,irrigation,0,1
121824,in,0,0
121825,addition,0,0
121826,to,0,0
121827,simple,0,0
121828,drainage,0,1
121829,.,0,0
121830,Perineal,0,1
121831,wound,0,1
121832,healing,0,1
121833,was,0,0
121834,taken,0,0
121835,as,0,0
121836,endpoint,0,0
121837,of,0,0
121838,this,0,0
121839,study,0,0
121840,.,0,0
121841,Major,0,1
121842,complication,0,1
121843,was,0,0
121844,defined,0,1
121845,as,0,0
121846,wound,1,1
121847,dehiscence,1,1
121848,or,1,1
121849,wound,1,1
121850,infection,1,1
121851,that,1,0
121852,the,1,0
121853,perineal,1,0
121854,wound,1,0
121855,should,1,0
121856,be,1,0
121857,reopened,1,0
121858,for,1,0
121859,drainage,1,0
121860,.,1,0
121861,Minor,0,1
121862,complication,0,1
121863,was,0,0
121864,defined,0,1
121865,as,0,0
121866,delayed,1,1
121867,healing,1,1
121868,wound,1,1
121869,with,1,0
121870,seroma,1,1
121871,or,1,0
121872,hematoma,1,1
121873,.,1,0
121874,RESULTS,0,0
121875,A,0,0
121876,total,0,0
121877,of,0,0
121878,74,0,0
121879,patients,0,0
121880,were,0,0
121881,enrolled,0,0
121882,in,0,0
121883,present,0,0
121884,study,0,0
121885,",",0,0
121886,with,0,0
121887,37,0,0
121888,patients,0,0
121889,in,0,0
121890,each,0,0
121891,arm,0,0
121892,",",0,1
121893,and,0,1
121894,there,0,0
121895,were,0,0
121896,12,0,0
121897,cases,0,0
121898,and,0,0
121899,10,0,0
121900,cases,0,0
121901,who,0,0
121902,received,0,0
121903,preoperative,0,1
121904,radiation,0,1
121905,therapy,0,0
121906,",",0,0
121907,respectively,0,0
121908,.,0,0
121909,In,0,0
121910,the,0,0
121911,arm,0,0
121912,A,0,0
121913,",",0,0
121914,2,0,0
121915,patients,0,0
121916,developed,0,0
121917,major,0,1
121918,complications,0,1
121919,",",0,0
121920,3,0,0
121921,patients,0,0
121922,incurred,0,0
121923,with,0,0
121924,minor,0,0
121925,complications,0,1
121926,and,0,0
121927,32,0,0
121928,patients,0,0
121929,got,0,0
121930,primary,0,0
121931,healing,1,1
121932,of,0,0
121933,the,0,0
121934,perineal,0,1
121935,wounds,0,0
121936,.,0,0
121937,In,0,0
121938,arm,0,0
121939,B,0,0
121940,",",0,0
121941,8,0,0
121942,patients,0,0
121943,suffered,0,0
121944,major,0,1
121945,complications,0,1
121946,",",0,0
121947,3,0,0
121948,patients,0,0
121949,incurred,0,0
121950,with,0,0
121951,minor,0,0
121952,complications,0,1
121953,and,0,0
121954,26,0,0
121955,patients,0,0
121956,got,0,0
121957,primary,0,0
121958,healing,0,1
121959,of,0,0
121960,the,0,0
121961,perineal,0,0
121962,wounds,0,0
121963,.,0,0
121964,The,0,0
121965,incidence,1,1
121966,of,1,0
121967,major,1,1
121968,complication,1,1
121969,was,0,0
121970,significantly,0,0
121971,lower,0,0
121972,in,0,0
121973,arm,0,0
121974,A,0,0
121975,(,0,0
121976,5.4,0,0
121977,%,0,0
121978,vs.21.6,0,0
121979,%,0,0
121980,",",0,1
121981,P,0,0
121982,=,0,0
121983,0.042,0,0
121984,),0,0
121985,.,0,0
121986,Patients,0,0
121987,received,0,0
121988,preoperative,0,1
121989,radiation,0,1
121990,therapy,0,0
121991,had,0,0
121992,significantly,0,0
121993,higher,0,0
121994,rate,1,1
121995,of,1,1
121996,minor,1,0
121997,complications,1,1
121998,than,0,0
121999,patients,0,0
122000,underwent,0,0
122001,surgery,0,0
122002,only,0,0
122003,(,0,0
122004,18.2,0,0
122005,%,0,0
122006,vs.,0,0
122007,3.9,0,0
122008,%,0,0
122009,",",0,0
122010,P,0,0
122011,=,0,0
122012,0.039,0,0
122013,),0,0
122014,.,0,0
122015,CONCLUSIONS,0,0
122016,Simple,0,0
122017,drainage,0,1
122018,with,0,0
122019,continuous,0,0
122020,irrigation,0,0
122021,of,0,0
122022,the,0,0
122023,presacral,0,1
122024,space,0,1
122025,",",0,0
122026,in,0,0
122027,patients,0,0
122028,with,0,0
122029,abdominoperineal,0,0
122030,resection,0,1
122031,or,0,1
122032,proctocolectomy,0,0
122033,",",0,0
122034,could,0,0
122035,significantly,0,0
122036,lower,0,0
122037,the,0,0
122038,incidence,0,1
122039,of,0,0
122040,major,0,1
122041,complication,0,1
122042,and,0,1
122043,improve,0,0
122044,wound,0,1
122045,healing,0,1
122046,for,0,0
122047,perineal,0,1
122048,wound,0,1
122049,when,0,0
122050,compared,0,0
122051,with,0,0
122052,simple,0,0
122053,drainage,0,0
122054,only,0,0
122055,.,0,0
122056,Preoperative,0,1
122057,radiation,0,0
122058,therapy,0,0
122059,tends,0,0
122060,to,0,0
122061,increase,0,0
122062,the,0,0
122063,incidence,0,1
122064,of,0,0
122065,minor,0,0
122066,complications,0,1
122067,.,0,0
122068,The,0,0
122069,effect,0,0
122070,of,0,0
122071,prophylactic,0,0
122072,calcium,0,1
122073,and,0,1
122074,magnesium,0,0
122075,infusions,0,0
122076,on,0,0
122077,the,0,0
122078,incidence,0,1
122079,of,0,1
122080,neurotoxicity,0,1
122081,and,0,1
122082,clinical,0,1
122083,outcome,0,1
122084,of,0,1
122085,oxaliplatin-based,0,0
122086,systemic,0,1
122087,treatment,0,0
122088,in,0,0
122089,advanced,0,0
122090,colorectal,0,0
122091,cancer,0,0
122092,patients,0,0
122093,.,0,0
122094,BACKGROUND,0,0
122095,Peripheral,0,1
122096,sensory,0,1
122097,neurotoxicity,0,1
122098,is,0,0
122099,a,0,0
122100,frequent,0,1
122101,and,0,0
122102,potentially,0,0
122103,debilitating,0,0
122104,side,0,1
122105,effect,0,1
122106,of,0,1
122107,oxaliplatin,0,0
122108,treatment,0,0
122109,.,0,1
122110,Calcium,0,1
122111,and,0,1
122112,magnesium,0,0
122113,(,0,1
122114,Ca/Mg,0,0
122115,),0,0
122116,infusions,0,0
122117,are,0,0
122118,frequently,0,0
122119,used,0,0
122120,to,0,0
122121,prevent,0,0
122122,this,0,0
122123,toxicity,0,1
122124,.,0,0
122125,However,0,0
122126,",",0,0
122127,concerns,0,0
122128,about,0,0
122129,a,0,0
122130,negative,0,1
122131,impact,0,0
122132,of,0,1
122133,Ca/Mg,0,0
122134,infusions,0,0
122135,on,0,0
122136,outcome,0,0
122137,have,0,0
122138,been,0,0
122139,raised,0,0
122140,.,0,0
122141,We,0,0
122142,retrospectively,0,0
122143,assessed,0,0
122144,the,0,0
122145,effect,0,1
122146,of,0,0
122147,Ca/Mg,0,0
122148,infusions,0,0
122149,on,0,0
122150,the,0,0
122151,incidence,1,1
122152,of,1,1
122153,neurotoxicity,1,1
122154,and,0,1
122155,on,0,0
122156,clinical,1,1
122157,outcome,1,1
122158,in,0,0
122159,advanced,0,0
122160,colorectal,0,0
122161,cancer,0,0
122162,(,0,1
122163,ACC,0,1
122164,),0,0
122165,patients,0,0
122166,treated,0,0
122167,in,0,0
122168,the,0,0
122169,phase,0,0
122170,III,0,1
122171,CAIRO2,0,0
122172,study,0,0
122173,.,0,1
122174,MATERIALS,0,0
122175,AND,0,0
122176,METHODS,0,0
122177,Seven,0,1
122178,hundred,0,0
122179,and,0,0
122180,fifty,0,0
122181,five,0,0
122182,previously,0,0
122183,untreated,0,0
122184,ACC,0,1
122185,patients,0,0
122186,were,0,0
122187,randomised,0,0
122188,between,0,0
122189,treatment,0,0
122190,with,0,0
122191,capecitabine,0,0
122192,",",0,1
122193,oxaliplatin,0,0
122194,and,0,1
122195,bevacizumab,0,0
122196,or,0,0
122197,the,0,0
122198,same,0,0
122199,combination,0,0
122200,with,0,0
122201,the,0,0
122202,addition,0,0
122203,of,0,0
122204,cetuximab,0,0
122205,.,0,1
122206,Patients,0,0
122207,were,0,0
122208,retrospectively,0,0
122209,divided,0,0
122210,into,0,0
122211,two,0,0
122212,groups,0,0
122213,:,0,0
122214,patients,0,0
122215,in,0,0
122216,the,0,0
122217,Ca/Mg,0,0
122218,(,0,0
122219,+,0,0
122220,),0,1
122221,group,0,0
122222,received,0,0
122223,Ca/Mg,0,0
122224,at,0,0
122225,least,0,0
122226,during,0,0
122227,their,0,0
122228,first,0,1
122229,treatment,0,0
122230,cycle,0,1
122231,",",0,1
122232,and,0,1
122233,patients,0,0
122234,in,0,0
122235,the,0,0
122236,Ca/Mg,0,0
122237,(,0,0
122238,-,0,0
122239,),0,1
122240,group,0,0
122241,did,0,0
122242,not,0,0
122243,.,0,0
122244,RESULTS,0,0
122245,Seven,0,0
122246,hundred,0,0
122247,and,0,0
122248,thirty,0,0
122249,two,0,0
122250,patients,0,0
122251,were,0,0
122252,evaluable,0,0
122253,for,0,0
122254,this,0,0
122255,analysis,0,0
122256,.,0,0
122257,The,0,0
122258,Ca/Mg,0,0
122259,(,0,0
122260,+,0,0
122261,),0,1
122262,group,0,0
122263,consisted,0,0
122264,of,0,0
122265,551,0,0
122266,patients,0,0
122267,",",0,0
122268,the,0,0
122269,Ca/Mg,0,0
122270,(,0,0
122271,-,0,0
122272,),0,1
122273,group,0,0
122274,consisted,0,0
122275,of,0,0
122276,181,0,0
122277,patients,0,0
122278,.,0,0
122279,The,0,0
122280,incidence,0,1
122281,of,0,0
122282,all,1,0
122283,grade,1,1
122284,neurotoxicity,1,1
122285,in,0,0
122286,the,0,0
122287,Ca/Mg,0,0
122288,(,0,0
122289,+,0,0
122290,),0,1
122291,group,0,0
122292,and,0,0
122293,the,0,0
122294,Ca/Mg,0,0
122295,(,0,0
122296,-,0,0
122297,),0,1
122298,group,0,0
122299,was,0,0
122300,85,0,0
122301,%,0,0
122302,and,0,0
122303,92,0,0
122304,%,0,0
122305,",",0,0
122306,respectively,0,0
122307,(,0,0
122308,p,0,0
122309,=,0,0
122310,0.02,0,0
122311,),0,0
122312,",",0,0
122313,and,0,0
122314,the,0,0
122315,incidence,0,1
122316,of,0,0
122317,grade,0,1
122318,?,0,0
122319,2,0,0
122320,neurotoxicity,1,1
122321,was,1,0
122322,40,0,0
122323,%,0,0
122324,and,0,0
122325,45,0,0
122326,%,0,0
122327,",",0,0
122328,respectively,0,0
122329,(,0,0
122330,p,0,0
122331,=,0,0
122332,0.22,0,0
122333,),0,0
122334,.,0,0
122335,The,1,0
122336,median,1,1
122337,PFS,1,1
122338,in,1,0
122339,the,0,0
122340,Ca/Mg,0,0
122341,(,0,0
122342,+,0,0
122343,),0,1
122344,versus,0,0
122345,Ca/Mg,0,0
122346,(,0,0
122347,-,0,0
122348,),0,1
122349,group,0,0
122350,was,0,0
122351,10.1,0,0
122352,versus,0,0
122353,10.7,0,0
122354,months,0,0
122355,(,0,0
122356,p,0,0
122357,=,0,0
122358,0.92,0,0
122359,),0,0
122360,",",0,0
122361,the,0,0
122362,median,0,1
122363,OS,0,1
122364,was,0,0
122365,19.8,0,0
122366,versus,0,0
122367,20.7,0,0
122368,months,0,0
122369,(,0,0
122370,p,0,0
122371,=,0,0
122372,0.10,0,0
122373,),0,0
122374,",",0,0
122375,and,0,0
122376,the,0,0
122377,response,0,1
122378,rate,0,1
122379,was,0,0
122380,43.1,0,0
122381,%,0,0
122382,versus,0,0
122383,50,0,0
122384,%,0,0
122385,(,0,0
122386,p,0,0
122387,=,0,0
122388,0.11,0,0
122389,),0,0
122390,",",0,0
122391,respectively,0,0
122392,.,0,0
122393,CONCLUSIONS,0,0
122394,In,0,0
122395,this,0,0
122396,largest,0,0
122397,retrospective,0,0
122398,analysis,0,0
122399,to,0,0
122400,date,0,0
122401,we,0,0
122402,observed,0,0
122403,that,0,0
122404,Ca/Mg,0,0
122405,infusions,0,0
122406,significantly,0,0
122407,reduced,0,0
122408,all,0,0
122409,grade,0,1
122410,oxaliplatin-related,0,0
122411,neurotoxicity,0,1
122412,.,0,0
122413,Ca/Mg,0,0
122414,infusions,0,1
122415,did,0,0
122416,not,0,0
122417,affect,0,0
122418,the,0,0
122419,clinical,0,0
122420,efficacy,0,1
122421,of,0,0
122422,treatment,0,0
122423,.,0,0
122424,Inhibin,0,1
122425,A,0,0
122426,is,0,0
122427,down-regulated,0,0
122428,during,0,0
122429,chemotherapy,0,0
122430,in,0,0
122431,patients,0,0
122432,with,0,0
122433,breast,0,0
122434,cancer,0,0
122435,.,0,0
122436,BACKGROUND,0,0
122437,Inhibins,0,1
122438,are,0,0
122439,dimeric,0,1
122440,glycoproteins,0,1
122441,",",0,0
122442,composed,0,0
122443,of,0,0
122444,an,0,0
122445,alpha-subunit,0,0
122446,(,0,0
122447,INH-?,0,1
122448,),0,0
122449,and,0,0
122450,one,0,0
122451,of,0,0
122452,two,0,0
122453,possible,0,0
122454,beta-subunits,0,0
122455,(,0,0
122456,?A,0,1
122457,or,0,0
122458,?B,0,0
122459,),0,1
122460,",",0,0
122461,with,0,0
122462,substantial,0,0
122463,roles,0,0
122464,in,0,0
122465,human,0,0
122466,reproduction,0,1
122467,and,0,1
122468,in,0,0
122469,endocrine-responsive,0,0
122470,tumours,0,0
122471,.,0,0
122472,Aims,0,0
122473,of,0,0
122474,this,0,0
122475,study,0,0
122476,were,0,0
122477,to,0,0
122478,determine,0,0
122479,the,0,0
122480,serological,0,1
122481,measurement,0,1
122482,of,0,1
122483,inhibin,1,1
122484,A,1,0
122485,(,1,1
122486,?-?A,1,0
122487,),1,0
122488,in,1,0
122489,breast,1,0
122490,cancer,0,0
122491,patients,0,0
122492,during,0,0
122493,chemotherapy,0,0
122494,.,0,1
122495,PATIENTS,0,0
122496,AND,0,0
122497,METHODS,0,0
122498,A,0,0
122499,series,0,0
122500,of,0,0
122501,30,0,0
122502,breast,0,0
122503,cancer,0,0
122504,patients,0,0
122505,who,0,0
122506,underwent,0,0
122507,standardised,0,0
122508,chemotherapy,0,0
122509,were,0,0
122510,prospectively,0,0
122511,evaluated,0,0
122512,before,0,0
122513,chemotherapeutic,0,0
122514,treatment,0,0
122515,as,0,0
122516,well,0,0
122517,as,0,0
122518,four,0,0
122519,weeks,0,0
122520,after,0,0
122521,chemotherapy,0,0
122522,and,0,0
122523,two,0,0
122524,years,0,0
122525,after,0,0
122526,chemotherapy,0,0
122527,for,0,0
122528,the,0,0
122529,serological,0,1
122530,expression,0,1
122531,of,0,1
122532,inhibin,0,1
122533,A,0,0
122534,.,0,0
122535,For,0,0
122536,statistical,0,0
122537,analysis,1,0
122538,the,1,0
122539,Wilcoxon,1,0
122540,rank,1,1
122541,sum,1,1
122542,test,1,1
122543,was,0,0
122544,used,0,0
122545,for,0,0
122546,paired,0,0
122547,samples,0,0
122548,.,0,0
122549,Statistical,0,0
122550,significance,0,1
122551,was,0,0
122552,assumed,0,0
122553,at,0,0
122554,p,0,0
122555,<,0,0
122556,0.05,0,0
122557,.,0,0
122558,RESULTS,1,0
122559,The,1,0
122560,concentration,1,1
122561,of,1,0
122562,inhibin,1,1
122563,A,1,0
122564,showed,1,0
122565,a,0,0
122566,significant,0,0
122567,decrease,0,1
122568,between,0,0
122569,data,0,0
122570,obtained,0,0
122571,before,0,0
122572,chemotherapy,0,0
122573,and,0,1
122574,after,0,0
122575,chemotherapy,0,0
122576,(,0,0
122577,p,0,0
122578,<,0,0
122579,0.005,0,0
122580,),0,0
122581,and,0,0
122582,two-year,0,0
122583,follow-up,0,0
122584,(,0,0
122585,p,0,0
122586,<,0,0
122587,0.001,0,0
122588,),0,0
122589,.,0,0
122590,Interestingly,0,0
122591,",",0,0
122592,there,0,0
122593,were,0,0
122594,no,0,0
122595,differences,1,0
122596,in,1,0
122597,inhibin,1,1
122598,A,1,0
122599,concentrations,1,1
122600,between,1,0
122601,the,0,0
122602,four-week,0,0
122603,and,0,1
122604,two-year,0,0
122605,follow-up,0,1
122606,(,0,1
122607,p=0.744,0,0
122608,),0,0
122609,.,0,0
122610,DISCUSSION,0,1
122611,Chemotherapy,0,0
122612,significantly,0,0
122613,decreases,0,0
122614,inhibin,0,1
122615,A,0,0
122616,concentration,0,1
122617,during,0,0
122618,chemotherapy,0,0
122619,.,0,0
122620,This,0,0
122621,might,0,0
122622,reflect,0,0
122623,a,0,0
122624,suppression,0,1
122625,of,0,0
122626,ovarian,0,1
122627,function,0,1
122628,",",0,0
122629,being,0,0
122630,also,0,0
122631,a,0,0
122632,marker,0,1
122633,for,0,0
122634,chemotherapy-induced,0,0
122635,amenorrhoea,0,1
122636,.,0,0
122637,Moreover,0,0
122638,",",0,0
122639,it,0,0
122640,has,0,0
122641,been,0,0
122642,suggested,0,0
122643,that,0,0
122644,inhibin,0,0
122645,A,0,0
122646,might,0,0
122647,be,0,0
122648,a,0,0
122649,tumour,0,1
122650,marker,0,1
122651,for,0,0
122652,breast,0,0
122653,cancer,0,1
122654,",",0,1
122655,and,0,0
122656,therefore,0,0
122657,a,0,0
122658,sudden,0,1
122659,increase,0,0
122660,in,0,0
122661,its,0,0
122662,concentration,0,1
122663,might,0,0
122664,be,0,0
122665,indicative,0,0
122666,of,0,0
122667,breast,0,0
122668,cancer,0,0
122669,recurrence,0,1
122670,.,0,0
122671,Mechanisms,0,0
122672,underlying,0,0
122673,the,0,0
122674,lack,0,0
122675,of,0,0
122676,effect,0,1
122677,of,0,0
122678,implantable,0,0
122679,cardioverter-defibrillator,0,0
122680,therapy,0,0
122681,on,0,0
122682,mortality,1,1
122683,in,0,0
122684,high-risk,0,0
122685,patients,0,0
122686,with,0,0
122687,recent,0,0
122688,myocardial,0,1
122689,infarction,0,1
122690,:,0,0
122691,insights,0,0
122692,from,0,0
122693,the,0,0
122694,Defibrillation,0,0
122695,in,0,0
122696,Acute,0,1
122697,Myocardial,0,1
122698,Infarction,0,1
122699,Trial,0,0
122700,(,0,1
122701,DINAMIT,0,0
122702,),0,0
122703,.,0,0
122704,BACKGROUND,0,0
122705,although,0,0
122706,implantable,0,0
122707,cardioverter-defibrillators,0,0
122708,(,0,0
122709,ICDs,0,1
122710,),0,1
122711,lower,0,1
122712,mortality,0,1
122713,in,0,0
122714,stable,0,1
122715,patients,0,0
122716,with,0,0
122717,low,0,0
122718,ejection,0,1
122719,fraction,0,1
122720,late,0,1
122721,after,0,0
122722,myocardial,0,1
122723,infarction,0,1
122724,",",0,0
122725,randomized,0,0
122726,trials,0,0
122727,of,0,0
122728,ICD,0,0
122729,versus,0,0
122730,control,0,0
122731,subjects,0,0
122732,implanted,0,0
122733,early,0,0
122734,after,0,0
122735,myocardial,0,1
122736,infarction,0,0
122737,do,0,0
122738,not,0,0
122739,show,0,0
122740,mortality,0,1
122741,benefit,0,0
122742,.,0,0
122743,Our,0,0
122744,objective,0,0
122745,was,0,0
122746,to,0,0
122747,investigate,0,0
122748,possible,0,0
122749,mechanisms,0,0
122750,underlying,0,0
122751,the,0,0
122752,lack,0,0
122753,of,0,1
122754,mortality,1,1
122755,benefit,0,0
122756,in,0,0
122757,the,0,0
122758,Defibrillation,0,0
122759,in,0,0
122760,Acute,0,1
122761,Myocardial,0,1
122762,Infarction,0,1
122763,Trial,0,0
122764,(,0,1
122765,DINAMIT,0,0
122766,),0,0
122767,.,0,0
122768,METHODS,0,0
122769,AND,0,0
122770,RESULTS,0,0
122771,this,0,0
122772,is,0,0
122773,a,0,0
122774,secondary,0,0
122775,analysis,0,0
122776,of,0,0
122777,the,0,0
122778,prospective,0,0
122779,randomized,0,0
122780,clinical,0,0
122781,trial,0,0
122782,.,0,0
122783,Outpatients,0,0
122784,with,0,0
122785,recent,0,0
122786,(,0,0
122787,6,0,0
122788,to,0,0
122789,40,0,0
122790,days,0,0
122791,),0,0
122792,acute,0,0
122793,myocardial,0,1
122794,infarction,0,1
122795,",",0,1
122796,left,0,1
122797,ventricular,0,1
122798,dysfunction,0,1
122799,(,0,0
122800,ejection,0,1
122801,fraction,0,1
122802,<,0,0
122803,35,0,0
122804,%,0,0
122805,),0,0
122806,",",0,1
122807,and,0,1
122808,low,0,1
122809,heart,0,1
122810,rate,0,1
122811,variability,0,1
122812,were,0,0
122813,randomized,0,0
122814,to,0,0
122815,ICD,0,0
122816,(,0,1
122817,n=311,0,0
122818,),0,1
122819,or,0,0
122820,to,0,0
122821,standard,0,0
122822,medical,0,1
122823,therapy,0,0
122824,(,0,1
122825,n=342,0,0
122826,),0,0
122827,.,0,0
122828,In,0,0
122829,a,0,0
122830,competing-risks,0,0
122831,analysis,0,0
122832,",",0,0
122833,those,0,0
122834,factors,0,1
122835,that,0,0
122836,increased,0,0
122837,the,0,0
122838,risk,1,1
122839,of,1,0
122840,arrhythmic,1,1
122841,death,1,1
122842,also,0,0
122843,increased,0,0
122844,the,0,0
122845,risk,1,1
122846,of,1,0
122847,nonarrhythmic,1,0
122848,deaths,1,1
122849,.,1,0
122850,After,0,0
122851,adjustment,0,0
122852,for,0,0
122853,these,0,0
122854,factors,0,0
122855,",",0,0
122856,receiving,0,0
122857,an,0,0
122858,ICD,0,0
122859,was,0,0
122860,associated,0,0
122861,with,0,0
122862,a,0,0
122863,decreased,0,1
122864,risk,1,1
122865,of,1,1
122866,arrhythmic,1,1
122867,death,1,1
122868,(,0,0
122869,hazard,0,1
122870,ratio,0,1
122871,",",0,0
122872,0.33,0,0
122873,;,0,0
122874,95,0,0
122875,%,0,0
122876,confidence,0,0
122877,interval,0,0
122878,",",0,0
122879,0.15,0,0
122880,to,0,0
122881,0.71,0,0
122882,),0,0
122883,but,0,0
122884,an,0,0
122885,increase,0,1
122886,in,0,0
122887,nonarrhythmic,1,1
122888,death,1,1
122889,(,0,0
122890,hazard,0,1
122891,ratio,0,1
122892,",",0,0
122893,1.70,0,0
122894,;,0,0
122895,95,0,0
122896,%,0,0
122897,confidence,0,0
122898,interval,0,0
122899,",",0,0
122900,1.00,0,0
122901,to,0,0
122902,2.80,0,0
122903,),0,0
122904,.,0,0
122905,In,0,0
122906,an,0,0
122907,adjusted,0,0
122908,time-dependent,0,1
122909,analysis,0,0
122910,",",0,0
122911,patients,0,0
122912,receiving,0,0
122913,an,0,0
122914,ICD,0,0
122915,and,0,1
122916,having,0,0
122917,appropriate,0,1
122918,ICD,0,0
122919,therapy,0,0
122920,had,0,0
122921,a,0,0
122922,15.1,0,0
122923,%,0,0
122924,yearly,1,0
122925,hazard,1,0
122926,of,1,1
122927,mortality,1,1
122928,compared,0,0
122929,with,0,0
122930,5.2,0,0
122931,%,0,0
122932,in,0,0
122933,ICD,0,0
122934,patients,0,0
122935,with,0,0
122936,no,0,0
122937,appropriate,0,0
122938,therapy,0,0
122939,(,0,0
122940,P,0,0
122941,<,0,0
122942,0.001,0,0
122943,),0,0
122944,.,0,0
122945,The,0,0
122946,reduction,0,1
122947,in,0,0
122948,sudden,1,1
122949,death,1,1
122950,in,0,0
122951,ICD,0,0
122952,patients,0,0
122953,was,0,0
122954,completely,0,0
122955,offset,0,0
122956,by,0,0
122957,increased,0,0
122958,nonarrhythmic,1,1
122959,deaths,1,1
122960,",",0,1
122961,which,0,0
122962,were,0,0
122963,greatest,0,0
122964,in,0,0
122965,patients,0,0
122966,receiving,0,0
122967,ICD,0,0
122968,shock,0,1
122969,therapy,0,0
122970,(,0,1
122971,hazard,0,1
122972,ratio,0,1
122973,",",0,0
122974,6.0,0,0
122975,;,0,0
122976,95,0,0
122977,%,0,0
122978,confidence,0,0
122979,interval,0,0
122980,",",0,0
122981,2.8,0,0
122982,to,0,0
122983,12.7,0,0
122984,),0,0
122985,.,0,0
122986,CONCLUSIONS,0,0
122987,in,0,0
122988,patients,0,0
122989,receiving,0,0
122990,ICDs,0,0
122991,early,0,0
122992,after,0,0
122993,myocardial,0,1
122994,infarction,0,1
122995,",",0,0
122996,those,0,0
122997,factors,0,0
122998,that,0,0
122999,are,0,0
123000,associated,0,0
123001,with,0,0
123002,arrhythmia,0,1
123003,requiring,0,1
123004,ICD,0,0
123005,therapy,0,0
123006,are,0,0
123007,also,0,0
123008,associated,0,0
123009,with,0,0
123010,a,0,0
123011,high,0,0
123012,risk,0,1
123013,of,0,1
123014,nonsudden,1,1
123015,death,1,1
123016,",",0,0
123017,negating,0,1
123018,the,0,0
123019,benefit,0,0
123020,of,0,0
123021,ICDs,0,0
123022,in,0,0
123023,this,0,0
123024,setting,0,0
123025,.,0,0
123026,Right,0,0
123027,ventricular,0,1
123028,pacing,0,0
123029,in,0,0
123030,MADIT-II,0,0
123031,:,0,0
123032,a,0,0
123033,risk,0,1
123034,factor,0,1
123035,for,0,0
123036,increased,0,1
123037,mortality,1,1
123038,",",0,1
123039,or,0,0
123040,mainly,0,0
123041,a,0,0
123042,marker,1,1
123043,of,1,0
123044,increased,1,0
123045,risk,1,0
123046,.,1,0
123047,Cost-effectiveness,1,1
123048,of,0,1
123049,ablation,0,0
123050,surgery,0,0
123051,in,0,0
123052,patients,0,0
123053,with,0,0
123054,atrial,0,1
123055,fibrillation,0,1
123056,undergoing,0,0
123057,cardiac,0,1
123058,surgery,0,0
123059,.,0,0
123060,This,0,0
123061,study,0,0
123062,was,0,0
123063,performed,0,0
123064,to,0,0
123065,assess,0,0
123066,the,0,0
123067,cost-effectiveness,0,0
123068,of,0,0
123069,concomitant,0,0
123070,ablation,0,0
123071,surgery,0,0
123072,(,0,1
123073,AS,0,1
123074,),0,0
123075,compared,0,0
123076,to,0,0
123077,regular,0,0
123078,cardiac,0,1
123079,surgery,0,0
123080,in,0,0
123081,atrial,0,1
123082,fibrillation,0,1
123083,(,0,1
123084,AF,0,1
123085,),0,0
123086,patients,0,0
123087,over,0,0
123088,a,0,0
123089,one-year,0,1
123090,follow-up,0,0
123091,.,0,1
123092,Cost,1,0
123093,analysis,1,0
123094,was,0,0
123095,performed,0,0
123096,from,0,0
123097,a,0,0
123098,societal,0,1
123099,perspective,0,0
123100,alongside,0,0
123101,a,0,0
123102,prospective,0,0
123103,",",0,0
123104,randomised,0,0
123105,",",0,1
123106,double-blinded,0,0
123107,",",0,1
123108,multicentre,0,0
123109,trial,0,0
123110,.,0,0
123111,One,0,0
123112,hundred,0,0
123113,and,0,0
123114,fifty,0,0
123115,patients,0,0
123116,with,0,0
123117,documented,0,0
123118,AF,0,1
123119,were,0,0
123120,randomly,0,0
123121,assigned,0,0
123122,to,0,0
123123,undergo,0,0
123124,cardiac,0,1
123125,surgery,0,0
123126,with,0,0
123127,or,0,0
123128,without,0,0
123129,AS,0,1
123130,.,0,0
123131,One,0,0
123132,hundred,0,0
123133,and,0,0
123134,thirty-two,0,0
123135,patients,0,0
123136,were,0,0
123137,included,0,0
123138,in,0,0
123139,the,0,0
123140,cost-effectiveness,0,0
123141,study,0,0
123142,.,0,0
123143,All,1,0
123144,costs,1,1
123145,(,1,0
123146,medical,1,1
123147,and,1,1
123148,non-medical,1,1
123149,),1,1
123150,were,0,0
123151,measured,0,0
123152,during,0,0
123153,follow-up,0,0
123154,.,0,0
123155,Costs,1,0
123156,data,1,0
123157,were,0,0
123158,combined,0,0
123159,with,0,0
123160,quality,1,1
123161,adjusted,1,0
123162,life,1,1
123163,years,1,0
123164,(,0,1
123165,QALYs,0,1
123166,),0,0
123167,to,0,0
123168,obtain,0,0
123169,the,0,0
123170,incremental,0,0
123171,costs,0,1
123172,per,0,0
123173,QALY,0,0
123174,.,0,0
123175,Total,1,1
123176,costs,1,1
123177,of,0,0
123178,the,0,0
123179,AS,0,1
123180,group,0,0
123181,were,0,0
123182,significantly,0,0
123183,higher,0,0
123184,compared,0,0
123185,to,0,0
123186,the,0,0
123187,regular,0,0
123188,cardiac,0,1
123189,surgery,0,0
123190,group,0,0
123191,[,0,0
123192,cost,0,1
123193,difference,0,0
123194,bootstrap,0,0
123195,:,0,0
123196,"?4,724",0,0
123197,;,0,0
123198,95,0,0
123199,%,0,0
123200,uncertainty,0,1
123201,interval,0,0
123202,(,0,1
123203,UI,0,1
123204,),0,1
123205,",",0,0
123206,"?2,770-?6,678",0,0
123207,],0,0
123208,.,0,0
123209,The,0,0
123210,bootstrapped,0,0
123211,difference,1,0
123212,in,1,0
123213,QALYs,1,1
123214,was,0,0
123215,not,0,0
123216,statistically,0,0
123217,significant,0,0
123218,(,0,0
123219,0.06,0,0
123220,;,0,0
123221,95,0,0
123222,%,0,0
123223,UI,0,0
123224,:,0,0
123225,-0.024,0,0
123226,to,0,0
123227,0.14,0,0
123228,),0,0
123229,.,0,0
123230,The,0,0
123231,incremental,0,1
123232,cost-effectiveness,0,0
123233,ratio,0,1
123234,is,0,0
123235,"?73,359",0,0
123236,per,0,0
123237,QALY,1,0
123238,.,1,0
123239,The,1,0
123240,acceptability,0,1
123241,curve,0,1
123242,showed,0,0
123243,that,0,0
123244,",",0,0
123245,even,0,0
123246,in,0,0
123247,the,0,0
123248,case,0,0
123249,of,0,0
123250,a,0,0
123251,maximum,0,1
123252,threshold,0,1
123253,value,0,1
123254,of,0,1
123255,"?80,000",0,1
123256,per,1,0
123257,QALY,1,1
123258,gained,0,0
123259,",",0,0
123260,the,0,0
123261,probability,0,1
123262,of,0,0
123263,AS,0,1
123264,being,0,0
123265,more,0,0
123266,cost-effective,0,0
123267,than,0,0
123268,regular,0,0
123269,cardiac,0,1
123270,surgery,0,0
123271,did,0,0
123272,not,0,0
123273,reach,0,0
123274,beyond,0,0
123275,50,0,0
123276,%,0,0
123277,.,0,0
123278,Concluding,0,0
123279,that,0,0
123280,concomitant,0,0
123281,AS,0,1
123282,in,0,0
123283,AF,0,0
123284,is,0,0
123285,not,0,0
123286,cost-effective,0,0
123287,after,0,0
123288,a,0,0
123289,one-year,0,1
123290,follow-up,0,0
123291,compared,0,0
123292,to,0,0
123293,regular,0,0
123294,cardiac,0,1
123295,surgery,0,0
123296,.,0,0
123297,Comparison,0,0
123298,of,0,0
123299,different,0,0
123300,approaches,0,0
123301,for,0,0
123302,assessment,0,0
123303,of,0,1
123304,HER2,0,1
123305,expression,0,1
123306,on,0,0
123307,protein,0,1
123308,and,0,1
123309,mRNA,0,0
123310,level,0,1
123311,:,0,0
123312,prediction,0,1
123313,of,0,1
123314,chemotherapy,0,0
123315,response,0,1
123316,in,0,0
123317,the,0,0
123318,neoadjuvant,0,0
123319,GeparTrio,0,1
123320,trial,0,0
123321,(,0,1
123322,NCT00544765,0,0
123323,),0,0
123324,.,0,0
123325,Human,0,0
123326,epidermal,0,1
123327,growth,0,1
123328,factor,0,1
123329,receptor,0,0
123330,2,0,0
123331,(,0,0
123332,HER2,0,0
123333,),0,0
123334,testing,0,0
123335,is,0,0
123336,an,0,0
123337,essential,0,0
123338,part,0,0
123339,of,0,1
123340,pathological,0,1
123341,assessment,0,0
123342,in,0,0
123343,breast,0,0
123344,cancer,0,0
123345,patients,0,0
123346,",",0,0
123347,as,0,0
123348,HER2,0,0
123349,provides,0,0
123350,not,0,0
123351,only,0,0
123352,prognostic,0,1
123353,but,0,0
123354,also,0,0
123355,predictive,0,1
123356,information,0,1
123357,on,0,0
123358,response,0,1
123359,to,0,0
123360,targeted,0,0
123361,therapy,0,0
123362,.,0,0
123363,So,0,0
123364,far,0,0
123365,",",0,0
123366,HER2,0,1
123367,test,0,1
123368,accuracy,0,1
123369,of,0,1
123370,immunohistochemistry/in,0,0
123371,situ-hybridization,0,0
123372,techniques,0,0
123373,is,0,0
123374,still,0,0
123375,under,0,0
123376,debate,0,0
123377,",",0,1
123378,and,0,1
123379,more,0,1
123380,reliable,0,1
123381,and,0,1
123382,robust,0,0
123383,technologies,0,0
123384,are,0,0
123385,needed,0,0
123386,.,0,0
123387,To,0,0
123388,address,0,0
123389,this,0,0
123390,issue,0,0
123391,and,0,0
123392,to,0,0
123393,evaluate,0,0
123394,the,0,0
123395,predictive,0,1
123396,value,0,1
123397,of,0,1
123398,HER2,0,1
123399,on,0,0
123400,chemotherapy,0,0
123401,",",0,0
123402,we,0,0
123403,investigated,0,0
123404,a,0,0
123405,cohort,0,0
123406,of,0,0
123407,278,0,0
123408,patients,0,0
123409,from,0,0
123410,the,0,0
123411,GeparTrio,0,1
123412,trial,0,0
123413,",",0,0
123414,a,0,0
123415,prospective,0,0
123416,neoadjuvant,0,0
123417,anthracycline/taxane-based,0,0
123418,multicenter,0,0
123419,study,0,0
123420,.,0,0
123421,In,0,0
123422,the,0,0
123423,GeparTrio,0,1
123424,trial,0,0
123425,",",0,1
123426,patients,0,0
123427,were,0,0
123428,not,0,0
123429,treated,0,0
123430,with,0,0
123431,any,0,0
123432,anti-HER2,0,1
123433,therapy,0,0
123434,",",0,0
123435,as,0,0
123436,this,0,0
123437,was,0,0
123438,not,0,0
123439,standard,0,0
123440,therapy,0,0
123441,at,0,0
123442,this,0,0
123443,time,0,1
123444,.,0,0
123445,The,0,0
123446,HER2,1,1
123447,status,1,1
123448,was,0,0
123449,analyzed,0,0
123450,by,0,0
123451,three,0,0
123452,different,0,0
123453,approaches,0,0
123454,:,0,0
123455,local,0,0
123456,and,0,1
123457,central,0,1
123458,evaluation,0,0
123459,using,0,0
123460,immunohistochemistry,0,1
123461,combined,0,0
123462,with,0,0
123463,in,0,0
123464,situ-hybridization,0,0
123465,as,0,0
123466,well,0,0
123467,as,0,0
123468,evaluation,0,0
123469,of,0,0
123470,HER2,1,1
123471,mRNA,1,0
123472,expression,1,1
123473,using,0,0
123474,kinetic,0,1
123475,RT-PCR,0,0
123476,from,0,0
123477,formalin-fixed,0,0
123478,",",0,1
123479,paraffin-embedded,0,1
123480,(,0,1
123481,FFPE,0,1
123482,),0,1
123483,tissue,0,1
123484,samples,0,0
123485,using,0,0
123486,a,0,0
123487,predefined,0,0
123488,cutoff,0,0
123489,.,0,0
123490,HER2,1,1
123491,overexpression/amplification,1,1
123492,was,0,0
123493,observed,0,0
123494,in,0,0
123495,37.3,0,0
123496,%,0,0
123497,(,0,0
123498,91/244,0,0
123499,),0,0
123500,and,0,0
123501,17.9,0,0
123502,%,0,0
123503,(,0,0
123504,41/229,0,0
123505,),0,0
123506,of,0,0
123507,the,0,0
123508,informative,0,0
123509,samples,0,0
123510,in,0,0
123511,the,0,0
123512,local,0,0
123513,and,0,0
123514,central,0,1
123515,evaluations,0,1
123516,",",0,0
123517,respectively,0,0
123518,.,0,0
123519,Positive,1,1
123520,HER2,1,1
123521,mRNA,1,0
123522,levels,1,1
123523,were,0,0
123524,found,0,0
123525,in,0,0
123526,19.8,0,0
123527,%,0,0
123528,(,0,0
123529,55/278,0,0
123530,),0,0
123531,.,0,0
123532,We,0,0
123533,observed,0,0
123534,a,0,0
123535,highly,0,0
123536,significant,0,0
123537,correlation,1,0
123538,between,1,0
123539,central,1,1
123540,HER2,1,1
123541,expression,1,1
123542,and,1,1
123543,HER2,1,1
123544,status,1,1
123545,measured,1,1
123546,by,1,0
123547,kinetic,1,1
123548,RT-PCR,1,0
123549,(,0,0
123550,r,0,0
123551,=,0,0
123552,0.856,0,0
123553,",",0,0
123554,P,0,0
123555,<,0,0
123556,0.0001,0,0
123557,),0,0
123558,and,0,0
123559,an,0,0
123560,overall,0,1
123561,agreement,0,0
123562,of,0,0
123563,95.6,0,0
123564,%,0,0
123565,(,0,0
123566,?,0,0
123567,statistic,0,1
123568,",",0,0
123569,0.862,0,0
123570,",",0,0
123571,CI,0,0
123572,0.77-0.94,0,0
123573,),0,0
123574,.,0,1
123575,Further,0,1
123576,",",0,0
123577,central,1,1
123578,HER2,1,1
123579,as,1,0
123580,well,1,0
123581,as,1,0
123582,HER2,1,1
123583,mRNA,1,0
123584,expression,1,1
123585,were,1,0
123586,predictors,1,0
123587,for,1,0
123588,a,1,0
123589,pathological,1,1
123590,complete,1,1
123591,response,1,1
123592,after,1,0
123593,neoadjuvant,1,0
123594,anthracycline/taxane-based,1,0
123595,primary,1,0
123596,chemotherapy,1,0
123597,in,0,0
123598,a,0,0
123599,univariate,0,0
123600,binary,0,1
123601,logistic,0,1
123602,regression,0,1
123603,analysis,0,0
123604,(,0,0
123605,OR,0,0
123606,3.29,0,0
123607,",",0,0
123608,P,0,0
123609,=,0,0
123610,0.002,0,0
123611,;,0,0
123612,OR,0,0
123613,2.65,0,0
123614,",",0,0
123615,P,0,0
123616,=,0,0
123617,0.004,0,0
123618,),0,0
123619,.,0,0
123620,The,1,0
123621,predictive,1,0
123622,value,1,0
123623,could,0,0
123624,be,0,0
123625,confirmed,0,0
123626,for,0,0
123627,the,1,0
123628,central,1,1
123629,HER2,1,1
123630,status,1,1
123631,by,0,0
123632,multivariate,0,1
123633,analysis,0,0
123634,(,0,0
123635,OR,0,0
123636,3.04,0,0
123637,",",0,0
123638,P,0,0
123639,=,0,0
123640,0.027,0,0
123641,),0,0
123642,.,0,0
123643,The,1,0
123644,locally,1,0
123645,assessed,1,0
123646,HER2,1,1
123647,status,1,1
123648,was,1,0
123649,not,1,0
123650,predictive,1,1
123651,of,1,0
123652,response,1,1
123653,to,1,0
123654,chemotherapy,1,0
123655,.,1,0
123656,Our,0,0
123657,results,0,0
123658,suggest,0,0
123659,that,0,0
123660,standardized,0,0
123661,methods,0,0
123662,are,0,0
123663,preferable,0,0
123664,for,0,0
123665,evaluation,0,0
123666,of,0,1
123667,HER2,0,1
123668,status,0,1
123669,.,0,0
123670,The,0,0
123671,kinetic,0,1
123672,RT-PCR,0,0
123673,from,0,0
123674,FFPE,0,0
123675,tissue,0,0
123676,might,0,0
123677,be,0,0
123678,an,0,0
123679,additional,0,0
123680,approach,0,0
123681,for,0,0
123682,assessment,0,0
123683,of,0,0
123684,this,0,0
123685,important,0,1
123686,prognostic,0,1
123687,and,0,1
123688,predictive,0,1
123689,parameter,0,1
123690,but,0,0
123691,has,0,0
123692,to,0,0
123693,be,0,0
123694,confirmed,0,0
123695,by,0,0
123696,other,0,0
123697,studies,0,0
123698,.,0,0
123699,The,0,0
123700,dud,0,0
123701,effect,0,0
123702,:,0,0
123703,adding,0,0
123704,highly,0,0
123705,dissimilar,0,0
123706,fillers,0,0
123707,increases,0,1
123708,confidence,0,0
123709,in,0,0
123710,lineup,0,0
123711,identifications,0,1
123712,.,0,0
123713,Recent,0,0
123714,research,0,0
123715,in,0,0
123716,decision-making,0,1
123717,has,0,0
123718,demonstrated,0,0
123719,the,0,0
123720,dud-alternative,0,0
123721,effect,0,0
123722,--,0,0
123723,the,0,0
123724,tendency,0,0
123725,to,0,0
123726,become,0,0
123727,more,0,0
123728,confident,0,0
123729,that,0,0
123730,a,0,0
123731,chosen,0,0
123732,response,0,1
123733,option,0,0
123734,is,0,0
123735,correct,0,0
123736,if,0,0
123737,it,0,0
123738,is,0,0
123739,surrounded,0,0
123740,by,0,0
123741,implausible,0,0
123742,response,0,1
123743,options,0,0
123744,(,0,1
123745,Windschitl,0,1
123746,&,0,1
123747,Chambers,0,0
123748,",",0,1
123749,J,0,0
123750,Exp,0,0
123751,Psychol,0,0
123752,30:198-215,0,0
123753,",",0,0
123754,2004,0,0
123755,),0,0
123756,.,0,0
123757,This,0,0
123758,finding,0,0
123759,may,0,0
123760,be,0,0
123761,applicable,0,0
123762,to,0,0
123763,a,0,0
123764,lineup,0,0
123765,task,0,0
123766,:,0,0
123767,The,0,0
123768,presence,0,0
123769,of,0,1
123770,duds,0,0
123771,(,0,0
123772,i.e.,0,0
123773,",",0,0
123774,highly,0,0
123775,dissimilar,0,0
123776,fillers,0,0
123777,),0,0
123778,may,0,0
123779,increase,0,0
123780,a,0,0
123781,witness,1,1
123782,'s,1,1
123783,confidence,1,0
123784,that,0,0
123785,an,0,0
123786,identified,0,0
123787,(,0,0
123788,non-dud,0,0
123789,),0,1
123790,lineup,0,0
123791,member,0,0
123792,is,0,0
123793,the,0,0
123794,criminal,0,0
123795,.,0,0
123796,Four,0,1
123797,studies,0,0
123798,(,0,0
123799,N,0,0
123800,=,0,0
123801,665,0,0
123802,),0,0
123803,demonstrate,0,0
123804,that,0,0
123805,the,0,0
123806,mere,0,0
123807,presence,0,0
123808,of,0,0
123809,highly,0,0
123810,dissimilar,0,0
123811,fillers,0,0
123812,inflates,0,0
123813,witnesses,1,1
123814,',1,1
123815,confidence,1,0
123816,in,0,0
123817,a,0,0
123818,mistaken,0,0
123819,identification,0,1
123820,(,0,0
123821,Studies,0,0
123822,1-4,0,0
123823,),0,0
123824,",",0,0
123825,provides,0,0
123826,evidence,0,0
123827,that,0,0
123828,this,0,0
123829,confidence,1,0
123830,inflation,1,1
123831,is,0,0
123832,due,0,0
123833,to,0,0
123834,the,0,0
123835,duds,0,0
123836,inflating,0,0
123837,the,0,0
123838,perceived,0,1
123839,similarity,0,1
123840,of,0,0
123841,the,0,0
123842,other,0,0
123843,lineup,0,0
123844,members,0,0
123845,to,0,0
123846,the,0,0
123847,criminal,0,0
123848,(,0,0
123849,Studies,0,0
123850,2,0,0
123851,",",0,0
123852,3,0,0
123853,),0,0
123854,",",0,0
123855,and,0,0
123856,delineates,0,0
123857,some,0,0
123858,conditions,0,0
123859,under,0,0
123860,which,0,0
123861,the,0,0
123862,effect,0,0
123863,holds,0,0
123864,(,0,0
123865,Studies,0,0
123866,3,0,0
123867,",",0,0
123868,4,0,0
123869,),0,0
123870,.,0,0
123871,The,0,0
123872,addition,0,0
123873,of,0,0
123874,highly,0,0
123875,dissimilar,0,0
123876,lineup,0,1
123877,members,0,0
123878,",",0,0
123879,far,0,0
123880,from,0,0
123881,being,0,0
123882,inert,0,0
123883,",",0,0
123884,as,0,0
123885,is,0,0
123886,often,0,0
123887,implicitly,0,0
123888,assumed,0,0
123889,",",0,0
123890,can,0,0
123891,bias,0,1
123892,witnesses,0,1
123893,',0,1
123894,confidence,0,0
123895,reports,0,0
123896,.,0,0
123897,Clinical,0,1
123898,evaluation,0,0
123899,of,0,1
123900,Er,0,0
123901,",",0,0
123902,Cr,0,0
123903,:,0,1
123904,YSGG,0,1
123905,and,0,1
123906,GaAlAs,0,0
123907,laser,0,0
123908,therapy,0,0
123909,for,0,0
123910,treating,0,0
123911,dentine,1,0
123912,hypersensitivity,1,0
123913,:,1,0
123914,A,0,0
123915,randomized,0,0
123916,controlled,0,0
123917,clinical,0,0
123918,trial,0,0
123919,.,0,0
123920,OBJECTIVE,0,0
123921,The,0,0
123922,advent,0,0
123923,of,0,0
123924,dental,0,0
123925,lasers,0,0
123926,has,0,0
123927,raised,0,0
123928,another,0,0
123929,possible,0,0
123930,treatment,0,0
123931,option,0,0
123932,for,0,0
123933,dentine,1,1
123934,hypersensitivity,1,1
123935,(,1,1
123936,DH,1,1
123937,),1,0
123938,and,0,0
123939,has,0,0
123940,become,0,0
123941,a,0,0
123942,research,0,0
123943,interest,0,0
123944,in,0,0
123945,the,0,0
123946,last,0,0
123947,decades,0,0
123948,.,0,0
123949,The,0,0
123950,aim,0,0
123951,of,0,0
123952,this,0,0
123953,randomized,0,0
123954,",",0,0
123955,controlled,0,0
123956,",",0,1
123957,double-blind,0,0
123958,",",0,1
123959,split,0,0
123960,mouth,0,1
123961,",",0,1
123962,clinical,0,1
123963,study,0,0
123964,was,0,0
123965,to,0,0
123966,evaluate,1,0
123967,and,1,0
123968,compare,1,0
123969,the,0,0
123970,desensitizing,0,0
123971,effects,0,1
123972,of,0,1
123973,erbium,0,0
123974,",",0,0
123975,chromium-doped,0,0
123976,:,0,0
123977,yttrium,0,0
123978,",",0,1
123979,scandium,0,1
123980,",",0,1
123981,gallium,0,1
123982,and,0,1
123983,garnet,0,0
123984,(,0,1
123985,Er,0,0
123986,",",0,0
123987,Cr,0,0
123988,:,0,1
123989,YSGG,0,0
123990,),0,0
123991,to,0,0
123992,galium-aluminium-arsenide,0,0
123993,(,0,0
123994,GaAlAs,0,0
123995,),0,1
123996,laser,0,0
123997,on,0,0
123998,DH,0,0
123999,.,0,0
124000,METHODS,0,0
124001,Fifty-one,0,0
124002,patients,0,0
124003,participated,0,0
124004,in,0,0
124005,this,0,0
124006,study,0,0
124007,for,0,0
124008,a,0,0
124009,total,0,0
124010,of,0,0
124011,174,0,0
124012,teeth,0,0
124013,.,0,0
124014,DH,1,0
124015,was,1,0
124016,assessed,1,0
124017,for,0,0
124018,all,0,0
124019,groups,0,0
124020,with,0,0
124021,a,0,0
124022,visual,1,1
124023,analog,1,1
124024,scale,1,1
124025,.,1,0
124026,For,0,0
124027,each,0,0
124028,patient,0,0
124029,",",0,0
124030,the,0,0
124031,teeth,0,0
124032,were,0,0
124033,randomized,0,0
124034,to,0,0
124035,three,0,0
124036,groups,0,0
124037,.,0,0
124038,In,0,0
124039,the,0,0
124040,diode,0,0
124041,laser,0,0
124042,group,0,0
124043,",",0,1
124044,sensitive,0,0
124045,teeth,0,0
124046,were,0,0
124047,irradiated,0,0
124048,with,0,0
124049,the,0,0
124050,GaAlAs,0,0
124051,laser,0,0
124052,at,0,0
124053,8.5J/cm,0,0
124054,(,0,0
124055,2,0,0
124056,),0,0
124057,energy,0,0
124058,density,0,1
124059,.,0,0
124060,In,0,0
124061,the,0,0
124062,Er,0,0
124063,",",0,0
124064,Cr,0,0
124065,:,0,0
124066,YSGG,0,1
124067,laser,0,0
124068,group,0,0
124069,",",0,1
124070,sensitive,0,0
124071,teeth,0,0
124072,were,0,0
124073,irradiated,0,0
124074,with,0,0
124075,Er,0,0
124076,",",0,0
124077,Cr,0,0
124078,:,0,0
124079,YSGG,0,0
124080,laser,0,0
124081,in,0,0
124082,the,0,0
124083,hard,0,0
124084,tissue,0,1
124085,mode,0,0
124086,using,0,0
124087,a,0,0
124088,none-contact,0,0
124089,probe,0,0
124090,at,0,0
124091,an,0,0
124092,energy,0,1
124093,level,0,1
124094,of,0,0
124095,0.25W,0,0
124096,and,0,0
124097,repetition,0,1
124098,rate,0,1
124099,of,0,0
124100,20Hz,0,0
124101,",",0,0
124102,0,0,0
124103,%,0,0
124104,water,0,0
124105,and,0,0
124106,10,0,0
124107,%,0,0
124108,air,0,0
124109,.,0,0
124110,In,0,0
124111,the,0,0
124112,control,0,0
124113,group,0,0
124114,no,0,0
124115,treatment,0,0
124116,was,0,0
124117,performed,0,0
124118,.,0,0
124119,Treatment,0,0
124120,time,0,1
124121,was,0,0
124122,60s,0,0
124123,for,0,0
124124,GaAlAs,0,0
124125,laser,0,0
124126,and,0,0
124127,30s,0,1
124128,for,0,0
124129,Er,0,0
124130,",",0,0
124131,Cr,0,0
124132,:,0,0
124133,YSGG,0,0
124134,laser,0,0
124135,.,0,0
124136,RESULTS,0,0
124137,When,0,0
124138,compared,0,0
124139,with,0,0
124140,the,0,0
124141,control,0,0
124142,group,0,0
124143,and,0,1
124144,baseline,0,1
124145,data,0,0
124146,",",0,0
124147,in,0,0
124148,both,0,0
124149,laser,0,0
124150,groups,0,0
124151,",",0,1
124152,laser,0,0
124153,irradiation,0,0
124154,provided,0,0
124155,a,0,0
124156,desensitizing,1,0
124157,effect,1,0
124158,immediately,0,0
124159,after,0,0
124160,treatment,0,0
124161,and,0,0
124162,this,0,0
124163,effect,0,1
124164,was,0,0
124165,maintained,0,0
124166,throughout,0,0
124167,the,0,0
124168,study,0,0
124169,(,0,0
124170,p,0,0
124171,<,0,0
124172,0.05,0,0
124173,),0,0
124174,.,0,0
124175,No,0,0
124176,significant,0,0
124177,differences,0,0
124178,between,0,0
124179,Er,0,0
124180,",",0,0
124181,Cr,0,0
124182,:,0,1
124183,YSGG,0,1
124184,and,0,1
124185,GaAlAs,0,0
124186,laser,0,0
124187,groups,0,0
124188,were,0,0
124189,found,0,0
124190,at,0,0
124191,any,0,0
124192,follow-up,0,0
124193,examination,0,0
124194,(,0,0
124195,p,0,0
124196,>,0,0
124197,0.05,0,0
124198,),0,0
124199,.,0,0
124200,CONCLUSION,0,0
124201,Based,0,0
124202,on,0,0
124203,these,0,0
124204,findings,0,0
124205,",",0,0
124206,it,0,0
124207,may,0,0
124208,be,0,0
124209,concluded,0,0
124210,that,0,0
124211,both,0,0
124212,Er,0,0
124213,",",0,0
124214,Cr,0,0
124215,:,0,1
124216,YSGG,0,1
124217,and,0,1
124218,GaAlAs,0,0
124219,lasers,0,0
124220,were,0,0
124221,effective,1,0
124222,in,0,0
124223,the,0,0
124224,treatment,0,0
124225,of,0,0
124226,DH,0,0
124227,following,0,0
124228,a,0,0
124229,single,0,0
124230,application,0,0
124231,.,0,0
124232,Impact,0,0
124233,of,0,1
124234,early,0,0
124235,parenteral,0,0
124236,nutrition,0,1
124237,completing,0,0
124238,enteral,0,0
124239,nutrition,0,1
124240,in,0,0
124241,adult,0,0
124242,critically,0,0
124243,ill,0,1
124244,patients,0,0
124245,(,0,0
124246,EPaNIC,0,0
124247,trial,0,0
124248,),0,0
124249,:,0,0
124250,a,0,0
124251,study,0,0
124252,protocol,0,0
124253,and,0,1
124254,statistical,0,1
124255,analysis,0,0
124256,plan,0,0
124257,for,0,0
124258,a,0,0
124259,randomized,0,0
124260,controlled,0,0
124261,trial,0,0
124262,.,0,0
124263,BACKGROUND,0,0
124264,For,0,0
124265,critically,0,0
124266,ill,0,1
124267,patients,0,0
124268,treated,0,0
124269,in,0,0
124270,intensive,0,0
124271,care,0,0
124272,units,0,0
124273,(,0,1
124274,ICU,0,1
124275,),0,0
124276,",",0,0
124277,two,0,0
124278,feeding,0,0
124279,strategies,0,0
124280,are,0,0
124281,currently,0,0
124282,being,0,0
124283,advocated,0,0
124284,",",0,0
124285,one,0,0
124286,by,0,0
124287,American/Canadian,0,0
124288,and,0,0
124289,the,0,0
124290,other,0,0
124291,by,0,0
124292,European,0,0
124293,expert,0,0
124294,guidelines,0,0
124295,.,0,0
124296,These,0,0
124297,guidelines,0,0
124298,differ,0,0
124299,particularly,0,0
124300,in,0,0
124301,the,0,0
124302,timing,0,1
124303,of,0,0
124304,initiating,0,0
124305,parenteral,0,0
124306,nutrition,0,1
124307,(,0,1
124308,PN,0,1
124309,),0,0
124310,in,0,0
124311,patients,0,0
124312,for,0,0
124313,whom,0,0
124314,enteral,0,0
124315,nutrition,0,1
124316,(,0,1
124317,EN,0,0
124318,),0,0
124319,does,0,0
124320,not,0,0
124321,reach,0,0
124322,caloric,0,1
124323,targets,0,0
124324,.,0,0
124325,METHODS/DESIGN,0,0
124326,The,0,0
124327,EPaNIC,0,0
124328,trial,0,0
124329,is,0,0
124330,an,0,0
124331,investigator-initiated,0,0
124332,",",0,0
124333,non-commercial,0,0
124334,",",0,1
124335,multi-center,0,0
124336,",",0,1
124337,randomized,0,0
124338,",",0,0
124339,controlled,0,0
124340,",",0,0
124341,clinical,0,0
124342,trial,0,0
124343,with,0,0
124344,a,0,0
124345,parallel,0,0
124346,group,0,0
124347,design,0,0
124348,.,0,0
124349,This,0,0
124350,study,0,0
124351,compares,0,0
124352,early,0,0
124353,(,0,0
124354,European,0,0
124355,guideline,0,0
124356,),0,1
124357,versus,0,0
124358,late,0,1
124359,(,0,0
124360,American/Canadian,0,1
124361,guideline,0,0
124362,),0,1
124363,initiation,0,0
124364,of,0,0
124365,PN,0,0
124366,when,0,0
124367,EN,0,0
124368,fails,0,0
124369,to,0,0
124370,reach,0,0
124371,a,0,0
124372,caloric,0,1
124373,target,0,0
124374,.,0,0
124375,In,0,0
124376,the,0,0
124377,early,0,0
124378,PN,0,1
124379,group,0,0
124380,",",0,0
124381,PN,0,0
124382,is,0,0
124383,initiated,0,0
124384,within,0,0
124385,24-48,0,0
124386,hours,0,0
124387,after,0,0
124388,ICU,0,0
124389,admission,0,0
124390,to,0,0
124391,complete,0,1
124392,early,0,0
124393,enteral,0,0
124394,nutrition,0,1
124395,(,0,1
124396,EN,0,0
124397,),0,0
124398,up,0,0
124399,to,0,0
124400,a,0,0
124401,calculated,0,0
124402,nutritional,0,1
124403,target,0,0
124404,.,0,0
124405,In,0,0
124406,the,0,0
124407,late,0,1
124408,PN,0,1
124409,group,0,0
124410,",",0,1
124411,PN,0,1
124412,completing,0,0
124413,EN,0,0
124414,is,0,0
124415,initiated,0,0
124416,when,0,0
124417,the,0,0
124418,target,0,0
124419,is,0,0
124420,not,0,0
124421,reached,0,0
124422,on,0,0
124423,day,0,0
124424,8,0,0
124425,.,0,0
124426,In,0,0
124427,both,0,0
124428,groups,0,0
124429,",",0,0
124430,the,0,0
124431,same,0,0
124432,early,0,0
124433,EN,0,0
124434,protocol,0,0
124435,is,0,0
124436,applied,0,0
124437,.,0,0
124438,The,0,0
124439,study,0,0
124440,is,0,0
124441,designed,0,0
124442,to,0,0
124443,compare,0,0
124444,clinical,1,1
124445,outcome,1,1
124446,(,1,1
124447,morbidity,1,1
124448,and,1,1
124449,mortality,1,1
124450,),1,0
124451,in,0,0
124452,the,0,0
124453,2,0,0
124454,study,0,0
124455,arms,0,0
124456,as,0,0
124457,well,0,0
124458,as,0,0
124459,to,0,0
124460,address,0,0
124461,several,0,0
124462,mechanistical,0,0
124463,questions,0,0
124464,.,0,0
124465,We,0,0
124466,here,0,0
124467,describe,0,0
124468,the,0,0
124469,EPaNIC,0,0
124470,study,0,0
124471,protocol,0,0
124472,and,0,0
124473,the,0,0
124474,statistical,0,1
124475,analysis,0,0
124476,plan,0,0
124477,for,0,0
124478,the,0,0
124479,primary,0,0
124480,report,0,0
124481,of,0,0
124482,the,0,0
124483,clinical,0,0
124484,results,0,0
124485,.,0,0
124486,DISCUSSION,0,0
124487,The,0,0
124488,study,0,0
124489,has,0,0
124490,been,0,0
124491,initiated,0,0
124492,as,0,0
124493,planned,0,0
124494,on,0,0
124495,august,0,0
124496,01,0,0
124497,2007,0,0
124498,.,0,0
124499,One,0,0
124500,interim,0,0
124501,analysis,0,0
124502,advised,0,0
124503,continuation,0,0
124504,of,0,0
124505,the,0,0
124506,trial,0,0
124507,.,0,0
124508,The,0,0
124509,study,0,0
124510,will,0,0
124511,be,0,0
124512,completed,0,0
124513,in,0,0
124514,February,0,0
124515,2011,0,0
124516,.,0,0
124517,TRIAL,0,0
124518,REGISTRATION,0,1
124519,ClinicalTrials,0,1
124520,(,0,1
124521,NCT,0,0
124522,),0,0
124523,:,0,0
124524,NCT00512122,0,0
124525,.,0,0
124526,Dark-phase,0,1
124527,light,0,1
124528,contamination,0,1
124529,disrupts,0,0
124530,circadian,0,1
124531,rhythms,0,1
124532,in,0,0
124533,plasma,1,1
124534,measures,0,1
124535,of,0,1
124536,endocrine,0,1
124537,physiology,1,1
124538,and,0,1
124539,metabolism,1,1
124540,in,0,0
124541,rats,0,0
124542,.,0,0
124543,Dark-phase,0,0
124544,light,0,0
124545,contamination,0,1
124546,can,0,0
124547,significantly,0,0
124548,disrupt,0,0
124549,chronobiologic,1,1
124550,rhythms,1,1
124551,",",0,0
124552,thereby,0,0
124553,potentially,0,0
124554,altering,0,0
124555,the,0,0
124556,endocrine,0,0
124557,physiology,0,1
124558,and,0,1
124559,metabolism,0,1
124560,of,0,1
124561,experimental,0,0
124562,animals,0,0
124563,and,0,0
124564,influencing,0,0
124565,the,0,0
124566,outcome,0,1
124567,of,0,0
124568,scientific,0,0
124569,investigations,0,0
124570,.,0,0
124571,We,0,0
124572,sought,0,0
124573,to,0,0
124574,determine,0,0
124575,whether,0,0
124576,exposure,0,0
124577,to,0,0
124578,low-level,0,0
124579,light,0,1
124580,contamination,0,1
124581,during,0,0
124582,the,0,0
124583,dark,0,1
124584,phase,0,0
124585,influenced,0,0
124586,the,0,0
124587,normally,0,0
124588,entrained,0,0
124589,circadian,0,1
124590,rhythms,0,1
124591,of,0,1
124592,various,0,0
124593,substances,0,1
124594,in,0,0
124595,plasma,0,1
124596,.,0,0
124597,Male,0,0
124598,Sprague-Dawley,0,0
124599,rats,0,0
124600,(,0,0
124601,n,0,0
124602,=,0,0
124603,6,0,0
124604,per,0,0
124605,group,0,0
124606,),0,1
124607,were,0,0
124608,housed,0,0
124609,in,0,0
124610,photobiologic,0,0
124611,light-exposure,0,1
124612,chambers,0,0
124613,configured,0,0
124614,to,0,0
124615,create,0,0
124616,1,0,0
124617,),0,0
124618,a,0,0
124619,12:12-h,0,0
124620,light,0,0
124621,:,0,0
124622,dark,0,1
124623,cycle,0,1
124624,without,0,0
124625,dark-phase,0,1
124626,light,0,1
124627,contamination,0,1
124628,(,0,0
124629,control,0,0
124630,condition,0,0
124631,;,0,0
124632,123,0,0
124633,?W/cm,0,0
124634,(,0,0
124635,2,0,0
124636,),0,0
124637,",",0,0
124638,lights,0,1
124639,on,0,0
124640,at,0,0
124641,0600,0,0
124642,),0,0
124643,",",0,0
124644,2,0,0
124645,),0,0
124646,experimental,0,0
124647,exposure,0,0
124648,to,0,0
124649,a,0,0
124650,low,0,0
124651,level,0,1
124652,of,0,1
124653,light,0,0
124654,during,0,0
124655,the,0,0
124656,12-h,0,0
124657,dark,0,1
124658,phase,0,0
124659,(,0,0
124660,with,0,0
124661,0.02,0,0
124662,",",0,0
124663,0.05,0,0
124664,",",0,0
124665,0.06,0,0
124666,",",0,0
124667,or,0,0
124668,0.08,0,0
124669,?W/cm,0,0
124670,(,0,0
124671,2,0,0
124672,),0,0
124673,light,0,0
124674,at,0,0
124675,night,0,1
124676,),0,1
124677,",",0,0
124678,or,0,0
124679,3,0,0
124680,),0,0
124681,constant,0,0
124682,bright,0,1
124683,light,0,1
124684,(,0,0
124685,123,0,0
124686,?W/cm,0,0
124687,(,0,0
124688,2,0,0
124689,),0,0
124690,),0,0
124691,.,0,0
124692,Dietary,0,1
124693,and,0,1
124694,water,0,1
124695,intakes,0,1
124696,were,0,0
124697,recorded,0,0
124698,daily,0,0
124699,.,0,0
124700,After,0,0
124701,2,0,0
124702,wk,0,0
124703,",",0,0
124704,rats,0,0
124705,underwent,0,0
124706,6,0,0
124707,low-volume,0,0
124708,blood,0,1
124709,draws,0,0
124710,at,0,0
124711,4-h,0,0
124712,intervals,0,1
124713,(,0,0
124714,beginning,0,0
124715,at,0,0
124716,0400,0,1
124717,),0,0
124718,during,0,0
124719,both,0,0
124720,the,0,0
124721,light,0,1
124722,and,0,1
124723,dark,0,1
124724,phases,1,0
124725,.,1,0
124726,Circadian,1,1
124727,rhythms,1,1
124728,in,1,0
124729,dietary,1,1
124730,and,1,1
124731,water,1,1
124732,intake,1,1
124733,and,1,1
124734,levels,1,1
124735,of,1,1
124736,plasma,1,1
124737,total,1,1
124738,fatty,1,1
124739,acids,1,1
124740,and,1,1
124741,lipid,1,1
124742,fractions,1,1
124743,remained,1,0
124744,entrained,0,0
124745,during,0,0
124746,exposure,0,0
124747,to,0,0
124748,either,0,0
124749,control,0,0
124750,conditions,0,0
124751,or,0,1
124752,low-intensity,0,0
124753,light,0,1
124754,during,0,0
124755,the,0,0
124756,dark,0,0
124757,phase,0,0
124758,.,0,0
124759,However,0,0
124760,",",0,0
124761,these,0,0
124762,patterns,0,1
124763,were,0,0
124764,disrupted,0,0
124765,in,0,0
124766,rats,0,0
124767,exposed,0,0
124768,to,0,0
124769,constant,0,0
124770,bright,0,0
124771,light,1,1
124772,.,1,0
124773,Circadian,1,1
124774,patterns,1,1
124775,of,1,1
124776,plasma,1,1
124777,melatonin,1,0
124778,",",1,1
124779,glucose,1,1
124780,",",1,1
124781,lactic,1,1
124782,acid,1,1
124783,",",1,1
124784,and,1,1
124785,corticosterone,1,1
124786,were,1,0
124787,maintained,0,0
124788,in,0,0
124789,all,0,0
124790,rats,0,0
124791,except,0,0
124792,those,0,0
124793,exposed,0,0
124794,to,0,0
124795,constant,0,0
124796,bright,0,1
124797,light,0,1
124798,or,0,0
124799,the,0,0
124800,highest,0,1
124801,level,0,1
124802,of,0,1
124803,light,0,0
124804,during,0,0
124805,the,0,0
124806,dark,0,0
124807,phase,0,0
124808,.,0,0
124809,Therefore,0,0
124810,even,0,0
124811,minimal,0,0
124812,light,0,1
124813,contamination,0,1
124814,during,0,0
124815,the,0,0
124816,dark,0,0
124817,phase,0,0
124818,can,0,0
124819,disrupt,0,0
124820,normal,1,0
124821,circadian,1,1
124822,rhythms,1,1
124823,of,1,1
124824,endocrine,0,1
124825,metabolism,0,1
124826,and,0,1
124827,physiology,0,1
124828,and,0,0
124829,may,0,0
124830,alter,0,0
124831,the,0,0
124832,outcome,0,1
124833,of,0,0
124834,scientific,0,0
124835,investigations,0,0
124836,.,0,0
124837,Effectiveness,0,1
124838,of,0,1
124839,sensory,0,1
124840,integration,0,1
124841,interventions,0,0
124842,in,0,0
124843,children,0,0
124844,with,0,0
124845,autism,0,0
124846,spectrum,0,0
124847,disorders,0,0
124848,:,0,0
124849,a,0,0
124850,pilot,0,0
124851,study,0,0
124852,.,0,0
124853,The,0,0
124854,purpose,0,0
124855,of,0,0
124856,this,0,0
124857,pilot,0,0
124858,study,0,0
124859,was,0,0
124860,to,0,0
124861,establish,0,0
124862,a,0,0
124863,model,0,0
124864,for,0,0
124865,randomized,0,0
124866,controlled,0,0
124867,trial,0,0
124868,research,0,0
124869,",",0,1
124870,identify,0,0
124871,appropriate,0,1
124872,outcome,0,1
124873,measures,0,1
124874,",",0,0
124875,and,0,0
124876,address,0,0
124877,the,0,0
124878,effectiveness,0,0
124879,of,0,0
124880,sensory,0,1
124881,integration,0,1
124882,(,0,1
124883,SI,0,1
124884,),0,0
124885,interventions,0,0
124886,in,0,0
124887,children,0,0
124888,with,0,0
124889,autism,0,0
124890,spectrum,0,0
124891,disorders,0,1
124892,(,0,1
124893,ASD,0,0
124894,),0,0
124895,.,0,0
124896,Children,0,0
124897,ages,0,0
124898,6-12,0,0
124899,with,0,0
124900,ASD,0,0
124901,were,0,0
124902,randomly,0,0
124903,assigned,0,0
124904,to,0,0
124905,a,0,0
124906,fine,0,0
124907,motor,0,1
124908,or,0,1
124909,SI,0,1
124910,treatment,0,0
124911,group,0,0
124912,.,0,1
124913,Pretests,0,1
124914,and,0,1
124915,posttests,0,1
124916,measured,0,1
124917,social,1,1
124918,responsiveness,1,1
124919,",",1,1
124920,sensory,1,1
124921,processing,1,1
124922,",",1,1
124923,functional,1,1
124924,motor,1,1
124925,skills,1,1
124926,",",1,1
124927,and,1,1
124928,social-emotional,1,1
124929,factors,1,1
124930,.,1,0
124931,Results,0,0
124932,identified,0,0
124933,significant,0,0
124934,positive,0,1
124935,changes,0,1
124936,in,0,0
124937,Goal,1,0
124938,Attainment,1,1
124939,Scaling,1,1
124940,scores,1,1
124941,for,0,0
124942,both,0,0
124943,groups,0,0
124944,;,0,0
124945,more,0,0
124946,significant,0,0
124947,changes,0,1
124948,occurred,0,0
124949,in,0,0
124950,the,0,0
124951,SI,0,0
124952,group,0,0
124953,",",0,0
124954,and,0,0
124955,a,0,0
124956,significant,0,0
124957,decrease,0,1
124958,in,0,0
124959,autistic,1,1
124960,mannerisms,1,1
124961,occurred,0,0
124962,in,0,0
124963,the,0,0
124964,SI,0,0
124965,group,0,0
124966,.,0,0
124967,No,0,0
124968,other,0,0
124969,results,0,0
124970,were,0,0
124971,significant,0,0
124972,.,0,0
124973,The,0,0
124974,study,0,0
124975,discusses,0,0
124976,considerations,0,0
124977,for,0,0
124978,designing,0,0
124979,future,0,0
124980,outcome,0,1
124981,studies,0,0
124982,for,0,0
124983,children,0,0
124984,with,0,0
124985,ASD,0,0
124986,.,0,0
124987,Anastrozole,0,0
124988,single-dose,0,0
124989,protocol,0,0
124990,in,0,0
124991,women,0,0
124992,with,0,0
124993,oligo-,0,1
124994,or,0,0
124995,anovulatory,0,1
124996,infertility,0,1
124997,:,0,0
124998,results,0,0
124999,of,0,0
125000,a,0,0
125001,randomized,0,0
125002,phase,0,0
125003,II,0,0
125004,dose-response,0,1
125005,study,0,0
125006,.,0,0
125007,OBJECTIVE,0,0
125008,To,0,0
125009,compare,0,0
125010,the,0,0
125011,effects,0,0
125012,of,0,1
125013,anastrozole,0,0
125014,and,0,1
125015,clomiphene,0,0
125016,citrate,0,0
125017,(,0,1
125018,CC,0,0
125019,),0,1
125020,on,0,0
125021,follicular,1,1
125022,development,1,1
125023,and,1,1
125024,ovulation,1,1
125025,in,0,0
125026,infertile,0,0
125027,women,0,0
125028,with,0,0
125029,ovulatory,0,1
125030,dysfunction,0,1
125031,.,0,0
125032,DESIGN,0,0
125033,Phase,0,1
125034,II,0,0
125035,",",0,1
125036,prospective,0,0
125037,",",0,1
125038,randomized,0,0
125039,",",0,0
125040,assessor-blind,0,0
125041,",",0,1
125042,multicenter,0,0
125043,",",0,1
125044,dose-finding,0,0
125045,",",0,1
125046,noninferiority,0,0
125047,study,0,0
125048,.,0,1
125049,SETTING,0,0
125050,Outpatient,0,0
125051,.,0,1
125052,PATIENT,0,0
125053,(,0,0
125054,S,0,0
125055,),0,1
125056,Infertile,0,1
125057,women,0,0
125058,with,0,0
125059,ovulatory,0,1
125060,dysfunction,0,1
125061,",",0,0
125062,aged,0,0
125063,18-35,0,0
125064,years,0,0
125065,",",0,0
125066,and,0,1
125067,body,0,1
125068,mass,0,1
125069,index,0,1
125070,<,0,0
125071,35,0,0
125072,kg/m,0,0
125073,(,0,0
125074,2,0,0
125075,),0,0
125076,.,0,0
125077,INTERVENTION,0,1
125078,(,0,0
125079,S,0,0
125080,),0,1
125081,Single-dose,0,0
125082,anastrozole,0,0
125083,at,0,0
125084,5,0,0
125085,mg,0,0
125086,(,0,0
125087,n,0,0
125088,=,0,0
125089,39,0,0
125090,),0,0
125091,",",0,0
125092,10,0,0
125093,mg,0,0
125094,(,0,0
125095,n,0,0
125096,=,0,0
125097,39,0,0
125098,),0,0
125099,",",0,0
125100,20,0,0
125101,mg,0,0
125102,(,0,0
125103,n,0,0
125104,=,0,0
125105,39,0,0
125106,),0,0
125107,",",0,0
125108,or,0,0
125109,30,0,0
125110,mg,0,0
125111,(,0,0
125112,n,0,0
125113,=,0,0
125114,38,0,0
125115,),0,0
125116,or,0,0
125117,a,0,0
125118,5-day,0,0
125119,course,0,0
125120,of,0,1
125121,CC,0,0
125122,at,0,0
125123,50,0,0
125124,mg/d,0,0
125125,(,0,0
125126,n,0,0
125127,=,0,0
125128,39,0,0
125129,),0,0
125130,as,0,0
125131,starting,0,0
125132,doses,0,0
125133,.,0,0
125134,MAIN,0,0
125135,OUTCOME,0,1
125136,MEASURE,0,1
125137,(,0,1
125138,S,0,0
125139,),0,0
125140,The,0,0
125141,primary,0,0
125142,endpoint,0,1
125143,was,0,0
125144,the,0,0
125145,ovulation,1,1
125146,rate,1,1
125147,in,0,0
125148,the,0,0
125149,first,0,0
125150,treatment,0,0
125151,cycle,0,1
125152,(,0,0
125153,cycle,0,1
125154,1,0,0
125155,),0,0
125156,.,0,0
125157,Ovulation,0,1
125158,was,0,0
125159,defined,0,0
125160,as,0,0
125161,a,0,0
125162,midluteal,0,0
125163,phase,0,0
125164,serum,0,1
125165,P,0,0
125166,level,0,1
125167,?,0,0
125168,10,0,0
125169,ng/mL,0,0
125170,or,0,0
125171,clinical,0,1
125172,pregnancy,0,1
125173,.,0,1
125174,RESULT,0,1
125175,(,0,0
125176,S,0,0
125177,),0,1
125178,In,0,0
125179,cycle,0,0
125180,1,0,0
125181,the,1,0
125182,ovulation,1,1
125183,rates,1,1
125184,for,1,0
125185,a,0,0
125186,single,0,0
125187,dose,0,0
125188,of,0,1
125189,anastrozole,0,0
125190,at,0,0
125191,5,0,0
125192,",",0,0
125193,10,0,0
125194,",",0,0
125195,20,0,0
125196,",",0,0
125197,and,0,0
125198,30,0,0
125199,mg,0,0
125200,were,0,0
125201,46.2,0,0
125202,%,0,0
125203,",",0,0
125204,41.0,0,0
125205,%,0,0
125206,",",0,0
125207,23.1,0,0
125208,%,0,0
125209,",",0,0
125210,and,0,0
125211,28.9,0,0
125212,%,0,0
125213,",",0,0
125214,respectively,0,0
125215,",",0,0
125216,whereas,0,0
125217,that,0,0
125218,for,0,0
125219,CC,0,0
125220,at,0,0
125221,50,0,0
125222,mg/d,0,0
125223,was,0,0
125224,61.5,0,0
125225,%,0,0
125226,.,0,0
125227,Among,0,0
125228,women,0,0
125229,with,0,0
125230,fewer,0,0
125231,than,0,0
125232,six,0,0
125233,menses,0,0
125234,per,0,0
125235,year,0,0
125236,",",0,0
125237,the,1,0
125238,cumulative,1,1
125239,ovulation,1,1
125240,rates,1,1
125241,over,1,0
125242,three,0,0
125243,cycles,0,0
125244,were,0,0
125245,comparable,0,0
125246,in,0,0
125247,the,0,0
125248,anastrozole,0,0
125249,5,0,0
125250,mg,0,0
125251,(,0,0
125252,52.4,0,0
125253,%,0,0
125254,),0,0
125255,and,0,0
125256,CC,0,0
125257,50,0,0
125258,mg/d,0,0
125259,(,0,0
125260,42.3,0,0
125261,%,0,0
125262,),0,0
125263,groups,0,0
125264,.,0,1
125265,CONCLUSION,0,0
125266,(,0,0
125267,S,0,0
125268,),0,0
125269,In,0,0
125270,terms,0,1
125271,of,0,0
125272,ovulation,1,1
125273,rates,1,1
125274,in,1,0
125275,cycle,0,1
125276,1,0,0
125277,",",0,0
125278,single-dose,0,0
125279,anastrozole,0,0
125280,at,0,0
125281,5,0,0
125282,",",0,0
125283,10,0,0
125284,",",0,0
125285,20,0,0
125286,",",0,0
125287,and,0,0
125288,30,0,0
125289,mg,0,0
125290,was,0,0
125291,not,0,0
125292,as,0,0
125293,effective,0,0
125294,as,0,0
125295,CC,0,0
125296,at,0,0
125297,50,0,0
125298,mg/d,0,0
125299,for,0,0
125300,5,0,0
125301,days,0,0
125302,(,0,0
125303,noninferiority,0,0
125304,was,0,0
125305,not,0,0
125306,shown,0,0
125307,),0,0
125308,.,0,0
125309,Effects,0,0
125310,of,0,1
125311,diet,0,0
125312,and,0,0
125313,Aspergillus,0,0
125314,oryzae,0,1
125315,extract,0,0
125316,or,0,0
125317,Saccharomyces,0,0
125318,cervisiae,0,0
125319,on,0,0
125320,growth,0,1
125321,and,0,1
125322,carcass,0,1
125323,characteristics,0,1
125324,of,0,1
125325,lambs,0,0
125326,and,0,0
125327,steers,0,0
125328,fed,0,0
125329,to,0,0
125330,meet,0,0
125331,requirements,0,1
125332,of,0,0
125333,natural,0,0
125334,markets,0,0
125335,.,0,0
125336,Two,0,0
125337,studies,0,0
125338,were,0,0
125339,conducted,0,0
125340,to,0,0
125341,determine,0,0
125342,the,0,0
125343,effects,0,0
125344,of,0,0
125345,diet,0,0
125346,and,0,1
125347,feed,0,1
125348,additive,0,1
125349,on,0,0
125350,growth,0,1
125351,and,0,1
125352,carcass,0,1
125353,characteristics,0,1
125354,of,0,1
125355,lambs,0,0
125356,and,0,1
125357,cattle,0,0
125358,destined,0,0
125359,for,0,0
125360,all,0,0
125361,natural,0,0
125362,markets,0,0
125363,.,0,0
125364,In,0,0
125365,Exp,0,0
125366,.,0,0
125367,1,0,0
125368,",",0,0
125369,48,0,0
125370,Dorset,0,0
125371,?,0,0
125372,Hampshire,0,0
125373,lambs,0,0
125374,(,0,0
125375,initial,0,0
125376,BW,0,0
125377,29.4,0,0
125378,?,0,0
125379,0.1,0,0
125380,kg,0,0
125381,),0,0
125382,were,0,0
125383,used,0,0
125384,in,0,0
125385,a,0,0
125386,randomized,0,0
125387,complete,0,1
125388,block,0,0
125389,experiment,0,0
125390,to,0,0
125391,determine,0,0
125392,the,0,0
125393,effects,0,0
125394,of,0,0
125395,Aspergillus,0,0
125396,oryzae,0,1
125397,extract,0,0
125398,",",0,1
125399,Amaferm,0,1
125400,(,0,1
125401,AMF,0,0
125402,),0,1
125403,supplementation,0,0
125404,(,0,0
125405,1,0,0
125406,g/d,0,0
125407,),0,0
125408,in,0,0
125409,an,0,0
125410,85,0,0
125411,%,0,0
125412,concentrate,0,0
125413,diet,0,0
125414,on,0,0
125415,growth,0,1
125416,and,0,1
125417,carcass,0,1
125418,characteristics,0,1
125419,.,0,1
125420,Lambs,0,1
125421,were,0,0
125422,allotted,0,0
125423,to,0,0
125424,12,0,0
125425,pens,0,0
125426,(,0,0
125427,4,0,0
125428,lambs,0,0
125429,per,0,0
125430,pen,0,0
125431,),0,1
125432,",",0,1
125433,and,0,1
125434,blocked,0,1
125435,by,0,0
125436,sex,0,0
125437,and,0,1
125438,BW,0,1
125439,.,0,1
125440,Lambs,0,1
125441,were,0,0
125442,fed,0,0
125443,until,0,0
125444,the,0,0
125445,average,0,1
125446,BW,0,0
125447,of,0,0
125448,each,0,0
125449,pen,0,0
125450,reached,0,0
125451,a,0,0
125452,target,0,1
125453,BW,0,0
125454,(,0,0
125455,55.4,0,0
125456,kg,0,0
125457,for,0,0
125458,wethers,0,0
125459,and,0,0
125460,50.0,0,0
125461,kg,0,0
125462,for,0,0
125463,ewes,0,1
125464,),0,1
125465,",",0,0
125466,at,0,0
125467,which,0,0
125468,time,0,1
125469,the,0,0
125470,entire,0,0
125471,pen,0,0
125472,of,0,1
125473,lambs,0,0
125474,was,0,0
125475,slaughtered,0,0
125476,.,0,0
125477,Amaferm,0,0
125478,resulted,0,0
125479,in,0,0
125480,a,0,0
125481,greater,0,0
125482,(,0,0
125483,P=0.07,1,1
125484,),1,0
125485,G,1,0
125486,:,1,0
125487,F.,1,0
125488,In,0,0
125489,Exp,0,0
125490,.,0,0
125491,2,0,0
125492,",",0,0
125493,168,0,0
125494,crossbred,0,0
125495,steers,0,0
125496,(,0,0
125497,initial,0,0
125498,BW,0,0
125499,300,0,0
125500,?,0,0
125501,0.7,0,0
125502,kg,0,0
125503,),0,0
125504,were,0,0
125505,used,0,0
125506,in,0,0
125507,a,0,0
125508,trial,0,0
125509,with,0,0
125510,a,0,0
125511,3,0,0
125512,?,0,0
125513,2,0,0
125514,factorial,0,0
125515,arrangement,0,0
125516,of,0,0
125517,treatments,0,0
125518,to,0,0
125519,examine,0,0
125520,the,0,0
125521,effects,0,0
125522,of,0,0
125523,0.5,0,0
125524,g/d,0,0
125525,of,0,0
125526,Saccaromyces,0,0
125527,cervisiae,0,0
125528,boulardii,0,0
125529,CNCM,0,0
125530,1079-Levucell,0,0
125531,SB,0,0
125532,(,0,0
125533,LEV,0,1
125534,),0,1
125535,",",0,0
125536,or,0,0
125537,3,0,0
125538,g/d,0,0
125539,of,0,0
125540,AMF,0,0
125541,with,0,0
125542,2,0,0
125543,corn,0,0
125544,sources,0,0
125545,",",0,0
125546,dry,0,1
125547,whole-shelled,0,0
125548,corn,0,0
125549,or,0,1
125550,high,0,1
125551,moisture,0,1
125552,corn,0,0
125553,",",0,1
125554,on,0,0
125555,growth,0,1
125556,and,0,1
125557,carcass,0,1
125558,characteristics,1,1
125559,.,1,1
125560,Neither,1,0
125561,LEV,1,1
125562,nor,1,0
125563,AMF,1,1
125564,improved,1,1
125565,(,1,0
125566,P,1,0
125567,>,1,0
125568,0.10,1,0
125569,),1,0
125570,carcass,1,0
125571,characteristics,1,1
125572,compared,1,0
125573,with,1,0
125574,control,1,0
125575,or,1,0
125576,non-feed-supplemented,1,0
125577,steers,1,0
125578,.,1,0
125579,Addition,1,0
125580,of,0,0
125581,LEV,0,1
125582,to,0,0
125583,high-concentrate,0,0
125584,",",0,0
125585,corn-based,0,0
125586,diets,1,0
125587,did,1,0
125588,not,1,0
125589,improve,1,0
125590,(,1,0
125591,P,1,0
125592,>,1,0
125593,0.10,1,0
125594,),1,0
125595,growth,1,1
125596,performance,1,1
125597,of,1,1
125598,feedlot,1,0
125599,steers,1,0
125600,.,1,0
125601,However,1,0
125602,",",0,0
125603,addition,0,0
125604,of,0,1
125605,AMF,0,0
125606,to,0,0
125607,a,0,0
125608,diet,0,0
125609,composed,0,0
125610,of,0,0
125611,dry,0,0
125612,whole-shelled,0,0
125613,corn,0,0
125614,resulted,0,0
125615,in,0,0
125616,an,1,0
125617,improvement,1,1
125618,(,1,0
125619,P,1,0
125620,<,1,0
125621,0.05,1,0
125622,),1,0
125623,in,1,0
125624,G,1,0
125625,:,1,0
125626,F,1,0
125627,(,0,0
125628,0.208,0,0
125629,vs.,0,0
125630,0.194,0,0
125631,),0,0
125632,.,0,0
125633,Results,0,0
125634,indicate,0,0
125635,that,0,0
125636,at,0,0
125637,the,0,0
125638,amounts,0,1
125639,fed,0,0
125640,",",0,0
125641,AMF,0,0
125642,may,0,0
125643,improve,1,0
125644,G,1,0
125645,:,1,0
125646,F,1,0
125647,for,0,0
125648,lambs,0,0
125649,and,0,0
125650,steers,0,0
125651,fed,0,0
125652,dry,0,0
125653,corn-based,0,0
125654,finishing,0,0
125655,diets,0,0
125656,.,0,0
125657,Intermittent,0,1
125658,theta-burst,0,1
125659,transcranial,0,0
125660,magnetic,0,0
125661,stimulation,0,1
125662,for,0,0
125663,treatment,0,0
125664,of,0,1
125665,Parkinson,1,0
125666,disease,1,1
125667,.,1,0
125668,OBJECTIVE,0,0
125669,To,0,0
125670,investigate,0,0
125671,the,0,0
125672,safety,1,1
125673,and,1,1
125674,efficacy,1,1
125675,of,0,1
125676,intermittent,0,0
125677,theta-burst,0,1
125678,stimulation,0,1
125679,(,0,1
125680,iTBS,0,1
125681,),0,0
125682,in,0,0
125683,the,0,0
125684,treatment,0,0
125685,of,0,0
125686,motor,1,1
125687,symptoms,1,1
125688,in,1,0
125689,Parkinson,1,0
125690,disease,1,1
125691,(,1,1
125692,PD,1,1
125693,),1,0
125694,.,0,0
125695,BACKGROUND,0,0
125696,Progression,0,1
125697,of,0,0
125698,PD,0,0
125699,is,0,0
125700,characterized,0,0
125701,by,0,0
125702,the,0,0
125703,emergence,0,1
125704,of,0,0
125705,motor,0,1
125706,deficits,0,1
125707,",",0,0
125708,which,0,0
125709,eventually,0,0
125710,respond,0,0
125711,less,0,0
125712,to,0,0
125713,dopaminergic,0,1
125714,therapy,0,0
125715,and,0,0
125716,pose,0,0
125717,a,0,0
125718,therapeutic,0,0
125719,challenge,0,0
125720,.,0,0
125721,Repetitive,0,1
125722,transcranial,0,0
125723,magnetic,0,0
125724,stimulation,0,1
125725,(,0,1
125726,rTMS,0,0
125727,),0,0
125728,has,0,0
125729,shown,0,0
125730,promising,0,0
125731,results,0,0
125732,in,0,0
125733,improving,1,1
125734,gait,1,1
125735,",",0,0
125736,a,0,0
125737,major,0,1
125738,cause,0,0
125739,of,0,1
125740,disability,1,1
125741,",",0,0
125742,and,0,0
125743,may,0,0
125744,provide,0,0
125745,a,0,0
125746,therapeutic,0,0
125747,alternative,0,0
125748,.,0,0
125749,iTBS,0,0
125750,is,0,0
125751,a,0,0
125752,novel,0,0
125753,type,0,0
125754,of,0,1
125755,rTMS,0,0
125756,that,0,0
125757,may,0,0
125758,be,0,0
125759,more,0,0
125760,efficacious,0,0
125761,than,0,0
125762,conventional,0,0
125763,rTMS,0,0
125764,.,0,0
125765,METHODS,0,0
125766,In,0,0
125767,this,0,0
125768,randomized,0,0
125769,",",0,0
125770,double-blind,0,0
125771,",",0,1
125772,sham-controlled,0,0
125773,study,0,0
125774,",",0,0
125775,we,0,0
125776,investigated,0,0
125777,safety,0,1
125778,and,0,1
125779,efficacy,0,1
125780,of,0,1
125781,iTBS,0,0
125782,of,0,0
125783,the,0,0
125784,motor,0,1
125785,and,0,1
125786,dorsolateral,0,1
125787,prefrontal,0,1
125788,cortices,0,1
125789,in,0,0
125790,8,0,0
125791,sessions,0,0
125792,over,0,0
125793,2,0,0
125794,weeks,0,0
125795,(,0,0
125796,evidence,0,0
125797,Class,0,1
125798,I,0,0
125799,),0,0
125800,.,0,0
125801,Assessment,0,1
125802,of,0,1
125803,safety,1,1
125804,and,1,1
125805,clinical,1,1
125806,efficacy,1,1
125807,over,0,0
125808,a,0,0
125809,1-month,0,1
125810,period,0,0
125811,included,0,0
125812,timed,0,1
125813,tests,0,1
125814,of,0,1
125815,gait,1,1
125816,and,1,1
125817,bradykinesia,1,1
125818,",",1,1
125819,Unified,1,1
125820,Parkinson,1,1
125821,'s,1,1
125822,Disease,1,1
125823,Rating,1,1
125824,Scale,1,1
125825,(,1,1
125826,UPDRS,1,1
125827,),1,1
125828,",",1,0
125829,and,1,1
125830,additional,1,0
125831,clinical,1,1
125832,",",1,1
125833,neuropsychological,1,1
125834,",",1,1
125835,and,1,1
125836,neurophysiologic,1,1
125837,measures,1,1
125838,.,1,0
125839,RESULTS,0,0
125840,We,0,0
125841,investigated,0,0
125842,26,0,0
125843,patients,0,0
125844,with,0,0
125845,mild,0,0
125846,to,0,0
125847,moderate,0,0
125848,PD,0,0
125849,:,0,0
125850,13,0,0
125851,received,0,0
125852,iTBS,0,0
125853,and,0,0
125854,13,0,0
125855,sham,0,0
125856,stimulation,0,0
125857,.,0,0
125858,We,0,0
125859,found,0,0
125860,beneficial,0,0
125861,effects,0,1
125862,of,0,0
125863,iTBS,0,1
125864,on,0,0
125865,mood,1,1
125866,",",0,0
125867,but,0,0
125868,no,0,0
125869,improvement,0,1
125870,of,0,1
125871,gait,1,1
125872,",",1,1
125873,bradykinesia,1,1
125874,",",1,1
125875,UPDRS,1,1
125876,",",1,1
125877,and,1,1
125878,other,1,0
125879,measures,1,1
125880,.,1,0
125881,EEG/EMG,1,0
125882,monitoring,0,0
125883,recorded,0,0
125884,no,0,0
125885,pathologic,0,1
125886,increase,1,0
125887,of,1,1
125888,cortical,1,1
125889,excitability,1,1
125890,or,1,1
125891,epileptic,1,1
125892,activity,1,1
125893,.,1,1
125894,Few,0,0
125895,reported,0,0
125896,discomfort,1,1
125897,or,1,1
125898,pain,1,1
125899,and,0,0
125900,one,0,0
125901,experienced,0,0
125902,tinnitus,1,0
125903,during,0,0
125904,real,0,1
125905,stimulation,0,1
125906,.,0,1
125907,CONCLUSION,0,0
125908,iTBS,0,0
125909,of,0,0
125910,the,0,0
125911,motor,0,1
125912,and,0,1
125913,prefrontal,0,1
125914,cortices,0,0
125915,appears,0,0
125916,safe,1,0
125917,and,1,0
125918,improves,1,1
125919,mood,1,1
125920,",",0,1
125921,but,0,0
125922,failed,0,0
125923,to,0,0
125924,improve,0,0
125925,motor,1,1
125926,performance,1,1
125927,and,1,1
125928,functional,1,1
125929,status,1,1
125930,in,0,0
125931,PD,0,1
125932,.,0,0
125933,CLASSIFICATION,0,1
125934,OF,0,0
125935,EVIDENCE,0,0
125936,This,0,0
125937,study,0,0
125938,provides,0,0
125939,Class,0,0
125940,I,0,0
125941,evidence,0,0
125942,that,0,0
125943,iTBS,0,1
125944,was,1,0
125945,not,1,0
125946,effective,1,1
125947,for,0,0
125948,gait,1,1
125949,",",1,1
125950,upper,1,1
125951,extremity,1,1
125952,bradykinesia,1,1
125953,",",1,1
125954,or,1,1
125955,other,1,1
125956,motor,1,1
125957,symptoms,1,1
125958,in,1,0
125959,PD,1,0
125960,.,1,0
125961,Human,0,0
125962,primary,0,0
125963,visual,0,1
125964,cortex,0,1
125965,(,0,1
125966,V1,0,0
125967,),0,0
125968,is,0,0
125969,selective,0,0
125970,for,0,0
125971,second-order,0,1
125972,spatial,0,1
125973,frequency,0,1
125974,.,0,0
125975,A,0,0
125976,variety,0,0
125977,of,0,0
125978,cues,0,0
125979,can,0,0
125980,differentiate,0,0
125981,objects,0,1
125982,from,0,0
125983,their,0,0
125984,surrounds,0,0
125985,.,0,0
125986,These,0,0
125987,include,0,0
125988,first-order,0,1
125989,cues,0,0
125990,such,0,0
125991,as,0,0
125992,luminance,0,1
125993,modulations,0,1
125994,and,0,1
125995,second-order,0,1
125996,cues,0,0
125997,involving,0,0
125998,modulations,0,1
125999,of,0,1
126000,orientation,0,1
126001,and,0,1
126002,contrast,0,0
126003,.,0,1
126004,Human,0,0
126005,sensitivity,0,1
126006,to,0,0
126007,first-order,0,0
126008,modulations,0,0
126009,is,0,0
126010,well,0,0
126011,described,0,0
126012,by,0,0
126013,a,0,0
126014,computational,0,0
126015,model,0,0
126016,involving,0,0
126017,spatially,0,0
126018,localized,0,0
126019,filters,0,0
126020,that,0,0
126021,are,0,0
126022,selective,0,0
126023,for,0,0
126024,orientation,0,1
126025,and,0,1
126026,spatial,0,1
126027,frequency,0,1
126028,(,0,1
126029,SF,0,0
126030,),0,0
126031,.,0,0
126032,It,0,0
126033,is,0,0
126034,widely,0,0
126035,held,0,0
126036,that,0,0
126037,first-order,0,0
126038,modulations,0,0
126039,are,0,0
126040,represented,0,0
126041,by,0,0
126042,the,0,0
126043,firing,0,1
126044,rates,0,1
126045,of,0,1
126046,simple,0,0
126047,and,0,1
126048,complex,0,0
126049,cells,0,1
126050,(,0,0
126051,first-order,0,1
126052,neurons,0,1
126053,),0,0
126054,in,0,0
126055,primary,0,0
126056,visual,0,1
126057,cortex,0,1
126058,(,0,1
126059,V1,0,0
126060,),0,1
126061,that,0,0
126062,",",0,0
126063,likewise,0,0
126064,",",0,0
126065,have,0,0
126066,spatially,0,1
126067,localized,0,0
126068,receptive,0,1
126069,fields,0,0
126070,that,0,0
126071,are,0,0
126072,selective,0,0
126073,for,0,0
126074,orientation-,0,1
126075,and,0,0
126076,SF,0,0
126077,.,0,1
126078,Human,0,0
126079,sensitivity,0,1
126080,to,0,0
126081,second-order,0,0
126082,modulations,0,0
126083,is,0,0
126084,well,0,0
126085,described,0,0
126086,by,0,0
126087,a,0,0
126088,filter-rectify-filter,0,0
126089,(,0,0
126090,FRF,0,1
126091,),0,1
126092,model,0,0
126093,",",0,0
126094,with,0,0
126095,first-,0,1
126096,and,0,1
126097,second-order,0,1
126098,filters,0,0
126099,selective,0,0
126100,for,0,0
126101,orientation,0,1
126102,and,0,1
126103,SF,0,0
126104,.,0,1
126105,However,0,0
126106,",",0,0
126107,little,0,0
126108,is,0,0
126109,known,0,0
126110,about,0,0
126111,how,0,0
126112,neuronal,0,1
126113,activity,0,1
126114,in,0,0
126115,visual,0,1
126116,cortex,0,0
126117,represents,0,0
126118,second-order,1,1
126119,modulations,1,0
126120,.,1,0
126121,We,0,0
126122,tested,0,0
126123,the,0,0
126124,FRF,0,0
126125,model,0,0
126126,by,0,0
126127,using,0,0
126128,an,0,0
126129,functional,0,1
126130,(,0,0
126131,f,0,1
126132,),0,1
126133,MRI-adaptation,0,0
126134,protocol,0,0
126135,to,0,0
126136,characterize,0,0
126137,the,0,0
126138,selectivity,0,1
126139,of,0,0
126140,activity,0,1
126141,in,0,0
126142,visual,0,1
126143,cortex,0,1
126144,to,0,0
126145,second-order,0,1
126146,",",0,0
126147,orientation-defined,0,0
126148,gratings,0,1
126149,of,0,0
126150,two,0,0
126151,different,0,0
126152,SFs,0,0
126153,.,0,0
126154,fMRI,0,1
126155,responses,0,1
126156,throughout,0,0
126157,early,0,0
126158,visual,0,1
126159,cortex,0,1
126160,exhibited,0,1
126161,selective,0,0
126162,adaptation,0,1
126163,to,0,0
126164,these,0,0
126165,stimuli,0,0
126166,.,0,0
126167,The,0,0
126168,low-SF,0,0
126169,grating,0,0
126170,was,0,0
126171,a,0,0
126172,more,0,0
126173,effective,0,1
126174,adapter,0,0
126175,than,0,0
126176,the,0,0
126177,high-SF,0,0
126178,grating,0,1
126179,",",0,1
126180,incompatible,0,0
126181,with,0,0
126182,the,0,0
126183,FRF,0,0
126184,model,0,0
126185,.,0,0
126186,To,0,0
126187,explain,0,0
126188,the,0,0
126189,results,0,0
126190,",",0,0
126191,we,0,0
126192,extended,0,0
126193,the,0,0
126194,FRF,0,0
126195,model,0,0
126196,by,0,0
126197,incorporating,0,0
126198,normalization,0,1
126199,",",0,0
126200,yielding,0,0
126201,a,0,0
126202,filter-rectify-normalize-filter,0,1
126203,model,0,0
126204,",",0,0
126205,in,0,0
126206,which,0,0
126207,normalization,0,1
126208,enhances,0,0
126209,selectivity,0,1
126210,for,0,0
126211,second-order,0,1
126212,SF,0,0
126213,but,0,0
126214,only,0,0
126215,for,0,0
126216,low,0,0
126217,spatial,0,1
126218,frequencies,0,1
126219,.,0,0
126220,We,0,0
126221,conclude,0,0
126222,that,0,0
126223,neurons,0,1
126224,in,0,0
126225,human,0,0
126226,visual,0,1
126227,cortex,0,0
126228,are,0,0
126229,selective,0,1
126230,for,0,0
126231,second-order,0,1
126232,SF,0,0
126233,",",0,1
126234,that,0,0
126235,normalization,0,1
126236,(,0,0
126237,surround,0,0
126238,suppression,0,1
126239,),0,0
126240,contributes,0,0
126241,to,0,0
126242,this,0,0
126243,selectivity,0,1
126244,",",0,1
126245,and,0,1
126246,that,0,0
126247,the,0,0
126248,selectivity,0,1
126249,in,0,0
126250,higher,0,0
126251,visual,0,1
126252,areas,0,1
126253,is,0,0
126254,simply,0,0
126255,fed,0,0
126256,forward,0,0
126257,from,0,0
126258,V1,0,0
126259,.,0,0
126260,Which,0,1
126261,women,0,0
126262,default,0,0
126263,from,0,0
126264,follow-up,0,0
126265,cervical,0,0
126266,cytology,0,1
126267,tests,0,1
126268,?,0,0
126269,A,0,0
126270,cohort,0,0
126271,study,0,0
126272,within,0,0
126273,the,0,0
126274,TOMBOLA,0,0
126275,trial,0,0
126276,.,0,0
126277,OBJECTIVE,0,0
126278,To,0,0
126279,identify,0,0
126280,factors,0,0
126281,associated,0,0
126282,with,0,0
126283,default,0,0
126284,from,0,0
126285,follow-up,1,0
126286,cervical,1,0
126287,cytology,1,1
126288,tests,1,1
126289,.,1,0
126290,METHODS,0,0
126291,A,0,0
126292,cohort,0,0
126293,study,0,0
126294,was,0,0
126295,conducted,0,0
126296,involving,0,0
126297,2166,0,0
126298,women,0,0
126299,",",0,0
126300,aged,0,0
126301,20-59,0,0
126302,",",0,0
126303,with,0,0
126304,recent,0,0
126305,low-grade,0,0
126306,cervical,0,0
126307,cytology,0,1
126308,taken,0,0
126309,within,0,0
126310,the,0,0
126311,NHS,0,0
126312,Cervical,0,1
126313,Screening,0,0
126314,Programmes,0,0
126315,in,0,0
126316,Scotland,0,0
126317,and,0,1
126318,England,0,1
126319,",",0,1
126320,and,0,1
126321,managed,0,0
126322,by,0,0
126323,6-monthly,0,1
126324,cytology,0,1
126325,in,0,0
126326,primary,0,0
126327,care,0,0
126328,.,0,0
126329,For,0,0
126330,the,0,0
126331,first,0,0
126332,(,0,0
126333,6-month,0,1
126334,),0,1
126335,and,0,1
126336,second,0,1
126337,(,0,1
126338,12-month,0,1
126339,),0,1
126340,surveillance,0,0
126341,cytology,0,1
126342,tests,0,1
126343,separately,0,0
126344,",",0,0
126345,women,0,0
126346,were,0,0
126347,categorized,0,0
126348,as,0,0
126349,'on-time,0,1
126350,attendees,0,0
126351,',0,1
126352,(,0,0
126353,attended,0,0
126354,?6,0,0
126355,months,0,0
126356,of,0,1
126357,test,0,1
126358,being,0,0
126359,due,0,0
126360,),0,0
126361,",",0,0
126362,'late,0,0
126363,attendees,0,1
126364,',0,1
126365,(,0,0
126366,attended,0,0
126367,greater,0,0
126368,than,0,0
126369,6,0,0
126370,months,0,0
126371,after,0,0
126372,test,0,1
126373,was,0,0
126374,due,0,0
126375,),0,1
126376,or,0,0
126377,'non-attendees,0,1
126378,',0,1
126379,(,0,0
126380,failed,0,0
126381,to,0,0
126382,attend,1,0
126383,),1,0
126384,.,1,0
126385,Multivariate,1,0
126386,odds,1,1
126387,ratios,1,1
126388,(,1,0
126389,ORs,0,0
126390,),0,1
126391,were,0,0
126392,computed,0,0
126393,for,0,0
126394,factors,0,0
126395,associated,0,0
126396,with,1,0
126397,late,1,1
126398,and,1,0
126399,non-attendance,1,1
126400,.,1,1
126401,RESULTS,0,0
126402,For,0,0
126403,the,0,0
126404,first,0,0
126405,surveillance,0,0
126406,test,1,1
126407,",",1,1
126408,risk,1,1
126409,of,1,1
126410,non-attendance,1,1
126411,was,1,0
126412,significantly,0,0
126413,higher,0,0
126414,in,0,0
126415,younger,0,0
126416,women,0,0
126417,",",0,0
126418,those,0,0
126419,without,0,0
126420,post-secondary,0,1
126421,education,0,0
126422,",",0,1
126423,and,0,1
126424,non-users,0,0
126425,of,0,1
126426,prescribed,0,0
126427,contraception,0,0
126428,.,0,0
126429,Factors,0,0
126430,significantly,0,0
126431,associated,0,0
126432,with,1,0
126433,late,1,1
126434,attendance,1,1
126435,for,1,0
126436,the,0,0
126437,first,0,1
126438,test,0,0
126439,were,0,0
126440,the,0,0
126441,same,0,0
126442,as,0,0
126443,for,0,0
126444,non-attendance,0,1
126445,",",0,1
126446,plus,0,0
126447,current,0,0
126448,smoking,0,1
126449,and,0,1
126450,having,0,0
126451,children,0,0
126452,.,0,0
126453,The,0,0
126454,most,0,0
126455,important,0,0
126456,predictor,0,0
126457,of,0,1
126458,non-attendance,1,1
126459,for,1,0
126460,the,0,0
126461,second,0,0
126462,surveillance,0,0
126463,test,0,1
126464,was,0,0
126465,late,0,1
126466,attendance,0,1
126467,for,0,0
126468,the,0,0
126469,first,0,1
126470,test,0,1
126471,(,0,0
126472,OR,0,0
126473,=,0,0
126474,9.65,0,0
126475,;,0,0
126476,95,0,0
126477,%,0,0
126478,CI,0,0
126479,",",0,1
126480,6.60-16.62,1,0
126481,),1,0
126482,.,1,0
126483,Non-attendance,1,1
126484,for,1,0
126485,the,0,0
126486,second,0,0
126487,test,0,1
126488,was,0,0
126489,also,0,0
126490,significantly,0,0
126491,higher,0,0
126492,among,0,0
126493,women,0,0
126494,who,0,0
126495,were,0,0
126496,younger,0,0
126497,",",0,1
126498,smokers,0,0
126499,and,0,1
126500,had,0,0
126501,negative,0,1
126502,cytology,0,1
126503,on,0,0
126504,the,0,0
126505,first,0,0
126506,surveillance,0,0
126507,test,1,1
126508,.,1,1
126509,Late,1,1
126510,attendance,1,1
126511,for,1,0
126512,the,0,0
126513,second,0,0
126514,surveillance,0,0
126515,test,0,1
126516,was,0,0
126517,higher,0,0
126518,in,0,0
126519,women,0,0
126520,who,0,0
126521,were,0,0
126522,younger,0,0
126523,",",0,1
126524,smokers,0,0
126525,",",0,1
126526,had,0,0
126527,children,0,0
126528,and,0,1
126529,attended,0,0
126530,late,0,1
126531,for,0,0
126532,the,0,0
126533,first,0,0
126534,test,0,0
126535,.,0,0
126536,CONCLUSIONS,0,0
126537,Women,0,0
126538,at,0,0
126539,highest,0,1
126540,risk,0,1
126541,of,0,1
126542,default,0,0
126543,from,0,0
126544,follow-up,0,0
126545,cytology,0,1
126546,tend,0,0
126547,to,0,0
126548,be,0,0
126549,young,0,0
126550,",",0,1
126551,smoke,0,1
126552,",",0,1
126553,lack,0,0
126554,post-secondary,0,1
126555,education,0,0
126556,",",0,0
126557,and,0,0
126558,have,0,0
126559,defaulted,0,0
126560,from,0,0
126561,a,0,0
126562,previous,0,0
126563,surveillance,0,0
126564,appointment,0,1
126565,.,0,1
126566,Tackling,0,0
126567,default,0,0
126568,will,0,0
126569,require,0,0
126570,development,0,1
126571,of,0,0
126572,targeted,0,0
126573,strategies,0,0
126574,to,0,0
126575,encourage,0,0
126576,attendance,0,1
126577,and,0,1
126578,research,0,0
126579,to,0,0
126580,better,0,0
126581,understand,0,0
126582,the,0,0
126583,reasons,0,0
126584,underpinning,0,0
126585,default,0,0
126586,.,0,0
126587,Sequential,0,0
126588,alternate,0,0
126589,administration,0,0
126590,of,0,1
126591,tamoxifen,0,0
126592,and,0,1
126593,medroxyprogesterone,0,0
126594,acetate,0,0
126595,in,0,0
126596,advanced,0,0
126597,breast,0,0
126598,cancer,0,0
126599,:,0,0
126600,clinical-biological,0,0
126601,randomized,0,0
126602,study,0,0
126603,.,0,0
126604,From,0,0
126605,January,0,0
126606,1985,0,0
126607,to,0,0
126608,September,0,0
126609,1988,0,0
126610,",",0,0
126611,60,0,0
126612,women,0,0
126613,with,0,0
126614,advanced,0,0
126615,breast,0,0
126616,cancer,0,0
126617,were,0,0
126618,randomized,0,0
126619,in,0,0
126620,two,0,0
126621,arms,0,0
126622,to,0,0
126623,receive,0,0
126624,:,0,0
126625,A,0,0
126626,),0,0
126627,tamoxifen,0,0
126628,(,0,1
126629,TAM,0,1
126630,),0,0
126631,(,0,0
126632,20,0,0
126633,mg/die,0,0
126634,),0,0
126635,until,0,0
126636,progression,0,1
126637,or,0,1
126638,B,0,0
126639,),0,1
126640,TAM,0,1
126641,(,0,0
126642,20,0,0
126643,mg/die,0,0
126644,for,0,0
126645,14,0,0
126646,days,0,0
126647,),0,0
126648,then,0,0
126649,medroxyprogesterone,0,0
126650,acetate,0,0
126651,(,0,1
126652,MPA,0,1
126653,),0,0
126654,(,0,0
126655,1500,0,0
126656,mg/die,0,0
126657,p.o,0,0
126658,.,0,0
126659,for,0,0
126660,14,0,0
126661,days,0,0
126662,),0,0
126663,followed,0,0
126664,by,0,0
126665,7,0,0
126666,days,0,0
126667,of,0,0
126668,wash-out,0,0
126669,before,0,0
126670,repeating,0,0
126671,the,0,0
126672,TAM/MPA,0,0
126673,treatment,0,0
126674,.,0,0
126675,All,0,0
126676,patients,0,0
126677,were,0,0
126678,post-menopausal,0,0
126679,",",0,0
126680,previously,0,0
126681,untreated,0,0
126682,with,0,0
126683,hormone,0,1
126684,therapy,0,0
126685,",",0,1
126686,and,0,1
126687,with,0,0
126688,tumor,0,1
126689,receptor,0,1
126690,status,0,1
126691,determined,0,0
126692,immediately,0,0
126693,before,0,0
126694,randomization,0,0
126695,;,0,0
126696,all,0,0
126697,had,0,0
126698,objectively,0,1
126699,evaluable,0,0
126700,lesions,0,1
126701,.,0,0
126702,In,0,0
126703,order,0,0
126704,to,0,0
126705,verify,0,0
126706,hormone,1,1
126707,receptor,1,1
126708,variations,1,0
126709,due,0,0
126710,to,0,0
126711,the,0,0
126712,antiestrogen,0,0
126713,",",0,0
126714,when,0,0
126715,possible,0,0
126716,a,0,0
126717,second,0,0
126718,biopsy,1,0
126719,was,0,0
126720,performed,0,0
126721,after,0,0
126722,the,0,0
126723,initial,0,0
126724,14,0,0
126725,day,0,0
126726,cycle,0,1
126727,of,0,0
126728,TAM,0,1
126729,.,0,1
126730,Thirty-one,0,0
126731,and,0,0
126732,29,0,0
126733,patients,0,0
126734,were,0,0
126735,included,0,0
126736,respectively,0,0
126737,in,0,0
126738,arms,0,0
126739,A,0,0
126740,and,0,0
126741,B,0,0
126742,.,0,1
126743,Objective,1,1
126744,regression,1,0
126745,(,0,0
126746,CR,0,1
126747,+,0,0
126748,PR,0,1
126749,),0,1
126750,was,0,0
126751,observed,0,0
126752,in,0,0
126753,58,0,0
126754,%,0,0
126755,of,0,0
126756,group,0,0
126757,A,0,0
126758,and,0,0
126759,75,0,0
126760,%,0,0
126761,of,0,0
126762,group,0,0
126763,B,0,0
126764,",",0,0
126765,with,0,0
126766,CR,0,1
126767,in,0,0
126768,11,0,0
126769,%,0,0
126770,and,0,0
126771,23,0,0
126772,%,0,0
126773,",",0,0
126774,respectively,0,0
126775,.,0,0
126776,Differences,0,1
126777,were,0,0
126778,not,0,0
126779,statistically,0,0
126780,significant,0,0
126781,.,0,0
126782,Median,1,1
126783,time,1,1
126784,to,1,0
126785,progression,1,1
126786,was,0,0
126787,12,0,0
126788,months,0,0
126789,for,0,0
126790,group,0,0
126791,A,0,0
126792,and,0,0
126793,9,0,0
126794,for,0,0
126795,group,0,0
126796,B,0,0
126797,.,0,1
126798,Overall,1,0
126799,survival,1,1
126800,has,0,0
126801,not,0,0
126802,yet,0,0
126803,been,0,0
126804,reached,0,0
126805,in,0,0
126806,group,0,0
126807,A,0,0
126808,while,0,0
126809,it,0,0
126810,was,0,0
126811,34,0,0
126812,months,0,0
126813,for,0,0
126814,patients,0,0
126815,of,0,0
126816,group,0,0
126817,B.,0,1
126818,Metrorrhagia,1,1
126819,was,0,0
126820,observed,0,0
126821,in,0,0
126822,two,0,0
126823,cases,0,0
126824,of,0,0
126825,group,0,0
126826,A,0,0
126827,and,0,0
126828,in,0,0
126829,6,0,0
126830,of,0,0
126831,group,0,0
126832,B,0,1
126833,",",0,1
126834,and,0,1
126835,thrombophlebitis,0,1
126836,in,0,0
126837,1,0,0
126838,and,0,0
126839,3,0,0
126840,cases,0,0
126841,",",0,0
126842,respectively,0,0
126843,.,0,0
126844,The,0,0
126845,second,0,0
126846,biopsy,0,0
126847,confirmed,0,0
126848,a,0,0
126849,clear,0,0
126850,increase,0,0
126851,of,0,1
126852,PgR,1,1
126853,content,1,1
126854,in,0,0
126855,8/11,0,1
126856,cases,0,0
126857,(,0,0
126858,75,0,0
126859,%,0,0
126860,),0,0
126861,.,0,0
126862,Plasma,1,1
126863,level,1,1
126864,variations,1,0
126865,of,1,1
126866,TAM,1,1
126867,",",1,0
126868,N-desmethyl,1,1
126869,TAM,1,1
126870,and,1,1
126871,MPA,1,1
126872,were,0,0
126873,checked,0,1
126874,at,0,0
126875,various,0,0
126876,intervals,0,0
126877,on,0,0
126878,3,0,0
126879,patients,0,0
126880,of,0,0
126881,group,0,0
126882,B,0,1
126883,",",0,1
126884,and,0,1
126885,confirmed,0,0
126886,that,0,0
126887,our,0,0
126888,schedule,0,0
126889,is,0,0
126890,able,0,0
126891,to,0,0
126892,produce,0,0
126893,a,0,0
126894,drug,0,0
126895,wash-out,0,0
126896,period,0,0
126897,for,0,0
126898,tumor,0,1
126899,cells,0,1
126900,.,0,0
126901,In,0,0
126902,conclusion,0,0
126903,",",0,0
126904,our,0,1
126905,study,0,0
126906,demonstrated,0,0
126907,that,0,0
126908,while,0,0
126909,the,0,0
126910,manipulation,0,0
126911,of,0,0
126912,hormone,0,0
126913,receptors,0,0
126914,seems,0,0
126915,possible,0,0
126916,",",0,0
126917,results,0,0
126918,indicating,0,0
126919,better,0,0
126920,overall,0,1
126921,survival,0,1
126922,and,0,1
126923,time,0,1
126924,to,0,1
126925,progression,0,1
126926,were,0,0
126927,not,0,0
126928,obtained,0,0
126929,with,0,0
126930,alternate,0,0
126931,sequential,0,0
126932,TAM-MPA,0,1
126933,therapy,0,0
126934,.,0,0
126935,Noninfiltrative,0,1
126936,anesthesia,0,0
126937,for,0,0
126938,transrectal,0,1
126939,prostate,0,0
126940,biopsy,0,0
126941,:,0,0
126942,a,0,0
126943,randomized,0,0
126944,prospective,0,0
126945,study,0,0
126946,comparing,0,0
126947,lidocaine-prilocaine,0,0
126948,cream,0,0
126949,and,0,1
126950,lidocaine-ketorolac,0,0
126951,gel,0,0
126952,.,0,0
126953,OBJECTIVES,0,1
126954,Periprostatic,0,0
126955,nerve,0,1
126956,block,0,1
126957,(,0,1
126958,PPNB,0,1
126959,),0,0
126960,is,0,0
126961,the,0,0
126962,standard,0,0
126963,anesthesia,0,0
126964,for,0,0
126965,ultrasound,0,1
126966,(,0,1
126967,US,0,1
126968,),0,1
126969,guided,0,0
126970,transrectal,0,1
126971,prostate,0,0
126972,biopsy,0,1
126973,(,0,1
126974,TPB,0,1
126975,),0,1
126976,",",0,0
126977,but,0,0
126978,periprostatic,0,1
126979,infiltration,0,1
126980,itself,0,0
126981,constitutes,0,0
126982,a,0,0
126983,major,0,1
126984,",",0,0
126985,though,0,0
126986,often,0,0
126987,neglected,0,0
126988,",",0,0
126989,source,0,1
126990,of,0,1
126991,discomfort,0,1
126992,even,0,0
126993,in,0,0
126994,patients,0,0
126995,receiving,0,0
126996,perianal-intrarectal,0,1
126997,lidocaine-prilocaine,0,0
126998,(,0,1
126999,PILP,0,0
127000,),0,1
127001,cream,0,0
127002,before,0,0
127003,PPNB,0,1
127004,.,0,0
127005,Noninfiltrative,0,1
127006,anesthesia,0,0
127007,therefore,0,0
127008,represents,0,0
127009,an,0,0
127010,attractive,0,0
127011,alternative,0,0
127012,to,0,0
127013,periprostatic,0,0
127014,infiltration,0,1
127015,.,0,0
127016,With,0,0
127017,this,0,0
127018,in,0,0
127019,mind,0,0
127020,",",0,0
127021,we,0,0
127022,aimed,0,0
127023,to,0,0
127024,determine,0,0
127025,the,0,0
127026,efficacy,1,1
127027,and,1,1
127028,safety,1,1
127029,of,0,1
127030,perianal-intrarectal,0,1
127031,(,0,0
127032,PI,0,0
127033,),0,1
127034,lidocaine,0,0
127035,gel,0,0
127036,",",0,1
127037,lidocaine-ketorolac,0,1
127038,gel,0,0
127039,",",0,1
127040,and,0,1
127041,lidocaine-prilocaine,0,0
127042,cream,0,0
127043,in,0,0
127044,relieving,1,1
127045,pain,1,1
127046,during,0,0
127047,TPB,0,0
127048,.,0,1
127049,MATERIALS,0,0
127050,AND,0,0
127051,METHODS,0,0
127052,Three,0,0
127053,hundred,0,0
127054,consecutive,0,0
127055,patients,0,0
127056,scheduled,0,0
127057,for,0,0
127058,US-guided,0,0
127059,TPB,0,1
127060,were,0,0
127061,randomized,0,0
127062,1:1:1,0,0
127063,to,0,0
127064,receive,0,0
127065,PI,0,0
127066,administration,0,0
127067,of,0,0
127068,5,0,0
127069,g,0,0
127070,2.5,0,0
127071,%,0,0
127072,lidocaine,0,0
127073,gel,0,0
127074,10,0,0
127075,minutes,0,0
127076,before,0,0
127077,TPB,0,0
127078,(,0,0
127079,Group,0,0
127080,1,0,0
127081,),0,0
127082,",",0,0
127083,or,0,0
127084,a,0,0
127085,mixture,0,0
127086,of,0,0
127087,5,0,0
127088,g,0,0
127089,2.5,0,0
127090,%,0,0
127091,lidocaine,0,0
127092,gel,0,0
127093,and,0,0
127094,0.3,0,0
127095,%,0,0
127096,ketorolac,0,0
127097,tromethamine,0,0
127098,solution,0,0
127099,1,0,0
127100,hour,0,0
127101,before,0,0
127102,TPB,0,1
127103,(,0,0
127104,Group,0,0
127105,2,0,0
127106,),0,0
127107,",",0,0
127108,or,0,0
127109,5,0,0
127110,g,0,0
127111,2.5,0,0
127112,%,0,0
127113,lidocaine,0,0
127114,and,0,0
127115,2.5,0,0
127116,%,0,0
127117,prilocaine,0,0
127118,cream,0,0
127119,20,0,0
127120,minutes,0,0
127121,before,0,0
127122,TPB,0,0
127123,(,0,0
127124,Group,0,0
127125,3,0,0
127126,),0,0
127127,.,0,0
127128,The,0,0
127129,0-to-10,1,1
127130,points,1,0
127131,visual,1,1
127132,analogue,1,1
127133,scale,1,1
127134,(,1,1
127135,VAS,1,1
127136,),1,1
127137,was,0,0
127138,used,0,0
127139,for,0,0
127140,assessing,0,0
127141,pain,0,1
127142,at,0,0
127143,probe,0,1
127144,insertion,0,1
127145,and,0,1
127146,movements,0,1
127147,(,0,1
127148,VAS-1,0,0
127149,),0,1
127150,",",0,0
127151,at,0,0
127152,prostate,0,0
127153,sampling,0,0
127154,(,0,1
127155,VAS-2,0,0
127156,),0,1
127157,",",0,0
127158,and,0,1
127159,maximal,0,1
127160,procedural,0,1
127161,pain,0,1
127162,(,0,1
127163,MPP,0,0
127164,),0,0
127165,.,0,0
127166,Complications,0,0
127167,occurring,0,0
127168,up,0,0
127169,to,0,0
127170,20,0,0
127171,days,0,0
127172,after,0,0
127173,the,0,0
127174,procedure,0,0
127175,were,0,0
127176,also,0,0
127177,recorded,0,0
127178,.,0,0
127179,RESULTS,0,0
127180,Four,0,1
127181,(,0,0
127182,1.3,0,0
127183,%,0,0
127184,),0,0
127185,patients,0,0
127186,were,0,0
127187,excluded,0,0
127188,because,0,0
127189,of,0,0
127190,unbearable,1,1
127191,pain,1,1
127192,during,0,0
127193,the,0,0
127194,procedure,0,0
127195,",",0,0
127196,leaving,0,0
127197,Group,0,0
127198,1,0,0
127199,with,0,0
127200,98,0,0
127201,patients,0,0
127202,",",0,0
127203,Group,0,0
127204,2,0,0
127205,with,0,0
127206,99,0,0
127207,",",0,0
127208,and,0,0
127209,Group,0,0
127210,3,0,0
127211,with,0,0
127212,99,0,0
127213,;,0,0
127214,the,0,0
127215,3,0,0
127216,groups,0,0
127217,were,0,0
127218,comparable,0,0
127219,for,0,0
127220,patients,0,0
127221,',0,1
127222,age,0,0
127223,",",0,1
127224,serum,1,1
127225,PSA,1,1
127226,",",1,1
127227,prostate,1,1
127228,volume,1,1
127229,",",1,1
127230,and,1,1
127231,cancer,1,1
127232,detection,1,1
127233,rate,1,1
127234,.,1,0
127235,The,0,0
127236,addition,0,0
127237,of,0,0
127238,either,0,0
127239,ketorolac,0,0
127240,or,0,0
127241,prilocaine,0,0
127242,to,0,0
127243,lidocaine,0,0
127244,significantly,0,0
127245,(,0,0
127246,P,0,0
127247,<,0,0
127248,0.0001,0,0
127249,),0,0
127250,reduced,0,0
127251,probe-related,0,1
127252,",",0,1
127253,sampling-related,0,1
127254,",",0,1
127255,and,0,1
127256,maximal,0,1
127257,procedural,1,1
127258,pain,1,1
127259,.,1,0
127260,Compared,0,0
127261,with,0,0
127262,lidocaine-prilocaine,0,0
127263,",",0,0
127264,lidocaine-ketorolac,0,1
127265,was,0,0
127266,less,0,0
127267,effective,0,1
127268,in,0,0
127269,relieving,0,0
127270,probe-related,1,1
127271,pain,1,1
127272,(,0,0
127273,mean,0,1
127274,VAS-1,0,0
127275,:,0,0
127276,1.47,0,0
127277,?,0,0
127278,1.30,0,0
127279,vs.,0,0
127280,0.39,0,0
127281,?,0,0
127282,0.65,0,0
127283,;,0,0
127284,P,0,0
127285,<,0,0
127286,0.0001,0,0
127287,),0,0
127288,but,0,0
127289,more,0,0
127290,effective,0,1
127291,in,0,0
127292,relieving,1,0
127293,sampling-related,1,1
127294,pain,1,1
127295,(,1,0
127296,mean,0,1
127297,VAS-2,0,0
127298,:,0,0
127299,0.76,0,0
127300,?,0,0
127301,0.94,0,0
127302,vs.,0,0
127303,1.54,0,0
127304,?,0,0
127305,1.02,0,0
127306,;,0,0
127307,P,0,0
127308,<,0,0
127309,0.0001,0,0
127310,),0,0
127311,;,0,0
127312,there,0,0
127313,was,0,0
127314,no,0,0
127315,difference,0,0
127316,in,0,0
127317,MPP,0,0
127318,(,0,0
127319,mean,0,0
127320,1.82,0,0
127321,?,0,0
127322,1.21,0,0
127323,vs.,0,0
127324,1.67,0,0
127325,?,0,0
127326,0.95,0,0
127327,),0,0
127328,",",0,0
127329,probably,0,0
127330,due,0,0
127331,to,0,0
127332,such,0,0
127333,different,0,0
127334,efficacy,0,1
127335,on,0,0
127336,the,0,0
127337,two,1,0
127338,pain,1,0
127339,sources,1,0
127340,.,1,1
127341,Complications,1,1
127342,were,0,0
127343,similar,0,0
127344,in,0,0
127345,the,0,0
127346,3,0,0
127347,groups,0,0
127348,.,0,0
127349,CONCLUSIONS,0,0
127350,Lidocaine-prilocaine,0,0
127351,cream,0,0
127352,was,0,0
127353,most,0,0
127354,effective,0,1
127355,on,0,0
127356,probe-related,1,1
127357,pain,1,1
127358,",",1,0
127359,whereas,0,0
127360,lidocaine-ketorolac,0,1
127361,gel,0,0
127362,was,0,0
127363,most,0,0
127364,effective,0,1
127365,on,0,0
127366,sampling-related,0,0
127367,pain,0,1
127368,.,0,0
127369,These,0,0
127370,noninfiltrative,0,0
127371,anesthetics,0,0
127372,were,0,0
127373,safe,0,1
127374,",",0,0
127375,easy,0,1
127376,to,0,0
127377,administer,0,0
127378,",",0,0
127379,and,0,1
127380,well,0,1
127381,accepted,0,0
127382,by,0,0
127383,patients,0,0
127384,;,0,0
127385,the,0,0
127386,possibility,0,0
127387,to,0,0
127388,combine,0,0
127389,them,0,0
127390,to,0,0
127391,further,0,0
127392,improve,1,0
127393,pain,1,1
127394,control,1,0
127395,during,1,0
127396,TPB,0,0
127397,deserves,0,0
127398,further,0,0
127399,well-designed,0,0
127400,studies,0,0
127401,.,0,0
127402,Evaluation,0,1
127403,of,0,0
127404,a,0,0
127405,preventive,0,0
127406,intervention,0,0
127407,for,0,0
127408,child,0,1
127409,anxiety,0,1
127410,in,0,0
127411,two,0,0
127412,randomized,0,0
127413,attention-control,0,0
127414,school,0,0
127415,trials,0,0
127416,.,0,0
127417,The,0,0
127418,present,0,0
127419,research,0,0
127420,examined,0,0
127421,the,0,0
127422,effectiveness,0,0
127423,of,0,0
127424,a,0,0
127425,cognitive-behavioral,1,0
127426,therapy,1,0
127427,(,0,1
127428,CBT,0,0
127429,),0,1
127430,based,0,0
127431,intervention,0,0
127432,program,0,0
127433,",",0,1
127434,FRIENDS,0,1
127435,",",0,1
127436,for,0,0
127437,children,0,0
127438,from,0,0
127439,grades,0,0
127440,4,0,0
127441,to,0,0
127442,6,0,0
127443,",",0,0
127444,using,0,0
127445,random,0,0
127446,assignment,0,0
127447,at,0,0
127448,the,0,0
127449,school-level,0,0
127450,and,0,0
127451,an,0,0
127452,attention-control,0,0
127453,design,0,0
127454,in,0,0
127455,two,0,0
127456,longitudinal,0,0
127457,studies,0,0
127458,.,0,0
127459,The,0,0
127460,first,0,1
127461,study,0,0
127462,targeted,0,0
127463,children,0,0
127464,with,0,0
127465,anxiety,1,1
127466,symptoms,1,1
127467,(,0,1
127468,N=191,0,0
127469,",",0,1
127470,mean,0,1
127471,age=10.1,0,0
127472,),0,0
127473,as,0,0
127474,screened,0,1
127475,with,0,0
127476,self,0,1
127477,",",0,1
127478,parent,0,1
127479,",",0,1
127480,and,0,1
127481,teacher-reports,0,1
127482,;,0,0
127483,the,0,0
127484,second,0,0
127485,study,0,0
127486,took,0,0
127487,a,0,0
127488,universal,0,0
127489,approach,0,0
127490,with,0,0
127491,full,0,0
127492,classrooms,0,0
127493,of,0,0
127494,children,0,0
127495,participating,0,0
127496,(,0,0
127497,N=253,0,0
127498,",",0,1
127499,mean,0,1
127500,age=9.8,0,0
127501,),0,0
127502,.,0,0
127503,The,0,0
127504,results,0,0
127505,showed,0,0
127506,no,0,0
127507,intervention,0,0
127508,effect,0,0
127509,in,0,0
127510,both,0,0
127511,studies,0,0
127512,",",0,0
127513,with,1,0
127514,children,1,0
127515,'s,1,1
127516,anxiety,1,1
127517,symptoms,1,1
127518,decreasing,0,1
127519,over,0,0
127520,time,0,1
127521,regardless,0,0
127522,of,0,0
127523,whether,0,0
127524,they,0,0
127525,were,0,0
127526,in,0,0
127527,the,0,0
127528,story-reading,0,1
127529,(,0,0
127530,attention,0,1
127531,control,0,0
127532,),0,1
127533,or,0,0
127534,FRIENDS,0,1
127535,condition,0,0
127536,.,0,0
127537,The,0,0
127538,findings,0,0
127539,also,0,0
127540,indicated,0,0
127541,that,0,0
127542,girls,0,0
127543,reported,0,0
127544,a,0,0
127545,higher,1,0
127546,level,1,1
127547,of,1,1
127548,anxiety,1,1
127549,than,0,0
127550,boys,0,0
127551,and,0,1
127552,children,0,0
127553,in,0,0
127554,higher,0,0
127555,grades,0,1
127556,reported,0,0
127557,lower,1,1
127558,anxiety,1,1
127559,relative,0,1
127560,to,0,0
127561,younger,0,0
127562,children,0,0
127563,in,0,0
127564,both,0,0
127565,studies,0,0
127566,.,0,0
127567,In,0,0
127568,addition,0,0
127569,",",0,0
127570,similar,0,0
127571,patterns,0,1
127572,were,0,0
127573,found,0,0
127574,using,0,0
127575,a,0,0
127576,subgroup,0,0
127577,of,0,0
127578,children,0,0
127579,with,1,0
127580,high-anxiety,1,0
127581,symptoms,1,1
127582,from,0,0
127583,both,0,0
127584,studies,0,0
127585,.,0,0
127586,Nephrotoxicity,0,1
127587,of,0,1
127588,cyclosporin,0,0
127589,A,0,0
127590,in,0,0
127591,patients,0,0
127592,with,0,0
127593,newly,0,0
127594,diagnosed,0,0
127595,type,0,0
127596,1,0,0
127597,diabetes,0,0
127598,mellitus,0,0
127599,.,0,0
127600,Renal,0,1
127601,function,0,1
127602,was,0,0
127603,studied,0,0
127604,in,0,0
127605,18,0,0
127606,patients,0,0
127607,with,0,0
127608,Type,0,0
127609,1,0,0
127610,diabetes,0,0
127611,mellitus,0,0
127612,.,0,0
127613,All,0,0
127614,were,0,0
127615,participating,0,0
127616,in,0,0
127617,the,0,0
127618,Canadian-European,0,0
127619,randomized,0,0
127620,placebo-controlled,0,0
127621,cyclosporin,0,0
127622,trial,0,0
127623,in,0,0
127624,newly,0,0
127625,diagnosed,0,0
127626,Type,0,0
127627,1,0,0
127628,diabetic,0,0
127629,patients,0,0
127630,",",0,0
127631,nine,0,0
127632,being,0,0
127633,randomized,0,0
127634,to,0,0
127635,placebo,0,0
127636,",",0,0
127637,and,0,0
127638,nine,0,0
127639,to,0,0
127640,cyclosporin,0,0
127641,A,0,0
127642,.,0,0
127643,During,0,0
127644,treatment,0,0
127645,for,0,0
127646,12,0,0
127647,to,0,0
127648,18,0,0
127649,months,0,0
127650,",",0,0
127651,cyclosporin,0,0
127652,A,0,0
127653,caused,0,0
127654,significant,0,0
127655,reductions,0,1
127656,in,0,0
127657,the,0,0
127658,glomerular,1,1
127659,filtration,1,1
127660,rate,1,1
127661,(,0,0
127662,before,0,0
127663,drug,0,1
127664,withdrawal,0,1
127665,",",0,0
127666,cyclosporin,0,0
127667,97,0,0
127668,+/-,0,0
127669,18,0,0
127670,vs,0,0
127671,placebo,0,0
127672,125,0,0
127673,+/-,0,0
127674,16,0,0
127675,ml,0,0
127676,min-1,0,0
127677,1.73-m-2,0,0
127678,",",0,0
127679,p,0,0
127680,less,0,0
127681,than,0,0
127682,0.05,0,0
127683,),0,0
127684,",",0,0
127685,renal,1,1
127686,plasma,1,1
127687,flow,1,1
127688,(,0,0
127689,454,0,0
127690,+/-,0,0
127691,83,0,0
127692,vs,0,0
127693,536,0,0
127694,+/-,0,0
127695,70,0,0
127696,ml,0,0
127697,min-1,0,0
127698,1.73-m-2,0,0
127699,",",0,0
127700,p,0,0
127701,less,0,0
127702,than,0,0
127703,0.05,0,0
127704,),0,0
127705,",",0,0
127706,and,0,1
127707,lithium,1,1
127708,clearance,1,1
127709,(,0,0
127710,17,0,0
127711,+/-,0,0
127712,3,0,0
127713,vs,0,0
127714,28,0,0
127715,+/-,0,0
127716,5,0,0
127717,ml,0,0
127718,min-1,0,0
127719,1.73-m-2,0,0
127720,",",0,0
127721,p,0,0
127722,less,0,0
127723,than,0,0
127724,0.05,0,0
127725,),0,0
127726,.,0,0
127727,The,0,0
127728,fractional,1,1
127729,proximal,1,0
127730,reabsorption,1,1
127731,was,0,0
127732,increased,0,0
127733,(,0,0
127734,0.82,0,0
127735,+/-,0,0
127736,0.03,0,0
127737,vs,0,0
127738,0.78,0,0
127739,+/-,0,0
127740,0.03,0,0
127741,",",0,0
127742,p,0,0
127743,less,0,0
127744,than,0,0
127745,0.05,0,0
127746,),0,0
127747,",",0,0
127748,and,0,0
127749,the,0,0
127750,fractional,1,1
127751,distal,1,1
127752,sodium,1,1
127753,reabsorption,1,1
127754,reduced,0,1
127755,(,0,0
127756,0.88,0,0
127757,+/-,0,0
127758,0.03,0,0
127759,vs,0,0
127760,0.94,0,0
127761,+/-,0,0
127762,0.02,0,0
127763,",",0,0
127764,p,0,0
127765,less,0,0
127766,than,0,0
127767,0.05,0,0
127768,),0,0
127769,.,0,0
127770,These,0,0
127771,results,0,0
127772,are,0,0
127773,in,0,0
127774,accordance,0,0
127775,with,0,0
127776,the,0,0
127777,hypothesis,0,0
127778,that,0,0
127779,the,0,0
127780,nephrotoxic,0,1
127781,effect,0,1
127782,of,0,1
127783,cyclosporin,0,0
127784,A,0,0
127785,results,0,0
127786,from,0,0
127787,a,0,0
127788,preferential,0,0
127789,constriction,0,1
127790,of,0,1
127791,afferent,0,1
127792,glomerular,0,1
127793,vessels,0,0
127794,.,0,0
127795,One,0,0
127796,year,0,0
127797,after,0,0
127798,withdrawal,0,1
127799,of,0,0
127800,the,0,0
127801,drug,0,0
127802,",",0,0
127803,all,0,0
127804,variables,0,1
127805,were,0,0
127806,similar,0,0
127807,in,0,0
127808,the,0,0
127809,two,0,0
127810,groups,0,0
127811,",",0,0
127812,except,0,0
127813,for,0,0
127814,blood,1,1
127815,glucose,1,1
127816,control,1,0
127817,which,0,0
127818,was,0,0
127819,worse,0,0
127820,in,0,0
127821,the,0,0
127822,cyclosporin,0,0
127823,A,0,0
127824,treated,0,0
127825,group,0,0
127826,.,0,0
127827,When,0,0
127828,corrected,0,0
127829,for,0,0
127830,differences,0,0
127831,in,0,0
127832,blood,0,1
127833,glucose,0,1
127834,control,0,0
127835,it,0,0
127836,appeared,0,0
127837,that,0,0
127838,in,0,0
127839,three,0,0
127840,out,0,0
127841,of,0,0
127842,nine,0,0
127843,patients,0,0
127844,glomerular,1,1
127845,filtration,1,1
127846,rate,1,1
127847,had,0,0
127848,not,0,0
127849,completely,0,0
127850,returned,0,0
127851,to,0,0
127852,the,0,0
127853,reference,0,0
127854,range,0,0
127855,of,0,0
127856,the,0,0
127857,placebo,0,0
127858,group,0,0
127859,.,0,0
127860,We,0,0
127861,conclude,0,0
127862,that,0,0
127863,the,0,0
127864,nephrotoxic,0,1
127865,side-effects,0,1
127866,of,0,0
127867,cyclosporin,0,0
127868,A,0,0
127869,treatment,0,0
127870,for,0,0
127871,1,0,0
127872,year,0,0
127873,are,0,0
127874,reversible,0,0
127875,.,0,0
127876,There,0,0
127877,are,0,0
127878,",",0,0
127879,however,0,0
127880,",",0,0
127881,signs,0,1
127882,of,0,1
127883,minor,0,1
127884,and,0,0
127885,perhaps,0,0
127886,chronic,0,0
127887,renal,0,1
127888,injury,0,1
127889,.,0,0
127890,[,0,0
127891,Results,0,0
127892,of,0,0
127893,three-year,0,0
127894,clinical,0,0
127895,study,0,0
127896,of,0,1
127897,prostamol,0,0
127898,uno,0,0
127899,efficacy,1,1
127900,and,0,1
127901,safety,1,1
127902,in,0,0
127903,patients,0,0
127904,with,0,0
127905,initial,0,0
127906,symptoms,0,1
127907,of,0,1
127908,prostatic,0,1
127909,adenoma,0,1
127910,and,0,1
127911,risk,0,1
127912,of,0,0
127913,its,0,0
127914,progression,0,1
127915,],0,0
127916,.,0,1
127917,Prostamol,0,0
127918,Uno,0,1
127919,(,0,1
127920,PU,0,1
127921,),0,1
127922,efficacy,1,1
127923,and,0,1
127924,safety,1,1
127925,were,0,0
127926,studied,0,0
127927,in,0,0
127928,a,0,0
127929,multicenter,0,0
127930,",",0,1
127931,open-population,0,1
127932,",",0,1
127933,randomized,0,0
127934,and,0,1
127935,comparative,0,0
127936,trial,0,0
127937,.,0,1
127938,PU,0,1
127939,was,0,0
127940,given,0,0
127941,in,0,0
127942,a,0,0
127943,single,0,0
127944,daily,0,0
127945,dose,0,0
127946,320,0,0
127947,mg,0,0
127948,for,0,0
127949,36,0,0
127950,months,0,0
127951,to,0,0
127952,50,0,0
127953,patients,0,0
127954,with,0,0
127955,initial,0,0
127956,symptoms,0,1
127957,of,0,1
127958,prostatic,0,1
127959,adenoma,0,1
127960,(,0,1
127961,PA,0,1
127962,),0,1
127963,in,0,0
127964,comparison,0,0
127965,with,0,0
127966,50,0,0
127967,matched,0,0
127968,controls,0,0
127969,.,0,0
127970,The,0,0
127971,trial,0,0
127972,evaluated,0,0
127973,PU,0,1
127974,action,0,1
127975,on,0,0
127976,the,0,0
127977,symptoms,1,1
127978,progression,1,1
127979,and,0,1
127980,quality,1,1
127981,of,1,1
127982,life,1,1
127983,with,0,0
127984,application,0,0
127985,of,0,0
127986,questionnaires,1,1
127987,IPSS,1,0
127988,and,1,1
127989,QoL,1,1
127990,(,1,1
127991,BS,1,0
127992,),1,0
127993,.,1,0
127994,It,0,0
127995,was,0,0
127996,found,0,0
127997,that,0,0
127998,PU,0,1
127999,treatment,0,0
128000,relieved,0,1
128001,PA,1,1
128002,symptoms,1,1
128003,by,0,0
128004,IPSS,0,0
128005,",",0,0
128006,while,0,0
128007,these,0,0
128008,symptoms,0,1
128009,progressed,0,0
128010,in,0,0
128011,the,0,0
128012,controls,0,0
128013,.,0,0
128014,QoL,1,1
128015,improved,0,0
128016,in,0,0
128017,the,0,0
128018,study,0,0
128019,group,0,0
128020,and,0,1
128021,deteriorated,0,0
128022,in,0,0
128023,the,0,0
128024,control,0,0
128025,one,0,0
128026,.,0,0
128027,Administration,0,0
128028,of,0,0
128029,PU,0,1
128030,significantly,0,0
128031,increased,0,0
128032,urinary,1,1
128033,flow,1,1
128034,rate,1,1
128035,though,0,0
128036,in,0,0
128037,the,0,0
128038,controls,0,0
128039,urinary,1,1
128040,flow,1,1
128041,rate,1,1
128042,decreased,0,1
128043,",",0,0
128044,size,1,1
128045,of,1,0
128046,the,1,0
128047,prostate,1,0
128048,diminished,0,1
128049,and,0,1
128050,increased,0,1
128051,",",0,0
128052,respectively,0,0
128053,.,0,0
128054,Changes,0,1
128055,in,0,0
128056,the,0,0
128057,PSA,1,1
128058,were,0,0
128059,not,0,0
128060,seen,0,0
128061,and,0,0
128062,were,0,0
128063,insignificant,0,1
128064,",",0,0
128065,respectively,0,0
128066,.,0,0
128067,The,0,0
128068,results,0,0
128069,of,0,0
128070,the,0,0
128071,study,0,0
128072,say,0,0
128073,that,0,0
128074,prostamol,0,0
128075,Uno,0,0
128076,in,0,0
128077,a,0,0
128078,dose,0,0
128079,320,0,0
128080,mg/day,0,0
128081,can,0,0
128082,prevent,0,0
128083,PA,0,1
128084,progression,0,1
128085,without,0,0
128086,side,1,1
128087,effects,1,0
128088,.,1,0
128089,Superior,0,1
128090,fixation,0,1
128091,of,0,1
128092,pegged,0,0
128093,trabecular,0,1
128094,metal,0,1
128095,over,0,0
128096,screw-fixed,0,0
128097,pegged,0,0
128098,porous,0,0
128099,titanium,0,1
128100,fiber,0,0
128101,mesh,0,0
128102,:,0,0
128103,a,0,0
128104,randomized,0,0
128105,clinical,0,0
128106,RSA,0,1
128107,study,0,0
128108,on,0,0
128109,cementless,0,0
128110,tibial,0,1
128111,components,0,1
128112,.,0,1
128113,BACKGROUND,0,0
128114,AND,0,0
128115,PURPOSE,0,0
128116,Lasting,0,1
128117,stability,1,1
128118,of,0,1
128119,cementless,0,0
128120,implants,0,0
128121,depends,0,0
128122,on,0,0
128123,osseointegration,0,1
128124,into,0,0
128125,the,0,0
128126,implant,0,0
128127,surface,0,1
128128,",",0,1
128129,and,0,1
128130,long-term,0,1
128131,implant,0,0
128132,fixation,0,0
128133,can,0,0
128134,be,0,0
128135,predicted,0,1
128136,using,0,0
128137,radiostereometric,0,0
128138,analysis,0,0
128139,(,0,1
128140,RSA,0,1
128141,),0,0
128142,with,0,0
128143,short-term,0,0
128144,follow-up,0,0
128145,.,0,0
128146,We,0,0
128147,hypothesized,0,0
128148,that,0,0
128149,there,0,0
128150,would,0,0
128151,be,0,0
128152,improved,0,0
128153,fixation,1,1
128154,of,0,0
128155,high-porosity,0,1
128156,trabecular,0,1
128157,metal,0,1
128158,(,0,1
128159,TM,0,1
128160,),0,1
128161,tibial,0,1
128162,components,0,0
128163,compared,0,0
128164,to,0,0
128165,low-porosity,0,1
128166,titanium,0,1
128167,pegged,0,0
128168,porous,0,0
128169,fiber-metal,0,0
128170,(,0,0
128171,Ti,0,0
128172,),0,1
128173,polyethylene,0,0
128174,metal,0,1
128175,backings,0,0
128176,.,0,0
128177,METHODS,0,0
128178,In,0,0
128179,a,0,0
128180,prospective,0,0
128181,",",0,0
128182,parallel-group,0,0
128183,",",0,1
128184,randomized,0,0
128185,unblinded,0,0
128186,clinical,0,0
128187,trial,0,0
128188,",",0,0
128189,we,0,0
128190,compared,0,0
128191,cementless,0,0
128192,tibial,0,1
128193,components,0,1
128194,in,0,0
128195,patients,0,0
128196,aged,0,0
128197,70,0,0
128198,years,0,0
128199,and,0,0
128200,younger,0,0
128201,with,0,0
128202,osteoarthritis,0,0
128203,.,0,0
128204,The,0,0
128205,pre-study,0,0
128206,sample,0,0
128207,size,0,1
128208,calculation,0,1
128209,was,0,0
128210,22,0,0
128211,patients,0,0
128212,per,0,0
128213,group,0,0
128214,.,0,0
128215,25,0,0
128216,TM,0,0
128217,tibial,0,0
128218,components,0,1
128219,were,0,0
128220,fixed,0,0
128221,press-fit,0,0
128222,by,0,0
128223,2,0,0
128224,hexagonal,0,0
128225,pegs,0,0
128226,(,0,1
128227,TM,0,1
128228,group,0,0
128229,),0,0
128230,and,0,0
128231,25,0,0
128232,Ti,0,0
128233,tibial,0,0
128234,components,0,1
128235,were,0,0
128236,fixed,0,0
128237,press-fit,0,0
128238,and,0,0
128239,by,0,0
128240,4,0,0
128241,supplemental,0,0
128242,screws,0,0
128243,(,0,0
128244,Ti,0,1
128245,group,0,0
128246,),0,0
128247,.,0,0
128248,Stereo,0,0
128249,radiographs,0,1
128250,for,0,0
128251,evaluation,0,0
128252,of,0,1
128253,absolute,0,1
128254,component,0,1
128255,migration,0,1
128256,(,0,1
128257,primary,0,1
128258,effect,0,1
128259,size,0,1
128260,),0,1
128261,and,0,1
128262,single-direction,0,0
128263,absolute,0,1
128264,component,0,1
128265,migration,0,1
128266,(,0,1
128267,secondary,0,1
128268,effect,0,1
128269,size,0,1
128270,),0,1
128271,were,0,0
128272,obtained,0,0
128273,within,0,0
128274,the,0,0
128275,first,0,0
128276,postoperative,0,1
128277,week,0,0
128278,and,0,0
128279,at,0,0
128280,6,0,0
128281,weeks,0,0
128282,",",0,0
128283,6,0,0
128284,months,0,0
128285,",",0,0
128286,1,0,0
128287,year,0,0
128288,",",0,0
128289,and,0,0
128290,2,0,0
128291,years,0,0
128292,.,0,0
128293,American,1,0
128294,Knee,1,1
128295,Society,1,1
128296,score,1,1
128297,was,0,0
128298,used,0,0
128299,for,0,0
128300,clinical,0,0
128301,assessment,0,0
128302,preoperatively,0,1
128303,",",0,0
128304,and,0,0
128305,at,0,0
128306,1,0,0
128307,and,0,0
128308,2,0,0
128309,years,0,0
128310,.,0,0
128311,RESULTS,0,0
128312,There,0,0
128313,were,0,0
128314,no,0,0
128315,intraoperative,1,1
128316,complications,1,1
128317,",",1,0
128318,and,1,0
128319,no,1,0
128320,postoperative,1,1
128321,infections,1,1
128322,or,1,0
128323,revisions,1,1
128324,.,1,0
128325,All,0,0
128326,patients,0,0
128327,had,0,0
128328,improved,1,1
128329,function,1,1
128330,and,1,1
128331,regained,1,0
128332,full,1,0
128333,extension,1,0
128334,.,1,0
128335,All,0,0
128336,tibial,0,1
128337,components,0,1
128338,migrated,1,0
128339,initially,0,0
128340,.,0,0
128341,Most,0,0
128342,migration,1,1
128343,of,1,0
128344,the,1,0
128345,TM,1,0
128346,components,1,1
128347,(,0,0
128348,n,0,0
128349,=,0,0
128350,24,0,0
128351,),0,0
128352,occurred,0,0
128353,within,0,0
128354,the,0,0
128355,first,0,0
128356,3,0,0
128357,months,0,0
128358,after,0,0
128359,surgery,0,0
128360,whereas,0,0
128361,migration,0,1
128362,of,0,0
128363,the,0,0
128364,Ti,0,0
128365,components,0,1
128366,(,0,0
128367,n,0,0
128368,=,0,0
128369,22,0,0
128370,),0,0
128371,appeared,0,0
128372,to,0,0
128373,stabilize,0,0
128374,first,0,0
128375,after,0,0
128376,1,0,0
128377,year,0,0
128378,.,0,0
128379,The,0,0
128380,TM,0,0
128381,components,0,1
128382,migrated,0,1
128383,less,0,0
128384,than,0,0
128385,the,0,0
128386,Ti,0,0
128387,components,0,0
128388,at,0,0
128389,1,0,0
128390,year,0,0
128391,(,0,0
128392,p,0,0
128393,=,0,0
128394,0.01,0,0
128395,),0,0
128396,and,0,0
128397,2,0,0
128398,years,0,0
128399,(,0,0
128400,p,0,0
128401,=,0,0
128402,0.004,0,0
128403,),0,0
128404,.,0,0
128405,INTERPRETATION,0,0
128406,We,0,0
128407,conclude,0,0
128408,that,0,0
128409,the,0,0
128410,mechanical,0,0
128411,fixation,0,1
128412,of,0,1
128413,TM,0,1
128414,tibial,0,0
128415,components,0,0
128416,is,0,0
128417,superior,0,0
128418,to,0,0
128419,that,0,0
128420,of,0,0
128421,screw-fixed,0,0
128422,Ti,0,0
128423,tibial,0,1
128424,components,0,0
128425,.,0,0
128426,We,0,0
128427,expect,0,0
128428,long-term,1,1
128429,implant,1,0
128430,survival,1,1
128431,to,0,0
128432,be,0,0
128433,better,0,0
128434,with,0,0
128435,the,0,0
128436,TM,0,0
128437,tibial,0,1
128438,component,0,1
128439,.,0,0
128440,A,0,0
128441,novel,0,0
128442,approach,0,0
128443,to,0,0
128444,the,0,0
128445,use,0,0
128446,of,0,0
128447,subgingival,0,1
128448,controlled-release,0,0
128449,chlorhexidine,0,0
128450,delivery,0,1
128451,in,0,0
128452,chronic,0,0
128453,periodontitis,0,0
128454,:,0,0
128455,a,0,0
128456,randomized,0,0
128457,clinical,0,0
128458,trial,0,0
128459,.,0,0
128460,BACKGROUND,0,0
128461,We,0,0
128462,aimed,0,0
128463,to,0,0
128464,analyze,0,0
128465,clinical,1,0
128466,",",1,0
128467,microbiologic,1,1
128468,",",1,1
128469,and,1,1
128470,serologic,1,1
128471,effects,1,1
128472,of,0,1
128473,chlorhexidine,0,0
128474,(,0,1
128475,CHX,0,1
128476,),0,0
128477,chips,0,0
128478,used,0,0
128479,as,0,0
128480,a,0,0
128481,subgingival,0,0
128482,controlled-release,0,0
128483,delivery,0,1
128484,device,0,0
128485,before,0,0
128486,and,0,0
128487,immediately,0,0
128488,after,0,0
128489,scaling,0,1
128490,and,0,1
128491,root,0,1
128492,planing,0,0
128493,(,0,1
128494,SRP,0,1
128495,),0,0
128496,.,0,0
128497,METHODS,0,0
128498,Twenty-four,0,0
128499,patients,0,0
128500,presenting,0,1
128501,with,0,0
128502,?12,0,0
128503,teeth,0,0
128504,with,0,0
128505,probing,0,1
128506,depth,0,1
128507,(,0,1
128508,PD,0,1
128509,),0,0
128510,?5,0,0
128511,mm,0,0
128512,and,0,1
128513,bleeding,0,1
128514,on,0,0
128515,probing,0,1
128516,were,0,0
128517,assigned,0,0
128518,in,0,0
128519,test,0,1
128520,or,0,1
128521,control,0,0
128522,groups,0,0
128523,.,0,0
128524,After,0,0
128525,prophylaxis,0,0
128526,",",0,1
128527,CHX,0,1
128528,chips,0,0
128529,(,0,1
128530,test,0,1
128531,),0,1
128532,or,0,0
128533,placebo,0,0
128534,chips,0,0
128535,(,0,1
128536,control,0,0
128537,),0,1
128538,were,0,0
128539,placed,0,0
128540,in,0,0
128541,pockets,0,1
128542,with,0,0
128543,PD,0,1
128544,?5,0,0
128545,mm,0,0
128546,.,0,0
128547,Ten,0,0
128548,days,0,0
128549,later,0,0
128550,",",0,0
128551,SRP,0,1
128552,was,0,0
128553,performed,0,0
128554,in,0,0
128555,all,0,0
128556,teeth,0,0
128557,with,0,0
128558,PD,0,1
128559,?4,0,0
128560,mm,0,0
128561,in,0,0
128562,a,0,0
128563,single,0,0
128564,appointment,0,0
128565,.,0,0
128566,Immediately,0,0
128567,after,0,0
128568,SRP,0,1
128569,",",0,0
128570,new,0,1
128571,chips,0,0
128572,were,0,0
128573,inserted,0,0
128574,in,0,0
128575,all,0,0
128576,pockets,0,1
128577,with,0,0
128578,PD,0,1
128579,?5,0,0
128580,mm,0,0
128581,.,0,1
128582,Parameters,0,1
128583,were,0,0
128584,assessed,0,0
128585,at,0,0
128586,baseline,0,0
128587,;,0,0
128588,beginning,0,0
128589,of,0,0
128590,SRP,0,1
128591,;,0,0
128592,and,0,0
128593,1,0,0
128594,",",0,0
128595,3,0,0
128596,",",0,0
128597,and,0,0
128598,6,0,0
128599,months,0,0
128600,after,0,0
128601,treatment,0,0
128602,.,0,0
128603,Subgingival,1,1
128604,samples,1,0
128605,were,1,0
128606,obtained,0,0
128607,at,0,0
128608,baseline,0,0
128609,;,0,0
128610,beginning,0,0
128611,of,0,0
128612,SRP,0,1
128613,;,0,0
128614,and,0,0
128615,at,0,0
128616,1,0,0
128617,month,0,0
128618,after,0,0
128619,treatment,0,0
128620,.,0,0
128621,Periodontal,1,1
128622,pathogens,1,1
128623,Aggregatibacter,1,1
128624,actinomycetemcomitans,1,1
128625,",",1,1
128626,Porphyromonas,1,1
128627,gingivalis,1,1
128628,",",1,1
128629,Prevotella,1,1
128630,intermedia,1,1
128631,",",1,1
128632,Tannerella,1,1
128633,forsythia,1,1
128634,",",1,1
128635,and,1,1
128636,Treponema,1,1
128637,denticola,1,1
128638,were,0,0
128639,analyzed,0,0
128640,.,0,0
128641,Serum,1,0
128642,levels,1,1
128643,of,1,0
128644,high,1,0
128645,sensitive,1,0
128646,C-reactive,1,1
128647,and,1,1
128648,lipopolysaccharide-binding,1,1
128649,proteins,1,1
128650,were,0,0
128651,measured,0,0
128652,.,0,0
128653,The,0,0
128654,changes,0,1
128655,of,0,0
128656,the,0,0
128657,parameters,0,1
128658,between,0,0
128659,and,0,0
128660,within,0,0
128661,the,0,0
128662,groups,0,0
128663,were,0,0
128664,tested,0,0
128665,by,0,0
128666,Mann-Whitney,1,0
128667,U,1,0
128668,test,1,1
128669,(,1,0
128670,P,1,0
128671,<,0,0
128672,0.05,0,0
128673,),0,0
128674,.,0,0
128675,RESULTS,0,0
128676,All,0,0
128677,clinical,0,1
128678,and,0,1
128679,serologic,0,1
128680,parameters,0,1
128681,improved,0,0
128682,in,0,0
128683,both,0,0
128684,groups,0,0
128685,over,0,0
128686,time,0,1
128687,.,0,0
128688,There,0,0
128689,was,0,0
128690,a,0,0
128691,significant,0,0
128692,difference,0,0
128693,in,1,0
128694,clinical,1,1
128695,attachment,1,1
128696,level,1,1
128697,(,1,1
128698,CAL,1,1
128699,),1,1
128700,gain,1,1
128701,from,1,0
128702,baseline,0,0
128703,to,0,0
128704,6,0,0
128705,months,0,0
128706,between,0,0
128707,groups,0,0
128708,(,0,0
128709,1.17,0,0
128710,mm,0,0
128711,in,0,0
128712,the,0,0
128713,test,0,1
128714,group,0,0
128715,versus,0,0
128716,0.79,0,0
128717,mm,0,0
128718,in,0,0
128719,the,0,0
128720,placebo,0,0
128721,group,0,0
128722,),0,1
128723,(,0,0
128724,P,0,0
128725,<,0,0
128726,0.05,0,0
128727,),0,0
128728,.,0,0
128729,The,0,0
128730,treatment,0,0
128731,with,0,0
128732,CHX,0,1
128733,chips,0,0
128734,showed,0,0
128735,a,0,0
128736,greater,0,0
128737,reduction,0,1
128738,of,1,0
128739,the,1,0
128740,microorganisms,1,1
128741,of,1,0
128742,the,1,0
128743,red,1,1
128744,complex,1,0
128745,after,0,0
128746,1,0,0
128747,month,0,0
128748,(,0,0
128749,P,0,0
128750,=,0,0
128751,0.02,0,0
128752,),0,0
128753,.,0,0
128754,CONCLUSION,0,0
128755,The,0,0
128756,use,0,0
128757,of,0,0
128758,CHX,0,1
128759,chips,0,0
128760,before,0,0
128761,and,0,0
128762,immediately,0,0
128763,after,0,0
128764,SRP,0,1
128765,improved,1,1
128766,CAL,1,1
128767,and,1,1
128768,reduced,1,0
128769,the,1,0
128770,subgingival,1,1
128771,microorganisms,1,1
128772,of,1,0
128773,the,1,0
128774,red,1,1
128775,complex,1,0
128776,in,1,0
128777,the,0,0
128778,treatment,0,0
128779,of,0,0
128780,chronic,0,0
128781,periodontitis,0,0
128782,.,0,0
128783,Immediate,0,1
128784,effects,0,0
128785,of,0,0
128786,a,0,0
128787,tibiofibular,0,1
128788,joint,0,1
128789,manipulation,0,0
128790,on,0,0
128791,lower,0,1
128792,extremity,0,1
128793,H-reflex,1,1
128794,measurements,1,1
128795,in,0,0
128796,individuals,0,0
128797,with,0,0
128798,chronic,0,0
128799,ankle,0,1
128800,instability,0,1
128801,.,0,1
128802,Persistent,0,1
128803,muscle,0,1
128804,inhibition,0,1
128805,of,0,0
128806,the,0,0
128807,fibularis,0,0
128808,longus,0,1
128809,and,0,1
128810,soleus,0,0
128811,muscles,0,1
128812,and,0,1
128813,altered,0,0
128814,joint,0,1
128815,arthrokinematics,0,0
128816,may,0,0
128817,play,0,0
128818,a,0,0
128819,role,0,0
128820,in,0,0
128821,chronic,0,0
128822,ankle,0,1
128823,instability,0,1
128824,(,0,1
128825,CAI,0,0
128826,),0,0
128827,.,0,0
128828,Joint,0,1
128829,mobilization,0,0
128830,has,0,0
128831,been,0,0
128832,shown,0,0
128833,to,0,0
128834,improve,0,0
128835,ankle,0,1
128836,joint,0,1
128837,motion,0,1
128838,",",0,1
128839,but,0,0
128840,effects,0,1
128841,on,0,0
128842,surrounding,0,0
128843,musculature,0,0
128844,is,0,0
128845,unknown,0,0
128846,.,0,0
128847,The,0,0
128848,purpose,0,0
128849,of,0,0
128850,this,0,0
128851,study,0,0
128852,was,0,0
128853,to,0,0
128854,determine,0,0
128855,the,0,0
128856,change,0,1
128857,in,0,0
128858,fibularis,0,1
128859,longus,0,1
128860,and,0,1
128861,soleus,0,0
128862,activation,0,1
128863,following,0,0
128864,tibiofibular,0,1
128865,joint,0,1
128866,manipulation,0,0
128867,in,0,0
128868,individuals,0,0
128869,with,0,0
128870,CAI,0,0
128871,.,0,0
128872,Forty-three,0,0
128873,subjects,0,0
128874,were,0,0
128875,randomized,0,0
128876,to,0,0
128877,one,0,0
128878,of,0,0
128879,three,0,0
128880,groups,0,0
128881,(,0,0
128882,proximal,0,0
128883,tibiofibular,0,1
128884,manipulation,0,0
128885,",",0,1
128886,distal,0,1
128887,tibiofibular,0,1
128888,manipulation,0,0
128889,",",0,1
128890,or,0,1
128891,control,0,0
128892,),0,0
128893,.,0,0
128894,A,0,0
128895,two-way,0,0
128896,mixed,0,0
128897,model,0,0
128898,ANOVA,0,0
128899,was,0,0
128900,used,0,0
128901,to,0,0
128902,compare,0,0
128903,changes,0,1
128904,in,0,0
128905,the,0,0
128906,ratio,0,1
128907,of,0,0
128908,the,0,0
128909,maximum,1,1
128910,H-reflex,1,1
128911,and,0,1
128912,maximum,1,1
128913,M-wave,1,1
128914,measurements,1,1
128915,(,0,0
128916,H/M,0,0
128917,ratio,0,1
128918,),0,0
128919,of,0,0
128920,the,0,0
128921,fibularis,0,0
128922,longus,0,1
128923,and,0,1
128924,soleus,0,0
128925,between,0,0
128926,groups,0,0
128927,over,0,0
128928,time,0,1
128929,(,0,1
128930,pre,0,1
128931,",",0,0
128932,post,0,0
128933,0,0,0
128934,",",0,0
128935,10,0,0
128936,",",0,0
128937,20,0,0
128938,",",0,0
128939,30,0,0
128940,min,0,0
128941,),0,0
128942,.,0,0
128943,The,0,0
128944,distal,0,1
128945,tibiofibular,0,1
128946,joint,0,1
128947,manipulation,0,1
128948,group,0,0
128949,demonstrated,0,0
128950,a,0,0
128951,significant,0,0
128952,increase,0,1
128953,(,0,0
128954,P,0,0
128955,<,0,0
128956,.05,0,0
128957,),0,0
128958,in,0,0
128959,soleus,1,0
128960,H/M,1,0
128961,ratio,1,1
128962,at,0,0
128963,all,0,0
128964,post-intervention,0,0
128965,time,0,1
128966,periods,0,0
128967,except,0,0
128968,20,0,0
128969,min,0,0
128970,post-intervention,0,0
128971,(,0,1
128972,P=.48,0,1
128973,),0,0
128974,.,0,0
128975,The,0,0
128976,proximal,0,0
128977,tibiofibular,0,1
128978,joint,0,1
128979,manipulation,0,1
128980,and,0,1
128981,control,0,0
128982,groups,0,0
128983,did,0,0
128984,not,0,0
128985,demonstrate,0,0
128986,a,0,0
128987,change,0,1
128988,in,0,0
128989,soleus,1,0
128990,H/M,1,0
128991,ratios,1,1
128992,.,1,0
128993,All,0,0
128994,groups,0,0
128995,demonstrated,0,0
128996,a,0,0
128997,decrease,0,1
128998,(,0,0
128999,P,0,0
129000,<,0,0
129001,.05,0,0
129002,),0,0
129003,from,0,0
129004,baseline,0,0
129005,values,0,1
129006,in,0,0
129007,fibularis,1,1
129008,longus,1,1
129009,(,0,0
129010,10-30,0,0
129011,min,0,1
129012,post-intervention,0,1
129013,),0,1
129014,and,0,1
129015,soleus,1,0
129016,(,0,0
129017,30,0,0
129018,min,0,0
129019,post-intervention,0,0
129020,),0,0
129021,H/M,1,0
129022,ratios,1,1
129023,.,1,0
129024,Interventions,0,0
129025,directed,0,0
129026,at,0,0
129027,the,0,0
129028,distal,0,1
129029,tibiofibular,0,1
129030,joint,0,1
129031,acutely,0,0
129032,increase,0,0
129033,soleus,1,0
129034,muscle,1,1
129035,activation,1,1
129036,.,1,0
129037,Pulsed,0,0
129038,azithromycin,0,0
129039,treatment,0,0
129040,is,0,0
129041,as,0,0
129042,effective,0,1
129043,and,0,1
129044,safe,0,1
129045,as,0,0
129046,2-week-longer,0,0
129047,daily,0,1
129048,doxycycline,0,0
129049,treatment,0,0
129050,of,0,1
129051,acne,0,1
129052,vulgaris,0,0
129053,:,0,0
129054,a,0,0
129055,randomized,0,0
129056,",",0,0
129057,double-blind,0,0
129058,",",0,1
129059,noninferiority,0,0
129060,study,0,0
129061,.,0,1
129062,Efficacy,0,1
129063,and,0,1
129064,safety,0,1
129065,of,0,1
129066,azithromycin,0,0
129067,and,0,1
129068,doxycycline,0,0
129069,for,0,0
129070,the,0,0
129071,treatment,0,0
129072,of,0,0
129073,moderate,0,0
129074,acne,0,1
129075,vulgaris,0,0
129076,were,0,0
129077,evaluated,0,0
129078,(,0,0
129079,240,0,0
129080,patients,0,0
129081,),0,0
129082,in,0,0
129083,both,0,0
129084,intention-to-treat,0,0
129085,and,0,0
129086,per-protocol,0,0
129087,populations,0,0
129088,.,0,0
129089,The,0,0
129090,evaluation,0,0
129091,of,0,0
129092,clinical,0,1
129093,efficacy,0,1
129094,was,0,0
129095,based,0,0
129096,on,0,0
129097,the,0,0
129098,change,0,0
129099,in,0,0
129100,the,0,0
129101,number,1,1
129102,of,1,0
129103,facial,1,1
129104,inflammatory,1,1
129105,lesions,1,1
129106,from,0,0
129107,baseline,0,0
129108,to,0,0
129109,the,0,0
129110,end,0,0
129111,of,0,1
129112,treatment,0,0
129113,",",0,1
129114,and,0,1
129115,noninferiority,0,1
129116,was,0,0
129117,defined,0,0
129118,by,0,0
129119,the,0,0
129120,upper,0,0
129121,95,0,0
129122,%,0,0
129123,confidence,0,0
129124,limit,0,0
129125,of,0,0
129126,the,0,0
129127,difference,0,0
129128,between,0,0
129129,two,0,0
129130,treatments,0,0
129131,being,0,0
129132,less,0,0
129133,than,0,0
129134,9,0,0
129135,.,0,0
129136,Reduction,0,0
129137,in,0,0
129138,the,0,0
129139,number,1,1
129140,of,1,0
129141,lesions,1,1
129142,was,0,0
129143,similar,0,0
129144,with,0,0
129145,both,0,0
129146,azithromycin,0,0
129147,and,0,1
129148,doxycycline,0,0
129149,treatments,0,0
129150,(,0,0
129151,27,0,0
129152,+/-,0,0
129153,12,0,0
129154,and,0,0
129155,30,0,0
129156,+/-,0,0
129157,12,0,0
129158,",",0,0
129159,respectively,0,0
129160,),0,0
129161,in,0,0
129162,both,0,0
129163,groups,0,0
129164,.,0,0
129165,Also,0,0
129166,",",0,0
129167,the,0,0
129168,upper,0,0
129169,95,0,0
129170,%,0,0
129171,confidence,0,0
129172,limit,0,0
129173,of,0,0
129174,5,0,0
129175,inflammatory,0,0
129176,lesions,0,0
129177,has,0,0
129178,satisfied,0,0
129179,the,0,0
129180,noninferiority,0,0
129181,criterion,0,0
129182,.,0,0
129183,The,0,0
129184,incidence,0,1
129185,of,0,0
129186,adverse,0,1
129187,events,0,1
129188,did,0,0
129189,not,0,0
129190,differ,0,0
129191,between,0,0
129192,the,0,0
129193,two,0,0
129194,treatment,0,0
129195,groups,0,0
129196,.,0,0
129197,The,0,0
129198,shorter,0,1
129199,and,0,1
129200,simpler,0,1
129201,treatment,0,0
129202,schedule,0,0
129203,of,0,1
129204,azithromycin,0,0
129205,had,0,0
129206,similar,0,0
129207,efficacy,1,1
129208,and,1,1
129209,safety,1,1
129210,as,0,0
129211,doxycycline,0,0
129212,in,0,0
129213,the,0,0
129214,treatment,0,0
129215,of,0,0
129216,moderate,0,0
129217,acne,0,1
129218,vulgaris,0,0
129219,",",0,1
129220,confirming,0,0
129221,noninferiority,0,0
129222,of,0,1
129223,azithromycin,0,0
129224,as,0,0
129225,compared,0,0
129226,with,0,0
129227,doxycycline,0,0
129228,.,0,0
129229,On,0,0
129230,the,0,0
129231,benign,0,0
129232,qualities,0,1
129233,of,0,1
129234,behavioral,0,1
129235,disinhibition,0,1
129236,:,0,0
129237,because,0,0
129238,of,0,0
129239,the,0,0
129240,prosocial,0,1
129241,nature,0,0
129242,of,0,1
129243,people,0,0
129244,",",0,0
129245,behavioral,0,1
129246,disinhibition,0,1
129247,can,0,0
129248,weaken,0,0
129249,pleasure,0,1
129250,with,0,0
129251,getting,0,1
129252,more,0,0
129253,than,0,0
129254,you,0,0
129255,deserve,0,0
129256,.,0,0
129257,This,0,0
129258,article,0,0
129259,focuses,0,0
129260,on,0,0
129261,social,0,1
129262,situations,0,0
129263,in,0,0
129264,which,0,0
129265,people,0,0
129266,are,0,0
129267,surprised,0,0
129268,about,0,0
129269,what,0,0
129270,is,0,0
129271,happening,0,0
129272,and,0,0
129273,inhibited,0,0
129274,about,0,0
129275,how,0,0
129276,to,0,0
129277,respond,0,0
129278,to,0,0
129279,the,0,0
129280,situation,0,0
129281,at,0,0
129282,hand,0,0
129283,.,0,0
129284,We,0,0
129285,study,0,0
129286,these,0,0
129287,situations,0,0
129288,by,0,0
129289,examining,0,0
129290,a,0,0
129291,classic,0,0
129292,topic,0,0
129293,in,0,0
129294,social,0,1
129295,psychology,0,0
129296,:,0,0
129297,how,0,0
129298,people,0,0
129299,respond,0,0
129300,to,0,0
129301,receiving,0,0
129302,better,0,0
129303,outcomes,0,1
129304,than,0,0
129305,are,0,0
129306,deserved,0,0
129307,.,0,0
129308,In,0,0
129309,these,0,0
129310,situations,0,0
129311,",",0,0
129312,the,0,0
129313,actions,0,0
129314,of,0,0
129315,an,0,0
129316,authority,0,0
129317,or,0,0
129318,a,0,0
129319,coworker,0,1
129320,push,0,0
129321,in,0,0
129322,the,0,0
129323,direction,0,0
129324,of,0,0
129325,accepting,0,0
129326,and,0,0
129327,enjoying,0,1
129328,the,0,0
129329,unfair,0,0
129330,outcome,0,1
129331,",",0,1
129332,whereas,0,0
129333,personal,0,1
129334,values,0,1
129335,for,0,0
129336,most,0,0
129337,people,0,0
129338,push,0,0
129339,in,0,0
129340,the,0,0
129341,direction,0,0
129342,of,0,0
129343,rejecting,0,0
129344,or,0,0
129345,being,0,0
129346,displeased,0,0
129347,with,0,0
129348,the,0,0
129349,outcome,0,0
129350,.,0,0
129351,This,0,0
129352,conflict,0,0
129353,may,0,0
129354,inhibit,0,0
129355,people,0,0
129356,'s,0,0
129357,response,0,1
129358,to,0,0
129359,the,0,0
129360,advantageous,0,0
129361,but,0,0
129362,unfair,0,0
129363,outcomes,0,1
129364,.,0,0
129365,If,0,0
129366,people,0,0
129367,are,0,0
129368,indeed,0,0
129369,inhibited,0,0
129370,about,0,0
129371,how,0,0
129372,to,0,0
129373,respond,0,0
129374,to,0,0
129375,these,0,0
129376,kinds,0,0
129377,of,0,0
129378,outcomes,0,1
129379,",",0,0
129380,then,0,0
129381,lowering,0,1
129382,behavioral,0,1
129383,inhibition,0,1
129384,by,0,0
129385,reminding,0,0
129386,people,0,0
129387,of,0,0
129388,having,0,0
129389,acted,0,0
129390,in,0,0
129391,the,0,0
129392,past,0,0
129393,without,0,0
129394,inhibitions,0,1
129395,(,0,0
129396,in,0,0
129397,a,0,0
129398,manner,0,0
129399,that,0,0
129400,is,0,0
129401,unrelated,0,0
129402,to,0,0
129403,the,0,0
129404,outcomes,0,1
129405,participants,0,0
129406,subsequently,0,0
129407,receive,0,0
129408,),0,0
129409,should,0,0
129410,affect,0,0
129411,reactions,0,1
129412,to,0,0
129413,the,0,0
129414,outcomes,0,1
129415,.,0,0
129416,Specifically,0,0
129417,",",0,0
129418,we,0,0
129419,hypothesize,0,0
129420,that,0,0
129421,because,0,0
129422,many,0,0
129423,people,0,0
129424,are,0,0
129425,prosocial,0,1
129426,and,0,0
129427,want,0,0
129428,to,0,0
129429,adhere,0,0
129430,to,0,0
129431,principles,0,0
129432,of,0,1
129433,fairness,0,1
129434,",",0,0
129435,reminders,0,0
129436,of,0,1
129437,behavioral,0,1
129438,disinhibition,0,0
129439,will,0,0
129440,lead,0,0
129441,to,0,0
129442,less,0,0
129443,pleasure,0,1
129444,with,0,0
129445,the,0,0
129446,unfairly,0,0
129447,obtained,0,0
129448,outcomes,0,0
129449,.,0,0
129450,The,0,0
129451,results,0,0
129452,of,0,0
129453,8,0,0
129454,experiments,0,0
129455,(,0,0
129456,conducted,0,0
129457,both,0,0
129458,inside,0,0
129459,and,0,0
129460,outside,0,0
129461,the,0,0
129462,psychology,0,0
129463,laboratory,0,1
129464,),0,1
129465,revealed,0,0
129466,evidence,0,0
129467,for,0,0
129468,this,0,0
129469,benign,0,0
129470,disinhibition,0,1
129471,effect,0,1
129472,on,0,0
129473,various,0,0
129474,reactions,0,1
129475,to,0,0
129476,outcomes,0,0
129477,that,0,0
129478,are,0,0
129479,better,0,0
129480,than,0,0
129481,deserved,0,0
129482,.,0,0
129483,In,0,0
129484,further,0,0
129485,accordance,0,0
129486,with,0,0
129487,our,0,0
129488,line,0,0
129489,of,0,1
129490,reasoning,0,1
129491,",",0,0
129492,the,0,0
129493,effect,0,0
129494,is,0,0
129495,particularly,0,0
129496,pronounced,0,0
129497,among,0,0
129498,those,0,0
129499,who,0,0
129500,adhere,0,0
129501,to,0,0
129502,a,0,0
129503,prosocial,0,1
129504,orientation,0,0
129505,or,0,0
129506,who,0,0
129507,have,0,0
129508,adopted,0,0
129509,a,0,0
129510,prosocial,0,1
129511,mindset,0,0
129512,and,0,0
129513,is,0,0
129514,not,0,0
129515,observed,0,0
129516,among,0,0
129517,those,0,0
129518,with,0,0
129519,proself,0,0
129520,orientations,0,1
129521,or,0,0
129522,mindsets,0,0
129523,.,0,0
129524,Safety,1,1
129525,and,1,1
129526,pharmacokinetics,1,1
129527,of,0,0
129528,a,0,0
129529,glycoPEGylated,0,1
129530,recombinant,0,0
129531,activated,0,1
129532,factor,0,1
129533,VII,0,0
129534,derivative,0,0
129535,:,0,0
129536,a,0,0
129537,randomized,0,0
129538,first,0,0
129539,human,0,0
129540,dose,0,0
129541,trial,0,0
129542,in,0,0
129543,healthy,0,0
129544,subjects,0,0
129545,.,0,0
129546,BACKGROUND,0,0
129547,Extensive,0,0
129548,research,0,0
129549,is,0,0
129550,currently,0,0
129551,ongoing,0,0
129552,to,0,0
129553,prolong,0,0
129554,the,0,0
129555,half-life,0,1
129556,of,0,0
129557,coagulation,0,1
129558,factors,0,0
129559,.,0,0
129560,One,0,0
129561,of,0,0
129562,these,0,0
129563,techniques,0,0
129564,is,0,0
129565,glycoPEGylation,0,0
129566,",",0,0
129567,which,0,0
129568,has,0,0
129569,also,0,0
129570,been,0,0
129571,applied,0,0
129572,to,0,0
129573,recombinant,0,0
129574,activated,0,1
129575,factor,0,1
129576,VII,0,1
129577,(,0,1
129578,rFVIIa,0,0
129579,),0,1
129580,",",0,0
129581,resulting,0,0
129582,in,0,0
129583,a,0,0
129584,rFVIIa,0,0
129585,derivative,0,0
129586,(,0,0
129587,N7-GP,0,0
129588,),0,0
129589,with,0,0
129590,a,0,0
129591,prolonged,0,1
129592,terminal,0,1
129593,half-life,0,1
129594,(,0,1
129595,t,0,0
129596,(,0,0
129597,1/2,0,0
129598,),0,0
129599,),0,0
129600,.,0,0
129601,The,0,0
129602,main,0,0
129603,clinical,0,0
129604,purpose,0,0
129605,of,0,0
129606,N7-GP,0,0
129607,is,0,0
129608,to,0,0
129609,provide,0,0
129610,safe,0,1
129611,and,0,1
129612,effective,0,1
129613,prophylaxis,0,0
129614,to,0,0
129615,patients,0,0
129616,with,0,0
129617,hemophilia,0,1
129618,and,0,0
129619,inhibitors,0,0
129620,.,0,0
129621,The,0,0
129622,prolonged,0,1
129623,t,0,0
129624,(,0,0
129625,1/2,0,0
129626,),0,0
129627,of,0,0
129628,N7-GP,0,0
129629,can,0,0
129630,potentially,0,0
129631,reduce,0,0
129632,the,0,0
129633,dosing,0,0
129634,frequency,0,1
129635,and,0,1
129636,thereby,0,1
129637,facilitate,0,0
129638,convenience,0,0
129639,and,0,1
129640,compliance,0,1
129641,",",0,0
129642,which,0,0
129643,are,0,0
129644,two,0,0
129645,significant,0,0
129646,barriers,0,0
129647,to,0,0
129648,effective,0,1
129649,prophylaxis,0,0
129650,.,0,0
129651,OBJECTIVES,0,0
129652,To,0,0
129653,determine,0,0
129654,the,1,0
129655,safety,1,1
129656,and,1,1
129657,pharmacokinetics,1,1
129658,of,0,1
129659,single,0,0
129660,doses,0,0
129661,of,0,0
129662,N7-GP,0,0
129663,in,0,0
129664,healthy,0,0
129665,men,0,0
129666,.,0,0
129667,METHODS,0,0
129668,A,0,0
129669,randomized,0,0
129670,",",0,0
129671,placebo-controlled,0,0
129672,",",0,1
129673,dose-escalation,0,0
129674,trial,0,0
129675,with,0,0
129676,five,0,0
129677,cohorts,0,0
129678,(,0,0
129679,N7-GP,0,0
129680,dose,0,0
129681,of,0,1
129682,12.5-100,0,0
129683,?g,0,1
129684,kg,0,0
129685,(,0,1
129686,-1,0,0
129687,),0,1
129688,),0,0
129689,was,0,0
129690,performed,0,0
129691,.,0,0
129692,In,0,0
129693,each,0,0
129694,cohort,0,0
129695,",",0,0
129696,eight,0,0
129697,subjects,0,0
129698,were,0,0
129699,randomized,0,0
129700,to,0,0
129701,receive,0,0
129702,N7-GP,0,0
129703,(,0,0
129704,n,0,0
129705,=,0,0
129706,6,0,0
129707,),0,0
129708,or,0,0
129709,placebo,0,0
129710,(,0,1
129711,n,0,0
129712,=,0,0
129713,2,0,0
129714,),0,0
129715,.,0,0
129716,RESULTS,0,0
129717,The,1,0
129718,mean,1,1
129719,FVIIa,1,0
129720,activity,1,1
129721,was,1,0
129722,measurable,0,1
129723,for,0,0
129724,up,0,0
129725,to,0,0
129726,at,0,0
129727,least,0,0
129728,72,0,0
129729,h,0,0
129730,after,0,0
129731,dosing,0,0
129732,",",0,0
129733,and,0,0
129734,the,0,0
129735,overall,0,1
129736,mean,0,1
129737,t,0,0
129738,(,0,0
129739,1/2,0,0
129740,),0,0
129741,for,0,0
129742,FVIIa,0,0
129743,activity,0,1
129744,was,0,0
129745,15,0,0
129746,h.,0,0
129747,The,1,0
129748,pharmacokinetics,1,0
129749,of,1,0
129750,N7-GP,1,0
129751,appeared,1,0
129752,to,0,0
129753,be,0,0
129754,dose-proportional,0,0
129755,in,0,0
129756,the,0,0
129757,dose,0,0
129758,range,0,0
129759,investigated,1,0
129760,.,1,0
129761,No,1,0
129762,serious,1,1
129763,adverse,1,1
129764,events,1,1
129765,(,1,0
129766,including,1,0
129767,thromboembolic,1,1
129768,events,1,1
129769,),1,0
129770,were,1,0
129771,reported,0,0
129772,.,0,0
129773,The,1,0
129774,frequency,1,1
129775,of,1,0
129776,adverse,1,1
129777,events,1,1
129778,was,1,0
129779,similar,0,0
129780,in,0,0
129781,both,0,0
129782,the,0,0
129783,placebo,0,0
129784,and,0,1
129785,N7-GP,0,0
129786,groups,0,0
129787,.,0,0
129788,No,0,0
129789,neutralizing,1,0
129790,antibodies,1,1
129791,against,1,1
129792,N7-GP,1,0
129793,were,1,0
129794,detected,0,0
129795,.,0,0
129796,A,0,0
129797,pharmacologic,1,0
129798,effect,1,1
129799,was,1,0
129800,apparent,0,0
129801,from,0,0
129802,a,0,0
129803,dose-dependent,0,0
129804,statistically,0,0
129805,significant,0,0
129806,decrease,0,0
129807,in,0,0
129808,the,1,0
129809,mean,1,1
129810,prothrombin,1,1
129811,time,1,1
129812,in,1,0
129813,all,0,0
129814,N7-GP,0,0
129815,groups,0,0
129816,as,0,0
129817,compared,0,0
129818,with,0,0
129819,placebo,0,0
129820,.,0,0
129821,CONCLUSIONS,0,0
129822,N7-GP,0,0
129823,had,0,0
129824,a,0,0
129825,plasma,0,1
129826,half-life,0,1
129827,of,0,0
129828,15,0,0
129829,h,0,0
129830,and,0,0
129831,a,0,0
129832,profile,0,1
129833,that,0,0
129834,makes,0,0
129835,it,0,0
129836,a,0,0
129837,potential,0,0
129838,candidate,0,0
129839,for,0,0
129840,prophylaxis,0,0
129841,in,0,0
129842,patients,0,0
129843,with,0,0
129844,hemophilia,0,1
129845,and,0,0
129846,inhibitors,0,0
129847,.,0,0
129848,Lung,0,1
129849,function,0,1
129850,and,0,1
129851,respiratory,0,1
129852,symptoms,0,1
129853,in,0,0
129854,a,0,0
129855,1-year,0,0
129856,randomized,0,0
129857,smoking,0,1
129858,cessation,0,1
129859,trial,0,0
129860,of,0,1
129861,varenicline,0,0
129862,in,0,0
129863,COPD,0,0
129864,patients,0,0
129865,.,0,0
129866,UNLABELLED,0,0
129867,There,0,0
129868,are,0,0
129869,few,0,0
129870,data,0,0
129871,concerning,0,0
129872,changes,0,1
129873,in,0,0
129874,lung,0,1
129875,function,0,1
129876,and,0,1
129877,respiratory,0,1
129878,symptoms,0,1
129879,in,0,0
129880,smokers,0,0
129881,with,0,0
129882,chronic,0,0
129883,obstructive,0,0
129884,pulmonary,0,1
129885,disease,0,1
129886,(,0,1
129887,COPD,0,0
129888,),0,0
129889,weeks,0,0
129890,to,0,0
129891,months,0,0
129892,after,0,0
129893,quitting,0,1
129894,smoking,0,0
129895,.,0,0
129896,We,0,0
129897,examined,0,0
129898,serial,0,0
129899,changes,0,1
129900,in,0,0
129901,spirometry,0,1
129902,and,0,1
129903,Clinical,0,1
129904,COPD,0,1
129905,Questionnaire,0,1
129906,(,0,1
129907,CCQ,0,1
129908,),0,0
129909,scores,0,1
129910,(,0,0
129911,measuring,0,1
129912,respiratory,0,1
129913,symptoms,0,1
129914,and,0,1
129915,health-related,0,1
129916,quality,0,1
129917,of,0,1
129918,life,0,1
129919,),0,0
129920,in,0,0
129921,COPD,0,0
129922,participants,0,0
129923,by,0,0
129924,smoking,0,1
129925,status,0,1
129926,during,0,0
129927,a,0,0
129928,smoking,0,1
129929,cessation,0,0
129930,trial,0,0
129931,.,0,0
129932,In,0,0
129933,this,0,0
129934,randomized,0,0
129935,",",0,0
129936,double-blind,0,0
129937,trial,0,0
129938,",",0,0
129939,smokers,0,0
129940,with,0,0
129941,mild-to-moderate,0,0
129942,COPD,0,0
129943,were,0,0
129944,treated,0,0
129945,with,0,0
129946,varenicline,0,0
129947,1,0,0
129948,mg,0,0
129949,b.i.d,0,0
129950,.,0,1
129951,or,0,0
129952,placebo,0,0
129953,for,0,0
129954,12,0,0
129955,weeks,0,0
129956,and,0,0
129957,followed,0,0
129958,to,0,0
129959,Week,0,0
129960,52,0,0
129961,.,0,0
129962,Primary,0,0
129963,endpoints,0,1
129964,of,0,1
129965,abstinence,1,1
129966,were,0,0
129967,previously,0,0
129968,reported,0,0
129969,.,0,0
129970,Secondary,0,0
129971,endpoints,0,1
129972,were,0,0
129973,mean,1,1
129974,changes,1,1
129975,from,1,0
129976,baseline,1,0
129977,in,0,0
129978,post-bronchodilator,1,0
129979,forced,1,0
129980,expired,1,1
129981,volume,1,1
129982,in,1,0
129983,1,1,0
129984,s,1,0
129985,(,1,0
129986,FEV,1,1
129987,(,1,0
129988,1,1,0
129989,),1,0
129990,),1,0
129991,and,1,1
129992,CCQ,1,1
129993,scores,1,1
129994,.,1,0
129995,Change,1,0
129996,from,1,0
129997,baseline,1,0
129998,in,0,0
129999,post-bronchodilator,0,1
130000,FEV,1,0
130001,(,1,0
130002,1,1,0
130003,),1,0
130004,was,0,0
130005,significantly,0,0
130006,improved,0,0
130007,in,0,0
130008,continuous,0,0
130009,abstainers,0,0
130010,(,0,0
130011,121.8,0,0
130012,mL,0,0
130013,),0,0
130014,vs.,0,0
130015,continuous,0,0
130016,smokers,0,0
130017,(,0,0
130018,37.9,0,0
130019,mL,0,0
130020,),0,0
130021,at,0,0
130022,Week,0,0
130023,12,0,0
130024,(,0,0
130025,P,0,0
130026,=,0,0
130027,0.0069,0,0
130028,),0,0
130029,",",0,0
130030,but,0,0
130031,not,0,0
130032,at,0,0
130033,Weeks,0,0
130034,24,0,0
130035,or,0,0
130036,52,0,0
130037,.,0,0
130038,Mean,1,0
130039,change,1,1
130040,from,1,0
130041,baseline,1,0
130042,at,1,0
130043,Week,1,0
130044,12,1,0
130045,in,1,0
130046,CCQ,1,0
130047,Total,1,1
130048,Score,1,1
130049,was,0,0
130050,significantly,0,0
130051,better,0,0
130052,in,0,0
130053,continuous,0,0
130054,abstainers,0,0
130055,(,0,1
130056,-1.04,0,0
130057,),0,1
130058,vs.,0,0
130059,continuous,0,0
130060,smokers,0,0
130061,(,0,0
130062,-0.53,0,0
130063,;,0,1
130064,P,0,0
130065,<,0,0
130066,0.0001,0,0
130067,),0,0
130068,:,0,0
130069,this,0,0
130070,improvement,0,1
130071,was,0,0
130072,sustained,0,0
130073,at,0,0
130074,Weeks,0,0
130075,24,0,0
130076,and,0,0
130077,52,0,0
130078,.,0,0
130079,In,0,0
130080,a,0,0
130081,1-year,0,1
130082,cessation,0,0
130083,trial,0,0
130084,of,0,1
130085,smokers,0,0
130086,with,0,0
130087,COPD,0,0
130088,",",0,1
130089,continuous,1,1
130090,abstinence,1,1
130091,compared,0,0
130092,with,0,0
130093,continuous,0,0
130094,smoking,0,0
130095,significantly,0,0
130096,improved,0,0
130097,post-bronchodilator,1,0
130098,FEV,0,0
130099,(,0,0
130100,1,0,0
130101,),0,0
130102,at,0,0
130103,Week,0,0
130104,12,0,0
130105,(,0,0
130106,although,0,0
130107,the,0,0
130108,difference,0,0
130109,narrowed,0,0
130110,subsequently,0,0
130111,),0,0
130112,and,0,1
130113,CCQ,1,1
130114,Total,1,1
130115,Scores,1,0
130116,at,0,0
130117,Week,0,0
130118,12,0,0
130119,",",0,0
130120,with,0,0
130121,sustained,0,1
130122,improvement,0,1
130123,thereafter,0,0
130124,.,0,0
130125,(,0,0
130126,TRIAL,0,0
130127,REGISTRY,0,1
130128,http,0,0
130129,:,0,0
130130,//www.clinicaltrials.gov,0,0
130131,;,0,0
130132,trial,0,0
130133,identifier,0,0
130134,:,0,0
130135,NCT00285012,0,0
130136,),0,0
130137,.,0,0
130138,A,0,0
130139,prospective,0,0
130140,double-blind,0,0
130141,",",0,1
130142,randomized,0,0
130143,clinical,0,1
130144,trial,0,0
130145,of,0,0
130146,levocarnitine,0,0
130147,to,0,0
130148,treat,0,0
130149,autism,0,0
130150,spectrum,0,0
130151,disorders,0,0
130152,.,0,0
130153,BACKGROUND,0,0
130154,L-carnitine,0,1
130155,was,0,0
130156,proposed,0,0
130157,as,0,0
130158,a,0,0
130159,potential,0,0
130160,treatment,0,0
130161,for,0,0
130162,patients,0,0
130163,diagnosed,0,0
130164,with,0,0
130165,an,0,0
130166,autism,0,0
130167,spectrum,0,0
130168,disorder,0,0
130169,to,0,0
130170,improve,0,0
130171,mitochondrial,0,1
130172,dysfunction,0,1
130173,",",0,0
130174,but,0,0
130175,no,0,0
130176,prior,0,0
130177,randomized,0,0
130178,controlled,0,0
130179,trials,0,0
130180,have,0,0
130181,been,0,0
130182,conducted,0,0
130183,.,0,0
130184,MATERIAL/METHODS,0,0
130185,Thirty,0,0
130186,subjects,0,0
130187,diagnosed,0,0
130188,with,0,0
130189,an,0,0
130190,ASD,0,0
130191,were,0,0
130192,randomly,0,0
130193,assigned,0,0
130194,to,0,0
130195,receive,0,0
130196,a,0,0
130197,standardized,0,0
130198,regimen,0,0
130199,(,0,0
130200,50,0,0
130201,mg,0,0
130202,L-carnitine/kg,0,0
130203,bodyweight/day,0,0
130204,),0,0
130205,of,0,0
130206,liquid,0,0
130207,L-carnitine,0,1
130208,(,0,1
130209,n=19,0,0
130210,),0,1
130211,or,0,1
130212,placebo,0,0
130213,(,0,1
130214,n=11,0,0
130215,),0,0
130216,for,0,0
130217,3-months,0,0
130218,.,0,0
130219,Measures,0,1
130220,included,0,0
130221,changes,0,1
130222,in,0,0
130223,professionally,0,0
130224,completed,0,0
130225,Childhood,1,0
130226,Autism,1,1
130227,Rating,1,1
130228,Scale,1,1
130229,(,1,1
130230,CARS,1,1
130231,),1,1
130232,",",1,0
130233,hand,1,1
130234,muscle,1,1
130235,testing,1,1
130236,",",1,1
130237,and,1,1
130238,modified,1,1
130239,clinical,1,1
130240,global,1,1
130241,impression,1,1
130242,(,1,1
130243,CGI,1,0
130244,),1,0
130245,forms,1,0
130246,;,1,0
130247,parent,1,1
130248,completed,1,0
130249,Autism,1,1
130250,Treatment,1,0
130251,Evaluation,1,1
130252,Checklist,1,1
130253,(,1,1
130254,ATEC,1,0
130255,),1,1
130256,",",1,0
130257,treatment,1,0
130258,adherence,1,1
130259,measurement,1,1
130260,(,1,1
130261,TAM,1,1
130262,),1,1
130263,",",1,1
130264,frequency,1,1
130265,and,1,1
130266,intensity,1,1
130267,of,1,1
130268,side,1,1
130269,effect,1,1
130270,rating,1,1
130271,(,1,1
130272,FISER,1,1
130273,),1,1
130274,/global,1,1
130275,rating,1,1
130276,of,1,1
130277,side,1,1
130278,effect,1,1
130279,burden,1,1
130280,(,1,1
130281,GRSEB,1,1
130282,),1,1
130283,/patient,1,1
130284,report,1,0
130285,of,1,1
130286,incidence,1,1
130287,of,1,1
130288,side,1,1
130289,effects,1,1
130290,(,1,1
130291,PRISE,1,1
130292,),1,0
130293,forms,1,0
130294,;,1,0
130295,and,1,0
130296,lab,1,0
130297,testing,1,0
130298,.,1,0
130299,RESULTS,0,0
130300,Significant,0,1
130301,improvements,0,1
130302,were,0,0
130303,observed,0,0
130304,in,0,0
130305,CARS,1,1
130306,(,0,1
130307,-2.03,0,0
130308,",",0,0
130309,95,0,0
130310,%,0,0
130311,CI=-3.7,0,0
130312,to,0,0
130313,-0.31,0,0
130314,),0,0
130315,",",0,0
130316,CGI,1,1
130317,(,0,1
130318,-0.69,0,0
130319,",",0,0
130320,95,0,0
130321,%,0,0
130322,CI=-1.1,0,0
130323,to,0,0
130324,-0.06,0,0
130325,),0,0
130326,",",0,0
130327,and,0,1
130328,ATEC,1,0
130329,scores,1,1
130330,.,1,0
130331,Significant,0,0
130332,correlations,0,1
130333,between,0,0
130334,changes,0,1
130335,in,0,0
130336,serum,0,1
130337,free-carnitine,0,1
130338,levels,0,1
130339,and,0,1
130340,positive,0,1
130341,clinical,0,1
130342,changes,0,1
130343,were,0,0
130344,observed,0,0
130345,for,0,0
130346,hand,1,1
130347,muscle,1,1
130348,strength,1,1
130349,(,0,1
130350,R2=0.23,0,1
130351,",",0,1
130352,P=0.046,0,0
130353,),0,1
130354,",",0,0
130355,cognitive,1,1
130356,scores,1,1
130357,(,0,1
130358,R2=0.27,0,1
130359,",",0,1
130360,P=0.019,0,0
130361,),0,1
130362,",",0,0
130363,and,0,1
130364,CARS,1,1
130365,scores,1,1
130366,(,0,1
130367,R2=0.20,0,1
130368,",",0,1
130369,P=0.047,0,0
130370,),0,0
130371,.,0,0
130372,Study,0,0
130373,subjects,0,0
130374,were,0,0
130375,protocol-compliant,0,1
130376,(,0,0
130377,average,0,1
130378,adherence,0,1
130379,was,0,0
130380,>,0,0
130381,85,0,0
130382,%,0,0
130383,),0,0
130384,and,0,1
130385,generally,0,0
130386,well-tolerated,0,0
130387,the,0,0
130388,L-carnitine,0,0
130389,therapy,0,0
130390,given,0,0
130391,.,0,0
130392,CONCLUSIONS,0,0
130393,L-carnitine,0,1
130394,therapy,0,0
130395,(,0,0
130396,50,0,0
130397,mg/kilogram-bodyweight/day,0,0
130398,),0,0
130399,administered,0,0
130400,for,0,0
130401,3-months,0,0
130402,significantly,0,0
130403,improved,0,0
130404,several,0,0
130405,clinical,0,0
130406,measurements,0,1
130407,of,0,1
130408,ASD,0,0
130409,severity,0,1
130410,",",0,1
130411,but,0,0
130412,subsequent,0,0
130413,studies,0,0
130414,are,0,0
130415,recommended,0,0
130416,.,0,0
130417,Design,0,1
130418,and,0,1
130419,subject,0,0
130420,characteristics,0,1
130421,in,0,0
130422,the,0,0
130423,federally-funded,0,0
130424,citalopram,0,0
130425,trial,0,0
130426,in,0,0
130427,children,0,0
130428,with,0,0
130429,pervasive,0,0
130430,developmental,0,0
130431,disorders,0,0
130432,.,0,0
130433,The,0,0
130434,Studies,0,0
130435,to,0,0
130436,Advance,0,1
130437,Autism,0,1
130438,Research,0,1
130439,and,0,1
130440,Treatment,0,1
130441,Network,0,1
130442,conducted,0,0
130443,a,0,0
130444,randomized,0,0
130445,trial,0,0
130446,with,0,0
130447,citalopram,0,0
130448,in,0,0
130449,children,0,0
130450,with,0,0
130451,Pervasive,0,1
130452,developmental,0,1
130453,disorders,0,0
130454,(,0,1
130455,PDDs,0,1
130456,),0,0
130457,.,0,0
130458,We,0,0
130459,present,0,0
130460,the,0,0
130461,rationale,0,0
130462,",",0,1
130463,design,0,0
130464,and,0,1
130465,sample,0,0
130466,characteristics,0,1
130467,of,0,0
130468,the,0,0
130469,citalopram,0,0
130470,trial,0,0
130471,.,0,1
130472,Subjects,0,0
130473,(,0,0
130474,128,0,0
130475,boys,0,0
130476,",",0,0
130477,21,0,0
130478,girls,0,0
130479,),0,0
130480,had,0,0
130481,a,0,0
130482,mean,0,1
130483,age,0,0
130484,of,0,0
130485,9.3,0,0
130486,(,0,0
130487,?3.12,0,0
130488,),0,0
130489,years,0,0
130490,;,0,0
130491,132,0,0
130492,(,0,0
130493,88.6,0,0
130494,%,0,0
130495,),0,0
130496,were,0,0
130497,diagnosed,0,0
130498,with,0,0
130499,autistic,0,0
130500,disorder,0,0
130501,(,0,0
130502,4.7,0,0
130503,%,0,0
130504,with,0,0
130505,Asperger,0,1
130506,'s,0,0
130507,Disorder,0,0
130508,;,0,0
130509,6.7,0,0
130510,%,0,0
130511,with,0,0
130512,PDD-not,0,1
130513,otherwise,0,0
130514,specified,0,0
130515,),0,0
130516,.,0,0
130517,Less,0,1
130518,than,0,0
130519,half,0,0
130520,of,0,0
130521,the,0,0
130522,subjects,0,0
130523,were,1,0
130524,intellectually,1,0
130525,disabled,1,0
130526,;,1,0
130527,117,0,0
130528,(,0,0
130529,78.5,0,0
130530,%,0,0
130531,),0,0
130532,were,0,0
130533,rated,0,1
130534,Moderate,0,0
130535,or,0,0
130536,Marked,0,0
130537,on,0,0
130538,the,1,0
130539,Clinical,1,1
130540,Global,1,1
130541,Impression,1,1
130542,for,1,0
130543,Severity,1,1
130544,.,1,0
130545,Study,0,0
130546,measures,0,1
130547,were,0,0
130548,similar,0,0
130549,to,0,0
130550,previous,0,0
130551,Research,0,0
130552,Units,0,0
130553,on,0,0
130554,Pediatric,0,0
130555,Psychopharmacology,0,0
130556,trials,0,0
130557,.,0,0
130558,Subjects,0,0
130559,in,0,0
130560,this,0,0
130561,trial,0,0
130562,were,0,0
130563,slightly,0,0
130564,older,0,0
130565,and,0,1
130566,more,0,0
130567,likely,0,0
130568,to,0,0
130569,have,0,0
130570,complaints,0,1
130571,of,1,0
130572,repetitive,1,1
130573,behavior,1,1
130574,than,0,0
130575,participants,0,0
130576,in,0,0
130577,RUPP,0,0
130578,trials,0,0
130579,.,0,0
130580,A,0,0
130581,simple,0,0
130582,meal,0,0
130583,plan,0,0
130584,of,0,1
130585,'eating,0,1
130586,vegetables,0,0
130587,before,0,0
130588,carbohydrate,0,1
130589,',0,1
130590,was,0,0
130591,more,0,0
130592,effective,0,1
130593,for,0,0
130594,achieving,0,1
130595,glycemic,1,1
130596,control,1,0
130597,than,0,0
130598,an,0,0
130599,exchange-based,0,0
130600,meal,0,0
130601,plan,0,0
130602,in,0,0
130603,Japanese,0,0
130604,patients,0,0
130605,with,0,0
130606,type,0,0
130607,2,0,0
130608,diabetes,0,0
130609,.,0,0
130610,This,0,0
130611,study,0,0
130612,aimed,0,0
130613,to,0,0
130614,determine,0,0
130615,whether,0,0
130616,educating,0,0
130617,diabetic,0,0
130618,patients,0,0
130619,to,0,0
130620,'eat,0,1
130621,vegetables,0,0
130622,before,0,0
130623,carbohydrate,0,1
130624,',0,1
130625,was,0,0
130626,as,0,0
130627,effective,0,1
130628,on,0,0
130629,long-term,1,1
130630,glycemic,1,1
130631,control,1,0
130632,as,0,0
130633,a,0,0
130634,traditional,0,0
130635,exchange-based,0,1
130636,meal,0,0
130637,plan,0,0
130638,.,0,0
130639,To,0,0
130640,test,0,0
130641,this,0,0
130642,hypothesis,0,0
130643,",",0,0
130644,we,0,0
130645,carried,0,0
130646,out,0,0
130647,a,0,0
130648,randomized,0,0
130649,",",0,0
130650,controlled,0,0
130651,trial,0,0
130652,in,0,0
130653,patients,0,0
130654,with,0,0
130655,type,0,0
130656,2,0,0
130657,diabetes,0,0
130658,that,0,0
130659,compared,0,0
130660,changes,1,1
130661,in,1,0
130662,HbA1c,1,0
130663,as,0,0
130664,the,0,0
130665,primary,0,0
130666,outcome,0,0
130667,.,0,0
130668,A,0,0
130669,total,0,0
130670,of,0,0
130671,101,0,0
130672,patients,0,0
130673,were,0,0
130674,stratified,0,0
130675,according,0,0
130676,to,0,0
130677,sex,0,0
130678,",",0,1
130679,age,0,1
130680,",",0,1
130681,BMI,0,1
130682,",",0,1
130683,duration,0,1
130684,of,0,1
130685,diabetes,0,1
130686,",",0,1
130687,and,0,1
130688,HbA1c,0,1
130689,",",0,1
130690,and,0,1
130691,then,0,0
130692,randomized,0,0
130693,to,0,0
130694,receive,0,0
130695,instructions,0,0
130696,to,0,0
130697,eat,0,0
130698,either,0,0
130699,vegetables,0,0
130700,before,0,0
130701,carbohydrate,0,1
130702,(,0,1
130703,VBC,0,0
130704,",",0,1
130705,n=69,0,0
130706,),0,1
130707,or,0,0
130708,an,0,0
130709,exchange-based,0,1
130710,meal,0,1
130711,plan,0,0
130712,(,0,1
130713,EXB,0,1
130714,",",0,1
130715,n=32,0,0
130716,),0,0
130717,.,0,0
130718,The,0,0
130719,impact,1,0
130720,of,1,0
130721,the,1,0
130722,two,1,0
130723,plans,1,0
130724,on,1,0
130725,glycemic,1,1
130726,control,1,0
130727,was,0,0
130728,compared,0,0
130729,over,0,0
130730,24,0,0
130731,months,0,0
130732,of,0,0
130733,follow-up,0,0
130734,.,0,0
130735,Significant,0,1
130736,improvements,1,1
130737,in,1,0
130738,HbA1c,1,0
130739,over,0,0
130740,24,0,0
130741,months,0,0
130742,were,0,0
130743,observed,0,0
130744,in,0,0
130745,both,0,0
130746,groups,0,0
130747,(,0,0
130748,VBC,0,0
130749,",",0,0
130750,8.3,0,0
130751,to,0,0
130752,6.8,0,0
130753,%,0,0
130754,vs,0,0
130755,EXB,0,0
130756,",",0,0
130757,8.2,0,0
130758,to,0,0
130759,7.3,0,0
130760,%,0,0
130761,),0,0
130762,.,0,0
130763,HbA1c,1,0
130764,levels,1,1
130765,were,1,0
130766,significantly,1,0
130767,lower,1,0
130768,in,0,0
130769,the,0,0
130770,VBC,0,0
130771,group,0,0
130772,than,0,0
130773,in,0,0
130774,the,0,0
130775,EXB,0,0
130776,group,0,0
130777,after,0,0
130778,6,0,0
130779,",",0,0
130780,9,0,0
130781,",",0,0
130782,12,0,0
130783,and,0,0
130784,24,0,0
130785,months,0,0
130786,of,0,0
130787,the,0,0
130788,study,0,0
130789,.,0,0
130790,Both,0,0
130791,groups,0,0
130792,exhibited,0,0
130793,similar,1,0
130794,improvements,1,1
130795,in,1,0
130796,dietary,1,0
130797,practices,1,0
130798,with,0,0
130799,respect,0,0
130800,to,0,0
130801,intake,0,1
130802,of,0,0
130803,carbohydrate,0,1
130804,",",0,1
130805,fats,0,1
130806,and,0,1
130807,sweets,0,1
130808,",",0,0
130809,while,0,0
130810,the,0,0
130811,VBC,0,0
130812,group,0,0
130813,had,0,0
130814,a,0,0
130815,significant,0,0
130816,increase,1,1
130817,in,0,0
130818,consumption,1,1
130819,of,1,0
130820,green,1,1
130821,vegetables,1,0
130822,and,0,0
130823,a,0,0
130824,significant,0,0
130825,decrease,1,1
130826,in,1,0
130827,fruit,1,1
130828,consumption,1,1
130829,.,1,0
130830,A,0,0
130831,simple,0,0
130832,meal,0,0
130833,plan,0,0
130834,of,0,1
130835,'eating,0,1
130836,vegetables,0,0
130837,before,0,0
130838,carbohydrate,0,1
130839,',0,1
130840,achieved,0,1
130841,better,1,0
130842,glycemic,1,1
130843,control,1,0
130844,than,0,0
130845,an,0,0
130846,exchange-based,0,0
130847,meal,0,0
130848,plan,0,0
130849,in,0,0
130850,Japanese,0,0
130851,patients,0,0
130852,with,0,0
130853,type,0,0
130854,2,0,0
130855,diabetes,0,0
130856,over,0,0
130857,a,0,0
130858,24-month,0,0
130859,period,0,0
130860,.,0,0
130861,Alternating,0,0
130862,chemotherapy,0,0
130863,in,0,0
130864,small,0,0
130865,cell,0,1
130866,lung,0,1
130867,cancer,0,0
130868,.,0,0
130869,Based,0,0
130870,on,0,0
130871,the,0,0
130872,hypothesis,0,0
130873,of,0,1
130874,Goldie,0,0
130875,and,0,1
130876,Coldman,0,1
130877,",",0,1
130878,rapid,0,1
130879,cyclic,0,1
130880,alternating,0,0
130881,chemotherapy,0,0
130882,has,0,0
130883,been,0,0
130884,supposed,0,0
130885,to,0,0
130886,be,0,0
130887,a,0,0
130888,favorable,0,0
130889,treatment,0,0
130890,modality,0,0
130891,in,0,0
130892,small,0,0
130893,cell,0,1
130894,lung,0,1
130895,cancer,0,0
130896,.,0,0
130897,This,0,0
130898,approach,0,0
130899,has,0,0
130900,been,0,0
130901,tested,0,0
130902,in,0,0
130903,a,0,0
130904,large,0,0
130905,series,0,0
130906,of,0,0
130907,trials,0,0
130908,since,0,0
130909,the,0,0
130910,late,0,0
130911,70,0,0
130912,'s,0,0
130913,.,0,0
130914,A,0,0
130915,few,0,0
130916,trials,0,0
130917,performed,0,0
130918,randomization,0,0
130919,between,0,0
130920,alternating,0,0
130921,and,0,1
130922,continuous,0,1
130923,treatment,0,0
130924,after,0,0
130925,a,0,0
130926,period,0,0
130927,of,0,0
130928,initial,0,0
130929,common,0,0
130930,continuous,0,0
130931,therapy,0,0
130932,.,0,0
130933,The,0,0
130934,results,0,0
130935,of,0,0
130936,these,0,0
130937,studies,0,0
130938,are,0,0
130939,controversial,0,0
130940,and,0,0
130941,their,0,0
130942,interpretation,0,0
130943,is,0,0
130944,complicated,0,0
130945,by,0,0
130946,the,0,0
130947,effects,0,0
130948,of,0,0
130949,the,0,0
130950,continuous,0,0
130951,pretreatment,0,0
130952,.,0,0
130953,Recently,0,0
130954,",",0,0
130955,most,0,0
130956,trials,0,0
130957,were,0,0
130958,designed,0,0
130959,as,0,0
130960,2-arm,0,0
130961,approaches,0,0
130962,with,0,0
130963,a,0,0
130964,comparison,0,0
130965,of,0,0
130966,continuous,0,0
130967,standard,0,0
130968,therapy,0,0
130969,based,0,0
130970,on,0,0
130971,the,0,0
130972,CAV-,0,1
130973,or,0,0
130974,CMC-protocol,0,0
130975,with,0,0
130976,an,0,0
130977,alternating,0,0
130978,schedule,0,0
130979,often,0,0
130980,consisting,0,0
130981,of,0,0
130982,the,0,0
130983,CAV-,0,1
130984,or,0,0
130985,CMC-derived,0,1
130986,combinations,0,0
130987,and,0,0
130988,a,0,0
130989,second,0,0
130990,regimen,0,0
130991,including,0,0
130992,cisplatinum,0,0
130993,and/or,0,0
130994,etoposide,0,0
130995,.,0,0
130996,In,0,0
130997,these,0,0
130998,trials,0,0
130999,the,0,0
131000,addition,0,0
131001,of,0,0
131002,the,0,0
131003,second,0,0
131004,regimen,0,0
131005,in,0,0
131006,the,0,0
131007,alternating,0,0
131008,treatment,0,0
131009,arms,0,0
131010,has,0,0
131011,improved,0,0
131012,the,0,0
131013,treatment,0,0
131014,results,0,0
131015,.,0,0
131016,However,0,0
131017,",",0,0
131018,these,0,0
131019,trials,0,0
131020,could,0,0
131021,not,0,0
131022,clarify,0,0
131023,whether,0,0
131024,this,0,0
131025,advantage,0,0
131026,was,0,0
131027,due,0,0
131028,to,0,0
131029,the,0,0
131030,concept,0,0
131031,of,0,0
131032,alternating,0,0
131033,treatment,0,0
131034,or,0,0
131035,to,0,0
131036,the,0,0
131037,high,0,0
131038,activity,0,1
131039,of,0,1
131040,new,0,0
131041,drugs,0,0
131042,given,0,0
131043,early,0,0
131044,in,0,0
131045,the,0,0
131046,course,0,0
131047,of,0,0
131048,therapy,0,0
131049,in,0,0
131050,the,0,0
131051,alternating,0,0
131052,treatment,0,0
131053,arms,0,0
131054,.,0,0
131055,To,0,0
131056,ameliorate,0,0
131057,this,0,0
131058,weakness,0,1
131059,",",0,0
131060,3,0,0
131061,studies,0,0
131062,were,0,0
131063,designed,0,0
131064,as,0,0
131065,3-arms,0,0
131066,approaches,0,0
131067,using,0,0
131068,both,0,0
131069,alternating,0,0
131070,protocols,0,0
131071,as,0,0
131072,continuous,0,0
131073,control,0,0
131074,arms,0,0
131075,.,0,0
131076,Whereas,0,0
131077,one,0,0
131078,investigation,0,0
131079,noticed,0,0
131080,an,0,0
131081,advantage,0,0
131082,of,0,0
131083,the,0,0
131084,alternating,0,0
131085,schedule,0,0
131086,",",0,0
131087,the,0,0
131088,two,0,0
131089,others,0,0
131090,observed,0,0
131091,no,0,0
131092,difference,0,0
131093,.,0,0
131094,These,0,0
131095,studies,0,0
131096,did,0,0
131097,not,0,0
131098,report,0,0
131099,their,0,0
131100,criteria,0,0
131101,for,0,0
131102,shifting,0,0
131103,non-responding,0,1
131104,patients,0,0
131105,from,0,0
131106,continuous,0,0
131107,treatment,0,0
131108,to,0,0
131109,second,0,0
131110,line,0,0
131111,therapy,0,0
131112,.,0,0
131113,The,0,0
131114,longer,0,0
131115,these,0,0
131116,patients,0,0
131117,stayed,0,0
131118,on,0,0
131119,the,0,0
131120,continuous,0,0
131121,protocol,0,0
131122,the,0,0
131123,more,0,0
131124,the,0,0
131125,study,0,0
131126,design,0,0
131127,favoured,0,0
131128,the,0,0
131129,alternating,0,0
131130,therapy,0,0
131131,.,0,1
131132,(,0,0
131133,ABSTRACT,0,1
131134,TRUNCATED,0,0
131135,AT,0,0
131136,250,0,0
131137,WORDS,0,0
131138,),0,0
131139,A,0,0
131140,pilot,0,0
131141,study,0,0
131142,to,0,0
131143,improve,0,0
131144,venipuncture,1,1
131145,compliance,1,1
131146,in,0,0
131147,children,0,0
131148,and,0,1
131149,adolescents,0,0
131150,with,0,0
131151,autism,0,0
131152,spectrum,0,0
131153,disorders,0,0
131154,.,0,0
131155,OBJECTIVE,0,0
131156,Medical,0,0
131157,procedures,0,0
131158,",",0,0
131159,particularly,0,0
131160,venipuncture,0,0
131161,(,0,0
131162,the,0,0
131163,puncture,0,0
131164,of,0,0
131165,a,0,0
131166,vein,0,0
131167,especially,0,0
131168,for,0,0
131169,the,0,0
131170,withdrawal,0,1
131171,of,0,1
131172,blood,0,1
131173,),0,0
131174,",",0,0
131175,can,0,0
131176,cause,0,1
131177,serious,1,1
131178,distress,1,1
131179,and,0,1
131180,behavior,1,1
131181,disturbance,1,1
131182,for,0,0
131183,many,0,0
131184,children,0,0
131185,.,0,0
131186,Noncompliance,0,0
131187,to,0,0
131188,blood,0,1
131189,draws,0,0
131190,can,0,0
131191,have,0,0
131192,significant,0,0
131193,ramifications,0,0
131194,in,0,0
131195,both,0,0
131196,research,0,0
131197,and,0,1
131198,clinical,0,0
131199,settings,0,0
131200,.,0,0
131201,The,0,0
131202,negative,1,0
131203,reactions,1,1
131204,may,0,0
131205,be,0,0
131206,exacerbated,0,0
131207,in,0,0
131208,individuals,0,0
131209,with,0,0
131210,autism,0,0
131211,spectrum,0,0
131212,disorders,0,0
131213,.,0,0
131214,Even,0,0
131215,so,0,0
131216,",",0,0
131217,there,0,0
131218,has,0,0
131219,been,0,0
131220,little,0,0
131221,research,0,0
131222,into,0,0
131223,the,0,0
131224,prevalence,0,0
131225,of,0,0
131226,the,0,0
131227,problem,0,0
131228,or,0,0
131229,effective,0,1
131230,intervention,0,0
131231,procedures,0,0
131232,.,0,0
131233,In,0,0
131234,response,0,1
131235,to,0,0
131236,these,0,0
131237,concerns,0,0
131238,",",0,0
131239,we,0,0
131240,developed,0,0
131241,and,0,0
131242,evaluated,0,0
131243,the,0,0
131244,Blood,0,1
131245,Draw,0,1
131246,Intervention,0,0
131247,Program,0,1
131248,.,0,0
131249,The,0,0
131250,program,0,0
131251,was,0,0
131252,designed,0,0
131253,to,0,0
131254,be,0,0
131255,easy,0,0
131256,to,0,0
131257,use,0,0
131258,",",0,0
131259,require,0,0
131260,little,0,0
131261,provider,0,1
131262,or,0,1
131263,family,0,1
131264,time,0,1
131265,",",0,0
131266,effectively,0,0
131267,reduce,0,0
131268,negative,1,1
131269,behaviors,1,1
131270,",",0,0
131271,and,0,1
131272,increase,1,1
131273,blood,1,1
131274,draw,1,0
131275,compliance,1,1
131276,.,1,0
131277,METHOD,0,0
131278,In,0,0
131279,a,0,0
131280,quasi-randomized,0,0
131281,trial,0,0
131282,over,0,0
131283,the,0,0
131284,course,0,0
131285,of,0,0
131286,?,0,0
131287,18,0,0
131288,months,0,0
131289,",",0,0
131290,58,0,0
131291,of,0,0
131292,210,0,0
131293,families,0,0
131294,with,0,0
131295,children,0,0
131296,with,0,0
131297,autism,0,0
131298,spectrum,0,0
131299,disorders,0,0
131300,participating,0,0
131301,in,0,0
131302,a,0,0
131303,larger,0,0
131304,study,0,0
131305,of,0,1
131306,phenotypic,0,1
131307,and,0,1
131308,genotypic,0,0
131309,factors,0,1
131310,reported,0,0
131311,significant,0,0
131312,concerns,0,1
131313,about,0,0
131314,blood,0,1
131315,draws,0,0
131316,and,0,0
131317,elected,0,0
131318,to,0,0
131319,use,0,0
131320,the,0,0
131321,Blood,0,1
131322,Draw,0,1
131323,Intervention,0,0
131324,Program,0,1
131325,.,0,0
131326,RESULTS,0,0
131327,Completion,0,0
131328,of,0,0
131329,the,0,0
131330,program,0,0
131331,increased,1,1
131332,blood,1,1
131333,draw,1,0
131334,compliance,1,1
131335,rates,1,1
131336,from,1,0
131337,85.4,0,0
131338,%,0,0
131339,to,0,0
131340,96.6,0,0
131341,%,0,0
131342,(,0,0
131343,odds,0,0
131344,ratio,0,1
131345,=,0,0
131346,4.80,0,0
131347,;,0,0
131348,95,0,0
131349,%,0,0
131350,confidence,0,0
131351,interval,0,0
131352,=,0,0
131353,1.12,0,0
131354,",",0,0
131355,20.59,0,0
131356,;,0,0
131357,p,0,0
131358,=,0,0
131359,.03,0,0
131360,),0,0
131361,.,0,0
131362,CONCLUSION,0,0
131363,Results,0,0
131364,indicate,0,0
131365,the,0,0
131366,efficacy,0,1
131367,of,0,0
131368,the,0,0
131369,program,0,0
131370,in,0,0
131371,a,0,0
131372,research,0,0
131373,setting,0,0
131374,and,0,1
131375,suggest,0,0
131376,a,0,0
131377,potential,0,0
131378,clinical,0,0
131379,application,0,0
131380,.,0,0
131381,The,0,0
131382,current,0,0
131383,intervention,0,0
131384,",",0,0
131385,unlike,0,0
131386,many,0,0
131387,others,0,0
131388,for,0,0
131389,the,0,0
131390,same,0,0
131391,or,0,0
131392,similar,0,0
131393,difficulties,0,1
131394,proposed,0,0
131395,in,0,0
131396,the,0,0
131397,past,0,0
131398,",",0,0
131399,was,0,0
131400,successful,0,1
131401,without,0,0
131402,requiring,0,0
131403,extensive,0,0
131404,time,0,1
131405,",",0,1
131406,training,0,0
131407,",",0,1
131408,or,0,1
131409,effort,0,1
131410,on,0,0
131411,the,0,0
131412,part,0,0
131413,of,0,0
131414,providers,0,0
131415,and,0,1
131416,parents,0,1
131417,or,0,0
131418,their,0,0
131419,children,0,0
131420,",",0,1
131421,nor,0,0
131422,did,0,0
131423,it,0,0
131424,require,0,0
131425,large-scale,0,0
131426,institutional,0,0
131427,changes,0,1
131428,.,0,0
131429,Pharmacodynamic,0,1
131430,effects,0,1
131431,on,0,0
131432,biochemical,1,1
131433,markers,1,1
131434,of,1,1
131435,bone,1,1
131436,turnover,1,1
131437,and,1,1
131438,pharmacokinetics,1,1
131439,of,0,0
131440,the,0,0
131441,cathepsin,0,1
131442,K,0,1
131443,inhibitor,0,0
131444,",",0,1
131445,ONO-5334,0,0
131446,",",0,0
131447,in,0,0
131448,an,0,0
131449,ascending,0,1
131450,multiple-dose,0,0
131451,",",0,0
131452,phase,0,0
131453,1,0,0
131454,study,0,0
131455,.,0,0
131456,Selective,0,0
131457,inhibitors,0,1
131458,of,0,0
131459,cathepsin,0,1
131460,K,0,1
131461,",",0,0
131462,which,0,0
131463,has,0,0
131464,a,0,0
131465,major,0,1
131466,role,0,0
131467,in,0,0
131468,the,0,0
131469,degradation,0,1
131470,of,0,1
131471,bone,0,1
131472,collagen,0,0
131473,",",0,0
131474,are,0,0
131475,potential,0,0
131476,new,0,0
131477,treatments,0,0
131478,for,0,0
131479,osteoporosis,0,0
131480,.,0,0
131481,The,0,0
131482,pharmacokinetics,1,0
131483,and,1,0
131484,the,1,0
131485,pharmacodynamic,1,1
131486,effects,1,1
131487,on,1,0
131488,biochemical,1,1
131489,markers,1,1
131490,of,1,1
131491,bone,1,1
131492,turnover,1,1
131493,of,0,0
131494,the,0,0
131495,new,0,0
131496,cathepsin,0,1
131497,K,0,1
131498,inhibitor,0,0
131499,",",0,1
131500,ONO-5334,0,1
131501,",",0,1
131502,were,0,0
131503,investigated,0,0
131504,in,0,0
131505,a,0,0
131506,multiple,0,0
131507,ascending,0,1
131508,dose,0,1
131509,",",0,0
131510,phase,0,0
131511,1,0,0
131512,study,0,0
131513,.,0,0
131514,A,0,0
131515,total,0,0
131516,of,0,0
131517,120,0,0
131518,healthy,0,0
131519,postmenopausal,0,0
131520,women,0,0
131521,were,0,0
131522,enrolled,0,0
131523,",",0,0
131524,and,0,1
131525,doses,0,0
131526,of,0,0
131527,10,0,0
131528,to,0,0
131529,600,0,0
131530,mg,0,0
131531,once,0,0
131532,daily,0,0
131533,and,0,0
131534,50,0,0
131535,and,0,0
131536,300,0,0
131537,mg,0,0
131538,twice,0,0
131539,daily,0,0
131540,were,0,0
131541,evaluated,0,0
131542,in,0,0
131543,15-,0,0
131544,and,0,1
131545,28-day,0,1
131546,multiple-dosing,0,0
131547,cohorts,0,0
131548,.,0,0
131549,Plasma,0,1
131550,ONO-5334,0,0
131551,concentration,0,1
131552,reached,0,1
131553,steady,0,1
131554,state,0,0
131555,within,0,0
131556,2,0,0
131557,days,0,0
131558,.,0,0
131559,Twenty-four,0,0
131560,hours,0,0
131561,after,0,0
131562,the,0,0
131563,last,0,0
131564,dose,0,0
131565,in,0,0
131566,the,0,0
131567,15-day,0,0
131568,multiple-dose,0,0
131569,cohort,0,0
131570,",",0,0
131571,100,0,0
131572,",",0,0
131573,300,0,0
131574,",",0,0
131575,and,0,0
131576,600,0,0
131577,mg,0,0
131578,once,0,0
131579,daily,0,0
131580,reduced,0,0
131581,urinary,1,1
131582,C-terminal,1,0
131583,telopeptide,1,1
131584,of,1,0
131585,type,1,0
131586,I,1,0
131587,collagen,1,0
131588,by,0,0
131589,a,0,0
131590,mean,0,1
131591,(,0,0
131592,?,0,0
131593,standard,0,0
131594,deviation,0,0
131595,),0,0
131596,44.9,0,0
131597,%,0,0
131598,?,0,0
131599,13.6,0,0
131600,%,0,0
131601,",",0,0
131602,84.5,0,0
131603,%,0,0
131604,?,0,0
131605,4.4,0,0
131606,%,0,0
131607,",",0,0
131608,and,0,0
131609,92.5,0,0
131610,%,0,0
131611,?,0,0
131612,1.3,0,0
131613,%,0,0
131614,",",0,0
131615,respectively,0,0
131616,.,0,0
131617,The,0,0
131618,28-day,0,1
131619,cohort,0,0
131620,showed,0,0
131621,similar,0,0
131622,effects,0,1
131623,.,0,0
131624,There,0,0
131625,were,0,0
131626,far,0,0
131627,smaller,0,0
131628,effects,1,1
131629,on,1,0
131630,bone-specific,1,1
131631,alkaline,1,1
131632,phosphatase,1,1
131633,(,1,1
131634,B-ALP,1,1
131635,),1,1
131636,",",1,0
131637,tartrate-resistant,1,1
131638,acid,1,1
131639,phosphatase,1,1
131640,5b,1,1
131641,(,1,0
131642,TRAP5b,1,0
131643,),1,1
131644,",",1,1
131645,or,1,1
131646,osteocalcin,1,1
131647,(,1,1
131648,OC,1,1
131649,),1,1
131650,(,1,0
131651,measured,1,0
131652,after,0,0
131653,28,0,0
131654,days,0,0
131655,),0,0
131656,.,0,0
131657,ONO-5334,0,0
131658,was,0,0
131659,well,0,0
131660,tolerated,0,1
131661,up,0,0
131662,to,0,0
131663,600,0,0
131664,mg/d,0,0
131665,and,0,0
131666,for,0,0
131667,up,0,0
131668,to,0,0
131669,28,0,0
131670,days,0,0
131671,of,0,0
131672,multiple,0,0
131673,dosing,0,0
131674,.,0,0
131675,Multiple,0,1
131676,dosing,0,0
131677,with,0,0
131678,ONO-5334,0,0
131679,100,0,0
131680,mg,0,0
131681,resulted,0,0
131682,in,0,0
131683,considerable,0,0
131684,suppression,1,1
131685,of,1,1
131686,bone,1,1
131687,resorption,1,1
131688,markers,1,1
131689,with,1,0
131690,no,0,0
131691,appreciable,0,1
131692,effects,1,1
131693,on,1,0
131694,bone,1,1
131695,formation,1,1
131696,markers,1,1
131697,(,1,1
131698,B-ALP,1,1
131699,",",1,1
131700,OC,1,1
131701,),1,1
131702,or,1,0
131703,osteoclast,1,1
131704,number,1,1
131705,(,1,1
131706,TRAP5b,1,1
131707,),1,0
131708,.,1,0
131709,Beverage,0,0
131710,vs.,0,0
131711,solid,0,0
131712,fruits,0,0
131713,and,0,0
131714,vegetables,0,0
131715,:,0,0
131716,effects,0,1
131717,on,0,0
131718,energy,0,1
131719,intake,0,1
131720,and,0,1
131721,body,1,1
131722,weight,1,1
131723,.,1,1
131724,Beverage,0,0
131725,consumption,0,0
131726,has,0,0
131727,been,0,0
131728,implicated,0,0
131729,in,0,0
131730,weight,0,1
131731,gain,0,1
131732,",",0,1
131733,but,0,0
131734,questions,0,1
131735,remain,0,0
131736,about,0,0
131737,the,0,0
131738,veracity,0,1
131739,of,0,0
131740,the,0,0
131741,association,0,0
131742,",",0,0
131743,whether,0,0
131744,the,0,0
131745,relationship,0,0
131746,is,0,0
131747,causal,0,0
131748,and,0,0
131749,what,0,0
131750,property,0,0
131751,of,0,0
131752,beverages,0,0
131753,is,0,0
131754,responsible,0,0
131755,.,0,0
131756,It,0,0
131757,was,0,0
131758,hypothesized,0,0
131759,that,0,0
131760,food,0,0
131761,form,0,0
131762,is,0,0
131763,the,0,0
131764,most,0,0
131765,salient,0,1
131766,attribute,0,0
131767,.,0,0
131768,Thus,0,1
131769,",",0,0
131770,a,0,0
131771,randomized,0,0
131772,controlled,0,0
131773,trial,0,0
131774,of,0,1
131775,food,0,0
131776,form,0,0
131777,was,0,0
131778,conducted,0,0
131779,.,0,0
131780,Energy-matched,0,0
131781,beverage,0,0
131782,or,0,1
131783,solid,0,1
131784,forms,0,0
131785,of,0,1
131786,fruits,0,0
131787,and,0,1
131788,vegetables,0,1
131789,were,0,0
131790,provided,0,0
131791,to,0,0
131792,34,0,0
131793,",",0,0
131794,lean,0,1
131795,or,0,1
131796,overweight/obese,0,0
131797,adults,0,0
131798,for,0,0
131799,two,0,0
131800,8-week,0,0
131801,periods,0,0
131802,with,0,0
131803,a,0,0
131804,3-week,0,0
131805,washout,0,0
131806,interspersed,0,0
131807,.,0,0
131808,Dietary,1,0
131809,compensation,1,0
131810,was,0,0
131811,incomplete,0,0
131812,(,0,0
131813,beverage,0,0
131814,53,0,0
131815,%,0,0
131816,;,0,0
131817,solid,0,0
131818,78,0,0
131819,%,0,0
131820,),0,0
131821,and,0,1
131822,body,1,1
131823,weight,1,1
131824,increased,0,0
131825,after,0,0
131826,the,0,0
131827,beverage,0,0
131828,(,0,0
131829,1.95,0,0
131830,?,0,0
131831,0.33,0,0
131832,kg,0,0
131833,),0,0
131834,(,0,0
131835,77,0,0
131836,%,0,0
131837,fat,0,1
131838,mass,0,1
131839,),0,1
131840,and,0,1
131841,solid,0,1
131842,(,0,0
131843,1.36,0,0
131844,?,0,0
131845,0.30,0,0
131846,kg,0,0
131847,),0,0
131848,(,0,0
131849,85,0,0
131850,%,0,0
131851,fat,0,1
131852,mass,0,1
131853,),0,1
131854,treatments,0,0
131855,(,0,0
131856,both,0,0
131857,P,0,0
131858,<,0,0
131859,0.0005,0,0
131860,),0,0
131861,.,0,0
131862,Differences,0,1
131863,between,0,0
131864,food,0,0
131865,forms,0,0
131866,were,0,0
131867,not,0,0
131868,significant,0,0
131869,.,0,0
131870,The,0,0
131871,lean,0,1
131872,group,0,0
131873,had,0,0
131874,the,0,0
131875,highest,1,1
131876,dietary,1,1
131877,compensation,1,0
131878,(,1,0
131879,119,0,0
131880,%,0,0
131881,),0,0
131882,and,0,0
131883,no,0,0
131884,significant,1,0
131885,weight,1,1
131886,change,1,1
131887,(,1,0
131888,0.84,0,0
131889,?,0,0
131890,0.53,0,0
131891,kg,0,0
131892,),0,0
131893,after,0,0
131894,consuming,0,0
131895,the,0,0
131896,solid,0,0
131897,fruits,0,0
131898,and,0,0
131899,vegetables,0,0
131900,whereas,0,0
131901,the,0,0
131902,overweight/obese,0,0
131903,group,0,0
131904,had,0,0
131905,lower,1,1
131906,compensation,1,1
131907,and,1,1
131908,significant,1,1
131909,weight,1,1
131910,gain,1,1
131911,during,1,0
131912,the,0,0
131913,solid,0,0
131914,arm,0,0
131915,(,0,0
131916,46,0,0
131917,%,0,0
131918,",",0,0
131919,1.77,0,0
131920,?,0,0
131921,0.32,0,0
131922,kg,0,0
131923,",",0,0
131924,P,0,0
131925,<,0,0
131926,0.0001,0,0
131927,),0,0
131928,.,0,0
131929,In,0,0
131930,contrast,0,0
131931,",",0,0
131932,incomplete,1,0
131933,dietary,1,1
131934,compensation,1,0
131935,and,1,1
131936,weight,1,1
131937,gain,1,1
131938,occurred,1,0
131939,in,0,0
131940,both,0,0
131941,the,0,0
131942,lean,0,1
131943,(,0,0
131944,43,0,0
131945,%,0,0
131946,",",0,0
131947,1.61,0,0
131948,?,0,0
131949,0.44,0,0
131950,kg,0,0
131951,",",0,0
131952,P,0,0
131953,=,0,0
131954,0.003,0,0
131955,),0,0
131956,and,0,0
131957,overweight/obese,0,0
131958,(,0,0
131959,61,0,0
131960,%,0,0
131961,",",0,0
131962,2.22,0,0
131963,?,0,0
131964,0.47,0,0
131965,kg,0,0
131966,",",0,0
131967,P,0,0
131968,<,0,0
131969,0.0005,0,0
131970,),0,0
131971,groups,0,0
131972,during,0,0
131973,the,0,0
131974,beverage,0,0
131975,arm,0,0
131976,.,0,1
131977,Secondary,0,0
131978,analyses,0,0
131979,revealed,0,0
131980,the,0,0
131981,obese,0,0
131982,group,0,0
131983,gained,0,0
131984,more,0,0
131985,weight,0,1
131986,than,0,0
131987,the,0,0
131988,lean,0,1
131989,and,0,0
131990,overweight,0,1
131991,groups,0,0
131992,during,0,0
131993,the,0,0
131994,beverage,0,0
131995,intervention,0,0
131996,(,0,1
131997,P,0,0
131998,=,0,0
131999,0.024,0,0
132000,),0,0
132001,.,0,0
132002,These,0,0
132003,data,0,0
132004,demonstrate,0,0
132005,energy,0,1
132006,consumed,0,0
132007,as,0,0
132008,beverages,0,0
132009,may,0,0
132010,be,0,0
132011,especially,0,0
132012,problematic,1,0
132013,for,1,0
132014,weight,1,1
132015,gain,1,1
132016,.,1,0
132017,They,0,0
132018,also,0,0
132019,indicate,0,0
132020,that,0,0
132021,advice,0,0
132022,to,0,0
132023,increase,0,1
132024,fruit,0,1
132025,and,0,1
132026,vegetable,0,0
132027,consumption,0,0
132028,should,0,0
132029,emphasize,0,0
132030,total,0,1
132031,energy,0,1
132032,intake,0,1
132033,because,0,0
132034,the,0,0
132035,additional,0,0
132036,energy,0,0
132037,contributed,0,0
132038,may,0,0
132039,promote,1,0
132040,weight,1,1
132041,gain,1,1
132042,",",1,0
132043,especially,0,0
132044,among,0,0
132045,overweight,0,1
132046,and,0,1
132047,obese,0,0
132048,individuals,0,0
132049,.,0,0
132050,Cross-modal,0,0
132051,attention-switching,0,0
132052,is,0,0
132053,impaired,0,0
132054,in,0,0
132055,autism,0,0
132056,spectrum,0,0
132057,disorders,0,0
132058,.,0,0
132059,This,0,0
132060,investigation,0,0
132061,aimed,0,0
132062,to,0,0
132063,determine,0,0
132064,if,0,0
132065,children,0,0
132066,with,0,0
132067,ASD,0,0
132068,are,0,0
132069,impaired,0,0
132070,in,0,0
132071,their,0,0
132072,ability,0,1
132073,to,0,0
132074,switch,0,0
132075,attention,0,1
132076,between,0,0
132077,different,0,0
132078,tasks,0,1
132079,",",0,1
132080,and,0,1
132081,whether,0,0
132082,performance,0,1
132083,is,0,0
132084,further,0,0
132085,impaired,0,0
132086,when,0,0
132087,required,0,0
132088,to,0,0
132089,switch,0,0
132090,across,0,0
132091,two,0,0
132092,separate,0,0
132093,modalities,0,0
132094,(,0,0
132095,visual,0,1
132096,and,0,1
132097,auditory,0,1
132098,),0,1
132099,.,0,0
132100,Eighteen,0,0
132101,children,0,0
132102,with,0,0
132103,ASD,0,0
132104,(,0,0
132105,9-13,0,0
132106,years,0,0
132107,old,0,0
132108,),0,0
132109,were,0,0
132110,compared,0,0
132111,with,0,0
132112,18,0,0
132113,typically-developing,0,0
132114,children,0,0
132115,matched,0,0
132116,with,0,0
132117,the,0,0
132118,ASD,0,0
132119,group,0,0
132120,for,0,0
132121,mental,0,1
132122,age,0,0
132123,",",0,1
132124,and,0,1
132125,also,0,0
132126,with,0,0
132127,18,0,0
132128,subjects,0,0
132129,with,0,0
132130,learning,0,1
132131,difficulties,0,0
132132,matched,0,0
132133,with,0,0
132134,the,0,0
132135,ASD,0,0
132136,group,0,0
132137,for,0,0
132138,mental,0,1
132139,and,0,1
132140,chronological,0,1
132141,age,0,0
132142,.,0,1
132143,Individuals,0,0
132144,alternated,0,0
132145,between,0,0
132146,two,0,0
132147,different,0,0
132148,visual,0,1
132149,tasks,0,1
132150,",",0,1
132151,and,0,0
132152,between,0,0
132153,a,0,0
132154,different,0,0
132155,visual,0,1
132156,task,0,1
132157,and,0,0
132158,an,0,0
132159,auditory,0,1
132160,task,0,1
132161,.,0,0
132162,Children,0,0
132163,with,0,0
132164,ASD,0,0
132165,performed,1,0
132166,worse,1,0
132167,than,0,0
132168,both,0,0
132169,comparison,0,0
132170,groups,0,0
132171,at,0,0
132172,both,0,0
132173,switching,1,0
132174,tasks,1,0
132175,.,1,0
132176,Moreover,0,0
132177,",",0,0
132178,children,0,0
132179,with,0,0
132180,ASD,0,0
132181,had,0,0
132182,greater,1,0
132183,difficulty,1,1
132184,when,1,0
132185,different,1,0
132186,modalities,1,0
132187,were,1,0
132188,required,1,0
132189,than,1,0
132190,where,1,0
132191,only,1,0
132192,one,1,0
132193,modality,1,0
132194,was,1,0
132195,required,1,0
132196,in,1,0
132197,the,1,0
132198,switching,1,0
132199,task,1,1
132200,in,0,0
132201,comparison,0,0
132202,with,0,0
132203,participants,0,0
132204,matched,0,0
132205,in,0,0
132206,terms,0,0
132207,of,0,1
132208,mental,0,1
132209,and,0,1
132210,chronological,0,1
132211,age,0,0
132212,.,0,0
132213,Validity,1,1
132214,and,1,1
132215,reliability,1,1
132216,assessment,0,0
132217,of,0,0
132218,the,0,0
132219,Siriraj,0,0
132220,Asthma,0,1
132221,Control,0,0
132222,Questionnaire,0,1
132223,.,0,0
132224,OBJECTIVE,0,0
132225,The,0,0
132226,present,0,0
132227,study,0,0
132228,assessed,0,0
132229,the,0,0
132230,validity,1,1
132231,and,0,1
132232,reliability,1,1
132233,of,0,0
132234,the,0,0
132235,Siriraj,0,0
132236,Asthma,0,1
132237,Control,0,1
132238,Questionnaire,0,1
132239,in,0,0
132240,Asthma,0,1
132241,Clinic,0,0
132242,",",0,1
132243,Siriraj,0,0
132244,Hospital,0,1
132245,.,0,1
132246,MATERIAL,0,0
132247,AND,0,0
132248,METHOD,0,0
132249,The,0,0
132250,data,0,0
132251,of,0,0
132252,the,0,0
132253,questionnaire,0,1
132254,responses,0,1
132255,and,0,1
132256,spirometric,0,1
132257,results,0,0
132258,from,0,0
132259,20,0,0
132260,randomized,0,0
132261,asthmatic,0,0
132262,patients,0,0
132263,in,0,0
132264,the,0,0
132265,clinic,0,0
132266,including,0,0
132267,the,0,0
132268,record,0,0
132269,of,0,0
132270,3,0,0
132271,visits,0,0
132272,for,0,0
132273,each,0,0
132274,subject,0,0
132275,.,0,0
132276,The,0,0
132277,validation,0,0
132278,was,0,0
132279,performed,0,0
132280,by,0,0
132281,Kruskal-Wallis,0,0
132282,test,0,0
132283,comparing,0,0
132284,the,0,0
132285,scores,0,1
132286,with,0,0
132287,the,0,0
132288,level,0,1
132289,of,0,0
132290,asthma,0,0
132291,control,0,0
132292,determined,0,0
132293,by,0,0
132294,physicians,0,0
132295,according,0,0
132296,to,0,0
132297,GINA,0,0
132298,guideline,0,0
132299,.,0,1
132300,Internal,0,0
132301,consistency,0,1
132302,reliability,0,1
132303,was,0,0
132304,analyzed,0,0
132305,by,0,0
132306,Cronbach,0,1
132307,'s,0,0
132308,alpha,0,1
132309,.,0,0
132310,RESULTS,0,0
132311,Sixty,0,0
132312,questionnaires,0,0
132313,from,0,0
132314,20,0,0
132315,patients,0,0
132316,with,0,0
132317,age,0,0
132318,29-73,0,0
132319,years,0,0
132320,were,0,0
132321,analyzed,0,0
132322,.,0,0
132323,There,0,0
132324,were,0,0
132325,40,0,0
132326,controlled,0,0
132327,",",0,0
132328,7,0,0
132329,partly,0,0
132330,controlled,0,0
132331,and,0,0
132332,13,0,0
132333,uncontrolled,0,0
132334,visits,0,0
132335,.,0,0
132336,The,0,0
132337,scores,1,1
132338,from,1,0
132339,5-items,1,1
132340,questionnaires,1,1
132341,and,1,1
132342,6-items,1,1
132343,clinical,1,1
132344,score,1,1
132345,were,0,0
132346,significantly,0,0
132347,associated,0,0
132348,with,0,0
132349,the,0,0
132350,physician-diagnosed,0,0
132351,groups,0,0
132352,(,0,0
132353,i.e.,0,0
132354,",",0,1
132355,controlled,0,0
132356,",",0,0
132357,partly,0,0
132358,controlled,0,0
132359,and,0,0
132360,uncontrolled,0,0
132361,groups,0,0
132362,),0,0
132363,.,0,0
132364,Median,1,1
132365,scores,1,1
132366,(,1,1
132367,min,1,0
132368,",",1,1
132369,max,1,1
132370,),1,1
132371,were,0,0
132372,0,0,0
132373,(,0,0
132374,0,0,0
132375,",",0,0
132376,5,0,0
132377,),0,0
132378,",",0,0
132379,2,0,0
132380,(,0,0
132381,0,0,0
132382,",",0,0
132383,6,0,0
132384,),0,0
132385,",",0,0
132386,4,0,0
132387,(,0,0
132388,0,0,0
132389,",",0,0
132390,12,0,0
132391,),0,0
132392,respectively,0,0
132393,",",0,0
132394,(,0,0
132395,5-items,0,1
132396,",",0,0
132397,p,0,0
132398,<,0,0
132399,0.001,0,0
132400,),0,0
132401,and,0,0
132402,2,0,0
132403,(,0,0
132404,0,0,0
132405,",",0,0
132406,7,0,0
132407,),0,0
132408,",",0,0
132409,3,0,0
132410,(,0,0
132411,1,0,0
132412,",",0,0
132413,7,0,0
132414,),0,0
132415,",",0,0
132416,6,0,0
132417,(,0,0
132418,"2,15",0,0
132419,),0,0
132420,respectively,0,0
132421,",",0,0
132422,(,0,0
132423,6-items,0,1
132424,",",0,0
132425,p,0,0
132426,<,0,0
132427,0.001,0,0
132428,),0,0
132429,.,0,0
132430,Internal,1,0
132431,consistency,1,1
132432,reliability,1,1
132433,of,0,0
132434,both,0,0
132435,5-items,0,1
132436,questionnaire,0,1
132437,and,0,1
132438,6-items,0,1
132439,clinical,0,1
132440,score,0,1
132441,were,0,0
132442,within,0,0
132443,the,0,0
132444,acceptable,0,0
132445,range,0,0
132446,(,0,0
132447,0.829,0,0
132448,and,0,0
132449,0.708,0,0
132450,respectively,0,0
132451,),0,0
132452,.,0,0
132453,5-items,1,1
132454,questionnaire,1,1
132455,is,0,0
132456,more,0,0
132457,associated,0,0
132458,with,0,0
132459,the,0,0
132460,physician,0,0
132461,diagnosed,0,0
132462,group,0,0
132463,and,0,0
132464,more,0,0
132465,consistent,1,0
132466,than,0,0
132467,6-items,1,1
132468,clinical,1,0
132469,score,1,1
132470,.,1,1
132471,Further,0,1
132472,analysis,0,0
132473,revealed,0,0
132474,cutoff,0,1
132475,point,0,0
132476,at,0,0
132477,2.5,0,0
132478,to,0,0
132479,separate,0,0
132480,uncontrolled,0,0
132481,from,0,0
132482,controlled,0,0
132483,or,0,0
132484,partly,0,0
132485,controlled,0,0
132486,patient,0,0
132487,with,0,0
132488,sensitivity,1,1
132489,76.9,0,0
132490,%,0,0
132491,and,0,0
132492,specificity,1,1
132493,89.4,0,0
132494,%,0,0
132495,and,0,0
132496,cutoff,1,1
132497,point,1,0
132498,at,0,0
132499,1.5,0,0
132500,to,0,0
132501,separate,0,0
132502,uncontrolled,0,0
132503,or,0,0
132504,partly,0,0
132505,controlled,0,0
132506,from,0,0
132507,controlled,0,0
132508,patient,0,0
132509,with,0,0
132510,sensitivity,1,1
132511,70.0,0,0
132512,%,0,0
132513,and,0,0
132514,specificity,1,1
132515,85.0,0,0
132516,%,0,0
132517,.,0,0
132518,CONCLUSION,0,0
132519,The,0,0
132520,validity,1,1
132521,and,1,1
132522,reliability,1,1
132523,of,0,1
132524,Siriraj,0,0
132525,Asthma,0,1
132526,Control,0,0
132527,Questionnaire,0,1
132528,is,0,0
132529,acceptable,0,0
132530,and,0,0
132531,might,0,0
132532,be,0,0
132533,used,0,0
132534,in,0,0
132535,the,0,0
132536,clinical,0,0
132537,practice,0,0
132538,and,0,1
132539,research,0,0
132540,in,0,0
132541,Thai,0,0
132542,asthmatic,0,0
132543,patients,0,0
132544,.,0,0
132545,Effect,0,1
132546,of,0,1
132547,shearing,0,0
132548,on,0,0
132549,water,1,1
132550,turnover,1,1
132551,and,1,1
132552,thermobiological,1,1
132553,variables,1,1
132554,in,0,0
132555,German,0,0
132556,Blackhead,0,1
132557,mutton,0,0
132558,sheep,0,0
132559,.,0,1
132560,Current,0,1
132561,equations,0,0
132562,for,0,0
132563,estimating,0,0
132564,water,0,0
132565,requirements,0,1
132566,in,0,0
132567,sheep,0,0
132568,do,0,0
132569,not,0,0
132570,differentiate,0,0
132571,between,0,0
132572,shorn,0,0
132573,and,0,1
132574,unshorn,0,0
132575,sheep,0,0
132576,.,0,0
132577,Furthermore,0,0
132578,",",0,0
132579,the,0,0
132580,effect,0,1
132581,of,0,0
132582,shearing,0,0
132583,on,0,0
132584,thermoregulative,1,0
132585,responses,1,1
132586,in,0,0
132587,sheep,0,0
132588,has,0,0
132589,not,0,0
132590,been,0,0
132591,adequately,0,0
132592,studied,0,0
132593,under,0,0
132594,temperate,0,0
132595,environmental,0,0
132596,conditions,0,0
132597,.,0,0
132598,Therefore,0,0
132599,",",0,0
132600,the,0,0
132601,present,0,0
132602,study,0,0
132603,was,0,0
132604,conducted,0,0
132605,to,0,0
132606,investigate,0,0
132607,the,0,0
132608,effect,0,0
132609,of,0,1
132610,wool,0,1
132611,coverage,0,1
132612,on,0,0
132613,water,1,1
132614,turnover,1,1
132615,in,0,0
132616,relation,0,1
132617,to,0,0
132618,thermoregulation,0,1
132619,in,0,0
132620,sheep,0,0
132621,by,0,0
132622,using,0,0
132623,the,0,0
132624,deuterium,0,1
132625,dilution,0,1
132626,technique,0,0
132627,to,0,0
132628,predict,0,1
132629,total,0,1
132630,water,0,0
132631,intake,0,1
132632,before,0,0
132633,and,0,1
132634,after,0,0
132635,shearing,0,0
132636,.,0,0
132637,Physiological,0,0
132638,responses,0,1
132639,",",0,0
132640,such,0,1
132641,as,0,0
132642,water,1,1
132643,turnover,1,1
132644,",",1,1
132645,surface,1,1
132646,temperature,1,1
132647,",",1,1
132648,and,1,1
132649,rectal,1,1
132650,temperature,1,1
132651,",",1,0
132652,as,1,0
132653,well,1,0
132654,as,1,0
132655,drinking,1,0
132656,behavior,1,1
132657,of,1,1
132658,sheep,1,0
132659,were,0,0
132660,also,0,0
132661,evaluated,0,0
132662,.,0,0
132663,Fourteen,0,0
132664,nonlactating,0,0
132665,German,0,0
132666,Blackhead,0,1
132667,mutton,0,1
132668,ewes,0,1
132669,were,0,0
132670,randomly,0,0
132671,allocated,0,0
132672,into,0,0
132673,2,0,0
132674,groups,0,0
132675,:,0,0
132676,a,0,0
132677,control,0,0
132678,group,0,0
132679,(,0,0
132680,n,0,0
132681,=,0,0
132682,7,0,0
132683,),0,0
132684,that,0,0
132685,was,0,0
132686,already,0,0
132687,shorn,0,0
132688,",",0,0
132689,and,0,0
132690,a,0,0
132691,treatment,0,0
132692,group,0,0
132693,(,0,0
132694,n,0,0
132695,=,0,0
132696,7,0,0
132697,),0,0
132698,that,0,0
132699,was,0,0
132700,left,0,1
132701,unshorn,0,0
132702,(,0,0
132703,wool,0,1
132704,length,0,1
132705,:,0,0
132706,10.6,0,0
132707,?,0,0
132708,1.2,0,0
132709,cm,0,0
132710,),0,0
132711,.,0,0
132712,Individual,1,1
132713,feed,1,1
132714,and,1,1
132715,water,1,1
132716,intakes,1,1
132717,were,0,0
132718,recorded,0,0
132719,throughout,0,0
132720,the,0,0
132721,experiment,0,0
132722,(,0,0
132723,d,0,0
132724,1,0,0
132725,to,0,0
132726,71,0,0
132727,),0,0
132728,.,0,0
132729,Two,0,0
132730,weeks,0,0
132731,after,0,0
132732,measurements,0,1
132733,commenced,0,0
132734,(,0,0
132735,d,0,0
132736,15,0,0
132737,),0,0
132738,",",0,0
132739,treatment,0,0
132740,sheep,0,0
132741,were,0,0
132742,shorn,0,0
132743,.,0,0
132744,Water,1,0
132745,intake,1,1
132746,was,0,0
132747,estimated,0,0
132748,twice,0,0
132749,for,0,0
132750,2,0,0
132751,consecutive,0,0
132752,weeks,0,0
132753,by,0,0
132754,using,0,0
132755,deuterium,0,1
132756,dilution,0,1
132757,techniques,0,0
132758,(,0,0
132759,d,0,0
132760,1,0,0
132761,to,0,0
132762,15,0,0
132763,and,0,0
132764,d,0,0
132765,57,0,0
132766,to,0,0
132767,71,0,0
132768,),0,0
132769,.,0,0
132770,Ambient,1,1
132771,temperature,1,1
132772,(,1,1
132773,T,1,1
132774,(,1,0
132775,a,1,0
132776,),1,0
132777,),1,0
132778,",",1,0
132779,relative,1,1
132780,humidity,1,1
132781,",",1,1
132782,and,1,1
132783,respiratory,1,1
132784,rate,1,1
132785,were,0,0
132786,measured,0,0
132787,daily,0,0
132788,",",0,0
132789,whereas,1,0
132790,BW,1,1
132791,",",1,1
132792,rectal,1,1
132793,and,1,1
132794,animal,1,0
132795,surface,1,1
132796,temperatures,1,1
132797,(,0,0
132798,using,0,0
132799,infrared,0,0
132800,thermography,0,1
132801,),0,0
132802,",",0,1
132803,and,1,1
132804,wool,1,1
132805,length,1,1
132806,were,0,0
132807,measured,0,0
132808,weekly,0,0
132809,.,0,0
132810,In,0,0
132811,the,0,0
132812,first,0,0
132813,2,0,0
132814,wk,0,0
132815,",",0,0
132816,when,0,0
132817,treatment,0,0
132818,sheep,0,0
132819,were,0,0
132820,unshorn,0,0
132821,",",0,1
132822,treatment,0,0
132823,and,0,1
132824,control,0,0
132825,ewes,0,1
132826,differed,0,0
132827,(,0,0
132828,P,0,0
132829,<,0,0
132830,0.05,0,0
132831,),0,0
132832,in,1,0
132833,DMI,1,1
132834,(,0,0
132835,52,0,0
132836,?,0,0
132837,4,0,0
132838,vs.,0,0
132839,59,0,0
132840,?,0,0
132841,4,0,0
132842,g?kg,1,0
132843,(,1,0
132844,-0.75,1,0
132845,),1,1
132846,?d,1,1
132847,(,1,1
132848,-1,1,0
132849,),1,1
132850,),1,0
132851,",",1,0
132852,water,1,1
132853,intake,1,1
132854,(,1,0
132855,165,1,0
132856,?,0,0
132857,17,0,0
132858,vs.,0,0
132859,134,0,0
132860,?,0,0
132861,18,0,0
132862,g?kg,0,0
132863,(,0,0
132864,-0.75,1,0
132865,),1,1
132866,?d,1,1
132867,(,1,1
132868,-1,1,0
132869,),1,1
132870,),1,0
132871,",",1,0
132872,respiratory,1,1
132873,rate,1,1
132874,(,1,0
132875,66,1,0
132876,?,0,0
132877,5,0,0
132878,vs.,0,0
132879,31,0,0
132880,?,0,0
132881,4,0,0
132882,breath/min,0,0
132883,),0,0
132884,",",1,0
132885,rectal,1,1
132886,temperature,1,1
132887,(,1,0
132888,39.3,1,0
132889,?,1,0
132890,0.2,1,0
132891,vs.,0,0
132892,38.8,0,0
132893,?,0,0
132894,0.1?C,0,0
132895,),0,0
132896,",",0,0
132897,and,1,1
132898,surface,1,1
132899,temperatures,1,1
132900,(,0,0
132901,body,0,1
132902,side,0,1
132903,:,0,0
132904,19.3,0,0
132905,?,0,0
132906,0.3,0,0
132907,vs.,0,0
132908,24.5,0,0
132909,?,0,0
132910,0.6?C,0,0
132911,;,0,0
132912,leg,0,0
132913,:,0,0
132914,25.8,0,0
132915,?,0,0
132916,2.4,0,0
132917,vs.,0,0
132918,27.4,0,0
132919,?,0,0
132920,1.6?C,0,0
132921,),0,0
132922,.,0,0
132923,However,0,0
132924,",",0,0
132925,after,0,0
132926,shearing,0,1
132927,",",0,0
132928,these,0,0
132929,differences,0,0
132930,partly,0,0
132931,disappeared,0,0
132932,.,0,0
132933,The,0,0
132934,same,1,0
132935,trend,1,0
132936,in,1,0
132937,water,1,1
132938,intake,1,1
132939,between,1,0
132940,groups,0,0
132941,was,0,0
132942,confirmed,0,0
132943,using,0,0
132944,the,0,0
132945,isotope,0,0
132946,dilution,0,1
132947,technique,0,0
132948,.,0,0
132949,We,0,0
132950,found,0,0
132951,a,0,0
132952,significant,0,0
132953,relationship,0,0
132954,between,0,0
132955,T,1,0
132956,(,1,0
132957,a,1,0
132958,),1,0
132959,and,1,1
132960,water,1,1
132961,intake,1,1
132962,",",1,1
132963,respiratory,1,1
132964,rate,1,1
132965,",",1,1
132966,and,1,1
132967,body,1,1
132968,surface,1,1
132969,temperatures,1,1
132970,.,1,0
132971,Even,1,0
132972,under,0,0
132973,temperate,0,0
132974,conditions,0,0
132975,(,0,1
132976,T,0,0
132977,(,0,0
132978,a,0,0
132979,),0,0
132980,<,0,0
132981,28?C,0,0
132982,),0,0
132983,",",0,0
132984,shearing,0,0
132985,significantly,0,0
132986,reduced,0,0
132987,core,1,1
132988,body,1,1
132989,temperature,1,1
132990,",",1,1
132991,water,1,1
132992,intake,1,1
132993,",",1,1
132994,and,1,1
132995,respiratory,1,1
132996,rate,1,1
132997,in,0,0
132998,German,0,0
132999,Blackhead,0,1
133000,mutton,0,1
133001,sheep,0,0
133002,",",0,0
133003,thus,0,0
133004,indicating,1,0
133005,heat,1,1
133006,stress,1,1
133007,in,1,0
133008,fleeced,1,1
133009,animals,0,0
133010,",",0,0
133011,which,0,0
133012,should,0,0
133013,be,0,0
133014,considered,0,0
133015,when,0,0
133016,determining,0,0
133017,the,0,0
133018,optimal,0,1
133019,shearing,0,1
133020,time,0,1
133021,in,0,0
133022,sheep,0,0
133023,as,0,0
133024,well,0,0
133025,as,0,0
133026,when,0,0
133027,estimating,0,0
133028,water,0,0
133029,requirements,0,1
133030,.,0,0
133031,Effect,0,1
133032,of,0,1
133033,ginseng,0,0
133034,extract,0,0
133035,supplementation,0,0
133036,on,0,0
133037,testicular,1,1
133038,functions,1,1
133039,in,0,0
133040,diabetic,0,0
133041,rats,0,0
133042,.,0,0
133043,OBJECTIVE,0,0
133044,It,0,0
133045,was,0,0
133046,aimed,0,0
133047,to,0,0
133048,investigate,0,0
133049,the,0,0
133050,effect,0,0
133051,of,0,0
133052,standardized,0,0
133053,ginseng,0,0
133054,extract,0,0
133055,on,0,0
133056,fertility,1,1
133057,parameters,1,1
133058,in,0,0
133059,diabetic,0,0
133060,rats,0,0
133061,.,0,0
133062,METHODS,0,0
133063,Thirty,0,0
133064,male,0,0
133065,rats,0,0
133066,were,0,0
133067,randomly,0,0
133068,allocated,0,0
133069,into,0,0
133070,three,0,0
133071,groups,0,0
133072,of,0,0
133073,10,0,0
133074,rats,0,0
133075,each,0,0
133076,:,0,0
133077,1.,0,0
133078,controls,0,0
133079,",",0,0
133080,2.,0,1
133081,diabetes,0,0
133082,(,0,0
133083,D,0,1
133084,),0,0
133085,and,0,0
133086,3.,0,0
133087,diabetes,0,0
133088,+,0,0
133089,ginseng,0,0
133090,(,0,1
133091,DG,0,0
133092,),0,0
133093,.,0,0
133094,The,0,0
133095,latter,0,0
133096,two,0,0
133097,groups,0,0
133098,were,0,0
133099,rendered,0,0
133100,diabetic,0,0
133101,by,0,0
133102,i.p,0,0
133103,.,0,0
133104,injection,0,0
133105,of,0,1
133106,streptozotocin,0,0
133107,(,0,0
133108,STZ,0,1
133109,;,0,0
133110,50,0,0
133111,mg/kg,0,0
133112,),0,0
133113,.,0,0
133114,Standardized,0,0
133115,ginseng,0,0
133116,extract,0,0
133117,(,0,1
133118,Dansk,0,0
133119,Droge,0,0
133120,A/S,0,0
133121,",",0,1
133122,Copenhagen,0,0
133123,",",0,1
133124,Denmark,0,1
133125,),0,1
133126,was,0,0
133127,administered,0,0
133128,per,0,0
133129,os,0,0
133130,(,0,0
133131,100,0,0
133132,mg/kg,0,0
133133,BW,0,0
133134,),0,0
133135,by,0,0
133136,stomach,0,1
133137,tube,0,0
133138,daily,0,0
133139,for,0,0
133140,90,0,0
133141,days,0,0
133142,starting,0,0
133143,one,0,0
133144,week,0,0
133145,after,0,0
133146,STZ,0,1
133147,.,0,0
133148,Ninety,0,0
133149,days,0,0
133150,post,0,0
133151,STZ,0,1
133152,the,0,0
133153,rats,0,0
133154,were,0,0
133155,sacrificed,0,0
133156,",",0,0
133157,and,0,1
133158,testis,1,1
133159,",",1,1
133160,epididymis,1,1
133161,",",1,1
133162,prostate,1,1
133163,",",1,1
133164,and,1,1
133165,seminal,1,1
133166,vesicles,1,1
133167,were,1,0
133168,weighed,1,0
133169,and,1,0
133170,subjected,1,0
133171,to,1,0
133172,histological,1,0
133173,examination,1,0
133174,.,1,0
133175,In,0,0
133176,addition,0,0
133177,",",0,1
133178,spermiogram,1,1
133179,",",1,1
133180,testicular,1,1
133181,enzyme,1,1
133182,markers,1,1
133183,",",1,0
133184,intratesticular,1,1
133185,steroid,1,1
133186,hormonal,1,1
133187,profile,1,1
133188,and,1,1
133189,testicular,1,1
133190,antioxidant,1,1
133191,status,1,1
133192,were,0,0
133193,estimated,0,0
133194,.,0,0
133195,RESULTS,0,0
133196,The,0,0
133197,administration,0,0
133198,of,0,0
133199,ginseng,0,0
133200,extract,0,0
133201,resulted,0,0
133202,in,0,0
133203,a,0,0
133204,significant,0,0
133205,improvement,0,1
133206,of,0,1
133207,fertility,1,1
133208,parameters,1,1
133209,and,1,1
133210,testicular,1,1
133211,antioxidants,1,0
133212,together,1,0
133213,with,0,0
133214,a,0,0
133215,decrease,1,1
133216,in,1,0
133217,malondialdehyde,1,1
133218,and,1,1
133219,testicular,1,1
133220,pathological,1,1
133221,signs,1,1
133222,including,1,0
133223,degenerative,1,0
133224,changes,1,1
133225,of,1,0
133226,the,1,0
133227,seminiferous,1,0
133228,tubules,1,1
133229,.,1,0
133230,CONCLUSION,0,0
133231,Ginseng,0,0
133232,extract,0,0
133233,may,0,0
133234,be,0,0
133235,a,0,0
133236,beneficial,0,0
133237,adjuvant,0,0
133238,therapy,0,0
133239,for,0,0
133240,diabetics,0,0
133241,suffering,0,0
133242,from,0,0
133243,infertility,1,1
133244,as,0,0
133245,a,0,0
133246,complication,0,1
133247,.,0,0
133248,Nasal,0,1
133249,versus,0,0
133250,oronasal,0,0
133251,continuous,0,0
133252,positive,0,1
133253,airway,0,1
133254,pressure,0,1
133255,masks,0,0
133256,for,0,0
133257,obstructive,0,0
133258,sleep,0,1
133259,apnea,0,0
133260,:,0,0
133261,a,0,0
133262,pilot,0,0
133263,investigation,0,0
133264,of,0,1
133265,pressure,0,1
133266,requirement,0,1
133267,",",0,1
133268,residual,0,1
133269,disease,0,1
133270,",",0,1
133271,and,0,1
133272,leak,0,1
133273,.,0,0
133274,PURPOSE,0,0
133275,This,0,0
133276,single-blinded,0,0
133277,",",0,0
133278,randomized,0,0
133279,",",0,0
133280,controlled,0,0
133281,pilot,0,0
133282,study,0,0
133283,aimed,0,0
133284,to,0,0
133285,investigate,0,0
133286,whether,0,0
133287,there,0,0
133288,is,0,0
133289,a,0,0
133290,difference,0,0
133291,between,0,0
133292,nasal,0,1
133293,and,0,1
133294,oronasal,0,1
133295,masks,0,0
133296,in,0,0
133297,therapeutic,0,0
133298,continuous,0,0
133299,positive,0,1
133300,airway,0,1
133301,pressure,0,1
133302,(,0,1
133303,CPAP,0,0
133304,),0,1
133305,requirement,0,1
133306,",",0,1
133307,residual,0,1
133308,disease,0,1
133309,",",0,0
133310,or,0,1
133311,leak,0,1
133312,when,0,0
133313,treating,0,0
133314,obstructive,0,0
133315,sleep,0,1
133316,apnea,0,1
133317,(,0,1
133318,OSA,0,1
133319,),0,1
133320,and,0,0
133321,if,0,0
133322,differences,0,0
133323,were,0,0
133324,related,0,0
133325,to,0,0
133326,measures,0,0
133327,of,0,0
133328,upper,0,0
133329,airway,0,1
133330,size,0,1
133331,.,0,1
133332,METHODS,0,0
133333,Patients,0,0
133334,with,0,0
133335,severe,0,1
133336,OSA,0,0
133337,currently,0,0
133338,using,0,0
133339,CPAP,0,0
133340,at,0,0
133341,?4,0,0
133342,h/night,0,0
133343,with,0,0
133344,a,0,0
133345,nasal,0,1
133346,mask,0,1
133347,were,0,0
133348,examined,0,0
133349,(,0,0
133350,including,0,0
133351,Mallampati,0,1
133352,scale,0,1
133353,",",0,1
133354,incisal,0,1
133355,relationship,0,1
133356,",",0,1
133357,and,0,1
133358,mandibular,0,1
133359,protrusion,0,1
133360,),0,1
133361,and,0,0
133362,then,0,0
133363,randomized,0,0
133364,to,0,0
133365,receive,0,0
133366,auto-positive,0,1
133367,airway,0,1
133368,pressure,0,1
133369,(,0,1
133370,PAP,0,1
133371,),0,1
133372,or,0,0
133373,fixed,0,0
133374,CPAP,0,0
133375,at,0,0
133376,a,0,0
133377,manually,0,0
133378,titrated,0,0
133379,pressure,0,1
133380,for,0,0
133381,1,0,0
133382,week,0,0
133383,each,0,0
133384,at,0,0
133385,home,0,0
133386,",",0,0
133387,with,0,0
133388,immediate,0,1
133389,crossover,0,0
133390,.,0,0
133391,Within,0,0
133392,each,0,0
133393,week,0,0
133394,",",0,0
133395,a,0,0
133396,nasal,0,1
133397,mask,0,1
133398,and,0,0
133399,two,0,0
133400,oronasal,0,0
133401,masks,0,0
133402,were,0,0
133403,to,0,0
133404,be,0,0
133405,used,0,0
133406,for,0,0
133407,two,0,0
133408,or,0,0
133409,three,0,0
133410,nights,0,0
133411,each,0,0
133412,in,0,0
133413,random,0,0
133414,order,0,0
133415,.,0,1
133416,Data,0,0
133417,were,0,0
133418,downloaded,0,0
133419,from,0,0
133420,the,0,0
133421,device,0,0
133422,.,0,0
133423,RESULTS,0,0
133424,Twelve,0,0
133425,patients,0,0
133426,completed,0,0
133427,the,0,0
133428,trial,0,0
133429,(,0,0
133430,mean,0,1
133431,?,0,0
133432,SD,0,0
133433,AHI,0,0
133434,59.8,0,0
133435,?,0,0
133436,28.6,0,0
133437,events/h,0,0
133438,;,0,0
133439,CPAP,0,0
133440,11.1,0,0
133441,?,0,0
133442,3.2,0,0
133443,cmH,0,0
133444,(,0,0
133445,2,0,0
133446,),0,0
133447,O,0,0
133448,;,0,0
133449,BMI,0,0
133450,37.7,0,0
133451,?,0,0
133452,5.0,0,0
133453,kg/m,0,0
133454,(,0,0
133455,2,0,0
133456,),0,0
133457,),0,0
133458,.,0,0
133459,During,0,0
133460,auto-PAP,1,0
133461,",",1,0
133462,the,1,0
133463,median,1,0
133464,95th,1,1
133465,percentile,1,0
133466,pressure,1,1
133467,delivered,1,0
133468,with,0,0
133469,all,0,0
133470,masks,0,0
133471,was,0,0
133472,within,0,0
133473,0.5,0,0
133474,cmH,0,0
133475,(,0,0
133476,2,0,0
133477,),0,0
133478,O,0,0
133479,(,0,0
133480,p,0,0
133481,>,0,0
133482,0.05,0,0
133483,),0,0
133484,.,0,0
133485,During,0,0
133486,CPAP,0,0
133487,",",0,0
133488,median,1,1
133489,residual,1,1
133490,AHI,1,1
133491,was,1,0
133492,0.61,0,0
133493,(,0,0
133494,IQR,0,0
133495,=,0,0
133496,1.18,0,0
133497,),0,0
133498,for,0,0
133499,the,0,0
133500,nasal,0,1
133501,mask,0,1
133502,",",0,0
133503,1.70,0,0
133504,(,0,0
133505,IQR,0,0
133506,=,0,0
133507,4.04,0,0
133508,),0,0
133509,for,0,0
133510,oronasal,0,0
133511,mask,0,0
133512,1,0,0
133513,",",0,0
133514,and,0,0
133515,2.48,0,0
133516,(,0,0
133517,IQR,0,0
133518,=,0,0
133519,3.74,0,0
133520,),0,0
133521,for,0,0
133522,oronasal,0,0
133523,mask,0,0
133524,2,0,0
133525,(,0,0
133526,p,0,0
133527,=,0,0
133528,0.03,0,0
133529,),0,0
133530,.,0,0
133531,The,1,0
133532,95th,1,1
133533,percentile,1,0
133534,leak,1,1
133535,was,0,0
133536,lowest,0,0
133537,with,0,0
133538,the,0,0
133539,nasal,0,1
133540,mask,0,0
133541,during,0,0
133542,both,0,0
133543,CPAP,0,0
133544,and,0,1
133545,auto-PAP,0,1
133546,(,0,0
133547,both,0,0
133548,p,0,0
133549,<,0,0
133550,0.01,0,0
133551,),0,0
133552,.,0,0
133553,Differences,0,1
133554,in,0,0
133555,pressure,0,1
133556,or,0,1
133557,residual,0,1
133558,disease,0,1
133559,were,0,0
133560,not,0,0
133561,related,0,0
133562,to,0,0
133563,measures,0,0
133564,of,0,0
133565,upper,0,0
133566,airway,0,1
133567,shape,0,1
133568,or,0,1
133569,body,0,1
133570,habitus,0,1
133571,.,0,1
133572,CONCLUSIONS,0,0
133573,In,0,0
133574,obese,0,0
133575,OSA,0,0
133576,patients,0,0
133577,changing,0,0
133578,from,0,0
133579,a,0,0
133580,nasal,0,0
133581,to,0,0
133582,oronasal,0,0
133583,mask,0,1
133584,increased,1,1
133585,leak,1,1
133586,and,1,0
133587,residual,1,1
133588,AHI,1,1
133589,but,1,0
133590,did,0,0
133591,not,0,0
133592,affect,0,0
133593,the,0,0
133594,therapeutic,0,0
133595,pressure,0,1
133596,requirement,0,1
133597,.,0,0
133598,The,0,0
133599,findings,0,0
133600,of,0,0
133601,the,0,0
133602,current,0,0
133603,study,0,0
133604,highlight,0,0
133605,mask,0,1
133606,leak,0,1
133607,as,0,0
133608,the,0,0
133609,major,0,1
133610,difficulty,0,1
133611,in,0,0
133612,the,0,0
133613,use,0,0
133614,of,0,0
133615,oronasal,0,0
133616,masks,0,0
133617,.,0,0
133618,MRI,1,1
133619,signal,1,1
133620,hyperintensities,1,1
133621,and,1,1
133622,failure,1,0
133623,to,1,0
133624,remit,1,0
133625,following,0,0
133626,antidepressant,0,0
133627,treatment,0,0
133628,.,0,0
133629,BACKGROUND,0,0
133630,MRI,0,1
133631,signal,0,1
133632,hyperintensities,0,1
133633,predict,0,1
133634,poor,0,0
133635,remission,1,1
133636,to,0,0
133637,antidepressant,0,0
133638,treatment,0,0
133639,.,0,0
133640,Previous,0,0
133641,studies,0,0
133642,using,0,0
133643,volumetrics,0,1
133644,in,0,0
133645,outpatient,0,0
133646,samples,0,0
133647,have,0,0
133648,relied,0,0
133649,on,0,0
133650,total,1,1
133651,lesion,1,1
133652,volume,1,1
133653,.,1,0
133654,The,0,0
133655,purpose,0,0
133656,of,0,0
133657,this,0,0
133658,study,0,0
133659,was,0,0
133660,to,0,0
133661,test,0,1
133662,whether,0,0
133663,remission,0,1
133664,from,0,0
133665,geriatric,0,0
133666,depression,0,1
133667,depends,0,0
133668,on,0,0
133669,lesion,1,1
133670,volume,1,1
133671,by,1,0
133672,region,1,0
133673,of,1,1
133674,interest,1,0
133675,(,1,1
133676,ROI,1,0
133677,),1,0
133678,.,1,0
133679,METHOD,0,0
133680,Thirty-eight,0,0
133681,patients,0,0
133682,received,0,0
133683,baseline,0,0
133684,MRIs,0,0
133685,as,0,0
133686,part,0,0
133687,of,0,0
133688,a,0,0
133689,larger,0,0
133690,12-week,0,0
133691,",",0,1
133692,randomized,0,0
133693,clinical,0,1
133694,trial,0,0
133695,comparing,0,0
133696,sertraline,0,0
133697,and,0,1
133698,nortriptyline,0,0
133699,in,0,0
133700,the,0,0
133701,treatment,0,0
133702,of,0,0
133703,late-life,0,1
133704,depression,0,1
133705,.,0,1
133706,MRIcro,0,1
133707,was,0,0
133708,used,0,0
133709,to,0,0
133710,quantify,0,0
133711,MRI-hyperintensity,0,1
133712,volume,0,1
133713,into,0,0
133714,total,0,1
133715,hyperintensity,0,1
133716,",",0,1
133717,deep,0,1
133718,white,0,0
133719,matter,0,1
133720,hyperintensity,0,1
133721,(,0,1
133722,DWMH,0,1
133723,),0,1
133724,",",0,0
133725,and,0,1
133726,periventricular,0,1
133727,hyperintensity,0,1
133728,(,0,1
133729,PVH,0,1
133730,),0,0
133731,volumes,0,1
133732,.,0,0
133733,High,0,0
133734,versus,0,0
133735,low,0,1
133736,total,0,1
133737,",",0,1
133738,DWMH,1,1
133739,",",1,1
133740,and,1,1
133741,PVH,1,1
133742,volumes,1,1
133743,were,0,0
133744,defined,0,1
133745,based,0,0
133746,on,0,0
133747,the,0,0
133748,highest,0,1
133749,quartile,0,1
133750,of,0,0
133751,their,0,0
133752,respective,0,0
133753,distributions,0,1
133754,.,0,0
133755,Remission,1,0
133756,from,1,0
133757,depression,1,1
133758,was,0,0
133759,defined,0,0
133760,as,0,0
133761,a,0,0
133762,24-item,0,1
133763,Hamilton,1,1
133764,Rating,1,1
133765,Scale,1,1
133766,for,1,0
133767,Depression,1,1
133768,score,1,1
133769,?,0,0
133770,7,0,0
133771,for,0,0
133772,two,0,0
133773,consecutive,0,0
133774,weeks,0,0
133775,.,0,0
133776,RESULTS,0,0
133777,Patients,0,0
133778,classified,0,0
133779,as,0,0
133780,having,0,0
133781,high,0,0
133782,DWMH,0,1
133783,were,0,0
133784,7.14,0,0
133785,times,0,0
133786,more,0,0
133787,likely,0,0
133788,not,0,0
133789,to,0,0
133790,remit,1,0
133791,following,1,0
133792,antidepressant,0,0
133793,treatment,0,0
133794,compared,0,0
133795,to,0,0
133796,patients,0,0
133797,classified,0,0
133798,as,0,0
133799,having,0,0
133800,low,0,0
133801,DWMH,0,1
133802,(,0,1
133803,p=0.02,0,0
133804,),0,0
133805,.,0,0
133806,Similar,0,0
133807,odds,0,0
133808,ratios,0,1
133809,were,0,0
133810,obtained,0,0
133811,for,0,0
133812,PVH,0,1
133813,(,0,1
133814,OR=4.17,0,1
133815,",",0,1
133816,p=0.16,0,0
133817,),0,1
133818,and,0,1
133819,total,0,1
133820,volumes,0,1
133821,(,0,1
133822,OR=5.00,0,0
133823,",",0,1
133824,p=0.05,0,0
133825,),0,1
133826,.,0,0
133827,Importantly,0,0
133828,",",0,0
133829,adjusting,0,0
133830,for,0,0
133831,age,0,0
133832,did,0,0
133833,not,0,0
133834,change,0,0
133835,the,0,0
133836,magnitude,0,1
133837,of,0,0
133838,these,0,0
133839,effects,0,0
133840,.,0,0
133841,LIMITATIONS,0,0
133842,A,0,0
133843,small,0,0
133844,and,0,0
133845,predominantly,0,0
133846,White,0,0
133847,sample,0,0
133848,.,0,0
133849,CONCLUSIONS,0,0
133850,This,0,0
133851,is,0,0
133852,the,0,0
133853,first,0,0
133854,study,0,0
133855,to,0,0
133856,test,0,1
133857,whether,1,0
133858,remission,1,1
133859,from,1,0
133860,geriatric,1,0
133861,depression,1,1
133862,depends,1,0
133863,on,0,0
133864,lesion,1,1
133865,volume,1,1
133866,by,1,0
133867,ROI,1,0
133868,in,1,0
133869,an,0,0
133870,outpatient,0,0
133871,sample,0,0
133872,.,0,0
133873,The,0,0
133874,pattern,0,0
133875,of,0,0
133876,remission,0,1
133877,rates,0,1
133878,and,0,1
133879,odds,0,1
133880,ratios,0,1
133881,was,0,0
133882,similar,0,0
133883,when,0,0
133884,patients,0,0
133885,were,0,0
133886,classified,0,0
133887,as,0,0
133888,having,0,0
133889,high,0,0
133890,DWMH,0,1
133891,",",0,1
133892,PVH,0,1
133893,or,0,1
133894,total,0,1
133895,volume,0,1
133896,suggesting,0,0
133897,that,1,0
133898,lesion,1,0
133899,location,1,0
133900,may,1,0
133901,not,0,0
133902,be,0,0
133903,critical,0,0
133904,.,0,0
133905,The,0,0
133906,effect,0,0
133907,of,0,1
133908,knee,0,1
133909,position,0,1
133910,on,0,0
133911,blood,1,1
133912,loss,1,1
133913,and,1,1
133914,range,1,1
133915,of,1,1
133916,motion,1,1
133917,following,0,0
133918,total,0,1
133919,knee,0,1
133920,arthroplasty,0,0
133921,.,0,0
133922,PURPOSE,0,0
133923,This,0,0
133924,study,0,0
133925,prospectively,0,0
133926,assessed,0,0
133927,the,0,0
133928,effects,0,1
133929,of,0,0
133930,knee,0,1
133931,position,0,1
133932,on,0,0
133933,blood,1,1
133934,loss,1,1
133935,and,1,1
133936,range,1,1
133937,of,1,1
133938,motion,1,1
133939,after,0,0
133940,primary,0,0
133941,total,0,1
133942,knee,0,1
133943,arthroplasty,0,1
133944,(,0,1
133945,TKA,0,0
133946,),0,0
133947,.,0,0
133948,METHODS,0,0
133949,One,0,0
133950,hundred,0,0
133951,and,0,0
133952,ten,0,0
133953,consecutive,0,0
133954,TKA,0,0
133955,patients,0,0
133956,were,0,0
133957,randomized,0,0
133958,into,0,0
133959,flexion,0,1
133960,group,0,0
133961,and,0,1
133962,extension,0,1
133963,group,0,0
133964,.,0,0
133965,Both,0,0
133966,groups,0,0
133967,had,0,0
133968,the,0,0
133969,leg,0,1
133970,elevated,0,0
133971,30?,0,0
133972,at,0,0
133973,the,0,0
133974,hip,0,0
133975,over,0,0
133976,an,0,0
133977,inactive,0,0
133978,CPM,0,0
133979,for,0,0
133980,72,0,0
133981,h,0,0
133982,postoperatively,0,0
133983,.,0,0
133984,The,0,0
133985,flexion,0,1
133986,group,0,0
133987,had,0,0
133988,the,0,0
133989,knee,0,1
133990,flexed,0,1
133991,to,0,0
133992,30?,0,0
133993,during,0,0
133994,this,0,0
133995,period,0,0
133996,.,0,0
133997,The,0,0
133998,extension,0,0
133999,group,0,0
134000,had,0,0
134001,the,0,0
134002,knee,0,1
134003,extended,0,0
134004,fully,1,0
134005,.,1,0
134006,Perioperative,1,0
134007,blood,1,1
134008,loss,1,1
134009,",",1,1
134010,hidden,1,1
134011,blood,1,1
134012,loss,1,1
134013,",",1,1
134014,knee,1,1
134015,swelling,1,1
134016,",",1,1
134017,ecchymosis,1,1
134018,",",1,1
134019,analgesia,1,1
134020,requirements,1,1
134021,",",1,1
134022,range,1,0
134023,of,1,1
134024,motion,1,1
134025,(,1,1
134026,ROM,1,1
134027,),1,1
134028,",",1,0
134029,fixed,1,0
134030,flexion,1,1
134031,deformity,1,1
134032,(,1,1
134033,FFD,1,0
134034,),1,1
134035,",",1,0
134036,straight-leg,1,1
134037,raising,1,0
134038,action,1,1
134039,",",1,1
134040,and,1,1
134041,postoperative,1,1
134042,complications,1,1
134043,within,1,0
134044,6,1,0
134045,weeks,1,0
134046,of,1,0
134047,surgery,1,0
134048,were,1,0
134049,measured,0,0
134050,for,0,0
134051,evaluation,0,0
134052,and,0,1
134053,comparison,0,0
134054,.,0,0
134055,RESULTS,0,0
134056,The,1,0
134057,postoperative,1,1
134058,hidden,1,1
134059,blood,1,1
134060,loss,1,1
134061,",",1,1
134062,knee,1,1
134063,swelling,1,1
134064,",",1,1
134065,and,1,1
134066,scope,1,1
134067,of,1,1
134068,ecchymosis,1,1
134069,were,1,0
134070,significantly,0,0
134071,lower,0,0
134072,in,0,0
134073,the,0,0
134074,flexion,0,1
134075,group,0,0
134076,than,0,0
134077,in,0,0
134078,the,0,0
134079,extension,0,0
134080,group,0,0
134081,",",0,1
134082,and,1,1
134083,ROM,1,1
134084,and,1,1
134085,straight-leg,1,1
134086,raising,1,0
134087,action,1,1
134088,were,1,0
134089,significantly,0,0
134090,higher,0,0
134091,during,0,0
134092,the,0,0
134093,early,0,0
134094,period,0,0
134095,after,0,0
134096,operation,0,0
134097,.,0,0
134098,No,0,0
134099,significant,0,0
134100,difference,0,0
134101,was,0,0
134102,observed,0,0
134103,in,0,0
134104,perioperative,1,1
134105,blood,1,1
134106,loss,1,1
134107,",",1,0
134108,the,1,0
134109,amount,1,1
134110,of,1,0
134111,morphine,1,1
134112,used,1,0
134113,",",1,0
134114,or,1,0
134115,FFD,1,0
134116,in,1,0
134117,the,0,0
134118,early,0,0
134119,postoperative,0,1
134120,period,0,0
134121,or,0,0
134122,in,0,0
134123,ROM,1,1
134124,and,1,1
134125,FFD,1,0
134126,at,1,0
134127,6,1,0
134128,weeks,1,0
134129,postoperatively,1,0
134130,.,0,0
134131,CONCLUSIONS,0,0
134132,The,0,0
134133,findings,0,0
134134,of,0,0
134135,this,0,0
134136,study,0,0
134137,indicate,0,0
134138,that,0,0
134139,flexion,0,1
134140,of,0,0
134141,the,0,0
134142,knee,0,1
134143,to,0,0
134144,30?,0,0
134145,with,0,0
134146,the,0,0
134147,leg,0,1
134148,elevated,0,0
134149,30?,0,0
134150,at,0,0
134151,the,0,0
134152,hip,0,1
134153,after,0,0
134154,total,0,1
134155,knee,0,1
134156,arthroplasty,0,0
134157,may,0,0
134158,mitigate,1,0
134159,knee,1,1
134160,swelling,1,1
134161,and,1,1
134162,provide,0,0
134163,other,1,0
134164,beneficial,1,0
134165,results,1,0
134166,during,1,0
134167,the,0,0
134168,early,0,0
134169,rehabilitation,0,0
134170,following,0,0
134171,TKA,0,0
134172,.,0,0
134173,LEVEL,0,1
134174,OF,0,0
134175,EVIDENCE,0,1
134176,Prospective,0,0
134177,comparative,0,0
134178,study,0,0
134179,",",0,0
134180,Level,0,0
134181,I,0,0
134182,.,0,0
134183,Comparative,1,0
134184,effectiveness,1,1
134185,of,0,1
134186,exercise,0,0
134187,electrocardiography,0,1
134188,with,0,0
134189,or,0,0
134190,without,0,0
134191,myocardial,0,1
134192,perfusion,0,1
134193,single,0,0
134194,photon,0,0
134195,emission,0,1
134196,computed,0,0
134197,tomography,0,0
134198,in,0,0
134199,women,0,0
134200,with,0,0
134201,suspected,0,0
134202,coronary,0,1
134203,artery,0,0
134204,disease,0,1
134205,:,0,0
134206,results,0,0
134207,from,0,0
134208,the,0,0
134209,What,0,0
134210,Is,0,0
134211,the,0,0
134212,Optimal,0,0
134213,Method,0,1
134214,for,0,0
134215,Ischemia,0,1
134216,Evaluation,0,1
134217,in,0,0
134218,Women,0,0
134219,(,0,0
134220,WOMEN,0,0
134221,),0,0
134222,trial,0,0
134223,.,0,0
134224,BACKGROUND,0,0
134225,There,0,0
134226,is,0,0
134227,a,0,0
134228,paucity,0,0
134229,of,0,0
134230,randomized,0,0
134231,trials,0,0
134232,regarding,0,0
134233,diagnostic,0,1
134234,testing,0,0
134235,in,0,0
134236,women,0,0
134237,with,0,0
134238,suspected,0,0
134239,coronary,0,1
134240,artery,0,1
134241,disease,0,1
134242,(,0,1
134243,CAD,0,0
134244,),0,0
134245,.,0,0
134246,It,0,0
134247,remains,0,0
134248,unclear,0,0
134249,whether,0,0
134250,the,0,0
134251,addition,0,0
134252,of,0,0
134253,myocardial,0,1
134254,perfusion,0,1
134255,imaging,0,1
134256,(,0,1
134257,MPI,0,1
134258,),0,0
134259,to,0,0
134260,the,0,0
134261,standard,0,0
134262,ECG,0,1
134263,exercise,0,0
134264,treadmill,0,0
134265,test,0,1
134266,(,0,1
134267,ETT,0,1
134268,),0,0
134269,provides,0,0
134270,incremental,0,1
134271,information,0,0
134272,to,0,0
134273,improve,0,0
134274,clinical,0,0
134275,decision,0,1
134276,making,0,1
134277,in,0,0
134278,women,0,0
134279,with,0,0
134280,suspected,0,0
134281,CAD,0,0
134282,.,0,1
134283,METHODS,0,0
134284,AND,0,0
134285,RESULTS,0,0
134286,We,0,0
134287,randomized,0,0
134288,symptomatic,0,1
134289,women,0,0
134290,with,0,0
134291,suspected,0,0
134292,CAD,0,0
134293,",",0,0
134294,an,0,0
134295,interpretable,0,1
134296,ECG,0,1
134297,",",0,1
134298,and,0,1
134299,?5,0,1
134300,metabolic,0,1
134301,equivalents,0,0
134302,on,0,0
134303,the,0,0
134304,Duke,0,1
134305,Activity,0,1
134306,Status,0,0
134307,Index,0,0
134308,to,0,0
134309,1,0,0
134310,of,0,0
134311,2,0,0
134312,diagnostic,0,0
134313,strategies,0,0
134314,:,0,0
134315,ETT,0,1
134316,or,0,1
134317,exercise,0,0
134318,MPI,0,1
134319,.,0,0
134320,The,0,0
134321,primary,0,0
134322,end,0,0
134323,point,0,0
134324,was,1,0
134325,2-year,1,0
134326,incidence,1,1
134327,of,1,1
134328,major,1,1
134329,adverse,1,1
134330,cardiac,1,1
134331,events,1,1
134332,",",1,0
134333,defined,1,1
134334,as,1,0
134335,CAD,1,0
134336,death,1,1
134337,or,1,1
134338,hospitalization,1,1
134339,for,1,0
134340,an,1,0
134341,acute,1,0
134342,coronary,1,1
134343,syndrome,1,0
134344,or,1,1
134345,heart,1,1
134346,failure,1,1
134347,.,1,0
134348,A,0,0
134349,total,0,0
134350,of,0,0
134351,824,0,0
134352,women,0,0
134353,were,0,0
134354,randomized,0,0
134355,to,0,0
134356,ETT,0,1
134357,or,0,1
134358,exercise,0,0
134359,MPI,0,1
134360,.,0,0
134361,For,0,0
134362,women,0,0
134363,randomized,0,0
134364,to,0,0
134365,ETT,1,1
134366,",",1,0
134367,ECG,1,1
134368,results,1,0
134369,were,0,0
134370,normal,0,0
134371,in,0,0
134372,64,0,0
134373,%,0,0
134374,",",0,0
134375,indeterminate,0,0
134376,in,0,0
134377,16,0,0
134378,%,0,0
134379,",",0,0
134380,and,0,1
134381,abnormal,0,1
134382,in,0,0
134383,20,0,0
134384,%,0,0
134385,.,0,0
134386,By,0,1
134387,comparison,0,0
134388,",",0,0
134389,the,1,0
134390,exercise,1,0
134391,MPI,1,1
134392,results,1,0
134393,were,1,0
134394,normal,0,0
134395,in,0,0
134396,91,0,0
134397,%,0,0
134398,",",0,0
134399,mildly,0,1
134400,abnormal,0,1
134401,in,0,0
134402,3,0,0
134403,%,0,0
134404,",",0,0
134405,and,0,1
134406,moderate,0,0
134407,to,0,0
134408,severely,0,0
134409,abnormal,0,1
134410,in,0,0
134411,6,0,0
134412,%,0,0
134413,.,0,0
134414,At,0,0
134415,2,0,0
134416,years,0,0
134417,",",0,0
134418,there,0,0
134419,was,0,0
134420,no,0,0
134421,difference,0,0
134422,in,0,0
134423,major,1,1
134424,adverse,1,1
134425,cardiac,1,1
134426,events,1,1
134427,(,1,0
134428,98.0,0,0
134429,%,0,0
134430,for,0,0
134431,ETT,0,1
134432,and,0,0
134433,97.7,0,0
134434,%,0,0
134435,for,0,0
134436,MPI,0,1
134437,;,0,0
134438,P=0.59,0,0
134439,),0,0
134440,.,0,0
134441,Compared,0,0
134442,with,0,0
134443,ETT,1,1
134444,",",1,0
134445,index,1,1
134446,testing,1,1
134447,costs,1,1
134448,were,1,0
134449,higher,0,0
134450,for,0,0
134451,exercise,0,0
134452,MPI,0,1
134453,(,0,0
134454,P,0,0
134455,<,0,0
134456,0.001,0,0
134457,),0,0
134458,",",0,0
134459,whereas,0,0
134460,downstream,0,1
134461,procedural,0,1
134462,costs,0,1
134463,were,0,0
134464,slightly,0,0
134465,lower,0,0
134466,(,0,1
134467,P=0.0008,0,0
134468,),0,0
134469,.,0,0
134470,Overall,0,0
134471,",",0,0
134472,the,1,0
134473,cumulative,1,1
134474,diagnostic,1,0
134475,cost,1,1
134476,savings,1,1
134477,was,1,0
134478,48,0,0
134479,%,0,0
134480,for,0,0
134481,ETT,0,1
134482,compared,0,0
134483,with,0,0
134484,exercise,0,0
134485,MPI,0,1
134486,(,0,0
134487,P,0,0
134488,<,0,0
134489,0.001,0,0
134490,),0,0
134491,.,0,0
134492,CONCLUSIONS,0,0
134493,In,0,0
134494,low-risk,0,0
134495,",",0,0
134496,exercising,0,1
134497,women,0,0
134498,",",0,0
134499,a,0,0
134500,diagnostic,0,1
134501,strategy,0,0
134502,that,0,0
134503,uses,0,0
134504,ETT,0,1
134505,versus,0,0
134506,exercise,0,0
134507,MPI,0,1
134508,yields,0,1
134509,similar,0,0
134510,2-year,0,0
134511,posttest,0,1
134512,outcomes,0,1
134513,while,0,0
134514,providing,0,0
134515,significant,0,0
134516,diagnostic,0,1
134517,cost,0,1
134518,savings,0,1
134519,.,0,0
134520,The,0,0
134521,ETT,0,1
134522,with,0,0
134523,selective,0,1
134524,follow-up,0,0
134525,testing,0,0
134526,should,0,0
134527,be,0,0
134528,considered,0,0
134529,as,0,0
134530,the,0,0
134531,initial,0,0
134532,diagnostic,0,0
134533,strategy,0,0
134534,in,0,0
134535,symptomatic,0,1
134536,women,0,0
134537,with,0,0
134538,suspected,0,0
134539,CAD,0,0
134540,.,0,0
134541,CLINICAL,0,0
134542,TRIAL,0,0
134543,REGISTRATION,0,0
134544,http,0,0
134545,:,0,0
134546,//www.clinicaltrials.gov,0,0
134547,.,0,1
134548,Unique,0,1
134549,identifier,0,0
134550,:,0,0
134551,NCT00282711,0,0
134552,.,0,0
134553,[,0,0
134554,The,0,0
134555,Antonio,0,0
134556,Raichs,0,0
134557,memorial,0,0
134558,lecture,0,0
134559,.,0,0
134560,Future,1,1
134561,trends,1,0
134562,in,1,0
134563,marrow,1,0
134564,transplantation,1,0
134565,],1,0
134566,.,1,0
134567,Effect,0,1
134568,of,0,1
134569,ozone,0,0
134570,application,0,0
134571,on,0,0
134572,the,0,0
134573,resin-dentin,1,0
134574,microtensile,1,0
134575,bond,1,1
134576,strength,1,1
134577,.,1,1
134578,When,0,0
134579,ozone,0,0
134580,is,0,0
134581,used,0,0
134582,during,0,0
134583,caries,0,1
134584,treatment,0,0
134585,",",0,1
134586,bond,0,1
134587,strength,0,1
134588,can,0,0
134589,be,0,0
134590,compromised,0,0
134591,by,0,0
134592,the,0,0
134593,release,0,1
134594,of,0,0
134595,oxygen,0,1
134596,.,0,0
134597,The,0,0
134598,use,0,0
134599,of,0,0
134600,antioxidant,0,0
134601,agents,0,0
134602,neutralizes,0,0
134603,the,0,0
134604,free,0,1
134605,oxygen,0,1
134606,.,0,0
134607,The,0,0
134608,aim,0,0
134609,of,0,0
134610,this,0,0
134611,study,0,0
134612,was,0,0
134613,to,0,0
134614,evaluate,0,0
134615,the,0,0
134616,effects,0,0
134617,of,0,1
134618,ozone,0,0
134619,and,0,1
134620,sodium,0,1
134621,ascorbate,0,0
134622,on,0,0
134623,resin-dentin,1,1
134624,microtensile,1,0
134625,bond,1,1
134626,strength,1,1
134627,(,1,1
134628,?TBS,1,1
134629,),1,0
134630,.,1,0
134631,Forty,0,0
134632,human,0,0
134633,third,0,0
134634,molars,0,1
134635,were,0,0
134636,divided,0,0
134637,into,0,0
134638,four,0,0
134639,groups,0,0
134640,:,0,0
134641,Group,0,0
134642,1,0,0
134643,",",0,0
134644,not,0,0
134645,treated,0,0
134646,with,0,0
134647,ozone,0,0
134648,;,0,0
134649,Group,0,0
134650,2,0,0
134651,",",0,0
134652,ozone,0,0
134653,application,0,0
134654,followed,0,0
134655,by,0,0
134656,acid,0,0
134657,etching,0,0
134658,;,0,0
134659,Group,0,0
134660,3,0,0
134661,",",0,0
134662,acid,0,0
134663,etching,0,0
134664,followed,0,0
134665,by,0,0
134666,ozone,0,0
134667,application,0,0
134668,;,0,1
134669,and,0,0
134670,Group,0,0
134671,4,0,0
134672,",",0,0
134673,ozone,0,0
134674,and,0,1
134675,application,0,0
134676,of,0,1
134677,sodium,0,0
134678,ascorbate,0,0
134679,.,0,1
134680,Bonded,0,0
134681,beams,0,0
134682,(,0,0
134683,1.0,0,0
134684,mm,0,0
134685,(,0,0
134686,2,0,0
134687,),0,0
134688,),0,0
134689,were,0,0
134690,tested,0,0
134691,under,0,0
134692,tension,0,1
134693,(,0,0
134694,0.5,0,0
134695,mm,0,0
134696,min,0,0
134697,(,0,1
134698,-1,0,0
134699,),0,0
134700,),0,0
134701,.,0,0
134702,The,1,0
134703,?TBS,1,1
134704,values,1,1
134705,were,0,0
134706,analyzed,0,0
134707,using,0,0
134708,one-way,0,0
134709,analysis,0,0
134710,of,0,1
134711,variance,0,1
134712,(,0,1
134713,ANOVA,0,1
134714,),0,0
134715,and,0,0
134716,the,0,0
134717,Tukey,0,1
134718,test,0,1
134719,(,0,1
134720,p=0.05,0,0
134721,),0,0
134722,.,0,0
134723,All,0,0
134724,beams,0,0
134725,that,0,0
134726,fractured,0,1
134727,were,0,0
134728,analyzed,0,0
134729,under,0,0
134730,stereomicroscopy,0,0
134731,(,0,0
134732,40?,0,0
134733,),0,0
134734,.,0,0
134735,Group,0,0
134736,1,0,0
134737,had,0,0
134738,significantly,0,0
134739,higher,1,0
134740,?TBS,1,1
134741,values,1,1
134742,than,1,0
134743,Group,0,0
134744,2,0,0
134745,or,0,0
134746,3,0,0
134747,.,0,0
134748,The,0,0
134749,?TBS,1,0
134750,values,1,1
134751,of,1,0
134752,Groups,1,0
134753,1,0,0
134754,and,0,0
134755,4,0,0
134756,were,0,0
134757,similar,0,0
134758,and,0,1
134759,higher,0,0
134760,than,0,0
134761,those,0,0
134762,of,0,0
134763,Group,0,0
134764,2,0,0
134765,.,0,0
134766,The,0,0
134767,use,0,0
134768,of,0,0
134769,ozone,0,0
134770,in,0,0
134771,Group,0,0
134772,2,0,0
134773,resulted,0,0
134774,in,0,0
134775,lower,0,0
134776,values,1,1
134777,of,1,1
134778,?TBS,1,0
134779,in,0,0
134780,all,0,0
134781,conditions,0,0
134782,evaluated,0,0
134783,.,0,0
134784,The,0,0
134785,predominant,1,0
134786,failure,1,1
134787,mode,1,0
134788,was,0,0
134789,adhesive,0,0
134790,.,0,0
134791,The,0,0
134792,application,0,0
134793,of,0,1
134794,ozone,0,0
134795,decreased,1,0
134796,the,1,0
134797,?TBS,1,0
134798,of,1,0
134799,the,1,0
134800,dentin-composite,1,1
134801,resin,1,0
134802,interface,1,1
134803,.,1,0
134804,These,1,0
134805,values,0,1
134806,were,0,0
134807,reversed,0,0
134808,when,0,0
134809,compared,0,0
134810,with,0,0
134811,Groups,0,0
134812,1,0,0
134813,and,0,0
134814,2,0,0
134815,when,0,0
134816,sodium,0,0
134817,ascorbate,0,0
134818,was,0,0
134819,used,0,0
134820,.,0,0
134821,Oral,0,1
134822,S-adenosylmethionine,0,0
134823,in,0,0
134824,the,0,0
134825,symptomatic,0,0
134826,treatment,0,0
134827,of,0,1
134828,intrahepatic,1,0
134829,cholestasis,1,1
134830,.,1,0
134831,A,0,0
134832,double-blind,0,0
134833,",",0,0
134834,placebo-controlled,0,0
134835,study,0,0
134836,.,0,0
134837,Parenteral,0,0
134838,S-adenosylmethionine,0,0
134839,proved,0,0
134840,to,0,0
134841,be,0,0
134842,effective,0,1
134843,in,0,0
134844,reversing,0,0
134845,intrahepatic,1,1
134846,cholestasis,1,1
134847,in,0,0
134848,pregnant,0,0
134849,women,0,0
134850,.,0,0
134851,Based,0,0
134852,on,0,0
134853,these,0,0
134854,findings,0,0
134855,",",0,0
134856,a,0,0
134857,prospective,0,0
134858,multicenter,0,0
134859,",",0,1
134860,double-blind,0,0
134861,",",0,1
134862,placebo-controlled,0,0
134863,trial,0,0
134864,was,0,0
134865,planned,0,0
134866,to,0,0
134867,assess,0,0
134868,whether,0,0
134869,oral,0,0
134870,S-adenosylmethionine,0,0
134871,is,0,0
134872,effective,0,1
134873,in,0,0
134874,cholestatic,1,1
134875,patients,1,0
134876,with,0,0
134877,chronic,0,0
134878,liver,0,1
134879,disease,0,1
134880,.,0,0
134881,Accordingly,0,0
134882,",",0,0
134883,220,0,0
134884,inpatients,0,0
134885,(,0,0
134886,26,0,0
134887,%,0,0
134888,chronic,0,0
134889,active,0,1
134890,hepatitis,0,0
134891,",",0,0
134892,68,0,0
134893,%,0,0
134894,cirrhosis,0,0
134895,",",0,0
134896,6,0,0
134897,%,0,0
134898,primary,0,0
134899,biliary,0,1
134900,cirrhosis,0,0
134901,),0,0
134902,with,0,0
134903,stable,0,1
134904,(,0,0
134905,1,0,0
134906,month,0,0
134907,or,0,0
134908,more,0,0
134909,),0,1
134910,at,0,0
134911,least,0,0
134912,twofold,0,1
134913,increases,0,1
134914,in,0,0
134915,serum,1,1
134916,total,1,1
134917,and,1,1
134918,conjugated,1,1
134919,bilirubin,1,1
134920,and,1,1
134921,alkaline,1,1
134922,phosphatase,1,1
134923,volunteered,0,0
134924,for,0,0
134925,the,0,0
134926,trial,0,0
134927,.,0,0
134928,Serum,1,0
134929,markers,1,1
134930,of,1,1
134931,cholestasis,1,1
134932,significantly,0,0
134933,(,0,0
134934,P,0,0
134935,less,0,0
134936,than,0,0
134937,0.01,0,0
134938,),0,0
134939,decreased,0,0
134940,after,0,0
134941,oral,0,0
134942,S-adenosylmethionine,0,1
134943,administration,0,0
134944,(,0,0
134945,1600,0,0
134946,mg/day,0,0
134947,),0,0
134948,",",0,1
134949,and,0,0
134950,their,0,1
134951,values,0,1
134952,were,0,0
134953,significantly,0,0
134954,(,0,0
134955,P,0,0
134956,less,0,0
134957,than,0,0
134958,0.01,0,0
134959,),0,0
134960,lower,0,0
134961,than,0,0
134962,the,0,0
134963,corresponding,0,1
134964,values,0,1
134965,in,0,0
134966,the,0,0
134967,placebo,0,0
134968,group,0,0
134969,.,0,1
134970,S-adenosylmethionine,0,1
134971,significantly,0,0
134972,(,0,0
134973,P,0,0
134974,less,0,0
134975,than,0,0
134976,0.01,0,0
134977,),0,0
134978,improved,0,0
134979,subjective,1,1
134980,symptoms,1,1
134981,such,1,0
134982,as,1,0
134983,pruritus,1,1
134984,",",1,1
134985,fatigue,1,1
134986,",",1,1
134987,and,1,1
134988,feeling,1,1
134989,of,1,1
134990,being,1,0
134991,unwell,1,1
134992,",",0,0
134993,whereas,0,0
134994,placebo,0,0
134995,was,0,0
134996,ineffective,0,0
134997,.,0,0
134998,Two,0,0
134999,patients,0,0
135000,in,0,0
135001,the,0,0
135002,S-adenosylmethionine,0,1
135003,group,0,0
135004,and,0,0
135005,9,0,0
135006,controls,0,0
135007,(,0,0
135008,P,0,0
135009,less,0,0
135010,than,0,0
135011,0.05,0,0
135012,),0,0
135013,withdrew,0,0
135014,from,0,0
135015,the,0,0
135016,trial,0,0
135017,for,0,0
135018,reduced,0,1
135019,compliance,1,1
135020,because,0,0
135021,of,0,0
135022,inefficacy,1,0
135023,of,0,0
135024,treatment,0,0
135025,.,0,0
135026,Oral,0,1
135027,S-adenosylmethionine,0,1
135028,was,0,0
135029,tolerated,1,1
135030,to,0,0
135031,the,0,0
135032,same,0,0
135033,extent,0,0
135034,as,0,0
135035,placebo,0,0
135036,.,0,0
135037,In,0,0
135038,conclusion,0,0
135039,",",0,1
135040,short-term,0,1
135041,administration,0,0
135042,of,0,1
135043,oral,0,0
135044,S-adenosylmethionine,0,0
135045,is,0,0
135046,more,0,0
135047,effective,0,1
135048,than,0,0
135049,placebo,0,0
135050,in,0,0
135051,improving,0,1
135052,clinical,1,0
135053,and,1,1
135054,laboratory,1,1
135055,measures,1,1
135056,of,1,1
135057,intrahepatic,1,1
135058,cholestasis,1,1
135059,and,0,0
135060,offers,0,0
135061,a,0,0
135062,new,0,0
135063,therapeutic,0,0
135064,modality,0,0
135065,for,0,0
135066,the,0,0
135067,symptomatic,1,0
135068,management,1,0
135069,of,0,0
135070,this,0,0
135071,syndrome,0,0
135072,.,0,0
135073,Effect,0,0
135074,of,0,0
135075,an,0,0
135076,induction,0,0
135077,period,0,0
135078,of,0,1
135079,pegylated,0,0
135080,interferon-?2a,0,0
135081,and,0,1
135082,ribavirin,0,0
135083,on,1,0
135084,early,1,0
135085,virological,1,1
135086,response,1,1
135087,in,0,0
135088,HIV-HCV-coinfected,0,0
135089,patients,0,0
135090,:,0,0
135091,results,0,0
135092,from,0,0
135093,the,0,0
135094,CORAL-2,0,0
135095,study,0,0
135096,.,0,0
135097,BACKGROUND,0,0
135098,It,0,0
135099,is,0,0
135100,uncertain,0,0
135101,whether,0,0
135102,a,0,0
135103,4-week,0,0
135104,induction,0,0
135105,period,0,0
135106,of,0,1
135107,pegylated,0,0
135108,interferon,0,1
135109,and,0,1
135110,ribavirin,0,0
135111,increases,1,1
135112,early,1,0
135113,virological,1,1
135114,response,1,1
135115,(,1,1
135116,EVR,1,1
135117,),1,0
135118,in,0,0
135119,HIV-HCV-coinfected,0,0
135120,patients,0,0
135121,.,0,0
135122,METHODS,0,0
135123,HIV,0,1
135124,and,0,0
135125,HCV,0,0
135126,genotype,0,0
135127,1-,0,0
135128,and,0,1
135129,4-coinfected,0,0
135130,subjects,0,0
135131,were,0,0
135132,randomized,0,0
135133,to,0,0
135134,receive,0,0
135135,pegylated,0,0
135136,interferon-?2a,0,0
135137,270,0,0
135138,?g/week,0,0
135139,plus,0,0
135140,ribavirin,0,0
135141,"1,600",0,0
135142,mg,0,0
135143,daily,0,0
135144,and,0,1
135145,epoetin-?,0,0
135146,for,0,0
135147,4,0,0
135148,weeks,0,0
135149,",",0,0
135150,followed,0,0
135151,by,0,0
135152,pegylated,0,0
135153,interferon-?2a,0,0
135154,at,0,0
135155,standard,0,0
135156,dosages,0,0
135157,plus,0,0
135158,weight-based,0,0
135159,ribavirin,0,0
135160,(,0,1
135161,WBR,0,1
135162,),0,1
135163,dosage,0,0
135164,for,0,0
135165,8,0,0
135166,weeks,0,0
135167,(,0,0
135168,induction,0,1
135169,arm,0,0
135170,[,0,0
135171,IA,0,1
135172,],0,0
135173,),0,1
135174,",",0,1
135175,or,0,1
135176,pegylated,0,0
135177,interferon-?2a,0,1
135178,plus,0,0
135179,WBR,0,0
135180,for,0,0
135181,12,0,0
135182,weeks,0,0
135183,(,0,0
135184,standard,0,0
135185,therapy,0,0
135186,arm,0,0
135187,[,0,0
135188,SA,0,0
135189,],0,0
135190,),0,0
135191,.,0,0
135192,HCV,1,0
135193,RNA,1,1
135194,was,1,0
135195,determined,0,0
135196,at,0,0
135197,weeks,0,0
135198,0,0,0
135199,",",0,0
135200,1,0,0
135201,",",0,0
135202,2,0,0
135203,",",0,0
135204,3,0,0
135205,",",0,0
135206,4,0,0
135207,",",0,0
135208,8,0,0
135209,and,0,0
135210,12,0,0
135211,.,1,0
135212,Ribavirin,1,0
135213,plasma,1,1
135214,trough,1,1
135215,concentrations,1,1
135216,were,1,0
135217,determined,0,0
135218,at,0,0
135219,weeks,0,0
135220,4,0,0
135221,(,0,0
135222,RBV-C,0,0
135223,(,0,0
135224,4,0,0
135225,),0,0
135226,),0,0
135227,and,0,0
135228,12,0,0
135229,(,0,0
135230,RBV-C,0,0
135231,(,0,0
135232,12,0,0
135233,),0,0
135234,),0,0
135235,.,0,0
135236,RESULTS,0,0
135237,A,0,0
135238,total,0,0
135239,of,0,0
135240,67,0,0
135241,patients,0,0
135242,were,0,0
135243,included,0,0
135244,;,0,0
135245,33,0,0
135246,in,0,0
135247,the,0,0
135248,SA,0,0
135249,and,0,0
135250,34,0,0
135251,in,0,0
135252,the,0,0
135253,IA,0,0
135254,.,0,0
135255,Overall,0,0
135256,",",0,0
135257,25,0,0
135258,%,0,0
135259,received,1,0
135260,nucleoside,1,1
135261,reverse,1,0
135262,transcriptase,1,0
135263,inhibitor,1,0
135264,(,1,1
135265,NRTI,1,1
135266,),1,0
135267,-sparing,1,0
135268,regimens,1,0
135269,.,1,0
135270,More,1,0
135271,patients,0,0
135272,achieved,1,1
135273,an,1,0
135274,HCV,1,0
135275,RNA,1,0
135276,decrease,1,1
135277,?1,1,0
135278,log,1,1
135279,(,0,0
135280,10,0,0
135281,),0,0
135282,at,0,0
135283,week,0,0
135284,4,0,0
135285,in,0,0
135286,the,0,0
135287,IA,0,0
135288,than,0,0
135289,in,0,0
135290,the,0,0
135291,SA,0,0
135292,(,0,0
135293,62,0,0
135294,%,0,0
135295,versus,0,0
135296,38,0,0
135297,%,0,0
135298,;,0,0
135299,P=0.017,0,0
135300,),0,1
135301,",",1,0
135302,but,1,0
135303,EVR,1,1
135304,rates,1,1
135305,were,1,0
135306,similar,0,0
135307,in,0,0
135308,the,0,0
135309,two,0,0
135310,groups,0,0
135311,(,0,0
135312,74,0,0
135313,%,0,0
135314,versus,0,0
135315,59,0,0
135316,%,0,0
135317,in,0,0
135318,the,0,0
135319,IA,0,1
135320,and,0,1
135321,SA,0,0
135322,",",0,0
135323,respectively,0,0
135324,;,0,0
135325,P=0.15,0,0
135326,),0,0
135327,.,0,0
135328,Independent,0,0
135329,predictors,0,0
135330,of,0,0
135331,faster,1,1
135332,HCV,1,1
135333,RNA,1,1
135334,decrease,1,1
135335,at,1,0
135336,12,1,0
135337,weeks,1,0
135338,were,0,0
135339,higher,0,0
135340,RBV-C,0,1
135341,(,0,0
135342,4,0,0
135343,),0,0
135344,and,0,0
135345,younger,0,0
135346,age,1,0
135347,.,1,1
135348,RBV-C,1,1
135349,(,1,0
135350,4,1,0
135351,),0,0
135352,were,1,0
135353,higher,1,0
135354,in,0,0
135355,patients,0,0
135356,allocated,0,0
135357,in,0,0
135358,the,0,0
135359,IA,0,1
135360,and,0,0
135361,in,0,0
135362,those,0,0
135363,receiving,0,0
135364,NRTIs,0,0
135365,(,0,0
135366,P=0.039,0,0
135367,),0,0
135368,.,0,0
135369,CONCLUSIONS,0,0
135370,A,0,0
135371,4-week,0,0
135372,induction,0,0
135373,with,0,0
135374,pegylated,0,0
135375,interferon-?2a,0,1
135376,plus,0,0
135377,ribavirin,0,0
135378,was,0,0
135379,associated,0,0
135380,with,0,0
135381,a,0,0
135382,greater,0,0
135383,decrease,1,1
135384,in,1,0
135385,HCV,1,0
135386,RNA,1,0
135387,at,0,0
135388,week,0,0
135389,4,0,0
135390,;,0,0
135391,however,0,0
135392,",",0,0
135393,this,0,0
135394,did,0,0
135395,not,0,0
135396,translate,0,0
135397,into,0,0
135398,higher,1,0
135399,EVR,1,0
135400,rates,1,1
135401,.,1,0
135402,Higher,1,0
135403,RBV,0,0
135404,doses,0,1
135405,and,0,1
135406,avoidance,0,1
135407,of,0,1
135408,NRTI-sparing,0,0
135409,antiretroviral,0,0
135410,regimens,0,0
135411,might,0,0
135412,improve,1,0
135413,HCV,1,0
135414,treatment,1,0
135415,efficacy,1,1
135416,.,0,0
135417,Enhancing,0,0
135418,the,0,0
135419,application,0,0
135420,and,0,1
135421,evaluation,0,0
135422,of,0,0
135423,a,0,0
135424,discrete,0,1
135425,trial,0,0
135426,intervention,0,0
135427,package,0,0
135428,for,0,0
135429,eliciting,0,0
135430,first,0,0
135431,words,0,1
135432,in,0,0
135433,preverbal,0,0
135434,preschoolers,0,0
135435,with,0,0
135436,ASD,0,0
135437,.,0,0
135438,This,0,0
135439,study,0,0
135440,evaluates,0,0
135441,the,0,0
135442,effectiveness,0,0
135443,of,0,0
135444,an,0,0
135445,intervention,0,0
135446,package,0,0
135447,including,0,0
135448,a,0,0
135449,discrete,0,1
135450,trial,0,0
135451,program,0,0
135452,(,0,1
135453,Rapid,0,1
135454,Motor,0,1
135455,Imitation,0,1
135456,Antecedent,0,0
135457,Training,0,1
135458,(,0,1
135459,Tsiouri,0,0
135460,and,0,1
135461,Greer,0,1
135462,",",0,1
135463,J,0,0
135464,Behav,0,0
135465,Educat,0,0
135466,12:185-206,0,0
135467,",",0,0
135468,2003,0,0
135469,),0,0
135470,combined,0,0
135471,with,0,0
135472,parent,0,1
135473,education,0,0
135474,for,0,0
135475,eliciting,0,0
135476,first,0,0
135477,words,0,1
135478,in,0,0
135479,children,0,0
135480,with,0,0
135481,ASD,0,0
135482,who,0,0
135483,had,0,0
135484,little,0,0
135485,or,0,0
135486,no,0,0
135487,spoken,0,0
135488,language,0,1
135489,.,0,1
135490,Evaluation,0,1
135491,of,0,0
135492,the,0,0
135493,approach,0,0
135494,includes,0,0
135495,specific,0,0
135496,intervention,0,0
135497,targets,0,1
135498,and,0,1
135499,functional,1,1
135500,spoken,1,1
135501,language,1,1
135502,outcomes,1,1
135503,(,1,0
135504,Tager-Flusberg,1,1
135505,et,1,1
135506,al.,1,0
135507,",",0,1
135508,J,1,0
135509,Speech,1,1
135510,Lang,1,1
135511,Hear,1,1
135512,Res,1,0
135513,52:643-652,1,0
135514,",",1,0
135515,2009,1,0
135516,),1,0
135517,.,1,0
135518,Results,0,0
135519,suggest,0,0
135520,that,0,0
135521,RMIA,0,0
135522,",",0,0
135523,with,0,0
135524,parent,0,1
135525,training,0,0
135526,",",0,0
135527,catalyzes,0,1
135528,development,0,1
135529,of,0,1
135530,verbal,1,1
135531,imitation,1,1
135532,and,1,1
135533,production,1,1
135534,for,0,0
135535,some,0,0
135536,children,0,0
135537,.,0,0
135538,Three,0,0
135539,of,0,0
135540,five,0,0
135541,participants,0,0
135542,acquired,0,0
135543,word,1,1
135544,production,1,1
135545,within,0,0
135546,the,0,0
135547,DTT,0,0
135548,framework,0,0
135549,and,0,1
135550,achieved,0,1
135551,milestones,0,1
135552,of,0,1
135553,early,1,0
135554,functional,1,1
135555,spoken,1,1
135556,language,1,1
135557,use,1,1
135558,(,0,1
135559,Tager-Flusberg,0,1
135560,et,0,1
135561,al.,0,0
135562,",",0,1
135563,J,0,0
135564,Speech,0,1
135565,Lang,0,1
135566,Hear,0,1
135567,Res,0,0
135568,52:643-652,0,0
135569,",",0,0
135570,2009,0,0
135571,),0,0
135572,.,0,0
135573,The,0,0
135574,implications,0,0
135575,of,0,0
135576,these,0,0
135577,findings,0,0
135578,for,0,0
135579,understanding,0,0
135580,the,0,0
135581,role,0,0
135582,of,0,0
135583,discrete,0,1
135584,trial,0,0
135585,approaches,0,0
135586,to,0,0
135587,language,0,0
135588,intervention,0,0
135589,are,0,0
135590,discussed,0,0
135591,.,0,0
135592,Side,0,0
135593,branch,0,1
135594,occlusion,0,0
135595,with,0,0
135596,everolimus-eluting,0,0
135597,and,0,1
135598,paclitaxel-eluting,0,0
135599,stents,0,0
135600,:,0,0
135601,three-year,0,0
135602,results,0,0
135603,from,0,0
135604,the,0,0
135605,SPIRIT,0,1
135606,III,0,1
135607,randomised,0,0
135608,trial,0,0
135609,.,0,1
135610,AIMS,0,1
135611,AND,0,0
135612,METHODS,0,0
135613,The,0,0
135614,rates,0,1
135615,of,0,0
135616,side,0,1
135617,branch,0,1
135618,occlusion,0,1
135619,and,0,1
135620,subsequent,0,1
135621,periprocedural,0,1
135622,MI,0,0
135623,during,0,0
135624,everolimus-eluting,0,0
135625,stent,0,1
135626,(,0,1
135627,EES,0,1
135628,),0,1
135629,and,0,1
135630,paclitaxel-eluting,0,0
135631,stent,0,1
135632,(,0,1
135633,PES,0,1
135634,),0,1
135635,placement,0,0
135636,were,0,0
135637,examined,0,0
135638,in,0,0
135639,the,0,0
135640,randomised,0,0
135641,SPIRIT,0,1
135642,III,0,0
135643,trial,0,0
135644,.,0,0
135645,Periprocedural,0,1
135646,myocardial,0,1
135647,infarction,0,1
135648,(,0,1
135649,MI,0,0
135650,),0,0
135651,following,0,0
135652,drug-eluting,0,0
135653,stent,0,0
135654,placement,0,0
135655,is,0,0
135656,associated,0,0
135657,with,0,0
135658,long-term,0,0
135659,adverse,0,1
135660,outcomes,0,1
135661,.,0,0
135662,Occlusion,0,1
135663,of,0,1
135664,side,0,1
135665,branches,0,0
135666,may,0,0
135667,be,0,0
135668,an,0,0
135669,important,0,0
135670,factor,0,0
135671,contributing,0,0
135672,to,0,0
135673,periprocedural,0,1
135674,MIs,0,0
135675,.,0,0
135676,Consecutive,0,0
135677,procedural,0,1
135678,angiograms,0,0
135679,of,0,0
135680,patients,0,0
135681,randomly,0,0
135682,assigned,0,0
135683,to,0,0
135684,EES,0,0
135685,(,0,1
135686,n=669,0,0
135687,),0,1
135688,or,0,1
135689,PES,0,1
135690,(,0,0
135691,n=333,0,0
135692,),0,0
135693,were,0,0
135694,analysed,0,0
135695,by,0,0
135696,an,0,0
135697,independent,0,0
135698,angiographic,0,1
135699,core,0,1
135700,laboratory,0,1
135701,.,0,1
135702,Side,0,0
135703,branch,0,1
135704,occlusion,0,1
135705,was,0,0
135706,defined,0,1
135707,as,0,0
135708,Thrombolysis,0,0
135709,In,0,0
135710,Myocardial,0,1
135711,Infarction,0,1
135712,(,0,1
135713,TIMI,0,1
135714,),0,1
135715,flow,0,1
135716,grade,0,0
135717,0,0,0
135718,or,0,0
135719,1,0,0
135720,.,0,0
135721,Clinical,0,0
135722,outcomes,0,1
135723,through,0,0
135724,three,0,0
135725,years,0,0
135726,were,0,0
135727,compared,0,0
135728,by,0,0
135729,stent,0,1
135730,type,0,1
135731,and,0,1
135732,presence,0,0
135733,of,0,1
135734,side,0,1
135735,branch,0,0
135736,occlusion,0,0
135737,.,0,0
135738,CONCLUSIONS,0,0
135739,A,0,0
135740,total,0,0
135741,of,0,0
135742,"2,048",0,0
135743,side,0,1
135744,branches,0,0
135745,were,0,0
135746,evaluated,0,0
135747,(,0,0
135748,EES,0,0
135749,"N=1,345",0,0
135750,side,0,1
135751,branches,0,0
135752,in,0,0
135753,688,0,0
135754,stented,0,0
135755,lesions,0,1
135756,",",0,0
135757,PES,0,1
135758,N=703,0,0
135759,side,0,1
135760,branches,0,0
135761,in,0,0
135762,346,0,0
135763,stented,0,0
135764,lesions,0,0
135765,),0,0
135766,.,0,0
135767,Patients,0,0
135768,with,0,0
135769,compared,0,0
135770,to,0,0
135771,those,0,0
135772,without,0,0
135773,transient,0,1
135774,or,0,1
135775,final,0,1
135776,side,0,1
135777,branch,0,1
135778,occlusion,0,1
135779,had,0,0
135780,significantly,0,0
135781,higher,0,0
135782,non-Q-wave,1,1
135783,MI,1,1
135784,(,1,1
135785,NQMI,1,0
135786,),1,0
135787,rates,1,1
135788,in-hospital,0,1
135789,(,0,0
135790,9.0,0,0
135791,%,0,0
135792,vs.,0,0
135793,0.5,0,0
135794,%,0,0
135795,",",0,0
135796,p,0,0
135797,<,0,0
135798,0.0001,0,0
135799,),0,0
135800,.,0,0
135801,By,0,0
135802,multivariable,0,0
135803,analysis,0,0
135804,side,0,1
135805,branch,0,1
135806,occlusion,0,0
135807,was,0,0
135808,an,0,0
135809,independent,0,0
135810,predictor,0,0
135811,of,0,1
135812,NQMI,1,0
135813,(,0,0
135814,OR,0,0
135815,4.45,0,0
135816,;,0,0
135817,95,0,0
135818,%,0,0
135819,CI,0,0
135820,[,0,0
135821,1.82,0,0
135822,",",0,0
135823,10.85,0,0
135824,],0,0
135825,),0,0
135826,.,0,1
135827,Transient,0,1
135828,or,0,1
135829,final,0,1
135830,side,0,1
135831,branch,0,1
135832,occlusion,0,1
135833,occurred,0,0
135834,less,0,0
135835,frequently,0,0
135836,in,0,0
135837,patients,0,0
135838,receiving,0,0
135839,EES,0,0
135840,compared,0,0
135841,to,0,0
135842,PES,0,1
135843,(,0,0
135844,2.8,0,0
135845,%,0,0
135846,vs.,0,0
135847,5.2,0,0
135848,%,0,0
135849,",",0,0
135850,p=0.009,0,0
135851,),0,1
135852,",",0,0
135853,contributing,0,0
135854,to,0,0
135855,the,0,0
135856,numerically,0,0
135857,lower,0,0
135858,rates,1,1
135859,of,1,1
135860,in-hospital,1,1
135861,NQMI,1,0
135862,with,0,0
135863,EES,0,0
135864,arm,0,0
135865,compared,0,0
135866,to,0,0
135867,PES,0,1
135868,(,0,0
135869,0.7,0,0
135870,%,0,0
135871,vs.,0,0
135872,2.3,0,0
135873,%,0,0
135874,",",0,0
135875,p=0.05,0,0
135876,),0,1
135877,.,0,0
135878,Patients,0,0
135879,treated,0,0
135880,with,0,0
135881,EES,0,0
135882,rather,0,0
135883,than,0,0
135884,PES,0,1
135885,were,0,0
135886,less,0,0
135887,likely,0,0
135888,to,0,0
135889,develop,0,0
135890,side,1,1
135891,branch,1,1
135892,occlusion,1,0
135893,during,0,0
135894,stent,0,1
135895,placement,0,0
135896,",",0,0
135897,contributing,0,0
135898,to,0,0
135899,lower,0,0
135900,rates,0,1
135901,of,0,0
135902,periprocedural,0,1
135903,MI,0,0
135904,with,0,0
135905,EES,0,0
135906,compared,0,0
135907,to,0,0
135908,PES,0,1
135909,.,0,0
135910,Learning,0,1
135911,through,0,0
135912,interaction,0,1
135913,in,0,0
135914,children,0,0
135915,with,0,0
135916,autism,0,0
135917,:,0,0
135918,preliminary,0,0
135919,data,0,0
135920,from,0,0
135921,asocial-communication-based,0,1
135922,intervention,0,0
135923,.,0,0
135924,The,0,0
135925,study,0,0
135926,evaluates,0,0
135927,a,0,0
135928,social-communication-based,0,1
135929,approach,0,0
135930,to,0,0
135931,autism,0,0
135932,intervention,0,0
135933,aimed,0,0
135934,at,0,0
135935,improving,0,0
135936,the,0,0
135937,social,1,1
135938,interaction,1,1
135939,skills,1,1
135940,of,0,0
135941,children,0,0
135942,with,0,0
135943,autism,0,0
135944,spectrum,0,0
135945,disorder,0,0
135946,.,0,0
135947,We,0,0
135948,report,0,0
135949,preliminary,0,0
135950,results,0,0
135951,from,0,0
135952,an,0,0
135953,ongoing,0,0
135954,randomized,0,0
135955,controlled,0,0
135956,trial,0,0
135957,of,0,0
135958,51,0,0
135959,children,0,0
135960,aged,0,0
135961,2,0,0
135962,years,0,0
135963,0,0,0
135964,months,0,0
135965,to,0,0
135966,4,0,0
135967,years,0,0
135968,11,0,0
135969,months,0,0
135970,.,0,0
135971,Participants,0,0
135972,were,0,0
135973,assigned,0,0
135974,to,0,0
135975,either,0,0
135976,a,0,0
135977,target,0,0
135978,treatment,0,0
135979,or,0,1
135980,community,0,1
135981,treatment,0,0
135982,group,0,0
135983,.,0,0
135984,Families,0,0
135985,in,0,0
135986,the,0,0
135987,target,0,0
135988,treatment,0,0
135989,group,0,0
135990,were,0,0
135991,given,0,0
135992,2,0,0
135993,hours,0,0
135994,of,0,0
135995,therapy,0,0
135996,and,0,0
135997,coaching,0,0
135998,each,0,0
135999,week,0,0
136000,in,0,0
136001,an,0,0
136002,intervention,0,0
136003,emphasizing,0,0
136004,social-interaction,0,1
136005,and,0,0
136006,the,0,0
136007,parent-child,0,0
136008,relationship,0,0
136009,.,0,0
136010,Children,0,0
136011,in,0,0
136012,the,0,0
136013,community,0,0
136014,treatment,0,0
136015,group,0,0
136016,received,0,0
136017,a,0,0
136018,variety,0,0
136019,of,0,0
136020,services,0,0
136021,averaging,0,0
136022,3.9,0,0
136023,hours,0,0
136024,per,0,0
136025,week,0,0
136026,.,0,0
136027,After,0,0
136028,12,0,0
136029,months,0,0
136030,",",0,0
136031,outcomes,0,1
136032,were,0,0
136033,measured,0,0
136034,to,0,0
136035,determine,0,0
136036,changes,0,1
136037,in,0,0
136038,the,0,0
136039,groups,0,0
136040,in,0,0
136041,social,0,1
136042,interaction,0,1
136043,and,0,1
136044,communication,0,1
136045,.,0,1
136046,In,0,0
136047,addition,0,0
136048,",",0,0
136049,a,0,0
136050,regression,0,1
136051,analysis,0,0
136052,was,0,0
136053,conducted,0,0
136054,to,0,0
136055,determine,0,0
136056,whether,0,0
136057,changes,0,1
136058,in,0,0
136059,social,0,1
136060,interaction,0,1
136061,skills,0,1
136062,were,0,0
136063,associated,0,0
136064,with,0,0
136065,language,0,0
136066,development,0,1
136067,.,0,0
136068,Results,0,0
136069,suggest,0,0
136070,that,0,0
136071,children,0,0
136072,in,0,0
136073,the,0,0
136074,treatment,0,0
136075,group,0,0
136076,made,0,0
136077,significantly,0,0
136078,greater,0,0
136079,gains,1,1
136080,in,1,0
136081,social,1,1
136082,interaction,1,1
136083,skills,1,1
136084,in,0,0
136085,comparison,0,0
136086,to,0,0
136087,the,0,0
136088,community,0,0
136089,treatment,0,0
136090,group,0,0
136091,",",0,0
136092,but,0,0
136093,no,0,0
136094,between-group,0,1
136095,differences,0,0
136096,were,0,0
136097,found,0,0
136098,for,0,0
136099,standard,1,0
136100,language,1,0
136101,assessments,1,0
136102,.,1,1
136103,Initiation,1,1
136104,of,1,1
136105,joint,1,1
136106,attention,1,1
136107,",",1,1
136108,involvement,1,1
136109,",",1,1
136110,and,1,1
136111,severity,1,1
136112,of,1,1
136113,language,1,1
136114,delay,1,1
136115,were,0,0
136116,found,0,0
136117,to,0,0
136118,be,0,0
136119,significantly,0,0
136120,associated,0,0
136121,with,0,0
136122,improvement,0,1
136123,of,0,1
136124,language,1,1
136125,skills,1,1
136126,in,0,0
136127,children,0,0
136128,with,0,0
136129,autism,0,0
136130,.,0,0
136131,Finally,0,0
136132,caregiver,0,1
136133,skills,0,1
136134,targeted,0,0
136135,by,0,0
136136,the,0,0
136137,intervention,0,0
136138,were,0,0
136139,found,0,0
136140,to,0,0
136141,be,0,0
136142,significantly,0,0
136143,associated,0,0
136144,with,0,0
136145,changes,0,1
136146,in,0,0
136147,children,1,0
136148,'s,1,1
136149,interaction,1,1
136150,skills,1,1
136151,.,1,0
136152,[,0,0
136153,Treatment,0,0
136154,of,0,1
136155,primary,0,0
136156,osteoporosis,0,1
136157,with,0,0
136158,calcium,0,1
136159,and,0,1
136160,salmon,0,0
136161,calcitonin,0,1
136162,],0,0
136163,.,0,1
136164,Fifty-nine,0,0
136165,consecutive,0,0
136166,patients,0,0
136167,(,0,0
136168,19,0,0
136169,men,0,0
136170,",",0,0
136171,40,0,0
136172,women,0,0
136173,",",0,0
136174,mean,0,1
136175,age,0,0
136176,60.8,0,0
136177,[,0,0
136178,27-80,0,0
136179,],0,0
136180,years,0,0
136181,),0,0
136182,with,0,0
136183,primary,0,0
136184,osteoporosis,0,1
136185,were,0,0
136186,studied,0,0
136187,to,0,0
136188,see,0,0
136189,if,0,0
136190,there,0,0
136191,was,0,0
136192,any,0,0
136193,significant,0,0
136194,gain,0,1
136195,in,0,0
136196,bone,0,1
136197,mass,0,1
136198,after,0,0
136199,treatment,0,0
136200,with,0,0
136201,salmon,0,0
136202,calcitonin,0,1
136203,.,0,0
136204,All,0,0
136205,the,0,0
136206,patients,0,0
136207,were,0,0
136208,given,0,0
136209,1,0,0
136210,g,0,0
136211,calcium,0,0
136212,by,0,0
136213,mouth,0,1
136214,every,0,0
136215,morning,0,0
136216,.,0,0
136217,Group,0,0
136218,1,0,0
136219,(,0,0
136220,n,0,0
136221,=,0,0
136222,20,0,0
136223,),0,0
136224,received,0,0
136225,no,0,0
136226,other,0,0
136227,specific,0,0
136228,medication,0,1
136229,while,0,0
136230,group,0,0
136231,2,0,0
136232,(,0,0
136233,n,0,0
136234,=,0,0
136235,19,0,0
136236,),0,0
136237,were,0,0
136238,given,0,0
136239,100,0,0
136240,I.U,0,0
136241,.,0,0
136242,calcitonin,0,0
136243,subcutaneously,0,0
136244,every,0,0
136245,second,0,0
136246,evening,0,1
136247,and,0,1
136248,group,0,0
136249,3,0,0
136250,(,0,0
136251,n,0,0
136252,=,0,0
136253,20,0,0
136254,),0,0
136255,received,0,0
136256,the,0,0
136257,same,0,0
136258,dose,0,0
136259,every,0,0
136260,evening,0,1
136261,.,0,0
136262,The,0,0
136263,pain,1,1
136264,reported,0,0
136265,by,0,0
136266,the,0,0
136267,patients,0,0
136268,was,0,0
136269,subdivided,0,0
136270,into,0,0
136271,four,0,0
136272,severity,0,1
136273,grades,0,1
136274,",",0,1
136275,and,0,1
136276,analgesic,1,1
136277,consumption,1,1
136278,was,0,0
136279,recorded,0,0
136280,.,0,0
136281,In,0,0
136282,group,0,0
136283,1,0,0
136284,there,0,0
136285,was,0,0
136286,a,0,0
136287,nonsignificant,0,1
136288,decrease,0,1
136289,in,0,0
136290,pain,1,1
136291,",",0,1
136292,but,0,0
136293,in,0,0
136294,groups,0,0
136295,2,0,0
136296,and,0,0
136297,3,0,0
136298,there,0,0
136299,was,0,0
136300,a,0,0
136301,highly,0,0
136302,significant,0,0
136303,diminution,0,1
136304,in,0,0
136305,pain,1,1
136306,(,0,0
136307,P,0,0
136308,less,0,0
136309,than,0,0
136310,0.005,0,0
136311,),0,0
136312,and,0,0
136313,in,0,0
136314,analgesic,1,1
136315,intake,1,1
136316,(,0,0
136317,P,0,0
136318,less,0,0
136319,than,0,0
136320,0.01,0,0
136321,),0,0
136322,.,0,0
136323,Measurements,0,0
136324,of,0,1
136325,bone,1,1
136326,density,1,1
136327,carried,0,0
136328,out,0,0
136329,by,0,0
136330,photon,0,0
136331,absorption,0,1
136332,at,0,0
136333,the,0,0
136334,end,0,0
136335,of,0,0
136336,12,0,0
136337,months,0,0
136338,showed,0,0
136339,a,0,0
136340,5.5,0,0
136341,%,0,0
136342,increase,0,0
136343,in,0,0
136344,the,0,0
136345,distal,1,1
136346,radius,1,1
136347,in,0,0
136348,group,0,0
136349,2,0,0
136350,(,0,0
136351,P,0,0
136352,=,0,0
136353,0.0001,0,0
136354,),0,0
136355,and,0,0
136356,a,0,0
136357,7.1,0,0
136358,%,0,0
136359,increase,0,0
136360,in,0,0
136361,group,0,0
136362,3,0,0
136363,(,0,0
136364,P,0,0
136365,=,0,0
136366,0.0001,0,0
136367,),0,0
136368,",",0,0
136369,while,0,0
136370,in,0,0
136371,group,0,0
136372,1,0,0
136373,mineral,0,1
136374,content,0,1
136375,had,0,0
136376,decreased,0,0
136377,by,0,0
136378,4.3,0,0
136379,%,0,0
136380,(,0,0
136381,nonsignificant,0,1
136382,),0,0
136383,.,0,0
136384,These,0,0
136385,results,0,0
136386,show,0,0
136387,that,0,0
136388,a,0,0
136389,significant,0,0
136390,gain,0,1
136391,in,0,0
136392,bone,1,1
136393,mass,1,1
136394,can,0,0
136395,be,0,0
136396,achieved,0,0
136397,by,0,0
136398,administration,0,0
136399,of,0,1
136400,calcitonin,0,1
136401,",",0,1
136402,either,0,0
136403,daily,0,1
136404,or,0,0
136405,on,0,0
136406,alternate,0,0
136407,days,0,0
136408,.,0,0
136409,The,0,0
136410,incidence,0,1
136411,of,0,0
136412,extravertebral,0,1
136413,fractures,0,1
136414,and,0,1
136415,of,0,1
136416,new,0,1
136417,or,0,0
136418,progressive,0,1
136419,vertebral,0,1
136420,deformity,0,1
136421,tended,0,0
136422,to,0,0
136423,be,0,0
136424,lower,0,0
136425,in,0,0
136426,groups,0,0
136427,2,0,0
136428,and,0,0
136429,3,0,0
136430,than,0,0
136431,in,0,0
136432,group,0,0
136433,1,0,0
136434,.,0,0
136435,The,0,0
136436,competition,0,0
136437,between,0,0
136438,enamel,0,0
136439,and,0,1
136440,dentin,0,0
136441,adhesion,0,1
136442,within,0,0
136443,a,0,0
136444,cavity,0,0
136445,:,0,0
136446,an,0,0
136447,in,0,0
136448,vitro,0,0
136449,evaluation,0,0
136450,of,0,1
136451,class,0,0
136452,V,0,0
136453,restorations,0,0
136454,.,0,0
136455,To,0,0
136456,gain,0,1
136457,more,0,0
136458,insight,0,0
136459,into,0,0
136460,the,0,0
136461,consequences,0,0
136462,of,0,0
136463,curing,0,0
136464,contraction,0,0
136465,within,0,0
136466,the,0,0
136467,tooth,0,1
136468,cavity,0,0
136469,",",0,0
136470,we,0,0
136471,assessed,0,0
136472,the,0,0
136473,margin,0,1
136474,behavior,0,1
136475,of,0,0
136476,12,0,0
136477,contemporary,0,0
136478,restorative,0,0
136479,systems,0,0
136480,in,0,0
136481,class,0,0
136482,V,0,1
136483,restorations,0,0
136484,with,0,0
136485,margins,0,1
136486,located,0,0
136487,on,0,0
136488,enamel,0,0
136489,and,0,1
136490,dentin,0,0
136491,after,0,0
136492,mechanical,0,1
136493,loading,0,1
136494,and,0,1
136495,water,0,1
136496,storage,0,1
136497,.,0,1
136498,Mixed,0,0
136499,class,0,0
136500,V,0,1
136501,cavities,0,0
136502,were,0,0
136503,prepared,0,0
136504,on,0,0
136505,extracted,0,0
136506,human,0,0
136507,molars,0,1
136508,and,0,1
136509,restored,0,0
136510,using,0,0
136511,five,0,0
136512,etch,0,0
136513,and,0,0
136514,rinse,0,0
136515,and,0,0
136516,seven,0,0
136517,self-etch,0,0
136518,adhesive,0,0
136519,systems,0,0
136520,with,0,0
136521,their,0,0
136522,corresponding,0,1
136523,composites,0,0
136524,.,0,1
136525,Marginal,0,1
136526,adaptation,0,1
136527,was,0,0
136528,evaluated,0,0
136529,by,0,0
136530,using,0,0
136531,a,0,0
136532,computer-assisted,0,0
136533,quantitative,0,0
136534,marginal,0,1
136535,analysis,0,0
136536,in,0,0
136537,a,0,0
136538,scanning,0,0
136539,electron,0,1
136540,microscope,0,1
136541,(,0,1
136542,SEM,0,0
136543,),0,0
136544,on,0,0
136545,epoxy,0,0
136546,replicas,0,0
136547,before,0,0
136548,",",0,0
136549,after,0,0
136550,thermal,0,1
136551,and,0,1
136552,mechanical,0,1
136553,stressing,0,0
136554,and,0,0
136555,after,0,0
136556,1,0,0
136557,year,0,0
136558,of,0,0
136559,water,0,0
136560,storage,0,1
136561,.,0,0
136562,The,0,0
136563,interactions,0,0
136564,of,0,0
136565,testing,0,0
136566,conditions,0,0
136567,",",0,0
136568,adhesive-composite,0,1
136569,combination,0,0
136570,and,0,1
136571,tooth,0,1
136572,substrate,0,1
136573,with,0,0
136574,marginal,0,1
136575,adaptation,0,1
136576,were,0,0
136577,evaluated,0,0
136578,by,0,0
136579,two-way,0,0
136580,ANOVA,0,0
136581,.,0,1
136582,Fatigue,1,1
136583,",",1,1
136584,stress,1,1
136585,and,1,1
136586,storage,1,1
136587,conditions,1,0
136588,had,0,0
136589,significant,0,0
136590,effects,0,0
136591,on,0,0
136592,the,0,0
136593,marginal,1,1
136594,adaptation,1,1
136595,.,1,0
136596,Only,0,0
136597,two,0,0
136598,groups,0,0
136599,(,0,0
136600,Optibond,0,0
136601,FL,0,1
136602,and,0,1
136603,G,0,0
136604,Bond,0,0
136605,),0,1
136606,presented,0,0
136607,equal,0,0
136608,percentages,0,1
136609,of,0,1
136610,marginal,1,1
136611,adaptation,1,1
136612,on,1,0
136613,enamel,1,0
136614,and,1,0
136615,dentin,1,0
136616,;,1,0
136617,in,0,0
136618,the,0,0
136619,other,0,0
136620,groups,0,0
136621,",",0,0
136622,the,0,0
136623,rate,1,1
136624,of,1,1
136625,degradation,1,1
136626,was,0,0
136627,product,0,1
136628,dependent,0,0
136629,.,0,0
136630,All,0,0
136631,materials,0,0
136632,tested,0,0
136633,showed,0,0
136634,a,0,0
136635,distinct,0,0
136636,behavior,0,1
136637,on,0,0
136638,enamel,1,0
136639,and,1,1
136640,dentin,1,0
136641,.,1,1
136642,In,0,0
136643,addition,0,0
136644,to,0,0
136645,mechanical,0,1
136646,resistance,0,1
136647,and,0,1
136648,long-term,0,1
136649,stability,0,1
136650,",",0,0
136651,differences,0,0
136652,within,0,0
136653,materials,0,0
136654,also,0,0
136655,exist,0,0
136656,in,0,0
136657,their,0,0
136658,ability,0,1
136659,to,0,0
136660,simultaneously,1,0
136661,bond,1,0
136662,to,1,0
136663,enamel,1,0
136664,and,1,0
136665,dentin,1,0
136666,.,1,0
136667,Single,0,1
136668,negative,0,1
136669,colposcopy,0,0
136670,:,0,0
136671,is,0,0
136672,it,0,0
136673,enough,0,0
136674,to,0,0
136675,rule,0,0
136676,out,0,0
136677,high-grade,0,0
136678,disease,0,0
136679,?,0,0
136680,It,0,0
136681,has,0,0
136682,been,0,0
136683,proposed,0,0
136684,that,0,0
136685,women,0,0
136686,who,0,0
136687,have,0,0
136688,a,0,0
136689,negative,0,1
136690,colposcopic,0,1
136691,examination,0,0
136692,or,0,0
136693,who,0,0
136694,have,0,0
136695,no,0,0
136696,cervical,0,0
136697,intraepithelial,0,1
136698,neoplasia,0,1
136699,(,0,1
136700,CIN,0,0
136701,),0,1
136702,on,0,0
136703,colposcopic,0,0
136704,biopsy,0,0
136705,can,0,0
136706,be,0,0
136707,safely,0,0
136708,returned,0,0
136709,to,0,0
136710,routine,0,0
136711,screening,0,0
136712,with,0,0
136713,the,0,0
136714,next,0,0
136715,visit,0,0
136716,being,0,0
136717,three,0,0
136718,or,0,0
136719,five,0,0
136720,years,0,0
136721,later,0,0
136722,.,0,0
136723,We,0,0
136724,present,0,0
136725,data,0,0
136726,regarding,0,0
136727,551,0,0
136728,women,0,0
136729,who,0,0
136730,had,0,0
136731,colposcopy,0,0
136732,in,0,0
136733,Wales,0,1
136734,for,0,0
136735,a,0,0
136736,low-grade,0,0
136737,cytological,0,1
136738,abnormality,0,0
136739,and,0,0
136740,who,0,0
136741,were,0,0
136742,followed,0,0
136743,through,0,0
136744,Cervical,0,0
136745,Screening,0,0
136746,Wales,0,1
136747,for,0,0
136748,subsequent,0,0
136749,CIN,0,0
136750,.,0,0
136751,Of,0,0
136752,436,0,0
136753,women,0,0
136754,declared,0,0
136755,CIN,1,0
136756,free,1,1
136757,initially,0,0
136758,",",0,0
136759,26,0,0
136760,(,0,0
136761,6.0,0,0
136762,%,0,0
136763,),0,0
136764,had,0,0
136765,high-grade,1,0
136766,CIN,1,0
136767,diagnosed,0,0
136768,on,0,0
136769,follow-up,0,0
136770,.,0,0
136771,We,0,0
136772,suggest,0,0
136773,that,0,0
136774,additional,0,0
136775,screening,0,0
136776,at,0,0
136777,an,0,0
136778,interval,0,0
136779,of,0,0
136780,less,0,0
136781,than,0,0
136782,three,0,0
136783,years,0,0
136784,should,0,0
136785,be,0,0
136786,offered,0,0
136787,to,0,0
136788,women,0,0
136789,with,0,0
136790,a,0,0
136791,negative,0,1
136792,colposcopy,0,0
136793,or,0,0
136794,a,0,0
136795,biopsy,0,0
136796,without,0,0
136797,CIN,0,0
136798,.,0,0
136799,Arthroscopic,0,1
136800,rotator,0,1
136801,cuff,0,1
136802,repair,0,0
136803,with,0,0
136804,and,0,1
136805,without,0,0
136806,acromioplasty,0,0
136807,in,0,0
136808,the,0,0
136809,treatment,0,0
136810,of,0,0
136811,full-thickness,0,1
136812,rotator,0,1
136813,cuff,0,1
136814,tears,0,0
136815,:,0,0
136816,a,0,0
136817,multicenter,0,0
136818,",",0,0
136819,randomized,0,0
136820,controlled,0,0
136821,trial,0,0
136822,.,0,0
136823,BACKGROUND,0,0
136824,The,0,0
136825,primary,0,0
136826,objective,0,0
136827,of,0,0
136828,this,0,0
136829,prospective,0,0
136830,randomized,0,0
136831,controlled,0,0
136832,trial,0,0
136833,was,0,0
136834,to,0,0
136835,compare,0,0
136836,functional,1,1
136837,and,1,1
136838,quality-of-life,1,1
136839,indices,1,1
136840,and,0,1
136841,rates,1,1
136842,of,1,1
136843,revision,1,1
136844,surgery,1,0
136845,in,0,0
136846,arthroscopic,0,0
136847,rotator,0,1
136848,cuff,0,1
136849,repair,0,0
136850,with,0,0
136851,and,0,1
136852,without,0,0
136853,acromioplasty,0,0
136854,.,0,0
136855,METHODS,0,0
136856,Eighty-six,0,0
136857,patients,0,0
136858,consented,0,0
136859,and,0,0
136860,were,0,0
136861,randomly,0,0
136862,assigned,0,0
136863,intraoperatively,0,0
136864,to,0,0
136865,one,0,0
136866,of,0,0
136867,two,0,0
136868,study,0,0
136869,groups,0,0
136870,",",0,1
136871,and,0,1
136872,sixty-eight,0,0
136873,of,0,0
136874,them,0,0
136875,completed,0,0
136876,the,0,0
136877,study,0,0
136878,.,0,0
136879,The,0,0
136880,primary,0,0
136881,outcome,0,1
136882,was,0,0
136883,the,0,0
136884,Western,1,0
136885,Ontario,1,0
136886,Rotator,1,1
136887,Cuff,1,1
136888,(,1,1
136889,WORC,1,0
136890,),1,0
136891,index,1,1
136892,.,1,0
136893,Secondary,0,0
136894,outcome,0,1
136895,measures,0,1
136896,included,0,0
136897,the,0,0
136898,American,1,0
136899,Shoulder,1,1
136900,and,1,1
136901,Elbow,1,1
136902,Surgeons,1,1
136903,(,1,1
136904,ASES,1,0
136905,),1,1
136906,shoulder,1,1
136907,assessment,1,1
136908,form,1,0
136909,and,1,0
136910,a,1,0
136911,count,1,1
136912,of,1,0
136913,revisions,1,1
136914,required,0,0
136915,in,0,0
136916,each,0,0
136917,group,0,0
136918,.,0,0
136919,Outcome,0,1
136920,measures,0,1
136921,were,0,0
136922,completed,0,0
136923,preoperatively,0,0
136924,and,0,0
136925,at,0,0
136926,three,0,0
136927,",",0,0
136928,six,0,0
136929,",",0,0
136930,twelve,0,0
136931,",",0,1
136932,eighteen,0,0
136933,",",0,1
136934,and,0,1
136935,twenty-four,0,0
136936,months,0,0
136937,after,0,0
136938,surgery,0,0
136939,.,0,0
136940,RESULTS,0,0
136941,WORC,1,0
136942,and,1,0
136943,ASES,1,0
136944,scores,1,1
136945,improved,0,0
136946,significantly,0,0
136947,in,0,0
136948,each,0,0
136949,group,0,0
136950,over,0,0
136951,time,0,1
136952,(,0,0
136953,p,0,0
136954,<,0,0
136955,0.001,0,0
136956,),0,0
136957,.,0,0
136958,There,0,0
136959,were,0,0
136960,no,0,0
136961,differences,0,0
136962,in,0,0
136963,WORC,1,0
136964,or,1,0
136965,ASES,1,1
136966,scores,1,1
136967,between,0,0
136968,the,0,0
136969,groups,0,0
136970,that,0,0
136971,had,0,0
136972,arthroscopic,0,0
136973,cuff,0,1
136974,repair,0,0
136975,with,0,0
136976,or,0,0
136977,without,0,0
136978,acromioplasty,0,0
136979,at,0,0
136980,any,0,0
136981,time,0,1
136982,point,0,0
136983,.,0,0
136984,There,0,0
136985,were,0,0
136986,no,0,0
136987,differences,0,0
136988,in,0,0
136989,scores,0,1
136990,on,0,0
136991,the,0,0
136992,basis,0,0
136993,of,0,1
136994,acromion,0,1
136995,type,0,1
136996,",",0,1
136997,nor,0,0
136998,were,0,0
136999,any,0,1
137000,interaction,0,1
137001,effects,0,1
137002,identified,0,0
137003,between,0,0
137004,group,0,0
137005,and,0,1
137006,acromion,0,1
137007,type,0,0
137008,.,0,0
137009,Four,0,1
137010,participants,0,0
137011,(,0,0
137012,9,0,0
137013,%,0,0
137014,),0,0
137015,in,0,0
137016,the,0,0
137017,group,0,0
137018,that,0,0
137019,had,0,0
137020,arthroscopic,0,0
137021,cuff,0,1
137022,repair,1,0
137023,alone,0,0
137024,",",0,0
137025,one,0,0
137026,with,0,0
137027,a,0,0
137028,Type-2,0,0
137029,and,0,0
137030,three,0,0
137031,with,0,0
137032,a,0,0
137033,Type-3,0,0
137034,acromion,0,1
137035,",",0,0
137036,required,0,1
137037,additional,1,0
137038,surgery,1,0
137039,by,0,0
137040,the,0,0
137041,twenty-four-month,0,0
137042,time,0,1
137043,point,0,0
137044,.,0,0
137045,The,0,0
137046,number,1,1
137047,of,1,0
137048,patients,1,0
137049,who,1,0
137050,required,1,1
137051,additional,1,0
137052,surgery,1,0
137053,was,0,0
137054,greater,0,1
137055,(,0,1
137056,p,0,0
137057,=,0,0
137058,0.05,0,0
137059,),0,0
137060,in,0,0
137061,the,0,0
137062,group,0,0
137063,that,0,0
137064,had,0,0
137065,arthroscopic,0,0
137066,cuff,0,1
137067,repair,0,0
137068,alone,0,0
137069,than,0,0
137070,in,0,0
137071,the,0,0
137072,group,0,0
137073,that,0,0
137074,had,0,0
137075,arthroscopic,0,0
137076,cuff,0,1
137077,repair,0,0
137078,and,0,1
137079,acromioplasty,0,0
137080,.,0,1
137081,CONCLUSIONS,0,0
137082,Our,0,0
137083,findings,0,0
137084,are,0,0
137085,consistent,0,0
137086,with,0,0
137087,previous,0,0
137088,research,0,0
137089,reports,0,0
137090,in,0,0
137091,which,0,0
137092,there,0,0
137093,was,0,0
137094,no,0,0
137095,difference,0,0
137096,in,0,0
137097,functional,1,1
137098,and,1,1
137099,quality-of-life,1,1
137100,indices,1,1
137101,for,0,0
137102,patients,0,0
137103,who,0,0
137104,had,0,0
137105,rotator,0,1
137106,cuff,0,1
137107,repair,0,0
137108,with,0,0
137109,or,0,0
137110,without,0,0
137111,acromioplasty,0,0
137112,.,0,0
137113,The,0,0
137114,higher,1,0
137115,reoperation,1,1
137116,rate,1,1
137117,was,0,0
137118,found,0,0
137119,in,0,0
137120,the,0,0
137121,group,0,0
137122,without,0,0
137123,acromioplasty,0,0
137124,.,0,1
137125,Further,0,0
137126,study,0,0
137127,that,0,0
137128,includes,0,0
137129,follow-up,0,0
137130,imaging,0,0
137131,and,0,1
137132,patient-reported,0,1
137133,outcomes,0,1
137134,over,0,0
137135,a,0,0
137136,greater,0,0
137137,follow-up,0,0
137138,period,0,0
137139,is,0,0
137140,needed,0,0
137141,.,0,0
137142,Evaluation,0,1
137143,of,0,1
137144,oral,0,0
137145,beclomethasone,0,0
137146,dipropionate,0,0
137147,for,0,0
137148,prevention,0,0
137149,of,0,0
137150,acute,0,0
137151,graft-versus-host,0,1
137152,disease,0,1
137153,.,0,0
137154,Results,0,0
137155,from,0,0
137156,two,0,0
137157,randomized,0,0
137158,trials,0,0
137159,have,0,0
137160,shown,0,0
137161,that,0,0
137162,oral,0,0
137163,beclomethasone,0,0
137164,dipropionate,0,0
137165,(,0,1
137166,BDP,0,1
137167,),0,0
137168,is,0,0
137169,effective,0,1
137170,for,0,0
137171,treatment,0,0
137172,of,0,0
137173,acute,0,0
137174,gastrointestinal,0,1
137175,graft-versus-host,0,1
137176,disease,0,1
137177,.,0,0
137178,Here,0,0
137179,",",0,0
137180,we,0,0
137181,report,0,0
137182,results,0,0
137183,of,0,0
137184,a,0,0
137185,double-blind,0,0
137186,",",0,0
137187,randomized,0,0
137188,placebo-controlled,0,0
137189,phase,0,0
137190,II,0,0
137191,study,0,0
137192,designed,0,0
137193,to,0,0
137194,test,0,0
137195,the,0,0
137196,hypothesis,0,0
137197,that,0,0
137198,acute,0,0
137199,graft-versus-host,0,1
137200,disease,0,0
137201,could,0,0
137202,be,0,0
137203,prevented,0,0
137204,by,0,0
137205,administration,0,0
137206,of,0,0
137207,oral,0,0
137208,BDP,0,1
137209,",",0,0
137210,beginning,0,0
137211,before,0,0
137212,hematopoietic,0,1
137213,cell,0,1
137214,transplantation,0,0
137215,and,0,1
137216,continuing,0,0
137217,until,0,0
137218,day,0,0
137219,75,0,0
137220,after,0,0
137221,hematopoietic,0,0
137222,cell,0,1
137223,transplantation,0,0
137224,after,0,0
137225,myeloablative,0,0
137226,conditioning,0,0
137227,.,0,1
137228,Study,0,0
137229,drug,0,0
137230,(,0,1
137231,BDP,0,1
137232,or,0,1
137233,placebo,0,0
137234,),0,1
137235,was,0,0
137236,administered,0,0
137237,as,0,0
137238,1-mg,0,0
137239,immediate-release,0,0
137240,formulation,0,0
137241,plus,0,0
137242,1-mg,0,0
137243,delayed-release,0,0
137244,formulation,0,0
137245,orally,0,0
137246,four,0,0
137247,times,0,0
137248,daily,0,0
137249,.,0,0
137250,According,0,0
137251,to,0,0
137252,the,0,0
137253,primary,0,0
137254,endpoint,0,1
137255,",",0,1
137256,systemic,1,1
137257,glucocorticoid,1,1
137258,treatment,1,0
137259,for,1,0
137260,graft-versus-host,1,1
137261,disease,1,1
137262,was,0,0
137263,given,0,0
137264,to,0,0
137265,60,0,0
137266,of,0,0
137267,the,0,0
137268,92,0,0
137269,participants,0,0
137270,(,0,0
137271,65,0,0
137272,%,0,0
137273,),0,0
137274,in,0,0
137275,the,0,0
137276,BDP,0,1
137277,arm,0,0
137278,",",0,0
137279,versus,0,0
137280,31,0,0
137281,of,0,0
137282,46,0,0
137283,participants,0,0
137284,(,0,0
137285,67,0,0
137286,%,0,0
137287,),0,0
137288,in,0,0
137289,the,0,0
137290,placebo,0,0
137291,arm,0,0
137292,.,0,0
137293,The,0,0
137294,secondary,1,0
137295,efficacy,1,1
137296,endpoints,1,1
137297,showed,0,0
137298,no,1,0
137299,statistically,1,0
137300,significant,1,0
137301,differences,1,0
137302,between,0,0
137303,the,0,0
137304,two,0,0
137305,arms,0,0
137306,.,0,0
137307,The,0,0
137308,proportion,1,0
137309,of,1,0
137310,participants,1,0
137311,who,1,0
137312,took,1,0
137313,at,1,0
137314,least,1,0
137315,90,1,0
137316,%,1,0
137317,of,1,0
137318,the,1,0
137319,prescribed,1,0
137320,study,1,0
137321,drug,1,0
137322,during,0,0
137323,the,0,0
137324,first,0,0
137325,4,0,0
137326,weeks,0,0
137327,after,0,0
137328,hematopoietic,1,1
137329,cell,1,1
137330,transplantation,1,0
137331,was,0,0
137332,54,0,0
137333,%,0,0
137334,overall,0,1
137335,.,0,0
137336,Lower,0,0
137337,severity,1,1
137338,of,1,1
137339,mucositis,1,1
137340,strongly,0,0
137341,correlated,0,0
137342,with,0,0
137343,higher,0,0
137344,adherence,1,1
137345,to,0,0
137346,the,0,0
137347,schedule,0,0
137348,of,0,0
137349,study,0,0
137350,drug,0,0
137351,administration,0,0
137352,.,0,1
137353,Inconsistent,0,0
137354,adherence,1,1
137355,related,0,0
137356,to,0,0
137357,mucositis,0,1
137358,during,0,0
137359,recovery,0,1
137360,after,0,0
137361,myeloablative,0,0
137362,conditioning,0,0
137363,may,0,0
137364,have,0,0
137365,obscured,0,0
137366,a,0,0
137367,beneficial,0,0
137368,therapeutic,0,0
137369,effect,0,0
137370,in,0,0
137371,the,0,0
137372,current,0,0
137373,study,0,0
137374,.,0,0
137375,Instant,0,0
137376,Recess?,0,0
137377,:,0,0
137378,a,0,0
137379,practical,0,0
137380,tool,0,0
137381,for,0,0
137382,increasing,1,0
137383,physical,1,1
137384,activity,1,1
137385,during,0,0
137386,the,0,0
137387,school,0,0
137388,day,0,0
137389,.,0,0
137390,BACKGROUND,0,0
137391,An,0,0
137392,increased,0,0
137393,prevalence,0,1
137394,of,0,1
137395,overweight/obesity,0,0
137396,among,0,0
137397,children,0,0
137398,has,0,0
137399,led,0,0
137400,to,0,0
137401,school,0,0
137402,district,0,0
137403,level,0,1
137404,policies,0,0
137405,to,0,0
137406,increase,1,1
137407,physical,1,1
137408,activity,1,1
137409,(,1,1
137410,PA,1,1
137411,),1,0
137412,among,0,0
137413,elementary,0,0
137414,school,0,0
137415,students,0,0
137416,.,0,0
137417,Interventions,0,0
137418,are,0,0
137419,needed,0,0
137420,that,0,0
137421,increase,0,0
137422,activity,0,1
137423,levels,0,1
137424,without,0,0
137425,sacrificing,0,1
137426,time,0,1
137427,spent,0,0
137428,in,0,0
137429,academics,0,0
137430,.,0,0
137431,OBJECTIVES,0,0
137432,We,0,0
137433,evaluated,0,0
137434,a,0,0
137435,policy,0,0
137436,implementation,0,0
137437,intervention,0,0
137438,for,0,0
137439,to,0,0
137440,increase,0,0
137441,in-school,0,0
137442,PA,0,1
137443,in,0,0
137444,elementary,0,0
137445,schools,0,0
137446,in,0,0
137447,Forsyth,0,1
137448,County,0,0
137449,",",0,1
137450,North,0,1
137451,Carolina,0,1
137452,",",0,0
137453,in,0,0
137454,a,0,0
137455,randomized,0,0
137456,study,0,0
137457,with,0,0
137458,a,0,0
137459,delayed,0,1
137460,intervention,0,0
137461,control,0,0
137462,group,0,0
137463,.,0,0
137464,METHODS,0,0
137465,The,0,0
137466,study,0,0
137467,included,0,0
137468,third-,0,0
137469,through,0,0
137470,fifth-grade,0,0
137471,classrooms,0,0
137472,in,0,0
137473,eight,0,0
137474,elementary,0,0
137475,schools,0,0
137476,.,0,0
137477,Instant,0,0
137478,Recess?,0,1
137479,was,0,0
137480,used,0,0
137481,to,0,0
137482,introduce,0,0
137483,10-minute,0,1
137484,PA,0,1
137485,breaks,0,1
137486,in,0,0
137487,classrooms,0,0
137488,on,0,0
137489,schedules,0,0
137490,determined,0,0
137491,by,0,0
137492,teachers,0,0
137493,.,0,0
137494,Direct,0,1
137495,observation,0,0
137496,was,0,0
137497,used,0,0
137498,to,0,0
137499,measure,1,0
137500,activity,1,1
137501,levels,1,1
137502,",",1,1
137503,other,1,0
137504,student,1,1
137505,behaviors,1,1
137506,",",1,1
137507,and,1,1
137508,teacher,1,1
137509,behaviors,1,1
137510,related,1,0
137511,to,0,0
137512,PA,0,1
137513,in,0,0
137514,the,0,0
137515,classrooms,0,0
137516,.,0,0
137517,RESULTS,0,0
137518,Twenty-eight,0,0
137519,visits,0,1
137520,to,0,0
137521,schools,0,0
137522,were,0,0
137523,made,0,0
137524,during,0,0
137525,the,0,0
137526,spring,0,1
137527,and,0,1
137528,fall,0,1
137529,semesters,0,0
137530,of,0,0
137531,2009,0,0
137532,.,0,0
137533,At,0,0
137534,baseline,0,0
137535,11,0,0
137536,%,0,0
137537,to,0,0
137538,44,0,0
137539,%,0,0
137540,of,0,0
137541,intervention,0,0
137542,and,0,1
137543,control,0,0
137544,schools,0,0
137545,were,0,0
137546,engaged,0,0
137547,in,0,0
137548,classroom-based,0,0
137549,PA.,1,1
137550,PA,1,1
137551,increased,1,1
137552,from,0,0
137553,baseline,0,0
137554,to,0,0
137555,spring,0,0
137556,follow-up,0,0
137557,in,0,0
137558,intervention,0,0
137559,schools,0,0
137560,and,0,1
137561,was,0,0
137562,maintained,0,0
137563,the,0,0
137564,following,0,0
137565,fall,0,0
137566,.,0,0
137567,Control,0,1
137568,schools,0,0
137569,decreased,1,1
137570,PA,1,1
137571,from,1,0
137572,baseline,0,0
137573,to,0,0
137574,spring,0,1
137575,and,0,1
137576,increased,1,1
137577,PA,1,1
137578,once,1,0
137579,they,0,0
137580,began,0,0
137581,the,0,0
137582,intervention,0,0
137583,.,0,0
137584,Students,0,0
137585,in,0,0
137586,classrooms,0,0
137587,engaged,0,0
137588,in,0,0
137589,Instant,0,0
137590,Recess,0,0
137591,exhibited,1,0
137592,statistically,1,0
137593,significant,1,0
137594,increases,1,1
137595,in,1,0
137596,light,1,1
137597,(,1,0
137598,51,1,0
137599,%,1,0
137600,),1,0
137601,and,1,1
137602,moderate-intensity,1,0
137603,(,1,0
137604,16,1,0
137605,%,1,0
137606,),1,0
137607,PA,1,1
137608,and,1,1
137609,increases,1,1
137610,in,1,0
137611,time,1,1
137612,spent,1,0
137613,in,1,0
137614,on-task,1,1
137615,behavior,1,1
137616,(,1,0
137617,11,0,0
137618,%,0,0
137619,),0,0
137620,.,0,0
137621,Control,0,0
137622,schools,0,0
137623,experienced,0,1
137624,similar,0,0
137625,benefits,0,0
137626,after,0,0
137627,they,0,0
137628,began,0,0
137629,implementing,0,0
137630,Instant,0,0
137631,Recess,0,0
137632,.,0,0
137633,CONCLUSIONS,0,0
137634,Instant,0,0
137635,Recess,0,0
137636,is,0,0
137637,useful,0,0
137638,for,1,0
137639,increasing,1,0
137640,PA,1,1
137641,and,1,1
137642,improving,1,1
137643,behavior,1,1
137644,among,1,0
137645,elementary,0,0
137646,school,0,0
137647,children,0,0
137648,.,0,1
137649,Additional,0,0
137650,research,0,0
137651,may,0,0
137652,be,0,0
137653,needed,0,0
137654,to,0,0
137655,understand,0,0
137656,how,0,0
137657,to,0,0
137658,create,0,0
137659,policies,0,0
137660,supporting,0,0
137661,classroom,0,0
137662,activity,0,1
137663,breaks,0,1
137664,and,0,0
137665,how,0,0
137666,to,0,0
137667,assess,0,0
137668,policy,0,0
137669,adherence,0,1
137670,.,0,0
137671,Maintaining,0,1
137672,tissue,0,1
137673,orientation,0,1
137674,during,0,0
137675,mohs,0,0
137676,micrographic,0,0
137677,surgery,0,0
137678,:,0,0
137679,scalpel,0,0
137680,versus,0,0
137681,marker,0,1
137682,.,0,1
137683,BACKGROUND,0,0
137684,Critical,0,0
137685,to,0,0
137686,the,0,0
137687,accuracy,0,1
137688,of,0,0
137689,Mohs,0,1
137690,surgery,0,0
137691,is,0,0
137692,the,0,0
137693,ability,0,1
137694,to,0,0
137695,maintain,0,1
137696,proper,0,0
137697,orientation,0,1
137698,of,0,1
137699,excised,0,0
137700,tissue,0,1
137701,with,0,0
137702,respect,0,0
137703,to,0,0
137704,the,0,0
137705,surrounding,0,0
137706,skin,0,1
137707,.,0,0
137708,Several,0,0
137709,techniques,0,0
137710,have,0,0
137711,been,0,0
137712,described,0,0
137713,for,0,0
137714,maintaining,0,0
137715,this,0,0
137716,orientation,0,1
137717,",",0,0
137718,although,0,0
137719,no,0,0
137720,prior,0,0
137721,investigations,0,0
137722,directly,0,0
137723,compare,0,0
137724,these,0,0
137725,techniques,0,0
137726,.,0,0
137727,OBJECTIVE,0,0
137728,To,0,0
137729,compare,0,0
137730,the,0,0
137731,incidence,0,1
137732,of,0,1
137733,tissue,0,1
137734,orientation,0,1
137735,loss,0,1
137736,resulting,0,0
137737,from,0,0
137738,inability,0,1
137739,to,0,0
137740,identify,0,0
137741,skin,0,1
137742,score,0,1
137743,marks,0,1
137744,with,0,0
137745,that,0,0
137746,occurring,0,0
137747,from,0,0
137748,failure,0,0
137749,to,0,0
137750,identify,0,0
137751,marks,0,1
137752,made,0,0
137753,using,0,0
137754,a,0,0
137755,gentian,0,0
137756,violet,0,0
137757,marker,0,1
137758,during,0,0
137759,Mohs,0,1
137760,micrographic,0,0
137761,surgery,0,0
137762,(,0,1
137763,MMS,0,1
137764,),0,0
137765,.,0,0
137766,We,0,0
137767,also,0,0
137768,sought,0,0
137769,to,0,0
137770,determine,0,0
137771,the,0,0
137772,incidence,0,1
137773,of,0,0
137774,scars,0,1
137775,resulting,0,0
137776,from,0,0
137777,skin,0,1
137778,scoring,0,1
137779,.,0,1
137780,MATERIALS,0,0
137781,AND,0,0
137782,METHODS,0,0
137783,Patients,0,0
137784,undergoing,0,0
137785,MMS,0,1
137786,were,0,0
137787,prospectively,0,0
137788,randomized,0,0
137789,to,0,0
137790,have,0,0
137791,their,0,0
137792,tissue,0,1
137793,margins,0,1
137794,oriented,0,0
137795,using,0,0
137796,light,0,0
137797,scoring,0,0
137798,using,0,0
137799,a,0,0
137800,scalpel,0,0
137801,versus,0,0
137802,marking,0,0
137803,them,0,0
137804,using,0,0
137805,a,0,0
137806,gentian,0,0
137807,violet,0,0
137808,marker,0,1
137809,.,0,1
137810,Incidence,0,1
137811,of,0,0
137812,scoring,0,1
137813,scars,0,1
137814,and,0,1
137815,tissue,0,1
137816,orientation,0,1
137817,loss,0,1
137818,were,0,0
137819,the,0,0
137820,primary,0,0
137821,outcome,0,1
137822,measures,0,1
137823,.,0,0
137824,RESULTS,0,0
137825,Data,0,1
137826,were,0,0
137827,analyzed,0,0
137828,for,0,0
137829,101,0,0
137830,tumors,0,0
137831,.,0,0
137832,There,0,0
137833,were,0,0
137834,no,0,0
137835,instances,0,0
137836,of,0,0
137837,tissue,1,1
137838,orientation,1,1
137839,loss,1,1
137840,in,0,0
137841,the,0,0
137842,scalpel,0,0
137843,or,0,0
137844,marker,0,1
137845,arms,0,1
137846,",",0,1
137847,nor,0,0
137848,were,0,0
137849,there,0,0
137850,any,0,0
137851,visible,1,1
137852,score,1,1
137853,mark,1,0
137854,scars,1,1
137855,at,0,0
137856,follow-up,0,0
137857,.,0,0
137858,CONCLUSION,0,0
137859,Incidence,0,1
137860,of,0,0
137861,excessive,1,0
137862,scars,1,1
137863,resulting,0,0
137864,from,0,0
137865,lightly,0,0
137866,scored,0,0
137867,tissue,0,1
137868,or,0,0
137869,loss,0,1
137870,of,0,1
137871,tissue,0,1
137872,orientation,0,1
137873,caused,0,0
137874,by,0,0
137875,lost,0,0
137876,gentian,0,0
137877,violet,0,0
137878,markings,0,0
137879,appears,0,0
137880,to,0,0
137881,be,0,0
137882,low,0,0
137883,.,0,0
137884,Both,0,0
137885,methods,0,0
137886,worked,0,0
137887,well,0,0
137888,within,0,0
137889,the,0,0
137890,confines,0,0
137891,of,0,0
137892,this,0,0
137893,study,0,0
137894,.,0,0
137895,Response,0,1
137896,prediction,0,1
137897,in,0,0
137898,metastasised,0,1
137899,colorectal,0,0
137900,cancer,0,0
137901,using,0,0
137902,intratumoural,0,1
137903,thymidylate,0,1
137904,synthase,0,1
137905,:,0,0
137906,results,0,0
137907,of,0,0
137908,a,0,0
137909,randomised,0,0
137910,multicentre,0,0
137911,trial,0,0
137912,.,0,1
137913,BACKGROUND,0,0
137914,Molecular,0,0
137915,markers,0,0
137916,to,0,0
137917,predict,0,0
137918,response,0,1
137919,to,0,0
137920,5-fluorouracil,0,0
137921,(,0,0
137922,FU,0,1
137923,),0,1
137924,-based,0,0
137925,treatment,0,0
137926,of,0,1
137927,recurrent,0,1
137928,or,0,0
137929,metastasised,0,0
137930,colorectal,0,0
137931,cancer,0,0
137932,(,0,1
137933,mCRC,0,0
137934,),0,0
137935,are,0,0
137936,not,0,0
137937,established,0,0
137938,.,0,0
137939,The,0,0
137940,aim,0,0
137941,of,0,0
137942,this,0,0
137943,trial,0,0
137944,was,0,0
137945,to,0,0
137946,determine,0,0
137947,the,0,0
137948,value,0,1
137949,of,0,0
137950,thymidylate,0,1
137951,synthase,0,1
137952,(,0,1
137953,TS,0,1
137954,),0,0
137955,",",0,0
137956,a,0,0
137957,key,0,1
137958,enzyme,0,0
137959,of,0,1
137960,DNA,0,1
137961,synthesis,0,1
137962,and,0,1
137963,target,0,1
137964,of,0,1
137965,5-FU,0,0
137966,",",0,0
137967,to,0,0
137968,predict,1,0
137969,response,1,1
137970,to,0,0
137971,chemotherapy,0,0
137972,of,0,0
137973,mCRC,0,0
137974,.,0,0
137975,METHODS,0,0
137976,Tumour,0,1
137977,tissue,0,1
137978,was,0,0
137979,obtained,0,0
137980,from,0,0
137981,168,0,0
137982,patients,0,0
137983,with,0,0
137984,mCRC,0,0
137985,for,0,0
137986,relative,0,1
137987,thymidylate,1,1
137988,synthase,1,1
137989,(,1,1
137990,TS,1,0
137991,),1,1
137992,mRNA,0,0
137993,quantitation,0,1
137994,.,0,1
137995,Patients,0,0
137996,were,0,0
137997,randomised,0,0
137998,to,0,0
137999,receive,0,0
138000,either,0,0
138001,5-FU/folinic,0,0
138002,acid,0,1
138003,(,0,1
138004,FA,0,1
138005,",",0,1
138006,FUFA,0,1
138007,),0,1
138008,alone,0,0
138009,or,0,0
138010,in,0,0
138011,combination,0,0
138012,with,0,0
138013,irinotecan,0,0
138014,5-fluorouracil/folinic,0,0
138015,acid,0,1
138016,and,0,1
138017,irinotecan,0,0
138018,(,0,1
138019,FOLFIRI,0,1
138020,),0,0
138021,stratified,0,0
138022,by,0,0
138023,TS,0,0
138024,(,0,0
138025,low,0,0
138026,versus,0,0
138027,high,0,0
138028,),0,0
138029,.,0,0
138030,Primary,0,1
138031,end-point,0,1
138032,was,0,0
138033,overall,1,1
138034,response,1,1
138035,to,1,0
138036,first-line,1,0
138037,treatment,1,0
138038,among,0,0
138039,TS,0,0
138040,high,0,0
138041,patients,0,0
138042,.,0,0
138043,All,0,0
138044,parties,0,0
138045,",",0,0
138046,except,0,0
138047,for,0,0
138048,the,0,0
138049,randomisation,0,0
138050,centre,0,0
138051,",",0,1
138052,were,0,0
138053,blinded,0,0
138054,for,0,0
138055,TS,0,0
138056,status,0,1
138057,.,0,1
138058,RESULTS,0,0
138059,Biopsies,0,1
138060,(,0,0
138061,n=168,0,0
138062,),0,0
138063,were,0,0
138064,taken,0,0
138065,without,0,0
138066,complications,0,1
138067,.,0,0
138068,TS,1,0
138069,levels,1,1
138070,were,0,0
138071,available,0,0
138072,for,0,0
138073,147,0,0
138074,patients,0,0
138075,(,0,0
138076,87.5,0,0
138077,%,0,0
138078,),0,0
138079,.,0,0
138080,Analysing,0,0
138081,response,1,1
138082,to,1,0
138083,FUFA,1,1
138084,and,1,1
138085,FOLFIRI,1,0
138086,in,0,0
138087,the,0,0
138088,per,0,0
138089,protocol,0,0
138090,set,0,0
138091,(,0,0
138092,n=119,0,0
138093,),0,0
138094,after,0,0
138095,un-blinding,0,0
138096,TS,0,0
138097,in,0,0
138098,the,0,0
138099,data,0,0
138100,base,0,0
138101,revealed,0,0
138102,a,0,0
138103,trend,0,0
138104,to,0,0
138105,better,0,0
138106,overall,0,1
138107,response,0,1
138108,to,0,0
138109,FOLFIRI,0,0
138110,(,0,0
138111,9/19,0,0
138112,",",0,0
138113,47,0,0
138114,%,0,0
138115,),0,0
138116,in,0,0
138117,TS,0,0
138118,high,0,0
138119,compared,0,0
138120,to,0,0
138121,FUFA,0,1
138122,(,0,0
138123,5/23,0,0
138124,",",0,0
138125,22,0,0
138126,%,0,0
138127,",",0,0
138128,p=0.077,0,0
138129,),0,1
138130,.,0,0
138131,In,0,0
138132,patients,0,0
138133,with,0,0
138134,biopsies,0,1
138135,taken,0,0
138136,from,0,0
138137,liver,0,1
138138,lesions,0,1
138139,(,0,1
138140,n=91,0,0
138141,),0,1
138142,overall,0,1
138143,response,0,1
138144,to,0,0
138145,FOLFIRI,0,1
138146,and,0,1
138147,FUFA,0,1
138148,in,0,0
138149,TS,0,0
138150,high,0,0
138151,was,0,0
138152,53,0,0
138153,%,0,0
138154,(,0,0
138155,9/17,0,0
138156,),0,0
138157,and,0,0
138158,18,0,0
138159,%,0,0
138160,(,0,0
138161,3/17,0,1
138162,),0,0
138163,",",0,0
138164,respectively,0,0
138165,(,0,0
138166,p=0.035,0,0
138167,),0,0
138168,.,0,0
138169,In,0,0
138170,patients,0,0
138171,with,0,0
138172,low,0,0
138173,TS,0,0
138174,",",0,0
138175,no,0,0
138176,remarkable,0,0
138177,difference,0,0
138178,in,0,0
138179,overall,0,1
138180,response,0,1
138181,to,0,0
138182,FOLFIRI,0,1
138183,and,0,1
138184,FUFA,0,1
138185,was,0,0
138186,observed,0,0
138187,.,0,0
138188,CONCLUSIONS,0,0
138189,Taking,0,1
138190,a,0,0
138191,pre-treatment,0,0
138192,biopsy,0,0
138193,is,0,0
138194,a,0,0
138195,safe,0,1
138196,and,0,1
138197,feasible,0,1
138198,procedure,0,0
138199,in,0,0
138200,mCRC,0,0
138201,.,0,0
138202,After,0,0
138203,validation,0,0
138204,of,0,0
138205,our,0,0
138206,data,0,0
138207,in,0,0
138208,a,0,0
138209,larger,0,0
138210,group,0,0
138211,TS,0,0
138212,determination,0,0
138213,may,0,0
138214,have,0,0
138215,the,0,0
138216,potential,0,0
138217,to,0,0
138218,better,0,0
138219,help,0,0
138220,direct,0,1
138221,systemic,0,1
138222,treatment,0,0
138223,in,0,0
138224,patients,0,0
138225,with,0,0
138226,primarily,0,0
138227,non-resectable,0,0
138228,mCRC,0,0
138229,.,0,0
138230,Object,1,1
138231,interest,1,0
138232,in,0,0
138233,autism,0,0
138234,spectrum,0,0
138235,disorder,0,0
138236,:,0,0
138237,a,0,0
138238,treatment,0,0
138239,comparison,0,0
138240,.,0,0
138241,A,0,0
138242,randomized,0,0
138243,control,0,0
138244,trial,0,0
138245,comparing,0,0
138246,two,0,0
138247,social,0,0
138248,communication,0,0
138249,treatments,0,0
138250,for,0,0
138251,children,0,0
138252,with,0,0
138253,autism,0,0
138254,spectrum,0,0
138255,disorder,0,0
138256,examined,0,0
138257,the,0,0
138258,effect,0,1
138259,of,0,0
138260,treatment,0,0
138261,on,0,0
138262,object,0,1
138263,interest,0,0
138264,.,0,0
138265,Thirty-two,0,0
138266,children,0,0
138267,",",0,0
138268,18-60,0,0
138269,months,0,1
138270,",",0,1
138271,were,0,0
138272,randomly,0,0
138273,assigned,0,0
138274,to,0,0
138275,the,0,0
138276,Picture,0,1
138277,Exchange,0,0
138278,Communication,0,1
138279,System,0,1
138280,(,0,1
138281,PECS,0,1
138282,),0,1
138283,or,0,0
138284,Responsive,0,1
138285,Education,0,1
138286,and,0,1
138287,Prelinguistic,0,1
138288,Milieu,0,1
138289,Teaching,0,1
138290,(,0,1
138291,RPMT,0,1
138292,),0,0
138293,condition,0,0
138294,.,0,0
138295,Assessment,0,1
138296,of,0,1
138297,object,1,1
138298,interest,1,0
138299,was,0,0
138300,conducted,0,0
138301,in,0,0
138302,an,0,0
138303,unstructured,0,0
138304,play,0,0
138305,session,0,0
138306,with,0,0
138307,different,0,0
138308,toys,0,0
138309,",",0,1
138310,activities,0,1
138311,",",0,1
138312,adult,0,0
138313,",",0,1
138314,and,0,1
138315,location,0,1
138316,than,0,0
138317,experienced,0,0
138318,in,0,0
138319,treatment,0,0
138320,.,0,1
138321,Results,0,0
138322,indicated,0,0
138323,children,0,0
138324,in,0,0
138325,the,0,0
138326,RPMT,0,1
138327,condition,0,0
138328,showed,0,0
138329,greater,0,0
138330,increases,0,1
138331,in,0,0
138332,object,1,1
138333,interest,1,0
138334,as,0,0
138335,compared,0,0
138336,to,0,0
138337,children,0,0
138338,in,0,0
138339,the,0,0
138340,PECS,0,0
138341,condition,0,0
138342,.,0,0
138343,Because,0,0
138344,child,0,0
138345,characteristics,0,1
138346,such,0,0
138347,as,0,0
138348,interest,0,0
138349,in,0,0
138350,objects,0,0
138351,may,0,0
138352,influence,0,0
138353,response,0,1
138354,to,0,0
138355,interventions,0,0
138356,using,0,0
138357,object,0,1
138358,play,0,0
138359,as,0,0
138360,contexts,0,0
138361,for,0,0
138362,treatment,0,0
138363,",",0,0
138364,it,0,0
138365,is,0,0
138366,important,0,0
138367,to,0,0
138368,improve,0,0
138369,our,0,0
138370,understanding,0,1
138371,of,0,0
138372,whether,0,0
138373,intervention,0,0
138374,can,0,0
138375,affect,0,1
138376,object,0,1
138377,interest,0,0
138378,.,0,0
138379,Brief,0,1
138380,report,0,0
138381,:,0,0
138382,effect,0,0
138383,of,0,0
138384,a,0,0
138385,focused,0,0
138386,imitation,0,1
138387,intervention,0,0
138388,on,0,0
138389,social,1,1
138390,functioning,1,1
138391,in,0,0
138392,children,0,0
138393,with,0,0
138394,autism,0,0
138395,.,0,0
138396,Imitation,0,0
138397,is,0,0
138398,an,0,0
138399,early,0,0
138400,skill,0,1
138401,thought,0,0
138402,to,0,0
138403,play,0,0
138404,a,0,0
138405,role,0,0
138406,in,0,0
138407,social,0,1
138408,development,0,1
138409,",",0,0
138410,leading,0,0
138411,some,0,0
138412,to,0,0
138413,suggest,0,0
138414,that,0,0
138415,teaching,0,0
138416,imitation,0,1
138417,to,0,0
138418,children,0,0
138419,with,0,0
138420,autism,0,0
138421,should,0,0
138422,lead,0,0
138423,to,0,0
138424,improvements,0,0
138425,in,0,0
138426,social,1,1
138427,functioning,1,1
138428,.,1,0
138429,This,0,0
138430,study,0,0
138431,used,0,0
138432,a,0,0
138433,randomized,0,0
138434,controlled,0,0
138435,trial,0,0
138436,to,0,0
138437,evaluate,0,0
138438,the,0,0
138439,effect,0,0
138440,of,0,0
138441,a,0,0
138442,focused,0,0
138443,imitation,0,1
138444,intervention,0,0
138445,on,0,0
138446,initiation,0,0
138447,of,0,1
138448,joint,1,1
138449,attention,1,1
138450,and,1,1
138451,social-emotional,1,1
138452,functioning,1,1
138453,in,0,0
138454,27,0,0
138455,young,0,0
138456,children,0,0
138457,with,0,0
138458,autism,0,0
138459,.,0,1
138460,Results,0,0
138461,indicated,0,0
138462,the,0,0
138463,treatment,0,0
138464,group,0,0
138465,made,0,0
138466,significantly,0,0
138467,more,0,0
138468,gains,0,1
138469,in,0,0
138470,joint,1,1
138471,attention,1,1
138472,initiations,1,0
138473,at,0,0
138474,post-treatment,0,1
138475,and,0,1
138476,follow-up,0,0
138477,and,0,1
138478,social-emotional,1,1
138479,functioning,1,1
138480,at,0,0
138481,follow-up,0,0
138482,than,0,0
138483,the,0,0
138484,control,0,0
138485,group,0,0
138486,.,0,0
138487,Although,0,0
138488,gains,1,1
138489,in,1,0
138490,social,1,1
138491,functioning,1,1
138492,were,0,0
138493,associated,0,0
138494,with,0,0
138495,treatment,0,0
138496,",",0,0
138497,a,0,0
138498,mediation,0,1
138499,analysis,0,0
138500,did,0,0
138501,not,0,0
138502,support,0,0
138503,imitation,0,0
138504,as,0,0
138505,the,0,0
138506,mechanism,0,0
138507,of,0,0
138508,action,0,0
138509,.,0,0
138510,These,0,0
138511,findings,0,0
138512,suggest,0,0
138513,the,0,0
138514,intervention,0,0
138515,improves,0,1
138516,social,1,1
138517,functioning,1,1
138518,in,1,0
138519,children,0,0
138520,with,0,0
138521,ASD,0,0
138522,.,0,0
138523,Safety,1,1
138524,",",1,1
138525,tolerability,1,1
138526,",",1,1
138527,and,1,1
138528,immunogenicity,1,1
138529,after,0,0
138530,1,0,0
138531,and,0,0
138532,2,0,0
138533,doses,0,0
138534,of,0,0
138535,zoster,0,1
138536,vaccine,0,0
138537,in,0,0
138538,healthy,0,0
138539,adults,0,0
138540,?60,0,0
138541,years,0,0
138542,of,0,0
138543,age,0,0
138544,.,0,0
138545,BACKGROUND,0,0
138546,Incidence,0,1
138547,and,0,1
138548,severity,0,1
138549,of,0,1
138550,herpes,0,1
138551,zoster,0,1
138552,(,0,0
138553,HZ,0,1
138554,),0,1
138555,and,0,1
138556,postherpetic,0,1
138557,neuralgia,0,1
138558,increase,0,1
138559,with,0,0
138560,age,0,0
138561,",",0,0
138562,associated,0,0
138563,with,0,0
138564,age-related,0,0
138565,decrease,0,1
138566,in,0,0
138567,immunity,0,1
138568,to,0,0
138569,varicella-zoster,0,0
138570,virus,0,1
138571,(,0,1
138572,VZV,0,1
138573,),0,0
138574,.,0,0
138575,One,0,0
138576,dose,0,0
138577,of,0,0
138578,zoster,0,1
138579,vaccine,0,0
138580,(,0,1
138581,ZV,0,0
138582,),0,0
138583,has,0,0
138584,demonstrated,0,0
138585,substantial,0,0
138586,protection,0,1
138587,against,0,0
138588,HZ,0,0
138589,;,0,0
138590,this,0,0
138591,study,0,0
138592,examined,0,0
138593,impact,0,0
138594,of,0,0
138595,a,0,0
138596,second,0,0
138597,dose,0,0
138598,of,0,0
138599,ZV,0,0
138600,.,0,0
138601,METHODS,0,0
138602,Randomized,0,0
138603,",",0,1
138604,double-blind,0,0
138605,",",0,1
138606,multicenter,0,0
138607,study,0,0
138608,with,0,0
138609,210,0,0
138610,subjects,0,0
138611,?60,0,0
138612,years,0,0
138613,old,0,0
138614,compared,1,0
138615,immunity,1,1
138616,and,1,1
138617,safety,1,1
138618,profiles,1,1
138619,after,1,0
138620,one,0,0
138621,and,0,0
138622,two,0,0
138623,doses,0,0
138624,of,0,0
138625,ZV,0,0
138626,",",0,0
138627,separated,0,0
138628,by,0,0
138629,6,0,0
138630,weeks,0,0
138631,",",0,0
138632,vs.,0,0
138633,placebo,1,0
138634,.,1,1
138635,Immunogenicity,1,1
138636,was,1,0
138637,evaluated,0,0
138638,using,1,0
138639,VZV,1,1
138640,interferon-gamma,1,1
138641,(,1,0
138642,IFN-?,1,0
138643,),1,1
138644,enzyme-linked,1,1
138645,immunospot,1,1
138646,(,1,1
138647,ELISPOT,1,1
138648,),1,1
138649,assay,1,1
138650,and,1,1
138651,VZV,1,1
138652,glycoprotein,1,1
138653,enzyme-linked,1,1
138654,immunosorbent,1,0
138655,antibody,1,1
138656,(,1,1
138657,gpELISA,1,1
138658,),1,0
138659,assay,1,0
138660,.,1,0
138661,Adverse,1,1
138662,experiences,1,1
138663,(,1,0
138664,AEs,1,1
138665,),1,1
138666,were,1,0
138667,recorded,0,0
138668,on,0,0
138669,a,0,0
138670,standardized,0,0
138671,Vaccination,0,0
138672,Report,0,0
138673,Card,0,0
138674,.,0,0
138675,RESULTS,1,0
138676,No,1,1
138677,serious,1,1
138678,vaccine-related,1,1
138679,AEs,1,1
138680,occurred,1,0
138681,.,1,0
138682,VZV,1,1
138683,IFN-?,1,0
138684,ELISPOT,1,1
138685,geometric,1,1
138686,mean,1,1
138687,count,1,1
138688,(,1,1
138689,GMC,1,1
138690,),1,0
138691,of,1,0
138692,spot-forming,1,1
138693,cells,1,1
138694,per,1,0
138695,10,1,0
138696,(,1,0
138697,6,1,0
138698,),1,0
138699,peripheral,1,0
138700,blood,1,1
138701,mononuclear,1,1
138702,cells,1,1
138703,increased,0,0
138704,in,0,0
138705,the,0,0
138706,ZV,0,0
138707,group,0,0
138708,from,0,0
138709,16.9,0,0
138710,prevaccination,0,0
138711,to,0,0
138712,49.5,0,0
138713,and,0,0
138714,32.8,0,0
138715,at,0,0
138716,2,0,0
138717,and,0,0
138718,6,0,0
138719,weeks,0,0
138720,postdose,0,0
138721,1,0,0
138722,",",0,0
138723,respectively,0,0
138724,.,0,0
138725,Two,0,0
138726,weeks,0,0
138727,",",0,0
138728,6,0,0
138729,weeks,0,0
138730,and,0,0
138731,6,0,0
138732,months,0,0
138733,postdose,1,0
138734,2,1,0
138735,",",1,0
138736,GMC,1,0
138737,was,0,0
138738,44.3,0,0
138739,",",0,0
138740,42.9,0,0
138741,",",0,0
138742,and,0,0
138743,36.5,0,0
138744,",",0,0
138745,respectively,1,0
138746,.,1,0
138747,GMC,1,0
138748,in,0,0
138749,the,0,0
138750,placebo,0,0
138751,group,0,0
138752,did,0,0
138753,not,0,0
138754,change,0,0
138755,during,0,0
138756,the,0,0
138757,study,0,0
138758,.,0,0
138759,The,0,0
138760,peak,1,1
138761,ELISPOT,1,1
138762,response,1,1
138763,occurred,1,0
138764,?2,0,1
138765,weeks,0,0
138766,after,0,0
138767,each,0,0
138768,ZV,0,0
138769,dose,0,0
138770,.,0,0
138771,The,1,0
138772,gpELISA,1,0
138773,geometric,1,1
138774,mean,1,1
138775,titers,1,1
138776,(,1,1
138777,GMTs,1,1
138778,),1,0
138779,in,0,0
138780,the,0,0
138781,ZV,0,0
138782,group,0,0
138783,were,0,0
138784,higher,0,0
138785,than,0,0
138786,in,0,0
138787,the,0,0
138788,placebo,0,0
138789,group,0,0
138790,at,0,0
138791,6,0,0
138792,weeks,0,0
138793,after,0,0
138794,each,0,0
138795,dose,1,0
138796,.,1,0
138797,Correlation,1,0
138798,between,1,0
138799,the,1,0
138800,IFN-?,1,0
138801,ELISPOT,1,1
138802,and,1,1
138803,gpELISA,1,1
138804,assays,1,1
138805,was,1,0
138806,poor,0,0
138807,.,0,0
138808,CONCLUSIONS,0,0
138809,ZV,0,0
138810,was,0,0
138811,generally,0,0
138812,well-tolerated,1,0
138813,and,1,1
138814,immunogenic,1,1
138815,in,1,0
138816,adults,1,0
138817,?60,0,0
138818,years,0,0
138819,old,0,0
138820,.,0,0
138821,A,0,0
138822,second,0,0
138823,dose,0,0
138824,of,0,1
138825,ZV,0,0
138826,was,0,0
138827,generally,1,0
138828,safe,1,1
138829,",",1,1
138830,but,1,0
138831,did,0,0
138832,not,0,0
138833,boost,0,0
138834,VZV-specific,1,1
138835,immunity,1,1
138836,beyond,1,0
138837,levels,0,1
138838,achieved,0,0
138839,postdose,0,0
138840,1,0,0
138841,.,0,0
138842,Efficacy,0,1
138843,of,0,0
138844,a,0,0
138845,total,0,1
138846,occlusive,0,1
138847,ionic,0,1
138848,silver-containing,0,0
138849,dressing,0,1
138850,combination,0,0
138851,in,0,0
138852,decreasing,0,1
138853,risk,1,1
138854,of,1,1
138855,surgical,1,1
138856,site,1,0
138857,infection,1,1
138858,:,1,0
138859,an,0,0
138860,RCT,0,0
138861,.,0,0
138862,OBJECTIVE,0,0
138863,To,0,0
138864,perform,0,0
138865,a,0,0
138866,comparative,0,0
138867,assessment,0,0
138868,of,0,0
138869,the,0,0
138870,efficacy,0,1
138871,of,0,0
138872,total,0,1
138873,occlusive,0,1
138874,ionic,0,1
138875,silver-containing,0,0
138876,dressing,0,1
138877,(,0,1
138878,TOISD,0,1
138879,),0,1
138880,combination,0,0
138881,vs,0,0
138882,no,0,0
138883,dressing,0,0
138884,after,0,0
138885,colorectal,0,0
138886,surgery,0,0
138887,.,0,0
138888,METHOD,0,0
138889,The,0,0
138890,surgical,0,0
138891,sites,0,0
138892,from,0,0
138893,both,0,0
138894,groups,0,0
138895,were,0,0
138896,swabbed,0,0
138897,and,0,0
138898,sent,0,0
138899,for,0,0
138900,culture,0,1
138901,and,0,1
138902,sensitivity,0,1
138903,upon,0,0
138904,wound,0,1
138905,closure,0,1
138906,(,0,0
138907,superficial,0,1
138908,incisional,0,1
138909,skin,0,1
138910,surface,0,1
138911,),0,0
138912,in,0,0
138913,the,0,0
138914,operating,0,1
138915,theatre,0,1
138916,",",0,0
138917,as,0,0
138918,a,0,0
138919,baseline,0,0
138920,for,0,0
138921,bacterial,0,1
138922,colonisation,0,1
138923,.,0,0
138924,The,0,0
138925,patients,0,0
138926,',0,1
138927,surgical,0,0
138928,wounds,0,0
138929,in,0,0
138930,the,0,0
138931,study,0,0
138932,group,0,0
138933,were,0,0
138934,dressed,0,0
138935,with,0,0
138936,TOISD,0,1
138937,combination,0,0
138938,and,0,0
138939,the,0,0
138940,patient,0,1
138941,'s,0,1
138942,surgical,0,0
138943,wounds,0,0
138944,in,0,0
138945,the,0,0
138946,control,0,0
138947,group,0,0
138948,received,0,0
138949,the,0,0
138950,conventional,0,0
138951,method,0,0
138952,of,0,0
138953,no,0,0
138954,dressing,0,0
138955,.,0,0
138956,A,0,0
138957,second,0,0
138958,swab,0,0
138959,was,0,0
138960,taken,0,0
138961,from,0,0
138962,the,0,0
138963,superficial,0,1
138964,incisional,0,0
138965,skin,0,1
138966,surface,0,1
138967,for,0,0
138968,culture,0,1
138969,and,0,1
138970,sensitivity,0,1
138971,investigation,0,0
138972,between,0,0
138973,the,0,0
138974,fifth,0,0
138975,to,0,0
138976,seventh,0,0
138977,postoperative,0,1
138978,day,0,0
138979,for,0,0
138980,comparison,0,0
138981,of,0,0
138982,the,0,0
138983,bacterial,0,1
138984,colonisation,0,1
138985,in,0,0
138986,the,0,0
138987,two,0,0
138988,groups,0,0
138989,.,0,0
138990,RESULTS,0,0
138991,One-hundred,0,0
138992,and,0,1
138993,sixty-six,0,0
138994,patients,0,0
138995,were,0,0
138996,recruited,0,0
138997,.,0,0
138998,Six,0,0
138999,patients,0,0
139000,dropped,0,0
139001,out,0,0
139002,before,0,0
139003,the,0,0
139004,fifth,0,0
139005,postoperative,0,1
139006,day,0,1
139007,",",0,0
139008,leaving,0,0
139009,79,0,0
139010,patients,0,0
139011,in,0,0
139012,the,0,0
139013,control,0,0
139014,group,0,0
139015,and,0,0
139016,81,0,0
139017,patients,0,0
139018,in,0,0
139019,the,0,0
139020,study,0,0
139021,group,0,0
139022,.,0,1
139023,Microbial,0,1
139024,swab,0,0
139025,cultures,0,1
139026,revealed,0,0
139027,significant,0,0
139028,differences,0,0
139029,between,0,0
139030,the,0,0
139031,two,0,0
139032,groups,0,0
139033,(,0,0
139034,p,0,0
139035,<,0,0
139036,0.001,0,0
139037,",",0,0
139038,mean=1.43?0.63,0,0
139039,),0,1
139040,in,1,0
139041,bacterial,1,1
139042,colonisation,1,1
139043,.,1,0
139044,The,1,0
139045,odds,1,0
139046,ratio,1,1
139047,(,1,1
139048,OR,1,1
139049,),1,0
139050,of,0,0
139051,patients,0,0
139052,with,0,0
139053,wounds,0,0
139054,in,0,0
139055,the,0,0
139056,control,0,0
139057,group,0,0
139058,was,0,0
139059,4.1,0,0
139060,(,0,0
139061,95,0,0
139062,%,0,0
139063,CI,0,0
139064,is,0,0
139065,1.884,0,0
139066,",",0,0
139067,8.964,0,0
139068,),0,0
139069,more,0,0
139070,likely,0,0
139071,to,0,0
139072,be,0,0
139073,contaminated,0,0
139074,with,0,0
139075,bacteria,0,1
139076,compared,0,0
139077,with,0,0
139078,wounds,0,0
139079,covered,0,0
139080,with,0,0
139081,occlusive,0,0
139082,ionic,0,1
139083,silver-containing,0,0
139084,dressing,0,0
139085,.,0,1
139086,CONCLUSION,0,0
139087,TOISD,0,1
139088,was,0,0
139089,found,0,0
139090,to,0,0
139091,be,0,0
139092,effective,0,1
139093,in,0,0
139094,reducing,1,0
139095,bacterial,1,1
139096,colonisation,1,1
139097,on,0,0
139098,the,0,0
139099,surgical,0,0
139100,site,0,0
139101,compared,0,0
139102,with,0,0
139103,no,0,0
139104,dressing,0,0
139105,.,0,0
139106,However,0,0
139107,",",0,0
139108,it,0,0
139109,properties,0,1
139110,were,0,0
139111,unable,0,0
139112,to,0,0
139113,be,0,0
139114,put,0,0
139115,into,0,0
139116,use,0,0
139117,if,0,0
139118,there,0,0
139119,were,0,0
139120,the,0,0
139121,surgical,0,0
139122,sites,0,0
139123,were,0,0
139124,not,0,0
139125,infested,0,0
139126,with,0,0
139127,bacterial,0,1
139128,.,0,0
139129,Although,0,0
139130,TOISD,0,0
139131,might,0,0
139132,not,0,0
139133,be,0,0
139134,necessarily,0,0
139135,on,0,0
139136,surgical,0,0
139137,incisional,0,0
139138,site,0,0
139139,not,0,0
139140,infested,0,0
139141,with,0,0
139142,bacteria,0,1
139143,for,0,0
139144,the,0,0
139145,initial,0,0
139146,post-operation,0,1
139147,days,0,0
139148,",",0,0
139149,it,0,0
139150,is,0,0
139151,helpful,0,0
139152,in,0,0
139153,preventing,0,0
139154,further,0,0
139155,transcription,0,1
139156,and,0,1
139157,division,0,1
139158,for,0,0
139159,opportunistic,0,0
139160,bacteria,0,1
139161,",",0,0
139162,thus,0,0
139163,might,0,0
139164,reduce,0,0
139165,the,1,0
139166,risk,1,1
139167,of,1,0
139168,superficial,1,1
139169,incisional,1,0
139170,SSI,1,0
139171,.,1,0
139172,The,0,0
139173,use,0,0
139174,of,0,0
139175,TOSID,0,0
139176,though,0,0
139177,statistically,0,0
139178,insignificant,0,0
139179,compared,0,0
139180,to,0,0
139181,no,0,0
139182,dressing,0,0
139183,",",0,0
139184,could,0,0
139185,also,0,0
139186,be,0,0
139187,possible,0,0
139188,in,0,0
139189,reducing,0,0
139190,the,1,0
139191,risk,1,1
139192,and,1,1
139193,exaceration,1,1
139194,of,1,1
139195,deep,1,1
139196,incisional,1,0
139197,SSI,1,0
139198,.,1,0
139199,Recombinant,0,0
139200,human,0,0
139201,erythropoietin,0,0
139202,.,0,0
139203,Randomized,0,0
139204,comparison,0,0
139205,of,0,0
139206,the,0,0
139207,efficacy,1,1
139208,and,1,1
139209,safety,1,1
139210,of,0,1
139211,zotarolimus-eluting,0,0
139212,stents,0,0
139213,vs.,0,0
139214,sirolimus-eluting,0,0
139215,stents,0,0
139216,for,0,0
139217,percutaneous,0,0
139218,coronary,0,1
139219,intervention,0,0
139220,in,0,0
139221,chronic,0,0
139222,total,0,1
139223,occlusion,0,0
139224,--,0,1
139225,CAtholic,0,0
139226,Total,0,1
139227,Occlusion,0,1
139228,Study,0,0
139229,(,0,1
139230,CATOS,0,1
139231,),0,0
139232,trial,0,0
139233,.,0,0
139234,BACKGROUND,0,0
139235,Limited,0,0
139236,data,0,0
139237,are,0,0
139238,available,0,0
139239,regarding,0,0
139240,the,0,0
139241,direct,0,0
139242,comparison,0,0
139243,of,0,1
139244,angiographic,0,1
139245,and,0,1
139246,clinical,0,1
139247,outcomes,0,1
139248,after,0,0
139249,percutaneous,0,0
139250,coronary,0,1
139251,intervention,0,0
139252,(,0,1
139253,PCI,0,1
139254,),0,0
139255,with,0,0
139256,drug-eluting,0,0
139257,stents,0,0
139258,(,0,0
139259,DESs,0,0
139260,),0,0
139261,for,0,0
139262,chronic,0,0
139263,total,0,1
139264,occlusion,0,1
139265,(,0,1
139266,CTO,0,0
139267,),0,0
139268,.,0,0
139269,METHODS,0,0
139270,AND,0,0
139271,RESULTS,0,0
139272,A,0,0
139273,prospective,0,0
139274,",",0,0
139275,randomized,0,0
139276,",",0,0
139277,multicenter,0,0
139278,trial,0,0
139279,was,0,0
139280,conducted,0,0
139281,to,0,0
139282,evaluate,0,0
139283,the,0,0
139284,non-inferiority,0,0
139285,of,0,0
139286,a,0,0
139287,zotarolimus-eluting,0,0
139288,stent,0,1
139289,(,0,0
139290,ZES,0,0
139291,;,0,0
139292,Endeavor,0,0
139293,Sprint?,0,0
139294,",",0,0
139295,n=80,0,0
139296,),0,0
139297,to,0,0
139298,a,0,0
139299,sirolimus-eluting,0,0
139300,stent,0,1
139301,(,0,0
139302,SES,0,0
139303,;,0,1
139304,Cypher?,0,1
139305,",",0,1
139306,n=80,0,0
139307,),0,1
139308,in,0,0
139309,patients,0,0
139310,with,0,0
139311,CTO,0,0
139312,lesion,0,0
139313,with,0,0
139314,a,0,0
139315,reference,0,0
139316,vessel,0,1
139317,diameter,0,1
139318,?,0,0
139319,2.5mm,0,0
139320,.,0,0
139321,The,0,0
139322,primary,0,0
139323,endpoint,0,1
139324,was,0,0
139325,in-segment,1,1
139326,binary,1,1
139327,restenosis,1,1
139328,rate,1,1
139329,at,1,0
139330,9-month,0,0
139331,angiographic,0,1
139332,follow-up,0,0
139333,.,0,0
139334,Key,0,0
139335,secondary,0,1
139336,endpoints,0,1
139337,included,1,0
139338,target,1,1
139339,vessel,1,1
139340,failure,1,1
139341,(,1,0
139342,TVF,1,0
139343,;,1,0
139344,including,1,0
139345,cardiac,1,1
139346,death,1,1
139347,",",1,1
139348,myocardial,1,1
139349,infarction,1,1
139350,",",1,0
139351,and,1,1
139352,target,1,1
139353,vessel,1,1
139354,revascularization,1,1
139355,),1,1
139356,and,1,1
139357,Academic,1,1
139358,Research,1,1
139359,Consortium-defined,1,0
139360,definite/probable,1,1
139361,stent,1,1
139362,thrombosis,1,1
139363,(,1,1
139364,ST,1,1
139365,),1,0
139366,within,1,0
139367,12,0,0
139368,months,0,0
139369,.,0,0
139370,The,0,0
139371,ZES,0,0
139372,was,0,0
139373,non-inferior,0,0
139374,to,0,0
139375,the,0,0
139376,SES,0,0
139377,with,0,0
139378,respect,0,0
139379,to,0,0
139380,the,0,0
139381,primary,0,0
139382,endpoint,1,1
139383,",",1,1
139384,which,1,0
139385,occurred,0,0
139386,in,0,0
139387,14.1,0,0
139388,%,0,0
139389,(,0,0
139390,95,0,0
139391,%,0,0
139392,confidence,0,0
139393,interval,0,0
139394,[,0,0
139395,CI,0,0
139396,],0,0
139397,:,0,0
139398,6.0-22.2,0,0
139399,),0,0
139400,and,0,0
139401,in,0,0
139402,13.7,0,0
139403,%,0,0
139404,(,0,0
139405,95,0,0
139406,%,0,0
139407,CI,0,0
139408,:,0,0
139409,5.8-21.6,0,0
139410,),0,0
139411,of,0,0
139412,patients,0,0
139413,",",0,0
139414,respectively,0,0
139415,(,0,0
139416,non-inferiority,0,0
139417,margin,0,1
139418,",",0,0
139419,15.0,0,0
139420,%,0,0
139421,;,0,0
139422,P,0,0
139423,for,0,0
139424,non-inferiority,0,0
139425,<,0,0
139426,0.001,0,0
139427,),0,0
139428,.,0,0
139429,There,0,0
139430,were,0,0
139431,no,0,0
139432,significant,0,0
139433,between-group,0,0
139434,differences,0,0
139435,in,0,0
139436,the,0,0
139437,rate,1,1
139438,of,1,1
139439,TVF,1,0
139440,(,0,0
139441,10.0,0,0
139442,%,0,0
139443,vs.,0,0
139444,17.5,0,0
139445,%,0,0
139446,;,0,0
139447,P=0.168,0,0
139448,),0,1
139449,nor,0,0
139450,in,0,0
139451,the,0,0
139452,rate,0,1
139453,of,0,1
139454,ST,0,1
139455,(,0,0
139456,0.0,0,0
139457,%,0,0
139458,vs.,0,0
139459,1.3,0,0
139460,%,0,0
139461,;,0,0
139462,P=0.316,0,0
139463,),0,0
139464,during,0,0
139465,the,0,0
139466,12-month,0,0
139467,clinical,0,0
139468,follow-up,0,0
139469,.,0,0
139470,CONCLUSIONS,0,0
139471,The,0,0
139472,effectiveness,0,1
139473,and,0,1
139474,safety,0,1
139475,of,0,0
139476,ZES,0,0
139477,are,0,0
139478,similar,0,0
139479,to,0,0
139480,those,0,0
139481,of,0,0
139482,SES,0,0
139483,and,0,0
139484,therefore,0,0
139485,it,0,0
139486,is,0,0
139487,a,0,0
139488,good,0,0
139489,treatment,0,0
139490,option,0,0
139491,in,0,0
139492,patients,0,0
139493,undergoing,0,0
139494,PCI,0,1
139495,for,0,0
139496,CTO,0,0
139497,with,0,0
139498,DESs,0,0
139499,.,0,0
139500,Enhancing,0,0
139501,the,0,0
139502,self-esteem,1,1
139503,of,0,0
139504,inpatient,0,0
139505,alcoholics,0,0
139506,.,0,0
139507,This,0,0
139508,study,0,0
139509,examined,0,0
139510,the,0,0
139511,effect,0,1
139512,of,0,0
139513,pairing,0,1
139514,inpatient,0,0
139515,alcoholics,0,0
139516,with,0,0
139517,nursing,0,1
139518,home,0,1
139519,residents,0,0
139520,(,0,1
139521,NHRs,0,0
139522,),0,0
139523,on,0,0
139524,the,0,0
139525,alcoholics,1,0
139526,',1,1
139527,self-esteem,1,1
139528,.,1,0
139529,In,0,0
139530,this,0,0
139531,PALS,0,1
139532,program,0,0
139533,",",0,0
139534,the,0,0
139535,alcoholic,0,0
139536,inpatients,0,0
139537,assumed,0,0
139538,a,0,0
139539,helping-companion,0,0
139540,relationship,0,0
139541,with,0,0
139542,the,0,0
139543,NHRs,0,0
139544,for,0,0
139545,2,0,0
139546,hr,0,0
139547,per,0,0
139548,day,0,0
139549,during,0,0
139550,their,0,0
139551,last,0,0
139552,2,0,0
139553,weeks,0,0
139554,of,0,0
139555,treatment,0,0
139556,.,0,0
139557,Fifty,0,0
139558,alcoholic,0,0
139559,inpatients,0,0
139560,were,0,0
139561,randomly,0,0
139562,assigned,0,0
139563,to,0,0
139564,the,0,0
139565,PALS,0,1
139566,program,0,0
139567,(,0,0
139568,n,0,0
139569,=,0,0
139570,25,0,0
139571,),0,0
139572,or,0,0
139573,to,0,0
139574,the,0,0
139575,library,0,0
139576,for,0,0
139577,free,0,1
139578,reading,0,1
139579,time,0,1
139580,(,0,0
139581,n,0,0
139582,=,0,0
139583,25,0,0
139584,),0,0
139585,.,0,0
139586,The,0,0
139587,Tennessee,1,1
139588,Self-Concept,1,0
139589,Scale,1,1
139590,(,1,1
139591,TSCS,1,1
139592,),1,1
139593,was,0,0
139594,administered,0,0
139595,to,0,0
139596,all,0,0
139597,subjects,0,0
139598,in,0,0
139599,both,0,0
139600,groups,0,0
139601,before,0,0
139602,and,0,0
139603,after,0,0
139604,the,0,0
139605,interventions,0,0
139606,.,0,0
139607,Of,0,0
139608,the,0,0
139609,nine,0,0
139610,TSCS,1,1
139611,scales,1,1
139612,",",0,0
139613,the,0,0
139614,improvement,0,1
139615,on,0,0
139616,the,0,0
139617,Moral-Ethical,1,0
139618,scale,1,1
139619,was,0,0
139620,significantly,0,0
139621,greater,0,0
139622,in,0,0
139623,the,0,0
139624,PALS,0,0
139625,group,0,0
139626,.,0,0
139627,Because,0,0
139628,the,0,0
139629,alcoholic,0,0
139630,inpatients,0,0
139631,in,0,0
139632,the,0,0
139633,PALS,0,1
139634,group,0,0
139635,engaged,0,0
139636,in,0,0
139637,altruistic,1,1
139638,(,1,0
139639,moral,1,1
139640,),1,1
139641,behavior,1,1
139642,",",0,0
139643,this,0,0
139644,study,0,0
139645,provides,0,0
139646,a,0,0
139647,logical,0,1
139648,link,0,0
139649,between,0,0
139650,the,0,0
139651,intervention,0,0
139652,and,0,0
139653,the,0,0
139654,outcome,0,1
139655,",",0,0
139656,which,0,0
139657,has,0,0
139658,been,0,0
139659,a,0,0
139660,prevalent,0,0
139661,weakness,0,1
139662,in,0,0
139663,previous,0,0
139664,studies,0,0
139665,of,0,0
139666,self-esteem,0,1
139667,in,0,0
139668,alcoholics,0,0
139669,.,0,0
139670,Bilateral,0,1
139671,transversus,0,0
139672,abdominis,0,1
139673,plane,0,1
139674,block,0,0
139675,does,0,0
139676,not,0,0
139677,decrease,0,0
139678,postoperative,0,1
139679,pain,0,1
139680,after,0,0
139681,laparoscopic,0,0
139682,cholecystectomy,0,0
139683,when,0,0
139684,compared,0,0
139685,with,0,0
139686,local,0,0
139687,anesthetic,0,1
139688,infiltration,0,1
139689,of,0,1
139690,trocar,0,0
139691,insertion,0,0
139692,sites,0,0
139693,.,0,0
139694,BACKGROUND,0,0
139695,AND,0,0
139696,OBJECTIVES,0,1
139697,Transversus,0,1
139698,abdominis,0,1
139699,plane,0,1
139700,(,0,1
139701,TAP,0,1
139702,),0,0
139703,block,0,0
139704,has,0,0
139705,been,0,0
139706,shown,0,0
139707,to,0,0
139708,reduce,0,0
139709,pain,0,1
139710,and,0,1
139711,analgesic,0,1
139712,requirements,0,1
139713,after,0,0
139714,abdominal,0,1
139715,surgery,0,0
139716,.,0,0
139717,Our,0,0
139718,hypothesis,0,0
139719,was,0,0
139720,that,0,0
139721,bilateral,0,0
139722,TAP,0,0
139723,blocks,0,0
139724,decrease,0,1
139725,pain,0,1
139726,after,0,0
139727,laparoscopic,0,0
139728,cholecystectomy,0,0
139729,when,0,0
139730,compared,0,0
139731,with,0,0
139732,local,0,0
139733,anesthetic,0,1
139734,infiltration,0,1
139735,of,0,1
139736,trocar,0,0
139737,insertion,0,0
139738,sites,0,0
139739,.,0,0
139740,METHODS,0,0
139741,Eighty,0,1
139742,patients,0,0
139743,undergoing,0,0
139744,laparoscopic,0,0
139745,cholecystectomy,0,0
139746,were,0,0
139747,randomized,0,0
139748,to,0,0
139749,receive,0,0
139750,either,0,0
139751,bilateral,0,0
139752,TAP,0,0
139753,blocks,0,0
139754,or,0,0
139755,local,0,1
139756,anesthetic,0,1
139757,infiltration,0,1
139758,of,0,1
139759,trocar,0,0
139760,insertion,0,0
139761,sites,0,0
139762,with,0,0
139763,ropivacaine,0,0
139764,0.5,0,0
139765,%,0,0
139766,.,0,0
139767,Postoperative,1,1
139768,pain,1,1
139769,scores,0,1
139770,and,0,1
139771,analgesic,0,1
139772,use,0,0
139773,for,0,0
139774,the,0,0
139775,first,0,0
139776,24,0,0
139777,hrs,0,1
139778,were,0,0
139779,recorded,0,0
139780,.,0,0
139781,RESULTS,0,0
139782,Eighty,0,1
139783,patients,0,0
139784,were,0,0
139785,enrolled,0,0
139786,in,0,0
139787,the,0,0
139788,study,0,0
139789,.,0,0
139790,After,0,0
139791,exclusions,0,0
139792,",",0,0
139793,data,0,0
139794,were,0,0
139795,analyzed,0,0
139796,on,0,0
139797,39,0,0
139798,patients,0,0
139799,in,0,0
139800,group,0,0
139801,T,0,1
139802,(,0,0
139803,bilateral,0,1
139804,TAP,0,1
139805,block,0,1
139806,),0,0
139807,and,0,0
139808,35,0,0
139809,patients,0,0
139810,in,0,0
139811,group,0,0
139812,I,0,0
139813,(,0,0
139814,infiltration,0,1
139815,),0,0
139816,.,0,0
139817,There,0,0
139818,was,0,0
139819,no,0,0
139820,statistically,1,0
139821,significant,1,0
139822,difference,1,0
139823,in,0,0
139824,pain,1,1
139825,scores,1,1
139826,on,1,0
139827,the,1,0
139828,numeric,1,1
139829,analog,1,1
139830,scale,1,1
139831,(,0,1
139832,0-10,0,1
139833,),0,0
139834,between,0,0
139835,the,0,0
139836,groups,0,0
139837,at,0,0
139838,4,0,0
139839,hrs,0,0
139840,after,0,0
139841,surgery,0,0
139842,(,0,0
139843,P,0,0
139844,=,0,0
139845,0.18,0,0
139846,),0,0
139847,or,0,0
139848,during,0,0
139849,the,0,0
139850,24,0,0
139851,hrs,0,0
139852,after,0,0
139853,surgery,0,0
139854,(,0,0
139855,P,0,0
139856,=,0,0
139857,0.23,0,0
139858,),0,0
139859,.,0,0
139860,The,0,0
139861,time,1,1
139862,interval,1,0
139863,from,1,0
139864,anesthesia,1,0
139865,start,1,0
139866,to,1,0
139867,surgery,1,0
139868,start,1,0
139869,was,0,0
139870,greater,0,0
139871,in,0,0
139872,group,0,0
139873,T,0,1
139874,than,0,0
139875,group,0,0
139876,I,0,0
139877,(,0,0
139878,48,0,0
139879,vs,0,0
139880,35,0,0
139881,mins,0,0
139882,",",0,0
139883,P,0,0
139884,<,0,0
139885,0.001,0,0
139886,),0,0
139887,.,0,0
139888,There,0,0
139889,was,0,0
139890,no,0,0
139891,significant,1,0
139892,difference,1,0
139893,found,0,0
139894,in,0,0
139895,analgesic,1,1
139896,use,1,0
139897,during,0,0
139898,the,0,0
139899,first,0,0
139900,24,0,0
139901,hrs,0,0
139902,after,0,0
139903,surgery,0,0
139904,.,0,0
139905,CONCLUSIONS,0,0
139906,Bilateral,0,1
139907,ultrasound-guided,0,0
139908,TAP,0,0
139909,block,0,0
139910,is,0,0
139911,equivalent,0,0
139912,to,0,0
139913,local,0,0
139914,anesthetic,0,1
139915,infiltration,0,1
139916,of,0,1
139917,trocar,0,0
139918,insertion,0,0
139919,sites,0,0
139920,for,0,0
139921,overall,0,1
139922,postoperative,1,1
139923,pain,1,1
139924,in,0,0
139925,a,0,0
139926,heterogeneous,0,0
139927,group,0,0
139928,of,0,0
139929,patients,0,0
139930,undergoing,0,0
139931,laparoscopic,0,0
139932,cholecystectomy,0,0
139933,.,0,0
139934,Infrared,0,0
139935,LED,0,0
139936,irradiation,0,0
139937,applied,0,0
139938,during,0,0
139939,high-intensity,0,0
139940,treadmill,0,0
139941,training,0,0
139942,improves,0,1
139943,maximal,1,1
139944,exercise,1,0
139945,tolerance,1,1
139946,in,0,0
139947,postmenopausal,0,0
139948,women,0,0
139949,:,0,0
139950,a,0,0
139951,6-month,0,0
139952,longitudinal,0,0
139953,study,0,0
139954,.,0,0
139955,Reduced,0,0
139956,aerobic,0,0
139957,fitness,0,1
139958,is,0,0
139959,associated,0,0
139960,with,0,0
139961,an,0,0
139962,increased,0,0
139963,risk,0,0
139964,of,0,0
139965,cardiovascular,0,1
139966,diseases,0,0
139967,among,0,0
139968,the,0,0
139969,older,0,0
139970,population,0,0
139971,.,0,0
139972,The,0,0
139973,aim,0,0
139974,of,0,0
139975,this,0,0
139976,study,0,0
139977,was,0,0
139978,to,0,0
139979,investigate,0,0
139980,the,0,0
139981,effects,1,0
139982,of,0,0
139983,LED,0,0
139984,irradiation,0,0
139985,(,0,0
139986,850,0,0
139987,nm,0,0
139988,),0,0
139989,applied,0,0
139990,during,0,0
139991,treadmill,0,0
139992,training,0,0
139993,on,0,0
139994,the,0,0
139995,maximal,1,1
139996,exercise,1,0
139997,tolerance,1,1
139998,in,0,0
139999,postmenopausal,0,0
140000,women,0,0
140001,.,0,0
140002,At,0,0
140003,the,0,0
140004,beginning,0,0
140005,of,0,0
140006,the,0,0
140007,study,0,0
140008,",",0,0
140009,45,0,0
140010,postmenopausal,0,0
140011,women,0,0
140012,were,0,0
140013,assigned,0,0
140014,randomly,0,0
140015,to,0,0
140016,three,0,0
140017,groups,0,0
140018,",",0,0
140019,and,0,0
140020,30,0,0
140021,women,0,0
140022,completed,0,0
140023,the,0,0
140024,entire,0,0
140025,6,0,0
140026,months,0,0
140027,of,0,0
140028,the,0,0
140029,study,0,0
140030,.,0,0
140031,The,0,0
140032,groups,0,0
140033,were,0,0
140034,:,0,0
140035,(,0,0
140036,1,0,0
140037,),0,0
140038,the,0,0
140039,LED,0,0
140040,group,0,0
140041,(,0,0
140042,treadmill,0,0
140043,training,0,0
140044,associated,0,0
140045,with,0,0
140046,phototherapy,0,0
140047,",",0,0
140048,n,0,0
140049,=,0,0
140050,10,0,0
140051,),0,0
140052,",",0,0
140053,(,0,0
140054,2,0,0
140055,),0,0
140056,the,0,0
140057,exercise,0,0
140058,group,0,0
140059,(,0,0
140060,treadmill,0,0
140061,training,0,0
140062,",",0,0
140063,n,0,0
140064,=,0,0
140065,10,0,0
140066,),0,0
140067,",",0,0
140068,and,0,1
140069,(,0,0
140070,3,0,0
140071,),0,0
140072,the,0,0
140073,sedentary,0,0
140074,group,0,0
140075,(,0,0
140076,neither,0,1
140077,physical,0,1
140078,training,0,0
140079,nor,0,0
140080,phototherapy,0,0
140081,",",0,1
140082,n,0,0
140083,=,0,0
140084,10,0,0
140085,),0,0
140086,.,0,0
140087,The,0,0
140088,training,0,0
140089,was,0,0
140090,performed,0,0
140091,for,0,0
140092,45,0,0
140093,min,0,0
140094,twice,0,0
140095,a,0,0
140096,week,0,0
140097,for,0,0
140098,6,0,0
140099,months,0,0
140100,at,0,0
140101,intensities,0,0
140102,between,0,0
140103,85,0,0
140104,%,0,0
140105,and,0,0
140106,90,0,0
140107,%,0,0
140108,maximal,0,1
140109,heart,0,1
140110,rate,0,1
140111,(,0,1
140112,HRmax,0,1
140113,),0,0
140114,.,0,0
140115,The,0,0
140116,irradiation,0,0
140117,parameters,0,1
140118,were,0,0
140119,39,0,0
140120,mW/cm,0,0
140121,(,0,0
140122,2,0,0
140123,),0,0
140124,",",0,0
140125,45,0,0
140126,min,0,0
140127,and,0,0
140128,108,0,0
140129,J/cm,0,0
140130,(,0,0
140131,2,0,0
140132,),0,0
140133,.,0,0
140134,The,0,0
140135,cardiovascular,1,1
140136,parameters,1,1
140137,were,0,0
140138,measured,0,0
140139,at,0,0
140140,baseline,0,0
140141,and,0,0
140142,after,0,0
140143,6,0,0
140144,months,0,0
140145,.,0,0
140146,As,0,0
140147,expected,0,0
140148,",",0,0
140149,no,0,0
140150,significant,0,0
140151,differences,0,0
140152,were,0,0
140153,found,0,0
140154,in,0,0
140155,the,0,0
140156,sedentary,0,0
140157,group,0,0
140158,(,0,0
140159,p,0,0
140160,?,0,0
140161,0.05,0,0
140162,),0,0
140163,.,0,0
140164,The,1,0
140165,maximal,1,1
140166,time,1,1
140167,of,1,1
140168,tolerance,1,1
140169,(,1,1
140170,Tlim,1,0
140171,),1,1
140172,",",1,0
140173,metabolic,1,1
140174,equivalents,1,1
140175,(,1,0
140176,METs,1,1
140177,),1,1
140178,and,1,1
140179,Bruce,1,1
140180,stage,1,1
140181,reached,1,0
140182,significantly,0,0
140183,higher,0,0
140184,values,0,1
140185,in,0,0
140186,the,0,0
140187,LED,0,0
140188,group,0,0
140189,and,0,0
140190,the,0,0
140191,exercise,0,0
140192,group,0,0
140193,(,0,0
140194,p,0,0
140195,<,0,0
140196,0.01,0,0
140197,),0,0
140198,.,0,0
140199,Furthermore,1,0
140200,",",1,0
140201,the,1,0
140202,HR,1,1
140203,",",1,0
140204,double,1,0
140205,product,1,1
140206,and,1,1
140207,Borg,1,0
140208,score,1,1
140209,at,1,1
140210,isotime,1,1
140211,were,0,0
140212,significantly,0,0
140213,lower,0,0
140214,in,0,0
140215,the,0,0
140216,LED,0,0
140217,group,0,0
140218,and,0,0
140219,in,0,0
140220,the,0,0
140221,exercise,0,0
140222,group,0,0
140223,(,0,0
140224,p,0,0
140225,<,0,0
140226,0.05,0,0
140227,),0,0
140228,.,0,0
140229,However,0,0
140230,",",0,0
140231,the,1,0
140232,time,1,1
140233,of,1,1
140234,recovery,1,1
140235,showed,1,0
140236,a,0,0
140237,significant,0,0
140238,decrease,0,1
140239,only,0,0
140240,in,0,0
140241,the,0,0
140242,LED,0,0
140243,group,0,0
140244,(,0,0
140245,p,0,0
140246,=,0,0
140247,0.003,0,0
140248,),0,0
140249,.,0,0
140250,Moreover,0,0
140251,",",0,0
140252,the,0,0
140253,differences,1,0
140254,between,1,0
140255,before,1,0
140256,and,1,0
140257,after,1,0
140258,training,1,0
140259,(,1,0
140260,delta,1,1
140261,values,1,1
140262,),1,0
140263,for,0,0
140264,the,1,0
140265,Tlim,1,0
140266,",",1,1
140267,METs,1,1
140268,and,1,1
140269,HR,1,1
140270,at,1,1
140271,isotime,0,1
140272,were,0,0
140273,greater,0,0
140274,in,0,0
140275,the,0,0
140276,LED,0,0
140277,group,0,0
140278,than,0,0
140279,in,0,0
140280,the,0,0
140281,exercise,0,0
140282,group,0,0
140283,with,0,0
140284,a,0,0
140285,significant,0,0
140286,intergroup,0,0
140287,difference,0,1
140288,(,0,0
140289,p,0,0
140290,<,0,0
140291,0.05,0,0
140292,),0,0
140293,.,0,0
140294,Therefore,0,0
140295,",",0,0
140296,the,0,0
140297,infrared,0,1
140298,LED,0,0
140299,irradiation,0,0
140300,during,0,0
140301,treadmill,0,0
140302,training,1,0
140303,can,1,0
140304,improve,1,0
140305,maximal,1,1
140306,performance,1,1
140307,and,1,1
140308,post-exercise,1,1
140309,recovery,1,1
140310,in,1,0
140311,postmenopausal,1,0
140312,women,0,0
140313,.,0,0
140314,Combination,0,1
140315,peel,0,0
140316,with,0,0
140317,incorporated,0,0
140318,fractional,0,1
140319,prickle,0,1
140320,coral,0,1
140321,calcium,0,1
140322,for,0,0
140323,the,0,0
140324,treatment,0,0
140325,of,0,1
140326,keratosis,0,1
140327,pilaris,0,0
140328,:,0,0
140329,a,0,0
140330,pilot,0,0
140331,study,0,0
140332,.,0,1
140333,BACKGROUND,0,0
140334,Keratosis,0,1
140335,pilaris,0,1
140336,(,0,1
140337,KP,0,1
140338,),0,0
140339,is,0,0
140340,a,0,0
140341,common,0,0
140342,condition,0,0
140343,of,0,1
140344,follicular,0,1
140345,plugging,0,1
140346,with,0,0
140347,variable,0,0
140348,erythema,0,1
140349,.,0,0
140350,There,0,0
140351,is,0,0
140352,a,0,0
140353,lack,0,0
140354,of,0,0
140355,reliable,0,1
140356,response,0,1
140357,to,0,0
140358,the,0,0
140359,treatment,0,0
140360,of,0,0
140361,KP,0,1
140362,.,0,0
140363,OBJECTIVE,0,0
140364,We,0,0
140365,evaluated,0,0
140366,the,0,0
140367,effect,0,1
140368,and,0,1
140369,safety,0,1
140370,of,0,1
140371,combination,0,0
140372,peel,0,0
140373,with,0,0
140374,fractional,0,1
140375,prickle,0,0
140376,coral,0,1
140377,calcium,0,1
140378,(,0,1
140379,FCR?,0,1
140380,),0,0
140381,in,0,0
140382,the,0,0
140383,treatment,0,0
140384,of,0,0
140385,KP,0,1
140386,.,0,1
140387,MATERIALS,0,0
140388,AND,0,0
140389,METHODS,0,0
140390,Sixteen,0,0
140391,Korean,0,0
140392,patients,0,0
140393,were,0,0
140394,treated,0,0
140395,with,0,0
140396,FCR?,0,0
140397,on,0,0
140398,both,0,0
140399,upper,0,0
140400,arms,0,0
140401,for,0,0
140402,five,0,0
140403,sessions,0,0
140404,at,0,0
140405,2-week,0,0
140406,intervals,1,0
140407,.,1,0
140408,Clinical,1,1
140409,evaluations,1,0
140410,",",1,1
140411,mexameter,1,1
140412,measurements,1,1
140413,",",1,1
140414,and,1,1
140415,assessment,1,1
140416,of,1,1
140417,patients,1,0
140418,',1,1
140419,satisfaction,1,1
140420,and,1,1
140421,adverse,1,1
140422,events,1,1
140423,were,1,0
140424,performed,0,0
140425,at,0,0
140426,baseline,0,0
140427,and,0,0
140428,every,0,0
140429,visit,0,1
140430,.,0,0
140431,RESULTS,0,0
140432,After,0,0
140433,treatments,0,0
140434,",",0,0
140435,statistically,0,0
140436,significant,0,0
140437,improvements,0,0
140438,in,0,0
140439,the,0,0
140440,baseline,1,0
140441,KP,1,1
140442,were,0,0
140443,observed,0,0
140444,in,0,0
140445,erythema,0,1
140446,and,0,1
140447,melanin,0,1
140448,index,0,1
140449,of,0,1
140450,mexameter,0,1
140451,on,0,0
140452,treated,0,0
140453,upper,0,0
140454,arms,0,0
140455,.,0,0
140456,Both,0,0
140457,the,0,0
140458,physicians,0,1
140459,',0,1
140460,and,0,0
140461,patients,0,0
140462,',0,1
140463,assessments,0,0
140464,correlate,0,0
140465,with,0,0
140466,the,0,0
140467,results,0,0
140468,of,0,0
140469,mexameter,0,0
140470,scores,0,1
140471,.,0,0
140472,CONCLUSION,0,0
140473,Our,0,0
140474,results,0,0
140475,suggest,0,0
140476,FCR?,0,0
140477,should,0,0
140478,be,0,0
140479,considered,0,0
140480,as,0,0
140481,an,0,0
140482,effective,1,1
140483,and,1,1
140484,safe,1,1
140485,treatment,0,0
140486,option,0,0
140487,for,0,0
140488,the,0,0
140489,patients,0,0
140490,with,0,0
140491,KP,0,1
140492,.,0,0
140493,Elevated,0,1
140494,concentration,0,1
140495,of,0,1
140496,placental,0,1
140497,growth,0,1
140498,factor,0,1
140499,(,0,1
140500,PlGF,0,0
140501,),0,1
140502,and,0,1
140503,long,0,1
140504,term,0,1
140505,risk,0,1
140506,in,0,0
140507,patients,0,0
140508,with,0,0
140509,acute,0,0
140510,coronary,0,1
140511,syndrome,0,0
140512,in,0,0
140513,the,0,0
140514,PROVE,0,0
140515,IT-TIMI,0,0
140516,22,0,0
140517,trial,0,0
140518,.,0,0
140519,Placental,1,1
140520,growth,1,1
140521,factor,1,1
140522,(,1,1
140523,PlGF,1,0
140524,),1,0
140525,",",0,0
140526,a,0,0
140527,member,0,0
140528,of,0,0
140529,the,0,0
140530,vascular,0,1
140531,endothelial,0,1
140532,growth,0,1
140533,factor,0,1
140534,(,0,1
140535,VEGF,0,1
140536,),0,1
140537,family,0,0
140538,",",0,0
140539,acts,0,0
140540,via,0,0
140541,the,0,0
140542,flt-1,0,1
140543,receptor,0,0
140544,and,0,0
140545,promotes,0,0
140546,endothelial,0,1
140547,activation,0,1
140548,and,0,1
140549,macrophage,0,1
140550,recruitment,0,1
140551,into,0,0
140552,atherosclerotic,0,1
140553,lesions,0,1
140554,.,0,0
140555,We,0,0
140556,investigated,0,0
140557,the,0,0
140558,relationship,0,0
140559,of,0,0
140560,PlGF,0,0
140561,with,0,0
140562,cardiovascular,0,1
140563,outcomes,0,1
140564,in,0,0
140565,a,0,0
140566,large,0,0
140567,cohort,0,0
140568,of,0,0
140569,patients,0,0
140570,presenting,0,0
140571,across,0,0
140572,the,0,0
140573,spectrum,0,0
140574,of,0,0
140575,ACS,0,1
140576,.,0,1
140577,PlGF,1,0
140578,was,0,0
140579,measured,0,0
140580,at,0,0
140581,baseline,0,0
140582,(,0,0
140583,n,0,0
140584,=,0,0
140585,"3,761",0,0
140586,),0,0
140587,and,0,0
140588,at,0,1
140589,four-months,0,0
140590,(,0,0
140591,n,0,0
140592,=,0,0
140593,"3,369",0,0
140594,),0,0
140595,in,0,0
140596,patients,0,0
140597,randomized,0,0
140598,to,0,0
140599,atorvastatin,0,0
140600,80,0,0
140601,mg,0,0
140602,or,0,0
140603,pravastatin,0,0
140604,40,0,0
140605,mg,0,0
140606,after,0,0
140607,ACS,0,1
140608,in,0,0
140609,the,0,0
140610,PROVE,0,0
140611,IT-TIMI,0,0
140612,22,0,0
140613,trial,0,0
140614,.,0,0
140615,The,0,0
140616,primary,0,0
140617,endpoint,0,1
140618,was,0,0
140619,death,1,1
140620,",",1,1
140621,myocardial,1,1
140622,infarction,1,1
140623,(,1,1
140624,MI,1,1
140625,),1,1
140626,",",1,0
140627,unstable,1,1
140628,angina,1,1
140629,",",1,1
140630,revascularization,1,1
140631,or,1,1
140632,stroke,1,1
140633,(,0,1
140634,mean,0,1
140635,follow-up,0,0
140636,24,0,0
140637,months,0,0
140638,),0,0
140639,.,0,0
140640,Elevated,0,1
140641,baseline,0,0
140642,PlGF,0,0
140643,was,0,0
140644,associated,0,0
140645,with,0,0
140646,a,0,0
140647,higher,0,0
140648,incidence,0,1
140649,of,0,0
140650,the,0,0
140651,primary,0,0
140652,endpoint,0,0
140653,through,0,0
140654,2,0,0
140655,years,0,0
140656,(,0,0
140657,Q1,0,1
140658,vs.,0,0
140659,Q5,0,0
140660,:,0,0
140661,18.7,0,0
140662,vs.,0,0
140663,29.3,0,0
140664,%,0,0
140665,",",0,0
140666,p,0,0
140667,<,0,0
140668,0.0001,0,0
140669,),0,0
140670,.,0,0
140671,The,0,0
140672,risk,1,1
140673,of,1,1
140674,death,1,1
140675,or,1,1
140676,MI,1,1
140677,was,0,0
140678,also,0,0
140679,higher,0,0
140680,in,0,0
140681,patients,0,0
140682,with,0,0
140683,elevated,0,1
140684,baseline,0,1
140685,PlGF,0,0
140686,(,0,0
140687,Q1,0,1
140688,vs.,0,0
140689,Q5,0,0
140690,:,0,0
140691,7.0,0,0
140692,vs.,0,0
140693,11.6,0,0
140694,%,0,0
140695,",",0,0
140696,p,0,0
140697,=,0,0
140698,0.029,0,0
140699,),0,0
140700,.,0,0
140701,Adjusting,0,1
140702,for,0,0
140703,baseline,0,0
140704,characteristics,0,1
140705,and,0,1
140706,risk,0,1
140707,factors,0,1
140708,",",0,1
140709,elevated,0,1
140710,baseline,0,1
140711,PlGF,0,0
140712,was,0,0
140713,independently,0,0
140714,associated,0,0
140715,with,0,0
140716,the,0,0
140717,risk,0,0
140718,of,0,0
140719,the,0,0
140720,primary,0,0
140721,endpoint,0,1
140722,(,0,0
140723,adjusted-HR,0,0
140724,for,0,0
140725,Q5,0,0
140726,vs.,0,0
140727,Q1,0,1
140728,1.45,0,0
140729,;,0,0
140730,95,0,0
140731,%,0,0
140732,CI,0,0
140733,1.16-1.83,0,0
140734,;,0,0
140735,p,0,0
140736,=,0,0
140737,0.001,0,0
140738,),0,0
140739,.,0,0
140740,Elevated,0,1
140741,PlGF,0,0
140742,at,0,0
140743,four,0,0
140744,months,0,0
140745,was,0,0
140746,associated,0,0
140747,with,0,0
140748,higher,0,0
140749,risk,1,1
140750,of,1,1
140751,death,1,1
140752,or,1,1
140753,MI,1,1
140754,(,0,1
140755,Adjusted,0,1
140756,HR,0,1
140757,Q5,0,0
140758,vs.,0,0
140759,Q1,0,1
140760,2.79,0,0
140761,",",0,0
140762,95,0,0
140763,%,0,0
140764,CI,0,0
140765,:,0,0
140766,1.37-5.68,0,0
140767,;,0,0
140768,p,0,0
140769,=,0,0
140770,0.005,0,0
140771,),0,0
140772,",",0,0
140773,and,0,1
140774,higher,0,1
140775,risk,0,1
140776,of,0,0
140777,the,0,0
140778,primary,0,0
140779,endpoint,0,1
140780,(,0,0
140781,Adjusted,0,1
140782,HR,0,1
140783,Q5,0,0
140784,vs.,0,0
140785,Q1,0,1
140786,1.78,0,0
140787,",",0,0
140788,95,0,0
140789,%,0,0
140790,CI,0,0
140791,:,0,0
140792,1.26-2.51,0,0
140793,;,0,0
140794,p,0,0
140795,=,0,0
140796,0.001,0,0
140797,),0,0
140798,.,0,0
140799,Higher,0,0
140800,concentration,0,1
140801,of,0,1
140802,PlGF,1,0
140803,after,0,0
140804,ACS,0,0
140805,is,0,0
140806,associated,0,0
140807,with,0,0
140808,long-term,0,0
140809,risk,0,1
140810,of,0,1
140811,recurrent,0,1
140812,cardiovascular,0,1
140813,events,0,1
140814,independent,0,0
140815,of,0,0
140816,traditional,0,0
140817,risk,0,1
140818,factors,0,0
140819,.,0,0
140820,This,0,0
140821,association,0,0
140822,is,0,0
140823,present,0,0
140824,early,0,0
140825,after,0,0
140826,ACS,0,1
140827,and,0,0
140828,appears,0,0
140829,to,0,0
140830,be,0,0
140831,stronger,0,0
140832,at,0,0
140833,four,0,0
140834,months,0,0
140835,.,0,0
140836,Impact,0,0
140837,of,0,0
140838,the,0,0
140839,quantity,1,1
140840,and,1,1
140841,flavonoid,1,1
140842,content,1,1
140843,of,0,1
140844,fruits,0,0
140845,and,0,1
140846,vegetables,0,0
140847,on,0,0
140848,markers,0,1
140849,of,0,0
140850,intake,0,1
140851,in,0,0
140852,adults,0,0
140853,with,0,0
140854,an,0,0
140855,increased,0,0
140856,risk,0,0
140857,of,0,0
140858,cardiovascular,0,1
140859,disease,0,0
140860,:,0,0
140861,the,0,0
140862,FLAVURS,0,0
140863,trial,0,0
140864,.,0,1
140865,PURPOSE,0,0
140866,Limited,0,0
140867,robust,0,1
140868,randomised,0,0
140869,controlled,0,0
140870,trials,0,0
140871,investigating,0,0
140872,fruit,1,1
140873,and,1,1
140874,vegetable,1,1
140875,(,1,1
140876,F,1,0
140877,&,1,1
140878,V,1,0
140879,),1,0
140880,intake,1,1
140881,in,0,0
140882,people,0,0
140883,at,0,0
140884,risk,0,1
140885,of,0,1
140886,cardiovascular,0,1
140887,disease,0,1
140888,(,0,1
140889,CVD,0,0
140890,),0,0
140891,exist,0,0
140892,.,0,0
140893,We,0,0
140894,aimed,0,0
140895,to,0,0
140896,design,0,0
140897,and,0,0
140898,validate,0,0
140899,a,0,0
140900,dietary,0,0
140901,strategy,0,0
140902,of,0,0
140903,increasing,0,0
140904,flavonoid-rich,0,0
140905,versus,0,0
140906,flavonoid-poor,0,0
140907,F,1,0
140908,&,1,1
140909,V,1,1
140910,consumption,1,1
140911,on,0,0
140912,nutrient,0,1
140913,biomarker,0,0
140914,profile,0,1
140915,.,0,1
140916,METHODS,0,0
140917,A,0,0
140918,parallel,0,0
140919,",",0,1
140920,randomised,0,0
140921,",",0,0
140922,controlled,0,0
140923,",",0,0
140924,dose-response,0,1
140925,dietary,0,1
140926,intervention,0,0
140927,study,0,0
140928,.,0,0
140929,Participants,0,0
140930,with,0,0
140931,a,0,0
140932,CVD,0,0
140933,relative,0,1
140934,risk,0,1
140935,of,0,0
140936,1.5,0,0
140937,assessed,0,0
140938,by,0,0
140939,risk,0,1
140940,scores,0,1
140941,were,0,0
140942,randomly,0,0
140943,assigned,0,0
140944,to,0,0
140945,one,0,0
140946,of,0,0
140947,the,0,0
140948,3,0,0
140949,groups,0,0
140950,:,0,0
140951,habitual,0,1
140952,(,0,0
140953,control,0,0
140954,",",0,1
140955,CT,0,1
140956,),0,1
140957,",",0,1
140958,high-flavonoid,0,0
140959,(,0,1
140960,HF,0,1
140961,),0,1
140962,or,0,1
140963,low-flavonoid,0,0
140964,(,0,1
140965,LF,0,1
140966,),0,0
140967,diets,0,0
140968,.,0,0
140969,While,0,0
140970,the,0,0
140971,CT,0,1
140972,group,0,0
140973,(,0,0
140974,n,0,0
140975,=,0,0
140976,57,0,0
140977,),0,0
140978,consumed,0,0
140979,their,0,0
140980,habitual,0,1
140981,diet,0,0
140982,throughout,0,0
140983,",",0,0
140984,the,0,0
140985,HF,0,1
140986,(,0,0
140987,n,0,0
140988,=,0,0
140989,58,0,0
140990,),0,0
140991,and,0,0
140992,LF,0,1
140993,(,0,1
140994,n,0,0
140995,=,0,0
140996,59,0,0
140997,),0,0
140998,groups,0,0
140999,sequentially,0,0
141000,increased,0,0
141001,their,0,0
141002,daily,0,1
141003,F,0,0
141004,&,0,1
141005,V,0,1
141006,intake,0,1
141007,by,0,0
141008,an,0,0
141009,additional,0,0
141010,2,0,0
141011,",",0,0
141012,4,0,0
141013,and,0,0
141014,6,0,0
141015,portions,0,0
141016,for,0,0
141017,6-week,0,0
141018,periods,0,0
141019,during,0,0
141020,the,0,0
141021,18-week,0,0
141022,study,0,0
141023,.,0,0
141024,RESULTS,0,0
141025,Compliance,0,1
141026,to,0,0
141027,target,0,0
141028,numbers,0,1
141029,and,0,1
141030,types,0,0
141031,of,0,1
141032,F,0,0
141033,&,0,1
141034,V,0,1
141035,was,0,0
141036,broadly,0,0
141037,met,0,0
141038,and,0,0
141039,verified,0,0
141040,by,0,0
141041,dietary,0,0
141042,records,0,0
141043,",",0,1
141044,and,0,1
141045,plasma,1,1
141046,and,1,1
141047,urinary,1,1
141048,biomarkers,1,0
141049,.,1,1
141050,Mean,0,1
141051,(,0,0
141052,?,0,0
141053,SEM,0,0
141054,),0,0
141055,number,0,1
141056,of,1,1
141057,F,1,0
141058,&,1,1
141059,V,1,1
141060,portions/day,1,1
141061,consumed,0,0
141062,by,0,0
141063,the,0,0
141064,HF,0,0
141065,and,0,1
141066,LF,0,1
141067,groups,0,0
141068,at,0,0
141069,baseline,0,0
141070,(,0,0
141071,3.8,0,0
141072,?,0,0
141073,0.3,0,0
141074,and,0,0
141075,3.4,0,0
141076,?,0,0
141077,0.3,0,0
141078,),0,0
141079,",",0,0
141080,6,0,0
141081,weeks,0,0
141082,(,0,0
141083,6.3,0,0
141084,?,0,0
141085,0.4,0,0
141086,and,0,0
141087,5.8,0,0
141088,?,0,0
141089,0.3,0,0
141090,),0,0
141091,",",0,0
141092,12,0,0
141093,weeks,0,0
141094,(,0,0
141095,7.0,0,0
141096,?,0,0
141097,0.3,0,0
141098,and,0,0
141099,6.8,0,0
141100,?,0,0
141101,0.3,0,0
141102,),0,0
141103,and,0,0
141104,18,0,0
141105,weeks,0,0
141106,(,0,0
141107,7.6,0,0
141108,?,0,0
141109,0.4,0,0
141110,and,0,0
141111,8.1,0,0
141112,?,0,0
141113,0.4,0,0
141114,),0,0
141115,",",0,0
141116,respectively,0,0
141117,",",0,0
141118,was,0,0
141119,similar,0,0
141120,at,0,0
141121,baseline,0,0
141122,yet,0,0
141123,higher,0,0
141124,than,0,0
141125,the,0,0
141126,CT,0,1
141127,group,0,0
141128,(,0,0
141129,3.9,0,0
141130,?,0,0
141131,0.3,0,0
141132,",",0,0
141133,4.3,0,0
141134,?,0,0
141135,0.3,0,0
141136,",",0,0
141137,4.6,0,0
141138,?,0,0
141139,0.4,0,0
141140,",",0,0
141141,4.5,0,0
141142,?,0,0
141143,0.3,0,0
141144,),0,0
141145,(,0,0
141146,P,0,0
141147,=,0,0
141148,0.015,0,0
141149,),0,0
141150,.,0,0
141151,There,0,0
141152,was,0,0
141153,a,0,0
141154,dose-dependent,1,0
141155,increase,1,0
141156,in,1,0
141157,dietary,1,1
141158,and,1,1
141159,urinary,1,1
141160,flavonoids,1,0
141161,in,1,0
141162,the,0,0
141163,HF,0,0
141164,group,0,0
141165,",",0,0
141166,with,0,0
141167,no,0,0
141168,change,0,1
141169,in,0,0
141170,other,0,0
141171,groups,0,0
141172,(,0,0
141173,P,0,0
141174,=,0,0
141175,0.0001,0,0
141176,),0,0
141177,.,0,0
141178,Significantly,0,0
141179,higher,1,0
141180,dietary,1,0
141181,intakes,1,1
141182,of,1,1
141183,folate,1,1
141184,(,1,0
141185,P,1,0
141186,=,0,0
141187,0.035,0,0
141188,),0,0
141189,",",0,0
141190,non-starch,1,1
141191,polysaccharides,1,1
141192,(,1,0
141193,P,1,0
141194,=,1,0
141195,0.001,1,0
141196,),1,0
141197,",",1,0
141198,vitamin,0,1
141199,C,0,1
141200,(,0,0
141201,P,0,0
141202,=,0,0
141203,0.0001,0,0
141204,),0,0
141205,and,0,0
141206,carotenoids,1,1
141207,(,0,1
141208,P,0,0
141209,=,0,0
141210,0.0001,0,0
141211,),0,0
141212,were,0,0
141213,observed,0,0
141214,in,0,0
141215,both,0,0
141216,intervention,0,0
141217,groups,0,0
141218,compared,0,0
141219,with,0,0
141220,CT,0,1
141221,",",0,1
141222,which,0,0
141223,were,0,0
141224,broadly,0,0
141225,supported,0,0
141226,by,0,0
141227,nutrient,0,1
141228,biomarker,0,0
141229,analysis,0,0
141230,.,0,0
141231,CONCLUSIONS,0,0
141232,The,0,0
141233,success,0,1
141234,of,0,0
141235,improving,0,1
141236,nutrient,1,1
141237,profile,1,1
141238,by,1,0
141239,active,1,0
141240,encouragement,0,0
141241,of,1,1
141242,F,1,0
141243,&,1,1
141244,V,1,1
141245,intake,1,1
141246,in,1,0
141247,an,0,0
141248,intervention,0,0
141249,study,0,0
141250,implies,0,0
141251,the,0,0
141252,need,0,0
141253,for,0,0
141254,a,0,0
141255,more,0,0
141256,hands-on,0,0
141257,public,0,0
141258,health,0,1
141259,approach,0,0
141260,.,0,0
141261,Moclobemide,0,0
141262,",",0,1
141263,imipramine,0,0
141264,and,0,1
141265,placebo,0,0
141266,in,0,0
141267,the,0,0
141268,treatment,0,0
141269,of,0,0
141270,major,0,1
141271,depression,1,1
141272,.,1,1
141273,Moclobemide,0,0
141274,was,0,0
141275,compared,0,0
141276,with,0,0
141277,imipramine,0,0
141278,and,0,1
141279,placebo,0,0
141280,in,0,0
141281,the,0,0
141282,treatment,0,0
141283,of,0,0
141284,major,0,1
141285,depressive,0,1
141286,episodes,0,1
141287,in,0,0
141288,75,0,0
141289,outpatients,0,0
141290,.,0,0
141291,The,0,0
141292,dosage,0,0
141293,of,0,1
141294,moclobemide,0,0
141295,(,0,0
141296,25,0,0
141297,patients,0,0
141298,),0,0
141299,was,0,0
141300,300,0,0
141301,mg,0,0
141302,daily,0,0
141303,for,0,0
141304,the,0,0
141305,first,0,0
141306,5,0,0
141307,days,0,0
141308,",",0,0
141309,after,0,0
141310,which,0,0
141311,it,0,0
141312,could,0,0
141313,be,0,0
141314,increased,0,0
141315,to,0,0
141316,600,0,0
141317,mg.,0,0
141318,Imipramine,0,0
141319,(,0,0
141320,25,0,0
141321,patients,0,0
141322,),0,0
141323,was,0,0
141324,given,0,0
141325,in,0,0
141326,a,0,0
141327,dosage,0,0
141328,starting,0,0
141329,with,0,0
141330,33,0,0
141331,mg,0,0
141332,and,0,0
141333,gradually,0,0
141334,increased,0,0
141335,to,0,0
141336,100,0,0
141337,mg/day,0,0
141338,in,0,0
141339,the,0,0
141340,first,0,0
141341,5,0,0
141342,days,0,0
141343,",",0,0
141344,after,0,0
141345,which,0,0
141346,it,0,0
141347,could,0,0
141348,be,0,0
141349,further,0,0
141350,increased,0,0
141351,;,0,0
141352,25,0,0
141353,patients,0,0
141354,received,0,0
141355,placebo,0,0
141356,.,0,0
141357,Both,0,0
141358,drugs,0,0
141359,were,0,0
141360,equally,0,0
141361,effective,0,0
141362,as,0,0
141363,measured,0,0
141364,by,0,0
141365,the,0,0
141366,Hamilton,1,1
141367,Rating,1,1
141368,Scale,1,1
141369,for,1,0
141370,Depression,1,1
141371,",",0,0
141372,the,0,0
141373,overall,1,1
141374,assessment,1,0
141375,of,1,1
141376,efficacy,1,1
141377,and,0,0
141378,the,0,0
141379,Zung,1,0
141380,Self-rating,1,1
141381,Scale,1,1
141382,",",0,1
141383,and,0,1
141384,clearly,0,0
141385,superior,0,0
141386,to,0,0
141387,placebo,0,0
141388,;,0,0
141389,there,0,0
141390,were,0,0
141391,no,0,0
141392,significant,0,0
141393,differences,0,0
141394,between,0,0
141395,the,0,0
141396,2,0,0
141397,active,0,0
141398,drugs,0,0
141399,.,0,1
141400,Moclobemide,0,0
141401,was,0,0
141402,better,1,0
141403,tolerated,1,1
141404,than,0,0
141405,imipramine,0,0
141406,",",0,1
141407,and,0,1
141408,was,0,0
141409,almost,0,0
141410,comparable,0,0
141411,to,0,0
141412,placebo,0,0
141413,in,0,0
141414,this,0,0
141415,respect,0,0
141416,.,0,0
141417,Kata,0,0
141418,techniques,0,0
141419,training,0,0
141420,consistently,0,0
141421,decreases,0,0
141422,stereotypy,0,1
141423,in,0,0
141424,children,0,0
141425,with,0,0
141426,autism,0,0
141427,spectrum,0,0
141428,disorder,0,0
141429,.,0,0
141430,The,0,0
141431,effects,0,0
141432,of,0,0
141433,14,0,0
141434,weeks,0,0
141435,of,0,0
141436,Kata,0,0
141437,techniques,0,0
141438,training,0,0
141439,on,0,0
141440,stereotypic,0,1
141441,behaviors,0,1
141442,of,0,0
141443,children,0,0
141444,with,0,0
141445,autism,0,0
141446,spectrum,0,0
141447,disorders,0,1
141448,(,0,1
141449,ASD,0,0
141450,),0,1
141451,were,0,0
141452,investigated,0,0
141453,.,0,0
141454,The,0,0
141455,study,0,0
141456,included,0,0
141457,30,0,0
141458,eligible,0,0
141459,(,0,0
141460,diagnosed,0,0
141461,ASD,0,0
141462,",",0,1
141463,school,0,1
141464,age,0,0
141465,),0,0
141466,children,0,0
141467,with,0,0
141468,ages,0,0
141469,ranging,0,0
141470,from,0,0
141471,5,0,0
141472,to,0,0
141473,16,0,0
141474,years,0,0
141475,whom,0,0
141476,they,0,0
141477,assigned,0,0
141478,to,0,0
141479,an,0,0
141480,exercise,0,0
141481,(,0,0
141482,n=15,0,0
141483,),0,0
141484,or,0,0
141485,a,0,0
141486,no-exercise,0,0
141487,control,0,0
141488,group,0,0
141489,(,0,0
141490,n=15,0,0
141491,),0,0
141492,.,0,0
141493,Participants,0,0
141494,of,0,0
141495,the,0,0
141496,exercise,0,0
141497,group,0,0
141498,received,0,0
141499,Kata,0,0
141500,techniques,0,0
141501,instruction,0,0
141502,four,0,0
141503,times,0,0
141504,per,0,0
141505,week,0,0
141506,for,0,0
141507,14,0,0
141508,weeks,0,0
141509,(,0,0
141510,56,0,0
141511,sessions,0,0
141512,),0,0
141513,.,0,0
141514,Stereotypy,0,1
141515,was,0,0
141516,assessed,0,0
141517,at,0,0
141518,baseline,0,0
141519,(,0,1
141520,pre-intervention,0,1
141521,),0,1
141522,",",0,0
141523,week,0,0
141524,14,0,0
141525,(,0,0
141526,post-intervention,0,0
141527,),0,1
141528,",",0,1
141529,and,0,0
141530,at,0,0
141531,one,0,0
141532,month,0,0
141533,follow,0,0
141534,up,0,0
141535,in,0,0
141536,both,0,0
141537,groups,0,0
141538,.,0,0
141539,Results,0,0
141540,showed,0,0
141541,that,0,0
141542,Kata,0,0
141543,techniques,0,0
141544,training,0,0
141545,significantly,0,0
141546,reduced,1,0
141547,stereotypy,1,1
141548,in,1,0
141549,the,1,0
141550,exercise,1,0
141551,group,1,0
141552,.,1,1
141553,Following,0,1
141554,participation,0,0
141555,in,0,0
141556,Kata,0,0
141557,techniques,0,0
141558,training,0,0
141559,",",0,1
141560,stereotypy,1,1
141561,decreased,1,1
141562,from,1,0
141563,baseline,1,0
141564,levels,1,1
141565,by,0,0
141566,a,0,0
141567,M,0,0
141568,of,0,0
141569,42.54,0,0
141570,%,0,0
141571,across,0,0
141572,participants,0,0
141573,.,0,1
141574,Interestingly,0,0
141575,",",0,0
141576,after,0,0
141577,30,0,0
141578,days,0,0
141579,of,0,0
141580,no,0,0
141581,practice,0,0
141582,",",0,0
141583,stereotypy,1,1
141584,in,1,0
141585,the,1,0
141586,exercise,1,0
141587,group,1,0
141588,remained,1,0
141589,significantly,1,0
141590,decreased,1,0
141591,compared,0,0
141592,to,0,0
141593,pre-intervention,0,0
141594,time,0,1
141595,.,0,0
141596,The,0,0
141597,participants,0,0
141598,of,0,0
141599,the,0,0
141600,control,0,0
141601,group,0,0
141602,did,0,0
141603,not,0,0
141604,show,0,0
141605,significant,0,0
141606,changes,0,1
141607,in,0,0
141608,the,0,0
141609,stereotypy,1,1
141610,.,1,0
141611,Teaching,0,0
141612,martial,0,0
141613,arts,0,0
141614,techniques,0,0
141615,to,0,0
141616,children,0,0
141617,with,0,0
141618,ASD,0,0
141619,for,0,0
141620,a,0,0
141621,long,0,0
141622,period,0,0
141623,of,0,1
141624,time,0,1
141625,consistently,0,0
141626,decreased,0,0
141627,their,0,0
141628,stereotypic,0,0
141629,behaviors,0,1
141630,.,0,0
141631,Right,0,1
141632,ventricular,0,1
141633,function,0,1
141634,during,0,0
141635,high-frequency,0,0
141636,oscillatory,0,1
141637,ventilation,0,1
141638,in,0,0
141639,adults,0,0
141640,with,0,0
141641,acute,0,0
141642,respiratory,0,1
141643,distress,0,1
141644,syndrome,0,0
141645,.,0,0
141646,OBJECTIVE,0,0
141647,To,0,0
141648,evaluate,0,0
141649,the,0,0
141650,effect,0,0
141651,of,0,0
141652,mean,0,1
141653,airway,0,1
141654,pressure,0,1
141655,under,0,0
141656,high-frequency,0,1
141657,oscillatory,0,1
141658,ventilation,0,1
141659,on,0,0
141660,right,0,1
141661,ventricular,0,1
141662,function,0,1
141663,.,0,0
141664,DESIGN,0,0
141665,Prospective,0,0
141666,randomized,0,0
141667,study,0,0
141668,.,0,1
141669,SETTING,0,0
141670,Intensive,0,0
141671,care,0,0
141672,unit,0,0
141673,of,0,0
141674,a,0,0
141675,tertiary,0,0
141676,care,0,0
141677,hospital,0,1
141678,.,0,1
141679,PATIENTS,0,0
141680,Sixteen,0,0
141681,consecutive,0,0
141682,patients,0,0
141683,within,0,0
141684,the,0,0
141685,first,0,0
141686,48,0,0
141687,hrs,0,0
141688,of,0,0
141689,mainly,0,0
141690,pulmonary,0,1
141691,acute,0,0
141692,respiratory,0,1
141693,distress,0,1
141694,syndrome,0,0
141695,.,0,0
141696,INTERVENTIONS,0,0
141697,After,0,0
141698,a,0,0
141699,6-hr-period,0,0
141700,of,0,0
141701,protective,0,0
141702,conventional,0,0
141703,mechanical,0,1
141704,ventilation,0,1
141705,",",0,1
141706,patients,0,0
141707,were,0,0
141708,submitted,0,0
141709,to,0,0
141710,three,0,0
141711,1-hr,0,0
141712,periods,0,0
141713,of,0,1
141714,high-frequency,0,0
141715,oscillatory,0,1
141716,ventilation,0,1
141717,(,0,1
141718,+5,0,0
141719,",",0,1
141720,+10,0,0
141721,",",0,1
141722,+15,0,0
141723,),0,0
141724,in,0,0
141725,a,0,0
141726,randomized,0,0
141727,order,0,0
141728,",",0,0
141729,with,0,0
141730,a,0,0
141731,mean,0,1
141732,airway,0,1
141733,pressure,0,1
141734,level,0,1
141735,determined,0,0
141736,by,0,0
141737,adding,0,0
141738,5,0,0
141739,",",0,0
141740,10,0,0
141741,",",0,0
141742,or,0,0
141743,15,0,0
141744,cm,0,0
141745,H2O,0,0
141746,to,0,0
141747,the,0,0
141748,mean,0,1
141749,airway,0,1
141750,pressure,0,1
141751,recorded,0,0
141752,during,0,0
141753,conventional,0,0
141754,mechanical,0,0
141755,ventilation,0,1
141756,.,0,1
141757,MEASUREMENTS,0,0
141758,AND,0,0
141759,MAIN,0,1
141760,RESULTS,0,0
141761,Mean,1,1
141762,airway,1,1
141763,pressure,1,1
141764,was,0,0
141765,18?3,0,0
141766,cm,0,0
141767,H2O,0,0
141768,during,0,0
141769,conventional,0,0
141770,mechanical,0,1
141771,ventilation,0,1
141772,and,0,1
141773,was,0,0
141774,increased,0,0
141775,until,0,0
141776,33?3,0,0
141777,cm,0,0
141778,H2O,0,0
141779,at,0,0
141780,high-frequency,0,0
141781,oscillatory,0,1
141782,ventilation+15,1,1
141783,.,1,1
141784,Right,1,1
141785,ventricular,1,1
141786,function,1,1
141787,was,1,0
141788,assessed,0,0
141789,using,1,0
141790,transesophageal,1,0
141791,echocardiography,1,0
141792,.,1,0
141793,During,0,0
141794,conventional,0,0
141795,mechanical,0,1
141796,ventilation,0,1
141797,",",0,0
141798,nine,0,0
141799,patients,0,0
141800,presented,0,0
141801,a,0,0
141802,right,1,1
141803,ventricular,1,1
141804,dysfunction,1,1
141805,(,1,1
141806,right,0,1
141807,ventricular,0,1
141808,end-diastolic,0,1
141809,area/left,0,0
141810,ventricular,0,1
141811,end-diastolic,0,1
141812,area,0,1
141813,ratio,0,1
141814,>,0,0
141815,0.6,0,0
141816,),0,0
141817,of,0,0
141818,whom,0,0
141819,four,0,0
141820,patients,0,0
141821,had,0,0
141822,a,0,0
141823,right,1,1
141824,ventricular,1,1
141825,failure,1,1
141826,(,1,1
141827,right,0,1
141828,ventricular,0,1
141829,end-diastolic,0,1
141830,area/left,0,0
141831,ventricular,0,1
141832,end-diastolic,0,1
141833,area,0,1
141834,ratio,0,1
141835,>,0,0
141836,0.9,0,0
141837,),0,0
141838,.,0,0
141839,High-frequency,0,1
141840,oscillatory,0,1
141841,ventilation+10,0,0
141842,and,0,1
141843,+15,0,0
141844,further,1,0
141845,worsened,1,0
141846,right,1,0
141847,ventricular,1,1
141848,function,1,1
141849,",",1,1
141850,resulting,0,0
141851,in,0,0
141852,about,0,0
141853,a,0,0
141854,40,0,0
141855,%,0,0
141856,increase,0,0
141857,in,0,0
141858,right,1,1
141859,ventricular,1,1
141860,end-diastolic,1,1
141861,area/left,1,0
141862,ventricular,1,1
141863,end-diastolic,1,1
141864,area,1,1
141865,ratio,1,1
141866,and,1,0
141867,a,0,0
141868,30,0,0
141869,%,0,0
141870,increase,0,0
141871,in,0,0
141872,end-diastolic,1,1
141873,eccentricity,1,1
141874,index,1,1
141875,when,1,0
141876,compared,0,0
141877,with,0,0
141878,conventional,0,0
141879,mechanical,0,1
141880,ventilation,0,1
141881,or,0,1
141882,high-frequency,0,1
141883,oscillatory,0,1
141884,ventilation+5,0,0
141885,periods,0,0
141886,.,0,0
141887,At,0,0
141888,high-frequency,0,0
141889,oscillatory,0,1
141890,ventilation+15,0,1
141891,",",0,0
141892,15,0,0
141893,patients,0,0
141894,had,1,0
141895,right,1,1
141896,ventricular,1,1
141897,dysfunction,1,1
141898,and,1,0
141899,nine,0,0
141900,had,1,0
141901,right,1,0
141902,ventricular,1,1
141903,failure,1,1
141904,.,1,0
141905,High-frequency,0,1
141906,oscillatory,0,1
141907,ventilation,0,1
141908,did,0,0
141909,not,1,0
141910,improve,1,0
141911,oxygenation,1,1
141912,whatever,1,0
141913,the,0,0
141914,mean,0,1
141915,airway,0,1
141916,pressure,0,1
141917,level,0,1
141918,.,0,0
141919,A,0,0
141920,significant,0,0
141921,redistribution,0,1
141922,of,0,1
141923,tidal,0,1
141924,variation,0,1
141925,to,0,0
141926,the,0,0
141927,posterior,0,0
141928,parts,0,0
141929,of,0,0
141930,the,0,0
141931,lung,0,0
141932,was,0,0
141933,observed,0,0
141934,on,0,0
141935,electrical,0,1
141936,impedance,0,1
141937,tomography,0,0
141938,measurements,0,1
141939,when,1,0
141940,increasing,1,0
141941,mean,1,1
141942,airway,1,1
141943,pressure,1,1
141944,.,1,0
141945,However,0,0
141946,",",0,0
141947,this,0,0
141948,redistribution,0,1
141949,was,0,0
141950,not,0,0
141951,observed,0,0
141952,in,0,0
141953,patients,0,0
141954,who,0,0
141955,presented,0,0
141956,a,0,0
141957,worsening,1,1
141958,of,1,0
141959,right,1,1
141960,ventricular,1,1
141961,function,1,1
141962,(,1,0
141963,right,0,1
141964,ventricular,0,1
141965,end-diastolic,0,1
141966,area/left,0,0
141967,ventricular,0,1
141968,end-diastolic,0,1
141969,area,0,1
141970,increase,0,1
141971,>,0,0
141972,40,0,0
141973,%,0,0
141974,),0,0
141975,at,0,0
141976,high-frequency,0,0
141977,oscillatory,0,1
141978,ventilation+15,0,1
141979,.,0,1
141980,CONCLUSIONS,0,0
141981,In,0,0
141982,patients,0,0
141983,with,0,0
141984,mainly,0,0
141985,pulmonary,0,1
141986,acute,0,0
141987,respiratory,0,1
141988,distress,0,1
141989,syndrome,0,1
141990,",",0,1
141991,using,0,0
141992,high,0,1
141993,mean,0,1
141994,airway,0,1
141995,pressure,0,1
141996,under,0,0
141997,high-frequency,0,0
141998,oscillatory,0,1
141999,ventilation,0,0
142000,can,1,0
142001,worsen,1,0
142002,right,1,1
142003,ventricular,1,1
142004,function,1,1
142005,when,1,0
142006,compared,0,0
142007,with,0,0
142008,protective,0,0
142009,conventional,0,0
142010,mechanical,0,1
142011,ventilation,0,1
142012,",",0,0
142013,notably,0,0
142014,in,0,0
142015,patients,0,0
142016,in,0,0
142017,whom,0,0
142018,high-frequency,0,0
142019,oscillatory,0,1
142020,ventilation,0,1
142021,produced,0,0
142022,less,0,0
142023,alveolar,0,1
142024,recruitment,0,0
142025,of,0,0
142026,the,0,0
142027,posterior,0,0
142028,parts,0,0
142029,of,0,0
142030,the,0,0
142031,lungs,0,0
142032,.,0,0
142033,This,0,0
142034,study,0,0
142035,highlights,0,0
142036,the,0,0
142037,interest,0,0
142038,of,0,0
142039,monitoring,0,0
142040,right,0,1
142041,ventricular,0,1
142042,function,0,1
142043,during,0,0
142044,high-frequency,0,0
142045,oscillatory,0,1
142046,ventilation,0,0
142047,.,0,0
142048,The,0,0
142049,Social,0,1
142050,Communication,0,1
142051,Intervention,0,0
142052,Project,0,1
142053,:,0,0
142054,a,0,0
142055,randomized,0,0
142056,controlled,0,0
142057,trial,0,0
142058,of,0,0
142059,the,0,0
142060,effectiveness,0,1
142061,of,0,1
142062,speech,0,1
142063,and,0,1
142064,language,0,1
142065,therapy,0,0
142066,for,0,0
142067,school-age,0,0
142068,children,0,0
142069,who,0,0
142070,have,0,0
142071,pragmatic,0,0
142072,and,0,1
142073,social,0,1
142074,communication,0,1
142075,problems,0,1
142076,with,0,0
142077,or,0,0
142078,without,0,0
142079,autism,0,1
142080,spectrum,0,0
142081,disorder,0,0
142082,.,0,1
142083,BACKGROUND,0,0
142084,Children,0,0
142085,who,0,0
142086,show,0,0
142087,disproportionate,0,1
142088,difficulty,0,1
142089,with,0,0
142090,the,0,0
142091,pragmatic,0,0
142092,as,0,0
142093,compared,0,0
142094,with,0,0
142095,the,0,0
142096,structural,0,0
142097,aspects,0,1
142098,of,0,0
142099,language,0,0
142100,are,0,0
142101,described,0,0
142102,as,0,0
142103,having,0,0
142104,pragmatic,0,0
142105,language,0,1
142106,impairment,0,1
142107,(,0,1
142108,PLI,0,0
142109,),0,1
142110,or,0,0
142111,social,0,1
142112,communication,0,1
142113,disorder,0,0
142114,(,0,1
142115,SCD,0,1
142116,),0,0
142117,.,0,0
142118,Some,0,0
142119,children,0,0
142120,who,0,0
142121,have,0,0
142122,PLI,0,0
142123,also,0,0
142124,show,0,0
142125,mild,0,0
142126,social,0,1
142127,impairments,0,1
142128,associated,0,0
142129,with,0,0
142130,high-functioning,0,0
142131,autism,0,0
142132,or,0,1
142133,autism,0,1
142134,spectrum,0,1
142135,disorder,0,0
142136,(,0,1
142137,ASD,0,0
142138,),0,0
142139,.,0,0
142140,There,0,0
142141,is,0,0
142142,little,0,0
142143,robust,0,0
142144,evidence,0,0
142145,of,0,1
142146,effectiveness,0,1
142147,of,0,1
142148,speech-language,0,0
142149,interventions,0,0
142150,which,0,0
142151,target,0,0
142152,the,0,0
142153,language,0,1
142154,",",0,1
142155,pragmatic,0,0
142156,or,0,1
142157,social,0,1
142158,communication,0,1
142159,needs,0,0
142160,of,0,0
142161,these,0,0
142162,children,0,0
142163,.,0,0
142164,AIMS,0,0
142165,To,0,0
142166,evaluate,0,0
142167,the,0,0
142168,effectiveness,0,0
142169,of,0,0
142170,an,0,0
142171,intensive,0,0
142172,manualized,0,0
142173,social,0,1
142174,communication,0,1
142175,intervention,0,0
142176,(,0,1
142177,SCIP,0,1
142178,),0,0
142179,for,0,0
142180,children,0,0
142181,who,0,0
142182,have,0,0
142183,PLI,0,0
142184,with,0,0
142185,or,0,0
142186,without,0,0
142187,features,0,0
142188,of,0,0
142189,ASD,0,0
142190,.,0,1
142191,METHODS,0,0
142192,&,0,0
142193,PROCEDURES,0,0
142194,In,0,0
142195,a,0,0
142196,single-blind,0,0
142197,RCT,0,0
142198,design,0,0
142199,",",0,0
142200,88,0,0
142201,children,0,0
142202,with,0,0
142203,pragmatic,0,0
142204,and,0,1
142205,social,0,1
142206,communication,0,1
142207,needs,0,0
142208,aged,0,0
142209,5,0,0
142210,;,0,0
142211,11-10,0,0
142212,;,0,0
142213,8,0,0
142214,",",0,0
142215,recruited,0,0
142216,from,0,0
142217,UK,0,1
142218,speech,0,1
142219,and,0,1
142220,language,0,1
142221,therapy,0,0
142222,services,0,1
142223,",",0,1
142224,were,0,0
142225,randomly,0,0
142226,assigned,0,0
142227,in,0,0
142228,a,0,0
142229,2:1,0,0
142230,ratio,0,0
142231,to,0,0
142232,SCIP,0,1
142233,or,0,0
142234,to,0,0
142235,treatment-as-usual,0,0
142236,.,0,0
142237,Children,0,0
142238,in,0,0
142239,the,0,0
142240,SCIP,0,1
142241,condition,0,0
142242,received,0,0
142243,up,0,0
142244,to,0,0
142245,20,0,0
142246,sessions,0,0
142247,of,0,0
142248,direct,0,1
142249,intervention,0,0
142250,from,0,0
142251,a,0,0
142252,specialist,0,0
142253,research,0,0
142254,speech,0,1
142255,and,0,1
142256,language,0,1
142257,therapist,0,1
142258,working,0,1
142259,with,0,0
142260,supervised,0,0
142261,assistants,0,0
142262,.,0,0
142263,All,0,0
142264,therapy,0,0
142265,content,0,1
142266,and,0,1
142267,methodology,0,0
142268,was,0,0
142269,derived,0,0
142270,from,0,0
142271,an,0,0
142272,intervention,0,0
142273,manual,0,0
142274,.,0,0
142275,A,0,0
142276,primary,0,0
142277,outcome,0,1
142278,measure,0,0
142279,of,0,1
142280,structural,1,0
142281,language,1,1
142282,and,0,1
142283,secondary,0,1
142284,outcome,0,1
142285,measures,0,1
142286,of,0,1
142287,narrative,1,0
142288,",",1,0
142289,parent-reported,1,1
142290,pragmatic,1,0
142291,functioning,1,1
142292,and,1,1
142293,social,1,1
142294,communication,1,1
142295,",",1,1
142296,blind-rated,1,1
142297,perceptions,1,1
142298,of,1,1
142299,conversational,1,1
142300,competence,1,1
142301,and,1,1
142302,teacher-reported,1,1
142303,ratings,1,1
142304,of,1,0
142305,classroom,1,0
142306,learning,1,1
142307,skills,1,1
142308,were,0,0
142309,taken,0,0
142310,pre-intervention,0,0
142311,",",0,0
142312,immediately,0,0
142313,post-intervention,0,1
142314,and,0,1
142315,at,0,1
142316,6-month,0,1
142317,follow-up,0,0
142318,.,0,1
142319,Analysis,0,0
142320,was,0,0
142321,by,0,0
142322,intention,0,1
142323,to,0,0
142324,treat,0,0
142325,.,0,0
142326,OUTCOMES,0,1
142327,&,0,0
142328,RESULTS,0,0
142329,No,0,1
142330,significant,0,0
142331,treatment,0,0
142332,effect,0,1
142333,was,0,0
142334,found,0,0
142335,for,0,0
142336,the,0,0
142337,primary,0,0
142338,outcome,0,1
142339,measure,0,0
142340,of,0,1
142341,structural,1,0
142342,language,1,1
142343,ability,1,1
142344,or,1,0
142345,for,1,0
142346,a,1,0
142347,measure,1,0
142348,of,1,0
142349,narrative,1,0
142350,ability,1,1
142351,.,1,1
142352,Significant,0,1
142353,treatment,0,0
142354,effects,0,1
142355,were,0,0
142356,found,0,0
142357,for,0,0
142358,blind-rated,1,0
142359,perceptions,1,0
142360,of,1,1
142361,conversational,1,1
142362,competence,1,1
142363,",",1,0
142364,for,1,0
142365,parent-reported,1,1
142366,measures,1,0
142367,of,1,1
142368,pragmatic,1,0
142369,functioning,1,1
142370,and,1,1
142371,social,1,1
142372,communication,1,1
142373,",",1,1
142374,and,1,1
142375,for,1,0
142376,teacher-reported,1,1
142377,ratings,1,1
142378,of,1,1
142379,classroom,1,0
142380,learning,1,1
142381,skills,1,1
142382,.,1,1
142383,CONCLUSIONS,0,0
142384,&,0,0
142385,IMPLICATIONS,0,0
142386,There,0,0
142387,is,0,0
142388,some,0,0
142389,evidence,0,0
142390,of,0,0
142391,an,0,0
142392,intervention,0,0
142393,effect,0,1
142394,on,0,0
142395,blind,0,0
142396,and,0,1
142397,parent/teacher-reported,0,1
142398,communication,0,1
142399,outcomes,0,1
142400,",",0,1
142401,but,0,0
142402,not,0,0
142403,standardized,0,0
142404,language,0,1
142405,assessment,0,1
142406,outcomes,0,1
142407,",",0,0
142408,for,0,0
142409,6-11-year-old,0,0
142410,children,0,0
142411,who,0,0
142412,have,0,0
142413,pragmatic,0,0
142414,and,0,1
142415,social,0,1
142416,communication,0,1
142417,needs,0,0
142418,.,0,0
142419,These,0,0
142420,findings,0,0
142421,are,0,0
142422,discussed,0,0
142423,in,0,0
142424,the,0,0
142425,context,0,0
142426,of,0,0
142427,the,0,0
142428,increasingly,0,0
142429,central,0,0
142430,role,0,0
142431,of,0,1
142432,service,0,0
142433,user,0,0
142434,outcomes,0,1
142435,in,0,0
142436,providing,0,0
142437,evidence,0,0
142438,for,0,0
142439,an,0,0
142440,intervention,0,0
142441,.,0,0
142442,The,0,0
142443,substantial,0,0
142444,overlap,0,1
142445,between,0,0
142446,the,0,0
142447,presence,0,0
142448,of,0,1
142449,PLI,0,0
142450,and,0,1
142451,ASD,0,0
142452,(,0,0
142453,75,0,0
142454,%,0,0
142455,),0,0
142456,across,0,0
142457,the,0,0
142458,whole,0,0
142459,cohort,0,0
142460,suggests,0,0
142461,that,0,0
142462,the,0,0
142463,intervention,0,0
142464,may,0,0
142465,also,0,0
142466,be,0,0
142467,applicable,0,0
142468,to,0,0
142469,some,0,0
142470,verbally,0,1
142471,able,0,0
142472,children,0,0
142473,with,0,0
142474,ASD,0,0
142475,who,0,0
142476,have,0,0
142477,pragmatic,0,0
142478,communication,0,1
142479,needs,0,0
142480,.,0,0
142481,Roles,1,1
142482,of,1,0
142483,adapalene,1,0
142484,in,0,0
142485,the,0,0
142486,treatment,0,0
142487,of,0,1
142488,pityriasis,0,1
142489,versicolor,0,0
142490,.,0,1
142491,BACKGROUND,0,0
142492,Ketoconazole,0,0
142493,is,0,0
142494,a,0,0
142495,typical,0,0
142496,treatment,0,0
142497,available,0,0
142498,for,0,0
142499,pityriasis,0,1
142500,versicolor,0,0
142501,;,0,1
142502,tretinoin,0,0
142503,cream,0,0
142504,is,0,0
142505,effective,0,1
142506,",",0,0
142507,too,0,0
142508,.,0,0
142509,Adapalene,0,0
142510,gel,0,0
142511,is,0,0
142512,a,0,0
142513,tretinoin,0,0
142514,derivative,0,0
142515,and,0,0
142516,has,0,0
142517,a,0,0
142518,lower,0,0
142519,incidence,0,1
142520,of,0,1
142521,irritation,1,1
142522,compared,0,0
142523,with,0,0
142524,other,0,0
142525,topical,0,0
142526,retinoid,0,0
142527,products,0,1
142528,.,0,0
142529,However,0,0
142530,",",0,0
142531,there,0,0
142532,are,0,0
142533,no,0,0
142534,reports,0,0
142535,on,0,0
142536,adapalene,0,0
142537,gel,0,0
142538,for,0,0
142539,the,0,0
142540,treatment,0,0
142541,of,0,1
142542,pityriasis,0,1
142543,versicolor,0,0
142544,.,0,0
142545,OBJECTIVE,0,0
142546,To,0,0
142547,study,0,0
142548,the,0,0
142549,effect,0,0
142550,of,0,1
142551,adapalene,0,0
142552,gel,0,0
142553,comparing,0,0
142554,the,0,0
142555,treatment,0,0
142556,with,0,0
142557,adapalene,0,0
142558,gel,0,0
142559,and,0,0
142560,2,0,0
142561,%,0,0
142562,ketoconazole,0,0
142563,cream,0,0
142564,in,0,0
142565,pityriasis,0,1
142566,versicolor,0,0
142567,.,0,1
142568,METHODS,0,0
142569,Eighty,0,1
142570,patients,0,0
142571,suffering,0,0
142572,from,0,0
142573,pityriasis,0,1
142574,versicolor,0,0
142575,were,0,0
142576,randomly,0,0
142577,divided,0,0
142578,into,0,0
142579,two,0,0
142580,groups,0,0
142581,;,0,0
142582,one,0,0
142583,group,0,0
142584,were,0,0
142585,treated,0,0
142586,with,0,0
142587,2,0,0
142588,%,0,0
142589,ketoconazole,0,0
142590,cream,0,0
142591,topically,0,0
142592,twice,0,0
142593,daily,0,0
142594,for,0,0
142595,2,0,0
142596,weeks,0,0
142597,",",0,0
142598,adapalene,0,0
142599,gel,0,0
142600,was,0,0
142601,used,0,0
142602,for,0,0
142603,the,0,0
142604,other,0,0
142605,group,0,0
142606,in,0,0
142607,a,0,0
142608,similar,0,0
142609,fashion,0,0
142610,.,0,1
142611,RESULTS,0,0
142612,There,0,0
142613,were,0,0
142614,no,0,0
142615,significant,0,0
142616,differences,0,0
142617,in,0,0
142618,efficacy,1,1
142619,between,0,0
142620,the,0,0
142621,two,0,0
142622,groups,0,0
142623,.,0,0
142624,No,0,0
142625,major,0,1
142626,side,1,1
142627,effects,1,1
142628,were,0,0
142629,noted,0,0
142630,in,0,0
142631,any,0,0
142632,of,0,0
142633,the,0,0
142634,groups,0,0
142635,either,0,0
142636,.,0,1
142637,CONCLUSION,0,1
142638,Adapalene,0,0
142639,was,0,0
142640,the,0,0
142641,favorable,0,0
142642,option,0,0
142643,in,0,0
142644,the,0,0
142645,treatment,0,0
142646,of,0,1
142647,pityriasis,0,1
142648,versicolor,0,0
142649,.,0,0
142650,The,0,0
142651,probable,0,1
142652,therapeutic,0,0
142653,mechanism,0,0
142654,of,0,0
142655,adapalene,0,0
142656,is,0,0
142657,also,0,0
142658,discussed,0,0
142659,.,0,0
142660,Effect,0,0
142661,of,0,0
142662,a,0,0
142663,mobile,0,0
142664,safety,0,1
142665,alarm,0,1
142666,on,0,0
142667,going,1,0
142668,outside,1,0
142669,",",1,0
142670,feeling,1,1
142671,safe,1,1
142672,",",1,0
142673,fear,1,1
142674,of,1,1
142675,falling,1,1
142676,",",1,0
142677,and,1,1
142678,quality,1,1
142679,of,1,1
142680,life,1,1
142681,in,0,0
142682,community-living,0,1
142683,older,0,0
142684,persons,0,0
142685,:,0,0
142686,a,0,0
142687,randomized,0,0
142688,controlled,0,0
142689,trial,0,0
142690,.,0,0
142691,Controlled-release,0,0
142692,melatonin,0,0
142693,",",0,0
142694,singly,0,0
142695,and,0,0
142696,combined,0,0
142697,with,0,0
142698,cognitive,0,1
142699,behavioural,0,1
142700,therapy,0,0
142701,",",0,0
142702,for,0,0
142703,persistent,0,1
142704,insomnia,1,1
142705,in,0,0
142706,children,0,0
142707,with,0,0
142708,autism,0,0
142709,spectrum,0,0
142710,disorders,0,0
142711,:,0,0
142712,a,0,0
142713,randomized,0,0
142714,placebo-controlled,0,0
142715,trial,0,0
142716,.,0,0
142717,Although,0,0
142718,melatonin,0,0
142719,and,0,1
142720,cognitive-behavioural,0,0
142721,therapy,0,0
142722,have,0,0
142723,shown,0,0
142724,efficacy,0,1
142725,in,0,0
142726,treating,0,0
142727,sleep,0,1
142728,disorders,0,0
142729,in,0,0
142730,children,0,0
142731,with,0,0
142732,autism,0,0
142733,spectrum,0,0
142734,disorders,0,0
142735,",",0,0
142736,little,0,0
142737,is,0,0
142738,known,0,0
142739,about,0,0
142740,their,0,0
142741,relative,0,1
142742,or,0,1
142743,combined,0,0
142744,efficacy,0,1
142745,.,0,0
142746,One,0,0
142747,hundred,0,0
142748,and,0,0
142749,sixty,0,0
142750,children,0,0
142751,with,0,0
142752,autism,0,0
142753,spectrum,0,0
142754,disorders,0,0
142755,",",0,0
142756,aged,0,0
142757,4-10,0,0
142758,years,0,0
142759,",",0,0
142760,suffering,0,1
142761,from,0,0
142762,sleep,0,1
142763,onset,0,1
142764,insomnia,0,1
142765,and,0,1
142766,impaired,0,1
142767,sleep,0,1
142768,maintenance,0,0
142769,",",0,1
142770,were,0,0
142771,assigned,0,0
142772,randomly,0,0
142773,to,0,0
142774,either,0,0
142775,(,0,0
142776,1,0,0
142777,),0,0
142778,combination,0,0
142779,of,0,1
142780,controlled-release,0,0
142781,melatonin,0,0
142782,and,0,1
142783,cognitive-behavioural,0,0
142784,therapy,0,0
142785,;,0,0
142786,(,0,0
142787,2,0,0
142788,),0,0
142789,controlled-release,0,0
142790,melatonin,0,0
142791,;,0,0
142792,(,0,0
142793,3,0,0
142794,),0,0
142795,four,0,0
142796,sessions,0,0
142797,of,0,0
142798,cognitive-behavioural,0,0
142799,therapy,0,0
142800,;,0,1
142801,or,0,0
142802,(,0,0
142803,4,0,0
142804,),0,0
142805,placebo,0,0
142806,drug,0,0
142807,treatment,0,0
142808,condition,0,0
142809,for,0,0
142810,12,0,0
142811,weeks,0,0
142812,in,0,0
142813,a,0,0
142814,1,0,0
142815,:,0,0
142816,1,0,0
142817,:,0,0
142818,1,0,0
142819,:,0,0
142820,1,0,0
142821,ratio,0,0
142822,.,0,0
142823,Children,0,0
142824,were,0,0
142825,studied,0,0
142826,at,0,0
142827,baseline,0,0
142828,and,0,0
142829,after,0,0
142830,12,0,0
142831,weeks,0,0
142832,of,0,0
142833,treatment,0,0
142834,.,0,1
142835,Treatment,0,0
142836,response,0,1
142837,was,0,0
142838,assessed,0,0
142839,with,0,0
142840,1-week,0,0
142841,actigraphic,0,1
142842,monitoring,0,0
142843,",",0,1
142844,sleep,0,1
142845,diary,0,1
142846,and,0,1
142847,sleep,0,1
142848,questionnaire,0,1
142849,.,0,1
142850,Main,0,0
142851,outcome,0,1
142852,measures,0,1
142853,",",0,0
142854,derived,0,0
142855,actigraphically,0,1
142856,",",0,0
142857,were,0,0
142858,sleep,1,1
142859,latency,1,1
142860,",",1,1
142861,total,1,1
142862,sleep,1,1
142863,time,1,1
142864,",",1,0
142865,wake,1,0
142866,after,1,0
142867,sleep,1,1
142868,onset,1,1
142869,and,1,1
142870,number,1,1
142871,of,1,0
142872,awakenings,1,1
142873,.,1,0
142874,The,0,0
142875,active,0,0
142876,treatment,0,0
142877,groups,0,0
142878,all,0,0
142879,resulted,0,0
142880,in,0,0
142881,improvements,0,0
142882,across,0,0
142883,all,0,0
142884,outcome,0,1
142885,measures,0,1
142886,",",0,0
142887,with,0,0
142888,moderate-to-large,0,1
142889,effect,0,0
142890,sizes,0,1
142891,from,0,0
142892,baseline,0,0
142893,to,0,0
142894,a,0,0
142895,12-week,0,0
142896,assessment,0,0
142897,.,0,1
142898,Melatonin,0,1
142899,treatment,0,0
142900,was,0,0
142901,mainly,0,0
142902,effective,0,0
142903,in,0,0
142904,reducing,0,0
142905,insomnia,1,1
142906,symptoms,1,1
142907,",",0,0
142908,while,0,0
142909,cognitive-behavioural,0,0
142910,therapy,0,0
142911,had,0,0
142912,a,0,0
142913,light,0,1
142914,positive,0,1
142915,impact,0,0
142916,mainly,0,0
142917,on,0,0
142918,sleep,1,1
142919,latency,1,1
142920,",",0,0
142921,suggesting,0,0
142922,that,0,0
142923,some,0,0
142924,behavioural,0,0
142925,aspects,0,0
142926,might,0,0
142927,play,0,0
142928,a,0,0
142929,role,0,0
142930,in,0,0
142931,determining,0,0
142932,initial,1,0
142933,insomnia,1,1
142934,.,1,0
142935,The,0,0
142936,combination,0,0
142937,treatment,0,0
142938,group,0,0
142939,showed,0,0
142940,a,0,0
142941,trend,0,0
142942,to,0,0
142943,outperform,0,0
142944,other,0,0
142945,active,0,0
142946,treatment,0,0
142947,groups,0,0
142948,",",0,0
142949,with,0,0
142950,fewer,0,1
142951,dropouts,0,0
142952,and,0,1
142953,a,0,0
142954,greater,0,1
142955,proportion,0,1
142956,of,0,1
142957,treatment,0,0
142958,responders,0,0
142959,achieving,0,1
142960,clinically,0,0
142961,significant,0,0
142962,changes,0,1
142963,(,0,0
142964,63.38,0,0
142965,%,0,0
142966,normative,0,0
142967,sleep,0,1
142968,efficiency,0,1
142969,criterion,0,1
142970,of,0,0
142971,>,0,0
142972,85,0,0
142973,%,0,0
142974,and,0,0
142975,84.62,0,0
142976,%,0,0
142977,",",0,0
142978,sleep,0,1
142979,onset,0,1
142980,latency,0,1
142981,<,0,0
142982,30,0,0
142983,min,0,0
142984,),0,0
142985,.,0,0
142986,This,0,0
142987,study,0,0
142988,demonstrates,0,0
142989,that,0,0
142990,adding,0,0
142991,behavioural,0,1
142992,intervention,0,0
142993,to,0,0
142994,melatonin,0,0
142995,treatment,0,0
142996,seems,0,0
142997,to,0,0
142998,result,0,0
142999,in,0,0
143000,a,0,0
143001,better,0,0
143002,treatment,0,0
143003,response,0,1
143004,",",0,0
143005,at,0,0
143006,least,0,0
143007,in,0,0
143008,the,0,0
143009,short,0,0
143010,term,0,0
143011,.,0,0
143012,Can,0,0
143013,simvastatin,0,0
143014,improve,0,0
143015,erectile,1,1
143016,function,1,1
143017,and,0,1
143018,health-related,1,1
143019,quality,1,1
143020,of,1,1
143021,life,1,1
143022,in,0,0
143023,men,0,0
143024,aged,0,0
143025,?40,0,0
143026,years,0,0
143027,with,0,0
143028,erectile,0,1
143029,dysfunction,0,1
143030,?,0,0
143031,Results,0,0
143032,of,0,0
143033,the,0,0
143034,Erectile,0,0
143035,Dysfunction,0,1
143036,and,0,1
143037,Statins,0,1
143038,Trial,0,0
143039,[,0,0
143040,ISRCTN66772971,0,0
143041,],0,0
143042,.,0,0
143043,OBJECTIVE,0,0
143044,To,0,0
143045,evaluate,0,0
143046,the,1,0
143047,effectiveness,1,1
143048,and,1,1
143049,cost-effectiveness,1,1
143050,of,1,1
143051,simvastatin,0,0
143052,on,0,0
143053,erectile,1,1
143054,function,1,1
143055,and,1,1
143056,health-related,1,1
143057,quality,1,1
143058,of,1,1
143059,life,1,1
143060,in,1,0
143061,men,0,0
143062,aged,0,0
143063,?40,0,0
143064,years,0,0
143065,with,0,0
143066,erectile,0,1
143067,dysfunction,0,1
143068,(,0,1
143069,ED,0,0
143070,),0,0
143071,.,0,0
143072,PATIENTS,0,0
143073,AND,0,0
143074,METHODS,0,0
143075,ED,0,0
143076,is,0,0
143077,common,0,0
143078,in,0,0
143079,men,0,0
143080,aged,0,0
143081,?40,0,0
143082,years,0,0
143083,and,0,0
143084,impacts,0,0
143085,upon,0,0
143086,their,0,0
143087,overall,0,1
143088,health-related,0,1
143089,quality,0,1
143090,of,0,1
143091,life,0,1
143092,and,0,1
143093,that,0,0
143094,of,0,0
143095,their,0,0
143096,partners,0,0
143097,.,0,1
143098,Men,0,0
143099,aged,0,0
143100,?40,0,0
143101,years,0,0
143102,who,0,0
143103,were,0,0
143104,not,0,0
143105,receiving,0,0
143106,lipid,0,1
143107,lowering,0,1
143108,or,0,1
143109,anti-hypertensive,0,1
143110,medication,0,1
143111,and,0,1
143112,not,0,0
143113,at,0,0
143114,high,0,0
143115,cardiovascular,0,1
143116,risk,0,1
143117,were,0,0
143118,recruited,0,0
143119,from,0,0
143120,10,0,0
143121,general,0,0
143122,practices,0,0
143123,in,0,0
143124,the,0,0
143125,East,0,0
143126,of,0,0
143127,England,0,0
143128,.,0,0
143129,In,0,0
143130,total,0,1
143131,",",0,0
143132,173,0,0
143133,eligible,0,0
143134,men,0,0
143135,with,0,0
143136,untreated,0,0
143137,ED,0,0
143138,were,0,0
143139,randomized,0,0
143140,to,0,0
143141,double-blind,0,0
143142,treatment,0,0
143143,with,0,0
143144,40,0,0
143145,mg,0,0
143146,of,0,0
143147,simvastatin,0,0
143148,or,0,1
143149,placebo,0,0
143150,once,0,0
143151,daily,0,0
143152,for,0,0
143153,6,0,0
143154,months,0,0
143155,.,0,0
143156,Data,0,0
143157,were,0,0
143158,collected,0,0
143159,at,0,0
143160,three,0,0
143161,points,0,0
143162,over,0,0
143163,30,0,0
143164,weeks,0,0
143165,.,0,0
143166,The,0,0
143167,main,0,1
143168,outcome,0,1
143169,was,1,0
143170,erectile,1,1
143171,function,1,1
143172,(,1,0
143173,International,1,1
143174,Index,1,1
143175,of,1,1
143176,Erectile,1,0
143177,Function-5,1,1
143178,score,1,1
143179,),1,0
143180,.,1,0
143181,Secondary,0,0
143182,outcomes,0,1
143183,included,0,0
143184,male,1,0
143185,ED-specific,1,1
143186,quality,1,1
143187,of,1,1
143188,life,1,1
143189,(,1,1
143190,MED-QoL,1,1
143191,),1,1
143192,",",1,0
143193,quality-adjusted,1,1
143194,life,1,1
143195,years,1,0
143196,(,1,1
143197,QALYs,1,1
143198,),1,0
143199,using,1,0
143200,the,1,0
143201,generic,1,0
143202,Euroqol,1,1
143203,measure,1,1
143204,(,1,1
143205,EQ-5D,1,1
143206,),1,1
143207,",",1,0
143208,endothelial,1,1
143209,function,1,1
143210,",",1,1
143211,cardiovascular,1,1
143212,risk,1,1
143213,",",1,1
143214,cholesterol,1,1
143215,and,1,1
143216,health,1,1
143217,service,1,0
143218,costs,1,1
143219,.,1,0
143220,RESULTS,0,0
143221,There,0,0
143222,was,0,0
143223,no,0,0
143224,significant,0,0
143225,difference,1,0
143226,in,1,0
143227,erectile,1,1
143228,function,1,1
143229,between,1,0
143230,the,0,0
143231,simvastatin,0,0
143232,and,0,1
143233,placebo,0,0
143234,groups,0,0
143235,(,0,0
143236,mean,0,1
143237,change,0,1
143238,",",0,0
143239,1.28,0,0
143240,vs,0,0
143241,0.07,0,0
143242,",",0,0
143243,z,0,0
143244,=,0,0
143245,1.1,0,0
143246,",",0,0
143247,p,0,0
143248,=,0,0
143249,0.27,0,0
143250,),0,0
143251,",",0,0
143252,although,0,0
143253,a,0,0
143254,significant,0,0
143255,improvement,1,1
143256,in,1,0
143257,MED-QoL,1,1
143258,was,0,0
143259,observed,0,0
143260,(,0,0
143261,5,0,0
143262,%,0,0
143263,vs,0,0
143264,2,0,0
143265,%,0,0
143266,",",0,0
143267,z,0,1
143268,=,0,0
143269,2.09,0,0
143270,",",0,0
143271,p,0,0
143272,=,0,0
143273,0.04,0,0
143274,),0,0
143275,.,0,0
143276,Both,1,0
143277,10-year,1,1
143278,cardiovascular,1,1
143279,risk,1,1
143280,and,1,1
143281,low-density,1,1
143282,lipoprotein,1,1
143283,were,1,0
143284,reduced,1,1
143285,(,0,0
143286,cardiovascular,0,1
143287,risk,0,1
143288,",",0,1
143289,z,0,1
143290,=,0,0
143291,-3.67,0,0
143292,",",0,1
143293,p,0,0
143294,<,0,0
143295,0.001,0,0
143296,;,0,0
143297,low-density,0,0
143298,lipoprotein,0,1
143299,",",0,1
143300,z,0,1
143301,=,0,0
143302,-5.46,0,0
143303,",",0,1
143304,p,0,0
143305,<,0,0
143306,0.001,0,0
143307,),0,0
143308,",",0,0
143309,with,0,0
143310,no,0,0
143311,consistent,0,0
143312,change,0,1
143313,in,1,0
143314,endothelial,1,1
143315,function,1,1
143316,.,1,0
143317,The,1,0
143318,frequency,1,1
143319,of,1,0
143320,sexual,1,1
143321,encounters,1,0
143322,is,1,0
143323,correlated,1,0
143324,with,1,0
143325,improved,1,1
143326,erectile,1,1
143327,function,1,1
143328,.,1,0
143329,The,1,0
143330,joint,1,1
143331,distribution,1,0
143332,of,1,1
143333,costs,1,1
143334,and,1,1
143335,QALY,1,0
143336,benefits,1,0
143337,indicates,1,0
143338,that,0,0
143339,the,0,0
143340,probability,0,1
143341,of,0,0
143342,simvastatin,1,0
143343,being,1,0
143344,cost-effective,1,0
143345,for,1,0
143346,willingness-to-pay,1,0
143347,thresholds,0,1
143348,of,0,1
143349,"?20,000",0,0
143350,and,0,0
143351,"?30,000",0,0
143352,is,0,0
143353,86,0,0
143354,%,0,0
143355,and,0,0
143356,83,0,0
143357,%,0,0
143358,",",0,0
143359,respectively,0,0
143360,.,0,0
143361,CONCLUSIONS,0,0
143362,Identifying,0,0
143363,men,0,0
143364,with,0,0
143365,ED,0,0
143366,provides,0,0
143367,an,0,0
143368,opportunity,0,0
143369,to,0,0
143370,modify,0,0
143371,future,0,0
143372,cardiovascular,0,1
143373,risk,0,1
143374,and,0,0
143375,to,0,0
143376,improve,0,0
143377,MED-QoL,0,0
143378,by,0,0
143379,treating,0,0
143380,them,0,0
143381,with,0,0
143382,40,0,0
143383,mg,0,0
143384,of,0,0
143385,simvastatin,0,0
143386,.,0,0
143387,The,0,0
143388,joint,0,1
143389,analysis,0,0
143390,of,1,1
143391,costs,1,1
143392,and,0,1
143393,QALY,1,0
143394,benefits,1,0
143395,suggests,0,0
143396,that,0,0
143397,there,0,0
143398,is,0,0
143399,high,0,0
143400,probability,0,1
143401,that,0,0
143402,simvastatin,0,0
143403,is,0,0
143404,a,0,0
143405,cost-effective,0,0
143406,strategy,0,0
143407,in,0,0
143408,men,0,0
143409,with,0,0
143410,ED,0,0
143411,.,0,0
143412,The,0,0
143413,findings,0,0
143414,could,0,0
143415,influence,0,0
143416,urological,0,0
143417,and,0,1
143418,primary,0,1
143419,care,0,0
143420,practice,0,0
143421,by,0,0
143422,including,0,0
143423,questions,0,1
143424,on,0,0
143425,ED,0,0
143426,during,0,0
143427,routine,0,0
143428,consultations,0,1
143429,and,0,1
143430,relevant,0,1
143431,clinical,0,0
143432,protocols,0,0
143433,.,0,0
143434,This,0,0
143435,provides,0,0
143436,an,0,0
143437,opportunity,0,0
143438,to,0,0
143439,impart,0,0
143440,lifestyle,0,0
143441,advice,0,0
143442,.,0,0
143443,Pilot,0,1
143444,randomized,0,0
143445,controlled,0,0
143446,dosing,0,0
143447,study,0,0
143448,of,0,1
143449,cranberry,0,0
143450,capsules,0,0
143451,for,0,0
143452,reduction,0,1
143453,of,0,1
143454,bacteriuria,1,1
143455,plus,1,0
143456,pyuria,1,1
143457,in,0,0
143458,female,0,0
143459,nursing,0,1
143460,home,0,0
143461,residents,0,0
143462,.,0,0
143463,The,0,0
143464,effects,0,0
143465,of,0,0
143466,orthotic,0,0
143467,heel,0,0
143468,lifts,0,1
143469,on,0,0
143470,Achilles,1,1
143471,tendon,1,1
143472,force,1,1
143473,and,1,1
143474,strain,1,1
143475,during,0,0
143476,running,0,0
143477,.,0,0
143478,This,0,0
143479,study,0,0
143480,assessed,0,0
143481,the,0,0
143482,effects,0,1
143483,of,0,0
143484,orthotic,0,0
143485,heel,0,0
143486,lifts,0,1
143487,on,0,0
143488,Achilles,1,1
143489,tendon,1,1
143490,(,1,1
143491,AT,1,0
143492,),1,1
143493,force,1,1
143494,and,1,1
143495,strain,1,1
143496,during,0,0
143497,running,0,0
143498,.,0,0
143499,Ten,0,0
143500,females,0,0
143501,ran,0,0
143502,barefoot,0,0
143503,over,0,0
143504,a,0,0
143505,force,0,1
143506,plate,0,0
143507,in,0,0
143508,three,0,0
143509,conditions,0,0
143510,:,0,0
143511,no,0,0
143512,heel,0,0
143513,lifts,0,1
143514,(,0,1
143515,NHL,0,1
143516,),0,1
143517,",",0,0
143518,with,0,0
143519,12,0,0
143520,mm,0,0
143521,heel,0,0
143522,lifts,0,0
143523,(,0,0
143524,12HL,0,0
143525,),0,0
143526,and,0,0
143527,with,0,0
143528,18,0,0
143529,mm,0,0
143530,heel,0,0
143531,lifts,0,0
143532,(,0,0
143533,18HL,0,0
143534,),0,0
143535,.,0,0
143536,Kinematics,1,0
143537,for,1,0
143538,the,1,0
143539,right,1,0
143540,lower,1,1
143541,limb,1,1
143542,were,0,0
143543,collected,0,0
143544,(,0,0
143545,200,0,0
143546,Hz,0,0
143547,),0,0
143548,.,0,0
143549,AT,1,0
143550,force,1,1
143551,was,0,0
143552,calculated,0,0
143553,from,0,0
143554,inverse,0,0
143555,dynamics,0,0
143556,.,0,0
143557,AT,1,0
143558,strain,1,1
143559,was,0,0
143560,determined,0,0
143561,from,0,0
143562,kinematics,0,1
143563,and,0,1
143564,ultrasound,0,1
143565,images,0,0
143566,of,0,1
143567,medial,0,1
143568,gastrocnemius,0,0
143569,(,0,0
143570,50,0,0
143571,Hz,0,0
143572,),0,0
143573,.,0,0
143574,Peak,1,1
143575,AT,1,0
143576,strain,1,1
143577,was,0,0
143578,less,0,0
143579,for,0,0
143580,18HL,0,0
143581,(,0,0
143582,5.5,0,0
143583,?,0,0
143584,4.4,0,0
143585,%,0,0
143586,),0,0
143587,than,0,0
143588,for,0,0
143589,NHL,0,0
143590,(,0,0
143591,7.4,0,0
143592,?,0,0
143593,4.2,0,0
143594,%,0,0
143595,),0,0
143596,(,0,0
143597,p,0,0
143598,=,0,0
143599,.029,0,0
143600,",",0,1
143601,effect,0,1
143602,size,0,1
143603,[,0,0
143604,ES,0,0
143605,],0,0
143606,=,0,0
143607,0.44,0,0
143608,),0,0
143609,but,0,0
143610,not,0,0
143611,for,0,0
143612,12HL,0,0
143613,(,0,0
143614,5.8,0,0
143615,?,0,0
143616,4.8,0,0
143617,%,0,0
143618,),0,0
143619,versus,0,0
143620,NHL,0,1
143621,(,0,0
143622,ES,0,0
143623,=,0,0
143624,0.35,1,0
143625,),1,0
143626,.,1,0
143627,Peak,1,1
143628,AT,1,0
143629,force,1,1
143630,was,1,0
143631,significantly,0,0
143632,(,0,0
143633,p,0,0
143634,=,0,0
143635,.024,0,0
143636,",",0,1
143637,ES,0,0
143638,=,0,0
143639,0.42,0,0
143640,),0,0
143641,less,0,0
143642,for,0,0
143643,18HL,0,0
143644,(,0,0
143645,2382,0,0
143646,?,0,0
143647,717,0,0
143648,N,0,0
143649,),0,0
143650,than,0,0
143651,for,0,0
143652,NHL,0,0
143653,(,0,0
143654,2710,0,0
143655,?,0,0
143656,830,0,0
143657,N,0,0
143658,),0,0
143659,but,0,0
143660,not,0,0
143661,for,0,0
143662,12HL,0,0
143663,(,0,0
143664,2538,0,0
143665,?,0,0
143666,823,0,0
143667,N,0,0
143668,",",0,0
143669,ES,0,0
143670,=,0,0
143671,0.21,0,0
143672,),0,0
143673,.,0,0
143674,The,0,0
143675,18HL,0,0
143676,reduced,1,0
143677,ankle,1,0
143678,dorsiflexion,1,1
143679,but,1,0
143680,not,1,0
143681,flexion-extension,1,1
143682,ankle,1,1
143683,moments,1,1
143684,and,1,1
143685,increased,1,0
143686,the,1,0
143687,AT,1,0
143688,moment,1,1
143689,arm,1,0
143690,compared,1,0
143691,with,0,0
143692,NHL,0,0
143693,.,0,1
143694,Thus,0,1
143695,",",0,0
143696,18HL,0,0
143697,reduced,1,0
143698,force,1,0
143699,and,1,1
143700,strain,1,1
143701,on,1,0
143702,the,1,0
143703,AT,0,0
143704,during,0,0
143705,running,0,0
143706,via,0,0
143707,a,0,0
143708,reduction,1,1
143709,in,1,0
143710,dorsiflexion,1,1
143711,",",1,1
143712,which,1,0
143713,lengthened,1,1
143714,the,1,0
143715,AT,1,0
143716,moment,1,0
143717,arm,1,0
143718,.,1,0
143719,Therefore,0,0
143720,",",0,0
143721,heel,0,0
143722,lifts,0,0
143723,could,0,0
143724,be,0,0
143725,used,0,0
143726,to,0,0
143727,reduce,0,0
143728,AT,1,0
143729,loading,1,1
143730,and,1,1
143731,strain,1,1
143732,during,1,0
143733,the,0,0
143734,rehabilitation,0,0
143735,of,0,0
143736,AT,0,0
143737,injuries,0,0
143738,.,0,0
143739,Comparing,0,0
143740,microvascular,1,0
143741,alterations,1,0
143742,during,0,0
143743,minimal,0,1
143744,extracorporeal,0,0
143745,circulation,0,1
143746,and,0,1
143747,conventional,0,0
143748,cardiopulmonary,0,1
143749,bypass,0,0
143750,in,0,0
143751,coronary,0,1
143752,artery,0,1
143753,bypass,0,1
143754,graft,0,1
143755,surgery,0,0
143756,:,0,0
143757,a,0,0
143758,prospective,0,0
143759,",",0,0
143760,randomized,0,0
143761,study,0,0
143762,.,0,0
143763,OBJECTIVES,0,1
143764,Minimal,0,1
143765,extracorporeal,0,0
143766,circulation,0,1
143767,(,0,1
143768,MECC,0,0
143769,),0,0
143770,has,0,0
143771,been,0,0
143772,introduced,0,0
143773,in,0,0
143774,coronary,0,0
143775,artery,0,1
143776,bypass,0,1
143777,graft,0,1
143778,(,0,1
143779,CABG,0,1
143780,),0,1
143781,surgery,0,0
143782,",",0,0
143783,offering,0,0
143784,clinical,0,1
143785,benefits,0,0
143786,owing,0,0
143787,to,0,0
143788,reduced,0,1
143789,hemodilution,0,0
143790,and,0,0
143791,no,0,0
143792,blood-air,0,1
143793,interface,0,1
143794,.,0,1
143795,Yet,0,0
143796,",",0,0
143797,the,0,0
143798,effects,0,1
143799,of,0,0
143800,MECC,0,0
143801,on,0,0
143802,the,0,0
143803,intraoperative,0,1
143804,microvascular,0,1
143805,perfusion,0,1
143806,in,0,0
143807,comparison,0,0
143808,with,0,0
143809,conventional,0,0
143810,extracorporeal,0,0
143811,circulation,0,1
143812,(,0,1
143813,CECC,0,0
143814,),0,0
143815,have,0,0
143816,not,0,0
143817,been,0,0
143818,studied,0,0
143819,so,0,0
143820,far,0,0
143821,.,0,0
143822,METHODS,0,0
143823,The,0,0
143824,current,0,0
143825,study,0,0
143826,aimed,0,0
143827,to,0,0
143828,analyze,0,0
143829,alterations,1,0
143830,in,1,0
143831,microvascular,1,1
143832,perfusion,1,0
143833,at,0,0
143834,4,0,0
143835,predefined,0,0
143836,time,0,1
143837,points,0,0
143838,(,0,1
143839,T1-T4,0,0
143840,),0,0
143841,during,0,0
143842,on-pump,0,0
143843,CABG,0,1
143844,using,0,0
143845,orthogonal,0,0
143846,polarization,0,1
143847,spectral,0,1
143848,imaging,0,0
143849,.,0,0
143850,Forty,0,0
143851,patients,0,0
143852,were,0,0
143853,randomized,0,0
143854,for,0,0
143855,being,0,0
143856,operated,0,0
143857,on,0,0
143858,with,0,0
143859,either,0,0
143860,MECC,0,0
143861,or,0,0
143862,CECC,0,0
143863,.,0,1
143864,Changes,0,1
143865,in,0,0
143866,functional,1,1
143867,capillary,1,1
143868,density,1,1
143869,(,1,1
143870,FCD,1,1
143871,),1,1
143872,",",1,0
143873,blood,1,1
143874,flow,1,1
143875,velocity,1,1
143876,",",1,1
143877,and,1,1
143878,vessel,1,1
143879,diameter,1,1
143880,were,0,0
143881,analyzed,0,0
143882,by,0,0
143883,a,0,0
143884,blinded,0,0
143885,investigator,0,0
143886,.,0,0
143887,RESULTS,0,0
143888,After,0,0
143889,start,0,0
143890,of,0,1
143891,extracorporeal,0,0
143892,circulation,0,1
143893,(,0,1
143894,ECC,0,1
143895,),0,1
143896,and,0,1
143897,aortic,0,1
143898,crossclamping,0,1
143899,(,0,1
143900,T2,0,0
143901,),0,0
143902,",",0,0
143903,both,0,0
143904,groups,0,0
143905,showed,0,0
143906,a,0,0
143907,significant,0,0
143908,drop,0,0
143909,of,0,1
143910,FCD,1,0
143911,",",0,0
143912,with,0,0
143913,a,0,0
143914,significantly,0,0
143915,higher,0,0
143916,FCD,1,0
143917,in,0,0
143918,the,0,0
143919,MECC,0,0
143920,group,0,0
143921,(,0,0
143922,206.8,0,0
143923,?,0,0
143924,33.6,0,0
143925,cm/cm?,0,0
143926,in,0,0
143927,CECC,0,0
143928,group,0,0
143929,versus,0,0
143930,217.8,0,0
143931,?,0,0
143932,35.3,0,0
143933,cm/cm?,0,0
143934,in,0,0
143935,MECC,0,0
143936,group,0,0
143937,;,0,0
143938,P,0,0
143939,=,0,0
143940,.034,0,0
143941,),0,0
143942,.,0,0
143943,In,0,0
143944,the,0,0
143945,late,0,1
143946,phase,0,0
143947,of,0,0
143948,the,0,0
143949,ECC,0,1
143950,(,0,0
143951,T3,0,0
143952,),0,1
143953,",",1,0
143954,FCD,1,0
143955,in,0,0
143956,the,0,0
143957,MECC,0,0
143958,group,0,0
143959,was,0,0
143960,already,0,0
143961,recovered,0,1
143962,",",0,0
143963,whereas,1,0
143964,FCD,1,0
143965,in,0,0
143966,the,0,0
143967,CECC,0,0
143968,group,0,0
143969,was,0,0
143970,still,0,0
143971,significantly,0,0
143972,depressed,0,0
143973,(,0,0
143974,223.1,0,0
143975,?,0,0
143976,35.6,0,0
143977,cm/cm?,0,0
143978,in,0,0
143979,MECC,0,0
143980,group,0,0
143981,;,0,0
143982,P,0,0
143983,=,0,0
143984,.100,0,0
143985,vs,0,0
143986,T1,0,0
143987,;,0,0
143988,211.1,0,0
143989,?,0,0
143990,36.9,0,0
143991,cm/cm?,0,0
143992,in,0,0
143993,CECC,0,0
143994,group,0,0
143995,;,0,0
143996,P,0,0
143997,=,0,0
143998,.017,0,0
143999,vs,0,0
144000,T1,0,1
144001,),0,0
144002,.,0,0
144003,After,0,0
144004,termination,0,0
144005,of,0,1
144006,ECC,0,1
144007,(,0,0
144008,T4,0,0
144009,),0,1
144010,",",1,1
144011,FCD,1,1
144012,recovered,1,1
144013,in,0,0
144014,both,0,0
144015,groups,0,0
144016,to,0,0
144017,baseline,0,0
144018,.,1,0
144019,Blood,1,1
144020,flow,1,1
144021,velocity,1,1
144022,tended,1,0
144023,to,0,0
144024,be,0,0
144025,higher,0,0
144026,in,0,0
144027,the,0,0
144028,MECC,0,0
144029,group,0,0
144030,",",0,0
144031,with,0,0
144032,a,0,0
144033,significant,0,0
144034,intergroup,0,0
144035,difference,0,0
144036,after,0,0
144037,aortic,0,1
144038,crossclamping,0,1
144039,(,0,1
144040,T2,0,0
144041,),0,0
144042,.,0,0
144043,CONCLUSIONS,0,0
144044,Orthogonal,0,1
144045,polarization,0,1
144046,spectral,0,1
144047,imaging,0,0
144048,data,0,0
144049,reveal,0,0
144050,an,0,0
144051,impairment,1,1
144052,of,1,0
144053,microvascular,1,1
144054,perfusion,1,1
144055,during,1,0
144056,on-pump,0,0
144057,CABG,0,1
144058,.,0,0
144059,Changes,0,1
144060,in,1,0
144061,FCD,1,0
144062,indicate,0,0
144063,a,0,0
144064,faster,0,0
144065,recovery,0,1
144066,of,0,0
144067,the,0,0
144068,microvascular,0,0
144069,perfusion,0,1
144070,in,0,0
144071,MECC,0,0
144072,during,0,0
144073,the,0,0
144074,reperfusion,0,0
144075,period,0,0
144076,.,0,1
144077,Beneficial,0,0
144078,recovery,0,1
144079,of,0,1
144080,microvascular,0,1
144081,organ,0,1
144082,perfusion,0,0
144083,could,0,0
144084,partly,0,0
144085,explain,0,0
144086,the,0,0
144087,perioperative,0,1
144088,advantages,0,0
144089,reported,0,0
144090,for,0,0
144091,MECC,0,0
144092,.,0,0
144093,Effect,0,1
144094,of,0,1
144095,chelation,0,0
144096,therapy,0,0
144097,on,0,0
144098,progressive,0,0
144099,diabetic,0,0
144100,nephropathy,0,1
144101,in,0,0
144102,patients,0,0
144103,with,0,0
144104,type,0,0
144105,2,0,0
144106,diabetes,0,0
144107,and,0,0
144108,high-normal,0,1
144109,body,0,1
144110,lead,0,0
144111,burdens,0,1
144112,.,0,0
144113,BACKGROUND,0,0
144114,A,0,0
144115,previous,0,0
144116,study,0,0
144117,in,0,0
144118,type,0,0
144119,2,0,0
144120,diabetic,0,0
144121,patients,0,0
144122,with,0,0
144123,high-normal,0,1
144124,body,0,1
144125,lead,0,0
144126,burdens,0,1
144127,showed,0,0
144128,that,0,0
144129,EDTA,0,1
144130,chelation,0,0
144131,therapy,0,0
144132,for,0,0
144133,3,0,0
144134,months,0,0
144135,slows,0,0
144136,progressive,0,0
144137,diabetic,0,0
144138,nephropathy,0,0
144139,during,0,0
144140,a,0,0
144141,12-month,0,0
144142,follow-up,0,0
144143,.,0,0
144144,The,0,0
144145,effect,0,0
144146,of,0,0
144147,a,0,0
144148,longer,0,0
144149,course,0,1
144150,of,0,1
144151,therapy,0,0
144152,on,0,0
144153,kidney,0,0
144154,function,0,1
144155,decrease,0,1
144156,over,0,0
144157,a,0,0
144158,longer,0,0
144159,follow-up,0,0
144160,is,0,0
144161,not,0,0
144162,known,0,0
144163,.,0,0
144164,STUDY,0,0
144165,DESIGN,0,0
144166,A,0,0
144167,12-month,0,1
144168,run-in,0,0
144169,phase,0,0
144170,",",0,0
144171,then,0,0
144172,a,0,0
144173,randomized,0,0
144174,single-blind,0,0
144175,study,0,0
144176,with,0,0
144177,a,0,0
144178,27-month,0,0
144179,intervention,0,0
144180,.,0,1
144181,SETTING,0,0
144182,&,0,0
144183,PARTICIPANTS,0,1
144184,University,0,0
144185,medical,0,0
144186,center,0,0
144187,;,0,0
144188,50,0,0
144189,patients,0,0
144190,(,0,0
144191,serum,0,1
144192,creatinine,0,1
144193,",",0,1
144194,1.5-3.9,0,1
144195,mg/dL,0,0
144196,),0,0
144197,with,0,0
144198,high-normal,0,1
144199,body,0,1
144200,lead,0,1
144201,burden,0,1
144202,(,0,0
144203,?80-,0,1
144204,<,0,0
144205,600,0,0
144206,?g,0,0
144207,),0,0
144208,were,0,0
144209,randomly,0,0
144210,assigned,0,0
144211,to,0,0
144212,the,0,0
144213,treatment,0,0
144214,and,0,1
144215,control,0,0
144216,groups,0,0
144217,.,0,0
144218,INTERVENTION,0,0
144219,The,0,0
144220,treatment,0,0
144221,group,0,0
144222,received,0,0
144223,weekly,0,0
144224,chelation,0,0
144225,therapy,0,0
144226,for,0,0
144227,3,0,0
144228,months,0,0
144229,to,0,0
144230,reduce,0,0
144231,their,0,0
144232,body,0,1
144233,lead,0,0
144234,burden,0,1
144235,to,0,0
144236,<,0,0
144237,60,0,0
144238,?g,0,0
144239,and,0,0
144240,then,0,0
144241,as,0,0
144242,needed,0,0
144243,for,0,0
144244,24,0,0
144245,months,0,0
144246,to,0,0
144247,maintain,0,0
144248,this,0,0
144249,level,0,1
144250,.,0,0
144251,The,0,0
144252,control,0,0
144253,group,0,0
144254,received,0,0
144255,placebo,0,0
144256,for,0,0
144257,3,0,0
144258,months,0,0
144259,and,0,0
144260,then,0,0
144261,weekly,0,0
144262,for,0,0
144263,5,0,0
144264,weeks,0,0
144265,at,0,0
144266,6-month,0,0
144267,intervals,0,0
144268,for,0,0
144269,24,0,0
144270,months,0,0
144271,.,0,0
144272,OUTCOMES,1,0
144273,The,1,0
144274,primary,1,0
144275,end,1,0
144276,point,1,0
144277,was,1,0
144278,change,1,1
144279,in,1,0
144280,estimated,1,0
144281,glomerular,1,1
144282,filtration,1,1
144283,rate,1,1
144284,(,1,1
144285,eGFR,1,0
144286,),1,1
144287,over,1,0
144288,time,1,1
144289,.,1,0
144290,A,1,0
144291,secondary,0,1
144292,end,0,0
144293,point,0,0
144294,was,0,0
144295,a,1,0
144296,2-fold,1,0
144297,increase,1,0
144298,in,1,0
144299,baseline,1,1
144300,serum,1,1
144301,creatinine,1,1
144302,level,1,1
144303,or,1,0
144304,the,1,0
144305,requirement,1,1
144306,for,1,0
144307,renal,1,1
144308,replacement,1,0
144309,therapy,1,0
144310,.,1,1
144311,MEASUREMENTS,1,0
144312,Body,0,0
144313,lead,0,0
144314,burdens,0,1
144315,were,0,0
144316,assessed,0,0
144317,by,0,0
144318,EDTA,0,0
144319,mobilization,0,1
144320,tests,0,1
144321,and,0,1
144322,eGFR,0,1
144323,was,0,0
144324,calculated,0,0
144325,using,0,0
144326,the,0,0
144327,equation,0,0
144328,for,0,0
144329,Chinese,0,0
144330,patients,0,0
144331,with,0,0
144332,type,0,0
144333,2,0,0
144334,diabetes,0,0
144335,.,0,0
144336,RESULTS,1,0
144337,Mean,1,1
144338,baseline,1,1
144339,eGFRs,1,0
144340,in,1,0
144341,the,0,0
144342,treatment,0,0
144343,and,0,1
144344,control,0,0
144345,groups,0,0
144346,were,0,0
144347,similar,0,0
144348,.,0,0
144349,After,0,0
144350,3,0,0
144351,months,0,0
144352,of,0,0
144353,chelation,0,0
144354,therapy,0,0
144355,",",0,0
144356,the,0,0
144357,change,1,1
144358,in,1,0
144359,eGFR,1,0
144360,in,1,0
144361,the,0,0
144362,treatment,0,0
144363,group,0,0
144364,(,0,0
144365,+1.0,0,0
144366,?,0,0
144367,4.8,0,0
144368,mL/min/1.73,0,0
144369,m,0,0
144370,(,0,0
144371,2,0,0
144372,),0,0
144373,),0,0
144374,differed,0,0
144375,significantly,0,0
144376,from,0,0
144377,that,0,0
144378,in,0,0
144379,the,0,0
144380,control,0,0
144381,group,0,0
144382,(,0,0
144383,-1.5,0,0
144384,?,0,0
144385,4.8,0,0
144386,mL/min/1.73,0,0
144387,m,0,0
144388,(,0,0
144389,2,0,0
144390,),0,0
144391,;,0,0
144392,P,0,0
144393,=,0,0
144394,0.04,0,0
144395,),0,0
144396,.,0,0
144397,In,0,0
144398,the,0,0
144399,subsequent,0,0
144400,24-month,0,0
144401,intervention,0,0
144402,",",0,0
144403,the,0,0
144404,yearly,0,1
144405,rate,1,1
144406,of,1,1
144407,decrease,1,1
144408,in,1,0
144409,eGFR,1,0
144410,(,0,0
144411,5.6,0,0
144412,?,0,0
144413,5.0,0,0
144414,mL/min/1.73,0,0
144415,m,0,0
144416,(,0,0
144417,2,0,0
144418,),0,0
144419,per,0,0
144420,year,0,0
144421,),0,0
144422,in,0,0
144423,the,0,0
144424,treatment,0,0
144425,group,0,0
144426,was,0,0
144427,slower,0,0
144428,than,0,0
144429,that,0,0
144430,(,0,0
144431,9.2,0,0
144432,?,0,0
144433,3.6,0,0
144434,mL/min/1.73,0,0
144435,m,0,0
144436,(,0,0
144437,2,0,0
144438,),0,0
144439,per,0,0
144440,year,0,0
144441,;,0,0
144442,P,0,0
144443,=,0,0
144444,0.04,0,0
144445,),0,0
144446,in,0,0
144447,the,0,0
144448,control,0,0
144449,group,0,0
144450,.,0,0
144451,17,0,0
144452,(,0,0
144453,68,0,0
144454,%,0,0
144455,),0,0
144456,control-group,0,0
144457,patients,0,0
144458,and,0,0
144459,9,0,0
144460,(,0,0
144461,36,0,0
144462,%,0,0
144463,),0,0
144464,treatment-group,0,0
144465,patients,0,0
144466,achieved,0,0
144467,the,0,0
144468,secondary,0,1
144469,end,0,0
144470,point,0,0
144471,.,0,1
144472,LIMITATIONS,0,0
144473,Small,0,0
144474,sample,0,0
144475,size,0,1
144476,",",0,0
144477,not,0,0
144478,double,0,0
144479,blind,0,0
144480,.,0,0
144481,CONCLUSIONS,0,0
144482,A,0,0
144483,27-month,0,0
144484,course,0,0
144485,of,0,1
144486,EDTA,0,0
144487,chelation,0,0
144488,therapy,0,0
144489,retards,0,0
144490,the,0,0
144491,progression,0,1
144492,of,0,0
144493,diabetic,0,0
144494,nephropathy,0,1
144495,in,0,0
144496,type,0,0
144497,2,0,0
144498,diabetic,0,0
144499,patients,0,0
144500,with,0,0
144501,high-normal,0,1
144502,body,0,1
144503,lead,0,0
144504,burdens,0,1
144505,.,0,0
144506,Rosiglitazone,0,0
144507,and,0,1
144508,cognitive,0,1
144509,function,0,1
144510,in,0,0
144511,clozapine-treated,0,0
144512,patients,0,0
144513,with,0,0
144514,schizophrenia,0,0
144515,:,0,0
144516,a,0,0
144517,pilot,0,0
144518,study,0,0
144519,.,0,0
144520,Studies,0,0
144521,have,0,0
144522,shown,0,0
144523,that,0,0
144524,insulin,0,0
144525,resistance,0,1
144526,is,0,0
144527,associated,0,0
144528,with,0,0
144529,cognitive,0,1
144530,impairment,0,1
144531,.,0,0
144532,Peroxisome,0,0
144533,proliferator-activated,0,0
144534,receptor-?,0,1
144535,(,0,1
144536,PPAR-?,0,1
144537,),0,0
144538,agonists,0,0
144539,improve,0,0
144540,insulin,0,1
144541,sensitivity,0,1
144542,.,0,0
144543,The,0,0
144544,purpose,0,0
144545,of,0,0
144546,this,0,0
144547,study,0,0
144548,was,0,0
144549,to,0,0
144550,evaluate,0,0
144551,the,1,0
144552,effect,1,0
144553,of,1,1
144554,rosiglitazone,1,0
144555,",",1,0
144556,a,0,0
144557,PPAR-?,0,1
144558,agonist,0,0
144559,",",0,0
144560,on,0,0
144561,cognition,0,1
144562,in,0,0
144563,clozapine-treated,0,0
144564,patients,0,0
144565,with,0,0
144566,schizophrenia,0,0
144567,.,0,0
144568,In,0,0
144569,an,0,0
144570,eight-week,0,0
144571,double-blind,0,0
144572,",",0,1
144573,placebo-controlled,0,0
144574,pilot,0,0
144575,trial,0,0
144576,",",0,1
144577,clozapine-treated,0,0
144578,patients,0,0
144579,with,0,0
144580,schizophrenia,0,1
144581,were,0,0
144582,randomized,0,0
144583,to,0,0
144584,receive,0,0
144585,rosiglitazone,0,0
144586,(,0,0
144587,4mg/day,0,0
144588,),0,0
144589,or,0,0
144590,placebo,0,0
144591,.,0,0
144592,A,0,0
144593,neuropsychological,0,1
144594,battery,0,0
144595,including,1,0
144596,the,1,0
144597,Digit,1,1
144598,Span,1,1
144599,subtest,1,1
144600,from,1,0
144601,the,1,0
144602,Wechsler,1,0
144603,Adult,1,0
144604,Intelligence,1,1
144605,Scale-III,1,1
144606,(,1,1
144607,WAIS-III,1,1
144608,),1,0
144609,",",1,0
144610,the,1,0
144611,verbal,1,1
144612,fluency,1,1
144613,test,1,1
144614,",",1,0
144615,the,1,0
144616,Hopkins,1,1
144617,Verbal,1,1
144618,Learning,1,1
144619,Test,1,1
144620,(,1,1
144621,HVLT,1,1
144622,),1,0
144623,",",1,0
144624,the,1,0
144625,Trail-Making,1,1
144626,Test,1,1
144627,(,1,1
144628,TMT,1,1
144629,),1,0
144630,and,1,0
144631,the,1,0
144632,Wisconsin,1,0
144633,Card,1,0
144634,Sorting,1,1
144635,Test,1,1
144636,(,1,1
144637,WCST,1,1
144638,),1,1
144639,was,1,0
144640,administered,0,0
144641,at,0,0
144642,baseline,0,0
144643,and,0,1
144644,week,0,0
144645,eight,0,0
144646,.,0,0
144647,Nineteen,0,0
144648,patients,0,0
144649,completed,0,0
144650,the,0,0
144651,study,0,0
144652,.,0,0
144653,There,0,0
144654,were,0,0
144655,no,0,0
144656,significant,0,0
144657,differences,0,0
144658,on,0,0
144659,any,0,0
144660,demographic,1,0
144661,or,1,0
144662,general,1,0
144663,clinical,1,1
144664,variables,1,0
144665,between,1,0
144666,the,0,0
144667,rosiglitazone,0,0
144668,group,0,0
144669,(,0,1
144670,n=9,0,0
144671,),0,1
144672,and,0,0
144673,the,0,0
144674,placebo,0,0
144675,group,0,0
144676,(,0,0
144677,n=10,0,0
144678,),0,0
144679,.,0,0
144680,When,0,0
144681,baseline,0,0
144682,scores,0,1
144683,were,0,0
144684,controlled,0,0
144685,",",0,0
144686,there,0,0
144687,were,0,0
144688,no,0,0
144689,significant,0,0
144690,differences,0,0
144691,in,0,0
144692,change,0,1
144693,scores,0,1
144694,of,0,1
144695,cognitive,1,1
144696,performance,1,1
144697,over,1,0
144698,eight,0,0
144699,weeks,0,0
144700,between,0,0
144701,the,0,0
144702,two,0,0
144703,groups,0,0
144704,.,0,0
144705,In,0,0
144706,this,0,0
144707,pilot,0,0
144708,study,0,0
144709,",",0,1
144710,rosiglitazone,0,0
144711,had,0,0
144712,no,0,0
144713,cognitive,1,1
144714,benefit,1,0
144715,in,1,0
144716,clozapine-treated,0,0
144717,patients,0,0
144718,with,0,0
144719,schizophrenia,0,0
144720,.,0,0
144721,Future,0,1
144722,studies,0,0
144723,with,0,0
144724,longer,0,0
144725,treatment,0,0
144726,duration,0,1
144727,and,0,1
144728,larger,0,0
144729,sample,0,0
144730,size,0,1
144731,are,0,0
144732,needed,0,0
144733,to,0,0
144734,further,0,0
144735,explore,0,0
144736,the,0,0
144737,potential,0,0
144738,role,0,0
144739,of,0,1
144740,rosiglitazone,0,0
144741,in,0,0
144742,improving,0,1
144743,cognitive,0,1
144744,function,0,1
144745,in,0,0
144746,patients,0,0
144747,with,0,0
144748,schizophrenia,0,0
144749,.,0,0
144750,The,0,0
144751,impact,0,0
144752,of,0,1
144753,patient,0,1
144754,and,0,1
144755,physician,0,1
144756,computer,0,1
144757,mediated,0,1
144758,communication,0,1
144759,skill,1,1
144760,training,1,0
144761,on,0,0
144762,reported,0,0
144763,communication,0,1
144764,and,0,1
144765,patient,0,1
144766,satisfaction,0,1
144767,.,0,0
144768,OBJECTIVE,0,0
144769,The,0,0
144770,objective,0,0
144771,was,0,0
144772,to,0,0
144773,evaluate,0,0
144774,parallel,1,0
144775,patient,1,1
144776,and,1,1
144777,physician,1,1
144778,computer-mediated,1,0
144779,communication,1,1
144780,skill,1,1
144781,training,1,0
144782,on,0,0
144783,participants,0,0
144784,',0,1
144785,report,0,0
144786,of,0,1
144787,skill,0,1
144788,use,0,1
144789,and,0,1
144790,patient,0,1
144791,satisfaction,0,1
144792,.,0,0
144793,METHODS,0,0
144794,Separate,0,0
144795,patient,0,1
144796,and,0,1
144797,clinician,0,1
144798,web-tools,0,0
144799,comprised,0,0
144800,of,0,0
144801,over,0,0
144802,500,0,0
144803,",",0,0
144804,10-s,0,0
144805,video,0,0
144806,clips,0,1
144807,demonstrating,0,0
144808,patient-centered,1,1
144809,skills,1,1
144810,in,0,0
144811,various,0,0
144812,ways,0,0
144813,.,0,0
144814,Four,0,0
144815,clinician,0,0
144816,members,0,0
144817,of,0,0
144818,the,0,0
144819,American,0,0
144820,Academy,0,0
144821,of,0,1
144822,Family,0,0
144823,Physicians,0,0
144824,National,0,1
144825,Research,0,1
144826,Network,0,1
144827,participated,0,0
144828,by,0,0
144829,enrolling,0,0
144830,194,0,0
144831,patients,0,0
144832,into,0,0
144833,a,0,0
144834,randomized,0,0
144835,patient,0,1
144836,trial,0,0
144837,and,0,0
144838,29,0,0
144839,physicians,0,0
144840,into,0,0
144841,a,0,0
144842,non-randomized,0,0
144843,clinician,0,0
144844,trial,0,0
144845,of,0,1
144846,respective,0,0
144847,interventions,0,0
144848,.,0,0
144849,All,0,0
144850,participants,0,0
144851,completed,0,0
144852,baseline,0,0
144853,and,0,0
144854,follow-up,0,0
144855,self-report,0,1
144856,measures,0,1
144857,of,0,1
144858,visit,0,1
144859,communication,1,1
144860,and,1,1
144861,satisfaction,1,1
144862,.,1,1
144863,RESULTS,0,0
144864,Intervention,0,0
144865,patients,0,0
144866,reported,0,0
144867,using,0,0
144868,more,0,0
144869,skills,1,1
144870,than,0,0
144871,controls,0,0
144872,in,0,0
144873,five,0,0
144874,of,0,0
144875,six,0,0
144876,skill,0,1
144877,areas,0,0
144878,",",0,0
144879,including,0,0
144880,identification,1,1
144881,of,1,1
144882,problems/concerns,1,1
144883,",",1,1
144884,information,1,1
144885,exchange,1,1
144886,",",1,1
144887,treatment,1,0
144888,adherence,1,1
144889,",",1,1
144890,shared,1,1
144891,decision-making,1,1
144892,and,1,1
144893,interpersonal,1,1
144894,rapport,1,1
144895,(,0,0
144896,all,0,0
144897,p,0,0
144898,<,0,0
144899,.05,0,0
144900,),0,0
144901,;,0,0
144902,post,0,0
144903,intervention,0,0
144904,",",0,0
144905,physicians,0,1
144906,reported,0,0
144907,using,0,0
144908,more,0,0
144909,skills,0,1
144910,in,0,0
144911,the,0,0
144912,same,0,0
144913,5,0,0
144914,areas,0,0
144915,(,0,0
144916,all,0,0
144917,p,0,0
144918,<,0,0
144919,.01,0,0
144920,),0,0
144921,.,0,0
144922,Intervention,0,0
144923,group,0,0
144924,patients,0,0
144925,reported,0,0
144926,higher,1,0
144927,levels,1,1
144928,of,1,1
144929,satisfaction,1,1
144930,than,0,0
144931,controls,0,0
144932,in,0,0
144933,five,0,0
144934,of,0,0
144935,six,0,0
144936,domains,0,0
144937,(,0,0
144938,all,0,0
144939,p,0,0
144940,<,0,0
144941,.05,0,0
144942,),0,0
144943,.,0,0
144944,CONCLUSION,0,0
144945,Communication,0,1
144946,skill,0,1
144947,training,0,0
144948,delivered,0,0
144949,in,0,0
144950,a,0,0
144951,computer,0,0
144952,mediated,0,0
144953,format,0,0
144954,had,0,0
144955,a,0,0
144956,positive,1,1
144957,and,1,1
144958,parallel,1,0
144959,impact,1,0
144960,on,0,0
144961,both,0,0
144962,patient,0,1
144963,and,0,1
144964,clinician,0,1
144965,reported,0,0
144966,use,0,0
144967,of,0,0
144968,patient-centered,1,1
144969,communication,1,1
144970,and,0,1
144971,in,0,0
144972,patient,1,1
144973,satisfaction,1,1
144974,.,1,0
144975,PRACTICE,0,1
144976,IMPLICATIONS,0,0
144977,Computer-mediated,0,0
144978,interventions,0,0
144979,are,0,0
144980,cost,1,1
144981,and,1,0
144982,time,1,1
144983,effective,1,1
144984,thereby,0,0
144985,increasing,0,0
144986,patient,0,1
144987,and,0,1
144988,clinician,0,1
144989,willingness,0,0
144990,to,0,0
144991,undertake,0,0
144992,training,0,0
144993,.,0,0
144994,Selected,0,0
144995,polymorphisms,0,0
144996,of,0,0
144997,GSTP1,0,1
144998,and,0,1
144999,TERT,0,1
145000,were,0,0
145001,associated,0,0
145002,with,0,0
145003,glioma,0,0
145004,risk,0,1
145005,in,0,0
145006,Han,0,1
145007,Chinese,0,0
145008,.,0,0
145009,BACKGROUND,0,0
145010,Current,0,1
145011,evidence,0,0
145012,suggests,0,0
145013,that,0,0
145014,a,0,0
145015,majority,0,0
145016,of,0,0
145017,the,0,0
145018,inherited,0,0
145019,risks,0,0
145020,play,0,0
145021,a,0,0
145022,major,0,1
145023,role,0,0
145024,in,0,0
145025,glioma,0,1
145026,susceptibility,0,1
145027,",",0,1
145028,and,0,0
145029,glioma,0,0
145030,is,0,0
145031,due,0,0
145032,to,0,0
145033,the,0,0
145034,co-inheritance,0,0
145035,of,0,0
145036,multiple,0,0
145037,low-risk,0,0
145038,variants,0,1
145039,.,0,0
145040,These,0,0
145041,variants,0,0
145042,can,0,0
145043,be,0,0
145044,identified,0,0
145045,through,0,0
145046,association,0,0
145047,studies,0,0
145048,including,0,0
145049,such,0,0
145050,as,0,0
145051,genome-wide,0,0
145052,association,0,0
145053,studies,0,0
145054,(,0,1
145055,GWAS,0,0
145056,),0,1
145057,",",0,0
145058,which,0,0
145059,has,0,0
145060,led,0,0
145061,the,0,0
145062,glioma,0,0
145063,epidemiology,0,0
145064,researchers,0,0
145065,to,0,0
145066,focus,0,0
145067,on,0,0
145068,identifying,0,0
145069,potential,0,0
145070,disease-causing,0,1
145071,factors,0,0
145072,.,0,0
145073,METHODS,0,0
145074,We,0,0
145075,evaluated,0,0
145076,and,0,0
145077,validated,0,0
145078,10,0,0
145079,tag,0,0
145080,single,0,0
145081,nucleotide,0,1
145082,polymorphisms,0,1
145083,(,0,1
145084,tSNPs,0,0
145085,),0,0
145086,in,0,0
145087,seven,0,0
145088,genes,0,0
145089,associated,0,0
145090,with,0,0
145091,glioma,0,0
145092,susceptibility,0,1
145093,in,0,0
145094,a,0,0
145095,Han,0,1
145096,Chinese,0,0
145097,population,0,0
145098,",",0,0
145099,including,0,0
145100,301,0,0
145101,glioma,0,0
145102,cases,0,0
145103,and,0,0
145104,302,0,0
145105,controls,0,0
145106,",",0,0
145107,using,0,0
145108,a,0,0
145109,multiplexed,0,0
145110,single,0,0
145111,nucleotide,0,1
145112,polymorphism,0,1
145113,(,0,1
145114,SNP,0,1
145115,),0,1
145116,MassEXTEND,0,0
145117,assay,0,0
145118,.,0,0
145119,We,0,0
145120,ascertained,0,0
145121,the,0,0
145122,genotypic,0,0
145123,frequencies,0,1
145124,for,0,0
145125,each,0,0
145126,tSNP,0,0
145127,in,0,0
145128,control,0,0
145129,subjects,0,0
145130,were,0,0
145131,within,0,0
145132,Hardy-Weinberg,0,1
145133,equilibrium,0,1
145134,(,0,1
145135,HWE,0,0
145136,),0,0
145137,using,0,0
145138,an,0,0
145139,exact,0,1
145140,test,0,1
145141,",",0,1
145142,and,0,1
145143,then,0,0
145144,compared,0,0
145145,the,0,0
145146,genotype,0,0
145147,and,0,1
145148,allele,0,1
145149,frequencies,0,1
145150,of,0,0
145151,glioma,0,0
145152,patients,0,0
145153,and,0,1
145154,control,0,0
145155,subjects,0,0
145156,using,0,0
145157,the,0,0
145158,?2,0,1
145159,test,0,0
145160,.,0,0
145161,We,0,0
145162,then,0,0
145163,applied,0,0
145164,three,0,0
145165,genetic,0,0
145166,models,0,0
145167,(,0,0
145168,dominant,0,0
145169,",",0,1
145170,recessive,0,1
145171,",",0,1
145172,and,0,1
145173,additive,0,1
145174,),0,0
145175,using,0,0
145176,PLINK,0,0
145177,software,0,0
145178,to,0,0
145179,assess,0,0
145180,the,0,0
145181,association,0,0
145182,of,0,0
145183,each,0,0
145184,tSNP,0,0
145185,with,0,0
145186,glioma,0,0
145187,risk,0,1
145188,.,0,0
145189,RESULTS,0,0
145190,We,0,0
145191,identified,0,0
145192,two,0,0
145193,tSNPs,0,0
145194,to,0,0
145195,be,0,0
145196,associated,0,0
145197,with,1,0
145198,glioma,1,0
145199,susceptibility,1,1
145200,(,0,1
145201,rs1695,0,0
145202,",",0,1
145203,GSTP1,0,1
145204,",",0,1
145205,P,0,0
145206,=,0,0
145207,0.019,0,0
145208,;,0,0
145209,rs2853676,0,0
145210,",",0,1
145211,TERT,0,1
145212,",",0,1
145213,P,0,0
145214,=,0,0
145215,0.039,0,0
145216,),0,0
145217,",",0,0
145218,which,0,0
145219,we,0,0
145220,confirmed,0,0
145221,using,0,0
145222,dominant,0,0
145223,and,0,1
145224,additive,0,1
145225,model,0,0
145226,analyses,0,0
145227,.,0,0
145228,The,0,0
145229,genotype,0,0
145230,&,0,0
145231,ldquo,0,0
145232,;,0,1
145233,GA,0,0
145234,&,0,0
145235,rdquo,0,0
145236,;,0,1
145237,for,0,0
145238,rs1695,0,0
145239,was,0,0
145240,recognized,0,0
145241,to,0,0
145242,be,0,0
145243,a,0,0
145244,protective,0,0
145245,genotype,0,0
145246,for,1,0
145247,glioma,1,0
145248,(,0,1
145249,OR,0,1
145250,",",0,0
145251,0.67,0,0
145252,;,0,0
145253,95,0,0
145254,%,0,0
145255,CI,0,0
145256,",",0,0
145257,0.47-0.96,0,0
145258,;,0,1
145259,P,0,0
145260,=,0,0
145261,0.027,0,0
145262,),0,0
145263,",",0,0
145264,while,0,0
145265,the,0,0
145266,genotype,0,0
145267,&,0,0
145268,ldquo,0,0
145269,;,0,1
145270,AG,0,0
145271,&,0,0
145272,rdquo,0,0
145273,;,0,1
145274,for,0,0
145275,rs2853676,0,0
145276,was,0,0
145277,shown,0,0
145278,to,0,0
145279,be,0,0
145280,a,0,0
145281,risk,0,1
145282,genotype,0,0
145283,for,1,0
145284,glioma,1,0
145285,(,0,1
145286,OR,0,1
145287,",",0,0
145288,1.50,0,0
145289,;,0,0
145290,95,0,0
145291,%,0,0
145292,CI,0,0
145293,",",0,0
145294,1.05-2.15,0,0
145295,;,0,0
145296,P,0,0
145297,=,0,0
145298,0.025,0,0
145299,),0,0
145300,.,0,0
145301,CONCLUSION,0,0
145302,Our,0,0
145303,results,0,0
145304,",",0,0
145305,and,0,0
145306,those,0,0
145307,from,0,0
145308,previous,0,0
145309,studies,0,0
145310,",",0,0
145311,suggest,0,0
145312,potential,0,0
145313,genetic,0,0
145314,contributes,0,0
145315,for,0,0
145316,GSTP1,0,1
145317,and,0,1
145318,TERT,0,1
145319,in,0,0
145320,glioma,0,0
145321,development,0,1
145322,.,0,0
145323,Different,0,1
145324,cardiac,0,1
145325,biomarkers,0,0
145326,to,0,0
145327,detect,0,0
145328,peri-procedural,0,1
145329,myocardial,0,1
145330,infarction,0,1
145331,in,0,0
145332,contemporary,0,0
145333,coronary,0,1
145334,stent,0,0
145335,trials,0,0
145336,:,0,0
145337,impact,0,0
145338,on,0,0
145339,outcome,0,1
145340,reporting,0,1
145341,.,0,0
145342,OBJECTIVE,0,0
145343,To,0,0
145344,assess,0,0
145345,the,0,0
145346,differential,0,0
145347,implications,0,0
145348,of,0,1
145349,cardiac,0,1
145350,biomarker,0,0
145351,type,0,0
145352,on,0,0
145353,peri-procedural,0,1
145354,myocardial,0,1
145355,infarction,0,1
145356,(,0,1
145357,PMI,0,0
145358,),0,0
145359,reporting,0,1
145360,.,0,0
145361,SETTING,0,0
145362,The,0,0
145363,Resolute,0,1
145364,'All-Comers,0,0
145365,',0,1
145366,stent,0,0
145367,trial,0,0
145368,.,0,0
145369,INTERVENTIONS,0,1
145370,Blood,0,1
145371,samples,0,0
145372,for,0,0
145373,creatine,0,1
145374,kinase,0,1
145375,(,0,1
145376,CK,0,1
145377,),0,1
145378,",",0,1
145379,CK-myoband,0,0
145380,(,0,1
145381,CK-MB,0,1
145382,),0,1
145383,mass,0,1
145384,or,0,1
145385,cardiac,0,1
145386,troponin,0,1
145387,(,0,1
145388,cTn,0,1
145389,),0,1
145390,(,0,0
145391,optional,0,0
145392,),0,1
145393,were,0,0
145394,collected,0,0
145395,before,0,0
145396,and,0,0
145397,at,0,0
145398,6,0,0
145399,",",0,0
145400,12,0,0
145401,and,0,0
145402,18,0,0
145403,h,0,0
145404,after,0,0
145405,the,0,0
145406,assigned,0,0
145407,percutaneous,0,0
145408,coronary,0,1
145409,intervention,0,0
145410,or,0,1
145411,at,0,0
145412,discharge,0,1
145413,.,0,1
145414,PMIs,0,1
145415,were,0,0
145416,adjudicated,0,0
145417,using,0,0
145418,either,0,0
145419,the,0,0
145420,2007,0,0
145421,universal,0,0
145422,definition,0,0
145423,of,0,1
145424,MI,0,0
145425,(,0,0
145426,type-4a,0,1
145427,),0,0
145428,or,0,0
145429,the,0,0
145430,extended,0,0
145431,historical,0,0
145432,definition,0,0
145433,of,0,0
145434,MI,0,0
145435,.,0,0
145436,PATIENTS,0,0
145437,2121/2292,0,0
145438,patients,0,0
145439,(,0,0
145440,92.5,0,0
145441,%,0,0
145442,),0,0
145443,had,0,0
145444,an,0,0
145445,analysable,0,0
145446,dataset,0,0
145447,for,0,0
145448,either,0,0
145449,biomarker,0,0
145450,.,0,0
145451,890/2121,0,0
145452,patients,0,0
145453,(,0,0
145454,42,0,0
145455,%,0,0
145456,),0,0
145457,presented,0,0
145458,with,0,0
145459,an,0,0
145460,acute,0,0
145461,coronary,0,1
145462,syndrome,0,0
145463,(,0,1
145464,ACS,0,1
145465,),0,0
145466,.,0,0
145467,267/890,0,0
145468,patients,0,0
145469,(,0,0
145470,30,0,0
145471,%,0,0
145472,),0,0
145473,were,0,0
145474,within,0,0
145475,24,0,0
145476,h,0,0
145477,of,0,0
145478,an,0,0
145479,ST-segment,0,0
145480,elevation,0,0
145481,MI,0,0
145482,.,0,1
145483,MAIN,0,0
145484,OUTCOME,0,1
145485,MEASURES,0,0
145486,Type-4a,1,0
145487,MI,1,0
145488,was,0,0
145489,diagnosed,0,0
145490,in,0,0
145491,208/2121,0,0
145492,patients,0,0
145493,(,0,0
145494,9.8,0,0
145495,%,0,0
145496,),0,0
145497,when,0,0
145498,cTn,0,0
145499,was,0,0
145500,used,0,0
145501,(,0,0
145502,CK-MB,0,1
145503,mass,0,1
145504,if,0,0
145505,cTn,0,0
145506,not,0,0
145507,available,0,0
145508,),0,1
145509,",",0,0
145510,and,0,0
145511,in,0,0
145512,93/2121,0,0
145513,of,0,0
145514,patients,0,0
145515,(,0,0
145516,4.4,0,0
145517,%,0,0
145518,),0,0
145519,when,0,0
145520,CK-MB,0,1
145521,mass,0,1
145522,was,0,0
145523,used,0,0
145524,(,0,0
145525,cTn,0,0
145526,if,0,0
145527,CK-MB,0,1
145528,mass,0,1
145529,not,0,0
145530,available,0,0
145531,),0,0
145532,.,0,0
145533,With,0,0
145534,the,0,0
145535,extended,0,0
145536,historical,0,0
145537,CK-based,0,0
145538,definition,0,0
145539,of,0,1
145540,MI,0,0
145541,",",0,1
145542,PMI,1,0
145543,was,0,0
145544,diagnosed,0,0
145545,in,0,0
145546,65/2121,0,0
145547,patients,0,0
145548,(,0,0
145549,3.1,0,0
145550,%,0,0
145551,),0,0
145552,.,0,0
145553,Adjudication,0,1
145554,of,0,0
145555,type-4a,1,1
145556,MI,1,0
145557,in,0,0
145558,patients,0,0
145559,with,0,0
145560,an,0,0
145561,ACS,0,1
145562,was,0,0
145563,problematic,0,0
145564,with,0,0
145565,<,0,0
145566,10,0,0
145567,%,0,0
145568,of,0,0
145569,the,0,0
145570,potential,0,0
145571,type-4a,0,1
145572,MI,0,0
145573,being,0,0
145574,confirmed,0,0
145575,as,0,0
145576,an,0,0
145577,event,0,1
145578,",",0,0
145579,as,0,0
145580,compared,0,0
145581,with,0,0
145582,approximately,0,0
145583,95,0,0
145584,%,0,0
145585,in,0,0
145586,stable,0,1
145587,patients,0,0
145588,undergoing,0,0
145589,elective,0,0
145590,PCI,0,1
145591,.,0,0
145592,Type-4a,0,0
145593,MI,0,0
145594,was,0,0
145595,not,0,0
145596,associated,0,0
145597,with,0,0
145598,the,0,0
145599,subsequent,0,0
145600,hazard,0,1
145601,for,0,0
145602,cardiac,1,1
145603,mortality,1,1
145604,(,0,1
145605,p=0.6,0,0
145606,),0,0
145607,.,0,0
145608,CONCLUSIONS,0,0
145609,The,0,0
145610,percentage,0,1
145611,of,0,0
145612,adjudicated,0,0
145613,PMI,1,0
145614,events,1,1
145615,is,0,0
145616,driven,0,0
145617,by,0,0
145618,the,0,0
145619,MI-definition,0,0
145620,criteria,0,0
145621,and,0,1
145622,biomarker,0,0
145623,type,0,0
145624,.,0,1
145625,Type-4a,0,0
145626,MI,0,0
145627,may,0,0
145628,not,0,0
145629,be,0,0
145630,a,0,0
145631,reliable,0,1
145632,component,0,0
145633,of,0,0
145634,the,0,0
145635,primary,0,0
145636,composite,0,1
145637,end,0,0
145638,point,0,0
145639,in,0,0
145640,coronary,0,1
145641,stent,0,1
145642,investigations,0,0
145643,which,0,0
145644,recruit,0,0
145645,patients,0,0
145646,with,0,0
145647,ACS,0,1
145648,.,0,0
145649,TRIAL,0,0
145650,REGISTRATION,0,0
145651,NUMBER,0,1
145652,http,0,0
145653,:,0,0
145654,//www.ClinicalTrials.gov,0,0
145655,;,0,0
145656,Unique,0,1
145657,identifier,0,0
145658,:,0,0
145659,NCT00617084,0,0
145660,.,0,0
145661,Adjunctive,0,1
145662,perampanel,0,0
145663,for,0,0
145664,refractory,0,0
145665,partial-onset,0,0
145666,seizures,0,1
145667,:,0,0
145668,randomized,0,0
145669,phase,0,0
145670,III,0,0
145671,study,0,0
145672,304,0,0
145673,.,0,0
145674,OBJECTIVE,0,0
145675,To,0,0
145676,assess,0,0
145677,efficacy,0,1
145678,and,0,1
145679,safety,0,1
145680,of,0,0
145681,once-daily,0,0
145682,8,0,0
145683,or,0,0
145684,12,0,0
145685,mg,0,0
145686,perampanel,0,0
145687,",",0,0
145688,a,0,0
145689,noncompetitive,0,0
145690,?-amino-3-hydroxy-5-methyl-4-isoxazole-propionic,0,0
145691,acid,0,1
145692,(,0,1
145693,AMPA,0,1
145694,),0,1
145695,receptor,0,1
145696,antagonist,0,0
145697,",",0,1
145698,when,0,0
145699,added,0,0
145700,to,0,0
145701,concomitant,0,0
145702,antiepileptic,0,0
145703,drugs,0,0
145704,(,0,0
145705,AEDs,0,1
145706,),0,0
145707,in,0,0
145708,the,0,0
145709,treatment,0,0
145710,of,0,0
145711,drug-resistant,0,1
145712,partial-onset,0,0
145713,seizures,0,1
145714,.,0,0
145715,METHODS,0,0
145716,This,0,0
145717,was,0,0
145718,a,0,0
145719,multicenter,0,0
145720,",",0,1
145721,double-blind,0,0
145722,",",0,1
145723,placebo-controlled,0,0
145724,trial,0,0
145725,(,0,1
145726,ClinicalTrials.gov,0,0
145727,identifier,0,0
145728,:,0,0
145729,NCT00699972,0,0
145730,),0,0
145731,.,0,0
145732,Patients,0,0
145733,(,0,0
145734,?12,0,0
145735,years,0,0
145736,",",0,0
145737,with,0,0
145738,ongoing,0,0
145739,seizures,0,1
145740,despite,0,0
145741,1-3,0,0
145742,AEDs,0,1
145743,),0,1
145744,were,0,0
145745,randomized,0,0
145746,(,0,0
145747,1:1:1,0,0
145748,),0,0
145749,to,0,0
145750,once-daily,0,0
145751,perampanel,0,0
145752,8,0,0
145753,mg,0,0
145754,",",0,0
145755,12,0,0
145756,mg,0,0
145757,",",0,0
145758,or,0,1
145759,placebo,0,0
145760,.,0,1
145761,Following,0,1
145762,baseline,0,0
145763,(,0,0
145764,6,0,0
145765,weeks,0,0
145766,),0,0
145767,",",0,0
145768,patients,0,0
145769,entered,0,0
145770,a,0,0
145771,19-week,0,0
145772,double-blind,0,0
145773,phase,0,0
145774,:,0,0
145775,6-week,0,0
145776,titration,0,0
145777,(,0,0
145778,2,0,0
145779,mg/week,0,0
145780,increments,0,0
145781,to,0,0
145782,target,0,0
145783,dose,0,0
145784,),0,0
145785,followed,0,0
145786,by,0,0
145787,a,0,0
145788,13-week,0,0
145789,maintenance,0,0
145790,period,0,0
145791,.,0,1
145792,Percent,0,0
145793,change,0,1
145794,in,0,0
145795,seizure,0,1
145796,frequency,0,1
145797,was,0,0
145798,the,0,0
145799,primary,0,0
145800,endpoint,0,0
145801,;,0,0
145802,50,0,0
145803,%,0,0
145804,responder,0,0
145805,rate,0,1
145806,was,0,0
145807,the,0,0
145808,primary,0,0
145809,endpoint,0,1
145810,for,0,0
145811,EU,0,0
145812,registration,0,0
145813,.,0,1
145814,RESULTS,0,0
145815,Of,0,0
145816,388,0,0
145817,patients,0,0
145818,randomized,0,0
145819,and,0,0
145820,treated,0,0
145821,",",0,0
145822,387,0,0
145823,provided,0,0
145824,seizure,0,1
145825,frequency,0,1
145826,data,0,0
145827,.,0,0
145828,Using,0,0
145829,this,0,0
145830,intent-to-treat,0,0
145831,population,0,0
145832,over,0,0
145833,the,0,0
145834,double-blind,0,0
145835,phase,0,0
145836,",",0,0
145837,the,0,0
145838,median,1,1
145839,percent,1,1
145840,change,1,1
145841,in,1,0
145842,seizure,1,1
145843,frequency,1,1
145844,was,1,0
145845,-21.0,0,0
145846,%,0,0
145847,",",0,0
145848,-26.3,0,0
145849,%,0,0
145850,",",0,0
145851,and,0,0
145852,-34.5,0,0
145853,%,0,0
145854,for,0,0
145855,placebo,0,0
145856,and,0,1
145857,perampanel,0,0
145858,8,0,0
145859,and,0,0
145860,12,0,0
145861,mg,0,0
145862,",",0,0
145863,respectively,0,0
145864,(,0,0
145865,p,0,0
145866,=,0,0
145867,0.0261,0,0
145868,and,0,0
145869,p,0,0
145870,=,0,0
145871,0.0158,0,0
145872,for,0,0
145873,8,0,0
145874,and,0,0
145875,12,0,0
145876,mg,0,0
145877,vs,0,0
145878,placebo,0,0
145879,",",0,0
145880,respectively,0,0
145881,),0,0
145882,.,0,0
145883,Fifty,0,0
145884,percent,0,1
145885,responder,0,1
145886,rates,0,1
145887,during,0,0
145888,the,0,0
145889,maintenance,0,0
145890,period,0,0
145891,were,0,0
145892,26.4,0,0
145893,%,0,0
145894,",",0,0
145895,37.6,0,0
145896,%,0,0
145897,",",0,0
145898,and,0,0
145899,36.1,0,0
145900,%,0,0
145901,",",0,0
145902,respectively,0,0
145903,",",0,0
145904,for,0,0
145905,placebo,0,0
145906,",",0,0
145907,perampanel,0,0
145908,8,0,0
145909,mg,0,0
145910,",",0,0
145911,and,0,1
145912,perampanel,0,0
145913,12,0,0
145914,mg,0,0
145915,;,0,0
145916,these,0,0
145917,differences,0,0
145918,were,0,0
145919,not,0,0
145920,statistically,0,0
145921,significant,0,0
145922,for,0,0
145923,8,0,0
145924,mg,0,0
145925,(,0,0
145926,p,0,0
145927,=,0,0
145928,0.0760,0,0
145929,),0,0
145930,or,0,0
145931,12,0,0
145932,mg,0,0
145933,(,0,0
145934,p,0,0
145935,=,0,0
145936,0.0914,0,0
145937,),0,0
145938,.,0,0
145939,Sixty-eight,0,0
145940,(,0,0
145941,17.5,0,0
145942,%,0,0
145943,),0,0
145944,patients,0,0
145945,discontinued,0,0
145946,",",0,0
145947,including,0,0
145948,40,0,0
145949,(,0,0
145950,10.3,0,0
145951,%,0,0
145952,),0,0
145953,for,0,0
145954,adverse,0,1
145955,events,0,1
145956,.,0,0
145957,Most,0,0
145958,frequent,0,1
145959,treatment-emergent,0,1
145960,adverse,0,1
145961,events,0,1
145962,were,1,0
145963,dizziness,1,1
145964,",",1,0
145965,somnolence,1,1
145966,",",1,1
145967,irritability,1,1
145968,",",1,1
145969,headache,1,1
145970,",",1,1
145971,fall,1,1
145972,",",1,1
145973,and,1,0
145974,ataxia,1,1
145975,.,1,0
145976,CONCLUSIONS,1,0
145977,This,0,0
145978,trial,0,0
145979,demonstrated,0,0
145980,that,0,0
145981,once-daily,0,0
145982,",",0,0
145983,adjunctive,0,0
145984,perampanel,0,0
145985,at,0,0
145986,doses,0,0
145987,of,0,0
145988,8,0,0
145989,or,0,0
145990,12,0,0
145991,mg,0,0
145992,improved,1,0
145993,seizure,1,1
145994,control,1,0
145995,in,1,0
145996,patients,0,0
145997,with,0,0
145998,uncontrolled,0,0
145999,partial-onset,0,0
146000,seizures,0,1
146001,.,0,0
146002,Doses,0,0
146003,of,0,0
146004,perampanel,0,0
146005,8,0,0
146006,and,0,0
146007,12,0,0
146008,mg,0,0
146009,were,0,0
146010,safe,0,1
146011,",",0,1
146012,and,0,1
146013,tolerability,0,1
146014,was,0,0
146015,acceptable,0,0
146016,.,0,0
146017,CLASSIFICATION,0,0
146018,OF,0,0
146019,EVIDENCE,0,0
146020,This,0,0
146021,study,0,0
146022,provides,0,0
146023,Class,0,0
146024,I,0,0
146025,evidence,0,0
146026,that,0,0
146027,once-daily,0,0
146028,8,0,0
146029,and,0,0
146030,12,0,0
146031,mg,0,0
146032,doses,0,0
146033,of,0,0
146034,adjunctive,0,0
146035,perampanel,0,0
146036,are,0,0
146037,effective,0,1
146038,in,0,0
146039,patients,0,0
146040,with,0,0
146041,uncontrolled,0,0
146042,partial-onset,0,0
146043,seizures,0,1
146044,.,0,0
146045,Virtual,0,0
146046,patients,0,0
146047,design,0,0
146048,and,0,0
146049,its,0,0
146050,effect,0,1
146051,on,0,0
146052,clinical,1,1
146053,reasoning,1,1
146054,and,0,1
146055,student,1,1
146056,experience,1,1
146057,:,1,0
146058,a,0,0
146059,protocol,0,0
146060,for,0,0
146061,a,0,0
146062,randomised,0,0
146063,factorial,0,0
146064,multi-centre,0,0
146065,study,0,0
146066,.,0,1
146067,BACKGROUND,0,0
146068,Virtual,0,1
146069,Patients,0,0
146070,(,0,1
146071,VPs,0,0
146072,),0,0
146073,are,0,0
146074,web-based,0,0
146075,representations,0,0
146076,of,0,0
146077,realistic,0,1
146078,clinical,0,0
146079,cases,0,0
146080,.,0,0
146081,They,0,0
146082,are,0,0
146083,proposed,0,0
146084,as,0,0
146085,being,0,0
146086,an,0,0
146087,optimal,0,0
146088,method,0,0
146089,for,0,0
146090,teaching,0,0
146091,clinical,0,0
146092,reasoning,0,1
146093,skills,0,1
146094,.,0,0
146095,International,0,0
146096,standards,0,0
146097,exist,0,0
146098,which,0,0
146099,define,0,0
146100,precisely,0,0
146101,what,0,0
146102,constitutes,0,0
146103,a,0,0
146104,VP,0,0
146105,.,0,0
146106,There,0,0
146107,are,0,0
146108,multiple,0,0
146109,design,0,0
146110,possibilities,0,0
146111,for,0,0
146112,VPs,0,0
146113,",",0,0
146114,however,0,0
146115,there,0,0
146116,is,0,0
146117,little,0,0
146118,formal,0,0
146119,evidence,0,0
146120,to,0,0
146121,support,0,0
146122,individual,0,0
146123,design,0,0
146124,features,0,0
146125,.,0,0
146126,The,0,0
146127,purpose,0,0
146128,of,0,0
146129,this,0,0
146130,trial,0,0
146131,is,0,0
146132,to,0,0
146133,explore,0,0
146134,the,0,0
146135,effect,0,0
146136,of,0,0
146137,two,0,0
146138,different,0,0
146139,potentially,0,0
146140,important,0,0
146141,design,0,0
146142,features,0,0
146143,on,0,0
146144,clinical,1,0
146145,reasoning,1,1
146146,skills,1,1
146147,and,1,0
146148,the,1,0
146149,student,1,0
146150,experience,1,0
146151,.,1,0
146152,These,0,0
146153,are,0,0
146154,the,0,0
146155,branching,0,1
146156,case,0,0
146157,pathways,0,1
146158,(,0,1
146159,present,0,0
146160,or,0,1
146161,absent,0,1
146162,),0,1
146163,and,0,1
146164,structured,0,0
146165,clinical,0,1
146166,reasoning,0,1
146167,feedback,0,0
146168,(,0,1
146169,present,0,0
146170,or,0,1
146171,absent,0,0
146172,),0,1
146173,.,0,0
146174,METHODS/DESIGN,0,0
146175,This,0,0
146176,is,0,0
146177,a,0,0
146178,multi-centre,0,0
146179,randomised,0,0
146180,2,0,0
146181,x,0,0
146182,2,0,0
146183,factorial,0,0
146184,design,0,0
146185,study,0,0
146186,evaluating,0,0
146187,two,0,0
146188,independent,0,0
146189,variables,0,0
146190,of,0,1
146191,VP,0,1
146192,design,0,0
146193,",",0,1
146194,branching,0,1
146195,(,0,1
146196,present,0,0
146197,or,0,1
146198,absent,0,1
146199,),0,1
146200,",",0,1
146201,and,0,1
146202,structured,0,0
146203,clinical,0,1
146204,reasoning,0,1
146205,feedback,0,0
146206,(,0,1
146207,present,0,0
146208,or,0,1
146209,absent,0,0
146210,),0,1
146211,.The,0,0
146212,study,0,0
146213,will,0,0
146214,be,0,0
146215,carried,0,0
146216,out,0,0
146217,in,0,0
146218,medical,0,0
146219,student,0,0
146220,volunteers,0,0
146221,in,0,0
146222,one,0,0
146223,year,0,0
146224,group,0,0
146225,from,0,0
146226,three,0,0
146227,university,0,0
146228,medical,0,0
146229,schools,0,0
146230,in,0,0
146231,the,0,0
146232,United,0,0
146233,Kingdom,0,0
146234,",",0,1
146235,Warwick,0,1
146236,",",0,1
146237,Keele,0,1
146238,and,0,1
146239,Birmingham,0,0
146240,.,0,0
146241,There,0,0
146242,are,0,0
146243,four,0,0
146244,core,0,0
146245,musculoskeletal,0,0
146246,topics,0,0
146247,.,0,0
146248,Each,0,0
146249,case,0,0
146250,can,0,0
146251,be,0,0
146252,designed,0,0
146253,in,0,0
146254,four,0,0
146255,different,0,0
146256,ways,0,0
146257,",",0,0
146258,equating,0,0
146259,to,0,0
146260,16,0,0
146261,VPs,0,0
146262,required,0,0
146263,for,0,0
146264,the,0,0
146265,research,0,0
146266,.,0,0
146267,Students,0,0
146268,will,0,0
146269,be,0,0
146270,randomised,0,0
146271,to,0,0
146272,four,0,0
146273,groups,0,0
146274,",",0,0
146275,completing,0,0
146276,the,0,0
146277,four,0,0
146278,VP,0,0
146279,topics,0,0
146280,in,0,0
146281,the,0,0
146282,same,0,0
146283,order,0,0
146284,",",0,1
146285,but,0,0
146286,with,0,0
146287,each,0,0
146288,group,0,0
146289,exposed,0,0
146290,to,0,0
146291,a,0,0
146292,different,0,0
146293,VP,0,0
146294,design,0,0
146295,sequentially,0,0
146296,.,0,0
146297,All,0,0
146298,students,0,0
146299,will,0,0
146300,be,0,0
146301,exposed,0,0
146302,to,0,0
146303,the,0,0
146304,four,0,0
146305,designs,0,0
146306,.,0,0
146307,Primary,0,0
146308,outcomes,0,1
146309,are,0,0
146310,performance,1,1
146311,for,1,0
146312,each,1,0
146313,case,1,0
146314,design,1,0
146315,in,1,0
146316,a,1,0
146317,standardized,1,0
146318,fifteen,1,0
146319,item,1,1
146320,clinical,1,1
146321,reasoning,1,1
146322,assessment,1,1
146323,",",1,1
146324,integrated,1,0
146325,into,1,0
146326,each,1,0
146327,VP,1,0
146328,",",1,0
146329,which,1,0
146330,is,1,0
146331,identical,1,0
146332,for,1,0
146333,each,1,0
146334,topic,1,0
146335,.,1,0
146336,Additionally,0,0
146337,a,0,0
146338,15-item,1,1
146339,self-reported,1,1
146340,evaluation,1,0
146341,is,0,0
146342,completed,0,0
146343,for,0,0
146344,each,0,0
146345,VP,0,0
146346,",",0,0
146347,based,0,0
146348,on,0,0
146349,a,0,0
146350,widely,0,0
146351,used,0,0
146352,EViP,0,1
146353,tool,0,0
146354,.,0,1
146355,Student,0,1
146356,patterns,0,1
146357,of,0,1
146358,use,0,0
146359,of,0,0
146360,the,0,0
146361,VPs,0,0
146362,will,0,0
146363,be,0,0
146364,recorded.In,0,0
146365,one,0,0
146366,centre,0,0
146367,",",0,0
146368,formative,0,0
146369,clinical,0,1
146370,and,0,1
146371,examination,0,0
146372,performance,0,1
146373,will,0,0
146374,be,0,0
146375,recorded,0,0
146376,",",0,0
146377,along,0,0
146378,with,0,0
146379,a,0,0
146380,self,0,1
146381,reported,0,0
146382,pre,0,1
146383,and,0,0
146384,post-intervention,0,1
146385,reasoning,0,1
146386,score,0,1
146387,",",0,0
146388,the,0,0
146389,DTI,0,1
146390,.,0,0
146391,Our,0,0
146392,power,0,1
146393,calculations,0,0
146394,indicate,0,0
146395,a,0,0
146396,sample,0,0
146397,size,0,1
146398,of,0,0
146399,112,0,0
146400,is,0,0
146401,required,0,0
146402,for,0,0
146403,both,0,0
146404,primary,0,0
146405,outcomes,0,1
146406,.,0,0
146407,DISCUSSION,0,0
146408,This,0,0
146409,trial,0,0
146410,will,0,0
146411,provide,0,0
146412,robust,0,0
146413,evidence,0,0
146414,to,0,0
146415,support,0,0
146416,the,0,0
146417,effectiveness,0,0
146418,of,0,0
146419,different,0,0
146420,designs,0,0
146421,of,0,0
146422,virtual,0,0
146423,patients,0,0
146424,",",0,0
146425,based,0,0
146426,on,0,0
146427,student,1,0
146428,performance,1,1
146429,and,1,1
146430,evaluation,1,0
146431,.,1,0
146432,The,0,0
146433,cases,0,0
146434,and,0,0
146435,all,0,0
146436,learning,0,1
146437,materials,0,0
146438,will,0,0
146439,be,0,0
146440,open,0,0
146441,access,0,1
146442,and,0,1
146443,available,0,0
146444,on,0,0
146445,a,0,0
146446,Creative,0,0
146447,Commons,0,1
146448,Attribution-Share-Alike,0,1
146449,license,0,0
146450,.,0,0
146451,Comparing,0,0
146452,the,0,0
146453,effectiveness,0,1
146454,of,0,1
146455,copper,0,1
146456,intrauterine,0,0
146457,devices,0,0
146458,available,0,0
146459,in,0,0
146460,Canada,0,0
146461,.,0,0
146462,Is,0,0
146463,FlexiT,0,0
146464,non-inferior,0,0
146465,to,0,0
146466,NovaT,0,0
146467,when,0,0
146468,inserted,0,0
146469,immediately,0,0
146470,after,0,0
146471,first-trimester,0,0
146472,abortion,0,1
146473,?,0,0
146474,Study,0,0
146475,protocol,0,0
146476,for,0,0
146477,a,0,0
146478,randomized,0,0
146479,controlled,0,0
146480,trial,0,0
146481,.,0,0
146482,BACKGROUND,0,0
146483,We,0,0
146484,describe,0,0
146485,the,0,0
146486,rationale,0,0
146487,and,0,1
146488,protocol,0,0
146489,for,0,0
146490,a,0,0
146491,randomized,0,0
146492,noninferiority,0,0
146493,controlled,0,0
146494,trial,0,0
146495,(,0,0
146496,RCT,0,0
146497,),0,0
146498,to,0,0
146499,determine,0,0
146500,if,0,0
146501,the,0,0
146502,Flexi-T380,0,0
146503,(,0,0
146504,+,0,0
146505,),0,1
146506,copper,0,1
146507,intrauterine,0,0
146508,contraceptive,0,0
146509,device,0,0
146510,(,0,1
146511,IUD,0,0
146512,),0,0
146513,is,0,0
146514,comparable,0,0
146515,in,0,0
146516,terms,0,1
146517,of,0,1
146518,effectiveness,0,1
146519,and,0,1
146520,expulsion,0,1
146521,rates,0,1
146522,to,0,0
146523,the,0,0
146524,most,0,0
146525,common,0,0
146526,Canadian,0,0
146527,IUD,0,0
146528,currently,0,0
146529,in,0,0
146530,use,0,0
146531,",",0,1
146532,NovaT-200,0,0
146533,",",0,1
146534,when,0,0
146535,placed,0,0
146536,immediately,0,0
146537,after,0,0
146538,a,0,0
146539,first-trimester,0,0
146540,abortion,0,1
146541,.,0,0
146542,METHODS/DESIGN,0,1
146543,Consenting,0,0
146544,women,0,0
146545,choosing,0,0
146546,to,0,0
146547,use,0,0
146548,an,0,0
146549,IUD,0,0
146550,after,0,0
146551,an,0,0
146552,abortion,0,0
146553,for,0,0
146554,a,0,0
146555,pregnancy,0,0
146556,of,0,0
146557,less,0,0
146558,than,0,0
146559,12,0,0
146560,weeks,0,0
146561,of,0,0
146562,gestation,0,0
146563,will,0,0
146564,be,0,0
146565,randomized,0,0
146566,to,0,0
146567,device-type,0,0
146568,groups,0,0
146569,to,0,0
146570,receive,0,0
146571,immediate,0,1
146572,post-abortion,0,0
146573,placement,0,0
146574,of,0,0
146575,either,0,0
146576,a,0,0
146577,Flexi-T380,0,0
146578,(,0,0
146579,+,0,0
146580,),0,1
146581,IUD,0,0
146582,",",0,0
146583,a,0,0
146584,device,0,0
146585,for,0,0
146586,which,0,0
146587,no,0,0
146588,current,0,0
146589,evidence,0,0
146590,on,0,0
146591,expulsion,0,1
146592,or,0,1
146593,effectiveness,0,1
146594,rates,0,1
146595,is,0,0
146596,available,0,0
146597,",",0,0
146598,or,0,0
146599,the,0,0
146600,Nova-T200,0,0
146601,IUD,0,0
146602,",",0,0
146603,the,0,0
146604,only,0,0
146605,other,0,0
146606,brand,0,0
146607,of,0,1
146608,copper,0,1
146609,IUD,0,0
146610,available,0,0
146611,in,0,0
146612,Canada,0,0
146613,at,0,0
146614,the,0,0
146615,time,0,1
146616,of,0,1
146617,study,0,0
146618,initiation,0,0
146619,.,0,0
146620,The,0,0
146621,primary,0,0
146622,outcome,0,0
146623,measure,0,0
146624,is,0,0
146625,IUD,1,0
146626,expulsion,1,1
146627,rate,1,1
146628,at,1,0
146629,1,1,0
146630,year,1,0
146631,.,1,0
146632,Secondary,0,0
146633,outcomes,0,0
146634,include,0,0
146635,:,0,0
146636,pregnancy,1,1
146637,rate,1,1
146638,",",1,1
146639,method,1,0
146640,continuation,1,1
146641,rate,1,1
146642,",",1,1
146643,complication,1,1
146644,rates,1,1
146645,(,1,1
146646,infection,1,1
146647,",",1,1
146648,perforation,1,1
146649,),1,1
146650,",",1,1
146651,and,1,1
146652,satisfaction,1,1
146653,with,1,0
146654,contraceptive,1,0
146655,method,1,0
146656,.,1,0
146657,A,0,0
146658,non-intervention,0,0
146659,group,0,0
146660,of,0,0
146661,consenting,0,0
146662,women,0,0
146663,choosing,0,0
146664,a,0,0
146665,range,0,0
146666,of,0,0
146667,other,0,0
146668,post-abortion,0,0
146669,contraception,0,0
146670,methods,0,0
146671,",",0,0
146672,including,0,0
146673,no,0,0
146674,contraception,0,0
146675,",",0,0
146676,will,0,0
146677,be,0,0
146678,included,0,0
146679,for,0,0
146680,comparison,0,0
146681,of,0,0
146682,secondary,0,0
146683,outcomes,0,1
146684,.,0,0
146685,Web-based,0,0
146686,contraception,0,0
146687,satisfaction,0,1
146688,questionnaires,0,1
146689,",",0,0
146690,clinical,0,1
146691,records,0,0
146692,",",0,1
146693,and,0,1
146694,government-linked,0,1
146695,health,0,1
146696,administrative,0,0
146697,databases,0,0
146698,will,0,0
146699,be,0,0
146700,used,0,0
146701,to,0,0
146702,assess,0,0
146703,primary,0,0
146704,and,0,1
146705,secondary,0,1
146706,outcomes,0,1
146707,.,0,0
146708,DISCUSSION,0,0
146709,The,0,0
146710,RCT,0,0
146711,design,0,0
146712,",",0,0
146713,combined,0,0
146714,with,0,0
146715,access,0,0
146716,to,0,0
146717,clinical,0,0
146718,records,0,0
146719,at,0,0
146720,all,0,0
146721,provincial,0,1
146722,abortion,0,1
146723,clinics,0,0
146724,",",0,0
146725,and,0,1
146726,to,0,1
146727,information,0,1
146728,in,0,0
146729,provincial,0,1
146730,single-payer,0,0
146731,linked,0,0
146732,administrative,0,1
146733,health,0,1
146734,databases,0,0
146735,",",0,1
146736,birth,0,1
146737,registry,0,1
146738,",",0,1
146739,and,0,1
146740,hospital,0,1
146741,records,0,0
146742,",",0,0
146743,offers,0,0
146744,a,0,0
146745,unique,0,0
146746,opportunity,0,0
146747,to,0,0
146748,determine,0,0
146749,if,0,0
146750,a,0,0
146751,novel,0,0
146752,IUD,0,0
146753,has,0,0
146754,a,0,0
146755,comparable,0,0
146756,expulsion,1,1
146757,rate,1,1
146758,to,0,0
146759,that,0,0
146760,of,0,0
146761,the,0,0
146762,current,0,0
146763,standard,0,0
146764,IUD,0,0
146765,in,0,0
146766,Canada,0,0
146767,",",0,0
146768,in,0,0
146769,addition,0,0
146770,to,0,0
146771,the,0,0
146772,first,0,0
146773,opportunity,0,0
146774,to,0,0
146775,determine,0,0
146776,pregnancy,1,1
146777,rate,1,1
146778,and,1,1
146779,method,1,0
146780,satisfaction,1,1
146781,at,0,0
146782,1,0,0
146783,year,0,0
146784,post-abortion,0,0
146785,for,0,0
146786,women,0,0
146787,choosing,0,0
146788,a,0,0
146789,range,0,0
146790,of,0,1
146791,post-abortion,0,0
146792,contraceptive,0,0
146793,options,0,0
146794,.,0,0
146795,We,0,0
146796,highlight,0,0
146797,considerations,0,0
146798,of,0,1
146799,design,0,0
146800,",",0,1
146801,implementation,0,1
146802,",",0,1
146803,and,0,1
146804,evaluation,0,0
146805,of,0,0
146806,the,0,0
146807,first,0,0
146808,trial,0,0
146809,to,0,0
146810,provide,0,0
146811,rigorous,0,0
146812,evidence,0,0
146813,for,0,0
146814,the,0,0
146815,effectiveness,0,0
146816,of,0,0
146817,current,0,0
146818,Canadian,0,0
146819,IUDs,0,1
146820,when,0,0
146821,inserted,0,0
146822,after,0,0
146823,first-trimester,0,0
146824,abortion,0,1
146825,.,0,0
146826,TRIAL,0,0
146827,REGISTRATION,0,0
146828,ClinicalTrials.gov,0,0
146829,Identifier,0,0
146830,NCT01174225,0,0
146831,.,0,0
146832,Sensitivity,0,1
146833,to,0,0
146834,musical,0,0
146835,structure,0,0
146836,in,0,0
146837,the,0,0
146838,human,0,0
146839,brain,0,1
146840,.,0,1
146841,Evidence,0,0
146842,from,0,0
146843,brain-damaged,0,0
146844,patients,0,0
146845,suggests,0,0
146846,that,0,0
146847,regions,0,0
146848,in,0,0
146849,the,0,0
146850,temporal,0,1
146851,lobes,0,1
146852,",",0,1
146853,distinct,0,0
146854,from,0,0
146855,those,0,0
146856,engaged,0,0
146857,in,0,0
146858,lower-level,0,1
146859,auditory,0,1
146860,analysis,0,0
146861,",",0,0
146862,process,0,0
146863,the,0,0
146864,pitch,0,0
146865,and,0,1
146866,rhythmic,0,1
146867,structure,0,1
146868,in,0,0
146869,music,0,0
146870,.,0,0
146871,In,0,0
146872,contrast,0,0
146873,",",0,0
146874,neuroimaging,0,1
146875,studies,0,0
146876,targeting,0,0
146877,the,0,0
146878,representation,0,0
146879,of,0,1
146880,music,0,0
146881,structure,0,0
146882,have,0,0
146883,primarily,0,0
146884,implicated,0,0
146885,regions,0,0
146886,in,0,0
146887,the,0,0
146888,inferior,0,0
146889,frontal,0,1
146890,cortices,0,1
146891,.,0,0
146892,Combining,0,0
146893,individual-subject,0,0
146894,fMRI,0,1
146895,analyses,0,0
146896,with,0,0
146897,a,0,0
146898,scrambling,0,1
146899,method,0,0
146900,that,0,0
146901,manipulated,0,0
146902,musical,0,0
146903,structure,0,0
146904,",",0,0
146905,we,0,0
146906,provide,0,0
146907,evidence,0,0
146908,of,0,1
146909,brain,1,1
146910,regions,1,0
146911,sensitive,1,0
146912,to,1,0
146913,musical,1,0
146914,structure,1,0
146915,bilaterally,0,0
146916,in,0,0
146917,the,0,0
146918,temporal,0,1
146919,lobes,0,1
146920,",",0,0
146921,thus,0,0
146922,reconciling,0,0
146923,the,0,0
146924,neuroimaging,0,0
146925,and,0,1
146926,patient,0,1
146927,findings,0,0
146928,.,0,0
146929,We,0,0
146930,further,0,0
146931,show,0,0
146932,that,0,0
146933,these,0,0
146934,regions,0,0
146935,are,0,0
146936,sensitive,0,0
146937,to,0,0
146938,the,0,0
146939,scrambling,1,1
146940,of,1,0
146941,both,1,0
146942,pitch,1,0
146943,and,1,1
146944,rhythmic,1,1
146945,structure,1,1
146946,but,0,0
146947,are,0,0
146948,insensitive,0,1
146949,to,0,0
146950,high-level,1,1
146951,linguistic,1,1
146952,structure,1,0
146953,.,1,0
146954,Our,0,0
146955,results,0,0
146956,suggest,0,0
146957,the,0,0
146958,existence,0,0
146959,of,0,0
146960,brain,0,1
146961,regions,0,1
146962,with,0,0
146963,representations,1,0
146964,of,1,0
146965,musical,1,0
146966,structure,1,0
146967,that,0,0
146968,are,0,0
146969,distinct,0,0
146970,from,0,0
146971,high-level,0,1
146972,linguistic,0,1
146973,representations,0,1
146974,and,0,1
146975,lower-level,0,1
146976,acoustic,0,1
146977,representations,0,0
146978,.,0,0
146979,These,0,0
146980,regions,0,0
146981,provide,0,0
146982,targets,0,0
146983,for,0,0
146984,future,0,0
146985,research,0,0
146986,investigating,0,0
146987,possible,0,0
146988,neural,0,0
146989,specialization,0,1
146990,for,0,0
146991,music,0,1
146992,or,0,0
146993,its,0,0
146994,associated,0,0
146995,mental,0,1
146996,processes,0,0
146997,.,0,0
146998,Adherence,1,1
146999,to,1,0
147000,lifestyle,1,0
147001,recommendations,1,0
147002,by,0,0
147003,patients,0,0
147004,with,0,0
147005,depression,0,1
147006,.,0,0
147007,INTRODUCTION,0,0
147008,There,0,0
147009,is,0,0
147010,an,0,0
147011,increasing,0,0
147012,amount,0,1
147013,of,0,1
147014,evidence,0,0
147015,showing,0,0
147016,that,0,0
147017,physical,1,1
147018,activity,1,1
147019,and,1,1
147020,sun,1,0
147021,exposure,1,0
147022,are,0,0
147023,effective,0,1
147024,coadjuvant,0,0
147025,treatments,0,0
147026,for,0,0
147027,patients,0,0
147028,with,0,0
147029,mild,0,0
147030,to,0,0
147031,moderate,0,0
147032,depression,0,1
147033,.,0,0
147034,However,0,0
147035,",",0,0
147036,there,0,0
147037,is,0,0
147038,a,0,0
147039,lack,0,0
147040,of,0,0
147041,information,0,1
147042,regarding,0,0
147043,patient,0,1
147044,'s,0,0
147045,adherence,1,1
147046,to,0,0
147047,these,0,0
147048,recommendations,0,0
147049,in,0,0
147050,daily,0,0
147051,clinical,0,0
147052,practice,0,0
147053,.,0,0
147054,METHODS,0,0
147055,We,0,0
147056,conducted,0,0
147057,a,0,0
147058,study,0,0
147059,including,0,0
147060,15,0,0
147061,depressive,0,0
147062,patients,0,0
147063,who,0,0
147064,had,0,0
147065,been,0,0
147066,under,0,0
147067,antidepressant,0,0
147068,treatment,0,0
147069,for,0,0
147070,at,0,0
147071,least,0,0
147072,one,0,0
147073,month,0,0
147074,.,0,0
147075,They,0,0
147076,wore,0,0
147077,a,0,0
147078,wrist-watch-like,0,1
147079,actimetry,0,0
147080,sensor,0,0
147081,to,0,0
147082,measure,0,0
147083,physical,1,1
147084,activity,1,1
147085,and,1,1
147086,sun,1,0
147087,exposure,1,0
147088,24,0,0
147089,hours,0,0
147090,a,0,0
147091,day,0,0
147092,.,0,0
147093,After,0,0
147094,one,0,0
147095,week,0,0
147096,of,0,0
147097,baseline,0,1
147098,assessment,0,1
147099,",",0,1
147100,patients,0,0
147101,were,0,0
147102,randomised,0,0
147103,into,0,0
147104,one,0,0
147105,of,0,0
147106,the,0,0
147107,two,0,0
147108,arms,0,0
147109,of,0,0
147110,the,0,0
147111,study,0,0
147112,.,0,0
147113,Patients,0,0
147114,in,0,0
147115,the,0,0
147116,experimental,0,0
147117,group,0,0
147118,received,0,0
147119,a,0,0
147120,brief,0,0
147121,note,0,0
147122,in,0,0
147123,which,0,0
147124,they,0,0
147125,were,0,0
147126,explicitly,0,0
147127,asked,0,0
147128,to,0,0
147129,increase,0,0
147130,both,0,0
147131,their,0,0
147132,physical,1,1
147133,activity,1,1
147134,level,1,1
147135,and,1,1
147136,time,1,1
147137,of,1,1
147138,sun,1,0
147139,exposure,1,0
147140,",",0,1
147141,while,0,0
147142,control,0,0
147143,group,0,0
147144,patients,0,0
147145,did,0,0
147146,not,0,0
147147,receive,0,0
147148,these,0,0
147149,explicit,0,0
147150,recommendations,0,0
147151,.,0,0
147152,RESULTS,0,0
147153,One,0,0
147154,week,0,0
147155,after,0,0
147156,recommendations,0,0
147157,were,0,0
147158,delivered,0,0
147159,",",0,0
147160,only,0,0
147161,patients,0,0
147162,in,0,0
147163,the,0,0
147164,experimental,0,0
147165,group,0,0
147166,had,0,0
147167,increased,0,0
147168,time,1,1
147169,of,1,0
147170,sun,1,0
147171,exposure,1,1
147172,and,1,1
147173,physical,1,1
147174,activity,1,1
147175,(,0,0
147176,25.8,0,0
147177,%,0,0
147178,and,0,0
147179,14.3,0,0
147180,%,0,0
147181,",",0,0
147182,respectively,0,0
147183,),0,0
147184,.,0,0
147185,CONCLUSIONS,0,0
147186,Depressive,0,0
147187,patients,0,0
147188,are,0,0
147189,able,1,0
147190,to,1,0
147191,follow,1,0
147192,prescribed,1,0
147193,lifestyle,1,0
147194,recommendations,1,0
147195,in,1,0
147196,the,1,0
147197,short-term,1,0
147198,.,1,0
147199,Multiple,0,1
147200,courses,0,0
147201,of,0,1
147202,rituximab,0,0
147203,produce,0,0
147204,sustained,0,1
147205,clinical,0,1
147206,and,0,1
147207,radiographic,0,1
147208,efficacy,0,1
147209,and,0,1
147210,safety,0,1
147211,in,0,0
147212,patients,0,0
147213,with,0,0
147214,rheumatoid,0,1
147215,arthritis,0,0
147216,and,0,0
147217,an,0,0
147218,inadequate,0,0
147219,response,0,1
147220,to,0,0
147221,1,0,0
147222,or,0,0
147223,more,0,0
147224,tumor,0,1
147225,necrosis,0,1
147226,factor,0,1
147227,inhibitors,0,1
147228,:,0,0
147229,5-year,0,0
147230,data,0,0
147231,from,0,0
147232,the,0,0
147233,REFLEX,0,0
147234,study,0,0
147235,.,0,0
147236,OBJECTIVE,0,0
147237,This,0,0
147238,5-year,0,0
147239,observational,0,0
147240,posthoc,0,0
147241,analysis,0,0
147242,of,0,0
147243,the,0,0
147244,REFLEX,0,0
147245,study,0,0
147246,and,0,0
147247,its,0,0
147248,open-label,0,0
147249,extension,0,1
147250,assessed,0,0
147251,clinical,0,1
147252,efficacy,0,1
147253,",",0,1
147254,radiographic,0,1
147255,response,0,1
147256,",",0,1
147257,and,0,1
147258,safety,0,1
147259,of,0,1
147260,rituximab,0,0
147261,(,0,1
147262,RTX,0,0
147263,),0,0
147264,in,0,0
147265,patients,0,0
147266,with,0,0
147267,rheumatoid,0,1
147268,arthritis,0,1
147269,(,0,1
147270,RA,0,0
147271,),0,0
147272,who,0,0
147273,had,0,0
147274,an,0,0
147275,inadequate,0,0
147276,response,0,1
147277,to,0,0
147278,tumor,0,1
147279,necrosis,0,1
147280,factor,0,1
147281,(,0,1
147282,TNF,0,0
147283,),0,0
147284,inhibitors,0,0
147285,.,0,0
147286,METHODS,0,0
147287,Patients,0,0
147288,in,0,0
147289,REFLEX,0,0
147290,were,0,0
147291,originally,0,0
147292,randomized,0,0
147293,to,0,0
147294,placebo,0,0
147295,(,0,0
147296,PBO,0,0
147297,),0,1
147298,+,0,0
147299,methotrexate,0,0
147300,(,0,0
147301,MTX,0,0
147302,;,0,1
147303,PBO-randomized,0,0
147304,),0,1
147305,or,0,0
147306,RTX,0,0
147307,+,0,1
147308,MTX,0,1
147309,(,0,1
147310,RTX-randomized,0,0
147311,),0,0
147312,.,0,0
147313,PBO-randomized,0,0
147314,patients,0,0
147315,were,0,0
147316,rescued,0,0
147317,with,0,0
147318,RTX,0,0
147319,as,0,0
147320,appropriate,0,0
147321,.,0,0
147322,Patients,0,0
147323,responding,0,0
147324,to,0,0
147325,initial,0,0
147326,RTX,0,0
147327,treatment,0,0
147328,could,0,0
147329,receive,0,0
147330,further,0,0
147331,RTX,0,0
147332,courses,0,0
147333,.,0,0
147334,For,0,0
147335,clinical,0,1
147336,efficacy,0,1
147337,and,0,1
147338,safety,0,1
147339,analyses,0,0
147340,",",0,0
147341,PBO-randomized,0,0
147342,patients,0,0
147343,were,0,0
147344,re-baselined,0,0
147345,prior,0,0
147346,to,0,0
147347,first,0,1
147348,RTX,0,0
147349,treatment,0,0
147350,and,0,0
147351,the,0,0
147352,data,0,0
147353,were,0,0
147354,pooled,0,0
147355,with,0,0
147356,RTX-randomized,0,0
147357,patient,0,1
147358,data,0,0
147359,.,0,0
147360,Efficacy,0,1
147361,outcomes,0,0
147362,24,0,0
147363,weeks,0,0
147364,after,0,0
147365,each,0,0
147366,course,0,0
147367,were,0,0
147368,calculated,0,0
147369,relative,0,0
147370,to,0,0
147371,first,0,1
147372,RTX,0,0
147373,pretreatment,0,0
147374,baseline,0,0
147375,.,0,1
147376,Radiographic,0,1
147377,outcomes,0,1
147378,were,0,0
147379,assessed,0,0
147380,relative,0,0
147381,to,0,0
147382,randomization,0,0
147383,baseline,0,0
147384,for,0,0
147385,both,0,0
147386,PBO-randomized,0,0
147387,and,0,1
147388,RTX-randomized,0,0
147389,groups,0,0
147390,.,0,0
147391,RESULTS,0,0
147392,A,0,0
147393,total,0,0
147394,of,0,0
147395,480,0,0
147396,patients,0,0
147397,received,0,0
147398,?,0,0
147399,1,0,0
147400,RTX,0,0
147401,course,0,0
147402,.,0,0
147403,At,0,0
147404,24,0,0
147405,weeks,1,0
147406,",",1,0
147407,American,1,0
147408,College,1,0
147409,of,1,0
147410,Rheumatology,1,0
147411,20/50/70,1,0
147412,responses,1,0
147413,were,1,0
147414,62.0,0,0
147415,%,0,0
147416,",",0,0
147417,30.8,0,0
147418,%,0,0
147419,",",0,0
147420,and,0,0
147421,13.0,0,0
147422,%,0,0
147423,",",0,0
147424,respectively,0,0
147425,at,0,0
147426,course,0,0
147427,1,0,0
147428,(,0,0
147429,n,0,0
147430,=,0,0
147431,400,0,0
147432,),0,0
147433,and,0,0
147434,70.3,0,0
147435,%,0,0
147436,",",0,0
147437,41.8,0,0
147438,%,0,0
147439,",",0,0
147440,and,0,0
147441,22.0,0,0
147442,%,0,0
147443,at,0,0
147444,course,0,0
147445,5,0,0
147446,(,0,0
147447,n,0,0
147448,=,0,0
147449,91,0,0
147450,),1,0
147451,.,1,0
147452,European,1,0
147453,League,1,1
147454,Against,1,1
147455,Rheumatism,1,1
147456,good/moderate,1,1
147457,responses,1,1
147458,were,1,0
147459,77.2,0,0
147460,%,0,0
147461,and,0,0
147462,84.4,0,0
147463,%,0,0
147464,at,0,0
147465,courses,0,0
147466,1,0,0
147467,(,0,0
147468,n,0,0
147469,=,0,0
147470,390,0,0
147471,),0,0
147472,and,0,0
147473,5,0,0
147474,(,0,0
147475,n,0,0
147476,=,0,0
147477,90,0,0
147478,),1,0
147479,.,1,0
147480,Rates,1,1
147481,of,1,0
147482,adverse,1,1
147483,events,1,1
147484,(,1,0
147485,AE,1,1
147486,),1,1
147487,",",1,0
147488,serious,1,1
147489,AE,1,1
147490,",",1,1
147491,and,1,1
147492,infections,1,1
147493,generally,1,0
147494,remained,0,0
147495,stable,1,1
147496,.,1,0
147497,Rate,1,0
147498,of,1,0
147499,progressive,1,0
147500,joint,1,1
147501,damage,1,1
147502,(,1,0
147503,PJD,0,1
147504,;,0,0
147505,change,0,1
147506,in,0,0
147507,mean,0,1
147508,Total,0,1
147509,Sharp,0,1
147510,Score,0,1
147511,),0,1
147512,decreased,0,1
147513,over,0,0
147514,time,0,1
147515,in,0,0
147516,both,0,0
147517,PBO-randomized,0,0
147518,(,0,0
147519,n,0,0
147520,=,0,0
147521,79,0,0
147522,),0,0
147523,and,0,0
147524,RTX-randomized,0,0
147525,(,0,1
147526,n,0,0
147527,=,0,0
147528,105,0,0
147529,),0,0
147530,groups,1,0
147531,.,1,0
147532,Mean,1,1
147533,change,1,1
147534,from,1,0
147535,baseline,1,0
147536,in,1,0
147537,PJD,1,0
147538,over,1,0
147539,5,0,0
147540,years,0,0
147541,was,0,0
147542,greater,0,0
147543,in,0,0
147544,PBO-randomized,0,0
147545,versus,0,0
147546,RTX-randomized,0,0
147547,patients,0,0
147548,(,0,0
147549,5.51,0,0
147550,vs,0,0
147551,3.21,0,0
147552,),0,0
147553,.,0,0
147554,CONCLUSION,0,0
147555,RTX,0,0
147556,re-treatment,0,0
147557,over,0,0
147558,5,0,0
147559,years,0,0
147560,is,0,0
147561,associated,0,0
147562,with,0,0
147563,maintained,0,0
147564,or,0,0
147565,improved,0,1
147566,efficacy,0,1
147567,",",0,0
147568,continued,0,0
147569,inhibition,0,1
147570,of,0,1
147571,PJD,0,1
147572,",",0,0
147573,and,0,0
147574,a,0,0
147575,safety,0,1
147576,profile,0,1
147577,consistent,0,0
147578,with,0,0
147579,that,0,0
147580,previously,0,0
147581,reported,0,0
147582,.,0,0
147583,A,0,0
147584,delay,0,1
147585,in,0,0
147586,initiating,0,0
147587,RTX,0,0
147588,treatment,0,0
147589,may,0,0
147590,result,0,0
147591,in,0,0
147592,increased,0,0
147593,PJD,0,0
147594,.,0,0
147595,Patient,0,0
147596,navigation,0,0
147597,improves,0,1
147598,cancer,0,0
147599,diagnostic,0,0
147600,resolution,0,1
147601,:,0,0
147602,an,0,0
147603,individually,0,0
147604,randomized,0,0
147605,clinical,0,0
147606,trial,0,0
147607,in,0,0
147608,an,0,0
147609,underserved,0,0
147610,population,0,0
147611,.,0,0
147612,BACKGROUND,0,0
147613,Barriers,0,1
147614,to,0,0
147615,timely,0,0
147616,resolution,0,1
147617,of,0,1
147618,abnormal,0,1
147619,cancer,0,0
147620,screening,0,0
147621,tests,0,0
147622,add,0,0
147623,to,0,0
147624,cancer,0,0
147625,health,0,1
147626,disparities,0,1
147627,among,0,0
147628,low-income,0,0
147629,",",0,0
147630,uninsured,0,1
147631,",",0,1
147632,and,0,1
147633,minority,0,0
147634,populations,0,0
147635,.,0,0
147636,We,0,0
147637,conducted,0,0
147638,a,0,0
147639,randomized,0,0
147640,trial,0,0
147641,to,0,0
147642,evaluate,0,0
147643,the,0,0
147644,impact,0,0
147645,of,0,1
147646,lay,0,0
147647,patient,0,1
147648,navigators,0,0
147649,on,0,0
147650,time,0,1
147651,to,0,0
147652,resolution,0,1
147653,and,0,1
147654,completion,0,1
147655,of,0,1
147656,follow-up,0,0
147657,testing,0,0
147658,among,0,0
147659,patients,0,0
147660,with,0,0
147661,abnormal,0,1
147662,screening,0,0
147663,tests,0,1
147664,in,0,0
147665,a,0,0
147666,medically,0,0
147667,underserved,0,0
147668,patient,0,1
147669,population,0,0
147670,.,0,0
147671,METHODS,0,0
147672,Denver,0,0
147673,Health,0,1
147674,",",0,0
147675,the,0,0
147676,safety-net,0,0
147677,health,0,1
147678,care,0,0
147679,system,0,0
147680,serving,0,0
147681,Denver,0,0
147682,",",0,0
147683,is,0,0
147684,one,0,0
147685,of,0,0
147686,10,0,0
147687,performance,0,0
147688,sites,0,0
147689,participating,0,0
147690,in,0,0
147691,the,0,0
147692,Patient,0,1
147693,Navigation,0,0
147694,Research,0,0
147695,Program,0,1
147696,.,0,0
147697,Of,0,0
147698,993,0,0
147699,eligible,0,0
147700,subjects,0,0
147701,with,0,0
147702,abnormal,0,1
147703,screening,0,0
147704,tests,0,1
147705,randomized,0,0
147706,to,0,0
147707,navigation,0,0
147708,and,0,1
147709,no-navigation,0,1
147710,(,0,1
147711,control,0,0
147712,),0,1
147713,arms,0,1
147714,and,0,1
147715,analyzed,0,0
147716,",",0,0
147717,628,0,0
147718,had,0,0
147719,abnormal,0,1
147720,breast,0,0
147721,screens,0,1
147722,(,0,0
147723,66,0,0
147724,abnormal,0,1
147725,clinical,0,0
147726,breast,0,0
147727,examinations,0,0
147728,",",0,0
147729,304,0,0
147730,BIRADS,0,0
147731,0,0,0
147732,",",0,0
147733,200,0,0
147734,BIRADS,0,0
147735,3,0,0
147736,",",0,0
147737,58,0,0
147738,BIRADS,0,0
147739,4,0,0
147740,or,0,0
147741,5,0,0
147742,),0,0
147743,whereas,0,0
147744,235,0,0
147745,had,0,0
147746,abnormal,0,1
147747,colorectal,0,0
147748,and,0,0
147749,130,0,0
147750,had,0,0
147751,abnormal,0,1
147752,prostate,0,0
147753,screens,0,1
147754,.,0,0
147755,RESULTS,0,0
147756,Time,1,0
147757,to,1,0
147758,resolution,1,1
147759,was,0,0
147760,significantly,0,0
147761,shorter,0,0
147762,in,0,0
147763,the,0,0
147764,navigated,0,0
147765,group,0,0
147766,(,0,0
147767,stratified,0,0
147768,log,0,1
147769,rank,0,1
147770,test,0,1
147771,",",0,1
147772,P,0,0
147773,<,0,0
147774,0.001,0,0
147775,),0,0
147776,.,0,0
147777,Patient,0,1
147778,navigation,0,0
147779,improved,0,1
147780,diagnostic,1,1
147781,resolution,1,1
147782,for,0,0
147783,patients,0,0
147784,presenting,0,1
147785,with,0,0
147786,mammographic,0,1
147787,BIRADS,0,0
147788,3,0,0
147789,(,0,0
147790,P,0,0
147791,=,0,0
147792,0.0003,0,0
147793,),0,0
147794,and,0,0
147795,BIRADS,0,0
147796,0,0,0
147797,(,0,0
147798,P,0,0
147799,=,0,0
147800,0.09,0,0
147801,),0,0
147802,",",0,0
147803,but,0,0
147804,not,0,0
147805,BIRADS,0,0
147806,4/5,0,0
147807,or,0,0
147808,abnormal,0,1
147809,breast,0,0
147810,examinations,0,0
147811,.,0,1
147812,Navigation,0,0
147813,shortened,0,1
147814,the,0,0
147815,time,0,1
147816,for,0,0
147817,both,0,0
147818,colorectal,1,0
147819,(,0,0
147820,P,0,0
147821,=,0,0
147822,0.0017,0,0
147823,),0,0
147824,and,0,0
147825,prostate,1,0
147826,screening,1,0
147827,resolution,1,1
147828,(,0,0
147829,P,0,0
147830,=,0,0
147831,0.06,0,0
147832,),0,0
147833,.,0,0
147834,Participant,0,0
147835,demographics,0,1
147836,included,0,0
147837,72,0,0
147838,%,0,0
147839,minority,0,0
147840,",",0,0
147841,49,0,0
147842,%,0,0
147843,with,0,0
147844,annual,0,0
147845,household,0,1
147846,income,0,1
147847,less,0,0
147848,than,0,0
147849,$,0,0
147850,"10,000",0,0
147851,",",0,0
147852,and,0,0
147853,36,0,0
147854,%,0,0
147855,uninsured,0,0
147856,.,0,0
147857,CONCLUSIONS,0,0
147858,Patient,0,1
147859,navigation,0,0
147860,positively,0,0
147861,impacts,0,0
147862,time,0,1
147863,to,0,0
147864,resolution,1,1
147865,of,0,1
147866,abnormal,0,1
147867,screening,0,0
147868,tests,0,1
147869,for,0,0
147870,breast,0,0
147871,",",0,1
147872,colorectal,0,0
147873,",",0,1
147874,and,0,1
147875,prostate,0,0
147876,cancers,0,1
147877,in,0,0
147878,a,0,0
147879,medically,0,0
147880,underserved,0,0
147881,population,0,0
147882,.,0,0
147883,IMPACT,0,0
147884,By,0,0
147885,shortening,0,1
147886,the,0,0
147887,time,0,1
147888,to,0,0
147889,and,0,0
147890,increasing,0,0
147891,the,0,0
147892,proportion,0,0
147893,of,0,0
147894,patients,0,0
147895,with,0,0
147896,diagnostic,0,1
147897,resolution,0,1
147898,patient,0,1
147899,navigation,0,0
147900,could,0,0
147901,reduce,0,0
147902,disparities,0,0
147903,in,0,0
147904,stage,0,0
147905,at,0,0
147906,diagnosis,0,0
147907,and,0,1
147908,improve,0,0
147909,cancer,0,0
147910,outcomes,0,1
147911,.,0,0
147912,Is,0,0
147913,prophylactic,0,0
147914,intravenous,0,0
147915,administration,0,0
147916,of,0,0
147917,a,0,0
147918,proton,0,0
147919,pump,0,1
147920,inhibitor,0,0
147921,necessary,0,0
147922,for,0,0
147923,perioperative,0,1
147924,management,0,0
147925,of,0,1
147926,cardiac,0,1
147927,surgery,0,0
147928,?,0,0
147929,BACKGROUND,0,0
147930,Mortality,0,1
147931,from,0,0
147932,gastrointestinal,0,1
147933,(,0,0
147934,GI,0,1
147935,),0,1
147936,hemorrhage,0,1
147937,caused,0,0
147938,by,0,0
147939,antiplatelet,0,0
147940,or,0,1
147941,anticoagulant,0,1
147942,therapy,0,0
147943,(,0,0
147944,or,0,0
147945,both,0,0
147946,),0,0
147947,is,0,0
147948,quite,0,0
147949,high,0,0
147950,after,0,0
147951,cardiac,0,1
147952,surgery,0,0
147953,.,0,0
147954,We,0,0
147955,previously,0,0
147956,reported,0,0
147957,that,0,0
147958,proton,0,0
147959,pump,0,1
147960,inhibitor,0,0
147961,(,0,1
147962,PPI,0,0
147963,),0,0
147964,therapy,0,0
147965,is,0,0
147966,indispensable,0,0
147967,in,0,0
147968,preventing,0,0
147969,postoperative,0,1
147970,GI,0,0
147971,complications,0,1
147972,.,0,0
147973,PPIs,0,0
147974,are,0,0
147975,usually,0,0
147976,administered,0,0
147977,intravenously,0,0
147978,immediately,0,0
147979,after,0,0
147980,surgery,0,0
147981,and,0,0
147982,subsequently,0,0
147983,by,0,0
147984,oral,0,0
147985,formulations,0,0
147986,.,0,0
147987,We,0,0
147988,conducted,0,0
147989,a,0,0
147990,prospective,0,0
147991,study,0,0
147992,to,0,0
147993,evaluate,0,0
147994,whether,0,0
147995,intravenous,0,0
147996,PPI,0,0
147997,followed,0,0
147998,by,0,0
147999,oral,0,0
148000,administration,0,0
148001,is,0,0
148002,more,0,0
148003,efficient,0,1
148004,as,0,0
148005,prophylaxis,0,0
148006,than,0,0
148007,oral-only,0,0
148008,administration,0,0
148009,.,0,1
148010,METHODS,0,0
148011,AND,0,0
148012,RESULTS,0,0
148013,We,0,0
148014,enrolled,0,0
148015,40,0,0
148016,patients,0,0
148017,scheduled,0,0
148018,to,0,0
148019,undergo,0,0
148020,coronary,0,1
148021,artery,0,1
148022,bypass,0,0
148023,grafting,0,0
148024,with,0,0
148025,cardiopulmonary,0,1
148026,bypass,0,0
148027,and,0,1
148028,randomly,0,0
148029,assigned,0,0
148030,them,0,0
148031,to,0,0
148032,receive,0,0
148033,oral,0,0
148034,PPIs,0,1
148035,alone,0,0
148036,(,0,0
148037,group,0,0
148038,1,0,0
148039,),0,0
148040,or,0,0
148041,intravenous,0,0
148042,PPI,0,0
148043,followed,0,0
148044,by,0,0
148045,oral,0,0
148046,administration,0,0
148047,(,0,0
148048,group,0,0
148049,2,0,0
148050,),0,0
148051,.,0,0
148052,Postoperative,0,1
148053,upper,0,0
148054,GI,0,1
148055,endoscopy,0,0
148056,evaluations,0,0
148057,showed,0,0
148058,no,0,0
148059,evidence,0,0
148060,of,0,0
148061,GI,1,0
148062,bleeding,1,1
148063,.,1,0
148064,Only,0,0
148065,gastritis,1,1
148066,",",1,1
148067,esophagitis,1,1
148068,",",1,1
148069,and,1,1
148070,hiatal,1,1
148071,hernia,1,0
148072,were,0,0
148073,observed,0,0
148074,at,0,0
148075,similar,0,0
148076,incidences,0,1
148077,in,0,0
148078,the,0,0
148079,groups,0,0
148080,.,0,0
148081,Mean,1,1
148082,hospital,1,1
148083,stays,1,1
148084,were,0,0
148085,also,0,0
148086,similar,0,0
148087,",",0,0
148088,but,0,0
148089,the,0,0
148090,cost,1,1
148091,of,1,0
148092,PPI,1,0
148093,treatment,1,0
148094,was,0,0
148095,significantly,0,0
148096,lower,0,0
148097,in,0,0
148098,group,0,0
148099,1,0,0
148100,.,0,0
148101,CONCLUSION,0,0
148102,No,0,1
148103,additional,0,0
148104,benefits,0,0
148105,of,0,0
148106,intravenous,0,0
148107,PPIs,0,1
148108,over,0,0
148109,oral,0,0
148110,formulations,0,0
148111,were,0,0
148112,demonstrated,0,0
148113,.,0,0
148114,Oral,0,0
148115,PPIs,0,1
148116,alone,0,0
148117,were,0,0
148118,effective,0,1
148119,and,0,1
148120,economical,0,1
148121,as,0,0
148122,prophylaxis,0,0
148123,against,0,0
148124,GI,0,0
148125,complications,0,1
148126,.,0,0
148127,Intravenous,0,0
148128,PPIs,0,0
148129,might,0,0
148130,be,0,0
148131,unnecessary,0,0
148132,in,0,0
148133,selected,0,0
148134,patients,0,0
148135,after,0,0
148136,cardiac,0,1
148137,surgery,0,0
148138,.,0,0
148139,Dysfunctional,0,1
148140,attitudes,0,1
148141,as,0,0
148142,a,0,0
148143,moderator,0,0
148144,of,0,1
148145,pharmacotherapy,0,0
148146,and,0,1
148147,psychotherapy,0,0
148148,for,0,0
148149,chronic,0,0
148150,depression,0,1
148151,.,0,0
148152,OBJECTIVE,0,0
148153,Individuals,0,0
148154,with,0,0
148155,chronic,0,0
148156,depression,0,1
148157,exhibit,0,0
148158,heterogeneous,0,0
148159,responses,0,1
148160,to,0,0
148161,treatment,0,0
148162,.,0,0
148163,Important,0,1
148164,individual,0,0
148165,differences,0,0
148166,may,0,0
148167,therefore,0,0
148168,exist,0,0
148169,within,0,0
148170,this,0,0
148171,particularly,0,0
148172,difficult,0,0
148173,to,0,0
148174,treat,0,0
148175,population,0,0
148176,that,0,0
148177,act,0,0
148178,as,0,0
148179,moderators,0,0
148180,of,0,1
148181,treatment,0,0
148182,response,0,1
148183,.,0,0
148184,METHOD,0,0
148185,The,0,0
148186,present,0,0
148187,study,0,0
148188,examined,0,0
148189,whether,0,0
148190,pretreatment,0,0
148191,levels,0,1
148192,of,0,0
148193,dysfunctional,0,1
148194,attitudes,0,1
148195,(,0,0
148196,DA,0,1
148197,),0,1
148198,moderated,0,0
148199,treatment,0,0
148200,response,0,1
148201,in,0,0
148202,a,0,0
148203,large,0,0
148204,sample,0,0
148205,of,0,0
148206,chronically,0,0
148207,depressed,0,0
148208,individuals,0,0
148209,.,0,0
148210,Data,0,0
148211,were,0,0
148212,taken,0,0
148213,from,0,0
148214,the,0,0
148215,Research,0,0
148216,Evaluating,0,0
148217,the,0,0
148218,Value,0,0
148219,of,0,0
148220,Augmenting,0,0
148221,Medication,0,0
148222,with,0,0
148223,Psychotherapy,0,0
148224,(,0,0
148225,REVAMP,0,1
148226,),0,1
148227,treatment,0,0
148228,study,0,0
148229,--,0,0
148230,a,0,0
148231,multi-site,0,0
148232,treatment,0,0
148233,and,0,1
148234,augmentation,0,1
148235,study,0,0
148236,of,0,0
148237,808,0,0
148238,chronically,0,0
148239,depressed,0,0
148240,individuals,0,0
148241,.,0,1
148242,REVAMP,0,0
148243,comprised,0,0
148244,two,0,0
148245,phases,0,0
148246,:,0,0
148247,1,0,0
148248,),0,0
148249,a,0,0
148250,12-week,0,0
148251,open-label,0,0
148252,antidepressant,0,0
148253,trial,0,0
148254,and,0,0
148255,2,0,0
148256,),0,0
148257,",",0,0
148258,a,0,0
148259,subsequent,0,1
148260,phase,0,0
148261,",",0,0
148262,in,0,0
148263,which,0,0
148264,phase,0,0
148265,1,0,0
148266,non-remitters,0,0
148267,(,0,0
148268,N,0,0
148269,=,0,0
148270,491,0,0
148271,),0,0
148272,were,0,0
148273,randomized,0,0
148274,to,0,0
148275,either,0,0
148276,receive,0,0
148277,an,0,0
148278,ongoing,0,0
148279,medication,0,0
148280,algorithm,0,0
148281,alone,0,0
148282,",",0,0
148283,medication,0,1
148284,plus,0,0
148285,cognitive,0,1
148286,behavioral,0,1
148287,analysis,0,0
148288,system,0,0
148289,of,0,1
148290,psychotherapy,0,0
148291,",",0,1
148292,or,0,1
148293,medication,0,1
148294,plus,0,0
148295,brief,0,1
148296,supportive,0,0
148297,psychotherapy,0,0
148298,.,0,0
148299,RESULT,0,0
148300,In,0,0
148301,phase,0,0
148302,1,0,0
148303,",",0,0
148304,compared,0,0
148305,to,0,0
148306,the,0,0
148307,pharmacotherapy,1,0
148308,response,1,1
148309,of,0,1
148310,patients,0,0
148311,with,0,0
148312,lower,0,0
148313,DA,0,1
148314,scores,0,1
148315,",",0,0
148316,the,0,0
148317,response,0,1
148318,for,0,0
148319,patients,0,0
148320,with,0,0
148321,higher,0,0
148322,DA,0,1
148323,scores,0,1
148324,was,0,0
148325,steeper,0,1
148326,",",0,1
148327,but,0,0
148328,leveled,0,1
148329,off,0,0
148330,toward,0,0
148331,the,0,0
148332,end,0,0
148333,of,0,0
148334,the,0,0
148335,phase,0,0
148336,.,0,0
148337,In,0,0
148338,phase,0,0
148339,2,0,0
148340,",",0,0
148341,DA,0,0
148342,predicted,0,1
148343,a,0,0
148344,differential,0,1
148345,response,0,1
148346,in,0,0
148347,the,0,0
148348,medication,0,0
148349,only,0,0
148350,arm,0,0
148351,",",0,1
148352,but,0,0
148353,not,0,0
148354,in,0,0
148355,the,0,0
148356,two,0,0
148357,psychotherapy,0,0
148358,+,0,0
148359,medication,0,0
148360,conditions,0,0
148361,.,0,0
148362,Specifically,0,0
148363,",",0,0
148364,in,0,0
148365,the,0,0
148366,phase,0,0
148367,2,0,0
148368,medication,0,0
148369,only,0,0
148370,condition,0,0
148371,",",0,0
148372,patients,0,0
148373,with,0,0
148374,higher,0,0
148375,DA,0,1
148376,improved,1,1
148377,while,0,0
148378,those,0,0
148379,with,0,0
148380,lower,0,0
148381,DA,0,1
148382,scores,0,1
148383,did,0,0
148384,not,0,0
148385,.,0,0
148386,CONCLUSION,0,0
148387,These,0,0
148388,results,0,0
148389,indicate,0,0
148390,that,0,0
148391,the,0,0
148392,relation,0,0
148393,between,0,0
148394,DA,0,1
148395,and,0,1
148396,treatment,0,0
148397,response,0,1
148398,in,0,0
148399,chronic,0,0
148400,depression,0,1
148401,is,0,0
148402,complex,0,0
148403,",",0,0
148404,but,0,0
148405,suggest,0,0
148406,that,0,0
148407,greater,0,0
148408,DA,0,0
148409,may,0,0
148410,be,0,0
148411,associated,0,0
148412,with,0,0
148413,a,0,0
148414,steeper,0,0
148415,reduction,0,1
148416,and/or,0,0
148417,better,0,0
148418,response,0,1
148419,to,0,0
148420,pharmacotherapy,0,0
148421,.,0,0
148422,Custom-fit,0,1
148423,minimally,0,0
148424,invasive,0,1
148425,total,0,1
148426,knee,0,1
148427,arthroplasty,0,0
148428,:,0,0
148429,effect,0,1
148430,on,0,0
148431,blood,1,1
148432,loss,1,1
148433,and,0,1
148434,early,1,1
148435,clinical,1,0
148436,outcomes,1,1
148437,.,1,0
148438,PURPOSE,0,0
148439,Recently,0,0
148440,",",0,0
148441,new,0,1
148442,custom-fit,0,1
148443,pin,0,1
148444,guides,0,0
148445,in,0,0
148446,total,0,1
148447,knee,0,1
148448,arthroplasty,0,1
148449,(,0,1
148450,TKA,0,0
148451,),0,0
148452,have,0,0
148453,been,0,0
148454,introduced,0,0
148455,.,0,0
148456,Use,0,0
148457,of,0,0
148458,these,0,0
148459,guides,0,0
148460,may,0,0
148461,reduce,0,0
148462,operating,0,1
148463,time,0,1
148464,.,0,1
148465,Use,0,0
148466,of,0,0
148467,the,0,0
148468,guides,0,0
148469,combined,0,0
148470,with,0,0
148471,the,0,0
148472,absence,0,0
148473,of,0,0
148474,intramedullary,0,1
148475,alignment,0,1
148476,jigs,0,0
148477,may,0,0
148478,lead,0,0
148479,to,0,0
148480,reduced,0,1
148481,blood,1,1
148482,loss,1,1
148483,and,0,1
148484,improved,0,1
148485,early,1,0
148486,outcomes,1,1
148487,.,1,0
148488,Our,0,0
148489,aim,0,0
148490,was,0,0
148491,to,0,0
148492,evaluate,0,0
148493,blood,1,1
148494,loss,1,1
148495,and,0,1
148496,early,1,1
148497,clinical,1,1
148498,outcomes,1,1
148499,in,0,0
148500,patients,0,0
148501,undergoing,0,0
148502,minimally,0,0
148503,invasive,0,0
148504,TKA,0,0
148505,using,0,0
148506,custom-fit,0,1
148507,magnetic,0,0
148508,resonance,0,0
148509,imaging,0,1
148510,(,0,1
148511,MRI,0,1
148512,),0,1
148513,-based,0,0
148514,pin,0,1
148515,guides,0,0
148516,.,0,0
148517,METHODS,0,0
148518,A,0,0
148519,prospective,0,0
148520,study,0,0
148521,in,0,0
148522,80,0,0
148523,patients,0,0
148524,was,0,0
148525,carried,0,0
148526,out,0,0
148527,.,0,0
148528,Patients,0,0
148529,were,0,0
148530,divided,0,0
148531,randomly,0,0
148532,into,0,0
148533,2,0,0
148534,equal,0,0
148535,groups,0,0
148536,.,0,0
148537,In,0,0
148538,one,0,0
148539,group,0,0
148540,",",0,0
148541,intramedullary,0,1
148542,alignment,0,1
148543,jigs,0,0
148544,were,0,0
148545,used,0,0
148546,.,0,0
148547,In,0,0
148548,the,0,0
148549,second,0,0
148550,group,0,0
148551,",",0,1
148552,custom-fit,0,1
148553,MRI-based,0,0
148554,pin,0,1
148555,guides,0,0
148556,were,0,0
148557,used,0,0
148558,.,0,0
148559,All,0,0
148560,patients,0,0
148561,received,0,0
148562,the,0,0
148563,same,0,0
148564,cemented,0,0
148565,posterior-stabilized,0,1
148566,implant,0,0
148567,through,0,0
148568,a,0,0
148569,mini-midvastus,0,0
148570,approach,0,0
148571,.,0,0
148572,The,0,0
148573,volume,0,1
148574,in,0,0
148575,the,0,0
148576,drain,0,1
148577,bottles,0,0
148578,was,0,0
148579,recorded,0,0
148580,after,0,0
148581,48,0,0
148582,h.,0,0
148583,Hb,1,0
148584,loss,1,1
148585,was,0,0
148586,estimated,0,0
148587,by,0,0
148588,subtracting,0,0
148589,the,0,0
148590,postoperative,0,1
148591,from,0,0
148592,the,0,0
148593,preoperative,0,1
148594,Hb,0,1
148595,level,0,1
148596,.,0,1
148597,Transfusion,1,1
148598,requirements,1,1
148599,and,0,1
148600,surgical,1,1
148601,time,1,1
148602,were,0,0
148603,recorded,0,0
148604,.,0,0
148605,Outcome,0,1
148606,measures,0,1
148607,were,0,0
148608,Knee,1,1
148609,Society,1,1
148610,Scores,1,1
148611,(,1,1
148612,KSS,1,1
148613,),1,1
148614,",",1,0
148615,knee,1,1
148616,flexion,1,1
148617,",",1,0
148618,knee,1,1
148619,swelling,1,1
148620,and,1,0
148621,pain,1,1
148622,.,1,1
148623,RESULTS,0,0
148624,There,0,0
148625,was,0,0
148626,lower,0,0
148627,mean,1,1
148628,drainage,1,1
148629,of,1,1
148630,blood,1,1
148631,in,0,0
148632,the,0,0
148633,custom-fit,0,1
148634,group,0,0
148635,(,0,0
148636,391,0,0
148637,ml,0,0
148638,vs.,0,0
148639,603,0,0
148640,ml,0,0
148641,;,0,0
148642,p,0,0
148643,<,0,0
148644,0.0001,0,0
148645,),0,0
148646,.,0,0
148647,There,0,0
148648,was,0,0
148649,no,0,0
148650,difference,0,0
148651,in,0,0
148652,estimated,0,0
148653,loss,1,1
148654,of,1,0
148655,Hb,1,1
148656,(,0,0
148657,3.6,0,0
148658,g/dl,0,0
148659,vs.,0,0
148660,4.1,0,0
148661,g/dl,0,0
148662,;,0,0
148663,n.s,0,0
148664,.,0,1
148665,),0,1
148666,and,0,0
148667,in,0,0
148668,transfusion,1,1
148669,requirements,1,1
148670,(,0,0
148671,7.5,0,0
148672,%,0,0
148673,vs.,0,0
148674,10,0,0
148675,%,0,0
148676,;,0,0
148677,n.s.,0,0
148678,),0,0
148679,.,0,1
148680,Surgical,1,1
148681,time,1,1
148682,was,0,0
148683,reduced,0,0
148684,in,0,0
148685,the,0,0
148686,custom-fit,0,1
148687,group,0,0
148688,(,0,0
148689,12,0,0
148690,min,0,0
148691,less,0,0
148692,;,0,0
148693,p,0,0
148694,=,0,0
148695,0.001,0,0
148696,),0,0
148697,.,0,0
148698,KSS,1,1
148699,measured,0,1
148700,at,0,0
148701,week,0,0
148702,2,0,0
148703,",",0,0
148704,6,0,0
148705,and,0,0
148706,12,0,0
148707,showed,0,0
148708,no,0,0
148709,significant,0,0
148710,difference,0,0
148711,between,0,0
148712,groups,0,0
148713,.,0,0
148714,Knee,1,1
148715,flexion,1,1
148716,measured,0,1
148717,on,0,0
148718,days,0,0
148719,7,0,0
148720,",",0,0
148721,10,0,0
148722,and,0,0
148723,at,0,0
148724,week,0,0
148725,6,0,0
148726,",",0,0
148727,12,0,0
148728,and,0,0
148729,knee,1,1
148730,swelling,1,1
148731,and,1,1
148732,pain,1,1
148733,measured,0,1
148734,on,0,0
148735,days,0,0
148736,1,0,0
148737,",",0,0
148738,3,0,0
148739,",",0,0
148740,10,0,0
148741,and,0,0
148742,at,0,0
148743,week,0,0
148744,6,0,0
148745,",",0,0
148746,12,0,0
148747,showed,0,0
148748,no,0,0
148749,significant,0,0
148750,difference,0,0
148751,between,0,0
148752,groups,0,0
148753,.,0,0
148754,CONCLUSIONS,0,0
148755,Using,0,0
148756,custom-fit,0,1
148757,pin,0,1
148758,guides,0,0
148759,reduces,0,1
148760,blood,1,1
148761,drainage,1,1
148762,",",0,1
148763,but,0,0
148764,not,0,0
148765,the,0,0
148766,estimated,0,0
148767,Hb,1,1
148768,loss,1,1
148769,in,0,0
148770,minimally,0,0
148771,invasive,0,1
148772,TKA,0,0
148773,and,0,0
148774,does,0,0
148775,not,0,0
148776,affect,0,0
148777,transfusion,1,1
148778,rate,1,1
148779,.,1,1
148780,Surgical,1,0
148781,time,1,1
148782,is,0,0
148783,reduced,0,0
148784,.,0,0
148785,There,0,0
148786,is,0,0
148787,no,0,0
148788,effect,0,0
148789,on,0,0
148790,the,0,0
148791,early,1,0
148792,clinical,1,0
148793,outcomes,1,1
148794,.,1,0
148795,LEVEL,0,1
148796,OF,0,0
148797,EVIDENCE,0,1
148798,Therapeutic,0,1
148799,study,0,0
148800,",",0,0
148801,Level,0,0
148802,I,0,0
148803,.,0,0
148804,Clinical,0,1
148805,trial,0,0
148806,:,0,0
148807,marine,0,0
148808,lipid,0,1
148809,suppositories,0,0
148810,as,0,0
148811,laxatives,0,1
148812,.,0,0
148813,UNLABELLED,0,0
148814,Cod-liver,0,0
148815,oil,0,0
148816,and,0,1
148817,other,0,1
148818,marine,0,0
148819,products,0,1
148820,containing,0,0
148821,polyunsaturated,0,1
148822,fatty,0,1
148823,acids,0,0
148824,have,0,0
148825,anti-inflammatory,0,0
148826,",",0,0
148827,anti-bacterial,0,1
148828,and,0,1
148829,anti-viral,0,0
148830,effects,0,1
148831,and,0,0
148832,may,0,0
148833,be,0,0
148834,useful,0,0
148835,in,0,0
148836,the,0,0
148837,treatment,0,0
148838,of,0,0
148839,various,0,0
148840,inflammatory,0,1
148841,and,0,1
148842,infectious,0,1
148843,diseases,0,0
148844,.,0,0
148845,We,0,0
148846,developed,0,0
148847,suppositories,0,0
148848,and,0,1
148849,ointment,0,0
148850,with,0,0
148851,30,0,0
148852,%,0,0
148853,free,0,1
148854,fatty,0,1
148855,acid,0,1
148856,(,0,1
148857,FFA,0,0
148858,),0,1
148859,extract,0,0
148860,from,0,0
148861,omega-3,0,0
148862,fish,0,0
148863,oil,0,0
148864,.,0,0
148865,Our,0,0
148866,purpose,0,0
148867,was,0,0
148868,to,0,0
148869,evaluate,0,0
148870,the,0,0
148871,safety,1,1
148872,of,0,0
148873,marine,0,0
148874,lipid,0,1
148875,suppositories,0,0
148876,and,0,1
148877,ointment,0,0
148878,in,0,0
148879,healthy,0,0
148880,volunteers,0,0
148881,and,0,0
148882,to,0,0
148883,explore,0,0
148884,the,0,0
148885,laxative,1,0
148886,effect,1,0
148887,of,0,0
148888,the,0,0
148889,suppositories,0,0
148890,.,0,0
148891,Thirty,0,0
148892,healthy,0,0
148893,volunteers,0,0
148894,were,0,0
148895,randomized,0,0
148896,either,0,0
148897,to,0,0
148898,a,0,0
148899,study,0,0
148900,group,0,0
148901,administrating,0,0
148902,30,0,0
148903,%,0,0
148904,FFA,0,0
148905,suppositories,0,0
148906,and,0,0
148907,applying,0,0
148908,30,0,0
148909,%,0,0
148910,FFA,0,0
148911,ointment,0,0
148912,to,0,0
148913,the,0,0
148914,perianal,0,1
148915,region,0,0
148916,twice,0,0
148917,per,0,0
148918,day,0,0
148919,for,0,0
148920,two,0,0
148921,weeks,0,0
148922,",",0,0
148923,or,0,0
148924,to,0,0
148925,a,0,0
148926,control,0,0
148927,group,0,0
148928,using,0,0
148929,placebo,0,0
148930,suppositories,0,0
148931,and,0,1
148932,ointment,0,0
148933,in,0,0
148934,a,0,0
148935,double,0,0
148936,blinded,0,0
148937,manner,0,0
148938,.,0,0
148939,RESULTS,0,0
148940,No,0,1
148941,serious,1,1
148942,toxic,1,1
148943,effects,1,1
148944,or,1,1
148945,irritation,1,1
148946,were,0,0
148947,observed,0,0
148948,.,0,0
148949,In,0,0
148950,the,0,0
148951,study,0,0
148952,group,0,0
148953,93,0,0
148954,%,0,0
148955,felt,0,0
148956,the,0,0
148957,urge,1,1
148958,to,1,0
148959,defecate,1,1
148960,after,0,0
148961,administration,0,0
148962,of,0,0
148963,the,0,0
148964,suppositories,0,0
148965,as,0,0
148966,compared,0,0
148967,to,0,0
148968,37,0,0
148969,%,0,0
148970,in,0,0
148971,the,0,0
148972,control,0,0
148973,group,0,0
148974,(,0,1
148975,P,0,0
148976,=,0,0
148977,0.001,0,0
148978,),0,0
148979,.,0,0
148980,Subsequently,0,0
148981,90,0,0
148982,%,0,0
148983,in,0,0
148984,the,0,0
148985,study,0,0
148986,group,0,0
148987,defecated,1,1
148988,",",0,0
148989,compared,0,0
148990,to,0,0
148991,33,0,0
148992,%,0,0
148993,in,0,0
148994,the,0,0
148995,control,0,0
148996,group,0,0
148997,(,0,1
148998,P,0,0
148999,=,0,0
149000,0.001,0,0
149001,),0,0
149002,.,0,0
149003,CONCLUSION,0,0
149004,The,0,0
149005,marine,0,0
149006,lipid,0,1
149007,suppositories,0,0
149008,and,0,1
149009,ointment,0,0
149010,were,0,0
149011,well,0,0
149012,tolerated,0,1
149013,with,0,0
149014,no,0,0
149015,significant,0,0
149016,toxic,1,1
149017,side,1,1
149018,effects,1,1
149019,observed,0,0
149020,during,0,0
149021,the,0,0
149022,study,0,0
149023,period,0,0
149024,.,0,0
149025,The,0,0
149026,suppositories,0,0
149027,have,0,0
149028,a,0,0
149029,distinct,0,0
149030,laxative,1,1
149031,effect,1,0
149032,and,0,0
149033,we,0,0
149034,aim,0,0
149035,to,0,0
149036,explore,0,0
149037,this,0,0
149038,effect,0,0
149039,in,0,0
149040,further,0,0
149041,clinical,0,0
149042,trials,0,0
149043,.,0,0
149044,B-type,0,1
149045,natriuretic,0,1
149046,peptide,0,1
149047,and,0,1
149048,risk,0,1
149049,of,0,1
149050,contrast-induced,0,1
149051,acute,0,0
149052,kidney,0,0
149053,injury,0,1
149054,in,0,0
149055,acute,0,0
149056,ST-segment-elevation,0,0
149057,myocardial,0,1
149058,infarction,0,0
149059,:,0,0
149060,a,0,0
149061,substudy,0,0
149062,from,0,0
149063,the,0,0
149064,HORIZONS-AMI,0,0
149065,trial,0,0
149066,.,0,1
149067,BACKGROUND,0,0
149068,Contrast-induced,0,1
149069,acute,0,1
149070,kidney,0,1
149071,injury,0,1
149072,(,0,1
149073,CI-AKI,0,1
149074,),0,0
149075,after,0,0
149076,percutaneous,0,0
149077,coronary,0,0
149078,intervention,0,0
149079,is,0,0
149080,associated,0,0
149081,with,0,0
149082,adverse,0,1
149083,short-,0,1
149084,and,0,1
149085,long-term,0,1
149086,outcomes,0,1
149087,.,0,0
149088,However,0,0
149089,",",0,0
149090,identification,0,1
149091,of,0,1
149092,patients,0,0
149093,at,0,0
149094,risk,0,1
149095,for,0,0
149096,CI-AKI,0,0
149097,is,0,0
149098,challenging,0,0
149099,.,0,0
149100,Using,0,0
149101,a,0,0
149102,large,0,0
149103,contemporary,0,0
149104,randomized,0,0
149105,trial,0,0
149106,database,0,0
149107,of,0,1
149108,patients,0,0
149109,with,0,0
149110,ST-segment-elevation,0,0
149111,myocardial,0,1
149112,infarction,0,1
149113,",",0,0
149114,we,0,0
149115,therefore,0,0
149116,sought,0,0
149117,to,0,0
149118,examine,0,0
149119,whether,0,0
149120,admission,0,1
149121,B-type,0,1
149122,natriuretic,0,1
149123,peptide,0,1
149124,(,0,1
149125,BNP,0,1
149126,),0,0
149127,levels,0,1
149128,predict,0,0
149129,the,0,0
149130,development,1,0
149131,of,0,0
149132,CI-AKI,0,0
149133,.,0,0
149134,METHODS,0,0
149135,AND,0,0
149136,RESULTS,0,0
149137,A,0,0
149138,total,0,1
149139,of,0,0
149140,979,0,0
149141,ST-segment-elevation,0,0
149142,myocardial,0,1
149143,infarction,0,1
149144,patients,0,0
149145,enrolled,0,0
149146,in,0,0
149147,the,0,0
149148,Harmonizing,0,0
149149,Outcomes,0,1
149150,with,0,0
149151,Revascularization,0,1
149152,and,0,1
149153,Stents,0,1
149154,in,0,0
149155,Acute,0,1
149156,Myocardial,0,1
149157,Infarction,0,1
149158,(,0,1
149159,HORIZONS-AMI,0,1
149160,),0,1
149161,trial,0,0
149162,had,0,0
149163,BNP,1,1
149164,levels,1,1
149165,measured,0,0
149166,in,0,0
149167,the,0,0
149168,emergency,0,1
149169,room,0,0
149170,prior,0,0
149171,to,0,0
149172,primary,0,0
149173,percutaneous,0,0
149174,coronary,0,1
149175,intervention,0,0
149176,as,0,0
149177,part,0,0
149178,of,0,0
149179,the,0,0
149180,study,0,0
149181,protocol,0,0
149182,.,0,1
149183,CI-AKI,1,0
149184,was,0,0
149185,defined,0,0
149186,as,0,0
149187,a,0,0
149188,relative,0,1
149189,increase,0,0
149190,in,0,0
149191,serum,0,1
149192,creatinine,0,1
149193,of,0,1
149194,?25,0,1
149195,%,0,0
149196,",",0,0
149197,or,0,0
149198,an,0,0
149199,absolute,0,1
149200,increase,0,0
149201,of,0,1
149202,?0.5,0,0
149203,mg/dL,0,0
149204,",",0,0
149205,occurring,0,0
149206,within,0,0
149207,48,0,0
149208,hours,0,0
149209,after,0,0
149210,contrast,0,0
149211,administration,1,0
149212,.,1,1
149213,Logistic,1,0
149214,regression,1,1
149215,analysis,1,0
149216,was,1,0
149217,used,0,0
149218,to,0,0
149219,estimate,0,0
149220,the,0,0
149221,association,0,0
149222,of,0,0
149223,admission,0,1
149224,BNP,0,1
149225,with,0,0
149226,development,0,1
149227,of,0,0
149228,CI-AKI,1,0
149229,.,1,1
149230,CI-AKI,1,0
149231,occurred,1,0
149232,in,0,0
149233,131,0,0
149234,patients,0,0
149235,(,0,0
149236,13.3,0,0
149237,%,0,0
149238,),0,0
149239,.,0,0
149240,Baseline,0,0
149241,BNP,0,1
149242,was,0,0
149243,a,0,0
149244,significant,0,0
149245,univariable,0,0
149246,correlate,1,0
149247,of,1,1
149248,CI-AKI,1,1
149249,(,1,0
149250,odds,1,0
149251,ratio,0,1
149252,1.31,0,0
149253,",",0,0
149254,95,0,0
149255,%,0,0
149256,confidence,0,0
149257,interval,0,0
149258,",",0,0
149259,1.14-1.51,0,0
149260,;,0,1
149261,P=0.0001,0,0
149262,),0,0
149263,.,0,0
149264,After,0,0
149265,multivariable,0,0
149266,adjustment,0,0
149267,for,0,0
149268,clinical,0,1
149269,",",0,1
149270,laboratory,0,1
149271,",",0,1
149272,and,0,1
149273,angiographic,0,1
149274,variables,1,1
149275,",",1,1
149276,BNP,1,1
149277,remained,0,0
149278,a,0,0
149279,significant,0,0
149280,independent,0,0
149281,predictor,0,0
149282,of,0,1
149283,CI-AKI,0,0
149284,(,0,0
149285,1.29,0,0
149286,[,0,0
149287,1.10,0,0
149288,",",0,0
149289,1.51,0,0
149290,],0,0
149291,;,0,0
149292,P,0,0
149293,<,0,0
149294,0.001,0,0
149295,),0,0
149296,.,0,0
149297,Significant,0,1
149298,net,0,1
149299,reclassification,0,1
149300,improvement,0,1
149301,was,0,0
149302,achieved,0,1
149303,by,0,0
149304,addition,0,0
149305,of,0,0
149306,BNP,0,1
149307,to,0,0
149308,the,0,0
149309,current,1,0
149310,clinical,1,0
149311,risk,1,1
149312,prediction,1,1
149313,model,1,0
149314,(,1,1
149315,net,1,1
149316,reclassification,0,1
149317,improvement=0.177,0,1
149318,;,0,0
149319,P,0,0
149320,<,0,0
149321,0.001,0,0
149322,),0,0
149323,and,0,0
149324,to,0,0
149325,the,0,0
149326,Mehran,1,0
149327,Risk,1,1
149328,Score,1,1
149329,(,1,0
149330,net,1,1
149331,reclassification,0,1
149332,improvement=0.100,0,0
149333,;,0,1
149334,P=0.015,0,0
149335,),0,0
149336,.,0,0
149337,CONCLUSIONS,0,0
149338,Measurement,1,1
149339,of,1,1
149340,serum,1,1
149341,BNP,1,1
149342,at,0,0
149343,hospital,0,0
149344,admission,0,0
149345,may,0,0
149346,help,0,0
149347,identify,0,0
149348,patients,0,0
149349,who,0,0
149350,are,0,0
149351,at,0,0
149352,risk,0,1
149353,for,0,0
149354,developing,0,0
149355,CI-AKI,0,0
149356,after,0,0
149357,primary,0,0
149358,percutaneous,0,0
149359,coronary,0,1
149360,intervention,0,0
149361,in,0,0
149362,ST-segment-elevation,0,0
149363,myocardial,0,1
149364,infarction,0,1
149365,.,0,0
149366,CLINICAL,0,0
149367,TRIAL,0,0
149368,REGISTRATION,0,0
149369,URL,0,0
149370,:,0,0
149371,http,0,0
149372,:,0,0
149373,//www.clinicaltrials.gov,0,0
149374,.,0,1
149375,Unique,0,1
149376,identifier,0,0
149377,:,0,0
149378,NCT00433966,0,0
149379,.,0,0
149380,A,0,0
149381,randomised,0,0
149382,controlled,0,0
149383,trial,0,0
149384,of,0,1
149385,bumetanide,0,0
149386,in,0,0
149387,the,0,0
149388,treatment,0,0
149389,of,0,0
149390,autism,0,0
149391,in,0,0
149392,children,0,0
149393,.,0,0
149394,Gamma,0,0
149395,aminobutyric,0,1
149396,acid,0,1
149397,(,0,1
149398,GABA,0,1
149399,),0,1
149400,-mediated,0,1
149401,synapses,0,0
149402,and,0,0
149403,the,0,0
149404,oscillations,0,0
149405,they,0,0
149406,orchestrate,0,0
149407,are,0,0
149408,altered,0,0
149409,in,0,0
149410,autism,0,0
149411,.,0,0
149412,GABA-acting,0,1
149413,benzodiazepines,0,0
149414,exert,0,0
149415,in,0,0
149416,some,0,0
149417,patients,0,0
149418,with,0,0
149419,autism,0,0
149420,paradoxical,0,1
149421,effects,1,1
149422,",",0,0
149423,raising,0,0
149424,the,0,0
149425,possibility,0,0
149426,that,0,0
149427,like,0,0
149428,in,0,0
149429,epilepsies,0,1
149430,",",0,0
149431,GABA,0,1
149432,excites,0,0
149433,neurons,0,1
149434,because,0,0
149435,of,0,0
149436,elevated,0,1
149437,intracellular,0,1
149438,concentrations,0,1
149439,of,0,0
149440,chloride,0,0
149441,.,0,0
149442,Following,0,0
149443,a,0,0
149444,successful,0,0
149445,pilot,0,0
149446,study,0,0
149447,",",0,0
149448,(,0,0
149449,1,0,0
149450,),0,0
149451,we,0,0
149452,have,0,0
149453,now,0,0
149454,performed,0,0
149455,a,0,0
149456,double-blind,0,0
149457,clinical,0,0
149458,trial,0,0
149459,using,0,0
149460,the,0,0
149461,diuretic,0,0
149462,",",0,0
149463,chloride-importer,0,1
149464,antagonist,0,0
149465,bumetanide,0,0
149466,that,0,0
149467,reduces,0,0
149468,intracellular,0,1
149469,chloride,0,0
149470,reinforcing,0,1
149471,GABAergic,0,0
149472,inhibition,0,1
149473,.,0,1
149474,Sixty,0,0
149475,children,0,0
149476,with,0,0
149477,autism,0,0
149478,or,0,0
149479,Asperger,0,1
149480,syndrome,0,0
149481,(,0,0
149482,3-11,0,0
149483,years,0,0
149484,old,0,0
149485,),0,0
149486,received,0,0
149487,for,0,0
149488,3,0,0
149489,months,0,0
149490,placebo,0,0
149491,or,0,1
149492,bumetanide,0,0
149493,(,0,0
149494,1,0,0
149495,mg,0,0
149496,daily,0,0
149497,),0,0
149498,",",0,0
149499,followed,0,0
149500,by,0,0
149501,1-month,0,0
149502,wash,0,0
149503,out,0,0
149504,.,0,0
149505,Determination,0,0
149506,of,0,0
149507,the,0,0
149508,severity,0,1
149509,of,0,1
149510,autism,0,0
149511,was,0,0
149512,made,0,0
149513,with,0,0
149514,video,0,0
149515,films,0,0
149516,at,0,0
149517,day,0,0
149518,0,0,0
149519,(,0,0
149520,D0,0,0
149521,),0,1
149522,and,0,1
149523,D90,0,0
149524,by,0,0
149525,blind,0,0
149526,",",0,0
149527,independent,0,0
149528,evaluators,0,0
149529,.,0,1
149530,Bumetanide,0,0
149531,reduced,0,0
149532,significantly,0,0
149533,the,0,0
149534,Childhood,1,0
149535,Autism,1,1
149536,Rating,1,1
149537,Scale,1,1
149538,(,1,1
149539,CARS,1,1
149540,),1,1
149541,(,0,0
149542,D90-D0,0,0
149543,;,0,1
149544,P,0,0
149545,<,0,0
149546,0.004,0,0
149547,treated,0,0
149548,vs,0,0
149549,placebo,0,0
149550,),0,1
149551,",",0,0
149552,Clinical,1,1
149553,Global,1,1
149554,Impressions,1,1
149555,(,0,0
149556,P,0,0
149557,<,0,0
149558,0.017,0,0
149559,treated,0,0
149560,vs,0,0
149561,placebo,0,0
149562,),0,1
149563,and,0,1
149564,Autism,1,1
149565,Diagnostic,1,1
149566,Observation,1,0
149567,Schedule,1,1
149568,values,1,1
149569,when,0,0
149570,the,0,0
149571,most,0,0
149572,severe,0,1
149573,cases,0,0
149574,(,0,0
149575,CARS,0,0
149576,values,0,1
149577,above,0,0
149578,the,0,0
149579,mean,0,1
149580,?,0,0
149581,s.d,0,0
149582,.,0,0
149583,;,0,0
149584,n=9,0,0
149585,),0,1
149586,were,0,0
149587,removed,0,0
149588,(,0,0
149589,Wilcoxon,0,0
149590,test,0,1
149591,:,0,0
149592,P-value=0.031,0,0
149593,;,0,0
149594,Student,0,1
149595,'s,0,0
149596,t-test,0,0
149597,:,0,0
149598,P-value=0.017,0,0
149599,),0,0
149600,.,0,0
149601,Side,1,0
149602,effects,1,1
149603,were,0,0
149604,restricted,0,0
149605,to,0,0
149606,an,0,0
149607,occasional,1,1
149608,mild,1,0
149609,hypokalaemia,1,1
149610,(,0,1
149611,3.0-3.5,0,0
149612,mM,0,1
149613,l,0,1
149614,(,0,1
149615,-1,0,0
149616,),0,1
149617,K,0,1
149618,(,0,0
149619,+,0,0
149620,),0,0
149621,),0,0
149622,that,0,0
149623,was,0,0
149624,treated,0,0
149625,with,0,0
149626,supplemental,0,0
149627,potassium,0,1
149628,.,0,0
149629,In,0,0
149630,a,0,0
149631,companion,0,0
149632,study,0,0
149633,",",0,1
149634,chronic,0,0
149635,bumetanide,0,0
149636,treatment,0,0
149637,significantly,0,0
149638,improved,1,0
149639,accuracy,1,1
149640,in,1,0
149641,facial,1,1
149642,emotional,1,1
149643,labelling,1,0
149644,",",1,1
149645,and,1,1
149646,increased,1,1
149647,brain,1,1
149648,activation,1,1
149649,in,1,0
149650,areas,1,1
149651,involved,1,0
149652,in,1,0
149653,social,1,1
149654,and,1,1
149655,emotional,1,1
149656,perception,1,1
149657,(,1,0
149658,Hadjikhani,1,0
149659,et,0,0
149660,al.,0,0
149661,",",0,0
149662,submitted,0,0
149663,),0,0
149664,.,0,0
149665,Therefore,0,0
149666,",",0,0
149667,bumetanide,0,0
149668,is,0,0
149669,a,0,0
149670,promising,0,0
149671,novel,0,0
149672,therapeutic,0,0
149673,agent,0,0
149674,to,0,0
149675,treat,0,0
149676,autism,0,0
149677,.,0,0
149678,Larger,0,0
149679,trials,0,0
149680,are,0,0
149681,warranted,0,0
149682,to,0,0
149683,better,0,0
149684,determine,0,0
149685,the,0,0
149686,population,0,0
149687,best,0,0
149688,suited,0,0
149689,for,0,0
149690,this,0,0
149691,treatment,0,0
149692,.,0,0
149693,A,0,0
149694,trial,0,0
149695,with,0,0
149696,"3'-azido-2',3'-dideoxythymidine",0,1
149697,and,0,1
149698,human,0,0
149699,interferon-?,0,0
149700,in,0,0
149701,cats,0,0
149702,naturally,0,0
149703,infected,0,0
149704,with,0,0
149705,feline,0,0
149706,leukaemia,0,0
149707,virus,0,1
149708,.,0,1
149709,Feline,0,0
149710,leukaemia,0,1
149711,virus,0,1
149712,(,0,1
149713,FeLV,0,1
149714,),0,0
149715,infection,0,1
149716,is,0,0
149717,still,0,0
149718,one,0,0
149719,of,0,0
149720,the,0,0
149721,leading,0,0
149722,causes,0,0
149723,of,0,0
149724,infection-related,0,1
149725,deaths,0,1
149726,in,0,0
149727,domestic,0,0
149728,cats,0,0
149729,.,0,0
149730,Treatment,0,0
149731,with,0,0
149732,various,0,0
149733,drugs,0,0
149734,has,0,0
149735,been,0,0
149736,attempted,0,0
149737,",",0,0
149738,but,0,0
149739,none,0,0
149740,has,0,0
149741,resulted,0,0
149742,in,0,0
149743,cure,0,1
149744,or,0,1
149745,complete,0,1
149746,virus,0,1
149747,elimination,0,1
149748,.,0,1
149749,Human,0,0
149750,interferon-?2a,0,1
149751,(,0,0
149752,huIFN-?2a,0,0
149753,),0,1
149754,and,0,1
149755,"3'-azido-2',3'-dideoxythymidine",0,1
149756,(,0,1
149757,AZT,0,1
149758,),0,0
149759,have,0,0
149760,been,0,0
149761,proven,0,0
149762,to,0,0
149763,decrease,0,0
149764,antigenaemia,0,1
149765,in,0,0
149766,cats,0,0
149767,infected,0,0
149768,experimentally,0,0
149769,with,0,0
149770,FeLV,0,0
149771,.,0,0
149772,The,0,0
149773,purpose,0,0
149774,of,0,0
149775,this,0,0
149776,study,0,0
149777,was,0,0
149778,to,0,0
149779,assess,0,0
149780,the,0,0
149781,efficacy,1,1
149782,of,1,1
149783,huIFN-?2a,0,0
149784,",",0,1
149785,AZT,0,1
149786,and,0,1
149787,a,0,0
149788,combination,0,0
149789,of,0,0
149790,both,0,0
149791,drugs,0,0
149792,in,0,0
149793,cats,0,0
149794,infected,0,0
149795,naturally,0,0
149796,with,0,0
149797,FeLV,0,0
149798,in,0,0
149799,a,0,0
149800,placebo-controlled,0,0
149801,double-blinded,0,0
149802,trial,0,0
149803,.,0,0
149804,Fourty-four,0,0
149805,FeLV-infected,0,0
149806,cats,0,0
149807,in,0,0
149808,which,0,0
149809,free,0,1
149810,FeLV,0,1
149811,p27,0,1
149812,antigen,0,1
149813,was,0,0
149814,detected,0,0
149815,in,0,0
149816,serum,0,1
149817,by,0,0
149818,enzyme-linked,0,1
149819,immunosorbent,0,0
149820,assay,0,1
149821,were,0,0
149822,included,0,0
149823,in,0,0
149824,the,0,0
149825,study,0,0
149826,.,0,0
149827,Cats,0,1
149828,were,0,0
149829,assigned,0,0
149830,to,0,0
149831,one,0,0
149832,of,0,0
149833,four,0,0
149834,treatment,0,0
149835,groups,0,0
149836,that,0,0
149837,received,0,0
149838,either,0,0
149839,high,0,0
149840,dose,0,0
149841,huIFN-?2a,0,0
149842,(,0,0
149843,10,0,0
149844,(,0,0
149845,5,0,0
149846,),0,0
149847,IU/kg,0,0
149848,q24h,0,0
149849,;,0,0
149850,12,0,0
149851,cats,0,0
149852,),0,0
149853,",",0,0
149854,AZT,0,1
149855,(,0,0
149856,5,0,0
149857,mg/kg,0,0
149858,q12h,0,0
149859,;,0,0
149860,10,0,0
149861,cats,0,0
149862,",",0,0
149863,both,0,0
149864,of,0,0
149865,these,0,0
149866,treatments,0,0
149867,(,0,0
149868,12,0,0
149869,cats,0,0
149870,),0,0
149871,or,0,1
149872,placebo,0,0
149873,(,0,0
149874,10,0,0
149875,cats,0,0
149876,),0,0
149877,.,0,0
149878,All,0,0
149879,cats,0,0
149880,were,0,0
149881,treated,0,0
149882,for,0,0
149883,6,0,0
149884,weeks,0,0
149885,.,0,0
149886,Clinical,0,1
149887,variables,0,1
149888,",",0,0
149889,including,1,0
149890,stomatitis,1,1
149891,",",1,1
149892,and,1,1
149893,laboratory,1,1
149894,parameters,1,1
149895,",",1,0
149896,such,1,0
149897,as,1,0
149898,CD4,1,1
149899,(,1,0
149900,+,1,0
149901,),1,1
149902,and,1,1
149903,CD8,1,0
149904,(,1,1
149905,+,1,0
149906,),1,1
149907,counts,1,1
149908,and,1,1
149909,serum,1,1
149910,FeLV,1,0
149911,p,1,0
149912,27,1,0
149913,antigen,1,0
149914,concentration,1,1
149915,",",1,1
149916,were,1,0
149917,recorded,0,0
149918,throughout,0,0
149919,the,0,0
149920,treatment,0,0
149921,period,1,0
149922,.,1,0
149923,No,1,0
149924,significant,1,0
149925,difference,1,0
149926,among,1,0
149927,the,0,0
149928,groups,0,0
149929,was,0,0
149930,observed,0,0
149931,during,0,0
149932,the,0,0
149933,treatment,0,0
149934,period,0,0
149935,for,0,0
149936,any,0,0
149937,of,0,0
149938,the,0,0
149939,parameters,0,0
149940,.,0,0
149941,Aside,0,1
149942,from,0,0
149943,anaemia,1,0
149944,in,1,0
149945,one,1,0
149946,cat,0,0
149947,treated,0,0
149948,with,0,0
149949,AZT,0,0
149950,",",0,0
149951,no,1,0
149952,adverse,1,1
149953,effects,1,1
149954,were,1,0
149955,observed,0,0
149956,.,0,0
149957,It,0,0
149958,was,0,0
149959,not,0,0
149960,possible,0,0
149961,to,0,0
149962,demonstrate,1,0
149963,efficacy,1,1
149964,of,1,1
149965,huIFN-?2a,1,0
149966,or,0,1
149967,AZT,0,1
149968,alone,0,0
149969,or,0,0
149970,together,0,0
149971,in,0,0
149972,cats,0,0
149973,infected,0,0
149974,naturally,0,0
149975,with,0,0
149976,FeLV,0,0
149977,when,0,0
149978,given,0,0
149979,according,0,0
149980,to,0,0
149981,this,0,0
149982,regimen,0,0
149983,for,0,0
149984,6,0,0
149985,weeks,0,0
149986,;,0,0
149987,however,1,0
149988,",",1,0
149989,no,1,0
149990,notable,1,1
149991,side,1,1
149992,effects,1,1
149993,were,1,0
149994,detected,0,0
149995,.,0,0
149996,Influence,0,1
149997,of,0,1
149998,lime,0,0
149999,juice,0,0
150000,on,0,0
150001,the,0,0
150002,severity,0,1
150003,of,0,1
150004,sickle,0,0
150005,cell,0,1
150006,anemia,0,1
150007,.,0,1
150008,BACKGROUND,0,0
150009,AND,0,0
150010,OBJECTIVES,0,0
150011,The,0,0
150012,pain,0,1
150013,in,0,0
150014,sickle,0,0
150015,cell,0,1
150016,anemia,0,1
150017,(,0,1
150018,SCA,0,1
150019,),0,0
150020,is,0,0
150021,often,0,0
150022,triggered,0,0
150023,by,0,0
150024,dehydration,0,1
150025,",",0,1
150026,acidosis,0,1
150027,",",0,1
150028,and,0,1
150029,fever,0,1
150030,that,0,0
150031,are,0,0
150032,usually,0,0
150033,due,0,0
150034,to,0,0
150035,malaria,0,0
150036,.,0,0
150037,Intake,0,1
150038,of,0,0
150039,lime,0,0
150040,juice,0,0
150041,was,0,0
150042,recently,0,0
150043,demonstrated,0,0
150044,to,0,0
150045,facilitate,0,0
150046,clearance,0,1
150047,of,0,0
150048,the,0,0
150049,malaria,0,0
150050,parasite,0,1
150051,.,0,0
150052,It,0,0
150053,was,0,0
150054,therefore,0,0
150055,sought,0,0
150056,to,0,0
150057,determine,0,0
150058,whether,0,0
150059,regular,0,0
150060,intake,0,1
150061,of,0,1
150062,lime,0,0
150063,juice,0,0
150064,will,0,0
150065,ameliorate,0,0
150066,crisis,0,1
150067,",",0,0
150068,especially,0,0
150069,recurrent,1,1
150070,bone,1,1
150071,pain,1,1
150072,.,1,1
150073,DESIGN,0,0
150074,In,0,0
150075,this,0,0
150076,preliminary,0,0
150077,",",0,0
150078,open-labeled,0,0
150079,",",0,1
150080,randomized,0,0
150081,study,0,0
150082,",",0,0
150083,the,0,0
150084,effects,0,1
150085,of,0,0
150086,lime,0,0
150087,juice,0,0
150088,on,0,0
150089,the,0,0
150090,clinical,0,0
150091,and,0,0
150092,some,0,0
150093,laboratory,0,1
150094,characteristics,0,0
150095,of,0,0
150096,children,0,0
150097,with,0,0
150098,SCA,0,1
150099,were,0,0
150100,tested,0,0
150101,.,0,0
150102,RESULTS,0,0
150103,Among,0,0
150104,the,0,0
150105,113,0,0
150106,children,0,0
150107,with,0,0
150108,SCA,0,1
150109,studied,0,0
150110,in,0,0
150111,two,0,0
150112,hospitals,0,0
150113,",",0,0
150114,the,0,0
150115,58,0,0
150116,receiving,0,0
150117,lime,0,0
150118,treatment,0,0
150119,had,0,0
150120,lower,0,0
150121,rates,0,1
150122,of,0,1
150123,significant,1,0
150124,painful,1,1
150125,episodes,1,1
150126,than,0,0
150127,the,0,0
150128,55,0,0
150129,without,0,0
150130,lime,0,0
150131,(,0,0
150132,37,0,0
150133,versus,0,0
150134,83,0,0
150135,crises,0,1
150136,in,0,0
150137,6,0,0
150138,months,0,0
150139,",",0,0
150140,and,0,0
150141,0.64?0.11,0,0
150142,versus,0,0
150143,1.51?0.34,0,0
150144,average,0,0
150145,rates,0,1
150146,per,0,1
150147,child,0,1
150148,",",0,0
150149,p,0,0
150150,<,0,0
150151,0.001,0,0
150152,),0,0
150153,.,0,0
150154,Also,0,0
150155,",",0,0
150156,fewer,0,1
150157,subjects,0,0
150158,than,0,0
150159,the,0,0
150160,controls,0,0
150161,had,0,0
150162,significant,1,0
150163,painful,1,1
150164,episodes,1,1
150165,(,1,0
150166,50.0,0,0
150167,%,0,0
150168,versus,0,0
150169,92.7,1,0
150170,%,1,0
150171,),1,0
150172,;,1,0
150173,febrile,1,1
150174,illness,1,1
150175,(,1,0
150176,46.6,0,0
150177,%,0,0
150178,versus,0,0
150179,87.3,0,0
150180,%,0,0
150181,),0,0
150182,and,1,1
150183,admission,1,1
150184,rate,1,1
150185,(,1,0
150186,3.4,0,0
150187,%,0,0
150188,versus,0,0
150189,34.5,0,0
150190,%,0,0
150191,),0,0
150192,(,0,0
150193,p,0,0
150194,<,0,0
150195,0.001,0,0
150196,),0,0
150197,.,0,0
150198,The,1,0
150199,mean,1,1
150200,hematocrit,1,1
150201,of,1,0
150202,the,0,0
150203,subjects,0,0
150204,(,0,0
150205,26.23?2.03,0,0
150206,%,0,0
150207,),0,0
150208,at,0,0
150209,the,0,0
150210,end,0,0
150211,of,0,0
150212,the,0,0
150213,study,0,0
150214,was,0,0
150215,also,0,0
150216,higher,0,0
150217,",",0,1
150218,p,0,0
150219,<,0,0
150220,0.001,0,0
150221,.,0,0
150222,However,1,0
150223,",",1,0
150224,transfusion,1,1
150225,rate,1,1
150226,",",1,1
150227,presence,1,0
150228,of,1,1
150229,hepatomegaly,1,1
150230,",",1,1
150231,splenomegaly,1,1
150232,",",1,1
150233,and,1,1
150234,jaundice,1,1
150235,was,1,0
150236,similar,0,0
150237,.,0,0
150238,Treatment,0,0
150239,with,0,0
150240,lime,0,0
150241,did,0,0
150242,not,0,0
150243,cause,0,0
150244,any,0,0
150245,significant,1,0
150246,side-effect,1,0
150247,.,1,0
150248,CONCLUSIONS,1,0
150249,Regular,0,0
150250,intake,0,1
150251,of,0,1
150252,lime,0,0
150253,juice,0,0
150254,may,0,0
150255,be,0,0
150256,of,0,0
150257,great,0,0
150258,therapeutic,0,1
150259,and,0,1
150260,nutritional,0,1
150261,relevance,0,1
150262,in,0,0
150263,children,0,0
150264,with,0,0
150265,SCA,0,1
150266,.,0,0
150267,The,0,0
150268,effect,0,0
150269,of,0,0
150270,cognitive-behavioral,0,0
150271,therapy,0,0
150272,versus,0,0
150273,treatment,0,0
150274,as,0,0
150275,usual,0,0
150276,for,0,0
150277,anxiety,1,1
150278,in,0,0
150279,children,0,0
150280,with,0,0
150281,autism,0,0
150282,spectrum,0,0
150283,disorders,0,0
150284,:,0,0
150285,a,0,0
150286,randomized,0,0
150287,",",0,0
150288,controlled,0,0
150289,trial,0,0
150290,.,0,0
150291,OBJECTIVE,0,0
150292,To,0,0
150293,examine,0,0
150294,the,0,0
150295,efficacy,1,1
150296,of,0,0
150297,a,0,0
150298,modular,0,0
150299,cognitive-behavioral,0,0
150300,therapy,0,0
150301,(,0,1
150302,CBT,0,0
150303,),0,0
150304,protocol,0,0
150305,relative,0,1
150306,to,0,0
150307,treatment,0,0
150308,as,0,0
150309,usual,0,0
150310,(,0,0
150311,TAU,0,1
150312,),0,0
150313,among,0,0
150314,children,0,0
150315,with,0,0
150316,high-functioning,0,0
150317,autism,0,0
150318,spectrum,0,0
150319,disorders,0,1
150320,(,0,1
150321,ASD,0,0
150322,),0,1
150323,and,0,0
150324,clinically,0,1
150325,significant,0,0
150326,anxiety,0,1
150327,.,0,0
150328,METHOD,0,0
150329,A,0,0
150330,total,0,1
150331,of,0,0
150332,45,0,0
150333,children,0,0
150334,(,0,0
150335,7-11,0,0
150336,years,0,0
150337,of,0,0
150338,age,0,0
150339,),0,0
150340,with,0,0
150341,high-functioning,0,0
150342,ASD,0,0
150343,and,0,0
150344,clinically,1,1
150345,significant,1,0
150346,anxiety,1,1
150347,were,0,0
150348,randomized,0,0
150349,to,0,0
150350,receive,0,0
150351,16,0,0
150352,sessions,0,0
150353,of,0,0
150354,weekly,0,0
150355,CBT,0,0
150356,or,0,1
150357,TAU,0,1
150358,for,0,0
150359,an,0,0
150360,equivalent,0,0
150361,duration,0,1
150362,.,0,0
150363,After,0,0
150364,screening,0,0
150365,",",0,0
150366,assessments,0,0
150367,were,0,0
150368,conducted,0,0
150369,at,0,0
150370,baseline,0,0
150371,",",0,1
150372,post-treatment,0,1
150373,",",0,1
150374,and,0,1
150375,3-month,0,1
150376,follow-up,0,0
150377,.,0,1
150378,Raters,0,1
150379,were,0,0
150380,blind,0,0
150381,to,0,0
150382,treatment,0,0
150383,condition,0,0
150384,.,0,1
150385,RESULTS,0,0
150386,Youth,0,1
150387,receiving,0,0
150388,CBT,0,0
150389,showed,0,0
150390,substantial,0,0
150391,improvement,1,1
150392,relative,0,0
150393,to,0,0
150394,TAU,0,1
150395,on,0,0
150396,primary,1,0
150397,anxiety,1,1
150398,outcomes,1,1
150399,.,1,0
150400,Of,0,0
150401,24,0,0
150402,children,0,0
150403,randomized,0,0
150404,to,0,0
150405,the,0,0
150406,CBT,0,0
150407,arm,0,0
150408,",",0,0
150409,18,0,0
150410,(,0,0
150411,75,0,0
150412,%,0,0
150413,),0,0
150414,were,0,0
150415,treatment,0,0
150416,responders,0,1
150417,",",0,0
150418,versus,0,0
150419,only,0,0
150420,3,0,0
150421,of,0,0
150422,21,0,0
150423,children,0,0
150424,(,0,0
150425,14,0,0
150426,%,0,0
150427,),0,0
150428,in,0,0
150429,the,0,0
150430,TAU,0,1
150431,arm,0,0
150432,.,0,1
150433,Gains,0,1
150434,were,0,0
150435,generally,0,0
150436,maintained,0,0
150437,at,0,0
150438,3-month,0,0
150439,follow-up,0,0
150440,for,0,0
150441,CBT,0,0
150442,responders,0,0
150443,.,0,0
150444,CONCLUSIONS,0,0
150445,Relative,0,0
150446,to,0,0
150447,usual,0,0
150448,care,0,0
150449,",",0,1
150450,CBT,0,1
150451,adapted,0,0
150452,for,0,0
150453,anxious,0,1
150454,youth,0,0
150455,with,0,0
150456,high-functioning,0,0
150457,ASD,0,0
150458,demonstrates,0,0
150459,large,0,0
150460,effects,0,1
150461,in,0,0
150462,reducing,0,0
150463,anxiety,1,1
150464,symptoms,1,1
150465,.,1,0
150466,This,0,0
150467,study,0,0
150468,contributes,0,0
150469,to,0,0
150470,the,0,0
150471,growing,0,0
150472,literature,0,0
150473,supporting,0,0
150474,adapted,0,0
150475,CBT,0,0
150476,approaches,0,0
150477,for,0,0
150478,treating,0,0
150479,anxiety,0,1
150480,in,0,0
150481,youth,0,0
150482,with,0,0
150483,ASD,0,0
150484,.,0,0
150485,Temporal,0,1
150486,expectation,0,1
150487,in,0,0
150488,focal,0,1
150489,hand,0,1
150490,dystonia,0,0
150491,.,0,0
150492,Patients,0,0
150493,with,0,0
150494,writer,0,0
150495,'s,0,1
150496,cramp,0,1
150497,present,0,0
150498,sensory,0,1
150499,and,0,1
150500,representational,0,0
150501,abnormalities,0,0
150502,relevant,0,0
150503,to,0,0
150504,motor,0,1
150505,control,0,0
150506,",",0,0
150507,such,0,1
150508,as,0,0
150509,impairment,0,1
150510,in,0,0
150511,the,0,0
150512,temporal,0,1
150513,discrimination,0,1
150514,between,0,0
150515,tactile,0,1
150516,stimuli,0,1
150517,and,0,1
150518,in,0,0
150519,pure,0,0
150520,motor,0,1
150521,imagery,0,0
150522,tasks,0,1
150523,",",0,0
150524,like,0,0
150525,the,0,0
150526,mental,0,1
150527,rotation,0,1
150528,of,0,1
150529,corporeal,0,1
150530,and,0,1
150531,inanimate,0,1
150532,objects,0,1
150533,.,0,0
150534,However,0,0
150535,",",0,0
150536,only,0,0
150537,limited,0,0
150538,information,0,0
150539,is,0,0
150540,available,0,0
150541,on,0,0
150542,the,0,0
150543,ability,0,1
150544,of,0,0
150545,patients,0,0
150546,with,0,0
150547,dystonia,0,0
150548,to,0,0
150549,process,0,0
150550,the,0,0
150551,time-dependent,0,1
150552,features,0,0
150553,(,0,0
150554,e.g,0,0
150555,.,0,1
150556,speed,0,1
150557,),0,0
150558,of,0,0
150559,movement,0,1
150560,in,0,0
150561,real,0,1
150562,time,0,1
150563,.,0,0
150564,The,0,0
150565,processing,0,0
150566,of,0,0
150567,time-dependent,0,1
150568,features,0,0
150569,of,0,0
150570,movement,0,1
150571,has,0,0
150572,a,0,0
150573,crucial,0,0
150574,role,0,0
150575,in,0,0
150576,predicting,0,1
150577,whether,0,0
150578,the,0,0
150579,outcome,0,0
150580,of,0,0
150581,a,0,0
150582,complex,0,0
150583,motor,0,1
150584,sequence,0,1
150585,",",0,1
150586,such,0,1
150587,as,0,0
150588,handwriting,0,1
150589,or,0,0
150590,playing,0,0
150591,a,0,0
150592,musical,0,0
150593,passage,0,1
150594,",",0,0
150595,will,0,0
150596,be,0,0
150597,consistent,0,0
150598,with,0,0
150599,its,0,0
150600,ultimate,0,1
150601,goal,0,1
150602,",",0,1
150603,or,0,1
150604,results,0,0
150605,instead,0,0
150606,in,0,0
150607,an,0,0
150608,execution,0,1
150609,error,0,1
150610,.,0,0
150611,In,0,0
150612,this,0,0
150613,study,0,0
150614,",",0,0
150615,we,0,0
150616,sought,0,0
150617,to,0,0
150618,evaluate,0,0
150619,the,0,0
150620,implicit,0,0
150621,ability,0,1
150622,to,0,0
150623,perceive,0,0
150624,the,0,0
150625,temporal,0,1
150626,outcome,0,1
150627,of,0,1
150628,different,0,0
150629,movements,0,1
150630,in,0,0
150631,a,0,0
150632,group,0,0
150633,of,0,0
150634,patients,0,0
150635,with,0,0
150636,writer,0,0
150637,'s,0,0
150638,cramp,0,1
150639,.,0,0
150640,Fourteen,0,0
150641,patients,0,0
150642,affected,0,0
150643,by,0,0
150644,writer,0,0
150645,'s,0,1
150646,cramp,0,1
150647,in,0,0
150648,the,0,0
150649,right,0,1
150650,hand,0,1
150651,and,0,0
150652,17,0,0
150653,age-,0,0
150654,and,0,0
150655,gender-matched,0,0
150656,healthy,0,0
150657,subjects,0,0
150658,were,0,0
150659,recruited,0,0
150660,for,0,0
150661,the,0,0
150662,study,0,0
150663,.,0,0
150664,Subjects,0,0
150665,were,0,0
150666,asked,0,0
150667,to,0,0
150668,perform,0,0
150669,a,0,0
150670,temporal,0,1
150671,expectation,0,1
150672,task,0,1
150673,by,0,0
150674,predicting,0,1
150675,the,0,0
150676,end,0,0
150677,of,0,0
150678,visually,0,1
150679,perceived,0,1
150680,human,0,0
150681,body,0,1
150682,motion,0,1
150683,(,0,1
150684,handwriting,0,1
150685,",",0,0
150686,i.e,0,0
150687,.,0,0
150688,the,0,0
150689,action,0,1
150690,performed,0,0
150691,by,0,0
150692,the,0,0
150693,human,0,0
150694,body,0,1
150695,segment,0,1
150696,specifically,0,0
150697,affected,0,0
150698,by,0,0
150699,writer,0,0
150700,'s,0,1
150701,cramp,0,1
150702,),0,1
150703,or,0,0
150704,inanimate,0,1
150705,object,0,1
150706,motion,0,1
150707,(,0,0
150708,a,0,0
150709,moving,0,0
150710,circle,0,0
150711,reaching,0,1
150712,a,0,0
150713,spatial,0,1
150714,target,0,0
150715,),0,0
150716,.,0,0
150717,Videos,0,0
150718,representing,0,1
150719,movements,0,1
150720,were,0,0
150721,shown,0,0
150722,in,0,0
150723,full,0,0
150724,before,0,0
150725,experimental,0,0
150726,trials,0,0
150727,;,0,0
150728,the,0,0
150729,actual,0,1
150730,tasks,0,1
150731,consisted,0,0
150732,of,0,0
150733,watching,0,0
150734,the,0,0
150735,same,0,0
150736,videos,0,0
150737,",",0,1
150738,but,0,0
150739,interrupted,0,0
150740,after,0,0
150741,a,0,0
150742,variable,0,0
150743,interval,0,0
150744,(,0,0
150745,'pre-dark,0,1
150746,',0,1
150747,),0,0
150748,from,0,0
150749,its,0,0
150750,onset,0,1
150751,by,0,0
150752,a,0,0
150753,dark,0,0
150754,interval,0,0
150755,of,0,1
150756,variable,0,0
150757,duration,0,1
150758,.,0,0
150759,During,0,0
150760,the,0,0
150761,'dark,0,1
150762,',0,1
150763,interval,0,0
150764,",",0,1
150765,subjects,0,0
150766,were,0,0
150767,asked,0,0
150768,to,0,0
150769,indicate,0,0
150770,when,0,0
150771,the,0,0
150772,movement,0,1
150773,represented,0,0
150774,in,0,0
150775,the,0,0
150776,video,0,0
150777,reached,0,0
150778,its,0,0
150779,end,0,0
150780,by,0,0
150781,clicking,0,1
150782,on,0,0
150783,the,0,0
150784,space,0,1
150785,bar,0,0
150786,of,0,0
150787,the,0,0
150788,keyboard,0,0
150789,.,0,0
150790,We,0,0
150791,also,0,0
150792,included,0,0
150793,a,0,0
150794,visual,1,1
150795,working,1,1
150796,memory,1,1
150797,task,1,1
150798,.,1,1
150799,Performance,0,1
150800,on,0,0
150801,the,0,0
150802,timing,0,1
150803,task,0,1
150804,was,0,0
150805,analysed,0,0
150806,measuring,0,0
150807,the,0,0
150808,absolute,0,1
150809,value,0,1
150810,of,0,1
150811,timing,0,1
150812,error,0,1
150813,",",0,0
150814,the,0,0
150815,coefficient,0,1
150816,of,0,1
150817,variability,0,1
150818,and,0,0
150819,the,0,0
150820,percentage,0,1
150821,of,0,0
150822,anticipation,0,1
150823,responses,0,1
150824,.,0,0
150825,Patients,0,0
150826,with,0,0
150827,writer,0,0
150828,'s,0,1
150829,cramp,0,1
150830,exhibited,0,0
150831,greater,0,1
150832,absolute,0,1
150833,timing,0,1
150834,error,0,1
150835,compared,0,0
150836,with,0,0
150837,control,0,0
150838,subjects,0,0
150839,in,0,0
150840,the,0,0
150841,human,0,0
150842,body,0,1
150843,motion,0,1
150844,task,0,1
150845,(,0,0
150846,whereas,0,0
150847,no,0,0
150848,difference,0,0
150849,was,0,0
150850,observed,0,0
150851,in,0,0
150852,the,0,0
150853,inanimate,0,0
150854,object,0,1
150855,motion,0,1
150856,task,0,1
150857,),0,0
150858,.,0,0
150859,No,0,0
150860,effect,0,0
150861,of,0,1
150862,group,0,0
150863,was,0,0
150864,documented,0,0
150865,on,0,0
150866,the,0,0
150867,visual,0,1
150868,working,0,1
150869,memory,0,1
150870,tasks,0,1
150871,.,0,0
150872,Absolute,1,1
150873,timing,1,1
150874,error,1,0
150875,on,0,0
150876,the,0,0
150877,human,0,0
150878,body,0,1
150879,motion,0,1
150880,task,0,1
150881,did,0,0
150882,not,0,0
150883,significantly,0,0
150884,correlate,0,0
150885,with,0,0
150886,symptom,0,1
150887,severity,0,1
150888,",",0,1
150889,disease,0,1
150890,duration,0,1
150891,or,0,1
150892,writing,0,1
150893,speed,0,1
150894,.,0,0
150895,Our,0,0
150896,findings,0,0
150897,suggest,0,0
150898,an,0,0
150899,alteration,0,0
150900,of,0,0
150901,the,0,0
150902,writing,0,1
150903,movement,0,1
150904,representation,0,1
150905,at,0,0
150906,a,0,0
150907,central,0,1
150908,level,0,1
150909,and,0,0
150910,are,0,0
150911,consistent,0,0
150912,with,0,0
150913,the,0,0
150914,view,0,0
150915,that,0,0
150916,dystonia,0,0
150917,is,0,0
150918,not,0,0
150919,a,0,0
150920,purely,0,0
150921,motor,0,1
150922,disorder,0,0
150923,",",0,0
150924,but,0,0
150925,it,0,0
150926,also,0,0
150927,involves,0,0
150928,non-motor,0,1
150929,(,0,1
150930,sensory,0,1
150931,",",0,1
150932,cognitive,0,1
150933,),0,0
150934,aspects,0,1
150935,related,0,0
150936,to,0,0
150937,movement,0,1
150938,processing,0,1
150939,and,0,1
150940,planning,0,1
150941,.,0,0
150942,Contribution,0,1
150943,of,0,1
150944,endogenous,0,1
150945,bradykinin,0,0
150946,to,0,0
150947,fibrinolysis,1,1
150948,",",1,1
150949,inflammation,1,1
150950,",",1,1
150951,and,1,1
150952,blood,1,1
150953,product,1,1
150954,transfusion,1,1
150955,following,0,0
150956,cardiac,0,1
150957,surgery,0,0
150958,:,0,0
150959,a,0,0
150960,randomized,0,0
150961,clinical,0,0
150962,trial,0,0
150963,.,0,0
150964,Bradykinin,0,0
150965,increases,0,1
150966,during,0,0
150967,cardiopulmonary,0,1
150968,bypass,0,0
150969,(,0,1
150970,CPB,0,1
150971,),0,0
150972,and,0,0
150973,stimulates,0,0
150974,the,0,0
150975,release,1,1
150976,of,1,0
150977,nitric,1,1
150978,oxide,1,1
150979,",",1,1
150980,inflammatory,1,1
150981,cytokines,1,1
150982,",",1,1
150983,and,1,1
150984,tissue-type,1,1
150985,plasminogen,1,1
150986,activator,1,0
150987,(,1,1
150988,t-PA,1,1
150989,),1,1
150990,",",0,0
150991,acting,0,0
150992,through,0,0
150993,its,0,0
150994,B2,0,0
150995,receptor,0,0
150996,.,0,0
150997,This,0,0
150998,study,0,0
150999,tested,0,0
151000,the,0,0
151001,hypothesis,0,0
151002,that,0,0
151003,endogenous,0,1
151004,bradykinin,0,0
151005,contributes,0,0
151006,to,0,0
151007,the,0,0
151008,fibrinolytic,1,1
151009,and,1,1
151010,inflammatory,1,1
151011,response,1,1
151012,to,1,0
151013,CPB,1,1
151014,and,1,1
151015,that,1,0
151016,bradykinin,1,1
151017,B2,1,1
151018,receptor,1,0
151019,antagonism,1,1
151020,reduces,1,1
151021,fibrinolysis,1,1
151022,",",1,1
151023,inflammation,1,1
151024,",",1,1
151025,and,1,1
151026,subsequent,1,1
151027,transfusion,1,1
151028,requirements,1,1
151029,.,1,1
151030,Patients,0,0
151031,(,0,0
151032,N,0,0
151033,=,0,0
151034,115,0,0
151035,),0,0
151036,were,0,0
151037,prospectively,0,0
151038,randomized,0,0
151039,to,0,0
151040,placebo,0,0
151041,",",0,0
151042,?-aminocaproic,0,0
151043,acid,0,1
151044,(,0,1
151045,EACA,0,1
151046,),0,1
151047,",",0,0
151048,or,0,0
151049,HOE,0,0
151050,140,0,0
151051,",",0,0
151052,a,0,0
151053,bradykinin,0,1
151054,B2,0,1
151055,receptor,0,1
151056,antagonist,0,0
151057,.,0,1
151058,Bradykinin,0,1
151059,B2,0,1
151060,receptor,0,1
151061,antagonism,0,1
151062,decreased,1,1
151063,intraoperative,1,1
151064,fibrinolytic,1,1
151065,capacity,1,1
151066,as,0,0
151067,much,0,0
151068,as,0,0
151069,EACA,0,1
151070,",",0,1
151071,but,0,0
151072,only,0,0
151073,EACA,0,1
151074,decreased,1,1
151075,D-dimer,1,1
151076,formation,1,1
151077,and,0,1
151078,tended,0,0
151079,to,0,0
151080,decrease,1,1
151081,postoperative,1,1
151082,bleeding,1,1
151083,.,1,0
151084,Although,0,0
151085,EACA,0,1
151086,and,0,0
151087,HOE,0,0
151088,140,0,0
151089,decreased,1,0
151090,fibrinolysis,1,1
151091,and,1,1
151092,EACA,1,1
151093,attenuated,1,0
151094,blood,1,1
151095,loss,1,1
151096,",",1,0
151097,these,0,0
151098,treatments,0,0
151099,did,0,0
151100,not,0,0
151101,reduce,0,0
151102,the,0,0
151103,proportion,0,0
151104,of,0,0
151105,patients,0,0
151106,transfused,0,1
151107,.,0,0
151108,These,0,0
151109,data,0,0
151110,suggest,0,0
151111,that,0,0
151112,endogenous,0,1
151113,bradykinin,0,0
151114,contributes,0,0
151115,to,1,0
151116,t-PA,1,1
151117,generation,1,1
151118,in,0,0
151119,patients,0,0
151120,undergoing,0,0
151121,CPB,0,1
151122,",",0,1
151123,but,0,0
151124,that,0,0
151125,additional,0,0
151126,effects,0,1
151127,on,1,0
151128,plasmin,1,1
151129,generation,1,1
151130,contribute,0,0
151131,to,1,0
151132,decreased,1,1
151133,D-dimer,1,0
151134,concentrations,1,1
151135,during,0,0
151136,EACA,0,1
151137,treatment,0,0
151138,.,0,0
151139,Effects,0,0
151140,of,0,0
151141,a,0,0
151142,dietetic,0,0
151143,treatment,0,0
151144,in,0,0
151145,older,0,0
151146,",",0,1
151147,undernourished,0,1
151148,",",0,1
151149,community-dwelling,0,0
151150,individuals,0,0
151151,in,0,0
151152,primary,0,0
151153,care,0,0
151154,:,0,0
151155,a,0,0
151156,randomized,0,0
151157,controlled,0,0
151158,trial,0,0
151159,.,0,0
151160,PURPOSE,0,0
151161,Undernutrition,0,0
151162,is,0,0
151163,a,0,0
151164,prevalent,0,0
151165,problem,0,0
151166,in,0,0
151167,older,0,0
151168,",",0,0
151169,community-dwelling,0,0
151170,individuals,0,0
151171,.,0,0
151172,Aim,0,0
151173,of,0,0
151174,this,0,0
151175,study,0,0
151176,was,0,0
151177,to,0,0
151178,determine,0,0
151179,the,0,0
151180,effects,0,0
151181,of,0,0
151182,a,0,0
151183,dietetic,0,0
151184,treatment,0,0
151185,in,0,0
151186,older,0,0
151187,",",0,1
151188,undernourished,0,1
151189,",",0,1
151190,community-dwelling,0,0
151191,individuals,0,0
151192,.,0,0
151193,METHODS,0,0
151194,A,0,0
151195,parallel,0,0
151196,randomized,0,0
151197,controlled,0,0
151198,trial,0,0
151199,was,0,0
151200,performed,0,0
151201,in,0,0
151202,146,0,0
151203,non-institutionalized,0,0
151204,",",0,0
151205,undernourished,0,0
151206,individuals,0,0
151207,aged,0,0
151208,?65,0,0
151209,years,0,0
151210,in,0,0
151211,primary,0,0
151212,care,0,0
151213,.,0,1
151214,Participants,0,0
151215,were,0,0
151216,randomly,0,0
151217,assigned,0,0
151218,to,0,0
151219,the,0,0
151220,intervention,0,0
151221,(,0,0
151222,referral,0,1
151223,to,0,0
151224,and,0,1
151225,treatment,0,0
151226,by,0,0
151227,a,0,0
151228,trained,0,0
151229,dietitian,0,1
151230,),0,0
151231,or,0,0
151232,control,0,0
151233,group,0,0
151234,(,0,0
151235,no,0,0
151236,referral,1,0
151237,),1,0
151238,.,1,1
151239,Body,1,0
151240,weight,1,1
151241,",",1,0
151242,physical,1,1
151243,performance,1,1
151244,",",1,1
151245,handgrip,1,1
151246,strength,1,1
151247,",",1,1
151248,energy,1,1
151249,intake,1,1
151250,",",1,1
151251,protein,1,1
151252,intake,1,1
151253,and,1,1
151254,fat-free,1,1
151255,mass,1,1
151256,were,1,0
151257,assessed,0,0
151258,at,0,0
151259,baseline,0,0
151260,",",0,0
151261,after,0,0
151262,3,0,0
151263,months,0,0
151264,and,0,0
151265,after,0,0
151266,6,0,0
151267,months,0,0
151268,.,0,0
151269,RESULTS,0,0
151270,All,0,0
151271,randomized,0,0
151272,participants,0,0
151273,(,0,0
151274,n,0,0
151275,=,0,0
151276,146,0,0
151277,),0,0
151278,were,0,0
151279,included,0,0
151280,in,0,0
151281,the,0,0
151282,intention-to-treat,0,0
151283,generalized,0,0
151284,estimating,0,0
151285,equations,0,0
151286,analysis,0,0
151287,(,0,0
151288,72,0,0
151289,in,0,0
151290,intervention,0,0
151291,and,0,0
151292,74,0,0
151293,in,0,0
151294,control,0,0
151295,group,0,0
151296,),0,0
151297,.,0,0
151298,No,0,0
151299,treatment,0,0
151300,effect,0,1
151301,was,0,0
151302,found,0,0
151303,on,0,0
151304,the,0,0
151305,primary,0,0
151306,outcomes,1,1
151307,body,1,1
151308,weight,1,1
151309,(,1,0
151310,?,0,0
151311,=,0,0
151312,0.49,0,0
151313,kg,0,0
151314,",",0,0
151315,95,0,0
151316,%,0,0
151317,CI,0,0
151318,:,0,0
151319,-0.15-1.12,1,0
151320,),1,1
151321,",",1,0
151322,physical,1,1
151323,performance,1,1
151324,(,1,0
151325,?,1,0
151326,=,0,0
151327,0.15,0,0
151328,points,0,0
151329,",",0,0
151330,95,0,0
151331,%,0,0
151332,CI,0,0
151333,:,0,0
151334,-0.33-0.64,0,0
151335,),0,1
151336,and,0,1
151337,handgrip,1,1
151338,strength,1,1
151339,(,1,0
151340,?,1,0
151341,=,0,0
151342,0.49,0,0
151343,kg,0,0
151344,",",0,0
151345,95,0,0
151346,%,0,0
151347,CI,0,0
151348,:,0,0
151349,-0.62-1.60,0,0
151350,),0,0
151351,.,0,1
151352,Furthermore,0,0
151353,",",0,0
151354,no,0,0
151355,treatment,0,0
151356,effect,0,1
151357,was,0,0
151358,found,0,0
151359,for,0,0
151360,the,0,0
151361,secondary,0,0
151362,outcomes,0,1
151363,.,0,0
151364,Predefined,0,0
151365,subgroup,0,0
151366,analyses,0,0
151367,showed,0,0
151368,a,0,0
151369,treatment,0,0
151370,effect,1,1
151371,on,1,0
151372,body,1,1
151373,weight,1,1
151374,in,1,0
151375,physically,1,1
151376,active,0,0
151377,participants,0,0
151378,(,0,0
151379,?,0,0
151380,=,0,0
151381,1.25,0,0
151382,kg,0,0
151383,",",0,0
151384,95,0,0
151385,%,0,0
151386,CI,0,0
151387,:,0,0
151388,0.70-2.11,0,0
151389,),0,1
151390,and,0,0
151391,not,0,0
151392,in,0,0
151393,inactive,0,0
151394,participants,0,0
151395,(,0,0
151396,?,0,0
151397,=,0,0
151398,-0.20,0,0
151399,kg,0,0
151400,",",0,0
151401,95,0,0
151402,%,0,0
151403,CI,0,0
151404,:,0,0
151405,-1.16-0.75,0,0
151406,),0,0
151407,.,0,0
151408,CONCLUSIONS,0,0
151409,After,0,0
151410,6,0,0
151411,months,0,0
151412,",",0,0
151413,a,0,0
151414,dietetic,0,0
151415,treatment,0,0
151416,by,0,0
151417,trained,0,0
151418,dietitians,0,0
151419,does,0,0
151420,not,0,0
151421,lead,0,0
151422,to,0,0
151423,increases,0,1
151424,in,0,0
151425,body,0,1
151426,weight,0,1
151427,and,0,1
151428,physical,0,1
151429,functioning,0,1
151430,in,0,0
151431,older,0,0
151432,",",0,1
151433,undernourished,0,1
151434,",",0,1
151435,community-dwelling,0,0
151436,individuals,0,0
151437,.,0,0
151438,Design,0,1
151439,and,0,1
151440,development,0,1
151441,of,0,0
151442,a,0,0
151443,Virtual,0,0
151444,Dolphinarium,0,1
151445,for,0,0
151446,children,0,0
151447,with,0,0
151448,autism,0,0
151449,.,0,0
151450,The,0,0
151451,recent,0,0
151452,proliferation,0,1
151453,of,0,1
151454,virtual,0,1
151455,reality,0,0
151456,(,0,1
151457,VR,0,1
151458,),0,1
151459,technology,0,0
151460,applications,0,0
151461,in,0,0
151462,the,0,0
151463,autism,0,0
151464,therapy,0,0
151465,to,0,0
151466,promote,0,0
151467,learning,0,1
151468,and,0,1
151469,positive,0,1
151470,behavior,0,1
151471,among,0,0
151472,such,0,0
151473,children,0,0
151474,has,0,0
151475,produced,0,0
151476,optimistic,0,0
151477,results,0,0
151478,in,0,0
151479,developing,0,0
151480,a,0,0
151481,variety,0,0
151482,of,0,0
151483,skills,0,1
151484,and,0,1
151485,abilities,0,1
151486,in,0,0
151487,them,0,0
151488,.,0,0
151489,Dolphin-assisted,0,0
151490,therapy,0,0
151491,has,0,0
151492,also,0,0
151493,become,0,0
151494,a,0,0
151495,topic,0,0
151496,of,0,1
151497,public,0,0
151498,and,0,1
151499,research,0,0
151500,interest,0,1
151501,for,0,0
151502,autism,0,0
151503,intervention,0,0
151504,and,0,1
151505,treatment,0,0
151506,.,0,0
151507,This,0,0
151508,paper,0,0
151509,will,0,0
151510,present,0,0
151511,an,0,0
151512,innovative,0,0
151513,design,0,0
151514,and,0,1
151515,development,0,1
151516,of,0,0
151517,a,0,0
151518,Virtual,0,0
151519,Dolphinarium,0,1
151520,for,0,0
151521,potential,0,0
151522,autism,0,0
151523,intervention,0,0
151524,.,0,0
151525,Instead,0,0
151526,of,0,0
151527,emulating,0,0
151528,the,0,0
151529,swimming,0,0
151530,with,0,0
151531,dolphins,0,0
151532,",",0,0
151533,our,0,0
151534,virtual,0,1
151535,dolphin,0,0
151536,interaction,0,0
151537,program,0,0
151538,will,0,0
151539,allow,0,0
151540,children,0,0
151541,with,0,0
151542,autism,0,0
151543,to,0,0
151544,act,0,0
151545,as,0,0
151546,dolphin,0,0
151547,trainers,0,0
151548,at,0,0
151549,the,0,0
151550,poolside,0,0
151551,and,0,0
151552,to,0,0
151553,learn,0,0
151554,(,0,0
151555,nonverbal,0,1
151556,),0,1
151557,communication,0,1
151558,through,0,0
151559,hand,0,1
151560,gestures,0,0
151561,with,0,0
151562,the,0,0
151563,virtual,0,0
151564,dolphins,0,0
151565,.,0,0
151566,Immersive,0,0
151567,visualization,0,1
151568,and,0,1
151569,gesture-based,0,0
151570,interaction,0,1
151571,are,0,0
151572,implemented,0,0
151573,to,0,0
151574,engage,0,0
151575,children,0,0
151576,with,0,0
151577,autism,0,0
151578,within,0,0
151579,an,0,0
151580,immersive,0,0
151581,room,0,0
151582,equipped,0,0
151583,with,0,0
151584,a,0,0
151585,curved,0,0
151586,screen,0,0
151587,spanning,0,0
151588,a,0,0
151589,320,0,0
151590,(,0,0
151591,?,0,0
151592,),0,0
151593,and,0,0
151594,a,0,0
151595,high-end,0,0
151596,five-panel,0,0
151597,projection,0,1
151598,system,0,0
151599,.,0,0
151600,This,0,0
151601,paper,0,0
151602,will,0,0
151603,also,0,0
151604,report,0,0
151605,a,0,0
151606,pilot,0,0
151607,study,0,0
151608,to,0,0
151609,establish,0,0
151610,trial,0,0
151611,protocol,0,0
151612,of,0,1
151613,autism,0,0
151614,screening,0,0
151615,to,0,0
151616,explore,0,0
151617,the,0,0
151618,participants,0,0
151619,',0,1
151620,readiness,0,1
151621,for,0,0
151622,the,0,0
151623,virtual,0,0
151624,dolphin,0,0
151625,interaction,0,1
151626,.,0,0
151627,This,0,0
151628,research,0,0
151629,will,0,0
151630,have,0,0
151631,two,0,0
151632,potential,0,0
151633,benefits,0,0
151634,in,0,0
151635,the,0,0
151636,sense,0,1
151637,of,0,0
151638,helping,0,0
151639,children,0,0
151640,with,0,0
151641,autism,0,0
151642,and,0,0
151643,protecting,0,0
151644,the,0,0
151645,endangered,0,0
151646,species,0,0
151647,.,0,0
151648,Supplementation,0,0
151649,with,0,0
151650,n3,0,1
151651,fatty,0,1
151652,acid,0,1
151653,ethyl,0,0
151654,esters,0,1
151655,increases,0,1
151656,large,0,0
151657,and,0,1
151658,small,0,1
151659,artery,0,1
151660,elasticity,1,1
151661,in,0,0
151662,obese,0,0
151663,adults,0,0
151664,on,0,0
151665,a,0,0
151666,weight,0,1
151667,loss,0,1
151668,diet,0,0
151669,.,0,0
151670,Increased,0,1
151671,arterial,0,0
151672,stiffness,0,1
151673,is,0,0
151674,associated,0,0
151675,with,0,0
151676,enhanced,0,0
151677,risk,0,1
151678,of,0,1
151679,cardiovascular,0,1
151680,disease,0,1
151681,in,0,0
151682,obese,0,0
151683,individuals,0,0
151684,.,0,0
151685,Whether,0,0
151686,n3,0,0
151687,fatty,0,1
151688,acid,0,0
151689,ethyl,0,0
151690,ester,0,1
151691,(,0,1
151692,FAEE,0,0
151693,),0,0
151694,supplementation,0,0
151695,improves,0,1
151696,arterial,0,1
151697,stiffness,0,1
151698,in,0,0
151699,obese,0,0
151700,participants,0,0
151701,on,0,0
151702,a,0,0
151703,weight,0,1
151704,loss,0,1
151705,diet,0,0
151706,has,0,0
151707,not,0,0
151708,yet,0,0
151709,been,0,0
151710,investigated,0,0
151711,.,0,0
151712,The,0,0
151713,objective,0,0
151714,of,0,0
151715,the,0,0
151716,study,0,0
151717,was,0,0
151718,to,0,0
151719,carry,0,0
151720,out,0,0
151721,a,0,0
151722,12-wk,0,0
151723,randomized,0,0
151724,",",0,1
151725,single-blind,0,0
151726,trial,0,0
151727,to,0,0
151728,test,0,0
151729,the,0,0
151730,effect,0,0
151731,of,0,0
151732,a,0,0
151733,25,0,0
151734,%,0,0
151735,energy,0,1
151736,deficit,0,1
151737,weight,0,1
151738,loss,0,1
151739,diet,0,0
151740,alone,0,0
151741,(,0,0
151742,WL,0,0
151743,),0,1
151744,(,0,0
151745,n,0,0
151746,=,0,0
151747,12,0,0
151748,),0,0
151749,or,0,0
151750,WL,0,0
151751,plus,0,0
151752,4,0,0
151753,g/d,0,0
151754,Omacor,0,0
151755,(,0,0
151756,46,0,0
151757,%,0,0
151758,EPA,0,0
151759,and,0,0
151760,38,0,0
151761,%,0,0
151762,DHA,0,1
151763,),0,1
151764,supplementation,0,0
151765,(,0,1
151766,WL+FAEE,0,1
151767,),0,1
151768,(,0,0
151769,n,0,0
151770,=,0,0
151771,13,0,0
151772,),0,0
151773,on,0,0
151774,arterial,0,1
151775,elasticity,0,1
151776,in,0,0
151777,obese,0,0
151778,adults,0,0
151779,.,0,1
151780,Large,1,0
151781,(,1,0
151782,C1,1,1
151783,),1,1
151784,and,1,1
151785,small,1,1
151786,artery,1,1
151787,elasticity,1,1
151788,(,1,1
151789,C2,1,1
151790,),1,1
151791,were,0,0
151792,measured,0,0
151793,by,0,0
151794,pulse,0,1
151795,contour,0,1
151796,analysis,0,0
151797,of,0,0
151798,the,0,0
151799,radial,0,1
151800,artery,0,0
151801,.,0,0
151802,WL,0,0
151803,alone,0,0
151804,reduced,1,0
151805,(,0,0
151806,P,0,0
151807,<,0,0
151808,0.05,0,0
151809,in,0,0
151810,all,0,0
151811,),0,0
151812,body,1,1
151813,weight,1,1
151814,(,0,0
151815,-3,0,0
151816,%,0,0
151817,),0,0
151818,",",0,0
151819,waist,1,1
151820,circumference,1,1
151821,(,0,0
151822,-4,0,0
151823,%,0,0
151824,),0,0
151825,",",0,1
151826,systolic,1,1
151827,(,0,0
151828,-3,0,0
151829,%,0,0
151830,),0,0
151831,and,0,1
151832,diastolic,1,1
151833,(,0,0
151834,-3,0,0
151835,%,0,0
151836,),0,0
151837,blood,1,1
151838,pressures,1,1
151839,",",1,1
151840,cardiac,1,1
151841,output,1,1
151842,(,1,0
151843,-4,1,0
151844,%,1,0
151845,),1,0
151846,",",1,0
151847,plasma,1,1
151848,TG,1,1
151849,concentration,1,1
151850,(,0,0
151851,-25,0,0
151852,%,0,0
151853,),0,0
151854,",",0,0
151855,and,0,0
151856,the,0,0
151857,homeostasis,1,1
151858,model,1,0
151859,assessment,1,1
151860,(,1,1
151861,HOMA,1,1
151862,),1,1
151863,score,1,1
151864,(,0,0
151865,-12,0,0
151866,%,0,0
151867,),0,0
151868,and,0,1
151869,increased,1,1
151870,plasma,1,1
151871,HDL,1,1
151872,cholesterol,1,1
151873,(,0,0
151874,+9,0,0
151875,%,0,0
151876,),0,0
151877,and,0,1
151878,adiponectin,1,1
151879,(,0,0
151880,+18,0,0
151881,%,0,0
151882,),0,0
151883,concentrations,1,1
151884,.,1,0
151885,However,0,0
151886,",",0,0
151887,WL,0,0
151888,alone,0,0
151889,did,0,0
151890,not,0,0
151891,alter,0,1
151892,C1,0,1
151893,and,0,0
151894,C2,0,1
151895,.,0,0
151896,The,0,0
151897,WL+FAEE,0,0
151898,intervention,0,0
151899,significantly,1,0
151900,reduced,1,0
151901,body,1,1
151902,weight,1,1
151903,(,0,0
151904,-4,0,0
151905,%,0,0
151906,),0,0
151907,",",0,0
151908,waist,1,1
151909,circumference,1,1
151910,(,0,0
151911,-4,0,0
151912,%,0,0
151913,),0,0
151914,",",0,1
151915,systolic,1,1
151916,(,0,0
151917,-8,0,0
151918,%,0,0
151919,),0,0
151920,and,0,1
151921,diastolic,1,1
151922,(,0,0
151923,-5,0,0
151924,%,0,0
151925,),0,0
151926,blood,1,1
151927,pressures,1,1
151928,",",1,1
151929,pulse,1,1
151930,pressure,1,1
151931,(,0,0
151932,-5,0,0
151933,%,0,0
151934,),0,0
151935,",",0,1
151936,heart,1,1
151937,rate,1,1
151938,(,0,0
151939,-8,0,0
151940,%,0,0
151941,),0,0
151942,",",0,0
151943,plasma,1,1
151944,TG,1,1
151945,concentration,1,1
151946,(,0,0
151947,-36,0,0
151948,%,0,0
151949,),0,0
151950,",",0,1
151951,and,0,1
151952,HOMA,1,1
151953,score,1,1
151954,(,0,0
151955,-12,0,0
151956,%,0,0
151957,),0,0
151958,and,0,1
151959,increased,1,1
151960,stroke,1,1
151961,volume,1,1
151962,(,0,0
151963,+3,0,0
151964,%,0,0
151965,),0,0
151966,",",0,0
151967,plasma,1,1
151968,HDL,1,1
151969,cholesterol,1,1
151970,(,0,0
151971,+6,0,0
151972,%,0,0
151973,),0,0
151974,and,0,1
151975,adiponectin,1,1
151976,concentrations,1,1
151977,(,0,0
151978,+28,0,0
151979,%,0,0
151980,),0,0
151981,",",0,1
151982,and,0,1
151983,C1,1,1
151984,(,0,1
151985,+20,0,0
151986,%,0,0
151987,),0,1
151988,and,0,1
151989,C2,1,1
151990,(,0,1
151991,+22,0,1
151992,%,0,0
151993,),0,1
151994,artery,1,0
151995,elasticity,1,1
151996,.,1,0
151997,The,0,0
151998,changes,0,1
151999,in,0,0
152000,systolic,1,1
152001,blood,1,1
152002,pressure,1,1
152003,",",1,1
152004,heart,1,1
152005,rate,1,1
152006,",",1,1
152007,plasma,1,1
152008,TGs,1,1
152009,",",1,1
152010,C1,1,1
152011,",",1,1
152012,and,1,1
152013,C2,1,1
152014,were,0,0
152015,significantly,1,0
152016,greater,1,0
152017,in,0,0
152018,the,0,0
152019,WL+FAEE,0,0
152020,group,0,0
152021,than,0,0
152022,in,0,0
152023,the,0,0
152024,WL,0,0
152025,group,0,0
152026,.,0,1
152027,Supplementation,0,0
152028,with,0,0
152029,n3,0,0
152030,FAEEs,0,0
152031,improves,0,1
152032,C1,1,1
152033,and,1,1
152034,C2,1,1
152035,independently,0,1
152036,of,0,0
152037,weight,1,1
152038,loss,1,1
152039,in,0,0
152040,obese,0,0
152041,adults,0,0
152042,.,0,0
152043,Heat-exercise,0,0
152044,performance,0,1
152045,of,0,1
152046,pyridostigmine-treated,0,0
152047,subjects,0,0
152048,wearing,0,1
152049,chemical,0,0
152050,protective,0,0
152051,clothing,0,1
152052,.,0,1
152053,Pyridostigmine,0,0
152054,bromide,0,0
152055,is,0,0
152056,currently,0,0
152057,the,0,0
152058,pretreatment,0,0
152059,of,0,0
152060,choice,0,0
152061,for,0,0
152062,operation,0,0
152063,in,0,0
152064,a,0,0
152065,chemical,0,0
152066,warfare,0,0
152067,(,0,1
152068,CW,0,1
152069,),0,0
152070,environment,0,0
152071,.,0,0
152072,Under,0,0
152073,CW,0,1
152074,conditions,0,0
152075,",",0,0
152076,subjects,0,0
152077,are,0,0
152078,exposed,0,0
152079,to,0,0
152080,thermal,0,0
152081,stress,0,1
152082,caused,0,0
152083,by,0,0
152084,CW,0,1
152085,protective,0,0
152086,clothing,0,1
152087,.,0,0
152088,This,0,0
152089,investigation,0,0
152090,was,0,0
152091,conducted,0,0
152092,to,0,0
152093,determine,0,0
152094,if,0,0
152095,pyridostigmine,0,0
152096,affects,0,0
152097,various,0,0
152098,physiological,0,1
152099,and,0,1
152100,biophysical,0,1
152101,parameters,0,1
152102,of,0,1
152103,human,0,0
152104,temperature,0,1
152105,regulation,0,1
152106,in,0,0
152107,subjects,0,0
152108,wearing,0,1
152109,CW,0,1
152110,protective,0,0
152111,clothing,0,1
152112,.,0,1
152113,Pyridostigmine,0,0
152114,was,0,0
152115,administered,0,0
152116,orally,0,0
152117,in,0,0
152118,a,0,0
152119,randomized,0,0
152120,double-blind,0,0
152121,cross-over,0,0
152122,study,0,0
152123,in,0,0
152124,four,0,0
152125,doses,0,0
152126,of,0,0
152127,30,0,0
152128,mg,0,0
152129,every,0,0
152130,8,0,0
152131,h.,0,0
152132,An,0,0
152133,average,0,0
152134,of,0,0
152135,33,0,0
152136,%,0,0
152137,whole,0,0
152138,blood,0,1
152139,cholinesterase,0,1
152140,inhibition,0,1
152141,was,0,0
152142,induced,0,0
152143,in,0,0
152144,the,0,0
152145,pyridostigmine,0,0
152146,treated,0,0
152147,group,0,0
152148,4,0,0
152149,h,0,0
152150,after,0,0
152151,ingestion,0,0
152152,of,0,1
152153,last,0,0
152154,tablet,0,0
152155,.,0,0
152156,The,0,0
152157,subjects,0,0
152158,were,0,0
152159,exposed,0,0
152160,to,0,0
152161,170,0,0
152162,min,0,0
152163,exercise-heat,0,0
152164,stress,0,1
152165,(,0,0
152166,Tdb,0,0
152167,=,0,0
152168,33,0,0
152169,degrees,0,0
152170,C,0,0
152171,;,0,0
152172,rh,0,0
152173,=,0,0
152174,60,0,0
152175,%,0,0
152176,),0,0
152177,consisting,0,0
152178,of,0,0
152179,60,0,0
152180,min,0,0
152181,in,0,0
152182,a,0,0
152183,sitting,0,1
152184,position,0,1
152185,and,0,0
152186,two,0,0
152187,50-min,0,0
152188,walks,0,0
152189,(,0,0
152190,1.39,0,0
152191,m.s-1,0,0
152192,",",0,0
152193,5,0,0
152194,%,0,0
152195,grade,0,0
152196,),0,0
152197,separated,0,0
152198,by,0,0
152199,10,0,0
152200,min,0,0
152201,of,0,0
152202,rest,0,0
152203,.,0,1
152204,Non-evaporative,1,1
152205,heat,1,1
152206,exchange,1,1
152207,was,0,0
152208,significantly,0,0
152209,higher,0,0
152210,",",0,1
152211,-14.0,0,0
152212,and,0,1
152213,-10.6,0,0
152214,W.m-2,0,0
152215,(,0,0
152216,p,0,0
152217,less,0,0
152218,than,0,0
152219,0.03,0,0
152220,),0,0
152221,",",0,0
152222,for,0,0
152223,the,0,0
152224,pyridostigmine-treated,0,0
152225,subjects,0,0
152226,.,0,0
152227,No,0,0
152228,additional,0,0
152229,differences,0,0
152230,were,0,0
152231,found,0,0
152232,between,0,0
152233,treatments,0,0
152234,in,0,0
152235,the,0,0
152236,physiological,0,0
152237,responses,0,1
152238,and,0,1
152239,heat,0,1
152240,balance,0,1
152241,parameters,0,1
152242,at,0,0
152243,the,0,0
152244,end,0,0
152245,of,0,0
152246,exposure,0,0
152247,:,0,0
152248,heart,0,1
152249,rate,0,1
152250,(,0,1
152251,HR,0,1
152252,),0,1
152253,was,0,0
152254,(,0,0
152255,mean,0,1
152256,+/-,0,0
152257,S.D,0,0
152258,.,0,0
152259,),0,0
152260,154,0,0
152261,+/-,0,0
152262,16,0,0
152263,and,0,0
152264,151,0,0
152265,+/-,0,0
152266,24,0,0
152267,bpm,0,0
152268,",",0,0
152269,rectal,0,1
152270,temperature,0,1
152271,(,0,1
152272,Tre,0,0
152273,),0,0
152274,was,0,0
152275,39.0,0,0
152276,+/-,0,0
152277,0.4,0,0
152278,and,0,0
152279,38.9,0,0
152280,+/-,0,0
152281,0.2,0,0
152282,degrees,0,0
152283,C,0,0
152284,",",0,1
152285,heat,0,1
152286,storage,0,1
152287,over,0,0
152288,the,0,0
152289,2,0,0
152290,h,0,0
152291,of,0,0
152292,exercise,0,0
152293,was,0,0
152294,62,0,0
152295,+/-,0,0
152296,15,0,0
152297,and,0,0
152298,70,0,0
152299,+/-,0,0
152300,15,0,0
152301,W.m-2,0,0
152302,",",0,0
152303,and,0,1
152304,sweat,0,1
152305,rate,0,1
152306,was,0,0
152307,832,0,0
152308,+/-,0,0
152309,185,0,0
152310,and,0,0
152311,748,0,0
152312,+/-,0,0
152313,52,0,0
152314,g.h-1,0,0
152315,",",0,0
152316,in,0,0
152317,the,0,0
152318,pyridostigmine,0,0
152319,and,0,1
152320,placebo,0,0
152321,treatments,0,0
152322,",",0,0
152323,respectively,0,0
152324,.,0,0
152325,(,0,0
152326,ABSTRACT,0,1
152327,TRUNCATED,0,0
152328,AT,0,0
152329,250,0,0
152330,WORDS,0,0
152331,),0,0
152332,Sex,1,0
152333,risk,1,1
152334,behavior,1,1
152335,among,0,0
152336,adolescent,0,0
152337,and,0,1
152338,young,0,0
152339,adult,0,0
152340,children,0,0
152341,of,0,0
152342,opiate,0,0
152343,addicts,0,0
152344,:,0,0
152345,outcomes,0,1
152346,from,0,0
152347,the,0,0
152348,focus,0,0
152349,on,0,0
152350,families,0,0
152351,prevention,0,0
152352,trial,0,0
152353,and,0,0
152354,an,0,0
152355,examination,0,0
152356,of,0,1
152357,childhood,0,1
152358,and,0,1
152359,concurrent,0,0
152360,predictors,0,1
152361,of,0,1
152362,sex,0,0
152363,risk,0,1
152364,behavior,0,1
152365,.,0,0
152366,This,0,0
152367,study,0,0
152368,reports,0,0
152369,on,0,0
152370,rates,1,1
152371,and,1,1
152372,predictors,1,1
152373,of,1,1
152374,sex,1,0
152375,risk,1,1
152376,behavior,1,1
152377,among,0,0
152378,a,0,0
152379,sample,0,0
152380,of,0,1
152381,adolescent,0,0
152382,and,0,1
152383,young,0,0
152384,adult,0,0
152385,children,0,0
152386,of,0,0
152387,parents,0,0
152388,enrolled,0,0
152389,in,0,0
152390,methadone,0,0
152391,treatment,0,0
152392,for,0,0
152393,opiate,0,0
152394,addiction,0,1
152395,.,0,0
152396,Data,0,0
152397,are,0,0
152398,from,0,0
152399,151,0,0
152400,participants,0,0
152401,(,0,0
152402,80,0,0
152403,males,0,0
152404,",",0,0
152405,71,0,0
152406,females,0,0
152407,),0,0
152408,in,0,0
152409,the,0,0
152410,Focus,0,0
152411,on,0,0
152412,Families,0,1
152413,(,0,0
152414,FOF,0,1
152415,),0,1
152416,project,0,0
152417,",",0,0
152418,a,0,0
152419,randomized,0,0
152420,trial,0,0
152421,of,0,0
152422,a,0,0
152423,family,0,1
152424,intervention,0,0
152425,and,0,0
152426,a,0,0
152427,study,0,0
152428,of,0,0
152429,the,0,0
152430,development,0,0
152431,of,0,0
152432,at-risk,0,0
152433,children,0,0
152434,.,0,0
152435,The,0,0
152436,study,0,0
152437,participants,0,0
152438,are,0,0
152439,children,0,0
152440,of,0,0
152441,parents,0,0
152442,enrolled,0,0
152443,in,0,0
152444,methadone,0,0
152445,treatment,0,0
152446,between,0,0
152447,1990,0,0
152448,and,0,0
152449,1993,0,0
152450,.,0,0
152451,Participants,0,0
152452,were,0,0
152453,interviewed,0,0
152454,in,0,0
152455,2005,0,0
152456,when,0,0
152457,they,0,0
152458,ranged,0,0
152459,in,0,0
152460,age,0,0
152461,from,0,0
152462,15,0,0
152463,to,0,0
152464,29,0,0
152465,years,0,0
152466,.,0,0
152467,In,0,0
152468,the,0,0
152469,year,0,0
152470,prior,0,0
152471,to,0,0
152472,the,0,0
152473,follow-up,0,0
152474,",",0,0
152475,79,0,0
152476,%,0,0
152477,of,0,0
152478,the,0,0
152479,males,0,0
152480,and,0,0
152481,83,0,0
152482,%,0,0
152483,of,0,0
152484,females,0,0
152485,were,0,0
152486,sexually,0,0
152487,active,0,0
152488,",",0,0
152489,26,0,0
152490,%,0,0
152491,of,0,0
152492,males,0,0
152493,and,0,0
152494,10,0,0
152495,%,0,0
152496,of,0,0
152497,females,0,0
152498,had,0,0
152499,more,0,0
152500,than,0,0
152501,one,0,0
152502,partner,0,0
152503,in,0,0
152504,the,0,0
152505,prior,0,0
152506,year,0,0
152507,",",0,0
152508,and,0,0
152509,34,0,0
152510,%,0,0
152511,of,0,0
152512,males,0,0
152513,and,0,0
152514,24,0,0
152515,%,0,0
152516,of,0,0
152517,females,0,0
152518,reported,0,0
152519,having,0,0
152520,sex,0,0
152521,outside,0,0
152522,of,0,0
152523,a,0,0
152524,committed,0,0
152525,relationship,0,0
152526,.,0,0
152527,Twenty-four,0,0
152528,percent,0,0
152529,of,0,0
152530,males,0,0
152531,and,0,0
152532,17,0,0
152533,%,0,0
152534,of,0,0
152535,females,0,0
152536,met,0,0
152537,criteria,0,0
152538,for,0,0
152539,high-risk,1,0
152540,sexual,1,1
152541,behavior,1,1
152542,",",0,0
152543,reporting,0,1
152544,casual,0,1
152545,or,0,0
152546,multiple,0,0
152547,partners,0,0
152548,in,0,0
152549,the,0,0
152550,prior,0,0
152551,year,0,0
152552,and,0,1
152553,inconsistent,0,0
152554,condom,0,1
152555,use,0,0
152556,.,0,0
152557,Participants,0,0
152558,in,0,0
152559,the,0,0
152560,intervention,0,0
152561,and,0,1
152562,control,0,0
152563,conditions,0,0
152564,did,0,0
152565,not,0,0
152566,differ,0,0
152567,significantly,0,0
152568,in,0,0
152569,terms,0,0
152570,of,0,0
152571,any,0,0
152572,measure,0,0
152573,of,0,1
152574,sex,1,0
152575,risk,1,1
152576,behavior,1,1
152577,examined,0,0
152578,.,0,0
152579,None,0,0
152580,of,0,0
152581,the,0,0
152582,measures,0,0
152583,of,0,0
152584,parent,0,1
152585,behavior,0,1
152586,and,0,1
152587,family,0,1
152588,processes,0,1
152589,derived,0,0
152590,from,0,0
152591,data,0,0
152592,at,0,0
152593,baseline,0,0
152594,of,0,0
152595,the,0,0
152596,FOF,0,1
152597,study,0,0
152598,predicted,0,1
152599,whether,0,0
152600,participants,0,0
152601,engaged,0,0
152602,in,0,0
152603,high-risk,1,0
152604,sex,1,0
152605,.,1,0
152606,Among,0,0
152607,measures,0,0
152608,derived,0,0
152609,from,0,0
152610,data,0,0
152611,collected,0,0
152612,at,0,0
152613,long-term,0,0
152614,follow-up,0,0
152615,",",0,0
152616,however,0,0
152617,",",0,0
152618,having,0,0
152619,ever,0,0
152620,met,0,0
152621,criteria,0,0
152622,for,0,0
152623,substance,0,1
152624,abuse,0,1
152625,or,0,1
152626,dependence,0,1
152627,predicted,0,1
152628,greater,0,0
152629,likelihood,0,1
152630,of,0,1
152631,high-risk,1,0
152632,sexual,1,1
152633,behavior,1,1
152634,",",0,1
152635,and,0,1
152636,being,0,0
152637,married,0,1
152638,or,0,0
152639,being,0,0
152640,in,0,0
152641,a,0,0
152642,romantic,0,1
152643,relationship,0,1
152644,was,0,0
152645,associated,0,0
152646,with,0,0
152647,lower,0,0
152648,likelihood,0,1
152649,of,0,1
152650,high-risk,1,0
152651,sexual,1,1
152652,behavior,1,1
152653,.,1,0
152654,The,0,0
152655,findings,0,0
152656,point,0,0
152657,to,0,0
152658,the,0,0
152659,important,0,0
152660,role,0,0
152661,of,0,1
152662,committed,0,1
152663,relationships,0,1
152664,in,0,0
152665,regulating,0,0
152666,sex,1,0
152667,risk,1,1
152668,behavior,1,1
152669,among,0,0
152670,this,0,0
152671,population,0,0
152672,",",0,0
152673,as,0,0
152674,well,0,0
152675,as,0,0
152676,heightened,0,0
152677,levels,0,1
152678,of,0,0
152679,sex,1,0
152680,risk,1,1
152681,behavior,1,1
152682,associated,0,0
152683,with,0,0
152684,substance,0,0
152685,abuse,0,1
152686,or,0,0
152687,dependence,0,1
152688,.,0,0
152689,Satisfactory,0,1
152690,sampling,0,0
152691,in,0,0
152692,cytological,0,1
152693,cervical,0,0
152694,diagnosis,0,0
152695,:,0,0
152696,comparison,0,0
152697,between,0,0
152698,a,0,0
152699,conventional,0,0
152700,and,0,0
152701,a,0,0
152702,new,0,1
152703,sampling,0,0
152704,device,0,0
152705,.,0,1
152706,AIM,0,1
152707,Inadequate,0,1
152708,cervical,0,0
152709,sampling,0,0
152710,is,0,0
152711,the,0,0
152712,most,0,0
152713,frequent,0,1
152714,cause,0,1
152715,of,0,1
152716,misdiagnosis,0,1
152717,in,0,0
152718,cervical,0,0
152719,cancer,0,0
152720,screening,0,0
152721,.,0,0
152722,The,0,0
152723,aim,0,0
152724,of,0,0
152725,this,0,0
152726,study,0,0
152727,was,0,0
152728,to,0,0
152729,test,0,0
152730,the,0,0
152731,ability,0,1
152732,of,0,0
152733,PapCone?,0,0
152734,versus,0,0
152735,the,0,0
152736,conventional,0,0
152737,sampling,0,0
152738,method,0,0
152739,(,0,1
152740,Ayre,0,1
152741,'s,0,1
152742,spatula,0,0
152743,plus,0,0
152744,cytobrush,0,0
152745,),0,0
152746,to,0,0
152747,collect,0,0
152748,ectocervical,0,1
152749,and,0,1
152750,glandular,0,1
152751,cells,0,1
152752,.,0,1
152753,MATERIALS,0,0
152754,AND,0,0
152755,METHODS,0,0
152756,In,0,0
152757,18,0,0
152758,healthy,0,0
152759,women,0,0
152760,",",0,0
152761,two,0,0
152762,ecto-endocervical,0,1
152763,samples,0,0
152764,",",0,0
152765,obtained,0,0
152766,by,0,0
152767,two,0,0
152768,different,0,0
152769,methods,0,0
152770,",",0,1
152771,were,0,0
152772,obtained,0,0
152773,at,0,0
152774,a,0,0
152775,three-month,0,0
152776,interval,0,0
152777,.,0,1
152778,Qualitative,0,1
152779,and,0,1
152780,quantitative,0,1
152781,parameters,0,1
152782,were,0,0
152783,evaluated,0,0
152784,.,0,0
152785,Ultrastructure,1,0
152786,features,1,0
152787,of,1,0
152788,sampling,1,0
152789,devices,1,0
152790,were,0,0
152791,analyzed,0,0
152792,by,0,0
152793,scanning,0,0
152794,electron,0,1
152795,microscopy,0,1
152796,(,0,1
152797,SEM,0,0
152798,),0,1
152799,before,0,0
152800,and,0,0
152801,after,0,0
152802,sampling,0,0
152803,.,0,0
152804,RESULTS,0,0
152805,The,0,0
152806,?,0,0
152807,(,0,0
152808,2,0,0
152809,),0,0
152810,test,0,0
152811,revealed,0,0
152812,a,0,0
152813,statistically,0,0
152814,significant,0,0
152815,difference,0,0
152816,between,0,0
152817,the,0,0
152818,two,0,0
152819,methods,0,0
152820,:,0,0
152821,PapCone?,0,1
152822,caused,0,0
152823,less,1,0
152824,cell,1,1
152825,overlap,1,1
152826,and,1,1
152827,sampled,0,0
152828,less,1,0
152829,white,1,0
152830,blood,1,1
152831,cells,1,1
152832,(,1,0
152833,p,1,0
152834,<,0,0
152835,0.05,0,0
152836,),0,0
152837,and,0,0
152838,more,1,0
152839,metaplastic,1,1
152840,cells,1,1
152841,(,1,0
152842,p,1,0
152843,<,0,0
152844,0.01,0,0
152845,),0,0
152846,.,0,0
152847,SEM,0,0
152848,evaluation,1,0
152849,highlighted,1,0
152850,the,0,0
152851,porous,0,0
152852,and,0,1
152853,spongy,0,1
152854,structure,0,1
152855,of,0,1
152856,PapCone?,0,1
152857,that,0,0
152858,was,0,0
152859,responsible,0,0
152860,for,0,0
152861,the,0,0
152862,large,0,0
152863,number,0,1
152864,of,0,1
152865,glandular,0,1
152866,cells,0,1
152867,on,0,0
152868,its,0,0
152869,surface,0,1
152870,.,0,0
152871,CONCLUSION,0,0
152872,Cervical,0,1
152873,smears,0,1
152874,performed,0,0
152875,by,0,0
152876,PapCone?,0,0
152877,were,0,0
152878,adequate,0,0
152879,and,0,0
152880,generally,0,0
152881,easier,0,0
152882,to,0,0
152883,screen,0,0
152884,than,0,0
152885,conventionally,0,0
152886,performed,0,0
152887,ones,0,0
152888,.,0,0
152889,Perioperative,1,0
152890,myocardial,1,1
152891,infarctions,1,0
152892,are,0,0
152893,common,0,0
152894,and,0,0
152895,often,0,0
152896,unrecognized,0,0
152897,in,0,0
152898,patients,0,0
152899,undergoing,0,0
152900,hip,0,1
152901,fracture,0,1
152902,surgery,0,0
152903,.,0,0
152904,BACKGROUND,0,0
152905,The,0,0
152906,aim,0,0
152907,of,0,0
152908,this,0,0
152909,prospective,0,0
152910,cohort,0,0
152911,study,0,0
152912,was,0,0
152913,to,0,0
152914,assess,0,0
152915,the,0,0
152916,incidence,0,1
152917,and,0,1
152918,characteristics,0,1
152919,of,0,1
152920,acute,0,0
152921,myocardial,0,1
152922,infarction,0,1
152923,in,0,0
152924,patients,0,0
152925,undergoing,0,0
152926,surgery,0,0
152927,for,0,0
152928,acute,0,0
152929,hip,0,1
152930,fracture,0,1
152931,.,0,1
152932,METHODS,0,0
152933,A,0,0
152934,consecutive,0,0
152935,cohort,0,0
152936,of,0,1
152937,patients,0,0
152938,(,0,0
152939,n,0,0
152940,=,0,0
152941,200,0,0
152942,",",0,0
152943,68,0,0
152944,men,0,0
152945,),0,0
152946,referred,0,0
152947,to,0,0
152948,acute,0,0
152949,surgical,0,0
152950,correction,0,0
152951,of,0,1
152952,hip,0,1
152953,fracture,0,1
152954,was,0,0
152955,studied,0,0
152956,.,0,0
152957,Troponin,0,0
152958,T,0,1
152959,(,0,1
152960,TnT,0,1
152961,),0,1
152962,measurements,0,1
152963,and,0,1
152964,electrocardiographic,0,1
152965,(,0,1
152966,ECG,0,1
152967,),0,1
152968,recordings,0,1
152969,were,0,0
152970,performed,0,0
152971,at,0,0
152972,admission,0,1
152973,",",0,0
152974,before,0,0
152975,operation,0,1
152976,",",0,1
152977,and,0,1
152978,on,0,0
152979,the,0,0
152980,first,0,0
152981,and,0,0
152982,2nd,0,0
152983,postoperative,0,1
152984,days,0,0
152985,",",0,1
152986,which,0,0
152987,were,0,0
152988,used,0,0
152989,for,0,0
152990,diagnosis,0,0
152991,.,0,0
152992,RESULTS,0,0
152993,The,0,0
152994,age,0,0
152995,of,0,0
152996,the,0,0
152997,patients,0,0
152998,ranged,0,0
152999,from,0,0
153000,32,0,0
153001,to,0,0
153002,98,0,0
153003,years,0,0
153004,(,0,0
153005,mean,0,1
153006,",",0,0
153007,80.8,0,0
153008,years,0,0
153009,),0,0
153010,",",0,0
153011,and,0,0
153012,65,0,0
153013,patients,0,0
153014,had,0,0
153015,a,0,0
153016,history,0,1
153017,of,0,0
153018,coronary,0,1
153019,artery,0,0
153020,disease,0,1
153021,.,0,0
153022,A,0,0
153023,significant,0,0
153024,rise,1,0
153025,in,1,0
153026,TnT,1,0
153027,as,0,0
153028,a,0,0
153029,sign,0,0
153030,of,0,0
153031,myocardial,1,1
153032,infarction,1,1
153033,was,0,0
153034,observed,0,0
153035,in,0,0
153036,71,0,0
153037,patients,0,0
153038,(,0,0
153039,35.5,0,0
153040,%,0,0
153041,),0,0
153042,",",0,0
153043,and,0,0
153044,25,0,0
153045,of,0,0
153046,them,0,0
153047,had,0,0
153048,a,0,0
153049,TnT,1,1
153050,elevation,1,0
153051,exceeding,0,1
153052,five,0,0
153053,times,0,0
153054,the,0,0
153055,upper,0,0
153056,normal,0,0
153057,limit,0,0
153058,.,0,1
153059,TnT,1,1
153060,elevation,1,1
153061,was,0,0
153062,observed,0,0
153063,in,0,0
153064,36,0,0
153065,patients,0,0
153066,(,0,0
153067,51,0,0
153068,%,0,0
153069,),0,0
153070,already,0,0
153071,before,0,0
153072,surgery,0,0
153073,.,0,0
153074,Seven,0,0
153075,patients,0,0
153076,(,0,0
153077,10,0,0
153078,%,0,0
153079,),0,0
153080,had,0,0
153081,ST,1,1
153082,elevation,1,1
153083,myocardial,1,1
153084,infarction,1,1
153085,",",0,0
153086,23,0,0
153087,patients,0,0
153088,(,0,0
153089,32,0,0
153090,%,0,0
153091,),0,0
153092,had,0,0
153093,new,1,0
153094,ST,1,1
153095,depressions,1,1
153096,",",0,0
153097,and,0,0
153098,21,0,0
153099,patients,0,0
153100,(,0,0
153101,30,0,0
153102,%,0,0
153103,),0,0
153104,had,0,0
153105,no,0,0
153106,new,0,1
153107,ST,0,1
153108,segment,0,1
153109,changes,0,1
153110,in,0,0
153111,the,0,0
153112,serial,0,0
153113,electrocardiographic,0,1
153114,recordings,0,1
153115,.,0,0
153116,In,0,0
153117,40,0,0
153118,patients,0,0
153119,(,0,0
153120,56,0,0
153121,%,0,0
153122,),0,0
153123,",",0,0
153124,the,0,0
153125,perioperative,0,1
153126,myocardial,0,1
153127,infarction,0,1
153128,was,0,0
153129,the,0,0
153130,first,0,0
153131,manifestation,0,0
153132,of,0,1
153133,coronary,0,1
153134,artery,0,0
153135,disease,0,1
153136,.,0,1
153137,Multivariate,0,0
153138,logistic,0,1
153139,regression,0,1
153140,revealed,0,0
153141,that,0,0
153142,old,0,0
153143,age,0,0
153144,(,0,0
153145,odds,0,0
153146,ratio,0,0
153147,[,0,0
153148,OR,0,0
153149,],0,0
153150,",",0,0
153151,1.06,0,0
153152,;,0,0
153153,95,0,0
153154,%,0,0
153155,confidence,0,0
153156,interval,0,0
153157,[,0,0
153158,CI,0,0
153159,],0,0
153160,",",0,0
153161,1.02-1.10,0,0
153162,;,0,0
153163,p,0,0
153164,=,0,0
153165,0.002,0,0
153166,),0,0
153167,",",0,0
153168,earlier,0,0
153169,revascularization,0,1
153170,(,0,1
153171,OR,0,1
153172,",",0,0
153173,3.29,0,0
153174,;,0,0
153175,95,0,0
153176,%,0,0
153177,CI,0,0
153178,1.12-9.73,0,0
153179,;,0,0
153180,p,0,0
153181,=,0,0
153182,0.03,0,0
153183,),0,0
153184,",",0,0
153185,and,0,1
153186,heart,0,1
153187,failure,0,1
153188,(,0,1
153189,OR,0,1
153190,",",0,0
153191,2.42,0,0
153192,;,0,0
153193,95,0,0
153194,%,0,0
153195,CI,0,0
153196,1.04-5.61,0,0
153197,;,0,0
153198,p,0,0
153199,=,0,0
153200,0.04,0,0
153201,),0,0
153202,were,0,0
153203,independent,0,0
153204,predictors,0,0
153205,of,0,1
153206,TnT,0,0
153207,elevation,0,1
153208,.,0,1
153209,Majority,1,0
153210,of,1,0
153211,myocardial,1,1
153212,infarctions,1,1
153213,were,0,0
153214,asymptomatic,0,1
153215,or,0,0
153216,unrecognized,0,0
153217,.,0,1
153218,Evidence-based,1,0
153219,medications,1,0
153220,of,0,1
153221,myocardial,0,1
153222,infarction,0,1
153223,were,0,0
153224,seldom,0,0
153225,started,0,0
153226,and,0,0
153227,cardiologist,0,0
153228,was,0,0
153229,consulted,0,0
153230,in,0,0
153231,12,0,0
153232,patients,0,0
153233,(,0,0
153234,16.9,0,0
153235,%,0,0
153236,),0,0
153237,.,0,0
153238,CONCLUSION,0,0
153239,Patients,0,0
153240,with,0,0
153241,hip,0,1
153242,fracture,0,0
153243,often,0,0
153244,develop,0,0
153245,asymptomatic,0,1
153246,and,0,0
153247,clinically,0,1
153248,unrecognized,0,0
153249,perioperative,0,1
153250,myocardial,0,1
153251,infarctions,0,1
153252,.,0,0
153253,Earlier,0,0
153254,diagnosis,0,1
153255,and,0,1
153256,appropriate,0,1
153257,treatment,0,0
153258,of,0,1
153259,cardiac,0,1
153260,infarction,0,0
153261,may,0,0
153262,improve,0,0
153263,survival,0,1
153264,of,0,1
153265,hip,0,1
153266,fracture,0,1
153267,patients,0,0
153268,.,0,0
153269,LEVEL,0,1
153270,OF,0,0
153271,EVIDENCE,0,1
153272,Epidemiologic,0,1
153273,study,0,0
153274,",",0,1
153275,level,0,1
153276,III,0,0
153277,.,0,0
153278,Effect,0,1
153279,of,0,1
153280,phenylephrine,0,0
153281,on,0,0
153282,the,0,0
153283,haemodynamic,1,1
153284,state,1,1
153285,and,1,1
153286,cerebral,1,1
153287,oxygen,1,1
153288,saturation,1,1
153289,during,0,0
153290,anaesthesia,0,0
153291,in,0,0
153292,the,0,0
153293,upright,0,0
153294,position,0,1
153295,.,0,0
153296,BACKGROUND,0,0
153297,The,0,0
153298,upright,0,0
153299,sitting,0,1
153300,or,0,1
153301,beachchair,0,0
153302,position,0,1
153303,is,0,0
153304,associated,0,0
153305,with,0,0
153306,hypotension,1,1
153307,",",1,1
153308,risk,1,1
153309,of,1,1
153310,cerebral,1,1
153311,hypoperfusion,1,1
153312,",",1,1
153313,and,1,1
153314,cerebral,1,1
153315,injury,1,1
153316,.,1,0
153317,We,0,0
153318,hypothesized,0,0
153319,that,0,0
153320,by,0,0
153321,increasing,0,0
153322,arterial,0,1
153323,pressure,0,1
153324,with,0,0
153325,phenylephrine,0,0
153326,administration,0,0
153327,",",0,1
153328,cerebral,1,1
153329,perfusion,1,1
153330,",",0,1
153331,and,0,1
153332,postoperative,1,1
153333,recovery,1,1
153334,would,0,0
153335,be,0,0
153336,improved,0,0
153337,.,0,0
153338,METHODS,0,0
153339,Thirty-four,0,0
153340,patients,0,0
153341,undergoing,0,0
153342,elective,0,0
153343,shoulder,0,1
153344,surgery,0,0
153345,were,0,0
153346,randomized,0,0
153347,to,0,0
153348,receive,0,0
153349,either,0,0
153350,saline,0,0
153351,or,0,1
153352,phenylephrine,0,0
153353,infusion,0,0
153354,(,0,1
153355,PE,0,1
153356,),0,0
153357,5,0,0
153358,min,0,0
153359,before,0,0
153360,being,0,0
153361,placed,0,0
153362,in,0,0
153363,the,0,0
153364,upright,0,0
153365,position,0,1
153366,.,0,0
153367,Simultaneous,0,0
153368,measurements,0,1
153369,of,0,0
153370,mean,1,1
153371,arterial,1,1
153372,pressure,1,1
153373,",",1,1
153374,cerebral,1,1
153375,oxygen,1,1
153376,saturation,1,1
153377,",",1,1
153378,middle,1,1
153379,cerebral,1,1
153380,artery,1,1
153381,velocity,1,1
153382,",",1,1
153383,and,1,1
153384,cardiac,1,1
153385,function,1,1
153386,using,1,0
153387,transthoracic,1,1
153388,echocardiography,1,0
153389,were,0,0
153390,made,0,0
153391,.,0,0
153392,Postoperative,0,1
153393,neurocognitive,1,1
153394,function,1,1
153395,was,0,0
153396,assessed,0,0
153397,.,0,0
153398,RESULTS,0,0
153399,At,0,0
153400,the,0,0
153401,commencement,0,0
153402,of,0,1
153403,PE,0,1
153404,",",0,1
153405,mean,1,1
153406,(,1,1
153407,SD,1,0
153408,),1,1
153409,cerebral,1,1
153410,oxygen,1,1
153411,saturation,1,1
153412,significantly,0,0
153413,decreased,0,0
153414,from,0,0
153415,77,0,0
153416,(,0,0
153417,10,0,0
153418,),0,0
153419,to,0,0
153420,67,0,0
153421,(,0,0
153422,13,0,0
153423,),0,0
153424,%,0,0
153425,(,0,1
153426,P=0.02,0,0
153427,),0,1
153428,",",0,0
153429,and,0,0
153430,further,0,0
153431,to,0,0
153432,59,0,0
153433,(,0,0
153434,11,0,0
153435,),0,0
153436,%,0,0
153437,on,0,0
153438,upright,0,0
153439,positioning,0,0
153440,.,0,0
153441,The,0,0
153442,level,1,1
153443,of,1,0
153444,cerebral,1,1
153445,saturation,1,1
153446,upright,1,0
153447,was,0,0
153448,not,0,0
153449,significantly,0,0
153450,different,0,0
153451,to,0,0
153452,patients,0,0
153453,receiving,0,0
153454,saline,0,0
153455,(,0,1
153456,P=0.07,0,0
153457,),0,1
153458,",",0,0
153459,with,0,0
153460,values,0,1
153461,remaining,0,0
153462,at,0,0
153463,room-air,0,0
153464,levels,0,1
153465,.,0,0
153466,Middle,1,1
153467,cerebral,1,1
153468,artery,1,1
153469,blood,1,1
153470,velocity,1,1
153471,increased,0,0
153472,by,0,0
153473,20,0,0
153474,%,0,0
153475,(,0,0
153476,P=0.04,0,0
153477,),0,0
153478,.,0,0
153479,Phenylephrine,0,0
153480,prevented,0,0
153481,hypotension,1,1
153482,in,0,0
153483,the,0,0
153484,upright,0,0
153485,position,0,1
153486,primarily,0,0
153487,by,0,0
153488,maintaining,0,1
153489,preload,0,0
153490,and,0,1
153491,increasing,0,0
153492,systemic,1,1
153493,vascular,1,1
153494,resistance,1,1
153495,(,0,1
153496,P=0.01,0,0
153497,),0,1
153498,",",0,1
153499,and,0,1
153500,was,0,0
153501,associated,0,0
153502,with,0,0
153503,a,0,0
153504,decrease,0,1
153505,in,0,0
153506,cardiac,1,1
153507,output,1,1
153508,.,1,0
153509,No,0,0
153510,postoperative,1,1
153511,neurocognitive,1,1
153512,dysfunction,1,1
153513,was,0,0
153514,identified,0,0
153515,.,0,0
153516,CONCLUSIONS,0,0
153517,Despite,0,0
153518,maintaining,0,1
153519,arterial,0,1
153520,pressure,0,1
153521,with,0,0
153522,phenylephrine,0,0
153523,",",0,1
153524,cerebral,1,1
153525,desaturation,1,1
153526,occurred,0,0
153527,with,0,0
153528,upright,0,0
153529,positioning,0,0
153530,.,0,0
153531,Cerebral,1,1
153532,oxygen,1,1
153533,saturation,1,1
153534,can,0,0
153535,provide,0,0
153536,a,0,0
153537,valuable,0,0
153538,endpoint,0,1
153539,when,0,0
153540,evaluating,0,0
153541,the,0,0
153542,effect,0,0
153543,of,0,1
153544,vasopressor,0,1
153545,therapy,0,0
153546,on,0,0
153547,cerebral,0,1
153548,perfusion,0,0
153549,.,0,0
153550,Acute,0,1
153551,effects,0,1
153552,of,0,0
153553,different,0,0
153554,stretching,0,0
153555,durations,0,0
153556,on,0,0
153557,passive,1,1
153558,torque,1,1
153559,",",1,1
153560,mobility,1,1
153561,",",1,1
153562,and,1,1
153563,isometric,1,1
153564,muscle,1,1
153565,force,1,1
153566,.,1,1
153567,Static,0,1
153568,stretching,0,0
153569,is,0,0
153570,widely,0,0
153571,applied,0,0
153572,in,0,0
153573,various,0,0
153574,disciplines,0,0
153575,.,0,0
153576,However,0,0
153577,",",0,0
153578,the,0,0
153579,acute,0,0
153580,effects,0,1
153581,of,0,0
153582,different,0,0
153583,durations,0,0
153584,of,0,0
153585,stretching,0,0
153586,are,0,0
153587,unclear,0,0
153588,.,0,0
153589,Therefore,0,0
153590,",",0,0
153591,this,0,0
153592,study,0,0
153593,was,0,0
153594,designed,0,0
153595,to,0,0
153596,investigate,0,0
153597,the,0,0
153598,acute,0,0
153599,effects,0,1
153600,of,0,0
153601,different,0,0
153602,stretching,0,0
153603,durations,0,1
153604,on,0,0
153605,muscle,0,1
153606,function,0,1
153607,and,0,1
153608,flexibility,0,1
153609,",",0,0
153610,and,0,1
153611,provide,0,0
153612,an,0,0
153613,insight,0,0
153614,into,0,0
153615,the,0,0
153616,optimal,0,0
153617,duration,0,1
153618,of,0,1
153619,static,0,0
153620,stretching,0,0
153621,.,0,0
153622,This,0,0
153623,randomized,0,0
153624,crossover,0,0
153625,trial,0,0
153626,included,0,0
153627,24,0,0
153628,healthy,0,0
153629,students,0,0
153630,(,0,0
153631,17,0,0
153632,men,0,0
153633,and,0,0
153634,7,0,0
153635,women,0,0
153636,),0,0
153637,who,0,0
153638,stretched,0,0
153639,their,0,0
153640,right,0,1
153641,hamstrings,0,1
153642,for,0,0
153643,durations,0,0
153644,of,0,0
153645,20,0,0
153646,",",0,0
153647,60,0,0
153648,",",0,0
153649,180,0,0
153650,",",0,0
153651,and,0,0
153652,300,0,0
153653,seconds,0,0
153654,in,0,0
153655,a,0,0
153656,random,0,0
153657,order,0,0
153658,.,0,0
153659,The,0,0
153660,following,0,0
153661,outcomes,0,1
153662,were,0,0
153663,assessed,0,0
153664,using,0,0
153665,an,0,0
153666,isokinetic,0,0
153667,dynamometer,0,0
153668,as,0,0
153669,markers,0,1
153670,of,0,0
153671,lower-limb,1,1
153672,function,1,1
153673,and,1,1
153674,flexibility,1,1
153675,:,1,0
153676,static,1,1
153677,passive,1,1
153678,torque,1,1
153679,(,1,1
153680,SPT,1,1
153681,),1,1
153682,",",1,0
153683,dynamic,1,1
153684,passive,1,1
153685,torque,1,1
153686,(,1,1
153687,DPT,1,1
153688,),1,1
153689,",",1,1
153690,stiffness,1,1
153691,",",1,1
153692,straight,1,1
153693,leg,1,1
153694,raise,1,0
153695,(,1,1
153696,SLR,1,0
153697,),1,1
153698,",",1,0
153699,and,1,1
153700,isometric,1,1
153701,muscle,1,1
153702,force,1,1
153703,.,1,1
153704,Static,1,1
153705,passive,1,1
153706,torque,1,1
153707,was,0,0
153708,significantly,0,0
153709,decreased,0,0
153710,after,0,0
153711,all,0,0
153712,stretching,0,0
153713,durations,0,1
153714,(,0,0
153715,p,0,0
153716,<,0,0
153717,0.05,0,0
153718,),0,0
153719,.,0,0
153720,Static,1,1
153721,passive,1,1
153722,torque,1,1
153723,was,0,0
153724,significantly,0,0
153725,lower,0,0
153726,after,0,0
153727,60,0,0
153728,",",0,0
153729,180,0,0
153730,",",0,0
153731,and,0,0
153732,300,0,0
153733,seconds,0,0
153734,of,0,0
153735,stretching,0,0
153736,compared,0,0
153737,with,0,0
153738,that,0,0
153739,after,0,0
153740,20-second,0,0
153741,stretching,0,0
153742,",",0,1
153743,and,0,1
153744,stiffness,0,1
153745,decreased,0,1
153746,significantly,0,0
153747,after,0,0
153748,180-,0,0
153749,and,0,1
153750,300-second,0,1
153751,stretching,0,1
153752,(,0,0
153753,p,0,0
153754,<,0,0
153755,0.05,0,0
153756,),0,0
153757,.,0,0
153758,In,0,0
153759,addition,0,0
153760,",",0,1
153761,DPT,1,1
153762,and,1,1
153763,stiffness,1,1
153764,were,0,0
153765,significantly,0,0
153766,lower,0,0
153767,after,0,0
153768,300,0,0
153769,seconds,0,0
153770,than,0,0
153771,after,0,0
153772,20-second,0,0
153773,stretching,0,0
153774,(,0,0
153775,p,0,0
153776,<,0,0
153777,0.05,0,0
153778,),0,0
153779,",",0,0
153780,and,0,1
153781,SLR,1,1
153782,increased,0,0
153783,significantly,0,0
153784,after,0,0
153785,all,0,0
153786,stretching,0,0
153787,durations,0,1
153788,(,0,0
153789,p,0,0
153790,<,0,0
153791,0.05,0,0
153792,),0,0
153793,.,0,0
153794,Straight,1,0
153795,leg,1,1
153796,raise,1,0
153797,was,0,0
153798,higher,1,0
153799,after,0,0
153800,180-,0,0
153801,and,0,1
153802,300-second,0,1
153803,stretching,0,0
153804,than,0,0
153805,after,0,0
153806,20-second,0,0
153807,stretching,0,0
153808,and,0,1
153809,higher,0,0
153810,after,0,0
153811,300-second,0,1
153812,stretching,0,0
153813,than,0,0
153814,after,0,0
153815,60-second,0,0
153816,stretching,0,0
153817,(,0,0
153818,p,0,0
153819,<,0,0
153820,0.05,0,0
153821,),0,0
153822,.,0,0
153823,Isometric,1,1
153824,muscle,1,1
153825,force,1,1
153826,significantly,1,0
153827,decreased,1,0
153828,after,0,0
153829,all,0,0
153830,stretching,0,0
153831,durations,0,1
153832,(,0,0
153833,p,0,0
153834,<,0,0
153835,0.05,0,0
153836,),0,0
153837,.,0,0
153838,Therefore,0,0
153839,",",0,0
153840,increased,0,1
153841,duration,0,1
153842,of,0,0
153843,stretching,0,0
153844,is,0,0
153845,associated,0,0
153846,with,0,0
153847,a,0,0
153848,decrease,0,1
153849,in,0,0
153850,SPT,1,1
153851,but,0,0
153852,an,0,0
153853,increase,0,1
153854,in,0,0
153855,SLR,1,0
153856,.,1,0
153857,Over,0,0
153858,180,0,0
153859,seconds,0,0
153860,of,0,0
153861,stretching,0,0
153862,was,0,0
153863,required,0,0
153864,to,0,0
153865,decrease,0,1
153866,DPT,1,1
153867,and,1,1
153868,stiffness,1,1
153869,",",0,1
153870,but,0,0
153871,isometric,1,1
153872,muscle,1,1
153873,force,1,1
153874,decreased,0,1
153875,regardless,0,0
153876,of,0,0
153877,the,0,0
153878,stretching,0,0
153879,duration,0,1
153880,.,0,0
153881,In,0,0
153882,conclusion,0,0
153883,",",0,0
153884,these,0,0
153885,results,0,0
153886,indicate,0,0
153887,that,0,0
153888,longer,0,0
153889,durations,0,1
153890,of,0,0
153891,stretching,0,0
153892,are,0,0
153893,needed,0,0
153894,to,0,0
153895,provide,0,0
153896,better,0,0
153897,flexibility,0,1
153898,.,0,0
153899,Randomized,0,0
153900,",",0,1
153901,controlled,0,0
153902,",",0,1
153903,parallel-group,0,0
153904,trial,0,0
153905,of,0,1
153906,routine,0,0
153907,prophylaxis,0,0
153908,vs.,0,0
153909,on-demand,0,0
153910,treatment,0,0
153911,with,0,0
153912,sucrose-formulated,0,0
153913,recombinant,0,0
153914,factor,0,1
153915,VIII,0,0
153916,in,0,0
153917,adults,0,0
153918,with,0,0
153919,severe,0,1
153920,hemophilia,0,1
153921,A,0,0
153922,(,0,1
153923,SPINART,0,0
153924,),0,0
153925,.,0,0
153926,BACKGROUND,0,0
153927,The,0,0
153928,benefits,0,0
153929,of,0,0
153930,routine,0,0
153931,prophylaxis,0,0
153932,vs.,0,0
153933,on-demand,0,0
153934,treatment,0,0
153935,with,0,0
153936,factor,0,1
153937,VIII,0,0
153938,products,0,0
153939,have,0,0
153940,not,0,0
153941,been,0,0
153942,evaluated,0,0
153943,in,0,0
153944,controlled,0,0
153945,clinical,0,0
153946,trials,0,0
153947,in,0,0
153948,older,0,0
153949,patients,0,0
153950,with,0,0
153951,hemophilia,0,0
153952,A,0,0
153953,.,0,0
153954,OBJECTIVES,0,0
153955,To,0,0
153956,report,0,0
153957,results,0,0
153958,from,0,0
153959,a,0,0
153960,preplanned,0,0
153961,analysis,0,0
153962,of,0,0
153963,data,0,0
153964,from,0,0
153965,the,0,0
153966,first,0,0
153967,year,0,0
153968,of,0,0
153969,the,0,0
153970,3-year,0,0
153971,SPINART,0,0
153972,study,0,0
153973,",",0,0
153974,which,0,0
153975,compares,0,0
153976,routine,0,0
153977,prophylaxis,0,0
153978,with,0,0
153979,on-demand,0,0
153980,treatment,0,0
153981,with,0,0
153982,sucrose-formulated,0,0
153983,recombinant,0,0
153984,FVIII,0,0
153985,(,0,1
153986,rFVIII-FS,0,0
153987,),0,0
153988,.,0,0
153989,PATIENTS/METHODS,0,0
153990,SPINART,0,0
153991,is,0,0
153992,an,0,0
153993,open-label,0,0
153994,",",0,0
153995,randomized,0,0
153996,",",0,0
153997,controlled,0,0
153998,",",0,1
153999,parallel-group,0,0
154000,",",0,1
154001,multinational,0,0
154002,trial,0,0
154003,.,0,0
154004,Males,0,0
154005,aged,0,0
154006,12-50,0,0
154007,years,0,0
154008,with,0,0
154009,severe,0,1
154010,hemophilia,0,1
154011,A,0,0
154012,",",0,0
154013,?,0,0
154014,150,0,0
154015,days,0,0
154016,of,0,0
154017,exposure,0,0
154018,to,0,0
154019,FVIII,0,0
154020,",",0,0
154021,no,0,0
154022,FVIII,0,0
154023,inhibitors,0,1
154024,",",0,0
154025,no,0,0
154026,prophylaxis,0,0
154027,for,0,0
154028,>,0,0
154029,12,0,0
154030,consecutive,0,0
154031,months,0,0
154032,in,0,0
154033,the,0,0
154034,past,0,0
154035,5,0,0
154036,years,0,0
154037,and,0,0
154038,6-24,0,0
154039,bleeding,0,1
154040,episodes,0,1
154041,in,0,0
154042,the,0,0
154043,preceding,0,0
154044,6,0,0
154045,months,0,0
154046,were,0,0
154047,randomized,0,0
154048,1,0,0
154049,:,0,0
154050,1,0,0
154051,to,0,0
154052,rFVIII-FS,0,0
154053,prophylaxis,0,0
154054,(,0,0
154055,25,0,0
154056,IU,0,0
154057,kg,0,0
154058,(,0,1
154059,-1,0,0
154060,),0,0
154061,",",0,0
154062,three,0,0
154063,times,0,1
154064,weekly,0,0
154065,),0,0
154066,or,0,0
154067,on-demand,0,0
154068,treatment,0,0
154069,.,0,0
154070,The,0,0
154071,primary,0,0
154072,efficacy,0,1
154073,endpoint,1,1
154074,",",1,1
154075,number,1,1
154076,of,1,1
154077,total,1,1
154078,bleeding,1,1
154079,episodes,1,1
154080,in,1,0
154081,the,0,0
154082,intent-to-treat,0,0
154083,population,0,0
154084,",",0,1
154085,was,0,0
154086,analyzed,0,0
154087,after,0,0
154088,the,0,0
154089,last,0,1
154090,patient,0,1
154091,had,0,0
154092,completed,0,0
154093,1,0,0
154094,year,0,0
154095,of,0,0
154096,follow-up,0,0
154097,.,0,0
154098,A,0,0
154099,negative,0,1
154100,binomial,0,1
154101,model,0,0
154102,was,0,0
154103,used,0,0
154104,for,0,0
154105,the,0,0
154106,primary,0,0
154107,endpoint,0,1
154108,analysis,0,0
154109,;,0,0
154110,analysis,0,0
154111,of,0,1
154112,variance,0,1
154113,was,0,0
154114,used,0,0
154115,for,0,0
154116,confirmatory,0,0
154117,analysis,0,0
154118,of,0,1
154119,annualized,0,1
154120,bleeding,0,1
154121,rates,0,1
154122,.,0,0
154123,RESULTS,0,0
154124,Eighty-four,0,0
154125,patients,0,0
154126,were,0,0
154127,enrolled,0,0
154128,and,0,1
154129,analyzed,0,0
154130,(,0,0
154131,n,0,0
154132,=,0,0
154133,42,0,0
154134,per,0,0
154135,group,0,0
154136,;,0,0
154137,mean,0,1
154138,age,0,0
154139,",",0,0
154140,30.6,0,0
154141,years,0,0
154142,;,0,0
154143,median,0,1
154144,treatment,0,0
154145,duration,0,1
154146,",",0,0
154147,1.7,0,0
154148,years,0,0
154149,),0,0
154150,.,0,0
154151,The,0,0
154152,median,0,1
154153,number,0,1
154154,of,0,1
154155,total,1,1
154156,bleeding,1,1
154157,episodes,1,1
154158,and,1,1
154159,total,1,1
154160,bleeding,1,1
154161,episodes,1,1
154162,per,0,1
154163,year,0,0
154164,were,0,0
154165,significantly,0,0
154166,lower,0,0
154167,with,0,0
154168,prophylaxis,0,0
154169,than,0,0
154170,with,0,0
154171,on-demand,0,0
154172,treatment,0,0
154173,(,0,1
154174,total,0,1
154175,",",0,0
154176,0,0,0
154177,vs.,0,0
154178,54.5,0,0
154179,;,0,0
154180,total,0,0
154181,per,0,0
154182,year,0,0
154183,",",0,0
154184,0,0,0
154185,vs.,0,0
154186,27.9,0,0
154187,;,0,0
154188,both,0,0
154189,P,0,0
154190,<,0,0
154191,0.0001,0,0
154192,),0,0
154193,.,0,0
154194,No,0,0
154195,treatment-related,0,1
154196,adverse,0,1
154197,events,0,1
154198,occurred,0,0
154199,",",0,0
154200,and,0,0
154201,no,0,0
154202,patients,0,0
154203,developed,0,0
154204,FVIII,0,0
154205,inhibitors,0,1
154206,.,0,0
154207,CONCLUSIONS,0,0
154208,Routine,0,0
154209,prophylaxis,0,0
154210,with,0,0
154211,rFVIII-FS,0,0
154212,leads,0,0
154213,to,0,0
154214,a,0,0
154215,significant,0,0
154216,reduction,0,1
154217,in,0,0
154218,bleeding,0,1
154219,as,0,0
154220,compared,0,0
154221,with,0,0
154222,on-demand,0,0
154223,treatment,0,0
154224,.,0,0
154225,Adverse,0,1
154226,events,0,1
154227,were,0,0
154228,consistent,0,0
154229,with,0,0
154230,the,0,0
154231,established,0,0
154232,rFVIII-FS,0,0
154233,safety,0,1
154234,profile,0,1
154235,.,0,0
154236,Erythropoietin,0,0
154237,treatment,0,0
154238,in,0,0
154239,chemotherapy-induced,0,0
154240,anemia,0,1
154241,in,0,0
154242,previously,0,0
154243,untreated,0,0
154244,advanced,0,0
154245,esophagogastric,0,0
154246,cancer,0,0
154247,patients,0,0
154248,.,0,0
154249,BACKGROUND,0,0
154250,The,0,0
154251,impact,0,0
154252,of,0,0
154253,erythropoiesis-stimulating,0,0
154254,agents,0,0
154255,in,0,0
154256,chemotherapy-induced,0,0
154257,anemia,0,1
154258,has,0,0
154259,been,0,0
154260,a,0,0
154261,constant,0,0
154262,topic,0,0
154263,of,0,1
154264,debate,0,0
154265,over,0,0
154266,recent,0,0
154267,years,0,0
154268,.,0,0
154269,We,0,0
154270,prospectively,0,0
154271,assessed,0,0
154272,the,0,0
154273,efficacy,0,1
154274,of,0,1
154275,epoetin,0,0
154276,beta,0,1
154277,(,0,1
154278,Epo-b,0,1
154279,),0,0
154280,in,0,0
154281,improving,0,1
154282,hemoglobin,1,1
154283,(,1,1
154284,Hb,1,1
154285,),1,1
154286,levels,1,1
154287,and,0,1
154288,outcome,0,1
154289,in,0,0
154290,patients,0,0
154291,within,0,0
154292,an,0,0
154293,open,0,0
154294,label,0,0
154295,",",0,1
154296,randomized,0,0
154297,clinical,0,1
154298,phase,0,0
154299,II,0,0
154300,trial,0,0
154301,with,0,0
154302,advanced,0,0
154303,or,0,0
154304,metastatic,0,0
154305,gastric/esophagogastric,0,0
154306,cancer,0,0
154307,.,0,0
154308,METHODS,0,0
154309,Previously,0,0
154310,untreated,0,0
154311,patients,0,0
154312,were,0,0
154313,randomized,0,0
154314,to,0,0
154315,receive,0,0
154316,3-weekly,0,0
154317,cycles,0,0
154318,of,0,1
154319,capecitabine,0,0
154320,(,0,0
154321,1000,0,0
154322,mg/m,0,0
154323,(,0,0
154324,2,0,0
154325,),0,0
154326,bid,0,0
154327,),0,0
154328,for,0,0
154329,14,0,0
154330,days,0,0
154331,plus,0,0
154332,on,0,0
154333,day,0,0
154334,1,0,0
154335,either,0,0
154336,irinotecan,0,0
154337,250,0,0
154338,mg/m,0,0
154339,(,0,0
154340,2,0,0
154341,),0,0
154342,or,0,0
154343,cisplatin,0,0
154344,80,0,0
154345,mg/m,0,0
154346,(,0,0
154347,2,0,0
154348,),0,0
154349,.,0,0
154350,Epo-b,0,1
154351,(,0,0
154352,30000,0,0
154353,IU,0,0
154354,once,0,0
154355,weekly,0,0
154356,),0,0
154357,was,0,0
154358,initiated,0,0
154359,in,0,0
154360,patients,0,0
154361,with,0,0
154362,Hb,0,1
154363,<,0,0
154364,11,0,0
154365,g/dl,0,1
154366,and,0,0
154367,continued,0,0
154368,until,0,0
154369,Hb,0,1
154370,?12,0,0
154371,g/dl,0,1
154372,was,0,0
154373,reached,0,0
154374,.,0,0
154375,If,0,0
154376,after,0,0
154377,4,0,0
154378,weeks,0,0
154379,the,1,0
154380,Hb,1,1
154381,increase,1,1
154382,was,0,0
154383,<,0,0
154384,0.5,0,0
154385,g/dl,0,1
154386,",",0,0
154387,Epo-b,0,1
154388,was,0,0
154389,increased,0,0
154390,to,0,0
154391,30000,0,0
154392,IU,0,0
154393,",",0,0
154394,twice,0,0
154395,weekly,0,0
154396,.,0,0
154397,RESULTS,0,0
154398,Of,0,0
154399,118,0,0
154400,patients,0,0
154401,enrolled,0,0
154402,",",0,0
154403,32,0,0
154404,received,0,0
154405,Epo-b,0,0
154406,treatment,0,0
154407,;,0,0
154408,of,0,0
154409,these,0,0
154410,",",0,0
154411,65,0,0
154412,%,0,0
154413,achieved,0,0
154414,an,0,0
154415,increase,0,0
154416,in,0,0
154417,Hb,1,1
154418,levels,1,1
154419,of,1,0
154420,at,0,0
154421,least,0,0
154422,2,0,0
154423,g/dl,0,1
154424,",",0,0
154425,with,0,0
154426,74,0,0
154427,%,0,0
154428,achieving,0,0
154429,the,0,0
154430,target,0,0
154431,Hb,0,1
154432,of,0,1
154433,?12,0,0
154434,g/dl,0,1
154435,.,0,0
154436,Within,0,0
154437,the,0,0
154438,study,0,0
154439,population,0,0
154440,",",0,1
154441,patients,0,0
154442,receiving,0,0
154443,Epo-b,0,1
154444,showed,0,0
154445,better,1,0
154446,overall,1,1
154447,survival,1,1
154448,(,1,0
154449,median,1,0
154450,14.5,0,0
154451,vs.,0,0
154452,8.0,0,0
154453,months,0,0
154454,",",0,0
154455,P,0,0
154456,=,0,0
154457,0.056,0,0
154458,),0,0
154459,as,0,0
154460,well,0,0
154461,as,0,0
154462,a,0,0
154463,significantly,0,0
154464,improved,1,0
154465,disease,1,1
154466,control,1,0
154467,rate,1,1
154468,(,1,0
154469,78,1,0
154470,vs.,0,0
154471,55,0,0
154472,%,0,0
154473,",",0,0
154474,P,0,0
154475,=,0,0
154476,0.025,0,0
154477,),0,0
154478,.,0,0
154479,Patients,0,0
154480,in,0,0
154481,the,0,0
154482,irinotecan,0,0
154483,group,0,0
154484,profited,0,0
154485,significantly,0,0
154486,(,0,0
154487,P,0,0
154488,<,0,0
154489,0.05,0,0
154490,),0,0
154491,in,0,0
154492,terms,1,1
154493,of,1,0
154494,progression-free,1,1
154495,survival,1,1
154496,and,1,1
154497,overall,1,1
154498,survival,1,1
154499,under,1,0
154500,Epo-b,0,1
154501,treatment,0,0
154502,(,0,0
154503,median,0,0
154504,6.5,0,0
154505,vs,0,0
154506,4.1,0,0
154507,months,0,0
154508,and,0,0
154509,median,0,0
154510,15.4,0,0
154511,vs,0,0
154512,8.4,0,0
154513,months,0,0
154514,",",0,0
154515,respectively,0,0
154516,),0,0
154517,.,0,0
154518,CONCLUSIONS,0,0
154519,Epo-b,0,1
154520,was,0,0
154521,effective,0,1
154522,in,0,0
154523,raising,1,0
154524,Hb,1,1
154525,levels,1,1
154526,in,1,0
154527,patients,0,0
154528,with,0,0
154529,advanced,0,0
154530,esophagogastric,0,0
154531,cancer,0,0
154532,.,0,0
154533,Patients,0,0
154534,receiving,0,0
154535,Epo-b,0,1
154536,had,0,0
154537,a,0,0
154538,significantly,0,0
154539,increased,1,0
154540,response,1,1
154541,to,1,0
154542,chemotherapy,1,0
154543,and,1,0
154544,a,0,0
154545,clear,0,0
154546,trend,0,0
154547,to,0,0
154548,improved,1,0
154549,survival,1,1
154550,.,1,0
154551,Successful,0,0
154552,treatment,0,0
154553,of,0,1
154554,depressed,0,1
154555,",",0,0
154556,distensible,0,1
154557,acne,0,1
154558,scars,0,1
154559,using,0,0
154560,autologous,0,0
154561,fibroblasts,0,1
154562,:,0,0
154563,a,0,0
154564,multi-site,0,0
154565,",",0,0
154566,prospective,0,0
154567,",",0,1
154568,double,0,0
154569,blind,0,0
154570,",",0,1
154571,placebo-controlled,0,0
154572,clinical,0,0
154573,trial,0,0
154574,.,0,0
154575,BACKGROUND,0,0
154576,A,0,0
154577,previous,0,0
154578,clinical,0,0
154579,trial,0,0
154580,evaluating,0,0
154581,autologous,0,0
154582,fibroblasts,0,1
154583,(,0,0
154584,human,0,0
154585,dermal,0,1
154586,),0,0
154587,injections,0,0
154588,for,0,0
154589,the,0,0
154590,treatment,0,0
154591,of,0,0
154592,facial,0,1
154593,contour,0,1
154594,deformities,0,1
154595,found,0,0
154596,significantly,0,0
154597,greater,0,0
154598,improvements,0,1
154599,in,0,1
154600,wrinkle,1,1
154601,and,1,1
154602,acne,1,1
154603,scar,1,1
154604,appearance,1,1
154605,than,0,0
154606,with,0,0
154607,placebo,0,0
154608,treatment,0,0
154609,.,0,0
154610,OBJECTIVE,0,0
154611,To,0,0
154612,compare,0,0
154613,the,0,0
154614,efficacy,0,1
154615,and,0,1
154616,safety,0,1
154617,of,0,1
154618,autologous,0,0
154619,fibroblast,0,1
154620,treatment,0,0
154621,of,0,0
154622,moderate,0,0
154623,to,0,0
154624,severe,0,1
154625,",",0,0
154626,depressed,0,1
154627,",",0,1
154628,distensible,0,1
154629,facial,0,1
154630,acne,0,1
154631,scars,0,1
154632,with,0,0
154633,that,0,0
154634,of,0,0
154635,vehicle,0,0
154636,control,0,0
154637,.,0,0
154638,METHODS,0,0
154639,This,0,0
154640,was,0,0
154641,a,0,0
154642,randomized,0,0
154643,multicenter,0,0
154644,",",0,1
154645,double-blind,0,0
154646,",",0,1
154647,placebo-controlled,0,0
154648,trial,0,0
154649,in,0,0
154650,subjects,0,0
154651,with,0,0
154652,bilateral,0,0
154653,moderate,0,0
154654,to,0,0
154655,severe,0,1
154656,acne,0,1
154657,scarring,0,1
154658,;,0,0
154659,subjects,0,0
154660,served,0,0
154661,as,0,0
154662,their,0,0
154663,own,0,0
154664,controls,0,0
154665,.,0,0
154666,Skin,0,1
154667,biopsies,0,1
154668,were,0,0
154669,obtained,0,0
154670,from,0,0
154671,randomized,0,0
154672,subjects,0,0
154673,for,0,0
154674,fibroblast,0,1
154675,production,0,1
154676,.,0,1
154677,Subjects,0,0
154678,(,0,0
154679,n,0,0
154680,=,0,0
154681,99,0,0
154682,),0,0
154683,underwent,0,0
154684,three,0,0
154685,intradermal,0,0
154686,injection,0,0
154687,sessions,0,0
154688,with,0,0
154689,2,0,0
154690,mL,0,0
154691,of,0,0
154692,autologous,0,0
154693,fibroblast,0,1
154694,suspension,0,0
154695,(,0,0
154696,10-20,0,0
154697,million,0,0
154698,cells/mL,0,0
154699,),0,0
154700,on,0,0
154701,one,0,0
154702,cheek,0,1
154703,and,0,0
154704,vehicle,0,0
154705,control,0,0
154706,(,0,1
154707,cell,0,1
154708,culture,0,1
154709,medium,0,0
154710,),0,0
154711,on,0,0
154712,the,0,0
154713,other,0,0
154714,at,0,0
154715,14-day,0,0
154716,intervals,0,0
154717,.,0,1
154718,Efficacy,0,1
154719,was,0,0
154720,based,0,0
154721,on,0,0
154722,the,0,0
154723,blinded,0,0
154724,subject,1,0
154725,'s,1,1
154726,",",1,0
154727,evaluator,1,1
154728,'s,1,1
154729,",",1,1
154730,and,1,1
154731,independent,1,1
154732,photographic,1,1
154733,viewer,1,0
154734,'s,1,1
154735,(,1,0
154736,IPR,1,1
154737,),1,1
154738,assessment,1,0
154739,of,1,1
154740,acne,1,1
154741,scarring,1,1
154742,1,0,0
154743,to,0,0
154744,4,0,0
154745,months,0,0
154746,after,0,0
154747,the,0,0
154748,last,0,0
154749,treatment,0,0
154750,.,0,0
154751,RESULTS,0,0
154752,Autologous,0,0
154753,fibroblast,0,1
154754,treatment,0,0
154755,was,0,0
154756,associated,0,0
154757,with,0,0
154758,significantly,0,0
154759,greater,0,0
154760,treatment,0,0
154761,success,0,1
154762,than,0,0
154763,vehicle,0,0
154764,control,0,0
154765,for,0,0
154766,the,0,0
154767,subject,0,0
154768,(,0,0
154769,43,0,0
154770,%,0,0
154771,vs.18,0,0
154772,%,0,0
154773,),0,1
154774,",",0,1
154775,evaluator,0,1
154776,(,0,0
154777,59,0,0
154778,%,0,0
154779,vs.,0,0
154780,2,0,0
154781,%,0,0
154782,),0,0
154783,",",0,1
154784,and,0,1
154785,IPR,0,1
154786,assessments,0,0
154787,.,0,0
154788,Autologous,0,0
154789,fibroblast,0,1
154790,injections,0,0
154791,were,0,0
154792,well,0,1
154793,tolerated,0,1
154794,",",0,0
154795,without,0,0
154796,permanent,0,1
154797,adverse,0,1
154798,effects,0,1
154799,.,0,0
154800,CONCLUSIONS,0,0
154801,Autologous,0,0
154802,fibroblast,0,1
154803,injections,0,0
154804,safely,0,0
154805,and,0,0
154806,effectively,0,0
154807,improved,0,0
154808,the,0,0
154809,appearance,1,1
154810,of,1,0
154811,depressed,1,1
154812,distensible,1,1
154813,acne,1,1
154814,scars,1,1
154815,.,1,0
154816,Altered,0,0
154817,accuracy,0,1
154818,of,0,1
154819,saccadic,0,1
154820,eye,0,0
154821,movements,0,1
154822,in,0,0
154823,children,0,0
154824,with,0,0
154825,fetal,0,1
154826,alcohol,0,1
154827,spectrum,0,0
154828,disorder,0,0
154829,.,0,1
154830,BACKGROUND,0,0
154831,Prenatal,0,0
154832,exposure,0,0
154833,to,0,0
154834,alcohol,0,0
154835,is,0,0
154836,a,0,0
154837,major,0,1
154838,",",0,0
154839,preventable,0,1
154840,cause,0,1
154841,of,0,1
154842,neurobehavioral,0,1
154843,dysfunction,0,1
154844,in,0,0
154845,children,0,0
154846,worldwide,0,0
154847,.,0,0
154848,The,0,0
154849,measurement,0,1
154850,and,0,1
154851,quantification,0,1
154852,of,0,1
154853,saccadic,0,1
154854,eye,0,0
154855,movements,0,1
154856,is,0,0
154857,a,0,0
154858,powerful,0,0
154859,tool,0,0
154860,for,0,0
154861,assessing,0,0
154862,sensory,0,1
154863,",",0,1
154864,motor,0,1
154865,",",0,1
154866,and,0,1
154867,cognitive,0,1
154868,function,0,1
154869,.,0,0
154870,The,0,0
154871,quality,0,1
154872,of,0,0
154873,the,0,0
154874,motor,0,1
154875,process,0,0
154876,of,0,0
154877,an,0,0
154878,eye,0,0
154879,movement,0,1
154880,is,0,0
154881,known,0,0
154882,as,0,0
154883,saccade,0,1
154884,metrics,0,0
154885,.,0,1
154886,Saccade,0,1
154887,accuracy,0,0
154888,is,0,0
154889,1,0,0
154890,component,0,0
154891,of,0,0
154892,metrics,0,1
154893,",",0,0
154894,which,0,0
154895,to,0,0
154896,function,0,1
154897,optimally,0,0
154898,requires,0,0
154899,several,0,0
154900,cortical,0,1
154901,brain,0,1
154902,structures,0,0
154903,as,0,0
154904,well,0,0
154905,as,0,0
154906,an,0,0
154907,intact,0,1
154908,cerebellum,0,1
154909,and,0,1
154910,brain-stem,0,1
154911,.,0,0
154912,The,0,0
154913,cerebellum,0,0
154914,has,0,0
154915,frequently,0,0
154916,been,0,0
154917,reported,0,0
154918,to,0,0
154919,be,0,0
154920,damaged,0,0
154921,by,0,0
154922,prenatal,0,0
154923,alcohol,0,1
154924,exposure,0,0
154925,.,0,0
154926,This,0,0
154927,study,0,0
154928,",",0,0
154929,therefore,0,0
154930,",",0,0
154931,tested,0,0
154932,the,0,0
154933,hypothesis,0,0
154934,that,0,0
154935,children,0,0
154936,with,0,0
154937,fetal,0,1
154938,alcohol,0,1
154939,spectrum,0,1
154940,disorder,0,0
154941,(,0,1
154942,FASD,0,0
154943,),0,0
154944,will,0,0
154945,exhibit,0,0
154946,deficits,0,0
154947,in,0,0
154948,the,0,0
154949,accuracy,0,1
154950,of,0,0
154951,saccades,0,1
154952,.,0,0
154953,METHODS,0,0
154954,A,0,0
154955,group,0,0
154956,of,0,0
154957,children,0,0
154958,with,0,0
154959,FASD,0,0
154960,(,0,0
154961,n,0,0
154962,=,0,0
154963,27,0,0
154964,),0,0
154965,between,0,0
154966,the,0,0
154967,ages,0,0
154968,of,0,0
154969,8,0,0
154970,and,0,0
154971,16,0,0
154972,and,0,0
154973,typically,0,0
154974,developing,0,0
154975,control,0,0
154976,children,0,0
154977,(,0,0
154978,n,0,0
154979,=,0,0
154980,27,0,0
154981,),0,0
154982,matched,0,0
154983,for,0,0
154984,age,0,0
154985,and,0,1
154986,sex,0,1
154987,",",0,1
154988,completed,0,0
154989,3,0,0
154990,saccadic,0,1
154991,eye,0,0
154992,movement,0,1
154993,tasks,0,1
154994,of,0,1
154995,increasing,0,0
154996,difficulty,0,1
154997,.,0,1
154998,Eye,0,1
154999,movement,0,1
155000,performance,0,1
155001,during,0,0
155002,the,0,0
155003,tasks,0,1
155004,was,0,0
155005,captured,0,0
155006,using,0,0
155007,an,0,0
155008,infrared,0,0
155009,eye,0,0
155010,tracker,0,0
155011,.,0,0
155012,Saccade,1,1
155013,metrics,1,1
155014,(,1,1
155015,e.g.,1,1
155016,",",0,1
155017,velocity,1,1
155018,",",1,1
155019,amplitude,1,1
155020,",",1,1
155021,accuracy,1,1
155022,),1,1
155023,were,0,0
155024,quantified,0,0
155025,and,0,0
155026,compared,0,0
155027,between,0,0
155028,the,0,0
155029,2,0,0
155030,groups,0,0
155031,for,0,0
155032,the,0,0
155033,3,0,0
155034,different,0,0
155035,tasks,0,0
155036,.,0,0
155037,RESULTS,0,0
155038,Children,0,0
155039,with,0,0
155040,FASD,0,0
155041,were,0,0
155042,more,0,0
155043,variable,0,1
155044,in,0,0
155045,saccade,1,1
155046,endpoint,1,1
155047,accuracy,1,1
155048,",",0,1
155049,which,0,0
155050,was,0,0
155051,reflected,0,0
155052,by,0,0
155053,statistically,0,0
155054,significant,0,0
155055,increases,0,0
155056,in,0,0
155057,the,0,0
155058,error,0,0
155059,of,0,0
155060,the,0,0
155061,initial,1,0
155062,saccade,1,1
155063,endpoint,1,1
155064,and,0,0
155065,the,0,0
155066,frequency,0,1
155067,of,0,1
155068,additional,0,0
155069,",",0,0
155070,corrective,1,1
155071,saccades,1,1
155072,required,0,0
155073,to,0,0
155074,achieve,0,0
155075,final,0,1
155076,fixation,0,1
155077,.,0,0
155078,This,0,0
155079,increased,0,0
155080,variability,0,1
155081,in,0,0
155082,accuracy,1,1
155083,was,0,0
155084,amplified,0,0
155085,when,0,0
155086,the,0,0
155087,cognitive,0,1
155088,demand,0,1
155089,of,0,0
155090,the,0,0
155091,tasks,0,0
155092,increased,0,0
155093,.,0,0
155094,Children,0,0
155095,with,0,0
155096,FASD,0,0
155097,also,0,0
155098,displayed,0,0
155099,a,0,0
155100,statistically,0,0
155101,significant,0,0
155102,increase,0,1
155103,in,0,0
155104,response,1,1
155105,inhibition,1,1
155106,errors,1,1
155107,.,1,0
155108,CONCLUSIONS,0,0
155109,These,0,0
155110,data,0,0
155111,suggest,0,0
155112,that,0,0
155113,children,0,0
155114,with,0,0
155115,FASD,0,0
155116,may,0,0
155117,have,0,0
155118,deficits,0,1
155119,in,0,0
155120,eye,0,1
155121,movement,0,1
155122,control,0,0
155123,and,0,1
155124,sensory-motor,0,1
155125,integration,0,1
155126,including,0,0
155127,cerebellar,0,1
155128,circuits,0,1
155129,",",0,0
155130,thereby,0,0
155131,impairing,0,0
155132,saccade,0,1
155133,accuracy,0,1
155134,.,0,0
155135,Promoting,0,0
155136,question-asking,0,1
155137,in,0,0
155138,school-aged,0,0
155139,children,0,0
155140,with,0,0
155141,autism,0,0
155142,spectrum,0,0
155143,disorders,0,0
155144,:,0,0
155145,effectiveness,0,0
155146,of,0,0
155147,a,0,0
155148,robot,0,0
155149,intervention,0,0
155150,compared,0,0
155151,to,0,0
155152,a,0,0
155153,human-trainer,0,0
155154,intervention,0,0
155155,.,0,0
155156,OBJECTIVE,0,0
155157,The,0,0
155158,purpose,0,0
155159,of,0,0
155160,the,0,0
155161,present,0,0
155162,study,0,0
155163,was,0,0
155164,to,0,0
155165,investigate,0,0
155166,the,0,0
155167,effectiveness,0,0
155168,of,0,0
155169,an,0,0
155170,applied,0,0
155171,behaviour,0,1
155172,analysis,0,0
155173,(,0,1
155174,ABA,0,1
155175,),0,1
155176,-based,0,0
155177,intervention,0,0
155178,conducted,0,0
155179,by,0,0
155180,a,0,0
155181,robot,0,0
155182,compared,0,0
155183,to,0,0
155184,an,0,0
155185,ABA-based,0,0
155186,intervention,0,0
155187,conducted,0,0
155188,by,0,0
155189,a,0,0
155190,human,0,0
155191,trainer,0,0
155192,in,0,0
155193,promoting,0,0
155194,self-initiated,0,1
155195,questions,0,1
155196,in,0,0
155197,children,0,0
155198,with,0,0
155199,autism,0,0
155200,spectrum,0,1
155201,disorder,0,0
155202,(,0,1
155203,ASD,0,0
155204,),0,0
155205,.,0,0
155206,METHODS,0,0
155207,Data,0,1
155208,were,0,0
155209,collected,0,0
155210,in,0,0
155211,a,0,0
155212,combined,0,0
155213,crossover,0,0
155214,multiple,0,0
155215,baseline,0,1
155216,design,0,0
155217,across,0,0
155218,participants,0,0
155219,.,0,0
155220,Six,0,0
155221,children,0,0
155222,were,0,0
155223,randomly,0,0
155224,assigned,0,0
155225,to,0,0
155226,two,0,0
155227,experimental,0,0
155228,groups,0,0
155229,.,0,0
155230,RESULTS,0,0
155231,Results,0,0
155232,revealed,0,0
155233,that,0,0
155234,the,0,0
155235,number,0,1
155236,of,0,0
155237,self-initiated,1,1
155238,questions,1,1
155239,for,0,0
155240,both,0,0
155241,experimental,0,0
155242,groups,0,0
155243,increased,0,0
155244,between,0,0
155245,baseline,0,0
155246,and,0,0
155247,the,0,0
155248,first,0,1
155249,intervention,0,0
155250,and,0,1
155251,was,0,0
155252,maintained,0,0
155253,during,0,0
155254,follow-up,0,0
155255,.,0,0
155256,The,0,0
155257,high,0,0
155258,number,0,1
155259,of,0,1
155260,self-initiated,1,1
155261,questions,1,1
155262,during,0,0
155263,follow-up,0,0
155264,indicates,0,0
155265,that,0,0
155266,both,0,0
155267,groups,0,0
155268,maintained,0,0
155269,this,0,0
155270,skill,0,1
155271,.,0,0
155272,CONCLUSIONS,0,0
155273,The,0,0
155274,interventions,0,0
155275,conducted,0,0
155276,by,0,0
155277,a,0,0
155278,robot,0,0
155279,and,0,0
155280,a,0,0
155281,human,0,0
155282,trainer,0,0
155283,were,0,0
155284,both,0,0
155285,effective,0,1
155286,in,0,0
155287,promoting,0,0
155288,self-initiated,0,1
155289,questions,0,1
155290,in,0,0
155291,children,0,0
155292,with,0,0
155293,ASD,0,0
155294,.,0,0
155295,No,0,0
155296,conclusion,0,0
155297,with,0,0
155298,regard,0,0
155299,to,0,0
155300,the,0,0
155301,differential,0,1
155302,effectiveness,0,0
155303,of,0,0
155304,both,0,0
155305,interventions,0,0
155306,could,0,0
155307,be,0,0
155308,drawn,0,0
155309,.,0,0
155310,Implications,0,0
155311,of,0,0
155312,the,0,0
155313,results,0,0
155314,and,0,0
155315,directions,0,0
155316,for,0,0
155317,future,0,0
155318,research,0,0
155319,are,0,0
155320,discussed,0,0
155321,.,0,0
155322,Evaluation,0,1
155323,of,0,0
155324,the,0,0
155325,effect,0,0
155326,of,0,0
155327,low,0,0
155328,level,0,1
155329,laser,0,0
155330,on,0,0
155331,prevention,1,0
155332,of,1,1
155333,chemotherapy-induced,1,0
155334,mucositis,1,1
155335,.,1,0
155336,Radiotherapy,0,0
155337,in,0,0
155338,the,0,0
155339,head,0,0
155340,and,0,1
155341,neck,0,1
155342,region,0,0
155343,and,0,0
155344,chemotherapy,0,0
155345,might,0,0
155346,give,0,0
155347,rise,0,0
155348,to,0,0
155349,oral,0,0
155350,mucositis,0,1
155351,which,0,0
155352,is,0,0
155353,a,0,0
155354,severe,0,1
155355,and,0,1
155356,painful,0,1
155357,inflammation,0,1
155358,.,0,0
155359,There,0,0
155360,is,0,0
155361,no,0,0
155362,known,0,0
155363,definite,0,0
155364,cure,0,1
155365,for,0,0
155366,mucositis,0,1
155367,.,0,0
155368,A,0,0
155369,number,0,1
155370,of,0,0
155371,studies,0,0
155372,have,0,0
155373,attempted,0,0
155374,to,0,0
155375,evaluate,0,0
155376,the,0,0
155377,effect,0,0
155378,of,0,0
155379,low-power,0,0
155380,laser,0,0
155381,on,0,0
155382,radiotherapy-,1,0
155383,and,0,1
155384,chemotherapy-induced,1,0
155385,mucositis,1,1
155386,.,1,0
155387,The,0,0
155388,present,0,0
155389,study,0,0
155390,was,0,0
155391,undertaken,0,0
155392,to,0,0
155393,evaluate,0,0
155394,the,0,0
155395,effect,0,0
155396,of,0,0
155397,low-power,0,0
155398,laser,0,0
155399,on,0,0
155400,the,0,0
155401,prevention,1,0
155402,of,1,1
155403,mucositis,1,1
155404,",",1,1
155405,xerostomia,1,1
155406,and,1,1
155407,pain,1,1
155408,as,1,0
155409,a,1,0
155410,result,1,0
155411,of,1,0
155412,chemotherapy,1,0
155413,.,1,0
155414,The,0,0
155415,subjects,0,0
155416,in,0,0
155417,this,0,0
155418,double-blind,0,0
155419,randomized,0,0
155420,controlled,0,0
155421,study,0,0
155422,were,0,0
155423,24,0,0
155424,adult,0,0
155425,patients,0,0
155426,who,0,0
155427,underwent,0,0
155428,chemotherapy,0,0
155429,during,0,0
155430,2009-2010,0,0
155431,.,0,0
155432,The,0,0
155433,results,0,0
155434,showed,0,0
155435,that,0,0
155436,low-power,0,0
155437,laser,0,0
155438,was,0,0
155439,able,0,0
155440,to,0,0
155441,decrease,0,0
155442,the,0,0
155443,effect,1,0
155444,of,1,0
155445,chemotherapy,1,0
155446,on,1,0
155447,oral,1,0
155448,mucositis,1,1
155449,",",1,1
155450,xerostomia,1,1
155451,and,1,1
155452,pain,1,1
155453,in,1,0
155454,a,1,0
155455,variety,1,0
155456,of,1,1
155457,malignancies,1,0
155458,(,0,0
155459,P,0,0
155460,&,0,0
155461,lt,0,0
155462,;,0,0
155463,0.05,0,0
155464,),0,0
155465,.,0,0
155466,It,0,0
155467,can,0,0
155468,be,0,0
155469,concluded,0,0
155470,that,0,0
155471,low-power,0,0
155472,laser,0,0
155473,might,0,0
155474,decrease,0,0
155475,the,0,0
155476,intensity,1,1
155477,of,1,0
155478,mucositis,1,1
155479,.,1,0
155480,Clinical,0,1
155481,pharmacokinetics,0,1
155482,of,0,0
155483,buffered,0,0
155484,propranolol,0,0
155485,sublingual,0,1
155486,tablet,0,0
155487,(,0,1
155488,Promptol?,0,0
155489,),0,1
155490,-application,0,0
155491,of,0,0
155492,a,0,0
155493,new,0,0
155494,physiologically,0,0
155495,based,0,0
155496,model,0,0
155497,to,0,0
155498,assess,0,0
155499,absorption,0,1
155500,and,0,1
155501,disposition,0,1
155502,.,0,1
155503,Sublingual,0,0
155504,administration,0,0
155505,of,0,1
155506,certain,0,0
155507,buffered,0,0
155508,propranolol,0,0
155509,may,0,0
155510,improve,0,0
155511,the,0,0
155512,rate,0,1
155513,and,0,1
155514,extent,0,1
155515,of,0,1
155516,absorption,0,1
155517,compared,0,0
155518,to,0,0
155519,oral,0,0
155520,administration,0,0
155521,.,0,0
155522,The,0,0
155523,main,0,0
155524,objectives,0,0
155525,of,0,0
155526,this,0,0
155527,study,0,0
155528,were,0,0
155529,to,0,0
155530,(,0,0
155531,1,0,0
155532,),0,0
155533,compare,0,0
155534,the,0,0
155535,plasma,0,1
155536,propranolol,0,0
155537,concentrations,0,1
155538,(,0,1
155539,Cp-prop,0,0
155540,),0,0
155541,following,0,0
155542,sublingual,0,1
155543,administration,0,0
155544,of,0,0
155545,a,0,0
155546,specially,0,0
155547,buffered,0,0
155548,formulation,0,0
155549,(,0,0
155550,Promptol?,0,0
155551,),0,0
155552,to,0,0
155553,that,0,0
155554,following,0,0
155555,oral,0,0
155556,administration,0,0
155557,of,0,1
155558,Inderal,0,0
155559,(,0,0
155560,?,0,0
155561,),0,1
155562,and,0,0
155563,(,0,0
155564,2,0,0
155565,),0,0
155566,evaluate,0,0
155567,the,0,0
155568,utility,0,0
155569,of,0,0
155570,a,0,0
155571,special,0,0
155572,pharmacokinetic,0,1
155573,model,0,0
155574,in,0,0
155575,describing,0,0
155576,the,0,0
155577,Cp-prop,0,0
155578,following,0,0
155579,sublingual,0,1
155580,administration,0,0
155581,.,0,0
155582,Eighteen,0,0
155583,healthy,0,0
155584,volunteers,0,0
155585,received,0,0
155586,10,0,0
155587,mg,0,0
155588,sublingual,0,0
155589,Promptol?,0,0
155590,or,0,0
155591,oral,0,0
155592,Inderal,0,0
155593,(,0,0
155594,?,0,0
155595,),0,0
155596,.,0,0
155597,Multiple,0,1
155598,Cp-prop,0,0
155599,were,0,0
155600,determined,0,0
155601,and,0,0
155602,their,0,0
155603,pharmacokinetics,0,1
155604,compared,0,0
155605,.,0,0
155606,Additional,0,0
155607,data,0,0
155608,following,0,0
155609,sublingual,0,0
155610,40,0,0
155611,mg,0,0
155612,Promptol?,0,0
155613,or,0,1
155614,Inderal,0,1
155615,(,0,1
155616,?,0,0
155617,),0,1
155618,were,0,0
155619,utilized,0,0
155620,for,0,0
155621,evaluation,0,0
155622,of,0,0
155623,a,0,0
155624,special,0,0
155625,advanced,0,0
155626,compartmental,0,1
155627,absorption,0,1
155628,and,0,1
155629,transit,0,1
155630,(,0,1
155631,ACAT,0,1
155632,),0,0
155633,model,0,0
155634,.,0,0
155635,For,0,0
155636,model,0,0
155637,simulation,0,0
155638,",",0,0
155639,the,0,0
155640,physicochemical,0,1
155641,parameters,0,1
155642,were,0,0
155643,imported,0,0
155644,from,0,0
155645,AMET,0,0
155646,predictor,0,1
155647,",",0,0
155648,whereas,0,0
155649,the,0,0
155650,pharmacokinetic,0,1
155651,parameters,0,1
155652,were,0,0
155653,calculated,0,0
155654,and,0,0
155655,optimized,0,0
155656,by,0,0
155657,Gastroplus,0,0
155658,(,0,0
155659,?,0,0
155660,),0,0
155661,.,0,0
155662,Based,0,0
155663,on,0,0
155664,this,0,0
155665,model,0,0
155666,",",0,0
155667,the,0,0
155668,quantity,0,1
155669,of,0,0
155670,drug,0,0
155671,absorbed,0,1
155672,via,1,0
155673,buccal/sublingual,1,0
155674,mucosa,1,1
155675,was,1,0
155676,estimated,1,0
155677,.,0,0
155678,Cp-prop,1,0
155679,was,1,0
155680,higher,0,0
155681,at,0,0
155682,earlier,0,0
155683,times,0,1
155684,with,0,0
155685,3-fold,0,1
155686,greater,0,0
155687,relative,0,1
155688,bioavailability,0,1
155689,following,0,0
155690,sublingual,0,1
155691,Promptol?,0,0
155692,compared,0,0
155693,to,0,0
155694,that,0,0
155695,from,0,0
155696,oral,0,0
155697,Inderal,0,0
155698,(,0,0
155699,?,0,0
155700,),0,0
155701,.,0,0
155702,The,0,0
155703,special,0,0
155704,ACAT,0,1
155705,model,0,0
155706,provided,0,0
155707,excellent,0,1
155708,goodness,0,1
155709,of,0,1
155710,fit,0,1
155711,of,1,1
155712,Cp-prop-time,1,1
155713,curve,1,1
155714,and,1,1
155715,estimated,1,0
155716,a,0,0
155717,56.6,0,0
155718,%,0,0
155719,increase,0,0
155720,in,0,0
155721,absorption,1,1
155722,rate,1,1
155723,from,0,0
155724,Promptol?,0,0
155725,and,0,1
155726,higher,0,1
155727,initial,0,1
155728,Cp-prop,1,0
155729,compared,1,0
155730,to,0,0
155731,the,0,0
155732,regular,0,0
155733,formulation,0,0
155734,.,0,0
155735,The,0,0
155736,modified,0,0
155737,ACAT,0,1
155738,model,0,0
155739,provided,0,0
155740,a,0,0
155741,useful,0,0
155742,approach,0,0
155743,to,0,0
155744,describe,0,0
155745,sublingual,0,1
155746,absorption,0,1
155747,of,0,1
155748,propranolol,0,0
155749,and,0,1
155750,clearly,0,0
155751,demonstrated,0,0
155752,an,0,0
155753,improvement,0,1
155754,of,0,0
155755,absorption,0,1
155756,of,0,0
155757,Promptol?,0,0
155758,.,0,0
155759,The,0,0
155760,sublingual,0,0
155761,10,0,0
155762,mg,0,0
155763,Promptol?,0,0
155764,achieved,0,1
155765,not,0,0
155766,only,0,0
155767,a,0,0
155768,similar,0,0
155769,systemic,0,1
155770,exposure,0,0
155771,as,0,0
155772,30,0,0
155773,mg,0,0
155774,oral,0,0
155775,Inderal,0,0
155776,(,0,0
155777,?,0,0
155778,),0,0
155779,but,0,0
155780,an,0,0
155781,earlier,0,0
155782,effective,0,1
155783,Cp-prop,0,0
155784,which,0,0
155785,may,0,0
155786,be,0,0
155787,advantageous,0,0
155788,for,0,0
155789,certain,0,0
155790,clinical,0,0
155791,conditions,0,0
155792,.,0,0
155793,Health-education,0,0
155794,package,0,0
155795,to,0,0
155796,prevent,0,0
155797,worm,0,1
155798,infections,0,1
155799,in,0,0
155800,Chinese,0,0
155801,schoolchildren,0,0
155802,.,0,0
155803,BACKGROUND,0,0
155804,Soil-transmitted,0,0
155805,helminths,0,1
155806,are,0,0
155807,among,0,0
155808,the,0,0
155809,most,0,0
155810,prevalent,0,0
155811,sources,0,0
155812,of,0,0
155813,human,0,0
155814,infections,0,1
155815,globally,0,0
155816,.,0,0
155817,We,0,0
155818,determined,0,0
155819,the,0,0
155820,effect,0,0
155821,of,0,0
155822,an,0,0
155823,educational,0,0
155824,package,0,0
155825,at,0,0
155826,rural,0,0
155827,schools,0,0
155828,in,0,0
155829,Linxiang,0,0
155830,City,0,1
155831,District,0,0
155832,",",0,1
155833,Hunan,0,1
155834,province,0,1
155835,",",0,1
155836,China,0,0
155837,",",0,0
155838,where,0,0
155839,these,0,0
155840,worms,0,0
155841,are,0,0
155842,prevalent,0,0
155843,.,0,0
155844,The,0,0
155845,intervention,0,0
155846,aimed,0,0
155847,to,0,0
155848,increase,0,0
155849,knowledge,0,1
155850,about,0,0
155851,soil-transmitted,0,0
155852,helminths,0,1
155853,",",0,0
155854,induce,0,0
155855,behavioral,1,1
155856,change,1,1
155857,",",0,0
155858,and,0,1
155859,reduce,0,0
155860,the,0,0
155861,rate,1,1
155862,of,1,0
155863,infection,1,1
155864,.,1,0
155865,METHODS,0,0
155866,We,0,0
155867,conducted,0,0
155868,a,0,0
155869,single-blind,0,0
155870,",",0,1
155871,unmatched,0,0
155872,",",0,1
155873,cluster-randomized,0,0
155874,intervention,0,0
155875,trial,0,0
155876,involving,0,0
155877,1718,0,0
155878,children,0,0
155879,",",0,0
155880,9,0,0
155881,to,0,0
155882,10,0,0
155883,years,0,0
155884,of,0,0
155885,age,0,0
155886,",",0,0
155887,in,0,0
155888,38,0,0
155889,schools,0,0
155890,over,0,0
155891,the,0,0
155892,course,0,0
155893,of,0,0
155894,1,0,0
155895,school,0,0
155896,year,0,0
155897,.,0,1
155898,Schools,0,0
155899,were,0,0
155900,randomly,0,0
155901,assigned,0,0
155902,to,0,0
155903,the,0,0
155904,health-education,0,1
155905,package,0,0
155906,",",0,1
155907,which,0,0
155908,included,0,0
155909,a,0,0
155910,cartoon,0,1
155911,video,0,0
155912,",",0,1
155913,or,0,0
155914,to,0,0
155915,a,0,0
155916,control,0,0
155917,package,0,0
155918,",",0,1
155919,which,0,0
155920,involved,0,0
155921,only,0,0
155922,the,0,0
155923,display,0,0
155924,of,0,0
155925,a,0,0
155926,health-education,0,0
155927,poster,0,0
155928,.,0,1
155929,Infection,1,1
155930,rates,1,1
155931,",",1,0
155932,knowledge,1,1
155933,about,1,0
155934,soil-transmitted,1,0
155935,helminths,1,1
155936,(,1,0
155937,as,1,0
155938,assessed,1,0
155939,with,1,0
155940,the,1,0
155941,use,1,0
155942,of,1,0
155943,a,1,0
155944,questionnaire,1,1
155945,),1,1
155946,",",1,1
155947,and,1,1
155948,hand-washing,1,1
155949,behavior,1,1
155950,were,0,0
155951,assessed,0,0
155952,before,0,0
155953,and,0,0
155954,after,0,0
155955,the,0,0
155956,intervention,0,0
155957,.,0,1
155958,Albendazole,0,0
155959,was,0,0
155960,administered,0,0
155961,in,0,0
155962,all,0,0
155963,the,0,0
155964,participants,0,0
155965,at,0,0
155966,baseline,0,0
155967,and,0,1
155968,in,0,0
155969,all,0,0
155970,the,0,0
155971,children,0,0
155972,who,0,0
155973,were,0,0
155974,found,0,0
155975,to,0,0
155976,be,0,0
155977,positive,0,1
155978,for,0,0
155979,infection,0,1
155980,with,0,0
155981,soil-transmitted,0,0
155982,helminths,0,1
155983,at,0,0
155984,the,0,0
155985,follow-up,0,0
155986,assessment,0,0
155987,at,0,0
155988,the,0,0
155989,end,0,0
155990,of,0,0
155991,the,0,0
155992,school,0,0
155993,year,0,0
155994,.,0,1
155995,RESULTS,0,0
155996,At,0,0
155997,the,0,0
155998,follow-up,0,0
155999,assessment,0,0
156000,",",0,0
156001,the,0,0
156002,mean,1,1
156003,score,1,1
156004,for,1,0
156005,the,1,0
156006,knowledge,1,0
156007,of,1,0
156008,helminths,1,1
156009,",",0,0
156010,calculated,0,0
156011,as,0,0
156012,a,0,0
156013,percentage,0,1
156014,of,0,0
156015,a,0,0
156016,total,0,0
156017,of,0,0
156018,43,0,0
156019,points,0,0
156020,on,0,0
156021,a,0,0
156022,questionnaire,1,1
156023,",",0,0
156024,was,0,0
156025,90,0,0
156026,%,0,0
156027,higher,0,0
156028,in,0,0
156029,the,0,0
156030,intervention,0,0
156031,group,0,0
156032,than,0,0
156033,in,0,0
156034,the,0,0
156035,control,0,0
156036,group,0,0
156037,(,0,0
156038,63.3,0,0
156039,vs.,0,0
156040,33.4,0,0
156041,",",0,0
156042,P,0,0
156043,<,0,0
156044,0.001,0,0
156045,),0,0
156046,",",0,0
156047,the,0,0
156048,percentage,0,1
156049,of,0,0
156050,children,1,0
156051,who,1,0
156052,washed,1,0
156053,their,1,0
156054,hands,1,1
156055,after,1,0
156056,using,1,0
156057,the,1,0
156058,toilet,1,0
156059,was,0,0
156060,nearly,1,0
156061,twice,1,0
156062,as,0,0
156063,high,0,0
156064,in,0,0
156065,the,0,0
156066,intervention,0,0
156067,group,0,0
156068,(,0,0
156069,98.9,0,0
156070,%,0,0
156071,",",0,0
156072,vs.,0,0
156073,54.2,0,0
156074,%,0,0
156075,in,0,0
156076,the,0,0
156077,control,0,0
156078,group,0,0
156079,;,0,0
156080,P,0,0
156081,<,0,0
156082,0.001,0,0
156083,),0,0
156084,",",0,0
156085,and,0,0
156086,the,0,0
156087,incidence,1,1
156088,of,1,0
156089,infection,1,1
156090,with,0,0
156091,soil-transmitted,0,0
156092,helminths,0,1
156093,was,0,0
156094,50,0,0
156095,%,0,0
156096,lower,0,0
156097,in,0,0
156098,the,0,0
156099,intervention,0,0
156100,group,0,0
156101,than,0,0
156102,in,0,0
156103,the,0,0
156104,control,0,0
156105,group,0,0
156106,(,0,0
156107,4.1,0,0
156108,%,0,0
156109,vs.,0,0
156110,8.4,0,0
156111,%,0,0
156112,",",0,0
156113,P,0,0
156114,<,0,0
156115,0.001,0,0
156116,),0,0
156117,.,0,0
156118,No,1,0
156119,adverse,1,1
156120,events,1,1
156121,were,0,0
156122,observed,0,0
156123,immediately,0,0
156124,(,0,0
156125,within,0,0
156126,15,0,0
156127,minutes,0,0
156128,),0,0
156129,after,0,0
156130,albendazole,0,0
156131,treatment,0,0
156132,.,0,0
156133,CONCLUSIONS,0,0
156134,The,0,0
156135,health-education,0,1
156136,package,0,0
156137,increased,0,1
156138,students,0,0
156139,',0,1
156140,knowledge,0,1
156141,about,0,0
156142,soil-transmitted,0,0
156143,helminths,0,1
156144,and,0,1
156145,led,0,0
156146,to,0,0
156147,a,0,0
156148,change,0,1
156149,in,0,0
156150,behavior,0,1
156151,and,0,0
156152,a,0,0
156153,reduced,0,1
156154,incidence,0,1
156155,of,0,1
156156,infection,0,1
156157,within,0,0
156158,1,0,0
156159,school,0,0
156160,year,0,0
156161,.,0,1
156162,(,0,0
156163,Funded,0,0
156164,by,0,0
156165,UBS,0,0
156166,Optimus,0,1
156167,Foundation,0,1
156168,",",0,1
156169,Zurich,0,0
156170,",",0,0
156171,Switzerland,0,0
156172,;,0,1
156173,Australian,0,0
156174,New,0,1
156175,Zealand,0,0
156176,Clinical,0,1
156177,Trials,0,1
156178,Registry,0,0
156179,number,0,1
156180,",",0,0
156181,ACTRN12610000048088,0,0
156182,.,0,0
156183,),0,0
156184,.,0,0
156185,Galactomannan,0,1
156186,and,0,1
156187,PCR,0,1
156188,versus,0,0
156189,culture,0,1
156190,and,0,1
156191,histology,0,1
156192,for,0,0
156193,directing,0,0
156194,use,0,0
156195,of,0,1
156196,antifungal,0,0
156197,treatment,0,0
156198,for,0,0
156199,invasive,0,1
156200,aspergillosis,0,0
156201,in,0,0
156202,high-risk,0,0
156203,haematology,0,0
156204,patients,0,0
156205,:,0,0
156206,a,0,0
156207,randomised,0,0
156208,controlled,0,0
156209,trial,0,0
156210,.,0,0
156211,BACKGROUND,0,0
156212,Empirical,0,1
156213,treatment,0,0
156214,with,0,0
156215,antifungal,0,0
156216,drugs,0,0
156217,is,0,0
156218,often,0,0
156219,used,0,0
156220,in,0,0
156221,haematology,0,0
156222,patients,0,0
156223,at,0,0
156224,high,0,0
156225,risk,0,1
156226,of,0,1
156227,invasive,0,1
156228,aspergillosis,0,0
156229,.,0,0
156230,We,0,0
156231,compared,0,0
156232,a,0,0
156233,standard,0,0
156234,diagnostic,0,1
156235,strategy,0,0
156236,(,0,1
156237,culture,0,1
156238,and,0,1
156239,histology,0,1
156240,),0,0
156241,with,0,0
156242,a,0,0
156243,rapid,0,0
156244,biomarker-based,0,0
156245,diagnostic,0,1
156246,strategy,0,0
156247,(,0,0
156248,aspergillus,0,1
156249,galactomannan,0,1
156250,and,0,1
156251,PCR,0,1
156252,),0,1
156253,for,0,0
156254,directing,0,0
156255,the,0,0
156256,use,0,0
156257,of,0,0
156258,antifungal,0,0
156259,treatment,0,0
156260,in,0,0
156261,this,0,0
156262,group,0,0
156263,of,0,0
156264,patients,0,0
156265,.,0,0
156266,METHODS,0,0
156267,In,0,0
156268,this,0,0
156269,open-label,0,0
156270,",",0,0
156271,parallel-group,0,0
156272,",",0,1
156273,randomised,0,0
156274,controlled,0,0
156275,trial,0,0
156276,",",0,0
156277,eligible,0,0
156278,patients,0,0
156279,were,0,0
156280,adults,0,0
156281,undergoing,0,0
156282,allogeneic,0,0
156283,stem-cell,0,0
156284,transplantation,0,0
156285,or,0,1
156286,chemotherapy,0,0
156287,for,0,0
156288,acute,0,1
156289,leukaemia,0,1
156290,",",0,0
156291,with,0,0
156292,no,0,0
156293,history,0,1
156294,of,0,0
156295,invasive,0,1
156296,fungal,0,0
156297,disease,0,1
156298,.,0,0
156299,Enrolled,0,0
156300,patients,0,0
156301,were,0,0
156302,randomly,0,0
156303,assigned,0,0
156304,(,0,0
156305,1:1,0,0
156306,),0,0
156307,by,0,0
156308,a,0,0
156309,computer-generated,0,0
156310,schedule,0,0
156311,to,0,0
156312,follow,0,0
156313,either,0,0
156314,a,0,0
156315,standard,0,0
156316,diagnostic,0,1
156317,strategy,0,0
156318,(,0,0
156319,based,0,0
156320,on,0,0
156321,culture,0,1
156322,and,0,1
156323,histology,0,1
156324,),0,1
156325,or,0,0
156326,a,0,0
156327,biomarker-based,0,0
156328,diagnostic,0,1
156329,strategy,0,0
156330,(,0,0
156331,aspergillus,0,1
156332,galactomannan,0,1
156333,and,0,1
156334,PCR,0,1
156335,),0,0
156336,to,0,0
156337,direct,0,0
156338,treatment,0,0
156339,with,0,0
156340,antifungal,0,0
156341,drugs,0,0
156342,.,0,0
156343,Patients,0,0
156344,",",0,0
156345,were,0,0
156346,followed,0,0
156347,up,0,0
156348,for,0,0
156349,26,0,0
156350,weeks,0,0
156351,or,0,0
156352,until,0,0
156353,death,0,1
156354,.,0,0
156355,Masking,0,0
156356,of,0,0
156357,the,0,0
156358,use,0,0
156359,of,0,0
156360,different,0,0
156361,diagnostic,0,1
156362,tests,0,1
156363,was,0,0
156364,not,0,0
156365,possible,0,0
156366,for,0,0
156367,patients,0,0
156368,",",0,0
156369,treating,0,1
156370,physicians,0,1
156371,",",0,1
156372,or,0,0
156373,investigators,0,0
156374,.,0,0
156375,The,0,0
156376,primary,0,0
156377,endpoint,0,1
156378,was,0,0
156379,empirical,1,0
156380,treatment,1,0
156381,with,1,0
156382,antifungal,1,0
156383,drugs,1,0
156384,in,0,0
156385,the,0,0
156386,26,0,0
156387,weeks,0,0
156388,after,0,0
156389,enrolment,0,0
156390,(,0,0
156391,for,0,0
156392,the,0,0
156393,biomarker-based,0,0
156394,diagnostic,0,1
156395,strategy,0,0
156396,",",0,0
156397,a,0,0
156398,single,0,0
156399,postive,0,1
156400,galactomannan,0,1
156401,or,0,1
156402,PCR,0,1
156403,result,0,1
156404,was,0,0
156405,deemed,0,0
156406,insufficient,0,0
156407,to,0,0
156408,confirm,0,0
156409,invasive,0,1
156410,aspergillosis,0,0
156411,",",0,0
156412,so,0,0
156413,treatment,0,0
156414,in,0,0
156415,this,0,0
156416,context,0,0
156417,was,0,0
156418,classified,0,0
156419,as,0,0
156420,empirical,0,0
156421,),0,0
156422,.,0,0
156423,This,0,0
156424,outcome,0,1
156425,was,0,0
156426,assessed,0,0
156427,by,0,0
156428,an,0,0
156429,independent,0,0
156430,data,0,0
156431,review,0,0
156432,committee,0,0
156433,from,0,0
156434,which,0,0
156435,the,0,0
156436,study,0,0
156437,allocations,0,1
156438,were,0,0
156439,masked,0,0
156440,.,0,0
156441,Analyses,0,0
156442,were,0,0
156443,by,0,0
156444,intention,0,1
156445,to,0,0
156446,treat,0,0
156447,and,0,0
156448,included,0,0
156449,all,0,0
156450,enrolled,0,0
156451,patients,0,0
156452,.,0,0
156453,This,0,0
156454,study,0,0
156455,is,0,0
156456,registered,0,0
156457,with,0,0
156458,ClinicalTrial.gov,0,0
156459,",",0,0
156460,number,0,1
156461,NCT00163722,0,0
156462,.,0,0
156463,FINDINGS,0,0
156464,240,0,0
156465,eligible,0,0
156466,patients,0,0
156467,were,0,0
156468,recruited,0,0
156469,from,0,0
156470,six,0,0
156471,Australian,0,0
156472,centres,0,0
156473,between,0,0
156474,Sept,0,0
156475,30,0,0
156476,",",0,0
156477,2005,0,0
156478,",",0,0
156479,and,0,0
156480,Nov,0,0
156481,19,0,0
156482,",",0,0
156483,2009,0,0
156484,.,0,0
156485,122,0,0
156486,were,0,0
156487,assigned,0,0
156488,the,0,0
156489,standard,0,0
156490,diagnostic,0,1
156491,strategy,0,0
156492,and,0,0
156493,118,0,0
156494,the,0,0
156495,biomarker-based,0,0
156496,diagnostic,0,0
156497,strategy,0,0
156498,.,0,0
156499,39,0,0
156500,patients,0,0
156501,(,0,0
156502,32,0,0
156503,%,0,0
156504,),0,0
156505,in,0,0
156506,the,0,0
156507,standard,0,0
156508,diagnosis,0,0
156509,group,0,0
156510,and,0,0
156511,18,0,0
156512,(,0,0
156513,15,0,0
156514,%,0,0
156515,),0,0
156516,in,0,0
156517,the,0,0
156518,biomarker,0,0
156519,diagnosis,0,1
156520,group,0,0
156521,received,0,0
156522,empirical,0,0
156523,antifungal,0,0
156524,treatment,0,0
156525,(,0,0
156526,difference,0,0
156527,17,0,0
156528,%,0,0
156529,",",0,0
156530,95,0,0
156531,%,0,0
156532,CI,0,0
156533,4-26,0,0
156534,;,0,0
156535,p=0?002,0,0
156536,),0,0
156537,.,0,0
156538,The,1,0
156539,numbers,1,1
156540,of,1,0
156541,patients,1,0
156542,who,1,0
156543,had,1,0
156544,hepatotoxic,1,1
156545,and,1,1
156546,nephrotoxic,1,1
156547,effects,1,1
156548,did,0,0
156549,not,0,0
156550,differ,0,0
156551,significantly,0,0
156552,between,0,0
156553,the,0,0
156554,standard,0,0
156555,diagnosis,0,0
156556,and,0,1
156557,biomarker,0,1
156558,diagnosis,0,1
156559,groups,0,0
156560,(,0,0
156561,hepatotoxic,1,1
156562,effects,1,0
156563,:,1,0
156564,21,0,0
156565,[,0,0
156566,17,0,0
156567,%,0,0
156568,],0,0
156569,vs,0,0
156570,12,0,0
156571,[,0,0
156572,10,0,0
156573,%,0,0
156574,],0,0
156575,",",0,0
156576,p=0?11,1,0
156577,;,1,1
156578,nephrotoxic,1,0
156579,effects,1,0
156580,:,1,0
156581,52,1,0
156582,[,0,0
156583,43,0,0
156584,%,0,0
156585,],0,0
156586,vs,0,0
156587,60,0,0
156588,[,0,0
156589,51,0,0
156590,%,0,0
156591,],0,0
156592,",",0,1
156593,p=0?20,0,0
156594,),0,1
156595,.,0,0
156596,INTERPRETATION,0,0
156597,Use,0,0
156598,of,0,1
156599,aspergillus,0,1
156600,galactomannan,0,1
156601,and,0,1
156602,PCR,0,1
156603,to,0,0
156604,direct,0,0
156605,treatment,0,0
156606,reduced,1,1
156607,use,1,0
156608,of,1,0
156609,empirical,1,0
156610,antifungal,1,0
156611,treatment,1,0
156612,.,1,0
156613,This,1,0
156614,approach,0,0
156615,is,0,0
156616,an,0,0
156617,effective,0,1
156618,strategy,0,0
156619,for,0,0
156620,the,0,0
156621,management,0,0
156622,of,0,0
156623,invasive,0,1
156624,aspergillosis,0,0
156625,in,0,0
156626,high-risk,0,0
156627,haematology,0,0
156628,patients,0,0
156629,.,0,0
156630,FUNDING,0,0
156631,Australian,0,0
156632,National,0,1
156633,Health,0,1
156634,and,0,1
156635,Medical,0,0
156636,Research,0,1
156637,Council,0,1
156638,",",0,1
156639,Cancer,0,1
156640,Council,0,1
156641,New,0,1
156642,South,0,1
156643,Wales,0,1
156644,",",0,1
156645,Pfizer,0,0
156646,",",0,1
156647,Merck,0,1
156648,",",0,1
156649,Gilead,0,1
156650,Sciences,0,0
156651,.,0,0
156652,Predicting,0,0
156653,the,0,0
156654,effect,0,0
156655,of,0,0
156656,anthelmintic,0,1
156657,treatment,0,0
156658,on,0,0
156659,milk,1,1
156660,production,1,1
156661,of,1,1
156662,dairy,1,0
156663,cattle,1,0
156664,in,0,0
156665,Canada,0,0
156666,using,0,0
156667,an,0,0
156668,Ostertagia,0,1
156669,ostertagi,0,0
156670,ELISA,0,1
156671,from,0,0
156672,individual,0,0
156673,milk,0,0
156674,samples,0,0
156675,.,0,0
156676,Gastrointestinal,0,1
156677,nematodes,0,1
156678,",",0,0
156679,such,0,0
156680,as,0,0
156681,Ostertagia,0,1
156682,ostertagi,0,0
156683,and,0,1
156684,several,0,0
156685,species,0,1
156686,of,0,1
156687,Cooperia,0,0
156688,",",0,0
156689,are,0,0
156690,ubiquitous,0,0
156691,in,0,0
156692,temperate,0,0
156693,climates,0,0
156694,and,0,0
156695,have,0,0
156696,been,0,0
156697,shown,0,0
156698,to,0,0
156699,have,0,0
156700,detrimental,0,1
156701,effects,0,1
156702,on,0,0
156703,production,0,1
156704,in,0,0
156705,adult,0,0
156706,dairy,0,0
156707,cattle,0,0
156708,.,0,0
156709,A,0,0
156710,published,0,0
156711,meta-analysis,0,0
156712,demonstrated,0,0
156713,that,0,0
156714,overall,0,1
156715,",",0,0
156716,producers,0,0
156717,lose,0,0
156718,approximately,0,0
156719,0.35,0,0
156720,kg,0,0
156721,of,0,0
156722,milk,0,1
156723,per,0,0
156724,parasitized,0,1
156725,cow,0,0
156726,per,0,0
156727,day,0,0
156728,.,0,0
156729,Enzyme-linked,0,0
156730,immunosorbent,0,0
156731,assays,0,1
156732,(,0,1
156733,ELISAs,0,0
156734,),0,0
156735,have,0,0
156736,the,0,0
156737,ability,0,1
156738,to,0,0
156739,quantify,0,0
156740,nematode,0,0
156741,infections,0,1
156742,in,0,0
156743,cattle,0,0
156744,",",0,1
156745,and,0,1
156746,thus,0,0
156747,",",0,0
156748,could,0,0
156749,be,0,0
156750,used,0,0
156751,to,0,0
156752,estimate,0,0
156753,the,0,0
156754,amount,0,1
156755,of,0,1
156756,milk,0,1
156757,production,0,1
156758,loss,0,1
156759,due,0,0
156760,to,0,0
156761,differing,0,0
156762,levels,0,1
156763,of,0,0
156764,parasitism,0,1
156765,at,0,0
156766,the,0,0
156767,individual,0,0
156768,cow,0,0
156769,level,0,1
156770,.,0,1
156771,ELISA,0,1
156772,results,0,0
156773,from,0,0
156774,individual,0,0
156775,cow,0,0
156776,milk,0,1
156777,samples,0,1
156778,were,0,0
156779,used,0,0
156780,to,0,0
156781,predict,0,0
156782,milk,0,1
156783,production,0,1
156784,response,0,1
156785,following,0,0
156786,a,0,0
156787,randomized,0,0
156788,anthelmintic,0,1
156789,treatment,0,0
156790,in,0,0
156791,a,0,0
156792,large,0,0
156793,field,0,0
156794,trial,0,0
156795,.,0,0
156796,To,0,0
156797,increase,0,1
156798,statistical,0,1
156799,power,0,1
156800,",",0,0
156801,the,0,0
156802,data,0,0
156803,collected,0,0
156804,from,0,0
156805,this,0,0
156806,field,0,0
156807,trial,0,0
156808,was,0,0
156809,pooled,0,0
156810,with,0,0
156811,data,0,0
156812,from,0,0
156813,two,0,0
156814,other,0,0
156815,published,0,0
156816,field,0,0
156817,trials,0,0
156818,to,0,0
156819,form,0,0
156820,an,0,0
156821,individual,0,0
156822,patient,0,1
156823,data,0,0
156824,meta-analysis,0,0
156825,(,0,1
156826,IPDMA,0,1
156827,),0,0
156828,.,0,0
156829,The,0,0
156830,ability,0,1
156831,to,0,0
156832,predict,0,0
156833,the,0,0
156834,effect,0,0
156835,of,0,0
156836,anthelmintic,0,1
156837,treatment,0,0
156838,on,0,0
156839,milk,0,0
156840,production,0,1
156841,depends,0,0
156842,on,0,0
156843,the,0,0
156844,level,0,1
156845,of,0,0
156846,parasitism,0,1
156847,quantified,0,0
156848,by,0,0
156849,an,0,0
156850,ELISA,0,1
156851,measuring,0,1
156852,milk,1,1
156853,antibodies,1,1
156854,against,0,1
156855,O.,0,0
156856,ostertagi,0,1
156857,",",0,1
156858,and,0,1
156859,reported,0,0
156860,as,0,0
156861,optical,1,1
156862,density,1,1
156863,ratios,1,1
156864,(,1,1
156865,ODRs,1,0
156866,),1,0
156867,.,0,0
156868,Therefore,0,0
156869,",",0,0
156870,the,0,0
156871,estimates,0,0
156872,from,0,0
156873,the,0,0
156874,interaction,0,1
156875,between,0,0
156876,ODR,0,1
156877,and,0,1
156878,treatment,0,0
156879,on,0,0
156880,milk,0,1
156881,production,0,1
156882,were,0,0
156883,used,0,0
156884,to,0,0
156885,determine,0,0
156886,how,0,0
156887,well,0,0
156888,the,0,0
156889,ODR,0,1
156890,predicted,0,0
156891,the,0,0
156892,response,0,1
156893,of,0,0
156894,the,0,0
156895,treatment,0,0
156896,.,0,0
156897,It,0,0
156898,was,0,0
156899,anticipated,0,0
156900,that,0,0
156901,the,0,0
156902,relationship,0,0
156903,between,0,0
156904,milk,1,1
156905,production,1,1
156906,and,0,1
156907,ODR,1,1
156908,was,0,0
156909,unlikely,0,0
156910,to,0,0
156911,be,0,0
156912,linear,0,0
156913,",",0,0
156914,so,0,0
156915,fractional,0,1
156916,polynomials,0,1
156917,were,0,0
156918,applied,0,0
156919,to,0,0
156920,the,0,0
156921,continuous,0,0
156922,ODR,1,1
156923,values,1,1
156924,.,1,0
156925,The,0,0
156926,interaction,0,0
156927,in,0,0
156928,the,0,0
156929,field,0,0
156930,trial,0,0
156931,showed,0,0
156932,a,0,0
156933,trend,0,0
156934,(,0,0
156935,p=0.138,0,0
156936,),0,0
156937,toward,0,0
156938,a,0,0
156939,beneficial,0,0
156940,treatment,0,0
156941,effect,0,1
156942,when,0,0
156943,the,0,0
156944,individual,0,0
156945,ODR,1,1
156946,values,1,1
156947,",",0,0
156948,measured,0,1
156949,in,0,0
156950,late,0,1
156951,lactation,0,1
156952,and,0,1
156953,using,0,0
156954,Svanovir,0,1
156955,(,0,0
156956,?,0,0
156957,),0,1
156958,",",0,0
156959,were,0,0
156960,greater,0,0
156961,than,0,0
156962,0.12,0,0
156963,.,0,0
156964,When,0,0
156965,individual,0,0
156966,data,0,0
156967,from,0,0
156968,two,0,0
156969,other,0,0
156970,similar,0,0
156971,studies,0,0
156972,were,0,0
156973,included,0,0
156974,in,0,0
156975,an,0,0
156976,IPDMA,0,0
156977,",",0,0
156978,the,0,0
156979,interaction,0,1
156980,terms,0,1
156981,became,0,0
156982,statistically,0,0
156983,significant,0,0
156984,(,0,0
156985,p=0.009,0,0
156986,),0,1
156987,indicating,0,0
156988,that,0,0
156989,there,0,0
156990,is,0,0
156991,a,0,0
156992,beneficial,0,0
156993,treatment,0,0
156994,effect,0,1
156995,when,1,0
156996,ODR,1,1
156997,values,1,1
156998,are,0,0
156999,slightly,0,0
157000,elevated,0,0
157001,.,0,0
157002,A,0,0
157003,graph,0,1
157004,was,0,0
157005,used,0,0
157006,to,0,0
157007,demonstrate,0,0
157008,the,0,0
157009,treatment,0,0
157010,effect,0,1
157011,(,0,0
157012,the,0,0
157013,estimated,0,0
157014,difference,0,0
157015,of,0,0
157016,kg/cow/day,0,0
157017,of,0,1
157018,milk,0,1
157019,yield,0,1
157020,between,0,0
157021,the,0,0
157022,treated,0,0
157023,and,0,0
157024,placebo,0,0
157025,cows,0,1
157026,),0,0
157027,",",0,0
157028,with,0,0
157029,95,0,0
157030,%,0,0
157031,confidence,0,0
157032,intervals,0,1
157033,",",0,0
157034,as,0,0
157035,the,1,0
157036,ODR,1,1
157037,values,1,1
157038,increase,0,0
157039,.,0,0
157040,It,0,0
157041,is,0,0
157042,important,0,0
157043,to,0,0
157044,note,0,0
157045,that,0,0
157046,the,0,0
157047,methods,0,0
157048,of,0,0
157049,quantifying,0,0
157050,the,0,0
157051,ODR,0,1
157052,values,0,1
157053,differed,0,0
157054,between,0,0
157055,the,0,0
157056,three,0,0
157057,studies,0,0
157058,in,0,0
157059,the,0,0
157060,IPDMA,0,0
157061,",",0,0
157062,therefore,0,0
157063,some,0,0
157064,caution,0,0
157065,should,0,0
157066,be,0,0
157067,used,0,0
157068,when,0,0
157069,using,0,0
157070,these,0,0
157071,final,0,1
157072,estimated,0,0
157073,values,0,1
157074,.,0,0
157075,However,0,0
157076,",",0,0
157077,the,0,0
157078,shape,0,1
157079,and,0,1
157080,magnitude,0,1
157081,of,0,0
157082,the,0,0
157083,treatment,0,0
157084,effects,0,1
157085,",",0,0
157086,as,0,0
157087,well,0,0
157088,as,0,0
157089,the,0,0
157090,other,0,0
157091,fixed,0,0
157092,model,0,0
157093,estimates,0,0
157094,",",0,1
157095,were,0,0
157096,very,0,0
157097,similar,0,0
157098,between,0,0
157099,the,0,0
157100,field,0,0
157101,trial,0,0
157102,and,0,0
157103,the,0,0
157104,IPDMA,0,1
157105,suggesting,0,0
157106,that,0,0
157107,any,0,0
157108,bias,0,0
157109,would,0,0
157110,likely,0,0
157111,be,0,0
157112,minimal,0,0
157113,.,0,0
157114,[,0,0
157115,Study,0,0
157116,of,0,1
157117,setting,0,0
157118,of,0,0
157119,ventilator,1,1
157120,volume,0,1
157121,tidal,0,1
157122,and,0,1
157123,airway,0,1
157124,pressure,0,1
157125,alarm,0,1
157126,threshold,0,1
157127,with,0,0
157128,continuous,0,0
157129,extra-sternum,0,1
157130,heart,0,1
157131,compression,0,0
157132,in,0,0
157133,cardiopulmonary,0,1
157134,resuscitation,0,0
157135,],0,0
157136,.,0,0
157137,OBJECTIVE,0,0
157138,To,0,0
157139,investigate,0,0
157140,the,0,0
157141,setting,0,0
157142,of,0,1
157143,ventilator,0,1
157144,volume,0,1
157145,tidal,0,1
157146,(,0,1
157147,VT,0,0
157148,),0,1
157149,and,0,1
157150,airway,0,1
157151,pressure,0,1
157152,alarm,0,1
157153,threshold,0,1
157154,during,0,0
157155,cardiopulmonary,0,1
157156,resuscitation,0,1
157157,(,0,1
157158,CPR,0,1
157159,),0,0
157160,by,0,0
157161,continuous,0,0
157162,extra-sternum,0,1
157163,heart,0,1
157164,compression,0,0
157165,.,0,1
157166,METHODS,0,0
157167,Forty,0,0
157168,cases,0,0
157169,with,0,0
157170,respiration,0,1
157171,and,0,1
157172,cardiac,0,1
157173,arrest,0,1
157174,in,0,0
157175,the,0,0
157176,department,0,0
157177,of,0,0
157178,critical,0,1
157179,care,0,0
157180,medicine,0,0
157181,were,0,0
157182,randomly,0,0
157183,divided,0,0
157184,into,0,0
157185,low,0,0
157186,VT,0,0
157187,ventilation,0,1
157188,group,0,0
157189,and,0,1
157190,conventional,0,0
157191,VT,0,0
157192,group,0,0
157193,.,0,0
157194,Both,0,0
157195,groups,0,0
157196,were,0,0
157197,given,0,0
157198,the,0,0
157199,volume,0,1
157200,control,0,0
157201,mode,0,0
157202,.,0,0
157203,In,0,0
157204,the,0,0
157205,low,0,0
157206,VT,0,0
157207,ventilation,0,1
157208,group,0,0
157209,",",0,1
157210,VT,0,0
157211,was,0,0
157212,set,0,0
157213,on,0,0
157214,6,0,0
157215,-,0,0
157216,7,0,0
157217,ml/kg,0,0
157218,",",0,0
157219,and,0,1
157220,high,0,1
157221,pressure,0,1
157222,alarm,0,1
157223,threshold,0,1
157224,was,0,0
157225,adjusted,0,0
157226,to,0,0
157227,60,0,0
157228,cm,0,0
157229,H2O,0,0
157230,by,0,0
157231,the,0,0
157232,conventional,0,0
157233,40,0,0
157234,cm,0,0
157235,H2O,0,0
157236,during,0,0
157237,CPR,0,1
157238,.,0,0
157239,In,0,0
157240,the,0,0
157241,conventional,0,0
157242,VT,0,0
157243,group,0,0
157244,",",0,1
157245,VT,0,0
157246,and,0,1
157247,high,0,1
157248,pressure,0,1
157249,alarm,0,1
157250,threshold,0,1
157251,were,0,0
157252,set,0,0
157253,at,0,0
157254,8,0,0
157255,-,0,0
157256,12,0,0
157257,ml/kg,0,0
157258,and,0,0
157259,40,0,0
157260,cm,0,0
157261,H2O,0,0
157262,",",0,0
157263,respectively,0,0
157264,.,0,0
157265,Real-time,1,1
157266,actual,1,1
157267,VT,1,0
157268,",",1,0
157269,peak,1,1
157270,inspiratory,1,1
157271,pressure,1,1
157272,(,1,1
157273,PIP,1,1
157274,),1,1
157275,",",1,0
157276,and,1,1
157277,arterial,1,1
157278,blood,1,1
157279,gas,1,1
157280,test,1,1
157281,",",1,1
157282,blood,1,1
157283,lactic,1,1
157284,acid,1,0
157285,at,1,0
157286,10,1,0
157287,minutes,1,0
157288,and,1,0
157289,30,1,0
157290,minutes,1,0
157291,after,1,0
157292,CPR,1,1
157293,were,0,0
157294,observed,0,0
157295,.,0,0
157296,RESULTS,0,0
157297,At,0,0
157298,10,0,0
157299,minutes,0,0
157300,after,0,0
157301,CPR,0,1
157302,",",0,0
157303,in,0,0
157304,the,0,0
157305,low,0,0
157306,VT,0,0
157307,ventilation,0,1
157308,group,0,0
157309,",",0,1
157310,arterial,1,1
157311,blood,1,1
157312,pH,1,1
157313,",",1,1
157314,arterial,1,1
157315,partial,1,1
157316,pressure,1,1
157317,of,1,1
157318,oxygen,1,1
157319,(,1,1
157320,PaO2,1,1
157321,),1,1
157322,",",1,0
157323,arterial,1,1
157324,partial,1,1
157325,pressure,1,1
157326,of,1,1
157327,carbon,1,1
157328,dioxide,1,1
157329,(,1,1
157330,PaCO2,1,1
157331,),1,1
157332,",",1,1
157333,HCO3,1,0
157334,(,1,0
157335,-,1,0
157336,),1,0
157337,",",1,0
157338,arterial,1,1
157339,oxygen,1,1
157340,saturation,1,1
157341,(,1,1
157342,SaO2,1,0
157343,),1,1
157344,and,1,1
157345,blood,1,1
157346,lactic,1,1
157347,acid,1,1
157348,were,0,0
157349,better,0,0
157350,as,0,0
157351,compared,0,0
157352,with,0,0
157353,those,0,0
157354,in,0,0
157355,the,0,0
157356,conventional,0,0
157357,VT,0,0
157358,ventilation,0,1
157359,group,0,0
157360,(,0,0
157361,pH,0,0
157362,:,0,0
157363,7.21?0.09,0,0
157364,vs.,0,0
157365,7.13?0.07,0,0
157366,",",0,0
157367,PaO2,0,0
157368,:,0,0
157369,45.35?5.92,0,0
157370,mm,0,0
157371,Hg,0,0
157372,vs.,0,0
157373,40.70?4.70,0,0
157374,mm,0,0
157375,Hg,0,0
157376,",",0,0
157377,PaCO2,0,0
157378,:,0,0
157379,57.10?7.59,0,0
157380,mm,0,0
157381,Hg,0,0
157382,vs.,0,0
157383,61.60?5.47,0,0
157384,mm,0,0
157385,Hg,0,0
157386,",",0,1
157387,HCO3,0,0
157388,(,0,0
157389,-,0,0
157390,),0,0
157391,:,0,0
157392,18.50?3.50,0,0
157393,mmol/L,0,0
157394,vs.,0,0
157395,14.75?2.65,0,0
157396,mmol/L,0,0
157397,",",0,0
157398,SaO2,0,0
157399,:,0,0
157400,0.796?0.069,0,0
157401,vs.,0,0
157402,0.699?0.066,0,0
157403,",",0,0
157404,blood,0,1
157405,lactic,0,1
157406,acid,0,0
157407,:,0,0
157408,7.07?1.60,0,0
157409,mmol/L,0,0
157410,vs.,0,0
157411,8.13?1.56,0,0
157412,mmol/L,0,0
157413,",",0,0
157414,all,0,0
157415,P,0,0
157416,<,0,0
157417,0.05,0,0
157418,),0,0
157419,.,0,0
157420,The,0,0
157421,success,1,1
157422,rate,1,1
157423,of,1,1
157424,resuscitation,1,0
157425,in,1,0
157426,the,1,0
157427,low,1,0
157428,VT,0,0
157429,ventilation,0,1
157430,group,0,0
157431,was,0,0
157432,higher,0,0
157433,than,0,0
157434,that,0,0
157435,of,0,0
157436,the,0,0
157437,conventional,0,0
157438,VT,0,0
157439,ventilation,0,1
157440,group,0,0
157441,(,0,0
157442,45,0,0
157443,%,0,0
157444,vs.,0,0
157445,15,0,0
157446,%,0,0
157447,",",0,0
157448,P,0,0
157449,<,0,0
157450,0.05,0,0
157451,),0,0
157452,",",0,0
157453,and,0,1
157454,PIP,0,1
157455,(,0,1
157456,cm,0,1
157457,H2O,0,1
157458,),0,0
157459,of,0,0
157460,low,0,0
157461,VT,0,0
157462,ventilation,0,1
157463,group,0,0
157464,was,0,0
157465,lower,0,0
157466,than,0,0
157467,that,0,0
157468,of,0,0
157469,the,0,0
157470,conventional,0,0
157471,VT,0,0
157472,group,0,0
157473,(,0,0
157474,37.25?7.99,0,0
157475,cm,0,0
157476,H2O,0,0
157477,vs.,0,0
157478,42.70?7.40,0,0
157479,cm,0,0
157480,H2O,0,0
157481,",",0,1
157482,P,0,0
157483,<,0,0
157484,0.05,0,0
157485,),0,0
157486,.,0,0
157487,In,0,0
157488,all,0,0
157489,the,0,0
157490,patients,0,0
157491,in,0,0
157492,both,0,0
157493,groups,0,0
157494,barotrauma,1,1
157495,did,1,0
157496,not,0,0
157497,occur,0,0
157498,.,0,0
157499,CONCLUSION,0,0
157500,The,0,0
157501,strategy,0,0
157502,of,0,0
157503,low,0,0
157504,ventilator,0,1
157505,VT,1,0
157506,(,0,0
157507,6,0,0
157508,-,0,0
157509,7,0,0
157510,ml/kg,0,0
157511,),0,0
157512,with,0,0
157513,appropriate,1,0
157514,elevation,1,1
157515,of,1,1
157516,airway,1,1
157517,pressure,1,1
157518,alarm,1,1
157519,threshold,1,1
157520,was,1,0
157521,better,0,0
157522,than,0,0
157523,that,0,0
157524,of,0,0
157525,conventional,0,0
157526,ventilation,0,1
157527,setting,0,0
157528,",",0,0
157529,with,0,0
157530,no,0,0
157531,increase,0,0
157532,in,0,0
157533,incidence,1,1
157534,of,1,1
157535,barotraumas,1,1
157536,during,1,0
157537,CPR,0,0
157538,.,0,0
157539,[,0,0
157540,Efficacy,0,1
157541,observation,0,0
157542,on,0,0
157543,chronic,1,0
157544,tension-type,1,1
157545,headache,1,1
157546,treated,0,0
157547,with,0,0
157548,acupuncture,0,0
157549,at,0,0
157550,galea,0,0
157551,tendon-muscle,0,1
157552,node,0,0
157553,],0,0
157554,.,0,0
157555,OBJECTIVE,0,0
157556,To,0,0
157557,explore,0,0
157558,the,0,0
157559,better,0,0
157560,therapy,0,0
157561,for,0,0
157562,chronic,1,0
157563,tension-type,1,1
157564,headache,1,1
157565,(,1,1
157566,CTTH,1,0
157567,),1,0
157568,.,1,0
157569,METHODS,0,0
157570,Two,0,0
157571,hundred,0,0
157572,and,0,0
157573,eighty-eight,0,0
157574,cases,0,0
157575,were,0,0
157576,randomized,0,0
157577,into,0,0
157578,a,0,0
157579,sticking,0,1
157580,needling,0,1
157581,group,0,0
157582,(,0,0
157583,150,0,0
157584,cases,0,0
157585,),0,0
157586,and,0,0
157587,an,0,0
157588,acupuncture,0,0
157589,group,0,0
157590,(,0,0
157591,138,0,0
157592,cases,0,0
157593,),0,0
157594,.,0,0
157595,In,0,0
157596,the,0,0
157597,sticking,0,1
157598,needling,0,1
157599,group,0,0
157600,",",0,0
157601,the,0,0
157602,manual,0,1
157603,sticking,0,1
157604,needling,0,1
157605,technique,0,0
157606,was,0,0
157607,adopted,0,0
157608,to,0,0
157609,stimulate,0,0
157610,the,0,0
157611,galea,0,0
157612,tendon-muscle,0,1
157613,node,0,0
157614,.,0,0
157615,In,0,0
157616,the,0,0
157617,acupuncture,0,0
157618,group,0,0
157619,",",0,0
157620,the,0,0
157621,conventional,0,0
157622,acupuncture,0,0
157623,therapy,0,0
157624,was,0,0
157625,applied,0,0
157626,to,0,0
157627,Baihui,0,0
157628,(,0,0
157629,GV,0,0
157630,20,0,0
157631,),0,0
157632,",",0,0
157633,Sishencong,0,0
157634,(,0,0
157635,EX-HN,0,0
157636,1,0,0
157637,),0,0
157638,",",0,0
157639,Fengchi,0,0
157640,(,0,0
157641,GB,0,1
157642,20,0,0
157643,),0,0
157644,",",0,0
157645,Taiyang,0,0
157646,(,0,0
157647,EX-HN,0,0
157648,5,0,0
157649,),0,0
157650,",",0,0
157651,Touwei,0,0
157652,(,0,0
157653,ST,0,0
157654,18,0,0
157655,),0,0
157656,",",0,0
157657,Hegu,0,1
157658,(,0,0
157659,LI,0,0
157660,4,0,0
157661,),0,0
157662,",",0,0
157663,etc,0,0
157664,.,0,0
157665,The,0,0
157666,treatment,0,0
157667,was,0,0
157668,given,0,0
157669,once,0,0
157670,a,0,0
157671,day,0,0
157672,",",0,0
157673,and,0,0
157674,30,0,0
157675,days,0,0
157676,made,0,0
157677,one,0,0
157678,session,0,0
157679,.,0,0
157680,After,0,0
157681,two,0,0
157682,sessions,0,0
157683,of,0,0
157684,treatment,0,0
157685,and,0,0
157686,after,0,0
157687,three,0,0
157688,months,0,0
157689,follow-up,0,0
157690,",",0,0
157691,CTTH,1,1
157692,score,1,1
157693,(,1,0
157694,including,1,0
157695,the,1,0
157696,score,1,1
157697,of,1,1
157698,headache,1,1
157699,attack,1,1
157700,frequency,1,1
157701,and,1,0
157702,the,1,0
157703,score,1,1
157704,of,1,1
157705,headache,1,1
157706,severity,1,1
157707,),1,1
157708,was,0,0
157709,observed,0,0
157710,and,0,0
157711,compared,0,0
157712,before,0,0
157713,and,0,0
157714,after,0,0
157715,treatment,0,0
157716,separately,0,0
157717,.,0,0
157718,The,0,0
157719,efficacy,1,1
157720,was,0,0
157721,evaluated,0,0
157722,in,0,0
157723,two,0,0
157724,groups,0,0
157725,.,0,0
157726,RESULTS,0,0
157727,CTTH,1,1
157728,score,1,1
157729,was,0,0
157730,all,0,0
157731,reduced,0,0
157732,after,0,0
157733,treatment,0,0
157734,in,0,0
157735,the,0,0
157736,two,0,0
157737,groups,0,0
157738,(,0,0
157739,both,0,0
157740,P,0,0
157741,<,0,0
157742,0.01,0,0
157743,),0,0
157744,",",0,0
157745,the,0,0
157746,score,1,1
157747,in,1,0
157748,the,1,0
157749,sticking,1,1
157750,needling,1,1
157751,group,1,0
157752,was,0,0
157753,lower,0,0
157754,than,0,0
157755,that,0,0
157756,in,0,0
157757,the,0,0
157758,acupuncture,0,0
157759,group,0,0
157760,(,0,0
157761,2.38,0,0
157762,+/-,0,0
157763,1.22,0,0
157764,vs,0,0
157765,4.16,0,0
157766,+/-,0,0
157767,2.54,0,0
157768,",",0,0
157769,P,0,0
157770,<,0,0
157771,0.01,0,0
157772,),0,0
157773,.,0,0
157774,The,0,0
157775,effective,1,1
157776,rate,1,1
157777,was,0,0
157778,97.3,0,0
157779,%,0,0
157780,(,0,0
157781,146/150,0,0
157782,),0,0
157783,in,0,0
157784,the,0,0
157785,sticking,0,1
157786,needling,0,1
157787,group,0,0
157788,",",0,1
157789,which,0,0
157790,was,0,0
157791,better,0,0
157792,than,0,0
157793,88.4,0,0
157794,%,0,0
157795,(,0,0
157796,122/138,0,0
157797,),0,0
157798,in,0,0
157799,the,0,0
157800,acupuncture,0,0
157801,group,0,0
157802,(,0,1
157803,P,0,0
157804,<,0,0
157805,0.05,0,0
157806,),0,0
157807,.,0,0
157808,CONCLUSION,0,0
157809,The,0,0
157810,manual,0,0
157811,sticking,0,1
157812,needling,0,1
157813,technique,0,0
157814,at,0,0
157815,galea,0,0
157816,tendon-muscle,0,1
157817,node,0,0
157818,achieves,0,0
157819,the,0,0
157820,superior,0,0
157821,results,0,0
157822,of,0,0
157823,reducing,1,0
157824,the,1,0
157825,pain,1,1
157826,attack,1,1
157827,frequency,1,1
157828,and,1,1
157829,severity,1,1
157830,of,1,1
157831,CTTH,1,0
157832,as,0,0
157833,compared,0,0
157834,with,0,0
157835,the,0,0
157836,acupuncture,0,0
157837,therapy,0,0
157838,of,0,0
157839,the,0,0
157840,routine,0,0
157841,acupoint,0,0
157842,selection,0,1
157843,.,0,0
157844,Prospective,0,0
157845,investigation,0,0
157846,of,0,1
157847,body,0,1
157848,mass,0,1
157849,index,0,1
157850,",",0,1
157851,colorectal,1,0
157852,adenoma,1,1
157853,",",0,1
157854,and,0,1
157855,colorectal,1,0
157856,cancer,1,0
157857,in,0,0
157858,the,0,0
157859,prostate,0,0
157860,",",0,1
157861,lung,0,1
157862,",",0,1
157863,colorectal,0,0
157864,",",0,1
157865,and,0,1
157866,ovarian,0,1
157867,cancer,0,0
157868,screening,0,0
157869,trial,0,0
157870,.,0,0
157871,PURPOSE,0,0
157872,Obesity,0,1
157873,has,0,0
157874,consistently,0,0
157875,been,0,0
157876,linked,0,0
157877,to,0,0
157878,an,0,0
157879,increased,0,0
157880,risk,1,0
157881,of,1,0
157882,colorectal,1,0
157883,cancer,1,0
157884,",",0,0
157885,particularly,0,0
157886,among,0,0
157887,men,0,0
157888,.,0,0
157889,Whether,0,0
157890,body,0,1
157891,mass,0,1
157892,index,0,1
157893,(,0,1
157894,BMI,0,1
157895,),0,0
157896,differentially,0,0
157897,influences,0,0
157898,the,0,0
157899,risk,0,0
157900,across,0,0
157901,the,0,0
157902,stages,0,0
157903,of,0,0
157904,colorectal,0,0
157905,cancer,0,0
157906,development,0,0
157907,remains,0,0
157908,unclear,0,0
157909,.,0,0
157910,We,0,0
157911,evaluated,0,0
157912,the,0,0
157913,associations,0,0
157914,of,0,0
157915,BMI,0,1
157916,with,0,0
157917,colorectal,1,0
157918,adenoma,1,1
157919,incidence,1,1
157920,",",1,1
157921,adenoma,1,1
157922,recurrence,1,1
157923,",",1,1
157924,and,1,1
157925,cancer,1,0
157926,in,0,0
157927,the,0,0
157928,context,0,0
157929,of,0,0
157930,a,0,0
157931,large,0,0
157932,screening,0,0
157933,trial,0,0
157934,",",0,0
157935,in,0,0
157936,which,0,0
157937,cases,0,0
157938,and,0,1
157939,controls,0,0
157940,had,0,0
157941,an,0,0
157942,equal,0,0
157943,chance,0,1
157944,for,0,0
157945,disease,0,1
157946,detection,0,1
157947,.,0,0
157948,METHODS,0,0
157949,We,0,0
157950,prospectively,0,0
157951,evaluated,0,0
157952,the,0,0
157953,association,0,0
157954,between,0,0
157955,baseline,0,1
157956,BMI,0,1
157957,and,0,0
157958,the,0,0
157959,risk,0,1
157960,of,0,0
157961,incident,1,1
157962,distal,1,1
157963,adenoma,1,1
157964,(,0,0
157965,"1,213",0,0
157966,cases,0,0
157967,),0,0
157968,",",0,0
157969,recurrent,1,1
157970,adenoma,1,1
157971,(,0,0
157972,752,0,0
157973,cases,0,0
157974,),0,0
157975,",",0,0
157976,and,0,1
157977,incident,1,1
157978,colorectal,1,0
157979,cancer,1,0
157980,(,0,0
157981,966,0,0
157982,cases,0,0
157983,),0,0
157984,among,0,0
157985,men,0,0
157986,and,0,1
157987,women,0,0
157988,",",0,0
157989,ages,0,0
157990,55,0,0
157991,to,0,0
157992,74,0,0
157993,years,0,0
157994,",",0,0
157995,randomly,0,0
157996,assigned,0,0
157997,to,0,0
157998,receive,0,0
157999,flexible,0,0
158000,sigmoidoscopy,0,0
158001,screening,0,0
158002,as,0,0
158003,part,0,0
158004,of,0,0
158005,the,0,0
158006,Prostate,0,0
158007,",",0,1
158008,Lung,0,1
158009,",",0,1
158010,Colorectal,0,0
158011,",",0,1
158012,and,0,1
158013,Ovarian,0,1
158014,Cancer,0,1
158015,Screening,0,0
158016,Trial,0,0
158017,.,0,0
158018,We,0,0
158019,calculated,0,0
158020,odds,1,0
158021,ratios,1,1
158022,(,1,0
158023,ORs,1,0
158024,),1,0
158025,and,1,0
158026,95,1,0
158027,%,1,0
158028,CIs,1,0
158029,for,0,0
158030,adenoma,1,1
158031,incidence,1,1
158032,and,1,1
158033,recurrence,1,1
158034,",",0,1
158035,and,0,1
158036,hazard,1,1
158037,ratios,1,1
158038,(,1,0
158039,HRs,1,0
158040,),1,0
158041,and,0,0
158042,95,1,0
158043,%,1,0
158044,CIs,1,0
158045,for,0,0
158046,colorectal,1,0
158047,cancer,1,0
158048,incidence,1,1
158049,",",0,1
158050,using,0,0
158051,multivariable-adjusted,0,0
158052,models,0,0
158053,.,0,1
158054,RESULTS,0,0
158055,Compared,0,0
158056,with,0,0
158057,normal-weight,0,0
158058,men,0,0
158059,(,0,0
158060,18.5,0,0
158061,to,0,0
158062,24.9,0,0
158063,kg/m,0,0
158064,(,0,0
158065,2,0,0
158066,),0,0
158067,),0,0
158068,",",0,0
158069,obese,0,0
158070,men,0,0
158071,(,0,0
158072,?,0,0
158073,30,0,0
158074,kg/m,0,0
158075,(,0,0
158076,2,0,0
158077,),0,0
158078,),0,0
158079,had,0,0
158080,significantly,0,0
158081,higher,1,0
158082,risk,1,1
158083,of,1,1
158084,incident,1,1
158085,adenoma,1,1
158086,(,1,1
158087,OR,0,1
158088,",",0,0
158089,1.32,0,0
158090,;,0,0
158091,95,0,0
158092,%,0,0
158093,CI,0,0
158094,",",0,0
158095,1.06,0,0
158096,to,0,0
158097,1.65,0,0
158098,),0,0
158099,and,1,0
158100,colorectal,1,0
158101,cancer,1,1
158102,(,1,1
158103,HR,0,1
158104,",",0,0
158105,1.48,0,0
158106,;,0,0
158107,95,0,0
158108,%,0,0
158109,CI,0,0
158110,",",0,0
158111,1.16,0,0
158112,to,0,0
158113,1.89,0,0
158114,),0,0
158115,and,0,0
158116,a,0,0
158117,borderline,0,1
158118,increased,0,0
158119,risk,0,1
158120,of,0,0
158121,recurrent,1,1
158122,adenoma,1,1
158123,(,1,1
158124,OR,0,1
158125,",",0,0
158126,1.50,0,0
158127,;,0,0
158128,95,0,0
158129,%,0,0
158130,CI,0,0
158131,",",0,0
158132,0.98,0,0
158133,to,0,0
158134,2.30,0,0
158135,),0,0
158136,.,0,0
158137,No,0,0
158138,associations,0,0
158139,were,0,0
158140,observed,0,0
158141,for,0,0
158142,either,1,0
158143,adenoma,1,1
158144,or,1,0
158145,cancer,1,0
158146,in,1,0
158147,women,0,0
158148,.,0,0
158149,CONCLUSION,0,0
158150,Data,0,0
158151,from,0,0
158152,this,0,0
158153,large,0,0
158154,prospective,0,0
158155,study,0,0
158156,suggest,0,0
158157,that,0,0
158158,obesity,0,0
158159,is,0,0
158160,important,0,0
158161,throughout,0,0
158162,the,0,0
158163,natural,0,0
158164,history,0,1
158165,of,0,1
158166,colorectal,1,0
158167,cancer,1,0
158168,",",1,0
158169,at,0,0
158170,least,0,0
158171,in,0,0
158172,men,0,0
158173,",",0,1
158174,and,1,1
158175,colorectal,1,0
158176,cancer,1,1
158177,prevention,1,0
158178,efforts,0,0
158179,should,0,0
158180,encourage,0,0
158181,the,0,0
158182,achievement,0,1
158183,and,0,1
158184,maintenance,0,0
158185,of,0,0
158186,a,0,0
158187,healthy,0,0
158188,body,0,1
158189,weight,0,1
158190,in,0,0
158191,addition,0,0
158192,to,0,0
158193,regular,0,0
158194,screenings,0,0
158195,.,0,0
158196,Learning,0,1
158197,curve,0,1
158198,in,0,0
158199,multidetector,0,0
158200,CT,0,1
158201,coronary,0,1
158202,angiography,0,0
158203,(,0,1
158204,MDCT-CA,0,0
158205,),0,0
158206,.,0,0
158207,PURPOSE,0,0
158208,Coronary,0,0
158209,angiography,0,0
158210,using,0,0
158211,multidetector,0,0
158212,computed,0,0
158213,tomography,0,1
158214,(,0,1
158215,MDCT-CA,0,0
158216,),0,0
158217,is,0,0
158218,a,0,0
158219,recent,0,0
158220,technique,0,0
158221,for,0,0
158222,the,0,0
158223,nonivasive,0,0
158224,study,0,0
158225,of,0,1
158226,coronary,0,0
158227,arteries,0,0
158228,.,0,0
158229,This,0,0
158230,study,0,0
158231,assessed,0,0
158232,the,0,0
158233,diagnostic,1,1
158234,accuracy,1,1
158235,of,1,1
158236,coronary,1,1
158237,artery,1,1
158238,stenosis,1,1
158239,evaluation,1,0
158240,obtained,0,0
158241,by,0,0
158242,three,0,0
158243,readers,0,0
158244,at,0,0
158245,different,0,0
158246,levels,0,1
158247,of,0,1
158248,training,0,0
158249,or,0,0
158250,at,0,0
158251,different,0,0
158252,points,0,0
158253,of,0,0
158254,the,0,0
158255,learning,0,1
158256,curve,0,1
158257,proposed,0,0
158258,by,0,0
158259,the,0,0
158260,international,0,0
158261,guidelines,0,0
158262,.,0,1
158263,MATERIALS,0,0
158264,AND,0,0
158265,METHODS,0,0
158266,Three,0,0
158267,radiologists,0,1
158268,in,0,0
158269,training,0,0
158270,with,0,0
158271,different,0,0
158272,levels,0,1
158273,of,0,0
158274,experience,0,1
158275,in,0,0
158276,MDCT-CA,0,0
158277,scored,0,0
158278,50,0,0
158279,cases,0,0
158280,at,0,0
158281,various,0,0
158282,time,0,1
158283,points,0,0
158284,of,0,0
158285,the,0,0
158286,learning,0,1
158287,curve,0,1
158288,:,0,0
158289,baseline,0,0
158290,",",0,0
158291,4,0,0
158292,weeks,0,0
158293,",",0,0
158294,8,0,0
158295,weeks,0,0
158296,and,0,0
158297,6,0,0
158298,months,0,0
158299,.,0,0
158300,The,0,0
158301,trainee,0,0
158302,radiologists,0,1
158303,evaluated,0,0
158304,the,0,0
158305,degree,1,1
158306,of,1,0
158307,stenosis,1,1
158308,on,1,0
158309,each,1,0
158310,coronary,1,0
158311,segment,1,1
158312,",",0,1
158313,and,0,1
158314,overall,1,1
158315,accuracy,1,1
158316,was,0,0
158317,calculated,0,0
158318,on,0,0
158319,a,0,0
158320,per-segment,0,1
158321,",",0,0
158322,pervessel,0,1
158323,and,0,1
158324,per-patient,0,1
158325,basis,0,0
158326,.,0,0
158327,RESULTS,0,0
158328,All,0,0
158329,readers,0,0
158330,improved,1,1
158331,analysis,1,0
158332,accuracy,1,1
158333,per,1,1
158334,segment,1,1
158335,(,0,1
158336,range,0,0
158337,",",0,0
158338,73-90,0,0
158339,%,0,0
158340,),0,0
158341,;,0,0
158342,sensitivity,1,1
158343,reached,0,0
158344,45,0,0
158345,%,0,0
158346,per,0,0
158347,segment,0,0
158348,",",0,0
158349,84,0,0
158350,%,0,0
158351,per,0,0
158352,vessel,0,1
158353,and,0,0
158354,93,0,0
158355,%,0,0
158356,per,0,0
158357,patient,0,1
158358,;,0,1
158359,specificity,1,1
158360,was,0,0
158361,99,0,0
158362,%,0,0
158363,per,0,0
158364,segment,0,1
158365,and,0,1
158366,vessel,0,1
158367,and,0,0
158368,98,0,0
158369,%,0,0
158370,per,0,0
158371,patient,0,1
158372,.,0,1
158373,Positive,1,1
158374,and,1,1
158375,negative,1,1
158376,predictive,1,1
158377,values,1,1
158378,increased,1,0
158379,to,0,0
158380,94,0,0
158381,%,0,0
158382,and,0,0
158383,92,0,0
158384,%,0,0
158385,",",0,0
158386,respectively,0,0
158387,.,0,0
158388,CONCLUSIONS,0,0
158389,Although,0,0
158390,all,0,0
158391,readers,0,0
158392,improved,0,0
158393,in,0,0
158394,diagnostic,1,0
158395,performance,1,1
158396,with,0,0
158397,growing,0,0
158398,experience,0,1
158399,with,0,0
158400,MDCT-CA,0,0
158401,",",0,0
158402,a,0,0
158403,longer,0,0
158404,training,0,0
158405,period,0,0
158406,may,0,0
158407,be,0,0
158408,necessary,0,0
158409,to,0,0
158410,achieve,0,0
158411,adequate,0,0
158412,levels,0,1
158413,of,0,0
158414,expertise,0,0
158415,in,0,0
158416,MDCT-CA,0,0
158417,to,0,0
158418,be,0,0
158419,able,0,0
158420,to,0,0
158421,perform,0,0
158422,as,0,0
158423,independent,0,0
158424,readers,0,0
158425,.,0,0
158426,A,0,0
158427,randomised,0,0
158428,trial,0,0
158429,comparing,0,0
158430,preoperative,0,1
158431,to,0,0
158432,perioperative,0,1
158433,chemotherapy,0,0
158434,in,0,0
158435,early-stage,0,0
158436,non-small-cell,0,0
158437,lung,0,1
158438,cancer,0,1
158439,(,0,0
158440,IFCT,0,1
158441,0002,0,0
158442,trial,0,0
158443,),0,0
158444,.,0,0
158445,HYPOTHESIS,0,0
158446,There,0,0
158447,will,0,0
158448,be,0,0
158449,a,0,0
158450,detectable,0,1
158451,increase,0,0
158452,in,0,0
158453,overall,1,1
158454,survival,1,1
158455,(,1,1
158456,OS,1,1
158457,),1,0
158458,using,0,0
158459,preoperative,0,1
158460,(,0,0
158461,PRE,0,0
158462,),0,0
158463,as,0,0
158464,opposed,0,0
158465,to,0,0
158466,perioperative,0,1
158467,(,0,0
158468,PERI,0,0
158469,),0,1
158470,chemotherapy,0,0
158471,in,0,0
158472,resectable,0,0
158473,StageI-II,0,0
158474,non-small-cell,0,0
158475,lung,0,1
158476,cancer,0,1
158477,(,0,1
158478,NSCLC,0,1
158479,),0,0
158480,.,0,0
158481,METHODS,0,0
158482,This,0,0
158483,multicenter,0,0
158484,",",0,1
158485,open-label,0,0
158486,",",0,1
158487,randomised,0,0
158488,trial,0,0
158489,with,0,0
158490,a,0,0
158491,2?2,0,0
158492,factorial,0,0
158493,design,0,0
158494,first,0,0
158495,compared,0,0
158496,two,0,0
158497,chemotherapy,0,0
158498,strategies,0,0
158499,(,0,0
158500,PRE,0,0
158501,versus,0,0
158502,PERI,0,0
158503,),0,1
158504,",",0,0
158505,then,0,0
158506,two,0,0
158507,chemotherapy,0,0
158508,regimens,0,0
158509,(,0,0
158510,gemcitabine-cisplatin,0,0
158511,[,0,0
158512,GP,0,0
158513,],0,0
158514,versus,0,0
158515,paclitaxel-carboplatin,0,0
158516,[,0,0
158517,TC,0,1
158518,],0,0
158519,),0,0
158520,.,0,0
158521,The,0,0
158522,PRE,0,0
158523,group,0,0
158524,received,0,0
158525,two,0,0
158526,preoperative,0,0
158527,cycles,0,0
158528,followed,0,0
158529,by,0,0
158530,two,0,0
158531,additional,0,0
158532,preoperative,0,0
158533,cycles,0,1
158534,",",0,0
158535,while,0,0
158536,the,0,0
158537,PERI,0,0
158538,group,0,0
158539,underwent,0,0
158540,two,0,0
158541,preoperative,0,0
158542,cycles,0,0
158543,followed,0,0
158544,by,0,0
158545,two,0,0
158546,postoperative,0,0
158547,cycles,0,0
158548,",",0,0
158549,the,0,0
158550,3rd,0,0
158551,and,0,0
158552,4th,0,0
158553,cycles,0,0
158554,being,0,0
158555,given,0,0
158556,only,0,0
158557,to,0,0
158558,responders,0,0
158559,in,0,0
158560,both,0,0
158561,cases,0,0
158562,.,0,0
158563,RESULTS,0,0
158564,A,0,0
158565,total,0,0
158566,of,0,0
158567,528,0,0
158568,patients,0,0
158569,were,0,0
158570,randomised,0,0
158571,",",0,0
158572,267,0,0
158573,of,0,0
158574,which,0,0
158575,were,0,0
158576,assigned,0,0
158577,to,0,0
158578,the,0,0
158579,PRE,0,0
158580,group,0,0
158581,and,0,0
158582,261,0,0
158583,to,0,0
158584,the,0,0
158585,PERI,0,0
158586,group,0,0
158587,.,0,0
158588,Three-year,1,0
158589,OS,1,1
158590,did,0,0
158591,not,0,0
158592,differ,0,0
158593,between,0,0
158594,the,0,0
158595,two,0,0
158596,groups,0,0
158597,(,0,0
158598,67.4,0,0
158599,%,0,0
158600,and,0,0
158601,67.7,0,0
158602,%,0,0
158603,",",0,0
158604,respectively,0,0
158605,;,0,0
158606,hazard,0,1
158607,ratio,0,1
158608,(,0,1
158609,HR,0,1
158610,),0,0
158611,=1.01,0,0
158612,[,0,0
158613,0.79-1.30,0,0
158614,],0,0
158615,",",0,1
158616,p=0.92,0,0
158617,),0,1
158618,",",0,1
158619,nor,0,0
158620,did,1,0
158621,3-year,1,0
158622,disease-free,1,1
158623,survival,1,1
158624,",",1,1
158625,response,1,1
158626,rates,1,1
158627,",",1,1
158628,toxicity,1,1
158629,",",1,1
158630,or,1,1
158631,postoperative,1,1
158632,mortality,1,1
158633,.,1,0
158634,Pathological,1,1
158635,complete,1,1
158636,response,1,1
158637,was,0,0
158638,observed,0,0
158639,in,0,0
158640,22,0,0
158641,(,0,0
158642,8.2,0,0
158643,%,0,0
158644,),0,0
158645,and,0,0
158646,16,0,0
158647,patients,0,0
158648,(,0,0
158649,6.1,0,0
158650,%,0,0
158651,),0,0
158652,",",0,0
158653,respectively,0,0
158654,.,0,0
158655,Although,1,0
158656,quality,1,1
158657,of,1,1
158658,life,1,1
158659,did,0,0
158660,not,0,0
158661,differ,0,0
158662,significantly,0,0
158663,",",0,0
158664,chemotherapy,1,0
158665,compliance,1,1
158666,was,0,0
158667,significantly,0,0
158668,higher,0,0
158669,in,0,0
158670,the,0,0
158671,PRE,0,0
158672,group,0,0
158673,.,0,0
158674,The,0,0
158675,proportion,0,0
158676,of,0,0
158677,responders,0,0
158678,who,0,0
158679,received,0,0
158680,Cycles,0,0
158681,3,0,0
158682,and,0,0
158683,4,0,0
158684,was,0,0
158685,significantly,0,0
158686,higher,0,0
158687,in,0,0
158688,the,0,0
158689,PRE,0,0
158690,group,0,0
158691,(,0,0
158692,90.4,0,0
158693,%,0,0
158694,versus,0,0
158695,75.2,0,0
158696,%,0,0
158697,",",0,0
158698,p=0.001,0,1
158699,),0,1
158700,.,0,0
158701,In,0,0
158702,responders,0,0
158703,",",0,0
158704,the,0,0
158705,dose,0,0
158706,intensity,0,1
158707,of,0,0
158708,Cycles,0,0
158709,3,0,0
158710,and,0,0
158711,4,0,0
158712,was,0,0
158713,higher,0,0
158714,in,0,0
158715,the,0,0
158716,PRE,0,0
158717,group,0,0
158718,than,0,0
158719,in,0,0
158720,the,0,0
158721,PERI,0,0
158722,group,0,0
158723,(,0,0
158724,mean,0,1
158725,relative,0,1
158726,dose,0,0
158727,intensity,0,1
158728,of,0,0
158729,90.4,0,0
158730,%,0,0
158731,versus,0,0
158732,82.6,0,0
158733,%,0,0
158734,",",0,0
158735,respectively,0,0
158736,;,0,0
158737,p=0.0007,0,0
158738,),0,0
158739,.,0,0
158740,There,0,0
158741,was,0,0
158742,no,0,0
158743,difference,0,0
158744,between,1,0
158745,GP,1,0
158746,and,1,1
158747,TC,1,1
158748,in,0,0
158749,3-year,1,0
158750,OS,1,1
158751,(,0,0
158752,HR=0.97,0,0
158753,[,0,0
158754,95,0,0
158755,%,0,0
158756,confidence,0,0
158757,interval,0,0
158758,(,0,1
158759,CI,0,0
158760,),0,0
158761,:,0,0
158762,0.76-1.25,0,0
158763,],0,0
158764,",",0,1
158765,p=0.80,0,0
158766,),0,1
158767,or,1,0
158768,response,1,1
158769,rates,1,1
158770,.,1,0
158771,However,0,0
158772,",",0,0
158773,the,0,0
158774,regimens,1,1
158775,',1,1
158776,toxicity,1,1
158777,profiles,0,1
158778,differed,0,0
158779,.,0,0
158780,CONCLUSIONS,0,0
158781,This,0,0
158782,study,0,0
158783,failed,0,0
158784,to,0,0
158785,demonstrate,0,0
158786,any,0,0
158787,difference,0,0
158788,in,1,0
158789,survival,1,1
158790,between,0,0
158791,patients,0,0
158792,receiving,0,0
158793,preoperative,0,1
158794,and,0,1
158795,perioperative,0,1
158796,chemotherapy,0,0
158797,in,0,0
158798,early-stage,0,0
158799,NSCLC,0,1
158800,.,0,0
158801,The,0,0
158802,increase,0,0
158803,from,0,0
158804,two,0,0
158805,to,0,0
158806,four,0,0
158807,preoperative,0,0
158808,chemotherapy,0,0
158809,cycles,0,1
158810,did,0,0
158811,not,0,0
158812,increase,0,0
158813,the,1,0
158814,pathological,1,1
158815,response,1,1
158816,rate,0,1
158817,.,0,0
158818,Nicotinic,0,0
158819,acid,0,1
158820,as,0,0
158821,therapy,0,0
158822,for,0,0
158823,dyslipidemia,0,0
158824,in,0,0
158825,non-insulin-dependent,0,0
158826,diabetes,0,0
158827,mellitus,0,0
158828,.,0,0
158829,Recently,0,0
158830,",",0,0
158831,nicotinic,0,0
158832,acid,0,0
158833,has,0,0
158834,been,0,0
158835,recommended,0,0
158836,as,0,0
158837,a,0,0
158838,first-line,0,0
158839,hypolipidemic,0,0
158840,drug,0,0
158841,.,0,0
158842,To,0,0
158843,determine,0,0
158844,the,0,0
158845,effectiveness,0,0
158846,of,0,0
158847,nicotinic,0,0
158848,acid,0,0
158849,in,0,0
158850,dyslipidemic,0,0
158851,patients,0,0
158852,with,0,0
158853,non-insulin-dependent,0,0
158854,diabetes,0,0
158855,mellitus,0,0
158856,",",0,0
158857,13,0,0
158858,patients,0,0
158859,were,0,0
158860,treated,0,0
158861,in,0,0
158862,a,0,0
158863,randomized,0,0
158864,crossover,0,0
158865,trial,0,0
158866,.,0,1
158867,Patients,0,0
158868,received,0,0
158869,either,0,0
158870,nicotinic,0,0
158871,acid,0,0
158872,(,0,0
158873,1.5,0,0
158874,g,0,0
158875,three,0,0
158876,times,0,0
158877,daily,0,0
158878,),0,0
158879,or,0,0
158880,no,0,0
158881,therapy,0,0
158882,(,0,0
158883,control,0,0
158884,period,0,0
158885,),0,0
158886,for,0,0
158887,8,0,0
158888,weeks,0,0
158889,each,0,0
158890,.,0,0
158891,Compared,0,0
158892,with,0,0
158893,the,0,0
158894,control,0,0
158895,period,0,0
158896,",",0,1
158897,nicotinic,0,0
158898,acid,0,1
158899,therapy,0,0
158900,reduced,0,0
158901,the,0,0
158902,plasma,1,1
158903,total,1,1
158904,cholesterol,1,1
158905,level,1,1
158906,by,0,0
158907,24,0,0
158908,%,0,0
158909,",",0,0
158910,plasma,1,1
158911,triglyceride,1,1
158912,level,1,1
158913,by,0,0
158914,45,0,0
158915,%,0,0
158916,",",0,0
158917,very-low-density,1,1
158918,lipoprotein,1,1
158919,cholesterol,1,1
158920,level,1,1
158921,by,0,0
158922,58,0,0
158923,%,0,0
158924,",",0,0
158925,and,0,1
158926,low-density,1,1
158927,lipoprotein,1,1
158928,cholesterol,1,1
158929,level,1,1
158930,by,0,0
158931,15,0,0
158932,%,0,0
158933,",",0,0
158934,and,0,1
158935,it,0,0
158936,increased,0,0
158937,the,0,0
158938,high-density,1,1
158939,lipoprotein,1,1
158940,cholesterol,1,1
158941,level,1,1
158942,by,0,0
158943,34,0,0
158944,%,0,0
158945,.,0,0
158946,However,0,0
158947,",",0,0
158948,nicotinic,0,0
158949,acid,0,1
158950,therapy,0,0
158951,resulted,0,0
158952,in,0,0
158953,the,0,0
158954,deterioration,1,1
158955,of,1,0
158956,glycemic,1,1
158957,control,1,0
158958,",",0,0
158959,as,0,0
158960,evidenced,0,0
158961,by,0,0
158962,a,0,0
158963,16,0,0
158964,%,0,0
158965,increase,0,0
158966,in,0,0
158967,mean,1,1
158968,plasma,1,1
158969,glucose,1,1
158970,concentrations,1,1
158971,",",0,0
158972,a,0,0
158973,21,0,0
158974,%,0,0
158975,increase,0,0
158976,in,0,0
158977,glycosylated,1,1
158978,hemoglobin,1,1
158979,levels,1,1
158980,",",0,0
158981,and,0,0
158982,the,0,0
158983,induction,0,0
158984,of,0,0
158985,marked,1,0
158986,glycosuria,1,1
158987,in,0,0
158988,some,0,0
158989,patients,0,0
158990,.,0,0
158991,Furthermore,0,0
158992,",",0,0
158993,a,0,0
158994,consistent,0,0
158995,increase,0,0
158996,in,0,0
158997,plasma,1,1
158998,uric,1,1
158999,acid,1,1
159000,levels,1,1
159001,was,0,0
159002,observed,0,0
159003,.,0,0
159004,Therefore,0,0
159005,",",0,0
159006,despite,0,0
159007,improvement,0,1
159008,in,0,0
159009,lipid,1,1
159010,and,1,1
159011,lipoprotein,1,1
159012,concentrations,1,1
159013,",",0,0
159014,because,0,0
159015,of,0,1
159016,worsening,0,1
159017,hyperglycemia,1,1
159018,and,0,0
159019,the,0,0
159020,development,0,1
159021,of,0,1
159022,hyperuricemia,1,1
159023,",",0,1
159024,nicotinic,0,0
159025,acid,0,0
159026,must,0,0
159027,be,0,0
159028,used,0,0
159029,with,0,0
159030,caution,0,0
159031,in,0,0
159032,patients,0,0
159033,with,0,0
159034,non-insulin-dependent,0,0
159035,diabetes,0,0
159036,mellitus,0,0
159037,with,0,0
159038,dyslipidemia,0,0
159039,.,0,0
159040,We,0,0
159041,suggest,0,0
159042,that,0,0
159043,the,0,0
159044,drug,0,0
159045,not,0,0
159046,be,0,0
159047,used,0,0
159048,as,0,0
159049,a,0,0
159050,first-line,0,0
159051,hypolipidemic,0,1
159052,drug,0,0
159053,in,0,0
159054,patients,0,0
159055,with,0,0
159056,non-insulin-dependent,0,0
159057,diabetes,0,0
159058,mellitus,0,0
159059,.,0,0
159060,Concomitant,0,0
159061,",",0,1
159062,sequential,0,0
159063,",",0,1
159064,and,0,1
159065,hybrid,0,0
159066,therapy,0,0
159067,for,0,0
159068,H.,1,0
159069,pylori,1,1
159070,eradication,1,1
159071,:,1,0
159072,a,0,0
159073,pilot,0,0
159074,study,0,0
159075,.,0,1
159076,BACKGROUND,0,0
159077,AND,0,0
159078,OBJECTIVE,0,0
159079,Since,0,0
159080,the,0,0
159081,efficacy,0,1
159082,of,0,0
159083,the,0,0
159084,standard,0,0
159085,triple,0,0
159086,therapies,0,0
159087,for,0,0
159088,Helicobacter,1,1
159089,pylori,1,1
159090,eradication,1,1
159091,has,0,0
159092,decreased,0,1
159093,",",0,0
159094,novel,0,0
159095,antibiotic,0,0
159096,regimens,0,0
159097,have,0,0
159098,been,0,0
159099,introduced,0,0
159100,",",0,0
159101,including,0,0
159102,concomitant,0,0
159103,",",0,1
159104,sequential,0,0
159105,",",0,1
159106,and,0,1
159107,hybrid,0,0
159108,therapies,0,0
159109,.,0,0
159110,We,0,0
159111,aimed,0,0
159112,to,0,0
159113,compare,0,0
159114,the,0,0
159115,cure,1,1
159116,rates,1,1
159117,achieved,0,0
159118,by,0,0
159119,these,0,0
159120,new,0,0
159121,therapy,0,0
159122,regimens,0,0
159123,.,0,0
159124,METHODS,0,0
159125,This,0,0
159126,was,0,0
159127,a,0,0
159128,multicenter,0,0
159129,",",0,1
159130,open-label,0,0
159131,",",0,1
159132,pilot,0,0
159133,study,0,0
159134,enrolling,0,0
159135,consecutive,0,0
159136,non-ulcer,0,0
159137,dyspepsia,0,1
159138,patients,0,0
159139,with,0,0
159140,H.,0,0
159141,pylori,0,1
159142,infection,0,1
159143,never,0,0
159144,previously,0,0
159145,treated,0,0
159146,for,0,0
159147,the,0,0
159148,infection,0,1
159149,.,0,0
159150,Patients,0,0
159151,were,0,0
159152,randomized,0,0
159153,to,0,0
159154,receive,0,0
159155,one,0,0
159156,of,0,0
159157,the,0,0
159158,following,0,0
159159,treatments,0,0
159160,:,0,0
159161,(,0,0
159162,a,0,0
159163,),0,0
159164,concomitant,0,0
159165,therapy,0,0
159166,:,0,0
159167,omeprazole,0,0
159168,20mg,0,0
159169,",",0,0
159170,amoxicillin,0,0
159171,1g,0,0
159172,",",0,0
159173,clarithromycin,0,0
159174,500,0,0
159175,mg,0,0
159176,",",0,0
159177,and,0,1
159178,tinidazole,0,0
159179,500,0,0
159180,mg,0,0
159181,for,0,0
159182,5,0,0
159183,days,0,0
159184,;,0,0
159185,(,0,0
159186,b,0,1
159187,),0,1
159188,sequential,0,0
159189,therapy,0,0
159190,:,0,0
159191,omeprazole,0,0
159192,20mg,0,0
159193,and,0,0
159194,amoxicillin,0,0
159195,1g,0,0
159196,for,0,0
159197,5,0,0
159198,days,0,0
159199,followed,0,0
159200,by,0,0
159201,omeprazole,0,0
159202,20mg,0,0
159203,",",0,0
159204,clarithromycin,0,0
159205,500,0,0
159206,mg,0,0
159207,",",0,0
159208,and,0,1
159209,tinidazole,0,0
159210,500,0,0
159211,mg,0,0
159212,for,0,0
159213,5,0,0
159214,days,0,0
159215,;,0,0
159216,(,0,0
159217,c,0,1
159218,),0,1
159219,hybrid,0,0
159220,therapy,0,0
159221,:,0,0
159222,omeprazole,0,0
159223,20mg,0,0
159224,",",0,0
159225,and,0,0
159226,amoxicillin,0,0
159227,1g,0,0
159228,for,0,0
159229,7,0,0
159230,days,0,0
159231,followed,0,0
159232,by,0,0
159233,omeprazole,0,0
159234,20mg,0,0
159235,",",0,0
159236,amoxicillin,0,0
159237,1g,0,0
159238,",",0,0
159239,clarithromycin,0,0
159240,500,0,0
159241,mg,0,0
159242,",",0,0
159243,and,0,1
159244,tinidazole,0,0
159245,500,0,0
159246,mg,0,0
159247,",",0,0
159248,for,0,0
159249,7,0,0
159250,days,0,0
159251,.,0,0
159252,All,0,0
159253,drugs,0,0
159254,were,0,0
159255,administered,0,0
159256,twice,0,0
159257,daily,0,0
159258,.,0,0
159259,Bacterial,1,0
159260,eradication,1,1
159261,was,0,0
159262,checked,0,0
159263,6,0,0
159264,weeks,0,0
159265,after,0,0
159266,treatment,0,0
159267,by,0,0
159268,using,0,0
159269,a,0,0
159270,(,0,0
159271,13,0,0
159272,),0,0
159273,C-urea,0,0
159274,breath,0,1
159275,test,0,0
159276,.,0,0
159277,A,0,0
159278,10-day,0,0
159279,",",0,0
159280,second-line,0,0
159281,therapy,0,0
159282,with,0,0
159283,omeprazole,0,0
159284,20mg,0,0
159285,",",0,0
159286,levofloxacin,0,0
159287,250,0,0
159288,mg,0,0
159289,",",0,0
159290,and,0,0
159291,amoxicillin,0,0
159292,1g,0,0
159293,",",0,0
159294,all,0,0
159295,given,0,0
159296,twice,0,0
159297,daily,0,0
159298,",",0,0
159299,was,0,0
159300,offered,0,0
159301,to,0,0
159302,the,0,0
159303,eradication,0,1
159304,failure,0,0
159305,patients,0,0
159306,.,0,0
159307,RESULTS,0,0
159308,Overall,0,0
159309,",",0,0
159310,270,0,0
159311,patients,0,0
159312,were,0,0
159313,enrolled,0,0
159314,",",0,0
159315,but,0,0
159316,13,0,0
159317,patients,0,0
159318,early,0,0
159319,interrupted,0,0
159320,treatment,0,0
159321,due,0,0
159322,to,0,0
159323,side,0,1
159324,effects,0,1
159325,.,0,0
159326,At,0,0
159327,intention-to-treat,0,0
159328,(,0,1
159329,ITT,0,1
159330,),0,1
159331,and,0,1
159332,per-protocol,0,0
159333,analysis,0,0
159334,(,0,1
159335,PP,0,0
159336,),0,0
159337,",",0,0
159338,the,0,0
159339,eradication,1,1
159340,rates,1,1
159341,were,0,0
159342,85.5,0,0
159343,%,0,0
159344,and,0,0
159345,91.6,0,0
159346,%,0,0
159347,with,0,0
159348,the,0,0
159349,concomitant,0,0
159350,regimen,0,0
159351,",",0,0
159352,91.1,0,0
159353,%,0,0
159354,and,0,0
159355,92.1,0,0
159356,%,0,0
159357,with,0,0
159358,the,0,0
159359,sequential,0,0
159360,therapy,0,0
159361,",",0,0
159362,and,0,0
159363,80,0,0
159364,%,0,0
159365,and,0,0
159366,85.7,0,0
159367,%,0,0
159368,with,0,0
159369,the,0,0
159370,hybrid,0,0
159371,regimen,0,0
159372,.,0,0
159373,Differences,0,1
159374,were,0,0
159375,not,0,0
159376,statistically,0,0
159377,significant,0,0
159378,.,0,0
159379,H.,1,0
159380,pylori,1,1
159381,infection,1,1
159382,was,0,0
159383,cured,1,0
159384,in,0,0
159385,10,0,0
159386,(,0,0
159387,55.6,0,0
159388,%,0,0
159389,),0,0
159390,patients,0,0
159391,with,0,0
159392,the,0,0
159393,second-line,0,0
159394,regimen,0,0
159395,.,0,0
159396,CONCLUSION,0,0
159397,In,0,0
159398,our,0,0
159399,study,0,0
159400,",",0,0
159401,both,0,0
159402,concomitant,0,0
159403,and,0,1
159404,sequential,0,0
159405,therapy,0,0
159406,",",0,1
159407,but,0,0
159408,not,0,0
159409,hybrid,0,0
159410,therapy,0,0
159411,",",0,0
159412,reached,0,1
159413,high,0,0
159414,eradication,1,1
159415,rates,1,1
159416,.,1,0
159417,The,0,0
159418,success,1,1
159419,rate,1,1
159420,of,0,1
159421,second-line,0,0
159422,levofloxacin-based,0,0
159423,triple,0,0
159424,therapy,0,0
159425,is,0,0
159426,decreasing,0,0
159427,.,0,0
159428,Ultracision,0,1
159429,versus,0,0
159430,electrocautery,0,0
159431,in,0,0
159432,performing,0,0
159433,modified,0,0
159434,radical,0,1
159435,mastectomy,0,0
159436,and,0,1
159437,axillary,0,1
159438,lymph,0,1
159439,node,0,1
159440,dissection,0,0
159441,for,0,0
159442,breast,0,0
159443,cancer,0,0
159444,:,0,0
159445,a,0,0
159446,prospective,0,0
159447,randomized,0,0
159448,control,0,0
159449,trial,0,0
159450,.,0,1
159451,BACKGROUND,0,0
159452,Treatment,0,0
159453,for,0,0
159454,breast,0,0
159455,cancer,0,0
159456,has,0,0
159457,improved,0,0
159458,dramatically,0,0
159459,over,0,0
159460,the,0,0
159461,decades,0,0
159462,.,0,0
159463,Nevertheless,0,0
159464,",",0,0
159465,modified,0,0
159466,radical,0,1
159467,mastectomy,0,0
159468,with,0,0
159469,axillary,0,0
159470,dissection,0,0
159471,remains,0,0
159472,the,0,0
159473,standard,0,0
159474,treatment,0,0
159475,for,0,0
159476,most,0,0
159477,patients,0,0
159478,",",0,0
159479,especially,0,0
159480,those,0,0
159481,with,0,0
159482,big,0,0
159483,tumours,0,0
159484,.,0,0
159485,The,0,0
159486,conventional,0,0
159487,technology,0,0
159488,is,0,0
159489,to,0,0
159490,use,0,0
159491,diathermy,0,0
159492,to,0,0
159493,cut,0,0
159494,and,0,1
159495,coagulate,0,0
159496,blood,0,1
159497,vessels,0,1
159498,.,0,0
159499,The,0,0
159500,Ultracision,0,0
159501,dissector,0,0
159502,has,0,0
159503,been,0,0
159504,widely,0,0
159505,used,0,0
159506,in,0,0
159507,laparoscopic,0,0
159508,surgery,0,0
159509,and,0,0
159510,is,0,0
159511,documented,0,0
159512,to,0,0
159513,be,0,0
159514,safe,0,1
159515,and,0,1
159516,fast,0,1
159517,for,0,0
159518,cutting,0,0
159519,and,0,1
159520,coagulating,0,0
159521,tissue,0,1
159522,.,0,0
159523,The,0,0
159524,aim,0,0
159525,of,0,0
159526,this,0,0
159527,study,0,0
159528,is,0,0
159529,to,0,0
159530,compare,0,0
159531,ultracision,0,0
159532,to,0,0
159533,electrocautery,0,0
159534,",",0,0
159535,looking,0,1
159536,in,0,0
159537,terms,0,1
159538,of,0,0
159539,amount,0,1
159540,of,0,1
159541,post,0,0
159542,operative,0,1
159543,drainage,0,1
159544,",",0,1
159545,duration,0,1
159546,of,0,1
159547,drain,0,1
159548,days,0,0
159549,",",0,1
159550,seroma,0,1
159551,formation,0,1
159552,and,0,1
159553,other,0,0
159554,complications,0,1
159555,.,0,0
159556,METHODOLOGY,0,0
159557,This,0,0
159558,study,0,0
159559,was,0,0
159560,a,0,0
159561,prospective,0,0
159562,randomized,0,0
159563,control,0,0
159564,trial,0,0
159565,of,0,1
159566,modified,0,0
159567,radical,0,1
159568,mastectomy,0,0
159569,performed,0,0
159570,for,0,0
159571,breast,0,0
159572,cancer,0,0
159573,in,0,0
159574,Pusat,0,0
159575,Perubatan,0,0
159576,Universiti,0,0
159577,Kebangsaan,0,0
159578,Malaysia,0,0
159579,(,0,1
159580,PPUKM,0,0
159581,),0,0
159582,between,0,0
159583,1st,0,0
159584,June,0,0
159585,2007,0,0
159586,to,0,0
159587,31st,0,0
159588,December,0,0
159589,2008,0,0
159590,.,0,0
159591,Patients,0,0
159592,were,0,0
159593,randomized,0,0
159594,in,0,0
159595,two,0,0
159596,groups,0,0
159597,:,0,0
159598,group,0,0
159599,A,0,0
159600,(,0,0
159601,n,0,0
159602,=,0,0
159603,20,0,0
159604,),0,0
159605,underwent,0,0
159606,modified,0,0
159607,radical,0,1
159608,mastectomy,0,0
159609,using,0,0
159610,ultracision,0,0
159611,(,0,1
159612,UC,0,1
159613,),0,1
159614,and,0,1
159615,group,0,0
159616,B,0,1
159617,(,0,0
159618,n,0,0
159619,=,0,0
159620,20,0,0
159621,),0,0
159622,with,0,0
159623,the,0,0
159624,conventional,0,0
159625,electrocautery,0,0
159626,(,0,1
159627,EC,0,1
159628,),0,0
159629,method,0,0
159630,.,0,0
159631,Main,0,0
159632,outcome,0,1
159633,measures,0,1
159634,were,0,0
159635,amount,1,1
159636,of,1,1
159637,drainage,1,1
159638,and,1,1
159639,duration,1,1
159640,of,1,1
159641,drain,1,1
159642,days,1,0
159643,.,1,0
159644,An,0,0
159645,unpaired,0,0
159646,2-tailed,0,1
159647,Student,0,1
159648,'s,0,1
159649,t,0,0
159650,test,0,1
159651,and,0,0
159652,the,0,0
159653,?2,0,1
159654,test,0,0
159655,to,0,0
159656,compare,0,0
159657,the,0,0
159658,groups,0,0
159659,.,0,0
159660,RESULTS,0,0
159661,A,0,0
159662,total,0,0
159663,of,0,0
159664,40,0,0
159665,patients,0,0
159666,were,0,0
159667,involved,0,0
159668,in,0,0
159669,this,0,0
159670,study,0,0
159671,.,0,0
159672,The,0,0
159673,majority,0,0
159674,of,0,0
159675,patients,0,0
159676,were,0,0
159677,Malay,0,0
159678,(,0,0
159679,55,0,0
159680,%,0,0
159681,),0,0
159682,followed,0,0
159683,by,0,0
159684,Chinese,0,0
159685,(,0,0
159686,35,0,0
159687,%,0,0
159688,),0,0
159689,",",0,1
159690,Indian,0,0
159691,(,0,0
159692,5,0,0
159693,%,0,0
159694,),0,0
159695,and,0,1
159696,others,0,0
159697,(,0,0
159698,5,0,0
159699,%,0,0
159700,),0,0
159701,.,0,0
159702,The,1,0
159703,mean,1,1
159704,volume,1,1
159705,of,1,1
159706,drainage,1,1
159707,from,1,0
159708,the,1,0
159709,axilla,1,0
159710,in,0,0
159711,the,0,0
159712,EC,0,1
159713,group,0,0
159714,was,0,0
159715,significantly,0,0
159716,higher,0,0
159717,than,0,0
159718,UC,0,1
159719,group,0,0
159720,[,0,0
159721,489.5,0,0
159722,versus,0,0
159723,188.1,0,0
159724,mls,0,0
159725,(,0,0
159726,p,0,0
159727,<,0,0
159728,0.001,0,0
159729,),0,0
159730,],0,0
159731,.,0,0
159732,The,1,0
159733,mean,1,1
159734,volume,1,1
159735,of,1,1
159736,drainage,1,1
159737,from,1,0
159738,the,1,0
159739,breast,1,0
159740,and,1,0
159741,the,1,0
159742,total,1,1
159743,drainage,1,1
159744,from,1,0
159745,both,1,0
159746,the,1,0
159747,breast,1,0
159748,and,1,1
159749,axilla,1,1
159750,was,0,0
159751,also,0,0
159752,significantly,0,0
159753,higher,0,0
159754,in,0,0
159755,the,0,0
159756,EC,0,1
159757,group,0,0
159758,compared,0,0
159759,to,0,0
159760,UC,0,0
159761,[,0,0
159762,169.3,0,0
159763,versus,0,0
159764,58.8,0,0
159765,mls,0,0
159766,(,0,0
159767,p,0,0
159768,=,0,0
159769,0.004,0,0
159770,),0,0
159771,and,0,0
159772,663.7,0,0
159773,versus,0,0
159774,247.0,0,0
159775,mls,0,0
159776,(,0,0
159777,p,0,0
159778,<,0,0
159779,0.002,0,0
159780,),0,0
159781,respectively,0,0
159782,],0,0
159783,.,0,0
159784,The,0,0
159785,drainage,0,1
159786,consequently,0,0
159787,showed,0,0
159788,significant,1,0
159789,reduction,1,1
159790,in,1,0
159791,terms,1,1
159792,of,1,0
159793,drain,1,1
159794,days,1,0
159795,in,0,0
159796,the,0,0
159797,axilla,0,0
159798,[,0,0
159799,6,0,0
159800,days,0,0
159801,versus,0,0
159802,3,0,0
159803,days,0,0
159804,(,0,0
159805,p,0,0
159806,<,0,0
159807,0.002,0,0
159808,),0,0
159809,],0,0
159810,and,0,0
159811,the,0,0
159812,breast,0,0
159813,[,0,0
159814,3,0,0
159815,days,0,0
159816,versus,0,0
159817,2,0,0
159818,days,0,0
159819,(,0,0
159820,p,0,0
159821,<,0,0
159822,0.002,0,0
159823,),0,0
159824,],0,0
159825,in,0,0
159826,the,0,0
159827,UC,0,0
159828,compared,0,0
159829,to,0,0
159830,the,0,0
159831,EC,0,1
159832,.,0,0
159833,There,0,0
159834,was,0,0
159835,no,0,0
159836,significant,1,0
159837,complication,1,1
159838,in,0,0
159839,both,0,0
159840,arms,0,0
159841,.,0,0
159842,In,0,0
159843,conclusion,0,0
159844,",",0,0
159845,the,0,0
159846,use,0,0
159847,of,0,0
159848,ultracision,0,0
159849,able,0,0
159850,to,0,0
159851,reduce,0,0
159852,the,1,0
159853,amount,1,1
159854,of,1,1
159855,drainage,1,1
159856,and,1,0
159857,the,1,0
159858,number,1,1
159859,of,1,0
159860,drain,1,1
159861,days,1,0
159862,after,0,0
159863,performing,0,0
159864,modified,0,0
159865,radical,0,0
159866,mastectomy,0,0
159867,.,0,0
159868,In,0,0
159869,doing,0,0
159870,so,0,0
159871,",",0,0
159872,the,0,0
159873,use,0,0
159874,of,0,0
159875,this,0,0
159876,technology,0,0
159877,enable,0,0
159878,us,0,0
159879,to,0,0
159880,discharge,0,0
159881,patients,0,0
159882,earlier,0,0
159883,without,0,0
159884,significant,0,0
159885,morbidities,0,1
159886,.,0,0
159887,An,0,0
159888,Exploratory,0,1
159889,",",0,1
159890,Open-Label,0,0
159891,",",0,1
159892,Randomized,0,0
159893,Trial,0,0
159894,Comparing,0,0
159895,Risperidone,0,0
159896,Long-Acting,0,0
159897,Injectable,0,0
159898,with,0,0
159899,Oral,0,1
159900,Antipsychotic,0,0
159901,Medication,0,0
159902,in,0,0
159903,the,0,0
159904,Treatment,0,0
159905,of,0,0
159906,Early,0,0
159907,Psychosis,0,1
159908,.,0,0
159909,Few,0,0
159910,studies,0,0
159911,have,0,0
159912,examined,0,0
159913,effectiveness,0,1
159914,and,0,1
159915,tolerability,0,1
159916,of,0,1
159917,risperidone,0,0
159918,long-acting,0,0
159919,injections,0,0
159920,(,0,0
159921,RLAI,0,0
159922,),0,0
159923,in,0,0
159924,the,0,0
159925,early,0,0
159926,phase,0,0
159927,of,0,0
159928,a,0,0
159929,schizophrenia,0,1
159930,spectrum,0,0
159931,(,0,1
159932,SS,0,1
159933,),0,1
159934,disorder,0,0
159935,using,0,0
159936,a,0,0
159937,randomized,0,0
159938,controlled,0,0
159939,trial,0,0
159940,(,0,0
159941,RCT,0,0
159942,),0,0
159943,design,0,0
159944,.,0,0
159945,Eighty-five,0,0
159946,patients,0,0
159947,in,0,0
159948,early,0,0
159949,phase,0,0
159950,of,0,0
159951,an,0,0
159952,SS,0,1
159953,disorder,0,0
159954,were,0,0
159955,randomized,0,0
159956,to,0,0
159957,receive,0,0
159958,either,0,0
159959,oral,0,0
159960,second-generation,0,0
159961,antipsychotics,0,0
159962,(,0,0
159963,SGAs,0,1
159964,;,0,1
159965,n=41,0,0
159966,),0,1
159967,or,0,1
159968,RLAI,0,1
159969,(,0,1
159970,n=44,0,0
159971,),0,0
159972,over,0,0
159973,two,0,0
159974,years,0,0
159975,.,0,0
159976,Analyses,0,0
159977,were,0,0
159978,conducted,0,0
159979,on,0,0
159980,eligible,0,0
159981,participants,0,0
159982,(,0,1
159983,n=77,0,0
159984,),0,0
159985,for,0,0
159986,the,0,0
159987,stabilization,0,1
159988,(,0,0
159989,maximum,0,0
159990,18,0,0
159991,weeks,0,0
159992,),0,0
159993,and,0,1
159994,maintenance,0,0
159995,phases,0,1
159996,(,0,0
159997,up,0,0
159998,to,0,0
159999,Week,0,0
160000,104,0,0
160001,),0,0
160002,on,0,0
160003,primary,0,0
160004,outcome,0,1
160005,measures,0,1
160006,of,0,0
160007,time,1,1
160008,to,1,0
160009,stabilization,1,1
160010,and,0,1
160011,relapse,1,1
160012,",",1,1
160013,change,1,1
160014,in,1,0
160015,symptoms,1,1
160016,and,1,1
160017,safety,1,1
160018,",",0,1
160019,and,0,1
160020,comparisons,1,0
160021,made,0,0
160022,across,0,0
160023,the,0,0
160024,two,0,0
160025,groups,0,0
160026,.,0,0
160027,Both,0,0
160028,groups,0,0
160029,showed,0,0
160030,improvement,0,1
160031,on,0,0
160032,Positive,1,1
160033,and,1,1
160034,Negative,1,1
160035,Syndrome,1,1
160036,Scale,1,1
160037,(,1,1
160038,PANSS,1,1
160039,),1,1
160040,scores,1,1
160041,and,1,1
160042,Clinical,1,1
160043,Global,1,1
160044,Impression-Severity,1,1
160045,(,1,1
160046,CGI-S,1,0
160047,),1,0
160048,scores,1,1
160049,.,1,0
160050,There,0,0
160051,were,0,0
160052,no,0,0
160053,time,0,1
160054,X,0,1
160055,group,0,0
160056,interactions,0,0
160057,on,0,0
160058,any,0,0
160059,of,0,0
160060,the,0,0
160061,primary,0,0
160062,outcome,0,1
160063,measures,0,1
160064,.,0,0
160065,Post,0,0
160066,hoc,0,0
160067,examination,0,0
160068,revealed,0,0
160069,that,0,0
160070,the,0,0
160071,RLAI,0,0
160072,group,0,0
160073,showed,0,0
160074,greater,0,1
160075,change,0,1
160076,on,0,1
160077,CGI-S,1,1
160078,and,1,1
160079,PANSS,1,1
160080,negative,1,1
160081,symptom,1,1
160082,scores,1,1
160083,during,0,0
160084,the,0,0
160085,stabilization,0,1
160086,phase,0,0
160087,",",0,0
160088,while,0,0
160089,the,0,0
160090,oral,0,0
160091,group,0,0
160092,reached,0,0
160093,the,0,0
160094,same,0,0
160095,level,0,1
160096,of,0,1
160097,improvement,0,1
160098,during,0,0
160099,the,0,0
160100,maintenance,0,0
160101,phase,0,0
160102,.,0,0
160103,The,0,0
160104,current,0,0
160105,exploratory,0,0
160106,study,0,0
160107,suggests,0,0
160108,that-within,0,1
160109,an,0,0
160110,RCT,0,0
160111,design-RLAI,0,0
160112,and,0,1
160113,oral,0,0
160114,SGAs,0,1
160115,are,0,0
160116,equally,0,0
160117,effective,1,0
160118,and,0,0
160119,have,0,0
160120,similar,1,0
160121,safety,1,1
160122,profiles,1,1
160123,in,0,0
160124,patients,0,0
160125,in,0,0
160126,the,0,0
160127,early,0,0
160128,phase,0,0
160129,of,0,1
160130,SS,0,1
160131,disorders,0,0
160132,.,0,0
160133,Thus,0,1
160134,",",0,0
160135,RLAI,0,0
160136,offers,0,0
160137,no,0,0
160138,advantage,0,0
160139,to,0,0
160140,patients,0,0
160141,in,0,0
160142,early,0,0
160143,phase,0,0
160144,of,0,1
160145,SS,0,1
160146,disorders,0,0
160147,",",0,0
160148,but,0,0
160149,is,0,0
160150,likely,0,0
160151,to,0,0
160152,be,0,0
160153,effective,1,1
160154,and,0,1
160155,safe,1,1
160156,for,0,0
160157,those,0,0
160158,who,0,0
160159,may,0,0
160160,have,0,0
160161,problems,0,1
160162,with,0,0
160163,adherence,0,0
160164,and,0,0
160165,may,0,0
160166,either,0,0
160167,choose,0,0
160168,to,0,0
160169,take,0,0
160170,it,0,0
160171,or,0,0
160172,be,0,0
160173,prescribed,0,0
160174,under,0,0
160175,conditions,0,0
160176,of,0,0
160177,external,0,0
160178,control,0,0
160179,such,0,0
160180,as,0,0
160181,community,0,0
160182,treatment,0,0
160183,orders,0,0
160184,.,0,0
160185,[,0,0
160186,Closure,0,0
160187,of,0,1
160188,persistent,1,0
160189,foramen,1,1
160190,ovale,1,0
160191,-,0,0
160192,the,0,0
160193,last,0,0
160194,closure,0,1
160195,?,0,0
160196,],0,0
160197,.,0,0
160198,Patient,1,1
160199,satisfaction,1,1
160200,with,0,0
160201,nutrition,0,1
160202,services,0,1
160203,amongst,0,0
160204,cancer,0,0
160205,patients,0,0
160206,treated,0,0
160207,with,0,0
160208,autologous,0,0
160209,stem,0,1
160210,cell,0,1
160211,transplantation,0,0
160212,:,0,0
160213,a,0,0
160214,comparison,0,0
160215,of,0,1
160216,usual,0,0
160217,and,0,1
160218,extended,0,0
160219,care,0,0
160220,.,0,0
160221,BACKGROUND,0,0
160222,This,0,0
160223,study,0,0
160224,aimed,0,0
160225,to,0,0
160226,determine,0,0
160227,patient,0,1
160228,satisfaction,0,1
160229,with,0,0
160230,clinical,0,1
160231,nutrition,0,1
160232,services,0,1
160233,delivered,0,0
160234,by,0,0
160235,an,0,0
160236,accredited,0,0
160237,practicing,0,0
160238,dietitian,0,1
160239,amongst,0,0
160240,cancer,0,0
160241,patients,0,0
160242,treated,0,0
160243,with,0,0
160244,autologous,0,0
160245,stem,0,1
160246,cell,0,1
160247,transplantation,0,0
160248,that,0,0
160249,was,0,0
160250,provided,0,0
160251,with,0,0
160252,usual,0,0
160253,and,0,1
160254,extended,0,0
160255,care,0,0
160256,at,0,0
160257,100,0,0
160258,days,0,0
160259,post-transplantation,0,0
160260,.,0,0
160261,METHODS,0,0
160262,Patients,0,0
160263,were,0,0
160264,randomised,0,0
160265,to,0,0
160266,receive,0,0
160267,usual,0,0
160268,nutrition,0,1
160269,care,0,0
160270,or,0,1
160271,extended,0,0
160272,nutrition,0,1
160273,care,0,0
160274,during,0,0
160275,the,0,0
160276,course,0,0
160277,of,0,0
160278,their,0,0
160279,stem,0,1
160280,cell,0,1
160281,transplantation,0,0
160282,.,0,0
160283,After,0,0
160284,hospital,0,1
160285,discharge,0,1
160286,",",0,1
160287,usual,0,0
160288,care,0,0
160289,patients,0,0
160290,received,0,0
160291,no,0,0
160292,further,0,0
160293,nutrition,0,1
160294,support,0,0
160295,",",0,0
160296,whereas,0,0
160297,extended,0,0
160298,care,0,0
160299,patients,0,0
160300,received,0,0
160301,telephone,0,0
160302,dietary,0,1
160303,counselling,0,0
160304,from,0,0
160305,the,0,0
160306,same,0,0
160307,dietitian,0,0
160308,for,0,0
160309,up,0,0
160310,to,0,0
160311,100,0,0
160312,days,0,0
160313,post-transplantation,0,0
160314,.,0,0
160315,The,0,0
160316,patient,0,1
160317,satisfaction,0,1
160318,with,0,0
160319,clinical,0,1
160320,nutrition,0,1
160321,service,0,1
160322,questionnaire,0,1
160323,was,0,0
160324,completed,0,0
160325,anonymously,0,0
160326,at,0,0
160327,100,0,0
160328,days,0,0
160329,post-transplantation,0,0
160330,.,0,0
160331,Group,0,0
160332,comparisons,0,0
160333,were,0,0
160334,made,0,0
160335,using,0,0
160336,independent,0,0
160337,t-tests,0,0
160338,.,0,0
160339,RESULTS,0,0
160340,Thirty-seven,0,0
160341,patients,0,0
160342,consented,0,0
160343,to,0,0
160344,participate,0,0
160345,in,0,0
160346,the,0,0
160347,study,0,0
160348,(,0,0
160349,54,0,0
160350,%,0,0
160351,male,0,0
160352,;,0,0
160353,mean,0,1
160354,age,0,0
160355,58.7,0,0
160356,?,0,0
160357,9.5,0,0
160358,years,0,0
160359,;,0,0
160360,median,0,1
160361,body,0,1
160362,mass,0,1
160363,index,0,1
160364,26.8,0,0
160365,kg,0,0
160366,m,0,0
160367,(,0,1
160368,-2,0,0
160369,),0,0
160370,",",0,0
160371,range,0,0
160372,16.4-47.6,0,0
160373,kg,0,0
160374,m,0,1
160375,(,0,1
160376,-2,0,0
160377,),0,0
160378,),0,0
160379,;,0,0
160380,33,0,0
160381,patients,0,0
160382,completed,0,0
160383,the,0,0
160384,study,0,0
160385,and,0,0
160386,28,0,0
160387,patients,0,0
160388,returned,0,0
160389,the,0,0
160390,questionnaire,0,1
160391,(,0,0
160392,response,0,1
160393,rate,0,1
160394,=,0,0
160395,85,0,0
160396,%,0,0
160397,),0,0
160398,.,1,0
160399,All,1,0
160400,components,1,0
160401,of,1,0
160402,the,1,0
160403,questionnaire,1,1
160404,were,1,0
160405,rated,1,1
160406,highly,1,0
160407,by,0,0
160408,both,0,0
160409,groups,0,0
160410,;,0,0
160411,there,0,0
160412,was,0,0
160413,no,0,0
160414,significant,0,0
160415,difference,0,0
160416,between,0,0
160417,the,0,0
160418,groups,0,0
160419,(,0,0
160420,P,0,0
160421,>,0,0
160422,0.05,0,0
160423,),0,0
160424,.,0,0
160425,Although,0,0
160426,not,0,0
160427,statistically,0,0
160428,significant,0,0
160429,",",0,1
160430,extended,0,0
160431,care,0,0
160432,patients,0,0
160433,who,0,0
160434,received,0,0
160435,at,0,0
160436,least,0,0
160437,three,0,0
160438,telephone,0,0
160439,calls,0,0
160440,rated,1,1
160441,a,1,0
160442,higher,0,0
160443,overall,0,1
160444,satisfaction,1,1
160445,compared,1,0
160446,to,0,0
160447,those,0,0
160448,who,0,0
160449,received,0,0
160450,less,0,0
160451,calls,0,0
160452,;,0,0
160453,this,0,0
160454,difference,0,0
160455,was,0,0
160456,clinically,0,1
160457,important,0,0
160458,(,0,0
160459,score,0,1
160460,difference,0,0
160461,=,0,0
160462,0.56,0,0
160463,),0,0
160464,.,0,0
160465,CONCLUSIONS,0,0
160466,Cancer,0,0
160467,patients,0,0
160468,treated,0,0
160469,with,0,0
160470,autologous,0,0
160471,stem,0,1
160472,cell,0,1
160473,transplantation,0,0
160474,were,0,0
160475,satisfied,0,0
160476,with,0,0
160477,usual,0,0
160478,and,0,1
160479,extended,0,1
160480,nutrition,0,1
160481,care,0,0
160482,.,0,1
160483,Extended,0,0
160484,care,0,0
160485,patients,0,0
160486,who,0,0
160487,received,0,0
160488,at,0,0
160489,least,0,0
160490,three,0,0
160491,telephone,0,0
160492,calls,0,0
160493,after,0,0
160494,hospital,0,1
160495,discharge,0,1
160496,were,0,0
160497,more,0,0
160498,satisfied,0,1
160499,than,0,0
160500,those,0,0
160501,with,0,0
160502,less,0,0
160503,frequent,0,1
160504,intervention,0,0
160505,.,0,1
160506,Further,0,1
160507,exploration,0,0
160508,regarding,0,0
160509,the,0,0
160510,frequency,0,1
160511,and,0,1
160512,intensity,0,1
160513,of,0,1
160514,nutrition,0,0
160515,service,0,0
160516,is,0,0
160517,required,0,0
160518,.,0,0
160519,Beliefs,0,1
160520,underlying,0,0
160521,the,0,0
160522,intention,0,0
160523,to,0,0
160524,donate,0,0
160525,again,0,0
160526,among,0,0
160527,first-time,0,0
160528,blood,0,1
160529,donors,0,0
160530,who,0,0
160531,experience,0,0
160532,a,0,0
160533,mild,0,0
160534,adverse,0,1
160535,event,0,1
160536,.,0,0
160537,Using,0,0
160538,the,0,0
160539,belief,0,0
160540,basis,0,0
160541,of,0,0
160542,the,0,0
160543,theory,0,0
160544,of,0,0
160545,planned,0,0
160546,behavior,0,1
160547,(,0,0
160548,TPB,0,1
160549,),0,0
160550,",",0,0
160551,the,0,0
160552,current,0,0
160553,study,0,0
160554,explored,0,0
160555,the,0,0
160556,rate,1,1
160557,of,1,0
160558,mild,1,0
160559,reactions,1,1
160560,reported,0,0
160561,by,0,0
160562,donors,0,0
160563,in,0,0
160564,relation,0,0
160565,to,0,0
160566,their,0,0
160567,first,0,1
160568,donation,0,1
160569,and,0,0
160570,the,0,0
160571,intention,0,1
160572,and,0,1
160573,beliefs,0,1
160574,of,0,0
160575,those,0,0
160576,donors,0,0
160577,with,0,0
160578,regard,0,0
160579,to,0,0
160580,returning,0,0
160581,to,0,0
160582,donate,0,0
160583,again,0,0
160584,.,0,0
160585,A,0,0
160586,high,0,0
160587,proportion,0,0
160588,of,0,1
160589,first-time,0,0
160590,donors,0,0
160591,indicated,0,0
160592,that,0,0
160593,they,0,0
160594,had,0,0
160595,experienced,0,0
160596,a,0,0
160597,reaction,0,1
160598,to,0,0
160599,blood,0,1
160600,donation,0,1
160601,.,0,1
160602,Further,0,1
160603,",",0,0
160604,donors,0,0
160605,who,0,0
160606,reacted,0,0
160607,were,0,0
160608,less,0,0
160609,likely,0,0
160610,to,0,0
160611,intend,0,0
160612,to,0,0
160613,return,0,1
160614,to,0,0
160615,donate,0,0
160616,.,0,0
160617,Regression,0,1
160618,analyses,0,0
160619,suggested,0,0
160620,that,0,0
160621,targeting,0,0
160622,different,0,0
160623,beliefs,0,1
160624,for,0,0
160625,those,0,0
160626,donors,0,0
160627,who,0,0
160628,had,0,0
160629,and,0,1
160630,had,0,0
160631,not,0,0
160632,reacted,0,0
160633,would,0,0
160634,yield,0,1
160635,most,0,0
160636,benefit,0,0
160637,in,0,0
160638,bolstering,0,1
160639,donors,0,1
160640,',0,1
160641,intentions,0,1
160642,to,0,0
160643,remain,0,0
160644,donating,0,0
160645,.,0,0
160646,The,0,0
160647,findings,0,0
160648,provide,0,0
160649,insight,0,0
160650,into,0,0
160651,those,0,0
160652,messages,0,0
160653,that,0,0
160654,could,0,0
160655,be,0,0
160656,communicated,0,0
160657,via,0,0
160658,the,0,0
160659,mass,0,1
160660,media,0,0
160661,or,0,0
160662,in,0,0
160663,targeted,0,0
160664,communications,0,0
160665,to,0,0
160666,retain,0,0
160667,first-time,0,0
160668,donors,0,0
160669,who,0,0
160670,have,0,0
160671,experienced,0,0
160672,a,0,0
160673,mild,0,0
160674,vasovagal,0,1
160675,reaction,0,1
160676,.,0,0
160677,Percutaneous,0,0
160678,coronary,0,1
160679,intervention,0,0
160680,in,0,0
160681,patients,0,0
160682,with,0,0
160683,previous,0,0
160684,coronary,0,1
160685,artery,0,1
160686,bypass,0,1
160687,grafting,0,1
160688,(,0,0
160689,from,0,0
160690,the,0,0
160691,j-Cypher,0,0
160692,Registry,0,0
160693,),0,0
160694,.,0,0
160695,A,0,0
160696,paucity,0,0
160697,of,0,0
160698,data,0,0
160699,is,0,0
160700,available,0,0
160701,from,0,0
160702,large-scale,0,0
160703,studies,0,0
160704,evaluating,0,0
160705,the,0,0
160706,long-term,0,0
160707,outcomes,0,1
160708,of,0,0
160709,percutaneous,0,0
160710,coronary,0,1
160711,intervention,0,0
160712,in,0,0
160713,patients,0,0
160714,who,0,0
160715,had,0,0
160716,previously,0,0
160717,undergone,0,0
160718,coronary,0,1
160719,artery,0,1
160720,bypass,0,1
160721,grafting,0,1
160722,(,0,1
160723,CABG,0,1
160724,),0,0
160725,in,0,0
160726,the,0,0
160727,drug-eluting,0,0
160728,stent,0,0
160729,era,0,0
160730,.,0,0
160731,Of,0,0
160732,"12,812",0,0
160733,patients,0,0
160734,who,0,0
160735,had,0,0
160736,undergone,0,0
160737,sirolimus-eluting,0,0
160738,stent,0,1
160739,implantation,0,0
160740,in,0,0
160741,the,0,0
160742,j-Cypher,0,0
160743,registry,0,0
160744,",",0,0
160745,919,0,0
160746,(,0,0
160747,7.2,0,0
160748,%,0,0
160749,),0,0
160750,had,0,0
160751,a,0,0
160752,history,0,1
160753,of,0,1
160754,CABG,0,1
160755,and,0,1
160756,had,0,0
160757,significantly,0,0
160758,higher,0,0
160759,crude,1,1
160760,5-year,1,1
160761,mortality,1,1
160762,(,0,0
160763,19.9,0,0
160764,%,0,0
160765,vs,0,0
160766,14.0,0,0
160767,%,0,0
160768,",",0,0
160769,p,0,0
160770,<,0,0
160771,0.001,0,0
160772,),0,0
160773,.,0,0
160774,After,0,0
160775,adjusting,0,0
160776,for,0,0
160777,confounders,0,0
160778,",",0,0
160779,the,1,0
160780,excess,1,1
160781,risk,1,1
160782,of,1,1
160783,death,1,1
160784,was,0,0
160785,no,0,0
160786,longer,0,0
160787,significant,0,0
160788,(,0,0
160789,hazard,0,1
160790,ratio,0,1
160791,0.99,0,0
160792,",",0,0
160793,95,0,0
160794,%,0,0
160795,confidence,0,0
160796,interval,0,0
160797,0.83,0,0
160798,to,0,0
160799,1.18,0,0
160800,",",0,0
160801,p,0,0
160802,=,0,0
160803,0.90,0,0
160804,),0,0
160805,",",0,0
160806,and,0,0
160807,the,0,0
160808,adjusted,1,0
160809,risk,1,1
160810,of,1,0
160811,target,1,1
160812,lesion,1,1
160813,revascularization,1,1
160814,was,1,0
160815,significantly,0,0
160816,higher,0,0
160817,in,0,0
160818,patients,0,0
160819,with,0,0
160820,previous,0,0
160821,CABG,0,1
160822,than,0,0
160823,in,0,0
160824,those,0,0
160825,without,0,0
160826,(,0,0
160827,hazard,0,1
160828,ratio,0,1
160829,1.25,0,0
160830,",",0,0
160831,95,0,0
160832,%,0,0
160833,confidence,0,0
160834,interval,0,0
160835,1.06,0,0
160836,to,0,0
160837,1.47,0,0
160838,",",0,0
160839,p,0,0
160840,=,0,0
160841,0.01,0,0
160842,),0,0
160843,.,0,0
160844,Of,0,0
160845,the,0,0
160846,patients,0,0
160847,with,0,0
160848,previous,0,0
160849,CABG,0,1
160850,",",0,0
160851,those,0,0
160852,who,0,0
160853,had,0,0
160854,undergone,0,0
160855,?1,0,0
160856,saphenous,0,1
160857,vein,0,1
160858,graft,0,1
160859,intervention,0,0
160860,had,0,0
160861,significantly,0,0
160862,higher,1,0
160863,adjusted,1,0
160864,risks,1,1
160865,of,1,1
160866,cardiac,1,1
160867,death,1,1
160868,(,1,0
160869,hazard,1,1
160870,ratio,0,1
160871,2.21,0,0
160872,",",0,0
160873,95,0,0
160874,%,0,0
160875,confidence,0,0
160876,interval,0,0
160877,1.26,0,0
160878,to,0,0
160879,3.76,0,0
160880,",",0,0
160881,p,0,0
160882,=,0,0
160883,0.01,0,0
160884,),0,0
160885,",",0,0
160886,myocardial,1,1
160887,infarction,1,1
160888,(,1,0
160889,hazard,1,1
160890,ratio,0,1
160891,2.56,0,0
160892,",",0,0
160893,95,0,0
160894,%,0,0
160895,confidence,0,0
160896,interval,0,0
160897,1.10,0,0
160898,to,0,0
160899,5.60,0,0
160900,",",0,0
160901,p,0,0
160902,=,0,0
160903,0.03,0,0
160904,),0,0
160905,",",0,0
160906,target,1,1
160907,lesion,1,1
160908,revascularization,1,1
160909,(,1,1
160910,hazard,1,1
160911,ratio,0,1
160912,2.65,0,0
160913,",",0,0
160914,95,0,0
160915,%,0,0
160916,confidence,0,0
160917,interval,0,0
160918,1.82,0,0
160919,to,0,0
160920,3.81,0,0
160921,",",0,0
160922,p,0,0
160923,<,0,0
160924,0.001,0,0
160925,),0,0
160926,",",1,0
160927,and,1,1
160928,definite,1,1
160929,stent,1,1
160930,thrombosis,1,1
160931,(,1,1
160932,hazard,1,1
160933,ratio,0,1
160934,7.70,0,0
160935,",",0,0
160936,95,0,0
160937,%,0,0
160938,confidence,0,0
160939,interval,0,0
160940,1.99,0,0
160941,to,0,0
160942,29.1,0,0
160943,",",0,0
160944,p,0,0
160945,=,0,0
160946,0.004,0,0
160947,),0,0
160948,compared,0,0
160949,with,0,0
160950,those,0,0
160951,who,0,0
160952,underwent,0,0
160953,percutaneous,0,0
160954,coronary,0,1
160955,intervention,0,0
160956,only,0,0
160957,for,0,0
160958,the,0,0
160959,native,0,0
160960,coronary,0,0
160961,artery,0,0
160962,.,0,0
160963,In,0,0
160964,conclusion,1,0
160965,",",1,0
160966,the,1,0
160967,adjusted,1,0
160968,mortality,1,1
160969,was,1,0
160970,similar,1,0
160971,between,0,0
160972,patients,0,0
160973,with,0,0
160974,and,0,0
160975,without,0,0
160976,previous,0,0
160977,CABG,0,1
160978,",",0,0
160979,despite,0,0
160980,a,0,0
160981,significantly,0,0
160982,different,1,0
160983,risk,1,1
160984,of,1,1
160985,target,1,1
160986,lesion,1,1
160987,revascularization,1,1
160988,.,1,0
160989,Among,1,0
160990,the,0,0
160991,patients,0,0
160992,with,0,0
160993,previous,0,0
160994,CABG,0,1
160995,",",0,0
160996,those,0,0
160997,with,0,0
160998,saphenous,0,1
160999,vein,0,1
161000,graft,0,1
161001,intervention,0,0
161002,using,0,0
161003,a,0,0
161004,first-generation,0,0
161005,drug-eluting,0,0
161006,stent,0,1
161007,had,1,0
161008,worse,1,1
161009,clinical,1,1
161010,outcomes,1,1
161011,than,1,0
161012,those,1,0
161013,with,0,0
161014,a,0,0
161015,native,0,0
161016,coronary,0,1
161017,artery,0,1
161018,target,0,0
161019,only,0,0
161020,.,0,0
161021,Singing,0,0
161022,can,0,0
161023,facilitate,0,0
161024,foreign,0,0
161025,language,0,1
161026,learning,0,1
161027,.,0,0
161028,This,0,0
161029,study,0,0
161030,presents,0,0
161031,the,0,0
161032,first,0,0
161033,experimental,0,0
161034,evidence,0,0
161035,that,0,0
161036,singing,0,0
161037,can,0,0
161038,facilitate,0,0
161039,short-term,0,1
161040,paired-associate,0,0
161041,phrase,0,1
161042,learning,0,1
161043,in,0,0
161044,an,0,0
161045,unfamiliar,0,0
161046,language,0,1
161047,(,0,1
161048,Hungarian,0,0
161049,),0,0
161050,.,0,0
161051,Sixty,0,0
161052,adult,0,0
161053,participants,0,0
161054,were,0,0
161055,randomly,0,0
161056,assigned,0,0
161057,to,0,0
161058,one,0,0
161059,of,0,0
161060,three,0,0
161061,listen-and-repeat,0,0
161062,learning,0,0
161063,conditions,0,0
161064,:,0,0
161065,speaking,0,0
161066,",",0,1
161067,rhythmic,0,1
161068,speaking,0,1
161069,",",0,1
161070,or,0,0
161071,singing,0,1
161072,.,0,0
161073,Participants,0,0
161074,in,0,0
161075,the,0,0
161076,singing,0,1
161077,condition,0,0
161078,showed,0,0
161079,superior,0,1
161080,overall,1,1
161081,performance,1,1
161082,on,1,0
161083,a,1,0
161084,collection,1,0
161085,of,1,0
161086,Hungarian,1,0
161087,language,1,1
161088,tests,1,1
161089,after,0,0
161090,a,0,0
161091,15-min,0,1
161092,learning,0,1
161093,period,0,0
161094,",",0,0
161095,as,0,0
161096,compared,0,0
161097,with,0,0
161098,participants,0,0
161099,in,0,0
161100,the,0,0
161101,speaking,0,0
161102,and,0,1
161103,rhythmic,0,1
161104,speaking,0,0
161105,conditions,0,0
161106,.,0,0
161107,This,0,0
161108,superior,1,1
161109,performance,1,1
161110,was,0,0
161111,statistically,0,0
161112,significant,0,0
161113,(,0,0
161114,p,0,0
161115,<,0,0
161116,.05,0,0
161117,),0,0
161118,for,0,0
161119,the,0,0
161120,two,0,0
161121,tests,0,0
161122,that,0,0
161123,required,0,0
161124,participants,0,0
161125,to,0,0
161126,recall,0,1
161127,and,0,0
161128,produce,0,0
161129,spoken,0,1
161130,Hungarian,0,0
161131,phrases,0,0
161132,.,0,0
161133,The,0,0
161134,differences,0,0
161135,in,0,0
161136,performance,1,1
161137,were,0,0
161138,not,0,0
161139,explained,0,0
161140,by,0,0
161141,potentially,0,0
161142,influencing,0,0
161143,factors,0,0
161144,such,0,0
161145,as,0,0
161146,age,0,0
161147,",",0,1
161148,gender,0,1
161149,",",0,1
161150,mood,0,1
161151,",",0,1
161152,phonological,0,1
161153,working,0,1
161154,memory,0,1
161155,ability,0,1
161156,",",0,1
161157,or,0,1
161158,musical,0,1
161159,ability,0,1
161160,and,0,1
161161,training,0,0
161162,.,0,0
161163,These,0,0
161164,results,0,0
161165,suggest,0,0
161166,that,0,0
161167,a,0,0
161168,listen-and-sing,0,0
161169,learning,0,1
161170,method,0,0
161171,can,0,0
161172,facilitate,0,0
161173,verbatim,1,0
161174,memory,1,1
161175,for,0,0
161176,spoken,0,1
161177,foreign,0,0
161178,language,0,1
161179,phrases,0,0
161180,.,0,0
161181,Effects,0,0
161182,of,0,0
161183,Positive,0,1
161184,Action,0,1
161185,on,0,0
161186,the,0,0
161187,emotional,0,1
161188,health,0,1
161189,of,0,1
161190,urban,0,0
161191,youth,0,0
161192,:,0,0
161193,a,0,0
161194,cluster-randomized,0,0
161195,trial,0,0
161196,.,0,0
161197,PURPOSE,0,0
161198,We,0,0
161199,examined,0,0
161200,the,0,0
161201,effects,0,1
161202,of,0,0
161203,Positive,0,1
161204,Action,0,1
161205,(,0,1
161206,PA,0,1
161207,),0,0
161208,",",0,0
161209,a,0,0
161210,school-based,0,0
161211,social-emotional,0,1
161212,learning,0,1
161213,and,0,1
161214,health,0,1
161215,promotion,0,1
161216,program,0,0
161217,",",0,0
161218,on,0,0
161219,the,0,0
161220,emotional,0,1
161221,health,0,1
161222,of,0,0
161223,predominately,0,0
161224,low-income,0,0
161225,and,0,1
161226,ethnic,0,1
161227,minority,0,0
161228,urban,0,1
161229,youth,0,0
161230,.,0,0
161231,METHODS,0,0
161232,The,0,0
161233,study,0,0
161234,was,0,0
161235,a,0,0
161236,matched-pair,0,0
161237,",",0,0
161238,cluster-randomized,0,0
161239,controlled,0,0
161240,trial,0,0
161241,involving,0,0
161242,14,0,0
161243,Chicago,0,0
161244,public,0,0
161245,schools,0,0
161246,.,0,0
161247,Outcomes,0,1
161248,were,0,0
161249,assessed,0,0
161250,over,0,0
161251,a,0,0
161252,6-year,0,0
161253,period,0,0
161254,of,0,1
161255,program,0,0
161256,implementation,0,0
161257,for,0,0
161258,a,0,0
161259,cohort,0,0
161260,of,0,0
161261,youth,0,0
161262,in,0,0
161263,each,0,0
161264,school,0,0
161265,",",0,0
161266,followed,0,0
161267,from,0,0
161268,grades,0,1
161269,3,0,0
161270,to,0,0
161271,8,0,0
161272,.,0,0
161273,Youth,0,0
161274,reported,0,0
161275,on,0,0
161276,their,0,0
161277,emotional,0,1
161278,health,0,1
161279,(,0,0
161280,positive,0,1
161281,affect,0,1
161282,",",0,1
161283,life,0,1
161284,satisfaction,0,1
161285,",",0,1
161286,depression,0,1
161287,",",0,1
161288,anxiety,0,1
161289,),0,1
161290,and,0,1
161291,social-emotional,0,1
161292,and,0,1
161293,character,0,0
161294,development,0,1
161295,.,0,1
161296,Growth-curve,0,1
161297,and,0,1
161298,structural-equation,0,1
161299,modeling,0,0
161300,analyses,0,0
161301,assessed,0,0
161302,overall,0,1
161303,program,0,0
161304,effects,0,1
161305,on,0,0
161306,the,0,0
161307,emotional,0,1
161308,health,0,1
161309,outcomes,0,1
161310,as,0,0
161311,well,0,0
161312,as,0,0
161313,mediation,0,0
161314,of,0,0
161315,these,0,0
161316,effects,0,0
161317,via,0,0
161318,the,0,0
161319,program,0,0
161320,'s,0,1
161321,impact,0,0
161322,on,0,0
161323,youths,0,0
161324,',0,1
161325,social-emotional,0,1
161326,and,0,1
161327,character,0,0
161328,development,0,1
161329,.,0,1
161330,RESULTS,0,0
161331,Students,0,0
161332,in,0,0
161333,PA,0,1
161334,schools,0,0
161335,",",0,0
161336,compared,0,0
161337,with,0,0
161338,those,0,0
161339,in,0,0
161340,control,0,0
161341,schools,0,0
161342,",",0,1
161343,had,0,0
161344,more,0,0
161345,favorable,0,1
161346,change,0,1
161347,over,0,0
161348,the,0,0
161349,course,0,0
161350,of,0,0
161351,the,0,0
161352,study,0,0
161353,in,0,0
161354,positive,0,1
161355,affect,0,1
161356,(,0,0
161357,standardized,0,1
161358,mean,0,1
161359,difference,0,1
161360,effect,0,1
161361,size,0,1
161362,[,0,0
161363,ES,0,0
161364,],0,0
161365,=,0,0
161366,.17,0,0
161367,),0,1
161368,and,1,1
161369,life,1,1
161370,satisfaction,1,1
161371,(,0,1
161372,ES,0,0
161373,=,0,0
161374,.13,0,0
161375,),0,0
161376,as,0,0
161377,well,0,0
161378,as,0,0
161379,significantly,0,0
161380,lower,1,0
161381,depression,1,1
161382,(,1,1
161383,ES,0,0
161384,=,0,0
161385,-.14,0,1
161386,),0,1
161387,and,0,1
161388,anxiety,1,1
161389,(,1,1
161390,ES,1,0
161391,=,0,0
161392,-.26,0,0
161393,),0,0
161394,at,0,0
161395,study,0,0
161396,end,0,0
161397,point,0,0
161398,.,0,1
161399,Program,0,1
161400,effects,1,1
161401,for,1,0
161402,positive,1,1
161403,affect,1,1
161404,",",1,1
161405,depression,1,1
161406,",",1,1
161407,and,1,1
161408,anxiety,1,1
161409,were,1,0
161410,mediated,0,0
161411,by,0,0
161412,more,0,0
161413,favorable,0,1
161414,change,0,1
161415,over,0,0
161416,time,0,1
161417,in,0,0
161418,social-emotional,0,1
161419,and,0,1
161420,character,0,0
161421,development,0,1
161422,for,0,0
161423,students,0,0
161424,in,0,0
161425,PA,0,1
161426,schools,0,0
161427,.,0,0
161428,CONCLUSIONS,0,0
161429,Results,0,0
161430,suggest,0,0
161431,that,0,0
161432,universal,0,0
161433,",",0,0
161434,school-based,0,0
161435,programs,0,0
161436,can,0,0
161437,benefit,0,0
161438,the,0,0
161439,emotional,0,1
161440,health,0,1
161441,of,0,1
161442,youth,0,0
161443,in,0,0
161444,low-income,0,0
161445,",",0,0
161446,urban,0,1
161447,settings,0,0
161448,.,0,0
161449,The,0,0
161450,modest,0,0
161451,magnitude,0,1
161452,of,0,0
161453,effects,0,0
161454,over,0,0
161455,an,0,0
161456,extended,0,0
161457,period,0,0
161458,of,0,1
161459,program,0,0
161460,implementation,0,0
161461,",",0,1
161462,however,0,0
161463,",",0,0
161464,reflects,0,0
161465,the,0,0
161466,challenges,0,0
161467,of,0,0
161468,both,0,0
161469,mounting,0,0
161470,interventions,0,0
161471,and,0,1
161472,offsetting,0,1
161473,formidable,0,0
161474,risks,0,1
161475,for,0,0
161476,mental,0,1
161477,health,0,1
161478,problems,0,1
161479,in,0,0
161480,such,0,0
161481,environments,0,0
161482,.,0,0
161483,Anemia,0,1
161484,and,0,1
161485,associated,0,0
161486,clinical,0,0
161487,outcomes,0,1
161488,in,0,0
161489,patients,0,0
161490,with,0,0
161491,heart,0,1
161492,failure,0,1
161493,due,0,0
161494,to,0,0
161495,reduced,0,1
161496,left,0,1
161497,ventricular,0,1
161498,systolic,0,1
161499,function,0,1
161500,.,0,0
161501,BACKGROUND,0,0
161502,Anemia,0,1
161503,is,0,0
161504,associated,0,0
161505,with,0,0
161506,decreased,0,1
161507,functional,0,1
161508,capacity,0,1
161509,",",0,1
161510,reduced,0,1
161511,quality,0,1
161512,of,0,1
161513,life,0,1
161514,",",0,1
161515,and,0,1
161516,worsened,0,1
161517,outcomes,0,1
161518,among,0,0
161519,patients,0,0
161520,with,0,0
161521,heart,0,1
161522,failure,0,1
161523,(,0,1
161524,HF,0,1
161525,),0,0
161526,due,0,0
161527,to,0,0
161528,reduced,0,1
161529,left,0,1
161530,ventricular,0,1
161531,ejection,0,1
161532,fraction,0,1
161533,(,0,1
161534,HFREF,0,1
161535,),0,0
161536,.,0,0
161537,We,0,0
161538,sought,0,0
161539,to,0,0
161540,evaluate,0,0
161541,the,0,0
161542,independent,0,0
161543,effect,0,1
161544,of,0,1
161545,anemia,0,1
161546,on,0,0
161547,clinical,0,0
161548,outcomes,0,1
161549,among,0,0
161550,those,0,0
161551,with,0,0
161552,HFREF,0,0
161553,.,0,0
161554,HYPOTHESIS,0,0
161555,Anemia,0,1
161556,is,0,0
161557,associated,0,0
161558,with,0,0
161559,cardiovascular,0,1
161560,events,0,1
161561,in,0,0
161562,patients,0,0
161563,with,0,0
161564,heart,0,1
161565,failure,0,1
161566,.,0,0
161567,METHODS,0,0
161568,The,0,0
161569,HF-ACTION,0,0
161570,trial,0,0
161571,was,0,0
161572,a,0,0
161573,prospective,0,0
161574,",",0,0
161575,randomized,0,0
161576,trial,0,0
161577,of,0,1
161578,exercise,0,0
161579,therapy,0,0
161580,vs,0,0
161581,usual,0,0
161582,care,0,0
161583,in,0,0
161584,2331,0,0
161585,patients,0,0
161586,with,0,0
161587,HFREF,0,1
161588,.,0,0
161589,Patients,0,0
161590,with,0,0
161591,New,0,1
161592,York,0,0
161593,Heart,0,1
161594,Association,0,0
161595,class,0,0
161596,II,0,0
161597,to,0,0
161598,IV,0,1
161599,HF,0,1
161600,and,0,1
161601,left,0,1
161602,ventricular,0,1
161603,ejection,0,1
161604,fractions,0,1
161605,of,0,0
161606,?,0,0
161607,35,0,0
161608,%,0,0
161609,were,0,0
161610,recruited,1,0
161611,.,1,0
161612,Hemoglobin,1,1
161613,(,1,0
161614,Hb,1,1
161615,),1,1
161616,was,1,0
161617,measured,0,0
161618,up,0,0
161619,to,0,0
161620,1,0,0
161621,year,0,0
161622,prior,0,0
161623,to,0,0
161624,entry,0,1
161625,and,0,1
161626,was,0,0
161627,stratified,0,0
161628,by,0,0
161629,quintile,1,0
161630,.,1,1
161631,Anemia,1,1
161632,was,1,0
161633,defined,0,1
161634,as,0,0
161635,baseline,0,0
161636,Hb,0,0
161637,<,0,0
161638,13,0,0
161639,g/dL,0,0
161640,and,0,0
161641,<,0,0
161642,12,0,0
161643,g/dL,0,0
161644,in,0,0
161645,men,0,0
161646,and,0,1
161647,women,0,0
161648,",",0,0
161649,respectively,1,0
161650,.,1,0
161651,Hemoglobin,1,1
161652,was,1,0
161653,assessed,0,0
161654,in,0,0
161655,2,0,0
161656,models,0,0
161657,:,0,0
161658,a,0,0
161659,global,0,1
161660,prediction,0,1
161661,model,0,0
161662,that,0,0
161663,had,0,0
161664,been,0,0
161665,previously,0,0
161666,developed,0,0
161667,",",0,0
161668,and,0,0
161669,a,0,0
161670,modified,0,0
161671,model,0,0
161672,including,0,0
161673,variables,0,1
161674,associated,0,0
161675,with,0,0
161676,anemia,0,1
161677,and,0,0
161678,the,0,0
161679,studied,0,0
161680,outcomes,0,1
161681,.,0,0
161682,RESULTS,1,0
161683,Hemoglobin,1,1
161684,was,1,0
161685,available,0,0
161686,at,0,0
161687,baseline,0,0
161688,in,0,0
161689,1763,0,0
161690,subjects,0,0
161691,(,0,0
161692,76,0,0
161693,%,0,0
161694,of,0,0
161695,total,0,1
161696,study,0,0
161697,population,0,0
161698,),0,0
161699,;,0,0
161700,their,0,0
161701,median,0,1
161702,age,0,0
161703,was,0,0
161704,59.0,0,0
161705,years,0,0
161706,",",0,0
161707,73,0,0
161708,%,0,0
161709,were,0,0
161710,male,0,0
161711,",",0,0
161712,and,0,0
161713,62,0,0
161714,%,0,0
161715,were,0,0
161716,Caucasian,0,0
161717,.,0,0
161718,The,0,0
161719,prevalence,0,1
161720,of,0,1
161721,anemia,0,1
161722,was,0,0
161723,515/1763,0,0
161724,(,0,0
161725,29,0,0
161726,%,0,0
161727,),0,0
161728,.,0,0
161729,Older,0,1
161730,age,0,0
161731,",",0,1
161732,female,0,0
161733,sex,0,1
161734,",",0,1
161735,African,0,0
161736,American,0,1
161737,race,0,0
161738,",",0,0
161739,diabetes,0,1
161740,",",0,1
161741,hypertension,0,1
161742,",",0,1
161743,and,0,1
161744,lower,0,1
161745,estimated,0,0
161746,glomerular,0,1
161747,filtration,0,1
161748,rates,0,1
161749,were,0,0
161750,all,0,0
161751,more,0,0
161752,frequent,0,1
161753,in,0,0
161754,lower,0,0
161755,Hb,0,1
161756,quintiles,0,1
161757,.,0,0
161758,Over,0,0
161759,a,0,0
161760,median,0,1
161761,follow-up,0,0
161762,of,0,0
161763,30,0,0
161764,months,0,0
161765,",",0,0
161766,the,0,0
161767,primary,0,0
161768,outcome,0,1
161769,of,0,1
161770,all-cause,1,1
161771,mortality,1,1
161772,or,1,1
161773,all-cause,1,1
161774,hospitalization,1,1
161775,occurred,1,0
161776,in,0,0
161777,78,0,0
161778,%,0,0
161779,of,0,0
161780,those,0,0
161781,with,0,0
161782,anemia,0,1
161783,and,0,0
161784,64,0,0
161785,%,0,0
161786,in,0,0
161787,those,0,0
161788,without,0,0
161789,(,0,0
161790,P,0,0
161791,<,0,0
161792,0.001,0,0
161793,),0,0
161794,.,0,0
161795,The,0,0
161796,secondary,0,0
161797,outcomes,0,1
161798,of,0,1
161799,all-cause,1,1
161800,mortality,1,1
161801,alone,1,0
161802,",",1,0
161803,cardiovascular,1,1
161804,(,1,1
161805,CV,1,1
161806,),1,1
161807,mortality,1,1
161808,or,1,1
161809,CV,1,1
161810,hospitalization,1,1
161811,",",1,1
161812,and,1,1
161813,CV,1,1
161814,mortality,1,1
161815,or,1,1
161816,HF,1,1
161817,hospitalization,1,1
161818,occurred,1,0
161819,in,0,0
161820,23,0,0
161821,%,0,0
161822,vs,0,0
161823,15,0,0
161824,%,0,0
161825,",",0,0
161826,67,0,0
161827,%,0,0
161828,vs,0,0
161829,54,0,0
161830,%,0,0
161831,",",0,0
161832,and,0,0
161833,44,0,0
161834,vs,0,0
161835,29,0,0
161836,%,0,0
161837,",",0,0
161838,respectively,0,0
161839,(,0,0
161840,P,0,0
161841,<,0,0
161842,0.001,1,0
161843,),1,0
161844,.,1,0
161845,Heart,1,0
161846,failure,1,1
161847,hospitalizations,1,1
161848,occurred,1,0
161849,in,0,0
161850,36,0,0
161851,%,0,0
161852,vs,0,0
161853,22,0,0
161854,%,0,0
161855,",",0,0
161856,and,1,1
161857,urgent,1,1
161858,outpatient,1,0
161859,visits,1,1
161860,for,1,0
161861,HF,1,0
161862,exacerbations,1,1
161863,occurred,1,0
161864,in,0,0
161865,67,0,0
161866,%,0,0
161867,and,0,0
161868,55,0,0
161869,%,0,0
161870,",",0,0
161871,respectively,0,0
161872,(,0,0
161873,P,0,0
161874,<,0,0
161875,0.001,0,0
161876,),0,0
161877,.,0,0
161878,For,0,0
161879,the,0,0
161880,global,0,1
161881,model,0,0
161882,",",0,0
161883,there,0,0
161884,was,0,0
161885,an,0,0
161886,association,0,0
161887,observed,0,0
161888,for,0,0
161889,anemia,0,1
161890,and,1,1
161891,all-cause,1,1
161892,mortality,1,1
161893,or,1,1
161894,hospitalization,1,1
161895,(,1,1
161896,adjusted,0,0
161897,hazard,0,0
161898,ratio,0,1
161899,[,0,0
161900,HR,0,1
161901,],0,0
161902,:,0,0
161903,1.15,0,0
161904,",",0,0
161905,95,0,0
161906,%,0,0
161907,confidence,0,0
161908,interval,0,0
161909,[,0,0
161910,CI,0,0
161911,],0,0
161912,:,0,0
161913,1.01-1.32,0,0
161914,",",0,0
161915,P,0,0
161916,=,0,0
161917,0.04,0,0
161918,),0,0
161919,",",0,0
161920,but,0,0
161921,other,0,1
161922,outcomes,0,1
161923,were,0,0
161924,not,0,0
161925,significant,0,0
161926,at,0,0
161927,P,0,0
161928,<,0,0
161929,0.05,0,0
161930,.,0,0
161931,In,0,0
161932,the,0,0
161933,modified,0,0
161934,model,0,0
161935,",",0,0
161936,the,0,0
161937,adjusted,1,0
161938,HR,1,1
161939,for,1,0
161940,anemia,0,1
161941,and,0,0
161942,the,0,0
161943,primary,0,0
161944,outcome,0,1
161945,of,0,1
161946,all-cause,0,1
161947,mortality,0,1
161948,or,0,1
161949,all-cause,0,1
161950,hospitalization,0,1
161951,was,0,0
161952,1.25,0,0
161953,(,0,0
161954,95,0,0
161955,%,0,0
161956,CI,0,0
161957,:,0,0
161958,1.10-1.42,0,0
161959,",",0,0
161960,P,0,0
161961,<,0,0
161962,0.001,0,0
161963,),0,0
161964,.,0,0
161965,There,0,0
161966,were,0,0
161967,independent,0,0
161968,associations,0,0
161969,between,1,0
161970,anemia,1,1
161971,and,1,1
161972,all-cause,1,1
161973,death,1,1
161974,(,1,0
161975,HR,0,0
161976,:,0,0
161977,1.11,0,0
161978,",",0,0
161979,95,0,0
161980,%,0,0
161981,CI,0,0
161982,:,0,0
161983,0.87-1.42,0,0
161984,",",0,0
161985,P,0,0
161986,=,0,0
161987,0.38,1,0
161988,),1,0
161989,",",1,0
161990,CV,1,1
161991,death,1,1
161992,or,1,1
161993,CV,1,1
161994,hospitalization,1,1
161995,(,1,0
161996,HR,0,0
161997,:,0,0
161998,1.16,0,0
161999,",",0,0
162000,95,0,0
162001,%,0,0
162002,CI,0,0
162003,:,0,0
162004,1.01-1.33,0,0
162005,",",0,0
162006,P,0,0
162007,=,0,0
162008,0.035,0,0
162009,),0,0
162010,",",0,0
162011,and,0,1
162012,CV,0,1
162013,death,0,1
162014,and,1,1
162015,HF,1,1
162016,hospitalization,1,1
162017,(,1,0
162018,HR,0,0
162019,:,0,0
162020,1.27,0,0
162021,",",0,0
162022,95,0,0
162023,%,0,0
162024,CI,0,0
162025,:,0,0
162026,1.06-1.51,0,0
162027,",",0,0
162028,P,0,0
162029,=,0,0
162030,0.008,0,0
162031,),0,0
162032,.,0,0
162033,CONCLUSIONS,0,0
162034,Anemia,0,1
162035,modestly,0,0
162036,is,0,0
162037,associated,0,0
162038,with,0,0
162039,increased,0,0
162040,rates,0,1
162041,of,0,1
162042,death,0,1
162043,",",0,1
162044,hospitalization,0,1
162045,",",0,1
162046,and,0,1
162047,HF,0,1
162048,exacerbation,0,1
162049,in,0,0
162050,patients,0,0
162051,with,0,0
162052,chronic,0,0
162053,HFREF,0,1
162054,.,0,0
162055,After,0,0
162056,adjusting,0,0
162057,for,0,0
162058,other,0,0
162059,important,0,1
162060,covariates,0,1
162061,",",0,0
162062,anemia,0,1
162063,is,0,0
162064,independently,0,0
162065,associated,0,0
162066,with,0,0
162067,an,0,0
162068,excess,0,1
162069,hazard,0,1
162070,for,0,0
162071,all-cause,0,1
162072,mortality,0,1
162073,and,0,1
162074,all-cause,0,1
162075,hospitalization,0,1
162076,.,0,0
162077,Anemia,0,1
162078,is,0,0
162079,also,0,0
162080,associated,0,0
162081,with,0,0
162082,combinations,0,0
162083,of,0,0
162084,CV,0,1
162085,death,0,1
162086,and,0,1
162087,CV/HF,0,1
162088,hospitalizations,0,1
162089,as,0,0
162090,composite,0,1
162091,endpoints,0,1
162092,.,0,0
162093,A,0,0
162094,study,0,0
162095,to,0,0
162096,evaluate,0,0
162097,safety,1,1
162098,and,0,1
162099,tolerability,1,1
162100,of,0,1
162101,repeated,0,0
162102,doses,0,0
162103,of,0,0
162104,tirasemtiv,0,0
162105,in,0,0
162106,patients,0,0
162107,with,0,0
162108,amyotrophic,0,0
162109,lateral,0,0
162110,sclerosis,0,0
162111,.,0,0
162112,Abstract,0,0
162113,Tirasemtiv,0,0
162114,is,0,0
162115,a,0,0
162116,fast,0,0
162117,skeletal,0,0
162118,muscle,0,1
162119,activator,0,0
162120,that,0,0
162121,increases,0,0
162122,the,0,0
162123,sensitivity,0,1
162124,of,0,0
162125,the,0,0
162126,sarcomere,0,1
162127,to,0,0
162128,calcium,0,1
162129,",",0,0
162130,increasing,0,0
162131,the,0,0
162132,efficiency,0,1
162133,of,0,1
162134,muscle,0,1
162135,contraction,0,1
162136,when,0,0
162137,the,0,0
162138,muscle,0,0
162139,is,0,0
162140,stimulated,0,0
162141,at,0,0
162142,submaximal,0,0
162143,contraction,0,1
162144,frequencies,0,1
162145,.,0,0
162146,A,0,0
162147,previous,0,0
162148,study,0,0
162149,showed,0,0
162150,single,0,0
162151,doses,0,0
162152,of,0,0
162153,tirasemtiv,0,0
162154,to,0,0
162155,be,0,0
162156,well,0,0
162157,tolerated,0,1
162158,and,0,0
162159,associated,0,0
162160,with,0,0
162161,potentially,0,0
162162,important,0,0
162163,improvements,0,0
162164,in,0,0
162165,a,0,0
162166,variety,0,0
162167,of,0,0
162168,functional,0,1
162169,outcomes,0,1
162170,.,0,0
162171,This,0,0
162172,study,0,0
162173,determined,0,0
162174,safety,1,1
162175,of,0,1
162176,tirasemtiv,0,0
162177,when,0,0
162178,given,0,0
162179,at,0,0
162180,doses,0,0
162181,up,0,0
162182,to,0,0
162183,500,0,0
162184,mg,0,0
162185,daily,0,0
162186,for,0,0
162187,three,0,0
162188,weeks,0,0
162189,.,0,0
162190,Tirasemtiv,0,0
162191,was,0,0
162192,given,0,0
162193,as,0,0
162194,a,0,0
162195,single,0,0
162196,daily,0,0
162197,dose,0,0
162198,up,0,0
162199,to,0,0
162200,375,0,0
162201,mg,0,0
162202,for,0,0
162203,two,0,0
162204,weeks,0,0
162205,",",0,0
162206,with,0,0
162207,and,0,1
162208,without,0,0
162209,concomitant,0,0
162210,riluzole,0,0
162211,.,0,0
162212,In,0,0
162213,a,0,0
162214,separate,0,0
162215,cohort,0,0
162216,",",0,0
162217,an,0,0
162218,ascending,0,1
162219,dose,0,0
162220,protocol,0,0
162221,evaluated,0,0
162222,a,0,0
162223,total,0,1
162224,dose,0,0
162225,of,0,0
162226,500,0,0
162227,mg,0,0
162228,daily,0,0
162229,given,0,0
162230,in,0,0
162231,two,0,0
162232,divided,0,0
162233,doses,0,0
162234,.,0,1
162235,Safety,1,1
162236,and,1,1
162237,tolerability,1,1
162238,were,0,0
162239,assessed,0,0
162240,",",0,0
162241,as,0,0
162242,well,0,0
162243,as,0,0
162244,measures,1,1
162245,of,1,1
162246,function,1,1
162247,",",1,1
162248,muscle,1,1
162249,strength,1,1
162250,and,1,1
162251,endurance,1,1
162252,.,1,1
162253,Results,0,0
162254,showed,0,0
162255,that,0,0
162256,tirasemtiv,0,0
162257,was,0,0
162258,well,0,1
162259,tolerated,1,1
162260,",",0,0
162261,with,0,0
162262,dizziness,1,1
162263,the,0,0
162264,most,0,0
162265,common,0,0
162266,adverse,0,1
162267,event,0,1
162268,.,0,0
162269,Tirasemtiv,0,0
162270,approximately,0,0
162271,doubled,0,0
162272,the,0,0
162273,serum,1,1
162274,concentration,1,1
162275,of,1,0
162276,riluzole,1,0
162277,.,1,1
162278,Trends,0,0
162279,were,0,0
162280,noted,0,0
162281,for,0,0
162282,improvement,0,1
162283,in,0,0
162284,ALSFRS-R,1,0
162285,",",1,0
162286,Maximum,1,1
162287,Minute,1,1
162288,Ventilation,1,1
162289,",",1,1
162290,and,1,1
162291,Nasal,1,1
162292,Inspiratory,1,1
162293,Pressure,1,1
162294,.,1,0
162295,In,0,0
162296,conclusion,0,0
162297,",",0,0
162298,tirasemtiv,0,0
162299,is,0,0
162300,well,0,1
162301,tolerated,0,1
162302,and,0,0
162303,can,0,0
162304,be,0,0
162305,given,0,0
162306,safely,1,0
162307,with,0,0
162308,a,0,0
162309,reduced,0,0
162310,dose,0,0
162311,of,0,0
162312,riluzole,0,0
162313,.,0,0
162314,Positive,0,1
162315,trends,0,0
162316,in,0,0
162317,multiple,1,0
162318,exploratory,1,0
162319,outcome,1,1
162320,measures,1,0
162321,support,0,0
162322,the,0,0
162323,further,0,0
162324,study,0,0
162325,of,0,0
162326,this,0,0
162327,agent,0,0
162328,in,0,0
162329,ALS,0,0
162330,.,0,0
162331,Why,0,0
162332,does,0,0
162333,lag,0,0
162334,affect,0,0
162335,the,0,0
162336,durability,1,1
162337,of,1,0
162338,memory-based,1,0
162339,automaticity,1,1
162340,:,1,0
162341,loss,0,1
162342,of,0,1
162343,memory,0,1
162344,strength,0,1
162345,or,0,0
162346,interference,0,1
162347,?,0,0
162348,In,0,0
162349,Rickard,0,0
162350,",",0,1
162351,Lau,0,0
162352,",",0,1
162353,and,0,1
162354,Pashler,0,1
162355,'s,0,1
162356,(,0,0
162357,2008,0,0
162358,),0,0
162359,investigation,0,0
162360,of,0,0
162361,the,0,0
162362,lag,0,1
162363,effect,0,1
162364,on,0,0
162365,memory-based,1,1
162366,automaticity,1,1
162367,",",0,1
162368,response,0,1
162369,times,0,1
162370,were,0,0
162371,faster,0,1
162372,and,0,1
162373,proportion,0,1
162374,of,0,1
162375,trials,0,0
162376,retrieved,0,0
162377,was,0,0
162378,higher,0,0
162379,at,0,0
162380,the,0,0
162381,end,0,0
162382,of,0,0
162383,practice,0,0
162384,for,0,0
162385,short,0,1
162386,lag,0,1
162387,items,0,1
162388,than,0,0
162389,for,0,0
162390,long,0,0
162391,lag,0,1
162392,items,0,1
162393,.,0,0
162394,However,0,0
162395,",",0,0
162396,during,0,0
162397,testing,0,0
162398,after,0,0
162399,a,0,0
162400,delay,0,1
162401,",",0,0
162402,response,1,1
162403,times,1,1
162404,were,0,0
162405,slower,0,0
162406,and,0,1
162407,proportion,0,1
162408,of,0,1
162409,trials,0,0
162410,retrieved,0,0
162411,was,0,0
162412,lower,0,0
162413,for,0,0
162414,short,0,1
162415,lag,0,1
162416,items,0,1
162417,than,0,0
162418,for,0,0
162419,long,0,0
162420,lag,0,1
162421,items,0,1
162422,.,0,0
162423,The,0,0
162424,current,0,0
162425,study,0,0
162426,investigated,0,0
162427,the,0,0
162428,extent,0,0
162429,to,0,0
162430,which,0,0
162431,the,0,0
162432,lag,0,1
162433,effect,0,0
162434,on,0,0
162435,the,0,0
162436,durability,1,1
162437,of,1,0
162438,memory-based,1,0
162439,automaticity,1,1
162440,is,0,0
162441,due,0,0
162442,to,0,0
162443,interference,0,1
162444,or,0,0
162445,to,0,0
162446,the,0,0
162447,loss,0,1
162448,of,0,1
162449,memory,0,1
162450,strength,0,1
162451,with,0,0
162452,time,0,1
162453,.,0,0
162454,Participants,0,0
162455,repeatedly,0,0
162456,practiced,0,0
162457,alphabet,0,0
162458,subtraction,0,1
162459,items,0,1
162460,in,0,0
162461,short,0,1
162462,lag,0,1
162463,and,0,1
162464,long,0,1
162465,lag,0,1
162466,conditions,0,0
162467,.,0,0
162468,After,0,0
162469,practice,0,0
162470,",",0,1
162471,half,0,0
162472,of,0,0
162473,the,0,0
162474,participants,0,0
162475,were,0,0
162476,immediately,0,0
162477,tested,0,0
162478,and,0,0
162479,the,0,0
162480,other,0,0
162481,half,0,1
162482,were,0,0
162483,tested,0,0
162484,after,0,0
162485,a,0,0
162486,7-day,0,0
162487,delay,0,1
162488,.,0,0
162489,Results,0,0
162490,indicate,0,0
162491,that,0,0
162492,the,0,0
162493,lag,1,1
162494,effect,1,0
162495,on,0,0
162496,the,0,0
162497,durability,1,1
162498,of,1,0
162499,memory-based,1,0
162500,automaticity,1,1
162501,is,0,0
162502,primarily,0,0
162503,due,0,0
162504,to,0,0
162505,interference,0,0
162506,.,0,0
162507,We,0,0
162508,discuss,0,0
162509,potential,0,0
162510,modification,0,0
162511,of,0,1
162512,current,0,0
162513,memory-based,0,0
162514,processing,0,1
162515,theories,0,0
162516,to,0,0
162517,account,0,0
162518,for,0,0
162519,these,0,0
162520,effects,0,0
162521,.,0,0
162522,The,0,0
162523,effect,0,0
162524,of,0,0
162525,person-centred,0,0
162526,dementia,0,1
162527,care,0,0
162528,to,0,0
162529,prevent,0,0
162530,agitation,0,1
162531,and,0,1
162532,other,0,0
162533,neuropsychiatric,0,1
162534,symptoms,0,1
162535,and,0,1
162536,enhance,0,0
162537,quality,0,1
162538,of,0,1
162539,life,0,1
162540,in,0,0
162541,nursing,0,1
162542,home,0,0
162543,patients,0,0
162544,:,0,0
162545,a,0,0
162546,10-month,0,0
162547,randomized,0,0
162548,controlled,0,0
162549,trial,0,0
162550,.,0,0
162551,AIMS,0,0
162552,We,0,0
162553,examined,0,0
162554,whether,0,0
162555,Dementia,0,1
162556,Care,0,1
162557,Mapping,0,1
162558,(,0,1
162559,DCM,0,1
162560,),0,0
162561,or,0,0
162562,the,0,0
162563,VIPS,0,1
162564,practice,0,0
162565,model,0,0
162566,(,0,1
162567,VPM,0,0
162568,),0,0
162569,is,0,0
162570,more,0,0
162571,effective,0,1
162572,than,0,0
162573,education,0,0
162574,of,0,0
162575,the,0,0
162576,nursing,0,1
162577,home,0,0
162578,staff,0,0
162579,about,0,1
162580,dementia,0,1
162581,(,0,0
162582,control,0,0
162583,group,0,0
162584,),0,0
162585,in,0,0
162586,reducing,0,0
162587,agitation,0,1
162588,and,0,1
162589,other,0,0
162590,neuropsychiatric,0,1
162591,symptoms,0,1
162592,as,0,0
162593,well,0,0
162594,as,0,0
162595,in,0,0
162596,enhancing,0,0
162597,the,0,0
162598,quality,0,1
162599,of,0,0
162600,life,0,1
162601,among,0,0
162602,nursing,0,1
162603,home,0,0
162604,patients,0,0
162605,.,0,0
162606,METHODS,0,0
162607,A,0,0
162608,10-month,0,0
162609,three-armed,0,0
162610,cluster-randomized,0,0
162611,controlled,0,0
162612,trial,0,0
162613,compared,0,0
162614,DCM,0,1
162615,and,0,0
162616,VPM,0,1
162617,with,0,0
162618,control,0,0
162619,.,0,0
162620,Of,0,0
162621,624,0,0
162622,nursing,0,0
162623,home,0,0
162624,patients,0,0
162625,with,0,0
162626,dementia,0,0
162627,",",0,0
162628,446,0,0
162629,completed,0,0
162630,follow-up,0,0
162631,assessments,0,0
162632,.,0,0
162633,The,0,0
162634,primary,0,0
162635,outcome,0,1
162636,was,0,0
162637,the,0,0
162638,change,0,0
162639,on,0,0
162640,the,0,0
162641,Brief,1,1
162642,Agitation,1,1
162643,Rating,1,1
162644,Scale,1,1
162645,(,1,1
162646,BARS,1,0
162647,),1,0
162648,.,1,0
162649,Secondary,0,0
162650,outcomes,0,1
162651,were,0,0
162652,changes,0,1
162653,on,0,0
162654,the,0,0
162655,10-item,1,0
162656,version,1,0
162657,of,1,0
162658,the,1,0
162659,Neuropsychiatric,1,0
162660,Inventory,1,1
162661,Questionnaire,1,1
162662,(,1,1
162663,NPI-Q,1,1
162664,),1,0
162665,",",1,0
162666,the,1,0
162667,Cornell,1,0
162668,Scale,1,1
162669,for,1,0
162670,Depression,1,1
162671,in,1,0
162672,Dementia,1,1
162673,(,1,0
162674,CSDD,1,1
162675,),1,0
162676,and,1,0
162677,the,1,0
162678,Quality,1,1
162679,of,1,0
162680,Life,1,0
162681,in,1,0
162682,Late-Stage,1,1
162683,Dementia,1,1
162684,(,1,1
162685,QUALID,1,1
162686,),1,0
162687,scale,1,1
162688,.,1,0
162689,RESULTS,0,0
162690,Changes,0,1
162691,in,0,0
162692,the,0,0
162693,BARS,1,0
162694,score,1,1
162695,did,0,0
162696,not,0,0
162697,differ,0,0
162698,significantly,0,0
162699,between,0,0
162700,the,0,0
162701,DCM,0,0
162702,and,0,0
162703,the,0,0
162704,control,0,0
162705,group,0,0
162706,or,0,0
162707,between,0,0
162708,the,0,0
162709,VPM,0,0
162710,and,0,0
162711,the,0,0
162712,control,0,0
162713,group,0,0
162714,after,0,0
162715,10,0,0
162716,months,0,0
162717,.,0,0
162718,Positive,0,1
162719,differences,0,0
162720,were,0,0
162721,found,0,0
162722,for,0,0
162723,changes,0,0
162724,in,0,0
162725,the,0,0
162726,secondary,0,0
162727,outcomes,0,0
162728,:,0,0
162729,the,0,0
162730,NPI-Q,1,0
162731,sum,1,1
162732,score,1,1
162733,as,0,0
162734,well,0,0
162735,as,0,0
162736,the,0,0
162737,subscales,0,1
162738,NPI-Q,1,1
162739,agitation,1,1
162740,and,1,1
162741,NPI-Q,1,1
162742,psychosis,1,1
162743,were,0,0
162744,in,0,0
162745,favour,0,0
162746,of,0,0
162747,both,0,0
162748,interventions,0,0
162749,versus,0,0
162750,control,0,0
162751,",",0,0
162752,the,0,0
162753,QUALID,1,1
162754,score,1,1
162755,was,0,0
162756,in,0,0
162757,favour,0,0
162758,of,0,1
162759,DCM,0,1
162760,versus,0,0
162761,control,0,0
162762,and,0,0
162763,the,0,0
162764,CSDD,1,1
162765,score,1,1
162766,was,0,0
162767,in,0,0
162768,favour,0,0
162769,of,0,1
162770,VPM,0,1
162771,versus,0,0
162772,control,0,0
162773,.,0,0
162774,CONCLUSIONS,0,0
162775,This,0,0
162776,study,0,0
162777,failed,0,0
162778,to,0,0
162779,find,0,0
162780,a,0,0
162781,significant,0,0
162782,effect,0,0
162783,of,0,0
162784,both,0,0
162785,interventions,0,0
162786,on,0,0
162787,the,0,0
162788,primary,0,0
162789,outcome,0,1
162790,.,0,0
162791,Positive,0,1
162792,effects,0,0
162793,on,0,0
162794,the,0,0
162795,secondary,0,0
162796,outcomes,0,0
162797,indicate,0,0
162798,that,0,0
162799,the,0,0
162800,methods,0,0
162801,merit,0,0
162802,further,0,0
162803,investigation,0,0
162804,.,0,0
162805,Data,0,0
162806,mining,0,0
162807,the,0,0
162808,ScanBrit,0,0
162809,study,0,0
162810,of,0,0
162811,a,0,0
162812,gluten-,0,1
162813,and,0,0
162814,casein-free,0,0
162815,dietary,0,1
162816,intervention,0,0
162817,for,0,0
162818,children,0,0
162819,with,0,0
162820,autism,0,0
162821,spectrum,0,0
162822,disorders,0,0
162823,:,0,0
162824,behavioural,1,1
162825,and,1,1
162826,psychometric,1,1
162827,measures,1,1
162828,of,0,1
162829,dietary,0,0
162830,response,0,1
162831,.,0,0
162832,We,0,0
162833,previously,0,0
162834,reported,0,0
162835,results,0,0
162836,based,0,0
162837,on,0,0
162838,the,0,0
162839,examination,0,0
162840,of,0,0
162841,a,0,0
162842,gluten-,0,1
162843,and,0,1
162844,casein-free,0,0
162845,diet,0,0
162846,as,0,0
162847,an,0,0
162848,intervention,0,0
162849,for,0,0
162850,children,0,0
162851,diagnosed,0,0
162852,with,0,0
162853,an,0,0
162854,autism,0,0
162855,spectrum,0,0
162856,disorder,0,0
162857,as,0,0
162858,part,0,0
162859,of,0,0
162860,the,0,0
162861,ScanBrit,0,0
162862,collaboration,0,0
162863,.,0,1
162864,Analysis,0,0
162865,based,0,0
162866,on,0,0
162867,grouped,0,0
162868,results,0,0
162869,indicated,0,0
162870,several,0,0
162871,significant,0,0
162872,differences,1,0
162873,between,1,0
162874,dietary,1,0
162875,and,1,1
162876,non-dietary,1,1
162877,participants,1,0
162878,across,0,0
162879,various,0,0
162880,core,0,1
162881,and,0,1
162882,peripheral,0,1
162883,areas,0,1
162884,of,0,0
162885,functioning,0,1
162886,.,0,0
162887,Results,0,0
162888,also,0,0
162889,indicated,0,0
162890,some,0,0
162891,disparity,0,1
162892,in,0,0
162893,individual,0,0
162894,responses,0,1
162895,to,0,0
162896,dietary,0,0
162897,modification,0,0
162898,potentially,0,0
162899,indicative,0,0
162900,of,0,1
162901,responder,0,1
162902,and,0,1
162903,non-responder,0,0
162904,differences,0,0
162905,.,0,0
162906,Further,0,0
162907,examination,0,0
162908,of,0,0
162909,the,0,0
162910,behavioural,0,1
162911,and,0,0
162912,psychometric,0,1
162913,data,0,0
162914,garnered,0,0
162915,from,0,0
162916,participants,0,0
162917,was,0,0
162918,undertaken,0,0
162919,",",0,0
162920,with,0,0
162921,a,0,0
162922,view,0,0
162923,to,0,0
162924,determining,0,0
162925,potential,0,0
162926,factors,0,0
162927,pertinent,0,0
162928,to,0,0
162929,response,0,1
162930,to,0,0
162931,dietary,0,0
162932,intervention,0,0
162933,.,0,0
162934,Participants,0,0
162935,with,0,0
162936,clinically,0,0
162937,significant,0,0
162938,scores,0,1
162939,indicative,1,0
162940,of,1,1
162941,inattention,1,1
162942,and,1,1
162943,hyperactivity,1,1
162944,behaviours,1,1
162945,and,0,0
162946,who,0,0
162947,had,0,0
162948,a,0,0
162949,significant,0,0
162950,positive,0,0
162951,changes,0,1
162952,to,0,0
162953,said,0,1
162954,scores,0,1
162955,were,0,0
162956,defined,0,1
162957,as,0,0
162958,responders,0,0
162959,to,0,0
162960,the,0,0
162961,dietary,0,0
162962,intervention,0,0
162963,.,0,1
162964,Analyses,0,0
162965,indicated,0,0
162966,several,1,0
162967,factors,1,0
162968,to,1,0
162969,be,1,0
162970,potentially,1,0
162971,pertinent,1,0
162972,to,1,0
162973,a,1,0
162974,positive,1,0
162975,response,1,1
162976,to,0,0
162977,dietary,0,0
162978,intervention,0,0
162979,in,0,0
162980,terms,0,1
162981,of,0,1
162982,symptom,0,1
162983,presentation,0,1
162984,.,0,1
162985,Chronological,0,0
162986,age,0,0
162987,was,0,0
162988,found,0,0
162989,to,0,0
162990,be,0,0
162991,the,0,0
162992,strongest,0,0
162993,predictor,0,0
162994,of,0,1
162995,response,0,1
162996,",",0,0
162997,where,0,0
162998,those,0,0
162999,participants,0,0
163000,aged,0,0
163001,between,0,0
163002,7,0,0
163003,and,0,0
163004,9,0,0
163005,years,0,0
163006,seemed,0,0
163007,to,0,0
163008,derive,0,0
163009,most,0,0
163010,benefit,0,0
163011,from,0,0
163012,dietary,0,0
163013,intervention,0,0
163014,.,0,1
163015,Further,0,0
163016,analysis,0,0
163017,based,0,0
163018,on,0,0
163019,the,0,0
163020,criteria,0,0
163021,for,0,0
163022,original,0,0
163023,study,0,0
163024,inclusion,0,0
163025,on,0,0
163026,the,0,0
163027,presence,0,0
163028,of,0,0
163029,the,0,0
163030,urine,0,1
163031,compound,0,0
163032,",",0,0
163033,trans-indolyl-3-acryloylglycine,0,0
163034,may,0,0
163035,also,0,0
163036,merit,0,0
163037,further,0,0
163038,investigation,0,0
163039,.,0,0
163040,These,0,0
163041,preliminary,0,0
163042,observations,0,0
163043,on,0,0
163044,potential,0,0
163045,best,0,0
163046,responder,0,0
163047,characteristics,0,0
163048,to,0,0
163049,a,0,0
163050,gluten-,0,1
163051,and,0,1
163052,casein-free,0,0
163053,diet,0,0
163054,for,0,0
163055,children,0,0
163056,with,0,0
163057,autism,0,0
163058,require,0,0
163059,independent,0,0
163060,replication,0,0
163061,.,0,0
163062,Intrathecal,0,0
163063,lentivirus-mediated,0,1
163064,transfer,0,1
163065,of,0,1
163066,interleukin-10,0,1
163067,attenuates,0,0
163068,chronic,1,0
163069,constriction,1,1
163070,injury-induced,1,1
163071,neuropathic,1,1
163072,pain,1,1
163073,through,0,0
163074,modulation,0,1
163075,of,0,1
163076,spinal,0,1
163077,high-mobility,0,0
163078,group,0,0
163079,box,0,0
163080,1,0,0
163081,in,0,0
163082,rats,0,0
163083,.,0,0
163084,BACKGROUND,0,0
163085,Neuropathic,0,0
163086,pain,0,1
163087,is,0,0
163088,a,0,0
163089,complex,0,0
163090,state,0,1
163091,of,0,1
163092,chronic,0,0
163093,pain,0,1
163094,that,0,0
163095,is,0,0
163096,usually,0,0
163097,accompanied,0,0
163098,by,0,0
163099,peripheral,0,1
163100,and,0,1
163101,central,0,1
163102,nervous,0,1
163103,system,0,0
163104,damage,0,1
163105,or,0,0
163106,dysfunction,0,1
163107,.,0,1
163108,Previous,0,0
163109,studies,0,0
163110,have,0,0
163111,indicated,0,0
163112,that,0,0
163113,neuroinflammation,0,1
163114,in,0,0
163115,the,0,0
163116,spinal,0,0
163117,cord,0,0
163118,is,0,0
163119,an,0,0
163120,important,0,0
163121,contributor,0,0
163122,to,0,0
163123,neuropathological,0,1
163124,and,0,1
163125,behavioral,0,1
163126,abnormalities,0,1
163127,.,0,0
163128,A,0,0
163129,series,0,0
163130,of,0,0
163131,early,0,0
163132,inflammatory,0,1
163133,markers,0,1
163134,",",0,0
163135,such,0,0
163136,as,0,0
163137,IL-1,0,0
163138,",",0,1
163139,TNF-?,0,1
163140,",",0,1
163141,and,0,1
163142,IFN-?,0,1
163143,",",0,1
163144,and,0,1
163145,advanced,0,0
163146,inflammatory,0,1
163147,markers,0,1
163148,",",0,0
163149,such,0,1
163150,as,0,0
163151,high-mobility,0,0
163152,group,0,0
163153,box,0,0
163154,1,0,0
163155,(,0,0
163156,HMGB1,0,0
163157,),0,0
163158,",",0,0
163159,are,0,0
163160,involved,0,0
163161,in,0,0
163162,neuroinflammation,0,1
163163,.,0,0
163164,STUDY,0,0
163165,DESIGN,0,0
163166,A,0,0
163167,randomized,0,0
163168,",",0,1
163169,double,0,0
163170,blind,0,0
163171,",",0,1
163172,controlled,0,0
163173,animal,0,0
163174,trial,0,0
163175,.,0,1
163176,OBJECTIVE,0,0
163177,In,0,0
163178,this,0,0
163179,study,0,0
163180,",",0,0
163181,a,0,0
163182,lentivirus,0,0
163183,delivering,0,0
163184,human,0,0
163185,IL-10,0,1
163186,(,0,1
163187,LV/hIL-10,0,1
163188,),0,1
163189,was,0,0
163190,administered,0,0
163191,intrathecally,0,0
163192,to,0,0
163193,determine,0,0
163194,the,0,0
163195,effects,0,0
163196,of,0,0
163197,IL-10,0,1
163198,on,0,0
163199,allodynia,1,1
163200,and,1,1
163201,hyperalgesia,1,1
163202,in,1,0
163203,a,0,0
163204,chronic,0,0
163205,constriction,0,1
163206,injury-induced,0,1
163207,(,0,0
163208,CCI,0,0
163209,),0,0
163210,rat,0,0
163211,model,0,0
163212,of,0,1
163213,neuropathic,0,1
163214,pain,0,1
163215,.,0,0
163216,METHODS,0,0
163217,Sprague-Dawley,0,0
163218,rats,0,0
163219,weighting,0,0
163220,260,0,0
163221,-,0,0
163222,320,0,0
163223,g,0,0
163224,were,0,0
163225,randomly,0,0
163226,divided,0,0
163227,into,0,0
163228,4,0,0
163229,groups,0,0
163230,.,0,0
163231,Group,0,0
163232,Sham,0,0
163233,(,0,1
163234,Sham,0,1
163235,),0,1
163236,",",0,0
163237,Group,0,0
163238,CCI?Normal,0,1
163239,Saline,0,0
163240,(,0,1
163241,NS,0,1
163242,),0,1
163243,",",0,0
163244,Group,0,0
163245,CCI?LV/hIL-10,0,1
163246,(,0,1
163247,LV/hIL-10,0,1
163248,),0,1
163249,",",0,0
163250,and,0,1
163251,Group,0,1
163252,CCI?LV/control,0,1
163253,(,0,1
163254,vector,0,0
163255,),0,0
163256,.,0,0
163257,Rats,0,0
163258,in,0,0
163259,each,0,0
163260,group,0,0
163261,were,0,0
163262,intrathecally,0,0
163263,delivered,0,0
163264,with,0,0
163265,NS,0,1
163266,",",0,1
163267,LV/control,0,1
163268,",",0,1
163269,or,0,1
163270,recombinant,0,0
163271,vector,0,0
163272,LV/hIL-10,0,0
163273,in,0,0
163274,a,0,0
163275,total,0,1
163276,volume,0,1
163277,of,0,0
163278,10,0,0
163279,?l,0,0
163280,.,1,0
163281,Paw,1,1
163282,withdrawal,1,1
163283,mechanical,1,0
163284,thresholds,1,1
163285,(,1,0
163286,PWMT,1,0
163287,),1,1
163288,and,1,1
163289,paw,1,1
163290,withdrawal,1,1
163291,thermal,1,1
163292,latency,1,1
163293,PWTL,1,1
163294,were,0,0
163295,measured,0,0
163296,one,0,0
163297,day,0,0
163298,before,0,0
163299,CCI,0,1
163300,(,0,1
163301,baseline,0,1
163302,),0,0
163303,and,0,0
163304,0,0,0
163305,",",0,0
163306,3,0,0
163307,",",0,0
163308,7,0,0
163309,",",0,0
163310,14,0,0
163311,",",0,0
163312,and,0,0
163313,28,0,0
163314,days,0,0
163315,after,0,0
163316,intrathecal,0,0
163317,administration,0,0
163318,.,0,1
163319,Cerebrospinal,0,1
163320,fluid,0,1
163321,(,0,1
163322,CSF,0,0
163323,),0,1
163324,samples,0,0
163325,were,0,0
163326,collected,0,0
163327,during,0,0
163328,surgical,0,0
163329,plane,0,1
163330,anesthesia,0,0
163331,and,0,0
163332,the,0,0
163333,collected,0,0
163334,CSF,0,0
163335,samples,0,0
163336,were,0,0
163337,used,0,0
163338,to,0,0
163339,assay,0,0
163340,for,0,0
163341,human,0,0
163342,IL-10,0,0
163343,",",0,0
163344,rat,0,1
163345,IL-1?,0,0
163346,",",0,0
163347,rat,0,1
163348,IL-6,0,1
163349,",",0,0
163350,and,0,1
163351,rat,0,1
163352,TNF-?,0,1
163353,by,0,0
163354,enzyme-linked,0,1
163355,immunosorbent,0,0
163356,assay,0,1
163357,(,0,1
163358,ELISA,0,1
163359,),0,0
163360,.,0,0
163361,Animals,0,0
163362,were,0,0
163363,sacrificed,0,0
163364,and,0,0
163365,the,0,0
163366,L4-5,0,1
163367,lumbar,0,1
163368,segment,0,0
163369,of,0,0
163370,the,0,0
163371,spinal,0,1
163372,cord,0,1
163373,was,0,0
163374,removed,0,0
163375,for,0,0
163376,determination,0,0
163377,of,0,1
163378,green,0,1
163379,fluorescent,0,1
163380,protein,0,1
163381,(,0,1
163382,GFP,0,0
163383,),0,0
163384,expression,0,1
163385,.,0,0
163386,Immunohistochemical,0,0
163387,analysis,0,0
163388,was,0,0
163389,performed,0,0
163390,using,0,0
163391,anti,0,0
163392,HMGB1,0,0
163393,antibodies,0,1
163394,and,0,0
163395,the,0,0
163396,expression,0,1
163397,of,0,0
163398,HMGB1,0,0
163399,protein,0,1
163400,in,0,0
163401,the,0,0
163402,spinal,0,1
163403,cord,0,1
163404,was,0,0
163405,determined,0,0
163406,by,0,0
163407,western,0,0
163408,blot,0,0
163409,analysis,0,0
163410,after,0,0
163411,intrathecal,0,1
163412,delivery,0,1
163413,(,0,0
163414,n,0,0
163415,=,0,0
163416,8,0,0
163417,each,0,0
163418,),0,0
163419,.,0,0
163420,RESULTS,0,0
163421,The,0,0
163422,results,0,0
163423,show,0,0
163424,that,0,0
163425,intrathecal,0,0
163426,LV/hIL-10,0,0
163427,reverses,0,1
163428,enhanced,1,1
163429,pain,1,1
163430,states,1,0
163431,.,1,0
163432,Moreover,0,0
163433,",",0,0
163434,the,0,0
163435,increased,1,0
163436,level,1,1
163437,of,1,0
163438,HMGB1,1,0
163439,exhibited,1,0
163440,in,1,0
163441,a,1,0
163442,late,1,1
163443,stage,1,0
163444,of,1,1
163445,CCI,1,1
163446,was,0,0
163447,inhibited,0,0
163448,by,0,0
163449,exogenous,0,0
163450,overexpression,0,1
163451,of,0,1
163452,hIL-10,0,1
163453,in,0,0
163454,the,0,0
163455,CCI,0,0
163456,model,1,0
163457,.,1,1
163458,Expression,1,1
163459,of,1,1
163460,HMGB1,1,0
163461,",",1,1
163462,RAGE,1,0
163463,",",1,1
163464,and,1,1
163465,pAkt,1,1
163466,were,1,0
163467,lower,0,0
163468,in,0,0
163469,CCI-induced,0,1
163470,rats,0,0
163471,treated,0,0
163472,with,0,0
163473,LV/hIL-10,0,0
163474,than,0,0
163475,in,0,0
163476,those,0,0
163477,treated,0,0
163478,with,0,0
163479,LV/control,0,0
163480,(,0,1
163481,vector,0,0
163482,),0,1
163483,or,0,1
163484,saline,0,0
163485,(,0,1
163486,NS,0,1
163487,),0,0
163488,.,0,0
163489,Our,0,0
163490,results,0,0
163491,showed,0,0
163492,that,1,0
163493,IL-10,1,0
163494,inhibits,1,1
163495,activation,1,1
163496,of,1,0
163497,the,1,0
163498,inflammatory,1,1
163499,HMGB1-RAGE,1,0
163500,pathway,1,0
163501,in,0,0
163502,the,0,0
163503,CCI,0,1
163504,rat,0,0
163505,model,0,0
163506,.,0,1
163507,LIMITATIONS,0,0
163508,Further,0,1
163509,experimental,0,0
163510,investigations,0,0
163511,are,0,0
163512,needed,0,0
163513,to,0,0
163514,clarify,0,0
163515,the,0,0
163516,specific,0,0
163517,biological,0,0
163518,roles,0,0
163519,played,0,0
163520,by,0,0
163521,HMGB1,0,0
163522,in,0,0
163523,IL-10-mediated,0,1
163524,regulation,1,1
163525,of,1,1
163526,neuropathic,1,1
163527,pain,1,1
163528,.,1,0
163529,CONCLUSION,1,0
163530,Our,0,0
163531,results,0,0
163532,indicate,0,0
163533,that,0,0
163534,intrathecal,0,0
163535,lentiviral-mediated,0,1
163536,transfer,0,1
163537,of,0,0
163538,IL-10,0,0
163539,attenuates,1,0
163540,CCI-induced,1,1
163541,neuropathic,1,1
163542,pain,1,1
163543,in,1,0
163544,rats,0,0
163545,.,0,0
163546,The,0,0
163547,anti-thermal,0,0
163548,hyperalgesia,0,1
163549,and,0,1
163550,anti-mechanical,0,0
163551,allodynia,0,1
163552,may,0,0
163553,be,0,0
163554,partly,0,0
163555,attributable,0,0
163556,to,0,0
163557,the,0,0
163558,decreased,0,1
163559,expression,0,1
163560,of,0,1
163561,HMGB1,0,0
163562,and,0,1
163563,inhibition,0,1
163564,of,0,1
163565,HMGB1-RAGE,0,0
163566,pathway,0,0
163567,.,0,0
163568,18F-FDG,0,0
163569,PET/CT,0,1
163570,for,0,0
163571,early,0,0
163572,prediction,0,1
163573,of,0,0
163574,response,0,1
163575,to,0,0
163576,neoadjuvant,0,0
163577,lapatinib,0,0
163578,",",0,1
163579,trastuzumab,0,0
163580,",",0,1
163581,and,0,1
163582,their,0,1
163583,combination,0,0
163584,in,0,0
163585,HER2-positive,0,1
163586,breast,0,0
163587,cancer,0,0
163588,:,0,0
163589,results,0,0
163590,from,0,0
163591,Neo-ALTTO,0,0
163592,.,0,0
163593,UNLABELLED,0,0
163594,Molecular,0,0
163595,imaging,0,0
163596,receives,0,0
163597,increased,0,1
163598,attention,0,1
163599,for,0,0
163600,selecting,0,0
163601,patients,0,0
163602,who,0,0
163603,will,0,0
163604,benefit,0,0
163605,from,0,0
163606,targeted,0,0
163607,anticancer,0,0
163608,therapies,0,0
163609,.,0,1
163610,Neo-ALTTO,0,0
163611,(,0,0
163612,Neoadjuvant,0,0
163613,Lapatinib,0,0
163614,and/or,0,0
163615,Trastuzumab,0,0
163616,Treatment,0,0
163617,Optimisation,0,1
163618,),0,0
163619,enrolled,0,0
163620,455,0,0
163621,women,0,0
163622,with,0,0
163623,invasive,0,1
163624,human,0,0
163625,epidermal,0,1
163626,growth,0,1
163627,factor,0,1
163628,receptor,0,0
163629,2,0,0
163630,(,0,0
163631,HER2,0,0
163632,),0,0
163633,-positive,0,1
163634,breast,0,0
163635,cancer,0,0
163636,and,0,1
163637,compared,0,0
163638,rates,0,1
163639,of,0,0
163640,pathologic,0,1
163641,complete,0,1
163642,response,0,1
163643,(,0,1
163644,pCR,0,0
163645,),0,1
163646,to,0,0
163647,neoadjuvant,0,0
163648,lapatinib,0,0
163649,",",0,1
163650,trastuzumab,0,0
163651,",",0,1
163652,and,0,1
163653,their,0,0
163654,combination,0,0
163655,.,0,0
163656,Each,0,0
163657,anti-HER2,0,1
163658,therapy,0,0
163659,was,0,0
163660,given,0,0
163661,alone,0,0
163662,for,0,0
163663,6,0,0
163664,wk,0,0
163665,",",0,0
163666,followed,0,0
163667,by,0,0
163668,12,0,0
163669,wk,0,0
163670,of,0,0
163671,the,0,0
163672,same,0,0
163673,therapy,0,0
163674,plus,0,0
163675,weekly,0,0
163676,paclitaxel,0,0
163677,.,0,0
163678,The,0,0
163679,early,0,0
163680,metabolic,1,1
163681,effects,1,0
163682,of,0,0
163683,the,0,0
163684,anti-HER2,0,0
163685,therapies,0,0
163686,on,0,0
163687,the,0,0
163688,primary,0,0
163689,tumors,0,0
163690,and,0,0
163691,their,0,0
163692,predictive,0,1
163693,values,0,1
163694,for,0,0
163695,pCR,0,0
163696,were,0,0
163697,assessed,0,0
163698,in,0,0
163699,a,0,0
163700,subset,0,0
163701,of,0,0
163702,patients,0,0
163703,.,0,0
163704,METHODS,0,0
163705,Eighty-six,0,0
163706,patients,0,0
163707,underwent,0,0
163708,(,0,0
163709,18,0,0
163710,),0,0
163711,F-FDG,0,0
163712,PET/CT,0,0
163713,at,0,0
163714,baseline,0,1
163715,and,0,0
163716,weeks,0,0
163717,2,0,0
163718,and,0,0
163719,6,0,0
163720,of,0,0
163721,anti-HER2,0,0
163722,treatment,0,0
163723,.,0,0
163724,An,0,0
163725,imaging,0,0
163726,core,0,1
163727,laboratory,0,1
163728,provided,0,0
163729,central,0,1
163730,validation,0,1
163731,",",0,0
163732,and,0,0
163733,2,0,0
163734,independent,0,0
163735,reviewers,0,0
163736,",",0,0
163737,masked,0,0
163738,to,0,0
163739,assigned,0,0
163740,treatment,0,0
163741,arm,0,0
163742,and,0,1
163743,clinical,0,1
163744,outcomes,0,1
163745,",",0,0
163746,performed,0,0
163747,consensus,0,0
163748,(,0,0
163749,18,0,0
163750,),0,0
163751,F-FDG,0,0
163752,PET/CT,0,1
163753,readings,0,1
163754,.,0,1
163755,Maximum,0,1
163756,standardized,1,0
163757,uptake,1,1
163758,value,1,1
163759,(,1,1
163760,SUVmax,1,1
163761,),1,0
163762,reductions,1,1
163763,from,1,0
163764,baseline,1,0
163765,were,0,0
163766,used,0,0
163767,to,0,0
163768,measure,0,0
163769,metabolic,0,1
163770,response,0,1
163771,.,0,0
163772,RESULTS,0,0
163773,Seventy-seven,0,0
163774,of,0,0
163775,the,0,0
163776,86,0,0
163777,enrolled,0,0
163778,patients,0,0
163779,presented,0,0
163780,an,0,0
163781,evaluable,0,0
163782,baseline,0,0
163783,(,0,0
163784,18,0,0
163785,),0,0
163786,F-FDG,0,0
163787,PET/CT,0,1
163788,scan,0,0
163789,;,0,0
163790,of,0,0
163791,these,0,0
163792,",",0,0
163793,68,0,0
163794,and,0,0
163795,66,0,0
163796,were,0,0
163797,evaluable,0,0
163798,at,0,0
163799,weeks,0,0
163800,2,0,0
163801,and,0,0
163802,6,0,0
163803,",",0,0
163804,respectively,0,0
163805,.,0,0
163806,Metabolic,1,0
163807,responses,1,1
163808,in,0,0
163809,the,0,0
163810,primary,0,0
163811,tumors,0,0
163812,were,0,0
163813,evident,0,0
163814,after,0,0
163815,2,0,0
163816,wk,0,0
163817,of,0,0
163818,targeted,0,0
163819,therapy,0,0
163820,and,0,1
163821,correlated,0,1
163822,highly,0,0
163823,with,0,0
163824,metabolic,0,1
163825,responses,0,1
163826,at,0,0
163827,week,0,0
163828,6,0,0
163829,(,0,0
163830,R,0,1
163831,(,0,0
163832,2,0,0
163833,),0,0
163834,=,0,0
163835,0.81,0,0
163836,),0,0
163837,.,0,0
163838,pCRs,0,0
163839,were,0,0
163840,associated,0,0
163841,with,0,0
163842,greater,0,0
163843,SUVmax,0,1
163844,reductions,0,1
163845,at,0,0
163846,both,0,0
163847,time,0,1
163848,points,0,0
163849,.,0,0
163850,Mean,0,1
163851,SUVmax,0,1
163852,reductions,0,1
163853,for,0,0
163854,pCR,0,0
163855,and,0,1
163856,non-pCR,0,1
163857,",",0,1
163858,respectively,0,0
163859,",",0,0
163860,were,0,0
163861,54.3,0,0
163862,%,0,0
163863,versus,0,0
163864,32.8,0,0
163865,%,0,0
163866,at,0,0
163867,week,0,0
163868,2,0,0
163869,(,0,0
163870,P,0,0
163871,=,0,0
163872,0.02,0,0
163873,),0,0
163874,and,0,0
163875,61.5,0,0
163876,%,0,0
163877,versus,0,0
163878,34.1,0,0
163879,%,0,0
163880,at,0,0
163881,week,0,0
163882,6,0,0
163883,(,0,0
163884,P,0,0
163885,=,0,0
163886,0.02,0,0
163887,),0,0
163888,.,0,0
163889,(,1,0
163890,18,1,0
163891,),1,0
163892,F-FDG,1,0
163893,PET/CT,1,1
163894,metabolic,1,1
163895,response,1,1
163896,rates,1,1
163897,at,0,0
163898,weeks,0,0
163899,2,0,0
163900,and,0,0
163901,6,0,0
163902,were,0,0
163903,71.6,0,0
163904,%,0,0
163905,and,0,0
163906,60,0,0
163907,%,0,0
163908,",",0,0
163909,respectively,0,0
163910,using,0,0
163911,European,0,0
163912,Organization,0,0
163913,for,0,0
163914,Research,0,0
163915,and,0,1
163916,Treatment,0,0
163917,of,0,1
163918,Cancer,0,0
163919,criteria,0,0
163920,;,0,0
163921,pCR,0,0
163922,rates,0,1
163923,were,0,0
163924,twice,0,0
163925,as,0,0
163926,high,0,0
163927,for,0,0
163928,(,0,0
163929,18,0,0
163930,),0,0
163931,F-FDG,0,0
163932,PET/CT,0,1
163933,responders,0,0
163934,than,0,0
163935,nonresponders,0,0
163936,(,0,0
163937,week,0,0
163938,2,0,0
163939,:,0,0
163940,42,0,0
163941,%,0,0
163942,vs.,0,0
163943,21,0,0
163944,%,0,0
163945,",",0,0
163946,P,0,0
163947,=,0,0
163948,0.12,0,0
163949,;,0,0
163950,week,0,0
163951,6,0,0
163952,:,0,0
163953,44,0,0
163954,%,0,0
163955,vs.,0,0
163956,19,0,0
163957,%,0,0
163958,",",0,0
163959,P,0,0
163960,=,0,0
163961,0.05,0,0
163962,),0,0
163963,.,0,0
163964,CONCLUSION,0,0
163965,Early,0,1
163966,metabolic,0,1
163967,assessment,0,0
163968,using,0,0
163969,(,0,0
163970,18,0,0
163971,),0,0
163972,F-FDG,0,0
163973,PET/CT,0,0
163974,can,0,0
163975,identify,0,0
163976,patients,0,0
163977,with,0,0
163978,an,0,0
163979,increased,0,0
163980,likelihood,0,1
163981,of,0,0
163982,pCR,0,0
163983,after,0,0
163984,neoadjuvant,0,0
163985,trastuzumab,0,0
163986,",",0,1
163987,lapatinib,0,0
163988,",",0,1
163989,or,0,0
163990,their,0,1
163991,combination,0,0
163992,when,0,0
163993,given,0,0
163994,with,0,0
163995,chemotherapy,0,0
163996,.,0,0
163997,Use,0,1
163998,of,0,0
163999,ketorolac,0,0
164000,is,0,0
164001,associated,0,0
164002,with,0,0
164003,decreased,0,0
164004,pneumonia,0,0
164005,following,0,0
164006,rib,0,1
164007,fractures,0,1
164008,.,0,0
164009,BACKGROUND,0,0
164010,The,0,0
164011,effectiveness,0,0
164012,of,0,0
164013,the,0,0
164014,nonsteroidal,0,0
164015,anti-inflammatory,0,0
164016,drug,0,0
164017,ketorolac,0,0
164018,in,0,0
164019,reducing,0,0
164020,pulmonary,0,1
164021,morbidity,0,1
164022,after,0,0
164023,rib,0,0
164024,fractures,0,0
164025,remains,0,0
164026,largely,0,0
164027,unknown,0,0
164028,.,0,0
164029,METHODS,0,0
164030,A,0,0
164031,retrospective,0,0
164032,cohort,0,0
164033,study,0,0
164034,was,0,0
164035,conducted,0,0
164036,spanning,0,0
164037,January,0,0
164038,2003,0,0
164039,to,0,0
164040,June,0,0
164041,2011,0,0
164042,assessing,0,0
164043,pneumonia,0,0
164044,within,0,0
164045,30,0,0
164046,days,0,0
164047,and,0,0
164048,potential,0,0
164049,adverse,0,1
164050,effects,0,1
164051,of,0,0
164052,ketorolac,0,0
164053,among,0,0
164054,all,0,0
164055,patients,0,0
164056,with,0,0
164057,rib,0,0
164058,fractures,0,0
164059,who,0,0
164060,received,0,0
164061,ketorolac,0,0
164062,<,0,0
164063,4,0,0
164064,days,0,0
164065,after,0,0
164066,injury,0,1
164067,compared,0,0
164068,with,0,0
164069,a,0,0
164070,random,0,0
164071,sample,0,0
164072,of,0,0
164073,those,0,0
164074,who,0,0
164075,did,0,0
164076,not,0,0
164077,.,0,0
164078,RESULTS,0,0
164079,Among,0,0
164080,202,0,0
164081,patients,0,0
164082,who,0,0
164083,received,0,0
164084,ketorolac,0,0
164085,and,0,0
164086,417,0,0
164087,who,0,0
164088,did,0,0
164089,not,0,0
164090,",",0,0
164091,ketorolac,0,1
164092,use,0,1
164093,was,0,0
164094,associated,0,0
164095,with,0,0
164096,decreased,0,0
164097,pneumonia,1,0
164098,(,0,0
164099,odds,0,1
164100,ratio,0,1
164101,",",0,0
164102,.14,0,0
164103,;,0,0
164104,95,0,0
164105,%,0,0
164106,confidence,0,0
164107,interval,0,0
164108,",",0,0
164109,.04,0,0
164110,to,0,0
164111,.46,0,0
164112,),0,0
164113,and,0,1
164114,increased,0,1
164115,ventilator-free,1,1
164116,days,1,1
164117,(,0,1
164118,difference,0,0
164119,",",0,0
164120,1.8,0,0
164121,days,0,0
164122,;,0,0
164123,95,0,0
164124,%,0,0
164125,confidence,0,0
164126,interval,0,0
164127,",",0,0
164128,1.1,0,0
164129,to,0,0
164130,2.5,0,0
164131,),0,0
164132,and,0,0
164133,intensive,1,0
164134,care,1,0
164135,unit-free,1,1
164136,days,1,1
164137,(,0,1
164138,difference,0,0
164139,",",0,0
164140,2.1,0,0
164141,days,0,0
164142,;,0,0
164143,95,0,0
164144,%,0,0
164145,confidence,0,0
164146,interval,0,0
164147,",",0,0
164148,1.3,0,0
164149,to,0,0
164150,3.0,0,0
164151,),0,0
164152,within,0,0
164153,30,0,0
164154,days,0,0
164155,.,0,0
164156,The,0,0
164157,rates,1,1
164158,of,1,0
164159,acute,1,0
164160,kidney,1,0
164161,injury,1,1
164162,",",1,1
164163,gastrointestinal,1,1
164164,hemorrhage,1,1
164165,",",1,1
164166,and,1,1
164167,fracture,1,1
164168,nonunion,1,1
164169,were,0,0
164170,not,0,0
164171,different,0,0
164172,.,0,0
164173,CONCLUSIONS,0,0
164174,Early,0,1
164175,administration,0,0
164176,of,0,0
164177,ketorolac,0,0
164178,to,0,0
164179,patients,0,0
164180,with,0,0
164181,rib,0,0
164182,fractures,0,0
164183,is,0,0
164184,associated,0,0
164185,with,0,0
164186,a,0,0
164187,decreased,0,1
164188,likelihood,0,1
164189,of,0,1
164190,pneumonia,1,1
164191,",",0,0
164192,without,0,0
164193,apparent,0,0
164194,risks,0,1
164195,.,0,0
164196,Entomological,0,1
164197,determinants,0,0
164198,of,0,0
164199,insecticide-treated,0,0
164200,bed,0,1
164201,net,0,1
164202,effectiveness,1,1
164203,in,0,0
164204,Western,0,0
164205,Myanmar,0,0
164206,.,0,0
164207,BACKGROUND,0,0
164208,In,0,0
164209,a,0,0
164210,large,0,0
164211,cluster,0,0
164212,randomized,0,0
164213,control,0,0
164214,trial,0,0
164215,of,0,1
164216,insecticide-treated,0,0
164217,bed,0,1
164218,nets,0,0
164219,(,0,1
164220,ITN,0,1
164221,),0,0
164222,in,0,0
164223,Western,0,0
164224,Myanmar,0,0
164225,the,0,0
164226,malaria,0,1
164227,protective,1,0
164228,effect,1,1
164229,of,0,1
164230,ITN,0,1
164231,was,0,0
164232,found,0,0
164233,to,0,0
164234,be,0,0
164235,highly,0,0
164236,variable,0,0
164237,and,0,1
164238,",",0,1
164239,in,0,1
164240,aggregate,0,0
164241,",",0,0
164242,the,0,0
164243,effect,0,1
164244,was,0,0
164245,not,0,0
164246,statistically,0,0
164247,significant,0,0
164248,.,0,0
164249,A,0,0
164250,coincident,0,0
164251,entomological,0,1
164252,investigation,0,0
164253,measured,0,1
164254,malaria,1,1
164255,vector,1,1
164256,abundance,1,1
164257,and,1,1
164258,biting,1,1
164259,behaviour,1,1
164260,and,0,0
164261,the,0,0
164262,human,1,0
164263,population,1,0
164264,sleeping,1,1
164265,habits,1,1
164266,",",0,0
164267,factors,0,0
164268,relevant,0,0
164269,to,0,0
164270,ITN,0,1
164271,effectiveness,1,1
164272,.,1,1
164273,METHODS,0,0
164274,Entomological,0,1
164275,surveys,0,0
164276,were,0,0
164277,carried,0,0
164278,out,0,0
164279,using,0,0
164280,different,0,0
164281,catching,0,1
164282,methods,0,0
164283,to,0,0
164284,identify,0,0
164285,potential,1,0
164286,malaria,1,1
164287,vector,1,0
164288,species,1,0
164289,and,0,1
164290,characterise,0,0
164291,their,0,0
164292,biting,1,1
164293,habits,1,1
164294,.,1,0
164295,The,0,0
164296,salivary,0,1
164297,glands,0,0
164298,were,0,0
164299,dissected,0,0
164300,from,0,0
164301,all,0,0
164302,female,0,0
164303,anophelines,0,0
164304,caught,0,0
164305,to,0,0
164306,identify,0,0
164307,sporozoites,0,0
164308,by,0,0
164309,microscopy,0,0
164310,.,0,0
164311,FINDINGS,0,0
164312,Between,0,0
164313,1995,0,0
164314,and,0,0
164315,2000,0,0
164316,a,0,0
164317,total,0,0
164318,of,0,0
164319,"4,824",0,0
164320,female,0,0
164321,anopheline,0,0
164322,mosquitoes,0,0
164323,were,0,0
164324,caught,0,0
164325,with,0,0
164326,various,0,0
164327,catching,0,1
164328,methods,0,0
164329,.,0,0
164330,A,0,0
164331,total,0,0
164332,of,0,0
164333,916,0,0
164334,person,0,0
164335,nights,0,0
164336,yielded,0,0
164337,"3,009",0,0
164338,female,0,0
164339,anopheline,0,0
164340,mosquitoes,0,0
164341,between,0,0
164342,6,0,0
164343,pm,0,0
164344,and,0,0
164345,6,0,0
164346,am,0,0
164347,.,0,0
164348,Except,0,0
164349,for,0,0
164350,Anopheles,0,0
164351,annularis,0,0
164352,",",0,1
164353,which,0,0
164354,showed,0,0
164355,no,0,0
164356,apparent,0,1
164357,preference,1,0
164358,(,0,0
164359,51,0,0
164360,%,0,0
164361,outdoor,0,1
164362,biting,0,1
164363,),0,0
164364,",",0,0
164365,all,0,0
164366,major,0,1
164367,species,0,0
164368,showed,0,0
164369,a,0,0
164370,strong,0,0
164371,preference,1,1
164372,for,0,0
164373,outdoor,1,1
164374,biting,1,1
164375,;,1,0
164376,Anopheles,0,0
164377,epiroticus,0,0
164378,(,0,0
164379,79,0,0
164380,%,0,0
164381,),0,0
164382,",",0,0
164383,Anopheles,0,1
164384,subpictus,0,1
164385,(,0,0
164386,72,0,0
164387,%,0,0
164388,),0,0
164389,",",0,0
164390,Anopheles,0,1
164391,maculatus,0,1
164392,(,0,0
164393,92,0,0
164394,%,0,0
164395,),0,0
164396,",",0,0
164397,Anopheles,0,1
164398,aconitus,0,1
164399,(,0,0
164400,85,0,0
164401,%,0,0
164402,),0,0
164403,and,0,1
164404,Anopheles,0,1
164405,vagus,0,1
164406,(,0,0
164407,72,0,0
164408,%,0,0
164409,),0,0
164410,.,0,0
164411,Most,0,0
164412,human,1,0
164413,biting,1,1
164414,occurred,0,0
164415,in,0,0
164416,the,0,0
164417,early,0,0
164418,evening,0,1
164419,with,0,0
164420,the,0,0
164421,peak,1,1
164422,biting,1,1
164423,time,1,1
164424,between,0,0
164425,6,0,0
164426,pm,0,0
164427,and,0,0
164428,7,0,0
164429,pm,0,0
164430,(,0,0
164431,35,0,0
164432,%,0,0
164433,),0,0
164434,.,0,0
164435,Overall,0,0
164436,51,0,0
164437,%,0,0
164438,(,0,0
164439,1447/2837,0,0
164440,),0,0
164441,of,0,0
164442,all,0,0
164443,bites,1,0
164444,recorded,1,0
164445,were,0,0
164446,between,0,0
164447,6,0,0
164448,pm,0,0
164449,and,0,0
164450,8,0,0
164451,pm,0,0
164452,.,0,0
164453,A,0,0
164454,large,0,0
164455,proportion,1,0
164456,of,1,1
164457,children,1,0
164458,were,0,0
164459,not,0,0
164460,sleeping,1,1
164461,under,0,0
164462,an,0,0
164463,ITN,0,1
164464,during,0,0
164465,peak,1,1
164466,biting,1,1
164467,times,1,1
164468,.,1,0
164469,Only,0,0
164470,one,0,0
164471,An,0,0
164472,.,0,0
164473,annularis,0,0
164474,mosquito,0,1
164475,(,0,0
164476,0.02,0,0
164477,%,0,0
164478,),0,0
164479,had,0,0
164480,malaria,1,0
164481,sporozoites,1,0
164482,identified,0,0
164483,in,0,0
164484,the,0,0
164485,salivary,0,1
164486,glands,0,0
164487,.,0,0
164488,CONCLUSIONS,0,0
164489,Peak,1,1
164490,vector,1,1
164491,biting,1,1
164492,occurred,0,0
164493,early,0,0
164494,in,0,0
164495,the,0,0
164496,evening,0,1
164497,and,0,1
164498,mainly,0,0
164499,occurred,0,0
164500,outdoors,1,0
164501,.,1,0
164502,The,0,0
164503,limited,0,0
164504,efficacy,1,1
164505,of,0,1
164506,ITN,0,1
164507,in,0,0
164508,this,0,0
164509,area,0,1
164510,of,0,0
164511,Western,0,0
164512,Myanmar,0,0
164513,may,0,0
164514,be,0,0
164515,explained,0,0
164516,by,0,0
164517,the,0,0
164518,biting,0,1
164519,behaviour,0,1
164520,of,0,0
164521,the,0,0
164522,prevalent,0,0
164523,Anopheles,0,0
164524,mosquito,0,1
164525,vectors,0,0
164526,in,0,0
164527,this,0,0
164528,area,0,1
164529,.,0,0
164530,Characterization,0,1
164531,of,0,1
164532,early,0,0
164533,thermal,0,1
164534,burns,0,1
164535,and,0,0
164536,the,0,0
164537,effects,0,1
164538,of,0,0
164539,hyperbaric,0,0
164540,oxygen,0,1
164541,treatment,0,0
164542,:,0,0
164543,a,0,0
164544,pilot,0,0
164545,study,0,0
164546,.,0,1
164547,BACKGROUND,0,0
164548,AND,0,0
164549,AIMS,0,1
164550,Studies,0,1
164551,investigating,0,0
164552,hyperbaric,0,0
164553,oxygen,0,1
164554,treatment,0,0
164555,(,0,1
164556,HBOT,0,1
164557,),0,0
164558,to,0,0
164559,improve,0,0
164560,outcome,0,1
164561,in,0,0
164562,burns,0,1
164563,have,0,0
164564,been,0,0
164565,inconclusive,0,0
164566,.,0,0
164567,In,0,0
164568,this,0,0
164569,study,0,0
164570,",",0,0
164571,we,0,0
164572,aimed,0,0
164573,to,0,0
164574,characterize,0,0
164575,early,0,0
164576,thermal,0,1
164577,burns,0,1
164578,injury,0,1
164579,in,0,0
164580,adult,0,0
164581,patients,0,0
164582,with,0,0
164583,<,0,0
164584,40,0,0
164585,%,0,0
164586,total,0,1
164587,body,0,1
164588,surface,0,1
164589,area,0,1
164590,(,0,1
164591,TBSA,0,0
164592,),0,0
164593,and,0,0
164594,to,0,0
164595,determine,0,0
164596,the,0,0
164597,effects,0,0
164598,of,0,0
164599,HBOT,0,1
164600,administered,0,0
164601,within,0,0
164602,24,0,0
164603,h,0,0
164604,to,0,0
164605,48,0,0
164606,h,0,0
164607,of,0,0
164608,a,0,0
164609,burn,0,0
164610,injury,0,1
164611,.,0,0
164612,METHODS,0,0
164613,Seventeen,0,1
164614,subjects,0,0
164615,were,0,0
164616,randomized,0,0
164617,into,0,0
164618,control,0,0
164619,(,0,0
164620,n,0,0
164621,=,0,0
164622,9,0,0
164623,),0,0
164624,and,0,0
164625,HBOT,0,1
164626,treatment,0,0
164627,(,0,0
164628,n,0,0
164629,=,0,0
164630,8,0,0
164631,),0,0
164632,arms,0,0
164633,.,0,0
164634,Burn,1,1
164635,depth,1,1
164636,",",0,0
164637,measured,0,1
164638,by,0,0
164639,laser,0,0
164640,Doppler,0,1
164641,imaging,0,1
164642,(,0,1
164643,LDI,0,1
164644,),0,1
164645,and,0,0
164646,histologically,0,0
164647,",",0,0
164648,white,1,0
164649,blood,1,1
164650,cell,1,1
164651,(,1,1
164652,WBC,1,1
164653,),1,1
164654,count,1,1
164655,and,0,1
164656,plasma,1,1
164657,cytokine,1,1
164658,inflammatory,1,1
164659,markers,1,1
164660,were,0,0
164661,assessed,0,0
164662,at,0,0
164663,24,0,0
164664,h,0,0
164665,(,0,0
164666,pre,0,1
164667,HBOT,0,1
164668,),0,0
164669,and,0,0
164670,48,0,0
164671,h,0,0
164672,(,0,0
164673,post,0,0
164674,HBOT,0,1
164675,),0,1
164676,post,0,0
164677,burn,0,1
164678,",",0,1
164679,as,0,0
164680,were,0,0
164681,immunohistochemistry,0,1
164682,and,0,1
164683,microbiology,0,1
164684,of,0,1
164685,burns,0,1
164686,tissue,0,1
164687,samples,0,0
164688,at,0,0
164689,48,0,0
164690,h,0,0
164691,post,0,0
164692,burn,0,1
164693,.,0,1
164694,RESULTS,0,0
164695,WBC,1,1
164696,count,1,1
164697,and,1,1
164698,serum,1,1
164699,interleukin,1,1
164700,(,1,1
164701,IL,1,0
164702,),1,1
164703,-1?,1,0
164704,",",1,1
164705,IL-4,1,1
164706,",",1,1
164707,IL-6,1,1
164708,",",1,1
164709,IL-10,1,1
164710,and,1,1
164711,interferon-?,1,1
164712,were,1,0
164713,significantly,0,0
164714,elevated,0,0
164715,24,0,0
164716,h,0,0
164717,after,0,0
164718,burn,0,1
164719,",",0,0
164720,but,0,0
164721,no,0,0
164722,significant,0,0
164723,changes,0,1
164724,in,0,0
164725,any,0,0
164726,of,0,0
164727,these,0,0
164728,parameters,0,1
164729,were,0,0
164730,found,0,0
164731,with,0,0
164732,HBOT,0,0
164733,.,0,1
164734,HBOT,0,1
164735,had,0,0
164736,no,0,0
164737,significant,0,0
164738,effect,0,1
164739,on,0,0
164740,burn,1,1
164741,depth,1,1
164742,.,1,0
164743,Two,0,0
164744,HBOT,0,0
164745,patients,0,0
164746,and,0,0
164747,four,0,0
164748,control,0,0
164749,patients,0,0
164750,developed,1,0
164751,positive,1,1
164752,bacterial,1,1
164753,cultures,1,0
164754,.,1,0
164755,CONCLUSIONS,0,0
164756,Slower,0,0
164757,than,0,0
164758,anticipated,0,0
164759,recruitment,0,0
164760,resulted,0,0
164761,in,0,0
164762,considerably,0,0
164763,fewer,0,0
164764,patients,0,0
164765,than,0,0
164766,planned,0,0
164767,being,0,0
164768,studied,1,0
164769,.,1,0
164770,Inflammatory,1,0
164771,markers,1,1
164772,were,1,0
164773,significantly,0,0
164774,increased,0,0
164775,at,0,0
164776,24,0,0
164777,h,0,0
164778,in,0,0
164779,patients,0,0
164780,with,0,0
164781,<,0,0
164782,40,0,0
164783,%,0,0
164784,TBSA,0,0
164785,burn,0,1
164786,.,0,0
164787,Early,0,1
164788,HBOT,0,1
164789,had,0,0
164790,no,0,0
164791,apparent,0,0
164792,effects,0,0
164793,on,0,0
164794,any,0,0
164795,of,0,0
164796,the,0,0
164797,parameters,0,1
164798,measured,0,0
164799,in,0,0
164800,this,0,0
164801,small,0,0
164802,pilot,0,0
164803,study,0,0
164804,.,0,0
164805,HBOT,0,0
164806,may,0,0
164807,possibly,0,0
164808,have,0,0
164809,a,0,0
164810,broad-spectrum,0,1
164811,antimicrobial,0,1
164812,effect,0,1
164813,worthy,0,0
164814,of,0,1
164815,further,0,0
164816,study,0,0
164817,.,0,0
164818,We,0,0
164819,report,0,0
164820,our,0,0
164821,methodology,0,0
164822,in,0,0
164823,detail,0,0
164824,as,0,0
164825,a,0,0
164826,possible,0,0
164827,model,0,0
164828,for,0,0
164829,future,0,0
164830,burns,0,1
164831,studies,0,0
164832,.,0,0
164833,Comparison,1,0
164834,of,0,0
164835,three,0,0
164836,software,0,0
164837,systems,0,0
164838,for,0,0
164839,semi-automatic,0,1
164840,volumetry,1,1
164841,of,1,1
164842,pulmonary,1,1
164843,nodules,1,1
164844,on,0,0
164845,baseline,0,0
164846,and,0,1
164847,follow-up,0,0
164848,CT,0,1
164849,examinations,0,0
164850,.,0,0
164851,BACKGROUND,0,0
164852,Early,0,1
164853,diagnosis,0,0
164854,of,0,1
164855,lung,0,1
164856,cancer,0,0
164857,in,0,0
164858,a,0,0
164859,treatable,0,0
164860,stage,0,0
164861,is,0,0
164862,the,0,0
164863,main,0,0
164864,purpose,0,0
164865,of,0,1
164866,lung,0,1
164867,cancer,0,0
164868,screening,0,0
164869,by,0,0
164870,computed,0,0
164871,tomography,0,0
164872,(,0,0
164873,CT,0,1
164874,),0,0
164875,.,0,0
164876,Accurate,0,1
164877,three-dimensional,0,1
164878,size,0,1
164879,and,0,1
164880,growth,0,1
164881,measurements,0,1
164882,are,0,0
164883,essential,0,0
164884,to,0,0
164885,assess,0,0
164886,the,0,0
164887,risk,0,1
164888,of,0,0
164889,malignancy,0,1
164890,.,0,0
164891,Nodule,0,0
164892,volumes,0,1
164893,can,0,0
164894,be,0,0
164895,calculated,0,0
164896,by,0,0
164897,using,0,0
164898,semi-automated,0,0
164899,volumetric,0,0
164900,software,0,0
164901,.,0,0
164902,Systematic,0,0
164903,differences,0,0
164904,in,0,0
164905,volume,0,1
164906,measurements,0,1
164907,between,0,0
164908,packages,0,0
164909,could,0,0
164910,influence,0,0
164911,nodule,0,1
164912,categorization,0,0
164913,and,0,1
164914,management,0,0
164915,decisions,0,1
164916,.,0,0
164917,PURPOSE,0,0
164918,To,0,0
164919,compare,0,0
164920,volumetric,1,1
164921,measurements,1,1
164922,of,0,0
164923,solid,0,0
164924,pulmonary,0,1
164925,nodules,0,1
164926,on,0,0
164927,baseline,0,0
164928,and,0,1
164929,follow-up,0,0
164930,CT,0,1
164931,scans,0,0
164932,as,0,0
164933,well,0,0
164934,as,0,0
164935,the,0,0
164936,volume,1,1
164937,doubling,1,1
164938,time,1,1
164939,(,1,1
164940,VDT,1,1
164941,),1,0
164942,for,0,0
164943,three,0,0
164944,software,0,0
164945,packages,0,0
164946,.,0,1
164947,MATERIAL,0,0
164948,AND,0,0
164949,METHODS,0,0
164950,From,0,0
164951,a,0,0
164952,Lung,0,0
164953,Cancer,0,0
164954,Screening,0,0
164955,study,0,0
164956,(,0,1
164957,NELSON,0,1
164958,),0,0
164959,",",0,0
164960,50,0,0
164961,participants,0,0
164962,were,0,0
164963,randomly,0,0
164964,selected,0,0
164965,from,0,0
164966,the,0,0
164967,baseline,0,0
164968,round,0,1
164969,.,0,0
164970,The,0,0
164971,study,0,0
164972,population,0,0
164973,comprised,0,0
164974,participants,0,0
164975,with,0,0
164976,at,0,0
164977,least,0,0
164978,one,0,0
164979,pulmonary,0,0
164980,nodule,0,0
164981,at,0,0
164982,the,0,0
164983,baseline,0,0
164984,and,0,1
164985,consecutive,0,0
164986,CT,0,1
164987,examination,0,0
164988,.,0,0
164989,The,0,0
164990,volume,1,1
164991,of,1,0
164992,each,1,0
164993,nodule,1,1
164994,was,0,0
164995,determined,0,0
164996,for,0,0
164997,both,0,0
164998,time,0,1
164999,points,0,0
165000,using,0,0
165001,three,0,0
165002,semi-automated,0,0
165003,software,0,0
165004,packages,0,0
165005,(,0,1
165006,P1,0,1
165007,",",0,1
165008,P2,0,0
165009,",",0,1
165010,and,0,1
165011,P3,0,1
165012,),0,0
165013,.,0,0
165014,Manual,0,1
165015,modification,0,0
165016,was,0,0
165017,performed,0,0
165018,when,0,0
165019,automated,0,0
165020,assessment,0,0
165021,was,0,0
165022,visually,0,0
165023,inaccurate,0,0
165024,.,0,0
165025,VDT,1,1
165026,was,0,0
165027,calculated,0,0
165028,to,0,0
165029,evaluate,1,0
165030,nodule,1,1
165031,growth,1,1
165032,.,1,1
165033,Volume,1,1
165034,",",1,1
165035,VDT,1,1
165036,",",1,1
165037,and,1,1
165038,nodule,1,1
165039,management,1,0
165040,were,0,0
165041,compared,0,0
165042,for,0,0
165043,the,0,0
165044,three,0,0
165045,software,0,0
165046,packages,0,0
165047,",",0,0
165048,using,0,0
165049,P1,0,1
165050,as,0,0
165051,the,0,0
165052,reference,0,0
165053,standard,0,0
165054,.,0,1
165055,RESULTS,0,0
165056,In,0,0
165057,25,0,0
165058,participants,0,0
165059,",",0,0
165060,147,0,0
165061,nodules,0,0
165062,were,0,0
165063,present,0,0
165064,on,0,0
165065,both,0,0
165066,examinations,0,0
165067,(,0,0
165068,volume,0,1
165069,:,0,0
165070,12.0-436.6,0,0
165071,mm,0,0
165072,(,0,0
165073,3,0,0
165074,),0,0
165075,),0,0
165076,.,0,0
165077,Initial,1,1
165078,segmentation,1,0
165079,at,0,0
165080,baseline,0,1
165081,was,0,0
165082,evaluated,0,0
165083,to,0,0
165084,be,0,0
165085,satisfactory,0,0
165086,in,0,0
165087,93.9,0,0
165088,%,0,0
165089,of,0,0
165090,nodules,0,1
165091,for,0,0
165092,P1,0,1
165093,",",0,0
165094,84.4,0,0
165095,%,0,0
165096,for,0,0
165097,P2,0,0
165098,",",0,0
165099,and,0,0
165100,88.4,0,0
165101,%,0,0
165102,for,0,0
165103,P3,0,0
165104,.,0,0
165105,Significant,0,1
165106,difference,0,1
165107,was,0,0
165108,found,0,0
165109,in,0,0
165110,measured,1,1
165111,volume,1,1
165112,between,0,0
165113,P1,0,1
165114,and,0,0
165115,the,0,0
165116,other,0,0
165117,two,0,0
165118,packages,0,0
165119,(,0,0
165120,P,0,0
165121,<,0,0
165122,0.001,0,0
165123,),0,0
165124,.,0,0
165125,P2,0,0
165126,overestimated,0,0
165127,the,0,0
165128,volume,1,1
165129,by,1,0
165130,38,0,0
165131,?,0,0
165132,24,0,0
165133,%,0,0
165134,",",0,0
165135,and,0,1
165136,P3,0,0
165137,by,0,0
165138,50,0,0
165139,?,0,0
165140,22,0,0
165141,%,0,0
165142,.,0,0
165143,At,0,0
165144,baseline,0,0
165145,",",0,0
165146,there,0,0
165147,was,0,0
165148,consensus,0,0
165149,on,1,0
165150,nodule,1,1
165151,size,1,1
165152,categorization,1,0
165153,in,1,0
165154,80,1,0
165155,%,1,0
165156,for,1,0
165157,P1,1,1
165158,&,0,1
165159,P2,0,0
165160,and,0,0
165161,74,0,0
165162,%,0,0
165163,for,0,0
165164,P1,0,1
165165,&,0,0
165166,P3,0,1
165167,.,0,1
165168,At,0,0
165169,follow-up,0,0
165170,",",0,0
165171,consensus,1,0
165172,on,1,0
165173,VDT,1,1
165174,categorization,1,0
165175,was,1,0
165176,present,1,0
165177,in,1,0
165178,47,0,0
165179,%,0,0
165180,for,0,0
165181,P1,0,1
165182,&,0,1
165183,P2,0,0
165184,and,0,0
165185,44,0,0
165186,%,0,0
165187,for,0,0
165188,P1,0,1
165189,&,0,0
165190,P3,0,1
165191,.,0,1
165192,CONCLUSION,0,0
165193,Software,0,0
165194,packages,0,0
165195,for,0,0
165196,lung,0,1
165197,nodule,0,1
165198,evaluation,0,0
165199,yield,0,1
165200,significant,0,0
165201,differences,0,0
165202,in,0,0
165203,volumetric,1,1
165204,measurements,1,1
165205,and,1,0
165206,VDT,1,0
165207,.,1,0
165208,This,1,0
165209,variation,0,0
165210,affects,1,0
165211,the,1,0
165212,classification,1,1
165213,of,1,0
165214,lung,1,1
165215,nodules,1,1
165216,",",1,0
165217,especially,0,0
165218,in,0,0
165219,follow-up,0,0
165220,examinations,0,0
165221,.,0,0
165222,A,0,0
165223,prospective,0,0
165224,randomized,0,0
165225,trial,0,0
165226,comparing,0,0
165227,hypofractionation,0,0
165228,with,0,0
165229,conventional,0,0
165230,fractionation,0,0
165231,radiotherapy,0,0
165232,for,0,0
165233,T1-2,0,1
165234,glottic,0,1
165235,squamous,0,0
165236,cell,0,0
165237,carcinomas,0,1
165238,:,0,0
165239,results,0,0
165240,of,0,0
165241,a,0,0
165242,Korean,0,0
165243,Radiation,0,1
165244,Oncology,0,1
165245,Group,0,0
165246,(,0,1
165247,KROG-0201,0,0
165248,),0,0
165249,study,0,0
165250,.,0,1
165251,BACKGROUND,0,0
165252,AND,0,0
165253,PURPOSE,0,0
165254,To,0,0
165255,prospectively,0,0
165256,investigate,0,0
165257,the,0,0
165258,effect,1,0
165259,of,1,1
165260,radiotherapy,1,0
165261,fraction,1,1
165262,size,1,1
165263,on,0,0
165264,clinical,1,0
165265,outcomes,1,1
165266,in,0,0
165267,early,0,0
165268,glottic,0,1
165269,carcinoma,0,0
165270,METHODS,0,0
165271,AND,0,0
165272,MATERIALS,0,0
165273,Patients,0,0
165274,with,0,0
165275,T1-2,0,1
165276,glottic,0,1
165277,carcinoma,0,0
165278,were,0,0
165279,eligible,0,0
165280,for,0,0
165281,the,0,0
165282,protocol,0,0
165283,.,0,0
165284,Although,0,0
165285,282,0,0
165286,patients,0,0
165287,were,0,0
165288,required,0,0
165289,",",0,0
165290,the,0,0
165291,study,0,0
165292,was,0,0
165293,closed,0,0
165294,prematurely,0,0
165295,due,0,0
165296,to,0,0
165297,poor,0,1
165298,accrual,0,1
165299,with,0,0
165300,only,0,0
165301,156,0,0
165302,patients,0,0
165303,.,0,0
165304,Of,0,0
165305,these,0,0
165306,",",0,0
165307,82,0,0
165308,patients,0,0
165309,were,0,0
165310,allocated,0,0
165311,to,0,0
165312,conventional,0,0
165313,fractionation,0,0
165314,(,0,1
165315,CONV,0,0
165316,),0,1
165317,arm,0,0
165318,(,0,0
165319,66,0,0
165320,Gy/33,0,0
165321,fractions,0,0
165322,for,0,0
165323,T1,0,1
165324,and,0,0
165325,70,0,0
165326,Gy/35,0,0
165327,fractions,0,0
165328,for,0,0
165329,T2,0,0
165330,),0,0
165331,",",0,0
165332,with,0,0
165333,74,0,0
165334,patients,0,0
165335,to,0,0
165336,hypofractionation,0,0
165337,(,0,1
165338,HYPO,0,0
165339,),0,1
165340,arm,0,0
165341,(,0,0
165342,63,0,0
165343,Gy/28,0,0
165344,fractions,0,0
165345,for,0,0
165346,T1,0,1
165347,and,0,0
165348,67.5,0,0
165349,Gy/30,0,0
165350,fractions,0,0
165351,for,0,0
165352,T2,0,0
165353,),0,0
165354,.,0,0
165355,The,0,0
165356,primary,0,0
165357,objective,0,0
165358,was,0,0
165359,local,1,0
165360,progression-free,1,1
165361,survival,1,1
165362,(,1,1
165363,LPFS,1,0
165364,),1,0
165365,.,1,0
165366,RESULTS,0,0
165367,With,0,0
165368,a,0,0
165369,median,0,1
165370,follow-up,0,0
165371,of,0,0
165372,67,0,0
165373,months,0,0
165374,(,0,0
165375,range,0,0
165376,",",0,1
165377,2-122,0,1
165378,months,0,0
165379,),0,0
165380,",",0,0
165381,the,0,0
165382,5-year,0,1
165383,LPFS,1,0
165384,was,0,0
165385,77.8,0,0
165386,%,0,0
165387,for,0,0
165388,CONV,0,0
165389,arm,0,0
165390,and,0,0
165391,88.5,0,0
165392,%,0,0
165393,for,0,0
165394,HYPO,0,0
165395,arm,0,0
165396,(,0,0
165397,HR,0,0
165398,1.55,0,0
165399,",",0,0
165400,p=0.213,0,0
165401,),0,0
165402,.,0,0
165403,No,0,0
165404,significant,0,0
165405,difference,0,0
165406,was,0,0
165407,observed,0,0
165408,in,0,0
165409,the,0,0
165410,toxicity,1,1
165411,profile,1,1
165412,between,0,0
165413,the,0,0
165414,two,0,0
165415,arms,0,0
165416,.,0,0
165417,In,0,0
165418,a,0,0
165419,subgroup,0,0
165420,exploratory,0,0
165421,analysis,0,0
165422,for,0,0
165423,T1a,0,0
165424,disease,0,1
165425,",",0,0
165426,the,0,0
165427,5-year,0,1
165428,LPFS,1,1
165429,trended,0,1
165430,positively,0,0
165431,in,0,0
165432,HYPO,0,0
165433,arm,0,0
165434,(,0,0
165435,76.7,0,0
165436,%,0,0
165437,vs.,0,0
165438,93.0,0,0
165439,%,0,0
165440,",",0,0
165441,HR,0,1
165442,3.65,0,0
165443,",",0,0
165444,p=0.056,0,0
165445,),0,0
165446,.,0,0
165447,CONCLUSIONS,0,0
165448,Given,0,0
165449,that,0,0
165450,HYPO,0,0
165451,is,0,0
165452,at,0,0
165453,least,0,0
165454,not,0,0
165455,inferior,0,0
165456,to,0,0
165457,CONV,0,0
165458,with,0,0
165459,a,0,0
165460,similar,0,0
165461,toxicity,0,1
165462,profile,0,1
165463,",",0,0
165464,the,0,0
165465,hypofractionation,0,0
165466,scheme,0,0
165467,used,0,0
165468,in,0,0
165469,this,0,0
165470,study,0,0
165471,can,0,0
165472,be,0,0
165473,offered,0,0
165474,to,0,0
165475,patients,0,0
165476,with,0,0
165477,T1-2,0,1
165478,glottic,0,1
165479,carcinoma,0,0
165480,with,0,0
165481,potential,0,0
165482,advantages,0,0
165483,in,0,0
165484,terms,0,1
165485,of,0,0
165486,local,0,0
165487,control,0,0
165488,and,0,0
165489,a,0,0
165490,shortened,0,1
165491,overall,0,1
165492,treatment,0,0
165493,time,0,1
165494,.,0,0
165495,Therapeutic,0,0
165496,effect,0,1
165497,of,0,1
165498,inhaled,0,0
165499,budesonide,0,0
165500,(,0,0
165501,Pulmicort?,0,0
165502,Turbuhaler,0,0
165503,),0,0
165504,on,0,0
165505,the,0,0
165506,inflammatory,0,1
165507,response,0,1
165508,to,0,0
165509,one-lung,0,0
165510,ventilation,0,0
165511,.,0,0
165512,This,0,0
165513,prospective,0,0
165514,",",0,0
165515,double-blind,0,0
165516,trial,0,0
165517,was,0,0
165518,designed,0,0
165519,to,0,0
165520,evaluate,0,0
165521,the,0,0
165522,effect,0,0
165523,of,0,0
165524,inhaled,0,0
165525,budesonide,0,0
165526,on,1,0
165527,lung,1,1
165528,function,1,1
165529,and,1,0
165530,the,1,0
165531,inflammatory,1,1
165532,response,1,1
165533,to,1,0
165534,one-lung,1,0
165535,ventilation,1,0
165536,.,1,0
165537,One,0,0
165538,hundred,0,0
165539,patients,0,0
165540,scheduled,0,0
165541,for,0,0
165542,lobectomy,0,0
165543,were,0,0
165544,allocated,0,0
165545,randomly,0,0
165546,to,0,0
165547,pre-operative,0,1
165548,nebulised,0,0
165549,budesonide,0,0
165550,or,0,0
165551,saline,0,0
165552,.,0,1
165553,Bronchoalveolar,0,1
165554,lavage,0,0
165555,fluid,0,1
165556,samples,0,1
165557,were,0,0
165558,collected,0,0
165559,from,0,0
165560,either,0,0
165561,the,0,0
165562,collapsed,0,0
165563,or,0,0
165564,the,0,0
165565,ventilated,0,0
165566,lung,0,0
165567,both,0,0
165568,before,0,0
165569,one-lung,0,0
165570,ventilation,0,1
165571,and,0,0
165572,30,0,0
165573,min,0,0
165574,after,0,0
165575,re-expansion,0,1
165576,of,0,0
165577,the,0,0
165578,lung,0,0
165579,.,0,0
165580,The,1,0
165581,concentrations,1,1
165582,of,1,1
165583,serum,1,1
165584,and,1,1
165585,bronchoalveolar,1,1
165586,lavage,1,1
165587,fluid,1,1
165588,cytokines,1,1
165589,were,0,0
165590,determined,0,0
165591,.,0,0
165592,Budesonide,0,0
165593,treatment,0,0
165594,",",0,0
165595,compared,0,0
165596,with,0,0
165597,saline,0,0
165598,",",0,0
165599,reduced,1,1
165600,both,1,0
165601,peak,1,1
165602,(,0,0
165603,mean,0,1
165604,(,0,1
165605,SD,0,0
165606,),0,0
165607,3.7,0,0
165608,(,0,0
165609,0.4,0,0
165610,),0,0
165611,vs,0,0
165612,2.5,0,0
165613,(,0,0
165614,0.2,0,0
165615,),0,0
165616,kPa,0,1
165617,),0,1
165618,and,1,1
165619,plateau,1,1
165620,(,0,1
165621,mean,0,1
165622,(,0,1
165623,SD,0,0
165624,),0,0
165625,3.1,0,0
165626,(,0,0
165627,0.2,0,0
165628,),0,0
165629,vs,0,0
165630,2.2,0,0
165631,(,0,0
165632,0.1,0,0
165633,),0,0
165634,kPa,0,1
165635,",",0,0
165636,respectively,0,0
165637,",",0,0
165638,p,0,0
165639,<,0,0
165640,0.001,0,0
165641,for,0,0
165642,both,1,0
165643,),1,0
165644,ventilatory,1,0
165645,pressures,1,1
165646,.,1,0
165647,Thirty,0,0
165648,minutes,0,1
165649,after,0,0
165650,re-expansion,0,1
165651,",",0,1
165652,lung,1,1
165653,compliance,1,1
165654,increased,0,0
165655,in,0,0
165656,the,0,0
165657,budesonide,0,0
165658,group,0,0
165659,compared,0,0
165660,with,0,0
165661,saline,0,0
165662,(,0,0
165663,57.5,0,0
165664,(,0,0
165665,4.1,0,0
165666,),0,0
165667,vs,0,0
165668,40.1,0,0
165669,(,0,0
165670,3.5,0,0
165671,),0,0
165672,ml.cmH,0,0
165673,(,0,0
165674,2,0,0
165675,),0,0
165676,O,0,0
165677,(,0,0
165678,-1,0,0
165679,),0,1
165680,",",0,0
165681,respectively,0,0
165682,p,0,0
165683,<,0,0
165684,0.001,0,0
165685,),0,0
165686,.,0,0
165687,Budesonide,0,0
165688,also,0,0
165689,reduced,0,0
165690,the,1,0
165691,concentrations,1,1
165692,of,1,0
165693,tumour,1,1
165694,necrosis,1,1
165695,factor-?,1,1
165696,",",1,1
165697,interleukin-1?,1,1
165698,",",1,1
165699,interleukin-6,1,1
165700,and,1,1
165701,interleukin-8,1,1
165702,in,1,0
165703,bronchoalveolar,1,1
165704,lavage,1,1
165705,fluid,1,1
165706,",",1,1
165707,but,1,0
165708,increased,1,1
165709,interleukin-10,1,0
165710,30,1,0
165711,min,0,0
165712,after,0,0
165713,re-expansion,0,1
165714,(,0,0
165715,p,0,0
165716,<,0,0
165717,0.05,0,0
165718,for,0,0
165719,all,0,0
165720,measures,0,0
165721,),0,0
165722,.,0,0
165723,Pre-operative,0,0
165724,nebulisation,0,0
165725,of,0,0
165726,budesonide,0,0
165727,may,0,0
165728,be,0,0
165729,effective,0,1
165730,in,0,0
165731,improving,1,1
165732,ventilatory,1,1
165733,mechanics,1,1
165734,and,1,0
165735,reducing,1,0
165736,the,1,0
165737,inflammatory,1,1
165738,response,1,1
165739,to,1,0
165740,one-lung,0,1
165741,ventilation,0,1
165742,during,0,0
165743,thoracic,0,0
165744,surgery,0,0
165745,.,0,0
165746,Central,0,1
165747,5-HT4,0,1
165748,receptor,0,1
165749,binding,0,1
165750,as,0,0
165751,biomarker,0,0
165752,of,0,1
165753,serotonergic,0,1
165754,tonus,0,1
165755,in,0,0
165756,humans,0,0
165757,:,0,0
165758,a,0,0
165759,[,0,0
165760,11C,0,0
165761,],0,0
165762,SB207145,0,0
165763,PET,0,0
165764,study,0,0
165765,.,0,1
165766,Identification,0,0
165767,of,0,0
165768,a,0,0
165769,biomarker,0,0
165770,that,0,0
165771,can,0,0
165772,inform,0,0
165773,on,0,0
165774,extracellular,0,1
165775,serotonin,0,1
165776,(,0,1
165777,5-HT,0,0
165778,),0,0
165779,levels,0,1
165780,in,0,0
165781,the,0,0
165782,brains,0,0
165783,of,0,0
165784,living,0,0
165785,humans,0,0
165786,would,0,0
165787,enable,0,0
165788,greater,0,0
165789,understanding,0,1
165790,of,0,0
165791,the,0,0
165792,way,0,0
165793,brain,0,1
165794,circuits,0,1
165795,are,0,0
165796,modulated,0,0
165797,by,0,0
165798,serotonergic,0,0
165799,neurotransmission,0,1
165800,.,0,1
165801,Substantial,0,0
165802,evidence,0,0
165803,from,0,0
165804,studies,0,0
165805,in,0,0
165806,animals,0,0
165807,and,0,0
165808,humans,0,0
165809,indicates,0,0
165810,an,0,0
165811,inverse,0,1
165812,relationship,0,1
165813,between,0,0
165814,central,0,1
165815,5-HT,0,0
165816,tonus,0,1
165817,and,0,1
165818,5-HT,0,0
165819,type,0,0
165820,4,0,0
165821,receptor,0,0
165822,(,0,0
165823,5-HT4R,0,0
165824,),0,1
165825,density,0,1
165826,",",0,0
165827,suggesting,0,0
165828,that,0,0
165829,5-HT4R,0,0
165830,receptor,0,0
165831,density,0,1
165832,may,0,0
165833,be,0,0
165834,a,0,0
165835,biomarker,0,0
165836,marker,0,1
165837,for,0,0
165838,5-HT,0,0
165839,tonus,0,1
165840,.,0,0
165841,Here,0,0
165842,",",0,0
165843,we,0,0
165844,investigated,0,0
165845,whether,0,0
165846,a,0,0
165847,3-week,0,0
165848,administration,0,0
165849,of,0,0
165850,a,0,0
165851,selective,0,0
165852,serotonin,0,1
165853,reuptake,0,0
165854,inhibitor,0,0
165855,",",0,0
165856,expected,0,0
165857,to,0,0
165858,increase,0,0
165859,brain,0,1
165860,5-HT,0,1
165861,levels,0,1
165862,",",0,0
165863,is,0,0
165864,associated,0,0
165865,with,0,0
165866,a,0,0
165867,decline,0,1
165868,in,0,0
165869,brain,0,1
165870,5-HT4R,0,0
165871,binding,0,0
165872,.,0,0
165873,A,0,0
165874,total,0,0
165875,of,0,0
165876,35,0,0
165877,healthy,0,0
165878,men,0,0
165879,were,0,0
165880,studied,0,0
165881,in,0,0
165882,a,0,0
165883,placebo-controlled,0,0
165884,",",0,0
165885,randomized,0,0
165886,",",0,0
165887,double-blind,0,0
165888,study,0,0
165889,.,0,1
165890,Participants,0,0
165891,were,0,0
165892,assigned,0,0
165893,to,0,0
165894,receive,0,0
165895,3,0,0
165896,weeks,0,0
165897,of,0,0
165898,oral,0,0
165899,dosing,0,0
165900,with,0,0
165901,placebo,0,0
165902,or,0,1
165903,fluoxetine,0,0
165904,",",0,0
165905,40,0,0
165906,mg,0,0
165907,per,0,0
165908,day,0,0
165909,.,0,0
165910,Brain,1,1
165911,5-HT4R,1,0
165912,binding,1,1
165913,was,0,0
165914,quantified,0,0
165915,at,0,0
165916,baseline,0,0
165917,and,0,1
165918,at,0,0
165919,follow-up,0,0
165920,with,0,0
165921,[,0,0
165922,(,0,0
165923,11,0,0
165924,),0,0
165925,C,0,0
165926,],0,0
165927,SB207145,0,0
165928,positron,1,0
165929,emission,1,1
165930,tomography,1,1
165931,(,1,1
165932,PET,1,0
165933,),1,0
165934,.,1,0
165935,Three,0,0
165936,weeks,0,0
165937,of,0,0
165938,intervention,0,0
165939,with,0,0
165940,fluoxetine,0,0
165941,was,0,0
165942,associated,0,0
165943,with,0,0
165944,a,0,0
165945,5.2,0,0
165946,%,0,0
165947,reduction,0,1
165948,in,0,0
165949,brain,1,1
165950,5-HT4R,1,0
165951,binding,1,1
165952,(,0,1
165953,P=0.017,0,0
165954,),0,1
165955,",",0,0
165956,whereas,0,0
165957,placebo,0,0
165958,intervention,0,0
165959,did,0,0
165960,not,0,0
165961,change,0,1
165962,5-HT4R,0,0
165963,binding,0,1
165964,(,0,1
165965,P=0.52,0,0
165966,),0,0
165967,.,0,0
165968,Our,0,0
165969,findings,0,0
165970,are,0,0
165971,consistent,0,0
165972,with,0,0
165973,a,0,0
165974,model,0,0
165975,",",0,0
165976,wherein,0,0
165977,the,0,0
165978,5-HT4R,1,0
165979,density,1,1
165980,adjusts,0,0
165981,to,0,0
165982,changes,0,1
165983,in,0,0
165984,the,0,0
165985,extracellular,0,0
165986,5-HT,0,0
165987,tonus,0,1
165988,.,0,0
165989,Our,0,0
165990,data,0,0
165991,demonstrate,0,0
165992,for,0,0
165993,the,0,0
165994,first,0,0
165995,time,0,1
165996,in,0,0
165997,humans,0,0
165998,that,0,0
165999,the,0,0
166000,imaging,0,0
166001,of,0,0
166002,central,0,1
166003,5-HT4R,0,0
166004,binding,0,0
166005,may,0,0
166006,be,0,0
166007,used,0,0
166008,as,0,0
166009,an,0,0
166010,in,0,0
166011,vivo,0,0
166012,biomarker,0,0
166013,of,0,0
166014,the,0,0
166015,central,0,1
166016,5-HT,0,0
166017,tonus,0,1
166018,.,0,0
166019,Combining,0,0
166020,afferent,0,1
166021,stimulation,0,1
166022,and,0,1
166023,mirror,0,0
166024,therapy,0,0
166025,for,0,0
166026,rehabilitating,0,1
166027,motor,1,1
166028,function,1,1
166029,",",1,1
166030,motor,1,1
166031,control,1,0
166032,",",1,1
166033,ambulation,1,1
166034,",",1,1
166035,and,1,1
166036,daily,1,1
166037,functions,1,1
166038,after,1,0
166039,stroke,1,1
166040,.,1,0
166041,BACKGROUND,0,0
166042,Mirror,0,1
166043,therapy,0,0
166044,(,0,1
166045,MT,0,1
166046,),0,1
166047,and,0,1
166048,mesh,0,1
166049,glove,0,1
166050,(,0,1
166051,MG,0,1
166052,),0,1
166053,afferent,0,1
166054,stimulation,0,0
166055,may,0,0
166056,be,0,0
166057,effective,0,1
166058,in,0,0
166059,reducing,0,0
166060,motor,0,1
166061,impairment,0,1
166062,after,0,0
166063,stroke,0,1
166064,.,0,0
166065,A,0,0
166066,hybrid,0,0
166067,intervention,0,0
166068,of,0,1
166069,MT,0,1
166070,combined,0,0
166071,with,0,0
166072,MG,0,1
166073,(,0,0
166074,MT,0,1
166075,+,0,0
166076,MG,0,0
166077,),0,0
166078,may,0,0
166079,broaden,0,0
166080,aspects,0,1
166081,of,0,0
166082,treatment,0,0
166083,benefits,0,0
166084,.,0,0
166085,OBJECTIVE,0,0
166086,To,0,0
166087,demonstrate,0,0
166088,the,0,0
166089,comparative,0,0
166090,effects,0,1
166091,of,0,0
166092,MG,0,1
166093,+,0,0
166094,MT,0,1
166095,",",0,1
166096,MT,0,1
166097,",",0,1
166098,and,0,0
166099,a,0,0
166100,control,0,0
166101,treatment,0,0
166102,(,0,1
166103,CT,0,1
166104,),0,0
166105,on,0,0
166106,the,0,0
166107,outcomes,0,1
166108,of,0,0
166109,motor,0,1
166110,impairments,0,1
166111,",",0,1
166112,manual,0,1
166113,dexterity,0,1
166114,",",0,1
166115,ambulation,0,1
166116,function,0,1
166117,",",0,1
166118,motor,0,1
166119,control,0,1
166120,",",0,1
166121,and,0,1
166122,daily,0,1
166123,function,0,1
166124,.,0,0
166125,METHODS,0,0
166126,Forty-three,0,0
166127,chronic,0,0
166128,stroke,0,1
166129,patients,0,0
166130,with,0,0
166131,mild,0,0
166132,to,0,0
166133,moderate,0,0
166134,upper,0,0
166135,extremity,0,1
166136,impairment,0,1
166137,were,0,0
166138,randomly,0,0
166139,assigned,0,0
166140,to,0,0
166141,receive,0,0
166142,MT,0,1
166143,+,0,0
166144,MG,0,1
166145,",",0,1
166146,MT,0,1
166147,",",0,1
166148,or,0,1
166149,CT,0,1
166150,for,0,0
166151,1.5,0,0
166152,hours/day,0,0
166153,",",0,0
166154,5,0,0
166155,days/week,0,0
166156,for,0,0
166157,4,0,0
166158,weeks,0,0
166159,.,0,0
166160,Outcome,0,1
166161,measures,0,1
166162,were,0,0
166163,the,0,0
166164,Fugl-Meyer,1,1
166165,Assessment,1,1
166166,(,1,1
166167,FMA,1,1
166168,),1,1
166169,and,1,1
166170,muscle,1,1
166171,tone,1,1
166172,measured,1,1
166173,by,1,0
166174,Myoton-3,1,1
166175,for,1,0
166176,motor,1,1
166177,impairment,1,1
166178,and,0,0
166179,the,0,0
166180,Box,1,1
166181,and,1,1
166182,Block,1,0
166183,Test,1,1
166184,(,1,1
166185,BBT,1,1
166186,),1,1
166187,and,0,1
166188,10-Meter,1,1
166189,Walk,1,1
166190,Test,1,1
166191,(,1,0
166192,10,1,0
166193,MWT,1,0
166194,),1,0
166195,for,0,0
166196,motor,0,1
166197,function,0,1
166198,.,0,1
166199,Secondary,0,0
166200,outcomes,0,1
166201,included,0,0
166202,kinematic,1,1
166203,parameters,1,1
166204,for,1,0
166205,motor,1,1
166206,control,1,0
166207,and,0,0
166208,the,0,0
166209,Motor,1,1
166210,Activity,1,1
166211,Log,1,0
166212,and,0,1
166213,ABILHAND,1,1
166214,Questionnaire,1,1
166215,for,1,0
166216,daily,1,0
166217,function,1,1
166218,.,1,0
166219,RESULTS,0,0
166220,FMA,1,0
166221,total,1,1
166222,scores,1,1
166223,were,0,0
166224,significantly,0,0
166225,higher,0,0
166226,and,0,1
166227,synergistic,1,1
166228,shoulder,1,1
166229,abduction,1,1
166230,during,1,0
166231,reach,1,1
166232,was,0,0
166233,less,0,0
166234,in,0,0
166235,the,0,0
166236,MT,0,1
166237,+,0,0
166238,MG,0,1
166239,and,0,1
166240,MT,0,1
166241,groups,0,0
166242,compared,0,0
166243,with,0,0
166244,the,0,0
166245,CT,0,1
166246,group,0,0
166247,.,0,1
166248,Performance,0,1
166249,on,0,0
166250,the,0,0
166251,BBT,1,0
166252,and,0,0
166253,the,0,0
166254,10,1,0
166255,MWT,1,0
166256,(,0,0
166257,velocity,0,1
166258,and,0,1
166259,stride,0,1
166260,length,0,1
166261,in,0,0
166262,self-paced,0,1
166263,task,0,1
166264,and,0,1
166265,velocity,0,1
166266,in,0,0
166267,as-quickly-as-possible,0,1
166268,task,0,1
166269,),0,1
166270,were,0,0
166271,improved,0,0
166272,after,0,0
166273,MT,0,1
166274,+,0,0
166275,MG,0,1
166276,compared,0,0
166277,with,0,0
166278,MT,0,1
166279,.,0,0
166280,CONCLUSIONS,0,0
166281,MT,0,1
166282,+,0,0
166283,MG,0,1
166284,improved,0,1
166285,manual,1,1
166286,dexterity,1,1
166287,and,1,1
166288,ambulation,1,1
166289,.,1,1
166290,MT,0,1
166291,+,0,0
166292,MG,0,1
166293,and,0,1
166294,MT,0,1
166295,reduced,0,1
166296,motor,1,1
166297,impairment,1,1
166298,and,1,1
166299,synergistic,1,1
166300,shoulder,1,1
166301,abduction,1,1
166302,more,0,0
166303,than,0,0
166304,CT.,0,0
166305,Future,0,0
166306,studies,0,0
166307,may,0,0
166308,integrate,0,0
166309,functional,0,1
166310,task,0,1
166311,practice,0,0
166312,into,0,0
166313,treatments,0,0
166314,to,0,0
166315,enhance,0,0
166316,functional,0,1
166317,outcomes,0,1
166318,in,0,0
166319,patients,0,0
166320,with,0,0
166321,various,0,0
166322,levels,0,1
166323,of,0,1
166324,motor,0,1
166325,severity,0,1
166326,.,0,0
166327,The,0,0
166328,long-term,0,0
166329,effects,0,1
166330,of,0,0
166331,MG,0,1
166332,+,0,0
166333,MT,0,1
166334,remain,0,0
166335,to,0,0
166336,be,0,0
166337,evaluated,0,0
166338,.,0,0
166339,The,0,0
166340,cardiovascular,0,1
166341,effects,0,1
166342,of,0,1
166343,sevoflurane,0,0
166344,and,0,1
166345,isoflurane,0,0
166346,after,0,0
166347,premedication,0,0
166348,of,0,0
166349,healthy,0,0
166350,dogs,0,0
166351,undergoing,0,0
166352,elective,0,0
166353,surgery,0,0
166354,.,0,1
166355,Sevoflurane,0,0
166356,and,0,0
166357,isoflurane,0,0
166358,are,0,0
166359,commonly,0,0
166360,used,0,0
166361,in,0,0
166362,veterinary,0,0
166363,anesthesia,0,0
166364,.,0,0
166365,The,0,0
166366,objective,0,0
166367,of,0,0
166368,this,0,0
166369,prospective,0,0
166370,",",0,0
166371,randomized,0,0
166372,",",0,0
166373,open-label,0,0
166374,clinical,0,1
166375,study,0,0
166376,was,0,0
166377,to,0,0
166378,compare,0,0
166379,the,0,0
166380,cardiovascular,0,1
166381,effects,0,1
166382,of,0,1
166383,sevoflurane,0,0
166384,and,0,1
166385,isoflurane,0,0
166386,via,0,0
166387,direct,0,1
166388,arterial,0,1
166389,blood,0,1
166390,pressure,0,1
166391,measurements,0,1
166392,and,0,0
166393,the,0,0
166394,lithium,0,0
166395,dilution,0,1
166396,cardiac,0,1
166397,output,0,1
166398,(,0,1
166399,LDCO,0,1
166400,),0,0
166401,on,0,0
166402,premedicated,0,0
166403,healthy,0,0
166404,dogs,0,0
166405,undergoing,0,0
166406,elective,0,0
166407,tibial,0,1
166408,plateau,0,1
166409,leveling,0,1
166410,osteotomy,0,0
166411,(,0,1
166412,TPLO,0,0
166413,),0,0
166414,.,0,0
166415,Nineteen,0,0
166416,client-owned,0,0
166417,dogs,0,0
166418,were,0,0
166419,included,0,0
166420,.,0,0
166421,All,0,0
166422,dogs,0,0
166423,were,0,0
166424,premedicated,0,0
166425,with,0,0
166426,hydromorphone,0,0
166427,(,0,0
166428,0.05,0,0
166429,mg/kg,0,0
166430,IV,0,0
166431,and,0,0
166432,glycopyrrolate,0,0
166433,0.01,0,0
166434,mg/kg,0,0
166435,subcutaneously,0,0
166436,),0,0
166437,.,0,0
166438,Ten,0,0
166439,dogs,0,0
166440,were,0,0
166441,anesthetized,0,0
166442,with,0,0
166443,sevoflurane,0,0
166444,and,0,0
166445,nine,0,0
166446,dogs,0,0
166447,were,0,0
166448,anesthetized,0,0
166449,with,0,0
166450,isoflurane,0,0
166451,.,0,0
166452,Eighteen,0,0
166453,dogs,0,0
166454,were,0,0
166455,instrumented,0,0
166456,with,0,0
166457,a,0,0
166458,dorsal,0,0
166459,pedal,0,1
166460,arterial,0,1
166461,catheter,0,1
166462,",",0,0
166463,and,0,0
166464,one,0,0
166465,dog,0,0
166466,had,0,0
166467,a,0,0
166468,femoral,0,1
166469,arterial,0,1
166470,catheter,0,0
166471,.,0,0
166472,All,0,0
166473,dogs,0,0
166474,had,0,0
166475,continuous,0,0
166476,",",0,1
166477,direct,1,1
166478,systolic,1,1
166479,(,1,1
166480,SAP,1,1
166481,),1,1
166482,",",1,1
166483,diastolic,1,1
166484,(,1,1
166485,DAP,1,1
166486,),1,1
166487,",",1,0
166488,and,1,1
166489,mean,1,1
166490,arterial,1,1
166491,(,1,1
166492,MAP,1,1
166493,),1,1
166494,blood,1,1
166495,pressure,1,1
166496,readings,1,1
166497,as,0,0
166498,well,0,0
166499,as,0,0
166500,heart,1,1
166501,rate,1,1
166502,(,1,1
166503,HR,1,1
166504,),1,1
166505,",",1,0
166506,cardiac,1,1
166507,output,1,1
166508,(,1,1
166509,CO,1,1
166510,),1,1
166511,",",1,0
166512,cardiac,1,1
166513,index,1,1
166514,(,1,1
166515,CI,1,0
166516,),1,1
166517,",",1,0
166518,systemic,1,1
166519,vascular,1,1
166520,resistance,1,1
166521,(,1,1
166522,SVR,1,1
166523,),1,1
166524,",",1,0
166525,systemic,1,1
166526,vascular,1,1
166527,resistance,1,1
166528,index,1,1
166529,(,1,1
166530,SVRI,1,1
166531,),1,1
166532,",",1,1
166533,stroke,1,1
166534,volume,1,1
166535,variation,1,1
166536,(,1,1
166537,SVV,1,0
166538,),1,1
166539,",",1,0
166540,and,1,1
166541,pulse,1,1
166542,pressure,1,1
166543,variation,1,1
166544,(,1,1
166545,PPV,1,1
166546,),1,1
166547,recorded,0,0
166548,q,0,0
166549,5,0,0
166550,min,0,0
166551,during,0,0
166552,the,0,0
166553,surgical,0,0
166554,procedure,0,0
166555,.,0,0
166556,There,0,0
166557,was,0,0
166558,no,0,0
166559,significant,0,0
166560,statistical,0,0
166561,difference,0,0
166562,in,0,0
166563,all,0,0
166564,parameters,0,0
166565,between,0,0
166566,the,0,0
166567,sevoflurane,0,0
166568,and,0,1
166569,isoflurane,0,0
166570,treatment,0,0
166571,groups,0,0
166572,.,0,0
166573,Both,0,0
166574,sevoflurane,0,0
166575,and,0,1
166576,isoflurane,0,0
166577,inhalant,0,0
166578,anesthetics,0,0
166579,appear,0,0
166580,to,0,0
166581,have,0,0
166582,similar,0,0
166583,hemodynamic,0,1
166584,effects,0,1
166585,when,0,0
166586,used,0,0
166587,as,0,0
166588,part,0,0
166589,of,0,0
166590,a,0,0
166591,multimodal,0,0
166592,anesthetic,0,0
166593,protocol,0,0
166594,in,0,0
166595,premedicated,0,0
166596,healthy,0,0
166597,dogs,0,0
166598,undergoing,0,0
166599,an,0,0
166600,elective,0,0
166601,surgical,0,0
166602,procedure,0,0
166603,.,0,0
166604,Effect,0,1
166605,of,0,1
166606,augmented,0,1
166607,sensorimotor,0,1
166608,input,0,1
166609,on,0,0
166610,learning,1,1
166611,verbal,1,1
166612,and,1,1
166613,nonverbal,1,1
166614,tasks,1,1
166615,among,0,0
166616,children,0,0
166617,with,0,0
166618,autism,0,0
166619,spectrum,0,0
166620,disorders,0,0
166621,.,0,0
166622,Thirty-four,0,0
166623,children,0,0
166624,",",0,0
166625,with,0,0
166626,autism,0,0
166627,spectrum,0,0
166628,disorders,0,0
166629,",",0,0
166630,ages,0,0
166631,4-14,0,0
166632,years,0,0
166633,",",0,0
166634,were,0,0
166635,matched,0,0
166636,and,0,0
166637,randomly,0,0
166638,assigned,0,0
166639,to,0,0
166640,one,0,0
166641,of,0,0
166642,two,0,0
166643,conditions,0,0
166644,for,0,0
166645,learning,1,1
166646,a,1,0
166647,novel,1,0
166648,juice-making,1,1
166649,task,1,1
166650,and,0,0
166651,producing,1,0
166652,two,1,0
166653,novel,1,0
166654,words,1,0
166655,about,1,0
166656,the,1,0
166657,event,1,0
166658,.,1,1
166659,Seventeen,0,1
166660,sighted,0,0
166661,children,0,0
166662,were,0,0
166663,manually,0,0
166664,guided,0,0
166665,to,0,0
166666,perform,0,0
166667,the,0,0
166668,task,0,1
166669,and,0,1
166670,tactually,0,1
166671,prompted,0,0
166672,during,0,0
166673,imitated,0,0
166674,productions,0,1
166675,of,0,0
166676,novel,0,0
166677,words,0,0
166678,for,0,0
166679,the,0,0
166680,event,0,0
166681,.,0,0
166682,Their,0,0
166683,matched,0,0
166684,controls,0,0
166685,heard,0,0
166686,the,0,0
166687,novel,1,0
166688,words,1,1
166689,and,0,1
166690,watched,0,0
166691,the,0,0
166692,juice-making,1,0
166693,task,1,1
166694,being,0,0
166695,performed,0,0
166696,.,0,0
166697,Performances,0,0
166698,on,0,0
166699,four,1,0
166700,verbal,1,0
166701,and,1,0
166702,two,1,0
166703,nonverbal,1,1
166704,measures,1,0
166705,right,0,1
166706,after,0,0
166707,instruction,0,0
166708,and,0,1
166709,at,0,1
166710,24-48,0,0
166711,h,0,0
166712,post-instruction,0,1
166713,",",0,1
166714,revealed,0,0
166715,higher,0,0
166716,scores,0,1
166717,for,0,0
166718,the,0,0
166719,??hands-on??,0,0
166720,",",0,0
166721,participation,0,1
166722,than,0,0
166723,observation,0,0
166724,group,0,0
166725,on,0,0
166726,both,0,0
166727,verbal,0,1
166728,and,0,0
166729,nonverbal,0,1
166730,tasks,0,1
166731,.,0,0
166732,This,0,0
166733,study,0,0
166734,offers,0,0
166735,a,0,0
166736,paradigm,0,0
166737,for,0,0
166738,exploring,0,0
166739,the,0,0
166740,instructional,0,0
166741,advantage,1,0
166742,of,1,1
166743,enhanced,1,1
166744,participatory,1,0
166745,experience,1,0
166746,.,1,0
166747,Remission,1,1
166748,in,1,0
166749,rheumatoid,1,1
166750,arthritis,1,0
166751,patients,0,0
166752,treated,0,0
166753,with,0,0
166754,etanercept,0,0
166755,monotherapy,0,0
166756,:,0,0
166757,clinical,0,1
166758,practice,0,0
166759,and,0,1
166760,clinical,0,1
166761,trial,0,0
166762,experience,0,1
166763,.,0,0
166764,OBJECTIVES,0,0
166765,To,0,0
166766,assess,0,0
166767,",",0,0
166768,in,0,0
166769,a,0,0
166770,randomised,0,0
166771,controlled,0,0
166772,trial,0,0
166773,(,0,0
166774,RCT,0,0
166775,),0,1
166776,and,0,0
166777,in,0,0
166778,clinical,0,1
166779,practice,0,0
166780,",",0,0
166781,an,0,0
166782,association,1,0
166783,of,1,0
166784,time,1,1
166785,to,1,0
166786,remission,1,1
166787,and,0,1
166788,baseline,1,1
166789,disease,1,1
166790,activity,1,1
166791,with,0,0
166792,both,0,0
166793,induction,0,0
166794,of,0,1
166795,remission,0,1
166796,and,0,1
166797,sustained,0,1
166798,remission,0,1
166799,in,0,0
166800,etanercept-treated,0,0
166801,patients,0,0
166802,with,0,0
166803,rheumatoid,0,1
166804,arthritis,0,1
166805,(,0,1
166806,RA,0,0
166807,),0,0
166808,.,0,0
166809,METHODS,0,0
166810,Data,0,0
166811,from,0,0
166812,an,0,0
166813,RCT,0,0
166814,(,0,0
166815,Trial,0,0
166816,of,0,1
166817,Etanercept,0,0
166818,and,0,1
166819,Methotrexate,0,1
166820,with,0,0
166821,Radiographic,0,1
166822,Patient,0,1
166823,Outcomes,0,1
166824,[,0,0
166825,TEMPO,0,1
166826,],0,0
166827,;,0,1
166828,n=682,0,0
166829,),0,0
166830,and,0,0
166831,an,0,0
166832,observational,0,0
166833,registry,0,0
166834,(,0,0
166835,Rheumatoid,0,1
166836,Arthritis,0,1
166837,DMARD,0,0
166838,Intervention,0,0
166839,and,0,1
166840,Utilization,0,1
166841,Study,0,0
166842,[,0,0
166843,RADIUS,0,0
166844,II,0,0
166845,],0,0
166846,;,0,1
166847,n=4341,0,0
166848,),0,1
166849,were,0,0
166850,used,0,0
166851,to,0,0
166852,evaluate,0,0
166853,disease,1,1
166854,activity,1,1
166855,(,0,0
166856,Clinical,0,1
166857,Disease,0,1
166858,Activity,0,1
166859,Index,0,1
166860,[,0,0
166861,CDAI,0,0
166862,],0,0
166863,score,0,1
166864,),0,0
166865,over,0,0
166866,time,0,1
166867,in,0,0
166868,patients,0,0
166869,initiating,0,0
166870,etanercept,0,0
166871,(,0,1
166872,monotherapy,0,0
166873,or,0,1
166874,with,0,0
166875,methotrexate,0,0
166876,),0,0
166877,.,0,0
166878,CDAI,1,0
166879,remission,1,1
166880,(,0,1
166881,CDAI?2.8,0,1
166882,),0,1
166883,and,1,1
166884,sustained,1,1
166885,remission,1,1
166886,(,1,0
166887,?6,0,0
166888,months,0,0
166889,),0,0
166890,were,0,0
166891,determined,0,0
166892,through,0,0
166893,year,0,0
166894,3,0,0
166895,by,0,0
166896,treatment,0,0
166897,group,0,0
166898,",",0,1
166899,study,0,0
166900,",",0,1
166901,time,0,1
166902,to,0,1
166903,remission,0,1
166904,",",0,1
166905,and,0,1
166906,disease,0,1
166907,severity,0,1
166908,.,0,1
166909,RESULTS,0,0
166910,Patients,0,0
166911,from,0,0
166912,TEMPO,0,1
166913,and,0,1
166914,RADIUS,0,0
166915,II,0,0
166916,who,0,0
166917,received,0,0
166918,etanercept,0,0
166919,monotherapy,0,0
166920,showed,0,0
166921,similar,1,0
166922,CDAI,1,0
166923,remission,1,1
166924,rates,1,1
166925,(,1,0
166926,39,1,0
166927,%,0,0
166928,and,0,0
166929,35,0,0
166930,%,0,0
166931,",",0,0
166932,respectively,0,0
166933,",",0,0
166934,at,0,0
166935,3,0,0
166936,years,0,0
166937,),0,0
166938,.,0,0
166939,Among,0,0
166940,patients,0,0
166941,who,0,0
166942,received,0,0
166943,etanercept,0,0
166944,with,0,0
166945,methotrexate,1,0
166946,",",1,1
166947,remission,1,1
166948,rates,1,1
166949,were,1,0
166950,54,0,0
166951,%,0,0
166952,and,0,0
166953,36,0,0
166954,%,0,0
166955,",",0,0
166956,respectively,1,0
166957,.,1,0
166958,Remission,1,0
166959,occurred,1,0
166960,more,0,0
166961,rapidly,0,0
166962,in,0,0
166963,TEMPO,0,1
166964,than,0,0
166965,RADIUS,0,0
166966,II,0,0
166967,perhaps,0,0
166968,from,0,0
166969,differences,1,0
166970,in,1,0
166971,compliance,1,1
166972,",",1,0
166973,patient,1,1
166974,populations,1,1
166975,",",1,1
166976,or,1,1
166977,sequence,1,1
166978,of,1,1
166979,combination,1,0
166980,therapy,1,0
166981,initiation,1,0
166982,.,1,0
166983,Generally,1,0
166984,",",0,0
166985,more,0,0
166986,patients,0,0
166987,with,0,0
166988,lower,1,0
166989,baseline,1,0
166990,CDAI,1,0
166991,scores,1,1
166992,achieved,1,1
166993,remission,1,1
166994,than,1,0
166995,those,0,0
166996,with,0,0
166997,higher,0,0
166998,scores,1,1
166999,.,1,1
167000,Continued,1,0
167001,remission,1,1
167002,appeared,1,0
167003,more,0,0
167004,likely,0,0
167005,in,0,0
167006,patients,0,0
167007,achieving,0,1
167008,remission,0,1
167009,earlier,0,0
167010,in,0,0
167011,the,0,0
167012,course,0,0
167013,of,0,0
167014,their,0,0
167015,therapy,0,0
167016,(,0,0
167017,0-6,0,0
167018,months,0,0
167019,),0,0
167020,.,0,0
167021,CONCLUSIONS,1,0
167022,Remission,1,1
167023,by,1,0
167024,year,0,0
167025,3,0,0
167026,in,0,0
167027,etanercept-treated,0,0
167028,(,0,0
167029,with,0,0
167030,and,0,1
167031,without,0,0
167032,methotrexate,0,0
167033,),0,0
167034,patients,0,0
167035,with,0,0
167036,RA,0,0
167037,occurred,0,0
167038,in,0,0
167039,?35,0,0
167040,%,0,0
167041,of,0,0
167042,patients,0,0
167043,in,0,0
167044,both,0,0
167045,an,0,0
167046,RCT,0,0
167047,(,0,0
167048,TEMPO,0,1
167049,),0,0
167050,and,0,0
167051,a,0,0
167052,clinical,0,1
167053,practice,0,0
167054,setting,0,0
167055,(,0,1
167056,RADIUS,0,0
167057,II,0,0
167058,),0,1
167059,",",0,0
167060,and,0,1
167061,more,0,0
167062,frequently,0,0
167063,in,0,0
167064,those,0,0
167065,with,0,0
167066,lower,0,0
167067,baseline,0,1
167068,disease,0,1
167069,severity,0,1
167070,.,0,0
167071,Patients,0,0
167072,with,0,0
167073,lower,0,1
167074,RA,0,0
167075,disease,0,1
167076,activity,0,1
167077,were,0,0
167078,more,0,0
167079,likely,0,0
167080,to,0,0
167081,reach,0,0
167082,remission,1,1
167083,.,1,0
167084,Continued,1,0
167085,remission,1,0
167086,may,1,0
167087,be,1,0
167088,more,0,0
167089,likely,0,0
167090,in,0,0
167091,patients,0,0
167092,who,0,0
167093,achieved,0,1
167094,remission,0,1
167095,earlier,0,0
167096,.,0,0
167097,The,0,0
167098,efficacy,1,1
167099,and,1,1
167100,safety,1,1
167101,of,0,1
167102,cyclosporine,0,0
167103,reduction,0,1
167104,in,0,0
167105,de,0,0
167106,novo,0,1
167107,renal,0,1
167108,allograft,0,1
167109,patients,0,0
167110,receiving,0,0
167111,sirolimus,0,0
167112,and,0,0
167113,corticosteroids,0,0
167114,:,0,0
167115,results,0,0
167116,from,0,0
167117,an,0,0
167118,open-label,0,0
167119,comparative,0,0
167120,study,0,0
167121,.,0,0
167122,This,0,0
167123,study,0,0
167124,evaluated,0,0
167125,the,0,0
167126,safety,1,1
167127,and,1,1
167128,efficacy,1,1
167129,of,0,0
167130,a,0,0
167131,sirolimus,0,0
167132,",",0,1
167133,corticosteroid,0,0
167134,",",0,0
167135,and,0,1
167136,cyclosporine,0,0
167137,reduction,0,1
167138,regimen,0,0
167139,in,0,0
167140,an,0,0
167141,open-label,0,0
167142,",",0,0
167143,12-month,0,1
167144,trial,0,0
167145,of,0,0
167146,420,0,0
167147,de,0,0
167148,novo,0,0
167149,renal,0,1
167150,allograft,0,1
167151,recipients,0,0
167152,at,0,0
167153,49,0,0
167154,European,0,0
167155,transplant,0,0
167156,centers,0,0
167157,.,0,0
167158,One,0,0
167159,month,0,0
167160,post-transplantation,0,0
167161,",",0,0
167162,357,0,0
167163,patients,0,0
167164,were,0,0
167165,randomized,0,0
167166,to,0,0
167167,receive,0,0
167168,standard-dose,0,0
167169,cyclosporine,0,0
167170,(,0,1
167171,sCsA,0,1
167172,",",0,1
167173,n,0,0
167174,=,0,0
167175,179,0,0
167176,),0,0
167177,or,0,0
167178,reduced-dose,0,0
167179,cyclosporine,0,0
167180,(,0,1
167181,rCsA,0,1
167182,",",0,1
167183,n,0,0
167184,=,0,0
167185,178,0,0
167186,),0,0
167187,.,0,0
167188,All,0,0
167189,patients,0,0
167190,also,0,0
167191,received,0,0
167192,sirolimus,0,0
167193,and,0,0
167194,corticosteroids,0,0
167195,.,0,0
167196,The,0,0
167197,primary,0,0
167198,end,0,0
167199,points,0,0
167200,were,0,0
167201,the,0,0
167202,rate,1,1
167203,of,1,0
167204,biopsy-confirmed,1,1
167205,acute,1,1
167206,rejection,1,1
167207,(,1,1
167208,BCAR,1,1
167209,),1,1
167210,and,1,1
167211,renal,1,1
167212,function,1,1
167213,",",1,0
167214,as,1,0
167215,measured,1,1
167216,by,1,0
167217,serum,1,1
167218,creatinine,1,1
167219,.,1,0
167220,Baseline,0,0
167221,demographic,0,1
167222,and,0,1
167223,donor,0,1
167224,characteristics,0,1
167225,were,0,0
167226,similar,0,0
167227,between,0,0
167228,groups,0,0
167229,.,0,0
167230,BCAR,1,0
167231,rates,0,1
167232,at,0,0
167233,12,0,0
167234,months,0,0
167235,were,0,0
167236,not,0,0
167237,significantly,0,0
167238,different,0,0
167239,:,0,0
167240,11.2,0,0
167241,%,0,0
167242,for,0,0
167243,rCsA,0,0
167244,patients,0,0
167245,and,0,0
167246,16.2,0,0
167247,%,0,0
167248,for,0,0
167249,sCsA,0,0
167250,patients,0,0
167251,.,0,0
167252,Mean,1,1
167253,serum,1,1
167254,creatinine,1,1
167255,(,0,1
167256,?SEM,0,0
167257,),0,1
167258,was,0,0
167259,significantly,0,0
167260,lower,0,0
167261,(,0,0
167262,1.75,0,0
167263,?,0,0
167264,0.10,0,0
167265,vs.,0,0
167266,1.97,0,0
167267,?,0,0
167268,0.07,0,0
167269,mg/dl,0,0
167270,",",0,0
167271,P,0,0
167272,<,0,0
167273,0.001,0,0
167274,),0,0
167275,",",0,0
167276,and,0,1
167277,creatinine,1,1
167278,clearance,1,1
167279,(,1,0
167280,?SEM,1,0
167281,;,0,1
167282,Nankivell,0,1
167283,method,0,0
167284,),0,1
167285,was,0,0
167286,significantly,0,0
167287,higher,0,0
167288,(,0,0
167289,57.8,0,0
167290,?,0,0
167291,1.78,0,0
167292,vs.,0,0
167293,49.5,0,0
167294,?,0,0
167295,2.46,0,0
167296,ml/min,0,0
167297,",",0,0
167298,P,0,0
167299,<,0,0
167300,0.001,0,0
167301,),0,0
167302,in,0,0
167303,patients,0,0
167304,receiving,0,0
167305,rCsA,0,0
167306,versus,0,0
167307,sCsA,0,0
167308,at,0,0
167309,1,0,0
167310,year,0,0
167311,",",0,0
167312,respectively,1,0
167313,.,1,0
167314,Patient,1,1
167315,and,1,1
167316,graft,1,1
167317,survival,1,1
167318,exceeded,1,0
167319,98,0,0
167320,%,0,0
167321,in,0,0
167322,both,0,0
167323,groups,0,0
167324,.,0,0
167325,No,0,0
167326,significant,0,0
167327,differences,1,0
167328,in,1,0
167329,infection,1,1
167330,or,1,1
167331,malignancy,1,1
167332,were,1,0
167333,noted,0,0
167334,between,0,0
167335,groups,0,0
167336,.,0,0
167337,The,0,0
167338,rCsA,0,0
167339,with,0,0
167340,sirolimus,0,0
167341,and,0,1
167342,corticosteroid,0,0
167343,regimen,0,0
167344,resulted,0,0
167345,in,0,0
167346,excellent,1,1
167347,12-month,1,1
167348,patient,1,1
167349,and,1,1
167350,graft,1,1
167351,survival,1,1
167352,",",1,0
167353,a,1,0
167354,low,1,0
167355,incidence,1,1
167356,of,1,1
167357,BCAR,1,1
167358,",",1,1
167359,and,1,1
167360,improved,1,1
167361,renal,1,1
167362,function,1,1
167363,in,1,0
167364,renal,1,1
167365,allograft,0,0
167366,recipients,0,0
167367,.,0,1
167368,Sirolimus,0,0
167369,administered,0,0
167370,with,0,0
167371,rCsA,0,0
167372,and,0,1
167373,corticosteroids,0,0
167374,provided,0,0
167375,adequate,1,0
167376,immunosuppression,1,0
167377,while,1,0
167378,reducing,0,0
167379,the,0,0
167380,potential,0,0
167381,for,0,0
167382,the,1,0
167383,nephrotoxic,1,1
167384,effects,1,1
167385,of,1,0
167386,cyclosporine,1,0
167387,.,1,0
167388,These,1,0
167389,findings,0,0
167390,may,0,0
167391,help,0,0
167392,to,0,0
167393,improve,0,0
167394,long-term,0,1
167395,renal,0,1
167396,allograft,0,0
167397,outcomes,0,1
167398,.,0,0
167399,Low-fluence,0,0
167400,photodynamic,0,0
167401,therapy,0,0
167402,versus,0,0
167403,ranibizumab,0,0
167404,for,0,0
167405,chronic,0,0
167406,central,0,1
167407,serous,0,0
167408,chorioretinopathy,0,1
167409,:,0,0
167410,one-year,0,1
167411,results,0,0
167412,of,0,0
167413,a,0,0
167414,randomized,0,0
167415,trial,0,0
167416,.,0,0
167417,PURPOSE,0,0
167418,To,0,0
167419,compare,0,0
167420,the,0,0
167421,efficacy,1,1
167422,and,0,1
167423,safety,1,1
167424,between,0,0
167425,low-fluence,0,0
167426,photodynamic,0,0
167427,therapy,0,0
167428,(,0,1
167429,PDT,0,0
167430,),0,0
167431,and,0,0
167432,the,0,0
167433,intravitreal,0,0
167434,ranibizumab,0,0
167435,in,0,0
167436,the,0,0
167437,treatment,0,0
167438,of,0,0
167439,chronic,0,0
167440,central,0,1
167441,serous,0,0
167442,chorioretinopathy,0,1
167443,(,0,1
167444,CSC,0,0
167445,),0,0
167446,.,0,0
167447,DESIGN,0,0
167448,Prospective,0,0
167449,",",0,1
167450,randomized,0,0
167451,",",0,1
167452,single-center,0,0
167453,",",0,1
167454,parallel-arm,0,0
167455,",",0,1
167456,controlled,0,0
167457,trial,0,0
167458,.,0,1
167459,PARTICIPANTS,0,1
167460,Thirty-four,0,0
167461,eyes,0,0
167462,of,0,0
167463,32,0,0
167464,patients,0,0
167465,with,0,0
167466,chronic,0,0
167467,CSC,0,0
167468,with,0,0
167469,>,0,0
167470,6,0,0
167471,months,0,0
167472,',0,0
167473,duration,0,1
167474,of,0,1
167475,symptoms,0,1
167476,or,0,0
167477,recurrent,0,1
167478,CSC,0,0
167479,were,0,0
167480,randomly,0,0
167481,placed,0,0
167482,into,0,0
167483,the,0,0
167484,low-fluence,0,0
167485,PDT,0,0
167486,group,0,0
167487,(,0,0
167488,n,0,0
167489,=,0,0
167490,18,0,0
167491,),0,0
167492,or,0,0
167493,the,0,0
167494,ranibizumab,0,0
167495,group,0,0
167496,(,0,0
167497,n,0,0
167498,=,0,0
167499,16,0,0
167500,),0,0
167501,.,0,0
167502,INTERVENTION,0,0
167503,The,0,0
167504,patients,0,0
167505,underwent,0,0
167506,a,0,0
167507,single,0,0
167508,session,0,0
167509,of,0,1
167510,low-fluence,0,0
167511,PDT,0,0
167512,or,0,0
167513,3,0,0
167514,consecutive,0,0
167515,monthly,0,0
167516,injections,0,0
167517,of,0,0
167518,ranibizumab,0,0
167519,.,0,1
167520,Rescue,0,1
167521,treatment,0,0
167522,was,0,0
167523,available,0,0
167524,from,0,0
167525,month,0,0
167526,3,0,0
167527,if,0,0
167528,the,0,0
167529,subretinal,0,1
167530,fluid,0,1
167531,(,0,1
167532,SRF,0,1
167533,),0,1
167534,persisted,0,1
167535,or,0,0
167536,recurred,0,0
167537,after,0,0
167538,primary,0,0
167539,treatment,0,0
167540,;,0,0
167541,low-fluence,0,0
167542,PDT,0,0
167543,was,0,0
167544,given,0,0
167545,to,0,0
167546,the,0,0
167547,ranibizumab,0,0
167548,group,0,0
167549,and,0,1
167550,intravitreal,0,0
167551,ranibizumab,0,0
167552,to,0,0
167553,the,0,0
167554,low-fluence,0,0
167555,PDT,0,0
167556,group,0,0
167557,.,0,1
167558,MAIN,0,0
167559,OUTCOME,0,0
167560,MEASURES,0,0
167561,The,0,0
167562,primary,0,0
167563,outcome,0,1
167564,was,0,0
167565,the,0,0
167566,proportion,1,0
167567,of,1,0
167568,eyes,1,0
167569,with,1,0
167570,complete,1,1
167571,resolution,1,1
167572,of,1,1
167573,SRF,1,1
167574,without,0,0
167575,rescue,0,1
167576,treatment,0,0
167577,.,0,1
167578,Secondary,0,0
167579,outcomes,0,1
167580,included,0,0
167581,the,0,0
167582,mean,1,1
167583,changes,1,1
167584,in,1,0
167585,logarithm,1,1
167586,of,1,0
167587,the,1,0
167588,minimum,1,1
167589,angle,1,1
167590,of,1,1
167591,resolution,1,1
167592,best-corrected,1,1
167593,visual,1,1
167594,acuity,1,1
167595,(,1,1
167596,BCVA,1,1
167597,),1,1
167598,",",1,0
167599,central,1,1
167600,retinal,1,1
167601,thickness,1,1
167602,(,1,1
167603,CRT,1,0
167604,),1,1
167605,",",0,0
167606,and,0,1
167607,angiographic,1,1
167608,findings,1,0
167609,from,0,0
167610,baseline,0,0
167611,to,0,0
167612,12,0,0
167613,months,0,0
167614,.,0,0
167615,RESULTS,0,0
167616,At,0,0
167617,month,0,0
167618,12,0,0
167619,",",0,0
167620,16,0,0
167621,eyes,0,0
167622,(,0,0
167623,88.9,0,0
167624,%,0,0
167625,),0,0
167626,of,0,0
167627,the,0,0
167628,low-fluence,0,0
167629,PDT,0,0
167630,group,0,0
167631,maintained,0,0
167632,complete,0,1
167633,resolution,1,1
167634,of,1,1
167635,SRF,1,1
167636,without,1,0
167637,rescue,1,1
167638,treatment,1,0
167639,versus,0,0
167640,2,0,0
167641,eyes,0,0
167642,(,0,0
167643,12.5,0,0
167644,%,0,0
167645,),0,0
167646,in,0,0
167647,the,0,0
167648,ranibizumab,0,0
167649,group,0,0
167650,(,0,1
167651,P,0,0
167652,<,0,0
167653,0.001,0,0
167654,),0,0
167655,.,0,0
167656,Two,0,0
167657,eyes,0,0
167658,(,0,0
167659,11.1,0,0
167660,%,0,0
167661,),0,0
167662,in,0,0
167663,the,0,0
167664,low-fluence,0,0
167665,PDT,0,0
167666,group,0,0
167667,and,0,0
167668,11,0,0
167669,eyes,0,0
167670,(,0,0
167671,68.8,0,0
167672,%,0,0
167673,),0,0
167674,in,0,0
167675,the,0,0
167676,ranibizumab,0,0
167677,group,0,0
167678,met,0,0
167679,the,0,0
167680,criteria,0,0
167681,for,0,0
167682,rescue,0,1
167683,treatment,0,0
167684,(,0,1
167685,P,0,0
167686,=,0,0
167687,0.001,0,0
167688,),0,0
167689,.,0,0
167690,In,0,0
167691,the,0,0
167692,low-fluence,0,0
167693,PDT,0,0
167694,group,0,0
167695,",",0,0
167696,the,0,0
167697,mean,1,1
167698,decrease,1,1
167699,in,1,0
167700,CRT,1,0
167701,from,0,0
167702,baseline,0,0
167703,was,0,0
167704,significantly,0,0
167705,greater,0,0
167706,than,0,0
167707,that,0,0
167708,in,0,0
167709,the,0,0
167710,ranibizumab,0,0
167711,group,0,0
167712,until,0,0
167713,month,0,0
167714,6,0,0
167715,(,0,0
167716,P,0,0
167717,<,0,0
167718,0.05,0,0
167719,),0,0
167720,",",0,0
167721,but,0,0
167722,the,0,0
167723,differences,0,0
167724,became,0,0
167725,insignificant,0,0
167726,thereafter,0,0
167727,.,0,0
167728,The,0,0
167729,improvement,1,1
167730,in,1,0
167731,BCVA,1,1
167732,from,0,0
167733,baseline,0,0
167734,was,0,0
167735,superior,0,0
167736,in,0,0
167737,the,0,0
167738,low-fluence,0,0
167739,PDT,0,0
167740,group,0,0
167741,to,0,0
167742,that,0,0
167743,in,0,0
167744,the,0,0
167745,ranibizumab,0,0
167746,group,0,0
167747,",",0,0
167748,but,0,0
167749,the,0,0
167750,differences,0,0
167751,were,0,0
167752,not,0,0
167753,statistically,0,0
167754,significant,0,0
167755,except,0,0
167756,at,0,0
167757,month,0,0
167758,3,0,0
167759,(,0,0
167760,P,0,0
167761,=,0,0
167762,0.025,0,0
167763,),0,0
167764,.,0,0
167765,On,0,0
167766,indocyanine,0,0
167767,green,0,1
167768,angiography,0,0
167769,",",0,0
167770,a,0,0
167771,significantly,0,0
167772,greater,0,0
167773,proportion,0,0
167774,of,0,0
167775,the,0,0
167776,low-fluence,0,0
167777,PDT,0,0
167778,group,0,0
167779,(,0,0
167780,16,0,0
167781,eyes,0,0
167782,;,0,0
167783,88.9,0,0
167784,%,0,0
167785,),0,0
167786,showed,0,0
167787,a,0,0
167788,marked,0,0
167789,reduction,0,1
167790,in,0,0
167791,choroidal,1,1
167792,hyperpermeability,1,1
167793,after,0,0
167794,primary,0,0
167795,treatment,0,0
167796,than,0,0
167797,that,0,0
167798,of,0,0
167799,the,0,0
167800,ranibizumab,0,0
167801,group,0,0
167802,(,0,0
167803,0,0,0
167804,eyes,0,0
167805,;,0,0
167806,P,0,0
167807,<,0,0
167808,0.001,0,0
167809,),0,0
167810,.,0,0
167811,No,0,0
167812,serious,1,1
167813,adverse,1,1
167814,events,1,1
167815,related,0,0
167816,to,0,0
167817,the,0,0
167818,drugs,0,0
167819,or,0,0
167820,procedures,0,0
167821,were,0,0
167822,observed,0,0
167823,.,0,0
167824,CONCLUSIONS,0,0
167825,This,0,0
167826,study,0,0
167827,represents,0,0
167828,the,0,0
167829,overall,0,1
167830,superiority,0,0
167831,of,0,1
167832,low-fluence,0,0
167833,PDT,0,0
167834,compared,0,0
167835,with,0,0
167836,intravitreal,0,0
167837,ranibizumab,0,0
167838,in,0,0
167839,the,0,0
167840,treatment,0,0
167841,of,0,0
167842,chronic,0,0
167843,CSC,0,0
167844,.,0,0
167845,A,0,0
167846,randomized,0,0
167847,trial,0,0
167848,comparison,0,0
167849,of,0,0
167850,the,0,0
167851,effects,0,0
167852,of,0,0
167853,verbal,0,1
167854,and,0,1
167855,pictorial,0,1
167856,naturalistic,0,0
167857,communication,0,1
167858,strategies,0,0
167859,on,0,0
167860,spoken,0,1
167861,language,0,1
167862,for,0,0
167863,young,0,0
167864,children,0,0
167865,with,0,0
167866,autism,0,0
167867,.,0,0
167868,Presently,0,0
167869,there,0,0
167870,is,0,0
167871,no,0,0
167872,consensus,0,0
167873,on,0,0
167874,the,0,0
167875,specific,0,0
167876,behavioral,0,1
167877,treatment,0,0
167878,of,0,1
167879,choice,0,0
167880,for,0,0
167881,targeting,0,0
167882,language,0,1
167883,in,0,0
167884,young,0,0
167885,nonverbal,0,1
167886,children,0,0
167887,with,0,0
167888,autism,0,0
167889,.,0,0
167890,This,0,0
167891,randomized,0,0
167892,clinical,0,0
167893,trial,0,0
167894,compared,0,0
167895,the,0,0
167896,effectiveness,0,0
167897,of,0,0
167898,a,0,0
167899,verbally-based,0,1
167900,intervention,0,0
167901,",",0,1
167902,Pivotal,0,1
167903,Response,0,1
167904,Training,0,1
167905,(,0,1
167906,PRT,0,0
167907,),0,0
167908,to,0,0
167909,a,0,0
167910,pictorially-based,0,0
167911,behavioral,0,1
167912,intervention,0,0
167913,",",0,0
167914,the,0,0
167915,Picture,0,1
167916,Exchange,0,0
167917,Communication,0,1
167918,System,0,1
167919,(,0,1
167920,PECS,0,1
167921,),0,0
167922,on,0,0
167923,the,0,0
167924,acquisition,0,0
167925,of,0,0
167926,spoken,0,1
167927,language,0,1
167928,by,0,0
167929,young,0,0
167930,(,0,0
167931,2-4,0,0
167932,years,0,0
167933,),0,0
167934,",",0,0
167935,nonverbal,0,1
167936,or,0,0
167937,minimally,0,0
167938,verbal,0,1
167939,(,0,0
167940,?9,0,1
167941,words,0,1
167942,),0,0
167943,children,0,0
167944,with,0,0
167945,autism,0,0
167946,.,0,0
167947,Thirty-nine,0,0
167948,children,0,0
167949,were,0,0
167950,randomly,0,0
167951,assigned,0,0
167952,to,0,0
167953,either,0,0
167954,the,0,0
167955,PRT,0,0
167956,or,0,0
167957,PECS,0,1
167958,condition,0,0
167959,.,0,1
167960,Participants,0,0
167961,received,0,0
167962,on,0,0
167963,average,0,0
167964,247,0,0
167965,h,0,0
167966,of,0,0
167967,intervention,0,0
167968,across,0,0
167969,23,0,0
167970,weeks,0,0
167971,.,0,0
167972,Dependent,0,0
167973,measures,0,1
167974,included,1,0
167975,overall,1,1
167976,communication,1,1
167977,",",1,1
167978,expressive,1,1
167979,vocabulary,1,1
167980,",",1,1
167981,pictorial,1,1
167982,communication,1,1
167983,and,1,1
167984,parent,1,1
167985,satisfaction,1,1
167986,.,1,1
167987,Children,1,0
167988,in,0,0
167989,both,0,0
167990,intervention,0,0
167991,groups,0,0
167992,demonstrated,0,0
167993,increases,1,1
167994,in,1,0
167995,spoken,1,1
167996,language,1,1
167997,skills,1,1
167998,",",1,0
167999,with,1,0
168000,no,0,0
168001,significant,0,0
168002,difference,0,0
168003,between,0,0
168004,the,0,0
168005,two,0,0
168006,conditions,0,0
168007,.,0,0
168008,Seventy-eight,0,0
168009,percent,0,0
168010,of,0,0
168011,all,0,0
168012,children,0,0
168013,exited,0,0
168014,the,0,0
168015,program,0,0
168016,with,0,0
168017,more,0,0
168018,than,0,0
168019,10,1,0
168020,functional,1,0
168021,words,1,0
168022,.,1,0
168023,Parents,1,1
168024,were,0,0
168025,very,0,0
168026,satisfied,0,0
168027,with,0,0
168028,both,0,0
168029,programs,0,0
168030,but,0,0
168031,indicated,0,1
168032,PECS,0,1
168033,was,0,0
168034,more,0,0
168035,difficult,0,0
168036,to,0,0
168037,implement,0,0
168038,.,0,0
168039,Predictors,0,1
168040,of,0,0
168041,postdischarge,0,0
168042,outcomes,0,1
168043,from,0,0
168044,information,0,0
168045,acquired,0,0
168046,shortly,0,0
168047,after,0,0
168048,admission,0,1
168049,for,0,0
168050,acute,0,0
168051,heart,0,1
168052,failure,0,0
168053,:,0,0
168054,a,0,0
168055,report,0,0
168056,from,0,0
168057,the,0,0
168058,Placebo-Controlled,0,0
168059,Randomized,0,0
168060,Study,0,0
168061,of,0,0
168062,the,0,0
168063,Selective,0,0
168064,A1,0,1
168065,Adenosine,0,1
168066,Receptor,0,1
168067,Antagonist,0,0
168068,Rolofylline,0,0
168069,for,0,0
168070,Patients,0,0
168071,Hospitalized,0,1
168072,With,0,0
168073,Acute,0,1
168074,Decompensated,0,1
168075,Heart,0,1
168076,Failure,0,1
168077,and,0,1
168078,Volume,0,1
168079,Overload,0,1
168080,to,0,0
168081,Assess,0,0
168082,Treatment,0,0
168083,Effect,0,1
168084,on,0,0
168085,Congestion,0,1
168086,and,0,1
168087,Renal,0,1
168088,Function,0,1
168089,(,0,1
168090,PROTECT,0,0
168091,),0,0
168092,Study,0,0
168093,.,0,0
168094,BACKGROUND,0,0
168095,Acute,0,1
168096,heart,0,1
168097,failure,0,0
168098,is,0,0
168099,a,0,0
168100,common,0,0
168101,reason,0,0
168102,for,0,0
168103,admission,0,1
168104,",",0,1
168105,and,0,0
168106,outcome,0,1
168107,is,0,0
168108,often,0,0
168109,poor,0,0
168110,.,0,0
168111,Improved,0,0
168112,prognostic,0,1
168113,risk,0,0
168114,stratification,0,0
168115,may,0,0
168116,assist,0,0
168117,in,0,0
168118,the,0,0
168119,design,0,0
168120,of,0,0
168121,future,0,0
168122,trials,0,0
168123,and,0,1
168124,in,0,0
168125,patient,0,1
168126,management,0,0
168127,.,0,0
168128,Using,0,0
168129,data,0,0
168130,from,0,0
168131,a,0,0
168132,large,0,0
168133,randomized,0,0
168134,trial,0,0
168135,",",0,0
168136,we,0,0
168137,explored,0,0
168138,the,0,0
168139,prognostic,0,1
168140,value,0,1
168141,of,0,1
168142,clinical,0,1
168143,variables,0,1
168144,",",0,0
168145,measured,0,1
168146,at,0,0
168147,hospital,0,1
168148,admission,0,1
168149,for,0,0
168150,acute,0,0
168151,heart,0,1
168152,failure,0,1
168153,",",0,0
168154,to,0,0
168155,determine,0,0
168156,whether,0,0
168157,a,0,0
168158,few,0,0
168159,selected,0,0
168160,variables,0,0
168161,were,0,0
168162,inferior,0,0
168163,to,0,0
168164,an,0,0
168165,extended,0,0
168166,data,0,0
168167,set,0,0
168168,.,0,1
168169,METHODS,0,0
168170,AND,0,0
168171,RESULTS,0,0
168172,The,0,0
168173,prognostic,0,1
168174,model,0,0
168175,included,0,0
168176,37,0,0
168177,clinical,0,0
168178,characteristics,0,0
168179,collected,0,0
168180,at,0,0
168181,baseline,0,0
168182,in,0,0
168183,PROTECT,0,0
168184,",",0,0
168185,a,0,0
168186,study,0,0
168187,comparing,0,0
168188,rolofylline,0,1
168189,and,0,1
168190,placebo,0,0
168191,in,0,0
168192,2033,0,0
168193,patients,0,0
168194,admitted,0,0
168195,with,0,0
168196,acute,0,0
168197,heart,0,1
168198,failure,0,1
168199,.,0,0
168200,Prespecified,0,0
168201,outcomes,0,0
168202,at,0,0
168203,30,0,0
168204,days,0,0
168205,were,0,0
168206,death,1,1
168207,or,1,1
168208,rehospitalization,1,1
168209,for,1,0
168210,any,1,0
168211,reason,1,0
168212,;,1,0
168213,death,1,1
168214,or,1,1
168215,rehospitalization,1,1
168216,for,1,0
168217,cardiovascular,1,1
168218,or,1,0
168219,renal,1,1
168220,reasons,1,0
168221,;,1,1
168222,and,0,1
168223,",",0,0
168224,at,0,0
168225,both,0,0
168226,30,0,0
168227,and,0,0
168228,180,0,0
168229,days,0,0
168230,",",0,0
168231,all-cause,0,1
168232,mortality,0,1
168233,.,0,0
168234,No,0,0
168235,variable,0,0
168236,had,0,0
168237,a,0,0
168238,c-index,0,1
168239,>,0,0
168240,0.70,0,0
168241,",",0,0
168242,and,0,0
168243,few,0,1
168244,had,0,0
168245,values,0,1
168246,>,0,0
168247,0.60,0,0
168248,;,0,0
168249,c-indices,0,1
168250,were,0,0
168251,lower,0,0
168252,for,0,0
168253,composite,0,1
168254,outcomes,0,1
168255,than,0,0
168256,for,0,0
168257,mortality,0,1
168258,.,0,1
168259,Blood,1,1
168260,urea,1,1
168261,was,0,0
168262,generally,0,0
168263,the,0,0
168264,strongest,0,0
168265,single,0,0
168266,predictor,0,0
168267,.,0,0
168268,Eighteen,0,1
168269,variables,0,1
168270,contributed,0,0
168271,independent,0,0
168272,prognostic,0,1
168273,information,0,1
168274,",",0,0
168275,but,0,0
168276,a,0,0
168277,reduced,0,1
168278,model,0,0
168279,using,0,0
168280,only,0,0
168281,8,0,0
168282,items,0,1
168283,(,0,0
168284,age,0,0
168285,",",0,1
168286,previous,0,0
168287,heart,0,1
168288,failure,0,1
168289,hospitalization,0,1
168290,",",0,1
168291,peripheral,0,1
168292,edema,0,1
168293,",",0,1
168294,systolic,0,1
168295,blood,0,1
168296,pressure,0,1
168297,",",0,1
168298,serum,0,1
168299,sodium,0,1
168300,",",0,1
168301,urea,0,1
168302,",",0,1
168303,creatinine,0,1
168304,",",0,1
168305,and,0,1
168306,albumin,0,1
168307,),0,1
168308,performed,0,0
168309,similarly,0,0
168310,.,0,0
168311,For,0,0
168312,prediction,0,1
168313,of,0,1
168314,all-cause,1,1
168315,mortality,1,1
168316,at,0,0
168317,180,0,0
168318,days,0,0
168319,",",0,0
168320,the,0,0
168321,model,0,0
168322,c-index,0,1
168323,using,0,0
168324,all,0,0
168325,variables,0,0
168326,was,0,0
168327,0.72,0,0
168328,and,0,0
168329,for,0,0
168330,the,0,0
168331,simplified,0,1
168332,model,0,0
168333,",",0,0
168334,also,0,0
168335,0.72,0,0
168336,.,0,0
168337,CONCLUSIONS,0,0
168338,A,0,0
168339,few,0,0
168340,simple,0,0
168341,clinical,0,0
168342,variables,0,1
168343,measured,0,1
168344,on,0,0
168345,admission,0,0
168346,in,0,0
168347,patients,0,0
168348,with,0,0
168349,acute,0,0
168350,heart,0,1
168351,failure,0,0
168352,predict,0,0
168353,a,0,0
168354,variety,1,0
168355,of,1,0
168356,adverse,1,1
168357,outcomes,1,1
168358,with,0,0
168359,accuracy,1,1
168360,similar,0,0
168361,to,0,0
168362,more,0,0
168363,complex,0,0
168364,models,0,0
168365,.,0,0
168366,However,0,0
168367,",",0,0
168368,predictive,0,1
168369,models,0,0
168370,were,0,0
168371,of,0,0
168372,only,0,0
168373,moderate,1,0
168374,accuracy,1,1
168375,",",0,0
168376,especially,0,0
168377,for,0,0
168378,outcomes,1,1
168379,that,1,0
168380,included,1,0
168381,nonfatal,1,1
168382,events,1,1
168383,.,1,0
168384,Better,0,1
168385,methods,0,0
168386,of,0,1
168387,risk,0,1
168388,stratification,0,0
168389,are,0,0
168390,required,0,0
168391,.,0,0
168392,CLINICAL,0,0
168393,TRIAL,0,0
168394,REGISTRATION,0,0
168395,URL,0,0
168396,:,0,0
168397,http,0,0
168398,:,0,0
168399,//www.clinicaltrials.gov,0,0
168400,.,0,0
168401,Unique,0,0
168402,identifiers,0,0
168403,:,0,0
168404,NCT00328692,0,0
168405,and,0,0
168406,NCT00354458,0,0
168407,.,0,0
168408,Radiation,0,1
168409,and,0,1
168410,contrast,0,0
168411,agent,0,0
168412,doses,0,0
168413,reductions,0,1
168414,by,0,0
168415,using,0,0
168416,80-kV,0,0
168417,tube,0,0
168418,voltage,0,1
168419,in,0,0
168420,coronary,0,1
168421,computed,0,0
168422,tomographic,0,0
168423,angiography,0,0
168424,:,0,0
168425,a,0,0
168426,comparative,0,0
168427,study,0,0
168428,.,0,0
168429,OBJECTIVE,0,0
168430,To,0,0
168431,investigate,0,0
168432,the,0,0
168433,effects,0,0
168434,of,0,1
168435,80-kilovoltage,0,0
168436,(,0,1
168437,kV,0,1
168438,),0,1
168439,tube,0,0
168440,voltage,0,1
168441,coronary,0,1
168442,computed,0,0
168443,tomographic,0,0
168444,angiography,0,0
168445,(,0,1
168446,CCTA,0,1
168447,),0,0
168448,with,0,0
168449,a,0,0
168450,reduced,0,1
168451,amount,0,1
168452,of,0,1
168453,contrast,0,0
168454,agent,0,0
168455,on,0,0
168456,qualitative,0,0
168457,and,0,1
168458,quantitative,0,1
168459,image,0,1
168460,quality,0,1
168461,parameters,0,1
168462,and,0,1
168463,on,0,0
168464,radiation,0,0
168465,dose,0,0
168466,in,0,0
168467,patients,0,0
168468,with,0,0
168469,a,0,0
168470,body,0,1
168471,mass,0,1
168472,index,0,1
168473,(,0,1
168474,BMI,0,1
168475,),0,0
168476,<,0,0
168477,23.0,0,0
168478,kg/m,0,0
168479,(,0,0
168480,2,0,0
168481,),0,0
168482,.,0,0
168483,METHODS,0,0
168484,One,0,0
168485,hundred,0,0
168486,and,0,0
168487,twenty,0,0
168488,consecutive,0,0
168489,patients,0,0
168490,with,0,0
168491,a,0,0
168492,BMI,0,0
168493,<,0,0
168494,23.0,0,0
168495,kg/m,0,0
168496,(,0,0
168497,2,0,0
168498,),0,0
168499,and,0,0
168500,a,0,0
168501,low,0,0
168502,calcium,0,1
168503,load,0,1
168504,undergoing,0,0
168505,retrospective,0,0
168506,electrocardiogram,0,1
168507,(,0,1
168508,ECG,0,1
168509,),0,1
168510,-gated,0,0
168511,dual-source,0,0
168512,CCTA,0,1
168513,were,0,0
168514,randomized,0,0
168515,into,0,0
168516,two,0,0
168517,groups,0,0
168518,[,0,0
168519,standard-tube,0,0
168520,voltage,0,1
168521,(,0,1
168522,120-kV,0,0
168523,),0,0
168524,vs.,0,0
168525,low-tube,0,0
168526,voltage,0,1
168527,(,0,1
168528,80-kV,0,0
168529,),0,0
168530,],0,0
168531,.,0,0
168532,The,0,0
168533,injection,0,0
168534,flow,0,1
168535,rate,0,1
168536,of,0,1
168537,contrast,0,0
168538,agent,0,0
168539,(,0,0
168540,350,0,0
168541,mg,0,0
168542,I/mL,0,0
168543,),0,0
168544,was,0,0
168545,adjusted,0,0
168546,to,0,0
168547,body,0,1
168548,weight,0,1
168549,of,0,0
168550,each,0,0
168551,patient,0,1
168552,(,0,0
168553,4.5-5.5,0,0
168554,mL/s,0,0
168555,in,0,0
168556,the,0,0
168557,120-kV,0,0
168558,group,0,0
168559,and,0,1
168560,2.8-3.8,0,0
168561,mL/s,0,0
168562,in,0,0
168563,the,0,0
168564,80-kV,0,0
168565,group,0,0
168566,),0,0
168567,.,0,1
168568,Radiation,1,1
168569,and,1,1
168570,contrast,1,0
168571,agent,1,0
168572,doses,1,1
168573,were,0,0
168574,evaluated,0,0
168575,.,0,0
168576,Quantitative,1,0
168577,image,1,1
168578,quality,1,1
168579,parameters,1,1
168580,and,1,1
168581,figure,1,0
168582,of,1,1
168583,merit,1,0
168584,(,1,1
168585,FOM,1,1
168586,),1,0
168587,of,0,0
168588,coronary,0,1
168589,artery,0,1
168590,were,0,0
168591,evaluated,0,0
168592,.,0,0
168593,Each,0,0
168594,coronary,0,0
168595,segment,0,1
168596,was,0,0
168597,evaluated,0,0
168598,for,0,0
168599,image,1,0
168600,quality,1,1
168601,on,0,0
168602,a,0,0
168603,4-point,0,1
168604,scale,0,1
168605,.,0,1
168606,RESULTS,0,0
168607,Compared,0,0
168608,with,0,0
168609,the,0,0
168610,120-kV,0,0
168611,group,0,0
168612,",",0,1
168613,effective,1,1
168614,dose,1,1
168615,and,1,1
168616,amount,1,1
168617,of,1,1
168618,contrast,1,0
168619,agent,1,0
168620,in,0,0
168621,the,0,0
168622,80-kV,0,0
168623,group,0,0
168624,were,0,0
168625,decreased,0,0
168626,by,0,0
168627,57.8,0,0
168628,%,0,0
168629,and,0,0
168630,30.5,0,0
168631,%,0,0
168632,(,0,0
168633,effective,0,1
168634,dose:2.7,0,0
168635,?,0,0
168636,0.5,0,0
168637,vs.,0,0
168638,6.4,0,0
168639,?,0,0
168640,1.3,0,0
168641,mSv,0,0
168642,;,0,0
168643,amount,0,1
168644,of,0,1
168645,contrast,0,0
168646,agent:57.1,0,0
168647,?,0,0
168648,3.2,0,0
168649,vs.,0,0
168650,82.1,0,0
168651,?,0,0
168652,6.1,0,0
168653,mL,0,0
168654,;,0,0
168655,both,0,0
168656,p,0,0
168657,<,0,0
168658,0.0001,0,0
168659,),0,0
168660,",",0,0
168661,respectively,1,0
168662,.,1,0
168663,Image,1,1
168664,noise,1,1
168665,was,1,0
168666,22.7,0,0
168667,?,0,0
168668,2.1HU,0,0
168669,for,0,0
168670,120-kV,0,0
168671,images,0,0
168672,and,0,0
168673,33.2,0,0
168674,?,0,0
168675,5.2,0,0
168676,HU,0,0
168677,for,0,0
168678,80-kV,0,0
168679,images,0,0
168680,(,0,0
168681,p,0,0
168682,<,0,0
168683,0.0001,1,0
168684,),1,0
168685,.,1,0
168686,Signal-to-noise,1,1
168687,ratio,1,1
168688,(,1,1
168689,SNR,1,1
168690,),1,1
168691,and,1,1
168692,contrast-to-noise,1,1
168693,ratio,1,1
168694,(,1,1
168695,CNR,1,0
168696,),1,0
168697,in,1,0
168698,the,1,0
168699,proximal,1,0
168700,right,1,1
168701,coronary,1,1
168702,artery,1,1
168703,(,1,1
168704,RCA,1,1
168705,),1,1
168706,and,1,1
168707,left,1,1
168708,main,1,1
168709,coronary,1,1
168710,artery,1,1
168711,(,1,1
168712,LMA,1,1
168713,),1,0
168714,were,0,0
168715,all,0,0
168716,lower,0,0
168717,in,0,0
168718,80-kV,0,0
168719,than,0,0
168720,120-kV,0,0
168721,images,0,0
168722,(,0,0
168723,SNR,0,1
168724,in,0,0
168725,the,0,0
168726,proximal,0,0
168727,RCA,0,0
168728,:,0,0
168729,16.5,0,0
168730,?,0,0
168731,1.8,0,0
168732,vs.,0,0
168733,19.4,0,0
168734,?,0,0
168735,2.8,0,0
168736,;,0,0
168737,SNR,0,0
168738,in,0,0
168739,the,0,0
168740,LMA,0,0
168741,:,0,0
168742,16.3,0,0
168743,?,0,0
168744,2.0,0,0
168745,vs.19.6,0,0
168746,?,0,0
168747,2.7,0,0
168748,;,0,0
168749,CNR,0,0
168750,in,0,0
168751,the,0,0
168752,proximal,0,0
168753,RCA,0,0
168754,:,0,0
168755,19.4,0,0
168756,?,0,0
168757,2.3,0,0
168758,vs.22.9,0,0
168759,?,0,0
168760,3.0,0,0
168761,;,0,0
168762,CNR,0,0
168763,in,0,0
168764,the,0,0
168765,LMA,0,0
168766,:,0,0
168767,18.8,0,0
168768,?,0,0
168769,2.4,0,0
168770,vs.,0,0
168771,22.7,0,0
168772,?,0,0
168773,2.9,0,0
168774,;,0,0
168775,all,0,0
168776,p,0,0
168777,<,0,0
168778,0.0001,0,0
168779,),0,0
168780,.,0,0
168781,FOM,1,0
168782,were,1,0
168783,all,1,0
168784,significantly,0,0
168785,higher,0,0
168786,in,0,0
168787,80-kV,0,0
168788,than,0,0
168789,120-kV,0,0
168790,images,0,0
168791,(,0,0
168792,proximal,0,0
168793,RCA,0,0
168794,:,0,0
168795,146.7,0,0
168796,?,0,0
168797,45.1,0,0
168798,vs.,0,0
168799,93.4,0,0
168800,?,0,0
168801,32.0,0,0
168802,;,0,0
168803,LMA,0,0
168804,:,0,0
168805,139.1,0,0
168806,?,0,0
168807,47.2,0,0
168808,vs.,0,0
168809,91.6,0,0
168810,?,0,0
168811,31.1,0,0
168812,;,0,0
168813,all,0,0
168814,p,0,0
168815,<,0,0
168816,0.0001,0,0
168817,),0,0
168818,.,0,0
168819,There,0,0
168820,was,0,0
168821,no,0,0
168822,significant,0,0
168823,difference,1,0
168824,in,1,0
168825,image,1,1
168826,quality,1,1
168827,score,1,1
168828,between,1,0
168829,the,0,0
168830,two,0,0
168831,groups,0,0
168832,(,0,0
168833,3.3,0,0
168834,?,0,0
168835,0.8,0,0
168836,vs.,0,0
168837,3.3,0,0
168838,?,0,0
168839,0.8,0,0
168840,",",0,0
168841,p=0.068,0,0
168842,),0,1
168843,despite,0,0
168844,decreased,1,1
168845,SNR,1,1
168846,and,1,0
168847,CNR,1,0
168848,of,1,1
168849,coronary,1,1
168850,artery,1,0
168851,in,0,0
168852,the,0,0
168853,80-kV,0,0
168854,group,0,0
168855,.,0,0
168856,CONCLUSION,0,0
168857,The,0,0
168858,80-kV,0,0
168859,protocol,0,0
168860,significantly,0,0
168861,reduces,1,0
168862,radiation,1,0
168863,and,1,1
168864,contrast,1,0
168865,agent,1,0
168866,doses,1,0
168867,in,1,0
168868,CCTA,1,0
168869,in,0,0
168870,patients,0,0
168871,with,0,0
168872,a,0,0
168873,low,0,0
168874,BMI,0,1
168875,<,0,0
168876,23.0,0,0
168877,kg/m,0,0
168878,(,0,0
168879,2,0,0
168880,),0,0
168881,and,0,0
168882,a,0,0
168883,low,0,0
168884,calcium,0,1
168885,load,0,1
168886,while,0,0
168887,maintaining,0,1
168888,image,0,0
168889,quality,0,1
168890,.,0,0
168891,Randomized,0,0
168892,clinical,0,1
168893,trial,0,0
168894,of,0,1
168895,cutting,0,0
168896,balloon,0,0
168897,angioplasty,0,1
168898,versus,0,0
168899,high-pressure,0,1
168900,balloon,0,0
168901,angioplasty,0,0
168902,in,0,0
168903,hemodialysis,0,1
168904,arteriovenous,0,1
168905,fistula,0,1
168906,stenoses,0,1
168907,resistant,0,1
168908,to,0,0
168909,conventional,0,0
168910,balloon,0,0
168911,angioplasty,0,0
168912,.,0,0
168913,PURPOSE,0,0
168914,To,0,0
168915,compare,0,0
168916,the,0,0
168917,efficacy,1,1
168918,and,1,1
168919,safety,1,1
168920,of,0,1
168921,cutting,0,0
168922,balloon,0,0
168923,angioplasty,0,1
168924,(,0,1
168925,CBA,0,1
168926,),0,1
168927,versus,0,0
168928,high-pressure,0,1
168929,balloon,0,1
168930,angioplasty,0,1
168931,(,0,1
168932,HPBA,0,0
168933,),0,0
168934,for,0,0
168935,the,0,0
168936,treatment,0,0
168937,of,0,0
168938,hemodialysis,0,1
168939,autogenous,0,0
168940,fistula,0,1
168941,stenoses,0,1
168942,resistant,0,1
168943,to,0,0
168944,conventional,0,0
168945,percutaneous,0,0
168946,transluminal,0,0
168947,angioplasty,0,0
168948,(,0,1
168949,PTA,0,1
168950,),0,0
168951,.,0,0
168952,MATERIALS,0,0
168953,AND,0,0
168954,METHODS,0,0
168955,In,0,0
168956,a,0,0
168957,prospective,0,0
168958,",",0,0
168959,randomized,0,0
168960,clinical,0,1
168961,trial,0,0
168962,involving,0,0
168963,patients,0,0
168964,with,0,0
168965,dysfunctional,0,1
168966,",",0,0
168967,stenotic,0,1
168968,hemodialysis,0,1
168969,arteriovenous,0,1
168970,fistulas,0,1
168971,(,0,0
168972,AVFs,0,1
168973,),0,1
168974,",",0,0
168975,patients,0,0
168976,were,0,0
168977,randomized,0,0
168978,to,0,0
168979,receive,0,0
168980,CBA,0,1
168981,or,0,0
168982,HPBA,0,0
168983,if,0,0
168984,conventional,0,0
168985,PTA,0,1
168986,had,0,0
168987,suboptimal,0,0
168988,results,0,0
168989,(,0,0
168990,ie,0,0
168991,",",0,1
168992,residual,0,1
168993,stenosis,0,1
168994,>,0,0
168995,30,0,0
168996,%,0,0
168997,),0,0
168998,.,0,0
168999,A,0,0
169000,total,0,0
169001,of,0,0
169002,516,0,0
169003,patients,0,0
169004,consented,0,0
169005,to,0,0
169006,participate,0,0
169007,in,0,0
169008,the,0,0
169009,study,0,0
169010,from,0,0
169011,October,0,0
169012,2008,0,0
169013,to,0,0
169014,September,0,0
169015,2011,0,0
169016,",",0,0
169017,85,0,0
169018,%,0,0
169019,of,0,0
169020,whom,0,0
169021,(,0,0
169022,n,0,0
169023,=,0,0
169024,439,0,0
169025,),0,0
169026,had,0,0
169027,technically,0,0
169028,successful,0,0
169029,conventional,0,0
169030,PTA,0,0
169031,.,0,0
169032,The,0,0
169033,remaining,0,0
169034,71,0,0
169035,patients,0,0
169036,(,0,0
169037,mean,0,1
169038,age,0,0
169039,",",0,0
169040,60,0,0
169041,y,0,0
169042,;,0,0
169043,49,0,0
169044,men,0,0
169045,),0,0
169046,with,0,0
169047,suboptimal,0,0
169048,PTA,0,1
169049,results,0,0
169050,were,0,0
169051,eventually,0,0
169052,randomized,0,0
169053,:,0,0
169054,36,0,0
169055,to,0,0
169056,the,0,0
169057,CBA,0,1
169058,arm,0,0
169059,and,0,0
169060,35,0,0
169061,to,0,0
169062,the,0,0
169063,HPBA,0,0
169064,arm,0,0
169065,.,0,1
169066,Primary,0,1
169067,and,0,1
169068,secondary,0,1
169069,target,0,1
169070,lesion,0,1
169071,patencies,0,1
169072,were,0,0
169073,determined,0,0
169074,by,0,0
169075,Kaplan-Meier,0,1
169076,analysis,0,0
169077,.,0,1
169078,RESULTS,0,0
169079,Clinical,1,1
169080,success,1,1
169081,rates,1,1
169082,were,0,0
169083,100,0,0
169084,%,0,0
169085,in,0,0
169086,both,0,0
169087,arms,0,0
169088,.,0,0
169089,Primary,1,1
169090,target,1,1
169091,lesion,1,1
169092,patency,1,1
169093,rates,1,1
169094,at,0,0
169095,6,0,0
169096,months,0,0
169097,were,0,0
169098,66.4,0,0
169099,%,0,0
169100,and,0,0
169101,39.9,0,0
169102,%,0,0
169103,for,0,0
169104,CBA,0,1
169105,and,0,1
169106,HPBA,0,0
169107,",",0,1
169108,respectively,0,0
169109,(,0,0
169110,P,0,0
169111,=,0,0
169112,.01,0,0
169113,),0,0
169114,.,0,0
169115,Secondary,1,0
169116,target,1,1
169117,lesion,1,1
169118,patency,1,1
169119,rates,1,1
169120,at,0,0
169121,6,0,0
169122,months,0,0
169123,were,0,0
169124,96.5,0,0
169125,%,0,0
169126,for,0,0
169127,CBA,0,1
169128,and,0,0
169129,80.0,0,0
169130,%,0,0
169131,for,0,0
169132,HPBA,0,0
169133,(,0,0
169134,P,0,0
169135,=,0,0
169136,.03,0,0
169137,),0,0
169138,.,0,0
169139,There,0,0
169140,was,0,0
169141,a,0,0
169142,single,0,0
169143,major,1,1
169144,complication,1,1
169145,of,0,1
169146,venous,1,1
169147,perforation,1,1
169148,following,0,0
169149,CBA,0,1
169150,.,0,0
169151,The,0,0
169152,30-day,1,1
169153,mortality,1,1
169154,rate,1,1
169155,was,0,0
169156,1.4,0,0
169157,%,0,0
169158,",",0,0
169159,with,0,0
169160,one,0,0
169161,non-procedure-related,0,1
169162,death,0,1
169163,in,0,0
169164,the,0,0
169165,HPBA,0,0
169166,group,0,0
169167,.,0,1
169168,CONCLUSIONS,0,0
169169,Primary,0,1
169170,and,0,1
169171,secondary,0,1
169172,target,0,1
169173,lesion,0,1
169174,patency,0,1
169175,rates,0,1
169176,of,0,1
169177,CBA,0,1
169178,were,0,0
169179,statistically,0,0
169180,superior,0,0
169181,to,0,0
169182,those,0,0
169183,of,0,0
169184,HPBA,0,0
169185,following,0,0
169186,suboptimal,0,0
169187,conventional,0,0
169188,PTA,0,0
169189,.,0,0
169190,For,0,0
169191,AVF,0,0
169192,stenoses,0,1
169193,resistant,0,1
169194,to,0,0
169195,conventional,0,0
169196,PTA,0,1
169197,",",0,0
169198,CBA,0,1
169199,may,0,0
169200,be,0,0
169201,a,0,0
169202,better,0,0
169203,second-line,0,0
169204,treatment,0,0
169205,given,0,0
169206,its,0,0
169207,superior,0,0
169208,patency,0,1
169209,rates,0,1
169210,.,0,0
169211,Using,0,0
169212,the,0,0
169213,virtual,0,0
169214,reality-cognitive,0,0
169215,rehabilitation,0,0
169216,approach,0,0
169217,to,0,0
169218,improve,0,0
169219,contextual,1,0
169220,processing,1,1
169221,in,1,0
169222,children,0,0
169223,with,0,0
169224,autism,0,0
169225,.,0,0
169226,BACKGROUND,0,0
169227,This,0,0
169228,pilot,0,0
169229,study,0,0
169230,investigated,0,0
169231,the,0,0
169232,efficacy,0,1
169233,of,0,0
169234,a,0,0
169235,novel,0,0
169236,virtual,0,0
169237,reality-cognitive,0,1
169238,rehabilitation,0,0
169239,(,0,1
169240,VR-CR,0,1
169241,),0,0
169242,intervention,0,0
169243,to,0,0
169244,improve,0,0
169245,contextual,1,0
169246,processing,1,1
169247,of,0,0
169248,objects,0,1
169249,in,0,0
169250,children,0,0
169251,with,0,0
169252,autism,0,0
169253,.,0,0
169254,Previous,0,0
169255,research,0,0
169256,supports,0,0
169257,that,0,0
169258,children,0,0
169259,with,0,0
169260,autism,0,0
169261,show,0,0
169262,deficits,0,1
169263,in,0,0
169264,contextual,1,1
169265,processing,1,1
169266,",",0,0
169267,as,0,0
169268,well,0,0
169269,as,0,0
169270,deficits,0,1
169271,in,0,0
169272,its,0,0
169273,elementary,0,0
169274,components,0,0
169275,:,0,0
169276,abstraction,1,1
169277,and,1,1
169278,cognitive,1,1
169279,flexibility,1,1
169280,.,1,0
169281,METHODS,0,0
169282,Four,0,1
169283,children,0,0
169284,with,0,0
169285,autism,0,0
169286,participated,0,0
169287,in,0,0
169288,a,0,0
169289,multiple-baseline,0,0
169290,",",0,0
169291,single-subject,0,0
169292,study,0,0
169293,.,0,0
169294,The,0,0
169295,children,0,0
169296,were,0,0
169297,taught,0,0
169298,how,0,0
169299,to,0,0
169300,see,0,0
169301,objects,0,1
169302,in,0,0
169303,context,0,0
169304,by,0,0
169305,reinforcing,0,0
169306,attention,0,1
169307,to,0,0
169308,pivotal,0,0
169309,contextual,0,0
169310,information,0,1
169311,.,0,0
169312,RESULTS,0,0
169313,All,0,0
169314,children,0,0
169315,demonstrated,0,0
169316,statistically,0,0
169317,significant,0,0
169318,improvements,0,1
169319,in,0,0
169320,contextual,1,1
169321,processing,1,1
169322,and,1,1
169323,cognitive,1,1
169324,flexibility,1,1
169325,.,1,0
169326,Mixed,0,0
169327,results,0,0
169328,were,0,0
169329,found,0,0
169330,on,0,0
169331,the,0,0
169332,control,0,0
169333,test,0,1
169334,and,0,1
169335,changes,0,1
169336,in,0,0
169337,context-related,1,0
169338,behaviours,1,1
169339,.,1,0
169340,CONCLUSIONS,0,0
169341,Larger-scale,0,0
169342,studies,0,0
169343,are,0,0
169344,warranted,0,0
169345,to,0,0
169346,determine,0,0
169347,the,0,0
169348,effectiveness,0,1
169349,and,0,1
169350,usability,0,1
169351,in,0,0
169352,comprehensive,0,0
169353,educational,0,0
169354,programs,0,0
169355,.,0,0
169356,Randomized,0,0
169357,study,0,0
169358,comparing,0,0
169359,use,0,0
169360,of,0,1
169361,THUNDERBEAT,0,0
169362,technology,0,0
169363,vs,0,0
169364,standard,0,0
169365,electrosurgery,0,0
169366,during,0,0
169367,laparoscopic,0,0
169368,radical,0,1
169369,hysterectomy,0,0
169370,and,0,1
169371,pelvic,0,0
169372,lymphadenectomy,0,0
169373,for,0,0
169374,gynecologic,0,0
169375,cancer,0,0
169376,.,0,0
169377,STUDY,0,0
169378,OBJECTIVE,0,0
169379,To,0,0
169380,compare,0,0
169381,operative,0,1
169382,time,0,1
169383,with,0,0
169384,use,0,0
169385,of,0,1
169386,THUNDERBEAT,0,0
169387,(,0,0
169388,TB,0,0
169389,),0,0
169390,vs,0,0
169391,standard,0,0
169392,electrosurgery,0,0
169393,(,0,1
169394,SES,0,0
169395,),0,0
169396,during,0,0
169397,laparoscopic,0,0
169398,radical,0,1
169399,hysterectomy,0,0
169400,and,0,1
169401,pelvic,0,0
169402,lymphadenectomy,0,0
169403,to,0,0
169404,treat,0,0
169405,gynecologic,0,0
169406,tumors,0,0
169407,.,0,0
169408,DESIGN,0,0
169409,Evidence,0,1
169410,obtained,0,0
169411,from,0,0
169412,a,0,0
169413,properly,0,0
169414,designed,0,0
169415,",",0,0
169416,randomized,0,0
169417,",",0,0
169418,controlled,0,0
169419,trial,0,0
169420,(,0,0
169421,Canadian,0,0
169422,Task,0,0
169423,Force,0,0
169424,classification,0,1
169425,I,0,0
169426,),0,0
169427,.,0,0
169428,SETTING,0,0
169429,Gynecologic,0,1
169430,Oncology,0,1
169431,Unit,0,0
169432,of,0,0
169433,the,0,0
169434,Catholic,0,0
169435,University,0,0
169436,of,0,0
169437,the,0,0
169438,Sacred,0,0
169439,Heart,0,0
169440,in,0,0
169441,Rome,0,1
169442,",",0,0
169443,Italy,0,0
169444,.,0,1
169445,PATIENTS,0,0
169446,Fifty,0,0
169447,patients,0,0
169448,with,0,0
169449,early,0,0
169450,cervical,0,1
169451,cancer,0,0
169452,(,0,0
169453,FIGO,0,0
169454,stages,0,1
169455,IA2,0,1
169456,",",0,1
169457,IB1,0,0
169458,",",0,0
169459,IIA,0,0
169460,<,0,0
169461,2,0,0
169462,cm,0,0
169463,),0,0
169464,or,0,0
169465,locally,0,0
169466,advanced,0,0
169467,cervical,0,1
169468,cancer,0,0
169469,(,0,0
169470,FIGO,0,0
169471,stages,0,1
169472,IB2,0,1
169473,",",0,0
169474,IIA,0,0
169475,>,0,0
169476,2cm,0,1
169477,",",0,0
169478,IIB,0,0
169479,),0,0
169480,who,0,0
169481,received,0,0
169482,neoadjuvant,0,0
169483,treatment,0,0
169484,(,0,1
169485,chemotherapy,0,0
169486,or,0,1
169487,radiochemotherapy,0,0
169488,),0,1
169489,and,0,0
169490,demonstrated,0,0
169491,a,0,0
169492,complete,0,1
169493,or,0,0
169494,partial,0,1
169495,clinical,0,1
169496,response,0,1
169497,and,0,1
169498,early,0,1
169499,stage,0,0
169500,endometrioid,0,1
169501,endometrial,0,1
169502,cancer,0,0
169503,(,0,0
169504,FIGO,0,0
169505,stages,0,1
169506,IB,0,0
169507,",",0,1
169508,II,0,0
169509,),0,1
169510,were,0,0
169511,randomly,0,0
169512,assigned,0,0
169513,to,0,0
169514,undergo,0,0
169515,TB,0,0
169516,(,0,0
169517,arm,0,0
169518,A,0,0
169519,),0,1
169520,or,0,1
169521,SES,0,1
169522,(,0,1
169523,arm,0,0
169524,B,0,0
169525,),0,0
169526,.,0,0
169527,INTERVENTION,0,1
169528,Laparoscopic,0,0
169529,radical,0,1
169530,hysterectomy,0,0
169531,with,0,0
169532,bilateral,0,0
169533,pelvic,0,0
169534,lymphadenectomy,0,0
169535,",",0,0
169536,using,0,0
169537,an,0,0
169538,easily,0,0
169539,reproducible,0,0
169540,technique,0,0
169541,was,0,0
169542,performed,0,0
169543,.,0,0
169544,MEASUREMENTS,0,0
169545,AND,0,0
169546,MAIN,0,1
169547,RESULTS,0,0
169548,Fifty,0,1
169549,patients,0,0
169550,were,0,0
169551,available,0,0
169552,for,0,0
169553,analysis,0,0
169554,",",0,0
169555,with,0,0
169556,25,0,0
169557,women,0,0
169558,randomly,0,0
169559,assigned,0,0
169560,to,0,0
169561,TB,0,0
169562,(,0,0
169563,arm,0,0
169564,A,0,0
169565,),0,0
169566,and,0,0
169567,25,0,0
169568,to,0,0
169569,SES,0,0
169570,(,0,0
169571,arm,0,0
169572,B,0,0
169573,),0,0
169574,.,0,0
169575,The,0,0
169576,median,1,1
169577,operative,1,1
169578,time,1,1
169579,was,0,0
169580,85,0,0
169581,minutes,0,0
169582,for,0,0
169583,TB,0,0
169584,vs,0,0
169585,115,0,0
169586,minutes,0,0
169587,for,0,0
169588,SES,0,0
169589,(,0,0
169590,p,0,0
169591,=,0,0
169592,.001,0,0
169593,),0,0
169594,.,0,0
169595,At,0,0
169596,multivariate,0,0
169597,analysis,0,0
169598,",",0,1
169599,endometrial,0,1
169600,cancer,0,1
169601,(,0,0
169602,p,0,0
169603,=,0,0
169604,.001,0,0
169605,),0,1
169606,and,0,1
169607,TB,0,0
169608,(,0,1
169609,p,0,0
169610,=,0,0
169611,.001,0,0
169612,),0,1
169613,were,0,0
169614,independently,0,0
169615,associated,0,0
169616,with,0,0
169617,shorter,1,1
169618,operating,1,1
169619,time,1,1
169620,.,1,0
169621,No,0,0
169622,differences,1,0
169623,in,0,0
169624,perioperative,1,1
169625,outcomes,1,1
169626,and,1,1
169627,postoperative,1,1
169628,complications,1,1
169629,were,0,0
169630,observed,0,0
169631,between,0,0
169632,the,0,0
169633,2,0,0
169634,arms,0,0
169635,.,0,0
169636,Patients,0,0
169637,who,0,0
169638,underwent,0,0
169639,TB,0,0
169640,reported,0,0
169641,less,0,0
169642,postoperative,1,1
169643,pain,1,1
169644,",",0,0
169645,both,0,0
169646,at,0,0
169647,rest,0,1
169648,(,0,0
169649,p,0,0
169650,=,0,0
169651,.005,0,0
169652,),0,1
169653,and,0,0
169654,after,0,0
169655,the,0,0
169656,Valsalva,0,1
169657,maneuver,0,1
169658,(,0,0
169659,p,0,0
169660,=,0,0
169661,.008,0,0
169662,),0,1
169663,",",0,0
169664,with,0,0
169665,less,0,0
169666,additional,0,0
169667,analgesic,0,1
169668,therapy,0,0
169669,other,0,0
169670,than,0,0
169671,standard,0,0
169672,therapy,0,0
169673,required,0,0
169674,in,0,0
169675,patients,0,0
169676,who,0,0
169677,underwent,0,0
169678,SES,0,0
169679,(,0,0
169680,p,0,0
169681,=,0,0
169682,.02,0,0
169683,),0,0
169684,.,0,0
169685,CONCLUSION,0,0
169686,TB,0,0
169687,is,0,0
169688,associated,0,0
169689,with,0,0
169690,shorter,1,1
169691,operative,1,1
169692,time,1,1
169693,and,1,1
169694,less,1,0
169695,postoperative,1,1
169696,pain,1,1
169697,than,0,0
169698,is,0,0
169699,the,0,0
169700,standard,0,0
169701,technique,0,0
169702,(,0,1
169703,SES,0,0
169704,),0,0
169705,in,0,0
169706,patients,0,0
169707,with,0,0
169708,uterine,0,1
169709,cancer,0,0
169710,.,0,0
169711,Similar,0,0
169712,MPA,0,1
169713,exposure,0,0
169714,on,0,0
169715,modified,0,0
169716,release,0,1
169717,and,0,1
169718,regular,0,0
169719,tacrolimus,0,0
169720,.,0,1
169721,Concomitant,0,0
169722,immunosuppression,0,0
169723,may,0,0
169724,affect,0,0
169725,the,0,0
169726,mycophenolate,1,0
169727,mofetil,1,0
169728,exposure,0,0
169729,.,0,1
169730,Astellas,0,0
169731,developed,0,0
169732,a,0,0
169733,once-daily,0,0
169734,modified,0,0
169735,release,0,1
169736,formulation,0,0
169737,of,0,1
169738,tacrolimus,0,0
169739,(,0,1
169740,TacMR,0,1
169741,),0,0
169742,with,0,0
169743,the,0,0
169744,potential,0,0
169745,to,0,0
169746,reduce,0,0
169747,the,0,0
169748,likelihood,0,1
169749,of,0,0
169750,nonadherence,1,1
169751,.,1,0
169752,It,0,0
169753,is,0,0
169754,unknown,0,0
169755,whether,0,0
169756,mycophenolic,0,0
169757,acid,0,1
169758,(,0,1
169759,MPA,0,1
169760,),0,1
169761,area,0,1
169762,under,0,0
169763,the,0,0
169764,concentration-time,0,1
169765,curve,0,1
169766,(,0,1
169767,AUC,0,0
169768,),0,0
169769,differs,0,0
169770,between,0,0
169771,the,0,0
169772,2,0,0
169773,tacrolimus,0,0
169774,(,0,0
169775,Tac,0,0
169776,),0,0
169777,formulations,0,0
169778,.,0,0
169779,In,0,0
169780,a,0,0
169781,2-by-2,0,0
169782,crossover,0,0
169783,design,0,0
169784,",",0,0
169785,20,0,0
169786,stable,0,0
169787,renal,0,0
169788,transplant,0,1
169789,recipients,0,0
169790,on,0,0
169791,twice-daily,0,0
169792,Tac,0,0
169793,either,0,0
169794,continued,0,0
169795,their,0,0
169796,usual,0,0
169797,Tac,0,0
169798,therapy,0,0
169799,(,0,1
169800,n,0,0
169801,=,0,0
169802,10,0,0
169803,",",0,0
169804,group,0,0
169805,1,0,0
169806,),0,0
169807,or,0,0
169808,switched,0,0
169809,to,0,0
169810,TacMR,0,1
169811,for,0,0
169812,a,0,0
169813,12-week,0,0
169814,period,0,0
169815,(,0,0
169816,n,0,0
169817,=,0,0
169818,10,0,0
169819,",",0,0
169820,group,0,0
169821,2,0,0
169822,),0,0
169823,",",0,0
169824,after,0,0
169825,which,0,0
169826,the,0,0
169827,patients,0,0
169828,crossed,0,0
169829,over,0,0
169830,to,0,0
169831,the,0,0
169832,other,0,0
169833,formulation,0,0
169834,for,0,0
169835,another,0,0
169836,12-week,0,0
169837,period,0,0
169838,.,0,0
169839,Pharmacokinetic,0,1
169840,profiles,0,1
169841,using,0,0
169842,limited,0,0
169843,sampling,0,0
169844,strategies,0,1
169845,were,0,0
169846,obtained,0,0
169847,before,0,0
169848,randomization,0,0
169849,(,0,0
169850,visit,0,0
169851,1,0,0
169852,),0,0
169853,",",0,0
169854,and,0,0
169855,at,0,0
169856,12,0,0
169857,(,0,0
169858,visit,0,0
169859,2,0,0
169860,),0,0
169861,and,0,0
169862,24,0,0
169863,weeks,0,0
169864,(,0,0
169865,visit,0,0
169866,3,0,0
169867,),0,0
169868,at,0,0
169869,steady,0,1
169870,state,0,1
169871,.,0,0
169872,MPA,0,1
169873,AUC,0,1
169874,was,0,0
169875,calculated,0,0
169876,using,0,0
169877,the,0,0
169878,Pawinski,0,0
169879,formula,0,0
169880,.,0,0
169881,When,0,0
169882,analyzing,0,0
169883,visits,0,0
169884,on,0,0
169885,Tac,1,0
169886,",",1,1
169887,TacMR,1,1
169888,",",1,1
169889,and,1,1
169890,back,1,1
169891,on,1,0
169892,Tac,1,0
169893,combined,1,0
169894,",",1,0
169895,the,1,0
169896,MPA,1,1
169897,AUC,1,0
169898,for,0,0
169899,all,0,0
169900,20,0,0
169901,patients,0,0
169902,at,0,0
169903,baseline,0,0
169904,was,0,0
169905,42.24,0,0
169906,(,0,0
169907,16.98,0,0
169908,),0,0
169909,",",0,0
169910,37.18,0,0
169911,(,0,0
169912,13.75,0,0
169913,),0,0
169914,",",0,0
169915,and,0,0
169916,40.09,0,0
169917,(,0,0
169918,16.69,0,0
169919,),0,0
169920,mg?h?L,0,0
169921,(,0,1
169922,-1,0,0
169923,),0,1
169924,",",0,0
169925,respectively,0,0
169926,",",0,0
169927,which,0,0
169928,was,0,0
169929,not,0,0
169930,statistically,0,0
169931,significant,0,0
169932,using,0,0
169933,repeated,0,0
169934,measures,0,0
169935,(,0,0
169936,P,0,0
169937,=,0,0
169938,0.1327,0,0
169939,",",0,0
169940,R,0,1
169941,(,0,0
169942,2,0,0
169943,),0,0
169944,=,0,0
169945,0.1109,0,0
169946,),0,0
169947,.,0,0
169948,We,0,0
169949,conclude,0,0
169950,that,1,0
169951,MPA,1,1
169952,pharmacokinetic,1,1
169953,profiles,1,0
169954,are,1,0
169955,not,0,0
169956,altered,0,0
169957,when,0,0
169958,converting,0,0
169959,patients,0,0
169960,from,0,0
169961,Tac,0,0
169962,to,0,0
169963,TacMR,0,1
169964,.,0,0
169965,Effects,0,0
169966,of,0,0
169967,water,0,0
169968,extracts,0,0
169969,of,0,1
169970,Graptopetalum,0,0
169971,paraguayense,0,1
169972,on,0,0
169973,blood,1,1
169974,pressure,1,1
169975,",",1,1
169976,fasting,1,1
169977,glucose,1,1
169978,",",1,1
169979,and,1,1
169980,lipid,1,1
169981,profiles,1,1
169982,of,0,0
169983,subjects,0,0
169984,with,0,0
169985,metabolic,0,1
169986,syndrome,0,0
169987,.,0,0
169988,This,0,0
169989,study,0,0
169990,was,0,0
169991,aimed,0,0
169992,to,0,0
169993,investigate,0,0
169994,the,0,0
169995,effects,0,0
169996,of,0,0
169997,water,0,0
169998,extracts,0,0
169999,of,0,1
170000,Graptopetalum,0,0
170001,paraguayense,0,1
170002,(,0,1
170003,WGP,0,0
170004,",",0,0
170005,4,0,0
170006,g/d,0,0
170007,),0,0
170008,on,0,0
170009,blood,1,1
170010,pressure,1,1
170011,",",1,1
170012,blood,1,1
170013,glucose,1,1
170014,level,1,1
170015,",",1,1
170016,and,1,1
170017,lipid,1,1
170018,profiles,1,1
170019,in,0,0
170020,subjects,0,0
170021,with,0,0
170022,metabolic,0,1
170023,syndrome,0,0
170024,(,0,1
170025,MS,0,1
170026,),0,0
170027,.,0,0
170028,Participants,0,0
170029,with,0,0
170030,MS,0,1
170031,(,0,0
170032,n,0,0
170033,=,0,0
170034,54,0,0
170035,),0,0
170036,were,0,0
170037,randomly,0,0
170038,assigned,0,0
170039,to,0,0
170040,the,0,0
170041,placebo,0,0
170042,(,0,0
170043,n,0,0
170044,=,0,0
170045,28,0,0
170046,),0,0
170047,and,0,0
170048,WGP,0,0
170049,groups,0,0
170050,(,0,0
170051,n,0,0
170052,=,0,0
170053,26,0,0
170054,),0,0
170055,",",0,0
170056,and,0,0
170057,the,0,0
170058,intervention,0,0
170059,was,0,0
170060,administered,0,0
170061,for,0,0
170062,12,0,0
170063,weeks,0,0
170064,.,0,0
170065,Systolic,1,1
170066,blood,1,1
170067,pressure,1,1
170068,(,1,1
170069,SBP,1,1
170070,),1,1
170071,",",1,0
170072,diastolic,1,1
170073,blood,1,1
170074,pressure,1,1
170075,(,1,1
170076,DBP,1,1
170077,),1,1
170078,",",1,0
170079,fasting,1,1
170080,glucose,1,1
170081,(,1,1
170082,FG,1,0
170083,),1,1
170084,",",1,0
170085,lipid,1,1
170086,profiles,1,1
170087,(,1,0
170088,total,1,1
170089,cholesterol,1,1
170090,(,1,1
170091,TC,1,1
170092,),1,1
170093,",",1,0
170094,triglyceride,1,1
170095,(,1,0
170096,TG,1,1
170097,),1,1
170098,",",1,0
170099,low,1,1
170100,density,1,1
170101,lipoprotein,1,1
170102,cholesterol,1,1
170103,(,1,1
170104,LDL-C,1,1
170105,),1,1
170106,",",1,0
170107,and,1,1
170108,high,1,1
170109,density,1,1
170110,lipoprotein,1,1
170111,(,1,1
170112,HDL-C,1,1
170113,),1,1
170114,),1,1
170115,",",1,0
170116,and,1,1
170117,antioxidant,1,1
170118,enzymes,1,1
170119,activities,0,1
170120,(,0,1
170121,catalase,0,1
170122,(,0,1
170123,CAT,0,1
170124,),0,1
170125,",",0,0
170126,superoxide,0,1
170127,dismutase,0,1
170128,(,0,1
170129,SOD,0,1
170130,),0,1
170131,",",0,1
170132,and,0,1
170133,glutathione,0,1
170134,peroxidase,0,1
170135,(,0,1
170136,GPx,0,1
170137,),0,1
170138,),0,0
170139,were,0,0
170140,measured,0,0
170141,.,0,0
170142,Forty-two,0,0
170143,subjects,0,0
170144,completed,0,0
170145,the,0,0
170146,study,0,0
170147,(,0,1
170148,placebo,0,0
170149,",",0,0
170150,n,0,0
170151,=,0,0
170152,19,0,0
170153,;,0,0
170154,WGP,0,0
170155,",",0,0
170156,n,0,0
170157,=,0,0
170158,23,0,0
170159,),0,0
170160,.,0,0
170161,FG,1,0
170162,",",1,1
170163,SBP,1,1
170164,",",1,1
170165,and,1,1
170166,LDL-C,1,1
170167,levels,1,1
170168,were,1,0
170169,significantly,1,0
170170,lower,1,0
170171,and,0,1
170172,HDL-C,1,1
170173,level,1,1
170174,and,1,1
170175,antioxidant,1,1
170176,enzymes,1,1
170177,activities,1,1
170178,(,1,0
170179,CAT,1,1
170180,and,1,1
170181,SOD,1,1
170182,),1,1
170183,were,1,0
170184,significantly,1,0
170185,higher,1,0
170186,after,0,0
170187,WGP,0,0
170188,supplementation,0,0
170189,.,0,1
170190,Blood,1,1
170191,pressure,1,1
170192,",",1,1
170193,FG,1,0
170194,",",1,1
170195,and,1,1
170196,lipid,1,1
170197,profiles,1,1
170198,were,0,0
170199,significantly,0,0
170200,correlated,0,0
170201,with,0,0
170202,antioxidant,0,0
170203,enzymes,0,1
170204,activities,0,1
170205,after,0,0
170206,supplementation,0,0
170207,(,0,0
170208,P,0,0
170209,<,0,0
170210,0.05,0,0
170211,),0,0
170212,.,0,0
170213,The,0,0
170214,present,0,0
170215,study,0,0
170216,demonstrated,0,0
170217,a,0,0
170218,significant,0,0
170219,reduction,0,1
170220,in,0,0
170221,blood,1,1
170222,pressure,1,1
170223,",",1,1
170224,blood,1,1
170225,glucose,1,1
170226,",",1,1
170227,and,1,1
170228,lipid,1,1
170229,profiles,1,1
170230,and,0,0
170231,an,0,0
170232,increase,0,1
170233,in,0,0
170234,antioxidant,1,1
170235,enzymes,1,1
170236,activities,1,1
170237,in,0,0
170238,subjects,0,0
170239,with,0,0
170240,MS,0,0
170241,after,0,0
170242,WGP,0,0
170243,supplementation,0,0
170244,.,0,0
170245,Taken,0,0
170246,together,0,0
170247,",",0,0
170248,the,0,0
170249,antioxidative,0,1
170250,capacity,0,1
170251,of,0,0
170252,WGP,0,0
170253,might,0,0
170254,exert,0,0
170255,a,0,0
170256,beneficial,0,0
170257,effect,0,0
170258,on,0,0
170259,MS,0,0
170260,.,0,0
170261,This,0,0
170262,trial,0,0
170263,is,0,0
170264,registered,0,0
170265,with,0,0
170266,ClinicalTrials.gov,0,0
170267,NCT01463748,0,0
170268,.,0,0
170269,Addressing,0,0
170270,dental,0,1
170271,fear,0,1
170272,in,0,0
170273,children,0,0
170274,with,0,0
170275,autism,0,0
170276,spectrum,0,0
170277,disorders,0,0
170278,:,0,0
170279,a,0,0
170280,randomized,0,0
170281,controlled,0,0
170282,pilot,0,0
170283,study,0,0
170284,using,0,0
170285,electronic,0,0
170286,screen,0,0
170287,media,0,0
170288,.,0,0
170289,BACKGROUND,0,0
170290,Dental,0,0
170291,care,0,0
170292,is,0,0
170293,a,0,0
170294,significant,0,0
170295,unmet,0,1
170296,health,0,1
170297,care,0,0
170298,need,0,1
170299,for,0,0
170300,children,0,0
170301,with,0,0
170302,autism,0,0
170303,spectrum,0,0
170304,disorders,0,1
170305,(,0,1
170306,ASD,0,0
170307,),0,0
170308,.,0,0
170309,Many,0,0
170310,children,0,0
170311,with,0,0
170312,ASD,0,0
170313,do,0,0
170314,not,0,0
170315,receive,0,0
170316,dental,0,0
170317,care,0,0
170318,because,0,0
170319,of,0,0
170320,fear,0,1
170321,associated,0,0
170322,with,0,0
170323,dental,0,0
170324,procedures,0,0
170325,;,0,0
170326,oftentimes,0,0
170327,they,0,0
170328,require,0,0
170329,general,0,0
170330,anesthesia,0,0
170331,for,0,0
170332,regular,0,0
170333,dental,0,0
170334,procedures,0,0
170335,",",0,0
170336,placing,0,0
170337,them,0,0
170338,at,0,0
170339,risk,0,1
170340,of,0,0
170341,associated,0,0
170342,complications,0,1
170343,.,0,0
170344,Many,0,0
170345,children,0,0
170346,with,0,0
170347,ASD,0,0
170348,have,0,0
170349,a,0,0
170350,strong,0,0
170351,preference,0,1
170352,for,0,0
170353,visual,0,1
170354,stimuli,0,1
170355,",",0,0
170356,particularly,0,0
170357,electronic,0,0
170358,screen,0,0
170359,media,0,0
170360,.,0,0
170361,The,0,0
170362,use,0,0
170363,of,0,0
170364,visual,0,1
170365,teaching,0,0
170366,materials,0,0
170367,is,0,0
170368,a,0,0
170369,fundamental,0,0
170370,principle,0,0
170371,in,0,0
170372,designing,0,0
170373,educational,0,0
170374,programs,0,0
170375,for,0,0
170376,children,0,0
170377,with,0,0
170378,ASD,0,0
170379,.,0,0
170380,PURPOSE,0,0
170381,To,0,0
170382,determine,0,0
170383,if,0,0
170384,an,0,0
170385,innovative,0,0
170386,strategy,0,0
170387,using,0,0
170388,2,0,0
170389,types,0,0
170390,of,0,0
170391,electronic,0,0
170392,screen,0,0
170393,media,0,0
170394,was,0,0
170395,feasible,0,0
170396,and,0,1
170397,beneficial,0,0
170398,in,0,0
170399,reducing,0,0
170400,fear,0,1
170401,and,0,1
170402,uncooperative,0,1
170403,behaviors,0,1
170404,in,0,0
170405,children,0,0
170406,with,0,0
170407,ASD,0,0
170408,undergoing,0,0
170409,dental,0,0
170410,visits,0,0
170411,.,0,0
170412,METHODS,0,0
170413,We,0,0
170414,conducted,0,0
170415,a,0,0
170416,randomized,0,0
170417,controlled,0,0
170418,trial,0,0
170419,at,0,0
170420,Boston,0,0
170421,Children,0,1
170422,'s,0,1
170423,Hospital,0,1
170424,dental,0,0
170425,clinic,0,0
170426,.,0,1
170427,Eighty,0,1
170428,(,0,0
170429,80,0,0
170430,),0,0
170431,children,0,0
170432,aged,0,0
170433,7,0,0
170434,to,0,0
170435,17,0,0
170436,years,0,0
170437,with,0,0
170438,a,0,0
170439,known,0,0
170440,diagnosis,0,0
170441,of,0,1
170442,ASD,0,0
170443,and,0,1
170444,history,0,1
170445,of,0,1
170446,dental,0,1
170447,fear,0,1
170448,were,0,0
170449,enrolled,0,0
170450,in,0,0
170451,the,0,0
170452,study,0,0
170453,.,0,0
170454,Each,0,0
170455,child,0,0
170456,completed,0,0
170457,2,0,0
170458,preventive,0,0
170459,dental,0,0
170460,visits,0,1
170461,that,0,0
170462,were,0,0
170463,scheduled,0,0
170464,6,0,0
170465,months,0,0
170466,apart,0,0
170467,(,0,0
170468,visit,0,0
170469,1,0,0
170470,and,0,0
170471,visit,0,0
170472,2,0,0
170473,),0,0
170474,.,0,0
170475,After,0,0
170476,visit,0,0
170477,1,0,0
170478,",",0,0
170479,subjects,0,0
170480,were,0,0
170481,randomly,0,0
170482,assigned,0,0
170483,to,0,0
170484,1,0,0
170485,of,0,0
170486,4,0,0
170487,groups,0,0
170488,:,0,0
170489,(,0,0
170490,1,0,0
170491,),0,0
170492,group,0,0
170493,A,0,0
170494,",",0,1
170495,control,0,0
170496,(,0,1
170497,usual,0,0
170498,care,0,0
170499,),0,0
170500,;,0,0
170501,(,0,0
170502,2,0,0
170503,),0,0
170504,group,0,0
170505,B,0,1
170506,",",0,1
170507,treatment,0,0
170508,(,0,1
170509,video,0,0
170510,peer,0,1
170511,modeling,0,0
170512,that,0,0
170513,involved,0,0
170514,watching,0,0
170515,a,0,0
170516,DVD,0,0
170517,recording,0,0
170518,of,0,0
170519,a,0,0
170520,typically,0,0
170521,developing,0,0
170522,child,0,0
170523,undergoing,0,0
170524,a,0,0
170525,dental,0,0
170526,visit,0,0
170527,),0,0
170528,;,0,0
170529,(,0,0
170530,3,0,0
170531,),0,0
170532,group,0,0
170533,C,0,0
170534,",",0,1
170535,treatment,0,0
170536,(,0,1
170537,video,0,0
170538,goggles,0,0
170539,that,0,0
170540,involved,0,0
170541,watching,0,0
170542,a,0,0
170543,favorite,0,0
170544,movie,0,0
170545,during,0,0
170546,the,0,0
170547,dental,0,0
170548,visit,0,1
170549,using,0,0
170550,sunglass-style,0,0
170551,video,0,0
170552,eyewear,0,1
170553,),0,0
170554,;,0,1
170555,and,0,0
170556,(,0,0
170557,4,0,0
170558,),0,0
170559,group,0,0
170560,D,0,1
170561,",",0,1
170562,treatment,0,0
170563,(,0,1
170564,video,0,0
170565,peer,0,1
170566,modeling,0,0
170567,plus,0,0
170568,video,0,0
170569,goggles,0,0
170570,),0,0
170571,.,0,0
170572,Subjects,0,0
170573,who,0,0
170574,refused,0,0
170575,or,0,0
170576,were,0,0
170577,unable,0,0
170578,to,0,0
170579,wear,0,1
170580,the,0,0
170581,goggles,0,0
170582,watched,0,0
170583,the,0,0
170584,movie,0,0
170585,using,0,0
170586,a,0,0
170587,handheld,0,0
170588,portable,0,0
170589,DVD,0,0
170590,player,0,1
170591,.,0,0
170592,During,0,0
170593,both,0,0
170594,visits,0,0
170595,",",0,0
170596,the,0,0
170597,subject,0,0
170598,'s,0,1
170599,level,0,1
170600,of,0,1
170601,anxiety,0,1
170602,and,0,1
170603,behavior,0,1
170604,were,0,0
170605,measured,0,0
170606,using,0,0
170607,the,0,0
170608,Venham,0,0
170609,Anxiety,0,1
170610,and,0,1
170611,Behavior,0,1
170612,Scales,0,1
170613,.,0,0
170614,Analyses,0,0
170615,of,0,1
170616,variance,0,1
170617,and,0,1
170618,Fisher,0,1
170619,'s,0,1
170620,exact,0,1
170621,tests,0,1
170622,compared,0,0
170623,baseline,0,0
170624,characteristics,0,0
170625,across,0,0
170626,groups,0,0
170627,.,0,0
170628,Using,0,0
170629,intention,0,1
170630,to,0,0
170631,treat,0,0
170632,approach,0,0
170633,",",0,1
170634,repeated,0,0
170635,measures,0,1
170636,analyses,0,0
170637,were,0,0
170638,employed,0,0
170639,to,0,0
170640,test,0,0
170641,whether,0,0
170642,the,0,0
170643,outcomes,0,1
170644,differed,0,0
170645,significantly,0,0
170646,:,0,0
170647,(,0,0
170648,1,0,0
170649,),0,0
170650,between,0,0
170651,visits,0,0
170652,1,0,0
170653,and,0,0
170654,2,0,0
170655,within,0,0
170656,each,0,0
170657,group,0,0
170658,and,0,1
170659,(,0,0
170660,2,0,0
170661,),0,0
170662,between,0,0
170663,each,0,0
170664,intervention,0,0
170665,group,0,0
170666,and,0,0
170667,the,0,0
170668,control,0,0
170669,group,0,0
170670,over,0,0
170671,time,0,1
170672,(,0,0
170673,an,0,0
170674,interaction,0,1
170675,),0,0
170676,.,0,0
170677,RESULTS,0,0
170678,Between,0,0
170679,visits,0,0
170680,1,0,0
170681,and,0,0
170682,2,0,0
170683,",",0,0
170684,mean,1,1
170685,anxiety,1,1
170686,and,1,1
170687,behavior,1,1
170688,scores,1,1
170689,decreased,0,0
170690,significantly,0,0
170691,by,0,0
170692,0.8,0,0
170693,points,0,0
170694,(,0,0
170695,P,0,0
170696,=,0,0
170697,.03,0,0
170698,),0,0
170699,for,0,0
170700,subjects,0,0
170701,within,0,0
170702,groups,0,0
170703,C,0,0
170704,and,0,1
170705,D.,0,0
170706,Significant,0,1
170707,changes,0,1
170708,were,0,0
170709,not,0,0
170710,observed,0,0
170711,within,0,0
170712,groups,0,0
170713,A,0,0
170714,and,0,0
170715,B,0,0
170716,.,0,1
170717,Mean,1,1
170718,anxiety,1,1
170719,and,1,1
170720,behavior,1,1
170721,scores,1,1
170722,did,0,0
170723,not,0,0
170724,differ,0,0
170725,significantly,0,0
170726,between,0,0
170727,groups,0,0
170728,over,0,0
170729,time,0,1
170730,",",0,0
170731,although,0,0
170732,group,0,0
170733,A,0,0
170734,versus,0,0
170735,C,0,0
170736,pairwise,0,1
170737,comparisons,0,0
170738,showed,0,0
170739,a,0,0
170740,trend,0,0
170741,toward,0,0
170742,significance,0,1
170743,(,0,0
170744,P,0,0
170745,=,0,0
170746,.06,0,0
170747,),0,0
170748,.,0,0
170749,CONCLUSION,0,0
170750,These,0,0
170751,findings,0,0
170752,suggest,0,0
170753,that,0,0
170754,certain,0,0
170755,electronic,0,0
170756,screen,0,0
170757,media,0,0
170758,technologies,0,0
170759,may,0,0
170760,be,0,0
170761,useful,0,0
170762,tools,0,1
170763,for,0,0
170764,reducing,1,0
170765,fear,1,1
170766,and,1,1
170767,uncooperative,1,1
170768,behaviors,1,1
170769,among,0,0
170770,children,0,0
170771,with,0,0
170772,ASD,0,0
170773,undergoing,0,0
170774,dental,0,0
170775,visits,0,0
170776,.,0,0
170777,Further,0,0
170778,studies,0,0
170779,are,0,0
170780,needed,0,0
170781,to,0,0
170782,assess,0,0
170783,the,0,0
170784,efficacy,0,1
170785,of,0,0
170786,these,0,0
170787,strategies,0,0
170788,using,0,0
170789,larger,0,0
170790,sample,0,0
170791,sizes,0,1
170792,.,0,0
170793,Findings,0,0
170794,from,0,0
170795,future,0,0
170796,studies,0,0
170797,could,0,0
170798,be,0,0
170799,relevant,0,0
170800,for,0,0
170801,nondental,0,0
170802,providers,0,0
170803,who,0,0
170804,care,0,0
170805,for,0,0
170806,children,0,0
170807,with,0,0
170808,ASD,0,0
170809,in,0,0
170810,other,0,0
170811,medical,0,0
170812,settings,0,0
170813,.,0,0
170814,Does,0,1
170815,privatisation,0,1
170816,of,0,1
170817,vocational,0,0
170818,rehabilitation,0,0
170819,improve,0,0
170820,labour,0,1
170821,market,0,0
170822,opportunities,0,0
170823,?,0,0
170824,Evidence,0,0
170825,from,0,0
170826,a,0,0
170827,field,0,0
170828,experiment,0,0
170829,in,0,0
170830,Sweden,0,0
170831,.,0,0
170832,This,0,0
170833,paper,0,0
170834,analyses,0,0
170835,if,0,0
170836,privatisation,0,1
170837,of,0,1
170838,vocational,0,0
170839,rehabilitation,0,0
170840,can,0,0
170841,improve,0,0
170842,labour,0,1
170843,market,0,0
170844,opportunities,0,0
170845,for,0,0
170846,individuals,0,0
170847,on,0,0
170848,long-term,0,1
170849,sickness,0,1
170850,absence,0,0
170851,.,0,0
170852,We,0,0
170853,use,0,0
170854,a,0,0
170855,field,0,0
170856,experiment,0,0
170857,performed,0,0
170858,by,0,0
170859,the,0,0
170860,Public,0,1
170861,Employment,0,1
170862,Service,0,0
170863,and,0,0
170864,the,0,0
170865,Social,0,1
170866,Insurance,0,1
170867,Agency,0,1
170868,in,0,0
170869,Sweden,0,0
170870,during,0,0
170871,2008-2010,0,0
170872,",",0,0
170873,in,0,0
170874,which,0,0
170875,over,0,0
170876,4000,0,0
170877,participants,0,0
170878,were,0,0
170879,randomly,0,0
170880,offered,0,0
170881,private,0,0
170882,and,0,0
170883,public,0,0
170884,rehabilitation,0,0
170885,.,0,0
170886,We,0,0
170887,find,0,0
170888,no,0,0
170889,differences,0,0
170890,in,0,0
170891,employment,1,1
170892,rates,1,1
170893,following,0,0
170894,rehabilitation,0,0
170895,between,0,0
170896,individuals,0,0
170897,who,0,0
170898,received,0,0
170899,rehabilitation,0,0
170900,by,0,0
170901,private,0,0
170902,and,0,1
170903,public,0,0
170904,providers,0,0
170905,.,0,0
170906,Also,0,0
170907,the,0,0
170908,average,1,1
170909,cost,1,1
170910,of,1,1
170911,rehabilitation,1,0
170912,was,0,0
170913,essentially,0,0
170914,equal,0,0
170915,for,0,0
170916,the,0,0
170917,two,0,0
170918,types,0,0
170919,of,0,0
170920,providers,0,0
170921,.,0,0
170922,This,0,0
170923,suggests,0,0
170924,that,0,0
170925,there,0,0
170926,are,0,0
170927,no,0,0
170928,large,0,0
170929,efficiency,1,1
170930,gains,1,1
170931,from,0,0
170932,privatising,0,1
170933,vocational,0,0
170934,rehabilitation,0,0
170935,.,0,0
170936,Examining,0,0
170937,the,0,0
170938,effectiveness,0,0
170939,of,0,0
170940,psychological,0,1
170941,strategies,0,0
170942,on,0,0
170943,physiologic,0,0
170944,markers,0,0
170945,:,0,0
170946,evidence-based,0,0
170947,suggestions,0,0
170948,for,0,0
170949,holistic,0,0
170950,care,0,0
170951,of,0,0
170952,the,0,0
170953,athlete,0,0
170954,.,0,0
170955,CONTEXT,0,0
170956,Current,0,1
170957,holistic,0,0
170958,rehabilitation,0,0
170959,blends,0,0
170960,both,0,0
170961,physical,0,1
170962,and,0,0
170963,psychological,0,1
170964,techniques,0,0
170965,.,0,0
170966,However,0,0
170967,",",0,0
170968,validation,0,0
170969,of,0,0
170970,the,0,0
170971,usefulness,0,0
170972,of,0,0
170973,psychological,0,1
170974,strategies,0,0
170975,is,0,0
170976,limited,0,0
170977,in,0,0
170978,the,0,0
170979,literature,0,0
170980,.,0,0
170981,OBJECTIVE,0,0
170982,To,0,0
170983,quantify,0,0
170984,the,0,0
170985,effects,0,0
170986,of,0,0
170987,psychological,0,1
170988,strategies,0,0
170989,on,0,0
170990,both,0,0
170991,physiologic,0,1
170992,(,0,0
170993,salivary,0,1
170994,cortisol,0,1
170995,),0,1
170996,and,0,1
170997,subjective,0,1
170998,assessments,0,0
170999,of,0,0
171000,stress,0,1
171001,.,0,0
171002,DESIGN,0,0
171003,Randomized,0,0
171004,controlled,0,0
171005,clinical,0,0
171006,trial,0,0
171007,.,0,1
171008,SETTING,0,0
171009,Laboratory,0,0
171010,.,0,1
171011,PATIENTS,0,0
171012,OR,0,1
171013,OTHER,0,1
171014,PARTICIPANTS,0,0
171015,A,0,0
171016,total,0,1
171017,of,0,0
171018,97,0,0
171019,college-aged,0,0
171020,students,0,0
171021,(,0,0
171022,age,0,0
171023,=,0,0
171024,20.65,0,0
171025,?,0,0
171026,4.38,0,0
171027,years,0,0
171028,),0,0
171029,",",0,0
171030,most,0,0
171031,with,0,0
171032,little,0,0
171033,to,0,0
171034,no,0,0
171035,experience,0,0
171036,with,0,0
171037,psychological,0,1
171038,strategies,0,0
171039,.,0,1
171040,INTERVENTION,0,1
171041,(,0,0
171042,S,0,0
171043,),0,0
171044,A,0,0
171045,15-minute,0,0
171046,script,0,0
171047,via,0,0
171048,an,0,0
171049,iPod,0,0
171050,led,0,0
171051,the,0,0
171052,participant,0,0
171053,through,0,0
171054,visual,0,1
171055,imagery,0,0
171056,(,0,0
171057,cognitive,0,1
171058,relaxation,0,1
171059,),0,1
171060,or,0,0
171061,deep,0,1
171062,breathing,0,1
171063,exercises,0,0
171064,(,0,0
171065,somatic,0,1
171066,relaxation,0,1
171067,),0,0
171068,cues,0,0
171069,.,0,0
171070,The,0,0
171071,control,0,0
171072,group,0,0
171073,listened,0,0
171074,to,0,0
171075,15,0,0
171076,minutes,0,0
171077,of,0,0
171078,ambient,0,0
171079,nature,0,0
171080,sounds,0,1
171081,.,0,0
171082,MAIN,0,0
171083,OUTCOME,0,1
171084,MEASURE,0,1
171085,(,0,1
171086,S,0,0
171087,),0,0
171088,Two,0,0
171089,samples,0,0
171090,(,0,0
171091,pretest,0,1
171092,",",0,1
171093,posttest,0,1
171094,),0,0
171095,of,1,0
171096,salivary,1,1
171097,cortisol,1,1
171098,were,0,0
171099,analyzed,0,0
171100,using,0,0
171101,an,0,0
171102,enzyme,0,0
171103,immunoassay,0,0
171104,kit,0,1
171105,;,0,0
171106,the,0,0
171107,average,0,1
171108,was,0,0
171109,used,0,0
171110,for,0,0
171111,statistical,0,0
171112,analysis,0,0
171113,.,0,0
171114,Descriptive,0,0
171115,statistics,0,1
171116,and,0,1
171117,correlations,0,1
171118,were,0,0
171119,conducted,0,0
171120,to,0,0
171121,examine,0,0
171122,group,0,0
171123,differences,0,0
171124,in,1,0
171125,time,1,1
171126,of,1,1
171127,day,1,1
171128,",",1,1
171129,salivary,1,1
171130,cortisol,1,1
171131,",",1,1
171132,sex,1,1
171133,",",1,1
171134,Stress-O-Meter,1,1
171135,values,1,1
171136,",",1,1
171137,and,1,1
171138,Perceived,1,1
171139,Stress,1,1
171140,Scale,1,1
171141,scores,1,1
171142,.,1,0
171143,RESULTS,1,0
171144,Salivary,1,1
171145,cortisol,1,1
171146,levels,1,1
171147,were,0,0
171148,lower,0,0
171149,in,0,0
171150,the,0,0
171151,treatment,0,0
171152,group,0,0
171153,than,0,0
171154,the,0,0
171155,control,0,0
171156,group,0,0
171157,(,0,1
171158,"F2,97",0,0
171159,=,0,0
171160,15.62,0,0
171161,",",0,0
171162,P,0,0
171163,<,0,0
171164,.001,0,0
171165,),0,0
171166,.,0,0
171167,Females,0,0
171168,had,0,0
171169,higher,0,0
171170,scores,0,1
171171,on,0,0
171172,both,0,0
171173,the,0,0
171174,pretest,1,0
171175,Stress-O-Meter,1,0
171176,(,0,0
171177,5.15,0,0
171178,?,0,0
171179,1.796,0,0
171180,),0,0
171181,and,0,0
171182,the,1,0
171183,Perceived,1,0
171184,Stress,1,1
171185,Scale,1,1
171186,(,1,0
171187,18.31,0,0
171188,?,0,0
171189,5.833,0,0
171190,),0,0
171191,than,0,0
171192,males,0,0
171193,(,0,0
171194,4.25,0,0
171195,?,0,0
171196,1.741,0,0
171197,and,0,0
171198,15.272,0,0
171199,?,0,0
171200,5.390,0,0
171201,",",0,0
171202,respectively,0,0
171203,),0,0
171204,.,0,0
171205,CONCLUSIONS,0,0
171206,Both,0,0
171207,cognitive,0,1
171208,and,0,1
171209,somatic,0,1
171210,relaxation,0,1
171211,strategies,0,1
171212,reduced,1,1
171213,cortisol,1,1
171214,levels,1,1
171215,.,1,0
171216,Participants,1,0
171217,who,0,0
171218,received,0,0
171219,verbal,0,1
171220,guidance,0,0
171221,achieved,0,0
171222,a,0,0
171223,larger,1,0
171224,cortisol,1,1
171225,reduction,1,1
171226,.,1,0
171227,However,1,0
171228,",",0,0
171229,the,0,0
171230,change,0,1
171231,in,0,0
171232,cortisol,0,1
171233,level,0,1
171234,was,0,0
171235,uncorrelated,0,0
171236,with,0,0
171237,the,0,0
171238,change,0,1
171239,in,0,0
171240,report,0,0
171241,of,0,1
171242,acute,0,0
171243,stress,0,1
171244,;,0,0
171245,females,0,0
171246,reported,0,0
171247,higher,0,0
171248,levels,0,1
171249,of,0,1
171250,stress,0,1
171251,.,0,0
171252,Clinical,0,0
171253,implications,0,0
171254,include,0,0
171255,attention,0,1
171256,to,0,0
171257,sex,0,0
171258,when,0,0
171259,assessing,0,0
171260,stress,0,1
171261,and,0,1
171262,providing,0,0
171263,coping,0,1
171264,skills,0,1
171265,during,0,0
171266,the,0,0
171267,rehabilitation,0,0
171268,process,0,0
171269,.,0,0
171270,Addictive,1,1
171271,internet,1,1
171272,use,1,0
171273,among,0,0
171274,Korean,0,0
171275,adolescents,0,0
171276,:,0,0
171277,a,0,0
171278,national,0,0
171279,survey,0,0
171280,.,0,0
171281,BACKGROUND,0,0
171282,A,0,0
171283,psychological,0,1
171284,disorder,0,0
171285,called,0,0
171286,'Internet,1,0
171287,addiction,1,0
171288,',1,0
171289,has,0,0
171290,newly,0,0
171291,emerged,0,0
171292,along,0,0
171293,with,0,0
171294,a,0,0
171295,dramatic,0,0
171296,increase,0,0
171297,of,0,1
171298,worldwide,0,0
171299,Internet,0,0
171300,use,0,0
171301,.,0,0
171302,However,0,0
171303,",",0,0
171304,few,0,0
171305,studies,0,0
171306,have,0,0
171307,used,0,0
171308,population-level,0,0
171309,samples,0,0
171310,nor,0,0
171311,taken,0,0
171312,into,0,0
171313,account,0,0
171314,contextual,0,0
171315,factors,0,0
171316,on,0,0
171317,Internet,0,0
171318,addiction,0,1
171319,.,0,1
171320,METHODS,0,0
171321,AND,0,0
171322,FINDINGS,0,0
171323,We,0,0
171324,identified,0,0
171325,"57,857",0,0
171326,middle,0,0
171327,and,0,0
171328,high,0,1
171329,school,0,1
171330,students,0,0
171331,(,0,0
171332,13-18,0,0
171333,year,0,0
171334,olds,0,0
171335,),0,0
171336,from,0,0
171337,a,0,0
171338,Korean,0,0
171339,nationally,0,0
171340,representative,0,0
171341,survey,0,0
171342,",",0,1
171343,which,0,0
171344,was,0,0
171345,surveyed,0,0
171346,in,0,0
171347,2009,0,0
171348,.,0,0
171349,To,0,0
171350,identify,0,0
171351,associated,0,0
171352,factors,0,0
171353,with,0,0
171354,addictive,1,1
171355,Internet,1,0
171356,use,1,1
171357,",",0,1
171358,two-level,0,0
171359,multilevel,0,0
171360,regression,0,1
171361,models,0,0
171362,were,0,0
171363,fitted,0,0
171364,with,0,0
171365,individual-level,0,0
171366,responses,0,1
171367,(,0,0
171368,1st,0,0
171369,level,0,1
171370,),0,0
171371,nested,0,0
171372,within,0,0
171373,schools,0,0
171374,(,0,0
171375,2nd,0,0
171376,level,0,0
171377,),0,0
171378,to,0,0
171379,estimate,0,0
171380,associations,0,0
171381,of,0,1
171382,individual,0,0
171383,and,0,1
171384,school,0,1
171385,characteristics,0,1
171386,simultaneously,0,0
171387,.,0,0
171388,Gender,0,1
171389,differences,0,0
171390,of,0,0
171391,addictive,1,1
171392,Internet,1,0
171393,use,1,1
171394,were,0,0
171395,estimated,0,0
171396,with,0,0
171397,the,0,0
171398,regression,0,0
171399,model,0,0
171400,stratified,0,0
171401,by,0,0
171402,gender,0,0
171403,.,0,0
171404,Significant,0,1
171405,associations,0,0
171406,were,0,0
171407,found,0,0
171408,between,0,0
171409,addictive,0,1
171410,Internet,1,0
171411,use,1,1
171412,and,0,1
171413,school,0,1
171414,grade,0,1
171415,",",0,1
171416,parental,0,1
171417,education,0,0
171418,",",0,1
171419,alcohol,0,1
171420,use,0,1
171421,",",0,1
171422,tobacco,0,0
171423,use,0,1
171424,",",0,1
171425,and,0,1
171426,substance,0,1
171427,use,0,1
171428,.,0,1
171429,Female,0,0
171430,students,0,0
171431,in,0,0
171432,girls,0,0
171433,',0,1
171434,schools,0,0
171435,were,0,0
171436,more,0,0
171437,likely,0,0
171438,to,0,0
171439,use,1,0
171440,Internet,1,0
171441,addictively,1,0
171442,than,0,0
171443,those,0,0
171444,in,0,0
171445,coeducational,0,0
171446,schools,0,0
171447,.,0,0
171448,Our,0,0
171449,results,0,0
171450,also,0,0
171451,revealed,0,0
171452,significant,0,0
171453,gender,0,0
171454,differences,0,0
171455,of,0,0
171456,addictive,1,1
171457,Internet,1,0
171458,use,1,0
171459,in,0,0
171460,its,0,0
171461,associated,0,0
171462,individual-,0,0
171463,and,0,0
171464,school-level,0,1
171465,factors,0,1
171466,.,0,0
171467,CONCLUSIONS,0,0
171468,Our,0,0
171469,results,0,0
171470,suggest,0,0
171471,that,0,0
171472,multilevel,0,0
171473,risk,0,1
171474,factors,0,1
171475,along,0,0
171476,with,0,0
171477,gender,0,0
171478,differences,0,0
171479,should,0,0
171480,be,0,0
171481,considered,0,0
171482,to,0,0
171483,protect,0,0
171484,adolescents,0,0
171485,from,0,0
171486,addictive,1,1
171487,Internet,1,0
171488,use,1,0
171489,.,1,0
171490,Economic,0,1
171491,burden,0,1
171492,of,0,1
171493,childhood,0,1
171494,autism,0,0
171495,spectrum,0,0
171496,disorders,0,0
171497,.,0,0
171498,OBJECTIVE,0,0
171499,To,0,0
171500,estimate,0,0
171501,the,0,0
171502,associations,0,0
171503,between,0,0
171504,autism,0,0
171505,spectrum,0,1
171506,disorder,0,0
171507,(,0,1
171508,ASD,0,0
171509,),0,1
171510,diagnoses,0,1
171511,and,0,1
171512,service,1,1
171513,use,1,1
171514,",",1,1
171515,caregiver,1,1
171516,time,1,1
171517,",",1,1
171518,and,1,1
171519,cost,1,1
171520,outcomes,1,1
171521,.,1,0
171522,METHODS,0,0
171523,We,0,0
171524,used,0,0
171525,national,0,0
171526,data,0,0
171527,from,0,0
171528,the,0,0
171529,Medical,0,0
171530,Expenditure,0,1
171531,Panel,0,1
171532,Survey,0,0
171533,linked,0,0
171534,to,0,0
171535,the,0,0
171536,National,0,0
171537,Health,0,1
171538,Interview,0,0
171539,Survey,0,0
171540,and,0,0
171541,a,0,0
171542,study-specific,0,1
171543,survey,0,0
171544,to,0,0
171545,estimate,0,0
171546,the,0,0
171547,annual,1,0
171548,utilization,1,1
171549,and,1,1
171550,costs,1,1
171551,for,0,0
171552,health,1,1
171553,care,1,0
171554,",",1,1
171555,school,1,1
171556,",",1,1
171557,ASD-related,1,1
171558,therapy,1,0
171559,",",1,1
171560,family-coordinated,1,1
171561,services,1,1
171562,",",0,0
171563,as,0,0
171564,well,0,0
171565,as,0,0
171566,caregiver,1,1
171567,time,1,1
171568,in,0,0
171569,children,0,0
171570,aged,0,0
171571,3,0,0
171572,to,0,0
171573,17,0,0
171574,years,0,0
171575,",",0,0
171576,with,0,0
171577,and,0,1
171578,without,0,0
171579,parent-reported,0,1
171580,ASD,0,0
171581,.,0,0
171582,Regression,0,1
171583,analyses,0,0
171584,estimated,0,0
171585,the,0,0
171586,association,0,0
171587,between,0,0
171588,ASD,0,0
171589,diagnosis,0,1
171590,and,0,1
171591,cost,1,1
171592,",",0,1
171593,controlling,0,1
171594,for,0,0
171595,child,0,1
171596,gender,0,1
171597,",",0,1
171598,age,0,1
171599,",",0,1
171600,race/ethnicity,0,0
171601,",",0,1
171602,insurance,0,1
171603,status,0,1
171604,",",0,1
171605,household,0,1
171606,income,0,1
171607,",",0,1
171608,country,0,1
171609,region,0,0
171610,and,0,1
171611,urban/rural,0,1
171612,classification,0,1
171613,",",0,1
171614,and,0,1
171615,non-ASD-related,0,1
171616,illnesses,0,1
171617,.,0,0
171618,RESULTS,0,0
171619,Children,0,0
171620,with,0,0
171621,parent-reported,0,1
171622,ASD,0,0
171623,had,0,0
171624,higher,1,0
171625,levels,1,1
171626,of,1,1
171627,health,1,1
171628,care,1,0
171629,office,1,1
171630,visits,1,1
171631,and,0,1
171632,prescription,1,1
171633,drug,1,1
171634,use,1,1
171635,compared,0,0
171636,with,0,0
171637,children,0,0
171638,without,0,0
171639,ASD,0,0
171640,(,0,0
171641,P,0,0
171642,<,0,0
171643,.05,0,0
171644,),0,0
171645,.,0,0
171646,A,0,0
171647,greater,0,0
171648,proportion,0,1
171649,of,0,1
171650,children,0,0
171651,in,0,0
171652,the,0,0
171653,ASD,0,0
171654,group,0,0
171655,used,0,0
171656,special,1,0
171657,educational,1,0
171658,services,1,0
171659,(,0,0
171660,76,0,0
171661,%,0,0
171662,vs.,0,0
171663,7,0,0
171664,%,0,0
171665,in,0,0
171666,the,0,0
171667,control,0,0
171668,group,0,0
171669,",",0,1
171670,P,0,0
171671,<,0,0
171672,.05,0,0
171673,),0,0
171674,.,0,0
171675,After,0,0
171676,adjusting,0,0
171677,for,0,0
171678,child,0,0
171679,demographic,0,1
171680,characteristics,0,1
171681,and,0,1
171682,non-ASD-associated,0,1
171683,illnesses,0,1
171684,",",0,1
171685,ASD,0,0
171686,was,0,0
171687,associated,0,0
171688,with,0,0
171689,$,0,0
171690,3020,0,0
171691,(,0,0
171692,95,0,0
171693,%,0,0
171694,confidence,0,0
171695,interval,0,0
171696,[,0,0
171697,CI,0,0
171698,],0,0
171699,:,0,0
171700,$,0,0
171701,1017-,0,0
171702,$,0,0
171703,4259,0,0
171704,),0,0
171705,higher,1,0
171706,health,1,1
171707,care,1,1
171708,costs,1,1
171709,and,0,0
171710,$,0,0
171711,"14,061",0,0
171712,(,0,0
171713,95,0,0
171714,%,0,0
171715,CI,0,0
171716,:,0,0
171717,$,0,0
171718,4390-,0,0
171719,$,0,0
171720,"24,302",0,0
171721,),0,0
171722,higher,1,0
171723,aggregate,1,1
171724,non-health,1,1
171725,care,1,0
171726,costs,1,1
171727,",",0,0
171728,including,0,0
171729,$,0,0
171730,8610,0,0
171731,(,0,0
171732,95,0,0
171733,%,0,0
171734,CI,0,0
171735,:,0,0
171736,$,0,0
171737,6595-,0,0
171738,$,0,0
171739,"10,421",0,0
171740,),0,0
171741,higher,1,0
171742,school,1,0
171743,costs,1,1
171744,.,1,0
171745,In,0,0
171746,adjusted,0,0
171747,analyses,0,0
171748,",",0,0
171749,parents,0,0
171750,who,0,0
171751,reported,0,0
171752,that,0,0
171753,their,0,0
171754,child,0,1
171755,had,0,0
171756,ASD,0,0
171757,did,0,0
171758,not,1,0
171759,have,1,0
171760,significantly,1,0
171761,higher,1,0
171762,out-of-pocket,1,1
171763,costs,1,1
171764,or,0,0
171765,spend,1,1
171766,more,1,0
171767,time,1,1
171768,on,1,0
171769,caregiving,1,1
171770,activities,1,1
171771,compared,0,0
171772,with,0,0
171773,control,0,0
171774,parents,0,0
171775,.,0,0
171776,CONCLUSIONS,0,0
171777,The,0,0
171778,economic,0,0
171779,burden,0,1
171780,associated,0,0
171781,with,0,0
171782,ASD,0,0
171783,is,0,0
171784,substantial,0,0
171785,and,0,0
171786,can,0,0
171787,be,0,0
171788,measured,0,0
171789,across,0,0
171790,multiple,0,0
171791,sectors,0,0
171792,of,0,0
171793,our,0,0
171794,society,0,0
171795,.,0,0
171796,Previous,0,0
171797,analyses,0,0
171798,that,0,0
171799,focused,0,0
171800,on,0,0
171801,health,0,1
171802,care,0,0
171803,underestimated,0,0
171804,this,0,0
171805,economic,0,1
171806,burden,0,1
171807,",",0,0
171808,particularly,0,0
171809,for,0,0
171810,school,0,0
171811,systems,0,0
171812,.,0,0
171813,Are,0,0
171814,'leaky,1,1
171815,gut,1,1
171816,',1,1
171817,and,0,0
171818,behavior,1,1
171819,associated,0,0
171820,with,0,0
171821,gluten,0,1
171822,and,0,1
171823,dairy,0,0
171824,containing,0,0
171825,diet,0,0
171826,in,0,0
171827,children,0,0
171828,with,0,0
171829,autism,0,0
171830,spectrum,0,0
171831,disorders,0,0
171832,?,0,0
171833,OBJECTIVES,0,0
171834,Studies,0,0
171835,have,0,0
171836,suggested,0,0
171837,a,0,0
171838,link,0,0
171839,between,0,0
171840,diet,0,0
171841,and,0,1
171842,behavior,1,1
171843,in,0,0
171844,children,0,0
171845,with,0,0
171846,autism,0,0
171847,spectrum,0,0
171848,disorders,0,1
171849,(,0,1
171850,ASDs,0,0
171851,),0,0
171852,.,0,0
171853,Parental,0,1
171854,reports,0,0
171855,of,0,0
171856,behavioral,0,1
171857,changes,0,1
171858,upon,0,0
171859,exposure,0,0
171860,to,0,0
171861,gluten,0,1
171862,and/or,0,0
171863,casein,0,0
171864,are,0,0
171865,common,0,0
171866,in,0,0
171867,clinical,0,0
171868,practice,0,0
171869,.,0,0
171870,An,0,0
171871,association,0,0
171872,between,0,0
171873,diet,0,0
171874,type,0,0
171875,",",0,1
171876,intestinal,1,1
171877,permeability,1,1
171878,(,1,1
171879,IP,1,1
171880,),1,1
171881,(,1,0
171882,'leaky,1,1
171883,gut,1,1
171884,',1,1
171885,),1,1
171886,",",0,0
171887,and,0,0
171888,behavior,1,1
171889,has,0,0
171890,been,0,0
171891,long,0,0
171892,proposed,0,0
171893,but,0,0
171894,not,0,0
171895,substantiated,0,0
171896,.,0,0
171897,We,0,0
171898,explored,0,0
171899,this,0,0
171900,possible,0,0
171901,association,0,0
171902,in,0,0
171903,this,0,0
171904,trial,0,0
171905,.,0,0
171906,METHODS,0,0
171907,This,0,0
171908,randomized,0,0
171909,double-blind,0,0
171910,",",0,1
171911,placebo-controlled,0,0
171912,study,0,0
171913,explored,0,0
171914,the,0,0
171915,effects,0,1
171916,of,0,0
171917,gluten,0,1
171918,and,0,1
171919,milk,0,1
171920,on,0,0
171921,IP,0,1
171922,and,0,1
171923,behavior,0,1
171924,in,0,0
171925,children,0,0
171926,with,0,0
171927,ASDs,0,0
171928,over,0,0
171929,a,0,0
171930,period,0,0
171931,of,0,0
171932,4,0,0
171933,weeks,0,0
171934,.,0,0
171935,IP,0,0
171936,assessed,0,0
171937,by,0,0
171938,lactulose,1,0
171939,:,1,0
171940,mannitol,1,1
171941,(,1,1
171942,L/M,1,1
171943,),1,1
171944,sugar,1,1
171945,permeability,1,1
171946,test,1,1
171947,and,0,1
171948,behavior,0,1
171949,assessed,0,0
171950,by,0,0
171951,the,0,0
171952,Aberrant,1,0
171953,Behavior,1,1
171954,Checklist,1,1
171955,and,1,1
171956,Conners,1,1
171957,Parent,1,1
171958,Rating,1,1
171959,were,0,0
171960,measured,0,0
171961,.,0,0
171962,Gastrointestinal,1,1
171963,symptoms,1,1
171964,in,0,0
171965,both,0,0
171966,groups,0,0
171967,were,0,0
171968,also,0,0
171969,monitored,0,0
171970,.,0,0
171971,RESULTS,0,0
171972,Neither,0,0
171973,the,0,0
171974,L/M,1,1
171975,ratio,1,1
171976,nor,1,0
171977,behavioral,1,1
171978,scores,1,1
171979,were,0,0
171980,different,0,0
171981,between,0,0
171982,groups,0,0
171983,exposed,0,0
171984,to,0,0
171985,gluten/dairy,0,0
171986,or,0,0
171987,placebo,0,0
171988,.,0,0
171989,The,0,0
171990,changes,0,1
171991,observed,0,0
171992,were,0,0
171993,noted,0,0
171994,to,0,0
171995,be,0,0
171996,small,0,0
171997,and,0,0
171998,not,0,0
171999,clinically,0,0
172000,significant,0,0
172001,.,0,0
172002,DISCUSSION,0,0
172003,Our,0,0
172004,study,0,0
172005,although,0,0
172006,underpowered,0,0
172007,to,0,0
172008,show,0,0
172009,small,0,0
172010,differences,0,0
172011,does,0,0
172012,not,0,0
172013,support,0,0
172014,an,0,0
172015,association,0,0
172016,between,0,0
172017,dietary,0,1
172018,gluten/milk,0,1
172019,",",0,1
172020,IP,1,1
172021,",",0,1
172022,and,0,1
172023,behavioral,1,1
172024,changes,1,1
172025,in,0,0
172026,subjects,0,0
172027,with,0,0
172028,ASD,0,0
172029,.,0,0
172030,Collagen,0,1
172031,cross-linking,0,0
172032,with,0,0
172033,photoactivated,0,0
172034,riboflavin,0,0
172035,(,0,1
172036,PACK-CXL,0,1
172037,),0,0
172038,for,0,0
172039,the,0,0
172040,treatment,0,0
172041,of,0,0
172042,advanced,0,0
172043,infectious,0,1
172044,keratitis,0,1
172045,with,0,0
172046,corneal,0,1
172047,melting,0,1
172048,.,0,0
172049,PURPOSE,0,0
172050,To,0,0
172051,investigate,0,0
172052,the,0,0
172053,efficacy,1,1
172054,and,1,1
172055,safety,1,1
172056,of,0,1
172057,corneal,0,1
172058,collagen,0,0
172059,cross-linking,0,1
172060,(,0,1
172061,CXL,0,1
172062,),0,0
172063,with,0,0
172064,photoactivated,0,0
172065,riboflavin,0,0
172066,(,0,0
172067,photoactivated,0,0
172068,chromophore,0,1
172069,for,0,0
172070,infectious,0,1
172071,keratitis,0,1
172072,[,0,0
172073,PACK,0,1
172074,],0,0
172075,-CXL,0,1
172076,),0,0
172077,in,0,0
172078,the,0,0
172079,management,0,0
172080,of,0,0
172081,infectious,0,1
172082,keratitis,0,1
172083,with,0,0
172084,corneal,0,1
172085,melting,0,1
172086,.,0,0
172087,DESIGN,0,0
172088,Prospective,0,0
172089,clinical,0,0
172090,trial,0,0
172091,.,0,0
172092,PARTICIPANTS,0,1
172093,Forty,0,0
172094,eyes,0,0
172095,from,0,0
172096,40,0,0
172097,patients,0,0
172098,with,0,0
172099,advanced,0,0
172100,infectious,0,1
172101,keratitis,0,1
172102,and,0,1
172103,coexisting,0,0
172104,corneal,0,1
172105,melting,0,1
172106,.,0,0
172107,METHODS,0,0
172108,Twenty-one,0,0
172109,patients,0,0
172110,(,0,0
172111,21,0,0
172112,eyes,0,0
172113,),0,0
172114,underwent,0,0
172115,PACK-CXL,0,1
172116,treatment,0,0
172117,in,0,0
172118,addition,0,0
172119,to,0,0
172120,antimicrobial,0,1
172121,therapy,0,0
172122,.,0,0
172123,The,0,0
172124,control,0,0
172125,group,0,0
172126,consisted,0,0
172127,of,0,0
172128,19,0,0
172129,patients,0,0
172130,(,0,0
172131,19,0,0
172132,eyes,0,0
172133,),0,0
172134,who,0,0
172135,received,0,0
172136,only,0,0
172137,antimicrobial,0,0
172138,therapy,0,0
172139,.,0,0
172140,MAIN,0,0
172141,OUTCOME,0,0
172142,MEASURES,0,0
172143,The,0,0
172144,slit-lamp,1,0
172145,characteristics,1,0
172146,of,1,0
172147,the,1,0
172148,corneal,1,1
172149,ulceration,1,1
172150,",",1,1
172151,corrected,1,1
172152,distance,1,1
172153,visual,1,1
172154,acuity,1,1
172155,",",1,1
172156,duration,1,1
172157,until,1,0
172158,healing,1,1
172159,",",1,0
172160,and,1,1
172161,complications,1,1
172162,were,0,0
172163,documented,0,0
172164,in,0,0
172165,each,0,0
172166,group,0,0
172167,.,0,0
172168,The,0,0
172169,Mann-Whitney,0,0
172170,U,0,0
172171,test,0,1
172172,was,0,0
172173,used,0,0
172174,for,0,0
172175,statistical,0,0
172176,analysis,0,0
172177,.,0,0
172178,P,0,0
172179,values,0,1
172180,less,0,0
172181,than,0,0
172182,0.05,0,0
172183,were,0,0
172184,considered,0,0
172185,statistically,0,0
172186,significant,0,0
172187,.,0,0
172188,RESULTS,0,0
172189,The,0,0
172190,average,0,1
172191,time,1,1
172192,until,1,0
172193,healing,1,1
172194,was,0,0
172195,39.76,0,0
172196,?,0,0
172197,18.22,0,0
172198,days,0,0
172199,in,0,0
172200,the,0,0
172201,PACK-CXL,0,1
172202,group,0,0
172203,and,0,0
172204,46.05,0,0
172205,?,0,0
172206,27.44,0,0
172207,days,0,0
172208,in,0,0
172209,the,0,0
172210,control,0,0
172211,group,0,0
172212,(,0,1
172213,P,0,0
172214,=,0,0
172215,0.68,0,0
172216,),0,0
172217,.,0,0
172218,After,0,0
172219,treatment,0,0
172220,and,0,1
172221,healing,1,1
172222,",",1,1
172223,corrected,1,1
172224,distance,1,1
172225,visual,1,1
172226,acuity,1,1
172227,was,1,0
172228,1.64,0,0
172229,?,0,0
172230,0.62,0,0
172231,in,0,0
172232,the,0,0
172233,PACK-CXL,0,1
172234,group,0,0
172235,and,0,0
172236,1.67,0,0
172237,?,0,0
172238,0.48,0,0
172239,in,0,0
172240,the,0,0
172241,control,0,0
172242,group,0,0
172243,(,0,1
172244,P,0,0
172245,=,0,0
172246,0.68,0,0
172247,),0,0
172248,.,0,0
172249,The,0,0
172250,corneal,1,1
172251,ulceration,1,1
172252,'s,1,1
172253,width,1,1
172254,and,1,1
172255,length,1,1
172256,was,1,0
172257,significantly,0,0
172258,bigger,0,0
172259,in,0,0
172260,the,0,0
172261,PACK-CXL,0,1
172262,group,0,0
172263,(,0,0
172264,P,0,0
172265,=,0,0
172266,0.004,0,0
172267,and,0,0
172268,P,0,0
172269,=,0,0
172270,0.007,0,0
172271,),0,0
172272,.,0,0
172273,Three,0,0
172274,patients,0,0
172275,in,0,0
172276,the,0,0
172277,control,0,0
172278,group,0,0
172279,demonstrated,1,0
172280,corneal,1,1
172281,perforation,1,1
172282,;,1,1
172283,infection,1,1
172284,recurred,0,0
172285,in,0,0
172286,1,0,0
172287,of,0,0
172288,them,0,0
172289,.,0,0
172290,No,0,0
172291,serious,0,1
172292,complications,0,1
172293,occurred,0,0
172294,in,0,0
172295,the,0,0
172296,PACK-CXL,0,0
172297,group,0,0
172298,.,0,1
172299,CONCLUSIONS,0,0
172300,Corneal,0,1
172301,CXL,0,1
172302,with,0,0
172303,photoactivated,0,0
172304,riboflavin,0,0
172305,did,0,0
172306,not,0,0
172307,shorten,0,0
172308,the,0,0
172309,time,1,1
172310,to,1,0
172311,corneal,1,1
172312,healing,1,1
172313,;,1,0
172314,however,1,0
172315,",",0,0
172316,the,0,0
172317,complication,0,1
172318,rate,0,1
172319,was,0,0
172320,21,0,0
172321,%,0,0
172322,in,0,0
172323,the,0,0
172324,control,0,0
172325,group,0,0
172326,",",0,0
172327,whereas,0,0
172328,there,0,0
172329,was,0,0
172330,no,0,0
172331,incidence,0,1
172332,of,0,0
172333,corneal,0,1
172334,perforation,1,1
172335,or,1,1
172336,recurrence,1,1
172337,of,1,0
172338,the,1,0
172339,infection,1,1
172340,in,1,0
172341,the,0,0
172342,PACK-CXL,0,0
172343,group,0,0
172344,.,0,0
172345,These,0,0
172346,results,0,0
172347,indicate,0,0
172348,that,0,0
172349,PACK-CXL,0,0
172350,may,0,0
172351,be,0,0
172352,an,0,0
172353,effective,0,1
172354,adjuvant,0,0
172355,therapy,0,0
172356,in,0,0
172357,the,0,0
172358,management,0,0
172359,of,0,0
172360,severe,0,1
172361,infectious,0,1
172362,keratitis,0,1
172363,associated,0,0
172364,with,0,0
172365,corneal,0,0
172366,melting,0,1
172367,.,0,0
172368,Effects,0,0
172369,of,0,0
172370,phosphorus-restricted,0,0
172371,diet,0,0
172372,and,0,1
172373,phosphate-binding,0,1
172374,therapy,0,0
172375,on,0,0
172376,outcomes,0,1
172377,in,0,0
172378,patients,0,0
172379,with,0,0
172380,chronic,0,0
172381,kidney,0,0
172382,disease,0,1
172383,.,0,1
172384,BACKGROUND,0,0
172385,Phosphorus,0,0
172386,is,0,0
172387,associated,0,0
172388,with,0,0
172389,mortality,0,1
172390,in,0,0
172391,patients,0,0
172392,with,0,0
172393,chronic,0,0
172394,kidney,0,0
172395,disease,0,1
172396,(,0,1
172397,CKD,0,0
172398,),0,0
172399,not,0,0
172400,on,0,0
172401,dialysis,0,0
172402,",",0,0
172403,possibly,0,0
172404,through,0,0
172405,phosphorus-dependent,0,1
172406,vascular,0,1
172407,calcification,0,1
172408,.,0,0
172409,Although,0,0
172410,a,0,0
172411,phosphorus-restricted,0,0
172412,diet,0,0
172413,reduces,0,0
172414,serum,0,1
172415,phosphorus,0,1
172416,",",0,0
172417,it,0,0
172418,is,0,0
172419,unlikely,0,0
172420,that,0,0
172421,it,0,0
172422,reduces,0,0
172423,vascular,0,1
172424,calcification,0,1
172425,progression,0,1
172426,in,0,0
172427,CKD,0,0
172428,.,0,0
172429,This,0,0
172430,study,0,0
172431,evaluated,0,0
172432,whether,0,0
172433,a,0,0
172434,combined,0,0
172435,strategy,0,0
172436,of,0,1
172437,phosphorus-restricted,0,0
172438,diet,0,0
172439,and,0,1
172440,phosphate-binding,0,1
172441,therapy,0,0
172442,can,0,0
172443,reduce,0,0
172444,the,0,0
172445,risk,1,1
172446,of,1,0
172447,all-cause,1,1
172448,mortality,1,1
172449,and/or,1,0
172450,dialysis,1,0
172451,initiation,1,0
172452,by,0,0
172453,attenuating,0,1
172454,coronary,1,1
172455,artery,1,1
172456,calcification,1,1
172457,(,1,1
172458,CAC,1,1
172459,),1,1
172460,progression,1,1
172461,in,0,0
172462,non-dialysis,0,0
172463,CKD,0,0
172464,patients,0,0
172465,.,0,0
172466,METHODS,0,0
172467,This,0,0
172468,was,0,0
172469,a,0,0
172470,post,0,0
172471,hoc,0,0
172472,analysis,0,0
172473,of,0,0
172474,a,0,0
172475,subgroup,0,0
172476,of,0,0
172477,patients,0,0
172478,from,0,0
172479,a,0,0
172480,study,0,0
172481,that,0,0
172482,evaluated,0,0
172483,the,0,0
172484,impact,0,0
172485,of,0,0
172486,two,0,0
172487,phosphorus,0,0
172488,binder,0,0
172489,regimens,0,0
172490,on,0,0
172491,hard,0,0
172492,outcomes,0,1
172493,in,0,0
172494,CKD,0,0
172495,.,0,1
172496,Patients,0,0
172497,(,0,0
172498,n,0,0
172499,=,0,0
172500,113,0,0
172501,),0,0
172502,with,0,0
172503,stage,0,0
172504,3-4,0,1
172505,CKD,0,0
172506,and,0,1
172507,evidence,0,0
172508,of,0,1
172509,CAC,0,0
172510,on,0,0
172511,a,0,0
172512,phosphorus-restricted,0,0
172513,diet,0,0
172514,were,0,0
172515,randomized,0,0
172516,to,0,0
172517,receive,0,0
172518,either,0,0
172519,calcium,0,1
172520,carbonate,0,0
172521,or,0,1
172522,sevelamer,0,0
172523,added,0,0
172524,to,0,0
172525,their,0,0
172526,phosphorus-restricted,0,0
172527,diet,0,0
172528,.,0,1
172529,End-points,0,1
172530,were,1,0
172531,death,1,1
172532,for,1,0
172533,any,1,1
172534,cause,1,1
172535,and,1,1
172536,initiation,1,1
172537,of,1,1
172538,dialysis,1,0
172539,.,1,1
172540,Patients,0,0
172541,were,0,0
172542,monitored,0,0
172543,to,0,0
172544,the,0,0
172545,first,0,1
172546,event,0,1
172547,or,0,1
172548,to,0,0
172549,conclusion,0,0
172550,of,0,0
172551,the,0,0
172552,36-month,0,0
172553,follow-up,0,0
172554,.,0,0
172555,RESULTS,0,0
172556,Overall,0,1
172557,",",0,1
172558,treatment,0,0
172559,with,0,0
172560,calcium,0,1
172561,carbonate,0,0
172562,was,0,0
172563,associated,0,0
172564,with,1,0
172565,increased,1,0
172566,CAC,1,1
172567,progression,1,1
172568,and,1,1
172569,occurrence,1,1
172570,of,1,1
172571,all-cause,1,1
172572,mortality,1,1
172573,",",1,1
172574,dialysis,1,1
172575,initiation,1,1
172576,",",1,0
172577,and,1,0
172578,the,1,0
172579,composite,1,1
172580,end-point,1,1
172581,.,1,0
172582,After,0,0
172583,adjustment,0,0
172584,for,0,0
172585,confounders,0,0
172586,",",0,1
172587,sevelamer,0,0
172588,use,0,1
172589,was,0,0
172590,the,0,0
172591,only,0,0
172592,independent,0,0
172593,predictive,0,1
172594,factor,0,1
172595,of,0,1
172596,reduced,1,1
172597,risk,1,1
172598,of,1,0
172599,each,1,0
172600,endpoint,1,1
172601,but,1,0
172602,only,0,0
172603,if,0,0
172604,CAC,1,0
172605,progression,1,1
172606,was,1,0
172607,either,0,0
172608,absent,0,1
172609,or,0,0
172610,moderate,1,0
172611,.,1,1
172612,Accelerated,1,0
172613,progression,1,1
172614,(,1,0
172615,annual,0,1
172616,CAC,0,1
172617,increase,0,1
172618,>,0,0
172619,75th,0,0
172620,percentile,0,0
172621,of,0,0
172622,the,0,0
172623,study,0,0
172624,cohort,0,0
172625,),0,0
172626,increased,0,0
172627,the,1,0
172628,risk,1,1
172629,of,1,0
172630,all-cause,1,1
172631,mortality,1,1
172632,and,1,1
172633,composite,1,1
172634,end-point,1,1
172635,(,1,0
172636,p,0,0
172637,=,0,0
172638,0.01,0,0
172639,),0,0
172640,independently,0,0
172641,of,0,0
172642,the,0,0
172643,use,0,0
172644,of,0,0
172645,sevelamer,0,0
172646,.,0,0
172647,CONCLUSIONS,0,0
172648,A,0,0
172649,significant,0,0
172650,reduction,1,1
172651,in,1,0
172652,all-cause,1,1
172653,mortality,1,1
172654,",",1,1
172655,dialysis,1,1
172656,initiation,1,1
172657,",",1,1
172658,and,1,1
172659,composite,1,1
172660,end-point,1,1
172661,risk,1,1
172662,was,1,0
172663,achieved,0,0
172664,by,0,0
172665,combining,0,0
172666,phosphorus-restricted,0,0
172667,diet,0,0
172668,and,0,1
172669,sevelamer,0,0
172670,in,0,0
172671,non-dialysis,0,0
172672,CKD,0,0
172673,patients,0,0
172674,with,0,0
172675,absent,0,0
172676,or,0,1
172677,moderate,0,0
172678,but,0,0
172679,not,0,0
172680,accelerated,1,0
172681,CAC,1,0
172682,progression,1,1
172683,.,1,0
172684,Future,1,0
172685,studies,0,0
172686,should,0,0
172687,investigate,0,0
172688,the,0,0
172689,role,0,0
172690,of,0,1
172691,serum,0,1
172692,phosphorus,0,1
172693,",",0,0
172694,the,0,0
172695,usefulness,0,0
172696,of,0,0
172697,a,0,0
172698,phosphorus-restricted,0,0
172699,diet,0,0
172700,",",0,0
172701,and,0,1
172702,the,0,0
172703,appropriateness,0,0
172704,of,0,0
172705,current,0,0
172706,normal,0,0
172707,ranges,0,1
172708,of,0,1
172709,serum,0,1
172710,phosphorus,0,1
172711,concentration,0,1
172712,in,0,0
172713,relation,0,0
172714,to,0,0
172715,events,0,1
172716,in,0,0
172717,non-dialyzed,0,0
172718,CKD,0,0
172719,patients,0,0
172720,.,0,0
172721,Intravenous,0,0
172722,lipid,0,1
172723,emulsion,0,0
172724,improves,0,1
172725,recovery,0,1
172726,time,0,1
172727,and,0,1
172728,quality,0,1
172729,from,0,0
172730,isoflurane,0,0
172731,anaesthesia,0,0
172732,:,0,0
172733,a,0,0
172734,double-blind,0,0
172735,clinical,0,0
172736,trial,0,0
172737,.,0,1
172738,Recovery,0,1
172739,time,0,1
172740,and,0,1
172741,quality,0,1
172742,after,0,0
172743,general,0,0
172744,anaesthesia,0,0
172745,is,0,0
172746,important,0,0
172747,for,0,0
172748,patient,0,1
172749,safety,0,1
172750,.,0,0
172751,This,0,0
172752,study,0,0
172753,aimed,0,0
172754,to,0,0
172755,determine,0,0
172756,whether,0,0
172757,intravenous,0,0
172758,lipid,0,1
172759,emulsion,0,0
172760,could,0,0
172761,improve,0,0
172762,recovery,0,1
172763,profiles,0,1
172764,from,0,0
172765,isoflurane,0,0
172766,anaesthesia,0,0
172767,in,0,0
172768,adult,0,0
172769,patients,0,0
172770,undergoing,0,0
172771,laparoscopic,0,0
172772,cholecystectomy,0,0
172773,.,0,0
172774,Sixty-six,0,0
172775,patients,0,0
172776,were,0,0
172777,enrolled,0,0
172778,.,0,0
172779,After,0,0
172780,anaesthesia,0,0
172781,induction,0,1
172782,",",0,1
172783,inspired,0,1
172784,isoflurane,0,0
172785,concentration,0,1
172786,was,0,0
172787,adjusted,0,0
172788,to,0,0
172789,maintain,0,0
172790,stable,0,1
172791,vital,0,1
172792,signs,0,1
172793,and,0,0
172794,the,0,0
172795,suitable,0,0
172796,conditions,0,0
172797,for,0,0
172798,operation,0,0
172799,.,0,0
172800,At,0,0
172801,the,0,0
172802,end,0,0
172803,of,0,0
172804,the,0,0
172805,operation,0,0
172806,",",0,0
172807,the,0,0
172808,isoflurane,0,0
172809,was,0,0
172810,discontinued,0,0
172811,",",0,0
172812,and,0,0
172813,either,0,0
172814,2,0,0
172815,ml/kg,0,0
172816,30,0,0
172817,%,0,0
172818,lipid,0,1
172819,emulsions,0,1
172820,or,0,0
172821,0.9,0,0
172822,%,0,0
172823,saline,0,0
172824,solution,0,1
172825,was,0,0
172826,administered,0,0
172827,intravenously,0,0
172828,.,0,0
172829,The,0,0
172830,time,0,1
172831,to,0,0
172832,eye,0,1
172833,opening,0,1
172834,",",0,1
172835,extubation,0,1
172836,and,0,1
172837,exit,0,1
172838,from,0,0
172839,the,0,0
172840,operation,0,0
172841,room,0,0
172842,was,0,0
172843,recorded,0,1
172844,",",0,0
172845,and,0,0
172846,the,0,0
172847,quality,0,1
172848,of,0,0
172849,recovery,0,1
172850,from,0,0
172851,anaesthesia,0,0
172852,was,0,0
172853,assessed,0,0
172854,.,0,0
172855,Sixty,0,0
172856,patients,0,0
172857,completed,0,0
172858,the,0,0
172859,study,0,0
172860,.,0,0
172861,The,0,0
172862,median,1,1
172863,time,1,1
172864,to,1,0
172865,eye,1,1
172866,opening,1,1
172867,and,1,1
172868,exit,1,1
172869,from,1,0
172870,the,1,0
172871,operation,1,0
172872,room,1,0
172873,was,0,0
172874,significantly,0,0
172875,shorter,0,0
172876,in,0,0
172877,the,0,0
172878,lipid,0,1
172879,emulsion,0,0
172880,group,0,0
172881,than,0,0
172882,in,0,0
172883,the,0,0
172884,saline,0,0
172885,group,0,0
172886,[,0,0
172887,15.5,0,0
172888,(,0,0
172889,interquartile,0,0
172890,range,0,0
172891,9.0,0,0
172892,),0,0
172893,versus,0,0
172894,20.0,0,0
172895,(,0,0
172896,10.0,0,0
172897,),0,0
172898,min.,0,0
172899,",",0,1
172900,p,0,0
172901,=,0,0
172902,0.01,0,0
172903,;,0,0
172904,19.5,0,0
172905,(,0,0
172906,8.3,0,0
172907,),0,0
172908,versus,0,0
172909,23.6,0,0
172910,(,0,0
172911,6.3,0,0
172912,),0,0
172913,min.,0,0
172914,",",0,1
172915,p,0,0
172916,=,0,0
172917,0.04,0,0
172918,",",0,0
172919,respectively,0,0
172920,],0,0
172921,",",0,0
172922,whereas,0,0
172923,the,0,0
172924,median,1,1
172925,time,1,1
172926,to,1,0
172927,extubation,1,1
172928,did,0,0
172929,not,0,0
172930,show,0,0
172931,any,0,0
172932,noticeable,0,0
172933,difference,0,0
172934,.,0,0
172935,The,0,0
172936,quality,1,1
172937,of,1,1
172938,recovery,1,1
172939,was,0,0
172940,better,0,0
172941,in,0,0
172942,the,0,0
172943,lipid,0,1
172944,emulsion,0,0
172945,group,0,0
172946,than,0,0
172947,that,0,0
172948,of,0,0
172949,the,0,0
172950,saline,0,0
172951,solution,0,0
172952,group,0,0
172953,with,0,0
172954,respect,0,0
172955,to,0,0
172956,drowsiness,0,1
172957,visual,1,1
172958,analogue,1,1
172959,scale,1,1
172960,score,1,1
172961,(,0,0
172962,p,0,0
172963,<,0,0
172964,0.01,0,0
172965,),0,0
172966,",",0,0
172967,Observer,1,1
172968,'s,1,1
172969,Assessment,1,1
172970,of,1,1
172971,Alertness/Sedation,1,1
172972,score,1,1
172973,(,0,0
172974,p,0,0
172975,<,0,0
172976,0.01,0,0
172977,),0,0
172978,",",0,0
172979,Mini-Mental,1,1
172980,State,1,1
172981,Examination,1,1
172982,score,1,1
172983,(,0,0
172984,p,0,0
172985,=,0,0
172986,0.04,0,0
172987,),0,0
172988,and,0,0
172989,Modified,1,1
172990,Aldrete,1,1
172991,Post,1,0
172992,Anaesthesia,1,1
172993,Recovery,1,1
172994,score,1,1
172995,(,0,0
172996,p,0,0
172997,=,0,0
172998,0.03,0,0
172999,),0,0
173000,.,0,0
173001,No,0,0
173002,serious,1,1
173003,adverse,1,1
173004,events,1,1
173005,were,0,0
173006,observed,0,0
173007,during,0,0
173008,the,0,0
173009,study,0,0
173010,period,0,0
173011,.,0,0
173012,In,0,0
173013,conclusion,0,0
173014,",",0,0
173015,intravenous,0,0
173016,lipid,0,1
173017,emulsion,0,0
173018,may,0,0
173019,effectively,0,0
173020,improve,0,0
173021,the,0,0
173022,recovery,1,1
173023,time,1,1
173024,and,0,1
173025,quality,0,1
173026,from,0,0
173027,isoflurane,0,0
173028,anaesthesia,0,0
173029,for,0,0
173030,laparoscopic,0,0
173031,cholecystectomy,0,0
173032,.,0,0
173033,Omitting,0,0
173034,radiotherapy,0,0
173035,in,0,0
173036,early,0,0
173037,positron,0,0
173038,emission,0,0
173039,tomography-negative,0,0
173040,stage,0,0
173041,I/II,0,1
173042,Hodgkin,0,0
173043,lymphoma,0,0
173044,is,0,0
173045,associated,0,0
173046,with,0,0
173047,an,0,0
173048,increased,0,0
173049,risk,0,0
173050,of,0,0
173051,early,0,0
173052,relapse,0,1
173053,:,0,0
173054,Clinical,0,1
173055,results,0,0
173056,of,0,0
173057,the,0,0
173058,preplanned,0,0
173059,interim,0,0
173060,analysis,0,0
173061,of,0,0
173062,the,0,0
173063,randomized,0,0
173064,EORTC/LYSA/FIL,0,0
173065,H10,0,1
173066,trial,0,0
173067,.,0,1
173068,PURPOSE,0,0
173069,Combined-modality,0,0
173070,treatment,0,0
173071,is,0,0
173072,standard,0,0
173073,treatment,0,0
173074,for,0,0
173075,patients,0,0
173076,with,0,0
173077,clinical,0,0
173078,stage,0,0
173079,I/II,0,1
173080,Hodgkin,0,1
173081,lymphoma,0,1
173082,(,0,1
173083,HL,0,1
173084,),0,0
173085,.,0,0
173086,We,0,0
173087,hypothesized,0,0
173088,that,0,0
173089,an,0,0
173090,early,0,0
173091,positron,0,0
173092,emission,0,1
173093,tomography,0,1
173094,(,0,1
173095,PET,0,1
173096,),0,0
173097,scan,0,0
173098,could,0,0
173099,be,0,0
173100,used,0,0
173101,to,0,0
173102,adapt,0,0
173103,treatment,0,0
173104,.,0,0
173105,Therefore,0,0
173106,",",0,0
173107,we,0,0
173108,started,0,0
173109,the,0,0
173110,randomized,0,0
173111,EORTC/LYSA/FIL,0,0
173112,Intergroup,0,0
173113,H10,0,1
173114,trial,0,0
173115,evaluating,0,0
173116,whether,0,0
173117,involved-node,0,0
173118,radiotherapy,0,0
173119,(,0,1
173120,IN-RT,0,0
173121,),0,0
173122,could,0,0
173123,be,0,0
173124,omitted,0,0
173125,without,0,0
173126,compromising,0,0
173127,progression-free,0,1
173128,survival,0,1
173129,in,0,0
173130,patients,0,0
173131,attaining,0,1
173132,a,0,0
173133,negative,0,1
173134,early,0,0
173135,PET,0,1
173136,scan,0,0
173137,after,0,0
173138,two,0,0
173139,cycles,0,0
173140,of,0,0
173141,ABVD,0,1
173142,(,0,1
173143,doxorubicin,0,0
173144,",",0,1
173145,bleomycin,0,0
173146,",",0,1
173147,vinblastine,0,0
173148,",",0,1
173149,and,0,1
173150,dacarbazine,0,0
173151,),0,1
173152,as,0,0
173153,compared,0,0
173154,with,0,0
173155,standard,0,0
173156,combined-modality,0,0
173157,treatment,0,0
173158,.,0,1
173159,PATIENTS,0,0
173160,AND,0,0
173161,METHODS,0,0
173162,Patients,0,0
173163,age,0,0
173164,15,0,0
173165,to,0,0
173166,70,0,0
173167,years,0,0
173168,with,0,0
173169,untreated,0,0
173170,clinical,0,0
173171,stage,0,0
173172,I/II,0,1
173173,HL,0,1
173174,were,0,0
173175,eligible,0,0
173176,.,0,0
173177,Here,0,0
173178,we,0,0
173179,report,0,0
173180,the,0,0
173181,clinical,0,0
173182,outcome,0,1
173183,of,0,0
173184,the,0,0
173185,preplanned,0,0
173186,interim,0,0
173187,futility,0,1
173188,analysis,0,0
173189,scheduled,0,0
173190,to,0,0
173191,occur,0,0
173192,after,0,0
173193,documentation,0,0
173194,of,0,0
173195,34,0,0
173196,events,0,1
173197,in,0,0
173198,the,0,0
173199,early,0,0
173200,PET-negative,0,0
173201,group,0,0
173202,.,0,0
173203,Because,0,0
173204,testing,0,0
173205,for,0,0
173206,futility,0,0
173207,in,0,0
173208,this,0,0
173209,noninferiority,0,0
173210,trial,0,0
173211,corresponds,0,0
173212,to,0,0
173213,testing,0,0
173214,the,0,0
173215,hypothesis,0,0
173216,of,0,0
173217,no,0,0
173218,difference,0,0
173219,",",0,0
173220,a,0,0
173221,one-sided,0,0
173222,superiority,0,1
173223,test,0,1
173224,was,0,0
173225,conducted,0,0
173226,.,0,0
173227,RESULTS,0,0
173228,The,0,0
173229,analysis,0,0
173230,included,0,0
173231,"1,137",0,0
173232,patients,0,0
173233,.,0,0
173234,In,0,0
173235,the,0,0
173236,favorable,0,0
173237,subgroup,0,0
173238,",",0,0
173239,85.8,0,0
173240,%,0,0
173241,had,0,0
173242,a,0,0
173243,negative,0,1
173244,early,0,0
173245,PET,0,1
173246,scan,0,0
173247,(,0,0
173248,standard,0,0
173249,arm,0,0
173250,",",0,0
173251,one,0,0
173252,event,0,0
173253,v,0,0
173254,experimental,0,0
173255,arm,0,0
173256,",",0,0
173257,nine,0,0
173258,events,0,1
173259,),0,0
173260,.,0,0
173261,In,0,0
173262,the,0,0
173263,unfavorable,0,1
173264,subgroup,0,0
173265,",",0,0
173266,74.8,0,0
173267,%,0,0
173268,had,0,0
173269,a,0,0
173270,negative,0,1
173271,early,0,0
173272,PET,0,1
173273,scan,0,0
173274,(,0,0
173275,standard,0,0
173276,arm,0,0
173277,",",0,0
173278,seven,0,0
173279,events,0,1
173280,v,0,0
173281,experimental,0,0
173282,arm,0,0
173283,",",0,0
173284,16,0,0
173285,events,0,1
173286,),0,0
173287,.,0,0
173288,The,0,0
173289,independent,0,0
173290,data,0,0
173291,monitoring,0,0
173292,committee,0,0
173293,concluded,0,0
173294,it,0,0
173295,was,0,0
173296,unlikely,0,0
173297,that,0,0
173298,we,0,0
173299,would,0,0
173300,show,0,0
173301,noninferiority,0,0
173302,in,0,0
173303,the,0,0
173304,final,0,1
173305,results,0,0
173306,for,0,0
173307,the,0,0
173308,experimental,0,0
173309,arm,0,0
173310,and,0,1
173311,advised,0,0
173312,stopping,0,1
173313,random,0,0
173314,assignment,0,0
173315,for,0,0
173316,early,0,0
173317,PET-negative,0,0
173318,patients,0,0
173319,.,0,0
173320,CONCLUSION,0,0
173321,On,0,0
173322,the,0,0
173323,basis,0,0
173324,of,0,0
173325,this,0,0
173326,analysis,0,0
173327,",",0,1
173328,combined-modality,0,0
173329,treatment,0,0
173330,resulted,0,0
173331,in,0,0
173332,fewer,0,1
173333,early,0,0
173334,progressions,0,1
173335,in,0,0
173336,clinical,1,0
173337,stage,1,0
173338,I/II,1,1
173339,HL,1,1
173340,",",0,0
173341,although,0,0
173342,early,0,1
173343,outcome,0,1
173344,was,0,0
173345,excellent,0,0
173346,in,0,0
173347,both,0,0
173348,arms,0,0
173349,.,0,0
173350,The,0,0
173351,final,0,0
173352,analysis,0,0
173353,will,0,0
173354,reveal,0,0
173355,whether,0,0
173356,this,0,0
173357,finding,0,0
173358,is,0,0
173359,maintained,0,0
173360,over,0,0
173361,time,0,1
173362,.,0,0
173363,Prophylactic,0,0
173364,vs,0,0
173365,therapeutic,0,1
173366,blood,0,1
173367,patch,0,0
173368,for,0,0
173369,obstetric,0,1
173370,patients,0,0
173371,with,0,0
173372,accidental,0,1
173373,dural,0,1
173374,puncture,0,0
173375,--,0,0
173376,a,0,0
173377,randomised,0,0
173378,controlled,0,0
173379,trial,0,0
173380,.,0,0
173381,Epidural,0,1
173382,blood,0,1
173383,patch,0,0
173384,is,0,0
173385,a,0,0
173386,standard,0,0
173387,treatment,0,0
173388,for,0,0
173389,obstetric,0,1
173390,patients,0,0
173391,experiencing,0,0
173392,a,0,0
173393,severe,0,1
173394,post-dural,0,1
173395,puncture,0,0
173396,headache,0,1
173397,.,0,0
173398,Patients,0,0
173399,who,0,0
173400,sustained,0,0
173401,an,0,0
173402,accidental,0,1
173403,dural,0,1
173404,puncture,0,0
173405,during,0,0
173406,establishment,0,0
173407,of,0,1
173408,epidural,0,0
173409,analgesia,0,1
173410,during,0,0
173411,labour,0,1
173412,or,0,0
173413,at,0,1
173414,caesarean,0,1
173415,delivery,0,1
173416,were,0,0
173417,randomly,0,0
173418,assigned,0,0
173419,to,0,0
173420,receive,0,0
173421,a,0,0
173422,prophylactic,0,0
173423,epidural,0,0
173424,blood,0,1
173425,patch,0,0
173426,or,0,1
173427,conservative,0,0
173428,treatment,0,0
173429,with,0,0
173430,a,0,0
173431,therapeutic,0,0
173432,epidural,0,0
173433,blood,0,1
173434,patch,0,0
173435,if,0,0
173436,required,0,0
173437,.,0,0
173438,Eleven,0,0
173439,of,0,0
173440,60,0,0
173441,(,0,0
173442,18.3,0,0
173443,%,0,0
173444,),0,0
173445,patients,0,0
173446,in,0,0
173447,the,0,0
173448,prophylactic,0,0
173449,epidural,0,0
173450,blood,0,1
173451,patch,0,0
173452,group,0,0
173453,developed,0,0
173454,a,0,0
173455,post-dural,1,1
173456,puncture,1,0
173457,headache,1,1
173458,compared,0,0
173459,with,0,0
173460,39,0,0
173461,of,0,0
173462,49,0,0
173463,(,0,0
173464,79.6,0,0
173465,%,0,0
173466,),0,0
173467,in,0,0
173468,the,0,0
173469,therapeutic,0,0
173470,epidural,0,0
173471,blood,0,1
173472,patch,0,0
173473,group,0,0
173474,(,0,0
173475,p,0,0
173476,<,0,0
173477,0.0001,0,0
173478,),0,0
173479,.,0,0
173480,A,0,0
173481,blood,0,1
173482,patch,0,0
173483,was,0,0
173484,performed,0,0
173485,in,0,0
173486,36,0,0
173487,(,0,0
173488,73.4,0,0
173489,%,0,0
173490,),0,0
173491,of,0,0
173492,patients,0,0
173493,in,0,0
173494,the,0,0
173495,therapeutic,0,0
173496,group,0,0
173497,.,0,0
173498,The,0,0
173499,number,1,1
173500,of,1,0
173501,patients,1,0
173502,who,1,0
173503,needed,1,0
173504,a,1,0
173505,second,1,0
173506,blood,1,1
173507,patch,1,0
173508,did,0,0
173509,not,0,0
173510,differ,0,0
173511,significantly,0,0
173512,between,0,0
173513,the,0,0
173514,two,0,0
173515,groups,0,0
173516,:,0,0
173517,6,0,0
173518,(,0,0
173519,10.0,0,0
173520,%,0,0
173521,),0,0
173522,for,0,0
173523,prophylactic,0,0
173524,epidural,0,0
173525,blood,0,1
173526,patch,0,0
173527,and,0,0
173528,4,0,0
173529,(,0,0
173530,11.1,0,0
173531,%,0,0
173532,),0,0
173533,for,0,0
173534,therapeutic,0,0
173535,epidural,0,0
173536,blood,0,1
173537,patch,0,0
173538,.,0,0
173539,We,0,0
173540,conclude,0,0
173541,that,0,0
173542,prophylactic,0,0
173543,epidural,0,0
173544,blood,0,1
173545,patch,0,0
173546,is,0,0
173547,an,0,0
173548,effective,1,0
173549,method,0,0
173550,to,0,0
173551,reduce,0,0
173552,the,0,0
173553,development,0,0
173554,of,0,0
173555,post-dural,0,1
173556,puncture,0,0
173557,headache,0,1
173558,in,0,0
173559,obstetric,0,0
173560,patients,0,0
173561,.,0,0
173562,Factors,0,1
173563,associated,0,0
173564,with,0,0
173565,low,1,0
173566,consumption,1,1
173567,of,1,1
173568,fruits,1,0
173569,and,1,1
173570,vegetables,1,0
173571,by,0,0
173572,preschoolers,0,0
173573,of,0,0
173574,low,0,0
173575,socio-economic,0,1
173576,level,0,1
173577,.,0,0
173578,OBJECTIVE,0,0
173579,To,0,0
173580,evaluate,0,0
173581,factors,0,0
173582,associated,0,0
173583,with,0,0
173584,low,0,0
173585,consumption,1,1
173586,of,1,1
173587,fruits,1,0
173588,and,1,1
173589,vegetables,1,0
173590,among,0,0
173591,preschoolers,0,0
173592,from,0,0
173593,families,0,0
173594,treated,0,0
173595,at,0,0
173596,basic,0,0
173597,health,0,1
173598,centers,0,0
173599,in,0,0
173600,Porto,0,0
173601,Alegre,0,1
173602,",",0,1
173603,RS,0,1
173604,",",0,0
173605,Brazil,0,0
173606,.,0,0
173607,METHODS,0,0
173608,This,0,0
173609,was,0,0
173610,a,0,0
173611,cohort,0,0
173612,study,0,0
173613,nested,0,0
173614,in,0,0
173615,a,0,0
173616,randomized,0,0
173617,field,0,0
173618,trial,0,0
173619,.,0,1
173620,Data,0,1
173621,collection,0,1
173622,was,0,0
173623,performed,0,0
173624,through,0,0
173625,structured,0,0
173626,questionnaires,0,0
173627,to,0,0
173628,obtain,0,0
173629,demographic,0,1
173630,and,0,1
173631,dietary,0,1
173632,data,0,0
173633,",",0,0
173634,combined,0,0
173635,with,0,0
173636,two,0,0
173637,24-hour,0,0
173638,recalls,0,0
173639,in,0,0
173640,the,0,0
173641,age,0,0
173642,groups,0,0
173643,12-16,0,0
173644,months,0,0
173645,and,0,0
173646,again,0,0
173647,at,0,0
173648,2-3,0,0
173649,years,0,0
173650,of,0,0
173651,age,0,0
173652,.,0,0
173653,Data,0,0
173654,on,0,0
173655,the,0,0
173656,consumption,1,0
173657,of,1,0
173658,one,1,0
173659,daily,1,0
173660,serving,1,0
173661,of,1,1
173662,fruits,1,0
173663,(,1,0
173664,80,1,0
173665,g,1,0
173666,),1,0
173667,and,1,1
173668,vegetables,1,0
173669,(,1,0
173670,60,1,0
173671,g,1,0
173672,),1,0
173673,were,0,0
173674,evaluated,0,0
173675,",",0,0
173676,as,0,0
173677,well,0,0
173678,as,0,0
173679,consumption,0,1
173680,of,0,0
173681,non-recommended,1,0
173682,foods,1,0
173683,such,0,0
173684,as,0,0
173685,candy,0,1
173686,",",0,1
173687,chocolate,0,1
173688,",",0,1
173689,and,0,1
173690,soft,0,0
173691,drinks,0,1
173692,.,0,0
173693,Statistical,0,0
173694,analyses,0,0
173695,were,0,0
173696,performed,0,0
173697,using,0,0
173698,Poisson,0,0
173699,regression,0,0
173700,with,0,0
173701,robust,0,0
173702,estimation,0,0
173703,.,0,0
173704,RESULTS,0,0
173705,A,0,0
173706,total,0,0
173707,of,0,0
173708,388,0,0
173709,children,0,0
173710,aged,0,0
173711,2-3,0,0
173712,years,0,0
173713,were,0,0
173714,evaluated,0,0
173715,;,0,0
173716,of,0,0
173717,these,0,0
173718,",",0,0
173719,58,0,0
173720,%,0,0
173721,and,0,0
173722,87.4,0,0
173723,%,0,0
173724,did,0,0
173725,not,0,0
173726,consume,0,0
173727,one,0,0
173728,daily,0,0
173729,serving,0,0
173730,of,0,1
173731,fruits,0,0
173732,and,0,1
173733,vegetables,0,1
173734,",",0,0
173735,respectively,0,0
173736,.,0,0
173737,The,0,0
173738,following,0,0
173739,factors,0,1
173740,were,0,0
173741,negatively,0,0
173742,associated,0,0
173743,with,0,0
173744,fruit,1,0
173745,consumption,1,1
173746,:,1,0
173747,family,1,1
173748,income,1,1
173749,higher,1,0
173750,than,1,0
173751,four,1,0
173752,minimum,1,0
173753,wages,1,1
173754,",",0,1
173755,(,0,1
173756,p=0.024,0,0
173757,),0,1
173758,",",0,0
173759,lower,1,1
173760,paternal,1,1
173761,educational,1,1
173762,level,1,1
173763,(,0,1
173764,p=0.03,0,1
173765,),0,1
173766,",",0,1
173767,and,0,1
173768,lower,1,1
173769,fruit,1,1
173770,consumption,1,1
173771,at,1,0
173772,12-16,1,0
173773,months,1,0
173774,(,0,1
173775,p=0.002,0,0
173776,),0,0
173777,.,0,0
173778,Factors,0,0
173779,negatively,0,0
173780,associated,0,0
173781,with,0,0
173782,the,0,0
173783,consumption,1,0
173784,of,1,0
173785,vegetables,1,0
173786,were,0,0
173787,low,1,0
173788,paternal,1,1
173789,educational,1,0
173790,level,1,1
173791,(,0,1
173792,p=0.033,0,0
173793,),0,1
173794,and,0,1
173795,consumption,1,1
173796,of,1,1
173797,high-sugar,1,0
173798,content,1,1
173799,beverages,1,0
173800,at,1,0
173801,12-16,1,0
173802,months,1,0
173803,(,0,1
173804,p=0.014,0,0
173805,),0,0
173806,.,0,0
173807,CONCLUSION,0,0
173808,This,0,0
173809,study,0,0
173810,demonstrated,0,0
173811,a,0,0
173812,high,0,0
173813,prevalence,0,1
173814,of,0,0
173815,children,0,0
173816,who,0,0
173817,consumed,0,0
173818,less,0,0
173819,than,0,0
173820,one,0,0
173821,daily,0,0
173822,serving,0,0
173823,of,0,1
173824,fruit,0,1
173825,and,0,0
173826,vegetables,0,0
173827,;,0,1
173828,early,1,0
173829,feeding,1,1
173830,practices,1,1
173831,",",1,1
173832,parental,1,1
173833,education,1,0
173834,",",0,1
173835,and,0,1
173836,family,1,1
173837,income,1,1
173838,were,0,0
173839,associated,0,0
173840,with,0,0
173841,this,0,0
173842,process,0,0
173843,.,0,0
173844,Left,1,1
173845,ventricular,1,1
173846,vortices,1,0
173847,as,0,0
173848,observed,0,0
173849,by,0,0
173850,vector,0,0
173851,flow,0,1
173852,mapping,0,0
173853,:,0,0
173854,main,0,1
173855,determinants,0,1
173856,and,0,0
173857,their,0,0
173858,relation,0,0
173859,to,0,0
173860,left,0,1
173861,ventricular,0,1
173862,filling,0,1
173863,.,0,0
173864,BACKGROUND,0,0
173865,Swirling,0,1
173866,flow,0,1
173867,",",0,0
173868,organized,0,0
173869,in,0,0
173870,vortices,0,0
173871,",",0,0
173872,contributes,0,0
173873,to,0,0
173874,adequate,0,0
173875,left,0,1
173876,ventricular,0,1
173877,function,0,1
173878,.,0,0
173879,In,0,0
173880,this,0,0
173881,study,0,0
173882,",",0,0
173883,we,0,0
173884,apply,0,0
173885,a,0,0
173886,novel,0,0
173887,echocardiographic,0,1
173888,flow-mapping,0,0
173889,technique,0,0
173890,",",0,1
173891,vector,0,1
173892,flow,0,1
173893,mapping,0,0
173894,(,0,1
173895,VFM,0,1
173896,),0,0
173897,",",0,0
173898,to,0,0
173899,evaluate,0,0
173900,the,0,0
173901,main,0,0
173902,characteristics,0,0
173903,of,0,0
173904,left,1,1
173905,ventricular,1,1
173906,vortices,1,1
173907,and,0,0
173908,its,0,0
173909,relation,0,1
173910,to,0,0
173911,filling,0,1
173912,parameters,0,1
173913,.,0,0
173914,METHODS,0,0
173915,Forty-eight,0,0
173916,subjects,0,0
173917,underwent,0,0
173918,conventional,0,0
173919,transthoracic,0,1
173920,echocardiographic,0,1
173921,examination,0,0
173922,with,0,0
173923,additional,0,0
173924,intracardiac,0,1
173925,flow,0,1
173926,assessment,0,0
173927,with,0,0
173928,VFM,0,1
173929,using,0,0
173930,a,0,0
173931,Aloka,0,0
173932,Alpha-10,0,0
173933,system,0,0
173934,and,0,1
173935,experimental,0,0
173936,VFM,0,1
173937,analysis,0,0
173938,software,0,0
173939,.,0,0
173940,To,0,0
173941,analyze,0,0
173942,vortex,1,1
173943,behavior,1,1
173944,",",0,0
173945,its,0,1
173946,rotation,0,1
173947,direction,0,1
173948,",",0,1
173949,duration,0,1
173950,",",0,1
173951,location,0,0
173952,inside,0,0
173953,the,0,0
173954,left,0,1
173955,ventricle,0,1
173956,",",0,1
173957,size,0,1
173958,",",0,1
173959,and,0,1
173960,intensity,0,1
173961,were,0,0
173962,assessed,0,0
173963,in,0,0
173964,apical,0,1
173965,long-axis,0,1
173966,view,0,0
173967,.,0,0
173968,Its,0,0
173969,relation,0,0
173970,to,0,0
173971,conventional,0,0
173972,left,0,1
173973,ventricular,0,1
173974,filling,0,1
173975,parameters,0,1
173976,was,0,0
173977,then,0,0
173978,analyzed,0,0
173979,.,0,0
173980,RESULTS,0,0
173981,Two,0,0
173982,vortex,1,0
173983,components,1,0
173984,were,0,0
173985,consistently,0,0
173986,identified,0,0
173987,following,0,0
173988,each,0,0
173989,transmitral,0,1
173990,filling,0,1
173991,wave,0,1
173992,.,0,0
173993,The,0,0
173994,anterior,1,1
173995,component,1,0
173996,of,1,0
173997,these,1,0
173998,visualized,1,0
173999,vortices,1,1
174000,was,0,0
174001,analyzed,0,0
174002,",",0,0
174003,due,0,0
174004,to,0,0
174005,its,0,0
174006,higher,0,0
174007,significance,0,1
174008,in,0,0
174009,the,0,0
174010,cardiac,0,1
174011,cycle,0,1
174012,",",0,0
174013,following,0,0
174014,early,0,1
174015,filling,0,1
174016,(,0,1
174017,V1,0,0
174018,),0,1
174019,and,0,1
174020,atrial,0,1
174021,contraction,0,1
174022,(,0,1
174023,V2,0,1
174024,),0,0
174025,.,0,0
174026,Differences,0,1
174027,were,0,0
174028,observed,0,0
174029,in,0,0
174030,several,0,0
174031,aspects,0,1
174032,of,0,1
174033,vortex,1,0
174034,behavior,1,1
174035,between,0,0
174036,V1,0,0
174037,and,0,1
174038,V2,0,1
174039,",",0,0
174040,particularly,0,0
174041,in,0,0
174042,patients,0,0
174043,with,0,0
174044,normal,0,0
174045,left,0,1
174046,ventricular,0,1
174047,filling,0,1
174048,parameters,0,1
174049,.,0,0
174050,These,0,0
174051,differences,0,0
174052,may,0,0
174053,be,0,0
174054,related,0,0
174055,to,0,0
174056,varying,0,0
174057,roles,0,0
174058,of,0,0
174059,vortices,1,0
174060,in,0,0
174061,different,0,0
174062,periods,0,0
174063,of,0,0
174064,the,0,0
174065,cardiac,0,1
174066,cycle,0,1
174067,.,0,0
174068,CONCLUSIONS,0,0
174069,Vector,0,0
174070,flow,0,1
174071,mapping,0,0
174072,allowed,0,0
174073,visualization,0,1
174074,and,0,1
174075,measurement,0,1
174076,of,0,1
174077,several,0,0
174078,parameters,0,1
174079,defining,0,0
174080,vortex,1,0
174081,behavior,1,1
174082,inside,0,0
174083,the,0,0
174084,cardiac,0,1
174085,cycle,0,1
174086,.,0,0
174087,The,0,0
174088,differences,0,0
174089,observed,0,0
174090,in,0,0
174091,these,0,0
174092,parameters,0,1
174093,between,0,0
174094,vortices,0,0
174095,in,0,0
174096,different,0,0
174097,phases,0,0
174098,of,0,0
174099,the,0,0
174100,cardiac,0,1
174101,cycle,0,0
174102,may,0,0
174103,be,0,0
174104,related,0,0
174105,to,0,0
174106,their,0,0
174107,role,0,0
174108,in,0,0
174109,optimizing,0,0
174110,cardiac,0,1
174111,function,0,1
174112,.,0,0
174113,Multicenter,0,0
174114,randomized,0,0
174115,phase,0,0
174116,2,0,0
174117,clinical,0,0
174118,trial,0,0
174119,of,0,0
174120,a,0,0
174121,recombinant,0,0
174122,human,0,0
174123,endostatin,0,0
174124,adenovirus,0,1
174125,in,0,0
174126,patients,0,0
174127,with,0,0
174128,advanced,0,0
174129,head,0,0
174130,and,0,1
174131,neck,0,1
174132,carcinoma,0,0
174133,.,0,0
174134,A,0,0
174135,randomized,0,0
174136,",",0,0
174137,open-label,0,0
174138,",",0,0
174139,phase,0,0
174140,2,0,0
174141,",",0,0
174142,multicenter,0,0
174143,clinical,0,1
174144,trial,0,0
174145,was,0,0
174146,conducted,0,0
174147,to,0,0
174148,evaluate,0,0
174149,the,0,0
174150,efficacy,1,1
174151,and,1,1
174152,safety,1,1
174153,of,0,0
174154,the,0,0
174155,addition,0,0
174156,of,0,0
174157,a,0,0
174158,recombinant,0,0
174159,human,0,0
174160,endostatin,0,1
174161,adenovirus,0,1
174162,(,0,1
174163,E10A,0,0
174164,),0,0
174165,to,0,0
174166,cisplatin,0,0
174167,and,0,0
174168,paclitaxel,0,0
174169,in,0,0
174170,patients,0,0
174171,with,0,0
174172,advanced,0,0
174173,head,0,0
174174,and,0,1
174175,neck,0,1
174176,squamous,0,0
174177,cell,0,1
174178,carcinoma,0,0
174179,or,0,1
174180,nasopharyngeal,0,0
174181,carcinoma,0,0
174182,.,0,0
174183,Patients,0,0
174184,with,0,0
174185,locally,0,0
174186,advanced,0,0
174187,or,0,0
174188,metastatic,0,0
174189,head,0,1
174190,and,0,1
174191,neck,0,1
174192,squamous,0,0
174193,cell,0,1
174194,carcinoma,0,0
174195,or,0,1
174196,nasopharyngeal,0,1
174197,carcinoma,0,0
174198,not,0,0
174199,suitable,0,0
174200,for,0,0
174201,operation,0,0
174202,or,0,1
174203,radiotherapy,0,0
174204,were,0,0
174205,randomly,0,0
174206,assigned,0,0
174207,to,0,0
174208,receive,0,0
174209,E10A,0,0
174210,plus,0,0
174211,chemotherapy,0,0
174212,every,0,0
174213,3,0,0
174214,weeks,0,0
174215,for,0,0
174216,a,0,0
174217,maximum,0,0
174218,of,0,0
174219,six,0,0
174220,cycles,0,0
174221,or,0,0
174222,to,0,0
174223,receive,0,0
174224,chemotherapy,0,0
174225,only,0,0
174226,.,0,0
174227,One,0,0
174228,hundred,0,0
174229,and,0,0
174230,thirty-six,0,0
174231,eligible,0,0
174232,patients,0,0
174233,were,0,0
174234,randomly,0,0
174235,assigned,0,0
174236,.,0,0
174237,The,0,0
174238,addition,0,0
174239,of,0,1
174240,E10A,0,0
174241,did,0,0
174242,not,0,0
174243,significantly,0,0
174244,improve,0,0
174245,the,0,0
174246,objective,1,0
174247,response,1,1
174248,rate,1,1
174249,(,0,0
174250,29.9,0,0
174251,versus,0,0
174252,39.7,0,0
174253,%,0,0
174254,",",0,0
174255,P,0,0
174256,=,0,0
174257,0.154,0,0
174258,),0,0
174259,.,0,0
174260,However,0,0
174261,",",0,0
174262,patients,0,0
174263,who,0,0
174264,received,0,0
174265,endostatin,0,0
174266,had,0,0
174267,longer,0,0
174268,progression-free,1,1
174269,survival,1,1
174270,(,0,0
174271,7.03,0,0
174272,versus,0,0
174273,3.60,0,0
174274,months,0,0
174275,",",0,0
174276,P,0,0
174277,=,0,0
174278,0.006,0,0
174279,;,0,0
174280,hazard,0,0
174281,ratio,0,0
174282,:,0,0
174283,0.55,0,0
174284,),0,0
174285,.,0,0
174286,The,0,0
174287,combination,0,0
174288,of,0,0
174289,E10A,0,0
174290,with,0,0
174291,chemotherapy,0,0
174292,benefited,0,0
174293,prior,0,0
174294,chemotherapy-treated,0,0
174295,patients,0,0
174296,and,0,0
174297,those,0,0
174298,who,0,0
174299,received,0,0
174300,three,0,0
174301,to,0,0
174302,four,0,0
174303,treatment,0,0
174304,cycles,0,0
174305,(,0,0
174306,6.50,0,0
174307,versus,0,0
174308,3.43,0,0
174309,months,0,0
174310,",",0,0
174311,P,0,0
174312,=,0,0
174313,0.003,0,0
174314,;,0,0
174315,8.27,0,0
174316,versus,0,0
174317,4.27,0,0
174318,months,0,0
174319,",",0,0
174320,P,0,0
174321,=,0,0
174322,0.018,0,0
174323,;,0,0
174324,respectively,0,0
174325,),0,0
174326,.,0,0
174327,The,0,0
174328,overall,1,1
174329,disease,1,1
174330,control,1,0
174331,rate,1,1
174332,significantly,0,0
174333,increased,0,0
174334,from,0,0
174335,80.6,0,0
174336,%,0,0
174337,in,0,0
174338,the,0,0
174339,control,0,0
174340,group,0,0
174341,to,0,0
174342,92.6,0,0
174343,%,0,0
174344,in,0,0
174345,the,0,0
174346,test,0,1
174347,group,0,0
174348,(,0,1
174349,P,0,0
174350,=,0,0
174351,0.034,0,0
174352,),0,0
174353,.,0,0
174354,Except,0,0
174355,for,0,0
174356,fever,1,1
174357,",",1,0
174358,no,1,0
174359,adverse,1,1
174360,events,1,1
174361,were,0,0
174362,associated,0,0
174363,with,0,0
174364,the,0,0
174365,E10A,0,0
174366,treatment,0,0
174367,.,0,0
174368,In,0,0
174369,summary,0,0
174370,",",0,1
174371,E10A,0,1
174372,plus,0,0
174373,chemotherapy,0,0
174374,is,0,0
174375,a,0,0
174376,safe,1,1
174377,and,1,0
174378,effective,1,1
174379,therapeutic,1,1
174380,approach,1,0
174381,in,0,0
174382,patients,0,0
174383,with,0,0
174384,advanced,0,0
174385,head,0,0
174386,and,0,1
174387,neck,0,1
174388,squamous,0,0
174389,cell,0,1
174390,carcinoma,0,0
174391,or,0,1
174392,nasopharyngeal,0,0
174393,carcinoma,0,0
174394,.,0,0
174395,[,0,0
174396,Encephalopathy,0,1
174397,therapeutic,0,1
174398,tongue,0,1
174399,acupoint,0,0
174400,apparatus,0,0
174401,(,0,1
174402,ETTAA,0,1
174403,),0,0
174404,for,0,0
174405,42,0,0
174406,cases,0,0
174407,of,0,0
174408,autism,0,0
174409,],0,0
174410,.,0,0
174411,OBJECTIVE,0,0
174412,To,0,0
174413,observe,0,0
174414,the,0,0
174415,efficacy,1,1
174416,of,0,0
174417,encephalopathy,0,1
174418,therapeutic,0,1
174419,tongue,0,1
174420,acupoint,0,0
174421,apparatus,0,0
174422,(,0,1
174423,ETTAA,0,1
174424,),0,0
174425,in,0,0
174426,the,0,0
174427,treatment,0,0
174428,of,0,0
174429,autism,0,0
174430,.,0,0
174431,METHODS,0,0
174432,Eighty-four,0,0
174433,children,0,0
174434,of,0,1
174435,autism,0,0
174436,were,0,0
174437,randomly,0,0
174438,divided,0,0
174439,into,0,0
174440,a,0,0
174441,tongue,0,1
174442,acupuncture,0,0
174443,group,0,0
174444,(,0,1
174445,group,0,0
174446,A,0,0
174447,),0,0
174448,and,0,0
174449,a,0,0
174450,conventional,0,0
174451,training,0,0
174452,group,0,0
174453,(,0,1
174454,group,0,0
174455,B,0,1
174456,),0,0
174457,",",0,0
174458,42,0,0
174459,cases,0,0
174460,in,0,0
174461,each,0,0
174462,group,0,0
174463,.,0,0
174464,The,0,0
174465,behavior,0,1
174466,training,0,0
174467,and,0,1
174468,sensory,0,1
174469,integration,0,1
174470,training,0,0
174471,were,0,0
174472,carried,0,0
174473,out,0,0
174474,in,0,0
174475,group,0,0
174476,B,0,0
174477,and,0,0
174478,the,0,0
174479,ETTAA,0,1
174480,was,0,0
174481,added,0,0
174482,in,0,0
174483,group,0,0
174484,A,0,0
174485,.,0,0
174486,The,0,0
174487,apparatus,0,0
174488,was,0,0
174489,switched,0,0
174490,on,0,0
174491,for,0,0
174492,20,0,0
174493,min,0,0
174494,every,0,0
174495,time,0,1
174496,and,0,0
174497,3,0,0
174498,times,0,0
174499,a,0,0
174500,day,0,0
174501,.,0,0
174502,Treatment,0,0
174503,of,0,0
174504,two,0,0
174505,months,0,0
174506,were,0,0
174507,carried,0,0
174508,out,0,0
174509,in,0,0
174510,both,0,0
174511,groups,0,0
174512,.,0,0
174513,The,0,0
174514,score,1,1
174515,of,1,1
174516,childhood,1,1
174517,autism,1,0
174518,rating,1,1
174519,scale,1,1
174520,(,1,1
174521,CARS,1,1
174522,),1,1
174523,and,0,1
174524,clinical,1,1
174525,efficacy,1,1
174526,in,0,0
174527,both,0,0
174528,groups,0,0
174529,were,0,0
174530,observed,0,0
174531,before,0,0
174532,and,0,0
174533,after,0,0
174534,treatment,0,0
174535,.,0,0
174536,RESULTS,0,0
174537,After,0,0
174538,treatment,0,0
174539,",",0,0
174540,the,0,0
174541,CARS,1,0
174542,in,0,0
174543,both,0,0
174544,groups,0,0
174545,were,0,0
174546,significantly,0,0
174547,reduced,0,0
174548,(,0,0
174549,42.39,0,0
174550,+/-,0,0
174551,6.86,0,0
174552,vs,0,0
174553,32.15,0,0
174554,+/-,0,0
174555,5.12,0,0
174556,",",0,0
174557,P,0,0
174558,<,0,0
174559,0.001,0,0
174560,;,0,0
174561,44.58,0,0
174562,+/-,0,0
174563,6.76,0,0
174564,vs,0,0
174565,39.72,0,0
174566,+/-,0,0
174567,7.11,0,0
174568,",",0,0
174569,P,0,0
174570,<,0,0
174571,0.05,0,0
174572,),0,0
174573,",",0,0
174574,which,0,0
174575,was,0,0
174576,more,0,0
174577,significant,0,0
174578,in,0,0
174579,group,0,0
174580,A,0,0
174581,(,0,0
174582,P,0,0
174583,<,0,0
174584,0.01,0,0
174585,),0,0
174586,.,0,0
174587,The,0,0
174588,totally,1,0
174589,effective,1,0
174590,rate,1,1
174591,in,0,0
174592,group,0,0
174593,A,0,0
174594,[,0,0
174595,90.5,0,0
174596,%,0,0
174597,(,0,0
174598,38/42,0,0
174599,),0,0
174600,],0,0
174601,was,0,0
174602,superior,0,0
174603,to,0,0
174604,that,0,0
174605,in,0,0
174606,group,0,0
174607,B,0,0
174608,[,0,0
174609,66.7,0,0
174610,%,0,0
174611,(,0,0
174612,28/42,0,0
174613,),0,0
174614,",",0,0
174615,P,0,0
174616,<,0,0
174617,0.01,0,0
174618,],0,0
174619,.,0,0
174620,CONCLUSION,0,0
174621,The,0,0
174622,clinical,1,0
174623,efficacy,1,1
174624,in,0,0
174625,tongue,0,1
174626,acupuncture,0,0
174627,group,0,0
174628,is,0,0
174629,apparently,0,0
174630,superior,0,0
174631,to,0,0
174632,that,0,0
174633,in,0,0
174634,conventional,0,0
174635,training,0,0
174636,group,0,0
174637,",",0,1
174638,ETTAA,0,1
174639,combined,0,0
174640,with,0,0
174641,conventional,0,0
174642,training,0,0
174643,have,0,0
174644,a,0,0
174645,better,0,0
174646,curative,1,1
174647,effect,1,1
174648,in,0,0
174649,the,0,0
174650,treatment,0,0
174651,of,0,0
174652,autism,0,0
174653,.,0,0
174654,Aspirin,0,0
174655,in,0,0
174656,patients,0,0
174657,undergoing,0,0
174658,noncardiac,0,1
174659,surgery,0,0
174660,.,0,0
174661,BACKGROUND,0,0
174662,There,0,0
174663,is,0,0
174664,substantial,0,0
174665,variability,0,1
174666,in,0,0
174667,the,0,0
174668,perioperative,0,1
174669,administration,0,0
174670,of,0,0
174671,aspirin,0,0
174672,in,0,0
174673,patients,0,0
174674,undergoing,0,0
174675,noncardiac,0,1
174676,surgery,0,0
174677,",",0,0
174678,both,0,0
174679,among,0,0
174680,patients,0,0
174681,who,0,0
174682,are,0,0
174683,already,0,0
174684,on,0,0
174685,an,0,0
174686,aspirin,0,0
174687,regimen,0,0
174688,and,0,0
174689,among,0,0
174690,those,0,0
174691,who,0,0
174692,are,0,0
174693,not,0,0
174694,.,0,0
174695,METHODS,0,0
174696,Using,0,0
174697,a,0,0
174698,2-by-2,0,0
174699,factorial,0,0
174700,trial,0,0
174701,design,0,0
174702,",",0,0
174703,we,0,0
174704,randomly,0,0
174705,assigned,0,0
174706,"10,010",0,0
174707,patients,0,0
174708,who,0,0
174709,were,0,0
174710,preparing,0,0
174711,to,0,0
174712,undergo,0,0
174713,noncardiac,0,1
174714,surgery,0,0
174715,and,0,1
174716,were,0,0
174717,at,0,0
174718,risk,0,1
174719,for,0,0
174720,vascular,0,1
174721,complications,0,1
174722,to,0,0
174723,receive,0,0
174724,aspirin,0,0
174725,or,0,1
174726,placebo,0,0
174727,and,0,1
174728,clonidine,0,0
174729,or,0,1
174730,placebo,0,0
174731,.,0,0
174732,The,0,0
174733,results,0,0
174734,of,0,0
174735,the,0,0
174736,aspirin,0,0
174737,trial,0,0
174738,are,0,0
174739,reported,0,0
174740,here,0,0
174741,.,0,0
174742,The,0,0
174743,patients,0,0
174744,were,0,0
174745,stratified,0,0
174746,according,0,0
174747,to,0,0
174748,whether,0,0
174749,they,0,0
174750,had,0,0
174751,not,0,0
174752,been,0,0
174753,taking,0,0
174754,aspirin,0,0
174755,before,0,0
174756,the,0,0
174757,study,0,0
174758,(,0,0
174759,initiation,0,1
174760,stratum,0,1
174761,",",0,0
174762,with,0,0
174763,5628,0,0
174764,patients,0,0
174765,),0,0
174766,or,0,0
174767,they,0,0
174768,were,0,0
174769,already,0,0
174770,on,0,0
174771,an,0,0
174772,aspirin,0,0
174773,regimen,0,0
174774,(,0,0
174775,continuation,0,1
174776,stratum,0,1
174777,",",0,0
174778,with,0,0
174779,4382,0,0
174780,patients,0,0
174781,),0,0
174782,.,0,0
174783,Patients,0,0
174784,started,0,0
174785,taking,0,0
174786,aspirin,0,0
174787,(,0,0
174788,at,0,0
174789,a,0,0
174790,dose,0,0
174791,of,0,0
174792,200,0,0
174793,mg,0,0
174794,),0,0
174795,or,0,0
174796,placebo,0,0
174797,just,0,0
174798,before,0,0
174799,surgery,0,0
174800,and,0,0
174801,continued,0,0
174802,it,0,0
174803,daily,0,0
174804,(,0,0
174805,at,0,0
174806,a,0,0
174807,dose,0,0
174808,of,0,0
174809,100,0,0
174810,mg,0,0
174811,),0,0
174812,for,0,0
174813,30,0,0
174814,days,0,0
174815,in,0,0
174816,the,0,0
174817,initiation,0,0
174818,stratum,0,1
174819,and,0,0
174820,for,0,0
174821,7,0,0
174822,days,0,0
174823,in,0,0
174824,the,0,0
174825,continuation,0,0
174826,stratum,0,1
174827,",",0,0
174828,after,0,0
174829,which,0,0
174830,patients,0,0
174831,resumed,0,0
174832,their,0,0
174833,regular,0,0
174834,aspirin,0,0
174835,regimen,0,0
174836,.,0,0
174837,The,0,0
174838,primary,0,0
174839,outcome,0,1
174840,was,0,0
174841,a,0,0
174842,composite,1,1
174843,of,1,0
174844,death,1,1
174845,or,1,0
174846,nonfatal,1,1
174847,myocardial,1,1
174848,infarction,1,1
174849,at,1,0
174850,30,1,0
174851,days,1,0
174852,.,1,0
174853,RESULTS,0,0
174854,The,0,0
174855,primary,1,0
174856,outcome,1,1
174857,occurred,0,0
174858,in,0,0
174859,351,0,0
174860,of,0,0
174861,4998,0,0
174862,patients,0,0
174863,(,0,0
174864,7.0,0,0
174865,%,0,0
174866,),0,0
174867,in,0,0
174868,the,0,0
174869,aspirin,0,0
174870,group,0,0
174871,and,0,0
174872,in,0,0
174873,355,0,0
174874,of,0,0
174875,5012,0,0
174876,patients,0,0
174877,(,0,0
174878,7.1,0,0
174879,%,0,0
174880,),0,0
174881,in,0,0
174882,the,0,0
174883,placebo,0,0
174884,group,0,0
174885,(,0,1
174886,hazard,0,1
174887,ratio,0,1
174888,in,0,0
174889,the,0,0
174890,aspirin,0,0
174891,group,0,0
174892,",",0,0
174893,0.99,0,0
174894,;,0,0
174895,95,0,0
174896,%,0,0
174897,confidence,0,0
174898,interval,0,0
174899,[,0,0
174900,CI,0,0
174901,],0,0
174902,",",0,0
174903,0.86,0,0
174904,to,0,0
174905,1.15,0,0
174906,;,0,0
174907,P=0.92,0,0
174908,),0,0
174909,.,0,0
174910,Major,1,1
174911,bleeding,1,1
174912,was,0,0
174913,more,0,0
174914,common,0,0
174915,in,0,0
174916,the,0,0
174917,aspirin,0,0
174918,group,0,0
174919,than,0,0
174920,in,0,0
174921,the,0,0
174922,placebo,0,0
174923,group,0,0
174924,(,0,0
174925,230,0,0
174926,patients,0,0
174927,[,0,0
174928,4.6,0,0
174929,%,0,0
174930,],0,0
174931,vs.,0,0
174932,188,0,0
174933,patients,0,0
174934,[,0,0
174935,3.8,0,0
174936,%,0,0
174937,],0,0
174938,;,0,1
174939,hazard,0,1
174940,ratio,0,1
174941,",",0,0
174942,1.23,0,0
174943,;,0,0
174944,95,0,0
174945,%,0,0
174946,CI,0,0
174947,",",0,0
174948,1.01,0,0
174949,",",0,0
174950,to,0,0
174951,1.49,0,0
174952,;,0,0
174953,P=0.04,0,0
174954,),0,0
174955,.,0,0
174956,The,0,0
174957,primary,0,0
174958,and,0,1
174959,secondary,0,1
174960,outcome,0,1
174961,results,0,0
174962,were,0,0
174963,similar,0,0
174964,in,0,0
174965,the,0,0
174966,two,0,0
174967,aspirin,0,0
174968,strata,0,0
174969,.,0,0
174970,CONCLUSIONS,0,0
174971,Administration,0,1
174972,of,0,1
174973,aspirin,0,0
174974,before,0,0
174975,surgery,0,0
174976,and,0,0
174977,throughout,0,0
174978,the,0,0
174979,early,0,0
174980,postsurgical,0,1
174981,period,0,0
174982,had,0,0
174983,no,0,0
174984,significant,0,0
174985,effect,0,0
174986,on,0,0
174987,the,0,0
174988,rate,1,1
174989,of,1,0
174990,a,1,0
174991,composite,1,1
174992,of,1,1
174993,death,1,1
174994,or,1,0
174995,nonfatal,1,1
174996,myocardial,1,1
174997,infarction,1,1
174998,but,0,0
174999,increased,0,0
175000,the,0,0
175001,risk,1,1
175002,of,1,0
175003,major,1,1
175004,bleeding,1,1
175005,.,1,1
175006,(,0,0
175007,Funded,0,0
175008,by,0,0
175009,the,0,0
175010,Canadian,0,0
175011,Institutes,0,0
175012,of,0,0
175013,Health,0,1
175014,Research,0,1
175015,and,0,0
175016,others,0,0
175017,;,0,1
175018,POISE-2,0,0
175019,ClinicalTrials.gov,0,0
175020,number,0,1
175021,",",0,0
175022,NCT01082874,0,0
175023,.,0,0
175024,),0,0
175025,.,0,0
175026,Interview,0,0
175027,skills,0,1
175028,for,0,0
175029,adults,0,0
175030,with,0,0
175031,autism,0,0
175032,spectrum,0,0
175033,disorder,0,0
175034,:,0,0
175035,a,0,0
175036,pilot,0,0
175037,randomized,0,0
175038,controlled,0,0
175039,trial,0,0
175040,.,0,0
175041,The,0,0
175042,purpose,0,0
175043,of,0,0
175044,this,0,0
175045,pilot,0,0
175046,study,0,0
175047,was,0,0
175048,to,0,0
175049,evaluate,0,0
175050,the,0,0
175051,efficacy,0,1
175052,of,0,0
175053,the,0,0
175054,interview,0,0
175055,skills,0,1
175056,curriculum,0,0
175057,(,0,1
175058,ISC,0,1
175059,),0,0
175060,",",0,0
175061,a,0,0
175062,manualized,0,0
175063,12-week,0,0
175064,group-delivered,0,0
175065,intervention,0,0
175066,for,0,0
175067,young,0,0
175068,adults,0,0
175069,with,0,0
175070,autism,0,0
175071,spectrum,0,1
175072,disorder,0,0
175073,(,0,1
175074,ASD,0,0
175075,),0,0
175076,.,0,0
175077,This,0,0
175078,intervention,0,0
175079,aims,0,0
175080,to,0,0
175081,increase,0,0
175082,social-pragmatic,0,1
175083,skills,0,1
175084,essential,0,0
175085,to,0,0
175086,a,0,0
175087,successful,0,0
175088,job,0,1
175089,interview,0,0
175090,.,0,1
175091,Twenty-eight,0,0
175092,adults,0,0
175093,(,0,0
175094,18-36,0,0
175095,years,0,0
175096,),0,0
175097,were,0,0
175098,randomly,0,0
175099,assigned,0,0
175100,to,0,0
175101,one,0,0
175102,of,0,0
175103,two,0,0
175104,groups,0,0
175105,:,0,0
175106,ISC,0,0
175107,or,0,0
175108,waitlist,0,0
175109,control,0,0
175110,.,0,1
175111,Results,0,0
175112,revealed,0,0
175113,that,0,0
175114,the,0,0
175115,experimental,0,0
175116,group,0,0
175117,showed,0,0
175118,larger,0,0
175119,gains,0,1
175120,in,0,0
175121,social-pragmatic,1,1
175122,skills,1,1
175123,observed,0,0
175124,during,0,0
175125,a,0,0
175126,mock,0,0
175127,job,0,1
175128,interview,0,0
175129,than,0,0
175130,the,0,0
175131,control,0,0
175132,group,0,0
175133,.,0,1
175134,Treatment,0,0
175135,effects,0,1
175136,on,0,0
175137,distal,0,1
175138,outcomes,0,1
175139,",",0,0
175140,including,0,0
175141,social,1,1
175142,adaptive,1,1
175143,behaviors,1,1
175144,and,1,1
175145,depressive,1,1
175146,symptoms,1,1
175147,were,0,0
175148,not,0,0
175149,significant,0,0
175150,",",0,0
175151,although,0,0
175152,the,0,0
175153,respective,0,0
175154,effect,0,1
175155,sizes,0,1
175156,were,0,0
175157,medium/large,0,0
175158,.,0,0
175159,Results,0,0
175160,indicate,0,0
175161,that,0,0
175162,a,0,0
175163,brief,0,0
175164,",",0,0
175165,low-intensity,0,0
175166,treatment,0,0
175167,can,0,0
175168,improve,0,0
175169,the,0,0
175170,job-interview,1,0
175171,performance,1,1
175172,of,0,1
175173,young,0,0
175174,adults,0,0
175175,with,0,0
175176,ASD,0,0
175177,.,0,0
175178,Triple,0,0
175179,combination,0,0
175180,as,0,0
175181,adjuvant,0,0
175182,to,0,0
175183,cryotherapy,0,0
175184,in,0,0
175185,the,0,0
175186,treatment,1,0
175187,of,1,0
175188,solar,1,0
175189,lentigines,1,0
175190,:,1,0
175191,investigator-blinded,0,0
175192,",",0,0
175193,randomized,0,0
175194,clinical,0,0
175195,trial,0,0
175196,.,0,0
175197,BACKGROUND,0,0
175198,Post-inflammatory,0,0
175199,hyperpigmentation,1,0
175200,is,0,0
175201,a,0,0
175202,frequent,0,1
175203,concern,0,0
175204,when,0,0
175205,treating,0,0
175206,solar,1,0
175207,lentigines,1,0
175208,.,1,0
175209,OBJECTIVES,0,0
175210,To,0,0
175211,assess,0,0
175212,the,0,0
175213,safety,1,1
175214,and,1,1
175215,efficacy,1,1
175216,of,0,0
175217,a,0,0
175218,triple,0,0
175219,combination,0,0
175220,cream,0,0
175221,with,0,0
175222,fluocinolone,0,0
175223,acetonide,0,0
175224,0.01,0,0
175225,%,0,0
175226,",",0,0
175227,hydroquinone,0,0
175228,4,0,0
175229,%,0,0
175230,and,0,0
175231,tretinoin,0,0
175232,0.05,0,0
175233,%,0,0
175234,as,0,0
175235,adjuvant,0,0
175236,to,0,0
175237,cryotherapy,0,0
175238,in,0,0
175239,the,0,0
175240,treatment,1,0
175241,of,1,0
175242,solar,1,0
175243,lentigines,1,0
175244,in,0,0
175245,hands,0,1
175246,dorsum,0,1
175247,",",0,0
175248,and,0,0
175249,in,0,0
175250,the,0,0
175251,prevention,1,0
175252,of,1,0
175253,post-inflammatory,1,0
175254,hyperpigmentation,1,1
175255,after,0,0
175256,cryotherapy,0,0
175257,.,0,0
175258,METHODS,0,0
175259,This,0,0
175260,prospective,0,0
175261,",",0,0
175262,randomized,0,0
175263,",",0,0
175264,controlled,0,0
175265,",",0,0
175266,investigator-blinded,0,0
175267,",",0,1
175268,single-centre,0,0
175269,study,0,0
175270,enrolled,0,0
175271,50,0,0
175272,patients,0,0
175273,.,0,0
175274,Twenty-five,0,0
175275,patients,0,0
175276,received,0,0
175277,a,0,0
175278,2-week,0,0
175279,daily,0,0
175280,triple,0,0
175281,combination,0,0
175282,cream,0,0
175283,plus,0,0
175284,sunscreen,0,1
175285,pre-treatment,0,0
175286,and,0,0
175287,25,0,0
175288,received,0,0
175289,sunscreen,0,0
175290,alone,0,0
175291,.,0,0
175292,After,0,0
175293,that,0,0
175294,",",0,0
175295,cryotherapy,0,0
175296,was,0,0
175297,performed,0,0
175298,in,0,0
175299,all,0,0
175300,patients,0,0
175301,followed,0,0
175302,by,0,0
175303,a,0,0
175304,3-week,0,0
175305,recovery,0,1
175306,period,0,0
175307,.,0,0
175308,After,0,0
175309,this,0,0
175310,period,0,0
175311,",",0,0
175312,patients,0,0
175313,received,0,0
175314,the,0,0
175315,same,0,0
175316,initial,0,0
175317,treatment,0,0
175318,and,0,1
175319,were,0,0
175320,followed,0,0
175321,up,0,0
175322,for,0,0
175323,8,0,0
175324,weeks,0,0
175325,.,0,0
175326,Melanin,1,1
175327,and,1,1
175328,erythema,1,1
175329,levels,1,1
175330,of,0,0
175331,a,0,0
175332,target,0,0
175333,and,0,0
175334,a,0,0
175335,control,0,0
175336,lentigo,0,0
175337,were,0,0
175338,objectively,0,1
175339,measured,0,0
175340,using,0,0
175341,a,0,0
175342,narrowband,0,0
175343,reflectance,0,1
175344,spectrophotometer,0,0
175345,.,0,1
175346,Lentigines,1,1
175347,count,1,1
175348,",",1,0
175349,colour,1,1
175350,homogeneity,1,1
175351,and,1,1
175352,global,1,1
175353,improvement,1,1
175354,were,0,0
175355,also,0,0
175356,assessed,0,0
175357,.,0,0
175358,RESULTS,0,0
175359,The,1,0
175360,number,1,1
175361,of,1,0
175362,solar,1,0
175363,lentigines,1,0
175364,reduced,0,0
175365,in,0,0
175366,the,0,0
175367,first,0,0
175368,2,0,0
175369,weeks,0,0
175370,only,0,0
175371,in,0,0
175372,patients,0,0
175373,who,0,0
175374,used,0,0
175375,the,0,0
175376,triple,0,0
175377,combination,0,0
175378,25,0,0
175379,?,0,0
175380,7,0,0
175381,vs.,0,0
175382,22,0,0
175383,?,0,0
175384,8,0,0
175385,(,0,0
175386,P,0,0
175387,<,0,0
175388,0.0001,0,0
175389,),0,0
175390,",",0,0
175391,and,0,1
175392,reduced,0,1
175393,at,0,0
175394,the,0,0
175395,end,0,0
175396,of,0,0
175397,the,0,0
175398,study,0,0
175399,for,0,0
175400,both,0,0
175401,groups,0,0
175402,(,0,0
175403,P,0,0
175404,<,0,0
175405,0.0001,1,0
175406,),1,0
175407,.,1,0
175408,The,1,0
175409,melanin,1,1
175410,levels,1,1
175411,also,1,0
175412,reduced,0,0
175413,in,0,0
175414,the,0,0
175415,first,0,0
175416,2,0,0
175417,weeks,0,0
175418,only,0,0
175419,in,0,0
175420,patients,0,0
175421,who,0,0
175422,used,0,0
175423,the,0,0
175424,triple,0,0
175425,combination,0,0
175426,297,0,0
175427,?,0,0
175428,69,0,0
175429,vs.,0,0
175430,273,0,0
175431,?,0,0
175432,66,0,0
175433,(,0,0
175434,P,0,0
175435,<,0,0
175436,0.0001,0,0
175437,),0,0
175438,and,0,0
175439,reduced,0,0
175440,at,0,0
175441,the,0,0
175442,end,0,0
175443,of,0,0
175444,the,0,0
175445,study,0,0
175446,for,0,0
175447,both,0,0
175448,groups,0,0
175449,(,0,0
175450,P,0,0
175451,<,0,0
175452,0.0001,0,0
175453,),0,0
175454,.,0,0
175455,Erythema,1,1
175456,and,1,1
175457,residual,1,1
175458,blisters,1,1
175459,from,1,0
175460,cryotherapy,1,0
175461,were,1,0
175462,the,0,0
175463,reported,1,0
175464,adverse,1,1
175465,reactions,1,1
175466,.,1,0
175467,CONCLUSION,1,0
175468,Triple,0,0
175469,combination,0,0
175470,cream,0,0
175471,can,0,0
175472,be,0,0
175473,used,0,0
175474,to,0,0
175475,enhance,0,0
175476,the,0,0
175477,resolution,1,1
175478,of,1,0
175479,solar,1,0
175480,lentigines,1,0
175481,",",1,0
175482,and,1,1
175483,to,0,0
175484,significantly,0,0
175485,reduce,0,0
175486,melanin,1,1
175487,levels,1,1
175488,and,1,1
175489,lentigines,1,1
175490,count,1,1
175491,",",1,0
175492,improving,1,1
175493,treatment,1,0
175494,results,1,0
175495,.,1,0
175496,It,1,0
175497,was,1,0
175498,well-tolerated,1,0
175499,and,0,1
175500,did,0,0
175501,not,0,0
175502,increase,0,0
175503,the,0,0
175504,occurrence,0,0
175505,of,0,0
175506,neither,1,1
175507,erythema,1,1
175508,nor,1,0
175509,other,1,0
175510,side-effects,1,1
175511,after,0,0
175512,the,0,0
175513,cryotherapy,0,0
175514,.,0,0
175515,A,0,0
175516,prospective,0,0
175517,",",0,0
175518,randomized,0,0
175519,controlled,0,0
175520,trial,0,0
175521,of,0,0
175522,single-incision,0,0
175523,laparoscopic,0,0
175524,vs,0,0
175525,conventional,0,0
175526,3-port,0,0
175527,laparoscopic,0,0
175528,appendectomy,0,0
175529,for,0,0
175530,treatment,0,0
175531,of,0,1
175532,acute,0,0
175533,appendicitis,0,0
175534,.,0,0
175535,BACKGROUND,0,0
175536,Proponents,0,0
175537,of,0,0
175538,single-incision,0,0
175539,laparoscopic,0,0
175540,surgery,0,0
175541,(,0,1
175542,SILS,0,1
175543,),0,1
175544,claim,0,0
175545,patients,0,0
175546,have,0,0
175547,less,0,0
175548,pain,0,1
175549,",",0,1
175550,faster,0,1
175551,recovery,0,1
175552,",",0,1
175553,and,0,1
175554,better,0,1
175555,long-term,0,1
175556,cosmetic,0,1
175557,results,0,0
175558,than,0,0
175559,patients,0,0
175560,who,0,0
175561,undergo,0,0
175562,multiport,0,0
175563,laparoscopy,0,0
175564,.,0,0
175565,However,0,0
175566,",",0,0
175567,randomized,0,0
175568,comparisons,0,0
175569,are,0,0
175570,lacking,0,0
175571,.,0,0
175572,This,0,0
175573,study,0,0
175574,presents,0,0
175575,the,0,0
175576,results,0,0
175577,of,0,0
175578,a,0,0
175579,prospective,0,0
175580,randomized,0,0
175581,trial,0,0
175582,of,0,0
175583,SILS,0,1
175584,or,0,1
175585,3-port,0,0
175586,laparoscopic,0,0
175587,appendectomy,0,0
175588,.,0,1
175589,STUDY,0,0
175590,DESIGN,0,0
175591,Adults,0,0
175592,with,0,0
175593,uncomplicated,0,0
175594,acute,0,0
175595,appendicitis,0,1
175596,were,0,0
175597,randomized,0,0
175598,1:1,0,0
175599,to,0,0
175600,either,0,0
175601,SILS,0,1
175602,or,0,0
175603,3-port,0,0
175604,laparoscopic,0,0
175605,appendectomy,0,0
175606,.,0,0
175607,The,0,0
175608,primary,0,0
175609,end,0,0
175610,point,0,0
175611,was,0,0
175612,early,1,0
175613,postoperative,1,1
175614,pain,1,1
175615,(,0,0
175616,measured,0,1
175617,by,0,0
175618,opiate,0,0
175619,usage,0,1
175620,and,0,1
175621,pain,0,1
175622,score,0,1
175623,in,0,0
175624,the,0,0
175625,first,0,0
175626,12,0,0
175627,hours,0,0
175628,),0,0
175629,.,0,0
175630,Secondary,0,0
175631,end,0,0
175632,points,0,0
175633,were,0,0
175634,operative,1,1
175635,time,1,1
175636,",",1,1
175637,complication,1,1
175638,rate,1,1
175639,(,1,0
175640,including,1,0
175641,conversions,1,1
175642,),1,1
175643,",",1,0
175644,and,1,1
175645,recovery,1,1
175646,time,1,1
175647,(,1,0
175648,days,1,0
175649,of,1,1
175650,oral,1,0
175651,opiate,1,0
175652,usage,1,1
175653,and,1,1
175654,return,1,1
175655,to,1,0
175656,work,1,0
175657,),1,0
175658,.,0,0
175659,After,0,0
175660,6,0,0
175661,months,0,0
175662,",",0,0
175663,body,1,1
175664,image,1,1
175665,and,0,1
175666,cosmetic,1,1
175667,appearance,1,1
175668,were,0,0
175669,assessed,0,0
175670,using,0,0
175671,a,0,0
175672,validated,0,0
175673,survey,0,0
175674,.,0,0
175675,RESULTS,0,0
175676,The,0,0
175677,trial,0,0
175678,was,0,0
175679,planned,0,0
175680,for,0,0
175681,150,0,0
175682,patients,0,0
175683,",",0,0
175684,but,0,0
175685,was,0,0
175686,halted,0,0
175687,after,0,0
175688,75,0,0
175689,patients,0,0
175690,when,0,0
175691,planned,0,0
175692,interim,0,0
175693,analysis,0,0
175694,showed,0,0
175695,that,0,0
175696,SILS,0,1
175697,patients,0,0
175698,had,0,0
175699,more,0,0
175700,postoperative,1,1
175701,pain,1,1
175702,(,0,1
175703,pain,0,1
175704,score,0,1
175705,:,0,0
175706,4.4,0,0
175707,?,0,0
175708,1.6,0,0
175709,vs,0,0
175710,3.5,0,0
175711,?,0,0
175712,1.5,0,0
175713,;,0,0
175714,p,0,0
175715,=,0,0
175716,0.01,0,0
175717,),0,0
175718,and,0,0
175719,higher,1,1
175720,inpatient,1,1
175721,opiate,1,1
175722,usage,1,1
175723,(,1,1
175724,hydromorphone,0,0
175725,use,0,0
175726,:,0,0
175727,3.9,0,0
175728,?,0,0
175729,1.9,0,0
175730,mg,0,0
175731,vs,0,0
175732,2.8,0,0
175733,?,0,0
175734,1.7,0,0
175735,mg,0,0
175736,;,0,0
175737,p,0,0
175738,=,0,0
175739,0.01,0,0
175740,),0,0
175741,than,0,0
175742,3-port,0,0
175743,laparoscopy,1,0
175744,.,1,1
175745,Operative,1,1
175746,time,1,1
175747,for,1,0
175748,SILS,0,1
175749,averaged,0,0
175750,40,0,0
175751,%,0,0
175752,longer,0,0
175753,(,0,0
175754,54,0,0
175755,?,0,0
175756,17,0,0
175757,minutes,0,0
175758,vs,0,0
175759,38,0,0
175760,?,0,0
175761,11,0,0
175762,minutes,0,0
175763,;,0,0
175764,p,0,0
175765,<,0,0
175766,0.01,0,0
175767,),0,0
175768,.,0,0
175769,Only,0,0
175770,1,0,0
175771,SILS,1,0
175772,case,1,0
175773,was,0,0
175774,converted,0,0
175775,to,0,0
175776,3-port,0,0
175777,.,0,0
175778,There,0,0
175779,were,0,0
175780,no,0,0
175781,significant,0,0
175782,differences,1,0
175783,in,1,0
175784,length,1,1
175785,of,1,1
175786,stay,1,1
175787,",",1,1
175788,complications,1,1
175789,",",1,1
175790,oral,1,0
175791,pain,1,1
175792,medication,1,1
175793,usage,1,1
175794,after,1,0
175795,discharge,1,1
175796,",",1,0
175797,or,1,0
175798,return,1,1
175799,to,1,0
175800,work,1,0
175801,.,1,0
175802,After,0,0
175803,6,0,0
175804,months,0,0
175805,",",0,0
175806,body,0,1
175807,image,0,1
175808,and,0,1
175809,cosmetic,0,1
175810,appearance,0,1
175811,were,0,0
175812,excellent,0,0
175813,for,0,0
175814,both,0,0
175815,groups,0,0
175816,and,0,1
175817,indistinguishable,0,0
175818,by,0,0
175819,most,0,0
175820,measures,0,0
175821,.,0,0
175822,However,0,0
175823,",",0,0
175824,3-port,0,0
175825,patients,0,0
175826,reported,0,0
175827,better,0,0
175828,physical,1,1
175829,attractiveness,1,1
175830,(,1,0
175831,4.0,1,0
175832,?,0,0
175833,0.4,0,0
175834,vs,0,0
175835,3.8,0,0
175836,?,0,0
175837,0.4,0,0
175838,;,0,0
175839,p,0,0
175840,=,0,0
175841,0.04,0,0
175842,),0,0
175843,and,0,0
175844,SILS,0,1
175845,patients,0,0
175846,reported,0,0
175847,better,1,0
175848,scars,1,1
175849,(,1,0
175850,score,0,1
175851,18.4,0,0
175852,?,0,0
175853,2.7,0,0
175854,vs,0,0
175855,16.4,0,0
175856,?,0,0
175857,3.0,0,0
175858,;,0,0
175859,p,0,0
175860,<,0,0
175861,0.01,0,0
175862,),0,0
175863,.,0,0
175864,Results,0,0
175865,are,0,0
175866,reported,0,0
175867,as,0,0
175868,mean,0,1
175869,?,0,0
175870,SD,0,0
175871,.,0,0
175872,CONCLUSIONS,0,0
175873,Single-incision,0,0
175874,laparoscopic,0,0
175875,surgery,0,0
175876,appendectomy,0,0
175877,resulted,0,0
175878,in,0,0
175879,more,1,0
175880,pain,1,1
175881,and,0,0
175882,longer,0,1
175883,operative,1,1
175884,times,1,1
175885,without,1,0
175886,improving,0,1
175887,short-term,0,1
175888,recovery,0,1
175889,or,0,0
175890,complications,0,1
175891,.,0,1
175892,Long-term,0,0
175893,body,0,1
175894,image,0,1
175895,and,0,1
175896,cosmetic,0,1
175897,appearance,0,1
175898,were,0,0
175899,excellent,0,0
175900,in,0,0
175901,both,0,0
175902,groups,0,0
175903,.,0,0
175904,A,0,0
175905,randomized,0,0
175906,controlled,0,0
175907,trial,0,0
175908,of,0,0
175909,an,0,0
175910,inference,0,0
175911,generation,0,1
175912,strategy,0,0
175913,intervention,0,0
175914,for,0,0
175915,adults,0,0
175916,with,0,0
175917,high-functioning,0,0
175918,autism,0,0
175919,spectrum,0,0
175920,disorder,0,0
175921,.,0,0
175922,PURPOSE,0,0
175923,The,0,0
175924,present,0,0
175925,intervention,0,0
175926,study,0,0
175927,investigated,0,0
175928,the,0,0
175929,efficacy,0,1
175930,of,0,0
175931,the,0,0
175932,ACT,0,0
175933,&,0,0
175934,Check,0,1
175935,Strategy,0,0
175936,intervention,0,0
175937,to,0,0
175938,improve,0,0
175939,inference,1,0
175940,generation,1,1
175941,when,1,0
175942,reading,1,0
175943,",",1,1
175944,metacognitive,1,1
175945,ability,1,1
175946,",",1,1
175947,general,1,1
175948,reading,1,1
175949,comprehension,1,1
175950,",",1,1
175951,and,1,1
175952,social,1,1
175953,inference,1,0
175954,ability,1,1
175955,in,0,0
175956,adults,0,0
175957,with,0,0
175958,high-functioning,0,0
175959,autism,0,0
175960,spectrum,0,1
175961,disorder,0,0
175962,(,0,1
175963,HF-ASD,0,0
175964,),0,0
175965,.,0,0
175966,METHOD,0,0
175967,Twenty-five,0,0
175968,adults,0,0
175969,with,0,0
175970,HF-ASD,0,0
175971,were,0,0
175972,randomly,0,0
175973,assigned,0,0
175974,to,0,0
175975,either,0,0
175976,a,0,0
175977,treatment,0,0
175978,or,0,0
175979,a,0,0
175980,control,0,0
175981,group,0,0
175982,.,0,1
175983,Treatment,0,0
175984,sessions,0,0
175985,were,0,0
175986,conducted,0,0
175987,in,0,0
175988,1-hr,0,0
175989,sessions,0,0
175990,",",0,0
175991,twice,0,0
175992,a,0,0
175993,week,0,0
175994,",",0,0
175995,for,0,0
175996,a,0,0
175997,total,0,0
175998,of,0,0
175999,6,0,0
176000,weeks,0,0
176001,.,0,0
176002,Treatment,0,0
176003,focused,0,0
176004,on,0,0
176005,explicit,0,1
176006,instruction,0,0
176007,of,0,0
176008,components,0,1
176009,of,0,1
176010,inference,0,0
176011,generation,0,1
176012,",",0,1
176013,categories,0,1
176014,of,0,1
176015,inferences,0,0
176016,",",0,1
176017,and,0,1
176018,increasingly,0,0
176019,independent,0,0
176020,strategy,0,0
176021,use,0,0
176022,.,0,0
176023,RESULTS,0,0
176024,The,0,0
176025,treatment,0,0
176026,group,0,0
176027,demonstrated,0,0
176028,significantly,0,0
176029,superior,1,0
176030,performance,1,1
176031,on,1,0
176032,1,1,0
176033,of,1,0
176034,2,1,0
176035,measures,1,0
176036,of,1,0
176037,inference,1,0
176038,generation,1,1
176039,in,1,0
176040,reading,1,0
176041,and,1,0
176042,1,1,0
176043,measure,1,0
176044,of,1,0
176045,metacognitive,1,1
176046,ability,1,1
176047,compared,0,0
176048,with,0,0
176049,the,0,0
176050,control,0,0
176051,group,0,0
176052,.,0,1
176053,Significant,0,1
176054,differences,0,0
176055,between,0,0
176056,groups,0,0
176057,were,0,0
176058,not,0,0
176059,found,0,0
176060,on,0,0
176061,measures,1,0
176062,of,1,0
176063,reading,1,0
176064,comprehension,1,1
176065,or,1,1
176066,social,1,1
176067,inference,1,0
176068,ability,1,1
176069,.,1,0
176070,CONCLUSION,0,0
176071,These,0,0
176072,findings,0,0
176073,suggest,0,0
176074,that,0,0
176075,the,0,0
176076,ACT,0,0
176077,&,0,0
176078,Check,0,1
176079,Strategy,0,1
176080,was,0,0
176081,effective,0,1
176082,in,0,0
176083,improving,0,0
176084,participants,1,0
176085,',1,1
176086,ability,1,1
176087,to,1,0
176088,generate,1,0
176089,inferences,1,0
176090,in,1,0
176091,reading,1,0
176092,and,1,1
176093,certain,1,0
176094,metacognitive,1,1
176095,abilities,1,1
176096,",",0,0
176097,but,0,0
176098,the,0,0
176099,skills,0,1
176100,do,0,0
176101,not,0,0
176102,appear,0,0
176103,to,0,0
176104,generalize,0,0
176105,to,0,0
176106,other,0,0
176107,social,0,1
176108,communication,0,1
176109,contexts,0,0
176110,",",0,0
176111,such,0,0
176112,as,0,0
176113,social,1,1
176114,inference,1,0
176115,generation,1,1
176116,.,1,0
176117,This,0,0
176118,research,0,0
176119,provides,0,0
176120,a,0,0
176121,measure,0,0
176122,of,0,0
176123,support,0,0
176124,for,0,0
176125,explicitly,0,0
176126,teaching,0,0
176127,inference,0,0
176128,generation,0,1
176129,to,0,0
176130,address,0,0
176131,a,0,0
176132,reading,1,0
176133,inference,1,0
176134,deficit,1,1
176135,in,0,0
176136,adults,0,0
176137,with,0,0
176138,HF-ASD,0,0
176139,.,0,0
176140,An,0,0
176141,oxytocin-induced,0,1
176142,facilitation,0,1
176143,of,0,1
176144,neural,1,0
176145,and,1,1
176146,emotional,1,1
176147,responses,1,1
176148,to,1,0
176149,social,1,1
176150,touch,1,1
176151,correlates,0,0
176152,inversely,0,0
176153,with,0,0
176154,autism,0,0
176155,traits,0,0
176156,.,0,1
176157,Social,0,1
176158,communication,0,1
176159,through,0,0
176160,touch,0,1
176161,and,0,1
176162,mutual,0,1
176163,grooming,0,1
176164,can,0,0
176165,convey,0,0
176166,highly,0,0
176167,salient,0,0
176168,socio-emotional,0,1
176169,signals,0,0
176170,and,0,0
176171,has,0,0
176172,been,0,0
176173,shown,0,0
176174,to,0,0
176175,involve,0,0
176176,the,0,0
176177,neuropeptide,0,0
176178,oxytocin,0,1
176179,(,0,1
176180,OXT,0,1
176181,),0,0
176182,in,0,0
176183,several,0,0
176184,species,0,0
176185,.,0,0
176186,Less,0,1
176187,is,0,0
176188,known,0,0
176189,about,0,0
176190,the,0,0
176191,modulatory,0,1
176192,influence,0,0
176193,of,0,1
176194,OXT,0,0
176195,on,0,0
176196,the,0,0
176197,neural,0,0
176198,and,0,0
176199,emotional,0,1
176200,responses,0,1
176201,to,0,0
176202,human,0,0
176203,interpersonal,0,0
176204,touch,0,1
176205,.,0,0
176206,The,0,0
176207,present,0,0
176208,randomized,0,0
176209,placebo,0,0
176210,(,0,0
176211,PLC,0,1
176212,),0,1
176213,-controlled,0,0
176214,within-subject,0,0
176215,pharmaco-functional,0,0
176216,magnetic,0,0
176217,resonance,0,0
176218,imaging,0,1
176219,(,0,1
176220,fMRI,0,1
176221,),0,1
176222,study,0,0
176223,was,0,0
176224,designed,0,0
176225,to,0,0
176226,test,0,0
176227,the,0,0
176228,hypothesis,0,0
176229,that,0,0
176230,a,0,0
176231,single,0,0
176232,intranasal,0,0
176233,dose,0,0
176234,of,0,1
176235,synthetic,0,1
176236,OXT,0,0
176237,(,0,0
176238,24,0,0
176239,IU,0,0
176240,),0,0
176241,would,0,0
176242,facilitate,0,0
176243,both,0,0
176244,neural,0,0
176245,and,0,0
176246,emotional,0,1
176247,responses,0,1
176248,to,0,0
176249,interpersonal,0,0
176250,touch,0,1
176251,in,0,0
176252,a,0,0
176253,context-,0,0
176254,(,0,0
176255,female,0,0
176256,vs,0,0
176257,male,0,0
176258,touch,0,1
176259,),0,1
176260,and,0,1
176261,trait-,0,1
176262,(,0,1
176263,autistic,0,1
176264,trait,0,1
176265,load,0,1
176266,),0,1
176267,specific,0,0
176268,manner,0,0
176269,.,0,0
176270,Specifically,0,0
176271,",",0,0
176272,the,0,0
176273,experimental,0,0
176274,rationale,0,0
176275,was,0,0
176276,to,0,0
176277,manipulate,0,0
176278,the,0,0
176279,reward,0,1
176280,value,0,1
176281,of,0,1
176282,interpersonal,0,1
176283,touch,0,1
176284,independent,0,0
176285,of,0,0
176286,the,0,0
176287,intensity,0,1
176288,and,0,1
176289,type,0,0
176290,of,0,1
176291,actual,0,1
176292,cutaneous,0,1
176293,stimulation,0,1
176294,administered,0,0
176295,.,0,0
176296,Thus,0,0
176297,",",0,0
176298,40,0,0
176299,heterosexual,0,0
176300,males,0,0
176301,believed,0,0
176302,that,0,0
176303,they,0,0
176304,were,0,0
176305,touched,0,0
176306,by,0,0
176307,either,0,0
176308,a,0,0
176309,man,0,0
176310,or,0,0
176311,a,0,0
176312,woman,0,0
176313,",",0,0
176314,although,0,0
176315,in,0,0
176316,fact,0,0
176317,an,0,0
176318,identical,0,0
176319,pattern,0,0
176320,of,0,1
176321,touch,0,1
176322,was,0,0
176323,always,0,0
176324,given,0,0
176325,by,0,0
176326,the,0,0
176327,same,0,0
176328,female,0,0
176329,experimenter,0,0
176330,blind,0,0
176331,to,0,0
176332,condition,0,0
176333,type,0,0
176334,.,0,0
176335,Our,0,0
176336,results,0,0
176337,show,0,0
176338,that,0,0
176339,OXT,0,0
176340,increased,0,0
176341,the,1,0
176342,perceived,1,1
176343,pleasantness,1,1
176344,of,1,1
176345,female,0,0
176346,",",0,0
176347,but,0,0
176348,not,1,0
176349,male,1,0
176350,touch,1,1
176351,",",1,1
176352,and,1,1
176353,associated,1,0
176354,neural,1,0
176355,responses,1,1
176356,in,1,0
176357,insula,1,1
176358,",",1,1
176359,precuneus,1,1
176360,",",1,1
176361,orbitofrontal,1,1
176362,",",1,1
176363,and,1,1
176364,pregenual,1,1
176365,anterior,1,1
176366,cingulate,1,1
176367,cortex,1,1
176368,.,1,0
176369,Moreover,0,0
176370,",",0,0
176371,the,1,0
176372,behavioral,1,1
176373,and,1,0
176374,neural,1,0
176375,effects,1,1
176376,of,1,1
176377,OXT,1,1
176378,were,1,0
176379,negatively,0,0
176380,correlated,0,0
176381,with,0,0
176382,autistic-like,0,0
176383,traits,0,0
176384,.,0,0
176385,Taken,0,0
176386,together,0,0
176387,",",0,0
176388,this,0,0
176389,is,0,0
176390,the,0,0
176391,first,0,0
176392,study,0,0
176393,to,0,0
176394,show,0,0
176395,that,0,0
176396,the,0,0
176397,perceived,0,1
176398,hedonic,0,1
176399,value,0,1
176400,of,0,1
176401,human,0,0
176402,heterosexual,0,0
176403,interpersonal,0,0
176404,touch,0,0
176405,is,0,0
176406,facilitated,0,0
176407,by,0,0
176408,OXT,0,0
176409,in,0,0
176410,men,0,0
176411,",",0,1
176412,but,0,0
176413,that,0,0
176414,its,1,0
176415,behavioral,1,1
176416,and,1,1
176417,neural,1,0
176418,effects,1,1
176419,in,1,0
176420,this,0,0
176421,context,0,0
176422,are,0,0
176423,blunted,0,0
176424,in,0,0
176425,individuals,0,0
176426,with,0,0
176427,autistic,0,0
176428,traits,0,0
176429,.,0,0
176430,Classification,0,1
176431,of,0,1
176432,motor,1,1
176433,imagery,1,0
176434,performance,1,1
176435,in,0,0
176436,acute,0,0
176437,stroke,0,1
176438,.,0,0
176439,OBJECTIVE,0,1
176440,Effective,1,1
176441,motor,1,1
176442,imagery,1,0
176443,performance,1,1
176444,",",0,1
176445,seen,0,0
176446,as,0,0
176447,strong,0,0
176448,suppression,0,1
176449,of,0,0
176450,the,0,0
176451,sensorimotor,0,1
176452,rhythm,0,1
176453,",",0,0
176454,is,0,0
176455,the,0,0
176456,key,0,1
176457,element,0,0
176458,in,0,0
176459,motor,0,1
176460,imagery,0,0
176461,therapy,0,0
176462,.,0,0
176463,Therefore,0,0
176464,",",0,0
176465,optimization,0,1
176466,of,0,0
176467,methods,0,0
176468,to,0,0
176469,classify,0,0
176470,whether,0,0
176471,the,0,0
176472,subject,0,0
176473,is,0,0
176474,performing,0,0
176475,the,0,0
176476,imagery,0,0
176477,task,0,0
176478,is,0,0
176479,a,0,0
176480,prerequisite,0,0
176481,.,0,0
176482,An,0,0
176483,optimal,0,1
176484,classification,0,1
176485,method,0,0
176486,should,0,0
176487,have,0,0
176488,high,0,0
176489,performance,0,1
176490,accuracy,0,1
176491,and,0,1
176492,use,0,0
176493,a,0,0
176494,small,0,0
176495,number,0,1
176496,of,0,0
176497,channels,0,0
176498,.,0,0
176499,We,0,0
176500,investigated,0,0
176501,the,0,0
176502,additional,0,0
176503,benefit,0,0
176504,of,0,0
176505,the,0,0
176506,common,0,0
176507,spatial,0,1
176508,pattern,0,1
176509,filtering,0,1
176510,(,0,1
176511,CSP,0,0
176512,),0,0
176513,to,0,0
176514,a,0,0
176515,linear,0,0
176516,discriminant,0,1
176517,analysis,0,0
176518,(,0,1
176519,LDA,0,1
176520,),0,1
176521,classifier,0,0
176522,",",0,0
176523,for,0,0
176524,different,0,0
176525,channel,0,0
176526,configurations,0,0
176527,.,0,0
176528,METHODS,0,0
176529,Ten,0,0
176530,hemispheric,0,1
176531,acute,0,0
176532,stroke,0,1
176533,patients,0,0
176534,and,0,0
176535,11,0,0
176536,healthy,0,0
176537,subjects,0,0
176538,were,0,0
176539,included,0,0
176540,.,0,0
176541,EEGs,0,0
176542,were,0,0
176543,recorded,0,0
176544,using,0,0
176545,60,0,0
176546,channels,0,0
176547,.,0,0
176548,The,0,0
176549,classifier,0,0
176550,was,0,0
176551,trained,0,0
176552,with,0,0
176553,a,0,0
176554,motor,0,1
176555,execution,0,1
176556,task,0,1
176557,.,0,0
176558,For,0,0
176559,both,0,0
176560,healthy,0,0
176561,controls,0,0
176562,and,0,1
176563,patients,0,0
176564,",",0,1
176565,analysis,0,0
176566,of,0,1
176567,recordings,0,1
176568,was,0,0
176569,initially,0,0
176570,limited,0,0
176571,to,0,0
176572,3,0,0
176573,and,0,0
176574,11,0,0
176575,electrodes,0,0
176576,recording,0,0
176577,from,0,0
176578,the,0,0
176579,motor,0,1
176580,cortex,0,1
176581,area,0,1
176582,",",0,1
176583,and,0,1
176584,later,0,1
176585,repeated,0,0
176586,using,0,0
176587,45,0,0
176588,electrodes,0,0
176589,.,0,0
176590,RESULTS,0,0
176591,No,0,1
176592,significant,0,0
176593,improvement,0,1
176594,on,0,0
176595,the,0,0
176596,addition,0,0
176597,of,0,0
176598,CSP,0,0
176599,to,0,0
176600,LDA,1,1
176601,was,0,0
176602,found,0,0
176603,(,0,0
176604,in,0,0
176605,both,0,0
176606,cases,0,0
176607,",",0,0
176608,the,0,0
176609,area,1,1
176610,under,1,0
176611,the,1,0
176612,receiving,1,0
176613,operating,1,1
176614,characteristic,1,1
176615,(,1,0
176616,AU-ROC,1,0
176617,),1,0
176618,?,0,0
176619,0.70,0,0
176620,(,0,0
176621,acceptable,0,0
176622,),0,0
176623,),0,0
176624,.,0,0
176625,We,0,0
176626,then,0,0
176627,repeated,0,0
176628,the,0,0
176629,LDA+CSP,0,1
176630,method,0,0
176631,on,0,0
176632,recordings,0,0
176633,of,0,0
176634,45,0,0
176635,electrodes,0,0
176636,",",0,0
176637,since,0,0
176638,the,0,0
176639,use,0,0
176640,of,0,0
176641,imagery,0,0
176642,neuronal,0,1
176643,circuits,0,1
176644,may,0,0
176645,well,0,0
176646,extend,0,0
176647,beyond,0,0
176648,the,0,0
176649,motor,0,1
176650,area,1,1
176651,.,1,1
176652,AU-ROC,1,0
176653,rose,1,0
176654,to,0,0
176655,0.90,0,0
176656,",",0,0
176657,but,0,0
176658,no,0,0
176659,virtual,1,1
176660,'most,1,0
176661,responsible,1,0
176662,',1,1
176663,electrode,1,1
176664,was,1,0
176665,observed,0,0
176666,.,0,0
176667,Finally,0,0
176668,",",0,0
176669,in,0,0
176670,mild-to-moderate,0,0
176671,stroke,0,1
176672,patients,0,0
176673,we,0,0
176674,could,0,0
176675,successfully,0,0
176676,use,0,0
176677,the,1,0
176678,EEG,1,0
176679,data,1,0
176680,recorded,1,0
176681,from,0,0
176682,the,0,0
176683,healthy,0,0
176684,hemisphere,0,0
176685,to,0,0
176686,train,0,0
176687,the,0,0
176688,classifier,0,0
176689,(,0,0
176690,AU-ROC,0,0
176691,?,0,0
176692,0.70,0,0
176693,),0,0
176694,.,0,0
176695,SIGNIFICANCE,0,0
176696,Including,0,0
176697,only,0,0
176698,the,0,0
176699,channels,0,0
176700,on,0,0
176701,the,0,0
176702,unaffected,0,0
176703,motor,0,1
176704,cortex,0,1
176705,is,0,0
176706,sufficient,0,0
176707,to,0,0
176708,train,0,0
176709,a,0,0
176710,classifier,0,0
176711,.,0,0
176712,LNH-84,0,0
176713,regimen,0,0
176714,:,0,0
176715,a,0,0
176716,multicenter,0,0
176717,study,0,0
176718,of,0,1
176719,intensive,0,0
176720,chemotherapy,0,0
176721,in,0,0
176722,737,0,0
176723,patients,0,0
176724,with,0,0
176725,aggressive,0,1
176726,malignant,0,0
176727,lymphoma,0,0
176728,.,0,0
176729,From,0,0
176730,July,0,0
176731,1984,0,0
176732,to,0,0
176733,September,0,0
176734,1987,0,0
176735,",",0,0
176736,737,0,0
176737,patients,0,0
176738,with,0,0
176739,aggressive,0,1
176740,malignant,0,1
176741,lymphoma,0,1
176742,(,0,1
176743,ML,0,1
176744,),0,1
176745,were,0,0
176746,treated,0,0
176747,by,0,0
176748,an,0,0
176749,intensive,0,0
176750,regimen,0,0
176751,(,0,0
176752,LNH-84,0,0
176753,),0,0
176754,comprising,0,0
176755,three,0,0
176756,or,0,0
176757,four,0,0
176758,courses,0,0
176759,of,0,0
176760,doxorubicin,0,0
176761,",",0,0
176762,75,0,0
176763,mg/m2,0,0
176764,;,0,0
176765,cyclophosphamide,0,0
176766,",",0,0
176767,"1,200",0,0
176768,mg/m2,0,0
176769,;,0,0
176770,vindesine,0,0
176771,",",0,0
176772,2,0,0
176773,mg/m2,0,0
176774,x,0,0
176775,2,0,0
176776,;,0,0
176777,bleomycin,0,0
176778,",",0,0
176779,10,0,0
176780,mg,0,0
176781,x,0,0
176782,2,0,0
176783,;,0,0
176784,and,0,0
176785,prednisolone,0,0
176786,",",0,0
176787,60,0,0
176788,mg/m2,0,0
176789,x,0,0
176790,5,0,0
176791,(,0,0
176792,ACVB,0,0
176793,),0,1
176794,",",0,0
176795,consolidation,0,1
176796,with,0,0
176797,high-dose,0,0
176798,methotrexate,0,0
176799,",",0,1
176800,ifosfamide,0,0
176801,",",0,1
176802,etoposide,0,0
176803,",",0,0
176804,asparaginase,0,0
176805,",",0,1
176806,and,0,1
176807,cytarabine,0,0
176808,",",0,1
176809,and,0,0
176810,a,0,0
176811,randomized,0,0
176812,late,0,1
176813,intensification,0,0
176814,with,0,0
176815,two,0,0
176816,courses,0,0
176817,of,0,0
176818,cytarabine,0,0
176819,",",0,1
176820,cyclophosphamide,0,0
176821,",",0,1
176822,teniposide,0,0
176823,",",0,1
176824,bleomycin,0,1
176825,",",0,1
176826,and,0,1
176827,prednisone,0,0
176828,(,0,1
176829,AraCVmB,0,0
176830,),0,0
176831,.,0,0
176832,Four,0,1
176833,hundred,0,0
176834,forty-two,0,0
176835,patients,0,0
176836,had,0,0
176837,intermediate-grade,0,1
176838,ML,0,1
176839,",",0,0
176840,221,0,0
176841,highgrade,0,0
176842,ML,0,0
176843,",",0,0
176844,and,0,0
176845,74,0,0
176846,unclassified,0,0
176847,ML,0,0
176848,.,0,0
176849,Most,0,0
176850,of,0,0
176851,the,0,0
176852,patients,0,0
176853,had,0,0
176854,advanced,0,0
176855,disease,0,1
176856,:,0,0
176857,stage,0,0
176858,IIE,0,1
176859,(,0,0
176860,23,0,0
176861,%,0,0
176862,),0,0
176863,",",0,1
176864,III,0,1
176865,(,0,0
176866,13,0,0
176867,%,0,0
176868,),0,0
176869,",",0,1
176870,or,0,1
176871,IV,0,1
176872,(,0,0
176873,47,0,0
176874,%,0,0
176875,),0,0
176876,;,0,0
176877,38,0,0
176878,%,0,0
176879,disseminated,0,0
176880,nodes,0,0
176881,;,0,0
176882,38,0,0
176883,%,0,0
176884,two,0,0
176885,or,0,0
176886,more,0,0
176887,extranodal,0,1
176888,sites,0,0
176889,;,0,0
176890,and,0,0
176891,41,0,0
176892,%,0,0
176893,a,0,0
176894,tumoral,0,0
176895,mass,0,1
176896,greater,0,0
176897,than,0,0
176898,10,0,0
176899,cm,0,0
176900,.,0,0
176901,Five,0,1
176902,hundred,0,0
176903,fifty-three,0,0
176904,patients,0,0
176905,(,0,0
176906,75,0,0
176907,%,0,0
176908,),0,0
176909,went,0,0
176910,into,0,0
176911,complete,1,1
176912,remission,1,1
176913,(,1,1
176914,CR,1,1
176915,),1,0
176916,",",0,0
176917,63,0,0
176918,(,0,0
176919,9,0,0
176920,%,0,0
176921,),0,0
176922,into,0,0
176923,partial,1,1
176924,remission,1,1
176925,",",0,0
176926,62,0,0
176927,(,0,0
176928,8,0,0
176929,%,0,0
176930,),0,0
176931,failed,1,0
176932,to,1,0
176933,respond,1,0
176934,",",0,0
176935,and,0,0
176936,59,0,0
176937,(,0,0
176938,8,0,0
176939,%,0,0
176940,),0,0
176941,died,1,1
176942,during,0,0
176943,ACVB,0,0
176944,courses,0,0
176945,",",0,0
176946,17,0,0
176947,of,0,0
176948,them,0,0
176949,from,0,0
176950,progression,0,1
176951,of,0,0
176952,the,0,0
176953,disease,0,0
176954,.,0,0
176955,With,0,0
176956,a,0,0
176957,median,0,1
176958,follow-up,0,0
176959,of,0,0
176960,23,0,0
176961,months,0,0
176962,",",0,0
176963,the,0,0
176964,estimated,0,0
176965,2-year,0,0
176966,overall,1,1
176967,survival,1,1
176968,time,1,1
176969,to,1,0
176970,failure,1,1
176971,(,1,1
176972,TTF,1,1
176973,),1,1
176974,",",0,1
176975,and,0,1
176976,time,1,1
176977,to,1,0
176978,relapse,1,1
176979,(,1,0
176980,TTR,1,1
176981,),1,0
176982,survival,1,1
176983,are,0,0
176984,67,0,0
176985,%,0,0
176986,",",0,0
176987,56,0,0
176988,%,0,0
176989,",",0,0
176990,and,0,0
176991,67,0,0
176992,%,0,0
176993,",",0,0
176994,respectively,0,0
176995,.,0,0
176996,Patients,0,0
176997,receiving,0,0
176998,a,0,0
176999,late,0,1
177000,intensification,0,0
177001,had,0,0
177002,the,0,0
177003,same,0,0
177004,relapse,1,1
177005,rate,1,1
177006,as,0,0
177007,the,0,0
177008,other,0,0
177009,patients,0,0
177010,.,0,0
177011,A,0,0
177012,persistent,1,0
177013,fibronecrotic,1,1
177014,mass,1,1
177015,was,0,0
177016,found,0,0
177017,in,0,0
177018,150,0,0
177019,patients,0,0
177020,(,0,0
177021,20,0,0
177022,%,0,0
177023,),0,0
177024,and,0,1
177025,did,0,0
177026,not,0,0
177027,influence,0,0
177028,the,0,0
177029,relapse,1,1
177030,rate,1,1
177031,.,1,1
177032,Toxicity,1,1
177033,was,0,0
177034,mainly,0,0
177035,neutropenia,1,1
177036,and,0,1
177037,infection,1,1
177038,during,0,0
177039,the,0,0
177040,ACVB,0,0
177041,courses,0,0
177042,",",0,0
177043,with,0,0
177044,40,0,0
177045,patients,0,0
177046,(,0,0
177047,5,0,0
177048,%,0,0
177049,),0,0
177050,dying,1,1
177051,from,1,0
177052,septic,1,1
177053,complications,1,1
177054,while,0,0
177055,responding,0,0
177056,to,0,0
177057,treatment,0,0
177058,.,0,0
177059,Fifty-three,0,0
177060,percent,0,0
177061,of,0,0
177062,the,0,0
177063,patients,0,0
177064,had,0,0
177065,a,0,0
177066,neutropenia,1,1
177067,less,0,0
177068,than,0,0
177069,0.500,0,0
177070,x,0,0
177071,10,0,0
177072,(,0,0
177073,9,0,0
177074,),0,0
177075,/L,0,0
177076,",",0,0
177077,58,0,0
177078,%,0,0
177079,fever,0,1
177080,(,0,0
177081,6,0,0
177082,%,0,0
177083,grade,0,0
177084,4,0,0
177085,),0,0
177086,",",0,0
177087,and,0,0
177088,49,0,0
177089,%,0,0
177090,a,0,0
177091,documented,1,0
177092,infection,1,1
177093,(,0,0
177094,8,0,0
177095,%,0,0
177096,grade,0,0
177097,4,0,0
177098,),0,0
177099,.,0,0
177100,These,0,0
177101,results,0,0
177102,obtained,0,0
177103,with,0,0
177104,the,0,0
177105,LNH-84,0,0
177106,regimen,0,0
177107,demonstrate,0,0
177108,that,0,0
177109,this,0,0
177110,therapeutic,0,0
177111,scheme,0,0
177112,is,0,0
177113,an,0,0
177114,effective,0,1
177115,treatment,0,0
177116,for,0,0
177117,aggressive,0,0
177118,ML,0,0
177119,.,0,0
177120,[,0,0
177121,The,0,0
177122,effects,0,0
177123,of,0,0
177124,tirofiban,0,0
177125,on,0,0
177126,acute,0,0
177127,non-ST,0,0
177128,segment,0,1
177129,elevation,0,1
177130,myocardial,1,1
177131,infarction,1,1
177132,patients,0,0
177133,not,0,0
177134,receiving,0,0
177135,early,0,0
177136,reperfusion,0,1
177137,intervention,0,0
177138,],0,0
177139,.,0,0
177140,OBJECTIVE,0,0
177141,To,0,0
177142,study,0,0
177143,the,0,0
177144,efficacy,1,1
177145,and,1,1
177146,safety,1,1
177147,of,0,1
177148,tirofiban,0,0
177149,in,0,0
177150,patients,0,0
177151,with,0,0
177152,acute,0,0
177153,non-ST-,0,0
177154,segment,0,1
177155,elevation,0,1
177156,myocardial,0,1
177157,infarction,0,1
177158,(,0,1
177159,NSTEMI,0,0
177160,),0,0
177161,without,0,0
177162,early,0,0
177163,reperfusion,0,1
177164,intervention,0,0
177165,.,0,1
177166,METHODS,0,0
177167,A,0,0
177168,total,0,1
177169,of,0,0
177170,151,0,0
177171,NSTEMI,0,0
177172,patients,0,0
177173,without,0,0
177174,early,0,0
177175,reperfusion,0,1
177176,intervention,0,0
177177,were,0,0
177178,enrolled,0,0
177179,in,0,0
177180,the,0,0
177181,study,0,0
177182,and,0,0
177183,randomized,0,0
177184,to,0,0
177185,the,0,0
177186,tirofiban,0,0
177187,group,0,0
177188,(,0,0
177189,n,0,0
177190,=,0,0
177191,76,0,0
177192,),0,0
177193,and,0,0
177194,the,0,0
177195,control,0,0
177196,group,0,0
177197,(,0,0
177198,n,0,0
177199,=,0,0
177200,75,0,0
177201,),0,0
177202,.,0,0
177203,Coronary,0,0
177204,angiography,0,0
177205,was,0,0
177206,performed,0,0
177207,at,0,0
177208,day,0,0
177209,3,0,0
177210,and,0,0
177211,day,0,0
177212,7,0,0
177213,",",0,0
177214,while,0,0
177215,percutaneous,0,0
177216,coronary,0,1
177217,intervention,0,0
177218,(,0,1
177219,PCI,0,1
177220,),0,1
177221,was,0,0
177222,performed,0,0
177223,when,0,0
177224,necessary,0,0
177225,.,0,0
177226,Parameters,0,1
177227,including,0,0
177228,thrombolysis,1,0
177229,in,1,0
177230,myocardial,1,1
177231,infarction,1,1
177232,(,1,1
177233,TIMI,1,1
177234,),1,1
177235,flow,1,1
177236,",",1,0
177237,bleeding,1,1
177238,complications,1,1
177239,and,1,1
177240,clinic,1,1
177241,events,1,1
177242,within,0,0
177243,30,0,0
177244,days,0,0
177245,were,0,0
177246,compared,0,0
177247,between,0,0
177248,the,0,0
177249,two,0,0
177250,groups,0,0
177251,.,0,0
177252,RESULTS,0,0
177253,Before,0,0
177254,PCI,0,1
177255,",",0,0
177256,no,0,0
177257,increase,0,0
177258,in,0,0
177259,the,0,0
177260,percentage,1,1
177261,of,1,0
177262,patient,1,1
177263,with,1,0
177264,TIMI,1,0
177265,flow,1,1
177266,better,0,0
177267,than,0,0
177268,TIMI-2,0,1
177269,was,0,0
177270,observed,0,0
177271,by,0,0
177272,the,0,0
177273,treatment,0,0
177274,of,0,1
177275,tirofiban,0,0
177276,(,0,0
177277,69.3,0,0
177278,%,0,0
177279,vs,0,0
177280,78.9,0,0
177281,%,0,0
177282,",",0,0
177283,P,0,0
177284,=,0,0
177285,0.10,0,0
177286,),0,0
177287,.,0,0
177288,While,0,0
177289,after,0,0
177290,PCI,0,1
177291,",",0,1
177292,significant,0,0
177293,increase,0,1
177294,in,0,0
177295,the,0,0
177296,percentage,1,1
177297,of,1,0
177298,patient,1,1
177299,with,1,0
177300,TIMI,1,0
177301,flow,1,1
177302,better,0,0
177303,than,0,0
177304,TIMI-2,0,1
177305,was,0,0
177306,manifested,0,0
177307,in,0,0
177308,the,0,0
177309,tirofiban,0,0
177310,group,0,0
177311,(,0,0
177312,96.0,0,0
177313,%,0,0
177314,vs,0,0
177315,100.0,0,0
177316,%,0,0
177317,",",0,0
177318,P,0,0
177319,=,0,0
177320,0.04,0,0
177321,),0,0
177322,.,0,0
177323,Tirofiban,0,0
177324,treatment,0,0
177325,also,0,0
177326,significantly,0,0
177327,decreased,1,0
177328,the,1,0
177329,rate,1,1
177330,of,1,0
177331,poor,1,1
177332,myocardial,1,1
177333,perfusion,1,1
177334,after,0,0
177335,PCI,0,1
177336,(,0,0
177337,19.7,0,0
177338,%,0,0
177339,vs,0,0
177340,34.7,0,0
177341,%,0,0
177342,",",0,0
177343,P,0,0
177344,=,0,0
177345,0.04,0,0
177346,),0,0
177347,.,0,0
177348,There,0,0
177349,were,0,0
177350,0,0,0
177351,and,0,0
177352,4,0,0
177353,major,1,0
177354,adverse,1,1
177355,cardiovascular,1,1
177356,events,1,1
177357,(,1,1
177358,MACE,1,1
177359,),1,0
177360,within,0,0
177361,30,0,0
177362,days,0,0
177363,observed,0,0
177364,in,0,0
177365,the,0,0
177366,tirofiban,0,0
177367,group,0,0
177368,and,0,0
177369,the,0,0
177370,control,0,0
177371,group,0,0
177372,(,0,0
177373,0.0,0,0
177374,%,0,0
177375,vs,0,0
177376,5.3,0,0
177377,%,0,0
177378,",",0,0
177379,P,0,0
177380,=,0,0
177381,0.05,0,0
177382,),0,0
177383,.,0,0
177384,No,0,0
177385,difference,0,0
177386,between,0,0
177387,the,0,0
177388,two,0,0
177389,groups,0,0
177390,was,0,0
177391,found,0,0
177392,in,0,0
177393,the,0,0
177394,bleeding,1,1
177395,complications,1,1
177396,within,0,0
177397,30,0,0
177398,days,0,0
177399,including,0,0
177400,the,0,0
177401,mild,1,0
177402,hemorrhage,1,1
177403,(,0,0
177404,5,0,0
177405,vs,0,0
177406,4,0,0
177407,cases,0,0
177408,",",0,0
177409,P,0,0
177410,=,0,0
177411,0.75,0,0
177412,),0,0
177413,",",0,0
177414,severe,1,1
177415,hemorrhage,1,1
177416,(,0,0
177417,2,0,0
177418,vs,0,0
177419,1,0,0
177420,cases,0,0
177421,",",0,0
177422,P,0,0
177423,=,0,0
177424,0.56,0,0
177425,),0,0
177426,or,0,0
177427,severe,1,1
177428,thrombocytopenia,1,1
177429,(,0,0
177430,2,0,0
177431,vs,0,0
177432,0,0,0
177433,cases,0,0
177434,",",0,0
177435,P,0,0
177436,=,0,0
177437,0.49,0,0
177438,),0,0
177439,.,0,0
177440,CONCLUSIONS,0,0
177441,Tirofiban,0,0
177442,treatment,0,0
177443,does,0,0
177444,not,0,0
177445,increase,0,0
177446,the,0,0
177447,bleeding,1,1
177448,complications,1,1
177449,in,0,0
177450,NSTEMI,0,0
177451,patients,0,0
177452,without,0,0
177453,early,0,0
177454,PCI,0,1
177455,.,0,0
177456,Tirofiban,0,0
177457,can,0,0
177458,improve,0,0
177459,the,0,0
177460,TIMI,0,1
177461,flow,0,1
177462,and,0,0
177463,the,0,0
177464,myocardial,0,1
177465,perfusion,0,1
177466,after,0,0
177467,PCI,0,1
177468,with,0,0
177469,less,0,0
177470,MACE,0,1
177471,within,0,0
177472,30,0,0
177473,days,0,0
177474,.,0,0
177475,Virtual,0,0
177476,reality,0,1
177477,job,0,1
177478,interview,0,0
177479,training,0,0
177480,in,0,0
177481,adults,0,0
177482,with,0,0
177483,autism,0,0
177484,spectrum,0,0
177485,disorder,0,0
177486,.,0,0
177487,The,0,0
177488,feasibility,0,1
177489,and,0,1
177490,efficacy,0,1
177491,of,0,1
177492,virtual,0,0
177493,reality,0,0
177494,job,0,1
177495,interview,0,0
177496,training,0,0
177497,(,0,1
177498,VR-JIT,0,1
177499,),0,1
177500,was,0,0
177501,assessed,0,0
177502,in,0,0
177503,a,0,0
177504,single-blinded,0,0
177505,randomized,0,0
177506,controlled,0,0
177507,trial,0,0
177508,.,0,0
177509,Adults,0,0
177510,with,0,0
177511,autism,0,0
177512,spectrum,0,0
177513,disorder,0,0
177514,were,0,0
177515,randomized,0,0
177516,to,0,0
177517,VR-JIT,0,0
177518,(,0,0
177519,n,0,0
177520,=,0,0
177521,16,0,0
177522,),0,0
177523,or,0,0
177524,treatment-as-usual,0,0
177525,(,0,1
177526,TAU,0,1
177527,),0,1
177528,(,0,0
177529,n,0,0
177530,=,0,0
177531,10,0,0
177532,),0,0
177533,groups,0,0
177534,.,0,1
177535,VR-JIT,0,1
177536,consisted,0,0
177537,of,0,0
177538,simulated,0,1
177539,job,0,1
177540,interviews,0,0
177541,with,0,0
177542,a,0,0
177543,virtual,0,0
177544,character,0,0
177545,and,0,1
177546,didactic,0,0
177547,training,0,0
177548,.,0,1
177549,Participants,0,0
177550,attended,0,0
177551,90,0,0
177552,%,0,0
177553,of,0,0
177554,laboratory-based,0,1
177555,training,0,0
177556,sessions,0,0
177557,",",0,1
177558,found,0,0
177559,VR-JIT,0,1
177560,easy,1,1
177561,to,1,0
177562,use,1,0
177563,and,0,1
177564,enjoyable,1,1
177565,",",0,0
177566,and,0,1
177567,they,0,0
177568,felt,0,0
177569,prepared,1,0
177570,for,1,0
177571,future,1,0
177572,interviews,1,0
177573,.,1,0
177574,VR-JIT,0,0
177575,participants,0,0
177576,had,0,0
177577,greater,1,0
177578,improvement,1,1
177579,during,1,0
177580,live,1,0
177581,standardized,1,0
177582,job,1,1
177583,interview,1,0
177584,role-play,1,1
177585,performances,1,1
177586,than,0,0
177587,TAU,0,1
177588,participants,0,0
177589,(,0,0
177590,p,0,0
177591,=,0,0
177592,0.046,0,0
177593,),0,0
177594,.,0,0
177595,A,0,0
177596,similar,0,0
177597,pattern,0,0
177598,was,0,0
177599,observed,0,0
177600,for,0,0
177601,self-reported,1,1
177602,self-confidence,1,1
177603,at,0,0
177604,a,0,0
177605,trend,0,0
177606,level,0,1
177607,(,0,0
177608,p,0,0
177609,=,0,0
177610,0.060,0,0
177611,),0,0
177612,.,0,0
177613,VR-JIT,1,1
177614,simulation,1,0
177615,performance,1,1
177616,scores,1,1
177617,increased,0,1
177618,over,0,0
177619,time,0,1
177620,(,0,1
177621,R,0,1
177622,(,0,0
177623,2,0,0
177624,),0,0
177625,=,0,0
177626,0.83,0,0
177627,),0,0
177628,.,0,0
177629,Results,0,0
177630,indicate,0,0
177631,preliminary,0,0
177632,support,0,0
177633,for,0,0
177634,the,0,0
177635,feasibility,1,1
177636,and,0,1
177637,efficacy,1,1
177638,of,0,1
177639,VR-JIT,0,1
177640,",",0,0
177641,which,0,0
177642,can,0,0
177643,be,0,0
177644,administered,0,0
177645,using,0,0
177646,computer,0,0
177647,software,0,0
177648,or,0,0
177649,via,0,0
177650,the,0,0
177651,internet,0,0
177652,.,0,0
177653,Internet-based,0,0
177654,",",0,0
177655,randomized,0,0
177656,",",0,0
177657,controlled,0,0
177658,trial,0,0
177659,of,0,1
177660,omega-3,0,0
177661,fatty,0,1
177662,acids,0,1
177663,for,0,0
177664,hyperactivity,1,1
177665,in,0,0
177666,autism,0,0
177667,.,0,0
177668,OBJECTIVE,0,1
177669,Preliminary,0,0
177670,evidence,0,0
177671,suggests,0,0
177672,that,0,0
177673,omega-3,0,0
177674,fatty,0,1
177675,acids,0,0
177676,may,0,0
177677,reduce,0,0
177678,hyperactivity,1,1
177679,in,0,0
177680,children,0,0
177681,with,0,0
177682,autism,0,0
177683,spectrum,0,1
177684,disorder,0,0
177685,(,0,1
177686,ASD,0,0
177687,),0,0
177688,.,0,0
177689,We,0,0
177690,sought,0,0
177691,to,0,0
177692,examine,0,0
177693,the,0,0
177694,feasibility,0,0
177695,of,0,0
177696,a,0,0
177697,novel,0,0
177698,",",0,0
177699,Internet-based,0,0
177700,clinical,0,1
177701,trial,0,0
177702,design,0,0
177703,to,0,0
177704,evaluate,0,0
177705,the,0,0
177706,efficacy,1,1
177707,of,0,0
177708,this,0,0
177709,supplement,0,0
177710,.,0,0
177711,METHOD,0,0
177712,E-mail,0,1
177713,invitations,0,0
177714,were,0,0
177715,sent,0,0
177716,to,0,0
177717,parents,0,0
177718,of,0,0
177719,children,0,0
177720,aged,0,0
177721,5,0,0
177722,to,0,0
177723,8,0,0
177724,years,0,0
177725,enrolled,0,0
177726,in,0,0
177727,the,0,0
177728,Interactive,0,0
177729,Autism,0,1
177730,Network,0,1
177731,.,0,0
177732,All,0,0
177733,study,0,0
177734,procedures,0,0
177735,",",0,1
177736,including,0,0
177737,screening,0,0
177738,",",0,1
177739,informed,0,1
177740,consent,0,1
177741,",",0,1
177742,and,0,1
177743,collection,0,1
177744,of,0,1
177745,outcome,0,1
177746,measures,0,1
177747,took,0,0
177748,place,0,0
177749,over,0,0
177750,the,0,0
177751,Internet,0,0
177752,.,0,0
177753,The,0,0
177754,primary,0,0
177755,outcome,0,1
177756,measures,0,1
177757,were,0,0
177758,parent-,1,1
177759,and,1,1
177760,teacher-rated,1,1
177761,changes,1,1
177762,in,1,0
177763,hyperactivity,1,1
177764,on,1,0
177765,the,1,0
177766,Aberrant,1,0
177767,Behavior,1,1
177768,Checklist,1,1
177769,(,1,1
177770,ABC-H,1,0
177771,),1,0
177772,.,1,0
177773,RESULTS,0,0
177774,During,0,0
177775,the,0,0
177776,6-week,0,0
177777,recruitment,0,1
177778,period,0,0
177779,",",0,0
177780,57,0,0
177781,children,0,0
177782,from,0,0
177783,28,0,0
177784,states,0,0
177785,satisfied,0,0
177786,all,0,0
177787,eligibility,0,0
177788,criteria,0,1
177789,and,0,1
177790,were,0,0
177791,randomly,0,0
177792,assigned,0,0
177793,to,0,0
177794,1.3,0,0
177795,grams,0,0
177796,of,0,0
177797,omega-3,0,0
177798,fatty,0,1
177799,acids,0,1
177800,or,0,0
177801,an,0,0
177802,identical,0,0
177803,placebo,0,0
177804,daily,0,0
177805,for,0,0
177806,6,0,0
177807,weeks,0,0
177808,.,0,0
177809,Outcome,0,1
177810,assessments,0,0
177811,were,0,0
177812,obtained,0,0
177813,from,0,0
177814,all,0,0
177815,57,0,0
177816,participants,0,0
177817,and,0,0
177818,57,0,0
177819,teachers,0,0
177820,",",0,0
177821,and,0,0
177822,the,0,0
177823,study,0,0
177824,was,0,0
177825,completed,0,0
177826,in,0,0
177827,3,0,0
177828,months,0,0
177829,.,0,0
177830,Children,0,0
177831,in,0,0
177832,the,0,0
177833,omega-3,0,0
177834,fatty,0,1
177835,acid,0,1
177836,group,0,0
177837,had,0,0
177838,a,0,0
177839,greater,0,0
177840,reduction,0,1
177841,in,0,1
177842,hyperactivity,1,1
177843,(,0,0
177844,-5.3,0,0
177845,points,0,0
177846,),0,0
177847,compared,0,0
177848,to,0,0
177849,the,0,0
177850,placebo,0,0
177851,group,0,0
177852,(,0,0
177853,-2.6,0,0
177854,points,0,0
177855,),0,0
177856,",",0,0
177857,but,0,0
177858,the,0,0
177859,difference,0,0
177860,was,0,0
177861,not,0,0
177862,statistically,0,0
177863,significant,0,0
177864,(,0,0
177865,1.9-point,0,1
177866,greater,0,1
177867,improvement,0,1
177868,in,0,0
177869,the,0,0
177870,omega-3,0,0
177871,group,0,0
177872,",",0,0
177873,95,0,0
177874,%,0,0
177875,CI,0,0
177876,=,0,0
177877,-2.2,0,0
177878,to,0,0
177879,5.2,0,0
177880,),0,0
177881,.,0,0
177882,Adverse,1,1
177883,events,1,1
177884,were,0,0
177885,rare,0,0
177886,and,0,0
177887,not,0,0
177888,associated,0,0
177889,with,0,0
177890,omega-3,0,0
177891,fatty,0,1
177892,acids,0,1
177893,.,0,0
177894,Participant,0,0
177895,feedback,1,0
177896,was,0,0
177897,positive,0,1
177898,.,0,0
177899,CONCLUSION,0,0
177900,Internet-based,0,0
177901,",",0,0
177902,randomized,0,0
177903,controlled,0,0
177904,trials,0,0
177905,of,0,0
177906,therapies,0,0
177907,in,0,0
177908,children,0,0
177909,with,0,0
177910,ASD,0,0
177911,are,0,0
177912,feasible,0,0
177913,and,0,0
177914,may,0,0
177915,lead,0,0
177916,to,0,0
177917,marked,0,0
177918,reductions,0,1
177919,in,0,0
177920,the,0,0
177921,time,0,1
177922,and,0,1
177923,cost,0,1
177924,of,0,1
177925,completing,0,0
177926,trials,0,0
177927,.,0,0
177928,A,0,0
177929,larger,0,0
177930,sample,0,0
177931,size,0,1
177932,is,0,0
177933,required,0,0
177934,to,0,0
177935,definitively,0,0
177936,determine,0,0
177937,the,0,0
177938,efficacy,1,1
177939,of,0,0
177940,omega-3,0,0
177941,fatty,0,1
177942,acids,0,1
177943,.,0,0
177944,Clinical,0,1
177945,trial,0,0
177946,registration,0,0
177947,information-Omega-3,0,1
177948,Fatty,0,1
177949,Acids,0,1
177950,for,0,0
177951,Hyperactivity,0,1
177952,Treatment,0,0
177953,in,0,0
177954,Autism,0,1
177955,Spectrum,0,0
177956,Disorder,0,0
177957,;,0,0
177958,http,0,0
177959,:,0,0
177960,//clinicaltrials.gov,0,0
177961,;,0,0
177962,NCT01694667,0,0
177963,.,0,0
177964,Balance,0,1
177965,training,0,0
177966,in,0,0
177967,elderly,0,0
177968,women,0,0
177969,using,0,0
177970,public,0,0
177971,parks,0,0
177972,.,0,0
177973,This,0,0
177974,study,0,0
177975,evaluates,0,0
177976,the,0,0
177977,effects,0,0
177978,of,0,0
177979,a,0,0
177980,balance,0,1
177981,training,0,0
177982,program,0,0
177983,developed,0,0
177984,in,0,0
177985,public,0,0
177986,parks,0,1
177987,on,0,0
177988,functionality,0,1
177989,and,0,1
177990,general,0,1
177991,state,0,1
177992,of,0,1
177993,health,0,1
177994,in,0,0
177995,elderly,0,0
177996,women,0,0
177997,.,0,0
177998,It,0,0
177999,was,0,0
178000,a,0,0
178001,randomized,0,0
178002,controlled,0,0
178003,trial,0,0
178004,.,0,0
178005,Women,0,0
178006,older,0,0
178007,than,0,0
178008,65,0,0
178009,years,0,0
178010,(,0,0
178011,n,0,0
178012,=,0,0
178013,28,0,0
178014,;,0,0
178015,68.5,0,0
178016,?,0,0
178017,2.9,0,0
178018,),0,0
178019,participated,0,0
178020,in,0,0
178021,a,0,0
178022,balance,0,1
178023,training,0,0
178024,program,0,0
178025,that,0,0
178026,lasted,0,0
178027,6,0,0
178028,weeks,0,0
178029,",",0,0
178030,with,0,0
178031,sessions,0,0
178032,taking,0,0
178033,place,0,0
178034,twice,0,0
178035,a,0,0
178036,week,0,0
178037,(,0,0
178038,12,0,0
178039,exercises/session,0,0
178040,",",0,0
178041,50,0,0
178042,min,0,0
178043,),0,0
178044,.,0,1
178045,Balance,1,1
178046,was,0,0
178047,analyzed,0,0
178048,by,0,0
178049,the,0,0
178050,Berg,1,0
178051,Balance,1,1
178052,Scale,1,1
178053,and,1,1
178054,Timed,1,1
178055,Up,1,1
178056,&,1,1
178057,Go,1,1
178058,Test,1,1
178059,.,1,0
178060,The,1,0
178061,generic,1,0
178062,health,1,1
178063,status,1,1
178064,was,0,0
178065,measured,0,0
178066,by,0,0
178067,the,0,0
178068,SF-12,0,0
178069,Health,0,0
178070,Survey,0,0
178071,.,0,0
178072,These,0,0
178073,tests,0,1
178074,showed,0,0
178075,statistically,0,0
178076,significant,0,0
178077,differences,0,0
178078,in,0,0
178079,the,0,0
178080,experimental,0,0
178081,group,0,0
178082,(,0,0
178083,p,0,0
178084,<,0,0
178085,.05,0,0
178086,),0,0
178087,.,0,0
178088,Public,0,0
178089,parks,0,0
178090,are,0,0
178091,adequate,0,0
178092,installations,0,0
178093,for,0,0
178094,developing,0,0
178095,balance,0,1
178096,.,0,0
178097,The,0,0
178098,effects,1,0
178099,of,0,0
178100,prism,0,0
178101,adaptation,0,1
178102,on,0,0
178103,egocentric,0,0
178104,metric,1,1
178105,distance,1,1
178106,estimation,1,1
178107,.,1,0
178108,OBJECTIVE,0,0
178109,The,0,0
178110,present,0,0
178111,experiment,0,0
178112,evaluated,0,0
178113,whether,0,0
178114,training,0,0
178115,involving,0,0
178116,throwing,0,1
178117,transferred,0,0
178118,to,0,0
178119,metric,0,0
178120,distance,0,1
178121,estimation,0,1
178122,(,0,1
178123,i.e.,0,0
178124,",",0,0
178125,describing,0,0
178126,in,0,0
178127,feet,0,0
178128,and,0,0
178129,inches,0,1
178130,the,0,0
178131,distance,0,1
178132,between,0,0
178133,oneself,0,1
178134,and,0,1
178135,targets,0,0
178136,),0,0
178137,.,0,0
178138,BACKGROUND,0,0
178139,In,0,0
178140,prior,0,0
178141,work,0,0
178142,",",0,0
178143,we,0,0
178144,found,0,0
178145,that,0,0
178146,metric,0,1
178147,estimation,0,0
178148,training,0,0
178149,negatively,0,0
178150,transferred,0,0
178151,to,0,0
178152,throwing,0,0
178153,.,0,0
178154,We,0,0
178155,explained,0,0
178156,our,0,0
178157,results,0,0
178158,in,0,0
178159,terms,0,1
178160,of,0,0
178161,cognitive,0,1
178162,intrusion,0,1
178163,.,0,0
178164,The,0,0
178165,present,0,0
178166,study,0,0
178167,tested,0,0
178168,that,0,0
178169,possibility,0,0
178170,by,0,0
178171,swapping,0,0
178172,our,0,0
178173,training,0,0
178174,and,0,1
178175,transfer,0,1
178176,tasks,0,1
178177,.,0,0
178178,METHOD,0,0
178179,During,0,0
178180,pretesting,0,0
178181,",",0,0
178182,participants,0,0
178183,verbally,0,1
178184,estimated,0,0
178185,the,0,0
178186,metric,0,0
178187,distances,0,0
178188,between,0,0
178189,themselves,0,0
178190,and,0,0
178191,targets,0,1
178192,",",0,0
178193,or,0,0
178194,they,0,0
178195,threw,0,0
178196,a,0,0
178197,beanbag,0,0
178198,to,0,0
178199,targets,0,0
178200,.,0,0
178201,During,0,0
178202,training,0,0
178203,",",0,1
178204,participants,0,0
178205,donned,0,0
178206,goggles,0,0
178207,that,0,0
178208,distorted,0,0
178209,their,0,0
178210,vision,0,1
178211,.,0,0
178212,While,0,0
178213,wearing,0,0
178214,the,0,0
178215,goggles,0,0
178216,",",0,0
178217,they,0,0
178218,threw,0,0
178219,a,0,0
178220,beanbag,0,0
178221,to,0,0
178222,targets,0,0
178223,.,0,1
178224,Half,0,0
178225,received,0,0
178226,feedback,0,0
178227,.,0,0
178228,During,0,0
178229,posttesting,0,0
178230,",",0,0
178231,participants,0,0
178232,removed,0,0
178233,the,0,0
178234,distorting,0,0
178235,goggles,0,1
178236,and,0,1
178237,completed,0,0
178238,the,0,0
178239,same,0,0
178240,task,0,0
178241,that,0,0
178242,they,0,0
178243,performed,0,0
178244,during,0,0
178245,pretesting,0,0
178246,.,0,0
178247,RESULTS,0,0
178248,The,0,0
178249,results,0,0
178250,indicated,0,0
178251,that,0,0
178252,the,0,0
178253,distorting,0,0
178254,goggles,0,0
178255,degraded,0,1
178256,throwing,0,1
178257,at,0,0
178258,the,0,0
178259,beginning,0,0
178260,of,0,1
178261,training,0,0
178262,",",0,1
178263,visual,0,1
178264,feedback,0,0
178265,improved,0,1
178266,throwing,0,1
178267,during,0,0
178268,training,0,0
178269,",",0,0
178270,the,0,0
178271,effects,0,1
178272,of,0,0
178273,training,0,0
178274,with,0,0
178275,feedback,0,0
178276,persisted,0,0
178277,into,0,0
178278,the,0,0
178279,throwing,0,1
178280,posttest,0,1
178281,",",0,0
178282,and,0,0
178283,the,0,0
178284,effects,0,1
178285,of,0,0
178286,training,0,0
178287,with,0,0
178288,feedback,0,0
178289,did,0,0
178290,not,0,0
178291,transfer,0,1
178292,to,0,0
178293,the,0,0
178294,verbal,1,1
178295,metric,1,0
178296,estimation,1,0
178297,posttest,0,1
178298,.,0,1
178299,CONCLUSION,0,0
178300,Training,0,0
178301,involving,0,0
178302,throwing,1,1
178303,was,0,0
178304,effective,1,1
178305,",",0,1
178306,but,0,0
178307,did,0,0
178308,not,0,0
178309,transfer,0,1
178310,to,0,0
178311,verbal,1,1
178312,metric,1,1
178313,distance,1,1
178314,estimation,1,0
178315,.,1,0
178316,This,0,0
178317,supports,0,0
178318,our,0,0
178319,argument,0,0
178320,that,0,0
178321,the,0,0
178322,negative,0,1
178323,transfer,0,1
178324,observed,0,0
178325,in,0,0
178326,our,0,0
178327,previous,0,0
178328,study,0,0
178329,stemmed,0,0
178330,from,0,0
178331,cognitive,0,1
178332,intrusion,0,1
178333,.,0,0
178334,APPLICATION,0,0
178335,The,0,0
178336,present,0,0
178337,experiment,0,0
178338,suggests,0,0
178339,that,0,0
178340,the,0,0
178341,creation,0,0
178342,of,0,1
178343,distance,0,1
178344,estimation,0,0
178345,training,0,0
178346,should,0,0
178347,begin,0,0
178348,with,0,0
178349,a,0,0
178350,careful,0,0
178351,analysis,0,0
178352,of,0,0
178353,the,0,0
178354,transfer,0,1
178355,task,0,1
178356,",",0,0
178357,and,0,1
178358,that,0,0
178359,distance,0,1
178360,estimation,0,1
178361,training,0,0
178362,programs,0,0
178363,should,0,0
178364,explicitly,0,0
178365,teach,0,0
178366,trainees,0,0
178367,that,0,0
178368,their,0,0
178369,training,0,0
178370,will,0,0
178371,not,0,0
178372,generalize,0,0
178373,to,0,0
178374,all,0,0
178375,distance,0,1
178376,estimation,0,0
178377,tasks,0,1
178378,.,0,0
178379,Intravenous,0,0
178380,flecainide,0,0
178381,versus,0,0
178382,verapamil,0,0
178383,for,0,0
178384,acute,0,0
178385,conversion,0,1
178386,of,0,1
178387,paroxysmal,0,1
178388,atrial,0,1
178389,fibrillation,0,1
178390,or,0,0
178391,flutter,0,0
178392,to,0,0
178393,sinus,0,0
178394,rhythm,0,1
178395,.,0,0
178396,In,0,0
178397,a,0,0
178398,single-blind,0,0
178399,randomized,0,0
178400,study,0,0
178401,",",0,0
178402,the,0,0
178403,efficacy,1,1
178404,of,0,0
178405,intravenous,0,0
178406,flecainide,0,0
178407,(,0,0
178408,2,0,0
178409,mg/kg/10,0,0
178410,minutes,0,0
178411,),0,0
178412,versus,0,0
178413,verapamil,0,0
178414,(,0,0
178415,10,0,0
178416,mg/1,0,0
178417,minute,0,0
178418,),0,1
178419,was,0,0
178420,assessed,0,0
178421,in,0,0
178422,40,0,0
178423,patients,0,0
178424,with,0,0
178425,paroxysmal,0,1
178426,atrial,0,1
178427,fibrillation,0,1
178428,(,0,1
178429,AF,0,1
178430,),0,1
178431,or,0,0
178432,atrial,0,1
178433,flutter,0,1
178434,(,0,1
178435,AFI,0,0
178436,),0,0
178437,.,0,0
178438,The,0,0
178439,treatment,0,0
178440,was,0,0
178441,considered,0,0
178442,successful,0,0
178443,if,0,0
178444,sinus,1,0
178445,rhythm,1,1
178446,occurred,0,0
178447,within,0,0
178448,1,0,0
178449,hour,0,0
178450,.,0,0
178451,Of,0,0
178452,20,0,0
178453,patients,0,0
178454,receiving,0,0
178455,flecainide,0,0
178456,",",0,0
178457,14,0,0
178458,of,0,0
178459,17,0,0
178460,(,0,0
178461,82,0,0
178462,%,0,0
178463,),0,0
178464,with,0,0
178465,AF,0,1
178466,converted,0,0
178467,to,0,0
178468,sinus,0,0
178469,rhythm,0,1
178470,",",0,1
178471,but,0,0
178472,in,0,0
178473,3,0,0
178474,patients,0,0
178475,with,0,0
178476,AFI,0,0
178477,flecainide,0,0
178478,failed,0,0
178479,.,0,0
178480,All,0,0
178481,patients,0,0
178482,treated,0,0
178483,with,0,0
178484,verapamil,0,0
178485,(,0,0
178486,17,0,0
178487,AF,0,0
178488,",",0,0
178489,3,0,0
178490,AFI,0,0
178491,),0,0
178492,showed,0,0
178493,lower,1,0
178494,ventricular,1,1
178495,rates,1,1
178496,after,0,0
178497,1,0,0
178498,hour,0,0
178499,;,0,0
178500,however,0,0
178501,",",0,0
178502,only,0,0
178503,1,0,0
178504,(,0,0
178505,6,0,0
178506,%,0,0
178507,),0,0
178508,with,0,0
178509,AF,0,1
178510,converted,0,0
178511,to,0,0
178512,sinus,0,0
178513,rhythm,0,1
178514,and,0,0
178515,1,0,0
178516,(,0,0
178517,6,0,0
178518,%,0,0
178519,),0,0
178520,converted,0,0
178521,to,0,0
178522,AFI,0,0
178523,.,0,0
178524,Patients,0,0
178525,who,0,0
178526,did,0,0
178527,not,0,0
178528,convert,0,0
178529,to,0,0
178530,sinus,0,0
178531,rhythm,0,1
178532,after,0,0
178533,treatment,0,0
178534,with,0,0
178535,verapamil,0,0
178536,were,0,0
178537,treated,0,0
178538,with,0,0
178539,flecainide,0,0
178540,and,0,1
178541,observed,0,0
178542,for,0,0
178543,another,0,0
178544,hour,0,0
178545,.,0,0
178546,After,0,0
178547,the,0,0
178548,change,0,0
178549,to,0,0
178550,flecainide,0,0
178551,",",0,0
178552,9,0,0
178553,of,0,0
178554,15,0,0
178555,patients,0,0
178556,(,0,0
178557,60,0,0
178558,%,0,0
178559,),0,0
178560,with,0,0
178561,AF,0,1
178562,still,0,0
178563,converted,1,0
178564,.,1,0
178565,Thus,0,1
178566,",",0,0
178567,23,0,0
178568,of,0,0
178569,32,0,0
178570,patients,0,0
178571,(,0,0
178572,72,0,0
178573,%,0,0
178574,),0,0
178575,with,0,0
178576,AF,0,1
178577,and,0,1
178578,none,0,0
178579,of,0,0
178580,7,0,0
178581,with,0,0
178582,AFI,0,0
178583,converted,0,0
178584,to,0,0
178585,sinus,1,0
178586,rhythm,1,1
178587,after,0,0
178588,treatment,0,0
178589,with,0,0
178590,flecainide,0,0
178591,.,0,0
178592,Conversion,1,1
178593,to,1,0
178594,sinus,1,0
178595,rhythm,1,1
178596,was,0,0
178597,achieved,0,0
178598,in,0,0
178599,19,0,0
178600,of,0,0
178601,22,0,0
178602,patients,0,0
178603,(,0,0
178604,86,0,0
178605,%,0,0
178606,),0,0
178607,when,0,0
178608,AF,0,1
178609,lasted,0,1
178610,less,0,0
178611,than,0,0
178612,24,0,0
178613,hours,0,0
178614,and,0,0
178615,in,0,0
178616,4,0,0
178617,of,0,0
178618,10,0,0
178619,(,0,0
178620,40,0,0
178621,%,0,0
178622,),0,0
178623,when,0,0
178624,the,0,0
178625,arrhythmia,0,1
178626,lasted,0,1
178627,greater,0,0
178628,than,0,0
178629,24,0,0
178630,hours,0,0
178631,.,0,0
178632,Transient,1,1
178633,adverse,1,1
178634,effects,1,1
178635,were,0,0
178636,noted,0,0
178637,in,0,0
178638,10,0,0
178639,patients,0,0
178640,(,0,0
178641,26,0,0
178642,%,0,0
178643,),0,0
178644,after,0,0
178645,flecainide,0,0
178646,.,0,0
178647,In,0,0
178648,summary,0,0
178649,",",0,0
178650,flecainide,0,0
178651,is,0,0
178652,an,0,0
178653,effective,1,1
178654,and,1,1
178655,safe,1,1
178656,drug,1,0
178657,for,0,0
178658,conversion,0,1
178659,of,0,0
178660,paroxysmal,0,1
178661,AF,0,0
178662,to,0,0
178663,sinus,0,0
178664,rhythm,0,1
178665,",",0,1
178666,but,0,0
178667,ineffective,0,1
178668,for,0,0
178669,AFI,1,0
178670,.,1,0
178671,Verapamil,0,0
178672,appears,0,0
178673,to,0,0
178674,be,0,0
178675,of,0,0
178676,no,0,0
178677,use,0,0
178678,for,0,0
178679,conversion,1,1
178680,of,1,1
178681,AF,1,1
178682,or,1,0
178683,AFI,1,0
178684,to,0,0
178685,sinus,0,0
178686,rhythm,0,1
178687,.,0,0
178688,[,0,0
178689,Mitomycin,0,0
178690,C,0,0
178691,plus,0,0
178692,HCFU,0,0
178693,adjuvant,0,0
178694,chemotherapy,0,0
178695,for,0,0
178696,noncuratively,0,0
178697,resected,0,0
178698,cases,0,0
178699,of,0,0
178700,colorectal,0,0
178701,carcinoma,0,0
178702,.,0,1
178703,(,0,0
178704,Second,0,1
178705,report,0,0
178706,),0,0
178707,:,0,0
178708,5-year,0,1
178709,survival,0,1
178710,rate,0,1
178711,.,0,1
178712,Cooperative,0,0
178713,Study,0,0
178714,Group,0,0
178715,of,0,1
178716,Kyushu,0,0
178717,and,0,1
178718,Chugoku,0,0
178719,for,0,0
178720,HCFU,0,0
178721,Adjuvant,0,0
178722,Chemotherapy,0,0
178723,],0,0
178724,.,0,0
178725,In,0,0
178726,order,0,0
178727,to,0,0
178728,examine,0,0
178729,the,0,0
178730,efficacy,0,1
178731,of,0,0
178732,adjuvant,0,0
178733,chemotherapy,0,0
178734,employing,0,0
178735,mitomycin,0,0
178736,C,0,0
178737,(,0,1
178738,MMC,0,1
178739,),0,1
178740,and,0,1
178741,carmofur,0,0
178742,(,0,1
178743,HCFU,0,0
178744,),0,0
178745,for,0,0
178746,patients,0,0
178747,with,0,0
178748,noncuratively,0,0
178749,resected,0,0
178750,colorectal,0,0
178751,carcinoma,0,0
178752,",",0,0
178753,a,0,0
178754,cooperative,0,0
178755,study,0,0
178756,was,0,0
178757,performed,0,0
178758,by,0,0
178759,54,0,0
178760,institutions,0,0
178761,in,0,0
178762,the,0,0
178763,Kyushu,0,0
178764,and,0,1
178765,Chugoku,0,0
178766,areas,0,1
178767,of,0,0
178768,Japan,0,0
178769,.,0,0
178770,The,0,0
178771,criteria,0,0
178772,for,0,0
178773,patient,0,1
178774,selection,0,1
178775,were,0,0
178776,as,0,0
178777,follows,0,0
178778,:,0,0
178779,1,0,0
178780,),0,0
178781,Age,0,0
178782,of,0,0
178783,75,0,0
178784,years,0,0
178785,or,0,0
178786,less,0,0
178787,and,0,1
178788,not,0,0
178789,accompanied,0,0
178790,by,0,0
178791,any,0,0
178792,serious,0,0
178793,disease,0,0
178794,.,0,0
178795,2,0,0
178796,),0,0
178797,Macroscopic,0,1
178798,diagnosis,0,0
178799,as,0,0
178800,being,0,0
178801,noncuratively,0,0
178802,resected,0,0
178803,on,0,0
178804,completion,0,0
178805,of,0,0
178806,the,0,0
178807,surgical,0,0
178808,procedure,0,0
178809,.,0,0
178810,3,0,0
178811,),0,0
178812,Definitive,0,0
178813,diagnosis,0,0
178814,of,0,1
178815,colorectal,0,0
178816,carcinomas,0,1
178817,",",0,0
178818,histologically,0,0
178819,.,0,0
178820,4,0,0
178821,),0,0
178822,No,0,0
178823,synchronous,0,0
178824,or,0,0
178825,metachronous,0,1
178826,double,0,0
178827,cancer,0,0
178828,.,0,0
178829,The,0,0
178830,prospective,0,0
178831,randomized,0,0
178832,controlled,0,0
178833,study,0,0
178834,consisted,0,0
178835,of,0,0
178836,two,0,0
178837,groups,0,0
178838,.,0,0
178839,In,0,0
178840,Group,0,0
178841,A,0,0
178842,",",0,0
178843,the,0,0
178844,MMC,0,1
178845,group,0,0
178846,received,0,0
178847,bolus,0,0
178848,intravenous,0,0
178849,injections,0,0
178850,of,0,0
178851,20,0,0
178852,mg,0,0
178853,MMC,0,0
178854,on,0,0
178855,the,0,0
178856,day,0,0
178857,of,0,1
178858,operation,0,0
178859,and,0,0
178860,10,0,0
178861,mg,0,0
178862,the,0,0
178863,next,0,0
178864,day,0,0
178865,",",0,0
178866,followed,0,0
178867,by,0,0
178868,10,0,0
178869,mg,0,0
178870,every,0,0
178871,4,0,0
178872,weeks,0,0
178873,until,0,0
178874,a,0,0
178875,total,0,0
178876,of,0,0
178877,100,0,0
178878,mg,0,0
178879,had,0,0
178880,been,0,0
178881,administered,0,0
178882,.,0,0
178883,In,0,0
178884,Group,0,0
178885,B,0,0
178886,",",0,0
178887,the,0,0
178888,MMC,0,0
178889,+,0,0
178890,HCFU,0,1
178891,group,0,0
178892,received,0,0
178893,the,0,0
178894,same,0,0
178895,treatment,0,0
178896,in,0,0
178897,Group,0,0
178898,A,0,0
178899,",",0,1
178900,but,0,0
178901,with,0,0
178902,the,0,0
178903,addition,0,0
178904,of,0,0
178905,600,0,0
178906,mg/day,0,0
178907,of,0,0
178908,HCFU,0,0
178909,from,0,0
178910,the,0,0
178911,second,0,0
178912,week,0,0
178913,",",0,0
178914,orally,0,0
178915,for,0,0
178916,at,0,0
178917,least,0,0
178918,one,0,0
178919,year,0,0
178920,.,0,0
178921,Concerning,0,0
178922,the,0,0
178923,69-month,1,0
178924,survival,1,1
178925,rate,1,1
178926,",",0,0
178927,a,0,0
178928,better,0,0
178929,result,0,0
178930,was,0,0
178931,observed,0,0
178932,in,0,0
178933,the,0,0
178934,MMC,0,0
178935,+,0,0
178936,HCFU,0,0
178937,group,0,0
178938,than,0,0
178939,in,0,0
178940,the,0,0
178941,MMC,0,0
178942,only,0,0
178943,group,0,0
178944,(,0,0
178945,generalized,0,0
178946,Wilcoxon,0,0
178947,test,0,0
178948,:,0,0
178949,p,0,0
178950,less,0,0
178951,than,0,0
178952,0.05,0,0
178953,),0,0
178954,.,0,0
178955,Significantly,0,0
178956,better,0,0
178957,survival,1,1
178958,rates,1,1
178959,were,0,0
178960,obtained,0,0
178961,in,0,0
178962,those,0,0
178963,cases,0,0
178964,with,0,0
178965,disseminating,0,1
178966,peritoneal,0,1
178967,metastasis,0,1
178968,",",0,1
178969,hepatic,0,1
178970,metastasis,0,1
178971,and,0,1
178972,stage,0,1
178973,V,0,1
178974,cancer,0,0
178975,in,0,0
178976,the,0,0
178977,MMC,0,0
178978,+,0,0
178979,HCFU,0,0
178980,group,0,0
178981,as,0,0
178982,when,0,0
178983,compared,0,0
178984,with,0,0
178985,the,0,0
178986,MMC,0,0
178987,only,0,0
178988,group,0,0
178989,.,0,0
178990,No,1,0
178991,significant,1,0
178992,side,1,1
178993,effects,1,1
178994,due,0,0
178995,to,0,0
178996,the,0,0
178997,combined,0,0
178998,administration,0,0
178999,of,0,1
179000,HCFU,0,0
179001,were,0,0
179002,recognized,0,0
179003,.,0,0
179004,The,0,0
179005,combined,0,0
179006,administration,0,0
179007,of,0,1
179008,MMC,0,0
179009,and,0,1
179010,HCFU,0,1
179011,was,0,0
179012,suggested,0,0
179013,to,0,0
179014,be,0,0
179015,a,0,0
179016,safe,0,1
179017,and,0,1
179018,effective,0,1
179019,adjuvant,0,0
179020,chemotherapy,0,0
179021,for,0,0
179022,noncuratively,0,0
179023,resected,0,0
179024,cases,0,0
179025,of,0,0
179026,colorectal,0,0
179027,carcinoma,0,0
179028,.,0,0
179029,Compared,0,0
179030,with,0,0
179031,the,0,0
179032,intake,0,1
179033,of,0,0
179034,commercial,0,0
179035,vegetable,0,0
179036,juice,0,0
179037,",",0,0
179038,the,0,0
179039,intake,0,1
179040,of,0,0
179041,fresh,0,0
179042,fruit,0,1
179043,and,0,1
179044,komatsuna,0,1
179045,(,0,0
179046,Brassica,0,0
179047,rapa,0,0
179048,L.,0,1
179049,var,0,1
179050,.,0,1
179051,perviridis,0,0
179052,),0,1
179053,juice,0,0
179054,mixture,0,0
179055,reduces,0,1
179056,serum,0,1
179057,cholesterol,0,1
179058,in,0,0
179059,middle-aged,0,0
179060,men,0,0
179061,:,0,0
179062,a,0,0
179063,randomized,0,0
179064,controlled,0,0
179065,pilot,0,0
179066,study,0,0
179067,.,0,1
179068,BACKGROUND,0,0
179069,Vegetables,0,1
179070,and,0,0
179071,fruits,0,0
179072,are,0,0
179073,rich,0,0
179074,in,0,0
179075,vitamins,0,0
179076,",",0,0
179077,minerals,0,1
179078,and,0,1
179079,",",0,1
179080,dietary,0,1
179081,fiber,0,0
179082,and,0,1
179083,contribute,0,0
179084,to,0,0
179085,the,0,0
179086,prevention,0,0
179087,and,0,1
179088,improvement,0,1
179089,of,0,1
179090,obesity,0,1
179091,and,0,1
179092,metabolic,0,1
179093,syndrome,0,0
179094,.,0,0
179095,However,0,0
179096,",",0,0
179097,inadequate,0,1
179098,intake,0,1
179099,of,0,1
179100,vegetable,0,0
179101,and,0,0
179102,fruit,0,0
179103,is,0,0
179104,a,0,0
179105,concern,0,0
179106,in,0,0
179107,Japan.We,0,1
179108,therefore,0,0
179109,produced,0,0
179110,a,0,0
179111,juice,0,0
179112,mixture,0,0
179113,of,0,1
179114,fresh,0,0
179115,fruit,0,1
179116,and,0,1
179117,komatsuna,0,1
179118,(,0,0
179119,Brassica,0,0
179120,rapa,0,0
179121,L.,0,1
179122,var,0,1
179123,.,0,0
179124,perviridis,0,0
179125,:,0,0
179126,B.,0,1
179127,rapa,0,0
179128,),0,0
179129,with,0,0
179130,the,0,0
179131,aim,0,0
179132,to,0,0
179133,investigate,0,0
179134,the,0,0
179135,effects,0,0
179136,of,0,0
179137,this,0,0
179138,juice,0,0
179139,mixture,0,0
179140,on,0,0
179141,anthropometric,1,1
179142,data,1,0
179143,",",1,1
179144,blood,1,1
179145,parameters,1,1
179146,",",0,1
179147,and,0,1
179148,dietary,0,1
179149,intake,0,1
179150,differences,0,0
179151,.,0,0
179152,METHODS,0,0
179153,This,0,0
179154,study,0,0
179155,was,0,0
179156,performed,0,0
179157,as,0,0
179158,a,0,0
179159,single,0,0
179160,blind,0,0
179161,and,0,1
179162,randomized,0,0
179163,controlled,0,0
179164,trial,0,0
179165,.,0,0
179166,Subjects,0,0
179167,were,0,0
179168,16,0,0
179169,men,0,0
179170,(,0,0
179171,mean,0,1
179172,age,0,0
179173,",",0,0
179174,46.4,0,0
179175,?,0,0
179176,7.1,0,0
179177,years,0,0
179178,),0,0
179179,",",0,0
179180,and,0,1
179181,they,0,0
179182,were,0,0
179183,divided,0,0
179184,into,0,0
179185,two,0,0
179186,groups,0,0
179187,(,0,0
179188,control,0,0
179189,group,0,0
179190,and,0,1
179191,intervention,0,0
179192,group,0,0
179193,),0,0
179194,.,0,0
179195,The,0,0
179196,intervention,0,0
179197,group,0,0
179198,consumed,0,0
179199,the,0,0
179200,juice,0,0
179201,mixture,0,0
179202,of,0,1
179203,fresh,0,0
179204,fruit,0,1
179205,and,0,1
179206,B.,0,1
179207,rapa,0,0
179208,.,0,0
179209,The,0,0
179210,control,0,0
179211,group,0,0
179212,consumed,0,0
179213,commercial,0,0
179214,vegetable,0,0
179215,juice,0,0
179216,.,0,1
179217,Subjects,0,0
179218,consumed,0,0
179219,juice,0,0
179220,twice,0,0
179221,a,0,0
179222,day,0,0
179223,throughout,0,0
179224,the,0,0
179225,weekday,0,0
179226,",",0,0
179227,for,0,0
179228,4,0,0
179229,weeks,0,0
179230,.,0,0
179231,We,0,0
179232,prepared,0,0
179233,both,0,0
179234,juices,0,0
179235,with,0,0
179236,an,0,0
179237,equivalent,0,0
179238,energy,0,1
179239,balance,0,1
179240,.,0,1
179241,RESULTS,0,0
179242,Weight,1,1
179243,and,1,1
179244,body,1,1
179245,mass,1,1
179246,index,1,1
179247,(,1,1
179248,BMI,1,1
179249,),1,0
179250,of,0,0
179251,the,0,0
179252,control,0,0
179253,group,0,0
179254,after,0,0
179255,4,0,0
179256,weeks,0,0
179257,were,0,0
179258,significantly,0,0
179259,increased,0,0
179260,compared,0,0
179261,with,0,0
179262,baseline,0,0
179263,values,0,1
179264,.,0,0
179265,Serum,1,1
179266,total,1,1
179267,cholesterol,1,1
179268,(,1,1
179269,T-Chol,1,1
179270,),1,1
179271,and,1,1
179272,low-density,1,1
179273,lipoprotein,1,1
179274,cholesterol,1,1
179275,(,1,1
179276,LDL-Chol,1,1
179277,),1,0
179278,of,1,0
179279,the,1,0
179280,intervention,0,0
179281,group,0,0
179282,after,0,0
179283,4,0,0
179284,weeks,0,0
179285,were,0,0
179286,significantly,0,0
179287,reduced,0,0
179288,compared,0,0
179289,with,0,0
179290,baseline,0,0
179291,values,0,1
179292,.,0,0
179293,Furthermore,1,0
179294,",",1,0
179295,intake,1,1
179296,of,1,1
179297,total,1,1
179298,vegetables,1,0
179299,and,1,1
179300,fruits,1,1
179301,were,1,0
179302,significantly,0,0
179303,increased,0,0
179304,compared,0,0
179305,with,0,0
179306,baseline,0,0
179307,values,0,1
179308,in,0,0
179309,both,0,0
179310,groups,0,0
179311,.,0,0
179312,CONCLUSIONS,0,0
179313,Both,0,0
179314,vegetable,0,0
179315,juices,0,1
179316,contributed,0,0
179317,to,0,0
179318,improved,0,1
179319,intake,1,1
179320,of,1,1
179321,total,1,1
179322,vegetables,1,0
179323,and,1,1
179324,fruit,1,1
179325,.,1,1
179326,Compared,1,0
179327,with,0,0
179328,the,0,0
179329,intake,0,1
179330,of,0,0
179331,commercial,0,0
179332,vegetable,0,0
179333,juice,0,0
179334,",",0,0
179335,the,0,0
179336,intake,0,1
179337,of,0,0
179338,fresh,0,0
179339,fruit,0,1
179340,and,0,1
179341,B.,0,1
179342,rapa,0,0
179343,juice,0,0
179344,is,0,0
179345,highly,0,0
179346,effective,0,0
179347,in,1,0
179348,reducing,1,0
179349,serum,1,1
179350,cholesterol,1,1
179351,.,1,1
179352,Short-term,1,0
179353,intake,0,1
179354,of,0,1
179355,fresh,0,0
179356,fruit,0,1
179357,and,0,1
179358,B.,0,1
179359,rapa,0,0
179360,juice,0,1
179361,was,0,0
179362,shown,0,0
179363,to,0,0
179364,enhance,1,0
179365,cholesterol,1,1
179366,metabolism,1,1
179367,.,1,0
179368,Intramuscular,0,0
179369,compared,0,0
179370,to,0,0
179371,intravenous,0,0
179372,midazolam,0,0
179373,for,0,0
179374,paediatric,0,0
179375,sedation,0,1
179376,:,0,0
179377,A,0,0
179378,study,0,0
179379,on,0,0
179380,cardiopulmonary,0,1
179381,safety,0,1
179382,and,0,1
179383,effectiveness,0,1
179384,.,0,1
179385,BACKGROUND,0,0
179386,Sedation,0,1
179387,in,0,0
179388,children,0,0
179389,remains,0,0
179390,a,0,0
179391,controversial,0,0
179392,issue,0,0
179393,in,0,0
179394,emergency,0,1
179395,departments,0,0
179396,(,0,1
179397,ED,0,0
179398,),0,0
179399,.,0,0
179400,Midazolam,0,0
179401,",",0,0
179402,as,0,0
179403,a,0,0
179404,benzodiazepine,0,0
179405,is,0,0
179406,widely,0,0
179407,used,0,0
179408,for,0,0
179409,procedural,0,1
179410,sedation,0,1
179411,among,0,0
179412,paediatrics,0,0
179413,.,0,0
179414,We,0,0
179415,compared,0,0
179416,the,0,0
179417,effectiveness,0,1
179418,and,0,1
179419,safety,0,1
179420,of,0,0
179421,two,0,0
179422,forms,0,0
179423,of,0,0
179424,midazolam,0,0
179425,prescription,0,0
179426,;,0,1
179427,intramuscular,0,0
179428,(,0,0
179429,IM,0,1
179430,),0,1
179431,and,0,1
179432,intravenous,0,0
179433,(,0,1
179434,IV,0,1
179435,),0,0
179436,.,0,0
179437,PATIENTS,0,0
179438,AND,0,0
179439,METHODS,0,0
179440,A,0,0
179441,cohort,0,0
179442,study,0,0
179443,was,0,0
179444,conducted,0,0
179445,on,0,0
179446,two,0,0
179447,matched,0,0
179448,groups,0,0
179449,of,0,0
179450,30,0,0
179451,children,0,0
179452,referred,0,0
179453,to,0,0
179454,our,0,0
179455,ED,0,0
179456,between,0,0
179457,2010,0,0
179458,and,0,0
179459,2011,0,0
179460,.,0,0
179461,The,0,0
179462,first,0,1
179463,group,0,0
179464,received,0,0
179465,IM,0,1
179466,midazolam,0,0
179467,(,0,0
179468,0.3,0,0
179469,mg/kg,0,0
179470,),0,0
179471,and,0,0
179472,the,0,0
179473,second,0,1
179474,group,0,0
179475,received,0,0
179476,IV,0,1
179477,midazolam,0,0
179478,(,0,0
179479,0.15,0,0
179480,mg/kg,0,0
179481,),0,0
179482,for,0,0
179483,sedation,0,1
179484,.,0,0
179485,For,0,0
179486,evaluating,0,0
179487,effectiveness,1,1
179488,",",1,1
179489,sedation,1,1
179490,",",1,1
179491,irritation,1,1
179492,and,1,1
179493,cooperation,1,1
179494,score,1,1
179495,were,0,0
179496,followed,0,0
179497,every,0,0
179498,15,0,0
179499,min,0,0
179500,for,0,0
179501,60,0,0
179502,min,0,0
179503,and,0,0
179504,for,0,0
179505,safety,1,1
179506,assessment,1,1
179507,",",1,1
179508,vital,1,1
179509,signs,1,1
179510,and,1,0
179511,O,1,0
179512,2,1,0
179513,saturation,1,1
179514,were,0,0
179515,observed,0,0
179516,.,0,0
179517,RESULTS,0,0
179518,Mean,0,1
179519,age,0,0
179520,was,0,0
179521,6.18,0,0
179522,?,0,0
179523,2.88,0,0
179524,years,0,0
179525,and,0,0
179526,31,0,0
179527,patients,0,0
179528,(,0,0
179529,51.7,0,0
179530,%,0,0
179531,),0,0
179532,were,0,0
179533,male,0,0
179534,.,0,0
179535,All,0,0
179536,patients,0,0
179537,were,1,0
179538,sedated,1,0
179539,completely,0,0
179540,after,0,0
179541,using,0,0
179542,first,0,0
179543,dose,0,0
179544,.,0,0
179545,There,0,0
179546,was,0,0
179547,an,1,0
179548,overall,1,1
179549,complication,1,1
179550,rate,1,1
179551,of,0,0
179552,68.3,0,0
179553,%,0,0
179554,.,0,0
179555,35,0,0
179556,(,0,0
179557,58.3,0,0
179558,%,0,0
179559,),0,0
179560,patients,0,0
179561,presented,1,0
179562,euphoria,1,1
179563,as,0,0
179564,the,0,0
179565,most,0,0
179566,common,0,0
179567,complication,0,1
179568,",",0,1
179569,but,0,0
179570,there,0,0
179571,was,0,0
179572,no,0,0
179573,statistical,0,0
179574,difference,0,0
179575,between,0,0
179576,the,0,0
179577,two,0,0
179578,groups,0,0
179579,(,0,0
179580,P,0,0
179581,=,0,0
179582,0.396,0,0
179583,),0,0
179584,.,0,0
179585,Cases,0,1
179586,who,0,0
179587,received,0,0
179588,IV,0,1
179589,midazolam,0,1
179590,became,1,0
179591,sedated,1,0
179592,faster,0,0
179593,than,0,0
179594,those,0,0
179595,received,0,0
179596,IM,0,1
179597,midazolam,0,0
179598,(,0,0
179599,P,0,0
179600,>,0,0
179601,0.001,0,0
179602,),0,0
179603,.,0,0
179604,The,0,0
179605,vital,0,1
179606,signs,0,1
179607,including,1,0
179608,heart,1,1
179609,rate,1,1
179610,",",1,1
179611,respiratory,1,1
179612,rate,1,1
179613,",",1,1
179614,systolic,1,1
179615,blood,1,1
179616,pressure,1,1
179617,and,1,1
179618,O,1,0
179619,2,1,0
179620,saturation,1,1
179621,changed,0,0
179622,significantly,0,0
179623,between,0,0
179624,and,0,0
179625,within,0,0
179626,groups,0,0
179627,during,0,0
179628,the,0,0
179629,sedation,0,1
179630,(,0,0
179631,P,0,0
179632,<,0,0
179633,0.05,0,0
179634,),0,0
179635,.,0,0
179636,CONCLUSION,0,0
179637,Both,0,0
179638,forms,0,0
179639,of,0,1
179640,midazolam,0,0
179641,",",0,1
179642,IM,0,1
179643,and,0,1
179644,IV,0,1
179645,",",0,0
179646,are,1,0
179647,effective,1,1
179648,and,1,1
179649,safe,1,1
179650,for,0,0
179651,paediatric,0,0
179652,sedation,0,1
179653,in,0,0
179654,ED,0,0
179655,.,0,0
179656,Although,0,0
179657,the,0,0
179658,sedative,0,1
179659,with,0,0
179660,IV,0,1
179661,form,0,0
179662,might,0,0
179663,appear,0,0
179664,sooner,0,1
179665,",",0,1
179666,IM,0,1
179667,form,0,0
179668,of,0,0
179669,midazolam,0,0
179670,can,0,0
179671,be,0,0
179672,effectively,0,0
179673,used,0,0
179674,in,0,0
179675,patient,0,0
179676,with,0,0
179677,limited,0,0
179678,IV,0,1
179679,access,0,1
179680,.,0,0
179681,Patients,0,0
179682,are,0,0
179683,better,0,0
179684,to,0,0
179685,observe,0,0
179686,closely,0,0
179687,for,0,0
179688,psychological,0,1
179689,side-effects,0,1
179690,.,0,0
179691,Contact,0,0
179692,lens,0,0
179693,lipid,0,1
179694,spoliation,0,0
179695,of,0,1
179696,hydrogel,0,0
179697,and,0,1
179698,silicone,0,0
179699,hydrogel,0,0
179700,lenses,0,0
179701,.,0,0
179702,PURPOSE,0,0
179703,The,0,0
179704,purpose,0,0
179705,of,0,0
179706,the,0,0
179707,study,0,0
179708,was,0,0
179709,to,0,0
179710,measure,0,0
179711,contact,0,0
179712,lens,0,0
179713,lipid,0,1
179714,spoliation,0,0
179715,of,0,1
179716,silicone,0,0
179717,hydrogel,0,0
179718,PureVision,0,0
179719,(,0,0
179720,balafilcon,0,0
179721,A,0,0
179722,),0,1
179723,and,0,1
179724,hydrogel,0,0
179725,Acuvue,0,0
179726,2,0,0
179727,(,0,0
179728,etafilcon,0,0
179729,A,0,0
179730,),0,0
179731,contact,0,0
179732,lenses,0,0
179733,worn,0,0
179734,for,0,0
179735,10,0,0
179736,hours,0,0
179737,single,0,0
179738,use,0,1
179739,(,0,1
179740,DD,0,0
179741,),0,0
179742,and,0,0
179743,7,0,0
179744,days,0,0
179745,of,0,0
179746,extended,0,0
179747,wear,0,1
179748,(,0,1
179749,EW,0,1
179750,),0,0
179751,.,0,0
179752,METHODS,0,0
179753,Two,0,0
179754,similar,0,0
179755,study,0,0
179756,populations,0,1
179757,(,0,1
179758,DD,0,0
179759,",",0,0
179760,n,0,0
179761,=,0,0
179762,55,0,0
179763,;,0,0
179764,EW,0,0
179765,",",0,0
179766,n,0,0
179767,=,0,0
179768,53,0,0
179769,),0,0
179770,",",0,0
179771,were,0,0
179772,enrolled,0,0
179773,at,0,0
179774,four,0,0
179775,study,0,0
179776,sites,0,0
179777,.,0,0
179778,In,0,0
179779,each,0,0
179780,population,0,0
179781,",",0,0
179782,a,0,0
179783,bilateral,0,0
179784,",",0,0
179785,randomized,0,0
179786,",",0,1
179787,crossover,0,0
179788,(,0,1
179789,lens,0,1
179790,material,0,1
179791,),0,1
179792,",",0,0
179793,subject-masked,0,0
179794,experimental,0,0
179795,design,0,0
179796,was,0,0
179797,followed,0,0
179798,.,0,0
179799,Worn,0,0
179800,contact,0,1
179801,lenses,0,1
179802,were,0,0
179803,analyzed,0,0
179804,for,0,0
179805,lipid,0,1
179806,uptake,0,1
179807,using,0,0
179808,high-performance,0,0
179809,liquid,0,0
179810,chromatography,0,0
179811,by,0,0
179812,two,0,0
179813,laboratories,0,0
179814,:,0,0
179815,Alcon,0,0
179816,Laboratories,0,0
179817,(,0,0
179818,right,0,1
179819,lens,0,0
179820,total,0,1
179821,uptake,0,1
179822,),0,1
179823,and,0,1
179824,OTG,0,1
179825,Research,0,1
179826,&,0,1
179827,Consultancy,0,1
179828,(,0,0
179829,left,0,0
179830,lens,0,0
179831,total,0,1
179832,uptake,0,1
179833,and,0,1
179834,individual,0,1
179835,lipid,0,1
179836,classes,0,0
179837,),0,0
179838,.,0,0
179839,RESULTS,0,0
179840,Lipid,1,0
179841,uptake,1,1
179842,was,0,0
179843,different,0,0
179844,for,0,0
179845,the,0,0
179846,two,0,0
179847,materials,0,0
179848,:,0,0
179849,total,1,1
179850,lipid,1,1
179851,(,0,0
179852,p,0,0
179853,<,0,0
179854,0.007,0,0
179855,),0,0
179856,",",0,0
179857,cholesterol,1,1
179858,esters,1,1
179859,(,0,0
179860,p,0,0
179861,<,0,0
179862,0.001,0,0
179863,),0,0
179864,",",0,0
179865,cholesterol,1,1
179866,(,0,1
179867,p,0,0
179868,<,0,0
179869,0.001,0,0
179870,EW,0,0
179871,only,0,0
179872,),0,0
179873,",",0,0
179874,and,0,1
179875,triglycerides/phospholipids,1,1
179876,(,0,1
179877,p,0,0
179878,<,0,0
179879,0.001,0,0
179880,),0,0
179881,were,0,0
179882,higher,0,0
179883,for,0,0
179884,balafilcon,0,0
179885,A,0,0
179886,",",0,1
179887,whereas,0,0
179888,fatty,1,1
179889,acid,1,1
179890,(,0,0
179891,p,0,0
179892,<,0,0
179893,0.0025,0,0
179894,EW,0,0
179895,only,0,0
179896,),0,0
179897,was,0,0
179898,higher,0,0
179899,for,0,0
179900,etafilcon,0,0
179901,A,0,0
179902,.,0,0
179903,The,0,0
179904,ratio,1,1
179905,of,1,0
179906,the,1,0
179907,extracted,1,0
179908,lipids,1,1
179909,was,0,0
179910,also,0,0
179911,different,0,0
179912,:,0,0
179913,higher,0,0
179914,percentages,0,1
179915,of,0,1
179916,triglycerides/phospholipids,1,1
179917,(,0,0
179918,p,0,0
179919,<,0,0
179920,0.001,0,0
179921,),0,0
179922,and,0,0
179923,cholesterol,1,1
179924,(,0,1
179925,p,0,0
179926,<,0,0
179927,0.001,0,0
179928,EW,0,0
179929,only,0,0
179930,),0,0
179931,for,0,0
179932,balafilcon,0,0
179933,A,0,0
179934,and,0,0
179935,higher,0,0
179936,percentages,0,1
179937,of,0,1
179938,fatty,1,1
179939,acids/di-,1,1
179940,and,1,1
179941,monoglycerides,1,1
179942,(,0,1
179943,p,0,0
179944,<,0,0
179945,0.014,0,0
179946,),0,0
179947,for,0,0
179948,etafilcon,0,0
179949,A,0,0
179950,.,0,1
179951,CONCLUSIONS,0,0
179952,Total,1,1
179953,lipid,1,1
179954,uptake,1,1
179955,was,0,0
179956,highly,0,0
179957,material,0,0
179958,dependent,0,0
179959,.,0,0
179960,Both,0,0
179961,laboratories,0,0
179962,measured,0,0
179963,a,0,0
179964,greater,0,0
179965,uptake,1,1
179966,of,1,1
179967,lipids,1,1
179968,by,0,0
179969,the,0,0
179970,silicone,0,0
179971,hydrogel,0,0
179972,than,0,0
179973,the,0,0
179974,hydrogel,0,0
179975,material,0,0
179976,",",0,0
179977,a,0,0
179978,difference,0,0
179979,that,0,0
179980,was,0,0
179981,evident,0,0
179982,after,0,0
179983,only,0,0
179984,10,0,0
179985,hours,0,0
179986,of,0,0
179987,DD,0,0
179988,.,0,0
179989,Total,1,1
179990,lipid,1,1
179991,uptake,1,1
179992,was,0,0
179993,greater,0,0
179994,after,0,0
179995,7,0,0
179996,days,0,0
179997,of,0,0
179998,EW,0,0
179999,compared,0,0
180000,with,0,0
180001,10,0,0
180002,hours,0,0
180003,of,0,0
180004,DD,0,0
180005,.,0,0
180006,Of,0,0
180007,interest,0,0
180008,for,0,0
180009,contact,0,1
180010,lens,0,1
180011,spoliation,0,0
180012,and,0,0
180013,its,0,1
180014,avoidance,0,1
180015,was,0,0
180016,the,0,0
180017,differential,0,1
180018,lipid,0,1
180019,uptake,0,1
180020,profile,0,1
180021,",",0,1
180022,indicating,0,0
180023,material,0,1
180024,selectivity,0,1
180025,.,0,1
180026,Whereas,0,0
180027,greater,0,1
180028,differentiation,0,1
180029,between,0,1
180030,materials,0,0
180031,was,0,0
180032,possible,0,0
180033,after,0,0
180034,7,0,0
180035,days,0,0
180036,of,0,0
180037,EW,0,0
180038,for,0,0
180039,each,0,0
180040,material,0,0
180041,",",0,0
180042,the,0,0
180043,lipid,0,1
180044,uptake,0,1
180045,profile,0,1
180046,was,0,0
180047,similar,0,0
180048,for,0,0
180049,DD,0,0
180050,and,0,1
180051,EW,0,1
180052,",",0,0
180053,indicating,0,0
180054,a,0,0
180055,greater,0,0
180056,material,0,1
180057,effect,0,1
180058,than,0,0
180059,a,0,0
180060,wear,0,1
180061,modality,0,0
180062,effect,0,0
180063,.,0,0
180064,A,0,0
180065,comparison,0,0
180066,of,0,0
180067,multiphasic,0,0
180068,oral,0,0
180069,contraceptives,0,0
180070,containing,0,0
180071,norgestimate,0,0
180072,or,0,1
180073,desogestrel,0,0
180074,in,0,0
180075,acne,1,1
180076,treatment,0,0
180077,:,0,0
180078,a,0,0
180079,randomized,0,0
180080,trial,0,0
180081,.,0,0
180082,OBJECTIVE,0,0
180083,This,0,0
180084,study,0,0
180085,aimed,0,0
180086,to,0,0
180087,compare,0,0
180088,the,0,0
180089,effectiveness,0,1
180090,and,0,1
180091,safety,0,1
180092,of,0,1
180093,triphasic,0,0
180094,combined,0,0
180095,oral,0,0
180096,contraceptives,0,0
180097,(,0,0
180098,OCs,0,0
180099,),0,0
180100,containing,0,0
180101,ethinyl,0,0
180102,estradiol,0,0
180103,(,0,1
180104,EE,0,1
180105,),0,1
180106,and,0,1
180107,norgestimate,0,0
180108,(,0,1
180109,NGM,0,0
180110,),0,1
180111,and,0,1
180112,biphasic,0,0
180113,combined,0,0
180114,OCs,0,0
180115,containing,0,0
180116,EE,0,1
180117,and,0,1
180118,desogestrel,0,0
180119,(,0,1
180120,DSG,0,1
180121,),0,0
180122,in,0,0
180123,the,0,0
180124,treatment,0,0
180125,of,0,0
180126,mild,0,0
180127,to,0,0
180128,moderate,0,0
180129,acne,0,1
180130,.,0,0
180131,STUDY,0,0
180132,DESIGN,0,0
180133,This,0,0
180134,was,0,0
180135,an,0,0
180136,investigator-blinded,0,0
180137,",",0,0
180138,randomized,0,0
180139,",",0,0
180140,parallel,0,0
180141,group,0,0
180142,trial,0,0
180143,conducted,0,0
180144,at,0,0
180145,3,0,0
180146,centers,0,0
180147,in,0,0
180148,Thailand,0,0
180149,.,0,0
180150,Female,0,0
180151,subjects,0,0
180152,18-45,0,0
180153,years,0,0
180154,old,0,0
180155,were,0,0
180156,assigned,0,0
180157,to,0,0
180158,one,0,0
180159,or,0,0
180160,the,0,0
180161,other,0,0
180162,OCs,0,0
180163,and,0,1
180164,evaluated,0,0
180165,for,0,0
180166,efficacy,0,1
180167,and,0,1
180168,safety,0,1
180169,parameters,0,1
180170,at,0,0
180171,the,0,0
180172,baseline,0,0
180173,visit,0,1
180174,and,0,0
180175,after,0,0
180176,1,0,0
180177,",",0,0
180178,3,0,0
180179,and,0,0
180180,6,0,0
180181,months,0,0
180182,of,0,0
180183,treatment,0,0
180184,.,0,0
180185,RESULTS,0,0
180186,Among,0,0
180187,201,0,0
180188,randomized,0,0
180189,subjects,0,0
180190,",",0,0
180191,data,0,0
180192,from,0,0
180193,93,0,0
180194,subjects,0,0
180195,in,0,0
180196,the,0,0
180197,EE/NGM,0,1
180198,group,0,0
180199,and,0,0
180200,95,0,0
180201,subjects,0,0
180202,in,0,0
180203,the,0,0
180204,EE/DSG,0,0
180205,group,0,0
180206,were,0,0
180207,analyzed,0,0
180208,.,0,0
180209,After,0,0
180210,6,0,0
180211,months,0,0
180212,of,0,0
180213,treatment,0,0
180214,with,0,0
180215,EE/NGM,0,1
180216,and,0,1
180217,EE/DSG,0,1
180218,",",0,0
180219,no,0,0
180220,differences,0,0
180221,between,0,0
180222,formulations,0,0
180223,were,0,0
180224,found,0,0
180225,for,0,0
180226,the,0,0
180227,decrease,1,1
180228,in,1,0
180229,total,1,1
180230,acne,1,1
180231,lesion,1,1
180232,counts,1,1
180233,(,0,0
180234,74.4,0,0
180235,%,0,0
180236,vs.,0,0
180237,65.1,0,0
180238,%,0,0
180239,",",0,0
180240,respectively,0,0
180241,",",0,0
180242,p=.070,0,0
180243,),0,1
180244,or,0,0
180245,facial,1,1
180246,improvement,1,1
180247,score,1,1
180248,.,1,0
180249,More,0,0
180250,women,0,0
180251,using,0,0
180252,EE/NGM,0,0
180253,showed,0,0
180254,a,0,0
180255,decrease,0,1
180256,in,0,0
180257,severity,1,1
180258,of,1,1
180259,facial,1,1
180260,seborrhea,1,1
180261,than,0,0
180262,those,0,0
180263,using,0,0
180264,EE/DSG,0,1
180265,(,0,1
180266,p=.005,0,0
180267,),0,0
180268,.,0,0
180269,No,0,0
180270,changes,1,1
180271,in,1,0
180272,weight,1,1
180273,were,0,0
180274,noted,0,0
180275,in,0,0
180276,either,0,0
180277,group,0,0
180278,as,0,0
180279,compared,0,0
180280,to,0,0
180281,baseline,0,0
180282,.,0,0
180283,CONCLUSION,0,0
180284,Multiphasic,0,1
180285,OCs,0,0
180286,containing,0,0
180287,EE/NGM,0,1
180288,and,0,1
180289,EE/DSG,0,1
180290,provided,0,0
180291,comparable,0,0
180292,efficacy,1,1
180293,and,1,1
180294,tolerability,1,1
180295,in,0,0
180296,the,0,0
180297,treatment,0,0
180298,of,0,0
180299,acne,0,1
180300,.,0,0
180301,However,0,0
180302,",",0,0
180303,EE/NGM,0,1
180304,had,0,0
180305,a,0,0
180306,more,0,0
180307,beneficial,0,0
180308,effect,0,1
180309,on,0,0
180310,facial,1,1
180311,seborrhea,1,1
180312,reduction,0,1
180313,than,0,0
180314,EE/DSG,0,0
180315,.,0,0
180316,IMPLICATIONS,0,1
180317,EE/NGM,0,1
180318,and,0,0
180319,EE/DSG,0,0
180320,are,0,0
180321,multiphasic,0,0
180322,OCs,0,0
180323,",",0,1
180324,which,0,0
180325,were,0,0
180326,shown,0,0
180327,to,0,0
180328,be,0,0
180329,clinically,0,0
180330,equally,0,0
180331,effective,0,0
180332,for,0,0
180333,mild,0,0
180334,to,0,0
180335,moderate,0,0
180336,facial,0,1
180337,acne,0,1
180338,",",0,0
180339,and,0,0
180340,the,0,0
180341,multiphasic,0,0
180342,combined,0,0
180343,OC,0,0
180344,with,0,0
180345,NGM,0,0
180346,was,0,0
180347,more,0,0
180348,effective,0,1
180349,for,0,0
180350,women,0,0
180351,with,0,0
180352,facial,0,1
180353,seborrhea,0,1
180354,.,0,0
180355,Clinicians,0,0
180356,may,0,0
180357,apply,0,0
180358,the,0,0
180359,results,0,0
180360,of,0,0
180361,this,0,0
180362,study,0,0
180363,when,0,0
180364,considering,0,0
180365,treatment,0,0
180366,options,0,0
180367,for,0,0
180368,facial,0,1
180369,acne,0,1
180370,and,0,1
180371,seborrhea,0,1
180372,.,0,0
180373,Assessing,0,0
180374,the,0,0
180375,benefit,1,0
180376,of,0,0
180377,a,0,0
180378,personalized,0,0
180379,EHR-generated,0,0
180380,informed,0,0
180381,consent,0,0
180382,in,0,0
180383,a,0,0
180384,dental,0,0
180385,school,0,0
180386,setting,0,0
180387,.,0,0
180388,Informed,0,0
180389,consents,0,0
180390,are,0,0
180391,routinely,0,0
180392,used,0,0
180393,as,0,0
180394,an,0,0
180395,important,0,0
180396,source,0,0
180397,of,0,0
180398,information,0,0
180399,to,0,0
180400,help,0,0
180401,patients,0,0
180402,make,0,0
180403,appropriate,0,0
180404,clinical,0,0
180405,decisions,0,0
180406,.,0,0
180407,However,0,0
180408,",",0,0
180409,current,0,0
180410,standard,0,0
180411,consent,0,0
180412,forms,0,0
180413,may,0,0
180414,not,0,0
180415,accomplish,0,0
180416,their,0,0
180417,intended,0,0
180418,purpose,0,0
180419,due,0,0
180420,to,0,0
180421,the,0,0
180422,variety,0,0
180423,of,0,0
180424,patient,0,1
180425,literacy,0,1
180426,and,0,1
180427,experiences,0,1
180428,and,0,1
180429,",",0,0
180430,in,0,0
180431,the,0,0
180432,dental,0,0
180433,school,0,0
180434,setting,0,0
180435,",",0,0
180436,the,0,0
180437,developing,0,0
180438,competence,0,1
180439,of,0,0
180440,students,0,0
180441,.,0,0
180442,The,0,0
180443,purpose,0,0
180444,of,0,0
180445,this,0,0
180446,pilot,0,0
180447,study,0,0
180448,was,0,0
180449,to,0,0
180450,test,0,0
180451,the,0,0
180452,efficacy,1,1
180453,of,0,0
180454,a,0,0
180455,personalized,0,0
180456,informed,0,0
180457,consent,0,0
180458,generated,0,0
180459,through,0,0
180460,an,0,0
180461,electronic,0,0
180462,health,0,1
180463,record,0,1
180464,(,0,1
180465,EHR,0,1
180466,),0,0
180467,at,0,0
180468,one,0,0
180469,dental,0,0
180470,school,0,0
180471,and,0,0
180472,its,0,0
180473,role,0,0
180474,in,0,0
180475,patient,0,1
180476,decision,0,1
180477,making,0,1
180478,.,0,0
180479,In,0,0
180480,the,0,0
180481,study,0,0
180482,",",0,0
180483,a,0,0
180484,set,0,0
180485,of,0,0
180486,informed,0,1
180487,consents,0,0
180488,",",0,1
180489,or,0,1
180490,SmartConsents,0,1
180491,",",0,1
180492,were,0,0
180493,developed,0,0
180494,for,0,0
180495,specific,0,0
180496,diagnoses,0,1
180497,and,0,1
180498,procedures,0,0
180499,",",0,1
180500,enhanced,0,0
180501,with,0,0
180502,graphics,0,0
180503,",",0,1
180504,and,0,1
180505,delivered,0,0
180506,through,0,0
180507,the,0,0
180508,school,0,1
180509,'s,0,0
180510,EHR,0,1
180511,.,0,0
180512,Fifty,0,0
180513,patients,0,0
180514,were,0,0
180515,recruited,0,0
180516,in,0,0
180517,the,0,0
180518,school,0,1
180519,'s,0,1
180520,Urgent,0,1
180521,Care,0,1
180522,Clinic,0,0
180523,and,0,1
180524,divided,0,0
180525,evenly,0,0
180526,into,0,0
180527,two,0,0
180528,groups,0,0
180529,:,0,0
180530,one,0,0
180531,(,0,0
180532,control,0,0
180533,),0,0
180534,receiving,0,0
180535,the,0,0
180536,standard,0,0
180537,consent,0,1
180538,",",0,0
180539,with,0,0
180540,the,0,0
180541,second,0,0
180542,receiving,0,0
180543,a,0,0
180544,SmartConsent,0,1
180545,.,0,0
180546,Following,0,1
180547,treatment,0,0
180548,",",0,1
180549,patients,0,0
180550,were,0,0
180551,assessed,0,0
180552,based,0,0
180553,on,0,0
180554,demographics,1,1
180555,",",1,0
180556,decisional,1,1
180557,conflict,1,1
180558,",",1,1
180559,satisfaction,1,1
180560,",",1,1
180561,health,1,1
180562,literacy,1,1
180563,",",1,1
180564,and,1,1
180565,knowledge,1,1
180566,.,1,1
180567,Overall,0,1
180568,",",0,0
180569,there,0,0
180570,were,0,0
180571,no,0,0
180572,significant,0,0
180573,differences,0,0
180574,in,0,0
180575,main,1,0
180576,effects,1,1
180577,between,0,0
180578,SmartConsent,0,1
180579,and,0,1
180580,standard,0,0
180581,informed,0,1
180582,consents,0,0
180583,for,0,0
180584,decisional,1,1
180585,conflict,1,1
180586,and,1,1
180587,satisfaction,1,1
180588,",",0,1
180589,although,0,0
180590,significant,0,0
180591,differences,0,0
180592,were,0,0
180593,identified,0,0
180594,during,0,0
180595,secondary,0,0
180596,analysis,0,0
180597,of,0,1
180598,satisfaction,1,1
180599,",",1,1
180600,gender,1,1
180601,",",1,1
180602,and,1,1
180603,ethnicity,1,0
180604,.,1,0
180605,The,0,0
180606,study,0,0
180607,also,0,0
180608,demonstrated,0,0
180609,the,0,0
180610,potential,0,0
180611,for,0,0
180612,consents,0,0
180613,to,0,0
180614,aid,0,0
180615,the,0,0
180616,student,0,0
180617,provider,0,1
180618,in,0,0
180619,better,1,0
180620,communicating,1,1
180621,with,1,0
180622,patients,1,0
180623,.,1,0
180624,The,0,0
180625,effects,0,0
180626,of,0,0
180627,a,0,0
180628,course,0,0
180629,of,0,0
180630,intranasal,0,0
180631,oxytocin,0,1
180632,on,0,0
180633,social,0,1
180634,behaviors,0,1
180635,in,0,0
180636,youth,0,0
180637,diagnosed,0,0
180638,with,0,0
180639,autism,0,0
180640,spectrum,0,0
180641,disorders,0,0
180642,:,0,0
180643,a,0,0
180644,randomized,0,0
180645,controlled,0,0
180646,trial,0,0
180647,.,0,0
180648,BACKGROUND,0,0
180649,There,0,0
180650,is,0,0
180651,increasing,0,0
180652,interest,0,0
180653,in,0,0
180654,oxytocin,0,0
180655,as,0,0
180656,a,0,0
180657,therapeutic,0,0
180658,to,0,0
180659,treat,0,0
180660,social,0,1
180661,deficits,0,1
180662,in,0,0
180663,autism,0,0
180664,spectrum,0,0
180665,disorders,0,1
180666,(,0,1
180667,ASD,0,0
180668,),0,0
180669,.,0,0
180670,The,0,0
180671,aim,0,0
180672,of,0,0
180673,this,0,0
180674,study,0,0
180675,was,0,0
180676,to,0,0
180677,investigate,0,0
180678,the,0,0
180679,efficacy,0,1
180680,of,0,0
180681,a,0,0
180682,course,0,0
180683,of,0,0
180684,oxytocin,0,1
180685,nasal,0,1
180686,spray,0,0
180687,to,0,0
180688,improve,0,0
180689,social,0,1
180690,behavior,0,1
180691,in,0,0
180692,youth,0,0
180693,with,0,0
180694,ASD,0,0
180695,.,0,0
180696,METHODS,0,0
180697,In,0,0
180698,a,0,0
180699,double-blind,0,0
180700,",",0,0
180701,placebo-controlled,0,0
180702,trial,0,0
180703,across,0,0
180704,two,0,0
180705,Australian,0,0
180706,university,0,0
180707,sites,0,0
180708,between,0,0
180709,February,0,0
180710,2009,0,0
180711,and,0,0
180712,January,0,0
180713,2012,0,0
180714,",",0,0
180715,50,0,0
180716,male,0,0
180717,participants,0,0
180718,aged,0,0
180719,between,0,0
180720,12,0,0
180721,and,0,0
180722,18,0,0
180723,years,0,0
180724,",",0,0
180725,with,0,0
180726,Autistic,0,1
180727,or,0,0
180728,Asperger,0,1
180729,'s,0,1
180730,Disorder,0,0
180731,",",0,1
180732,were,0,0
180733,randomized,0,0
180734,to,0,0
180735,receive,0,0
180736,either,0,0
180737,oxytocin,0,1
180738,(,0,0
180739,n,0,0
180740,=,0,0
180741,26,0,0
180742,),0,0
180743,or,0,0
180744,placebo,0,0
180745,(,0,1
180746,n,0,0
180747,=,0,0
180748,24,0,0
180749,),0,0
180750,nasal,0,0
180751,sprays,0,0
180752,(,0,0
180753,either,0,0
180754,18,0,0
180755,or,0,0
180756,24,0,0
180757,International,0,0
180758,Units,0,0
180759,),0,1
180760,",",0,0
180761,administered,0,0
180762,twice-daily,0,0
180763,for,0,0
180764,8,0,0
180765,weeks,0,0
180766,.,0,0
180767,Participants,0,0
180768,were,0,0
180769,assessed,0,0
180770,at,0,0
180771,baseline,0,0
180772,",",0,0
180773,after,0,0
180774,4-,0,0
180775,and,0,0
180776,8-weeks,0,0
180777,of,0,0
180778,treatment,0,0
180779,",",0,1
180780,and,0,1
180781,at,0,1
180782,3-month,0,1
180783,follow-up,0,0
180784,.,0,0
180785,Primary,0,1
180786,outcomes,0,1
180787,were,0,0
180788,change,0,1
180789,in,0,0
180790,total,1,1
180791,scores,1,1
180792,on,1,0
180793,the,1,0
180794,caregiver-completed,1,0
180795,Social,1,1
180796,Responsiveness,1,1
180797,Scale,1,1
180798,and,1,1
180799,clinician-ratings,1,1
180800,on,1,0
180801,the,1,0
180802,Clinical,1,1
180803,Global,1,1
180804,Impressions-Improvement,1,1
180805,scale,1,1
180806,.,1,0
180807,Secondary,0,0
180808,assessments,0,0
180809,included,0,0
180810,caregiver,1,1
180811,reports,1,0
180812,of,1,1
180813,repetitive,1,1
180814,and,1,1
180815,other,1,0
180816,developmental,1,1
180817,behaviors,1,1
180818,and,1,1
180819,social,1,1
180820,cognition,1,1
180821,.,1,0
180822,CLINICAL,0,0
180823,TRIAL,0,0
180824,REGISTRATION,0,0
180825,Australian,0,0
180826,New,0,1
180827,Zealand,0,0
180828,Clinical,0,1
180829,Trials,0,1
180830,Registry,0,0
180831,www.anzctr.org.au,0,0
180832,ACTRN12609000513213,0,0
180833,.,0,1
180834,RESULTS,0,0
180835,Participants,0,0
180836,who,0,0
180837,received,0,0
180838,oxytocin,0,0
180839,showed,0,0
180840,no,0,0
180841,benefit,0,0
180842,following,0,0
180843,treatment,0,0
180844,on,0,0
180845,primary,0,0
180846,or,0,0
180847,secondary,0,1
180848,outcomes,0,1
180849,.,0,0
180850,However,0,0
180851,",",0,0
180852,caregivers,0,0
180853,who,0,0
180854,believed,0,0
180855,their,0,0
180856,children,0,0
180857,received,0,0
180858,oxytocin,0,0
180859,reported,0,0
180860,greater,0,0
180861,improvements,0,0
180862,compared,0,0
180863,to,0,0
180864,caregivers,0,0
180865,who,0,0
180866,believed,0,0
180867,their,0,0
180868,child,0,1
180869,received,0,0
180870,placebo,0,0
180871,.,0,1
180872,Nasal,0,1
180873,sprays,0,0
180874,were,0,0
180875,well,0,0
180876,tolerated,1,1
180877,and,0,0
180878,there,0,0
180879,was,0,0
180880,no,0,0
180881,evidence,0,0
180882,of,0,0
180883,increased,0,1
180884,side,1,1
180885,effects,1,1
180886,resulting,0,0
180887,from,0,0
180888,oxytocin,0,1
180889,administration,0,0
180890,.,0,0
180891,CONCLUSIONS,0,0
180892,This,0,0
180893,is,0,0
180894,the,0,0
180895,first,0,0
180896,evaluation,0,0
180897,of,0,0
180898,the,0,0
180899,efficacy,0,1
180900,for,0,0
180901,a,0,0
180902,course,0,0
180903,of,0,0
180904,oxytocin,0,1
180905,treatment,0,0
180906,for,0,0
180907,youth,0,0
180908,with,0,0
180909,ASD,0,0
180910,.,0,0
180911,Although,0,0
180912,results,0,0
180913,did,0,0
180914,not,0,0
180915,suggest,0,0
180916,clinical,0,1
180917,efficacy,0,1
180918,",",0,1
180919,further,0,0
180920,research,0,0
180921,is,0,0
180922,needed,0,0
180923,to,0,0
180924,explore,0,0
180925,alternative,0,0
180926,delivery,0,1
180927,methods,0,0
180928,",",0,1
180929,earlier,0,0
180930,age,0,1
180931,of,0,1
180932,intervention,0,0
180933,",",0,0
180934,and,0,1
180935,the,0,0
180936,influence,0,1
180937,of,0,1
180938,caregiver,0,1
180939,expectation,0,1
180940,on,0,0
180941,treatment,0,0
180942,response,0,1
180943,.,0,0
180944,A,0,0
180945,randomized,0,0
180946,",",0,0
180947,double-blind,0,0
180948,",",0,1
180949,placebo-controlled,0,0
180950,pilot,0,0
180951,study,0,0
180952,of,0,0
180953,naltrexone,0,0
180954,to,0,0
180955,counteract,0,0
180956,antipsychotic-associated,1,1
180957,weight,1,1
180958,gain,1,1
180959,:,1,0
180960,proof,0,0
180961,of,0,0
180962,concept,0,0
180963,.,0,0
180964,Patients,0,0
180965,with,0,0
180966,schizophrenia,0,0
180967,experience,0,1
180968,higher,0,0
180969,rates,0,1
180970,of,0,1
180971,obesity,0,0
180972,as,0,0
180973,well,0,0
180974,as,0,0
180975,related,0,1
180976,morbidity,0,1
180977,and,0,1
180978,mortality,0,1
180979,than,0,0
180980,the,0,0
180981,general,0,0
180982,population,0,0
180983,does,0,0
180984,.,0,0
180985,Women,0,0
180986,with,0,0
180987,schizophrenia,0,0
180988,are,0,0
180989,at,0,0
180990,particular,0,0
180991,risk,0,1
180992,for,0,0
180993,antipsychotic-associated,1,1
180994,weight,1,1
180995,gain,1,1
180996,",",1,1
180997,obesity,1,1
180998,",",1,1
180999,and,1,1
181000,related,1,1
181001,medical,1,1
181002,disorders,1,0
181003,such,0,0
181004,as,0,0
181005,diabetes,1,0
181006,and,0,1
181007,cardiovascular,1,1
181008,disease,1,1
181009,.,1,0
181010,Given,0,1
181011,preclinical,0,0
181012,studies,0,0
181013,revealing,0,0
181014,the,0,0
181015,role,0,0
181016,of,0,0
181017,the,0,0
181018,endogenous,0,1
181019,opioid,0,0
181020,systems,0,0
181021,in,0,0
181022,human,0,0
181023,appetite,0,1
181024,and,0,0
181025,the,0,0
181026,potential,0,0
181027,of,0,0
181028,antipsychotic,0,0
181029,medications,0,0
181030,to,0,0
181031,interfere,0,0
181032,with,0,0
181033,this,0,0
181034,system,0,0
181035,",",0,0
181036,we,0,0
181037,hypothesized,0,0
181038,that,0,0
181039,opioid,0,0
181040,antagonists,0,0
181041,may,0,0
181042,be,0,0
181043,beneficial,0,0
181044,in,0,0
181045,arresting,0,1
181046,antipsychotic-associated,1,1
181047,weight,1,1
181048,gain,1,1
181049,and,0,1
181050,promoting,0,0
181051,further,0,0
181052,weight,1,1
181053,loss,1,1
181054,in,0,0
181055,women,0,0
181056,with,0,0
181057,schizophrenia,0,0
181058,.,0,0
181059,In,0,0
181060,the,0,0
181061,present,0,0
181062,study,0,0
181063,",",0,0
181064,24,0,0
181065,overweight,0,0
181066,women,0,0
181067,with,0,0
181068,a,0,0
181069,diagnosis,0,0
181070,of,0,1
181071,schizophrenia,0,1
181072,or,0,1
181073,schizoaffective,0,1
181074,disorder,0,0
181075,were,0,0
181076,randomized,0,0
181077,to,0,0
181078,placebo,0,0
181079,or,0,0
181080,naltrexone,0,0
181081,(,0,1
181082,NTX,0,0
181083,),0,0
181084,25,0,0
181085,mg/d,0,0
181086,for,0,0
181087,8,0,0
181088,weeks,0,0
181089,.,0,0
181090,The,0,0
181091,primary,0,0
181092,outcome,0,1
181093,measure,0,1
181094,was,0,0
181095,a,0,0
181096,change,1,1
181097,in,1,0
181098,body,1,1
181099,weight,1,1
181100,from,1,0
181101,baseline,1,0
181102,.,1,0
181103,The,0,0
181104,patients,0,0
181105,in,0,0
181106,the,0,0
181107,NTX,0,1
181108,group,0,0
181109,had,0,0
181110,significant,1,0
181111,weight,1,1
181112,loss,1,1
181113,(,0,0
181114,-3.40,0,0
181115,kg,0,0
181116,),0,0
181117,compared,0,0
181118,with,0,0
181119,weight,1,1
181120,gain,1,1
181121,(,0,1
181122,+1.37,0,0
181123,kg,0,0
181124,),0,0
181125,in,0,0
181126,the,0,0
181127,patients,0,0
181128,in,0,0
181129,the,0,0
181130,placebo,0,0
181131,group,0,0
181132,.,0,0
181133,Mainly,0,0
181134,",",0,0
181135,nondiabetic,0,0
181136,subjects,0,0
181137,lost,1,0
181138,weight,1,1
181139,in,0,0
181140,the,0,0
181141,NTX,0,0
181142,arm,0,0
181143,.,0,0
181144,These,0,0
181145,data,0,0
181146,support,0,0
181147,the,0,0
181148,need,0,0
181149,to,0,0
181150,further,0,0
181151,investigate,0,0
181152,the,0,0
181153,role,0,0
181154,of,0,0
181155,D2,0,0
181156,blockade,0,1
181157,in,0,0
181158,reducing,0,0
181159,food,1,0
181160,reward-based,1,1
181161,overeating,1,1
181162,.,1,0
181163,A,0,0
181164,larger,0,0
181165,study,0,0
181166,addressing,0,0
181167,the,0,0
181168,weaknesses,0,0
181169,of,0,0
181170,this,0,0
181171,pilot,0,0
181172,study,0,0
181173,is,0,0
181174,currently,0,0
181175,underway,0,0
181176,.,0,0
181177,Methylprednisolone,0,0
181178,in,0,0
181179,patients,0,0
181180,with,0,0
181181,cancer,0,0
181182,using,0,0
181183,opioids,0,0
181184,.,0,0
181185,Efficacy,0,1
181186,of,0,1
181187,rhubarb,0,0
181188,combined,0,0
181189,with,0,0
181190,early,0,0
181191,enteral,0,0
181192,nutrition,0,0
181193,for,0,0
181194,the,0,0
181195,treatment,0,0
181196,of,0,0
181197,severe,0,1
181198,acute,0,0
181199,pancreatitis,0,0
181200,:,0,0
181201,a,0,0
181202,randomized,0,0
181203,controlled,0,0
181204,trial,0,0
181205,.,0,0
181206,OBJECTIVE,0,0
181207,To,0,0
181208,investigate,0,0
181209,the,0,0
181210,effect,0,0
181211,of,0,0
181212,rhubarb,0,0
181213,combined,0,0
181214,with,0,0
181215,early,0,0
181216,enteral,0,0
181217,nutrition,0,1
181218,(,0,1
181219,EEN,0,0
181220,),0,0
181221,on,0,0
181222,the,0,0
181223,gastrointestinal,0,1
181224,function,0,1
181225,",",0,1
181226,disease,0,1
181227,severity,0,1
181228,and,0,1
181229,systemic,0,1
181230,inflammation,0,1
181231,in,0,0
181232,patients,0,0
181233,with,0,0
181234,severe,0,1
181235,acute,0,1
181236,pancreatitis,0,1
181237,(,0,1
181238,SAP,0,1
181239,),0,1
181240,.,0,0
181241,METHODS,0,0
181242,A,0,0
181243,total,0,1
181244,of,0,0
181245,126,0,0
181246,patients,0,0
181247,with,0,0
181248,SAP,0,1
181249,were,0,0
181250,randomly,0,0
181251,assigned,0,0
181252,into,0,0
181253,three,0,0
181254,groups,0,0
181255,:,0,0
181256,parenteral,0,0
181257,nutrition,0,1
181258,group,0,0
181259,",",0,1
181260,treated,0,0
181261,with,0,0
181262,standard,0,0
181263,solution,0,0
181264,first,0,1
181265,and,0,0
181266,EN,0,0
181267,14,0,0
181268,days,0,0
181269,later,0,0
181270,;,0,0
181271,EEN,0,0
181272,group,0,0
181273,",",0,0
181274,treated,0,0
181275,with,0,0
181276,EN,0,0
181277,suspension,0,0
181278,;,0,0
181279,or,0,0
181280,EEN,0,0
181281,combined,0,0
181282,with,0,0
181283,rhubarb,0,0
181284,group,0,0
181285,",",0,1
181286,treated,0,0
181287,with,0,0
181288,rhubarb,0,0
181289,and,0,0
181290,then,0,0
181291,EN,0,0
181292,2,0,0
181293,h,0,0
181294,later,0,0
181295,.,0,0
181296,The,0,0
181297,gastrointestinal,1,1
181298,function,1,1
181299,",",1,1
181300,APACHE,1,1
181301,II,1,0
181302,scores,1,1
181303,",",1,0
181304,the,1,0
181305,levels,1,1
181306,of,1,0
181307,plasma,1,1
181308,IL-6,1,0
181309,",",1,1
181310,IL-11,1,0
181311,",",1,1
181312,C-reactive,1,1
181313,proteins,1,1
181314,(,1,0
181315,CRP,1,1
181316,),1,0
181317,and,1,0
181318,the,1,0
181319,liver,1,1
181320,and,1,1
181321,kidney,1,0
181322,functional,1,1
181323,measures,1,1
181324,were,0,0
181325,longitudinally,0,0
181326,analyzed,0,0
181327,.,0,0
181328,RESULTS,0,0
181329,Patients,0,0
181330,in,0,0
181331,the,0,0
181332,EEN/rhubarb,0,0
181333,group,0,0
181334,had,0,0
181335,the,0,0
181336,shortest,0,1
181337,period,1,0
181338,of,1,1
181339,abdominal,1,1
181340,pain,1,1
181341,and,1,0
181342,the,1,0
181343,fastest,1,1
181344,recovery,1,1
181345,from,1,0
181346,abnormal,1,1
181347,bowel,1,1
181348,movement,1,1
181349,and,1,1
181350,high,1,1
181351,fever,1,1
181352,as,0,0
181353,well,0,0
181354,as,0,0
181355,significantly,0,0
181356,shorter,0,1
181357,periods,0,0
181358,of,0,1
181359,intensive-care,0,1
181360,unit,0,0
181361,and,0,1
181362,hospital,0,1
181363,stays,0,1
181364,.,0,0
181365,The,0,0
181366,combination,0,0
181367,of,0,1
181368,EEN,0,0
181369,and,0,1
181370,rhubarb,0,0
181371,significantly,0,0
181372,reduced,0,0
181373,the,0,0
181374,values,0,0
181375,of,0,0
181376,APACHE,1,1
181377,II,1,0
181378,scores,1,1
181379,.,1,0
181380,Combination,0,0
181381,therapies,0,0
181382,significantly,0,0
181383,reduced,0,0
181384,abnormally,0,0
181385,higher,0,0
181386,white,1,0
181387,blood,1,1
181388,cell,1,1
181389,(,1,1
181390,WBC,1,1
181391,),1,1
181392,counts,1,1
181393,and,1,1
181394,levels,1,1
181395,of,1,1
181396,plasma,1,1
181397,CRP,1,1
181398,and,1,1
181399,IL-6,1,1
181400,",",0,1
181401,but,0,0
181402,increased,0,0
181403,the,0,0
181404,levels,1,1
181405,of,1,0
181406,plasma,1,1
181407,IL-11,1,0
181408,.,1,1
181409,Finally,0,0
181410,",",0,0
181411,combination,0,0
181412,therapies,0,0
181413,improved,0,0
181414,the,0,0
181415,SAP-related,0,1
181416,damages,0,1
181417,of,0,1
181418,liver,1,1
181419,and,1,1
181420,kidney,1,0
181421,function,1,1
181422,by,0,0
181423,reducing,0,0
181424,abnormally,0,0
181425,higher,0,0
181426,levels,1,1
181427,of,1,1
181428,plasma,1,1
181429,alanine,1,1
181430,aminotransferase,1,1
181431,",",1,1
181432,aspartate,1,1
181433,aminotransferase,1,1
181434,",",1,1
181435,and,1,1
181436,creatinine,1,1
181437,(,1,1
181438,Cr,1,0
181439,),1,0
181440,.,1,0
181441,CONCLUSION,0,0
181442,Combination,0,1
181443,of,0,1
181444,EEN,0,0
181445,and,0,1
181446,rhubarb,0,0
181447,significantly,0,0
181448,improved,0,0
181449,the,0,0
181450,gastrointestinal,0,1
181451,function,0,1
181452,",",0,1
181453,inhibited,0,1
181454,systemic,0,1
181455,inflammation,0,1
181456,and,0,1
181457,disease,0,1
181458,severity,0,1
181459,and,0,1
181460,mitigated,0,0
181461,the,0,0
181462,disease-related,0,1
181463,damages,0,1
181464,of,0,1
181465,liver,0,1
181466,and,0,1
181467,kidney,0,0
181468,function,0,1
181469,in,0,0
181470,SAP,0,1
181471,patients,0,0
181472,.,0,0
181473,Efficacy,0,1
181474,of,0,1
181475,artemisinin-based,0,0
181476,combination,0,0
181477,treatments,0,0
181478,of,0,1
181479,uncomplicated,0,0
181480,falciparum,0,0
181481,malaria,0,1
181482,in,0,0
181483,under-five-year-old,0,0
181484,Nigerian,0,0
181485,children,0,0
181486,.,0,0
181487,The,0,0
181488,efficacy,0,1
181489,of,0,0
181490,3-day,0,0
181491,regimens,0,0
181492,of,0,1
181493,artemether-lumefantrine,0,0
181494,and,0,1
181495,artesunate-amodiaquine,0,0
181496,were,0,0
181497,evaluated,0,0
181498,in,0,0
181499,747,0,0
181500,children,0,0
181501,<,0,0
181502,5,0,0
181503,years,0,0
181504,of,0,0
181505,age,0,0
181506,with,0,0
181507,uncomplicated,0,0
181508,malaria,0,0
181509,from,0,0
181510,six,0,0
181511,geographical,0,0
181512,areas,0,0
181513,of,0,0
181514,Nigeria,0,0
181515,.,0,0
181516,Fever,0,1
181517,clearance,1,1
181518,was,0,0
181519,significantly,0,0
181520,faster,0,0
181521,(,0,1
181522,P,0,0
181523,=,0,0
181524,0.006,0,0
181525,),0,0
181526,and,0,0
181527,the,0,0
181528,proportion,0,1
181529,of,0,0
181530,children,0,0
181531,with,0,0
181532,parasitemia,0,1
181533,1,0,0
181534,day,0,0
181535,after,0,0
181536,treatment,0,0
181537,began,0,0
181538,was,0,0
181539,significantly,0,0
181540,lower,0,0
181541,(,0,0
181542,P,0,0
181543,=,0,0
181544,0.016,0,0
181545,),0,0
181546,in,0,0
181547,artesunate-amodiaquine-compared,0,0
181548,with,0,0
181549,artemether-lumefantrine-treated,0,0
181550,children,0,0
181551,.,0,0
181552,Parasite,1,1
181553,clearance,1,1
181554,times,0,1
181555,were,0,0
181556,similar,0,0
181557,with,0,0
181558,both,0,0
181559,treatments,0,0
181560,.,0,0
181561,Overall,0,1
181562,efficacy,0,1
181563,was,0,0
181564,96.3,0,0
181565,%,0,0
181566,(,0,0
181567,95,0,0
181568,%,0,0
181569,confidence,0,0
181570,interval,0,0
181571,[,0,0
181572,CI,0,0
181573,],0,0
181574,94.5-97.6,0,0
181575,%,0,0
181576,),0,0
181577,",",0,1
181578,and,0,1
181579,was,0,0
181580,similar,0,0
181581,for,0,0
181582,both,0,0
181583,regimens,0,0
181584,.,0,0
181585,Polymerase,1,1
181586,chain,1,0
181587,reaction-corrected,1,1
181588,parasitologic,1,1
181589,cure,1,1
181590,rates,1,1
181591,on,0,0
181592,Day,0,0
181593,28,0,0
181594,were,0,0
181595,96.9,0,0
181596,%,0,0
181597,(,0,0
181598,95,0,0
181599,%,0,0
181600,CI,0,0
181601,93.9-98.2,0,0
181602,%,0,0
181603,),0,0
181604,and,0,0
181605,98.3,0,0
181606,%,0,0
181607,(,0,0
181608,95,0,0
181609,%,0,0
181610,CI,0,0
181611,96.1-99.3,0,0
181612,%,0,0
181613,),0,0
181614,for,0,0
181615,artemether-lumefantrine,0,0
181616,and,0,1
181617,artesunate-amodiaquine,0,0
181618,",",0,0
181619,respectively,0,0
181620,.,0,0
181621,Gametocyte,1,1
181622,carriage,1,1
181623,post,1,1
181624,treatment,1,0
181625,was,0,0
181626,significantly,0,0
181627,lower,0,0
181628,than,0,0
181629,pretreatment,0,0
181630,(,0,0
181631,P,0,0
181632,<,0,0
181633,0.0001,0,0
181634,),0,0
181635,.,0,0
181636,In,0,0
181637,anemic,0,0
181638,children,0,0
181639,",",0,1
181640,mean,1,1
181641,time,1,1
181642,to,1,0
181643,recovery,1,1
181644,from,1,0
181645,anemia,1,1
181646,was,0,0
181647,10,0,0
181648,days,0,0
181649,(,0,0
181650,95,0,0
181651,%,0,0
181652,CI,0,0
181653,9.04-10.9,0,0
181654,),0,0
181655,and,0,0
181656,was,0,0
181657,similar,0,0
181658,for,0,0
181659,both,0,0
181660,regimens,0,0
181661,.,0,0
181662,Both,0,0
181663,treatments,0,0
181664,were,0,0
181665,well,1,0
181666,tolerated,1,1
181667,and,1,0
181668,are,1,0
181669,safe,1,1
181670,and,1,1
181671,efficacious,1,1
181672,treatments,1,0
181673,of,0,1
181674,uncomplicated,0,0
181675,falciparum,0,0
181676,malaria,0,1
181677,in,0,0
181678,young,0,0
181679,Nigerian,0,0
181680,children,0,0
181681,.,0,0
181682,Dental,0,0
181683,prophylaxis,0,0
181684,decreases,0,0
181685,the,0,0
181686,risk,0,1
181687,of,0,0
181688,esophageal,1,1
181689,cancer,1,0
181690,in,0,0
181691,males,0,0
181692,;,0,0
181693,a,0,0
181694,nationwide,0,0
181695,population-based,0,0
181696,study,0,0
181697,in,0,0
181698,Taiwan,0,0
181699,.,0,0
181700,BACKGROUND,0,0
181701,Periodontal,0,1
181702,disease,0,1
181703,(,0,1
181704,PD,0,0
181705,),0,0
181706,is,0,0
181707,one,0,0
181708,of,0,0
181709,the,0,0
181710,most,0,0
181711,common,0,0
181712,chronic,0,0
181713,inflammatory,0,1
181714,diseases,0,0
181715,.,0,1
181716,Esophageal,1,1
181717,cancer,1,0
181718,(,1,1
181719,EC,1,1
181720,),1,0
181721,is,0,0
181722,also,0,0
181723,a,0,0
181724,common,0,0
181725,cause,0,0
181726,of,0,1
181727,death,0,1
181728,due,0,0
181729,to,0,0
181730,cancer,0,0
181731,among,0,0
181732,males,0,0
181733,.,0,0
181734,Systemic,0,0
181735,inflammatory,0,1
181736,processes,0,0
181737,have,0,0
181738,been,0,0
181739,shown,0,0
181740,to,0,0
181741,increase,0,0
181742,the,0,0
181743,risk,0,1
181744,of,0,0
181745,cancer,1,0
181746,.,1,0
181747,We,0,0
181748,conducted,0,0
181749,a,0,0
181750,retrospective,0,0
181751,cohort,0,0
181752,study,0,0
181753,to,0,0
181754,investigate,0,0
181755,the,0,0
181756,association,0,0
181757,between,0,0
181758,PD,1,1
181759,and,1,0
181760,EC,1,1
181761,.,1,1
181762,METHODS,0,0
181763,A,0,0
181764,total,0,1
181765,of,0,0
181766,"718,409",0,0
181767,subjects,0,0
181768,were,0,0
181769,recruited,0,0
181770,from,0,0
181771,the,0,0
181772,Taiwan,0,0
181773,National,0,1
181774,Health,0,1
181775,Insurance,0,1
181776,Research,0,1
181777,Database,0,1
181778,(,0,1
181779,NHIRD,0,1
181780,),0,1
181781,and,0,1
181782,followed,0,0
181783,from,0,0
181784,January,0,0
181785,1,0,0
181786,",",0,0
181787,2000,0,0
181788,to,0,0
181789,December,0,0
181790,31,0,0
181791,",",0,0
181792,2010,0,0
181793,.,0,0
181794,Of,0,0
181795,these,0,0
181796,",",0,0
181797,"519,831",0,0
181798,subjects,0,0
181799,were,0,0
181800,diagnosed,0,0
181801,with,0,0
181802,PD,0,1
181803,and,0,1
181804,were,0,0
181805,grouped,0,0
181806,according,0,0
181807,to,0,0
181808,the,0,0
181809,most,0,0
181810,advanced,0,0
181811,treatment,0,0
181812,they,0,0
181813,received,0,0
181814,:,0,0
181815,dental,0,1
181816,prophylaxis,0,0
181817,",",0,1
181818,intensive,0,0
181819,treatment,0,0
181820,",",0,0
181821,or,0,0
181822,no,0,0
181823,treatment,0,0
181824,.,0,0
181825,The,0,0
181826,IRs,1,0
181827,of,1,1
181828,EC,1,1
181829,were,0,0
181830,compared,0,0
181831,among,0,0
181832,groups,0,0
181833,.,0,0
181834,RESULTS,0,0
181835,A,0,0
181836,total,0,0
181837,of,0,0
181838,682,0,0
181839,patients,0,0
181840,developed,0,0
181841,EC,1,1
181842,",",0,0
181843,resulting,0,0
181844,in,0,0
181845,an,0,0
181846,overall,1,1
181847,IR,1,0
181848,of,0,0
181849,0.11,0,0
181850,case-number,0,0
181851,per,0,0
181852,1000,0,0
181853,person-years,0,0
181854,(,0,0
181855,?/y,0,0
181856,),0,0
181857,.,0,0
181858,The,0,0
181859,dental,0,0
181860,prophylaxis,0,0
181861,group,0,0
181862,had,0,0
181863,a,0,0
181864,significantly,0,0
181865,lower,1,0
181866,IR,1,0
181867,of,1,1
181868,EC,1,1
181869,(,1,0
181870,0.06?/y,0,0
181871,),0,0
181872,than,0,0
181873,other,0,0
181874,groups,0,0
181875,(,0,0
181876,p,0,0
181877,<,0,0
181878,0.001,1,0
181879,),1,0
181880,.,1,0
181881,Multivariable,1,0
181882,Cox,1,0
181883,regression,1,1
181884,analysis,1,0
181885,further,1,0
181886,revealed,0,0
181887,that,0,0
181888,male,0,0
181889,subjects,0,0
181890,[,0,0
181891,hazard,0,1
181892,ratio,0,1
181893,(,0,1
181894,HR,0,1
181895,),0,0
181896,=,0,0
181897,10.04,0,0
181898,",",0,0
181899,95,0,0
181900,%,0,0
181901,confidence,0,0
181902,interval,0,0
181903,(,0,1
181904,CI,0,0
181905,),0,1
181906,=,0,0
181907,7.58-13.30,0,0
181908,],0,0
181909,",",0,0
181910,as,0,0
181911,well,0,0
181912,as,0,0
181913,a,0,0
181914,history,0,1
181915,of,0,0
181916,esophageal,0,1
181917,ulcers,0,1
181918,(,0,0
181919,HR,0,1
181920,=,0,0
181921,7.10,0,0
181922,",",0,0
181923,95,0,0
181924,%,0,0
181925,CI,0,0
181926,=,0,0
181927,5.03-10.01,0,0
181928,),0,1
181929,",",0,0
181930,alcohol,0,1
181931,abuse,0,1
181932,(,0,1
181933,HR,0,1
181934,=,0,0
181935,5.46,0,0
181936,",",0,0
181937,95,0,0
181938,%,0,0
181939,CI,0,0
181940,=,0,0
181941,2.26-13.18,0,0
181942,),0,1
181943,",",0,0
181944,or,0,1
181945,esophageal,0,1
181946,reflux,0,1
181947,(,0,0
181948,HR,0,1
181949,=,0,0
181950,1.86,0,0
181951,",",0,0
181952,95,0,0
181953,%,0,0
181954,CI,0,0
181955,=,0,0
181956,1.02-3.52,0,0
181957,),0,1
181958,",",0,0
181959,were,0,0
181960,factors,0,1
181961,associated,0,0
181962,with,0,0
181963,a,0,0
181964,higher,0,0
181965,risk,0,1
181966,of,0,1
181967,EC,0,1
181968,.,0,0
181969,And,0,0
181970,the,0,0
181971,dental,0,1
181972,prophylaxis,0,0
181973,group,0,0
181974,showed,0,0
181975,a,0,0
181976,significantly,0,0
181977,lower,0,0
181978,risk,0,1
181979,for,1,0
181980,EC,1,1
181981,(,1,0
181982,HR,0,1
181983,=,0,0
181984,0.53,0,0
181985,",",0,0
181986,95,0,0
181987,%,0,0
181988,CI,0,0
181989,=,0,0
181990,0.44-0.65,0,0
181991,),0,0
181992,.,0,0
181993,Further,0,1
181994,subgroup,0,0
181995,analysis,0,0
181996,showed,0,0
181997,that,0,0
181998,the,0,0
181999,dental,0,0
182000,prophylaxis,0,0
182001,group,0,0
182002,among,0,0
182003,males,0,0
182004,had,0,0
182005,a,0,0
182006,significant,0,0
182007,lower,0,1
182008,risk,0,1
182009,(,0,1
182010,HR,0,1
182011,=,0,0
182012,0.54,0,0
182013,",",0,0
182014,95,0,0
182015,%,0,0
182016,CI,0,0
182017,=,0,0
182018,0.44-0.66,0,0
182019,),0,0
182020,for,1,0
182021,EC,1,1
182022,",",0,0
182023,while,0,0
182024,that,0,0
182025,of,0,0
182026,the,0,0
182027,females,0,0
182028,did,0,0
182029,not,0,0
182030,has,0,0
182031,statistically,0,0
182032,significant,0,0
182033,difference,0,0
182034,.,0,1
182035,CONCLUSION,0,0
182036,For,0,0
182037,this,0,0
182038,cohort,0,0
182039,",",0,0
182040,subjects,0,0
182041,received,0,0
182042,dental,0,0
182043,prophylaxis,0,0
182044,reduced,0,0
182045,the,1,0
182046,risk,1,1
182047,of,1,0
182048,EC,1,1
182049,compared,0,0
182050,to,0,0
182051,all,0,0
182052,PD,0,0
182053,and,0,0
182054,no,0,0
182055,PD,0,1
182056,groups,0,0
182057,among,0,0
182058,males,0,0
182059,.,0,0
182060,Inhibition,0,1
182061,of,0,1
182062,PCSK9,0,0
182063,with,0,0
182064,evolocumab,0,0
182065,in,0,0
182066,homozygous,0,1
182067,familial,0,1
182068,hypercholesterolaemia,0,0
182069,(,0,0
182070,TESLA,0,0
182071,Part,0,1
182072,B,0,0
182073,),0,0
182074,:,0,0
182075,a,0,0
182076,randomised,0,0
182077,",",0,0
182078,double-blind,0,0
182079,",",0,1
182080,placebo-controlled,0,0
182081,trial,0,0
182082,.,0,0
182083,BACKGROUND,0,0
182084,Homozygous,0,1
182085,familial,0,1
182086,hypercholesterolaemia,0,0
182087,is,0,0
182088,a,0,0
182089,rare,0,0
182090,",",0,0
182091,serious,0,1
182092,disorder,0,0
182093,caused,0,0
182094,by,0,0
182095,very,0,0
182096,low,0,0
182097,or,0,0
182098,absent,0,1
182099,plasma,0,1
182100,clearance,0,1
182101,of,0,1
182102,LDL,0,1
182103,",",0,0
182104,substantially,0,0
182105,raised,0,0
182106,LDL,0,1
182107,cholesterol,0,1
182108,",",0,1
182109,and,0,1
182110,accelerated,1,1
182111,development,1,1
182112,of,1,1
182113,cardiovascular,1,1
182114,disease,1,1
182115,.,1,0
182116,Conventional,0,0
182117,lipid-lowering,0,0
182118,treatments,0,0
182119,are,0,0
182120,modestly,0,0
182121,effective,0,0
182122,.,0,0
182123,Evolocumab,0,0
182124,",",0,0
182125,a,0,0
182126,monoclonal,0,0
182127,antibody,0,0
182128,to,0,0
182129,proprotein,0,1
182130,convertase,0,1
182131,subtilisin/kexin,0,1
182132,type,0,0
182133,9,0,0
182134,(,0,0
182135,PCSK9,0,0
182136,),0,1
182137,",",0,0
182138,reduced,0,1
182139,LDL,1,1
182140,cholesterol,1,1
182141,by,0,0
182142,16,0,0
182143,%,0,0
182144,in,0,0
182145,a,0,0
182146,pilot,0,0
182147,study,0,0
182148,.,0,0
182149,We,0,0
182150,now,0,0
182151,report,0,0
182152,results,0,0
182153,with,0,0
182154,evolocumab,0,0
182155,in,0,0
182156,a,0,0
182157,randomised,0,0
182158,",",0,0
182159,double-blind,0,0
182160,",",0,1
182161,placebo-controlled,0,0
182162,phase,0,0
182163,3,0,0
182164,trial,0,0
182165,.,0,0
182166,METHODS,0,0
182167,This,0,0
182168,randomised,0,0
182169,",",0,0
182170,double-blind,0,0
182171,",",0,1
182172,placebo-controlled,0,0
182173,phase,0,0
182174,3,0,0
182175,trial,0,0
182176,was,0,0
182177,undertaken,0,0
182178,at,0,0
182179,17,0,0
182180,sites,0,0
182181,in,0,0
182182,ten,0,0
182183,countries,0,0
182184,in,0,0
182185,North,0,0
182186,America,0,1
182187,",",0,1
182188,Europe,0,0
182189,",",0,0
182190,the,0,0
182191,Middle,0,1
182192,East,0,1
182193,",",0,1
182194,and,0,1
182195,South,0,1
182196,Africa,0,0
182197,.,0,0
182198,50,0,0
182199,eligible,0,0
182200,patients,0,0
182201,(,0,0
182202,aged,0,0
182203,?12,0,0
182204,years,0,0
182205,),0,0
182206,with,0,0
182207,homozygous,0,1
182208,familial,0,1
182209,hypercholesterolaemia,0,0
182210,",",0,0
182211,on,0,0
182212,stable,0,1
182213,lipid-regulating,0,1
182214,therapy,0,0
182215,for,0,0
182216,at,0,0
182217,least,0,0
182218,4,0,0
182219,weeks,0,0
182220,",",0,0
182221,and,0,1
182222,not,0,0
182223,receiving,0,0
182224,lipoprotein,0,1
182225,apheresis,0,1
182226,",",0,1
182227,were,0,0
182228,randomly,0,0
182229,allocated,0,0
182230,by,0,0
182231,a,0,0
182232,computer-generated,0,0
182233,randomisation,0,0
182234,sequence,0,0
182235,in,0,0
182236,a,0,0
182237,2:1,0,0
182238,ratio,0,0
182239,to,0,0
182240,receive,0,0
182241,subcutaneous,0,0
182242,evolocumab,0,0
182243,420,0,0
182244,mg,0,0
182245,or,0,0
182246,placebo,0,0
182247,every,0,0
182248,4,0,0
182249,weeks,0,0
182250,for,0,0
182251,12,0,0
182252,weeks,0,0
182253,.,0,0
182254,Randomisation,0,0
182255,was,0,0
182256,stratified,0,0
182257,by,0,0
182258,LDL,0,1
182259,cholesterol,0,1
182260,at,0,0
182261,screening,0,0
182262,(,0,0
182263,<,0,0
182264,11,0,0
182265,mmol/L,0,0
182266,or,0,0
182267,?11,0,1
182268,mmol/L,0,0
182269,),0,1
182270,and,0,1
182271,implemented,0,0
182272,by,0,0
182273,a,0,0
182274,computerised,0,0
182275,interactive,0,1
182276,voice-response,0,1
182277,system,0,0
182278,.,0,1
182279,Patients,0,0
182280,",",0,0
182281,study,0,0
182282,personnel,0,1
182283,",",0,0
182284,and,0,0
182285,the,0,0
182286,funder,0,0
182287,were,0,0
182288,masked,0,0
182289,to,0,0
182290,treatment,0,0
182291,and,0,0
182292,to,0,0
182293,the,0,0
182294,efficacy,0,1
182295,results,0,0
182296,by,0,0
182297,the,0,0
182298,central,0,1
182299,laboratory,0,0
182300,not,0,0
182301,returning,0,0
182302,LDL,0,1
182303,cholesterol,0,1
182304,or,0,0
182305,any,0,1
182306,lipid,0,1
182307,results,0,0
182308,to,0,0
182309,the,0,0
182310,clinical,0,0
182311,sites,0,0
182312,after,0,0
182313,the,0,0
182314,baseline,0,0
182315,visit,0,1
182316,.,0,0
182317,The,0,0
182318,primary,0,0
182319,endpoint,0,1
182320,was,0,0
182321,percentage,0,1
182322,change,1,1
182323,in,1,0
182324,ultracentrifugation,1,0
182325,LDL,1,1
182326,cholesterol,1,1
182327,from,1,0
182328,baseline,0,0
182329,at,0,0
182330,week,0,0
182331,12,0,0
182332,compared,0,0
182333,with,0,0
182334,placebo,0,0
182335,",",0,0
182336,analysed,0,0
182337,by,0,0
182338,intention-to-treat,0,0
182339,.,0,0
182340,This,0,0
182341,trial,0,0
182342,is,0,0
182343,registered,0,0
182344,with,0,0
182345,ClinicalTrials.gov,0,0
182346,",",0,0
182347,number,0,1
182348,NCT01588496,0,0
182349,.,0,1
182350,FINDINGS,0,0
182351,Of,0,0
182352,the,0,0
182353,50,0,0
182354,eligible,0,0
182355,patients,0,0
182356,randomly,0,0
182357,assigned,0,0
182358,to,0,0
182359,the,0,0
182360,two,0,0
182361,treatment,0,0
182362,groups,0,0
182363,",",0,0
182364,49,0,0
182365,actually,0,0
182366,received,0,0
182367,the,0,0
182368,study,0,0
182369,drug,0,1
182370,and,0,1
182371,completed,0,0
182372,the,0,0
182373,study,0,0
182374,(,0,0
182375,16,0,0
182376,in,0,0
182377,the,0,0
182378,placebo,0,0
182379,group,0,0
182380,and,0,0
182381,33,0,0
182382,in,0,0
182383,the,0,0
182384,evolocumab,0,0
182385,group,0,0
182386,),0,0
182387,.,0,0
182388,Compared,0,0
182389,with,0,0
182390,placebo,0,0
182391,",",0,0
182392,evolocumab,0,0
182393,significantly,0,0
182394,reduced,1,0
182395,ultracentrifugation,1,0
182396,LDL,1,1
182397,cholesterol,1,1
182398,at,1,0
182399,12,0,0
182400,weeks,0,0
182401,by,0,0
182402,30?9,0,0
182403,%,0,0
182404,(,0,0
182405,95,0,0
182406,%,0,0
182407,CI,0,0
182408,-43?9,0,1
182409,%,0,0
182410,to,0,0
182411,-18?0,0,0
182412,%,0,0
182413,;,0,0
182414,p,0,0
182415,<,0,0
182416,0?0001,1,0
182417,),1,0
182418,.,1,0
182419,Treatment-emergent,1,1
182420,adverse,1,1
182421,events,1,1
182422,occurred,0,0
182423,in,0,0
182424,ten,0,0
182425,(,0,0
182426,63,0,0
182427,%,0,0
182428,),0,0
182429,of,0,0
182430,16,0,0
182431,patients,0,0
182432,in,0,0
182433,the,0,0
182434,placebo,0,0
182435,group,0,0
182436,and,0,0
182437,12,0,0
182438,(,0,0
182439,36,0,0
182440,%,0,0
182441,),0,0
182442,of,0,0
182443,33,0,0
182444,in,0,0
182445,the,0,0
182446,evolocumab,0,0
182447,group,0,0
182448,.,0,0
182449,No,0,0
182450,serious,0,1
182451,clinical,0,0
182452,or,0,0
182453,laboratory,0,1
182454,adverse,0,1
182455,events,0,1
182456,occurred,0,0
182457,",",0,0
182458,and,0,0
182459,no,0,0
182460,anti-evolocumab,1,0
182461,antibody,1,1
182462,development,1,1
182463,was,1,0
182464,detected,1,0
182465,during,0,0
182466,the,0,0
182467,study,0,0
182468,.,0,0
182469,INTERPRETATION,0,0
182470,In,0,0
182471,patients,0,0
182472,with,0,0
182473,homozygous,0,1
182474,familial,0,1
182475,hypercholesterolaemia,0,0
182476,receiving,0,0
182477,stable,0,1
182478,background,0,0
182479,lipid-lowering,0,0
182480,treatment,0,0
182481,and,0,1
182482,not,0,0
182483,on,0,0
182484,apheresis,0,0
182485,",",0,0
182486,evolocumab,0,0
182487,420,0,0
182488,mg,0,0
182489,administered,0,0
182490,every,0,0
182491,4,0,0
182492,weeks,0,0
182493,was,0,0
182494,well,0,0
182495,tolerated,1,1
182496,and,1,0
182497,significantly,1,0
182498,reduced,0,0
182499,LDL,1,1
182500,cholesterol,1,1
182501,compared,1,0
182502,with,0,0
182503,placebo,0,0
182504,.,0,0
182505,FUNDING,0,0
182506,Amgen,0,0
182507,Inc,0,0
182508,.,0,0
182509,Secondary,0,0
182510,analysis,0,0
182511,of,0,0
182512,RTOG,0,0
182513,9508,0,0
182514,",",0,0
182515,a,0,0
182516,phase,0,0
182517,3,0,0
182518,randomized,0,0
182519,trial,0,0
182520,of,0,1
182521,whole-brain,0,0
182522,radiation,0,0
182523,therapy,0,0
182524,versus,0,0
182525,WBRT,0,0
182526,plus,0,0
182527,stereotactic,0,0
182528,radiosurgery,0,0
182529,in,0,0
182530,patients,0,0
182531,with,0,0
182532,1-3,0,0
182533,brain,0,1
182534,metastases,0,0
182535,;,0,0
182536,poststratified,0,0
182537,by,0,0
182538,the,0,0
182539,graded,0,1
182540,prognostic,0,1
182541,assessment,0,0
182542,(,0,1
182543,GPA,0,1
182544,),0,0
182545,.,0,0
182546,PURPOSE,0,0
182547,Radiation,0,1
182548,Therapy,0,0
182549,Oncology,0,1
182550,Group,0,0
182551,(,0,1
182552,RTOG,0,1
182553,),0,0
182554,9508,0,0
182555,showed,0,0
182556,a,0,0
182557,survival,0,1
182558,advantage,0,0
182559,for,0,0
182560,patients,0,0
182561,with,0,0
182562,1,0,0
182563,but,0,0
182564,not,0,0
182565,2,0,0
182566,or,0,0
182567,3,0,0
182568,brain,0,1
182569,metastasis,0,1
182570,(,0,1
182571,BM,0,1
182572,),0,1
182573,treated,0,0
182574,with,0,0
182575,whole-brain,0,0
182576,radiation,0,0
182577,therapy,0,0
182578,(,0,1
182579,WBRT,0,0
182580,),0,1
182581,and,0,1
182582,stereotactic,0,0
182583,radiosurgery,0,0
182584,(,0,1
182585,SRS,0,1
182586,),0,1
182587,versus,0,0
182588,WBRT,0,0
182589,alone,0,0
182590,.,0,0
182591,An,0,0
182592,improved,0,1
182593,prognostic,0,1
182594,index,0,1
182595,",",0,0
182596,the,0,0
182597,graded,0,1
182598,prognostic,0,1
182599,assessment,0,0
182600,(,0,1
182601,GPA,0,1
182602,),0,0
182603,has,0,0
182604,been,0,0
182605,developed,0,0
182606,.,0,0
182607,Our,0,0
182608,hypothesis,0,0
182609,was,0,0
182610,that,0,0
182611,if,0,0
182612,the,0,0
182613,data,0,0
182614,from,0,0
182615,RTOG,0,0
182616,9508,0,0
182617,were,0,0
182618,poststratified,0,0
182619,by,0,0
182620,the,0,0
182621,GPA,0,1
182622,",",0,0
182623,the,0,0
182624,conclusions,0,0
182625,may,0,0
182626,vary,0,0
182627,.,0,0
182628,METHODS,0,0
182629,AND,0,0
182630,MATERIALS,0,0
182631,In,0,0
182632,this,0,0
182633,analysis,0,0
182634,",",0,0
182635,252,0,0
182636,of,0,0
182637,the,0,0
182638,331,0,0
182639,patients,0,0
182640,were,0,0
182641,evaluable,0,0
182642,by,0,0
182643,GPA,0,1
182644,.,0,0
182645,Of,0,0
182646,those,0,0
182647,",",0,0
182648,211,0,0
182649,had,0,0
182650,lung,0,0
182651,cancer,0,0
182652,.,0,1
182653,Breast,0,1
182654,cancer,0,0
182655,patients,0,0
182656,were,0,0
182657,excluded,0,0
182658,because,0,0
182659,the,0,0
182660,components,0,0
182661,of,0,0
182662,the,0,0
182663,breast,0,0
182664,GPA,0,1
182665,are,0,0
182666,not,0,0
182667,in,0,0
182668,the,0,0
182669,RTOG,0,1
182670,database,0,0
182671,.,0,1
182672,Multiple,0,1
182673,Cox,0,1
182674,regression,0,1
182675,was,0,0
182676,used,0,0
182677,to,0,0
182678,compare,0,0
182679,survival,0,1
182680,between,0,0
182681,treatment,0,0
182682,groups,0,0
182683,",",0,0
182684,adjusting,0,0
182685,for,0,0
182686,GPA,0,1
182687,.,0,0
182688,Treatment,0,0
182689,comparisons,0,0
182690,within,0,0
182691,subgroups,0,0
182692,were,0,0
182693,performed,0,0
182694,with,0,0
182695,the,0,0
182696,log-rank,0,0
182697,test,0,0
182698,.,0,0
182699,A,0,0
182700,free,0,1
182701,online,0,0
182702,tool,0,1
182703,(,0,1
182704,brainmetgpa.com,0,0
182705,),0,1
182706,simplified,0,1
182707,GPA,0,1
182708,use,0,0
182709,.,0,0
182710,RESULTS,0,0
182711,The,0,0
182712,fundamental,0,0
182713,conclusions,0,0
182714,of,0,0
182715,the,0,0
182716,primary,0,0
182717,analysis,0,0
182718,were,0,0
182719,confirmed,0,0
182720,in,0,0
182721,that,0,0
182722,there,0,0
182723,was,0,0
182724,no,0,0
182725,survival,1,1
182726,benefit,1,0
182727,overall,0,1
182728,for,0,0
182729,patients,0,0
182730,with,0,0
182731,1,0,0
182732,to,0,0
182733,3,0,0
182734,metastases,0,0
182735,;,0,0
182736,however,0,0
182737,",",0,0
182738,there,0,0
182739,was,0,0
182740,a,0,0
182741,benefit,0,0
182742,for,0,0
182743,the,0,0
182744,subset,0,0
182745,of,0,0
182746,patients,0,0
182747,with,0,0
182748,GPA,0,0
182749,3.5,0,0
182750,to,0,0
182751,4.0,0,0
182752,(,0,0
182753,median,0,1
182754,survival,0,1
182755,time,0,1
182756,[,0,0
182757,MST,0,1
182758,],0,0
182759,for,0,0
182760,WBRT,0,0
182761,+,0,0
182762,SRS,0,1
182763,vs,0,0
182764,WBRT,0,0
182765,alone,0,0
182766,was,0,0
182767,21.0,0,0
182768,versus,0,0
182769,10.3,0,0
182770,months,0,0
182771,",",0,0
182772,P=.05,0,1
182773,),0,1
182774,regardless,0,0
182775,of,0,0
182776,the,0,0
182777,number,0,1
182778,of,0,0
182779,metastases,0,0
182780,.,0,0
182781,Among,0,0
182782,patients,0,0
182783,with,0,0
182784,GPA,0,0
182785,3.5,0,0
182786,to,0,0
182787,4.0,0,0
182788,treated,0,0
182789,with,0,0
182790,WBRT,0,0
182791,and,0,1
182792,SRS,0,1
182793,",",0,0
182794,the,0,0
182795,MST,1,1
182796,for,0,0
182797,patients,0,0
182798,with,0,0
182799,1,0,0
182800,versus,0,0
182801,2,0,0
182802,to,0,0
182803,3,0,0
182804,metastases,0,0
182805,was,0,0
182806,21,0,0
182807,and,0,0
182808,14.1,0,0
182809,months,0,0
182810,",",0,0
182811,respectively,0,0
182812,.,0,0
182813,CONCLUSIONS,0,0
182814,This,0,0
182815,secondary,0,0
182816,analysis,0,0
182817,of,0,0
182818,predominantly,0,0
182819,lung,0,0
182820,cancer,0,0
182821,patients,0,0
182822,",",0,0
182823,consistent,0,0
182824,with,0,0
182825,the,0,0
182826,original,0,0
182827,analysis,0,0
182828,",",0,0
182829,shows,0,0
182830,no,0,0
182831,survival,1,1
182832,advantage,1,0
182833,for,0,0
182834,the,0,0
182835,group,0,0
182836,overall,0,1
182837,when,0,0
182838,treated,0,0
182839,with,0,0
182840,WBRT,0,0
182841,and,0,0
182842,SRS,0,1
182843,;,0,0
182844,however,0,0
182845,",",0,0
182846,in,0,0
182847,patients,0,0
182848,with,0,0
182849,high,0,0
182850,GPA,0,1
182851,(,0,0
182852,3.5-4,0,1
182853,),0,1
182854,",",0,0
182855,there,0,0
182856,is,0,0
182857,a,0,0
182858,survival,0,1
182859,advantage,0,0
182860,regardless,0,0
182861,of,0,0
182862,whether,0,0
182863,they,0,0
182864,have,0,0
182865,1,0,0
182866,",",0,0
182867,2,0,0
182868,",",0,0
182869,or,0,0
182870,3,0,0
182871,BM,0,0
182872,.,0,0
182873,This,0,0
182874,benefit,0,0
182875,did,0,0
182876,not,0,0
182877,extend,0,0
182878,to,0,0
182879,patients,0,0
182880,with,0,0
182881,lower,0,0
182882,GPA,0,1
182883,.,0,1
182884,Prospective,0,0
182885,validation,0,0
182886,of,0,0
182887,this,0,0
182888,survival,0,1
182889,benefit,0,0
182890,for,0,0
182891,patients,0,0
182892,with,0,0
182893,multiple,0,0
182894,BM,0,1
182895,and,0,1
182896,high,0,1
182897,GPA,0,1
182898,when,0,0
182899,treated,0,0
182900,with,0,0
182901,WBRT,0,0
182902,and,0,0
182903,SRS,0,0
182904,is,0,0
182905,warranted,0,0
182906,.,0,0
182907,Benefits,0,1
182908,of,0,0
182909,an,0,0
182910,oxygen,0,1
182911,reservoir,0,1
182912,cannula,0,0
182913,versus,0,0
182914,a,0,0
182915,conventional,0,0
182916,nasal,0,1
182917,cannula,0,1
182918,during,0,0
182919,exercise,0,0
182920,in,0,0
182921,hypoxemic,0,1
182922,COPD,0,0
182923,patients,0,0
182924,:,0,0
182925,a,0,0
182926,crossover,0,0
182927,trial,0,0
182928,.,0,0
182929,BACKGROUND,0,0
182930,The,0,0
182931,Oxymizer?,0,0
182932,is,0,0
182933,a,0,0
182934,special,0,0
182935,nasal,0,1
182936,cannula,0,0
182937,that,0,0
182938,provides,0,0
182939,a,0,0
182940,higher,0,0
182941,luminal,0,1
182942,diameter,0,1
182943,in,0,0
182944,combination,0,0
182945,with,0,0
182946,an,0,0
182947,incorporated,0,0
182948,oxygen,0,1
182949,(,0,1
182950,O2,0,1
182951,),0,0
182952,reservoir,0,1
182953,.,0,0
182954,It,0,0
182955,is,0,0
182956,assumed,0,0
182957,that,0,0
182958,a,0,0
182959,higher,0,0
182960,O2,0,0
182961,concentration,0,1
182962,can,0,0
182963,be,0,0
182964,delivered,0,0
182965,breath,0,1
182966,by,0,0
182967,breath,0,1
182968,in,0,0
182969,order,0,0
182970,to,0,0
182971,increase,0,0
182972,oxygenation,0,1
182973,.,0,0
182974,OBJECTIVE,0,0
182975,We,0,0
182976,aimed,0,0
182977,to,0,0
182978,investigate,0,0
182979,the,0,0
182980,effects,0,0
182981,of,0,0
182982,the,0,0
182983,Oxymizer,0,1
182984,on,1,0
182985,endurance,1,1
182986,time,1,1
182987,in,0,0
182988,comparison,0,0
182989,to,0,0
182990,a,0,0
182991,conventional,0,0
182992,nasal,0,1
182993,cannula,0,1
182994,(,0,1
182995,CNC,0,1
182996,),0,0
182997,.,0,0
182998,METHODS,0,0
182999,Forty-three,0,0
183000,patients,0,0
183001,with,0,0
183002,severe,0,1
183003,chronic,0,0
183004,obstructive,0,1
183005,pulmonary,0,1
183006,disease,0,1
183007,(,0,1
183008,COPD,0,1
183009,",",0,0
183010,age,0,0
183011,60,0,0
183012,?,0,0
183013,9,0,0
183014,years,0,0
183015,",",0,0
183016,FEV1,0,0
183017,37,0,0
183018,?,0,0
183019,16,0,0
183020,%,0,0
183021,pred,0,0
183022,.,0,0
183023,),0,0
183024,and,0,0
183025,indications,0,0
183026,for,0,0
183027,LTOT,0,0
183028,were,0,0
183029,recruited,0,0
183030,during,0,0
183031,pulmonary,0,1
183032,rehabilitation,0,0
183033,for,0,0
183034,this,0,0
183035,cross-over,0,0
183036,study,0,0
183037,.,0,0
183038,After,0,0
183039,an,0,0
183040,initial,0,0
183041,maximal,0,1
183042,incremental,0,1
183043,cycle,0,1
183044,test,0,1
183045,",",0,0
183046,all,0,0
183047,patients,0,0
183048,performed,0,0
183049,4,0,0
183050,cycling,0,0
183051,endurance,0,0
183052,time,0,1
183053,tests,0,1
183054,at,0,0
183055,70,0,0
183056,%,0,0
183057,of,0,0
183058,their,0,0
183059,peak,0,1
183060,work,0,1
183061,rate,0,1
183062,(,0,0
183063,twice,0,0
183064,with,0,0
183065,the,0,0
183066,Oxymizer,0,1
183067,and,0,0
183068,twice,0,0
183069,with,0,0
183070,a,0,0
183071,CNC,0,0
183072,",",0,0
183073,in,0,0
183074,reverse,0,1
183075,order,0,0
183076,),0,0
183077,.,0,0
183078,RESULTS,0,0
183079,The,0,0
183080,endurance,1,1
183081,time,1,1
183082,was,1,0
183083,significantly,0,0
183084,higher,0,0
183085,when,0,0
183086,patients,0,0
183087,cycled,0,0
183088,while,0,0
183089,using,0,0
183090,the,0,0
183091,Oxymizer,0,1
183092,in,0,0
183093,comparison,0,0
183094,to,0,0
183095,while,0,0
183096,using,0,0
183097,the,0,0
183098,CNC,0,0
183099,[,0,0
183100,858,0,0
183101,?,0,0
183102,754,0,0
183103,vs.,0,0
183104,766,0,0
183105,?,0,0
183106,652,0,0
183107,s,0,0
183108,;,0,0
183109,between-group,0,0
183110,difference,0,0
183111,92,0,0
183112,s,0,0
183113,(,0,0
183114,95,0,0
183115,%,0,0
183116,confidence,0,0
183117,interval,0,0
183118,32-152,0,1
183119,),0,0
183120,",",0,0
183121,p,0,0
183122,<,0,0
183123,0.001,0,0
183124,],0,0
183125,.,0,0
183126,In,0,0
183127,addition,0,0
183128,to,0,0
183129,a,0,0
183130,longer,1,0
183131,cycling,1,1
183132,duration,1,1
183133,",",1,1
183134,O2,1,1
183135,saturation,1,1
183136,at,1,1
183137,isotime,1,1
183138,was,1,0
183139,significantly,0,0
183140,higher,0,0
183141,with,0,0
183142,the,0,0
183143,Oxymizer,0,1
183144,(,0,0
183145,93.5,0,0
183146,?,0,0
183147,5.4,0,0
183148,vs.,0,0
183149,90.4,0,0
183150,?,0,0
183151,5.3,0,0
183152,%,0,0
183153,;,0,0
183154,p,0,0
183155,=,0,0
183156,0.027,0,0
183157,),0,0
183158,.,0,0
183159,Furthermore,0,0
183160,",",0,0
183161,there,0,0
183162,was,0,0
183163,a,0,0
183164,positive,0,1
183165,correlation,0,0
183166,(,0,0
183167,r,0,1
183168,=,0,0
183169,0.427,0,0
183170,",",0,0
183171,p,0,0
183172,=,0,0
183173,0.002,0,0
183174,),0,0
183175,between,0,0
183176,the,1,0
183177,O2,1,0
183178,flow,1,1
183179,rate,1,1
183180,and,1,1
183181,improvements,1,1
183182,in,1,0
183183,the,1,0
183184,constant,1,1
183185,work,1,1
183186,rate,1,1
183187,test,1,1
183188,",",1,1
183189,showing,0,0
183190,greater,0,1
183191,improvements,0,1
183192,in,0,0
183193,favor,0,0
183194,of,0,0
183195,the,0,0
183196,Oxymizer,0,1
183197,in,0,0
183198,patients,0,0
183199,with,0,0
183200,a,0,0
183201,higher,0,0
183202,demand,0,1
183203,for,0,0
183204,O2,0,1
183205,(,0,0
183206,?,0,0
183207,4,0,0
183208,liters/min,0,0
183209,),0,0
183210,.,0,0
183211,CONCLUSION,0,0
183212,We,0,0
183213,show,0,0
183214,that,0,0
183215,O2,0,1
183216,delivery,0,0
183217,via,0,0
183218,the,0,0
183219,Oxymizer,0,0
183220,is,0,0
183221,superior,0,0
183222,to,0,0
183223,a,0,0
183224,CNC,0,0
183225,with,0,0
183226,regard,0,0
183227,to,0,0
183228,endurance,1,1
183229,capacity,1,1
183230,and,1,1
183231,oxygenation,1,1
183232,during,1,0
183233,exercise,1,0
183234,in,0,0
183235,patients,0,0
183236,with,0,0
183237,severe,0,1
183238,COPD,0,0
183239,.,0,0
183240,It,0,0
183241,seems,0,0
183242,that,0,0
183243,patients,0,0
183244,with,0,0
183245,a,0,0
183246,higher,0,0
183247,demand,0,1
183248,for,0,0
183249,O2,0,1
183250,(,0,0
183251,?,0,0
183252,4,0,0
183253,liters/min,0,0
183254,),0,0
183255,",",0,0
183256,in,0,0
183257,particular,0,0
183258,",",0,0
183259,may,0,0
183260,benefit,0,0
183261,more,0,0
183262,from,0,0
183263,the,0,0
183264,use,0,0
183265,of,0,0
183266,the,0,0
183267,Oxymizer,0,0
183268,.,0,0
183269,Comparison,0,0
183270,of,0,1
183271,insulin,0,1
183272,glargine,0,0
183273,and,0,1
183274,liraglutide,0,0
183275,added,0,0
183276,to,0,0
183277,oral,0,0
183278,agents,0,0
183279,in,0,0
183280,patients,0,0
183281,with,0,0
183282,poorly,0,0
183283,controlled,0,0
183284,type,0,0
183285,2,0,0
183286,diabetes,0,0
183287,.,0,0
183288,AIM,0,0
183289,To,0,0
183290,compare,0,0
183291,safety,0,1
183292,and,0,1
183293,efficacy,0,1
183294,of,0,1
183295,insulin,0,1
183296,glargine,0,0
183297,and,0,1
183298,liraglutide,0,0
183299,in,0,0
183300,patients,0,0
183301,with,0,0
183302,type,0,0
183303,2,0,0
183304,diabetes,0,0
183305,(,0,0
183306,T2DM,0,0
183307,),0,0
183308,.,0,0
183309,METHODS,0,0
183310,This,0,0
183311,randomized,0,0
183312,",",0,0
183313,multinational,0,0
183314,",",0,1
183315,open-label,0,0
183316,trial,0,0
183317,included,0,0
183318,subjects,0,0
183319,treated,0,0
183320,for,0,0
183321,T2DM,0,0
183322,with,0,0
183323,metformin,0,0
183324,?,0,0
183325,sulphonylurea,0,0
183326,",",0,0
183327,who,0,0
183328,had,0,0
183329,glycated,0,1
183330,haemoglobin,0,1
183331,(,0,0
183332,HbA1c,0,0
183333,),0,0
183334,levels,0,1
183335,of,0,0
183336,7.5-12,0,0
183337,%,0,0
183338,.,0,0
183339,Subjects,0,0
183340,were,0,0
183341,assigned,0,0
183342,to,0,0
183343,24,0,0
183344,weeks,0,0
183345,of,0,0
183346,insulin,0,1
183347,glargine,0,0
183348,",",0,0
183349,titrated,0,0
183350,to,0,0
183351,target,0,0
183352,fasting,0,1
183353,plasma,0,1
183354,glucose,0,1
183355,of,0,1
183356,4.0-5.5,0,1
183357,mmol/L,0,0
183358,or,0,1
183359,liraglutide,0,0
183360,",",0,0
183361,escalated,0,0
183362,to,0,0
183363,the,0,0
183364,highest,0,1
183365,approved,0,0
183366,clinical,0,0
183367,dose,0,0
183368,of,0,0
183369,1.8,0,0
183370,mg,0,0
183371,daily,0,0
183372,.,0,0
183373,The,0,0
183374,trial,0,0
183375,was,0,0
183376,powered,0,0
183377,to,0,0
183378,detect,0,0
183379,superiority,0,0
183380,of,0,1
183381,glargine,0,0
183382,over,0,0
183383,liraglutide,0,0
183384,in,0,0
183385,percentage,0,1
183386,of,0,0
183387,people,0,0
183388,reaching,0,1
183389,HbA1c,0,0
183390,<,0,0
183391,7,0,0
183392,%,0,0
183393,.,0,0
183394,RESULTS,0,0
183395,The,0,0
183396,mean,0,1
183397,[,0,0
183398,standard,0,0
183399,deviation,0,1
183400,(,0,0
183401,s.d,0,0
183402,.,0,0
183403,),0,0
183404,],0,0
183405,age,0,0
183406,of,0,0
183407,the,0,0
183408,participants,0,0
183409,was,0,0
183410,57,0,0
183411,(,0,0
183412,9,0,0
183413,),0,0
183414,years,0,0
183415,",",0,0
183416,the,0,0
183417,duration,0,1
183418,of,0,0
183419,diabetes,0,0
183420,was,0,0
183421,9,0,0
183422,(,0,0
183423,6,0,0
183424,),0,0
183425,years,0,0
183426,",",0,1
183427,body,0,1
183428,mass,0,1
183429,index,0,1
183430,was,0,0
183431,31.9,0,0
183432,(,0,0
183433,4.2,0,0
183434,),0,0
183435,kg/m,0,0
183436,(,0,0
183437,2,0,0
183438,),0,0
183439,and,0,0
183440,HbA1c,0,0
183441,level,0,1
183442,was,0,0
183443,9.0,0,0
183444,(,0,0
183445,1.1,0,0
183446,),0,0
183447,%,0,0
183448,.,0,0
183449,Equal,0,1
183450,numbers,0,1
183451,(,0,0
183452,n,0,0
183453,=,0,0
183454,489,0,0
183455,),0,0
183456,were,0,0
183457,allocated,0,0
183458,to,0,0
183459,glargine,0,0
183460,and,0,0
183461,liraglutide,0,0
183462,.,0,0
183463,Similar,0,0
183464,numbers,0,1
183465,of,0,0
183466,subjects,0,0
183467,in,0,0
183468,both,0,0
183469,groups,0,0
183470,attained,0,0
183471,an,1,0
183472,HbA1c,1,0
183473,level,1,1
183474,of,1,0
183475,<,1,0
183476,7,1,0
183477,%,0,0
183478,(,0,0
183479,48.4,0,0
183480,vs.,0,0
183481,45.9,0,0
183482,%,0,0
183483,),0,0
183484,;,0,0
183485,therefore,0,0
183486,",",0,0
183487,superiority,0,1
183488,of,0,1
183489,glargine,0,0
183490,over,0,0
183491,liraglutide,0,0
183492,was,0,0
183493,not,0,0
183494,observed,0,0
183495,(,0,0
183496,p,0,0
183497,=,0,0
183498,0.44,0,0
183499,),0,0
183500,.,0,0
183501,Subjects,0,0
183502,treated,0,0
183503,with,0,0
183504,glargine,0,0
183505,had,0,0
183506,greater,0,0
183507,reductions,0,1
183508,of,0,1
183509,HbA1c,1,0
183510,[,1,0
183511,-1.94,1,0
183512,%,0,0
183513,(,0,0
183514,0.05,0,0
183515,),0,0
183516,and,0,0
183517,-1.79,0,0
183518,%,0,0
183519,(,0,0
183520,0.05,0,0
183521,),0,0
183522,;,0,0
183523,p,0,0
183524,=,0,0
183525,0.019,0,0
183526,],0,0
183527,and,1,0
183528,fasting,1,1
183529,plasma,1,1
183530,glucose,1,1
183531,[,1,0
183532,6.2,0,0
183533,(,0,0
183534,1.6,0,0
183535,),0,0
183536,and,0,0
183537,7.9,0,0
183538,(,0,0
183539,2.2,0,0
183540,),0,0
183541,mmol/L,0,0
183542,;,0,0
183543,p,0,0
183544,<,0,0
183545,0.001,0,0
183546,],0,0
183547,than,0,0
183548,those,0,0
183549,receiving,0,0
183550,liraglutide,0,0
183551,.,0,0
183552,The,0,0
183553,liraglutide,0,0
183554,group,0,0
183555,reported,0,0
183556,a,0,0
183557,greater,1,0
183558,number,1,1
183559,of,1,1
183560,gastrointestinal,1,1
183561,treatment-emergent,1,1
183562,adverse,1,1
183563,events,1,1
183564,(,1,0
183565,p,1,0
183566,<,1,0
183567,0.001,1,0
183568,),1,0
183569,.,1,0
183570,The,1,0
183571,mean,1,1
183572,(,1,0
183573,s.d,1,0
183574,.,1,1
183575,),1,0
183576,weight,1,1
183577,change,1,1
183578,was,1,0
183579,+2.0,1,0
183580,(,0,0
183581,4.0,0,0
183582,),0,0
183583,kg,0,0
183584,for,0,0
183585,glargine,0,0
183586,and,0,1
183587,-3.0,0,0
183588,(,0,0
183589,3.6,0,0
183590,),0,0
183591,kg,0,0
183592,for,0,0
183593,liraglutide,0,0
183594,(,0,0
183595,p,0,0
183596,<,0,0
183597,0.001,1,0
183598,),1,0
183599,.,1,0
183600,Symptomatic,1,1
183601,hypoglycaemia,1,1
183602,was,1,0
183603,more,0,0
183604,common,0,1
183605,with,0,0
183606,glargine,0,0
183607,(,0,0
183608,p,0,0
183609,<,0,0
183610,0.001,0,0
183611,),0,0
183612,.,0,0
183613,A,0,0
183614,greater,0,0
183615,number,0,1
183616,of,0,1
183617,subjects,0,0
183618,in,0,0
183619,the,0,0
183620,liraglutide,0,0
183621,arm,0,0
183622,withdrew,0,0
183623,as,0,0
183624,a,0,0
183625,result,0,0
183626,of,0,0
183627,adverse,0,1
183628,events,0,1
183629,(,0,0
183630,p,0,0
183631,<,0,0
183632,0.001,0,0
183633,),0,0
183634,.,0,0
183635,CONCLUSION,0,0
183636,Adding,0,1
183637,either,0,0
183638,insulin,0,1
183639,glargine,0,1
183640,or,0,0
183641,liraglutide,0,0
183642,to,0,0
183643,subjects,0,0
183644,with,0,0
183645,poorly,0,0
183646,controlled,0,0
183647,T2DM,0,0
183648,reduces,0,0
183649,HbA1c,0,0
183650,substantially,0,0
183651,",",0,0
183652,with,0,0
183653,nearly,0,1
183654,half,0,0
183655,of,0,0
183656,subjects,0,0
183657,reaching,0,1
183658,target,0,0
183659,levels,0,1
183660,of,0,0
183661,7,0,0
183662,%,0,0
183663,.,0,0
183664,Topiramate,0,0
183665,impairs,0,1
183666,cognitive,0,1
183667,function,0,1
183668,in,0,0
183669,methadone-maintained,0,0
183670,individuals,0,0
183671,with,0,0
183672,concurrent,0,0
183673,cocaine,0,0
183674,dependence,0,1
183675,.,0,0
183676,Topiramate,0,0
183677,is,0,0
183678,being,0,0
183679,investigated,0,0
183680,as,0,0
183681,a,0,0
183682,potential,0,0
183683,pharmacotherapy,0,0
183684,for,0,0
183685,the,0,0
183686,treatment,0,0
183687,of,0,0
183688,addictive,0,1
183689,disorders,0,0
183690,.,0,0
183691,However,0,0
183692,",",0,0
183693,its,0,0
183694,cognitive,0,1
183695,side,0,1
183696,effects,0,0
183697,raise,0,0
183698,concerns,0,0
183699,about,0,0
183700,its,0,0
183701,use,0,0
183702,",",0,0
183703,especially,0,0
183704,in,0,0
183705,populations,0,0
183706,with,0,0
183707,cognitive,0,1
183708,impairment,0,1
183709,",",0,1
183710,such,0,1
183711,as,0,0
183712,persons,0,0
183713,with,0,0
183714,chronic,0,0
183715,substance,0,1
183716,use,0,0
183717,disorders,0,0
183718,.,0,0
183719,This,0,0
183720,study,0,0
183721,investigated,0,0
183722,topiramate,0,0
183723,'s,0,1
183724,cognitive,0,1
183725,effects,0,1
183726,in,0,0
183727,individuals,0,0
183728,dually,0,0
183729,dependent,0,0
183730,on,0,0
183731,cocaine,0,0
183732,and,0,1
183733,opioids,0,0
183734,as,0,0
183735,part,0,0
183736,of,0,0
183737,a,0,0
183738,double-blind,0,0
183739,",",0,0
183740,randomized,0,0
183741,",",0,0
183742,controlled,0,0
183743,trial,0,0
183744,of,0,1
183745,topiramate,0,0
183746,for,0,0
183747,cocaine,0,1
183748,dependence,0,1
183749,treatment,0,0
183750,.,0,0
183751,After,0,0
183752,5,0,0
183753,weeks,0,0
183754,of,0,0
183755,stabilization,0,1
183756,on,0,0
183757,daily,0,0
183758,oral,0,0
183759,methadone,0,0
183760,(,0,0
183761,M,0,0
183762,=,0,0
183763,96,0,0
183764,mg,0,0
183765,),0,0
183766,",",0,0
183767,participants,0,0
183768,were,0,0
183769,randomized,0,0
183770,to,0,0
183771,topiramate,0,0
183772,(,0,0
183773,n,0,0
183774,=,0,0
183775,18,0,0
183776,),0,0
183777,or,0,0
183778,placebo,0,0
183779,(,0,1
183780,n,0,0
183781,=,0,0
183782,22,0,0
183783,),0,0
183784,.,0,0
183785,Cognitive,0,1
183786,testing,0,0
183787,took,0,0
183788,place,0,0
183789,at,0,0
183790,2,0,0
183791,time,0,0
183792,points,0,0
183793,:,0,0
183794,study,0,0
183795,weeks,0,0
183796,4,0,0
183797,through,0,0
183798,5,0,0
183799,to,0,0
183800,assess,0,0
183801,baseline,0,1
183802,performance,0,1
183803,and,0,0
183804,10,0,0
183805,to,0,0
183806,13,0,0
183807,weeks,0,0
183808,later,0,0
183809,to,0,0
183810,assess,0,0
183811,performance,0,1
183812,during,0,0
183813,stable,0,1
183814,dosing,0,0
183815,(,0,0
183816,300,0,0
183817,mg,0,0
183818,topiramate,0,0
183819,or,0,1
183820,placebo,0,0
183821,),0,0
183822,.,0,0
183823,All,0,0
183824,participants,0,0
183825,were,0,0
183826,maintained,0,0
183827,on,0,0
183828,methadone,0,0
183829,at,0,0
183830,both,0,0
183831,testing,0,0
183832,times,0,1
183833,",",0,1
183834,and,0,1
183835,testing,0,1
183836,occurred,0,0
183837,2,0,0
183838,hours,0,0
183839,after,0,0
183840,the,0,0
183841,daily,0,0
183842,methadone,0,0
183843,plus,0,0
183844,topiramate/placebo,0,0
183845,administration,0,0
183846,.,0,0
183847,The,0,0
183848,topiramate,0,0
183849,and,0,1
183850,placebo,0,0
183851,groups,0,0
183852,did,0,0
183853,not,0,0
183854,differ,0,0
183855,on,0,0
183856,sex,0,0
183857,",",0,1
183858,level,0,1
183859,of,0,1
183860,education,0,0
183861,",",0,1
183862,premorbid,0,1
183863,intelligence,0,1
183864,",",0,1
183865,methadone,0,0
183866,dose,0,1
183867,",",0,1
183868,or,0,1
183869,illicit,0,1
183870,drug,0,0
183871,use,0,1
183872,.,0,1
183873,Topiramate,0,0
183874,slowed,0,1
183875,psychomotor,1,1
183876,and,1,1
183877,information,1,1
183878,processing,1,1
183879,speed,1,1
183880,",",1,1
183881,worsened,1,1
183882,divided,1,0
183883,attention,1,1
183884,",",1,0
183885,reduced,1,1
183886,n-back,1,0
183887,working,1,1
183888,memory,1,1
183889,accuracy,1,1
183890,",",1,1
183891,and,1,1
183892,increased,1,0
183893,the,1,0
183894,false,1,1
183895,alarm,1,1
183896,rate,1,1
183897,in,1,0
183898,recognition,1,0
183899,memory,1,1
183900,.,1,1
183901,Topiramate,0,0
183902,had,0,0
183903,no,0,0
183904,effects,0,1
183905,on,0,0
183906,visual,1,1
183907,processing,1,1
183908,",",1,1
183909,other,1,0
183910,measures,1,1
183911,of,1,1
183912,psychomotor,1,1
183913,function,1,1
183914,",",1,1
183915,risk-taking,1,1
183916,",",1,1
183917,self-control,1,1
183918,",",1,1
183919,Sternberg,1,1
183920,working,1,1
183921,memory,1,1
183922,",",1,1
183923,free,1,1
183924,recall,1,1
183925,",",1,1
183926,and,1,1
183927,metamemory,1,1
183928,.,1,0
183929,These,0,0
183930,findings,0,0
183931,indicate,0,0
183932,that,0,0
183933,topiramate,0,0
183934,may,0,0
183935,cause,0,1
183936,cognitive,1,1
183937,impairment,1,1
183938,in,0,0
183939,this,0,0
183940,population,0,0
183941,.,0,0
183942,This,0,0
183943,effect,0,0
183944,may,1,0
183945,limit,1,0
183946,its,1,0
183947,acceptability,1,1
183948,and,0,1
183949,use,0,0
183950,as,0,0
183951,a,0,0
183952,treatment,0,0
183953,in,0,0
183954,individuals,0,0
183955,with,0,0
183956,chronic,0,0
183957,opioid,0,1
183958,and,0,1
183959,cocaine,0,1
183960,use,0,1
183961,disorders,0,0
183962,",",0,0
183963,among,0,0
183964,whom,0,0
183965,preexisting,0,0
183966,cognitive,0,1
183967,impairments,0,0
183968,are,0,0
183969,common,0,0
183970,.,0,0
183971,(,0,0
183972,PsycINFO,0,1
183973,Database,0,1
183974,Record,0,1
183975,Prospective,0,0
183976,randomized,0,0
183977,comparison,0,0
183978,between,0,0
183979,transperitoneal,0,0
183980,laparoscopic,0,0
183981,pyeloplasty,0,0
183982,and,0,1
183983,retroperitoneoscopic,0,0
183984,pyeloplasty,0,0
183985,for,0,0
183986,primary,0,0
183987,ureteropelvic,0,1
183988,junction,0,0
183989,obstruction,0,1
183990,.,0,1
183991,BACKGROUND,0,0
183992,AND,0,0
183993,OBJECTIVES,0,0
183994,To,0,0
183995,compare,0,0
183996,laparoscopic,0,0
183997,transperitoneal,0,0
183998,versus,0,0
183999,retroperitoneoscopic,0,0
184000,pyeloplasty,0,0
184001,for,0,0
184002,primary,0,0
184003,ureteropelvic,0,1
184004,junction,0,1
184005,obstruction,0,1
184006,in,0,0
184007,a,0,0
184008,prospective,0,0
184009,randomized,0,0
184010,manner,0,0
184011,and,0,1
184012,assess,0,1
184013,overall,0,1
184014,results,0,0
184015,with,0,0
184016,long-term,0,0
184017,follow-up,0,0
184018,.,0,0
184019,METHODS,0,0
184020,In,0,0
184021,this,0,0
184022,prospective,0,0
184023,study,0,0
184024,",",0,0
184025,from,0,0
184026,2008,0,0
184027,to,0,0
184028,2012,0,0
184029,",",0,0
184030,112,0,0
184031,cases,0,0
184032,of,0,0
184033,primary,0,0
184034,ureteropelvic,0,1
184035,junction,0,1
184036,obstruction,0,1
184037,were,0,0
184038,randomized,0,0
184039,in,0,0
184040,a,0,0
184041,1:1,0,0
184042,ratio,0,0
184043,into,0,0
184044,2,0,0
184045,groups,0,0
184046,.,0,0
184047,Group,0,0
184048,I,0,0
184049,included,0,0
184050,patients,0,0
184051,who,0,0
184052,underwent,0,0
184053,transperitoneal,0,0
184054,laparoscopic,0,0
184055,pyeloplasty,0,0
184056,",",0,1
184057,and,0,1
184058,group,0,0
184059,II,0,0
184060,consisted,0,0
184061,of,0,0
184062,patients,0,0
184063,who,0,0
184064,underwent,0,0
184065,retroperitoneoscopic,0,0
184066,laparoscopic,0,0
184067,pyeloplasty,0,0
184068,.,0,1
184069,Demographic,0,1
184070,and,0,1
184071,clinical,0,1
184072,characteristics,0,1
184073,and,0,1
184074,postoperative,0,1
184075,and,0,1
184076,operative,0,1
184077,data,0,0
184078,were,0,0
184079,collected,0,0
184080,and,0,0
184081,analyzed,0,0
184082,.,0,0
184083,The,0,0
184084,statistical,0,0
184085,analysis,0,0
184086,was,0,0
184087,performed,0,0
184088,with,0,0
184089,the,0,0
184090,Fisher,0,1
184091,exact,0,1
184092,test,0,1
184093,",",0,1
184094,?2,0,1
184095,test,0,1
184096,",",0,1
184097,and,0,1
184098,Mann-Whitney,0,1
184099,U,0,1
184100,test,0,1
184101,for,0,0
184102,independent,0,0
184103,groups,0,0
184104,",",0,1
184105,and,0,1
184106,P,0,0
184107,<,0,0
184108,.05,0,0
184109,was,0,0
184110,considered,0,0
184111,statistically,0,0
184112,significant,0,0
184113,.,0,0
184114,RESULTS,0,0
184115,The,1,0
184116,total,1,1
184117,operative,1,1
184118,time,1,1
184119,and,1,1
184120,intracorporeal,1,0
184121,suturing,1,1
184122,time,1,1
184123,were,0,0
184124,significantly,0,0
184125,higher,0,0
184126,in,0,0
184127,group,0,0
184128,II,0,0
184129,than,0,0
184130,in,0,0
184131,group,0,0
184132,I,0,0
184133,(,0,0
184134,P,0,0
184135,<,0,0
184136,.001,0,0
184137,),0,0
184138,.,0,0
184139,The,1,0
184140,visual,1,1
184141,analog,1,1
184142,scale,1,1
184143,score,1,1
184144,for,1,0
184145,pain,1,1
184146,on,0,0
184147,postoperative,0,1
184148,day,0,0
184149,1,0,0
184150,and,0,0
184151,the,0,0
184152,requirement,0,1
184153,for,0,0
184154,tramadol,0,0
184155,were,0,0
184156,significantly,0,0
184157,higher,0,0
184158,in,0,0
184159,group,0,0
184160,I,0,0
184161,than,0,0
184162,in,0,0
184163,group,0,0
184164,II,0,0
184165,(,0,1
184166,P=.004,0,1
184167,),0,0
184168,.,0,0
184169,The,1,0
184170,hospital,1,1
184171,stay,1,1
184172,and,1,0
184173,the,1,0
184174,rate,1,1
184175,of,1,0
184176,temporary,1,1
184177,ileus,1,0
184178,were,0,0
184179,significantly,0,0
184180,greater,0,0
184181,(,0,0
184182,P,0,0
184183,<,0,0
184184,.036,0,0
184185,and,0,1
184186,P,0,0
184187,<,0,0
184188,.02,0,0
184189,",",0,0
184190,respectively,0,0
184191,),0,0
184192,in,0,0
184193,group,0,0
184194,I,0,0
184195,than,0,0
184196,in,0,0
184197,group,0,0
184198,II,0,0
184199,.,0,0
184200,The,1,0
184201,success,1,1
184202,rate,1,1
184203,of,0,1
184204,transperitoneal,0,0
184205,laparoscopic,0,0
184206,pyeloplasty,0,0
184207,versus,0,0
184208,retroperitoneoscopic,0,0
184209,laparoscopic,0,0
184210,pyeloplasty,0,0
184211,was,0,0
184212,96.4,0,0
184213,%,0,0
184214,versus,0,0
184215,96.6,0,0
184216,%,0,0
184217,with,0,0
184218,a,0,0
184219,mean,0,1
184220,follow-up,0,0
184221,period,0,0
184222,of,0,0
184223,30.75?4.85,0,0
184224,months,0,0
184225,versus,0,0
184226,30.99?5.59,0,0
184227,months,0,0
184228,(,0,0
184229,P,0,0
184230,<,0,0
184231,.88,0,1
184232,),0,0
184233,.,0,0
184234,CONCLUSION,0,0
184235,Transperitoneal,0,0
184236,laparoscopic,0,0
184237,pyeloplasty,0,0
184238,is,0,0
184239,associated,0,0
184240,with,0,0
184241,significantly,0,0
184242,greater,0,0
184243,postoperative,0,1
184244,pain,0,1
184245,",",0,0
184246,a,0,0
184247,higher,0,1
184248,tramadol,0,0
184249,dose,0,1
184250,",",0,0
184251,a,0,0
184252,higher,0,0
184253,rate,0,1
184254,of,0,1
184255,ileus,0,1
184256,",",0,0
184257,and,0,0
184258,a,0,0
184259,longer,0,0
184260,hospital,0,1
184261,stay,0,1
184262,in,0,0
184263,comparison,0,0
184264,with,0,0
184265,retroperitoneoscopic,0,0
184266,laparoscopic,0,0
184267,pyeloplasty,0,0
184268,.,0,0
184269,Although,0,0
184270,the,0,0
184271,operative,0,1
184272,time,0,1
184273,for,0,0
184274,retroperitoneoscopic,0,0
184275,laparoscopic,0,0
184276,pyeloplasty,0,0
184277,is,0,0
184278,significantly,0,0
184279,longer,0,0
184280,",",0,0
184281,the,0,0
184282,success,0,1
184283,rate,0,1
184284,remains,0,0
184285,the,0,0
184286,same,0,0
184287,for,0,0
184288,both,0,0
184289,procedures,0,0
184290,.,0,0
184291,Evaluating,0,0
184292,the,0,0
184293,efficacy,1,1
184294,of,0,1
184295,thoracoscopy,0,0
184296,and,0,1
184297,talc,0,0
184298,poudrage,0,0
184299,versus,0,0
184300,pleurodesis,0,0
184301,using,0,0
184302,talc,0,0
184303,slurry,0,0
184304,(,0,1
184305,TAPPS,0,0
184306,trial,0,0
184307,),0,0
184308,:,0,0
184309,protocol,0,0
184310,of,0,0
184311,an,0,0
184312,open-label,0,0
184313,randomised,0,0
184314,controlled,0,0
184315,trial,0,0
184316,.,0,0
184317,INTRODUCTION,0,0
184318,The,0,0
184319,management,0,0
184320,of,0,0
184321,recurrent,0,1
184322,malignant,0,1
184323,pleural,0,1
184324,effusions,0,1
184325,(,0,0
184326,MPE,0,0
184327,),0,0
184328,can,0,0
184329,be,0,0
184330,challenging,0,0
184331,.,0,0
184332,Various,0,0
184333,options,0,0
184334,are,0,0
184335,available,0,0
184336,",",0,0
184337,with,0,0
184338,the,0,0
184339,most,0,0
184340,efficacious,0,0
184341,and,0,0
184342,widely,0,0
184343,used,0,0
184344,being,0,0
184345,talc,0,0
184346,pleurodesis,0,0
184347,.,0,0
184348,Talc,0,0
184349,can,0,0
184350,either,0,0
184351,be,0,0
184352,applied,0,0
184353,via,0,0
184354,a,0,0
184355,chest,0,1
184356,drain,0,1
184357,in,0,0
184358,the,0,0
184359,form,0,0
184360,of,0,1
184361,slurry,0,0
184362,",",0,1
184363,or,0,1
184364,at,0,1
184365,medical,0,1
184366,thoracoscopy,0,0
184367,using,0,0
184368,poudrage,0,0
184369,.,0,0
184370,Current,0,1
184371,evidence,0,0
184372,regarding,0,0
184373,which,0,0
184374,method,0,0
184375,is,0,0
184376,most,0,0
184377,effective,0,0
184378,is,0,0
184379,conflicting,0,0
184380,and,0,0
184381,often,0,0
184382,methodologically,0,0
184383,flawed,0,0
184384,.,0,0
184385,The,0,0
184386,TAPPS,0,0
184387,trial,0,0
184388,is,0,0
184389,a,0,0
184390,suitably,0,0
184391,powered,0,0
184392,",",0,0
184393,multicentre,0,0
184394,",",0,1
184395,open-label,0,0
184396,",",0,1
184397,randomised,0,0
184398,controlled,0,0
184399,trial,0,0
184400,designed,0,0
184401,to,0,0
184402,compare,0,0
184403,the,0,0
184404,pleurodesis,0,0
184405,success,0,1
184406,rate,0,1
184407,of,0,1
184408,medical,0,1
184409,thoracoscopy,0,0
184410,and,0,1
184411,talc,0,0
184412,poudrage,0,0
184413,with,0,0
184414,chest,0,1
184415,drain,0,1
184416,insertion,0,1
184417,and,0,1
184418,talc,0,0
184419,slurry,0,0
184420,.,0,1
184421,METHODS,0,0
184422,AND,0,0
184423,ANALYSIS,0,0
184424,330,0,0
184425,patients,0,0
184426,with,0,0
184427,a,0,0
184428,confirmed,0,0
184429,MPE,0,0
184430,requiring,0,0
184431,intervention,0,0
184432,will,0,0
184433,be,0,0
184434,recruited,0,0
184435,from,0,0
184436,UK,0,0
184437,hospitals,0,0
184438,.,0,0
184439,Patients,0,0
184440,will,0,0
184441,be,0,0
184442,randomised,0,0
184443,(,0,0
184444,1:1,0,0
184445,),0,0
184446,to,0,0
184447,undergo,0,0
184448,either,0,0
184449,small,0,0
184450,bore,0,1
184451,(,0,0
184452,<,0,0
184453,14,0,0
184454,Fr,0,0
184455,),0,0
184456,Seldinger,0,0
184457,chest,0,1
184458,drain,0,1
184459,insertion,0,1
184460,followed,0,0
184461,by,0,0
184462,instillation,0,0
184463,of,0,1
184464,sterile,0,0
184465,talc,0,0
184466,(,0,0
184467,4,0,0
184468,g,0,0
184469,),0,0
184470,",",0,0
184471,or,0,0
184472,to,0,0
184473,undergo,0,0
184474,medical,0,1
184475,thoracoscopy,0,0
184476,and,0,1
184477,simultaneous,0,1
184478,poudrage,0,0
184479,(,0,0
184480,4,0,0
184481,g,0,0
184482,),0,0
184483,.,0,0
184484,The,0,0
184485,allocated,0,0
184486,procedure,0,0
184487,will,0,0
184488,be,0,0
184489,performed,0,0
184490,as,0,0
184491,an,0,0
184492,inpatient,0,0
184493,within,0,0
184494,3,0,0
184495,days,0,0
184496,of,0,0
184497,randomisation,0,0
184498,taking,0,0
184499,place,0,0
184500,.,0,0
184501,Following,0,1
184502,discharge,0,1
184503,",",0,0
184504,patients,0,0
184505,will,0,0
184506,be,0,0
184507,followed,0,0
184508,up,0,0
184509,at,0,0
184510,regular,0,0
184511,intervals,0,0
184512,for,0,0
184513,6,0,0
184514,months,0,0
184515,.,0,0
184516,The,0,0
184517,primary,0,0
184518,outcome,0,0
184519,measure,0,0
184520,is,0,0
184521,pleurodesis,1,0
184522,failure,1,1
184523,rates,1,1
184524,at,1,0
184525,3,0,0
184526,months,0,0
184527,.,0,0
184528,Pleurodesis,1,0
184529,failure,1,0
184530,is,1,0
184531,defined,0,0
184532,as,0,0
184533,the,0,0
184534,need,0,0
184535,for,0,0
184536,further,0,0
184537,pleural,0,1
184538,intervention,0,0
184539,for,0,0
184540,fluid,0,1
184541,management,0,0
184542,on,0,0
184543,the,0,0
184544,side,0,1
184545,of,0,0
184546,the,0,0
184547,trial,0,0
184548,intervention,0,0
184549,.,0,1
184550,ETHICS,0,0
184551,AND,0,0
184552,DISSEMINATION,0,0
184553,The,0,0
184554,trial,0,0
184555,has,0,0
184556,received,0,0
184557,ethical,0,0
184558,approval,0,0
184559,from,0,0
184560,the,0,0
184561,National,0,0
184562,Research,0,0
184563,Ethics,0,1
184564,Service,0,1
184565,Committee,0,0
184566,North,0,1
184567,West-Preston,0,0
184568,(,0,0
184569,12/NW/0467,0,0
184570,),0,0
184571,.,0,0
184572,There,0,0
184573,is,0,0
184574,a,0,0
184575,trial,0,0
184576,steering,0,0
184577,committee,0,0
184578,which,0,0
184579,includes,0,0
184580,independent,0,0
184581,members,0,0
184582,and,0,0
184583,a,0,0
184584,patient,0,1
184585,and,0,1
184586,public,0,0
184587,representative,0,0
184588,.,0,0
184589,The,0,0
184590,trial,0,0
184591,results,0,0
184592,will,0,0
184593,be,0,0
184594,published,0,0
184595,in,0,0
184596,a,0,0
184597,peer-reviewed,0,0
184598,journal,0,0
184599,and,0,1
184600,presented,0,0
184601,at,0,0
184602,international,0,0
184603,conferences,0,0
184604,",",0,0
184605,as,0,0
184606,well,0,0
184607,as,0,0
184608,being,0,0
184609,disseminated,0,0
184610,via,0,0
184611,local,0,0
184612,and,0,1
184613,national,0,1
184614,charities,0,1
184615,and,0,1
184616,patient,0,1
184617,groups,0,0
184618,.,0,0
184619,All,0,0
184620,participants,0,0
184621,who,0,0
184622,wish,0,0
184623,to,0,0
184624,know,0,0
184625,the,0,0
184626,study,0,0
184627,results,0,0
184628,will,0,0
184629,also,0,0
184630,be,0,0
184631,contacted,0,0
184632,directly,0,0
184633,on,0,0
184634,their,0,0
184635,publication,0,0
184636,.,0,0
184637,TRIAL,0,0
184638,REGISTRATION,0,0
184639,NUMBER,0,1
184640,ISRCTN47845793,0,0
184641,.,0,0
184642,Time,0,0
184643,to,0,0
184644,onset,0,1
184645,of,0,0
184646,clinically,0,0
184647,meaningful,0,1
184648,improvement,0,1
184649,with,0,0
184650,tadalafil,0,0
184651,5,0,0
184652,mg,0,0
184653,once,0,0
184654,daily,0,0
184655,for,0,0
184656,lower,0,1
184657,urinary,0,1
184658,tract,0,1
184659,symptoms,0,1
184660,secondary,0,0
184661,to,0,0
184662,benign,0,0
184663,prostatic,0,0
184664,hyperplasia,0,1
184665,:,0,0
184666,analysis,0,0
184667,of,0,0
184668,data,0,0
184669,pooled,0,0
184670,from,0,0
184671,4,0,0
184672,pivotal,0,0
184673,",",0,0
184674,double-blind,0,0
184675,",",0,1
184676,placebo,0,0
184677,controlled,0,0
184678,studies,0,0
184679,.,0,0
184680,PURPOSE,0,0
184681,Tadalafil,0,0
184682,once,0,0
184683,daily,0,0
184684,for,0,0
184685,lower,0,0
184686,urinary,0,1
184687,tract,0,1
184688,symptoms,0,1
184689,secondary,0,0
184690,to,0,0
184691,benign,0,0
184692,prostatic,0,0
184693,hyperplasia,0,0
184694,consistently,0,0
184695,shows,0,0
184696,statistically,0,0
184697,significant,0,0
184698,I-PSS,0,0
184699,improvements,0,1
184700,.,0,0
184701,However,0,0
184702,",",0,0
184703,physicians,0,1
184704,and,0,1
184705,patients,0,0
184706,wish,0,0
184707,to,0,0
184708,know,1,0
184709,whether,0,0
184710,tadalafil,0,0
184711,provides,0,0
184712,rapid,0,0
184713,",",0,0
184714,clinically,0,1
184715,meaningful,0,1
184716,improvement,0,1
184717,in,0,0
184718,lower,0,1
184719,urinary,0,1
184720,tract,0,1
184721,symptoms,0,1
184722,.,0,0
184723,In,0,0
184724,this,0,0
184725,post,0,0
184726,hoc,0,0
184727,analysis,0,0
184728,we,0,0
184729,integrated,0,0
184730,results,0,0
184731,from,0,0
184732,4,0,0
184733,placebo,0,0
184734,controlled,0,0
184735,studies,0,0
184736,to,0,0
184737,determine,0,0
184738,the,0,0
184739,duration,0,1
184740,of,0,0
184741,tadalafil,0,0
184742,once,0,0
184743,daily,0,0
184744,required,0,0
184745,to,0,0
184746,achieve,0,0
184747,clinically,0,0
184748,meaningful,0,1
184749,improvement,0,1
184750,.,0,1
184751,MATERIALS,0,0
184752,AND,0,0
184753,METHODS,0,0
184754,We,0,0
184755,performed,0,0
184756,post,0,0
184757,hoc,0,0
184758,analysis,0,0
184759,of,0,1
184760,data,0,0
184761,integrated,0,0
184762,from,0,0
184763,4,0,0
184764,double-blind,0,0
184765,studies,0,0
184766,of,0,0
184767,tadalafil,0,0
184768,5,0,0
184769,mg,0,0
184770,and,0,0
184771,placebo,0,0
184772,once,0,0
184773,daily,0,0
184774,in,0,0
184775,742,0,0
184776,and,0,0
184777,735,0,0
184778,men,0,0
184779,",",0,0
184780,respectively,0,0
184781,",",0,0
184782,45,0,0
184783,years,0,0
184784,old,0,0
184785,or,0,0
184786,older,0,0
184787,with,0,0
184788,total,0,1
184789,I-PSS,0,0
184790,13,0,0
184791,or,0,0
184792,greater,0,0
184793,.,0,0
184794,Two,0,0
184795,clinically,0,0
184796,meaningful,0,0
184797,improvement,0,1
184798,categories,0,1
184799,were,0,0
184800,assessed,0,0
184801,",",0,0
184802,including,0,0
184803,1,1,0
184804,),1,0
184805,3-point,1,0
184806,or,1,0
184807,greater,1,0
184808,baseline,1,0
184809,to,1,0
184810,end,1,0
184811,point,1,0
184812,total,1,1
184813,I-PSS,1,1
184814,improvement,1,1
184815,and,1,0
184816,2,1,0
184817,),1,0
184818,25,1,0
184819,%,1,0
184820,or,1,0
184821,greater,1,1
184822,baseline,1,0
184823,to,1,0
184824,end,1,0
184825,point,1,0
184826,total,1,1
184827,I-PSS,1,0
184828,improvement,1,1
184829,.,1,1
184830,I-PSS,1,1
184831,was,0,0
184832,assessed,0,0
184833,at,0,0
184834,weeks,0,0
184835,4,0,0
184836,",",0,0
184837,8,0,0
184838,and,0,0
184839,12,0,0
184840,in,0,0
184841,all,0,0
184842,studies,0,0
184843,",",0,0
184844,week,0,0
184845,1,0,0
184846,in,0,0
184847,2,0,0
184848,and,0,0
184849,week,0,0
184850,2,0,0
184851,in,0,0
184852,1,0,0
184853,.,0,0
184854,Results,0,0
184855,in,0,0
184856,men,0,0
184857,treated,0,0
184858,with,0,0
184859,tadalafil,0,0
184860,who,0,0
184861,showed,0,0
184862,clinically,0,0
184863,meaningful,0,1
184864,improvement,0,1
184865,(,0,0
184866,responders,0,1
184867,),0,1
184868,were,0,0
184869,further,0,0
184870,examined,0,0
184871,to,0,0
184872,determine,0,0
184873,the,0,0
184874,earliest,1,0
184875,time,1,1
184876,to,1,0
184877,clinically,1,0
184878,meaningful,1,1
184879,improvement,1,1
184880,.,1,0
184881,RESULTS,0,0
184882,Of,0,0
184883,742,0,0
184884,tadalafil,0,0
184885,treated,0,0
184886,patients,0,0
184887,513,0,0
184888,(,0,0
184889,69.1,0,0
184890,%,0,0
184891,),0,0
184892,and,0,0
184893,444,0,0
184894,(,0,0
184895,59.8,0,0
184896,%,0,0
184897,),0,0
184898,demonstrated,0,0
184899,category,0,0
184900,1,0,0
184901,and,0,0
184902,2,0,0
184903,clinically,1,0
184904,meaningful,1,0
184905,improvement,1,1
184906,",",0,0
184907,respectively,0,0
184908,",",0,0
184909,at,0,0
184910,the,0,0
184911,study,0,0
184912,end,0,0
184913,point,0,0
184914,.,0,0
184915,Of,0,0
184916,234,0,0
184917,category,0,0
184918,1,0,0
184919,responders,0,0
184920,with,0,0
184921,week,0,0
184922,1,0,0
184923,assessments,0,0
184924,140,0,0
184925,(,0,0
184926,59.8,0,0
184927,%,0,0
184928,),0,0
184929,achieved,0,0
184930,clinically,1,0
184931,meaningful,1,1
184932,improvement,1,1
184933,by,0,0
184934,week,0,0
184935,1,0,0
184936,and,0,0
184937,407,0,0
184938,of,0,0
184939,the,0,0
184940,total,0,0
184941,of,0,0
184942,513,0,0
184943,category,0,0
184944,1,0,0
184945,responders,0,0
184946,(,0,0
184947,79.3,0,0
184948,%,0,0
184949,),0,0
184950,showed,0,0
184951,it,0,0
184952,by,0,0
184953,week,0,0
184954,4,0,0
184955,.,0,0
184956,Of,0,0
184957,the,0,0
184958,205,0,0
184959,category,0,0
184960,2,0,0
184961,responders,0,0
184962,with,0,0
184963,week,0,0
184964,1,0,0
184965,assessments,0,0
184966,103,0,0
184967,(,0,0
184968,50.2,0,0
184969,%,0,0
184970,),0,0
184971,achieved,0,0
184972,clinically,1,0
184973,meaningful,1,1
184974,improvement,1,1
184975,by,0,0
184976,week,0,0
184977,1,0,0
184978,while,0,0
184979,322,0,0
184980,of,0,0
184981,the,0,0
184982,444,0,0
184983,category,0,0
184984,2,0,0
184985,responders,0,0
184986,(,0,0
184987,72.5,0,0
184988,%,0,0
184989,),0,0
184990,did,0,0
184991,so,0,0
184992,by,0,0
184993,week,0,0
184994,4,0,0
184995,.,0,0
184996,CONCLUSIONS,0,0
184997,Tadalafil,0,0
184998,5,0,0
184999,mg,0,0
185000,once,0,0
185001,daily,0,0
185002,led,0,0
185003,to,0,0
185004,clinically,0,0
185005,meaningful,0,1
185006,improvement,0,1
185007,in,0,0
185008,approximately,0,0
185009,two-thirds,0,0
185010,of,0,0
185011,men,0,0
185012,with,0,0
185013,lower,0,0
185014,urinary,0,1
185015,tract,0,1
185016,symptoms,0,1
185017,secondary,0,0
185018,to,0,0
185019,benign,0,0
185020,prostatic,0,0
185021,hyperplasia,0,1
185022,.,0,0
185023,More,0,0
185024,than,0,0
185025,half,0,0
185026,of,0,0
185027,this,0,0
185028,group,0,0
185029,of,0,0
185030,tadalafil,0,0
185031,treated,0,0
185032,responders,0,0
185033,achieved,0,0
185034,clinically,0,0
185035,meaningful,0,1
185036,improvement,0,1
185037,after,0,0
185038,1,0,0
185039,week,0,0
185040,of,0,0
185041,therapy,0,0
185042,and,0,1
185043,more,0,0
185044,than,0,0
185045,70,0,0
185046,%,0,0
185047,did,0,0
185048,so,0,0
185049,within,0,0
185050,4,0,0
185051,weeks,0,0
185052,.,0,0
185053,Treatment,0,0
185054,of,0,1
185055,Wilms,0,1
185056,',0,1
185057,tumor,0,1
185058,.,0,0
185059,Results,0,0
185060,of,0,0
185061,the,0,0
185062,Third,0,0
185063,National,0,1
185064,Wilms,0,1
185065,',0,1
185066,Tumor,0,1
185067,Study,0,0
185068,.,0,0
185069,The,0,0
185070,Third,0,0
185071,National,0,1
185072,Wilms,0,1
185073,',0,1
185074,Tumor,0,1
185075,Study,0,0
185076,sought,0,0
185077,to,0,0
185078,reduce,0,0
185079,treatment,0,0
185080,for,0,0
185081,low-risk,0,0
185082,patients,0,0
185083,and,0,1
185084,find,0,0
185085,better,0,0
185086,chemotherapy,0,0
185087,for,0,0
185088,those,0,0
185089,at,0,0
185090,high,0,0
185091,risk,0,1
185092,for,0,0
185093,relapse,0,1
185094,.,0,0
185095,Eligible,0,1
185096,patients,0,0
185097,(,0,0
185098,1439,0,0
185099,),0,0
185100,were,0,0
185101,randomized,0,0
185102,according,0,0
185103,to,0,0
185104,stage,0,0
185105,(,0,1
185106,I-IV,0,1
185107,),0,1
185108,and,0,1
185109,histology,0,1
185110,(,0,1
185111,favorable,0,1
185112,[,0,0
185113,FH,0,1
185114,],0,0
185115,or,0,1
185116,unfavorable,0,1
185117,[,0,0
185118,UH,0,1
185119,],0,0
185120,),0,1
185121,",",0,1
185122,and,0,1
185123,contributed,0,0
185124,data,0,0
185125,to,0,0
185126,survival,0,1
185127,and,0,1
185128,relapse-free,0,1
185129,survival,0,1
185130,(,0,1
185131,RFS,0,1
185132,),0,0
185133,analyses,0,0
185134,.,0,0
185135,Four-year,0,1
185136,(,0,0
185137,postnephrectomy,0,0
185138,),0,1
185139,survival,0,1
185140,percentages,0,1
185141,and,0,1
185142,randomized,0,0
185143,treatment,0,0
185144,regimens,0,0
185145,for,0,0
185146,low-risk,0,0
185147,patients,0,0
185148,were,0,0
185149,96.5,0,0
185150,%,0,0
185151,for,0,0
185152,607,0,0
185153,Stage,0,0
185154,I/FH,0,0
185155,patients,0,0
185156,who,0,0
185157,received,0,0
185158,dactinomycin,0,0
185159,(,0,1
185160,Actinomycin,0,0
185161,D,0,1
185162,[,0,0
185163,AMD,0,1
185164,],0,0
185165,",",0,1
185166,Merck,0,1
185167,Sharp,0,1
185168,&,0,1
185169,Dohme,0,0
185170,",",0,1
185171,West,0,1
185172,Point,0,1
185173,",",0,1
185174,PA,0,1
185175,),0,1
185176,and,0,1
185177,vincristine,0,0
185178,(,0,1
185179,VCR,0,0
185180,),0,0
185181,for,0,0
185182,10,0,0
185183,weeks,0,0
185184,versus,0,0
185185,6,0,0
185186,months,0,0
185187,;,0,0
185188,92.2,0,0
185189,%,0,0
185190,for,0,0
185191,278,0,0
185192,Stage,0,0
185193,II/FH,0,0
185194,patients,0,0
185195,;,0,0
185196,and,0,0
185197,86.9,0,0
185198,%,0,0
185199,for,0,0
185200,275,0,0
185201,Stage,0,0
185202,III/FH,0,0
185203,patients,0,0
185204,who,0,0
185205,received,0,0
185206,AMD,0,1
185207,+,0,0
185208,VCR,0,0
185209,+/-,0,0
185210,Adriamycin,0,0
185211,(,0,1
185212,ADR,0,1
185213,",",0,1
185214,Adria,0,1
185215,Laboratories,0,1
185216,",",0,1
185217,Columbus,0,0
185218,",",0,1
185219,OH,0,1
185220,),0,0
185221,for,0,0
185222,15,0,0
185223,months,0,0
185224,.,0,0
185225,Stage,0,1
185226,II/FH,0,0
185227,patients,0,0
185228,also,0,0
185229,had,0,0
185230,either,0,0
185231,zero,0,1
185232,or,0,0
185233,2000,0,0
185234,cGy,0,0
185235,irradiation,0,0
185236,(,0,1
185237,RT,0,0
185238,),0,0
185239,postoperatively,0,1
185240,and,0,0
185241,Stage,0,1
185242,III/FH,0,1
185243,patients,0,0
185244,either,0,0
185245,1000,0,0
185246,or,0,0
185247,2000,0,0
185248,cGy,0,0
185249,.,0,0
185250,Four-year,1,1
185251,survival,1,1
185252,was,0,0
185253,73.0,0,0
185254,%,0,0
185255,for,0,0
185256,279,0,0
185257,high-risk,0,0
185258,patients,0,0
185259,(,0,0
185260,any,0,0
185261,Stage,0,1
185262,IV,0,1
185263,",",0,0
185264,all,0,0
185265,UH,0,0
185266,),0,0
185267,who,0,0
185268,received,0,0
185269,postoperative,0,1
185270,radiation,0,1
185271,therapy,0,0
185272,(,0,1
185273,RT,0,0
185274,),0,1
185275,and,0,1
185276,AMD,0,1
185277,+,0,0
185278,VCR,0,0
185279,+,0,0
185280,ADR,0,1
185281,+/-,0,0
185282,cyclophosphamide,0,0
185283,(,0,1
185284,CPM,0,0
185285,),0,0
185286,.,0,0
185287,Statistical,0,0
185288,analysis,0,0
185289,of,0,1
185290,survival,1,1
185291,and,1,1
185292,RFS,1,1
185293,experience,1,1
185294,shows,1,0
185295,that,0,0
185296,the,0,0
185297,less,0,0
185298,intensive,0,0
185299,therapy,0,0
185300,does,0,0
185301,not,0,0
185302,worsen,0,0
185303,results,0,0
185304,for,0,0
185305,low-risk,0,0
185306,patients,0,0
185307,and,0,0
185308,CPM,0,0
185309,does,0,0
185310,not,0,0
185311,benefit,0,0
185312,those,0,0
185313,at,0,0
185314,high,0,0
185315,risk,0,1
185316,.,0,0
185317,Selective,0,0
185318,attention,0,1
185319,effects,0,1
185320,on,0,0
185321,early,0,0
185322,integration,0,1
185323,of,0,1
185324,social,0,1
185325,signals,0,0
185326,:,0,0
185327,same,0,0
185328,timing,0,1
185329,",",0,1
185330,modulated,0,0
185331,neural,0,0
185332,sources,0,0
185333,.,0,0
185334,Humans,0,0
185335,combine,0,0
185336,co-emitted,0,0
185337,social,0,1
185338,signals,0,0
185339,to,0,0
185340,predict,0,0
185341,other,0,1
185342,'s,0,0
185343,immediate,0,1
185344,intentions,0,1
185345,and,0,0
185346,prepare,0,0
185347,an,0,0
185348,adapted,0,0
185349,response,0,1
185350,.,0,0
185351,However,0,0
185352,",",0,0
185353,little,0,0
185354,is,0,0
185355,known,0,0
185356,about,0,0
185357,whether,0,0
185358,attending,0,0
185359,to,0,0
185360,only,0,0
185361,one,0,0
185362,of,0,0
185363,co-emitted,0,0
185364,social,0,1
185365,signals,0,0
185366,impacts,0,0
185367,on,0,0
185368,its,0,0
185369,combination,0,0
185370,with,0,0
185371,other,0,0
185372,signals,0,0
185373,.,0,0
185374,Here,0,0
185375,",",0,0
185376,using,0,0
185377,electroencephalography,0,1
185378,",",0,0
185379,we,0,0
185380,address,0,0
185381,selective,1,1
185382,attention,1,1
185383,effects,1,1
185384,on,0,0
185385,early,0,0
185386,combination,0,0
185387,of,0,1
185388,social,0,1
185389,signals,0,0
185390,.,0,0
185391,We,0,0
185392,manipulated,0,0
185393,three,0,0
185394,visual,0,1
185395,cues,0,0
185396,:,0,0
185397,gaze,0,1
185398,direction,0,1
185399,",",0,1
185400,emotional,0,1
185401,expression,0,1
185402,",",0,1
185403,and,0,1
185404,pointing,0,1
185405,gesture,0,1
185406,",",0,0
185407,while,0,0
185408,participants,0,0
185409,performed,0,0
185410,either,0,0
185411,emotion,0,1
185412,or,0,1
185413,gaze,0,1
185414,direction,0,1
185415,judgments,0,1
185416,.,0,1
185417,Results,0,0
185418,showed,0,0
185419,that,0,0
185420,a,0,0
185421,temporal,0,1
185422,marker,0,1
185423,of,0,1
185424,social,0,1
185425,cues,0,0
185426,integration,0,0
185427,emerges,0,0
185428,170ms,0,0
185429,after,0,0
185430,the,0,0
185431,stimulus,0,1
185432,onset,0,1
185433,",",0,0
185434,even,0,0
185435,if,0,0
185436,the,0,0
185437,integration,0,0
185438,of,0,0
185439,the,0,0
185440,three,0,0
185441,visual,0,1
185442,cues,0,0
185443,was,0,0
185444,not,0,0
185445,required,0,0
185446,to,0,0
185447,perform,0,0
185448,the,0,0
185449,task,0,1
185450,",",0,0
185451,as,0,0
185452,only,0,0
185453,one,0,0
185454,feature,0,0
185455,at,0,0
185456,a,0,0
185457,time,0,1
185458,was,0,0
185459,task,0,1
185460,relevant,0,0
185461,.,0,1
185462,Yet,0,0
185463,in,0,0
185464,addition,0,0
185465,to,0,0
185466,common,0,0
185467,temporal,0,1
185468,regions,0,0
185469,",",0,0
185470,the,0,0
185471,relative,0,1
185472,contribution,0,0
185473,of,0,1
185474,specific,0,0
185475,neural,0,0
185476,sources,0,0
185477,of,0,0
185478,this,0,0
185479,integration,0,1
185480,changed,0,0
185481,as,0,0
185482,a,0,0
185483,function,0,1
185484,of,0,0
185485,the,0,0
185486,attended,0,0
185487,feature,0,0
185488,:,0,0
185489,integration,0,1
185490,during,0,0
185491,emotion,0,1
185492,judgments,0,1
185493,was,0,0
185494,mainly,0,0
185495,implemented,0,0
185496,in,0,0
185497,classic,0,0
185498,limbic,0,1
185499,areas,0,1
185500,but,0,0
185501,in,0,0
185502,the,0,0
185503,dorsal,0,0
185504,pathway,0,0
185505,during,0,0
185506,gaze,0,1
185507,direction,0,0
185508,judgments,0,1
185509,.,0,0
185510,Together,0,0
185511,",",0,0
185512,these,0,0
185513,findings,0,0
185514,demonstrate,0,0
185515,that,0,0
185516,co-emitted,1,0
185517,social,1,1
185518,cues,1,0
185519,are,1,0
185520,integrated,1,0
185521,as,0,0
185522,long,0,0
185523,as,0,0
185524,they,0,0
185525,are,0,0
185526,relevant,0,0
185527,to,0,0
185528,the,0,0
185529,observer,0,1
185530,",",0,0
185531,even,0,0
185532,when,0,0
185533,they,0,0
185534,are,0,0
185535,irrelevant,0,0
185536,to,0,0
185537,the,0,0
185538,ongoing,0,0
185539,task,0,0
185540,.,0,0
185541,Everolimus,0,0
185542,for,0,0
185543,subependymal,0,1
185544,giant,0,1
185545,cell,0,1
185546,astrocytoma,0,0
185547,in,0,0
185548,patients,0,0
185549,with,0,0
185550,tuberous,0,0
185551,sclerosis,0,0
185552,complex,0,0
185553,:,0,0
185554,2-year,0,0
185555,open-label,0,0
185556,extension,0,0
185557,of,0,0
185558,the,0,0
185559,randomised,0,0
185560,EXIST-1,0,0
185561,study,0,0
185562,.,0,1
185563,BACKGROUND,0,0
185564,In,0,0
185565,the,0,0
185566,EXIST-1,0,0
185567,trial,0,0
185568,",",0,0
185569,initiated,0,0
185570,on,0,0
185571,Aug,0,0
185572,10,0,0
185573,",",0,0
185574,2009,0,0
185575,",",0,0
185576,more,0,0
185577,than,0,0
185578,35,0,0
185579,%,0,0
185580,of,0,0
185581,patients,0,0
185582,with,0,0
185583,subependymal,0,1
185584,giant,0,1
185585,cell,0,1
185586,astrocytoma,0,0
185587,(,0,1
185588,SEGA,0,1
185589,),0,0
185590,associated,0,0
185591,with,0,0
185592,tuberous,0,0
185593,sclerosis,0,0
185594,complex,0,0
185595,had,0,0
185596,at,0,0
185597,least,0,0
185598,50,0,0
185599,%,0,0
185600,reduction,0,1
185601,in,0,0
185602,SEGA,0,1
185603,volume,0,1
185604,after,0,0
185605,9?6,0,0
185606,months,0,0
185607,of,0,0
185608,treatment,0,0
185609,with,0,0
185610,everolimus,0,0
185611,.,0,0
185612,In,0,0
185613,this,0,0
185614,Article,0,0
185615,",",0,0
185616,we,0,0
185617,report,0,0
185618,interim,0,0
185619,data,0,0
185620,(,0,0
185621,up,0,0
185622,to,0,0
185623,Jan,0,0
185624,11,0,0
185625,",",0,0
185626,2013,0,0
185627,),0,0
185628,to,0,0
185629,support,0,0
185630,longer-term,0,1
185631,tolerability,0,1
185632,and,0,1
185633,efficacy,0,1
185634,of,0,1
185635,everolimus,0,0
185636,from,0,0
185637,the,0,0
185638,continuing,0,0
185639,4-year,0,0
185640,extension,0,0
185641,phase,0,0
185642,of,0,0
185643,EXIST-1,0,0
185644,.,0,0
185645,METHODS,0,0
185646,We,0,0
185647,assessed,0,0
185648,data,0,0
185649,from,0,0
185650,a,0,0
185651,prospective,0,0
185652,",",0,0
185653,open-label,0,0
185654,extension,0,0
185655,of,0,0
185656,a,0,0
185657,multicentre,0,0
185658,",",0,0
185659,phase,0,0
185660,3,0,0
185661,",",0,0
185662,randomised,0,0
185663,",",0,0
185664,double-blind,0,0
185665,",",0,1
185666,placebo-controlled,0,0
185667,study,0,0
185668,in,0,0
185669,patients,0,0
185670,with,0,0
185671,tuberous,0,0
185672,sclerosis,0,0
185673,complex,0,0
185674,who,0,0
185675,had,0,0
185676,SEGA,0,1
185677,that,0,0
185678,was,0,0
185679,growing,0,0
185680,and,0,1
185681,needed,0,0
185682,treatment,0,0
185683,.,0,0
185684,In,0,0
185685,this,0,0
185686,extension,0,0
185687,study,0,0
185688,",",0,0
185689,we,0,0
185690,included,0,0
185691,all,0,0
185692,patients,0,0
185693,who,0,0
185694,had,0,0
185695,been,0,0
185696,assigned,0,0
185697,everolimus,0,0
185698,during,0,0
185699,the,0,0
185700,double-blind,0,0
185701,",",0,1
185702,randomised,0,0
185703,phase,0,0
185704,of,0,0
185705,the,0,0
185706,trial,0,0
185707,and,0,0
185708,those,0,0
185709,patients,0,0
185710,who,0,0
185711,crossed,0,0
185712,over,0,0
185713,from,0,0
185714,the,0,0
185715,placebo,0,0
185716,group,0,0
185717,to,0,0
185718,receive,0,0
185719,everolimus,0,0
185720,during,0,0
185721,the,0,0
185722,randomised,0,0
185723,phase,0,0
185724,or,0,0
185725,at,0,0
185726,the,0,0
185727,start,0,0
185728,of,0,0
185729,the,0,0
185730,extension,0,0
185731,phase,0,0
185732,.,0,0
185733,All,0,0
185734,patients,0,0
185735,received,0,0
185736,oral,0,0
185737,everolimus,0,0
185738,at,0,0
185739,a,0,0
185740,starting,0,0
185741,dose,0,0
185742,of,0,0
185743,4?5,0,0
185744,mg/m,0,0
185745,(,0,0
185746,2,0,0
185747,),0,0
185748,per,0,0
185749,day,0,0
185750,.,0,1
185751,Everolimus,0,0
185752,dose,0,0
185753,was,0,0
185754,subsequently,0,0
185755,adjusted,0,0
185756,subject,0,0
185757,to,0,0
185758,tolerability,0,1
185759,to,0,0
185760,attain,1,0
185761,blood,1,1
185762,trough,1,1
185763,concentrations,1,1
185764,of,1,0
185765,5-15,0,0
185766,ng/mL,0,0
185767,.,0,0
185768,An,0,0
185769,independent,0,0
185770,central,0,1
185771,radiology,0,0
185772,review,0,0
185773,team,0,1
185774,assessed,0,0
185775,SEGA,0,1
185776,response,0,1
185777,(,0,0
185778,at,0,0
185779,least,0,0
185780,a,0,0
185781,50,0,0
185782,%,0,0
185783,reduction,0,1
185784,from,0,0
185785,baseline,0,0
185786,in,0,0
185787,total,0,1
185788,volume,0,1
185789,of,0,0
185790,all,0,0
185791,target,0,0
185792,SEGAs,0,0
185793,;,0,0
185794,the,0,0
185795,primary,0,0
185796,endpoint,0,1
185797,),0,0
185798,by,0,0
185799,MRI,0,0
185800,at,0,0
185801,12,0,0
185802,",",0,0
185803,24,0,0
185804,",",0,0
185805,and,0,0
185806,48,0,0
185807,weeks,0,0
185808,",",0,0
185809,then,0,0
185810,every,0,0
185811,year,0,0
185812,thereafter,0,0
185813,in,0,0
185814,all,0,0
185815,patients,0,0
185816,who,0,0
185817,received,0,0
185818,at,0,0
185819,least,0,0
185820,one,0,0
185821,dose,0,0
185822,of,0,0
185823,everolimus,0,0
185824,.,0,0
185825,This,0,0
185826,study,0,0
185827,was,0,0
185828,registered,0,0
185829,with,0,0
185830,ClinicalTrials.gov,0,0
185831,",",0,0
185832,number,0,1
185833,NCT00789828,0,0
185834,.,0,1
185835,FINDINGS,0,0
185836,Of,0,0
185837,the,0,0
185838,original,0,0
185839,117,0,0
185840,randomly,0,0
185841,assigned,0,0
185842,patients,0,0
185843,",",0,0
185844,111,0,0
185845,were,0,0
185846,given,0,0
185847,everolimus,0,0
185848,between,0,0
185849,Aug,0,0
185850,20,0,0
185851,",",0,0
185852,2009,0,0
185853,",",0,0
185854,and,0,0
185855,Jan,0,0
185856,11,0,0
185857,",",0,0
185858,2013,0,0
185859,(,0,0
185860,date,0,0
185861,of,0,1
185862,data,0,0
185863,cutoff,0,0
185864,),0,0
185865,;,0,0
185866,we,0,0
185867,included,0,0
185868,these,0,0
185869,patients,0,0
185870,in,0,0
185871,our,0,0
185872,longer-term,0,0
185873,analysis,0,0
185874,.,0,1
185875,Median,0,1
185876,duration,0,1
185877,of,0,1
185878,everolimus,0,0
185879,exposure,0,0
185880,was,0,0
185881,29?3,0,0
185882,months,0,0
185883,(,0,0
185884,IQR,0,0
185885,19?4-33?8,0,0
185886,),0,0
185887,.,0,0
185888,Median,0,1
185889,follow-up,0,0
185890,was,0,0
185891,28?3,0,0
185892,months,0,0
185893,(,0,0
185894,IQR,0,0
185895,19?3-33?0,0,0
185896,),0,0
185897,.,0,0
185898,54,0,0
185899,(,0,0
185900,49,0,0
185901,%,0,0
185902,),0,0
185903,patients,0,0
185904,had,0,0
185905,a,0,0
185906,response,0,1
185907,of,0,0
185908,50,0,0
185909,%,0,0
185910,or,0,0
185911,greater,0,1
185912,reduction,1,1
185913,in,1,0
185914,SEGA,1,1
185915,volume,1,1
185916,(,0,0
185917,95,0,0
185918,%,0,0
185919,CI,0,0
185920,39?0-58?3,1,0
185921,),1,0
185922,",",1,0
185923,and,1,1
185924,duration,1,1
185925,of,1,1
185926,response,1,1
185927,was,0,0
185928,between,0,0
185929,2?1,0,0
185930,and,0,0
185931,31?1,0,0
185932,months,0,0
185933,(,0,0
185934,median,0,1
185935,not,0,0
185936,reached,0,0
185937,),0,0
185938,.,1,0
185939,SEGA,1,1
185940,volume,1,1
185941,was,0,0
185942,reduced,0,0
185943,by,0,0
185944,50,0,0
185945,%,0,0
185946,or,0,0
185947,more,0,0
185948,in,0,0
185949,39,0,0
185950,(,0,0
185951,37,0,0
185952,%,0,0
185953,),0,0
185954,of,0,0
185955,105,0,0
185956,patients,0,0
185957,at,0,0
185958,24,0,0
185959,weeks,0,0
185960,",",0,0
185961,48,0,0
185962,(,0,0
185963,46,0,0
185964,%,0,0
185965,),0,0
185966,of,0,0
185967,104,0,0
185968,patients,0,0
185969,at,0,0
185970,48,0,0
185971,weeks,0,0
185972,",",0,0
185973,36,0,0
185974,(,0,0
185975,47,0,0
185976,%,0,0
185977,),0,0
185978,of,0,0
185979,76,0,0
185980,patients,0,0
185981,at,0,0
185982,96,0,0
185983,weeks,0,0
185984,",",0,0
185985,and,0,0
185986,11,0,0
185987,(,0,0
185988,38,0,0
185989,%,0,0
185990,),0,0
185991,of,0,0
185992,29,0,0
185993,patients,0,0
185994,at,0,0
185995,144,0,0
185996,weeks,0,0
185997,.,1,0
185998,Stomatitis,1,1
185999,(,0,0
186000,48,0,0
186001,[,0,0
186002,43,0,0
186003,%,0,0
186004,],0,0
186005,patients,0,0
186006,),0,1
186007,and,1,1
186008,mouth,1,1
186009,ulceration,1,1
186010,(,0,0
186011,33,0,0
186012,[,0,0
186013,30,0,0
186014,%,0,0
186015,],0,0
186016,patients,0,0
186017,),0,0
186018,were,0,0
186019,the,0,0
186020,most,0,0
186021,frequent,0,1
186022,treatment-related,0,1
186023,adverse,0,1
186024,events,1,1
186025,;,1,0
186026,infections,1,1
186027,were,0,0
186028,the,0,0
186029,most,0,0
186030,commonly,0,0
186031,reported,0,0
186032,treatment-related,0,1
186033,serious,0,1
186034,adverse,0,1
186035,event,0,1
186036,",",0,0
186037,occurring,0,0
186038,in,0,0
186039,15,0,0
186040,(,0,0
186041,14,0,0
186042,%,0,0
186043,),0,0
186044,patients,0,0
186045,.,0,0
186046,35,0,0
186047,(,0,0
186048,32,0,0
186049,%,0,0
186050,),0,0
186051,patients,0,0
186052,reported,0,0
186053,treatment-related,0,1
186054,grade,0,0
186055,3,0,0
186056,or,0,0
186057,4,0,0
186058,adverse,1,1
186059,events,1,1
186060,",",1,0
186061,the,1,0
186062,most,0,0
186063,common,0,0
186064,of,0,0
186065,which,0,0
186066,were,1,0
186067,stomatitis,1,0
186068,(,0,0
186069,nine,0,0
186070,[,0,0
186071,8,0,0
186072,%,0,0
186073,],0,0
186074,),0,1
186075,and,1,1
186076,pneumonia,1,1
186077,(,1,0
186078,nine,0,0
186079,[,0,0
186080,8,0,0
186081,%,0,0
186082,],0,0
186083,),0,0
186084,.,0,0
186085,18,0,0
186086,(,0,0
186087,16,0,0
186088,%,0,0
186089,),0,0
186090,patients,0,0
186091,had,0,0
186092,treatment-related,1,1
186093,serious,1,1
186094,adverse,1,1
186095,events,1,1
186096,.,1,1
186097,Six,1,0
186098,(,0,0
186099,5,0,0
186100,%,0,0
186101,),0,0
186102,patients,0,0
186103,withdrew,0,0
186104,because,1,0
186105,of,1,0
186106,adverse,1,1
186107,events,1,1
186108,.,1,0
186109,INTERPRETATION,1,0
186110,These,0,0
186111,results,0,0
186112,support,0,0
186113,the,0,0
186114,longer-term,0,0
186115,use,0,0
186116,of,0,1
186117,everolimus,0,0
186118,in,0,0
186119,patients,0,0
186120,who,0,0
186121,have,0,0
186122,few,0,0
186123,treatment,0,0
186124,options,0,0
186125,and,0,0
186126,who,0,0
186127,need,0,1
186128,continued,0,0
186129,treatment,0,0
186130,for,0,0
186131,tuberous,0,0
186132,sclerosis,0,0
186133,complex,0,0
186134,and,0,0
186135,its,0,0
186136,varied,0,0
186137,manifestations,1,1
186138,.,1,1
186139,Reduction,1,1
186140,or,1,1
186141,stabilisation,1,1
186142,of,1,1
186143,tumour,1,1
186144,volume,1,1
186145,with,1,0
186146,everolimus,0,0
186147,will,0,0
186148,hopefully,0,0
186149,provide,0,0
186150,long-term,0,1
186151,clinical,0,0
186152,benefit,0,0
186153,in,0,0
186154,patients,0,0
186155,with,0,0
186156,SEGA,0,0
186157,.,0,1
186158,FUNDING,0,0
186159,Novartis,0,0
186160,Pharmaceuticals,0,0
186161,.,0,0
186162,The,0,0
186163,durability,0,1
186164,of,0,0
186165,endovascular,0,0
186166,coiling,0,0
186167,versus,0,0
186168,neurosurgical,0,1
186169,clipping,0,0
186170,of,0,1
186171,ruptured,0,1
186172,cerebral,0,1
186173,aneurysms,0,0
186174,:,0,0
186175,18,0,0
186176,year,0,0
186177,follow-up,0,0
186178,of,0,0
186179,the,0,0
186180,UK,0,1
186181,cohort,0,0
186182,of,0,0
186183,the,0,0
186184,International,0,1
186185,Subarachnoid,0,1
186186,Aneurysm,0,1
186187,Trial,0,0
186188,(,0,1
186189,ISAT,0,0
186190,),0,0
186191,.,0,0
186192,BACKGROUND,0,0
186193,Previous,0,0
186194,analyses,0,0
186195,of,0,0
186196,the,0,0
186197,International,0,1
186198,Subarachnoid,0,1
186199,Aneurysm,0,1
186200,Trial,0,0
186201,(,0,1
186202,ISAT,0,1
186203,),0,0
186204,cohort,0,0
186205,have,0,0
186206,reported,0,0
186207,on,0,0
186208,the,0,0
186209,risks,0,1
186210,of,0,0
186211,recurrent,0,1
186212,subarachnoid,0,1
186213,haemorrhage,0,1
186214,and,0,1
186215,death,0,1
186216,or,0,1
186217,dependency,0,1
186218,for,0,0
186219,a,0,0
186220,minimum,0,1
186221,of,0,0
186222,5,0,0
186223,years,0,0
186224,and,0,0
186225,up,0,0
186226,to,0,0
186227,a,0,0
186228,maximum,0,0
186229,of,0,0
186230,14,0,0
186231,years,0,0
186232,after,0,0
186233,treatment,0,0
186234,of,0,0
186235,a,0,0
186236,ruptured,0,0
186237,intracranial,0,1
186238,aneurysm,0,1
186239,with,0,0
186240,either,0,0
186241,neurosurgical,0,0
186242,clipping,0,0
186243,or,0,1
186244,endovascular,0,0
186245,coiling,0,0
186246,.,0,0
186247,At,0,0
186248,1,0,0
186249,year,0,0
186250,there,0,0
186251,was,0,0
186252,a,0,0
186253,7,0,0
186254,%,0,0
186255,absolute,0,1
186256,and,0,0
186257,a,0,0
186258,24,0,0
186259,%,0,0
186260,relative,0,0
186261,risk,0,1
186262,reduction,0,1
186263,of,0,1
186264,death,1,1
186265,and,0,1
186266,dependency,1,1
186267,in,0,0
186268,the,0,0
186269,coiling,0,0
186270,group,0,0
186271,compared,0,0
186272,with,0,0
186273,the,0,0
186274,clipping,0,0
186275,group,0,0
186276,",",0,0
186277,but,0,0
186278,the,0,0
186279,medium-term,0,1
186280,results,0,0
186281,showed,0,0
186282,the,0,0
186283,increased,0,0
186284,need,0,0
186285,for,0,0
186286,re-treatment,1,0
186287,of,0,0
186288,the,0,0
186289,target,0,0
186290,aneurysm,0,1
186291,in,0,0
186292,the,0,0
186293,patients,0,0
186294,given,0,0
186295,coiling,0,0
186296,.,0,0
186297,We,0,0
186298,report,0,0
186299,the,0,0
186300,long-term,0,0
186301,follow-up,0,0
186302,of,0,0
186303,patients,0,0
186304,in,0,0
186305,this,0,0
186306,UK,0,1
186307,cohort,0,0
186308,.,0,1
186309,METHODS,0,0
186310,In,0,0
186311,ISAT,0,1
186312,",",0,1
186313,patients,0,0
186314,were,0,0
186315,randomly,0,0
186316,allocated,0,0
186317,to,0,0
186318,either,0,0
186319,neurosurgical,0,0
186320,clipping,0,0
186321,or,0,1
186322,endovascular,0,0
186323,coiling,0,0
186324,after,0,0
186325,a,0,0
186326,subarachnoid,0,1
186327,haemorrhage,0,1
186328,",",0,1
186329,assuming,0,0
186330,treatment,0,0
186331,equipoise,0,0
186332,",",0,0
186333,between,0,0
186334,Sept,0,0
186335,12,0,0
186336,",",0,0
186337,1994,0,0
186338,",",0,0
186339,and,0,0
186340,May,0,0
186341,1,0,0
186342,",",0,0
186343,2002,0,0
186344,.,0,0
186345,We,0,0
186346,followed,0,0
186347,up,0,0
186348,1644,0,0
186349,patients,0,0
186350,in,0,0
186351,22,0,0
186352,UK,0,0
186353,neurosurgical,0,0
186354,centres,0,0
186355,for,0,0
186356,death,0,1
186357,and,0,1
186358,clinical,0,1
186359,outcomes,0,1
186360,for,0,0
186361,10?0-18?5,0,0
186362,years,0,0
186363,.,0,0
186364,We,0,0
186365,assessed,1,0
186366,dependency,1,1
186367,as,1,0
186368,self-reported,0,1
186369,modified,1,0
186370,Rankin,1,1
186371,scale,1,1
186372,score,1,1
186373,obtained,1,0
186374,through,0,0
186375,yearly,0,0
186376,questionnaires,0,0
186377,.,0,0
186378,Data,0,0
186379,for,1,0
186380,recurrent,1,1
186381,aneurysms,1,1
186382,and,1,1
186383,rebleeding,1,1
186384,events,1,1
186385,were,1,0
186386,collected,0,0
186387,from,0,0
186388,questionnaires,0,0
186389,and,0,1
186390,from,0,0
186391,hospital,0,1
186392,and,0,1
186393,general,0,1
186394,practitioner,0,0
186395,records,0,0
186396,.,0,0
186397,The,0,0
186398,Office,0,0
186399,for,0,0
186400,National,0,1
186401,Statistics,0,1
186402,supplied,0,0
186403,data,0,0
186404,on,0,0
186405,deaths,0,1
186406,.,0,0
186407,This,0,0
186408,study,0,0
186409,is,0,0
186410,registered,0,0
186411,",",0,0
186412,number,0,1
186413,ISRCTN49866681,0,0
186414,.,0,1
186415,FINDINGS,0,0
186416,At,0,0
186417,10,0,0
186418,years,0,0
186419,",",0,0
186420,674,0,0
186421,(,0,0
186422,83,0,0
186423,%,0,0
186424,),0,0
186425,of,0,0
186426,809,0,0
186427,patients,0,0
186428,allocated,0,0
186429,endovascular,0,0
186430,coiling,0,0
186431,and,0,0
186432,657,0,0
186433,(,0,0
186434,79,0,0
186435,%,0,0
186436,),0,0
186437,of,0,0
186438,835,0,0
186439,patients,0,0
186440,allocated,0,0
186441,neurosurgical,0,1
186442,clipping,0,0
186443,were,0,0
186444,alive,0,1
186445,(,0,0
186446,odds,0,0
186447,ratio,0,0
186448,[,0,0
186449,OR,0,0
186450,],0,0
186451,1?35,0,0
186452,",",0,0
186453,95,0,0
186454,%,0,0
186455,CI,0,0
186456,1?06-1?73,0,0
186457,),0,0
186458,.,0,0
186459,Of,0,0
186460,1003,0,0
186461,individuals,0,0
186462,who,0,0
186463,returned,0,0
186464,a,0,0
186465,questionnaire,0,1
186466,at,0,0
186467,10,0,0
186468,years,0,0
186469,",",0,0
186470,435,0,0
186471,(,0,0
186472,82,0,0
186473,%,0,0
186474,),0,0
186475,patients,0,0
186476,treated,0,0
186477,with,0,0
186478,endovascular,0,0
186479,coiling,0,0
186480,and,0,0
186481,370,0,0
186482,(,0,0
186483,78,0,0
186484,%,0,0
186485,),0,0
186486,patients,0,0
186487,treated,0,0
186488,with,0,0
186489,neurosurgical,0,0
186490,clipping,0,0
186491,were,0,0
186492,independent,1,0
186493,(,1,0
186494,modified,1,0
186495,Rankin,0,1
186496,scale,0,1
186497,score,0,1
186498,0-2,0,0
186499,;,0,0
186500,OR,0,0
186501,1?25,0,0
186502,;,0,0
186503,95,0,0
186504,%,0,0
186505,CI,0,0
186506,0?92-1?71,0,0
186507,),0,0
186508,.,0,0
186509,Patients,0,0
186510,in,0,0
186511,the,0,0
186512,endovascular,0,0
186513,treatment,0,0
186514,group,0,0
186515,were,0,0
186516,more,0,0
186517,likely,0,0
186518,to,1,0
186519,be,1,0
186520,alive,1,1
186521,and,1,1
186522,independent,1,0
186523,at,1,0
186524,10,1,0
186525,years,1,0
186526,than,1,0
186527,were,0,0
186528,patients,0,0
186529,in,0,0
186530,the,0,0
186531,neurosurgery,0,0
186532,group,0,0
186533,(,0,0
186534,OR,0,0
186535,1?34,0,0
186536,",",0,0
186537,95,0,0
186538,%,0,0
186539,CI,0,0
186540,1?07-1?67,0,0
186541,),0,0
186542,.,0,0
186543,33,0,0
186544,patients,0,0
186545,had,1,0
186546,a,1,0
186547,recurrent,1,1
186548,subarachnoid,1,1
186549,haemorrhage,1,0
186550,more,1,0
186551,than,1,0
186552,1,0,0
186553,year,0,0
186554,after,0,0
186555,their,0,0
186556,initial,0,0
186557,haemorrhage,0,0
186558,(,0,0
186559,17,0,0
186560,from,0,0
186561,the,0,0
186562,target,0,0
186563,aneurysm,0,1
186564,),0,0
186565,.,0,0
186566,INTERPRETATION,0,0
186567,Although,0,0
186568,rates,1,1
186569,of,1,0
186570,increased,1,1
186571,dependency,1,1
186572,alone,0,0
186573,did,0,0
186574,not,0,0
186575,differ,0,0
186576,between,0,0
186577,groups,0,0
186578,",",0,0
186579,the,0,0
186580,probability,1,1
186581,of,1,1
186582,death,1,1
186583,or,1,1
186584,dependency,1,1
186585,was,0,0
186586,significantly,0,0
186587,greater,0,0
186588,in,0,0
186589,the,0,0
186590,neurosurgical,0,0
186591,group,0,0
186592,than,0,0
186593,in,0,0
186594,the,0,0
186595,endovascular,1,0
186596,group,1,0
186597,.,1,1
186598,Rebleeding,1,1
186599,was,0,0
186600,more,0,0
186601,likely,0,0
186602,after,0,0
186603,endovascular,0,0
186604,coiling,0,0
186605,than,0,0
186606,after,0,0
186607,neurosurgical,0,1
186608,clipping,0,0
186609,",",0,0
186610,but,0,0
186611,the,0,0
186612,risk,0,1
186613,was,0,0
186614,small,0,0
186615,and,0,0
186616,the,0,0
186617,probability,0,1
186618,of,1,0
186619,disability-free,1,1
186620,survival,1,1
186621,was,1,0
186622,significantly,0,0
186623,greater,0,0
186624,in,0,0
186625,the,0,0
186626,endovascular,0,0
186627,group,0,0
186628,than,0,0
186629,in,0,0
186630,the,0,0
186631,neurosurgical,0,0
186632,group,0,0
186633,at,0,0
186634,10,0,0
186635,years,0,0
186636,.,0,0
186637,FUNDING,0,0
186638,UK,0,1
186639,Medical,0,0
186640,Research,0,0
186641,Council,0,1
186642,.,0,0
186643,Comparison,0,0
186644,on,0,0
186645,therapeutic,0,0
186646,effect,1,1
186647,of,0,1
186648,plasma,0,1
186649,exchange,0,1
186650,and,0,1
186651,intravenous,0,0
186652,immunoglobulin,0,1
186653,for,0,0
186654,Guillian-Barre,0,0
186655,syndrome,0,0
186656,.,0,0
186657,OBJECTIVES,0,0
186658,To,0,0
186659,observe,0,0
186660,and,0,0
186661,compare,0,0
186662,the,0,0
186663,clinical,1,0
186664,curative,1,1
186665,effect,1,0
186666,of,0,0
186667,the,0,0
186668,plasma,0,1
186669,exchange,0,1
186670,(,0,1
186671,PE,0,1
186672,),0,1
186673,and,0,1
186674,intravenous,0,0
186675,immunoglobulin,0,1
186676,(,0,1
186677,IVIg,0,1
186678,),0,0
186679,for,0,0
186680,Guillian-Barre,0,1
186681,Syndrome,0,1
186682,(,0,1
186683,GBS,0,0
186684,),0,0
186685,.,0,0
186686,METHODS,0,0
186687,Overall,0,0
186688,",",0,0
186689,64,0,0
186690,adult,0,0
186691,patients,0,0
186692,with,0,0
186693,GBS,0,0
186694,for,0,0
186695,PE,0,1
186696,and,0,1
186697,IVIg,0,1
186698,treatment,0,0
186699,",",0,0
186700,respectively,0,0
186701,",",0,0
186702,and,0,1
186703,nerve,1,1
186704,function,1,1
186705,were,0,0
186706,observed,0,0
186707,pre-treatment,0,0
186708,and,0,0
186709,at,0,0
186710,1,0,0
186711,week/2,0,0
186712,weeks,0,0
186713,after,0,0
186714,completion,0,1
186715,of,0,0
186716,treatment,0,0
186717,;,0,0
186718,the,0,0
186719,blood,0,1
186720,immunoglobulin,0,1
186721,",",0,1
186722,complement,0,1
186723,",",0,1
186724,fibrinogen,0,1
186725,(,0,1
186726,Fib,0,1
186727,),0,1
186728,and,0,1
186729,monocyte,0,1
186730,percentage,0,1
186731,(,0,1
186732,MON,0,1
186733,%,0,0
186734,),0,1
186735,were,0,0
186736,detected,0,0
186737,simultaneously,0,0
186738,.,0,0
186739,RESULTS,0,0
186740,After,0,0
186741,PE,0,1
186742,treatment,1,0
186743,",",1,1
186744,nerve,1,1
186745,function,1,1
186746,defect,1,1
186747,appeared,1,0
186748,to,0,0
186749,improve,0,0
186750,better,0,0
186751,than,0,0
186752,the,0,0
186753,IVIg,0,1
186754,group,0,0
186755,and,0,1
186756,clinical,0,1
186757,effect,0,1
186758,was,0,0
186759,better,0,0
186760,than,0,0
186761,the,0,0
186762,IVIg,0,0
186763,group,0,0
186764,.,0,1
186765,Treatment,1,0
186766,effective,1,1
186767,rates,1,1
186768,of,1,0
186769,the,0,0
186770,two,0,0
186771,groups,0,0
186772,after,0,0
186773,2,0,0
186774,weeks,0,0
186775,",",0,0
186776,respectively,0,0
186777,",",0,0
186778,are,0,0
186779,96,0,0
186780,and,0,0
186781,79,0,0
186782,%,0,0
186783,.,0,0
186784,PE,0,1
186785,and,0,0
186786,IVIg,0,1
186787,can,0,0
186788,significantly,0,0
186789,reduce,0,0
186790,the,1,0
186791,GBS,1,0
186792,patients,1,0
186793,',1,1
186794,blood,1,1
186795,immunoglobulin,1,1
186796,IgG,1,1
186797,",",1,1
186798,IgA,1,1
186799,",",1,1
186800,IgM,1,1
186801,",",1,1
186802,C3,1,1
186803,and,1,1
186804,C4,1,1
186805,",",1,1
186806,but,1,0
186807,these,0,0
186808,were,0,0
186809,significantly,0,0
186810,lower,0,0
186811,in,0,0
186812,the,0,0
186813,PE,0,1
186814,group,0,0
186815,than,0,0
186816,in,0,0
186817,the,0,0
186818,IVIg,0,0
186819,group,0,0
186820,.,0,1
186821,Fib,1,1
186822,and,1,1
186823,MON,1,1
186824,%,1,0
186825,were,0,0
186826,significantly,0,0
186827,lower,0,0
186828,in,0,0
186829,the,0,0
186830,PE,0,1
186831,group,0,0
186832,than,0,0
186833,in,0,0
186834,the,0,0
186835,IVIg,0,0
186836,group,0,0
186837,.,0,1
186838,CONCLUSION,0,0
186839,Both,0,0
186840,PE,0,1
186841,and,0,0
186842,IVIg,0,0
186843,have,0,0
186844,a,0,0
186845,high,0,0
186846,response,0,1
186847,as,0,0
186848,therapy,0,0
186849,and,0,0
186850,are,0,0
186851,reasonable,0,0
186852,therapeutic,0,0
186853,options,0,0
186854,for,0,0
186855,GBS,0,0
186856,.,0,0
186857,However,0,0
186858,",",0,0
186859,PE,0,1
186860,treatment,0,0
186861,has,0,0
186862,a,0,0
186863,more,0,0
186864,significantly,0,0
186865,curative,0,0
186866,effect,0,1
186867,",",0,0
186868,as,0,0
186869,it,0,0
186870,can,0,0
186871,effectively,0,0
186872,improve,0,0
186873,symptoms,0,1
186874,and,0,1
186875,be,0,0
186876,helpful,0,0
186877,in,0,0
186878,the,0,0
186879,early,0,0
186880,rehabilitation,0,0
186881,of,0,0
186882,patients,0,0
186883,.,0,0
186884,Carboplatin,0,0
186885,and,0,1
186886,pegylated,0,0
186887,liposomal,0,0
186888,doxorubicin,0,0
186889,versus,0,0
186890,carboplatin,0,0
186891,and,0,1
186892,paclitaxel,0,0
186893,in,0,0
186894,very,0,0
186895,platinum-sensitive,0,0
186896,ovarian,0,1
186897,cancer,0,0
186898,patients,0,0
186899,:,0,0
186900,results,0,0
186901,from,0,0
186902,a,0,0
186903,subset,0,0
186904,analysis,0,0
186905,of,0,0
186906,the,0,0
186907,CALYPSO,0,0
186908,phase,0,0
186909,III,0,0
186910,trial,0,0
186911,.,0,0
186912,AIM,0,0
186913,To,0,0
186914,perform,0,0
186915,a,0,0
186916,subset,0,0
186917,analysis,0,0
186918,of,0,0
186919,patients,0,0
186920,with,0,0
186921,very,0,0
186922,platinum-sensitive,0,0
186923,recurrent,0,1
186924,ovarian,0,1
186925,cancer,0,0
186926,(,0,1
186927,ROC,0,1
186928,),0,1
186929,enrolled,0,0
186930,in,0,0
186931,the,0,0
186932,phase,0,0
186933,III,0,1
186934,CALYPSO,0,1
186935,trial,0,0
186936,.,0,1
186937,PATIENTS,0,0
186938,AND,0,0
186939,METHODS,0,0
186940,The,0,0
186941,international,0,0
186942,non-inferiority,0,0
186943,trial,0,0
186944,enrolled,0,0
186945,women,0,0
186946,with,0,0
186947,ROC,0,0
186948,that,0,0
186949,relapsed,0,0
186950,>,0,0
186951,6,0,0
186952,months,0,0
186953,following,0,0
186954,first-,0,0
186955,or,0,0
186956,second-line,0,0
186957,platinum-,0,1
186958,and,0,1
186959,paclitaxel-based,0,0
186960,therapies,0,0
186961,.,0,0
186962,Patients,0,0
186963,were,0,0
186964,randomised,0,0
186965,to,0,0
186966,CD,0,0
186967,[,0,0
186968,carboplatin-pegylated,0,0
186969,liposomal,0,0
186970,doxorubicin,0,0
186971,(,0,1
186972,PLD,0,0
186973,),0,1
186974,],0,0
186975,or,0,1
186976,CP,0,1
186977,(,0,1
186978,carboplatin-paclitaxel,0,0
186979,),0,1
186980,and,0,1
186981,stratified,0,0
186982,by,0,0
186983,treatment-free,0,0
186984,interval,0,0
186985,(,0,1
186986,TFI,0,1
186987,),0,0
186988,.,0,0
186989,In,0,0
186990,this,0,0
186991,analysis,0,0
186992,",",0,0
186993,patients,0,0
186994,with,0,0
186995,a,0,0
186996,TFI,0,0
186997,>,0,0
186998,24,0,0
186999,months,0,0
187000,were,0,0
187001,analysed,0,0
187002,separately,0,0
187003,for,0,0
187004,progression,0,1
187005,free,0,1
187006,survival,0,1
187007,(,0,1
187008,PFS,0,1
187009,),0,0
187010,",",0,0
187011,the,0,0
187012,primary,0,0
187013,endpoint,0,1
187014,of,0,1
187015,CALYPSO,0,1
187016,",",0,1
187017,overall,0,1
187018,survival,0,1
187019,(,0,1
187020,OS,0,1
187021,),0,1
187022,and,0,0
187023,safety,0,1
187024,.,0,0
187025,RESULTS,0,0
187026,A,0,0
187027,total,0,0
187028,of,0,0
187029,259,0,0
187030,very,0,0
187031,platinum-sensitive,0,0
187032,patients,0,0
187033,were,0,0
187034,included,0,0
187035,(,0,0
187036,n=131,0,0
187037,",",0,0
187038,CD,0,0
187039,;,0,0
187040,n=128,0,0
187041,",",0,0
187042,CP,0,0
187043,),0,0
187044,.,0,0
187045,Median,1,1
187046,PFS,1,1
187047,was,0,0
187048,12.0,0,0
187049,months,0,0
187050,for,0,0
187051,the,0,0
187052,CD,0,0
187053,arm,0,0
187054,and,0,0
187055,12.3,0,0
187056,months,0,0
187057,for,0,0
187058,CP,0,0
187059,[,0,0
187060,HR=1.05,0,0
187061,(,0,0
187062,95,0,0
187063,%,0,0
187064,CI,0,0
187065,",",0,1
187066,0.79-1.40,0,0
187067,),0,0
187068,;,0,0
187069,P=0.73,0,0
187070,for,0,0
187071,superiority,0,1
187072,],0,0
187073,and,0,1
187074,median,1,1
187075,OS,1,1
187076,was,0,0
187077,40.2,0,0
187078,months,0,0
187079,for,0,0
187080,CD,0,0
187081,and,0,0
187082,43.9,0,0
187083,for,0,0
187084,CP,0,0
187085,[,0,0
187086,HR=1.18,0,0
187087,(,0,0
187088,95,0,0
187089,%,0,0
187090,CI,0,0
187091,0.85-1.63,0,0
187092,),0,0
187093,;,0,0
187094,P=0.33,0,0
187095,for,0,0
187096,superiority,0,0
187097,],0,0
187098,.,0,1
187099,Overall,0,1
187100,response,1,1
187101,rates,1,1
187102,were,0,0
187103,42,0,0
187104,%,0,0
187105,and,0,0
187106,38,0,0
187107,%,0,0
187108,",",0,0
187109,respectively,0,0
187110,(,0,0
187111,P=0.46,0,0
187112,),0,0
187113,.,0,0
187114,Toxicities,1,1
187115,were,0,0
187116,more,0,0
187117,common,0,1
187118,with,0,0
187119,CP,0,0
187120,versus,0,0
187121,CD,0,0
187122,",",0,1
187123,including,0,0
187124,grade,1,0
187125,3/4,1,1
187126,neutropenia,1,1
187127,(,0,0
187128,40.8,0,0
187129,%,0,0
187130,versus,0,0
187131,27.5,0,0
187132,%,0,0
187133,;,0,0
187134,P=0.025,0,0
187135,),0,1
187136,",",0,1
187137,nausea,1,1
187138,(,0,0
187139,4.8,0,0
187140,%,0,0
187141,versus,0,0
187142,3.1,0,0
187143,%,0,0
187144,;,0,0
187145,P=0.47,0,0
187146,),0,0
187147,",",0,0
187148,allergic,1,1
187149,reaction,1,1
187150,(,0,0
187151,8,0,0
187152,%,0,0
187153,versus,0,0
187154,3.1,0,0
187155,%,0,0
187156,;,0,0
187157,P=0.082,0,0
187158,),0,0
187159,sensory,1,1
187160,neuropathy,1,1
187161,(,0,0
187162,4.8,0,0
187163,%,0,0
187164,versus,0,0
187165,2.3,0,0
187166,%,0,0
187167,;,0,0
187168,P=0.27,0,0
187169,),0,1
187170,and,0,0
187171,grade,1,0
187172,2,1,0
187173,alopecia,1,1
187174,(,0,0
187175,88,0,0
187176,%,0,0
187177,versus,0,0
187178,9.2,0,0
187179,%,0,0
187180,;,0,0
187181,P,0,0
187182,<,0,0
187183,0.001,0,0
187184,),0,0
187185,.,0,0
187186,Grade,1,0
187187,3/4,1,0
187188,thrombocytopenia,1,0
187189,(,0,0
187190,12.2,0,0
187191,%,0,0
187192,versus,0,0
187193,3.2,0,0
187194,%,0,0
187195,;,0,0
187196,P=0.007,0,0
187197,),0,1
187198,and,0,1
187199,mucositis,1,1
187200,(,0,0
187201,2.3,0,0
187202,%,0,0
187203,versus,0,0
187204,0,0,0
187205,%,0,0
187206,;,0,0
187207,P=0.089,0,0
187208,),0,0
187209,were,0,0
187210,more,0,0
187211,common,0,1
187212,with,0,0
187213,CD,0,0
187214,.,0,0
187215,Grade,1,0
187216,3/4,1,0
187217,hand-foot,1,0
187218,syndrome,1,0
187219,occurred,0,0
187220,rarely,0,0
187221,with,0,0
187222,CD,0,0
187223,(,0,0
187224,3,0,0
187225,patients,0,0
187226,versus,0,0
187227,0,0,0
187228,in,0,0
187229,CP,0,0
187230,arm,0,0
187231,;,0,1
187232,P=0.089,0,0
187233,),0,0
187234,.,0,0
187235,CONCLUSION,0,0
187236,CP,0,1
187237,and,0,1
187238,CD,0,0
187239,were,0,0
187240,equally,0,0
187241,effective,0,1
187242,treatment,0,0
187243,regimens,0,0
187244,for,0,0
187245,patients,0,0
187246,with,0,0
187247,very,0,0
187248,platinum-sensitive,0,0
187249,ROC,0,0
187250,.,0,0
187251,The,0,0
187252,favourable,0,0
187253,risk-benefit,0,0
187254,profile,0,1
187255,suggests,0,0
187256,carboplatin-PLD,0,0
187257,as,0,0
187258,treatment,0,0
187259,of,0,1
187260,choice,0,0
187261,for,0,0
187262,these,0,0
187263,patients,0,0
187264,.,0,0
187265,Inclusion,0,0
187266,of,0,1
187267,anti-phospholipase,0,1
187268,A2,0,0
187269,antibody,0,1
187270,to,0,0
187271,backgrounding,0,0
187272,diets,0,0
187273,on,0,0
187274,performance,1,1
187275,",",1,1
187276,feed,1,1
187277,efficiency,1,1
187278,",",1,0
187279,in,1,0
187280,vitro,1,1
187281,fermentation,1,1
187282,",",1,0
187283,and,1,0
187284,the,1,0
187285,acute-phase,1,1
187286,response,1,1
187287,of,1,1
187288,growing,1,0
187289,beef,1,0
187290,calves,1,0
187291,.,1,0
187292,In,0,0
187293,Exp,0,0
187294,.,0,0
187295,1,0,0
187296,",",0,0
187297,individual,0,0
187298,performance,0,1
187299,and,0,1
187300,daily,0,1
187301,DMI,0,1
187302,was,0,0
187303,measured,0,0
187304,on,0,0
187305,70,0,0
187306,crossbred,0,0
187307,weaned,0,0
187308,calves,0,0
187309,during,0,0
187310,a,0,0
187311,70-d,0,0
187312,period,0,0
187313,using,0,0
187314,a,0,0
187315,GrowSafe,0,1
187316,system,0,0
187317,(,0,0
187318,GrowSafe,0,1
187319,Systems,0,0
187320,Ltd.,0,0
187321,",",0,1
187322,Airdrie,0,1
187323,",",0,1
187324,AB,0,1
187325,",",0,1
187326,Canada,0,1
187327,),0,0
187328,at,0,0
187329,the,0,0
187330,University,0,0
187331,of,0,0
187332,Florida,0,0
187333,North,0,0
187334,Florida,0,0
187335,Research,0,1
187336,and,0,1
187337,Education,0,1
187338,Center,0,0
187339,Feed,0,1
187340,Efficiency,0,1
187341,Facility,0,1
187342,(,0,1
187343,FEF,0,1
187344,),0,0
187345,.,0,0
187346,Calves,0,0
187347,were,0,0
187348,fed,0,0
187349,a,0,0
187350,low-concentrate,0,0
187351,(,0,0
187352,LC,0,1
187353,),0,0
187354,growing,0,0
187355,diet,0,0
187356,",",0,0
187357,blocked,0,0
187358,by,0,0
187359,weight,0,1
187360,and,0,1
187361,sex,0,1
187362,",",0,1
187363,and,0,1
187364,then,0,0
187365,randomly,0,0
187366,assigned,0,0
187367,to,0,0
187368,pens,0,0
187369,to,0,0
187370,receive,0,0
187371,either,0,0
187372,no,0,0
187373,additional,0,0
187374,supplement,0,0
187375,(,0,0
187376,CON,0,0
187377,;,0,0
187378,n,0,0
187379,=,0,0
187380,35,0,0
187381,),0,0
187382,or,0,0
187383,receive,0,0
187384,a,0,0
187385,supplement,0,0
187386,of,0,0
187387,anti-phospholipase,0,1
187388,A2,0,1
187389,antibody,0,1
187390,(,0,1
187391,aPLA2,0,1
187392,),0,0
187393,at,0,0
187394,an,0,0
187395,inclusion,0,0
187396,rate,0,1
187397,of,0,0
187398,0.6,0,0
187399,%,0,0
187400,of,0,0
187401,the,0,0
187402,diet,0,0
187403,DM,0,1
187404,(,0,0
187405,n,0,0
187406,=,0,0
187407,35,0,0
187408,),0,0
187409,.,0,0
187410,After,0,0
187411,the,0,0
187412,70-d,0,0
187413,feed,0,1
187414,efficiency,0,1
187415,(,0,1
187416,FE,0,1
187417,),0,1
187418,trial,0,0
187419,(,0,0
187420,Phase,0,0
187421,1,0,0
187422,),0,0
187423,",",0,0
187424,calves,0,0
187425,were,0,0
187426,loaded,0,0
187427,into,0,0
187428,a,0,0
187429,commercial,0,0
187430,livestock,0,0
187431,trailer,0,0
187432,and,0,1
187433,were,0,0
187434,driven,0,0
187435,for,0,0
187436,approximately,0,0
187437,"1,600",0,0
187438,km,0,0
187439,during,0,0
187440,24,0,0
187441,h.,0,0
187442,Upon,0,0
187443,return,0,1
187444,to,0,0
187445,the,0,0
187446,FEF,0,1
187447,(,0,0
187448,Phase,0,0
187449,2,0,0
187450,),0,0
187451,",",0,0
187452,calves,0,0
187453,were,0,0
187454,relocated,0,0
187455,to,0,0
187456,the,0,0
187457,same,0,0
187458,pens,0,0
187459,and,0,1
187460,groups,0,0
187461,and,0,1
187462,received,0,0
187463,the,0,0
187464,same,0,0
187465,diets,0,0
187466,and,0,1
187467,treatments,0,0
187468,for,0,0
187469,28,0,0
187470,d.,0,0
187471,Blood,0,0
187472,samples,0,0
187473,from,0,0
187474,each,0,0
187475,calf,0,1
187476,were,0,0
187477,collected,0,0
187478,on,0,0
187479,d,0,0
187480,0,0,0
187481,",",0,0
187482,1,0,0
187483,",",0,0
187484,3,0,0
187485,",",0,0
187486,5,0,0
187487,",",0,0
187488,7,0,0
187489,",",0,0
187490,14,0,0
187491,",",0,0
187492,21,0,0
187493,",",0,0
187494,and,0,0
187495,28,0,0
187496,relative,0,0
187497,to,0,0
187498,initiation,0,0
187499,of,0,1
187500,transportation,0,1
187501,and,0,1
187502,were,0,0
187503,analyzed,0,0
187504,for,0,0
187505,determination,0,0
187506,of,0,0
187507,concentrations,1,1
187508,of,1,1
187509,plasma,1,1
187510,ceruloplasmin,1,1
187511,and,1,1
187512,haptoglobin,1,1
187513,.,1,1
187514,In,0,0
187515,Phase,0,0
187516,1,0,0
187517,",",0,0
187518,initial,0,0
187519,BW,1,0
187520,(,0,0
187521,242.0,0,0
187522,?,0,0
187523,3.7,0,0
187524,kg,0,0
187525,;,0,0
187526,P,0,0
187527,=,0,0
187528,0.92,0,0
187529,),0,0
187530,",",0,0
187531,BW,1,1
187532,at,0,0
187533,d,0,0
187534,70,0,0
187535,(,0,0
187536,313.0,0,0
187537,?,0,0
187538,4.1,0,0
187539,kg,0,0
187540,;,0,0
187541,P,0,0
187542,=,0,0
187543,0.79,0,0
187544,),0,0
187545,",",0,0
187546,and,1,1
187547,ADG,1,1
187548,(,1,0
187549,1.01,0,0
187550,?,0,0
187551,0.02,0,0
187552,kg,0,0
187553,;,0,0
187554,P,0,0
187555,=,0,0
187556,0.95,0,0
187557,),0,0
187558,were,0,0
187559,similar,0,0
187560,between,0,0
187561,treatments,0,0
187562,.,0,0
187563,However,1,0
187564,",",1,0
187565,daily,1,1
187566,DMI,1,1
187567,was,1,0
187568,greater,0,1
187569,(,0,1
187570,P,0,0
187571,=,0,0
187572,0.01,0,0
187573,),0,0
187574,for,0,0
187575,CON,0,0
187576,(,0,0
187577,9.18,0,0
187578,?,0,0
187579,0.15,0,0
187580,kg,0,0
187581,),0,0
187582,than,0,0
187583,aPLA2,0,0
187584,(,0,0
187585,8.53,0,0
187586,?,0,0
187587,0.15,0,0
187588,kg,0,0
187589,),0,0
187590,.,0,0
187591,In,0,0
187592,addition,1,0
187593,",",1,1
187594,residual,1,1
187595,feed,1,1
187596,intake,1,1
187597,was,1,0
187598,greater,0,1
187599,(,0,1
187600,P,0,0
187601,=,0,0
187602,0.002,0,0
187603,),0,0
187604,for,0,0
187605,CON,0,0
187606,(,0,0
187607,0.389,0,0
187608,?,0,0
187609,0.110,0,0
187610,kg/d,0,0
187611,),0,0
187612,than,0,0
187613,aPLA2,0,1
187614,calves,0,0
187615,(,0,0
187616,-0.272,0,0
187617,?,0,0
187618,0.110,0,0
187619,kg/d,0,0
187620,),0,0
187621,.,0,0
187622,In,0,0
187623,Phase,0,0
187624,2,0,0
187625,",",0,0
187626,after,0,0
187627,transportation,0,1
187628,",",0,0
187629,there,0,0
187630,were,0,0
187631,no,0,0
187632,differences,0,0
187633,between,0,0
187634,treatments,1,0
187635,on,1,0
187636,BW,1,0
187637,loss,1,1
187638,due,1,0
187639,to,1,0
187640,transportation,1,1
187641,shrink,1,0
187642,(,0,0
187643,26.0,0,0
187644,?,0,0
187645,0.6,0,0
187646,kg,0,0
187647,;,0,0
187648,P,0,0
187649,=,0,0
187650,0.86,0,0
187651,),0,0
187652,",",0,0
187653,BW,0,1
187654,at,0,0
187655,d,0,0
187656,28,0,0
187657,(,0,0
187658,339.0,0,0
187659,?,0,0
187660,4.1,0,0
187661,kg,0,0
187662,;,0,0
187663,P,0,0
187664,=,0,0
187665,0.72,0,0
187666,),0,0
187667,",",0,0
187668,ADG,0,1
187669,(,0,0
187670,1.28,0,0
187671,?,0,0
187672,0.03,0,0
187673,kg/d,0,0
187674,;,0,0
187675,P,0,0
187676,=,0,0
187677,0.72,0,0
187678,),0,0
187679,",",0,0
187680,G,0,0
187681,:,0,1
187682,F,0,0
187683,(,0,0
187684,0.164,0,0
187685,?,0,0
187686,0.004,0,0
187687,;,0,0
187688,P,0,0
187689,=,0,0
187690,0.83,0,0
187691,),0,0
187692,",",0,0
187693,and,0,1
187694,concentrations,0,1
187695,of,0,1
187696,plasma,0,1
187697,haptoglobin,0,1
187698,(,0,0
187699,0.08,0,0
187700,?,0,0
187701,0.02,0,0
187702,mg/mL,0,0
187703,;,0,0
187704,P,0,0
187705,=,0,0
187706,0.41,0,0
187707,),0,0
187708,.,0,0
187709,However,1,0
187710,",",1,0
187711,concentrations,1,1
187712,of,1,1
187713,plasma,1,1
187714,ceruloplasmin,1,1
187715,were,1,0
187716,greater,1,1
187717,(,0,1
187718,P,0,0
187719,<,0,0
187720,0.001,0,0
187721,),0,0
187722,for,0,0
187723,CON,0,0
187724,calves,0,0
187725,(,0,0
187726,14.3,0,0
187727,?,0,0
187728,0.3,0,0
187729,mg/dL,0,0
187730,),0,0
187731,compared,0,0
187732,to,0,0
187733,aPLA2,0,0
187734,calves,0,0
187735,(,0,0
187736,13.0,0,0
187737,?,0,0
187738,0.3,0,0
187739,mg/dL,0,0
187740,),0,0
187741,.,0,0
187742,In,0,0
187743,Exp,0,0
187744,.,0,0
187745,2,0,0
187746,",",0,0
187747,the,0,0
187748,effects,0,1
187749,of,0,0
187750,aPLA2,1,1
187751,inclusion,1,0
187752,on,1,0
187753,LC,1,1
187754,and,1,1
187755,high-concentrate,1,0
187756,(,1,1
187757,HC,1,0
187758,),1,0
187759,substrates,1,1
187760,on,1,0
187761,in,1,0
187762,vitro,1,1
187763,fermentation,1,0
187764,parameters,1,1
187765,were,1,0
187766,assessed,0,0
187767,.,0,0
187768,Addition,0,0
187769,of,0,1
187770,aPLA2,0,0
187771,had,0,0
187772,no,0,0
187773,effects,0,1
187774,on,0,0
187775,in,1,0
187776,vitro,1,1
187777,fermentation,1,0
187778,parameters,1,1
187779,of,1,1
187780,LC,1,1
187781,and,1,1
187782,HC,1,0
187783,substrates,1,1
187784,.,0,0
187785,In,0,0
187786,conclusion,0,0
187787,",",0,1
187788,supplementation,0,0
187789,of,0,1
187790,aPLA2,0,1
187791,improved,0,1
187792,FE,1,1
187793,of,1,0
187794,growing,0,0
187795,beef,0,0
187796,calves,0,0
187797,when,0,0
187798,fed,0,0
187799,LC,0,0
187800,diets,0,0
187801,in,0,0
187802,Phase,0,0
187803,1,0,0
187804,and,0,0
187805,addition,0,0
187806,of,0,1
187807,aPLA2,0,0
187808,had,0,0
187809,no,0,0
187810,effect,0,1
187811,on,1,0
187812,fermentation,1,0
187813,parameters,1,1
187814,of,1,1
187815,LC,1,1
187816,and,1,1
187817,HC,1,0
187818,substrates,1,1
187819,.,0,0
187820,In,0,0
187821,addition,0,0
187822,",",0,1
187823,calves,0,0
187824,supplemented,0,0
187825,with,0,0
187826,aPLA2,0,1
187827,had,0,0
187828,reduced,1,0
187829,concentrations,1,1
187830,of,1,0
187831,plasma,1,1
187832,ceruloplasmin,1,1
187833,after,0,0
187834,24,0,0
187835,h,0,0
187836,of,0,0
187837,transportation,0,0
187838,.,0,0
187839,Exploring,0,0
187840,the,0,0
187841,role,0,0
187842,of,0,0
187843,tanezumab,0,0
187844,as,0,0
187845,a,0,0
187846,novel,0,0
187847,treatment,0,0
187848,for,0,0
187849,the,0,0
187850,relief,0,1
187851,of,0,0
187852,neuropathic,0,1
187853,pain,0,1
187854,.,0,0
187855,OBJECTIVE,0,1
187856,Evaluate,0,1
187857,efficacy,0,1
187858,and,0,1
187859,safety,0,1
187860,of,0,1
187861,tanezumab,0,0
187862,",",0,0
187863,a,0,0
187864,humanized,0,0
187865,monoclonal,0,0
187866,antibody,0,1
187867,against,0,1
187868,nerve,0,1
187869,growth,0,1
187870,factor,0,1
187871,",",0,0
187872,in,0,0
187873,neuropathic,0,1
187874,pain,0,1
187875,.,0,0
187876,DESIGN,0,0
187877,Two,0,0
187878,randomized,0,0
187879,controlled,0,0
187880,trials,0,0
187881,.,0,0
187882,SUBJECTS,0,1
187883,Patients,0,0
187884,with,0,0
187885,pain,0,1
187886,due,0,0
187887,to,0,0
187888,diabetic,0,0
187889,peripheral,0,1
187890,neuropathy,0,1
187891,(,0,1
187892,DPN,0,1
187893,),0,1
187894,or,0,0
187895,postherpetic,0,1
187896,neuralgia,0,1
187897,(,0,1
187898,PHN,0,0
187899,),0,0
187900,.,0,0
187901,METHODS,0,0
187902,In,0,0
187903,the,0,0
187904,DPN,0,0
187905,study,0,0
187906,",",0,1
187907,patients,0,0
187908,received,0,0
187909,subcutaneous,0,0
187910,tanezumab,0,0
187911,20,0,0
187912,mg,0,0
187913,or,0,0
187914,placebo,0,0
187915,on,0,0
187916,Day,0,0
187917,1,0,0
187918,and,0,0
187919,Week,0,0
187920,8,0,0
187921,.,0,0
187922,Evaluations,0,0
187923,included,0,0
187924,change,0,1
187925,from,0,0
187926,baseline,0,0
187927,in,0,0
187928,average,0,1
187929,DPN,0,0
187930,pain,0,1
187931,(,0,1
187932,primary,0,1
187933,endpoint,0,1
187934,),0,1
187935,",",0,0
187936,Patient,0,1
187937,'s,0,1
187938,Global,0,1
187939,Assessment,0,1
187940,of,0,1
187941,DPN,0,0
187942,",",0,1
187943,and,0,1
187944,safety,0,1
187945,(,0,1
187946,including,0,0
187947,neuropathy,0,1
187948,assessments,0,0
187949,),0,0
187950,.,0,0
187951,Due,0,1
187952,to,0,0
187953,a,0,0
187954,partial,0,1
187955,clinical,0,0
187956,hold,0,0
187957,limiting,0,1
187958,enrollment,0,0
187959,and,0,1
187960,treatment,0,0
187961,duration,0,1
187962,",",0,0
187963,the,0,0
187964,prespecified,0,1
187965,landmark,0,1
187966,analysis,0,0
187967,was,0,0
187968,modified,0,0
187969,post,0,0
187970,hoc,0,0
187971,from,0,0
187972,Week,0,0
187973,16,0,0
187974,to,0,0
187975,Week,0,0
187976,8,0,0
187977,.,0,0
187978,In,0,0
187979,the,0,0
187980,PHN,0,0
187981,study,0,0
187982,",",0,1
187983,patients,0,0
187984,received,0,0
187985,intravenous,0,0
187986,tanezumab,0,0
187987,50,0,0
187988,?g/kg,0,0
187989,",",0,0
187990,tanezumab,0,0
187991,200,0,0
187992,?g/kg,0,0
187993,",",0,0
187994,or,0,1
187995,placebo,0,0
187996,on,0,0
187997,Day,0,0
187998,1,0,0
187999,.,0,0
188000,Evaluations,0,0
188001,included,0,0
188002,change,0,1
188003,from,0,0
188004,baseline,0,0
188005,in,0,0
188006,average,1,1
188007,daily,1,1
188008,pain,1,1
188009,(,1,0
188010,primary,1,1
188011,endpoint,1,1
188012,),1,1
188013,",",1,0
188014,Brief,1,1
188015,Pain,1,1
188016,Inventory-short,1,1
188017,form,1,0
188018,",",1,1
188019,Patient,1,1
188020,'s,1,1
188021,Global,1,1
188022,Assessment,1,1
188023,of,1,1
188024,pain,1,1
188025,from,1,0
188026,PHN,1,0
188027,",",1,1
188028,and,1,1
188029,safety,1,1
188030,.,1,1
188031,RESULTS,1,0
188032,Mean,1,0
188033,DPN,1,0
188034,pain,1,1
188035,reduction,1,1
188036,from,1,0
188037,baseline,0,0
188038,to,0,0
188039,Week,0,0
188040,8,0,0
188041,was,0,0
188042,greater,0,0
188043,with,0,0
188044,tanezumab,0,1
188045,vs,0,0
188046,placebo,0,0
188047,(,0,1
188048,P,0,0
188049,=,0,0
188050,0.009,0,0
188051,),0,0
188052,;,0,0
188053,differences,0,0
188054,in,0,0
188055,Patient,1,1
188056,'s,1,1
188057,Global,1,1
188058,Assessment,1,1
188059,of,1,1
188060,DPN,1,0
188061,were,1,0
188062,not,0,0
188063,significant,0,0
188064,(,0,0
188065,P,0,0
188066,>,0,0
188067,0.05,0,0
188068,),0,0
188069,.,0,0
188070,Neither,0,0
188071,tanezumab,0,1
188072,dose,0,1
188073,resulted,0,0
188074,in,0,0
188075,significant,0,0
188076,differences,0,0
188077,vs,0,0
188078,placebo,0,0
188079,in,0,0
188080,efficacy,1,1
188081,in,1,0
188082,PHN,0,0
188083,(,0,0
188084,P,0,0
188085,>,0,0
188086,0.05,0,0
188087,),0,0
188088,",",0,0
188089,although,0,0
188090,tanezumab,0,0
188091,200,0,0
188092,?g/kg,0,0
188093,provided,0,0
188094,some,0,0
188095,benefit,1,0
188096,.,1,0
188097,Neuropathy,1,1
188098,assessments,1,0
188099,showed,1,0
188100,no,0,0
188101,meaningful,0,1
188102,changes,0,1
188103,.,0,0
188104,CONCLUSIONS,0,0
188105,Tanezumab,0,1
188106,provided,0,0
188107,effective,1,1
188108,pain,1,1
188109,reduction,1,1
188110,in,1,0
188111,DPN,0,0
188112,.,0,0
188113,In,0,0
188114,PHN,0,0
188115,",",0,0
188116,only,0,0
188117,the,0,0
188118,highest,0,1
188119,tanezumab,0,0
188120,dose,0,1
188121,reduced,1,1
188122,pain,1,1
188123,;,1,0
188124,treatment,1,0
188125,differences,0,0
188126,were,0,0
188127,not,0,0
188128,significant,0,0
188129,.,0,0
188130,No,0,0
188131,new,0,0
188132,safety,0,1
188133,concerns,0,1
188134,were,0,0
188135,observed,0,0
188136,despite,0,0
188137,preexisting,0,0
188138,neuropathy,0,0
188139,.,0,0
188140,Randomized,0,0
188141,Controlled,0,0
188142,Trial,0,0
188143,of,0,1
188144,Mind,0,1
188145,Reading,0,1
188146,and,0,1
188147,In,0,0
188148,Vivo,0,0
188149,Rehearsal,0,1
188150,for,0,0
188151,High-Functioning,0,1
188152,Children,0,0
188153,with,0,0
188154,ASD,0,0
188155,.,0,0
188156,This,0,0
188157,randomized,0,0
188158,controlled,0,0
188159,trial,0,0
188160,evaluated,0,0
188161,the,0,0
188162,efficacy,0,1
188163,of,0,0
188164,a,0,0
188165,computer,0,0
188166,software,0,0
188167,(,0,1
188168,i.e.,0,0
188169,",",0,0
188170,Mind,0,1
188171,Reading,0,1
188172,),0,1
188173,and,0,0
188174,in,0,0
188175,vivo,0,0
188176,rehearsal,0,1
188177,treatment,0,0
188178,on,0,0
188179,the,0,0
188180,emotion,1,1
188181,decoding,1,1
188182,and,1,1
188183,encoding,1,1
188184,skills,1,1
188185,",",1,0
188186,autism,1,1
188187,symptoms,1,1
188188,",",1,1
188189,and,1,1
188190,social,1,1
188191,skills,1,1
188192,of,0,0
188193,43,0,0
188194,children,0,0
188195,",",0,0
188196,ages,0,0
188197,7-12,0,0
188198,years,0,0
188199,with,0,0
188200,high-functioning,0,0
188201,autism,0,0
188202,spectrum,0,1
188203,disorder,0,0
188204,(,0,1
188205,HFASD,0,0
188206,),0,0
188207,.,0,0
188208,Children,0,0
188209,in,0,0
188210,treatment,0,0
188211,(,0,0
188212,n,0,0
188213,=,0,0
188214,22,0,0
188215,),0,0
188216,received,0,0
188217,the,0,0
188218,manualized,0,0
188219,protocol,0,0
188220,over,0,0
188221,12,0,0
188222,weeks,0,0
188223,.,0,0
188224,Primary,0,1
188225,analyses,0,0
188226,indicated,1,0
188227,significantly,1,0
188228,better,1,0
188229,posttest,1,1
188230,performance,1,1
188231,for,1,0
188232,the,0,0
188233,treatment,0,0
188234,group,0,0
188235,(,0,0
188236,compared,0,0
188237,to,0,0
188238,controls,1,0
188239,),1,0
188240,on,1,0
188241,3,1,0
188242,of,1,0
188243,the,1,0
188244,4,1,0
188245,measures,1,0
188246,of,1,0
188247,emotion,1,1
188248,decoding,1,1
188249,and,1,1
188250,encoding,1,1
188251,and,1,1
188252,these,0,0
188253,were,0,0
188254,maintained,0,0
188255,at,0,0
188256,5-week,0,0
188257,follow-up,0,0
188258,.,0,0
188259,Analyses,0,0
188260,of,0,0
188261,secondary,0,1
188262,measures,0,0
188263,favored,0,0
188264,the,0,0
188265,treatment,0,0
188266,group,0,0
188267,for,0,0
188268,1,0,0
188269,of,0,0
188270,the,0,0
188271,2,0,0
188272,measures,0,0
188273,;,0,0
188274,specifically,1,0
188275,",",1,0
188276,ASD,1,0
188277,symptoms,1,1
188278,were,1,0
188279,significantly,1,0
188280,lower,1,0
188281,at,1,0
188282,posttest,0,1
188283,and,0,1
188284,follow-up,0,0
188285,.,0,0
188286,Oxytocin,0,0
188287,increases,0,1
188288,eye,1,1
188289,contact,1,1
188290,during,0,0
188291,a,0,0
188292,real-time,0,0
188293,",",0,0
188294,naturalistic,0,0
188295,social,0,1
188296,interaction,0,1
188297,in,0,0
188298,males,0,0
188299,with,0,0
188300,and,0,0
188301,without,0,0
188302,autism,0,0
188303,.,0,0
188304,Autism,0,1
188305,spectrum,0,0
188306,conditions,0,0
188307,(,0,1
188308,autism,0,0
188309,),0,0
188310,affect,0,0
188311,~1,0,0
188312,%,0,0
188313,of,0,0
188314,the,0,0
188315,population,0,0
188316,and,0,0
188317,are,0,0
188318,characterized,0,0
188319,by,0,0
188320,deficits,0,0
188321,in,0,0
188322,social,0,1
188323,communication,0,1
188324,.,0,0
188325,Oxytocin,0,0
188326,has,0,0
188327,been,0,0
188328,widely,0,0
188329,reported,0,0
188330,to,0,0
188331,affect,0,0
188332,social-communicative,0,1
188333,function,0,1
188334,and,0,0
188335,its,0,0
188336,neural,0,0
188337,underpinnings,0,0
188338,.,0,0
188339,Here,0,0
188340,we,0,0
188341,report,0,0
188342,the,0,0
188343,first,0,0
188344,evidence,0,0
188345,that,0,0
188346,intranasal,0,0
188347,oxytocin,0,0
188348,administration,0,0
188349,improves,0,0
188350,a,0,0
188351,core,0,1
188352,problem,0,0
188353,that,0,0
188354,individuals,0,0
188355,with,0,0
188356,autism,0,0
188357,have,0,0
188358,in,0,0
188359,using,1,0
188360,eye,1,0
188361,contact,1,1
188362,appropriately,0,0
188363,in,0,0
188364,real-world,0,0
188365,social,0,1
188366,settings,0,0
188367,.,0,0
188368,A,0,0
188369,randomized,0,0
188370,double-blind,0,0
188371,",",0,1
188372,placebo-controlled,0,0
188373,",",0,1
188374,within-subjects,0,0
188375,design,0,0
188376,is,0,0
188377,used,0,0
188378,to,0,0
188379,examine,0,0
188380,how,0,0
188381,intranasal,0,0
188382,administration,0,0
188383,of,0,0
188384,24,0,0
188385,IU,0,0
188386,of,0,0
188387,oxytocin,0,0
188388,affects,1,0
188389,gaze,1,1
188390,behavior,1,1
188391,for,1,0
188392,32,0,0
188393,adult,0,0
188394,males,0,0
188395,with,0,0
188396,autism,0,0
188397,and,0,0
188398,34,0,0
188399,controls,0,0
188400,in,0,0
188401,a,0,0
188402,real-time,0,0
188403,interaction,0,0
188404,with,0,0
188405,a,0,0
188406,researcher,0,0
188407,.,0,0
188408,This,0,0
188409,interactive,0,0
188410,paradigm,0,0
188411,bypasses,0,1
188412,many,0,0
188413,of,0,0
188414,the,0,0
188415,limitations,0,0
188416,encountered,0,0
188417,with,0,0
188418,conventional,0,0
188419,static,0,0
188420,or,0,0
188421,computer-based,0,0
188422,stimuli,1,1
188423,.,1,0
188424,Eye,1,0
188425,movements,1,1
188426,are,1,0
188427,recorded,0,0
188428,using,0,0
188429,eye,0,0
188430,tracking,0,1
188431,",",0,0
188432,providing,0,0
188433,an,0,0
188434,objective,0,0
188435,measurement,0,1
188436,of,0,0
188437,looking,0,0
188438,patterns,0,0
188439,.,0,0
188440,The,0,0
188441,measure,0,0
188442,is,0,0
188443,shown,0,0
188444,to,0,0
188445,be,0,0
188446,sensitive,0,0
188447,to,0,0
188448,the,0,0
188449,reduced,1,0
188450,eye,1,0
188451,contact,1,1
188452,commonly,1,0
188453,reported,0,0
188454,in,0,0
188455,autism,0,0
188456,",",0,0
188457,with,0,0
188458,the,0,0
188459,autism,0,0
188460,group,0,0
188461,spending,0,1
188462,less,0,0
188463,time,0,1
188464,looking,0,1
188465,to,0,0
188466,the,0,0
188467,eye,0,0
188468,region,0,0
188469,of,0,0
188470,the,0,0
188471,face,0,0
188472,than,0,0
188473,controls,0,0
188474,.,0,0
188475,Oxytocin,0,1
188476,administration,0,0
188477,selectively,0,0
188478,enhanced,1,0
188479,gaze,1,1
188480,to,1,0
188481,the,1,0
188482,eyes,1,0
188483,in,1,0
188484,both,0,0
188485,the,0,0
188486,autism,0,0
188487,and,0,1
188488,control,0,0
188489,groups,0,0
188490,(,0,0
188491,transformed,0,0
188492,mean,1,1
188493,eye-fixation,1,1
188494,difference,1,0
188495,per,1,0
188496,second=0.082,1,0
188497,;,1,0
188498,95,1,0
188499,%,0,0
188500,CI:0.025-0.14,0,0
188501,",",0,1
188502,P=0.006,0,0
188503,),0,0
188504,.,0,0
188505,Within,0,0
188506,the,0,0
188507,autism,0,0
188508,group,0,0
188509,",",0,0
188510,oxytocin,0,0
188511,has,0,0
188512,the,0,0
188513,most,0,0
188514,effect,0,1
188515,on,0,0
188516,fixation,1,1
188517,duration,1,1
188518,in,1,0
188519,individuals,0,0
188520,with,0,0
188521,impaired,0,1
188522,levels,0,1
188523,of,0,1
188524,eye,1,0
188525,contact,1,1
188526,at,1,1
188527,baseline,0,1
188528,(,0,0
188529,Cohen,0,1
188530,'s,0,1
188531,d=0.86,0,0
188532,),0,0
188533,.,0,0
188534,These,0,0
188535,findings,0,0
188536,demonstrate,0,0
188537,that,0,0
188538,the,0,0
188539,potential,0,0
188540,benefits,0,0
188541,of,0,0
188542,oxytocin,0,1
188543,in,0,0
188544,autism,0,0
188545,extend,0,0
188546,to,0,0
188547,a,0,0
188548,real-time,0,0
188549,interaction,0,1
188550,",",0,1
188551,providing,0,0
188552,evidence,0,0
188553,of,0,0
188554,a,0,0
188555,therapeutic,0,0
188556,effect,0,0
188557,in,0,0
188558,a,0,0
188559,key,0,1
188560,aspect,0,1
188561,of,0,1
188562,social,0,1
188563,communication,0,0
188564,.,0,0
188565,Role,0,1
188566,of,0,1
188567,warm,0,1
188568,saline,0,0
188569,mouth,0,1
188570,rinse,0,0
188571,in,0,0
188572,prevention,0,0
188573,of,0,1
188574,alveolar,1,1
188575,osteitis,1,1
188576,:,1,0
188577,a,0,0
188578,randomized,0,0
188579,controlled,0,0
188580,trial,0,0
188581,.,0,0
188582,BACKGROUND,0,0
188583,The,0,0
188584,present,0,0
188585,study,0,0
188586,was,0,0
188587,aimed,0,0
188588,at,0,0
188589,determining,0,0
188590,the,0,0
188591,role,0,0
188592,warm,0,1
188593,saline,0,0
188594,rinse,0,0
188595,in,0,0
188596,the,0,0
188597,prevention,1,0
188598,of,1,0
188599,alveolar,1,1
188600,osteitis,1,1
188601,following,0,0
188602,dental,0,0
188603,extractions,0,0
188604,.,0,1
188605,MATERIALS,0,0
188606,AND,0,0
188607,METHODS,0,0
188608,Apparently,0,0
188609,patients,0,0
188610,aged,0,0
188611,16,0,0
188612,and,0,0
188613,above,0,0
188614,who,0,0
188615,were,0,0
188616,referred,0,0
188617,to,0,0
188618,the,0,0
188619,Oral,0,1
188620,Surgery,0,0
188621,Clinic,0,0
188622,of,0,0
188623,our,0,0
188624,institution,0,0
188625,",",0,0
188626,with,0,0
188627,an,0,0
188628,indication,0,0
188629,for,0,0
188630,non-surgical,0,0
188631,extraction,0,1
188632,of,0,1
188633,pathologic,0,1
188634,teeth,0,0
188635,were,0,0
188636,prospectively,0,0
188637,and,0,0
188638,uniformly,0,0
188639,randomized,0,0
188640,into,0,0
188641,warm,0,0
188642,saline,0,0
188643,group,0,0
188644,and,0,1
188645,control,0,0
188646,.,0,0
188647,The,0,0
188648,experimental,0,0
188649,group,0,0
188650,(,0,0
188651,n,0,0
188652,=,0,0
188653,80,0,0
188654,),0,0
188655,were,0,0
188656,instructed,0,0
188657,to,0,0
188658,gargle,0,0
188659,6,0,0
188660,times,0,0
188661,daily,0,0
188662,with,0,0
188663,warm,0,1
188664,saline,0,0
188665,and,0,0
188666,no,0,0
188667,such,0,0
188668,instructions,0,1
188669,were,0,0
188670,given,0,0
188671,to,0,0
188672,the,0,0
188673,second,0,0
188674,group,0,0
188675,(,0,0
188676,n,0,0
188677,=,0,0
188678,80,0,0
188679,),0,0
188680,to,0,0
188681,serve,0,0
188682,as,0,0
188683,controls,0,0
188684,.,0,0
188685,Information,0,0
188686,on,0,0
188687,demographic,1,1
188688,",",1,0
188689,indications,1,0
188690,for,1,0
188691,extraction,1,1
188692,",",1,1
188693,and,1,1
188694,development,1,1
188695,of,1,1
188696,alveolar,1,1
188697,osteitis,1,1
188698,were,0,0
188699,obtained,0,0
188700,and,0,0
188701,analyzed,0,0
188702,.,0,0
188703,Comparative,0,0
188704,statistics,0,1
188705,were,0,0
188706,done,0,0
188707,using,0,0
188708,Pearson,0,1
188709,'s,0,1
188710,chi,0,0
188711,square,0,0
188712,or,0,1
188713,Fisher,0,1
188714,'s,0,1
188715,exact,0,1
188716,test,0,1
188717,as,0,0
188718,appropriate,0,0
188719,.,0,0
188720,A,0,0
188721,p,0,0
188722,value,0,1
188723,of,0,0
188724,less,0,0
188725,than,0,0
188726,0.05,0,0
188727,was,0,0
188728,considered,0,0
188729,significant,0,0
188730,.,0,0
188731,RESULTS,0,0
188732,The,0,0
188733,demographic,1,0
188734,and,1,1
188735,other,1,0
188736,baseline,1,1
188737,parameters,1,1
188738,such,1,0
188739,as,1,0
188740,indications,1,0
188741,for,1,0
188742,extractions,1,0
188743,were,0,0
188744,comparable,0,0
188745,among,0,0
188746,the,0,0
188747,study,0,0
188748,groups,0,0
188749,(,0,0
188750,p,0,0
188751,>,0,0
188752,0.05,0,0
188753,),0,0
188754,.,0,0
188755,The,0,0
188756,overall,1,1
188757,prevalence,1,1
188758,of,1,1
188759,alveolar,1,1
188760,osteitis,1,1
188761,was,0,0
188762,13.7,0,0
188763,%,0,0
188764,.,0,0
188765,There,0,0
188766,was,0,0
188767,a,0,0
188768,statistical,0,0
188769,significant,0,0
188770,difference,0,0
188771,between,0,0
188772,the,0,0
188773,study,0,0
188774,groups,0,0
188775,with,0,0
188776,respect,0,0
188777,to,0,0
188778,development,0,1
188779,of,0,1
188780,alveolar,1,1
188781,osteitis,1,1
188782,(,0,0
188783,X2,0,1
188784,=,0,0
188785,15.00,0,0
188786,",",0,0
188787,df,0,0
188788,=,0,0
188789,1,0,0
188790,",",0,0
188791,p,0,0
188792,=,0,0
188793,0.001,0,0
188794,),0,0
188795,.The,0,0
188796,risk,1,1
188797,of,1,1
188798,development,1,1
188799,of,1,1
188800,alveolar,1,1
188801,osteitis,1,1
188802,was,0,0
188803,4,0,0
188804,times,0,0
188805,higher,0,0
188806,in,0,0
188807,the,0,0
188808,control,0,0
188809,group,0,0
188810,(,0,0
188811,OR,0,0
188812,=,0,0
188813,4.33,0,0
188814,",",0,0
188815,P,0,0
188816,=,0,0
188817,0.001,0,0
188818,),0,0
188819,.,0,0
188820,CONCLUSION,0,0
188821,Warm,0,1
188822,saline,0,0
188823,mouth,0,1
188824,rinse,0,0
188825,instruction,0,0
188826,is,0,0
188827,beneficial,0,0
188828,in,0,0
188829,the,0,0
188830,prevention,0,0
188831,of,0,0
188832,development,0,1
188833,of,0,1
188834,alveolar,1,1
188835,osteitis,1,1
188836,after,0,0
188837,dental,0,0
188838,extractions,0,0
188839,.,0,0
188840,Visual,0,1
188841,Assessment,0,1
188842,of,0,0
188843,Relative,0,0
188844,Apical,0,0
188845,Sparing,0,0
188846,Pattern,0,0
188847,Is,0,0
188848,More,0,0
188849,Useful,0,1
188850,Than,0,0
188851,Quantitative,0,0
188852,Assessment,0,1
188853,for,0,0
188854,Diagnosing,0,1
188855,Cardiac,0,1
188856,Amyloidosis,0,1
188857,in,0,0
188858,Borderline,0,1
188859,or,0,0
188860,Mildly,0,0
188861,Increased,0,1
188862,Left,0,1
188863,Ventricular,0,1
188864,Wall,0,1
188865,Thickness,0,1
188866,.,0,0
188867,BACKGROUND,0,0
188868,Relative,0,0
188869,apical,0,1
188870,sparing,0,1
188871,pattern,0,0
188872,of,0,1
188873,longitudinal,0,0
188874,strain,0,1
188875,(,0,1
188876,RapSP-LS,0,1
188877,),0,1
188878,was,0,0
188879,suggested,0,0
188880,in,0,0
188881,advanced,0,0
188882,cardiac,0,1
188883,amyloidosis,0,1
188884,(,0,1
188885,CA,0,0
188886,),0,0
188887,.,0,0
188888,It,0,0
188889,is,0,0
188890,unclear,0,0
188891,whether,0,0
188892,it,0,0
188893,is,0,0
188894,present,0,0
188895,in,0,0
188896,less,0,0
188897,advanced,0,0
188898,CA,0,0
188899,.,0,1
188900,METHODS,0,0
188901,AND,0,0
188902,RESULTS,0,0
188903,Patients,0,0
188904,with,0,0
188905,presumptive,0,1
188906,diagnosis,0,0
188907,of,0,1
188908,CA,0,0
188909,and,0,1
188910,mean,0,1
188911,left,0,1
188912,ventricular,0,1
188913,wall,0,1
188914,thickness,0,1
188915,(,0,1
188916,LVWT,0,0
188917,),0,0
188918,?14,0,0
188919,mm,0,0
188920,were,0,0
188921,recruited,0,0
188922,.,0,0
188923,Apart,0,0
188924,from,0,0
188925,RapSP-LS,0,0
188926,visually,0,1
188927,identified,0,0
188928,",",0,0
188929,relative,0,1
188930,apical,0,1
188931,longitudinal,0,0
188932,strain,0,1
188933,index,0,1
188934,(,0,1
188935,RapLSI,0,1
188936,),0,1
188937,was,0,0
188938,defined,0,1
188939,as,0,0
188940,[,0,0
188941,average,0,1
188942,apical,0,1
188943,LS/,0,0
188944,(,0,0
188945,average,0,1
188946,basal,0,1
188947,LS+average,0,1
188948,mid-ventricle,0,1
188949,LS,0,1
188950,),0,0
188951,],0,0
188952,.,0,0
188953,Among,0,0
188954,119,0,0
188955,patients,0,0
188956,included,0,0
188957,",",0,0
188958,47,0,0
188959,were,0,0
188960,finally,0,0
188961,diagnosed,0,0
188962,with,0,0
188963,CA,0,0
188964,.,1,1
188965,RapLSI,1,0
188966,was,1,0
188967,higher,0,0
188968,in,0,0
188969,the,0,0
188970,CA,0,0
188971,group,0,0
188972,compared,0,0
188973,to,0,0
188974,other,0,0
188975,causes,0,0
188976,of,0,1
188977,increased,1,1
188978,mean,1,1
188979,LVWT,1,0
188980,(,1,0
188981,P,0,0
188982,<,0,0
188983,0.001,0,0
188984,),0,0
188985,",",0,0
188986,but,0,0
188987,with,0,0
188988,a,0,0
188989,significant,0,0
188990,range,0,0
188991,of,0,1
188992,overlap,0,1
188993,noted,0,0
188994,.,0,0
188995,In,0,0
188996,contrast,0,0
188997,",",0,1
188998,RapSP-LS,0,1
188999,visually,0,1
189000,assessed,0,0
189001,was,0,0
189002,noted,0,0
189003,in,0,0
189004,most,0,0
189005,CA,0,0
189006,patients,0,0
189007,(,0,0
189008,31/47,0,0
189009,",",0,0
189010,66.0,0,0
189011,%,0,0
189012,),0,0
189013,except,0,0
189014,in,0,0
189015,those,0,0
189016,with,0,0
189017,preserved,0,0
189018,LV,0,1
189019,ejection,0,1
189020,fraction,0,1
189021,",",0,1
189022,normal,0,1
189023,LVWT,0,0
189024,",",0,1
189025,and,0,1
189026,mildly,0,1
189027,decreased,0,0
189028,global,0,1
189029,LS,0,1
189030,",",0,0
189031,suggesting,0,0
189032,least,0,0
189033,advanced,0,0
189034,CA,0,0
189035,.,0,0
189036,On,0,0
189037,multivariate,0,0
189038,analysis,0,0
189039,of,0,0
189040,the,0,0
189041,added,0,0
189042,diagnostic,0,0
189043,role,0,0
189044,of,0,1
189045,RapSP-LS,0,1
189046,or,0,0
189047,RapLSI,0,0
189048,on,0,0
189049,top,0,0
189050,of,0,1
189051,clinical,0,1
189052,",",0,0
189053,electrocardiographic,0,1
189054,",",0,1
189055,and,0,1
189056,conventional,0,0
189057,echocardiographic,0,1
189058,parameters,0,1
189059,",",0,1
189060,addition,0,0
189061,of,0,1
189062,RapLSI,0,0
189063,produced,0,0
189064,only,0,0
189065,borderline,0,0
189066,increase,0,1
189067,in,0,0
189068,area,0,1
189069,under,0,0
189070,the,0,0
189071,curve,0,1
189072,of,0,0
189073,the,0,0
189074,multivariate,0,0
189075,model,0,0
189076,(,0,1
189077,P=0.05,0,0
189078,),0,1
189079,",",0,0
189080,whereas,0,0
189081,addition,0,0
189082,of,0,1
189083,RapSP-LS,0,0
189084,significantly,0,0
189085,increased,0,0
189086,it,0,0
189087,(,0,0
189088,P,0,0
189089,<,0,0
189090,0.001,0,0
189091,),0,0
189092,.,0,0
189093,CONCLUSIONS,0,0
189094,Visual,0,1
189095,identification,0,1
189096,of,0,0
189097,RapSP-LS,0,0
189098,is,0,0
189099,useful,0,0
189100,in,0,0
189101,terms,0,1
189102,of,0,0
189103,added,1,0
189104,diagnostic,1,0
189105,value,1,1
189106,compared,1,0
189107,with,0,0
189108,quantitative,0,0
189109,calculation,0,0
189110,of,0,0
189111,RapLSI,0,0
189112,.,0,0
189113,Its,0,0
189114,clinical,0,1
189115,application,0,0
189116,",",0,0
189117,however,0,0
189118,",",0,0
189119,should,0,0
189120,be,0,0
189121,used,0,0
189122,with,0,0
189123,caution,0,0
189124,in,0,0
189125,patients,0,0
189126,with,0,0
189127,less,0,0
189128,advanced,0,0
189129,CA,0,0
189130,.,0,0
189131,The,0,0
189132,short-term,0,0
189133,effects,0,1
189134,of,0,0
189135,transcranial,0,0
189136,direct,0,1
189137,current,0,0
189138,stimulation,0,1
189139,on,0,0
189140,electroencephalography,0,1
189141,in,0,0
189142,children,0,0
189143,with,0,0
189144,autism,0,0
189145,:,0,0
189146,a,0,0
189147,randomized,0,0
189148,crossover,0,0
189149,controlled,0,0
189150,trial,0,0
189151,.,0,0
189152,Abnormal,0,1
189153,synaptic,0,1
189154,maturation,0,1
189155,and,0,0
189156,connectivity,0,1
189157,are,0,0
189158,possible,0,0
189159,etiologies,0,0
189160,of,0,0
189161,autism,0,0
189162,.,0,0
189163,Previous,0,0
189164,studies,0,0
189165,showed,0,0
189166,significantly,0,0
189167,less,0,0
189168,alpha,0,1
189169,activity,0,1
189170,in,0,0
189171,autism,0,0
189172,than,0,0
189173,normal,0,0
189174,children,0,0
189175,.,0,0
189176,Therefore,0,0
189177,",",0,0
189178,we,0,0
189179,studied,0,0
189180,the,0,0
189181,effects,0,1
189182,of,0,0
189183,anodal,0,0
189184,tDCS,0,0
189185,on,0,0
189186,peak,0,1
189187,alpha,0,1
189188,frequency,0,1
189189,(,0,1
189190,PAF,0,1
189191,),0,0
189192,related,0,0
189193,to,0,0
189194,autism,0,0
189195,treatment,0,0
189196,evaluation,0,0
189197,checklist,0,1
189198,(,0,1
189199,ATEC,0,0
189200,),0,0
189201,.,0,0
189202,Twenty,0,0
189203,male,0,0
189204,children,0,0
189205,with,0,0
189206,autism,0,0
189207,were,0,0
189208,randomly,0,0
189209,assigned,0,0
189210,in,0,0
189211,a,0,0
189212,crossover,0,0
189213,design,0,0
189214,to,0,0
189215,receive,0,0
189216,a,0,0
189217,single,0,0
189218,session,0,0
189219,of,0,0
189220,both,0,0
189221,active,0,0
189222,and,0,1
189223,sham,0,0
189224,tDCS,0,1
189225,stimulation,0,1
189226,(,0,0
189227,11,0,0
189228,mA,0,0
189229,),0,0
189230,over,0,0
189231,F3,0,0
189232,(,0,0
189233,left,0,1
189234,dorsolateral,0,1
189235,prefrontal,0,1
189236,cortex,0,1
189237,),0,0
189238,.,0,0
189239,Pre-,0,0
189240,to,0,0
189241,postsession,0,0
189242,changes,1,1
189243,in,1,0
189244,a,1,0
189245,measure,1,0
189246,of,1,0
189247,cortical,1,1
189248,activity,1,1
189249,impacted,0,0
189250,by,0,0
189251,tDCS,1,0
189252,(,1,1
189253,PAF,1,1
189254,),1,1
189255,and,0,1
189256,ATEC,1,0
189257,were,0,0
189258,compared,0,0
189259,between,0,0
189260,groups,0,0
189261,.,0,0
189262,We,0,0
189263,also,0,0
189264,examined,0,0
189265,the,0,0
189266,associations,0,0
189267,between,0,0
189268,pre-,0,1
189269,and,0,1
189270,postsession,0,1
189271,changes,0,1
189272,in,0,0
189273,the,0,0
189274,PAF,1,1
189275,and,0,0
189276,ATEC,1,0
189277,.,1,0
189278,The,0,0
189279,results,1,0
189280,show,1,0
189281,significant,1,0
189282,pre-,1,1
189283,to,1,0
189284,postsession,1,0
189285,improvements,1,0
189286,in,0,0
189287,two,1,0
189288,domains,1,0
189289,of,1,0
189290,ATEC,1,0
189291,(,1,0
189292,social,1,1
189293,and,1,1
189294,health/behavior,1,1
189295,domains,1,1
189296,),1,0
189297,following,0,0
189298,active,0,0
189299,tDCS,1,0
189300,",",0,0
189301,relative,0,1
189302,to,0,0
189303,sham,0,0
189304,treatment,0,0
189305,.,0,0
189306,PAF,1,1
189307,also,0,0
189308,significantly,0,0
189309,increased,1,0
189310,at,0,0
189311,the,0,0
189312,stimulation,0,1
189313,site,0,1
189314,",",0,0
189315,and,0,1
189316,an,0,0
189317,increase,1,1
189318,in,1,0
189319,PAF,1,1
189320,was,0,0
189321,significantly,0,0
189322,associated,0,0
189323,with,0,0
189324,improvements,0,0
189325,in,0,0
189326,the,0,0
189327,two,0,0
189328,domains,0,0
189329,of,0,0
189330,ATEC,1,0
189331,impacted,0,0
189332,by,0,0
189333,tDCS,0,0
189334,.,0,0
189335,The,0,0
189336,findings,0,0
189337,suggest,0,0
189338,that,0,0
189339,a,0,0
189340,single,0,0
189341,session,0,0
189342,of,0,1
189343,anodal,0,0
189344,tDCS,0,0
189345,over,0,0
189346,the,0,0
189347,F3,0,0
189348,may,0,0
189349,have,0,0
189350,clinical,1,0
189351,benefits,1,0
189352,in,0,0
189353,children,0,0
189354,with,0,0
189355,autism,0,0
189356,and,0,0
189357,that,0,0
189358,those,0,0
189359,benefits,0,0
189360,may,0,0
189361,be,0,0
189362,related,0,0
189363,to,0,0
189364,an,0,0
189365,increase,0,0
189366,in,0,0
189367,PAF,1,1
189368,.,1,0
189369,Oxytocin,0,0
189370,reduces,0,1
189371,caloric,0,1
189372,intake,0,1
189373,in,0,0
189374,men,0,0
189375,.,0,0
189376,OBJECTIVE,0,0
189377,Preclinical,0,0
189378,studies,0,0
189379,indicate,0,0
189380,that,0,0
189381,oxytocin,0,0
189382,is,0,0
189383,anorexigenic,0,1
189384,and,0,0
189385,has,0,0
189386,beneficial,0,0
189387,metabolic,0,1
189388,effects,0,1
189389,.,0,0
189390,Oxytocin,0,1
189391,effects,0,1
189392,on,0,0
189393,nutrition,0,1
189394,and,0,1
189395,metabolism,0,1
189396,in,0,0
189397,humans,0,0
189398,are,0,0
189399,not,0,0
189400,well,0,0
189401,defined,0,0
189402,.,0,0
189403,It,0,0
189404,was,0,0
189405,hypothesized,0,0
189406,that,0,0
189407,oxytocin,0,0
189408,would,0,0
189409,reduce,0,0
189410,caloric,0,1
189411,intake,0,1
189412,and,0,1
189413,appetite,0,1
189414,and,0,1
189415,alter,0,1
189416,levels,0,1
189417,of,0,0
189418,appetite-regulating,0,1
189419,hormones,0,1
189420,.,0,0
189421,Metabolic,0,0
189422,effects,0,1
189423,of,0,1
189424,oxytocin,0,1
189425,were,0,0
189426,also,0,0
189427,explored,0,0
189428,.,0,0
189429,METHODS,0,0
189430,A,0,0
189431,randomized,0,0
189432,",",0,0
189433,placebo-controlled,0,0
189434,crossover,0,0
189435,study,0,0
189436,of,0,1
189437,single-dose,0,0
189438,intranasal,0,0
189439,oxytocin,0,1
189440,(,0,0
189441,24,0,0
189442,IU,0,0
189443,),0,0
189444,in,0,0
189445,25,0,0
189446,fasting,0,0
189447,healthy,0,0
189448,men,0,0
189449,was,0,0
189450,performed,0,0
189451,.,0,0
189452,After,0,0
189453,oxytocin/placebo,0,0
189454,",",0,0
189455,subjects,0,0
189456,selected,0,0
189457,breakfast,0,0
189458,from,0,0
189459,a,0,0
189460,menu,0,0
189461,and,0,1
189462,were,0,0
189463,given,0,0
189464,double,0,0
189465,portions,0,0
189466,.,0,0
189467,Caloric,0,0
189468,content,0,1
189469,of,0,1
189470,food,0,0
189471,consumed,0,0
189472,was,0,0
189473,measured,0,0
189474,.,0,0
189475,Visual,0,0
189476,analog,0,1
189477,scales,0,1
189478,were,0,0
189479,used,0,0
189480,to,0,0
189481,assess,0,0
189482,appetite,1,1
189483,",",0,1
189484,and,0,1
189485,blood,0,1
189486,was,0,0
189487,drawn,0,0
189488,for,0,0
189489,appetite-regulating,0,1
189490,hormones,0,1
189491,",",0,1
189492,insulin,0,1
189493,",",0,0
189494,and,0,1
189495,glucose,0,1
189496,before,0,0
189497,and,0,0
189498,after,0,0
189499,oxytocin/placebo,0,0
189500,.,0,0
189501,Indirect,0,1
189502,calorimetry,0,0
189503,assessed,0,0
189504,resting,0,1
189505,energy,0,1
189506,expenditure,0,1
189507,(,0,1
189508,REE,0,0
189509,),0,1
189510,and,0,1
189511,substrate,0,1
189512,utilization,0,1
189513,.,0,0
189514,RESULTS,0,0
189515,Oxytocin,0,1
189516,reduced,1,1
189517,caloric,1,1
189518,intake,1,1
189519,with,0,0
189520,a,0,0
189521,preferential,0,0
189522,effect,0,0
189523,on,0,0
189524,fat,1,1
189525,intake,1,1
189526,and,0,1
189527,increased,1,1
189528,levels,1,1
189529,of,1,0
189530,the,1,0
189531,anorexigenic,1,1
189532,hormone,1,1
189533,cholecystokinin,1,0
189534,without,0,0
189535,affecting,0,1
189536,appetite,0,1
189537,or,0,0
189538,other,0,0
189539,appetite-regulating,0,1
189540,hormones,0,1
189541,.,0,0
189542,There,0,0
189543,was,0,0
189544,no,0,0
189545,effect,0,1
189546,of,0,0
189547,oxytocin,0,1
189548,on,0,0
189549,REE,1,0
189550,.,1,1
189551,Oxytocin,0,1
189552,resulted,0,0
189553,in,0,0
189554,a,0,0
189555,shift,0,0
189556,from,0,0
189557,carbohydrate,0,0
189558,to,0,0
189559,fat,0,1
189560,utilization,0,1
189561,and,0,1
189562,improved,0,1
189563,insulin,0,1
189564,sensitivity,0,1
189565,.,0,1
189566,CONCLUSIONS,0,0
189567,Intranasal,0,0
189568,oxytocin,0,1
189569,reduces,0,1
189570,caloric,0,1
189571,intake,0,1
189572,and,0,0
189573,has,0,0
189574,beneficial,0,0
189575,metabolic,0,1
189576,effects,0,1
189577,in,0,0
189578,men,0,0
189579,without,0,0
189580,concerning,0,0
189581,side,0,1
189582,effects,0,0
189583,.,0,0
189584,The,0,0
189585,efficacy,0,1
189586,and,0,1
189587,safety,0,1
189588,of,0,1
189589,sustained,0,1
189590,oxytocin,0,1
189591,administration,0,0
189592,in,0,0
189593,the,0,0
189594,treatment,0,0
189595,of,0,0
189596,obesity,0,1
189597,warrants,0,0
189598,investigation,0,0
189599,.,0,0
189600,Peritoneovenous,0,0
189601,shunting,0,1
189602,as,0,0
189603,compared,0,0
189604,with,0,0
189605,medical,0,0
189606,treatment,0,0
189607,in,0,0
189608,patients,0,0
189609,with,0,0
189610,alcoholic,0,0
189611,cirrhosis,0,0
189612,and,0,1
189613,massive,0,1
189614,ascites,0,1
189615,.,0,0
189616,Veterans,0,0
189617,Administration,0,0
189618,Cooperative,0,0
189619,Study,0,0
189620,on,0,0
189621,Treatment,0,0
189622,of,0,0
189623,Alcoholic,0,0
189624,Cirrhosis,0,0
189625,with,0,0
189626,Ascites,0,0
189627,.,0,0
189628,The,0,0
189629,optimal,0,0
189630,management,0,0
189631,of,0,1
189632,severe,0,1
189633,ascites,0,1
189634,in,0,0
189635,patients,0,0
189636,with,0,0
189637,alcoholic,0,0
189638,cirrhosis,0,0
189639,has,0,0
189640,not,0,0
189641,been,0,0
189642,defined,0,0
189643,.,0,0
189644,in,0,0
189645,a,0,0
189646,5,0,0
189647,1/2-year,0,0
189648,study,0,0
189649,",",0,0
189650,we,0,0
189651,randomly,0,0
189652,assigned,0,0
189653,299,0,0
189654,men,0,0
189655,with,0,0
189656,alcoholic,0,0
189657,cirrhosis,0,0
189658,",",0,0
189659,who,0,0
189660,had,0,0
189661,persistent,0,1
189662,or,0,1
189663,recurrent,0,0
189664,severe,0,1
189665,ascites,0,1
189666,despite,0,0
189667,a,0,0
189668,standard,0,0
189669,medical,0,0
189670,regimen,0,0
189671,",",0,0
189672,to,0,0
189673,receive,0,0
189674,either,0,0
189675,intensive,0,0
189676,medical,0,1
189677,treatment,0,0
189678,or,0,1
189679,peritoneovenous,0,1
189680,(,0,1
189681,LeVeen,0,0
189682,),0,0
189683,shunting,0,0
189684,.,0,0
189685,We,0,0
189686,identified,0,0
189687,three,0,0
189688,risk,0,0
189689,groups,0,0
189690,:,0,0
189691,Group,0,0
189692,1,0,0
189693,had,0,0
189694,normal,0,0
189695,or,0,0
189696,mildly,0,1
189697,abnormal,0,1
189698,results,0,0
189699,on,0,0
189700,liver-function,0,1
189701,tests,0,1
189702,",",0,0
189703,Group,0,0
189704,2,0,0
189705,had,0,0
189706,more,0,0
189707,severe,0,1
189708,liver,0,1
189709,dysfunction,0,1
189710,or,0,1
189711,previous,0,0
189712,complications,0,1
189713,",",0,1
189714,and,0,1
189715,Group,0,0
189716,3,0,0
189717,had,0,0
189718,severe,0,0
189719,prerenal,0,0
189720,azotemia,0,1
189721,without,0,0
189722,kidney,0,0
189723,disease,0,1
189724,.,0,0
189725,For,0,0
189726,the,0,0
189727,patients,0,0
189728,who,0,0
189729,received,0,0
189730,the,0,0
189731,medical,0,1
189732,treatment,0,0
189733,and,0,0
189734,those,0,0
189735,who,0,0
189736,received,0,0
189737,the,0,0
189738,surgical,0,0
189739,treatment,0,0
189740,combined,0,0
189741,",",0,0
189742,the,0,0
189743,median,0,1
189744,survival,0,1
189745,times,0,1
189746,were,0,0
189747,1093,0,0
189748,days,0,0
189749,in,0,0
189750,Group,0,0
189751,1,0,0
189752,",",0,0
189753,222,0,0
189754,days,0,0
189755,in,0,0
189756,Group,0,0
189757,2,0,0
189758,",",0,0
189759,and,0,0
189760,37,0,0
189761,days,0,0
189762,in,0,0
189763,Group,0,0
189764,3,0,0
189765,(,0,0
189766,P,0,0
189767,less,0,0
189768,than,0,0
189769,or,0,0
189770,equal,0,0
189771,to,0,0
189772,0.01,0,0
189773,),0,0
189774,for,0,0
189775,all,0,0
189776,comparisons,0,0
189777,),0,0
189778,.,0,0
189779,For,0,0
189780,all,0,0
189781,the,0,0
189782,groups,0,0
189783,combined,0,0
189784,",",0,0
189785,the,0,0
189786,median,0,1
189787,time,0,1
189788,to,0,0
189789,the,0,0
189790,resolution,0,1
189791,of,0,0
189792,ascites,0,1
189793,was,0,0
189794,5.4,0,0
189795,weeks,0,0
189796,for,0,0
189797,medical,0,0
189798,patients,0,0
189799,and,0,0
189800,3.0,0,0
189801,weeks,0,0
189802,for,0,0
189803,surgical,0,0
189804,patients,0,0
189805,(,0,0
189806,P,0,0
189807,less,0,0
189808,than,0,0
189809,0.01,0,0
189810,),0,0
189811,.,0,0
189812,Within,0,0
189813,each,0,0
189814,risk,0,1
189815,group,0,0
189816,",",0,1
189817,mortality,1,1
189818,during,0,0
189819,the,0,0
189820,initial,0,0
189821,hospitalization,0,1
189822,and,0,1
189823,median,1,1
189824,long-term,1,1
189825,survival,1,1
189826,were,0,0
189827,similar,0,0
189828,among,0,0
189829,patients,0,0
189830,receiving,0,0
189831,either,0,0
189832,treatment,0,0
189833,.,0,0
189834,However,0,0
189835,",",0,0
189836,the,0,0
189837,median,0,1
189838,time,0,1
189839,to,0,0
189840,the,0,0
189841,recurrence,1,1
189842,of,1,0
189843,ascites,1,1
189844,in,0,0
189845,Group,0,0
189846,1,0,0
189847,was,0,0
189848,4,0,0
189849,months,0,0
189850,in,0,0
189851,medical,0,0
189852,patients,0,0
189853,",",0,0
189854,as,0,0
189855,compared,0,0
189856,with,0,0
189857,18,0,0
189858,months,0,0
189859,in,0,0
189860,surgical,0,0
189861,patients,0,0
189862,(,0,0
189863,P,0,0
189864,=,0,0
189865,0.01,0,0
189866,),0,0
189867,;,0,0
189868,in,0,0
189869,Group,0,0
189870,2,0,0
189871,it,0,0
189872,was,0,0
189873,3,0,0
189874,months,0,0
189875,in,0,0
189876,medical,0,0
189877,patients,0,0
189878,as,0,0
189879,compared,0,0
189880,with,0,0
189881,12,0,0
189882,months,0,0
189883,in,0,0
189884,surgical,0,0
189885,patients,0,0
189886,(,0,0
189887,P,0,0
189888,=,0,0
189889,0.04,0,0
189890,),0,0
189891,.,0,0
189892,The,0,0
189893,median,1,1
189894,duration,1,1
189895,of,1,1
189896,hospitalization,1,1
189897,was,0,0
189898,longer,0,0
189899,in,0,0
189900,medical,0,0
189901,patients,0,0
189902,than,0,0
189903,in,0,0
189904,surgical,0,0
189905,patients,0,0
189906,(,0,0
189907,6.1,0,0
189908,vs.,0,0
189909,2.4,0,0
189910,weeks,0,0
189911,in,0,0
189912,Group,0,0
189913,1,0,0
189914,[,0,0
189915,P,0,0
189916,less,0,0
189917,than,0,0
189918,0.001,0,0
189919,],0,0
189920,and,0,0
189921,5.0,0,0
189922,vs.,0,0
189923,3.1,0,0
189924,weeks,0,0
189925,in,0,0
189926,Group,0,0
189927,2,0,0
189928,[,0,0
189929,P,0,0
189930,less,0,0
189931,than,0,0
189932,0.01,0,0
189933,],0,0
189934,),0,0
189935,.,0,0
189936,Group,0,0
189937,3,0,0
189938,was,0,0
189939,too,0,0
189940,small,0,0
189941,to,0,0
189942,permit,0,0
189943,a,0,0
189944,meaningful,0,1
189945,comparison,0,0
189946,.,0,0
189947,During,0,0
189948,the,0,0
189949,initial,0,0
189950,hospitalization,0,1
189951,",",0,0
189952,the,0,0
189953,incidence,1,1
189954,of,1,0
189955,infections,1,1
189956,",",1,0
189957,gastrointestinal,1,1
189958,bleeding,1,1
189959,",",1,1
189960,and,1,1
189961,encephalopathy,1,1
189962,was,0,0
189963,similar,0,0
189964,among,0,0
189965,the,0,0
189966,medical,0,0
189967,and,0,0
189968,surgical,0,0
189969,patients,0,0
189970,.,0,0
189971,We,0,0
189972,conclude,0,0
189973,that,0,0
189974,peritoneovenous,0,0
189975,shunting,0,1
189976,alleviated,0,0
189977,disabling,1,1
189978,ascites,1,1
189979,more,0,0
189980,rapidly,0,0
189981,than,0,0
189982,medical,0,0
189983,management,0,0
189984,.,0,0
189985,However,0,0
189986,",",0,0
189987,survival,1,1
189988,was,0,0
189989,closely,0,0
189990,related,0,0
189991,to,0,0
189992,the,0,0
189993,severity,0,1
189994,of,0,0
189995,the,0,0
189996,illness,0,1
189997,at,0,0
189998,the,0,0
189999,time,0,1
190000,of,0,1
190001,randomization,0,0
190002,and,0,1
190003,was,0,0
190004,not,0,0
190005,altered,0,0
190006,by,0,0
190007,shunting,0,0
190008,.,0,0
190009,Feasibility,0,1
190010,of,0,0
190011,a,0,0
190012,sensory-adapted,0,0
190013,dental,0,0
190014,environment,0,0
190015,for,0,0
190016,children,0,0
190017,with,0,0
190018,autism,0,0
190019,.,0,0
190020,OBJECTIVE,0,0
190021,To,0,0
190022,provide,0,0
190023,an,0,0
190024,example,0,0
190025,of,0,0
190026,an,0,0
190027,occupational,0,1
190028,therapy,0,0
190029,feasibility,0,1
190030,study,0,0
190031,and,0,1
190032,evaluate,0,0
190033,the,0,0
190034,implementation,0,0
190035,of,0,0
190036,a,0,0
190037,randomized,0,0
190038,controlled,0,0
190039,pilot,0,0
190040,and,0,1
190041,feasibility,0,1
190042,trial,0,0
190043,examining,0,0
190044,the,0,0
190045,impact,0,0
190046,of,0,0
190047,a,0,0
190048,sensory-adapted,0,0
190049,dental,0,1
190050,environment,0,0
190051,(,0,1
190052,SADE,0,1
190053,),0,0
190054,to,0,0
190055,enhance,0,0
190056,oral,0,0
190057,care,0,0
190058,for,0,0
190059,children,0,0
190060,with,0,0
190061,autism,0,0
190062,spectrum,0,1
190063,disorder,0,0
190064,(,0,1
190065,ASD,0,0
190066,),0,0
190067,.,0,0
190068,METHOD,0,0
190069,Twenty-two,0,0
190070,children,0,0
190071,with,0,0
190072,ASD,0,0
190073,and,0,0
190074,22,0,0
190075,typically,0,0
190076,developing,0,0
190077,children,0,0
190078,",",0,0
190079,ages,0,0
190080,6-12,0,0
190081,yr,0,0
190082,",",0,0
190083,attended,0,0
190084,a,0,0
190085,dental,0,0
190086,clinic,0,0
190087,in,0,0
190088,an,0,0
190089,urban,0,0
190090,hospital,0,1
190091,.,0,1
190092,Participants,0,0
190093,completed,0,0
190094,two,0,0
190095,dental,0,0
190096,cleanings,0,0
190097,",",0,1
190098,3-4,0,1
190099,mo,0,0
190100,apart,0,0
190101,",",0,0
190102,one,0,0
190103,in,0,0
190104,a,0,0
190105,regular,0,0
190106,environment,0,0
190107,and,0,0
190108,one,0,0
190109,in,0,0
190110,a,0,0
190111,SADE,0,0
190112,.,0,0
190113,Feasibility,0,1
190114,outcome,0,1
190115,measures,0,1
190116,were,0,0
190117,recruitment,1,1
190118,",",1,1
190119,retention,1,1
190120,",",1,1
190121,accrual,1,1
190122,",",1,1
190123,dropout,1,1
190124,",",1,1
190125,and,1,1
190126,protocol,1,0
190127,adherence,1,1
190128,.,1,1
190129,Intervention,0,0
190130,outcome,0,1
190131,measures,0,1
190132,were,0,0
190133,physiological,1,1
190134,stress,1,1
190135,",",1,1
190136,behavioral,1,1
190137,distress,1,1
190138,",",1,1
190139,pain,1,1
190140,",",1,1
190141,and,1,1
190142,cost,1,1
190143,.,1,0
190144,RESULTS,0,0
190145,We,0,0
190146,successfully,0,0
190147,recruited,0,0
190148,and,0,1
190149,retained,0,0
190150,participants,0,0
190151,.,0,1
190152,Parents,0,1
190153,expressed,0,1
190154,satisfaction,0,1
190155,with,0,0
190156,research,0,0
190157,study,0,0
190158,participation,0,0
190159,.,0,1
190160,Dentists,0,0
190161,stated,0,0
190162,that,0,0
190163,the,0,0
190164,intervention,0,0
190165,could,0,0
190166,be,0,0
190167,incorporated,0,0
190168,in,0,0
190169,normal,0,0
190170,practice,0,0
190171,.,0,1
190172,Intervention,0,0
190173,outcome,0,1
190174,measures,0,1
190175,favored,0,0
190176,the,0,0
190177,SADE,0,0
190178,condition,0,0
190179,.,0,1
190180,CONCLUSION,0,0
190181,Preliminary,0,1
190182,positive,0,1
190183,benefit,0,0
190184,of,0,1
190185,SADE,0,1
190186,in,0,0
190187,children,0,0
190188,with,0,0
190189,ASD,0,0
190190,warrants,0,0
190191,moving,0,0
190192,forward,0,0
190193,with,0,0
190194,a,0,0
190195,large-scale,0,0
190196,clinical,0,0
190197,trial,0,0
190198,.,0,0
190199,Comparison,0,0
190200,of,0,0
190201,4,0,0
190202,supraglotttic,0,0
190203,devices,0,0
190204,used,0,0
190205,by,0,0
190206,paramedics,0,0
190207,during,0,0
190208,simulated,0,0
190209,CPR,0,0
190210,:,0,0
190211,a,0,0
190212,randomized,0,0
190213,controlled,0,0
190214,crossover,0,0
190215,trial,0,0
190216,.,0,0
190217,BACKGROUND,0,0
190218,Ensuring,0,1
190219,an,0,0
190220,open,0,0
190221,airway,0,1
190222,during,0,0
190223,cardiopulmonary,0,0
190224,resuscitation,0,0
190225,is,0,0
190226,fundamental,0,0
190227,.,0,0
190228,The,0,0
190229,aim,0,0
190230,of,0,0
190231,this,0,0
190232,study,0,0
190233,was,0,0
190234,to,0,0
190235,determine,0,0
190236,the,0,0
190237,success,0,1
190238,rate,0,1
190239,of,0,1
190240,blind,0,0
190241,intubation,0,0
190242,during,0,0
190243,simulated,0,1
190244,cardiopulmonary,0,1
190245,resuscitation,0,0
190246,by,0,0
190247,untrained,0,0
190248,personnel,0,1
190249,.,0,0
190250,METHODS,0,0
190251,Four,0,1
190252,devices,0,0
190253,were,0,0
190254,compared,0,0
190255,in,0,0
190256,a,0,0
190257,simulated,0,1
190258,resuscitation,0,0
190259,scenario,0,0
190260,:,0,0
190261,ILMA,0,1
190262,(,0,0
190263,Intavent,0,1
190264,Direct,0,1
190265,Ltd,0,1
190266,",",0,1
190267,Buckinghamshire,0,0
190268,",",0,1
190269,United,0,0
190270,Kingdom,0,0
190271,),0,1
190272,",",0,0
190273,Cobra,0,1
190274,PLA,0,0
190275,(,0,0
190276,Engineered,0,0
190277,Medical,0,0
190278,Systems,0,1
190279,Inc,0,1
190280,",",0,1
190281,Indianapolis,0,0
190282,",",0,1
190283,IN,0,1
190284,),0,1
190285,",",0,0
190286,Supraglottic,0,1
190287,Airway,0,1
190288,Laryngopharyngeal,0,1
190289,Tube,0,1
190290,(,0,1
190291,SALT,0,1
190292,),0,1
190293,(,0,0
190294,ECOLAB,0,0
190295,",",0,1
190296,St.,0,1
190297,Paul,0,0
190298,",",0,1
190299,MN,0,1
190300,),0,1
190301,",",0,0
190302,and,0,1
190303,Air-Q,0,1
190304,(,0,1
190305,Mercury,0,0
190306,Medical,0,1
190307,",",0,1
190308,Clearwater,0,1
190309,",",0,1
190310,FL,0,1
190311,),0,0
190312,.,0,0
190313,A,0,0
190314,group,0,0
190315,of,0,0
190316,210,0,0
190317,paramedics,0,0
190318,intubated,0,0
190319,a,0,0
190320,manikin,0,0
190321,with,0,0
190322,continuous,0,0
190323,chest,0,1
190324,compressions,0,0
190325,.,0,0
190326,RESULTS,0,0
190327,The,0,0
190328,mean,0,1
190329,times,0,0
190330,to,0,0
190331,intubation,0,0
190332,were,0,0
190333,40.46,0,0
190334,?,0,0
190335,4.64,0,0
190336,",",0,0
190337,33.96,0,0
190338,?,0,0
190339,6.23,0,0
190340,",",0,0
190341,17.2,0,0
190342,?,0,0
190343,4.63,0,0
190344,",",0,0
190345,and,0,0
190346,49.23,0,0
190347,?,0,0
190348,13.19,0,0
190349,seconds,0,0
190350,(,0,0
190351,SALT,0,1
190352,vs,0,0
190353,ILMA,0,1
190354,",",0,1
190355,Cobra,0,1
190356,PLA,0,1
190357,",",0,1
190358,and,0,1
190359,Air-Q,0,1
190360,;,0,1
190361,P,0,0
190362,<,0,0
190363,.05,0,0
190364,),0,0
190365,.,0,0
190366,The,0,0
190367,success,1,1
190368,ratios,1,1
190369,of,1,1
190370,blind,1,0
190371,intubation,1,0
190372,for,1,0
190373,the,0,0
190374,devices,0,0
190375,were,0,0
190376,86.7,0,0
190377,%,0,0
190378,",",0,0
190379,85.7,0,0
190380,%,0,0
190381,",",0,0
190382,100,0,0
190383,%,0,0
190384,",",0,0
190385,and,0,0
190386,71.4,0,1
190387,%,0,0
190388,(,0,0
190389,SALT,0,1
190390,vs,0,0
190391,ILMA,0,1
190392,",",0,1
190393,Cobra,0,1
190394,PLA,0,1
190395,",",0,1
190396,and,0,1
190397,Air-Q,0,1
190398,;,0,1
190399,P,0,0
190400,<,0,0
190401,.05,0,0
190402,),0,0
190403,.,0,0
190404,CONCLUSION,0,0
190405,The,0,0
190406,study,0,0
190407,showed,0,0
190408,that,0,0
190409,the,0,0
190410,most,0,0
190411,efficient,0,1
190412,device,0,0
190413,with,0,0
190414,the,0,0
190415,shortest,0,1
190416,blind,0,0
190417,intubation,0,1
190418,time,0,1
190419,was,0,0
190420,the,0,0
190421,SALT,0,0
190422,device,0,0
190423,.,0,0
190424,The,0,0
190425,effects,0,0
190426,of,0,0
190427,bromazepam,0,0
190428,over,0,0
190429,the,0,0
190430,central,0,1
190431,and,0,0
190432,frontal,0,1
190433,areas,0,1
190434,during,0,0
190435,a,0,0
190436,motor,0,1
190437,task,0,0
190438,:,0,0
190439,an,0,0
190440,EEG,0,0
190441,study,0,0
190442,.,0,0
190443,The,0,0
190444,present,0,0
190445,study,0,0
190446,investigates,0,0
190447,the,0,0
190448,influence,0,0
190449,of,0,0
190450,bromazepam,0,0
190451,while,0,0
190452,executing,0,0
190453,a,0,0
190454,motor,0,1
190455,task,0,1
190456,.,0,0
190457,Specifically,0,0
190458,",",0,0
190459,we,0,0
190460,intend,0,0
190461,to,0,0
190462,analyze,0,0
190463,the,0,0
190464,changes,0,1
190465,in,0,0
190466,alpha,1,1
190467,absolute,1,1
190468,power,1,1
190469,under,0,0
190470,two,0,0
190471,experimental,0,0
190472,conditions,0,0
190473,",",0,1
190474,bromazepam,0,0
190475,and,0,1
190476,placebo,0,0
190477,.,0,0
190478,We,0,0
190479,also,0,0
190480,included,0,0
190481,analyses,0,0
190482,of,0,1
190483,theta,0,1
190484,and,0,1
190485,beta,0,1
190486,frequencies,0,1
190487,.,0,0
190488,We,0,0
190489,collected,0,0
190490,electroencephalographic,0,1
190491,data,0,0
190492,before,0,0
190493,",",0,0
190494,during,0,0
190495,",",0,1
190496,and,0,1
190497,after,0,0
190498,motor,0,1
190499,task,0,1
190500,execution,0,1
190501,.,0,0
190502,We,0,0
190503,used,0,0
190504,a,0,0
190505,Two,0,0
190506,Way,0,0
190507,ANOVA,0,0
190508,to,0,0
190509,investigate,0,0
190510,the,0,0
190511,condition,0,0
190512,(,0,0
190513,PL,0,0
190514,?,0,0
190515,Br6,0,1
190516,mg,0,0
190517,),0,1
190518,and,0,1
190519,moment,0,1
190520,(,0,1
190521,pre,0,1
190522,and,0,1
190523,post,0,0
190524,),0,1
190525,variables,0,0
190526,for,0,0
190527,the,0,0
190528,following,0,0
190529,electrodes,0,0
190530,:,0,0
190531,Fp1,0,0
190532,",",0,1
190533,Fp2,0,1
190534,",",0,1
190535,F7,0,1
190536,",",0,1
190537,F3,0,0
190538,",",0,1
190539,Fz,0,1
190540,",",0,1
190541,F4,0,1
190542,",",0,1
190543,F8,0,1
190544,",",0,1
190545,C3,0,1
190546,",",0,1
190547,CZ,0,0
190548,and,0,1
190549,C4,0,0
190550,.,0,0
190551,We,0,0
190552,found,0,0
190553,a,0,0
190554,main,0,1
190555,effect,0,1
190556,for,0,0
190557,condition,0,0
190558,on,0,0
190559,the,0,0
190560,electrodes,0,1
190561,FP1,0,1
190562,",",0,1
190563,F7,0,1
190564,",",0,1
190565,F3,0,0
190566,",",0,1
190567,Fz,0,1
190568,",",0,1
190569,F4,0,1
190570,",",0,1
190571,C3,0,1
190572,and,0,1
190573,CZ,0,0
190574,",",0,1
190575,for,0,0
190576,alpha,0,1
190577,and,0,1
190578,beta,0,1
190579,bands,0,1
190580,.,0,0
190581,For,0,0
190582,beta,0,0
190583,band,0,0
190584,we,0,0
190585,also,0,0
190586,found,0,0
190587,a,0,0
190588,main,0,1
190589,effect,0,1
190590,for,0,0
190591,condition,0,0
190592,on,0,0
190593,the,0,0
190594,electrodes,0,1
190595,Fp2,0,0
190596,",",0,1
190597,F8,0,1
190598,and,0,1
190599,C4,0,0
190600,;,0,0
190601,for,0,0
190602,theta,0,1
190603,band,0,0
190604,we,0,0
190605,identified,0,0
190606,a,0,0
190607,main,0,1
190608,effect,0,1
190609,for,0,0
190610,condition,0,0
190611,on,0,0
190612,C3,0,1
190613,",",0,1
190614,Cz,0,1
190615,and,0,1
190616,C4,0,0
190617,electrodes,0,1
190618,.,0,0
190619,This,0,0
190620,finding,0,0
190621,suggests,0,0
190622,that,0,0
190623,the,0,0
190624,motor,0,1
190625,task,0,1
190626,did,0,0
190627,not,0,0
190628,have,0,0
190629,any,0,0
190630,influence,0,0
190631,on,0,0
190632,the,1,0
190633,electrocortical,1,1
190634,activity,1,1
190635,in,0,0
190636,alpha,0,1
190637,",",0,1
190638,and,0,1
190639,that,0,0
190640,the,0,0
190641,existing,0,0
190642,modifications,0,0
190643,were,0,0
190644,a,0,0
190645,consequence,0,0
190646,due,0,0
190647,merely,0,0
190648,to,0,0
190649,the,0,0
190650,drug,0,0
190651,use,0,0
190652,.,0,0
190653,Despite,0,0
190654,its,0,0
190655,anxiolytic,0,1
190656,and,0,1
190657,sedative,0,1
190658,action,0,1
190659,",",0,1
190660,bromazepam,0,0
190661,did,0,0
190662,not,0,0
190663,show,0,0
190664,any,0,0
190665,significant,0,0
190666,changes,0,1
190667,when,0,0
190668,the,0,0
190669,individuals,0,0
190670,executed,0,0
190671,a,0,0
190672,finger,0,1
190673,extension,0,1
190674,motor,0,1
190675,task,0,1
190676,.,0,0
190677,A,0,0
190678,Comparison,0,0
190679,of,0,0
190680,Teaching,0,1
190681,Modalities,0,1
190682,and,0,1
190683,Fidelity,0,1
190684,of,0,1
190685,Simulation,0,1
190686,Levels,0,1
190687,in,0,0
190688,Teaching,0,0
190689,Resuscitation,0,0
190690,Scenarios,0,0
190691,.,0,0
190692,INTRODUCTION,0,0
190693,The,0,0
190694,purpose,0,0
190695,of,0,0
190696,our,0,0
190697,study,0,0
190698,was,0,0
190699,to,0,0
190700,examine,0,0
190701,the,0,0
190702,ability,0,1
190703,of,0,0
190704,novices,0,0
190705,to,0,0
190706,learn,0,0
190707,selected,0,0
190708,aspects,0,0
190709,of,0,0
190710,Advanced,0,0
190711,Cardiac,0,1
190712,Life,0,0
190713,Support,0,1
190714,(,0,1
190715,ACLS,0,1
190716,),0,1
190717,in,0,0
190718,training,0,0
190719,conditions,0,0
190720,that,0,0
190721,did,0,0
190722,not,0,0
190723,incorporate,0,0
190724,simulation,0,0
190725,compared,0,0
190726,to,0,0
190727,those,0,0
190728,that,0,0
190729,contained,0,0
190730,low-,0,0
190731,and,0,1
190732,high-fidelity,0,1
190733,simulation,0,0
190734,activities,0,1
190735,.,0,0
190736,We,0,0
190737,sought,0,0
190738,to,0,0
190739,determine,0,0
190740,at,0,0
190741,what,0,0
190742,level,0,1
190743,additional,0,0
190744,educational,0,0
190745,opportunities,0,1
190746,and,0,1
190747,simulation,0,0
190748,fidelity,0,1
190749,become,0,0
190750,superfluous,0,0
190751,with,0,0
190752,respect,0,0
190753,to,0,0
190754,learning,0,1
190755,outcomes,0,1
190756,.,0,0
190757,METHODS,0,0
190758,Totally,0,0
190759,39,0,0
190760,medical,0,0
190761,students,0,0
190762,and,0,1
190763,physician,0,1
190764,assistant,0,0
190765,students,0,0
190766,were,0,0
190767,randomly,0,0
190768,assigned,0,0
190769,to,0,0
190770,4,0,0
190771,training,0,0
190772,conditions,0,0
190773,:,0,0
190774,control,0,0
190775,(,0,0
190776,lecture,0,0
190777,only,0,0
190778,),0,0
190779,",",0,0
190780,video-based,0,0
190781,didactic,0,0
190782,instruction,0,0
190783,",",0,1
190784,low-,0,0
190785,",",0,1
190786,and,0,1
190787,high-fidelity,0,1
190788,simulation,0,0
190789,activities,0,1
190790,.,0,1
190791,Participants,0,0
190792,were,0,0
190793,assessed,0,0
190794,using,0,0
190795,a,0,0
190796,baseline,0,0
190797,written,0,0
190798,pretest,1,0
190799,of,1,0
190800,ACLS,1,1
190801,knowledge,1,1
190802,.,1,0
190803,Following,0,0
190804,this,0,0
190805,",",0,0
190806,all,0,0
190807,participants,0,0
190808,received,0,0
190809,a,0,0
190810,lecture,0,0
190811,outlining,0,0
190812,ACLS,0,1
190813,science,0,0
190814,and,0,1
190815,algorithm,0,0
190816,interpretation,0,0
190817,.,0,1
190818,Participants,0,0
190819,were,0,0
190820,then,0,0
190821,trained,0,0
190822,in,0,0
190823,specific,0,0
190824,aspects,0,1
190825,of,0,0
190826,ACLS,0,1
190827,according,0,0
190828,to,0,0
190829,their,0,0
190830,assigned,0,0
190831,instructional,0,0
190832,condition,0,0
190833,.,0,0
190834,After,0,0
190835,training,0,0
190836,",",0,0
190837,each,0,0
190838,participant,0,0
190839,was,0,0
190840,assessed,0,0
190841,via,0,0
190842,a,0,0
190843,Megacode,1,1
190844,performance,1,1
190845,examination,1,0
190846,and,0,0
190847,a,0,0
190848,written,1,0
190849,posttest,1,0
190850,.,1,0
190851,RESULTS,0,0
190852,All,0,0
190853,groups,0,0
190854,performed,0,0
190855,significantly,0,0
190856,better,0,0
190857,on,0,0
190858,the,0,0
190859,written,0,0
190860,posttest,0,1
190861,compared,0,0
190862,with,0,0
190863,the,0,0
190864,pretest,0,1
190865,(,0,0
190866,p,0,0
190867,<,0,0
190868,0.001,0,0
190869,),0,0
190870,;,0,0
190871,however,0,0
190872,",",0,0
190873,no,0,0
190874,groups,0,0
190875,outperformed,0,0
190876,any,0,0
190877,other,0,0
190878,groups,0,0
190879,.,0,0
190880,On,0,0
190881,the,0,0
190882,Megacode,1,1
190883,performance,1,1
190884,test,1,1
190885,",",0,0
190886,the,0,0
190887,video-based,0,0
190888,",",0,0
190889,low-,0,0
190890,",",0,1
190891,and,0,1
190892,high-fidelity,0,1
190893,groups,0,0
190894,performed,0,0
190895,significantly,0,0
190896,better,0,0
190897,than,0,0
190898,the,0,0
190899,control,0,0
190900,group,0,0
190901,(,0,1
190902,p,0,0
190903,=,0,0
190904,0.028,0,0
190905,",",0,0
190906,p,0,0
190907,<,0,0
190908,0.001,0,0
190909,",",0,0
190910,p,0,0
190911,=,0,0
190912,0.019,0,0
190913,),0,0
190914,.,0,0
190915,Equivalence,0,1
190916,testing,0,0
190917,revealed,0,0
190918,that,0,0
190919,the,0,0
190920,high-fidelity,0,0
190921,simulation,0,1
190922,condition,0,1
190923,was,0,0
190924,statistically,0,0
190925,equivalent,0,0
190926,to,0,0
190927,the,0,0
190928,video-based,0,0
190929,and,0,1
190930,low-fidelity,0,1
190931,simulation,0,0
190932,conditions,0,0
190933,.,0,0
190934,CONCLUSION,0,0
190935,Video-based,0,1
190936,and,0,1
190937,simulation-based,0,0
190938,training,0,0
190939,is,0,0
190940,associated,0,0
190941,with,0,0
190942,better,0,0
190943,learning,0,1
190944,outcomes,0,1
190945,when,0,0
190946,compared,0,0
190947,with,0,0
190948,traditional,0,0
190949,didactic,0,0
190950,lectures,0,0
190951,only,0,0
190952,.,0,0
190953,Video-based,0,0
190954,",",0,1
190955,low-fidelity,0,1
190956,",",0,1
190957,and,0,1
190958,high-fidelity,0,1
190959,simulation,0,1
190960,training,0,0
190961,yield,0,1
190962,equivalent,0,0
190963,outcomes,0,1
190964,",",0,0
190965,which,0,0
190966,may,0,0
190967,indicate,0,0
190968,that,0,0
190969,high-fidelity,0,0
190970,simulation,0,0
190971,is,0,0
190972,superfluous,0,0
190973,for,0,0
190974,the,0,0
190975,novice,0,0
190976,trainee,0,0
190977,.,0,0
190978,Environmental,0,0
190979,enrichment,0,1
190980,as,0,0
190981,a,0,0
190982,therapy,0,0
190983,for,0,0
190984,autism,0,0
190985,:,0,0
190986,A,0,0
190987,clinical,0,0
190988,trial,0,0
190989,replication,0,0
190990,and,0,1
190991,extension,0,1
190992,.,0,1
190993,Based,0,0
190994,on,0,0
190995,work,0,0
190996,done,0,0
190997,in,0,0
190998,animal,0,0
190999,models,0,0
191000,showing,0,0
191001,that,0,0
191002,autism-like,0,0
191003,symptoms,0,1
191004,are,0,0
191005,ameliorated,0,0
191006,following,0,0
191007,exposure,0,0
191008,to,0,0
191009,an,0,0
191010,enriched,0,0
191011,sensorimotor,0,1
191012,environment,0,0
191013,",",0,0
191014,we,0,0
191015,attempted,0,0
191016,to,0,0
191017,develop,0,0
191018,a,0,0
191019,comparable,0,0
191020,therapy,0,0
191021,for,0,0
191022,children,0,0
191023,with,0,0
191024,autism,0,0
191025,.,0,0
191026,In,0,0
191027,an,0,0
191028,initial,0,0
191029,randomized,0,0
191030,controlled,0,0
191031,trial,0,0
191032,",",0,1
191033,children,0,0
191034,with,0,0
191035,autism,0,0
191036,who,0,0
191037,received,0,0
191038,sensorimotor,0,1
191039,enrichment,0,1
191040,at,0,0
191041,home,0,0
191042,for,0,0
191043,6,0,0
191044,months,0,0
191045,had,0,0
191046,significant,0,0
191047,improvements,0,0
191048,in,0,0
191049,both,0,0
191050,their,0,0
191051,cognitive,0,1
191052,ability,0,1
191053,and,0,0
191054,the,0,0
191055,severity,0,1
191056,of,0,0
191057,their,0,0
191058,autism,0,0
191059,symptoms,0,1
191060,(,0,1
191061,Woo,0,1
191062,&,0,1
191063,Leon,0,1
191064,",",0,0
191065,2013,0,0
191066,),0,0
191067,.,0,0
191068,We,0,0
191069,now,0,0
191070,report,0,0
191071,the,0,0
191072,outcomes,0,0
191073,of,0,0
191074,a,0,0
191075,similar,0,0
191076,randomized,0,0
191077,controlled,0,0
191078,trial,0,0
191079,in,0,0
191080,which,0,0
191081,children,0,0
191082,with,0,0
191083,autism,0,0
191084,",",0,0
191085,3,0,0
191086,to,0,0
191087,6,0,0
191088,years,0,0
191089,old,0,0
191090,",",0,0
191091,were,0,0
191092,randomly,0,0
191093,assigned,0,0
191094,to,0,0
191095,groups,0,0
191096,that,0,0
191097,received,0,0
191098,either,0,0
191099,daily,0,0
191100,sensorimotor,0,1
191101,enrichment,0,1
191102,",",0,1
191103,administered,0,0
191104,by,0,0
191105,their,0,0
191106,parents,0,1
191107,",",0,0
191108,along,0,0
191109,with,0,0
191110,standard,0,0
191111,care,0,0
191112,",",0,0
191113,or,0,0
191114,they,0,0
191115,received,0,0
191116,standard,0,0
191117,care,0,0
191118,alone,0,0
191119,.,0,0
191120,After,0,0
191121,6,0,0
191122,months,0,0
191123,",",0,0
191124,enriched,0,0
191125,children,0,0
191126,showed,0,0
191127,statistically,0,0
191128,significant,0,0
191129,gains,0,1
191130,in,0,0
191131,their,0,0
191132,IQ,1,1
191133,scores,1,1
191134,",",0,0
191135,a,0,0
191136,decline,0,1
191137,in,0,0
191138,their,0,0
191139,atypical,1,0
191140,sensory,1,1
191141,responses,1,1
191142,",",0,0
191143,and,0,0
191144,an,0,0
191145,improvement,0,1
191146,in,0,0
191147,their,0,0
191148,receptive,1,1
191149,language,1,1
191150,performance,1,1
191151,",",0,0
191152,compared,0,0
191153,to,0,0
191154,controls,0,0
191155,.,0,1
191156,Furthermore,0,0
191157,",",0,0
191158,after,0,0
191159,6,0,0
191160,months,0,0
191161,of,0,0
191162,enrichment,0,1
191163,therapy,0,0
191164,",",0,0
191165,21,0,0
191166,%,0,0
191167,of,0,0
191168,the,0,0
191169,children,0,0
191170,who,0,0
191171,initially,0,0
191172,had,0,0
191173,been,0,0
191174,given,0,0
191175,an,0,0
191176,autism,0,0
191177,classification,0,1
191178,",",0,0
191179,using,0,0
191180,the,0,0
191181,Autism,0,1
191182,Diagnostic,0,1
191183,Observation,0,0
191184,Schedule,0,1
191185,",",0,0
191186,improved,0,0
191187,to,0,0
191188,the,0,0
191189,point,0,0
191190,that,0,0
191191,",",0,0
191192,although,0,0
191193,they,0,0
191194,remained,0,0
191195,on,0,0
191196,the,0,0
191197,autism,0,0
191198,spectrum,0,0
191199,",",0,0
191200,they,0,0
191201,no,0,0
191202,longer,0,0
191203,met,0,0
191204,the,0,0
191205,criteria,0,0
191206,for,0,0
191207,classic,0,0
191208,autism,0,0
191209,.,0,1
191210,None,0,0
191211,of,0,0
191212,the,0,0
191213,standard,0,0
191214,care,0,0
191215,controls,0,0
191216,reached,0,0
191217,an,0,0
191218,equivalent,0,0
191219,level,0,1
191220,of,0,0
191221,improvement,0,1
191222,.,0,0
191223,Finally,0,0
191224,",",0,0
191225,the,0,0
191226,outcome,1,1
191227,measures,1,1
191228,for,0,0
191229,children,0,0
191230,who,0,0
191231,received,0,0
191232,only,0,0
191233,a,0,0
191234,subset,0,0
191235,of,0,0
191236,sensory,0,1
191237,stimuli,0,1
191238,were,0,0
191239,similar,0,0
191240,to,0,0
191241,those,0,0
191242,receiving,0,0
191243,the,0,0
191244,full,0,0
191245,complement,0,1
191246,of,0,1
191247,enrichment,0,1
191248,exercises,0,0
191249,.,0,0
191250,Sensorimotor,0,1
191251,enrichment,0,1
191252,therapy,0,0
191253,therefore,0,0
191254,appears,0,0
191255,to,0,0
191256,be,0,0
191257,a,0,0
191258,cost-effective,1,0
191259,means,0,0
191260,of,0,0
191261,treating,0,0
191262,a,0,0
191263,range,0,0
191264,of,0,0
191265,symptoms,0,1
191266,for,0,0
191267,children,0,0
191268,with,0,0
191269,autism,0,0
191270,.,0,0
191271,[,0,0
191272,Effect,0,0
191273,of,0,0
191274,Preoperative,0,1
191275,Oral,0,1
191276,Rehydration,1,0
191277,on,0,0
191278,Onset,0,0
191279,Time,0,1
191280,and,0,1
191281,Recovery,0,1
191282,Time,0,1
191283,of,0,1
191284,Rocuronium,0,0
191285,],0,0
191286,.,0,0
191287,BACKGROUND,0,0
191288,Preoperative,0,1
191289,oral,0,0
191290,rehydration,1,0
191291,solution,0,1
191292,(,0,1
191293,ORS,0,0
191294,),0,0
191295,prevents,0,0
191296,hypovolemia,1,0
191297,.,1,0
191298,The,0,0
191299,aim,0,0
191300,of,0,0
191301,this,0,0
191302,study,0,0
191303,was,0,0
191304,to,0,0
191305,compare,0,0
191306,the,0,0
191307,effect,0,0
191308,of,0,0
191309,intubating,0,0
191310,dose,0,0
191311,of,0,1
191312,rocuronium,0,0
191313,in,0,0
191314,patients,0,0
191315,taking,0,0
191316,and,0,0
191317,those,0,0
191318,not,0,0
191319,taking,0,0
191320,preoperative,1,0
191321,ORS,1,0
191322,.,1,0
191323,METHODS,0,0
191324,Twenty,0,0
191325,patients,0,0
191326,",",0,0
191327,ASA,0,1
191328,I,0,0
191329,aged,0,0
191330,20-50,0,0
191331,years,0,0
191332,scheduled,0,0
191333,for,0,0
191334,elective,0,0
191335,surgery,0,0
191336,",",0,1
191337,were,0,0
191338,investigated,0,0
191339,and,0,0
191340,randomly,0,0
191341,assigned,0,0
191342,to,0,0
191343,two,0,0
191344,groups,0,0
191345,:,0,0
191346,drinking,0,0
191347,"1,500",0,0
191348,ml,0,0
191349,ORS,0,0
191350,6,0,0
191351,to,0,0
191352,2,0,0
191353,hours,0,0
191354,before,0,0
191355,anesthesia,0,0
191356,(,0,0
191357,ORS,0,1
191358,group,0,0
191359,),0,1
191360,and,0,1
191361,nothing,0,0
191362,by,0,0
191363,mouth,0,1
191364,from,0,0
191365,6,0,0
191366,hours,0,0
191367,before,0,0
191368,anesthesia,0,0
191369,(,0,0
191370,control,0,0
191371,group,0,0
191372,),0,0
191373,.,0,1
191374,Anesthesia,0,1
191375,was,0,0
191376,maintained,0,0
191377,with,0,0
191378,propofol,0,0
191379,and,0,1
191380,remifentanil,1,0
191381,",",0,1
191382,and,0,1
191383,rocuronium,0,0
191384,0.6,0,0
191385,mg,0,0
191386,x,0,0
191387,kg,0,0
191388,(,0,1
191389,-1,0,0
191390,),0,1
191391,was,0,0
191392,administrated,0,0
191393,.,0,0
191394,To,0,0
191395,evaluate,0,0
191396,the,0,0
191397,effect,0,0
191398,of,0,1
191399,rocuronium,0,0
191400,",",0,1
191401,acceleromyography,1,1
191402,at,0,0
191403,the,0,0
191404,adductor,0,1
191405,pollicis,0,1
191406,was,0,0
191407,performed,0,0
191408,using,0,0
191409,0.1,0,0
191410,Hz,0,0
191411,stimulation,0,0
191412,.,0,1
191413,Cardiac,1,1
191414,index,1,1
191415,(,1,1
191416,CI,1,0
191417,),1,1
191418,and,1,1
191419,stroke,1,1
191420,volume,1,1
191421,variation,1,1
191422,(,1,1
191423,SVV,1,0
191424,),1,0
191425,from,0,0
191426,FloTra/Vigileo,0,0
191427,",",0,0
191428,times,0,1
191429,to,0,0
191430,95,0,0
191431,%,0,0
191432,twitch,0,1
191433,depression,1,1
191434,as,0,0
191435,onset,1,1
191436,time,1,1
191437,(,1,1
191438,OT,1,1
191439,),1,1
191440,",",0,0
191441,and,0,1
191442,times,0,1
191443,to,0,0
191444,first,0,0
191445,twitch,1,1
191446,re-detection,1,1
191447,(,1,1
191448,TR,1,1
191449,),1,1
191450,were,0,0
191451,recorded,0,0
191452,.,0,0
191453,RESULTS,0,0
191454,SVV,0,0
191455,was,0,0
191456,significantly,0,0
191457,lower,0,0
191458,in,0,0
191459,ORS,1,1
191460,group,0,0
191461,(,0,0
191462,P,0,0
191463,=,0,0
191464,0.03,0,0
191465,),0,0
191466,",",0,0
191467,and,0,1
191468,CI,0,0
191469,showed,0,0
191470,no,0,0
191471,difference,0,0
191472,.,0,0
191473,In,0,0
191474,ORS,0,0
191475,group,0,0
191476,",",0,1
191477,TR,0,1
191478,was,0,0
191479,significantly,0,0
191480,shorter,0,0
191481,than,0,0
191482,that,0,0
191483,of,0,0
191484,control,0,0
191485,group,0,0
191486,(,0,1
191487,P=0.002,0,0
191488,),0,1
191489,",",0,0
191490,and,0,1
191491,OT,0,1
191492,tended,0,0
191493,to,0,0
191494,be,0,0
191495,prolonged,0,0
191496,(,0,0
191497,99.0,0,0
191498,?,0,0
191499,36.3,0,0
191500,s,0,0
191501,vs.,0,0
191502,84.0,0,0
191503,?,0,0
191504,37.5,0,0
191505,s,0,0
191506,),0,0
191507,",",0,1
191508,but,0,0
191509,not,0,0
191510,significantly,0,0
191511,.,0,0
191512,CONCLUSIONS,0,0
191513,Preoperative,0,1
191514,oral,0,0
191515,rehydration,0,0
191516,possibly,0,0
191517,increases,0,0
191518,circulating,0,1
191519,blood,0,1
191520,volume,0,1
191521,",",0,0
191522,and,0,0
191523,shortens,0,0
191524,the,0,0
191525,duration,0,1
191526,of,0,1
191527,rocuronium,1,0
191528,effect,1,0
191529,.,1,0
191530,Risk,0,0
191531,of,0,1
191532,anterior,0,1
191533,cruciate,0,1
191534,ligament,0,1
191535,fatigue,0,1
191536,failure,0,0
191537,is,0,0
191538,increased,0,0
191539,by,0,0
191540,limited,0,0
191541,internal,0,0
191542,femoral,0,1
191543,rotation,0,1
191544,during,0,0
191545,in,0,0
191546,vitro,0,0
191547,repeated,0,0
191548,pivot,0,1
191549,landings,0,0
191550,.,0,0
191551,BACKGROUND,0,0
191552,A,0,0
191553,reduced,0,1
191554,range,0,0
191555,of,0,1
191556,hip,0,1
191557,internal,0,0
191558,rotation,0,0
191559,is,0,0
191560,associated,0,0
191561,with,0,0
191562,increased,0,0
191563,peak,0,1
191564,anterior,0,1
191565,cruciate,0,1
191566,ligament,0,1
191567,(,0,1
191568,ACL,0,1
191569,),0,1
191570,strain,0,1
191571,and,0,1
191572,risk,0,1
191573,for,0,0
191574,injury,0,0
191575,.,0,0
191576,It,0,0
191577,is,0,0
191578,unknown,0,0
191579,",",0,0
191580,however,0,0
191581,",",0,0
191582,whether,0,0
191583,limiting,0,1
191584,the,0,0
191585,available,0,0
191586,range,0,0
191587,of,0,1
191588,internal,0,0
191589,femoral,0,0
191590,rotation,0,0
191591,increases,0,1
191592,the,0,0
191593,susceptibility,0,1
191594,of,0,0
191595,the,0,0
191596,ACL,0,0
191597,to,0,0
191598,fatigue,0,1
191599,failure,0,0
191600,.,0,0
191601,HYPOTHESIS,0,1
191602,Risk,0,0
191603,of,0,1
191604,ACL,0,0
191605,failure,0,0
191606,is,0,0
191607,significantly,0,0
191608,greater,0,0
191609,in,0,0
191610,female,0,0
191611,knee,0,1
191612,specimens,0,0
191613,with,0,0
191614,a,0,0
191615,limited,0,0
191616,range,0,0
191617,of,0,1
191618,internal,0,0
191619,femoral,0,1
191620,rotation,0,1
191621,",",0,0
191622,smaller,0,0
191623,femoral-ACL,0,1
191624,attachment,0,1
191625,angle,0,1
191626,",",0,1
191627,and,0,1
191628,smaller,0,1
191629,tibial,0,1
191630,eminence,0,1
191631,volume,0,1
191632,during,0,0
191633,repeated,0,0
191634,in,0,0
191635,vitro,0,0
191636,simulated,0,1
191637,single-leg,0,0
191638,pivot,0,1
191639,landings,0,0
191640,.,0,0
191641,STUDY,0,0
191642,DESIGN,0,0
191643,Controlled,0,0
191644,laboratory,0,1
191645,study,0,0
191646,.,0,0
191647,METHODS,0,0
191648,A,0,0
191649,custom-built,0,0
191650,testing,0,0
191651,apparatus,0,0
191652,was,0,0
191653,used,0,0
191654,to,0,0
191655,simulate,0,0
191656,repeated,0,0
191657,single-leg,0,0
191658,pivot,0,1
191659,landings,0,0
191660,with,0,0
191661,a,0,0
191662,4?-body,0,1
191663,weight,0,1
191664,impulsive,0,1
191665,load,0,0
191666,that,0,0
191667,induces,0,0
191668,knee,0,1
191669,compression,0,1
191670,",",0,1
191671,knee,0,1
191672,flexion,0,1
191673,",",0,1
191674,and,0,1
191675,internal,0,1
191676,tibial,0,1
191677,torque,0,1
191678,in,0,0
191679,32,0,0
191680,paired,0,0
191681,human,0,0
191682,knee,0,1
191683,specimens,0,0
191684,from,0,0
191685,8,0,0
191686,male,0,0
191687,and,0,0
191688,8,0,0
191689,female,0,0
191690,donors,0,0
191691,.,0,0
191692,These,0,0
191693,test,0,1
191694,loads,0,1
191695,were,0,0
191696,applied,0,0
191697,to,0,0
191698,each,0,0
191699,pair,0,0
191700,of,0,0
191701,specimens,0,1
191702,",",0,0
191703,in,0,0
191704,one,0,0
191705,knee,0,0
191706,with,0,0
191707,limited,0,0
191708,internal,0,0
191709,femoral,0,1
191710,rotation,0,1
191711,and,0,0
191712,in,0,0
191713,the,0,0
191714,contralateral,0,1
191715,knee,0,1
191716,with,0,0
191717,femoral,0,1
191718,rotation,0,1
191719,resisted,0,0
191720,by,0,0
191721,2,0,0
191722,springs,0,0
191723,to,0,0
191724,simulate,0,0
191725,the,0,0
191726,active,0,0
191727,hip,0,1
191728,rotator,0,1
191729,muscles,0,1
191730,',0,1
191731,resistance,0,1
191732,to,0,0
191733,stretch,0,0
191734,.,0,0
191735,The,0,0
191736,landings,0,0
191737,were,0,0
191738,repeated,0,0
191739,until,0,0
191740,ACL,0,0
191741,failure,0,1
191742,occurred,0,0
191743,or,0,0
191744,until,0,0
191745,a,0,0
191746,minimum,0,1
191747,of,0,0
191748,100,0,0
191749,trials,0,0
191750,were,0,0
191751,executed,0,0
191752,.,0,0
191753,The,0,0
191754,angle,0,1
191755,at,0,0
191756,which,0,0
191757,the,0,0
191758,ACL,0,0
191759,originates,0,0
191760,from,0,0
191761,the,0,0
191762,femur,0,0
191763,and,0,0
191764,the,0,0
191765,tibial,0,1
191766,eminence,0,1
191767,volume,0,1
191768,were,0,0
191769,measured,0,0
191770,on,0,0
191771,magnetic,0,0
191772,resonance,0,0
191773,images,0,0
191774,.,0,0
191775,RESULTS,0,0
191776,The,0,0
191777,final,0,1
191778,Cox,0,0
191779,regression,0,1
191780,model,0,0
191781,(,0,1
191782,P,0,0
191783,=,0,0
191784,.024,0,0
191785,),0,1
191786,revealed,0,0
191787,that,0,0
191788,range,0,0
191789,of,1,0
191790,internal,1,0
191791,femoral,1,1
191792,rotation,1,1
191793,and,1,1
191794,sex,1,1
191795,of,1,1
191796,donor,1,1
191797,were,0,0
191798,significant,0,0
191799,factors,0,1
191800,in,0,0
191801,determining,0,0
191802,risk,0,1
191803,of,1,0
191804,ACL,1,1
191805,fatigue,1,1
191806,failure,1,0
191807,.,1,0
191808,The,0,0
191809,specimens,0,0
191810,with,0,0
191811,limited,0,0
191812,range,0,0
191813,of,0,1
191814,internal,0,0
191815,femoral,0,1
191816,rotation,0,1
191817,had,0,0
191818,a,0,0
191819,failure,1,0
191820,risk,1,0
191821,17.1,0,0
191822,times,0,0
191823,higher,0,0
191824,than,0,0
191825,did,0,0
191826,the,0,0
191827,specimens,0,0
191828,with,0,0
191829,free,0,1
191830,rotation,0,1
191831,(,0,0
191832,P,0,0
191833,=,0,0
191834,.016,0,0
191835,),0,0
191836,.,0,0
191837,The,0,0
191838,female,0,0
191839,knee,0,1
191840,specimens,0,0
191841,had,0,0
191842,a,0,0
191843,risk,1,1
191844,of,1,0
191845,ACL,1,0
191846,failure,1,0
191847,26.9,0,0
191848,times,0,0
191849,higher,0,0
191850,than,0,0
191851,the,0,0
191852,male,0,0
191853,specimens,0,1
191854,(,0,0
191855,P,0,0
191856,=,0,0
191857,.055,0,0
191858,),0,0
191859,.,0,0
191860,CONCLUSION,0,0
191861,Limiting,0,0
191862,the,0,0
191863,range,0,0
191864,of,0,0
191865,internal,0,0
191866,femoral,0,1
191867,rotation,0,1
191868,during,0,0
191869,repetitive,0,1
191870,pivot,0,1
191871,landings,0,0
191872,increases,0,0
191873,the,1,0
191874,risk,1,0
191875,of,1,0
191876,an,1,0
191877,ACL,1,0
191878,fatigue,1,1
191879,failure,0,1
191880,in,0,0
191881,comparison,0,0
191882,with,0,0
191883,free,0,1
191884,rotation,0,0
191885,in,0,0
191886,a,0,0
191887,cadaveric,0,0
191888,model,0,0
191889,.,0,0
191890,CLINICAL,0,0
191891,RELEVANCE,0,1
191892,Screening,0,0
191893,for,0,0
191894,restricted,0,0
191895,internal,0,0
191896,rotation,0,0
191897,at,0,0
191898,the,0,0
191899,hip,0,1
191900,in,0,0
191901,ACL,0,1
191902,injury,0,1
191903,prevention,0,0
191904,programs,0,0
191905,as,0,0
191906,well,0,0
191907,as,0,0
191908,in,0,0
191909,individuals,0,0
191910,with,0,0
191911,ACL,0,0
191912,injuries,0,0
191913,and/or,0,0
191914,reconstructions,0,0
191915,is,0,0
191916,warranted,0,0
191917,.,0,0
191918,Brief,0,0
191919,Report,0,0
191920,:,0,0
191921,Cobicistat,0,0
191922,Compared,0,0
191923,With,0,0
191924,Ritonavir,0,0
191925,as,0,0
191926,a,0,0
191927,Pharmacoenhancer,0,0
191928,for,0,0
191929,Atazanavir,0,0
191930,in,0,0
191931,Combination,0,0
191932,With,0,0
191933,Emtricitabine/Tenofovir,0,0
191934,Disoproxil,0,0
191935,Fumarate,0,0
191936,:,0,0
191937,Week,0,0
191938,144,0,0
191939,Results,0,0
191940,.,0,0
191941,BACKGROUND,0,0
191942,Cobicistat,0,0
191943,(,0,1
191944,COBI,0,0
191945,),0,0
191946,is,0,0
191947,a,0,0
191948,pharmacoenhancer,0,0
191949,with,0,0
191950,no,0,0
191951,antiretroviral,0,0
191952,activity,0,1
191953,.,0,0
191954,METHODS,0,0
191955,International,0,1
191956,",",0,1
191957,randomized,0,0
191958,double-blind,0,0
191959,active-controlled,0,0
191960,trial,0,0
191961,to,0,0
191962,evaluate,0,0
191963,the,0,0
191964,efficacy,1,1
191965,and,1,1
191966,safety,1,1
191967,of,0,1
191968,COBI,0,0
191969,vs,0,0
191970,ritonavir,0,0
191971,(,0,1
191972,RTV,0,1
191973,),0,0
191974,as,0,0
191975,a,0,0
191976,pharmacoenhancer,0,0
191977,of,0,0
191978,atazanavir,0,1
191979,in,0,0
191980,combination,0,0
191981,with,0,0
191982,emtricitabine/tenofovir,0,0
191983,disoproxil,0,0
191984,fumarate,0,0
191985,in,0,0
191986,HIV,0,1
191987,treatment-naive,0,0
191988,patients,0,0
191989,followed,0,0
191990,through,0,0
191991,week,0,0
191992,144,0,0
191993,.,0,0
191994,RESULTS,0,0
191995,At,0,0
191996,Week,0,0
191997,144,0,0
191998,",",0,0
191999,virologic,1,1
192000,suppression,1,1
192001,was,0,0
192002,achieved,0,0
192003,in,0,0
192004,72,0,0
192005,%,0,0
192006,(,0,0
192007,COBI,0,1
192008,),0,0
192009,and,0,0
192010,74,0,0
192011,%,0,0
192012,(,0,0
192013,RTV,0,1
192014,),0,0
192015,of,0,0
192016,patients,0,0
192017,.,0,0
192018,Adverse,1,1
192019,events,1,1
192020,leading,0,0
192021,to,0,0
192022,study,0,0
192023,drug,0,0
192024,discontinuation,0,1
192025,occurred,0,0
192026,in,0,0
192027,11,0,0
192028,%,0,0
192029,of,0,0
192030,patients,0,0
192031,in,0,0
192032,each,0,0
192033,group,0,0
192034,.,0,0
192035,Median,0,1
192036,changes,1,1
192037,in,1,0
192038,serum,1,1
192039,creatinine,1,1
192040,(,0,1
192041,mg/dL,0,0
192042,),0,1
192043,were,0,0
192044,+0.13,0,0
192045,(,0,1
192046,COBI,0,1
192047,),0,1
192048,and,0,1
192049,+0.07,0,0
192050,(,0,1
192051,RTV,0,1
192052,),0,1
192053,and,0,1
192054,were,0,0
192055,unchanged,0,0
192056,from,0,0
192057,week,0,0
192058,48,0,0
192059,.,0,0
192060,CONCLUSIONS,0,0
192061,Once-daily,0,0
192062,COBI,0,0
192063,is,0,0
192064,a,0,0
192065,safe,0,1
192066,and,0,1
192067,effective,0,1
192068,pharmacoenhancer,1,0
192069,of,0,0
192070,the,0,0
192071,protease,0,1
192072,inhibitor,0,0
192073,atazanavir,0,1
192074,.,0,0
192075,Chromium,0,1
192076,Supplementation,0,0
192077,and,0,0
192078,the,0,0
192079,Effects,0,0
192080,on,0,0
192081,Metabolic,1,1
192082,Status,1,0
192083,in,0,0
192084,Women,0,0
192085,with,0,0
192086,Polycystic,0,1
192087,Ovary,0,1
192088,Syndrome,0,0
192089,:,0,0
192090,A,0,0
192091,Randomized,0,0
192092,",",0,1
192093,Double-Blind,0,0
192094,",",0,1
192095,Placebo-Controlled,0,0
192096,Trial,0,0
192097,.,0,0
192098,BACKGROUND,0,0
192099,The,0,0
192100,aim,0,0
192101,of,0,0
192102,the,0,0
192103,present,0,0
192104,study,0,0
192105,was,0,0
192106,to,0,0
192107,evaluate,0,0
192108,the,0,0
192109,beneficial,0,0
192110,effects,0,1
192111,of,0,1
192112,chromium,0,1
192113,intake,0,1
192114,on,0,0
192115,markers,0,1
192116,of,0,1
192117,insulin,1,1
192118,metabolism,1,1
192119,and,0,1
192120,lipid,1,1
192121,profiles,1,1
192122,in,0,0
192123,women,0,0
192124,with,0,0
192125,polycystic,0,0
192126,ovary,0,1
192127,syndrome,0,0
192128,(,0,1
192129,PCOS,0,0
192130,),0,0
192131,.,0,0
192132,METHODS,0,0
192133,In,0,0
192134,a,0,0
192135,prospective,0,0
192136,",",0,0
192137,randomized,0,0
192138,",",0,0
192139,double-blind,0,0
192140,",",0,1
192141,placebo-controlled,0,0
192142,trial,0,0
192143,",",0,0
192144,64,0,0
192145,women,0,0
192146,with,0,0
192147,PCOS,0,0
192148,were,0,0
192149,randomized,0,0
192150,to,0,0
192151,receive,0,0
192152,200,0,0
192153,?g,0,0
192154,chromium,0,0
192155,picolinate,0,0
192156,supplements,0,0
192157,(,0,0
192158,n,0,0
192159,=,0,0
192160,32,0,0
192161,),0,0
192162,or,0,0
192163,placebo,0,0
192164,(,0,1
192165,n,0,0
192166,=,0,0
192167,32,0,0
192168,),0,0
192169,for,0,0
192170,8,0,0
192171,weeks,0,0
192172,.,0,0
192173,Fasting,1,1
192174,blood,1,1
192175,samples,1,0
192176,were,0,0
192177,obtained,0,0
192178,at,0,0
192179,baseline,0,0
192180,and,0,0
192181,8,0,0
192182,weeks,0,0
192183,after,0,0
192184,the,0,0
192185,intervention,0,0
192186,to,0,0
192187,quantify,0,0
192188,markers,0,1
192189,of,0,1
192190,insulin,0,1
192191,metabolism,0,1
192192,and,0,1
192193,lipid,0,1
192194,concentrations,0,1
192195,.,0,0
192196,RESULTS,0,0
192197,Chromium,0,1
192198,supplementation,0,0
192199,in,0,0
192200,women,0,0
192201,with,0,0
192202,PCOS,0,0
192203,resulted,0,0
192204,in,0,0
192205,significant,0,0
192206,decreases,0,0
192207,in,1,0
192208,serum,1,1
192209,insulin,1,1
192210,levels,1,1
192211,(,0,0
192212,-3.6,0,0
192213,?,0,0
192214,7.4,0,0
192215,vs.,0,0
192216,+3.6,0,0
192217,?,0,0
192218,6.2,0,0
192219,?IU/ml,0,0
192220,",",0,0
192221,p,0,0
192222,<,0,0
192223,0.001,1,0
192224,),1,0
192225,",",1,0
192226,homeostasis,1,1
192227,model,1,0
192228,of,1,1
192229,assessment-insulin,1,1
192230,resistance,1,1
192231,(,1,0
192232,HOMA-IR,1,0
192233,;,0,0
192234,-0.8,0,0
192235,?,0,0
192236,1.6,0,0
192237,vs.,0,0
192238,+0.9,0,0
192239,?,0,0
192240,1.5,0,0
192241,",",0,0
192242,p,0,0
192243,<,0,0
192244,0.001,0,0
192245,),0,0
192246,",",1,0
192247,homeostatic,1,1
192248,model,1,0
192249,assessment-beta,1,1
192250,cell,1,1
192251,function,1,1
192252,(,1,0
192253,HOMA-B,1,0
192254,;,0,0
192255,-15.5,0,0
192256,?,0,0
192257,32.3,0,0
192258,vs.,0,0
192259,+13.6,0,0
192260,?,0,0
192261,23.1,0,0
192262,",",0,0
192263,p,0,0
192264,<,0,0
192265,0.001,0,0
192266,),0,0
192267,",",0,0
192268,and,0,0
192269,a,0,0
192270,significant,0,0
192271,increase,0,0
192272,in,1,0
192273,quantitative,1,0
192274,insulin,1,1
192275,sensitivity,1,1
192276,check,1,1
192277,index,1,1
192278,(,1,1
192279,QUICKI,1,1
192280,),1,1
192281,score,1,1
192282,(,1,0
192283,+0.02,0,0
192284,?,0,0
192285,0.03,0,0
192286,vs.,0,0
192287,-0.008,0,0
192288,?,0,0
192289,0.02,0,0
192290,",",0,0
192291,p,0,0
192292,=,0,0
192293,0.001,0,0
192294,),0,0
192295,compared,0,0
192296,with,0,0
192297,the,0,0
192298,placebo,0,0
192299,.,0,0
192300,In,0,0
192301,addition,0,0
192302,",",0,0
192303,a,0,0
192304,trend,0,0
192305,toward,0,0
192306,a,0,0
192307,significant,0,0
192308,effect,0,1
192309,of,0,1
192310,chromium,0,1
192311,supplementation,0,0
192312,on,0,0
192313,decreasing,0,1
192314,serum,1,1
192315,triglycerides,1,1
192316,(,1,0
192317,-12.4,1,0
192318,?,1,0
192319,74.4,0,0
192320,vs.,0,0
192321,+15.2,0,0
192322,?,0,0
192323,32.4,0,0
192324,mg/dl,0,0
192325,",",0,0
192326,p,0,0
192327,=,0,0
192328,0.05,0,0
192329,),0,0
192330,",",0,0
192331,very,0,0
192332,low-density,1,1
192333,lipoprotein-cholesterol,1,1
192334,(,1,0
192335,-2.5,1,0
192336,?,1,0
192337,14.9,1,0
192338,vs.,0,0
192339,+3.0,0,0
192340,?,0,0
192341,6.5,0,0
192342,mg/dl,0,0
192343,",",0,0
192344,p,0,0
192345,=,0,0
192346,0.05,0,0
192347,),0,0
192348,",",0,0
192349,and,0,1
192350,cholesterol,1,1
192351,concentrations,1,1
192352,(,1,0
192353,-8.6,1,0
192354,?,1,0
192355,21.9,1,0
192356,vs.,0,0
192357,+0.7,0,0
192358,?,0,0
192359,22.4,0,0
192360,mg/dl,0,0
192361,",",0,0
192362,p,0,0
192363,=,0,0
192364,0.09,0,0
192365,),0,0
192366,was,0,0
192367,seen,0,0
192368,.,0,0
192369,CONCLUSIONS,0,0
192370,Eight,0,1
192371,weeks,0,0
192372,of,0,1
192373,chromium,0,1
192374,supplementation,0,0
192375,among,0,0
192376,PCOS,0,0
192377,women,0,0
192378,had,0,0
192379,favorable,0,0
192380,effects,1,1
192381,on,1,0
192382,markers,1,1
192383,of,1,1
192384,insulin,1,1
192385,metabolism,1,1
192386,.,1,0
192387,Recruitment,1,1
192388,and,1,1
192389,Reasons,1,1
192390,for,1,0
192391,Non-Participation,1,1
192392,in,0,0
192393,a,0,0
192394,Family-Coping-Orientated,0,0
192395,Palliative,0,0
192396,Home,0,1
192397,Care,0,1
192398,Trial,0,0
192399,(,0,1
192400,FamCope,0,0
192401,),0,0
192402,.,0,0
192403,Cancer,0,0
192404,patients,0,0
192405,and,0,0
192406,their,0,0
192407,family,0,0
192408,caregivers,0,0
192409,need,0,0
192410,support,0,0
192411,to,0,0
192412,cope,0,0
192413,with,0,0
192414,physical,0,1
192415,",",0,0
192416,psychosocial,0,1
192417,",",0,1
192418,and,0,1
192419,existential,0,1
192420,problems,0,1
192421,early,0,0
192422,in,0,0
192423,the,0,0
192424,palliative,0,0
192425,care,0,0
192426,trajectory,0,1
192427,.,0,1
192428,Many,0,0
192429,interventions,0,0
192430,target,0,0
192431,patient,0,1
192432,symptomatology,0,1
192433,",",0,0
192434,with,0,0
192435,health,0,1
192436,care,0,0
192437,professionals,0,0
192438,acting,0,0
192439,as,0,0
192440,problem-solvers,0,0
192441,.,0,0
192442,Family,0,0
192443,coping,0,1
192444,",",0,0
192445,however,0,0
192446,",",0,0
192447,is,0,0
192448,a,0,0
192449,new,0,0
192450,research,0,0
192451,area,0,1
192452,within,0,0
192453,palliative,0,0
192454,care,0,0
192455,.,0,0
192456,The,0,0
192457,FamCope,0,0
192458,intervention,0,0
192459,was,0,0
192460,developed,0,0
192461,to,0,0
192462,test,0,0
192463,if,0,0
192464,a,0,0
192465,nurse-led,0,0
192466,family-coping-orientated,0,1
192467,palliative,0,0
192468,home,0,1
192469,care,0,0
192470,intervention,0,0
192471,would,0,0
192472,help,0,0
192473,families,0,0
192474,cope,0,0
192475,with,0,0
192476,physical,0,1
192477,and,0,1
192478,psychosocial,0,1
192479,problems,0,1
192480,at,0,0
192481,home,0,0
192482,--,0,0
192483,together,0,0
192484,as,0,0
192485,a,0,0
192486,family,0,1
192487,and,0,1
192488,in,0,0
192489,interaction,0,1
192490,with,0,0
192491,health,0,1
192492,care,0,0
192493,professionals,0,0
192494,.,0,0
192495,However,0,0
192496,",",0,0
192497,an,0,0
192498,unexpectedly,0,0
192499,high,0,0
192500,number,0,1
192501,of,0,1
192502,families,0,0
192503,declined,0,0
192504,participation,1,0
192505,in,0,0
192506,the,0,0
192507,trial,0,0
192508,.,0,0
192509,We,0,0
192510,describe,0,0
192511,and,0,0
192512,discuss,0,0
192513,the,0,0
192514,recruitment,1,0
192515,strategy,1,0
192516,and,0,1
192517,patient,1,1
192518,reported,1,0
192519,reasons,1,0
192520,for,0,0
192521,non-participation,1,0
192522,to,0,0
192523,add,0,0
192524,to,0,0
192525,the,0,0
192526,knowledge,0,0
192527,about,0,0
192528,what,0,0
192529,impedes,0,0
192530,recruitment,0,0
192531,and,0,0
192532,to,0,0
192533,identify,0,0
192534,the,0,0
192535,factors,0,0
192536,that,0,0
192537,influence,0,0
192538,willingness,0,0
192539,to,0,0
192540,participate,0,0
192541,in,0,0
192542,research,0,0
192543,aimed,0,0
192544,at,0,0
192545,family,0,0
192546,coping,0,1
192547,early,0,0
192548,in,0,0
192549,the,0,0
192550,palliative,0,0
192551,care,0,0
192552,trajectory,0,1
192553,.,0,0
192554,Patients,0,0
192555,with,0,0
192556,advanced,0,0
192557,cancer,0,0
192558,and,0,0
192559,their,0,0
192560,closest,0,1
192561,relative,0,1
192562,were,0,0
192563,recruited,0,0
192564,from,0,0
192565,medical,0,0
192566,",",0,0
192567,surgical,0,1
192568,",",0,1
192569,and,0,1
192570,oncological,0,1
192571,departments,0,0
192572,.,0,0
192573,Reasons,0,0
192574,for,0,0
192575,non-participation,1,0
192576,were,0,0
192577,registered,0,0
192578,and,0,0
192579,characteristics,0,1
192580,of,0,1
192581,participants,0,0
192582,and,0,1
192583,non-participants,0,0
192584,were,0,0
192585,compared,0,0
192586,to,0,0
192587,evaluate,0,0
192588,differences,0,0
192589,between,0,0
192590,subgroups,0,0
192591,of,0,0
192592,non-participants,0,0
192593,based,0,0
192594,on,0,0
192595,reasons,0,0
192596,not,0,0
192597,to,0,0
192598,participate,0,0
192599,and,0,0
192600,reasons,0,0
192601,to,0,0
192602,participate,0,0
192603,in,0,0
192604,the,0,0
192605,trial,0,0
192606,.,0,0
192607,A,0,0
192608,total,0,0
192609,of,0,0
192610,65.9,0,0
192611,%,0,0
192612,of,0,0
192613,the,0,0
192614,families,0,0
192615,declined,0,0
192616,participation,1,0
192617,.,1,0
192618,Two,0,0
192619,main,0,0
192620,categories,0,0
192621,for,0,0
192622,declining,0,1
192623,participation,1,0
192624,emerged,0,0
192625,:,0,0
192626,first,0,1
192627,",",0,0
192628,that,0,0
192629,the,0,0
192630,burden,0,1
192631,of,0,0
192632,illness,0,1
192633,is,0,0
192634,too,0,0
192635,great,0,0
192636,and,0,1
192637,",",0,1
192638,second,0,1
192639,",",0,0
192640,that,0,0
192641,it,0,0
192642,was,0,0
192643,too,0,0
192644,soon,0,0
192645,to,0,0
192646,receive,0,0
192647,this,0,0
192648,kind,0,0
192649,of,0,0
192650,support,0,0
192651,.,0,1
192652,Men,0,0
192653,were,0,0
192654,more,0,0
192655,likely,0,0
192656,to,0,0
192657,participate,1,0
192658,than,0,0
192659,women,0,0
192660,.,0,0
192661,Patients,0,0
192662,in,0,0
192663,the,0,0
192664,too,0,0
192665,soon,0,0
192666,group,0,0
192667,had,0,0
192668,similar,0,0
192669,characteristics,0,1
192670,to,0,0
192671,participants,0,0
192672,in,0,0
192673,the,0,0
192674,trial,0,0
192675,.,0,0
192676,Timing,0,1
192677,of,0,1
192678,interventions,0,0
192679,and,0,1
192680,readiness,0,1
192681,of,0,1
192682,patients,0,0
192683,and,0,0
192684,their,0,0
192685,relatives,0,1
192686,seems,0,0
192687,to,0,0
192688,affect,0,0
192689,willingness,1,0
192690,to,1,0
192691,receive,1,0
192692,a,1,0
192693,family-coping-orientated,1,1
192694,care,1,0
192695,approach,1,0
192696,and,0,1
192697,impeded,0,0
192698,recruitment,0,0
192699,to,0,0
192700,this,0,0
192701,trial,0,0
192702,.,0,0
192703,Our,0,0
192704,findings,0,0
192705,can,0,0
192706,be,0,0
192707,used,0,0
192708,in,0,0
192709,further,0,0
192710,research,0,0
192711,and,0,1
192712,in,0,0
192713,clinical,0,1
192714,practice,0,0
192715,in,0,0
192716,order,0,0
192717,to,0,0
192718,construct,0,0
192719,interventions,0,0
192720,and,0,1
192721,target,0,1
192722,relevant,0,1
192723,populations,0,0
192724,for,0,0
192725,early,0,0
192726,family-coping-orientated,0,1
192727,palliative,0,0
192728,care,0,0
192729,.,0,0
192730,Use,0,0
192731,of,0,0
192732,the,0,0
192733,learning,0,1
192734,conversation,0,0
192735,improves,0,0
192736,instructor,0,0
192737,confidence,0,1
192738,in,0,0
192739,life,0,1
192740,support,0,0
192741,training,0,0
192742,:,0,0
192743,An,0,0
192744,open,0,0
192745,randomised,0,0
192746,controlled,0,0
192747,cross-over,0,0
192748,trial,0,0
192749,comparing,0,0
192750,teaching,0,0
192751,feedback,0,0
192752,mechanisms,0,0
192753,.,0,1
192754,AIMS,0,0
192755,Feedback,0,0
192756,is,0,0
192757,vital,0,1
192758,for,0,0
192759,the,0,0
192760,effective,0,1
192761,delivery,0,0
192762,of,0,1
192763,skills-based,0,0
192764,education,0,0
192765,.,0,0
192766,We,0,0
192767,sought,0,0
192768,to,0,0
192769,compare,0,0
192770,the,0,0
192771,sandwich,0,0
192772,technique,0,0
192773,and,0,1
192774,learning,0,1
192775,conversation,0,1
192776,structured,0,0
192777,methods,0,0
192778,of,0,1
192779,feedback,0,0
192780,delivery,0,1
192781,in,0,0
192782,competency-based,0,0
192783,basic,0,0
192784,life,0,1
192785,support,0,0
192786,(,0,1
192787,BLS,0,1
192788,),0,0
192789,training,0,0
192790,.,0,0
192791,METHODS,0,0
192792,Open,0,0
192793,randomised,0,0
192794,crossover,0,0
192795,study,0,0
192796,undertaken,0,0
192797,between,0,0
192798,October,0,0
192799,2014,0,0
192800,and,0,0
192801,March,0,0
192802,2015,0,0
192803,at,0,0
192804,the,0,0
192805,University,0,0
192806,of,0,1
192807,Birmingham,0,0
192808,",",0,0
192809,United,0,0
192810,Kingdom,0,0
192811,.,0,1
192812,Six-hundred,0,0
192813,and,0,1
192814,forty,0,0
192815,healthcare,0,1
192816,students,0,0
192817,undertaking,0,0
192818,a,0,0
192819,European,0,0
192820,Resuscitation,0,1
192821,Council,0,1
192822,(,0,1
192823,ERC,0,0
192824,),0,1
192825,BLS,0,1
192826,course,0,1
192827,were,0,0
192828,enrolled,0,0
192829,",",0,0
192830,each,0,0
192831,of,0,0
192832,whom,0,0
192833,was,0,0
192834,randomised,0,0
192835,to,0,0
192836,receive,0,0
192837,teaching,0,0
192838,using,0,0
192839,either,0,0
192840,the,0,0
192841,sandwich,0,0
192842,technique,0,0
192843,or,0,0
192844,the,0,0
192845,learning,0,1
192846,conversation,0,1
192847,.,0,0
192848,Fifty-eight,0,0
192849,instructors,0,0
192850,were,0,0
192851,randomised,0,0
192852,to,0,0
192853,initially,0,0
192854,teach,0,0
192855,using,0,0
192856,either,0,0
192857,the,0,0
192858,learning,0,1
192859,conversation,0,1
192860,or,0,1
192861,sandwich,0,0
192862,technique,0,0
192863,",",0,0
192864,prior,0,0
192865,to,0,0
192866,crossing-over,0,1
192867,and,0,1
192868,teaching,0,0
192869,with,0,0
192870,the,0,0
192871,alternative,0,0
192872,technique,0,0
192873,after,0,0
192874,a,0,0
192875,pre-defined,0,1
192876,time,0,1
192877,period,0,0
192878,.,0,1
192879,Outcome,0,1
192880,measures,0,1
192881,included,0,0
192882,skill,1,1
192883,acquisition,1,0
192884,as,1,0
192885,measured,1,0
192886,by,1,0
192887,an,1,0
192888,end-of-course,1,1
192889,competency,1,1
192890,assessment,1,1
192891,",",1,1
192892,instructors,1,0
192893,',1,1
192894,perception,1,1
192895,of,1,0
192896,teaching,1,0
192897,with,1,0
192898,each,1,0
192899,feedback,1,0
192900,technique,1,0
192901,and,1,1
192902,candidates,1,1
192903,',1,1
192904,perception,1,1
192905,of,1,0
192906,the,1,0
192907,feedback,1,0
192908,they,1,0
192909,were,1,0
192910,provided,1,0
192911,with,1,0
192912,.,1,0
192913,RESULTS,0,0
192914,Scores,0,0
192915,assigned,0,0
192916,to,0,0
192917,use,0,0
192918,of,0,0
192919,the,0,0
192920,learning,0,1
192921,conversation,0,1
192922,by,0,0
192923,instructors,0,0
192924,were,0,0
192925,significantly,0,0
192926,more,0,0
192927,favourable,0,0
192928,than,0,0
192929,for,0,0
192930,the,0,0
192931,sandwich,0,0
192932,technique,0,0
192933,across,0,0
192934,all,0,0
192935,but,0,0
192936,two,0,0
192937,assessed,0,0
192938,domains,0,0
192939,relating,0,0
192940,to,0,0
192941,instructor,1,0
192942,perception,1,1
192943,of,1,0
192944,the,1,0
192945,feedback,1,0
192946,technique,1,0
192947,",",0,0
192948,including,0,0
192949,all,0,0
192950,skills-based,0,0
192951,domains,0,1
192952,.,0,0
192953,No,0,0
192954,difference,0,0
192955,was,0,0
192956,seen,0,0
192957,in,0,0
192958,either,0,0
192959,assessment,1,0
192960,pass,1,1
192961,rates,1,1
192962,(,0,0
192963,80.9,0,0
192964,%,0,0
192965,sandwich,0,0
192966,technique,0,0
192967,vs.,0,0
192968,77.2,0,0
192969,%,0,0
192970,learning,0,0
192971,conversation,0,1
192972,;,0,0
192973,OR,0,0
192974,1.2,0,0
192975,",",0,0
192976,95,0,0
192977,%,0,0
192978,CI,0,0
192979,0.85-1.84,0,0
192980,;,0,0
192981,p=0.29,0,0
192982,),0,0
192983,or,0,0
192984,any,0,1
192985,domain,0,0
192986,relating,0,0
192987,to,0,0
192988,candidates,0,1
192989,',0,1
192990,perception,0,1
192991,of,0,0
192992,their,0,0
192993,teaching,0,0
192994,technique,0,0
192995,.,0,1
192996,CONCLUSIONS,0,0
192997,&,0,0
192998,RELEVANCE,0,0
192999,This,0,0
193000,is,0,0
193001,the,0,0
193002,first,0,0
193003,direct,0,0
193004,comparison,0,0
193005,of,0,0
193006,two,0,0
193007,feedback,0,0
193008,techniques,0,0
193009,in,0,0
193010,clinical,0,0
193011,medical,0,0
193012,education,0,0
193013,using,0,0
193014,both,0,0
193015,quantitative,0,0
193016,and,0,1
193017,qualitative,0,0
193018,methodology,0,0
193019,.,0,0
193020,The,0,0
193021,learning,0,1
193022,conversation,0,0
193023,is,0,0
193024,preferred,0,0
193025,by,0,0
193026,instructors,0,0
193027,providing,0,0
193028,competency-based,0,0
193029,life,0,1
193030,support,0,0
193031,training,0,0
193032,and,0,0
193033,is,0,0
193034,perceived,0,1
193035,to,0,0
193036,favour,0,0
193037,skills,0,1
193038,acquisition,0,0
193039,.,0,0
193040,U.S.,0,1
193041,Food,0,1
193042,and,0,1
193043,Drug,0,0
193044,Administration,0,1
193045,Approval,0,1
193046,Summary,0,0
193047,:,0,0
193048,Ramucirumab,0,0
193049,for,0,0
193050,the,0,0
193051,Treatment,0,0
193052,of,0,0
193053,Metastatic,0,1
193054,Non-Small,0,0
193055,Cell,0,0
193056,Lung,0,0
193057,Cancer,0,0
193058,Following,0,1
193059,Disease,0,1
193060,Progression,0,1
193061,On,0,0
193062,or,0,0
193063,After,0,0
193064,Platinum-Based,0,0
193065,Chemotherapy,0,0
193066,.,0,0
193067,UNLABELLED,0,0
193068,On,0,0
193069,December,0,0
193070,12,0,0
193071,",",0,0
193072,2014,0,0
193073,",",0,0
193074,the,0,0
193075,U.S.,0,1
193076,Food,0,1
193077,and,0,1
193078,Drug,0,1
193079,Administration,0,1
193080,(,0,1
193081,FDA,0,1
193082,),0,1
193083,approved,0,0
193084,ramucirumab,0,0
193085,for,0,0
193086,use,0,0
193087,in,0,0
193088,combination,0,0
193089,with,0,0
193090,docetaxel,0,0
193091,for,0,0
193092,the,0,0
193093,treatment,0,0
193094,of,0,0
193095,patients,0,0
193096,with,0,0
193097,metastatic,0,0
193098,non-small,0,0
193099,cell,0,1
193100,lung,0,1
193101,cancer,0,1
193102,(,0,1
193103,NSCLC,0,1
193104,),0,1
193105,with,0,0
193106,disease,0,1
193107,progression,0,1
193108,on,0,0
193109,or,0,0
193110,after,0,0
193111,platinum-based,0,0
193112,chemotherapy,0,0
193113,.,0,0
193114,Patients,0,0
193115,with,0,0
193116,epidermal,0,1
193117,growth,0,1
193118,factor,0,1
193119,receptor,0,1
193120,or,0,1
193121,anaplastic,0,1
193122,lymphoma,0,1
193123,kinase,0,1
193124,genomic,0,1
193125,tumor,0,0
193126,aberrations,0,1
193127,should,0,0
193128,have,0,0
193129,disease,0,1
193130,progression,0,1
193131,on,0,0
193132,FDA-approved,0,0
193133,therapy,0,0
193134,for,0,0
193135,these,0,0
193136,aberrations,0,1
193137,prior,0,0
193138,to,0,0
193139,receiving,0,0
193140,ramucirumab,0,0
193141,.,0,0
193142,This,0,0
193143,approval,0,0
193144,was,0,0
193145,based,0,0
193146,on,0,0
193147,an,0,0
193148,improvement,0,1
193149,in,0,0
193150,overall,0,1
193151,survival,0,1
193152,(,0,1
193153,OS,0,1
193154,),0,0
193155,with,0,0
193156,an,0,0
193157,acceptable,0,0
193158,toxicity,0,1
193159,profile,0,1
193160,in,0,0
193161,a,0,0
193162,randomized,0,0
193163,",",0,0
193164,multicenter,0,0
193165,",",0,1
193166,double-blinded,0,0
193167,",",0,1
193168,placebo-controlled,0,0
193169,trial,0,0
193170,of,0,0
193171,"1,253",0,0
193172,patients,0,0
193173,with,0,0
193174,metastatic,0,0
193175,NSCLC,0,1
193176,previously,0,0
193177,treated,0,0
193178,with,0,0
193179,a,0,0
193180,platinum-based,0,0
193181,combination,0,0
193182,therapy,0,0
193183,.,0,1
193184,Patients,0,0
193185,were,0,0
193186,randomized,0,0
193187,1:1,0,0
193188,to,0,0
193189,receive,0,0
193190,either,0,0
193191,ramucirumab,0,0
193192,in,0,0
193193,combination,0,0
193194,with,0,0
193195,docetaxel,0,0
193196,or,0,1
193197,placebo,0,0
193198,in,0,0
193199,combination,0,0
193200,with,0,0
193201,docetaxel,0,0
193202,.,0,0
193203,The,0,0
193204,primary,0,0
193205,endpoint,0,1
193206,was,0,0
193207,OS,1,1
193208,.,1,0
193209,Patients,0,0
193210,who,0,0
193211,received,0,0
193212,ramucirumab,0,0
193213,in,0,0
193214,combination,0,0
193215,with,0,0
193216,docetaxel,0,0
193217,had,0,0
193218,improved,1,1
193219,OS,1,1
193220,(,0,0
193221,hazard,0,1
193222,ratio,0,1
193223,[,0,0
193224,HR,0,1
193225,],0,0
193226,:,0,0
193227,0.86,0,0
193228,;,0,0
193229,95,0,0
193230,%,0,0
193231,confidence,0,0
193232,interval,0,0
193233,[,0,0
193234,CI,0,0
193235,],0,0
193236,:,0,0
193237,0.75,0,0
193238,",",0,0
193239,0.98,0,0
193240,),0,0
193241,.,0,0
193242,Median,1,1
193243,OS,1,1
193244,was,0,0
193245,10.5,0,0
193246,months,0,0
193247,on,0,0
193248,the,0,0
193249,ramucirumab,0,0
193250,plus,0,0
193251,docetaxel,0,0
193252,arm,0,0
193253,versus,0,0
193254,9.1,0,0
193255,months,0,0
193256,on,0,0
193257,the,0,0
193258,placebo,0,0
193259,plus,0,0
193260,docetaxel,0,0
193261,arm,0,0
193262,.,0,0
193263,The,0,0
193264,most,0,0
193265,frequent,0,1
193266,(,0,0
193267,?,0,0
193268,30,0,0
193269,%,1,0
193270,),1,0
193271,adverse,1,1
193272,reactions,1,1
193273,in,1,0
193274,ramucirumab-treated,0,0
193275,patients,0,0
193276,were,1,0
193277,fatigue,1,1
193278,",",1,1
193279,neutropenia,1,1
193280,",",1,1
193281,and,1,1
193282,diarrhea,1,1
193283,.,1,0
193284,The,0,0
193285,most,0,0
193286,frequent,0,1
193287,(,0,0
193288,?,0,0
193289,5,0,0
193290,%,0,0
193291,),0,0
193292,grade,0,0
193293,3,0,0
193294,and,0,0
193295,4,1,0
193296,adverse,1,1
193297,reactions,1,0
193298,in,1,0
193299,the,0,0
193300,ramucirumab,0,0
193301,arm,0,0
193302,were,0,0
193303,fatigue,1,1
193304,",",1,0
193305,neutropenia,1,1
193306,",",1,0
193307,febrile,1,1
193308,neutropenia,1,1
193309,",",1,1
193310,leukopenia,1,1
193311,",",1,1
193312,and,1,1
193313,hypertension,1,1
193314,.,1,1
193315,IMPLICATIONS,1,0
193316,FOR,0,0
193317,PRACTICE,0,0
193318,This,0,0
193319,report,0,0
193320,presents,0,0
193321,key,0,1
193322,information,0,0
193323,on,0,0
193324,the,0,0
193325,U.S.,0,1
193326,Food,0,1
193327,and,0,1
193328,Drug,0,0
193329,Administration,0,1
193330,approval,0,0
193331,of,0,1
193332,ramucirumab,0,0
193333,",",0,0
193334,a,0,0
193335,monoclonal,0,1
193336,antibody,0,1
193337,targeting,0,0
193338,vascular,0,1
193339,endothelial,0,1
193340,growth,0,1
193341,factor,0,1
193342,receptor-2,0,1
193343,",",0,1
193344,given,0,0
193345,in,0,0
193346,combination,0,0
193347,with,0,0
193348,docetaxel,0,0
193349,for,0,0
193350,the,0,0
193351,treatment,0,0
193352,of,0,0
193353,patients,0,0
193354,with,0,0
193355,metastatic,0,0
193356,non-small,0,0
193357,cell,0,1
193358,lung,0,1
193359,cancer,0,0
193360,whose,0,0
193361,disease,0,0
193362,has,0,0
193363,progressed,0,1
193364,on,0,0
193365,or,0,0
193366,after,0,0
193367,platinum-based,0,0
193368,chemotherapy,0,0
193369,.,0,0
193370,This,0,0
193371,report,0,0
193372,specifically,0,0
193373,addresses,0,0
193374,the,0,0
193375,issues,0,0
193376,of,0,0
193377,safety,0,1
193378,in,0,0
193379,patients,0,0
193380,with,0,0
193381,squamous,0,0
193382,cell,0,1
193383,tumors,0,1
193384,",",0,1
193385,effect,0,1
193386,of,0,1
193387,treatment,0,0
193388,in,0,0
193389,elderly,0,0
193390,patients,0,0
193391,",",0,1
193392,and,0,1
193393,uncertainties,0,1
193394,regarding,0,0
193395,effects,0,1
193396,in,0,0
193397,patients,0,0
193398,with,0,0
193399,tumors,0,0
193400,harboring,0,1
193401,epidermal,0,1
193402,growth,0,1
193403,factor,0,1
193404,receptor,0,1
193405,or,0,1
193406,anaplastic,0,1
193407,lymphoma,0,1
193408,kinase,0,1
193409,genomic,0,1
193410,tumor,0,1
193411,aberrations,0,1
193412,.,0,0
193413,Rituximab,0,0
193414,maintenance,0,0
193415,improves,0,1
193416,survival,0,1
193417,in,0,0
193418,male,0,0
193419,patients,0,0
193420,with,0,0
193421,diffuse,0,1
193422,large,0,0
193423,B-cell,0,1
193424,lymphoma,0,1
193425,.,0,0
193426,Results,0,0
193427,of,0,0
193428,the,0,0
193429,HD2002,0,0
193430,prospective,0,0
193431,multicentre,0,0
193432,randomized,0,0
193433,phase,0,0
193434,III,0,0
193435,trial,0,0
193436,.,0,0
193437,In,0,0
193438,the,0,0
193439,multicentre,0,0
193440,prospective,0,0
193441,randomized,0,0
193442,HD2002,0,0
193443,trial,0,0
193444,",",0,1
193445,rituximab,0,0
193446,maintenance,0,0
193447,therapy,0,0
193448,(,0,0
193449,375,0,0
193450,mg/m,0,0
193451,(,0,0
193452,2,0,0
193453,),0,0
193454,every,0,0
193455,3,0,0
193456,months,0,0
193457,for,0,0
193458,2,0,0
193459,years,0,0
193460,),0,0
193461,versus,0,0
193462,observation,0,0
193463,was,0,0
193464,evaluated,0,0
193465,for,0,0
193466,CD20,0,0
193467,(,0,0
193468,+,0,0
193469,),0,1
193470,B-cell,0,1
193471,lymphoma,0,0
193472,.,0,0
193473,Out,0,0
193474,of,0,0
193475,321,0,0
193476,patients,0,0
193477,[,0,0
193478,161,0,0
193479,randomized,0,0
193480,to,0,0
193481,the,0,0
193482,treatment,0,0
193483,group,0,0
193484,(,0,1
193485,TG,0,1
193486,),0,0
193487,",",0,0
193488,160,0,0
193489,to,0,0
193490,the,0,0
193491,observation,0,0
193492,group,0,0
193493,(,0,1
193494,OG,0,1
193495,),0,1
193496,],0,0
193497,",",0,0
193498,295,0,0
193499,data,0,0
193500,sets,0,0
193501,were,0,0
193502,evaluable,0,0
193503,for,0,0
193504,statistical,0,0
193505,analysis,0,0
193506,.,0,0
193507,Estimated,0,0
193508,5-year,1,0
193509,relapse-free,1,1
193510,survival,1,1
193511,(,1,1
193512,RFS,1,1
193513,),1,0
193514,was,0,0
193515,81,0,0
193516,%,0,0
193517,in,0,0
193518,the,0,0
193519,TG,0,0
193520,and,0,0
193521,70,0,0
193522,%,0,0
193523,in,0,0
193524,the,0,0
193525,OG,0,1
193526,(,0,0
193527,logrank,0,1
193528,test,0,1
193529,",",0,1
193530,P,0,0
193531,=,0,0
193532,0?047,0,0
193533,),0,0
193534,.,0,0
193535,In,0,0
193536,the,0,0
193537,diffuse,0,1
193538,large,0,1
193539,B-cell,0,1
193540,lymphoma,0,1
193541,(,0,1
193542,DLBCL,0,1
193543,),0,1
193544,subgroup,0,0
193545,(,0,0
193546,n,0,0
193547,=,0,0
193548,152,0,0
193549,),0,0
193550,",",0,0
193551,5-year,1,1
193552,RFS,1,1
193553,was,0,0
193554,excellent,0,1
193555,",",0,0
193556,at,0,0
193557,87,0,0
193558,%,0,0
193559,in,0,0
193560,the,0,0
193561,TG,0,0
193562,and,0,0
193563,84,0,0
193564,%,0,0
193565,in,0,0
193566,the,0,0
193567,OG,0,1
193568,(,0,0
193569,logrank,0,1
193570,test,0,1
193571,",",0,1
193572,P,0,0
193573,=,0,0
193574,0?35,0,0
193575,),0,0
193576,.,0,0
193577,Of,0,0
193578,note,0,0
193579,",",0,0
193580,only,0,0
193581,in,0,0
193582,male,0,0
193583,patients,0,0
193584,of,0,0
193585,the,0,0
193586,DLBCL,0,1
193587,subgroup,0,0
193588,was,1,0
193589,RFS,1,1
193590,significantly,1,0
193591,superior,0,0
193592,in,0,0
193593,the,0,0
193594,TG,0,0
193595,in,0,0
193596,comparison,0,0
193597,to,0,0
193598,the,0,0
193599,OG,0,1
193600,(,0,0
193601,5-year,0,0
193602,RFS,0,1
193603,:,0,0
193604,88,0,0
193605,%,0,0
193606,vs.,0,0
193607,74,0,0
193608,%,0,0
193609,;,0,0
193610,logrank,0,1
193611,test,0,1
193612,",",0,1
193613,P,0,0
193614,=,0,0
193615,0?05,0,0
193616,),0,0
193617,.,0,0
193618,Cox,0,0
193619,regression,0,1
193620,analysis,0,0
193621,showed,0,0
193622,a,0,0
193623,significant,0,0
193624,interaction,0,1
193625,between,0,0
193626,treatment,0,0
193627,and,0,1
193628,gender,0,0
193629,regarding,1,0
193630,overall,1,1
193631,survival,1,1
193632,(,1,1
193633,OS,1,1
193634,),1,1
193635,(,1,0
193636,P,1,0
193637,=,0,0
193638,0?006,0,0
193639,),0,0
193640,and,0,0
193641,RFS,1,1
193642,(,0,1
193643,P,0,0
193644,=,0,0
193645,0?02,0,0
193646,),0,0
193647,",",0,0
193648,with,0,0
193649,a,0,0
193650,lower,0,0
193651,hazard,0,1
193652,in,0,0
193653,females,0,0
193654,than,0,0
193655,males,0,0
193656,in,0,0
193657,the,1,0
193658,OG,1,1
193659,[,1,0
193660,OS,1,1
193661,:,1,0
193662,hazard,1,1
193663,ratio,1,1
193664,(,1,1
193665,HR,1,1
193666,),1,1
193667,(,0,0
193668,female,0,0
193669,:,0,0
193670,male,0,0
193671,),0,0
193672,=,0,0
193673,0?11,0,0
193674,;,0,0
193675,95,1,0
193676,%,1,0
193677,confidence,1,0
193678,interval,1,0
193679,(,1,1
193680,CI,1,0
193681,),1,0
193682,=,0,0
193683,0?00-1?03,1,0
193684,;,1,0
193685,RFS,1,1
193686,:,1,0
193687,HR,1,1
193688,(,0,0
193689,female,0,0
193690,:,0,0
193691,male,0,0
193692,),0,0
193693,=,0,0
193694,0?27,0,0
193695,;,0,0
193696,95,0,0
193697,%,0,0
193698,CI,0,0
193699,=,0,0
193700,0?05-0?97,0,1
193701,],0,0
193702,",",0,0
193703,and,0,0
193704,no,0,0
193705,significant,0,0
193706,differences,0,0
193707,between,0,0
193708,males,0,0
193709,and,0,1
193710,females,0,0
193711,in,0,0
193712,the,0,0
193713,TG,0,0
193714,.,0,0
193715,We,0,0
193716,conclude,0,0
193717,that,0,0
193718,Rituximab,0,0
193719,maintenance,0,0
193720,therapy,0,0
193721,improves,0,1
193722,survival,0,1
193723,in,0,0
193724,male,0,0
193725,patients,0,0
193726,with,0,0
193727,DLBCL,0,0
193728,.,0,0
193729,Assessment,0,1
193730,of,0,1
193731,bone,0,1
193732,marrow-derived,0,0
193733,Cellular,0,1
193734,Therapy,0,0
193735,in,0,0
193736,progressive,0,0
193737,Multiple,0,1
193738,Sclerosis,0,1
193739,(,0,1
193740,ACTiMuS,0,1
193741,),0,0
193742,:,0,0
193743,study,0,0
193744,protocol,0,0
193745,for,0,0
193746,a,0,0
193747,randomised,0,0
193748,controlled,0,0
193749,trial,0,0
193750,.,0,0
193751,BACKGROUND,0,0
193752,We,0,0
193753,have,0,0
193754,recently,0,0
193755,completed,0,0
193756,an,0,0
193757,evaluation,0,0
193758,of,0,0
193759,the,0,0
193760,safety,1,1
193761,and,0,1
193762,feasibility,1,1
193763,of,0,1
193764,intravenous,0,0
193765,delivery,0,1
193766,of,0,1
193767,autologous,0,0
193768,bone,0,1
193769,marrow,0,0
193770,in,0,0
193771,patients,0,0
193772,with,0,0
193773,progressive,0,0
193774,multiple,0,0
193775,sclerosis,0,0
193776,(,0,1
193777,MS,0,1
193778,),0,0
193779,.,0,0
193780,The,0,0
193781,possibility,0,0
193782,of,0,1
193783,repair,0,0
193784,was,0,0
193785,suggested,0,0
193786,by,0,0
193787,improvement,0,0
193788,in,0,0
193789,the,0,0
193790,neurophysiological,0,1
193791,secondary,0,1
193792,outcome,0,1
193793,measure,0,1
193794,seen,0,0
193795,in,0,0
193796,all,0,0
193797,participants,0,0
193798,.,0,0
193799,The,0,0
193800,current,0,0
193801,study,0,0
193802,will,0,0
193803,examine,0,0
193804,the,0,0
193805,efficacy,1,1
193806,of,0,0
193807,intravenous,0,0
193808,delivery,0,1
193809,of,0,1
193810,autologous,0,0
193811,marrow,0,0
193812,in,0,0
193813,progressive,0,0
193814,MS,0,0
193815,.,0,0
193816,Laboratory,0,0
193817,studies,0,0
193818,performed,0,0
193819,in,0,0
193820,parallel,0,0
193821,with,0,0
193822,the,0,0
193823,clinical,0,0
193824,trial,0,0
193825,will,0,0
193826,further,0,0
193827,investigate,0,0
193828,the,0,0
193829,biology,0,0
193830,of,0,0
193831,bone,0,1
193832,marrow-derived,0,0
193833,stem,0,1
193834,cell,0,1
193835,infusion,0,0
193836,in,0,0
193837,MS,0,1
193838,",",0,0
193839,including,0,0
193840,mechanisms,0,0
193841,underlying,0,0
193842,repair,0,0
193843,.,0,0
193844,METHODS/DESIGN,0,0
193845,A,0,0
193846,prospective,0,0
193847,",",0,0
193848,randomised,0,0
193849,",",0,1
193850,double-blind,0,0
193851,",",0,1
193852,placebo-controlled,0,0
193853,",",0,1
193854,stepped,0,0
193855,wedge,0,0
193856,design,0,0
193857,will,0,0
193858,be,0,0
193859,employed,0,0
193860,at,0,0
193861,a,0,0
193862,single,0,0
193863,centre,0,0
193864,(,0,1
193865,Bristol,0,1
193866,",",0,1
193867,UK,0,1
193868,),0,0
193869,.,0,0
193870,Eighty,0,0
193871,patients,0,0
193872,with,0,0
193873,progressive,0,0
193874,MS,0,0
193875,will,0,0
193876,be,0,0
193877,recruited,0,0
193878,;,0,0
193879,60,0,0
193880,will,0,0
193881,have,0,0
193882,secondary,0,1
193883,progressive,0,1
193884,disease,0,1
193885,(,0,1
193886,SPMS,0,0
193887,),0,0
193888,but,0,0
193889,a,0,0
193890,subset,0,0
193891,(,0,0
193892,n,0,0
193893,=,0,0
193894,20,0,0
193895,),0,0
193896,will,0,0
193897,have,0,0
193898,primary,0,0
193899,progressive,0,1
193900,disease,0,1
193901,(,0,1
193902,PPMS,0,1
193903,),0,0
193904,.,0,0
193905,Participants,0,0
193906,will,0,0
193907,be,0,0
193908,randomised,0,0
193909,to,0,0
193910,either,0,0
193911,early,0,0
193912,or,0,0
193913,late,0,1
193914,(,0,0
193915,1,0,0
193916,year,0,0
193917,),0,0
193918,intravenous,0,0
193919,infusion,0,0
193920,of,0,1
193921,autologous,0,0
193922,",",0,0
193923,unfractionated,0,0
193924,bone,0,1
193925,marrow,0,0
193926,.,0,0
193927,The,0,0
193928,placebo,0,0
193929,intervention,0,0
193930,is,0,0
193931,infusion,0,0
193932,of,0,1
193933,autologous,0,0
193934,blood,0,1
193935,.,0,0
193936,The,0,0
193937,primary,0,0
193938,outcome,0,0
193939,measure,0,0
193940,is,0,0
193941,global,1,1
193942,evoked,1,1
193943,potential,1,0
193944,derived,1,0
193945,from,1,0
193946,multimodal,1,0
193947,evoked,1,0
193948,potentials,1,1
193949,.,1,0
193950,Secondary,0,0
193951,outcome,0,1
193952,measures,0,0
193953,include,0,0
193954,adverse,1,1
193955,event,1,1
193956,reporting,1,1
193957,",",1,1
193958,clinical,1,1
193959,(,1,1
193960,EDSS,1,0
193961,and,1,1
193962,MSFC,1,1
193963,),1,1
193964,and,1,1
193965,self-assessment,1,1
193966,(,1,1
193967,MSIS-29,1,0
193968,),1,1
193969,rating,1,1
193970,scales,1,1
193971,",",1,1
193972,optical,1,1
193973,coherence,1,1
193974,tomography,1,1
193975,(,1,1
193976,OCT,1,0
193977,),1,0
193978,as,1,0
193979,well,1,0
193980,as,1,0
193981,brain,1,1
193982,and,1,1
193983,spine,1,1
193984,MRI,1,1
193985,.,1,0
193986,Participants,0,0
193987,will,0,0
193988,be,0,0
193989,followed,0,0
193990,up,0,0
193991,for,0,0
193992,a,0,0
193993,further,0,0
193994,year,0,0
193995,following,0,0
193996,the,0,0
193997,final,0,1
193998,intervention,0,0
193999,.,0,0
194000,Outcomes,0,0
194001,will,0,0
194002,be,0,0
194003,analysed,0,0
194004,on,0,0
194005,an,0,0
194006,intention-to-treat,0,0
194007,basis,0,0
194008,.,0,0
194009,DISCUSSION,0,1
194010,Assessment,0,1
194011,of,0,1
194012,bone,0,1
194013,marrow-derived,0,0
194014,Cellular,0,1
194015,Therapy,0,0
194016,in,0,0
194017,progressive,0,0
194018,Multiple,0,1
194019,Sclerosis,0,1
194020,(,0,1
194021,ACTiMuS,0,0
194022,),0,0
194023,is,0,0
194024,the,0,0
194025,first,0,0
194026,randomised,0,0
194027,",",0,0
194028,placebo-controlled,0,0
194029,trial,0,0
194030,of,0,1
194031,non-myeloablative,0,0
194032,autologous,0,0
194033,bone,0,1
194034,marrow-derived,0,1
194035,stem,0,1
194036,cell,0,1
194037,therapy,0,0
194038,in,0,0
194039,MS,0,0
194040,.,0,0
194041,It,0,0
194042,will,0,0
194043,determine,0,0
194044,whether,0,0
194045,bone,0,1
194046,marrow,0,0
194047,cell,0,1
194048,therapy,0,0
194049,can,0,0
194050,",",0,0
194051,as,0,0
194052,was,0,0
194053,suggested,0,0
194054,by,0,0
194055,the,0,0
194056,phase,0,0
194057,I,0,0
194058,safety,0,1
194059,study,0,0
194060,",",0,1
194061,improve,0,0
194062,conduction,0,1
194063,in,0,0
194064,multiple,0,0
194065,central,0,1
194066,nervous,0,1
194067,system,0,0
194068,pathways,0,0
194069,affected,0,0
194070,in,0,0
194071,progressive,0,0
194072,MS,0,0
194073,.,0,1
194074,Furthermore,0,0
194075,",",0,0
194076,laboratory,0,1
194077,studies,0,0
194078,performed,0,0
194079,in,0,0
194080,parallel,0,0
194081,with,0,0
194082,the,0,0
194083,clinical,0,0
194084,trial,0,0
194085,will,0,0
194086,inform,0,0
194087,our,0,0
194088,understanding,0,0
194089,of,0,0
194090,the,0,0
194091,cellular,0,1
194092,pharmacodynamics,0,0
194093,of,0,1
194094,bone,0,1
194095,marrow,0,0
194096,infusion,0,0
194097,in,0,0
194098,MS,0,1
194099,patients,0,0
194100,and,0,0
194101,the,0,0
194102,mechanisms,0,0
194103,underlying,0,0
194104,cell,0,1
194105,therapy,0,0
194106,.,0,1
194107,TRIAL,0,0
194108,REGISTRATION,0,0
194109,ISRCTN27232902,0,0
194110,Registration,0,1
194111,date,0,0
194112,11/09/2012,0,0
194113,.,0,0
194114,NCT01815632,0,0
194115,Registration,0,1
194116,date,0,0
194117,19/03/2013,0,0
194118,.,0,0
194119,Preoperative,0,1
194120,Local,0,1
194121,Administration,0,1
194122,of,0,1
194123,Morphine,0,0
194124,as,0,0
194125,an,0,0
194126,Add-on,0,0
194127,Therapy,0,0
194128,in,0,0
194129,Patients,0,0
194130,Undergoing,0,0
194131,Surgical,0,0
194132,Removal,0,0
194133,of,0,0
194134,an,0,0
194135,Odontogenic,0,0
194136,Maxillary,0,0
194137,Cyst,0,0
194138,.,0,0
194139,A,0,0
194140,Randomized,0,0
194141,",",0,1
194142,Double-Blind,0,0
194143,Pilot,0,1
194144,Study,0,0
194145,.,0,0
194146,AIMS,0,0
194147,To,0,0
194148,evaluate,0,0
194149,whether,0,0
194150,a,0,0
194151,combination,0,0
194152,of,0,0
194153,locally,0,0
194154,administered,0,0
194155,morphine,0,0
194156,(,0,0
194157,1,0,0
194158,mg,0,0
194159,),0,0
194160,and,0,1
194161,lidocaine,0,0
194162,as,0,0
194163,part,0,0
194164,of,0,0
194165,a,0,0
194166,multimodal,0,0
194167,analgesic,0,1
194168,approach,0,0
194169,is,0,0
194170,safe,0,1
194171,",",0,0
194172,and,0,0
194173,whether,0,0
194174,it,0,0
194175,improves,0,0
194176,pain,0,1
194177,control,0,0
194178,during,0,0
194179,the,0,0
194180,first,0,0
194181,24,0,0
194182,hours,0,0
194183,after,0,0
194184,odontogenic,0,0
194185,maxillary,0,0
194186,cyst,0,1
194187,removal,0,1
194188,under,0,0
194189,general,0,0
194190,anesthesia,0,0
194191,compared,0,0
194192,to,0,0
194193,local,0,0
194194,lidocaine,0,0
194195,alone,0,0
194196,.,0,0
194197,METHODS,0,0
194198,In,0,0
194199,a,0,0
194200,double-blind,0,0
194201,",",0,0
194202,sham-controlled,0,0
194203,",",0,1
194204,single-center,0,0
194205,trial,0,0
194206,",",0,0
194207,patients,0,0
194208,scheduled,0,0
194209,for,0,0
194210,surgical,0,0
194211,removal,0,0
194212,of,0,0
194213,an,0,0
194214,odontogenic,0,0
194215,maxillary,0,0
194216,cyst,0,1
194217,under,0,0
194218,general,0,0
194219,anesthesia,0,0
194220,were,0,0
194221,randomly,0,0
194222,assigned,0,0
194223,to,0,0
194224,receive,0,0
194225,a,0,0
194226,local,0,0
194227,injection,0,0
194228,of,0,1
194229,lidocaine,0,0
194230,solution,0,0
194231,with,0,0
194232,either,0,0
194233,1,0,0
194234,mg,0,0
194235,of,0,0
194236,morphine,0,1
194237,(,0,0
194238,MLA,0,1
194239,group,0,0
194240,),0,1
194241,or,0,0
194242,with,0,0
194243,no,0,0
194244,morphine,0,0
194245,(,0,0
194246,LA,0,1
194247,group,0,0
194248,),0,0
194249,.,0,0
194250,Pain,0,1
194251,management,0,0
194252,included,0,0
194253,intravenous,0,0
194254,acetaminophen,0,0
194255,(,0,0
194256,1,0,0
194257,g,0,0
194258,every,0,0
194259,6,0,0
194260,hours,0,0
194261,),0,0
194262,in,0,0
194263,all,0,0
194264,patients,0,0
194265,.,0,0
194266,Upon,0,0
194267,request,0,0
194268,",",0,0
194269,the,0,0
194270,patients,0,0
194271,could,0,0
194272,additionally,0,0
194273,receive,0,0
194274,ketoprofen,0,0
194275,(,0,0
194276,first-line,0,0
194277,additional,0,0
194278,analgesia,0,1
194279,),0,1
194280,or,0,1
194281,tramadol,0,0
194282,(,0,0
194283,second-line,0,0
194284,additional,0,0
194285,analgesia,0,1
194286,),0,0
194287,.,0,0
194288,Pain,0,1
194289,intensity,0,1
194290,was,0,0
194291,assessed,0,0
194292,using,0,0
194293,a,0,0
194294,numeric,0,1
194295,rating,0,1
194296,scale,0,1
194297,.,0,1
194298,Primary,0,1
194299,outcome,0,1
194300,measures,0,1
194301,were,0,0
194302,(,1,0
194303,1,1,0
194304,),1,0
194305,no,1,0
194306,need,1,0
194307,for,1,0
194308,any,1,0
194309,additional,1,0
194310,analgesic,1,1
194311,therapy,1,0
194312,and,1,1
194313,(,1,0
194314,2,1,0
194315,),1,0
194316,time,1,0
194317,to,1,0
194318,the,1,0
194319,first,1,0
194320,rescue,1,1
194321,analgesic,1,1
194322,therapy,1,0
194323,during,1,0
194324,the,1,0
194325,first,1,0
194326,24,1,0
194327,hours,1,0
194328,after,1,0
194329,the,1,0
194330,surgery,1,0
194331,.,1,0
194332,RESULTS,0,0
194333,Of,0,0
194334,48,0,0
194335,eligible,0,0
194336,patients,0,0
194337,",",0,0
194338,24,0,0
194339,were,0,0
194340,allocated,0,0
194341,to,0,0
194342,the,0,0
194343,MLA,0,1
194344,group,0,0
194345,and,0,0
194346,24,0,0
194347,to,0,0
194348,the,0,0
194349,LA,0,0
194350,group,0,0
194351,.,0,0
194352,The,0,0
194353,necessity,0,0
194354,of,0,0
194355,additional,1,0
194356,ketoprofen,1,0
194357,therapy,1,0
194358,did,0,0
194359,not,0,0
194360,differ,0,0
194361,significantly,0,0
194362,between,0,0
194363,the,0,0
194364,groups,0,0
194365,(,0,0
194366,25.0,0,0
194367,%,0,0
194368,vs,0,0
194369,50.0,0,0
194370,%,0,0
194371,",",0,0
194372,P=.074,0,0
194373,),0,0
194374,.,0,0
194375,According,0,0
194376,to,0,0
194377,the,0,0
194378,Kaplan-Meier,0,1
194379,analysis,0,0
194380,",",0,0
194381,the,0,0
194382,probability,0,1
194383,of,0,0
194384,remaining,0,0
194385,without,0,0
194386,additional,1,0
194387,analgesic,1,1
194388,intervention,1,0
194389,was,0,0
194390,significantly,0,0
194391,higher,0,0
194392,in,0,0
194393,the,0,0
194394,MLA,0,1
194395,group,0,0
194396,(,0,1
194397,log-rank,0,0
194398,test,0,1
194399,",",0,1
194400,P=.040,0,1
194401,),0,1
194402,",",0,0
194403,but,0,0
194404,there,0,0
194405,were,0,0
194406,no,0,0
194407,significant,0,0
194408,(,0,0
194409,P,0,0
194410,>,0,1
194411,.05,0,0
194412,),0,0
194413,differences,0,0
194414,in,0,0
194415,overall,0,1
194416,and,0,1
194417,maximum,0,1
194418,pain,1,1
194419,severity,1,1
194420,between,0,0
194421,the,0,0
194422,two,0,0
194423,groups,0,0
194424,.,0,0
194425,No,0,0
194426,adverse,1,1
194427,effects,1,1
194428,of,0,1
194429,morphine,0,1
194430,were,0,0
194431,recorded,0,0
194432,.,0,0
194433,CONCLUSION,0,0
194434,Within,0,0
194435,the,0,0
194436,limitations,0,0
194437,of,0,0
194438,this,0,0
194439,study,0,0
194440,",",0,0
194441,local,0,1
194442,administration,0,0
194443,of,0,0
194444,1,0,0
194445,mg,0,0
194446,of,0,0
194447,morphine,0,0
194448,prior,0,0
194449,to,0,0
194450,the,0,0
194451,surgical,0,0
194452,removal,0,0
194453,of,0,0
194454,an,0,0
194455,odontogenic,0,0
194456,maxillary,0,0
194457,cyst,0,1
194458,was,0,0
194459,safe,0,1
194460,",",0,0
194461,but,0,0
194462,it,0,0
194463,did,0,0
194464,not,0,0
194465,prove,0,0
194466,to,0,0
194467,be,0,0
194468,very,0,0
194469,effective,0,0
194470,as,0,0
194471,an,0,0
194472,add-on,0,0
194473,therapy,0,0
194474,for,0,0
194475,postoperative,0,1
194476,pain,0,1
194477,control,0,0
194478,.,0,0
194479,Effects,0,0
194480,of,0,1
194481,propofol,0,0
194482,and,0,1
194483,isoflurane,0,0
194484,on,0,0
194485,haemodynamics,1,1
194486,and,1,0
194487,the,1,0
194488,inflammatory,1,1
194489,response,1,1
194490,in,0,0
194491,cardiopulmonary,0,1
194492,bypass,0,0
194493,surgery,0,0
194494,.,0,1
194495,Cardiopulmonary,0,1
194496,bypass,0,0
194497,(,0,1
194498,CPB,0,0
194499,),0,0
194500,causes,0,0
194501,reperfusion,0,1
194502,injury,0,1
194503,that,0,0
194504,when,0,0
194505,most,0,0
194506,severe,0,0
194507,is,0,0
194508,clinically,0,0
194509,manifested,0,0
194510,as,0,0
194511,a,0,0
194512,systemic,0,1
194513,inflammatory,0,1
194514,response,0,1
194515,syndrome,0,0
194516,.,0,0
194517,The,0,0
194518,anaesthetic,0,0
194519,propofol,0,0
194520,may,0,0
194521,have,0,0
194522,anti-inflammatory,0,0
194523,properties,0,0
194524,that,0,0
194525,may,0,0
194526,reduce,0,0
194527,such,0,0
194528,a,0,0
194529,response,0,1
194530,.,0,0
194531,We,0,0
194532,hypothesised,0,0
194533,differing,0,0
194534,effects,0,1
194535,of,0,1
194536,propofol,0,0
194537,and,0,1
194538,isoflurane,0,0
194539,on,0,0
194540,inflammatory,1,1
194541,markers,1,1
194542,in,0,0
194543,patients,0,0
194544,having,0,0
194545,CBR,0,1
194546,Forty,0,0
194547,patients,0,0
194548,undergoing,0,0
194549,elective,0,0
194550,CPB,0,1
194551,were,0,0
194552,randomised,0,0
194553,to,0,0
194554,receive,0,0
194555,either,0,0
194556,propofol,0,0
194557,or,0,0
194558,isoflurane,0,0
194559,for,0,0
194560,maintenance,0,0
194561,of,0,0
194562,anaesthesia,0,0
194563,.,0,1
194564,CRP,1,1
194565,",",1,1
194566,IL-6,1,1
194567,",",1,1
194568,IL-8,1,1
194569,",",1,1
194570,HIF-1?,1,0
194571,(,1,1
194572,ELISA,1,1
194573,),1,1
194574,",",1,1
194575,CD11,1,0
194576,and,1,1
194577,CD18,1,0
194578,expression,1,1
194579,(,1,1
194580,flow,1,1
194581,cytometry,1,1
194582,),1,1
194583,",",1,1
194584,and,1,1
194585,haemoxygenase,1,1
194586,(,1,1
194587,HO-1,1,1
194588,),1,1
194589,promoter,1,1
194590,polymorphisms,1,1
194591,(,1,1
194592,PCR/electrophoresis,1,1
194593,),1,1
194594,were,0,0
194595,measured,0,0
194596,before,0,0
194597,anaesthetic,0,0
194598,induction,0,0
194599,",",0,0
194600,4,0,0
194601,hours,0,0
194602,post-CPB,0,0
194603,",",0,0
194604,and,0,0
194605,24,0,0
194606,hours,0,0
194607,later,0,0
194608,.,0,0
194609,There,0,0
194610,were,0,0
194611,no,0,0
194612,differences,0,0
194613,in,0,0
194614,the,0,0
194615,4,0,0
194616,hours,0,0
194617,changes,0,0
194618,in,1,0
194619,CRP,1,1
194620,",",1,1
194621,IL-6,1,1
194622,",",1,1
194623,IL-8,1,1
194624,or,1,1
194625,CD18,1,0
194626,between,0,0
194627,the,0,0
194628,two,0,0
194629,groups,0,0
194630,",",0,0
194631,but,0,0
194632,those,0,0
194633,in,0,0
194634,the,0,0
194635,propofol,0,0
194636,group,0,0
194637,had,0,0
194638,higher,1,1
194639,HIF-1?,1,0
194640,(,1,1
194641,P,0,0
194642,=,0,0
194643,0.016,0,0
194644,),0,0
194645,and,0,0
194646,lower,1,1
194647,CD11,1,1
194648,expression,1,1
194649,(,1,0
194650,P,0,0
194651,=,0,0
194652,0.026,0,0
194653,),0,0
194654,.,0,0
194655,After,0,0
194656,24,0,0
194657,hours,0,0
194658,",",0,0
194659,compared,0,0
194660,to,0,0
194661,the,0,0
194662,isoflurane,0,0
194663,group,0,0
194664,",",0,0
194665,the,0,0
194666,propofol,0,0
194667,group,0,0
194668,had,0,0
194669,significantly,0,0
194670,lower,0,0
194671,levels,0,1
194672,of,0,1
194673,CRP,1,1
194674,(,1,0
194675,P,0,0
194676,<,0,0
194677,0.001,1,0
194678,),1,0
194679,",",1,0
194680,IL-6,1,1
194681,(,1,1
194682,P,0,0
194683,<,0,0
194684,0.001,0,0
194685,),0,0
194686,and,1,0
194687,IL-8,1,1
194688,(,1,1
194689,P,0,0
194690,<,0,0
194691,0.001,0,0
194692,),0,0
194693,",",0,0
194694,with,0,0
194695,higher,0,0
194696,levels,1,1
194697,CD11,1,1
194698,(,1,0
194699,P,0,0
194700,=,0,0
194701,0.009,0,0
194702,),0,0
194703,and,1,0
194704,CD18,1,0
194705,(,1,1
194706,P,0,0
194707,=,0,0
194708,0.002,0,0
194709,),0,0
194710,expression,0,0
194711,.,0,0
194712,After,0,0
194713,24,0,0
194714,hours,0,0
194715,",",0,0
194716,patients,0,0
194717,on,0,0
194718,propofol,0,0
194719,had,0,0
194720,increased,1,0
194721,expression,1,1
194722,of,1,0
194723,shorter,1,1
194724,HO-1,1,1
194725,GT,1,1
194726,(,1,1
194727,n,1,0
194728,),1,1
194729,repeats,1,1
194730,than,1,0
194731,patients,0,0
194732,on,0,0
194733,isoflurane,0,0
194734,(,0,0
194735,P,0,0
194736,=,0,0
194737,0.001,0,0
194738,),0,0
194739,.,0,0
194740,Use,0,0
194741,of,0,1
194742,propofol,0,0
194743,in,0,0
194744,CPB,0,0
194745,is,0,0
194746,associated,0,0
194747,with,0,0
194748,a,0,0
194749,less,0,0
194750,adverse,0,1
194751,inflammatory,0,1
194752,profile,0,1
194753,than,0,0
194754,is,0,0
194755,isofluorane,0,0
194756,",",0,0
194757,and,0,0
194758,an,0,0
194759,increased,0,0
194760,up-regulation,0,1
194761,of,0,0
194762,HO-1,1,0
194763,.,1,0
194764,This,0,0
194765,supports,0,0
194766,the,0,0
194767,hypothesis,0,0
194768,that,0,0
194769,propofol,0,0
194770,has,0,0
194771,anti-inflammatory,0,0
194772,activity,0,1
194773,.,0,0
194774,Treatments,0,0
194775,of,0,0
194776,preterm,0,0
194777,premature,0,0
194778,rupture,0,0
194779,of,0,0
194780,the,0,0
194781,membranes,0,0
194782,:,0,0
194783,a,0,0
194784,meta-analysis,0,0
194785,.,0,0
194786,The,0,0
194787,objective,0,0
194788,of,0,0
194789,this,0,0
194790,overview,0,0
194791,was,0,0
194792,to,0,0
194793,critically,0,0
194794,evaluate,0,0
194795,published,0,0
194796,randomized,0,0
194797,controlled,0,0
194798,trials,0,0
194799,on,0,0
194800,treatments,0,0
194801,in,0,0
194802,preterm,0,0
194803,premature,0,0
194804,rupture,0,0
194805,of,0,0
194806,the,0,0
194807,membranes,0,0
194808,.,0,0
194809,The,0,0
194810,Oxford,0,0
194811,data,0,0
194812,base,0,0
194813,on,0,0
194814,perinatal,0,1
194815,trials,0,0
194816,",",0,1
194817,MEDLINE,0,1
194818,",",0,1
194819,Excerpta,0,0
194820,Medica,0,0
194821,",",0,1
194822,and,0,1
194823,Index,0,1
194824,Medicus,0,0
194825,were,0,0
194826,searched,0,0
194827,.,0,0
194828,Through,0,0
194829,primary,0,0
194830,and,0,1
194831,secondary,0,1
194832,review,0,0
194833,with,0,0
194834,preset,0,0
194835,inclusion,0,0
194836,criteria,0,0
194837,",",0,0
194838,two,0,0
194839,independent,0,0
194840,judges,0,0
194841,identified,0,0
194842,27,0,0
194843,randomized,0,0
194844,controlled,0,0
194845,trials,0,0
194846,",",0,0
194847,of,0,0
194848,which,0,0
194849,13,0,0
194850,met,0,0
194851,inclusion,0,0
194852,criteria,0,0
194853,.,0,0
194854,The,0,0
194855,quality,0,1
194856,of,0,0
194857,these,0,0
194858,randomized,0,0
194859,controlled,0,0
194860,trials,0,0
194861,was,0,0
194862,scored,0,0
194863,.,0,0
194864,Five,0,0
194865,randomized,0,0
194866,controlled,0,0
194867,trials,0,0
194868,regarding,0,0
194869,antenatal,0,0
194870,use,0,0
194871,of,0,0
194872,corticosteroids,0,0
194873,to,0,0
194874,prevent,0,0
194875,respiratory,1,1
194876,distress,1,1
194877,syndrome,1,0
194878,could,0,0
194879,be,0,0
194880,combined,0,0
194881,meta-analytically,0,0
194882,and,0,0
194883,showed,0,0
194884,a,0,0
194885,reduction,0,1
194886,in,0,0
194887,respiratory,1,1
194888,distress,1,1
194889,syndrome,1,0
194890,in,0,0
194891,the,0,0
194892,treatment,0,0
194893,group,0,0
194894,(,0,0
194895,p,0,0
194896,=,0,0
194897,0.001,0,0
194898,),0,0
194899,.,0,0
194900,However,0,0
194901,",",0,0
194902,no,0,0
194903,significant,0,0
194904,reduction,0,1
194905,in,0,0
194906,respiratory,1,1
194907,distress,1,1
194908,syndrome,1,1
194909,(,0,0
194910,p,0,0
194911,=,0,0
194912,0.286,0,0
194913,),0,0
194914,was,0,0
194915,found,0,0
194916,after,0,0
194917,one,0,0
194918,study,0,0
194919,",",0,0
194920,with,0,0
194921,the,0,0
194922,lowest,0,0
194923,quality,0,1
194924,score,0,1
194925,",",0,1
194926,was,0,0
194927,excluded,0,0
194928,.,0,0
194929,A,0,0
194930,significant,0,0
194931,increase,0,1
194932,in,0,0
194933,endometritis,1,1
194934,and,0,0
194935,a,0,0
194936,trend,0,0
194937,toward,0,0
194938,an,0,0
194939,increase,0,0
194940,in,0,0
194941,neonatal,1,1
194942,infections,1,1
194943,and,1,1
194944,cesarean,1,1
194945,section,1,1
194946,rates,1,1
194947,were,0,0
194948,noted,0,0
194949,with,0,0
194950,treatment,0,0
194951,.,0,1
194952,Tocolysis,0,0
194953,",",0,0
194954,prophylactic,0,0
194955,antibiotics,0,1
194956,",",0,1
194957,and,0,1
194958,other,0,1
194959,interventions,0,0
194960,studied,0,0
194961,were,0,0
194962,not,0,0
194963,found,0,0
194964,to,0,0
194965,be,0,0
194966,of,0,0
194967,proved,0,0
194968,benefit,0,0
194969,and,0,0
194970,therefore,0,0
194971,should,0,0
194972,not,0,0
194973,be,0,0
194974,used,0,0
194975,outside,0,0
194976,of,0,0
194977,a,0,0
194978,randomized,0,0
194979,controlled,0,0
194980,trial,0,0
194981,.,0,0
194982,Influence,1,1
194983,of,0,1
194984,ibopamine,0,0
194985,on,0,0
194986,heart,1,1
194987,rate,1,1
194988,and,1,1
194989,arrhythmic,1,1
194990,pattern,1,0
194991,in,0,0
194992,patients,0,0
194993,with,0,0
194994,congestive,0,1
194995,heart,0,1
194996,failure,0,0
194997,.,0,0
194998,A,0,0
194999,double-blind,0,0
195000,multicentre,0,0
195001,study,0,0
195002,.,0,0
195003,Ibopamine,0,0
195004,is,0,0
195005,a,0,0
195006,dopaminergic,0,0
195007,and,0,1
195008,adrenergic,0,1
195009,receptor,0,1
195010,agonist,0,0
195011,",",0,0
195012,which,0,0
195013,is,0,0
195014,active,0,0
195015,in,0,0
195016,the,0,0
195017,treatment,0,0
195018,of,0,0
195019,congestive,0,1
195020,heart,0,1
195021,failure,0,1
195022,.,0,0
195023,Since,0,0
195024,the,0,0
195025,long-term,0,0
195026,prognosis,0,1
195027,for,0,0
195028,patients,0,0
195029,with,0,0
195030,congestive,0,1
195031,heart,0,1
195032,failure,0,0
195033,remains,0,0
195034,very,0,0
195035,poor,0,0
195036,and,0,0
195037,the,0,0
195038,incidence,0,1
195039,of,0,0
195040,arrhythmic,0,1
195041,death,0,1
195042,is,0,0
195043,high,0,0
195044,",",0,0
195045,every,0,0
195046,new,0,0
195047,drug,0,0
195048,to,0,0
195049,be,0,0
195050,employed,0,0
195051,against,0,0
195052,this,0,0
195053,disease,0,0
195054,should,0,0
195055,be,0,0
195056,thoroughly,0,0
195057,tested,0,0
195058,in,0,0
195059,order,0,0
195060,to,0,0
195061,rule,0,0
195062,out,0,0
195063,any,0,0
195064,possible,0,0
195065,arrhythmogenic,1,0
195066,action,1,0
195067,.,1,0
195068,This,0,0
195069,multicentre,0,0
195070,study,0,0
195071,was,0,0
195072,designed,0,0
195073,to,0,0
195074,evaluate,0,0
195075,the,0,0
195076,effect,1,0
195077,of,0,1
195078,ibopamine,0,0
195079,versus,0,0
195080,placebo,0,0
195081,in,0,0
195082,double-blind,0,0
195083,conditions,0,0
195084,on,0,0
195085,heart,1,1
195086,rate,1,1
195087,",",1,1
195088,rhythm,1,1
195089,and,1,1
195090,electrical,1,1
195091,safety,1,1
195092,.,1,1
195093,Ibopamine,0,0
195094,was,0,0
195095,employed,0,0
195096,at,0,0
195097,a,0,0
195098,dose,0,0
195099,of,0,0
195100,100,0,0
195101,mg,0,0
195102,t.i.d,0,0
195103,.,0,0
195104,in,0,0
195105,97,0,0
195106,patients,0,0
195107,(,0,0
195108,aged,0,0
195109,31-83,0,0
195110,years,0,0
195111,),0,0
195112,belonging,0,0
195113,to,0,0
195114,NYHA,0,1
195115,class,0,0
195116,II,0,0
195117,and,0,1
195118,III,0,1
195119,with,0,0
195120,congestive,0,1
195121,heart,0,1
195122,failure,0,1
195123,of,0,1
195124,different,0,0
195125,aetiology,0,1
195126,",",0,1
195127,but,0,0
195128,without,0,0
195129,any,0,1
195130,complex,0,0
195131,ventricular,0,1
195132,arrhythmias,0,1
195133,in,0,0
195134,basal,0,1
195135,conditions,0,0
195136,(,0,0
195137,couplets,0,1
195138,with,0,0
195139,R'-R,0,0
195140,less,0,0
195141,than,0,0
195142,or,0,0
195143,equal,0,0
195144,to,0,0
195145,400,0,0
195146,msec,0,0
195147,",",0,0
195148,ventricular,0,1
195149,tachycardia,0,1
195150,",",0,1
195151,R,0,1
195152,on,0,0
195153,T,0,1
195154,phenomena,0,1
195155,),0,0
195156,.,0,0
195157,Using,0,0
195158,a,0,0
195159,random,0,0
195160,cross-over,0,0
195161,design,0,0
195162,the,0,0
195163,patients,0,0
195164,were,0,0
195165,submitted,0,0
195166,to,0,0
195167,48,0,0
195168,hr,0,0
195169,.,0,0
195170,Holter,1,0
195171,recordings,1,1
195172,in,0,0
195173,basal,0,1
195174,conditions,0,0
195175,and,0,0
195176,following,0,0
195177,7,0,0
195178,days,0,0
195179,of,0,0
195180,ibopamine,0,0
195181,and,0,1
195182,placebo,0,0
195183,treatment,0,0
195184,.,0,0
195185,No,0,0
195186,influence,0,0
195187,on,0,0
195188,heart,1,1
195189,rhythm,1,1
195190,was,0,0
195191,noted,0,0
195192,.,0,0
195193,No,0,0
195194,significant,0,0
195195,variations,0,0
195196,in,0,0
195197,maximum,1,1
195198,heart,1,1
195199,rate,1,1
195200,(,0,0
195201,ibopamine,0,0
195202,117.7,0,0
195203,+/-,0,0
195204,20.9,0,0
195205,;,0,0
195206,placebo,0,0
195207,118.1,0,0
195208,+/-,0,0
195209,20.7,0,0
195210,),0,0
195211,",",0,0
195212,medium,1,1
195213,heart,1,1
195214,rate,1,1
195215,(,0,0
195216,ibopamine,0,0
195217,71.8,0,0
195218,+/-,0,0
195219,10.2,0,0
195220,;,0,0
195221,placebo,0,0
195222,72.6,0,0
195223,+/-,0,0
195224,10.1,0,0
195225,),0,0
195226,or,0,0
195227,minimum,1,1
195228,heart,1,1
195229,rate,1,1
195230,(,0,0
195231,ibopamine,0,0
195232,55.3,0,0
195233,+/-,0,0
195234,11.7,0,0
195235,;,0,0
195236,placebo,0,0
195237,54.6,0,0
195238,+/-,0,0
195239,10.6,0,0
195240,),0,0
195241,were,0,0
195242,observed,0,0
195243,.,0,0
195244,The,0,0
195245,mean,0,1
195246,number/hr,0,1
195247,.,0,0
195248,of,0,0
195249,ectopic,1,1
195250,supraventricular,1,1
195251,beats,1,1
195252,was,0,0
195253,26.1,0,0
195254,+/-,0,0
195255,61.9,0,0
195256,after,0,0
195257,ibopamine,0,0
195258,and,0,0
195259,21.7,0,0
195260,+/-,0,0
195261,35.8,0,0
195262,after,0,0
195263,placebo,0,0
195264,(,0,0
195265,p,0,0
195266,=,0,0
195267,ns,0,0
195268,),0,0
195269,.,0,0
195270,The,0,0
195271,complexity,0,1
195272,of,0,0
195273,ectopic,1,1
195274,supraventricular,1,1
195275,beats,1,1
195276,did,0,0
195277,not,0,0
195278,change,0,0
195279,.,0,0
195280,The,0,0
195281,mean,0,1
195282,number/hr,0,1
195283,.,0,0
195284,of,0,0
195285,ectopic,1,1
195286,ventricular,1,1
195287,beats,1,1
195288,was,0,0
195289,31.1,0,0
195290,+/-,0,0
195291,52.5,0,0
195292,after,0,0
195293,ibopamine,0,0
195294,and,0,0
195295,30.4,0,0
195296,+/-,0,0
195297,57.8,0,0
195298,after,0,0
195299,placebo,0,0
195300,(,0,0
195301,p,0,0
195302,=,0,0
195303,ns,0,0
195304,),0,0
195305,.,0,0
195306,Neither,0,0
195307,the,0,0
195308,distribution,0,0
195309,of,0,0
195310,the,0,0
195311,patients,0,0
195312,among,0,0
195313,Lown,1,0
195314,classification,1,1
195315,nor,1,0
195316,the,1,0
195317,Final,1,1
195318,Score,1,0
195319,of,1,0
195320,the,1,0
195321,Italian,1,0
195322,Lown,1,0
195323,Classification,1,1
195324,(,0,0
195325,26.1,0,0
195326,+/-,0,0
195327,18.0,0,0
195328,and,0,0
195329,26.6,0,0
195330,+/-,0,0
195331,17.9,0,0
195332,in,0,0
195333,the,0,0
195334,1st,0,0
195335,and,0,0
195336,2nd,0,0
195337,day,0,0
195338,of,0,0
195339,monitoring,0,0
195340,after,0,0
195341,ibopamine,0,0
195342,and,0,0
195343,25.7,0,0
195344,+/-,0,0
195345,18.6,0,0
195346,and,0,0
195347,25.7,0,0
195348,+/-,0,0
195349,18.8,0,0
195350,after,0,0
195351,placebo,0,0
195352,;,0,0
195353,p,0,0
195354,=,0,0
195355,ns,0,0
195356,),0,0
195357,showed,0,0
195358,any,0,0
195359,difference,0,0
195360,between,0,0
195361,active,0,0
195362,treatment,0,0
195363,and,0,1
195364,placebo,0,0
195365,.,0,1
195366,Similar,0,0
195367,results,0,0
195368,were,0,0
195369,achieved,0,0
195370,when,0,0
195371,the,0,0
195372,patients,0,0
195373,were,0,0
195374,sub-divided,0,0
195375,into,0,0
195376,subgroups,0,0
195377,according,0,0
195378,to,0,0
195379,sequences,0,0
195380,of,0,1
195381,treatment,0,0
195382,(,0,0
195383,basal,0,1
195384,--,0,1
195385,--,0,0
195386,ibopamine,0,0
195387,--,0,0
195388,--,0,1
195389,placebo,0,0
195390,and,0,0
195391,basal,0,1
195392,--,0,1
195393,--,0,0
195394,placebo,0,0
195395,--,0,0
195396,--,0,1
195397,ibopamine,0,0
195398,),0,1
195399,",",0,0
195400,NYHA,0,1
195401,class,0,1
195402,II,0,0
195403,or,0,1
195404,III,0,1
195405,",",0,1
195406,aetiology,0,0
195407,of,0,1
195408,congestive,0,1
195409,heart,0,1
195410,failure,0,1
195411,(,0,1
195412,dilatative,0,1
195413,cardiomyopathy,0,1
195414,",",0,1
195415,ischemic,0,1
195416,cardiomyopathy,0,1
195417,and,0,1
195418,other,0,1
195419,aetiologies,0,0
195420,),0,0
195421,",",0,0
195422,associated,0,0
195423,treatment,0,0
195424,with,0,0
195425,digitalis,0,1
195426,or,0,1
195427,diuretics,0,0
195428,and,0,1
195429,the,0,0
195430,number,0,1
195431,and,0,1
195432,complexity,0,1
195433,of,0,1
195434,base,0,0
195435,ectopic,0,1
195436,ventricular,0,1
195437,beats,0,1
195438,.,0,0
195439,None,0,0
195440,of,0,0
195441,the,0,0
195442,patients,0,0
195443,experienced,0,0
195444,sustained,0,1
195445,ventricular,0,1
195446,tachycardia,0,1
195447,.,0,1
195448,(,0,0
195449,ABSTRACT,0,1
195450,TRUNCATED,0,0
195451,AT,0,0
195452,400,0,0
195453,WORDS,0,0
195454,),0,0
195455,West,0,1
195456,Midlands,0,0
195457,Oncology,0,1
195458,Association,0,0
195459,trials,0,0
195460,of,0,1
195461,adjuvant,0,0
195462,chemotherapy,0,0
195463,in,0,0
195464,operable,0,0
195465,breast,0,0
195466,cancer,0,0
195467,:,0,0
195468,results,0,0
195469,after,0,0
195470,a,0,0
195471,median,0,1
195472,follow-up,0,0
195473,of,0,0
195474,7,0,0
195475,years,0,0
195476,.,0,0
195477,I,0,0
195478,.,0,0
195479,Patients,0,0
195480,with,0,0
195481,involved,0,0
195482,axillary,0,1
195483,lymph,0,1
195484,nodes,0,0
195485,.,0,0
195486,The,0,0
195487,aim,0,0
195488,of,0,0
195489,this,0,0
195490,study,0,0
195491,was,0,0
195492,to,0,0
195493,test,0,0
195494,the,0,0
195495,effectiveness,0,0
195496,of,0,0
195497,a,0,0
195498,regimen,0,0
195499,of,0,0
195500,combination,0,0
195501,chemotherapy,0,0
195502,known,0,0
195503,to,0,0
195504,be,0,0
195505,active,0,0
195506,in,0,0
195507,advanced,0,0
195508,breast,0,0
195509,cancer,0,0
195510,when,0,0
195511,given,0,0
195512,as,0,0
195513,an,0,0
195514,adjuvant,0,0
195515,treatment,0,0
195516,after,0,0
195517,mastectomy,0,0
195518,.,0,0
195519,A,0,0
195520,total,0,0
195521,of,0,0
195522,569,0,0
195523,patients,0,0
195524,with,0,0
195525,cancer,0,0
195526,of,0,0
195527,the,0,0
195528,breast,0,0
195529,and,0,1
195530,involvement,0,1
195531,of,0,1
195532,axillary,0,1
195533,lymph,0,1
195534,nodes,0,1
195535,were,0,0
195536,randomised,0,0
195537,",",0,0
195538,after,0,0
195539,simple,0,0
195540,mastectomy,0,0
195541,with,0,0
195542,axillary,0,1
195543,sampling,0,0
195544,",",0,0
195545,to,0,0
195546,receive,0,0
195547,either,0,0
195548,no,0,0
195549,adjuvant,0,0
195550,treatment,0,0
195551,or,0,1
195552,intravenous,0,0
195553,adriamycin,0,0
195554,50,0,0
195555,mg,0,0
195556,",",0,0
195557,vincristine,0,0
195558,1,0,0
195559,mg,0,0
195560,",",0,0
195561,cyclophosphamide,0,0
195562,250,0,0
195563,mg,0,0
195564,",",0,0
195565,methotrexate,0,0
195566,150,0,0
195567,mg,0,0
195568,and,0,0
195569,fluorouracil,0,0
195570,250,0,0
195571,mg,0,0
195572,(,0,0
195573,AVCMF,0,0
195574,),0,0
195575,every,0,0
195576,21,0,0
195577,days,0,0
195578,for,0,0
195579,eight,0,0
195580,cycles,0,0
195581,.,0,0
195582,Randomisation,0,0
195583,was,0,0
195584,stratified,0,0
195585,according,0,0
195586,to,0,0
195587,menopausal,0,0
195588,status,0,1
195589,and,0,1
195590,tumour,0,1
195591,size,0,1
195592,.,0,1
195593,Treatment,0,0
195594,was,0,0
195595,started,0,0
195596,within,0,0
195597,14,0,0
195598,days,0,0
195599,of,0,0
195600,surgery,0,0
195601,in,0,0
195602,94,0,0
195603,%,0,0
195604,of,0,0
195605,patients,0,0
195606,.,0,0
195607,Eighty-eight,0,0
195608,per,0,0
195609,cent,0,0
195610,of,0,0
195611,patients,0,0
195612,received,0,0
195613,at,0,0
195614,least,0,0
195615,seven,0,0
195616,cycles,0,0
195617,of,0,0
195618,chemotherapy,0,0
195619,with,0,0
195620,no,0,0
195621,dose,0,0
195622,reduction,0,1
195623,.,0,0
195624,The,0,0
195625,median,1,1
195626,relapse-free,1,1
195627,survival,1,1
195628,was,0,0
195629,prolonged,0,0
195630,by,0,0
195631,14,0,0
195632,months,0,0
195633,in,0,0
195634,patients,0,0
195635,treated,0,0
195636,with,0,0
195637,AVCMF,0,0
195638,(,0,0
195639,chi2,0,0
195640,1,0,0
195641,=,0,0
195642,11.7,0,0
195643,;,0,0
195644,P,0,0
195645,=,0,0
195646,0.0006,0,0
195647,),0,0
195648,.,0,0
195649,In,0,0
195650,the,0,0
195651,premenopausal,0,0
195652,group,0,0
195653,this,0,0
195654,period,0,0
195655,was,0,0
195656,17,0,0
195657,months,0,0
195658,(,0,0
195659,chi2,0,0
195660,1,0,0
195661,=,0,0
195662,8.8,0,0
195663,;,0,0
195664,P,0,0
195665,=,0,0
195666,0.003,0,0
195667,),0,0
195668,compared,0,0
195669,with,0,0
195670,8,0,0
195671,months,0,0
195672,in,0,0
195673,the,0,0
195674,post-menopausal,0,0
195675,group,0,0
195676,(,0,0
195677,chi2,0,0
195678,1,0,0
195679,=,0,0
195680,3.3,0,0
195681,;,0,0
195682,P,0,0
195683,=,0,0
195684,0.07,0,0
195685,),0,0
195686,.,0,0
195687,Neither,0,0
195688,overall,1,1
195689,survival,1,1
195690,nor,1,0
195691,survival,1,1
195692,in,0,0
195693,these,0,0
195694,subgroups,0,0
195695,was,0,0
195696,significantly,0,0
195697,influenced,0,0
195698,by,0,0
195699,treatment,0,0
195700,.,0,0
195701,Dacarbazine,0,0
195702,versus,0,0
195703,dacarbazine-vindesine,0,0
195704,in,0,0
195705,disseminated,0,0
195706,malignant,0,0
195707,melanoma,0,0
195708,:,0,0
195709,a,0,0
195710,randomized,0,0
195711,phase,0,0
195712,II,0,0
195713,study,0,0
195714,.,0,0
195715,In,0,0
195716,a,0,0
195717,phase,0,0
195718,II,0,0
195719,study,0,0
195720,119,0,0
195721,patients,0,0
195722,with,0,0
195723,disseminated,0,0
195724,malignant,0,1
195725,melanoma,0,0
195726,were,0,0
195727,randomized,0,0
195728,to,0,0
195729,receive,0,0
195730,treatment,0,0
195731,with,0,0
195732,dacarbazine,0,0
195733,alone,0,0
195734,or,0,1
195735,in,0,0
195736,combination,0,0
195737,with,0,0
195738,vindesine,0,0
195739,.,0,0
195740,The,0,0
195741,study,0,0
195742,was,0,0
195743,designed,0,0
195744,to,0,0
195745,reveal,0,0
195746,an,0,0
195747,additive,0,0
195748,response,0,1
195749,rate,0,1
195750,when,0,0
195751,the,0,0
195752,drugs,0,0
195753,were,0,0
195754,combined,0,0
195755,.,0,0
195756,Dacarbazine,0,0
195757,was,0,0
195758,given,0,0
195759,i.v,0,0
195760,.,0,0
195761,at,0,0
195762,250,0,0
195763,mg,0,0
195764,m-2,0,0
195765,per,0,0
195766,day,0,0
195767,X,0,1
195768,V,0,0
195769,every,0,0
195770,4,0,0
195771,weeks,0,0
195772,.,0,0
195773,In,0,0
195774,the,0,0
195775,combination,0,0
195776,regimen,0,0
195777,vindesine,0,0
195778,given,0,0
195779,at,0,0
195780,3,0,0
195781,mg,0,0
195782,m-2,0,0
195783,per,0,0
195784,week,0,0
195785,was,0,0
195786,included,0,0
195787,.,0,0
195788,One,0,0
195789,hundred,0,0
195790,and,0,0
195791,ten,0,0
195792,patients,0,0
195793,were,0,0
195794,available,0,0
195795,for,0,0
195796,evaluation,0,0
195797,of,0,0
195798,response,0,1
195799,.,0,0
195800,With,0,0
195801,dacarbazine,0,0
195802,4/51,0,0
195803,patients,0,0
195804,obtained,0,0
195805,a,0,0
195806,complete,1,1
195807,remission,1,1
195808,(,0,0
195809,8,0,0
195810,%,0,0
195811,),0,0
195812,and,0,0
195813,5/51,0,0
195814,patients,0,0
195815,a,0,0
195816,partial,1,1
195817,remission,1,1
195818,(,0,0
195819,10,0,0
195820,%,0,0
195821,),0,0
195822,.,0,0
195823,Overall,1,1
195824,response,1,1
195825,rate,1,1
195826,was,0,0
195827,18,0,0
195828,%,0,0
195829,.,0,0
195830,With,0,0
195831,dacarbazine-vindesine,0,0
195832,8/59,0,0
195833,patients,0,0
195834,obtained,0,0
195835,a,0,0
195836,complete,1,1
195837,remission,1,1
195838,(,0,0
195839,13,0,0
195840,%,0,0
195841,),0,0
195842,and,0,0
195843,7/59,0,0
195844,patients,0,0
195845,a,0,0
195846,partial,1,1
195847,remission,1,1
195848,(,0,0
195849,12,0,0
195850,%,0,0
195851,),0,0
195852,.,0,0
195853,Overall,1,1
195854,response,1,1
195855,rate,1,1
195856,was,0,0
195857,25,0,0
195858,%,0,0
195859,.,0,0
195860,The,0,0
195861,difference,0,0
195862,in,0,0
195863,response,1,1
195864,rates,1,1
195865,observed,0,0
195866,between,0,0
195867,the,0,0
195868,treatment,0,0
195869,arms,0,0
195870,is,0,0
195871,not,0,0
195872,statistically,0,0
195873,significant,0,0
195874,.,0,0
195875,Median,0,1
195876,response,0,1
195877,duration,0,1
195878,was,0,0
195879,123,0,0
195880,days,0,0
195881,for,0,0
195882,dacarbazine,0,0
195883,patients,0,0
195884,and,0,0
195885,171,0,0
195886,days,0,0
195887,for,0,0
195888,patients,0,0
195889,receiving,0,0
195890,dacarbazine-vindesine,0,0
195891,(,0,0
195892,difference,0,0
195893,not,0,0
195894,statistically,0,0
195895,significant,0,0
195896,),0,0
195897,.,0,0
195898,Low,0,0
195899,power,0,1
195900,laser,0,0
195901,therapy,0,0
195902,of,0,1
195903,shoulder,0,0
195904,tendonitis,0,0
195905,.,0,0
195906,30,0,0
195907,patients,0,0
195908,with,0,0
195909,supraspinatus,0,0
195910,or,0,1
195911,bicipital,0,1
195912,tendonitis,0,1
195913,were,0,0
195914,randomly,0,0
195915,allocated,0,0
195916,to,0,0
195917,active,0,0
195918,infrared,0,0
195919,laser,0,0
195920,therapy,0,0
195921,at,0,0
195922,904,0,0
195923,nm,0,0
195924,three,0,0
195925,times,0,0
195926,weekly,0,0
195927,for,0,0
195928,2,0,0
195929,weeks,0,0
195930,",",0,0
195931,dummy,0,0
195932,laser,0,0
195933,or,0,1
195934,drug,0,1
195935,treatment,0,0
195936,for,0,0
195937,2,0,0
195938,weeks,0,0
195939,.,0,0
195940,Objectively,0,1
195941,maximum,0,1
195942,active,0,0
195943,extension,0,1
195944,",",0,1
195945,flexion,0,1
195946,and,0,1
195947,abduction,0,1
195948,of,0,0
195949,the,0,0
195950,shoulder,0,1
195951,",",0,1
195952,and,0,0
195953,subjectively,0,1
195954,pain,0,1
195955,stiffness,0,1
195956,movement,0,1
195957,and,0,1
195958,function,0,1
195959,were,0,0
195960,measured,0,0
195961,at,0,0
195962,0,0,0
195963,and,0,0
195964,2,0,0
195965,weeks,0,0
195966,.,0,0
195967,Significant,1,1
195968,improvement,1,1
195969,of,1,1
195970,active,1,0
195971,over,1,0
195972,dummy,1,0
195973,laser,1,0
195974,was,1,0
195975,noted,1,0
195976,for,0,0
195977,all,0,0
195978,seven,0,0
195979,assessments,0,0
195980,.,0,0
195981,Active,1,1
195982,laser,1,0
195983,therapy,1,0
195984,produced,1,0
195985,significant,1,0
195986,improvement,1,1
195987,over,1,0
195988,drug,1,0
195989,therapy,1,0
195990,for,1,0
195991,all,1,0
195992,three,1,0
195993,objective,1,0
195994,measures,1,0
195995,and,1,1
195996,pain,1,1
195997,.,1,1
195998,Naproxen,1,0
195999,sodium,1,0
196000,significantly,1,0
196001,improved,1,0
196002,only,1,0
196003,movement,1,1
196004,and,1,1
196005,function,1,1
196006,compared,1,0
196007,to,1,0
196008,dummy,1,0
196009,laser,1,0
196010,.,1,0
196011,These,0,0
196012,results,1,0
196013,demonstrate,1,0
196014,the,1,0
196015,effectiveness,1,1
196016,of,1,1
196017,laser,1,0
196018,therapy,1,0
196019,in,1,0
196020,tendonitis,1,0
196021,of,1,0
196022,the,1,0
196023,shoulder,1,0
196024,.,1,0
196025,Methods,0,0
196026,for,0,0
196027,assessing,0,0
196028,treatment,1,0
196029,efficacy,1,1
196030,in,0,0
196031,trials,0,0
196032,for,0,0
196033,adjuvant,0,0
196034,therapy,0,0
196035,for,0,0
196036,breast,0,0
196037,cancer,0,0
196038,.,0,0
196039,[,0,0
196040,Diabetic,0,1
196041,constipation,0,1
196042,treated,0,0
196043,with,0,0
196044,acupoint,0,0
196045,embedding,0,0
196046,therapy,0,0
196047,and,0,0
196048,forlax,0,0
196049,:,0,0
196050,a,0,0
196051,randomized,0,0
196052,controlled,0,0
196053,trial,0,0
196054,],0,0
196055,.,0,0
196056,OBJECTIVE,0,0
196057,To,0,0
196058,compare,0,0
196059,the,0,0
196060,difference,0,0
196061,among,0,0
196062,the,0,0
196063,combined,0,0
196064,method,0,0
196065,of,0,1
196066,oral,0,0
196067,administration,0,0
196068,of,0,1
196069,forlaxand,0,0
196070,acupoint,0,0
196071,embedding,0,0
196072,therapy,0,0
196073,",",0,0
196074,the,0,0
196075,simple,0,0
196076,acupoint,0,0
196077,embedding,0,0
196078,therapy,0,0
196079,and,0,0
196080,the,0,0
196081,simple,0,0
196082,oral,0,0
196083,administration,0,0
196084,of,0,1
196085,for-lax,0,1
196086,in,0,0
196087,the,0,0
196088,clinical,0,0
196089,efficacy,0,1
196090,on,0,0
196091,diabetic,0,0
196092,constipation,0,1
196093,.,0,0
196094,METHODS,0,0
196095,One,0,0
196096,hundred,0,0
196097,and,0,0
196098,fifty,0,0
196099,patients,0,0
196100,were,0,0
196101,randomized,0,0
196102,intoa,0,0
196103,comprehensive,0,0
196104,group,0,0
196105,",",0,0
196106,an,0,0
196107,acupoint,0,0
196108,embedding,0,0
196109,group,0,0
196110,and,0,0
196111,a,0,0
196112,forlax,0,0
196113,group,0,0
196114,",",0,0
196115,50,0,0
196116,cases,0,0
196117,in,0,0
196118,each,0,0
196119,one,0,0
196120,.,0,0
196121,In,0,0
196122,the,0,0
196123,acupointembedding,0,0
196124,group,0,0
196125,",",0,0
196126,the,0,0
196127,embedding,0,0
196128,therapy,0,0
196129,was,0,0
196130,applied,0,0
196131,to,0,0
196132,bilateral,0,0
196133,Tianshu,0,0
196134,(,0,0
196135,ST,0,0
196136,25,0,0
196137,),0,0
196138,",",0,0
196139,Daheng,0,1
196140,(,0,0
196141,SP,0,0
196142,15,0,0
196143,),0,0
196144,",",0,0
196145,Shangjuxu,0,0
196146,(,0,0
196147,ST,0,0
196148,37,0,0
196149,),0,0
196150,and,0,0
196151,Dachangshu,0,0
196152,(,0,0
196153,BL,0,0
196154,25,0,0
196155,),0,0
196156,",",0,0
196157,once,0,0
196158,a,0,0
196159,week,0,0
196160,.,0,0
196161,In,0,0
196162,the,0,0
196163,forlax,0,0
196164,group,0,0
196165,",",0,1
196166,forlax,0,0
196167,(,0,1
196168,polyethylene,0,1
196169,glycol,0,0
196170,),0,1
196171,was,0,0
196172,prescribedfor,0,0
196173,oral,0,0
196174,administration,0,0
196175,",",0,0
196176,once,0,0
196177,a,0,0
196178,day,0,0
196179,",",0,0
196180,10,0,0
196181,g,0,0
196182,each,0,0
196183,time,0,1
196184,.,0,0
196185,In,0,0
196186,the,0,0
196187,comprehensive,0,0
196188,group,0,0
196189,",",0,0
196190,the,0,0
196191,acupoint,0,0
196192,embedding,0,0
196193,therapyand,0,0
196194,forlax,0,0
196195,were,0,0
196196,combined,0,0
196197,and,0,0
196198,the,0,0
196199,methods,0,0
196200,were,0,0
196201,the,0,0
196202,same,0,0
196203,as,0,0
196204,the,0,0
196205,first,0,0
196206,two,0,0
196207,groups,0,0
196208,.,0,0
196209,The,0,0
196210,treatment,0,0
196211,for,0,0
196212,4,0,0
196213,weeks,0,0
196214,wasas,0,0
196215,one,0,0
196216,session,0,0
196217,",",0,0
196218,and,0,0
196219,2,0,0
196220,sessions,0,0
196221,were,0,0
196222,required,0,0
196223,in,0,0
196224,the,0,0
196225,three,0,0
196226,groups,0,0
196227,.,0,0
196228,Separately,0,0
196229,",",0,0
196230,in,0,0
196231,4,0,0
196232,weeks,0,0
196233,",",0,0
196234,8,0,0
196235,weeks,0,0
196236,of,0,0
196237,treatment,0,0
196238,and2,0,0
196239,months,0,0
196240,after,0,0
196241,treatment,0,0
196242,",",0,0
196243,the,0,0
196244,constipation,0,1
196245,symptom,0,1
196246,scores,0,1
196247,were,0,0
196248,compared,0,0
196249,among,0,0
196250,the,0,0
196251,three,0,0
196252,groups,0,0
196253,.,0,0
196254,At,0,0
196255,the,0,0
196256,end,0,0
196257,of2,0,0
196258,sessions,0,0
196259,of,0,1
196260,treatment,0,0
196261,",",0,0
196262,the,0,0
196263,clinical,1,1
196264,efficacy,1,1
196265,and,1,1
196266,adverse,1,1
196267,reactions,1,1
196268,were,0,0
196269,compared,0,0
196270,among,0,0
196271,the,0,0
196272,three,0,0
196273,groups,0,0
196274,.,0,0
196275,In2,0,0
196276,months,0,0
196277,after,0,0
196278,treatment,0,0
196279,",",0,0
196280,the,0,0
196281,recurrence,0,1
196282,rate,0,1
196283,was,0,0
196284,compared,0,0
196285,among,0,0
196286,the,0,0
196287,three,0,0
196288,groups,0,0
196289,.,0,0
196290,RESULTS,0,0
196291,The,0,0
196292,total,1,1
196293,effectiverate,1,0
196294,was,0,0
196295,98,0,0
196296,.,0,0
196297,0,0,0
196298,%,0,0
196299,(,0,0
196300,49/50,0,0
196301,),0,0
196302,in,0,0
196303,the,0,0
196304,comprehensive,0,0
196305,group,0,0
196306,",",0,0
196307,better,0,0
196308,than,0,0
196309,86,0,0
196310,.,0,0
196311,0,0,0
196312,%,0,0
196313,(,0,0
196314,43/50,0,0
196315,),0,0
196316,in,0,0
196317,the,0,0
196318,acupoint,0,0
196319,embeddinggroup,0,0
196320,and,0,0
196321,78,0,0
196322,.,0,0
196323,0,0,0
196324,%,0,0
196325,(,0,0
196326,11/50,0,0
196327,),0,0
196328,in,0,0
196329,the,0,0
196330,forlax,0,0
196331,group,0,0
196332,(,0,0
196333,both,0,0
196334,P,0,0
196335,<,0,0
196336,0,0,0
196337,.,0,0
196338,01,0,0
196339,),0,0
196340,.,0,0
196341,In,0,0
196342,the,0,0
196343,4,0,0
196344,weeks,0,0
196345,and,0,0
196346,8,0,0
196347,weeks,0,0
196348,of,0,0
196349,treatment,0,0
196350,",",0,0
196351,the,0,0
196352,con-stipation,1,1
196353,symptom,1,1
196354,scores,1,1
196355,were,0,0
196356,reduced,0,0
196357,significantly,0,0
196358,as,0,0
196359,compared,0,0
196360,with,0,0
196361,those,0,0
196362,before,0,0
196363,treatment,0,0
196364,in,0,0
196365,the,0,0
196366,three,0,0
196367,groups,0,0
196368,(,0,0
196369,all,0,0
196370,P,0,0
196371,<,0,0
196372,0,0,0
196373,.,0,0
196374,05,0,0
196375,),0,0
196376,.,0,0
196377,The,0,0
196378,results,0,0
196379,in,0,0
196380,the,0,0
196381,comprehensive,0,0
196382,group,0,0
196383,were,0,0
196384,lower,0,0
196385,than,0,0
196386,those,0,0
196387,in,0,0
196388,the,0,0
196389,other,0,0
196390,two,0,0
196391,groups,0,0
196392,(,0,0
196393,all,0,0
196394,P,0,0
196395,<,0,0
196396,0,0,0
196397,.,0,0
196398,05,0,0
196399,),0,0
196400,.,0,0
196401,In,0,0
196402,the,0,0
196403,4,0,0
196404,weeks,0,0
196405,of,0,0
196406,treatment,0,0
196407,",",0,0
196408,the,0,0
196409,scores,0,1
196410,were,0,0
196411,not,0,0
196412,different,0,0
196413,significantly,0,0
196414,between,0,0
196415,the,0,0
196416,acupoint,0,0
196417,embedding,0,0
196418,group,0,0
196419,and,0,0
196420,the,0,0
196421,forlax,0,0
196422,group,0,0
196423,(,0,1
196424,P,0,0
196425,>,0,0
196426,0.05,0,0
196427,),0,0
196428,.,0,0
196429,In,0,0
196430,8,0,0
196431,weeks,0,0
196432,of,0,0
196433,treatment,0,0
196434,and,0,0
196435,2,0,0
196436,months,0,0
196437,after,0,0
196438,treatment,0,0
196439,",",0,0
196440,the,0,0
196441,scores,0,1
196442,in,0,0
196443,the,0,0
196444,acupoint,0,0
196445,embedding,0,0
196446,group,0,0
196447,were,0,0
196448,better,0,0
196449,tan,0,0
196450,those,0,0
196451,in,0,0
196452,the,0,0
196453,forlax,0,0
196454,group,0,0
196455,(,0,0
196456,all,0,0
196457,p,0,0
196458,<,0,0
196459,0.05,0,0
196460,),0,0
196461,.,0,0
196462,There,0,0
196463,were,0,0
196464,2,0,0
196465,cases,0,0
196466,of,0,0
196467,drug,0,0
196468,adverse,0,1
196469,reaction,0,1
196470,in,0,0
196471,the,0,0
196472,comprehensive,0,0
196473,group,0,0
196474,",",0,0
196475,6,0,0
196476,cases,0,0
196477,in,0,0
196478,the,0,0
196479,forlax,0,0
196480,group,0,0
196481,and,0,0
196482,0,0,0
196483,case,0,0
196484,in,0,0
196485,the,0,0
196486,acupoint,0,0
196487,embedding,0,0
196488,group,0,0
196489,.,0,0
196490,The,0,0
196491,recurrence,1,1
196492,rate,1,1
196493,was,0,0
196494,8.1,0,0
196495,%,0,0
196496,(,0,0
196497,4/49,0,0
196498,),0,0
196499,in,0,0
196500,the,0,0
196501,comprehensive,0,0
196502,group,0,0
196503,",",0,0
196504,lower,0,0
196505,than,0,0
196506,32.6,0,0
196507,%,0,0
196508,(,0,0
196509,14/43,0,0
196510,),0,0
196511,in,0,0
196512,the,0,0
196513,acupoint,0,0
196514,embedding,0,0
196515,group,0,0
196516,and,0,0
196517,59.0,0,0
196518,%,0,0
196519,(,0,0
196520,23/39,0,0
196521,),0,0
196522,in,0,0
196523,the,0,0
196524,forlax,0,0
196525,group,0,0
196526,(,0,0
196527,both,0,0
196528,P,0,0
196529,<,0,0
196530,0.01,0,0
196531,),0,0
196532,.,0,0
196533,CONCLUSION,0,0
196534,the,0,0
196535,combined,0,0
196536,therapy,0,0
196537,of,0,1
196538,acupoint,0,0
196539,embedding,0,0
196540,and,0,0
196541,forlax,0,0
196542,achieves,0,0
196543,the,0,0
196544,better,0,0
196545,clinical,0,1
196546,efficacy,0,1
196547,on,0,0
196548,diabetic,0,0
196549,constipation,0,1
196550,and,0,1
196551,constipation,1,1
196552,symptom,1,1
196553,scores,1,1
196554,as,0,0
196555,compared,0,0
196556,with,0,0
196557,the,0,0
196558,simple,0,0
196559,acupoint,0,0
196560,embedding,0,0
196561,therapy,0,0
196562,and,0,0
196563,the,0,0
196564,oral,0,0
196565,administration,0,0
196566,of,0,0
196567,forlax,0,0
196568,the,0,0
196569,short-term,0,0
196570,efficacy,0,1
196571,of,0,0
196572,the,0,0
196573,simple,0,0
196574,acupoint,0,0
196575,embedding,0,0
196576,therapy,0,0
196577,is,0,0
196578,not,0,0
196579,different,0,0
196580,significantly,0,0
196581,from,0,0
196582,the,0,0
196583,simple,0,0
196584,forlax,0,0
196585,medication,0,1
196586,",",0,0
196587,but,0,0
196588,the,0,0
196589,long-term,0,1
196590,efficacy,0,1
196591,and,0,0
196592,safety,0,1
196593,are,0,0
196594,better,0,0
196595,than,0,0
196596,those,0,0
196597,of,0,0
196598,simple,0,0
196599,forlax,0,0
196600,medicaiton,0,0
196601,.,0,0
196602,Strategies,0,0
196603,for,0,0
196604,dietary,0,0
196605,and,0,1
196606,anti-smoking,0,0
196607,advice,0,0
196608,.,0,0
196609,Practical,0,0
196610,experiences,0,1
196611,from,0,0
196612,the,0,0
196613,Oslo,0,0
196614,Study,0,0
196615,.,0,0
196616,One,0,0
196617,of,0,0
196618,the,0,0
196619,2,0,0
196620,controlled,0,0
196621,preventive,0,0
196622,trials,0,0
196623,within,0,0
196624,the,0,0
196625,Oslo,0,0
196626,Study,0,0
196627,was,0,0
196628,a,0,0
196629,non-drug,0,0
196630,trial,0,0
196631,on,0,0
196632,the,0,0
196633,effect,1,0
196634,of,1,1
196635,diet,1,0
196636,and,1,1
196637,smoking,1,1
196638,intervention,1,0
196639,on,0,0
196640,coronary,0,1
196641,heart,0,1
196642,disease,0,1
196643,in,0,0
196644,1232,0,0
196645,middleaged,0,0
196646,",",0,0
196647,normotensive,0,0
196648,",",0,1
196649,healthy,0,0
196650,men,0,0
196651,.,0,0
196652,All,0,0
196653,had,0,0
196654,elevated,0,1
196655,serum,0,1
196656,cholesterol,0,1
196657,and,0,0
196658,4,0,0
196659,out,0,0
196660,of,0,0
196661,5,0,0
196662,smoked,0,0
196663,every,0,0
196664,day,0,0
196665,.,0,0
196666,The,0,0
196667,participants,0,0
196668,in,0,0
196669,the,0,0
196670,intervention,0,0
196671,group,0,0
196672,met,0,0
196673,every,0,0
196674,6,0,0
196675,months,0,0
196676,during,0,0
196677,the,0,0
196678,5-year,0,0
196679,study,0,0
196680,for,0,0
196681,clinical,0,1
196682,examination,0,0
196683,and,0,1
196684,for,0,0
196685,dietary,1,1
196686,and,1,1
196687,smoking,1,1
196688,counselling,1,0
196689,.,1,0
196690,The,0,0
196691,effect,1,0
196692,on,1,0
196693,serum,1,1
196694,cholesterol,1,1
196695,was,0,0
196696,a,0,0
196697,13,0,0
196698,%,0,0
196699,lowering,0,0
196700,(,0,0
196701,i.e,0,0
196702,.,0,0
196703,10,0,0
196704,%,0,0
196705,net,0,0
196706,reduction,0,1
196707,compared,0,0
196708,with,0,0
196709,control,0,0
196710,group,0,0
196711,),0,1
196712,",",0,1
196713,and,0,0
196714,about,0,0
196715,a,0,0
196716,50,0,0
196717,%,0,0
196718,reduction,0,1
196719,in,0,0
196720,cigarette,1,0
196721,consumption,1,1
196722,.,1,0
196723,The,0,0
196724,effect,1,0
196725,on,1,0
196726,coronary,1,1
196727,heart,1,1
196728,disease,1,1
196729,(,1,1
196730,fatal,1,1
196731,and,1,1
196732,non-fatal,1,1
196733,myocardial,1,1
196734,infarction,1,1
196735,or,1,1
196736,sudden,1,1
196737,death,1,1
196738,),1,0
196739,was,0,0
196740,a,0,0
196741,47,0,0
196742,%,0,0
196743,lowering,0,0
196744,of,0,0
196745,the,0,0
196746,5-year,0,0
196747,incidence,0,1
196748,in,0,0
196749,the,0,0
196750,intervention,0,0
196751,group,0,0
196752,compared,0,0
196753,with,0,0
196754,the,0,0
196755,control,0,0
196756,group,0,0
196757,(,0,1
196758,p,0,0
196759,=,0,0
196760,0.02,0,0
196761,",",0,0
196762,2-sided,0,0
196763,),0,0
196764,.,0,0
196765,The,0,0
196766,main,0,0
196767,intervention,0,0
196768,strategies,0,0
196769,were,0,0
196770,:,0,0
196771,information,0,0
196772,about,0,0
196773,the,0,0
196774,risk,0,1
196775,factor,0,1
196776,concept,0,0
196777,to,0,0
196778,participant,0,0
196779,and,0,1
196780,spouse,0,1
196781,(,0,0
196782,in,0,0
196783,groups,0,0
196784,),0,0
196785,individual,0,0
196786,diet,0,0
196787,and,0,1
196788,anti-smoking,0,1
196789,counselling,0,0
196790,after,0,0
196791,finishing,0,0
196792,an,0,0
196793,extensive,0,0
196794,clinical,0,0
196795,and,0,1
196796,electrocardiographic,0,1
196797,examination,0,1
196798,",",0,0
196799,including,0,0
196800,exercise-ECG,0,0
196801,basis,0,0
196802,and,0,1
196803,background,0,0
196804,for,0,0
196805,the,0,0
196806,counselling,0,0
196807,strategy,0,0
196808,:,0,0
196809,the,0,0
196810,total,0,1
196811,situation,0,0
196812,of,0,0
196813,the,0,0
196814,participant,0,0
196815,.,0,0
196816,Some,0,0
196817,of,0,0
196818,the,0,0
196819,most,0,0
196820,important,0,0
196821,items,0,1
196822,:,0,0
196823,personality,0,1
196824,",",0,1
196825,motivation,0,1
196826,",",0,1
196827,diet,0,0
196828,history,0,1
196829,",",0,1
196830,bodyweight,0,1
196831,",",0,1
196832,blood,0,1
196833,lipids,0,1
196834,and,0,1
196835,blood,0,1
196836,sugar,0,1
196837,anti-smoking,0,1
196838,advice,0,0
196839,given,0,0
196840,individually,0,0
196841,to,0,0
196842,all,0,0
196843,smokers,0,0
196844,in,0,0
196845,the,0,0
196846,intervention,0,0
196847,group,0,0
196848,advice,0,0
196849,that,0,0
196850,smoking,0,1
196851,cessation,0,0
196852,was,0,0
196853,expected,0,0
196854,to,0,0
196855,be,0,0
196856,of,0,0
196857,special,0,0
196858,importance,0,0
196859,for,0,0
196860,those,0,0
196861,with,0,0
196862,elevated,0,1
196863,blood,0,1
196864,lipids,0,1
196865,.,0,0
196866,Comparison,0,0
196867,of,0,0
196868,the,0,0
196869,efficacy,1,1
196870,and,1,1
196871,safety,1,1
196872,of,0,1
196873,esmolol,0,0
196874,",",0,0
196875,a,0,0
196876,short-acting,0,0
196877,beta,0,1
196878,blocker,0,0
196879,",",0,1
196880,with,0,0
196881,placebo,0,0
196882,in,0,0
196883,the,0,0
196884,treatment,0,0
196885,of,0,0
196886,supraventricular,0,0
196887,tachyarrhythmias,0,1
196888,.,0,0
196889,The,0,0
196890,Esmolol,0,0
196891,vs,0,0
196892,Placebo,0,0
196893,Multicenter,0,0
196894,Study,0,0
196895,Group,0,0
196896,.,0,0
196897,The,0,0
196898,efficacy,1,1
196899,and,1,1
196900,safety,1,1
196901,of,0,1
196902,esmolol,0,0
196903,",",0,0
196904,a,0,0
196905,short-acting,0,0
196906,intravenous,0,0
196907,beta-adrenergic-blocking,0,1
196908,agent,0,0
196909,",",0,1
196910,and,0,1
196911,placebo,0,0
196912,were,0,0
196913,compared,0,0
196914,in,0,0
196915,patients,0,0
196916,with,0,0
196917,supraventricular,0,1
196918,tachyarrhythmias,0,1
196919,(,0,1
196920,heart,0,1
196921,rate,0,1
196922,greater,0,0
196923,than,0,0
196924,120,0,0
196925,bpm,0,0
196926,),0,0
196927,in,0,0
196928,a,0,0
196929,multicenter,0,0
196930,",",0,1
196931,double-blind,0,0
196932,",",0,1
196933,partial-crossover,0,0
196934,study,0,0
196935,.,0,0
196936,Seventy-one,0,0
196937,patients,0,0
196938,were,0,0
196939,randomized,0,0
196940,to,0,0
196941,receive,0,0
196942,either,0,0
196943,esmolol,0,0
196944,(,0,0
196945,n,0,0
196946,=,0,0
196947,36,0,0
196948,),0,0
196949,or,0,0
196950,placebo,0,0
196951,(,0,1
196952,n,0,0
196953,=,0,0
196954,35,0,0
196955,),0,0
196956,as,0,0
196957,initial,0,0
196958,treatment,0,0
196959,.,0,0
196960,Therapeutic,0,0
196961,failures,0,1
196962,were,0,0
196963,crossed,0,0
196964,over,0,0
196965,to,0,0
196966,the,0,0
196967,other,0,0
196968,study,0,0
196969,medication,0,1
196970,.,0,1
196971,Therapeutic,1,0
196972,response,1,1
196973,was,0,0
196974,defined,0,1
196975,as,0,0
196976,greater,0,0
196977,than,0,0
196978,or,0,0
196979,equal,0,0
196980,to,0,0
196981,20,0,0
196982,%,0,0
196983,reduction,0,1
196984,in,0,0
196985,heart,1,1
196986,rate,1,1
196987,",",1,1
196988,heart,1,1
196989,rate,1,1
196990,less,1,0
196991,than,1,0
196992,100,1,0
196993,bpm,1,0
196994,",",1,0
196995,or,1,1
196996,conversion,1,1
196997,to,1,0
196998,normal,1,0
196999,sinus,1,0
197000,rhythm,1,1
197001,.,1,0
197002,The,1,0
197003,therapeutic,1,0
197004,response,1,1
197005,to,0,0
197006,esmolol,0,0
197007,during,0,0
197008,the,0,0
197009,initial,0,0
197010,treatment,0,0
197011,period,0,0
197012,(,0,0
197013,72,0,0
197014,%,0,0
197015,),0,0
197016,was,0,0
197017,similar,0,0
197018,to,0,0
197019,that,0,0
197020,obtained,0,0
197021,when,0,0
197022,esmolol,0,0
197023,was,0,0
197024,given,0,0
197025,as,0,0
197026,a,0,0
197027,second,0,0
197028,agent,0,0
197029,.,0,0
197030,The,0,0
197031,average,0,1
197032,esmolol,0,0
197033,dosage,0,0
197034,producing,0,0
197035,a,0,0
197036,therapeutic,0,0
197037,response,0,1
197038,was,0,0
197039,97.5,0,0
197040,micrograms/kg/min,0,0
197041,.,0,0
197042,Four,0,1
197043,patients,0,0
197044,(,0,0
197045,6,0,0
197046,%,0,0
197047,),0,0
197048,converted,0,0
197049,to,0,0
197050,normal,1,0
197051,sinus,1,0
197052,rhythm,1,1
197053,during,0,0
197054,esmolol,0,0
197055,infusion,0,0
197056,.,0,0
197057,In,0,0
197058,the,0,0
197059,majority,0,0
197060,of,0,1
197061,patients,0,0
197062,(,0,0
197063,80,0,0
197064,%,0,0
197065,),0,0
197066,",",0,0
197067,therapeutic,1,1
197068,response,1,1
197069,was,0,0
197070,lost,0,0
197071,within,0,0
197072,30,0,0
197073,minutes,0,0
197074,following,0,0
197075,discontinuation,0,0
197076,of,0,1
197077,esmolol,0,0
197078,infusion,0,0
197079,",",0,0
197080,a,0,0
197081,finding,0,0
197082,indicative,0,0
197083,of,0,1
197084,rapid,0,0
197085,reversal,0,1
197086,of,0,1
197087,beta-adrenoceptor,0,0
197088,blockade,0,0
197089,.,0,0
197090,The,0,0
197091,most,0,0
197092,prevalent,0,0
197093,adverse,1,1
197094,effect,1,1
197095,during,0,0
197096,esmolol,0,0
197097,infusion,0,0
197098,was,0,0
197099,hypotension,1,1
197100,which,0,0
197101,occurred,0,0
197102,in,0,0
197103,eight,0,0
197104,patients,0,0
197105,(,0,0
197106,12,0,0
197107,%,0,0
197108,),0,0
197109,.,0,1
197110,Hypotension,1,1
197111,and,1,1
197112,associated,1,0
197113,symptoms,1,1
197114,resolved,0,0
197115,within,0,0
197116,30,0,0
197117,minutes,0,0
197118,after,0,0
197119,discontinuation,0,0
197120,of,0,1
197121,esmolol,0,0
197122,infusion,0,0
197123,",",0,0
197124,which,0,0
197125,is,0,0
197126,consistent,0,0
197127,with,0,0
197128,the,0,0
197129,short,0,1
197130,duration,0,1
197131,of,0,1
197132,action,0,1
197133,of,0,1
197134,esmolol,0,0
197135,(,0,0
197136,elimination,0,1
197137,half-life,0,1
197138,of,0,0
197139,9.2,0,0
197140,minutes,0,0
197141,),0,0
197142,.,0,0
197143,[,0,0
197144,Effects,0,0
197145,of,0,0
197146,simvastatin,0,0
197147,on,0,0
197148,plasma,1,1
197149,lipids,1,1
197150,",",1,1
197151,lipoproteins,1,1
197152,and,0,1
197153,apoproteins,1,1
197154,(,0,1
197155,A1,0,1
197156,and,0,1
197157,B,0,0
197158,),0,0
197159,.,0,0
197160,24,0,0
197161,cases,0,0
197162,of,0,0
197163,major,0,1
197164,primary,0,0
197165,hypercholesterolemia,0,0
197166,],0,0
197167,.,0,0
197168,We,0,0
197169,studied,0,0
197170,the,0,0
197171,effects,0,1
197172,of,0,1
197173,simvastatin,0,0
197174,(,0,0
197175,MK,0,1
197176,733,0,0
197177,),0,0
197178,",",0,0
197179,a,0,0
197180,new,0,1
197181,competitive,0,0
197182,inhibitor,0,0
197183,of,0,1
197184,HMG,0,0
197185,CoA,0,1
197186,reductase,0,1
197187,",",0,0
197188,alone,0,0
197189,and,0,0
197190,in,0,0
197191,combination,0,0
197192,with,0,0
197193,a,0,0
197194,bile,0,1
197195,acid,0,1
197196,sequestrant,0,1
197197,",",0,1
197198,cholestyramine,0,0
197199,",",0,1
197200,on,0,0
197201,serum,0,1
197202,levels,0,1
197203,of,0,1
197204,lipoproteins,0,1
197205,and,0,1
197206,apoproteins,0,1
197207,A1,0,1
197208,and,0,1
197209,B,0,1
197210,",",0,0
197211,in,0,0
197212,24,0,0
197213,patients,0,0
197214,with,0,0
197215,familial,0,1
197216,hypercholesterolemia,0,0
197217,.,0,0
197218,After,0,0
197219,simvastatin,0,0
197220,treatment,0,0
197221,(,0,0
197222,40,0,0
197223,mg/day,0,0
197224,),0,0
197225,alone,0,0
197226,for,0,0
197227,12,0,0
197228,weeks,0,0
197229,",",0,0
197230,serum,0,1
197231,total,0,1
197232,and,0,1
197233,low,1,1
197234,density,1,1
197235,lipoprotein,1,1
197236,cholesterol,1,1
197237,decreased,0,0
197238,by,0,0
197239,31,0,0
197240,and,0,0
197241,36,0,0
197242,percent,0,0
197243,respectively,0,0
197244,.,0,0
197245,With,0,0
197246,the,0,0
197247,addition,0,0
197248,of,0,1
197249,cholestyramine,0,0
197250,",",0,0
197251,there,0,0
197252,was,0,0
197253,a,0,0
197254,41,0,0
197255,per,0,0
197256,cent,0,0
197257,total,0,1
197258,decrease,0,1
197259,in,0,0
197260,serum,1,1
197261,cholesterol,1,1
197262,from,0,0
197263,the,0,0
197264,control,0,0
197265,value,0,1
197266,and,0,0
197267,a,0,0
197268,50,0,0
197269,percent,0,0
197270,decrease,0,0
197271,in,0,0
197272,low,1,0
197273,density,1,1
197274,lipoprotein,1,1
197275,cholesterol,1,1
197276,.,1,0
197277,After,0,0
197278,cholestyramine,0,0
197279,treatment,0,0
197280,alone,0,0
197281,for,0,0
197282,12,0,0
197283,weeks,0,0
197284,",",0,0
197285,serum,1,1
197286,total,1,1
197287,and,1,1
197288,low,1,1
197289,density,1,1
197290,lipoprotein,1,1
197291,cholesterol,1,1
197292,decreased,0,0
197293,by,0,0
197294,20,0,0
197295,percent,0,0
197296,and,0,0
197297,29,0,0
197298,percent,0,0
197299,respectively,0,0
197300,.,0,0
197301,With,0,0
197302,the,0,0
197303,addition,0,0
197304,of,0,1
197305,simvastatin,0,0
197306,(,0,0
197307,20,0,0
197308,mg,0,0
197309,per,0,0
197310,day,0,0
197311,),0,1
197312,",",0,0
197313,there,0,0
197314,was,0,0
197315,a,0,0
197316,32,0,0
197317,percent,0,0
197318,total,0,1
197319,decrease,0,1
197320,in,0,0
197321,serum,1,1
197322,cholesterol,1,1
197323,from,0,0
197324,the,0,0
197325,control,0,0
197326,value,0,1
197327,and,0,0
197328,a,0,0
197329,43,0,0
197330,percent,0,0
197331,decrease,0,0
197332,in,0,0
197333,low,0,0
197334,density,1,1
197335,lipoprotein,1,1
197336,cholesterol,1,1
197337,.,1,1
197338,High,1,0
197339,density,1,1
197340,lipoprotein,1,1
197341,cholesterol,1,1
197342,remained,0,0
197343,unchanged,0,0
197344,.,0,0
197345,No,0,0
197346,major,1,1
197347,adverse,1,1
197348,effect,1,1
197349,was,0,0
197350,observed,0,0
197351,.,0,0
197352,If,0,0
197353,long,0,0
197354,term,0,0
197355,safety,0,1
197356,can,0,0
197357,be,0,0
197358,confirmed,0,0
197359,",",0,0
197360,the,0,0
197361,simvastatin-cholestyramine,0,0
197362,regimen,0,0
197363,may,0,0
197364,prove,0,0
197365,useful,0,0
197366,in,0,0
197367,heterozygous,0,1
197368,familial,0,1
197369,hypercholesterolemia,0,0
197370,.,0,0
197371,Arginine,0,0
197372,vasopressin,0,0
197373,dissociates,0,0
197374,the,0,0
197375,diuresis,1,1
197376,and,1,1
197377,natriuresis,1,1
197378,due,0,0
197379,to,0,0
197380,atrial,0,1
197381,natriuretic,0,1
197382,factor,0,1
197383,in,0,0
197384,man,0,0
197385,.,0,0
197386,The,0,0
197387,possible,0,0
197388,interaction,0,1
197389,between,0,0
197390,arginine,0,1
197391,vasopressin,0,0
197392,(,0,1
197393,AVP,0,1
197394,),0,1
197395,and,0,1
197396,atrial,0,1
197397,natriuretic,0,1
197398,factor,0,1
197399,(,0,1
197400,ANF,0,0
197401,),0,0
197402,in,0,0
197403,the,0,0
197404,control,0,0
197405,of,0,0
197406,urinary,0,1
197407,sodium,0,0
197408,and,0,1
197409,water,0,1
197410,excretion,0,1
197411,was,0,0
197412,investigated,0,0
197413,in,0,0
197414,man,0,0
197415,.,0,0
197416,Nine,0,0
197417,healthy,0,0
197418,male,0,0
197419,volunteers,0,0
197420,undergoing,0,0
197421,stable,0,1
197422,maximal,0,1
197423,water,0,1
197424,diuresis,0,1
197425,were,0,0
197426,studied,0,0
197427,on,0,0
197428,four,0,0
197429,separate,0,0
197430,occasions,0,0
197431,.,0,0
197432,Atrial,0,0
197433,natriuretic,0,1
197434,factor,0,0
197435,15,0,0
197436,pmol,0,0
197437,kg-1,0,0
197438,min-1,0,0
197439,or,0,1
197440,placebo,0,0
197441,(,0,1
197442,P,0,0
197443,),0,1
197444,was,0,0
197445,concomitantly,0,0
197446,administered,0,0
197447,against,0,0
197448,a,0,0
197449,background,0,0
197450,infusion,0,0
197451,of,0,0
197452,either,0,0
197453,AVP,0,0
197454,0.003,0,0
197455,pmol,0,0
197456,kg-1,0,0
197457,min-1,0,0
197458,or,0,0
197459,P,0,0
197460,;,0,0
197461,thus,0,0
197462,the,0,0
197463,combinations,0,0
197464,P,0,0
197465,+,0,0
197466,P,0,0
197467,",",0,1
197468,AVP,0,1
197469,+,0,1
197470,P,0,0
197471,",",0,1
197472,P,0,0
197473,+,0,1
197474,ANF,0,0
197475,and,0,1
197476,AVP,0,1
197477,+,0,1
197478,ANF,0,0
197479,were,0,0
197480,studied,0,0
197481,.,0,0
197482,Atrial,0,0
197483,natriuretic,0,1
197484,factor,0,1
197485,caused,0,0
197486,a,0,0
197487,significant,0,0
197488,increase,0,0
197489,in,0,0
197490,sodium,1,1
197491,excretion,1,1
197492,(,1,1
197493,UNaV,1,0
197494,),1,0
197495,[,0,0
197496,+56,0,0
197497,%,0,0
197498,],0,0
197499,",",0,1
197500,urinary,1,1
197501,flow,1,1
197502,rate,1,1
197503,(,1,1
197504,V,1,0
197505,),1,0
197506,[,0,0
197507,+17,0,0
197508,%,0,0
197509,],0,0
197510,and,0,1
197511,free,1,1
197512,water,1,1
197513,clearance,1,1
197514,(,1,1
197515,CH2O,1,0
197516,),1,0
197517,[,0,0
197518,+23,0,0
197519,%,0,0
197520,],0,0
197521,;,0,0
197522,creatinine,1,1
197523,clearance,1,1
197524,(,1,1
197525,Ccr,1,0
197526,),1,1
197527,did,0,0
197528,not,0,0
197529,change,0,0
197530,.,0,1
197531,Arginine,0,1
197532,vasopressin,0,0
197533,reduced,0,1
197534,V,1,1
197535,(,0,1
197536,-58,0,1
197537,%,0,0
197538,),0,1
197539,and,0,1
197540,CH2O,1,0
197541,(,0,0
197542,-68,0,1
197543,%,0,0
197544,),0,0
197545,but,0,0
197546,did,0,0
197547,not,0,0
197548,alter,0,1
197549,UNaV,1,0
197550,or,1,0
197551,Ccr,1,0
197552,.,1,0
197553,On,0,0
197554,the,0,0
197555,AVP,0,0
197556,+,0,0
197557,ANF,0,0
197558,study,0,0
197559,day,0,1
197560,",",0,1
197561,UNaV,1,1
197562,increased,0,1
197563,(,0,0
197564,+64,0,0
197565,%,0,0
197566,),0,0
197567,as,0,0
197568,with,0,0
197569,P,1,0
197570,+,1,0
197571,ANF,1,0
197572,",",0,1
197573,but,0,0
197574,V,1,1
197575,(,0,1
197576,-44,0,0
197577,%,0,0
197578,),0,1
197579,and,0,1
197580,CH2O,1,1
197581,(,0,1
197582,-52,0,1
197583,%,0,0
197584,),0,0
197585,continued,0,0
197586,to,0,0
197587,decrease,0,1
197588,below,0,0
197589,baseline,0,0
197590,levels,0,1
197591,;,0,0
197592,analysis,0,0
197593,of,0,1
197594,variance,0,1
197595,showed,0,0
197596,this,0,0
197597,antidiuresis,0,1
197598,reflected,0,0
197599,the,0,0
197600,prevalent,0,0
197601,effect,0,0
197602,of,0,1
197603,AVP,0,0
197604,rather,0,0
197605,than,0,0
197606,any,0,0
197607,specific,0,0
197608,interaction,0,0
197609,.,0,0
197610,These,0,0
197611,results,0,0
197612,show,0,0
197613,that,0,0
197614,AVP,0,0
197615,is,0,0
197616,able,0,0
197617,to,0,0
197618,dissociate,0,0
197619,the,0,0
197620,natriuretic,1,1
197621,and,1,0
197622,diuretic,1,1
197623,effects,1,1
197624,of,0,0
197625,ANF,0,0
197626,.,0,0
197627,Intensive,0,0
197628,induction,0,1
197629,chemotherapy,0,0
197630,for,0,0
197631,small,0,0
197632,cell,0,1
197633,anaplastic,0,1
197634,carcinoma,0,0
197635,of,0,0
197636,the,0,0
197637,lung,0,0
197638,.,0,0
197639,The,0,0
197640,role,0,0
197641,of,0,0
197642,intensive,0,0
197643,induction,0,0
197644,chemotherapy,0,0
197645,in,0,0
197646,small,0,0
197647,cell,0,1
197648,cancer,0,0
197649,of,0,0
197650,the,0,0
197651,lung,0,0
197652,remains,0,0
197653,unclear,0,0
197654,.,0,0
197655,Twenty-eight,0,0
197656,newly,0,0
197657,diagnosed,0,0
197658,patients,0,0
197659,with,0,0
197660,small,0,0
197661,cell,0,1
197662,lung,0,1
197663,cancer,0,1
197664,were,0,0
197665,randomized,0,0
197666,to,0,0
197667,receive,0,0
197668,either,0,0
197669,high-dose,0,0
197670,or,0,0
197671,standard-dose,0,0
197672,cyclophosphamide,0,0
197673,",",0,1
197674,vincristine,0,0
197675,",",0,1
197676,and,0,1
197677,semustine,0,0
197678,in,0,0
197679,a,0,0
197680,trial,0,0
197681,where,0,0
197682,the,0,0
197683,dose,0,0
197684,of,0,1
197685,induction,0,1
197686,chemotherapy,0,0
197687,was,0,0
197688,the,0,0
197689,sole,0,0
197690,treatment,0,0
197691,variable,0,0
197692,.,0,0
197693,Complete,1,0
197694,responses,1,1
197695,(,1,0
197696,CR,1,1
197697,),1,1
197698,were,0,0
197699,achieved,0,0
197700,in,0,0
197701,57,0,0
197702,%,0,0
197703,of,0,0
197704,patients,0,0
197705,receiving,0,0
197706,high-dose,0,0
197707,therapy,0,0
197708,as,0,0
197709,compared,0,0
197710,to,0,0
197711,21,0,0
197712,%,0,0
197713,of,0,0
197714,patients,0,0
197715,receiving,0,0
197716,standard-dose,0,0
197717,therapy,0,0
197718,(,0,0
197719,P,0,0
197720,less,0,0
197721,than,0,0
197722,0.05,0,0
197723,),0,0
197724,.,0,0
197725,There,0,0
197726,was,0,0
197727,a,0,0
197728,higher,0,0
197729,rate,0,1
197730,of,0,1
197731,severe,1,1
197732,toxicity,1,1
197733,in,0,0
197734,the,0,0
197735,high-dose,0,0
197736,group,0,0
197737,(,0,0
197738,P,0,0
197739,less,0,0
197740,than,0,0
197741,0.01,0,0
197742,),0,0
197743,.,0,0
197744,The,0,0
197745,overall,1,1
197746,median,1,1
197747,survival,1,1
197748,was,0,0
197749,not,0,0
197750,improved,0,0
197751,(,0,0
197752,36,0,0
197753,weeks,0,0
197754,for,0,0
197755,the,0,0
197756,high-dose,0,0
197757,group,0,0
197758,vs,0,0
197759,43,0,0
197760,weeks,0,0
197761,for,0,0
197762,the,0,0
197763,standard-dose,0,0
197764,group,0,0
197765,),0,0
197766,;,0,0
197767,however,0,0
197768,",",0,0
197769,the,0,0
197770,median,1,1
197771,survival,1,1
197772,in,0,0
197773,patients,0,0
197774,achieving,0,1
197775,CR,0,1
197776,was,0,0
197777,prolonged,0,0
197778,(,0,0
197779,92,0,0
197780,weeks,0,0
197781,for,0,0
197782,the,0,0
197783,high-dose,0,0
197784,group,0,0
197785,vs,0,0
197786,50,0,0
197787,weeks,0,0
197788,for,0,0
197789,the,0,0
197790,standard-dose,0,0
197791,group,0,0
197792,),0,0
197793,.,0,0
197794,These,0,0
197795,effects,0,1
197796,were,0,0
197797,most,0,0
197798,pronounced,0,0
197799,in,0,0
197800,patients,0,0
197801,with,0,0
197802,extensive,0,0
197803,disease,0,0
197804,;,0,0
197805,a,0,0
197806,CR,1,0
197807,after,0,0
197808,induction,0,1
197809,was,0,0
197810,achieved,0,0
197811,in,0,0
197812,five,0,0
197813,of,0,0
197814,nine,0,0
197815,patients,0,0
197816,treated,0,0
197817,with,0,0
197818,high,0,0
197819,doses,0,0
197820,but,0,0
197821,not,0,0
197822,in,0,0
197823,any,0,0
197824,of,0,0
197825,those,0,0
197826,treated,0,0
197827,with,0,0
197828,standard,0,0
197829,doses,0,0
197830,(,0,0
197831,P,0,0
197832,less,0,0
197833,than,0,0
197834,0.05,0,0
197835,),0,0
197836,.,0,0
197837,A,0,0
197838,small,0,0
197839,group,0,0
197840,of,0,0
197841,patients,0,0
197842,appear,0,0
197843,to,0,0
197844,benefit,0,0
197845,by,0,0
197846,achieving,0,0
197847,a,0,0
197848,long-term,0,0
197849,remission,0,1
197850,with,0,0
197851,intensive,0,0
197852,induction,0,1
197853,chemotherapy,0,0
197854,",",0,0
197855,but,0,0
197856,this,0,0
197857,effect,0,0
197858,may,0,0
197859,be,0,0
197860,offset,0,0
197861,by,0,0
197862,increased,0,0
197863,morbidity,0,1
197864,.,0,0
197865,[,0,0
197866,Whole,0,1
197867,gut,0,1
197868,irrigation,0,1
197869,with,0,0
197870,isotonic,0,0
197871,mannitol,0,0
197872,solution,0,0
197873,in,0,0
197874,the,0,0
197875,treatment,0,0
197876,of,0,0
197877,gastrointestinal,1,1
197878,bleeding,1,1
197879,due,0,0
197880,to,0,0
197881,cirrhosis,0,0
197882,:,0,0
197883,a,0,0
197884,controlled,0,0
197885,study,0,0
197886,(,0,0
197887,author,0,1
197888,'s,0,1
197889,transl,0,0
197890,),0,0
197891,],0,0
197892,.,0,0
197893,Comparison,0,0
197894,of,0,1
197895,5-aminosalicylic,0,0
197896,acid,0,0
197897,(,0,0
197898,3,0,0
197899,g,0,0
197900,),0,0
197901,and,0,1
197902,prednisolone,0,0
197903,phosphate,0,0
197904,sodium,0,1
197905,enemas,0,0
197906,(,0,0
197907,30,0,0
197908,mg,0,0
197909,),0,0
197910,in,0,0
197911,the,0,0
197912,treatment,0,0
197913,of,0,0
197914,distal,1,1
197915,ulcerative,1,1
197916,colitis,1,0
197917,.,1,0
197918,A,0,0
197919,prospective,0,0
197920,",",0,0
197921,randomized,0,0
197922,",",0,0
197923,double-blind,0,0
197924,trial,0,0
197925,.,0,0
197926,Twenty-nine,0,0
197927,patients,0,0
197928,with,0,0
197929,attacks,0,1
197930,of,0,0
197931,distal,0,1
197932,ulcerative,0,1
197933,colitis,0,0
197934,were,0,0
197935,treated,0,0
197936,randomly,0,0
197937,with,0,0
197938,3,0,0
197939,g,0,0
197940,5-aminosalicylic,0,0
197941,acid,0,1
197942,(,0,1
197943,5-ASA,0,1
197944,),0,0
197945,or,0,0
197946,30,0,0
197947,mg,0,0
197948,of,0,0
197949,prednisolone,0,0
197950,phosphate,0,0
197951,sodium,0,1
197952,(,0,1
197953,PP,0,0
197954,),0,1
197955,enemas,0,0
197956,(,0,0
197957,40,0,0
197958,ml,0,0
197959,),0,0
197960,.,0,1
197961,Endoscopic,1,1
197962,",",1,1
197963,clinical,1,1
197964,",",1,1
197965,and,1,1
197966,histologic,1,1
197967,improvement,1,1
197968,were,0,0
197969,comparable,0,0
197970,in,0,0
197971,the,0,0
197972,two,0,0
197973,treatment,0,0
197974,groups,0,0
197975,.,0,0
197976,Our,0,0
197977,study,0,0
197978,showed,0,0
197979,that,0,0
197980,topical,0,0
197981,treatment,0,0
197982,with,0,0
197983,5-ASA,0,0
197984,is,0,0
197985,as,0,0
197986,efficacious,0,0
197987,as,0,0
197988,PP,0,0
197989,in,0,0
197990,improving,0,1
197991,distal,1,1
197992,ulcerative,1,1
197993,colitis,1,0
197994,.,1,0
197995,Plasma,0,1
197996,"3,4-dihydroxyphenylethyleneglycol",0,1
197997,and,0,1
197998,3-methoxy-4-hydroxyphenylethyleneglycol,0,1
197999,as,0,0
198000,indicators,0,1
198001,of,0,0
198002,central,0,1
198003,noradrenergic,0,1
198004,activity,0,1
198005,.,0,0
198006,A,0,0
198007,comparative,0,0
198008,study,0,0
198009,on,0,0
198010,control,0,0
198011,subjects,0,0
198012,and,0,1
198013,depressed,0,1
198014,patients,0,0
198015,.,0,0
198016,Animal,0,0
198017,studies,0,0
198018,have,0,0
198019,suggested,0,0
198020,interspecies,0,0
198021,differences,0,0
198022,in,0,0
198023,brain,0,1
198024,norepinephrine,0,1
198025,(,0,1
198026,NE,0,1
198027,),0,1
198028,metabolism,0,1
198029,",",0,0
198030,especially,0,0
198031,with,0,0
198032,regard,0,0
198033,to,0,0
198034,the,0,0
198035,relative,0,0
198036,proportions,0,1
198037,of,0,1
198038,"3,4-dihydroxyphenylethyleneglycol",0,1
198039,(,0,0
198040,DOPEG,0,0
198041,),0,0
198042,compared,0,0
198043,to,0,0
198044,3-methoxy-4-hydroxyphenylethyleneglycol,0,0
198045,(,0,0
198046,MOPEG,0,0
198047,),0,0
198048,.,0,0
198049,In,0,0
198050,order,0,0
198051,to,0,0
198052,question,0,0
198053,the,0,0
198054,value,0,0
198055,of,0,0
198056,both,0,0
198057,glycol,0,0
198058,metabolites,0,1
198059,as,0,0
198060,peripheral,0,1
198061,indices,0,1
198062,of,0,0
198063,central,1,1
198064,noradrenergic,1,1
198065,activity,1,1
198066,",",0,0
198067,a,0,0
198068,comparative,0,0
198069,study,0,0
198070,of,0,1
198071,plasma,0,1
198072,DOPEG,0,0
198073,and,0,1
198074,MOPEG,0,1
198075,(,0,1
198076,measured,0,1
198077,by,0,0
198078,HPLC,0,1
198079,),0,0
198080,related,0,0
198081,to,0,0
198082,depression,0,1
198083,",",0,1
198084,sex,0,1
198085,",",0,1
198086,age,0,1
198087,and,0,1
198088,diagnostic,0,1
198089,categories,0,1
198090,(,0,0
198091,DSM-III,0,1
198092,),0,1
198093,was,0,0
198094,carried,0,0
198095,out,0,0
198096,on,0,0
198097,depressed,0,1
198098,and,0,1
198099,control,0,0
198100,subjects,0,0
198101,.,0,0
198102,In,0,0
198103,addition,0,0
198104,",",0,0
198105,two,0,0
198106,groups,0,0
198107,of,0,0
198108,8,0,0
198109,patients,0,0
198110,were,0,0
198111,randomly,0,0
198112,submitted,0,0
198113,to,0,0
198114,a,0,0
198115,desipramine,0,0
198116,150,0,0
198117,mg/day,0,0
198118,",",0,0
198119,or,0,0
198120,a,0,0
198121,metapramine,0,0
198122,450,0,0
198123,mg/day,0,0
198124,antidepressant,0,0
198125,treatment,0,0
198126,influencing,0,0
198127,the,0,0
198128,formation,0,1
198129,of,0,1
198130,DOPEG,0,0
198131,and,0,1
198132,MOPEG,0,1
198133,in,0,0
198134,a,0,0
198135,different,0,0
198136,way,0,0
198137,.,0,0
198138,The,0,0
198139,study,0,0
198140,did,0,0
198141,not,0,0
198142,demonstrate,0,0
198143,any,0,0
198144,difference,0,0
198145,between,0,0
198146,DOPEG,0,0
198147,and,0,1
198148,MOPEG,0,1
198149,for,0,0
198150,most,0,0
198151,of,0,0
198152,the,0,0
198153,experimental,0,0
198154,factors,0,0
198155,.,0,0
198156,We,0,0
198157,found,0,0
198158,also,0,0
198159,a,0,0
198160,significant,0,0
198161,positive,1,1
198162,correlation,1,0
198163,between,1,0
198164,plasma,1,1
198165,levels,1,1
198166,of,1,1
198167,DOPEG,1,0
198168,and,1,0
198169,MOPEG,1,1
198170,.,1,0
198171,Our,0,0
198172,results,0,0
198173,support,0,0
198174,the,0,0
198175,idea,0,0
198176,that,0,0
198177,each,0,0
198178,of,0,0
198179,these,0,0
198180,two,0,0
198181,biological,0,0
198182,indices,0,0
198183,can,0,0
198184,be,0,0
198185,used,0,0
198186,in,0,0
198187,the,0,0
198188,assessment,0,0
198189,of,0,0
198190,central,1,1
198191,noradrenergic,1,1
198192,activity,1,1
198193,.,1,0
198194,Double-blind,0,0
198195,comparison,0,0
198196,of,0,1
198197,doxepin,0,0
198198,versus,0,0
198199,bupropion,0,0
198200,in,0,0
198201,outpatients,0,0
198202,with,0,0
198203,a,0,0
198204,major,0,1
198205,depressive,0,1
198206,disorder,0,0
198207,.,0,0
198208,A,0,0
198209,double-blind,0,0
198210,controlled,0,0
198211,study,0,0
198212,comparing,0,0
198213,the,0,0
198214,effects,0,0
198215,of,0,0
198216,bupropion,0,0
198217,to,0,0
198218,doxepin,0,0
198219,in,0,0
198220,outpatients,0,0
198221,with,0,0
198222,primary,0,0
198223,depression,0,1
198224,was,0,0
198225,conducted,0,0
198226,to,0,0
198227,evaluate,0,0
198228,efficacy,1,1
198229,and,1,1
198230,safety,1,1
198231,differences,0,0
198232,between,0,0
198233,the,0,0
198234,two,0,0
198235,drugs,0,0
198236,.,0,0
198237,Following,0,0
198238,a,0,0
198239,7-day,0,0
198240,placebo,0,0
198241,washout,0,1
198242,period,0,0
198243,",",0,0
198244,patients,0,0
198245,could,0,0
198246,be,0,0
198247,treated,0,0
198248,for,0,0
198249,up,0,0
198250,to,0,0
198251,13,0,0
198252,weeks,0,0
198253,on,0,0
198254,either,0,0
198255,treatment,0,0
198256,.,0,0
198257,Antidepressant,1,0
198258,response,1,1
198259,was,0,0
198260,assessed,0,0
198261,by,0,0
198262,the,0,0
198263,Hamilton,1,1
198264,Depression,1,1
198265,and,1,1
198266,Anxiety,1,1
198267,Scales,1,1
198268,",",1,1
198269,Clinical,1,1
198270,Global,1,1
198271,Severity,1,1
198272,and,1,1
198273,Improvement,1,1
198274,Ratings,1,1
198275,",",0,0
198276,and,0,0
198277,the,0,0
198278,Zung,1,0
198279,Self-Rating,1,0
198280,Depression,1,1
198281,Scale,1,1
198282,.,1,1
198283,Comparable,0,0
198284,efficacy,1,1
198285,between,0,0
198286,the,0,0
198287,compounds,0,0
198288,was,0,0
198289,found,0,0
198290,across,0,0
198291,the,0,0
198292,13-week,0,0
198293,study,0,0
198294,.,0,1
198295,Doxepin,0,1
198296,differed,0,0
198297,from,0,0
198298,bupropion,0,0
198299,mainly,0,0
198300,on,0,0
198301,the,0,0
198302,sleep,1,1
198303,factor,1,0
198304,of,1,0
198305,the,1,0
198306,Hamilton,1,1
198307,Depression,1,1
198308,Scale,1,1
198309,",",0,0
198310,with,0,0
198311,doxepin,0,0
198312,improving,0,1
198313,sleep,1,1
198314,to,0,0
198315,a,0,0
198316,greater,0,0
198317,extent,0,0
198318,than,0,0
198319,bupropion,0,0
198320,.,0,1
198321,Doxepin,0,1
198322,produced,0,0
198323,a,0,0
198324,greater,0,0
198325,incidence,0,1
198326,of,0,1
198327,anticholinergic,1,1
198328,side,1,1
198329,effects,1,1
198330,",",1,0
198331,including,1,0
198332,dry,1,1
198333,mouth,1,1
198334,",",1,1
198335,constipation,1,1
198336,",",1,1
198337,sleepiness,1,1
198338,",",1,1
198339,and,1,1
198340,tiredness,1,1
198341,",",0,1
198342,in,0,0
198343,comparison,0,0
198344,to,0,0
198345,bupropion,0,0
198346,.,0,0
198347,Also,0,0
198348,",",0,0
198349,increased,0,1
198350,appetite,1,1
198351,and,1,1
198352,weight,1,1
198353,gain,1,1
198354,were,0,0
198355,consistent,0,0
198356,side,0,1
198357,effects,0,1
198358,of,0,1
198359,doxepin,0,0
198360,relative,0,1
198361,to,0,0
198362,bupropion,0,0
198363,.,0,0
198364,Comparison,0,0
198365,of,0,1
198366,amiodarone,0,0
198367,and,0,1
198368,disopyramide,0,0
198369,in,0,0
198370,the,0,0
198371,control,1,0
198372,of,1,0
198373,paroxysmal,1,1
198374,atrial,1,1
198375,fibrillation,1,1
198376,and,1,1
198377,atrial,1,1
198378,flutter,1,1
198379,(,0,0
198380,interim,0,1
198381,report,0,0
198382,),0,0
198383,.,0,0
198384,Dose,0,1
198385,dependent,0,0
198386,response,0,1
198387,of,0,1
198388,symptoms,0,1
198389,",",0,1
198390,pituitary,0,1
198391,",",0,1
198392,and,0,1
198393,bone,0,1
198394,to,0,0
198395,transdermal,0,0
198396,oestrogen,0,1
198397,in,0,0
198398,postmenopausal,0,0
198399,women,0,0
198400,.,0,0
198401,The,0,0
198402,effect,0,0
198403,of,0,0
198404,the,0,0
198405,plasma,0,1
198406,oestradiol,0,1
198407,concentration,0,1
198408,on,0,0
198409,climacteric,1,1
198410,symptoms,1,1
198411,",",1,1
198412,gonadotrophin,1,1
198413,release,1,1
198414,",",0,1
198415,and,0,1
198416,bone,1,1
198417,resorption,1,1
198418,was,0,0
198419,studied,0,0
198420,in,0,0
198421,three,0,0
198422,groups,0,0
198423,of,0,0
198424,postmenopausal,0,0
198425,women,0,0
198426,given,0,0
198427,0.025,0,0
198428,mg,0,0
198429,",",0,0
198430,0.05,0,0
198431,mg,0,0
198432,",",0,0
198433,or,0,0
198434,0.1,0,0
198435,mg,0,0
198436,transdermal,0,0
198437,oestradiol,0,0
198438,daily,0,0
198439,.,0,0
198440,There,0,0
198441,was,0,0
198442,a,0,0
198443,dose,0,0
198444,related,0,0
198445,reduction,1,1
198446,in,1,0
198447,symptoms,1,1
198448,",",1,0
198449,plasma,1,1
198450,follicle,1,1
198451,stimulating,1,1
198452,hormone,1,1
198453,concentration,1,1
198454,",",1,1
198455,and,1,1
198456,urinary,1,1
198457,calcium,1,1
198458,and,1,1
198459,hydroxyproline,1,1
198460,excretion,1,1
198461,.,1,0
198462,The,0,0
198463,relation,1,0
198464,of,1,0
198465,the,1,0
198466,response,1,1
198467,to,1,0
198468,plasma,1,1
198469,oestradiol,1,1
198470,values,1,1
198471,was,0,0
198472,similar,0,0
198473,for,0,0
198474,each,0,0
198475,variable,0,0
198476,with,0,0
198477,an,0,0
198478,initial,0,0
198479,large,0,0
198480,reduction,0,1
198481,and,0,1
198482,little,0,0
198483,change,0,1
198484,in,0,0
198485,response,0,1
198486,to,0,0
198487,increases,0,0
198488,in,0,0
198489,the,0,0
198490,plasma,0,1
198491,oestradiol,0,1
198492,concentration,0,1
198493,above,0,0
198494,150,0,0
198495,pmol/l,0,0
198496,(,0,0
198497,41,0,0
198498,pg/ml,0,0
198499,),0,0
198500,.,0,0
198501,Hormone,0,0
198502,replacement,0,0
198503,therapy,0,0
198504,producing,0,0
198505,an,0,0
198506,effect,0,0
198507,equivalent,0,0
198508,to,0,0
198509,higher,0,0
198510,oestradiol,0,0
198511,concentrations,0,1
198512,is,0,0
198513,likely,0,0
198514,to,0,0
198515,increase,0,0
198516,the,0,0
198517,risk,0,1
198518,of,0,0
198519,side,1,1
198520,effects,1,1
198521,without,0,0
198522,conferring,0,0
198523,any,0,0
198524,additional,1,0
198525,benefit,1,0
198526,.,1,0
198527,[,0,1
198528,Bupivacaine-CO2,0,1
198529,and,0,1
198530,bupivacaine-HCl,0,0
198531,at,0,0
198532,various,0,0
198533,injection,0,0
198534,temperatures,0,1
198535,in,0,0
198536,peridural,0,0
198537,anesthesia,0,0
198538,for,0,0
198539,extracorporeal,0,0
198540,shock,0,0
198541,wave,0,1
198542,lithotripsy,0,0
198543,],0,0
198544,.,0,0
198545,INTRODUCTION,0,0
198546,The,0,0
198547,effect,0,0
198548,of,0,0
198549,different,0,0
198550,injection,0,0
198551,temperatures,0,1
198552,on,0,0
198553,carbonated,0,0
198554,anesthetics,0,0
198555,has,0,0
198556,been,0,0
198557,controversial,0,0
198558,since,0,0
198559,1965,0,0
198560,.,0,0
198561,The,0,0
198562,current,0,0
198563,study,0,0
198564,was,0,0
198565,undertaken,0,0
198566,to,0,0
198567,determine,0,0
198568,onset,1,1
198569,times,1,1
198570,of,1,1
198571,sensory,1,1
198572,and,1,1
198573,motor,1,1
198574,blockade,1,1
198575,after,0,0
198576,epidural,0,0
198577,anesthesia,0,0
198578,with,0,0
198579,0.5,0,0
198580,%,0,0
198581,bupivacaine-CO2,0,0
198582,and,0,0
198583,0.5,0,0
198584,%,0,0
198585,bupivacaine-HCl,0,0
198586,at,0,0
198587,various,0,0
198588,injection,0,0
198589,temperatures,0,1
198590,.,0,1
198591,MATERIALS,0,0
198592,AND,0,0
198593,METHODS,0,0
198594,The,0,0
198595,study,0,0
198596,was,0,0
198597,performed,0,0
198598,on,0,0
198599,90,0,0
198600,ASA,0,0
198601,class,0,0
198602,I-II,0,0
198603,urologic,0,0
198604,patients,0,0
198605,during,0,0
198606,extracorporeal,0,0
198607,shock,0,1
198608,wave,0,1
198609,lithotripsy,0,0
198610,.,0,0
198611,The,0,0
198612,patients,0,0
198613,were,0,0
198614,randomized,0,0
198615,in,0,0
198616,six,0,0
198617,groups,0,0
198618,to,0,0
198619,receive,0,0
198620,either,0,0
198621,0.5,0,0
198622,%,0,0
198623,bupivacaine-CO2,0,0
198624,or,0,0
198625,0.5,0,0
198626,%,0,0
198627,bupivacaine-HCl,0,0
198628,at,0,0
198629,temperatures,0,1
198630,of,0,0
198631,4,0,0
198632,degrees,0,0
198633,",",0,0
198634,20,0,0
198635,degrees,0,0
198636,",",0,0
198637,or,0,0
198638,36,0,0
198639,degrees,0,0
198640,C.,0,0
198641,The,0,0
198642,six,0,0
198643,groups,0,0
198644,were,0,0
198645,comparable,0,0
198646,in,0,0
198647,age,0,0
198648,",",0,1
198649,height,0,1
198650,",",0,1
198651,and,0,1
198652,weight,0,1
198653,.,0,1
198654,Epidural,0,1
198655,anesthesia,0,0
198656,was,0,0
198657,performed,0,0
198658,at,0,0
198659,the,0,0
198660,L2-3,0,0
198661,interspace,0,1
198662,with,0,0
198663,an,0,0
198664,18-gauge,0,0
198665,Tuohy,0,0
198666,needle,0,0
198667,using,0,0
198668,loss,0,1
198669,of,0,0
198670,resistance,0,1
198671,.,0,0
198672,A,0,0
198673,catheter,0,1
198674,was,0,0
198675,advanced,0,0
198676,4,0,0
198677,cm,0,0
198678,in,0,0
198679,the,0,0
198680,epidural,0,0
198681,space,0,0
198682,and,0,0
198683,4,0,0
198684,ml,0,0
198685,0.5,0,0
198686,%,0,0
198687,bupivacaine,0,0
198688,with,0,0
198689,adrenaline,0,0
198690,"1:200,000",0,0
198691,was,0,0
198692,given,0,0
198693,as,0,0
198694,a,0,0
198695,test,0,0
198696,dose,0,0
198697,.,0,0
198698,After,0,0
198699,4,0,0
198700,min,0,0
198701,the,0,0
198702,full,0,0
198703,anesthetic,0,1
198704,dose,0,0
198705,",",0,0
198706,based,0,0
198707,on,0,0
198708,body,0,1
198709,size,0,1
198710,",",0,1
198711,was,0,0
198712,injected,0,0
198713,with,0,0
198714,the,0,0
198715,patient,0,0
198716,supine,0,0
198717,.,0,1
198718,Sensory,1,0
198719,blockade,1,1
198720,was,0,0
198721,determined,0,0
198722,by,0,0
198723,the,0,0
198724,pinprick,0,1
198725,method,0,0
198726,and,0,1
198727,motor,1,1
198728,blockade,1,1
198729,by,0,0
198730,the,0,0
198731,Bromage,0,1
198732,method,0,0
198733,at,0,0
198734,2-min,0,0
198735,intervals,0,0
198736,for,0,0
198737,the,0,0
198738,first,0,0
198739,20,0,0
198740,min,0,0
198741,",",0,0
198742,at,0,0
198743,5-min,0,1
198744,intervals,0,0
198745,for,0,0
198746,the,0,0
198747,next,0,0
198748,10,0,0
198749,min,0,0
198750,",",0,0
198751,and,0,0
198752,then,0,0
198753,every,0,0
198754,15,0,0
198755,min,0,0
198756,to,0,0
198757,a,0,0
198758,total,0,0
198759,of,0,0
198760,240,0,0
198761,min,0,0
198762,.,0,0
198763,Statistical,0,0
198764,analysis,0,0
198765,was,0,0
198766,done,0,0
198767,by,0,0
198768,the,0,0
198769,Mann-Whitney,0,0
198770,test,0,1
198771,",",0,0
198772,with,0,0
198773,P,0,0
198774,less,0,0
198775,than,0,0
198776,0.05,0,0
198777,considered,0,0
198778,significant,0,0
198779,.,0,0
198780,RESULTS,0,0
198781,Spread,1,0
198782,of,1,1
198783,sensory,1,1
198784,blockade,1,1
198785,was,0,0
198786,significantly,0,0
198787,faster,0,0
198788,with,0,0
198789,bupivacaine-CO2,0,0
198790,and,0,1
198791,-HCl,0,0
198792,at,0,0
198793,a,0,0
198794,temperature,0,1
198795,of,0,0
198796,36,0,0
198797,degrees,0,0
198798,C,0,0
198799,as,0,0
198800,compared,0,0
198801,to,0,0
198802,4,0,0
198803,degrees,0,0
198804,or,0,0
198805,20,0,0
198806,degrees,0,0
198807,C,0,0
198808,(,0,0
198809,P,0,0
198810,less,0,0
198811,than,0,0
198812,0.05,0,0
198813,),0,0
198814,(,0,0
198815,Figs,0,0
198816,.,0,0
198817,1,0,0
198818,",",0,0
198819,2,0,0
198820,and,0,0
198821,Table,0,0
198822,2,0,0
198823,),0,0
198824,.,0,0
198825,(,0,0
198826,ABSTRACT,0,1
198827,TRUNCATED,0,0
198828,AT,0,0
198829,250,0,0
198830,WORDS,0,0
198831,),0,0
198832,Effect,0,1
198833,of,0,1
198834,fenfluramine,0,0
198835,on,0,0
198836,autistic,0,0
198837,symptoms,0,1
198838,.,0,0
198839,Prospective,0,0
198840,controlled,0,0
198841,study,0,0
198842,of,0,1
198843,androgen,0,1
198844,therapy,0,0
198845,in,0,0
198846,the,0,0
198847,anemia,1,1
198848,of,0,0
198849,chronic,0,0
198850,renal,0,1
198851,disease,0,0
198852,:,0,0
198853,effects,0,1
198854,on,0,0
198855,iron,0,0
198856,kinetics,0,1
198857,.,0,1
198858,Ferrokinetic,1,1
198859,and,1,1
198860,RBC,1,1
198861,mass,1,1
198862,determinations,1,1
198863,were,0,0
198864,made,0,0
198865,at,0,0
198866,3-month,0,0
198867,intervals,0,0
198868,in,0,0
198869,iron-replete,0,0
198870,hemodialysis,0,0
198871,patients,0,0
198872,randomized,0,0
198873,to,0,0
198874,a,0,0
198875,control,0,0
198876,group,0,0
198877,or,0,0
198878,to,0,0
198879,nandrolone,0,0
198880,decanoate,0,0
198881,therapy,0,0
198882,.,0,0
198883,After,0,0
198884,3,0,0
198885,months,0,0
198886,",",0,0
198887,RBC,1,1
198888,mass,1,1
198889,increased,0,0
198890,in,0,0
198891,two,0,0
198892,of,0,0
198893,4,0,0
198894,androgen-treated,0,0
198895,patients,0,0
198896,.,0,0
198897,Erythron,1,0
198898,iron,1,1
198899,turnover,1,1
198900,",",0,0
198901,an,0,0
198902,index,0,1
198903,of,0,0
198904,RBC,0,1
198905,production,0,1
198906,",",0,0
198907,increased,0,0
198908,in,0,0
198909,the,0,0
198910,one,0,0
198911,responder,0,0
198912,studied,0,0
198913,but,0,0
198914,not,0,0
198915,in,0,0
198916,the,0,0
198917,two,0,0
198918,nonresponders,0,0
198919,.,0,0
198920,Similarly,0,0
198921,",",0,0
198922,in,0,0
198923,a,0,0
198924,fifth,0,0
198925,subject,0,0
198926,",",0,0
198927,who,0,0
198928,was,0,0
198929,not,0,0
198930,restudied,0,0
198931,until,0,0
198932,6,0,0
198933,months,0,0
198934,of,0,0
198935,androgen,0,1
198936,therapy,0,0
198937,were,0,0
198938,completed,0,0
198939,",",0,0
198940,an,0,0
198941,increase,0,1
198942,in,0,0
198943,RBC,1,1
198944,mass,1,1
198945,was,0,0
198946,associated,0,0
198947,with,0,0
198948,an,0,0
198949,increase,0,0
198950,in,0,0
198951,erythron,0,1
198952,iron,0,0
198953,turnover,0,1
198954,.,0,0
198955,However,0,0
198956,",",0,0
198957,between,0,0
198958,3,0,0
198959,and,0,0
198960,6,0,0
198961,months,0,0
198962,",",0,0
198963,RBC,1,1
198964,mass,1,1
198965,increased,0,0
198966,in,0,0
198967,all,0,0
198968,4,0,0
198969,androgen-treated,0,0
198970,patients,0,0
198971,studied,0,0
198972,even,0,0
198973,though,0,0
198974,erythron,0,1
198975,iron,0,1
198976,turnovers,0,1
198977,remained,0,1
198978,unchanged,0,0
198979,and,0,1
198980,dialysis-associated,1,1
198981,blood,1,1
198982,losses,1,1
198983,did,0,0
198984,not,0,0
198985,decrease,0,0
198986,.,0,0
198987,Thus,0,1
198988,",",0,0
198989,at,0,0
198990,least,0,0
198991,two,0,0
198992,androgen-treated,0,0
198993,patients,0,0
198994,had,0,0
198995,increases,0,1
198996,in,0,0
198997,RBC,1,1
198998,mass,1,1
198999,without,0,0
199000,ever,0,0
199001,increasing,0,0
199002,their,0,0
199003,erythron,1,1
199004,iron,1,0
199005,turnover,1,1
199006,.,1,0
199007,Two,0,0
199008,of,0,0
199009,three,0,0
199010,control,0,0
199011,subjects,0,0
199012,also,0,0
199013,had,0,0
199014,increased,0,0
199015,erythron,1,1
199016,iron,1,0
199017,turnovers,1,1
199018,",",0,0
199019,which,0,0
199020,in,0,0
199021,one,0,0
199022,case,0,0
199023,was,0,0
199024,related,0,0
199025,to,0,0
199026,increased,0,0
199027,dialysis-associated,1,0
199028,blood,1,1
199029,losses,1,1
199030,.,1,0
199031,Changes,0,1
199032,in,0,0
199033,RBC,1,1
199034,mass,1,1
199035,were,0,0
199036,not,0,0
199037,consistently,0,0
199038,paralleled,0,0
199039,by,0,0
199040,changes,0,1
199041,in,0,0
199042,Hb,0,0
199043,.,0,0
199044,These,0,0
199045,findings,0,0
199046,suggest,0,0
199047,that,0,0
199048,increases,0,1
199049,in,0,0
199050,RBC,1,1
199051,mass,1,1
199052,during,0,0
199053,nandrolone,0,0
199054,decanoate,0,0
199055,therapy,0,0
199056,result,0,0
199057,from,0,0
199058,two,0,0
199059,mechanisms,0,0
199060,:,0,0
199061,increased,0,0
199062,erythropoiesis,0,1
199063,(,0,0
199064,shown,0,0
199065,by,0,0
199066,simultaneous,0,0
199067,increases,0,1
199068,in,0,0
199069,RBC,1,1
199070,mass,1,1
199071,and,0,1
199072,erythron,1,1
199073,iron,1,1
199074,turnover,1,1
199075,),1,1
199076,and,0,1
199077,increased,0,1
199078,RBC,1,1
199079,survival,1,1
199080,(,0,0
199081,indirectly,0,1
199082,shown,0,0
199083,by,0,0
199084,increases,0,0
199085,in,0,0
199086,RBC,1,1
199087,mass,1,1
199088,without,0,0
199089,increases,0,1
199090,in,0,0
199091,erythron,1,1
199092,iron,1,1
199093,turnover,1,1
199094,),1,0
199095,.,0,0
199096,The,0,0
199097,importance,0,0
199098,of,0,0
199099,control,0,0
199100,groups,0,0
199101,",",0,1
199102,RBC,1,1
199103,mass,1,1
199104,determinations,0,1
199105,and,0,0
199106,the,0,0
199107,monitoring,0,0
199108,of,0,0
199109,dialysis-associated,1,1
199110,blood,1,1
199111,losses,1,1
199112,in,0,0
199113,studying,0,0
199114,the,0,0
199115,effects,0,0
199116,of,0,0
199117,androgens,0,1
199118,on,0,0
199119,erythropoiesis,0,1
199120,in,0,0
199121,chronic,0,0
199122,hemodialysis,0,0
199123,patients,0,0
199124,is,0,0
199125,also,0,0
199126,demonstrated,0,0
199127,.,0,0
199128,[,0,0
199129,Supplementary,0,0
199130,treatment,0,0
199131,with,0,0
199132,Esberitox,0,0
199133,of,0,0
199134,female,0,0
199135,patients,0,0
199136,undergoing,0,0
199137,curative,0,1
199138,adjuvant,0,0
199139,irradiation,0,0
199140,following,0,0
199141,breast,0,0
199142,cancer,0,0
199143,],0,0
199144,.,0,0
199145,1,0,0
199146,.,0,0
199147,The,0,0
199148,study,0,0
199149,was,0,0
199150,supposed,0,0
199151,to,0,0
199152,investigate,0,0
199153,a,0,0
199154,possible,0,0
199155,prevention,1,0
199156,or,1,1
199157,reduction,1,1
199158,of,1,0
199159,the,1,0
199160,toxicity,1,1
199161,of,0,0
199162,radiotherapy,0,0
199163,by,0,0
199164,an,0,0
199165,additional,0,0
199166,treatment,0,0
199167,with,0,0
199168,Esberitox,0,0
199169,.,0,0
199170,This,0,0
199171,question,0,0
199172,arose,0,0
199173,when,0,0
199174,performing,0,0
199175,an,0,0
199176,investigation,0,0
199177,about,0,0
199178,the,0,0
199179,effect,0,0
199180,of,0,0
199181,Esberitox,0,0
199182,in,0,0
199183,a,0,0
199184,combined,0,0
199185,chemo-radiotherapy,0,0
199186,.,0,0
199187,Whereas,0,0
199188,the,0,0
199189,latter,0,0
199190,induces,0,0
199191,above,0,0
199192,all,0,0
199193,a,0,0
199194,systemic,0,1
199195,damage,0,1
199196,to,0,0
199197,the,0,0
199198,hemopoietic,0,1
199199,system,0,0
199200,",",0,0
199201,radiotherapy,0,0
199202,is,0,0
199203,a,0,0
199204,regional,0,0
199205,noxa,0,0
199206,.,0,0
199207,2,0,0
199208,.,0,0
199209,The,0,0
199210,present,0,0
199211,prospective,0,0
199212,",",0,1
199213,randomized,0,0
199214,study,0,0
199215,was,0,0
199216,conducted,0,0
199217,with,0,0
199218,50,0,0
199219,patients,0,0
199220,submitted,0,0
199221,to,0,0
199222,curative,0,0
199223,adjuvant,0,0
199224,irradiation,0,0
199225,following,0,0
199226,surgery,0,0
199227,for,0,0
199228,mammary,0,1
199229,carcinoma,0,0
199230,.,0,0
199231,The,0,0
199232,radiotherapy,0,0
199233,was,0,0
199234,performed,0,0
199235,in,0,0
199236,the,0,0
199237,same,0,0
199238,way,0,0
199239,in,0,0
199240,all,0,0
199241,patients,0,0
199242,with,0,0
199243,irradiations,0,0
199244,of,0,0
199245,the,0,0
199246,thoracic,0,0
199247,wall,0,1
199248,and,0,0
199249,the,0,0
199250,regional,0,0
199251,lymph,0,1
199252,nodes,0,0
199253,.,0,0
199254,Two,0,0
199255,groups,0,0
199256,were,0,0
199257,built,0,0
199258,by,0,0
199259,randomization,0,0
199260,.,0,0
199261,The,0,0
199262,study,0,0
199263,group,0,0
199264,received,0,0
199265,an,0,0
199266,additional,0,0
199267,treatment,0,0
199268,with,0,0
199269,Esberitox,0,0
199270,",",0,0
199271,the,0,0
199272,control,0,0
199273,group,0,0
199274,did,0,0
199275,not,0,0
199276,receive,0,0
199277,an,0,0
199278,additional,0,0
199279,treatment,0,0
199280,.,0,0
199281,3,0,0
199282,.,0,0
199283,As,0,0
199284,a,0,0
199285,result,0,0
199286,",",0,0
199287,no,0,0
199288,protective,0,0
199289,influence,0,0
199290,of,0,0
199291,Esberitox,0,0
199292,could,0,0
199293,be,0,0
199294,demonstrated,0,0
199295,.,0,0
199296,The,0,0
199297,parameters,0,1
199298,investigated,0,0
199299,were,0,0
199300,the,0,0
199301,peripheral,1,1
199302,blood,1,1
199303,count,1,1
199304,(,1,1
199305,leucocytes,1,1
199306,",",1,1
199307,granulocytes,1,1
199308,",",1,1
199309,lymphocytes,1,1
199310,",",1,1
199311,monocytes,1,1
199312,",",1,1
199313,thrombocytes,1,1
199314,",",1,1
199315,hemoglobin,1,1
199316,",",1,1
199317,hematocrit,1,1
199318,),1,1
199319,and,1,0
199320,the,1,0
199321,incidence,1,1
199322,of,1,0
199323,infections,1,1
199324,.,1,0
199325,4,0,0
199326,.,0,0
199327,This,0,0
199328,result,0,0
199329,diverging,0,0
199330,from,0,0
199331,literature,0,0
199332,is,0,0
199333,discussed,0,0
199334,.,0,0
199335,It,0,0
199336,is,0,0
199337,probably,0,0
199338,affected,0,0
199339,by,0,0
199340,volume,0,1
199341,and,0,1
199342,extension,0,0
199343,of,0,0
199344,the,0,0
199345,injury,0,1
199346,induced,0,0
199347,by,0,0
199348,a,0,0
199349,hematotoxic,0,1
199350,noxa,0,1
199351,and,0,1
199352,furthermore,0,0
199353,by,0,0
199354,the,0,0
199355,ability,0,1
199356,of,0,0
199357,regeneration,0,1
199358,.,0,0
199359,If,0,0
199360,this,0,0
199361,ability,0,0
199362,is,0,0
199363,exhausted,0,0
199364,",",0,0
199365,the,0,0
199366,protective,0,0
199367,effect,0,0
199368,of,0,0
199369,Esberitox,0,0
199370,can,0,0
199371,act,0,0
199372,no,0,0
199373,longer,0,0
199374,.,0,0
199375,Therefore,0,0
199376,the,0,0
199377,essential,0,0
199378,factor,0,0
199379,seems,0,0
199380,to,0,0
199381,be,0,0
199382,the,0,0
199383,duration,0,1
199384,of,0,0
199385,exposure,0,0
199386,to,0,0
199387,the,0,0
199388,noxa,0,0
199389,.,0,1
199390,Esberitox,0,0
199391,was,0,0
199392,effective,0,1
199393,in,0,0
199394,case,0,0
199395,of,0,0
199396,a,0,0
199397,short,0,1
199398,toxicity,0,1
199399,",",0,0
199400,it,0,0
199401,was,0,0
199402,ineffective,0,1
199403,in,0,0
199404,case,0,0
199405,of,0,1
199406,prolonged,0,1
199407,toxicity,0,1
199408,",",0,0
199409,if,0,0
199410,the,0,0
199411,treatment,0,0
199412,continuity,0,1
199413,(,0,1
199414,noxa,0,1
199415,),0,1
199416,was,0,0
199417,not,0,0
199418,broken,0,0
199419,up,0,0
199420,by,0,0
199421,some,0,0
199422,regeneration,0,0
199423,intervals,0,0
199424,.,0,0
199425,The,0,0
199426,radiotherapy,0,0
199427,studied,0,0
199428,in,0,0
199429,this,0,0
199430,trial,0,0
199431,had,0,0
199432,a,0,0
199433,duration,0,1
199434,of,0,0
199435,50,0,0
199436,days,0,0
199437,",",0,0
199438,and,0,1
199439,its,0,1
199440,effect,0,1
199441,was,0,0
199442,that,0,0
199443,of,0,0
199444,a,0,0
199445,longterm,0,0
199446,injury,0,0
199447,.,0,0
199448,The,0,0
199449,therapeutic,1,0
199450,efficacy,1,1
199451,and,1,1
199452,cost-effectiveness,1,1
199453,of,0,1
199454,aggressive,0,1
199455,tocolysis,0,1
199456,for,0,0
199457,premature,0,0
199458,labor,0,1
199459,associated,0,0
199460,with,0,0
199461,premature,0,0
199462,rupture,0,0
199463,of,0,0
199464,the,0,0
199465,membranes,0,0
199466,.,0,0
199467,We,0,0
199468,conducted,0,0
199469,a,0,0
199470,randomized,0,0
199471,trial,0,0
199472,comparing,0,0
199473,bed,0,1
199474,rest,0,0
199475,with,0,0
199476,tocolysis,0,0
199477,to,0,0
199478,determine,0,0
199479,the,0,0
199480,therapeutic,1,0
199481,efficacy,1,1
199482,",",1,1
199483,safety,1,1
199484,",",1,1
199485,and,1,1
199486,cost-effectiveness,1,1
199487,of,0,1
199488,tocolysis,0,0
199489,for,0,0
199490,the,0,0
199491,treatment,0,0
199492,of,0,0
199493,preterm,0,0
199494,labor,0,1
199495,after,0,0
199496,membrane,0,1
199497,rupture,0,0
199498,.,0,0
199499,One,0,0
199500,hundred,0,0
199501,nine,0,0
199502,women,0,0
199503,participated,0,0
199504,over,0,0
199505,a,0,0
199506,26-month,0,0
199507,interval,0,0
199508,.,0,0
199509,Treatment,0,0
199510,groups,0,0
199511,did,0,0
199512,not,0,0
199513,differ,0,0
199514,significantly,0,0
199515,in,0,0
199516,terms,0,1
199517,of,0,0
199518,gestational,1,1
199519,age,1,0
199520,at,1,0
199521,membrane,1,1
199522,rupture,1,1
199523,",",1,1
199524,gestational,1,1
199525,age,1,0
199526,at,1,1
199527,delivery,1,1
199528,",",1,1
199529,birth,1,1
199530,weight,1,1
199531,",",1,1
199532,maternal,1,1
199533,or,1,1
199534,fetal,1,1
199535,infectious,1,1
199536,morbidity,1,1
199537,",",1,1
199538,respiratory,1,1
199539,distress,1,1
199540,syndrome,1,1
199541,",",1,1
199542,necrotizing,1,1
199543,enterocolitis,1,1
199544,",",1,1
199545,or,1,1
199546,perinatal,1,1
199547,mortality,1,1
199548,.,1,1
199549,Prolongation,0,1
199550,of,0,1
199551,intrauterine,0,0
199552,time,0,1
199553,after,0,0
199554,the,0,0
199555,onset,0,1
199556,of,0,0
199557,uterine,0,1
199558,contractions,0,1
199559,was,0,0
199560,seen,0,0
199561,in,0,0
199562,women,0,0
199563,receiving,0,0
199564,tocolysis,0,1
199565,(,0,0
199566,105.2,0,0
199567,+/-,0,0
199568,157,0,0
199569,hours,0,0
199570,versus,0,0
199571,62.1,0,0
199572,+/-,0,0
199573,77,0,0
199574,hours,0,0
199575,",",0,0
199576,p,0,0
199577,=,0,0
199578,0.06,0,0
199579,),0,0
199580,.,0,0
199581,This,0,0
199582,prolongation,0,1
199583,was,0,0
199584,not,0,0
199585,associated,0,0
199586,with,0,0
199587,a,0,0
199588,significant,0,0
199589,reduction,0,1
199590,in,0,0
199591,the,0,0
199592,total,1,1
199593,cost,1,1
199594,per,0,0
199595,surviving,0,1
199596,infant,0,1
199597,(,0,1
199598,tocolysis,0,1
199599,",",0,0
199600,$,0,0
199601,"38,593",0,0
199602,+/-,0,0
199603,$,0,0
199604,"40,887",0,0
199605,versus,0,0
199606,bed,0,1
199607,rest,0,1
199608,",",0,0
199609,$,0,0
199610,"43,158",0,0
199611,+/-,0,0
199612,$,0,0
199613,"37,116",0,0
199614,;,0,0
199615,p,0,0
199616,=,0,0
199617,0.445,0,0
199618,),0,0
199619,.,0,0
199620,The,0,0
199621,cost,1,1
199622,difference,1,0
199623,was,0,0
199624,artifactual,0,1
199625,.,0,0
199626,The,0,0
199627,number,0,1
199628,of,0,0
199629,very,1,0
199630,premature,1,0
199631,infants,1,0
199632,born,1,0
199633,(,0,0
199634,less,0,0
199635,than,0,0
199636,28,0,0
199637,weeks,0,0
199638,',0,0
199639,gestation,0,1
199640,),0,1
199641,was,0,0
199642,unequal,0,0
199643,in,0,0
199644,the,0,0
199645,two,0,0
199646,groups,0,0
199647,(,0,0
199648,12,0,0
199649,in,0,0
199650,the,0,0
199651,bed,0,1
199652,rest,0,1
199653,group,0,0
199654,and,0,0
199655,5,0,0
199656,in,0,0
199657,the,0,0
199658,tocolysis,0,1
199659,group,0,0
199660,),0,1
199661,and,0,0
199662,skewed,0,0
199663,the,0,0
199664,results,0,0
199665,.,0,0
199666,Before,0,0
199667,28,0,0
199668,weeks,0,0
199669,',0,0
199670,gestation,0,1
199671,tocolysis,0,1
199672,was,0,0
199673,associated,0,0
199674,with,0,0
199675,a,0,0
199676,significant,0,0
199677,increase,1,0
199678,in,1,0
199679,intrauterine,1,0
199680,time,1,1
199681,after,0,0
199682,the,0,0
199683,onset,0,1
199684,of,0,0
199685,regular,1,0
199686,contractions,1,1
199687,(,0,0
199688,p,0,0
199689,=,0,0
199690,0.05,0,0
199691,),0,0
199692,.,0,0
199693,However,0,0
199694,",",0,0
199695,there,0,0
199696,was,0,0
199697,no,0,0
199698,identifiable,0,0
199699,perinatal,0,1
199700,benefit,0,0
199701,garnered,0,0
199702,from,0,0
199703,the,0,0
199704,additional,0,0
199705,5,0,0
199706,days,0,0
199707,.,0,0
199708,After,0,0
199709,28,0,0
199710,weeks,0,0
199711,there,0,0
199712,were,0,0
199713,no,0,0
199714,significant,0,0
199715,differences,0,0
199716,between,0,0
199717,treatment,0,0
199718,groups,0,0
199719,in,0,0
199720,terms,0,1
199721,of,0,1
199722,intrauterine,1,0
199723,time,1,1
199724,after,0,0
199725,the,0,0
199726,onset,0,1
199727,of,0,0
199728,regular,1,0
199729,contractions,1,1
199730,and,0,1
199731,total,1,1
199732,cost,1,1
199733,per,0,0
199734,surviving,0,1
199735,infant,0,0
199736,.,0,0
199737,Because,0,0
199738,tocolysis,0,0
199739,does,0,0
199740,not,0,0
199741,improve,0,0
199742,perinatal,0,1
199743,outcome,0,1
199744,and,0,0
199745,can,0,0
199746,itself,0,0
199747,be,0,0
199748,associated,0,0
199749,with,0,0
199750,major,0,0
199751,maternal,0,1
199752,morbidity,0,1
199753,",",0,0
199754,it,0,0
199755,should,0,0
199756,be,0,0
199757,avoided,0,0
199758,after,0,0
199759,28,0,0
199760,weeks,0,0
199761,',0,0
199762,gestation,0,1
199763,.,0,0
199764,Before,0,0
199765,28,0,0
199766,weeks,0,0
199767,',0,0
199768,gestation,0,0
199769,tocolysis,0,0
199770,may,0,0
199771,greatly,0,0
199772,increase,0,0
199773,intrauterine,0,0
199774,time,0,1
199775,",",0,0
199776,but,0,0
199777,the,0,0
199778,benefit,0,0
199779,of,0,0
199780,this,0,0
199781,prolongation,0,1
199782,is,0,0
199783,not,0,0
199784,clear,0,0
199785,.,0,0
199786,Heparin,0,1
199787,plus,0,0
199788,dipyridamole,0,0
199789,in,0,0
199790,childhood,0,0
199791,hemolytic-uremic,0,1
199792,syndrome,0,0
199793,:,0,0
199794,a,0,0
199795,prospective,0,0
199796,",",0,0
199797,randomized,0,0
199798,study,0,0
199799,.,0,0
199800,From,0,0
199801,1976,0,0
199802,to,0,0
199803,1985,0,0
199804,",",0,0
199805,a,0,0
199806,total,0,1
199807,of,0,0
199808,58,0,0
199809,infants,0,0
199810,and,0,0
199811,children,0,0
199812,with,0,0
199813,the,0,0
199814,hemolytic-uremic,0,1
199815,syndrome,0,0
199816,were,0,0
199817,randomly,0,0
199818,assigned,0,0
199819,to,0,0
199820,treatment,0,0
199821,either,0,0
199822,with,0,0
199823,heparin,0,0
199824,and,0,1
199825,dipyridamole,0,0
199826,or,0,1
199827,with,0,0
199828,supportive,0,0
199829,management,0,0
199830,only,0,0
199831,.,0,0
199832,In,0,0
199833,the,0,0
199834,treatment,0,0
199835,group,0,0
199836,",",0,0
199837,two,0,0
199838,patients,0,0
199839,died,0,0
199840,in,0,0
199841,the,0,0
199842,early,0,0
199843,weeks,0,0
199844,of,0,0
199845,the,0,0
199846,disease,0,0
199847,.,0,0
199848,Analysis,0,0
199849,of,0,1
199850,clinical,0,1
199851,and,0,1
199852,laboratory,0,1
199853,data,0,0
199854,showed,0,0
199855,no,0,0
199856,significant,0,0
199857,difference,0,0
199858,between,0,0
199859,either,0,0
199860,group,0,0
199861,of,0,0
199862,patients,0,0
199863,as,0,0
199864,to,0,0
199865,the,0,0
199866,evolution,0,1
199867,of,0,0
199868,their,0,0
199869,illness,0,1
199870,except,0,0
199871,for,0,0
199872,a,0,0
199873,significantly,0,0
199874,higher,0,0
199875,incidence,1,1
199876,of,1,1
199877,anuria,1,1
199878,and,0,0
199879,a,0,0
199880,significantly,0,0
199881,faster,1,0
199882,recovery,1,1
199883,from,1,0
199884,hypertension,1,0
199885,in,0,0
199886,the,0,0
199887,treated,0,0
199888,group,0,0
199889,.,0,1
199890,Renal,0,1
199891,biopsy,0,1
199892,studies,0,0
199893,showed,0,0
199894,no,0,0
199895,differences,0,0
199896,between,0,0
199897,the,0,0
199898,two,0,0
199899,groups,0,0
199900,in,0,0
199901,terms,0,1
199902,of,0,1
199903,incidence,1,1
199904,and,1,1
199905,severity,1,1
199906,of,1,0
199907,the,1,0
199908,histologic,1,1
199909,lesions,1,1
199910,.,1,0
199911,The,0,0
199912,long-term,0,0
199913,data,0,0
199914,on,0,0
199915,blood,1,1
199916,pressure,1,1
199917,and,1,1
199918,creatinine,1,1
199919,clearance,1,1
199920,values,1,1
199921,in,0,0
199922,the,0,0
199923,survivors,0,0
199924,were,0,0
199925,similar,0,0
199926,in,0,0
199927,both,0,0
199928,groups,0,0
199929,.,0,0
199930,This,0,0
199931,study,0,0
199932,indicates,0,0
199933,that,0,0
199934,treatment,0,0
199935,with,0,0
199936,heparin,1,0
199937,and,1,0
199938,dipyridamole,1,0
199939,has,0,0
199940,no,0,0
199941,benefit,1,0
199942,over,1,0
199943,symptomatic,1,1
199944,therapy,1,0
199945,alone,0,0
199946,in,0,0
199947,the,0,0
199948,typical,0,0
199949,form,0,0
199950,of,0,1
199951,childhood,0,0
199952,hemolytic-uremic,0,1
199953,syndrome,0,0
199954,.,0,0
199955,Comparison,0,0
199956,of,0,1
199957,intermittent,0,0
199958,or,0,0
199959,continuous,0,1
199960,methotrexate,0,0
199961,plus,0,0
199962,6-mercaptopurine,0,0
199963,in,0,0
199964,regimens,0,0
199965,for,0,0
199966,standard-risk,0,0
199967,acute,0,0
199968,lymphoblastic,0,0
199969,leukemia,0,0
199970,in,0,0
199971,childhood,0,1
199972,(,0,1
199973,JCCLSG-S811,0,0
199974,),0,0
199975,.,0,0
199976,The,0,0
199977,Japanese,0,0
199978,Children,0,0
199979,'s,0,1
199980,Cancer,0,0
199981,and,0,1
199982,Leukemia,0,1
199983,Study,0,0
199984,Group,0,0
199985,.,0,0
199986,From,0,0
199987,1981,0,0
199988,to,0,0
199989,1983,0,0
199990,",",0,0
199991,131,0,0
199992,previously,0,0
199993,untreated,0,0
199994,patients,0,0
199995,with,0,0
199996,acute,0,0
199997,lymphoblastic,0,0
199998,leukemia,0,0
199999,(,0,0
200000,ALL,0,0
200001,),0,0
200002,standard-risk,0,0
200003,group,0,0
200004,were,0,0
200005,entered,0,0
200006,to,0,0
200007,the,0,0
200008,protocol,0,0
200009,JCCLSG-S811,0,0
200010,.,0,0
200011,Of,0,0
200012,119,0,0
200013,eligible,0,0
200014,patients,0,0
200015,",",0,0
200016,115,0,0
200017,(,0,0
200018,96.6,0,0
200019,%,0,0
200020,),0,0
200021,attained,0,0
200022,complete,0,1
200023,remission,0,1
200024,by,0,0
200025,treatment,0,0
200026,with,0,0
200027,prednisone,0,0
200028,(,0,1
200029,PRD,0,1
200030,),0,1
200031,plus,0,0
200032,vincristine,0,0
200033,(,0,1
200034,VCR,0,0
200035,),0,1
200036,or,0,1
200037,vindesine,0,0
200038,(,0,1
200039,VDS,0,0
200040,),0,0
200041,.,0,0
200042,After,0,0
200043,preventive,0,0
200044,central,0,1
200045,nervous,0,1
200046,system,0,0
200047,(,0,1
200048,CNS,0,0
200049,),0,1
200050,therapy,0,0
200051,including,0,0
200052,18,0,0
200053,Gy,0,0
200054,cranial,0,1
200055,irradiation,0,0
200056,and,0,0
200057,three,0,0
200058,doses,0,0
200059,of,0,0
200060,intrathecal,0,1
200061,methotrexate,0,0
200062,(,0,1
200063,MTX,0,1
200064,),0,0
200065,",",0,0
200066,the,0,0
200067,patients,0,0
200068,were,0,0
200069,assigned,0,0
200070,randomly,0,0
200071,to,0,0
200072,the,0,0
200073,two,0,0
200074,maintenance,0,0
200075,chemotherapies,0,0
200076,",",0,1
200077,Regimen,0,0
200078,A,0,0
200079,and,0,1
200080,Regimen,0,0
200081,B,0,0
200082,.,0,0
200083,Regimen,0,0
200084,A,0,0
200085,(,0,0
200086,intermittent,0,0
200087,regimen,0,0
200088,),0,0
200089,consisted,0,0
200090,of,0,0
200091,PRD,0,0
200092,(,0,0
200093,120,0,0
200094,mg/m2/day,0,0
200095,by,0,0
200096,mouth,0,1
200097,for,0,0
200098,5,0,0
200099,days,0,0
200100,),0,0
200101,plus,0,0
200102,6-mercaptopurine,0,0
200103,(,0,0
200104,6MP,0,1
200105,),0,0
200106,(,0,0
200107,175,0,0
200108,mg/m2/day,0,0
200109,by,0,0
200110,mouth,0,1
200111,for,0,0
200112,5,0,0
200113,days,0,0
200114,),0,0
200115,plus,0,0
200116,VCR,0,0
200117,(,0,0
200118,2.0,0,0
200119,mg/m2,0,0
200120,intravenously,0,0
200121,),0,0
200122,alternating,0,0
200123,biweekly,0,0
200124,with,0,0
200125,MTX,0,0
200126,(,0,0
200127,225,0,0
200128,mg/m2,0,0
200129,intravenously,0,0
200130,),0,0
200131,.,0,0
200132,Regimen,0,0
200133,B,0,0
200134,(,0,0
200135,continuous,0,0
200136,regimen,0,0
200137,),0,0
200138,consisted,0,0
200139,of,0,0
200140,6MP,0,0
200141,(,0,0
200142,50,0,0
200143,mg/m2/day,0,0
200144,by,0,0
200145,mouth,0,1
200146,),0,1
200147,plus,0,0
200148,MTX,0,0
200149,(,0,0
200150,20,0,0
200151,mg/m2/week,0,0
200152,by,0,0
200153,mouth,0,1
200154,),0,0
200155,combined,0,0
200156,with,0,0
200157,pulses,1,0
200158,of,1,1
200159,PRD,1,0
200160,and,1,1
200161,VCR,1,0
200162,(,0,0
200163,the,0,0
200164,same,0,0
200165,dosages,0,0
200166,as,0,0
200167,Regimen,0,0
200168,A,0,0
200169,),0,0
200170,every,0,0
200171,4,0,0
200172,weeks,0,0
200173,.,0,0
200174,As,0,0
200175,the,0,0
200176,late,0,1
200177,intensification,0,1
200178,therapy,0,0
200179,(,0,1
200180,LIT,0,1
200181,),0,0
200182,",",0,0
200183,five,0,0
200184,courses,0,0
200185,of,0,0
200186,high-dose,0,0
200187,MTX,0,0
200188,(,0,0
200189,2000,0,0
200190,mg/m2,0,0
200191,per,0,0
200192,dose,0,0
200193,per,0,0
200194,week,0,0
200195,intravenously,0,0
200196,for,0,0
200197,three,0,0
200198,doses,0,0
200199,every,0,0
200200,12,0,0
200201,weeks,0,0
200202,),0,0
200203,with,0,0
200204,leucovorin,0,0
200205,rescue,0,1
200206,were,0,0
200207,administered,0,0
200208,to,0,0
200209,all,0,0
200210,patients,0,0
200211,who,0,0
200212,were,0,0
200213,in,0,0
200214,continuous,0,0
200215,complete,0,1
200216,remission,0,1
200217,(,0,1
200218,CCR,0,0
200219,),0,0
200220,for,0,0
200221,more,0,0
200222,than,0,0
200223,2,0,0
200224,years,0,0
200225,.,0,0
200226,Sixty,0,0
200227,and,0,0
200228,55,0,0
200229,patients,0,0
200230,",",0,0
200231,respectively,0,0
200232,",",0,0
200233,were,0,0
200234,registered,0,0
200235,in,0,0
200236,Regimen,0,0
200237,A,0,0
200238,and,0,1
200239,B,0,0
200240,.,0,0
200241,The,0,0
200242,CCR,1,0
200243,rates,1,1
200244,in,0,0
200245,Regimen,0,0
200246,A,0,0
200247,and,0,1
200248,B,0,0
200249,were,0,0
200250,75.1,0,0
200251,%,0,0
200252,+/-,0,0
200253,5.8,0,0
200254,%,0,0
200255,(,0,0
200256,mean,0,1
200257,+/-,0,0
200258,1,0,0
200259,SE,0,0
200260,),0,0
200261,and,0,0
200262,49.7,0,0
200263,%,0,0
200264,+/-,0,0
200265,7.3,0,0
200266,%,0,0
200267,(,0,0
200268,P,0,0
200269,less,0,0
200270,than,0,0
200271,0.01,0,0
200272,),0,0
200273,at,0,0
200274,4,0,0
200275,years,0,0
200276,",",0,0
200277,and,0,0
200278,72.1,0,0
200279,%,0,0
200280,+/-,0,0
200281,6.3,0,0
200282,%,0,0
200283,and,0,0
200284,49.7,0,0
200285,%,0,0
200286,+/-,0,0
200287,7.3,0,0
200288,%,0,0
200289,(,0,0
200290,P,0,0
200291,less,0,0
200292,than,0,0
200293,0.05,0,0
200294,),0,0
200295,at,0,0
200296,5,0,0
200297,years,0,0
200298,",",0,0
200299,respectively,0,0
200300,.,0,0
200301,In,0,0
200302,Regimen,0,0
200303,B,0,0
200304,",",0,1
200305,CNS,1,1
200306,and,1,1
200307,testicular,1,1
200308,relapses,1,1
200309,increased,0,0
200310,after,0,0
200311,3,0,0
200312,years,0,0
200313,of,0,0
200314,CCR,0,0
200315,.,0,0
200316,In,0,0
200317,addition,0,0
200318,",",0,0
200319,the,0,0
200320,patients,0,0
200321,in,0,0
200322,Regimen,0,0
200323,B,0,0
200324,had,0,0
200325,a,0,0
200326,much,0,0
200327,higher,0,0
200328,incidence,1,1
200329,of,1,1
200330,infections,1,1
200331,than,0,0
200332,Regimen,0,0
200333,A,0,0
200334,.,0,0
200335,The,0,0
200336,LIT,0,1
200337,did,0,0
200338,not,0,0
200339,seem,0,0
200340,to,0,0
200341,have,0,0
200342,important,0,0
200343,effects,0,0
200344,on,0,0
200345,the,0,0
200346,duration,1,1
200347,of,1,0
200348,CCR,1,0
200349,.,1,0
200350,From,0,0
200351,these,0,0
200352,data,0,0
200353,we,0,0
200354,conclude,0,0
200355,that,0,0
200356,the,0,0
200357,intermittent,0,0
200358,cyclic,0,1
200359,regimen,0,0
200360,of,0,0
200361,6MP,0,0
200362,and,0,0
200363,MTX,0,0
200364,may,0,0
200365,be,0,0
200366,more,0,0
200367,effective,0,1
200368,as,0,0
200369,compared,0,0
200370,to,0,0
200371,the,0,0
200372,continuous,0,0
200373,administration,0,0
200374,of,0,0
200375,these,0,0
200376,drugs,0,0
200377,in,0,0
200378,the,0,0
200379,maintenance,0,0
200380,chemotherapy,0,0
200381,.,0,0
200382,[,1,0
200383,Prevention,1,0
200384,of,1,1
200385,thromboembolism,1,1
200386,in,0,0
200387,patients,0,0
200388,operated,0,0
200389,on,0,0
200390,for,0,0
200391,hip,0,1
200392,prosthesis,0,0
200393,],0,0
200394,.,0,0
200395,The,0,0
200396,latest,0,0
200397,research,0,0
200398,into,0,0
200399,the,0,0
200400,prevention,1,0
200401,of,1,1
200402,peri-,1,1
200403,and,1,1
200404,postoperative,1,1
200405,thromboembolic,1,1
200406,disease,1,0
200407,has,0,0
200408,found,0,0
200409,orthopaedic,0,0
200410,surgery,0,0
200411,patients,0,0
200412,to,0,0
200413,be,0,0
200414,most,0,0
200415,at,0,0
200416,risk,0,1
200417,.,0,0
200418,As,0,0
200419,the,0,0
200420,genesis,0,0
200421,of,0,0
200422,deep,0,1
200423,venous,0,1
200424,thrombosis,0,1
200425,(,0,1
200426,DVT,0,0
200427,),0,0
200428,is,0,0
200429,due,0,0
200430,to,0,0
200431,haemodynamic,0,1
200432,",",0,0
200433,hemorheologic,0,1
200434,and,0,1
200435,parietal,0,1
200436,factors,0,1
200437,",",0,0
200438,various,0,0
200439,prophylactic,0,0
200440,measures,0,0
200441,have,0,0
200442,been,0,0
200443,considered,0,0
200444,in,0,0
200445,the,0,0
200446,past,0,0
200447,",",0,0
200448,measures,0,0
200449,which,0,0
200450,have,0,0
200451,not,0,0
200452,proved,0,0
200453,able,0,0
200454,to,0,0
200455,provide,0,0
200456,satisfactory,0,1
200457,protection,0,1
200458,in,0,0
200459,orthopaedics,0,0
200460,.,0,0
200461,The,0,0
200462,results,0,0
200463,obtained,0,0
200464,with,0,0
200465,Defibrotide,0,0
200466,in,0,0
200467,a,0,0
200468,random,0,0
200469,and,0,1
200470,controlled,0,0
200471,clinical,0,1
200472,study,0,0
200473,versus,0,0
200474,calcium,0,1
200475,heparin,0,0
200476,involving,0,0
200477,211,0,0
200478,patients,0,0
200479,of,0,0
200480,both,0,0
200481,sexes,0,0
200482,candidates,0,0
200483,to,0,0
200484,receive,0,0
200485,total,0,1
200486,hip,0,1
200487,arthroplasty,0,1
200488,and,0,1
200489,presenting,0,1
200490,at,0,0
200491,least,0,0
200492,one,0,0
200493,major,0,0
200494,thromboembolic,0,1
200495,risk,0,1
200496,factor,0,0
200497,are,0,0
200498,reported,0,0
200499,.,0,0
200500,The,0,0
200501,patients,0,0
200502,were,0,0
200503,assigned,0,0
200504,at,0,0
200505,random,0,0
200506,to,0,0
200507,one,0,0
200508,of,0,0
200509,the,0,0
200510,following,0,0
200511,treatments,0,0
200512,:,0,0
200513,1,0,0
200514,),0,0
200515,Defibrotide,0,0
200516,at,0,0
200517,a,0,0
200518,dose,0,0
200519,of,0,0
200520,400,0,0
200521,mg,0,0
200522,b.i.d,0,0
200523,.,0,0
200524,i.v,0,0
200525,.,0,0
200526,in,0,0
200527,50,0,0
200528,ml,0,0
200529,phleboclysis,0,0
200530,in,0,0
200531,5,0,0
200532,minutes,0,0
200533,(,0,0
200534,n,0,0
200535,=,0,0
200536,108,0,0
200537,),0,0
200538,;,0,0
200539,2,0,0
200540,),0,0
200541,calcium,0,0
200542,heparin,0,0
200543,at,0,0
200544,a,0,0
200545,dose,0,0
200546,of,0,0
200547,5000,0,0
200548,IU,0,0
200549,t.i.d,0,0
200550,.,0,0
200551,subcutaneously,0,0
200552,(,0,0
200553,n,0,0
200554,=,0,0
200555,103,0,0
200556,),0,0
200557,.,0,0
200558,The,0,0
200559,treatment,0,0
200560,began,0,0
200561,the,0,0
200562,day,0,0
200563,before,0,0
200564,operation,0,0
200565,and,0,1
200566,continued,0,0
200567,on,0,0
200568,average,0,0
200569,up,0,0
200570,to,0,0
200571,the,0,0
200572,eighth,0,0
200573,day,0,0
200574,for,0,0
200575,the,0,0
200576,Defibrotide,0,0
200577,group,0,0
200578,.,0,0
200579,With,0,0
200580,the,0,0
200581,control,0,0
200582,group,0,0
200583,it,0,0
200584,continued,0,0
200585,until,0,0
200586,discharge,0,1
200587,(,0,0
200588,usually,0,0
200589,on,0,0
200590,the,0,0
200591,15th,0,0
200592,day,0,0
200593,),0,1
200594,and,0,1
200595,at,0,0
200596,home,0,0
200597,for,0,0
200598,about,0,0
200599,three,0,0
200600,weeks,0,0
200601,until,0,0
200602,the,0,0
200603,completion,0,0
200604,of,0,0
200605,the,0,0
200606,physiotherapy,0,0
200607,cycle,0,1
200608,.,0,0
200609,In,0,0
200610,the,0,0
200611,108,0,0
200612,patients,0,0
200613,treated,0,0
200614,with,0,0
200615,Defibrotide,0,0
200616,only,0,0
200617,one,0,0
200618,case,0,0
200619,of,0,0
200620,DVT,1,1
200621,was,0,0
200622,reported,0,0
200623,and,0,0
200624,in,0,0
200625,none,0,0
200626,of,0,0
200627,these,0,0
200628,patients,0,0
200629,were,0,0
200630,symptoms,1,1
200631,or,1,0
200632,signs,1,1
200633,of,1,1
200634,pulmonary,1,1
200635,embolism,1,0
200636,encountered,0,0
200637,.,0,0
200638,In,0,0
200639,the,0,0
200640,group,0,0
200641,treated,0,0
200642,with,0,0
200643,calcium,0,1
200644,heparin,0,0
200645,2,0,0
200646,cases,0,0
200647,of,0,0
200648,clinically,0,0
200649,and,0,0
200650,radiologically,1,1
200651,diagnosed,1,0
200652,pulmonary,1,1
200653,embolism,1,1
200654,and,0,0
200655,4,0,0
200656,cases,1,0
200657,of,1,0
200658,DVT,1,1
200659,were,0,0
200660,observed,0,0
200661,.,0,0
200662,Although,0,0
200663,the,0,0
200664,differences,0,0
200665,were,0,0
200666,not,0,0
200667,statistically,0,0
200668,significant,0,0
200669,",",0,0
200670,the,0,0
200671,tendency,0,0
200672,favours,0,0
200673,Defibrotide,0,0
200674,.,0,0
200675,Statistically,0,0
200676,significant,0,0
200677,(,0,0
200678,p,0,0
200679,less,0,0
200680,than,0,0
200681,0.01,0,0
200682,),0,0
200683,was,0,0
200684,the,0,0
200685,difference,0,0
200686,in,0,0
200687,postoperative,1,1
200688,bleeding,1,1
200689,evaluated,1,0
200690,with,0,0
200691,particular,0,0
200692,attention,0,1
200693,in,0,0
200694,patients,0,0
200695,of,0,0
200696,advanced,0,0
200697,age,0,0
200698,.,0,1
200699,Further,0,1
200700,",",0,0
200701,in,0,0
200702,the,0,0
200703,Defibrotide,0,0
200704,group,0,0
200705,",",0,1
200706,scarring,1,1
200707,was,0,0
200708,considered,0,0
200709,excellent,0,0
200710,in,0,0
200711,96,0,0
200712,%,0,0
200713,of,0,0
200714,cases,0,0
200715,while,0,0
200716,in,0,0
200717,the,0,0
200718,heparin,0,0
200719,group,0,0
200720,scarring,1,1
200721,was,0,0
200722,excellent,0,0
200723,in,0,0
200724,85,0,0
200725,%,0,0
200726,(,0,0
200727,p,0,0
200728,less,0,0
200729,than,0,0
200730,0.05,0,0
200731,),0,0
200732,.,0,0
200733,To,0,0
200734,conclude,0,0
200735,",",0,0
200736,the,0,0
200737,sure,0,1
200738,clinical,1,1
200739,effectiveness,1,1
200740,",",1,1
200741,tolerance,1,1
200742,",",1,1
200743,handiness,1,1
200744,and,1,1
200745,lack,1,0
200746,of,1,1
200747,interference,1,1
200748,with,1,0
200749,clotting,1,1
200750,functions,1,0
200751,make,0,0
200752,Defibrotide,0,0
200753,a,0,0
200754,really,0,0
200755,useful,0,0
200756,drug,0,0
200757,for,0,0
200758,the,0,0
200759,prevention,0,0
200760,of,0,0
200761,thromboembolic,1,1
200762,episodes,0,1
200763,in,0,0
200764,patients,0,0
200765,undergoing,0,0
200766,major,0,1
200767,orthopaedic,0,0
200768,surgery,0,0
200769,.,0,0
200770,Alpha,0,1
200771,interferon,0,1
200772,clinical,0,0
200773,trial,0,0
200774,for,0,0
200775,multiple,0,0
200776,sclerosis,0,0
200777,:,0,0
200778,design,0,0
200779,considerations,0,0
200780,.,0,0
200781,The,0,0
200782,design,0,0
200783,and,0,1
200784,course,0,1
200785,of,0,0
200786,a,0,0
200787,placebo-controlled,0,0
200788,alpha-2,0,0
200789,interferon,0,1
200790,trial,0,0
200791,in,0,0
200792,MS,0,0
200793,patients,0,0
200794,are,0,0
200795,described,0,0
200796,.,0,0
200797,No,1,0
200798,beneficial,1,0
200799,effect,1,0
200800,of,0,0
200801,the,0,0
200802,interferon,1,0
200803,on,0,0
200804,the,0,0
200805,course,0,0
200806,of,0,0
200807,MS,0,0
200808,could,0,0
200809,be,0,0
200810,shown,0,0
200811,.,0,0
200812,Incidence,0,1
200813,of,0,1
200814,infectious,1,1
200815,symptoms,1,1
200816,after,0,0
200817,radiation,0,0
200818,therapy,0,0
200819,for,0,0
200820,breast,0,0
200821,cancer,0,0
200822,.,0,1
200823,Long-term,0,0
200824,effects,0,0
200825,.,0,0
200826,The,0,0
200827,incidence,0,1
200828,of,0,0
200829,symptoms,0,1
200830,generally,0,0
200831,associated,0,0
200832,with,0,0
200833,infectious,0,1
200834,disease,0,1
200835,was,0,0
200836,assessed,0,0
200837,by,0,0
200838,a,0,0
200839,questionnaire,0,1
200840,sent,0,0
200841,out,0,0
200842,to,0,0
200843,519,0,0
200844,disease-free,0,0
200845,breast,0,0
200846,cancer,0,0
200847,patients,0,0
200848,7,0,0
200849,to,0,0
200850,12,0,0
200851,years,0,0
200852,after,0,0
200853,primary,0,0
200854,treatment,0,0
200855,.,0,0
200856,All,0,0
200857,patients,0,0
200858,were,0,0
200859,treated,0,0
200860,in,0,0
200861,the,0,0
200862,context,0,0
200863,of,0,0
200864,a,0,0
200865,randomized,0,0
200866,trial,0,0
200867,where,0,0
200868,pre-,0,1
200869,and,0,1
200870,postoperative,0,1
200871,radiation,0,0
200872,(,0,0
200873,45,0,0
200874,Gy,0,0
200875,),0,0
200876,was,0,0
200877,evaluated,0,0
200878,versus,0,0
200879,surgery,0,0
200880,only,0,0
200881,.,0,0
200882,The,0,0
200883,results,0,0
200884,indicate,0,0
200885,a,0,0
200886,significantly,0,0
200887,higher,1,0
200888,morbidity,1,1
200889,among,0,0
200890,patients,0,0
200891,treated,0,0
200892,with,0,0
200893,preoperative,0,0
200894,irradiation,0,0
200895,compared,0,0
200896,with,0,0
200897,those,0,0
200898,irradiated,0,0
200899,postoperative,0,1
200900,(,0,0
200901,p,0,0
200902,less,0,0
200903,than,0,0
200904,0.05,0,0
200905,),0,0
200906,.,0,0
200907,This,0,0
200908,increased,0,0
200909,morbidity,0,1
200910,mainly,0,0
200911,seemed,0,0
200912,to,0,0
200913,be,0,0
200914,caused,0,0
200915,by,0,0
200916,symptoms,0,1
200917,usually,0,0
200918,associated,0,0
200919,with,0,0
200920,respiratory,0,1
200921,tract,0,1
200922,infection,0,1
200923,(,0,0
200924,p,0,0
200925,less,0,0
200926,than,0,0
200927,0.05,0,0
200928,),0,0
200929,.,0,0
200930,Although,0,0
200931,statistically,0,0
200932,not,0,0
200933,significant,0,0
200934,the,0,0
200935,preoperatively,0,0
200936,irradiated,0,0
200937,patients,0,0
200938,also,0,0
200939,had,0,0
200940,a,0,0
200941,higher,0,0
200942,morbidity,1,1
200943,than,0,0
200944,those,0,0
200945,treated,0,0
200946,with,0,0
200947,surgery,0,0
200948,alone,0,0
200949,.,0,0
200950,There,0,0
200951,was,0,0
200952,no,0,0
200953,difference,0,0
200954,between,0,0
200955,postoperatively,0,1
200956,irradiated,0,0
200957,patients,0,0
200958,and,0,1
200959,patients,0,0
200960,treated,0,0
200961,with,0,0
200962,surgery,0,0
200963,only,0,0
200964,.,0,0
200965,A,0,0
200966,significantly,0,0
200967,higher,0,0
200968,integral,0,1
200969,dose,0,1
200970,(,0,0
200971,absorbed,0,1
200972,energy,0,1
200973,within,0,0
200974,the,0,0
200975,body,0,1
200976,),0,0
200977,of,0,0
200978,the,0,0
200979,pre-,0,0
200980,compared,0,0
200981,with,0,0
200982,the,0,0
200983,postoperative,0,1
200984,group,0,0
200985,(,0,0
200986,p,0,0
200987,less,0,0
200988,than,0,0
200989,0.025,0,0
200990,),0,0
200991,is,0,0
200992,associated,0,0
200993,with,0,0
200994,the,0,0
200995,differences,0,0
200996,in,0,0
200997,morbidity,0,1
200998,between,0,0
200999,the,0,0
201000,two,0,0
201001,irradiated,0,0
201002,groups,0,0
201003,.,0,0
201004,An,0,0
201005,explanation,0,0
201006,for,0,0
201007,the,0,0
201008,increased,0,0
201009,morbidity,1,1
201010,seems,0,0
201011,to,0,0
201012,be,0,0
201013,that,0,0
201014,the,0,0
201015,volume,0,1
201016,of,0,1
201017,lung,0,1
201018,tissue,0,1
201019,",",0,1
201020,encompassed,0,0
201021,within,0,0
201022,the,0,0
201023,full-dose,0,0
201024,target,0,1
201025,volume,0,1
201026,",",0,0
201027,is,0,0
201028,the,0,0
201029,crucial,0,0
201030,factor,0,0
201031,.,0,0
201032,This,0,0
201033,volume,0,1
201034,was,0,0
201035,considerable,0,0
201036,in,0,0
201037,the,0,0
201038,preoperatively,0,0
201039,treated,0,0
201040,patients,0,0
201041,but,0,0
201042,kept,0,0
201043,at,0,0
201044,a,0,0
201045,minimum,0,1
201046,in,0,0
201047,the,0,0
201048,postoperative,0,1
201049,group,0,0
201050,.,0,0
201051,An,0,0
201052,evaluation,0,0
201053,of,0,1
201054,family,0,1
201055,therapy,0,0
201056,in,0,0
201057,anorexia,0,1
201058,nervosa,0,0
201059,and,0,1
201060,bulimia,0,1
201061,nervosa,0,0
201062,.,0,0
201063,A,0,0
201064,controlled,0,0
201065,trial,0,0
201066,comparing,0,0
201067,family,0,1
201068,therapy,0,0
201069,with,0,0
201070,individual,0,0
201071,supportive,0,0
201072,therapy,0,0
201073,in,0,0
201074,anorexia,0,1
201075,nervosa,0,0
201076,and,0,1
201077,bulimia,0,1
201078,nervosa,0,1
201079,was,0,0
201080,undertaken,0,0
201081,.,0,0
201082,Eighty,0,0
201083,patients,0,0
201084,(,0,0
201085,57,0,0
201086,with,0,0
201087,anorexia,0,0
201088,nervosa,0,0
201089,;,0,0
201090,23,0,0
201091,with,0,0
201092,bulimia,0,0
201093,nervosa,0,0
201094,),0,1
201095,were,0,0
201096,first,0,0
201097,admitted,0,0
201098,to,0,0
201099,a,0,0
201100,specialized,0,0
201101,unit,0,0
201102,to,0,0
201103,restore,0,0
201104,their,0,0
201105,weight,0,1
201106,to,0,0
201107,normal,0,0
201108,.,0,0
201109,Before,0,0
201110,discharge,0,0
201111,",",0,0
201112,they,0,0
201113,were,0,0
201114,randomly,0,0
201115,allocated,0,0
201116,to,0,0
201117,family,0,1
201118,therapy,0,0
201119,or,0,0
201120,the,0,0
201121,control,0,0
201122,treatment,0,0
201123,(,0,0
201124,individual,0,1
201125,supportive,0,0
201126,therapy,0,0
201127,),0,0
201128,.,0,0
201129,After,0,0
201130,one,0,0
201131,year,0,0
201132,of,0,0
201133,psychological,0,1
201134,treatment,0,0
201135,",",0,0
201136,they,0,0
201137,were,0,0
201138,reassessed,0,0
201139,",",0,0
201140,using,0,0
201141,body,1,1
201142,weight,1,1
201143,",",1,1
201144,menstrual,1,1
201145,function,1,1
201146,",",1,1
201147,and,1,1
201148,ratings,1,1
201149,on,1,0
201150,the,1,0
201151,Morgan,1,1
201152,and,1,1
201153,Russell,1,0
201154,scales,1,1
201155,.,1,1
201156,Family,1,1
201157,therapy,1,0
201158,was,1,0
201159,found,1,0
201160,to,1,0
201161,be,1,0
201162,more,1,0
201163,effective,1,1
201164,than,1,0
201165,individual,1,0
201166,therapy,1,0
201167,in,0,0
201168,patients,0,0
201169,whose,0,1
201170,illness,0,1
201171,was,0,0
201172,not,0,0
201173,chronic,0,0
201174,and,0,1
201175,had,0,0
201176,begun,0,0
201177,before,0,0
201178,the,0,0
201179,age,0,0
201180,of,0,0
201181,19,0,0
201182,years,0,0
201183,.,0,0
201184,A,0,0
201185,more,0,0
201186,tentative,0,0
201187,finding,0,0
201188,was,0,0
201189,the,0,0
201190,greater,0,0
201191,value,0,1
201192,of,0,1
201193,individual,0,0
201194,supportive,0,0
201195,therapy,0,0
201196,in,0,0
201197,older,0,0
201198,patients,0,0
201199,.,0,1
201200,To,0,0
201201,our,0,0
201202,knowledge,0,1
201203,",",0,0
201204,this,0,0
201205,is,0,0
201206,the,0,0
201207,first,0,0
201208,controlled,0,0
201209,trial,0,0
201210,of,0,1
201211,family,0,1
201212,therapy,0,0
201213,in,0,0
201214,anorexia,0,1
201215,nervosa,0,0
201216,and,0,0
201217,clarifies,0,0
201218,the,0,0
201219,specific,0,0
201220,indications,0,0
201221,for,0,0
201222,this,0,0
201223,treatment,0,0
201224,.,0,0
201225,Speech,0,1
201226,following,0,0
201227,sign,0,1
201228,language,0,1
201229,training,0,0
201230,in,0,0
201231,autistic,0,0
201232,children,0,0
201233,with,0,0
201234,minimal,0,1
201235,verbal,0,1
201236,language,0,0
201237,.,0,0
201238,This,0,0
201239,study,0,0
201240,was,0,0
201241,carried,0,0
201242,out,0,0
201243,to,0,0
201244,test,0,0
201245,the,0,0
201246,main,1,0
201247,and,1,0
201248,interaction,1,1
201249,effects,1,1
201250,of,0,0
201251,training,0,0
201252,condition,0,0
201253,and,0,1
201254,pretreatment-elicited,0,1
201255,verbal,0,1
201256,imitation,0,1
201257,ability,0,1
201258,when,0,0
201259,predicting,0,1
201260,spoken,0,1
201261,language,0,1
201262,use,0,1
201263,during,0,0
201264,language,0,1
201265,training,0,0
201266,of,0,0
201267,60,0,0
201268,minimally,0,0
201269,verbal,0,0
201270,autistic,0,0
201271,children,0,0
201272,.,0,0
201273,Subjects,0,0
201274,were,0,0
201275,randomly,0,0
201276,assigned,0,0
201277,to,0,0
201278,Speech,1,1
201279,Alone,1,1
201280,",",1,1
201281,Sign,1,1
201282,Alone,1,1
201283,",",1,1
201284,Simultaneous,1,1
201285,Presentation,1,1
201286,of,1,1
201287,Sign,1,1
201288,and,1,1
201289,Speech,1,1
201290,",",1,1
201291,and,1,1
201292,Alternating,1,0
201293,Presentation,1,1
201294,of,1,1
201295,Sign,1,1
201296,and,1,1
201297,Speech,1,1
201298,training,1,0
201299,conditions,1,0
201300,.,1,0
201301,Speech,1,0
201302,Alone,1,1
201303,",",1,0
201304,Simultaneous,1,1
201305,Presentation,1,1
201306,",",1,1
201307,and,1,1
201308,Alternating,1,0
201309,Presentation,1,1
201310,condition,1,1
201311,facilitated,0,0
201312,more,0,0
201313,child-initiated,0,1
201314,speech,0,1
201315,during,0,0
201316,treatment,0,0
201317,than,0,0
201318,did,0,0
201319,the,0,0
201320,Sign,0,0
201321,Alone,0,1
201322,condition,0,0
201323,.,0,1
201324,Regardless,0,0
201325,of,0,0
201326,training,0,0
201327,condition,0,0
201328,",",0,1
201329,pretreatment,0,0
201330,verbal,0,1
201331,imitation,0,1
201332,ability,0,1
201333,positively,0,0
201334,predicted,0,0
201335,the,0,0
201336,size,1,1
201337,of,1,0
201338,child-initiated,1,0
201339,spoken,1,1
201340,vocabulary,1,1
201341,observed,0,0
201342,during,0,0
201343,training,0,0
201344,.,0,0
201345,Exploratory,0,1
201346,analyses,0,0
201347,indicated,0,0
201348,that,0,0
201349,",",0,0
201350,in,0,0
201351,addition,0,0
201352,to,0,0
201353,verbal,0,1
201354,imitation,0,1
201355,",",0,1
201356,pretreatment,0,0
201357,age,0,1
201358,and,0,0
201359,IQ,0,1
201360,may,0,0
201361,also,0,0
201362,predict,0,0
201363,spoken,0,1
201364,language,0,1
201365,developed,0,0
201366,during,0,0
201367,training,0,0
201368,.,0,0
201369,The,0,0
201370,effect,0,0
201371,of,0,0
201372,metronidazole,0,0
201373,on,0,0
201374,the,0,0
201375,incidence,1,1
201376,of,1,0
201377,postoperative,1,1
201378,wound,1,1
201379,infection,1,1
201380,in,0,0
201381,elective,0,0
201382,colon,0,0
201383,surgery,0,0
201384,.,0,0
201385,A,0,0
201386,prospective,0,0
201387,randomized,0,0
201388,clinical,0,0
201389,trial,0,0
201390,assessing,0,0
201391,the,0,0
201392,relative,0,1
201393,effectiveness,0,1
201394,of,0,1
201395,erythromycin-neomycin,0,0
201396,and,0,1
201397,metronidazole-neomycin,0,0
201398,as,0,0
201399,a,0,0
201400,preoperative,0,1
201401,bowel,0,1
201402,preparation,0,0
201403,was,0,0
201404,carried,0,0
201405,out,0,0
201406,.,0,0
201407,Bacteriologic,0,1
201408,studies,0,0
201409,of,0,1
201410,feces,0,1
201411,and,0,1
201412,colon,0,1
201413,content,0,1
201414,revealed,0,0
201415,no,0,0
201416,significant,0,0
201417,difference,0,0
201418,in,0,0
201419,the,0,0
201420,reduction,1,1
201421,of,1,0
201422,aerobic,1,0
201423,bacteria,1,1
201424,between,0,0
201425,the,0,0
201426,two,0,0
201427,groups,0,0
201428,.,0,0
201429,There,0,0
201430,was,0,0
201431,",",0,0
201432,however,0,0
201433,",",0,0
201434,a,0,0
201435,significantly,0,0
201436,greater,0,0
201437,reduction,1,1
201438,in,0,0
201439,anaerobic,1,1
201440,bacteria,1,1
201441,in,0,0
201442,the,0,0
201443,feces,0,1
201444,and,0,1
201445,colon,0,1
201446,contents,0,1
201447,of,0,0
201448,patients,0,0
201449,receiving,0,0
201450,metronidazole,0,0
201451,.,0,0
201452,Wound,1,0
201453,infection,1,1
201454,rate,1,1
201455,was,0,0
201456,25,0,0
201457,%,0,0
201458,in,0,0
201459,the,0,0
201460,erythromycin,0,0
201461,group,0,0
201462,",",0,1
201463,and,0,1
201464,organisms,0,1
201465,recovered,0,1
201466,from,0,0
201467,the,0,0
201468,wound,0,0
201469,in,0,0
201470,all,0,0
201471,cases,0,0
201472,were,0,0
201473,fecal,0,1
201474,in,0,0
201475,nature,0,0
201476,.,0,0
201477,Two,0,0
201478,wound,1,0
201479,infections,1,0
201480,occurred,0,0
201481,in,0,0
201482,the,0,0
201483,metronidazole,0,0
201484,group,0,0
201485,(,0,0
201486,5,0,0
201487,%,0,0
201488,),0,0
201489,and,0,0
201490,in,0,0
201491,both,0,0
201492,cases,0,0
201493,the,0,0
201494,organisms,0,0
201495,recovered,0,1
201496,were,0,0
201497,staphylococci,1,0
201498,of,1,1
201499,presumed,1,0
201500,skin,1,1
201501,origin,1,0
201502,.,1,0
201503,These,0,0
201504,studies,0,0
201505,suggest,0,0
201506,that,0,0
201507,anaerobic,0,0
201508,bacteria,0,1
201509,are,0,0
201510,the,0,0
201511,major,0,0
201512,contributors,0,0
201513,to,0,0
201514,wound,1,0
201515,infection,1,1
201516,after,0,0
201517,colon,0,1
201518,surgery,0,0
201519,and,0,1
201520,that,0,0
201521,their,0,0
201522,specific,0,0
201523,reduction,0,1
201524,is,0,0
201525,associated,0,0
201526,with,0,0
201527,a,0,0
201528,lower,0,0
201529,incidence,0,1
201530,of,0,1
201531,wound,1,0
201532,infection,1,1
201533,.,1,0
201534,Effect,0,1
201535,of,0,1
201536,negative,0,1
201537,air,0,0
201538,ionization,0,0
201539,on,0,0
201540,hyperactive,0,1
201541,and,0,1
201542,autistic,0,0
201543,children,0,0
201544,.,0,0
201545,Twenty-one,0,0
201546,attention,0,0
201547,deficit,0,0
201548,disorder,0,0
201549,with,0,0
201550,hyperactivity,0,1
201551,and,0,0
201552,seven,0,0
201553,autistic,0,0
201554,children,0,0
201555,were,0,0
201556,randomly,0,0
201557,exposed,0,0
201558,to,0,0
201559,negatively,0,0
201560,ionized,0,1
201561,and,0,1
201562,ambient,0,0
201563,atmospheres,0,0
201564,under,0,0
201565,rigorously,0,0
201566,controlled,0,0
201567,experimental,0,0
201568,conditions,0,0
201569,.,0,0
201570,The,0,0
201571,negatively,0,0
201572,ionized,0,1
201573,condition,0,0
201574,did,0,0
201575,not,0,0
201576,significantly,0,0
201577,affect,0,0
201578,measurements,0,1
201579,of,0,1
201580,activity,1,1
201581,level,1,1
201582,",",1,1
201583,impulsivity,1,1
201584,",",1,1
201585,reality,1,1
201586,orientation,1,1
201587,",",1,1
201588,destructive/constructiveness,1,1
201589,",",1,1
201590,attention,1,1
201591,",",1,1
201592,or,1,1
201593,task,1,1
201594,performance,1,1
201595,.,1,1
201596,Significant,0,0
201597,results,0,0
201598,might,0,0
201599,be,0,0
201600,obtained,0,0
201601,if,0,0
201602,subgroups,0,0
201603,of,0,0
201604,known,0,0
201605,hyperserotoninemic,0,1
201606,autistic,0,1
201607,and,0,1
201608,attention,0,1
201609,deficit,0,1
201610,disorder,0,0
201611,children,0,0
201612,were,0,0
201613,exposed,0,0
201614,to,0,0
201615,negatively,0,0
201616,ionized,0,0
201617,conditions,0,0
201618,.,0,0
201619,Effects,0,0
201620,of,0,1
201621,platelet,0,1
201622,suppressant,0,0
201623,",",0,1
201624,anticoagulant,0,1
201625,and,0,1
201626,fibrinolytic,0,1
201627,therapy,0,0
201628,in,0,0
201629,patients,0,0
201630,with,0,0
201631,recurrent,0,1
201632,venous,0,1
201633,thrombosis,0,1
201634,.,0,0
201635,Hexetidine,0,0
201636,(,0,0
201637,'Oraldene,0,1
201638,',0,1
201639,),0,0
201640,:,0,0
201641,a,0,0
201642,report,0,0
201643,on,0,0
201644,its,0,0
201645,antibacterial,1,1
201646,and,1,1
201647,antifungal,1,0
201648,properties,1,1
201649,on,0,0
201650,the,0,0
201651,oral,0,0
201652,flora,0,1
201653,in,0,0
201654,healthy,0,0
201655,subjects,0,0
201656,.,0,0
201657,A,0,0
201658,randomized,0,0
201659,",",0,0
201660,double-blind,0,0
201661,crossover,0,0
201662,trial,0,0
201663,",",0,0
201664,in,0,0
201665,10,0,0
201666,adult,0,0
201667,healthy,0,0
201668,subjects,0,0
201669,",",0,1
201670,was,0,0
201671,carried,0,0
201672,out,0,0
201673,to,0,0
201674,compare,0,0
201675,the,0,0
201676,antibacterial,1,1
201677,and,1,1
201678,antifungal,1,0
201679,activity,1,1
201680,of,0,0
201681,a,0,0
201682,0.1,0,0
201683,%,0,0
201684,solution,0,0
201685,of,0,1
201686,hexetidine,0,0
201687,with,0,0
201688,that,0,0
201689,of,0,0
201690,placebo,0,0
201691,.,0,0
201692,The,0,0
201693,pre-dosing,0,1
201694,oral,0,0
201695,flora,0,1
201696,of,0,0
201697,the,0,0
201698,subjects,0,0
201699,was,0,0
201700,assessed,0,0
201701,from,0,0
201702,saliva,1,0
201703,samples,1,0
201704,cultured,0,1
201705,for,0,0
201706,aerobic,1,0
201707,and,1,1
201708,anaerobic,1,1
201709,bacteria,1,1
201710,",",0,0
201711,as,0,0
201712,well,0,0
201713,as,0,0
201714,Candida,1,0
201715,albicans,1,0
201716,.,1,0
201717,Subjects,0,0
201718,then,0,0
201719,rinsed,0,0
201720,their,0,0
201721,mouths,0,0
201722,for,0,0
201723,1,0,0
201724,minute,0,0
201725,3-times,0,0
201726,a,0,0
201727,day,0,0
201728,with,0,0
201729,15,0,0
201730,ml,0,0
201731,0.1,0,0
201732,%,0,0
201733,hexetidine,0,0
201734,or,0,1
201735,placebo,0,0
201736,",",0,1
201737,saliva,0,1
201738,samples,0,1
201739,being,0,0
201740,collected,0,0
201741,at,0,0
201742,2,0,0
201743,minutes,0,0
201744,",",0,0
201745,30,0,0
201746,minutes,0,0
201747,",",0,0
201748,1,0,0
201749,hour,0,0
201750,",",0,0
201751,3,0,0
201752,hours,0,0
201753,and,0,0
201754,5,0,0
201755,hours,0,0
201756,post-dosing,0,0
201757,.,0,0
201758,Dosing,0,1
201759,was,0,0
201760,continued,0,0
201761,for,0,0
201762,8,0,0
201763,consecutive,0,0
201764,days,0,0
201765,on,0,0
201766,each,0,0
201767,treatment,0,0
201768,with,0,0
201769,an,0,0
201770,intervening,0,0
201771,wash-out,0,0
201772,period,0,0
201773,of,0,0
201774,1,0,0
201775,week,0,0
201776,.,0,0
201777,Hexetidine,0,0
201778,reduced,0,1
201779,aerobic,1,0
201780,bacterial,1,1
201781,counts,1,1
201782,on,0,0
201783,Day,0,0
201784,1,0,0
201785,and,0,0
201786,Day,0,0
201787,8,0,0
201788,by,0,0
201789,a,0,0
201790,maximum,0,0
201791,of,0,0
201792,83,0,0
201793,%,0,0
201794,and,0,0
201795,86,0,0
201796,%,0,0
201797,",",0,0
201798,respectively,0,0
201799,",",0,0
201800,at,0,0
201801,2,0,0
201802,minutes,0,0
201803,post-dosing,0,0
201804,.,0,0
201805,The,0,0
201806,reductions,0,1
201807,were,0,0
201808,statistically,0,0
201809,significantly,0,0
201810,lower,0,0
201811,than,0,0
201812,placebo,0,0
201813,up,0,0
201814,to,0,0
201815,1,0,0
201816,hour,0,0
201817,post-dose,0,0
201818,on,0,0
201819,Day,0,0
201820,1,0,0
201821,and,0,0
201822,up,0,0
201823,to,0,0
201824,3,0,0
201825,hours,0,0
201826,post-dose,0,0
201827,on,0,0
201828,Day,0,0
201829,8,0,0
201830,.,0,0
201831,Similarly,0,0
201832,for,0,0
201833,anaerobic,1,1
201834,bacterial,1,1
201835,counts,1,1
201836,",",0,0
201837,92,0,0
201838,%,0,0
201839,and,0,0
201840,88,0,0
201841,%,0,0
201842,maximum,0,1
201843,reductions,0,1
201844,were,0,0
201845,recorded,0,0
201846,on,0,0
201847,Day,0,0
201848,1,0,0
201849,and,0,0
201850,Day,0,0
201851,8,0,0
201852,",",0,0
201853,which,0,0
201854,again,0,0
201855,were,0,0
201856,significantly,0,0
201857,lower,0,0
201858,than,0,0
201859,placebo,0,0
201860,for,0,0
201861,up,0,0
201862,to,0,0
201863,3,0,0
201864,hours,0,0
201865,post-dose,0,0
201866,.,0,0
201867,For,0,0
201868,Candida,1,0
201869,albicans,1,0
201870,",",0,0
201871,however,0,0
201872,",",0,0
201873,the,0,0
201874,maximum,0,1
201875,reduction,0,1
201876,was,0,0
201877,91,0,0
201878,%,0,0
201879,on,0,0
201880,the,0,0
201881,first,0,1
201882,day,0,0
201883,and,0,0
201884,67,0,0
201885,%,0,0
201886,on,0,0
201887,Day,0,0
201888,8,0,0
201889,",",0,0
201890,maintained,0,0
201891,for,0,0
201892,30,0,0
201893,minutes,0,0
201894,post-dosing,0,0
201895,.,0,0
201896,Although,0,0
201897,not,0,0
201898,eradicating,1,0
201899,completely,1,0
201900,aerobic,1,0
201901,and,1,1
201902,anaerobic,1,1
201903,bacteria,1,1
201904,",",0,0
201905,it,0,0
201906,is,0,0
201907,concluded,0,0
201908,that,0,0
201909,the,0,0
201910,substantial,0,0
201911,reduction,1,1
201912,in,0,0
201913,their,0,0
201914,numbers,0,0
201915,should,0,0
201916,prove,0,0
201917,clinically,0,0
201918,useful,0,0
201919,.,0,0
201920,An,0,0
201921,international,0,0
201922,multi-clinic,0,0
201923,study,0,0
201924,comparing,0,0
201925,the,0,0
201926,therapeutic,0,0
201927,efficacy,0,1
201928,of,0,1
201929,colloidal,0,0
201930,bismuth,0,0
201931,subcitrate,0,0
201932,coated,0,0
201933,tablets,0,0
201934,with,0,0
201935,chewing,0,0
201936,tablets,0,0
201937,in,0,0
201938,the,0,0
201939,treatment,0,0
201940,of,0,0
201941,duodenal,0,0
201942,ulceration,0,1
201943,.,0,0
201944,The,0,0
201945,results,0,0
201946,of,0,0
201947,a,0,0
201948,randomized,0,0
201949,",",0,0
201950,single-blind,0,0
201951,",",0,1
201952,multi-clinic,0,0
201953,study,0,0
201954,comparing,0,0
201955,the,0,0
201956,therapeutic,1,0
201957,efficacy,1,1
201958,and,1,1
201959,degree,1,1
201960,of,1,1
201961,oral,1,0
201962,staining,1,1
201963,of,0,1
201964,new,0,1
201965,colloidal,0,0
201966,bismuth,0,0
201967,subcitrate,0,0
201968,(,0,1
201969,CBS,0,1
201970,),0,1
201971,coated,0,0
201972,tablets,0,0
201973,over,0,0
201974,4,0,0
201975,weeks,0,0
201976,of,0,0
201977,treatment,0,0
201978,in,0,0
201979,patients,0,0
201980,suffering,0,0
201981,from,0,0
201982,duodenal,0,0
201983,ulceration,0,1
201984,are,0,0
201985,reported,0,0
201986,.,0,0
201987,The,0,0
201988,data,0,0
201989,were,0,0
201990,collected,0,0
201991,from,0,0
201992,9,0,0
201993,clinics,0,0
201994,in,0,0
201995,the,0,0
201996,Netherlands,0,0
201997,",",0,1
201998,Belgium,0,1
201999,",",0,1
202000,Ireland,0,0
202001,",",0,0
202002,the,0,0
202003,United,0,0
202004,Kingdom,0,0
202005,",",0,1
202006,and,0,1
202007,Italy,0,0
202008,.,0,0
202009,The,0,0
202010,results,0,0
202011,from,0,0
202012,94,0,0
202013,patients,0,0
202014,treated,0,0
202015,with,0,0
202016,CBS,0,0
202017,coated,0,0
202018,tablets,0,0
202019,and,0,0
202020,95,0,0
202021,patients,0,0
202022,treated,0,0
202023,with,0,0
202024,CBS,0,0
202025,chewing,0,1
202026,tablets,0,0
202027,were,0,0
202028,statistically,0,0
202029,evaluated,0,0
202030,.,0,0
202031,Healing,1,0
202032,rates,1,1
202033,after,0,0
202034,4,0,0
202035,weeks,0,0
202036,of,0,0
202037,therapy,0,0
202038,appeared,0,0
202039,to,0,0
202040,be,0,0
202041,76,0,0
202042,%,0,0
202043,for,0,0
202044,CBS,0,1
202045,coated,0,0
202046,tablets,0,0
202047,and,0,0
202048,72,0,0
202049,%,0,0
202050,for,0,0
202051,CBS,0,0
202052,chewing,0,1
202053,tablets,0,0
202054,",",0,0
202055,so,0,0
202056,no,0,0
202057,statistically,0,0
202058,significant,0,0
202059,difference,0,0
202060,in,0,0
202061,therapeutic,0,1
202062,efficacy,0,1
202063,was,0,0
202064,seen,0,0
202065,.,0,0
202066,A,1,0
202067,highly,1,0
202068,significant,1,0
202069,degree,1,1
202070,of,1,1
202071,discolouration,1,1
202072,of,1,0
202073,all,1,0
202074,parts,1,0
202075,of,1,0
202076,the,1,0
202077,oral,1,0
202078,cavity,1,0
202079,was,0,0
202080,observed,0,0
202081,in,0,0
202082,patients,0,0
202083,treated,0,0
202084,with,0,0
202085,CBS,0,0
202086,chewing,0,1
202087,tablets,0,0
202088,",",0,0
202089,whereas,0,0
202090,only,0,0
202091,a,0,0
202092,few,0,0
202093,patients,0,0
202094,treated,0,0
202095,with,0,0
202096,CBS,0,0
202097,coated,0,0
202098,tablets,0,0
202099,experienced,0,0
202100,a,0,0
202101,slight,1,1
202102,staining,1,0
202103,of,1,0
202104,the,1,0
202105,tongue,1,0
202106,.,1,0
202107,Blood,1,1
202108,bismuth,1,0
202109,concentrations,1,1
202110,during,0,0
202111,the,0,0
202112,study,0,0
202113,had,0,0
202114,a,0,0
202115,range,0,0
202116,of,0,0
202117,less,0,0
202118,than,0,0
202119,or,0,0
202120,equal,0,0
202121,to,0,0
202122,3,0,0
202123,to,0,0
202124,33,0,0
202125,micrograms/l,0,0
202126,.,0,0
202127,The,0,0
202128,new,0,0
202129,CBS,0,0
202130,coated,0,0
202131,tablet,0,0
202132,form,0,0
202133,has,0,0
202134,an,0,0
202135,excellent,1,1
202136,patient,1,1
202137,compliance,1,1
202138,as,0,0
202139,compared,0,0
202140,to,0,0
202141,the,0,0
202142,chewing,0,0
202143,tablets,0,0
202144,.,0,0
202145,Effects,0,0
202146,of,0,0
202147,nifedipine,0,0
202148,on,0,0
202149,gastric,1,1
202150,acid,1,1
202151,secretion,1,1
202152,and,0,1
202153,gastrin,1,1
202154,release,1,1
202155,in,0,0
202156,man,0,0
202157,.,0,0
202158,As,0,0
202159,calcium,0,0
202160,is,0,0
202161,important,0,0
202162,in,0,0
202163,the,0,0
202164,regulation,0,0
202165,of,0,0
202166,gastric,0,1
202167,acid,0,1
202168,secretion,0,1
202169,and,0,1
202170,gastrin,0,1
202171,release,0,1
202172,",",0,0
202173,we,0,0
202174,have,0,0
202175,examined,0,0
202176,the,0,0
202177,effect,0,0
202178,of,0,0
202179,the,0,0
202180,calcium,0,1
202181,antagonist,0,0
202182,nifedipine,0,0
202183,on,0,0
202184,these,0,0
202185,processes,0,0
202186,in,0,0
202187,man,0,0
202188,.,0,0
202189,Nifedipine,0,0
202190,30,0,0
202191,mg,0,0
202192,orally,0,0
202193,inhibited,0,0
202194,basal,0,1
202195,acid,0,0
202196,output,0,1
202197,by,0,0
202198,37,0,0
202199,%,0,0
202200,(,0,0
202201,p,0,0
202202,less,0,0
202203,than,0,0
202204,0.025,0,0
202205,),0,0
202206,and,0,0
202207,that,0,0
202208,stimulated,0,0
202209,by,0,0
202210,low,0,0
202211,infusion,0,0
202212,rates,0,1
202213,of,0,0
202214,pentagastrin,0,1
202215,--,0,0
202216,that,0,0
202217,is,0,0
202218,",",0,0
202219,0.031,0,0
202220,and,0,0
202221,0.062,0,0
202222,microgram/kg/h,0,0
202223,by,0,0
202224,44,0,0
202225,%,0,0
202226,(,0,0
202227,p,0,0
202228,=,0,0
202229,0.05,0,0
202230,),0,0
202231,and,0,0
202232,39,0,0
202233,%,0,0
202234,(,0,0
202235,p,0,0
202236,less,0,0
202237,than,0,0
202238,0.02,0,0
202239,),0,0
202240,respectively,0,0
202241,.,0,0
202242,On,0,0
202243,increasing,0,0
202244,the,0,0
202245,pentagastrin,0,1
202246,infusion,0,0
202247,rate,0,1
202248,the,0,0
202249,inhibition,0,1
202250,was,0,0
202251,surmounted,0,0
202252,suggesting,0,0
202253,it,0,0
202254,was,0,0
202255,competitive,0,0
202256,in,0,0
202257,type,0,0
202258,.,0,1
202259,Nifedipine,0,0
202260,did,0,0
202261,not,0,0
202262,affect,0,0
202263,basal,1,1
202264,or,1,1
202265,Oxo,1,1
202266,meal,1,1
202267,stimulated,1,0
202268,gastrin,1,1
202269,concentrations,1,1
202270,in,0,0
202271,normal,0,0
202272,volunteers,0,0
202273,nor,0,0
202274,did,0,0
202275,it,0,0
202276,affect,0,0
202277,resting,1,1
202278,serum,1,1
202279,gastrin,1,1
202280,or,1,1
202281,calcium,1,1
202282,stimulated,1,1
202283,increase,1,1
202284,in,1,0
202285,gastrin,1,1
202286,in,0,0
202287,a,0,0
202288,single,0,0
202289,patient,0,1
202290,with,0,0
202291,Zollinger-Ellison,0,0
202292,syndrome,0,0
202293,.,0,0
202294,These,0,0
202295,findings,0,0
202296,are,0,0
202297,consistent,0,0
202298,with,0,0
202299,the,0,0
202300,transmembrane,0,1
202301,flux,0,1
202302,of,0,1
202303,calcium,0,1
202304,ions,0,0
202305,being,0,0
202306,involved,0,0
202307,in,0,0
202308,basal,0,1
202309,and,0,1
202310,pentagastrin,0,1
202311,stimulated,0,1
202312,acid,0,1
202313,secretion,0,1
202314,in,0,0
202315,man,0,0
202316,.,0,0
202317,[,0,0
202318,The,0,0
202319,chemotherapy,0,0
202320,of,0,0
202321,advanced,0,0
202322,breast,0,0
202323,cancer,0,0
202324,.,0,0
202325,A,0,0
202326,report,0,0
202327,on,0,0
202328,the,0,0
202329,first,0,0
202330,600,0,0
202331,cases,0,0
202332,in,0,0
202333,a,0,0
202334,cooperative,0,0
202335,programme,0,0
202336,to,0,0
202337,carry,0,0
202338,out,0,0
202339,a,0,0
202340,systematic,0,0
202341,study,0,0
202342,(,0,1
202343,1974-1977,0,1
202344,),0,1
202345,(,0,0
202346,author,0,1
202347,'s,0,1
202348,transl,0,0
202349,),0,0
202350,],0,0
202351,.,0,0
202352,The,0,0
202353,authors,0,0
202354,explain,0,0
202355,the,0,0
202356,objectives,0,0
202357,and,0,0
202358,the,0,0
202359,structure,0,0
202360,of,0,0
202361,a,0,0
202362,programme,0,0
202363,evolved,0,0
202364,for,0,0
202365,the,0,0
202366,methodic,0,0
202367,study,0,0
202368,of,0,1
202369,advanced,0,0
202370,breast,0,0
202371,cancers,0,0
202372,which,0,0
202373,they,0,0
202374,have,0,0
202375,worked,0,0
202376,out,0,0
202377,and,0,0
202378,carried,0,0
202379,out,0,0
202380,in,0,0
202381,cooperation,0,0
202382,with,0,0
202383,the,0,0
202384,departments,0,0
202385,of,0,0
202386,medicine,0,0
202387,in,0,0
202388,eight,0,0
202389,French,0,0
202390,anticancer,0,0
202391,centres,0,0
202392,.,0,0
202393,They,0,0
202394,analyse,0,0
202395,the,0,0
202396,initial,0,0
202397,phases,0,0
202398,",",0,0
202399,which,0,0
202400,correspond,0,0
202401,to,0,0
202402,the,0,0
202403,three,0,0
202404,first,0,0
202405,years,0,0
202406,of,0,0
202407,work,0,0
202408,.,0,0
202409,They,0,0
202410,give,0,0
202411,the,0,0
202412,state,0,0
202413,of,0,0
202414,the,0,0
202415,results,0,0
202416,that,0,0
202417,have,0,0
202418,been,0,0
202419,obtained,0,0
202420,in,0,0
202421,603,0,0
202422,patients,0,0
202423,using,0,0
202424,three,0,0
202425,protocols,0,0
202426,for,0,0
202427,treatment,0,0
202428,.,0,0
202429,These,0,0
202430,consisted,0,0
202431,of,0,0
202432,the,0,0
202433,administration,0,0
202434,in,0,0
202435,interrupted,0,0
202436,doses,0,0
202437,of,0,0
202438,chemotherapy,0,0
202439,which,0,0
202440,consisted,0,0
202441,of,0,0
202442,vincristine,0,0
202443,associated,0,0
202444,for,0,0
202445,the,0,0
202446,one,0,0
202447,part,0,0
202448,with,0,0
202449,cyclophosphamide,0,0
202450,and,0,1
202451,5-fluoro-uracil,0,0
202452,and,0,0
202453,on,0,0
202454,the,0,0
202455,other,0,0
202456,hand,0,1
202457,with,0,0
202458,doxorubicine,0,0
202459,or/and,0,0
202460,with,0,0
202461,methotrexate,0,0
202462,.,0,0
202463,From,0,0
202464,this,0,0
202465,study,0,0
202466,there,0,0
202467,emerged,0,0
202468,the,0,0
202469,value,0,1
202470,of,0,0
202471,combined,0,0
202472,therapy,0,0
202473,using,0,0
202474,doxorubicine,0,0
202475,as,0,0
202476,much,0,0
202477,because,0,0
202478,of,0,0
202479,the,0,0
202480,frequency,1,1
202481,with,1,0
202482,which,1,0
202483,results,1,0
202484,better,1,0
202485,than,0,0
202486,50,0,0
202487,%,0,0
202488,were,0,0
202489,obtained,0,0
202490,(,0,0
202491,in,0,0
202492,a,0,0
202493,randomised,0,0
202494,trial,0,0
202495,),0,0
202496,as,0,0
202497,by,0,0
202498,their,0,0
202499,quality,1,1
202500,",",0,1
202501,which,0,0
202502,was,0,0
202503,made,0,0
202504,clear,0,0
202505,in,0,0
202506,an,0,0
202507,important,0,0
202508,series,0,0
202509,of,0,0
202510,240,0,0
202511,cases,0,0
202512,.,0,0
202513,They,0,0
202514,point,0,0
202515,out,0,0
202516,the,0,0
202517,conditions,0,0
202518,required,0,0
202519,to,0,0
202520,initiate,0,0
202521,the,0,0
202522,place,0,0
202523,of,0,0
202524,such,0,0
202525,a,0,0
202526,scheme,0,0
202527,in,0,0
202528,all,0,0
202529,complex,0,0
202530,therapy,0,0
202531,which,0,0
202532,aims,0,0
202533,as,0,0
202534,much,0,0
202535,at,0,0
202536,palliation,0,1
202537,as,0,0
202538,at,0,0
202539,cure,0,1
202540,",",0,0
202541,and,0,1
202542,point,0,0
202543,out,0,0
202544,how,0,0
202545,important,0,0
202546,it,0,0
202547,is,0,0
202548,to,0,0
202549,be,0,0
202550,methodical,0,1
202551,in,0,0
202552,the,0,0
202553,application,0,0
202554,of,0,0
202555,chemotherapy,0,0
202556,in,0,0
202557,order,0,0
202558,to,0,0
202559,ensure,0,0
202560,its,0,0
202561,development,0,0
202562,as,0,0
202563,an,0,0
202564,anticancer,0,0
202565,therapy,0,0
202566,.,0,0
202567,A,0,0
202568,randomised,0,0
202569,comparison,0,0
202570,of,0,0
202571,three,0,0
202572,drainage,0,0
202573,systems,0,0
202574,following,0,0
202575,cholecystectomy,0,0
202576,.,0,0
202577,The,0,0
202578,efficacy,1,1
202579,of,0,0
202580,low,0,1
202581,pressure,0,1
202582,",",0,1
202583,high,0,1
202584,pressure,0,1
202585,and,0,1
202586,passive,0,1
202587,drainage,0,1
202588,systems,0,0
202589,have,0,0
202590,been,0,0
202591,compared,0,0
202592,after,0,0
202593,cholecystectomy,0,0
202594,.,0,0
202595,Symptoms,1,1
202596,of,1,1
202597,pain,1,1
202598,",",1,1
202599,discomfort,1,1
202600,and,1,1
202601,nausea,1,1
202602,were,0,0
202603,compared,0,0
202604,using,0,0
202605,linear,0,0
202606,analogue,0,1
202607,scales,0,1
202608,and,0,1
202609,spirometry,0,1
202610,was,0,0
202611,used,0,0
202612,to,0,0
202613,examine,0,0
202614,pre-operative,0,1
202615,and,0,1
202616,postoperative,0,1
202617,respiratory,1,1
202618,function,1,1
202619,.,1,0
202620,The,0,0
202621,low,0,0
202622,pressure,0,1
202623,suction,0,1
202624,drain,0,1
202625,removed,0,0
202626,an,0,0
202627,intraperitoneal,1,0
202628,marker,1,1
202629,",",1,1
202630,gentamicin,1,0
202631,",",0,1
202632,more,0,0
202633,effectively,0,0
202634,than,0,0
202635,the,0,0
202636,high,0,0
202637,pressure,0,1
202638,suction,0,1
202639,drain,0,1
202640,",",0,1
202641,but,0,0
202642,not,0,0
202643,more,0,0
202644,effectively,0,0
202645,than,0,0
202646,the,0,0
202647,passive,0,0
202648,drain,0,1
202649,.,0,0
202650,There,0,0
202651,were,0,0
202652,no,0,0
202653,differences,0,0
202654,in,0,0
202655,postoperative,1,1
202656,respiratory,1,1
202657,function,1,1
202658,nor,0,0
202659,in,0,0
202660,the,0,0
202661,amount,1,1
202662,of,1,1
202663,pain,1,1
202664,or,1,1
202665,discomfort,1,1
202666,between,0,0
202667,the,0,0
202668,groups,0,0
202669,.,0,0
202670,The,0,0
202671,passive,0,0
202672,drain,0,1
202673,group,0,0
202674,reported,0,0
202675,less,0,0
202676,nausea,1,1
202677,than,0,0
202678,the,0,0
202679,suction,0,0
202680,drain,0,1
202681,groups,0,0
202682,.,0,0
202683,If,0,0
202684,a,0,0
202685,negative,0,1
202686,pressure,0,1
202687,drainage,0,1
202688,system,0,0
202689,is,0,0
202690,to,0,0
202691,be,0,0
202692,used,0,0
202693,",",0,0
202694,a,0,0
202695,low,0,0
202696,pressure,0,1
202697,suction,0,0
202698,drain,0,0
202699,should,0,0
202700,be,0,0
202701,used,0,0
202702,in,0,0
202703,preference,0,0
202704,to,0,0
202705,a,0,0
202706,high,0,0
202707,pressure,0,1
202708,system,0,0
202709,.,0,0
202710,The,0,0
202711,additive,0,0
202712,analgesic,0,1
202713,efficacy,0,1
202714,of,0,1
202715,acetaminophen,0,0
202716,",",0,0
202717,1000,0,0
202718,mg,0,0
202719,",",0,0
202720,and,0,1
202721,codeine,0,1
202722,",",0,0
202723,60,0,0
202724,mg,0,0
202725,",",0,0
202726,in,0,0
202727,dental,0,0
202728,pain,0,1
202729,.,0,0
202730,In,0,0
202731,a,0,0
202732,double-blind,0,0
202733,",",0,0
202734,randomized,0,0
202735,",",0,0
202736,single-dose,0,0
202737,trial,0,0
202738,the,0,0
202739,analgesic,0,1
202740,contribution,0,0
202741,of,0,1
202742,acetaminophen,0,0
202743,",",0,0
202744,1000,0,0
202745,mg,0,0
202746,",",0,0
202747,and,0,1
202748,codeine,0,1
202749,",",0,0
202750,60,0,0
202751,mg,0,0
202752,",",0,0
202753,was,0,0
202754,determined,0,0
202755,.,0,0
202756,The,0,0
202757,study,0,0
202758,was,0,0
202759,a,0,0
202760,2,0,0
202761,X,0,0
202762,2,0,0
202763,factorial,0,0
202764,experiment,0,0
202765,in,0,0
202766,which,0,0
202767,120,0,0
202768,patients,0,0
202769,suffering,0,0
202770,from,0,0
202771,pain,0,1
202772,as,0,0
202773,a,0,0
202774,result,0,0
202775,of,0,0
202776,oral,0,0
202777,surgery,0,0
202778,rated,0,1
202779,their,0,0
202780,pain,1,1
202781,intensity,1,1
202782,and,1,1
202783,pain,1,1
202784,relief,1,1
202785,for,0,0
202786,up,0,0
202787,to,0,0
202788,5,0,0
202789,hours,0,0
202790,after,0,0
202791,a,0,0
202792,single,0,0
202793,dose,0,0
202794,of,0,0
202795,one,0,0
202796,of,0,0
202797,:,0,0
202798,1000,0,0
202799,mg,0,0
202800,acetaminophen,0,0
202801,",",0,0
202802,60,0,0
202803,mg,0,0
202804,codeine,0,0
202805,",",0,0
202806,1000,0,0
202807,mg,0,0
202808,acetaminophen,0,0
202809,plus,0,0
202810,60,0,0
202811,mg,0,0
202812,codeine,0,0
202813,",",0,1
202814,or,0,1
202815,placebo,0,0
202816,.,0,0
202817,The,0,0
202818,factorial,0,0
202819,analysis,0,0
202820,showed,0,0
202821,that,0,0
202822,both,0,0
202823,1000,0,0
202824,mg,0,0
202825,acetaminophen,0,0
202826,and,0,0
202827,60,0,0
202828,mg,0,0
202829,codeine,0,0
202830,made,0,0
202831,a,0,0
202832,statistically,0,0
202833,significant,0,0
202834,(,0,0
202835,P,0,0
202836,less,0,0
202837,than,0,0
202838,0.05,0,0
202839,),0,0
202840,contribution,0,0
202841,to,0,0
202842,the,0,0
202843,analgesic,1,1
202844,effectiveness,1,0
202845,of,1,0
202846,the,1,0
202847,combination,1,0
202848,on,1,0
202849,all,1,0
202850,measures,1,0
202851,of,1,1
202852,efficacy,1,1
202853,(,1,0
202854,sum,1,1
202855,of,1,1
202856,pain,1,1
202857,intensity,1,1
202858,differences,1,1
202859,",",1,1
202860,largest,1,1
202861,pain,1,1
202862,intensity,1,1
202863,difference,1,1
202864,",",1,1
202865,total,1,1
202866,pain,1,1
202867,relief,1,1
202868,",",1,1
202869,largest,1,1
202870,pain,1,1
202871,relief,1,1
202872,",",1,1
202873,and,1,1
202874,time,1,1
202875,to,1,1
202876,remedication,1,0
202877,),1,0
202878,.,1,0
202879,The,0,0
202880,incidence,1,1
202881,of,1,0
202882,adverse,1,1
202883,effects,1,1
202884,did,0,0
202885,not,0,0
202886,appear,0,0
202887,to,0,0
202888,differ,0,0
202889,among,0,0
202890,the,0,0
202891,treatments,0,0
202892,",",0,0
202893,including,0,0
202894,placebo,0,0
202895,.,0,0
202896,Therapeutic,0,0
202897,recommendations,1,0
202898,in,0,0
202899,polycythemia,0,1
202900,vera,0,0
202901,based,0,0
202902,on,0,0
202903,Polycythemia,0,0
202904,Vera,0,1
202905,Study,0,0
202906,Group,0,0
202907,protocols,0,0
202908,.,0,0
202909,The,0,0
202910,PVSG,0,0
202911,was,0,0
202912,organized,0,0
202913,in,0,0
202914,1967,0,0
202915,to,0,0
202916,establish,0,0
202917,effective,0,1
202918,diagnostic,0,0
202919,criteria,0,0
202920,for,0,0
202921,polycythemia,0,1
202922,vera,0,0
202923,",",0,0
202924,to,0,0
202925,study,0,0
202926,the,0,0
202927,natural,0,0
202928,history,0,0
202929,of,0,0
202930,the,0,0
202931,disease,0,0
202932,and,0,0
202933,to,0,0
202934,define,0,0
202935,the,0,0
202936,optimal,0,0
202937,treatment,0,0
202938,.,0,0
202939,Although,0,0
202940,polycythemia,0,1
202941,vera,0,0
202942,and,0,0
202943,the,0,0
202944,other,0,0
202945,myeloproliferative,0,0
202946,diseases,0,0
202947,are,0,0
202948,relatively,0,0
202949,uncommon,0,0
202950,",",0,0
202951,the,0,0
202952,PVSG,0,1
202953,was,0,0
202954,able,0,0
202955,to,0,0
202956,accumulate,0,0
202957,well,0,0
202958,over,0,0
202959,"1,000",0,0
202960,patients,0,0
202961,with,0,0
202962,these,0,0
202963,various,0,0
202964,disorders,0,0
202965,and,0,0
202966,to,0,0
202967,study,0,0
202968,them,0,0
202969,according,0,0
202970,to,0,0
202971,a,0,0
202972,total,0,0
202973,of,0,0
202974,15,0,0
202975,different,0,0
202976,protocols,0,0
202977,.,0,1
202978,PVSG-01,0,0
202979,",",0,0
202980,a,0,0
202981,long-term,0,1
202982,randomized,0,0
202983,controlled,0,0
202984,study,0,0
202985,of,0,1
202986,phlebotomy,0,0
202987,alone,0,0
202988,compared,0,0
202989,with,0,0
202990,the,0,0
202991,myelosuppressive,0,1
202992,agents,0,0
202993,",",0,0
202994,32P,0,0
202995,or,0,0
202996,chlorambucil,0,0
202997,supplemented,0,0
202998,by,0,0
202999,phlebotomy,0,0
203000,",",0,0
203001,continues,0,0
203002,to,0,0
203003,receive,0,0
203004,follow-up,0,0
203005,data,0,0
203006,on,0,0
203007,93,0,0
203008,%,0,0
203009,of,0,0
203010,surviving,0,1
203011,patients,0,0
203012,18,0,0
203013,years,0,0
203014,after,0,0
203015,initiation,0,0
203016,of,0,0
203017,the,0,0
203018,study,0,0
203019,.,0,0
203020,During,0,0
203021,its,0,0
203022,lifetime,0,1
203023,",",0,0
203024,PVSG,0,0
203025,has,0,0
203026,developed,0,0
203027,a,0,0
203028,widely,0,0
203029,accepted,0,0
203030,and,0,0
203031,highly,0,0
203032,effective,0,1
203033,set,0,0
203034,of,0,0
203035,criteria,0,0
203036,for,0,0
203037,the,0,0
203038,specific,0,0
203039,diagnosis,0,0
203040,of,0,1
203041,polycythemia,0,1
203042,vera,0,0
203043,as,0,0
203044,well,0,0
203045,as,0,0
203046,useful,0,0
203047,criteria,0,0
203048,for,0,0
203049,the,0,0
203050,diagnosis,0,0
203051,of,0,0
203052,essential,0,0
203053,thrombocythemia,0,0
203054,.,0,0
203055,It,0,0
203056,has,0,0
203057,gathered,0,0
203058,an,0,0
203059,enormous,0,0
203060,volume,0,1
203061,of,0,0
203062,data,0,0
203063,on,0,0
203064,the,0,0
203065,natural,0,0
203066,history,0,0
203067,of,0,0
203068,the,0,0
203069,myeloproliferative,0,1
203070,diseases,0,0
203071,and,0,1
203072,in,0,0
203073,particular,0,0
203074,on,0,0
203075,the,0,0
203076,nature,0,0
203077,of,0,0
203078,the,0,0
203079,prevalent,0,0
203080,complications,0,1
203081,",",0,0
203082,such,0,0
203083,as,0,0
203084,thrombotic,0,1
203085,events,0,1
203086,and,0,1
203087,hematologic,0,1
203088,and,0,1
203089,nonhematologic,0,1
203090,malignancies,0,0
203091,.,0,0
203092,With,0,0
203093,respect,0,0
203094,to,0,0
203095,the,0,0
203096,final,0,1
203097,question,0,0
203098,",",0,0
203099,the,0,0
203100,optimal,0,1
203101,treatment,0,0
203102,for,0,0
203103,polycythemia,0,1
203104,vera,0,0
203105,",",0,0
203106,it,0,0
203107,is,0,0
203108,apparent,0,0
203109,that,0,0
203110,the,0,0
203111,expectation,0,0
203112,of,0,0
203113,a,0,0
203114,single,0,0
203115,optimal,0,1
203116,therapy,0,0
203117,that,0,0
203118,would,0,0
203119,apply,0,0
203120,to,0,0
203121,all,0,0
203122,patients,0,0
203123,at,0,0
203124,all,0,0
203125,ages,0,0
203126,and,0,0
203127,stages,0,0
203128,of,0,0
203129,the,0,0
203130,disease,0,1
203131,was,0,0
203132,naive,0,0
203133,.,0,0
203134,Nevertheless,0,0
203135,considerable,0,0
203136,progress,0,0
203137,has,0,0
203138,been,0,0
203139,made,0,0
203140,.,0,0
203141,Moreover,0,0
203142,",",0,0
203143,the,0,0
203144,group,0,0
203145,has,0,0
203146,defined,0,1
203147,more,0,0
203148,precisely,0,0
203149,than,0,0
203150,ever,0,0
203151,before,0,0
203152,the,0,0
203153,nature,1,0
203154,of,1,0
203155,the,1,0
203156,complications,1,1
203157,of,0,0
203158,the,0,0
203159,disease,0,0
203160,and,0,0
203161,the,0,0
203162,association,0,0
203163,of,0,0
203164,the,0,0
203165,risks,1,1
203166,of,1,0
203167,specific,1,0
203168,complications,1,1
203169,with,0,0
203170,specific,0,0
203171,forms,0,0
203172,of,0,0
203173,therapy,0,0
203174,.,0,0
203175,It,0,0
203176,thus,0,0
203177,has,0,0
203178,made,0,0
203179,it,0,0
203180,possible,0,0
203181,to,0,0
203182,pose,0,0
203183,the,0,0
203184,next,0,0
203185,series,0,0
203186,of,0,1
203187,therapeutic,0,0
203188,questions,0,0
203189,that,0,0
203190,must,0,0
203191,be,0,0
203192,addressed,0,0
203193,in,0,0
203194,this,0,0
203195,disorder,0,0
203196,with,0,0
203197,a,0,0
203198,greater,0,0
203199,degree,0,1
203200,of,0,1
203201,sophistication,0,1
203202,than,0,0
203203,was,0,0
203204,previously,0,0
203205,possible,0,0
203206,.,0,0
203207,Abstinence,0,1
203208,or,0,1
203209,controlled,0,0
203210,drinking,0,0
203211,in,0,0
203212,clinical,0,0
203213,practice,0,0
203214,:,0,0
203215,indications,0,0
203216,at,0,0
203217,initial,0,0
203218,assessment,0,0
203219,.,0,1
203220,Previous,0,0
203221,research,0,0
203222,has,0,0
203223,suggested,0,0
203224,two,0,0
203225,leading,0,0
203226,hypotheses,0,0
203227,concerning,0,0
203228,which,0,0
203229,excessive,0,0
203230,drinkers,0,0
203231,can,0,0
203232,re-establish,0,0
203233,control,0,0
203234,:,0,0
203235,one,0,0
203236,based,0,0
203237,upon,0,0
203238,level,0,1
203239,of,0,1
203240,dependence,0,1
203241,",",0,0
203242,the,0,0
203243,other,0,0
203244,upon,0,0
203245,the,0,0
203246,client,0,1
203247,'s,0,1
203248,personal,0,1
203249,persuasion,0,1
203250,.,0,0
203251,Using,0,0
203252,initial,0,0
203253,assessment,0,0
203254,data,0,0
203255,from,0,0
203256,46,0,0
203257,clients,0,0
203258,of,0,0
203259,a,0,0
203260,clinical,0,0
203261,psychology,0,0
203262,alcohol,0,1
203263,problems,0,1
203264,service,0,0
203265,(,0,0
203266,30,0,0
203267,men,0,0
203268,",",0,0
203269,16,0,0
203270,women,0,0
203271,),0,0
203272,",",0,0
203273,an,0,0
203274,attempt,0,0
203275,was,0,0
203276,made,0,0
203277,to,0,0
203278,operationalize,0,0
203279,the,0,0
203280,concepts,0,0
203281,of,0,1
203282,dependence,0,1
203283,and,0,1
203284,personal,0,1
203285,persuasion,0,1
203286,using,0,0
203287,a,0,0
203288,variety,0,0
203289,of,0,0
203290,indicators,0,1
203291,of,0,0
203292,each,0,0
203293,.,0,0
203294,Although,0,0
203295,SADQ,1,1
203296,scores,1,1
203297,and,1,0
203298,Rand,1,0
203299,definite,1,1
203300,alcoholism,1,1
203301,were,0,0
203302,in,0,0
203303,general,0,0
203304,agreement,0,1
203305,",",0,0
203306,there,0,0
203307,were,0,0
203308,a,0,0
203309,number,0,1
203310,of,0,0
203311,borderline,0,1
203312,instances,0,0
203313,and,0,1
203314,cases,0,0
203315,of,0,1
203316,disagreement,0,1
203317,",",0,0
203318,and,0,1
203319,neither,0,1
203320,was,0,0
203321,in,0,0
203322,good,0,0
203323,agreement,0,0
203324,with,0,0
203325,estimates,0,0
203326,of,0,1
203327,problem,0,1
203328,duration,0,1
203329,",",0,1
203330,nor,0,0
203331,with,0,0
203332,reports,0,0
203333,of,0,1
203334,recent,0,0
203335,or,0,0
203336,earlier,0,0
203337,attainment,0,1
203338,of,0,1
203339,abstinence,0,1
203340,or,0,0
203341,control,0,0
203342,.,0,1
203343,Indicators,0,1
203344,of,0,0
203345,personal,1,1
203346,persuasion,1,1
203347,were,0,0
203348,more,0,0
203349,consistent,0,0
203350,.,0,0
203351,Those,0,0
203352,with,0,0
203353,dependence,0,1
203354,indicators,1,1
203355,for,1,0
203356,abstinence,1,1
203357,tended,0,0
203358,to,0,0
203359,prefer,0,0
203360,abstinence,0,1
203361,as,0,0
203362,a,0,0
203363,goal,0,0
203364,",",0,1
203365,but,0,0
203366,there,0,0
203367,were,0,0
203368,many,0,0
203369,departures,0,0
203370,from,0,0
203371,this,0,0
203372,pattern,0,0
203373,particularly,0,0
203374,for,0,0
203375,women,0,0
203376,.,0,0
203377,It,0,0
203378,is,0,0
203379,concluded,0,0
203380,that,0,0
203381,in,0,0
203382,clinical,0,0
203383,practice,0,0
203384,it,0,0
203385,will,0,0
203386,be,0,0
203387,very,0,0
203388,difficult,0,0
203389,to,0,0
203390,make,0,0
203391,a,0,0
203392,clear,0,0
203393,cut,0,0
203394,recommendation,0,0
203395,about,0,0
203396,treatment,0,0
203397,goal,0,0
203398,at,0,0
203399,initial,0,0
203400,assessment,0,0
203401,except,0,0
203402,in,0,0
203403,a,0,0
203404,few,0,0
203405,cases,0,0
203406,.,0,0
203407,Intravenous,0,0
203408,regional,0,0
203409,anaesthesia,0,0
203410,below,0,0
203411,the,0,0
203412,knee,0,0
203413,.,0,0
203414,A,0,0
203415,cross-over,0,0
203416,study,0,0
203417,with,0,0
203418,prilocaine,0,0
203419,in,0,0
203420,volunteers,0,0
203421,.,0,0
203422,The,0,0
203423,quality,0,1
203424,of,0,0
203425,anaesthesia,0,0
203426,provided,0,0
203427,by,0,0
203428,three,0,0
203429,dosages,0,0
203430,of,0,0
203431,prilocaine,0,0
203432,",",0,0
203433,40,0,0
203434,ml,0,0
203435,0.5,0,0
203436,%,0,0
203437,",",0,0
203438,20,0,0
203439,ml,0,0
203440,1,0,0
203441,%,0,0
203442,",",0,0
203443,or,0,0
203444,40,0,0
203445,ml,0,0
203446,1,0,0
203447,%,0,0
203448,",",0,0
203449,administered,0,0
203450,in,0,0
203451,random,0,0
203452,order,0,0
203453,",",0,0
203454,for,0,0
203455,intravenous,0,0
203456,regional,0,0
203457,anaesthesia,0,0
203458,of,0,0
203459,the,0,0
203460,lower,0,0
203461,extremity,0,0
203462,below,0,0
203463,the,0,0
203464,knee,0,1
203465,was,0,0
203466,compared,0,0
203467,in,0,0
203468,six,0,0
203469,volunteers,0,0
203470,.,0,0
203471,Limited,0,0
203472,sensory,0,1
203473,blockade,0,1
203474,was,0,0
203475,achieved,0,0
203476,in,0,0
203477,the,0,0
203478,groups,0,0
203479,with,0,0
203480,40,0,0
203481,ml,0,0
203482,0.5,0,0
203483,%,0,0
203484,and,0,0
203485,20,0,0
203486,ml,0,0
203487,1,0,0
203488,%,0,0
203489,during,0,0
203490,the,0,0
203491,30-minute,0,0
203492,test,0,0
203493,period,0,0
203494,.,0,0
203495,One,0,0
203496,subject,0,0
203497,was,0,0
203498,not,0,0
203499,fully,0,0
203500,anaesthetised,0,0
203501,with,0,0
203502,any,0,0
203503,of,0,0
203504,the,0,0
203505,dosages,0,0
203506,used,0,0
203507,.,0,0
203508,Recovery,1,1
203509,was,1,0
203510,rapid,1,1
203511,(,0,0
203512,mean,0,1
203513,12-13,0,0
203514,minutes,0,0
203515,),0,0
203516,in,0,0
203517,these,0,0
203518,two,0,0
203519,groups,0,0
203520,.,0,0
203521,In,0,0
203522,two,0,0
203523,subjects,0,0
203524,given,0,0
203525,40,0,0
203526,ml,0,0
203527,of,0,0
203528,1,0,0
203529,%,0,0
203530,",",0,0
203531,complete,1,1
203532,recovery,1,1
203533,took,0,0
203534,90,0,0
203535,minutes,0,0
203536,.,0,0
203537,At,0,0
203538,30,0,0
203539,minutes,0,0
203540,",",0,0
203541,the,0,0
203542,degree,1,1
203543,of,1,0
203544,flexion,1,1
203545,remaining,1,0
203546,in,1,0
203547,the,1,0
203548,great,1,0
203549,toe,1,1
203550,(,0,0
203551,control,0,0
203552,100,0,0
203553,%,0,0
203554,),0,0
203555,was,0,0
203556,4,0,0
203557,%,0,0
203558,in,0,0
203559,the,0,0
203560,groups,0,0
203561,who,0,0
203562,received,0,0
203563,40,0,0
203564,ml,0,0
203565,of,0,0
203566,0.5,0,0
203567,%,0,0
203568,and,0,0
203569,1,0,0
203570,%,0,0
203571,",",0,0
203572,but,0,0
203573,34,0,0
203574,%,0,0
203575,in,0,0
203576,those,0,0
203577,who,0,0
203578,received,0,0
203579,20,0,0
203580,ml,0,0
203581,of,0,0
203582,1,0,0
203583,%,0,0
203584,respectively,0,0
203585,.,0,0
203586,Full,1,0
203587,motor,1,1
203588,recovery,1,1
203589,was,0,0
203590,achieved,0,0
203591,in,0,0
203592,8-9,0,0
203593,minutes,0,0
203594,.,0,0
203595,Five,0,0
203596,of,0,0
203597,six,0,0
203598,volunteers,0,0
203599,who,0,0
203600,received,0,0
203601,the,0,0
203602,400-mg,0,0
203603,dose,0,0
203604,experienced,0,1
203605,subjective,1,1
203606,signs,1,1
203607,of,1,0
203608,central,1,1
203609,nervous,1,1
203610,system,1,0
203611,side,1,1
203612,effects,1,1
203613,when,0,0
203614,the,0,0
203615,cuff,0,1
203616,was,0,0
203617,released,0,0
203618,.,0,0
203619,In,0,0
203620,this,0,0
203621,group,0,0
203622,",",0,0
203623,the,0,0
203624,mean,1,1
203625,plasma,1,1
203626,level,1,1
203627,of,0,1
203628,prilocaine,0,0
203629,at,0,0
203630,2,0,0
203631,minutes,0,0
203632,was,0,0
203633,1.22,0,0
203634,micrograms/ml,0,0
203635,",",0,0
203636,maximum,0,1
203637,2.12,0,0
203638,micrograms/ml,0,0
203639,.,0,0
203640,In,0,0
203641,a,0,0
203642,radiological,0,1
203643,examination,0,0
203644,",",0,0
203645,no,1,0
203646,leak,1,1
203647,of,1,1
203648,contrast,1,0
203649,medium,1,0
203650,under,1,0
203651,the,1,0
203652,tourniquet,1,1
203653,cuff,1,1
203654,(,1,0
203655,300,1,0
203656,mmHg,1,0
203657,),1,0
203658,was,0,0
203659,detected,0,0
203660,.,0,0
203661,The,0,0
203662,development,0,1
203663,of,0,1
203664,anaesthesia,0,0
203665,was,0,0
203666,fastest,1,1
203667,following,0,0
203668,the,0,0
203669,largest,0,0
203670,dose,0,0
203671,",",0,0
203672,but,0,0
203673,the,0,0
203674,large,1,0
203675,number,1,1
203676,of,1,1
203677,central,1,1
203678,side,1,1
203679,effects,1,0
203680,makes,0,0
203681,that,0,0
203682,dosage,0,0
203683,less,1,0
203684,suitable,1,0
203685,for,1,0
203686,clinical,1,0
203687,work,1,0
203688,.,1,0
203689,Beta-adrenoceptor,0,1
203690,blockade,0,1
203691,and,0,1
203692,cardiovascular,1,1
203693,response,1,1
203694,to,0,0
203695,the,0,0
203696,cold,0,1
203697,pressor,0,1
203698,test,0,1
203699,.,0,1
203700,Seven,0,1
203701,healthy,0,0
203702,subjects,0,0
203703,immersed,0,0
203704,a,0,0
203705,hand,0,1
203706,in,0,0
203707,random,0,0
203708,order,0,0
203709,in,0,0
203710,either,0,0
203711,warm,0,1
203712,water,0,1
203713,or,0,0
203714,in,0,0
203715,cold,0,1
203716,water,0,0
203717,at,0,0
203718,5,0,0
203719,degrees,0,0
203720,C,0,0
203721,for,0,0
203722,2,0,0
203723,min,0,0
203724,",",0,0
203725,after,0,0
203726,taking,0,0
203727,orally,0,0
203728,a,0,0
203729,single,0,0
203730,dose,0,0
203731,of,0,0
203732,120,0,0
203733,mg,0,0
203734,of,0,0
203735,propranolol,0,0
203736,or,0,0
203737,a,0,0
203738,placebo,0,0
203739,in,0,0
203740,a,0,0
203741,double,0,0
203742,blind,0,0
203743,fashion,0,0
203744,.,0,0
203745,The,0,0
203746,cold,0,1
203747,stress,0,1
203748,resulted,0,0
203749,in,0,0
203750,a,0,0
203751,significant,0,0
203752,increase,0,1
203753,in,0,0
203754,blood,1,1
203755,pressure,1,1
203756,and,0,0
203757,the,0,0
203758,rate,1,1
203759,pressure,1,1
203760,product,1,1
203761,without,0,0
203762,a,0,0
203763,change,0,1
203764,in,0,0
203765,heart,1,1
203766,rate,1,1
203767,.,1,1
203768,Beta-adrenoceptor,0,1
203769,blockade,0,1
203770,did,0,0
203771,not,0,0
203772,affect,0,0
203773,the,0,0
203774,pressor,1,1
203775,response,1,1
203776,the,1,0
203777,cold,1,0
203778,.,1,0
203779,The,0,0
203780,changes,0,1
203781,induced,0,0
203782,by,0,0
203783,the,0,0
203784,cold,0,1
203785,stress,0,1
203786,in,0,0
203787,the,0,0
203788,cardiovascular,1,1
203789,variables,1,0
203790,in,0,0
203791,the,0,0
203792,placebo,0,0
203793,and,0,1
203794,propranolol,0,0
203795,experiments,0,0
203796,were,0,0
203797,not,0,0
203798,statistically,0,0
203799,different,0,0
203800,.,0,0
203801,The,0,0
203802,highest,0,1
203803,rate,1,1
203804,pressure,1,1
203805,product,1,1
203806,during,0,0
203807,the,0,0
203808,cold,0,1
203809,pressor,0,1
203810,test,0,1
203811,was,0,0
203812,about,0,0
203813,109,0,0
203814,units,0,0
203815,.,0,0
203816,This,0,0
203817,was,0,0
203818,well,0,0
203819,below,0,0
203820,the,0,0
203821,pain,1,1
203822,threshold,1,1
203823,value,0,1
203824,of,0,0
203825,about,0,0
203826,200,0,0
203827,found,0,0
203828,during,0,0
203829,exercise,0,0
203830,in,0,0
203831,patients,0,0
203832,with,0,0
203833,ischaemic,0,1
203834,heart,0,1
203835,disease,0,1
203836,.,0,0
203837,In,0,0
203838,the,0,0
203839,recovery,0,1
203840,phase,0,0
203841,",",0,0
203842,the,0,0
203843,cardiovascular,1,1
203844,variables,1,0
203845,reverted,0,0
203846,to,0,0
203847,pre-immersion,0,0
203848,values,0,1
203849,within,0,0
203850,1,0,0
203851,min,0,0
203852,inspite,0,0
203853,of,0,1
203854,continued,0,0
203855,low,0,0
203856,hand,0,1
203857,skin,0,1
203858,temperature,0,1
203859,.,0,0
203860,[,0,0
203861,Results,0,0
203862,of,0,0
203863,a,0,0
203864,cooperative,0,0
203865,prospective,0,0
203866,study,0,0
203867,of,0,1
203868,treatment,0,0
203869,of,0,0
203870,primary,0,0
203871,digestive,0,1
203872,localizations,0,1
203873,of,0,0
203874,non-Hodgkin,0,0
203875,'s,0,1
203876,lymphoma,0,0
203877,],0,0
203878,.,0,0
203879,We,0,0
203880,report,0,0
203881,the,0,0
203882,results,0,0
203883,of,0,0
203884,chemotherapy,0,0
203885,treatment,0,0
203886,in,0,0
203887,82,0,0
203888,patients,0,0
203889,presenting,0,0
203890,with,0,0
203891,primary,0,0
203892,digestive,0,1
203893,lymphoma,0,1
203894,and,0,1
203895,included,0,0
203896,in,0,0
203897,a,0,0
203898,study,0,0
203899,conducted,0,0
203900,between,0,0
203901,October,0,0
203902,1977,0,0
203903,and,0,0
203904,October,0,0
203905,1985,0,0
203906,.,0,0
203907,There,0,0
203908,were,0,0
203909,31,0,0
203910,gastric,0,0
203911,lymphoma,0,0
203912,",",0,0
203913,18,0,0
203914,small,0,0
203915,intestinal,0,1
203916,lymphomas,0,1
203917,",",0,0
203918,and,0,0
203919,19,0,0
203920,with,0,0
203921,multiple,0,0
203922,involvement,0,0
203923,:,0,0
203924,63,0,0
203925,patients,0,0
203926,had,0,0
203927,had,0,0
203928,a,0,0
203929,surgical,0,0
203930,staging,0,0
203931,with,0,0
203932,total,0,1
203933,tumor,0,1
203934,resection,0,0
203935,in,0,0
203936,15,0,0
203937,cases,0,0
203938,.,0,0
203939,Nineteen,0,0
203940,patients,0,0
203941,with,0,0
203942,limited,0,0
203943,disease,0,1
203944,(,0,1
203945,ID,0,1
203946,and,0,1
203947,IID,0,1
203948,),0,1
203949,were,0,0
203950,randomly,0,0
203951,assigned,0,0
203952,to,0,0
203953,either,0,0
203954,a,0,0
203955,3-week,0,0
203956,chemotherapy,0,0
203957,regimen,0,0
203958,associated,0,0
203959,with,0,0
203960,whole,0,0
203961,abdominal,0,1
203962,radiotherapy,0,0
203963,or,0,1
203964,chemotherapy,0,0
203965,for,0,0
203966,3,0,0
203967,years,0,0
203968,.,0,0
203969,Twenty-seven,0,0
203970,stage,0,0
203971,IIID,0,1
203972,and,0,1
203973,thirty-six,0,0
203974,stage,0,1
203975,IV,0,1
203976,were,0,0
203977,treated,0,0
203978,with,0,0
203979,chemotherapy,0,0
203980,alone,0,0
203981,for,0,0
203982,3,0,0
203983,years,0,0
203984,.,0,0
203985,Low,0,0
203986,grade,0,1
203987,lymphomas,0,1
203988,(,0,0
203989,16,0,0
203990,patients,0,0
203991,),0,0
203992,received,0,0
203993,a,0,0
203994,cyclophosphamide,0,0
203995,",",0,1
203996,vincristine,0,0
203997,",",0,1
203998,prednisone,0,0
203999,association,0,1
204000,.,0,1
204001,Intermediate,0,1
204002,(,0,0
204003,56,0,0
204004,patients,0,0
204005,),0,0
204006,and,0,1
204007,high,0,1
204008,grade,0,1
204009,(,0,0
204010,10,0,0
204011,patients,0,0
204012,),0,0
204013,lymphomas,0,1
204014,received,0,0
204015,cyclophosphamide,0,0
204016,",",0,0
204017,vincristine,0,0
204018,",",0,1
204019,adriamycin,0,0
204020,",",0,1
204021,prednisone,0,0
204022,.,0,0
204023,The,0,0
204024,overall,1,1
204025,complete,1,1
204026,remission,1,1
204027,obtained,0,0
204028,was,0,0
204029,63,0,0
204030,p.,0,0
204031,100,0,0
204032,(,0,0
204033,51,0,0
204034,patients,0,0
204035,),0,0
204036,with,0,0
204037,17,0,0
204038,patients,0,0
204039,in,0,0
204040,relapse,1,1
204041,within,0,0
204042,6,0,0
204043,to,0,0
204044,40,0,0
204045,months,0,0
204046,.,0,0
204047,Overall,1,1
204048,survival,1,1
204049,was,0,0
204050,46,0,0
204051,p.,0,0
204052,100,0,0
204053,at,0,0
204054,5,0,0
204055,years,0,0
204056,.,0,0
204057,Survival,1,1
204058,was,0,0
204059,dependent,0,0
204060,on,0,0
204061,abdominal,1,1
204062,extension,1,1
204063,",",1,1
204064,histologic,1,1
204065,grade,1,1
204066,according,1,0
204067,to,1,0
204068,the,1,0
204069,new,1,0
204070,working,1,1
204071,formulation,1,0
204072,used,1,0
204073,for,1,0
204074,lymph-node,1,0
204075,lymphomas,1,1
204076,",",1,1
204077,initial,1,1
204078,localization,1,1
204079,(,0,0
204080,gastric,0,1
204081,lymphomas,0,0
204082,have,0,0
204083,the,0,0
204084,best,0,0
204085,survival,0,1
204086,),0,1
204087,and,0,1
204088,achievement,0,1
204089,of,0,1
204090,complete,1,1
204091,remission,1,1
204092,.,1,0
204093,Chemotherapy,0,0
204094,is,0,0
204095,an,0,0
204096,effective,0,1
204097,treatment,1,0
204098,for,0,0
204099,primary,0,0
204100,digestive,0,1
204101,lymphomas,0,1
204102,.,0,0
204103,The,0,0
204104,role,0,0
204105,of,0,0
204106,surgery,0,0
204107,in,0,0
204108,the,0,0
204109,management,0,0
204110,of,0,0
204111,lymphomas,0,0
204112,has,0,0
204113,to,0,0
204114,be,0,0
204115,defined,0,1
204116,by,0,0
204117,further,0,0
204118,studies,0,0
204119,.,0,0
204120,Results,0,0
204121,of,0,0
204122,a,0,0
204123,prospective,0,0
204124,randomized,0,0
204125,study,0,0
204126,of,0,0
204127,hepatic,0,1
204128,artery,0,1
204129,infusion,0,0
204130,with,0,0
204131,5-fluorouracil,0,0
204132,versus,0,0
204133,intravenous,0,0
204134,5-fluorouracil,0,0
204135,in,0,0
204136,patients,0,0
204137,with,0,0
204138,hepatic,0,1
204139,metastases,0,0
204140,from,0,0
204141,colorectal,0,0
204142,cancer,0,0
204143,:,0,0
204144,A,0,0
204145,Central,0,1
204146,Oncology,0,1
204147,Group,0,0
204148,study,0,0
204149,.,0,0
204150,In,0,0
204151,a,0,0
204152,controlled,0,0
204153,",",0,0
204154,prospectively,0,0
204155,randomized,0,0
204156,trial,0,0
204157,",",0,0
204158,74,0,0
204159,patients,0,0
204160,with,0,0
204161,hepatic,0,1
204162,metastases,0,0
204163,from,0,0
204164,colorectal,0,0
204165,cancer,0,0
204166,were,0,0
204167,randomized,0,0
204168,to,0,0
204169,either,0,0
204170,intra-arterial,0,0
204171,hepatic,0,1
204172,artery,0,1
204173,infusion,0,0
204174,with,0,0
204175,5-fluorouracil,0,0
204176,(,0,0
204177,5-FU,0,0
204178,),0,1
204179,or,0,0
204180,systemic,0,1
204181,chemotherapy,0,0
204182,with,0,0
204183,5-FU,0,0
204184,.,0,0
204185,In,0,0
204186,61,0,0
204187,acceptable,0,0
204188,patients,0,0
204189,",",0,0
204190,there,0,0
204191,was,0,0
204192,no,0,0
204193,significant,0,0
204194,difference,0,0
204195,in,0,0
204196,terms,0,1
204197,of,0,1
204198,response,1,1
204199,rate,1,1
204200,",",1,0
204201,time,1,1
204202,to,1,1
204203,progression,1,1
204204,",",1,1
204205,duration,1,1
204206,of,1,0
204207,the,1,0
204208,response,1,1
204209,",",1,1
204210,and,1,1
204211,survival,1,1
204212,rate,1,1
204213,.,1,0
204214,Though,0,0
204215,the,0,0
204216,response,1,1
204217,rate,1,1
204218,for,0,0
204219,the,0,0
204220,intra-arterial,0,0
204221,infusion,0,0
204222,arm,0,0
204223,was,0,0
204224,slightly,0,0
204225,higher,0,0
204226,than,0,0
204227,for,0,0
204228,the,0,0
204229,systemic,0,1
204230,arm,0,0
204231,",",0,0
204232,the,0,0
204233,difference,0,0
204234,was,0,0
204235,not,0,0
204236,significant,0,0
204237,",",0,0
204238,and,0,0
204239,the,0,0
204240,intra-arterial,0,1
204241,infusion,0,0
204242,arm,0,0
204243,was,0,0
204244,associated,0,0
204245,with,0,0
204246,a,0,0
204247,greater,0,0
204248,incidence,0,1
204249,of,0,1
204250,nausea,1,1
204251,",",1,1
204252,vomiting,1,1
204253,",",1,1
204254,diarrhea,1,1
204255,",",1,1
204256,in,1,0
204257,addition,1,0
204258,to,1,0
204259,complications,1,1
204260,of,1,0
204261,femoral-arterial,1,1
204262,thrombosis,1,1
204263,",",1,1
204264,bleeding,1,1
204265,",",1,1
204266,and,1,1
204267,infection,1,1
204268,at,1,0
204269,the,1,0
204270,catheter,1,0
204271,site,1,0
204272,not,0,0
204273,seen,0,0
204274,in,0,0
204275,patients,0,0
204276,treated,0,0
204277,by,0,0
204278,systemic,0,0
204279,chemotherapy,0,0
204280,.,0,0
204281,Patients,0,0
204282,with,0,0
204283,an,0,0
204284,objective,0,0
204285,response,0,1
204286,to,0,0
204287,chemotherapy,0,0
204288,on,0,0
204289,either,0,0
204290,treatment,0,0
204291,arm,0,0
204292,survived,1,0
204293,twice,0,0
204294,as,0,0
204295,long,0,0
204296,as,0,0
204297,the,0,0
204298,nonresponders,0,0
204299,.,0,0
204300,Long-term,1,0
204301,survival,1,1
204302,in,0,0
204303,one,0,0
204304,patient,0,0
204305,",",0,0
204306,77,0,0
204307,months,0,0
204308,",",0,0
204309,can,0,0
204310,occasionally,0,0
204311,be,0,0
204312,achieved,0,0
204313,in,0,0
204314,patients,0,0
204315,with,0,0
204316,hepatic,0,0
204317,metastases,0,0
204318,.,0,0
204319,Comparison,0,0
204320,of,0,1
204321,maintenance,0,0
204322,treatment,0,0
204323,regimens,0,0
204324,for,0,0
204325,first,0,0
204326,central,0,1
204327,nervous,0,1
204328,system,0,0
204329,relapse,0,1
204330,in,0,0
204331,children,0,0
204332,with,0,0
204333,acute,0,0
204334,lymphocytic,0,1
204335,leukemia,0,0
204336,.,0,0
204337,A,0,0
204338,Pediatric,0,0
204339,Oncology,0,1
204340,Group,0,0
204341,study,0,0
204342,.,0,0
204343,Eighty-seven,0,0
204344,children,0,0
204345,with,0,0
204346,central,0,1
204347,nervous,0,1
204348,system,0,0
204349,(,0,1
204350,CNS,0,0
204351,),0,1
204352,leukemia,0,0
204353,were,0,0
204354,randomized,0,0
204355,to,0,0
204356,receive,0,0
204357,either,0,0
204358,induction,0,0
204359,intrathecal,0,1
204360,chemotherapy,0,0
204361,(,0,1
204362,ITC,0,1
204363,),0,1
204364,and,0,1
204365,cranial,0,1
204366,irradiation,0,0
204367,(,0,1
204368,CRT,0,0
204369,),0,1
204370,plus,0,0
204371,maintenance,0,0
204372,ITC,0,1
204373,",",0,1
204374,or,0,1
204375,induction,0,1
204376,ITC,0,1
204377,and,0,1
204378,craniospinal,0,0
204379,irradiation,0,0
204380,(,0,1
204381,CSpRT,0,1
204382,),0,0
204383,with,0,0
204384,no,0,0
204385,maintenance,0,0
204386,ITC,0,1
204387,.,0,1
204388,ITC,0,1
204389,consisted,0,0
204390,of,0,0
204391,six,0,0
204392,weekly,0,0
204393,injections,0,0
204394,of,0,1
204395,methotrexate,0,0
204396,",",0,1
204397,hydrocortisone,0,0
204398,",",0,1
204399,and,0,1
204400,arabinosylcytosine,0,0
204401,.,0,1
204402,Also,0,0
204403,",",0,0
204404,intensification,0,1
204405,of,0,1
204406,systemic,0,1
204407,induction,0,1
204408,and,0,1
204409,maintenance,0,0
204410,chemotherapy,0,0
204411,was,0,0
204412,given,0,0
204413,.,0,0
204414,CRT,0,0
204415,+,0,0
204416,ITC,0,1
204417,was,0,0
204418,given,0,0
204419,as,0,0
204420,CRT,0,0
204421,",",0,0
204422,2400,0,0
204423,rad,0,0
204424,in,0,0
204425,12,0,0
204426,fractions,0,0
204427,followed,0,0
204428,by,0,0
204429,ITC,0,1
204430,maintenance,0,0
204431,bimonthly,0,0
204432,for,0,0
204433,2,0,0
204434,years,0,0
204435,.,0,0
204436,Craniospinal,0,0
204437,irradiation,0,0
204438,consisted,0,0
204439,of,0,0
204440,CRT,0,0
204441,+,0,0
204442,1400,0,0
204443,rad,0,0
204444,in,0,0
204445,ten,0,0
204446,fractions,0,1
204447,to,0,0
204448,the,0,0
204449,spine,0,0
204450,.,0,1
204451,Randomization,0,0
204452,was,0,0
204453,stratified,0,0
204454,according,0,0
204455,to,0,0
204456,whether,0,0
204457,CNS,0,0
204458,leukemia,0,0
204459,occurred,0,0
204460,at,0,0
204461,initial,0,0
204462,diagnosis,0,0
204463,of,0,1
204464,acute,0,0
204465,lymphocytic,0,1
204466,leukemia,0,0
204467,(,0,0
204468,ALL,0,0
204469,),0,0
204470,(,0,0
204471,Stratum,0,0
204472,I,0,0
204473,",",0,0
204474,15,0,0
204475,patients,0,0
204476,),0,0
204477,",",0,0
204478,during,0,0
204479,first,0,1
204480,bone,0,1
204481,marrow,0,0
204482,(,0,1
204483,BM,0,1
204484,),0,1
204485,remission,0,1
204486,(,0,0
204487,Stratum,0,1
204488,II,0,0
204489,",",0,0
204490,49,0,0
204491,patients,0,0
204492,),0,0
204493,",",0,0
204494,simultaneous,0,0
204495,with,0,0
204496,first,0,1
204497,BM,0,1
204498,relapse,0,1
204499,(,0,0
204500,Stratum,0,1
204501,III,0,1
204502,",",0,0
204503,12,0,0
204504,patients,0,0
204505,),0,0
204506,",",0,0
204507,or,0,0
204508,during,0,0
204509,second,0,1
204510,BM,0,1
204511,remission,0,1
204512,(,0,0
204513,Stratum,0,1
204514,IV,0,1
204515,",",0,0
204516,11,0,0
204517,patients,0,0
204518,),0,0
204519,.,0,0
204520,The,0,0
204521,median,0,1
204522,follow-up,0,0
204523,for,0,0
204524,patients,0,0
204525,who,0,0
204526,remain,0,0
204527,at,0,0
204528,risk,0,0
204529,is,0,0
204530,15,0,0
204531,+,0,0
204532,months,0,0
204533,.,0,0
204534,Eight,0,1
204535,children,0,0
204536,(,0,0
204537,seven,0,0
204538,on,0,0
204539,CRT,0,0
204540,+,0,0
204541,ITC,0,1
204542,",",0,0
204543,one,0,0
204544,on,0,0
204545,CSpRT,0,0
204546,),0,0
204547,developed,0,0
204548,presumed,1,0
204549,therapy,1,0
204550,related,1,0
204551,encephalopathy,1,0
204552,.,1,0
204553,In,0,0
204554,Stratum,0,1
204555,II,0,0
204556,",",0,0
204557,16,0,0
204558,of,0,0
204559,29,0,0
204560,(,0,0
204561,55,0,0
204562,%,0,0
204563,),0,0
204564,patients,0,0
204565,receiving,0,0
204566,CRT,0,0
204567,+,0,0
204568,ITC,0,1
204569,experienced,0,1
204570,adverse,1,1
204571,events,1,1
204572,:,1,0
204573,3,0,0
204574,deaths,1,1
204575,during,1,0
204576,continuous,1,0
204577,complete,1,1
204578,remission,1,1
204579,(,1,1
204580,CCR,1,0
204581,),1,0
204582,and,0,0
204583,13,0,0
204584,relapses,1,1
204585,(,0,0
204586,2,0,0
204587,CNS,0,0
204588,",",0,0
204589,1,0,0
204590,CNS,0,0
204591,+,0,0
204592,BM,0,1
204593,",",0,0
204594,1,0,0
204595,BM,0,0
204596,+,0,0
204597,testes,0,1
204598,",",0,0
204599,and,0,0
204600,2,0,0
204601,testes,0,0
204602,),0,0
204603,as,0,0
204604,compared,0,0
204605,with,0,0
204606,only,0,0
204607,5,0,0
204608,relapses,1,0
204609,in,0,0
204610,20,0,0
204611,(,0,0
204612,25,0,0
204613,%,0,0
204614,),0,0
204615,patients,0,0
204616,on,0,0
204617,CSpRT,0,1
204618,(,0,0
204619,1,0,0
204620,CNS,0,0
204621,",",0,0
204622,1,0,0
204623,CNS,0,0
204624,+,0,0
204625,BM,0,1
204626,",",0,0
204627,1,0,0
204628,BM,0,1
204629,",",0,0
204630,and,0,0
204631,2,0,0
204632,testes,0,0
204633,),0,0
204634,.,0,0
204635,The,0,0
204636,children,0,0
204637,on,0,0
204638,both,0,0
204639,regimens,0,0
204640,were,0,0
204641,comparable,0,0
204642,for,0,0
204643,sex,0,0
204644,",",0,1
204645,race,0,0
204646,",",0,1
204647,age,0,0
204648,at,0,0
204649,initial,0,0
204650,ALL,0,0
204651,diagnosis,0,1
204652,",",0,1
204653,time,1,1
204654,from,1,0
204655,ALL,1,0
204656,diagnosis,1,0
204657,to,1,0
204658,first,1,1
204659,episode,1,1
204660,of,1,1
204661,CNS,1,0
204662,leukemia,1,0
204663,",",1,1
204664,systemic,1,1
204665,therapy,1,0
204666,both,1,0
204667,before,1,0
204668,and,1,0
204669,after,1,0
204670,CNS,1,1
204671,relapse,1,1
204672,",",1,1
204673,and,1,1
204674,number,1,1
204675,of,1,1
204676,blasts,1,1
204677,in,1,0
204678,the,1,0
204679,spinal,1,1
204680,fluid,1,1
204681,at,1,0
204682,diagnosis,1,0
204683,of,1,1
204684,CNS,1,0
204685,leukemia,1,0
204686,.,1,0
204687,The,0,0
204688,conclusion,0,0
204689,is,0,0
204690,that,0,0
204691,children,0,0
204692,with,0,0
204693,isolated,0,0
204694,CNS,0,0
204695,leukemia,0,0
204696,can,0,0
204697,achieve,0,0
204698,prolonged,1,1
204699,survival,1,1
204700,with,1,0
204701,aggressive,1,1
204702,therapy,1,0
204703,",",0,1
204704,and,0,1
204705,that,0,0
204706,CSpRT,1,0
204707,is,1,0
204708,possibly,1,0
204709,less,1,0
204710,toxic,1,1
204711,and,0,1
204712,more,0,0
204713,likely,0,0
204714,than,0,0
204715,is,0,0
204716,CRT,0,0
204717,+,0,0
204718,ITC,0,1
204719,to,0,0
204720,prevent,0,0
204721,subsequent,1,0
204722,BM,1,1
204723,and,1,1
204724,testicular,1,1
204725,relapse,1,1
204726,(,0,0
204727,P,0,0
204728,less,0,0
204729,than,0,0
204730,0.02,0,0
204731,),0,0
204732,",",0,0
204733,but,0,0
204734,not,0,0
204735,subsequent,0,0
204736,CNS,1,0
204737,relapse,1,1
204738,(,0,0
204739,P,0,0
204740,=,0,0
204741,0.7,0,0
204742,),0,0
204743,.,0,0
204744,A,0,0
204745,possible,0,0
204746,systemic,0,1
204747,therapy,0,0
204748,effect,0,1
204749,of,0,1
204750,spinal,1,1
204751,irradiation,1,0
204752,is,0,0
204753,postulated,0,0
204754,to,0,0
204755,explain,0,0
204756,the,0,0
204757,superiority,1,0
204758,of,1,0
204759,CSpRT,1,0
204760,.,1,0
204761,Randomized,0,0
204762,trial,0,0
204763,of,0,0
204764,combination,0,0
204765,chemotherapy,0,0
204766,in,0,0
204767,hormone-resistant,0,1
204768,metastatic,0,0
204769,prostate,0,0
204770,carcinoma,0,0
204771,.,0,0
204772,A,0,0
204773,prospective,0,0
204774,randomized,0,0
204775,study,0,0
204776,was,0,0
204777,conducted,0,0
204778,in,0,0
204779,51,0,0
204780,patients,0,0
204781,with,0,0
204782,stage,0,0
204783,D,0,1
204784,hormone-resistant,0,1
204785,prostatic,0,1
204786,carcinoma,0,0
204787,",",0,0
204788,comparing,0,0
204789,a,0,0
204790,combination,0,0
204791,of,0,1
204792,doxorubicin,0,0
204793,and,0,1
204794,lomustine,0,0
204795,(,0,1
204796,DC,0,0
204797,),0,1
204798,with,0,0
204799,cyclophosphamide,0,0
204800,and,0,1
204801,5-FU,0,1
204802,(,0,1
204803,CF,0,1
204804,),0,0
204805,.,0,0
204806,Patients,0,0
204807,were,0,0
204808,assessed,0,0
204809,objectively,0,1
204810,(,0,0
204811,employing,0,0
204812,National,0,1
204813,Prostate,0,0
204814,Cancer,0,0
204815,Project,0,1
204816,criteria,0,0
204817,),0,1
204818,and,0,0
204819,subjectively,0,1
204820,(,0,0
204821,using,0,0
204822,a,0,0
204823,numerical,0,1
204824,scoring,0,1
204825,scheme,0,0
204826,),0,0
204827,.,0,0
204828,Each,0,0
204829,regimen,0,0
204830,was,0,0
204831,well,0,0
204832,tolerated,1,1
204833,with,0,0
204834,acceptable,0,0
204835,levels,1,1
204836,of,1,0
204837,myelosuppression,1,1
204838,.,1,0
204839,The,0,0
204840,objective,1,0
204841,partial,1,1
204842,response,1,1
204843,rate,1,1
204844,was,0,0
204845,57,0,0
204846,%,0,0
204847,for,0,0
204848,DC,0,0
204849,and,0,0
204850,8,0,0
204851,%,0,0
204852,for,0,0
204853,CF,0,1
204854,.,0,0
204855,Objective,1,1
204856,stabilization,1,1
204857,occurred,0,0
204858,",",0,0
204859,respectively,0,0
204860,",",0,0
204861,in,0,0
204862,14,0,0
204863,%,0,0
204864,and,0,0
204865,44,0,0
204866,%,0,0
204867,of,0,0
204868,the,0,0
204869,patients,0,0
204870,.,0,0
204871,Similarly,0,0
204872,",",0,0
204873,DC,0,0
204874,demonstrated,0,0
204875,a,0,0
204876,significantly,0,0
204877,superior,0,0
204878,subjective,1,1
204879,response,1,1
204880,rate,1,1
204881,(,1,1
204882,partial,1,1
204883,plus,1,0
204884,complete,1,1
204885,),1,0
204886,of,0,0
204887,82,0,0
204888,%,0,0
204889,",",0,0
204890,compared,0,0
204891,to,0,0
204892,48,0,0
204893,%,0,0
204894,for,0,0
204895,CF,0,1
204896,.,0,0
204897,Patients,0,0
204898,with,0,0
204899,poor,0,1
204900,initial,0,0
204901,performance,0,1
204902,status,0,1
204903,or,0,1
204904,liver,0,1
204905,involvement,0,1
204906,had,0,0
204907,significantly,0,0
204908,lower,0,0
204909,response,1,1
204910,rates,1,1
204911,and,0,1
204912,reduced,0,1
204913,survival,1,1
204914,.,1,1
204915,Overall,0,1
204916,",",0,0
204917,there,1,0
204918,was,1,0
204919,no,1,0
204920,significant,1,0
204921,difference,1,0
204922,in,1,0
204923,survival,1,1
204924,between,1,0
204925,the,1,0
204926,two,1,0
204927,arms,1,0
204928,",",1,0
204929,reflecting,1,0
204930,the,1,0
204931,similarity,1,1
204932,between,1,0
204933,DC,1,0
204934,and,1,1
204935,CF,1,1
204936,in,1,0
204937,total,1,1
204938,objective,1,0
204939,response,1,1
204940,rate,1,1
204941,(,1,1
204942,partial,1,1
204943,response,1,1
204944,plus,1,0
204945,stable,1,1
204946,disease,1,1
204947,),1,0
204948,.,1,1
204949,DC,0,0
204950,provided,0,0
204951,superior,0,1
204952,palliation,1,1
204953,and,0,1
204954,was,0,0
204955,well,0,1
204956,tolerated,1,1
204957,by,0,0
204958,an,0,0
204959,essentially,0,0
204960,geriatric,0,0
204961,population,0,0
204962,.,0,0
204963,[,0,0
204964,Clinical,0,1
204965,trials,0,0
204966,with,0,0
204967,pirprofen,0,0
204968,and,0,1
204969,naproxen,0,0
204970,in,0,0
204971,patients,0,0
204972,with,0,0
204973,gonarthrosis,1,1
204974,and,1,1
204975,coxarthrosis,1,1
204976,],1,0
204977,.,0,0
204978,Relief,0,1
204979,of,0,1
204980,pain,1,1
204981,by,0,0
204982,infusion,0,0
204983,of,0,1
204984,morphine,0,0
204985,after,0,0
204986,operation,0,0
204987,:,0,0
204988,does,0,0
204989,tolerance,1,1
204990,develop,0,0
204991,?,0,0
204992,To,0,0
204993,see,0,0
204994,whether,0,0
204995,continuous,0,0
204996,intravenous,0,0
204997,infusion,0,0
204998,of,0,0
204999,opiates,0,0
205000,provides,0,0
205001,more,0,0
205002,effective,0,1
205003,postoperative,1,1
205004,relief,1,1
205005,of,1,1
205006,pain,1,1
205007,than,0,0
205008,conventional,0,0
205009,intramuscular,0,0
205010,injection,0,0
205011,these,0,0
205012,regimens,0,0
205013,were,0,0
205014,compared,0,0
205015,in,0,0
205016,a,0,0
205017,prospective,0,0
205018,double,0,0
205019,blind,0,0
205020,trial,0,0
205021,.,0,0
205022,Thirty,0,0
205023,patients,0,0
205024,undergoing,0,0
205025,elective,0,0
205026,cholecystectomy,0,0
205027,were,0,0
205028,allocated,0,0
205029,randomly,0,0
205030,to,0,0
205031,receive,0,0
205032,an,0,0
205033,infusion,0,0
205034,of,0,1
205035,morphine,0,0
205036,or,0,0
205037,an,0,0
205038,infusion,0,0
205039,of,0,1
205040,placebo,0,0
205041,(,0,0
205042,control,0,0
205043,group,0,0
205044,),0,0
205045,for,0,0
205046,24,0,0
205047,hours,0,0
205048,.,0,0
205049,Both,0,0
205050,groups,0,0
205051,were,0,0
205052,allowed,0,0
205053,supplementary,0,0
205054,morphine,0,0
205055,boluses,0,0
205056,as,0,0
205057,requested,0,0
205058,.,0,0
205059,During,0,0
205060,the,0,0
205061,first,0,0
205062,48,0,0
205063,hours,0,0
205064,after,0,0
205065,operation,0,0
205066,the,0,0
205067,degree,1,1
205068,of,1,1
205069,pain,1,1
205070,was,0,0
205071,almost,0,0
205072,identical,0,0
205073,between,0,0
205074,the,0,0
205075,groups,0,0
205076,.,0,0
205077,Surprisingly,0,0
205078,",",0,0
205079,the,0,0
205080,group,0,0
205081,that,0,0
205082,was,0,0
205083,given,0,0
205084,the,0,0
205085,infusion,0,0
205086,of,0,0
205087,morphine,0,0
205088,received,0,0
205089,as,0,0
205090,much,0,0
205091,supplementary,0,0
205092,morphine,0,0
205093,as,0,0
205094,the,0,0
205095,control,0,0
205096,group,0,0
205097,during,0,0
205098,the,0,0
205099,first,0,0
205100,24,0,0
205101,hours,0,0
205102,and,0,0
205103,appreciably,0,0
205104,more,0,0
205105,during,0,0
205106,the,0,0
205107,24,0,0
205108,hours,0,0
205109,after,0,0
205110,the,0,0
205111,infusion,0,0
205112,had,0,0
205113,been,0,0
205114,withdrawn,0,0
205115,.,0,0
205116,Nausea,1,1
205117,and,1,1
205118,vomiting,1,1
205119,were,0,0
205120,more,0,0
205121,prevalent,0,0
205122,among,0,0
205123,the,0,0
205124,patients,0,0
205125,given,0,0
205126,the,0,0
205127,infusion,0,0
205128,of,0,0
205129,morphine,0,0
205130,.,0,0
205131,These,0,0
205132,results,0,0
205133,suggest,0,0
205134,that,0,0
205135,continuous,0,0
205136,infusion,0,0
205137,of,0,0
205138,morphine,0,0
205139,may,0,0
205140,be,0,0
205141,an,0,0
205142,inferior,0,0
205143,regimen,0,0
205144,to,0,0
205145,intermittent,0,0
205146,bolus,0,0
205147,administration,0,0
205148,in,0,0
205149,the,0,0
205150,relief,1,1
205151,of,1,0
205152,postoperative,1,1
205153,pain,1,1
205154,.,1,0
205155,This,0,0
205156,may,0,0
205157,be,0,0
205158,explained,0,0
205159,by,0,0
205160,the,0,0
205161,development,0,1
205162,of,0,0
205163,tolerance,1,1
205164,in,0,0
205165,patients,0,0
205166,who,0,0
205167,received,0,0
205168,the,0,0
205169,infusion,0,0
205170,of,0,0
205171,morphine,0,0
205172,.,0,0
205173,Zinc,1,0
205174,and,1,1
205175,copper,1,1
205176,balances,1,1
205177,in,0,0
205178,preterm,0,0
205179,infants,0,0
205180,.,0,0
205181,Preterm,0,0
205182,infants,0,0
205183,are,0,0
205184,at,0,0
205185,risk,0,1
205186,for,0,0
205187,copper,0,1
205188,and,0,1
205189,zinc,0,1
205190,depletion,0,1
205191,if,0,0
205192,sufficient,0,0
205193,quantities,0,1
205194,of,0,0
205195,these,0,0
205196,nutrients,0,0
205197,are,0,0
205198,not,0,0
205199,provided,0,0
205200,in,0,0
205201,a,0,0
205202,bioavailable,0,1
205203,form,0,0
205204,in,0,0
205205,postnatal,0,1
205206,life,0,1
205207,.,0,0
205208,The,0,0
205209,purpose,0,0
205210,of,0,0
205211,this,0,0
205212,study,0,0
205213,was,0,0
205214,to,0,0
205215,determine,0,0
205216,whether,0,0
205217,the,0,0
205218,use,0,0
205219,of,0,0
205220,a,0,0
205221,whey-predominant,0,0
205222,",",0,0
205223,50,0,0
205224,%,0,0
205225,medium,0,0
205226,chain,0,1
205227,triglyceride,0,1
205228,formula,0,0
205229,with,0,0
205230,relatively,0,0
205231,high,0,0
205232,concentrations,0,1
205233,of,0,1
205234,zinc,0,0
205235,and,0,0
205236,copper,0,0
205237,would,0,0
205238,promote,0,0
205239,the,0,0
205240,achievement,0,1
205241,of,0,0
205242,the,0,0
205243,in,1,0
205244,utero,1,0
205245,accretion,1,1
205246,rate,1,1
205247,for,1,0
205248,zinc,1,1
205249,and,1,1
205250,copper,1,1
205251,in,0,0
205252,the,0,0
205253,preterm,0,0
205254,infant,0,0
205255,.,0,0
205256,Two,0,0
205257,groups,0,0
205258,of,0,0
205259,five,0,0
205260,preterm,0,0
205261,infants,0,0
205262,were,0,0
205263,fed,0,0
205264,a,0,0
205265,diet,0,0
205266,containing,0,0
205267,12.5,0,0
205268,mg/L,0,0
205269,of,0,0
205270,zinc,0,0
205271,and,0,0
205272,either,0,0
205273,0.9,0,0
205274,mg/L,0,0
205275,or,0,0
205276,2.1,0,0
205277,mg/L,0,0
205278,of,0,0
205279,copper,0,1
205280,.,0,0
205281,Seventy-two-hour,0,1
205282,metabolic,0,1
205283,balance,0,1
205284,studies,0,0
205285,were,0,0
205286,performed,0,0
205287,at,0,0
205288,an,0,0
205289,average,0,1
205290,postconceptual,0,1
205291,age,0,0
205292,of,0,0
205293,34,0,0
205294,weeks,0,0
205295,and,0,0
205296,an,0,0
205297,average,0,1
205298,weight,0,1
205299,of,0,0
205300,"1,549",0,0
205301,g.,0,0
205302,All,0,0
205303,infants,0,0
205304,were,0,0
205305,in,0,0
205306,positive,1,1
205307,zinc,1,1
205308,balance,1,1
205309,and,0,0
205310,nine,0,0
205311,of,0,0
205312,ten,0,0
205313,achieved,0,0
205314,the,0,0
205315,in,1,0
205316,utero,1,0
205317,accretion,1,1
205318,rate,1,1
205319,for,1,0
205320,zinc,1,0
205321,for,0,0
205322,a,0,0
205323,34-week,0,0
205324,gestation,0,1
205325,fetus,0,1
205326,(,0,0
205327,greater,0,1
205328,than,0,0
205329,or,0,0
205330,equal,0,0
205331,to,0,0
205332,0.432,0,0
205333,mg/d,0,0
205334,),0,0
205335,.,0,0
205336,Three,0,0
205337,infants,0,0
205338,receiving,0,0
205339,the,0,0
205340,high,0,0
205341,copper,0,1
205342,formula,0,0
205343,and,0,0
205344,two,0,0
205345,receiving,0,0
205346,the,0,0
205347,lower,0,0
205348,copper,0,1
205349,formula,0,1
205350,were,0,0
205351,in,0,0
205352,positive,1,1
205353,copper,1,0
205354,balance,1,1
205355,.,1,0
205356,Two,0,0
205357,infants,0,0
205358,from,0,0
205359,each,0,0
205360,group,0,0
205361,achieved,0,0
205362,the,0,0
205363,in,1,0
205364,utero,1,0
205365,accretion,1,1
205366,rate,1,1
205367,for,1,0
205368,copper,1,0
205369,for,0,0
205370,a,0,0
205371,34-week,0,0
205372,gestation,0,1
205373,fetus,0,1
205374,(,0,0
205375,0.088,0,0
205376,mg/d,0,0
205377,),0,0
205378,.,0,0
205379,A,0,0
205380,formula,0,0
205381,that,0,0
205382,provides,0,0
205383,12.5,0,0
205384,mg/L,0,0
205385,of,0,0
205386,zinc,0,0
205387,permits,0,0
205388,positive,1,1
205389,zinc,1,1
205390,balance,1,1
205391,and,1,1
205392,zinc,1,1
205393,retention,1,1
205394,similar,0,0
205395,to,0,0
205396,in,0,0
205397,utero,0,0
205398,rates,0,1
205399,.,0,0
205400,A,0,0
205401,formula,0,0
205402,that,0,0
205403,provides,0,0
205404,as,0,0
205405,much,0,0
205406,as,0,0
205407,2.1,0,0
205408,mg/L,0,0
205409,of,0,0
205410,copper,0,1
205411,",",0,0
205412,however,0,0
205413,",",0,0
205414,may,0,0
205415,not,0,0
205416,always,0,0
205417,permit,0,0
205418,positive,0,1
205419,copper,1,0
205420,balance,1,1
205421,.,1,0
205422,The,0,0
205423,effect,0,0
205424,of,0,0
205425,polyvinylpyrrolidone-iodine,0,0
205426,as,0,0
205427,an,0,0
205428,disinfectant,1,0
205429,in,0,0
205430,eye,0,0
205431,surgery,0,0
205432,.,0,0
205433,105,0,0
205434,patients,0,0
205435,admitted,0,0
205436,for,0,0
205437,cataract,0,0
205438,surgery,0,0
205439,were,0,0
205440,treated,0,0
205441,pre-operatively,0,0
205442,with,0,0
205443,polyvinylpyrrolidone-iodine,0,0
205444,(,0,0
205445,PVP-I,0,1
205446,),0,0
205447,as,0,0
205448,a,0,0
205449,disinfectant,0,1
205450,",",0,1
205451,and,0,1
205452,consecutive,0,0
205453,bacterial,0,1
205454,cultures,0,1
205455,were,0,0
205456,obtained,0,0
205457,before,0,0
205458,initiating,0,0
205459,surgery,0,0
205460,and,0,0
205461,at,0,0
205462,the,0,0
205463,end,0,0
205464,of,0,0
205465,the,0,0
205466,operation,0,0
205467,.,0,0
205468,A,0,0
205469,control,0,0
205470,group,0,0
205471,(,0,0
205472,n,0,0
205473,=,0,0
205474,99,0,0
205475,),0,0
205476,only,0,0
205477,had,0,0
205478,a,0,0
205479,standard,1,0
205480,disinfection,1,1
205481,procedure,0,0
205482,of,0,0
205483,the,0,0
205484,eye,0,0
205485,(,0,0
205486,including,0,0
205487,instillation,0,0
205488,of,0,1
205489,Terramycin,0,0
205490,cum,0,1
205491,polymyxin,0,0
205492,B,0,1
205493,cream,0,0
205494,in,0,0
205495,the,0,0
205496,conjunctival,0,1
205497,sac,0,1
205498,the,0,0
205499,evening,0,1
205500,before,0,0
205501,surgery,0,0
205502,),0,0
205503,.,0,0
205504,The,0,0
205505,cultures,0,0
205506,obtained,0,0
205507,from,0,0
205508,the,0,0
205509,conjunctival,0,1
205510,sac,0,1
205511,of,0,0
205512,the,0,0
205513,control,0,0
205514,group,0,0
205515,principally,0,0
205516,showed,0,0
205517,growth,0,1
205518,of,0,0
205519,Staph,0,1
205520,.,0,1
205521,albus,0,0
205522,and,0,1
205523,Staph,0,1
205524,.,0,1
205525,aureus,0,1
205526,",",0,0
205527,and,0,1
205528,to,0,0
205529,a,0,0
205530,minor,0,0
205531,degree,0,1
205532,diphtheroids,0,1
205533,(,0,0
205534,Corynebacterium,0,1
205535,species,0,0
205536,),0,0
205537,.,0,0
205538,Proteus,0,1
205539,mirabilis,0,1
205540,",",0,1
205541,Escherichia,0,1
205542,coli,0,1
205543,and,0,1
205544,micrococci,0,1
205545,.,0,0
205546,There,0,0
205547,was,0,0
205548,a,0,0
205549,significant,1,0
205550,quantitative,1,0
205551,diminished,1,1
205552,growth,1,1
205553,(,0,0
205554,P,0,0
205555,less,0,0
205556,than,0,0
205557,0.05,0,0
205558,),0,0
205559,of,0,0
205560,bacteria,0,1
205561,in,0,0
205562,the,0,0
205563,group,0,0
205564,of,0,0
205565,patients,0,0
205566,treated,0,0
205567,with,0,0
205568,PVP-I,0,0
205569,compared,0,0
205570,to,0,0
205571,the,0,0
205572,control,0,0
205573,group,0,0
205574,.,0,0
205575,Concerning,0,0
205576,the,0,0
205577,growth,0,1
205578,of,0,0
205579,Staph,0,1
205580,.,0,1
205581,albus,0,0
205582,",",0,0
205583,this,0,0
205584,was,0,0
205585,reduced,0,0
205586,to,0,0
205587,almost,0,0
205588,one,0,0
205589,third,0,0
205590,and,0,0
205591,other,0,1
205592,bacteria,0,1
205593,were,0,0
205594,almost,0,0
205595,eliminated,0,0
205596,in,0,0
205597,the,0,0
205598,group,0,0
205599,receiving,0,0
205600,PVP-I,0,0
205601,.,0,0
205602,As,0,0
205603,we,0,0
205604,disclosed,0,0
205605,no,0,0
205606,toxic,1,1
205607,or,1,0
205608,allergic,1,1
205609,reaction,1,1
205610,post-operatively,1,0
205611,which,0,0
205612,could,0,0
205613,be,0,0
205614,related,0,0
205615,to,0,0
205616,the,0,0
205617,use,0,0
205618,of,0,0
205619,PVP-I,0,0
205620,as,0,0
205621,a,0,0
205622,disinfectant,0,0
205623,",",0,0
205624,this,0,0
205625,agent,0,0
205626,seems,0,0
205627,to,0,0
205628,constitute,0,0
205629,an,0,0
205630,effective,1,1
205631,pre-operative,1,1
205632,antimicrobial,1,1
205633,treatment,1,0
205634,",",0,0
205635,taking,0,0
205636,into,0,0
205637,consideration,0,0
205638,the,0,0
205639,broad,0,0
205640,antimicrobial,0,1
205641,spectrum,0,0
205642,of,0,1
205643,PVP-I,0,0
205644,shown,0,0
205645,by,0,0
205646,other,0,0
205647,authors,0,0
205648,.,0,0
205649,Prevention,0,0
205650,of,0,1
205651,premature,0,0
205652,labor,0,1
205653,by,0,0
205654,17,0,0
205655,alpha-hydroxyprogesterone,0,0
205656,caproate,0,0
205657,.,0,0
205658,Eighty,0,1
205659,pregnant,0,0
205660,women,0,0
205661,at,0,0
205662,high,0,0
205663,risk,0,1
205664,of,0,1
205665,giving,0,1
205666,birth,0,0
205667,prematurely,0,0
205668,were,0,0
205669,divided,0,0
205670,randomly,0,0
205671,into,0,0
205672,two,0,0
205673,groups,0,0
205674,.,0,0
205675,Treatment,0,0
205676,with,0,0
205677,either,0,0
205678,17,0,0
205679,alpha-hydroxyprogesterone,0,0
205680,caproate,0,0
205681,",",0,0
205682,250,0,0
205683,mg,0,0
205684,by,0,0
205685,intramuscular,0,0
205686,injection,0,0
205687,once,0,0
205688,a,0,0
205689,week,0,0
205690,",",0,0
205691,or,0,0
205692,a,0,0
205693,placebo,0,0
205694,was,0,0
205695,given,0,0
205696,in,0,0
205697,a,0,0
205698,double-blind,0,0
205699,fashion,0,0
205700,.,0,1
205701,Imminent,0,1
205702,premature,0,0
205703,labor,0,1
205704,occurred,0,0
205705,in,0,0
205706,29.0,0,0
205707,%,0,0
205708,of,0,0
205709,the,0,0
205710,treated,0,0
205711,group,0,0
205712,and,0,0
205713,in,0,0
205714,59.4,0,0
205715,%,0,0
205716,of,0,0
205717,the,0,0
205718,control,0,0
205719,group,0,0
205720,(,0,0
205721,p,0,0
205722,less,0,0
205723,than,0,0
205724,0.025,0,0
205725,),0,0
205726,.,0,0
205727,The,0,0
205728,rate,1,1
205729,of,1,0
205730,premature,1,0
205731,deliveries,1,1
205732,was,0,0
205733,also,0,0
205734,significantly,0,0
205735,lower,0,0
205736,in,0,0
205737,the,0,0
205738,treated,0,0
205739,group,0,0
205740,(,0,0
205741,16.1,0,0
205742,%,0,0
205743,),0,0
205744,than,0,0
205745,in,0,0
205746,the,0,0
205747,control,0,0
205748,group,0,0
205749,(,0,0
205750,37.82,0,0
205751,%,0,0
205752,),0,0
205753,(,0,0
205754,p,0,0
205755,less,0,0
205756,than,0,0
205757,0.05,0,0
205758,),0,0
205759,.,0,0
205760,There,0,0
205761,were,0,0
205762,no,0,0
205763,cases,0,0
205764,of,0,0
205765,perinatal,1,1
205766,death,1,1
205767,or,1,1
205768,fetal,1,1
205769,malformations,1,0
205770,in,0,0
205771,either,0,0
205772,group,0,0
205773,.,0,0
205774,The,0,0
205775,mean,1,1
205776,birth,1,1
205777,weight,1,1
205778,of,0,0
205779,all,0,0
205780,infants,0,0
205781,of,0,0
205782,the,0,0
205783,treated,0,0
205784,group,0,0
205785,was,0,0
205786,significantly,0,0
205787,higher,0,0
205788,than,0,0
205789,in,0,0
205790,those,0,0
205791,of,0,0
205792,the,0,0
205793,control,0,0
205794,group,0,0
205795,(,0,0
205796,3111.9,0,0
205797,+/-,0,0
205798,905,0,0
205799,gm,0,0
205800,versus,0,0
205801,2680,0,0
205802,+/-,0,0
205803,813.4,0,0
205804,gm,0,0
205805,",",0,0
205806,p,0,0
205807,less,0,0
205808,than,0,0
205809,0.05,0,0
205810,),0,0
205811,.,0,0
205812,The,0,0
205813,results,0,0
205814,support,0,0
205815,treatment,0,0
205816,with,0,0
205817,progesterone,0,1
205818,caproate,0,0
205819,for,0,0
205820,the,0,0
205821,prevention,0,0
205822,of,0,0
205823,premature,0,0
205824,labor,0,1
205825,.,0,0
205826,Fluorouracil,0,0
205827,as,0,0
205828,an,0,0
205829,adjuvant,0,0
205830,to,0,0
205831,surgery,0,0
205832,in,0,0
205833,carcinoma,0,0
205834,of,0,0
205835,the,0,0
205836,colon,0,0
205837,.,0,0
205838,Protective,0,0
205839,effect,0,1
205840,of,0,1
205841,1-adamantanamine,0,1
205842,hydrochloride,0,0
205843,on,0,0
205844,influenza,0,1
205845,A2,0,1
205846,infections,1,1
205847,in,0,0
205848,the,0,0
205849,family,0,0
205850,environment,0,0
205851,:,0,0
205852,a,0,0
205853,controlled,0,0
205854,double-blind,0,0
205855,study,0,0
205856,.,0,0
205857,[,0,0
205858,Prognostic,0,1
205859,experiences,0,1
205860,in,0,0
205861,the,0,0
205862,long-term,0,0
205863,differential,0,1
205864,therapy,0,0
205865,of,0,1
205866,chronic,0,0
205867,aggressive,0,0
205868,hepatitides,0,0
205869,],0,0
205870,.,0,0
205871,A,0,0
205872,double-blind,0,0
205873,crossover,0,0
205874,comparison,0,0
205875,of,0,1
205876,pindolol,0,0
205877,",",0,1
205878,metoprolol,0,0
205879,",",0,1
205880,atenolol,0,0
205881,and,0,1
205882,labetalol,0,1
205883,in,0,0
205884,mild,0,0
205885,to,0,0
205886,moderate,0,0
205887,hypertension,0,0
205888,.,0,0
205889,1,0,0
205890,This,0,0
205891,study,0,0
205892,was,0,0
205893,designed,0,0
205894,to,0,0
205895,compare,0,0
205896,in,0,0
205897,a,0,0
205898,double-blind,0,0
205899,randomized,0,0
205900,crossover,0,0
205901,trial,0,0
205902,",",0,1
205903,atenolol,0,0
205904,",",0,1
205905,labetalol,0,1
205906,",",0,1
205907,metoprolol,0,0
205908,and,0,1
205909,pindolol,0,0
205910,.,0,1
205911,Considerable,0,0
205912,differences,0,0
205913,in,0,0
205914,dose,1,0
205915,(,0,0
205916,atenolol,0,0
205917,138,0,0
205918,+/-,0,0
205919,13,0,0
205920,mg,0,0
205921,daily,0,0
205922,;,0,0
205923,labetalol,0,0
205924,308,0,0
205925,+/-,0,0
205926,34,0,0
205927,mg,0,0
205928,daily,0,0
205929,;,0,0
205930,metoprolol,0,0
205931,234,0,0
205932,+/-,0,0
205933,22,0,0
205934,mg,0,0
205935,daily,0,0
205936,;,0,0
205937,and,0,0
205938,pindolol,0,0
205939,24,0,0
205940,+/-2,0,0
205941,mg,0,0
205942,daily,0,1
205943,were,0,0
205944,required,0,0
205945,to,0,0
205946,produce,0,0
205947,similar,0,0
205948,antihypertensive,1,0
205949,effects,1,0
205950,.,1,0
205951,3,0,0
205952,The,1,0
205953,overall,1,1
205954,incidence,1,1
205955,of,1,1
205956,side-effects,1,1
205957,was,1,0
205958,similar,1,0
205959,with,1,0
205960,atenolol,1,0
205961,",",1,1
205962,metoprolol,1,0
205963,and,1,1
205964,pindolol,1,0
205965,but,1,0
205966,was,1,0
205967,slightly,1,0
205968,less,1,0
205969,with,1,0
205970,labetalol,1,1
205971,.,0,0
205972,Sleep,1,1
205973,disturbances,1,1
205974,and,1,1
205975,abnormal,1,1
205976,dreaming,1,1
205977,patterns,1,1
205978,were,1,0
205979,most,1,0
205980,frequent,1,1
205981,with,1,0
205982,pindolol,1,0
205983,.,0,0
205984,4,0,0
205985,There,1,0
205986,was,1,0
205987,a,1,0
205988,significantly,1,0
205989,greater,1,0
205990,fall,1,1
205991,in,1,0
205992,pulse,1,1
205993,rate,1,1
205994,during,1,0
205995,atenolol,1,0
205996,and,1,1
205997,metoprolol,1,0
205998,treatment,1,0
205999,periods,1,0
206000,.,0,0
206001,On,0,0
206002,the,0,0
206003,possibility,0,0
206004,of,0,0
206005,incorporating,0,0
206006,patients,0,0
206007,from,0,0
206008,non-randomising,0,0
206009,centres,0,0
206010,into,0,0
206011,a,0,0
206012,randomised,0,0
206013,clinical,0,0
206014,trial,0,0
206015,.,0,0
206016,[,0,0
206017,Pivampicillin,0,0
206018,treatment,0,0
206019,of,0,1
206020,uro-genital,1,1
206021,infections,1,1
206022,in,0,0
206023,gynaecological,0,0
206024,patients,0,0
206025,.,0,0
206026,A,0,0
206027,clinical,0,0
206028,evaluation,0,0
206029,],0,0
206030,.,0,0
206031,Mebendazole,0,0
206032,in,0,0
206033,enterobiasis,1,0
206034,:,1,0
206035,a,0,0
206036,placebo,0,0
206037,--,0,1
206038,controlled,0,0
206039,trial,0,0
206040,in,0,0
206041,a,0,0
206042,paediatric,0,0
206043,community,0,0
206044,.,0,0
206045,[,1,0
206046,Folic,1,1
206047,acid,1,1
206048,deficiency,1,0
206049,in,0,0
206050,pregnant,0,0
206051,women,0,0
206052,in,0,0
206053,Switzerland,0,0
206054,],0,0
206055,.,0,0
206056,A,0,0
206057,randomized,0,0
206058,controlled,0,0
206059,trial,0,0
206060,of,0,1
206061,ergotamine,0,0
206062,tartrate,0,0
206063,.,0,0
206064,Protection,1,1
206065,of,0,1
206066,man,0,0
206067,from,0,0
206068,natural,1,0
206069,infection,1,1
206070,with,1,0
206071,influenza,1,1
206072,A2,1,1
206073,Hong,1,0
206074,Kong,1,0
206075,virus,1,1
206076,by,0,0
206077,amantadine,0,0
206078,:,0,0
206079,a,0,0
206080,controlled,0,0
206081,field,0,0
206082,trial,0,0
206083,.,0,1
206084,Prophylactic,0,0
206085,administration,0,0
206086,of,0,1
206087,amantadine,0,0
206088,in,0,0
206089,doses,0,0
206090,of,0,0
206091,100,0,0
206092,mg.,0,0
206093,twice,0,0
206094,a,0,0
206095,day,0,0
206096,offered,0,0
206097,statistically,0,0
206098,significant,0,0
206099,protection,1,1
206100,against,1,0
206101,influenza,1,1
206102,A2,1,1
206103,infection,1,1
206104,in,0,0
206105,a,0,0
206106,double-blind,0,0
206107,field,0,0
206108,trial,0,0
206109,involving,0,0
206110,391,0,0
206111,medical,0,0
206112,student,0,0
206113,volunteers,0,0
206114,during,0,0
206115,the,0,0
206116,influenza,0,0
206117,A2,0,1
206118,Hong,0,0
206119,Kong,0,0
206120,epidemic,0,1
206121,in,0,0
206122,Helsinki,0,0
206123,in,0,0
206124,the,0,0
206125,winter,0,0
206126,of,0,0
206127,1969,0,0
206128,.,0,0
206129,Serologically,1,0
206130,verified,1,0
206131,influenza,1,1
206132,",",0,0
206133,as,0,0
206134,measured,0,1
206135,by,0,0
206136,complement,1,0
206137,fixation,1,1
206138,and/or,1,0
206139,haemagglutination,1,1
206140,inhibition,1,1
206141,",",0,1
206142,occurred,0,0
206143,in,0,0
206144,27,0,0
206145,out,0,0
206146,of,0,0
206147,192,0,0
206148,students,0,0
206149,in,0,0
206150,the,0,0
206151,amantadine,0,0
206152,group,0,0
206153,against,0,0
206154,57,0,0
206155,out,0,0
206156,of,0,0
206157,199,0,0
206158,in,0,0
206159,the,0,0
206160,placebo,0,0
206161,group,0,0
206162,",",0,0
206163,giving,0,0
206164,a,0,0
206165,protection,0,1
206166,rate,0,1
206167,of,0,0
206168,52,0,0
206169,%,0,0
206170,.,0,0
206171,Psychiatric,0,1
206172,treatment,0,0
206173,of,0,0
206174,eczema,0,0
206175,:,0,0
206176,a,0,0
206177,controlled,0,0
206178,trial,0,0
206179,.,0,0
206180,Seventy-two,0,0
206181,patients,0,0
206182,with,0,0
206183,eczema,0,1
206184,were,0,0
206185,randomly,0,0
206186,allotted,0,0
206187,to,0,0
206188,one,0,0
206189,of,0,0
206190,two,0,0
206191,treatment,0,0
206192,groups,0,0
206193,:,0,0
206194,A,0,0
206195,",",0,0
206196,those,0,0
206197,receiving,0,0
206198,dermatological,0,0
206199,treatment,0,0
206200,only,0,0
206201,",",0,0
206202,and,0,1
206203,B,0,1
206204,",",0,0
206205,those,0,0
206206,receiving,0,0
206207,the,0,0
206208,same,0,0
206209,dermatological,0,1
206210,treatment,0,0
206211,plus,0,0
206212,psychiatric,0,1
206213,treatment,0,0
206214,",",0,0
206215,limited,0,0
206216,where,0,0
206217,possible,0,0
206218,to,0,0
206219,four,0,0
206220,months,0,0
206221,.,0,0
206222,Cases,0,1
206223,were,0,0
206224,followed,0,0
206225,up,0,0
206226,at,0,0
206227,six-monthly,0,0
206228,dermatological,0,1
206229,assessments,0,0
206230,",",0,0
206231,57,0,0
206232,(,0,0
206233,79,0,0
206234,%,0,0
206235,),0,0
206236,for,0,0
206237,18,0,0
206238,months,0,0
206239,.,0,0
206240,The,0,0
206241,findings,0,0
206242,suggest,0,0
206243,that,0,0
206244,in,0,0
206245,the,0,0
206246,presence,1,0
206247,of,1,0
206248,overt,1,1
206249,emotional,1,1
206250,disturbance,1,1
206251,",",0,0
206252,of,0,1
206253,new,1,1
206254,psychological,1,1
206255,or,1,0
206256,psychophysiological,1,1
206257,symptoms,1,1
206258,preceding,1,0
206259,the,1,0
206260,rash,1,1
206261,by,0,0
206262,up,0,0
206263,to,0,0
206264,a,0,0
206265,year,0,0
206266,",",0,1
206267,and,0,1
206268,of,0,1
206269,high,1,1
206270,motivation,1,1
206271,for,0,0
206272,it,0,0
206273,",",0,0
206274,brief,0,0
206275,psychiatric,0,1
206276,treatment,0,0
206277,improves,1,0
206278,the,0,0
206279,outcome,0,1
206280,in,0,0
206281,eczema,1,1
206282,(,0,0
206283,the,0,0
206284,proportion,0,1
206285,clear,0,0
206286,at,0,0
206287,18,0,0
206288,months,0,0
206289,was,0,0
206290,about,0,0
206291,doubled,0,0
206292,),0,0
206293,",",0,0
206294,whereas,0,0
206295,in,0,0
206296,their,0,0
206297,absence,0,0
206298,such,0,0
206299,treatment,0,0
206300,may,0,0
206301,worsen,1,0
206302,it,1,0
206303,",",0,0
206304,especially,0,0
206305,in,0,0
206306,the,0,0
206307,short,0,0
206308,term,0,0
206309,.,0,0
206310,A,0,0
206311,tube,0,0
206312,spacer,0,0
206313,to,0,0
206314,improve,0,0
206315,inhalation,1,0
206316,of,1,0
206317,drugs,1,0
206318,from,0,0
206319,pressurised,0,0
206320,aerosols,0,0
206321,.,0,0
206322,Effects,0,0
206323,of,0,0
206324,progressive,0,0
206325,relaxation,0,1
206326,on,0,0
206327,autonomic,0,1
206328,processes,0,0
206329,.,0,0
206330,Generalizability,1,1
206331,and,1,1
206332,durability,1,1
206333,of,1,1
206334,treatment,1,0
206335,effects,1,1
206336,in,0,0
206337,an,0,0
206338,intervention,0,0
206339,program,0,0
206340,for,0,0
206341,coronary-prone,0,0
206342,(,0,0
206343,Type,0,1
206344,A,0,0
206345,),0,0
206346,managers,0,0
206347,.,0,0
206348,To,0,0
206349,test,0,0
206350,the,0,0
206351,reliability,1,1
206352,and,1,1
206353,durability,1,1
206354,of,1,1
206355,positive,1,1
206356,treatment,1,0
206357,effects,1,1
206358,obtained,0,0
206359,in,0,0
206360,a,0,0
206361,type,0,0
206362,A,0,0
206363,intervention,0,0
206364,project,0,0
206365,for,0,0
206366,healthy,0,0
206367,managers,0,0
206368,",",0,0
206369,the,0,0
206370,analysis,0,0
206371,was,0,0
206372,extended,0,0
206373,to,0,0
206374,data,0,0
206375,available,0,0
206376,from,0,0
206377,a,0,0
206378,third,0,0
206379,treatment,0,0
206380,group,0,0
206381,(,0,0
206382,a,0,0
206383,special,0,0
206384,behavior,0,1
206385,therapy,0,0
206386,group,0,0
206387,for,0,0
206388,participants,0,0
206389,eliminated,0,0
206390,from,0,0
206391,the,0,0
206392,main,0,0
206393,sample,0,0
206394,because,0,0
206395,of,0,0
206396,manifestations,0,1
206397,of,0,0
206398,clinical,0,1
206399,CHD,0,0
206400,),0,0
206401,and,0,1
206402,to,0,0
206403,measures,0,0
206404,obtained,0,0
206405,6,0,0
206406,months,0,0
206407,following,0,0
206408,the,0,0
206409,end,0,0
206410,of,0,0
206411,treatment,0,0
206412,.,0,0
206413,Immediately,0,0
206414,after,0,0
206415,treatment,0,0
206416,all,0,0
206417,three,0,0
206418,groups,0,0
206419,showed,0,0
206420,a,0,0
206421,similar,0,0
206422,pattern,0,0
206423,of,0,1
206424,improvement,0,1
206425,",",0,0
206426,although,0,0
206427,the,0,0
206428,two,0,0
206429,behavior,0,1
206430,therapy,0,0
206431,groups,0,0
206432,did,0,0
206433,show,0,0
206434,a,0,0
206435,greater,0,0
206436,decrease,0,1
206437,in,0,1
206438,serum,1,1
206439,cholesterol,1,1
206440,levels,1,1
206441,.,1,0
206442,Six,0,0
206443,months,0,0
206444,after,0,0
206445,treatment,0,0
206446,the,0,0
206447,sample,0,0
206448,as,0,0
206449,a,0,0
206450,whole,0,0
206451,showed,0,0
206452,good,1,0
206453,maintenance,1,0
206454,of,1,1
206455,treatment,1,0
206456,effects,1,1
206457,",",0,0
206458,but,0,0
206459,the,0,0
206460,differences,0,0
206461,between,0,0
206462,groups,0,0
206463,had,0,0
206464,become,0,0
206465,somewhat,0,0
206466,sharper,0,0
206467,",",0,0
206468,with,0,0
206469,the,0,0
206470,special,0,0
206471,behavior,0,1
206472,therapy,0,0
206473,group,0,0
206474,faring,0,1
206475,best,0,0
206476,",",0,0
206477,the,0,0
206478,regular,0,1
206479,behavior,0,1
206480,therapy,0,0
206481,group,0,0
206482,intermediate,0,1
206483,",",0,0
206484,and,0,1
206485,the,0,0
206486,psychotherapy,0,0
206487,group,0,0
206488,worst,0,1
206489,.,0,0
206490,The,0,0
206491,logical,0,1
206492,consistency,0,1
206493,of,0,0
206494,these,0,0
206495,findings,0,0
206496,increases,0,0
206497,our,0,0
206498,confidence,0,0
206499,in,0,0
206500,the,0,0
206501,initial,0,0
206502,treatment,0,0
206503,results,0,0
206504,",",0,0
206505,as,0,0
206506,well,0,0
206507,as,0,0
206508,permitting,0,0
206509,cautious,0,0
206510,optimism,0,1
206511,concerning,0,0
206512,the,0,0
206513,possibility,0,0
206514,of,0,0
206515,developing,0,0
206516,effective,0,1
206517,intervention,0,0
206518,programs,0,0
206519,for,0,0
206520,coronary-type,0,0
206521,(,0,0
206522,type,0,0
206523,A,0,0
206524,),0,0
206525,behavior,0,1
206526,.,0,0
206527,Triamcinolone,0,0
206528,acetonide,0,0
206529,in,0,0
206530,the,0,0
206531,treatment,0,0
206532,of,0,1
206533,bursitis,0,1
206534,and,0,1
206535,other,0,1
206536,foot,0,0
206537,disorders,0,0
206538,.,0,0
206539,A,0,0
206540,double,0,0
206541,blind,0,0
206542,trial,0,0
206543,of,0,1
206544,terfenadine,0,0
206545,and,0,1
206546,placebo,0,0
206547,in,0,0
206548,hay,0,1
206549,fever,0,1
206550,using,0,0
206551,a,0,0
206552,substitution,0,1
206553,technique,0,0
206554,for,0,0
206555,non-responders,0,0
206556,.,0,0
206557,A,0,0
206558,double-blind,0,0
206559,study,0,0
206560,of,0,1
206561,terfenadine,0,0
206562,and,0,1
206563,placebo,0,0
206564,in,0,0
206565,110,0,0
206566,patients,0,0
206567,suffering,0,0
206568,from,0,0
206569,hay,0,1
206570,fever,0,1
206571,(,0,0
206572,confirmed,0,0
206573,by,0,0
206574,skin,0,1
206575,tests,0,1
206576,),0,1
206577,was,0,0
206578,conducted,0,0
206579,.,0,0
206580,A,0,0
206581,novel,0,0
206582,technique,0,0
206583,was,0,0
206584,applied,0,0
206585,using,0,0
206586,an,0,0
206587,escape,0,0
206588,envelope,0,0
206589,containing,0,0
206590,a,0,0
206591,reference,0,0
206592,drug,0,0
206593,which,0,0
206594,could,0,0
206595,be,0,0
206596,taken,0,0
206597,under,0,0
206598,controlled,0,0
206599,conditions,0,0
206600,if,0,0
206601,",",0,0
206602,after,0,0
206603,48,0,0
206604,hours,0,0
206605,",",0,0
206606,the,0,0
206607,patient,0,1
206608,experienced,0,0
206609,no,0,0
206610,relief,1,1
206611,.,1,0
206612,Significantly,0,0
206613,more,0,0
206614,patients,0,0
206615,on,0,0
206616,placebo,0,0
206617,opened,1,0
206618,the,1,0
206619,envelope,1,1
206620,than,0,0
206621,patients,0,0
206622,taking,0,0
206623,the,0,0
206624,active,0,0
206625,drug,0,0
206626,.,0,1
206627,Terfenadine,0,0
206628,was,0,0
206629,demonstrated,0,0
206630,to,0,0
206631,be,0,0
206632,an,0,0
206633,effective,1,1
206634,drug,1,0
206635,in,0,0
206636,hay,0,1
206637,fever,0,1
206638,and,0,1
206639,produced,0,0
206640,no,0,0
206641,more,0,0
206642,drowsiness,1,1
206643,than,0,0
206644,placebo,0,0
206645,.,0,0
206646,Double-blind,0,0
206647,comparison,0,0
206648,of,0,1
206649,ketazolam,0,0
206650,",",0,1
206651,diazepam,0,0
206652,and,0,1
206653,placebo,0,0
206654,in,0,0
206655,once-a-day,0,0
206656,vs,0,0
206657,t.i.d,0,0
206658,.,0,0
206659,dosing,0,0
206660,.,0,0
206661,Comparison,0,0
206662,of,0,0
206663,ketazolam,0,0
206664,given,0,0
206665,once-a-day,0,0
206666,with,0,0
206667,diazepam,0,0
206668,given,0,0
206669,three,0,0
206670,times,0,0
206671,a,0,0
206672,day,0,0
206673,and,0,1
206674,placebo,0,0
206675,given,0,0
206676,either,0,0
206677,once,0,0
206678,or,0,0
206679,3,0,0
206680,times,0,0
206681,a,0,0
206682,day,0,0
206683,in,0,0
206684,101,0,0
206685,anxious,0,1
206686,outpatients,0,0
206687,showed,0,0
206688,ketazolam,0,0
206689,to,0,0
206690,be,0,0
206691,significantly,0,0
206692,better,0,0
206693,than,0,0
206694,placebo,0,0
206695,in,0,0
206696,alleviating,0,0
206697,the,0,0
206698,symptoms,0,1
206699,of,0,1
206700,anxiety,0,1
206701,and,0,1
206702,",",0,1
206703,on,0,0
206704,several,0,0
206705,measures,0,1
206706,of,0,1
206707,efficacy,0,1
206708,",",0,0
206709,better,0,0
206710,than,0,0
206711,diazepam,0,0
206712,as,0,0
206713,well,0,0
206714,.,0,0
206715,Significantly,0,0
206716,fewer,0,0
206717,patients,0,0
206718,on,0,0
206719,ketazolam,0,0
206720,dropped,0,1
206721,out,0,0
206722,of,0,0
206723,the,0,0
206724,study,0,0
206725,due,0,0
206726,to,0,0
206727,ineffective,0,1
206728,medication,0,0
206729,than,0,0
206730,on,0,0
206731,the,0,0
206732,other,0,0
206733,3,0,0
206734,treatments,0,0
206735,.,0,0
206736,The,0,0
206737,incidence,1,1
206738,of,1,0
206739,side,1,1
206740,effects,1,1
206741,was,1,0
206742,lowest,1,0
206743,in,0,0
206744,the,0,0
206745,ketazolam,0,0
206746,group,0,0
206747,.,0,0
206748,Of,0,0
206749,particular,0,0
206750,note,0,0
206751,",",0,1
206752,drowsiness,1,1
206753,was,0,0
206754,reported,0,0
206755,twice,0,0
206756,as,0,0
206757,often,0,0
206758,by,0,0
206759,diazepam,0,0
206760,patients,0,0
206761,as,0,0
206762,by,0,0
206763,ketazolam,0,0
206764,patients,0,0
206765,.,0,0
206766,A,0,0
206767,double-blind,0,0
206768,comparison,0,0
206769,of,0,1
206770,bromperidol,0,0
206771,and,0,1
206772,haloperidol,0,0
206773,in,0,0
206774,newly,0,0
206775,admitted,0,0
206776,schizophrenic,0,0
206777,patients,0,0
206778,.,0,0
206779,Acute,0,1
206780,intervention,0,0
206781,studies,0,0
206782,in,0,0
206783,patients,0,0
206784,with,0,0
206785,myocardial,0,1
206786,infarction,0,1
206787,using,0,0
206788,atenolol,0,0
206789,",",0,1
206790,propranolol,0,0
206791,",",0,1
206792,oxprenolol,0,0
206793,and,0,1
206794,disopyramide,0,0
206795,phosphate,0,0
206796,.,0,0
206797,The,0,0
206798,value,0,1
206799,of,0,1
206800,beta-blockade,0,0
206801,and,0,0
206802,of,0,1
206803,disopyramide,0,0
206804,phosphate,0,0
206805,in,0,0
206806,the,0,0
206807,immediate,0,1
206808,treatment,0,0
206809,of,0,0
206810,patients,0,0
206811,with,0,0
206812,suspected,0,0
206813,acute,0,0
206814,myocardial,0,1
206815,infarction,0,1
206816,was,0,0
206817,assessed,0,0
206818,in,0,0
206819,two,0,0
206820,placebo,0,0
206821,controlled,0,0
206822,trials,0,0
206823,.,0,0
206824,In,0,0
206825,the,0,0
206826,first,0,0
206827,study,0,0
206828,388,0,0
206829,patients,0,0
206830,with,0,0
206831,suspected,0,0
206832,acute,0,0
206833,myocardial,0,1
206834,infarction,0,1
206835,were,0,0
206836,randomly,0,0
206837,allocated,0,0
206838,to,0,0
206839,treatment,0,0
206840,with,0,0
206841,propranolol,0,0
206842,",",0,1
206843,atenolol,0,0
206844,",",0,1
206845,or,0,1
206846,placebo,0,0
206847,",",0,1
206848,and,0,1
206849,when,0,0
206850,analysed,0,0
206851,on,0,0
206852,an,0,0
206853,initial,0,0
206854,intention,0,1
206855,to,0,0
206856,treat,0,0
206857,basis,0,0
206858,there,0,0
206859,was,0,0
206860,no,0,0
206861,significant,0,0
206862,difference,0,0
206863,between,0,0
206864,the,0,0
206865,three,0,0
206866,groups,0,0
206867,in,0,0
206868,respect,0,0
206869,of,0,0
206870,the,0,0
206871,mortality,1,1
206872,at,0,0
206873,one,0,0
206874,year,0,0
206875,.,0,0
206876,In,0,0
206877,addition,0,0
206878,",",0,0
206879,there,0,0
206880,was,0,0
206881,no,0,0
206882,evidence,0,0
206883,to,0,0
206884,suggest,0,0
206885,that,0,0
206886,either,0,0
206887,atenolol,0,0
206888,",",0,1
206889,or,0,1
206890,propranolol,0,0
206891,reduced,0,1
206892,the,0,0
206893,incidence,0,1
206894,of,1,0
206895,'serious,1,1
206896,',1,1
206897,ventricular,1,1
206898,arrhythmias,1,1
206899,in,0,0
206900,the,0,0
206901,coronary,0,0
206902,care,0,0
206903,unit,0,0
206904,.,0,0
206905,In,0,0
206906,the,0,0
206907,second,0,0
206908,study,0,0
206909,473,0,0
206910,patients,0,0
206911,with,0,0
206912,suspected,0,0
206913,acute,0,0
206914,myocardial,0,1
206915,infarction,0,1
206916,were,0,0
206917,randomly,0,0
206918,allocated,0,0
206919,to,0,0
206920,treatment,0,0
206921,with,0,0
206922,oxprenolol,0,0
206923,",",0,1
206924,disopyramide,0,1
206925,phosphate,0,0
206926,",",0,1
206927,or,0,1
206928,placebo,0,0
206929,.,0,0
206930,Again,0,0
206931,no,1,0
206932,significant,1,0
206933,differences,1,0
206934,were,0,0
206935,seen,0,0
206936,with,0,0
206937,respect,0,0
206938,to,0,0
206939,the,0,0
206940,mortality,1,1
206941,at,0,0
206942,six,0,0
206943,weeks,0,0
206944,.,0,0
206945,There,0,0
206946,was,0,0
206947,",",0,0
206948,however,0,0
206949,",",0,0
206950,a,0,0
206951,significantly,0,0
206952,increased,0,0
206953,incidence,1,1
206954,of,1,0
206955,heart,1,1
206956,failure,1,0
206957,in,0,0
206958,the,0,0
206959,group,0,0
206960,which,0,0
206961,received,0,0
206962,disopyramide,0,0
206963,phosphate,0,0
206964,.,0,0
206965,Patients,0,0
206966,who,0,0
206967,received,0,0
206968,this,0,0
206969,drug,0,0
206970,also,0,0
206971,showed,0,0
206972,a,0,0
206973,reduced,0,1
206974,number,1,1
206975,of,1,1
206976,dysrhythmic,1,1
206977,episodes,1,1
206978,on,1,0
206979,24-hour,1,1
206980,ECG,1,1
206981,recordings,1,1
206982,",",0,0
206983,but,0,0
206984,this,0,0
206985,trend,0,0
206986,did,0,0
206987,not,0,0
206988,achieve,0,0
206989,statistical,0,0
206990,significance,0,1
206991,.,0,0
206992,These,0,0
206993,results,0,0
206994,suggest,0,0
206995,that,0,0
206996,none,0,0
206997,of,0,0
206998,the,0,0
206999,three,0,0
207000,beta-blockers,0,0
207001,tested,0,0
207002,nor,0,0
207003,disopyramide,0,0
207004,phosphate,0,0
207005,is,0,0
207006,likely,0,0
207007,to,0,0
207008,reduce,1,0
207009,the,1,0
207010,mortality,1,1
207011,from,1,0
207012,acute,1,0
207013,myocardial,1,1
207014,infarction,1,1
207015,when,0,0
207016,given,0,0
207017,prophylactically,0,0
207018,",",0,0
207019,although,0,0
207020,disopyramide,0,0
207021,phosphate,0,0
207022,does,0,0
207023,reduce,1,0
207024,the,1,0
207025,incidence,1,1
207026,of,1,0
207027,'serious,1,1
207028,',1,1
207029,ventriicular,1,1
207030,arrhythmias,1,1
207031,.,1,0
207032,Comparison,0,0
207033,of,0,0
207034,the,0,0
207035,antihypertensive,1,0
207036,effect,1,1
207037,of,0,1
207038,metipranolol,0,0
207039,",",0,1
207040,butizide,0,0
207041,and,0,1
207042,torrat,0,0
207043,in,0,0
207044,Kenyan,0,0
207045,Africans,0,0
207046,.,0,0
207047,An,0,0
207048,assessment,0,0
207049,of,0,1
207050,beta-adrenoceptor,0,1
207051,blockade,0,1
207052,in,0,0
207053,man,0,0
207054,by,0,0
207055,prizidilol,0,0
207056,hydrochloride,0,0
207057,.,0,0
207058,1,0,0
207059,Prizidilol,0,0
207060,hydrochloride,0,0
207061,(,0,1
207062,SK,0,1
207063,&,0,0
207064,F,0,0
207065,92657,0,0
207066,),0,0
207067,is,0,0
207068,a,0,0
207069,new,0,0
207070,compound,0,0
207071,which,0,0
207072,causes,0,0
207073,both,0,0
207074,arteriolar,0,1
207075,dilatation,0,1
207076,and,0,1
207077,beta-adrenoceptor,1,1
207078,blockade,1,1
207079,.,1,0
207080,The,0,0
207081,effect,0,0
207082,of,0,0
207083,a,0,0
207084,single,0,0
207085,oral,0,0
207086,dose,0,0
207087,on,0,0
207088,the,0,0
207089,responses,0,1
207090,of,0,0
207091,heart,0,1
207092,rate,0,1
207093,and,0,1
207094,blood,0,1
207095,pressure,0,1
207096,to,0,0
207097,isoprenaline,0,0
207098,infusion,0,0
207099,has,0,0
207100,been,0,0
207101,studied,0,0
207102,in,0,0
207103,healthy,0,0
207104,volunteers,0,0
207105,.,0,0
207106,2,0,0
207107,Isoprenaline,0,0
207108,heart,1,0
207109,rate,1,1
207110,dose-response,1,1
207111,curves,1,1
207112,showed,0,0
207113,parallel,0,0
207114,shifts,0,0
207115,to,0,0
207116,the,0,0
207117,right,0,0
207118,after,0,0
207119,oral,0,0
207120,prizidilol,0,0
207121,",",0,1
207122,indicating,0,0
207123,antagonism,0,1
207124,by,0,0
207125,this,0,0
207126,compound,0,0
207127,at,0,0
207128,beta-adrenoceptors,0,0
207129,in,0,0
207130,the,0,0
207131,heart,0,0
207132,.,0,0
207133,3,0,0
207134,Isoprenaline,0,0
207135,dose-response,0,0
207136,curves,0,1
207137,for,0,0
207138,decreases,0,0
207139,in,0,0
207140,diastolic,1,1
207141,blood,1,1
207142,pressure,1,1
207143,also,0,0
207144,showed,0,0
207145,shifts,0,0
207146,to,0,0
207147,the,0,0
207148,right,0,0
207149,after,0,0
207150,oral,0,0
207151,prizidilol,0,0
207152,",",0,1
207153,providing,0,0
207154,evidence,0,0
207155,of,0,1
207156,beta-adrenoceptor,0,1
207157,antagonism,0,1
207158,by,0,0
207159,this,0,0
207160,drug,0,0
207161,in,0,0
207162,peripheral,0,1
207163,resistance,0,1
207164,vessels,0,1
207165,.,0,0
207166,4,0,0
207167,The,0,0
207168,peak,0,1
207169,effect,0,0
207170,of,0,0
207171,a,0,0
207172,40,0,0
207173,mg,0,0
207174,dose,0,0
207175,of,0,1
207176,propranolol,0,0
207177,was,0,0
207178,greater,0,0
207179,than,0,0
207180,that,0,0
207181,of,0,0
207182,a,0,0
207183,200,0,0
207184,mg,0,0
207185,dose,0,0
207186,of,0,1
207187,prizidilol,0,0
207188,but,0,0
207189,both,0,0
207190,drugs,0,0
207191,caused,0,0
207192,persistent,0,1
207193,beta-adrenoceptor,1,1
207194,blockade,1,1
207195,for,0,0
207196,at,0,0
207197,least,0,0
207198,7,0,0
207199,h,0,0
207200,after,0,0
207201,ingestion,0,0
207202,.,0,0
207203,[,0,0
207204,The,0,0
207205,somatostatin,0,1
207206,infusion,0,0
207207,test,0,1
207208,for,0,0
207209,the,0,0
207210,evaluation,0,0
207211,of,0,0
207212,glucose,1,1
207213,utilization,1,1
207214,in,0,0
207215,bezafibrate,0,0
207216,medication,0,0
207217,],0,0
207218,.,0,0
207219,The,0,0
207220,utilisation,0,0
207221,of,0,1
207222,blood,1,1
207223,glucose,1,0
207224,may,0,0
207225,be,0,0
207226,used,0,0
207227,for,0,0
207228,definition,0,0
207229,of,0,1
207230,insulin,0,1
207231,resistance,0,1
207232,in,0,0
207233,type,0,0
207234,II,0,0
207235,diabetes,0,0
207236,mellitus,0,0
207237,.,0,0
207238,To,0,0
207239,evaluate,0,0
207240,this,0,0
207241,possibility,0,0
207242,we,0,0
207243,adapted,0,0
207244,an,0,0
207245,infusion,0,0
207246,test,0,1
207247,of,0,1
207248,somatostatin,0,0
207249,in,0,0
207250,10,0,0
207251,normal,0,0
207252,persons,0,0
207253,(,0,0
207254,age,0,0
207255,26,0,0
207256,+/-,0,0
207257,3,0,0
207258,years,0,0
207259,",",0,0
207260,relative,0,1
207261,body,0,1
207262,weight,0,1
207263,26,0,0
207264,+/-,0,0
207265,10,0,0
207266,%,0,0
207267,according,0,0
207268,to,0,0
207269,Broca,0,1
207270,),0,0
207271,in,0,0
207272,a,0,0
207273,randomized,0,0
207274,cross-over,0,0
207275,therapy,0,0
207276,with,0,0
207277,bezafibrate,0,0
207278,(,0,0
207279,3,0,0
207280,X,0,0
207281,200,0,0
207282,mg/die,0,0
207283,),0,0
207284,.,0,0
207285,As,0,0
207286,the,0,0
207287,coefficient,0,1
207288,of,0,1
207289,variation,0,1
207290,(,0,1
207291,VC,0,1
207292,),0,0
207293,of,0,0
207294,measured,0,1
207295,blood,1,1
207296,glucose,1,1
207297,continuously,0,0
207298,increased,0,0
207299,the,0,0
207300,best,0,0
207301,time,0,1
207302,of,0,0
207303,a,0,0
207304,steady,0,1
207305,state,0,1
207306,was,0,0
207307,between,0,0
207308,90,0,0
207309,and,0,0
207310,130,0,0
207311,min,0,0
207312,after,0,0
207313,beginning,0,0
207314,the,0,0
207315,infusion,0,0
207316,(,0,0
207317,mean,0,1
207318,VC,0,0
207319,8.9,0,0
207320,%,0,0
207321,),0,0
207322,.,0,0
207323,While,0,0
207324,insulin,1,1
207325,remained,0,0
207326,nearly,0,0
207327,constant,0,0
207328,(,0,0
207329,41,0,0
207330,(,0,0
207331,45,0,0
207332,;,0,0
207333,38,0,0
207334,),0,0
207335,microU/ml,0,0
207336,),0,1
207337,blood,1,1
207338,glucose,1,1
207339,dropped,0,1
207340,by,0,0
207341,about,0,0
207342,14,0,0
207343,%,0,0
207344,and,0,0
207345,reached,0,0
207346,a,0,0
207347,steady,0,1
207348,state,0,0
207349,of,0,0
207350,89,0,0
207351,(,0,0
207352,134,0,0
207353,;,0,0
207354,45,0,0
207355,),0,0
207356,mg/dl,0,0
207357,.,0,0
207358,During,0,0
207359,the,0,0
207360,therapy,0,0
207361,of,0,1
207362,bezafibrate,0,0
207363,blood,1,1
207364,glucose,1,1
207365,was,0,0
207366,significantly,0,0
207367,decreased,0,0
207368,by,0,0
207369,36,0,0
207370,%,0,0
207371,130,0,0
207372,min,0,0
207373,after,0,0
207374,beginning,0,0
207375,the,0,0
207376,infusion,0,0
207377,.,0,0
207378,Although,0,0
207379,the,0,0
207380,effect,0,1
207381,was,0,0
207382,not,0,0
207383,significant,0,0
207384,during,0,0
207385,the,0,0
207386,whole,0,0
207387,time,0,1
207388,of,0,0
207389,the,0,0
207390,steady,0,0
207391,state,0,0
207392,it,0,0
207393,became,0,0
207394,evident,0,0
207395,by,0,0
207396,a,0,0
207397,negative,0,1
207398,correlation,0,0
207399,with,0,0
207400,lactate,0,1
207401,(,0,0
207402,r,0,1
207403,=,0,0
207404,-0.687,0,0
207405,),0,1
207406,and,0,1
207407,pyruvate,0,1
207408,(,0,1
207409,r,0,1
207410,=,0,0
207411,-0.843,0,0
207412,),0,0
207413,.,0,0
207414,A,0,0
207415,correlation,0,0
207416,with,0,0
207417,a,0,0
207418,concomitant,0,0
207419,decrease,0,1
207420,of,0,1
207421,triglyceride,1,1
207422,and,1,1
207423,cholesterol,1,1
207424,also,0,0
207425,induced,0,0
207426,by,0,0
207427,bezafibrate,0,0
207428,could,0,0
207429,not,0,0
207430,be,0,0
207431,proven,0,0
207432,.,0,0
207433,The,0,0
207434,results,0,0
207435,show,0,0
207436,that,0,0
207437,the,0,0
207438,infusion,0,0
207439,test,0,1
207440,of,0,0
207441,somatostatin,0,0
207442,is,0,0
207443,fitted,0,0
207444,to,0,0
207445,measure,0,0
207446,a,0,0
207447,steady,0,1
207448,state,0,1
207449,of,0,1
207450,blood,1,1
207451,glucose,1,1
207452,and,1,1
207453,insulin,1,1
207454,and,0,0
207455,that,0,0
207456,it,0,0
207457,is,0,0
207458,possible,0,0
207459,by,0,0
207460,this,0,0
207461,technique,0,0
207462,to,0,0
207463,quantify,0,0
207464,a,0,0
207465,changed,0,0
207466,utilisation,0,0
207467,of,0,1
207468,blood,0,1
207469,glucose,0,1
207470,induced,0,0
207471,by,0,0
207472,specific,0,0
207473,therapy,0,0
207474,.,0,0
207475,Anti-IgG,0,0
207476,antibodies,0,1
207477,during,0,0
207478,immunotherapy,0,0
207479,with,0,0
207480,purified,0,0
207481,grass,0,0
207482,pollen,0,0
207483,extracts,0,0
207484,.,0,0
207485,In,0,0
207486,a,0,0
207487,double,0,0
207488,blind,0,0
207489,study,0,0
207490,40,0,0
207491,patients,0,0
207492,were,0,0
207493,allocated,0,0
207494,specific,0,0
207495,immunotherapy,0,0
207496,(,0,1
207497,hyposensitization,0,1
207498,),0,0
207499,with,0,0
207500,partially,0,0
207501,purified,0,0
207502,timothy,0,0
207503,extract,0,0
207504,or,0,0
207505,two,0,0
207506,timothy,0,0
207507,major,0,0
207508,allergens,0,0
207509,19,0,0
207510,",",0,0
207511,25,0,0
207512,.,0,0
207513,All,0,0
207514,patients,0,0
207515,had,0,0
207516,typical,0,0
207517,grass,0,0
207518,pollen,0,1
207519,hay,0,1
207520,fever,0,1
207521,",",0,0
207522,in,0,0
207523,27,0,0
207524,%,0,0
207525,associated,0,0
207526,with,0,0
207527,grass,0,0
207528,pollen,0,1
207529,asthma,0,1
207530,and,0,0
207531,in,0,0
207532,13,0,0
207533,%,0,0
207534,with,0,0
207535,birch,0,0
207536,pollen,0,0
207537,allergy,0,1
207538,.,0,1
207539,Serum,1,1
207540,IgG,1,1
207541,anti-IgG,1,1
207542,antibodies,1,1
207543,were,0,0
207544,determined,0,0
207545,after,0,0
207546,dithiothreitol,0,1
207547,treatment,0,0
207548,.,0,0
207549,Before,0,0
207550,hyposensitization,0,1
207551,",",0,1
207552,IgG,1,1
207553,anti-IgG,1,1
207554,titres,1,1
207555,greater,0,1
207556,than,0,0
207557,or,0,0
207558,equal,0,0
207559,to,0,0
207560,9,0,0
207561,were,0,0
207562,demonstrated,0,0
207563,in,0,0
207564,45,0,0
207565,%,0,0
207566,of,0,0
207567,the,0,0
207568,patients,0,0
207569,.,0,0
207570,During,0,0
207571,hyposensitization,0,1
207572,IgG,1,1
207573,anti-IgG,1,1
207574,titres,1,1
207575,showed,0,0
207576,a,0,0
207577,slight,0,1
207578,initial,0,0
207579,increase,0,1
207580,followed,0,0
207581,by,0,0
207582,a,0,0
207583,decrease,0,1
207584,below,0,0
207585,pretreatment,0,0
207586,level,0,1
207587,.,0,0
207588,Neither,0,0
207589,increase,0,0
207590,nor,0,0
207591,decrease,0,1
207592,was,0,0
207593,statistically,0,0
207594,significant,0,0
207595,.,0,0
207596,Reactions,1,0
207597,to,1,0
207598,rabbit,1,0
207599,IgG,1,1
207600,F,1,0
207601,(,1,0
207602,ab,1,1
207603,',1,1
207604,),1,0
207605,2,1,0
207606,fractions,0,0
207607,were,0,0
207608,only,0,0
207609,obtained,0,0
207610,during,0,0
207611,hyposensitization,0,0
207612,.,0,0
207613,The,0,0
207614,occurrence,0,1
207615,of,0,0
207616,anti-IgG,1,1
207617,antibodies,1,1
207618,did,0,0
207619,no,0,0
207620,correlate,0,0
207621,with,0,0
207622,symptoms,1,1
207623,",",1,0
207624,side,1,1
207625,effects,1,1
207626,",",1,0
207627,or,1,0
207628,the,1,0
207629,level,1,1
207630,of,1,0
207631,allergen-specific,1,1
207632,IgG,1,0
207633,.,1,0
207634,In,0,0
207635,a,0,0
207636,previous,0,0
207637,study,0,0
207638,it,0,0
207639,was,0,0
207640,demonstrated,0,0
207641,that,0,0
207642,patients,0,0
207643,with,0,0
207644,multiallergy,0,0
207645,hyposensitized,0,0
207646,with,0,0
207647,combined,0,0
207648,allergen,0,0
207649,extracts,0,0
207650,showed,0,0
207651,a,0,0
207652,statistically,0,0
207653,significant,0,0
207654,increase,0,1
207655,in,0,0
207656,IgG,1,1
207657,anti-IgG,1,1
207658,titres,1,1
207659,during,0,0
207660,treatment,0,0
207661,.,0,0
207662,The,0,0
207663,increase,0,0
207664,failed,0,0
207665,to,0,0
207666,appear,0,0
207667,in,0,0
207668,the,0,0
207669,present,0,0
207670,patients,0,0
207671,allergic,0,1
207672,only,0,0
207673,to,0,0
207674,pollen,0,0
207675,and,0,0
207676,treated,0,0
207677,with,0,0
207678,purified,0,0
207679,allergen,0,0
207680,extracts,0,0
207681,.,0,0
207682,It,0,0
207683,is,0,0
207684,therefore,0,0
207685,suggested,0,0
207686,that,0,0
207687,a,0,0
207688,multiallergic,0,0
207689,condition,0,0
207690,and,0,0
207691,the,0,0
207692,combination,0,0
207693,and/or,0,0
207694,purification,0,1
207695,of,0,1
207696,allergen,0,0
207697,extracts,0,0
207698,administered,0,0
207699,during,0,0
207700,hyposensitization,0,0
207701,may,0,0
207702,influence,0,0
207703,the,0,0
207704,production,0,1
207705,of,0,0
207706,IgG,1,1
207707,anti-,1,1
207708,IgG,1,0
207709,antibodies,1,1
207710,.,1,0
207711,Metabolic,0,1
207712,and,0,1
207713,circulatory,0,1
207714,effects,0,1
207715,of,0,1
207716,oral,0,0
207717,salbutamol,0,0
207718,in,0,0
207719,the,0,0
207720,third,0,0
207721,trimester,0,0
207722,of,0,1
207723,pregnancy,0,1
207724,in,0,0
207725,diabetic,0,0
207726,and,0,1
207727,non-diabetic,0,0
207728,women,0,0
207729,.,0,1
207730,Metabolic,1,1
207731,and,1,1
207732,cardiovascular,1,1
207733,effects,1,1
207734,of,0,0
207735,4,0,0
207736,mg,0,0
207737,oral,0,0
207738,salbutamol,0,0
207739,were,0,0
207740,studied,0,0
207741,in,0,0
207742,ten,0,0
207743,non-diabetic,0,0
207744,",",0,0
207745,ten,0,0
207746,chemical,0,1
207747,diabetic,0,0
207748,and,0,0
207749,five,0,0
207750,juvenile,0,0
207751,diabetic,0,0
207752,women,0,0
207753,in,0,0
207754,late,0,1
207755,pregnancy,0,1
207756,.,0,1
207757,None,0,0
207758,of,0,0
207759,the,0,0
207760,women,0,0
207761,had,0,0
207762,been,0,0
207763,treated,0,0
207764,with,0,0
207765,beta-sympathomimetic,0,0
207766,drugs,0,0
207767,earlier,0,0
207768,in,0,0
207769,their,0,0
207770,pregnancy,0,1
207771,.,0,1
207772,Heart,1,1
207773,rate,1,1
207774,and,1,1
207775,blood,1,1
207776,pressure,1,1
207777,were,0,0
207778,recorded,0,1
207779,and,0,0
207780,blood,1,1
207781,samples,1,1
207782,for,1,0
207783,measurement,1,1
207784,of,1,0
207785,plasma,1,1
207786,cyclic,1,1
207787,AMP,1,1
207788,",",1,1
207789,insulin,1,1
207790,",",1,1
207791,C-peptide,1,1
207792,",",1,1
207793,glucose,1,1
207794,",",1,1
207795,lactate,1,1
207796,",",1,1
207797,glycerol,1,1
207798,",",1,1
207799,non-esterified,1,1
207800,fatty,1,1
207801,acids,1,1
207802,(,1,0
207803,NEFA,1,1
207804,),1,1
207805,and,1,1
207806,3-hydroxybutyrate,1,1
207807,(,1,1
207808,3-HB,1,1
207809,),1,1
207810,were,0,0
207811,collected,0,0
207812,every,0,0
207813,30,0,0
207814,minutes,0,0
207815,for,0,0
207816,120,0,0
207817,minutes,0,0
207818,after,0,0
207819,salbutamol,0,0
207820,.,0,0
207821,All,0,0
207822,women,0,0
207823,underwent,0,0
207824,the,0,0
207825,same,0,0
207826,procedure,0,0
207827,at,0,0
207828,random,0,0
207829,without,0,0
207830,salbutamol,0,0
207831,.,0,0
207832,There,0,0
207833,were,0,0
207834,significant,0,0
207835,cardiovascular,1,1
207836,effects,1,1
207837,of,0,0
207838,salbutamol,0,0
207839,in,0,0
207840,all,0,0
207841,the,0,0
207842,groups,0,0
207843,but,0,0
207844,no,0,0
207845,differences,0,0
207846,in,0,0
207847,these,0,0
207848,effects,0,0
207849,between,0,0
207850,the,0,0
207851,groups,0,0
207852,.,0,0
207853,Salbutamol,0,0
207854,caused,0,0
207855,significant,0,0
207856,increases,1,1
207857,of,1,1
207858,glycogenolysis,1,1
207859,and,1,1
207860,lipolysis,1,1
207861,in,0,0
207862,all,0,0
207863,the,0,0
207864,groups,0,0
207865,",",0,0
207866,significantly,0,0
207867,larger,0,0
207868,in,0,0
207869,the,0,0
207870,juvenile,0,0
207871,diabetic,0,0
207872,than,0,0
207873,the,0,0
207874,non-diabetic,0,0
207875,and,0,0
207876,chemical,0,0
207877,diabetic,0,0
207878,women,0,0
207879,.,0,0
207880,This,0,0
207881,observation,0,0
207882,could,0,0
207883,be,0,0
207884,explained,0,0
207885,by,0,0
207886,the,0,0
207887,inability,0,1
207888,of,0,0
207889,the,0,0
207890,juvenile,0,0
207891,diabetics,0,0
207892,to,0,0
207893,secrete,0,1
207894,insulin,0,1
207895,",",0,0
207896,shown,0,0
207897,by,0,0
207898,their,0,0
207899,non-measureable,0,0
207900,plasma,0,1
207901,C-peptide,0,0
207902,levels,0,1
207903,.,0,0
207904,The,0,0
207905,metabolic,1,1
207906,responses,1,1
207907,following,0,0
207908,salbutamol,0,0
207909,in,0,0
207910,the,0,0
207911,chemical,0,0
207912,diabetics,0,0
207913,were,0,0
207914,intermediate,0,0
207915,between,0,0
207916,the,0,0
207917,non-diabetic,0,0
207918,and,0,0
207919,juvenile,0,0
207920,diabetic,0,0
207921,groups,0,0
207922,.,0,0
207923,The,0,0
207924,results,0,0
207925,show,0,0
207926,that,0,0
207927,diabetes,0,0
207928,does,0,0
207929,not,0,0
207930,alter,0,0
207931,the,0,0
207932,sensitivity,0,1
207933,of,0,0
207934,beta-receptors,0,1
207935,involved,0,0
207936,in,0,0
207937,cardiovascular,0,1
207938,regulation,0,1
207939,",",0,0
207940,while,0,0
207941,the,0,0
207942,metabolic,0,1
207943,responses,0,1
207944,to,0,0
207945,oral,0,0
207946,salbutamol,0,0
207947,are,0,0
207948,enhanced,0,0
207949,",",0,0
207950,especially,0,0
207951,in,0,0
207952,juvenile,0,0
207953,diabetics,0,0
207954,.,0,0
207955,We,0,0
207956,suggest,0,0
207957,that,0,0
207958,during,0,0
207959,treatment,0,0
207960,with,0,0
207961,beta-sympathomimetic,0,0
207962,drugs,0,0
207963,",",0,1
207964,blood,0,1
207965,glucose,0,1
207966,should,0,0
207967,be,0,0
207968,monitored,0,0
207969,in,0,0
207970,all,0,0
207971,patients,0,0
207972,showing,0,0
207973,criteria,0,0
207974,of,0,0
207975,potential,0,0
207976,diabetes,0,0
207977,.,0,0
207978,[,0,0
207979,Long-term,0,0
207980,treatment,0,0
207981,of,0,1
207982,cerebrovascular,0,1
207983,changes,0,1
207984,in,0,0
207985,the,0,0
207986,elderly,0,0
207987,(,0,0
207988,author,0,1
207989,'s,0,1
207990,transl,0,0
207991,),0,0
207992,],0,0
207993,.,0,0
207994,A,0,0
207995,prospective,0,0
207996,study,0,0
207997,over,0,0
207998,15,0,0
207999,months,0,0
208000,in,0,0
208001,100,0,0
208002,elderly,0,0
208003,patients,0,0
208004,with,0,0
208005,signs,0,1
208006,of,0,0
208007,cerebro-vascular,0,1
208008,impairment,0,1
208009,demonstrated,0,0
208010,by,0,0
208011,psychometric,0,1
208012,testing,0,0
208013,that,0,0
208014,Hydergine,0,0
208015,(,0,0
208016,an,0,0
208017,ergot,0,0
208018,alkaloid,0,0
208019,preparation,0,0
208020,:,0,0
208021,4.5,0,0
208022,mg,0,0
208023,daily,0,0
208024,),0,0
208025,compensated,0,0
208026,the,0,0
208027,signs,0,1
208028,of,0,1
208029,dementia,0,1
208030,",",0,1
208031,present,0,0
208032,in,0,0
208033,the,0,0
208034,placebo,0,0
208035,group,0,0
208036,",",0,1
208037,and,0,1
208038,in,0,0
208039,some,0,0
208040,patients,0,0
208041,actually,0,0
208042,brought,0,0
208043,about,0,0
208044,a,0,0
208045,significant,0,0
208046,improvement,1,1
208047,in,1,0
208048,mental,1,1
208049,activity,1,1
208050,.,1,1
208051,Similar,0,0
208052,compensatory,1,1
208053,effect,1,1
208054,was,0,0
208055,also,0,0
208056,demonstrable,0,0
208057,in,0,0
208058,cerebral,1,1
208059,haemodynamics,1,1
208060,:,1,0
208061,in,0,0
208062,the,0,0
208063,placebo,0,0
208064,group,0,0
208065,there,0,0
208066,was,0,0
208067,a,0,0
208068,progressive,1,0
208069,increase,1,0
208070,in,1,0
208071,cerebral,1,1
208072,circulation,1,1
208073,time,1,1
208074,",",0,0
208075,an,0,0
208076,expression,1,1
208077,of,1,0
208078,decreased,1,1
208079,cerebral,1,1
208080,blood,1,1
208081,flow,1,1
208082,",",0,0
208083,while,0,0
208084,with,0,0
208085,Hydergine,0,0
208086,cerebral,0,1
208087,circulation,0,1
208088,time,0,1
208089,was,0,0
208090,shortened,0,1
208091,and,0,0
208092,stabilized,0,0
208093,.,0,0
208094,Serial,0,0
208095,EEGs,0,1
208096,",",0,0
208097,obtained,0,0
208098,in,0,0
208099,parallel,0,0
208100,with,0,0
208101,psychometric,0,1
208102,and,0,1
208103,circulation,0,1
208104,time,0,1
208105,tests,0,1
208106,",",0,0
208107,demonstrated,0,0
208108,a,0,0
208109,marked,0,0
208110,increase,0,0
208111,in,0,0
208112,the,0,0
208113,8-10,1,0
208114,Hz,1,0
208115,pattern,1,0
208116,which,0,0
208117,corresponds,0,0
208118,to,0,0
208119,the,0,0
208120,physiological,0,0
208121,alpha,0,1
208122,activity,0,1
208123,in,0,0
208124,this,0,0
208125,age,0,0
208126,group,0,0
208127,.,0,0
208128,Furthermore,0,0
208129,",",0,0
208130,there,0,0
208131,was,0,0
208132,a,0,0
208133,diminished,0,1
208134,variability,0,1
208135,in,0,0
208136,performance,1,1
208137,in,0,0
208138,the,0,0
208139,tested,0,0
208140,frequency,0,1
208141,bands,0,1
208142,with,0,0
208143,Hydergine,0,0
208144,",",0,0
208145,the,0,0
208146,opposite,0,0
208147,tendency,0,0
208148,being,0,0
208149,obtained,0,0
208150,in,0,0
208151,the,0,0
208152,placebo,0,0
208153,group,0,0
208154,.,0,0
208155,Comparison,0,0
208156,of,0,1
208157,hypnotherapy,0,0
208158,with,0,0
208159,systematic,0,0
208160,relaxation,0,1
208161,in,0,0
208162,the,0,0
208163,treatment,0,0
208164,of,0,1
208165,cigarette,0,0
208166,habituation,0,1
208167,.,0,0
208168,Because,0,0
208169,of,0,0
208170,the,0,0
208171,methodological,0,1
208172,deficiencies,0,0
208173,in,0,0
208174,this,0,0
208175,area,0,1
208176,of,0,1
208177,research,0,0
208178,",",0,0
208179,it,0,0
208180,is,0,0
208181,impossible,0,0
208182,to,0,0
208183,make,0,0
208184,any,0,0
208185,valid,0,0
208186,conclusions,0,0
208187,about,0,0
208188,whether,0,0
208189,hypnosis,0,0
208190,itself,0,0
208191,is,0,0
208192,effective,0,0
208193,in,0,0
208194,the,0,0
208195,treatment,0,0
208196,of,0,1
208197,cigarette,0,0
208198,habituation,0,1
208199,.,0,0
208200,In,0,0
208201,this,0,0
208202,study,0,0
208203,",",0,0
208204,87,0,0
208205,volunteers,0,0
208206,who,0,0
208207,wanted,0,0
208208,to,0,0
208209,quit,0,1
208210,cigarette,0,0
208211,smoking,0,1
208212,were,0,0
208213,assigned,0,0
208214,randomly,0,0
208215,to,0,0
208216,the,0,0
208217,experimental,0,0
208218,hypnosis,0,1
208219,group,0,0
208220,",",0,0
208221,the,0,0
208222,comparison,0,0
208223,relaxation,0,1
208224,group,0,0
208225,",",0,0
208226,and,0,0
208227,the,0,0
208228,waiting,0,1
208229,list,0,0
208230,control,0,0
208231,group,0,0
208232,.,0,1
208233,Ss,0,0
208234,in,0,0
208235,the,0,0
208236,treatment,0,0
208237,groups,0,0
208238,had,0,0
208239,four,0,0
208240,weekly,0,0
208241,50-minute,0,0
208242,",",0,1
208243,individual,0,0
208244,sessions,0,0
208245,.,0,0
208246,Four,0,0
208247,months,0,0
208248,after,0,0
208249,the,0,0
208250,completion,0,1
208251,of,0,1
208252,treatment,0,0
208253,",",0,1
208254,Ss,0,1
208255,were,0,0
208256,administered,0,0
208257,a,0,0
208258,questionnaire,1,1
208259,and,1,0
208260,a,1,0
208261,hypnotic,1,1
208262,susceptibility,1,1
208263,scale,1,1
208264,.,1,1
208265,Ss,0,0
208266,in,0,0
208267,the,0,0
208268,hypnosis,0,0
208269,group,0,0
208270,who,0,0
208271,were,0,0
208272,in,0,0
208273,the,0,0
208274,upper,0,0
208275,two-thirds,0,0
208276,of,0,0
208277,the,0,0
208278,group,0,0
208279,in,0,0
208280,terms,0,1
208281,of,0,0
208282,hypnotic,0,1
208283,susceptibility,0,1
208284,reduced,0,0
208285,their,0,0
208286,cigarette,1,0
208287,consumption,1,1
208288,substantially,0,0
208289,more,0,0
208290,than,0,0
208291,Ss,0,0
208292,in,0,0
208293,the,0,0
208294,relaxation,0,1
208295,group,0,0
208296,who,0,0
208297,were,0,0
208298,in,0,0
208299,the,0,0
208300,upper,0,0
208301,two-thirds,0,0
208302,of,0,0
208303,the,0,0
208304,group,0,0
208305,in,0,0
208306,terms,0,1
208307,of,0,0
208308,hypnotic,1,0
208309,susceptibility,1,1
208310,.,1,0
208311,Therefore,0,0
208312,",",0,0
208313,the,0,0
208314,hypnotic,0,0
208315,state,0,0
208316,appears,0,0
208317,to,0,0
208318,be,0,0
208319,therapeutic,0,0
208320,for,0,0
208321,individuals,0,0
208322,who,0,0
208323,can,0,0
208324,enter,0,0
208325,medium,0,0
208326,or,0,0
208327,deep,0,1
208328,states,0,1
208329,of,0,0
208330,hypnosis,0,0
208331,.,0,0
208332,Effect,0,1
208333,of,0,1
208334,cicloxilic,0,0
208335,acid,0,0
208336,on,0,0
208337,bile,1,1
208338,lipid,1,1
208339,composition,1,1
208340,in,0,0
208341,patients,0,0
208342,with,0,0
208343,gallstones,0,0
208344,:,0,0
208345,a,0,0
208346,multicenter,0,0
208347,trial,0,0
208348,.,0,0
208349,24,0,0
208350,gallstone,0,0
208351,patients,0,0
208352,were,0,0
208353,treated,0,0
208354,with,0,0
208355,cicloxilic,0,0
208356,acid,0,0
208357,",",0,0
208358,an,0,0
208359,agent,0,0
208360,endowed,0,0
208361,with,0,0
208362,choleretic,0,0
208363,activity,0,1
208364,",",0,0
208365,at,0,0
208366,the,0,0
208367,dose,0,0
208368,of,0,0
208369,240,0,0
208370,mg/day,0,0
208371,for,0,0
208372,1,0,0
208373,month,0,0
208374,.,0,0
208375,24,0,0
208376,comparable,0,0
208377,patients,0,0
208378,on,0,0
208379,placebo,0,0
208380,treatment,0,0
208381,acted,0,0
208382,as,0,0
208383,controls,0,0
208384,.,0,0
208385,Bile,1,0
208386,lipid,1,1
208387,composition,1,1
208388,was,0,0
208389,determined,0,0
208390,and,0,0
208391,the,0,0
208392,saturation,0,1
208393,index,0,1
208394,calculated,0,0
208395,before,0,0
208396,and,0,1
208397,after,0,0
208398,treatment,0,0
208399,",",0,0
208400,on,0,0
208401,samples,0,0
208402,collected,0,0
208403,by,0,0
208404,duodenal,0,0
208405,siphonage,0,0
208406,after,0,0
208407,caerulein,0,0
208408,stimulation,0,1
208409,",",0,0
208410,in,0,0
208411,both,0,0
208412,groups,0,0
208413,.,0,0
208414,In,0,0
208415,the,0,0
208416,cicloxilic,0,0
208417,group,0,0
208418,there,0,0
208419,was,0,0
208420,little,0,0
208421,or,0,0
208422,no,0,0
208423,change,0,1
208424,in,0,0
208425,bile,1,1
208426,salts,1,1
208427,and,1,1
208428,phospholipids,1,1
208429,",",0,0
208430,whereas,0,0
208431,biliary,1,1
208432,cholesterol,1,1
208433,concentration,1,1
208434,was,0,0
208435,significantly,0,0
208436,reduced,0,0
208437,(,0,0
208438,p,0,0
208439,less,0,0
208440,than,0,0
208441,0.05,0,0
208442,),0,0
208443,and,0,0
208444,consequently,0,0
208445,the,0,0
208446,lithogenic,1,1
208447,index,1,1
208448,lowered,0,1
208449,(,0,0
208450,from,0,0
208451,1.5,0,0
208452,to,0,0
208453,1.2,0,0
208454,",",0,0
208455,p,0,0
208456,less,0,0
208457,than,0,0
208458,0.01,0,0
208459,),0,0
208460,.,0,0
208461,Cicloxilic,0,0
208462,acid,0,0
208463,can,0,0
208464,have,0,0
208465,a,0,0
208466,place,0,0
208467,in,0,0
208468,gallstone,0,0
208469,disease,0,1
208470,therapy,0,0
208471,in,0,0
208472,association,0,0
208473,with,0,0
208474,the,0,0
208475,litholytic,0,0
208476,bile,0,1
208477,acids,0,1
208478,or,0,0
208479,in,0,0
208480,the,0,0
208481,prevention,0,0
208482,of,0,1
208483,gallstone,1,0
208484,formation,1,1
208485,in,0,0
208486,high-risk,0,0
208487,populations,0,0
208488,.,0,0
208489,The,0,0
208490,treatment,0,0
208491,of,0,0
208492,localized,0,0
208493,non-Hodgkin,0,0
208494,'s,0,1
208495,lymphoma,0,0
208496,in,0,0
208497,children,0,0
208498,:,0,0
208499,a,0,0
208500,report,0,0
208501,from,0,0
208502,the,0,0
208503,Children,0,0
208504,'s,0,1
208505,Cancer,0,0
208506,Study,0,0
208507,Group,0,0
208508,.,0,0
208509,Investigators,0,0
208510,of,0,0
208511,the,0,0
208512,Children,0,0
208513,'s,0,1
208514,Cancer,0,0
208515,Study,0,0
208516,Group,0,0
208517,entered,0,0
208518,73,0,0
208519,children,0,0
208520,with,0,0
208521,previously,0,0
208522,untreated,0,0
208523,localized,0,0
208524,non-Hodgkin,0,0
208525,'s,0,1
208526,lymphoma,0,0
208527,on,0,0
208528,a,0,0
208529,prospective,0,0
208530,randomized,0,0
208531,trial,0,0
208532,of,0,0
208533,systemic,0,1
208534,treatment,0,0
208535,with,0,0
208536,either,0,0
208537,a,0,0
208538,four-drug,0,0
208539,program,0,0
208540,(,0,1
208541,cyclophosphamide,0,0
208542,",",0,1
208543,vincristine,0,0
208544,",",0,1
208545,methotrexate,0,0
208546,",",0,1
208547,prednisone,0,0
208548,[,0,1
208549,COMP,0,0
208550,],0,0
208551,),0,0
208552,or,0,0
208553,a,0,0
208554,10-drug,0,0
208555,(,0,0
208556,LSA2-L2,0,1
208557,modified,0,0
208558,),0,0
208559,program,0,0
208560,of,0,0
208561,18,0,0
208562,months,0,0
208563,duration,0,0
208564,.,0,0
208565,All,0,0
208566,patients,0,0
208567,received,0,0
208568,central,0,1
208569,nervous,0,1
208570,system,0,0
208571,prophylaxis,0,0
208572,with,0,0
208573,intrathecal,0,1
208574,methotrexate,0,0
208575,and,0,1
208576,most,0,0
208577,received,0,0
208578,local,0,0
208579,or,0,0
208580,regional,0,1
208581,radiation,0,0
208582,treatment,0,0
208583,.,0,0
208584,The,0,0
208585,three-year,1,0
208586,relapse-free,1,1
208587,survival,1,1
208588,rate,1,1
208589,for,0,0
208590,all,0,0
208591,patients,0,0
208592,(,0,0
208593,N,0,0
208594,=,0,0
208595,73,0,0
208596,),0,0
208597,was,0,0
208598,84,0,0
208599,%,0,0
208600,;,0,0
208601,for,0,0
208602,COMP,0,0
208603,(,0,0
208604,N,0,0
208605,=,0,0
208606,42,0,0
208607,),0,0
208608,was,0,0
208609,85,0,0
208610,%,0,0
208611,",",0,0
208612,and,0,1
208613,for,0,1
208614,LSA2-L2,0,1
208615,(,0,0
208616,N,0,0
208617,=,0,0
208618,31,0,0
208619,),0,0
208620,was,0,0
208621,84,0,0
208622,%,0,0
208623,.,0,0
208624,Of,0,0
208625,the,0,0
208626,12,0,0
208627,patients,0,0
208628,who,0,0
208629,suffered,0,0
208630,adverse,1,1
208631,events,1,1
208632,eight,0,0
208633,relapsed,1,0
208634,and,0,0
208635,four,0,0
208636,died,1,0
208637,of,1,0
208638,toxicity,1,1
208639,.,1,1
208640,Histopathology,0,1
208641,was,0,0
208642,reviewed,0,0
208643,centrally,0,0
208644,.,0,0
208645,Of,0,0
208646,32,0,0
208647,patients,0,0
208648,with,0,0
208649,nonlymphoblastic,0,0
208650,disease,0,1
208651,treated,0,0
208652,with,0,0
208653,COMP,0,0
208654,only,0,0
208655,one,0,0
208656,relapsed,1,0
208657,.,1,0
208658,Of,0,0
208659,26,0,0
208660,patients,0,0
208661,treated,0,0
208662,with,0,0
208663,LSA2-L2,0,0
208664,",",0,0
208665,four,0,0
208666,relapsed,1,0
208667,.,1,0
208668,Patients,0,0
208669,with,0,0
208670,localized,1,0
208671,lymphoblastic,1,0
208672,disease,1,1
208673,were,0,0
208674,uncommon,0,0
208675,.,0,0
208676,None,0,0
208677,of,0,0
208678,three,0,0
208679,patients,0,0
208680,treated,0,0
208681,with,0,0
208682,LSA2-L2,0,0
208683,relapsed,0,0
208684,compared,0,0
208685,with,0,0
208686,three,0,0
208687,of,0,0
208688,nine,0,0
208689,treated,0,0
208690,with,0,0
208691,COMP,0,0
208692,.,0,0
208693,COMP,0,0
208694,is,0,0
208695,an,0,0
208696,excellent,0,1
208697,treatment,0,0
208698,for,0,0
208699,patients,0,0
208700,with,0,0
208701,localized,0,0
208702,disease,0,1
208703,of,0,1
208704,nonlymphoblastic,0,0
208705,type,0,0
208706,",",0,0
208707,but,0,0
208708,the,0,0
208709,relative,0,1
208710,value,0,0
208711,of,0,0
208712,the,0,0
208713,two,0,0
208714,regimens,0,0
208715,for,0,0
208716,patients,0,0
208717,with,0,0
208718,localized,0,0
208719,lymphoblastic,0,0
208720,disease,0,0
208721,is,0,0
208722,uncertain,0,0
208723,.,0,0
208724,Blood,0,1
208725,pressure,0,1
208726,control,0,0
208727,during,0,0
208728,weight,0,1
208729,reduction,0,1
208730,in,0,0
208731,obese,0,0
208732,hypertensive,0,0
208733,men,0,0
208734,:,0,0
208735,separate,0,0
208736,effects,0,1
208737,of,0,1
208738,sodium,0,0
208739,and,0,1
208740,energy,0,1
208741,restriction,0,0
208742,.,0,0
208743,The,0,0
208744,separate,0,0
208745,and,0,0
208746,combined,0,0
208747,effects,0,1
208748,of,0,1
208749,dietary,0,1
208750,energy,0,1
208751,and,0,1
208752,sodium,0,1
208753,restriction,0,0
208754,on,0,0
208755,regulation,0,1
208756,of,0,1
208757,blood,1,1
208758,pressure,1,1
208759,were,0,0
208760,investigated,0,0
208761,in,0,0
208762,30,0,0
208763,middle,0,0
208764,aged,0,0
208765,obese,0,0
208766,men,0,0
208767,with,0,0
208768,essential,0,0
208769,hypertension,0,0
208770,attending,0,0
208771,the,0,0
208772,outpatient,0,0
208773,department,0,0
208774,.,0,0
208775,In,0,0
208776,group,0,0
208777,1,0,0
208778,(,0,0
208779,n,0,0
208780,=,0,0
208781,15,0,0
208782,),0,0
208783,a,0,0
208784,basal,0,1
208785,period,0,0
208786,with,0,0
208787,no,0,0
208788,dietary,0,0
208789,restriction,0,0
208790,was,0,0
208791,followed,0,0
208792,by,0,0
208793,a,0,0
208794,period,0,0
208795,taking,0,0
208796,an,0,0
208797,energy,0,1
208798,reduced,0,1
208799,diet,0,0
208800,(,0,0
208801,5.1,0,0
208802,MJ,0,0
208803,;,0,0
208804,1230,0,0
208805,kcal,0,0
208806,),0,0
208807,",",0,0
208808,the,0,0
208809,sodium,0,0
208810,intake,0,1
208811,being,0,0
208812,supplemented,0,0
208813,and,0,0
208814,hence,0,0
208815,unchanged,0,0
208816,(,0,0
208817,1,0,0
208818,:,0,0
208819,ErSn,0,0
208820,),0,0
208821,.,0,0
208822,In,0,0
208823,group,0,0
208824,2,0,0
208825,(,0,0
208826,n,0,0
208827,=,0,0
208828,15,0,0
208829,),0,0
208830,the,0,0
208831,basal,0,1
208832,period,0,0
208833,preceded,0,0
208834,a,0,0
208835,control,0,0
208836,period,0,0
208837,with,0,0
208838,no,0,0
208839,intervention,0,0
208840,",",0,0
208841,which,0,0
208842,was,0,0
208843,followed,0,0
208844,by,0,0
208845,taking,0,0
208846,a,0,0
208847,diet,0,0
208848,restricted,0,0
208849,in,0,0
208850,energy,0,0
208851,(,0,0
208852,5.1,0,0
208853,MJ,0,0
208854,;,0,0
208855,1220,0,0
208856,kcal,0,0
208857,),0,0
208858,and,0,1
208859,sodium,0,0
208860,(,0,0
208861,2,0,0
208862,:,0,0
208863,ErSr,0,0
208864,),0,0
208865,.,0,0
208866,During,0,0
208867,period,0,0
208868,1,0,0
208869,:,0,0
208870,ErSn,0,0
208871,there,0,0
208872,were,0,0
208873,reductions,0,1
208874,in,0,0
208875,heart,1,1
208876,rate,1,1
208877,and,1,1
208878,urinary,1,1
208879,noradrenaline,1,1
208880,output,1,1
208881,but,0,0
208882,not,0,0
208883,in,0,0
208884,systolic,1,1
208885,or,1,0
208886,diastolic,1,1
208887,blood,1,1
208888,pressure,1,1
208889,.,1,1
208890,Body,1,0
208891,weight,1,1
208892,decreased,0,0
208893,by,0,0
208894,4.9-11.7,0,0
208895,kg,0,0
208896,and,0,1
208897,urinary,1,1
208898,sodium,1,1
208899,excretion,1,1
208900,did,0,0
208901,not,0,0
208902,change,0,0
208903,.,0,0
208904,In,0,0
208905,period,0,0
208906,2,0,0
208907,:,0,0
208908,ErSr,0,0
208909,urinary,1,1
208910,sodium,1,1
208911,output,1,1
208912,was,0,0
208913,reduced,0,0
208914,by,0,0
208915,81.4,0,0
208916,(,0,0
208917,SEM,0,0
208918,17.8,0,0
208919,),0,0
208920,mmol,0,0
208921,(,0,1
208922,mEq,0,0
208923,),0,1
208924,/24,0,0
208925,h,0,0
208926,and,0,1
208927,there,0,0
208928,was,0,0
208929,a,0,0
208930,weight,1,1
208931,loss,1,1
208932,of,0,0
208933,8.2,0,0
208934,(,0,0
208935,SEM,0,0
208936,0.7,0,0
208937,),0,0
208938,kg,0,0
208939,.,0,1
208940,Systolic,1,1
208941,and,1,1
208942,diastolic,1,1
208943,blood,1,1
208944,pressures,1,1
208945,fell,0,1
208946,significantly,0,0
208947,",",0,0
208948,as,0,0
208949,did,0,0
208950,the,0,0
208951,heart,1,1
208952,rate,1,1
208953,and,0,1
208954,urinary,1,1
208955,noradrenaline,1,1
208956,excretion,1,1
208957,.,1,0
208958,These,0,0
208959,results,0,0
208960,show,0,0
208961,that,0,0
208962,in,0,0
208963,hypertensive,0,0
208964,obese,0,0
208965,men,0,0
208966,a,0,0
208967,moderate,0,0
208968,weight,0,1
208969,reducing,0,0
208970,diet,0,0
208971,decreases,0,0
208972,indices,0,1
208973,of,0,0
208974,sympathetic,1,1
208975,nervous,1,1
208976,system,1,0
208977,activity,1,1
208978,.,1,1
208979,Reduction,0,1
208980,of,0,1
208981,blood,1,1
208982,pressure,1,1
208983,to,0,0
208984,the,0,0
208985,normotensive,0,0
208986,range,0,0
208987,was,0,0
208988,observed,0,0
208989,only,0,0
208990,when,0,0
208991,there,0,0
208992,was,0,0
208993,a,0,0
208994,concomitant,0,0
208995,restriction,0,0
208996,of,0,1
208997,sodium,0,0
208998,intake,0,1
208999,.,0,0
209000,Effects,0,0
209001,of,0,0
209002,mild,0,0
209003,physical,0,1
209004,exercise,0,0
209005,on,0,0
209006,serum,1,1
209007,lipoproteins,1,1
209008,and,0,1
209009,metabolites,1,1
209010,of,1,1
209011,arachidonic,1,1
209012,acid,1,0
209013,:,1,0
209014,a,0,0
209015,controlled,0,0
209016,randomised,0,0
209017,trial,0,0
209018,in,0,0
209019,middle,0,0
209020,aged,0,0
209021,men,0,0
209022,.,0,0
209023,To,0,0
209024,study,0,0
209025,the,0,0
209026,effects,0,0
209027,of,0,0
209028,physical,0,1
209029,exercise,0,0
209030,on,0,0
209031,biochemical,1,1
209032,risk,1,1
209033,factors,1,1
209034,for,1,0
209035,ischaemic,1,1
209036,heart,1,1
209037,disease,1,0
209038,31,0,0
209039,healthy,0,0
209040,middle,0,0
209041,aged,0,0
209042,men,0,0
209043,undertook,0,0
209044,regular,0,0
209045,physical,0,1
209046,exercise,0,0
209047,for,0,0
209048,two,0,0
209049,months,0,0
209050,and,0,0
209051,29,0,0
209052,served,0,0
209053,as,0,0
209054,controls,0,0
209055,in,0,0
209056,a,0,0
209057,randomised,0,0
209058,trial,0,0
209059,.,0,0
209060,In,0,0
209061,the,0,0
209062,men,0,0
209063,taking,0,0
209064,regular,0,0
209065,exercise,0,0
209066,serum,1,1
209067,cholesterol,1,1
209068,concentrations,1,1
209069,increased,0,0
209070,26,0,0
209071,%,0,0
209072,more,0,0
209073,in,0,0
209074,the,0,0
209075,high,1,0
209076,density,1,1
209077,lipoprotein,1,1
209078,subfraction,1,1
209079,two,1,0
209080,(,1,0
209081,HDL2,1,0
209082,),1,1
209083,and,0,0
209084,decreased,0,0
209085,31,0,0
209086,%,0,0
209087,more,0,0
209088,in,0,0
209089,the,0,0
209090,subfraction,1,1
209091,three,1,0
209092,(,1,0
209093,HDL3,1,0
209094,),1,0
209095,and,0,0
209096,9,0,0
209097,%,0,0
209098,more,0,0
209099,in,0,0
209100,the,0,0
209101,low,1,0
209102,density,1,1
209103,lipoprotein,1,1
209104,fraction,1,1
209105,than,0,0
209106,in,0,0
209107,the,0,0
209108,control,0,0
209109,group,0,0
209110,.,0,0
209111,A,0,0
209112,tendency,0,1
209113,towards,0,0
209114,increased,0,1
209115,plasma,1,1
209116,6-keto-prostaglandin,1,1
209117,F1,1,1
209118,alpha,1,1
209119,concentration,1,1
209120,and,0,1
209121,decreased,0,1
209122,serum,1,1
209123,thromboxane,1,1
209124,B2,1,1
209125,concentration,1,1
209126,was,0,0
209127,found,0,0
209128,during,0,0
209129,the,0,0
209130,period,0,0
209131,of,0,0
209132,regular,0,1
209133,exercise,0,0
209134,",",0,0
209135,but,0,0
209136,prostaglandin,1,1
209137,E2,1,1
209138,concentrations,1,1
209139,remained,0,0
209140,unchanged,0,0
209141,.,0,0
209142,The,0,0
209143,increase,0,0
209144,in,0,0
209145,plasma,1,1
209146,6-keto-prostaglandin,1,1
209147,F1,1,1
209148,alpha,1,1
209149,concentration,1,1
209150,was,0,0
209151,associated,0,0
209152,with,0,0
209153,an,0,0
209154,increase,0,0
209155,in,0,0
209156,serum,1,1
209157,HDL2,1,1
209158,cholesterol,1,1
209159,concentration,1,1
209160,in,0,0
209161,the,0,0
209162,group,0,0
209163,taking,0,0
209164,regular,0,0
209165,exercise,0,0
209166,.,0,0
209167,Our,0,0
209168,data,0,0
209169,suggest,0,0
209170,that,0,0
209171,mild,0,0
209172,regular,0,0
209173,physical,0,1
209174,exercise,0,0
209175,favourably,0,0
209176,influences,0,0
209177,cholesterol,1,1
209178,distribution,1,1
209179,in,0,0
209180,serum,1,1
209181,lipoproteins,1,1
209182,in,0,0
209183,healthy,0,0
209184,middle,0,0
209185,aged,0,0
209186,men,0,0
209187,and,0,0
209188,may,0,0
209189,have,0,0
209190,beneficial,0,0
209191,effects,0,1
209192,on,0,0
209193,circulating,1,1
209194,metabolites,1,1
209195,of,1,0
209196,arachidonic,1,1
209197,acid,1,0
209198,.,1,0
209199,Endotracheal,0,1
209200,cuff,0,1
209201,pressure,0,1
209202,and,0,1
209203,tracheal,0,1
209204,mucosal,0,1
209205,blood,0,1
209206,flow,0,1
209207,:,0,0
209208,endoscopic,0,1
209209,study,0,0
209210,of,0,1
209211,effects,0,0
209212,of,0,0
209213,four,0,0
209214,large,0,0
209215,volume,0,1
209216,cuffs,0,0
209217,.,0,1
209218,Large,0,0
209219,volume,0,1
209220,",",0,1
209221,low,0,1
209222,pressure,0,1
209223,endotracheal,0,1
209224,tube,0,0
209225,cuffs,0,0
209226,are,0,0
209227,claimed,0,0
209228,to,0,0
209229,have,0,0
209230,less,0,0
209231,deleterious,0,1
209232,effect,0,1
209233,on,0,0
209234,tracheal,1,1
209235,mucosa,1,1
209236,than,0,0
209237,high,0,1
209238,pressure,0,1
209239,",",0,1
209240,low,0,1
209241,volume,0,1
209242,cuffs,0,0
209243,.,0,1
209244,Low,0,0
209245,pressure,0,1
209246,cuffs,0,1
209247,",",0,0
209248,however,0,0
209249,",",0,0
209250,may,0,0
209251,easily,0,1
209252,be,0,0
209253,overinflated,0,0
209254,to,0,0
209255,yield,0,1
209256,pressures,0,1
209257,that,0,0
209258,will,0,0
209259,exceed,0,0
209260,capillary,0,1
209261,perfusion,0,1
209262,pressure,0,1
209263,.,0,1
209264,Various,0,1
209265,large,0,1
209266,volume,0,1
209267,cuffed,0,0
209268,endotracheal,0,1
209269,tubes,0,0
209270,were,0,0
209271,studied,0,0
209272,",",0,0
209273,including,0,0
209274,Portex,0,1
209275,Profile,0,1
209276,",",0,1
209277,Searle,0,1
209278,Sensiv,0,0
209279,",",0,1
209280,Mallinkrodt,0,0
209281,Hi-Lo,0,1
209282,",",0,1
209283,and,0,1
209284,Lanz,0,1
209285,.,0,1
209286,Tracheal,0,1
209287,mucosal,0,1
209288,blood,0,1
209289,flow,0,1
209290,in,0,0
209291,40,0,0
209292,patients,0,0
209293,undergoing,0,0
209294,surgery,0,0
209295,was,0,0
209296,assessed,0,0
209297,using,0,0
209298,an,0,0
209299,endoscopic,0,0
209300,photographic,0,1
209301,technique,0,0
209302,while,0,0
209303,varying,0,0
209304,the,0,0
209305,cuff,0,1
209306,inflation,0,1
209307,pressure,0,1
209308,.,0,0
209309,It,0,0
209310,was,0,0
209311,found,0,0
209312,that,0,0
209313,these,0,0
209314,cuffs,0,0
209315,when,0,0
209316,overpressurised,0,0
209317,impaired,1,0
209318,mucosal,1,1
209319,blood,1,1
209320,flow,1,1
209321,.,1,0
209322,This,0,0
209323,impairment,0,1
209324,of,0,1
209325,tracheal,1,1
209326,mucosal,1,1
209327,blood,1,1
209328,flow,1,1
209329,is,0,0
209330,an,0,0
209331,important,0,0
209332,factor,0,1
209333,in,0,0
209334,tracheal,1,1
209335,morbidity,1,1
209336,associated,0,0
209337,with,0,0
209338,intubation,0,0
209339,.,0,0
209340,Hence,0,0
209341,it,0,0
209342,is,0,0
209343,recommended,0,0
209344,that,0,0
209345,a,0,0
209346,cuff,1,1
209347,inflation,1,1
209348,pressure,1,1
209349,of,0,0
209350,30,0,0
209351,cm,0,0
209352,H2O,0,0
209353,(,0,0
209354,22,0,0
209355,mm,0,0
209356,Hg,0,0
209357,),0,0
209358,should,0,0
209359,not,0,0
209360,be,0,0
209361,exceeded,0,0
209362,.,0,0
209363,Cognitive,0,1
209364,effects,0,1
209365,of,0,1
209366,lithium,0,0
209367,carbonate,0,0
209368,and,0,1
209369,haloperidol,0,0
209370,in,0,0
209371,treatment-resistant,0,0
209372,aggressive,0,0
209373,children,0,0
209374,.,0,0
209375,The,0,0
209376,effects,0,0
209377,of,0,0
209378,lithium,0,0
209379,carbonate,0,0
209380,and,0,1
209381,haloperidol,0,0
209382,on,0,0
209383,cognition,0,1
209384,were,0,0
209385,examined,0,0
209386,in,0,0
209387,a,0,0
209388,placebo-controlled,0,0
209389,",",0,0
209390,double-blind,0,0
209391,study,0,0
209392,of,0,0
209393,61,0,0
209394,treatment-resistant,0,0
209395,",",0,0
209396,hospitalized,0,1
209397,school-aged,0,0
209398,children,0,0
209399,.,0,0
209400,They,0,0
209401,all,0,0
209402,had,0,0
209403,a,0,0
209404,DSM-III,0,0
209405,diagnosis,0,0
209406,of,0,1
209407,conduct,0,0
209408,disorder,0,0
209409,--,0,1
209410,undersocialized,0,0
209411,",",0,0
209412,aggressive,0,1
209413,",",0,0
209414,with,0,0
209415,a,0,0
209416,profile,0,1
209417,of,0,0
209418,highly,0,0
209419,explosive,0,0
209420,and,0,1
209421,aggressive,0,1
209422,behavior,0,1
209423,.,0,1
209424,Children,0,0
209425,were,0,0
209426,assessed,0,0
209427,at,0,0
209428,the,0,0
209429,end,0,0
209430,of,0,0
209431,a,0,0
209432,two-week,0,0
209433,placebo-baseline,0,0
209434,period,0,0
209435,and,0,1
209436,again,0,0
209437,after,0,0
209438,four,0,0
209439,weeks,0,0
209440,of,0,0
209441,treatment,0,0
209442,.,0,0
209443,Drug,0,0
209444,effects,0,1
209445,on,0,0
209446,cognition,0,1
209447,were,0,0
209448,mild,0,0
209449,.,0,1
209450,Haloperidol,0,0
209451,(,0,0
209452,mean,0,1
209453,dose,0,0
209454,",",0,0
209455,2.95,0,0
209456,mg/day,0,0
209457,),0,0
209458,caused,0,0
209459,significant,0,0
209460,decreases,0,1
209461,in,0,0
209462,Porteus,1,0
209463,Maze,1,0
209464,test,1,1
209465,quotient,1,1
209466,scores,1,1
209467,and,0,0
209468,a,0,0
209469,slowing,1,1
209470,of,1,1
209471,reaction,1,1
209472,time,1,1
209473,(,1,1
209474,RT,1,0
209475,),1,0
209476,on,0,0
209477,a,0,0
209478,simple,0,0
209479,RT,0,0
209480,task,0,1
209481,.,0,1
209482,Lithium,0,0
209483,carbonate,0,0
209484,(,0,0
209485,mean,0,1
209486,dose,0,0
209487,",",0,0
209488,"1,166",0,0
209489,mg/day,0,0
209490,),0,0
209491,adversely,0,0
209492,affected,0,0
209493,qualitative,1,0
209494,scores,1,1
209495,on,1,0
209496,the,1,0
209497,Porteus,1,0
209498,Maze,1,0
209499,test,1,0
209500,.,1,0
209501,No,0,0
209502,significant,0,0
209503,treatment,0,0
209504,effects,0,1
209505,were,0,0
209506,found,0,0
209507,for,0,0
209508,the,0,0
209509,Matching,1,1
209510,Familiar,1,1
209511,Figures,1,1
209512,Test,1,1
209513,",",1,1
209514,short-term,1,1
209515,recognition,1,1
209516,memory,1,1
209517,and,1,1
209518,concept,1,1
209519,attainment,1,1
209520,tasks,1,1
209521,",",1,0
209522,or,1,0
209523,the,1,0
209524,Stroop,1,0
209525,Test,1,1
209526,.,1,0
209527,Relief,0,1
209528,of,0,1
209529,osteoporotic,1,1
209530,backache,1,1
209531,with,0,0
209532,fluoride,0,0
209533,",",0,1
209534,calcium,0,1
209535,",",0,1
209536,and,0,1
209537,calciferol,0,1
209538,.,0,0
209539,In,0,0
209540,a,0,0
209541,prospective,0,0
209542,randomized,0,0
209543,clinical,0,0
209544,trial,0,0
209545,comprising,0,0
209546,22,0,0
209547,postmenopausal,0,0
209548,women,0,0
209549,with,0,0
209550,backache,0,1
209551,and,0,0
209552,a,0,0
209553,halisteretic,0,1
209554,spine,0,0
209555,with,0,0
209556,crush,0,0
209557,fracture,0,1
209558,(,0,1
209559,s,0,1
209560,),0,0
209561,",",0,0
209562,12,0,0
209563,women,0,0
209564,completed,0,0
209565,a,0,0
209566,12-week,0,0
209567,therapy,0,0
209568,with,0,0
209569,sodium,0,1
209570,fluoride,0,0
209571,",",0,1
209572,calcium,0,1
209573,and,0,1
209574,calciferol,0,1
209575,and,0,0
209576,10,0,0
209577,with,0,0
209578,placebo,0,0
209579,.,0,0
209580,A,0,0
209581,statistically,0,0
209582,significant,0,0
209583,improvement,0,1
209584,(,0,0
209585,p,0,0
209586,less,0,0
209587,than,0,0
209588,0.05,0,0
209589,),0,0
209590,",",0,0
209591,evaluated,0,0
209592,by,0,0
209593,a,0,0
209594,four-stage,1,0
209595,scale,1,1
209596,on,1,0
209597,pains,1,1
209598,",",1,1
209599,infirmity,1,1
209600,",",1,1
209601,and,1,1
209602,consumption,1,1
209603,of,1,1
209604,analgesics,1,1
209605,",",0,0
209606,was,0,0
209607,observed,0,0
209608,in,0,0
209609,the,0,0
209610,actively,0,0
209611,treated,0,0
209612,patients,0,0
209613,.,0,0
209614,Rational-emotive,0,1
209615,therapy,0,0
209616,and,0,0
209617,the,0,0
209618,reduction,0,1
209619,of,0,0
209620,interpersonal,1,1
209621,anxiety,1,1
209622,in,0,0
209623,junior,0,0
209624,high,0,0
209625,school,0,0
209626,students,0,0
209627,.,0,0
209628,This,0,0
209629,study,0,0
209630,evaluated,0,0
209631,the,0,0
209632,effectiveness,0,1
209633,of,0,0
209634,rational-emotive,0,1
209635,therapy,0,0
209636,and,0,1
209637,rational-emotive,0,1
209638,imagery,0,0
209639,.,0,0
209640,Fifty-nine,0,0
209641,junior,0,0
209642,high,0,0
209643,school,0,0
209644,students,0,0
209645,who,0,0
209646,volunteered,0,0
209647,to,0,0
209648,participate,0,0
209649,in,0,0
209650,treatment,0,0
209651,for,0,0
209652,interpersonal,1,1
209653,anxiety,1,1
209654,were,0,0
209655,randomly,0,0
209656,assigned,0,0
209657,to,0,0
209658,rational-emotive,0,0
209659,therapy,0,0
209660,without,0,0
209661,imagery,0,0
209662,(,0,1
209663,RET,0,0
209664,),0,1
209665,",",0,0
209666,rational-emotive,0,1
209667,therapy,0,0
209668,with,0,0
209669,imagery,0,0
209670,(,0,1
209671,REI,0,1
209672,),0,1
209673,",",0,0
209674,relationship-oriented,0,1
209675,counseling,0,0
209676,(,0,1
209677,ROC,0,1
209678,),0,1
209679,",",0,0
209680,and,0,1
209681,waiting-list,0,1
209682,control,0,0
209683,(,0,1
209684,WLC,0,0
209685,),0,0
209686,groups,0,0
209687,.,0,1
209688,Groups,0,0
209689,met,0,0
209690,for,0,0
209691,seven,0,0
209692,50-minute,0,0
209693,treatment,0,0
209694,sessions,0,0
209695,during,0,0
209696,a,0,0
209697,three-week,0,0
209698,period,0,0
209699,.,0,1
209700,Assessments,0,1
209701,were,0,0
209702,conducted,0,0
209703,at,0,0
209704,pretreatment,0,0
209705,",",0,1
209706,posttreatment,0,1
209707,",",0,1
209708,and,0,1
209709,three-week,0,0
209710,follow-up,0,0
209711,.,0,0
209712,Both,0,0
209713,self-report,1,1
209714,and,1,0
209715,sociometric,1,1
209716,measures,1,1
209717,were,0,0
209718,used,0,0
209719,to,0,0
209720,evaluate,0,0
209721,treatment,0,0
209722,outcome,0,1
209723,.,0,0
209724,At,0,0
209725,postassessment,0,1
209726,",",0,0
209727,both,0,0
209728,the,0,0
209729,RET,0,0
209730,and,0,1
209731,REI,0,1
209732,groups,0,0
209733,were,0,0
209734,rated,0,1
209735,on,0,0
209736,sociometric,1,1
209737,measures,1,0
209738,as,0,0
209739,significantly,1,0
209740,less,1,0
209741,interpersonally,1,0
209742,anxious,1,1
209743,than,0,0
209744,the,0,0
209745,WLC,0,0
209746,group,0,0
209747,.,0,0
209748,Mean,1,0
209749,scores,1,1
209750,favored,0,0
209751,the,0,0
209752,RET,0,0
209753,and,0,1
209754,REI,0,1
209755,groups,0,0
209756,",",0,0
209757,but,0,0
209758,no,0,0
209759,significant,0,0
209760,differences,0,0
209761,between,0,0
209762,these,0,0
209763,groups,0,0
209764,and,0,0
209765,the,0,0
209766,ROC,0,1
209767,group,0,0
209768,were,0,0
209769,obtained,0,0
209770,.,0,0
209771,The,0,0
209772,self-report,1,1
209773,measure,1,1
209774,did,0,0
209775,not,0,0
209776,significantly,0,0
209777,differentiate,0,0
209778,between,0,0
209779,groups,0,0
209780,",",0,0
209781,but,0,0
209782,the,0,0
209783,REI,0,1
209784,group,0,0
209785,demonstrated,0,0
209786,significant,0,0
209787,pre-,0,1
209788,to,0,0
209789,follow-up,0,0
209790,changes,0,1
209791,.,0,0
209792,Both,0,0
209793,the,0,0
209794,RET,0,0
209795,and,0,1
209796,REI,0,1
209797,groups,0,0
209798,yielded,0,0
209799,greater,0,0
209800,reductions,1,1
209801,in,1,0
209802,irrational,1,1
209803,thinking,1,1
209804,than,0,0
209805,did,0,0
209806,the,0,0
209807,ROC,0,1
209808,and,0,1
209809,WLC,0,0
209810,groups,0,0
209811,.,0,0
209812,In,0,0
209813,addition,0,0
209814,",",0,0
209815,the,0,0
209816,pattern,0,0
209817,of,0,0
209818,the,0,0
209819,results,0,0
209820,supported,0,0
209821,the,0,0
209822,use,0,0
209823,of,0,0
209824,rational-emotive,0,1
209825,imagery,0,0
209826,as,0,0
209827,a,0,0
209828,component,0,1
209829,of,0,0
209830,rational-emotive,0,0
209831,therapy,0,0
209832,.,0,0
209833,The,0,0
209834,practical,0,0
209835,implications,0,0
209836,of,0,0
209837,these,0,0
209838,findings,0,0
209839,are,0,0
209840,discussed,0,0
209841,.,0,0
209842,[,0,0
209843,Tocolysis,0,0
209844,with,0,0
209845,hexoprenalin,0,0
209846,and,0,1
209847,salbutamol,0,0
209848,in,0,0
209849,a,0,0
209850,clinical,0,0
209851,comparison,0,0
209852,],0,0
209853,.,0,0
209854,140,0,0
209855,patients,0,0
209856,with,0,0
209857,a,0,0
209858,threatening,0,1
209859,premature,0,0
209860,birth,0,0
209861,at,0,0
209862,the,0,0
209863,greater,0,0
209864,than,0,0
209865,or,0,0
209866,equal,0,0
209867,to,0,0
209868,24-less,0,0
209869,than,0,0
209870,37,0,0
209871,week,0,0
209872,of,0,0
209873,gestation,0,1
209874,were,0,0
209875,in,0,0
209876,this,0,0
209877,study,0,0
209878,randomly,0,0
209879,treated,0,0
209880,with,0,0
209881,hexoprenalin,0,0
209882,or,0,0
209883,salbutamol,0,0
209884,.,0,0
209885,In,0,0
209886,77,0,0
209887,%,0,0
209888,in,0,0
209889,the,0,0
209890,hexoprenalin,0,0
209891,and,0,0
209892,in,0,0
209893,74,0,0
209894,%,0,0
209895,in,0,0
209896,the,0,0
209897,salbutamol,0,0
209898,group,0,0
209899,the,0,0
209900,weight,1,1
209901,of,1,0
209902,the,1,0
209903,newborn,1,0
209904,was,0,0
209905,greater,0,0
209906,than,0,0
209907,or,0,0
209908,equal,0,0
209909,to,0,0
209910,2500,0,0
209911,g.,0,0
209912,In,0,0
209913,66,0,0
209914,%,0,0
209915,in,0,0
209916,both,0,0
209917,study,0,0
209918,groups,0,0
209919,the,0,0
209920,birth,0,0
209921,occurred,0,0
209922,after,0,0
209923,the,0,0
209924,completed,0,0
209925,37,0,0
209926,weeks,1,0
209927,of,1,0
209928,gestation,1,1
209929,.,1,0
209930,During,0,0
209931,infusion,0,0
209932,of,0,1
209933,hexoprenalin,0,0
209934,tachycardia,1,1
209935,in,0,0
209936,mothers,0,0
209937,occurred,0,0
209938,statistically,0,0
209939,highly,0,0
209940,significantly,0,0
209941,less,0,0
209942,than,0,0
209943,during,0,0
209944,salbutamol,0,0
209945,.,0,0
209946,11,0,0
209947,%,0,0
209948,of,0,0
209949,the,0,0
209950,mothers,0,0
209951,in,0,0
209952,the,0,0
209953,hexoprenalin,0,0
209954,group,0,0
209955,had,0,0
209956,side-effects,1,1
209957,during,1,0
209958,infusion,1,0
209959,compared,0,0
209960,to,0,0
209961,30,0,0
209962,%,0,0
209963,in,0,0
209964,the,0,0
209965,salbutamol,0,0
209966,group,0,0
209967,.,0,0
209968,The,0,0
209969,correlation,0,0
209970,between,0,0
209971,the,0,0
209972,tocolysis-index,1,1
209973,(,1,0
209974,Baumgarten,1,1
209975,),1,0
209976,and,0,0
209977,the,0,0
209978,prolongation-index,1,1
209979,(,1,0
209980,Richter,1,0
209981,),1,0
209982,given,0,0
209983,by,0,0
209984,the,0,0
209985,regression,0,0
209986,lines,0,1
209987,facilitates,0,0
209988,in,0,0
209989,some,0,0
209990,measure,0,0
209991,the,0,0
209992,comparison,0,0
209993,of,0,0
209994,different,0,0
209995,tocolytic,0,0
209996,drugs,0,0
209997,concerning,0,0
209998,its,0,0
209999,tocolytic,0,0
210000,effect,0,0
210001,.,0,0
210002,[,0,0
210003,Maintaining,0,1
210004,sinus,0,1
210005,rhythm,0,1
210006,with,0,0
210007,quinidine,0,0
210008,and,0,1
210009,amiodarone,0,0
210010,after,0,0
210011,electric,0,0
210012,cardioversion,0,0
210013,],0,0
210014,.,0,0
210015,Bovine,0,0
210016,carotid,0,1
210017,artery,0,0
210018,heterografts,0,0
210019,versus,0,0
210020,polytetrafluoroethylene,0,0
210021,grafts,0,1
210022,.,0,0
210023,A,0,0
210024,prospective,0,0
210025,",",0,0
210026,randomized,0,0
210027,study,0,0
210028,.,0,0
210029,A,0,0
210030,prospective,0,0
210031,",",0,0
210032,randomized,0,0
210033,comparison,0,0
210034,of,0,1
210035,BCAH,0,1
210036,and,0,1
210037,PTFE,0,1
210038,vascular,0,1
210039,access,0,1
210040,grafts,0,1
210041,resulted,0,0
210042,in,0,0
210043,no,0,0
210044,statistically,0,0
210045,significant,0,0
210046,difference,0,0
210047,when,0,0
210048,analyzed,0,0
210049,for,0,0
210050,survival,1,1
210051,rates,1,1
210052,of,1,1
210053,complications,1,1
210054,",",1,0
210055,types,1,0
210056,of,1,1
210057,complications,1,1
210058,",",1,0
210059,reasons,1,0
210060,for,1,0
210061,failure,1,1
210062,",",1,1
210063,and,1,1
210064,clot,1,1
210065,salvageability,1,1
210066,.,1,0
210067,The,0,0
210068,results,0,0
210069,in,0,0
210070,diabetic,0,0
210071,patients,0,0
210072,were,0,0
210073,similar,0,0
210074,to,0,0
210075,those,0,0
210076,in,0,0
210077,nondiabetic,0,0
210078,patients,0,0
210079,.,0,0
210080,The,0,0
210081,majority,0,0
210082,of,0,0
210083,retrospective,0,0
210084,studies,0,0
210085,and,0,1
210086,subjective,0,1
210087,experiences,0,1
210088,favor,0,0
210089,PTFE,0,0
210090,grafts,0,1
210091,over,0,0
210092,BCAHs,0,0
210093,.,0,0
210094,The,0,0
210095,explanation,0,0
210096,may,0,0
210097,be,0,0
210098,part,0,0
210099,that,0,0
210100,BCAH,0,1
210101,preceded,0,0
210102,PTFE,0,0
210103,grafts,0,1
210104,into,0,0
210105,clinical,0,1
210106,use,0,1
210107,",",0,1
210108,and,0,1
210109,inexperience,0,1
210110,in,0,0
210111,the,0,0
210112,operating,0,1
210113,room,0,0
210114,and,0,0
210115,in,0,0
210116,the,0,0
210117,dialysis,0,0
210118,unit,0,0
210119,had,0,0
210120,an,0,0
210121,effect,0,1
210122,on,0,0
210123,BCAH,0,1
210124,results,0,0
210125,.,0,0
210126,A,0,0
210127,review,0,0
210128,of,0,0
210129,impressions,0,0
210130,of,0,0
210131,the,0,0
210132,graft,0,1
210133,materials,0,0
210134,indicated,0,0
210135,a,0,0
210136,decided,0,0
210137,preference,0,1
210138,for,0,0
210139,PTFE,0,0
210140,grafts,0,1
210141,.,0,0
210142,High-dose,0,0
210143,weekly,0,0
210144,fractionation,0,0
210145,radiotherapy,0,0
210146,in,0,0
210147,advanced,0,0
210148,cancer,0,0
210149,of,0,0
210150,the,0,0
210151,uterine,0,1
210152,cervix,0,0
210153,.,0,0
210154,A,0,0
210155,trial,0,0
210156,comparing,0,0
210157,two,0,0
210158,different,0,0
210159,radiotherapy,0,0
210160,techniques,0,0
210161,and,0,1
210162,schedules,0,0
210163,in,0,0
210164,the,0,0
210165,treatment,0,0
210166,of,0,0
210167,83,0,0
210168,patients,0,0
210169,with,0,0
210170,advanced,0,0
210171,cancer,0,0
210172,of,0,0
210173,the,0,0
210174,uterine,0,1
210175,cervix,0,0
210176,(,0,0
210177,stage,0,1
210178,IIIB,0,1
210179,),0,0
210180,employing,0,0
210181,external,0,0
210182,irradiation,0,0
210183,alone,0,0
210184,is,0,0
210185,described,0,0
210186,.,0,0
210187,The,0,0
210188,one,0,0
210189,technique,0,0
210190,",",0,0
210191,used,0,0
210192,routinely,0,0
210193,in,0,0
210194,this,0,0
210195,department,0,0
210196,",",0,0
210197,employed,0,0
210198,a,0,0
210199,conventional,0,0
210200,daily,0,0
210201,fractionation,0,0
210202,schedule,0,0
210203,while,0,0
210204,the,0,0
210205,other,0,0
210206,used,0,0
210207,a,0,0
210208,high-dose,0,0
210209,weekly,0,0
210210,fractionation,0,0
210211,regimen,0,0
210212,.,0,0
210213,The,0,0
210214,techniques,0,0
210215,are,0,0
210216,described,0,0
210217,.,0,0
210218,The,0,0
210219,aim,0,0
210220,of,0,0
210221,the,0,0
210222,trial,0,0
210223,was,0,0
210224,to,0,0
210225,compare,0,0
210226,the,0,0
210227,efficacy,1,1
210228,and,1,1
210229,morbidity,1,1
210230,of,0,0
210231,these,0,0
210232,two,0,0
210233,methods,0,0
210234,of,0,0
210235,treatment,0,0
210236,.,0,1
210237,Dose,0,1
210238,distribution,0,1
210239,curves,0,1
210240,in,0,0
210241,cross-section,0,1
210242,and,0,1
210243,midsagittal,0,1
210244,planes,0,0
210245,are,0,0
210246,shown,0,0
210247,and,0,0
210248,calculations,0,0
210249,or,0,1
210250,equivalent,0,0
210251,doses,0,0
210252,at,0,0
210253,various,0,0
210254,selected,0,0
210255,points,0,0
210256,using,0,0
210257,Ellis,0,1
210258,'s,0,1
210259,nominal,0,1
210260,single-dose,0,0
210261,formula,0,0
210262,are,0,0
210263,tabulated,0,0
210264,.,0,0
210265,The,0,0
210266,2-year,0,0
210267,survival,1,1
210268,figures,0,1
210269,were,0,0
210270,33,0,0
210271,%,0,0
210272,for,0,0
210273,the,0,0
210274,daily,0,0
210275,fractionation,0,0
210276,technique,0,0
210277,and,0,0
210278,22,0,0
210279,%,0,0
210280,for,0,0
210281,the,0,0
210282,weekly,0,0
210283,regimen,0,0
210284,.,0,0
210285,Serious,1,0
210286,late,1,1
210287,complication,1,1
210288,rates,1,1
210289,were,0,0
210290,6,0,0
210291,%,0,0
210292,for,0,0
210293,the,0,0
210294,daily,0,0
210295,regimen,0,0
210296,and,0,0
210297,22,0,0
210298,%,0,0
210299,for,0,0
210300,the,0,0
210301,weekly,0,0
210302,schedule,0,0
210303,.,0,0
210304,These,0,0
210305,differences,0,0
210306,are,0,0
210307,not,0,0
210308,statistically,0,0
210309,significant,0,0
210310,.,0,0
210311,Late,1,1
210312,complication,1,1
210313,rates,1,1
210314,in,0,0
210315,the,0,0
210316,weekly,0,0
210317,fractionation,0,0
210318,regimen,0,0
210319,appeared,0,0
210320,to,0,0
210321,be,0,0
210322,lower,0,0
210323,than,0,0
210324,figures,0,1
210325,quoted,0,0
210326,by,0,0
210327,other,0,0
210328,authors,0,0
210329,.,0,0
210330,Local,0,1
210331,control,0,0
210332,within,0,0
210333,the,0,0
210334,irradiated,0,0
210335,volume,0,1
210336,was,0,0
210337,better,0,0
210338,in,0,0
210339,the,0,0
210340,group,0,0
210341,treated,0,0
210342,by,0,0
210343,the,0,0
210344,daily,0,0
210345,fractionation,0,0
210346,method,0,0
210347,.,0,0
210348,[,0,0
210349,Treatment,0,0
210350,of,0,0
210351,the,0,0
210352,hyperkinetic,0,0
210353,response,0,1
210354,to,0,0
210355,exercise,0,0
210356,after,0,0
210357,myocardial,0,1
210358,infarct,0,1
210359,.,0,0
210360,Results,0,0
210361,of,0,0
210362,a,0,0
210363,randomized,0,0
210364,ergometric,0,0
210365,study,0,0
210366,],0,0
210367,.,0,0
210368,[,0,0
210369,The,0,0
210370,analgetic,1,0
210371,effect,1,0
210372,of,0,1
210373,intramuscular,0,0
210374,pethidine,0,0
210375,compared,0,0
210376,with,0,0
210377,epidural,0,0
210378,morphine,0,0
210379,in,0,0
210380,upper,0,0
210381,abdominal,0,0
210382,laparotomies,0,0
210383,],0,0
210384,.,0,0
210385,Human,0,1
210386,platelet,0,1
210387,response,0,1
210388,to,0,0
210389,three,0,0
210390,salicylate,0,0
210391,dosage,0,0
210392,forms,0,0
210393,.,0,1
210394,Acetylsalicylic,0,0
210395,acid,0,1
210396,(,0,1
210397,ASA,0,1
210398,),0,1
210399,inhibition,0,1
210400,of,0,1
210401,platelet,0,1
210402,aggregation,0,1
210403,as,0,0
210404,evaluated,0,0
210405,by,0,0
210406,collagen-induced,0,1
210407,14C-serotonin,0,1
210408,release,0,1
210409,",",0,0
210410,has,0,0
210411,been,0,0
210412,measured,0,0
210413,in,0,0
210414,12,0,0
210415,healthy,0,0
210416,male,0,0
210417,subjects,0,0
210418,.,0,0
210419,Each,0,0
210420,subject,0,0
210421,received,0,0
210422,a,0,0
210423,single,0,0
210424,oral,0,0
210425,dose,0,0
210426,(,0,0
210427,650,0,0
210428,mg,0,0
210429,),0,0
210430,of,0,0
210431,enteric-coated,0,0
210432,ASA,0,1
210433,(,0,1
210434,ecASA,0,0
210435,),0,1
210436,and,0,1
210437,compressed,0,0
210438,ASA,0,1
210439,tablets,0,0
210440,(,0,1
210441,cASA,0,1
210442,),0,1
210443,",",0,1
210444,or,0,1
210445,ecASA,0,1
210446,and,0,1
210447,sodium,0,1
210448,salicylate,0,1
210449,(,0,0
210450,578,0,0
210451,mg,0,0
210452,),0,0
210453,separated,0,0
210454,by,0,0
210455,a,0,0
210456,minimum,0,1
210457,of,0,0
210458,5,0,0
210459,weeks,0,0
210460,.,0,0
210461,The,0,0
210462,platelet,0,1
210463,response,0,1
210464,was,0,0
210465,related,0,0
210466,to,0,0
210467,plasma,0,1
210468,ASA,0,1
210469,and,0,1
210470,salicyclic,0,1
210471,acid,0,1
210472,determined,0,0
210473,by,0,0
210474,high-pressure,0,1
210475,liquid,0,0
210476,chromatography,0,0
210477,.,0,0
210478,Both,0,0
210479,ecASA,0,0
210480,and,0,0
210481,cASA,0,1
210482,inhibited,0,0
210483,14C-serotonin,0,0
210484,release,0,1
210485,;,0,0
210486,no,0,0
210487,significant,0,0
210488,difference,1,0
210489,was,0,0
210490,observed,0,0
210491,in,0,0
210492,the,0,0
210493,maximum,1,1
210494,effect,1,0
210495,between,0,0
210496,these,0,0
210497,two,0,0
210498,products,0,0
210499,(,0,0
210500,p,0,0
210501,less,0,0
210502,than,0,0
210503,0.05,0,0
210504,),0,0
210505,.,0,0
210506,No,0,0
210507,relationship,0,1
210508,was,0,0
210509,found,0,0
210510,between,0,0
210511,the,0,0
210512,maximum,0,1
210513,observed,0,0
210514,plasma,1,1
210515,ASA,1,1
210516,level,1,1
210517,and,1,0
210518,the,1,0
210519,maximum,1,1
210520,effect,1,0
210521,.,1,1
210522,Further,0,0
210523,",",0,0
210524,no,0,0
210525,correlation,0,0
210526,was,0,0
210527,found,0,0
210528,between,0,0
210529,the,0,0
210530,maximum,0,1
210531,inhibition,0,1
210532,of,0,1
210533,14C-serotonin,0,1
210534,release,0,1
210535,in,0,0
210536,vivo,0,0
210537,and,0,0
210538,the,0,0
210539,release,0,1
210540,predicted,0,1
210541,from,0,0
210542,in,0,0
210543,vitro,0,0
210544,experiments,0,0
210545,wherein,0,0
210546,the,0,0
210547,effect,0,1
210548,was,0,0
210549,measured,0,0
210550,after,0,0
210551,incubating,0,0
210552,plasma,0,1
210553,containing,0,0
210554,specified,0,0
210555,ASA,0,0
210556,concentrations,0,1
210557,.,0,0
210558,Breathlessness,0,1
210559,and,0,1
210560,psychiatric,0,1
210561,morbidity,0,1
210562,in,0,0
210563,chronic,0,0
210564,bronchitis,0,1
210565,and,0,1
210566,emphysema,0,1
210567,:,0,0
210568,a,0,0
210569,study,0,0
210570,of,0,0
210571,psychotherapeutic,0,0
210572,management,0,0
210573,.,0,0
210574,This,0,0
210575,paper,0,0
210576,describes,0,0
210577,a,0,0
210578,study,0,0
210579,of,0,0
210580,the,0,0
210581,outcome,0,1
210582,of,0,0
210583,psychotherapy,0,0
210584,with,0,0
210585,patients,0,0
210586,disabled,0,0
210587,by,0,0
210588,chronic,0,0
210589,obstructive,0,0
210590,airways,0,1
210591,disease,0,1
210592,giving,0,1
210593,rise,0,0
210594,to,0,0
210595,dyspnoea,0,1
210596,.,0,0
210597,Forty-three,0,0
210598,men,0,0
210599,and,0,0
210600,22,0,0
210601,women,0,0
210602,with,0,0
210603,severe,0,1
210604,COAD,0,0
210605,were,0,0
210606,randomly,0,0
210607,allocated,0,0
210608,for,0,0
210609,8,0,0
210610,weeks,0,0
210611,to,0,0
210612,one,0,0
210613,of,0,0
210614,three,0,0
210615,types,0,0
210616,of,0,0
210617,psychotherapy,0,0
210618,or,0,0
210619,to,0,0
210620,an,0,0
210621,untreated,0,0
210622,control,0,0
210623,group,0,0
210624,",",0,1
210625,and,0,1
210626,were,0,0
210627,followed,0,0
210628,up,0,0
210629,six,0,0
210630,months,0,0
210631,later,0,0
210632,.,0,0
210633,The,0,0
210634,group,0,0
210635,treated,0,0
210636,by,0,0
210637,a,0,0
210638,medical,0,0
210639,nurse,0,0
210640,without,0,0
210641,training,0,0
210642,in,0,0
210643,psychotherapy,0,0
210644,experienced,0,1
210645,sustained,0,1
210646,relief,0,1
210647,of,0,1
210648,dyspnoea,1,1
210649,but,0,0
210650,tended,0,0
210651,to,0,0
210652,undergo,0,0
210653,less,0,0
210654,psychodynamic,1,0
210655,change,1,1
210656,;,1,0
210657,psychiatric,1,1
210658,symptoms,1,1
210659,were,0,0
210660,reduced,0,0
210661,in,0,0
210662,those,0,0
210663,receiving,0,0
210664,supportive,0,0
210665,",",0,0
210666,but,0,0
210667,not,0,0
210668,analytical,0,1
210669,",",0,0
210670,psychotherapy,0,0
210671,.,0,0
210672,The,0,0
210673,psychosomatic,0,0
210674,mechanisms,0,0
210675,involved,0,0
210676,and,0,0
210677,the,0,0
210678,implications,0,0
210679,for,0,0
210680,medical,0,0
210681,and,0,1
210682,nursing,0,1
210683,practice,0,0
210684,and,0,1
210685,for,0,0
210686,liaison,0,0
210687,psychotherapy,0,0
210688,are,0,0
210689,discussed,0,0
210690,.,0,0
210691,Changes,0,1
210692,in,0,0
210693,heart,1,1
210694,rate,1,1
210695,and,1,1
210696,forearm,1,1
210697,blood,1,1
210698,flow,1,1
210699,following,0,0
210700,intravenous,0,0
210701,boluses,0,0
210702,of,0,0
210703,isoprenaline,0,0
210704,in,0,0
210705,the,0,0
210706,presence,0,0
210707,of,0,1
210708,practolol,0,0
210709,and,0,1
210710,propranolol,0,0
210711,.,0,0
210712,1,0,0
210713,Increases,0,0
210714,in,0,0
210715,heart,1,1
210716,rate,1,1
210717,and,1,1
210718,forearm,1,1
210719,blood,1,1
210720,flow,1,1
210721,following,0,0
210722,graded,0,1
210723,intravenous,0,0
210724,bolus,0,0
210725,injections,0,0
210726,of,0,1
210727,isoprenaline,0,0
210728,sulphate,0,1
210729,",",0,1
210730,were,0,0
210731,measured,0,0
210732,in,0,0
210733,a,0,0
210734,double-blind,0,0
210735,randomised,0,0
210736,study,0,0
210737,of,0,0
210738,six,0,0
210739,subjects,0,0
210740,who,0,0
210741,received,0,0
210742,either,0,0
210743,placebo,0,0
210744,",",0,0
210745,practolol,0,0
210746,50,0,0
210747,mg,0,0
210748,",",0,0
210749,practolol,0,0
210750,200,0,0
210751,mg,0,0
210752,",",0,0
210753,propranolol,0,0
210754,10,0,0
210755,mg,0,0
210756,or,0,0
210757,propranolol,0,0
210758,40,0,0
210759,mg.,0,0
210760,2,0,0
210761,Dose,0,0
210762,related,0,0
210763,increases,0,1
210764,in,0,0
210765,forearm,1,1
210766,blood,1,1
210767,flow,1,1
210768,were,0,0
210769,produced,0,0
210770,by,0,0
210771,the,0,0
210772,graded,0,1
210773,boluses,0,0
210774,of,0,1
210775,isoprenaline,0,0
210776,sulphate,0,0
210777,.,0,0
210778,3,0,0
210779,Practolol,0,0
210780,50,0,0
210781,mg,0,0
210782,attenuated,0,0
210783,the,0,0
210784,heart,1,1
210785,rate,1,1
210786,response,1,1
210787,to,0,0
210788,isoprenaline,0,0
210789,but,0,0
210790,did,0,0
210791,not,0,0
210792,significantly,0,0
210793,affect,0,0
210794,the,0,0
210795,changes,0,1
210796,in,0,0
210797,forearm,1,1
210798,blood,1,1
210799,flow,1,1
210800,.,1,0
210801,Practolol,0,0
210802,200,0,0
210803,mg,0,0
210804,further,0,0
210805,attenuated,0,0
210806,the,0,0
210807,heart,1,1
210808,rate,1,1
210809,responses,1,1
210810,but,0,0
210811,also,0,0
210812,decreased,0,0
210813,the,0,0
210814,forearm,1,1
210815,blood,1,1
210816,flow,1,1
210817,responses,1,1
210818,.,1,0
210819,4,0,0
210820,Propranolol,0,0
210821,10,0,0
210822,mg,0,0
210823,and,0,0
210824,propranolol,0,0
210825,40,0,0
210826,mg,0,0
210827,significantly,0,0
210828,attenuated,0,0
210829,both,0,0
210830,the,0,0
210831,heart,1,1
210832,rate,1,1
210833,and,1,1
210834,forearm,1,1
210835,blood,1,1
210836,flow,1,1
210837,responses,1,1
210838,.,1,0
210839,The,0,0
210840,effect,0,0
210841,on,0,0
210842,forearm,1,1
210843,blood,1,1
210844,flow,1,1
210845,tended,0,0
210846,to,0,0
210847,be,0,0
210848,greater,0,0
210849,than,0,0
210850,the,0,0
210851,effect,0,0
210852,on,0,0
210853,heart,1,1
210854,rate,1,1
210855,.,1,0
210856,5,0,0
210857,Practolol,0,0
210858,200,0,0
210859,mg,0,0
210860,had,0,0
210861,the,0,0
210862,same,0,0
210863,effect,0,1
210864,on,0,0
210865,heart,1,1
210866,rate,1,1
210867,responses,1,1
210868,as,0,0
210869,propranolol,0,0
210870,10,0,0
210871,mg,0,0
210872,but,0,0
210873,a,0,0
210874,significantly,0,0
210875,smaller,0,0
210876,effect,0,1
210877,on,0,0
210878,the,0,0
210879,forearm,1,1
210880,blood,1,1
210881,flow,1,1
210882,responses,1,1
210883,.,1,0
210884,6,0,0
210885,The,0,0
210886,measurement,0,0
210887,of,0,1
210888,forearm,1,1
210889,blood,1,1
210890,flow,1,1
210891,following,0,0
210892,intravenous,0,0
210893,bolus,0,0
210894,injections,0,0
210895,of,0,0
210896,isoprenaline,0,0
210897,provides,0,0
210898,useful,0,0
210899,information,0,0
210900,about,0,0
210901,the,0,0
210902,beta,0,1
210903,2-adrenoceptor,0,0
210904,antagonism,0,1
210905,of,0,1
210906,propranolol,0,0
210907,and,0,1
210908,practolol,0,0
210909,.,0,1
210910,However,0,0
210911,",",0,0
210912,application,0,0
210913,of,0,0
210914,the,0,0
210915,technique,0,0
210916,may,0,0
210917,be,0,0
210918,limited,0,0
210919,by,0,0
210920,the,0,0
210921,magnitude,0,1
210922,of,0,0
210923,the,0,0
210924,heart,1,1
210925,rate,1,1
210926,response,0,1
210927,and,0,0
210928,by,0,0
210929,the,0,0
210930,short-lived,0,1
210931,nature,0,0
210932,of,0,0
210933,the,0,0
210934,increase,0,0
210935,in,0,0
210936,forearm,1,1
210937,blood,1,1
210938,flow,1,1
210939,.,1,0
210940,Tolfenamic,0,0
210941,acid,0,1
210942,and,0,1
210943,caffeine,0,0
210944,:,0,0
210945,a,0,0
210946,useful,0,0
210947,combination,0,0
210948,in,0,0
210949,migraine,1,1
210950,.,1,1
210951,Tolfenamic,0,0
210952,acid,0,0
210953,is,0,0
210954,a,0,0
210955,potent,0,0
210956,inhibitor,0,0
210957,of,0,1
210958,prostaglandin,0,1
210959,biosynthesis,0,1
210960,",",0,0
210961,which,0,0
210962,has,0,0
210963,been,0,0
210964,proved,0,0
210965,effective,0,0
210966,in,0,0
210967,the,0,0
210968,treatment,0,0
210969,of,0,0
210970,acute,1,0
210971,migraine,1,1
210972,attacks,1,1
210973,.,1,0
210974,The,0,0
210975,usefulness,0,0
210976,of,0,1
210977,caffeine,0,0
210978,",",0,1
210979,metoclopramide,0,0
210980,and,0,1
210981,pyridoxine,0,0
210982,as,0,0
210983,adjuncts,0,0
210984,to,0,0
210985,tolfenamic,0,0
210986,acid,0,0
210987,was,0,0
210988,tested,0,0
210989,in,0,0
210990,acute,1,0
210991,migraine,1,1
210992,attacks,1,1
210993,in,0,0
210994,ten,0,0
210995,patients,0,0
210996,.,0,0
210997,A,0,0
210998,combination,0,0
210999,of,0,0
211000,tolfenamic,0,0
211001,acid,0,0
211002,(,0,0
211003,200,0,0
211004,mg,0,0
211005,),0,0
211006,with,0,0
211007,either,0,0
211008,caffeine,0,0
211009,(,0,0
211010,100,0,0
211011,mg,0,0
211012,),0,0
211013,",",0,0
211014,metoclopramide,0,0
211015,(,0,0
211016,10,0,0
211017,mg,0,0
211018,),0,0
211019,or,0,1
211020,pyridoxine,0,0
211021,(,0,0
211022,300,0,0
211023,mg,0,0
211024,),0,0
211025,was,0,0
211026,given,0,0
211027,twice,0,0
211028,to,0,0
211029,each,0,0
211030,patient,0,0
211031,in,0,0
211032,random,0,0
211033,order,0,0
211034,.,0,0
211035,Thus,0,0
211036,60,0,0
211037,attacks,0,1
211038,were,0,0
211039,treated,0,0
211040,.,0,0
211041,The,0,0
211042,tolfenamic,0,0
211043,acid-caffeine,0,0
211044,combination,0,0
211045,proved,0,0
211046,the,0,0
211047,most,0,0
211048,effective,0,1
211049,as,0,0
211050,judged,0,0
211051,by,0,0
211052,duration,1,1
211053,and,1,1
211054,intensity,1,1
211055,of,1,1
211056,attacks,1,1
211057,",",1,0
211058,working,1,1
211059,ability,1,1
211060,",",1,1
211061,vigilance,1,1
211062,",",1,1
211063,and,1,1
211064,overall,1,1
211065,evaluation,1,0
211066,of,1,0
211067,the,1,0
211068,drugs,1,0
211069,by,0,0
211070,the,0,0
211071,patients,0,0
211072,.,0,0
211073,Metoclopramide,0,0
211074,was,0,0
211075,somewhat,0,0
211076,better,0,0
211077,than,0,0
211078,pyridoxine,0,0
211079,as,0,0
211080,an,0,0
211081,additive,0,0
211082,.,0,0
211083,Report,0,0
211084,on,0,0
211085,the,0,0
211086,second,0,0
211087,myelomatosis,0,1
211088,trial,0,0
211089,after,0,0
211090,five,0,0
211091,years,0,0
211092,of,0,0
211093,follow-up,0,0
211094,.,0,0
211095,Medical,0,0
211096,Research,0,0
211097,Council,0,1
211098,'s,0,1
211099,Working,0,0
211100,Party,0,1
211101,on,0,0
211102,Leukaemia,0,1
211103,in,0,0
211104,Adults,0,0
211105,.,0,0
211106,Three,0,0
211107,hundred,0,0
211108,and,0,0
211109,seventy-two,0,0
211110,patients,0,0
211111,were,0,0
211112,randomized,0,0
211113,between,0,0
211114,3,0,0
211115,regimens,0,0
211116,of,0,0
211117,chemotherapy,0,0
211118,:,0,0
211119,cyclophosphamide,0,0
211120,",",0,1
211121,intermittent,0,1
211122,melphalan,0,0
211123,",",0,1
211124,and,0,1
211125,melphalan,0,0
211126,with,0,0
211127,prednisone,0,0
211128,",",0,1
211129,and,0,1
211130,were,0,0
211131,followed,0,0
211132,up,0,0
211133,to,0,0
211134,death,0,1
211135,or,0,0
211136,for,0,0
211137,at,0,0
211138,least,0,0
211139,5,0,0
211140,years,0,0
211141,.,0,0
211142,There,0,0
211143,was,0,0
211144,no,0,0
211145,difference,0,0
211146,in,0,0
211147,survival,1,1
211148,between,0,0
211149,the,0,0
211150,treatments,0,0
211151,",",0,0
211152,either,0,0
211153,overall,0,1
211154,or,0,0
211155,in,0,0
211156,any,0,1
211157,subgroup,0,0
211158,of,0,0
211159,patients,0,0
211160,.,0,0
211161,Therefore,0,0
211162,",",0,0
211163,the,0,0
211164,choice,0,0
211165,among,0,0
211166,these,0,0
211167,3,0,0
211168,treatments,0,0
211169,should,0,0
211170,be,0,0
211171,guided,0,0
211172,by,0,0
211173,the,0,0
211174,patient,0,1
211175,'s,0,1
211176,comfort,0,1
211177,and,0,1
211178,convenience,0,0
211179,.,0,0
211180,The,0,0
211181,most,0,0
211182,important,0,0
211183,prognostic,0,1
211184,feature,0,0
211185,at,0,0
211186,presentation,0,1
211187,was,0,0
211188,the,0,0
211189,quality,0,1
211190,of,0,0
211191,renal,1,1
211192,function,1,1
211193,.,1,0
211194,It,0,0
211195,was,0,0
211196,possible,0,0
211197,to,0,0
211198,define,0,0
211199,good,0,0
211200,",",0,0
211201,intermediate,0,1
211202,and,0,1
211203,poor,0,1
211204,renal-function,0,0
211205,groups,0,0
211206,which,0,0
211207,were,0,0
211208,highly,0,0
211209,correlated,0,0
211210,with,0,0
211211,prognosis,0,1
211212,(,0,0
211213,X2,0,1
211214,for,0,0
211215,trend,0,0
211216,=,0,0
211217,62.6,0,0
211218,),0,0
211219,.,0,0
211220,The,0,0
211221,haemoglobin,1,1
211222,level,1,1
211223,at,0,0
211224,presentation,0,1
211225,was,0,0
211226,strongly,0,0
211227,correlated,0,0
211228,with,0,0
211229,prognosis,0,1
211230,among,0,0
211231,patients,0,0
211232,in,0,0
211233,the,0,0
211234,good,0,0
211235,renal-function,0,0
211236,group,0,0
211237,.,0,0
211238,Among,0,0
211239,107,0,0
211240,patients,0,0
211241,who,0,0
211242,presented,0,0
211243,with,0,0
211244,good,0,0
211245,renal,0,1
211246,function,0,1
211247,and,0,1
211248,with,0,0
211249,haemoglobin,0,1
211250,above,0,0
211251,100,0,0
211252,g/l,0,0
211253,",",0,0
211254,the,0,0
211255,5-year,0,1
211256,survival,1,1
211257,was,0,0
211258,43,0,0
211259,%,0,0
211260,.,0,0
211261,Other,0,1
211262,prognostic,0,1
211263,features,0,0
211264,were,0,0
211265,much,0,0
211266,less,0,0
211267,important,0,1
211268,when,0,0
211269,account,0,0
211270,was,0,0
211271,taken,0,0
211272,of,0,0
211273,renal,0,1
211274,function,0,1
211275,and,0,1
211276,haemoglobin,0,1
211277,level,0,1
211278,.,0,0
211279,[,0,1
211280,Biological,0,1
211281,and,0,1
211282,clinical,0,1
211283,effects,0,1
211284,of,0,1
211285,oral,0,0
211286,magnesium,0,0
211287,and,0,1
211288,associated,0,0
211289,magnesium-vitamin,0,0
211290,B6,0,0
211291,administration,0,0
211292,on,0,0
211293,certain,0,0
211294,disorders,0,0
211295,observed,0,0
211296,in,0,0
211297,infantile,0,0
211298,autism,0,0
211299,(,0,0
211300,author,0,1
211301,'s,0,1
211302,transl,0,0
211303,),0,0
211304,],0,0
211305,.,0,0
211306,[,0,0
211307,Prevention,0,0
211308,of,0,1
211309,stress,0,1
211310,ulcers,0,1
211311,with,0,0
211312,synthetic,0,1
211313,depot,0,0
211314,secretin,0,1
211315,],0,0
211316,.,0,0
211317,The,0,0
211318,pathogenesis,0,0
211319,of,0,0
211320,stress,0,1
211321,ulcers,0,1
211322,is,0,0
211323,still,0,0
211324,far,0,0
211325,from,0,0
211326,being,0,0
211327,understood,0,0
211328,.,0,0
211329,It,0,0
211330,is,0,0
211331,reported,0,0
211332,about,0,0
211333,a,0,0
211334,synthetic,0,1
211335,secretin,0,1
211336,(,0,0
211337,Hoe,0,0
211338,069,0,0
211339,+,0,0
211340,depot,0,0
211341,component,0,1
211342,),0,0
211343,given,0,0
211344,prophylactically,0,0
211345,to,0,0
211346,100,0,0
211347,patients,0,0
211348,postoperatively,0,0
211349,.,0,0
211350,It,0,0
211351,eliminated,1,0
211352,or,1,0
211353,ameliorated,1,1
211354,stress,1,1
211355,ulcers,1,1
211356,.,1,0
211357,The,0,0
211358,result,0,0
211359,",",0,0
211360,confirmed,0,0
211361,by,0,0
211362,gastroscopy,0,0
211363,",",0,0
211364,demonstrates,0,0
211365,the,0,0
211366,treatment,0,0
211367,with,0,0
211368,secretin,0,1
211369,plus,0,0
211370,depot,0,0
211371,component,0,1
211372,as,0,0
211373,a,0,0
211374,highly,0,0
211375,recommendable,0,0
211376,prophylaxis,0,0
211377,in,0,0
211378,the,0,0
211379,postsurgical,0,1
211380,intensive,0,0
211381,care,0,0
211382,treatment,0,0
211383,.,0,0
211384,A,0,0
211385,controlled,0,0
211386,trial,0,0
211387,with,0,0
211388,diclofensine,0,0
211389,",",0,0
211390,a,0,0
211391,new,0,1
211392,psychoactive,0,1
211393,drug,0,0
211394,",",0,0
211395,in,0,0
211396,the,0,0
211397,treatment,0,0
211398,of,0,0
211399,depression,0,1
211400,.,0,0
211401,Diclofensine,0,0
211402,inhibits,0,1
211403,the,0,0
211404,uptake,0,1
211405,of,0,1
211406,serotonin,0,1
211407,",",0,1
211408,noradrenaline,0,1
211409,and,0,1
211410,dopamine,0,1
211411,.,0,0
211412,In,0,0
211413,a,0,0
211414,controlled,0,0
211415,study,0,0
211416,",",0,0
211417,out-patients,0,0
211418,suffering,0,1
211419,from,0,0
211420,moderate,0,0
211421,to,0,0
211422,severe,0,1
211423,depression,0,1
211424,were,0,0
211425,treated,0,0
211426,with,0,0
211427,the,0,0
211428,objective,0,0
211429,of,0,0
211430,assessing,0,0
211431,the,0,0
211432,new,0,0
211433,drug,0,1
211434,'s,0,0
211435,therapeutically,0,0
211436,effective,0,1
211437,dose,0,0
211438,range,0,0
211439,.,0,1
211440,Maprotiline,0,0
211441,was,0,0
211442,used,0,0
211443,as,0,0
211444,a,0,0
211445,reference,0,0
211446,drug,0,0
211447,:,0,0
211448,fourteen,0,0
211449,patients,0,0
211450,were,0,0
211451,assigned,0,0
211452,to,0,0
211453,receive,0,0
211454,diclofensine,0,0
211455,and,0,1
211456,thirteen,0,0
211457,to,0,0
211458,receive,0,0
211459,maprotiline,0,0
211460,in,0,0
211461,a,0,0
211462,double-blind,0,0
211463,design,0,0
211464,.,0,0
211465,Depending,0,0
211466,on,0,0
211467,tolerance,0,1
211468,and,0,1
211469,efficacy,0,1
211470,",",0,0
211471,they,0,0
211472,were,0,0
211473,treated,0,0
211474,for,0,0
211475,periods,0,0
211476,ranging,0,0
211477,from,0,0
211478,5,0,0
211479,to,0,0
211480,150,0,0
211481,days,0,0
211482,.,0,0
211483,Doses,0,1
211484,were,0,0
211485,titrated,0,0
211486,to,0,0
211487,the,0,0
211488,optimum,0,1
211489,.,0,0
211490,Findings,0,0
211491,suggest,0,0
211492,that,0,0
211493,a,0,0
211494,50,0,0
211495,mg,0,0
211496,daily,0,0
211497,dose,0,0
211498,of,0,0
211499,diclofensine,0,0
211500,would,0,0
211501,be,0,0
211502,sufficient,0,0
211503,for,0,0
211504,the,0,0
211505,majority,0,0
211506,of,0,0
211507,the,0,0
211508,patients,0,0
211509,.,0,0
211510,The,0,0
211511,dosage,0,0
211512,can,0,0
211513,be,0,0
211514,safely,0,0
211515,increased,0,0
211516,up,0,0
211517,to,0,0
211518,150,0,0
211519,mg,0,0
211520,daily,0,0
211521,but,0,0
211522,this,0,0
211523,offers,0,0
211524,few,0,0
211525,therapeutic,0,0
211526,advantages,0,0
211527,.,0,0
211528,While,0,0
211529,the,0,0
211530,efficacy,1,1
211531,index,1,1
211532,of,0,0
211533,the,0,0
211534,two,0,0
211535,drugs,0,0
211536,was,0,0
211537,similar,0,0
211538,(,0,0
211539,approximately,0,0
211540,60,0,0
211541,%,0,0
211542,),0,0
211543,",",0,0
211544,they,0,0
211545,differed,0,0
211546,greatly,0,0
211547,in,0,0
211548,their,0,0
211549,profile,1,1
211550,of,1,0
211551,side-effects,1,1
211552,.,1,0
211553,No,1,0
211554,signs,1,1
211555,of,1,0
211556,abrupt,1,1
211557,dissipation,1,1
211558,of,1,0
211559,the,1,0
211560,achieved,1,1
211561,clinical,1,0
211562,effects,1,1
211563,were,0,0
211564,observed,0,0
211565,during,0,0
211566,continued,0,0
211567,treatment,0,0
211568,",",0,0
211569,and,0,1
211570,no,1,0
211571,withdrawal,1,1
211572,reactions,1,1
211573,were,0,0
211574,observed,0,0
211575,when,0,0
211576,the,0,0
211577,treatment,0,0
211578,was,0,0
211579,stopped,0,0
211580,.,0,0
211581,The,0,0
211582,new,0,0
211583,drug,0,0
211584,may,0,0
211585,be,0,0
211586,more,0,0
211587,effective,1,1
211588,in,0,0
211589,treating,0,0
211590,patients,0,0
211591,in,0,0
211592,whom,0,0
211593,a,0,0
211594,psycho-energizing,0,1
211595,and,0,1
211596,mood,0,1
211597,alleviating,0,0
211598,effect,0,0
211599,is,0,0
211600,desired,0,0
211601,.,0,0
211602,Treatment,1,0
211603,of,1,1
211604,human,1,0
211605,tungiasis,1,1
211606,with,0,0
211607,niridazole,0,0
211608,(,0,0
211609,Ambilhar,0,0
211610,),0,0
211611,a,0,0
211612,double-blind,0,0
211613,placebo-controlled,0,0
211614,trial,0,0
211615,.,0,0
211616,Non-Hodgkin,0,1
211617,'s,0,1
211618,malignant,0,0
211619,lymphomas,0,1
211620,:,0,0
211621,treatment,0,0
211622,of,0,0
211623,localized,0,0
211624,relapses,0,1
211625,with,0,0
211626,chemo,0,0
211627,+,0,0
211628,radio,0,1
211629,+,0,0
211630,BCG-therapy,0,0
211631,.,0,0
211632,16,0,0
211633,patients,0,0
211634,with,0,0
211635,relapsing,0,0
211636,non-Hodgkin,0,0
211637,'s,0,1
211638,malignant,0,1
211639,lymphomas,0,1
211640,considered,0,0
211641,as,0,0
211642,clinical,0,0
211643,stage,0,0
211644,I,0,0
211645,or,0,0
211646,II,0,0
211647,were,0,0
211648,treated,0,0
211649,by,0,0
211650,an,0,0
211651,association,0,0
211652,of,0,0
211653,chemo,0,0
211654,+,0,0
211655,radiotherapy,0,0
211656,and,0,1
211657,thereafter,0,0
211658,by,0,0
211659,maintenance,0,0
211660,BCG,0,0
211661,therapy,0,0
211662,.,0,0
211663,5,0,0
211664,of,0,0
211665,them,0,0
211666,were,0,0
211667,included,0,0
211668,in,0,0
211669,a,0,0
211670,randomized,0,0
211671,trial,0,0
211672,and,0,0
211673,have,0,0
211674,a,0,0
211675,significantly,0,0
211676,different,0,0
211677,disease-free,1,1
211678,survival,1,1
211679,from,0,0
211680,patients,0,0
211681,receiving,0,0
211682,the,0,0
211683,same,0,0
211684,treatment,0,0
211685,but,0,0
211686,without,0,0
211687,BCG,0,0
211688,.,0,0
211689,11,0,0
211690,were,0,0
211691,systematically,0,0
211692,treated,0,0
211693,by,0,0
211694,BCG,0,0
211695,and,0,0
211696,they,0,0
211697,also,0,0
211698,have,0,0
211699,a,0,0
211700,fairly,0,0
211701,good,0,0
211702,disease-free,1,1
211703,survival,1,1
211704,.,1,0
211705,Such,0,0
211706,a,0,0
211707,treatment,0,0
211708,appears,0,0
211709,to,0,0
211710,be,0,0
211711,of,0,0
211712,value,0,1
211713,in,0,0
211714,treating,0,0
211715,these,0,0
211716,patients,0,0
211717,and,0,0
211718,even,0,0
211719,probably,0,0
211720,of,0,0
211721,curing,0,0
211722,some,0,0
211723,of,0,0
211724,them,0,0
211725,.,0,0
211726,Effects,0,0
211727,of,0,0
211728,vicarious,0,0
211729,reinforcement,0,1
211730,in,0,0
211731,normal,0,0
211732,and,0,0
211733,severely,0,0
211734,disturbed,0,0
211735,children,0,0
211736,.,0,0
211737,Perception,0,1
211738,of,0,1
211739,social,1,1
211740,interactions,1,0
211741,in,0,0
211742,depressed,0,1
211743,psychiatric,0,1
211744,patients,0,0
211745,.,0,0
211746,A,0,0
211747,comparison,0,0
211748,of,0,1
211749,dorsal,0,1
211750,and,0,1
211751,volar,0,1
211752,resting,0,1
211753,hand,0,1
211754,splints,0,0
211755,in,0,0
211756,the,0,0
211757,reduction,0,1
211758,of,0,0
211759,hypertonus,0,0
211760,.,0,0
211761,Ten,0,0
211762,adults,0,0
211763,with,0,0
211764,hypertonic,0,0
211765,wrist,0,0
211766,flexors,0,1
211767,volunteered,0,0
211768,as,0,0
211769,subjects,0,0
211770,in,0,0
211771,an,0,0
211772,experiment,0,0
211773,comparing,0,0
211774,the,0,0
211775,effectiveness,0,1
211776,of,0,1
211777,dorsal,0,1
211778,and,0,1
211779,volar,0,1
211780,resting,0,1
211781,hand,0,1
211782,splints,0,0
211783,in,0,0
211784,the,0,0
211785,reduction,0,1
211786,of,0,0
211787,abnormal,1,1
211788,muscle,1,1
211789,tone,1,1
211790,.,1,1
211791,Subjects,0,0
211792,were,0,0
211793,randomly,0,0
211794,assigned,0,0
211795,to,0,0
211796,two,0,0
211797,groups,0,0
211798,of,0,0
211799,five,0,0
211800,each,0,0
211801,.,0,0
211802,Individuals,0,0
211803,in,0,0
211804,one,0,0
211805,group,0,0
211806,were,0,0
211807,fitted,0,0
211808,with,0,0
211809,dorsal,0,0
211810,splints,0,1
211811,",",0,1
211812,and,0,1
211813,individuals,0,0
211814,in,0,0
211815,a,0,0
211816,second,0,0
211817,group,0,0
211818,with,0,0
211819,volar,0,0
211820,splints,0,0
211821,.,0,0
211822,Measurements,0,0
211823,by,0,0
211824,spring-weighted,0,1
211825,scales,0,1
211826,were,0,0
211827,taken,0,0
211828,to,0,0
211829,assess,0,0
211830,the,0,0
211831,efficiency,0,1
211832,of,0,0
211833,each,0,0
211834,splint,0,0
211835,design,0,0
211836,in,0,0
211837,the,0,0
211838,reduction,0,1
211839,of,0,0
211840,hypertonus,1,1
211841,.,1,1
211842,Results,0,0
211843,demonstrated,0,0
211844,no,1,0
211845,significant,1,0
211846,differences,1,0
211847,between,0,0
211848,the,0,0
211849,volar,0,1
211850,and,0,1
211851,dorsal,0,1
211852,splints,0,0
211853,in,0,0
211854,reducing,0,0
211855,hypertonus,1,1
211856,.,1,0
211857,However,0,0
211858,",",0,0
211859,the,0,0
211860,age,0,0
211861,of,0,0
211862,the,0,0
211863,subjects,0,0
211864,was,0,0
211865,found,0,0
211866,to,0,0
211867,be,0,0
211868,an,0,0
211869,intervening,0,0
211870,variable,0,0
211871,:,0,0
211872,The,0,0
211873,older,0,0
211874,subjects,0,0
211875,of,0,0
211876,both,0,0
211877,groups,0,0
211878,demonstrated,0,0
211879,a,0,0
211880,gradual,0,1
211881,but,0,0
211882,not,0,0
211883,significant,0,0
211884,decline,0,1
211885,in,0,0
211886,hypertonus,0,1
211887,",",0,0
211888,whereas,0,0
211889,the,0,0
211890,younger,0,0
211891,adults,0,0
211892,demonstrated,0,0
211893,a,0,0
211894,significant,0,0
211895,decline,0,1
211896,in,0,0
211897,hypertonus,0,0
211898,over,0,0
211899,a,0,0
211900,6-week,0,0
211901,period,0,0
211902,.,0,0
211903,Menstrual,1,1
211904,cycle,1,1
211905,symptoms,1,1
211906,in,0,0
211907,infertile,0,0
211908,and,0,1
211909,control,0,0
211910,subjects,0,0
211911,:,0,0
211912,a,0,0
211913,re-evaluation,0,0
211914,of,0,0
211915,the,0,0
211916,evidence,0,0
211917,for,0,0
211918,psychological,1,1
211919,changes,1,1
211920,.,1,0
211921,[,1,0
211922,Changes,1,1
211923,in,0,0
211924,renal,1,1
211925,arterial,1,1
211926,flow,1,1
211927,during,0,0
211928,the,0,0
211929,treatment,0,0
211930,of,0,0
211931,essential,0,0
211932,arterial,0,1
211933,hypertension,0,1
211934,;,0,0
211935,prazosin,0,0
211936,in,0,0
211937,comparison,0,0
211938,with,0,0
211939,propranolol,0,0
211940,],0,0
211941,.,0,0
211942,Is,0,0
211943,anti-Pseudomonas,0,1
211944,therapy,0,0
211945,warranted,0,0
211946,in,0,0
211947,acute,0,0
211948,respiratory,1,1
211949,exacerbations,1,1
211950,in,0,0
211951,children,0,0
211952,with,0,0
211953,cystic,0,0
211954,fibrosis,0,1
211955,?,0,0
211956,A,0,0
211957,controlled,0,0
211958,study,0,0
211959,was,0,0
211960,designed,0,0
211961,to,0,0
211962,clarify,0,0
211963,the,0,0
211964,indications,0,0
211965,for,0,0
211966,antibiotic,0,0
211967,therapy,0,0
211968,in,0,0
211969,children,0,0
211970,with,0,0
211971,advanced,0,0
211972,cystic,0,1
211973,fibrosis,0,1
211974,hospitalized,0,0
211975,with,0,0
211976,respiratory,0,1
211977,exacerbations,0,1
211978,.,0,0
211979,Twenty-two,0,0
211980,children,0,0
211981,with,0,0
211982,severe,0,1
211983,CF,0,1
211984,and,0,1
211985,signs,0,1
211986,of,0,1
211987,acute,0,0
211988,lower,0,1
211989,respiratory,0,1
211990,infection,0,1
211991,were,0,0
211992,randomly,0,0
211993,assigned,0,0
211994,to,0,0
211995,receive,0,0
211996,either,0,0
211997,cloxacillin,0,1
211998,or,0,1
211999,carbenicillin,0,0
212000,plus,0,0
212001,gentamicin,0,0
212002,administered,0,0
212003,intravenously,0,0
212004,for,0,0
212005,ten,0,0
212006,days,0,0
212007,.,0,0
212008,Other,0,0
212009,aspects,0,1
212010,of,0,1
212011,therapy,0,0
212012,were,0,0
212013,constant,0,0
212014,.,0,0
212015,The,0,0
212016,groups,0,0
212017,were,0,0
212018,comparable,0,0
212019,in,0,0
212020,all,0,0
212021,respects,0,0
212022,and,0,1
212023,Pseudomonas,0,1
212024,aeruginosa,0,0
212025,was,0,0
212026,the,0,0
212027,predominant,0,0
212028,sputum,0,1
212029,pathogen,0,0
212030,in,0,0
212031,most,0,0
212032,patients,0,0
212033,.,0,0
212034,Clinical,1,1
212035,improvement,1,1
212036,",",1,0
212037,chest,1,1
212038,radiograph,1,1
212039,changes,1,1
212040,",",1,1
212041,evidence,1,0
212042,of,1,1
212043,airway,1,1
212044,obstruction,1,1
212045,",",1,1
212046,and,1,1
212047,bacteriologic,1,1
212048,flora,1,1
212049,of,1,1
212050,sputum,1,0
212051,were,0,0
212052,no,0,0
212053,different,0,0
212054,regardless,0,0
212055,of,0,0
212056,the,0,0
212057,regimen,0,0
212058,used,0,0
212059,.,0,0
212060,These,0,0
212061,results,0,0
212062,suggest,0,0
212063,that,0,0
212064,the,0,0
212065,use,0,0
212066,of,0,0
212067,anti-Pseudomonas,0,1
212068,medication,0,0
212069,in,0,0
212070,these,0,0
212071,children,0,0
212072,may,0,0
212073,not,0,0
212074,always,0,0
212075,be,0,0
212076,necessary,0,0
212077,.,0,0
212078,These,0,0
212079,observations,0,0
212080,need,0,0
212081,to,0,0
212082,be,0,0
212083,confirmed,0,0
212084,by,0,0
212085,blind-controlled,0,0
212086,studies,0,0
212087,in,0,0
212088,larger,0,0
212089,numbers,0,1
212090,of,0,1
212091,patients,0,0
212092,with,0,0
212093,mild,0,0
212094,as,0,0
212095,well,0,0
212096,as,0,0
212097,severe,0,1
212098,respiratory,0,1
212099,involvement,0,1
212100,.,0,0
212101,[,0,0
212102,Obstetrical,0,1
212103,analgesia,0,1
212104,with,0,0
212105,tramadol,0,0
212106,],0,0
212107,.,0,1
212108,Parenteral,0,0
212109,analgesia,0,1
212110,with,0,0
212111,Tramal,0,1
212112,was,0,0
212113,performed,0,0
212114,in,0,0
212115,23,0,0
212116,normal,0,0
212117,deliveries,0,0
212118,.,0,0
212119,The,0,0
212120,results,0,0
212121,were,0,0
212122,compared,0,0
212123,with,0,0
212124,a,0,0
212125,group,0,0
212126,of,0,0
212127,normal,0,0
212128,deliveries,0,1
212129,in,0,0
212130,which,0,0
212131,analgesia,1,1
212132,was,0,0
212133,achieved,0,1
212134,with,0,0
212135,pethidine,0,0
212136,.,0,0
212137,Both,0,0
212138,medicaments,0,0
212139,excerted,0,0
212140,an,0,0
212141,identical,1,0
212142,analgetic,1,0
212143,efficiency,1,1
212144,.,1,0
212145,No,0,0
212146,adverse,1,1
212147,side,1,1
212148,effects,1,1
212149,were,0,0
212150,observed,0,0
212151,with,0,0
212152,Tramal,0,0
212153,concerning,0,0
212154,the,0,0
212155,follow-up,0,0
212156,of,0,1
212157,labour,0,1
212158,or,0,0
212159,the,0,0
212160,newborn,0,0
212161,.,0,0
212162,Tramal,0,0
212163,can,0,0
212164,be,0,0
212165,recommended,0,0
212166,for,0,0
212167,obstetrical,1,1
212168,analgesia,1,1
212169,since,0,0
212170,it,0,0
212171,does,0,0
212172,not,0,0
212173,excert,0,0
212174,inhibitory,1,1
212175,effects,1,0
212176,upon,0,0
212177,the,0,0
212178,respiratory,0,1
212179,center,0,0
212180,.,0,0
212181,Corticosteroids,0,0
212182,plus,0,0
212183,pulse,0,1
212184,cyclophosphamide,0,0
212185,and,0,1
212186,plasma,0,1
212187,exchanges,0,1
212188,versus,0,0
212189,corticosteroids,0,0
212190,plus,0,0
212191,pulse,0,1
212192,cyclophosphamide,0,0
212193,alone,0,0
212194,in,0,0
212195,the,0,0
212196,treatment,0,0
212197,of,0,1
212198,polyarteritis,0,1
212199,nodosa,0,0
212200,and,0,1
212201,Churg-Strauss,0,1
212202,syndrome,0,1
212203,patients,0,0
212204,with,0,0
212205,factors,0,0
212206,predicting,0,1
212207,poor,0,0
212208,prognosis,0,1
212209,.,0,0
212210,A,0,0
212211,prospective,0,0
212212,",",0,0
212213,randomized,0,0
212214,trial,0,0
212215,in,0,0
212216,sixty-two,0,0
212217,patients,0,0
212218,.,0,0
212219,OBJECTIVE,0,0
212220,To,0,0
212221,define,0,0
212222,the,0,0
212223,most,0,0
212224,effective,0,1
212225,treatment,0,0
212226,for,0,0
212227,severe,0,1
212228,polyarteritis,0,1
212229,nodosa,0,0
212230,(,0,1
212231,PAN,0,1
212232,),0,1
212233,and,0,1
212234,Churg-Strauss,0,1
212235,syndrome,0,1
212236,(,0,1
212237,CSS,0,0
212238,),0,0
212239,and,0,0
212240,to,0,0
212241,investigate,0,0
212242,the,0,0
212243,indication,0,0
212244,for,0,0
212245,plasma,0,1
212246,exchange,0,1
212247,treatment,0,0
212248,.,0,0
212249,METHODS,0,0
212250,We,0,0
212251,conducted,0,0
212252,a,0,0
212253,prospective,0,0
212254,",",0,0
212255,randomized,0,0
212256,",",0,0
212257,multicenter,0,0
212258,trial,0,0
212259,in,0,0
212260,which,0,0
212261,62,0,0
212262,patients,0,0
212263,were,0,0
212264,randomly,0,0
212265,assigned,0,0
212266,to,0,0
212267,receive,0,0
212268,either,0,0
212269,prednisone,0,0
212270,plus,0,0
212271,cyclophosphamide,0,0
212272,(,0,1
212273,intravenous,0,0
212274,bolus,0,0
212275,),0,1
212276,(,0,0
212277,group,0,0
212278,A,0,0
212279,;,0,0
212280,n,0,0
212281,=,0,0
212282,28,0,0
212283,),0,0
212284,or,0,0
212285,prednisone,0,0
212286,plus,0,0
212287,cyclophosphamide,0,0
212288,(,0,1
212289,intravenous,0,0
212290,bolus,0,0
212291,),0,1
212292,plus,0,0
212293,plasma,0,1
212294,exchanges,0,1
212295,(,0,0
212296,group,0,0
212297,B,0,0
212298,;,0,0
212299,n,0,0
212300,=,0,0
212301,34,0,0
212302,),0,0
212303,as,0,0
212304,first-line,0,0
212305,treatment,0,0
212306,for,0,0
212307,severe,0,1
212308,PAN,0,1
212309,or,0,0
212310,CSS,0,0
212311,.,0,1
212312,Factors,0,0
212313,predicting,0,1
212314,poor,0,1
212315,prognosis,0,1
212316,were,0,0
212317,renal,0,1
212318,symptoms,0,1
212319,",",0,1
212320,gastrointestinal,0,1
212321,tract,0,1
212322,involvement,0,1
212323,",",0,1
212324,cardiomyopathy,0,1
212325,",",0,1
212326,central,0,1
212327,nervous,0,1
212328,system,0,0
212329,involvement,0,1
212330,",",0,1
212331,weight,0,1
212332,loss,0,1
212333,>,0,0
212334,10,0,0
212335,%,0,0
212336,of,0,0
212337,body,0,1
212338,weight,0,1
212339,",",0,1
212340,and,0,1
212341,age,0,0
212342,>,0,0
212343,50,0,0
212344,years,0,0
212345,old,0,0
212346,.,0,0
212347,Patients,0,0
212348,with,0,0
212349,hepatitis,0,0
212350,B,0,0
212351,virus-related,0,1
212352,PAN,0,1
212353,were,0,0
212354,not,0,0
212355,included,0,0
212356,in,0,0
212357,this,0,0
212358,study,0,0
212359,.,0,0
212360,The,0,0
212361,end,0,0
212362,point,0,0
212363,of,0,0
212364,the,0,0
212365,study,0,0
212366,was,0,0
212367,control,0,0
212368,of,0,0
212369,the,0,0
212370,disease,0,1
212371,(,0,1
212372,recovery,0,1
212373,or,0,1
212374,remission,0,1
212375,),0,1
212376,or,0,0
212377,death,0,1
212378,.,0,1
212379,RESULTS,0,0
212380,Clinical,0,1
212381,symptoms,0,1
212382,and,0,1
212383,laboratory,0,1
212384,findings,0,0
212385,did,0,0
212386,not,0,0
212387,differ,0,0
212388,significantly,0,0
212389,in,0,0
212390,the,0,0
212391,2,0,0
212392,groups,0,0
212393,.,0,0
212394,Initial,0,1
212395,control,0,0
212396,of,0,0
212397,the,0,0
212398,disease,0,1
212399,was,0,0
212400,similar,0,0
212401,in,0,0
212402,both,0,0
212403,groups,0,0
212404,.,0,0
212405,Relapse,1,1
212406,after,0,0
212407,initial,0,0
212408,control,0,0
212409,of,0,0
212410,the,0,0
212411,disease,0,1
212412,was,0,0
212413,observed,0,0
212414,in,0,0
212415,7,0,0
212416,patients,0,0
212417,(,0,0
212418,4,0,0
212419,in,0,0
212420,group,0,0
212421,A,0,0
212422,and,0,0
212423,3,0,0
212424,in,0,0
212425,group,0,0
212426,B,0,0
212427,),0,0
212428,.,0,0
212429,The,0,0
212430,mean,1,1
212431,+/-,1,0
212432,SD,1,0
212433,followup,1,1
212434,period,0,0
212435,was,0,0
212436,31.1,0,0
212437,+/-,0,0
212438,20,0,0
212439,months,0,0
212440,for,0,0
212441,group,0,0
212442,A,0,0
212443,and,0,0
212444,35.9,0,0
212445,+/-,0,0
212446,16.8,0,0
212447,months,0,0
212448,for,0,0
212449,group,0,0
212450,B,0,0
212451,.,0,0
212452,At,0,0
212453,5,0,0
212454,years,0,0
212455,of,0,0
212456,followup,0,1
212457,",",0,0
212458,38,0,0
212459,patients,0,0
212460,(,0,0
212461,61.3,0,0
212462,%,0,0
212463,),0,0
212464,were,0,0
212465,cured,1,0
212466,(,0,0
212467,16,0,0
212468,in,0,0
212469,group,0,0
212470,A,0,0
212471,and,0,0
212472,22,0,0
212473,in,0,0
212474,group,0,0
212475,B,0,0
212476,),0,1
212477,",",0,0
212478,and,0,0
212479,5,0,0
212480,(,0,0
212481,8.1,0,0
212482,%,0,0
212483,),0,0
212484,were,0,0
212485,in,0,0
212486,remission,0,1
212487,without,0,0
212488,treatment,0,0
212489,but,0,0
212490,had,0,0
212491,not,0,0
212492,yet,0,0
212493,completed,0,0
212494,the,0,0
212495,cure-defining,0,0
212496,period,0,0
212497,of,0,0
212498,18,0,0
212499,months,0,0
212500,(,0,0
212501,3,0,0
212502,in,0,0
212503,group,0,0
212504,A,0,0
212505,and,0,0
212506,2,0,0
212507,in,0,0
212508,group,0,0
212509,B,0,0
212510,),0,0
212511,.,0,1
212512,Eight,0,0
212513,(,0,0
212514,12.9,0,0
212515,%,0,0
212516,),0,0
212517,(,0,0
212518,2,0,0
212519,in,0,0
212520,group,0,0
212521,A,0,0
212522,and,0,0
212523,2,0,0
212524,in,0,0
212525,group,0,0
212526,B,0,0
212527,),0,1
212528,were,0,0
212529,considered,0,0
212530,to,0,0
212531,be,0,0
212532,in,0,0
212533,clinical,1,1
212534,remission,1,1
212535,and,0,1
212536,required,0,0
212537,a,0,0
212538,maintenance,1,0
212539,regimen,1,0
212540,of,1,1
212541,low-dose,1,0
212542,corticosteroids,1,0
212543,.,1,0
212544,Eleven,0,0
212545,patients,0,0
212546,died,1,0
212547,during,0,0
212548,the,0,0
212549,study,0,0
212550,period,0,0
212551,(,0,0
212552,7,0,0
212553,in,0,0
212554,group,0,0
212555,A,0,0
212556,[,0,0
212557,25,0,0
212558,%,0,0
212559,],0,0
212560,",",0,0
212561,4,0,0
212562,in,0,0
212563,group,0,0
212564,B,0,0
212565,[,0,0
212566,11.8,0,0
212567,%,0,0
212568,],0,0
212569,),0,0
212570,.,0,0
212571,Uncontrolled,0,0
212572,vasculitis,0,1
212573,was,0,0
212574,responsible,0,0
212575,for,0,0
212576,4,0,0
212577,deaths,1,0
212578,(,0,0
212579,2,0,0
212580,in,0,0
212581,each,0,0
212582,group,0,0
212583,),0,1
212584,",",0,1
212585,and,0,1
212586,treatment,1,0
212587,side,1,1
212588,effects,1,1
212589,caused,0,0
212590,the,0,0
212591,death,1,1
212592,of,0,0
212593,1,0,0
212594,patient,0,0
212595,in,0,0
212596,group,0,0
212597,A,0,0
212598,.,0,0
212599,There,0,0
212600,was,0,0
212601,no,0,0
212602,significant,0,0
212603,difference,0,0
212604,between,0,0
212605,the,0,0
212606,5-year,1,0
212607,cumulative,1,1
212608,survival,1,1
212609,rates,1,1
212610,of,0,0
212611,the,0,0
212612,2,0,0
212613,groups,0,0
212614,(,0,0
212615,75,0,0
212616,%,0,0
212617,and,0,0
212618,88,0,0
212619,%,0,0
212620,",",0,0
212621,respectively,0,0
212622,),0,0
212623,.,0,0
212624,CONCLUSION,0,0
212625,Based,0,0
212626,on,0,0
212627,our,0,0
212628,data,0,0
212629,",",0,0
212630,combined,0,0
212631,treatment,0,0
212632,with,0,0
212633,prednisone,0,0
212634,",",0,1
212635,cyclophosphamide,0,0
212636,",",0,1
212637,and,0,1
212638,plasma,0,1
212639,exchanges,0,1
212640,is,0,0
212641,not,0,0
212642,superior,0,0
212643,to,0,0
212644,treatment,0,0
212645,with,0,0
212646,prednisone,0,0
212647,and,0,1
212648,cyclophosphamide,0,0
212649,alone,0,0
212650,",",0,0
212651,and,0,1
212652,plasma,0,1
212653,exchanges,0,1
212654,should,0,0
212655,not,0,0
212656,be,0,0
212657,systematically,0,0
212658,proposed,0,0
212659,for,0,0
212660,initial,0,0
212661,treatment,0,0
212662,of,0,1
212663,severe,0,1
212664,PAN,0,1
212665,or,0,0
212666,CSS,0,0
212667,.,0,0
212668,The,0,0
212669,effect,1,0
212670,of,0,0
212671,iron,0,0
212672,in,0,0
212673,formula,0,0
212674,milk,0,0
212675,after,0,0
212676,6,0,0
212677,months,0,0
212678,of,0,0
212679,age,0,0
212680,.,0,0
212681,Ninety,0,0
212682,two,0,0
212683,normal,0,0
212684,birthweight,0,0
212685,infants,0,0
212686,aged,0,0
212687,6,0,0
212688,months,0,0
212689,entered,0,0
212690,a,0,0
212691,double,0,0
212692,blind,0,0
212693,controlled,0,0
212694,trial,0,0
212695,which,0,0
212696,compared,0,0
212697,a,0,0
212698,follow,0,0
212699,on,0,0
212700,formula,0,0
212701,milk,0,0
212702,with,0,0
212703,no,0,0
212704,added,0,0
212705,iron,0,0
212706,against,0,0
212707,the,0,0
212708,same,0,0
212709,formula,0,0
212710,milk,0,1
212711,containing,0,0
212712,1.2,0,0
212713,mg,0,0
212714,of,0,0
212715,iron,0,0
212716,per,0,0
212717,100,0,0
212718,ml,0,0
212719,.,0,0
212720,There,0,0
212721,was,0,0
212722,no,0,0
212723,significant,0,0
212724,difference,0,0
212725,in,0,0
212726,the,0,0
212727,social,0,1
212728,class,0,0
212729,or,0,1
212730,demographic,0,1
212731,characteristics,0,1
212732,of,0,0
212733,the,0,0
212734,two,0,0
212735,treatment,0,0
212736,groups,0,0
212737,or,0,0
212738,in,0,0
212739,the,0,0
212740,proportion,0,0
212741,of,0,0
212742,each,0,0
212743,group,0,0
212744,completing,0,0
212745,the,0,0
212746,trial,0,0
212747,.,0,0
212748,There,0,0
212749,was,0,0
212750,no,0,0
212751,difference,0,0
212752,between,0,0
212753,the,0,0
212754,two,0,0
212755,groups,0,0
212756,in,0,0
212757,the,0,0
212758,quantity,1,1
212759,of,1,0
212760,milk,1,1
212761,taken,1,0
212762,but,0,0
212763,the,0,0
212764,amounts,0,1
212765,taken,0,0
212766,lessened,0,0
212767,between,0,0
212768,6,0,0
212769,and,0,0
212770,18,0,0
212771,months,0,0
212772,of,0,0
212773,age,0,0
212774,.,0,0
212775,There,0,0
212776,was,0,0
212777,no,0,0
212778,difference,0,0
212779,between,0,0
212780,the,0,0
212781,two,0,0
212782,groups,0,0
212783,with,0,0
212784,respect,0,0
212785,to,0,0
212786,mean,1,1
212787,haemoglobin,1,1
212788,and,1,1
212789,median,1,1
212790,serum,1,1
212791,ferritin,1,1
212792,at,0,0
212793,6,0,0
212794,",",0,0
212795,9,0,0
212796,",",0,0
212797,12,0,0
212798,",",0,0
212799,15,0,0
212800,",",0,0
212801,and,0,0
212802,18,0,0
212803,months,0,0
212804,of,0,0
212805,age,0,0
212806,.,0,0
212807,Very,0,1
212808,few,0,0
212809,infants,0,0
212810,developed,0,0
212811,iron,1,0
212812,deficiency,1,1
212813,anaemia,1,1
212814,in,0,0
212815,either,0,0
212816,group,0,0
212817,but,0,0
212818,there,0,0
212819,was,0,0
212820,a,0,0
212821,tendency,0,1
212822,for,0,0
212823,serum,1,1
212824,ferritin,1,1
212825,levels,1,1
212826,to,0,0
212827,fall,0,0
212828,between,0,0
212829,6,0,0
212830,and,0,0
212831,18,0,0
212832,months,0,0
212833,of,0,0
212834,age,0,0
212835,in,0,0
212836,both,0,0
212837,groups,0,0
212838,.,0,0
212839,The,0,0
212840,results,0,0
212841,suggest,0,0
212842,that,0,0
212843,iron,0,0
212844,added,0,0
212845,to,0,0
212846,follow,0,0
212847,on,0,0
212848,milk,0,1
212849,was,0,0
212850,not,0,0
212851,an,0,0
212852,important,0,0
212853,source,0,0
212854,of,0,1
212855,dietary,0,0
212856,iron,0,0
212857,in,0,0
212858,the,0,0
212859,infants,0,0
212860,studied,0,0
212861,.,0,0
212862,Ebeltoft,0,0
212863,project,0,0
212864,:,0,0
212865,baseline,0,0
212866,data,0,0
212867,from,0,0
212868,a,0,0
212869,five-year,0,1
212870,randomized,0,0
212871,",",0,1
212872,controlled,0,0
212873,",",0,0
212874,prospective,0,0
212875,health,0,1
212876,promotion,0,1
212877,study,0,0
212878,in,0,0
212879,a,0,0
212880,Danish,0,0
212881,population,0,0
212882,.,0,0
212883,BACKGROUND,0,0
212884,There,0,0
212885,is,0,0
212886,increasing,0,0
212887,political,0,0
212888,pressure,0,1
212889,on,0,0
212890,the,0,0
212891,medical,0,0
212892,profession,0,0
212893,to,0,0
212894,approach,0,0
212895,welfare,0,1
212896,diseases,0,1
212897,",",0,0
212898,such,0,0
212899,as,0,0
212900,coronary,0,1
212901,heart,0,1
212902,disease,0,1
212903,and,0,1
212904,diabetes,0,1
212905,",",0,1
212906,through,0,0
212907,prevention,0,0
212908,.,0,0
212909,General,0,0
212910,practitioners,0,0
212911,are,0,0
212912,required,0,0
212913,to,0,0
212914,offer,0,0
212915,regular,0,0
212916,health,0,1
212917,checks,0,1
212918,to,0,0
212919,healthy,0,0
212920,people,0,0
212921,",",0,0
212922,in,0,0
212923,spite,0,0
212924,of,0,0
212925,the,0,0
212926,lack,0,0
212927,of,0,0
212928,scientific,0,0
212929,evidence,0,0
212930,for,0,0
212931,the,0,0
212932,universal,0,0
212933,need,0,0
212934,",",0,1
212935,usefulness,0,1
212936,and,0,1
212937,side,0,1
212938,effects,0,1
212939,of,0,0
212940,such,0,0
212941,an,0,0
212942,intervention,0,0
212943,.,0,0
212944,Randomized,0,0
212945,controlled,0,0
212946,trials,0,0
212947,are,0,0
212948,needed,0,0
212949,.,0,0
212950,AIM,0,0
212951,A,0,0
212952,study,0,0
212953,was,0,0
212954,carried,0,0
212955,out,0,0
212956,to,0,0
212957,investigate,0,0
212958,people,0,0
212959,'s,0,1
212960,interest,0,0
212961,in,0,0
212962,participating,0,0
212963,in,0,0
212964,health,0,1
212965,checks,0,1
212966,and,0,1
212967,in,0,0
212968,discussions,0,0
212969,about,0,0
212970,health,0,1
212971,with,0,0
212972,their,0,0
212973,own,0,0
212974,general,0,0
212975,practitioner,0,0
212976,",",0,0
212977,participants,0,0
212978,',0,1
212979,health,0,1
212980,status,0,1
212981,",",0,0
212982,the,0,0
212983,proportion,0,0
212984,who,0,0
212985,received,0,0
212986,health,0,1
212987,advice,0,0
212988,following,0,0
212989,health,0,1
212990,checks,0,1
212991,",",0,0
212992,and,0,0
212993,the,0,0
212994,lifestyle,0,0
212995,goals,0,0
212996,they,0,0
212997,set,0,0
212998,following,0,0
212999,discussion,0,0
213000,with,0,0
213001,their,0,0
213002,general,0,0
213003,practitioner,0,0
213004,.,0,0
213005,This,0,0
213006,study,0,0
213007,reports,0,0
213008,the,0,0
213009,baseline,0,0
213010,data,0,0
213011,from,0,0
213012,a,0,0
213013,five-year,0,1
213014,randomized,0,0
213015,",",0,1
213016,controlled,0,0
213017,",",0,0
213018,prospective,0,0
213019,",",0,1
213020,population-based,0,0
213021,study,0,0
213022,in,0,0
213023,general,0,0
213024,practices,0,0
213025,in,0,0
213026,Ebeltoft,0,0
213027,",",0,0
213028,Denmark,0,0
213029,.,0,1
213030,METHOD,0,0
213031,All,0,0
213032,general,0,0
213033,practitioners,0,0
213034,from,0,0
213035,the,0,0
213036,four,0,0
213037,practices,0,0
213038,in,0,0
213039,Ebeltoft,0,0
213040,and,0,0
213041,a,0,0
213042,random,0,0
213043,sample,0,0
213044,of,0,0
213045,2000,0,0
213046,people,0,0
213047,aged,0,0
213048,between,0,0
213049,30,0,0
213050,and,0,0
213051,50,0,0
213052,years,0,0
213053,were,0,0
213054,invited,0,0
213055,to,0,0
213056,participate,0,0
213057,.,0,0
213058,Participants,0,0
213059,were,0,0
213060,randomly,0,0
213061,divided,0,0
213062,into,0,0
213063,three,0,0
213064,groups,0,0
213065,--,0,0
213066,one,0,0
213067,control,0,0
213068,group,0,0
213069,and,0,0
213070,two,0,0
213071,intervention,0,0
213072,groups,0,0
213073,.,0,0
213074,One,0,0
213075,intervention,0,0
213076,group,0,0
213077,were,0,0
213078,given,0,0
213079,a,0,0
213080,health,0,1
213081,check,0,1
213082,which,0,0
213083,included,0,0
213084,being,0,0
213085,screened,0,1
213086,for,0,0
213087,cardiovascular,0,1
213088,risk,0,1
213089,factors,0,1
213090,",",0,1
213091,lung,0,1
213092,and,0,1
213093,liver,0,1
213094,function,0,1
213095,",",0,1
213096,fitness,0,1
213097,",",0,1
213098,sight,0,1
213099,and,0,1
213100,hearing,0,1
213101,and,0,1
213102,an,0,0
213103,optional,0,0
213104,test,0,0
213105,for,0,0
213106,the,0,0
213107,human,0,0
213108,immunodeficiency,0,0
213109,virus,0,1
213110,(,0,1
213111,HIV,0,1
213112,),0,0
213113,;,0,0
213114,this,0,0
213115,group,0,0
213116,received,0,0
213117,written,0,0
213118,feedback,0,0
213119,from,0,0
213120,the,0,0
213121,general,0,0
213122,practitioner,0,0
213123,.,0,0
213124,The,0,0
213125,other,0,0
213126,intervention,0,0
213127,group,0,0
213128,were,0,0
213129,also,0,0
213130,given,0,0
213131,a,0,0
213132,health,0,1
213133,check,0,1
213134,and,0,1
213135,written,0,0
213136,feedback,0,0
213137,;,0,0
213138,in,0,0
213139,addition,0,0
213140,",",0,0
213141,they,0,0
213142,were,0,0
213143,given,0,0
213144,the,0,0
213145,opportunity,0,0
213146,to,0,0
213147,attend,0,0
213148,their,0,0
213149,general,0,0
213150,practitioner,0,0
213151,to,0,0
213152,discuss,0,0
213153,preventive,0,0
213154,health,0,0
213155,.,0,0
213156,RESULTS,0,0
213157,A,0,0
213158,total,0,0
213159,of,0,0
213160,1370,0,0
213161,people,0,0
213162,participated,0,0
213163,in,0,0
213164,the,0,0
213165,study,0,0
213166,(,0,0
213167,69,0,0
213168,%,0,0
213169,response,0,1
213170,rate,0,1
213171,),0,0
213172,.,0,0
213173,Health,1,1
213174,advice,1,0
213175,was,0,0
213176,given,0,0
213177,to,0,0
213178,76,0,0
213179,%,0,0
213180,of,0,0
213181,905,0,0
213182,participants,0,0
213183,following,0,0
213184,health,0,1
213185,checks,0,1
213186,.,0,0
213187,Almost,0,0
213188,all,0,0
213189,of,0,0
213190,the,0,0
213191,456,0,0
213192,participants,0,0
213193,(,0,0
213194,96,0,0
213195,%,0,0
213196,),0,0
213197,who,0,0
213198,were,0,0
213199,offered,0,0
213200,the,0,0
213201,opportunity,0,0
213202,of,0,0
213203,discussing,0,0
213204,their,0,0
213205,health,0,1
213206,with,0,0
213207,their,0,0
213208,general,0,0
213209,practitioner,0,0
213210,took,0,0
213211,up,0,0
213212,the,0,0
213213,offer,0,0
213214,;,0,0
213215,64,0,0
213216,%,0,0
213217,of,0,0
213218,the,0,0
213219,456,0,0
213220,participants,0,0
213221,reported,0,0
213222,that,0,0
213223,they,0,0
213224,had,0,0
213225,decided,0,0
213226,to,0,0
213227,undertake,1,0
213228,lifestyle,1,0
213229,changes,1,1
213230,.,1,0
213231,Eleven,0,0
213232,of,0,0
213233,those,0,0
213234,who,0,0
213235,discussed,0,0
213236,their,0,0
213237,health,0,1
213238,with,0,0
213239,the,0,0
213240,doctor,0,1
213241,were,0,0
213242,referred,1,0
213243,to,1,0
213244,a,1,0
213245,specialist,1,0
213246,(,0,0
213247,2,0,0
213248,%,0,0
213249,),0,0
213250,.,0,0
213251,CONCLUSION,0,0
213252,There,0,0
213253,was,0,0
213254,considerable,0,0
213255,interest,0,0
213256,in,0,0
213257,participating,0,0
213258,in,0,0
213259,health,0,1
213260,promotion,0,0
213261,.,0,0
213262,Three,0,0
213263,out,0,0
213264,of,0,0
213265,four,0,0
213266,of,0,0
213267,those,0,0
213268,having,0,0
213269,a,0,0
213270,health,0,1
213271,check,0,1
213272,were,0,0
213273,given,0,0
213274,health,0,1
213275,advice,0,0
213276,.,0,0
213277,Two,0,0
213278,out,0,0
213279,of,0,0
213280,three,0,0
213281,of,0,0
213282,those,0,0
213283,offered,0,0
213284,a,0,0
213285,health,0,1
213286,talk,0,0
213287,with,0,0
213288,the,0,0
213289,general,0,0
213290,practitioner,0,0
213291,appeared,0,0
213292,willing,0,0
213293,to,0,0
213294,make,0,0
213295,relevant,0,0
213296,lifestyle,0,0
213297,changes,0,1
213298,.,0,1
213299,Long-term,0,0
213300,follow,0,0
213301,up,0,0
213302,is,0,0
213303,needed,0,0
213304,to,0,0
213305,determine,0,0
213306,effects,0,1
213307,and,0,1
213308,side,0,1
213309,effects,0,1
213310,of,0,0
213311,health,0,1
213312,checks,0,1
213313,and,0,1
213314,health,0,1
213315,talks,0,0
213316,.,0,0
213317,Comparison,1,0
213318,of,0,1
213319,autologous,0,0
213320,bone,0,1
213321,marrow,0,0
213322,transplantation,0,0
213323,with,0,0
213324,sequential,0,0
213325,chemotherapy,0,0
213326,for,0,0
213327,intermediate-grade,0,1
213328,and,0,1
213329,high-grade,0,1
213330,non-Hodgkin,0,1
213331,'s,0,1
213332,lymphoma,0,0
213333,in,0,0
213334,first,0,1
213335,complete,1,1
213336,remission,1,1
213337,:,1,0
213338,a,0,0
213339,study,0,0
213340,of,0,0
213341,464,0,0
213342,patients,0,0
213343,.,0,0
213344,Groupe,0,0
213345,d'Etude,0,0
213346,des,0,1
213347,Lymphomes,0,0
213348,de,0,0
213349,l'Adulte,0,0
213350,.,0,0
213351,PURPOSE,0,0
213352,Intensive,0,0
213353,chemotherapy,0,0
213354,followed,0,0
213355,by,0,0
213356,autotransplantation,0,0
213357,has,0,0
213358,given,0,0
213359,promising,0,0
213360,results,0,0
213361,in,0,0
213362,partially,0,0
213363,responding,0,0
213364,or,0,0
213365,sensitive,0,0
213366,relapsed,0,0
213367,patients,0,0
213368,with,0,0
213369,aggressive,0,1
213370,non-Hodgkin,0,0
213371,'s,0,0
213372,lymphoma,0,0
213373,.,0,0
213374,In,0,0
213375,1987,0,0
213376,",",0,0
213377,we,0,0
213378,designed,0,0
213379,a,0,0
213380,randomized,0,0
213381,study,0,0
213382,to,0,0
213383,evaluate,0,0
213384,the,0,0
213385,potential,0,0
213386,benefit,1,0
213387,of,0,0
213388,a,0,0
213389,high-dose,0,0
213390,regimen,0,0
213391,containing,0,0
213392,cyclophosphamide,0,0
213393,",",0,1
213394,carmustine,0,0
213395,",",0,1
213396,and,0,1
213397,etoposide,0,0
213398,(,0,0
213399,CBV,0,1
213400,),0,0
213401,followed,0,0
213402,by,0,0
213403,autotransplantation,0,0
213404,over,0,0
213405,a,0,0
213406,consolidative,0,0
213407,sequential,0,0
213408,chemotherapy,0,0
213409,(,0,1
213410,ifosfamide,0,0
213411,",",0,0
213412,etoposide,0,0
213413,",",0,0
213414,asparaginase,0,0
213415,",",0,1
213416,and,0,1
213417,cytarabine,0,0
213418,),0,1
213419,in,0,0
213420,patients,0,0
213421,in,0,0
213422,first,0,1
213423,complete,0,1
213424,remission,0,1
213425,with,0,0
213426,intermediate-,0,1
213427,and,0,1
213428,high-grade,0,1
213429,non-Hodgkin,0,1
213430,'s,0,0
213431,lymphoma,0,0
213432,.,0,1
213433,PATIENTS,0,0
213434,AND,0,0
213435,METHODS,0,0
213436,Patients,0,0
213437,were,0,0
213438,younger,0,0
213439,than,0,0
213440,55,0,0
213441,years,0,0
213442,and,0,0
213443,had,0,0
213444,at,0,0
213445,least,0,0
213446,one,0,0
213447,adverse,0,1
213448,prognostic,0,0
213449,factor,0,1
213450,.,0,1
213451,Induction,0,1
213452,treatment,0,0
213453,was,0,0
213454,that,0,0
213455,of,0,0
213456,the,0,0
213457,LNH84,0,0
213458,protocol,0,0
213459,with,0,0
213460,an,0,0
213461,open,0,0
213462,randomization,0,0
213463,on,0,0
213464,the,0,0
213465,anthracycline,0,0
213466,.,0,0
213467,Patients,0,0
213468,in,0,0
213469,complete,1,1
213470,remission,1,1
213471,were,0,0
213472,further,0,0
213473,randomly,0,0
213474,assigned,0,0
213475,to,0,0
213476,receive,0,0
213477,either,0,0
213478,consolidation,0,0
213479,procedure,0,0
213480,.,0,1
213481,RESULTS,0,0
213482,After,0,0
213483,induction,0,1
213484,treatment,0,0
213485,",",0,0
213486,464,0,0
213487,patients,0,0
213488,were,0,0
213489,assessable,0,0
213490,for,0,0
213491,the,0,0
213492,consolidation,0,0
213493,phase,0,0
213494,.,0,0
213495,With,0,0
213496,a,0,0
213497,median,0,1
213498,follow-up,0,0
213499,duration,0,1
213500,of,0,0
213501,28,0,0
213502,months,0,0
213503,",",0,0
213504,the,0,0
213505,3-year,1,0
213506,disease-free,1,1
213507,survival,1,1
213508,rate,1,1
213509,was,0,0
213510,52,0,0
213511,%,0,0
213512,(,0,0
213513,95,0,0
213514,%,0,0
213515,confidence,0,0
213516,interval,0,0
213517,",",0,0
213518,45,0,0
213519,%,0,0
213520,to,0,0
213521,59,0,0
213522,%,0,0
213523,),0,0
213524,in,0,0
213525,the,0,0
213526,sequential,0,0
213527,chemotherapy,0,0
213528,arm,0,0
213529,and,0,0
213530,59,0,0
213531,%,0,0
213532,(,0,0
213533,95,0,0
213534,%,0,0
213535,confidence,0,0
213536,interval,0,0
213537,",",0,0
213538,52,0,0
213539,%,0,0
213540,to,0,0
213541,66,0,0
213542,%,0,0
213543,),0,0
213544,in,0,0
213545,the,0,0
213546,autologous,0,0
213547,transplant,0,1
213548,arm,0,0
213549,(,0,1
213550,P,0,0
213551,=,0,0
213552,.46,0,0
213553,",",0,1
213554,relative,0,1
213555,risk,0,1
213556,=,0,0
213557,0.90,0,0
213558,),0,0
213559,.,0,0
213560,The,0,0
213561,3-year,1,0
213562,survival,1,1
213563,rate,1,1
213564,did,0,0
213565,not,0,0
213566,differ,0,0
213567,between,0,0
213568,sequential,0,0
213569,chemotherapy,0,0
213570,and,0,1
213571,autotransplantation,0,0
213572,",",0,0
213573,at,0,0
213574,71,0,0
213575,%,0,0
213576,(,0,0
213577,95,0,0
213578,%,0,0
213579,confidence,0,0
213580,interval,0,0
213581,",",0,0
213582,64,0,0
213583,%,0,0
213584,to,0,0
213585,78,0,0
213586,%,0,0
213587,),0,0
213588,and,0,0
213589,69,0,0
213590,%,0,0
213591,(,0,0
213592,95,0,0
213593,%,0,0
213594,confidence,0,0
213595,interval,0,0
213596,",",0,0
213597,62,0,0
213598,%,0,0
213599,to,0,0
213600,76,0,0
213601,%,0,0
213602,),0,0
213603,",",0,0
213604,respectively,0,0
213605,(,0,0
213606,P,0,0
213607,=,0,0
213608,.60,0,1
213609,",",0,1
213610,relative,0,1
213611,risk,0,1
213612,=,0,0
213613,1.11,0,0
213614,),0,0
213615,.,0,0
213616,CONCLUSION,0,0
213617,For,0,0
213618,such,0,0
213619,a,0,0
213620,subset,0,0
213621,of,0,0
213622,patients,0,0
213623,",",0,0
213624,consolidation,0,0
213625,with,0,0
213626,the,0,0
213627,CBV,0,0
213628,regimen,0,0
213629,followed,0,0
213630,by,0,0
213631,autologous,0,0
213632,bone,0,1
213633,marrow,0,0
213634,transplantation,0,0
213635,is,0,0
213636,not,0,0
213637,superior,1,0
213638,to,0,0
213639,sequential,0,0
213640,chemotherapy,0,0
213641,.,0,0
213642,Multicyclic,0,1
213643,",",0,1
213644,dose-intensive,0,0
213645,chemotherapy,0,0
213646,supported,0,0
213647,by,0,0
213648,sequential,0,0
213649,reinfusion,0,0
213650,of,0,1
213651,hematopoietic,0,1
213652,progenitors,0,1
213653,in,0,0
213654,whole,0,0
213655,blood,0,1
213656,.,0,0
213657,PURPOSE,0,0
213658,To,0,0
213659,support,0,0
213660,multicyclic,0,0
213661,",",0,0
213662,dose-intensive,0,0
213663,chemotherapy,0,0
213664,",",0,0
213665,we,0,0
213666,assessed,0,0
213667,the,0,0
213668,effects,0,1
213669,of,0,0
213670,reinfusing,0,1
213671,hematopoietic,0,1
213672,progenitors,0,1
213673,collected,0,0
213674,at,0,0
213675,each,0,0
213676,cycle,0,1
213677,in,0,0
213678,leukapheresis,0,0
213679,product,0,1
213680,or,0,1
213681,whole,0,1
213682,blood,0,1
213683,.,0,1
213684,PATIENTS,0,0
213685,AND,0,0
213686,METHODS,0,0
213687,Twenty-five,0,0
213688,patients,0,0
213689,with,0,0
213690,small-cell,0,0
213691,lung,0,1
213692,cancer,0,1
213693,(,0,1
213694,SCLC,0,1
213695,),0,1
213696,were,0,0
213697,treated,0,0
213698,with,0,0
213699,six,0,0
213700,cycles,0,0
213701,of,0,0
213702,ifosfamide,0,0
213703,",",0,1
213704,carboplatin,0,0
213705,",",0,1
213706,and,0,1
213707,etoposide,0,0
213708,(,0,0
213709,ICE,0,1
213710,),0,0
213711,with,0,0
213712,granulocyte,0,1
213713,colony-stimulating,0,1
213714,factor,0,1
213715,(,0,1
213716,G-CSF,0,0
213717,),0,0
213718,300,0,0
213719,micrograms/d,0,0
213720,subcutaneously,0,0
213721,(,0,0
213722,SC,0,1
213723,),0,0
213724,on,0,0
213725,days,0,0
213726,4,0,0
213727,to,0,0
213728,15,0,0
213729,.,0,0
213730,Hematopoietic,0,0
213731,progenitors,0,1
213732,collected,0,0
213733,during,0,0
213734,each,0,0
213735,cycle,0,1
213736,were,0,0
213737,reinfused,0,0
213738,on,0,0
213739,day,0,0
213740,3,0,0
213741,of,0,0
213742,the,0,0
213743,next,0,0
213744,cycle,0,1
213745,.,0,0
213746,Cohort,0,0
213747,1,0,0
213748,(,0,0
213749,n,0,0
213750,=,0,0
213751,6,0,0
213752,),0,0
213753,was,0,0
213754,treated,0,0
213755,every,0,0
213756,3,0,0
213757,weeks,0,0
213758,",",0,0
213759,with,0,0
213760,leukapheresis,0,0
213761,after,0,0
213762,2,0,0
213763,weeks,0,0
213764,and,0,0
213765,cryopreservation,0,0
213766,of,0,0
213767,the,0,0
213768,leukapheresis,0,0
213769,product,0,1
213770,.,0,1
213771,Chemotherapy,0,0
213772,was,0,0
213773,given,0,0
213774,if,0,0
213775,the,0,0
213776,WBC,0,1
213777,count,0,1
213778,was,0,0
213779,>,0,1
213780,or,0,0
213781,=,0,0
213782,3,0,0
213783,x,0,0
213784,10,0,0
213785,(,0,0
213786,9,0,0
213787,),0,0
213788,/L,0,1
213789,and,0,1
213790,platelet,0,1
213791,count,0,1
213792,>,0,1
213793,or,0,0
213794,=,0,0
213795,100,0,0
213796,x,0,0
213797,10,0,0
213798,(,0,0
213799,9,0,0
213800,),0,0
213801,/L,0,0
213802,.,0,0
213803,Cohort,0,0
213804,2,0,0
213805,(,0,0
213806,n,0,0
213807,=,0,0
213808,7,0,0
213809,),0,0
213810,was,0,0
213811,treated,0,0
213812,every,0,0
213813,2,0,0
213814,weeks,0,0
213815,",",0,0
213816,with,0,0
213817,leukapheresis,0,0
213818,on,0,0
213819,day,0,0
213820,1,0,0
213821,of,0,0
213822,the,0,0
213823,next,0,0
213824,cycle,0,1
213825,and,0,1
213826,storage,0,1
213827,of,0,0
213828,the,0,0
213829,leukapheresis,0,0
213830,product,0,1
213831,at,0,0
213832,4,0,0
213833,degrees,0,0
213834,C.,0,1
213835,Cohort,0,0
213836,3,0,0
213837,(,0,0
213838,n,0,0
213839,=,0,0
213840,12,0,0
213841,),0,0
213842,was,0,0
213843,treated,0,0
213844,every,0,0
213845,2,0,0
213846,weeks,0,0
213847,",",0,0
213848,with,0,0
213849,500,0,0
213850,to,0,0
213851,750,0,0
213852,mL,0,0
213853,of,0,0
213854,blood,0,1
213855,drawn,0,0
213856,by,0,0
213857,venesection,0,0
213858,on,0,0
213859,day,0,0
213860,1,0,0
213861,of,0,0
213862,the,0,0
213863,next,0,0
213864,cycle,0,1
213865,and,0,1
213866,stored,0,0
213867,at,0,0
213868,4,0,0
213869,degrees,0,0
213870,C.,0,1
213871,In,0,0
213872,cohorts,0,0
213873,2,0,0
213874,and,0,0
213875,3,0,0
213876,",",0,0
213877,chemotherapy,0,0
213878,was,0,0
213879,given,0,0
213880,if,0,0
213881,the,0,0
213882,WBC,0,1
213883,count,0,1
213884,was,0,0
213885,>,0,1
213886,or,0,0
213887,=,0,0
213888,3,0,0
213889,x,0,0
213890,10,0,0
213891,(,0,0
213892,9,0,0
213893,),0,0
213894,/L,0,1
213895,and,0,1
213896,platelet,0,1
213897,count,0,1
213898,>,0,1
213899,or,0,0
213900,=,0,0
213901,30,0,0
213902,x,0,0
213903,10,0,0
213904,(,0,0
213905,9,0,0
213906,),0,0
213907,/L,0,0
213908,.,0,1
213909,Blood,1,1
213910,and,1,1
213911,leukapheresis,1,0
213912,products,1,1
213913,were,0,0
213914,assayed,0,0
213915,for,0,0
213916,hematopoietic,0,0
213917,progenitors,0,1
213918,.,0,0
213919,RESULTS,0,0
213920,ICE,0,1
213921,chemotherapy,0,0
213922,with,0,0
213923,G-CSF,0,0
213924,was,0,0
213925,effective,0,1
213926,in,0,0
213927,mobilizing,1,0
213928,blood,1,1
213929,progenitors,1,1
213930,(,0,1
213931,median,0,1
213932,",",0,1
213933,120-fold,0,1
213934,),0,0
213935,.,0,0
213936,Long-term,0,0
213937,cultures,0,0
213938,showed,0,0
213939,no,0,0
213940,evidence,0,0
213941,of,0,0
213942,stem-cell,1,0
213943,depletion,1,0
213944,.,1,0
213945,The,0,0
213946,cytotoxic,1,1
213947,dose-intensity,1,0
213948,of,0,1
213949,standard,0,0
213950,every-4-weeks,0,0
213951,ICE,0,0
213952,is,0,0
213953,100,0,0
213954,%,0,0
213955,.,0,0
213956,In,0,0
213957,the,0,0
213958,first,0,0
213959,three,0,0
213960,cycles,0,0
213961,",",0,0
213962,it,0,0
213963,was,0,0
213964,134,0,0
213965,%,0,0
213966,(,0,0
213967,median,0,1
213968,),0,0
213969,in,0,0
213970,cohort,0,0
213971,1,0,0
213972,and,0,0
213973,200,0,0
213974,%,0,0
213975,in,0,0
213976,cohorts,0,0
213977,2,0,0
213978,and,0,0
213979,3,0,0
213980,(,0,0
213981,P,0,0
213982,<,0,0
213983,.0001,0,0
213984,),0,0
213985,.,0,1
213986,Toxicity,1,1
213987,and,1,1
213988,supportive,1,0
213989,care,1,0
213990,requirements,1,1
213991,were,0,0
213992,not,0,0
213993,increased,0,0
213994,.,0,0
213995,CONCLUSION,0,0
213996,The,0,0
213997,dose-intensity,0,0
213998,of,0,0
213999,ICE,0,0
214000,chemotherapy,0,0
214001,can,0,0
214002,be,0,0
214003,doubled,0,0
214004,by,0,0
214005,reinfusing,0,0
214006,hematopoietic,0,1
214007,progenitors,0,1
214008,collected,0,0
214009,by,0,0
214010,leukapheresis,0,0
214011,or,0,1
214012,venesection,0,0
214013,and,0,1
214014,stored,0,0
214015,at,0,0
214016,4,0,0
214017,degrees,0,0
214018,C,0,0
214019,.,0,0
214020,Randomised,0,0
214021,",",0,0
214022,placebo-controlled,0,0
214023,",",0,1
214024,double-blind,0,0
214025,clinical,0,1
214026,trial,0,0
214027,of,0,1
214028,beta-sitosterol,0,1
214029,in,0,0
214030,patients,0,0
214031,with,0,0
214032,benign,0,0
214033,prostatic,0,0
214034,hyperplasia,0,1
214035,.,0,0
214036,Beta-sitosterol,0,0
214037,Study,0,0
214038,Group,0,0
214039,.,0,0
214040,Medical,0,0
214041,treatments,0,0
214042,have,0,0
214043,become,0,0
214044,available,0,0
214045,for,0,0
214046,benign,0,0
214047,hypertrophy,0,1
214048,of,0,0
214049,the,0,0
214050,prostate,0,0
214051,",",0,0
214052,including,0,0
214053,alpha-receptor,0,1
214054,blocking,0,0
214055,agents,0,0
214056,and,0,1
214057,5-alpha-reductase,0,1
214058,inhibitors,0,1
214059,.,0,0
214060,Drugs,0,1
214061,derived,0,0
214062,from,0,0
214063,plants,0,0
214064,",",0,0
214065,for,0,0
214066,which,0,0
214067,no,0,0
214068,precise,0,0
214069,mechanism,0,0
214070,of,0,0
214071,action,0,0
214072,has,0,0
214073,been,0,0
214074,described,0,0
214075,",",0,0
214076,are,0,0
214077,widely,0,0
214078,used,0,0
214079,for,0,0
214080,this,0,0
214081,purpose,0,0
214082,in,0,0
214083,Europe,0,0
214084,.,0,0
214085,In,0,0
214086,a,0,0
214087,randomised,0,0
214088,",",0,0
214089,double-blind,0,0
214090,",",0,1
214091,placebo-controlled,0,0
214092,multicentre,0,0
214093,study,0,0
214094,",",0,0
214095,200,0,0
214096,patients,0,0
214097,(,0,0
214098,recruited,0,0
214099,between,0,0
214100,April,0,0
214101,and,0,0
214102,October,0,0
214103,1993,0,0
214104,),0,0
214105,with,0,0
214106,symptomatic,0,1
214107,benign,0,0
214108,prostatic,0,1
214109,hyperplasia,0,1
214110,were,0,0
214111,treated,0,0
214112,with,0,0
214113,either,0,0
214114,20,0,0
214115,mg,0,0
214116,beta-sitosterol,0,0
214117,(,0,0
214118,which,0,0
214119,contains,0,0
214120,a,0,0
214121,mixture,0,0
214122,of,0,0
214123,phytosterols,0,0
214124,),0,0
214125,three,0,0
214126,times,0,0
214127,per,0,0
214128,day,0,1
214129,or,0,0
214130,placebo,0,0
214131,.,0,1
214132,Primary,0,1
214133,end-point,0,1
214134,was,0,0
214135,a,0,0
214136,difference,0,0
214137,of,0,0
214138,modified,0,0
214139,Boyarsky,1,1
214140,score,1,1
214141,between,0,0
214142,treatment,0,0
214143,groups,0,0
214144,after,0,0
214145,6,0,0
214146,months,0,0
214147,;,0,0
214148,secondary,0,1
214149,end-points,0,1
214150,were,0,0
214151,changes,0,1
214152,in,0,0
214153,International,1,1
214154,Prostate,1,0
214155,Symptom,1,1
214156,Score,1,1
214157,(,1,1
214158,IPSS,1,1
214159,),1,1
214160,",",1,0
214161,urine,1,1
214162,flow,1,1
214163,",",1,1
214164,and,1,1
214165,prostate,1,0
214166,volume,1,1
214167,.,1,1
214168,Modified,1,1
214169,Boyarsky,1,1
214170,score,1,1
214171,decreased,0,1
214172,significantly,0,0
214173,with,0,0
214174,a,0,0
214175,mean,0,1
214176,of,0,1
214177,-6.7,0,0
214178,(,0,0
214179,SD,0,0
214180,4.0,0,0
214181,),0,0
214182,points,0,0
214183,in,0,0
214184,the,0,0
214185,beta-sitosterol-treated,0,0
214186,group,0,0
214187,versus,0,0
214188,-2.1,0,0
214189,(,0,0
214190,3.2,0,0
214191,),0,0
214192,points,0,0
214193,in,0,0
214194,the,0,0
214195,placebo,0,0
214196,group,0,0
214197,p,0,0
214198,<,0,0
214199,0.01,0,0
214200,.,0,0
214201,There,0,0
214202,was,0,0
214203,a,0,0
214204,decrease,0,1
214205,in,0,0
214206,IPSS,1,0
214207,(,0,0
214208,-7.4,0,0
214209,[,0,0
214210,3.8,0,0
214211,],0,0
214212,points,0,0
214213,in,0,0
214214,the,0,0
214215,beta-sitosterol-treated,0,0
214216,group,0,0
214217,vs,0,0
214218,-2.1,0,0
214219,[,0,0
214220,3.8,0,0
214221,],0,0
214222,points,0,0
214223,in,0,0
214224,the,0,0
214225,placebo,0,0
214226,group,0,0
214227,),0,1
214228,and,0,1
214229,changes,0,1
214230,in,0,0
214231,urine,1,1
214232,flow,1,1
214233,parameters,1,1
214234,:,1,0
214235,beta-sitosterol,0,1
214236,treatment,0,0
214237,resulted,0,0
214238,in,0,0
214239,increasing,0,0
214240,peak,1,1
214241,flow,1,1
214242,(,0,0
214243,15.2,0,0
214244,[,0,0
214245,5.7,0,0
214246,],0,0
214247,mL/s,0,0
214248,from,0,0
214249,9.9,0,0
214250,[,0,0
214251,2.5,0,0
214252,],0,0
214253,mL/s,0,0
214254,),0,1
214255,",",0,1
214256,and,0,1
214257,decrease,0,1
214258,of,0,1
214259,mean,1,1
214260,residual,1,1
214261,urinary,1,1
214262,volume,1,1
214263,(,0,0
214264,30.4,0,0
214265,[,0,0
214266,39.9,0,0
214267,],0,0
214268,mL,0,0
214269,from,0,0
214270,65.8,0,0
214271,[,0,0
214272,20.8,0,0
214273,],0,0
214274,mL,0,0
214275,),0,0
214276,.,0,0
214277,These,0,0
214278,parameters,0,1
214279,did,1,0
214280,not,1,0
214281,change,1,0
214282,in,0,0
214283,the,0,0
214284,placebo,0,0
214285,group,0,0
214286,(,0,0
214287,p,0,0
214288,<,0,0
214289,0.01,0,0
214290,),0,0
214291,.,0,0
214292,No,0,0
214293,relevant,0,0
214294,reduction,0,1
214295,of,0,1
214296,prostatic,1,1
214297,volume,1,1
214298,was,0,0
214299,observed,0,0
214300,in,0,0
214301,either,0,0
214302,group,0,0
214303,.,0,0
214304,Significant,0,1
214305,improvement,0,1
214306,in,0,0
214307,symptoms,1,1
214308,and,1,1
214309,urinary,1,1
214310,flow,1,1
214311,parameters,1,0
214312,show,0,0
214313,the,0,0
214314,effectiveness,0,1
214315,of,0,0
214316,beta-sitosterol,0,0
214317,in,0,0
214318,the,0,0
214319,treatment,0,0
214320,of,0,0
214321,benign,0,0
214322,prostatic,0,0
214323,hyperplasia,0,1
214324,.,0,0
214325,Why,0,0
214326,are,0,0
214327,there,0,0
214328,sometimes,0,0
214329,concreteness,1,1
214330,effects,1,1
214331,in,1,0
214332,memory,1,1
214333,for,0,0
214334,prose,0,0
214335,?,0,0
214336,Four,0,1
214337,experiments,0,0
214338,explored,0,0
214339,on-line,0,0
214340,encoding,0,1
214341,strategies,0,1
214342,and,0,1
214343,memory,0,1
214344,for,0,0
214345,high,0,1
214346,imagery,0,0
214347,and,0,1
214348,low,0,1
214349,imagery,0,0
214350,texts,0,0
214351,.,0,1
214352,Results,0,0
214353,consistently,0,1
214354,indicated,0,0
214355,that,0,0
214356,concreteness,1,1
214357,effects,1,1
214358,in,1,0
214359,memory,1,1
214360,for,1,0
214361,text,1,0
214362,depend,0,0
214363,on,0,0
214364,how,0,0
214365,materials,0,0
214366,are,0,0
214367,presented,0,0
214368,in,0,0
214369,several,0,0
214370,different,0,0
214371,respects,0,0
214372,.,0,0
214373,Most,0,0
214374,importantly,0,0
214375,",",0,0
214376,the,0,0
214377,experiments,0,0
214378,clarified,0,0
214379,apparently,0,0
214380,contradictory,0,0
214381,results,0,0
214382,of,0,0
214383,previous,0,0
214384,studies,0,0
214385,by,0,0
214386,indicating,0,0
214387,that,0,0
214388,concreteness,1,1
214389,effects,1,0
214390,generally,0,0
214391,do,0,0
214392,not,0,0
214393,occur,0,0
214394,in,0,0
214395,memory,0,1
214396,for,0,0
214397,prose,0,1
214398,when,0,0
214399,imageability,0,0
214400,is,0,0
214401,manipulated,0,0
214402,between-subjects,0,0
214403,",",0,0
214404,and,0,1
214405,that,0,0
214406,their,0,0
214407,occurrence,0,1
214408,when,0,0
214409,imageability,0,0
214410,is,0,0
214411,manipulated,0,0
214412,within-subjects,0,0
214413,depends,0,0
214414,on,0,0
214415,the,0,0
214416,order,0,0
214417,occurrence,0,1
214418,when,0,0
214419,imageability,0,0
214420,is,0,0
214421,manipulated,0,0
214422,within-subjects,0,0
214423,depends,0,0
214424,on,0,0
214425,the,0,0
214426,order,0,0
214427,of,0,0
214428,presentation,0,1
214429,.,0,0
214430,In,0,0
214431,addition,0,0
214432,",",0,0
214433,moving,0,1
214434,window,0,0
214435,analyses,0,0
214436,of,0,1
214437,text,0,0
214438,processing,0,1
214439,strategies,0,1
214440,indicated,0,0
214441,that,0,0
214442,differential,0,1
214443,strategies,0,0
214444,observed,0,0
214445,in,0,0
214446,previous,0,0
214447,studies,0,0
214448,when,0,0
214449,subjects,0,0
214450,listened,0,0
214451,to,0,0
214452,high,0,0
214453,vs,0,0
214454,low,0,1
214455,imagery,0,0
214456,text,0,0
214457,do,0,0
214458,not,0,0
214459,generalize,0,0
214460,to,0,0
214461,reading,0,0
214462,of,0,0
214463,the,0,0
214464,same,0,0
214465,materials,0,0
214466,.,0,0
214467,Potential,0,1
214468,explanations,0,0
214469,for,0,0
214470,the,0,0
214471,pattern,0,0
214472,of,0,0
214473,results,0,0
214474,are,0,0
214475,evaluated,0,0
214476,",",0,0
214477,and,0,1
214478,implications,0,0
214479,for,0,0
214480,theories,0,0
214481,of,0,0
214482,mental,0,1
214483,imagery,0,0
214484,and,0,0
214485,memory,0,1
214486,are,0,0
214487,considered,0,0
214488,.,0,0
214489,Quantifying,0,0
214490,the,0,0
214491,extent,0,0
214492,of,0,0
214493,osteonecrosis,0,1
214494,of,0,0
214495,the,0,0
214496,femoral,0,1
214497,head,0,0
214498,.,0,0
214499,A,0,0
214500,new,0,0
214501,method,0,0
214502,using,0,0
214503,MRI,0,1
214504,.,0,0
214505,In,0,0
214506,a,0,0
214507,randomised,0,0
214508,trial,0,0
214509,comparing,0,0
214510,core,0,1
214511,decompression,0,0
214512,with,0,0
214513,conservative,0,0
214514,treatment,0,0
214515,we,0,0
214516,tested,0,0
214517,the,0,0
214518,hypothesis,0,0
214519,that,0,0
214520,the,0,0
214521,extent,0,0
214522,of,0,0
214523,necrosis,0,1
214524,at,0,0
214525,the,0,0
214526,initial,0,0
214527,MRI,0,0
214528,predicts,0,0
214529,the,0,0
214530,subsequent,0,0
214531,risk,0,1
214532,of,0,1
214533,collapse,0,1
214534,of,0,0
214535,the,0,0
214536,femoral,0,1
214537,head,0,0
214538,.,0,0
214539,After,0,0
214540,the,0,0
214541,initial,0,0
214542,clinical,0,1
214543,evaluation,0,0
214544,",",0,1
214545,including,0,0
214546,plain,0,0
214547,radiography,0,1
214548,and,0,1
214549,MRI,0,1
214550,",",0,0
214551,37,0,0
214552,hips,0,0
214553,with,0,0
214554,early-stage,0,0
214555,osteonecrosis,0,1
214556,(,0,1
214557,ON,0,1
214558,),0,0
214559,in,0,0
214560,33,0,0
214561,patients,0,0
214562,were,0,0
214563,randomly,0,0
214564,assigned,0,0
214565,to,0,0
214566,a,0,0
214567,core-decompression,0,0
214568,group,0,0
214569,or,0,0
214570,a,0,0
214571,conservatively-treated,0,0
214572,group,0,0
214573,.,0,0
214574,All,0,0
214575,were,0,0
214576,followed,0,0
214577,regularly,0,0
214578,by,0,0
214579,clinical,0,1
214580,evaluation,0,0
214581,",",0,0
214582,plain,0,0
214583,radiography,0,1
214584,and,0,1
214585,MRI,0,1
214586,at,0,0
214587,intervals,0,0
214588,of,0,0
214589,three,0,0
214590,months,0,0
214591,.,0,0
214592,The,0,0
214593,extent,0,0
214594,of,0,1
214595,ON,0,1
214596,was,0,0
214597,estimated,0,0
214598,on,0,0
214599,the,0,0
214600,basis,0,0
214601,of,0,0
214602,abnormal,0,1
214603,signal,0,1
214604,intensity,0,1
214605,in,0,0
214606,the,0,0
214607,weight-bearing,0,1
214608,portion,0,0
214609,of,0,0
214610,the,0,0
214611,femoral,0,1
214612,head,0,0
214613,as,0,0
214614,determined,0,0
214615,from,0,0
214616,a,0,0
214617,combination,0,0
214618,of,0,1
214619,coronal,0,1
214620,and,0,1
214621,sagittal,0,1
214622,MRIs,0,0
214623,.,0,0
214624,The,0,0
214625,arc,0,0
214626,of,0,0
214627,the,0,0
214628,necrotic,0,1
214629,portion,0,0
214630,in,0,0
214631,the,0,0
214632,mid-coronal,0,1
214633,image,0,0
214634,(,0,0
214635,A,0,0
214636,),0,0
214637,and,0,0
214638,that,0,0
214639,in,0,0
214640,the,0,0
214641,mid-sagittal,0,1
214642,image,0,1
214643,(,0,1
214644,B,0,1
214645,),0,1
214646,were,0,0
214647,used,0,0
214648,to,0,0
214649,quantify,0,0
214650,the,0,0
214651,extent,0,0
214652,of,0,0
214653,necrosis,0,1
214654,by,0,0
214655,the,0,0
214656,formula,0,0
214657,:,0,0
214658,(,0,0
214659,A/180,0,0
214660,),0,1
214661,x,0,0
214662,(,0,1
214663,B/180,0,1
214664,),0,0
214665,x,0,0
214666,100,0,0
214667,.,0,0
214668,There,0,0
214669,was,0,0
214670,a,0,0
214671,strong,0,0
214672,correlation,0,0
214673,between,0,0
214674,this,0,0
214675,index,1,1
214676,and,1,0
214677,the,1,0
214678,risk,1,1
214679,of,1,0
214680,collapse,1,1
214681,before,0,0
214682,and,0,1
214683,after,0,0
214684,adjustment,0,1
214685,for,0,0
214686,age,0,0
214687,",",0,1
214688,gender,0,1
214689,",",0,1
214690,stage,0,1
214691,and,0,1
214692,treatment,0,0
214693,group,0,0
214694,.,0,0
214695,We,0,0
214696,conclude,0,0
214697,that,0,0
214698,the,0,0
214699,extent,1,0
214700,of,1,0
214701,the,1,0
214702,necrotic,1,1
214703,portion,1,0
214704,ascertain,0,0
214705,by,0,0
214706,this,0,0
214707,method,0,0
214708,is,0,0
214709,a,0,0
214710,major,0,1
214711,predictor,0,0
214712,of,0,1
214713,future,0,0
214714,collapse,0,1
214715,.,0,0
214716,We,0,0
214717,propose,0,0
214718,a,0,0
214719,systematic,0,0
214720,method,0,0
214721,of,0,0
214722,determining,0,0
214723,the,0,0
214724,index,0,1
214725,of,0,0
214726,the,0,0
214727,necrotic,1,1
214728,portion,1,0
214729,which,0,0
214730,may,0,0
214731,be,0,0
214732,clinically,0,0
214733,useful,0,0
214734,in,0,0
214735,the,0,0
214736,management,0,0
214737,of,0,0
214738,early-stage,0,0
214739,ON,1,0
214740,of,0,0
214741,the,0,0
214742,femoral,0,1
214743,head,0,0
214744,.,0,0
214745,Cisplatin,0,0
214746,plus,0,0
214747,etoposide,0,0
214748,with,0,0
214749,and,0,1
214750,without,0,0
214751,ifosfamide,0,0
214752,in,0,0
214753,extensive,0,0
214754,small-cell,0,0
214755,lung,0,0
214756,cancer,0,0
214757,:,0,0
214758,a,0,0
214759,Hoosier,0,0
214760,Oncology,0,1
214761,Group,0,0
214762,study,0,0
214763,.,0,0
214764,PURPOSE,0,0
214765,To,0,0
214766,determine,0,0
214767,whether,0,0
214768,the,0,0
214769,addition,0,0
214770,of,0,0
214771,ifosfamide,0,0
214772,to,0,0
214773,cisplatin,0,0
214774,plus,0,0
214775,etoposide,0,0
214776,improves,0,0
214777,the,0,0
214778,response,1,1
214779,rate,1,1
214780,",",1,0
214781,time,1,1
214782,to,1,0
214783,disease,1,1
214784,progression,1,1
214785,",",1,1
214786,or,1,1
214787,overall,1,1
214788,survival,1,1
214789,in,0,0
214790,previously,0,0
214791,untreated,0,0
214792,patients,0,0
214793,with,0,0
214794,extensive-stage,0,0
214795,small-cell,0,0
214796,carcinoma,0,0
214797,of,0,0
214798,the,0,0
214799,lung,0,0
214800,(,0,0
214801,SCLC,0,1
214802,),0,0
214803,.,0,0
214804,PATIENTS,0,0
214805,AND,0,0
214806,METHODS,0,0
214807,Patients,0,0
214808,with,0,0
214809,extensive,0,0
214810,SCLC,0,1
214811,with,0,0
214812,a,0,0
214813,Karnofsky,0,1
214814,performance,0,1
214815,score,0,1
214816,(,0,1
214817,KPS,0,1
214818,),0,1
214819,>,0,0
214820,or,0,0
214821,=,0,0
214822,50,0,0
214823,and,0,0
214824,adequate,0,0
214825,renal,0,1
214826,function,0,1
214827,and,0,1
214828,bone,0,1
214829,marrow,0,1
214830,reserve,0,1
214831,were,0,0
214832,eligible,0,0
214833,.,0,0
214834,Patients,0,0
214835,with,0,0
214836,CNS,0,0
214837,metastases,0,1
214838,were,0,0
214839,eligible,0,0
214840,and,0,1
214841,received,0,0
214842,concurrent,0,0
214843,whole-brain,0,0
214844,radiotherapy,0,0
214845,.,0,1
214846,Patients,0,0
214847,were,0,0
214848,randomized,0,0
214849,to,0,0
214850,receive,0,0
214851,cisplatin,0,0
214852,(,0,0
214853,20,0,0
214854,mg/m2,0,0
214855,),0,0
214856,plus,0,0
214857,etoposide,0,0
214858,(,0,0
214859,100,0,0
214860,mg/m2,0,0
214861,),0,0
214862,(,0,0
214863,VP,0,0
214864,),0,0
214865,both,0,0
214866,given,0,0
214867,intravenously,0,0
214868,(,0,0
214869,i.v,0,0
214870,.,0,0
214871,),0,0
214872,on,0,0
214873,days,0,0
214874,1,0,0
214875,to,0,0
214876,4,0,0
214877,or,0,0
214878,cisplatin,0,0
214879,(,0,0
214880,20,0,0
214881,mg/m2,0,0
214882,),0,0
214883,",",0,0
214884,ifosfamide,0,0
214885,(,0,0
214886,1.2,0,0
214887,g/m2,0,0
214888,),0,0
214889,",",0,1
214890,and,0,1
214891,etoposide,0,0
214892,(,0,0
214893,75,0,0
214894,mg/m2,0,0
214895,),0,0
214896,(,0,0
214897,VIP,0,0
214898,),0,0
214899,all,0,0
214900,given,0,0
214901,i.v,0,0
214902,.,0,0
214903,on,0,0
214904,days,0,0
214905,1,0,0
214906,to,0,0
214907,4,0,0
214908,.,0,0
214909,Cycles,0,0
214910,were,0,0
214911,repeated,0,0
214912,every,0,0
214913,3,0,0
214914,weeks,0,0
214915,for,0,0
214916,four,0,0
214917,cycles,0,0
214918,.,0,0
214919,RESULTS,0,0
214920,From,0,0
214921,May,0,0
214922,1989,0,0
214923,through,0,0
214924,March,0,0
214925,1993,0,0
214926,",",0,0
214927,171,0,0
214928,patients,0,0
214929,were,0,0
214930,randomized,0,0
214931,(,0,0
214932,84,0,0
214933,to,0,0
214934,VP,0,0
214935,and,0,0
214936,87,0,0
214937,to,0,0
214938,VIP,0,0
214939,),0,0
214940,.,0,0
214941,The,0,0
214942,median,0,1
214943,follow-up,0,0
214944,duration,0,1
214945,is,0,0
214946,26,0,0
214947,months,0,0
214948,.,0,0
214949,All,0,0
214950,patients,0,0
214951,were,0,0
214952,assessable,0,0
214953,for,0,0
214954,survival,1,1
214955,;,1,0
214956,163,0,0
214957,were,0,0
214958,fully,0,0
214959,assessable,1,0
214960,for,1,0
214961,response,1,1
214962,and,0,0
214963,162,0,0
214964,for,0,0
214965,toxicity,1,1
214966,.,1,1
214967,Myelosuppression,1,1
214968,was,0,0
214969,greater,1,0
214970,with,0,0
214971,VIP,0,0
214972,.,0,0
214973,Objective,1,1
214974,responses,1,1
214975,were,0,0
214976,observed,0,0
214977,in,0,0
214978,55,0,0
214979,of,0,0
214980,82,0,0
214981,(,0,0
214982,67,0,0
214983,%,0,0
214984,),0,0
214985,and,0,0
214986,59,0,0
214987,of,0,0
214988,81,0,0
214989,(,0,0
214990,73,0,0
214991,%,0,0
214992,),0,0
214993,assessable,0,0
214994,patients,0,0
214995,treated,0,0
214996,with,0,0
214997,VP,0,0
214998,and,0,1
214999,VIP,0,1
215000,",",0,1
215001,respectively,0,0
215002,(,0,0
215003,difference,0,0
215004,not,0,0
215005,significant,0,0
215006,),0,0
215007,.,0,0
215008,The,0,0
215009,difference,0,0
215010,in,0,0
215011,the,0,0
215012,median,1,1
215013,time,1,1
215014,to,1,0
215015,progression,1,1
215016,was,0,0
215017,statistically,0,0
215018,different,0,0
215019,(,0,0
215020,P,0,0
215021,=,0,0
215022,.039,0,0
215023,),0,0
215024,.,0,0
215025,The,0,0
215026,median,1,1
215027,survival,1,1
215028,times,1,1
215029,on,0,0
215030,VP,0,1
215031,and,0,1
215032,VIP,0,0
215033,were,0,0
215034,7.3,0,0
215035,months,0,0
215036,and,0,0
215037,9.0,0,0
215038,months,0,0
215039,",",0,0
215040,respectively,0,0
215041,(,0,0
215042,P,0,0
215043,=,0,0
215044,.045,0,0
215045,for,0,0
215046,survival,0,1
215047,curves,0,1
215048,by,0,0
215049,stratified,0,0
215050,log-rank,0,0
215051,test,0,1
215052,),0,0
215053,with,0,0
215054,2-year,1,0
215055,survival,1,1
215056,rates,1,1
215057,of,0,0
215058,5,0,0
215059,%,0,0
215060,versus,0,0
215061,13,0,0
215062,%,0,0
215063,",",0,0
215064,respectively,0,0
215065,.,0,0
215066,CONCLUSION,0,0
215067,VIP,0,1
215068,combination,0,0
215069,chemotherapy,0,0
215070,is,0,0
215071,associated,0,0
215072,with,0,0
215073,an,0,0
215074,improved,0,0
215075,time,1,1
215076,to,1,0
215077,progression,1,1
215078,and,1,1
215079,overall,1,1
215080,survival,1,1
215081,over,0,0
215082,VP,0,1
215083,therapy,0,0
215084,in,0,0
215085,patients,0,0
215086,with,0,0
215087,extensive,0,0
215088,SCLC,0,1
215089,.,0,0
215090,Brief,0,1
215091,report,0,0
215092,:,0,0
215093,a,0,0
215094,pilot,0,0
215095,study,0,0
215096,of,0,1
215097,auditory,1,1
215098,integration,1,1
215099,training,0,0
215100,in,0,0
215101,autism,0,0
215102,.,0,0
215103,Prospective,0,0
215104,trial,0,0
215105,of,0,1
215106,intraoperative,0,1
215107,mitomycin,0,0
215108,C,0,0
215109,in,0,0
215110,the,0,0
215111,treatment,0,0
215112,of,0,0
215113,primary,0,0
215114,pterygium,0,0
215115,.,0,0
215116,AIMS,0,0
215117,A,0,0
215118,prospective,0,0
215119,",",0,1
215120,randomised,0,0
215121,",",0,1
215122,double,0,0
215123,blind,0,0
215124,",",0,1
215125,placebo,0,0
215126,controlled,0,0
215127,study,0,0
215128,of,0,1
215129,intraoperative,0,1
215130,mitomycin,0,0
215131,C,0,0
215132,as,0,0
215133,adjunctive,0,0
215134,treatment,0,0
215135,of,0,1
215136,primary,0,1
215137,pterygium,0,0
215138,was,0,0
215139,conducted,0,0
215140,.,0,0
215141,METHODS,0,0
215142,A,0,0
215143,total,0,1
215144,of,0,0
215145,66,0,0
215146,eyes,0,0
215147,of,0,0
215148,54,0,0
215149,patients,0,0
215150,with,0,0
215151,primary,0,0
215152,pterygium,0,0
215153,were,0,0
215154,treated,0,0
215155,with,0,0
215156,excision,0,0
215157,",",0,1
215158,with,0,0
215159,or,0,0
215160,without,0,0
215161,a,0,0
215162,single,0,0
215163,intraoperative,0,1
215164,application,0,0
215165,of,0,1
215166,mitomycin,0,0
215167,C,0,0
215168,(,0,0
215169,0.1,0,0
215170,mg/ml,0,0
215171,for,0,0
215172,5,0,0
215173,minutes,0,0
215174,),0,0
215175,to,0,0
215176,evaluate,0,0
215177,the,0,0
215178,efficacy,1,1
215179,and,1,1
215180,toxicity,1,1
215181,of,0,0
215182,this,0,0
215183,adjunctive,0,0
215184,treatment,0,0
215185,.,0,0
215186,The,0,0
215187,mean,0,0
215188,follow,0,0
215189,up,0,0
215190,was,0,0
215191,14.1,0,0
215192,months,0,0
215193,(,0,0
215194,range,0,0
215195,12-23,0,0
215196,months,0,0
215197,),0,0
215198,.,0,0
215199,RESULTS,0,0
215200,Of,0,0
215201,the,0,0
215202,36,0,0
215203,eyes,0,0
215204,that,0,0
215205,underwent,0,0
215206,simple,0,0
215207,excision,0,0
215208,",",0,0
215209,14,0,0
215210,(,0,0
215211,38.8,0,0
215212,%,0,0
215213,),0,0
215214,exhibited,0,0
215215,recurrences,1,1
215216,whereas,0,0
215217,only,0,0
215218,one,0,0
215219,of,0,0
215220,30,0,0
215221,eyes,0,0
215222,(,0,0
215223,3.33,0,0
215224,%,0,0
215225,),0,0
215226,treated,0,0
215227,with,0,0
215228,excision,0,0
215229,and,0,1
215230,intraoperative,0,1
215231,application,0,0
215232,of,0,1
215233,mitomycin,0,0
215234,C,0,1
215235,had,0,0
215236,recurrence,1,1
215237,(,0,0
215238,p,0,0
215239,=,0,0
215240,0.0006,0,0
215241,),0,0
215242,.,0,0
215243,Neither,0,0
215244,serious,0,1
215245,ocular,1,1
215246,complications,1,1
215247,nor,1,0
215248,systemic,1,1
215249,toxicity,1,1
215250,were,0,0
215251,noted,0,0
215252,in,0,0
215253,the,0,0
215254,mitomycin,0,0
215255,C,0,0
215256,treated,0,0
215257,group,0,0
215258,.,0,1
215259,CONCLUSION,0,0
215260,Intraoperative,0,1
215261,mitomycin,0,0
215262,C,0,0
215263,appears,0,0
215264,to,0,0
215265,be,0,0
215266,an,0,0
215267,effective,0,1
215268,and,0,0
215269,safe,0,1
215270,adjunctive,0,0
215271,treatment,0,0
215272,of,0,1
215273,primary,0,0
215274,pterygium,0,0
215275,.,0,0
215276,Effect,0,1
215277,of,0,1
215278,postmenopausal,0,0
215279,hormonal,0,1
215280,replacement,0,0
215281,therapy,0,0
215282,on,0,0
215283,mammographic,1,1
215284,density,1,1
215285,and,1,1
215286,parenchymal,1,1
215287,pattern,1,0
215288,.,1,0
215289,PURPOSE,0,0
215290,To,0,0
215291,measure,0,0
215292,changes,0,1
215293,and,0,1
215294,predictors,0,1
215295,of,0,1
215296,change,0,1
215297,in,0,0
215298,mammograms,0,1
215299,obtained,0,0
215300,in,0,0
215301,postmenopausal,0,0
215302,women,0,0
215303,undergoing,0,0
215304,continuous,0,0
215305,combined,0,0
215306,hormonal,0,0
215307,replacement,0,0
215308,therapy,0,0
215309,(,0,1
215310,HRT,0,0
215311,),0,0
215312,.,0,0
215313,MATERIALS,0,0
215314,AND,0,0
215315,METHODS,0,0
215316,Mammograms,0,1
215317,of,0,0
215318,41,0,0
215319,postmenopausal,0,0
215320,women,0,0
215321,obtained,0,0
215322,before,0,0
215323,and,0,0
215324,1,0,0
215325,year,0,0
215326,after,0,0
215327,the,0,0
215328,initiation,0,0
215329,of,0,1
215330,HRT,0,1
215331,were,0,0
215332,evaluated,0,0
215333,blindly,0,0
215334,according,0,0
215335,to,0,0
215336,the,0,0
215337,quantitative,0,0
215338,density,0,1
215339,percentage,0,1
215340,method,0,0
215341,and,0,0
215342,the,0,0
215343,Wolfe,0,1
215344,classification,0,1
215345,system,0,0
215346,.,0,1
215347,RESULTS,0,0
215348,Mammographic,1,1
215349,densities,1,1
215350,increased,0,0
215351,compared,0,0
215352,with,0,0
215353,baseline,0,0
215354,values,0,1
215355,in,0,0
215356,73,0,0
215357,%,0,0
215358,of,0,0
215359,subjects,0,0
215360,(,0,0
215361,mean,0,1
215362,increase,0,1
215363,",",0,0
215364,6.7,0,0
215365,%,0,0
215366,;,0,0
215367,95,0,0
215368,%,0,0
215369,confidence,0,0
215370,interval,0,0
215371,",",0,0
215372,2.5,0,0
215373,%,0,0
215374,",",0,0
215375,11.0,0,0
215376,%,0,0
215377,;,0,0
215378,P,0,0
215379,=,0,0
215380,.003,0,0
215381,),0,0
215382,.,0,0
215383,A,0,0
215384,shift,0,0
215385,in,0,0
215386,Wolfe,0,0
215387,classification,0,1
215388,from,0,0
215389,lower,1,0
215390,to,1,0
215391,greater,1,1
215392,parenchymal,1,1
215393,density,1,1
215394,was,0,0
215395,noted,0,0
215396,in,0,0
215397,24,0,0
215398,%,0,0
215399,of,0,0
215400,subjects,0,0
215401,(,0,0
215402,P,0,0
215403,=,0,0
215404,.016,0,0
215405,),0,0
215406,.,0,0
215407,Multivariate,0,0
215408,analysis,0,0
215409,results,0,0
215410,indicated,0,0
215411,that,0,0
215412,the,0,0
215413,lower,0,0
215414,the,0,0
215415,tissue,1,1
215416,density,1,1
215417,percentage,1,1
215418,before,0,0
215419,treatment,0,0
215420,",",0,0
215421,the,0,0
215422,greater,0,0
215423,the,0,0
215424,increase,1,1
215425,in,1,0
215426,density,1,1
215427,percentage,1,1
215428,after,0,0
215429,treatment,0,0
215430,.,0,0
215431,CONCLUSION,0,0
215432,An,0,0
215433,increase,0,0
215434,in,0,0
215435,mammographic,1,1
215436,density,1,1
215437,was,0,0
215438,demonstrated,0,0
215439,in,0,0
215440,most,0,0
215441,subjects,0,0
215442,undergoing,0,0
215443,continuous,0,0
215444,combined,0,0
215445,HRT,0,1
215446,and,0,1
215447,was,0,0
215448,most,0,0
215449,pronounced,0,0
215450,in,0,0
215451,subjects,0,0
215452,with,0,0
215453,a,0,0
215454,lower,0,0
215455,baseline,0,1
215456,density,0,1
215457,percentage,0,1
215458,.,0,0
215459,Efficacy,0,1
215460,of,0,1
215461,Contractubex,0,1
215462,gel,0,0
215463,in,0,0
215464,the,0,0
215465,treatment,0,0
215466,of,0,0
215467,fresh,0,0
215468,scars,0,1
215469,after,0,0
215470,thoracic,0,0
215471,surgery,0,0
215472,in,0,0
215473,children,0,0
215474,and,0,0
215475,adolescents,0,0
215476,.,0,1
215477,Scar,0,1
215478,development,0,1
215479,was,0,0
215480,investigated,0,0
215481,in,0,0
215482,45,0,0
215483,young,0,0
215484,patients,0,0
215485,who,0,0
215486,had,0,0
215487,undergone,0,0
215488,thoracic,0,0
215489,surgery,0,0
215490,.,0,1
215491,Patients,0,0
215492,were,0,0
215493,randomly,0,0
215494,assigned,0,0
215495,either,0,0
215496,to,0,0
215497,a,0,0
215498,group,0,0
215499,which,0,0
215500,was,0,0
215501,treated,0,0
215502,topically,0,0
215503,with,0,0
215504,Contractubex,0,1
215505,gel,0,0
215506,(,0,0
215507,Merz,0,0
215508,+,0,1
215509,Co.,0,0
215510,",",0,1
215511,D-Frankfurt/Main,0,0
215512,),0,1
215513,",",0,0
215514,containing,0,0
215515,10,0,0
215516,%,0,0
215517,onion,0,0
215518,extract,0,0
215519,",",0,0
215520,50/U,0,0
215521,of,0,0
215522,sodium,0,0
215523,heparin,0,0
215524,per,0,0
215525,one,0,0
215526,g,0,0
215527,of,0,0
215528,gel,0,0
215529,and,0,0
215530,1,0,0
215531,%,0,0
215532,allantoin,0,1
215533,",",0,1
215534,or,0,0
215535,to,0,0
215536,a,0,0
215537,group,0,0
215538,receiving,0,0
215539,no,0,0
215540,treatment,0,0
215541,.,0,0
215542,The,0,0
215543,treatment,0,0
215544,began,0,0
215545,on,0,0
215546,average,0,0
215547,26,0,0
215548,days,0,0
215549,after,0,0
215550,the,0,0
215551,operation,0,0
215552,and,0,1
215553,was,0,0
215554,continued,0,0
215555,for,0,0
215556,one,0,0
215557,year,0,0
215558,.,0,0
215559,The,0,0
215560,scars,0,1
215561,of,0,0
215562,all,0,0
215563,treated,0,0
215564,and,0,0
215565,untreated,0,0
215566,patients,0,0
215567,were,0,0
215568,evaluated,0,0
215569,at,0,0
215570,monthly,0,0
215571,intervals,0,0
215572,.,0,0
215573,The,0,0
215574,appearance,1,0
215575,of,1,0
215576,the,1,0
215577,scar,1,1
215578,",",1,0
215579,including,1,0
215580,scar,1,1
215581,type,1,1
215582,and,1,1
215583,scar,1,1
215584,size,1,1
215585,as,1,0
215586,well,1,0
215587,as,1,0
215588,scar,1,1
215589,colour,1,1
215590,",",0,1
215591,was,0,0
215592,assessed,0,0
215593,by,0,0
215594,the,0,0
215595,physician,0,0
215596,.,0,0
215597,A,0,0
215598,reduction,0,1
215599,of,0,0
215600,the,0,0
215601,increase,0,0
215602,of,0,1
215603,scar,1,1
215604,width,0,1
215605,was,0,0
215606,seen,0,0
215607,in,0,0
215608,the,0,0
215609,Contractubex-treated,0,0
215610,group,0,0
215611,as,0,0
215612,compared,0,0
215613,with,0,0
215614,the,0,0
215615,untreated,0,0
215616,group,0,0
215617,.,0,1
215618,Further,0,1
215619,",",0,0
215620,physiological,1,1
215621,scars,1,1
215622,and,1,1
215623,skin-coloured,1,1
215624,scars,1,1
215625,were,0,0
215626,more,0,0
215627,frequent,0,1
215628,in,0,0
215629,the,0,0
215630,treated,0,0
215631,group,0,0
215632,than,0,0
215633,in,0,0
215634,the,0,0
215635,untreated,0,0
215636,group,0,0
215637,.,0,1
215638,Hypertrophic,1,1
215639,or,1,0
215640,keloidal,1,1
215641,scars,1,1
215642,were,0,0
215643,less,0,0
215644,frequent,0,1
215645,in,0,0
215646,the,0,0
215647,treated,0,0
215648,group,0,0
215649,.,0,0
215650,No,0,0
215651,differences,0,0
215652,in,0,0
215653,scar,1,1
215654,length,1,1
215655,and,1,1
215656,scar,1,1
215657,height,1,1
215658,were,0,0
215659,seen,0,0
215660,.,0,0
215661,At,0,0
215662,the,0,0
215663,end,0,0
215664,of,0,0
215665,the,0,0
215666,observation,0,0
215667,period,0,0
215668,",",0,0
215669,the,0,0
215670,clinical,0,1
215671,course,0,0
215672,of,0,1
215673,scar,1,1
215674,development,1,1
215675,was,0,0
215676,rated,0,1
215677,as,0,0
215678,very,0,0
215679,good,0,0
215680,or,0,0
215681,good,0,0
215682,in,0,0
215683,more,0,0
215684,than,0,0
215685,90,0,0
215686,%,0,0
215687,of,0,0
215688,the,0,0
215689,treated,0,0
215690,patients,0,0
215691,",",0,0
215692,good,0,0
215693,in,0,0
215694,less,0,0
215695,than,0,0
215696,40,0,0
215697,%,0,0
215698,and,0,0
215699,moderate,0,0
215700,or,0,1
215701,bad,0,1
215702,in,0,0
215703,more,0,0
215704,than,0,0
215705,60,0,0
215706,%,0,0
215707,of,0,0
215708,the,0,0
215709,untreated,0,0
215710,cases,0,0
215711,.,0,0
215712,The,0,0
215713,tolerability,0,1
215714,of,0,0
215715,the,0,0
215716,drug,0,0
215717,was,0,0
215718,good,0,0
215719,or,0,0
215720,very,0,0
215721,good,0,0
215722,in,0,0
215723,all,0,0
215724,cases,0,0
215725,.,0,0
215726,In,0,0
215727,conclusion,0,0
215728,",",0,1
215729,Contractubex,0,1
215730,gel,0,0
215731,is,0,0
215732,useful,0,0
215733,in,0,0
215734,scar,0,1
215735,treatment,0,0
215736,after,0,0
215737,thoracic,0,0
215738,surgery,0,0
215739,.,0,0
215740,Cyproheptadine,0,0
215741,augmentation,0,1
215742,of,0,1
215743,haloperidol,0,0
215744,in,0,0
215745,chronic,0,0
215746,schizophrenic,0,0
215747,patients,0,0
215748,:,0,0
215749,a,0,0
215750,double-blind,0,0
215751,placebo-controlled,0,0
215752,study,0,0
215753,.,0,0
215754,A,0,0
215755,6,0,0
215756,week,0,0
215757,double-blind,0,0
215758,placebo-controlled,0,0
215759,trial,0,0
215760,of,0,1
215761,cyproheptadine,0,0
215762,augmentation,0,1
215763,of,0,1
215764,ongoing,0,0
215765,haloperidol,0,0
215766,treatment,0,0
215767,was,0,0
215768,conducted,0,0
215769,in,0,0
215770,40,0,0
215771,chronic,0,0
215772,schizophrenic,0,0
215773,in-patients,0,0
215774,.,0,0
215775,Cyproheptadine,0,0
215776,augmentation,0,1
215777,",",0,0
215778,compared,0,0
215779,to,0,0
215780,administration,0,0
215781,of,0,1
215782,haloperidol,0,0
215783,with,0,0
215784,placebo,0,0
215785,",",0,1
215786,did,0,0
215787,not,0,0
215788,produce,0,0
215789,a,0,0
215790,statistically,0,0
215791,significant,0,0
215792,improvement,0,1
215793,in,0,0
215794,psychotic,1,1
215795,symptoms,1,1
215796,.,1,0
215797,Cyproheptadine,0,0
215798,augmentation,0,1
215799,caused,0,0
215800,significant,0,0
215801,reduction,0,1
215802,in,0,0
215803,the,0,0
215804,extrapyramidal,1,1
215805,symptoms,1,1
215806,",",0,0
215807,which,0,0
215808,supports,0,0
215809,the,0,0
215810,atypical,0,0
215811,profile,0,1
215812,of,0,0
215813,antipsychotics,0,0
215814,.,0,0
215815,As,0,0
215816,to,0,0
215817,the,0,0
215818,neuroendocrinological,1,1
215819,effect,1,1
215820,",",0,1
215821,cyproheptadine,0,0
215822,augmentation,0,1
215823,did,0,0
215824,not,0,0
215825,reduce,0,0
215826,the,0,0
215827,plasma,1,1
215828,prolactin,1,1
215829,level,1,1
215830,but,0,0
215831,did,0,0
215832,induce,0,0
215833,a,0,0
215834,decrease,0,0
215835,in,0,0
215836,the,0,0
215837,plasma,1,1
215838,cortisol,1,1
215839,level,1,1
215840,.,1,0
215841,Although,0,0
215842,long-term,0,0
215843,follow-up,0,0
215844,studies,0,0
215845,are,0,0
215846,needed,0,0
215847,to,0,0
215848,confirm,0,0
215849,the,0,0
215850,results,0,0
215851,",",0,0
215852,this,0,0
215853,study,0,0
215854,suggests,0,0
215855,that,0,0
215856,cyproheptadine,0,0
215857,augmentation,0,0
215858,may,0,0
215859,be,0,0
215860,effective,0,1
215861,in,0,0
215862,treating,0,0
215863,chronic,1,0
215864,schizophrenic,1,0
215865,patients,1,0
215866,who,0,0
215867,are,0,0
215868,intolerant,0,0
215869,of,0,0
215870,extrapyramidal,1,1
215871,side,1,1
215872,effects,1,1
215873,of,0,0
215874,conventional,0,0
215875,antipsychotics,0,0
215876,.,0,0
215877,Comparison,0,0
215878,of,0,1
215879,eltanolone,0,1
215880,and,0,1
215881,thiopental,0,0
215882,in,0,0
215883,anaesthesia,1,0
215884,for,0,0
215885,termination,0,0
215886,of,0,0
215887,pregnancy,0,1
215888,.,0,1
215889,Eltanolone,0,1
215890,",",0,0
215891,a,0,0
215892,new,0,1
215893,steroid,0,0
215894,hypnotic,0,1
215895,",",0,1
215896,was,0,0
215897,compared,0,0
215898,to,0,0
215899,thiopental,0,0
215900,in,0,0
215901,short,0,0
215902,anaesthesia,0,0
215903,.,0,1
215904,Sixty,0,0
215905,unpremedicated,0,0
215906,",",0,0
215907,Asa,0,1
215908,1-2,0,1
215909,women,0,0
215910,were,0,0
215911,randomized,0,0
215912,to,0,0
215913,receive,0,0
215914,eltanolone,0,0
215915,0.6,0,0
215916,(,0,0
215917,group,0,0
215918,E1,0,1
215919,),0,0
215920,or,0,0
215921,0.8,0,0
215922,mg.kg-1,0,0
215923,(,0,0
215924,group,0,0
215925,E2,0,1
215926,),0,1
215927,or,0,0
215928,thiopental,0,0
215929,4,0,0
215930,mg.kg-1,0,0
215931,(,0,0
215932,group,0,0
215933,T,0,1
215934,),0,0
215935,for,0,0
215936,induction,0,0
215937,of,0,0
215938,anaesthesia,0,0
215939,.,0,0
215940,One,0,0
215941,minute,0,0
215942,before,0,0
215943,induction,0,0
215944,glycopyrrolate,0,0
215945,0.2,0,0
215946,mg,0,0
215947,and,0,0
215948,alfentanil,0,0
215949,15,0,0
215950,micrograms.kg-1,0,0
215951,i.v,0,0
215952,.,0,1
215953,were,0,0
215954,administered,0,0
215955,.,0,0
215956,If,0,0
215957,induction,0,1
215958,failed,0,0
215959,",",0,0
215960,additional,0,0
215961,boluses,0,0
215962,of,0,0
215963,the,0,0
215964,test,0,1
215965,drug,0,0
215966,were,0,0
215967,given,0,0
215968,.,0,0
215969,Anaesthesia,0,1
215970,was,0,0
215971,maintained,0,0
215972,with,0,0
215973,67,0,0
215974,%,0,0
215975,nitrous,0,0
215976,oxide,0,1
215977,in,0,0
215978,oxygen,0,1
215979,",",0,1
215980,and,0,1
215981,additional,0,0
215982,bolus,0,0
215983,doses,0,0
215984,of,0,0
215985,the,0,0
215986,test,0,1
215987,drug,0,0
215988,were,0,0
215989,given,0,0
215990,in,0,0
215991,a,0,0
215992,standardized,0,0
215993,fashion,0,0
215994,",",0,0
215995,if,0,0
215996,needed,0,0
215997,.,0,0
215998,Recovery,1,1
215999,was,0,0
216000,assessed,0,0
216001,by,0,0
216002,a,0,0
216003,research,0,0
216004,nurse,0,0
216005,blinded,0,0
216006,to,0,0
216007,the,0,0
216008,agent,0,0
216009,used,0,0
216010,.,0,0
216011,Mean,1,0
216012,+/-,1,0
216013,s.d,1,0
216014,.,1,1
216015,induction,1,1
216016,doss,1,1
216017,were,0,0
216018,0.7,0,0
216019,+/-,0,0
216020,0.1,0,0
216021,mg.kg-1,0,0
216022,(,0,0
216023,group,0,0
216024,E1,0,1
216025,),0,0
216026,",",0,0
216027,0.8,0,0
216028,+/-,0,0
216029,0.1,0,0
216030,mg.kg-1,0,0
216031,(,0,0
216032,group,0,0
216033,E2,0,1
216034,),0,0
216035,and,0,0
216036,4.0,0,0
216037,+/-,0,0
216038,0.0,0,0
216039,mg.kg-1,0,0
216040,(,0,0
216041,group,0,0
216042,T,0,0
216043,),0,0
216044,.,0,0
216045,Induction,1,1
216046,time,1,1
216047,was,0,0
216048,prolonged,0,0
216049,in,0,0
216050,the,0,0
216051,group,0,0
216052,E1,0,0
216053,compared,0,0
216054,to,0,0
216055,the,0,0
216056,other,0,0
216057,two,0,0
216058,groups,0,0
216059,(,0,0
216060,P,0,0
216061,<,0,0
216062,0.05,0,0
216063,),0,0
216064,.,0,0
216065,Side,1,0
216066,effects,1,1
216067,were,0,0
216068,few,0,0
216069,in,0,0
216070,all,0,0
216071,groups,0,0
216072,",",0,0
216073,but,0,0
216074,involuntary,1,1
216075,muscle,1,1
216076,movements,1,1
216077,or,1,1
216078,hypertonus,1,1
216079,occurred,0,0
216080,in,0,0
216081,23,0,0
216082,%,0,0
216083,of,0,0
216084,the,0,0
216085,patients,0,0
216086,in,0,0
216087,the,0,0
216088,eltanolone,0,1
216089,and,0,0
216090,in,0,0
216091,3,0,0
216092,%,0,0
216093,in,0,0
216094,the,0,0
216095,thiopental,0,0
216096,groups,0,0
216097,(,0,1
216098,n.s,0,0
216099,),0,0
216100,.,0,0
216101,Early,1,1
216102,recovery,1,1
216103,(,1,1
216104,eye,1,1
216105,opening,1,1
216106,",",1,1
216107,orientation,1,1
216108,and,1,1
216109,sitting,1,1
216110,),1,1
216111,was,0,0
216112,slower,0,0
216113,in,0,0
216114,both,0,0
216115,eltanolone,0,0
216116,groups,0,0
216117,compared,0,0
216118,to,0,0
216119,the,0,0
216120,thiopental,0,0
216121,group,0,0
216122,(,0,0
216123,P,0,0
216124,<,0,0
216125,0.01,0,0
216126,),0,0
216127,.,0,0
216128,No,0,0
216129,differences,0,0
216130,between,0,0
216131,the,0,0
216132,groups,0,0
216133,were,0,0
216134,found,0,0
216135,in,0,0
216136,toleration,0,1
216137,of,0,0
216138,oral,0,0
216139,fluids,0,0
216140,",",0,1
216141,walking,0,1
216142,",",0,1
216143,voiding,0,1
216144,",",0,1
216145,postoperative,0,1
216146,analgesic,0,1
216147,requirements,0,1
216148,or,0,1
216149,postoperative,0,1
216150,nausea,0,1
216151,and,0,1
216152,vomiting,0,1
216153,.,0,1
216154,(,0,0
216155,ABSTRACT,0,1
216156,TRUNCATED,0,0
216157,AT,0,0
216158,250,0,0
216159,WORDS,0,0
216160,),0,0
216161,Dose-related,0,1
216162,difference,0,0
216163,in,0,0
216164,progression,0,1
216165,rates,0,1
216166,of,0,1
216167,cytomegalovirus,0,0
216168,retinopathy,0,1
216169,during,0,0
216170,foscarnet,0,0
216171,maintenance,0,0
216172,therapy,0,0
216173,.,0,1
216174,AIDS,0,0
216175,Clinical,0,1
216176,Trials,0,1
216177,Group,0,0
216178,Protocol,0,0
216179,915,0,0
216180,Team,0,0
216181,.,0,0
216182,PURPOSE,0,0
216183,A,0,0
216184,previous,0,0
216185,dose-ranging,0,0
216186,study,0,0
216187,of,0,1
216188,foscarnet,0,0
216189,maintenance,0,0
216190,therapy,0,0
216191,for,0,0
216192,cytomegalovirus,0,1
216193,retinopathy,0,1
216194,showed,0,0
216195,a,0,0
216196,positive,0,1
216197,relationship,0,1
216198,between,0,0
216199,dose,0,0
216200,and,0,1
216201,survival,0,1
216202,but,0,0
216203,could,0,0
216204,not,0,0
216205,confirm,0,0
216206,a,0,0
216207,relationship,0,0
216208,between,0,0
216209,dose,0,0
216210,and,0,1
216211,time,0,1
216212,to,0,0
216213,first,0,0
216214,progression,0,1
216215,.,0,0
216216,This,0,0
216217,retrospective,0,0
216218,analysis,0,0
216219,of,0,0
216220,data,0,0
216221,from,0,0
216222,that,0,0
216223,study,0,0
216224,was,0,0
216225,undertaken,0,0
216226,to,0,0
216227,determine,0,0
216228,whether,0,0
216229,there,0,0
216230,was,0,0
216231,a,0,0
216232,relationship,0,1
216233,between,0,0
216234,dose,0,0
216235,and,0,1
216236,progression,0,1
216237,rates,0,1
216238,",",0,0
216239,which,0,0
216240,reflects,0,0
216241,the,0,0
216242,amount,0,1
216243,of,0,0
216244,retina,0,1
216245,destroyed,0,0
216246,when,0,0
216247,progression,0,1
216248,occurs,0,0
216249,.,0,0
216250,METHODS,0,0
216251,Patients,0,0
216252,were,0,0
216253,randomly,0,0
216254,given,0,0
216255,one,0,0
216256,of,0,0
216257,two,0,0
216258,foscarnet,0,0
216259,maintenance,0,0
216260,therapy,0,0
216261,doses,0,0
216262,(,0,0
216263,90,0,0
216264,mg/kg,0,0
216265,of,0,0
216266,body,0,1
216267,weight/day,0,0
216268,[,0,0
216269,FOS-90,0,1
216270,group,0,0
216271,],0,0
216272,or,0,0
216273,120,0,0
216274,mg/kg,0,0
216275,of,0,0
216276,body,0,1
216277,weight/day,0,0
216278,[,0,0
216279,FOS-120,0,0
216280,group,0,0
216281,],0,0
216282,after,0,0
216283,induction,0,0
216284,therapy,0,0
216285,.,0,1
216286,Using,0,1
216287,baseline,0,0
216288,and,0,1
216289,follow-up,0,1
216290,photographs,0,1
216291,and,0,1
216292,pre-established,0,1
216293,definitions,0,1
216294,and,0,1
216295,methodology,0,0
216296,in,0,0
216297,a,0,0
216298,masked,0,0
216299,analysis,0,0
216300,",",0,1
216301,posterior,0,0
216302,progression,0,1
216303,rates,0,1
216304,and,0,1
216305,foveal,0,1
216306,proximity,0,1
216307,rates,0,1
216308,for,0,0
216309,individual,0,0
216310,lesions,0,1
216311,",",0,0
216312,selected,0,0
216313,by,0,0
216314,prospectively,0,0
216315,defined,0,0
216316,criteria,0,0
216317,",",0,0
216318,were,0,0
216319,calculated,0,0
216320,in,0,0
216321,each,0,0
216322,patient,0,0
216323,.,0,0
216324,Rates,0,1
216325,were,0,0
216326,compared,0,0
216327,between,0,0
216328,groups,0,0
216329,.,0,0
216330,RESULTS,0,0
216331,The,0,0
216332,following,0,0
216333,median,1,1
216334,rates,1,1
216335,were,0,0
216336,greater,0,0
216337,for,0,0
216338,the,0,0
216339,FOS-90,0,1
216340,group,0,0
216341,(,0,0
216342,N,0,0
216343,=,0,0
216344,8,0,0
216345,),0,0
216346,than,0,0
216347,for,0,0
216348,the,0,0
216349,FOS-120,0,0
216350,group,0,0
216351,(,0,0
216352,N,0,0
216353,=,0,0
216354,10,0,0
216355,),0,0
216356,:,0,0
216357,greatest,1,0
216358,maximum,1,1
216359,rate,1,1
216360,at,1,0
216361,which,1,0
216362,lesions,1,1
216363,enlarged,0,0
216364,in,0,0
216365,a,0,0
216366,posterior,0,0
216367,direction,0,1
216368,(,0,0
216369,43.5,0,0
216370,vs,0,0
216371,12.5,0,0
216372,microns/day,0,0
216373,;,0,0
216374,P,0,0
216375,=,0,0
216376,.002,0,0
216377,),0,0
216378,;,0,0
216379,posterior,1,0
216380,progression,1,1
216381,rate,1,1
216382,for,1,0
216383,lesions,1,1
216384,closest,1,0
216385,to,1,0
216386,the,1,0
216387,fovea,1,1
216388,(,0,0
216389,42.8,0,0
216390,vs,0,0
216391,5.5,0,0
216392,microns/day,0,0
216393,;,0,0
216394,P,0,0
216395,=,0,0
216396,.010,0,0
216397,),0,0
216398,;,0,0
216399,and,0,1
216400,maximum,1,1
216401,foveal,1,1
216402,proximity,1,1
216403,rate,1,1
216404,for,1,0
216405,either,1,0
216406,eye,1,0
216407,(,0,0
216408,32.3,0,0
216409,vs,0,0
216410,3.4,0,0
216411,microns/day,0,0
216412,;,0,0
216413,P,0,0
216414,=,0,0
216415,.031,0,0
216416,),0,0
216417,.,0,0
216418,CONCLUSION,0,0
216419,Patients,0,0
216420,receiving,0,0
216421,higher,0,0
216422,doses,0,0
216423,of,0,0
216424,foscarnet,0,0
216425,have,0,0
216426,slower,0,0
216427,rates,0,1
216428,of,0,0
216429,progression,0,1
216430,and,0,0
216431,therefore,0,0
216432,less,0,0
216433,retinal,0,1
216434,tissue,0,1
216435,damage,0,1
216436,during,0,0
216437,maintenance,0,0
216438,therapy,0,0
216439,.,0,0
216440,A,0,0
216441,foscarnet,0,0
216442,maintenance,0,0
216443,therapy,0,0
216444,dose,0,0
216445,of,0,0
216446,120,0,0
216447,mg/kg,0,0
216448,of,0,0
216449,body,0,1
216450,weight/day,0,0
216451,instead,0,0
216452,of,0,0
216453,90,0,0
216454,mg/kg,0,0
216455,of,0,0
216456,body,0,1
216457,weight/day,0,0
216458,may,0,0
216459,help,0,0
216460,to,0,0
216461,preserve,0,0
216462,vision,0,1
216463,in,0,0
216464,patients,0,0
216465,with,0,0
216466,cytomegalovirus,0,0
216467,retinopathy,0,1
216468,.,0,0
216469,The,0,0
216470,costs,1,1
216471,and,0,0
216472,effects,1,1
216473,of,0,0
216474,a,0,0
216475,nutritional,0,1
216476,education,0,0
216477,program,0,0
216478,following,0,0
216479,work-site,0,0
216480,cholesterol,0,1
216481,screening,0,0
216482,.,0,0
216483,OBJECTIVES,0,0
216484,The,0,0
216485,purpose,0,0
216486,of,0,0
216487,this,0,0
216488,study,0,0
216489,was,0,0
216490,to,0,0
216491,assess,0,0
216492,the,0,0
216493,costs,1,1
216494,and,0,1
216495,impact,1,0
216496,of,0,0
216497,a,0,0
216498,nutrition,0,1
216499,education,0,0
216500,program,0,0
216501,following,0,0
216502,a,0,0
216503,cholesterol,0,1
216504,screening,0,0
216505,.,0,1
216506,METHODS,0,0
216507,Forty,0,0
216508,work-sites,0,0
216509,were,0,0
216510,randomly,0,0
216511,assigned,0,0
216512,to,0,0
216513,one,0,0
216514,of,0,0
216515,two,0,0
216516,educational,0,0
216517,interventions,0,0
216518,:,0,0
216519,a,0,0
216520,usual,0,0
216521,intervention,0,0
216522,of,0,0
216523,5,0,0
216524,minutes,0,0
216525,of,0,0
216526,counseling,0,0
216527,",",0,0
216528,or,0,0
216529,a,0,0
216530,special,0,0
216531,intervention,0,0
216532,of,0,0
216533,2,0,0
216534,hours,0,0
216535,of,0,0
216536,behaviorally,0,0
216537,based,0,0
216538,education,0,0
216539,on,0,0
216540,dietary,0,0
216541,changes,0,1
216542,to,0,0
216543,lower,0,1
216544,serum,0,1
216545,cholesterol,0,1
216546,.,0,1
216547,Costs,1,0
216548,were,0,0
216549,monitored,0,0
216550,",",0,0
216551,and,0,1
216552,cholesterol,1,1
216553,levels,1,1
216554,were,0,0
216555,retested,0,0
216556,6,0,0
216557,and,0,0
216558,12,0,0
216559,months,0,0
216560,later,0,0
216561,.,0,0
216562,RESULTS,0,0
216563,The,0,0
216564,total,1,1
216565,per-person,1,1
216566,cost,1,1
216567,for,0,0
216568,screening,0,0
216569,and,0,0
216570,the,0,0
216571,educational,0,0
216572,intervention,0,0
216573,was,0,0
216574,about,0,0
216575,$,0,0
216576,50,0,0
216577,.,0,0
216578,Cholesterol,1,0
216579,levels,1,1
216580,differed,0,0
216581,little,0,0
216582,between,0,0
216583,the,0,0
216584,two,0,0
216585,intervention,0,0
216586,groups,0,0
216587,6,0,0
216588,months,0,0
216589,after,0,0
216590,screening,0,0
216591,",",0,0
216592,but,0,0
216593,after,0,0
216594,12,0,0
216595,months,0,0
216596,those,0,0
216597,in,0,0
216598,the,0,0
216599,special,0,0
216600,intervention,0,0
216601,worksites,0,0
216602,showed,0,0
216603,a,0,0
216604,6.5,0,0
216605,%,0,0
216606,drop,0,0
216607,in,0,0
216608,cholesterol,1,1
216609,",",0,0
216610,whereas,0,0
216611,those,0,0
216612,at,0,0
216613,the,0,0
216614,usual,0,0
216615,intervention,0,0
216616,worksites,0,0
216617,showed,0,0
216618,a,0,0
216619,drop,0,0
216620,of,0,0
216621,only,0,0
216622,3.0,0,0
216623,%,0,0
216624,.,0,0
216625,Hence,0,0
216626,a,0,0
216627,3.5,0,0
216628,%,0,0
216629,cholesterol,1,1
216630,reduction,1,1
216631,was,0,0
216632,attributable,0,0
216633,to,0,0
216634,the,0,0
216635,special,0,0
216636,intervention,0,0
216637,.,0,0
216638,CONCLUSIONS,0,0
216639,A,0,0
216640,behaviorally,0,0
216641,based,0,0
216642,nutrition,0,1
216643,education,0,0
216644,program,0,0
216645,following,0,0
216646,cholesterol,0,1
216647,screening,0,0
216648,can,0,0
216649,have,0,0
216650,a,0,0
216651,meaningful,0,1
216652,impact,0,0
216653,on,0,0
216654,long-term,0,1
216655,cholesterol,0,1
216656,levels,0,1
216657,at,0,0
216658,a,0,0
216659,low,0,0
216660,cost,0,1
216661,.,0,1
216662,Nutrition,0,1
216663,education,0,0
216664,in,0,0
216665,work-sites,0,0
216666,may,0,0
216667,therefore,0,0
216668,be,0,0
216669,a,0,0
216670,useful,0,0
216671,way,0,0
216672,to,0,0
216673,lower,0,0
216674,the,0,0
216675,risk,0,1
216676,of,0,1
216677,heart,0,1
216678,disease,0,1
216679,in,0,0
216680,communities,0,0
216681,.,0,0
216682,[,0,0
216683,Postoperative,0,1
216684,analgesia,0,1
216685,:,0,0
216686,peridural,0,0
216687,morphine,0,1
216688,versus,0,0
216689,sublingual,0,1
216690,buprenorphine,0,0
216691,.,0,0
216692,Comparative,0,0
216693,clinical,0,1
216694,study,0,0
216695,],0,0
216696,.,0,0
216697,The,0,0
216698,authors,0,0
216699,herein,0,0
216700,present,0,0
216701,their,0,0
216702,personal,0,1
216703,series,0,0
216704,on,0,0
216705,the,0,0
216706,clinical,0,0
216707,evaluation,0,0
216708,of,0,0
216709,the,0,0
216710,analgesic,0,1
216711,efficacy,0,1
216712,of,0,0
216713,2,0,0
216714,opiodes,0,0
216715,",",0,0
216716,peridural,0,0
216717,morphine,0,1
216718,hydrochloride,0,0
216719,(,0,0
216720,0.5,0,0
216721,mg/kg,0,0
216722,),0,0
216723,administered,0,0
216724,to,0,0
216725,group,0,0
216726,A,0,0
216727,patients,0,0
216728,",",0,1
216729,and,0,1
216730,sublingual,0,1
216731,buprenorphine,0,0
216732,(,0,0
216733,0.4,0,0
216734,mg,0,0
216735,),0,0
216736,administered,0,0
216737,to,0,0
216738,group,0,0
216739,B,0,0
216740,patients,0,0
216741,in,0,0
216742,the,0,0
216743,management,0,0
216744,of,0,0
216745,post-operative,0,1
216746,pain,0,1
216747,in,0,0
216748,major,0,1
216749,abdominal,0,1
216750,surgery,0,0
216751,.,0,0
216752,The,0,0
216753,study,0,0
216754,was,0,0
216755,conducted,0,0
216756,on,0,0
216757,44,0,0
216758,patients,0,0
216759,",",0,0
216760,both,0,0
216761,male,0,0
216762,and,0,1
216763,female,0,0
216764,",",0,1
216765,classified,0,0
216766,as,0,0
216767,ASA,0,1
216768,II,0,0
216769,and,0,1
216770,III,0,1
216771,.,0,1
216772,Statistical,0,0
216773,analysis,0,0
216774,of,0,1
216775,cardiovascular,1,1
216776,parameters,1,1
216777,(,1,1
216778,BP,1,1
216779,and,1,1
216780,cardiac,1,1
216781,frequency,1,1
216782,),1,1
216783,",",1,0
216784,respiratory,1,1
216785,frequency,1,1
216786,and,1,1
216787,pain,1,1
216788,score,1,1
216789,showed,0,0
216790,an,0,0
216791,overlapping,0,0
216792,progression,0,1
216793,among,0,0
216794,the,0,0
216795,two,0,0
216796,groups,0,0
216797,.,0,0
216798,Spontaneous,1,1
216799,pain,1,1
216800,decreased,0,0
216801,significantly,0,0
216802,to,0,0
216803,zero,0,0
216804,at,0,0
216805,T6,0,0
216806,(,0,0
216807,p,0,0
216808,<,0,0
216809,0.001,0,0
216810,),0,0
216811,.,0,0
216812,However,0,0
216813,",",0,0
216814,the,0,0
216815,necessity,0,0
216816,to,0,0
216817,administer,0,0
216818,buprenorphine,0,0
216819,more,0,0
216820,frequently,0,0
216821,after,0,0
216822,the,0,0
216823,sixth,0,0
216824,hour,0,0
216825,and,0,0
216826,the,0,0
216827,consequent,0,0
216828,increase,0,0
216829,in,0,0
216830,side,1,1
216831,effects,1,0
216832,",",0,0
216833,lead,0,0
216834,us,0,0
216835,to,0,0
216836,believe,0,0
216837,that,0,0
216838,the,0,0
216839,method,0,0
216840,used,0,0
216841,for,0,0
216842,group,0,0
216843,A,0,0
216844,patients,0,0
216845,is,0,0
216846,more,0,0
216847,advantageous,0,0
216848,.,0,0
216849,Randomized,0,0
216850,",",0,0
216851,controlled,0,0
216852,study,0,0
216853,of,0,1
216854,various,0,0
216855,agents,0,0
216856,for,0,0
216857,endoscopic,0,1
216858,injection,0,0
216859,sclerotherapy,0,0
216860,of,0,1
216861,bleeding,0,1
216862,canine,0,0
216863,gastric,0,1
216864,varices,0,0
216865,.,0,0
216866,The,0,0
216867,purpose,0,0
216868,of,0,0
216869,this,0,0
216870,study,0,0
216871,was,0,0
216872,to,0,0
216873,compare,0,0
216874,the,0,0
216875,relative,1,1
216876,efficacy,1,1
216877,and,1,1
216878,technical,1,1
216879,ease,1,1
216880,of,1,1
216881,use,1,0
216882,of,0,0
216883,eight,0,0
216884,different,0,0
216885,agents,0,0
216886,for,0,0
216887,endoscopic,0,1
216888,hemostasis,0,1
216889,and,0,1
216890,obliteration,0,1
216891,of,0,1
216892,bleeding,0,1
216893,gastric,0,1
216894,varices,0,0
216895,in,0,0
216896,a,0,0
216897,canine,0,0
216898,model,0,0
216899,",",0,0
216900,as,0,0
216901,no,0,0
216902,comparative,0,0
216903,data,0,0
216904,are,0,0
216905,available,0,0
216906,on,0,0
216907,gastric,0,1
216908,variceal,0,1
216909,sclerotherapy,0,0
216910,.,0,1
216911,Large,0,0
216912,bleeding,0,1
216913,gastric,0,1
216914,varices,0,0
216915,in,0,0
216916,20,0,0
216917,heparinized,0,0
216918,dogs,0,0
216919,were,0,0
216920,randomized,0,0
216921,to,0,0
216922,endoscopic,0,0
216923,injection,0,0
216924,treatment,0,0
216925,with,0,0
216926,one,0,0
216927,of,0,0
216928,the,0,0
216929,following,0,0
216930,agents,0,0
216931,:,0,0
216932,cyanoacrylate,0,0
216933,;,0,0
216934,a,0,0
216935,1:1:1,0,0
216936,mixture,0,0
216937,of,0,0
216938,sodium,0,0
216939,tetradecyl,0,0
216940,sulfate,0,0
216941,3,0,0
216942,%,0,0
216943,",",0,0
216944,ethanol,0,0
216945,98,0,0
216946,%,0,0
216947,",",0,0
216948,and,0,1
216949,normal,0,1
216950,saline,0,0
216951,solution,0,0
216952,;,0,0
216953,ethanolamine,0,0
216954,oleate,0,0
216955,5,0,0
216956,%,0,0
216957,;,0,0
216958,sodium,0,0
216959,morrhuate,0,0
216960,5,0,0
216961,%,0,0
216962,;,0,0
216963,sodium,0,0
216964,tetradecyl,0,0
216965,sulfate,0,0
216966,1.5,0,0
216967,%,0,0
216968,;,0,0
216969,polidocanol,0,0
216970,1,0,0
216971,%,0,0
216972,;,0,0
216973,normal,0,0
216974,saline,0,0
216975,solution,0,0
216976,with,0,0
216977,epinephrine,0,0
216978,"1:10,000",0,0
216979,;,0,0
216980,or,0,0
216981,normal,0,1
216982,saline,0,0
216983,solution,0,1
216984,(,0,1
216985,control,0,0
216986,),0,0
216987,.,0,0
216988,The,0,0
216989,number,0,1
216990,and,0,1
216991,volume,0,1
216992,of,0,1
216993,injections,0,0
216994,and,0,0
216995,the,0,0
216996,time,0,1
216997,required,0,0
216998,to,0,0
216999,achieve,0,0
217000,complete,0,1
217001,hemostasis,0,1
217002,were,0,0
217003,evaluated,0,0
217004,;,0,0
217005,follow-up,0,0
217006,endoscopy,0,0
217007,was,0,0
217008,performed,0,0
217009,at,0,0
217010,1,0,0
217011,month,0,0
217012,to,0,0
217013,assess,0,0
217014,gastric,0,1
217015,variceal,0,1
217016,obliteration,0,1
217017,.,0,1
217018,Cyanoacrylate,0,0
217019,was,0,0
217020,the,0,0
217021,best,0,0
217022,agent,0,0
217023,overall,0,1
217024,in,0,0
217025,terms,0,1
217026,of,0,0
217027,immediate,1,1
217028,efficacy,1,1
217029,",",1,1
217030,low,1,1
217031,volume,1,1
217032,requirement,1,1
217033,",",1,1
217034,time,1,1
217035,required,1,1
217036,for,1,0
217037,initial,1,0
217038,hemostasis,1,1
217039,",",1,1
217040,and,1,1
217041,reduction,1,1
217042,of,1,1
217043,gastric,1,1
217044,variceal,1,1
217045,size,1,1
217046,.,1,1
217047,Cyanoacrylate,1,0
217048,",",1,1
217049,tetradecyl,1,0
217050,sulfate,1,1
217051,",",1,1
217052,and,1,1
217053,polidocanol,1,0
217054,were,0,0
217055,the,0,0
217056,most,0,0
217057,effective,0,1
217058,agents,0,0
217059,for,0,0
217060,reducing,0,0
217061,gastric,0,1
217062,variceal,0,1
217063,size,0,1
217064,.,0,1
217065,Epinephrine,0,0
217066,was,0,0
217067,effective,0,1
217068,for,0,0
217069,controlling,0,0
217070,induced,1,0
217071,or,1,0
217072,secondary,1,1
217073,bleeding,1,1
217074,caused,0,0
217075,by,0,0
217076,puncture,0,0
217077,of,0,0
217078,the,0,0
217079,gastric,0,0
217080,varices,0,0
217081,with,0,0
217082,the,0,0
217083,sclerotherapy,0,0
217084,needle,0,0
217085,during,0,0
217086,intravariceal,0,0
217087,injections,0,0
217088,.,0,0
217089,Ongoing,0,0
217090,studies,0,0
217091,are,0,0
217092,evaluating,0,0
217093,combinations,0,0
217094,of,0,0
217095,agents,0,0
217096,with,0,0
217097,different,0,0
217098,mechanisms,0,0
217099,of,0,1
217100,action,0,1
217101,",",0,0
217102,such,0,1
217103,as,0,0
217104,epinephrine,0,0
217105,(,0,0
217106,for,0,0
217107,vasoconstriction,0,1
217108,to,0,0
217109,minimize,0,0
217110,secondary,0,1
217111,bleeding,0,1
217112,),0,1
217113,plus,0,0
217114,alcohol,0,1
217115,",",0,1
217116,and/or,0,0
217117,tetradecyl,0,0
217118,sulfate,0,1
217119,(,0,0
217120,for,0,0
217121,variceal,0,1
217122,thrombosis,0,1
217123,and,0,1
217124,sclerosis,0,0
217125,),0,1
217126,.,0,0
217127,(,0,0
217128,ABSTRACT,0,1
217129,TRUNCATED,0,0
217130,AT,0,0
217131,250,0,0
217132,WORDS,0,0
217133,),0,0
217134,Lipoprotein,0,1
217135,(,0,0
217136,a,0,0
217137,),0,0
217138,serum,0,1
217139,levels,0,1
217140,in,0,0
217141,post-menopausal,0,0
217142,women,0,0
217143,treated,0,0
217144,with,0,0
217145,oral,0,0
217146,estrogens,0,0
217147,administered,0,0
217148,at,0,0
217149,different,0,0
217150,times,0,1
217151,.,0,0
217152,The,0,0
217153,different,0,0
217154,effects,1,1
217155,on,0,0
217156,serum,0,1
217157,lipoprotein,0,1
217158,(,0,0
217159,a,0,0
217160,),0,0
217161,[,0,0
217162,Lp,0,0
217163,(,0,0
217164,a,0,0
217165,),0,0
217166,],0,0
217167,levels,0,1
217168,by,0,0
217169,administering,0,0
217170,estrogens,0,0
217171,at,0,0
217172,different,0,0
217173,times,0,1
217174,of,0,0
217175,the,0,0
217176,day,0,0
217177,(,0,0
217178,8,0,0
217179,a.m.,0,0
217180,and,0,0
217181,8,0,0
217182,p.m.,0,1
217183,),0,0
217184,were,0,0
217185,evaluated,0,0
217186,in,0,0
217187,twenty-four,0,0
217188,post-menopausal,0,0
217189,women,0,0
217190,.,0,0
217191,Patients,0,0
217192,were,0,0
217193,assigned,0,0
217194,to,0,0
217195,one,0,0
217196,of,0,0
217197,the,0,0
217198,two,0,0
217199,treatment,0,0
217200,groups,0,0
217201,by,0,0
217202,random,0,0
217203,sampling,0,0
217204,numbers,0,1
217205,.,0,0
217206,Patients,0,0
217207,of,0,0
217208,both,0,0
217209,groups,0,0
217210,received,0,0
217211,0.625,0,0
217212,mg,0,0
217213,conjugated,0,0
217214,equine,0,0
217215,estrogens,0,0
217216,daily,0,0
217217,per,0,0
217218,os,0,0
217219,for,0,0
217220,21,0,0
217221,days,0,0
217222,.,0,0
217223,Group,0,0
217224,A,0,0
217225,patients,0,0
217226,(,0,0
217227,n,0,0
217228,:,0,0
217229,9,0,0
217230,),0,0
217231,received,0,0
217232,the,0,0
217233,pill,0,0
217234,at,0,0
217235,8,0,0
217236,a.m.,0,0
217237,",",0,0
217238,and,0,1
217239,group,0,0
217240,B,0,1
217241,patients,0,0
217242,(,0,0
217243,n,0,0
217244,:,0,0
217245,12,0,0
217246,),0,0
217247,received,0,0
217248,the,0,0
217249,pill,0,0
217250,at,0,0
217251,8,0,0
217252,p.m,0,0
217253,.,0,0
217254,There,0,0
217255,were,0,0
217256,no,0,0
217257,statistically,0,0
217258,significant,0,0
217259,differences,0,0
217260,between,0,0
217261,the,0,0
217262,two,0,0
217263,treatment,0,0
217264,groups,0,0
217265,as,0,0
217266,regards,0,0
217267,the,0,0
217268,anthropometric,1,1
217269,characteristics,1,0
217270,",",1,0
217271,the,1,0
217272,basal,1,1
217273,values,1,1
217274,of,1,0
217275,the,1,0
217276,Lp,1,0
217277,(,1,0
217278,a,1,0
217279,),1,0
217280,",",1,0
217281,the,1,0
217282,sex,1,0
217283,steroid,1,0
217284,and,1,1
217285,pituitary,1,1
217286,hormone,1,1
217287,levels,1,1
217288,.,1,1
217289,Administration,0,0
217290,of,0,1
217291,conjugated,0,1
217292,equine,0,0
217293,estrogens,0,1
217294,resulted,0,0
217295,in,0,0
217296,decreased,0,1
217297,levels,1,1
217298,of,1,1
217299,Lp,1,0
217300,(,1,0
217301,a,1,0
217302,),1,0
217303,only,0,0
217304,in,0,0
217305,group,0,0
217306,B,0,0
217307,after,0,0
217308,treatment,0,0
217309,.,0,0
217310,The,0,0
217311,different,0,0
217312,Lp,0,0
217313,(,0,0
217314,a,0,0
217315,),0,0
217316,behaviour,0,1
217317,in,0,0
217318,the,0,0
217319,two,0,0
217320,groups,0,0
217321,and,0,0
217322,in,0,0
217323,the,0,0
217324,presence,0,0
217325,of,0,0
217326,the,0,0
217327,same,0,0
217328,serum,0,1
217329,hormonal,0,1
217330,levels,0,1
217331,",",0,0
217332,seems,0,0
217333,to,0,0
217334,be,0,0
217335,dependent,0,0
217336,on,0,0
217337,the,0,0
217338,existence,0,0
217339,of,0,0
217340,a,0,0
217341,circadian,0,1
217342,rhythm,0,1
217343,of,0,0
217344,the,0,0
217345,hepatic,0,0
217346,responsiveness,0,1
217347,to,0,0
217348,estrogens,0,0
217349,",",0,0
217350,whose,0,0
217351,expression,0,1
217352,is,0,0
217353,higher,0,0
217354,during,0,0
217355,evening,0,1
217356,hours,0,0
217357,.,0,0
217358,[,0,0
217359,Double-blind,0,0
217360,placebo-controlled,0,0
217361,study,0,0
217362,of,0,0
217363,the,0,0
217364,effectiveness,1,1
217365,and,1,1
217366,tolerability,1,1
217367,of,0,0
217368,10,0,0
217369,and,0,0
217370,30,0,0
217371,mg,0,0
217372,ketorolac,0,0
217373,tromethamine,0,0
217374,suppositories,0,0
217375,in,0,0
217376,post-cholecystectomy,0,0
217377,pain,0,1
217378,],0,0
217379,.,0,0
217380,OBJECTIVE,0,0
217381,To,0,0
217382,evaluate,0,0
217383,the,0,0
217384,efficacy,1,1
217385,and,0,1
217386,tolerability,1,1
217387,of,0,1
217388,ketorolac,0,0
217389,tromethamine,0,0
217390,10,0,0
217391,mg,0,0
217392,and,0,0
217393,30,0,0
217394,mg,0,0
217395,suppositories,0,0
217396,in,0,0
217397,comparison,0,0
217398,to,0,0
217399,placebo,0,0
217400,",",0,0
217401,after,0,0
217402,single,0,0
217403,dose,0,0
217404,administration,0,0
217405,in,0,0
217406,patients,0,0
217407,suffering,0,0
217408,from,0,0
217409,post-operative,0,1
217410,pain,0,1
217411,after,0,0
217412,cholecystectomy,0,0
217413,.,0,0
217414,DESIGN,0,0
217415,Double-blind,0,0
217416,",",0,1
217417,randomized,0,0
217418,",",0,1
217419,controlled,0,0
217420,study,0,0
217421,.,0,1
217422,SETTING,0,0
217423,Anaesthesia,0,1
217424,Service,0,0
217425,.,0,0
217426,PATIENTS,0,0
217427,99,0,0
217428,patients,0,0
217429,with,0,0
217430,severe,0,1
217431,pain,0,1
217432,following,0,0
217433,surgery,0,0
217434,.,0,0
217435,INTERVENTIONS,0,1
217436,Cholecystectomy,0,0
217437,.,0,1
217438,MEASUREMENTS,0,0
217439,AND,0,0
217440,MAIN,0,0
217441,RESULTS,0,0
217442,The,0,0
217443,analgesia,0,1
217444,activity,0,1
217445,of,0,1
217446,ketorolac,0,0
217447,tromethamine,0,0
217448,10,0,0
217449,mg,0,0
217450,and,0,0
217451,30,0,0
217452,mg,0,0
217453,suppositories,0,0
217454,were,0,0
217455,evaluated,0,0
217456,after,0,0
217457,single,0,0
217458,dose,0,0
217459,administration,0,0
217460,by,0,0
217461,assessing,0,0
217462,pain,1,1
217463,intensity,1,1
217464,and,1,1
217465,pain,1,1
217466,relief,1,1
217467,using,1,0
217468,a,1,0
217469,4,1,0
217470,point,1,0
217471,scale,1,1
217472,(,1,1
217473,VRS,1,1
217474,),1,0
217475,.,1,0
217476,At,0,0
217477,the,0,0
217478,end,0,0
217479,of,0,0
217480,the,0,0
217481,treatment,0,0
217482,period,0,0
217483,overall,0,1
217484,assessment,0,0
217485,of,0,1
217486,safety,1,1
217487,and,1,1
217488,efficacy,1,1
217489,were,0,0
217490,recorded,0,0
217491,by,0,0
217492,physician,0,0
217493,and,0,0
217494,patient,0,1
217495,.,0,0
217496,The,0,0
217497,results,0,0
217498,show,0,0
217499,that,0,0
217500,in,0,0
217501,both,0,0
217502,active,0,0
217503,groups,0,0
217504,after,0,0
217505,30,0,0
217506,',0,0
217507,and,0,0
217508,until,0,0
217509,4,0,0
217510,hours,0,0
217511,",",0,0
217512,pain,1,1
217513,intensity,1,1
217514,decreased,0,0
217515,significantly,0,0
217516,with,0,0
217517,respect,0,0
217518,to,0,0
217519,the,0,0
217520,baseline,0,0
217521,.,0,0
217522,However,0,0
217523,a,0,0
217524,statistically,0,0
217525,significant,0,0
217526,difference,0,0
217527,between,0,0
217528,groups,0,0
217529,of,0,1
217530,p,0,0
217531,<,0,0
217532,0.02,0,0
217533,",",0,0
217534,p,0,0
217535,<,0,0
217536,0.01,0,0
217537,and,0,0
217538,p,0,0
217539,<,0,0
217540,0.05,0,0
217541,was,0,0
217542,found,0,0
217543,in,0,0
217544,favour,0,0
217545,of,0,0
217546,the,0,0
217547,30,0,0
217548,mg,0,0
217549,dose,0,0
217550,respectively,0,0
217551,at,0,0
217552,30,0,0
217553,',0,0
217554,",",0,0
217555,6,0,0
217556,and,0,0
217557,8,0,0
217558,hours,0,0
217559,after,0,0
217560,administration,0,0
217561,.,0,0
217562,All,0,0
217563,the,0,0
217564,patients,0,0
217565,treated,0,0
217566,with,0,0
217567,placebo,0,0
217568,suppositories,0,0
217569,required,0,0
217570,another,0,0
217571,rescue,1,1
217572,analgesic,1,1
217573,drug,1,1
217574,and,0,1
217575,withdrew,0,0
217576,from,0,0
217577,the,0,0
217578,trial,0,0
217579,.,0,0
217580,Three,0,0
217581,patients,0,0
217582,complained,0,0
217583,adverse,1,1
217584,events,1,1
217585,not,0,0
217586,related,0,0
217587,to,0,0
217588,treatment,0,0
217589,:,0,0
217590,two,0,0
217591,on,0,0
217592,placebo,0,0
217593,and,0,0
217594,one,0,0
217595,on,0,0
217596,ketorolac,0,0
217597,10,0,0
217598,mg,0,0
217599,.,0,0
217600,The,0,0
217601,systemic,1,1
217602,and,1,1
217603,local,1,1
217604,tolerability,1,1
217605,of,0,0
217606,the,0,0
217607,drug,0,0
217608,was,0,0
217609,good,0,0
217610,.,0,0
217611,CONCLUSIONS,0,0
217612,This,0,0
217613,study,0,0
217614,shows,0,0
217615,that,0,0
217616,ketorolac,0,0
217617,30,0,0
217618,mg,0,0
217619,suppositories,0,0
217620,are,0,0
217621,effective,0,1
217622,in,0,0
217623,clinical,0,0
217624,conditions,0,0
217625,",",0,0
217626,such,0,0
217627,as,0,0
217628,after,0,0
217629,surgery,0,0
217630,",",0,0
217631,in,0,0
217632,which,0,0
217633,pain,0,1
217634,control,0,0
217635,must,0,0
217636,be,0,0
217637,achieved,0,0
217638,within,0,0
217639,the,0,0
217640,shortest,0,1
217641,time,0,1
217642,interval,0,0
217643,and,0,1
217644,maintained,0,0
217645,or,0,0
217646,improved,0,1
217647,by,0,0
217648,means,0,0
217649,of,0,0
217650,a,0,0
217651,single,0,0
217652,route,0,0
217653,of,0,0
217654,administration,0,0
217655,.,0,0
217656,Effect,0,1
217657,of,0,1
217658,flurbiprofen,0,0
217659,sodium,0,0
217660,on,0,0
217661,pupillary,1,1
217662,dilatation,1,1
217663,during,0,0
217664,scleral,0,1
217665,buckling,0,1
217666,surgery,0,0
217667,.,0,1
217668,Maintenance,0,0
217669,of,0,1
217670,pupillary,1,1
217671,dilatation,1,0
217672,is,0,0
217673,necessary,0,0
217674,for,0,0
217675,success,0,1
217676,of,0,1
217677,scleral,0,1
217678,buckling,0,0
217679,procedures,0,0
217680,.,0,0
217681,The,0,0
217682,efficacy,0,1
217683,of,0,0
217684,0.03,0,0
217685,%,0,0
217686,flurbiprofen,0,0
217687,in,0,0
217688,preventing,0,0
217689,intraoperative,0,1
217690,miosis,0,1
217691,was,0,0
217692,evaluated,0,0
217693,by,0,0
217694,a,0,0
217695,prospective,0,0
217696,randomized,0,0
217697,",",0,0
217698,double-masked,0,0
217699,controlled,0,0
217700,trial,0,0
217701,of,0,0
217702,60,0,0
217703,patients,0,0
217704,.,0,0
217705,Thirty,0,0
217706,patients,0,0
217707,received,0,0
217708,0.03,0,0
217709,%,0,0
217710,flurbiprofen,0,0
217711,6,0,0
217712,times,0,0
217713,at,0,0
217714,15,0,0
217715,minute,0,0
217716,intervals,0,0
217717,90,0,0
217718,minutes,0,0
217719,preoperatively,0,0
217720,in,0,0
217721,addition,0,0
217722,to,0,0
217723,the,0,0
217724,routine,0,0
217725,dilation,0,0
217726,regimen,0,0
217727,.,0,0
217728,The,0,0
217729,treated,0,0
217730,group,0,0
217731,had,0,0
217732,a,0,0
217733,mean,1,1
217734,pupillary,1,1
217735,decrease,1,1
217736,of,0,0
217737,1.88,0,0
217738,mm,0,0
217739,and,0,0
217740,the,0,0
217741,control,0,0
217742,group,0,0
217743,had,0,0
217744,a,0,0
217745,decrease,0,0
217746,of,0,0
217747,1.57,0,0
217748,mm,0,0
217749,(,0,0
217750,p,0,0
217751,>,0,0
217752,0.05,0,0
217753,),0,0
217754,.,0,0
217755,Flurbiprofen,0,0
217756,did,0,0
217757,not,0,0
217758,affect,0,0
217759,the,0,0
217760,pupillary,1,1
217761,size,1,1
217762,at,0,0
217763,any,0,0
217764,step,0,0
217765,of,0,0
217766,the,0,0
217767,surgery,0,0
217768,.,0,0
217769,Factors,0,0
217770,such,0,0
217771,as,0,0
217772,age,1,0
217773,of,1,0
217774,the,1,0
217775,patient,1,0
217776,",",1,0
217777,lens,1,1
217778,status,1,1
217779,",",1,1
217780,number,1,1
217781,of,1,1
217782,cryo,1,0
217783,applications,1,0
217784,",",1,1
217785,duration,1,1
217786,of,1,1
217787,surgery,1,0
217788,",",1,0
217789,and,1,1
217790,the,1,0
217791,size,1,1
217792,and,1,1
217793,extent,1,1
217794,of,1,1
217795,buckle,1,0
217796,were,0,0
217797,assessed,0,0
217798,.,0,0
217799,The,0,0
217800,use,0,0
217801,of,0,1
217802,flurbiprofen,0,0
217803,did,0,0
217804,not,0,0
217805,affect,0,0
217806,the,0,0
217807,mean,1,1
217808,pupillary,1,1
217809,change,1,1
217810,for,0,0
217811,any,0,0
217812,of,0,0
217813,these,0,0
217814,groups,0,0
217815,.,0,0
217816,Preoperative,0,1
217817,use,0,0
217818,of,0,0
217819,flurbiprofen,0,0
217820,does,0,0
217821,not,0,0
217822,significantly,0,0
217823,decrease,0,0
217824,intraoperative,1,1
217825,miosis,1,1
217826,during,1,0
217827,scleral,1,1
217828,buckling,1,0
217829,procedures,1,0
217830,.,1,0
217831,Scales,0,0
217832,for,0,0
217833,the,0,0
217834,assessment,0,0
217835,of,0,0
217836,neuroleptic,1,1
217837,response,1,1
217838,in,0,0
217839,schizophrenic,0,0
217840,children,0,0
217841,:,0,0
217842,specific,0,0
217843,measures,0,1
217844,derived,0,0
217845,from,0,0
217846,the,0,0
217847,CPRS,0,0
217848,.,0,0
217849,This,0,0
217850,article,0,0
217851,reports,0,0
217852,the,0,0
217853,psychometric,0,1
217854,properties,0,1
217855,of,0,0
217856,two,0,0
217857,scales,0,1
217858,for,0,0
217859,rating,0,1
217860,positive,0,1
217861,and,0,1
217862,negative,0,1
217863,schizophrenic,0,1
217864,signs,0,1
217865,and,0,0
217866,symptoms,0,1
217867,.,0,0
217868,These,0,0
217869,Positive,1,1
217870,and,1,1
217871,Negative,1,1
217872,Syndrome,1,1
217873,Scales,1,1
217874,consist,0,0
217875,of,0,0
217876,items,0,1
217877,selected,0,0
217878,from,0,0
217879,the,0,0
217880,Children,0,0
217881,'s,0,1
217882,Psychiatric,0,1
217883,Rating,0,1
217884,Scale,0,1
217885,(,0,1
217886,CPRS,0,1
217887,),0,1
217888,",",0,0
217889,which,0,0
217890,contains,0,0
217891,items,0,1
217892,covering,0,0
217893,a,0,0
217894,wide,0,0
217895,range,0,0
217896,of,0,1
217897,childhood,0,0
217898,psychopathology,0,1
217899,.,0,1
217900,CPRS,0,1
217901,rating,0,1
217902,data,0,0
217903,were,0,0
217904,analyzed,0,0
217905,for,0,0
217906,19,0,0
217907,schizophrenic,0,0
217908,children,0,0
217909,",",0,0
217910,16,0,0
217911,males,0,0
217912,and,0,0
217913,3,0,0
217914,females,0,0
217915,",",0,0
217916,mean,0,1
217917,age,0,0
217918,8.9,0,0
217919,years,0,0
217920,(,0,0
217921,range,0,0
217922,5.5-11.7,0,0
217923,),0,0
217924,",",0,0
217925,evaluated,0,0
217926,in,0,0
217927,a,0,0
217928,double-blind,0,0
217929,",",0,0
217930,placebo-controlled,0,0
217931,crossover,0,0
217932,study,0,0
217933,of,0,0
217934,haloperidol,0,0
217935,.,0,0
217936,We,0,0
217937,describe,0,0
217938,the,0,0
217939,item,0,1
217940,composition,0,1
217941,and,0,1
217942,coherence,0,1
217943,of,0,0
217944,each,0,0
217945,scale,0,1
217946,",",0,0
217947,the,0,0
217948,interrater,0,1
217949,reliabilities,0,1
217950,of,0,0
217951,clinicians,0,0
217952,using,0,0
217953,the,0,0
217954,scales,0,1
217955,",",0,0
217956,and,0,0
217957,the,0,0
217958,sensitivity,0,1
217959,of,0,0
217960,the,0,0
217961,scales,0,1
217962,for,0,0
217963,resolving,0,1
217964,treatment,0,0
217965,response,0,1
217966,.,0,1
217967,Schizophrenic,0,0
217968,children,0,0
217969,showed,0,0
217970,both,0,0
217971,positive,1,1
217972,and,1,0
217973,negative,1,1
217974,signs,1,1
217975,and,1,1
217976,symptoms,1,1
217977,",",0,1
217978,and,0,0
217979,both,0,0
217980,improved,0,0
217981,with,0,0
217982,neuroleptic,1,0
217983,treatment,1,0
217984,.,1,0
217985,Measurement,0,1
217986,of,0,1
217987,transfer,1,1
217988,factor,1,1
217989,during,0,0
217990,constant,0,0
217991,exhalation,0,1
217992,.,0,0
217993,BACKGROUND,0,0
217994,Transfer,1,1
217995,factor,1,1
217996,of,1,0
217997,the,1,0
217998,lung,1,0
217999,for,1,0
218000,carbon,1,1
218001,monoxide,1,1
218002,(,1,1
218003,TLCO,1,1
218004,),1,1
218005,was,0,0
218006,measured,0,0
218007,by,0,0
218008,a,0,0
218009,new,0,0
218010,method,0,0
218011,based,0,0
218012,on,0,0
218013,analysis,0,0
218014,of,0,0
218015,the,0,0
218016,ratio,0,1
218017,of,0,0
218018,the,0,0
218019,concentrations,0,1
218020,of,0,0
218021,carbon,0,0
218022,monoxide,0,0
218023,to,0,0
218024,an,0,0
218025,inert,0,0
218026,gas,0,1
218027,(,0,1
218028,methane,0,0
218029,),0,0
218030,relative,0,1
218031,to,0,0
218032,lung,0,1
218033,volume,0,1
218034,during,0,0
218035,a,0,0
218036,constant,0,0
218037,exhalation,0,1
218038,.,0,0
218039,Since,0,0
218040,this,0,0
218041,new,0,0
218042,technique,0,0
218043,is,0,0
218044,based,0,0
218045,solely,0,0
218046,upon,0,0
218047,exhalation,0,1
218048,",",0,0
218049,anomalies,0,1
218050,associated,0,0
218051,with,0,0
218052,inspiration,0,1
218053,and,0,1
218054,breath,0,1
218055,holding,0,0
218056,do,0,0
218057,not,0,0
218058,affect,0,0
218059,results,0,0
218060,.,0,0
218061,Additionally,0,0
218062,",",0,0
218063,because,0,0
218064,prolonged,0,1
218065,breath,0,1
218066,holding,0,0
218067,is,0,0
218068,not,0,0
218069,required,0,0
218070,",",0,0
218071,measurements,0,0
218072,can,0,0
218073,readily,0,0
218074,be,0,0
218075,made,0,0
218076,in,0,0
218077,dyspnoeic,0,1
218078,patients,0,0
218079,.,0,0
218080,METHODS,0,0
218081,Exhalation,1,1
218082,TLCO,1,1
218083,(,1,1
218084,TLCO,1,1
218085,",",1,1
218086,ex,1,0
218087,),1,1
218088,was,0,0
218089,compared,0,0
218090,with,0,0
218091,the,0,0
218092,standard,1,0
218093,(,1,0
218094,Jones,1,1
218095,and,1,1
218096,Meade,1,1
218097,),1,0
218098,10,1,0
218099,second,1,0
218100,breath,1,1
218101,holding,1,1
218102,TLCO,1,1
218103,(,1,1
218104,TLCO,1,1
218105,",",1,1
218106,bh,1,1
218107,),1,0
218108,in,0,0
218109,100,0,0
218110,consecutive,0,0
218111,patients,0,0
218112,.,0,0
218113,Patients,0,0
218114,did,0,0
218115,not,0,0
218116,practise,0,0
218117,the,0,0
218118,exhalation,0,1
218119,manoeuvre,0,0
218120,prior,0,0
218121,to,0,0
218122,testing,0,0
218123,.,0,0
218124,RESULTS,0,0
218125,The,0,0
218126,comparative,0,0
218127,results,0,0
218128,were,0,0
218129,very,0,0
218130,close,0,0
218131,;,0,0
218132,mean,0,1
218133,difference,0,0
218134,(,0,1
218135,bias,0,1
218136,),0,0
218137,+/-,0,0
218138,standard,0,0
218139,deviation,0,1
218140,(,0,1
218141,precision,0,1
218142,),0,0
218143,was,0,0
218144,0.05,0,0
218145,(,0,0
218146,0.84,0,0
218147,),0,0
218148,mmol/min/kPa,0,0
218149,.,0,0
218150,The,0,0
218151,relation,1,0
218152,was,0,0
218153,equally,0,0
218154,strong,0,0
218155,in,0,0
218156,patients,0,0
218157,with,0,0
218158,severe,0,1
218159,pulmonary,0,1
218160,disease,0,0
218161,;,0,0
218162,for,0,0
218163,patients,0,0
218164,with,0,0
218165,FEV1,0,1
218166,<,0,0
218167,1.51,0,0
218168,the,0,0
218169,mean,0,0
218170,difference,0,0
218171,was,0,0
218172,0.21,0,0
218173,(,0,0
218174,0.80,0,0
218175,),0,0
218176,mmol/min/kPa,0,0
218177,.,0,0
218178,CONCLUSIONS,0,0
218179,Since,0,0
218180,the,0,0
218181,results,0,0
218182,were,0,0
218183,essentially,0,0
218184,identical,0,0
218185,between,0,0
218186,the,0,0
218187,techniques,0,0
218188,",",0,0
218189,it,0,0
218190,seems,0,0
218191,that,0,0
218192,comparable,1,0
218193,pathophysiological,1,0
218194,factors,1,0
218195,affect,0,1
218196,TLCO,0,1
218197,during,0,0
218198,breath,0,1
218199,holding,0,1
218200,and,0,1
218201,constant,0,1
218202,exhalation,0,1
218203,.,0,1
218204,Constant,0,1
218205,exhalation,0,1
218206,may,0,0
218207,therefore,0,0
218208,be,0,0
218209,a,0,0
218210,useful,0,0
218211,alternative,0,0
218212,to,0,0
218213,the,0,0
218214,breath,0,1
218215,holding,0,1
218216,technique,0,0
218217,for,0,0
218218,clinical,0,1
218219,measurement,0,1
218220,of,0,0
218221,TLCO,0,0
218222,.,0,0
218223,Hypericum,0,0
218224,treatment,0,0
218225,of,0,1
218226,mild,0,0
218227,depressions,0,1
218228,with,0,0
218229,somatic,0,1
218230,symptoms,0,1
218231,.,0,0
218232,In,0,0
218233,a,0,0
218234,randomized,0,0
218235,",",0,0
218236,placebo-controlled,0,0
218237,",",0,1
218238,double-blind,0,0
218239,study,0,0
218240,",",0,0
218241,39,0,0
218242,patients,0,0
218243,with,0,0
218244,depression,0,1
218245,with,0,0
218246,somatic,0,1
218247,symptoms,0,1
218248,were,0,0
218249,treated,0,0
218250,with,0,0
218251,hypericum,0,0
218252,extract,0,0
218253,LI,0,0
218254,160,0,0
218255,.,0,0
218256,The,0,0
218257,therapy,0,0
218258,lasted,0,0
218259,for,0,0
218260,4,0,0
218261,weeks,0,0
218262,;,0,0
218263,the,0,0
218264,dosage,0,0
218265,was,0,0
218266,300,0,0
218267,mg,0,0
218268,three,0,0
218269,times,0,0
218270,daily,0,0
218271,.,0,0
218272,At,0,0
218273,the,0,0
218274,onset,0,1
218275,of,0,0
218276,the,0,0
218277,study,0,0
218278,as,0,0
218279,well,0,0
218280,as,0,0
218281,after,0,0
218282,2,0,0
218283,and,0,0
218284,4,0,0
218285,weeks,0,0
218286,",",0,0
218287,the,0,0
218288,following,0,0
218289,criteria,0,0
218290,were,0,0
218291,analyzed,0,0
218292,:,0,0
218293,HAMD,0,0
218294,",",0,1
218295,B-L,0,1
218296,",",0,1
218297,CGI,0,1
218298,",",0,1
218299,and,0,1
218300,vegetative,0,1
218301,symptoms,0,1
218302,.,0,0
218303,The,0,0
218304,results,0,0
218305,show,0,0
218306,a,0,0
218307,significant,1,0
218308,improvement,1,1
218309,in,0,0
218310,the,0,0
218311,active,0,0
218312,treatment,0,0
218313,group,0,0
218314,at,0,0
218315,the,0,0
218316,5,0,0
218317,%,0,0
218318,level,0,0
218319,as,0,0
218320,compared,0,0
218321,to,0,0
218322,placebo,0,0
218323,.,0,0
218324,Seventy,0,0
218325,percent,0,1
218326,of,0,0
218327,the,0,0
218328,patients,0,0
218329,treated,0,0
218330,with,0,0
218331,LI,0,0
218332,160,0,0
218333,were,0,0
218334,free,1,0
218335,of,1,0
218336,symptoms,1,1
218337,after,0,0
218338,4,0,0
218339,weeks,0,0
218340,.,0,0
218341,Typical,0,0
218342,symptoms,0,1
218343,of,0,0
218344,the,0,0
218345,depression,0,1
218346,such,0,0
218347,as,0,0
218348,lack,1,0
218349,of,1,1
218350,activity,1,1
218351,",",1,1
218352,tiredness,1,1
218353,",",1,1
218354,fatigue,1,1
218355,",",1,1
218356,and,1,1
218357,disturbed,1,1
218358,sleep,1,1
218359,",",0,1
218360,were,0,0
218361,especially,0,0
218362,responsive,0,0
218363,.,0,0
218364,In,0,0
218365,no,1,0
218366,case,0,0
218367,were,0,0
218368,any,0,0
218369,undesirable,1,1
218370,side,1,1
218371,effects,1,1
218372,observed,0,0
218373,.,0,0
218374,Immune,1,1
218375,response,1,1
218376,in,0,0
218377,healthy,0,0
218378,volunteers,0,0
218379,vaccinated,0,1
218380,with,0,0
218381,BCG,0,0
218382,plus,0,0
218383,killed,0,0
218384,leishmanial,0,0
218385,promastigotes,0,1
218386,:,0,0
218387,antibody,0,0
218388,responses,0,1
218389,to,0,0
218390,mycobacterial,0,1
218391,and,0,1
218392,leishmanial,0,1
218393,antigens,0,1
218394,.,0,1
218395,Antibody,1,1
218396,(,1,0
218397,IgG,1,0
218398,),1,0
218399,responses,1,1
218400,to,0,0
218401,mycobacterial,0,1
218402,(,0,0
218403,BCG,0,0
218404,;,0,0
218405,PPD,0,0
218406,;,0,0
218407,Mycobacterium,0,0
218408,leprae,0,1
218409,soluble,0,1
218410,antigen,0,1
218411,",",0,1
218412,MLSA,0,0
218413,),0,1
218414,and,0,1
218415,leishmanial,0,1
218416,(,0,1
218417,Leishmania,0,1
218418,mexicana,0,1
218419,LV4,0,1
218420,),0,1
218421,antigens,0,1
218422,were,0,0
218423,measured,0,0
218424,in,0,0
218425,208,0,0
218426,initially,0,0
218427,PPD,0,0
218428,and,0,1
218429,leishmanin,0,1
218430,skin-test,0,1
218431,negative,0,1
218432,volunteers,0,0
218433,divided,0,0
218434,into,0,0
218435,four,0,0
218436,vaccine,0,0
218437,groups,0,0
218438,as,0,0
218439,follows,0,0
218440,:,0,0
218441,68,0,0
218442,received,0,0
218443,BCG,0,0
218444,plus,0,0
218445,killed,0,0
218446,promastigotes,0,1
218447,(,0,0
218448,group,0,0
218449,A,0,0
218450,),0,0
218451,",",0,0
218452,47,0,0
218453,received,0,0
218454,BCG,0,0
218455,alone,0,0
218456,(,0,0
218457,group,0,0
218458,B,0,1
218459,),0,0
218460,",",0,0
218461,47,0,0
218462,received,0,0
218463,killed,0,0
218464,promastigotes,0,1
218465,alone,0,0
218466,(,0,0
218467,group,0,0
218468,C,0,1
218469,),0,1
218470,",",0,0
218471,and,0,0
218472,46,0,0
218473,formed,0,0
218474,the,0,0
218475,diluent,0,1
218476,control,0,0
218477,(,0,1
218478,placebo,0,0
218479,",",0,1
218480,group,0,0
218481,D,0,1
218482,),0,0
218483,.,0,0
218484,Three,0,0
218485,vaccine,0,0
218486,doses,0,0
218487,were,0,0
218488,administered,0,0
218489,at,0,0
218490,8-12,0,0
218491,week,0,0
218492,intervals,0,0
218493,.,0,1
218494,Vaccinees,0,1
218495,were,0,0
218496,bled,0,0
218497,immediately,0,0
218498,prior,0,0
218499,to,0,0
218500,each,0,0
218501,vaccination,0,0
218502,",",0,1
218503,and,0,1
218504,again,0,0
218505,at,0,0
218506,3-,0,0
218507,and,0,1
218508,12-month,0,1
218509,follow-up,0,0
218510,.,0,0
218511,Skin,1,1
218512,tests,1,1
218513,were,0,0
218514,performed,0,0
218515,prevaccination,0,0
218516,",",0,0
218517,and,0,1
218518,again,0,0
218519,at,0,0
218520,the,0,0
218521,3-,0,0
218522,and,0,1
218523,12-month,0,1
218524,follow-up,0,0
218525,.,0,1
218526,Anti-BCG,0,0
218527,",",0,0
218528,anti-PPD,0,1
218529,and,0,1
218530,anti-MLSA,0,1
218531,IgG,0,1
218532,levels,0,1
218533,increased,0,0
218534,significantly,0,0
218535,in,0,0
218536,groups,0,0
218537,A,0,0
218538,and,0,1
218539,B,0,0
218540,receiving,0,0
218541,BCG,0,0
218542,.,0,0
218543,The,0,0
218544,presence,0,0
218545,of,0,0
218546,leishmanial,0,1
218547,antigen,0,1
218548,(,0,0
218549,with,0,0
218550,BCG,0,0
218551,),0,0
218552,in,0,0
218553,the,0,0
218554,inoculum,0,1
218555,suppressed,0,1
218556,the,0,0
218557,IgG,0,0
218558,response,0,1
218559,to,0,0
218560,Mycobacterium,0,1
218561,tuberculosis/Mycobacterium,0,1
218562,bovis-related,0,1
218563,(,0,1
218564,PPD,0,1
218565,and,0,1
218566,BCG,0,1
218567,),0,1
218568,",",0,0
218569,but,0,0
218570,not,0,0
218571,M.,0,0
218572,leprae-related,0,1
218573,(,0,0
218574,MLSA,0,0
218575,),0,1
218576,-related,0,0
218577,",",0,0
218578,antigens,0,1
218579,.,0,0
218580,A,0,0
218581,small,0,0
218582,but,0,0
218583,significant,0,1
218584,increase,0,1
218585,(,0,0
218586,relative,0,0
218587,to,0,0
218588,prevaccination,0,0
218589,level,0,1
218590,),0,0
218591,in,0,0
218592,response,0,1
218593,to,0,0
218594,MLSA,0,0
218595,",",0,1
218596,but,0,0
218597,not,0,0
218598,to,0,0
218599,BCG,0,0
218600,or,0,1
218601,PPD,0,1
218602,was,0,0
218603,observed,0,0
218604,in,0,0
218605,the,0,0
218606,non-BCG-vaccinated,0,0
218607,groups,0,0
218608,.,0,0
218609,The,0,0
218610,background,0,0
218611,level,0,1
218612,of,0,0
218613,response,0,1
218614,to,0,0
218615,mycobacterial,0,1
218616,and,0,1
218617,leishmanial,0,1
218618,antigens,0,1
218619,was,0,0
218620,higher,0,0
218621,in,0,0
218622,the,0,0
218623,Venezuelan,0,0
218624,vaccinees,0,0
218625,than,0,0
218626,in,0,0
218627,non-endemic,0,1
218628,(,0,0
218629,British,0,0
218630,),0,0
218631,volunteers,0,0
218632,.,0,0
218633,Responses,0,1
218634,to,0,0
218635,leishmanial,1,1
218636,antigen,1,1
218637,were,0,0
218638,not,0,0
218639,enhanced,0,0
218640,in,0,0
218641,the,0,0
218642,two,0,0
218643,vaccine,0,0
218644,groups,0,0
218645,receiving,0,0
218646,killed,0,0
218647,promastigotes,0,1
218648,(,0,0
218649,with/without,0,0
218650,BCG,0,0
218651,),0,0
218652,compared,0,0
218653,with,0,0
218654,the,0,0
218655,BCG,0,0
218656,alone,0,0
218657,and,0,0
218658,placebo,0,0
218659,groups,0,0
218660,.,0,0
218661,Instead,0,0
218662,",",0,0
218663,all,0,0
218664,vaccine,0,0
218665,groups,0,0
218666,showed,0,0
218667,a,0,0
218668,pattern,0,0
218669,of,0,1
218670,response,0,1
218671,consistent,0,0
218672,with,0,0
218673,either,0,0
218674,(,0,0
218675,i,0,0
218676,),0,0
218677,a,0,0
218678,response,0,1
218679,to,0,0
218680,the,0,0
218681,skin-test,0,1
218682,antigen,0,1
218683,or,0,1
218684,",",0,1
218685,more,0,1
218686,likely,0,1
218687,",",0,1
218688,(,0,1
218689,ii,0,0
218690,),0,1
218691,seasonal,0,1
218692,endemic,0,0
218693,exposure,0,0
218694,to,0,0
218695,leishmanial,0,1
218696,antigen,0,1
218697,.,0,0
218698,Interestingly,0,0
218699,",",0,0
218700,this,0,0
218701,endemic,0,1
218702,response,0,1
218703,to,0,0
218704,leishmanial,0,1
218705,antigen,0,1
218706,was,0,0
218707,enhanced,0,0
218708,in,0,0
218709,the,0,0
218710,vaccine,0,0
218711,groups,0,0
218712,receiving,0,0
218713,BCG,0,0
218714,",",0,0
218715,despite,0,0
218716,the,0,0
218717,fact,0,0
218718,that,0,0
218719,group,0,0
218720,B,0,0
218721,received,0,0
218722,no,0,0
218723,leishmanial,0,1
218724,antigen,0,1
218725,in,0,0
218726,the,0,0
218727,vaccine,0,0
218728,inoculum,0,1
218729,.,0,1
218730,When,0,0
218731,prevaccination,0,0
218732,IgG,0,1
218733,levels,0,1
218734,(,0,0
218735,mean,0,1
218736,+,0,0
218737,3,0,0
218738,standard,0,0
218739,deviations,0,0
218740,),0,0
218741,were,0,0
218742,used,0,0
218743,to,0,0
218744,determine,0,0
218745,a,0,0
218746,negative,0,1
218747,cut-off,0,0
218748,",",0,0
218749,a,0,0
218750,low,0,1
218751,percentage,0,1
218752,(,0,0
218753,<,0,0
218754,38,0,0
218755,%,0,0
218756,),0,0
218757,of,0,0
218758,vaccinees,0,0
218759,converted,0,0
218760,to,0,0
218761,responder,0,0
218762,status,0,1
218763,for,0,0
218764,either,0,0
218765,anti-mycobacterial,0,1
218766,or,0,0
218767,anti-leishmanial,0,1
218768,responses,0,1
218769,",",0,0
218770,and,0,0
218771,those,0,0
218772,who,0,0
218773,did,0,0
218774,would,0,0
218775,be,0,0
218776,classified,0,0
218777,as,0,0
218778,'low-responder,0,0
218779,',0,1
218780,status,0,1
218781,compared,0,0
218782,with,0,0
218783,titres,0,1
218784,observed,0,0
218785,in,0,0
218786,severe,0,0
218787,forms,0,0
218788,of,0,0
218789,disease,0,1
218790,.,0,1
218791,Hence,0,1
218792,",",0,0
218793,although,0,0
218794,there,0,0
218795,was,0,0
218796,evidence,0,0
218797,for,0,0
218798,a,0,0
218799,background,0,0
218800,endemic,0,1
218801,response,0,1
218802,to,0,0
218803,both,0,0
218804,leishmanial,0,1
218805,and,0,0
218806,mycobacterial,0,1
218807,antigens,0,1
218808,",",0,0
218809,there,0,0
218810,was,0,0
218811,no,0,0
218812,evidence,0,0
218813,that,0,0
218814,vaccination,0,0
218815,per,0,1
218816,se,0,1
218817,led,0,0
218818,to,0,0
218819,a,0,0
218820,potentially,0,0
218821,disease,0,0
218822,exacerbatory,0,1
218823,level,0,1
218824,of,0,1
218825,TH2-associated,0,1
218826,antibody,0,1
218827,response,0,1
218828,especially,0,0
218829,with,0,0
218830,respect,0,0
218831,to,0,0
218832,the,0,0
218833,anti-leishmanial,0,1
218834,response,0,1
218835,.,0,1
218836,(,0,0
218837,ABSTRACT,0,1
218838,TRUNCATED,0,0
218839,AT,0,0
218840,400,0,0
218841,WORDS,0,0
218842,),0,0
218843,[,0,0
218844,Postlaparoscopic,0,0
218845,pain,0,1
218846,syndrome,0,0
218847,.,0,0
218848,Results,0,0
218849,of,0,0
218850,a,0,0
218851,prospective,0,0
218852,",",0,0
218853,randomized,0,0
218854,study,0,0
218855,],0,0
218856,.,0,0
218857,The,0,0
218858,so-called,0,0
218859,post-laparoscopic,0,0
218860,algesia,0,0
218861,is,0,0
218862,a,0,0
218863,specific,0,0
218864,impairment,0,1
218865,of,0,0
218866,about,0,0
218867,63,0,0
218868,%,0,0
218869,of,0,0
218870,the,0,0
218871,patients,0,0
218872,who,0,0
218873,undergo,0,0
218874,laparoscopic,0,0
218875,surgical,0,0
218876,operations,0,0
218877,.,0,0
218878,This,0,0
218879,impairment,0,0
218880,takes,0,0
218881,the,0,0
218882,form,0,0
218883,of,0,0
218884,mild,0,0
218885,to,0,0
218886,moderate,0,0
218887,shoulder,0,0
218888,pain,0,1
218889,.,0,0
218890,Eliminating,0,0
218891,the,0,0
218892,causes,0,0
218893,of,0,0
218894,pain,0,1
218895,has,0,0
218896,a,0,0
218897,clear,0,0
218898,advantage,0,0
218899,over,0,0
218900,symptomatic,0,1
218901,treatment,0,0
218902,using,0,0
218903,analgetics,0,1
218904,",",0,0
218905,a,0,0
218906,fact,0,0
218907,worth,0,0
218908,a,0,0
218909,good,0,0
218910,consideration,0,0
218911,especially,0,0
218912,with,0,0
218913,the,0,0
218914,post-operative,0,1
218915,sojourn,0,1
218916,at,0,0
218917,the,0,0
218918,hospital,0,1
218919,becoming,0,0
218920,shorter,0,1
218921,and,0,0
218922,shorter,0,1
218923,.,0,0
218924,In,0,0
218925,a,0,0
218926,prospective,0,0
218927,controlled,0,0
218928,study,0,0
218929,",",0,0
218930,involving,0,0
218931,42,0,0
218932,patients,0,0
218933,subdivided,0,0
218934,into,0,0
218935,four,0,0
218936,groups,0,0
218937,namely,0,0
218938,",",0,0
218939,higher,0,1
218940,or,0,1
218941,lower,0,1
218942,insufflation,0,1
218943,pressures,0,1
218944,",",0,0
218945,chemically,0,0
218946,inert,0,0
218947,insufflation,0,1
218948,gas,0,1
218949,and,0,1
218950,control,0,0
218951,groups,0,0
218952,;,0,0
218953,the,0,0
218954,use,0,0
218955,of,0,0
218956,analgetics,1,1
218957,",",1,1
218958,lung,1,1
218959,function,1,1
218960,",",1,1
218961,operation,1,1
218962,duration,1,1
218963,",",1,1
218964,amount,1,1
218965,of,1,1
218966,insufflated,1,0
218967,gas,1,1
218968,",",1,1
218969,intraperitoneal,1,1
218970,pH-values,1,1
218971,and,1,1
218972,post-operative,1,1
218973,complications,1,1
218974,in,0,0
218975,the,0,0
218976,various,0,0
218977,subgroups,0,0
218978,were,0,0
218979,compared,0,0
218980,to,0,0
218981,each,0,0
218982,other,0,0
218983,with,0,0
218984,regard,0,0
218985,to,0,0
218986,post-operative,0,1
218987,pain,0,1
218988,perception,0,1
218989,.,0,0
218990,The,0,0
218991,results,0,0
218992,did,0,0
218993,not,0,0
218994,show,0,0
218995,any,0,0
218996,significant,0,0
218997,differences,0,0
218998,among,0,0
218999,the,0,0
219000,groups,0,0
219001,regarding,0,0
219002,the,0,0
219003,main,0,0
219004,parameters,0,1
219005,like,0,0
219006,pH-value,1,1
219007,or,1,0
219008,different,1,1
219009,insufflation,1,1
219010,pressures,1,1
219011,etc,0,0
219012,.,0,0
219013,These,0,0
219014,results,0,0
219015,led,0,0
219016,to,0,0
219017,the,0,0
219018,termination,0,0
219019,of,0,0
219020,the,0,0
219021,study,0,0
219022,based,0,0
219023,on,0,0
219024,the,0,0
219025,raised,0,0
219026,criteria,0,0
219027,since,0,0
219028,we,0,0
219029,anticipated,0,0
219030,the,0,0
219031,actual,0,1
219032,cause,0,0
219033,of,0,0
219034,the,0,0
219035,shoulder,0,0
219036,pain,0,1
219037,to,0,0
219038,be,0,0
219039,due,0,0
219040,to,0,0
219041,an,0,0
219042,unknown,0,0
219043,factor,0,0
219044,.,0,0
219045,By,0,0
219046,the,0,0
219047,evaluation,0,0
219048,of,0,0
219049,the,0,0
219050,individual,0,0
219051,data,0,0
219052,",",0,0
219053,it,0,0
219054,became,0,0
219055,apparent,0,0
219056,that,0,0
219057,",",0,0
219058,the,0,0
219059,pains,1,1
219060,increase,1,1
219061,with,0,0
219062,increasing,0,0
219063,gas,0,1
219064,consumption,0,1
219065,",",0,0
219066,a,0,0
219067,fact,0,0
219068,which,0,0
219069,led,0,0
219070,to,0,0
219071,assumption,0,0
219072,that,0,0
219073,the,0,0
219074,pains,1,1
219075,are,0,0
219076,caused,0,0
219077,by,0,0
219078,a,0,0
219079,physical,0,1
219080,effect,0,1
219081,such,0,0
219082,as,0,0
219083,the,0,0
219084,cooling,0,0
219085,of,0,0
219086,the,0,0
219087,peritoneum,0,0
219088,.,0,0
219089,Influence,0,1
219090,of,0,1
219091,ball,0,1
219092,weight,0,1
219093,on,0,0
219094,junior,0,0
219095,high,0,0
219096,school,0,0
219097,girls,0,1
219098,',0,1
219099,volleyball,0,0
219100,performance,1,1
219101,.,1,0
219102,This,0,0
219103,study,0,0
219104,was,0,0
219105,designed,0,0
219106,to,0,0
219107,investigate,0,0
219108,the,0,0
219109,influence,1,0
219110,of,0,0
219111,a,0,0
219112,lighter,0,0
219113,ball,0,1
219114,(,0,1
219115,Tachikara,0,1
219116,Volley,0,1
219117,Lite,0,0
219118,),0,0
219119,on,0,0
219120,72,0,0
219121,seventh-grade,0,0
219122,girls,0,0
219123,',0,1
219124,tournament,0,0
219125,game,0,0
219126,play,0,0
219127,and,0,1
219128,pretest-to-posttest,0,0
219129,improvement,0,1
219130,for,0,0
219131,a,0,0
219132,16-day,0,0
219133,volleyball,0,0
219134,practice,0,0
219135,period,0,0
219136,.,0,0
219137,Two,0,0
219138,intact,0,0
219139,classes,0,0
219140,were,0,0
219141,randomly,0,0
219142,assigned,0,0
219143,to,0,0
219144,groups,0,0
219145,",",0,0
219146,one,0,0
219147,of,0,0
219148,whom,0,0
219149,used,0,0
219150,lighter,0,0
219151,balls,0,1
219152,during,0,0
219153,skills,0,1
219154,progressions,0,1
219155,while,0,0
219156,a,0,0
219157,second,0,0
219158,used,0,0
219159,regulation,0,0
219160,balls,0,0
219161,.,0,0
219162,All,0,0
219163,students,0,0
219164,used,0,0
219165,regulation,0,0
219166,balls,0,0
219167,during,0,0
219168,tournament,0,0
219169,game,0,0
219170,play,0,0
219171,and,0,1
219172,skills,0,1
219173,tests,0,1
219174,.,0,0
219175,Both,0,0
219176,groups,0,0
219177,significantly,0,0
219178,improved,0,0
219179,the,0,0
219180,forearm,1,1
219181,pass,1,1
219182,from,0,0
219183,pretest,0,0
219184,to,0,0
219185,posttest,0,1
219186,.,0,0
219187,Analysis,1,0
219188,of,1,1
219189,covariance,1,0
219190,indicated,0,0
219191,no,0,0
219192,significant,0,0
219193,differences,0,0
219194,between,0,0
219195,groups,0,0
219196,on,0,0
219197,posttest,0,1
219198,means,0,0
219199,for,0,0
219200,any,0,0
219201,skill,0,1
219202,.,0,0
219203,A,0,0
219204,2,0,0
219205,x,0,0
219206,6,0,0
219207,(,0,0
219208,treatment,0,0
219209,x,0,0
219210,game,0,0
219211,day,0,1
219212,),0,1
219213,analysis,0,0
219214,of,0,1
219215,variance,0,1
219216,indicated,0,0
219217,that,0,0
219218,the,0,0
219219,group,0,0
219220,practicing,0,0
219221,with,0,0
219222,lighter,0,0
219223,balls,0,1
219224,had,0,0
219225,significantly,0,0
219226,more,0,0
219227,correct,1,1
219228,sets,1,0
219229,and,0,0
219230,a,0,0
219231,higher,1,0
219232,average,1,1
219233,daily,1,1
219234,success,1,1
219235,rate,1,1
219236,for,0,0
219237,the,0,0
219238,set,0,0
219239,and,0,1
219240,underhand,0,1
219241,serve,0,0
219242,on,0,0
219243,game,0,0
219244,days,0,0
219245,than,0,0
219246,the,0,0
219247,group,0,0
219248,using,0,0
219249,a,0,0
219250,regulation,0,0
219251,ball,0,0
219252,.,0,0
219253,Effects,0,0
219254,of,0,0
219255,a,0,0
219256,fish-oil,0,0
219257,and,0,1
219258,vegetable-oil,0,0
219259,formula,0,0
219260,on,0,0
219261,aggregation,0,1
219262,and,0,1
219263,ethanolamine-containing,0,0
219264,lysophospholipid,1,1
219265,generation,1,1
219266,in,0,0
219267,activated,0,1
219268,human,0,0
219269,platelets,0,1
219270,and,0,1
219271,on,0,0
219272,leukotriene,1,1
219273,production,1,1
219274,in,0,0
219275,stimulated,0,0
219276,neutrophils,0,1
219277,.,0,0
219278,The,0,0
219279,effects,0,0
219280,of,0,0
219281,consuming,0,0
219282,a,0,0
219283,liquid,0,0
219284,formula,0,0
219285,containing,0,0
219286,either,0,0
219287,fish,0,0
219288,oil,0,0
219289,enriched,0,0
219290,in,0,0
219291,omega-3,0,0
219292,fatty,0,1
219293,acids,0,1
219294,or,0,1
219295,vegetable,0,0
219296,oil,0,0
219297,enriched,0,0
219298,in,0,0
219299,oleic,0,1
219300,acid,0,1
219301,was,0,0
219302,evaluated,0,0
219303,in,0,0
219304,20,0,0
219305,male,0,0
219306,subjects,0,0
219307,randomly,0,0
219308,allocated,0,0
219309,into,0,0
219310,two,0,0
219311,groups,0,0
219312,over,0,0
219313,a,0,0
219314,42-d,0,0
219315,period,0,0
219316,.,0,0
219317,A,0,0
219318,decrease,0,1
219319,in,0,0
219320,collagen-induced,1,1
219321,aggregation,1,1
219322,by,0,0
219323,using,0,0
219324,washed,0,0
219325,platelet,0,1
219326,suspensions,0,1
219327,was,0,0
219328,found,0,0
219329,in,0,0
219330,both,0,0
219331,groups,0,0
219332,after,0,0
219333,nutritional,0,1
219334,supplementation,0,0
219335,.,0,0
219336,A,0,0
219337,considerable,0,0
219338,rise,0,0
219339,in,0,0
219340,omega-3,1,0
219341,and,0,0
219342,a,0,0
219343,decrease,0,1
219344,in,0,0
219345,omega-6,1,0
219346,fatty,1,1
219347,acids,1,1
219348,occurred,0,0
219349,in,0,0
219350,the,0,0
219351,platelet,0,1
219352,phospholipid,0,1
219353,with,0,0
219354,fish-oil,0,0
219355,consumption,0,0
219356,.,0,0
219357,The,0,0
219358,degree,0,0
219359,of,0,1
219360,eicosapentaenoic,1,1
219361,acid,1,1
219362,(,0,1
219363,EPA,0,1
219364,",",0,1
219365,20:5n-3,0,1
219366,),0,1
219367,enrichment,0,1
219368,(,0,0
219369,fish-oil,0,0
219370,group,0,0
219371,),0,1
219372,was,0,0
219373,dramatically,0,0
219374,greater,0,0
219375,in,0,0
219376,the,0,0
219377,ether-containing,0,0
219378,plasmenylethanolamine,0,1
219379,(,0,0
219380,13.5,0,0
219381,mol,0,0
219382,%,0,0
219383,of,0,0
219384,fatty,0,1
219385,acids,0,0
219386,;,0,0
219387,mol,0,0
219388,%,0,0
219389,of,0,0
219390,fatty,0,1
219391,acids,0,0
219392,=,0,0
219393,moles,0,0
219394,per,0,0
219395,100,0,0
219396,moles,0,0
219397,of,0,0
219398,total,0,1
219399,fatty,0,1
219400,acids,0,1
219401,),0,0
219402,than,0,0
219403,in,0,0
219404,phosphatidylethanolamine,0,1
219405,(,0,0
219406,2.8,0,0
219407,mol,0,0
219408,%,0,0
219409,),0,0
219410,or,0,1
219411,phosphatidylcholine,0,1
219412,(,0,0
219413,2.9,0,0
219414,mol,0,0
219415,%,0,0
219416,),0,0
219417,.,0,1
219418,Neither,0,0
219419,treatment,0,0
219420,significantly,0,0
219421,influenced,0,0
219422,the,0,0
219423,agonist-induced,1,1
219424,accumulation,1,1
219425,of,1,1
219426,lysoplasmenylethanolamine,1,1
219427,as,0,0
219428,derived,0,0
219429,via,0,0
219430,phospholipase,0,1
219431,A2,0,1
219432,hydrolysis,0,1
219433,of,0,0
219434,plasmenylethanolamine,0,1
219435,.,0,0
219436,HPLC,1,1
219437,measurements,1,1
219438,of,0,1
219439,eicosanoid,1,1
219440,production,1,1
219441,in,0,0
219442,A23187-stimulated,0,1
219443,neutrophils,0,1
219444,revealed,0,0
219445,a,0,0
219446,considerable,0,0
219447,decrease,0,0
219448,in,0,0
219449,the,0,0
219450,formation,1,1
219451,of,1,0
219452,arachidonic,1,1
219453,acid-derived,1,0
219454,leukotriene,1,1
219455,B4,1,1
219456,(,0,1
219457,LTB4,0,1
219458,),0,1
219459,",",0,0
219460,by,0,0
219461,41,0,0
219462,%,0,0
219463,",",0,0
219464,and,0,1
219465,5-HETE,1,1
219466,(,1,1
219467,5-hydroxyeicosatetraenoic,1,1
219468,acid,1,1
219469,),1,1
219470,",",0,0
219471,by,0,0
219472,30,0,0
219473,%,0,0
219474,",",0,0
219475,in,0,0
219476,the,0,0
219477,fish-oil,0,0
219478,group,0,0
219479,along,0,0
219480,with,0,0
219481,the,0,0
219482,appearance,0,0
219483,of,0,0
219484,the,0,0
219485,corresponding,0,1
219486,EPA-derived,0,0
219487,products,0,1
219488,[,0,0
219489,LTB5,0,0
219490,and,0,1
219491,5-HEPE,0,1
219492,(,0,1
219493,5-hydroxyeicosapentaenoic,0,1
219494,acid,0,1
219495,),0,0
219496,],0,0
219497,.,0,0
219498,No,0,0
219499,such,0,0
219500,alterations,0,0
219501,in,0,0
219502,the,0,0
219503,formation,0,1
219504,of,0,0
219505,lipoxygenase,0,1
219506,products,0,1
219507,were,0,0
219508,found,0,0
219509,with,0,0
219510,the,0,0
219511,vegetable,0,0
219512,oil,0,0
219513,treatment,0,0
219514,.,0,0
219515,Enhanced,0,0
219516,small,0,0
219517,group,0,0
219518,instruction,0,0
219519,using,0,0
219520,choral,0,1
219521,responding,0,1
219522,and,0,1
219523,student,0,1
219524,interaction,0,1
219525,for,0,0
219526,children,0,0
219527,with,0,0
219528,autism,0,0
219529,and,0,1
219530,developmental,0,1
219531,disabilities,0,0
219532,.,0,0
219533,The,0,0
219534,use,0,0
219535,of,0,0
219536,effective,0,1
219537,instructional,0,0
219538,strategies,0,0
219539,in,0,0
219540,small,0,0
219541,groups,0,0
219542,was,0,0
219543,investigated,0,0
219544,to,0,0
219545,determine,0,0
219546,learning,0,1
219547,effects,0,0
219548,for,0,0
219549,24,0,0
219550,elementary,0,0
219551,age,0,0
219552,students,0,0
219553,with,0,0
219554,autism,0,0
219555,and,0,1
219556,developmental,0,1
219557,disabilities,0,1
219558,.,0,0
219559,Effective,0,0
219560,strategies,0,0
219561,included,0,0
219562,(,0,0
219563,a,0,0
219564,),0,0
219565,the,0,0
219566,use,0,0
219567,of,0,0
219568,choral,0,0
219569,responding,0,1
219570,;,0,1
219571,(,0,0
219572,b,0,1
219573,),0,0
219574,the,0,0
219575,use,0,0
219576,of,0,0
219577,student-to-student,0,1
219578,responding,0,1
219579,;,0,1
219580,(,0,0
219581,c,0,0
219582,),0,0
219583,the,0,0
219584,rotation,0,0
219585,of,0,0
219586,materials,0,0
219587,every,0,0
219588,5,0,0
219589,minutes,0,0
219590,during,0,0
219591,the,0,0
219592,30-minute,0,0
219593,group,0,0
219594,while,0,0
219595,teaching,0,0
219596,2,0,0
219597,to,0,0
219598,3,0,0
219599,concepts,0,0
219600,;,0,0
219601,and,0,1
219602,(,0,1
219603,d,0,1
219604,),0,0
219605,the,0,0
219606,use,0,0
219607,of,0,1
219608,random,0,0
219609,",",0,0
219610,unpredictable,0,0
219611,trials,0,0
219612,for,0,0
219613,student,0,0
219614,responding,0,0
219615,.,0,0
219616,Thirty-minute,0,0
219617,language,0,1
219618,groups,0,0
219619,were,0,0
219620,targeted,0,0
219621,to,0,0
219622,teach,0,0
219623,receptive,0,1
219624,and,0,1
219625,expressive,0,1
219626,skills,0,1
219627,using,0,0
219628,pictures,0,0
219629,and,0,1
219630,common,0,0
219631,objects,0,1
219632,across,0,0
219633,five,0,0
219634,categories,0,0
219635,(,0,0
219636,e.g.,0,1
219637,",",0,1
219638,household,0,1
219639,items,0,1
219640,",",0,1
219641,foods,0,0
219642,),0,0
219643,.,0,0
219644,Results,0,0
219645,showed,0,0
219646,increased,1,0
219647,opportunities,1,0
219648,to,1,0
219649,respond,1,0
219650,",",1,0
219651,increased,1,1
219652,levels,1,1
219653,of,1,1
219654,responding,1,1
219655,and,1,1
219656,academic,1,1
219657,engagement,1,1
219658,",",1,0
219659,higher,1,1
219660,gains,1,1
219661,on,1,0
219662,weekly,1,0
219663,criterion-referenced,1,0
219664,pre-,1,1
219665,and,1,1
219666,posttests,1,1
219667,",",1,1
219668,and,1,1
219669,decreased,1,1
219670,passive,1,1
219671,and,1,1
219672,inappropriate,1,1
219673,student,1,1
219674,behavior,1,1
219675,during,0,0
219676,interventions,0,0
219677,.,0,0
219678,Brief,0,1
219679,report,0,0
219680,:,0,0
219681,a,0,0
219682,controlled,0,0
219683,evaluation,0,0
219684,of,0,1
219685,facilitated,0,0
219686,communication,0,1
219687,using,0,0
219688,open-ended,0,0
219689,and,0,1
219690,fill-in,0,1
219691,questions,0,1
219692,.,0,0
219693,Osteocalcin,0,1
219694,in,0,0
219695,patients,0,0
219696,with,0,0
219697,rheumatoid,0,0
219698,arthritis,0,0
219699,.,0,0
219700,A,0,0
219701,one-year,0,1
219702,followup,0,1
219703,study,0,0
219704,.,0,0
219705,OBJECTIVE,0,0
219706,To,0,0
219707,analyze,0,0
219708,clinical,0,0
219709,",",0,0
219710,radiological,0,1
219711,",",0,1
219712,and,0,1
219713,drug,0,1
219714,(,0,1
219715,disease,0,1
219716,modifying,0,0
219717,antirheumatic,0,0
219718,drug,0,0
219719,",",0,1
219720,DMARD,0,0
219721,),0,1
219722,dependent,0,0
219723,factors,0,1
219724,influencing,0,1
219725,bone,0,1
219726,turnover,0,1
219727,in,0,0
219728,patients,0,0
219729,with,0,0
219730,rheumatoid,0,1
219731,arthritis,0,1
219732,(,0,1
219733,RA,0,0
219734,),0,0
219735,.,0,0
219736,METHODS,0,0
219737,We,0,0
219738,investigated,0,0
219739,in,0,0
219740,a,0,0
219741,one-year,0,1
219742,double,0,0
219743,blind,0,0
219744,randomized,0,0
219745,study,0,0
219746,comparing,0,0
219747,intramuscular,0,0
219748,(,0,0
219749,im,0,0
219750,),0,1
219751,gold,0,0
219752,with,0,0
219753,im,0,0
219754,methotrexate,0,0
219755,(,0,1
219756,MTX,0,1
219757,),0,1
219758,",",0,0
219759,whether,0,0
219760,the,0,0
219761,variation,0,1
219762,of,0,0
219763,inflammatory,1,1
219764,activity,1,1
219765,or,0,1
219766,functional,1,1
219767,capacity,1,1
219768,",",0,0
219769,the,0,0
219770,ascending,0,1
219771,anatomic,0,1
219772,stage,0,0
219773,",",0,1
219774,or,0,1
219775,DMARD,0,0
219776,treatments,0,0
219777,have,0,0
219778,an,0,0
219779,influence,0,0
219780,on,0,0
219781,bone,0,1
219782,formation,0,1
219783,(,0,1
219784,osteocalcin,0,1
219785,),0,0
219786,in,0,0
219787,patients,0,0
219788,with,0,0
219789,RA,0,0
219790,.,0,0
219791,RESULTS,0,0
219792,Patients,0,0
219793,(,0,0
219794,n,0,0
219795,=,0,0
219796,48,0,0
219797,),0,0
219798,enrolled,0,0
219799,at,0,0
219800,the,0,0
219801,beginning,0,0
219802,of,0,0
219803,our,0,0
219804,study,0,0
219805,had,0,0
219806,significantly,0,0
219807,increased,0,0
219808,osteocalcin,1,1
219809,levels,1,1
219810,(,0,0
219811,3.45,0,0
219812,+/-,0,0
219813,0.93,0,0
219814,--,0,0
219815,>,0,0
219816,4.42,0,0
219817,+/-,0,0
219818,1.39,0,0
219819,ng/ml,0,0
219820,p,0,0
219821,<,0,0
219822,0.02,0,0
219823,),0,0
219824,after,0,0
219825,one,0,0
219826,year,0,0
219827,if,0,0
219828,inflammatory,1,1
219829,activity,1,1
219830,decreased,0,1
219831,(,0,0
219832,>,0,0
219833,or,0,0
219834,=,0,0
219835,1,0,0
219836,SD,0,0
219837,:,0,0
219838,erythrocyte,1,1
219839,sedimentation,1,1
219840,rate,1,1
219841,(,1,1
219842,ESR,1,0
219843,),1,0
219844,26.4,0,0
219845,mm/h,0,1
219846,",",0,0
219847,C-reactive,1,1
219848,protein,1,1
219849,(,1,1
219850,CRP,1,0
219851,),1,0
219852,3.8,0,0
219853,mg/dl,0,0
219854,),0,0
219855,.,0,0
219856,We,0,0
219857,found,0,0
219858,a,0,0
219859,significant,0,0
219860,negative,0,1
219861,correlation,0,0
219862,of,0,0
219863,the,0,0
219864,one-year,0,1
219865,CRP-,1,1
219866,(,0,0
219867,r,0,1
219868,=,0,0
219869,-0.44,0,0
219870,",",0,1
219871,p,0,0
219872,<,0,0
219873,0.001,0,0
219874,),0,0
219875,or,0,0
219876,ESR,1,0
219877,differences,1,1
219878,(,0,0
219879,r,0,1
219880,=,0,0
219881,-0.45,0,0
219882,",",0,1
219883,p,0,0
219884,<,0,0
219885,0.001,0,0
219886,),0,0
219887,with,0,0
219888,the,0,0
219889,corresponding,0,1
219890,osteocalcin,0,1
219891,differences,0,0
219892,.,0,0
219893,This,0,0
219894,was,0,0
219895,also,0,0
219896,evident,0,0
219897,if,0,0
219898,these,0,0
219899,patients,0,0
219900,were,0,0
219901,pooled,0,0
219902,with,0,0
219903,15,0,0
219904,patients,0,0
219905,excluded,0,0
219906,from,0,0
219907,the,0,0
219908,double,0,0
219909,blind,0,0
219910,study,0,0
219911,as,0,0
219912,already,0,0
219913,receiving,0,0
219914,DMARD,0,0
219915,treatment,0,0
219916,(,0,0
219917,n,0,0
219918,=,0,0
219919,63,0,0
219920,;,0,0
219921,p,0,0
219922,<,0,0
219923,0.01,0,0
219924,),0,0
219925,.,0,0
219926,Patients,0,0
219927,with,0,0
219928,impaired,0,1
219929,functional,1,1
219930,capacity,1,1
219931,also,0,0
219932,had,0,0
219933,significantly,0,0
219934,reduced,0,0
219935,osteocalcin,1,1
219936,levels,1,1
219937,(,0,0
219938,p,0,0
219939,<,0,0
219940,0.01,0,0
219941,),0,0
219942,.,0,0
219943,In,0,0
219944,both,0,0
219945,cases,0,0
219946,",",0,0
219947,alkaline,1,1
219948,phosphatase,1,1
219949,showed,0,0
219950,no,0,0
219951,significant,0,0
219952,differences,0,0
219953,.,0,0
219954,CONCLUSIONS,0,0
219955,Our,0,0
219956,data,0,0
219957,suggest,0,0
219958,that,0,0
219959,osteocalcin,0,1
219960,",",0,0
219961,a,0,0
219962,useful,0,0
219963,followup,0,1
219964,variable,0,1
219965,of,0,1
219966,bone,1,1
219967,turnover,1,1
219968,",",0,0
219969,is,0,0
219970,changed,0,0
219971,significantly,0,0
219972,(,0,0
219973,p,0,0
219974,<,0,0
219975,0.02,0,0
219976,),0,0
219977,in,0,0
219978,patients,0,0
219979,with,0,0
219980,RA,0,0
219981,regarding,0,0
219982,inflammatory,1,1
219983,activity,1,1
219984,and,1,1
219985,functional,1,1
219986,capacity,1,1
219987,.,1,0
219988,In,0,0
219989,contrast,0,0
219990,to,0,0
219991,alkaline,1,1
219992,phosphatase,1,1
219993,",",0,0
219994,a,0,0
219995,fall,0,1
219996,in,0,0
219997,inflammatory,0,1
219998,activity,0,1
219999,stimulated,0,0
220000,and,0,0
220001,impairment,0,1
220002,of,0,1
220003,functional,1,1
220004,capacity,1,1
220005,significantly,0,0
220006,decreased,0,0
220007,osteocalcin,0,1
220008,levels,0,1
220009,in,0,0
220010,patients,0,0
220011,with,0,0
220012,RA,0,0
220013,.,0,0
220014,Correlation,0,1
220015,between,0,0
220016,in,0,0
220017,vivo,0,0
220018,humoral,0,1
220019,and,0,1
220020,in,0,0
220021,vitro,0,1
220022,cellular,0,1
220023,immune,0,1
220024,responses,0,1
220025,following,0,0
220026,immunization,0,0
220027,with,0,0
220028,hepatitis,0,0
220029,B,0,0
220030,surface,0,1
220031,antigen,0,1
220032,(,0,1
220033,HBsAg,0,1
220034,),0,0
220035,vaccines,0,0
220036,.,0,0
220037,To,0,0
220038,study,0,0
220039,the,0,0
220040,regulation,0,0
220041,of,0,0
220042,the,0,0
220043,human,0,0
220044,immune,0,1
220045,response,0,1
220046,to,0,0
220047,hepatitis,0,0
220048,B,0,0
220049,surface,0,1
220050,antigen,0,1
220051,(,0,1
220052,HBsAg,0,0
220053,),0,0
220054,we,0,0
220055,have,0,0
220056,carefully,0,0
220057,monitored,0,0
220058,the,0,0
220059,in,0,0
220060,vivo,0,0
220061,humoral,0,1
220062,and,0,1
220063,in,0,0
220064,vitro,0,1
220065,cellular,0,1
220066,immune,0,1
220067,responses,0,1
220068,to,0,0
220069,HBsAg,0,0
220070,in,0,0
220071,50,0,0
220072,subjects,0,0
220073,receiving,0,0
220074,four,0,0
220075,doses,0,0
220076,of,0,0
220077,hepatitis,0,0
220078,B,0,0
220079,vaccine,0,0
220080,according,0,0
220081,to,0,0
220082,a,0,0
220083,0,0,0
220084,",",0,0
220085,1,0,0
220086,",",0,0
220087,2,0,0
220088,",",0,0
220089,12,0,0
220090,month,0,0
220091,vaccination,0,0
220092,scheme,0,0
220093,.,0,1
220094,Twenty-three,0,0
220095,subjects,0,0
220096,were,0,0
220097,given,0,0
220098,a,0,0
220099,plasma-derived,0,0
220100,vaccine,0,0
220101,(,0,0
220102,Hevac,0,0
220103,B,0,1
220104,),0,0
220105,and,0,0
220106,27,0,0
220107,received,0,0
220108,a,0,0
220109,recombinant,0,0
220110,HBsAg,0,1
220111,vaccine,0,0
220112,(,0,0
220113,yeast-derived,0,0
220114,;,0,0
220115,Engerix-B,0,0
220116,),0,0
220117,.,0,0
220118,The,0,0
220119,humoral,0,1
220120,and,0,1
220121,cellular,0,1
220122,immune,0,1
220123,responses,0,1
220124,were,0,0
220125,measured,0,0
220126,before,0,0
220127,vaccination,0,0
220128,(,0,0
220129,day,0,0
220130,0,0,0
220131,),0,0
220132,;,0,0
220133,6,0,0
220134,days,0,0
220135,after,0,0
220136,the,0,0
220137,second,0,0
220138,dose,0,0
220139,(,0,0
220140,day,0,0
220141,36,0,0
220142,),0,0
220143,;,0,0
220144,6,0,0
220145,days,0,0
220146,(,0,0
220147,day,0,0
220148,66,0,0
220149,),0,0
220150,",",0,0
220151,2,0,0
220152,months,0,0
220153,(,0,0
220154,day,0,0
220155,120,0,0
220156,),0,0
220157,and,0,0
220158,10,0,0
220159,months,0,0
220160,(,0,0
220161,day,0,0
220162,365,0,0
220163,),0,0
220164,after,0,0
220165,the,0,0
220166,third,0,0
220167,dose,0,0
220168,and,0,0
220169,1,0,0
220170,month,0,0
220171,after,0,0
220172,the,0,0
220173,fourth,0,0
220174,dose,0,0
220175,(,0,0
220176,day,0,0
220177,395,0,0
220178,),0,0
220179,.,0,0
220180,Based,0,0
220181,on,0,0
220182,the,0,0
220183,kinetics,0,1
220184,of,0,0
220185,the,0,0
220186,humoral,0,1
220187,immune,0,1
220188,responses,0,1
220189,",",0,0
220190,the,0,0
220191,vaccinees,0,0
220192,could,0,0
220193,be,0,0
220194,classified,0,0
220195,into,0,0
220196,fast,0,0
220197,",",0,1
220198,intermediate,0,1
220199,and,0,1
220200,slow/non-responders,0,0
220201,.,0,1
220202,Based,0,0
220203,on,0,0
220204,the,0,0
220205,magnitude,0,1
220206,of,0,0
220207,the,0,0
220208,immune,0,1
220209,response,0,1
220210,(,0,0
220211,anti-HBs,0,1
220212,titre,0,1
220213,),0,0
220214,on,0,0
220215,day,0,0
220216,395,0,0
220217,",",0,0
220218,the,0,0
220219,vaccinees,0,0
220220,could,0,0
220221,be,0,0
220222,divided,0,0
220223,into,0,0
220224,high,0,0
220225,(,0,0
220226,>,0,0
220227,or,0,0
220228,=,0,0
220229,2000,0,0
220230,U,0,0
220231,l-1,0,0
220232,),0,1
220233,and,0,1
220234,low,0,0
220235,(,0,0
220236,<,0,0
220237,or,0,0
220238,=,0,0
220239,2000,0,0
220240,U,0,0
220241,l-1,0,0
220242,),0,0
220243,responders,0,0
220244,.,0,0
220245,A,0,0
220246,close,0,0
220247,correlation,0,0
220248,between,0,0
220249,the,0,0
220250,kinetics,0,1
220251,and,0,0
220252,the,0,0
220253,magnitude,0,1
220254,of,0,0
220255,the,0,0
220256,humoral,1,1
220257,immune,1,1
220258,response,1,1
220259,was,0,0
220260,observed,0,0
220261,.,0,0
220262,The,0,0
220263,in,1,0
220264,vivo,1,0
220265,anti-HBs,1,1
220266,response,1,1
220267,was,0,0
220268,measured,0,0
220269,using,0,0
220270,commercially,0,0
220271,available,0,0
220272,immunoradiometric,0,0
220273,assays,0,0
220274,.,0,0
220275,The,0,0
220276,in,1,0
220277,vitro,1,0
220278,cellular,1,1
220279,immune,1,1
220280,response,1,1
220281,was,0,0
220282,measured,0,0
220283,using,0,0
220284,an,0,0
220285,HBsAg-specific,0,1
220286,lymphoproliferation,0,1
220287,assay,0,1
220288,.,0,0
220289,Because,0,0
220290,of,0,0
220291,interassay,0,1
220292,variability,0,1
220293,the,0,0
220294,results,0,0
220295,were,0,0
220296,considered,0,0
220297,as,0,0
220298,dichotomous,1,1
220299,variables,1,1
220300,(,0,0
220301,proliferation,0,1
220302,versus,0,0
220303,non-proliferation,0,1
220304,),0,0
220305,for,0,0
220306,further,0,0
220307,data,0,0
220308,analysis,0,0
220309,.,0,0
220310,A,0,0
220311,statistically,0,0
220312,significant,0,0
220313,correlation,0,0
220314,was,0,0
220315,observed,0,0
220316,between,0,0
220317,the,0,0
220318,kinetics,0,1
220319,and,0,1
220320,magnitude,0,1
220321,of,0,0
220322,the,0,0
220323,humoral,0,1
220324,immune,0,1
220325,response,0,1
220326,on,0,0
220327,the,0,0
220328,one,0,0
220329,hand,0,0
220330,and,0,0
220331,the,0,0
220332,in,0,0
220333,vitro,0,0
220334,anti-HBs,0,1
220335,response,0,1
220336,on,0,0
220337,the,0,0
220338,other,0,0
220339,hand,0,1
220340,.,0,1
220341,(,0,0
220342,ABSTRACT,0,1
220343,TRUNCATED,0,0
220344,AT,0,0
220345,250,0,0
220346,WORDS,0,0
220347,),0,0
220348,Paromomycin,0,0
220349,for,0,0
220350,cryptosporidiosis,0,0
220351,in,0,0
220352,AIDS,0,0
220353,:,0,0
220354,a,0,0
220355,prospective,0,0
220356,",",0,0
220357,double-blind,0,0
220358,trial,0,0
220359,.,0,0
220360,To,0,0
220361,test,0,0
220362,the,0,0
220363,effects,0,0
220364,of,0,1
220365,paromomycin,0,0
220366,",",0,0
220367,10,0,0
220368,patients,0,0
220369,with,0,0
220370,AIDS,0,1
220371,and,0,1
220372,cryptosporidiosis,0,1
220373,were,0,0
220374,randomized,0,0
220375,to,0,0
220376,paromomycin,0,0
220377,or,0,0
220378,placebo,0,0
220379,in,0,0
220380,a,0,0
220381,double-blind,0,0
220382,trial,0,0
220383,.,0,0
220384,After,0,0
220385,14,0,0
220386,days,0,0
220387,",",0,0
220388,patients,0,0
220389,were,0,0
220390,switched,0,0
220391,to,0,0
220392,the,0,0
220393,other,0,0
220394,treatment,0,0
220395,for,0,0
220396,14,0,0
220397,additional,0,0
220398,days,0,0
220399,.,0,0
220400,Measures,0,1
220401,included,0,0
220402,the,0,0
220403,number,1,1
220404,and,1,1
220405,character,1,0
220406,of,1,0
220407,each,1,0
220408,stool,1,1
220409,and,0,1
220410,weekly,0,1
220411,24-h,0,1
220412,stool,1,1
220413,specimens,1,1
220414,for,1,0
220415,weight,1,1
220416,and,1,1
220417,oocyst,1,1
220418,excretion,1,1
220419,.,1,0
220420,During,0,0
220421,the,0,0
220422,paromomycin,0,0
220423,treatment,0,0
220424,phase,0,0
220425,",",0,1
220426,oocyst,1,1
220427,excretion,1,1
220428,decreased,0,0
220429,from,0,0
220430,314,0,0
220431,x,0,0
220432,10,0,0
220433,(,0,0
220434,6,0,0
220435,),0,0
220436,to,0,0
220437,109,0,0
220438,x,0,0
220439,10,0,0
220440,(,0,0
220441,6,0,0
220442,),0,0
220443,24,0,0
220444,h,0,0
220445,(,0,0
220446,P,0,0
220447,<,0,0
220448,.02,0,0
220449,),0,0
220450,.,0,0
220451,Oocyst,1,1
220452,excretion,1,1
220453,increased,0,0
220454,for,0,0
220455,the,0,0
220456,4,0,0
220457,patients,0,0
220458,initially,0,0
220459,on,0,0
220460,placebo,0,0
220461,compared,0,0
220462,to,0,0
220463,a,0,0
220464,median,0,1
220465,decrease,0,0
220466,of,0,0
220467,128,0,0
220468,x,0,0
220469,10,0,0
220470,(,0,0
220471,6,0,0
220472,),0,0
220473,/24,0,0
220474,h,0,0
220475,for,0,0
220476,the,0,0
220477,6,0,0
220478,initially,0,0
220479,treated,0,0
220480,with,0,0
220481,drug,0,0
220482,(,0,0
220483,P,0,0
220484,<,0,0
220485,.02,0,0
220486,),0,0
220487,.,0,0
220488,Stool,1,0
220489,frequency,1,1
220490,also,0,0
220491,decreased,0,0
220492,more,0,0
220493,in,0,0
220494,those,0,0
220495,treated,0,0
220496,with,0,0
220497,drug,0,0
220498,(,0,0
220499,3.6,0,0
220500,fewer,0,0
220501,vs.,0,0
220502,1.25,0,0
220503,fewer/24,0,0
220504,h,0,0
220505,",",0,1
220506,P,0,0
220507,<,0,0
220508,.05,0,0
220509,),0,0
220510,.,0,0
220511,Trends,0,0
220512,favored,0,0
220513,drug,0,0
220514,over,0,0
220515,placebo,0,0
220516,for,0,0
220517,stool,1,1
220518,weight,1,1
220519,",",1,1
220520,stool,1,1
220521,character,1,1
220522,",",1,1
220523,and,1,1
220524,Karnofsky,1,1
220525,score,1,1
220526,.,1,1
220527,Paromomycin,0,1
220528,treatment,0,0
220529,resulted,0,0
220530,in,0,0
220531,improvement,0,1
220532,in,0,0
220533,both,0,0
220534,clinical,0,0
220535,and,0,0
220536,parasitologic,0,1
220537,parameters,0,1
220538,in,0,0
220539,cryptosporidiosis,0,0
220540,in,0,0
220541,AIDS,0,0
220542,.,0,0
220543,Effects,0,0
220544,of,0,0
220545,short-term,0,1
220546,isotonic,0,0
220547,&,0,0
220548,isometric,0,1
220549,training,0,0
220550,on,0,0
220551,cardiovascular,1,1
220552,&,1,0
220553,pulmonary,1,1
220554,function,1,1
220555,.,1,0
220556,A,0,0
220557,randomised,0,0
220558,control,0,0
220559,trial,0,0
220560,of,0,1
220561,short-term,0,0
220562,exercises,0,0
220563,on,0,0
220564,specific,0,0
220565,cardiovascular,0,1
220566,and,0,1
220567,respiratory,0,1
220568,parameters,0,1
220569,was,0,0
220570,undertaken,0,0
220571,in,0,0
220572,normal,0,0
220573,male,0,0
220574,college,0,0
220575,students,0,0
220576,.,0,0
220577,The,0,0
220578,effects,0,0
220579,of,0,0
220580,isotonic,0,0
220581,training,0,0
220582,(,0,0
220583,5BX,0,0
220584,programme,0,0
220585,),0,0
220586,and,0,1
220587,isometric,0,1
220588,training,0,0
220589,(,0,0
220590,a,0,0
220591,programme,0,0
220592,of,0,0
220593,isometric,0,1
220594,exercises,0,0
220595,working,0,0
220596,all,0,0
220597,major,0,0
220598,groups,0,0
220599,of,0,0
220600,muscles,0,0
220601,),0,0
220602,were,0,0
220603,compared,0,0
220604,with,0,0
220605,a,0,0
220606,control,0,0
220607,group,0,0
220608,with,0,0
220609,no,0,0
220610,specific,0,0
220611,workout,0,0
220612,.,0,0
220613,Both,0,0
220614,isotonic,0,0
220615,and,0,1
220616,isometric,0,1
220617,training,0,0
220618,resulted,0,0
220619,in,0,0
220620,significant,1,0
220621,cardiovascular,1,1
220622,improvement,1,1
220623,but,0,0
220624,seemed,0,0
220625,inadequate,0,0
220626,to,0,0
220627,improve,0,0
220628,vital,1,1
220629,capacity,1,1
220630,and,1,1
220631,flow,1,1
220632,rates,1,1
220633,.,1,1
220634,Isotonic,0,0
220635,training,0,0
220636,in,0,0
220637,addition,0,0
220638,",",0,1
220639,improved,0,1
220640,ventilatory,1,1
220641,efficiency,1,1
220642,.,1,0
220643,It,0,0
220644,is,0,0
220645,concluded,0,0
220646,that,0,0
220647,such,0,0
220648,isotonic,0,0
220649,or,0,0
220650,isometric,0,1
220651,training,0,0
220652,of,0,0
220653,thrice,0,0
220654,a,0,0
220655,week,0,0
220656,for,0,0
220657,ten,0,0
220658,weeks,0,0
220659,",",0,0
220660,requiring,0,0
220661,no,0,0
220662,equipment,0,0
220663,",",0,0
220664,less,0,0
220665,time,0,1
220666,and,0,1
220667,space,0,0
220668,can,0,0
220669,be,0,0
220670,promoted,0,0
220671,to,0,0
220672,improve,0,0
220673,physical,1,1
220674,fitness,1,1
220675,.,1,0
220676,Milk,1,1
220677,production,1,1
220678,in,0,0
220679,cows,0,1
220680,with,0,0
220681,endotoxin-induced,0,1
220682,mastitis,0,1
220683,treated,0,0
220684,with,0,0
220685,isotonic,0,0
220686,or,0,0
220687,hypertonic,0,0
220688,sodium,0,1
220689,chloride,0,0
220690,solution,0,0
220691,.,0,1
220692,Milk,1,1
220693,production,1,1
220694,was,0,0
220695,monitored,0,0
220696,in,0,0
220697,16,0,0
220698,cows,0,0
220699,for,0,0
220700,6,0,0
220701,milkings,0,0
220702,after,0,0
220703,intramammary,0,0
220704,infusion,0,0
220705,of,0,0
220706,1,0,0
220707,mg,0,0
220708,of,0,0
220709,endotoxin,0,1
220710,in,0,0
220711,a,0,0
220712,single,0,0
220713,forequarter,0,0
220714,.,0,0
220715,The,0,0
220716,cows,0,1
220717,were,0,0
220718,randomly,0,0
220719,assigned,0,0
220720,to,0,0
220721,1,0,0
220722,of,0,0
220723,2,0,0
220724,treatment,0,0
220725,groups,0,0
220726,;,0,0
220727,8,0,0
220728,cows,0,0
220729,were,0,0
220730,treated,0,0
220731,with,0,0
220732,isotonic,0,0
220733,saline,0,0
220734,solution,0,0
220735,and,0,0
220736,8,0,0
220737,cows,0,0
220738,were,0,0
220739,treated,0,0
220740,with,0,0
220741,hypertonic,0,0
220742,saline,0,0
220743,solution,0,0
220744,.,0,0
220745,Saline,0,0
220746,solutions,0,0
220747,were,0,0
220748,administered,0,0
220749,IV,0,1
220750,(,0,0
220751,5,0,0
220752,ml/kg,0,0
220753,of,0,0
220754,body,0,1
220755,weight,0,1
220756,),0,0
220757,4,0,0
220758,hours,0,0
220759,after,0,0
220760,infusion,0,0
220761,of,0,0
220762,endotoxin,0,1
220763,.,0,0
220764,Mean,1,1
220765,cumulative,1,1
220766,change,1,1
220767,in,1,0
220768,milk,1,1
220769,yield,1,1
220770,and,1,1
220771,interval,1,0
220772,change,1,1
220773,in,1,0
220774,milk,1,1
220775,yield,1,1
220776,were,0,0
220777,greater,0,0
220778,in,0,0
220779,cows,0,1
220780,treated,0,0
220781,with,0,0
220782,isotonic,0,0
220783,saline,0,0
220784,solution,0,0
220785,than,0,0
220786,in,0,0
220787,cows,0,0
220788,treated,0,0
220789,with,0,0
220790,hypertonic,0,0
220791,saline,0,0
220792,solution,0,0
220793,.,0,0
220794,Significant,0,1
220795,differences,0,0
220796,between,0,0
220797,treatment,0,0
220798,groups,0,0
220799,were,0,0
220800,not,0,0
220801,detected,0,0
220802,.,0,0
220803,Intestinal,0,1
220804,absorption,0,1
220805,of,0,1
220806,dietary,0,0
220807,fat,0,1
220808,in,0,0
220809,patients,0,0
220810,with,0,0
220811,multiple,0,0
220812,sclerosis,0,0
220813,.,0,1
220814,Fat,1,1
220815,absorption,1,1
220816,was,0,0
220817,studied,0,0
220818,in,0,0
220819,24,0,0
220820,patients,0,0
220821,with,0,0
220822,clinically,0,0
220823,definite,0,0
220824,multiple,0,0
220825,sclerosis,0,0
220826,and,0,0
220827,in,0,0
220828,36,0,0
220829,healthy,0,0
220830,control,0,0
220831,subjects,0,0
220832,.,0,1
220833,Beta-carotene,1,0
220834,and,1,1
220835,vitamin,1,1
220836,A,1,0
220837,in,1,0
220838,their,1,0
220839,plasma,1,1
220840,were,0,0
220841,also,0,0
220842,measured,0,0
220843,.,0,0
220844,This,0,0
220845,double-blind,0,0
220846,and,0,1
220847,randomized,0,0
220848,study,0,0
220849,showed,0,0
220850,no,0,0
220851,differences,0,0
220852,between,0,0
220853,these,0,0
220854,two,0,0
220855,populations,0,0
220856,with,0,0
220857,regard,0,0
220858,to,0,0
220859,the,0,0
220860,three,0,0
220861,parameters,0,0
220862,.,0,0
220863,We,0,0
220864,did,0,0
220865,not,0,0
220866,find,0,0
220867,evidence,0,0
220868,for,0,0
220869,fat,0,1
220870,malabsorption,0,1
220871,in,0,0
220872,multiple,0,0
220873,sclerosis,0,0
220874,.,0,0
220875,Citalopram,0,0
220876,for,0,0
220877,post-stroke,0,1
220878,pathological,0,1
220879,crying,0,1
220880,.,0,0
220881,Post-stroke,0,0
220882,pathological,0,0
220883,crying,0,1
220884,is,0,0
220885,a,0,0
220886,distressing,0,1
220887,condition,0,0
220888,in,0,0
220889,which,0,0
220890,episodes,0,0
220891,occur,0,0
220892,in,0,0
220893,response,0,1
220894,to,0,0
220895,minor,0,0
220896,stimuli,0,0
220897,without,0,0
220898,associated,0,0
220899,mood,0,1
220900,changes,0,1
220901,.,0,0
220902,There,0,0
220903,is,0,0
220904,preliminary,0,0
220905,evidence,0,0
220906,of,0,1
220907,disturbed,0,1
220908,serotoninergic,0,1
220909,neurotransmission,0,1
220910,in,0,0
220911,such,0,0
220912,cases,0,0
220913,.,0,0
220914,We,0,0
220915,investigated,0,0
220916,the,0,0
220917,effect,0,0
220918,of,0,0
220919,the,0,0
220920,selective,1,0
220921,serotonin,1,1
220922,reuptake,1,0
220923,inhibitor,1,0
220924,citalopram,1,0
220925,on,0,0
220926,uncontrolled,1,0
220927,crying,1,1
220928,in,0,0
220929,stroke,0,1
220930,patients,0,0
220931,in,0,0
220932,a,0,0
220933,double-blind,0,0
220934,placebo-controlled,0,0
220935,crossover,0,0
220936,study,0,0
220937,.,0,0
220938,16,0,0
220939,consecutive,0,0
220940,patients,0,0
220941,(,0,0
220942,median,0,1
220943,age,0,0
220944,58.5,0,0
220945,years,0,0
220946,",",0,0
220947,range,0,0
220948,40-83,0,0
220949,),0,0
220950,entered,0,0
220951,the,0,0
220952,9-week,0,0
220953,study,0,0
220954,a,0,0
220955,median,0,0
220956,of,0,0
220957,168,0,0
220958,days,0,0
220959,(,0,0
220960,range,0,0
220961,6-913,0,0
220962,),0,1
220963,post,0,0
220964,stroke,0,1
220965,and,0,1
220966,were,0,0
220967,treated,0,0
220968,with,0,0
220969,citalopram,0,0
220970,10-20,0,0
220971,mg,0,0
220972,daily,0,0
220973,for,0,0
220974,3,0,0
220975,weeks,0,0
220976,.,0,0
220977,Crying,1,0
220978,history,1,1
220979,was,0,0
220980,determined,0,0
220981,from,0,0
220982,semistructured,0,0
220983,interviews,0,0
220984,and,0,0
220985,from,0,0
220986,diaries,0,1
220987,kept,0,0
220988,by,0,0
220989,the,0,0
220990,patients,0,0
220991,.,0,0
220992,Psychiatric,1,1
220993,assessment,1,1
220994,was,0,0
220995,made,0,0
220996,with,0,0
220997,the,0,0
220998,Hamilton,1,1
220999,depression,1,1
221000,scale,1,1
221001,(,0,1
221002,HDS,0,1
221003,),0,1
221004,",",0,0
221005,and,0,1
221006,unwanted,1,1
221007,effects,1,1
221008,were,0,0
221009,measured,0,0
221010,with,0,0
221011,the,0,0
221012,UKU,1,1
221013,side-effect,1,1
221014,scale,1,1
221015,.,1,0
221016,In,0,0
221017,13,0,0
221018,patients,0,0
221019,in,0,0
221020,whom,0,0
221021,frequency,1,1
221022,of,1,0
221023,crying,1,1
221024,could,0,0
221025,be,0,0
221026,assessed,0,0
221027,",",0,0
221028,the,0,0
221029,number,1,1
221030,of,1,0
221031,daily,1,0
221032,crying,1,1
221033,episodes,1,1
221034,decreased,0,0
221035,by,0,0
221036,at,0,0
221037,least,0,0
221038,50,0,0
221039,%,0,0
221040,in,0,0
221041,all,0,0
221042,cases,0,0
221043,during,0,0
221044,citalopram,0,0
221045,treatment,0,0
221046,vs,0,0
221047,2,0,0
221048,patients,0,0
221049,during,0,0
221050,placebo,0,0
221051,treatment,0,0
221052,(,0,0
221053,p,0,0
221054,<,0,0
221055,0.005,0,0
221056,",",0,0
221057,McNemar,0,1
221058,'s,0,1
221059,test,0,1
221060,),0,0
221061,",",0,0
221062,the,0,0
221063,effect,0,1
221064,being,0,0
221065,rapid,0,1
221066,(,0,0
221067,1-3,0,0
221068,days,0,0
221069,),0,1
221070,and,0,0
221071,pronounced,0,0
221072,in,0,0
221073,11,0,0
221074,(,0,0
221075,73,0,0
221076,%,0,0
221077,),0,0
221078,.,0,0
221079,There,0,0
221080,was,0,0
221081,a,0,0
221082,concomitant,0,0
221083,significant,0,0
221084,decrease,1,1
221085,in,1,0
221086,depression,1,1
221087,rating,1,1
221088,from,0,0
221089,HDS,0,0
221090,8.9,0,0
221091,to,0,0
221092,5.3,0,0
221093,(,0,0
221094,p,0,0
221095,<,0,0
221096,0.005,0,0
221097,",",0,0
221098,Wilcoxon,0,1
221099,'s,0,1
221100,test,0,0
221101,),0,0
221102,.,0,1
221103,Citalopram,0,0
221104,was,0,0
221105,well,0,1
221106,tolerated,0,1
221107,",",0,0
221108,the,0,0
221109,few,0,0
221110,side-effects,0,1
221111,being,0,0
221112,mild,0,0
221113,and,0,0
221114,transient,0,1
221115,.,0,0
221116,We,0,0
221117,conclude,0,0
221118,that,0,0
221119,serotoninergic,0,0
221120,neurotransmission,0,1
221121,plays,0,0
221122,an,0,0
221123,important,0,0
221124,part,0,0
221125,in,0,0
221126,post-stroke,0,1
221127,pathological,0,1
221128,crying,0,1
221129,and,0,0
221130,that,0,0
221131,citalopram,0,0
221132,is,0,0
221133,an,0,0
221134,effective,0,1
221135,and,0,1
221136,well-tolerated,0,0
221137,treatment,0,0
221138,.,0,0
221139,Topical,0,1
221140,anesthesia,0,0
221141,during,0,0
221142,infant,0,0
221143,eye,0,0
221144,examinations,0,0
221145,:,0,0
221146,does,0,0
221147,it,0,0
221148,reduce,0,0
221149,stress,0,1
221150,?,0,0
221151,We,0,0
221152,studied,0,0
221153,the,0,0
221154,effect,0,1
221155,of,0,0
221156,topical,0,0
221157,anesthesia,0,0
221158,on,0,0
221159,infant,0,1
221160,stress,0,1
221161,and,0,1
221162,corneal,0,1
221163,haze,0,1
221164,during,0,0
221165,the,0,0
221166,routine,0,0
221167,eye,0,0
221168,examination,0,0
221169,for,0,0
221170,retinopathy,0,1
221171,of,0,0
221172,prematurity,0,1
221173,.,0,0
221174,Using,0,0
221175,a,0,0
221176,double-blind,0,0
221177,protocol,0,0
221178,",",0,0
221179,55,0,0
221180,premature,0,0
221181,infants,0,0
221182,weighing,0,0
221183,less,0,0
221184,than,0,0
221185,1501,0,0
221186,g,0,0
221187,at,0,0
221188,birth,0,1
221189,were,0,0
221190,selected,0,0
221191,randomly,0,0
221192,to,0,0
221193,receive,0,0
221194,normal,0,0
221195,saline,0,0
221196,or,0,1
221197,proparacaine,0,0
221198,HCl,0,1
221199,0.5,0,0
221200,%,0,0
221201,eye,0,0
221202,drops,0,0
221203,as,0,0
221204,a,0,0
221205,corneal,0,1
221206,wetting,0,1
221207,agent,0,0
221208,at,0,0
221209,their,0,0
221210,initial,0,0
221211,eye,0,0
221212,examination,0,0
221213,.,0,1
221214,Before,0,0
221215,",",0,0
221216,during,0,0
221217,",",0,1
221218,and,0,0
221219,after,0,0
221220,the,0,0
221221,procedure,0,0
221222,",",0,0
221223,infant,0,1
221224,stress,0,1
221225,was,0,0
221226,evaluated,0,0
221227,by,0,0
221228,heart,1,1
221229,rate,1,1
221230,",",1,1
221231,respiration,1,1
221232,rate,1,1
221233,",",1,1
221234,blood,1,1
221235,pressure,1,1
221236,",",1,1
221237,and,1,1
221238,transcutaneous,1,1
221239,oxygen,1,1
221240,saturation,1,1
221241,.,1,1
221242,Subjective,1,1
221243,assessment,1,0
221244,of,1,0
221245,the,1,0
221246,infant,1,1
221247,'s,1,1
221248,cry,1,1
221249,intensity,1,1
221250,and,1,1
221251,corneal,1,1
221252,haze,1,1
221253,also,0,0
221254,were,0,0
221255,recorded,0,0
221256,.,0,0
221257,Adequate,0,0
221258,data,0,0
221259,were,0,0
221260,collected,0,0
221261,on,0,0
221262,42,0,0
221263,patients,0,0
221264,.,0,0
221265,Using,0,0
221266,analysis,0,0
221267,of,0,1
221268,variance,0,1
221269,and,0,1
221270,chi-square,0,0
221271,tests,0,1
221272,",",0,0
221273,we,0,0
221274,found,0,0
221275,no,0,0
221276,difference,0,0
221277,in,0,0
221278,any,0,0
221279,of,0,0
221280,these,0,0
221281,parameters,0,0
221282,between,0,0
221283,the,0,0
221284,two,0,0
221285,patients,0,0
221286,groups,0,0
221287,.,0,0
221288,These,0,0
221289,data,0,0
221290,suggest,0,0
221291,that,0,0
221292,topical,0,0
221293,anesthetic,0,0
221294,agents,0,0
221295,offer,0,0
221296,no,0,0
221297,advantage,0,0
221298,over,0,0
221299,normal,0,0
221300,saline,0,0
221301,eye,0,0
221302,drops,0,0
221303,during,0,0
221304,the,0,0
221305,examination,0,0
221306,of,0,0
221307,premature,0,0
221308,infants,0,0
221309,.,0,0
221310,Videofluoroscopic,0,1
221311,evidence,0,0
221312,of,0,1
221313,aspiration,0,1
221314,predicts,0,1
221315,pneumonia,1,1
221316,and,1,1
221317,death,1,1
221318,but,0,0
221319,not,0,0
221320,dehydration,0,1
221321,following,0,0
221322,stroke,0,1
221323,.,0,0
221324,In,0,0
221325,order,0,0
221326,to,0,0
221327,assess,0,0
221328,the,0,0
221329,risk,0,1
221330,of,0,1
221331,pneumonia,0,1
221332,",",0,1
221333,dehydration,0,1
221334,",",0,1
221335,and,0,1
221336,death,0,1
221337,associated,0,0
221338,with,0,0
221339,videofluoroscopic,0,0
221340,evidence,0,0
221341,of,0,1
221342,aspiration,0,1
221343,following,0,0
221344,stroke,0,1
221345,",",0,0
221346,the,0,0
221347,clinical,0,0
221348,records,0,0
221349,of,0,0
221350,26,0,0
221351,patients,0,0
221352,with,0,0
221353,aspiration,0,0
221354,and,0,0
221355,33,0,0
221356,randomly,0,0
221357,selected,0,0
221358,",",0,0
221359,case-matched,0,0
221360,",",0,1
221361,dysphagic,0,1
221362,controls,0,0
221363,without,0,0
221364,videofluoroscopic,0,0
221365,evidence,0,0
221366,of,0,1
221367,aspiration,1,1
221368,were,0,0
221369,reviewed,0,0
221370,.,0,0
221371,The,0,0
221372,videofluoroscopic,0,0
221373,modified,0,0
221374,barium,0,1
221375,swallow,0,1
221376,technique,0,0
221377,included,0,0
221378,5,0,0
221379,ml-thin,0,0
221380,and,0,0
221381,thick,0,1
221382,liquid,0,0
221383,barium,0,1
221384,",",0,0
221385,5,0,0
221386,ml,0,0
221387,barium,0,0
221388,pudding,0,1
221389,",",0,0
221390,and,0,0
221391,1/4,0,1
221392,cookie,0,0
221393,coated,0,0
221394,with,0,0
221395,barium,0,1
221396,",",0,1
221397,plus,0,0
221398,additional,0,0
221399,20,0,0
221400,and,0,0
221401,30,0,0
221402,ml,0,0
221403,of,0,0
221404,thin,0,1
221405,liquid,0,0
221406,barium,0,0
221407,.,0,1
221408,Patients,0,0
221409,were,0,0
221410,assessed,0,0
221411,a,0,0
221412,mean,0,0
221413,of,0,0
221414,2,0,0
221415,+/-,0,0
221416,1,0,0
221417,SD,0,0
221418,months,0,0
221419,poststroke,0,1
221420,and,0,1
221421,were,0,0
221422,followed,0,0
221423,for,0,0
221424,a,0,0
221425,mean,0,0
221426,of,0,0
221427,16,0,0
221428,+/-,0,0
221429,8,0,0
221430,SD,0,0
221431,months,0,0
221432,poststroke,0,0
221433,.,0,0
221434,The,0,0
221435,odds,1,0
221436,ratio,1,1
221437,for,0,0
221438,developing,1,0
221439,pneumonia,1,0
221440,was,0,0
221441,7.6,0,0
221442,times,0,0
221443,greater,0,0
221444,for,0,0
221445,those,0,0
221446,who,0,0
221447,aspirated,0,0
221448,any,0,0
221449,amount,0,1
221450,of,0,1
221451,barium,0,1
221452,irrespective,0,0
221453,of,0,0
221454,its,0,0
221455,consistency,0,1
221456,(,0,0
221457,p,0,0
221458,=,0,0
221459,0.05,0,0
221460,),0,0
221461,.,0,0
221462,The,0,0
221463,odds,0,0
221464,ratio,0,1
221465,for,0,0
221466,developing,0,0
221467,pneumonia,1,0
221468,was,0,0
221469,5.6,0,0
221470,times,0,0
221471,greater,0,0
221472,for,0,0
221473,those,0,0
221474,who,0,0
221475,aspirated,0,0
221476,thickened,0,0
221477,liquids,0,0
221478,or,0,0
221479,more,0,0
221480,solid,0,1
221481,consistencies,0,0
221482,compared,0,0
221483,with,0,0
221484,those,0,0
221485,who,0,0
221486,did,0,0
221487,not,0,0
221488,aspirate,0,1
221489,",",0,0
221490,or,0,0
221491,who,0,0
221492,aspirated,0,0
221493,thin,0,0
221494,liquids,0,0
221495,only,0,0
221496,(,0,0
221497,p,0,0
221498,=,0,0
221499,0.06,0,0
221500,),0,0
221501,.,0,0
221502,Dehydration,1,1
221503,was,0,0
221504,unrelated,0,0
221505,to,0,0
221506,the,0,0
221507,presence,0,0
221508,or,0,0
221509,absence,0,0
221510,of,0,1
221511,aspiration,0,0
221512,.,0,0
221513,The,0,0
221514,odds,0,0
221515,ratio,0,1
221516,for,0,0
221517,death,1,1
221518,was,0,0
221519,9.2,0,0
221520,times,0,0
221521,greater,0,0
221522,for,0,0
221523,those,0,0
221524,aspirating,0,0
221525,thickened,0,0
221526,liquids,0,0
221527,or,0,0
221528,more,0,0
221529,solid,0,1
221530,consistencies,0,0
221531,compared,0,0
221532,with,0,0
221533,those,0,0
221534,who,0,0
221535,did,0,0
221536,not,0,0
221537,aspirate,0,0
221538,or,0,0
221539,who,0,0
221540,aspirated,0,0
221541,thin,0,0
221542,liquids,0,0
221543,only,0,0
221544,(,0,0
221545,p,0,0
221546,=,0,0
221547,0.01,0,0
221548,),0,0
221549,.,0,0
221550,Aspiration,0,1
221551,documented,0,0
221552,by,0,0
221553,modified,0,0
221554,videofluoroscopic,0,0
221555,barium,0,1
221556,swallow,0,0
221557,technique,0,0
221558,is,0,0
221559,associated,0,0
221560,with,0,0
221561,a,0,0
221562,significant,0,0
221563,increase,0,1
221564,in,0,0
221565,risk,1,1
221566,of,1,1
221567,pneumonia,1,1
221568,and,0,1
221569,death,0,1
221570,but,0,0
221571,not,0,0
221572,dehydration,0,1
221573,following,0,0
221574,stroke,0,1
221575,.,0,0
221576,[,0,0
221577,A,0,0
221578,controlled,0,0
221579,study,0,0
221580,of,0,0
221581,treating,0,0
221582,haemophilia,0,0
221583,A,0,0
221584,on,0,0
221585,an,0,0
221586,out-patient,0,0
221587,basis,0,0
221588,(,0,0
221589,author,0,1
221590,'s,0,1
221591,transl,0,0
221592,),0,0
221593,],0,0
221594,.,0,0
221595,For,0,0
221596,six,0,0
221597,months,0,0
221598,36,0,0
221599,U,0,0
221600,factor,0,0
221601,VIII,0,0
221602,concentrates,0,0
221603,per,0,0
221604,kg,0,0
221605,bodyweight,0,1
221606,and,0,1
221607,week,0,0
221608,were,0,0
221609,administered,0,0
221610,to,0,0
221611,six,0,0
221612,out-patients,0,0
221613,with,0,0
221614,severe,0,1
221615,haemophilia,0,0
221616,A,0,0
221617,.,0,0
221618,The,0,0
221619,injection,0,0
221620,regimen,0,0
221621,was,0,0
221622,changed,0,0
221623,in,0,0
221624,every,0,0
221625,patient,0,0
221626,every,0,0
221627,two,0,0
221628,months,0,0
221629,",",0,0
221630,from,0,0
221631,36,0,0
221632,U/kg,0,0
221633,once,0,0
221634,to,0,0
221635,18,0,0
221636,U/kg,0,0
221637,twice,0,0
221638,and,0,0
221639,12,0,0
221640,U/kg,0,0
221641,three,0,0
221642,times,0,0
221643,",",0,0
221644,intravenously,0,0
221645,.,0,0
221646,The,0,0
221647,six,0,0
221648,possible,0,0
221649,combinations,0,0
221650,of,0,0
221651,these,0,0
221652,three,0,0
221653,dosage,0,0
221654,schedules,0,0
221655,were,0,0
221656,used,0,0
221657,in,0,0
221658,the,0,0
221659,patients,0,0
221660,in,0,0
221661,a,0,0
221662,strictly,0,0
221663,randomised,0,0
221664,manner,0,0
221665,",",0,0
221666,and,0,0
221667,all,0,1
221668,patients,0,0
221669,were,0,0
221670,treated,0,0
221671,during,0,0
221672,the,0,0
221673,same,0,0
221674,period,0,0
221675,.,0,0
221676,In,0,0
221677,the,0,0
221678,pre-trial,0,1
221679,period,0,0
221680,(,0,0
221681,treatment,0,0
221682,as,0,0
221683,needed,0,0
221684,),0,0
221685,there,0,0
221686,were,0,0
221687,an,0,0
221688,average,0,0
221689,of,0,0
221690,35,0,0
221691,bleedings,1,0
221692,per,0,0
221693,two,0,0
221694,months,0,0
221695,.,0,0
221696,On,0,0
221697,continual,0,1
221698,treatment,0,0
221699,there,0,0
221700,were,0,0
221701,21,0,0
221702,bleedings,1,1
221703,on,0,0
221704,weekly,0,0
221705,injections,0,0
221706,of,0,0
221707,36,0,0
221708,U,0,0
221709,factor,0,0
221710,VIII,0,0
221711,per,0,1
221712,kg,0,0
221713,",",0,0
221714,14,0,0
221715,on,0,0
221716,twice,0,0
221717,weekly,0,0
221718,18,0,0
221719,U/kg,0,0
221720,and,0,0
221721,none,0,0
221722,on,0,0
221723,12,0,0
221724,U/kg,0,0
221725,",",0,0
221726,three,0,0
221727,times,0,0
221728,weekly,0,0
221729,.,0,0
221730,The,0,0
221731,differences,0,0
221732,are,0,0
221733,statistically,0,0
221734,significant,0,0
221735,.,0,0
221736,The,0,0
221737,absence,1,0
221738,of,1,0
221739,bleeding,1,1
221740,on,0,0
221741,the,0,0
221742,last,0,0
221743,dosage,0,0
221744,schedule,0,0
221745,was,0,0
221746,achieved,0,0
221747,during,0,0
221748,normal,0,0
221749,working,0,1
221750,.,0,0
221751,Days,1,1
221752,lost,1,0
221753,from,1,0
221754,work,1,1
221755,per,1,0
221756,patient,1,1
221757,per,1,0
221758,month,1,0
221759,was,0,0
221760,zero,0,1
221761,on,0,0
221762,three,0,0
221763,times,0,0
221764,12,0,0
221765,U/kg,0,0
221766,",",0,0
221767,0.4,0,0
221768,day,0,0
221769,on,0,0
221770,twice,0,0
221771,18,0,0
221772,U/kg,0,0
221773,and,0,0
221774,once,0,0
221775,36,0,0
221776,U/kg,0,0
221777,",",0,0
221778,while,0,0
221779,it,0,0
221780,had,0,0
221781,been,0,0
221782,five,0,0
221783,days,0,0
221784,in,0,0
221785,the,0,0
221786,pre-trial,0,0
221787,period,0,0
221788,.,0,0
221789,In,0,0
221790,addition,0,0
221791,to,0,0
221792,freedom,1,1
221793,from,1,0
221794,bleeding,1,1
221795,and,0,0
221796,no,0,0
221797,lost,1,1
221798,days,1,0
221799,from,0,0
221800,work,0,1
221801,",",0,0
221802,there,0,0
221803,was,0,0
221804,increased,0,0
221805,mobility,1,1
221806,and,1,1
221807,physical,1,1
221808,capacity,1,1
221809,.,1,0
221810,Lithium,0,0
221811,sustains,0,0
221812,the,0,0
221813,acute,0,0
221814,antidepressant,1,0
221815,effects,1,1
221816,of,0,1
221817,sleep,0,1
221818,deprivation,0,0
221819,:,0,0
221820,preliminary,0,0
221821,findings,0,0
221822,from,0,0
221823,a,0,0
221824,controlled,0,0
221825,study,0,0
221826,.,0,0
221827,Early,0,1
221828,morning,0,1
221829,sleep,0,1
221830,deprivation,0,0
221831,(,0,0
221832,patient,0,1
221833,awake,0,0
221834,from,0,0
221835,0200,0,0
221836,to,0,0
221837,2200,0,0
221838,hours,0,0
221839,),0,0
221840,produces,0,0
221841,a,0,0
221842,same-day,0,0
221843,antidepressant,1,0
221844,effect,1,1
221845,in,0,0
221846,approximately,0,0
221847,one-half,0,0
221848,of,0,0
221849,patients,0,0
221850,with,0,0
221851,major,0,0
221852,depression,0,1
221853,.,0,0
221854,Unfortunately,0,0
221855,",",0,0
221856,these,0,0
221857,antidepressant,0,0
221858,effects,1,0
221859,are,0,0
221860,short-lived,0,1
221861,and,0,1
221862,patients,0,0
221863,usually,0,0
221864,relapse,0,0
221865,to,0,0
221866,baseline,0,0
221867,depression,0,1
221868,levels,0,1
221869,within,0,0
221870,48,0,0
221871,hours,0,0
221872,.,0,0
221873,Recent,0,0
221874,work,0,0
221875,suggests,0,0
221876,",",0,0
221877,however,0,0
221878,",",0,0
221879,that,0,0
221880,the,0,0
221881,use,0,0
221882,of,0,0
221883,lithium,0,0
221884,with,0,0
221885,early,0,0
221886,morning,0,1
221887,sleep,0,1
221888,deprivation,0,0
221889,sustains,0,0
221890,this,0,0
221891,rapid,0,0
221892,antidepressant,1,0
221893,effect,1,0
221894,and,0,0
221895,makes,0,0
221896,it,0,0
221897,clinically,0,0
221898,useful,0,0
221899,.,0,0
221900,In,0,0
221901,a,0,0
221902,30-day,0,1
221903,study,0,0
221904,",",0,0
221905,we,0,0
221906,compared,0,0
221907,the,0,0
221908,abilities,0,1
221909,of,0,0
221910,four,0,0
221911,different,0,0
221912,treatments,0,0
221913,(,0,0
221914,lithium,0,0
221915,plus,0,0
221916,early,0,1
221917,morning,0,1
221918,sleep,0,1
221919,deprivation,0,1
221920,",",0,1
221921,lithium,0,0
221922,plus,0,0
221923,a,0,0
221924,control,0,0
221925,sleep,0,1
221926,deprivation,0,1
221927,procedure,0,0
221928,",",0,1
221929,and,0,1
221930,desipramine,0,0
221931,with,0,0
221932,either,0,0
221933,of,0,0
221934,the,0,0
221935,two,0,0
221936,sleep,0,1
221937,manipulations,0,0
221938,),0,0
221939,to,0,0
221940,induce,0,0
221941,a,0,0
221942,rapid,0,0
221943,(,0,0
221944,next-day,0,1
221945,),0,1
221946,and,0,0
221947,sustained,0,1
221948,antidepressant,1,0
221949,response,1,1
221950,in,0,0
221951,16,0,0
221952,depressed,0,0
221953,patients,0,0
221954,.,0,1
221955,Lithium,0,0
221956,plus,0,0
221957,early,0,1
221958,morning,0,1
221959,sleep,0,1
221960,deprivation,0,0
221961,produced,0,0
221962,a,0,0
221963,quicker,0,1
221964,response,1,1
221965,than,0,0
221966,lithium,0,0
221967,with,0,0
221968,the,0,0
221969,control,0,0
221970,sleep,0,1
221971,deprivation,0,1
221972,",",0,0
221973,and,0,1
221974,the,0,0
221975,response,1,1
221976,was,0,0
221977,sustained,0,0
221978,for,0,0
221979,at,0,0
221980,least,0,0
221981,30,0,0
221982,days,0,0
221983,.,0,0
221984,In,0,0
221985,this,0,0
221986,design,0,0
221987,",",0,0
221988,however,0,0
221989,",",0,0
221990,lithium/early,0,0
221991,morning,0,1
221992,sleep,0,1
221993,deprivation,0,0
221994,was,0,0
221995,no,0,0
221996,faster,0,0
221997,than,0,0
221998,either,0,0
221999,of,0,0
222000,the,0,0
222001,two,0,0
222002,desipramine/sleep,0,0
222003,deprivation,0,0
222004,conditions,0,0
222005,in,0,0
222006,inducing,1,0
222007,remission,1,1
222008,.,1,0
222009,These,0,0
222010,results,0,0
222011,support,0,0
222012,the,0,0
222013,results,0,0
222014,of,0,0
222015,previous,0,0
222016,studies,0,0
222017,and,0,0
222018,suggest,0,0
222019,further,0,0
222020,investigation,0,0
222021,of,0,0
222022,this,0,0
222023,novel,0,0
222024,sleep/pharmacologic,0,0
222025,intervention,0,0
222026,is,0,0
222027,warranted,0,0
222028,.,0,0
222029,Femoral,0,1
222030,vein,0,1
222031,delivery,0,1
222032,of,0,1
222033,contrast,0,0
222034,medium,0,0
222035,enhances,0,0
222036,transthoracic,1,1
222037,echocardiographic,1,1
222038,detection,1,1
222039,of,0,1
222040,patent,1,0
222041,foramen,1,1
222042,ovale,1,0
222043,.,1,0
222044,OBJECTIVES,0,0
222045,We,0,0
222046,postulated,0,0
222047,that,0,0
222048,femoral,0,1
222049,vein,0,1
222050,delivery,0,1
222051,of,0,1
222052,contrast,0,0
222053,medium,0,0
222054,because,0,0
222055,of,0,1
222056,streaming,0,0
222057,",",0,0
222058,might,0,0
222059,enhance,0,0
222060,precordial,1,1
222061,echocardiographic,1,1
222062,detection,1,1
222063,of,0,1
222064,patent,0,0
222065,foramen,0,1
222066,ovale,0,0
222067,.,0,0
222068,BACKGROUND,0,0
222069,Although,0,0
222070,precordial,0,1
222071,contrast,0,0
222072,echocardiography,0,0
222073,is,0,0
222074,widely,0,0
222075,used,0,0
222076,to,0,0
222077,diagnose,0,0
222078,patent,0,0
222079,foramen,0,1
222080,ovale,0,0
222081,",",0,0
222082,this,0,0
222083,method,0,0
222084,is,0,0
222085,limited,0,0
222086,by,0,0
222087,poor,0,0
222088,sensitivity,0,1
222089,.,0,0
222090,Previous,0,0
222091,investigators,0,0
222092,have,0,0
222093,demonstrated,0,0
222094,enhanced,0,0
222095,detection,0,1
222096,of,0,1
222097,atrial,1,1
222098,defects,1,0
222099,by,0,0
222100,the,0,0
222101,dye-dilution,0,0
222102,technique,0,0
222103,after,0,0
222104,delivery,0,1
222105,of,0,1
222106,contrast,0,0
222107,medium,0,0
222108,into,0,0
222109,the,0,0
222110,inferior,0,0
222111,rather,0,0
222112,than,0,0
222113,the,0,0
222114,superior,0,1
222115,vena,0,1
222116,cava,0,1
222117,.,0,1
222118,METHODS,0,0
222119,Transthoracic,0,1
222120,contrast,0,0
222121,examinations,0,1
222122,were,0,0
222123,performed,0,0
222124,in,0,0
222125,a,0,0
222126,randomly,0,0
222127,selected,0,0
222128,group,0,0
222129,of,0,0
222130,70,0,0
222131,patients,0,0
222132,(,0,0
222133,without,0,0
222134,previous,0,0
222135,history,0,1
222136,of,0,1
222137,cerebral,0,1
222138,or,0,0
222139,systemic,0,1
222140,embolus,0,1
222141,),0,0
222142,undergoing,0,0
222143,cardiac,0,1
222144,catheterization,0,0
222145,.,0,0
222146,Paired,0,0
222147,contrast,0,0
222148,agent,0,0
222149,injections,0,0
222150,(,0,0
222151,10,0,0
222152,ml,0,0
222153,dextrose,0,0
222154,in,0,0
222155,water/0.25,0,0
222156,ml,0,0
222157,air,0,0
222158,),0,1
222159,were,0,0
222160,administered,0,0
222161,from,0,0
222162,an,0,0
222163,upper,0,0
222164,extremity,0,1
222165,vein,0,1
222166,and,0,1
222167,femoral,0,1
222168,vein,0,1
222169,in,0,0
222170,each,0,0
222171,patient,0,0
222172,during,0,0
222173,spontaneous,0,1
222174,respiration,0,1
222175,",",0,1
222176,cough,0,1
222177,and,0,1
222178,Valsalva,0,1
222179,maneuvers,0,0
222180,.,0,0
222181,Studies,0,0
222182,were,0,0
222183,interpreted,0,0
222184,by,0,0
222185,an,0,0
222186,experienced,0,0
222187,echocardiographer,0,1
222188,unaware,0,0
222189,of,0,0
222190,the,0,0
222191,sequence,0,0
222192,and,0,1
222193,site,0,1
222194,of,0,0
222195,injections,0,0
222196,.,0,0
222197,Positive,0,1
222198,studies,0,0
222199,were,0,0
222200,semiquantitatively,0,0
222201,graded,0,0
222202,from,0,0
222203,+1,0,0
222204,(,0,0
222205,minimal,0,1
222206,left,0,1
222207,ventricular,0,1
222208,opacification,0,1
222209,),0,0
222210,to,0,0
222211,+4,0,0
222212,(,0,0
222213,intense,0,0
222214,left,0,1
222215,ventricular,0,1
222216,opacification,0,1
222217,),0,0
222218,.,0,1
222219,Catheterization,1,1
222220,and,1,1
222221,echocardiographic,1,1
222222,assessment,1,1
222223,of,1,1
222224,patent,1,0
222225,foramen,1,1
222226,ovale,1,1
222227,were,0,0
222228,compared,0,0
222229,in,0,0
222230,21,0,0
222231,subjects,0,0
222232,.,0,0
222233,RESULTS,0,0
222234,Patent,1,1
222235,foramen,1,1
222236,ovale,1,1
222237,was,0,0
222238,detected,0,0
222239,significantly,0,0
222240,more,0,0
222241,often,0,0
222242,during,0,0
222243,femoral,0,0
222244,vein,0,0
222245,versus,0,0
222246,upper,0,0
222247,extremity,0,1
222248,contrast,0,0
222249,delivery,0,1
222250,(,0,0
222251,23,0,0
222252,of,0,0
222253,70,0,0
222254,patients,0,0
222255,[,0,0
222256,prevalence,0,0
222257,33,0,0
222258,%,0,0
222259,],0,0
222260,vs.,0,0
222261,9,0,0
222262,of,0,0
222263,70,0,0
222264,patients,0,0
222265,[,0,0
222266,prevalence,0,0
222267,13,0,0
222268,%,0,0
222269,],0,0
222270,",",0,1
222271,p,0,0
222272,<,0,0
222273,0.001,0,0
222274,),0,0
222275,.,0,0
222276,The,0,0
222277,intensity,1,1
222278,of,1,0
222279,left,1,1
222280,ventricular,1,1
222281,opacification,1,1
222282,was,0,0
222283,also,0,0
222284,greater,0,0
222285,during,0,0
222286,femoral,0,1
222287,vein,0,1
222288,contrast,0,0
222289,injection,0,0
222290,.,0,1
222291,Precordial,0,1
222292,echocardiography,0,0
222293,combined,0,0
222294,with,0,0
222295,femoral,0,1
222296,contrast,0,0
222297,delivery,0,1
222298,was,0,0
222299,significantly,0,0
222300,more,0,0
222301,sensitive,1,0
222302,than,0,0
222303,cardiac,0,1
222304,catheterization,0,1
222305,for,0,0
222306,assessment,1,0
222307,of,1,1
222308,patent,1,0
222309,foramen,1,1
222310,ovale,1,0
222311,(,0,0
222312,8,0,0
222313,of,0,0
222314,21,0,0
222315,patients,0,0
222316,vs.,0,0
222317,2,0,0
222318,of,0,0
222319,21,0,0
222320,patients,0,0
222321,",",0,0
222322,p,0,0
222323,<,0,0
222324,0.05,0,0
222325,),0,0
222326,.,0,0
222327,CONCLUSIONS,0,0
222328,Femoral,0,1
222329,vein,0,1
222330,contrast,0,0
222331,delivery,0,0
222332,significantly,0,0
222333,enhances,0,0
222334,the,0,0
222335,ability,1,1
222336,of,1,0
222337,precordial,1,1
222338,contrast,1,0
222339,echocardiography,1,0
222340,to,1,0
222341,diagnose,1,0
222342,patent,1,0
222343,foramen,1,0
222344,ovale,1,0
222345,.,1,0
222346,Physiologic,0,0
222347,patency,0,1
222348,of,0,0
222349,the,0,0
222350,foramen,0,0
222351,ovale,0,0
222352,is,0,0
222353,more,0,0
222354,common,0,1
222355,(,0,0
222356,prevalence,0,0
222357,33,0,0
222358,%,0,0
222359,),0,0
222360,than,0,0
222361,previously,0,0
222362,documented,0,0
222363,.,0,0
222364,Deficiency,1,1
222365,of,1,1
222366,serum,1,1
222367,ionized,1,1
222368,magnesium,1,0
222369,in,0,0
222370,patients,0,0
222371,receiving,0,0
222372,hemodialysis,0,0
222373,or,0,1
222374,peritoneal,0,1
222375,dialysis,0,0
222376,.,0,0
222377,Serum,0,1
222378,total,0,1
222379,magnesium,0,0
222380,(,0,1
222381,TMg,0,1
222382,),0,0
222383,measurements,0,1
222384,in,0,0
222385,dialysis,0,0
222386,patients,0,0
222387,are,0,0
222388,variable,0,0
222389,",",0,0
222390,with,0,0
222391,some,0,0
222392,groups,0,0
222393,reporting,0,1
222394,hypermagnesemia,0,1
222395,and,0,0
222396,some,0,0
222397,hypomagnesemia,0,1
222398,.,0,0
222399,It,0,0
222400,had,0,0
222401,not,0,0
222402,been,0,0
222403,possible,0,0
222404,to,0,0
222405,measure,0,0
222406,the,0,0
222407,biologically,0,0
222408,active,0,0
222409,fraction,0,1
222410,",",0,1
222411,ionized,0,1
222412,magnesium,0,0
222413,(,0,1
222414,IMg2+,0,0
222415,),0,0
222416,.,0,0
222417,The,0,0
222418,authors,0,0
222419,utilized,0,0
222420,an,0,0
222421,ion-selective,0,0
222422,electrode,0,0
222423,to,0,0
222424,measure,0,0
222425,IMg,1,0
222426,in,0,0
222427,26,0,0
222428,hemodialysis,0,0
222429,patients,0,0
222430,and,0,0
222431,10,0,0
222432,peritoneal,0,1
222433,dialysis,0,0
222434,(,0,1
222435,CAPD,0,0
222436,),0,1
222437,patients,0,0
222438,and,0,0
222439,compared,0,0
222440,the,0,0
222441,results,0,0
222442,with,0,0
222443,those,0,0
222444,from,0,0
222445,66,0,0
222446,age,0,0
222447,matched,0,0
222448,control,0,0
222449,subjects,0,0
222450,.,0,1
222451,Dialysate,0,1
222452,magnesium,0,0
222453,was,0,0
222454,0.375,0,0
222455,mM/L,0,0
222456,for,0,0
222457,the,0,0
222458,hemodialysis,0,0
222459,and,0,0
222460,0.25,0,0
222461,mM/L,0,0
222462,for,0,0
222463,the,0,0
222464,CAPD,0,0
222465,patients,0,0
222466,.,0,0
222467,When,0,0
222468,compared,0,0
222469,with,0,0
222470,control,0,0
222471,subjects,0,0
222472,",",0,0
222473,both,0,0
222474,hemodialysis,0,1
222475,and,0,1
222476,CAPD,0,1
222477,patients,0,0
222478,had,0,0
222479,significantly,0,0
222480,lower,0,0
222481,IMg2+,1,0
222482,(,0,0
222483,0.55,0,0
222484,+/-,0,0
222485,0.02,0,0
222486,and,0,0
222487,0.50,0,0
222488,+/-,0,0
222489,0.02,0,0
222490,vs.,0,0
222491,0.60,0,0
222492,+/-,0,0
222493,0.004,0,0
222494,mM/L,0,0
222495,;,0,0
222496,p,0,0
222497,<,0,0
222498,0.05,0,0
222499,),0,0
222500,and,0,0
222501,greater,1,1
222502,or,1,1
222503,normal,1,1
222504,TMg,1,1
222505,values,1,1
222506,(,0,0
222507,0.99,0,0
222508,+/-,0,0
222509,0.04,0,0
222510,",",0,0
222511,different,0,0
222512,at,0,0
222513,the,0,0
222514,p,0,0
222515,<,0,0
222516,0.001,0,0
222517,level,0,1
222518,",",0,0
222519,and,0,0
222520,0.85,0,0
222521,+/-,0,0
222522,0.04,0,0
222523,vs.,0,0
222524,0.84,0,0
222525,+/-,0,0
222526,0.008,0,0
222527,),0,0
222528,.,0,0
222529,Ionized,1,0
222530,calcium,1,1
222531,(,1,0
222532,ICa2+,1,1
222533,),1,1
222534,values,1,1
222535,were,0,0
222536,similar,0,0
222537,for,0,0
222538,all,0,0
222539,three,0,0
222540,groups,0,0
222541,(,0,0
222542,1.15,0,0
222543,+/-,0,0
222544,0.02,0,0
222545,and,0,0
222546,1.21,0,0
222547,+/-,0,0
222548,0.04,0,0
222549,vs.,0,0
222550,1.17,0,0
222551,+/-,0,0
222552,0.01,0,0
222553,),0,0
222554,",",0,0
222555,resulting,0,0
222556,in,0,0
222557,increased,0,0
222558,mean,0,1
222559,ICa2+/IMg2+,1,1
222560,ratios,1,1
222561,(,0,0
222562,2.14,0,0
222563,+/-,0,0
222564,0.07,0,0
222565,and,0,0
222566,2.42,0,0
222567,+/-,0,0
222568,0.06,0,0
222569,vs.,0,0
222570,1.95,0,0
222571,+/-,0,0
222572,0.02,0,0
222573,for,0,0
222574,the,0,0
222575,control,0,0
222576,subjects,0,0
222577,;,0,0
222578,p,0,0
222579,<,0,0
222580,0.05,0,0
222581,),0,0
222582,.,0,0
222583,The,0,0
222584,percent,0,1
222585,of,0,0
222586,total,1,1
222587,magnesium,1,0
222588,that,0,0
222589,was,0,0
222590,ionized,1,1
222591,(,1,0
222592,%,1,0
222593,IMg2+,1,1
222594,),1,1
222595,was,0,0
222596,low,0,0
222597,in,0,0
222598,both,0,0
222599,the,0,0
222600,hemodialysis,0,0
222601,and,0,1
222602,CAPD,0,1
222603,patients,0,0
222604,(,0,0
222605,55.6,0,0
222606,+/-,0,0
222607,0.93,0,0
222608,and,0,0
222609,59.2,0,0
222610,+/-,0,0
222611,1.05,0,0
222612,),0,0
222613,compared,0,0
222614,with,0,0
222615,that,0,0
222616,of,0,0
222617,control,0,0
222618,subjects,0,0
222619,(,0,0
222620,72,0,0
222621,+/-,0,0
222622,0.61,0,0
222623,;,0,0
222624,p,0,0
222625,<,0,0
222626,0.05,0,0
222627,),0,0
222628,.,0,0
222629,IMg2+,0,0
222630,values,0,1
222631,correlated,0,0
222632,with,0,0
222633,TMg,0,0
222634,values,0,1
222635,in,0,0
222636,both,0,0
222637,hemodialysis,0,0
222638,(,0,0
222639,r,0,0
222640,=,0,0
222641,0.93,0,0
222642,;,0,0
222643,p,0,0
222644,<,0,0
222645,0.0001,0,0
222646,),0,0
222647,and,0,0
222648,CAPD,0,0
222649,(,0,1
222650,r,0,0
222651,=,0,0
222652,0.92,0,0
222653,;,0,0
222654,p,0,0
222655,<,0,0
222656,0.0001,0,0
222657,),0,0
222658,patients,0,0
222659,did,0,0
222660,not,0,0
222661,correlate,0,0
222662,with,0,0
222663,age,0,0
222664,",",0,1
222665,time,0,1
222666,on,0,0
222667,dialysis,0,0
222668,",",0,1
222669,weight,0,1
222670,",",0,1
222671,fasting,0,1
222672,cholesterol,0,1
222673,or,0,1
222674,triglyceride,0,1
222675,",",0,1
222676,albumin,0,1
222677,",",0,1
222678,blood,0,1
222679,urea,0,1
222680,nitrogen,0,0
222681,(,0,1
222682,BUN,0,0
222683,),0,1
222684,",",0,1
222685,creatinine,0,1
222686,",",0,1
222687,hematocrit,0,1
222688,",",0,1
222689,phosphate,0,0
222690,",",0,1
222691,or,0,1
222692,PTH,0,1
222693,values,0,1
222694,.,0,1
222695,(,0,0
222696,ABSTRACT,0,1
222697,TRUNCATED,0,0
222698,AT,0,0
222699,250,0,0
222700,WORDS,0,0
222701,),0,0
222702,Noradrenergic,1,1
222703,response,1,1
222704,to,0,0
222705,intravenous,0,0
222706,yohimbine,0,0
222707,in,0,0
222708,patients,0,0
222709,with,0,0
222710,depression,0,1
222711,and,0,1
222712,comorbidity,0,1
222713,of,0,1
222714,depression,0,1
222715,and,0,1
222716,panic,0,1
222717,.,0,1
222718,Adrenergic,1,1
222719,response,1,1
222720,following,0,0
222721,infusions,0,0
222722,of,0,1
222723,yohimbine,0,0
222724,or,0,1
222725,normal,0,1
222726,saline,0,0
222727,was,0,0
222728,evaluated,0,0
222729,in,0,0
222730,9,0,0
222731,control,0,0
222732,subjects,0,0
222733,",",0,0
222734,8,0,0
222735,patients,0,0
222736,suffering,0,0
222737,from,0,0
222738,a,0,0
222739,major,0,1
222740,depressive,0,1
222741,episode,0,1
222742,(,0,1
222743,MDE,0,1
222744,),0,1
222745,",",0,0
222746,and,0,0
222747,12,0,0
222748,patients,0,0
222749,suffering,0,0
222750,from,0,0
222751,concurrent,0,0
222752,MDE,0,0
222753,and,0,1
222754,panic,0,1
222755,disorder,0,0
222756,(,0,0
222757,MDE,0,1
222758,+,0,0
222759,P,0,0
222760,),0,0
222761,.,0,0
222762,Blood,0,1
222763,was,0,0
222764,drawn,0,0
222765,at,0,0
222766,-20,0,0
222767,",",0,0
222768,0,0,0
222769,",",0,0
222770,5,0,0
222771,",",0,0
222772,10,0,0
222773,",",0,0
222774,20,0,0
222775,",",0,0
222776,45,0,0
222777,",",0,0
222778,and,0,0
222779,90,0,0
222780,min,0,0
222781,following,0,0
222782,the,0,0
222783,infusions,0,0
222784,",",0,1
222785,and,0,1
222786,assayed,0,1
222787,for,0,0
222788,norepinephrine,1,1
222789,(,1,1
222790,NE,1,1
222791,),1,1
222792,and,1,1
222793,3-methoxy-4-hydroxy-phenyl,1,1
222794,glycol,1,0
222795,(,1,1
222796,MHPG,1,1
222797,),1,0
222798,.,1,0
222799,Although,0,0
222800,the,0,0
222801,patient,0,1
222802,groups,0,0
222803,exhibited,0,1
222804,higher,0,0
222805,baseline,1,1
222806,NE,1,1
222807,concentrations,1,1
222808,",",0,0
222809,and,0,0
222810,a,0,0
222811,greater,0,1
222812,NE,1,1
222813,area,1,1
222814,under,1,0
222815,the,1,0
222816,plasma,1,1
222817,concentration,1,1
222818,versus,1,0
222819,time,1,1
222820,curve,1,1
222821,(,0,1
222822,AUC0-90,0,0
222823,),0,0
222824,during,0,0
222825,the,0,0
222826,yohimbine,0,0
222827,infusion,0,0
222828,",",0,0
222829,the,0,0
222830,differences,0,0
222831,were,0,0
222832,not,0,0
222833,statistically,0,0
222834,significant,0,0
222835,.,0,0
222836,Baseline,1,0
222837,NE,1,1
222838,was,0,0
222839,significantly,0,0
222840,correlated,0,0
222841,with,0,0
222842,the,0,0
222843,NE,1,1
222844,AUC0-90,1,0
222845,in,0,0
222846,all,0,0
222847,three,0,0
222848,groups,0,0
222849,",",0,0
222850,suggesting,0,0
222851,that,0,0
222852,",",0,0
222853,although,0,0
222854,the,0,0
222855,NE,0,1
222856,system,0,0
222857,may,0,0
222858,be,0,0
222859,dysregulated,0,0
222860,in,0,0
222861,the,0,0
222862,MDE,0,0
222863,and,0,1
222864,MDE,0,1
222865,+,0,0
222866,P,0,0
222867,patients,0,0
222868,",",0,0
222869,the,0,0
222870,NE,0,1
222871,system,0,0
222872,still,0,0
222873,appears,0,0
222874,to,0,0
222875,respond,0,0
222876,somewhat,0,0
222877,predictably,0,0
222878,following,0,0
222879,a,0,0
222880,challenge,0,0
222881,",",0,0
222882,even,0,0
222883,though,0,0
222884,the,0,0
222885,actual,0,1
222886,magnitude,0,1
222887,of,0,0
222888,response,0,1
222889,may,0,0
222890,vary,0,0
222891,.,0,0
222892,A,0,0
222893,program,0,0
222894,of,0,0
222895,screening,0,0
222896,and,0,0
222897,prompting,0,0
222898,improves,0,1
222899,short-term,0,1
222900,physician,0,1
222901,counseling,0,0
222902,of,0,1
222903,dependent,0,0
222904,and,0,1
222905,nondependent,0,1
222906,harmful,0,0
222907,drinkers,0,0
222908,.,0,0
222909,BACKGROUND,0,0
222910,Physicians,0,0
222911,in,0,0
222912,the,0,0
222913,general,0,0
222914,medical,0,0
222915,setting,0,0
222916,commonly,0,0
222917,encounter,0,0
222918,but,0,0
222919,rarely,0,0
222920,counsel,0,0
222921,patients,0,0
222922,with,0,0
222923,dependent,0,0
222924,or,0,0
222925,harmful,0,1
222926,drinking,0,0
222927,behaviors,0,1
222928,.,0,0
222929,We,0,0
222930,tested,0,0
222931,whether,0,0
222932,providing,0,0
222933,physicians,0,0
222934,with,0,0
222935,their,0,0
222936,patients,0,0
222937,',0,1
222938,results,0,0
222939,on,0,0
222940,the,0,0
222941,alcohol,0,1
222942,module,0,0
222943,of,0,0
222944,the,0,0
222945,Diagnostic,0,0
222946,Interview,0,0
222947,Schedule,0,1
222948,and,0,1
222949,counseling,0,0
222950,directives,0,0
222951,would,0,0
222952,prompt,0,0
222953,them,0,0
222954,to,0,0
222955,counsel,0,0
222956,these,0,0
222957,patients,0,0
222958,.,0,0
222959,METHODS,0,0
222960,We,0,0
222961,randomly,0,0
222962,assigned,0,0
222963,83,0,0
222964,first-,0,0
222965,",",0,0
222966,second-,0,1
222967,",",0,1
222968,and,0,1
222969,third-year,0,0
222970,medical,0,0
222971,residents,0,0
222972,to,0,0
222973,receive,0,0
222974,or,0,0
222975,not,0,0
222976,to,0,0
222977,receive,0,0
222978,diagnostic,0,1
222979,information,0,1
222980,and,0,1
222981,counseling,0,0
222982,directives,0,0
222983,on,0,0
222984,214,0,0
222985,patients,0,0
222986,who,0,0
222987,reported,0,0
222988,at,0,0
222989,least,0,0
222990,one,0,0
222991,symptom,0,1
222992,of,0,0
222993,alcohol,0,1
222994,impairment,0,1
222995,as,0,0
222996,defined,0,0
222997,in,0,0
222998,the,0,0
222999,Diagnostic,0,0
223000,and,0,1
223001,Statistical,0,1
223002,Manual,0,1
223003,of,0,1
223004,Mental,0,1
223005,Disorders,0,1
223006,",",0,1
223007,Third,0,0
223008,Edition,0,1
223009,.,0,0
223010,Using,0,0
223011,binary,0,1
223012,logistic,0,1
223013,regression,0,0
223014,",",0,0
223015,we,0,0
223016,examined,0,0
223017,the,0,0
223018,effect,0,1
223019,of,0,0
223020,specific,0,0
223021,covariables,0,1
223022,on,0,0
223023,rates,0,1
223024,of,0,0
223025,physician,0,0
223026,counseling,0,0
223027,.,0,0
223028,These,0,0
223029,variables,0,1
223030,included,0,0
223031,physician,0,1
223032,information,0,1
223033,status,0,1
223034,",",0,1
223035,patient,0,1
223036,gender,0,1
223037,",",0,1
223038,and,0,1
223039,drinking,0,1
223040,disorder,0,0
223041,severity,0,1
223042,and,0,1
223043,recency,0,1
223044,.,0,0
223045,We,0,0
223046,also,0,0
223047,examined,0,0
223048,the,0,0
223049,effect,0,1
223050,of,0,0
223051,physician,0,1
223052,prompting,0,0
223053,on,0,0
223054,counseling,0,0
223055,of,0,0
223056,female,0,0
223057,patients,0,0
223058,",",0,0
223059,patients,0,0
223060,with,0,0
223061,inactive,0,0
223062,disorders,0,0
223063,",",0,1
223064,and,0,1
223065,nondependent,0,1
223066,but,0,0
223067,harmful,0,0
223068,drinkers,0,0
223069,.,0,0
223070,We,0,0
223071,determined,0,0
223072,counseling,0,0
223073,by,0,0
223074,post-visit,0,1
223075,patient,0,1
223076,interviews,0,0
223077,.,0,0
223078,RESULTS,0,0
223079,Physician,1,1
223080,prompting,1,0
223081,",",1,1
223082,dependent,1,1
223083,drinking,1,1
223084,",",1,1
223085,and,1,1
223086,recent,1,0
223087,disorder,1,0
223088,activity,1,1
223089,were,0,0
223090,significant,0,0
223091,correlates,0,0
223092,of,0,1
223093,physician,0,1
223094,counseling,0,0
223095,(,0,0
223096,P,0,0
223097,<,0,0
223098,.05,0,0
223099,),0,1
223100,",",0,0
223101,while,0,0
223102,male,0,0
223103,gender,0,0
223104,was,0,0
223105,a,0,0
223106,marginally,0,0
223107,significant,0,0
223108,correlate,0,0
223109,(,0,0
223110,P,0,0
223111,=,0,0
223112,.08,0,0
223113,),0,0
223114,.,0,0
223115,Informed,0,0
223116,physicians,0,0
223117,counseled,0,0
223118,female,0,0
223119,patients,0,0
223120,",",0,1
223121,harmful,0,1
223122,but,0,0
223123,nondependent,0,1
223124,drinkers,0,0
223125,",",0,1
223126,and,0,1
223127,patients,0,0
223128,with,0,0
223129,inactive,0,0
223130,disorders,0,0
223131,more,0,0
223132,often,0,0
223133,than,0,0
223134,their,0,0
223135,uninformed,0,0
223136,colleagues,0,0
223137,",",0,0
223138,although,0,0
223139,only,0,0
223140,the,0,0
223141,last,0,0
223142,variable,0,0
223143,achieved,0,1
223144,statistical,0,0
223145,significance,0,1
223146,.,0,0
223147,CONCLUSIONS,0,0
223148,Providing,0,0
223149,physicians,0,0
223150,with,0,0
223151,the,0,0
223152,results,0,0
223153,of,0,0
223154,the,0,0
223155,Diagnostic,0,0
223156,Interview,0,0
223157,Schedule,0,1
223158,and,0,1
223159,counseling,0,0
223160,directives,0,0
223161,resulted,0,0
223162,in,0,0
223163,short-term,0,1
223164,improvement,0,1
223165,in,0,0
223166,their,0,0
223167,rates,0,1
223168,of,0,0
223169,counseling,0,0
223170,patients,0,0
223171,with,0,0
223172,a,0,0
223173,history,0,1
223174,of,0,1
223175,dependent,0,0
223176,or,0,1
223177,nondependent,0,1
223178,but,0,0
223179,harmful,0,0
223180,drinking,0,1
223181,.,0,1
223182,Further,0,0
223183,research,0,0
223184,is,0,0
223185,necessary,0,0
223186,to,0,0
223187,determine,0,0
223188,long-term,0,0
223189,gains,0,1
223190,in,0,0
223191,rates,0,1
223192,of,0,0
223193,physician,0,1
223194,counseling,0,0
223195,and,0,1
223196,improvements,0,1
223197,in,0,0
223198,the,0,0
223199,course,0,0
223200,of,0,0
223201,these,0,0
223202,patients,0,0
223203,.,0,0
223204,Torasemide,0,1
223205,versus,0,0
223206,furosemide,0,0
223207,in,0,0
223208,cirrhosis,0,0
223209,:,0,0
223210,a,0,0
223211,long-term,0,0
223212,",",0,0
223213,double-blind,0,0
223214,",",0,1
223215,randomized,0,0
223216,clinical,0,0
223217,study,0,0
223218,.,0,0
223219,The,0,0
223220,effects,0,0
223221,of,0,0
223222,long-term,0,1
223223,therapy,0,0
223224,(,0,0
223225,70,0,0
223226,days,0,0
223227,),0,0
223228,with,0,0
223229,torasemide,0,0
223230,(,0,0
223231,20,0,0
223232,mg/day,0,0
223233,),0,0
223234,",",0,0
223235,a,0,0
223236,new,0,1
223237,loop,0,1
223238,diuretic,0,1
223239,",",0,1
223240,were,0,0
223241,compared,0,0
223242,with,0,0
223243,those,0,0
223244,of,0,0
223245,furosemide,0,0
223246,(,0,0
223247,50,0,0
223248,mg/day,0,0
223249,),0,0
223250,in,0,0
223251,a,0,0
223252,randomized,0,0
223253,double-blind,0,0
223254,trial,0,0
223255,.,0,0
223256,Both,0,0
223257,drugs,0,0
223258,were,0,0
223259,administered,0,0
223260,in,0,0
223261,association,0,0
223262,with,0,0
223263,spironolactone,0,0
223264,(,0,0
223265,200,0,0
223266,mg/day,0,0
223267,),0,0
223268,in,0,0
223269,28,0,0
223270,nonazotemic,0,0
223271,cirrhotic,0,0
223272,patients,0,0
223273,with,0,0
223274,controlled,0,0
223275,ascites,0,1
223276,.,0,0
223277,The,0,0
223278,treatments,0,0
223279,did,0,0
223280,not,0,0
223281,modify,0,0
223282,creatinine,1,1
223283,clearance,1,1
223284,and,0,1
223285,exhibited,0,0
223286,a,0,0
223287,similar,0,0
223288,effect,0,1
223289,on,0,0
223290,body,1,1
223291,weight,1,1
223292,",",1,1
223293,urinary,1,1
223294,volume,1,1
223295,",",0,1
223296,and,0,1
223297,fractional,1,1
223298,excretion,1,1
223299,of,1,1
223300,uric,1,1
223301,acid,1,1
223302,",",1,1
223303,sodium,1,1
223304,",",1,1
223305,and,1,1
223306,chloride,1,0
223307,.,1,0
223308,The,0,0
223309,effect,0,0
223310,of,0,0
223311,torasemide,0,0
223312,on,0,0
223313,fractional,1,1
223314,potassium,1,1
223315,excretion,1,1
223316,was,0,0
223317,lower,0,0
223318,than,0,0
223319,that,0,0
223320,of,0,0
223321,furosemide,0,0
223322,.,0,1
223323,Torasemide,0,1
223324,showed,0,0
223325,higher,0,0
223326,sparing,1,1
223327,effect,1,1
223328,than,0,0
223329,furosemide,0,0
223330,on,0,0
223331,calcium,1,1
223332,",",1,1
223333,inorganic,1,1
223334,phosphate,1,0
223335,",",1,1
223336,and,1,1
223337,magnesium,1,1
223338,excretion,1,1
223339,and,0,1
223340,stronger,0,0
223341,action,0,1
223342,on,0,0
223343,free,1,1
223344,water,1,0
223345,clearance,1,1
223346,.,1,0
223347,No,0,0
223348,changes,0,1
223349,in,0,0
223350,serum,1,1
223351,parameters,1,1
223352,were,0,0
223353,induced,0,0
223354,by,0,0
223355,either,0,0
223356,treatment,0,0
223357,.,0,0
223358,Two,0,0
223359,episodes,0,0
223360,of,0,0
223361,hepatic,1,1
223362,encephalopathy,1,1
223363,occurred,0,0
223364,in,0,0
223365,the,0,0
223366,torasemide,0,0
223367,group,0,0
223368,.,0,0
223369,In,0,0
223370,view,0,0
223371,of,0,0
223372,its,0,0
223373,effects,1,1
223374,on,1,0
223375,sodium,1,0
223376,and,1,1
223377,water,1,1
223378,excretion,1,1
223379,and,0,1
223380,on,1,0
223381,other,1,0
223382,urinary,1,1
223383,parameters,1,1
223384,",",0,0
223385,torasemide,0,0
223386,can,0,0
223387,represent,0,0
223388,an,0,0
223389,alternative,0,0
223390,tool,0,0
223391,for,0,0
223392,the,0,0
223393,long-term,0,0
223394,treatment,0,0
223395,of,0,0
223396,ascites,0,1
223397,.,0,0
223398,Pharmacokinetic,0,1
223399,study,0,0
223400,of,0,0
223401,RU,0,0
223402,486,0,0
223403,and,0,0
223404,its,0,0
223405,metabolites,0,1
223406,after,0,0
223407,oral,0,0
223408,administration,0,0
223409,of,0,1
223410,single,0,0
223411,doses,0,0
223412,to,0,0
223413,pregnant,0,0
223414,and,0,1
223415,non-pregnant,0,0
223416,women,0,0
223417,.,0,0
223418,RU,0,0
223419,486,0,0
223420,and,0,0
223421,three,0,0
223422,of,0,0
223423,its,0,0
223424,metabolites,0,1
223425,(,0,0
223426,RU,0,0
223427,42633-monodemethyl,0,0
223428,",",0,0
223429,RU,0,0
223430,42848-didemethyl,0,1
223431,",",0,0
223432,and,0,0
223433,RU,0,1
223434,42698-hydroxymetabolite,0,1
223435,),0,0
223436,were,0,0
223437,determined,0,0
223438,by,0,0
223439,HPLC,0,0
223440,in,0,0
223441,plasma,0,1
223442,from,0,0
223443,nine,0,0
223444,non-pregnant,0,0
223445,and,0,0
223446,36,0,0
223447,pregnant,0,0
223448,women,0,0
223449,.,0,0
223450,Each,0,0
223451,non-pregnant,0,0
223452,subject,0,0
223453,took,0,0
223454,an,0,0
223455,oral,0,0
223456,dose,0,0
223457,of,0,0
223458,RU,0,0
223459,486,0,0
223460,(,0,0
223461,25,0,0
223462,",",0,0
223463,100,0,0
223464,",",0,0
223465,400,0,0
223466,and,0,0
223467,600,0,0
223468,mg,0,0
223469,consecutively,0,0
223470,),0,0
223471,once,0,0
223472,per,0,0
223473,menstrual,0,1
223474,cycle,0,1
223475,.,0,0
223476,Six,0,0
223477,of,0,0
223478,the,0,0
223479,nine,0,0
223480,women,0,0
223481,also,0,0
223482,received,0,0
223483,a,0,0
223484,dose,0,0
223485,of,0,0
223486,200,0,0
223487,mg,0,0
223488,.,0,0
223489,The,0,0
223490,36,0,0
223491,pregnant,0,0
223492,women,0,0
223493,were,0,0
223494,randomized,0,0
223495,into,0,0
223496,four,0,0
223497,groups,0,0
223498,which,0,0
223499,were,0,0
223500,given,0,0
223501,a,0,0
223502,single,0,0
223503,dose,0,0
223504,of,0,0
223505,25,0,0
223506,",",0,0
223507,100,0,0
223508,",",0,0
223509,400,0,0
223510,or,0,0
223511,600,0,0
223512,mg,0,0
223513,RU,0,0
223514,486,0,0
223515,.,0,0
223516,Blood,1,0
223517,samples,1,0
223518,were,0,0
223519,taken,0,0
223520,up,0,0
223521,to,0,0
223522,120,0,0
223523,h,0,0
223524,after,0,0
223525,dosing,0,0
223526,.,0,0
223527,Peak,1,1
223528,concentrations,1,1
223529,of,1,0
223530,RU,1,0
223531,486,1,0
223532,occurred,0,0
223533,on,0,0
223534,most,0,0
223535,occasions,0,0
223536,within,0,0
223537,2,0,0
223538,h.,0,0
223539,Plasma,1,1
223540,concentrations,1,1
223541,at,0,0
223542,1,0,0
223543,h,0,0
223544,and,0,0
223545,at,0,0
223546,24,0,0
223547,h,0,0
223548,increased,0,0
223549,in,0,0
223550,proportion,0,0
223551,to,0,0
223552,log,0,1
223553,dose,0,0
223554,.,0,0
223555,There,0,0
223556,was,0,0
223557,a,0,0
223558,wide,0,0
223559,variability,0,1
223560,(,0,0
223561,up,0,0
223562,to,0,0
223563,ten-fold,0,1
223564,),0,0
223565,in,0,0
223566,the,0,0
223567,pharmacokinetic,0,1
223568,parameters,0,0
223569,within,0,0
223570,each,0,0
223571,dose,0,0
223572,group,0,0
223573,.,0,1
223574,Plasma,1,1
223575,concentrations,1,1
223576,of,1,0
223577,RU,1,0
223578,42633,1,0
223579,were,0,0
223580,similar,0,0
223581,to,0,0
223582,those,0,0
223583,of,0,0
223584,RU,0,0
223585,486,0,0
223586,but,0,0
223587,concentrations,0,1
223588,of,0,0
223589,RU,0,0
223590,42848,0,0
223591,and,0,0
223592,RU,0,0
223593,42698,0,0
223594,were,0,0
223595,much,0,0
223596,lower,0,0
223597,.,0,0
223598,As,0,0
223599,with,0,0
223600,RU,0,0
223601,486,0,0
223602,",",0,0
223603,the,0,0
223604,plasma,1,1
223605,concentrations,1,1
223606,of,1,0
223607,the,1,0
223608,metabolites,1,1
223609,were,0,0
223610,maintained,0,0
223611,at,0,0
223612,high,0,0
223613,levels,0,1
223614,for,0,0
223615,up,0,0
223616,to,0,0
223617,48-72,0,0
223618,h,0,0
223619,after,0,0
223620,dosing,0,0
223621,.,0,0
223622,The,0,0
223623,findings,0,0
223624,were,0,0
223625,consistent,0,0
223626,with,0,0
223627,a,0,0
223628,rapid,0,0
223629,metabolism,0,1
223630,of,0,0
223631,RU,1,0
223632,486,1,0
223633,to,1,0
223634,RU,1,0
223635,42633,1,0
223636,;,1,0
223637,removal,0,0
223638,of,0,0
223639,the,0,0
223640,second,0,0
223641,methyl,0,0
223642,group,0,0
223643,leading,0,0
223644,to,0,0
223645,RU,0,0
223646,42698,0,0
223647,occurred,0,0
223648,much,0,0
223649,more,0,0
223650,slowly,0,0
223651,and,0,0
223652,to,0,0
223653,a,0,0
223654,much,0,0
223655,less,0,0
223656,extent,0,0
223657,than,0,0
223658,removal,0,0
223659,of,0,0
223660,the,0,0
223661,first,0,0
223662,.,0,0
223663,There,0,0
223664,appeared,0,0
223665,to,0,0
223666,be,0,0
223667,no,0,0
223668,significant,0,0
223669,differences,0,0
223670,between,0,0
223671,the,0,0
223672,non-pregnant,0,0
223673,and,0,0
223674,pregnant,0,0
223675,women,0,0
223676,in,0,0
223677,either,0,0
223678,the,0,0
223679,plasma,0,1
223680,concentrations,0,1
223681,or,0,0
223682,pharmacokinetic,0,1
223683,parameters,0,1
223684,of,0,0
223685,RU,0,0
223686,486,0,0
223687,and,0,0
223688,its,0,0
223689,metabolites,0,1
223690,.,0,0
223691,Effects,0,0
223692,of,0,0
223693,reducing,0,0
223694,dietary,0,1
223695,[,0,0
223696,(,0,0
223697,Na+,0,1
223698,+,0,0
223699,K+,0,0
223700,),0,0
223701,-,0,0
223702,(,0,0
223703,Cl-,0,1
223704,+,0,0
223705,SO4=,0,0
223706,),0,0
223707,],0,0
223708,on,0,0
223709,the,0,0
223710,rate,0,1
223711,of,0,1
223712,calcium,0,1
223713,mobilisation,0,1
223714,by,0,0
223715,dairy,0,0
223716,cows,0,1
223717,at,0,0
223718,parturition,0,1
223719,.,0,0
223720,The,0,0
223721,effects,0,0
223722,of,0,0
223723,feeding,0,1
223724,diets,0,0
223725,with,0,0
223726,different,0,0
223727,milliequivalents,0,0
223728,(,0,1
223729,meq,0,0
223730,),0,0
223731,of,0,0
223732,dietary,0,1
223733,[,0,0
223734,(,0,0
223735,Na+,0,1
223736,+,0,0
223737,K+,0,0
223738,),0,0
223739,-,0,0
223740,(,0,0
223741,Cl-,0,1
223742,+,0,0
223743,SO4=,0,0
223744,),0,0
223745,],0,0
223746,to,0,0
223747,dairy,0,0
223748,cows,0,0
223749,during,0,0
223750,the,0,0
223751,last,0,0
223752,seven,0,0
223753,weeks,0,0
223754,of,0,0
223755,pregnancy,0,1
223756,on,0,0
223757,their,0,0
223758,acid-base,0,1
223759,status,0,1
223760,and,0,1
223761,calcium,0,1
223762,mobilisation,0,1
223763,rate,0,1
223764,around,0,0
223765,parturition,0,1
223766,were,0,0
223767,studied,0,0
223768,.,0,0
223769,Ten,0,0
223770,monozygotic,0,0
223771,twin,0,0
223772,pairs,0,0
223773,of,0,0
223774,pregnant,0,0
223775,cows,0,0
223776,(,0,0
223777,five,0,0
223778,pairs,0,0
223779,of,0,0
223780,parity,0,0
223781,1,0,0
223782,or,0,0
223783,2,0,0
223784,",",0,0
223785,and,0,0
223786,five,0,0
223787,pairs,0,0
223788,of,0,0
223789,parity,0,0
223790,3,0,0
223791,or,0,0
223792,more,0,0
223793,),0,1
223794,were,0,0
223795,allocated,0,0
223796,to,0,0
223797,two,0,0
223798,diets,0,0
223799,which,0,0
223800,were,0,0
223801,formulated,0,0
223802,to,0,0
223803,provide,0,0
223804,either,0,0
223805,-4,0,0
223806,meq,0,0
223807,(,0,1
223808,anion,0,1
223809,diet,0,0
223810,),0,1
223811,or,0,0
223812,+572.5,0,0
223813,meq,0,0
223814,(,0,1
223815,cation,0,1
223816,diet,0,0
223817,),0,0
223818,of,0,1
223819,[,0,0
223820,(,0,0
223821,Na+,0,1
223822,+,0,0
223823,K+,0,0
223824,),0,0
223825,-,0,0
223826,(,0,0
223827,Cl-,0,1
223828,+,0,0
223829,SO4=,0,0
223830,),0,1
223831,],0,0
223832,kg-1,0,0
223833,dietary,0,1
223834,dry,0,1
223835,matter,0,1
223836,(,0,1
223837,DM,0,0
223838,),0,0
223839,.,0,0
223840,The,0,0
223841,daily,0,0
223842,rations,0,0
223843,consisted,0,0
223844,of,0,0
223845,4,0,0
223846,kg,0,0
223847,grass,0,0
223848,hay,0,1
223849,and,0,0
223850,7,0,0
223851,kg,0,0
223852,concentrates,0,0
223853,.,0,0
223854,Changes,0,1
223855,in,0,0
223856,meq,0,0
223857,of,0,0
223858,dietary,1,1
223859,[,1,0
223860,(,1,0
223861,Na+,1,1
223862,+,1,0
223863,K+,1,0
223864,),1,0
223865,-,1,0
223866,(,1,0
223867,Cl-,1,1
223868,+,1,0
223869,SO4=,1,0
223870,),1,1
223871,],1,0
223872,were,0,0
223873,achieved,0,0
223874,by,0,0
223875,adding,0,0
223876,KCl,0,1
223877,",",0,1
223878,K2SO4,0,1
223879,and,0,1
223880,(,0,1
223881,NH4,0,0
223882,),0,0
223883,2SO4,0,0
223884,(,0,0
223885,anion,0,1
223886,diet,0,0
223887,),0,1
223888,or,0,1
223889,K2CO3,0,1
223890,(,0,1
223891,cation,0,1
223892,diet,0,0
223893,),0,0
223894,to,0,0
223895,basal,0,0
223896,concentrates,0,0
223897,.,0,0
223898,Plasma,1,1
223899,calcium,1,1
223900,concentration,1,1
223901,and,1,1
223902,blood,1,1
223903,acid-base,1,1
223904,parameters,1,1
223905,were,0,0
223906,not,0,0
223907,affected,0,0
223908,by,0,0
223909,dietary,0,0
223910,treatment,0,0
223911,.,0,0
223912,However,0,0
223913,",",0,0
223914,urinary,1,1
223915,calcium,1,1
223916,excretion,1,1
223917,was,0,0
223918,markedly,0,0
223919,higher,0,0
223920,and,0,1
223921,urinary,1,1
223922,pH,1,1
223923,and,1,1
223924,bicarbonate,1,1
223925,excretion,1,1
223926,significantly,0,0
223927,lower,0,0
223928,in,0,0
223929,cows,0,0
223930,fed,0,0
223931,the,0,0
223932,anion,0,1
223933,diet,0,0
223934,than,0,0
223935,in,0,0
223936,cows,0,0
223937,fed,0,0
223938,the,0,0
223939,cation,0,1
223940,diet,0,0
223941,.,0,0
223942,The,0,0
223943,responses,0,0
223944,to,0,0
223945,hypocalcaemia,0,1
223946,induced,0,0
223947,by,0,0
223948,an,0,0
223949,intravenous,0,0
223950,infusion,0,0
223951,of,0,1
223952,EDTA,0,1
223953,solution,0,1
223954,were,0,0
223955,similar,0,0
223956,in,0,0
223957,the,0,0
223958,cows,0,0
223959,fed,0,0
223960,either,0,0
223961,diet,0,0
223962,.,0,0
223963,Torasemide,0,0
223964,in,0,0
223965,the,0,0
223966,treatment,0,0
223967,of,0,0
223968,patients,0,0
223969,with,0,0
223970,cirrhosis,0,0
223971,and,0,0
223972,ascites,0,1
223973,.,0,0
223974,The,0,0
223975,effects,0,0
223976,of,0,1
223977,torasemide,0,0
223978,(,0,0
223979,20,0,0
223980,mg/day,0,0
223981,),0,0
223982,and,0,1
223983,furosemide,0,0
223984,(,0,0
223985,50,0,0
223986,mg/day,0,0
223987,),0,0
223988,",",0,0
223989,each,0,0
223990,given,0,0
223991,over,0,0
223992,4,0,0
223993,days,0,0
223994,",",0,0
223995,were,0,0
223996,compared,0,0
223997,in,0,0
223998,a,0,0
223999,randomized,0,0
224000,and,0,1
224001,crossover,0,0
224002,study,0,0
224003,carried,0,0
224004,out,0,0
224005,in,0,0
224006,seven,0,0
224007,patients,0,0
224008,with,0,0
224009,cirrhosis,0,0
224010,and,0,1
224011,tense,0,1
224012,ascites,0,1
224013,.,0,0
224014,Patients,0,0
224015,also,0,0
224016,received,0,0
224017,a,0,0
224018,low-sodium,0,0
224019,(,0,0
224020,40,0,0
224021,mmol/day,0,0
224022,),0,0
224023,diet,0,0
224024,and,0,0
224025,the,0,0
224026,aldosterone,0,1
224027,antagonist,0,0
224028,",",0,1
224029,potassium,0,1
224030,canrenoate,0,0
224031,(,0,0
224032,100,0,0
224033,mg,0,0
224034,b.i.d.,0,0
224035,),0,0
224036,.,0,1
224037,Torasemide,0,0
224038,induced,0,0
224039,a,0,0
224040,remarkably,0,0
224041,higher,0,0
224042,natriuretic,1,1
224043,(,0,0
224044,120,0,0
224045,+/-,0,0
224046,15,0,0
224047,vs.,0,0
224048,33,0,0
224049,+/-,0,0
224050,6,0,0
224051,mmol/day,0,0
224052,",",0,0
224053,p,0,0
224054,<,0,0
224055,0.02,0,0
224056,),0,0
224057,and,0,0
224058,diuretic,1,1
224059,(,0,0
224060,1450,0,0
224061,+/-,0,0
224062,63,0,0
224063,vs.,0,0
224064,900,0,0
224065,+/-,0,0
224066,58,0,0
224067,ml,0,0
224068,",",0,0
224069,p,0,0
224070,<,0,0
224071,0.005,0,0
224072,),0,0
224073,effect,0,0
224074,than,0,0
224075,furosemide,0,0
224076,.,0,0
224077,Body,1,0
224078,weight,1,1
224079,loss,1,1
224080,was,0,0
224081,also,0,0
224082,significantly,0,0
224083,higher,0,0
224084,(,0,0
224085,2.5,0,0
224086,+/-,0,0
224087,1.6,0,0
224088,vs.,0,0
224089,0.2,0,0
224090,+/-,0,0
224091,1.3,0,0
224092,kg,0,0
224093,",",0,0
224094,p,0,0
224095,<,0,0
224096,0.01,0,0
224097,),0,0
224098,during,0,0
224099,the,0,0
224100,torasemide,0,0
224101,period,0,0
224102,.,0,1
224103,Kaliuresis,1,1
224104,was,0,0
224105,similar,0,0
224106,during,0,0
224107,the,0,0
224108,two,0,0
224109,treatment,0,0
224110,periods,0,0
224111,",",0,0
224112,despite,0,0
224113,the,0,0
224114,striking,0,0
224115,differences,0,0
224116,observed,0,0
224117,in,0,0
224118,natriuresis,0,1
224119,.,0,1
224120,Neither,0,0
224121,torasemide,0,0
224122,nor,0,0
224123,furosemide,0,0
224124,induced,0,0
224125,any,0,0
224126,significant,0,0
224127,change,0,1
224128,in,0,0
224129,serum,1,1
224130,electrolyte,1,1
224131,or,1,1
224132,creatinine,1,1
224133,concentrations,1,1
224134,",",1,1
224135,or,1,0
224136,in,1,0
224137,ammonia,1,1
224138,levels,1,1
224139,.,1,0
224140,The,0,0
224141,results,0,0
224142,of,0,0
224143,this,0,0
224144,study,0,0
224145,indicate,0,0
224146,that,0,0
224147,torasemide,0,0
224148,is,0,0
224149,suitable,0,0
224150,for,0,0
224151,the,0,0
224152,treatment,0,0
224153,of,0,1
224154,sodium,0,0
224155,retention,0,1
224156,in,0,0
224157,patients,0,0
224158,with,0,0
224159,cirrhosis,0,0
224160,and,0,0
224161,ascites,0,1
224162,.,0,0
224163,Clinical,0,1
224164,and,0,1
224165,prognostic,0,1
224166,significance,0,1
224167,of,0,1
224168,serum,0,1
224169,magnesium,0,0
224170,concentration,0,1
224171,in,0,0
224172,patients,0,0
224173,with,0,0
224174,severe,0,1
224175,chronic,0,0
224176,congestive,0,1
224177,heart,0,1
224178,failure,0,0
224179,:,0,0
224180,the,0,0
224181,PROMISE,0,0
224182,Study,0,0
224183,.,0,0
224184,OBJECTIVES,0,0
224185,The,0,0
224186,aim,0,0
224187,of,0,0
224188,this,0,0
224189,study,0,0
224190,was,0,0
224191,to,0,0
224192,determine,0,0
224193,the,0,0
224194,prognostic,0,1
224195,significance,0,1
224196,of,0,0
224197,alterations,0,0
224198,in,0,0
224199,serum,0,1
224200,magnesium,0,0
224201,in,0,0
224202,patients,0,0
224203,with,0,0
224204,moderate,0,0
224205,to,0,0
224206,severe,0,1
224207,congestive,0,1
224208,heart,0,1
224209,failure,0,1
224210,.,0,1
224211,BACKGROUND,0,0
224212,Reductions,0,1
224213,in,0,0
224214,serum,0,1
224215,magnesium,0,0
224216,have,0,0
224217,been,0,0
224218,postulated,0,0
224219,to,0,0
224220,play,0,0
224221,a,0,0
224222,role,0,0
224223,in,0,0
224224,promoting,0,0
224225,arrhythmias,0,1
224226,and,0,0
224227,to,0,0
224228,have,0,0
224229,an,0,0
224230,adverse,0,1
224231,impact,0,0
224232,on,0,0
224233,survival,0,1
224234,in,0,0
224235,congestive,0,1
224236,heart,0,1
224237,failure,0,1
224238,",",0,1
224239,although,0,0
224240,support,0,0
224241,for,0,0
224242,this,0,0
224243,postulate,0,0
224244,is,0,0
224245,lacking,0,0
224246,.,0,0
224247,METHODS,0,0
224248,Serum,1,1
224249,magnesium,1,0
224250,levels,1,1
224251,were,1,0
224252,measured,1,0
224253,in,0,0
224254,"1,068",0,0
224255,patients,0,0
224256,enrolled,0,0
224257,in,0,0
224258,a,0,0
224259,survival,0,1
224260,study,0,0
224261,of,0,1
224262,class,0,0
224263,III,0,1
224264,or,0,1
224265,IV,0,1
224266,heart,0,1
224267,failure,0,1
224268,at,0,0
224269,the,0,0
224270,time,0,1
224271,of,0,0
224272,double-blind,0,0
224273,randomization,0,0
224274,to,0,0
224275,milrinone,0,0
224276,",",0,0
224277,a,0,0
224278,phosphodiesterase,0,1
224279,inhibitor,0,0
224280,",",0,1
224281,or,0,1
224282,placebo,0,0
224283,.,0,0
224284,All,0,0
224285,patients,0,0
224286,received,0,0
224287,conventional,0,0
224288,therapy,0,0
224289,with,0,0
224290,digoxin,0,1
224291,",",0,0
224292,diuretic,0,1
224293,drugs,0,0
224294,and,0,0
224295,a,0,0
224296,converting,0,0
224297,enzyme,0,0
224298,inhibitor,0,0
224299,throughout,0,0
224300,the,0,0
224301,trial,0,0
224302,.,0,0
224303,The,0,0
224304,median,0,1
224305,follow-up,0,0
224306,period,0,0
224307,was,0,0
224308,6.1,0,0
224309,months,0,0
224310,(,0,0
224311,range,0,0
224312,1,0,0
224313,day,0,0
224314,to,0,0
224315,20,0,0
224316,months,0,0
224317,),0,0
224318,.,0,0
224319,RESULTS,0,0
224320,Patients,0,0
224321,with,0,0
224322,high,0,0
224323,serum,0,1
224324,magnesium,0,0
224325,(,0,0
224326,defined,0,1
224327,as,0,0
224328,>,0,0
224329,or,0,0
224330,=,0,0
224331,1.9,0,0
224332,mEq/liter,0,0
224333,",",0,0
224334,n,0,0
224335,=,0,0
224336,242,0,0
224337,),0,0
224338,were,0,0
224339,less,0,0
224340,likely,0,0
224341,to,0,0
224342,survive,1,1
224343,than,0,0
224344,were,0,0
224345,patients,0,0
224346,with,0,0
224347,a,0,0
224348,normal,0,0
224349,magnesium,0,0
224350,level,0,1
224351,(,0,0
224352,n,0,0
224353,=,0,0
224354,627,0,0
224355,),0,0
224356,(,0,0
224357,p,0,0
224358,<,0,0
224359,0.05,0,0
224360,",",0,0
224361,risk,0,1
224362,ratio,0,1
224363,=,0,0
224364,1.41,0,0
224365,),0,0
224366,.,0,0
224367,Patients,0,0
224368,with,0,0
224369,a,0,0
224370,low,0,0
224371,magnesium,0,0
224372,level,0,1
224373,(,0,0
224374,defined,0,1
224375,as,0,0
224376,<,0,0
224377,or,0,0
224378,=,0,0
224379,1.5,0,0
224380,mEq/liter,0,0
224381,",",0,0
224382,n,0,0
224383,=,0,0
224384,199,0,0
224385,),0,0
224386,had,0,0
224387,no,0,0
224388,difference,0,0
224389,in,0,0
224390,survival,1,1
224391,compared,0,0
224392,with,0,0
224393,the,0,0
224394,group,0,0
224395,with,0,0
224396,a,0,0
224397,normal,0,0
224398,magnesium,0,0
224399,level,0,1
224400,(,0,0
224401,p,0,0
224402,=,0,0
224403,NS,0,1
224404,",",0,1
224405,risk,0,1
224406,ratio,0,1
224407,=,0,0
224408,0.89,0,0
224409,),0,0
224410,.,0,0
224411,At,0,0
224412,baseline,0,0
224413,",",0,0
224414,the,0,0
224415,patients,0,0
224416,in,0,0
224417,the,0,0
224418,high,0,0
224419,magnesium,0,0
224420,group,0,0
224421,were,0,0
224422,older,0,0
224423,and,0,1
224424,had,0,0
224425,more,0,0
224426,severe,0,1
224427,functional,1,1
224428,and,1,1
224429,renal,1,1
224430,impairment,1,1
224431,.,1,0
224432,An,0,0
224433,analysis,0,0
224434,after,0,0
224435,adjustment,0,0
224436,for,0,0
224437,these,0,0
224438,variables,0,0
224439,demonstrated,0,0
224440,no,0,0
224441,difference,0,0
224442,in,0,0
224443,survival,1,1
224444,comparing,0,0
224445,the,0,0
224446,low,0,0
224447,",",0,0
224448,normal,0,1
224449,and,0,1
224450,high,0,1
224451,magnesium,0,0
224452,groups,0,0
224453,.,0,0
224454,Although,0,0
224455,the,0,0
224456,three,0,0
224457,groups,0,0
224458,had,0,0
224459,no,0,0
224460,difference,0,0
224461,in,0,0
224462,frequency,0,1
224463,of,0,1
224464,ventricular,1,1
224465,tachycardia,1,1
224466,",",1,1
224467,length,1,1
224468,of,1,1
224469,longest,1,1
224470,run,1,1
224471,or,1,1
224472,frequency,1,1
224473,of,1,1
224474,ventricular,1,1
224475,premature,1,0
224476,beats,1,1
224477,on,0,0
224478,baseline,1,0
224479,Holter,1,1
224480,monitoring,1,0
224481,",",0,0
224482,the,0,0
224483,group,0,0
224484,with,0,0
224485,hypomagnesemia,0,1
224486,had,0,0
224487,more,0,0
224488,frequent,0,1
224489,ventricular,0,1
224490,couplets,0,1
224491,.,0,0
224492,CONCLUSIONS,0,0
224493,Serum,0,0
224494,magnesium,0,0
224495,does,0,0
224496,not,0,0
224497,appear,0,0
224498,to,0,0
224499,be,0,0
224500,an,0,0
224501,independent,0,0
224502,risk,0,1
224503,factor,0,1
224504,for,0,0
224505,either,0,0
224506,sudden,1,1
224507,death,1,1
224508,or,1,1
224509,death,1,1
224510,due,0,0
224511,to,0,0
224512,all,0,0
224513,causes,0,0
224514,in,0,0
224515,patients,0,0
224516,with,0,0
224517,moderate,0,0
224518,to,0,0
224519,severe,0,1
224520,heart,0,1
224521,failure,0,1
224522,.,0,0
224523,Hypomagnesemia,0,1
224524,is,0,0
224525,associated,0,0
224526,with,0,0
224527,an,0,0
224528,increase,0,0
224529,in,0,0
224530,the,0,0
224531,frequency,0,1
224532,of,0,0
224533,certain,0,0
224534,forms,0,0
224535,of,0,1
224536,ventricular,1,1
224537,ectopic,1,1
224538,activity,1,1
224539,",",0,0
224540,but,0,0
224541,this,0,0
224542,is,0,0
224543,not,0,0
224544,associated,0,0
224545,with,0,0
224546,an,0,0
224547,increase,0,0
224548,in,0,0
224549,clinical,0,0
224550,events,0,1
224551,.,0,0
224552,The,0,0
224553,higher,0,0
224554,mortality,0,1
224555,rate,0,1
224556,among,0,0
224557,the,0,0
224558,patients,0,0
224559,with,0,0
224560,hypermagnesemia,0,0
224561,is,0,0
224562,attributable,0,0
224563,to,0,0
224564,older,0,0
224565,age,0,0
224566,",",0,1
224567,more,0,0
224568,advanced,0,1
224569,heart,0,1
224570,failure,0,1
224571,and,0,1
224572,renal,0,1
224573,insufficiency,0,1
224574,.,0,0
224575,Beta-carotene,0,0
224576,in,0,0
224577,HIV,0,1
224578,infection,0,1
224579,.,0,0
224580,beta-Carotene,0,0
224581,has,0,0
224582,been,0,0
224583,reported,0,0
224584,to,0,0
224585,have,0,0
224586,an,0,0
224587,immunostimulatory,0,0
224588,effect,0,0
224589,.,0,0
224590,Recent,0,0
224591,studies,0,0
224592,suggest,0,0
224593,that,0,0
224594,beta-carotene,0,0
224595,supplementation,0,0
224596,can,0,0
224597,increase,0,1
224598,CD4,1,1
224599,counts,1,1
224600,in,0,0
224601,HIV-infected,0,0
224602,patients,0,0
224603,.,0,0
224604,Our,0,0
224605,double-blind,0,0
224606,",",0,0
224607,placebo-controlled,0,0
224608,clinical,0,1
224609,trial,0,0
224610,was,0,0
224611,designed,0,0
224612,to,0,0
224613,test,0,0
224614,the,0,0
224615,efficacy,0,1
224616,of,0,0
224617,beta-carotene,0,0
224618,in,0,0
224619,raising,0,0
224620,CD4,0,1
224621,counts,0,1
224622,in,0,0
224623,HIV-infected,0,0
224624,patients,0,0
224625,.,0,0
224626,Twenty-one,0,0
224627,HIV-seropositive,0,0
224628,patients,0,0
224629,were,0,0
224630,randomized,0,0
224631,to,0,0
224632,receive,0,0
224633,either,0,0
224634,beta-carotene,0,0
224635,",",0,0
224636,180,0,0
224637,mg/day,0,0
224638,or,0,0
224639,placebo,0,0
224640,for,0,0
224641,4,0,0
224642,weeks,0,0
224643,",",0,0
224644,and,0,1
224645,then,0,0
224646,crossed,0,0
224647,over,0,0
224648,to,0,0
224649,receive,0,0
224650,the,0,0
224651,alternative,0,0
224652,treatment,0,0
224653,for,0,0
224654,the,0,0
224655,following,0,0
224656,4,0,0
224657,weeks,0,0
224658,.,0,0
224659,beta-Carotene,0,0
224660,resulted,0,0
224661,in,0,0
224662,a,0,0
224663,statistically,0,0
224664,significant,0,0
224665,increase,0,1
224666,in,0,0
224667,total,1,1
224668,WBC,1,1
224669,count,1,1
224670,(,0,0
224671,p,0,0
224672,=,0,0
224673,0.01,0,0
224674,),0,0
224675,",",0,0
224676,%,1,0
224677,change,1,1
224678,in,1,0
224679,CD4,1,1
224680,count,1,1
224681,(,0,0
224682,p,0,0
224683,=,0,0
224684,0.02,0,0
224685,),0,0
224686,",",0,0
224687,and,0,1
224688,%,1,0
224689,change,1,1
224690,in,1,0
224691,CD4/CD8,1,1
224692,ratios,1,1
224693,(,0,0
224694,p,0,0
224695,=,0,0
224696,0.02,0,0
224697,),0,0
224698,compared,0,0
224699,to,0,0
224700,placebo,0,0
224701,.,0,0
224702,The,0,0
224703,absolute,1,1
224704,CD4,1,1
224705,count,1,1
224706,",",1,1
224707,absolute,1,1
224708,CD4/CD8,1,1
224709,ratio,1,1
224710,",",1,1
224711,and,1,1
224712,total,1,1
224713,and,1,1
224714,B-lymphocytes,1,1
224715,all,0,0
224716,increased,0,0
224717,on,0,0
224718,carotene,0,1
224719,and,0,1
224720,fell,0,1
224721,during,0,0
224722,placebo,0,0
224723,",",0,0
224724,but,0,0
224725,these,0,0
224726,differences,0,0
224727,did,0,0
224728,not,0,0
224729,reach,0,0
224730,statistical,0,0
224731,significance,0,1
224732,.,0,0
224733,No,0,0
224734,toxicity,1,1
224735,was,0,0
224736,observed,0,0
224737,on,0,0
224738,either,0,0
224739,treatment,0,0
224740,.,0,0
224741,beta-Carotene,0,0
224742,appears,0,0
224743,to,0,0
224744,have,0,0
224745,an,0,0
224746,immunostimulatory,1,1
224747,effect,1,0
224748,in,0,0
224749,HIV-infected,0,0
224750,patients,0,0
224751,.,0,0
224752,Further,0,0
224753,studies,0,0
224754,are,0,0
224755,needed,0,0
224756,to,0,0
224757,demonstrate,0,0
224758,whether,0,0
224759,beta-carotene,0,0
224760,has,0,0
224761,a,0,0
224762,role,0,0
224763,as,0,0
224764,adjunct,0,0
224765,therapy,0,0
224766,in,0,0
224767,treatment,0,0
224768,of,0,0
224769,HIV-infected,1,0
224770,patients,1,0
224771,.,1,0
224772,Adjuvant,0,0
224773,cyclophosphamide,0,0
224774,",",0,1
224775,doxorubicin,0,0
224776,",",0,1
224777,vincristine,0,0
224778,",",0,1
224779,and,0,1
224780,prednisone,0,0
224781,chemotherapy,0,0
224782,after,0,0
224783,radiation,0,0
224784,therapy,0,0
224785,in,0,0
224786,stage,0,0
224787,I,0,0
224788,low-grade,0,0
224789,and,0,1
224790,intermediate-grade,0,1
224791,non-Hodgkin,0,0
224792,lymphoma,0,0
224793,.,0,0
224794,Results,0,0
224795,of,0,0
224796,a,0,0
224797,prospective,0,0
224798,randomized,0,0
224799,study,0,0
224800,.,0,1
224801,BACKGROUND,0,0
224802,In,0,0
224803,a,0,0
224804,prospective,0,0
224805,randomized,0,0
224806,manner,0,0
224807,",",0,0
224808,this,0,0
224809,study,0,0
224810,evaluated,0,0
224811,the,0,0
224812,effect,0,1
224813,of,0,0
224814,adjuvant,0,0
224815,chemotherapy,0,0
224816,(,0,1
224817,cyclophosphamide,0,0
224818,",",0,1
224819,doxorubicin,0,0
224820,",",0,1
224821,vincristine,0,0
224822,",",0,1
224823,and,0,1
224824,prednisone,0,0
224825,;,0,1
224826,CHOP,0,1
224827,),0,0
224828,in,0,0
224829,patients,0,0
224830,with,0,0
224831,Stage,0,0
224832,I,0,0
224833,non-Hodgkin,0,0
224834,lymphoma,0,1
224835,(,0,1
224836,NHL,0,0
224837,),0,0
224838,who,0,0
224839,have,0,0
224840,achieved,0,0
224841,a,0,0
224842,complete,0,1
224843,response,0,1
224844,(,0,1
224845,CR,0,1
224846,),0,1
224847,after,0,0
224848,radiation,0,0
224849,therapy,0,0
224850,(,0,1
224851,RT,0,0
224852,),0,0
224853,.,0,0
224854,METHODS,0,0
224855,Forty-four,0,0
224856,patients,0,0
224857,with,0,0
224858,clinical,0,0
224859,or,0,0
224860,pathologic,0,1
224861,Stage,0,0
224862,I,0,0
224863,intermediate-grade,0,0
224864,or,0,0
224865,low-grade,0,1
224866,NHL,0,1
224867,were,0,0
224868,randomized,0,0
224869,to,0,0
224870,receive,0,0
224871,regional,0,0
224872,RT,0,0
224873,alone,0,0
224874,(,0,0
224875,median,0,1
224876,dose,0,0
224877,",",0,0
224878,40,0,0
224879,Gy,0,1
224880,),0,0
224881,or,0,0
224882,regional,0,0
224883,RT,0,0
224884,followed,0,0
224885,by,0,0
224886,six,0,0
224887,cycles,0,0
224888,of,0,0
224889,CHOP,0,1
224890,chemotherapy,0,0
224891,.,0,0
224892,There,0,0
224893,were,0,0
224894,no,0,0
224895,differences,0,0
224896,in,0,0
224897,clinical,0,0
224898,and,0,1
224899,pathologic,0,1
224900,characteristics,1,1
224901,between,0,0
224902,the,0,0
224903,two,0,0
224904,treatment,0,0
224905,groups,0,0
224906,.,0,0
224907,RESULTS,0,0
224908,The,0,0
224909,median,1,1
224910,follow-up,1,0
224911,was,0,0
224912,7,0,0
224913,years,0,0
224914,(,0,0
224915,range,0,0
224916,",",0,1
224917,2-10,0,1
224918,years,0,0
224919,),0,0
224920,.,0,0
224921,The,0,0
224922,actuarial,1,1
224923,relapse-free,1,1
224924,survival,1,1
224925,(,1,1
224926,RFS,1,1
224927,),1,1
224928,rate,1,1
224929,for,0,0
224930,the,0,0
224931,RT,0,0
224932,plus,0,0
224933,CHOP,0,1
224934,group,0,0
224935,at,0,0
224936,7,0,0
224937,years,0,0
224938,was,0,0
224939,83,0,0
224940,%,0,0
224941,compared,0,0
224942,with,0,0
224943,47,0,0
224944,%,0,0
224945,(,0,0
224946,P,0,0
224947,<,0,0
224948,0.03,0,0
224949,),0,0
224950,for,0,0
224951,the,0,0
224952,RT-alone,0,0
224953,group,0,0
224954,.,0,0
224955,The,0,0
224956,overall,1,1
224957,survival,1,1
224958,(,1,1
224959,OS,1,1
224960,),1,0
224961,for,0,0
224962,the,0,0
224963,two,0,0
224964,groups,0,0
224965,was,0,0
224966,88,0,0
224967,%,0,0
224968,and,0,0
224969,66,0,0
224970,%,0,0
224971,",",0,0
224972,respectively,0,0
224973,(,0,0
224974,P,0,0
224975,=,0,0
224976,0.2,0,0
224977,),0,0
224978,.,0,0
224979,In,0,0
224980,patients,0,0
224981,with,0,0
224982,intermediate-grade,0,1
224983,NHL,0,1
224984,",",0,0
224985,the,0,0
224986,7-year,1,0
224987,actuarial,1,1
224988,RFS,1,1
224989,for,0,0
224990,RT,0,0
224991,and,0,1
224992,CHOP,0,1
224993,was,0,0
224994,86,0,0
224995,%,0,0
224996,compared,0,0
224997,with,0,0
224998,20,0,0
224999,%,0,0
225000,for,0,0
225001,RT,0,0
225002,alone,0,0
225003,(,0,0
225004,P,0,0
225005,=,0,0
225006,0.004,0,0
225007,),0,0
225008,.,0,0
225009,The,0,0
225010,corresponding,1,1
225011,actuarial,1,1
225012,survival,1,1
225013,rates,1,1
225014,were,0,0
225015,92,0,0
225016,%,0,0
225017,and,0,0
225018,47,0,0
225019,%,0,0
225020,",",0,0
225021,respectively,0,0
225022,(,0,0
225023,P,0,0
225024,=,0,0
225025,0.08,0,0
225026,),0,0
225027,.,0,0
225028,In,0,0
225029,patients,0,0
225030,with,0,0
225031,low-grade,0,0
225032,histologic,0,1
225033,findings,0,0
225034,",",0,0
225035,the,0,0
225036,addition,0,0
225037,of,0,0
225038,adjuvant,0,0
225039,CHOP,0,1
225040,did,0,0
225041,not,0,0
225042,improve,0,0
225043,RFS,1,1
225044,(,0,0
225045,P,0,0
225046,=,0,0
225047,0.6,0,0
225048,),0,0
225049,or,0,0
225050,OS,0,1
225051,.,0,0
225052,All,0,0
225053,relapses,0,1
225054,in,0,0
225055,this,0,0
225056,study,0,0
225057,were,0,0
225058,at,0,0
225059,sites,0,0
225060,remote,0,0
225061,from,0,0
225062,the,0,0
225063,initially,0,0
225064,involved,0,0
225065,areas,0,1
225066,",",0,1
225067,and,0,0
225068,in,0,0
225069,5,0,0
225070,of,0,0
225071,11,0,0
225072,patients,0,0
225073,(,0,0
225074,45,0,0
225075,%,0,0
225076,),0,0
225077,",",0,0
225078,there,0,0
225079,were,0,0
225080,recurrences,0,1
225081,5,0,0
225082,years,0,0
225083,or,0,0
225084,longer,0,0
225085,after,0,0
225086,initial,0,0
225087,treatment,0,0
225088,.,0,0
225089,CONCLUSIONS,0,0
225090,This,0,0
225091,study,0,0
225092,showed,0,0
225093,that,0,0
225094,adjuvant,0,0
225095,CHOP,0,1
225096,chemotherapy,0,0
225097,significantly,0,0
225098,improves,0,0
225099,RFS,0,1
225100,in,0,0
225101,patients,0,0
225102,with,0,0
225103,Stage,0,0
225104,I,0,0
225105,intermediate-grade,0,0
225106,NHL,0,0
225107,who,0,0
225108,achieve,0,0
225109,a,0,0
225110,CR,0,0
225111,after,0,0
225112,regional-field,0,0
225113,RT,0,0
225114,.,0,0
225115,The,0,0
225116,chemotherapeutic,0,0
225117,regimen,0,0
225118,favorably,0,0
225119,affected,0,0
225120,their,0,0
225121,probability,1,1
225122,of,0,0
225123,survival,1,1
225124,.,1,0
225125,Use,0,0
225126,of,0,0
225127,granulocyte-macrophage,0,1
225128,colony-stimulating,0,1
225129,factor,0,1
225130,and,0,1
225131,erythropoietin,0,0
225132,in,0,0
225133,combination,0,0
225134,after,0,0
225135,autologous,0,0
225136,marrow,0,0
225137,transplantation,0,0
225138,.,0,0
225139,The,0,0
225140,toxicities,0,1
225141,and,0,1
225142,possible,0,0
225143,utility,0,1
225144,of,0,0
225145,the,0,0
225146,combination,0,0
225147,of,0,0
225148,recombinant,0,0
225149,human,0,0
225150,granulocyte-macrophage,0,1
225151,colony-stimulating,0,1
225152,factor,0,1
225153,(,0,1
225154,rhGM-CSF,0,1
225155,),0,1
225156,and,0,1
225157,recombinant,0,0
225158,human,0,0
225159,erythropoietin,0,0
225160,(,0,1
225161,rHuEPO,0,0
225162,),0,1
225163,given,0,0
225164,after,0,0
225165,autologous,0,0
225166,BMT,0,1
225167,were,0,0
225168,evaluated,0,0
225169,in,0,0
225170,this,0,0
225171,pilot,0,0
225172,trial,0,0
225173,.,0,1
225174,Eighteen,0,0
225175,patients,0,0
225176,received,0,0
225177,the,0,0
225178,combination,0,0
225179,and,0,1
225180,were,0,0
225181,compared,0,0
225182,with,0,0
225183,six,0,0
225184,concurrent,0,0
225185,control,0,0
225186,and,0,0
225187,65,0,0
225188,historical,0,0
225189,control,0,0
225190,patients,0,0
225191,treated,0,0
225192,with,0,0
225193,rhGM-CSF,0,0
225194,alone,0,0
225195,.,0,1
225196,Patients,0,0
225197,treated,0,0
225198,with,0,0
225199,the,0,0
225200,combination,0,0
225201,tended,0,0
225202,to,0,0
225203,have,0,0
225204,more,0,0
225205,rapid,0,0
225206,recovery,1,1
225207,to,0,0
225208,an,0,0
225209,absolute,1,1
225210,neutrophil,1,1
225211,count,1,1
225212,of,0,0
225213,500,0,0
225214,x,0,0
225215,10,0,0
225216,(,0,0
225217,6,0,0
225218,),0,0
225219,/l,0,0
225220,(,0,0
225221,median,0,1
225222,=,0,0
225223,12.5,0,0
225224,vs,0,0
225225,18,0,0
225226,days,0,0
225227,for,0,0
225228,concurrent,0,0
225229,and,0,0
225230,19,0,0
225231,days,0,0
225232,for,0,0
225233,historical,0,0
225234,control,0,0
225235,patients,0,0
225236,),0,0
225237,.,0,0
225238,There,0,0
225239,was,0,0
225240,no,0,0
225241,apparent,0,0
225242,impact,0,0
225243,on,0,0
225244,red,1,1
225245,cell,1,1
225246,transfusion,1,1
225247,requirements,1,1
225248,",",1,1
225249,platelet,1,1
225250,recovery,1,1
225251,or,1,1
225252,duration,1,1
225253,of,1,1
225254,hospitalization,1,1
225255,.,1,1
225256,Patients,0,0
225257,treated,0,0
225258,in,0,0
225259,the,0,0
225260,current,0,0
225261,study,0,0
225262,with,0,0
225263,rhGM-CSF,0,1
225264,plus,0,0
225265,either,0,0
225266,rHuEPO,0,1
225267,or,0,1
225268,with,0,0
225269,placebo,0,0
225270,had,0,0
225271,a,0,0
225272,higher,0,0
225273,incidence,1,1
225274,of,1,1
225275,rash,1,1
225276,than,0,0
225277,seen,0,0
225278,in,0,0
225279,our,0,0
225280,historical,0,0
225281,experience,0,1
225282,using,0,0
225283,rhGM-CSF,0,0
225284,.,0,0
225285,This,0,0
225286,difference,0,0
225287,may,0,0
225288,reflect,0,0
225289,changes,0,1
225290,in,0,0
225291,the,0,0
225292,source,0,0
225293,of,0,1
225294,rhGM-CSF,0,0
225295,or,0,0
225296,in,0,0
225297,the,0,0
225298,infusion,0,0
225299,schedule,0,0
225300,.,0,0
225301,Erythropoietin,0,0
225302,can,0,0
225303,be,0,0
225304,combined,0,0
225305,safely,0,0
225306,with,0,0
225307,rhGM-CSF,0,0
225308,after,0,0
225309,autologous,0,0
225310,transplantation,0,0
225311,.,0,1
225312,Larger,0,1
225313,controlled,0,0
225314,trials,0,0
225315,will,0,0
225316,be,0,0
225317,necessary,0,0
225318,to,0,0
225319,detect,0,0
225320,possible,0,0
225321,therapeutic,0,0
225322,effects,0,0
225323,.,0,0
225324,Abdominal,0,1
225325,surgical,0,1
225326,wound,0,0
225327,infection,0,1
225328,is,0,0
225329,lowered,0,0
225330,with,0,0
225331,improved,0,1
225332,perioperative,0,1
225333,enterococcus,0,1
225334,and,0,1
225335,bacteroides,0,1
225336,therapy,0,0
225337,.,0,0
225338,Perioperative,0,0
225339,antibiotics,0,0
225340,decrease,0,1
225341,surgical,1,0
225342,wound,1,1
225343,infection,1,1
225344,(,1,1
225345,SWI,1,0
225346,),1,1
225347,in,0,0
225348,trauma,0,0
225349,patients,0,0
225350,requiring,0,1
225351,abdominal,0,1
225352,exploration,0,0
225353,.,0,0
225354,This,0,0
225355,investigation,0,0
225356,evaluated,0,0
225357,24,0,0
225358,hours,0,0
225359,of,0,0
225360,cefoxitin,0,0
225361,or,0,1
225362,ampicillin/sulbactam,0,0
225363,used,0,0
225364,for,0,0
225365,early,0,0
225366,therapy,0,0
225367,in,0,0
225368,such,0,0
225369,patients,0,0
225370,.,0,0
225371,Patients,0,0
225372,were,0,0
225373,randomly,0,0
225374,assigned,0,0
225375,to,0,0
225376,one,0,0
225377,of,0,0
225378,two,0,0
225379,treatment,0,0
225380,groups,0,0
225381,.,0,0
225382,The,0,0
225383,primary,0,0
225384,endpoint,0,1
225385,evaluated,0,0
225386,was,0,0
225387,SWI,1,0
225388,",",0,1
225389,which,0,0
225390,was,0,0
225391,defined,0,1
225392,as,0,0
225393,purulent,0,1
225394,drainage,0,1
225395,or,0,1
225396,active,0,1
225397,wound,0,1
225398,treatment,0,0
225399,.,0,0
225400,Five,0,1
225401,hundred,0,0
225402,ninety-two,0,0
225403,patients,0,0
225404,were,0,0
225405,evaluated,0,0
225406,:,0,0
225407,283,0,0
225408,received,0,0
225409,ampicillin/sulbactam,0,0
225410,and,0,0
225411,309,0,0
225412,received,0,0
225413,cefoxitin,0,0
225414,.,0,0
225415,The,0,0
225416,incidence,1,1
225417,of,1,0
225418,wound,1,1
225419,infection,1,1
225420,among,0,0
225421,the,0,0
225422,ampicillin/sulbactam,0,0
225423,patients,0,0
225424,was,0,0
225425,2,0,0
225426,%,0,0
225427,and,0,0
225428,among,0,0
225429,cefoxitin,0,0
225430,patients,0,0
225431,it,0,0
225432,was,0,0
225433,7,0,0
225434,%,0,0
225435,(,0,0
225436,p,0,0
225437,<,0,0
225438,0.004,0,0
225439,),0,0
225440,.,0,0
225441,The,0,0
225442,cefoxitin,0,0
225443,patients,0,0
225444,with,0,0
225445,colon,0,1
225446,injuries,0,1
225447,were,0,0
225448,analyzed,0,0
225449,(,0,0
225450,p,0,0
225451,<,0,0
225452,0.007,0,0
225453,),0,0
225454,.,0,0
225455,The,0,0
225456,major,0,1
225457,difference,0,0
225458,between,0,0
225459,the,0,0
225460,two,0,0
225461,groups,0,0
225462,was,0,0
225463,an,0,0
225464,increased,0,1
225465,incidence,1,1
225466,of,1,1
225467,enterococcal,1,1
225468,infections,1,1
225469,in,0,0
225470,the,0,0
225471,cefoxitin-treated,0,0
225472,patients,0,0
225473,.,0,0
225474,A,0,0
225475,single,0,0
225476,broad-spectrum,0,1
225477,antibiotic,0,0
225478,given,0,0
225479,for,0,0
225480,24,0,0
225481,hour,0,0
225482,perioperatively,0,0
225483,effectively,0,0
225484,controls,0,0
225485,SWI,0,0
225486,.,0,0
225487,Use,0,0
225488,of,0,0
225489,ampicillin/sulbactam,0,0
225490,results,0,0
225491,in,0,0
225492,a,0,0
225493,significantly,0,0
225494,lower,0,0
225495,SWI,1,1
225496,rate,1,1
225497,than,0,0
225498,use,0,0
225499,of,0,1
225500,cefoxitin,0,0
225501,",",0,0
225502,which,0,0
225503,may,0,0
225504,be,0,0
225505,a,0,0
225506,result,0,0
225507,of,0,0
225508,improved,0,1
225509,enterococcal,1,1
225510,and,1,1
225511,Bacteroides,1,1
225512,coverage,1,1
225513,.,1,0
225514,Double-blind,0,0
225515,randomized,0,0
225516,evaluation,0,0
225517,of,0,1
225518,intercostal,0,1
225519,nerve,0,1
225520,blocks,0,0
225521,as,0,0
225522,an,0,0
225523,adjuvant,0,0
225524,to,0,0
225525,subarachnoid,0,1
225526,administered,0,0
225527,morphine,0,0
225528,for,0,0
225529,post-thoracotomy,0,1
225530,analgesia,0,1
225531,.,0,0
225532,BACKGROUND,0,0
225533,AND,0,0
225534,OBJECTIVES,0,0
225535,Thoracotomy,0,0
225536,is,0,0
225537,associated,0,0
225538,with,0,0
225539,pain,0,1
225540,and,0,1
225541,compromised,0,0
225542,pulmonary,0,1
225543,function,0,1
225544,.,0,1
225545,Intercostal,0,1
225546,nerve,0,1
225547,blocks,0,0
225548,(,0,1
225549,INB,0,1
225550,),0,1
225551,and,0,1
225552,subarachnoid,0,1
225553,morphine,0,1
225554,(,0,1
225555,SM,0,1
225556,),0,1
225557,act,0,0
225558,on,0,0
225559,different,0,0
225560,portions,0,0
225561,of,0,0
225562,the,0,0
225563,pain,0,1
225564,pathway,0,0
225565,.,0,0
225566,Each,0,0
225567,is,0,0
225568,effective,0,1
225569,for,0,0
225570,post-thoracotomy,0,1
225571,pain,1,1
225572,relief,0,1
225573,.,0,0
225574,The,0,0
225575,combination,0,0
225576,of,0,0
225577,these,0,0
225578,two,0,0
225579,modalities,0,0
225580,in,0,0
225581,relieving,0,0
225582,post-thoracotomy,1,1
225583,pain,1,1
225584,and,0,1
225585,improving,0,1
225586,postoperative,1,1
225587,pulmonary,1,0
225588,function,1,1
225589,has,0,0
225590,not,0,0
225591,been,0,0
225592,investigated,0,0
225593,.,0,0
225594,METHODS,0,0
225595,In,0,0
225596,a,0,0
225597,double-blind,0,0
225598,study,0,0
225599,",",0,0
225600,20,0,0
225601,patients,0,0
225602,undergoing,0,0
225603,lateral,0,0
225604,thoracotomy,0,0
225605,for,0,0
225606,lung,0,1
225607,resection,0,1
225608,were,0,0
225609,randomized,0,0
225610,to,0,0
225611,receive,0,0
225612,0.5,0,0
225613,mg,0,0
225614,SM,0,0
225615,preoperatively,0,0
225616,and,0,0
225617,INB,0,1
225618,with,0,0
225619,bupivacaine,0,0
225620,(,0,1
225621,INB+,0,1
225622,),0,0
225623,prior,0,0
225624,to,0,0
225625,wound,0,1
225626,closure,0,1
225627,or,0,0
225628,0.5,0,0
225629,mg,0,0
225630,SM,0,0
225631,with,0,0
225632,INB,0,1
225633,using,0,0
225634,saline,0,0
225635,(,0,1
225636,INB-,0,0
225637,),0,0
225638,.,0,0
225639,Visual,1,1
225640,analog,1,1
225641,scale,1,1
225642,pain,1,1
225643,scores,1,1
225644,at,0,0
225645,rest,0,1
225646,",",0,0
225647,with,1,0
225648,cough,1,1
225649,",",1,1
225650,and,1,1
225651,with,1,0
225652,movement,1,1
225653,of,1,0
225654,the,1,0
225655,ipsilateral,1,1
225656,arm,1,0
225657,",",1,1
225658,forced,1,1
225659,expiratory,1,1
225660,volume,1,1
225661,in,1,0
225662,1,1,0
225663,second,1,0
225664,(,1,0
225665,FEV1,1,1
225666,),1,1
225667,",",0,1
225668,and,0,1
225669,forced,1,1
225670,vital,1,1
225671,capacity,1,1
225672,(,1,1
225673,FVC,1,1
225674,),1,1
225675,were,0,0
225676,measured,0,0
225677,at,0,0
225678,4,0,0
225679,",",0,0
225680,24,0,0
225681,",",0,0
225682,48,0,0
225683,",",0,0
225684,and,0,0
225685,72,0,0
225686,hours,0,0
225687,after,0,0
225688,the,0,0
225689,operation,0,0
225690,.,0,0
225691,Opioid,1,0
225692,use,1,1
225693,was,0,0
225694,measured,0,0
225695,during,0,0
225696,the,0,0
225697,initial,0,0
225698,24,0,0
225699,hours,0,0
225700,after,0,0
225701,the,0,0
225702,operation,0,0
225703,.,0,0
225704,RESULTS,0,0
225705,At,0,0
225706,4,0,0
225707,hours,0,0
225708,",",0,0
225709,the,0,0
225710,INB+,0,1
225711,group,0,0
225712,demonstrated,0,0
225713,better,0,0
225714,FEV1,1,1
225715,(,0,0
225716,56.6,0,0
225717,%,0,0
225718,vs.,0,0
225719,40.4,0,0
225720,%,0,0
225721,of,0,0
225722,baseline,0,1
225723,",",0,1
225724,P,0,0
225725,<,0,0
225726,.05,0,0
225727,),0,1
225728,and,0,1
225729,FVC,1,1
225730,values,0,1
225731,(,0,0
225732,54.6,0,0
225733,%,0,0
225734,vs.,0,0
225735,39.6,0,0
225736,%,0,0
225737,of,0,0
225738,baseline,0,1
225739,",",0,1
225740,P,0,0
225741,<,0,0
225742,.05,0,0
225743,),0,1
225744,and,0,1
225745,less,0,0
225746,resting,0,1
225747,and,0,1
225748,cough,0,1
225749,pain,0,1
225750,(,0,0
225751,P,0,0
225752,<,0,0
225753,.05,0,0
225754,),0,0
225755,.,0,0
225756,However,0,0
225757,",",0,0
225758,FEV1,1,1
225759,continued,0,0
225760,to,0,0
225761,decline,0,0
225762,in,0,0
225763,the,0,0
225764,INB+,0,0
225765,group,0,0
225766,at,0,0
225767,24,0,0
225768,hours,0,0
225769,to,0,0
225770,lower,0,0
225771,than,0,0
225772,the,0,0
225773,INB-,0,0
225774,group,0,0
225775,although,0,0
225776,pain,1,1
225777,scores,1,1
225778,were,0,0
225779,similar,0,0
225780,beyond,0,0
225781,4,0,0
225782,hours,0,0
225783,.,0,0
225784,Opioid,1,0
225785,usage,1,1
225786,during,0,0
225787,the,0,0
225788,first,0,0
225789,24,0,0
225790,hours,0,0
225791,was,0,0
225792,similar,0,0
225793,(,0,1
225794,INB-,0,0
225795,",",0,0
225796,16.7,0,0
225797,mg,0,0
225798,vs.,0,0
225799,INB+,0,0
225800,",",0,0
225801,13.2,0,0
225802,mg,0,0
225803,",",0,0
225804,P,0,0
225805,=,0,0
225806,.7,0,0
225807,),0,0
225808,.,0,0
225809,CONCLUSIONS,0,0
225810,Although,0,0
225811,postoperative,0,1
225812,INB,0,1
225813,provided,0,0
225814,modest,0,0
225815,improvements,0,1
225816,in,0,0
225817,pain,0,1
225818,and,0,1
225819,pulmonary,0,1
225820,function,0,1
225821,when,0,0
225822,used,0,0
225823,as,0,0
225824,an,0,0
225825,adjuvant,0,0
225826,to,0,0
225827,0.5,0,0
225828,mg,0,0
225829,SM,0,0
225830,for,0,0
225831,post-thoracotomy,0,1
225832,analgesia,0,1
225833,",",0,0
225834,the,0,0
225835,benefits,0,0
225836,were,0,0
225837,transient,0,1
225838,.,0,0
225839,The,0,0
225840,authors,0,0
225841,do,0,0
225842,not,0,0
225843,recommend,0,0
225844,adding,0,0
225845,INB,0,1
225846,for,0,0
225847,patients,0,0
225848,undergoing,0,0
225849,lateral,0,0
225850,thoracotomy,0,0
225851,who,0,0
225852,receive,0,0
225853,0.5,0,0
225854,mg,0,0
225855,SM,0,0
225856,.,0,0
225857,Differential,0,0
225858,effects,0,1
225859,on,0,0
225860,bone,1,1
225861,density,1,1
225862,of,0,1
225863,progestogen-only,0,0
225864,methods,0,0
225865,for,0,0
225866,contraception,0,0
225867,in,0,0
225868,premenopausal,0,0
225869,women,0,0
225870,.,0,0
225871,The,0,0
225872,question,0,0
225873,of,0,0
225874,differential,0,1
225875,effects,0,1
225876,on,0,0
225877,bone,0,1
225878,density,0,1
225879,by,0,0
225880,two,0,0
225881,different,0,0
225882,types,0,0
225883,of,0,0
225884,progestogen-only,0,0
225885,methods,0,0
225886,for,0,0
225887,contraception,0,0
225888,in,0,0
225889,premenopausal,0,0
225890,women,0,0
225891,was,0,0
225892,addressed,0,0
225893,.,0,0
225894,Data,0,0
225895,from,0,0
225896,a,0,0
225897,prospective,0,0
225898,randomized,0,0
225899,clinical,0,0
225900,trial,0,0
225901,among,0,0
225902,22,0,0
225903,premenopausal,0,0
225904,women,0,0
225905,",",0,0
225906,age,0,0
225907,32.6,0,0
225908,(,0,0
225909,range,0,0
225910,20-45,0,0
225911,years,0,0
225912,),0,0
225913,",",0,0
225914,who,0,0
225915,were,0,0
225916,randomly,0,0
225917,assigned,0,0
225918,to,0,0
225919,either,0,0
225920,of,0,0
225921,two,0,0
225922,treatments,0,0
225923,with,0,0
225924,continuous,0,0
225925,progestogens,0,0
225926,for,0,0
225927,contraception,0,0
225928,were,0,0
225929,analyzed,0,0
225930,;,0,0
225931,depot-medroxyprogesterone,0,0
225932,acetate,0,0
225933,(,0,1
225934,DMPA,0,1
225935,),0,1
225936,or,0,0
225937,continuous,0,1
225938,levonorgestrel,0,0
225939,treatment,0,0
225940,with,0,0
225941,subdermal,0,0
225942,implants,0,0
225943,(,0,0
225944,Norplant,0,0
225945,),0,1
225946,",",0,0
225947,respectively,0,0
225948,.,0,0
225949,Forearm,1,1
225950,bone,1,1
225951,density,1,1
225952,(,1,1
225953,BMDprox,1,1
225954,),1,1
225955,increased,0,0
225956,with,0,0
225957,2.94,0,0
225958,%,0,0
225959,(,0,0
225960,p,0,0
225961,=,0,0
225962,0.006,0,0
225963,),0,0
225964,in,0,0
225965,women,0,0
225966,who,0,0
225967,were,0,0
225968,prescribed,0,0
225969,levonorgestrel,0,0
225970,",",0,0
225971,which,0,0
225972,was,0,0
225973,in,0,0
225974,contrast,0,0
225975,to,0,0
225976,stable,0,1
225977,values,0,1
225978,in,0,0
225979,those,0,0
225980,prescribed,0,0
225981,depot-medroxy-progesterone,0,0
225982,acetate,0,0
225983,;,0,0
225984,group,0,0
225985,difference,0,0
225986,at,0,0
225987,6,0,0
225988,months,0,0
225989,for,0,0
225990,BMDprox,1,0
225991,3.4,0,0
225992,%,0,0
225993,(,0,0
225994,95,0,0
225995,%,0,0
225996,CI,0,0
225997,1.3,0,0
225998,",",0,0
225999,5.5,0,0
226000,;,0,0
226001,p,0,0
226002,=,0,0
226003,0.025,0,0
226004,),0,0
226005,and,0,0
226006,BMDdist,1,0
226007,4.1,0,0
226008,%,0,0
226009,(,0,0
226010,95,0,0
226011,%,0,0
226012,CI,0,0
226013,-,0,0
226014,1.3,0,0
226015,",",0,0
226016,9.6,0,0
226017,;,0,0
226018,p,0,0
226019,=,0,0
226020,0.077,0,0
226021,),0,0
226022,.,0,0
226023,The,0,0
226024,changes,1,1
226025,in,1,0
226026,bone,1,1
226027,density,1,1
226028,were,0,0
226029,consistent,0,0
226030,with,0,0
226031,the,0,0
226032,changes,0,1
226033,in,0,0
226034,biochemical,1,1
226035,indices,1,1
226036,for,1,0
226037,bone,1,1
226038,metabolism,1,1
226039,;,1,0
226040,DMPA,0,1
226041,users,0,0
226042,showed,0,0
226043,signs,0,1
226044,of,0,1
226045,increased,0,0
226046,bone,1,1
226047,turnover,1,1
226048,and,0,1
226049,users,0,0
226050,of,0,1
226051,levonorgestrel,0,0
226052,showed,0,0
226053,increased,1,1
226054,bone,1,1
226055,formation,1,1
226056,with,0,0
226057,increased,0,1
226058,levels,0,1
226059,of,0,0
226060,both,0,0
226061,alkaline,0,1
226062,phosphatase,0,1
226063,(,0,0
226064,p,0,0
226065,=,0,0
226066,0.004,0,0
226067,),0,0
226068,and,0,0
226069,osteocalcin,0,1
226070,(,0,0
226071,p,0,0
226072,=,0,0
226073,0.007,0,0
226074,),0,0
226075,.,0,0
226076,The,0,0
226077,findings,0,0
226078,suggest,0,0
226079,an,0,0
226080,increase,0,0
226081,in,0,0
226082,bone,1,1
226083,density,1,1
226084,during,0,0
226085,treatment,0,0
226086,with,0,0
226087,levonorgestrel,0,0
226088,and,0,1
226089,stable,0,1
226090,values,0,1
226091,during,0,0
226092,short-term,0,1
226093,administration,0,0
226094,of,0,1
226095,DMPA,0,1
226096,",",0,0
226097,in,0,0
226098,standard,0,0
226099,clinical,0,0
226100,doses,0,0
226101,for,0,0
226102,contraception,0,0
226103,.,0,0
226104,Laparoscopic,0,0
226105,hysterectomy,0,0
226106,:,0,0
226107,is,0,0
226108,dissecting,0,0
226109,the,0,0
226110,ureter,0,1
226111,necessary,0,0
226112,?,0,0
226113,Laparoscopic,0,0
226114,hysterectomy,0,0
226115,has,0,0
226116,been,0,0
226117,first,0,0
226118,reported,0,0
226119,by,0,0
226120,Reich,0,0
226121,et,0,0
226122,al,0,1
226123,.,0,0
226124,in,0,0
226125,1989,0,0
226126,",",0,0
226127,which,0,0
226128,confirmed,0,0
226129,the,0,0
226130,possibility,0,0
226131,of,0,0
226132,laparoscopic,0,0
226133,hysterectomy,0,0
226134,being,0,0
226135,employed,0,0
226136,as,0,0
226137,a,0,0
226138,replacement,0,0
226139,of,0,0
226140,the,0,0
226141,vast,0,0
226142,majority,0,0
226143,of,0,1
226144,traditional,0,0
226145,abdominal,0,1
226146,hysterectomies,0,0
226147,.,0,0
226148,There,0,0
226149,are,0,0
226150,three,0,0
226151,critical,0,0
226152,points,0,0
226153,in,0,0
226154,laparoscopic,0,0
226155,hysterectomy,0,0
226156,.,0,0
226157,The,0,0
226158,most,0,0
226159,important,0,0
226160,critical,0,0
226161,point,0,0
226162,is,0,0
226163,to,0,0
226164,identify,0,0
226165,uterine,0,1
226166,arteries,0,0
226167,from,0,0
226168,the,0,0
226169,ureter,0,0
226170,in,0,0
226171,the,0,0
226172,paracervical,0,0
226173,area,0,1
226174,.,0,0
226175,Several,0,0
226176,ureteral,1,1
226177,injuries,1,0
226178,at,0,0
226179,operative,0,0
226180,laparoscopy,0,0
226181,have,0,0
226182,been,0,0
226183,reported,0,0
226184,.,0,0
226185,We,0,0
226186,performed,0,0
226187,two,0,0
226188,hundred,0,0
226189,and,0,0
226190,thirty,0,0
226191,laparoscopic,0,0
226192,hysterectomies,0,0
226193,during,0,0
226194,the,0,0
226195,period,0,0
226196,from,0,0
226197,March,0,0
226198,1991,0,0
226199,to,0,0
226200,October,0,0
226201,1993,0,0
226202,.,0,0
226203,Sixty,0,0
226204,patients,0,0
226205,were,0,0
226206,later,0,0
226207,included,0,0
226208,in,0,0
226209,this,0,0
226210,study,0,0
226211,.,0,0
226212,Thirty,0,0
226213,of,0,0
226214,these,0,0
226215,applied,0,0
226216,the,0,0
226217,technique,0,0
226218,of,0,0
226219,dissecting,0,0
226220,the,0,0
226221,ureter,0,0
226222,at,0,0
226223,the,0,0
226224,initiation,0,0
226225,of,0,0
226226,laparoscopic,0,0
226227,hysterectomy,0,0
226228,.,0,0
226229,Most,0,0
226230,of,0,0
226231,the,0,0
226232,patients,0,0
226233,were,0,0
226234,discharged,0,0
226235,on,0,0
226236,the,0,0
226237,second,0,0
226238,postoperative,0,1
226239,day,0,0
226240,.,0,0
226241,Although,0,0
226242,dissecting,0,0
226243,the,0,0
226244,ureter,0,0
226245,at,0,0
226246,the,0,0
226247,beginning,0,0
226248,of,0,0
226249,the,0,0
226250,operation,0,0
226251,did,0,0
226252,not,0,0
226253,produce,0,0
226254,a,0,0
226255,significant,0,0
226256,discrepancy,1,1
226257,in,0,0
226258,operation,1,0
226259,time,1,1
226260,",",1,1
226261,blood,1,1
226262,loss,1,1
226263,",",1,1
226264,hospitalization,1,1
226265,day,1,1
226266,and,1,1
226267,ureter,1,1
226268,injury,1,1
226269,when,0,0
226270,compared,0,0
226271,with,0,0
226272,the,0,0
226273,control,0,0
226274,group,0,0
226275,",",0,0
226276,the,0,0
226277,uterine,0,1
226278,arteries,0,1
226279,",",0,0
226280,however,0,0
226281,",",0,0
226282,may,0,0
226283,be,0,0
226284,confidently,0,0
226285,desiccated,0,0
226286,once,0,0
226287,the,0,0
226288,path,0,1
226289,of,0,0
226290,the,0,0
226291,ureter,0,0
226292,near,0,0
226293,the,0,0
226294,uterosacral,0,0
226295,ligament,0,0
226296,is,0,0
226297,identified,0,0
226298,.,0,0
226299,Synthetic,0,1
226300,serum,0,1
226301,substitute,0,0
226302,(,0,1
226303,SSS,0,1
226304,),0,0
226305,:,0,0
226306,a,0,0
226307,globulin-enriched,0,0
226308,protein,0,1
226309,supplement,0,0
226310,for,0,0
226311,human,0,0
226312,embryo,0,1
226313,culture,0,1
226314,.,0,0
226315,OBJECTIVE,0,0
226316,The,0,0
226317,purpose,0,0
226318,of,0,0
226319,the,0,0
226320,present,0,0
226321,study,0,0
226322,was,0,0
226323,to,0,0
226324,evaluate,0,0
226325,whether,0,0
226326,an,0,0
226327,IVF,0,1
226328,protein,0,1
226329,supplement,0,0
226330,prepared,0,0
226331,from,0,0
226332,human,0,0
226333,serum,0,1
226334,albumin,0,1
226335,(,0,1
226336,HSA,0,1
226337,),0,1
226338,and,0,1
226339,human,0,0
226340,globulins,0,1
226341,would,0,0
226342,retain,0,0
226343,performance,1,1
226344,characteristics,1,1
226345,equivalent,0,0
226346,to,0,0
226347,those,0,0
226348,reported,0,0
226349,for,0,0
226350,the,0,0
226351,commercial,0,0
226352,plasma,0,1
226353,expanders,0,0
226354,",",0,1
226355,Plasmatein,0,1
226356,(,0,1
226357,Alpha,0,1
226358,Therapeutics,0,1
226359,",",0,1
226360,Los,0,1
226361,Angeles,0,1
226362,",",0,1
226363,California,0,0
226364,),0,1
226365,and,0,1
226366,Plasmanate,0,1
226367,(,0,1
226368,Cutter,0,1
226369,Biological,0,1
226370,",",0,1
226371,Miles,0,1
226372,Inc.,0,1
226373,",",0,1
226374,Elkhart,0,1
226375,",",0,1
226376,Indiana,0,0
226377,),0,0
226378,.,0,0
226379,METHODS,0,0
226380,Pronuclear-stage,0,0
226381,human,0,0
226382,embryos,0,1
226383,were,0,0
226384,randomly,0,0
226385,divided,0,0
226386,and,0,0
226387,cultured,0,1
226388,in,0,0
226389,human,0,0
226390,tubal,0,1
226391,fluid,0,1
226392,medium,0,1
226393,(,0,1
226394,HTF,0,1
226395,),0,1
226396,supplemented,0,0
226397,with,0,0
226398,either,0,0
226399,HSA,0,1
226400,(,0,0
226401,5,0,0
226402,mg/mL,0,0
226403,),0,0
226404,or,0,1
226405,Plasmatein,0,1
226406,(,0,0
226407,10,0,0
226408,%,0,0
226409,",",0,0
226410,v/v,0,0
226411,;,0,0
226412,5,0,0
226413,mg/ml,0,0
226414,),0,0
226415,as,0,0
226416,a,0,0
226417,means,0,0
226418,of,0,0
226419,indirectly,0,0
226420,assessing,0,0
226421,the,0,0
226422,effect,0,1
226423,alpha-,0,1
226424,and,0,0
226425,beta-globulins,0,1
226426,have,0,0
226427,on,0,0
226428,embryonic,0,0
226429,development,0,0
226430,.,0,0
226431,Those,0,0
226432,results,0,0
226433,coupled,0,0
226434,with,0,0
226435,the,0,0
226436,known,0,0
226437,composition,0,0
226438,characteristics,0,0
226439,of,0,1
226440,Plasmatein,0,1
226441,were,0,0
226442,used,0,0
226443,as,0,0
226444,the,0,0
226445,starting,0,0
226446,basis,0,0
226447,to,0,0
226448,formulate,0,0
226449,test,0,1
226450,lots,0,0
226451,of,0,1
226452,synthetic,0,1
226453,serum,0,1
226454,substitute,0,0
226455,(,0,1
226456,SSS,0,1
226457,),0,0
226458,.,0,0
226459,RESULTS,0,0
226460,Significantly,0,0
226461,(,0,0
226462,P,0,0
226463,<,0,0
226464,0.05,0,0
226465,),0,0
226466,more,0,0
226467,of,0,0
226468,the,0,0
226469,human,0,0
226470,embryos,0,0
226471,cultured,0,1
226472,in,0,0
226473,Plasmatein,0,1
226474,supplemented,0,0
226475,medium,0,0
226476,reached,0,0
226477,the,0,0
226478,four-cell,1,0
226479,or,1,0
226480,greater,1,1
226481,stage,1,0
226482,by,0,0
226483,40,0,0
226484,hr,0,0
226485,postinsemination,0,0
226486,than,0,0
226487,a,0,0
226488,comparable,0,0
226489,group,0,0
226490,cultured,0,1
226491,in,0,0
226492,HSA,0,1
226493,alone,0,0
226494,.,0,0
226495,Lot,0,0
226496,1,0,0
226497,of,0,0
226498,SSS,0,1
226499,",",0,1
226500,formulated,0,0
226501,with,0,0
226502,HSA,0,1
226503,(,0,0
226504,84,0,0
226505,%,0,0
226506,of,0,0
226507,total,0,1
226508,protein,0,1
226509,),0,1
226510,and,0,1
226511,human,0,0
226512,globulins,0,1
226513,(,0,0
226514,16,0,0
226515,%,0,0
226516,of,0,0
226517,total,0,1
226518,protein,0,1
226519,),0,0
226520,and,0,0
226521,an,0,0
226522,aqueous,0,1
226523,lipoprotein,0,1
226524,fraction,0,1
226525,derived,0,0
226526,from,0,0
226527,human,0,0
226528,plasma,0,1
226529,(,0,0
226530,Excyte,0,1
226531,IV,0,1
226532,;,0,0
226533,Miles,0,1
226534,Diagnostics,0,1
226535,",",0,1
226536,Kankakee,0,1
226537,",",0,1
226538,Illinois,0,1
226539,),0,1
226540,",",0,0
226541,produced,0,0
226542,accelerated,0,0
226543,early,1,0
226544,embryonic,1,1
226545,growth,1,1
226546,relative,0,0
226547,to,0,0
226548,control,0,0
226549,murine,0,0
226550,embryos,0,0
226551,grown,0,0
226552,in,0,0
226553,the,0,0
226554,presence,0,0
226555,of,0,1
226556,Plasmatein,0,1
226557,",",0,0
226558,however,0,0
226559,",",0,0
226560,the,0,0
226561,percentage,0,1
226562,of,0,0
226563,the,0,0
226564,embryos,0,0
226565,reaching,0,1
226566,the,0,0
226567,hatched,0,0
226568,blastocyst,0,1
226569,stage,0,1
226570,was,0,0
226571,decreased,0,0
226572,(,0,0
226573,45,0,0
226574,vs,0,0
226575,100,0,0
226576,%,0,0
226577,),0,0
226578,.,0,0
226579,Human,0,0
226580,embryos,0,0
226581,from,0,0
226582,seven,0,0
226583,patients,0,0
226584,",",0,0
226585,randomized,0,0
226586,to,0,0
226587,HTF,0,1
226588,medium,0,0
226589,supplemented,0,0
226590,with,0,0
226591,Plasmatein,0,1
226592,or,0,0
226593,lot,0,0
226594,1,0,0
226595,of,0,0
226596,SSS,0,1
226597,",",0,1
226598,showed,0,0
226599,equivalent,0,0
226600,growth,1,1
226601,at,0,0
226602,36-40,0,0
226603,hr,0,1
226604,postinsemination,0,0
226605,.,0,0
226606,A,0,0
226607,microprecipitate,0,0
226608,developed,0,0
226609,in,0,0
226610,media,0,0
226611,supplemented,0,0
226612,with,0,0
226613,lot,0,0
226614,1,0,0
226615,after,0,0
226616,several,0,0
226617,days,0,0
226618,of,0,0
226619,culture,0,1
226620,.,0,0
226621,The,0,0
226622,Excyte,1,1
226623,IV,1,1
226624,concentration,1,1
226625,was,0,0
226626,reduced,0,1
226627,and,0,0
226628,",",0,0
226629,ultimately,0,1
226630,",",0,0
226631,eliminated,0,0
226632,from,0,0
226633,the,0,0
226634,subsequent,0,0
226635,and,0,1
226636,final,0,1
226637,prototype,0,0
226638,lots,0,0
226639,of,0,0
226640,SSS,0,1
226641,.,0,0
226642,Murine,0,1
226643,embryos,0,1
226644,grown,0,0
226645,in,0,0
226646,the,0,0
226647,presence,0,0
226648,of,0,0
226649,lipoprotein,0,1
226650,free,0,1
226651,SSS,0,1
226652,showed,0,0
226653,significantly,0,0
226654,accelerated,1,0
226655,(,1,0
226656,P,1,0
226657,<,1,0
226658,0.01,1,0
226659,),1,0
226660,growth,1,0
226661,at,0,0
226662,17,0,0
226663,hr,0,0
226664,postthaw,0,0
226665,compared,0,0
226666,to,0,0
226667,Plasmatein,0,1
226668,and,0,0
226669,all,0,0
226670,embryos,0,0
226671,progressed,0,1
226672,to,0,0
226673,hatching,1,0
226674,by,0,0
226675,41,0,0
226676,hr,0,0
226677,.,0,0
226678,Human,0,0
226679,embryos,0,1
226680,",",0,0
226681,randomized,0,0
226682,to,0,0
226683,either,0,0
226684,Plasmatein,0,1
226685,or,0,0
226686,lot,0,0
226687,3,0,0
226688,of,0,0
226689,SSS,0,1
226690,",",0,1
226691,showed,0,0
226692,significantly,0,0
226693,accelerated,1,0
226694,growth,1,1
226695,(,0,0
226696,P,0,0
226697,<,0,0
226698,0.01,0,0
226699,),0,0
226700,when,0,0
226701,scored,0,0
226702,at,0,0
226703,38,0,0
226704,hr,0,0
226705,following,0,0
226706,insemination,0,0
226707,.,0,0
226708,CONCLUSION,0,0
226709,Synthetic,0,1
226710,serum,0,1
226711,substitute,0,0
226712,provides,0,0
226713,a,0,0
226714,convient,0,0
226715,",",0,0
226716,standardized,0,0
226717,means,0,0
226718,of,0,0
226719,adding,0,0
226720,protein,0,1
226721,to,0,0
226722,media,0,0
226723,used,0,0
226724,in,0,0
226725,assisted,0,0
226726,reproductive,0,1
226727,technology,0,0
226728,(,0,1
226729,ART,0,1
226730,),0,0
226731,procedures,0,0
226732,.,0,0
226733,Hypertension,0,1
226734,and,0,1
226735,non-insulin-dependent,0,0
226736,diabetes,0,0
226737,.,0,0
226738,A,0,0
226739,comparison,0,0
226740,between,0,0
226741,an,0,0
226742,angiotensin-converting,0,0
226743,enzyme,0,0
226744,inhibitor,0,0
226745,and,0,0
226746,a,0,0
226747,calcium,0,1
226748,antagonist,0,0
226749,.,0,0
226750,The,0,0
226751,effects,0,0
226752,of,0,0
226753,the,0,0
226754,angiotensin-converting,0,0
226755,enzyme,0,0
226756,lisinopril,0,0
226757,were,0,0
226758,compared,0,0
226759,with,0,0
226760,those,0,0
226761,of,0,0
226762,the,0,0
226763,calcium,0,1
226764,antagonist,0,0
226765,nifedipine,0,0
226766,in,0,0
226767,162,0,0
226768,non-insulin-dependent,0,0
226769,diabetic,0,0
226770,hypertensive,0,0
226771,patients,0,0
226772,for,0,0
226773,a,0,0
226774,24-week,0,0
226775,period,0,0
226776,.,0,0
226777,In,0,0
226778,83,0,0
226779,and,0,0
226780,79,0,0
226781,patients,0,0
226782,",",0,0
226783,respectively,0,0
226784,",",0,0
226785,lisinopril,0,0
226786,and,0,1
226787,slow-release,0,0
226788,nifedipine,0,0
226789,produced,0,0
226790,similar,0,0
226791,reductions,1,1
226792,in,1,0
226793,blood,1,1
226794,pressure,1,1
226795,(,0,0
226796,systolic/diastolic,0,1
226797,:,0,0
226798,-16/-13,0,1
226799,mmHg,0,0
226800,supine,0,1
226801,and,0,1
226802,-14/-11,0,1
226803,mmHg,0,0
226804,standing,0,1
226805,after,0,0
226806,lisinopril,0,0
226807,;,0,0
226808,-15/-12,0,0
226809,mmHg,0,0
226810,supine,0,1
226811,and,0,1
226812,-14/-11,0,1
226813,mmHg,0,0
226814,standing,0,1
226815,nifedipine,0,0
226816,),0,0
226817,.,0,0
226818,Fasting,1,1
226819,and,1,1
226820,post-prandial,1,1
226821,plasma,1,1
226822,glucose,1,1
226823,",",1,1
226824,glycosylated,1,1
226825,haemoglobin,1,1
226826,and,1,0
226827,plasma,1,1
226828,lipids,1,1
226829,appeared,0,0
226830,to,0,0
226831,be,0,0
226832,unaffected,0,0
226833,by,0,0
226834,either,0,0
226835,agent,0,0
226836,.,0,0
226837,Also,0,0
226838,",",0,0
226839,28,0,0
226840,%,0,0
226841,of,0,0
226842,the,0,0
226843,patients,0,0
226844,on,0,0
226845,lisinopril,0,0
226846,and,0,0
226847,30,0,0
226848,%,0,0
226849,of,0,0
226850,those,0,0
226851,on,0,0
226852,nifedipine,0,0
226853,presented,0,0
226854,microalbuminuria,0,0
226855,.,0,0
226856,Both,0,0
226857,drugs,0,0
226858,induced,0,0
226859,a,0,0
226860,reduction,0,1
226861,in,0,0
226862,the,0,0
226863,albumin,1,1
226864,excretion,1,1
226865,rate,1,1
226866,(,1,1
226867,AER,1,1
226868,),1,0
226869,.,1,0
226870,The,0,0
226871,geometric,0,1
226872,mean,0,1
226873,x,0,0
226874,:,0,0
226875,tolerance,0,1
226876,factor,0,0
226877,of,0,0
226878,the,0,0
226879,reduction,1,1
226880,in,1,0
226881,AER,1,1
226882,among,0,0
226883,the,0,0
226884,23,0,0
226885,microalbuminuric,0,0
226886,patients,0,0
226887,on,0,0
226888,lisinopril,0,0
226889,(,0,0
226890,-10.0,0,0
226891,x:1.3,0,0
226892,micrograms/min,0,0
226893,),0,1
226894,was,0,0
226895,greater,0,0
226896,",",0,1
226897,though,0,0
226898,not,0,0
226899,significantly,0,0
226900,so,0,0
226901,",",0,0
226902,than,0,0
226903,that,0,0
226904,observed,0,0
226905,in,0,0
226906,the,0,0
226907,26,0,0
226908,on,0,0
226909,nifedipine,0,0
226910,(,0,0
226911,-0.9,0,0
226912,x,0,0
226913,1.2,0,0
226914,micrograms/min,0,0
226915,),0,0
226916,.,0,0
226917,Moreover,0,0
226918,",",0,0
226919,lisinopril,0,0
226920,appeared,0,0
226921,to,0,0
226922,be,0,0
226923,better,0,0
226924,tolerated,1,1
226925,than,0,0
226926,nifedipine,0,0
226927,in,0,0
226928,our,0,0
226929,study,0,0
226930,population,0,0
226931,.,0,0
226932,Microalbuminuria,0,0
226933,is,0,0
226934,an,0,0
226935,important,0,0
226936,risk,0,1
226937,factor,0,1
226938,for,0,0
226939,cardiovascular,0,1
226940,mortality,0,1
226941,in,0,0
226942,non-insulin-dependent,0,0
226943,diabetic,0,0
226944,patients,0,0
226945,as,0,0
226946,well,0,0
226947,as,0,0
226948,in,0,0
226949,the,0,0
226950,general,0,0
226951,population,0,0
226952,.,0,0
226953,To,0,0
226954,what,0,0
226955,extent,0,0
226956,a,0,0
226957,reduction,0,1
226958,in,0,0
226959,the,0,0
226960,AER,1,0
226961,could,0,0
226962,ameliorate,0,0
226963,diabetic,0,0
226964,patients,0,0
226965,is,0,0
226966,",",0,0
226967,at,0,0
226968,present,0,0
226969,",",0,0
226970,unknown,0,0
226971,.,0,0
226972,Finally,0,0
226973,",",0,0
226974,both,0,0
226975,lisinopril,0,0
226976,and,0,1
226977,nifedipine,0,0
226978,showed,0,0
226979,a,0,0
226980,similar,0,0
226981,antihypertensive,1,0
226982,effect,1,0
226983,in,0,0
226984,these,0,0
226985,patients,0,0
226986,which,0,0
226987,was,0,0
226988,not,0,0
226989,associated,0,0
226990,with,0,0
226991,significant,0,0
226992,differences,0,0
226993,in,0,0
226994,plasma,0,1
226995,glucose,0,1
226996,",",0,1
226997,insulin,0,1
226998,or,0,1
226999,lipid,0,1
227000,concentrations,0,1
227001,.,0,0
227002,The,0,0
227003,clinical,0,0
227004,consequences,0,0
227005,of,0,0
227006,the,0,0
227007,insignificant,0,0
227008,differences,0,0
227009,in,0,0
227010,AER,1,0
227011,remain,0,0
227012,unclear,0,0
227013,.,0,0
227014,A,0,0
227015,randomised,0,0
227016,controlled,0,0
227017,trial,0,0
227018,comparing,0,0
227019,two,0,0
227020,schedules,0,0
227021,of,0,0
227022,antenatal,0,0
227023,visits,0,0
227024,:,0,0
227025,the,0,0
227026,antenatal,0,0
227027,care,0,0
227028,project,0,0
227029,.,0,0
227030,OBJECTIVE,0,0
227031,To,0,0
227032,compare,0,0
227033,the,0,0
227034,clinical,0,0
227035,and,0,1
227036,psychological,0,1
227037,effectiveness,0,1
227038,of,0,0
227039,the,0,0
227040,traditional,0,0
227041,British,0,0
227042,antenatal,0,0
227043,visit,0,1
227044,schedule,0,0
227045,(,0,1
227046,traditional,0,0
227047,care,0,0
227048,),0,0
227049,with,0,0
227050,a,0,0
227051,reduced,0,1
227052,schedule,0,0
227053,of,0,1
227054,visits,0,1
227055,(,0,0
227056,new,0,1
227057,style,0,1
227058,care,0,0
227059,),0,0
227060,for,0,0
227061,low,0,0
227062,risk,0,1
227063,women,0,0
227064,",",0,0
227065,together,0,0
227066,with,0,0
227067,maternal,0,1
227068,and,0,1
227069,professional,0,1
227070,satisfaction,0,1
227071,with,0,0
227072,care,0,0
227073,.,0,1
227074,DESIGN,0,0
227075,Randomised,0,0
227076,controlled,0,0
227077,trial,0,0
227078,.,0,0
227079,SETTING,0,0
227080,Places,0,0
227081,in,0,0
227082,south,0,0
227083,east,0,1
227084,London,0,0
227085,providing,0,0
227086,antenatal,0,0
227087,care,0,0
227088,for,0,0
227089,women,0,0
227090,receiving,0,0
227091,shared,0,1
227092,care,0,0
227093,and,0,0
227094,planning,0,1
227095,to,0,0
227096,deliver,0,0
227097,in,0,0
227098,one,0,0
227099,of,0,0
227100,three,0,0
227101,hospitals,0,0
227102,or,0,0
227103,at,0,0
227104,home,0,0
227105,.,0,0
227106,SUBJECT,0,0
227107,2794,0,0
227108,women,0,0
227109,at,0,0
227110,low,0,0
227111,risk,0,1
227112,fulfilling,0,0
227113,the,0,0
227114,trial,0,0
227115,'s,0,1
227116,inclusion,0,0
227117,criteria,0,0
227118,between,0,0
227119,June,0,0
227120,1993,0,0
227121,and,0,0
227122,July,0,0
227123,1994,0,0
227124,.,0,0
227125,MAIN,0,0
227126,OUTCOME,0,1
227127,MEASURES,0,0
227128,Measures,1,1
227129,of,1,1
227130,fetal,1,1
227131,and,1,1
227132,maternal,1,1
227133,morbidity,1,1
227134,",",1,1
227135,health,1,1
227136,service,1,1
227137,use,1,1
227138,",",1,1
227139,psychosocial,1,1
227140,outcomes,1,1
227141,",",1,1
227142,and,1,1
227143,maternal,1,1
227144,and,1,1
227145,professional,1,1
227146,satisfaction,1,1
227147,.,1,0
227148,RESULTS,0,0
227149,Pregnant,0,0
227150,women,0,0
227151,allocated,0,0
227152,to,0,0
227153,new,0,1
227154,style,0,1
227155,care,0,0
227156,had,0,0
227157,fewer,0,1
227158,day,1,1
227159,admissions,1,1
227160,(,0,0
227161,0.8,0,0
227162,v,0,0
227163,1.0,0,0
227164,;,0,0
227165,P=0.002,0,0
227166,),0,1
227167,and,0,1
227168,ultrasound,1,1
227169,scans,1,0
227170,(,0,0
227171,1.6,0,0
227172,v,0,0
227173,1.7,0,0
227174,;,0,0
227175,P=0.003,0,0
227176,),0,1
227177,and,0,1
227178,were,0,0
227179,less,0,0
227180,often,0,0
227181,suspected,1,0
227182,of,1,0
227183,carrying,1,0
227184,fetuses,1,1
227185,that,1,0
227186,were,1,0
227187,small,1,0
227188,for,1,0
227189,gestational,1,1
227190,age,1,0
227191,(,0,0
227192,odds,0,0
227193,ratio,0,0
227194,0.73,0,0
227195,;,0,0
227196,95,0,0
227197,%,0,0
227198,confidence,0,0
227199,interval,0,0
227200,0.54,0,0
227201,to,0,0
227202,0.99,0,0
227203,),0,0
227204,.,0,0
227205,They,0,0
227206,also,0,0
227207,had,0,0
227208,some,0,0
227209,poorer,1,0
227210,psychosocial,1,0
227211,outcomes,1,1
227212,;,1,0
227213,for,0,0
227214,example,0,0
227215,",",0,0
227216,they,0,0
227217,were,0,0
227218,more,0,0
227219,worried,0,1
227220,about,0,0
227221,fetal,1,1
227222,wellbeing,1,1
227223,antenatally,1,0
227224,and,0,0
227225,coping,1,1
227226,with,1,0
227227,the,1,0
227228,baby,1,0
227229,postnatally,1,0
227230,",",0,0
227231,and,0,1
227232,they,0,0
227233,had,0,0
227234,more,0,0
227235,negative,0,1
227236,attitudes,1,1
227237,to,0,0
227238,their,0,0
227239,babies,0,0
227240,",",0,0
227241,both,0,0
227242,in,0,0
227243,pregnancy,0,1
227244,and,0,0
227245,postnatally,0,0
227246,.,0,0
227247,These,0,0
227248,women,0,0
227249,were,0,0
227250,also,0,0
227251,more,0,0
227252,dissatisfied,1,1
227253,with,1,0
227254,the,1,0
227255,number,1,1
227256,of,1,0
227257,visits,1,0
227258,they,0,0
227259,received,0,0
227260,(,0,0
227261,odds,0,0
227262,ratio,0,0
227263,2.50,0,0
227264,;,0,0
227265,2.00,0,0
227266,to,0,0
227267,3.11,0,0
227268,),0,0
227269,.,0,0
227270,CONCLUSIONS,0,0
227271,Patterns,0,1
227272,of,0,1
227273,antenatal,0,0
227274,care,0,0
227275,involving,0,0
227276,fewer,0,1
227277,routine,0,0
227278,visits,0,1
227279,for,0,0
227280,women,0,0
227281,at,0,0
227282,low,0,0
227283,risk,0,0
227284,may,0,0
227285,lead,0,0
227286,to,0,0
227287,reduced,0,1
227288,psychosocial,1,1
227289,effectiveness,1,1
227290,and,0,1
227291,dissatisfaction,1,1
227292,with,0,0
227293,frequency,0,1
227294,of,0,0
227295,visits,0,0
227296,.,0,0
227297,The,0,0
227298,number,0,1
227299,of,0,0
227300,antenatal,1,0
227301,day,1,0
227302,admissions,1,1
227303,and,0,1
227304,ultrasound,1,1
227305,scans,1,0
227306,performed,1,0
227307,may,0,0
227308,also,0,0
227309,be,0,0
227310,reduced,0,0
227311,.,0,0
227312,For,0,0
227313,the,0,0
227314,variables,0,1
227315,reported,0,0
227316,",",0,0
227317,the,0,0
227318,visit,0,1
227319,schedules,0,0
227320,studied,0,0
227321,are,0,0
227322,similar,0,0
227323,in,0,0
227324,their,0,0
227325,clinical,0,0
227326,effectiveness,0,1
227327,.,0,0
227328,Uncertainty,0,1
227329,remains,0,0
227330,as,0,0
227331,to,0,0
227332,the,0,0
227333,clinical,0,0
227334,effectiveness,0,1
227335,of,0,1
227336,reduced,0,1
227337,visit,0,1
227338,schedules,0,0
227339,for,0,0
227340,rare,0,0
227341,pregnancy,0,0
227342,problems,0,1
227343,.,0,0
227344,Concentration,0,1
227345,of,0,1
227346,inhaled,0,0
227347,amiloride,0,0
227348,in,0,0
227349,cystic,0,1
227350,fibrosis,0,1
227351,.,0,0
227352,Measurement,0,1
227353,of,0,1
227354,health-related,1,1
227355,quality,1,1
227356,of,1,1
227357,life,1,1
227358,in,0,0
227359,multiple,0,0
227360,myeloma,0,1
227361,.,0,0
227362,Nordic,0,0
227363,Myeloma,0,0
227364,Study,0,0
227365,Group,0,0
227366,.,0,0
227367,When,0,0
227368,a,0,0
227369,randomized,0,0
227370,trial,0,0
227371,(,0,0
227372,NMSG,0,0
227373,4/90,0,0
227374,),0,0
227375,comparing,0,0
227376,treatment,0,0
227377,with,0,0
227378,melphalan/prednisone,0,0
227379,to,0,0
227380,melphalan/,0,0
227381,prednisone,0,0
227382,+,0,0
227383,interferon,0,1
227384,alpha-2b,0,0
227385,in,0,0
227386,newly,0,0
227387,diagnosed,0,0
227388,multiple,0,0
227389,myeloma,0,1
227390,was,0,0
227391,initiated,0,0
227392,in,0,0
227393,1990,0,0
227394,",",0,0
227395,a,0,0
227396,quality-of-life,1,1
227397,assessment,1,0
227398,was,0,0
227399,integrated,0,0
227400,into,0,0
227401,the,0,0
227402,study,0,0
227403,.,0,0
227404,We,0,0
227405,used,0,0
227406,the,0,0
227407,questionnaire,0,1
227408,(,0,0
227409,QLQ-C30,0,1
227410,),0,0
227411,developed,0,0
227412,by,0,0
227413,the,0,0
227414,European,0,0
227415,Organization,0,0
227416,of,0,1
227417,Research,0,0
227418,and,0,1
227419,Treatment,0,0
227420,of,0,1
227421,Cancer,0,0
227422,(,0,0
227423,EORTC,0,0
227424,),0,1
227425,Study,0,0
227426,Group,0,0
227427,on,0,0
227428,Quality,1,1
227429,of,1,0
227430,Life,1,0
227431,.,1,0
227432,The,0,0
227433,QLQ-C30,0,0
227434,incorporates,0,0
227435,five,0,0
227436,functional,0,0
227437,scales,0,1
227438,",",0,0
227439,three,0,0
227440,symptom,0,1
227441,scales,0,1
227442,",",0,0
227443,a,0,0
227444,global,0,1
227445,health,0,1
227446,and,0,1
227447,quality-of,1,1
227448,life,1,1
227449,scale,1,1
227450,and,0,0
227451,some,0,0
227452,single,0,0
227453,symptom,0,1
227454,measures,0,0
227455,.,0,0
227456,The,0,0
227457,questionnaire,0,1
227458,was,0,0
227459,completed,0,0
227460,prior,0,0
227461,to,0,0
227462,treatment,0,0
227463,and,0,0
227464,after,0,0
227465,1,0,0
227466,",",0,0
227467,6,0,0
227468,",",0,0
227469,12,0,0
227470,",",0,0
227471,24,0,0
227472,",",0,0
227473,36,0,0
227474,and,0,0
227475,48,0,0
227476,months,0,0
227477,.,0,0
227478,524,0,0
227479,(,0,0
227480,90.2,0,0
227481,%,0,0
227482,),0,0
227483,of,0,0
227484,581,0,0
227485,patients,0,0
227486,enrolled,0,0
227487,in,0,0
227488,the,0,0
227489,NMSG,0,0
227490,4/90,0,0
227491,completed,0,0
227492,the,0,0
227493,first,0,1
227494,questionnaire,0,1
227495,",",0,0
227496,and,0,0
227497,484,0,0
227498,(,0,0
227499,83.3,0,0
227500,%,0,0
227501,),0,0
227502,completed,0,0
227503,all,0,0
227504,questionnaires,0,0
227505,given,0,0
227506,to,0,0
227507,them,0,0
227508,.,0,0
227509,All,0,0
227510,but,0,0
227511,one,0,0
227512,of,0,0
227513,the,0,0
227514,scales,0,1
227515,met,0,0
227516,the,0,0
227517,minimum,0,1
227518,criteria,0,0
227519,of,0,1
227520,reliability,0,1
227521,(,0,0
227522,Cronbach,0,1
227523,'s,0,1
227524,alpha,0,1
227525,>,0,0
227526,/,0,0
227527,0.70,0,0
227528,),0,0
227529,.,0,0
227530,Validity,0,1
227531,was,0,0
227532,shown,0,0
227533,by,0,0
227534,(,0,0
227535,1,0,0
227536,),0,0
227537,the,0,0
227538,ability,0,1
227539,of,0,0
227540,the,0,0
227541,scales,0,1
227542,to,0,0
227543,discriminate,0,0
227544,clearly,0,0
227545,between,0,0
227546,patients,0,0
227547,differing,0,0
227548,in,0,0
227549,clinical,0,0
227550,status,0,1
227551,as,0,0
227552,defined,0,1
227553,by,0,0
227554,pretreatment,0,0
227555,W.H.O,0,1
227556,.,0,1
227557,performance,0,1
227558,index,0,1
227559,and,0,1
227560,Durie,0,1
227561,&,0,1
227562,Salmon,0,1
227563,stage,0,1
227564,",",0,1
227565,and,0,1
227566,(,0,0
227567,2,0,0
227568,),0,0
227569,the,0,0
227570,sensitivity,0,1
227571,to,0,0
227572,changes,0,1
227573,in,0,0
227574,objective,0,0
227575,disease,0,1
227576,status,0,1
227577,(,0,1
227578,response,0,1
227579,and,0,1
227580,relapse,0,1
227581,),0,0
227582,.,0,0
227583,This,0,0
227584,is,0,0
227585,the,0,0
227586,first,0,0
227587,report,0,0
227588,of,0,0
227589,the,0,0
227590,measurement,0,0
227591,of,0,0
227592,health-related,1,1
227593,quality,1,1
227594,of,1,1
227595,life,1,1
227596,in,0,0
227597,a,0,0
227598,prospective,0,0
227599,clinical,0,0
227600,trial,0,0
227601,in,0,0
227602,multiple,0,0
227603,myeloma,0,1
227604,.,0,0
227605,The,1,0
227606,results,1,0
227607,demonstrate,1,0
227608,that,1,0
227609,the,1,0
227610,QLQ-C30,1,0
227611,is,1,0
227612,a,1,0
227613,reliable,1,1
227614,and,1,1
227615,valid,1,0
227616,instrument,1,0
227617,for,1,0
227618,the,1,0
227619,measurement,1,0
227620,of,1,0
227621,quality,1,1
227622,of,1,1
227623,life,1,1
227624,in,1,0
227625,these,1,0
227626,patients,1,0
227627,.,1,0
227628,The,0,0
227629,data,0,0
227630,will,0,0
227631,be,0,0
227632,used,0,0
227633,for,0,0
227634,a,0,0
227635,cost-utility,0,0
227636,analysis,0,0
227637,of,0,0
227638,the,0,0
227639,results,0,0
227640,of,0,0
227641,the,0,0
227642,NMSG,0,0
227643,4/90,0,0
227644,trial,0,0
227645,.,0,0
227646,Feedlot,0,0
227647,performance,0,1
227648,and,0,1
227649,carcass,0,1
227650,characteristics,0,1
227651,of,0,1
227652,Holstein,0,0
227653,steers,0,0
227654,as,0,0
227655,affected,0,0
227656,by,0,0
227657,source,0,0
227658,of,0,1
227659,dietary,0,1
227660,protein,0,1
227661,and,0,1
227662,level,0,1
227663,of,0,0
227664,ruminally,0,0
227665,protected,0,0
227666,lysine,0,0
227667,and,0,0
227668,methionine,0,0
227669,.,0,0
227670,The,0,0
227671,objective,0,0
227672,of,0,0
227673,this,0,0
227674,study,0,0
227675,was,0,0
227676,to,0,0
227677,determine,0,0
227678,the,0,0
227679,effects,1,0
227680,of,0,0
227681,source,0,0
227682,of,0,0
227683,dietary,0,1
227684,CP,0,0
227685,and,0,1
227686,level,0,1
227687,of,0,0
227688,ruminally,0,0
227689,protected,0,0
227690,lysine,0,0
227691,and,0,1
227692,methionine,0,1
227693,(,0,1
227694,RPLM,0,1
227695,),0,1
227696,on,0,0
227697,feedlot,1,0
227698,performance,1,1
227699,and,1,1
227700,carcass,1,1
227701,characteristics,1,1
227702,of,0,1
227703,Holstein,0,0
227704,steers,0,0
227705,during,0,0
227706,a,0,0
227707,growing-finishing,0,0
227708,trial,0,0
227709,(,0,0
227710,266,0,0
227711,d,0,0
227712,),0,0
227713,.,0,0
227714,A,0,0
227715,total,0,0
227716,of,0,0
227717,168,0,0
227718,Holstein,0,0
227719,steers,0,0
227720,(,0,0
227721,182.7,0,0
227722,+/-,0,0
227723,27.5,0,0
227724,kg,0,0
227725,),0,0
227726,were,0,0
227727,used,0,0
227728,in,0,0
227729,a,0,0
227730,completely,0,0
227731,randomized,0,0
227732,design,0,0
227733,experiment,0,0
227734,(,0,0
227735,eight,0,0
227736,treatments,0,0
227737,;,0,0
227738,three,0,0
227739,pens,0,0
227740,of,0,0
227741,seven,0,0
227742,steers/treatment,0,0
227743,),0,0
227744,.,0,0
227745,Steers,0,0
227746,were,0,0
227747,given,0,0
227748,ad,0,0
227749,libitum,0,0
227750,access,0,1
227751,to,0,0
227752,high-concentrate,0,0
227753,diets,0,0
227754,(,0,0
227755,13,0,0
227756,%,0,0
227757,CP,0,0
227758,),0,0
227759,containing,0,0
227760,71,0,0
227761,%,0,0
227762,whole,0,0
227763,shelled,0,0
227764,corn,0,0
227765,",",0,0
227766,10,0,0
227767,%,0,0
227768,corn,0,0
227769,silage,0,0
227770,",",0,0
227771,4,0,0
227772,%,0,0
227773,condensed,0,0
227774,distillers,0,0
227775,solubles,0,1
227776,",",0,0
227777,and,0,0
227778,15,0,0
227779,%,0,0
227780,protein,0,0
227781,supplements,0,0
227782,(,0,1
227783,DM,0,1
227784,basis,0,0
227785,),0,0
227786,.,0,0
227787,Treatments,0,0
227788,were,0,0
227789,arranged,0,0
227790,as,0,0
227791,a,0,0
227792,2,0,0
227793,x,0,0
227794,4,0,0
227795,factorial,0,0
227796,.,0,0
227797,The,0,0
227798,main,0,0
227799,factors,0,0
227800,were,0,0
227801,two,0,0
227802,sources,0,0
227803,of,0,0
227804,dietary,0,1
227805,CP,0,0
227806,and,0,0
227807,four,0,0
227808,levels,0,1
227809,of,0,0
227810,RPLM,0,1
227811,.,0,0
227812,The,0,0
227813,sources,0,0
227814,of,0,0
227815,dietary,1,1
227816,CP,1,0
227817,were,0,0
227818,soybean,0,0
227819,meal,0,1
227820,(,0,1
227821,SBM,0,1
227822,),0,1
227823,or,0,1
227824,SBM,0,1
227825,and,0,1
227826,urea,0,1
227827,(,0,1
227828,SBM-U,0,0
227829,),0,0
227830,.,0,0
227831,Urea-N,1,0
227832,replaced,0,0
227833,50,0,0
227834,%,0,0
227835,of,0,0
227836,SBM-N,0,0
227837,in,0,0
227838,the,0,0
227839,SBM-U,0,0
227840,diet,0,0
227841,.,0,0
227842,The,0,0
227843,levels,0,1
227844,of,0,0
227845,RPLM,0,1
227846,were,0,0
227847,0,0,0
227848,",",0,0
227849,5,0,0
227850,",",0,0
227851,10,0,0
227852,",",0,0
227853,and,0,0
227854,15,0,0
227855,g,0,0
227856,per,0,0
227857,steer,0,0
227858,daily,0,0
227859,.,0,0
227860,No,0,0
227861,interactions,0,1
227862,(,0,0
227863,P,0,0
227864,>,0,1
227865,.10,0,0
227866,),0,0
227867,between,0,0
227868,source,0,0
227869,of,0,0
227870,dietary,1,1
227871,CP,1,0
227872,and,1,1
227873,level,1,1
227874,of,1,1
227875,RPLM,1,1
227876,were,0,0
227877,observed,0,0
227878,for,0,0
227879,feedlot,0,0
227880,performance,0,1
227881,or,0,1
227882,carcass,1,1
227883,characteristics,1,1
227884,.,1,1
227885,Feedlot,1,0
227886,performance,1,1
227887,showed,0,0
227888,an,0,0
227889,advantage,0,0
227890,(,0,0
227891,P,0,0
227892,<,0,0
227893,.10,0,0
227894,),0,0
227895,to,0,0
227896,feeding,0,1
227897,SMB,0,0
227898,during,0,0
227899,the,0,0
227900,first,0,0
227901,84,0,0
227902,d,0,0
227903,of,0,0
227904,the,0,0
227905,trial,0,0
227906,and,0,0
227907,an,0,0
227908,advantage,0,0
227909,to,0,0
227910,feeding,0,1
227911,SBM-U,0,0
227912,during,0,0
227913,the,0,0
227914,last,0,0
227915,98,0,0
227916,d,0,0
227917,of,0,0
227918,the,0,0
227919,trial,0,0
227920,.,0,0
227921,However,0,0
227922,",",0,0
227923,feedlot,1,0
227924,performance,1,1
227925,for,0,0
227926,the,0,0
227927,whole,0,0
227928,trial,0,0
227929,and,0,1
227930,carcass,0,1
227931,characteristics,0,1
227932,(,0,0
227933,except,0,0
227934,for,0,0
227935,fat,1,1
227936,thickness,1,1
227937,),1,1
227938,were,0,0
227939,not,0,0
227940,affected,0,0
227941,(,0,0
227942,P,0,0
227943,>,0,1
227944,.10,0,0
227945,),0,0
227946,by,0,0
227947,the,0,0
227948,source,0,0
227949,of,0,0
227950,dietary,0,0
227951,CP,0,0
227952,.,0,1
227953,Steers,0,0
227954,fed,0,0
227955,diets,0,0
227956,containing,0,0
227957,SBM-U,0,0
227958,had,0,0
227959,12,0,0
227960,%,0,0
227961,less,0,0
227962,(,0,1
227963,P,0,0
227964,<,0,0
227965,.10,0,0
227966,),0,0
227967,fat,1,1
227968,thickness,1,1
227969,than,0,0
227970,those,0,0
227971,fed,0,0
227972,diets,0,0
227973,containing,0,0
227974,SBM,0,0
227975,.,0,0
227976,Supplementation,0,0
227977,of,0,0
227978,diets,0,0
227979,with,0,0
227980,increasing,0,0
227981,levels,0,1
227982,of,0,1
227983,RPLM,1,1
227984,did,0,0
227985,not,0,0
227986,affect,0,0
227987,(,0,0
227988,P,0,0
227989,>,0,1
227990,.10,0,0
227991,),0,1
227992,ADG,0,1
227993,or,0,1
227994,carcass,0,1
227995,characteristics,0,1
227996,.,0,0
227997,However,0,0
227998,",",0,0
227999,DMI,0,1
228000,and,0,1
228001,gain,0,1
228002,:,0,1
228003,feed,0,1
228004,showed,0,0
228005,cubic,1,0
228006,(,1,0
228007,P,1,0
228008,<,1,0
228009,.10,1,0
228010,),1,0
228011,responses,1,1
228012,to,0,0
228013,increasing,0,0
228014,dietary,0,0
228015,level,0,1
228016,of,0,0
228017,RPLM,0,1
228018,.,0,0
228019,Supplementation,0,0
228020,of,0,0
228021,RPLM,0,1
228022,at,0,0
228023,the,0,0
228024,10,0,0
228025,g/d,0,0
228026,level,0,1
228027,improved,0,0
228028,gain,1,1
228029,:,1,0
228030,feed,1,0
228031,by,0,0
228032,12,0,0
228033,%,0,0
228034,during,0,0
228035,the,0,0
228036,last,0,0
228037,98,0,0
228038,d,0,0
228039,of,0,0
228040,the,0,0
228041,trial,0,0
228042,",",0,0
228043,and,0,1
228044,this,0,0
228045,was,0,0
228046,a,0,0
228047,direct,0,0
228048,response,0,1
228049,to,0,0
228050,the,0,0
228051,cubic,0,0
228052,effects,0,1
228053,of,0,0
228054,RPLM,0,1
228055,on,0,0
228056,DMI,0,1
228057,.,0,0
228058,Results,0,0
228059,suggest,0,0
228060,a,0,0
228061,cost,0,1
228062,advantage,0,0
228063,for,0,0
228064,replacing,0,0
228065,50,0,0
228066,%,0,0
228067,of,0,0
228068,SBM-N,0,0
228069,with,0,0
228070,that,0,0
228071,from,0,0
228072,urea,0,1
228073,in,0,0
228074,high-corn,0,0
228075,diets,0,0
228076,without,0,0
228077,negative,0,1
228078,effects,0,1
228079,on,0,0
228080,feedlot,0,0
228081,performance,0,1
228082,or,0,1
228083,carcass,0,1
228084,characteristics,0,1
228085,of,0,0
228086,growing-finishing,0,0
228087,Holstein,0,0
228088,steers,0,0
228089,with,0,0
228090,extended,0,0
228091,feeding,0,1
228092,periods,0,0
228093,(,0,0
228094,266,0,0
228095,d,0,0
228096,),0,0
228097,.,0,0
228098,These,0,0
228099,types,0,0
228100,of,0,0
228101,diets,0,0
228102,seem,0,0
228103,to,0,0
228104,meet,0,0
228105,the,0,0
228106,amino,0,0
228107,acid,0,1
228108,requirements,0,1
228109,and,0,0
228110,are,0,0
228111,not,0,0
228112,limiting,0,1
228113,in,0,0
228114,lysine,0,0
228115,and,0,1
228116,methionine,0,0
228117,.,0,0
228118,Fludarabine,0,0
228119,in,0,0
228120,chronic,0,0
228121,leukaemia,0,0
228122,.,0,0
228123,[,0,0
228124,Effectiveness,0,1
228125,of,0,1
228126,adjuvant,0,0
228127,hormone,0,1
228128,therapy,0,0
228129,in,0,0
228130,breast,0,0
228131,cancer,0,0
228132,],0,0
228133,.,0,1
228134,A,0,0
228135,third,0,0
228136,series,0,0
228137,of,0,1
228138,randomized,0,0
228139,tests,0,1
228140,was,0,0
228141,undertaken,0,0
228142,to,0,0
228143,evaluate,1,0
228144,the,0,0
228145,efficacy,1,1
228146,of,0,0
228147,postoperative,0,1
228148,adjuvant,0,0
228149,hormone,0,1
228150,therapy,0,0
228151,(,0,1
228152,tamoxifen,0,0
228153,",",0,1
228154,diethylstilbestrol,0,0
228155,",",0,0
228156,orimethen,0,0
228157,amino,0,0
228158,glutethymide,0,0
228159,),0,0
228160,in,0,0
228161,breast,0,0
228162,cancer,0,0
228163,patients,0,0
228164,.,0,1
228165,Tamoxifen,0,0
228166,was,0,0
228167,studied,0,0
228168,in,0,0
228169,176,0,0
228170,patients,0,0
228171,with,0,0
228172,T1-2N0M0,0,1
228173,tumors,0,0
228174,.,0,0
228175,Five-year,1,0
228176,recurrence-free,1,1
228177,survival,1,1
228178,was,0,0
228179,registered,0,0
228180,in,0,0
228181,85.2,0,0
228182,%,0,0
228183,of,0,0
228184,menopausal,0,0
228185,patients,0,0
228186,treated,0,0
228187,with,0,0
228188,tamoxifen,0,0
228189,versus,0,0
228190,71.1,0,0
228191,%,0,0
228192,in,0,0
228193,control,0,0
228194,(,0,0
228195,P,0,0
228196,<,0,0
228197,0.05,0,0
228198,),0,0
228199,.,0,0
228200,Five-year,1,0
228201,recurrence-free,1,1
228202,survival,1,1
228203,in,0,0
228204,menopausal,0,0
228205,females,0,0
228206,with,0,0
228207,breast,0,0
228208,tumors,0,1
228209,",",0,1
228210,stage,0,1
228211,IIb,0,1
228212,",",0,0
228213,was,0,0
228214,71.1,0,0
228215,%,0,0
228216,among,0,0
228217,those,0,0
228218,treated,0,0
228219,with,0,0
228220,diethylstilbestrol,0,0
228221,and,0,0
228222,as,0,0
228223,low,0,0
228224,as,0,0
228225,57.4,0,0
228226,%,0,0
228227,in,0,0
228228,the,0,0
228229,tamoxifen,0,0
228230,group,0,0
228231,(,0,1
228232,P,0,0
228233,<,0,0
228234,0.05,0,0
228235,),0,0
228236,.,0,0
228237,Untoward,1,1
228238,side-effect,1,1
228239,incidence,1,1
228240,was,0,0
228241,much,1,0
228242,higher,1,0
228243,in,0,0
228244,the,0,0
228245,diethylstilbestrol,0,0
228246,group,0,0
228247,(,0,0
228248,30.4,0,0
228249,%,0,0
228250,),0,0
228251,as,0,0
228252,compared,0,0
228253,with,0,0
228254,tamoxifen,0,0
228255,(,0,0
228256,3.5,0,0
228257,%,0,0
228258,),0,0
228259,.,0,0
228260,No,0,0
228261,significant,0,0
228262,difference,0,0
228263,was,0,0
228264,found,0,0
228265,for,0,0
228266,the,0,0
228267,relationship,0,0
228268,between,0,0
228269,orimethen,0,0
228270,and,0,1
228271,tamoxifen,0,0
228272,treatment,0,0
228273,with,0,0
228274,respect,0,0
228275,to,0,0
228276,5-year,1,1
228277,survival,1,1
228278,and,1,1
228279,recurrence-free,1,1
228280,survival,1,1
228281,.,1,0
228282,The,0,0
228283,effect,0,0
228284,of,0,0
228285,body,0,1
228286,positioning,0,0
228287,upon,0,0
228288,maximal,0,1
228289,oxygenation,0,1
228290,of,0,0
228291,patients,0,0
228292,with,0,0
228293,unilateral,0,0
228294,lung,0,0
228295,pathology,0,1
228296,.,0,0
228297,A,0,0
228298,quasi-experimental,0,0
228299,",",0,0
228300,repeated-measures,0,0
228301,cross-over,0,0
228302,design,0,0
228303,study,0,0
228304,on,0,0
228305,the,0,0
228306,effect,0,0
228307,of,0,1
228308,body,0,1
228309,position,0,1
228310,on,0,0
228311,oxygenation,0,1
228312,(,0,1
228313,SaO2,0,0
228314,),0,1
228315,blood,0,1
228316,pressure,0,1
228317,",",0,1
228318,respiration,0,1
228319,and,0,1
228320,pulse,0,1
228321,in,0,0
228322,patients,0,0
228323,with,0,0
228324,unilateral,0,0
228325,lung,0,1
228326,pathology,0,1
228327,was,0,0
228328,conducted,0,0
228329,.,0,0
228330,Previous,0,0
228331,research,0,0
228332,strongly,0,0
228333,suggests,0,0
228334,that,0,0
228335,positioning,0,0
228336,with,0,0
228337,the,0,0
228338,healthy,0,0
228339,(,0,0
228340,unaffected,0,0
228341,),0,1
228342,lung,0,0
228343,in,0,0
228344,the,0,0
228345,dependent,0,0
228346,lateral,0,0
228347,(,0,0
228348,down,0,1
228349,),0,0
228350,position,0,0
228351,is,0,0
228352,related,0,0
228353,to,0,0
228354,improved,0,0
228355,oxygenation,0,1
228356,",",0,0
228357,but,0,0
228358,knowledge,0,1
228359,about,0,0
228360,whether,0,0
228361,this,0,0
228362,effect,0,0
228363,is,0,0
228364,maintained,0,0
228365,over,0,0
228366,time,0,1
228367,is,0,0
228368,lacking,0,0
228369,.,0,0
228370,The,0,0
228371,purpose,0,0
228372,of,0,0
228373,this,0,0
228374,investigation,0,0
228375,was,0,0
228376,to,0,0
228377,determine,0,0
228378,:,0,0
228379,(,0,0
228380,1,0,0
228381,),0,0
228382,Is,0,0
228383,positioning,0,0
228384,with,0,0
228385,the,0,0
228386,unaffected,0,0
228387,lung,0,0
228388,in,0,0
228389,the,0,0
228390,dependent,0,0
228391,lateral,0,0
228392,position,0,1
228393,related,0,0
228394,to,0,0
228395,increased,0,0
228396,arterial,0,1
228397,blood,0,1
228398,saturation,0,1
228399,levels,0,1
228400,and,0,1
228401,decreased,0,1
228402,blood,0,1
228403,pressure,0,1
228404,",",0,1
228405,pulse,0,1
228406,and,0,1
228407,respiration,0,1
228408,?,0,0
228409,(,0,0
228410,2,0,0
228411,),0,0
228412,What,0,0
228413,is,0,0
228414,the,0,0
228415,relationship,0,0
228416,between,0,0
228417,the,0,0
228418,dependent,0,0
228419,variables,0,0
228420,--,0,1
228421,oxygenation,0,1
228422,saturation,0,1
228423,levels,0,1
228424,",",0,1
228425,blood,0,1
228426,pressure,0,1
228427,",",0,1
228428,pulse,0,1
228429,and,0,1
228430,respiration,0,1
228431,--,0,1
228432,and,0,0
228433,the,0,0
228434,independent,0,0
228435,variables,0,0
228436,--,0,1
228437,body,0,1
228438,position,0,1
228439,and,0,1
228440,time,0,1
228441,in,0,0
228442,the,0,0
228443,position,0,1
228444,?,0,0
228445,Thirty-nine,0,0
228446,patients,0,0
228447,with,0,0
228448,unilateral,0,0
228449,lung,0,1
228450,pathology,0,1
228451,were,0,0
228452,positioned,0,0
228453,on,0,0
228454,their,0,0
228455,sides,0,0
228456,with,0,0
228457,the,0,0
228458,unaffected,0,0
228459,lung,0,1
228460,down,0,1
228461,",",0,0
228462,on,0,0
228463,their,0,0
228464,sides,0,0
228465,with,0,0
228466,the,0,0
228467,affected,0,0
228468,lung,0,0
228469,down,0,1
228470,",",0,0
228471,and,0,1
228472,also,0,0
228473,in,0,0
228474,semi-Fowler,0,1
228475,'s,0,0
228476,position,0,1
228477,.,0,1
228478,Arterial,1,1
228479,(,1,0
228480,SaO2,1,0
228481,),1,1
228482,blood,1,1
228483,saturation,1,1
228484,and,1,1
228485,vital,1,1
228486,signs,1,1
228487,were,0,0
228488,measured,0,0
228489,at,0,0
228490,baseline,0,0
228491,0,0,0
228492,",",0,0
228493,15,0,0
228494,and,0,0
228495,30,0,0
228496,minutes,0,0
228497,.,0,0
228498,There,0,0
228499,was,0,0
228500,no,0,0
228501,statistically,0,0
228502,significant,0,0
228503,relationship,0,1
228504,between,0,0
228505,oxygenation,1,1
228506,level,1,1
228507,or,1,1
228508,systolic,1,1
228509,blood,1,1
228510,pressure,1,1
228511,.,1,1
228512,Diastolic,1,1
228513,blood,1,1
228514,pressure,1,1
228515,",",1,1
228516,respiration,1,1
228517,and,1,1
228518,pulse,1,1
228519,did,0,0
228520,vary,0,0
228521,significantly,0,0
228522,with,0,0
228523,position,0,1
228524,.,0,0
228525,Randomized,0,0
228526,trial,0,0
228527,comparing,0,0
228528,induction,0,1
228529,chemotherapy,0,0
228530,versus,0,0
228531,induction,0,1
228532,chemotherapy,0,0
228533,followed,0,0
228534,by,0,0
228535,maintenance,0,0
228536,chemotherapy,0,0
228537,in,0,0
228538,small-cell,0,0
228539,lung,0,0
228540,cancer,0,0
228541,.,0,1
228542,European,0,0
228543,Lung,0,0
228544,Cancer,0,0
228545,Working,0,0
228546,Party,0,1
228547,.,0,1
228548,PURPOSE,0,0
228549,AND,0,0
228550,METHODS,0,0
228551,The,0,0
228552,European,0,0
228553,Lung,0,0
228554,Cancer,0,0
228555,Working,0,0
228556,Party,0,1
228557,(,0,1
228558,ELCWP,0,1
228559,),0,0
228560,performed,0,0
228561,a,0,0
228562,randomized,0,0
228563,trial,0,0
228564,with,0,0
228565,the,0,0
228566,primary,0,0
228567,end,0,0
228568,point,0,0
228569,to,0,0
228570,determine,0,0
228571,if,0,0
228572,maintenance,0,0
228573,chemotherapy,0,0
228574,with,0,0
228575,12,0,0
228576,courses,0,0
228577,of,0,0
228578,etoposide,0,0
228579,(,0,0
228580,120,0,0
228581,mg/m2,0,0
228582,on,0,0
228583,days,0,0
228584,1,0,0
228585,and,0,0
228586,3,0,0
228587,),0,0
228588,and,0,0
228589,vindesine,0,0
228590,(,0,0
228591,3,0,0
228592,mg/m2,0,0
228593,on,0,0
228594,day,0,0
228595,3,0,0
228596,),0,0
228597,could,0,0
228598,improve,0,0
228599,progression-free,1,1
228600,survival,1,1
228601,in,0,0
228602,small-cell,0,0
228603,lung,0,1
228604,cancer,0,1
228605,(,0,1
228606,SCLC,0,1
228607,),0,0
228608,patients,0,0
228609,who,0,0
228610,responded,0,0
228611,to,0,0
228612,six,0,0
228613,courses,0,0
228614,of,0,0
228615,induction,0,0
228616,chemotherapy,0,0
228617,with,0,0
228618,ifosfamide,0,0
228619,",",0,0
228620,etoposide,0,0
228621,",",0,0
228622,and,0,0
228623,an,0,0
228624,anthracycline,0,0
228625,(,0,1
228626,doxorubicin,0,0
228627,or,0,1
228628,epirubicin,0,0
228629,),0,1
228630,.,0,0
228631,RESULTS,0,0
228632,Among,0,0
228633,235,0,0
228634,eligible,0,0
228635,patients,0,0
228636,initially,0,0
228637,registered,0,0
228638,",",0,0
228639,91,0,0
228640,were,0,0
228641,randomized,0,0
228642,to,0,0
228643,receive,0,0
228644,maintenance,0,0
228645,therapy,0,0
228646,",",0,0
228647,including,0,0
228648,seven,0,0
228649,patients,0,0
228650,who,0,0
228651,were,0,0
228652,no,0,0
228653,longer,0,0
228654,responding,0,1
228655,.,0,0
228656,Among,0,0
228657,84,0,0
228658,randomized,0,0
228659,responders,0,0
228660,",",0,1
228661,progression-free,1,1
228662,survival,1,1
228663,was,0,0
228664,significantly,0,0
228665,improved,0,0
228666,(,0,0
228667,P,0,0
228668,=,0,0
228669,.003,0,0
228670,),0,0
228671,by,0,0
228672,maintenance,0,0
228673,therapy,0,0
228674,",",0,0
228675,with,0,0
228676,median,0,1
228677,durations,0,1
228678,(,0,0
228679,maintenance,0,0
228680,v,0,1
228681,follow-up,0,0
228682,),0,0
228683,of,0,0
228684,25,0,0
228685,versus,0,0
228686,12,0,0
228687,weeks,0,0
228688,after,0,0
228689,the,0,0
228690,second,0,0
228691,randomization,0,0
228692,",",0,1
228693,but,0,0
228694,survival,1,1
228695,was,0,0
228696,not,0,0
228697,significantly,0,0
228698,increased,0,0
228699,(,0,0
228700,P,0,0
228701,=,0,0
228702,.10,0,0
228703,),0,1
228704,",",0,0
228705,with,0,0
228706,median,0,1
228707,durations,0,0
228708,of,0,0
228709,48,0,0
228710,and,0,0
228711,38,0,0
228712,weeks,0,0
228713,.,0,0
228714,However,0,0
228715,",",0,0
228716,in,0,0
228717,a,0,0
228718,multi-variate,0,0
228719,analysis,0,0
228720,that,0,0
228721,took,0,0
228722,into,0,0
228723,account,1,0
228724,disease,1,1
228725,extent,1,1
228726,",",1,1
228727,maintenance,1,0
228728,therapy,1,0
228729,",",1,1
228730,Karnofsky,1,1
228731,performance,1,1
228732,status,1,1
228733,(,1,1
228734,PS,1,1
228735,),1,1
228736,",",1,0
228737,and,1,1
228738,absolute,1,1
228739,dose-intensity,1,1
228740,(,1,1
228741,ADI,1,1
228742,),1,1
228743,of,1,0
228744,anthracycline,1,0
228745,given,0,0
228746,during,0,0
228747,induction,0,0
228748,",",0,1
228749,limited,1,0
228750,disease,1,1
228751,(,1,1
228752,LD,1,1
228753,),1,1
228754,and,1,1
228755,maintenance,1,0
228756,were,0,0
228757,found,0,0
228758,to,0,0
228759,be,0,0
228760,independent,0,0
228761,positive,0,1
228762,predictors,0,0
228763,of,0,0
228764,survival,1,1
228765,.,1,0
228766,CONCLUSION,0,0
228767,We,0,0
228768,conclude,0,0
228769,that,0,0
228770,maintenance,0,0
228771,chemotherapy,0,0
228772,in,0,0
228773,responding,0,0
228774,patients,0,0
228775,is,0,0
228776,beneficial,0,0
228777,in,0,0
228778,SCLC,0,1
228779,.,0,0
228780,[,0,0
228781,Clinical,0,1
228782,early,0,0
228783,phase,0,0
228784,II,0,0
228785,study,0,0
228786,of,0,1
228787,bicalutamide,0,0
228788,(,0,1
228789,Casodex,0,0
228790,),0,0
228791,in,0,0
228792,patients,0,0
228793,with,0,0
228794,prostatic,0,1
228795,cancer,0,0
228796,],0,0
228797,.,0,0
228798,To,0,0
228799,investigate,0,0
228800,the,0,0
228801,efficacy,1,1
228802,and,1,1
228803,safety,1,1
228804,of,0,1
228805,bicalutamide,0,0
228806,(,0,1
228807,Casodex,0,0
228808,),0,0
228809,with,0,0
228810,its,0,0
228811,clinically,0,1
228812,recommended,0,0
228813,dose,0,0
228814,",",0,0
228815,the,0,0
228816,randomized,0,0
228817,early,0,0
228818,phase,0,0
228819,II,0,0
228820,study,0,0
228821,was,0,0
228822,performed,0,0
228823,in,0,0
228824,124,0,0
228825,patients,0,0
228826,with,0,0
228827,prostatic,0,1
228828,cancer,0,0
228829,(,0,0
228830,stage,0,1
228831,C,0,1
228832,",",0,1
228833,D,0,1
228834,),0,0
228835,.,0,0
228836,The,0,0
228837,patients,0,0
228838,were,0,0
228839,given,0,0
228840,50,0,0
228841,",",0,0
228842,80,0,0
228843,or,0,0
228844,100,0,0
228845,mg,0,0
228846,of,0,0
228847,bicalutamide,0,0
228848,orally,0,0
228849,once,0,0
228850,a,0,0
228851,day,0,0
228852,in,0,0
228853,fixed,0,0
228854,doses,0,0
228855,for,0,0
228856,12,0,0
228857,weeks,0,0
228858,;,0,0
228859,122,0,0
228860,patients,0,0
228861,were,0,0
228862,eligible,0,0
228863,for,0,0
228864,evaluation,0,0
228865,.,0,0
228866,The,0,0
228867,overall,1,1
228868,response,1,1
228869,rate,1,1
228870,was,0,0
228871,50.0,0,0
228872,%,0,0
228873,(,0,0
228874,20/40,0,0
228875,),0,0
228876,",",0,0
228877,61.0,0,0
228878,%,0,0
228879,(,0,0
228880,25/41,0,0
228881,),0,0
228882,and,0,0
228883,53.7,0,0
228884,%,0,0
228885,(,0,0
228886,22/41,0,1
228887,),0,0
228888,in,0,0
228889,the,0,0
228890,50,0,0
228891,mg,0,0
228892,",",0,0
228893,80,0,0
228894,mg,0,0
228895,and,0,0
228896,100,0,0
228897,mg,0,0
228898,groups,0,0
228899,",",0,0
228900,respectively,0,0
228901,.,0,0
228902,The,0,0
228903,response,1,1
228904,rate,1,1
228905,in,1,0
228906,prostate,1,0
228907,lesion,1,1
228908,",",1,1
228909,bone,1,1
228910,and,1,1
228911,lymph,1,1
228912,node,1,1
228913,metastases,1,1
228914,was,0,0
228915,slightly,0,0
228916,higher,0,0
228917,in,0,0
228918,the,0,0
228919,80,0,0
228920,mg,0,0
228921,group,0,0
228922,than,0,0
228923,in,0,0
228924,the,0,0
228925,50,0,0
228926,mg,0,0
228927,and,0,0
228928,100,0,0
228929,mg,0,0
228930,groups,0,0
228931,.,0,0
228932,The,0,0
228933,proportion,1,0
228934,of,1,0
228935,patients,1,0
228936,showing,1,0
228937,a,1,0
228938,response,1,1
228939,with,1,0
228940,regard,1,0
228941,to,1,0
228942,serum,1,1
228943,PSA,1,1
228944,(,1,1
228945,CR,1,1
228946,and,1,1
228947,PR,1,1
228948,),1,0
228949,was,0,0
228950,84.2,0,0
228951,",",0,0
228952,92.7,0,0
228953,and,0,0
228954,97.6,0,0
228955,%,0,0
228956,in,0,0
228957,the,0,0
228958,50,0,0
228959,",",0,0
228960,80,0,0
228961,and,0,0
228962,100,0,0
228963,mg,0,0
228964,groups,0,0
228965,",",0,0
228966,respectively,0,0
228967,.,0,0
228968,The,0,0
228969,incidence,1,1
228970,of,1,0
228971,adverse,1,1
228972,reactions,1,1
228973,was,0,0
228974,65.0,0,0
228975,",",0,0
228976,61.0,0,0
228977,and,0,0
228978,61.0,0,0
228979,%,0,0
228980,in,0,0
228981,the,0,0
228982,50,0,0
228983,",",0,0
228984,80,0,0
228985,and,0,0
228986,100,0,0
228987,mg,0,0
228988,groups,0,0
228989,",",0,0
228990,respectively,0,0
228991,",",0,0
228992,and,0,1
228993,there,0,0
228994,was,0,0
228995,no,1,0
228996,significant,1,0
228997,difference,1,0
228998,in,0,0
228999,overall,1,1
229000,safety,1,1
229001,rating,1,1
229002,in,0,0
229003,the,0,0
229004,three,0,0
229005,groups,0,0
229006,.,0,0
229007,Frequent,1,0
229008,adverse,1,1
229009,reactions,1,1
229010,were,0,0
229011,gynecomastia,1,1
229012,and,1,1
229013,breast,1,0
229014,pain,1,1
229015,.,1,0
229016,Only,0,0
229017,one,0,0
229018,patient,0,0
229019,in,0,0
229020,the,0,0
229021,80,0,0
229022,mg,0,0
229023,group,0,0
229024,was,0,0
229025,withdrawn,1,0
229026,due,1,0
229027,to,1,0
229028,shortness,1,1
229029,of,1,0
229030,breath,1,1
229031,.,1,0
229032,Serum,1,0
229033,concentrations,1,1
229034,of,1,1
229035,LH,1,1
229036,",",1,1
229037,testosterone,1,1
229038,and,1,1
229039,estradiol,1,1
229040,increased,1,1
229041,significantly,1,0
229042,after,0,0
229043,treatment,0,0
229044,.,0,1
229045,Bicalutamide,0,0
229046,was,0,0
229047,concluded,0,0
229048,to,0,0
229049,be,0,0
229050,effective,0,1
229051,and,0,0
229052,well,0,1
229053,tolerated,0,1
229054,in,0,0
229055,patients,0,0
229056,with,0,0
229057,prostatic,0,1
229058,cancer,0,0
229059,",",0,1
229060,and,0,1
229061,its,0,1
229062,recommended,0,0
229063,dose,0,0
229064,was,0,0
229065,80,0,0
229066,mg,0,0
229067,once,0,0
229068,daily,0,0
229069,.,0,0
229070,Comparison,0,0
229071,of,0,1
229072,diclofenac,0,0
229073,sodium,0,0
229074,and,0,1
229075,morphine,0,1
229076,sulphate,0,1
229077,for,0,0
229078,postoperative,1,1
229079,analgesia,1,1
229080,after,0,0
229081,day,0,0
229082,case,0,0
229083,inguinal,0,0
229084,hernia,0,0
229085,surgery,0,0
229086,.,0,1
229087,Postoperative,1,1
229088,pain,1,1
229089,may,0,0
229090,be,0,0
229091,a,0,0
229092,significant,0,0
229093,reason,0,0
229094,for,0,0
229095,delayed,0,1
229096,discharge,0,1
229097,from,0,0
229098,hospital,0,1
229099,",",0,0
229100,increased,0,1
229101,morbidity,0,1
229102,and,0,0
229103,reduced,0,1
229104,patient,0,1
229105,satisfaction,0,1
229106,with,0,0
229107,ambulatory,0,0
229108,hernia,0,0
229109,surgery,0,0
229110,.,0,0
229111,This,0,0
229112,study,0,0
229113,compared,0,0
229114,two,0,0
229115,postoperative,0,0
229116,oral,0,0
229117,analgesic,0,1
229118,protocols,0,0
229119,after,0,0
229120,day,0,0
229121,case,0,0
229122,inguinal,0,0
229123,hernia,0,0
229124,repair,0,0
229125,;,0,0
229126,30,0,0
229127,mg,0,0
229128,morphine,0,0
229129,sulphate,0,1
229130,(,0,1
229131,MST,0,1
229132,),0,0
229133,and,0,0
229134,10,0,0
229135,mg,0,0
229136,metoclopramide,0,0
229137,every,0,0
229138,8,0,0
229139,h,0,0
229140,for,0,0
229141,48,0,0
229142,h,0,0
229143,or,0,0
229144,75,0,0
229145,mg,0,0
229146,diclofenac,0,0
229147,twice,0,0
229148,daily,0,0
229149,for,0,0
229150,48,0,0
229151,h.,0,0
229152,The,0,0
229153,pain,1,1
229154,reported,1,0
229155,in,0,0
229156,the,0,0
229157,MST,0,1
229158,group,0,0
229159,was,0,0
229160,significantly,0,0
229161,greater,0,0
229162,on,0,0
229163,both,0,0
229164,the,0,0
229165,day,0,0
229166,of,0,1
229167,operation,0,0
229168,and,0,0
229169,the,0,0
229170,first,0,1
229171,postoperative,0,1
229172,day,0,1
229173,(,0,0
229174,P,0,0
229175,<,0,0
229176,0.05,0,0
229177,",",0,0
229178,Mann-Whitney,0,0
229179,U,0,1
229180,test,0,1
229181,),0,0
229182,.,0,0
229183,A,0,0
229184,significantly,0,0
229185,higher,0,0
229186,proportion,0,1
229187,of,0,1
229188,patients,0,0
229189,taking,0,0
229190,MST,0,1
229191,complained,0,0
229192,of,0,0
229193,nausea,1,1
229194,on,0,0
229195,the,0,0
229196,day,0,0
229197,of,0,1
229198,operation,0,0
229199,and,0,0
229200,on,0,0
229201,the,0,0
229202,1st,0,0
229203,postoperative,0,1
229204,day,0,0
229205,(,0,0
229206,P,0,0
229207,<,0,0
229208,0.05,0,0
229209,",",0,0
229210,chi,0,0
229211,2,0,0
229212,),0,0
229213,.,0,0
229214,The,0,0
229215,time,1,1
229216,taken,1,0
229217,to,1,0
229218,walk,1,0
229219,",",1,0
229220,dress,1,1
229221,and,1,1
229222,leave,1,1
229223,home,1,0
229224,alone,1,0
229225,were,0,0
229226,achieved,0,0
229227,in,0,0
229228,a,0,0
229229,significantly,0,0
229230,shorter,0,1
229231,duration,0,1
229232,in,0,0
229233,patients,0,0
229234,taking,0,0
229235,diclofenac,0,0
229236,.,0,0
229237,We,0,0
229238,conclude,0,0
229239,that,0,0
229240,diclofenac,0,0
229241,provides,0,0
229242,effective,0,1
229243,analgesia,1,1
229244,",",0,0
229245,has,0,0
229246,a,0,0
229247,more,0,0
229248,acceptable,0,1
229249,side-effect,0,1
229250,profile,0,1
229251,than,0,0
229252,morphine,0,1
229253,sulphate,0,0
229254,and,0,0
229255,is,0,0
229256,the,0,0
229257,treatment,0,0
229258,of,0,0
229259,choice,0,0
229260,after,0,0
229261,ambulatory,0,0
229262,hernia,0,0
229263,surgery,0,0
229264,.,0,0
229265,Pharmacokinetics,1,1
229266,of,0,1
229267,adriamycin,0,0
229268,and,0,0
229269,adriamycin,0,0
229270,--,0,1
229271,DNA,0,1
229272,complex,0,0
229273,in,0,0
229274,L1210,0,0
229275,mice,0,0
229276,and,0,0
229277,men,0,0
229278,.,0,0
229279,Effect,0,1
229280,of,0,1
229281,chronic,0,0
229282,aerobic,0,0
229283,exercise,0,0
229284,and,0,1
229285,progressive,0,1
229286,relaxation,0,1
229287,on,0,0
229288,motor,0,1
229289,performance,0,1
229290,and,0,1
229291,affect,0,1
229292,following,0,0
229293,acute,0,0
229294,stress,0,1
229295,.,0,0
229296,The,0,0
229297,effects,0,0
229298,of,0,0
229299,a,0,0
229300,10-week,0,0
229301,aerobic,0,0
229302,exercise,0,0
229303,and,0,1
229304,progressive,0,1
229305,relaxation,0,1
229306,training,0,0
229307,program,0,0
229308,on,0,0
229309,somatic,0,1
229310,",",0,0
229311,emotional,0,1
229312,",",0,1
229313,and,0,1
229314,behavioral,0,1
229315,responses,0,1
229316,to,0,0
229317,acute,0,0
229318,stress,0,1
229319,",",0,0
229320,as,0,0
229321,determined,0,0
229322,by,0,0
229323,quality,0,1
229324,of,0,1
229325,motor,0,1
229326,performance,0,1
229327,and,0,1
229328,affect,0,1
229329,",",0,1
229330,were,0,0
229331,examined,0,0
229332,.,0,0
229333,The,0,0
229334,participants,0,0
229335,consisted,0,0
229336,of,0,0
229337,60,0,0
229338,unfit,0,0
229339,male,0,0
229340,university,0,0
229341,undergraduate,0,0
229342,students,0,0
229343,with,0,0
229344,no,0,0
229345,previous,0,0
229346,training,0,0
229347,in,0,0
229348,stress,0,1
229349,management,0,0
229350,who,0,0
229351,were,0,0
229352,randomly,0,0
229353,and,0,0
229354,evenly,0,0
229355,assigned,0,0
229356,to,0,0
229357,engage,0,0
229358,in,0,0
229359,one,0,0
229360,of,0,0
229361,four,0,0
229362,treatments,0,0
229363,over,0,0
229364,10,0,0
229365,weeks,0,0
229366,:,0,0
229367,(,0,0
229368,a,0,0
229369,),0,0
229370,moderate,0,0
229371,aerobic,0,0
229372,exercise,0,0
229373,",",0,1
229374,(,0,1
229375,b,0,1
229376,),0,1
229377,progressive,0,1
229378,relaxation,0,1
229379,",",0,1
229380,(,0,1
229381,c,0,1
229382,),0,0
229383,a,0,0
229384,placebo,0,0
229385,group,0,0
229386,that,0,0
229387,engaged,0,0
229388,in,0,0
229389,group,0,0
229390,discussion,0,1
229391,but,0,0
229392,did,0,0
229393,experience,0,1
229394,acute,0,1
229395,stress,0,1
229396,",",0,1
229397,and,0,1
229398,(,0,1
229399,d,0,1
229400,),0,0
229401,a,0,0
229402,nonintervention,0,0
229403,control,0,0
229404,group,0,0
229405,that,0,0
229406,did,0,0
229407,not,0,0
229408,experience,0,0
229409,stress,0,1
229410,while,0,0
229411,performing,0,0
229412,the,0,0
229413,motor,0,1
229414,task,0,1
229415,.,0,1
229416,Acute,0,1
229417,stress,0,1
229418,consisted,0,0
229419,of,0,0
229420,losing,0,0
229421,against,0,0
229422,a,0,0
229423,competitor,0,0
229424,of,0,0
229425,the,0,0
229426,opposite,0,0
229427,sex,0,0
229428,on,0,0
229429,the,0,0
229430,criterion,0,1
229431,motor,0,1
229432,task,0,1
229433,while,0,0
229434,receiving,0,0
229435,unpleasant,0,1
229436,information,0,1
229437,about,0,0
229438,their,0,0
229439,performance,0,1
229440,over,0,0
229441,30,0,0
229442,preintervention,0,0
229443,and,0,0
229444,30,0,0
229445,postintervention,0,0
229446,trials,0,0
229447,.,0,1
229448,Analyses,0,0
229449,indicated,0,0
229450,that,0,0
229451,aerobic,0,0
229452,exercisers,0,0
229453,",",0,0
229454,in,0,0
229455,comparisons,0,0
229456,with,0,0
229457,the,0,0
229458,other,0,0
229459,groups,0,0
229460,",",0,0
229461,responded,0,0
229462,to,0,0
229463,acute,1,0
229464,stress,1,1
229465,with,0,0
229466,more,0,0
229467,positive,0,1
229468,affect,0,1
229469,",",0,1
229470,lower,1,1
229471,stressor,1,1
229472,task,1,1
229473,heart,1,1
229474,rate,1,1
229475,",",1,1
229476,reduced,1,1
229477,systolic,1,1
229478,(,1,0
229479,but,1,0
229480,not,1,0
229481,diastolic,1,1
229482,),1,0
229483,blood,1,1
229484,pressure,1,1
229485,",",0,1
229486,and,0,1
229487,superior,0,1
229488,motor,1,1
229489,performance,1,1
229490,.,1,1
229491,Progressive,0,0
229492,relaxation,0,1
229493,markedly,0,0
229494,reduced,0,0
229495,systolic,1,1
229496,blood,1,1
229497,pressure,1,1
229498,but,0,0
229499,did,0,0
229500,not,0,0
229501,favorably,0,0
229502,influence,0,0
229503,performance,0,1
229504,or,0,0
229505,affect,0,1
229506,in,0,0
229507,response,0,1
229508,to,0,0
229509,acute,1,0
229510,stress,1,1
229511,.,1,1
229512,Placebo,0,0
229513,and,0,1
229514,control,0,0
229515,groups,0,0
229516,were,0,0
229517,statistically,0,0
229518,similar,0,0
229519,on,0,0
229520,all,0,0
229521,measures,0,0
229522,.,0,0
229523,The,0,0
229524,findings,0,0
229525,indicated,0,0
229526,support,0,0
229527,for,0,0
229528,the,0,0
229529,use,0,0
229530,of,0,0
229531,chronic,0,0
229532,aerobic,0,0
229533,exercise,0,0
229534,as,0,0
229535,a,0,0
229536,strategy,0,0
229537,for,0,0
229538,improved,0,1
229539,coping,0,1
229540,with,0,0
229541,acute,0,0
229542,stress,0,1
229543,.,0,0
229544,Risperidone,0,0
229545,in,0,0
229546,the,0,0
229547,treatment,0,0
229548,of,0,0
229549,negative,1,1
229550,symptoms,1,1
229551,of,0,0
229552,schizophrenia,0,0
229553,:,0,0
229554,a,0,0
229555,meta-analysis,0,0
229556,.,0,0
229557,Risperidone,0,0
229558,has,0,0
229559,antiserotonergic,0,1
229560,and,0,0
229561,antidopaminergic,0,1
229562,properties,0,1
229563,that,0,0
229564,may,0,0
229565,make,0,0
229566,it,0,0
229567,more,0,0
229568,effective,0,1
229569,than,0,0
229570,conventional,0,0
229571,antipsychotic,0,0
229572,agents,0,0
229573,in,0,0
229574,the,0,0
229575,treatment,0,0
229576,of,0,0
229577,the,0,0
229578,negative,1,1
229579,symptoms,1,1
229580,of,0,0
229581,schizophrenia,0,0
229582,.,0,0
229583,Clinical,0,1
229584,trials,0,0
229585,in,0,0
229586,chronic,0,0
229587,schizophrenic,0,0
229588,patients,0,0
229589,have,0,0
229590,shown,0,0
229591,trends,0,0
229592,in,0,0
229593,favor,0,0
229594,of,0,1
229595,risperidone,0,0
229596,in,0,0
229597,the,0,0
229598,control,0,0
229599,of,0,0
229600,negative,1,1
229601,symptoms,1,1
229602,compared,0,0
229603,with,0,0
229604,haloperidol,0,0
229605,",",0,1
229606,perphenazine,0,0
229607,or,0,1
229608,zuclopenthixol,0,0
229609,",",0,1
229610,but,0,0
229611,the,0,0
229612,differences,0,0
229613,were,0,0
229614,not,0,0
229615,consistently,0,0
229616,statistically,0,0
229617,significant,0,0
229618,.,0,0
229619,A,0,0
229620,meta-analysis,0,0
229621,of,0,0
229622,the,0,0
229623,pooled,0,0
229624,results,0,0
229625,from,0,0
229626,six,0,0
229627,double-blind,0,0
229628,trials,0,0
229629,showed,0,0
229630,that,0,0
229631,risperidone,0,0
229632,at,0,0
229633,doses,0,0
229634,ranging,0,0
229635,from,0,0
229636,4,0,0
229637,to,0,0
229638,8,0,0
229639,mg/day,0,0
229640,had,0,0
229641,a,0,0
229642,significantly,0,0
229643,(,0,0
229644,p,0,0
229645,<,0,0
229646,0.004,0,0
229647,),0,0
229648,higher,0,0
229649,negative,1,1
229650,symptom,1,1
229651,response,1,1
229652,rate,1,1
229653,",",0,1
229654,defined,0,1
229655,as,0,0
229656,the,0,0
229657,percentage,0,1
229658,of,0,0
229659,patients,0,0
229660,with,0,0
229661,a,0,0
229662,20,0,0
229663,%,0,0
229664,or,0,0
229665,more,1,0
229666,reduction,1,1
229667,in,1,0
229668,scores,1,1
229669,on,1,0
229670,the,1,0
229671,negative,1,1
229672,subscale,1,1
229673,of,1,0
229674,the,1,0
229675,Positive,1,1
229676,and,1,1
229677,Negative,1,1
229678,Syndrome,1,1
229679,Scale,1,1
229680,",",0,0
229681,than,0,0
229682,patients,0,0
229683,receiving,0,0
229684,active,0,0
229685,controls,0,0
229686,.,0,0
229687,The,0,0
229688,combined,0,0
229689,patient,0,1
229690,population,0,0
229691,treated,0,0
229692,with,0,0
229693,4-8,0,0
229694,mg/day,0,0
229695,of,0,1
229696,risperidone,0,0
229697,was,0,0
229698,1.43,0,0
229699,times,0,0
229700,more,0,0
229701,likely,0,0
229702,to,0,0
229703,have,0,0
229704,had,0,0
229705,a,0,0
229706,clinical,1,0
229707,response,1,1
229708,on,1,0
229709,the,1,0
229710,negative,1,1
229711,symptom,1,1
229712,subscale,1,1
229713,than,0,0
229714,the,0,0
229715,combined,0,0
229716,population,0,0
229717,treated,0,0
229718,with,0,0
229719,haloperidol,0,0
229720,",",0,1
229721,perphenazine,0,0
229722,or,0,1
229723,zuclopenthixol,0,0
229724,.,0,0
229725,Measuring,0,0
229726,the,0,0
229727,impact,0,0
229728,of,0,0
229729,patient,0,1
229730,counseling,0,0
229731,in,0,0
229732,the,0,0
229733,outpatient,0,0
229734,pharmacy,0,0
229735,setting,0,0
229736,:,0,0
229737,the,0,0
229738,research,0,0
229739,design,0,0
229740,of,0,0
229741,the,0,0
229742,Kaiser,0,0
229743,Permanente/USC,0,0
229744,patient,0,1
229745,consultation,0,1
229746,study,0,0
229747,.,0,0
229748,This,0,0
229749,article,0,0
229750,describes,0,0
229751,the,0,0
229752,research,0,0
229753,method,0,0
229754,used,0,0
229755,to,0,0
229756,measure,0,0
229757,the,0,0
229758,impact,0,0
229759,of,0,0
229760,three,0,0
229761,alternative,0,0
229762,models,0,0
229763,of,0,1
229764,patient,0,1
229765,counseling,0,0
229766,in,0,0
229767,the,0,0
229768,outpatient,0,0
229769,pharmacy,0,0
229770,setting,0,0
229771,.,0,0
229772,The,0,0
229773,study,0,0
229774,was,0,0
229775,conducted,0,0
229776,in,0,0
229777,pharmacies,0,0
229778,operated,0,0
229779,by,0,0
229780,the,0,0
229781,Southern,0,1
229782,California,0,0
229783,region,0,0
229784,Kaiser,0,0
229785,Permanente,0,0
229786,Medical,0,0
229787,Care,0,0
229788,Program,0,1
229789,.,0,0
229790,Both,0,0
229791,random,0,0
229792,assignment,0,0
229793,and,0,1
229794,large-scale,0,0
229795,geographic,0,1
229796,area,0,1
229797,research,0,0
229798,designs,0,0
229799,were,0,0
229800,used,0,0
229801,.,0,0
229802,The,0,0
229803,presentation,0,0
229804,of,0,0
229805,the,0,0
229806,research,0,0
229807,design,0,0
229808,includes,0,0
229809,discussions,0,0
229810,of,0,0
229811,data,0,0
229812,collection,0,1
229813,and,0,1
229814,patient,0,1
229815,sampling,0,0
229816,methods,0,0
229817,;,0,0
229818,the,0,0
229819,measurement,0,0
229820,of,0,0
229821,patient,1,1
229822,outcomes,1,1
229823,",",0,0
229824,including,0,0
229825,measures,1,1
229826,of,1,1
229827,health,1,1
229828,care,1,0
229829,costs,1,1
229830,and,1,1
229831,utilization,1,1
229832,",",1,1
229833,patient,1,1
229834,functional,1,1
229835,status,1,1
229836,",",1,1
229837,and,1,1
229838,quality,1,1
229839,of,1,1
229840,life,1,1
229841,.,1,0
229842,Demographic,0,1
229843,data,0,0
229844,are,0,0
229845,presented,0,0
229846,for,0,0
229847,the,0,0
229848,study,0,0
229849,population,0,0
229850,",",0,0
229851,including,0,0
229852,an,0,0
229853,analysis,0,0
229854,of,0,0
229855,potential,0,0
229856,biased,0,0
229857,selection,0,1
229858,of,0,0
229859,patients,0,0
229860,electing,0,0
229861,to,0,0
229862,participate,0,0
229863,in,0,0
229864,random,0,0
229865,assignment,0,0
229866,.,0,0
229867,Data,0,0
229868,are,0,0
229869,also,0,0
229870,presented,0,0
229871,documenting,0,0
229872,potential,0,0
229873,selection,0,1
229874,bias,0,1
229875,across,0,0
229876,geographically,0,0
229877,determined,0,0
229878,treatment,0,0
229879,groups,0,0
229880,in,0,0
229881,the,0,0
229882,geographic,0,1
229883,area,0,1
229884,design,0,0
229885,arm,0,0
229886,.,0,0
229887,Finally,0,0
229888,",",0,0
229889,the,0,0
229890,article,0,0
229891,presents,0,0
229892,the,0,0
229893,analysis,0,0
229894,plan,0,0
229895,for,0,0
229896,the,0,0
229897,study,0,0
229898,and,0,0
229899,discusses,0,0
229900,study,0,0
229901,limitations,0,0
229902,.,0,0
229903,Effects,0,0
229904,of,0,0
229905,glucocorticoids,0,0
229906,on,0,0
229907,energy,1,1
229908,metabolism,1,1
229909,and,0,1
229910,food,1,1
229911,intake,1,1
229912,in,0,0
229913,humans,0,0
229914,.,0,0
229915,The,0,0
229916,effect,0,0
229917,of,0,0
229918,glucocorticoid,0,1
229919,administration,0,0
229920,on,0,0
229921,energy,1,1
229922,metabolism,1,1
229923,and,0,1
229924,food,1,1
229925,intake,1,1
229926,was,0,0
229927,studied,0,0
229928,in,0,0
229929,20,0,0
229930,healthy,0,0
229931,",",0,0
229932,nondiabetic,0,0
229933,Caucasian,0,0
229934,male,0,0
229935,volunteers,0,0
229936,[,0,0
229937,27,0,0
229938,+/-,0,0
229939,5,0,0
229940,(,0,0
229941,SD,0,0
229942,),0,1
229943,yr,0,0
229944,",",0,0
229945,72,0,0
229946,+/-,0,0
229947,9,0,0
229948,kg,0,0
229949,",",0,0
229950,20,0,0
229951,+/-,0,0
229952,7,0,0
229953,%,0,0
229954,body,0,1
229955,fat,0,1
229956,],0,0
229957,randomly,0,0
229958,and,0,1
229959,blindly,0,0
229960,assigned,0,0
229961,to,0,0
229962,glucocorticoid,0,1
229963,(,0,0
229964,methylprednisolone,0,0
229965,",",0,0
229966,METH,0,1
229967,;,0,0
229968,n,0,0
229969,=,0,0
229970,10,0,0
229971,),0,0
229972,or,0,0
229973,placebo,0,0
229974,(,0,0
229975,PLAC,0,1
229976,;,0,0
229977,n,0,0
229978,=,0,0
229979,10,0,0
229980,),0,0
229981,treatment,0,0
229982,.,0,0
229983,Each,0,0
229984,subject,0,0
229985,was,0,0
229986,studied,0,0
229987,twice,0,0
229988,:,0,0
229989,during,0,0
229990,a,0,0
229991,weight,0,1
229992,maintenance,0,0
229993,diet,0,0
229994,and,0,1
229995,during,0,0
229996,ad,0,1
229997,libitum,0,0
229998,food,0,0
229999,intake,0,1
230000,.,0,1
230001,Energy,1,1
230002,metabolism,1,1
230003,was,0,0
230004,measured,0,0
230005,by,0,0
230006,indirect,0,0
230007,calorimetry,0,0
230008,and,0,1
230009,food,1,1
230010,intake,1,1
230011,by,0,0
230012,an,0,0
230013,automated,0,0
230014,food-selection,0,0
230015,system,0,0
230016,.,0,1
230017,Twenty-four-hour,0,1
230018,urinary,1,1
230019,norepinephrine,1,1
230020,excretion,1,1
230021,(,0,0
230022,24-h,0,1
230023,NE,0,1
230024,),0,1
230025,was,0,0
230026,used,0,0
230027,as,0,0
230028,an,0,0
230029,estimate,0,0
230030,of,0,0
230031,sympathetic,1,1
230032,nervous,1,1
230033,system,1,0
230034,activity,1,1
230035,.,1,0
230036,During,0,0
230037,weight,0,1
230038,maintenance,0,0
230039,",",0,1
230040,METH,0,1
230041,intravenous,0,0
230042,infusion,0,0
230043,(,0,0
230044,125,0,0
230045,mg/30,0,0
230046,min,0,0
230047,),0,1
230048,increased,0,1
230049,energy,1,1
230050,expenditure,1,1
230051,compared,0,0
230052,with,0,0
230053,PLAC,0,1
230054,",",0,1
230055,and,0,0
230056,after,0,0
230057,4,0,0
230058,days,0,0
230059,of,0,0
230060,oral,0,0
230061,therapy,0,0
230062,",",0,1
230063,METH,0,1
230064,(,0,0
230065,40,0,0
230066,mg/day,0,0
230067,),0,0
230068,decreased,0,1
230069,24-h,1,1
230070,NE,1,1
230071,and,0,1
230072,increased,0,1
230073,energy,1,1
230074,expenditure,1,1
230075,compared,0,0
230076,with,0,0
230077,PLAC,0,0
230078,.,0,0
230079,During,0,0
230080,ad,0,1
230081,libitum,0,0
230082,food,0,1
230083,intake,0,1
230084,",",0,0
230085,after,0,0
230086,4,0,0
230087,days,0,0
230088,of,0,0
230089,METH,0,0
230090,(,0,0
230091,40,0,0
230092,mg/day,0,0
230093,),0,0
230094,or,0,0
230095,PLAC,0,1
230096,oral,0,0
230097,therapy,0,0
230098,",",0,0
230099,both,0,0
230100,groups,0,0
230101,increased,0,0
230102,their,0,0
230103,energy,1,1
230104,intake,1,1
230105,over,0,0
230106,weight,0,1
230107,maintenance,0,0
230108,",",0,0
230109,but,0,0
230110,the,0,0
230111,increase,0,1
230112,was,0,0
230113,significantly,0,0
230114,larger,0,0
230115,in,0,0
230116,the,0,0
230117,METH,0,0
230118,group,0,0
230119,compared,0,0
230120,with,0,0
230121,the,0,0
230122,PLAC,0,1
230123,group,0,0
230124,(,0,0
230125,"4,554",0,0
230126,+/-,0,0
230127,"1,857",0,0
230128,vs.,0,0
230129,"2,867",0,0
230130,+/-,0,0
230131,846,0,0
230132,kcal/day,0,0
230133,;,0,0
230134,P,0,0
230135,=,0,0
230136,0.04,0,0
230137,),0,0
230138,.,0,0
230139,Our,0,0
230140,data,0,0
230141,suggest,0,0
230142,that,0,0
230143,therapeutic,0,0
230144,doses,0,0
230145,of,0,0
230146,glucocorticoids,0,0
230147,induce,0,0
230148,obesity,0,0
230149,mostly,0,0
230150,by,0,0
230151,increasing,0,0
230152,energy,1,1
230153,intake,1,1
230154,",",0,0
230155,an,0,0
230156,effect,0,0
230157,which,0,0
230158,may,0,0
230159,be,0,0
230160,related,0,0
230161,to,0,0
230162,the,0,0
230163,ability,0,1
230164,of,0,0
230165,glucocorticoids,0,0
230166,to,0,0
230167,act,0,0
230168,directly,0,0
230169,or,0,0
230170,indirectly,0,0
230171,on,0,0
230172,the,0,0
230173,central,0,1
230174,regulation,0,1
230175,of,0,0
230176,appetite,0,1
230177,.,0,0
230178,MRI,0,1
230179,signal,0,1
230180,hyperintensities,0,1
230181,in,0,0
230182,geriatric,0,0
230183,depression,0,1
230184,.,0,0
230185,OBJECTIVE,0,0
230186,The,0,0
230187,authors,0,0
230188,rated,0,1
230189,periventricular,0,1
230190,and,0,1
230191,subcortical,0,1
230192,signal,0,1
230193,hyperintensities,0,1
230194,on,0,0
230195,magnetic,0,0
230196,resonance,0,0
230197,imaging,0,1
230198,(,0,1
230199,MRI,0,0
230200,),0,0
230201,scans,0,0
230202,in,0,0
230203,elderly,0,0
230204,patients,0,0
230205,with,0,0
230206,depression,0,1
230207,and,0,1
230208,in,0,0
230209,normal,0,0
230210,subjects,0,0
230211,with,0,0
230212,similar,0,0
230213,demographic,0,0
230214,features,0,0
230215,to,0,0
230216,examine,0,0
230217,whether,0,0
230218,such,0,0
230219,changes,0,1
230220,discriminate,0,0
230221,patients,0,0
230222,with,0,0
230223,depression,0,1
230224,from,0,0
230225,normal,0,0
230226,subjects,0,0
230227,and,0,0
230228,whether,0,0
230229,they,0,0
230230,are,0,0
230231,associated,0,0
230232,with,0,0
230233,any,0,0
230234,clinical,0,0
230235,variables,0,0
230236,.,0,0
230237,METHOD,0,0
230238,Two,0,0
230239,established,0,0
230240,hyperintensity,0,0
230241,rating,0,1
230242,systems,0,0
230243,were,0,0
230244,used,0,0
230245,to,0,0
230246,compare,0,0
230247,the,0,0
230248,MRI,0,1
230249,brain,0,1
230250,scans,0,0
230251,of,0,0
230252,48,0,0
230253,elderly,0,0
230254,patients,0,0
230255,with,0,0
230256,depression,0,1
230257,diagnosed,0,0
230258,according,0,0
230259,to,0,0
230260,DSM-III-R,0,0
230261,with,0,0
230262,the,0,0
230263,scans,0,0
230264,of,0,0
230265,39,0,0
230266,normal,0,0
230267,elderly,0,0
230268,subjects,0,0
230269,.,0,0
230270,RESULTS,0,0
230271,Elderly,0,1
230272,depressed,0,1
230273,patients,0,0
230274,manifested,0,0
230275,significantly,0,0
230276,more,0,0
230277,severe,0,1
230278,hyperintensity,1,1
230279,ratings,1,1
230280,in,0,0
230281,the,0,0
230282,subcortical,0,1
230283,gray,0,1
230284,matter,0,0
230285,than,0,0
230286,age-matched,0,0
230287,comparison,0,0
230288,subjects,0,0
230289,.,0,0
230290,Significant,0,1
230291,differences,0,0
230292,were,0,0
230293,not,0,0
230294,identified,0,0
230295,between,0,0
230296,patients,0,0
230297,with,0,0
230298,similar,0,0
230299,current,0,0
230300,ages,0,0
230301,and,0,1
230302,cerebrovascular,0,1
230303,disease,0,1
230304,risk,0,1
230305,who,0,0
230306,had,0,0
230307,early-onset,0,1
230308,or,0,1
230309,late-onset,0,1
230310,depression,0,1
230311,.,0,0
230312,CONCLUSIONS,0,0
230313,These,0,0
230314,findings,0,0
230315,support,0,0
230316,those,0,0
230317,of,0,0
230318,neuroimaging,0,0
230319,studies,0,0
230320,implicating,0,0
230321,the,0,0
230322,basal,0,1
230323,ganglia,0,1
230324,in,0,0
230325,depression,0,1
230326,and,0,1
230327,geriatric,0,1
230328,depression,0,1
230329,.,0,0
230330,The,0,0
230331,data,0,0
230332,suggest,0,0
230333,that,0,0
230334,the,0,0
230335,relationship,0,1
230336,observed,0,0
230337,in,0,0
230338,some,0,0
230339,reports,0,0
230340,between,0,0
230341,late-onset,0,1
230342,depression,0,1
230343,and,0,1
230344,MRI,0,1
230345,hyperintensities,0,1
230346,is,0,0
230347,most,0,0
230348,likely,0,0
230349,a,0,0
230350,function,0,1
230351,of,0,0
230352,cerebrovascular,0,1
230353,disease,0,1
230354,risk,0,1
230355,and,0,1
230356,age,0,0
230357,.,0,0
230358,Randomized,0,0
230359,controlled,0,0
230360,trial,0,0
230361,of,0,1
230362,acellular,0,1
230363,diphtheria,0,1
230364,",",0,1
230365,pertussis,0,1
230366,and,0,1
230367,tetanus,0,0
230368,vaccines,1,0
230369,in,0,0
230370,southern,0,0
230371,Ghana,0,0
230372,.,0,1
230373,A,0,0
230374,randomized,0,0
230375,controlled,0,0
230376,trial,0,0
230377,of,0,1
230378,acellular,0,1
230379,diphtheria/pertussis/tetanus,0,0
230380,(,0,1
230381,ADPT,0,0
230382,),0,1
230383,freeze-dried,0,0
230384,and,0,1
230385,liquid,0,0
230386,vaccines,0,0
230387,in,0,0
230388,infants,0,0
230389,was,0,0
230390,conducted,0,0
230391,in,0,0
230392,a,0,0
230393,peri-urban,0,1
230394,community,0,0
230395,(,0,1
230396,Ashaiman,0,0
230397,),0,0
230398,in,0,0
230399,southern,0,0
230400,Ghana,0,0
230401,.,0,0
230402,Immunogenicity,1,1
230403,of,0,0
230404,the,0,0
230405,acellular,0,0
230406,vaccines,0,0
230407,",",0,1
230408,persistence,0,1
230409,of,0,1
230410,antibodies,0,1
230411,and,0,1
230412,adverse,0,1
230413,reactions,0,1
230414,were,0,0
230415,compared,0,0
230416,with,0,0
230417,those,0,0
230418,achieved,0,0
230419,with,0,0
230420,a,0,0
230421,whole-cell,0,1
230422,diphtheria-pertussis-tetanus,0,0
230423,(,0,1
230424,DPT,0,1
230425,),0,0
230426,vaccine,0,0
230427,.,0,0
230428,The,0,0
230429,incidence,0,1
230430,of,0,0
230431,pertussis,0,0
230432,in,0,0
230433,the,0,0
230434,vaccine,0,0
230435,groups,0,0
230436,and,0,1
230437,prevalence,0,1
230438,of,0,1
230439,pertussis,0,0
230440,in,0,0
230441,children,0,0
230442,under,0,0
230443,5,0,0
230444,years,0,0
230445,of,0,0
230446,age,0,0
230447,in,0,0
230448,the,0,0
230449,study,0,0
230450,area,0,1
230451,were,0,0
230452,also,0,0
230453,determined,0,0
230454,.,0,0
230455,The,0,0
230456,acellular,0,0
230457,vaccines,0,0
230458,produced,0,0
230459,significantly,0,0
230460,fewer,0,0
230461,local,1,1
230462,and,1,1
230463,systemic,1,1
230464,reactions,1,1
230465,.,1,0
230466,Local,1,0
230467,reactions,1,1
230468,such,0,0
230469,as,0,0
230470,swelling,1,1
230471,and,1,1
230472,redness,1,1
230473,were,0,0
230474,observed,0,0
230475,in,0,0
230476,2,0,0
230477,%,0,0
230478,(,0,0
230479,8/399,0,0
230480,),0,0
230481,to,0,0
230482,2.3,0,0
230483,%,0,0
230484,(,0,0
230485,9/385,0,0
230486,),0,0
230487,of,0,0
230488,the,0,0
230489,acellular,0,0
230490,vaccine,0,0
230491,recipients,0,0
230492,as,0,0
230493,against,0,0
230494,31,0,0
230495,%,0,0
230496,(,0,0
230497,122/394,0,0
230498,),0,0
230499,in,0,0
230500,the,0,0
230501,whole-cell,0,1
230502,vaccine,0,0
230503,group,0,0
230504,.,0,1
230505,Fever,1,1
230506,(,0,0
230507,>,0,0
230508,or,0,0
230509,=,0,0
230510,37.5,0,0
230511,degrees,0,0
230512,C,0,0
230513,),0,0
230514,occurred,0,0
230515,in,0,0
230516,7.27,0,0
230517,%,0,0
230518,(,0,0
230519,29/399,0,0
230520,),0,0
230521,to,0,0
230522,9.8,0,0
230523,%,0,0
230524,(,0,0
230525,38/385,0,0
230526,),0,0
230527,in,0,0
230528,the,0,0
230529,acellular,0,0
230530,vaccine,0,0
230531,groups,0,0
230532,compared,0,0
230533,with,0,0
230534,36.6,0,0
230535,%,0,0
230536,(,0,0
230537,145/394,0,0
230538,),0,0
230539,in,0,0
230540,the,0,0
230541,whole-cell,0,1
230542,vaccine,0,0
230543,group,0,0
230544,.,0,1
230545,Geometric,1,1
230546,mean,1,1
230547,titres,1,1
230548,(,1,0
230549,GMTs,1,1
230550,),1,1
230551,",",0,0
230552,measured,0,1
230553,by,0,0
230554,ELISA,1,0
230555,",",0,0
230556,to,0,0
230557,pertussis,1,0
230558,toxin,1,1
230559,(,1,1
230560,PT,1,1
230561,),1,1
230562,and,1,1
230563,filamentous,1,1
230564,haemagglutinin,1,1
230565,(,1,1
230566,FHA,1,1
230567,),1,1
230568,were,0,0
230569,significantly,0,0
230570,higher,0,0
230571,in,0,0
230572,the,0,0
230573,acellular,0,0
230574,vaccine,0,0
230575,groups,0,0
230576,than,0,0
230577,in,0,0
230578,the,0,0
230579,whole-cell,0,1
230580,DPT,0,1
230581,(,0,1
230582,WCDPT,0,1
230583,),0,0
230584,group,0,0
230585,.,0,0
230586,There,0,0
230587,were,0,0
230588,no,0,0
230589,significant,0,0
230590,differences,0,0
230591,in,0,0
230592,the,0,0
230593,GMTs,1,1
230594,of,1,1
230595,tetanus,1,0
230596,and,1,1
230597,diphtheria,1,1
230598,antitoxins,1,1
230599,between,0,0
230600,the,0,0
230601,two,0,0
230602,groups,0,0
230603,after,0,0
230604,each,0,0
230605,vaccination,0,0
230606,.,0,0
230607,Twelve,0,0
230608,months,0,0
230609,after,0,0
230610,primary,0,0
230611,vaccination,0,0
230612,",",0,0
230613,GMTs,1,1
230614,to,1,0
230615,PT,1,1
230616,in,0,0
230617,the,0,0
230618,freeze-dried,0,0
230619,",",0,0
230620,liquid,0,0
230621,ADPT,0,0
230622,groups,0,0
230623,and,0,0
230624,the,0,0
230625,WCDPT,0,0
230626,group,0,0
230627,have,0,0
230628,fallen,0,0
230629,from,0,0
230630,56.23,0,0
230631,",",0,0
230632,62.63,0,0
230633,and,0,0
230634,44.97,0,0
230635,ELISA,0,0
230636,U/ml,0,0
230637,to,0,0
230638,6.08,0,0
230639,",",0,0
230640,6.18,0,0
230641,and,0,0
230642,11.30,0,0
230643,ELISA,0,1
230644,U/ml,0,0
230645,",",0,0
230646,respectively,0,0
230647,.,0,0
230648,GMTs,1,1
230649,to,1,0
230650,FHA,1,0
230651,in,0,0
230652,all,0,0
230653,the,0,0
230654,vaccine,0,0
230655,groups,0,0
230656,also,0,0
230657,dropped,0,0
230658,during,0,0
230659,the,0,0
230660,same,0,0
230661,period,0,0
230662,from,0,0
230663,49.94,0,0
230664,",",0,0
230665,41.73,0,0
230666,and,0,0
230667,20.74,0,0
230668,ELISA,0,0
230669,U/ml,0,0
230670,to,0,0
230671,7.26,0,0
230672,",",0,0
230673,7.72,0,0
230674,and,0,0
230675,5.91,0,0
230676,ELISA,0,1
230677,U/ml,0,0
230678,",",0,0
230679,respectively,0,0
230680,.,0,0
230681,In,0,0
230682,this,0,0
230683,comparative,0,0
230684,controlled,0,0
230685,trial,0,0
230686,",",0,0
230687,the,0,0
230688,ADPT,0,0
230689,vaccines,0,0
230690,were,0,0
230691,more,0,0
230692,immunogenic,1,1
230693,",",0,1
230694,with,0,0
230695,less,1,0
230696,local,1,1
230697,and,1,1
230698,systemic,1,1
230699,reactions,1,1
230700,",",0,0
230701,than,0,0
230702,the,0,0
230703,WCDPT,0,0
230704,vaccine,0,0
230705,but,0,0
230706,there,0,0
230707,was,0,0
230708,a,0,0
230709,considerable,0,0
230710,drop,0,1
230711,in,0,0
230712,antibody,1,1
230713,titres,1,1
230714,in,0,0
230715,all,0,0
230716,the,0,0
230717,vaccine,0,0
230718,groups,0,0
230719,12,0,0
230720,months,0,0
230721,after,0,0
230722,primary,0,0
230723,vaccination,0,0
230724,.,0,0
230725,However,0,0
230726,",",0,0
230727,the,0,0
230728,levels,0,1
230729,of,0,0
230730,titres,0,1
230731,of,0,1
230732,anti-PT,1,1
230733,and,1,1
230734,anti-FHA,1,1
230735,antibodies,1,1
230736,in,0,0
230737,all,0,0
230738,the,0,0
230739,three,0,0
230740,vaccines,0,0
230741,that,0,0
230742,confer,0,0
230743,protection,0,1
230744,are,0,0
230745,not,0,0
230746,known,0,0
230747,.,0,0
230748,Further,0,0
230749,studies,0,0
230750,are,0,0
230751,necessary,0,0
230752,to,0,0
230753,provide,0,0
230754,this,0,0
230755,information,0,0
230756,in,0,0
230757,order,0,0
230758,to,0,0
230759,assess,0,0
230760,the,0,0
230761,need,0,0
230762,for,0,0
230763,subsequent,0,0
230764,booster,0,0
230765,doses,0,0
230766,after,0,0
230767,primary,0,0
230768,immunization,0,0
230769,with,0,0
230770,both,0,0
230771,ADPT,0,0
230772,and,0,1
230773,WCDPT,0,0
230774,vaccines,0,0
230775,.,0,0
230776,Intraumbilical,0,1
230777,vein,0,1
230778,injection,0,0
230779,of,0,1
230780,prostaglandin,0,1
230781,F2,0,0
230782,alpha,0,1
230783,in,0,0
230784,retained,0,0
230785,placenta,0,1
230786,.,0,0
230787,A,0,0
230788,randomized,0,0
230789,protocol,0,0
230790,was,0,0
230791,used,0,0
230792,to,0,0
230793,study,0,0
230794,the,0,0
230795,effect,0,0
230796,of,0,0
230797,intraumbilical,0,1
230798,prostaglandin,0,1
230799,F2,0,0
230800,alpha,0,1
230801,(,0,1
230802,Hembate,0,1
230803,",",0,1
230804,Upjohn,0,1
230805,),0,1
230806,and,0,1
230807,oxytocin,0,1
230808,injection,0,0
230809,in,0,0
230810,women,0,0
230811,with,0,0
230812,retained,0,0
230813,placenta,0,1
230814,.,0,0
230815,Prostaglandin,0,0
230816,F2,0,0
230817,alpha,0,1
230818,",",0,0
230819,20,0,0
230820,mg,0,0
230821,",",0,0
230822,diluted,0,0
230823,to,0,0
230824,20,0,0
230825,ml,0,0
230826,in,0,0
230827,normal,0,0
230828,saline,0,0
230829,solution,0,0
230830,(,0,0
230831,10,0,0
230832,women,0,0
230833,",",0,0
230834,group,0,0
230835,1,0,0
230836,),0,0
230837,",",0,0
230838,30,0,0
230839,IU,0,0
230840,of,0,0
230841,oxytocin,0,1
230842,",",0,0
230843,diluted,0,0
230844,to,0,0
230845,20,0,0
230846,ml,0,0
230847,in,0,0
230848,normal,0,0
230849,saline,0,0
230850,solution,0,0
230851,(,0,0
230852,11,0,0
230853,women,0,0
230854,",",0,0
230855,group,0,0
230856,2,0,0
230857,),0,0
230858,",",0,0
230859,or,0,0
230860,20,0,0
230861,ml,0,0
230862,of,0,0
230863,normal,0,0
230864,saline,0,0
230865,solution,0,0
230866,alone,0,0
230867,(,0,0
230868,7,0,0
230869,women,0,0
230870,",",0,0
230871,group,0,0
230872,3,0,0
230873,),0,0
230874,",",0,0
230875,were,0,0
230876,injected,0,0
230877,into,0,0
230878,the,0,0
230879,umbilical,0,1
230880,vein,0,0
230881,1,0,0
230882,h,0,0
230883,after,0,0
230884,delivery,0,1
230885,.,0,0
230886,Nine,0,0
230887,women,0,0
230888,(,0,0
230889,group,0,0
230890,4,0,0
230891,",",0,0
230892,controls,0,0
230893,),0,0
230894,underwent,0,0
230895,manual,0,0
230896,removal,0,0
230897,of,0,0
230898,the,0,0
230899,retained,0,0
230900,placenta,0,1
230901,.,0,0
230902,In,0,0
230903,group,0,0
230904,1,0,0
230905,",",0,0
230906,placental,1,1
230907,expulsion,1,1
230908,occurred,0,0
230909,in,0,0
230910,all,0,0
230911,patients,0,0
230912,and,0,0
230913,the,0,0
230914,duration,1,1
230915,of,1,0
230916,the,1,0
230917,placental,1,1
230918,expulsion,1,1
230919,after,1,0
230920,prostaglandin,1,1
230921,F2,1,0
230922,alpha,1,1
230923,injection,1,0
230924,was,0,0
230925,6.8,0,0
230926,+/-,0,0
230927,1.36,0,0
230928,(,0,0
230929,mean,0,1
230930,+/-,0,0
230931,SE,0,0
230932,),0,0
230933,min,0,0
230934,:,0,0
230935,in,0,0
230936,group,0,0
230937,2,0,0
230938,",",0,0
230939,six,0,0
230940,placental,1,1
230941,expulsions,1,1
230942,occurred,0,0
230943,after,0,0
230944,13.3,0,0
230945,+/-,0,0
230946,1.97,0,0
230947,min,0,0
230948,(,0,0
230949,mean,0,1
230950,+/-,0,0
230951,SE,0,0
230952,),0,0
230953,;,0,0
230954,and,0,0
230955,in,0,0
230956,group,0,0
230957,3,0,0
230958,",",0,0
230959,no,0,0
230960,effect,0,1
230961,was,0,0
230962,recorded,0,0
230963,after,0,0
230964,intraumbilical,0,1
230965,saline,0,0
230966,injection,0,0
230967,.,0,0
230968,We,0,0
230969,suggest,0,0
230970,that,0,0
230971,intraumbilical,0,1
230972,vein,0,1
230973,injection,0,0
230974,of,0,1
230975,prostaglandin,0,1
230976,F2,0,0
230977,alpha,0,0
230978,might,0,0
230979,be,0,0
230980,a,0,0
230981,beneficial,0,0
230982,",",0,0
230983,non-surgical,0,0
230984,method,0,0
230985,for,0,0
230986,treating,0,0
230987,retained,0,0
230988,placenta,0,1
230989,.,0,0
230990,Oxytocin,0,0
230991,might,0,0
230992,reduce,0,0
230993,the,0,0
230994,incidence,1,1
230995,of,1,0
230996,manual,1,1
230997,lysis,1,1
230998,of,1,0
230999,the,1,0
231000,placenta,1,1
231001,and,0,0
231002,achieve,0,0
231003,partial,0,1
231004,success,0,1
231005,.,0,0
231006,Ganciclovir,0,1
231007,use,0,0
231008,during,0,0
231009,mild,0,0
231010,renal,1,1
231011,failure,1,1
231012,in,0,0
231013,heart,0,1
231014,transplantation,0,0
231015,.,0,0
231016,Final,0,1
231017,report,0,0
231018,of,0,0
231019,a,0,0
231020,randomized,0,0
231021,controlled,0,0
231022,study,0,0
231023,with,0,0
231024,streptococcal,0,0
231025,preparation,0,0
231026,OK-432,0,0
231027,as,0,0
231028,a,0,0
231029,supplementary,0,0
231030,immunopotentiator,0,1
231031,for,0,0
231032,laryngeal,0,0
231033,cancer,0,0
231034,.,0,0
231035,We,0,0
231036,conducted,0,0
231037,a,0,0
231038,randomized,0,0
231039,controlled,0,0
231040,study,0,0
231041,of,0,0
231042,streptococcal,0,0
231043,preparation,0,0
231044,OK-432,0,0
231045,on,0,0
231046,120,0,0
231047,newly,0,0
231048,identified,0,0
231049,cases,0,0
231050,of,0,0
231051,laryngeal,0,0
231052,squamous,0,0
231053,cell,0,0
231054,carcinoma,0,0
231055,who,0,0
231056,were,0,0
231057,registered,0,0
231058,at,0,0
231059,10,0,0
231060,participating,0,0
231061,institutions,0,0
231062,between,0,0
231063,November,0,0
231064,1984,0,0
231065,and,0,0
231066,October,0,0
231067,1989,0,0
231068,.,0,0
231069,The,0,0
231070,patients,0,0
231071,were,0,0
231072,divided,0,0
231073,into,0,0
231074,two,0,0
231075,groups,0,0
231076,:,0,0
231077,those,0,0
231078,in,0,0
231079,early,0,0
231080,stages,0,1
231081,(,0,0
231082,stage,0,0
231083,I,0,1
231084,or,0,0
231085,II,0,0
231086,),0,1
231087,and,0,0
231088,those,0,0
231089,in,0,0
231090,advanced,0,0
231091,stages,0,1
231092,(,0,0
231093,stage,0,1
231094,III,0,1
231095,or,0,1
231096,IV,0,1
231097,),0,0
231098,;,0,0
231099,these,0,0
231100,groups,0,0
231101,were,0,0
231102,further,0,0
231103,subdivided,0,0
231104,into,0,0
231105,an,0,0
231106,immunotherapy,0,0
231107,group,0,0
231108,(,0,0
231109,receiving,0,0
231110,OK-432,0,0
231111,),0,0
231112,and,0,0
231113,a,0,0
231114,control,0,0
231115,group,0,0
231116,(,0,0
231117,who,0,0
231118,did,0,0
231119,not,0,0
231120,receive,0,0
231121,OK-432,0,0
231122,),0,0
231123,.,0,0
231124,The,0,0
231125,usefulness,0,0
231126,of,0,1
231127,OK-432,0,0
231128,was,0,0
231129,studied,0,0
231130,using,0,0
231131,the,0,0
231132,sealed,0,0
231133,envelope,0,0
231134,method,0,0
231135,.,0,0
231136,The,0,0
231137,basic,0,0
231138,therapy,0,0
231139,for,0,0
231140,all,0,0
231141,cases,0,0
231142,was,0,0
231143,radiotherapy,0,0
231144,and,0,1
231145,",",0,1
231146,when,0,0
231147,required,0,1
231148,",",0,0
231149,surgery,0,0
231150,.,0,1
231151,As,0,0
231152,adjuvant,0,0
231153,therapy,0,0
231154,",",0,0
231155,5Fu,0,0
231156,or,0,0
231157,derivatives,0,1
231158,were,0,0
231159,administered,0,0
231160,to,0,0
231161,all,0,0
231162,cases,0,0
231163,from,0,0
231164,the,0,0
231165,beginning,0,0
231166,of,0,0
231167,the,0,0
231168,treatment,0,0
231169,period,0,0
231170,to,0,0
231171,one,0,0
231172,year,0,0
231173,after,0,0
231174,the,0,0
231175,basic,0,0
231176,therapy,0,0
231177,",",0,0
231178,with,0,0
231179,the,0,0
231180,exception,0,0
231181,of,0,0
231182,cases,0,0
231183,in,0,0
231184,whom,0,0
231185,side,0,1
231186,effects,0,1
231187,were,0,0
231188,serious,0,0
231189,enough,0,0
231190,to,0,0
231191,contraindicate,0,0
231192,use,0,0
231193,of,0,0
231194,the,0,0
231195,drug,0,0
231196,.,0,0
231197,The,0,0
231198,target,0,0
231199,administration,0,0
231200,period,0,0
231201,was,0,0
231202,5,0,0
231203,years,0,0
231204,.,0,0
231205,Of,0,0
231206,the,0,0
231207,initial,0,0
231208,120,0,0
231209,cases,0,0
231210,",",0,0
231211,11,0,0
231212,cases,0,0
231213,were,0,0
231214,disqualified,0,0
231215,(,0,0
231216,3,0,0
231217,cases,0,0
231218,of,0,0
231219,double,0,0
231220,cancer,0,0
231221,and,0,0
231222,8,0,0
231223,of,0,0
231224,incomplete,0,0
231225,primary,0,0
231226,therapy,0,0
231227,),0,0
231228,and,0,0
231229,the,0,0
231230,remaining,0,0
231231,109,0,0
231232,were,0,0
231233,used,0,0
231234,for,0,0
231235,evaluation,0,0
231236,.,0,0
231237,The,0,0
231238,5-year,1,1
231239,survival,1,1
231240,rate,1,1
231241,and,1,0
231242,the,1,0
231243,5-year,1,1
231244,recurrence-free,1,1
231245,rate,1,1
231246,were,0,0
231247,76,0,0
231248,%,0,0
231249,and,0,0
231250,84,0,0
231251,%,0,0
231252,",",0,0
231253,respectively,0,0
231254,",",0,0
231255,in,0,0
231256,the,0,0
231257,immunized,0,0
231258,groups,0,0
231259,(,0,0
231260,both,0,0
231261,the,0,0
231262,early,0,0
231263,and,0,0
231264,advanced,0,0
231265,groups,0,0
231266,),0,0
231267,",",0,0
231268,whereas,0,0
231269,the,0,0
231270,same,0,0
231271,rates,0,1
231272,for,0,0
231273,the,0,0
231274,control,0,0
231275,groups,0,0
231276,were,0,0
231277,78,0,0
231278,%,0,0
231279,and,0,0
231280,75,0,0
231281,%,0,0
231282,.,0,0
231283,There,0,0
231284,was,0,0
231285,a,0,0
231286,tendency,0,0
231287,for,0,0
231288,the,0,0
231289,immunized,0,0
231290,groups,0,0
231291,to,0,0
231292,enjoy,0,0
231293,a,0,0
231294,slightly,1,0
231295,longer,1,0
231296,recurrence-free,1,1
231297,period,1,0
231298,.,1,0
231299,Over,0,0
231300,a,0,0
231301,24-month,0,0
231302,observation,0,0
231303,period,0,0
231304,the,0,0
231305,immunized,0,0
231306,group,0,0
231307,always,0,0
231308,had,0,0
231309,higher,0,0
231310,levels,1,1
231311,of,1,1
231312,peripheral,1,1
231313,leukocytes,1,1
231314,and,1,1
231315,peripheral,1,1
231316,lymphocytes,1,1
231317,;,1,0
231318,this,0,0
231319,difference,0,0
231320,was,0,0
231321,significant,0,0
231322,for,0,0
231323,the,0,0
231324,first,0,0
231325,21,0,0
231326,months,0,0
231327,.,0,0
231328,Inhibition,1,1
231329,of,1,1
231330,bone,1,1
231331,marrow,1,0
231332,function,1,1
231333,is,0,0
231334,sometimes,0,0
231335,observed,0,0
231336,with,0,0
231337,radiotherapy,0,0
231338,.,0,0
231339,It,0,0
231340,is,0,0
231341,hoped,0,0
231342,that,0,0
231343,",",0,0
231344,if,0,0
231345,this,0,0
231346,inhibition,0,0
231347,can,0,0
231348,be,0,0
231349,mitigated,0,0
231350,",",0,0
231351,it,0,0
231352,will,0,0
231353,be,0,0
231354,possible,0,0
231355,to,0,0
231356,assist,0,0
231357,the,0,0
231358,compromised,0,0
231359,immune,0,1
231360,system,0,0
231361,and,0,1
231362,maintain,0,0
231363,a,0,0
231364,certain,1,0
231365,level,1,1
231366,of,1,1
231367,immune,1,1
231368,performance,1,1
231369,which,0,0
231370,will,0,0
231371,prevent,0,0
231372,recurrence,0,1
231373,and,0,1
231374,improve,1,0
231375,survival,1,1
231376,rate,1,1
231377,.,1,0
231378,In,0,0
231379,the,0,0
231380,present,0,0
231381,study,0,0
231382,we,0,0
231383,observed,0,0
231384,a,0,0
231385,tendency,0,0
231386,of,0,0
231387,the,0,0
231388,lower,0,0
231389,recurrence,0,1
231390,rate,0,1
231391,in,0,0
231392,the,0,0
231393,immunized,0,0
231394,group,0,0
231395,",",0,0
231396,and,0,0
231397,we,0,0
231398,hypothesize,0,0
231399,that,0,0
231400,OK-432,0,0
231401,is,0,0
231402,effective,0,1
231403,in,0,0
231404,extending,0,0
231405,the,0,0
231406,recurrence-free,0,1
231407,period,0,0
231408,.,0,0
231409,Effects,0,0
231410,of,0,0
231411,tryptophan,0,1
231412,depletion,0,1
231413,in,0,0
231414,drug-free,0,0
231415,adults,0,0
231416,with,0,0
231417,autistic,0,0
231418,disorder,0,0
231419,.,0,0
231420,BACKGROUND,0,0
231421,The,0,0
231422,primary,0,0
231423,objective,0,0
231424,of,0,0
231425,this,0,0
231426,study,0,0
231427,was,0,0
231428,to,0,0
231429,investigate,0,0
231430,the,0,0
231431,behavioral,0,1
231432,and,0,0
231433,biochemical,0,1
231434,responses,0,1
231435,to,0,0
231436,acute,0,0
231437,tryptophan,0,1
231438,depletion,0,1
231439,in,0,0
231440,drug-free,0,0
231441,adult,0,0
231442,patients,0,0
231443,with,0,0
231444,autistic,0,0
231445,disorder,0,0
231446,.,0,0
231447,METHODS,0,0
231448,Twenty,0,0
231449,drug-free,0,0
231450,adults,0,0
231451,with,0,0
231452,autistic,0,1
231453,disorder,0,0
231454,(,0,0
231455,16,0,0
231456,men,0,0
231457,and,0,0
231458,4,0,0
231459,women,0,0
231460,),0,0
231461,(,0,0
231462,mean,0,1
231463,[,0,0
231464,+/-,0,0
231465,SD,0,1
231466,],0,1
231467,age,0,0
231468,",",0,0
231469,30.5,0,0
231470,+/-,0,0
231471,8.5,0,0
231472,years,0,0
231473,),0,0
231474,underwent,0,0
231475,short-term,0,1
231476,tryptophan,0,1
231477,depletion,0,1
231478,in,0,0
231479,a,0,0
231480,double-blind,0,0
231481,",",0,0
231482,placebo-controlled,0,0
231483,",",0,1
231484,randomized,0,0
231485,crossover,0,0
231486,design,0,0
231487,.,0,1
231488,Patients,0,0
231489,received,0,0
231490,a,0,0
231491,24-hour,0,1
231492,",",0,0
231493,low-tryptophan,0,1
231494,diet,0,0
231495,followed,0,0
231496,the,0,0
231497,next,0,0
231498,morning,0,0
231499,by,0,0
231500,an,0,0
231501,amino,0,0
231502,acid,0,0
231503,drink,0,0
231504,.,0,1
231505,Behavioral,0,1
231506,ratings,0,1
231507,were,0,0
231508,obtained,0,0
231509,on,0,0
231510,the,0,0
231511,morning,0,0
231512,of,0,0
231513,the,0,0
231514,amino,0,0
231515,acid,0,1
231516,drink,0,1
231517,(,0,1
231518,baseline,0,1
231519,),0,0
231520,and,0,0
231521,180,0,0
231522,",",0,0
231523,300,0,0
231524,",",0,0
231525,and,0,0
231526,420,0,0
231527,minutes,0,0
231528,after,0,0
231529,the,0,0
231530,drink,0,0
231531,.,0,0
231532,Plasma,1,1
231533,free,1,1
231534,and,1,1
231535,total,1,1
231536,tryptophan,1,1
231537,levels,1,1
231538,were,0,0
231539,obtained,0,0
231540,at,0,0
231541,baseline,0,0
231542,and,0,0
231543,5,0,0
231544,hours,0,0
231545,after,0,0
231546,the,0,0
231547,drink,0,0
231548,.,0,0
231549,The,0,0
231550,active,0,0
231551,and,0,1
231552,sham,0,0
231553,testing,0,1
231554,sessions,0,0
231555,were,0,0
231556,separated,0,0
231557,by,0,0
231558,7,0,0
231559,days,0,0
231560,.,0,0
231561,RESULTS,0,0
231562,Eleven,0,0
231563,(,0,0
231564,65,0,0
231565,%,0,0
231566,),0,0
231567,of,0,0
231568,the,0,0
231569,17,0,0
231570,patients,0,0
231571,who,0,0
231572,completed,0,0
231573,both,0,0
231574,test,0,1
231575,days,0,0
231576,showed,0,0
231577,a,0,0
231578,significant,0,0
231579,global,0,1
231580,worsening,0,1
231581,of,0,1
231582,behavioral,0,1
231583,symptoms,0,1
231584,with,0,0
231585,short-term,0,1
231586,tryptophan,0,1
231587,depletion,0,1
231588,",",0,1
231589,but,0,0
231590,none,0,0
231591,of,0,0
231592,the,0,0
231593,17,0,0
231594,patients,0,0
231595,showed,0,0
231596,any,0,0
231597,significant,0,0
231598,change,0,1
231599,in,0,0
231600,clinical,0,1
231601,status,0,1
231602,from,0,0
231603,baseline,0,0
231604,after,0,0
231605,sham,0,0
231606,depletion,0,1
231607,(,0,0
231608,P,0,0
231609,=,0,0
231610,.001,0,0
231611,),0,0
231612,.,0,0
231613,Tryptophan,0,1
231614,depletion,0,1
231615,led,0,0
231616,to,0,0
231617,a,0,0
231618,significant,0,0
231619,increase,0,0
231620,in,0,0
231621,behaviors,0,1
231622,such,0,0
231623,as,0,0
231624,whirling,1,1
231625,",",1,1
231626,flapping,1,1
231627,",",1,1
231628,pacing,1,1
231629,",",1,1
231630,banging,1,1
231631,and,1,1
231632,hitting,1,1
231633,self,1,1
231634,",",1,1
231635,rocking,1,1
231636,",",1,1
231637,and,1,1
231638,toe,1,1
231639,walking,1,1
231640,(,0,1
231641,P,0,0
231642,<,0,0
231643,.05,0,0
231644,),0,0
231645,.,0,0
231646,In,0,0
231647,addition,0,0
231648,",",0,1
231649,patients,0,0
231650,were,0,0
231651,significantly,0,0
231652,less,0,0
231653,calm,1,1
231654,and,1,1
231655,happy,1,1
231656,and,1,1
231657,more,1,0
231658,anxious,1,1
231659,.,1,0
231660,No,0,0
231661,significant,0,0
231662,change,0,1
231663,was,0,0
231664,observed,0,0
231665,in,0,0
231666,social,1,1
231667,relatedness,1,1
231668,or,1,1
231669,repetitive,1,1
231670,thoughts,1,1
231671,and,1,1
231672,behavior,1,1
231673,.,1,1
231674,Plasma,1,1
231675,total,1,1
231676,and,1,1
231677,free,1,1
231678,tryptophan,1,1
231679,levels,1,1
231680,were,0,0
231681,reduced,0,0
231682,86,0,0
231683,%,0,0
231684,and,0,0
231685,69,0,0
231686,%,0,0
231687,",",0,0
231688,respectively,0,0
231689,",",0,0
231690,5,0,0
231691,hours,0,0
231692,after,0,0
231693,the,0,0
231694,tryptophan-deficient,0,0
231695,amino,0,0
231696,acid,0,0
231697,drink,0,0
231698,.,0,0
231699,Patients,0,0
231700,who,0,0
231701,had,0,0
231702,a,0,0
231703,significant,0,0
231704,global,0,1
231705,exacerbation,0,1
231706,of,0,1
231707,symptoms,0,1
231708,had,0,0
231709,significantly,0,0
231710,higher,0,0
231711,baseline,1,0
231712,plasma,1,1
231713,total,1,1
231714,tryptophan,1,1
231715,levels,1,1
231716,(,0,0
231717,P,0,0
231718,<,0,0
231719,.001,0,0
231720,),0,1
231721,and,0,1
231722,Autism,1,1
231723,Behavior,1,1
231724,Checklist,1,1
231725,scores,1,1
231726,(,0,0
231727,P,0,0
231728,=,0,0
231729,.005,0,0
231730,),0,0
231731,than,0,0
231732,did,0,0
231733,patients,0,0
231734,who,0,0
231735,showed,0,0
231736,no,0,0
231737,significant,0,0
231738,change,0,1
231739,in,0,0
231740,symptoms,0,1
231741,after,0,0
231742,tryptophan,0,0
231743,depletion,0,0
231744,.,0,0
231745,CONCLUSIONS,0,0
231746,The,0,0
231747,results,0,0
231748,of,0,0
231749,this,0,0
231750,study,0,0
231751,are,0,0
231752,consistent,0,0
231753,with,0,0
231754,previous,0,0
231755,research,0,0
231756,that,0,0
231757,has,0,0
231758,implicated,0,0
231759,a,0,0
231760,dysregulation,0,1
231761,in,0,0
231762,serotonin,0,1
231763,function,0,1
231764,in,0,0
231765,some,0,0
231766,patients,0,0
231767,with,0,0
231768,autism,0,0
231769,.,0,0
231770,These,0,0
231771,data,0,0
231772,suggest,0,0
231773,that,0,0
231774,the,0,0
231775,short-term,0,0
231776,reduction,0,1
231777,of,0,1
231778,serotonin,0,1
231779,precursor,0,0
231780,availability,0,0
231781,may,0,0
231782,exacerbate,0,0
231783,some,0,0
231784,symptoms,1,1
231785,characteristic,1,1
231786,of,1,0
231787,autism,1,0
231788,in,0,0
231789,some,0,0
231790,patients,0,0
231791,.,0,0
231792,Continued,0,0
231793,investigation,0,0
231794,into,0,0
231795,the,0,0
231796,role,0,0
231797,of,0,0
231798,serotonin,0,1
231799,in,0,0
231800,the,0,0
231801,pathogenesis,0,1
231802,and,0,1
231803,treatment,0,0
231804,of,0,1
231805,autistic,0,0
231806,disorder,0,0
231807,is,0,0
231808,warranted,0,0
231809,.,0,0
231810,A,0,0
231811,double-blind,0,0
231812,",",0,0
231813,placebo-controlled,0,0
231814,study,0,0
231815,of,0,1
231816,fluvoxamine,0,0
231817,in,0,0
231818,adults,0,0
231819,with,0,0
231820,autistic,0,0
231821,disorder,0,0
231822,.,0,0
231823,BACKGROUND,0,0
231824,Autistic,0,0
231825,disorder,0,0
231826,is,0,0
231827,characterized,0,0
231828,by,0,0
231829,a,0,0
231830,fundamental,0,0
231831,disturbance,0,1
231832,in,0,0
231833,social,0,1
231834,interaction,0,1
231835,",",0,0
231836,impairments,0,1
231837,in,0,0
231838,communication,0,1
231839,",",0,0
231840,and,0,0
231841,a,0,0
231842,markedly,0,0
231843,restricted,0,0
231844,repertoire,0,1
231845,of,0,1
231846,activities,0,1
231847,and,0,0
231848,interests,0,1
231849,.,0,1
231850,Abnormalities,0,0
231851,in,0,0
231852,the,0,0
231853,serotonin,0,1
231854,neurotransmitter,0,1
231855,system,0,0
231856,have,0,0
231857,been,0,0
231858,identified,0,0
231859,in,0,0
231860,some,0,0
231861,persons,0,0
231862,with,0,0
231863,autism,0,0
231864,.,0,0
231865,No,0,0
231866,consistently,0,0
231867,effective,0,1
231868,and,0,1
231869,safe,0,1
231870,drugs,0,0
231871,have,0,0
231872,been,0,0
231873,developed,0,0
231874,for,0,0
231875,treating,0,0
231876,the,0,0
231877,symptoms,0,1
231878,of,0,0
231879,autism,0,0
231880,.,0,0
231881,METHODS,0,0
231882,Thirty,0,0
231883,adults,0,0
231884,with,0,0
231885,autistic,0,1
231886,disorder,0,0
231887,completed,0,0
231888,a,0,0
231889,12-week,0,0
231890,double-blind,0,0
231891,",",0,1
231892,placebo-controlled,0,0
231893,trial,0,0
231894,of,0,0
231895,the,0,0
231896,potent,0,0
231897,and,0,1
231898,selective,0,1
231899,serotonin,0,1
231900,uptake,0,1
231901,inhibitor,0,0
231902,fluvoxamine,0,0
231903,maleate,0,0
231904,.,0,1
231905,Behavioral,1,1
231906,ratings,1,1
231907,were,0,0
231908,obtained,0,0
231909,at,0,0
231910,baseline,0,0
231911,and,0,0
231912,after,0,0
231913,4,0,0
231914,",",0,0
231915,8,0,0
231916,",",0,0
231917,and,0,0
231918,12,0,0
231919,weeks,0,0
231920,of,0,0
231921,treatment,0,0
231922,.,0,0
231923,RESULTS,0,0
231924,Eight,0,1
231925,(,0,0
231926,53,0,0
231927,%,0,0
231928,),0,0
231929,of,0,0
231930,15,0,0
231931,patients,0,0
231932,in,0,0
231933,the,0,0
231934,fluvoxamine-treated,0,0
231935,group,0,0
231936,were,0,0
231937,categorized,0,0
231938,as,0,0
231939,responders,0,0
231940,compared,0,0
231941,with,0,0
231942,none,0,0
231943,of,0,0
231944,15,0,0
231945,in,0,0
231946,the,0,0
231947,placebo,0,0
231948,group,0,0
231949,(,0,1
231950,P,0,0
231951,=,0,0
231952,.001,0,0
231953,),0,0
231954,.,0,0
231955,Fluvoxamine,0,0
231956,was,0,0
231957,superior,0,0
231958,to,0,0
231959,placebo,0,0
231960,in,0,0
231961,reducing,0,0
231962,repetitive,1,1
231963,thoughts,1,1
231964,and,1,1
231965,behavior,1,1
231966,(,0,1
231967,P,0,0
231968,<,0,0
231969,.001,0,0
231970,),0,1
231971,",",0,0
231972,maladaptive,1,1
231973,behavior,1,1
231974,(,0,0
231975,P,0,0
231976,<,0,0
231977,.001,0,0
231978,),0,1
231979,",",0,1
231980,and,0,1
231981,aggression,1,1
231982,(,0,1
231983,P,0,0
231984,<,0,0
231985,.03,0,0
231986,),0,1
231987,",",0,0
231988,and,0,1
231989,in,0,0
231990,improving,0,0
231991,some,0,0
231992,aspects,0,0
231993,of,0,0
231994,social,1,1
231995,relatedness,1,1
231996,(,0,0
231997,P,0,0
231998,<,0,0
231999,.04,0,0
232000,),0,1
232001,",",0,0
232002,especially,0,0
232003,language,1,1
232004,usage,1,1
232005,(,0,1
232006,P,0,0
232007,<,0,0
232008,.008,0,0
232009,),0,0
232010,.,0,0
232011,Treatment,0,0
232012,response,0,1
232013,was,0,0
232014,not,0,0
232015,correlated,0,0
232016,with,0,0
232017,age,0,0
232018,level,0,1
232019,of,0,1
232020,autistic,0,1
232021,behavior,0,1
232022,",",0,1
232023,or,0,1
232024,full-scale,0,1
232025,IQ,0,1
232026,.,0,0
232027,Other,0,0
232028,than,0,0
232029,mild,1,1
232030,sedation,1,1
232031,and,1,1
232032,nausea,1,1
232033,in,0,0
232034,a,0,0
232035,few,0,0
232036,patients,0,0
232037,",",0,1
232038,fluvoxamine,0,0
232039,was,0,0
232040,well,0,0
232041,tolerated,0,1
232042,.,0,0
232043,No,0,0
232044,dyskinesias,1,1
232045,",",1,0
232046,adverse,1,1
232047,cardiovascular,1,1
232048,events,1,1
232049,",",1,1
232050,or,1,1
232051,seizures,1,1
232052,occurred,0,0
232053,.,0,0
232054,CONCLUSIONS,0,0
232055,Fluvoxamine,0,0
232056,is,0,0
232057,more,0,0
232058,effective,0,1
232059,than,0,0
232060,placebo,0,0
232061,in,0,0
232062,the,0,0
232063,short-term,0,0
232064,treatment,0,0
232065,of,0,0
232066,the,0,0
232067,symptoms,0,1
232068,of,0,0
232069,autistic,0,0
232070,disorder,0,0
232071,in,0,0
232072,adults,0,0
232073,.,0,0
232074,Controlled,0,0
232075,studies,0,0
232076,of,0,1
232077,fluvoxamine,0,0
232078,and,0,1
232079,other,0,1
232080,potent,0,1
232081,and,0,1
232082,selective,0,1
232083,serotonin,0,1
232084,uptake,0,1
232085,inhibitors,0,0
232086,seem,0,0
232087,warranted,0,0
232088,in,0,0
232089,children,0,0
232090,and,0,1
232091,adolescents,0,0
232092,with,0,0
232093,autism,0,0
232094,.,0,0
232095,Ranitidine,0,0
232096,improves,0,1
232097,lymphocyte,0,1
232098,function,0,1
232099,after,0,0
232100,severe,0,1
232101,head,0,0
232102,injury,0,1
232103,:,0,0
232104,results,0,0
232105,of,0,0
232106,a,0,0
232107,randomized,0,0
232108,",",0,0
232109,double-blind,0,0
232110,study,0,0
232111,.,0,0
232112,OBJECTIVE,0,0
232113,To,0,0
232114,study,0,0
232115,the,0,0
232116,immunomodulatory,0,0
232117,effect,0,0
232118,of,0,0
232119,the,0,0
232120,histamine,0,1
232121,receptor,0,1
232122,antagonist,0,0
232123,",",0,1
232124,ranitidine,0,0
232125,",",0,1
232126,in,0,0
232127,patients,0,0
232128,admitted,0,0
232129,to,0,0
232130,the,0,0
232131,intensive,0,0
232132,care,0,0
232133,unit,0,0
232134,after,0,0
232135,severe,0,1
232136,head,0,0
232137,injury,0,1
232138,.,0,1
232139,DESIGN,0,0
232140,Randomized,0,0
232141,",",0,1
232142,prospective,0,0
232143,",",0,1
232144,double-blind,0,0
232145,study,0,0
232146,.,0,0
232147,SETTING,0,0
232148,Surgical,0,1
232149,intensive,0,0
232150,care,0,0
232151,unit,0,0
232152,of,0,0
232153,a,0,0
232154,university,0,0
232155,Level,0,0
232156,I,0,0
232157,trauma,0,0
232158,center,0,0
232159,.,0,0
232160,PATIENTS,0,0
232161,Twenty,0,0
232162,patients,0,0
232163,admitted,0,0
232164,with,0,0
232165,a,0,0
232166,Glasgow,0,1
232167,Coma,0,0
232168,Scale,0,1
232169,score,0,1
232170,of,0,0
232171,<,0,0
232172,10,0,0
232173,who,0,0
232174,were,0,0
232175,enrolled,0,0
232176,as,0,0
232177,part,0,0
232178,of,0,0
232179,a,0,0
232180,prospective,0,0
232181,",",0,0
232182,multicenter,0,0
232183,trial,0,0
232184,to,0,0
232185,assess,0,0
232186,the,0,0
232187,impact,0,0
232188,of,0,0
232189,multiple,0,0
232190,risk,0,1
232191,factors,0,0
232192,and,0,1
232193,ranitidine,0,0
232194,prophylaxis,0,0
232195,on,0,0
232196,the,0,0
232197,development,0,0
232198,of,0,0
232199,stress-related,0,1
232200,upper,0,0
232201,gastrointestinal,0,1
232202,bleeding,0,1
232203,.,0,1
232204,INTERVENTIONS,0,1
232205,Continuous,0,0
232206,infusion,0,0
232207,of,0,1
232208,ranitidine,0,0
232209,at,0,0
232210,6.25,0,0
232211,mg/hr,0,0
232212,(,0,0
232213,n,0,0
232214,=,0,0
232215,9,0,0
232216,),0,0
232217,or,0,0
232218,placebo,0,0
232219,(,0,1
232220,n,0,0
232221,=,0,0
232222,11,0,0
232223,),0,0
232224,for,0,0
232225,a,0,0
232226,maximum,0,0
232227,of,0,0
232228,5,0,0
232229,days,0,0
232230,.,0,0
232231,MEASUREMENTS,0,0
232232,AND,0,0
232233,MAIN,0,1
232234,RESULTS,0,0
232235,Before,0,0
232236,the,0,0
232237,patients,0,0
232238,were,0,0
232239,enrolled,0,0
232240,in,0,0
232241,the,0,0
232242,study,0,0
232243,and,0,1
232244,on,0,0
232245,completion,0,1
232246,of,0,1
232247,treatment,0,0
232248,",",0,1
232249,lymphocyte,1,1
232250,cell-surface,1,1
232251,antigen,1,1
232252,expression,1,1
232253,was,0,0
232254,determined,0,0
232255,by,0,0
232256,flow,0,1
232257,cytometry,0,1
232258,(,0,0
232259,n,0,0
232260,=,0,0
232261,14,0,0
232262,patients,0,0
232263,),0,0
232264,;,0,0
232265,mitogen-stimulated,1,1
232266,interferon-gamma,1,1
232267,and,1,1
232268,interleukin-2,1,1
232269,production,1,1
232270,were,0,0
232271,measured,0,0
232272,by,0,0
232273,enzyme-linked,0,0
232274,immunosorbent,0,0
232275,assay,0,1
232276,(,0,0
232277,n,0,0
232278,=,0,0
232279,19,0,0
232280,patients,0,0
232281,),0,0
232282,.,0,0
232283,Treatment,0,0
232284,with,0,0
232285,ranitidine,0,0
232286,",",0,1
232287,but,0,0
232288,not,0,0
232289,placebo,0,0
232290,",",0,0
232291,was,0,0
232292,associated,0,0
232293,with,0,0
232294,a,0,0
232295,significant,0,0
232296,increase,0,0
232297,in,0,0
232298,CD4+,1,1
232299,lymphocytes,1,1
232300,(,0,0
232301,33,0,0
232302,%,0,0
232303,to,0,0
232304,49,0,0
232305,%,0,0
232306,;,0,0
232307,p,0,0
232308,<,0,0
232309,.05,0,1
232310,),0,0
232311,and,0,0
232312,a,0,0
232313,significant,0,0
232314,decrease,0,1
232315,in,0,0
232316,CD8+,1,1
232317,lymphocytes,1,1
232318,(,0,0
232319,41,0,0
232320,%,0,0
232321,to,0,0
232322,27,0,0
232323,%,0,0
232324,;,0,0
232325,p,0,0
232326,<,0,0
232327,.05,0,0
232328,),0,0
232329,.,0,0
232330,Also,0,0
232331,",",0,0
232332,the,0,0
232333,mitogen-stimulated,1,1
232334,interferon-gamma,1,1
232335,production,1,1
232336,increased,0,0
232337,from,0,0
232338,121,0,0
232339,to,0,0
232340,269,0,0
232341,pg/mL,0,0
232342,(,0,0
232343,p,0,0
232344,<,0,0
232345,.05,0,0
232346,),0,0
232347,in,0,0
232348,patients,0,0
232349,treated,0,0
232350,with,0,0
232351,ranitidine,0,0
232352,",",0,1
232353,but,0,0
232354,not,0,0
232355,in,0,0
232356,patients,0,0
232357,treated,0,0
232358,with,0,0
232359,placebo,0,0
232360,.,0,0
232361,There,0,0
232362,were,0,0
232363,no,0,0
232364,significant,0,0
232365,differences,0,0
232366,in,0,0
232367,interleukin-2,1,1
232368,production,1,1
232369,or,1,0
232370,circulating,1,1
232371,B-cell,1,1
232372,concentrations,1,1
232373,between,0,0
232374,both,0,0
232375,groups,0,0
232376,.,0,0
232377,CONCLUSION,0,0
232378,This,0,0
232379,study,0,0
232380,demonstrates,0,0
232381,an,0,0
232382,immunostimulatory,0,1
232383,effect,0,0
232384,of,0,0
232385,the,0,0
232386,histamine-2-receptor,0,0
232387,antagonist,0,0
232388,",",0,1
232389,ranitidine,0,0
232390,",",0,0
232391,both,0,0
232392,at,0,0
232393,the,0,0
232394,cellular,0,1
232395,and,0,1
232396,mediator,0,1
232397,levels,0,1
232398,in,0,0
232399,patients,0,0
232400,after,0,0
232401,head,0,0
232402,injury,0,1
232403,.,0,0
232404,[,0,0
232405,Therapy,0,0
232406,of,0,1
232407,metastatic,0,0
232408,endocrine,0,0
232409,tumors,0,0
232410,of,0,0
232411,the,0,0
232412,gastrointestinal,0,1
232413,tract,0,0
232414,],0,0
232415,.,0,0
232416,Prevention,0,0
232417,of,0,1
232418,spinal,1,1
232419,anesthesia-induced,1,0
232420,hypotension,1,1
232421,in,0,0
232422,the,0,0
232423,elderly,0,0
232424,:,0,0
232425,comparison,0,0
232426,between,0,0
232427,preanesthetic,0,1
232428,administration,0,0
232429,of,0,1
232430,crystalloids,0,0
232431,",",0,0
232432,colloids,0,0
232433,",",0,1
232434,and,0,0
232435,no,0,0
232436,prehydration,0,0
232437,.,0,0
232438,The,0,0
232439,practice,0,0
232440,of,0,0
232441,routinely,0,0
232442,prehydrating,0,0
232443,patients,0,0
232444,by,0,0
232445,infusing,0,0
232446,a,0,0
232447,crystalloid,0,0
232448,or,0,0
232449,colloid,0,1
232450,solution,0,1
232451,(,0,0
232452,up,0,0
232453,to,0,0
232454,1.0,0,0
232455,L/70,0,0
232456,kg,0,0
232457,),0,0
232458,for,0,0
232459,prevention,0,0
232460,of,0,0
232461,spinal,1,1
232462,anesthesia-induced,1,0
232463,hypotension,1,1
232464,has,0,0
232465,been,0,0
232466,challenged,0,0
232467,recently,0,0
232468,",",0,0
232469,after,0,0
232470,several,0,0
232471,reports,0,0
232472,of,0,0
232473,failure,0,0
232474,to,0,0
232475,demonstrate,0,0
232476,its,0,0
232477,efficacy,0,1
232478,in,0,0
232479,young,0,0
232480,women,0,0
232481,.,0,0
232482,We,0,0
232483,compared,0,0
232484,the,0,0
232485,incidence,1,1
232486,and,1,1
232487,frequency,1,1
232488,of,1,1
232489,hypotension,1,1
232490,and,1,1
232491,vasopressor,1,1
232492,therapy,1,0
232493,after,0,0
232494,spinal,0,1
232495,anesthesia,0,0
232496,and,0,0
232497,no,0,0
232498,prehydration,0,0
232499,with,0,0
232500,crystalloid,0,0
232501,and,0,1
232502,colloid,0,1
232503,prehydration,0,0
232504,in,0,0
232505,elderly,0,0
232506,patients,0,0
232507,.,0,0
232508,Eighty-five,0,0
232509,ASA,0,0
232510,grade,0,1
232511,I,0,0
232512,or,0,0
232513,II,0,0
232514,patients,0,0
232515,(,0,0
232516,aged,0,0
232517,60-89,0,0
232518,yr,0,0
232519,),0,0
232520,for,0,0
232521,elective,0,0
232522,total,0,1
232523,hip,0,1
232524,replacement,0,0
232525,were,0,0
232526,randomized,0,0
232527,to,0,0
232528,receive,0,0
232529,500,0,0
232530,mL,0,0
232531,crystalloid,0,0
232532,solution,0,1
232533,(,0,1
232534,Hartmanns,0,1
232535,",",0,1
232536,n,0,0
232537,=,0,0
232538,29,0,0
232539,),0,0
232540,",",0,0
232541,500,0,0
232542,mL,0,0
232543,colloid,0,0
232544,(,0,1
232545,Haemaccel,0,1
232546,",",0,1
232547,n,0,0
232548,=,0,0
232549,28,0,0
232550,),0,0
232551,",",0,0
232552,or,0,0
232553,no,0,1
232554,prehydration,0,0
232555,(,0,0
232556,n,0,0
232557,=,0,0
232558,28,0,0
232559,),0,0
232560,over,0,0
232561,10,0,0
232562,min,0,0
232563,prior,0,0
232564,to,0,0
232565,spinal,0,1
232566,anesthesia,0,0
232567,.,0,1
232568,Hypotension,1,1
232569,was,0,0
232570,defined,0,0
232571,as,0,0
232572,a,0,0
232573,30,0,0
232574,%,0,0
232575,decrease,0,0
232576,from,0,0
232577,baseline,0,1
232578,systolic,1,1
232579,blood,1,1
232580,pressure,1,1
232581,(,0,1
232582,BP,0,1
232583,),0,1
232584,or,0,0
232585,systolic,0,1
232586,<,0,0
232587,90,0,0
232588,mm,0,0
232589,Hg,0,0
232590,",",0,1
232591,and,0,1
232592,was,0,0
232593,treated,0,0
232594,with,0,0
232595,ephedrine,0,0
232596,3-mg,0,0
232597,boluses,0,0
232598,.,0,0
232599,Although,0,0
232600,absolute,1,1
232601,systolic,1,1
232602,BP,1,1
232603,readings,1,1
232604,were,0,0
232605,significantly,0,0
232606,higher,0,0
232607,in,0,0
232608,the,0,0
232609,colloid,0,0
232610,group,0,0
232611,between,0,0
232612,6,0,0
232613,and,0,0
232614,30,0,0
232615,min,0,0
232616,(,0,0
232617,P,0,0
232618,<,0,0
232619,0.05,0,0
232620,),0,0
232621,",",0,0
232622,the,0,0
232623,incidence,1,1
232624,of,1,1
232625,hypotension,1,1
232626,was,0,0
232627,not,0,0
232628,significantly,0,0
232629,different,0,0
232630,between,0,0
232631,the,0,0
232632,groups,0,0
232633,.,0,0
232634,The,0,0
232635,incidence,1,1
232636,of,1,1
232637,ephedrine,1,0
232638,use,1,1
232639,",",1,1
232640,incidence,1,1
232641,of,1,1
232642,nausea/vomiting,1,1
232643,",",0,1
232644,and,0,1
232645,median,1,1
232646,total,1,1
232647,dose,1,0
232648,of,1,1
232649,ephedrine,1,0
232650,were,0,0
232651,similar,0,0
232652,in,0,0
232653,all,0,0
232654,groups,0,0
232655,.,0,0
232656,We,0,0
232657,conclude,0,0
232658,that,0,0
232659,",",0,0
232660,in,0,0
232661,elderly,0,0
232662,patients,0,0
232663,undergoing,0,0
232664,elective,0,0
232665,procedures,0,0
232666,",",0,0
232667,withholding,0,0
232668,prehydration,0,0
232669,is,0,0
232670,not,0,0
232671,associated,0,0
232672,with,0,0
232673,any,0,0
232674,greater,0,0
232675,degree,0,1
232676,of,0,1
232677,hypotension,1,1
232678,or,0,1
232679,need,1,1
232680,for,1,0
232681,vasopressor,1,1
232682,therapy,1,0
232683,compared,0,0
232684,with,0,0
232685,crystalloid,0,0
232686,or,0,1
232687,colloid,0,1
232688,prehydration,0,0
232689,.,0,0
232690,Dexamethasone,0,0
232691,in,0,0
232692,salbutamol-treated,0,0
232693,inpatients,0,0
232694,with,0,0
232695,acute,0,0
232696,bronchiolitis,0,0
232697,:,0,0
232698,a,0,0
232699,randomized,0,0
232700,",",0,0
232701,controlled,0,0
232702,trial,0,0
232703,.,0,0
232704,OBJECTIVE,0,0
232705,To,0,0
232706,determine,0,0
232707,the,0,0
232708,clinical,1,0
232709,benefit,1,0
232710,of,0,1
232711,oral,0,0
232712,dexamethasone,0,0
232713,in,0,0
232714,children,0,0
232715,admitted,0,0
232716,to,0,0
232717,the,0,0
232718,hospital,0,1
232719,with,0,0
232720,bronchiolitis,0,1
232721,treated,0,0
232722,with,0,0
232723,nebulized,0,0
232724,salbutamol,0,0
232725,.,0,0
232726,METHODS,0,0
232727,Randomized,0,0
232728,",",0,1
232729,double-blind,0,0
232730,",",0,1
232731,placebo-controlled,0,0
232732,trial,0,0
232733,in,0,0
232734,the,0,0
232735,inpatient,0,0
232736,wards,0,0
232737,of,0,0
232738,a,0,0
232739,pediatric,0,0
232740,tertiary,0,0
232741,care,0,0
232742,hospital,0,1
232743,.,0,0
232744,The,0,0
232745,participants,0,0
232746,",",0,0
232747,children,0,0
232748,aged,0,0
232749,6,0,0
232750,weeks,0,0
232751,to,0,0
232752,15,0,0
232753,months,0,0
232754,",",0,0
232755,admitted,0,0
232756,with,0,0
232757,first-time,0,0
232758,wheezing,0,1
232759,",",0,1
232760,were,0,0
232761,eligible,0,0
232762,if,0,0
232763,their,0,0
232764,oxygen,0,1
232765,saturation,0,1
232766,was,0,0
232767,less,0,0
232768,than,0,0
232769,95,0,0
232770,%,0,0
232771,on,0,0
232772,admission,0,1
232773,to,0,0
232774,the,0,0
232775,hospital,0,1
232776,and,0,0
232777,their,0,0
232778,Respiratory,1,1
232779,Distress,1,1
232780,Assessment,1,1
232781,Instrument,1,1
232782,(,1,1
232783,RDAI,1,1
232784,),1,1
232785,score,1,1
232786,was,0,0
232787,greater,0,0
232788,than,0,0
232789,6,0,0
232790,.,0,0
232791,Patients,0,0
232792,were,0,0
232793,excluded,0,0
232794,if,0,0
232795,they,0,0
232796,had,0,0
232797,any,0,0
232798,one,0,0
232799,of,0,0
232800,the,0,0
232801,following,0,0
232802,:,0,0
232803,an,0,0
232804,underlying,0,0
232805,disease,0,0
232806,that,0,0
232807,might,0,0
232808,affect,0,0
232809,cardiopulmonary,0,1
232810,status,0,1
232811,",",0,1
232812,asthma,0,1
232813,",",0,1
232814,recent,0,0
232815,treatment,0,0
232816,with,0,0
232817,steroids,0,0
232818,(,0,0
232819,within,0,0
232820,2,0,0
232821,weeks,0,0
232822,),0,0
232823,",",0,0
232824,or,0,0
232825,any,0,1
232826,history,0,1
232827,of,0,0
232828,adverse,0,1
232829,reaction,0,1
232830,to,0,0
232831,steroids,0,0
232832,.,0,0
232833,Patients,0,0
232834,were,0,0
232835,randomly,0,0
232836,assigned,0,0
232837,to,0,0
232838,receive,0,0
232839,either,0,0
232840,orally,0,0
232841,administered,0,0
232842,dexamethasone,0,0
232843,with,0,0
232844,0.5,0,0
232845,mg/kg,0,0
232846,as,0,0
232847,the,0,0
232848,first,0,1
232849,dose,0,0
232850,and,0,0
232851,0.3,0,0
232852,mg/kg,0,0
232853,for,0,0
232854,the,0,0
232855,next,0,0
232856,2,0,0
232857,mornings,0,0
232858,",",0,0
232859,or,0,0
232860,an,0,0
232861,equal,0,0
232862,volume,0,1
232863,of,0,0
232864,an,0,0
232865,orally,0,0
232866,administered,0,0
232867,placebo,0,0
232868,with,0,0
232869,an,0,0
232870,identical,0,0
232871,appearance,0,1
232872,.,0,0
232873,All,0,0
232874,patients,0,0
232875,received,0,0
232876,nebulized,0,0
232877,salbutamol,0,0
232878,at,0,0
232879,0.15,0,0
232880,mg/kg,0,0
232881,every,0,0
232882,4,0,0
232883,hours,0,0
232884,for,0,0
232885,the,0,0
232886,first,0,0
232887,24,0,0
232888,hours,0,0
232889,.,0,0
232890,The,0,0
232891,primary,0,0
232892,outcome,0,1
232893,measure,0,1
232894,was,0,0
232895,the,0,0
232896,change,0,1
232897,from,0,0
232898,baseline,0,0
232899,in,0,0
232900,the,0,0
232901,RDAI,1,1
232902,score,1,1
232903,at,0,0
232904,24,0,0
232905,hours,0,0
232906,.,0,0
232907,Secondary,0,0
232908,outcome,0,1
232909,measures,0,1
232910,were,0,0
232911,oxygen,1,1
232912,saturation,1,1
232913,",",1,1
232914,respiratory,1,1
232915,rate,1,1
232916,",",1,1
232917,RDAI,1,1
232918,measurement,1,1
232919,twice,1,0
232920,daily,1,0
232921,for,0,0
232922,the,0,0
232923,first,0,0
232924,4,0,0
232925,days,0,0
232926,",",0,0
232927,and,0,0
232928,the,0,0
232929,length,1,1
232930,of,1,0
232931,hospitalization,1,1
232932,.,1,0
232933,RESULTS,0,0
232934,At,0,0
232935,24,0,0
232936,hours,0,0
232937,the,0,0
232938,mean,1,1
232939,change,1,1
232940,(,1,1
232941,SD,1,0
232942,),1,1
232943,from,0,0
232944,baseline,0,0
232945,in,0,0
232946,the,0,0
232947,RDAI,1,1
232948,score,1,1
232949,was,0,0
232950,1.6,0,0
232951,(,0,0
232952,2.3,0,0
232953,),0,0
232954,in,0,0
232955,the,0,0
232956,placebo,0,0
232957,group,0,0
232958,(,0,0
232959,n,0,0
232960,=,0,0
232961,28,0,0
232962,),0,0
232963,and,0,0
232964,1.4,0,0
232965,(,0,0
232966,2.0,0,0
232967,),0,0
232968,in,0,0
232969,the,0,0
232970,dexamethasone,0,0
232971,group,0,0
232972,(,0,0
232973,n,0,0
232974,=,0,0
232975,33,0,0
232976,;,0,0
232977,p,0,0
232978,=,0,0
232979,0.74,0,0
232980,),0,0
232981,.,0,0
232982,There,0,0
232983,were,0,0
232984,no,0,0
232985,significant,0,0
232986,differences,0,0
232987,between,0,0
232988,the,0,0
232989,two,0,0
232990,groups,0,0
232991,in,0,0
232992,change,0,1
232993,in,0,0
232994,oxygen,1,1
232995,saturation,1,1
232996,",",1,1
232997,respiratory,1,1
232998,rate,1,1
232999,",",1,1
233000,and,1,1
233001,RDAI,1,1
233002,score,1,1
233003,at,0,0
233004,any,0,0
233005,assessment,0,0
233006,period,0,0
233007,.,0,0
233008,The,0,0
233009,median,1,1
233010,length,1,1
233011,of,1,1
233012,stay,1,1
233013,(,0,0
233014,95,0,0
233015,%,0,0
233016,confidence,0,0
233017,interval,0,0
233018,),0,0
233019,for,0,0
233020,the,0,0
233021,placebo,0,0
233022,group,0,0
233023,was,0,0
233024,48,0,0
233025,(,0,0
233026,42,0,0
233027,",",0,0
233028,54,0,0
233029,),0,0
233030,hours,0,0
233031,compared,0,0
233032,with,0,0
233033,57,0,0
233034,(,0,0
233035,38,0,0
233036,",",0,0
233037,76,0,0
233038,),0,0
233039,hours,0,0
233040,in,0,0
233041,the,0,0
233042,dexamethasone,0,0
233043,group,0,0
233044,(,0,0
233045,p,0,0
233046,=,0,0
233047,0.19,0,0
233048,),0,0
233049,.,0,0
233050,CONCLUSIONS,0,0
233051,Oral,0,1
233052,dexamethasone,0,0
233053,therapy,0,0
233054,does,0,0
233055,not,0,0
233056,affect,0,0
233057,the,0,0
233058,clinical,1,0
233059,course,1,0
233060,of,0,0
233061,children,0,0
233062,hospitalized,0,0
233063,with,0,0
233064,bronchiolitis,0,1
233065,and,0,0
233066,therefore,0,0
233067,can,0,0
233068,not,0,0
233069,be,0,0
233070,recommended,0,0
233071,in,0,0
233072,this,0,0
233073,clinical,0,0
233074,situation,0,0
233075,.,0,0
233076,Long-term,0,0
233077,follow-up,0,0
233078,of,0,1
233079,cytostatic,0,0
233080,intravesical,0,0
233081,instillation,0,0
233082,in,0,0
233083,patients,0,0
233084,with,0,0
233085,superficial,0,1
233086,bladder,0,1
233087,carcinoma,0,0
233088,.,0,0
233089,Is,0,0
233090,short-term,0,1
233091,",",0,0
233092,intensive,0,0
233093,instillation,0,0
233094,better,0,0
233095,than,0,0
233096,maintenance,0,0
233097,therapy,0,0
233098,?,0,0
233099,OBJECTIVES,0,0
233100,Comparisons,0,0
233101,of,0,0
233102,two,0,0
233103,3-year,0,0
233104,protocols,0,0
233105,",",0,0
233106,one,0,0
233107,20-week,0,0
233108,protocol,0,0
233109,of,0,1
233110,mitomycin,0,0
233111,C,0,1
233112,instillation,0,0
233113,and,0,0
233114,one,0,0
233115,3-year,0,0
233116,protocol,0,0
233117,of,0,1
233118,doxorubicin,0,0
233119,instillation,0,0
233120,for,0,0
233121,the,0,0
233122,prevention,0,0
233123,of,0,0
233124,recurrent,1,1
233125,tumors,1,1
233126,and,0,1
233127,progression,1,1
233128,in,0,0
233129,patients,0,0
233130,whose,0,0
233131,superficial,0,1
233132,bladder,0,1
233133,tumors,0,1
233134,had,0,0
233135,been,0,0
233136,removed,0,0
233137,by,0,0
233138,transurethral,0,0
233139,resection,0,0
233140,.,0,0
233141,METHODS,0,0
233142,A,0,0
233143,prospective,0,0
233144,",",0,0
233145,randomized,0,0
233146,parallel,0,0
233147,group,0,0
233148,multicenter,0,0
233149,trial,0,0
233150,was,0,0
233151,conducted,0,0
233152,.,0,0
233153,419,0,0
233154,patients,0,0
233155,were,0,0
233156,evaluated,0,0
233157,after,0,0
233158,a,0,0
233159,median,0,1
233160,follow-up,0,0
233161,of,0,0
233162,57,0,0
233163,months,0,0
233164,.,0,0
233165,Cox,0,0
233166,proportional,0,1
233167,hazards,0,1
233168,analysis,0,0
233169,was,0,0
233170,performed,0,0
233171,.,0,0
233172,RESULTS,0,0
233173,An,0,0
233174,overall,1,1
233175,recurrence,1,1
233176,rate,1,1
233177,of,0,0
233178,22.7,0,0
233179,%,0,0
233180,and,0,0
233181,an,0,0
233182,overall,1,1
233183,progression,1,1
233184,rate,1,1
233185,of,0,0
233186,9.8,0,0
233187,%,0,0
233188,was,0,0
233189,found,0,0
233190,.,0,0
233191,For,0,0
233192,time,0,1
233193,to,0,0
233194,progression,0,1
233195,a,0,0
233196,significant,0,0
233197,overall,1,1
233198,treatment,1,0
233199,effect,1,1
233200,was,0,0
233201,detected,0,0
233202,dependent,0,0
233203,on,0,0
233204,the,0,0
233205,recurrence,0,1
233206,status,0,1
233207,before,0,0
233208,entry,0,1
233209,into,0,0
233210,the,0,0
233211,study,0,0
233212,(,0,0
233213,p,0,0
233214,=,0,0
233215,0.0059,0,0
233216,),0,0
233217,.,0,0
233218,Pairwise,0,0
233219,comparisons,0,0
233220,showed,0,0
233221,the,0,0
233222,mitomycin,0,0
233223,protocol,0,0
233224,with,0,0
233225,short-term,0,1
233226,intensive,0,0
233227,(,0,0
233228,weekly,0,0
233229,),0,0
233230,combined,0,0
233231,with,0,0
233232,long-term,0,0
233233,maintenance,0,0
233234,instillation,0,0
233235,to,0,0
233236,have,0,0
233237,a,0,0
233238,highly,0,0
233239,beneficial,1,0
233240,effect,1,0
233241,compared,0,0
233242,to,0,0
233243,long-term,0,0
233244,maintenance,0,0
233245,instillation,0,0
233246,only,0,0
233247,especially,0,0
233248,for,0,0
233249,patients,0,0
233250,entering,0,0
233251,the,0,0
233252,study,0,0
233253,with,0,0
233254,recurrent,0,1
233255,tumors,0,0
233256,(,0,0
233257,RR,0,1
233258,=,0,0
233259,0.06,0,0
233260,",",0,0
233261,95,0,0
233262,%,0,0
233263,CI,0,0
233264,:,0,0
233265,[,0,0
233266,0.008,0,0
233267,",",0,0
233268,0.506,0,0
233269,],0,0
233270,.,0,0
233271,CONCLUSION,0,0
233272,These,0,0
233273,results,0,0
233274,show,0,0
233275,that,0,0
233276,intensive,1,0
233277,therapeutic,1,0
233278,instillation,1,0
233279,may,0,0
233280,have,0,0
233281,an,0,0
233282,advantage,0,0
233283,over,0,0
233284,less,0,0
233285,intensive,0,0
233286,",",0,1
233287,prophylactic,0,0
233288,regimens,0,0
233289,.,0,0
233290,Randomised,0,0
233291,trial,0,0
233292,of,0,0
233293,effect,0,1
233294,of,0,1
233295,amiodarone,0,0
233296,on,0,0
233297,mortality,1,1
233298,in,0,0
233299,patients,0,0
233300,with,0,0
233301,left-ventricular,0,1
233302,dysfunction,0,1
233303,after,0,0
233304,recent,0,0
233305,myocardial,0,1
233306,infarction,0,1
233307,:,0,0
233308,EMIAT,0,0
233309,.,0,0
233310,European,0,0
233311,Myocardial,0,1
233312,Infarct,0,1
233313,Amiodarone,0,0
233314,Trial,0,0
233315,Investigators,0,0
233316,.,0,0
233317,BACKGROUND,0,0
233318,Ventricular,0,1
233319,arrhythmias,0,1
233320,are,0,0
233321,a,0,0
233322,major,0,1
233323,cause,0,0
233324,of,0,1
233325,death,0,1
233326,after,0,0
233327,myocardial,0,1
233328,infarction,0,1
233329,",",0,0
233330,especially,0,0
233331,in,0,0
233332,patients,0,0
233333,with,0,0
233334,poor,0,1
233335,left-ventricular,0,1
233336,function,0,1
233337,.,0,0
233338,Previous,0,0
233339,attempts,0,0
233340,to,0,0
233341,identify,0,0
233342,and,0,1
233343,suppress,0,1
233344,arrhythmias,0,1
233345,with,0,0
233346,various,0,0
233347,antiarrhythmic,0,1
233348,drugs,0,0
233349,failed,0,0
233350,to,0,0
233351,reduce,0,0
233352,or,0,0
233353,actually,0,0
233354,increase,0,0
233355,mortality,0,1
233356,.,0,0
233357,Amiodarone,0,0
233358,is,0,0
233359,a,0,0
233360,powerful,0,0
233361,antiarrhythmic,0,1
233362,drug,0,0
233363,with,0,0
233364,several,0,0
233365,potentially,0,0
233366,beneficial,0,0
233367,actions,0,1
233368,",",0,0
233369,and,0,0
233370,has,0,0
233371,shown,0,0
233372,benefit,0,0
233373,in,0,0
233374,several,0,0
233375,small-scale,0,0
233376,studies,0,0
233377,.,0,0
233378,We,0,0
233379,postulated,0,0
233380,that,0,0
233381,this,0,0
233382,drug,0,0
233383,might,0,0
233384,reduce,0,0
233385,mortality,0,1
233386,in,0,0
233387,patients,0,0
233388,at,0,0
233389,high,0,0
233390,risk,0,1
233391,of,0,1
233392,death,0,1
233393,after,0,0
233394,myocardial,0,1
233395,infarction,0,1
233396,because,0,0
233397,of,0,0
233398,impaired,0,1
233399,ventricular,0,1
233400,function,0,1
233401,",",0,1
233402,irrespective,0,0
233403,of,0,0
233404,whether,0,0
233405,they,0,0
233406,had,0,0
233407,ventricular,0,1
233408,arrhythmias,0,1
233409,.,0,0
233410,METHODS,0,0
233411,The,0,0
233412,European,0,0
233413,Myocardial,0,1
233414,Infarct,0,1
233415,Amiodarone,0,1
233416,Trial,0,0
233417,(,0,1
233418,EMIAT,0,1
233419,),0,0
233420,was,0,0
233421,a,0,0
233422,randomised,0,0
233423,double-blind,0,0
233424,placebo-controlled,0,0
233425,trial,0,0
233426,to,0,0
233427,assess,0,0
233428,whether,0,0
233429,amiodarone,0,0
233430,reduced,0,1
233431,all-cause,1,1
233432,mortality,1,1
233433,(,0,0
233434,primary,0,1
233435,endpoint,0,1
233436,),0,1
233437,and,0,1
233438,cardiac,1,1
233439,mortality,1,1
233440,and,1,1
233441,arrhythmic,1,1
233442,death,1,1
233443,(,0,0
233444,secondary,0,1
233445,endpoints,0,1
233446,),0,0
233447,in,0,0
233448,survivors,0,0
233449,of,0,0
233450,myocardial,0,1
233451,infarction,0,1
233452,with,0,0
233453,a,0,0
233454,left-ventricular,0,1
233455,ejection,0,1
233456,fraction,0,1
233457,(,0,1
233458,LVEF,0,1
233459,),0,0
233460,of,0,0
233461,40,0,0
233462,%,0,0
233463,or,0,0
233464,less,0,0
233465,.,0,1
233466,Intention-to-treat,0,1
233467,and,0,1
233468,on-treatment,0,1
233469,analyses,0,0
233470,were,0,0
233471,done,0,0
233472,.,0,0
233473,FINDINGS,0,0
233474,EMIAT,0,0
233475,enrolled,0,0
233476,1486,0,0
233477,patients,0,0
233478,(,0,0
233479,743,0,0
233480,in,0,0
233481,the,0,0
233482,amiodarone,0,0
233483,group,0,0
233484,",",0,0
233485,743,0,0
233486,in,0,0
233487,the,0,0
233488,placebo,0,0
233489,group,0,0
233490,),0,0
233491,.,0,0
233492,Median,0,1
233493,follow-up,0,0
233494,was,0,0
233495,21,0,0
233496,months,0,0
233497,.,0,0
233498,All-cause,1,1
233499,mortality,1,1
233500,(,0,0
233501,103,0,0
233502,deaths,0,0
233503,in,0,0
233504,the,0,0
233505,amiodarone,0,0
233506,group,0,0
233507,",",0,0
233508,102,0,0
233509,in,0,0
233510,the,0,0
233511,placebo,0,0
233512,group,0,0
233513,),0,1
233514,and,0,1
233515,cardiac,1,1
233516,mortality,1,1
233517,did,0,0
233518,not,0,0
233519,differ,0,0
233520,between,0,0
233521,the,0,0
233522,two,0,0
233523,groups,0,0
233524,.,0,0
233525,However,0,0
233526,",",0,0
233527,in,0,0
233528,the,0,0
233529,amiodarone,0,0
233530,group,0,0
233531,",",0,0
233532,there,0,0
233533,was,0,0
233534,a,0,0
233535,35,0,0
233536,%,0,0
233537,risk,1,1
233538,reduction,1,1
233539,(,0,0
233540,95,0,0
233541,%,0,0
233542,CI,0,0
233543,0-58,0,0
233544,",",0,0
233545,p,0,0
233546,=,0,0
233547,0.05,0,0
233548,),0,0
233549,in,0,0
233550,arrhythmic,1,1
233551,deaths,1,1
233552,.,1,0
233553,INTERPRETATION,0,0
233554,Our,0,0
233555,findings,0,0
233556,do,0,0
233557,not,0,0
233558,support,0,0
233559,the,0,0
233560,systematic,0,0
233561,prophylactic,0,0
233562,use,0,0
233563,of,0,1
233564,amiodarone,0,0
233565,in,0,0
233566,all,0,0
233567,patients,0,0
233568,with,0,0
233569,depressed,0,1
233570,left-ventricular,0,1
233571,function,0,1
233572,after,0,0
233573,myocardial,0,1
233574,infarction,0,1
233575,.,0,0
233576,However,0,0
233577,",",0,0
233578,the,0,0
233579,lack,0,0
233580,of,0,1
233581,proarrhythmia,0,1
233582,and,0,0
233583,the,0,0
233584,reduction,0,1
233585,in,0,0
233586,arrhythmic,1,1
233587,death,1,1
233588,support,0,0
233589,the,0,0
233590,use,0,0
233591,of,0,0
233592,amiodarone,0,0
233593,in,0,0
233594,patients,0,0
233595,for,0,0
233596,whom,0,0
233597,antiarrhythmic,0,0
233598,therapy,0,0
233599,is,0,0
233600,indicated,0,0
233601,.,0,0
233602,[,0,0
233603,Initial,0,1
233604,nuclear,0,1
233605,magnetic,0,0
233606,resonance,0,0
233607,tomography,0,0
233608,results,0,0
233609,of,0,0
233610,the,0,0
233611,treatment,0,0
233612,course,0,1
233613,of,0,1
233614,avascular,0,1
233615,femur,0,0
233616,head,0,0
233617,necrosis,0,1
233618,after,0,0
233619,femoral,0,1
233620,core,0,1
233621,decompression,0,0
233622,],0,0
233623,.,0,0
233624,The,0,0
233625,vascular,0,1
233626,femoral,0,1
233627,head,0,0
233628,necrosis,0,0
233629,is,0,0
233630,a,0,0
233631,serious,0,1
233632,illness,0,1
233633,",",0,0
233634,especially,0,0
233635,when,0,0
233636,appearing,0,0
233637,in,0,0
233638,patients,0,0
233639,aged,0,0
233640,30,0,0
233641,to,0,0
233642,50,0,0
233643,years,0,0
233644,.,0,0
233645,Many,0,0
233646,etiologic,0,0
233647,factors,0,0
233648,cause,0,0
233649,a,0,0
233650,femoral,0,1
233651,head,0,0
233652,necrosis,0,1
233653,such,0,1
233654,as,0,0
233655,",",0,0
233656,for,0,0
233657,example,0,0
233658,",",0,0
233659,high-dose,0,0
233660,steroids,0,0
233661,",",0,1
233662,abuse,0,1
233663,of,0,1
233664,alcohol,0,1
233665,",",0,1
233666,defect,0,1
233667,of,0,1
233668,bone,0,1
233669,marrow,0,0
233670,and,0,1
233671,trauma,0,0
233672,of,0,0
233673,the,0,0
233674,hip,0,0
233675,.,0,0
233676,Often,0,0
233677,the,0,0
233678,X-ray,0,0
233679,photograph,0,0
233680,leads,0,0
233681,to,0,0
233682,the,0,0
233683,diagnosis,0,0
233684,in,0,0
233685,the,0,0
233686,second,0,0
233687,stage,0,0
233688,(,0,0
233689,ARCO,0,0
233690,1992,0,0
233691,),0,0
233692,or,0,0
233693,in,0,0
233694,the,0,0
233695,third,0,0
233696,stage,0,0
233697,",",0,0
233698,when,0,0
233699,the,0,0
233700,femoral,0,0
233701,head,0,0
233702,has,0,0
233703,begun,0,0
233704,to,0,0
233705,collapse,0,1
233706,.,0,0
233707,The,0,0
233708,stage,0,0
233709,IIc,0,1
233710,and,0,0
233711,III,0,0
233712,shows,0,0
233713,an,0,0
233714,evident,0,0
233715,enhancement,0,1
233716,in,0,0
233717,contrast,0,0
233718,media,0,0
233719,in,0,0
233720,MRI,0,1
233721,.,0,0
233722,Contrast,0,0
233723,enhancement,0,1
233724,is,0,0
233725,demonstrated,0,0
233726,by,0,0
233727,STIR,0,0
233728,",",0,1
233729,FATSAT,0,1
233730,",",0,1
233731,T1-weighted,0,1
233732,and,0,1
233733,dynamic,0,1
233734,screening,0,0
233735,sequence,0,0
233736,.,0,0
233737,The,0,0
233738,characteristics,0,0
233739,of,0,0
233740,the,0,0
233741,contrast,0,0
233742,media,0,0
233743,enhancement,0,1
233744,argue,0,0
233745,for,0,0
233746,an,0,0
233747,active,0,0
233748,concomitant,0,0
233749,process,0,0
233750,of,0,1
233751,destruction,0,1
233752,and,0,1
233753,regeneration,0,1
233754,.,0,0
233755,This,0,0
233756,stage,0,0
233757,has,0,0
233758,the,0,0
233759,best,0,0
233760,chances,0,0
233761,for,0,0
233762,a,0,0
233763,drug,0,0
233764,or,0,0
233765,a,0,0
233766,surgical,0,0
233767,therapy,0,0
233768,.,0,0
233769,The,0,0
233770,evaluation,0,0
233771,of,0,0
233772,the,0,0
233773,signal,0,1
233774,intensity,0,0
233775,by,0,0
233776,the,0,0
233777,dynamic,1,0
233778,screening,1,0
233779,sequence,1,0
233780,is,0,0
233781,considered,0,0
233782,as,0,0
233783,an,0,0
233784,objective,0,0
233785,contribution,0,0
233786,for,0,0
233787,the,0,0
233788,staging,1,0
233789,of,1,0
233790,the,1,0
233791,femoral,1,1
233792,head,1,0
233793,necrosis,1,1
233794,.,1,0
233795,This,0,0
233796,enables,0,0
233797,one,0,0
233798,to,0,0
233799,differentiate,0,0
233800,between,0,0
233801,the,0,0
233802,curable,1,0
233803,stage,1,0
233804,IIc,1,1
233805,and,0,0
233806,the,0,0
233807,stage,1,0
233808,III,1,1
233809,",",0,0
233810,showing,0,0
233811,the,0,0
233812,beginning,0,0
233813,of,0,0
233814,breakdown,1,1
233815,of,1,0
233816,the,1,0
233817,femoral,1,1
233818,head,1,0
233819,.,1,0
233820,Field,0,1
233821,trials,0,0
233822,of,0,0
233823,a,0,0
233824,vaccine,0,0
233825,against,0,0
233826,bovine,0,0
233827,mastitis,0,1
233828,.,0,0
233829,1,0,0
233830,.,0,0
233831,Evaluation,0,0
233832,in,0,0
233833,heifers,0,0
233834,.,0,0
233835,A,0,0
233836,vaccine,0,0
233837,was,0,0
233838,developed,0,0
233839,against,0,0
233840,bovine,0,0
233841,mastitis,0,1
233842,based,0,0
233843,on,0,0
233844,inactivated,0,0
233845,",",0,0
233846,highly,0,0
233847,encapsulated,0,0
233848,Staphylococcus,0,1
233849,aureus,0,0
233850,cells,0,1
233851,;,0,0
233852,a,0,0
233853,crude,0,1
233854,extract,0,0
233855,of,0,0
233856,Staph,0,1
233857,.,0,0
233858,aureus,0,0
233859,exopolysaccharides,0,1
233860,;,0,1
233861,and,0,1
233862,inactivated,0,0
233863,",",0,1
233864,unencapsulated,0,1
233865,Staph,0,1
233866,",",0,1
233867,aureus,0,1
233868,and,0,1
233869,Streptococcus,0,1
233870,spp,0,1
233871,.,0,0
233872,cells,0,1
233873,.,0,0
233874,This,0,0
233875,vaccine,0,0
233876,was,0,0
233877,tested,0,0
233878,on,0,0
233879,30,0,0
233880,heifers,0,0
233881,during,0,0
233882,a,0,0
233883,7-mo,0,1
233884,period,0,0
233885,.,0,0
233886,The,0,0
233887,30,0,0
233888,heifers,0,0
233889,were,0,0
233890,randomly,0,0
233891,assigned,0,0
233892,to,0,0
233893,three,0,0
233894,groups,0,0
233895,of,0,0
233896,10,0,0
233897,heifers,0,0
233898,each,0,0
233899,.,0,0
233900,The,0,0
233901,prepartum,0,1
233902,group,0,0
233903,received,0,0
233904,two,0,0
233905,injections,0,0
233906,of,0,0
233907,the,0,0
233908,vaccine,0,0
233909,at,0,0
233910,8,0,0
233911,and,0,0
233912,4,0,0
233913,wk,0,0
233914,before,0,0
233915,calving,0,1
233916,",",0,0
233917,and,0,1
233918,the,0,0
233919,postpartum,0,1
233920,group,0,0
233921,received,0,0
233922,two,0,0
233923,injections,0,0
233924,at,0,0
233925,1,0,0
233926,and,0,0
233927,5,0,0
233928,wk,0,0
233929,after,0,0
233930,calving,0,0
233931,.,0,0
233932,The,0,0
233933,control,0,0
233934,group,0,0
233935,received,0,0
233936,two,0,0
233937,injections,0,0
233938,of,0,0
233939,a,0,0
233940,placebo,0,0
233941,at,0,0
233942,8,0,0
233943,and,0,0
233944,4,0,0
233945,wk,0,0
233946,before,0,0
233947,calving,0,0
233948,.,0,0
233949,The,0,0
233950,vaccine,0,0
233951,or,0,0
233952,the,0,0
233953,placebo,0,0
233954,was,0,0
233955,administered,0,0
233956,subcutaneously,0,0
233957,in,0,0
233958,the,0,0
233959,brachiocephalicus,0,1
233960,muscle,0,1
233961,of,0,0
233962,the,0,0
233963,neck,0,0
233964,.,0,0
233965,The,0,0
233966,frequencies,1,1
233967,of,1,0
233968,intramammary,1,0
233969,infections,1,1
233970,caused,1,0
233971,by,1,0
233972,Staph,1,0
233973,.,1,1
233974,aureus,1,1
233975,were,0,0
233976,reduced,0,0
233977,from,0,0
233978,18.8,0,0
233979,%,0,0
233980,for,0,0
233981,heifers,0,0
233982,in,0,0
233983,the,0,0
233984,control,0,0
233985,group,0,0
233986,to,0,0
233987,6.7,0,0
233988,and,0,0
233989,6.0,0,0
233990,%,0,0
233991,for,0,0
233992,heifers,0,0
233993,in,0,0
233994,the,0,0
233995,prepartum,0,1
233996,and,0,1
233997,postpartum,0,1
233998,groups,0,0
233999,",",0,0
234000,respectively,0,0
234001,.,0,0
234002,This,0,0
234003,protective,1,0
234004,effect,1,1
234005,was,0,0
234006,maintained,0,0
234007,for,0,0
234008,at,0,0
234009,least,0,0
234010,6,0,0
234011,mo,0,0
234012,.,0,0
234013,The,0,0
234014,relative,1,1
234015,risk,1,1
234016,of,1,1
234017,mastitis,1,1
234018,caused,1,0
234019,by,1,0
234020,Staph,1,0
234021,.,1,1
234022,aureus,1,0
234023,was,0,0
234024,0.31,0,0
234025,and,0,0
234026,0.28,0,0
234027,for,0,0
234028,heifers,0,0
234029,in,0,0
234030,the,0,0
234031,prepartum,0,1
234032,and,0,1
234033,postpartum,0,1
234034,groups,0,0
234035,",",0,0
234036,respectively,0,0
234037,",",0,0
234038,compared,0,0
234039,with,0,0
234040,that,0,0
234041,for,0,0
234042,heifers,0,0
234043,in,0,0
234044,the,0,0
234045,control,0,0
234046,group,0,0
234047,.,0,0
234048,The,0,0
234049,results,1,0
234050,of,1,0
234051,the,1,0
234052,trial,1,0
234053,indicated,1,0
234054,the,1,0
234055,effectiveness,1,0
234056,of,1,0
234057,the,1,0
234058,vaccine,1,0
234059,in,0,0
234060,decreasing,0,0
234061,the,0,0
234062,incidence,0,1
234063,of,0,0
234064,intrammammary,0,1
234065,infections,0,1
234066,caused,0,0
234067,by,0,0
234068,Staph,0,0
234069,.,0,0
234070,aureus,0,0
234071,.,0,0
234072,A,0,0
234073,slight,0,1
234074,but,0,0
234075,nonsignificant,0,1
234076,increase,0,1
234077,occurred,0,0
234078,in,0,0
234079,fat,1,1
234080,production,1,1
234081,in,0,0
234082,the,0,0
234083,milk,0,0
234084,of,0,0
234085,vaccinated,0,0
234086,cows,0,0
234087,.,0,0
234088,The,0,0
234089,vaccine,0,0
234090,had,0,0
234091,no,0,0
234092,observable,0,0
234093,effect,0,0
234094,on,0,0
234095,somatic,0,1
234096,cell,0,1
234097,count,0,1
234098,or,0,1
234099,streptococcal,0,0
234100,infections,0,1
234101,.,0,0
234102,The,0,0
234103,low-dose,0,0
234104,monoethylglycinexylidide,0,0
234105,test,0,1
234106,:,0,0
234107,assessment,1,0
234108,of,0,1
234109,liver,0,1
234110,function,0,1
234111,with,0,0
234112,fewer,0,1
234113,side,0,1
234114,effects,0,1
234115,.,0,0
234116,The,0,0
234117,hepatic,0,1
234118,metabolism,0,1
234119,of,0,1
234120,lidocaine,0,0
234121,(,0,0
234122,1,0,0
234123,mg/kg,0,0
234124,intravenously,0,0
234125,),0,0
234126,to,0,0
234127,its,0,0
234128,metabolite,0,1
234129,monoethylglycinexylidide,0,1
234130,(,0,1
234131,MEG-X,0,0
234132,),0,0
234133,is,0,0
234134,the,0,0
234135,basis,0,0
234136,of,0,0
234137,the,0,0
234138,standard,0,0
234139,MEG-X,0,0
234140,test,0,0
234141,.,0,0
234142,To,0,0
234143,reduce,0,0
234144,the,0,0
234145,lidocaine-induced,0,1
234146,side,0,1
234147,effects,0,1
234148,",",0,0
234149,we,0,0
234150,evaluated,0,0
234151,the,0,0
234152,MEG-X,0,0
234153,formation,0,1
234154,after,0,0
234155,0.5,0,0
234156,and,0,0
234157,1,0,0
234158,mg/kg,0,0
234159,lidocaine,0,0
234160,intravenously,0,0
234161,in,0,0
234162,subjects,0,0
234163,with,0,0
234164,normal,0,0
234165,(,0,0
234166,n,0,0
234167,=,0,0
234168,5,0,0
234169,),0,0
234170,and,0,0
234171,severely,0,0
234172,impaired,0,1
234173,liver,0,1
234174,function,0,1
234175,(,0,0
234176,n,0,0
234177,=,0,0
234178,7,0,0
234179,),0,0
234180,(,0,0
234181,study,0,0
234182,I,0,0
234183,),0,0
234184,.,0,0
234185,From,0,0
234186,this,0,0
234187,study,0,0
234188,",",0,0
234189,a,0,0
234190,low-dose,0,0
234191,test,0,1
234192,(,0,1
234193,MEG-X,0,0
234194,concentration,0,1
234195,30,0,0
234196,minutes,0,0
234197,after,0,0
234198,50,0,0
234199,mg,0,0
234200,lidocaine,0,0
234201,intravenously,0,0
234202,[,0,0
234203,MEG-X30min,0,1
234204,],0,0
234205,normalized,0,0
234206,to,0,0
234207,standard,0,0
234208,MEG-X,0,0
234209,test,0,1
234210,results,0,0
234211,),0,1
234212,was,0,0
234213,developed,0,0
234214,.,0,0
234215,Sensory,0,0
234216,side,0,1
234217,effects,0,1
234218,from,0,0
234219,this,0,0
234220,low,0,0
234221,dose,0,0
234222,and,0,0
234223,from,0,0
234224,the,0,0
234225,standard,0,0
234226,MEG-X,0,0
234227,test,0,1
234228,were,0,0
234229,compared,0,0
234230,in,0,0
234231,a,0,0
234232,double-blind,0,0
234233,",",0,0
234234,randomized,0,0
234235,",",0,0
234236,cross-over,0,0
234237,study,0,0
234238,(,0,0
234239,study,0,0
234240,II,0,0
234241,),0,0
234242,comprising,0,0
234243,15,0,0
234244,individuals,0,0
234245,with,0,0
234246,normal,0,0
234247,liver,0,1
234248,function,0,1
234249,and,0,0
234250,45,0,0
234251,patients,0,0
234252,with,0,0
234253,cirrhosis,0,0
234254,(,0,0
234255,15,0,0
234256,Child,0,0
234257,A,0,0
234258,",",0,0
234259,15,0,0
234260,Child,0,0
234261,B,0,0
234262,",",0,0
234263,and,0,0
234264,15,0,0
234265,Child,0,0
234266,C,0,0
234267,),0,0
234268,.,0,0
234269,In,0,0
234270,study,0,0
234271,I,0,0
234272,",",0,0
234273,MEG-X,1,0
234274,formation,1,1
234275,rate,1,1
234276,was,0,0
234277,dose-independent,0,0
234278,in,0,0
234279,patients,0,0
234280,with,0,0
234281,severely,0,0
234282,impaired,0,0
234283,liver,0,1
234284,function,0,1
234285,.,0,0
234286,In,0,0
234287,study,0,0
234288,II,0,0
234289,",",0,1
234290,normalized,0,0
234291,MEG-X,0,0
234292,test,0,1
234293,results,0,0
234294,(,0,0
234295,ranging,0,0
234296,from,0,0
234297,<,0,0
234298,or,0,0
234299,=,0,0
234300,4,0,0
234301,to,0,0
234302,120,0,0
234303,microg/L,0,0
234304,),0,0
234305,were,0,0
234306,virtually,0,0
234307,identical,0,0
234308,to,0,0
234309,the,0,0
234310,standard,0,0
234311,test,0,1
234312,results,0,0
234313,(,0,0
234314,mean,0,1
234315,difference,0,0
234316,:,0,0
234317,-1.9,0,0
234318,microg/L,0,0
234319,;,0,0
234320,95,0,0
234321,%,0,0
234322,confidence,0,0
234323,interval,0,0
234324,[,0,0
234325,CI,0,0
234326,],0,0
234327,:,0,0
234328,-5.3,0,0
234329,;,0,0
234330,1.5,0,0
234331,microg/L,0,0
234332,),0,0
234333,.,0,0
234334,Fewer,0,0
234335,individuals,0,0
234336,experienced,0,1
234337,side,1,1
234338,effects,1,1
234339,(,0,0
234340,30,0,0
234341,%,0,0
234342,vs.,0,0
234343,53,0,0
234344,%,0,0
234345,),0,0
234346,with,0,0
234347,the,0,0
234348,low-dose,0,0
234349,test,0,1
234350,(,0,0
234351,P,0,0
234352,=,0,0
234353,.0013,0,0
234354,),0,0
234355,.,0,0
234356,In,0,0
234357,a,0,0
234358,multivariate,0,0
234359,analysis,0,0
234360,",",0,0
234361,the,0,0
234362,Child-Pugh,1,1
234363,score,1,1
234364,was,0,0
234365,inversely,0,0
234366,related,0,0
234367,to,0,0
234368,the,0,0
234369,occurrence,0,1
234370,of,0,0
234371,side,1,1
234372,effects,1,0
234373,.,1,0
234374,The,0,0
234375,low-dose,0,0
234376,MEG-X,0,0
234377,test,0,0
234378,gives,0,0
234379,almost,0,0
234380,identical,0,0
234381,results,0,0
234382,to,0,0
234383,the,0,0
234384,standard,0,0
234385,MEG-X,0,0
234386,test,0,0
234387,and,0,0
234388,is,0,0
234389,associated,0,0
234390,with,0,0
234391,fewer,1,0
234392,side,1,1
234393,effects,1,1
234394,",",0,0
234395,which,0,0
234396,occur,0,0
234397,less,0,0
234398,often,0,0
234399,in,0,0
234400,individuals,0,0
234401,with,0,0
234402,more,0,0
234403,severely,0,0
234404,compromised,0,0
234405,liver,0,0
234406,function,0,1
234407,.,0,0
234408,Treatment,0,0
234409,with,0,0
234410,buspirone,0,0
234411,in,0,0
234412,a,0,0
234413,patient,0,1
234414,with,0,0
234415,autism,0,0
234416,.,0,0
234417,This,0,0
234418,study,0,0
234419,evaluates,0,0
234420,the,0,0
234421,safety,0,1
234422,and,0,1
234423,efficacy,0,1
234424,of,0,1
234425,buspirone,0,0
234426,hydrochloride,0,0
234427,for,0,0
234428,the,0,0
234429,treatment,0,0
234430,of,0,0
234431,a,0,0
234432,patient,0,1
234433,with,0,0
234434,autism,0,0
234435,and,0,1
234436,hyperactivity,0,1
234437,disorder,0,0
234438,and,0,0
234439,determines,0,0
234440,the,0,0
234441,effect,0,0
234442,of,0,0
234443,buspirone,0,0
234444,on,0,0
234445,the,0,0
234446,number,0,1
234447,of,0,0
234448,performance,0,1
234449,tasks,0,1
234450,completed,0,0
234451,by,0,0
234452,the,0,0
234453,patient,0,1
234454,at,0,0
234455,school,0,0
234456,.,0,0
234457,A,0,0
234458,3-week,0,0
234459,",",0,0
234460,double-blind,0,0
234461,",",0,1
234462,placebo-controlled,0,0
234463,crossover,0,0
234464,study,0,0
234465,was,0,0
234466,performed,0,0
234467,in,0,0
234468,a,0,0
234469,private,0,0
234470,physician,0,1
234471,",",0,1
234472,office-based,0,0
234473,practice,0,0
234474,.,0,0
234475,A,0,0
234476,child,0,0
234477,with,0,0
234478,autism,0,0
234479,",",0,1
234480,which,0,0
234481,was,0,0
234482,diagnosed,0,0
234483,by,0,0
234484,Diagnostic,0,0
234485,and,0,1
234486,Statistical,0,1
234487,Manual,0,1
234488,of,0,1
234489,Mental,0,1
234490,Disorders,0,1
234491,",",0,1
234492,Third,0,1
234493,Edition,0,1
234494,",",0,1
234495,Revised,0,1
234496,",",0,0
234497,criteria,0,0
234498,",",0,1
234499,was,0,0
234500,studied,0,0
234501,.,0,0
234502,The,0,0
234503,child,0,1
234504,received,0,0
234505,placebo,0,0
234506,for,0,0
234507,3,0,0
234508,weeks,0,0
234509,and,0,0
234510,buspirone,0,0
234511,for,0,0
234512,3,0,0
234513,weeks,0,0
234514,;,0,0
234515,there,0,0
234516,was,0,0
234517,a,0,0
234518,1-week,0,0
234519,interval,0,0
234520,between,0,0
234521,the,0,0
234522,2,0,0
234523,treatments,0,0
234524,.,0,0
234525,The,0,0
234526,outcome,0,1
234527,was,0,0
234528,measured,0,0
234529,by,0,0
234530,using,0,0
234531,Conners,1,1
234532,abbreviated,1,1
234533,parent,1,1
234534,and,1,1
234535,teacher,1,1
234536,questionnaires,1,1
234537,and,0,1
234538,by,0,0
234539,determining,0,0
234540,the,0,0
234541,number,0,1
234542,of,0,0
234543,daily,0,0
234544,performance,0,1
234545,tasks,0,1
234546,completed,0,0
234547,by,0,0
234548,the,0,0
234549,child,0,0
234550,at,0,0
234551,school,0,0
234552,.,0,0
234553,Statistical,0,0
234554,analysis,0,0
234555,was,0,0
234556,performed,0,0
234557,by,0,0
234558,linear,0,0
234559,models,0,0
234560,and,0,1
234561,standard,0,0
234562,F,0,0
234563,tests,0,1
234564,.,0,1
234565,Buspirone,0,0
234566,was,0,0
234567,found,0,0
234568,to,0,0
234569,be,0,0
234570,safe,1,1
234571,and,1,1
234572,efficacious,1,1
234573,",",1,0
234574,without,1,0
234575,side,1,1
234576,effects,1,1
234577,",",0,0
234578,for,0,0
234579,decreasing,0,1
234580,hyperactivity,1,1
234581,and,0,1
234582,increasing,0,0
234583,completed,1,0
234584,performance,1,0
234585,tasks,1,0
234586,.,1,0
234587,The,0,0
234588,beneficial,0,0
234589,effects,0,1
234590,of,0,0
234591,buspirone,0,0
234592,in,0,0
234593,helping,0,0
234594,this,0,0
234595,patient,0,1
234596,with,0,0
234597,autism,0,0
234598,in,0,0
234599,his,0,1
234600,natural,0,0
234601,daily,0,0
234602,settings,0,0
234603,suggest,0,0
234604,that,0,0
234605,buspirone,0,0
234606,may,0,0
234607,be,0,0
234608,an,0,0
234609,alternative,0,0
234610,to,0,0
234611,neuroleptic,0,0
234612,agents,0,0
234613,in,0,0
234614,the,0,0
234615,medical,0,0
234616,therapy,0,0
234617,of,0,0
234618,autism,0,0
234619,;,0,0
234620,further,0,0
234621,study,0,0
234622,in,0,0
234623,other,0,0
234624,patients,0,0
234625,is,0,0
234626,needed,0,0
234627,.,0,0
234628,Gonadotropin-releasing,0,1
234629,hormone,0,1
234630,agonist,0,0
234631,in,0,0
234632,the,0,0
234633,treatment,0,0
234634,of,0,0
234635,premenstrual,0,0
234636,symptoms,0,1
234637,with,0,0
234638,and,0,0
234639,without,0,0
234640,ongoing,0,0
234641,dysphoria,0,1
234642,:,0,0
234643,a,0,0
234644,controlled,0,0
234645,study,0,0
234646,.,0,0
234647,Gonadotropin-releasing,0,1
234648,hormone,0,1
234649,(,0,1
234650,GnRH,0,1
234651,),0,0
234652,agonists,0,0
234653,have,0,0
234654,been,0,0
234655,shown,0,0
234656,to,0,0
234657,reduce,0,0
234658,symptoms,1,1
234659,of,1,0
234660,premenstrual,1,1
234661,syndrome,1,0
234662,(,1,1
234663,PMS,1,0
234664,),1,0
234665,.,1,0
234666,This,0,0
234667,randomized,0,0
234668,",",0,0
234669,placebo-controlled,0,0
234670,study,0,0
234671,examined,0,0
234672,the,0,0
234673,efficacy,0,1
234674,of,0,0
234675,the,0,0
234676,GnRH,0,0
234677,agonist,0,0
234678,",",0,1
234679,leuprolide,0,0
234680,acetate,0,0
234681,depot,0,0
234682,",",0,0
234683,in,0,0
234684,a,0,0
234685,clearly,0,0
234686,defined,0,0
234687,PMS,0,0
234688,sample,0,0
234689,versus,0,0
234690,women,0,0
234691,with,0,0
234692,premenstrual,0,0
234693,symptoms,0,1
234694,in,0,0
234695,combination,0,0
234696,with,0,0
234697,dysphoric,0,0
234698,symptoms,0,1
234699,throughout,0,0
234700,the,0,0
234701,cycle,0,1
234702,",",0,0
234703,termed,0,0
234704,the,0,0
234705,premenstrual,0,1
234706,exacerbation,0,1
234707,(,0,1
234708,PME,0,1
234709,),0,0
234710,group,0,0
234711,.,0,1
234712,Evaluation,0,1
234713,included,0,0
234714,the,0,0
234715,Structured,1,0
234716,Clinical,1,1
234717,Interview,1,0
234718,for,1,0
234719,DSM-III-R,1,1
234720,",",0,0
234721,administered,0,0
234722,in,0,0
234723,the,0,0
234724,follicular,0,1
234725,phase,0,0
234726,",",0,0
234727,and,0,1
234728,the,0,0
234729,subject,1,0
234730,Penn,1,0
234731,Dally,1,0
234732,Symptoms,1,1
234733,Report,1,0
234734,(,1,1
234735,DSR,1,1
234736,),1,1
234737,maintained,0,0
234738,throughout,0,0
234739,the,0,0
234740,study,0,0
234741,.,0,0
234742,Thirty-three,0,0
234743,eligible,0,0
234744,women,0,0
234745,were,0,0
234746,randomized,0,0
234747,to,0,0
234748,double-blind,0,0
234749,treatment,0,0
234750,and,0,1
234751,administered,0,0
234752,3.75,0,0
234753,mg,0,0
234754,of,0,0
234755,depot,0,0
234756,leuprolide,0,0
234757,or,0,0
234758,a,0,0
234759,placebo,0,0
234760,once,0,0
234761,a,0,0
234762,month,0,0
234763,for,0,0
234764,3,0,0
234765,months,0,0
234766,.,0,0
234767,The,0,0
234768,subjects,0,0
234769,were,0,0
234770,seen,0,0
234771,for,0,0
234772,efficacy,1,1
234773,evaluations,0,0
234774,at,0,0
234775,the,0,0
234776,end,0,0
234777,of,0,0
234778,each,0,0
234779,cycle,0,1
234780,.,0,0
234781,Outcome,0,1
234782,measures,0,1
234783,were,0,0
234784,the,0,0
234785,DSRs,1,0
234786,and,1,0
234787,the,1,0
234788,17-item,1,1
234789,Hamilton,1,1
234790,Depression,1,1
234791,Rating,1,1
234792,Scale,1,1
234793,(,1,1
234794,HAM-D17,1,0
234795,),1,0
234796,.,1,0
234797,The,0,0
234798,PMS,0,0
234799,leuprolide,0,0
234800,subjects,0,0
234801,improved,0,0
234802,significantly,0,0
234803,compared,0,0
234804,with,0,0
234805,the,0,0
234806,PMS,0,0
234807,placebo,0,0
234808,and,0,1
234809,PME,0,1
234810,leuprolide,0,0
234811,groups,0,0
234812,.,0,0
234813,The,0,0
234814,PME,0,1
234815,leuprolide,0,0
234816,group,0,0
234817,",",0,0
234818,who,0,0
234819,had,0,0
234820,dysphoric,1,0
234821,symptoms,1,1
234822,throughout,0,0
234823,the,0,0
234824,cycle,0,1
234825,",",0,0
234826,did,0,0
234827,not,0,0
234828,improve,0,0
234829,.,0,0
234830,Depression,1,1
234831,symptoms,1,1
234832,were,0,0
234833,at,0,0
234834,clinical,0,0
234835,levels,0,1
234836,premenstrually,0,0
234837,in,0,0
234838,the,0,0
234839,PMS,0,0
234840,and,0,1
234841,PME,0,1
234842,groups,0,0
234843,;,0,0
234844,following,0,0
234845,treatment,0,0
234846,they,0,0
234847,remitted,0,0
234848,in,0,0
234849,the,0,0
234850,PMS,0,0
234851,group,0,0
234852,but,0,0
234853,not,0,0
234854,in,0,0
234855,the,0,0
234856,PME,0,0
234857,leuprolide,0,0
234858,subjects,0,0
234859,.,0,1
234860,Efficacy,0,1
234861,did,0,0
234862,not,0,0
234863,occur,0,0
234864,until,0,0
234865,after,0,0
234866,several,0,0
234867,months,0,0
234868,of,0,1
234869,leuprolide,0,0
234870,treatment,0,0
234871,",",0,1
234872,but,0,0
234873,there,0,0
234874,was,0,0
234875,no,0,0
234876,evidence,0,0
234877,that,0,0
234878,PMS,1,0
234879,symptoms,1,1
234880,worsened,0,0
234881,with,0,0
234882,the,0,0
234883,onset,0,1
234884,of,0,0
234885,treatment,0,0
234886,.,0,0
234887,These,0,0
234888,results,0,0
234889,replicate,0,0
234890,the,0,0
234891,findings,0,0
234892,in,0,0
234893,our,0,0
234894,preliminary,0,0
234895,open-label,0,0
234896,study,0,0
234897,.,0,1
234898,Leuprolide,0,0
234899,reduced,0,1
234900,PMS,1,0
234901,symptoms,1,1
234902,to,0,0
234903,minimal,0,1
234904,levels,0,1
234905,where,0,0
234906,symptoms,0,1
234907,were,0,0
234908,limited,0,0
234909,to,0,0
234910,the,0,0
234911,luteal,0,1
234912,phase,0,0
234913,.,0,1
234914,Leuprolide,0,0
234915,was,0,0
234916,not,0,0
234917,effective,0,0
234918,for,0,0
234919,women,0,0
234920,with,0,0
234921,ongoing,0,0
234922,dysphoric,0,0
234923,symptoms,0,1
234924,",",0,0
234925,suggesting,0,0
234926,that,0,0
234927,premenstrual,0,0
234928,depression,0,0
234929,may,0,0
234930,have,0,0
234931,mechanisms,0,0
234932,different,0,0
234933,from,0,0
234934,those,0,0
234935,of,0,0
234936,other,0,0
234937,dysphoric,0,0
234938,mood,0,1
234939,disorders,0,0
234940,.,0,0
234941,Safety,1,1
234942,of,0,1
234943,nifedipine,0,0
234944,in,0,0
234945,patients,0,0
234946,with,0,0
234947,hypertension,0,0
234948,:,0,0
234949,a,0,0
234950,meta-analysis,0,0
234951,.,0,0
234952,Our,0,0
234953,objective,0,0
234954,was,0,0
234955,to,0,0
234956,compare,0,0
234957,cardiovascular,1,1
234958,event,1,1
234959,rates,1,1
234960,in,0,0
234961,patients,0,0
234962,with,0,0
234963,mild,0,0
234964,or,0,0
234965,moderate,0,0
234966,hypertension,0,1
234967,who,0,0
234968,received,0,0
234969,nifedipine,0,0
234970,with,0,0
234971,active,0,0
234972,drug,0,0
234973,controls,0,0
234974,.,0,0
234975,We,0,0
234976,performed,0,0
234977,a,0,0
234978,MEDLARS,0,0
234979,search,0,0
234980,using,0,0
234981,the,0,0
234982,MeSH,0,0
234983,heading,0,1
234984,hypertension,0,1
234985,and,0,0
234986,the,0,0
234987,text,0,0
234988,word,0,1
234989,nifedipine,0,0
234990,to,0,0
234991,identify,0,0
234992,all,0,0
234993,articles,0,0
234994,that,0,0
234995,were,0,0
234996,published,0,0
234997,between,0,0
234998,1966,0,0
234999,and,0,0
235000,August,0,0
235001,1995,0,0
235002,in,0,0
235003,English,0,0
235004,",",0,1
235005,French,0,0
235006,",",0,1
235007,German,0,1
235008,",",0,1
235009,Italian,0,1
235010,",",0,1
235011,and,0,1
235012,Spanish,0,1
235013,languages,0,1
235014,and,0,0
235015,that,0,0
235016,involved,0,0
235017,human,0,0
235018,subjects,0,0
235019,.,0,0
235020,The,0,0
235021,computerized,0,0
235022,search,0,0
235023,was,0,0
235024,supplemented,0,0
235025,by,0,0
235026,a,0,0
235027,manual,0,0
235028,search,0,0
235029,of,0,1
235030,article,0,0
235031,bibliographies,0,0
235032,.,0,0
235033,Review,0,0
235034,of,0,0
235035,1880,0,0
235036,citations,0,0
235037,revealed,0,0
235038,98,0,0
235039,randomized,0,0
235040,controlled,0,0
235041,clinical,0,0
235042,trials,0,0
235043,that,0,0
235044,met,0,0
235045,protocol,0,0
235046,criteria,0,0
235047,.,0,1
235048,Articles,0,0
235049,were,0,0
235050,extracted,0,0
235051,independently,0,0
235052,by,0,0
235053,two,0,0
235054,doctors,0,0
235055,who,0,0
235056,were,0,0
235057,blinded,0,0
235058,for,0,0
235059,author,0,0
235060,",",0,1
235061,institution,0,0
235062,",",0,1
235063,and,0,1
235064,treatment,0,0
235065,regimen,0,0
235066,",",0,0
235067,using,0,0
235068,a,0,0
235069,structured,0,0
235070,",",0,0
235071,pretested,0,0
235072,extraction,0,0
235073,form,0,0
235074,.,0,0
235075,Differences,0,1
235076,of,0,1
235077,opinion,0,0
235078,were,0,0
235079,resolved,0,0
235080,by,0,0
235081,consensus,0,0
235082,.,0,0
235083,Fourteen,0,0
235084,events,0,1
235085,occurred,0,0
235086,in,0,0
235087,5198,0,0
235088,exposures,0,0
235089,(,0,0
235090,0.27,0,0
235091,%,0,0
235092,),0,0
235093,to,0,0
235094,nifedipine,0,0
235095,and,0,0
235096,24,0,0
235097,events,0,1
235098,in,0,0
235099,5402,0,0
235100,exposures,0,0
235101,(,0,0
235102,0.44,0,0
235103,%,0,0
235104,),0,0
235105,to,0,0
235106,other,0,0
235107,active,0,0
235108,drug,0,0
235109,controls,0,0
235110,.,0,0
235111,Unadjusted,1,0
235112,odds,1,0
235113,ratios,1,1
235114,for,0,0
235115,nifedipine,0,0
235116,versus,0,0
235117,controls,0,0
235118,were,0,0
235119,0.49,0,0
235120,(,0,0
235121,95,0,0
235122,%,0,0
235123,confidence,0,0
235124,interval,0,0
235125,[,0,0
235126,CI,0,0
235127,],0,0
235128,",",0,1
235129,0.22-1.09,0,0
235130,),0,1
235131,for,0,0
235132,definitive,1,0
235133,events,1,1
235134,(,1,1
235135,death,1,1
235136,",",1,1
235137,nonfatal,1,1
235138,myocardial,1,1
235139,infarction,1,1
235140,or,1,1
235141,stroke,1,1
235142,",",1,1
235143,revascularization,1,1
235144,procedure,1,0
235145,),1,0
235146,and,0,0
235147,0.61,0,0
235148,(,0,0
235149,95,0,0
235150,%,0,0
235151,CI,0,0
235152,",",0,1
235153,0.31-1.17,0,0
235154,),0,0
235155,for,0,0
235156,all,1,0
235157,events,1,1
235158,(,1,0
235159,definitive,1,0
235160,plus,1,0
235161,increased,1,0
235162,angina,1,0
235163,),1,0
235164,.,1,0
235165,The,0,0
235166,odds,1,0
235167,ratio,1,1
235168,for,1,0
235169,nifedipine,1,0
235170,monotherapy,1,0
235171,(,0,1
235172,sustained-,0,1
235173,or,0,1
235174,extended-release,0,0
235175,in,0,0
235176,91,0,0
235177,%,0,0
235178,of,0,0
235179,exposures,0,0
235180,),0,0
235181,was,0,0
235182,nonsignificantly,0,0
235183,higher,0,0
235184,for,0,0
235185,definitive,0,0
235186,and,0,0
235187,all,0,0
235188,events,0,1
235189,(,0,0
235190,odds,0,1
235191,ratio,0,1
235192,",",0,0
235193,1.40,0,0
235194,;,0,0
235195,95,0,0
235196,%,0,0
235197,CI,0,0
235198,",",0,1
235199,0.49-4.03,0,0
235200,and,0,1
235201,odds,0,1
235202,ratio,0,1
235203,",",0,0
235204,1.39,0,0
235205,;,0,0
235206,95,0,0
235207,%,0,0
235208,CI,0,0
235209,",",0,1
235210,0.59-3.32,0,1
235211,",",0,1
235212,respectively,0,0
235213,),0,0
235214,.,0,0
235215,The,0,0
235216,odds,1,0
235217,ratio,1,1
235218,for,1,0
235219,nifedipine,1,0
235220,in,1,0
235221,combination,1,0
235222,with,1,0
235223,another,1,0
235224,drug,1,0
235225,was,0,0
235226,significantly,0,0
235227,lower,0,0
235228,for,0,0
235229,definitive,0,0
235230,and,0,0
235231,all,0,0
235232,events,0,1
235233,(,0,0
235234,odds,0,1
235235,ratio,0,1
235236,",",0,0
235237,0.09,0,0
235238,;,0,0
235239,95,0,0
235240,%,0,0
235241,CI,0,0
235242,",",0,1
235243,0.01-0.66,0,0
235244,and,0,1
235245,odds,0,1
235246,ratio,0,1
235247,",",0,0
235248,0.15,0,0
235249,;,0,0
235250,95,0,0
235251,%,0,0
235252,CI,0,0
235253,",",0,1
235254,0.03-0.65,0,0
235255,",",0,1
235256,respectively,0,0
235257,),0,0
235258,.,0,0
235259,Differences,1,1
235260,in,1,0
235261,odds,1,0
235262,ratio,1,1
235263,for,1,0
235264,nifedipine,1,0
235265,monotherapy,1,0
235266,and,1,1
235267,combined,1,0
235268,therapy,1,0
235269,were,0,0
235270,statistically,0,0
235271,significant,0,0
235272,(,0,0
235273,P=.02,0,1
235274,for,0,0
235275,definitive,0,0
235276,events,0,1
235277,and,0,1
235278,P=.001,0,0
235279,for,0,0
235280,all,0,0
235281,events,0,1
235282,),0,0
235283,.,0,0
235284,Results,0,0
235285,support,0,0
235286,the,0,0
235287,safety,1,1
235288,of,1,1
235289,sustained-,1,0
235290,and,1,1
235291,extended-release,1,0
235292,nifedipine,1,0
235293,in,0,0
235294,the,0,0
235295,treatment,0,0
235296,of,0,1
235297,mild,0,0
235298,or,0,1
235299,moderate,0,0
235300,hypertension,0,1
235301,when,0,0
235302,it,0,0
235303,is,0,0
235304,used,0,0
235305,in,0,0
235306,combination,0,0
235307,with,0,0
235308,other,0,0
235309,drugs,0,0
235310,.,0,0
235311,High-dose,0,0
235312,pyridoxine,0,0
235313,and,0,1
235314,magnesium,0,0
235315,administration,0,0
235316,in,0,0
235317,children,0,0
235318,with,0,0
235319,autistic,0,0
235320,disorder,0,0
235321,:,0,0
235322,an,0,0
235323,absence,0,0
235324,of,0,0
235325,salutary,0,0
235326,effects,0,0
235327,in,0,0
235328,a,0,0
235329,double-blind,0,0
235330,",",0,0
235331,placebo-controlled,0,0
235332,study,0,0
235333,.,0,0
235334,Several,0,0
235335,reports,0,0
235336,have,0,0
235337,described,0,0
235338,salutary,0,0
235339,effects,0,0
235340,such,0,0
235341,as,0,0
235342,decreased,0,1
235343,physical,0,1
235344,aggression,0,1
235345,and,0,1
235346,improved,0,1
235347,social,0,1
235348,responsiveness,0,1
235349,being,0,0
235350,associated,0,0
235351,with,0,0
235352,the,0,0
235353,administration,0,0
235354,of,0,0
235355,high,0,0
235356,doses,0,0
235357,of,0,1
235358,pyridoxine,0,0
235359,and,0,1
235360,magnesium,0,0
235361,(,0,1
235362,HDPM,0,0
235363,),0,0
235364,in,0,0
235365,open-labeled,0,0
235366,and,0,1
235367,controlled,0,0
235368,studies,0,0
235369,of,0,0
235370,patients,0,0
235371,with,0,0
235372,autism,0,0
235373,.,0,0
235374,Despite,0,0
235375,this,0,0
235376,fact,0,0
235377,",",0,0
235378,this,0,0
235379,intervention,0,0
235380,remains,0,0
235381,controversial,0,0
235382,.,0,0
235383,A,0,0
235384,10-week,0,0
235385,double-blind,0,0
235386,",",0,1
235387,placebo-controlled,0,0
235388,trial,0,0
235389,was,0,0
235390,undertaken,0,0
235391,to,0,0
235392,examine,0,0
235393,both,0,0
235394,the,0,0
235395,efficacy,0,1
235396,and,0,1
235397,safety,0,1
235398,of,0,1
235399,HDPM,0,0
235400,in,0,0
235401,autism,0,0
235402,.,0,0
235403,Twelve,0,0
235404,patients,0,0
235405,were,0,0
235406,enrolled,0,0
235407,",",0,0
235408,and,0,0
235409,10,0,0
235410,patients,0,0
235411,(,0,0
235412,mean,0,1
235413,age,0,0
235414,6,0,0
235415,years,0,0
235416,3,0,0
235417,months,0,0
235418,),0,0
235419,were,0,0
235420,able,0,0
235421,to,0,0
235422,complete,0,1
235423,the,0,0
235424,study,0,0
235425,.,0,0
235426,HDPM,0,0
235427,at,0,0
235428,an,0,0
235429,average,0,1
235430,dose,0,0
235431,of,0,0
235432,638.9,0,0
235433,mg,0,0
235434,of,0,0
235435,pyridoxine,0,0
235436,and,0,0
235437,216.3,0,0
235438,mg,0,0
235439,of,0,0
235440,magnesium,0,0
235441,oxide,0,1
235442,was,0,0
235443,ineffective,0,1
235444,in,0,0
235445,ameliorating,1,0
235446,autistic,1,0
235447,behaviors,1,1
235448,as,0,0
235449,assessed,0,0
235450,by,0,0
235451,the,0,0
235452,Children,1,0
235453,'s,1,1
235454,Psychiatric,1,1
235455,Rating,1,1
235456,Scale,1,1
235457,(,1,1
235458,CPRS,1,1
235459,),1,0
235460,",",1,0
235461,the,1,0
235462,Clinical,1,1
235463,Global,1,1
235464,Impression,1,1
235465,Scale,1,1
235466,",",1,0
235467,and,1,0
235468,the,1,0
235469,NIMH,1,0
235470,Global,1,1
235471,Obsessive,1,0
235472,Compulsive,1,1
235473,Scale,1,1
235474,.,1,1
235475,Furthermore,0,0
235476,",",0,0
235477,no,0,0
235478,clinically,0,0
235479,significant,0,0
235480,side,0,1
235481,effects,0,1
235482,were,0,0
235483,noted,0,0
235484,during,0,0
235485,HDPM,0,0
235486,administration,0,0
235487,.,0,0
235488,A,0,0
235489,trend,0,0
235490,for,0,0
235491,a,0,0
235492,transient,0,1
235493,change,0,0
235494,on,0,0
235495,the,0,0
235496,CPRS,0,0
235497,was,0,0
235498,found,0,0
235499,that,0,0
235500,was,0,0
235501,possibly,0,0
235502,due,0,0
235503,to,0,0
235504,a,0,0
235505,placebo,0,0
235506,response,0,1
235507,.,0,0
235508,This,0,0
235509,study,0,0
235510,raises,0,0
235511,doubts,0,0
235512,about,0,0
235513,the,0,0
235514,clinical,0,0
235515,effectiveness,0,1
235516,of,0,1
235517,HDPM,0,0
235518,in,0,0
235519,autistic,0,0
235520,disorder,0,0
235521,.,0,0
235522,Design,0,0
235523,of,0,0
235524,a,0,0
235525,cost-effectiveness,0,0
235526,study,0,0
235527,within,0,0
235528,a,0,0
235529,randomized,0,0
235530,trial,0,0
235531,:,0,0
235532,the,0,0
235533,LIPID,0,0
235534,Trial,0,0
235535,for,0,0
235536,Secondary,0,0
235537,Prevention,0,0
235538,of,0,0
235539,IHD,0,1
235540,.,0,0
235541,Long-term,0,0
235542,Intervention,0,0
235543,with,0,0
235544,Pravastatin,0,0
235545,in,0,0
235546,Ischemic,0,0
235547,Heart,0,0
235548,disease,0,0
235549,.,0,0
235550,The,0,0
235551,Long-term,0,0
235552,Intervention,0,0
235553,with,0,0
235554,Pravastatin,0,0
235555,in,0,0
235556,Ischemic,0,0
235557,Heart,0,1
235558,Disease,0,1
235559,(,0,1
235560,LIPID,0,0
235561,),0,0
235562,trial,0,0
235563,is,0,0
235564,a,0,0
235565,double-blind,0,0
235566,",",0,0
235567,randomized,0,0
235568,",",0,0
235569,placebo-controlled,0,0
235570,trial,0,0
235571,evaluating,0,0
235572,the,0,0
235573,long-term,0,0
235574,effect,0,1
235575,of,0,1
235576,pravastatin,0,0
235577,on,0,0
235578,coronary,0,1
235579,mortality,0,1
235580,in,0,0
235581,patients,0,0
235582,with,0,0
235583,a,0,0
235584,previous,0,0
235585,myocardial,0,1
235586,infarction,0,1
235587,or,0,1
235588,unstable,0,1
235589,angina-ischemic,0,1
235590,heart,0,1
235591,disease,0,1
235592,(,0,1
235593,IHD,0,1
235594,),0,0
235595,.,0,0
235596,It,0,0
235597,is,0,0
235598,planned,0,0
235599,to,0,0
235600,run,0,0
235601,for,0,0
235602,at,0,0
235603,least,0,0
235604,five,0,0
235605,years,0,0
235606,with,0,0
235607,9014,0,0
235608,patients,0,0
235609,from,0,0
235610,85,0,0
235611,centers,0,0
235612,in,0,0
235613,Australia,0,0
235614,and,0,1
235615,New,0,1
235616,Zealand,0,0
235617,.,0,0
235618,The,0,0
235619,trial,0,0
235620,will,0,0
235621,monitor,0,0
235622,cause-specific,0,1
235623,mortality,0,1
235624,and,0,1
235625,major,0,1
235626,clinical,0,1
235627,events,0,1
235628,associated,0,0
235629,with,0,0
235630,each,0,0
235631,treatment,0,0
235632,.,0,0
235633,Running,0,0
235634,in,0,0
235635,parallel,0,0
235636,with,0,0
235637,the,0,0
235638,main,0,0
235639,study,0,0
235640,is,0,0
235641,a,0,0
235642,prospective,0,0
235643,economic,0,1
235644,analysis,0,0
235645,",",0,0
235646,the,0,0
235647,objectives,0,0
235648,of,0,0
235649,which,0,0
235650,are,0,0
235651,(,0,0
235652,1,0,0
235653,),0,0
235654,to,0,0
235655,estimate,0,0
235656,the,0,0
235657,effectiveness,0,1
235658,of,0,0
235659,pravastatin,0,0
235660,compared,0,0
235661,with,0,0
235662,placebo,0,0
235663,in,0,0
235664,terms,0,1
235665,of,0,1
235666,survival,1,1
235667,",",1,1
235668,quality,1,1
235669,of,1,1
235670,life,1,1
235671,(,1,1
235672,QOL,1,1
235673,),1,1
235674,",",1,0
235675,and,1,1
235676,quality-adjusted,1,1
235677,life-years,1,1
235678,(,1,0
235679,QALY,1,0
235680,),1,0
235681,;,1,0
235682,(,0,0
235683,2,0,0
235684,),0,0
235685,to,0,0
235686,estimate,0,0
235687,the,0,0
235688,resource,0,1
235689,usage,0,1
235690,associated,0,0
235691,with,0,0
235692,pravastatin,0,0
235693,compared,0,0
235694,with,0,0
235695,placebo-in,0,0
235696,particular,0,0
235697,",",0,0
235698,to,0,0
235699,study,0,0
235700,whether,0,0
235701,it,0,0
235702,alters,0,0
235703,resource,0,1
235704,usage,0,1
235705,through,0,0
235706,prevention,0,0
235707,of,0,1
235708,disease,0,1
235709,progression,0,1
235710,;,0,1
235711,and,0,0
235712,(,0,0
235713,3,0,0
235714,),0,0
235715,to,0,0
235716,use,0,0
235717,this,0,0
235718,information,0,0
235719,for,0,0
235720,a,0,0
235721,cost-utility,0,0
235722,analysis,0,0
235723,with,0,0
235724,cost,0,1
235725,per,0,0
235726,quality-adjusted,0,1
235727,life-year,0,0
235728,as,0,0
235729,the,0,0
235730,unit,0,0
235731,of,0,0
235732,analysis,0,0
235733,.,0,0
235734,A,0,0
235735,novel,0,0
235736,aspect,0,0
235737,of,0,0
235738,the,0,0
235739,design,0,0
235740,is,0,0
235741,the,0,0
235742,use,0,0
235743,of,0,0
235744,a,0,0
235745,preliminary,0,0
235746,cost-effectiveness,0,1
235747,analysis,0,0
235748,",",0,1
235749,based,0,0
235750,on,0,0
235751,best-guess,0,0
235752,values,0,1
235753,",",0,0
235754,and,0,0
235755,a,0,0
235756,sensitivity,0,1
235757,analysis,0,0
235758,over,0,0
235759,plausible,0,0
235760,ranges,0,1
235761,to,0,0
235762,guide,0,0
235763,the,0,0
235764,choice,0,0
235765,of,0,0
235766,subsample,0,0
235767,size,0,1
235768,.,0,0
235769,Some,0,0
235770,data,0,0
235771,",",0,0
235772,such,0,0
235773,a,0,0
235774,mortality,1,1
235775,",",1,0
235776,days,1,1
235777,spent,1,1
235778,in,1,0
235779,hospital,1,1
235780,",",1,0
235781,major,1,1
235782,clinical,1,1
235783,events,1,1
235784,",",1,1
235785,and,1,1
235786,drug,1,1
235787,use,1,0
235788,",",0,0
235789,are,0,0
235790,being,0,0
235791,collected,0,0
235792,within,0,0
235793,the,0,0
235794,main,0,0
235795,LIPID,0,0
235796,trial,0,0
235797,.,0,0
235798,However,0,0
235799,",",0,0
235800,additional,0,0
235801,subsamples,0,0
235802,for,0,0
235803,the,0,0
235804,cost-effectiveness,1,0
235805,study,0,0
235806,will,0,0
235807,include,0,0
235808,information,0,1
235809,on,0,0
235810,quality,1,1
235811,of,1,1
235812,life,1,1
235813,",",1,1
235814,time,1,1
235815,off,1,1
235816,work,1,1
235817,",",1,1
235818,and,1,1
235819,resources,1,1
235820,used,1,0
235821,",",1,0
235822,such,1,0
235823,as,1,0
235824,time,1,1
235825,in,1,0
235826,hospital,1,1
235827,",",1,1
235828,procedures,1,0
235829,",",1,1
235830,and,1,1
235831,medications,1,0
235832,taken,1,0
235833,.,1,0
235834,The,0,0
235835,methods,0,0
235836,and,0,1
235837,sample,0,0
235838,sizes,0,1
235839,for,0,0
235840,these,0,0
235841,substudies,0,0
235842,have,0,0
235843,been,0,0
235844,a,0,0
235845,crucial,0,0
235846,issue,0,0
235847,in,0,0
235848,validity,0,1
235849,and,0,1
235850,feasibility,0,1
235851,.,0,0
235852,A,0,0
235853,comparison,0,0
235854,of,0,0
235855,intermittent,0,0
235856,vaginal,0,0
235857,administration,0,0
235858,of,0,1
235859,misoprostol,0,0
235860,with,0,0
235861,continuous,0,0
235862,dinoprostone,0,0
235863,for,0,0
235864,cervical,1,1
235865,ripening,1,1
235866,and,1,1
235867,labor,1,1
235868,induction,1,1
235869,.,1,1
235870,OBJECTIVE,0,0
235871,Our,0,0
235872,purpose,0,0
235873,was,0,0
235874,to,0,0
235875,compare,0,0
235876,the,0,0
235877,effect,0,0
235878,of,0,0
235879,vaginal,0,0
235880,administration,0,0
235881,of,0,1
235882,misoprostol,0,0
235883,(,0,1
235884,Cytotec,0,1
235885,),0,0
235886,with,0,0
235887,that,0,0
235888,of,0,0
235889,dinoprostone,0,0
235890,(,0,1
235891,Cervidil,0,0
235892,),0,0
235893,on,0,0
235894,cervical,1,0
235895,ripening,1,1
235896,and,1,1
235897,labor,1,1
235898,induction,1,1
235899,.,1,1
235900,STUDY,0,0
235901,DESIGN,0,0
235902,Two,0,0
235903,hundred,0,0
235904,patients,0,0
235905,with,0,0
235906,indications,0,0
235907,for,0,0
235908,induction,0,0
235909,of,0,1
235910,labor,0,1
235911,and,0,1
235912,unfavorable,0,1
235913,cervical,0,1
235914,examinations,0,0
235915,were,0,0
235916,randomly,0,0
235917,assigned,0,0
235918,to,0,0
235919,receive,0,0
235920,vaginally,0,0
235921,administered,0,0
235922,misoprostol,0,0
235923,(,0,0
235924,prostaglandin,0,1
235925,E1,0,1
235926,),0,0
235927,or,0,0
235928,the,0,0
235929,dinoprostone,0,0
235930,(,0,0
235931,prostaglandin,0,1
235932,E2,0,1
235933,),0,1
235934,vaginal,0,0
235935,insert,0,1
235936,.,0,1
235937,Twenty-five,0,0
235938,microgram,0,0
235939,tablets,0,0
235940,of,0,1
235941,misoprostol,0,0
235942,were,0,0
235943,placed,0,0
235944,in,0,0
235945,the,0,0
235946,posterior,0,0
235947,vaginal,0,0
235948,fornix,0,1
235949,every,0,0
235950,4,0,0
235951,hours,0,0
235952,for,0,0
235953,a,0,0
235954,maximum,0,0
235955,of,0,0
235956,six,0,0
235957,doses,0,0
235958,.,0,0
235959,Additional,0,0
235960,misoprostol,0,0
235961,was,0,0
235962,not,0,0
235963,given,0,0
235964,after,0,0
235965,either,0,0
235966,spontaneous,0,1
235967,rupture,0,0
235968,of,0,1
235969,membranes,0,1
235970,",",0,0
235971,adequate,0,1
235972,cervical,0,1
235973,ripening,0,0
235974,(,0,1
235975,Bishop,0,1
235976,score,0,1
235977,of,0,1
235978,>,0,0
235979,or,0,0
235980,=,0,0
235981,8,0,0
235982,or,0,0
235983,cervical,0,0
235984,dilatation,0,1
235985,of,0,1
235986,>,0,1
235987,or,0,0
235988,=,0,0
235989,3,0,0
235990,cm,0,0
235991,),0,0
235992,",",0,1
235993,or,0,1
235994,beginning,0,0
235995,of,0,1
235996,active,0,0
235997,labor,0,1
235998,.,0,0
235999,The,0,0
236000,vaginal,0,0
236001,insert,0,1
236002,",",0,1
236003,Cervidil,0,0
236004,",",0,0
236005,containing,0,0
236006,10,0,0
236007,mg,0,0
236008,of,0,0
236009,dinoprostone,0,0
236010,in,0,0
236011,a,0,0
236012,timed-release,0,0
236013,preparation,0,0
236014,was,0,0
236015,placed,0,0
236016,in,0,0
236017,the,0,0
236018,posterior,0,0
236019,vaginal,0,0
236020,formix,0,0
236021,for,0,0
236022,a,0,0
236023,maximum,0,1
236024,period,0,0
236025,of,0,0
236026,24,0,0
236027,hours,0,0
236028,.,0,0
236029,The,0,0
236030,vaginal,0,0
236031,insert,0,1
236032,was,0,0
236033,removed,0,0
236034,for,0,0
236035,spontaneous,0,1
236036,rupture,0,1
236037,of,0,1
236038,membranes,0,1
236039,",",0,0
236040,entry,0,1
236041,into,0,0
236042,active,0,0
236043,labor,0,1
236044,",",0,1
236045,adequate,0,1
236046,cervical,0,1
236047,ripening,0,1
236048,",",0,1
236049,or,0,1
236050,abnormality,0,1
236051,of,0,1
236052,uterine,0,1
236053,contractile,0,1
236054,pattern,0,1
236055,or,0,1
236056,fetal,0,1
236057,cardiac,0,1
236058,activity,0,1
236059,.,0,1
236060,RESULTS,0,0
236061,Of,0,0
236062,the,0,0
236063,200,0,0
236064,patients,0,0
236065,enrolled,0,0
236066,",",0,0
236067,99,0,0
236068,were,0,0
236069,randomized,0,0
236070,to,0,0
236071,misoprostol,0,0
236072,and,0,0
236073,101,0,0
236074,to,0,0
236075,dinoprostone,0,0
236076,.,0,0
236077,The,0,0
236078,average,1,1
236079,interval,1,0
236080,from,1,0
236081,start,1,0
236082,of,1,0
236083,induction,1,0
236084,to,1,0
236085,vaginal,1,0
236086,delivery,1,1
236087,was,0,0
236088,1,0,0
236089,hour,0,0
236090,shorter,0,0
236091,in,0,0
236092,the,0,0
236093,misoprostol,0,0
236094,group,0,0
236095,(,0,0
236096,1296.7,0,0
236097,+/-,0,0
236098,722.1,0,0
236099,minutes,0,0
236100,),0,0
236101,than,0,0
236102,in,0,0
236103,the,0,0
236104,dinoprostone,0,0
236105,group,0,0
236106,(,0,0
236107,1360.0,0,0
236108,+/-,0,0
236109,792.0,0,0
236110,minutes,0,0
236111,),0,0
236112,",",0,0
236113,but,0,0
236114,this,0,0
236115,difference,0,0
236116,was,0,0
236117,not,0,0
236118,statistically,0,0
236119,significant,0,0
236120,(,0,0
236121,p,0,0
236122,=,0,0
236123,0.97,0,0
236124,),0,0
236125,.,0,0
236126,Oxytocin,1,1
236127,augmentation,1,1
236128,of,1,1
236129,labor,1,1
236130,was,0,0
236131,used,0,0
236132,in,0,0
236133,50,0,0
236134,(,0,0
236135,50.5,0,0
236136,%,0,0
236137,),0,0
236138,misoprostol-treated,0,0
236139,patients,0,0
236140,and,0,0
236141,43,0,0
236142,(,0,0
236143,43.5,0,0
236144,%,0,0
236145,),0,0
236146,dinoprostone-treated,0,0
236147,patients,0,0
236148,(,0,0
236149,relative,0,1
236150,risk,0,1
236151,1.14,0,0
236152,",",0,0
236153,95,0,0
236154,%,0,0
236155,confidence,0,0
236156,interval,0,0
236157,0.86,0,0
236158,to,0,0
236159,1.51,0,0
236160,",",0,0
236161,p,0,0
236162,=,0,0
236163,0.35,0,0
236164,),0,0
236165,.,0,0
236166,There,0,0
236167,were,0,0
236168,no,0,0
236169,significant,0,0
236170,differences,0,0
236171,between,0,0
236172,routes,1,0
236173,of,1,0
236174,delivery,1,1
236175,with,0,0
236176,misoprostol,0,0
236177,or,0,0
236178,dinoprostone,0,0
236179,.,0,1
236180,Overall,0,0
236181,",",0,0
236182,38,0,0
236183,patients,0,0
236184,(,0,0
236185,19.3,0,0
236186,%,0,0
236187,),0,0
236188,had,0,0
236189,cesarean,1,1
236190,deliveries,1,1
236191,.,1,0
236192,There,0,0
236193,was,0,0
236194,a,0,0
236195,significantly,0,0
236196,lower,0,0
236197,prevalence,0,1
236198,of,0,1
236199,tachysystole,1,1
236200,(,0,0
236201,six,0,0
236202,or,0,0
236203,more,0,0
236204,uterine,0,1
236205,contractions,0,1
236206,in,0,0
236207,a,0,0
236208,10-minute,0,1
236209,window,0,0
236210,for,0,0
236211,two,0,0
236212,consecutive,0,0
236213,10-minute,0,0
236214,periods,0,0
236215,),0,0
236216,in,0,0
236217,the,0,0
236218,misoprostol,0,0
236219,group,0,0
236220,(,0,0
236221,7.1,0,0
236222,%,0,0
236223,),0,0
236224,than,0,0
236225,in,0,0
236226,the,0,0
236227,dinoprostone,0,0
236228,group,0,0
236229,(,0,0
236230,18.4,0,0
236231,%,0,0
236232,),0,0
236233,(,0,0
236234,relative,0,1
236235,risk,0,1
236236,0.52,0,0
236237,",",0,0
236238,95,0,0
236239,%,0,0
236240,confidence,0,0
236241,interval,0,0
236242,0.31,0,0
236243,to,0,0
236244,0.89,0,0
236245,",",0,0
236246,p,0,0
236247,=,0,0
236248,0.02,0,0
236249,),0,0
236250,.,0,0
236251,There,0,0
236252,were,0,0
236253,no,0,0
236254,significant,0,0
236255,differences,0,0
236256,in,0,0
236257,frequency,1,1
236258,of,1,1
236259,uterine,1,1
236260,hyperstimulation,1,1
236261,or,1,0
236262,hypertonus,1,1
236263,.,1,1
236264,Abnormal,1,1
236265,fetal,1,1
236266,heart,1,1
236267,rate,1,1
236268,tracings,1,0
236269,were,0,0
236270,found,0,0
236271,in,0,0
236272,23,0,0
236273,(,0,0
236274,23.2,0,0
236275,%,0,0
236276,),0,0
236277,of,0,0
236278,misoprostol-treated,0,0
236279,patients,0,0
236280,and,0,0
236281,35,0,0
236282,(,0,0
236283,35.7,0,0
236284,%,0,0
236285,),0,0
236286,of,0,0
236287,dinoprostone-treated,0,0
236288,patients,0,0
236289,(,0,0
236290,relative,0,1
236291,risk,0,1
236292,0.73,0,0
236293,",",0,0
236294,95,0,0
236295,%,0,0
236296,confidence,0,0
236297,interval,0,0
236298,0.52,0,0
236299,to,0,0
236300,1.01,0,0
236301,",",0,0
236302,p,0,0
236303,=,0,0
236304,0.0546,0,0
236305,),0,0
236306,.,0,0
236307,No,0,0
236308,significant,0,0
236309,differences,0,0
236310,were,0,0
236311,found,0,0
236312,in,0,0
236313,meconium,1,1
236314,passage,1,1
236315,",",0,1
236316,1-,0,1
236317,or,0,1
236318,5-minute,0,1
236319,Apgar,1,1
236320,scores,1,1
236321,<,0,0
236322,7,0,0
236323,",",0,0
236324,neonatal,1,1
236325,resuscitations,1,1
236326,",",1,1
236327,or,1,0
236328,admissions,1,1
236329,to,1,0
236330,the,1,0
236331,neonatal,1,1
236332,intensive,1,0
236333,care,1,0
236334,unit,1,0
236335,between,0,0
236336,the,0,0
236337,two,0,0
236338,groups,0,0
236339,.,0,0
236340,CONCLUSIONS,0,0
236341,Vaginally,0,0
236342,administered,0,0
236343,misoprostol,0,0
236344,is,0,0
236345,as,0,0
236346,effective,1,0
236347,as,0,0
236348,dinoprostone,0,0
236349,for,0,0
236350,cervical,1,1
236351,ripening,1,0
236352,and,1,0
236353,the,1,0
236354,induction,1,0
236355,of,1,0
236356,labor,1,1
236357,.,1,0
236358,Mean,1,1
236359,time,1,1
236360,intervals,1,1
236361,to,1,0
236362,delivery,1,1
236363,",",1,1
236364,need,1,1
236365,for,1,0
236366,oxytocin,1,1
236367,augmentation,1,1
236368,",",1,1
236369,and,1,1
236370,routes,1,1
236371,of,1,1
236372,delivery,1,1
236373,were,0,0
236374,similar,0,0
236375,between,0,0
236376,the,0,0
236377,two,0,0
236378,groups,0,0
236379,.,0,0
236380,Incidence,0,1
236381,of,0,1
236382,uterine,1,1
236383,tachysystole,1,1
236384,with,0,0
236385,misoprostol,0,0
236386,every,0,0
236387,4,0,0
236388,hours,0,0
236389,was,0,0
236390,significantly,0,0
236391,less,0,0
236392,than,0,0
236393,with,0,0
236394,dinoprostone,0,0
236395,.,0,0
236396,Intravenous,0,0
236397,magnesium,0,0
236398,sulfate,0,1
236399,in,0,0
236400,acute,1,0
236401,severe,1,1
236402,asthma,1,0
236403,not,0,0
236404,responding,0,0
236405,to,0,0
236406,conventional,0,0
236407,therapy,0,0
236408,.,0,0
236409,OBJECTIVE,0,0
236410,To,0,0
236411,evaluate,0,0
236412,the,0,0
236413,effectiveness,0,0
236414,of,0,0
236415,early,0,0
236416,administration,0,0
236417,of,0,1
236418,intravenous,0,0
236419,Magnesium,0,0
236420,sulfate,0,1
236421,(,0,0
236422,i.v,0,0
236423,.,0,1
236424,MgSO4,0,0
236425,),0,0
236426,in,0,0
236427,children,0,0
236428,with,0,0
236429,acute,0,0
236430,severe,0,1
236431,asthma,0,0
236432,not,0,0
236433,responding,0,0
236434,to,0,0
236435,conventional,0,0
236436,therapy,0,0
236437,.,0,0
236438,DESIGN,0,0
236439,Randomized,0,0
236440,double-blind,0,0
236441,",",0,1
236442,placebo-controlled,0,0
236443,trial,0,0
236444,.,0,1
236445,SETTING,0,0
236446,Pediatric,0,0
236447,emergency,0,1
236448,service,0,0
236449,of,0,0
236450,a,0,0
236451,large,0,0
236452,teaching,0,0
236453,hospital,0,1
236454,.,0,0
236455,SUBJECTS,0,0
236456,47,0,0
236457,children,0,0
236458,aged,0,0
236459,between,0,0
236460,1-12,0,0
236461,years,0,0
236462,with,0,0
236463,acute,0,0
236464,severe,0,1
236465,asthma,0,0
236466,showing,0,0
236467,inadequate,1,1
236468,or,1,0
236469,poor,1,1
236470,response,1,1
236471,to,0,0
236472,3,0,0
236473,doses,0,0
236474,of,0,0
236475,nebulized,0,0
236476,salbutamol,0,0
236477,given,0,0
236478,at,0,0
236479,an,0,0
236480,interval,0,0
236481,of,0,0
236482,20,0,0
236483,min,0,0
236484,each,0,0
236485,.,0,0
236486,INTERVENTION,0,0
236487,The,0,0
236488,MgSO4,0,0
236489,group,0,0
236490,received,0,0
236491,0.2,0,0
236492,ml/kg,0,0
236493,of,0,0
236494,50,0,0
236495,%,0,0
236496,MgSO4,0,0
236497,as,0,0
236498,intravenous,0,0
236499,(,0,0
236500,i.v,0,0
236501,.,0,0
236502,),0,0
236503,infusion,0,0
236504,over,0,0
236505,35,0,0
236506,minutes,0,0
236507,and,0,0
236508,the,0,0
236509,placebo,0,0
236510,group,0,0
236511,received,0,0
236512,normal,0,0
236513,saline,0,0
236514,infusion,0,0
236515,in,0,0
236516,the,0,0
236517,same,0,0
236518,dose,0,0
236519,and,0,0
236520,at,0,0
236521,the,0,0
236522,same,0,0
236523,rate,0,1
236524,.,0,1
236525,MgSO4,0,1
236526,solution,0,1
236527,and,0,1
236528,normal,0,1
236529,saline,0,0
236530,were,0,0
236531,coded,0,0
236532,and,0,0
236533,dispensed,0,0
236534,in,0,0
236535,identical,0,0
236536,containers,0,0
236537,.,0,0
236538,Decoding,0,1
236539,was,0,0
236540,done,0,0
236541,at,0,0
236542,the,0,0
236543,completion,0,0
236544,of,0,0
236545,the,0,0
236546,study,0,0
236547,.,0,0
236548,All,0,0
236549,the,0,0
236550,patients,0,0
236551,received,0,0
236552,oxygen,0,1
236553,",",0,1
236554,nebulized,0,1
236555,salbutamol,0,0
236556,",",0,0
236557,i.v,0,0
236558,.,0,1
236559,aminophylline,0,0
236560,and,0,0
236561,corticosteroids,0,0
236562,.,0,1
236563,RESULTS,0,0
236564,MgSO4,0,1
236565,group,0,0
236566,showed,0,0
236567,early,1,0
236568,and,1,1
236569,significant,1,0
236570,improvement,1,1
236571,as,0,0
236572,compared,0,0
236573,to,0,0
236574,placebo,0,0
236575,group,0,0
236576,in,0,0
236577,PEFR,1,1
236578,and,1,1
236579,SaO2,1,0
236580,at,0,0
236581,30,0,0
236582,min,0,0
236583,and,0,0
236584,1,0,0
236585,",",0,0
236586,2,0,0
236587,",",0,0
236588,3,0,0
236589,and,0,0
236590,7,0,0
236591,hours,0,0
236592,after,0,0
236593,stopping,0,0
236594,the,0,0
236595,infusion,0,0
236596,(,0,0
236597,p,0,0
236598,ranging,0,0
236599,from,0,0
236600,<,0,0
236601,0.05,0,0
236602,to,0,0
236603,<,0,0
236604,0.01,0,0
236605,),0,0
236606,.,0,0
236607,The,0,0
236608,clinical,1,0
236609,asthma,1,0
236610,score,1,1
236611,also,0,0
236612,showed,0,0
236613,significant,0,0
236614,improvement,0,1
236615,in,0,0
236616,the,0,0
236617,MgSO4,0,0
236618,group,0,0
236619,1,0,0
236620,",",0,0
236621,2,0,0
236622,",",0,0
236623,3,0,0
236624,and,0,0
236625,11,0,0
236626,hours,0,0
236627,after,0,0
236628,stopping,0,0
236629,the,0,0
236630,infusion,0,0
236631,(,0,0
236632,p,0,0
236633,<,0,0
236634,0.01,0,0
236635,),0,0
236636,.,0,0
236637,CONCLUSION,0,0
236638,Addition,0,0
236639,of,0,0
236640,MgSO4,0,0
236641,to,0,0
236642,conventional,0,0
236643,therapy,0,0
236644,helps,0,0
236645,in,0,0
236646,achieving,0,1
236647,earlier,0,0
236648,improvement,1,1
236649,in,1,0
236650,clinical,1,1
236651,signs,1,1
236652,and,1,1
236653,symptoms,1,1
236654,of,1,1
236655,asthma,1,1
236656,and,1,1
236657,PEFR,1,1
236658,in,0,0
236659,patients,0,0
236660,not,0,0
236661,responding,0,0
236662,to,0,0
236663,conventional,0,0
236664,therapy,0,0
236665,alone,0,0
236666,.,0,0
236667,The,0,0
236668,influence,0,0
236669,of,0,0
236670,preoperative,0,1
236671,antibiotics,0,0
236672,on,0,0
236673,success,1,1
236674,of,0,0
236675,endosseous,0,0
236676,implants,0,0
236677,up,0,0
236678,to,0,0
236679,and,0,1
236680,including,0,0
236681,stage,0,1
236682,II,0,0
236683,surgery,0,0
236684,:,0,0
236685,a,0,0
236686,study,0,0
236687,of,0,0
236688,"2,641",0,0
236689,implants,0,0
236690,.,0,0
236691,According,0,0
236692,to,0,0
236693,the,0,0
236694,American,0,0
236695,College,0,0
236696,of,0,1
236697,Surgeons,0,1
236698,",",0,0
236699,complex,0,0
236700,oral,0,0
236701,surgical,0,0
236702,procedures,0,0
236703,",",0,0
236704,including,0,0
236705,the,0,0
236706,transoral,0,0
236707,placement,0,0
236708,of,0,1
236709,endosseous,0,0
236710,implants,0,0
236711,",",0,0
236712,are,0,0
236713,of,0,0
236714,the,0,0
236715,type,0,0
236716,that,0,0
236717,may,0,0
236718,require,0,0
236719,prophylactic,0,0
236720,antibiotics,0,0
236721,.,0,0
236722,However,0,0
236723,",",0,0
236724,the,0,0
236725,routine,0,0
236726,use,0,0
236727,of,0,1
236728,prophylactic,0,0
236729,antibiotics,0,0
236730,in,0,0
236731,the,0,0
236732,field,0,0
236733,of,0,0
236734,dental,0,0
236735,implantology,0,0
236736,continues,0,0
236737,to,0,0
236738,be,0,0
236739,controversial,0,0
236740,",",0,0
236741,and,0,1
236742,their,0,1
236743,utilization,0,1
236744,varies,0,0
236745,widely,0,0
236746,.,0,0
236747,No,0,0
236748,data,0,0
236749,from,0,0
236750,a,0,0
236751,randomized,0,0
236752,prospective,0,0
236753,clinical,0,1
236754,study,0,0
236755,of,0,0
236756,the,0,0
236757,prophylactic,0,0
236758,use,0,0
236759,of,0,0
236760,antibiotics,0,0
236761,in,0,0
236762,implant,0,0
236763,surgery,0,0
236764,have,0,0
236765,been,0,0
236766,previously,0,0
236767,published,0,0
236768,.,0,0
236769,As,0,0
236770,part,0,0
236771,of,0,0
236772,the,0,0
236773,comprehensive,0,0
236774,Dental,0,1
236775,Implant,0,1
236776,Clinical,0,1
236777,Research,0,1
236778,Group,0,0
236779,clinical,0,1
236780,implant,0,1
236781,study,0,0
236782,",",0,0
236783,the,0,0
236784,preoperative,0,1
236785,or,0,0
236786,postoperative,0,1
236787,use,0,1
236788,of,0,1
236789,antibiotics,0,0
236790,",",0,0
236791,the,0,0
236792,type,0,0
236793,used,0,0
236794,",",0,0
236795,and,0,0
236796,the,0,0
236797,duration,0,1
236798,of,0,1
236799,coverage,0,1
236800,was,0,0
236801,left,0,1
236802,to,0,0
236803,the,0,0
236804,discretion,0,0
236805,of,0,0
236806,the,0,0
236807,surgeon,0,0
236808,.,0,0
236809,These,0,0
236810,data,0,0
236811,were,0,0
236812,recorded,0,0
236813,and,0,0
236814,correlated,0,0
236815,with,0,0
236816,failure,1,0
236817,of,1,1
236818,osseointegration,1,1
236819,during,1,0
236820,healing,1,1
236821,(,1,0
236822,stage,1,0
236823,I,1,0
236824,),1,0
236825,and,1,0
236826,at,1,0
236827,stage,1,1
236828,II,1,0
236829,surgery,1,0
236830,(,1,1
236831,uncovering,1,0
236832,),1,0
236833,.,1,0
236834,The,0,0
236835,results,0,0
236836,showed,0,0
236837,that,0,0
236838,significantly,0,0
236839,fewer,0,0
236840,failures,1,1
236841,occurred,0,0
236842,when,0,0
236843,preoperative,0,1
236844,antibiotics,0,1
236845,were,0,0
236846,used,0,0
236847,.,0,0
236848,Naltrexone,0,0
236849,in,0,0
236850,young,0,0
236851,autistic,0,0
236852,children,0,0
236853,:,0,0
236854,replication,0,0
236855,study,0,0
236856,and,0,1
236857,learning,0,1
236858,measures,0,1
236859,.,0,0
236860,OBJECTIVE,0,0
236861,This,0,0
236862,study,0,0
236863,expanded,0,0
236864,upon,0,0
236865,previous,0,0
236866,work,0,1
236867,on,0,0
236868,naltrexone,0,0
236869,efficacy,0,1
236870,and,0,1
236871,safety,0,1
236872,in,0,0
236873,young,0,0
236874,autistic,0,1
236875,children,0,0
236876,and,0,1
236877,assessed,0,1
236878,performance,0,1
236879,on,0,0
236880,learning,0,1
236881,measures,0,0
236882,.,0,0
236883,METHOD,0,0
236884,Eleven,0,0
236885,children,0,0
236886,with,0,0
236887,autistic,0,1
236888,disorder,0,0
236889,",",0,0
236890,aged,0,0
236891,3.0,0,0
236892,to,0,0
236893,8.3,0,0
236894,years,0,0
236895,",",0,0
236896,were,0,0
236897,studied,0,0
236898,in,0,0
236899,home,0,0
236900,",",0,1
236901,school,0,1
236902,",",0,1
236903,and,0,1
236904,outpatient,0,0
236905,laboratory,0,1
236906,",",0,0
236907,bringing,0,0
236908,to,0,0
236909,24,0,0
236910,the,0,0
236911,combined,0,0
236912,study,0,0
236913,sample,0,0
236914,.,0,1
236915,Naltrexone,0,0
236916,",",0,0
236917,1.0,0,0
236918,mg/kg,0,0
236919,",",0,0
236920,was,0,0
236921,given,0,0
236922,daily,0,0
236923,in,0,0
236924,a,0,0
236925,randomized,0,0
236926,",",0,0
236927,double-blind,0,0
236928,",",0,1
236929,crossover,0,0
236930,design,0,0
236931,.,0,0
236932,Dependent,0,0
236933,measures,0,1
236934,were,0,0
236935,parent,0,1
236936,and,0,1
236937,teacher,0,1
236938,Clinical,1,1
236939,Global,1,1
236940,Impressions,1,1
236941,(,1,1
236942,CGI,1,1
236943,),1,1
236944,and,0,1
236945,Naltrexone,1,0
236946,Side,1,0
236947,Effects,1,0
236948,Rating,1,1
236949,Scale,1,1
236950,(,1,1
236951,SE,1,1
236952,),1,1
236953,",",1,0
236954,Conners,1,1
236955,Parent,1,1
236956,Impulsivity/Hyperactivity,1,1
236957,Factor,1,0
236958,",",1,1
236959,Teacher,1,1
236960,Hyperactivity,1,1
236961,Factor,1,0
236962,",",0,1
236963,laboratory,0,1
236964,CGI,0,1
236965,",",0,1
236966,and,0,1
236967,analysis,0,0
236968,of,0,1
236969,videotaped,0,0
236970,behavior,0,1
236971,.,0,0
236972,Learning,0,1
236973,measures,0,0
236974,were,0,0
236975,the,0,0
236976,Early,1,0
236977,Intervention,1,0
236978,Developmental,1,1
236979,Profile-Language,1,1
236980,and,0,1
236981,paired-associate,1,0
236982,learning,1,1
236983,.,1,0
236984,RESULTS,0,0
236985,Comparisons,0,0
236986,between,0,0
236987,naltrexone,0,0
236988,and,0,1
236989,baseline,0,1
236990,",",0,1
236991,but,0,0
236992,not,0,0
236993,naltrexone,0,0
236994,and,0,0
236995,placebo,0,0
236996,",",0,1
236997,on,0,0
236998,parent,0,1
236999,and,0,1
237000,teacher,0,1
237001,ratings,0,1
237002,showed,0,0
237003,statistical,0,0
237004,significance,0,1
237005,.,0,0
237006,Three,0,0
237007,of,0,0
237008,11,0,0
237009,subjects,0,0
237010,improved,0,0
237011,in,0,0
237012,two,0,0
237013,or,0,0
237014,more,0,0
237015,settings,0,0
237016,.,0,1
237017,Side,1,0
237018,effects,1,1
237019,were,0,0
237020,mild,0,0
237021,.,0,0
237022,Administering,0,0
237023,naltrexone,0,0
237024,was,0,0
237025,a,0,0
237026,challenge,0,0
237027,.,0,0
237028,The,0,0
237029,combined,0,0
237030,study,0,0
237031,sample,0,0
237032,showed,0,0
237033,improvement,0,1
237034,on,0,0
237035,all,0,0
237036,parent,1,1
237037,measures,1,1
237038,and,0,1
237039,on,0,0
237040,Teacher,1,1
237041,CGI,1,1
237042,and,0,1
237043,SE-Restlessness,1,1
237044,compared,0,0
237045,with,0,0
237046,baseline,0,0
237047,and,0,1
237048,placebo,0,0
237049,.,0,1
237050,Eleven,0,0
237051,of,0,0
237052,the,0,0
237053,24,0,0
237054,children,0,0
237055,improved,0,0
237056,in,0,0
237057,two,0,0
237058,or,0,0
237059,more,0,0
237060,settings,0,0
237061,.,0,1
237062,Scores,0,0
237063,on,0,0
237064,learning,1,1
237065,measures,1,1
237066,did,0,0
237067,not,0,0
237068,change,0,0
237069,across,0,0
237070,conditions,0,0
237071,.,0,0
237072,CONCLUSIONS,0,0
237073,Naltrexone,0,0
237074,was,0,0
237075,associated,0,0
237076,with,0,0
237077,modest,0,0
237078,improvement,0,1
237079,of,0,1
237080,behavior,1,1
237081,in,0,0
237082,11,0,0
237083,of,0,0
237084,24,0,0
237085,children,0,0
237086,",",0,0
237087,but,0,0
237088,learning,1,1
237089,did,0,0
237090,not,0,0
237091,improve,0,0
237092,.,0,0
237093,Safety,0,1
237094,and,0,1
237095,immunogenicity,0,1
237096,of,0,0
237097,a,0,0
237098,combined,0,0
237099,pentavalent,0,0
237100,diphtheria,0,1
237101,",",0,1
237102,tetanus,0,1
237103,",",0,1
237104,acellular,0,1
237105,pertussis,0,0
237106,",",0,1
237107,inactivated,0,0
237108,poliovirus,0,1
237109,and,0,0
237110,Haemophilus,0,0
237111,influenzae,0,1
237112,type,0,0
237113,b-tetanus,0,1
237114,conjugate,0,0
237115,vaccine,0,0
237116,in,0,0
237117,infants,0,0
237118,",",0,0
237119,compared,0,0
237120,with,0,0
237121,a,0,0
237122,whole,0,0
237123,cell,0,1
237124,pertussis,0,0
237125,pentavalent,0,0
237126,vaccine,0,0
237127,.,0,0
237128,BACKGROUND,0,0
237129,We,0,0
237130,compared,0,0
237131,the,0,0
237132,safety,0,1
237133,and,0,1
237134,immunogenicity,0,1
237135,of,0,0
237136,two,0,0
237137,combined,0,0
237138,diphtheria-tetanus-pertussis-inactivated,0,0
237139,poliovirus,0,1
237140,vaccines,0,0
237141,containing,0,0
237142,either,0,0
237143,acellular,0,1
237144,(,0,1
237145,Pa,0,1
237146,",",0,1
237147,SmithKline,0,1
237148,Beecham,0,0
237149,Biologicals,0,1
237150,),0,1
237151,or,0,0
237152,whole,0,1
237153,cell,0,1
237154,(,0,1
237155,Pw,0,1
237156,",",0,1
237157,Pasteur,0,0
237158,Merieux,0,0
237159,Connaught,0,0
237160,),0,0
237161,pertussis,0,0
237162,components,0,1
237163,",",0,0
237164,mixed,0,0
237165,with,0,0
237166,a,0,0
237167,Haemophilus,0,0
237168,influenzae,0,1
237169,type,0,1
237170,b,0,1
237171,polysaccharide,0,1
237172,polyribosylribitol,0,1
237173,phosphate-tetanus,0,1
237174,conjugate,0,0
237175,vaccine,0,0
237176,in,0,0
237177,an,0,0
237178,open,0,0
237179,",",0,0
237180,randomized,0,0
237181,study,0,0
237182,in,0,0
237183,healthy,0,0
237184,infants,0,0
237185,.,0,0
237186,DESIGN,0,0
237187,The,0,0
237188,combined,0,0
237189,vaccines,0,0
237190,were,0,0
237191,given,0,0
237192,at,0,0
237193,2,0,0
237194,",",0,0
237195,4,0,0
237196,",",0,0
237197,6,0,0
237198,and,0,0
237199,12,0,0
237200,months,0,0
237201,of,0,0
237202,age,0,0
237203,",",0,1
237204,and,0,1
237205,serum,0,1
237206,samples,0,1
237207,were,0,0
237208,obtained,0,0
237209,at,0,0
237210,ages,0,0
237211,2,0,0
237212,",",0,0
237213,6,0,0
237214,",",0,0
237215,7,0,0
237216,",",0,0
237217,12,0,0
237218,and,0,0
237219,13,0,0
237220,months,0,0
237221,.,0,0
237222,Adverse,0,1
237223,events,0,1
237224,were,0,0
237225,obtained,0,0
237226,by,0,0
237227,diary,0,0
237228,cards,0,0
237229,.,0,0
237230,RESULTS,0,0
237231,The,0,0
237232,Pa,0,1
237233,group,0,0
237234,(,0,0
237235,n,0,0
237236,=,0,0
237237,101,0,0
237238,),0,0
237239,had,0,0
237240,a,0,0
237241,clearly,0,0
237242,lower,1,0
237243,incidence,1,1
237244,of,1,0
237245,both,1,0
237246,local,1,0
237247,and,1,0
237248,systemic,1,1
237249,adverse,1,1
237250,events,1,1
237251,than,0,0
237252,the,0,0
237253,Pw,0,1
237254,group,0,0
237255,(,0,0
237256,n,0,0
237257,=,0,0
237258,100,0,0
237259,),0,0
237260,.,0,0
237261,Immunogenicity,1,1
237262,was,0,0
237263,comparable,0,0
237264,for,0,0
237265,the,0,0
237266,diphtheria,0,0
237267,and,0,1
237268,tetanus,0,1
237269,components,0,1
237270,",",0,1
237271,but,0,0
237272,significantly,0,1
237273,superior,0,0
237274,for,0,0
237275,pertussis,1,0
237276,toxin,1,1
237277,",",1,1
237278,filamentous,1,1
237279,hemagglutinin,1,1
237280,",",1,1
237281,pertactin,1,1
237282,and,1,0
237283,polioviruses,1,0
237284,1,1,0
237285,",",1,0
237286,2,1,0
237287,and,1,0
237288,3,1,0
237289,in,1,0
237290,the,1,0
237291,Pa,1,1
237292,group,1,0
237293,.,1,0
237294,Both,0,0
237295,groups,0,0
237296,had,0,0
237297,an,0,0
237298,appropriate,0,0
237299,response,0,1
237300,with,0,0
237301,regard,0,0
237302,to,0,0
237303,H.,0,0
237304,influenzae,0,1
237305,type,0,1
237306,b,0,1
237307,polysaccharide,0,1
237308,polyribosylribitol,0,1
237309,phosphate,0,0
237310,",",0,0
237311,but,0,0
237312,the,0,0
237313,dynamics,0,0
237314,of,0,0
237315,the,0,0
237316,response,0,1
237317,were,0,0
237318,significantly,0,0
237319,different,0,0
237320,:,0,0
237321,geometric,1,1
237322,mean,1,1
237323,concentrations,1,1
237324,(,0,0
237325,micrograms,0,0
237326,per,0,1
237327,ml,0,0
237328,),0,0
237329,after,0,0
237330,the,0,0
237331,second,0,0
237332,",",0,0
237333,third,0,1
237334,and,0,1
237335,booster,0,0
237336,doses,0,0
237337,were,0,0
237338,1.27,0,0
237339,",",0,0
237340,5.06,0,0
237341,and,0,0
237342,23.12,0,0
237343,in,0,0
237344,the,0,0
237345,Pa,0,1
237346,group,0,0
237347,and,0,0
237348,2.72,0,0
237349,",",0,0
237350,6.66,0,0
237351,and,0,0
237352,13.59,0,0
237353,in,0,0
237354,the,0,0
237355,Pw,0,1
237356,group,0,0
237357,",",0,0
237358,respectively,0,0
237359,(,0,0
237360,P,0,0
237361,=,0,0
237362,0.0002,0,0
237363,after,0,0
237364,second,0,0
237365,dose,0,0
237366,;,0,1
237367,P,0,0
237368,=,0,0
237369,0.0005,0,0
237370,after,0,0
237371,booster,0,0
237372,),0,0
237373,.,0,0
237374,CONCLUSION,0,0
237375,The,0,0
237376,presently,0,0
237377,studied,0,0
237378,diphtheria,0,0
237379,",",0,0
237380,tetanus,0,1
237381,",",0,1
237382,acellular,0,1
237383,pertussis-H.,0,0
237384,influenzae,0,1
237385,b,0,1
237386,vaccine,0,0
237387,conjugated,0,0
237388,to,0,0
237389,tetanus,0,0
237390,toxoid,0,1
237391,combination,0,0
237392,was,0,0
237393,at,0,0
237394,least,0,0
237395,as,0,0
237396,immunogenic,0,0
237397,as,0,0
237398,the,0,0
237399,diphtheria,0,0
237400,",",0,1
237401,tetanus,0,1
237402,",",0,1
237403,whole,0,1
237404,cell,0,1
237405,pertussis-H.,0,0
237406,influenzae,0,1
237407,b,0,1
237408,vaccine,0,0
237409,conjugated,0,0
237410,to,0,0
237411,tetanus,0,0
237412,toxoid,0,1
237413,combination,0,0
237414,",",0,0
237415,with,0,0
237416,a,0,0
237417,significantly,0,0
237418,better,0,0
237419,safety,0,1
237420,profile,0,1
237421,.,0,0
237422,This,0,0
237423,is,0,0
237424,of,0,0
237425,obvious,0,1
237426,importance,0,0
237427,in,0,0
237428,countries,0,0
237429,where,0,0
237430,inactivated,0,0
237431,poliovirus,0,1
237432,vaccine,0,0
237433,is,0,0
237434,part,0,0
237435,of,0,0
237436,the,0,0
237437,routine,0,0
237438,infant,0,0
237439,immunization,0,0
237440,programs,0,0
237441,.,0,0
237442,Postoperative,0,1
237443,analgesia,0,1
237444,by,0,0
237445,"D-myo-inositol-1,2,6-trisphosphate",0,1
237446,in,0,0
237447,patients,0,0
237448,undergoing,0,0
237449,cholecystectomy,0,0
237450,.,0,0
237451,UNLABELLED,0,1
237452,"D-myo-inositol-1,2,6-trisphosphate",0,1
237453,(,0,0
237454,"1,2,6-IP3",0,0
237455,),0,0
237456,possesses,0,0
237457,antiinflammatory,0,0
237458,properties,0,1
237459,",",0,0
237460,such,0,0
237461,as,0,0
237462,reduced,0,1
237463,eicosanoid,0,1
237464,synthesis,0,1
237465,and,0,1
237466,inhibition,0,1
237467,of,0,1
237468,inflammation-induced,0,0
237469,edema,0,0
237470,.,0,0
237471,These,0,0
237472,properties,0,0
237473,suggest,0,0
237474,possible,0,0
237475,analgesic,1,1
237476,effects,1,0
237477,.,1,0
237478,The,0,0
237479,analgesic,1,1
237480,effect,1,1
237481,of,0,1
237482,"1,2,6-IP3",0,1
237483,was,0,0
237484,evaluated,0,0
237485,in,0,0
237486,a,0,0
237487,double-blind,0,0
237488,",",0,0
237489,randomized,0,0
237490,study,0,0
237491,in,0,0
237492,24,0,0
237493,patients,0,0
237494,undergoing,0,0
237495,cholecystectomy,0,0
237496,.,0,0
237497,Ten,0,0
237498,patients,0,0
237499,received,0,0
237500,"1,2,6-IP3",0,0
237501,as,0,0
237502,an,0,0
237503,intravenous,0,0
237504,(,0,0
237505,i.v,0,0
237506,.,0,0
237507,),0,0
237508,bolus,0,0
237509,dose,0,0
237510,of,0,0
237511,240,0,0
237512,mg,0,0
237513,",",0,0
237514,followed,0,0
237515,by,0,0
237516,a,0,0
237517,continuous,0,0
237518,i.v,0,0
237519,.,0,1
237520,infusion,0,0
237521,at,0,0
237522,90,0,0
237523,mg/h,0,0
237524,for,0,0
237525,24,0,0
237526,h.,0,0
237527,The,0,0
237528,placebo,0,0
237529,group,0,0
237530,(,0,0
237531,n,0,0
237532,=,0,0
237533,14,0,0
237534,),0,0
237535,received,0,0
237536,corresponding,0,1
237537,volumes,0,1
237538,of,0,0
237539,isotonic,0,0
237540,saline,0,0
237541,.,0,1
237542,Postoperative,1,1
237543,pain,1,1
237544,(,1,0
237545,visual,1,1
237546,analog,1,1
237547,pain,1,1
237548,scale,1,1
237549,;,1,0
237550,VAS,1,1
237551,),1,1
237552,and,1,1
237553,opiate,1,0
237554,analgesic,1,1
237555,requirements,1,1
237556,(,1,1
237557,ketobemidon,1,0
237558,),1,1
237559,were,0,0
237560,evaluated,0,0
237561,during,0,0
237562,five,0,0
237563,postoperative,0,0
237564,days,0,0
237565,.,0,0
237566,Results,0,0
237567,showed,0,0
237568,significantly,0,0
237569,reduced,0,0
237570,pain,1,1
237571,during,0,0
237572,the,0,0
237573,first,0,0
237574,five,0,0
237575,postoperative,0,0
237576,days,0,0
237577,in,0,0
237578,patients,0,0
237579,treated,0,0
237580,with,0,0
237581,"1,2,6-IP3",0,1
237582,",",0,0
237583,as,0,0
237584,measured,0,1
237585,by,0,0
237586,using,0,0
237587,a,0,0
237588,VAS,1,1
237589,(,0,0
237590,P,0,0
237591,<,0,0
237592,0.05,0,0
237593,),0,0
237594,.,0,0
237595,The,0,0
237596,requirements,1,1
237597,of,1,0
237598,opioid,1,0
237599,analgesics,1,1
237600,were,0,0
237601,significantly,0,0
237602,reduced,0,0
237603,during,0,0
237604,the,0,0
237605,first,0,0
237606,three,0,0
237607,postoperative,0,1
237608,days,0,0
237609,(,0,0
237610,P,0,0
237611,<,0,0
237612,0.05,0,0
237613,),0,0
237614,.,0,0
237615,No,0,0
237616,drug-related,1,1
237617,side,1,1
237618,effects,1,1
237619,were,0,0
237620,observed,0,0
237621,.,0,0
237622,Results,0,0
237623,of,0,0
237624,the,0,0
237625,present,0,0
237626,study,0,0
237627,demonstrate,0,0
237628,a,0,0
237629,potent,1,0
237630,and,1,1
237631,long-lasting,1,1
237632,analgesic,1,1
237633,effect,1,1
237634,of,0,1
237635,"1,2,6-IP3",0,1
237636,",",0,0
237637,possibly,0,0
237638,related,0,0
237639,to,0,0
237640,its,0,0
237641,antiinflammatory,0,0
237642,properties,0,1
237643,.,0,0
237644,IMPLICATIONS,0,0
237645,A,0,0
237646,new,0,0
237647,antiinflammatory,0,0
237648,drug,0,0
237649,under,0,0
237650,investigation,0,0
237651,",",0,1
237652,"inositol-1,2,6-trisphosphate",0,1
237653,",",0,1
237654,was,0,0
237655,evaluated,0,0
237656,as,0,0
237657,a,0,0
237658,possible,0,0
237659,analgesic,0,1
237660,in,0,0
237661,a,0,0
237662,pilot,0,0
237663,study,0,0
237664,during,0,0
237665,the,0,0
237666,postoperative,0,1
237667,period,0,0
237668,in,0,0
237669,cholecystectomized,0,0
237670,patients,0,0
237671,.,0,0
237672,Results,0,0
237673,showed,0,0
237674,significantly,0,0
237675,lower,1,0
237676,pain,1,1
237677,assessment,1,1
237678,and,1,1
237679,opioid,1,1
237680,consumption,1,1
237681,",",0,0
237682,which,0,0
237683,should,0,0
237684,encourage,0,0
237685,further,0,0
237686,studies,0,0
237687,.,0,0
237688,A,0,0
237689,carbohydrate,0,0
237690,meal,0,0
237691,attenuates,0,0
237692,the,0,0
237693,forearm,0,1
237694,vasoconstrictor,0,1
237695,response,0,1
237696,to,0,0
237697,lower,0,1
237698,body,0,1
237699,subatmospheric,0,1
237700,pressure,0,1
237701,in,0,0
237702,healthy,0,0
237703,young,0,0
237704,adults,0,0
237705,.,0,0
237706,The,0,0
237707,cardiovascular,0,1
237708,(,0,0
237709,CV,0,1
237710,),0,0
237711,responses,0,1
237712,to,0,0
237713,meal,0,0
237714,ingestion,0,1
237715,and,0,0
237716,orthostasis,0,1
237717,are,0,0
237718,well,0,0
237719,established,0,0
237720,.,0,0
237721,The,0,0
237722,effect,0,0
237723,of,0,1
237724,meal,0,1
237725,ingestion,0,1
237726,and,0,1
237727,meal,0,1
237728,composition,0,0
237729,on,0,0
237730,the,0,0
237731,CV,0,1
237732,responses,0,1
237733,to,0,0
237734,orthostasis,0,1
237735,are,0,0
237736,unknown,0,0
237737,.,0,0
237738,The,0,0
237739,effect,0,0
237740,of,0,0
237741,high,0,1
237742,carbohydrate,0,1
237743,(,0,1
237744,HC,0,1
237745,),0,1
237746,and,0,1
237747,high,0,1
237748,fat,0,1
237749,(,0,1
237750,HF,0,1
237751,),0,1
237752,meal,0,0
237753,ingestion,0,0
237754,on,0,0
237755,the,0,0
237756,CV,0,1
237757,responses,0,1
237758,to,0,0
237759,simulated,0,1
237760,orthostatic,0,1
237761,stress,0,1
237762,(,0,0
237763,using,0,0
237764,graded,0,1
237765,lower,0,0
237766,body,0,1
237767,subatmospheric,0,1
237768,pressure,0,1
237769,(,0,1
237770,LBSP,0,0
237771,),0,1
237772,),0,0
237773,was,0,0
237774,assessed,0,0
237775,in,0,0
237776,nine,0,0
237777,healthy,0,0
237778,young,0,0
237779,volunteers,0,0
237780,.,0,0
237781,Cardiac,1,1
237782,output,1,1
237783,(,1,1
237784,CO,1,1
237785,),1,1
237786,",",1,0
237787,forearm,1,1
237788,blood,1,1
237789,flow,1,1
237790,(,1,1
237791,FABF,1,1
237792,),1,1
237793,heart,1,1
237794,rate,1,1
237795,(,1,1
237796,HR,1,1
237797,),1,1
237798,and,1,1
237799,blood,1,1
237800,pressure,1,1
237801,(,1,1
237802,BP,1,1
237803,),1,1
237804,were,0,0
237805,measured,0,0
237806,before,0,0
237807,and,0,0
237808,during,0,0
237809,LBSP,0,0
237810,while,0,0
237811,fasted,0,0
237812,and,0,0
237813,after,0,0
237814,eating,0,1
237815,HC,0,0
237816,and,0,1
237817,HF,0,0
237818,meals,0,1
237819,.,0,0
237820,Ingestion,0,0
237821,of,0,0
237822,both,0,0
237823,meals,0,1
237824,led,0,0
237825,to,0,0
237826,an,0,0
237827,increase,0,0
237828,in,0,0
237829,CO,1,1
237830,and,1,0
237831,HR,1,1
237832,.,1,0
237833,Both,0,0
237834,meals,0,1
237835,resulted,0,0
237836,in,0,0
237837,a,0,0
237838,fall,0,0
237839,in,0,0
237840,total,1,1
237841,peripheral,1,1
237842,resistance,1,1
237843,but,0,0
237844,only,0,0
237845,HC,0,0
237846,led,0,0
237847,to,0,0
237848,a,0,0
237849,significant,0,0
237850,fall,0,0
237851,in,0,0
237852,BP,1,1
237853,(,0,0
237854,p,0,0
237855,<,0,0
237856,0.05,0,0
237857,),0,0
237858,.,0,0
237859,HF,0,0
237860,had,0,0
237861,no,0,0
237862,effect,0,0
237863,on,0,0
237864,the,0,0
237865,CV,0,1
237866,responses,0,1
237867,to,0,0
237868,LBSP,1,0
237869,",",0,0
237870,whereas,0,0
237871,HC,0,1
237872,resulted,0,0
237873,in,0,0
237874,attenuated,1,0
237875,FABF,1,1
237876,and,1,1
237877,forearm,1,1
237878,vascular,1,1
237879,resistance,1,1
237880,responses,1,1
237881,(,0,0
237882,p,0,0
237883,<,0,0
237884,0.05,0,0
237885,),0,0
237886,.,0,0
237887,Thus,0,1
237888,",",0,0
237889,ingestion,0,0
237890,of,0,0
237891,an,0,0
237892,HC,0,0
237893,meal,0,0
237894,significantly,0,0
237895,attenuates,0,0
237896,the,0,0
237897,forearm,0,1
237898,vascular,0,1
237899,response,0,1
237900,to,0,0
237901,orthostatic,0,1
237902,stress,0,1
237903,and,0,0
237904,the,0,0
237905,hypotensive,0,1
237906,effect,0,1
237907,of,0,0
237908,orthostasis,0,1
237909,is,0,0
237910,additive,0,0
237911,to,0,0
237912,that,0,0
237913,occurring,0,0
237914,after,0,0
237915,an,0,0
237916,HC,0,0
237917,meal,0,0
237918,.,0,0
237919,Electrical,0,1
237920,sources,0,0
237921,of,0,0
237922,P300,0,0
237923,event-related,0,0
237924,brain,0,1
237925,potentials,0,1
237926,revealed,0,0
237927,by,0,0
237928,low,0,0
237929,resolution,0,1
237930,electromagnetic,0,0
237931,tomography,0,0
237932,.,0,0
237933,2,0,0
237934,.,0,0
237935,Effects,0,0
237936,of,0,0
237937,nootropic,0,0
237938,therapy,0,0
237939,in,0,0
237940,age-associated,0,1
237941,memory,0,1
237942,impairment,0,1
237943,.,0,0
237944,In,0,0
237945,a,0,0
237946,double-blind,0,0
237947,",",0,0
237948,placebo-controlled,0,0
237949,study,0,0
237950,the,0,0
237951,effects,0,1
237952,of,0,0
237953,Actovegin,0,0
237954,on,0,0
237955,frontal,0,1
237956,and,0,1
237957,parietal,0,1
237958,electrical,0,1
237959,P300,0,0
237960,sources,0,0
237961,revealed,0,0
237962,by,0,0
237963,low,0,0
237964,resolution,0,1
237965,electromagnetic,0,0
237966,tomography,0,1
237967,(,0,1
237968,LORETA,0,0
237969,),0,1
237970,were,0,0
237971,studied,0,0
237972,in,0,0
237973,age-associated,0,0
237974,memory,0,1
237975,impairment,0,1
237976,(,0,1
237977,AAMI,0,1
237978,),0,0
237979,patients,0,0
237980,.,0,0
237981,Actovegin,0,0
237982,is,0,0
237983,a,0,0
237984,protein-free,0,0
237985,metabolically,0,1
237986,active,0,0
237987,hemoderivative,0,1
237988,improving,0,1
237989,oxygen,0,1
237990,and,0,1
237991,glucose,0,1
237992,utilization,0,1
237993,.,0,0
237994,Each,0,0
237995,patient,0,1
237996,had,0,0
237997,",",0,0
237998,in,0,0
237999,randomized,0,0
238000,order,0,0
238001,",",0,0
238002,a,0,0
238003,treatment,0,0
238004,of,0,0
238005,2,0,0
238006,weeks,0,0
238007,with,0,0
238008,250,0,0
238009,ml,0,0
238010,20,0,0
238011,%,0,0
238012,Actovegin,0,0
238013,and,0,0
238014,250,0,0
238015,ml,0,0
238016,placebo,0,0
238017,daily,0,0
238018,.,0,0
238019,Auditory,0,1
238020,ERPs,0,0
238021,were,0,0
238022,recorded,0,0
238023,before,0,0
238024,and,0,0
238025,5,0,0
238026,h,0,0
238027,after,0,0
238028,drug,0,0
238029,administration,0,0
238030,on,0,0
238031,day,0,0
238032,1,0,0
238033,(,0,0
238034,acute,0,0
238035,effect,0,1
238036,),0,1
238037,and,0,1
238038,on,0,0
238039,day,0,0
238040,15,0,0
238041,(,0,0
238042,subacute,0,0
238043,and,0,1
238044,superimposed,0,0
238045,effect,0,1
238046,),0,0
238047,.,0,0
238048,Compared,0,0
238049,to,0,0
238050,age-,0,0
238051,and,0,1
238052,sex-matched,0,0
238053,normal,0,1
238054,controls,0,0
238055,",",0,0
238056,AAMI,0,1
238057,patients,0,0
238058,showed,0,0
238059,a,0,0
238060,trend,0,0
238061,towards,0,0
238062,P300,1,0
238063,latency,1,1
238064,prolongation,1,1
238065,and,0,0
238066,a,0,0
238067,significantly,0,0
238068,reduced,0,0
238069,P300,1,0
238070,global,1,1
238071,field,1,0
238072,power,1,1
238073,(,0,1
238074,GFP,0,0
238075,),0,0
238076,.,0,0
238077,Maximal,1,1
238078,LORETA,1,0
238079,source,1,1
238080,strength,1,1
238081,did,0,0
238082,not,0,0
238083,differ,0,0
238084,from,0,0
238085,controls,0,0
238086,.,0,0
238087,After,0,0
238088,Actovegin,1,0
238089,parietal,1,1
238090,P300,1,0
238091,scalp,1,1
238092,amplitudes,1,1
238093,increased,0,1
238094,",",0,0
238095,while,0,0
238096,frontal,1,1
238097,and,1,1
238098,temporal,1,1
238099,amplitudes,1,1
238100,decreased,0,1
238101,as,0,0
238102,compared,0,0
238103,to,0,0
238104,placebo,0,0
238105,.,0,0
238106,This,0,0
238107,increase,0,0
238108,in,0,0
238109,hilliness,1,1
238110,",",0,0
238111,measured,0,0
238112,by,0,0
238113,the,0,0
238114,GFP,0,0
238115,",",0,0
238116,was,0,0
238117,significant,0,0
238118,.,0,0
238119,Moreover,0,0
238120,",",0,0
238121,the,0,0
238122,parietal,1,1
238123,P300,1,0
238124,source,1,1
238125,strength,1,1
238126,increased,0,1
238127,after,0,0
238128,acute,0,1
238129,",",0,1
238130,subacute,0,1
238131,and,0,1
238132,superimposed,0,0
238133,infusion,0,0
238134,of,0,1
238135,Actovegin,0,0
238136,as,0,0
238137,compared,0,0
238138,to,0,0
238139,placebo,0,0
238140,.,0,0
238141,This,0,0
238142,may,0,0
238143,reflect,0,0
238144,improved,0,1
238145,availability,0,0
238146,of,0,1
238147,cognitive,0,1
238148,processing,0,1
238149,resources,0,0
238150,in,0,0
238151,the,0,0
238152,parietal,0,1
238153,cortex,0,1
238154,",",0,0
238155,an,0,0
238156,area,0,1
238157,that,0,0
238158,on,0,0
238159,the,0,0
238160,one,0,0
238161,hand,0,0
238162,plays,0,0
238163,an,0,0
238164,important,0,0
238165,role,0,0
238166,in,0,0
238167,fundamental,0,0
238168,aspects,0,1
238169,of,0,1
238170,attention,0,1
238171,and,0,0
238172,on,0,0
238173,the,0,0
238174,other,0,0
238175,hand,0,0
238176,has,0,0
238177,been,0,0
238178,found,0,0
238179,to,0,0
238180,be,0,0
238181,functionally,0,0
238182,impaired,0,0
238183,in,0,0
238184,dementia,0,0
238185,.,0,0
238186,The,0,0
238187,cognitive,1,1
238188,",",1,1
238189,subjective,1,1
238190,",",1,1
238191,and,1,1
238192,physical,1,1
238193,effects,1,1
238194,of,0,0
238195,a,0,0
238196,ginkgo,0,0
238197,biloba/panax,0,0
238198,ginseng,0,0
238199,combination,0,0
238200,in,0,0
238201,healthy,0,0
238202,volunteers,0,0
238203,with,0,0
238204,neurasthenic,0,0
238205,complaints,0,1
238206,.,0,0
238207,We,0,0
238208,evaluated,0,0
238209,the,0,0
238210,effects,1,0
238211,of,0,0
238212,a,0,0
238213,Ginkgo,0,0
238214,biloba/ginseng,0,0
238215,combination,0,0
238216,on,0,0
238217,cognitive,1,1
238218,function,1,1
238219,in,0,0
238220,this,0,0
238221,90-day,0,1
238222,",",0,0
238223,double-blind,0,0
238224,",",0,1
238225,placebo-controlled,0,0
238226,",",0,1
238227,parallel-group,0,0
238228,study,0,0
238229,.,0,0
238230,Sixty-four,0,0
238231,healthy,0,0
238232,volunteers,0,0
238233,(,0,0
238234,aged,0,0
238235,40,0,0
238236,to,0,0
238237,65,0,0
238238,years,0,0
238239,),0,0
238240,",",0,0
238241,selected,0,0
238242,on,0,0
238243,the,0,0
238244,basis,0,0
238245,of,0,0
238246,fulfilling,0,0
238247,the,0,0
238248,ICD-10,0,0
238249,F48.0,0,1
238250,criteria,0,0
238251,for,0,0
238252,neurasthenia,0,1
238253,",",0,1
238254,were,0,0
238255,assigned,0,0
238256,randomly,0,0
238257,to,0,0
238258,four,0,0
238259,equal,0,0
238260,dosing,0,0
238261,groups,0,0
238262,",",0,0
238263,receiving,0,0
238264,80,0,0
238265,",",0,0
238266,160,0,0
238267,",",0,0
238268,or,0,0
238269,320,0,0
238270,mg,0,0
238271,of,0,0
238272,the,0,0
238273,combination,0,0
238274,b.i.d,0,0
238275,.,0,1
238276,or,0,0
238277,placebo,0,0
238278,.,0,1
238279,Assessments,0,1
238280,were,0,0
238281,performed,0,0
238282,on,0,0
238283,the,0,0
238284,day,0,0
238285,before,0,0
238286,dosing,0,0
238287,",",0,1
238288,and,0,1
238289,again,0,0
238290,at,0,0
238291,Days,0,0
238292,1,0,0
238293,",",0,0
238294,30,0,0
238295,",",0,0
238296,and,0,0
238297,90,0,0
238298,at,0,0
238299,1,0,0
238300,hour,0,0
238301,after,0,0
238302,the,0,0
238303,morning,0,1
238304,dose,0,0
238305,and,0,0
238306,1,0,0
238307,hour,0,0
238308,after,0,0
238309,the,0,0
238310,afternoon,0,1
238311,dose,0,0
238312,.,0,0
238313,The,0,0
238314,assessments,0,0
238315,included,0,0
238316,the,0,0
238317,Cognitive,1,1
238318,Drug,1,0
238319,Research,1,1
238320,(,1,1
238321,CDR,1,1
238322,),1,1
238323,computerized,1,0
238324,assessment,1,0
238325,system,1,0
238326,",",1,0
238327,the,1,0
238328,Vienna,1,0
238329,Determination,1,0
238330,Unit,1,0
238331,",",1,1
238332,cycle,1,1
238333,ergometry,1,0
238334,",",1,1
238335,and,1,1
238336,various,1,0
238337,questionnaires,1,0
238338,.,1,0
238339,The,0,0
238340,treatments,0,0
238341,were,0,0
238342,well,1,0
238343,tolerated,1,1
238344,by,0,0
238345,all,0,0
238346,volunteers,0,0
238347,.,0,0
238348,On,0,0
238349,Day,0,0
238350,90,0,0
238351,at,0,0
238352,1,0,0
238353,hour,0,0
238354,post,0,0
238355,morning,0,1
238356,dosing,0,1
238357,",",0,1
238358,dose-related,1,1
238359,improvements,1,1
238360,were,0,0
238361,seen,0,0
238362,on,0,0
238363,the,0,0
238364,CDR,0,0
238365,tests,0,1
238366,",",0,0
238367,the,0,0
238368,320,0,0
238369,mg,0,0
238370,dose,0,0
238371,being,0,0
238372,significantly,0,0
238373,superior,0,0
238374,to,0,0
238375,placebo,0,0
238376,.,0,0
238377,These,0,0
238378,effects,0,1
238379,",",0,0
238380,however,0,0
238381,",",0,0
238382,were,0,0
238383,reversed,0,0
238384,1,0,0
238385,hour,0,0
238386,after,0,0
238387,the,0,0
238388,afternoon,0,1
238389,dose,0,0
238390,",",0,0
238391,possibly,0,0
238392,suggesting,0,0
238393,that,0,0
238394,a,0,0
238395,longer,0,0
238396,inter-dosing,0,1
238397,interval,0,0
238398,would,0,0
238399,be,0,0
238400,preferable,0,0
238401,.,0,0
238402,The,0,0
238403,80-mg,0,0
238404,dose,0,0
238405,produced,0,0
238406,a,0,0
238407,significant,0,0
238408,benefit,0,0
238409,on,0,0
238410,the,0,0
238411,ergometry,1,0
238412,assessment,1,0
238413,of,1,1
238414,heart,1,1
238415,rate,1,1
238416,at,0,0
238417,maximum,0,1
238418,load,0,1
238419,.,0,0
238420,There,0,0
238421,were,0,0
238422,also,0,0
238423,several,0,0
238424,supporting,0,0
238425,changes,0,1
238426,from,0,0
238427,other,0,0
238428,assessments,0,0
238429,",",0,0
238430,including,0,0
238431,an,0,0
238432,advantage,0,0
238433,of,0,0
238434,320,0,0
238435,mg,0,0
238436,over,0,0
238437,placebo,0,0
238438,on,0,0
238439,the,0,0
238440,global,0,1
238441,score,0,1
238442,from,0,0
238443,the,0,0
238444,Symptom,0,1
238445,Checklist-90-revised,0,1
238446,(,0,0
238447,SCL-90-R,0,1
238448,),0,0
238449,at,0,0
238450,Day,0,0
238451,90,0,0
238452,.,0,0
238453,The,0,0
238454,importance,0,0
238455,of,0,0
238456,the,0,0
238457,dual-switch,0,0
238458,valve,0,0
238459,for,0,0
238460,the,0,0
238461,treatment,0,0
238462,of,0,0
238463,adult,0,0
238464,normotensive,0,0
238465,or,0,1
238466,hypertensive,0,0
238467,hydrocephalus,0,1
238468,.,0,0
238469,Since,0,0
238470,the,0,0
238471,beginning,0,0
238472,of,0,0
238473,1995,0,0
238474,the,0,0
238475,new,0,0
238476,hydrostatic,0,1
238477,dual-switch,0,0
238478,valve,0,1
238479,(,0,1
238480,DSV,0,1
238481,),0,1
238482,was,0,0
238483,implanted,0,0
238484,in,0,0
238485,35,0,0
238486,adult,0,0
238487,patients,0,0
238488,with,0,0
238489,hydrocephalus,0,1
238490,of,0,1
238491,different,0,0
238492,etiology,0,1
238493,.,0,0
238494,26,0,0
238495,patients,0,0
238496,suffered,0,0
238497,from,0,0
238498,normotensive,0,0
238499,hydrocephalus,0,1
238500,(,0,0
238501,10,0,0
238502,idiopathic,0,0
238503,and,0,0
238504,16,0,0
238505,symptomatic,0,0
238506,),0,0
238507,",",0,0
238508,and,0,0
238509,9,0,0
238510,patients,0,0
238511,from,0,0
238512,hypertensive,0,0
238513,hydrocephalus,0,1
238514,of,0,1
238515,various,0,0
238516,origin,0,0
238517,.,0,0
238518,The,0,0
238519,first,0,0
238520,21,0,0
238521,cases,0,0
238522,of,0,0
238523,this,0,0
238524,cohort,0,0
238525,were,0,0
238526,compared,0,0
238527,in,0,0
238528,a,0,0
238529,randomized,0,0
238530,study,0,0
238531,with,0,0
238532,a,0,0
238533,comparable,0,0
238534,group,0,0
238535,of,0,0
238536,21,0,0
238537,hydrocephalic,0,0
238538,patients,0,0
238539,who,0,0
238540,received,0,0
238541,a,0,0
238542,conventional,0,0
238543,differential-pressure,0,1
238544,(,0,1
238545,DP-,0,1
238546,),0,0
238547,valve,0,0
238548,.,0,0
238549,The,0,0
238550,clinical,0,0
238551,status,0,1
238552,and,0,1
238553,CT,0,1
238554,were,0,0
238555,assessed,0,0
238556,prior,0,0
238557,to,0,0
238558,shunting,0,1
238559,",",0,0
238560,14,0,0
238561,days,0,0
238562,and,0,0
238563,3,0,0
238564,and,0,0
238565,6,0,0
238566,months,0,0
238567,after,0,0
238568,the,0,0
238569,operation,0,0
238570,.,0,0
238571,The,0,0
238572,reduction,0,1
238573,of,0,0
238574,ventricular,1,1
238575,size,1,1
238576,was,0,0
238577,evaluated,0,0
238578,by,0,0
238579,the,0,0
238580,measurement,0,0
238581,of,0,0
238582,the,0,0
238583,Evans,0,0
238584,Index,0,0
238585,.,0,0
238586,The,0,0
238587,CT,0,1
238588,follow-up,0,0
238589,in,0,0
238590,the,0,0
238591,DSV,0,1
238592,group,0,0
238593,was,0,0
238594,characterized,0,0
238595,by,0,0
238596,an,0,0
238597,only,0,0
238598,minimal,0,1
238599,(,0,0
238600,14,0,0
238601,),0,0
238602,or,0,0
238603,only,0,0
238604,slight,0,1
238605,(,0,0
238606,16,0,0
238607,),0,0
238608,reduction,0,0
238609,of,0,1
238610,ventricular,0,1
238611,size,0,1
238612,in,0,0
238613,the,0,0
238614,vast,0,0
238615,majority,0,0
238616,of,0,0
238617,cases,0,0
238618,.,0,0
238619,A,0,0
238620,comparison,0,0
238621,of,0,0
238622,21,0,0
238623,patients,0,0
238624,with,0,0
238625,a,0,0
238626,DSV,0,1
238627,and,0,0
238628,the,0,0
238629,patients,0,0
238630,with,0,0
238631,DP,0,0
238632,valves,0,0
238633,",",0,0
238634,evaluated,0,0
238635,by,0,0
238636,measuring,0,0
238637,the,0,0
238638,reduction,0,1
238639,of,0,0
238640,the,0,0
238641,Evans,1,0
238642,Index,1,1
238643,",",0,0
238644,revealed,0,0
238645,a,0,0
238646,distinctly,0,0
238647,higher,0,0
238648,percentage,0,1
238649,of,0,1
238650,significant,0,0
238651,regressions,0,0
238652,in,0,0
238653,the,0,0
238654,DP,0,0
238655,valve,0,1
238656,collective,0,1
238657,",",0,1
238658,without,0,0
238659,doubt,0,0
238660,due,0,0
238661,to,0,0
238662,chronic,0,0
238663,overdrainage,0,0
238664,.,0,0
238665,The,0,0
238666,overall,0,1
238667,clinical,0,0
238668,result,0,0
238669,of,0,0
238670,our,0,0
238671,35,0,0
238672,patients,0,0
238673,with,0,0
238674,a,0,0
238675,DSV,0,1
238676,was,0,0
238677,excellent,0,1
238678,and,0,1
238679,good,0,0
238680,in,0,0
238681,31,0,0
238682,patients,0,0
238683,",",0,0
238684,but,0,0
238685,the,0,0
238686,outcome,0,0
238687,seems,0,0
238688,to,0,0
238689,be,0,0
238690,more,0,0
238691,dependent,0,0
238692,on,0,0
238693,the,0,0
238694,preshunt,1,1
238695,damage,1,1
238696,of,1,0
238697,the,1,0
238698,brain,1,1
238699,than,0,0
238700,on,0,0
238701,hydrocephalic,1,1
238702,aspects,1,0
238703,.,1,0
238704,A,0,0
238705,neglegible,0,0
238706,incidence,0,1
238707,of,0,1
238708,subdural,1,0
238709,effusions,1,0
238710,in,0,0
238711,the,0,0
238712,DSV,0,1
238713,group,0,0
238714,compared,0,0
238715,to,0,0
238716,11,0,0
238717,cases,0,0
238718,in,0,0
238719,the,0,0
238720,DP,0,0
238721,valve,0,0
238722,collective,0,0
238723,reflects,0,0
238724,the,0,0
238725,ability,0,1
238726,of,0,0
238727,the,0,0
238728,DSV,0,1
238729,to,0,0
238730,prevent,0,0
238731,overdrainage,1,0
238732,.,1,0
238733,The,0,0
238734,capability,0,0
238735,of,0,0
238736,the,0,0
238737,DSV,0,1
238738,to,0,0
238739,maintain,0,0
238740,the,0,0
238741,IVP,1,1
238742,within,0,0
238743,physiological,0,0
238744,limits,0,0
238745,after,0,0
238746,shunting,0,1
238747,",",0,0
238748,especially,0,0
238749,in,0,0
238750,the,0,0
238751,upright,0,0
238752,position,0,1
238753,",",0,0
238754,is,0,0
238755,documented,0,0
238756,by,0,0
238757,a,0,0
238758,comparison,0,0
238759,with,0,0
238760,possible,1,0
238761,unphysiological,1,0
238762,IVP,1,1
238763,variations,1,0
238764,in,0,0
238765,other,0,0
238766,valve,0,1
238767,constructions,0,0
238768,",",0,0
238769,which,0,0
238770,depend,0,0
238771,on,0,0
238772,the,0,0
238773,level,1,1
238774,of,1,1
238775,implantation,1,0
238776,",",1,1
238777,subcutaneous,1,0
238778,pressure,1,1
238779,or,1,0
238780,CSF,1,0
238781,flow,1,1
238782,through,1,0
238783,the,1,0
238784,valve,1,0
238785,.,1,0
238786,Incidence,0,1
238787,and,0,1
238788,clinical,0,1
238789,significance,0,1
238790,of,0,1
238791,false-negative,0,1
238792,sextant,0,0
238793,prostate,0,0
238794,biopsies,0,1
238795,.,0,0
238796,PURPOSE,0,0
238797,Since,0,0
238798,most,0,0
238799,patients,0,0
238800,do,0,0
238801,not,0,0
238802,undergo,0,0
238803,repeat,0,1
238804,sextant,0,0
238805,prostate,0,0
238806,biopsies,0,1
238807,after,0,0
238808,a,0,0
238809,biopsy,0,0
238810,is,0,0
238811,positive,0,1
238812,for,0,0
238813,prostate,0,0
238814,cancer,0,0
238815,",",0,0
238816,the,0,0
238817,true,0,0
238818,incidence,0,1
238819,of,0,1
238820,false-negative,0,1
238821,biopsies,0,0
238822,is,0,0
238823,not,0,0
238824,well,0,0
238825,defined,0,0
238826,.,0,0
238827,We,0,0
238828,assess,0,0
238829,the,0,0
238830,incidence,0,1
238831,and,0,1
238832,clinical,0,1
238833,significance,0,1
238834,of,0,1
238835,false-negative,0,1
238836,sextant,0,0
238837,prostate,0,0
238838,biopsies,0,1
238839,in,0,0
238840,patients,0,0
238841,undergoing,0,0
238842,radical,0,0
238843,prostatectomy,0,0
238844,.,0,0
238845,MATERIALS,0,0
238846,AND,0,0
238847,METHODS,0,0
238848,A,0,0
238849,total,0,1
238850,of,0,0
238851,118,0,0
238852,patients,0,0
238853,with,0,0
238854,biopsy,0,0
238855,proved,0,0
238856,prostate,0,0
238857,cancer,0,0
238858,underwent,0,0
238859,repeat,0,1
238860,sextant,0,0
238861,prostate,0,0
238862,biopsy,0,1
238863,before,0,0
238864,enrollment,0,0
238865,in,0,0
238866,a,0,0
238867,prospective,0,0
238868,randomized,0,0
238869,trial,0,0
238870,of,0,0
238871,radical,0,1
238872,prostatectomy,0,0
238873,with,0,0
238874,or,0,0
238875,without,0,0
238876,neoadjuvant,0,0
238877,hormonal,0,0
238878,therapy,0,0
238879,.,0,0
238880,Clinical,0,1
238881,parameters,0,1
238882,were,0,0
238883,assessed,0,0
238884,to,0,0
238885,determine,0,0
238886,potential,0,0
238887,sources,0,0
238888,of,0,0
238889,bias,0,1
238890,.,0,0
238891,Pathological,0,1
238892,parameters,0,1
238893,and,0,1
238894,prostate,1,0
238895,specific,1,1
238896,antigen,1,1
238897,relapse-free,1,1
238898,survival,1,1
238899,rates,1,1
238900,were,0,0
238901,compared,0,0
238902,to,0,0
238903,determine,0,0
238904,the,0,0
238905,clinical,0,0
238906,significance,0,1
238907,of,0,1
238908,false-negative,0,1
238909,biopsies,0,1
238910,.,0,0
238911,RESULTS,0,0
238912,Of,0,0
238913,the,0,0
238914,118,0,0
238915,patients,0,0
238916,27,0,0
238917,(,0,0
238918,23,0,0
238919,%,0,0
238920,),0,0
238921,had,0,0
238922,a,0,0
238923,negative,0,1
238924,repeat,0,1
238925,sextant,0,0
238926,biopsy,0,0
238927,.,0,0
238928,Except,0,0
238929,for,0,0
238930,initial,0,0
238931,clinical,0,1
238932,stage,0,0
238933,",",0,0
238934,no,0,0
238935,differences,0,0
238936,were,0,0
238937,noted,0,0
238938,in,0,0
238939,the,0,0
238940,clinical,1,0
238941,or,1,0
238942,pathological,1,1
238943,parameters,1,1
238944,",",0,0
238945,or,0,1
238946,prostate,1,0
238947,specific,1,0
238948,antigen,1,1
238949,relapse,1,1
238950,rates,1,1
238951,in,0,0
238952,patients,0,0
238953,with,0,0
238954,negative,0,1
238955,versus,0,0
238956,positive,0,1
238957,repeat,0,1
238958,biopsies,0,1
238959,.,0,0
238960,CONCLUSIONS,0,0
238961,Our,0,0
238962,findings,0,0
238963,suggest,0,0
238964,that,0,0
238965,this,0,0
238966,23,0,0
238967,%,0,0
238968,incidence,0,1
238969,of,0,1
238970,false-negative,0,1
238971,biopsies,0,0
238972,represents,0,0
238973,significant,0,0
238974,cancer,0,0
238975,.,0,0
238976,This,0,0
238977,relatively,0,0
238978,high,0,0
238979,incidence,0,1
238980,is,0,0
238981,important,0,0
238982,to,0,0
238983,consider,0,0
238984,in,0,0
238985,treatment,0,0
238986,modalities,0,0
238987,in,0,0
238988,which,0,0
238989,prostate,0,0
238990,biopsy,0,0
238991,may,0,0
238992,be,0,0
238993,performed,0,0
238994,to,0,0
238995,determine,0,0
238996,response,0,1
238997,to,0,0
238998,therapy,0,0
238999,.,0,0
239000,Primary,0,1
239001,glaucoma,0,1
239002,triple,0,0
239003,procedure,0,0
239004,in,0,0
239005,patients,0,0
239006,with,0,0
239007,primary,0,0
239008,open-angle,0,0
239009,glaucoma,0,0
239010,:,0,0
239011,the,0,0
239012,effect,1,0
239013,of,0,0
239014,mitomycin,0,0
239015,C,0,0
239016,in,0,0
239017,patients,0,0
239018,with,0,0
239019,and,0,0
239020,without,0,0
239021,prognostic,0,1
239022,factors,0,0
239023,for,0,0
239024,filtration,0,1
239025,failure,0,1
239026,.,0,0
239027,PURPOSE,0,0
239028,To,0,0
239029,investigate,0,0
239030,the,0,0
239031,effect,1,0
239032,of,0,0
239033,adjunctive,0,0
239034,mitomycin,0,0
239035,C,0,0
239036,on,0,0
239037,primary,0,0
239038,glaucoma,0,1
239039,triple,0,0
239040,procedure,0,0
239041,in,0,0
239042,patients,0,0
239043,with,0,0
239044,primary,0,0
239045,open-angle,0,0
239046,glaucoma,0,1
239047,with,0,0
239048,and,0,0
239049,without,0,0
239050,one,0,0
239051,or,0,0
239052,more,0,0
239053,of,0,0
239054,the,0,0
239055,prognostic,0,1
239056,factors,0,0
239057,for,0,0
239058,filtration,0,1
239059,failure,0,1
239060,of,0,1
239061,primary,0,0
239062,glaucoma,0,1
239063,triple,0,0
239064,procedure,0,0
239065,.,0,0
239066,Those,0,0
239067,factors,0,0
239068,include,0,0
239069,being,0,0
239070,of,0,0
239071,African-American,0,0
239072,race,0,0
239073,",",0,0
239074,having,0,0
239075,a,0,0
239076,preoperative,0,1
239077,intraocular,0,1
239078,pressure,0,1
239079,of,0,0
239080,20,0,0
239081,mm,0,0
239082,Hg,0,0
239083,or,0,0
239084,more,0,0
239085,on,0,0
239086,maximum,0,1
239087,tolerated,0,1
239088,medications,0,1
239089,",",0,1
239090,and,0,1
239091,being,0,0
239092,on,0,0
239093,two,0,0
239094,or,0,0
239095,more,0,0
239096,medications,0,0
239097,preoperatively,0,0
239098,.,0,0
239099,METHODS,0,0
239100,Study,0,0
239101,patients,0,0
239102,consisted,0,0
239103,of,0,0
239104,197,0,0
239105,consecutive,0,0
239106,patients,0,0
239107,with,0,0
239108,primary,0,0
239109,open-angle,0,0
239110,glaucoma,0,0
239111,who,0,0
239112,were,0,0
239113,randomly,0,0
239114,assigned,0,0
239115,to,0,0
239116,receive,0,0
239117,either,0,0
239118,no,0,0
239119,adjunctive,0,0
239120,mitomycin,0,0
239121,C,0,0
239122,(,0,0
239123,101,0,0
239124,eyes,0,0
239125,of,0,0
239126,101,0,0
239127,patients,0,0
239128,),0,0
239129,or,0,0
239130,to,0,0
239131,receive,0,0
239132,adjunctive,0,0
239133,subconjunctival,0,0
239134,mitomycin,0,0
239135,C,0,0
239136,(,0,0
239137,96,0,0
239138,eyes,0,0
239139,of,0,0
239140,96,0,0
239141,patients,0,0
239142,),0,0
239143,during,0,0
239144,the,0,0
239145,primary,0,0
239146,glaucoma,0,1
239147,triple,0,0
239148,procedure,0,0
239149,.,0,0
239150,Kaplan-Meier,1,1
239151,survival,1,1
239152,analysis,1,0
239153,comparisons,1,0
239154,were,0,0
239155,made,0,0
239156,between,0,0
239157,respective,0,0
239158,subgroups,0,0
239159,with,0,0
239160,and,0,0
239161,without,0,0
239162,prognostic,0,1
239163,indicators,0,1
239164,for,0,0
239165,filtration,0,1
239166,failures,0,1
239167,using,0,0
239168,a,0,0
239169,relatively,0,0
239170,stringent,0,0
239171,set,0,0
239172,of,0,0
239173,criteria,0,0
239174,for,0,0
239175,filtration,0,1
239176,success,0,1
239177,of,0,1
239178,primary,0,0
239179,glaucoma,0,1
239180,triple,0,0
239181,procedure,0,0
239182,.,0,0
239183,RESULTS,0,0
239184,There,0,0
239185,was,0,0
239186,no,0,0
239187,statistically,0,0
239188,significant,0,0
239189,(,0,0
239190,P,0,0
239191,=,0,0
239192,.117,0,0
239193,),0,0
239194,difference,0,0
239195,in,0,0
239196,filtration,1,1
239197,success,1,1
239198,of,0,1
239199,primary,0,0
239200,glaucoma,0,1
239201,triple,0,0
239202,procedure,0,0
239203,between,0,0
239204,the,0,0
239205,control,0,0
239206,and,0,1
239207,mitomycin,0,0
239208,C,0,0
239209,groups,0,0
239210,.,0,1
239211,Adjunctive,0,1
239212,mitomycin,0,0
239213,C,0,0
239214,significantly,0,0
239215,(,0,0
239216,P,0,0
239217,<,0,0
239218,.05,0,0
239219,),0,0
239220,improved,0,0
239221,the,0,0
239222,filtration,1,1
239223,outcome,0,1
239224,of,0,0
239225,the,0,0
239226,primary,0,0
239227,glaucoma,0,1
239228,triple,0,0
239229,procedure,0,0
239230,in,0,0
239231,the,0,0
239232,subgroups,0,0
239233,with,0,0
239234,each,0,0
239235,of,0,0
239236,the,0,0
239237,three,0,0
239238,prognostic,0,0
239239,factors,0,0
239240,for,0,0
239241,filtration,0,1
239242,failure,0,1
239243,of,0,1
239244,primary,0,0
239245,glaucoma,0,1
239246,triple,0,0
239247,procedure,0,0
239248,.,0,0
239249,On,0,0
239250,the,0,0
239251,other,0,0
239252,hand,0,1
239253,",",0,0
239254,in,0,0
239255,the,0,0
239256,subgroups,0,0
239257,without,0,0
239258,the,0,0
239259,prognostic,0,1
239260,factors,0,1
239261,",",0,1
239262,adjunctive,0,0
239263,mitomycin,0,0
239264,C,0,0
239265,did,0,0
239266,not,0,0
239267,significantly,0,0
239268,(,0,0
239269,P,0,0
239270,>,0,1
239271,.05,0,0
239272,),0,0
239273,change,0,0
239274,the,0,0
239275,filtration,1,1
239276,outcome,1,1
239277,of,0,0
239278,the,0,0
239279,primary,0,0
239280,glaucoma,0,1
239281,triple,0,0
239282,procedure,0,0
239283,.,0,0
239284,CONCLUSION,0,0
239285,These,0,0
239286,findings,0,0
239287,establish,0,0
239288,the,0,0
239289,basis,0,0
239290,for,0,0
239291,selective,0,1
239292,use,0,0
239293,of,0,1
239294,mitomycin,0,0
239295,C,0,0
239296,in,0,0
239297,patients,0,0
239298,with,0,0
239299,primary,0,0
239300,open-angle,0,0
239301,glaucoma,0,1
239302,undergoing,0,0
239303,primary,0,0
239304,glaucoma,0,1
239305,triple,0,0
239306,procedure,0,0
239307,.,0,0
239308,Pruritus,0,1
239309,in,0,0
239310,HIV-1,0,0
239311,disease,0,1
239312,:,0,0
239313,therapy,0,0
239314,with,0,0
239315,drugs,0,0
239316,which,0,0
239317,may,0,0
239318,modulate,0,0
239319,the,0,0
239320,pattern,0,0
239321,of,0,0
239322,immune,1,1
239323,dysregulation,1,1
239324,.,1,0
239325,BACKGROUND,0,0
239326,Pruritus,0,1
239327,in,0,0
239328,HIV-1+,0,0
239329,patients,0,0
239330,is,0,0
239331,common,0,0
239332,and,0,0
239333,increases,0,1
239334,with,0,0
239335,disease,0,0
239336,progression,0,1
239337,.,0,0
239338,The,0,0
239339,causes,0,0
239340,of,0,0
239341,pruritus,0,1
239342,are,0,0
239343,numerous,0,0
239344,including,0,0
239345,xerosis,0,1
239346,",",0,1
239347,drug,0,1
239348,and,0,1
239349,photoeruptions,0,1
239350,",",0,1
239351,follicular,0,1
239352,and,0,1
239353,papular,0,1
239354,eruptions,0,1
239355,as,0,0
239356,well,0,0
239357,as,0,0
239358,infestations,0,1
239359,and,0,1
239360,infections,0,1
239361,by,0,0
239362,a,0,0
239363,wide,0,0
239364,range,0,0
239365,of,0,0
239366,organisms,0,0
239367,.,0,0
239368,One,0,0
239369,other,0,0
239370,possible,0,0
239371,factor,0,0
239372,contributing,0,0
239373,to,0,0
239374,pruritus,0,1
239375,is,0,0
239376,the,0,0
239377,pattern,0,0
239378,of,0,0
239379,immune,0,1
239380,dysregulation,0,1
239381,.,0,0
239382,With,0,0
239383,advancing,0,0
239384,HIV-1,0,0
239385,disease,0,0
239386,there,0,0
239387,is,0,0
239388,Th1,0,0
239389,to,0,0
239390,Th2,0,0
239391,cytokine,0,1
239392,switching,0,0
239393,.,0,0
239394,METHODS,0,0
239395,After,0,0
239396,some,0,0
239397,positive,0,0
239398,results,0,0
239399,with,0,0
239400,prostaglandin,0,1
239401,inhibitors,0,0
239402,",",0,0
239403,we,0,0
239404,undertook,0,0
239405,a,0,0
239406,study,0,0
239407,in,0,0
239408,which,0,0
239409,we,0,0
239410,randomly,0,0
239411,placed,0,0
239412,patients,0,0
239413,on,0,0
239414,four,0,0
239415,different,0,0
239416,forms,0,0
239417,of,0,0
239418,therapy,0,0
239419,for,0,0
239420,their,0,0
239421,pruritus,0,1
239422,.,0,0
239423,The,0,0
239424,therapies,0,0
239425,included,0,0
239426,hydroxyzine,0,1
239427,with,0,0
239428,or,0,0
239429,without,0,0
239430,doxepin,0,0
239431,at,0,0
239432,night,0,1
239433,",",0,1
239434,pentoxifylline,0,0
239435,",",0,1
239436,indomethacin,0,0
239437,and,0,1
239438,topical,0,0
239439,moisturization,0,1
239440,with,0,0
239441,medium-strength,0,0
239442,topical,0,0
239443,steroids,0,0
239444,.,0,0
239445,All,0,0
239446,patients,0,0
239447,were,0,0
239448,evaluated,0,0
239449,for,0,0
239450,both,0,0
239451,subjective,1,1
239452,relief,1,1
239453,as,0,0
239454,well,0,0
239455,as,0,0
239456,side,1,1
239457,effects,1,1
239458,.,1,0
239459,RESULTS,0,0
239460,Patients,0,0
239461,placed,0,0
239462,on,0,0
239463,indomethacin,0,0
239464,obtained,0,0
239465,relief,1,1
239466,more,0,0
239467,consistently,0,1
239468,and,0,0
239469,more,0,0
239470,completely,0,0
239471,.,0,0
239472,Patients,0,0
239473,on,0,0
239474,pentoxifylline,0,0
239475,had,0,0
239476,the,0,0
239477,fewest,0,0
239478,side,1,1
239479,effects,1,1
239480,of,0,0
239481,all,0,0
239482,oral,0,0
239483,therapies,0,0
239484,.,0,0
239485,Patients,0,0
239486,on,0,0
239487,antihistamines,0,0
239488,with,0,0
239489,or,0,0
239490,without,0,0
239491,doxepin,0,0
239492,had,0,0
239493,the,0,0
239494,highest,0,1
239495,incidence,1,1
239496,of,1,1
239497,side,1,1
239498,effects,1,1
239499,",",0,0
239500,although,0,0
239501,more,0,0
239502,of,0,0
239503,these,0,0
239504,patients,0,0
239505,reported,0,0
239506,a,0,0
239507,greater,0,0
239508,degree,1,1
239509,of,1,1
239510,relief,1,1
239511,than,0,0
239512,patients,0,0
239513,on,0,0
239514,pentoxifylline,0,0
239515,.,0,0
239516,All,0,0
239517,patients,0,0
239518,on,0,0
239519,oral,0,0
239520,therapy,0,0
239521,overall,0,1
239522,had,0,0
239523,greater,1,1
239524,relief,1,1
239525,than,0,0
239526,patients,0,0
239527,using,0,0
239528,topical,0,0
239529,steroids,0,0
239530,.,0,0
239531,CONCLUSION,0,0
239532,The,0,0
239533,systemic,0,1
239534,therapies,0,0
239535,which,0,0
239536,may,0,0
239537,modulate,0,0
239538,the,0,0
239539,pattern,0,0
239540,of,0,0
239541,immune,1,1
239542,dysregulation,1,1
239543,seen,0,0
239544,in,0,0
239545,HIV-1,0,0
239546,disease,0,0
239547,may,0,0
239548,be,0,0
239549,beneficial,1,0
239550,in,0,0
239551,the,0,0
239552,pruritus,0,1
239553,seen,0,0
239554,in,0,0
239555,late-stage,0,0
239556,patients,0,0
239557,.,0,0
239558,A,0,0
239559,prospective,0,0
239560,randomized,0,0
239561,study,0,0
239562,of,0,0
239563,amoxycillin,0,0
239564,and,0,1
239565,omeprazole,0,0
239566,with,0,0
239567,and,0,1
239568,without,0,0
239569,metronidazole,0,0
239570,in,0,0
239571,the,0,0
239572,eradication,0,1
239573,treatment,0,0
239574,of,0,1
239575,Helicobacter,0,0
239576,pylori,0,1
239577,.,0,0
239578,A,0,0
239579,combination,0,0
239580,of,0,1
239581,amoxycillin,0,0
239582,and,0,0
239583,omeprazole,0,0
239584,is,0,0
239585,often,0,0
239586,used,0,0
239587,to,0,0
239588,treat,0,0
239589,Helicobacter,0,1
239590,pylori,0,1
239591,infection,0,1
239592,.,0,0
239593,A,0,0
239594,three-drug,0,0
239595,regimen,0,0
239596,comprising,0,0
239597,metronidazole,0,0
239598,",",0,1
239599,amoxycillin,0,0
239600,and,0,1
239601,omeprazole,0,0
239602,has,0,0
239603,been,0,0
239604,proposed,0,0
239605,as,0,0
239606,an,0,0
239607,alternative,0,0
239608,therapy,0,0
239609,.,0,0
239610,In,0,0
239611,a,0,0
239612,prospective,0,0
239613,",",0,0
239614,randomized,0,0
239615,",",0,0
239616,comparative,0,0
239617,study,0,0
239618,",",0,0
239619,we,0,0
239620,evaluated,0,0
239621,these,0,0
239622,two,0,0
239623,regimens,0,0
239624,with,0,0
239625,respect,0,0
239626,to,0,0
239627,safety,0,1
239628,and,0,1
239629,efficacy,0,1
239630,in,0,0
239631,patients,0,0
239632,with,0,0
239633,H.,0,0
239634,pylori,0,1
239635,infection,0,1
239636,.,0,0
239637,Sixty,0,0
239638,patients,0,0
239639,with,0,0
239640,peptic,0,0
239641,ulcer,0,1
239642,(,0,1
239643,gastric,0,1
239644,",",0,0
239645,32,0,0
239646,patients,0,0
239647,;,0,0
239648,duodenal,0,0
239649,",",0,0
239650,28,0,0
239651,patients,0,0
239652,),0,0
239653,who,0,0
239654,had,0,0
239655,a,0,0
239656,history,0,1
239657,of,0,0
239658,ulcer,0,1
239659,recurrence,0,1
239660,were,0,0
239661,randomly,0,0
239662,assigned,0,0
239663,to,0,0
239664,dual,0,0
239665,therapy,0,0
239666,with,0,0
239667,amoxycillin,0,0
239668,(,0,0
239669,500,0,0
239670,mg,0,0
239671,three,0,0
239672,times,0,0
239673,daily,0,0
239674,for,0,0
239675,2,0,0
239676,weeks,0,0
239677,),0,0
239678,and,0,1
239679,omeprazole,0,0
239680,(,0,0
239681,20,0,0
239682,mg,0,0
239683,once,0,0
239684,daily,0,0
239685,for,0,0
239686,8,0,0
239687,weeks,0,0
239688,),0,0
239689,or,0,0
239690,to,0,0
239691,triple,0,0
239692,therapy,0,0
239693,with,0,0
239694,metronidazole,0,0
239695,(,0,0
239696,500,0,0
239697,mg,0,0
239698,twice,0,0
239699,daily,0,0
239700,for,0,0
239701,2,0,0
239702,weeks,0,0
239703,),0,0
239704,plus,0,0
239705,amoxycillin,0,0
239706,and,0,1
239707,omeprazole,0,0
239708,",",0,1
239709,given,0,0
239710,in,0,0
239711,the,0,0
239712,same,0,0
239713,dosages,0,0
239714,as,0,0
239715,dual,0,0
239716,therapy,0,0
239717,.,0,0
239718,Forty-eight,0,0
239719,patients,0,0
239720,completed,0,0
239721,the,0,0
239722,protocol,0,0
239723,;,0,0
239724,treatment,0,0
239725,was,0,0
239726,discontinued,0,0
239727,because,0,0
239728,of,0,0
239729,side,0,1
239730,effects,0,0
239731,in,0,0
239732,nine,0,0
239733,patients,0,0
239734,",",0,0
239735,and,0,0
239736,three,0,0
239737,patients,0,0
239738,dropped,0,0
239739,out,0,0
239740,of,0,0
239741,the,0,0
239742,study,0,0
239743,.,0,0
239744,On,0,0
239745,the,0,0
239746,basis,0,0
239747,of,0,0
239748,all,0,0
239749,patients,0,0
239750,treated,0,0
239751,",",0,0
239752,the,1,0
239753,rate,1,1
239754,of,1,0
239755,H.,1,0
239756,pylori,1,1
239757,eradication,1,1
239758,was,1,0
239759,significantly,1,0
239760,higher,1,0
239761,for,1,0
239762,triple,1,0
239763,therapy,1,0
239764,20/23,1,0
239765,cases,1,0
239766,",",1,0
239767,87.0,1,0
239768,%,1,0
239769,;,1,0
239770,95,1,0
239771,%,1,0
239772,confidence,1,0
239773,interval,1,0
239774,(,1,1
239775,CI,1,0
239776,),1,1
239777,",",1,0
239778,0.664-0.972,1,0
239779,),1,0
239780,than,1,0
239781,for,1,0
239782,dual,1,0
239783,therapy,1,0
239784,13/25,0,0
239785,",",0,0
239786,52.0,0,0
239787,%,0,0
239788,;,0,0
239789,0.313-0.722,0,0
239790,;,0,0
239791,P,0,0
239792,<,0,0
239793,0.05,0,0
239794,),0,0
239795,.,0,0
239796,On,0,0
239797,an,0,0
239798,intention-to-treat,0,0
239799,basis,0,0
239800,",",0,0
239801,the,1,0
239802,difference,1,0
239803,between,1,0
239804,the,1,0
239805,groups,1,0
239806,in,1,0
239807,the,1,0
239808,rate,1,1
239809,of,1,0
239810,H.,1,0
239811,pylori,1,1
239812,eradication,1,1
239813,was,1,0
239814,marginally,1,0
239815,significant,1,0
239816,(,0,0
239817,P,0,0
239818,=,0,0
239819,0.06,0,0
239820,[,0,0
239821,0.028-0.512,0,0
239822,],0,0
239823,),0,0
239824,.,0,0
239825,Side,1,0
239826,effects,1,1
239827,were,1,0
239828,reported,1,0
239829,by,1,0
239830,five,1,0
239831,patients,1,0
239832,receiving,1,0
239833,triple,1,0
239834,therapy,1,0
239835,(,1,0
239836,skin,1,1
239837,rash,1,1
239838,",",0,0
239839,one,0,0
239840,;,0,0
239841,nausea,1,1
239842,",",0,0
239843,two,0,0
239844,;,0,0
239845,headache,1,0
239846,",",0,0
239847,one,0,0
239848,;,0,0
239849,abdominal,1,0
239850,pain,1,1
239851,",",0,0
239852,one,0,0
239853,),0,0
239854,",",0,0
239855,and,0,0
239856,four,1,0
239857,patients,1,0
239858,receiving,1,0
239859,dual,1,0
239860,therapy,1,0
239861,(,1,0
239862,skin,1,1
239863,rash,1,1
239864,",",0,0
239865,two,0,0
239866,;,0,0
239867,abdominal,1,0
239868,pain,1,1
239869,",",0,0
239870,one,0,0
239871,;,0,0
239872,diarrhoea,1,1
239873,",",0,0
239874,one,0,0
239875,),0,0
239876,.,0,0
239877,All,1,0
239878,side,1,1
239879,effects,1,1
239880,resolved,1,0
239881,spontaneously,1,0
239882,after,1,0
239883,termination,1,0
239884,of,1,0
239885,treatment,1,0
239886,.,1,0
239887,There,1,0
239888,was,1,0
239889,no,1,0
239890,significant,1,0
239891,difference,1,0
239892,in,1,0
239893,safety,1,1
239894,between,1,0
239895,the,1,0
239896,two,1,0
239897,regimens,1,0
239898,.,1,0
239899,Triple,1,0
239900,therapy,1,0
239901,with,1,0
239902,metronidazole,1,0
239903,",",1,1
239904,amoxycillin,1,0
239905,",",1,1
239906,and,1,1
239907,omeprazole,1,0
239908,was,1,0
239909,significantly,1,0
239910,more,1,0
239911,effective,1,1
239912,for,1,0
239913,the,1,0
239914,eradication,1,1
239915,of,1,0
239916,H.,1,0
239917,pylori,1,1
239918,than,1,0
239919,dual,1,0
239920,therapy,1,0
239921,with,1,0
239922,amoxycillin,1,0
239923,and,1,1
239924,omeprazole,1,0
239925,alone,1,0
239926,.,1,0
239927,The,0,0
239928,safety,0,1
239929,of,0,0
239930,these,0,0
239931,regimens,0,0
239932,was,0,0
239933,similar,0,0
239934,",",0,1
239935,and,0,1
239936,triple,0,1
239937,therapy,0,0
239938,was,0,0
239939,found,0,0
239940,to,0,0
239941,be,0,0
239942,clinically,0,0
239943,acceptable,0,0
239944,.,0,0
239945,Comparison,0,0
239946,of,0,1
239947,single-,0,0
239948,and,0,1
239949,dual-coil,0,0
239950,active,0,1
239951,pectoral,0,1
239952,defibrillation,0,0
239953,lead,0,0
239954,systems,0,0
239955,.,0,0
239956,OBJECTIVES,0,0
239957,The,0,0
239958,purpose,0,0
239959,of,0,0
239960,this,0,0
239961,study,0,0
239962,was,0,0
239963,to,0,0
239964,compare,0,0
239965,defibrillation,0,0
239966,thresholds,0,1
239967,with,0,0
239968,lead,0,0
239969,systems,0,0
239970,consisting,0,0
239971,of,0,0
239972,an,0,0
239973,active,0,0
239974,left,0,1
239975,pectoral,0,1
239976,electrode,0,1
239977,and,0,0
239978,either,0,0
239979,single,0,0
239980,or,0,0
239981,dual,0,0
239982,transvenous,0,0
239983,coils,0,0
239984,.,0,0
239985,BACKGROUND,0,0
239986,Lead,0,1
239987,systems,0,0
239988,that,0,0
239989,include,0,0
239990,an,0,0
239991,active,0,0
239992,pectoral,0,1
239993,pulse,0,1
239994,generator,0,1
239995,reduce,0,0
239996,defibrillation,0,0
239997,thresholds,0,1
239998,and,0,0
239999,permit,0,0
240000,transvenous,0,0
240001,defibrillation,0,0
240002,in,0,0
240003,nearly,0,0
240004,all,0,0
240005,patients,0,0
240006,.,0,0
240007,A,0,0
240008,further,0,0
240009,improvement,0,1
240010,in,0,0
240011,defibrillation,1,0
240012,efficacy,1,1
240013,is,0,0
240014,desirable,0,0
240015,to,0,0
240016,allow,0,0
240017,for,0,0
240018,smaller,0,0
240019,pulse,0,1
240020,generators,0,1
240021,with,0,0
240022,a,0,0
240023,reduced,0,0
240024,maximal,0,1
240025,output,0,1
240026,.,0,0
240027,METHODS,0,0
240028,This,0,0
240029,prospective,0,0
240030,study,0,0
240031,was,0,0
240032,performed,0,0
240033,in,0,0
240034,50,0,0
240035,consecutive,0,0
240036,patients,0,0
240037,.,0,0
240038,Each,0,0
240039,patient,0,1
240040,was,0,0
240041,evaluated,0,0
240042,with,0,0
240043,two,0,0
240044,lead,0,0
240045,configurations,0,0
240046,with,0,0
240047,the,0,0
240048,order,0,0
240049,of,0,0
240050,testing,0,0
240051,randomized,0,0
240052,.,0,0
240053,Shocks,0,0
240054,were,0,0
240055,delivered,0,0
240056,between,0,0
240057,the,0,0
240058,right,0,1
240059,ventricular,0,1
240060,coil,0,0
240061,and,0,0
240062,either,0,0
240063,an,0,0
240064,active,0,0
240065,can,0,0
240066,alone,0,0
240067,(,0,0
240068,single,0,0
240069,coil,0,1
240070,),0,0
240071,or,0,0
240072,an,0,0
240073,active,0,0
240074,can,0,0
240075,with,0,0
240076,the,0,0
240077,proximal,0,0
240078,atrial,0,1
240079,coil,0,1
240080,(,0,0
240081,dual,0,0
240082,coil,0,0
240083,),0,0
240084,.,0,0
240085,The,0,0
240086,right,0,1
240087,ventricular,0,1
240088,coil,0,0
240089,was,0,0
240090,the,0,0
240091,cathode,0,0
240092,for,0,0
240093,the,0,0
240094,first,0,0
240095,phase,0,0
240096,of,0,0
240097,the,0,0
240098,biphasic,0,0
240099,defibrillation,0,0
240100,waveform,0,1
240101,.,0,1
240102,RESULTS,0,0
240103,Delivered,1,0
240104,energy,1,1
240105,at,0,0
240106,the,0,0
240107,defibrillation,1,0
240108,threshold,1,1
240109,was,0,0
240110,10.1+/-5.0,0,0
240111,J,0,0
240112,for,0,0
240113,the,0,0
240114,single-coil,0,0
240115,configuration,0,0
240116,and,0,1
240117,8.7+/-4.0,0,0
240118,J,0,0
240119,for,0,0
240120,the,0,0
240121,dual-coil,0,0
240122,configuration,0,0
240123,(,0,0
240124,p,0,0
240125,<,0,0
240126,0.02,0,0
240127,),0,0
240128,.,0,0
240129,Moreover,0,0
240130,",",0,0
240131,98,0,0
240132,%,0,0
240133,of,0,0
240134,patients,0,0
240135,had,0,0
240136,low,0,0
240137,(,0,0
240138,<,0,0
240139,15,0,0
240140,J,0,0
240141,),0,0
240142,thresholds,1,1
240143,with,0,0
240144,the,0,0
240145,dual-coil,0,0
240146,lead,0,0
240147,system,0,0
240148,",",0,1
240149,compared,0,0
240150,with,0,0
240151,88,0,0
240152,%,0,0
240153,of,0,0
240154,patients,0,0
240155,with,0,0
240156,the,0,0
240157,single-coil,0,0
240158,configuration,0,0
240159,(,0,1
240160,p=0.05,0,0
240161,),0,0
240162,.,0,0
240163,Leading,1,1
240164,edge,1,1
240165,voltage,1,1
240166,(,0,0
240167,p,0,0
240168,<,0,0
240169,0.001,0,0
240170,),0,0
240171,and,0,0
240172,shock,1,1
240173,impedance,1,1
240174,(,0,0
240175,p,0,0
240176,<,0,0
240177,0.001,0,0
240178,),0,0
240179,were,0,0
240180,also,0,0
240181,decreased,0,0
240182,with,0,0
240183,the,0,0
240184,dual-coil,0,0
240185,configuration,0,0
240186,",",0,0
240187,although,0,0
240188,peak,1,1
240189,current,1,0
240190,was,0,0
240191,increased,0,0
240192,(,0,0
240193,p,0,0
240194,<,0,0
240195,0.001,0,0
240196,),0,0
240197,.,0,0
240198,CONCLUSIONS,0,0
240199,A,0,0
240200,dual-coil,0,0
240201,",",0,0
240202,active,0,1
240203,pectoral,0,1
240204,lead,0,0
240205,system,0,0
240206,reduces,0,1
240207,defibrillation,1,0
240208,energy,1,1
240209,requirements,1,1
240210,compared,0,0
240211,with,0,0
240212,a,0,0
240213,single-coil,0,0
240214,",",0,0
240215,unipolar,0,0
240216,configuration,0,0
240217,.,0,0
240218,Bronchodilator,0,1
240219,response,0,1
240220,to,0,0
240221,salbutamol,0,0
240222,after,0,0
240223,spontaneous,0,1
240224,recovery,0,1
240225,from,0,0
240226,nonspecific,0,0
240227,bronchial,0,1
240228,provocation,0,0
240229,tests,0,1
240230,in,0,0
240231,asthma,0,0
240232,.,0,0
240233,Assessment,0,1
240234,of,0,1
240235,airway,0,1
240236,responsiveness,0,1
240237,by,0,0
240238,bronchoprovocation,0,1
240239,and,0,1
240240,bronchodilatation,0,0
240241,tests,0,1
240242,is,0,0
240243,important,0,0
240244,in,0,0
240245,the,0,0
240246,diagnostic,0,0
240247,work-up,0,0
240248,protocol,0,0
240249,of,0,1
240250,bronchial,0,1
240251,asthma,0,0
240252,and,0,0
240253,it,0,0
240254,would,0,0
240255,be,0,0
240256,convenient,0,0
240257,to,0,0
240258,undertake,0,0
240259,both,0,0
240260,tests,0,0
240261,on,0,0
240262,the,0,0
240263,same,0,0
240264,occasion,0,0
240265,.,0,0
240266,However,0,0
240267,",",0,0
240268,it,0,0
240269,is,0,0
240270,not,0,0
240271,known,0,0
240272,whether,0,0
240273,this,0,0
240274,can,0,0
240275,be,0,0
240276,done,0,0
240277,accurately,0,0
240278,.,0,0
240279,Therefore,0,0
240280,",",0,0
240281,this,0,0
240282,study,0,0
240283,evaluated,0,0
240284,the,0,0
240285,effect,0,0
240286,of,0,0
240287,a,0,0
240288,prior,0,0
240289,bronchial,0,1
240290,provocation,0,1
240291,test,0,1
240292,on,0,0
240293,the,0,0
240294,bronchodilator,0,0
240295,response,0,1
240296,to,0,0
240297,salbutamol,0,0
240298,after,0,0
240299,spontaneous,0,1
240300,recovery,0,1
240301,of,0,0
240302,the,0,0
240303,forced,0,0
240304,expiratory,0,1
240305,volume,0,1
240306,in,0,0
240307,one,0,0
240308,second,0,0
240309,(,1,0
240310,FEV1,1,1
240311,),1,0
240312,in,0,0
240313,a,0,0
240314,group,0,0
240315,of,0,0
240316,asthmatic,0,0
240317,subjects,0,0
240318,.,0,0
240319,On,0,0
240320,two,0,0
240321,separate,0,0
240322,occasions,0,0
240323,at,0,0
240324,the,0,0
240325,same,0,0
240326,time,0,1
240327,of,0,1
240328,day,0,1
240329,",",0,0
240330,concentration-response,0,1
240331,studies,0,0
240332,with,0,0
240333,inhaled,0,0
240334,histamine,0,1
240335,or,0,1
240336,methacholine,0,1
240337,",",0,1
240338,or,0,0
240339,a,0,0
240340,sham,0,0
240341,challenge,0,0
240342,with,0,0
240343,normal,0,1
240344,saline,0,0
240345,were,0,0
240346,carried,0,0
240347,out,0,0
240348,in,0,0
240349,a,0,0
240350,blinded,0,0
240351,",",0,0
240352,randomized,0,0
240353,manner,0,0
240354,.,0,0
240355,Changes,0,1
240356,in,0,0
240357,airway,0,1
240358,calibre,0,1
240359,were,0,0
240360,followed,0,0
240361,as,0,0
240362,FEV1,1,1
240363,and,0,1
240364,agonist,0,0
240365,responsiveness,0,1
240366,expressed,0,0
240367,as,0,0
240368,the,0,0
240369,provocative,0,0
240370,concentration,0,1
240371,causing,0,0
240372,a,0,0
240373,20,0,0
240374,%,0,0
240375,fall,0,0
240376,in,0,0
240377,FEV1,1,1
240378,(,0,0
240379,PC20,0,1
240380,),0,0
240381,.,0,0
240382,After,0,0
240383,either,0,0
240384,spontaneous,0,1
240385,recovery,0,1
240386,or,0,0
240387,a,0,0
240388,fixed-duration,0,0
240389,wait,0,0
240390,of,0,0
240391,45,0,0
240392,min,0,0
240393,(,0,0
240394,when,0,0
240395,appropriate,0,1
240396,),0,0
240397,",",0,0
240398,the,0,0
240399,subjects,0,0
240400,received,0,0
240401,2x100,0,0
240402,microg,0,0
240403,of,0,0
240404,salbutamol,0,0
240405,from,0,0
240406,a,0,0
240407,metered,0,0
240408,dose,0,0
240409,inhaler,0,0
240410,with,0,0
240411,a,0,0
240412,spacer,0,0
240413,.,0,0
240414,The,0,0
240415,bronchodilator,0,0
240416,response,0,1
240417,to,0,0
240418,salbutamol,0,0
240419,was,0,0
240420,expressed,0,0
240421,as,0,0
240422,a,0,0
240423,percentage,0,1
240424,of,0,0
240425,initial,1,0
240426,FEV1,1,1
240427,(,0,0
240428,deltaFEV1,0,1
240429,%,0,0
240430,init,0,0
240431,),0,0
240432,.,0,0
240433,Bronchial,0,1
240434,challenge,0,0
240435,with,0,0
240436,both,0,0
240437,agonists,0,0
240438,failed,0,0
240439,to,0,0
240440,alter,0,0
240441,significantly,0,0
240442,the,0,0
240443,airway,1,1
240444,response,1,1
240445,to,0,0
240446,salbutamol,0,0
240447,",",0,0
240448,with,0,0
240449,the,0,0
240450,deltaFEV1,1,1
240451,%,1,0
240452,init,1,1
240453,mean,1,1
240454,value,1,1
240455,(,0,1
240456,range,0,0
240457,),0,0
240458,being,0,0
240459,16.9,0,0
240460,%,0,0
240461,(,0,0
240462,9.0-31.9,0,0
240463,),0,0
240464,and,0,0
240465,17.5,0,0
240466,%,0,0
240467,(,0,0
240468,11.6-31.2,0,0
240469,),0,0
240470,on,0,0
240471,the,0,0
240472,sham,0,0
240473,and,0,1
240474,histamine/methacholine,0,1
240475,challenge,0,0
240476,day,0,0
240477,respectively,0,0
240478,.,0,0
240479,It,0,0
240480,was,0,0
240481,shown,0,0
240482,that,0,0
240483,the,0,0
240484,degree,0,0
240485,of,0,0
240486,bronchodilatation,0,1
240487,achieved,0,1
240488,after,0,0
240489,salbutamol,0,0
240490,200,0,0
240491,microg,0,0
240492,is,0,0
240493,not,0,0
240494,affected,0,0
240495,by,0,0
240496,prior,0,0
240497,bronchoprovocation,0,1
240498,testing,0,0
240499,when,0,0
240500,enough,0,0
240501,time,0,1
240502,is,0,0
240503,allowed,0,0
240504,for,0,0
240505,the,0,0
240506,airways,0,0
240507,to,0,0
240508,recover,0,0
240509,spontaneously,0,0
240510,to,0,0
240511,baseline,0,0
240512,forced,0,1
240513,expiratory,0,1
240514,volume,0,1
240515,in,0,0
240516,one,0,0
240517,second,0,0
240518,.,0,0
240519,Thus,0,1
240520,evaluation,0,0
240521,of,0,1
240522,airway,0,1
240523,responsiveness,0,1
240524,by,0,0
240525,both,0,0
240526,bronchial,0,0
240527,provocation,0,0
240528,tests,0,1
240529,and,0,1
240530,bronchodilator,0,0
240531,testing,0,0
240532,can,0,0
240533,be,0,0
240534,assessed,0,0
240535,reliably,0,0
240536,within,0,0
240537,a,0,0
240538,few,0,0
240539,hours,0,0
240540,in,0,0
240541,asthmatic,0,0
240542,patients,0,0
240543,.,0,0
240544,Randomised,0,0
240545,placebo-controlled,0,0
240546,trial,0,0
240547,of,0,1
240548,rhesus-human,0,0
240549,reassortant,0,1
240550,rotavirus,0,0
240551,vaccine,0,0
240552,for,0,0
240553,prevention,0,0
240554,of,0,1
240555,severe,1,1
240556,rotavirus,1,0
240557,gastroenteritis,1,1
240558,.,1,1
240559,BACKGROUND,0,0
240560,Rotavirus,0,0
240561,is,0,0
240562,the,0,0
240563,most,0,0
240564,common,0,0
240565,cause,0,0
240566,of,0,1
240567,acute,0,0
240568,childhood,0,0
240569,gastroenteritis,0,1
240570,.,0,1
240571,Vaccination,0,0
240572,with,0,0
240573,live,0,0
240574,oral,0,0
240575,heterologous,0,1
240576,rotavirus,0,0
240577,vaccines,0,0
240578,may,0,0
240579,prevent,0,0
240580,rotavirus,0,0
240581,gastroenteritis,0,0
240582,.,0,0
240583,We,0,0
240584,assessed,0,0
240585,the,0,0
240586,efficacy,1,1
240587,of,0,0
240588,rhesus-human,0,0
240589,reassortant,0,1
240590,rotavirus,0,0
240591,tetravalent,0,1
240592,vaccine,0,0
240593,(,0,1
240594,RRV-TV,0,1
240595,),0,0
240596,against,0,0
240597,severe,0,1
240598,rotavirus,0,0
240599,gastroenteritis,0,1
240600,in,0,0
240601,Finnish,0,0
240602,children,0,0
240603,in,0,0
240604,a,0,0
240605,randomised,0,0
240606,placebo-controlled,0,0
240607,double-blind,0,0
240608,trial,0,0
240609,.,0,0
240610,METHODS,0,0
240611,Placebo,0,0
240612,or,0,1
240613,RRV-TV,0,1
240614,(,0,0
240615,titre,0,1
240616,4x10,0,0
240617,(,0,0
240618,5,0,0
240619,),0,0
240620,plaque-forming,0,1
240621,units,0,0
240622,),0,0
240623,was,0,0
240624,given,0,0
240625,to,0,0
240626,infants,0,0
240627,at,0,0
240628,ages,0,0
240629,2,0,0
240630,",",0,0
240631,3,0,0
240632,",",0,0
240633,and,0,0
240634,5,0,0
240635,months,0,0
240636,.,0,0
240637,The,0,0
240638,children,0,0
240639,were,0,0
240640,followed,0,0
240641,up,0,0
240642,for,0,0
240643,one,0,0
240644,or,0,0
240645,two,0,0
240646,rotavirus,0,0
240647,epidemic,0,0
240648,seasons,0,0
240649,.,0,0
240650,The,0,0
240651,main,0,0
240652,outcome,0,1
240653,measure,0,1
240654,was,0,0
240655,protection,1,1
240656,against,1,1
240657,severe,1,1
240658,rotavirus,1,0
240659,gastroenteritis,1,1
240660,(,0,1
240661,score,0,1
240662,>,0,1
240663,or,0,1
240664,=11,0,0
240665,on,0,0
240666,a,0,0
240667,20-point,0,1
240668,severity,0,1
240669,scale,0,1
240670,),0,0
240671,.,0,0
240672,2398,0,0
240673,children,0,0
240674,were,0,0
240675,enrolled,0,0
240676,and,0,0
240677,received,0,0
240678,at,0,0
240679,least,0,0
240680,one,0,0
240681,dose,0,0
240682,of,0,0
240683,RRV-TV,0,1
240684,(,0,1
240685,n=1191,0,0
240686,),0,1
240687,or,0,1
240688,placebo,0,0
240689,(,0,1
240690,n=1207,0,0
240691,),0,0
240692,.,0,0
240693,The,0,0
240694,primary,0,0
240695,efficacy,0,1
240696,analysis,0,0
240697,was,0,0
240698,based,0,0
240699,on,0,0
240700,children,0,0
240701,who,0,0
240702,received,0,0
240703,three,0,0
240704,doses,0,0
240705,of,0,0
240706,RRV-TV,0,1
240707,(,0,1
240708,n=1128,0,0
240709,),0,1
240710,or,0,1
240711,placebo,0,0
240712,(,0,1
240713,n=1145,0,0
240714,),0,0
240715,.,0,0
240716,FINDINGS,0,0
240717,256,0,0
240718,episodes,0,0
240719,of,0,0
240720,rotavirus,0,0
240721,gastroenteritis,0,1
240722,occurred,0,0
240723,at,0,0
240724,any,0,0
240725,time,0,1
240726,during,0,0
240727,the,0,0
240728,study,0,0
240729,;,0,0
240730,65,0,0
240731,were,0,0
240732,among,0,0
240733,1191,0,0
240734,RRV-TV,0,0
240735,recipients,0,0
240736,",",0,0
240737,and,0,0
240738,191,0,0
240739,among,0,0
240740,1207,0,0
240741,placebo,0,0
240742,recipients,0,0
240743,(,0,0
240744,vaccine,0,0
240745,efficacy,0,1
240746,66,0,0
240747,%,0,0
240748,[,0,0
240749,95,0,0
240750,%,0,0
240751,CI,0,0
240752,55-74,0,0
240753,],0,0
240754,;,0,0
240755,intention-to-treat,0,0
240756,analysis,0,0
240757,),0,0
240758,.,0,0
240759,226,0,0
240760,episodes,0,0
240761,were,0,0
240762,included,0,0
240763,in,0,0
240764,the,0,0
240765,primary,0,0
240766,efficacy,1,1
240767,analysis,0,0
240768,of,0,0
240769,fully,0,0
240770,vaccinated,0,0
240771,children,0,0
240772,(,0,0
240773,54,0,0
240774,among,0,0
240775,1128,0,0
240776,RRV-TV,0,0
240777,recipients,0,0
240778,",",0,0
240779,172,0,0
240780,among,0,0
240781,1145,0,0
240782,placebo,0,0
240783,recipients,0,0
240784,;,0,0
240785,vaccine,0,0
240786,efficacy,0,1
240787,68,0,0
240788,%,0,0
240789,[,0,0
240790,57-76,0,0
240791,],0,0
240792,),0,0
240793,.,0,0
240794,100,0,0
240795,episodes,0,0
240796,were,0,0
240797,severe,0,1
240798,",",0,0
240799,eight,0,0
240800,in,0,0
240801,RRV-TV,0,0
240802,recipients,0,0
240803,and,0,0
240804,92,0,0
240805,in,0,0
240806,placebo,0,0
240807,recipients,0,0
240808,(,0,0
240809,vaccine,0,0
240810,efficacy,0,1
240811,91,0,0
240812,%,0,0
240813,[,0,0
240814,82-96,0,0
240815,],0,0
240816,),0,0
240817,.,0,0
240818,INTERPRETATION,0,0
240819,RRV-TV,0,1
240820,vaccine,0,0
240821,was,0,0
240822,highly,0,0
240823,effective,0,0
240824,against,0,0
240825,severe,0,1
240826,rotavirus,0,0
240827,gastroenteritis,0,1
240828,in,0,0
240829,young,0,0
240830,children,0,0
240831,.,0,0
240832,Incorporation,0,0
240833,of,0,0
240834,this,0,0
240835,vaccine,0,0
240836,into,0,0
240837,routine,0,0
240838,immunisation,0,0
240839,schedules,0,0
240840,of,0,0
240841,infants,0,0
240842,could,0,0
240843,reduce,0,0
240844,severe,1,1
240845,rotavirus,1,0
240846,gastroenteritis,1,1
240847,by,0,0
240848,90,0,0
240849,%,0,0
240850,and,0,0
240851,severe,1,1
240852,gastroenteritis,1,1
240853,of,0,0
240854,all,0,0
240855,causes,0,0
240856,in,0,0
240857,young,0,0
240858,children,0,0
240859,by,0,0
240860,60,0,0
240861,%,0,0
240862,.,0,0
240863,Salbutamol,0,0
240864,or,0,1
240865,mist,0,1
240866,in,0,0
240867,acute,0,0
240868,bronchiolitis,0,1
240869,.,0,0
240870,BACKGROUND,0,0
240871,The,0,0
240872,role,0,0
240873,of,0,0
240874,bronchodilators,0,0
240875,in,0,0
240876,the,0,0
240877,treatment,0,0
240878,of,0,0
240879,bronchiolitis,0,0
240880,remains,0,0
240881,controversial,0,0
240882,.,0,0
240883,METHODS,0,0
240884,A,0,0
240885,double-blind,0,0
240886,",",0,1
240887,placebo,0,0
240888,controlled,0,0
240889,trial,0,0
240890,was,0,0
240891,performed,0,0
240892,to,0,0
240893,evaluate,0,0
240894,the,0,0
240895,clinical,0,0
240896,response,0,1
240897,to,0,0
240898,nebulized,0,0
240899,salbutamol,0,0
240900,.,0,0
240901,One,0,0
240902,hundred,0,0
240903,and,0,0
240904,fifty-six,0,0
240905,infants,0,0
240906,aged,0,0
240907,between,0,0
240908,7,0,0
240909,weeks,0,0
240910,and,0,0
240911,24,0,0
240912,months,0,0
240913,who,0,0
240914,had,0,0
240915,had,0,0
240916,an,0,0
240917,episode,0,0
240918,of,0,1
240919,wheezing,0,1
240920,and,0,1
240921,other,0,1
240922,signs,0,1
240923,and,0,1
240924,symptoms,0,1
240925,of,0,1
240926,bronchiolitis,0,1
240927,were,0,0
240928,randomized,0,0
240929,to,0,0
240930,three,0,0
240931,groups,0,0
240932,as,0,0
240933,follows,0,0
240934,:,0,0
240935,(,0,0
240936,i,0,0
240937,),0,1
240938,nebulized,0,0
240939,salbutamol,0,0
240940,was,0,0
240941,administered,0,0
240942,to,0,0
240943,52,0,0
240944,patients,0,0
240945,in,0,0
240946,group,0,0
240947,I,0,0
240948,at,0,0
240949,a,0,0
240950,dose,0,0
240951,of,0,0
240952,0.15,0,0
240953,mg/kg,0,0
240954,in,0,0
240955,2,0,0
240956,mL,0,0
240957,saline,0,0
240958,;,0,1
240959,(,0,0
240960,ii,0,0
240961,),0,1
240962,saline,0,0
240963,was,0,0
240964,nebulized,0,0
240965,to,0,0
240966,52,0,0
240967,patients,0,0
240968,in,0,0
240969,group,0,0
240970,II,0,0
240971,and,0,1
240972,(,0,1
240973,iii,0,1
240974,),0,1
240975,in,0,0
240976,group,0,0
240977,III,0,0
240978,52,0,0
240979,patients,0,0
240980,received,0,0
240981,mist,0,0
240982,in,0,0
240983,a,0,0
240984,tent,0,0
240985,.,0,0
240986,All,0,0
240987,three,0,0
240988,groups,0,0
240989,were,0,0
240990,administered,0,0
240991,oxygen,0,0
240992,during,0,0
240993,the,0,0
240994,procedures,0,0
240995,.,0,0
240996,Treatment,0,0
240997,was,0,0
240998,repeated,0,0
240999,with,0,0
241000,the,0,0
241001,same,0,0
241002,agent,0,0
241003,after,0,0
241004,30,0,0
241005,min,0,0
241006,if,0,0
241007,the,0,0
241008,respiratory,0,1
241009,score,0,1
241010,was,0,0
241011,5,0,0
241012,or,0,0
241013,more,0,0
241014,.,0,1
241015,Respiratory,1,1
241016,rate,1,1
241017,",",1,1
241018,heart,1,1
241019,rate,1,1
241020,",",1,1
241021,oxygen,1,1
241022,saturation,1,1
241023,and,1,1
241024,presence,1,0
241025,of,1,1
241026,cyanosis,1,1
241027,",",1,1
241028,wheezing,1,1
241029,",",1,1
241030,retractions,1,1
241031,were,0,0
241032,recorded,0,0
241033,before,0,0
241034,and,0,0
241035,after,0,0
241036,each,0,0
241037,treatment,0,0
241038,.,0,0
241039,RESULTS,0,0
241040,The,0,0
241041,decrease,0,0
241042,in,0,0
241043,the,0,0
241044,respiratory,1,1
241045,score,1,1
241046,was,0,0
241047,5.2,0,0
241048,+/-,0,0
241049,1.8,0,0
241050,",",0,0
241051,0.82,0,0
241052,+/-,0,0
241053,2.4,0,0
241054,and,0,0
241055,1.7,0,0
241056,+/-,0,0
241057,1.3,0,0
241058,in,0,0
241059,group,0,0
241060,I,0,0
241061,",",0,0
241062,II,0,0
241063,and,0,1
241064,III,0,1
241065,",",0,0
241066,respectively,0,0
241067,.,0,0
241068,The,0,0
241069,decrease,0,1
241070,in,0,0
241071,group,0,0
241072,I,0,0
241073,was,0,0
241074,significantly,0,0
241075,higher,0,0
241076,than,0,0
241077,in,0,0
241078,the,0,0
241079,other,0,0
241080,groups,0,0
241081,.,0,0
241082,Heart,1,1
241083,rate,1,1
241084,was,0,0
241085,similar,0,0
241086,between,0,0
241087,groups,0,0
241088,.,0,0
241089,Oxygen,1,1
241090,saturation,1,1
241091,decreased,0,1
241092,in,0,0
241093,group,0,0
241094,I,0,0
241095,without,0,0
241096,reaching,0,1
241097,statistical,0,0
241098,significance,0,1
241099,.,0,0
241100,CONCLUSIONS,0,0
241101,Salbutamol,0,0
241102,was,0,0
241103,shown,0,0
241104,to,0,0
241105,be,0,0
241106,effective,1,1
241107,and,1,1
241108,safe,1,1
241109,in,0,0
241110,the,0,0
241111,treatment,0,0
241112,of,0,0
241113,acute,0,0
241114,bronchiolitis,0,0
241115,.,0,0
241116,Pelvic,0,0
241117,lymphocysts,0,1
241118,following,0,0
241119,retroperitoneal,0,0
241120,lymphadenectomy,0,0
241121,:,0,0
241122,retroperitoneal,0,1
241123,partial,0,1
241124,no-closure,0,1
241125,for,0,0
241126,ovarian,0,1
241127,and,0,1
241128,endometrial,0,1
241129,cancers,0,1
241130,.,0,0
241131,BACKGROUND,0,0
241132,AND,0,0
241133,OBJECTIVES,0,1
241134,Pelvic,0,0
241135,lymphocysts,0,0
241136,have,0,0
241137,been,0,0
241138,reported,0,0
241139,mainly,0,0
241140,following,0,0
241141,pelvic,0,0
241142,lymphadenectomy,0,0
241143,for,0,0
241144,cervical,0,0
241145,cancer,0,0
241146,.,0,0
241147,We,0,0
241148,attempted,0,0
241149,to,0,0
241150,assess,0,0
241151,whether,0,0
241152,retroperitoneal,0,1
241153,partial,0,0
241154,no-closure,0,0
241155,reduces,0,0
241156,the,0,0
241157,incidence,0,1
241158,of,0,0
241159,lymphocyst,1,1
241160,formation,1,1
241161,following,0,0
241162,retroperitoneal,0,0
241163,lymphadenectomy,0,0
241164,.,0,0
241165,METHODS,0,0
241166,Sixty-one,0,0
241167,patients,0,0
241168,with,0,0
241169,ovarian,0,1
241170,cancer,0,0
241171,or,0,1
241172,endometrial,0,1
241173,cancer,0,0
241174,who,0,0
241175,underwent,0,0
241176,retroperitoneal,0,1
241177,lymph,0,1
241178,node,0,1
241179,resection,0,1
241180,were,0,0
241181,assigned,0,0
241182,at,0,0
241183,random,0,0
241184,to,0,0
241185,a,0,0
241186,retroperitoneal,0,0
241187,partial,0,1
241188,no-closure,0,1
241189,group,0,0
241190,or,0,0
241191,a,0,0
241192,closure,0,1
241193,group,0,0
241194,.,0,0
241195,The,0,0
241196,incidence,0,1
241197,of,0,0
241198,lymphocysts,1,0
241199,in,0,0
241200,the,0,0
241201,two,0,0
241202,groups,0,0
241203,as,0,0
241204,determined,0,0
241205,using,0,0
241206,ultrasonography,0,1
241207,was,0,0
241208,compared,0,0
241209,.,0,0
241210,RESULTS,0,0
241211,Lymphocysts,1,1
241212,appeared,0,0
241213,in,0,0
241214,23/61,0,0
241215,patients,0,0
241216,(,0,0
241217,38,0,0
241218,%,0,0
241219,),0,0
241220,in,0,0
241221,total,0,1
241222,.,0,0
241223,In,0,0
241224,the,0,0
241225,closure,0,1
241226,group,0,0
241227,",",0,0
241228,the,0,0
241229,incidence,0,1
241230,was,0,0
241231,52,0,0
241232,%,0,0
241233,(,0,0
241234,16/31,0,0
241235,),0,0
241236,",",0,0
241237,but,0,0
241238,in,0,0
241239,the,0,0
241240,no-closure,0,0
241241,group,0,0
241242,it,0,0
241243,was,0,0
241244,only,0,0
241245,23,0,0
241246,%,0,0
241247,(,0,0
241248,7/30,0,0
241249,),0,0
241250,;,0,0
241251,the,0,0
241252,incidence,0,1
241253,in,0,0
241254,the,0,0
241255,no-closure,0,1
241256,group,0,0
241257,was,0,0
241258,significantly,0,0
241259,lower,0,0
241260,(,0,0
241261,P,0,0
241262,<,0,0
241263,0.05,0,0
241264,),0,0
241265,.,0,0
241266,The,0,0
241267,incidence,0,1
241268,of,0,0
241269,postoperative,1,1
241270,fever,1,1
241271,was,0,0
241272,17,0,0
241273,%,0,0
241274,(,0,0
241275,5/30,0,0
241276,),0,0
241277,in,0,0
241278,the,0,0
241279,no-closure,0,1
241280,group,0,0
241281,",",0,1
241282,which,0,0
241283,was,0,0
241284,lower,0,0
241285,than,0,0
241286,that,0,0
241287,in,0,0
241288,the,0,0
241289,closure,0,1
241290,group,0,0
241291,(,0,0
241292,42,0,0
241293,%,0,0
241294,",",0,0
241295,13/31,0,0
241296,),0,0
241297,",",0,0
241298,but,0,0
241299,not,0,0
241300,significantly,0,0
241301,so,0,0
241302,(,0,0
241303,P,0,0
241304,<,0,0
241305,0.1,0,0
241306,),0,0
241307,.,0,0
241308,No,0,0
241309,patients,0,0
241310,in,0,0
241311,the,0,0
241312,no-closure,0,1
241313,group,0,0
241314,required,0,1
241315,surgical,0,0
241316,procedures,0,0
241317,such,0,0
241318,as,0,0
241319,needle,0,0
241320,aspiration,0,1
241321,or,0,1
241322,cyst,0,1
241323,drainage,0,1
241324,.,0,1
241325,CONCLUSIONS,0,0
241326,Retroperitoneal,0,0
241327,partial,0,0
241328,no-closure,0,0
241329,appears,0,0
241330,to,0,0
241331,be,0,0
241332,a,0,0
241333,useful,0,0
241334,procedure,0,0
241335,for,0,0
241336,reducing,0,0
241337,the,0,0
241338,incidence,0,1
241339,of,0,0
241340,pelvic,1,0
241341,lymphocysts,1,0
241342,associated,0,0
241343,with,0,0
241344,retroperitoneal,0,0
241345,lymphadenectomy,0,0
241346,.,0,0
241347,Laser,0,0
241348,therapy,0,0
241349,combined,0,0
241350,with,0,0
241351,brachytherapy,0,0
241352,for,0,0
241353,the,0,0
241354,palliation,0,0
241355,of,0,0
241356,malignant,0,0
241357,dysphagia,0,1
241358,.,0,0
241359,BACKGROUND/AIM,0,0
241360,OF,0,0
241361,STUDY,0,0
241362,Laser,0,0
241363,therapy,0,0
241364,is,0,0
241365,effective,0,1
241366,in,0,0
241367,relieving,0,0
241368,malignant,1,1
241369,dysphagia,1,1
241370,",",0,1
241371,but,0,0
241372,repeated,0,0
241373,treatments,0,0
241374,at,0,0
241375,4,0,0
241376,to,0,0
241377,6,0,0
241378,week,0,0
241379,intervals,0,0
241380,are,0,0
241381,usually,0,0
241382,required,0,0
241383,.,0,0
241384,This,0,0
241385,prospective,0,0
241386,randomised,0,0
241387,trial,0,0
241388,is,0,0
241389,designed,0,0
241390,to,0,0
241391,determine,0,0
241392,if,0,0
241393,addition,0,0
241394,of,0,1
241395,brachytherapy,0,0
241396,offers,0,0
241397,any,0,0
241398,advantages,0,0
241399,over,0,0
241400,laser,0,0
241401,therapy,0,0
241402,alone,0,0
241403,.,0,0
241404,METHODS,0,0
241405,Patients,0,0
241406,with,0,0
241407,inoperable,0,0
241408,carcinoma,0,0
241409,of,0,0
241410,the,0,0
241411,oesophagus,0,1
241412,were,0,0
241413,randomised,0,0
241414,to,0,0
241415,receive,0,0
241416,either,0,0
241417,endoscopic,0,0
241418,Nd,0,0
241419,:,0,0
241420,YAG,0,0
241421,laser,0,0
241422,therapy,0,0
241423,alone,0,0
241424,",",0,0
241425,or,0,1
241426,laser,0,0
241427,followed,0,0
241428,by,0,0
241429,brachytherapy,0,0
241430,.,0,0
241431,Patients,0,0
241432,who,0,0
241433,developed,0,0
241434,worsening,0,1
241435,dysphagia,0,1
241436,during,0,0
241437,follow-up,0,0
241438,were,0,0
241439,offered,0,0
241440,further,0,0
241441,treatment,0,0
241442,as,0,0
241443,appropriate,0,0
241444,.,0,0
241445,RESULTS,0,0
241446,Fourteen,0,0
241447,patients,0,0
241448,were,0,0
241449,randomised,0,0
241450,to,0,0
241451,receive,0,0
241452,laser,0,0
241453,only,0,0
241454,",",0,0
241455,and,0,0
241456,12,0,0
241457,to,0,0
241458,receive,0,0
241459,laser,0,0
241460,followed,0,0
241461,by,0,0
241462,brachytherapy,0,0
241463,.,0,0
241464,Of,0,0
241465,these,0,0
241466,12,0,0
241467,",",0,0
241468,one,0,0
241469,was,0,0
241470,lost,0,0
241471,to,0,0
241472,follow-up,0,0
241473,and,0,0
241474,four,0,0
241475,did,0,0
241476,not,0,0
241477,receive,0,0
241478,brachytherapy,0,0
241479,because,0,0
241480,they,0,0
241481,were,0,0
241482,unfit,0,0
241483,",",0,1
241484,had,0,0
241485,extension,0,0
241486,into,0,0
241487,the,0,0
241488,cardia,0,0
241489,or,0,1
241490,had,0,0
241491,mainly,0,0
241492,extrinsic,0,0
241493,compression,0,0
241494,.,0,0
241495,These,0,0
241496,4,0,0
241497,are,0,0
241498,included,0,0
241499,on,0,0
241500,an,0,0
241501,'intention-to-treat,0,0
241502,',0,1
241503,basis,0,0
241504,.,0,0
241505,The,0,0
241506,mean,1,1
241507,therapeutic,1,0
241508,interval,1,0
241509,for,0,0
241510,the,0,0
241511,brachytherapy,0,0
241512,group,0,0
241513,was,0,0
241514,significantly,0,0
241515,longer,0,0
241516,",",0,0
241517,83,0,0
241518,days,0,0
241519,compared,0,0
241520,to,0,0
241521,36,0,0
241522,days,0,0
241523,for,0,0
241524,the,0,0
241525,laser,0,0
241526,group,0,0
241527,(,0,0
241528,p,0,0
241529,=,0,0
241530,0.026,0,0
241531,),0,0
241532,.,0,0
241533,There,0,0
241534,were,0,0
241535,no,0,0
241536,differences,0,0
241537,in,0,0
241538,the,0,0
241539,degree,1,0
241540,of,1,1
241541,dysphagia,1,1
241542,relief,1,1
241543,",",1,1
241544,number,1,1
241545,of,1,1
241546,endoscopic,1,1
241547,procedures,1,0
241548,or,1,0
241549,survival,1,1
241550,times,1,1
241551,.,1,0
241552,CONCLUSION,0,0
241553,The,0,0
241554,preliminary,0,0
241555,results,0,0
241556,of,0,0
241557,this,0,0
241558,trial,0,0
241559,suggest,0,0
241560,that,0,0
241561,brachytherapy,0,0
241562,in,0,0
241563,addition,0,0
241564,to,0,0
241565,laser,0,0
241566,therapy,0,0
241567,prolongs,0,0
241568,the,0,0
241569,first,0,0
241570,therapeutic,1,0
241571,interval,1,0
241572,.,1,0
241573,However,0,0
241574,",",0,0
241575,no,0,0
241576,long-term,0,0
241577,advantages,0,0
241578,have,0,0
241579,been,0,0
241580,shown,0,0
241581,.,0,0
241582,Braced,0,0
241583,for,0,0
241584,impact,0,0
241585,:,0,0
241586,reducing,0,0
241587,military,0,0
241588,paratroopers,0,1
241589,',0,1
241590,ankle,0,1
241591,sprains,0,1
241592,using,0,0
241593,outside-the-boot,0,0
241594,braces,0,0
241595,.,0,0
241596,BACKGROUND,0,0
241597,Ankle,0,0
241598,injuries,0,1
241599,account,0,0
241600,for,0,0
241601,30,0,0
241602,to,0,0
241603,60,0,0
241604,%,0,0
241605,of,0,0
241606,all,0,0
241607,parachuting,0,0
241608,injuries,0,0
241609,.,0,0
241610,This,0,0
241611,study,0,0
241612,was,0,0
241613,designed,0,0
241614,to,0,0
241615,determine,0,0
241616,if,0,0
241617,outside-the-boot,0,0
241618,ankle,0,0
241619,braces,0,0
241620,could,0,0
241621,reduce,0,0
241622,ankle,0,1
241623,sprains,0,1
241624,during,0,0
241625,Army,0,1
241626,paratrooper,0,0
241627,training,0,0
241628,.,0,0
241629,METHODS,0,0
241630,The,0,0
241631,randomized,0,0
241632,trial,0,0
241633,involved,0,0
241634,777,0,0
241635,volunteers,0,0
241636,from,0,0
241637,the,0,0
241638,U.S.,0,1
241639,Army,0,1
241640,Airborne,0,0
241641,School,0,1
241642,",",0,1
241643,Fort,0,0
241644,Benning,0,1
241645,",",0,1
241646,Ga.,0,1
241647,Of,0,0
241648,this,0,0
241649,group,0,0
241650,",",0,0
241651,745,0,0
241652,completed,0,0
241653,all,0,0
241654,study,0,0
241655,requirements,0,1
241656,(,0,0
241657,369,0,0
241658,brace-wearers,0,0
241659,and,0,0
241660,376,0,0
241661,non-brace-wearers,0,0
241662,),0,0
241663,.,0,0
241664,Each,0,0
241665,volunteer,0,0
241666,made,0,0
241667,five,0,0
241668,parachute,0,0
241669,jumps,0,0
241670,",",0,0
241671,for,0,0
241672,a,0,0
241673,total,0,0
241674,of,0,0
241675,"3,674",0,0
241676,jumps,0,0
241677,.,0,0
241678,RESULTS,0,0
241679,The,0,0
241680,incidence,1,1
241681,of,1,1
241682,inversion,1,1
241683,ankle,1,1
241684,sprains,1,1
241685,was,0,0
241686,1.9,0,0
241687,%,0,0
241688,in,0,0
241689,non-brace-wearers,0,0
241690,and,0,0
241691,0.3,0,0
241692,%,0,0
241693,in,0,0
241694,brace-wearers,0,1
241695,(,0,0
241696,risk,0,1
241697,ratio,0,1
241698,",",0,0
241699,6.9,0,0
241700,;,0,0
241701,p,0,0
241702,=,0,0
241703,0.04,0,0
241704,),0,0
241705,.,0,0
241706,Other,0,1
241707,injuries,0,0
241708,appeared,0,0
241709,unaffected,0,0
241710,by,0,0
241711,the,0,0
241712,brace,0,0
241713,.,0,1
241714,Overall,0,0
241715,",",0,0
241716,5.3,0,0
241717,%,0,0
241718,of,0,0
241719,the,0,0
241720,non-brace,0,0
241721,group,0,0
241722,and,0,0
241723,4.6,0,0
241724,%,0,0
241725,of,0,0
241726,the,0,0
241727,brace,0,0
241728,group,0,0
241729,experienced,0,1
241730,at,0,0
241731,least,0,0
241732,one,0,0
241733,injury,0,0
241734,.,0,0
241735,The,0,0
241736,risk,1,1
241737,ratio,1,1
241738,for,1,0
241739,injured,1,1
241740,individuals,1,0
241741,was,0,0
241742,1.2:1,0,0
241743,(,0,0
241744,non-brace,0,0
241745,to,0,0
241746,brace,0,0
241747,groups,0,0
241748,;,0,0
241749,p,0,0
241750,=,0,0
241751,0.65,0,0
241752,),0,0
241753,.,0,0
241754,CONCLUSION,0,0
241755,Inversion,1,1
241756,ankle,1,1
241757,sprains,1,1
241758,during,0,0
241759,parachute,0,0
241760,training,0,0
241761,can,0,0
241762,be,0,0
241763,significantly,0,0
241764,reduced,0,0
241765,by,0,0
241766,using,0,0
241767,an,0,0
241768,outside-the-boot,0,0
241769,ankle,0,1
241770,brace,0,0
241771,",",0,0
241772,with,0,0
241773,no,0,0
241774,increase,0,0
241775,in,0,0
241776,risk,0,1
241777,for,0,0
241778,other,0,0
241779,injuries,0,0
241780,.,0,0
241781,Preventing,0,0
241782,disability,1,1
241783,and,1,1
241784,managing,1,1
241785,chronic,1,0
241786,illness,1,1
241787,in,0,0
241788,frail,0,0
241789,older,0,0
241790,adults,0,0
241791,:,0,0
241792,a,0,0
241793,randomized,0,0
241794,trial,0,0
241795,of,0,0
241796,a,0,0
241797,community-based,0,0
241798,partnership,0,0
241799,with,0,0
241800,primary,0,0
241801,care,0,0
241802,.,0,0
241803,BACKGROUND,0,0
241804,Effective,0,1
241805,new,0,1
241806,strategies,0,0
241807,that,0,0
241808,complement,0,0
241809,primary,0,0
241810,care,0,0
241811,are,0,0
241812,needed,0,0
241813,to,0,0
241814,reduce,1,0
241815,disability,1,1
241816,risks,1,1
241817,and,1,1
241818,improve,1,0
241819,self-management,1,0
241820,of,1,1
241821,chronic,1,0
241822,illness,1,1
241823,in,0,0
241824,frail,0,0
241825,older,0,0
241826,people,0,0
241827,living,0,1
241828,in,0,0
241829,the,0,0
241830,community,0,0
241831,.,0,0
241832,OBJECTIVE,0,0
241833,To,0,0
241834,evaluate,0,0
241835,the,0,0
241836,impact,0,0
241837,of,0,0
241838,a,0,0
241839,1-year,0,0
241840,",",0,0
241841,senior,0,0
241842,center-based,0,0
241843,chronic,1,0
241844,illness,1,1
241845,self-management,1,0
241846,and,1,1
241847,disability,1,1
241848,prevention,1,1
241849,program,1,0
241850,on,1,0
241851,health,1,1
241852,",",1,1
241853,functioning,1,1
241854,",",1,1
241855,and,1,1
241856,healthcare,1,1
241857,utilization,1,1
241858,in,0,0
241859,frail,0,0
241860,older,0,0
241861,adults,0,0
241862,.,0,0
241863,DESIGN,0,0
241864,A,0,0
241865,randomized,0,0
241866,controlled,0,0
241867,trial,0,0
241868,.,0,0
241869,SETTING,0,0
241870,A,0,0
241871,large,0,0
241872,senior,0,0
241873,center,0,0
241874,located,0,0
241875,in,0,0
241876,a,0,0
241877,northeast,0,0
241878,Seattle,0,0
241879,suburb,0,0
241880,.,0,0
241881,The,0,0
241882,trial,0,0
241883,was,0,0
241884,conducted,0,0
241885,in,0,0
241886,collaboration,0,0
241887,with,0,0
241888,primary,0,0
241889,care,0,0
241890,providers,0,0
241891,of,0,0
241892,two,0,0
241893,large,0,0
241894,managed,0,0
241895,care,0,0
241896,organizations,0,0
241897,.,0,0
241898,PARTICIPANTS,0,0
241899,A,0,0
241900,total,0,0
241901,of,0,0
241902,201,0,0
241903,chronically,0,0
241904,ill,0,0
241905,older,0,0
241906,adults,0,0
241907,seniors,0,0
241908,aged,0,0
241909,70,0,0
241910,and,0,0
241911,older,0,0
241912,recruited,0,0
241913,through,0,0
241914,medical,0,0
241915,practices,0,0
241916,.,0,0
241917,INTERVENTION,0,1
241918,A,0,0
241919,targeted,0,0
241920,",",0,0
241921,multi-component,0,0
241922,disability,0,1
241923,prevention,0,0
241924,and,0,1
241925,disease,0,1
241926,self-management,0,0
241927,program,0,0
241928,led,0,0
241929,by,0,0
241930,a,0,0
241931,geriatric,0,1
241932,nurse,0,1
241933,practitioner,0,0
241934,(,0,1
241935,GNP,0,0
241936,),0,0
241937,.,0,0
241938,MEASUREMENTS,0,0
241939,Self-reported,1,1
241940,Physical,1,1
241941,function,1,1
241942,",",1,1
241943,physical,1,1
241944,performance,1,1
241945,tests,1,1
241946,",",1,1
241947,health,1,1
241948,care,1,1
241949,utilization,1,1
241950,",",1,1
241951,and,1,1
241952,health,1,1
241953,behaviors,1,1
241954,.,1,0
241955,RESULTS,0,0
241956,Each,0,0
241957,of,0,0
241958,101,0,0
241959,intervention,0,0
241960,participants,0,0
241961,met,0,0
241962,with,0,0
241963,the,0,0
241964,GNP,0,0
241965,from,0,0
241966,1,0,0
241967,to,0,0
241968,8,0,0
241969,times,0,0
241970,(,0,0
241971,median,0,1
241972,=,0,0
241973,3,0,0
241974,),0,0
241975,during,0,0
241976,the,0,0
241977,study,0,0
241978,year,0,0
241979,.,0,0
241980,The,0,0
241981,intervention,0,0
241982,group,0,0
241983,showed,0,0
241984,less,1,0
241985,decline,1,1
241986,in,1,1
241987,function,1,1
241988,",",1,0
241989,as,1,0
241990,measured,1,1
241991,by,1,0
241992,disability,1,1
241993,days,1,0
241994,and,0,1
241995,lower,1,1
241996,scores,1,1
241997,on,1,0
241998,the,1,0
241999,Health,1,0
242000,Assessment,1,1
242001,Questionnaire,1,1
242002,.,1,0
242003,Other,0,0
242004,measures,0,1
242005,of,0,1
242006,function,0,1
242007,",",0,0
242008,including,0,0
242009,the,1,0
242010,SF-36,1,0
242011,and,1,0
242012,a,1,0
242013,battery,1,0
242014,of,1,0
242015,physical,1,1
242016,performance,1,1
242017,tests,1,1
242018,",",0,1
242019,did,0,0
242020,not,0,0
242021,change,0,0
242022,with,0,0
242023,the,0,0
242024,intervention,0,0
242025,.,0,0
242026,The,0,0
242027,number,1,1
242028,of,1,0
242029,hospitalized,1,0
242030,participants,1,0
242031,increased,0,0
242032,by,0,0
242033,69,0,0
242034,%,0,0
242035,among,0,0
242036,the,0,0
242037,controls,0,0
242038,and,0,0
242039,decreased,0,0
242040,by,0,0
242041,38,0,0
242042,%,0,0
242043,in,0,0
242044,the,0,0
242045,intervention,0,0
242046,group,0,0
242047,(,0,1
242048,P,0,0
242049,=,0,0
242050,.083,0,0
242051,),0,0
242052,.,0,0
242053,The,0,0
242054,total,1,1
242055,number,1,1
242056,of,1,1
242057,inpatient,1,0
242058,hospital,1,1
242059,days,1,0
242060,during,0,0
242061,the,0,0
242062,study,0,0
242063,year,0,0
242064,was,0,0
242065,significantly,0,0
242066,less,0,0
242067,in,0,0
242068,the,0,0
242069,intervention,0,0
242070,group,0,0
242071,compared,0,0
242072,with,0,0
242073,controls,0,0
242074,(,0,0
242075,total,0,1
242076,days,0,0
242077,=,0,0
242078,33,0,0
242079,vs,0,0
242080,116,0,0
242081,",",0,0
242082,P,0,0
242083,=,0,0
242084,.049,0,0
242085,),0,0
242086,.,0,0
242087,The,0,0
242088,intervention,0,0
242089,led,0,0
242090,to,0,0
242091,significantly,0,0
242092,higher,1,0
242093,levels,1,1
242094,of,1,1
242095,physical,1,1
242096,activity,1,1
242097,and,1,1
242098,senior,1,0
242099,center,1,0
242100,participation,1,1
242101,and,1,1
242102,significant,1,0
242103,reductions,1,1
242104,in,0,0
242105,the,0,0
242106,use,1,0
242107,of,1,0
242108,psychoactive,1,1
242109,medications,1,0
242110,.,1,0
242111,CONCLUSIONS,0,0
242112,This,0,0
242113,project,0,0
242114,provides,0,0
242115,evidence,0,0
242116,that,0,0
242117,a,0,0
242118,community-based,0,0
242119,collaboration,0,0
242120,with,0,0
242121,primary,0,0
242122,care,0,0
242123,providers,0,0
242124,can,0,0
242125,improve,1,0
242126,function,1,1
242127,and,1,1
242128,reduce,1,1
242129,inpatient,1,1
242130,utilization,1,1
242131,in,0,0
242132,chronically,0,0
242133,ill,0,1
242134,older,0,0
242135,adults,0,0
242136,.,0,1
242137,Linking,0,0
242138,organized,0,0
242139,medical,0,0
242140,care,0,0
242141,with,0,0
242142,complementary,0,0
242143,community-based,0,0
242144,interventions,0,0
242145,may,0,0
242146,be,0,0
242147,a,0,0
242148,promising,0,0
242149,direction,0,1
242150,for,0,0
242151,research,0,0
242152,and,0,1
242153,practice,0,0
242154,.,0,0
242155,The,0,0
242156,SPEM,0,1
242157,(,0,0
242158,Studio,0,1
242159,Policentrico,0,1
242160,Elettrocateteri,0,1
242161,Membrane,0,0
242162,),0,0
242163,:,0,0
242164,a,0,0
242165,multicenter,0,0
242166,study,0,0
242167,on,0,0
242168,membrane,0,1
242169,leads,0,0
242170,.,0,0
242171,SPEM,0,0
242172,is,0,0
242173,a,0,0
242174,multicenter,0,0
242175,randomized,0,0
242176,double-blind,0,0
242177,study,0,0
242178,performed,0,0
242179,to,0,0
242180,test,0,0
242181,the,0,0
242182,acute,1,0
242183,and,1,1
242184,chronic,1,0
242185,electrophysiological,1,1
242186,behavior,1,1
242187,of,0,0
242188,three,0,0
242189,different,0,0
242190,ventricular,0,0
242191,leads,0,0
242192,:,0,0
242193,(,0,0
242194,1,0,0
242195,),0,0
242196,an,0,0
242197,ion,0,1
242198,exchange,0,1
242199,membrane,0,1
242200,with,0,0
242201,30-microgram,0,1
242202,dexamethasone,0,0
242203,elution,0,1
242204,in,0,0
242205,a,0,0
242206,contoured,0,1
242207,activated,0,1
242208,carbon,0,0
242209,tip,0,1
242210,lead,0,1
242211,(,0,0
242212,Membrane,0,0
242213,1400T,0,0
242214,",",0,0
242215,30,0,0
242216,patients,0,0
242217,),0,0
242218,;,0,0
242219,(,0,0
242220,2,0,0
242221,),0,0
242222,the,0,0
242223,same,0,0
242224,lead,0,0
242225,design,0,0
242226,without,0,0
242227,steroid,0,0
242228,(,0,0
242229,Membrane,0,0
242230,1401T,0,0
242231,",",0,0
242232,24,0,0
242233,patients,0,0
242234,),0,0
242235,;,0,0
242236,and,0,0
242237,(,0,0
242238,3,0,0
242239,),0,0
242240,the,0,0
242241,same,0,0
242242,lead,0,0
242243,design,0,0
242244,without,0,0
242245,steroid,0,0
242246,or,0,1
242247,membrane,0,1
242248,(,0,1
242249,control,0,0
242250,group,0,0
242251,",",0,0
242252,27,0,0
242253,patients,0,0
242254,),0,0
242255,.,0,0
242256,Twenty-three,0,0
242257,of,0,0
242258,the,0,0
242259,81,0,0
242260,patients,0,0
242261,were,0,0
242262,women,0,0
242263,;,0,0
242264,the,0,0
242265,mean,0,1
242266,age,0,0
242267,for,0,0
242268,all,0,0
242269,patients,0,0
242270,was,0,0
242271,74,0,0
242272,+/-,0,0
242273,10,0,0
242274,years,0,0
242275,.,0,0
242276,Parameters,0,1
242277,are,0,0
242278,calculated,0,0
242279,both,0,0
242280,in,0,0
242281,uni-,0,0
242282,and,0,1
242283,bipolar,0,0
242284,configuration,0,0
242285,at,0,0
242286,implant,0,1
242287,and,0,0
242288,at,0,0
242289,follow-up,0,0
242290,after,0,0
242291,1,0,0
242292,",",0,0
242293,5,0,0
242294,",",0,0
242295,15,0,0
242296,",",0,0
242297,30,0,0
242298,",",0,0
242299,90,0,0
242300,",",0,0
242301,180,0,0
242302,",",0,0
242303,and,0,0
242304,360,0,0
242305,days,0,0
242306,.,0,0
242307,Implant,0,1
242308,threshold,0,1
242309,(,0,0
242310,chronaxie,0,1
242311,=,0,0
242312,0.413,0,0
242313,+/-,0,0
242314,0.280,0,0
242315,ms,0,0
242316,",",0,0
242317,rheobase,0,1
242318,=,0,0
242319,0.264,0,0
242320,+/-,0,0
242321,0.099,0,0
242322,V,0,0
242323,),0,0
242324,",",0,0
242325,signal,0,1
242326,amplitude,0,1
242327,(,0,0
242328,13.45,0,0
242329,+/-,0,0
242330,5.87,0,0
242331,mV,0,0
242332,),0,0
242333,",",0,1
242334,and,0,1
242335,slew,0,1
242336,rate,0,1
242337,(,0,0
242338,2.05,0,0
242339,+/-,0,0
242340,1.38,0,0
242341,V/s,0,0
242342,),0,0
242343,reveal,0,0
242344,no,0,0
242345,significant,0,0
242346,differences,0,0
242347,.,0,0
242348,Pacing,1,0
242349,impedance,1,1
242350,values,1,1
242351,both,0,0
242352,at,0,0
242353,implant,0,0
242354,(,0,0
242355,unipolar,0,0
242356,571,0,0
242357,+/-,0,0
242358,165,0,0
242359,omega,0,0
242360,;,0,0
242361,bipolar,0,0
242362,605,0,0
242363,+/-,0,0
242364,123,0,0
242365,omega,0,0
242366,),0,0
242367,and,0,1
242368,at,0,0
242369,follow-ups,0,1
242370,(,0,0
242371,unipolar,0,0
242372,480,0,0
242373,+/-,0,0
242374,72,0,0
242375,omega,0,0
242376,;,0,0
242377,bipolar,0,0
242378,518,0,0
242379,+/-,0,0
242380,75,0,0
242381,omega,0,0
242382,),0,0
242383,are,0,0
242384,slightly,0,0
242385,lower,0,0
242386,in,0,0
242387,the,0,0
242388,unipolar,0,0
242389,configuration,0,0
242390,.,0,0
242391,At,0,0
242392,15,0,0
242393,and,0,0
242394,30-day,0,1
242395,follow-ups,0,1
242396,",",0,1
242397,control,0,0
242398,group,0,0
242399,and,0,0
242400,nonsteroid,0,0
242401,leads,0,0
242402,show,0,0
242403,a,0,0
242404,higher,0,0
242405,threshold,1,1
242406,value,0,1
242407,growth,0,1
242408,(,0,0
242409,in,0,0
242410,unipolar,0,0
242411,from,0,0
242412,0.16,0,0
242413,+/-,0,0
242414,0.11,0,0
242415,to,0,0
242416,1.19,0,0
242417,+/-,0,0
242418,0.85,0,0
242419,microJ,0,0
242420,;,0,0
242421,in,0,0
242422,bipolar,0,0
242423,from,0,0
242424,0.18,0,0
242425,+/-,0,0
242426,0.13,0,0
242427,to,0,0
242428,1.24,0,0
242429,+/-,0,0
242430,0.88,0,0
242431,microJ,0,0
242432,),0,0
242433,than,0,0
242434,the,0,0
242435,membrane,0,0
242436,steroid,0,0
242437,leads,0,1
242438,(,0,0
242439,in,0,0
242440,unipolar,0,0
242441,from,0,0
242442,0.13,0,0
242443,+/-,0,0
242444,0.11,0,0
242445,to,0,0
242446,0.70,0,0
242447,+/-,0,0
242448,0.39,0,0
242449,microJ,0,0
242450,;,0,0
242451,in,0,0
242452,bipolar,0,0
242453,from,0,0
242454,0.23,0,0
242455,+/-,0,0
242456,0.32,0,0
242457,to,0,0
242458,0.76,0,0
242459,+/-,0,0
242460,0.36,0,0
242461,microJ,0,0
242462,),0,0
242463,;,0,0
242464,the,0,0
242465,threshold,1,1
242466,of,0,0
242467,nonsteroid,0,0
242468,leads,0,0
242469,decreases,0,1
242470,after,0,0
242471,1-3,0,0
242472,months,0,0
242473,and,0,0
242474,it,0,0
242475,settles,0,0
242476,at,0,0
242477,the,0,0
242478,same,0,0
242479,threshold,1,1
242480,level,0,1
242481,of,0,0
242482,the,0,0
242483,leads,0,0
242484,with,0,0
242485,membrane,0,1
242486,and,0,1
242487,steroid,0,1
242488,(,0,1
242489,in,0,0
242490,unipolar,0,0
242491,0.60,0,0
242492,+/-,0,0
242493,0.33,0,0
242494,microJ,0,0
242495,;,0,0
242496,in,0,0
242497,bipolar,0,0
242498,0.55,0,0
242499,+/-,0,0
242500,0.26,0,0
242501,microJ,0,0
242502,),0,0
242503,",",0,0
242504,which,0,0
242505,has,0,0
242506,been,0,0
242507,stable,0,0
242508,since,0,0
242509,the,0,0
242510,first,0,0
242511,month,0,0
242512,.,0,0
242513,The,0,0
242514,ion,0,1
242515,exchange,0,1
242516,membrane,0,1
242517,is,0,0
242518,effective,0,1
242519,in,0,0
242520,reducing,0,0
242521,the,0,0
242522,chronic,1,0
242523,pacing,1,0
242524,threshold,1,1
242525,like,0,0
242526,acute,0,0
242527,steroid,0,0
242528,elution,0,1
242529,at,0,0
242530,low,0,0
242531,doses,0,1
242532,",",0,1
242533,but,0,0
242534,membrane,0,0
242535,alone,0,0
242536,does,0,0
242537,not,0,0
242538,prevent,0,0
242539,an,0,0
242540,acute,1,0
242541,pacing,1,0
242542,threshold,1,1
242543,increase,0,0
242544,through,0,0
242545,the,0,0
242546,first,0,0
242547,month,0,0
242548,postimplant,0,1
242549,.,0,0
242550,A,0,0
242551,search,0,0
242552,for,0,0
242553,serologic,0,1
242554,correlates,0,0
242555,of,0,0
242556,immunity,0,1
242557,to,0,0
242558,Bordetella,0,1
242559,pertussis,0,0
242560,cough,0,1
242561,illnesses,0,1
242562,.,0,0
242563,In,0,0
242564,a,0,0
242565,pertussis,0,0
242566,vaccine,0,0
242567,efficacy,0,1
242568,trial,0,0
242569,in,0,0
242570,Germany,0,0
242571,we,0,0
242572,collected,0,0
242573,sera,0,1
242574,from,0,0
242575,vaccinees,0,1
242576,(,0,0
242577,DTaP,0,1
242578,or,0,1
242579,DTP,0,0
242580,),0,0
242581,after,0,0
242582,the,0,0
242583,third,0,0
242584,and,0,0
242585,fourth,0,0
242586,doses,0,0
242587,of,0,1
242588,vaccine,0,0
242589,or,0,0
242590,at,0,1
242591,comparable,0,0
242592,time,0,1
242593,periods,0,0
242594,in,0,0
242595,DT,0,1
242596,vaccine,0,0
242597,recipients,0,0
242598,.,0,0
242599,In,0,0
242600,addition,0,0
242601,",",0,1
242602,sera,0,1
242603,were,0,0
242604,collected,0,0
242605,from,0,0
242606,a,0,0
242607,randomized,0,0
242608,sample,0,0
242609,of,0,0
242610,subjects,0,0
242611,in,0,0
242612,each,0,0
242613,vaccine,0,0
242614,group,0,0
242615,at,0,0
242616,approximately,0,0
242617,3-month,0,0
242618,intervals,0,0
242619,from,0,0
242620,which,0,0
242621,antibody,0,1
242622,kinetic,0,1
242623,curves,0,1
242624,were,0,0
242625,constructed,0,0
242626,",",0,0
242627,which,0,0
242628,allowed,0,0
242629,us,0,0
242630,to,0,0
242631,estimate,0,0
242632,specific,0,0
242633,antibody,0,1
242634,values,0,1
242635,to,0,0
242636,pertussis,0,0
242637,toxin,0,1
242638,(,0,1
242639,PT,0,1
242640,),0,1
242641,",",0,0
242642,filamentous,0,1
242643,hemagglutinin,0,1
242644,(,0,1
242645,FHA,0,1
242646,),0,1
242647,",",0,0
242648,pertactin,0,1
242649,and,0,1
242650,fimbriae-2,0,1
242651,at,0,0
242652,the,0,0
242653,time,0,1
242654,of,0,0
242655,exposure,0,0
242656,in,0,0
242657,the,0,0
242658,household,0,1
242659,setting,0,0
242660,.,0,0
242661,The,0,0
242662,imputed,0,0
242663,geometric,0,1
242664,mean,0,1
242665,antibody,0,1
242666,values,0,1
242667,to,0,0
242668,PT,0,1
242669,",",0,1
242670,pertactin,0,1
242671,and,0,1
242672,fimbriae-2,0,1
242673,at,0,0
242674,the,0,0
242675,time,0,1
242676,of,0,1
242677,household,0,1
242678,exposure,0,0
242679,to,0,0
242680,Bordetella,0,1
242681,pertussis,0,0
242682,infection,0,1
242683,were,0,0
242684,higher,0,1
242685,(,0,0
242686,p,0,0
242687,<,0,0
242688,0.07,0,0
242689,or,0,0
242690,lower,0,0
242691,),0,1
242692,in,0,0
242693,non-cases,0,0
242694,compared,0,0
242695,with,0,0
242696,cases,0,0
242697,.,0,0
242698,A,0,0
242699,multivariate,0,0
242700,(,0,0
242701,classification,0,1
242702,tree,0,1
242703,),0,1
242704,analysis,0,0
242705,found,0,0
242706,that,0,0
242707,only,0,0
242708,pertactin,0,1
242709,and,0,1
242710,PT,0,1
242711,were,0,0
242712,significant,0,0
242713,in,0,0
242714,protection,0,1
242715,.,0,0
242716,Subjects,0,0
242717,with,0,0
242718,an,0,0
242719,imputed,0,0
242720,pertactin,0,1
242721,value,0,1
242722,of,0,0
242723,<,0,0
242724,7,0,0
242725,EU,0,0
242726,ml-1,0,0
242727,had,0,0
242728,a,0,0
242729,67,0,0
242730,%,0,0
242731,(,0,0
242732,18/27,0,0
242733,),0,0
242734,chance,0,0
242735,of,0,1
242736,infection,0,1
242737,regardless,0,0
242738,of,0,0
242739,the,0,0
242740,PT,0,1
242741,value,0,1
242742,.,0,0
242743,If,0,0
242744,the,0,0
242745,pertactin,0,1
242746,value,0,1
242747,was,0,0
242748,>,0,1
242749,or,0,0
242750,=,0,0
242751,7,0,0
242752,EU,0,0
242753,ml-1,0,0
242754,and,0,0
242755,the,0,0
242756,PT,0,1
242757,value,0,1
242758,>,0,1
242759,or,0,0
242760,=,0,0
242761,66,0,0
242762,EU,0,0
242763,ml-1,0,0
242764,all,0,0
242765,subjects,0,0
242766,were,0,0
242767,non-cases,0,0
242768,.,0,0
242769,If,0,0
242770,the,0,0
242771,pertactin,0,1
242772,value,0,1
242773,was,0,0
242774,>,0,1
242775,or,0,0
242776,=,0,0
242777,7,0,0
242778,and,0,0
242779,the,0,0
242780,PT,0,1
242781,value,0,1
242782,was,0,0
242783,<,0,0
242784,66,0,0
242785,EU,0,0
242786,ml-1,0,0
242787,the,0,0
242788,predicted,0,0
242789,probability,0,1
242790,of,0,0
242791,being,0,0
242792,a,0,0
242793,case,0,0
242794,was,0,0
242795,31,0,0
242796,%,0,0
242797,(,0,0
242798,15/49,0,0
242799,),0,0
242800,.,0,0
242801,Logistic,1,0
242802,regression,1,0
242803,analysis,1,0
242804,also,0,0
242805,found,0,0
242806,that,0,0
242807,high,0,0
242808,versus,0,0
242809,low,0,0
242810,pertactin,0,1
242811,values,0,1
242812,were,0,0
242813,associated,0,0
242814,with,0,0
242815,illness,0,1
242816,prevention,0,0
242817,following,0,0
242818,household,0,1
242819,exposure,0,0
242820,.,0,0
242821,In,0,0
242822,the,0,0
242823,presence,0,0
242824,of,0,0
242825,antibody,0,0
242826,to,0,0
242827,pertactin,0,1
242828,",",0,0
242829,PT,0,1
242830,and,0,1
242831,fimbriae-2,0,1
242832,",",0,0
242833,the,0,0
242834,additional,0,0
242835,presence,0,0
242836,of,0,0
242837,antibody,0,1
242838,to,0,0
242839,FHA,0,0
242840,did,0,0
242841,not,0,0
242842,contribute,0,0
242843,to,0,0
242844,protection,0,1
242845,.,0,0
242846,Our,0,0
242847,data,0,0
242848,support,0,0
242849,historical,0,0
242850,data,0,0
242851,indicating,0,0
242852,that,0,0
242853,agglutinating,0,0
242854,antibodies,0,0
242855,are,0,0
242856,associated,0,0
242857,with,0,0
242858,protection,0,1
242859,and,0,0
242860,also,0,0
242861,recent,0,0
242862,serologic,0,1
242863,correlates,0,0
242864,data,0,0
242865,and,0,1
242866,clinical,0,1
242867,efficacy,0,1
242868,data,0,0
242869,which,0,0
242870,indicate,0,0
242871,that,0,0
242872,multicomponent,0,0
242873,vaccines,0,0
242874,containing,0,0
242875,pertactin,0,1
242876,and,0,0
242877,fimbriae,0,1
242878,have,0,0
242879,better,0,0
242880,efficacy,0,1
242881,than,0,0
242882,PT,0,1
242883,or,0,0
242884,PT/FHA,0,1
242885,vaccines,0,0
242886,.,0,0
242887,Blind,0,0
242888,versus,0,0
242889,open,0,0
242890,approach,0,0
242891,to,0,0
242892,laparoscopic,0,0
242893,cholecystectomy,0,0
242894,:,0,0
242895,a,0,0
242896,randomized,0,0
242897,study,0,0
242898,.,0,0
242899,Intraabdominal,0,0
242900,structures,0,0
242901,may,0,0
242902,be,0,0
242903,damaged,0,0
242904,during,0,0
242905,blind,0,0
242906,introduction,0,0
242907,of,0,0
242908,the,0,0
242909,first,0,0
242910,trocar,0,0
242911,for,0,0
242912,laparoscopic,0,0
242913,operations,0,0
242914,.,0,0
242915,In,0,0
242916,this,0,0
242917,study,0,0
242918,",",0,0
242919,150,0,0
242920,patients,0,0
242921,with,0,0
242922,gallbladder,0,1
242923,lithiasis,0,1
242924,who,0,0
242925,underwent,0,0
242926,laparoscopy,0,0
242927,were,0,0
242928,randomly,0,0
242929,assigned,0,0
242930,to,0,0
242931,two,0,0
242932,groups,0,0
242933,",",0,0
242934,a,0,0
242935,blind,0,0
242936,(,0,0
242937,V,0,1
242938,group,0,0
242939,),0,0
242940,or,0,0
242941,an,0,0
242942,open,0,0
242943,(,0,0
242944,H,0,1
242945,group,0,0
242946,),0,1
242947,",",0,0
242948,in,0,0
242949,order,0,0
242950,to,0,0
242951,compare,0,0
242952,the,0,0
242953,results,0,0
242954,and,0,0
242955,the,0,0
242956,rate,1,1
242957,of,1,0
242958,complications,1,1
242959,.,1,0
242960,No,0,0
242961,mortality,1,1
242962,was,0,0
242963,observed,0,0
242964,.,0,0
242965,Major,1,1
242966,complications,1,1
242967,occurred,0,0
242968,in,0,0
242969,3/75,0,0
242970,(,0,0
242971,4,0,0
242972,%,0,0
242973,),0,0
242974,patients,0,0
242975,of,0,0
242976,the,0,0
242977,V,0,0
242978,group,0,0
242979,and,0,0
242980,in,0,0
242981,1/75,0,0
242982,(,0,0
242983,1.3,0,0
242984,%,0,0
242985,),0,0
242986,patient,0,1
242987,of,0,0
242988,the,0,0
242989,H,0,1
242990,group,0,0
242991,(,0,0
242992,p,0,0
242993,<,0,0
242994,0.05,0,0
242995,),0,0
242996,.,0,0
242997,Minor,1,1
242998,complications,1,1
242999,occurred,0,0
243000,in,0,0
243001,5/75,0,0
243002,(,0,0
243003,6.7,0,0
243004,%,0,0
243005,),0,0
243006,patients,0,0
243007,of,0,0
243008,either,0,0
243009,group,0,0
243010,.,0,0
243011,The,0,0
243012,achievement,1,1
243013,of,1,0
243014,pneumoperitoneum,1,0
243015,required,0,1
243016,4.5+/-0.4,0,0
243017,min,0,0
243018,in,0,0
243019,the,0,0
243020,V,0,0
243021,group,0,0
243022,and,0,1
243023,3.2+/-0.2,0,0
243024,min,0,0
243025,in,0,0
243026,the,0,0
243027,H,0,1
243028,group,0,0
243029,(,0,0
243030,p,0,0
243031,<,0,0
243032,0.05,0,0
243033,),0,0
243034,.,0,0
243035,The,0,0
243036,open,0,0
243037,laparoscopic,0,0
243038,technique,0,0
243039,is,0,0
243040,safer,0,1
243041,and,0,1
243042,faster,0,1
243043,than,0,0
243044,the,0,0
243045,blind,0,0
243046,approach,0,0
243047,;,0,0
243048,therefore,0,0
243049,",",0,0
243050,it,0,0
243051,is,0,0
243052,proposed,0,0
243053,that,0,0
243054,this,0,0
243055,approach,0,0
243056,be,0,0
243057,routinely,0,0
243058,used,0,0
243059,in,0,0
243060,all,0,0
243061,laparoscopic,0,0
243062,procedures,0,0
243063,.,0,0
243064,Oral,0,1
243065,ganciclovir,0,0
243066,dosing,0,0
243067,in,0,0
243068,transplant,0,1
243069,recipients,0,0
243070,and,0,1
243071,dialysis,0,0
243072,patients,0,0
243073,based,0,0
243074,on,0,0
243075,renal,0,1
243076,function,0,1
243077,.,0,0
243078,BACKGROUND,0,0
243079,An,0,0
243080,oral,0,0
243081,formulation,0,0
243082,of,0,1
243083,ganciclovir,0,0
243084,(,0,1
243085,GCV,0,0
243086,),0,1
243087,was,0,0
243088,recently,0,0
243089,approved,0,0
243090,for,0,0
243091,the,0,0
243092,prevention,0,0
243093,of,0,1
243094,cytomegalovirus,0,1
243095,disease,0,1
243096,in,0,0
243097,solid,0,1
243098,organ,0,1
243099,transplant,0,0
243100,recipients,0,0
243101,.,0,0
243102,This,0,0
243103,study,0,0
243104,was,0,0
243105,designed,0,0
243106,to,0,0
243107,determine,0,0
243108,the,0,0
243109,bioavailability,0,1
243110,of,0,1
243111,GCV,0,0
243112,and,0,0
243113,to,0,0
243114,test,0,0
243115,a,0,0
243116,dosing,0,0
243117,algorithm,0,0
243118,in,0,0
243119,transplant,0,1
243120,and,0,1
243121,dialysis,0,0
243122,patients,0,0
243123,with,0,0
243124,different,0,0
243125,levels,0,1
243126,of,0,1
243127,renal,0,1
243128,function,0,1
243129,.,0,0
243130,METHODS,0,0
243131,Pharmacokinetic,0,1
243132,studies,0,0
243133,were,0,0
243134,carried,0,0
243135,out,0,0
243136,in,0,0
243137,23,0,0
243138,patients,0,0
243139,who,0,0
243140,were,0,0
243141,either,0,0
243142,a,0,0
243143,recipient,0,0
243144,of,0,0
243145,an,0,0
243146,organ,0,1
243147,transplant,0,1
243148,or,0,1
243149,on,0,0
243150,hemodialysis,0,0
243151,.,0,1
243152,Drug,0,0
243153,dosing,0,0
243154,was,0,0
243155,established,0,0
243156,by,0,0
243157,the,0,0
243158,following,0,0
243159,algorithm,0,0
243160,based,0,0
243161,on,0,0
243162,calculated,0,0
243163,creatinine,0,1
243164,clearance,0,1
243165,(,0,1
243166,CrCl,0,0
243167,),0,0
243168,:,0,0
243169,CrCl,0,0
243170,=,0,0
243171,[,0,0
243172,(,0,1
243173,140-age,0,0
243174,),0,0
243175,x,0,0
243176,body,0,1
243177,weight,0,1
243178,],0,0
243179,/,0,0
243180,(,0,0
243181,72,0,0
243182,x,0,0
243183,Cr,0,0
243184,),0,0
243185,x,0,0
243186,0.85,0,0
243187,for,0,0
243188,women,0,0
243189,that,0,0
243190,is,0,0
243191,",",0,0
243192,CrCl,0,0
243193,>,0,0
243194,50,0,0
243195,ml/min,0,0
243196,",",0,0
243197,1000,0,0
243198,mg,0,0
243199,every,0,0
243200,8,0,0
243201,hr,0,0
243202,;,0,0
243203,CrCl,0,0
243204,of,0,0
243205,25-50,0,0
243206,ml/min,0,0
243207,",",0,0
243208,1000,0,0
243209,mg,0,0
243210,every,0,0
243211,24,0,0
243212,hr,0,0
243213,;,0,0
243214,CrCl,0,0
243215,of,0,0
243216,10-24,0,0
243217,ml/,0,0
243218,min,0,0
243219,",",0,0
243220,500,0,0
243221,mg,0,0
243222,every,0,0
243223,day,0,0
243224,;,0,0
243225,CrCl,0,0
243226,<,0,0
243227,10,0,0
243228,ml/min,0,0
243229,(,0,0
243230,or,0,1
243231,on,0,0
243232,dialysis,0,0
243233,),0,0
243234,",",0,0
243235,500,0,0
243236,mg,0,0
243237,every,0,0
243238,other,0,0
243239,day,0,0
243240,after,0,0
243241,dialysis,0,0
243242,.,0,1
243243,GCV,0,0
243244,was,0,0
243245,taken,0,0
243246,within,0,0
243247,30,0,0
243248,min,0,0
243249,after,0,0
243250,a,0,0
243251,meal,0,0
243252,.,0,0
243253,The,0,0
243254,patients,0,0
243255,received,0,0
243256,oral,0,0
243257,GCV,0,0
243258,for,0,0
243259,between,0,0
243260,12,0,0
243261,days,0,0
243262,and,0,0
243263,14,0,0
243264,weeks,0,0
243265,.,0,0
243266,Serum,1,0
243267,specimens,1,1
243268,(,1,0
243269,or,1,1
243270,plasma,1,1
243271,from,1,0
243272,patients,1,0
243273,on,1,0
243274,hemodialysis,1,0
243275,),1,1
243276,obtained,0,0
243277,at,0,0
243278,steady,0,1
243279,state,0,1
243280,were,0,0
243281,analyzed,0,0
243282,for,0,0
243283,GCV,0,0
243284,concentrations,0,1
243285,by,0,0
243286,high-performance,0,0
243287,liquid,0,0
243288,chromatography,0,0
243289,.,0,0
243290,In,0,0
243291,nine,0,0
243292,of,0,0
243293,the,0,0
243294,transplant,0,0
243295,recipients,0,0
243296,",",0,1
243297,absolute,1,1
243298,bioavailability,1,1
243299,was,0,0
243300,determined,0,0
243301,by,0,0
243302,comparing,0,0
243303,GCV,1,0
243304,levels,1,1
243305,after,0,0
243306,single,0,0
243307,oral,0,0
243308,and,0,1
243309,intravenous,0,0
243310,doses,0,0
243311,of,0,0
243312,GCV,0,0
243313,.,0,0
243314,RESULTS,0,0
243315,The,0,0
243316,following,0,0
243317,GCV,1,0
243318,concentrations,1,1
243319,(,0,0
243320,mean,0,1
243321,+/-SD,0,0
243322,),0,1
243323,were,0,0
243324,determined,0,0
243325,:,0,0
243326,with,0,0
243327,CrCl,0,0
243328,of,0,1
243329,>,0,1
243330,or,0,1
243331,=70,0,0
243332,ml/min,0,0
243333,",",0,0
243334,the,0,0
243335,minimum,0,1
243336,steady-state,0,1
243337,concentration,0,1
243338,(,0,1
243339,Cmin,0,0
243340,),0,1
243341,and,0,1
243342,maximum,0,1
243343,concentration,0,1
243344,(,0,1
243345,Cmax,0,1
243346,),0,1
243347,were,0,0
243348,0.78+/-0.46,0,0
243349,microg/ml,0,1
243350,and,0,1
243351,1.42+/-0.37,0,0
243352,microg/ml,0,1
243353,",",0,0
243354,respectively,0,0
243355,",",0,0
243356,with,0,0
243357,a,0,0
243358,24-hr,0,1
243359,area,0,1
243360,under,0,0
243361,the,0,0
243362,concentration,0,1
243363,time,0,1
243364,curve,0,1
243365,(,0,1
243366,AUC0-24,0,1
243367,),0,0
243368,of,0,0
243369,24.7+/-7.8,0,0
243370,microg,0,0
243371,x,0,0
243372,hr/ml,0,0
243373,;,0,0
243374,with,0,0
243375,CrCl,0,0
243376,of,0,0
243377,50-69,0,0
243378,ml/min,0,0
243379,",",0,0
243380,the,0,0
243381,Cmin,0,0
243382,and,0,1
243383,Cmax,0,1
243384,were,0,0
243385,1.93+/-0.48,0,0
243386,and,0,1
243387,2.57+/-0.39,0,0
243388,microg/ml,0,1
243389,",",0,0
243390,respectively,0,0
243391,",",0,0
243392,with,0,0
243393,an,0,0
243394,AUC0-24,0,0
243395,of,0,0
243396,52.1+/-10.1,0,0
243397,microg,0,0
243398,x,0,0
243399,hr/ml,0,0
243400,;,0,0
243401,with,0,0
243402,CrCl,0,0
243403,of,0,0
243404,25-50,0,0
243405,ml/min,0,0
243406,",",0,0
243407,the,0,0
243408,Cmin,0,0
243409,and,0,1
243410,Cmax,0,1
243411,were,0,0
243412,0.41+/-0.27,0,0
243413,and,0,1
243414,1.17+/-0.32,0,0
243415,microg/ml,0,1
243416,",",0,0
243417,respectively,0,0
243418,",",0,0
243419,with,0,0
243420,an,0,0
243421,AUC0-24,0,0
243422,of,0,0
243423,14.6+/-7.4,0,0
243424,microg,0,0
243425,x,0,0
243426,hr/ml,0,0
243427,.,0,0
243428,For,0,0
243429,one,0,0
243430,patient,0,0
243431,with,0,0
243432,a,0,0
243433,CrCl,0,0
243434,of,0,0
243435,23.8,0,0
243436,ml/min,0,0
243437,",",0,0
243438,the,0,0
243439,Cmin,0,0
243440,and,0,1
243441,Cmax,0,1
243442,were,0,0
243443,0.32,0,0
243444,and,0,0
243445,0.7,0,0
243446,microg/ml,0,0
243447,",",0,0
243448,respectively,0,0
243449,",",0,0
243450,with,0,0
243451,an,0,0
243452,AUC0-24,0,0
243453,of,0,0
243454,10.7,0,0
243455,microg,0,0
243456,x,0,0
243457,hr/ml,0,0
243458,.,0,0
243459,With,0,0
243460,CrCl,0,0
243461,of,0,0
243462,<,0,0
243463,10,0,0
243464,ml/min,0,0
243465,",",0,0
243466,the,0,0
243467,mean,0,1
243468,Cmin,0,0
243469,and,0,1
243470,Cmax,0,1
243471,were,0,0
243472,0.75+/-0.42,0,0
243473,and,0,1
243474,1.59+/-0.55,0,0
243475,microg/ml,0,1
243476,",",0,0
243477,respectively,0,0
243478,",",0,0
243479,with,0,0
243480,a,0,0
243481,mean,0,1
243482,AUC0-24,0,0
243483,of,0,1
243484,64.6+/-18.8,0,0
243485,microg,0,0
243486,x,0,0
243487,hr/ml,0,0
243488,.,0,1
243489,Absolute,1,1
243490,bioavailability,1,1
243491,",",0,0
243492,for,0,0
243493,the,0,0
243494,nine,0,0
243495,patients,0,0
243496,so,0,0
243497,analyzed,0,0
243498,",",0,0
243499,was,0,0
243500,7.2+/-2.4,0,0
243501,%,0,0
243502,.,0,0
243503,For,0,0
243504,those,0,0
243505,patients,0,0
243506,with,0,0
243507,end-stage,0,0
243508,renal,0,1
243509,failure,0,1
243510,",",0,1
243511,GCV,1,0
243512,concentrations,1,1
243513,fell,0,1
243514,during,0,0
243515,dialysis,0,0
243516,from,0,0
243517,a,0,0
243518,mean,0,1
243519,of,0,0
243520,1.47+/-0.48,0,0
243521,microg/ml,0,0
243522,before,0,0
243523,dialysis,0,0
243524,to,0,0
243525,0.69+/-0.38,0,0
243526,microg/ml,0,0
243527,after,0,0
243528,dialysis,0,0
243529,.,0,0
243530,CONCLUSIONS,0,0
243531,The,0,0
243532,bioavailability,0,1
243533,of,0,0
243534,oral,0,0
243535,GCV,0,0
243536,in,0,0
243537,transplant,0,1
243538,patients,0,0
243539,was,0,0
243540,similar,0,0
243541,to,0,0
243542,that,0,0
243543,observed,0,0
243544,in,0,0
243545,human,0,0
243546,immunodeficiency,0,0
243547,virus-infected,0,0
243548,patients,0,0
243549,.,0,0
243550,However,0,0
243551,",",0,0
243552,levels,0,1
243553,between,0,0
243554,0.5,0,0
243555,and,0,0
243556,1,0,0
243557,microg/ml,0,0
243558,(,0,0
243559,within,0,0
243560,the,0,0
243561,IC50,0,0
243562,of,0,0
243563,most,0,0
243564,cytomegalovirus,0,0
243565,isolates,0,0
243566,),0,0
243567,could,0,0
243568,be,0,0
243569,achieved,0,0
243570,with,0,0
243571,tolerable,0,1
243572,oral,0,0
243573,doses,0,0
243574,.,0,0
243575,The,0,0
243576,proposed,0,0
243577,dosing,0,0
243578,algorithm,0,0
243579,resulted,0,0
243580,in,0,0
243581,adequate,0,0
243582,levels,0,1
243583,for,0,0
243584,patients,0,0
243585,with,0,0
243586,CrCl,0,0
243587,greater,0,0
243588,than,0,0
243589,50,0,0
243590,ml/min,0,0
243591,and,0,0
243592,for,0,0
243593,patients,0,0
243594,on,0,0
243595,dialysis,0,0
243596,.,0,0
243597,For,0,0
243598,patients,0,0
243599,with,0,0
243600,CrCl,0,0
243601,between,0,0
243602,10,0,0
243603,and,0,0
243604,50,0,0
243605,ml/min,0,0
243606,",",0,0
243607,the,0,0
243608,levels,0,1
243609,achieved,0,1
243610,were,0,0
243611,low,0,0
243612,and,0,0
243613,these,0,0
243614,patients,0,0
243615,would,0,0
243616,likely,0,0
243617,benefit,0,0
243618,from,0,0
243619,increased,0,0
243620,doses,0,0
243621,.,0,0
243622,Treatment,0,0
243623,of,0,1
243624,children,0,0
243625,with,0,0
243626,autism,0,0
243627,:,0,0
243628,a,0,0
243629,randomized,0,0
243630,controlled,0,0
243631,trial,0,0
243632,to,0,0
243633,evaluate,0,0
243634,a,0,0
243635,caregiver-based,0,1
243636,intervention,0,0
243637,program,0,0
243638,in,0,0
243639,community,0,1
243640,day-care,0,0
243641,centers,0,0
243642,.,0,0
243643,This,0,0
243644,study,0,0
243645,reports,0,0
243646,on,0,0
243647,the,0,0
243648,results,0,0
243649,of,0,0
243650,a,0,0
243651,randomized,0,0
243652,controlled,0,0
243653,trial,0,0
243654,that,0,0
243655,evaluated,0,0
243656,a,0,0
243657,caregiver-based,0,1
243658,intervention,0,0
243659,program,0,0
243660,for,0,0
243661,children,0,0
243662,with,0,0
243663,autism,0,0
243664,in,0,0
243665,community,0,1
243666,day-care,0,0
243667,centers,0,0
243668,.,0,1
243669,Thirty-five,0,0
243670,preschool,0,0
243671,children,0,0
243672,with,0,0
243673,a,0,0
243674,DSM,0,0
243675,III-R,0,0
243676,diagnosis,0,0
243677,of,0,1
243678,autism,0,0
243679,or,0,0
243680,pervasive,0,0
243681,developmental,0,1
243682,disorder,0,0
243683,were,0,0
243684,randomized,0,0
243685,to,0,0
243686,an,0,0
243687,experimental,0,0
243688,or,0,0
243689,control,0,0
243690,group,0,0
243691,.,0,1
243692,Children,0,0
243693,in,0,0
243694,the,0,0
243695,experimental,0,0
243696,group,0,0
243697,were,0,0
243698,enrolled,0,0
243699,in,0,0
243700,day,0,0
243701,care,0,0
243702,and,0,0
243703,their,0,1
243704,parents,0,1
243705,and,0,1
243706,child,0,1
243707,care,0,1
243708,workers,0,0
243709,received,0,0
243710,a,0,0
243711,12-week,0,0
243712,intervention,0,0
243713,consisting,0,0
243714,of,0,1
243715,lectures,0,0
243716,and,0,1
243717,on-site,0,0
243718,consultations,0,1
243719,to,0,0
243720,day-care,0,0
243721,centers,0,0
243722,.,0,0
243723,In,0,0
243724,addition,0,0
243725,",",0,1
243726,supportive,0,0
243727,work,0,1
243728,was,0,0
243729,undertaken,0,0
243730,with,0,0
243731,families,0,0
243732,.,0,0
243733,Control,0,0
243734,subjects,0,0
243735,received,0,0
243736,day,0,0
243737,care,0,0
243738,alone,0,0
243739,.,0,0
243740,In,0,0
243741,the,0,0
243742,experimental,0,0
243743,group,0,0
243744,",",0,0
243745,there,0,0
243746,were,0,0
243747,greater,0,0
243748,gains,0,1
243749,in,0,0
243750,language,1,1
243751,abilities,1,1
243752,",",0,0
243753,significant,0,0
243754,increases,0,1
243755,in,0,0
243756,caregivers,1,1
243757,',1,1
243758,knowledge,1,1
243759,about,1,0
243760,autism,1,0
243761,",",0,0
243762,greater,0,1
243763,perception,1,1
243764,of,1,1
243765,control,1,0
243766,on,1,0
243767,the,1,0
243768,part,1,0
243769,of,1,0
243770,mothers,1,0
243771,",",0,1
243772,and,0,1
243773,greater,0,1
243774,parent,1,1
243775,satisfaction,1,1
243776,.,1,0
243777,We,0,0
243778,conclude,0,0
243779,that,0,0
243780,this,0,0
243781,research,0,0
243782,design,0,0
243783,demonstrated,0,0
243784,that,0,0
243785,the,0,0
243786,intervention,0,0
243787,was,0,0
243788,significantly,0,0
243789,superior,0,0
243790,to,0,0
243791,day,0,0
243792,care,0,0
243793,alone,0,0
243794,.,0,0
243795,Accuracy,0,1
243796,and,0,1
243797,feasibility,0,1
243798,of,0,1
243799,contrast,0,0
243800,echocardiography,0,0
243801,for,0,0
243802,detection,0,1
243803,of,0,1
243804,perfusion,0,1
243805,defects,0,1
243806,in,0,0
243807,routine,0,0
243808,practice,0,0
243809,:,0,0
243810,comparison,0,0
243811,with,0,0
243812,wall,0,1
243813,motion,0,1
243814,and,0,1
243815,technetium-99m,0,0
243816,sestamibi,0,0
243817,single-photon,0,0
243818,emission,0,0
243819,computed,0,0
243820,tomography,0,0
243821,.,0,0
243822,The,0,0
243823,Nycomed,0,0
243824,NC100100,0,0
243825,Investigators,0,0
243826,.,0,0
243827,OBJECTIVES,0,0
243828,We,0,0
243829,sought,0,0
243830,to,0,0
243831,assess,0,0
243832,the,0,0
243833,feasibility,0,1
243834,and,0,1
243835,accuracy,0,1
243836,of,0,1
243837,myocardial,0,1
243838,contrast,0,0
243839,echocardiography,0,1
243840,(,0,1
243841,MCE,0,0
243842,),0,0
243843,using,0,0
243844,standard,0,0
243845,imaging,0,0
243846,approaches,0,0
243847,for,0,0
243848,the,0,0
243849,detection,0,1
243850,of,0,0
243851,perfusion,0,1
243852,defects,0,1
243853,in,0,0
243854,patients,0,0
243855,who,0,0
243856,had,0,0
243857,a,0,0
243858,myocardial,0,1
243859,infarction,0,1
243860,(,0,1
243861,MI,0,0
243862,),0,0
243863,.,0,0
243864,BACKGROUND,0,0
243865,Myocardial,0,1
243866,contrast,0,0
243867,echocardiography,0,0
243868,may,0,0
243869,be,0,0
243870,more,0,0
243871,versatile,0,0
243872,than,0,0
243873,perfusion,0,1
243874,scintigraphy,0,1
243875,for,0,0
243876,identifying,0,0
243877,the,0,0
243878,presence,0,0
243879,and,0,1
243880,extent,0,1
243881,of,0,1
243882,perfusion,0,1
243883,defects,0,1
243884,after,0,0
243885,MI,0,0
243886,.,0,0
243887,However,0,0
243888,",",0,0
243889,its,0,0
243890,reliability,0,1
243891,in,0,0
243892,routine,0,0
243893,practice,0,0
243894,is,0,0
243895,unclear,0,0
243896,.,0,0
243897,METHODS,0,0
243898,Fundamental,0,1
243899,or,0,1
243900,harmonic,0,1
243901,MCE,0,0
243902,was,0,0
243903,performed,0,0
243904,with,0,0
243905,continuous,0,0
243906,or,0,0
243907,triggered,0,1
243908,imaging,0,0
243909,in,0,0
243910,203,0,0
243911,patients,0,0
243912,with,0,0
243913,a,0,0
243914,previous,0,0
243915,MI,0,0
243916,using,0,0
243917,bolus,0,0
243918,doses,0,0
243919,of,0,0
243920,a,0,0
243921,perfluorocarbon-filled,0,0
243922,contrast,0,0
243923,agent,0,0
243924,(,0,1
243925,NC100100,0,0
243926,),0,0
243927,.,0,0
243928,All,0,0
243929,patients,0,0
243930,underwent,0,0
243931,single-photon,0,0
243932,emission,0,0
243933,computed,0,0
243934,tomography,0,0
243935,(,0,0
243936,SPECT,0,0
243937,),0,0
243938,after,0,0
243939,the,0,0
243940,injection,0,0
243941,of,0,1
243942,technetium-99m,0,0
243943,(,0,0
243944,Tc-99m,0,0
243945,),0,1
243946,sestamibi,0,0
243947,at,0,0
243948,rest,0,0
243949,.,0,1
243950,Quantitative,0,0
243951,and,0,1
243952,semiquantitative,0,1
243953,SPECT,0,0
243954,",",0,1
243955,wall,0,1
243956,motion,0,1
243957,and,0,1
243958,digitized,0,1
243959,echocardiographic,0,1
243960,data,0,0
243961,were,0,0
243962,interpreted,0,0
243963,independently,0,0
243964,.,0,0
243965,The,0,0
243966,accuracy,0,1
243967,of,0,1
243968,MCE,0,0
243969,was,0,0
243970,assessed,0,0
243971,for,0,0
243972,detection,0,1
243973,of,0,1
243974,segments,0,1
243975,and,0,1
243976,patients,0,0
243977,with,0,0
243978,moderate,0,0
243979,and,0,1
243980,severe,0,1
243981,sestamibi-SPECT,0,1
243982,defects,0,1
243983,",",0,0
243984,as,0,0
243985,well,0,0
243986,as,0,0
243987,for,0,0
243988,detection,0,1
243989,of,0,0
243990,patients,0,0
243991,with,0,0
243992,extensive,0,0
243993,perfusion,0,1
243994,defects,0,0
243995,(,0,0
243996,>,0,0
243997,12,0,0
243998,%,0,0
243999,of,0,0
244000,left,0,1
244001,ventricle,0,1
244002,),0,0
244003,.,0,0
244004,RESULTS,0,0
244005,In,0,0
244006,segments,0,0
244007,with,0,0
244008,diagnostic,0,1
244009,MCE,0,0
244010,",",0,0
244011,the,0,0
244012,segmental,1,1
244013,sensitivity,1,1
244014,ranged,0,0
244015,from,0,0
244016,14,0,0
244017,%,0,0
244018,to,0,0
244019,65,0,0
244020,%,0,0
244021,",",0,0
244022,and,0,1
244023,the,0,0
244024,specificity,1,1
244025,varied,0,0
244026,from,0,0
244027,78,0,0
244028,%,0,0
244029,to,0,0
244030,95,0,0
244031,%,0,0
244032,",",0,0
244033,depending,0,0
244034,on,0,0
244035,the,0,0
244036,dose,0,0
244037,of,0,1
244038,contrast,0,0
244039,agent,0,0
244040,.,0,0
244041,Using,0,0
244042,both,0,0
244043,segment-,0,0
244044,and,0,1
244045,patient-based,0,1
244046,analysis,0,0
244047,",",0,0
244048,the,0,0
244049,greatest,0,1
244050,accuracy,0,1
244051,and,0,1
244052,proportion,0,1
244053,of,0,1
244054,interpretable,0,1
244055,images,0,0
244056,were,0,0
244057,obtained,0,0
244058,using,0,0
244059,harmonic,0,0
244060,imaging,0,0
244061,in,0,0
244062,the,0,0
244063,triggered,0,0
244064,mode,0,0
244065,.,0,0
244066,For,0,0
244067,the,0,0
244068,detection,0,1
244069,of,0,0
244070,extensive,0,0
244071,defects,0,0
244072,",",0,0
244073,the,0,0
244074,sensitivity,1,1
244075,varied,0,0
244076,from,0,0
244077,13,0,0
244078,%,0,0
244079,to,0,0
244080,48,0,0
244081,%,0,0
244082,",",0,0
244083,with,0,0
244084,specificity,0,1
244085,from,0,0
244086,63,0,0
244087,%,0,0
244088,to,0,0
244089,100,0,0
244090,%,0,0
244091,.,0,0
244092,Harmonic,0,1
244093,imaging,0,0
244094,remained,0,0
244095,the,0,0
244096,most,0,0
244097,accurate,0,0
244098,approach,0,0
244099,.,0,0
244100,Time,1,0
244101,since,1,0
244102,MI,1,0
244103,and,1,0
244104,SPECT,1,0
244105,defect,1,1
244106,location,1,1
244107,and,1,1
244108,intensity,1,1
244109,were,0,0
244110,all,0,0
244111,determinants,0,0
244112,of,0,0
244113,the,0,0
244114,MCE,0,0
244115,response,0,1
244116,.,0,0
244117,The,0,0
244118,extent,1,0
244119,of,1,0
244120,defects,1,0
244121,on,1,0
244122,MCE,1,0
244123,was,0,0
244124,less,0,0
244125,than,0,0
244126,the,0,0
244127,extent,0,0
244128,of,0,0
244129,either,0,0
244130,abnormal,0,1
244131,wall,0,1
244132,motion,0,1
244133,or,0,1
244134,SPECT,0,0
244135,abnormalities,0,1
244136,.,0,0
244137,The,0,0
244138,combination,0,0
244139,of,0,0
244140,wall,0,1
244141,motion,0,1
244142,and,0,1
244143,MCE,0,0
244144,assessment,0,1
244145,gave,0,0
244146,the,0,0
244147,best,0,0
244148,balance,0,1
244149,of,0,1
244150,sensitivity,0,1
244151,(,0,0
244152,46,0,0
244153,%,0,0
244154,to,0,0
244155,55,0,0
244156,%,0,0
244157,),0,0
244158,and,0,1
244159,specificity,0,1
244160,(,0,0
244161,82,0,0
244162,%,0,0
244163,to,0,0
244164,83,0,0
244165,%,0,0
244166,),0,0
244167,.,0,0
244168,CONCLUSIONS,0,0
244169,Although,0,0
244170,MCE,0,0
244171,is,0,0
244172,specific,0,0
244173,",",0,0
244174,it,0,0
244175,has,0,0
244176,limited,0,0
244177,sensitivity,0,1
244178,for,0,0
244179,detection,0,1
244180,of,0,1
244181,moderate,1,0
244182,or,1,0
244183,severe,1,1
244184,perfusion,1,1
244185,defects,1,1
244186,",",0,0
244187,and,0,0
244188,it,0,0
244189,underestimates,0,0
244190,the,0,0
244191,extent,0,0
244192,of,0,0
244193,SPECT,1,0
244194,defects,1,0
244195,.,0,0
244196,The,0,0
244197,best,0,0
244198,results,0,0
244199,are,0,0
244200,obtained,0,0
244201,by,0,0
244202,integration,0,0
244203,with,0,0
244204,wall,0,1
244205,motion,0,1
244206,.,0,0
244207,More,0,0
244208,sophisticated,0,0
244209,methods,0,0
244210,of,0,1
244211,acquisition,0,1
244212,and,0,0
244213,interpretation,0,0
244214,are,0,0
244215,needed,0,0
244216,to,0,0
244217,enhance,0,0
244218,the,0,0
244219,feasibility,0,0
244220,of,0,0
244221,this,0,0
244222,technique,0,0
244223,in,0,0
244224,routine,0,0
244225,practice,0,0
244226,.,0,0
244227,Yohimbine,0,0
244228,in,0,0
244229,neurally,0,0
244230,mediated,0,0
244231,syncope,0,1
244232,.,0,0
244233,Pathophysiological,0,0
244234,implications,0,0
244235,.,0,0
244236,In,0,0
244237,this,0,0
244238,study,0,0
244239,",",0,0
244240,we,0,0
244241,evaluated,0,0
244242,if,0,0
244243,increased,0,0
244244,sympathetic,0,0
244245,stimulation,0,0
244246,is,0,0
244247,an,0,0
244248,essential,0,0
244249,requirement,0,1
244250,for,0,0
244251,the,0,0
244252,development,0,0
244253,of,0,0
244254,neurally,0,0
244255,mediated,0,0
244256,syncope,0,1
244257,(,0,0
244258,NMS,0,1
244259,),0,0
244260,by,0,0
244261,manipulating,0,0
244262,overall,0,1
244263,sympathetic,0,1
244264,outflow,0,1
244265,in,0,0
244266,subjects,0,0
244267,susceptible,0,0
244268,to,0,0
244269,tilt-induced,0,0
244270,syncope,0,1
244271,.,0,0
244272,Eight,0,1
244273,previously,0,0
244274,characterized,0,0
244275,patients,0,0
244276,with,0,0
244277,recurrent,0,1
244278,NMS,0,1
244279,(,0,0
244280,five,0,0
244281,females,0,0
244282,and,0,0
244283,three,0,0
244284,males,0,0
244285,;,0,0
244286,34+/-2,0,0
244287,yr,0,0
244288,),0,1
244289,were,0,0
244290,recruited,0,0
244291,from,0,0
244292,the,0,0
244293,Vanderbilt,0,0
244294,Syncope,0,0
244295,Unit,0,0
244296,and,0,0
244297,eight,0,0
244298,age-matched,0,0
244299,controls,0,0
244300,underwent,0,0
244301,initial,0,0
244302,administration,0,0
244303,of,0,1
244304,clonidine,0,0
244305,(,0,1
244306,CLO,0,0
244307,),0,1
244308,or,0,1
244309,yohimbine,0,0
244310,(,0,1
244311,YHO,0,1
244312,),0,0
244313,.,0,0
244314,This,0,0
244315,was,0,0
244316,done,0,0
244317,",",0,0
244318,prospectively,0,0
244319,",",0,0
244320,to,0,0
244321,determine,0,0
244322,doses,0,0
244323,of,0,0
244324,these,0,0
244325,agents,0,0
244326,that,0,0
244327,would,0,0
244328,increase,0,0
244329,or,0,0
244330,decrease,0,1
244331,plasma,1,1
244332,norepinephrine,1,1
244333,levels,1,1
244334,by,0,0
244335,>,0,0
244336,/=,0,0
244337,30,0,0
244338,%,0,0
244339,.,0,0
244340,On,0,0
244341,a,0,0
244342,different,0,0
244343,day,0,0
244344,",",0,0
244345,in,0,0
244346,all,0,0
244347,subjects,0,0
244348,we,0,0
244349,determined,0,0
244350,intraarterial,1,0
244351,blood,1,1
244352,pressure,1,1
244353,",",1,1
244354,EKG,1,1
244355,and,1,1
244356,muscle,1,1
244357,sympathetic,1,1
244358,nerve,1,1
244359,activity,1,1
244360,(,1,1
244361,MSNA,1,1
244362,),1,0
244363,both,0,0
244364,supine,0,1
244365,and,0,0
244366,during,0,0
244367,upright,0,0
244368,tilt,0,1
244369,.,0,0
244370,After,0,0
244371,this,0,0
244372,",",0,0
244373,subjects,0,0
244374,randomly,0,0
244375,received,0,0
244376,either,0,0
244377,CLO,0,0
244378,or,0,1
244379,YHO,0,1
244380,",",0,1
244381,and,0,0
244382,3,0,0
244383,h,0,0
244384,later,0,0
244385,another,0,0
244386,tilt,0,1
244387,was,0,0
244388,performed,0,0
244389,.,0,0
244390,After,0,0
244391,1,0,0
244392,wk,0,0
244393,",",0,0
244394,a,0,0
244395,similar,0,0
244396,procedure,0,0
244397,with,0,0
244398,the,0,0
244399,other,0,0
244400,drug,0,0
244401,was,0,0
244402,performed,0,0
244403,.,0,0
244404,During,0,0
244405,the,0,0
244406,two,0,0
244407,basal,0,0
244408,tilts,0,1
244409,",",0,0
244410,all,0,0
244411,the,0,0
244412,control,0,0
244413,subjects,0,0
244414,completed,0,0
244415,the,0,0
244416,study,0,0
244417,",",0,0
244418,whereas,0,0
244419,all,0,0
244420,the,0,0
244421,NMS,0,1
244422,patients,0,0
244423,developed,0,0
244424,syncope,0,1
244425,.,0,1
244426,Reduction,1,1
244427,in,1,0
244428,sympathetic,1,1
244429,tone,1,1
244430,by,0,0
244431,CLO,0,0
244432,resulted,0,0
244433,in,0,0
244434,a,0,0
244435,decreased,0,0
244436,tolerance,1,1
244437,to,1,0
244438,tilt,1,1
244439,in,0,0
244440,three,0,0
244441,out,0,0
244442,of,0,0
244443,eight,0,0
244444,controls,0,0
244445,and,0,0
244446,in,0,0
244447,all,0,0
244448,the,0,0
244449,NMS,0,0
244450,patients,0,0
244451,.,0,0
244452,In,0,0
244453,contrast,0,0
244454,",",0,1
244455,YHO,0,1
244456,not,0,0
244457,only,0,0
244458,increased,0,0
244459,basal,1,1
244460,plasma,1,1
244461,NorEpi,1,1
244462,levels,1,1
244463,and,1,1
244464,MSNA,1,1
244465,",",0,1
244466,but,0,0
244467,also,0,0
244468,prevented,0,0
244469,syncope,1,1
244470,in,0,0
244471,seven,0,0
244472,out,0,0
244473,of,0,0
244474,eight,0,0
244475,patients,0,0
244476,.,0,0
244477,In,0,0
244478,a,0,0
244479,selected,0,0
244480,population,0,0
244481,of,0,1
244482,patients,0,0
244483,",",0,0
244484,increased,0,1
244485,sympathetic,1,1
244486,activity,1,1
244487,is,0,0
244488,not,0,0
244489,a,0,0
244490,prerequisite,0,0
244491,for,0,0
244492,the,0,0
244493,development,0,1
244494,of,0,0
244495,syncope,0,1
244496,.,0,0
244497,Yohimbine-induced,0,1
244498,enhancement,0,1
244499,of,0,1
244500,sympathetic,0,1
244501,tone,0,1
244502,in,0,0
244503,patients,0,0
244504,with,0,0
244505,NMS,0,0
244506,improves,0,1
244507,orthostatic,0,1
244508,tolerance,0,1
244509,and,0,0
244510,raises,0,0
244511,the,0,0
244512,possibility,0,0
244513,that,0,0
244514,this,0,0
244515,drug,0,0
244516,may,0,0
244517,be,0,0
244518,a,0,0
244519,useful,0,0
244520,agent,0,0
244521,in,0,0
244522,the,0,0
244523,treatment,0,0
244524,of,0,0
244525,NMS,0,0
244526,.,0,0
244527,Concurrent,0,0
244528,administration,0,0
244529,of,0,1
244530,donepezil,0,0
244531,HCl,0,1
244532,and,0,0
244533,digoxin,0,1
244534,:,0,0
244535,assessment,0,0
244536,of,0,0
244537,pharmacokinetic,0,1
244538,changes,0,1
244539,.,0,0
244540,AIM,0,0
244541,The,0,0
244542,aim,0,0
244543,of,0,0
244544,this,0,0
244545,study,0,0
244546,was,0,0
244547,to,0,0
244548,examine,0,0
244549,the,0,0
244550,pharmacokinetics,0,0
244551,of,0,0
244552,donepezil,0,0
244553,HCl,0,1
244554,and,0,1
244555,digoxin,0,1
244556,separately,0,0
244557,",",0,0
244558,and,0,1
244559,in,0,1
244560,combination,0,0
244561,",",0,0
244562,following,0,0
244563,administration,0,0
244564,of,0,0
244565,single,0,0
244566,oral,0,0
244567,doses,0,0
244568,.,0,0
244569,Changes,0,1
244570,in,0,0
244571,cardiac,0,1
244572,conduction,0,1
244573,parameters,0,1
244574,following,0,0
244575,drug,0,0
244576,administration,0,0
244577,were,0,0
244578,also,0,0
244579,assessed,0,0
244580,.,0,0
244581,METHODS,0,0
244582,This,0,0
244583,was,0,0
244584,an,0,0
244585,open-label,0,0
244586,",",0,0
244587,randomized,0,0
244588,",",0,0
244589,three-period,0,0
244590,crossover,0,0
244591,study,0,0
244592,in,0,0
244593,healthy,0,0
244594,male,0,0
244595,volunteers,0,0
244596,(,0,1
244597,n=12,0,0
244598,),0,0
244599,.,0,0
244600,During,0,0
244601,each,0,0
244602,treatment,0,0
244603,period,0,0
244604,",",0,0
244605,subjects,0,0
244606,received,0,0
244607,a,0,0
244608,single,0,0
244609,dose,0,0
244610,of,0,1
244611,either,0,0
244612,donepezil,0,0
244613,HCl,0,1
244614,(,0,0
244615,5,0,0
244616,mg,0,0
244617,),0,0
244618,",",0,1
244619,digoxin,0,1
244620,(,0,0
244621,0.25,0,0
244622,mg,0,0
244623,),0,0
244624,",",0,0
244625,or,0,0
244626,a,0,0
244627,combination,0,0
244628,of,0,0
244629,both,0,0
244630,drugs,0,0
244631,.,0,0
244632,Each,0,0
244633,treatment,0,0
244634,period,0,0
244635,was,0,0
244636,followed,0,0
244637,by,0,0
244638,a,0,0
244639,2-week,0,0
244640,",",0,0
244641,drug-free,0,1
244642,washout,0,0
244643,period,0,0
244644,.,0,0
244645,RESULTS,0,0
244646,All,0,0
244647,12,0,0
244648,volunteers,0,0
244649,completed,0,0
244650,the,0,0
244651,study,0,0
244652,without,0,0
244653,incident,0,1
244654,.,0,0
244655,No,0,0
244656,statistically,0,0
244657,significant,0,0
244658,differences,0,0
244659,in,0,0
244660,donepezil,1,0
244661,pharmacokinetics,1,1
244662,(,1,1
244663,Cmax,1,1
244664,",",1,1
244665,tmax,1,0
244666,",",1,1
244667,AUC,1,1
244668,(,1,1
244669,0-120,1,0
244670,),1,1
244671,",",1,1
244672,AUC,1,1
244673,(,1,1
244674,0-infinity,1,1
244675,),1,1
244676,or,0,1
244677,t1/2,0,1
244678,),0,1
244679,were,0,0
244680,observed,0,0
244681,when,0,0
244682,donepezil,0,0
244683,administered,0,0
244684,alone,0,0
244685,was,0,0
244686,compared,0,0
244687,with,0,0
244688,donepezil,0,0
244689,administered,0,0
244690,in,0,0
244691,combination,0,0
244692,with,0,0
244693,digoxin,0,0
244694,.,0,0
244695,Similarly,0,0
244696,",",0,0
244697,no,0,0
244698,statistically,0,0
244699,significant,0,0
244700,differences,0,0
244701,in,0,0
244702,digoxin,0,1
244703,pharmacokinetics,0,1
244704,were,0,0
244705,observed,0,0
244706,when,0,0
244707,digoxin,0,0
244708,was,0,0
244709,administered,0,0
244710,alone,0,0
244711,or,0,0
244712,in,0,0
244713,combination,0,0
244714,with,0,0
244715,donepezil,0,0
244716,.,0,0
244717,No,0,0
244718,clinically,0,0
244719,relevant,0,0
244720,changes,0,1
244721,in,0,0
244722,cardiac,1,1
244723,conduction,1,1
244724,(,0,0
244725,lead,0,0
244726,II,0,0
244727,ECG,0,1
244728,),0,1
244729,were,0,0
244730,observed,0,0
244731,in,0,0
244732,any,0,0
244733,subject,0,0
244734,during,0,0
244735,any,0,0
244736,treatment,0,0
244737,period,0,0
244738,.,0,1
244739,CONCLUSIONS,0,0
244740,Co-administration,0,0
244741,of,0,1
244742,single,0,0
244743,doses,0,0
244744,of,0,0
244745,donepezil,0,0
244746,HCl,0,1
244747,(,0,0
244748,5,0,0
244749,mg,0,0
244750,),0,0
244751,and,0,1
244752,digoxin,0,1
244753,(,0,0
244754,0.25,0,0
244755,mg,0,0
244756,),0,0
244757,produced,0,0
244758,no,0,0
244759,changes,0,1
244760,in,0,0
244761,the,0,0
244762,pharmacokinetic,0,1
244763,profile,0,1
244764,of,0,0
244765,either,0,0
244766,drug,0,0
244767,.,0,0
244768,In,0,0
244769,addition,0,0
244770,",",0,1
244771,co-administration,0,0
244772,produced,0,0
244773,no,0,0
244774,changes,0,1
244775,in,0,0
244776,cardiac,0,1
244777,conduction,0,1
244778,parameters,0,1
244779,during,0,0
244780,the,0,0
244781,24,0,0
244782,h,0,0
244783,of,0,0
244784,telemetry,0,0
244785,monitoring,0,0
244786,following,0,0
244787,drug,0,0
244788,administration,0,0
244789,.,0,0
244790,Ten-year,0,0
244791,results,0,0
244792,of,0,0
244793,a,0,0
244794,randomised,0,0
244795,trial,0,0
244796,comparing,0,0
244797,cisplatin,0,0
244798,with,0,0
244799,cisplatin,0,0
244800,and,0,1
244801,cyclophosphamide,0,0
244802,in,0,0
244803,advanced,0,0
244804,",",0,0
244805,suboptimally,0,0
244806,debulked,0,0
244807,ovarian,0,1
244808,cancer,0,0
244809,.,0,0
244810,176,0,0
244811,eligible,0,0
244812,patients,0,0
244813,with,0,0
244814,advanced,0,0
244815,suboptimally,0,0
244816,operated,0,0
244817,ovarian,0,1
244818,carcinoma,0,0
244819,were,0,0
244820,randomly,0,0
244821,allocated,0,0
244822,to,0,0
244823,receive,0,0
244824,either,0,0
244825,cisplatin,0,0
244826,75,0,0
244827,mg/m2,0,0
244828,or,0,0
244829,cisplatin,0,0
244830,50,0,0
244831,mg/m2,0,0
244832,and,0,0
244833,cyclophosphamide,0,0
244834,500,0,0
244835,mg/m2,0,0
244836,(,0,0
244837,CP,0,0
244838,),0,0
244839,every,0,0
244840,28,0,0
244841,days,0,0
244842,for,0,0
244843,six,0,0
244844,courses,0,0
244845,.,0,0
244846,The,0,0
244847,overall,1,1
244848,clinical,1,0
244849,response,1,1
244850,rates,1,1
244851,(,1,0
244852,complete,1,1
244853,response,0,1
244854,plus,0,0
244855,partial,0,1
244856,response,0,1
244857,),0,0
244858,were,0,0
244859,52,0,0
244860,and,0,0
244861,63,0,0
244862,%,0,0
244863,for,0,0
244864,CP,0,1
244865,and,0,1
244866,cisplatin,0,0
244867,",",0,1
244868,respectively,0,0
244869,(,0,0
244870,non-significant,0,1
244871,),0,0
244872,.,0,0
244873,Including,0,0
244874,results,0,0
244875,obtained,0,0
244876,by,0,0
244877,second-look,0,0
244878,laparotomy,0,0
244879,",",0,0
244880,we,0,0
244881,did,0,0
244882,not,0,0
244883,observe,0,0
244884,a,0,0
244885,statistically,0,0
244886,significant,0,0
244887,difference,0,0
244888,in,0,0
244889,response,0,1
244890,rates,0,1
244891,in,0,0
244892,the,0,0
244893,two,0,0
244894,treatment,0,0
244895,groups,0,0
244896,.,0,0
244897,Median,1,1
244898,progression-free,1,1
244899,survival,1,1
244900,was,0,0
244901,10,0,0
244902,and,0,0
244903,11.9,0,0
244904,months,0,0
244905,for,0,0
244906,CP,0,0
244907,and,0,1
244908,cisplatin,0,0
244909,",",0,1
244910,respectively,0,0
244911,(,0,0
244912,non-significant,0,1
244913,),0,0
244914,.,0,0
244915,No,0,0
244916,significant,0,0
244917,difference,0,0
244918,was,0,0
244919,observed,0,0
244920,in,0,0
244921,overall,1,1
244922,survival,1,1
244923,",",0,0
244924,with,0,0
244925,a,0,0
244926,median,0,0
244927,of,0,0
244928,19.4,0,0
244929,and,0,0
244930,21.5,0,0
244931,months,0,0
244932,for,0,0
244933,CP,0,0
244934,and,0,1
244935,cisplatin,0,0
244936,",",0,0
244937,respectively,0,0
244938,.,0,0
244939,Thirty-seven,0,0
244940,platinum-resistant,0,0
244941,and,0,0
244942,27,0,0
244943,platinum-sensitive,0,0
244944,tumours,0,0
244945,were,0,0
244946,treated,0,0
244947,with,0,0
244948,carboplatin,0,0
244949,or,0,1
244950,cisplatin,0,0
244951,as,0,0
244952,second-line,0,0
244953,therapy,0,0
244954,.,0,0
244955,Response,1,0
244956,rates,1,1
244957,to,0,0
244958,platinum,0,0
244959,second-line,0,0
244960,therapy,0,0
244961,were,0,0
244962,6,0,0
244963,and,0,0
244964,50,0,0
244965,%,0,0
244966,for,0,0
244967,resistant,0,1
244968,and,0,1
244969,sensitive,0,0
244970,tumours,0,0
244971,",",0,0
244972,respectively,0,0
244973,(,0,0
244974,P,0,0
244975,<,0,0
244976,0.001,0,0
244977,),0,0
244978,.,0,0
244979,This,0,0
244980,difference,0,0
244981,in,0,0
244982,response,1,1
244983,rate,1,1
244984,was,0,0
244985,also,0,0
244986,confirmed,0,0
244987,by,0,0
244988,survival,0,1
244989,analysis,0,0
244990,.,0,0
244991,Patients,0,0
244992,with,0,0
244993,platinum-sensitive,0,0
244994,tumours,0,0
244995,survived,0,0
244996,longer,0,0
244997,when,0,0
244998,they,0,0
244999,were,0,0
245000,treated,0,0
245001,with,0,0
245002,platinum-containing,0,0
245003,chemotherapy,0,0
245004,(,0,0
245005,P,0,0
245006,=,0,0
245007,0.005,0,0
245008,),0,0
245009,.,0,0
245010,Median,1,1
245011,survival,1,1
245012,was,0,0
245013,22.8,0,0
245014,and,0,0
245015,8.5,0,0
245016,months,0,0
245017,after,0,0
245018,initiation,0,0
245019,of,0,1
245020,second-line,0,0
245021,treatment,0,0
245022,for,0,0
245023,the,0,0
245024,platinum-containing,0,0
245025,and,0,0
245026,platinum-free,0,0
245027,regimens,0,0
245028,",",0,0
245029,respectively,0,0
245030,.,0,0
245031,In,0,0
245032,summary,0,0
245033,",",0,0
245034,we,0,0
245035,observed,0,0
245036,in,0,0
245037,suboptimally,0,0
245038,operated,0,0
245039,ovarian,0,1
245040,carcinoma,0,0
245041,patients,0,0
245042,similar,0,0
245043,response,1,1
245044,rates,1,1
245045,",",1,1
245046,progression-free,1,1
245047,interval,1,1
245048,",",1,1
245049,and,1,1
245050,overall,1,1
245051,survival,1,1
245052,for,0,0
245053,equitoxic,0,1
245054,cisplatin,0,0
245055,and,0,1
245056,CP,0,0
245057,.,0,1
245058,However,0,0
245059,",",0,0
245060,the,0,0
245061,doses,0,0
245062,of,0,1
245063,cisplatin,0,0
245064,and,0,1
245065,cyclophosphamide,0,0
245066,chosen,0,0
245067,were,0,0
245068,substantially,0,0
245069,lower,0,0
245070,than,0,0
245071,current,0,0
245072,standard,0,0
245073,doses,0,0
245074,of,0,0
245075,CP,0,0
245076,.,0,0
245077,Our,0,0
245078,study,0,0
245079,demonstrates,0,0
245080,",",0,0
245081,therefore,0,0
245082,",",0,0
245083,that,0,0
245084,a,0,0
245085,suboptimal,0,0
245086,dose,0,0
245087,of,0,0
245088,CP,0,0
245089,is,0,0
245090,as,0,0
245091,effective,0,0
245092,as,0,0
245093,optimal,0,1
245094,dose,0,0
245095,monotherapy,0,0
245096,cisplatin,0,0
245097,.,0,0
245098,Patients,0,0
245099,with,0,0
245100,recurrences,0,1
245101,considered,0,0
245102,as,0,0
245103,platinum-sensitive,0,0
245104,had,0,0
245105,a,0,0
245106,significantly,0,0
245107,higher,0,0
245108,response,1,1
245109,rate,1,1
245110,and,0,1
245111,improved,0,1
245112,survival,1,1
245113,when,0,0
245114,retreated,0,0
245115,with,0,0
245116,platinum-containing,0,0
245117,therapy,0,0
245118,.,0,0
245119,The,0,0
245120,preparation,0,0
245121,of,0,0
245122,patients,0,0
245123,for,0,0
245124,cardiac,0,1
245125,surgery,0,0
245126,.,0,0
245127,This,0,0
245128,study,0,0
245129,examines,0,0
245130,the,0,0
245131,impact,0,0
245132,of,0,0
245133,a,0,0
245134,preadmission,0,1
245135,telephone,0,0
245136,intervention,0,0
245137,on,0,0
245138,anxiety,1,1
245139,",",1,1
245140,knowledge,1,1
245141,",",1,1
245142,and,1,1
245143,readiness,1,1
245144,for,1,0
245145,discharge,1,1
245146,for,0,0
245147,patients,0,0
245148,attending,0,0
245149,a,0,0
245150,preadmission,0,1
245151,teaching,0,0
245152,program,0,0
245153,prior,0,0
245154,to,0,0
245155,cardiac,0,1
245156,surgery,0,0
245157,.,0,0
245158,The,0,0
245159,primary,0,0
245160,goal,0,0
245161,of,0,0
245162,the,0,0
245163,telephone,0,0
245164,intervention,0,0
245165,was,0,0
245166,to,0,0
245167,provide,0,0
245168,support,0,0
245169,by,0,0
245170,giving,0,1
245171,additional,0,0
245172,information,0,1
245173,about,0,0
245174,individual,0,0
245175,concerns,0,0
245176,.,0,0
245177,The,0,0
245178,telephone,0,0
245179,intervention,0,0
245180,did,0,0
245181,not,0,0
245182,have,0,0
245183,an,0,0
245184,effect,0,0
245185,on,0,0
245186,anxiety,1,1
245187,and,1,1
245188,knowledge,1,1
245189,.,1,0
245190,A,0,0
245191,significantly,0,0
245192,higher,0,0
245193,level,1,1
245194,of,1,1
245195,anxiety,1,1
245196,was,0,0
245197,found,0,0
245198,in,0,0
245199,the,0,0
245200,experimental,0,0
245201,group,0,0
245202,on,0,0
245203,admission,0,1
245204,",",0,0
245205,but,0,0
245206,this,0,0
245207,difference,0,0
245208,became,0,0
245209,nonsignificant,0,1
245210,when,0,0
245211,baseline,0,1
245212,level,0,1
245213,and,0,1
245214,length,0,1
245215,of,0,1
245216,waiting,0,1
245217,time,0,1
245218,were,0,0
245219,entered,0,0
245220,as,0,0
245221,covariates,0,0
245222,.,0,0
245223,The,0,0
245224,more,0,0
245225,anxious,0,1
245226,group,0,0
245227,rated,0,1
245228,their,0,0
245229,perceived,1,1
245230,knowledge,1,1
245231,level,0,1
245232,lower,0,1
245233,",",0,0
245234,despite,0,0
245235,the,0,0
245236,fact,0,0
245237,that,0,0
245238,both,0,0
245239,groups,0,0
245240,had,0,0
245241,similar,0,0
245242,scores,1,1
245243,in,1,0
245244,actual,1,1
245245,knowledge,1,1
245246,.,1,0
245247,Given,0,0
245248,the,0,0
245249,potential,0,0
245250,barrier,0,1
245251,that,0,0
245252,anxiety,0,1
245253,can,0,0
245254,pose,0,0
245255,for,0,0
245256,patient,0,1
245257,learning,0,1
245258,",",0,0
245259,nurses,0,0
245260,need,0,0
245261,to,0,0
245262,adapt,0,0
245263,their,0,0
245264,interventions,0,0
245265,to,0,0
245266,deal,0,0
245267,with,0,0
245268,the,0,0
245269,patients,0,0
245270,',0,1
245271,feelings,0,1
245272,of,0,0
245273,anxiety,1,1
245274,that,0,0
245275,accompany,0,0
245276,cardiac,0,1
245277,surgery,0,0
245278,to,0,0
245279,make,0,0
245280,the,0,0
245281,learning,0,1
245282,process,0,0
245283,effective,0,1
245284,.,0,0
